PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Koob, M; Viola, A; Le Fur, Y; Viout, P; Ratiney, H; Confort-Gouny, S; Cozzone, PJ; Girard, N				Koob, Meriam; Viola, Angele; Le Fur, Yann; Viout, Patrick; Ratiney, Helene; Confort-Gouny, Sylviane; Cozzone, Patrick J.; Girard, Nadine			Creatine, Glutamine plus Glutamate, and Macromolecules Are Decreased in the Central White Matter of Premature Neonates around Term	PLOS ONE			English	Article							MAGNETIC-RESONANCE-SPECTROSCOPY; CENTRAL-NERVOUS-SYSTEM; EXTREMELY PRETERM INFANTS; PROTON MR SPECTROSCOPY; T-2 RELAXATION-TIMES; BRAIN IN-VIVO; EQUIVALENT AGE; CEREBRAL METABOLITES; LANGUAGE-DEVELOPMENT; DEFICIENCY SYNDROMES	Preterm birth represents a high risk of neurodevelopmental disabilities when associated with white-matter damage. Recent studies have reported cognitive deficits in children born preterm without brain injury on MRI at term-equivalent age. Understanding the microstructural and metabolic underpinnings of these deficits is essential for their early detection. Here, we used diffusion-weighted imaging and single-voxel H-1 magnetic resonance spectroscopy (MRS) to compare brain maturation at term-equivalent age in premature neonates with no evidence of white matter injury on conventional MRI except diffuse excessive highsignal intensity, and normal term neonates. Thirty-two infants, 16 term neonates (mean post-conceptional age at scan: 39.8 +/- 1 weeks) and 16 premature neonates (mean gestational age at birth: 29.1 +/- 2 weeks, mean post-conceptional age at scan: 39.2 +/- 1 weeks) were investigated. The MRI/MRS protocol performed at 1.5T involved diffusion-weighted MRI and localized H-1-MRS with the Point RESolved Spectroscopy (PRESS) sequence. Preterm neonates showed significantly higher ADC values in the temporal white matter (P<0.05), the occipital white matter (P<0.005) and the thalamus (P<0.05). The proton spectrum of the centrum semiovale was characterized by significantly lower taurine/H2O and macromolecules/ H2O ratios (P<0.05) at a TE of 30 ms, and reduced (creatine+phosphocreatine)/H2O and (glutamine+ glutamate)/H2O ratios (P<0.05) at a TE of 135 ms in the preterm neonates than in full-term neonates. Our findings indicate that premature neonates with normal conventional MRI present a delay in brain maturation affecting the white matter and the thalamus. Their brain metabolic profile is characterized by lower levels of creatine, glutamine plus glutamate, and macromolecules in the centrum semiovale, a finding suggesting altered energy metabolism and protein synthesis.	[Koob, Meriam; Girard, Nadine] Aix Marseille Univ, AP HM Timone, Serv Neuroradiol, Marseille, France; [Koob, Meriam] CHU Strasbourg, Hop Hautepierre, Serv Radiopediat Imagerie 2, Strasbourg, France; [Koob, Meriam] Univ Strasbourg, CNRS, Lab ICube, UMR 7357,FMTS, Strasbourg, France; [Viola, Angele; Le Fur, Yann; Viout, Patrick; Confort-Gouny, Sylviane; Cozzone, Patrick J.; Girard, Nadine] Aix Marseille Univ, CNRS, Ctr Resonance Magnet Biol & Med, Fac Med Timone,UMR 7339, Marseille, France; [Ratiney, Helene] Univ Lyon 1, INSA Lyon, Lab CREATIS, CNRS UMR 5220,Inserm U1044, Lyon, France	UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National des Sciences Appliquees de Lyon - INSA Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Girard, N (corresponding author), Aix Marseille Univ, AP HM Timone, Serv Neuroradiol, Marseille, France.; Viola, A; Girard, N (corresponding author), Aix Marseille Univ, CNRS, Ctr Resonance Magnet Biol & Med, Fac Med Timone,UMR 7339, Marseille, France.	angele.viola@univ-amu.fr; Nadine.girard@ap-hm.fr	, Girard/E-8537-2013; Ratiney, Helene/K-9503-2019; Ratiney, Helene/H-4186-2014; Girard, Nadine/B-7109-2017	, Girard/0000-0001-8639-9275; Ratiney, Helene/0000-0002-0662-2172; Ratiney, Helene/0000-0002-0662-2172; 				Aeby A, 2013, NEUROIMAGE, V78, P145, DOI 10.1016/j.neuroimage.2013.03.076; Andres RH, 2008, BRAIN RES BULL, V76, P329, DOI 10.1016/j.brainresbull.2008.02.035; Anjari M, 2007, NEUROIMAGE, V35, P1021, DOI 10.1016/j.neuroimage.2007.01.035; Back SA, 2007, STROKE, V38, P724, DOI 10.1161/01.STR.0000254729.27386.05; Ball G, 2013, CORTEX, V49, P1711, DOI 10.1016/j.cortex.2012.07.006; Bapat R, 2014, PEDIATR NEUROL, V51, P53, DOI 10.1016/j.pediatrneurol.2014.03.011; Beard E, 2010, J NEUROCHEM, V115, P297, DOI 10.1111/j.1471-4159.2010.06935.x; BEHAR KL, 1993, MAGNET RESON MED, V30, P38, DOI 10.1002/mrm.1910300107; BEHAR KL, 1994, MAGNET RESON MED, V32, P294, DOI 10.1002/mrm.1910320304; Bianchi MC, 2007, AM J NEURORADIOL, V28, P548; Bluml S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085829; Braissant O, 2005, BMC DEV BIOL, V5, DOI 10.1186/1471-213X-5-9; Braissant O, 2012, J INHERIT METAB DIS, V35, P655, DOI 10.1007/s10545-011-9433-2; Braissant O, 2011, AMINO ACIDS, V40, P1315, DOI 10.1007/s00726-011-0852-z; Braissant O, 2010, NEUROBIOL DIS, V37, P423, DOI 10.1016/j.nbd.2009.10.022; Brand A, 1998, J NEUROCHEM, V71, P827; Brekke E, 2015, NEUROCHEM INT, V82, P33, DOI 10.1016/j.neuint.2015.02.002; Choi CH, 2006, MAGN RESON MED, V56, P971, DOI 10.1002/mrm.21055; Constable RT, 2008, PEDIATRICS, V121, P306, DOI 10.1542/peds.2007-0414; de Graaf-Peters VB, 2006, EARLY HUM DEV, V82, P257, DOI 10.1016/j.earlhumdev.2005.10.013; Fulford J, 2009, SEMIN PERINATOL, V33, P281, DOI 10.1053/j.semperi.2009.04.006; Girard N, 2006, EUR J RADIOL, V57, P217, DOI 10.1016/j.ejrad.2005.11.021; Girard N, 2006, MAGN RESON MED, V56, P768, DOI 10.1002/mrm.21017; Huppi PS, 1996, PEDIATR RES, V39, P895; Huppi PS, 1998, PEDIATR RES, V44, P584; Ireland Z, 2011, NEUROSCIENCE, V194, P372, DOI 10.1016/j.neuroscience.2011.05.012; Iwata S, 2012, PEDIATRICS, V129, pE1138, DOI 10.1542/peds.2011-1735; Ke Y, 2002, MAGNET RESON MED, V47, P232, DOI 10.1002/mrm.10063; Kidokoro H, 2011, AM J NEURORADIOL, V32, P2005, DOI 10.3174/ajnr.A2703; KINNEY HC, 1994, NEUROCHEM RES, V19, P983, DOI 10.1007/BF00968708; Kirov II, 2008, MAGN RESON MED, V60, P790, DOI 10.1002/mrm.21715; Kreis R, 2002, MAGNET RESON MED, V48, P949, DOI 10.1002/mrm.10304; KREIS R, 1993, MAGNET RESON MED, V30, P424, DOI 10.1002/mrm.1910300405; Krishnan ML, 2007, PEDIATRICS, V120, pE604, DOI 10.1542/peds.2006-3054; Kugel H, 2003, J MAGN RESON IMAGING, V17, P634, DOI 10.1002/jmri.10315; Kwon HB, 2011, NATURE, V474, P100, DOI 10.1038/nature09986; Kwon SH, 2014, NEONATOLOGY, V106, P149, DOI 10.1159/000362433; Lage S, 2013, J PEDIATR ENDOCR MET, V26, P53, DOI 10.1515/jpem-2012-0293; Laigle C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053266; Le Fur Y, 2010, MAGN RESON MATER PHY, V23, P23, DOI 10.1007/s10334-009-0186-y; Leuzzi V, 2013, EPILEPSIA, V54, P217, DOI 10.1111/epi.12020; Ling XY, 2013, EUR J RADIOL, V82, pE476, DOI 10.1016/j.ejrad.2013.04.003; Mader I, 2001, BRAIN, V124, P953, DOI 10.1093/brain/124.5.953; Manent JB, 2007, NEUROSCIENTIST, V13, P268, DOI 10.1177/1073858406298918; Marjanska M, 2012, NMR BIOMED, V25, P332, DOI 10.1002/nbm.1754; Mathur AM, 2010, SEMIN PERINATOL, V34, P57, DOI 10.1053/j.semperi.2009.10.006; Ment LR, 2009, LANCET NEUROL, V8, P1042, DOI 10.1016/S1474-4422(09)70257-1; Mewes AUJ, 2006, PEDIATRICS, V118, P23, DOI 10.1542/peds.2005-2675; Miller TJ, 2000, COMP BIOCHEM PHYS A, V125, P45, DOI 10.1016/S1095-6433(99)00160-9; Mullen KM, 2011, NEUROIMAGE, V54, P2563, DOI 10.1016/j.neuroimage.2010.11.019; Nagy Z, 2011, CEREB CORTEX, V21, P300, DOI 10.1093/cercor/bhq095; Nguyen L, 2001, CELL TISSUE RES, V305, P187, DOI 10.1007/s004410000343; Pannek K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068593; Phillips JP, 2011, PEDIATR RES, V69, P224, DOI 10.1203/PDR.0b013e3182091d52; Ratiney H, 2005, NMR BIOMED, V18, P1, DOI 10.1002/nbm.895; Ratiney H, 2010, P INT SOC MAGN RESON, V18, P322; Ratiney H, 2010, NMR BIOMED, V23, P1146, DOI 10.1002/nbm.1541; Rees S, 2011, INT J DEV NEUROSCI, V29, P551, DOI 10.1016/j.ijdevneu.2011.04.004; Rutherford MA, 2010, NEURORADIOLOGY, V52, P505, DOI 10.1007/s00234-010-0700-y; Saransaari P, 2000, AMINO ACIDS, V19, P509, DOI 10.1007/s007260070003; Saunders DE, 1997, JMRI-J MAGN RESON IM, V7, P1116, DOI 10.1002/jmri.1880070626; Schaffer S, 2000, AMINO ACIDS, V19, P527, DOI 10.1007/s007260070004; Seeger U, 2003, MAGNET RESON MED, V49, P19, DOI 10.1002/mrm.10332; Shim SY, 2012, NEONATOLOGY, V102, P309, DOI 10.1159/000341867; Skiold B, 2012, J PEDIATR-US, V160, P559, DOI 10.1016/j.jpeds.2011.09.053; Stockler S, 1996, LANCET, V348, P789, DOI 10.1016/S0140-6736(96)04116-5; STURMAN JA, 1993, PHYSIOL REV, V73, P119, DOI 10.1152/physrev.1993.73.1.119; Viola A, 2011, AM J NEURORADIOL, V32, P1451, DOI 10.3174/ajnr.A2555; Vitvitsky V, 2011, J BIOL CHEM, V286, P32002, DOI 10.1074/jbc.M111.253344; Volpe JJ, 2005, PEDIATRICS, V116, P221, DOI 10.1542/peds.2005-0191; Walls AB, 2015, NEUROCHEM RES, V40, P402, DOI 10.1007/s11064-014-1473-1; Weindling M, 2010, ACTA PAEDIATR, V99, P961, DOI 10.1111/j.1651-2227.2010.01785.x; Wisnowski JL, 2014, NEURORADIOLOGY, V56, P771, DOI 10.1007/s00234-014-1380-9; Woodward LJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051879; Woodward LJ, 2011, DEV NEUROPSYCHOL, V36, P22, DOI 10.1080/87565641.2011.540530; Xin L, 2008, NMR BIOMED, V21, P396, DOI 10.1002/nbm.1205; Yao FS, 1999, NMR BIOMED, V12, P463, DOI 10.1002/(SICI)1099-1492(199911)12:7<463::AID-NBM586>3.0.CO;2-S; Zhang Y, 2016, MAGN RESON MED, V76, P725, DOI 10.1002/mrm.25922	78	17	17	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2016	11	8							e0160990	10.1371/journal.pone.0160990	http://dx.doi.org/10.1371/journal.pone.0160990			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT8TP	27547969	Green Submitted, Green Published, gold			2022-12-27	WOS:000381768400027
J	Lin, CY; Chang, SL; Chung, FP; Chen, YY; Lin, YJ; Lo, LW; Hu, YF; Tuan, TC; Chao, TF; Liao, JN; Chang, YT; Lin, CH; Allamsetty, S; Walia, R; Te, ALD; Yamada, S; Chiang, SJ; Tsao, HM; Chen, SA				Lin, Chin-Yu; Chang, Shih-Lin; Chung, Fa-Po; Chen, Yun-Yu; Lin, Yenn-Jiang; Lo, Li-Wei; Hu, Yu-Feng; Tuan, Ta-Chuan; Chao, Tze-Fan; Liao, Jo-Nan; Chang, Yao-Ting; Lin, Chung-Hsing; Allamsetty, Suresh; Walia, Rohit; Te, Abigail Louise D.; Yamada, Shinya; Chiang, Shuo-Ju; Tsao, Hsuan-Ming; Chen, Shih-Ann			Long-Term Outcome of Non-Sustained Ventricular Tachycardia in Structurally Normal Hearts	PLOS ONE			English	Article							PROGNOSTIC-SIGNIFICANCE; RATE TURBULENCE; FREQUENT; RISK; ARRHYTHMIAS; COMPLEXES; DEATH; DISEASE; ECTOPY	Background The impact of non-sustained ventricular tachycardia (NSVT) on the risk of thromboembolic event and clinical outcomes in patients without structural heart disease remains undetermined. This study aimed to evaluate the association between NSVT and clinical outcomes. Methods The study population of 5903 patients was culled from the "Registry of 24-hour ECG monitoring at Taipei Veterans General Hospital" (REMOTE database) between January 1, 2002 and December 31, 2004. Of that total, we enrolled 3767 patients without sustained ventricular tachycardia, structural heart disease, and permanent pacemaker. For purposes of this study, NSVT was defined as 3 or more consecutive beats arising below the atrioventricular node with an RR interval of < 600 ms (> 100 beats/min) and lasting < 30 seconds. Result There were 776 deaths, 2042 hospitalizations for any reason, 638 cardiovascular (CV)related hospitalizations, 350 ischemic strokes, 409 transient ischemic accident (TIA), 368 new-onset heart failure (HF), and 260 new-onset atrial fibrillation (AF) with a mean follow-up duration of 10 +/- 1 years. In multivariate analysis, the presence of NSVT was independently associated with death (hazard ratio [HR]: 1.362, 95% confidence interval [CI]: 1.071-1.731), CV hospitalization (HR: 1.527, 95% CI: 1.171-1.992), ischemic stroke (HR: 1.436, 95% CI: 1.014-2.032), TIA (HR 1.483, 95% CI: 1.069-2.057), and new-onset HF (HR: 1.716, 95% CI: 1.243-2.368). There was no significant association between the presence of NSVT and all-cause hospitalization or new-onset AF. Conclusion In patients without structural heart disease, presence of NSVT on 24-hour monitoring was independently associated with death, CV hospitalization, ischemic stroke, TIA, and new onset heart failure.	[Lin, Chin-Yu; Chang, Shih-Lin; Chung, Fa-Po; Chen, Yun-Yu; Lin, Yenn-Jiang; Lo, Li-Wei; Hu, Yu-Feng; Tuan, Ta-Chuan; Chao, Tze-Fan; Liao, Jo-Nan; Chang, Yao-Ting; Lin, Chung-Hsing; Allamsetty, Suresh; Walia, Rohit; Te, Abigail Louise D.; Yamada, Shinya; Chen, Shih-Ann] Taipei Vet Gen Hosp, Div Cardiol, Dept Med, Taipei, Taiwan; [Lin, Chin-Yu; Chang, Shih-Lin; Chung, Fa-Po; Lin, Yenn-Jiang; Lo, Li-Wei; Hu, Yu-Feng; Tuan, Ta-Chuan; Chao, Tze-Fan; Liao, Jo-Nan; Chang, Yao-Ting; Lin, Chung-Hsing; Tsao, Hsuan-Ming; Chen, Shih-Ann] Natl Yang Ming Univ, Sch Med, Dept Med, Taipei, Taiwan; [Chen, Yun-Yu] Natl Taiwan Univ, Inst Epidemiol & Prevent Med, Coll Publ Hlth, Taipei, Taiwan; [Chiang, Shuo-Ju] Taipei Med Univ, Sch Med, Div Cardiol, Dept Internal Med,Coll Med, Taipei, Taiwan; [Tsao, Hsuan-Ming] Natl Yang Ming Univ Hosp, Div Cardiol, Yilan, Taiwan	Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Taiwan University; Taipei Medical University	Tsao, HM (corresponding author), Natl Yang Ming Univ, Sch Med, Dept Med, Taipei, Taiwan.; Tsao, HM (corresponding author), Natl Yang Ming Univ Hosp, Div Cardiol, Yilan, Taiwan.	hmtsao.pohai@msa.hinet.net	Walia, Rohit/AAN-9711-2020; Chang, Shih-Lin/AGT-1191-2022; Hu, Yu-Feng/V-1401-2019	Hu, Yu-Feng/0000-0001-5715-2070; Lin, Chin-Yu/0000-0003-3282-7523; Te, Abigail Louise/0000-0002-7461-2793	National Yang Ming University Hospital [RD 2016-005]; NSC [MOST104-2314-B-010-055-MY3, MOST104-2314-B-075-070]; Taipei Veterans General Hospital grant [V104E7-002, V105C-116, V105C-121, VGHUST104-G7-3-1, VGHUST104-G7-3-2, VGHUST105-G7-9-1, VGHUST105-G7-9-2]; Taipei Veterans General Hospital-National Yang-Ming University Excellent Physicians Scientists Cultivation Program [105-V-B-021]	National Yang Ming University Hospital; NSC(Ministry of Science and Technology, Taiwan); Taipei Veterans General Hospital grant(Taipei Veterans General Hospital); Taipei Veterans General Hospital-National Yang-Ming University Excellent Physicians Scientists Cultivation Program	This study was supported by grants from National Yang Ming University Hospital (grant RD 2016-005), NSC grants MOST104-2314-B-010-055-MY3, MOST104-2314-B-075-070, Taipei Veterans General Hospital grant V104E7-002, V105C-116, V105C-121, VGHUST104-G7-3-1 and -2, VGHUST105-G7-9-1 and -2, and Taipei Veterans General Hospital-National Yang-Ming University Excellent Physicians Scientists Cultivation Program (105-V-B-021).; This study was supported by grants of National Yang Ming University Hospital RD 2016-005, MOST104-2314-B-010-055-MY3, MOST104-2314-B-075-070, Taipei Veterans General Hospital grant V104E7-002, V105C-116, V105C-121, VGHUST104-G7-3-1 and -2, VGHUST105-G7-9-1 and -2, and Taipei Veterans General Hospital-National Yang-Ming University Excellent Physicians Scientists Cultivation Program (105-V-B-021).	Agarwal SK, 2010, STROKE, V41, P588, DOI 10.1161/STROKEAHA.109.567800; Alizadeh A, 2006, PACE, V29, P1251, DOI 10.1111/j.1540-8159.2006.00520.x; Ashley T, 2001, J Insur Med, V33, P204; Biffi A, 2002, J AM COLL CARDIOL, V40, P446, DOI 10.1016/S0735-1097(02)01977-0; BIKKINA M, 1993, J AM COLL CARDIOL, V22, P1111, DOI 10.1016/0735-1097(93)90424-Y; BIKKINA M, 1992, ANN INTERN MED, V117, P990, DOI 10.7326/0003-4819-117-12-990; Bogun F, 2007, HEART RHYTHM, V4, P863, DOI 10.1016/j.hrthm.2007.03.003; Chao TF, 2013, INT J CARDIOL, V168, P4027, DOI 10.1016/j.ijcard.2013.06.067; Engstrom G, 1999, J INTERN MED, V246, P363, DOI 10.1046/j.1365-2796.1999.00509.x; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; FLEG JL, 1992, AM J CARDIOL, V70, P748, DOI 10.1016/0002-9149(92)90553-B; Frolkis JP, 2003, NEW ENGL J MED, V348, P781, DOI 10.1056/NEJMoa022353; Hsieh CY, 2015, J FORMOS MED ASSOC, V114, P254, DOI 10.1016/j.jfma.2013.09.009; Ioana Mozos, 2014, CARDIAC ARRHYTHMIAS, P89, DOI [10.5772/57008, DOI 10.5772/57008]; Katritsis DG, 2012, J AM COLL CARDIOL, V60, P1993, DOI 10.1016/j.jacc.2011.12.063; Katritsis DG, 2004, EUR HEART J, V25, P1093, DOI 10.1016/j.ehj.2004.03.022; KENNEDY HL, 1985, NEW ENGL J MED, V312, P193, DOI 10.1056/NEJM198501243120401; Kerr KF, 2011, AM J EPIDEMIOL, V174, P364, DOI 10.1093/aje/kwr086; Lee V, 2012, HEART, V98, P1290, DOI 10.1136/heartjnl-2012-302005; Lin CY, 2015, INT J CARDIOL, V180, P80, DOI 10.1016/j.ijcard.2014.11.110; Lu TH, 2000, INT J EPIDEMIOL, V29, P336, DOI 10.1093/ije/29.2.336; Narang R, 1996, EUR HEART J, V17, P1390; Ofoma U, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.112.002519; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Segerson NM, 2007, HEART RHYTHM, V4, P284, DOI 10.1016/j.hrthm.2006.10.020; Sheldon Seth H, 2010, Indian Pacing Electrophysiol J, V10, P357; Spragg DD, 2006, PROG CARDIOVASC DIS, V49, P26, DOI 10.1016/j.pcad.2006.05.001; Wang KL, 2012, J AM COLL CARDIOL, V60, P1231, DOI 10.1016/j.jacc.2012.05.019; Wichterle D, 2006, J CARDIOVASC ELECTR, V17, P286, DOI 10.1111/j.1540-8167.2005.00330.x	29	21	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2016	11	8							e0160181	10.1371/journal.pone.0160181	http://dx.doi.org/10.1371/journal.pone.0160181			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT8TP	27548469	Green Submitted, Green Published, gold			2022-12-27	WOS:000381768400013
J	Fan, XF; Gu, XJ; Zhao, R; Zheng, QQ; Li, L; Yang, WB; Ding, L; Xue, F; Fan, JM; Gong, YS; Wang, YY				Fan, Xiaofang; Gu, Xuejiang; Zhao, Ru; Zheng, Qingqing; Li, Lan; Yang, Wenbing; Ding, Lu; Xue, Feng; Fan, Junming; Gong, Yongsheng; Wang, Yongyu			Cardiac beta(2)-Adrenergic Receptor Phosphorylation at Ser(355/356) Regulates Receptor Internalization and Functional Resensitization	PLOS ONE			English	Article							PROTEIN-KINASE-A; BETA-ARRESTIN; MYOCYTES; BINDING; MICE	Previous studies have demonstrated that beta(2)-adrenergic receptors (beta(2)ARs) can be phosphorylated by G protein-coupled receptor kinases (GRKs) and protein kinase A (PKA), affecting beta(2)AR internalization and desensitization. However, the exact physiological function of beta(2)ARs in cardiomyocytes is unknown. In this study, we showed that neonatal mouse cardiomyocytes had different contraction and internalization responses to sustained or repeated, transient agonist stimulation. Specifically, short-time stimulation (10 min) with epinephrine or norepinephrine increased the cardiomyocyte contraction rate, reaching a maximum at 5 min, followed by a slow decline. When the agonist was re-added after a 60-min wash-out period, the increase in the cardiomyocyte contraction rate was similar to the initial response. In contrast, when cardiomyocytes were exposed continuously to epinephrine or norepinephrine for 60 min, the second agonist stimulation did not increase the contraction response. These results indicated that continuous beta(2)AR stimulation caused functional desensitization. Phosphorylation of beta(2)ARs at serine (Ser)(355/356) GRK phosphorylation sites, but not at Ser(345/346) PKA phosphorylation sites increased with continuous epinephrine stimulation for 60 min. Accordingly, beta(2)AR internalization increased. Interestingly, beta(2)AR internalization was blocked by mutations at the GRK phosphorylation sites, but not by mutations at the PKA phosphorylation sites. Furthermore, inhibition of beta(2)AR dephosphorylation by okadaic acid, a phosphatase 2A inhibitor, impaired the recovery of internalized beta(2)ARs and reduced the cardiomyocyte contraction rate in response to epinephrine. Finally, epinephrine treatment induced the physical interaction of beta-arrestin with internalized beta(2)ARs in cardiomyocytes. Together, these data revealed the essential role of the Ser(355/356) phosphorylation status of beta(2)ARs in regulating receptor internalization and physiological resensitization in neonatal cardiomyocytes to contraction functions.	[Fan, Xiaofang; Zhao, Ru; Zheng, Qingqing; Ding, Lu; Xue, Feng; Fan, Junming; Gong, Yongsheng; Wang, Yongyu] Wenzhou Med Univ, Inst Hypoxia Med, Wenzhou, Zhejiang, Peoples R China; [Gu, Xuejiang] Wenzhou Med Univ, Dept Endocrine & Metab Dis, Affiliated Hosp 1, Wenzhou, Zhejiang, Peoples R China; [Li, Lan; Yang, Wenbing] Shantou Univ, Dept Pathol, Coll Med, Shantou, Guangdong, Peoples R China	Wenzhou Medical University; Wenzhou Medical University; Shantou University	Gong, YS; Wang, YY (corresponding author), Wenzhou Med Univ, Inst Hypoxia Med, Wenzhou, Zhejiang, Peoples R China.	fxb@wmu.edu.cn; yywangut@163.com	Yang, Wenbing/AAH-5134-2021	Wang, Yongyu/0000-0002-6088-8887	National Natural Science Foundation of China [81270321, 81200576]; Natural Science Foundation of Zhejiang Province [LY16H010005]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province)	This work was supported by the National Natural Science Foundation of China (81270321, 81200576) and Natural Science Foundation of Zhejiang Province (LY16H010005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cong M, 2001, J BIOL CHEM, V276, P15192, DOI 10.1074/jbc.M009130200; Devic E, 2001, MOL PHARMACOL, V60, P577; Gupta MK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125803; Krueger KM, 1997, J BIOL CHEM, V272, P5; Liu RJ, 2009, J BIOL CHEM, V284, P32279, DOI 10.1074/jbc.M109.021428; McGraw Dennis W, 2005, Proc Am Thorac Soc, V2, P292, DOI 10.1513/pats.200504-027SR; Nobles KN, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001707; Rajagopal S, 2010, NAT REV DRUG DISCOV, V9, P373, DOI 10.1038/nrd3024; Rockman HA, 2002, NATURE, V415, P206, DOI 10.1038/415206a; Rohrer DK, 1999, J BIOL CHEM, V274, P16701, DOI 10.1074/jbc.274.24.16701; Rohrer DK, 1996, P NATL ACAD SCI USA, V93, P7375, DOI 10.1073/pnas.93.14.7375; Shenoy Sudha K, 2005, Sci STKE, V2005, pcm10, DOI 10.1126/stke.2005/308/cm10; Swaminath G, 2004, J BIOL CHEM, V279, P686, DOI 10.1074/jbc.M310888200; Tao JC, 2003, EMBO J, V22, P6419, DOI 10.1093/emboj/cdg628; Tobin AB, 2008, BRIT J PHARMACOL, V153, pS167, DOI 10.1038/sj.bjp.0707662; Tobin AB, 2008, TRENDS PHARMACOL SCI, V29, P413, DOI 10.1016/j.tips.2008.05.006; Vasudevan NT, 2011, CELL CYCLE, V10, P3684, DOI 10.4161/cc.10.21.18042; Vaughan DJ, 2006, J BIOL CHEM, V281, P7684, DOI 10.1074/jbc.M500328200; Wang Y, 2008, J BIOL CHEM, V283, P1799, DOI 10.1074/jbc.M705747200; Xiang Y, 2002, J BIOL CHEM, V277, P34280, DOI 10.1074/jbc.M201644200; Zhang J, 1997, J BIOL CHEM, V272, P27005, DOI 10.1074/jbc.272.43.27005	21	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2016	11	8							e0161373	10.1371/journal.pone.0161373	http://dx.doi.org/10.1371/journal.pone.0161373			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6UQ	27541735	Green Published, Green Submitted, gold			2022-12-27	WOS:000381620200005
J	Adjakossa, EH; Sadissou, I; Hounkonnou, MN; Nuel, G				Adjakossa, Eric Houngla; Sadissou, Ibrahim; Hounkonnou, Mahouton Norbert; Nuel, Gregory			Multivariate Longitudinal Analysis with Bivariate Correlation Test	PLOS ONE			English	Article							LIKELIHOOD RATIO TESTS; MIXED-EFFECTS MODELS; MULTILEVEL ANALYSIS; OUTCOMES; INDIVIDUALS; PROFILES; QUALITY	In the context of multivariate multilevel data analysis, this paper focuses on the multivariate linear mixed-effects model, including all the correlations between the random effects when the dimensional residual terms are assumed uncorrelated. Using the EM algorithm, we suggest more general expressions of the model's parameters estimators. These estimators can be used in the framework of the multivariate longitudinal data analysis as well as in the more general context of the analysis of multivariate multilevel data. By using a likelihood ratio test, we test the significance of the correlations between the random effects of two dependent variables of the model, in order to investigate whether or not it is useful to model these dependent variables jointly. Simulation studies are done to assess both the parameter recovery performance of the EM estimators and the power of the test. Using two empirical data sets which are of longitudinal multivariate type and multivariate multilevel type, respectively, the usefulness of the test is illustrated.	[Adjakossa, Eric Houngla; Nuel, Gregory] Univ Paris 06, Lab Probabilites & Modeles Aleatoires, Case Courrier 188 4, Pl Jussieu, F-75252 Paris 05, France; [Adjakossa, Eric Houngla; Hounkonnou, Mahouton Norbert] Univ Abomey Calavi, 072 BP 50, Cotonou, Benin; [Sadissou, Ibrahim] Univ Abomey Calavi, Lab Biol & Physiol Cellulaires, Cotonou, Benin; [Sadissou, Ibrahim] CERPAGE, Cotonou, Benin	UDICE-French Research Universities; Sorbonne Universite; University of Abomey Calavi; University of Abomey Calavi	Adjakossa, EH (corresponding author), Univ Paris 06, Lab Probabilites & Modeles Aleatoires, Case Courrier 188 4, Pl Jussieu, F-75252 Paris 05, France.; Adjakossa, EH (corresponding author), Univ Abomey Calavi, 072 BP 50, Cotonou, Benin.	ericadjakossah@gmail.com	Hounkonnou, Mahouton Norbert/AAF-4695-2019; Sadissou, IBRAHIM/AAT-2692-2020	Hounkonnou, Mahouton Norbert/0000-0002-6231-4975; Sadissou, IBRAHIM/0000-0001-7300-3753	Institut de Recherche pour le Developpement; Service de Cooperation et d'Action Culturelle of France embassy in Benin; SCAC (Service de Cooperation et d'Actions Culturelles) of the France Embassy in Benin; IRD (Institut de Recherche pour le Developpement)	Institut de Recherche pour le Developpement; Service de Cooperation et d'Action Culturelle of France embassy in Benin; SCAC (Service de Cooperation et d'Actions Culturelles) of the France Embassy in Benin; IRD (Institut de Recherche pour le Developpement)	EHA: Joint scholarship from Institut de Recherche pour le Developpement (http://www.ird.fr/les-partenariats/renforcement-des-capacites/desprogrammes-specifiques/allocations-de-recherchepour-une-these-au-sud-arts) and Service de Cooperation et d'Action Culturelle of France embassy in Benin (http://www.ambafrance-bj.org/Service-decooperation-et-d-action). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We warmly thank the SCAC (Service de Cooperation et d'Actions Culturelles) of the France Embassy in Benin, as well as the IRD (Institut de Recherche pour le Developpement) for their financial support in the realization of this work.	An XM, 2013, STAT MED, V32, P4229, DOI 10.1002/sim.5825; [Anonymous], 2011, MULTILEVEL ANAL; [Anonymous], 2014, R LANG ENV STAT COMP; BALLARD JL, 1991, J PEDIATR-US, V119, P417, DOI 10.1016/S0022-3476(05)82056-6; Bandyopadhyay S, 2011, STAT METHODS MED RES, V20, P299, DOI 10.1177/0962280209340191; Bartlett MS, 1937, PROC R SOC LON SER-A, V160, P0268, DOI 10.1098/rspa.1937.0109; Bates D., 2013, LME4 LINEAR MIXED EF; Bates Douglas, 2014, LME4 LINEAR MIXED EF; Beckett LA, 2004, STAT MED, V23, P231, DOI 10.1002/sim.1712; BENTLER PM, 1980, PSYCHOMETRIKA, V45, P289, DOI 10.1007/BF02293905; Brandsma H. P., 1989, INT J EDUC RES, V13, P777, DOI DOI 10.1016/0883-0355(89)90028-1; Bringmann LF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060188; Brombin C, 2014, STAT METHODS; Carey VJ, 2001, STAT MED, V20, P21, DOI 10.1002/1097-0258(20010115)20:1<21::AID-SIM639>3.0.CO;2-5; Cattell R. B., 1988, HDB MULTIVARIATE EXP, V2, P561, DOI DOI 10.1007/978-1-4613-0893-5_17; CHAMIGO R, 2011, EVAL HEALTH PROF, V34, P181, DOI DOI 10.1177/0163278710392982; CHANT D, 1974, BIOMETRIKA, V61, P291, DOI 10.1093/biomet/61.2.291; Cottrell G, 2012, MODELING THE INFLUEN; Courtin D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007590; Crouchley R, 2010, MULTIVARIATE GEN LIN; CROWDER M, 1995, BIOMETRIKA, V82, P407; Davidian M, 2003, J AGR BIOL ENVIR ST, V8, P387, DOI 10.1198/1085711032697; Diggle P, 2013, ANAL LONGITUDINAL DA, V25; Djenontin A, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-83; Duncan SC, 1996, STRUCT EQU MODELING, V3, P323, DOI 10.1080/10705519609540050; Faraway JJ., 2005, EXTENDING LINEAR MOD; Fieuws S, 2006, BIOMETRICS, V62, P424, DOI 10.1111/j.1541-0420.2006.00507.x; Fieuws S, 2004, STAT MED, V23, P3093, DOI 10.1002/sim.1885; Fieuws S, 2008, BIOSTATISTICS, V9, P419, DOI 10.1093/biostatistics/kxm041; Fieuws S, 2009, CH CRC HANDB MOD STA, P367; Funatogawa I, 2007, STAT MED, V26, P2113, DOI 10.1002/sim.2670; GALECKI AT, 1994, COMMUN STAT THEORY, V23, P3105, DOI 10.1080/03610929408831436; Gates KM, 2012, NEUROIMAGE, V63, P310, DOI 10.1016/j.neuroimage.2012.06.026; Gelman A., 2006, DATA ANAL USING REGR, DOI DOI 10.1017/CBO9780511790942.005; Geys H, 1999, J AM STAT ASSOC, V94, P734, DOI 10.2307/2669986; Giampaoli V, 2009, J STAT PLAN INFER, V139, P1435, DOI 10.1016/j.jspi.2008.06.016; Gray SM, 2000, J AM STAT ASSOC, V95, P396; Gray SM, 1998, BIOMETRICS, V54, P976, DOI 10.2307/2533850; HAMILTON JD, 1994, J ECONOMETRICS, V64, P307, DOI 10.1016/0304-4076(94)90067-1; Hancock GR, 2001, STRUCT EQU MODELING, V8, P470, DOI 10.1207/S15328007SEM0803_7; Horvath C, 2008, STAT NEERL, V62, P208, DOI 10.1111/j.1467-9574.2007.00382.x; LAIRD N, 1987, J AM STAT ASSOC, V82, P97, DOI 10.2307/2289129; Lambert P, 2002, STAT MED, V21, P3197, DOI 10.1002/sim.1249; Le Port A, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000342; LIANG KY, 1992, J R STAT SOC B, V54, P3; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; LINDSTROM MJ, 1988, J AM STAT ASSOC, V83, P1014; Littell R. C., 2006, SAS SYSTEMS MIXED MO, V2nd; Lodewyckx T, 2011, J MATH PSYCHOL, V55, P68, DOI 10.1016/j.jmp.2010.08.004; MacCallum RC, 1997, MULTIVAR BEHAV RES, V32, P215, DOI 10.1207/s15327906mbr3203_1; MACURDY TE, 1982, J ECONOMETRICS, V18, P83, DOI 10.1016/0304-4076(82)90096-3; Molenberghs G., 2005, MODELS DISCRETE LONG; Nelsen RB., 2007, INTRO COPULAS; O'Brien LM, 2004, J R STAT SOC C-APPL, V53, P177, DOI 10.1046/j.0035-9254.2003.05296.x; Oort FJ, 2001, BRIT J MATH STAT PSY, V54, P49, DOI 10.1348/000711001159429; Pinheiro J., 2006, MIXED EFFECTS MODELS; Pinheiro J., 2014, NLME LINEAR NONLINEA, V3, P1; PRENTICE RL, 1991, BIOMETRICS, V47, P825, DOI 10.2307/2532642; Ramsay JO., 1997, FUNCTIONAL DATA ANAL, DOI 10.1007/978-1-4757-7107-7; REINSEL G, 1984, J AM STAT ASSOC, V79, P406, DOI 10.2307/2288283; Ribaudo HJ, 2002, STAT METHODS MED RES, V11, P69, DOI 10.1191/0962280202sm272ra; Rice JA, 2001, BIOMETRICS, V57, P253, DOI 10.1111/j.0006-341X.2001.00253.x; Rochon J, 1996, BIOMETRICS, V52, P740, DOI 10.2307/2532914; Schafer JL, 2002, J COMPUT GRAPH STAT, V11, P437, DOI 10.1198/106186002760180608; SELF SG, 1987, J AM STAT ASSOC, V82, P605, DOI 10.2307/2289471; Shah A, 1997, J AM STAT ASSOC, V92, P775, DOI 10.2307/2965726; Shock N.W., 1984, NORMAL HUMAN AGING B; Sklar A., 1959, PUBL I STAT U PARIS, V8, P22; Sturtz S, 2005, J STAT SOFTW, V12, P1, DOI 10.18637/jss.v012.i03; Subramanian SV, 2005, J EPIDEMIOL COMMUN H, V59, P664, DOI 10.1136/jech.2004.025742; Sy JP, 1997, BIOMETRICS, V53, P542, DOI 10.2307/2533956; Thiebaut R, 2002, COMPUT METH PROG BIO, V69, P249, DOI 10.1016/S0169-2607(02)00017-2; Tsay R, 2013, MULTIVARIATE TIME SE; Tschacher W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039687; Tschacher W, 2009, PSYCHOTHER RES, V19, P469, DOI 10.1080/10503300802654496; Tseloni A, 2008, EUR J CRIMINOL, V5, P387, DOI 10.1177/1477370808095123; Verbeke G, 2014, STAT METHODS MED RES, V23, P42, DOI 10.1177/0962280212445834; Verbeke G, 2009, SPRINGER SER STAT, P1; Vu HTV, 1997, ANN STAT, V25, P897; Wang XF, 2012, BIOMETRICAL J, V54, P264, DOI 10.1002/bimj.201100041; Wichern, 2007, APPL MULTIVARIATE ST, V4; Wilks SS, 1938, ANN MATH STAT, V9, P60, DOI 10.1214/aoms/1177732360; Wu H., 2006, NONPARAMETRIC REGRES, V515; ZEGER SL, 1988, BIOMETRICS, V44, P1049, DOI 10.2307/2531734; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248; Zhang M, 2011, BIOSTATISTICS, V12, P258, DOI 10.1093/biostatistics/kxq054; Zuur Alain F., 2009, P1	88	4	4	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0159649	10.1371/journal.pone.0159649	http://dx.doi.org/10.1371/journal.pone.0159649			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DT6ES	27537692	Green Published, Green Submitted, gold			2022-12-27	WOS:000381577000009
J	Gosby, AK; Lau, NS; Tam, CS; Iglesias, MA; Morrison, CD; Caterson, ID; Brand-Miller, J; Conigrave, AD; Raubenheimer, D; Simpson, SJ				Gosby, Alison K.; Lau, Namson S.; Tam, Charmaine S.; Iglesias, Miguel A.; Morrison, Christopher D.; Caterson, Ian D.; Brand-Miller, Jennie; Conigrave, Arthur D.; Raubenheimer, David; Simpson, Stephen J.			Raised FGF-21 and Triglycerides Accompany Increased Energy Intake Driven by Protein Leverage in Lean, Healthy Individuals: A Randomised Trial	PLOS ONE			English	Article							GLUCAGON-LIKE PEPTIDE-1; WEIGHT-LOSS; DIETARY-PROTEIN; GLYCEMIC INDEX; CALORIC-INTAKE; FGF21 LEVELS; BODY-WEIGHT; SHORT-TERM; GHRELIN; FAT	A dominant appetite for protein drives increased energy intake in humans when the proportion of protein in the diet is reduced down to approximately 10% of total energy. Compensatory feeding for protein is apparent over a 1-2 d period but the mechanisms driving this regulation are not fully understood. Fibroblast growth factor-21 (FGF-21) has been identified as a candidate protein signal as levels increase in the circulation when dietary protein is low. The aim of this randomised controlled trial was to assess whether changes in percent dietary protein over a 4 d ad libitum experimental period in lean, healthy participants influenced energy intake, metabolic health, circulating FGF-21 and appetite regulating hormones including ghrelin, glucagon like peptide-1 and cholecystokinin. Twenty-two lean, healthy participants were fed ad libitum diets containing 10, 15 and 25% protein, over three, 4 d controlled, in-house experimental periods. Reduced dietary protein intake from 25% to 10% over a period of 4 d was associated with 14% increased energy intake (p = 0.02) as previously reported, and a 6-fold increase in fasting circulating plasma FGF-21 levels (p < 0.0001), a 1.5-fold increase in serum triglycerides (p < 0.0001), and a 0.9-fold decrease in serum total cholesterol (p = 0.02). Serum HDL cholesterol was reduced with a reduction in dietary protein from 15% to 10% (p = 0.01) over 4 d but not from 25% to 10% (p = 0.1) and the change from baseline was not different between diets. Plasma fasting insulin levels following the 4 d study period were significantly lower following the 25% ad libitum study period compared to the 15% protein period (p = 0.014) but not the 10% protein period (p = 0.2). Variability in interstitial glucose during each study period increased with a decrease in dietary protein from 25% to 15% and 10% (p = 0.001 and p = 0.04, respectively). Ghrelin, glucagon-like peptide-1 and cholecystokinin were unchanged. Increases in energy intake, plasma FGF-21 and serum triglycerides were associated with reductions in percent dietary protein from 25% to 10% energy over a 4 d ad libitum in-house feeding period and may be important in regulation of dietary protein intake.	[Gosby, Alison K.; Lau, Namson S.; Tam, Charmaine S.; Caterson, Ian D.; Brand-Miller, Jennie; Conigrave, Arthur D.; Raubenheimer, David; Simpson, Stephen J.] Univ Sydney, Charles Perkins Ctr D17, Sydney, NSW, Australia; [Gosby, Alison K.; Tam, Charmaine S.; Caterson, Ian D.; Brand-Miller, Jennie; Conigrave, Arthur D.; Raubenheimer, David; Simpson, Stephen J.] Univ Sydney, Sch Life & Environm Sci, Sydney, NSW, Australia; [Lau, Namson S.; Tam, Charmaine S.; Caterson, Ian D.; Brand-Miller, Jennie] Univ Sydney, Boden Inst Obes Nutr Exercise & Eating Disorders, Sydney, NSW, Australia; [Iglesias, Miguel A.] Univ Tasmania, Sch Hlth Sci, Darlinghurst Campus, Darlinghurst, NSW, Australia; [Morrison, Christopher D.] Pennington Biomed Res Ctr, 6400 Perkins Rd, Baton Rouge, LA 70808 USA; [Raubenheimer, David] Univ Sydney, Sch Vet Sci, Sydney, NSW 2006, Australia	University of Sydney; University of Sydney; University of Sydney; University of Tasmania; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; University of Sydney	Gosby, AK (corresponding author), Univ Sydney, Charles Perkins Ctr D17, Sydney, NSW, Australia.; Gosby, AK (corresponding author), Univ Sydney, Sch Life & Environm Sci, Sydney, NSW, Australia.	alison.gosby@sydney.edu.au	Iglesias, Miguel A/J-7879-2014; Morrison, Christopher D/A-6093-2010; Brand-Miller, Jennie C/A-6835-2013	Iglesias, Miguel A/0000-0001-5781-2091; Morrison, Christopher D/0000-0002-5492-102X; Brand-Miller, Jennie C/0000-0002-6797-8754; Raubenheimer, David/0000-0001-9050-1447; Conigrave, Arthur/0000-0002-7232-3891; Lau, Namson/0000-0002-9400-8470; Simpson, Stephen J./0000-0003-0256-7687	National Health and Medical Research Council [457522, 1037275]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by a National Health and Medical Research Council Project grant (#457522). CST was supported by a National Health and Medical Research Council Early Career Fellowship (#1037275). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Awar R, 2005, CLIN SCI, V109, P405, DOI 10.1042/CS20050072; Austin GL, 2011, AM J CLIN NUTR, V93, P836, DOI 10.3945/ajcn.110.000141; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Blom WAM, 2006, AM J CLIN NUTR, V83, P211; Bowen J, 2006, J CLIN ENDOCR METAB, V91, P2913, DOI 10.1210/jc.2006-0609; Bray GA, 2012, JAMA-J AM MED ASSOC, V307, P47, DOI 10.1001/jama.2011.1918; Campbell CP, 2016, EVOL MED PUBLIC HLTH, P158, DOI 10.1093/emph/eov030; Chlup R, 2006, EXP CLIN ENDOCR DIAB, V114, P68, DOI 10.1055/s-2006-923806; Cummings DE, 2006, PHYSIOL BEHAV, V89, P71, DOI 10.1016/j.physbeh.2006.05.022; Du HD, 2010, AM J CLIN NUTR, V91, P329, DOI 10.3945/ajcn.2009.28191; Dushay J, 2010, GASTROENTEROLOGY, V139, P456, DOI 10.1053/j.gastro.2010.04.054; Dushay JR, 2015, MOL METAB, V4, P51, DOI 10.1016/j.molmet.2014.09.008; ELLIOTT RM, 1993, J ENDOCRINOL, V138, P159, DOI 10.1677/joe.0.1380159; Fazeli PK, 2015, J CLIN INVEST, V125, P4601, DOI 10.1172/JCI83349; Felton AM, 2009, FUNCT ECOL, V23, P70, DOI 10.1111/j.1365-2435.2008.01526.x; Fisher FM, 2016, ANNU REV PHYSIOL, V78, P223, DOI 10.1146/annurev-physiol-021115-105339; Floegel A, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5109; Gardner CD, 2007, JAMA-J AM MED ASSOC, V297, P969, DOI 10.1001/jama.297.9.969; Gardner CD, 2016, OBESITY, V24, P79, DOI 10.1002/oby.21331; GARZA C, 1977, BRIT J NUTR, V37, P403, DOI 10.1079/BJN19770044; Gosby AK, 2014, OBES REV, V15, P13, DOI [10.1056/NEJMoa1007137, DOI 10.1056/NEJMOA1007137]; Gosby AK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025929; Gosby AK, 2010, APPETITE, V55, P367, DOI 10.1016/j.appet.2010.06.009; Griffioen-Roose S, 2014, AM J CLIN NUTR, V100, P113, DOI 10.3945/ajcn.113.079392; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Kharitonenkov A, 2011, TRENDS ENDOCRIN MET, V22, P81, DOI 10.1016/j.tem.2010.11.003; Kovatchev BP, 2004, DIABETES CARE, V27, P1922, DOI 10.2337/diacare.27.8.1922; Kuznetsova A, LMERTEST TESTS RANDO; Laeger T, 2014, J CLIN INVEST, V124, P3913, DOI 10.1172/JCI74915; Lagiou P, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e4026; Larsen Thomas Meinert, 2010, N Engl J Med, V363, P2102, DOI 10.1056/NEJMoa1007137; Leidy HJ, 2015, AM J CLIN NUTR, V101, p1320S, DOI 10.3945/ajcn.114.084038; LIDDLE RA, 1985, J CLIN INVEST, V75, P1144, DOI 10.1172/JCI111809; Marmonier C, 2000, APPETITE, V34, P161, DOI 10.1006/appe.1999.0302; Martens EA, 2014, NUTR METAB, V11, DOI 10.1186/1743-7075-11-38; Martens EA, 2014, AM J CLIN NUTR, V99, P1397, DOI 10.3945/ajcn.113.078774; Martens EA, 2013, AM J CLIN NUTR, V97, P86, DOI 10.3945/ajcn.112.046540; Martinez-Cordero C, 2012, APPETITE, V59, P312, DOI 10.1016/j.appet.2012.05.013; Morrison CD, 2015, TRENDS ENDOCRIN MET, V26, P256, DOI 10.1016/j.tem.2015.02.008; Orskov C, 1996, SCAND J GASTROENTERO, V31, P665, DOI 10.3109/00365529609009147; Pissios P, 2013, MOL METAB, V2, P306, DOI 10.1016/j.molmet.2013.07.003; Psichas A, 2015, INT J OBESITY, V39, P424, DOI 10.1038/ijo.2014.153; Raubenheimer D, 2015, BRIT J NUTR, V113, pS26, DOI 10.1017/S0007114514002323; Robertson MD, 2002, AM J CLIN NUTR, V75, P505, DOI 10.1093/ajcn/75.3.505; Simpson SJ, 2005, OBES REV, V6, P133, DOI 10.1111/j.1467-789X.2005.00178.x; Simpson SJ, 1997, APPETITE, V28, P201, DOI 10.1006/appe.1996.0077; Simpson SJ, 2012, NATURE NUTR UNIFYING; Simpson SJ, 2014, NATURE, V508, pS66, DOI 10.1038/508S66a; Smeets AJ, 2008, J NUTR, V138, P698, DOI 10.1093/jn/138.4.698; Solon-Biet SM, 2015, J ENDOCRINOL, V226, pR17, DOI 10.1530/JOE-15-0173; Solon-Biet SM, 2014, CELL METAB, V19, P418, DOI 10.1016/j.cmet.2014.02.009; Sorensen A, 2008, OBESITY, V16, P566, DOI 10.1038/oby.2007.58; Urbanek S, 2014, WOODEN CHRISTMAS TRE; Vienberg SG, 2012, EUR J ENDOCRINOL, V167, P49, DOI 10.1530/EJE-12-0039; Wallace AJ, 2006, NUTR RES, V26, P403, DOI 10.1016/j.nutres.2006.07.007; Weigle DS, 2005, AM J CLIN NUTR, V82, P41, DOI 10.1093/ajcn/82.1.41; Westerterp-Plantenga MS, 2009, ANNU REV NUTR, V29, P21, DOI 10.1146/annurev-nutr-080508-141056	57	27	27	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0161003	10.1371/journal.pone.0161003	http://dx.doi.org/10.1371/journal.pone.0161003			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27536869	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000381577000041
J	Ogasawara, S; Chiba, T; Ooka, Y; Suzuki, E; Inoue, M; Wakamatsu, T; Tawada, A; Yokosuka, O				Ogasawara, Sadahisa; Chiba, Tetsuhiro; Ooka, Yoshihiko; Suzuki, Eiichiro; Inoue, Masanori; Wakamatsu, Toru; Tawada, Akinobu; Yokosuka, Osamu			Analysis of Sorafenib Outcome: Focusing on the Clinical Course in Patients with Hepatocellular Carcinoma	PLOS ONE			English	Article							TRANSARTERIAL CHEMOEMBOLIZATION; CHILD-PUGH; EFFICACY; SURVIVAL; PROPOSAL; THERAPY; SUBCLASSIFICATION; PROGNOSIS; ABLATION; CRITERIA	Background Treatment outcomes of sorafenib therapy may greatly vary depending not only on tumor spread but also on past clinical processes prior to sorafenib therapy and timing of sorafenib administration in the past clinical course of hepatocellular carcinoma (HCC). We evaluated the efficacy of sorafenib in patients with HCC, taking into account of their past clinical courses. Methods Patients with HCC treated with sorafenib as a first-line systemic therapy, whose courses documented from the time of the initial diagnosis, were retrospectively analyzed. Results Of the 123 patients receiving sorafenib therapy at an advanced-stage, baseline characteristics differed including the rate of hepatitis C virus, Child-Pugh class, and status of intrahepatic lesions according to stage progression processes. Overall survival (OS) in patients progressed directly from the early-stage (15.3 months) was significantly longer than that in patients diagnosed at the advanced-stage (5.3 months, P = 0.022) and progressed from the intermediate-stages (6.0 months, P = 0.041). Of 105 patients diagnosed at the intermediate-stage on past clinical courses, OS of starting sorafenib therapy before progression to the advanced-stage (6 patients) was significantly longer than for patients starting sorafenib therapy only after progression to the advanced-stage (38 patients) (P = 0.015). Conclusion Characteristic differences between past stage progression processes might affect prognosis in advanced-stage HCC patients receiving sorafenib. Switching to sorafenib therapy before progression to the advanced-stage appears more effective than that after progression to the advanced-stage in patients diagnosed in the intermediate-stage on past clinical courses prior to sorafenib administration.	[Ogasawara, Sadahisa; Chiba, Tetsuhiro; Ooka, Yoshihiko; Suzuki, Eiichiro; Inoue, Masanori; Wakamatsu, Toru; Tawada, Akinobu; Yokosuka, Osamu] Chiba Univ, Grad Sch Med, Dept Gastroenterol & Nephrol, Chiba, Japan	Chiba University	Chiba, T (corresponding author), Chiba Univ, Grad Sch Med, Dept Gastroenterol & Nephrol, Chiba, Japan.	techiba@faculty.chiba-u.jp	Ogasawara, Sadahisa/GRF-7061-2022	Ogasawara, Sadahisa/0000-0002-6540-9064				Arizumi T, 2015, LIVER CANCER, V4, P253, DOI 10.1159/000367743; Arizumi T, 2015, DIGEST DIS, V33, P728, DOI 10.1159/000439079; Bolondi L, 2012, SEMIN LIVER DIS, V32, P348, DOI 10.1055/s-0032-1329906; Bruix J, 2012, J HEPATOL, V57, P821, DOI 10.1016/j.jhep.2012.06.014; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Cheng AL, 2009, LANCET ONCOL, V10, P25, DOI 10.1016/S1470-2045(08)70285-7; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Forner A, 2012, LANCET, V379, P1245, DOI 10.1016/S0140-6736(11)61347-0; Hasegawa K, 2013, J HEPATOL, V58, P724, DOI 10.1016/j.jhep.2012.11.009; Iavarone M, 2011, HEPATOLOGY, V54, P2055, DOI 10.1002/hep.24644; Jung SM, 2012, J GASTROEN HEPATOL, V27, P684, DOI 10.1111/j.1440-1746.2011.06917.x; Kadalayil L, 2013, ANN ONCOL, V24, P2565, DOI 10.1093/annonc/mdt247; Kudo M, 2015, DIGEST DIS, V33, P751, DOI 10.1159/000439290; Kudo M, 2014, ONCOLOGY-BASEL, V87, P22, DOI 10.1159/000368142; Kudo M, 2014, HEPATOLOGY, V60, P1697, DOI 10.1002/hep.27290; Kudo M, 2011, DIGEST DIS, V29, P339, DOI 10.1159/000327577; Lee IC, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000688; Lencioni R, 2010, SEMIN LIVER DIS, V30, P52, DOI 10.1055/s-0030-1247132; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Llovet JM, 2012, J HEPATOL, V56, P908, DOI 10.1016/j.jhep.2011.12.001; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Ogasawara S, 2016, INVEST NEW DRUG, V34, P255, DOI 10.1007/s10637-016-0323-1; Ogasawara S, 2015, INVEST NEW DRUG, V33, P729, DOI 10.1007/s10637-015-0237-3; Ogasawara S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125244; Ogasawara S, 2014, ONCOLOGY-BASEL, V87, P330, DOI 10.1159/000365993; Raoul JL, 2011, CANCER TREAT REV, V37, P212, DOI 10.1016/j.ctrv.2010.07.006; Reig M, 2014, J HEPATOL, V61, P318, DOI 10.1016/j.jhep.2014.03.030; Reig M, 2013, HEPATOLOGY, V58, P2023, DOI 10.1002/hep.26586; Shao YY, 2015, ONCOLOGY-BASEL, V88, P345, DOI 10.1159/000369559; Sherman M, 2008, NEW ENGL J MED, V359, P2045, DOI 10.1056/NEJMe0807581; Shiina S, 2012, AM J GASTROENTEROL, V107, P569, DOI 10.1038/ajg.2011.425; Sohn W, 2015, J HEPATOL, V62, P1112, DOI 10.1016/j.jhep.2014.12.009; Takeda H, 2015, HEPATOL RES, V45, pE130, DOI 10.1111/hepr.12480; Uchino K, 2011, CANCER-AM CANCER SOC, V117, P4475, DOI 10.1002/cncr.25960; Yamakado K, 2014, JPN J RADIOL, V32, P260, DOI 10.1007/s11604-014-0298-9	36	7	7	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0161303	10.1371/journal.pone.0161303	http://dx.doi.org/10.1371/journal.pone.0161303			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27537374	Green Submitted, Green Published, gold			2022-12-27	WOS:000381577000086
J	Rainey, JJ; Phelps, T; Shi, JR				Rainey, Jeanette J.; Phelps, Tiffani; Shi, Jianrong			Mass Gatherings and Respiratory Disease Outbreaks in the United States - Should We Be Worried? Results from a Systematic Literature Review and Analysis of the National Outbreak Reporting System	PLOS ONE			English	Review							PANDEMIC INFLUENZA-A; PUBLIC-HEALTH; SYNDROMIC SURVEILLANCE; INFECTIOUS-DISEASES; H1N1; TRANSMISSION; VIRUS; PREVENTION; CROWD	Background Because mass gatherings create environments conducive for infectious disease transmission, public health officials may recommend postponing or canceling large gatherings during a moderate or severe pandemic. Despite these recommendations, limited empirical information exists on the frequency and characteristics of mass gathering-related respiratory disease outbreaks occurring in the United States. Methods We conducted a systematic literature review to identify articles about mass gathering-related respiratory disease outbreaks occurring in the United States from 2005 to 2014. A standard form was used to abstract information from relevant articles identified from six medical, behavioral and social science literature databases. We also analyzed data from the National Outbreaks Reporting System (NORS), maintained by the Centers for Disease Control and Prevention since 2009, to estimate the frequency of mass gathering-related respiratory disease outbreaks reported to the system. Results We identified 21 published articles describing 72 mass gathering-related respiratory disease outbreaks. Of these 72, 40 (56%) were associated with agriculture fairs and Influenza A H3N2v following probable swine exposure, and 25 (35%) with youth summer camps and pandemic Influenza A H1N1. Outbreaks of measles (n = 1) and mumps (n = 2) were linked to the international importation of disease. Between 2009 and 2013, 1,114 outbreaks were reported to NORS, including 96 respiratory disease outbreaks due to Legionella. None of these legionellosis outbreaks was linked to a mass gathering according to available data. Conclusion Mass gathering-related respiratory disease outbreaks may be uncommon in the United States, but have been reported from fairs (zoonotic transmission) as well as at camps where participants have close social contact in communal housing. International importation can also be a contributing factor. NORS collects information on certain respiratory diseases and could serve as a platform to monitor mass gathering-related respiratory outbreaks in the future.	[Rainey, Jeanette J.; Phelps, Tiffani; Shi, Jianrong] Ctr Dis Control & Prevent, Div Global Migrat & Quarantine, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Rainey, JJ (corresponding author), Ctr Dis Control & Prevent, Div Global Migrat & Quarantine, Atlanta, GA 30333 USA.	jkr7@cdc.gov						Abubakar I, 2012, LANCET INFECT DIS, V12, P66, DOI 10.1016/S1473-3099(11)70246-8; Beer KD, 2015, MMWR-MORBID MORTAL W, V64, P849, DOI 10.15585/mmwr.mm6431a3; Centers for Disease Control and Prevention, LEGIONELLA LEGIONNAI; Centers for Disease Control and Prevention (CDC), 2012, MMWR Morb Mortal Wkly Rep, V61, P561; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P969; Centers for Disease Control and Prevention (CDC), NOTIFICATION OF OUTB; Centers for Disease Control and Prevention (CDC), 2009, INTERIM CDC GUIDANCE; Centers for Disease Control and Prevention (CDC), 2008, MMWR-MORBID MORTAL W, V57, P167; Chen TH, 2010, PEDIATR INFECT DIS J, V29, P794, DOI 10.1097/INF.0b013e3181dbaacf; Chou YY, 2011, J VIROL, V85, P11235, DOI 10.1128/JVI.05794-11; Chowell G, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-159; Chowell G, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000436; Coletta M., 2006, Morbidity and Mortality Weekly Report, V55, P71; Cox CM, 2011, EMERG INFECT DIS, V17, P1143, DOI [10.3201/eid1706.101488, 10.3201/eid/1706.101488]; Doyle TJ, 2011, EPIDEMIOL INFECT, V139, P45, DOI 10.1017/S095026881000141X; Gesteland PH, 2003, J AM MED INFORM ASSN, V10, P547, DOI 10.1197/jamia.M1352; Glass LM, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-61; GLEZEN WP, 1978, NEW ENGL J MED, V298, P587, DOI 10.1056/NEJM197803162981103; Grant WD, 2010, PREHOSP DISASTER MED, V25, P183, DOI 10.1017/S1049023X00007950; Guclu H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151139; Henry K., 2006, Morbidity and Mortality Weekly Report, V55, P175; High P., 2010, Morbidity and Mortality Weekly Report, V59, P125; High P., 2009, Morbidity and Mortality Weekly Report, V58, P1270; Isella L, 2011, J THEOR BIOL, V271, P166, DOI 10.1016/j.jtbi.2010.11.033; Ishola DA, 2011, J EPIDEMIOL GLOB HEA, V1, P33, DOI 10.1016/j.jegh.2011.06.004; Jhung MA, 2013, CLIN INFECT DIS, V57, P1703, DOI 10.1093/cid/cit649; Johansson A, 2012, LANCET INFECT DIS, V12, P150, DOI 10.1016/S1473-3099(11)70287-0; Khan K, 2012, LANCET INFECT DIS, V12, P222, DOI 10.1016/S1473-3099(11)70313-9; Killian ML, 2013, ZOONOSES PUBLIC HLTH, V60, P196, DOI 10.1111/j.1863-2378.2012.01508.x; Kimberlin DW, 2010, ARCH PEDIAT ADOL MED, V164, P323, DOI 10.1001/archpediatr.2009.299; LANGMUIR AD, 1958, ANN INTERN MED, V49, P483, DOI 10.7326/0003-4819-49-3-483; Libel M, 2014, THE WORLDS FIRST APP; McCloskey B, 2014, LANCET, V383, P2083, DOI 10.1016/S0140-6736(13)62342-9; Milsten Andrew M, 2002, Prehosp Disaster Med, V17, P151; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Morrison C, 2011, EMERG INFECT DIS, V17, P87, DOI 10.3201/eid1701.091499; Nalluswami Kumar, 2011, Morbidity and Mortality Weekly Report, V60, P1213; Nsoesie EO, 2015, CLIN MICROBIOL INFEC, V21, P134, DOI 10.1016/j.cmi.2014.12.017; Pogreba-Brown K, 2013, DISASTER MED PUBLIC, V7, P467, DOI 10.1017/dmp.2013.83; Polkinghorne BG, 2013, PUBLIC HEALTH, V127, P32, DOI 10.1016/j.puhe.2012.09.014; Rainey JJ, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1101; Rashid H, 2008, LANCET INFECT DIS, V8, P526, DOI 10.1016/S1473-3099(08)70186-5; Robinson S, 2012, PEDIATR INFECT DIS J, V31, P547, DOI 10.1097/INF.0b013e31824f8124; Schaffzin JK, 2007, PEDIATRICS, V120, pE862, DOI 10.1542/peds.2006-3451; Selig B, 2013, J EMERG NURS, V39, pE39, DOI 10.1016/j.jen.2011.10.002; Shi PY, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-778; Shinde V, 2009, NEW ENGL J MED, V360, P2616, DOI 10.1056/NEJMoa0903812; Shrestha SS, 2011, CLIN INFECT DIS, V52, pS75, DOI 10.1093/cid/ciq012; Sniegoski C, 2007, ADV DIS SURVEILL, P4195; Stehle J, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-87; Sugimoto JD, 2011, EPIDEMIOLOGY, V22, P180, DOI 10.1097/EDE.0b013e3182060ca5; Tsalik EL, 2011, J AM COLL HEALTH, V59, P419, DOI 10.1080/07448481.2010.534215; Tsalik EL, 2010, J CLIN VIROL, V47, P286, DOI 10.1016/j.jcv.2009.12.012; United States Department of Health and Human Services, THE GREAT PANDEMIC; Viboud C, 2004, INT CONGR SER, V1263, P291, DOI 10.1016/j.ics.2004.01.013; Wong KK, 2012, EMERG INFECT DIS, V18, P1937, DOI 10.3201/eid1812.121097; Zepeda-Lopez HM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013256; Zielinski Andrzej, 2009, Przegl Epidemiol, V63, P343	58	12	12	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0160378	10.1371/journal.pone.0160378	http://dx.doi.org/10.1371/journal.pone.0160378			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DT6ES	27536770	gold, Green Published, Green Submitted			2022-12-27	WOS:000381577000020
J	Yang, M; Zhang, W; Wu, XJ; Wei, DT; Zhao, YX; Zhao, G; Han, X; Zhang, SL				Yang, Min; Zhang, Wen; Wu, Xiaojun; Wei, Dongtao; Zhao, Yixin; Zhao, Gang; Han, Xu; Zhang, Shunli			Consecutive Short-Scan CT for Geological Structure Analog Models with Large Size on In-Situ Stage	PLOS ONE			English	Article							SPHERICAL FUEL-ELEMENTS; RAY COMPUTED-TOMOGRAPHY; GAS-COOLED REACTOR; STRAIN ANALYSIS; SYSTEM; IMAGE; GRADIENT; DETECTOR; ROCK	For the analysis of interior geometry and property changes of a large-sized analog model during a loading or other medium (water or oil) injection process with a non-destructive way, a consecutive X-ray computed tomography (XCT) short-scan method is developed to realize an in-situ tomography imaging. With this method, the X-ray tube and detector rotate 270 degrees around the center of the guide rail synchronously by switching positive and negative directions alternately on the way of translation until all the needed cross-sectional slices are obtained. Compared with traditional industrial XCTs, this method well solves the winding problems of high voltage cables and oil cooling service pipes during the course of rotation, also promotes the convenience of the installation of high voltage generator and cooling system. Furthermore, hardware costs are also significantly decreased. This kind of scanner has higher spatial resolution and penetrating ability than medical XCTs. To obtain an effective sinogram which matches rotation angles accurately, a structural similarity based method is applied to elimination of invalid projection data which do not contribute to the image reconstruction. Finally, on the basis of geometrical symmetry property of fan-beam CT scanning, a whole sinogram filling a full 360 degrees range is produced and a standard filtered back-projection (FBP) algorithm is performed to reconstruct artifacts-free images.	[Yang, Min; Zhang, Wen; Zhao, Gang; Han, Xu] Beijing Univ Aeronaut & Astronaut, Sch Mech Engn & Automat, Beijing 100191, Peoples R China; [Wu, Xiaojun] Nanjing Univ, Dept Earth Sci, Nanjing 210093, Jiangsu, Peoples R China; [Wu, Xiaojun] Nanjing Univ, Inst Energy Sci, Nanjing 210093, Jiangsu, Peoples R China; [Wei, Dongtao] Reservoir Descript Key Lab CNPC, Lanzhou 730000, Peoples R China; [Zhao, Yixin] China Univ Min & Technol, Coll Resources & Safety Engn, Beijing 100083, Peoples R China; [Zhang, Shunli] Northwest Univ, Sch Informat Sci & Technol, Xian 710127, Peoples R China	Beihang University; Nanjing University; Nanjing University; China University of Mining & Technology; Northwest University Xi'an	Yang, M (corresponding author), Beijing Univ Aeronaut & Astronaut, Sch Mech Engn & Automat, Beijing 100191, Peoples R China.; Wu, XJ (corresponding author), Nanjing Univ, Dept Earth Sci, Nanjing 210093, Jiangsu, Peoples R China.; Wu, XJ (corresponding author), Nanjing Univ, Inst Energy Sci, Nanjing 210093, Jiangsu, Peoples R China.	minyang.ndt@263.net; nj_wuxiaojun@hotmail.com	Zhao, Yixin/J-3074-2017	Zhao, Yixin/0000-0003-0604-9756	National Key Scientific Apparatus Development of Special Item of China [2014YQ240445]; National Natural Science Foundation of China [11275019, 61572400]	National Key Scientific Apparatus Development of Special Item of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Key Scientific Apparatus Development of Special Item of China, Award Number: 2014YQ240445, Recipient: Min Yang; National Natural Science Foundation of China, Award Number: 11275019, Recipient: Min Yang; National Natural Science Foundation of China, Award Number: 61572400, Recipient: Shunli Zhang.	Adam J, 2013, J STRUCT GEOL, V55, P127, DOI 10.1016/j.jsg.2013.07.011; Ahmed S., 2016, Plant and Soil, V401, P125; Bonomo MF, 2014, GEOARCHAEOLOGY, V29, P121, DOI 10.1002/gea.21470; Chen P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141789; Christe P, 2007, ACTA GEOTECH, V2, P269, DOI 10.1007/s11440-007-0045-9; COLLETTA B, 1991, GEOLOGY, V19, P1063, DOI 10.1130/0091-7613(1991)019<1063:CXRTAO>2.3.CO;2; Gan R, 2008, MED IMAGE ANAL, V12, P452, DOI 10.1016/j.media.2008.01.004; Guido S, 2001, GEOLOGICAL SOC AM ME, V193, P179; Hirono T, 2003, ENG GEOL, V70, P37, DOI 10.1016/S0013-7952(03)00074-7; HOUNDSFIELD GN, 1972, Patent No. 1283915; Jensen-Jarolim E, 2016, ALLERGY, V71, P286, DOI 10.1111/all.12797; Jha D, 2014, APPL PHYS LETT, V105, DOI 10.1063/1.4897441; Laberke PJ, 2016, AM J ROENTGENOL, V206, P740, DOI 10.2214/AJR.15.15374; Li L, 2016, APPL MATH MODEL, V40, P4765, DOI 10.1016/j.apm.2015.12.003; Liu XF, 2015, OPT EXPRESS, V23, P33802, DOI 10.1364/OE.23.033802; Luo YH, 2012, EARTH PLANET SC LETT, V313, P12, DOI 10.1016/j.epsl.2011.11.004; Mao LT, 2015, COMPOS STRUCT, V134, P782, DOI 10.1016/j.compstruct.2015.08.129; Noo F, 2003, PHYS MED BIOL, V48, P3787, DOI 10.1088/0031-9155/48/23/001; Park HS, 2016, IEEE T MED IMAGING, V35, P480, DOI 10.1109/TMI.2015.2478905; Park YK, 2016, TECHNOL CANCER RES T, V15, P387, DOI 10.1177/1533034615576829; Sun GQ, 2016, NONLINEAR DYNAM, V85, P1, DOI 10.1007/s11071-016-2671-y; Sun GQ, 2016, NONLINEAR DYNAM, V83, P811, DOI 10.1007/s11071-015-2369-6; Sun GQ, 2015, SCI REP-UK, V5, DOI 10.1038/srep12655; Sun GQ, 2012, NONLINEAR DYNAM, V69, P1631, DOI 10.1007/s11071-012-0374-6; Thornton DA, 2014, ROCK MECH ROCK ENG, V47, P1533, DOI 10.1007/s00603-014-0589-6; Tseng CS, 2016, IET COMPUT VIS, V10, P163, DOI 10.1049/iet-cvi.2015.0030; Uesugi M, 2010, EARTH PLANET SC LETT, V299, P359, DOI 10.1016/j.epsl.2010.09.016; Wang Z, 2004, IEEE T IMAGE PROCESS, V13, P600, DOI 10.1109/TIP.2003.819861; Yang M, 2014, J BEIJING U AERONAUT, V38, DOI [10.1088/1674- 1137/38/4/046202, DOI 10.1088/1674-1137/38/4/046202]; Yang M, 2014, ENERGY, V68, P385, DOI 10.1016/j.energy.2014.02.076; Yang M, 2013, NDT&E INT, V60, P77, DOI 10.1016/j.ndteint.2013.07.006; Yang M, 2013, NEUROCOMPUTING, V120, P250, DOI 10.1016/j.neucom.2012.08.066; Yang M, 2012, NDT&E INT, V46, P48, DOI 10.1016/j.ndteint.2011.09.001; Yang M, 2011, CHINESE PHYS C, V35, P1074, DOI 10.1088/1674-1137/35/11/018; Yang M, 2010, CHINESE PHYS C, V34, P1665, DOI 10.1088/1674-1137/34/10/022; Yang Min, 2007, Journal of Beijing University of Aeronautics and Astronautics, V33, P1216; Zhang F, 2014, J X-RAY SCI TECHNOL, V22, P19, DOI 10.3233/XST-130406	37	1	1	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0161358	10.1371/journal.pone.0161358	http://dx.doi.org/10.1371/journal.pone.0161358			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27537104	Green Published, Green Submitted, gold			2022-12-27	WOS:000381577000093
J	Taylor, LA; Tan, AX; Coyle, CE; Ndumele, C; Rogan, E; Canavan, M; Curry, LA; Bradley, EH				Taylor, Lauren A.; Tan, Annabel Xulin; Coyle, Caitlin E.; Ndumele, Chima; Rogan, Erika; Canavan, Maureen; Curry, Leslie A.; Bradley, Elizabeth H.			Leveraging the Social Determinants of Health: What Works?	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; PRENATAL WIC PARTICIPATION; CASE-MANAGEMENT PROGRAM; ILL HOMELESS ADULTS; AGING IN-PLACE; UNITED-STATES; COMMUNITY INTERVENTION; PEDIATRIC ASTHMA; COST-ANALYSIS; BIRTH-WEIGHT	We summarized the recently published, peer-reviewed literature that examined the impact of investments in social services or investments in integrated models of health care and social services on health outcomes and health care spending. Of 39 articles that met criteria for inclusion in the review, 32 (82%) reported some significant positive effects on either health outcomes (N = 20), health care costs (N = 5), or both (N = 7). Of the remaining 7 (18%) studies, 3 had non-significant results, 2 had mixed results, and 2 had negative results in which the interventions were associated with poorer health outcomes. Our analysis of the literature indicates that several interventions in the areas of housing, income support, nutrition support, and care coordination and community outreach have had positive impact in terms of health improvements or health care spending reductions. These interventions may be of interest to health care policymakers and practitioners seeking to leverage social services to improve health or reduce costs. Further testing of models that achieve better outcomes at less cost is needed.	[Taylor, Lauren A.] Harvard Sch Business, Dept Hlth Policy & Management, Boston, MA USA; [Tan, Annabel Xulin; Coyle, Caitlin E.; Ndumele, Chima; Rogan, Erika; Canavan, Maureen; Curry, Leslie A.; Bradley, Elizabeth H.] Yale Sch Publ Hlth, Dept Hlth Policy & Management, New Haven, CT 06510 USA	Harvard University; Yale University	Bradley, EH (corresponding author), Yale Sch Publ Hlth, Dept Hlth Policy & Management, New Haven, CT 06510 USA.	Elizabeth.bradley@yale.edu	curry, leslie/AAA-6100-2022; Curry, Leslie A/ABA-1890-2021	curry, leslie/0000-0002-3419-4654; 	Blue Cross Blue Shield of Massachusetts Foundation Inc (BCBS)	Blue Cross Blue Shield of Massachusetts Foundation Inc (BCBS)	The study was funded by Blue Cross Blue Shield of Massachusetts Foundation Inc (BCBS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arno PS, 2009, J PUBLIC HEALTH POL, V30, P198, DOI 10.1057/jphp.2009.3; Barton A, 2007, J EPIDEMIOL COMMUN H, V61, P771, DOI 10.1136/jech.2006.048462; Basu A, 2012, HEALTH SERV RES, V47, P523, DOI 10.1111/j.1475-6773.2011.01350.x; Bhaumik U, 2013, J ASTHMA, V50, P310, DOI 10.3109/02770903.2013.765447; Bradley E., 2013, AM HLTH CARE PARADOX; Braveman PA, 2010, AM J PUBLIC HEALTH, V100, pS186, DOI 10.2105/AJPH.2009.166082; Campbell F, 2014, SCIENCE, V343, P1478, DOI 10.1126/science.1248429; Carroll-Scott A, 2013, SOC SCI MED, V95, P106, DOI 10.1016/j.socscimed.2013.04.003; Castle N, 2016, J APPL GERONTOL, V35, P857, DOI 10.1177/0733464814540049; Counsell SR, 2007, JAMA-J AM MED ASSOC, V298, P2623, DOI 10.1001/jama.298.22.2623; Edwards RT, 2011, BRIT J GEN PRACT, V61, DOI 10.3399/bjgp11X606645; El-Bastawissi AY, 2007, MATERN CHILD HLTH J, V11, P611, DOI 10.1007/s10995-007-0212-5; Erickson D., 2014, HEALTH AND COMMUNITY; Fagg J, 2014, INT J OBESITY, V38, P1343, DOI 10.1038/ijo.2014.103; Foster EM, 2010, HEALTH SERV RES, V45, P1083, DOI 10.1111/j.1475-6773.2010.01115.x; Frank DA, 2006, PEDIATRICS, V118, pE1293, DOI 10.1542/peds.2005-2943; Freedman VA, 2011, AM J PUBLIC HEALTH, V101, P79, DOI 10.2105/AJPH.2009.178640; Garland E, 2013, PROG COMM HLTH PARTN, V7, P29, DOI 10.1353/cpr.2013.0010; Goldberg DS, 2012, SOC SCI MED, V74, P1139, DOI 10.1016/j.socscimed.2011.11.040; Hacker K, 2013, AM J PUBLIC HEALTH, V103, P1163, DOI 10.2105/AJPH.2013.301254; Hawk M, 2012, AIDS CARE, V24, P577, DOI 10.1080/09540121.2011.630352; Herd P, 2008, MILBANK Q, V86, P5, DOI 10.1111/j.1468-0009.2007.00512.x; Hogan SR, 2010, SOC WORK PUBLIC HLTH, V25, P438, DOI 10.1080/19371918.2010.494471; Hu FB, 2001, NEW ENGL J MED, V345, P790, DOI 10.1056/NEJMoa010492; Irwin A, 2006, PLOS MED, V3, P749, DOI 10.1371/journal.pmed.0030106; Jacobs DE, 2014, J ENV HLTH, V76; Joyce T, 2008, J POLICY ANAL MANAG, V27, P277, DOI 10.1002/pam.20325; Karnick P, 2007, J ASTHMA, V44, P39, DOI 10.1080/02770900601125391; Kessler RC, 2014, JAMA-J AM MED ASSOC, V311, P937, DOI 10.1001/jama.2014.607; Khanani I, 2010, AM J PUBLIC HEALTH, V100, pS204, DOI 10.2105/AJPH.2009.168922; Kim K, 2007, J NUTR, V137, P1005, DOI 10.1093/jn/137.4.1005; Kothari CL, 2014, AM J PUBLIC HEALTH, V104, pS96, DOI 10.2105/AJPH.2013.301359; Kumar S, 2012, SOC SCI MED, V74, P696, DOI 10.1016/j.socscimed.2011.11.017; Larimer ME, 2009, JAMA-J AM MED ASSOC, V301, P1349, DOI 10.1001/jama.2009.414; Lazariu-Bauer V, 2004, MATERN CHILD HLTH J, V8, P77, DOI 10.1023/B:MACI.0000025730.02966.62; Lee P, 1997, ANNU REV PUBL HEALTH, V18, P1, DOI 10.1146/annurev.publhealth.18.1.1; Leung CW, 2012, AM J CLIN NUTR, V95, P17, DOI 10.3945/ajcn.111.012294; Loucks EB, 2015, HEALTH EDUC BEHAV, V42, P370, DOI 10.1177/1090198114560020; Ludwig J, 2011, NEW ENGL J MED, V365, P1509, DOI 10.1056/NEJMsa1103216; Marmot M, 2005, LANCET, V365, P1099, DOI 10.1016/S0140-6736(05)74234-3; McGinnis JM, 2002, HEALTH AFFAIR, V21, P78, DOI 10.1377/hlthaff.21.2.78; Muhajarine N, 2012, CAN J PUBLIC HEALTH, V103, pS26, DOI 10.1007/BF03404456; Murray CJL, 2006, PLOS MED, V3, P1513, DOI 10.1371/journal.pmed.0030260; Myers V, 2014, INT J CARDIOL, V170, P338, DOI 10.1016/j.ijcard.2013.11.009; Nicholas LH, 2011, ECON HUM BIOL, V9, P1, DOI 10.1016/j.ehb.2010.10.003; Olds DL, 2014, JAMA PEDIATR, V168, P800, DOI 10.1001/jamapediatrics.2014.472; Platz EA, 2000, CANCER CAUSE CONTROL, V11, P579, DOI 10.1023/A:1008999232442; Ploeg MV, 2007, ECON HUM BIOL, V5, P20, DOI 10.1016/j.ehb.2006.10.002; Prus SG, 2011, SOC SCI MED, V73, P50, DOI 10.1016/j.socscimed.2011.04.010; Rantz M, 2014, NURS OUTLOOK, V62, P237, DOI 10.1016/j.outlook.2014.02.005; Rimmer JH, 2013, AM J PHYS MED REHAB, V92, P1084, DOI 10.1097/PHM.0b013e31829e780e; Sacher PM, 2010, OBESITY, V18, pS62, DOI 10.1038/oby.2009.433; Sadowski LS, 2009, JAMA-J AM MED ASSOC, V301, P1771, DOI 10.1001/jama.2009.561; Song Z, 2013, HEALTH AFFAIR, V32, P36, DOI 10.1377/hlthaff.2011.1392; Stampfer MJ, 2000, NEW ENGL J MED, V343, P16, DOI 10.1056/NEJM200007063430103; Szanton SL, 2011, J AM GERIATR SOC, V59, P2314, DOI 10.1111/j.1532-5415.2011.03698.x; Thomas KS, 2013, HEALTH SERV RES, V48, P1215, DOI 10.1111/1475-6773.12015; Woods ER, 2012, PEDIATRICS, V129, P465, DOI 10.1542/peds.2010-3472	58	163	164	5	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2016	11	8							e0160217	10.1371/journal.pone.0160217	http://dx.doi.org/10.1371/journal.pone.0160217			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DT4YN	27532336	Green Submitted, Green Published, gold			2022-12-27	WOS:000381487600027
J	Wang, FBA; Liu, JC; Chen, MX; Zhou, LJ; Li, ZW; Zhao, Q; Pan, G; Zaidi, SHR; Cheng, FM				Wang, Fubiao; Liu, Jianchao; Chen, Minxue; Zhou, Lujian; Li, Zhaowei; Zhao, Qian; Pan, Gang; Zaidi, Syed-Hassan-Raza; Cheng, Fangmin			Involvement of Abscisic Acid in PSII Photodamage and D1 Protein Turnover for Light-Induced Premature Senescence of Rice Flag Leaves	PLOS ONE			English	Article							DARK-INDUCED SENESCENCE; LEAF SENESCENCE; PHOTOSYSTEM-II; ARABIDOPSIS-THALIANA; CARBON RESERVES; FTSH PROTEASE; WATER-STRESS; WHEAT; CHLOROPLAST; REMOBILIZATION	D1 protein in the PSII reaction center is the major target of photodamage, and it exhibits the highest turnover rate among all the thylakoid proteins. In this paper, rice psf (premature senescence of flag leaves) mutant and its wild type were used to investigate the genotype-dependent alteration in PSII photo-damage and D1 protein turnover during leaf senescence and its relation to ABA accumulation in senescent leaves. The symptom and extent of leaf senescence of the psf mutant appeared to be sunlight-dependent under natural field condition. The psf also displayed significantly higher levels of ABA accumulation in senescent leaves than the wild type. However, the premature senescence lesion of psf leaves could be alleviated by shaded treatment, concomitantly with the strikingly suppressed ABA level in the shaded areas of flag leaves. The change in ABA concentration contributed to the regulation of shade-delayed leaf senescence. The participation of ABA in the timing of senescence initiation and in the subsequent rate of leaf senescence was closely associated with PSII photodamage and D1 protein turnover during leaf senescence, in which the transcriptional expression of several key genes (psbA, psbB, psbC and OsFtsH2) involved in D1 protein biosynthesis and PSII repair cycle was seriously suppressed by the significantly increased ABA level. This response resulted in the low rate of D1 protein synthesis and impaired repair recovery in the presence of ABA. The psf showed evidently decreased D1 protein amount in the senescent leaves. Both the inhibition of de novo synthesized D1 protein and the slow rate of proteolytic removal for the photodamaged D1 protein was among the most crucial steps for the linkage between light-dependent leaf senescence and the varying ABA concentration in psf mutant leaves. OsFtsH2 transcriptional expression possibly played an important role in the regulation of D1 protein turnover and PSII repair cycle in relation to ABA mediated leaf senescence.	[Wang, Fubiao; Liu, Jianchao; Zhou, Lujian; Li, Zhaowei; Zhao, Qian; Pan, Gang; Zaidi, Syed-Hassan-Raza; Cheng, Fangmin] Zhejiang Univ, Inst Crop Sci, Coll Agr & Biotechnol, Hangzhou 310058, Zhejiang, Peoples R China; [Chen, Minxue] China Natl Rice Res Inst, State Key Lab Rice Biol, Hangzhou 310006, Zhejiang, Peoples R China; [Liu, Jianchao; Li, Zhaowei; Cheng, Fangmin] Jiangsu Collaborat Innovat Ctr Modern Crop Prod, Nanjing, Jiangsu, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Zhejiang University; Chinese Academy of Agricultural Sciences; China National Rice Research Institute, CAAS	Cheng, FM (corresponding author), Zhejiang Univ, Inst Crop Sci, Coll Agr & Biotechnol, Hangzhou 310058, Zhejiang, Peoples R China.; Cheng, FM (corresponding author), Jiangsu Collaborat Innovat Ctr Modern Crop Prod, Nanjing, Jiangsu, Peoples R China.	chengfm@zju.edu.cn	Zaidi, Syed Hassan Raza/AAB-6307-2019	Zaidi, Syed Hassan Raza/0000-0003-0093-1481; Zhao, Qian/0000-0001-9238-0810	National Natural Science Foundation of China [31271655, 31571602]; National Key Research and Development Plan of China [2016YFD0300500]; Zhejiang Provincial Natural Science Foundation of China [LZ15C130001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Plan of China; Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province)	The authors are deeply indebted to National Natural Science Foundation of China (No. 31271655 and 31571602), National Key Research and Development Plan of China (No 2016YFD0300500) and Zhejiang Provincial Natural Science Foundation of China (LZ15C130001) for their financial support to this research project.	Adam Z, 2006, CURR OPIN PLANT BIOL, V9, P234, DOI 10.1016/j.pbi.2006.03.010; Allakhverdiev SI, 2002, PLANT PHYSIOL, V130, P1443, DOI 10.1104/pp.011114; Almoguera C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051443; ARO EM, 1993, BIOCHIM BIOPHYS ACTA, V1143, P113, DOI 10.1016/0005-2728(93)90134-2; BARBER J, 1992, TRENDS BIOCHEM SCI, V17, P61, DOI 10.1016/0968-0004(92)90503-2; Brouwer B, 2012, PLANT CELL ENVIRON, V35, P1084, DOI 10.1111/j.1365-3040.2011.02474.x; Buchanan-Wollaston V, 2005, PLANT J, V42, P567, DOI 10.1111/j.1365-313X.2005.02399.x; Carrion CA, 2013, J EXP BOT, V64, P4967, DOI 10.1093/jxb/ert285; Causin HF, 2006, PLANT SCI, V171, P24, DOI 10.1016/j.plantsci.2006.02.009; Chen M, 2000, PLANT J, V22, P303, DOI 10.1046/j.1365-313x.2000.00738.x; Cutler SR, 2010, ANNU REV PLANT BIOL, V61, P651, DOI 10.1146/annurev-arplant-042809-112122; Distelfeld A, 2014, J EXP BOT, V65, P3783, DOI 10.1093/jxb/ert477; DUNGEY NO, 1982, J EXP BOT, V33, P12, DOI 10.1093/jxb/33.1.12; Fischer AM, 2012, CRIT REV PLANT SCI, V31, P124, DOI 10.1080/07352689.2011.616065; Fujiki Y, 2001, PHYSIOL PLANTARUM, V111, P345, DOI 10.1034/j.1399-3054.2001.1110312.x; Gan SS, 1997, PLANT PHYSIOL, V113, P313, DOI 10.1104/pp.113.2.313; Hankamer B, 1997, ANNU REV PLANT PHYS, V48, P641, DOI 10.1146/annurev.arplant.48.1.641; Hung KT, 2004, J PLANT PHYSIOL, V161, P1347, DOI 10.1016/j.jplph.2004.05.011; Jia YX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065687; Jiang MY, 2001, PLANT CELL PHYSIOL, V42, P1265, DOI 10.1093/pcp/pce162; Jibran R, 2013, PLANT MOL BIOL, V82, P547, DOI 10.1007/s11103-013-0043-2; Kato Y, 2009, J BIOCHEM, V146, P463, DOI 10.1093/jb/mvp073; Keech O, 2007, PLANT CELL ENVIRON, V30, P1523, DOI 10.1111/j.1365-3040.2007.01724.x; Kempa S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003935; Kojima M, 2009, PLANT CELL PHYSIOL, V50, P1201, DOI 10.1093/pcp/pcp057; Kusaba M, 2007, PLANT CELL, V19, P1362, DOI 10.1105/tpc.106.042911; Li ZW, 2015, J PLANT PHYSIOL, V176, P1, DOI 10.1016/j.jplph.2014.09.020; LICHTENTHALER HK, 1987, METHOD ENZYMOL, V148, P350; Lim PO, 2003, TRENDS PLANT SCI, V8, P272, DOI 10.1016/S1360-1385(03)00103-1; Lim PO, 2007, J PLANT BIOL, V50, P291, DOI 10.1007/BF03030657; Lindahl M, 2000, PLANT CELL, V12, P419, DOI 10.1105/tpc.12.3.419; Lu S, 2008, J AM SOC HORTIC SCI, V133, P360, DOI 10.21273/JASHS.133.3.360; Luo PG, 2013, PLANT CELL ENVIRON, V36, P683, DOI 10.1111/pce.12006; Martinez DE, 2008, PLANT BIOLOGY, V10, P15, DOI 10.1111/j.1438-8677.2008.00089.x; Murata N, 2007, BBA-BIOENERGETICS, V1767, P414, DOI 10.1016/j.bbabio.2006.11.019; Nelson N, 2006, ANNU REV PLANT BIOL, V57, P521, DOI 10.1146/annurev.arplant.57.032905.105350; Nixon PJ, 2005, J EXP BOT, V56, P357, DOI 10.1093/jxb/eri021; Nooden LD, 1996, PHYSIOL PLANTARUM, V96, P491, DOI 10.1111/j.1399-3054.1996.tb00463.x; Prochazkova D, 2004, BIOL PLANTARUM, V48, P33, DOI 10.1023/B:BIOP.0000024272.98338.5b; Quirino BF, 2000, TRENDS PLANT SCI, V5, P278, DOI 10.1016/S1360-1385(00)01655-1; Roberts IN, 2012, PHYSIOL PLANTARUM, V145, P130, DOI 10.1111/j.1399-3054.2012.01574.x; Sakamoto W, 2003, PLANT CELL, V15, P2843, DOI 10.1105/tpc.017319; Shaik R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077261; Sinvany-Villalobo G, 2004, PLANT PHYSIOL, V135, P1336, DOI 10.1104/pp.104.043299; Takahashi S, 2011, TRENDS PLANT SCI, V16, P53, DOI 10.1016/j.tplants.2010.10.001; Takechi K, 2000, PLANT CELL PHYSIOL, V41, P1334, DOI 10.1093/pcp/pcd067; Tyystjarvi E, 1996, P NATL ACAD SCI USA, V93, P2213, DOI 10.1073/pnas.93.5.2213; Weaver LM, 2001, PLANT PHYSIOL, V127, P876, DOI 10.1104/pp.010312; Wingler A, 2006, J EXP BOT, V57, P391, DOI 10.1093/jxb/eri279; Wu XY, 2012, J INTEGR PLANT BIOL, V54, P936, DOI 10.1111/jipb.12005; Yang JC, 2003, PLANT CELL ENVIRON, V26, P1621, DOI 10.1046/j.1365-3040.2003.01081.x; Yang JC, 2002, PLANTA, V215, P645, DOI 10.1007/s00425-002-0789-2; Yang JC, 2001, AGRON J, V93, P196, DOI 10.2134/agronj2001.931196x; Yu F, 2005, PLANT PHYSIOL, V138, P1957, DOI 10.1104/pp.105.061234; Zhang KW, 2012, PLANT J, V69, P667, DOI 10.1111/j.1365-313X.2011.04821.x; Zhao LF, 2012, J INTEGR PLANT BIOL, V54, P567, DOI 10.1111/j.1744-7909.2012.01139.x	56	26	33	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2016	11	8							e0161203	10.1371/journal.pone.0161203	http://dx.doi.org/10.1371/journal.pone.0161203			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4YN	27532299	Green Published, gold, Green Submitted			2022-12-27	WOS:000381487600074
J	Davies, HN; Beckley, LE; Kobryn, HT; Lombard, AT; Radford, B; Heyward, A				Davies, Harriet N.; Beckley, Lynnath E.; Kobryn, Halina T.; Lombard, Amanda T.; Radford, Ben; Heyward, Andrew			Integrating Climate Change Resilience Features into the Incremental Refinement of an Existing Marine Park	PLOS ONE			English	Article							CORAL-REEFS; BIODIVERSITY CONSERVATION; PROTECTED AREAS; RESERVE DESIGN; PHASE-SHIFTS; TRADE-OFFS; NINGALOO; SYSTEM; COMMUNITIES; TEMPERATURE	Marine protected area (MPA) designs are likely to require iterative refinement as new knowledge is gained. In particular, there is an increasing need to consider the effects of climate change, especially the ability of ecosystems to resist and/or recover from climate-related disturbances, within the MPA planning process. However, there has been limited research addressing the incorporation of climate change resilience into MPA design. This study used Marxan conservation planning software with fine-scale shallow water (<20 m) bathymetry and habitat maps, models of major benthic communities for deeper water, and comprehensive human use information from Ningaloo Marine Park in Western Australia to identify climate change resilience features to integrate into the incremental refinement of the marine park. The study assessed the representation of benthic habitats within the current marine park zones, identified priority areas of high resilience for inclusion within no-take zones and examined if any iterative refinements to the current no-take zones are necessary. Of the 65 habitat classes, 16 did not meet representation targets within the current no-take zones, most of which were in deeper offshore waters. These deeper areas also demonstrated the highest resilience values and, as such, Marxan outputs suggested minor increases to the current no-take zones in the deeper offshore areas. This work demonstrates that inclusion of fine-scale climate change resilience features within the design process for MPAs is feasible, and can be applied to future marine spatial planning practices globally.	[Davies, Harriet N.; Beckley, Lynnath E.; Kobryn, Halina T.] Murdoch Univ, Sch Vet & Life Sci, Perth, WA, Australia; [Lombard, Amanda T.] Nelson Mandela Metropolitan Univ, Inst Coastal & Marine Res, Port Elizabeth, South Africa; [Radford, Ben; Heyward, Andrew] Australian Inst Marine Sci, Perth, WA, Australia	Murdoch University; Nelson Mandela University; Australian Institute of Marine Science	Davies, HN (corresponding author), Murdoch Univ, Sch Vet & Life Sci, Perth, WA, Australia.	Harriet_Davies@hotmail.com	Lombard, Mandy/AAE-4649-2019; Kobryn, Halina/E-5051-2012	Lombard, Mandy/0000-0002-4323-1170; Kobryn, Halina/0000-0003-1004-7593	Murdoch University	Murdoch University	H.D. received scholarship funding through Murdoch University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABPmer (ABP Marine Environmental Research Limited), 2011, ARCGIS 10 BOUNDARY T; Airame S, 2003, ECOL APPL, V13, pS170; Anthony KRN, 2015, GLOBAL CHANGE BIOL, V21, P48, DOI 10.1111/gcb.12700; Ardron J. A., 2010, MARXAN GOOD PRACTICE; Aronson RB, 2000, NATURE, V405, P36, DOI 10.1038/35011132; Babcock R, 2008, CSIRO MARINE AND ATM; Ball I. R., 2009, SPATIAL CONSERVATION, P185, DOI DOI 10.1111/EVA.12631; Beckley LE, 2012, MAR FRESHWATER RES, V63, P17, DOI 10.1071/MF11074; Brown K, 2001, ECOL ECON, V37, P417, DOI 10.1016/S0921-8009(00)00293-7; Cassata L, 2008, J COASTAL RES, V24, P139, DOI 10.2112/05-0623.1; Cheung WWL, 2012, MAR FRESHWATER RES, V63, P415, DOI 10.1071/MF11205; Chollett I, 2013, BIOL CONSERV, V167, P179, DOI 10.1016/j.biocon.2013.08.010; Colquhoun J., 2007, NINGALOO REEF MARINE; Depczynski M, 2013, CORAL REEFS, V32, P233, DOI 10.1007/s00338-012-0974-0; Edgar GJ, 2014, NATURE, V506, P216, DOI 10.1038/nature13022; Edinger EN, 1998, MAR POLLUT BULL, V36, P617, DOI 10.1016/S0025-326X(98)00047-2; Fabricius KE, 2004, MOL ECOL, V13, P2445, DOI 10.1111/j.1365-294X.2004.02230.x; Falter JL, 2014, LIMNOL OCEANOGR, V59, P1241, DOI 10.4319/lo.2014.59.4.1241; Feng M, 2015, GEOPHYS RES LETT, V42, P104, DOI 10.1002/2014GL062509; Feng M, 2013, SCI REP-UK, V3, DOI 10.1038/srep01277; Fox NJ, 2005, BIOL CONSERV, V125, P399, DOI 10.1016/j.biocon.2005.02.006; Game ET, 2008, ECOL APPL, V18, P670, DOI 10.1890/07-1027.1; Game ET, 2008, CONSERV BIOL, V22, P1619, DOI 10.1111/j.1523-1739.2008.01037.x; Game ET, 2009, TRENDS ECOL EVOL, V24, P360, DOI 10.1016/j.tree.2009.01.011; Game ET, 2008, MARXAN USER MANUAL F; Geoscience Australia, 2004, GEODATA COAST 100K D; Gilmour JP, 2013, SCIENCE, V340, P69, DOI 10.1126/science.1232310; Graham NAJ, 2015, NATURE, V518, P94, DOI 10.1038/nature14140; Graham NAJ, 2011, OCEANOGR MAR BIOL, V49, P105; Grantham HS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016552; Green AL, 2014, COAST MANAGE, V42, P143, DOI 10.1080/08920753.2014.877763; Groves CR, 2012, BIODIVERS CONSERV, V21, P1651, DOI 10.1007/s10531-012-0269-3; Guidetti P, 2013, AQUAT CONSERV, V23, P179, DOI 10.1002/aqc.2314; Hansen GJA, 2011, BIOL CONSERV, V144, P1866, DOI 10.1016/j.biocon.2011.04.002; Harris LR, 2014, J APPL ECOL, V51, P1504, DOI 10.1111/1365-2664.12345; Harrison HB, 2012, CURR BIOL, V22, P1023, DOI 10.1016/j.cub.2012.04.008; Harvell CD, 1999, SCIENCE, V285, P1505, DOI 10.1126/science.285.5433.1505; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hoegh-Guldberg O, 2010, SCIENCE, V328, P1523, DOI 10.1126/science.1189930; Hughes TP, 2007, CURR BIOL, V17, P360, DOI 10.1016/j.cub.2006.12.049; Hughes TP, 2010, TRENDS ECOL EVOL, V25, P633, DOI 10.1016/j.tree.2010.07.011; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; IUCN (International Union for the Conservation of Nature), 2014, THE PROMISE OF SYDNE; Januchowski-Hartley FA, 2013, ECOL LETT, V16, P191, DOI 10.1111/ele.12028; Jennings S, 1996, BIOL CONSERV, V75, P201, DOI 10.1016/0006-3207(95)00081-X; Johansson CL, 2010, MAR ECOL PROG SER, V414, P65, DOI 10.3354/meps08730; Jones KR, 2016, BIOL CONSERV, V194, P121, DOI 10.1016/j.biocon.2015.12.008; Keller BD, 2009, ENVIRON MANAGE, V44, P1069, DOI 10.1007/s00267-009-9346-0; Klein CJ, 2008, CONSERV BIOL, V22, P691, DOI 10.1111/j.1523-1739.2008.00896.x; Kobryn HT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070105; Ledlie MH, 2007, CORAL REEFS, V26, P641, DOI 10.1007/s00338-007-0230-1; Levy JS, 2013, MAR POLICY, V38, P16, DOI 10.1016/j.marpol.2012.05.015; Magris RA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140828; Magris RA, 2014, BIOL CONSERV, V170, P207, DOI 10.1016/j.biocon.2013.12.032; Maina JM, 2015, REMOTE SENS-BASEL, V7, P16571, DOI 10.3390/rs71215849; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; Maynard JA, 2010, CORAL REEFS, V29, P381, DOI 10.1007/s00338-010-0603-8; McClanahan T, 2002, CONSERV ECOL, V6; McClanahan TR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042884; McClanahan TR, 2009, MAR ECOL PROG SER, V396, P99, DOI 10.3354/meps08279; McCook LJ, 2010, P NATL ACAD SCI USA, V107, P18278, DOI 10.1073/pnas.0909335107; McLeod E, 2010, COAST MANAGE, V38, P518, DOI 10.1080/08920753.2010.509466; McLeod E, 2009, FRONT ECOL ENVIRON, V7, P362, DOI 10.1890/070211; Mcmanus JW, 1997, ENVIRON MANAGE, V21, P69, DOI 10.1007/s002679900006; Mellin C, 2016, ECOL LETT, V19, P629, DOI 10.1111/ele.12598; Moore JAY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051807; MPRA (Marine Parks and Reserves Authority), 2013, NINGALOO MARINE PARK; Mumby PJ, 2008, J APPL ECOL, V45, P854, DOI 10.1111/j.1365-2664.2008.01459.x; Mumby PJ, 2011, ECOL LETT, V14, P132, DOI 10.1111/j.1461-0248.2010.01562.x; Mumby PJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008657; Mumby PJ, 2006, ECOL APPL, V16, P747, DOI 10.1890/1051-0761(2006)016[0747:TIOEGS]2.0.CO;2; Obura D, 2011, CORAL REEFS, V30, P607, DOI 10.1007/s00338-011-0741-7; Olds AD, 2014, GLOBAL CHANGE BIOL, V20, P3050, DOI 10.1111/gcb.12606; Onton K, 2011, MAR ECOL PROG SER, V433, P75, DOI 10.3354/meps09156; Palumbi SR, 2014, SCIENCE, V344, P895, DOI 10.1126/science.1251336; Pearce AF, 2013, J MARINE SYST, V111, P139, DOI 10.1016/j.jmarsys.2012.10.009; Possingham H, 2000, MARINE RESERVE DESIG; Pressey RL, 2003, BIOL CONSERV, V112, P99, DOI 10.1016/S0006-3207(02)00424-X; Rowlands G, 2012, MAR POLLUT BULL, V64, P1222, DOI 10.1016/j.marpolbul.2012.03.003; Santoro K, 2014, STATUS REPORT OF THE; Selig ER, 2012, GLOBAL CHANGE BIOL, V18, P1561, DOI 10.1111/j.1365-2486.2012.02658.x; Selig ER, 2010, GLOBAL ECOL BIOGEOGR, V19, P397, DOI 10.1111/j.1466-8238.2009.00522.x; Smallwood CB, 2012, TOURISM MANAGE, V33, P517, DOI 10.1016/j.tourman.2011.06.001; Smallwood CB, 2011, OCEAN COAST MANAGE, V54, P330, DOI 10.1016/j.ocecoaman.2010.11.007; Smith JE, 2006, ECOL LETT, V9, P835, DOI 10.1111/j.1461-0248.2006.00937.x; Speed CW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069863; Spencer T, 2000, MAR POLLUT BULL, V40, P569, DOI 10.1016/S0025-326X(00)00026-6; Stewart RR, 2007, CONSERV BIOL, V21, P346, DOI 10.1111/j.1523-1739.2006.00618.x; Stewart RR, 2005, ENVIRON MODEL ASSESS, V10, P203, DOI 10.1007/s10666-005-9001-y; Szmant AM, 2002, ESTUARIES, V25, P743, DOI 10.1007/BF02804903; Taebi S, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2010JC006439; van Woesik R, 2011, MAR ECOL PROG SER, V434, P67, DOI 10.3354/meps09203; Webster FJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124162; Weeks R, 2013, CONSERV BIOL, V27, P1234, DOI 10.1111/cobi.12153; Weeks R, 2010, BIOL CONSERV, V143, P1236, DOI 10.1016/j.biocon.2010.02.031; West JM, 2003, CONSERV BIOL, V17, P956, DOI 10.1046/j.1523-1739.2003.02055.x; Wilkinson C., 2008, STATUS OF CORAL REEF; Williams ID, 2001, CORAL REEFS, V19, P358, DOI 10.1007/s003380000121; Wilson SK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015185; Yates KK, 2014, BIOGEOSCIENCES, V11, P4321, DOI 10.5194/bg-11-4321-2014; Zinke J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4607	102	13	13	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2016	11	8							e0161094	10.1371/journal.pone.0161094	http://dx.doi.org/10.1371/journal.pone.0161094			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4UN	27529820	Green Submitted, Green Published, gold			2022-12-27	WOS:000381476700046
J	Loreto, RG; Hughes, DP				Loreto, Raquel G.; Hughes, David P.			Disease in the Society: Infectious Cadavers Result in Collapse of Ant Sub-Colonies	PLOS ONE			English	Article							HONEY-BEE; RESISTANCE; NESTS; RESIN; TRANSMISSION; ARCHITECTURE; PROPHYLAXIS; HYMENOPTERA; DIVERSITY; IMMUNITY	Despite the growing number of experimental studies on mechanisms of social immunity in ant societies, little is known about how social behavior relates to disease progression within the nests of ants. In fact, when empirically studying disease in ant societies, it is common to remove dead ants from experiments to confirm infection by the studied parasite. This unfortunately does not allow disease to progress within the nest as it may be assumed would happen under natural conditions. Therefore, the approach taken so far has resulted in a limited knowledge of diseases dynamics within the nest environment. Here we introduced a single infectious cadaver killed by the fungus Beauveria bassiana into small nests of the ant Camponotus castaneus. We then observed the natural progression of the disease by not removing the corpses of the ants that died following the first entry of the disease. Because some behaviors such as social isolation of sick individuals or the removal of cadavers by nestmates are considered social immune functions and thus adaptations at the colony level that reduce disease spread, we also experimentally confined some sub-colonies to one or two chamber nests to prevent the expression of such behaviors. Based on 51 small nests and survival studies in 1,003 ants we found that a single introduced infectious cadaver was able to transmit within the nest, and social immunity did not prevent the collapse of the small sub-colonies here tested. This was true whether ants did or did not have the option to remove the infectious cadaver. Therefore, we found no evidence that the typically studied social immunity behaviors can reduce disease spread in the conditions here tested.	[Loreto, Raquel G.; Hughes, David P.] Penn State Univ, Dept Entomol, University Pk, PA 16802 USA; [Loreto, Raquel G.; Hughes, David P.] Penn State Univ, Ctr Infect Dis Dynam, University Pk, PA 16802 USA; [Loreto, Raquel G.] Minist Educ Brazil, CAPES Fdn, BR-70040020 Brasilia, DF, Brazil; [Hughes, David P.] Penn State Univ, Dept Biol, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Loreto, RG; Hughes, DP (corresponding author), Penn State Univ, Dept Entomol, University Pk, PA 16802 USA.; Loreto, RG; Hughes, DP (corresponding author), Penn State Univ, Ctr Infect Dis Dynam, University Pk, PA 16802 USA.; Loreto, RG (corresponding author), Minist Educ Brazil, CAPES Fdn, BR-70040020 Brasilia, DF, Brazil.; Hughes, DP (corresponding author), Penn State Univ, Dept Biol, University Pk, PA 16802 USA.	raquelgloreto@gmail.com; dph14@psu.edu			Coordernacao de Aperfeicoamento de Pessoa de Nivea Superior (CAPES-Brazil) [6203-10-8]; Pennsylvania State University; National Science Foundation as part of the joint NSF-NIH-USDA Ecology and Evolution of Infectious Diseases program [1414296]	Coordernacao de Aperfeicoamento de Pessoa de Nivea Superior (CAPES-Brazil); Pennsylvania State University; National Science Foundation as part of the joint NSF-NIH-USDA Ecology and Evolution of Infectious Diseases program	RGL was funded by Coordernacao de Aperfeicoamento de Pessoa de Nivea Superior (CAPES-Brazil), grant # 6203-10-8) and by The Pennsylvania State University. DPH is funded by The Pennsylvania State University. Part of this work was funded by National Science Foundation (grant # 1414296) as part of the joint NSF-NIH-USDA Ecology and Evolution of Infectious Diseases program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1971, INSECT SOC; Boomsma J.J., 2005, P139, DOI 10.1079/9780851998121.0139; Bos N, 2012, J EVOLUTION BIOL, V25, P342, DOI 10.1111/j.1420-9101.2011.02425.x; Brown MJF, 2009, APIDOLOGIE, V40, P410, DOI 10.1051/apido/2009019; Castella G, 2008, ANIM BEHAV, V75, P1591, DOI 10.1016/j.anbehav.2007.10.014; Chapuisat M, 2007, P ROY SOC B-BIOL SCI, V274, P2013, DOI 10.1098/rspb.2007.0531; Chouvenc T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034484; Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498; Cremer S, 2007, CURR BIOL, V17, pR693, DOI 10.1016/j.cub.2007.06.008; Graystock P, 2011, BEHAV ECOL SOCIOBIOL, V65, P2319, DOI 10.1007/s00265-011-1242-y; Heinze J, 2010, CURR BIOL, V20, P249, DOI 10.1016/j.cub.2009.12.031; Holldobler B., 1990, pi; Holldobler B., 2009, SUPERORGANISM; Hughes DP, 2016, ADV GENETIC IN PRESS; Hughes WOH, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-45; Hughes WOH, 2004, J INVERTEBR PATHOL, V85, P46, DOI 10.1016/j.jip.2003.12.005; Hughes WOH, 2002, P ROY SOC B-BIOL SCI, V269, P1811, DOI 10.1098/rspb.2002.2113; Humber RA, 2011, CATALOG SPECIES ARSE; Jaccoud DB, 1999, ENTOMOL EXP APPL, V93, P51, DOI 10.1023/A:1003830625680; Keller S, 2003, BIOCONTROL, V48, P307, DOI 10.1023/A:1023646207455; Konrad M, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001300; Lach L, 2010, ANT ECOLOGY, P1; McMenamin AJ, 2015, CURR OPIN INSECT SCI, V8, P121, DOI 10.1016/j.cois.2015.01.015; Moreau SJM, 2013, J INSECT PHYSIOL, V59, P186, DOI 10.1016/j.jinsphys.2012.10.005; Okuno M, 2012, J ETHOL, V30, P23, DOI 10.1007/s10164-011-0285-x; PENG YS, 1987, J INVERTEBR PATHOL, V49, P54, DOI 10.1016/0022-2011(87)90125-X; PEREIRA RM, 1992, ENVIRON ENTOMOL, V21, P1427, DOI 10.1093/ee/21.6.1427; Pettis JS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070182; Pinter-Wollman N, 2015, BIOL LETTERS, V11, DOI 10.1098/rsbl.2015.0695; Qiu HL, 2014, J INSECT BEHAV, V27, P678, DOI 10.1007/s10905-014-9459-z; Reber A, 2011, J EVOLUTION BIOL, V24, P954, DOI 10.1111/j.1420-9101.2011.02230.x; Reber A, 2008, ECOL LETT, V11, P682, DOI 10.1111/j.1461-0248.2008.01177.x; Reber A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035372; Rosengaus RB, 1998, BEHAV ECOL SOCIOBIOL, V44, P125, DOI 10.1007/s002650050523; Schmid-Hempel P., 1998, Parasites in social insects.; Simone M, 2009, EVOLUTION, V63, P3016, DOI 10.1111/j.1558-5646.2009.00772.x; Steinhauer NA, 2014, J APICULT RES, V53, P1, DOI 10.3896/IBRA.1.53.1.01; Stokstad E, 2007, SCIENCE, V316, P970, DOI 10.1126/science.316.5827.970; Tobin JE, 1991, ANT PLANT INTERACTIO; Tragust S, 2013, CURR BIOL, V23, P76, DOI 10.1016/j.cub.2012.11.034; Tranter C, 2015, BEHAV ECOL, V26, P396, DOI 10.1093/beheco/aru203; Tschinkel Walter R., 2015, Journal of Bioeconomics, V17, P271; Ugelvig LV, 2007, CURR BIOL, V17, P1967, DOI 10.1016/j.cub.2007.10.029; Westhus C, 2014, BEHAV ECOL SOCIOBIOL, V68, P1701, DOI 10.1007/s00265-014-1778-8; Wilfert L, 2016, SCIENCE, V351, P594, DOI 10.1126/science.aac9976; Williams GR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099465	46	9	10	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2016	11	8							e0160820	10.1371/journal.pone.0160820	http://dx.doi.org/10.1371/journal.pone.0160820			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4UN	27529548	Green Submitted, Green Published, gold			2022-12-27	WOS:000381476700024
J	Park, CK; Oh, HJ; Choi, HY; Shin, HJ; Lim, JH; Oh, IJ; Kim, YI; Lim, SC; Kim, YC; Kwon, YS				Park, Cheol-Kyu; Oh, Hyoung-Joo; Choi, Ha-Young; Shin, Hong-Joon; Lim, Jung Hwan; Oh, In-Jae; Kim, Yu-Il; Lim, Sung-Chul; Kim, Young-Chul; Kwon, Yong-Soo			Microbiological Characteristics and Predictive Factors for Mortality in Pleural Infection: A Single-Center Cohort Study in Korea	PLOS ONE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; COMPLICATED PARAPNEUMONIC EFFUSIONS; INTENSIVE-CARE-UNIT; THORACIC EMPYEMA; BACTERIOLOGY; ADULTS; MANAGEMENT; GUIDELINE; CRITERIA; OUTCOMES	Background Identification and understanding of the pathogens responsible for pleural infection is critical for appropriate antibiotic treatment. This study sought to determine the microbiological characteristics of pleural infection and to identify potential predictive factors associated with mortality. Methods In this retrospective study, we analyzed patient data from 421 cases of parapneumonic effusion. A total of 184 microorganisms were isolated from 164 patients, using two culture systems: a standard method and a method using pairs of aerobic and anaerobic blood culture bottles. Results The most frequently isolated microorganisms were streptococci (31.5%), followed by staphylococci (23.4%), gram-negative bacteria (18.5%) and anaerobes (10.3%). Streptococci were the main microorganisms found in standard culture (41.9%) and community-acquired infections (52.2%), and were susceptible to all antimicrobial agents in drug sensitivity testing. Staphylococci were the most frequently isolated pathogens in blood cultures (30.8%) and hospital-acquired infections (38.3%), and were primarily multidrug-resistant (61.8%). In multivariate analysis, the following were significant predictive factors for 30-day mortality among the total population: CURB-65 >= 2 (aOR 5.549, 95% CI 2.296-13.407, p<0.001), structural lung disease (aOR 2.708, 95% CI 1.346-5.379, p = 0.004), PSI risk class IV-V (aOR 4.714, 95% CI 1.530-14.524, p = 0.007), no use of intrapleural fibrinolytics (aOR 3.062, 95% CI 1.102-8.511, p = 0.014), hospital-acquired infection (aOR 2.205, 95% CI 1.165-4.172, p = 0.015), age (aOR 0.964, 95% CI 0.935-0.994, p = 0.018), and SOFA score >= 2 (aOR 2.361, 95% CI 1.134-4.916, p = 0.022). Conclusion In this study, common pathogens causing pleural infection were comparable to previous studies, and consisted of streptococci, staphylococci, and anaerobes. CURB-65 >= 2, structural lung disease, PSI risk class IV-V, no use of intrapleural fibrinolytics, hospital-acquired infection, older age, and SOFA score >= 2 are potential predictors of mortality in pleural infection.	[Park, Cheol-Kyu; Oh, Hyoung-Joo; Choi, Ha-Young; Shin, Hong-Joon; Lim, Jung Hwan; Oh, In-Jae; Kim, Yu-Il; Lim, Sung-Chul; Kim, Young-Chul; Kwon, Yong-Soo] Chonnam Natl Univ Hosp, Dept Internal Med, Gwangju, South Korea	Chonnam National University; Chonnam National University Hospital	Kwon, YS (corresponding author), Chonnam Natl Univ Hosp, Dept Internal Med, Gwangju, South Korea.	yskwon@jnu.ac.kr	Oh, In-Jae/AAG-5919-2020; Kwon, Yong-Soo/AAH-6718-2019; Park, Cheol-Kyu/AAT-9872-2021	Oh, In-Jae/0000-0003-4837-1321; Park, Cheol-Kyu/0000-0001-8701-0786; Kwon, Yong-Soo/0000-0001-5121-4488	Chonnam National University Hospital [CRI16011-1]	Chonnam National University Hospital	This study was supported by a grant (CRI16011-1) from Chonnam National University Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burgos J, 2013, CURR OPIN PULM MED, V19, P350, DOI 10.1097/MCP.0b013e3283606ab5; Capelastegul A, 2006, EUR RESPIR J, V27, P151, DOI 10.1183/09031936.06.00062505; Chen CH, 2007, CHEST, V132, P532, DOI 10.1378/chest.07-0005; Chen W, 2009, SOUTH MED J, V102, P909, DOI 10.1097/SMJ.0b013e3181b22c52; Chi SY, 2012, TUBERC RESPIR DIS, V73, P32, DOI 10.4046/trd.2012.73.1.32; Colicc GL, 2000, CHEST, V118, P1158, DOI 10.1378/chest.118.4.1158; Davies CWH, 2003, THORAX, V58, pII18, DOI 10.1136/thorax.58.suppl_2.ii18; Davies HE, 2010, THORAX, V65, P41, DOI 10.1136/thx.2010.137000; Fine MJ, 1997, NEW ENGL J MED, V336, P243, DOI 10.1056/NEJM199701233360402; Foster S, 2007, CURR OPIN PULM MED, V13, P319, DOI 10.1097/MCP.0b013e3281864691; Janda S, 2012, CHEST, V142, P401, DOI 10.1378/chest.11-3071; Jang HC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099192; Kim SK, 2014, KOREAN J INTERN MED, V29, P603, DOI 10.3904/kjim.2014.29.5.603; Kim YJ, 2007, TUBERC RESPIR DIS, V63, P24, DOI 10.4046/trd.2007.63.1.24; Liang SJ, 2007, SOUTH MED J, V100, P1075, DOI 10.1097/SMJ.0b013e318158ba49; LIGHT RW, 1980, AM J MED, V69, P507, DOI 10.1016/0002-9343(80)90460-X; Lin YC, 2008, SOUTH MED J, V101, P484, DOI 10.1097/SMJ.0b013e31816c00fa; Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x; Malhotra P, 2007, RESP MED, V101, P423, DOI 10.1016/j.rmed.2006.07.016; Marks DJB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030074; Maskell NA, 2005, NEW ENGL J MED, V352, P865, DOI 10.1056/NEJMoa042473; Maskell NA, 2006, AM J RESP CRIT CARE, V174, P817, DOI 10.1164/rccm.200601-074OC; Menzies SM, 2011, THORAX, V66, P658, DOI 10.1136/thx.2010.157842; Meyer CN, 2011, SCAND J INFECT DIS, V43, P165, DOI 10.3109/00365548.2010.536162; Neill AM, 1996, THORAX, V51, P1010, DOI 10.1136/thx.51.10.1010; Okiror L, 2014, EUR J CARDIO-THORAC, V46, P901, DOI 10.1093/ejcts/ezu104; 염정숙, 2006, Clinical and Experimental Pediatrics, V49, P56; Rahman NM, 2011, NEW ENGL J MED, V365, P518, DOI 10.1056/NEJMoa1012740; Seymour CW, 2016, JAMA-J AM MED ASSOC, V315, P762, DOI 10.1001/jama.2016.0288; Tsang K. Y., 2007, Hong Kong Medical Journal, V13, P178; Tu CY, 2006, INTENS CARE MED, V32, P570, DOI 10.1007/s00134-005-0064-7	31	12	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2016	11	8							e0161280	10.1371/journal.pone.0161280	http://dx.doi.org/10.1371/journal.pone.0161280			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4UN	27529628	Green Published, Green Submitted, gold			2022-12-27	WOS:000381476700061
J	Qin, C; Sun, YQ; Dong, YD				Qin, Chao; Sun, Yongqi; Dong, Yadong			A New Method for Identifying Essential Proteins Based on Network Topology Properties and Protein Complexes	PLOS ONE			English	Article							ESSENTIAL GENES; CENTRALITY; IDENTIFICATION; GENOME; INTERACTOME; DISCOVERY; DATABASE	Essential proteins are indispensable to the viability and reproduction of an organism. The identification of essential proteins is necessary not only for understanding the molecular mechanisms of cellular life but also for disease diagnosis, medical treatments and drug design. Many computational methods have been proposed for discovering essential proteins, but the precision of the prediction of essential proteins remains to be improved. In this paper, we propose a new method, LBCC, which is based on the combination of local density, betweenness centrality (BC) and in-degree centrality of complex (IDC). First, we introduce the common centrality measures; second, we propose the densities Den1(v) and Den2(v) of a node v to describe its local properties in the network; and finally, the combined strategy of Den1, Den2, BC and IDC is developed to improve the prediction precision. The experimental results demonstrate that LBCC outperforms traditional topological measures for predicting essential proteins, including degree centrality (DC), BC, subgraph centrality (SC), eigenvector centrality (EC), network centrality (NC), and the local average connectivity- based method (LAC). LBCC also improves the prediction precision by approximately 10 percent on the YMIPS and YMBD datasets compared to the most recently developed method, LIDC.	[Qin, Chao; Sun, Yongqi; Dong, Yadong] Beijing Jiaotong Univ, Beijing Key Lab Traff Data Anal & Min, Beijing, Peoples R China	Beijing Jiaotong University	Sun, YQ (corresponding author), Beijing Jiaotong Univ, Beijing Key Lab Traff Data Anal & Min, Beijing, Peoples R China.	yqsun@bjtu.edu.cn	Dong, Yadong/GXG-3093-2022		National Natural Science Foundation of China [61572005, 61562066, 61272004]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by NO. 61572005, National Natural Science Foundation of China, www.nsfc.gov.cn, YQS CQ; NO. 61562066, National Natural Science Foundation of China, www.nsfc.gov.cn, YQS; and NO. 61272004, National Natural Science Foundation of China, www.nsfc.gov.cn, YQS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BONACICH P, 1987, AM J SOCIOL, V92, P1170, DOI 10.1086/228631; Cole ST, 2002, EUR RESPIR J, V20, p78S, DOI 10.1183/09031936.02.00400202; Cullen LM, 2005, IMMUNOL CELL BIOL, V83, P217, DOI 10.1111/j.1440-1711.2005.01332.x; del Rio G, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-102; Estrada E, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.056103; Fraser HB, 2002, SCIENCE, V296, P750, DOI 10.1126/science.1068696; FREEMAN LC, 1977, SOCIOMETRY, V40, P35, DOI 10.2307/3033543; Friedel CC, 2009, J COMPUT BIOL, V16, P971, DOI 10.1089/cmb.2009.0023; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Holman AG, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-243; Issel-Tarver L, 2002, METHOD ENZYMOL, V350, P329, DOI 10.1016/S0076-6879(02)50972-1; Li M, 2017, IEEE ACM T COMPUT BI, V14, P370, DOI 10.1109/TCBB.2015.2394487; Li M, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-15; Li M, 2011, COMPUT BIOL CHEM, V35, P143, DOI 10.1016/j.compbiolchem.2011.04.002; Luo JW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131418; Mewes HW, 2006, NUCLEIC ACIDS RES, V34, pD169, DOI 10.1093/nar/gkj148; Pal C, 2003, NATURE, V421, P496, DOI 10.1038/421496b; Park K, 2009, PROTEOMICS, V9, P5143, DOI 10.1002/pmic.200900357; Peng W, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-87; Proctor C.H., 1951, RES METHODS SOCIAL R, P561; Pu SY, 2007, PROTEOMICS, V7, P944, DOI 10.1002/pmic.200600636; Pu SY, 2009, NUCLEIC ACIDS RES, V37, P825, DOI 10.1093/nar/gkn1005; Roemer T, 2003, MOL MICROBIOL, V50, P167, DOI 10.1046/j.1365-2958.2003.03697.x; Ruepp A, 2010, NUCLEIC ACIDS RES, V38, pD497, DOI 10.1093/nar/gkp914; Tang XW, 2014, IEEE ACM T COMPUT BI, V11, P407, DOI 10.1109/TCBB.2013.2295318; Tang Y, 2015, BIOSYSTEMS, V127, P67, DOI 10.1016/j.biosystems.2014.11.005; Wang JX, 2012, IEEE ACM T COMPUT BI, V9, P1070, DOI 10.1109/TCBB.2011.147; Wang Y., 2014, INT J DISTRIB SENS N, V2014, P9, DOI DOI 10.1371/J0URNAL.P0NE.0110024; Watts D.J., 1999, SMALL WORLDS DYNAMIC; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Xenarios I, 2000, NUCLEIC ACIDS RES, V28, P289, DOI 10.1093/nar/28.1.289; Yu HY, 2004, TRENDS GENET, V20, P227, DOI 10.1016/j.tig.2004.04.008; Zhang R, 2009, NUCLEIC ACIDS RES, V37, pD455, DOI 10.1093/nar/gkn858; Zhang X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058763; Zotenko E, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000140	35	28	32	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2016	11	8							e0161042	10.1371/journal.pone.0161042	http://dx.doi.org/10.1371/journal.pone.0161042			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4UN	27529423	Green Published, gold, Green Submitted			2022-12-27	WOS:000381476700040
J	Veta, M; van Diest, PJ; Jiwa, M; Al-Janabi, S; Pluim, JPW				Veta, Mitko; van Diest, Paul J.; Jiwa, Mehdi; Al-Janabi, Shaimaa; Pluim, Josien P. W.			Mitosis Counting in Breast Cancer: Object-Level Interobserver Agreement and Comparison to an Automatic Method	PLOS ONE			English	Article							PROGNOSTIC VALUE	Background Tumor proliferation speed, most commonly assessed by counting of mitotic figures in histological slide preparations, is an important biomarker for breast cancer. Although mitosis counting is routinely performed by pathologists, it is a tedious and subjective task with poor reproducibility, particularly among non-experts. Inter-and intraobserver reproducibility of mitosis counting can be improved when a strict protocol is defined and followed. Previous studies have examined only the agreement in terms of the mitotic count or the mitotic activity score. Studies of the observer agreement at the level of individual objects, which can provide more insight into the procedure, have not been performed thus far. Methods The development of automatic mitosis detection methods has received large interest in recent years. Automatic image analysis is viewed as a solution for the problem of subjectivity of mitosis counting by pathologists. In this paper we describe the results from an interobserver agreement study between three human observers and an automatic method, and make two unique contributions. For the first time, we present an analysis of the object-level interobserver agreement on mitosis counting. Furthermore, we train an automatic mitosis detection method that is robust with respect to staining appearance variability and compare it with the performance of expert observers on an "external" dataset, i.e. on histopathology images that originate from pathology labs other than the pathology lab that provided the training data for the automatic method. Results The object-level interobserver study revealed that pathologists often do not agree on individual objects, even if this is not reflected in the mitotic count. The disagreement is larger for objects from smaller size, which suggests that adding a size constraint in the mitosis counting protocol can improve reproducibility. The automatic mitosis detection method can perform mitosis counting in an unbiased way, with substantial agreement with human experts.	[Veta, Mitko; Pluim, Josien P. W.] Eindhoven Univ Technol, Med Image Anal Grp IMAG E, Eindhoven, Netherlands; [van Diest, Paul J.; Jiwa, Mehdi] Univ Med Ctr Utrecht, Dept Pathol, Utrecht, Netherlands; [Al-Janabi, Shaimaa] Vrije Univ Amsterdam, Med Ctr, Dept Pathol, Amsterdam, Netherlands; [Pluim, Josien P. W.] Univ Med Ctr Utrecht, Image Sci Inst, Utrecht, Netherlands	Eindhoven University of Technology; Utrecht University; Utrecht University Medical Center; Vrije Universiteit Amsterdam; Utrecht University; Utrecht University Medical Center	Veta, M (corresponding author), Eindhoven Univ Technol, Med Image Anal Grp IMAG E, Eindhoven, Netherlands.	M.Veta@tue.nl						Al-Janabi S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082576; Baak JPA, 2005, J CLIN ONCOL, V23, P5993, DOI 10.1200/JCO.2005.05.511; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Ciresan DC, 2013, LECT NOTES COMPUT SC, V8150, P411, DOI 10.1007/978-3-642-40763-5_51; DICE LR, 1945, ECOLOGY, V26, P297, DOI 10.2307/1932409; LeCun Y, 2015, NATURE, V521, P436, DOI 10.1038/nature14539; Macenko M, 2009, I S BIOMED IMAGING, P1107, DOI 10.1109/ISBI.2009.5193250; Roux Ludovic, 2013, J Pathol Inform, V4, P8, DOI 10.4103/2153-3539.112693; van Diest PJ, 2004, J CLIN PATHOL, V57, P675, DOI 10.1136/jcp.2003.010777; VANDIEST PJ, 1992, HUM PATHOL, V23, P603, DOI 10.1016/0046-8177(92)90313-R; Veta M, 2013, SPIE MED IMAGING, V2013; Veta M, 2015, MED IMAGE ANAL, V20, P237, DOI 10.1016/j.media.2014.11.010; Vink JP, 2013, J MICROSC-OXFORD, V249, P124, DOI 10.1111/jmi.12001	13	56	56	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2016	11	8							e0161286	10.1371/journal.pone.0161286	http://dx.doi.org/10.1371/journal.pone.0161286			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4UN	27529701	Green Submitted, Green Published, gold			2022-12-27	WOS:000381476700062
J	Fernandez, O; Arroyo, R; Martinez-Yelamos, S; Marco, M; Merino, JAG; Munoz, D; Merino, E; Roque, A				Fernandez, O.; Arroyo, R.; Martinez-Yelamos, S.; Marco, M.; Garcia Merino, J. A.; Munoz, D.; Merino, E.; Roque, A.		RELOAD Study Grp	Long-Term Adherence to IFN Beta-1 alpha Treatment when Using RebiSmart (R) Device in Patients with Relapsing-Remitting Multiple Sclerosis	PLOS ONE			English	Article							DISEASE-MODIFYING THERAPIES; INJECTION-SITE REACTIONS; MS; MULTICENTER; TOLERABILITY; INTERFERONS; PROGRESSION; PREVALENCE; TRIAL; DRUGS	The effectiveness of disease-modifying drugs in the treatment of multiple sclerosis is associated with adherence. RebiSmart (R) electronic device provides useful information about adherence to the treatment with subcutaneous (sc) interferon (IFN) beta-1 alpha (Rebif (R)). The aim of the study was to determine long-term adherence to this treatment in patients with relapsing-remitting multiple sclerosis (RRMS). This retrospective multicentre observational study analysed 258 patients with RRMS who were receiving sc IFN beta-1 alpha (Rebif (R)) treatment by using RebiSmart (R) until replacement (36 months maximum lifetime) or treatment discontinuation. Adherence was calculated with data (injection dosage, time, and date) automatically recorded by RebiSmart (R). Patients in the study had a mean age of 41 years with a female proportion of 68%. Mean EDSS score at start of treatment was 1.8 (95% CI, 1.6-1.9). Overall adherence was 92.6%(95% CI, 90.6-94.5%). A total of 30.2% of patients achieved an adherence rate of 100%, 80.6% at least 90%, and only 13.2% of patients showed a suboptimal adherence (<80%). A total of 59.9% of subjects were relapse-free after treatment initiation. Among 106 subjects (41.1%) who experienced, on average, 1.4 relapses, the majority were mild (40.6%) or moderate (47.2%). Having experienced relapses from the beginning of the treatment was the only variable significantly related to achieving an adherence of at least 80% (OR = 3.06, 1.28-7.31). Results of this study indicate that sc IFN beta-1 alpha administration facilitated by RebiSmart (R) could lead to high rates of adherence to a prescribed dose regimen over 36 months.	[Fernandez, O.] Univ Malaga, Hosp Univ Reg Malaga & Virgen Victoria, IBIMA, E-29071 Malaga, Spain; [Arroyo, R.] Hosp Univ Clin San Carlos, Madrid, Spain; [Martinez-Yelamos, S.] Hosp Univ Bellvitge, Barcelona, Spain; [Marco, M.] Corporacio Sanitaria Parc Tauli, Barcelona, Spain; [Garcia Merino, J. A.] Hosp Univ Puerta de Hierro, Madrid, Spain; [Munoz, D.] Hosp Xeral Cies, Vigo, Spain; [Merino, E.; Roque, A.] Merck SL, Dept Med, Barcelona, Spain	Universidad de Malaga; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; Autonomous University of Barcelona; Parc Tauli Hospital Universitari; Hospital Puerta de Hierro-Majadahonda; Complexo Hospitalario Universitario de Vigo	Fernandez, O (corresponding author), Univ Malaga, Hosp Univ Reg Malaga & Virgen Victoria, IBIMA, E-29071 Malaga, Spain.	oscar.fernandez.sspa@gmail.com	MARTÍNEZ-YÉLAMOS, Sergio/ABH-3087-2020; Merino, Esperanza/AAV-3244-2021; Merino de Lucas, Esperanza/AFQ-1126-2022	Merino de Lucas, Esperanza/0000-0003-3854-4874	Biogen Idec; Teva; Sanofi-Aventis; Merck-Serono; Novartis; Bayer-Schering	Biogen Idec(Biogen); Teva(Teva Pharmaceutical Industries); Sanofi-Aventis(Sanofi-Aventis); Merck-Serono(Merck & Company); Novartis(Novartis); Bayer-Schering(Bayer AG)	OF and RA have received honoraria as consultants in advisory boards, and as chairmen or lecturer in meetings, and have also participated in clinical trials and other research projects promoted by Biogen-Idec, Bayer-Schering, Merck-Serono, Teva, Novartis, Genzyme, Roche, Allergan, and Almirall; SM-Y has received honoraria compensation to participate in advisory boards, collaborations as a consultant and scientific communications from Biogen-Idec, Teva, Sanofi-Aventis, Merck-Serono, Novartis, and Bayer-Schering, and has received research support, funding for travel, and congress expenses from Biogen Idec, Teva, Sanofi-Aventis, Merck-Serono, Novartis, and Bayer-Schering; MM declares no conflict of interest; JAGM has received compensations for travel, lecturing or advisory work from Merck-Serono, Biogen-Idec, Bayer, Novartis, Almirall, Sanofi-Aventis, and research grants from Novartis and Biogen-Idec; DM has received honoraria as consultant in advisory boards, has participated and collaborated in meetings, and has also participated in clinical trials and other research projects promoted by Bayer-Schering, Merck-Serono, Novartis, Biogen-Idec, and Genzyme; EM and AR are employees at Merck-Serono. The authors received no specific funding for this work. The funder provided support in the form of salaries for authors [EM and AR], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	AL-Sabbagh A, 2008, J NEUROL, V255, P79; Bartulos Iglesias M, 2014, NEUROLOGIA; Bayas A, 2013, EXPERT OPIN DRUG DEL, V10, P285, DOI 10.1517/17425247.2013.763793; Beer K, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-144; Brochet B, 2006, REV NEUROL-FRANCE, V162, P735, DOI 10.1016/S0035-3787(06)75071-8; Brown MG, 2007, NEUROLOGY, V69, P1498, DOI 10.1212/01.wnl.0000271884.11129.f3; Compston A, 2008, LANCET, V372, P1502, DOI 10.1016/S0140-6736(08)61620-7; Costello Kathleen, 2008, Medscape J Med, V10, P225; Cox Darcy, 2006, J Neurosci Nurs, V38, P167; Cramer JA, 2006, ACTA NEUROL SCAND, V113, P156, DOI 10.1111/j.1600-0404.2005.00568.x; de Sa J, 2010, CURR MED RES OPIN, V26, P2237, DOI 10.1185/03007995.2010.508688; Devonshire V, 2011, EUR J NEUROL, V18, P69, DOI 10.1111/j.1468-1331.2010.03110.x; Ebers GC, 1998, LANCET, V352, P1498, DOI 10.1016/S0140-6736(98)03334-0; Exell S, 2011, EXPERT REV MED DEVIC, V8, P543, DOI [10.1586/ERD.11.29, 10.1586/erd.11.29]; Fernandez O, 2012, MULT SCLER J, V18, P372, DOI 10.1177/1352458511421917; Fernandez O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035600; IFNB Multiple Sclerosis Study Group, 1993, NEUROLOGY, V43, P655; Jacobs LD, 1996, ANN NEUROL, V39, P285, DOI 10.1002/ana.410390304; JOHNSON KP, 1995, NEUROLOGY, V45, P1268, DOI 10.1212/WNL.45.7.1268; Lugaresi A, 2013, EXPERT OPIN DRUG DEL, V10, P273, DOI 10.1517/17425247.2013.746311; Lugaresi A, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-7; Mikol D, 2005, MULT SCLER J, V11, P585, DOI 10.1191/1352458505ms1197oa; Mohr DC, 2001, ANN BEHAV MED, V23, P125, DOI 10.1207/S15324796ABM2302_7; Noseworthy JH, 2000, NEW ENGL J MED, V343, P938, DOI 10.1056/NEJM200009283431307; Seddighzadeh A, 2014, EXPERT OPIN DRUG DEL, V11, P1713, DOI 10.1517/17425247.2014.944159; Steinberg SC, 2010, CLIN DRUG INVEST, V30, P89, DOI 10.2165/11533330-000000000-00000; Treadaway K, 2009, J NEUROL, V256, P568, DOI 10.1007/s00415-009-0096-y; Tremlett HL, 2003, NEUROLOGY, V61, P551, DOI 10.1212/01.WNL.0000078885.05053.7D; WEINSHENKER BG, 1989, BRAIN, V112, P133, DOI 10.1093/brain/112.1.133; Willis H, 2014, PATIENT PREFER ADHER, V8, P843, DOI 10.2147/PPA.S54986	30	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2016	11	8							e0160313	10.1371/journal.pone.0160313	http://dx.doi.org/10.1371/journal.pone.0160313			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4SL	27526201	Green Published, gold, Green Submitted			2022-12-27	WOS:000381471100013
J	Cho, KI; Cho, SH; Her, AY; Singh, GB; Shin, ES				Cho, Kyoung Im; Cho, Sang Hoon; Her, Ae-Young; Singh, Gillian Balbir; Shin, Eun-Seok			Prognostic Utility of Neutrophil-to-Lymphocyte Ratio on Adverse Clinical Outcomes in Patients with Severe Calcific Aortic Stenosis	PLOS ONE			English	Article							C-REACTIVE PROTEIN; ELEVATION MYOCARDIAL-INFARCTION; RISK-EVALUATION EUROSCORE; VALVE STENOSIS; NEUTROPHIL/LYMPHOCYTE RATIO; EUROPEAN SYSTEM; CARDIAC-SURGERY; DISEASE; INFLAMMATION; PROGRESSION	Background Inflammation is an important factor in the pathogenesis of calcific aortic stenosis (AS). We aimed to evaluate the association between an inflammatory marker, neutrophil-to-lymphocyte ratio (NLR) and major adverse cardiovascular events (MACE) in patients with severe calcific AS. Methods A total of 336 patients with isolated severe calcific AS newly diagnosed between 2010 and 2015 were enrolled in this study. Using Cox proportional hazards (PH) regression models, we investigated the prognostic value of NLR adjusted for baseline covariates including logistic European System for Cardiac Operative Risk Evaluation score (EuroSCORE-I) and undergoing aortic valve replacement (AVR). We also evaluated the clinical relevance of NLR risk groups (divided into low, intermediate, high risk) as categorized by NLR cutoff values. MACE was defined as a composite of all-cause mortality, cardiac death and non-fatal myocardial infarction during the follow-up period. Results The inflammatory marker NLR was an independent prognostic factor most significantly associated with MACE [hazard ratio (HR), 1.06; 95% confidence interval (CI), 1.04-1.09; pvalue < 0.001]. The goodness-of-fit and discriminability of the model including EuroSCOREI and AVR (loglikelihood difference, 15.49; p-value < 0.001; c-index difference, 0.035; pvalue = 0.03) were significantly improved when NLR was incorporated into the model. The estimated Kaplan-Meier survival rates at 5 years for the NLR risk groups were 84.6% for the low risk group (NLR <= 2), 67.7% for the intermediate risk group ( 2 < NLR <= 9), and 42.6% for the high risk group ( NLR > 9), respectively. Conclusion The findings of the present study demonstrate the potential utility of NLR in risk stratification of patients with severe calcific AS.	[Cho, Kyoung Im] Kosin Univ, Sch Med, Dept Cardiol, Busan, South Korea; [Cho, Sang Hoon] Soongsil Univ, Dept Stat & Actuarial Sci, Seoul, South Korea; [Her, Ae-Young] Kangwon Natl Univ, Sch Med, Dept Internal Med, Div Cardiol, Chunchon, South Korea; [Singh, Gillian Balbir; Shin, Eun-Seok] Univ Ulsan, Coll Med, Ulsan Univ Hosp, Dept Cardiol, Ulsan, South Korea	Soongsil University; Kangwon National University; University of Ulsan; Ulsan University Hospital	Shin, ES (corresponding author), Univ Ulsan, Coll Med, Ulsan Univ Hosp, Dept Cardiol, Ulsan, South Korea.	sesim1989@gmail.com						Arangalage D, 2014, ARCH CARDIOVASC DIS, V107, P353, DOI 10.1016/j.acvd.2014.05.002; Avci A, 2014, ECHOCARDIOGR-J CARD, V31, P1031, DOI 10.1111/echo.12534; Azab B, 2010, AM J CARDIOL, V106, P470, DOI 10.1016/j.amjcard.2010.03.062; Baumgartner H, 2009, J AM SOC ECHOCARDIOG, V22, P1, DOI 10.1016/j.echo.2008.11.029; Bergler-Klein J, 2004, CIRCULATION, V109, P2302, DOI 10.1161/01.CIR.0000126825.50903.18; Chan KL, 2011, AM HEART J, V161, P1133, DOI 10.1016/j.ahj.2011.03.016; Cho KI, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133934; Cote N, 2013, INFLAMMATION, V36, P573, DOI 10.1007/s10753-012-9579-6; Fowler AJ, 2013, ATHEROSCLEROSIS, V228, P44, DOI 10.1016/j.atherosclerosis.2013.02.008; Hamirani YS, 2008, ATHEROSCLEROSIS, V201, P1, DOI 10.1016/j.atherosclerosis.2008.04.045; HARRELL FE, 1982, JAMA-J AM MED ASSOC, V247, P2543, DOI 10.1001/jama.247.18.2543; Heymans S, 2009, EUR J HEART FAIL, V11, P119, DOI 10.1093/eurjhf/hfn043; Imai K, 2008, AM HEART J, V156, P713, DOI 10.1016/j.ahj.2008.04.011; Jander N, 2011, CIRCULATION, V123, P887, DOI 10.1161/CIRCULATIONAHA.110.983510; Jeevanantham V, 2007, MAYO CLIN PROC, V82, P171; Kim SI, 2013, BRIT J CANCER, V109, P1165, DOI 10.1038/bjc.2013.465; Lindman BR, 2013, CIRC RES, V113, P223, DOI 10.1161/CIRCRESAHA.111.300084; Nashef SAM, 2002, EUR J CARDIO-THORAC, V22, P101, DOI 10.1016/S1010-7940(02)00208-7; Novaro GM, 2007, J AM COLL CARDIOL, V50, P1992, DOI 10.1016/j.jacc.2007.07.064; O'Gara PT, 2013, J AM COLL CARDIOL, V61, pE78, DOI [10.1016/j.jacc.2012.11.019, 10.1161/CIR.0b013e3182742cf6]; Otto CM, 2014, NEW ENGL J MED, V371, P744, DOI 10.1056/NEJMra1313875; Park BJ, 2011, CLIN CHIM ACTA, V412, P925, DOI 10.1016/j.cca.2011.01.021; Poludasu Shyam, 2009, Clin Cardiol, V32, pE6, DOI 10.1002/clc.20503; Schemper M, 1996, CONTROL CLIN TRIALS, V17, P343, DOI 10.1016/0197-2456(96)00075-X; Wang C, 2010, J HEART VALVE DIS, V19, P21; Wang XD, 2014, ATHEROSCLEROSIS, V234, P206, DOI 10.1016/j.atherosclerosis.2014.03.003; Wendt D, 2015, J CARDIOL, V66, P292, DOI 10.1016/j.jjcc.2015.04.003; Wiegers SE, 2013, CIRCULATION, V128, P576, DOI 10.1161/CIRCULATIONAHA.113.004193	28	12	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2016	11	8							e0161530	10.1371/journal.pone.0161530	http://dx.doi.org/10.1371/journal.pone.0161530			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT8TP	27548384	Green Published, gold, Green Submitted			2022-12-27	WOS:000381768400067
J	Georgiadis, M; Guizar-Sicairos, M; Gschwend, O; Hangartner, P; Bunk, O; Muller, R; Schneider, P				Georgiadis, Marios; Guizar-Sicairos, Manuel; Gschwend, Oliver; Hangartner, Peter; Bunk, Oliver; Mueller, Ralph; Schneider, Philipp			Ultrastructure Organization of Human Trabeculae Assessed by 3D sSAXS and Relation to Bone Microarchitecture	PLOS ONE			English	Article							COLLAGEN FIBER ORIENTATION; SCANNING ELECTRON-MICROSCOPY; POLARIZED-LIGHT MICROSCOPY; PHASE NANO-TOMOGRAPHY; HUMAN LAMELLAR BONE; COMPACT-BONE; 2ND-HARMONIC GENERATION; COMPUTED-TOMOGRAPHY; ELASTIC-ANISOTROPY; SINGLE OSTEONS	Although the organization of bone ultrastructure, i.e. the orientation and arrangement of the mineralized collagen fibrils, has been in the focus of research for many years for cortical bone, and many models on the osteonal arrangement have been proposed, limited attention has been paid to trabecular bone ultrastructure. This is surprising because trabeculae play a crucial role for the mechanical strength of several bone sites, including the vertebrae and the femoral head. On this account, we first validated a recently developed method (3D sSAXS or 3D scanning small-angle X-ray scattering) for investigating bone ultrastructure in a quantitative and spatially resolved way, using conventional linearly polarized light microscopy as a gold standard. While both methods are used to analyze thin tissue sections, in contrast to polarized light microscopy, 3D sSAXS has the important advantage that it provides 3D information on the orientation and arrangement of bone ultrastructure. In this first study of its kind, we used 3D sSAXS to investigate the ultrastructural organization of 22 vertebral trabeculae of different alignment, types and sizes, obtained from 4 subjects of different ages. Maps of ultrastructure orientation and arrangement of the trabeculae were retrieved by stacking information from consecutive 20-mu m-thick bone sections. The organization of the ultrastructure was analyzed in relation to trabecular microarchitecture obtained from computed tomography and to relevant parameters such as distance to trabecular surface, local curvature or local bone mineralization. We found that (i) ultrastructure organization is similar for all investigated trabeculae independent of their particular characteristics, (ii) bone ultrastructure exhibiting a high degree of orientation was arranged in domains, (iii) highly oriented ultrastructural areas were located closer to the bone surface, (iv) the ultrastructure of the human trabecular bone specimens followed the microarchitecture, being oriented mostly parallel to bone surface, and (v) local surface curvature seems to have an effect on the ultrastructure organization. Further studies that investigate bone ultrastructure orientation and arrangement are needed in order to understand its organization and consequently its relation to bone biology and mechanics.	[Georgiadis, Marios; Gschwend, Oliver; Hangartner, Peter; Mueller, Ralph; Schneider, Philipp] ETH, Inst Biomech, Zurich, Switzerland; [Guizar-Sicairos, Manuel; Bunk, Oliver] Paul Scherrer Inst, Villigen, Switzerland; [Schneider, Philipp] Univ Southampton, Fac Engn & Environm, Bioengn Sci Res Grp, Southampton, Hants, England	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; University of Southampton	Schneider, P (corresponding author), ETH, Inst Biomech, Zurich, Switzerland.; Schneider, P (corresponding author), Univ Southampton, Fac Engn & Environm, Bioengn Sci Res Grp, Southampton, Hants, England.	p.schneider@soton.ac.uk	Bunk, Oliver/B-7602-2013; Schneider, Philipp/AAP-6133-2021; Müller, Ralph/A-1198-2008; Guizar-Sicairos, Manuel/AAB-3793-2019; Guizar-Sicairos, Manuel/I-4899-2013	Bunk, Oliver/0000-0001-6563-4053; Schneider, Philipp/0000-0001-7499-3576; Müller, Ralph/0000-0002-5811-7725; Guizar-Sicairos, Manuel/0000-0002-8293-3634; Guizar-Sicairos, Manuel/0000-0002-8293-3634; Georgiadis, Marios/0000-0003-0733-4559	ETH Research Grant [ETH-39 11-1]	ETH Research Grant	This work was supported by ETH Research Grant ETH-39 11-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, RADIONUCLIDE HYBRID; ASCENZI A, 1967, ANAT REC, V158, P375, DOI 10.1002/ar.1091580403; ASCENZI A, 1968, ANAT REC, V161, P377, DOI 10.1002/ar.1091610309; Ascenzi MG, 2003, J STRUCT BIOL, V141, P22, DOI 10.1016/S1047-8477(02)00578-6; ATKINSON P. J., 1967, CALCIFIED TISSUE RES, V1, P24, DOI 10.1007/BF02008071; Bi X, 2005, OSTEOARTHR CARTILAGE, V13, P1050, DOI 10.1016/j.joca.2005.07.008; Bidan CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036336; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; BOYDE A, 1969, Z ZELLFORSCH MIK ANA, V93, P213; BOYDE A, 1990, BONE, V11, P35, DOI 10.1016/8756-3282(90)90069-B; BOYDE A, 1984, METAB BONE DIS RELAT, V5, P299, DOI 10.1016/0221-8747(84)90017-1; Bromage Timothy G., 2003, Anatomical Record, V274B, P157, DOI 10.1002/ar.b.10031; Bunk O, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/12/123016; Chen XY, 2012, NAT PROTOC, V7, P654, DOI 10.1038/nprot.2012.009; Cotter MM, 2009, ANAT REC, V292, P1098, DOI 10.1002/ar.20932; Dierolf M, 2010, NATURE, V467, P436, DOI 10.1038/nature09419; Donnelly E, 2006, J MATER RES, V21, P2106, DOI 10.1557/JMR.2006.0259; Faingold A, 2013, ACTA BIOMATER, V9, P5956, DOI 10.1016/j.actbio.2012.11.032; Galvis L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063518; Gautieri A, 2011, NANO LETT, V11, P757, DOI 10.1021/nl103943u; Georgiadis M, 2016, J ROYAL SOC IN PRESS; Georgiadis M, 2015, BONE, V71, P42, DOI 10.1016/j.bone.2014.10.002; Giannini C, 2012, SCI REP-UK, V2, DOI 10.1038/srep00435; GIRAUDGUILLE MM, 1988, CALCIFIED TISSUE INT, V42, P167, DOI 10.1007/BF02556330; Granke M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058043; Guizar-Sicairos M, 2008, OPT LETT, V33, P156, DOI 10.1364/OL.33.000156; Hofmann T, 2006, J BIOMECH, V39, P2282, DOI 10.1016/j.jbiomech.2005.07.009; Holler M, 2014, SCI REP, P4; JAYASINGHE JAP, 1993, VIRCHOWS ARCH A, V422, P25, DOI 10.1007/BF01605129; Kagias M, 2016, PHYS REV LETT, V116, DOI 10.1103/PhysRevLett.116.093902; Karunaratne A, 2012, BONE, V51, P553, DOI 10.1016/j.bone.2012.04.021; Langer M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035691; Liebi M, 2015, NATURE, V527, P349, DOI 10.1038/nature16056; MARTIN RB, 1989, J BIOMECH, V22, P419, DOI 10.1016/0021-9290(89)90202-9; Meek KM, 2009, PROG RETIN EYE RES, V28, P369, DOI 10.1016/j.preteyeres.2009.06.005; MOSEKILDE L, 1990, BONE MINER, V10, P13, DOI 10.1016/0169-6009(90)90046-I; Reisinger AG, 2011, BIOMECH MODEL MECHAN, V10, P67, DOI 10.1007/s10237-010-0218-6; Reznikov N, 2015, BONE, V71, P189, DOI 10.1016/j.bone.2014.10.017; Reznikov N, 2014, BONE, V59, P93, DOI 10.1016/j.bone.2013.10.023; Reznikov N, 2013, BONE, V52, P676, DOI 10.1016/j.bone.2012.10.034; Rieppo J, 2008, MICROSC RES TECHNIQ, V71, P279, DOI 10.1002/jemt.20551; RIGGS CM, 1993, ANAT EMBRYOL, V187, P239; RIGGS CM, 1993, ANAT EMBRYOL, V187, P231; Rinnerthaler S, 1999, CALCIFIED TISSUE INT, V64, P422, DOI 10.1007/PL00005824; Ripamonti U, 2009, J CELL MOL MED, V13, P2953, DOI 10.1111/j.1582-4934.2008.00562.x; Rumpler M, 2008, J R SOC INTERFACE, V5, P1173, DOI 10.1098/rsif.2008.0064; Schaff F, 2015, NATURE, V527, P353, DOI 10.1038/nature16060; Stoller P, 2002, BIOPHYS J, V82, P3330, DOI 10.1016/S0006-3495(02)75673-7; Takano Y, 1999, J ORTHOP RES, V17, P59, DOI 10.1002/jor.1100170110; Thomsen JS, 2002, BONE, V31, P136, DOI 10.1016/S8756-3282(02)00801-3; Trussel A.J., 2012, J BIOMECH, V45, pS108; Varga P, 2015, BIOMECH MODEL MECHAN, V14, P267, DOI 10.1007/s10237-014-0601-9; Varga P, 2013, ACTA BIOMATER, V9, P8118, DOI 10.1016/j.actbio.2013.05.015; Wagermaier W, 2006, BIOINTERPHASES, V1, P1, DOI 10.1116/1.2178386; Weiner S, 1998, ANNU REV MATER SCI, V28, P271, DOI 10.1146/annurev.matsci.28.1.271; WEINER S, 1991, FEBS LETT, V285, P49, DOI 10.1016/0014-5793(91)80722-F; Wenk HR, 1999, BONE, V24, P361, DOI 10.1016/S8756-3282(98)00192-6; WOLMAN M, 1986, HISTOCHEMISTRY, V85, P41, DOI 10.1007/BF00508652; Zwahlen A, 2015, J BIOMECHANICAL ENG, V137, P9	59	18	18	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2016	11	8							e0159838	10.1371/journal.pone.0159838	http://dx.doi.org/10.1371/journal.pone.0159838			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT8TP	27547973	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000381768400009
J	Hokke, S; Puelles, VG; Armitage, JA; Fong, K; Bertram, JF; Cullen-McEwen, LA				Hokke, Stacey; Puelles, Victor G.; Armitage, James A.; Fong, Karen; Bertram, John F.; Cullen-McEwen, Luise A.			Maternal Fat Feeding Augments Offspring Nephron Endowment in Mice	PLOS ONE			English	Article							DIET-INDUCED OBESITY; RENAL-FUNCTION; INSULIN-RESISTANCE; ANIMAL-MODELS; RICH DIET; HYPERTENSION; PREGNANCY; FETAL; NUMBER; RAT	Increasing consumption of a high fat 'Western' diet has led to a growing number of pregnancies complicated by maternal obesity. Maternal overnutrition and obesity have health implications for offspring, yet little is known about their effects on offspring kidney development and renal function. Female C57B16 mice were fed a high fat diet (HFD, 21% fat) or matched normal fat diet (NFD, 6% fat) for 6 weeks prior to pregnancy and throughout gestation and lactation. HFD dams were overweight and glucose intolerant prior to mating but not in late gestation. Offspring of NFD and HFD dams had similar body weights at embryonic day (E) 15.5, E18.5 and at postnatal day (PN)21. HFD offspring had normal ureteric tree development and nephron number at E15.5. However, using unbiased stereology, kidneys of HFD offspring were found to have 20-25% more nephrons than offspring of NFD dams at E18.5 and PN21. Offspring of HFD dams with body weight and glucose profiles similar to NFD dams prior to pregnancy also had an elevated nephron endowment. At 9 months of age, adult offspring of HFD dams displayed mild fasting hyperglycaemia but similar body weights to NFD offspring. Renal function and morphology, measured by transcutaneous clearance of FITC-sinistrin and stereology respectively, were normal. This study demonstrates that maternal fat feeding augments offspring nephron endowment with no long-term consequences for offspring renal health. Future studies assessing the effects of a chronic stressor on adult mice with augmented nephron number are warranted, as are studies investigating the molecular mechanisms that result in high nephron endowment.	[Hokke, Stacey; Puelles, Victor G.; Armitage, James A.; Fong, Karen; Bertram, John F.; Cullen-McEwen, Luise A.] Monash Univ, Monash Biomed Discovery Inst, Dev & Stem Cells Program, Melbourne, Vic, Australia; [Hokke, Stacey; Puelles, Victor G.; Armitage, James A.; Fong, Karen; Bertram, John F.; Cullen-McEwen, Luise A.] Monash Univ, Dept Anat & Dev Biol, Melbourne, Vic, Australia; [Armitage, James A.] Deakin Univ, Sch Med Optometry, Waurn Ponds, Vic, Australia	Monash University; Monash University; Deakin University	Cullen-McEwen, LA (corresponding author), Monash Univ, Monash Biomed Discovery Inst, Dev & Stem Cells Program, Melbourne, Vic, Australia.; Cullen-McEwen, LA (corresponding author), Monash Univ, Dept Anat & Dev Biol, Melbourne, Vic, Australia.	luise.cullen-mcewen@monash.edu	Armitage, James/AAX-1294-2021; Bertram, John/I-2588-2014	Puelles, Victor/0000-0002-7735-5462; Armitage, James/0000-0002-3762-0911; Bertram, John/0000-0001-5863-6464; Hokke, Stacey/0000-0003-1338-0156; Cullen-McEwen, Luise/0000-0003-2229-5762	Diabetes Australia Research Trust [Y13G-CULL]	Diabetes Australia Research Trust	LACM received funding by Diabetes Australia Research Trust to support this work (www.diabelesaustralia.com.au/current-research-projects; Y13G-CULL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainge H, 2011, INT J OBESITY, V35, P325, DOI 10.1038/ijo.2010.149; American College of Obstetricians and Gynecologists, 2013, Obstet Gynecol, V121, P213, DOI http://10.1097/01.AOG.0000425667.10377.60; Armitage JA, 2005, J PHYSIOL-LONDON, V565, P171, DOI 10.1113/jphysiol.2005.084947; Ashino NG, 2012, J NUTR BIOCHEM, V23, P341, DOI 10.1016/j.jnutbio.2010.12.011; Avci ME, 2015, J MATERN-FETAL NEO M, V28, P2080, DOI 10.3109/14767058.2014.978279; Barker DJP, 1998, CLIN SCI, V95, P115, DOI 10.1042/CS19980019; Boubred F, 2007, AM J PHYSIOL-RENAL, V293, pF1944, DOI 10.1152/ajprenal.00141.2007; BRENNER BM, 1988, AM J HYPERTENS, V1, P335, DOI 10.1093/ajh/1.4.335; Bruce KD, 2009, HEPATOLOGY, V50, P1796, DOI 10.1002/hep.23205; Catalano PM, 2009, AM J CLIN NUTR, V90, P1303, DOI 10.3945/ajcn.2008.27416; Cullen LA, 2000, NEPHROLOGY, V5, P115, DOI 10.1046/j.1440-1797.2000.00512.x; Cullen-McEwen LA, 2003, HYPERTENSION, V41, P335, DOI 10.1161/01.HYP.0000050961.70182.56; Cullen-McEwen Luise A, 2012, Methods Mol Biol, V886, P109, DOI 10.1007/978-1-61779-851-1_10; Cullen-McEwen LA, 2011, AM J PHYSIOL-RENAL, V300, pF1448, DOI 10.1152/ajprenal.00055.2011; Dunn GA, 2009, ENDOCRINOLOGY, V150, P4999, DOI 10.1210/en.2009-0500; Elahi MM, 2009, BRIT J NUTR, V102, P514, DOI 10.1017/S000711450820749X; Ferezou-Viala J, 2007, AM J PHYSIOL-REG I, V293, pR1056, DOI 10.1152/ajpregu.00117.2007; Festing MFW, 2006, ILAR J, V47, P5, DOI 10.1093/ilar.47.1.5; Franco MDP, 2002, J CARDIOVASC PHARM, V39, P369, DOI 10.1097/00005344-200203000-00008; Hanson MA, 2014, PHYSIOL REV, V94, P1027, DOI 10.1152/physrev.00029.2013; Hokke SN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058243; Holemans K, 2004, AM J OBSTET GYNECOL, V190, P858, DOI 10.1016/j.ajog.2003.09.025; Hoppe CC, 2007, AM J PHYSIOL-REG I, V292, pR1768, DOI 10.1152/ajpregu.00442.2006; Jackson CM, 2012, AM J PHYSIOL-RENAL, V302, pF774, DOI 10.1152/ajprenal.00491.2011; Jones HN, 2009, FASEB J, V23, P271, DOI 10.1096/fj.08-116889; Khan LY, 2003, HYPERTENSION, V41, P168, DOI 10.1161/01.HYP.0000047511.97879.FC; Lagisz M, 2015, INT J OBESITY, V39, P1669, DOI 10.1038/ijo.2015.160; Langley-Evans SC, 1999, LIFE SCI, V64, P965, DOI 10.1016/S0024-3205(99)00022-3; Lelievre-Pegorier M, 1998, KIDNEY INT, V54, P1455, DOI 10.1046/j.1523-1755.1998.00151.x; Li HP, 2013, INT J CLIN EXP PATHO, V6, P650; Liang CY, 2010, METABOLISM, V59, P943, DOI 10.1016/j.metabol.2009.10.015; Lin Y, 2012, NUTRITION, V28, P1037, DOI 10.1016/j.nut.2012.01.002; Luyckx VA, 2013, LANCET, V382, P273, DOI 10.1016/S0140-6736(13)60311-6; Magliano DC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064258; Main ML, 2010, JAMA-J AM MED ASSOC, V303, P1695, DOI 10.1001/jama.2010.517; Maka N, 2008, PEDIATR NEPHROL, V23, P55, DOI 10.1007/s00467-007-0641-9; Mansano R, 2007, AM J OBSTET GYNECOL, V196, DOI 10.1016/j.ajog.2007.02.008; Masuyama H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092805; Mazzucco MB, 2013, J ENDOCRINOL, V217, P303, DOI 10.1530/JOE-13-0021; Nicholas LM, 2016, INT J OBESITY, V40, P229, DOI 10.1038/ijo.2015.178; Nivoit P, 2009, DIABETOLOGIA, V52, P1133, DOI 10.1007/s00125-009-1316-9; Ornellas F, 2013, LIFE SCI, V93, P454, DOI 10.1016/j.lfs.2013.08.005; Owens LA, 2010, DIABETES CARE, V33, P577, DOI 10.2337/dc09-0911; Reynolds RM, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4539; Samuelsson AM, 2008, HYPERTENSION, V51, P383, DOI 10.1161/HYPERTENSIONAHA.107.101477; Schock-Kusch D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071519; Schreiber A, 2012, AM J PHYSIOL-RENAL, V303, pF783, DOI 10.1152/ajprenal.00279.2012; Short K, 2013, DEVELOPMENT, V140, P471, DOI 10.1242/dev.088500; Shweta A, 2009, AM J PHYSIOL-RENAL, V296, pF583, DOI 10.1152/ajprenal.90359.2008; Sims-Lucas S, 2008, PEDIATR RES, V63, P607, DOI 10.1203/PDR.0b013e31816d9130; Srinivasan M, 2006, AM J PHYSIOL-ENDOC M, V291, pE792, DOI 10.1152/ajpendo.00078.2006; Taylor PD, 2005, AM J PHYSIOL-REG I, V288, pR134, DOI 10.1152/ajpregu.00355.2004; Vehaskari VM, 2001, KIDNEY INT, V59, P238, DOI 10.1046/j.1523-1755.2001.00484.x; Walker KA, 2012, AM J PHYSIOL-RENAL, V303, pF253, DOI 10.1152/ajprenal.00028.2012; Walls HL, 2010, PUBLIC HEALTH NUTR, V13, P631, DOI 10.1017/S1368980009991455; Woods LL, 2001, HYPERTENSION, V38, P337, DOI 10.1161/01.HYP.38.3.337	56	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2016	11	8							e0161578	10.1371/journal.pone.0161578	http://dx.doi.org/10.1371/journal.pone.0161578			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT8TP	27547968	Green Published, Green Submitted, gold			2022-12-27	WOS:000381768400072
J	Rega, D; Pecori, B; Scala, D; Avallone, A; Pace, U; Petrillo, A; Aloj, L; Tatangelo, F; Delrio, P				Rega, Daniela; Pecori, Biagio; Scala, Dario; Avallone, Antonio; Pace, Ugo; Petrillo, Antonella; Aloj, Luigi; Tatangelo, Fabiana; Delrio, Paolo			Evaluation of Tumor Response after Short-Course Radiotherapy and Delayed Surgery for Rectal Cancer	PLOS ONE			English	Article							PREOPERATIVE RADIOTHERAPY; RADIATION-THERAPY; RANDOMIZED-TRIAL; CHEMORADIOTHERAPY; INTERVAL	Purpose Neoadjuvant therapy is able to reduce local recurrence in rectal cancer. Immediate surgery after short course radiotherapy allows only for minimal downstaging. We investigated the effect of delayed surgery after short-course radiotherapy at different time intervals before surgery, in patients affected by rectal cancer. Methods From January 2003 to December 2013 sixty-seven patients with the following characteristics have been selected: clinical (c) stage T3N0 <= 12 cm from the anal verge and with circumferential resection margin >5 mm (by magnetic resonance imaging); cT2, any N, <5 cm from anal verge; and patients facing tumors with enlarged nodes and/or CRM+ve who resulted unfit for chemo-radiation, were also included. Patients underwent preoperative short-course radiotherapy with different interval to surgery were divided in three groups: A (within 6 weeks), B (between 6 and 8 weeks) and C (after more than 8 weeks). Hystopatolgical response to radiotherapy was measured by Mandard's modified tumor regression grade (TRG). Results All patients completed the scheduled treatment. Sixty-six patients underwent surgery. Fifty-three of which (80.3%) received a sphincter saving procedure. Downstaging occurred in 41 cases (62.1%). The analysis of subgroups showed an increasing prevalence of TRG 1-2 prolonging the interval to surgery (group A-16.7%, group B-36.8% and 54.3% in group C; p value 0.023). Conclusions Preoperative short-course radiotherapy is able to downstage rectal cancer if surgery is delayed. A higher rate of TRG 1-2 can be obtained if interval to surgery is prolonged to more than 8 weeks.	[Rega, Daniela; Scala, Dario; Pace, Ugo; Delrio, Paolo] Fdn Giovanni Pascale IRCCS, Ist Nazl Studio & Cura Tumori, Colorectal Surg Oncol, Naples, Italy; [Pecori, Biagio] Fdn Giovanni Pascale IRCCS, Ist Nazl Studio & Cura Tumori, Div Radiotherapy, Dept Diagnost Imaging Radiant & Metab Therapy, Naples, Italy; [Avallone, Antonio] Fdn Giovanni Pascale IRCCS, Ist Nazl Studio & Cura Tumori, Div Gastrointestinal Med Oncol, Naples, Italy; [Petrillo, Antonella] Fdn Giovanni Pascale IRCCS, Ist Nazl Studio & Cura Tumori, Div Radiol, Dept Diagnost Imaging Radiant & Metab Therapy, Naples, Italy; [Aloj, Luigi] Fdn Giovanni Pascale IRCCS, Ist Nazl Studio & Cura Tumori, Nucl Med Unit, Naples, Italy; [Tatangelo, Fabiana] Fdn Giovanni Pascale IRCCS, Ist Nazl Studio & Cura Tumori, Pathol Unit, Naples, Italy	IRCCS Fondazione Pascale; IRCCS Fondazione Pascale; IRCCS Fondazione Pascale; IRCCS Fondazione Pascale; IRCCS Fondazione Pascale; IRCCS Fondazione Pascale	Rega, D (corresponding author), Fdn Giovanni Pascale IRCCS, Ist Nazl Studio & Cura Tumori, Colorectal Surg Oncol, Naples, Italy.	daniela.rega@gmail.com	Tatangelo, Fabiana/AAA-8413-2020; Aloj, Luigi/AAK-5104-2020; Rega, Daniela/K-4876-2018; Scala, Dario/ABA-3610-2020; Petrillo, Antonella/J-5450-2018; Avallone, Antonio/K-4662-2016	Tatangelo, Fabiana/0000-0002-9943-6079; Petrillo, Antonella/0000-0003-2465-5370; Rega, Daniela/0000-0001-8326-050X; Avallone, Antonio/0000-0001-6188-5664; Aloj, Luigi/0000-0002-7452-4961				Avallone A, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-875; Avallone A, 2011, INT J RADIAT ONCOL, V79, P670, DOI 10.1016/j.ijrobp.2009.12.007; Berger C, 1997, INT J RADIAT ONCOL, V37, P619, DOI 10.1016/S0360-3016(96)00577-9; Bosset JF, 2006, NEW ENGL J MED, V355, P1114, DOI 10.1056/NEJMoa060829; Clavien PA, 2009, ANN SURG, V250, P187, DOI 10.1097/SLA.0b013e3181b13ca2; COX JD, 1995, INT J RADIAT ONCOL, V31, P1341, DOI 10.1016/0360-3016(95)00060-C; de Campos-Lobato LF, 2011, J GASTROINTEST SURG, V15, P444, DOI 10.1007/s11605-010-1197-8; Evans J, 2011, DIS COLON RECTUM, V54, P1251, DOI 10.1097/DCR.0b013e3182281f4b; Foster JD, 2013, DIS COLON RECTUM, V56, P921, DOI 10.1097/DCR.0b013e31828aedcb; Francois Y, 1999, J CLIN ONCOL, V17, P2396, DOI 10.1200/JCO.1999.17.8.2396; Gerard JP, 2006, J CLIN ONCOL, V24, P4620, DOI 10.1200/JCO.2006.06.7629; Graf W, 1997, RADIOTHER ONCOL, V43, P133, DOI 10.1016/S0167-8140(96)01867-1; Guillerme F, 2014, INT J COLORECTAL DIS, V29, P157, DOI 10.1007/s00384-013-1778-6; Hatfield P, 2009, RADIOTHER ONCOL, V92, P210, DOI 10.1016/j.radonc.2009.04.007; Latkauskas T, 2012, COLORECTAL DIS, V14, P294, DOI 10.1111/j.1463-1318.2011.02815.x; MANDARD AM, 1994, CANCER, V73, P2680, DOI 10.1002/1097-0142(19940601)73:11<2680::AID-CNCR2820731105>3.0.CO;2-C; Pach R, 2012, LANGENBECK ARCH SURG, V397, P801, DOI 10.1007/s00423-011-0890-8; Petrelli F, 2016, ANN SURG, V263, P458, DOI 10.1097/SLA.0000000000000368; Pettersson D, 2012, BRIT J SURG, V99, P577, DOI 10.1002/bjs.7796; Pettersson D, 2010, BRIT J SURG, V97, P580, DOI 10.1002/bjs.6914; Radu C, 2008, RADIOTHER ONCOL, V87, P343, DOI 10.1016/j.radonc.2007.11.025; Tulchinsky H, 2008, ANN SURG ONCOL, V15, P2661, DOI 10.1245/s10434-008-9892-3; Wasserberg N, 2014, WORLD J GASTROENTERO, V20, P4256, DOI 10.3748/wjg.v20.i15.4256; Yeo SG, 2013, INT J RADIAT ONCOL, V86, P34, DOI 10.1016/j.ijrobp.2012.11.018; 1997, SWEDISH RECTAL CANC, V336, P980	25	19	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2016	11	8							e0160732	10.1371/journal.pone.0160732	http://dx.doi.org/10.1371/journal.pone.0160732			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT8TP	27548058	gold, Green Published, Green Submitted			2022-12-27	WOS:000381768400019
J	Ceacero, TM; Mercadante, MEZ; Cyrillo, JNDG; Canesin, RC; Bonilha, SFM; de Albuquerque, LG				Ceacero, Thais Matos; Zerlotti Mercadante, Maria Eugenia; dos Santos Goncalves Cyrillo, Joslaine Noely; Canesin, Roberta Carrilho; Martins Bonilha, Sarah Figueiredo; de Albuquerque, Lucia Galvao			Phenotypic and Genetic Correlations of Feed Efficiency Traits with Growth and Carcass Traits in Nellore Cattle Selected for Postweaning Weight	PLOS ONE			English	Article							BEEF-CATTLE; BODY-WEIGHT; MUSCLE AREA; PERFORMANCE; PARAMETERS; BEHAVIOR; BULLS; ANGUS; ULTRASOUND; THICKNESS	This study evaluated phenotypic (r(ph)) and genetic correlations (r(g)) between 8 feed efficiency traits and other traits of economic interest including weight at selection (WS), loin-eye area (LEA), backfat thickness (BF), and rump fat thickness (RF) in Nellore cattle. Feed efficiency traits were gain: feed, residual feed intake (RFI), residual feed intake adjusted for backfat thickness (RFIb) and for backfat and rump fat thickness (RFIsf), residual body weight gain (RG), residual intake and body weight gain (RIG), and residual intake and body weight gain using RFIb (RIG(b)) and RFIsf (RIG(sf)). The variance components were estimated by the restricted maximum likelihood method using a two-trait animal model. The heritability estimates (h(2)) were 0.14, 0.24, 0.20, 0.22, 0.19, 0.15, 0.11 and 0.11 for gain: feed, RFI, RFIb, RFIsf, RG, RIG, RIG(b) and RIG(sf), respectively. All r(ph) values between traits were close to zero, except for the correlation of feed efficiency traits with dry matter intake and average daily gain. High r(g) values were observed for the correlation of dry matter intake, average daily gain and metabolic weight with WS and hip height (>0.61) and low to medium values (0.15 to 0.48) with the carcass traits (LEA, BF, RF). Among the feed efficiency traits, RG showed the highest r(g) with WS and hip height (0.34 and 0.25) and the lowest r(g) with subcutaneous fat thickness (-0.17 to 0.18). The r(g) values of RFI, RFIb and RFIsf with WS (0.17, 0.23 and 0.22), BF (0.37, 0.33 and 0.33) and RF (0.30, 0.31 and 0.32) were unfavorable. The r(g) values of gain: feed, RIG, RIG(b) and RIG(sf) with WS were low and favorable (0.07 to 0.22), while medium and unfavorable (-0.22 to -0.45) correlations were observed with fat thickness. The inclusion of subcutaneous fat thickness in the models used to calculate RFI did not reduce the r(g) between these traits. Selecting animals for higher feed efficiency will result in little or no genetic change in growth and will decrease subcutaneous fat thickness in the carcass.	[Ceacero, Thais Matos; Zerlotti Mercadante, Maria Eugenia; dos Santos Goncalves Cyrillo, Joslaine Noely; Canesin, Roberta Carrilho; Martins Bonilha, Sarah Figueiredo] Ctr APTA Bovinos Corte, Sertaozinho, SP, Brazil; [de Albuquerque, Lucia Galvao] Univ Paulista Julio de Mesquita Filho, Fac Ciencias Agr & Vet, Jaboticabal, SP, Brazil	Universidade Estadual Paulista	Mercadante, MEZ (corresponding author), Ctr APTA Bovinos Corte, Sertaozinho, SP, Brazil.	mercadante@iz.sp.gov.br	Canesin, Roberta C/A-5548-2015; Bonilha, Sarah F M/D-1043-2012; Mercadante, Maria Eugenia/C-9536-2012; Albuquerque, Lucia/A-7402-2013; Cyrillo, Joslaine/S-2637-2019; Canesin, Roberta Carrilho/AAH-1806-2019	Bonilha, Sarah F M/0000-0002-8055-4112; Mercadante, Maria Eugenia/0000-0002-1218-5378; Albuquerque, Lucia/0000-0002-2030-7590; Cyrillo, Joslaine/0000-0002-4390-630X; Carrilho Canesin, Roberta/0000-0003-1938-4596	Sao Paulo Research Foundation (FAPESP) [2009/16118-5]; National Council of Technological and Scientific Development of Brazil (CNPq); Coordination for the Improvement of Higher Education Personnel (CAPES)	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); National Council of Technological and Scientific Development of Brazil (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordination for the Improvement of Higher Education Personnel (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by Sao Paulo Research Foundation (FAPESP, grant #2009/16118-5) for financial support, National Council of Technological and Scientific Development of Brazil (CNPq) for providing research grants to MEZM SFMB LGA, and Coordination for the Improvement of Higher Education Personnel (CAPES) for providing grants to TMC RCC.	Albuquerque LG, 2006, P 8 WORLD C GEN APPL, P1; [Anonymous], 2014, BMC GENET, DOI DOI 10.1186/S12863-014-0100-0.W0S:000343677100001; Arthur PF, 2001, J ANIM SCI, V79, P2805; Berry DP, 2013, J ANIM SCI, V91, P1594, DOI 10.2527/jas.2012-5862; Berry DP, 2012, J ANIM SCI, V90, P109, DOI 10.2527/jas.2011-4245; Chizzotti ML, 2007, J ANIM SCI, V85, P1971, DOI 10.2527/jas.2006-632; Coutinho CC, 2015, GENET MOL RES, V14, P14076, DOI 10.4238/2015.October.29.27; Crews DH, 2005, GENETICS OF EFFICIEN, V4, P14; Del Claro AC, 2012, PESQUI AGROPECU BRAS, V47, P302, DOI 10.1590/S0100-204X2012000200020; Grion AL, 2014, J ANIM SCI, V92, P955, DOI 10.2527/jas.2013-6682; Karin Meyer, 2007, Journal of Zhejiang University-Science B, V8, P815, DOI 10.1631/jzus.2007.B0815; KOCH RM, 1963, J ANIM SCI, V22, P486, DOI 10.2527/jas1963.222486x; Lancaster PA, 2009, J ANIM SCI, V87, P1528, DOI 10.2527/jas.2008-1352; Sobrinho TL, 2013, REV BRAS ZOOTECN, V42, P125, DOI 10.1590/S1516-35982013000200007; Malheiros JM, 2015, B IND ANIM, V72, P341, DOI 10.17523/bia.v72n4p341; Mao F, 2013, J ANIM SCI, V91, P2067, DOI 10.2527/jas.2012-5470; Bonilha SFM, 2015, TROP ANIM HEALTH PRO, V47, P1381, DOI 10.1007/s11250-015-0875-7; Mercadante MEZ, 2003, J ANIM SCI, V81, P376; Nkrumah JD, 2007, J ANIM SCI, V85, P2711, DOI 10.2527/jas.2006-767; Parnell PF, 1994, 20TH BIENNIAL CONFER; Pinheiro TR, 2012, REV BRAS ZOOTECN, V41, P1426, DOI 10.1590/S1516-35982012000600016; Robinson DL, 2004, LIVEST PROD SCI, V90, P255, DOI 10.1016/j.livprodsci.2004.06.011; Rolfe KM, 2011, J ANIM SCI, V89, P3452, DOI 10.2527/jas.2011-3961; Sakamoto LS, 2014, J ANIM SCI, V92, P5230, DOI 10.2527/jas.2012-6065; Santana MHA, 2014, LIVEST SCI, V167, P80, DOI 10.1016/j.livsci.2014.06.002; Schenkel FS, 2004, CAN J ANIM SCI, V84, P177, DOI 10.4141/A03-085; Yokoo MJ, 2010, J ANIM SCI, V88, P52, DOI 10.2527/jas.2008-1028	27	39	39	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0161366	10.1371/journal.pone.0161366	http://dx.doi.org/10.1371/journal.pone.0161366			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27537268	Green Published, Green Submitted, gold			2022-12-27	WOS:000381577000094
J	Song, LP; Wang, HY				Song, Li-Peng; Wang, Hao-Yu			Modeling and Control of Colorectal Cancer	PLOS ONE			English	Article							SCREENING STRATEGIES	Colorectal Cancer (CRC) is becoming a major threat to people's life in China. Screening methods adopted by many other countries as effective counter-cancer methods have not been explicitly explored for people there. Thus, we present a Markov model with detailed precancerous adenoma states and then evaluate various screening strategies in this paper. Different from current researches, our model considers the population's heterogeneous risk of developing adenomas and observation-based screening strategies. Furthermore, we also give a new cost-effectiveness metric. After calibrating, the model is simulated using the Monte Carlo method. Numerical results show that there are threshold values of compliance rates below which strategy with every ten-year colonoscopy becomes the most cost-effective method; otherwise, an observation-based screening strategy is the most cost-effective. We also find that strategy with single colonoscopy for adenoma-free individuals and every three-year colonoscopy for those with adenoma is recommended when the observation-based strategy is not considered. Our findings give an explicit and complete instruction in CRC screening protocol in average-risk Chinese.	[Song, Li-Peng; Wang, Hao-Yu] North Univ China, Dept Comp Sci & Technol, Taiyuan, Shanxi, Peoples R China	North University of China	Song, LP (corresponding author), North Univ China, Dept Comp Sci & Technol, Taiyuan, Shanxi, Peoples R China.	slp880@nuc.edu.cn						Chen WQ, 2015, CHIN J CANCER, V34, DOI 10.1186/s40880-015-0042-6; Greuter MJE, 2014, RISK ANAL, V34, P889, DOI 10.1111/risa.12137; Guy GP, 2014, CANCER-AM CANCER SOC, V120, P2308, DOI 10.1002/cncr.28724; Howlader N, 2012, SEER CANCER STATISTI; Huang WD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109150; Li L, 2016, APPL MATH MODEL, V40, P4765, DOI 10.1016/j.apm.2015.12.003; Li Y, 2014, EUR J OPER RES, V238, P313, DOI 10.1016/j.ejor.2014.03.004; Rex DK, 1997, GASTROENTEROLOGY, V112, P24, DOI 10.1016/S0016-5085(97)70214-2; Rubinstein R., 2007, SIMULATION AND THE M; Rutter CM, 2007, STAT MED, V26, P98, DOI 10.1002/sim.2460; Schreuders EH, 2015, GUT, V64, P1637, DOI 10.1136/gutjnl-2014-309086; Sun GQ, 2016, NONLINEAR DYNAM, V85, P1, DOI 10.1007/s11071-016-2671-y; Sun GQ, 2016, NONLINEAR DYNAM, V83, P811, DOI 10.1007/s11071-015-2369-6; Sun GQ, 2015, SCI REP-UK, V5, DOI 10.1038/srep11246; Sun GQ, 2014, APPL MATH COMPUT, V246, P336, DOI 10.1016/j.amc.2014.08.028; Sun GQ, 2014, COMMUN NONLINEAR SCI, V19, P1507, DOI 10.1016/j.cnsns.2013.09.016; Sung JJY, 2015, GUT, V64, P121, DOI 10.1136/gutjnl-2013-306503; Tafazzoli A, 2009, ACM T MODEL COMPUT S, V19, DOI 10.1145/1502787.1502789; Wang ZH, 2012, ASIAN PAC J CANCER P, V13, P1761, DOI 10.7314/APJCP.2012.13.5.1761; Zhao P, 2010, CHINESE CANC REGISTR, P110; Zheng S, 2003, DIS COLON RECTUM, V46, P51, DOI 10.1007/s10350-004-6496-2; Zheng S, 2009, CHINA CANC, V18, P700	22	3	3	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0161349	10.1371/journal.pone.0161349	http://dx.doi.org/10.1371/journal.pone.0161349			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27536786	Green Submitted, gold, Green Published			2022-12-27	WOS:000381577000090
J	Vink, MA; Berkhof, J; van de Kassteele, J; van Boven, M; Bogaards, JA				Vink, Margaretha A.; Berkhof, Johannes; van de Kassteele, Jan; van Boven, Michiel; Bogaards, Johannes A.			A Bivariate Mixture Model for Natural Antibody Levels to Human Papillomavirus Types 16 and 18: Baseline Estimates for Monitoring the Herd Effects of Immunization	PLOS ONE			English	Article							HIGH-RISK HPV; INTRAEPITHELIAL NEOPLASIA; VACCINATION PROGRAMS; CERVICAL-CANCER; PREVALENCE; SEROPREVALENCE; POPULATION; INFECTIONS; IMPACT	Post-vaccine monitoring programs for human papillomavirus (HPV) have been introduced in many countries, but HPV serology is still an underutilized tool, partly owing to the weak antibody response to HPV infection. Changes in antibody levels among non-vaccinated individuals could be employed to monitor herd effects of immunization against HPV vaccine types 16 and 18, but inference requires an appropriate statistical model. The authors developed a four-component bivariate mixture model for jointly estimating vaccine-type seroprevalence from correlated antibody responses against HPV16 and -18 infections. This model takes account of the correlation between HPV16 and -18 antibody concentrations within subjects, caused e.g. by heterogeneity in exposure level and immune response. The model was fitted to HPV16 and -18 antibody concentrations as measured by a multiplex immunoassay in a large serological survey (3,875 females) carried out in the Netherlands in 2006/2007, before the introduction of mass immunization. Parameters were estimated by Bayesian analysis. We used the deviance information criterion for model selection; performance of the preferred model was assessed through simulation. Our analysis uncovered elevated antibody concentrations in doubly as compared to singly seropositive individuals, and a strong clustering of HPV16 and -18 seropositivity, particularly around the age of sexual debut. The bivariate model resulted in a more reliable classification of singly and doubly seropositive individuals than achieved by a combination of two univariate models, and suggested a higher pre-vaccine HPV16 seroprevalence than previously estimated. The bivariate mixture model provides valuable baseline estimates of vaccine-type seroprevalence and may prove useful in seroepidemiologic assessment of the herd effects of HPV vaccination.	[Vink, Margaretha A.; van Boven, Michiel; Bogaards, Johannes A.] Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, Bilthoven, Netherlands; [Vink, Margaretha A.; Berkhof, Johannes] Vrije Univ Amsterdam, Med Ctr, Dept Epidemiol & Biostat, Amsterdam, Netherlands; [van de Kassteele, Jan] Natl Inst Publ Hlth & Environm, Dept Stat Informat & Modelling, Bilthoven, Netherlands	Netherlands National Institute for Public Health & the Environment; Vrije Universiteit Amsterdam; Netherlands National Institute for Public Health & the Environment	Bogaards, JA (corresponding author), Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, Bilthoven, Netherlands.	hans.bogaards@rivm.nl		van de Kassteele, Jan/0000-0001-5926-6709; Bogaards, Johannes/0000-0002-3389-5141	Dutch Ministry of Health, Welfare and Sports; National Institute for Public Health and the Environment (RIVM) [S/113005/01/PT]	Dutch Ministry of Health, Welfare and Sports; National Institute for Public Health and the Environment (RIVM)	This research was supported by the Dutch Ministry of Health, Welfare and Sports, and carried out within the framework of RIVM Strategic Programme (SPR grant number S/113005/01/PT), preparing the National Institute for Public Health and the Environment (RIVM) to respond to future issues in health and sustainability. See http://www.rivm.nl/en/About_RIVM/Mission_and_strategy/RIVM_s_Strategic_Programme.	Abogunrin S, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-968; Bogaards JA, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h2016; Bogaards JA, 2011, EPIDEMIOLOGY, V22, P505, DOI 10.1097/EDE.0b013e31821d107b; Bogaards JA, 2010, AM J EPIDEMIOL, V171, P817, DOI 10.1093/aje/kwp466; Bosch FX, 2013, VACCINE, V31, pF1, DOI [10.1016/j.vaccine.2013.10.001, 10.1016/j.vaccine.2013.07.026, 10.1016/j.vaccine.2013.10.003]; Brisson M, 2011, SEX TRANSM INFECT, V87, P41, DOI 10.1136/sti.2010.044412; Combes JD, 2014, INT J CANCER, V135, P2453, DOI 10.1002/ijc.28888; DALE JR, 1986, BIOMETRICS, V42, P909, DOI 10.2307/2530704; de Graaf H, 2005, SEX AGE 25 SEXUAL HL; de Koning L, 2012, CLIN BIOCHEM, V45, P848, DOI 10.1016/j.clinbiochem.2012.04.006; De Vuyst H, 2009, INT J CANCER, V124, P1626, DOI 10.1002/ijc.24116; Drolet M, 2015, LANCET INFECT DIS, V15, P565, DOI 10.1016/S1473-3099(14)71073-4; Farrington CP, 2013, AM J EPIDEMIOL, V177, P474, DOI 10.1093/aje/kws260; Farrington CP, 2001, J R STAT SOC C-APPL, V50, P251, DOI 10.1111/1467-9876.00233; GELFAND AE, 1990, J AM STAT ASSOC, V85, P398, DOI 10.2307/2289776; Gelman A., 2004, BAYESIAN DATA ANAL; Hariri S, 2015, EMERG INFECT DIS, V21, P1557, DOI 10.3201/eid2109.141841; Hens N, 2008, STAT MED, V27, P2651, DOI 10.1002/sim.3089; Hens N, 2009, STAT MED, V28, P2785, DOI 10.1002/sim.3660; Hens N., 2012, MODELING INFECT DIS; Li N, 2011, INT J CANCER, V128, P927, DOI 10.1002/ijc.25396; Miralles-Guri C, 2009, J CLIN PATHOL, V62, P870, DOI 10.1136/jcp.2008.063149; Mooij SH, 2013, CANCER EPIDEM BIOMAR, V22, P1698, DOI 10.1158/1055-9965.EPI-13-0460; Plummer M, 2008, BIOSTATISTICS, V9, P523, DOI 10.1093/biostatistics/kxm049; Scherpenisse M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074797; Scherpenisse M, 2012, VACCINE, V30, P6686, DOI 10.1016/j.vaccine.2012.08.068; Schiffman M, 2015, CANCER EPIDEM BIOMAR, V24, P1304, DOI 10.1158/1055-9965.EPI-14-1353; Schurink-van't Klooster TM, 2014, NATL IMMUNISATION PR; Schwarz TF, 2008, GYNECOL ONCOL, V110, pS1, DOI 10.1016/j.ygyno.2008.05.036; Smits G, 2014, VACCINE, V32, P1890, DOI 10.1016/j.vaccine.2014.01.066; Smits G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058234; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Stanley M, 2008, GYNECOL ONCOL, V109, pS15, DOI 10.1016/j.ygyno.2008.02.003; Vaccarella S, 2010, CANCER EPIDEM BIOMAR, V19, P2379, DOI 10.1158/1055-9965.EPI-10-0336; Vaccarella S, 2010, CANCER EPIDEM BIOMAR, V19, P503, DOI 10.1158/1055-9965.EPI-09-0983; Vink MA, 2015, EPIDEMIOLOGY, V26, P8, DOI 10.1097/EDE.0000000000000196; Vink MA, 2013, AM J EPIDEMIOL, V178, P1161, DOI 10.1093/aje/kwt077; Vriend HJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060696; Yee TW, 1996, J ROY STAT SOC B MET, V58, P481	40	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0161109	10.1371/journal.pone.0161109	http://dx.doi.org/10.1371/journal.pone.0161109			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27537200	Green Published, Green Submitted, gold			2022-12-27	WOS:000381577000054
J	Christman, MC; Doctor, DH; Niemiller, ML; Weary, DJ; Young, JA; Zigler, KS; Culver, DC				Christman, Mary C.; Doctor, Daniel H.; Niemiller, Matthew L.; Weary, David J.; Young, John A.; Zigler, Kirk S.; Culver, David C.			Predicting the Occurrence of Cave-Inhabiting Fauna Based on Features of the Earth Surface Environment	PLOS ONE			English	Article							SPECIES DISTRIBUTION MODELS; TELEOSTEI AMBLYOPSIDAE; COMMUNITY-LEVEL; BIODIVERSITY; PATTERNS; DIVERSITY; FUTURE; CRUSTACEANS; TENNESSEE; ECOLOGY	One of the most challenging fauna to study in situ is the obligate cave fauna because of the difficulty of sampling. Cave-limited species display patchy and restricted distributions, but it is often unclear whether the observed distribution is a sampling artifact or a true restriction in range. Further, the drivers of the distribution could be local environmental conditions, such as cave humidity, or they could be associated with surface features that are surrogates for cave conditions. If surface features can be used to predict the distribution of important cave taxa, then conservation management is more easily obtained. We examined the hypothesis that the presence of major faunal groups of cave obligate species could be predicted based on features of the earth surface. Georeferenced records of cave obligate amphipods, crayfish, fish, isopods, beetles, millipedes, pseudoscorpions, spiders, and springtails within the area of Appalachian Landscape Conservation Cooperative in the eastern United States (Illinois to Virginia and New York to Alabama) were assigned to 20 x 20 km grid cells. Habitat suitability for these faunal groups was modeled using logistic regression with twenty predictor variables within each grid cell, such as percent karst, soil features, temperature, precipitation, and elevation. Models successfully predicted the presence of a group greater than 65% of the time (mean = 88%) for the presence of single grid cell endemics, and for all faunal groups except pseudoscorpions. The most common predictor variables were latitude, percent karst, and the standard deviation of the Topographic Position Index (TPI), a measure of landscape rugosity within each grid cell. The overall success of these models points to a number of important connections between the surface and cave environments, and some of these, especially soil features and topographic variability, suggest new research directions. These models should prove to be useful tools in predicting the presence of species in understudied areas.	[Christman, Mary C.] Univ Florida, Dept Biol & Stat, Gainesville, FL USA; [Christman, Mary C.] MCC Stat Consulting LLC, Gainesville, FL USA; [Doctor, Daniel H.; Weary, David J.] US Geol Survey, Reston, VA 22092 USA; [Niemiller, Matthew L.] Univ Illinois, Illinois Nat Hist Survey, Prairie Res Inst, Champaign, IL USA; [Young, John A.] US Geol Survey, Leetown Sci Ctr, Kearneysville, WV USA; [Zigler, Kirk S.] Univ South, Dept Biol, Sewanee, TN USA; [Culver, David C.] Amer Univ, Dept Environm Sci, Washington, DC 20016 USA	State University System of Florida; University of Florida; United States Department of the Interior; United States Geological Survey; Illinois Natural History Survey; University of Illinois System; University of Illinois Urbana-Champaign; United States Department of the Interior; United States Geological Survey; Sewanee: University of the South; American University	Culver, DC (corresponding author), Amer Univ, Dept Environm Sci, Washington, DC 20016 USA.	dculver@american.edu	Zigler, Kirk S./GZM-2049-2022; Niemiller, Matthew L./B-2454-2012	Niemiller, Matthew L./0000-0001-6353-8797; Young, John/0000-0002-4500-3673	Wildlife Management Institute through the Appalachian Land Conservation Cooperative (ALCC); commercial company, MCC Statistical Consulting LCC	Wildlife Management Institute through the Appalachian Land Conservation Cooperative (ALCC); commercial company, MCC Statistical Consulting LCC	This work was supported by the Wildlife Management Institute through the Appalachian Land Conservation Cooperative (ALCC 2013-4) to DCC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. One author (MCC) is employed by a commercial company, MCC Statistical Consulting LCC. The funder provided support in the form of salaries for an author [MCC], but did not have any additional role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.; We thank the Alabama and Tennessee Cave Surveys and the Georgia, Illinois, Kentucky, Virginia, and West Virginia Speleological Surveys for assistance with georeferencing data. We thank D. Feller, E. Hazelton, G. Moni, J. Lewis, Alabama Natural Heritage Program, Georgia Natural Heritage Program, Kentucky State Nature Preserves Commission, Maryland Natural Heritage Program, Tennessee Chapter of The Nature Conservancy, Tennessee Natural Heritage Program, Virginia Natural Heritage Program, and West Virginia Natural Heritage Program for providing biological data. Funding for this work was provided by the Wildlife Management Institute through the Appalachian Land Conservation Cooperative (ALCC 2013-4). The data used for this work are available online through the USGS ScienceBase system [48]. Any use of trade, firm, or productnames is for descriptive purposes only and does not imply endorsement by the U.S. Government.	BARR TC, 1967, AM NAT, V101, P475, DOI 10.1086/282512; BARR THOMAS C., 1968, P35; BARR THOMAS C., 1960, AMER MIDLAND NAT, V63, P307, DOI 10.2307/2422794; Christman MC, 2005, J BIOGEOGR, V32, P1441, DOI 10.1111/j.1365-2699.2005.01263.x; Christman MC, 2001, J BIOGEOGR, V28, P367, DOI 10.1046/j.1365-2699.2001.00549.x; Corrigan LJ, 2014, EVOL BIOL, V41, P154, DOI 10.1007/s11692-013-9255-2; Culver DC, 2006, ECOGRAPHY, V29, P120; Culver DC, 2004, BIODIVERS CONSERV, V13, P1209, DOI 10.1023/B:BIOC.0000018153.49280.89; Culver DC, 2003, BIODIVERS CONSERV, V12, P441, DOI 10.1023/A:1022425908017; Doctor DH, 2016, GIS DATA PREDICTING; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Eme D, 2015, ECOGRAPHY, V38, P531, DOI 10.1111/ecog.01092; Engel A. S., 2012, ENCY CAVES, V2nd, P125, DOI DOI 10.1016/B978-0-12-383832-2.00019-0; Faille A, 2014, J BIOGEOGR, V41, P1979, DOI 10.1111/jbi.12349; Farlow JO, 2010, INDIANA GEOLOGICAL S, V69, P1; Ferrier S, 2002, BIODIVERS CONSERV, V11, P2309, DOI 10.1023/A:1021374009951; Ferrier S, 2006, J APPL ECOL, V43, P393, DOI 10.1111/j.1365-2664.2006.01149.x; Gers C, 1998, ACTA OECOL, V19, P205, DOI 10.1016/S1146-609X(98)80025-8; Gibert J, 2002, BIOSCIENCE, V52, P473, DOI 10.1641/0006-3568(2002)052[0473:SEATFB]2.0.CO;2; Graening GO, 2011, 2011 CAVE LIFE OKLAH; Guillera-Arroita G, 2015, GLOBAL ECOL BIOGEOGR, V24, P276, DOI 10.1111/geb.12268; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Hawes RS, 1939, J ANIM ECOL, V8, P1, DOI 10.2307/1248; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Jeannel R., 1943, FOSSILES VIVANTS CAV; Jenness J., 2013, LAND FACET CORRIDOR; Loarie SR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002502; Malard F, 2009, FRESHWATER BIOL, V54, P756, DOI 10.1111/j.1365-2427.2009.02180.x; Morvan C, 2013, SYST BIOL, V62, P512, DOI 10.1093/sysbio/syt015; Niemiller ML, 2008, MOL ECOL, V17, P2258, DOI 10.1111/j.1365-294X.2008.03750.x; Niemiller ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064177; Niemiller ML, 2013, EVOLUTION, V67, P1011, DOI 10.1111/evo.12017; Niemiller ML, 2013, EVOLUTION, V67, P732, DOI 10.1111/j.1558-5646.2012.01822.x; Niemiller ML, 2009, P 15 INT C SPEL, V15, P242; Ovaskainen O, 2011, ECOLOGY, V92, P289, DOI 10.1890/10-1251.1; Palmer AN., 2009, CAVES KARST US; Peck S.B., 1980, Bulletin of the National Speleological Society, V42, P53; Platts PJ, 2014, DIVERS DISTRIB, V20, P1307, DOI 10.1111/ddi.12244; Shunk AJ, 2009, PALAEOGEOGR PALAEOCL, V274, P173, DOI 10.1016/j.palaeo.2009.01.008; Simon KS, 2010, FUND APPL LIMNOL, V177, P81, DOI 10.1127/1863-9135/2010/0177-0081; Sinclair SJ, 2010, ECOL SOC, V15, DOI 10.5751/ES-03089-150108; Taylor Steven J., 2016, Subterranean Biology, V17, P1, DOI 10.3897/subtbiol.17.7298; Tschudy RH, 1965, US GEOL SURVEY PROF, V525-B, pB64; Weary DJ, 2014, 20141156 USGS; WOLOCK DM, 2003, 03146 USGS; Zagmajster M, 2007, THESIS; Zagmajster M, 2014, GLOBAL ECOL BIOGEOGR, V23, P1135, DOI 10.1111/geb.12200; Zobaa MK, 2011, PALAEOGEOGR PALAEOCL, V308, P433, DOI 10.1016/j.palaeo.2011.05.051	48	32	32	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2016	11	8							e0160408	10.1371/journal.pone.0160408	http://dx.doi.org/10.1371/journal.pone.0160408			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4YN	27532611	Green Submitted, gold, Green Published			2022-12-27	WOS:000381487600029
J	Gardner, B; Gruning, A				Gardner, Brian; Gruning, Andre			Supervised Learning in Spiking Neural Networks for Precise Temporal Encoding	PLOS ONE			English	Article							BACKPROPAGATION; REINFORCEMENT; NEURONS; TRAINS	Precise spike timing as a means to encode information in neural networks is biologically supported, and is advantageous over frequency-based codes by processing input features on a much shorter time-scale. For these reasons, much recent attention has been focused on the development of supervised learning rules for spiking neural networks that utilise a temporal coding scheme. However, despite significant progress in this area, there still lack rules that have a theoretical basis, and yet can be considered biologically relevant. Here we examine the general conditions under which synaptic plasticity most effectively takes place to support the supervised learning of a precise temporal code. As part of our analysis we examine two spike-based learning methods: one of which relies on an instantaneous error signal to modify synaptic weights in a network (INST rule), and the other one relying on a filtered error signal for smoother synaptic weight modifications (FILT rule). We test the accuracy of the solutions provided by each rule with respect to their temporal encoding precision, and then measure the maximum number of input patterns they can learn to memorise using the precise timings of individual spikes as an indication of their storage capacity. Our results demonstrate the high performance of the FILT rule in most cases, underpinned by the rule's error-filtering mechanism, which is predicted to provide smooth convergence towards a desired solution during learning. We also find the FILT rule to be most efficient at performing input pattern memorisations, and most noticeably when patterns are identified using spikes with sub-millisecond temporal precision. In comparison with existing work, we determine the performance of the FILT rule to be consistent with that of the highly efficient E-learning Chronotron rule, but with the distinct advantage that our FILT rule is also implementable as an online method for increased biological realism.	[Gardner, Brian; Gruning, Andre] Univ Surrey, Dept Comp Sci, Guildford, Surrey, England	University of Surrey	Gardner, B (corresponding author), Univ Surrey, Dept Comp Sci, Guildford, Surrey, England.	b.gardner@surrey.ac.uk			Engineering and Physical Sciences Research Council [EP/J500562/1]; European Community [604102]; Horizon [284941]	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); European Community(European Commission); Horizon	BG was supported by the Engineering and Physical Sciences Research Council (grant no. EP/J500562/1, http://www.epsrc.ac.uk/). AG and BG were supported by the European Community's Seventh Framework Programme (grant no. 604102, The Human Brain Project, http://cordis.europa.eu/fp7/). AG and BG were supported by Horizon 2020 (grant no. 284941, The Human Brain Project, https://ec.europa.eu/programmes/horizon2020/).	Albers C., 2013, ADV NEURAL INFORM PR, P1709; Albers C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148948; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; Bohte SM, 2002, NEUROCOMPUTING, V48, P17, DOI 10.1016/S0925-2312(01)00658-0; Brea J, 2013, J NEUROSCI, V33, P9565, DOI 10.1523/JNEUROSCI.4098-12.2013; Bush D, 2012, J COMPUT NEUROSCI, V33, P495, DOI 10.1007/s10827-012-0397-5; Farries MA, 2007, J NEUROPHYSIOL, V98, P3648, DOI 10.1152/jn.00364.2007; Florian RV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040233; Fremaux N, 2010, J NEUROSCI, V30, P13326, DOI 10.1523/JNEUROSCI.6249-09.2010; Furber SB, 2014, P IEEE, V102, P652, DOI 10.1109/JPROC.2014.2304638; Gardner B, 2015, NEURAL COMPUT, V27, P2548, DOI 10.1162/NECO_a_00790; Gardner B, 2013, LECT NOTES COMPUT SC, V8131, P256, DOI 10.1007/978-3-642-40728-4_32; Gerstner W, 2002, SPIKING NEURON MODEL; Gollisch T, 2008, SCIENCE, V319, P1108, DOI 10.1126/science.1149639; Gruning A, 2007, NEURAL COMPUT, V19, P3108, DOI 10.1162/neco.2007.19.11.3108; Gutig R, 2014, CURR OPIN NEUROBIOL, V25, P134, DOI 10.1016/j.conb.2014.01.004; Gutig R, 2006, NAT NEUROSCI, V9, P420, DOI 10.1038/nn1643; Izhikevich EM, 2007, CEREB CORTEX, V17, P2443, DOI 10.1093/cercor/bhl152; Johansson RS, 2004, NAT NEUROSCI, V7, P170, DOI 10.1038/nn1177; Jolivet R, 2006, J COMPUT NEUROSCI, V21, P35, DOI 10.1007/s10827-006-7074-5; Kasinski A., 2006, International Journal of Applied Mathematics and Computer Science, V16, P101; KNUDSEN EI, 1994, J NEUROSCI, V14, P3985; MAINEN ZF, 1995, SCIENCE, V268, P1503, DOI 10.1126/science.7770778; Memmesheimer RM, 2014, NEURON, V82, P925, DOI 10.1016/j.neuron.2014.03.026; Miall RC, 1996, NEURAL NETWORKS, V9, P1265, DOI 10.1016/S0893-6080(96)00035-4; Mohemmed A, 2012, INT J NEURAL SYST, V22, DOI 10.1142/S0129065712500128; Nichols E, 2016, SUPERVISED IN PRESS; Paninski L, 2004, NETWORK-COMP NEURAL, V15, P243, DOI 10.1088/0954-898X/15/4/002; Pfister JP, 2006, NEURAL COMPUT, V18, P1318, DOI 10.1162/neco.2006.18.6.1318; Ponulak F, 2010, NEURAL COMPUT, V22, P467, DOI 10.1162/neco.2009.11-08-901; Reich DS, 1997, J NEUROPHYSIOL, V77, P2836, DOI 10.1152/jn.1997.77.5.2836; Rezende DJ, 2014, FRONT COMPUT NEUROSC, V8, DOI 10.3389/fncom.2014.00038; Sporea I, 2013, NEURAL COMPUT, V25, P473, DOI 10.1162/NECO_a_00396; Urbanczik R, 2014, NEURON, V81, P521, DOI 10.1016/j.neuron.2013.11.030; Uzzell VJ, 2004, J NEUROPHYSIOL, V92, P780, DOI 10.1152/jn.01171.2003; van Rossum MCW, 2001, NEURAL COMPUT, V13, P751, DOI 10.1162/089976601300014321; VanRullen R, 2005, TRENDS NEUROSCI, V28, P1, DOI 10.1016/j.tins.2004.10.010; Victor JD, 1996, J NEUROPHYSIOL, V76, P1310, DOI 10.1152/jn.1996.76.2.1310; Yu Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078318	40	33	35	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2016	11	8							e0161335	10.1371/journal.pone.0161335	http://dx.doi.org/10.1371/journal.pone.0161335			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4YN	27532262	gold, Green Published, Green Submitted			2022-12-27	WOS:000381487600086
J	Benedet, M; Falchi, FA; Puccio, S; Di Benedetto, C; Peano, C; Polissi, A; Deho, G				Benedet, Mattia; Falchi, Federica A.; Puccio, Simone; Di Benedetto, Cristiano; Peano, Clelia; Polissi, Alessandra; Deho, Gianni			The Lack of the Essential LptC Protein in the Trans-Envelope Lipopolysaccharide Transport Machine Is Circumvented by Suppressor Mutations in LptF, an Inner Membrane Component of the Escherichia coli Transporter	PLOS ONE			English	Article							OUTER-MEMBRANE; FUNCTIONAL-ANALYSIS; STRUCTURAL BASIS; ESSENTIAL GENES; COMPLEX; IDENTIFICATION; OLIGOMERIZATION; MUTAGENESIS; ASSEMBLES; REGION	The lipopolysaccharide (LPS) transport (Lpt) system is responsible for transferring LPS from the periplasmic surface of the inner membrane (IM) to the outer leaflet of the outer membrane (OM), where it plays a crucial role in OM selective permeability. In E. coli seven essential proteins are assembled in an Lpt trans-envelope complex, which is conserved in gamma-Proteobacteria. LptBFG constitute the IMABC transporter, LptDE form the OM translocon for final LPS delivery, whereas LptC, an IM-anchored protein with a periplasmic domain, interacts with the IM ABC transporter, the periplasmic protein LptA, and LPS. Although essential, LptC can tolerate several mutations and its role in LPS transport is unclear. To get insights into the functional role of LptC in the Lpt machine we searched for viable mutants lacking LptC by applying a strong double selection for lptC deletion mutants. Genome sequencing of viable Delta lptC mutants revealed single amino acid substitutions at a unique position in the predicted large periplasmic domain of the IM component LptF (LptF(SupC)). In complementation tests, lptF(SupC) mutants suppress lethality of both Delta lptC and lptC conditional expressionmutants. Our data show that mutations in a specific residue of the predicted LptF periplasmic domain can compensate the lack of the essential protein LptC, implicate such LptF domain in the formation of the periplasmic bridge between the IM and OM complexes, and suggest that LptC may have evolved to improve the performance of an ancestral six-component Lpt machine.	[Benedet, Mattia; Falchi, Federica A.; Di Benedetto, Cristiano; Deho, Gianni] Univ Milan, Dipartimento Biosci, Milan, Italy; [Puccio, Simone] Univ Milan, Scuola Dottorato Med Mol & Traslaz, Segrate, Italy; [Puccio, Simone; Peano, Clelia] CNR, Ist Tecnol Biomed, Milan, Italy; [Polissi, Alessandra] Univ Milano Bicocca, Dipartimento Biotecnol & Biosci, Milan, Italy; [Benedet, Mattia] Univ Trento, Ctr Integrat Biol, Trento, Italy; [Di Benedetto, Cristiano] King Abdullah Univ Sci & Technol, Biol & Environm Sci & Engn Div, Thuwal, Saudi Arabia; [Polissi, Alessandra] Univ Milan, Dipartimento Sci Farmacol & Biomol, Milan, Italy	University of Milan; University of Milan; Consiglio Nazionale delle Ricerche (CNR); Istituto di Tecnologie Biomediche (ITB-CNR); University of Milano-Bicocca; University of Trento; King Abdullah University of Science & Technology; University of Milan	Deho, G (corresponding author), Univ Milan, Dipartimento Biosci, Milan, Italy.	gianni.deho@unimi.it	Puccio, Simone/P-9571-2018; Peano, Clelia/C-4015-2018	Puccio, Simone/0000-0003-4007-4365; Peano, Clelia/0000-0001-7055-3629; POLISSI, ALESSANDRA/0000-0003-0903-8024; DEHO', GIOVANNI/0000-0001-5492-7766; FALCHI, FEDERICA ANNA/0000-0002-1692-8167	Fondazione per la Ricerca sulla Fibrosi Cistica [13/2010]; Regione Lombardia-MIUR [30190679]	Fondazione per la Ricerca sulla Fibrosi Cistica(Ministry of Health, ItalyItalian Cystic Fibrosis Research Foundation); Regione Lombardia-MIUR(Regione Lombardia)	This work was supported by Fondazione per la Ricerca sulla Fibrosi Cistica (http://www.fibrosicisticaricerca.it/) (grant FFC#13/2010 to AP) and by Regione Lombardia-MIUR (http://www.regione.lombardia.it; http://www.istruzione.it), project ID 30190679 (to GD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERTANI G, 1951, J BACTERIOL, V62, P293, DOI 10.1128/JB.62.3.293-300.1951; Bollati M, 2015, FEBS J, V282, P1980, DOI 10.1111/febs.13254; Bos MP, 2004, P NATL ACAD SCI USA, V101, P9417, DOI 10.1073/pnas.0402340101; Chimalakonda G, 2011, P NATL ACAD SCI USA, V108, P2492, DOI 10.1073/pnas.1019089108; Chng SS, 2010, BIOCHEMISTRY-US, V49, P4565, DOI 10.1021/bi100493e; Chng SS, 2010, P NATL ACAD SCI USA, V107, P5363, DOI 10.1073/pnas.0912872107; Daley DO, 2005, SCIENCE, V308, P1321, DOI 10.1126/science.1109730; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Davidson AL, 2008, MICROBIOL MOL BIOL R, V72, P317, DOI 10.1128/MMBR.00031-07; De Baets G, 2012, NUCLEIC ACIDS RES, V40, pD935, DOI 10.1093/nar/gkr996; Dong HH, 2014, NATURE, V511, P52, DOI 10.1038/nature13464; Ferenci T, 2009, J BACTERIOL, V191, P4025, DOI 10.1128/JB.00118-09; Freinkman E, 2012, BIOCHEMISTRY; Freinkman E, 2011, P NATL ACAD SCI USA, V108, P2486, DOI 10.1073/pnas.1015617108; Gerdes S, 2006, CURR OPIN BIOTECH, V17, P448, DOI 10.1016/j.copbio.2006.08.006; GHISOTTI D, 1992, MOL MICROBIOL, V6, P3405, DOI 10.1111/j.1365-2958.1992.tb02208.x; Gu Y, 2015, STRUCTURE; LEDERBERG J, 1951, J BACTERIOL, V61, P549, DOI 10.1128/JB.61.5.549-550.1951; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lima S, 2013, SCIENCE, V340, P837, DOI 10.1126/science.1235358; Ma B, 2008, P NATL ACAD SCI USA, V105, P13823, DOI 10.1073/pnas.0807028105; Martorana AM, 2011, RES MICROBIOL, V162, P470, DOI 10.1016/j.resmic.2011.03.007; Martorana AM, 2016, J BACTERIOL IN PRESS; Merten JA, 2012, PROTEIN SCI, V21, P211, DOI 10.1002/pro.2004; Narita S, 2009, FEBS LETT, V583, P2160, DOI 10.1016/j.febslet.2009.05.051; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; Okuda S, 2016, NAT REV MICROBIOL; Okuda S, 2012, SCIENCE, V338, P1214, DOI 10.1126/science.1228984; Qiao S, 2014, NATURE, V511, P108, DOI 10.1038/nature13484; Ruiz N, 2008, P NATL ACAD SCI USA, V105, P5537, DOI 10.1073/pnas.0801196105; Sambrock J, 1989, MOL CLONING LAB MANU, V1; SAMPSON BA, 1989, GENETICS, V122, P491; Santambrogio C, 2013, J AM SOC MASS SPECTR, V24, P1593, DOI 10.1007/s13361-013-0687-9; Schultz KM, 2013, PROTEIN SCI, V22, P1639, DOI 10.1002/pro.2369; Serina S, 2004, RES MICROBIOL, V155, P692, DOI 10.1016/j.resmic.2004.05.006; Sestito SE, 2014, CHEMBIOCHEM, V15, P734, DOI 10.1002/cbic.201300805; Sherman DJ, 2014, P NATL ACAD SCI USA, V111, P4982, DOI 10.1073/pnas.1323516111; Sperandeo P, 2014, BACTERIAL MEMBRANES, P55; Sperandeo P, 2008, J BACTERIOL, V190, P4460, DOI 10.1128/JB.00270-08; Sperandeo P, 2007, J BACTERIOL, V189, P244, DOI 10.1128/JB.01126-06; Sperandeo P, 2006, RES MICROBIOL, V157, P547, DOI 10.1016/j.resmic.2005.11.014; Sperandeo P, 2011, J BACTERIOL, V193, P1042, DOI 10.1128/JB.01037-10; Stenberg F, 2005, J BIOL CHEM, V280, P34409, DOI 10.1074/jbc.M506479200; Suits MDL, 2008, J MOL BIOL, V380, P476, DOI 10.1016/j.jmb.2008.04.045; TAKASE I, 1987, J BACTERIOL, V169, P5692, DOI 10.1128/jb.169.12.5692-5699.1987; Tran AX, 2010, J BIOL CHEM, V285, P33529, DOI 10.1074/jbc.M110.144709; Tran AX, 2008, JBIOLCHEM; Villa R, 2013, J BACTERIOL, V195, P1100, DOI 10.1128/JB.02057-12; Wang ZS, 2014, BIOCHEM BIOPH RES CO, V452, P443, DOI 10.1016/j.bbrc.2014.08.094; Wu T, 2006, P NATL ACAD SCI USA, V103, P11754, DOI 10.1073/pnas.0604744103; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zerbino DR, 2010, CURR PROTOC BIOINFOR, V11, P11	52	20	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2016	11	8							e0161354	10.1371/journal.pone.0161354	http://dx.doi.org/10.1371/journal.pone.0161354			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4UN	27529623	gold, Green Published, Green Submitted			2022-12-27	WOS:000381476700070
J	Kunyanee, C; Kamjumphol, W; Taweechaisupapong, S; Kanthawong, S; Wongwajana, S; Wongratanacheewin, S; Hahnvajanawong, C; Chareonsudjai, S				Kunyanee, Chanikarn; Kamjumphol, Watcharaporn; Taweechaisupapong, Suwimol; Kanthawong, Sakawrat; Wongwajana, Suwin; Wongratanacheewin, Surasak; Hahnvajanawong, Chariya; Chareonsudjai, Sorujsiri			Burkholderia pseudomallei Biofilm Promotes Adhesion, Internalization and Stimulates Proinflammatory Cytokines in Human Epithelial A549 Cells	PLOS ONE			English	Article							INTRACELLULAR SURVIVAL; MOUSE MACROPHAGES; IN-VIVO; MELIOIDOSIS; INFECTION; APOPTOSIS; INVASION; INDUCTION; BACTERIA; DEATH	Burkholderia pseudomallei is a Gram-negative bacterium that causes melioidosis. Inhalational exposure leading to pulmonary melioidosis is the most common clinical manifestation with significant mortality. However, the role of B. pseudomallei biofilm phenotype during bacterial-host interaction remains unclear. We hypothesize that biofilm phenotype may play a role in such interactions. In this study, B. pseudomallei H777 (biofilm wild type), B. pseudomallei M10 (biofilm mutant) and B. pseudomallei C17 (biofilm-complemented) strains were used to assess the contribution of biofilm to adhesion to human lung epithelial cells (A549), intracellular interactions, apoptosis/necrosis and impact on proinflammatory responses. Confocal laser scanning microscopy demonstrated that B. pseudomallei H777 and C17 produced biofilm, whereas M10 did not. To determine the role of biofilm in host interaction, we assessed the ability of each of the three strains to interact with the A549 cells at MOI 10. Strain H777 exhibited higher levels of attachment and invasion compared to strain M10 (p < 0.05). In addition, the biofilm-complemented strain, C17 exhibited restored bacterial invasion ability. Flow cytometry combined with a double-staining assay using annexin V and propidium iodide revealed significantly higher numbers of early apoptotic and late apoptotic A549 cells when these were infected with strain H777 (1.52%) and C17 (1.43%) compared to strain M10 (0.85%) (p < 0.05). Strains H777 and C17 were able to stimulate significant secretion of IL-6 and IL-8 compared with the biofilm mutant (p < 0.05). Together, these findings demonstrated the role of biofilm-associated phenotypes of B. pseudomallei in cellular pathogenesis of human lung epithelial cells with respect to initial attachment and invasion, apoptosis and proinflammatory responses.	[Kunyanee, Chanikarn; Kamjumphol, Watcharaporn; Kanthawong, Sakawrat; Wongwajana, Suwin; Wongratanacheewin, Surasak; Hahnvajanawong, Chariya; Chareonsudjai, Sorujsiri] Khon Kaen Univ, Dept Microbiol, Fac Med, Khon Kaen, Thailand; [Taweechaisupapong, Suwimol] Khon Kaen Univ, Dept Oral Diag, Fac Dent, Khon Kaen, Thailand; [Kunyanee, Chanikarn; Kamjumphol, Watcharaporn; Taweechaisupapong, Suwimol; Kanthawong, Sakawrat; Wongratanacheewin, Surasak; Chareonsudjai, Sorujsiri] Khon Kaen Univ, Melioidosis Res Ctr, Khon Kaen, Thailand; [Taweechaisupapong, Suwimol; Kanthawong, Sakawrat; Chareonsudjai, Sorujsiri] Khon Kaen Univ, Biofilm Res Grp, Khon Kaen, Thailand	Khon Kaen University; Khon Kaen University; Khon Kaen University; Khon Kaen University	Chareonsudjai, S (corresponding author), Khon Kaen Univ, Dept Microbiol, Fac Med, Khon Kaen, Thailand.; Chareonsudjai, S (corresponding author), Khon Kaen Univ, Melioidosis Res Ctr, Khon Kaen, Thailand.; Chareonsudjai, S (corresponding author), Khon Kaen Univ, Biofilm Res Grp, Khon Kaen, Thailand.	sorujsr@kku.ac.th	Chareonsudjai, Sorujsiri/AFM-5607-2022; Taweechaisupapong, suwimol/F-6759-2010; Wongratanacheewin, Surasakdi/F-7324-2010	Chareonsudjai, Sorujsiri/0000-0001-7176-2924; Wongratanacheewin, Surasakdi/0000-0003-2921-2536	Higher Education Research Promotion; National Research University Project of Thailand; Office of the Higher Education Commission through Center of Excellence in Specific Health Problems in the Greater Mekong Sub-Region Cluster (SHeP-GMS), Khon Kaen University, Thailand; Office of the Higher Education Commission through the Center of Excellence in Specific Health Problems in the Greater Mekong Sub-Region Cluster (SHeP-GMS), Khon Kaen University	Higher Education Research Promotion; National Research University Project of Thailand; Office of the Higher Education Commission through Center of Excellence in Specific Health Problems in the Greater Mekong Sub-Region Cluster (SHeP-GMS), Khon Kaen University, Thailand; Office of the Higher Education Commission through the Center of Excellence in Specific Health Problems in the Greater Mekong Sub-Region Cluster (SHeP-GMS), Khon Kaen University	The Higher Education Research Promotion and National Research University Project of Thailand and the Office of the Higher Education Commission through the Center of Excellence in Specific Health Problems in the Greater Mekong Sub-Region Cluster (SHeP-GMS), Khon Kaen University, Thailand.; This study was supported by the Higher Education Research Promotion and National Research University Project of Thailand and the Office of the Higher Education Commission through the Center of Excellence in Specific Health Problems in the Greater Mekong Sub-Region Cluster (SHeP-GMS), Khon Kaen University. We would like to acknowledge Prof. David Blair for editing the manuscript via the Publication Clinic of KKU, Thailand. We would like to acknowledge Mr. Chaiwat Pongtornprid for the B. pseudomallei H777 and M10 images using Zeiss 500 CLSM.	Adler NRL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079461; Ahmed K, 1999, AM J TROP MED HYG, V60, P90, DOI 10.4269/ajtmh.1999.60.90; Anutrakunchai C, 2015, TROP BIOMED, V32, P300; Byrd MS, 2010, MBIO, V1, DOI 10.1128/mBio.00140-10; Cheng AC, 2005, CLIN MICROBIOL REV, V18, P383, DOI 10.1128/CMR.18.2.383-416.2005; Cheng Allen C, 2008, Trans R Soc Trop Med Hyg, V102 Suppl 1, pS26, DOI 10.1016/S0035-9203(08)70008-7; Cheung KJ, 2007, MICROBES INFECT, V9, P829, DOI 10.1016/j.micinf.2007.03.001; Currie BJ, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000900; Currie BJ, 2003, EMERG INFECT DIS, V9, P1538, DOI 10.3201/eid0912.020750; Ereshefsky M, 2015, P NATL ACAD SCI USA, V112, P10126, DOI 10.1073/pnas.1421377112; Essex-Lopresti AE, 2005, INFECT IMMUN, V73, P1260, DOI 10.1128/IAI.73.2.1260-1264.2005; Garcia-Medina R, 2005, INFECT IMMUN, V73, P8298, DOI 10.1128/IAI.73.12.8298-8305.2005; Grassme H, 2001, APOPTOSIS, V6, P441, DOI 10.1023/A:1012485506972; Herigstad B, 2001, J MICROBIOL METH, V44, P121, DOI 10.1016/S0167-7012(00)00241-4; Hii CS, 2008, J INFECT DIS, V197, P1537, DOI 10.1086/587905; Hseu YC, 2014, J MICROBIOL IMMUNOL, V47, P394, DOI 10.1016/j.jmii.2013.03.011; Jones AL, 1997, INFECT IMMUN, V65, P4972, DOI 10.1128/IAI.65.12.4972-4977.1997; Kamjumphol W, 2015, AM J TROP MED HYG, V93, P1058, DOI 10.4269/ajtmh.15-0177; Kamjumphol W, 2013, SE ASIAN J TROP MED, V44, P72; Kespichayawattana W, 2000, INFECT IMMUN, V68, P5377, DOI 10.1128/IAI.68.9.5377-5384.2000; Korbsrisate S, 2007, MICROBIOL-SGM, V153, P1907, DOI 10.1099/mic.0.2006/003004-0; KOVACH ME, 1994, BIOTECHNIQUES, V16, P800; Lee HS, 2010, INFECT IMMUN, V78, P1832, DOI 10.1128/IAI.00446-09; Lengwehasatit I, 2008, MICROB PATHOGENESIS, V44, P238, DOI 10.1016/j.micpath.2007.08.017; Limmathurotsakul D, 2014, CLIN MICROBIOL INFEC, V20, pO854, DOI 10.1111/1469-0691.12614; Limmathurotsakul D, 2011, BRIT MED BULL, V99, P125, DOI 10.1093/bmb/ldr007; Parker D, 2011, AM J RESP CELL MOL, V45, P189, DOI 10.1165/rcmb.2011-0011RT; Pease James E, 2002, Am J Respir Med, V1, P19; Phewkliang A, 2010, SE ASIAN J TROP MED, V41, P1164; Pumirat P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096298; Ramli NSK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044104; Rammaert B, 2014, AM J TROP MED HYG, V90, P383, DOI 10.4269/ajtmh.13-0657a; Rammaert B, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-126; Reechaipichitkul Wipa, 2004, Southeast Asian Journal of Tropical Medicine and Public Health, V35, P664; Savoia D, 2007, CURR MICROBIOL, V54, P440, DOI 10.1007/s00284-006-0601-9; Sim SH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007308; Simpson AJH, 2000, J INFECT DIS, V181, P621, DOI 10.1086/315271; Spiliopoulou AI, 2012, FEMS MICROBIOL LETT, V330, P56, DOI 10.1111/j.1574-6968.2012.02533.x; Stevens MP, 2003, J BACTERIOL, V185, P4992, DOI 10.1128/JB.185.16.4992-4996.2003; Sun GW, 2005, CELL MICROBIOL, V7, P1447, DOI 10.1111/j.1462-5822.2005.00569.x; Suparak S, 2005, J BACTERIOL, V187, P6556, DOI 10.1128/JB.187.18.6556-6560.2005; Suzuki T, 2008, INT J BIOCHEM CELL B, V40, P1348, DOI 10.1016/j.biocel.2008.01.003; Takenaka S, 2001, J Infect Chemother, V7, P87, DOI 10.1007/s101560100014; Taweechaisupapong S, 2005, MICROB PATHOGENESIS, V39, P77, DOI 10.1016/j.micpath.2005.06.001; Techawiwattanaboon T, 2015, J MICROBIOL, V53, P134, DOI 10.1007/s12275-015-4522-9; Utaisincharoen P, 2004, CLIN EXP IMMUNOL, V138, P61, DOI 10.1111/j.1365-2249.2004.02601.x; Vorachit M, 1995, J TROP MED HYG, V98, P379; Warawa JM, 2009, INFECT IMMUN, V77, P5252, DOI 10.1128/IAI.00824-09; West TE, 2012, INT J EXP PATHOL, V93, P421, DOI 10.1111/j.1365-2613.2012.00842.x; White NJ, 2003, LANCET, V361, P1715, DOI 10.1016/S0140-6736(03)13374-0; Wiersinga WJ, 2008, CELL MICROBIOL, V10, P81, DOI 10.1111/j.1462-5822.2007.01016.x; Wiersinga WJ, 2007, INFECT IMMUN, V75, P3074, DOI 10.1128/IAI.01733-06; Wiersinga WJ, 2012, NEW ENGL J MED, V367, P1035, DOI 10.1056/NEJMra1204699; Wiersinga WJ, 2006, NAT REV MICROBIOL, V4, P272, DOI 10.1038/nrmicro1385; Wonprompitak P, 2009, ASIAN PAC J ALLERGY, V27, P59; Yeager JJ, 2012, INFECT IMMUN, V80, P3332, DOI 10.1128/IAI.00675-12	56	20	20	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2016	11	8							e0160741	10.1371/journal.pone.0160741	http://dx.doi.org/10.1371/journal.pone.0160741			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4UN	27529172	Green Submitted, gold, Green Published			2022-12-27	WOS:000381476700020
J	Ardehed, A; Johansson, D; Sundqvist, L; Schagerstrom, E; Zagrodzka, Z; Kovaltchouk, NA; Bergstrom, L; Kautsky, L; Rafajlovic, M; Pereyra, RT; Johannesson, K				Ardehed, Angelica; Johansson, Daniel; Sundqvist, Lisa; Schagerstrom, Ellen; Zagrodzka, Zuzanna; Kovaltchouk, Nikolaj A.; Bergstrom, Lena; Kautsky, Lena; Rafajlovic, Marina; Pereyra, Ricardo T.; Johannesson, Kerstin			Divergence within and among Seaweed Siblings (Fucus vesiculosus and F. radicans) in the Baltic Sea	PLOS ONE			English	Article							POPULATION-STRUCTURE; MORPHOLOGICAL VARIATION; PHAEOPHYCEAE; HETEROKONTOPHYTA; SERRATUS; HYBRIDIZATION; FUCACEAE; DIFFERENTIATION; EVANESCENS; SPECIATION	Closely related taxa provide significant case studies for understanding evolution of new species but may simultaneously challenge species identification and definition. In the Baltic Sea, two dominant and perennial brown algae share a very recent ancestry. Fucus vesiculosus invaded this recently formed postglacial sea 8000 years ago and shortly thereafter Fucus radicans diverged from this lineage as an endemic species. In the Baltic Sea both species reproduce sexually but also recruit fully fertile new individuals by asexual fragmentation. Earlier studies have shown local differences in morphology and genetics between the two taxa in the northern and western Bothnian Sea, and around the island of Saaremaa in Estonia, but geographic patterns seemin conflict with a single origin of F. radicans. To investigate the relationship between northern and Estonian distributions, we analysed the genetic variation using 9 microsatellite loci in populations from eastern Bothnian Sea, Archipelago Sea and the Gulf of Finland. These populations are located in between earlier studied populations. However, instead of bridging the disparate genetic gap between N-W Bothnian Sea and Estonia, as expected from a simple isolation-by-distance model, the new populations substantially increased overall genetic diversity and showed to be strongly divergent from the two earlier analysed regions, showing signs of additional distinct populations. Contrasting earlier findings of increased asexual recruitment in low salinity in the Bothnian Sea, we found high levels of sexual reproduction in some of the Gulf of Finland populations that inhabit extremely low salinity. The new data generated in this study supports the earlier conclusion of two reproductively isolated but very closely related species. However, the new results also add considerable genetic and morphological complexity within species. This makes species separation at geographic scales more demanding and suggests a need for more comprehensive approaches to further disentangle the intriguing relationship and history of the Baltic Sea fucoids.	[Ardehed, Angelica; Johansson, Daniel] Univ Gothenburg, Dept Biol & Environm Sci, Gothenburg, Sweden; [Ardehed, Angelica; Johansson, Daniel; Sundqvist, Lisa; Zagrodzka, Zuzanna; Rafajlovic, Marina; Pereyra, Ricardo T.; Johannesson, Kerstin] Univ Gothenburg, Ctr Marine Evolutionary Biol, Gothenburg, Sweden; [Sundqvist, Lisa] Univ Gothenburg, Dept Marine Sci, Gothenburg, Sweden; [Schagerstrom, Ellen; Kautsky, Lena] Stockholm Univ, Dept Ecol Environm & Plant Sci, Stockholm, Sweden; [Zagrodzka, Zuzanna; Pereyra, Ricardo T.; Johannesson, Kerstin] Univ Gothenburg, Dept Marine Sci Tjarno, Stromstad, Sweden; [Kovaltchouk, Nikolaj A.] Russian Acad Sci, Komarov Bot Inst, St Petersburg, Russia; [Bergstrom, Lena] Swedish Univ Agr Sci, Dept Aquat Resources, Oregrund, Sweden; [Rafajlovic, Marina] Univ Gothenburg, Dept Phys, Gothenburg, Sweden	University of Gothenburg; University of Gothenburg; University of Gothenburg; Stockholm University; University of Gothenburg; Russian Academy of Sciences; Komarov Botanical Institute, Russian Academy of Sciences; Swedish University of Agricultural Sciences; University of Gothenburg	Johannesson, K (corresponding author), Univ Gothenburg, Ctr Marine Evolutionary Biol, Gothenburg, Sweden.; Johannesson, K (corresponding author), Univ Gothenburg, Dept Marine Sci Tjarno, Stromstad, Sweden.	Kerstin.Johannesson@gu.se	Johannesson, Kerstin/X-7994-2019; Rafajlovic, Marina/ABB-8142-2021; Zagrodzka, Zuzanna/AAE-4541-2021; Sundqvist, Lisa/G-7270-2015	Johannesson, Kerstin/0000-0003-0176-7986; Rafajlovic, Marina/0000-0003-2177-4622; Bergstrom, Lena/0000-0002-8059-8764; Sundqvist, Lisa/0000-0001-6200-2894; Schagerstrom, Ellen/0000-0003-2085-0013	C.F. Lundstrom foundation; Centre of Marine Evolutionary Biology at University of Gothenburg - Swedish Research Council (Formas); Centre of Marine Evolutionary Biology at University of Gothenburg - Swedish Research Council (VR); BONUS (Art 185) - EU; BONUS (Art 185) - Formas	C.F. Lundstrom foundation; Centre of Marine Evolutionary Biology at University of Gothenburg - Swedish Research Council (Formas); Centre of Marine Evolutionary Biology at University of Gothenburg - Swedish Research Council (VR); BONUS (Art 185) - EU; BONUS (Art 185) - Formas	The authors acknowledge financial support from C.F. Lundstrom foundation, Centre of Marine Evolutionary Biology (www.cemeb.gu.se) at University of Gothenburg supported by the Swedish Research Councils (Formas and VR), and support to the project BAMBI from BONUS (Art 185) funded jointly by EU and Formas. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Helena Forslund, Jens Perus, Jessica Oremus, Tomas Meier and Annika Lindstrom who contributed to different parts of the fieldwork. We also kindly acknowledge the financial support from C.F. Lundstrom foundation, Centre of Marine Evolutionary Biology (www.cemeb.gu.se) at University of Gothenburg supported by the Swedish Research Councils (Formas and VR), and support to the project BAMBI from BONUS (Art 185) funded jointly by EU and Formas.	Andrejev O, 2004, BOREAL ENVIRON RES, V9, P1; [Anonymous], 1963, ANIMAL SPECIES EVOLU; Ardehed A, 2015, ECOL EVOL, V5, P4233, DOI 10.1002/ece3.1629; Arnaud-Haond S, 2007, MOL ECOL, V16, P5115, DOI 10.1111/j.1365-294X.2007.03535.x; BACK S, 1993, ANN BOT FENN, V30, P275; BAKER HG, 1967, EVOLUTION, V21, P853, DOI 10.1111/j.1558-5646.1967.tb03440.x; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bergstrom L, 2005, J PHYCOL, V41, P1025, DOI 10.1111/j.1529-8817.2005.00125.x; Bergstrom L, 2003, BOT MAR, V46, P125, DOI 10.1515/BOT.2003.013; BJORCK S, 1995, QUATERN INT, V27, P19, DOI 10.1016/1040-6182(94)00057-C; Canovas FG, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-371; Carlsson J, 2008, J HERED, V99, P616, DOI 10.1093/jhered/esn048; Coyer JA, 2007, J EVOLUTION BIOL, V20, P2322, DOI 10.1111/j.1420-9101.2007.01411.x; Coyer JA, 2006, MOL PHYLOGENET EVOL, V39, P209, DOI 10.1016/j.ympev.2006.01.019; Coyer JA, 2002, P ROY SOC B-BIOL SCI, V269, P1829, DOI 10.1098/rspb.2002.2093; Coyer JA, 2003, MOL ECOL, V12, P1817, DOI 10.1046/j.1365-294X.2003.01850.x; Durrant HMS, 2014, CONSERV BIOL, V28, P438, DOI 10.1111/cobi.12203; Engel CR, 2003, MOL ECOL NOTES, V3, P180, DOI 10.1046/j.1471-8286.2003.00390.x; Excoffier L, 2008, TRENDS ECOL EVOL, V23, P347, DOI 10.1016/j.tree.2008.04.004; Feistel R, 2010, OCEAN SCI, V6, P3, DOI 10.5194/os-6-3-2010; Forslund H, 2013, MAR BIOL RES, V9, P262, DOI 10.1080/17451000.2012.731694; Forslund H, 2012, MAR BIOL RES, V8, P322, DOI 10.1080/17451000.2011.637565; Goudet J., 2005, PCAGEN 1 2 1; Gunnarsson K, 2012, MAR BIOL RES, V8, P87, DOI 10.1080/17451000.2011.594890; Gylle AM, 2011, J PHYCOL, V47, P98, DOI 10.1111/j.1529-8817.2010.00928.x; Johannesson K, 2006, MOL ECOL, V15, P2013, DOI 10.1111/j.1365-294X.2006.02919.x; Johannesson K, 2011, J PHYCOL, V47, P990, DOI 10.1111/j.1529-8817.2011.01032.x; Jost L, 2008, MOL ECOL, V17, P4015, DOI 10.1111/j.1365-294X.2008.03887.x; Kemppainen P, 2009, J EVOLUTION BIOL, V22, P2000, DOI 10.1111/j.1420-9101.2009.01810.x; Lepparanta M, 2009, SPRINGER-PRAX BOOKS, pXI; McCarthy MA, 1997, ECOL MODEL, V103, P99, DOI 10.1016/S0304-3800(97)00104-X; Panova M, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-687; Pereyra RT, 2013, J EVOLUTION BIOL, V26, P1727, DOI 10.1111/jeb.12170; Pereyra RT, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-70; Perrin C, 2007, EUR J PHYCOL, V42, P219, DOI 10.1080/09670260701336554; Pritchard JK, 2000, GENETICS, V155, P945; Raberg S, 2007, ESTUAR COAST SHELF S, V73, P249, DOI 10.1016/j.ecss.2007.01.005; Reich D, 2008, NAT GENET, V40, P491, DOI 10.1038/ng0508-491; Reichel K, 2016, BMC GENET, V17, DOI 10.1186/s12863-016-0388-z; Rothausler E, 2015, LIMNOL OCEANOGR, V60, P2173, DOI 10.1002/lno.10195; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Ruuskanen A, 1999, OPHELIA, V50, P43, DOI 10.1080/00785326.1999.10409388; Schagerstrom E, 2014, ESTUAR COAST SHELF S, V149, P187, DOI 10.1016/j.ecss.2014.08.022; Serrao EA, 1999, J PHYCOL, V35, P254, DOI 10.1046/j.1529-8817.1999.3520254.x; Serrao EA, 1996, OECOLOGIA, V107, P1, DOI 10.1007/BF00582229; Sundqvist L, 2016, ECOL EVOL, V6, P3461, DOI 10.1002/ece3.2096; Tatarenkov A, 2005, MOL ECOL, V14, P647, DOI 10.1111/j.1365-294X.2005.02425.x; Tatarenkov A, 2007, J PHYCOL, V43, P675, DOI 10.1111/j.1529-8817.2007.00369.x; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Voipio A., 1981, BALTIC SEA; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Westerbom M, 2002, MAR BIOL, V140, P991, DOI 10.1007/s00227-001-0765-6	52	25	25	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2016	11	8							e0161266	10.1371/journal.pone.0161266	http://dx.doi.org/10.1371/journal.pone.0161266			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4SL	27525655	Green Published, gold, Green Submitted			2022-12-27	WOS:000381471100050
J	Liu, TK; Wang, YC; Chuang, LZH; Chen, CH				Liu, Ta-Kang; Wang, Yu-Cheng; Chuang, Laurence Zsu-Hsin; Chen, Chih-How			Conservation of the Eastern Taiwan Strait Chinese White Dolphin (Sousa chinensis): Fishers' Perspectives and Management Implications	PLOS ONE			English	Article							PACIFIC HUMPBACK DOLPHINS; PEARL RIVER ESTUARY; FINLESS PORPOISES; RISK-ASSESSMENT; SMALL CETACEANS; POPULATION; ABUNDANCE; WATERS; BAY	The abundance of the eastern Taiwan Strait (ETS) population of the Chinese white dolphin (Sousa chinensis) has been estimated to be less than 100 individuals. It is categorized as critically endangered in the IUCN Red List of Threatened Species. Thus, immediate measures of conservation should be taken to protect it from extinction. Currently, the Taiwanese government plans to designate its habitat as a Major Wildlife Habitat (MWH), a type of marine protected area (MPA) for conservation of wildlife species. Although the designation allows continuing the current exploitation, however, it may cause conflicts among multiple stakeholders with competing interests. The study is to explore the attitude and opinions among the stakeholders in order to better manage the MPA. This study employs a semistructured interview and a questionnaire survey of local fishers. Results from interviews indicated that the subsistence of fishers remains a major problem. It was found that stakeholders have different perceptions of the fishers' attitude towards conservation and also thought that the fishery-related law enforcement could be difficult. Quantitative survey showed that fishers are generally positive towards the conservation of the Chinese white dolphin but are less willing to participate in the planning process. Most fishers considered temporary fishing closure as feasible for conservation. The results of this study provide recommendations for future efforts towards the goal of better conservation for this endangered species.	[Liu, Ta-Kang; Chuang, Laurence Zsu-Hsin; Chen, Chih-How] Natl Cheng Kung Univ, Inst Ocean Technol & Marine Affairs, Tainan, Taiwan; [Wang, Yu-Cheng] Natl Cheng Kung Univ, Dept Law, Tainan, Taiwan	National Cheng Kung University; National Cheng Kung University	Liu, TK (corresponding author), Natl Cheng Kung Univ, Inst Ocean Technol & Marine Affairs, Tainan, Taiwan.	tkliu@mail.ncku.edu.tw	Liu, Ta-Kang/A-7941-2010	Liu, Ta-Kang/0000-0002-8375-3934	Taiwan's Forestry Bureau [100-FD-07.1-C-33]; Forestry Bureau [100-FD-07.1-C-33]	Taiwan's Forestry Bureau; Forestry Bureau	TKL received the funding from Taiwan's Forestry Bureau. The grant number is 100-FD-07.1-C-33. Their website is: http://www.forest.gov.tw/mp.asp?mp=204. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to express sincere thanks to the officers from Forestry Bureau and Fisheries Agency for providing valuable information and assistance. The research was partially funded by Forestry Bureau contract 100-FD-07.1-C-33. The authors are grateful for their financial support. The opinions expressed therein are of the authors only and any error remains the sole responsibility of the authors.	Agency Fishery, 2011, FISH STAT YB; Chang W.-L., 2011, THESIS; Chen B, 2006, MAMM BIOL, V73, P156; Chen BY, 2009, INTEGR ZOOL, V4, P240, DOI 10.1111/j.1749-4877.2009.00160.x; Chen T, 2011, MAMM BIOL, V76, P93, DOI 10.1016/j.mambio.2010.01.001; Chen T, 2010, MAMMALIA, V74, P117, DOI 10.1515/MAMM.2010.024; Chilvers BL, 2005, BIOL CONSERV, V122, P559, DOI 10.1016/j.biocon.2004.08.013; Chou LS, 2011, CHINESE WHITE DOLPHI; Creswell J. W., 2014, RES DESIGN QUALITATI; Gleason M, 2010, OCEAN COAST MANAGE, V53, P52, DOI 10.1016/j.ocecoaman.2009.12.001; Guo XH, 2011, AQUAT ECOSYST HEALTH, V14, P298, DOI 10.1080/14634988.2011.598111; Hennink M., 2020, QUALITATIVE RES METH; Hung CLH, 2007, CHEMOSPHERE, V66, P1175, DOI 10.1016/j.chemosphere.2006.08.005; Jefferson TA, 2000, WILDLIFE MONOGR, P1; Jefferson Thomas A., 2004, Aquatic Mammals, V30, P149, DOI 10.1578/AM.30.1.2004.149; Jefferson Thomas A., 2004, Aquatic Mammals, V30, P3, DOI 10.1578/AM.30.1.2004.3; Jefferson Thomas A., 2001, Mammalian Species, V655, P1, DOI 10.1644/1545-1410(2001)655<0001:SC>2.0.CO;2; Jefferson TA, 2009, MAR POLICY, V33, P305, DOI 10.1016/j.marpol.2008.07.011; Karczmarski L, 2000, MAR MAMMAL SCI, V16, P65, DOI 10.1111/j.1748-7692.2000.tb00904.x; Ko M.-C., 2011, THESIS; Liu TK, 2015, MAR POLICY, V61, P113, DOI 10.1016/j.marpol.2015.06.023; Minh TB, 2000, ENVIRON POLLUT, V110, P459, DOI 10.1016/S0269-7491(99)00316-4; Ng SL, 2003, MAR ENVIRON RES, V56, P555, DOI 10.1016/S0141-1136(03)00041-2; Osmond M, 2010, OCEAN COAST MANAGE, V53, P41, DOI 10.1016/j.ocecoaman.2010.01.002; Parra GJ, 2006, BIOL CONSERV, V129, P167, DOI 10.1016/j.biocon.2005.10.031; Parsons ECM, 1999, ENVIRON CONSERV, V26, P30, DOI 10.1017/S0376892999000065; Pomeroy R, 2008, MAR POLICY, V32, P816, DOI 10.1016/j.marpol.2008.03.017; Ramu K, 2005, MAR POLLUT BULL, V51, P669, DOI 10.1016/j.marpolbul.2005.02.041; Reeves RR, 2008, IUCN RED LIST THREAT; Wang JY, 2007, MAMMALIA, V71, P157, DOI 10.1515/MAMM.2007.032; Wang JY, 2011, MAR MAMMAL SCI, V27, P652, DOI 10.1111/j.1748-7692.2010.00422.x; Wang JY, 2008, MAMMALIA, V72, P302, DOI 10.1515/MAMM.2008.030; WANG JY, 2004, 1 WORKSH CONS RES NE; Wang JY, 2007, 2 INT WORKSH CONS RE; Wang XY, 2016, MAR MAMMAL SCI, V32, P390, DOI 10.1111/mms.12257; Yeh CA, 2004, THESIS; Yeung LWY, 2009, ENVIRON POLLUT, V157, P17, DOI 10.1016/j.envpol.2008.08.005; Yu SY, 2010, INT C CONS CHIN WHIT; Zhang Li-feng, 2008, Journal of Oceanography in Taiwan Strait, V27, P79	39	4	5	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2016	11	8							e0161321	10.1371/journal.pone.0161321	http://dx.doi.org/10.1371/journal.pone.0161321			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4SL	27526102	Green Published, Green Submitted, gold			2022-12-27	WOS:000381471100054
J	Chiarelli, N; Carini, G; Zoppi, N; Dordoni, C; Ritelli, M; Venturini, M; Castori, M; Colombi, M				Chiarelli, Nicola; Carini, Giulia; Zoppi, Nicoletta; Dordoni, Chiara; Ritelli, Marco; Venturini, Marina; Castori, Marco; Colombi, Marina			Transcriptome-Wide Expression Profiling in Skin Fibroblasts of Patients with Joint Hypermobility Syndrome/Ehlers-Danlos Syndrome Hypermobility Type	PLOS ONE			English	Article							SMALL FIBER NEUROPATHY; MATRIX PROTEIN MINDIN; EXTRACELLULAR-MATRIX; DIFFERENTIAL-DIAGNOSIS; PROTEOMIC ANALYSIS; UP-REGULATION; CHRONIC PAIN; MUTATIONS; INTEGRIN; GENE	Joint hypermobility syndrome/Ehlers-Danlos syndrome hypermobility type (JHS/EDS-HT), is likely the most common systemic heritable connective tissue disorder, and is mostly recognized by generalized joint hypermobility, joint instability complications, minor skin changes and a wide range of satellite features. JHS/EDS-HT is considered an autosomal dominant trait but is still without a defined molecular basis. The absence of (a) causative gene(s) for JHS/EDS-HT is likely attributable to marked genetic heterogeneity and/or interaction of multiple loci. In order to help in deciphering such a complex molecular background, we carried out a comprehensive immunofluorescence analysis and gene expression profiling in cultured skin fibroblasts from five women affected with JHS/EDS-HT. Protein study revealed disarray of several matrix structural components such as fibrillins, tenascins, elastin, collagens, fibronectin, and their integrin receptors. Transcriptome analysis indicated perturbation of different signaling cascades that are required for homeostatic regulation either during development or in adult tissues as well as altered expression of several genes involved in maintenance of extracellular matrix architecture and homeostasis (e.g., SPON2, TGM2, MMP16, GPC4, SULF1), cell-cell adhesion (e.g., CDH2, CHD10, PCDH9, CLDN11, FLG, DSP), immune/inflammatory/pain responses (e.g., CFD, AQP9, COLEC12, KCNQ5, PRLR), and essential for redox balance (e.g., ADH1C, AKR1C2, AKR1C3, MAOB, GSTM5). Our findings provide a picture of the gene expression profile and dysregulated pathways in JHS/EDS-HT skin fibroblasts that correlate well with the systemic phenotype of the patients.	[Chiarelli, Nicola; Carini, Giulia; Zoppi, Nicoletta; Dordoni, Chiara; Ritelli, Marco; Colombi, Marina] Univ Brescia, Div Biol & Genet, Dept Mol & Translat Med, Brescia, Italy; [Venturini, Marina] Spedali Civili Univ Hosp, Div Dermatol, Dept Clin & Expt Sci, Brescia, Italy; [Castori, Marco] Sapienza Univ, San Camillo Forlanini Hosp, Dept Mol Med, Unit Med Genet, Rome, Italy	University of Brescia; Hospital Spedali Civili Brescia; Azienda Ospedaliera San Camillo-Forlanini; Sapienza University Rome	Colombi, M (corresponding author), Univ Brescia, Div Biol & Genet, Dept Mol & Translat Med, Brescia, Italy.	marina.colombi@unibs.it	Chiarelli, Nicola/T-4923-2019; Carini, Giulia/AAA-8800-2022; Castori, Marco/K-1099-2016	Carini, Giulia/0000-0001-8096-9417; Castori, Marco/0000-0002-6069-0993; ZOPPI, Nicoletta/0000-0003-0197-8927; VENTURINI, MARINA/0000-0001-6800-3695; Chiarelli, Nicola/0000-0002-1760-5079; RITELLI, Marco/0000-0002-7025-2495	Fondazione Cariplo and Regione Lombardia through the Grant "New Opportunities and Ways towards ERC" (NOW ERC) [2014-2256]	Fondazione Cariplo and Regione Lombardia through the Grant "New Opportunities and Ways towards ERC" (NOW ERC)	This work was supported by Fondazione Cariplo and Regione Lombardia supported the Open Access publication through the Grant "New Opportunities and Ways towards ERC" (NOW ERC, Project: 2014-2256) to NC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adan N, 2013, J CLIN INVEST, V123, P3902, DOI 10.1172/JCI69485; Anders HJ, 2014, J AM SOC NEPHROL, V25, P1; Balakrishnan L, 2014, CLIN PROTEOM, V11, DOI 10.1186/1559-0275-11-6; Baumann M, 2012, AM J HUM GENET, V90, P201, DOI 10.1016/j.ajhg.2011.12.004; Beighton P, 1998, AM J MED GENET, V77, P31, DOI 10.1002/(SICI)1096-8628(19980428)77:1<31::AID-AJMG8>3.3.CO;2-P; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Camerota F, 2011, J PAIN SYMPTOM MANAG, V41, pE2, DOI 10.1016/j.jpainsymman.2010.09.012; Candi E, 2005, NAT REV MOL CELL BIO, V6, P328, DOI 10.1038/nrm1619; Castori M, 2014, IRAN J NEUROL, V13, P195; Castori M, 2015, AM J MED GENET C, V169, P54, DOI 10.1002/ajmg.c.31431; Castori M, 2015, AM J MED GENET C, V169, P43, DOI 10.1002/ajmg.c.31425; Castori M, 2014, AM J MED GENET A, V164, P3010, DOI 10.1002/ajmg.a.36805; Castori M, 2013, AM J MED GENET A, V161, P2989, DOI 10.1002/ajmg.a.36315; Castori Marco, 2012, ISRN Dermatol, V2012, P751768, DOI 10.5402/2012/751768; Castori M, 2012, AM J MED GENET A, V158A, P2055, DOI 10.1002/ajmg.a.35483; Cazzato D, 2016, NEUROLOGY, V87, P155, DOI 10.1212/WNL.0000000000002847; Colombi M, 2015, AM J MED GENET C, V169, P6, DOI 10.1002/ajmg.c.31429; De Wandele I, 2014, SEMIN ARTHRITIS RHEU, V44, P353, DOI 10.1016/j.semarthrit.2014.05.013; Donkervoort S, 2015, AM J MED GENET C, V169, P23, DOI 10.1002/ajmg.c.31433; Dordoni C, 2013, AM J MED GENET A, V161A, P1143, DOI 10.1002/ajmg.a.35825; Frush S, 2011, ENVIRON HEALTH PERSP, V119, P1403, DOI 10.1289/ehp.1003339; Ghosh D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144316; Glatt SJ, 2005, P NATL ACAD SCI USA, V102, P15533, DOI 10.1073/pnas.0507666102; Graham SA, 2011, J BIOL CHEM, V286, P24336, DOI 10.1074/jbc.M111.244772; Grahame R, 2000, J RHEUMATOL, V27, P1777; Granata G, 2013, CLIN NEUROPHYSIOL, V124, P1689, DOI 10.1016/j.clinph.2012.12.051; Gumbiner BM, 2005, NAT REV MOL CELL BIO, V6, P622, DOI 10.1038/nrm1699; Hakim AJ, 2003, INT J CLIN PRACT, V57, P163; HAUSSER I, 1994, HUM GENET, V93, P394; Hayashi H, 2014, MOL PAIN, V10, DOI 10.1186/1744-8069-10-15; He YW, 2004, NAT IMMUNOL, V5, P88, DOI 10.1038/ni1021; Hershenfeld SA, 2016, RHEUMATOL INT, V36, P341, DOI 10.1007/s00296-015-3375-1; Ichikawa-Tomikawa N, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/253048; Janecke AR, 2016, AM J MED GENET A, V170, P103, DOI 10.1002/ajmg.a.37383; Kuttner V, 2014, J INVEST DERMATOL, V134, P2381, DOI 10.1038/jid.2014.185; Kumar MJ, 2004, MOL NEUROBIOL, V30, P77, DOI 10.1385/MN:30:1:077; Li ZW, 2013, J BIOCHEM MOL TOXIC, V27, P3, DOI 10.1002/jbt.21453; Li ZW, 2009, J LEUKOCYTE BIOL, V85, P124, DOI 10.1189/jlb.0208135; Liang YS, 2016, CLIN REV ALLERG IMMU, V51, P315, DOI 10.1007/s12016-015-8508-5; Mantel A, 2012, J INVEST DERMATOL, V132, P1103, DOI 10.1038/jid.2011.412; Martel-Pelletier J, 2016, RHEUMATOLOGY, V55, P680, DOI 10.1093/rheumatology/kev408; Matsushima A, 2014, SHOCK, V42, P322, DOI 10.1097/SHK.0000000000000218; Mazziotti G, 2016, BONE, V84, P88, DOI 10.1016/j.bone.2015.12.007; McAleer MA, 2013, J ALLERGY CLIN IMMUN, V131, P280, DOI 10.1016/j.jaci.2012.12.668; McCrea PD, 2015, CURR TOP DEV BIOL, V112, P129, DOI 10.1016/bs.ctdb.2014.11.018; Mesko B, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-15; Morgan AW, 2007, ANN RHEUM DIS, V66, P1369, DOI 10.1136/ard.2006.062224; Murphy EP, 2015, BIOMOLECULES, V5, P1302, DOI 10.3390/biom5031302; Nielsen RH, 2014, FASEB J, V28, P4668, DOI 10.1096/fj.14-249656; Ogrodowczyk A, 2014, PRZ GASTROENTEROL, V9, P200, DOI 10.5114/pg.2014.45100; Paco S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077430; Pascarella A, 2016, CLIN NEUROPHYSIOL, V127, P1914, DOI 10.1016/j.clinph.2015.12.004; Pasquini M, 2014, RHEUMATOL INT, V34, P631, DOI 10.1007/s00296-013-2901-2; Patil MJ, 2014, CHANNELS, V8, DOI 10.4161/chan.28946; Porter LF, 2015, ORPHANET J RARE DIS, V10, DOI 10.1186/s13023-015-0360-4; Proske Sylvia, 2006, J Dtsch Dermatol Ges, V4, P308, DOI 10.1111/j.1610-0387.2006.05958.x; Ritelli M, 2015, MOLEC GENET METAB RE, V2, P1, DOI 10.1016/j.ymgmr.2014.11.005; Rombaut L, 2015, CLIN RHEUMATOL, V34, P1121, DOI 10.1007/s10067-014-2499-0; Scoville DH, 2008, GASTROENTEROLOGY, V134, P849, DOI 10.1053/j.gastro.2008.01.079; Singh S, 2013, FREE RADICAL BIO MED, V56, P89, DOI 10.1016/j.freeradbiomed.2012.11.010; Skah S, 2015, EXP CELL RES, V330, P56, DOI 10.1016/j.yexcr.2014.10.014; Steinmann B, 2002, CONNECTIVE TISSUE IT, P351; Syx D, 2015, DIS MARKERS, V2015, P1, DOI 10.1155/2015/828970; Tajerian M, 2015, PAIN, V156, P366, DOI 10.1097/01.j.pain.0000460323.80020.9d; Thurman JM, 2006, J IMMUNOL, V176, P1305, DOI 10.4049/jimmunol.176.3.1305; Tighe RM, 2011, J ALLERGY THER S1, V2011; Tinkle BT, 2009, AM J MED GENET A, V149A, P2368, DOI 10.1002/ajmg.a.33070; Vasioukhin V, 2001, NAT CELL BIOL, V3, P1076, DOI 10.1038/ncb1201-1076; Wang D, 2014, NEUROSCIENCE, V280, P31, DOI 10.1016/j.neuroscience.2014.08.048; Watanabe A, 2016, INT J MOL MED, V37, P461, DOI 10.3892/ijmm.2015.2437; Wright EMMB, 2011, AM J HUM GENET, V88, P767, DOI 10.1016/j.ajhg.2011.05.007; Zarate N, 2010, NEUROGASTROENT MOTIL, V22, DOI 10.1111/j.1365-2982.2009.01421.x; Zhu LH, 2015, CLIN SCI, V129, P129, DOI 10.1042/CS20140679; Zoppi N, 2004, J BIOL CHEM, V279, P18157, DOI 10.1074/jbc.M312609200; Zoppi N, 2008, BBA-MOL CELL RES, V1783, P1177, DOI 10.1016/j.bbamcr.2008.03.003; Zoppi N, 2015, HUM MOL GENET, V24, P6769, DOI 10.1093/hmg/ddv382	76	35	36	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2016	11	8							e0161347	10.1371/journal.pone.0161347	http://dx.doi.org/10.1371/journal.pone.0161347			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3LI	27518164	gold, Green Published, Green Submitted			2022-12-27	WOS:000381382100069
J	Ma, W; Waffo-Teguo, P; Jourdes, M; Li, H; Teissedre, PL				Ma, Wen; Waffo-Teguo, Pierre; Jourdes, Michael; Li, Hua; Teissedre, Pierre-Louis			Chemical Affinity between Tannin Size and Salivary Protein Binding Abilities: Implications for Wine Astringency	PLOS ONE			English	Article							TANDEM MASS-SPECTROMETRY; GRAPE SEEDS; RED WINE; POLYMERIC PROCYANIDINS; BY-PRODUCTS; PROANTHOCYANIDINS; CHROMATOGRAPHY; VARIETIES; PHASE; QUANTIFICATION	Astringency perception, as an essential parameter for high-quality red wine, is principally elicited by condensed tannins in diversified chemical structures. Condensed tannins, which are also known as proanthocyanidins (PAs), belong to the flavonoid class of polyphenols and are incorporated by multiple flavan-3-ols units according to their degree of polymerization (DP). However, the influence of DP size of PAs on astringency perception remains unclear for decades. This controversy was mainly attributed to the lack of efficient strategies to isolate the PAs in non-galloylated forms and with individual degree size from grape/ wine. In the present study, the astringency intensity of purified and identified grape oligomeric tannins (DP ranged from 1 to 5) was firstly explored. A novel non-solid phase strategy was used to rapidly exclude the galloylated PAs from the non-galloylated PAs and fractionate the latter according to their DP size. Then, a series of PAs with individual DP size and galloylation were purified by an approach of preparative hydrophilic interaction chromatography. Furthermore, purified compounds were identified by both normal phase HPLC-FLD and reverse phase UHPLC-ESI-Q-TOF. Finally, the contribution of the astringency perception of the individual purified tannins was examined with a salivary protein binding ability test. The results were observed by HPLC-FLD and quantified by changes in PA concentration remaining in the filtrate. In summary, a new approach without a solid stationary phase was developed to isolate PAs according to their DP size. And a positive relationship between the DP of PAs and salivary protein affinity was revealed.	[Ma, Wen; Li, Hua] Northwest A&F Univ, Coll Enol, Yangling, Shaanxi, Peoples R China; [Ma, Wen; Li, Hua] Northwest A&F Univ, Shaanxi Engn Res Ctr Viti Viniculture, Yangling, Shaanxi, Peoples R China; [Ma, Wen; Waffo-Teguo, Pierre; Jourdes, Michael; Teissedre, Pierre-Louis] Univ Bordeaux, ISVV, EA 4577, Unite Rech OENOL, F-33882 Villenave Dornon, France; [Ma, Wen; Waffo-Teguo, Pierre; Jourdes, Michael; Teissedre, Pierre-Louis] INRA, ISVV, USC OENOL 1366, F-33882 Villenave Dornon, France	Northwest A&F University - China; Northwest A&F University - China; UDICE-French Research Universities; Universite de Bordeaux; INRAE	Li, H (corresponding author), Northwest A&F Univ, Coll Enol, Yangling, Shaanxi, Peoples R China.; Li, H (corresponding author), Northwest A&F Univ, Shaanxi Engn Res Ctr Viti Viniculture, Yangling, Shaanxi, Peoples R China.; Teissedre, PL (corresponding author), Univ Bordeaux, ISVV, EA 4577, Unite Rech OENOL, F-33882 Villenave Dornon, France.; Teissedre, PL (corresponding author), INRA, ISVV, USC OENOL 1366, F-33882 Villenave Dornon, France.	lihuawine@nwsuaf.edu.cn; pierre-louis.teissedre@u-bordeaux.fr	Teissedre, Pierre-Louis/I-6885-2016	TEISSEDRE, Pierre-Louis/0000-0002-0115-5456; Ma, Wen/0000-0003-2765-6301	China Scholarship Council, China	China Scholarship Council, China(China Scholarship Council)	Wen Ma was supported by a grant from China Scholarship Council, China.	Bindon K, 2014, J AGR FOOD CHEM, V62, P11582, DOI 10.1021/jf503922h; Cala O, 2010, FASEB J, V24, P4281, DOI 10.1096/fj.10-158741; Cheah KY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098921; Chen SZ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126457; Cheynier V, 1998, METHOD ENZYMOL, P178; Chira K, 2011, MOLECULES, V16, P1519, DOI 10.3390/molecules16021519; de Freitas VAP, 1998, PHYTOCHEMISTRY, V49, P1435, DOI 10.1016/S0031-9422(98)00107-1; Gabetta B, 2000, FITOTERAPIA, V71, P162, DOI 10.1016/S0367-326X(99)00161-6; Gu LW, 2002, J AGR FOOD CHEM, V50, P4852, DOI 10.1021/jf020214v; Kelm MA, 2006, J AGR FOOD CHEM, V54, P1571, DOI 10.1021/jf0525941; Kennedy JA, 2003, J CHROMATOGR A, V995, P99, DOI 10.1016/S0021-9673(03)00420-5; Ky I, 2014, MOLECULES, V19, P482, DOI 10.3390/molecules19010482; Labarbe B, 1999, J AGR FOOD CHEM, V47, P2719, DOI 10.1021/jf990029q; LEA AGH, 1992, BASIC LIFE SCI, V59, P827; Li HJ, 2008, J MASS SPECTROM, V43, P1353, DOI 10.1002/jms.1411; Li HJ, 2007, ANAL CHEM, V79, P1739, DOI 10.1021/ac061823v; Liu X, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151276; Lorrain B, 2013, FOOD CHEM, V140, P76, DOI 10.1016/j.foodchem.2013.02.048; Ma W, 2014, TRENDS FOOD SCI TECH, V40, P6, DOI 10.1016/j.tifs.2014.08.001; Pechamat L, 2014, J AGR FOOD CHEM, V62, P1701, DOI 10.1021/jf4052754; Peleg H, 1999, J SCI FOOD AGR, V79, P1123, DOI 10.1002/(SICI)1097-0010(199906)79:8<1123::AID-JSFA336>3.3.CO;2-4; Peynaud E., 2013, LE GOUT DU VIN; Rendeiro C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063535; Gonzalez-Centeno MR, 2012, J AGR FOOD CHEM, V60, P11850, DOI 10.1021/jf303047k; Ribereau-Gayon P., 2006, HDB ENOLOGY MICROBIO, VVolume 1, P327, DOI [10.1002/0470010398, DOI 10.1002/0470010398]; Robbins RJ, 2012, J AOAC INT, V95, P1153, DOI 10.5740/jaoacint.12-162; Schwarz B, 2008, EUR FOOD RES TECHNOL, V227, P1693, DOI 10.1007/s00217-008-0895-x; Spranger I, 2008, FOOD CHEM, V108, P519, DOI 10.1016/j.foodchem.2007.11.004; Sun BS, 1999, J CHROMATOGR A, V841, P115, DOI 10.1016/S0021-9673(99)00281-2; Sun BS, 1998, J AGR FOOD CHEM, V46, P1390, DOI 10.1021/jf970753d; Waterhouse AL, 2000, AM J ENOL VITICULT, V51, P383; Xiao JS, 2008, J AGR FOOD CHEM, V56, P2096, DOI 10.1021/jf072679x; Zeng L, 2016, RAPID COMMUN MASS SP, V30, P81, DOI 10.1002/rcm.7416	33	24	25	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2016	11	8							e0161095	10.1371/journal.pone.0161095	http://dx.doi.org/10.1371/journal.pone.0161095			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3LI	27518822	Green Submitted, Green Published, gold			2022-12-27	WOS:000381382100046
J	Togo, Y; Takahashi, K; Saito, K; Kiso, H; Tsukamoto, H; Huang, B; Yanagita, M; Sugai, M; Harada, H; Komori, T; Shimizu, A; MacDougall, M; Bessho, K				Togo, Yumiko; Takahashi, Katsu; Saito, Kazuyuki; Kiso, Honoka; Tsukamoto, Hiroko; Huang, Boyen; Yanagita, Motoko; Sugai, Manabu; Harada, Hidemitsu; Komori, Toshihisa; Shimizu, Akira; MacDougall, Mary; Bessho, Kazuhisa			Antagonistic Functions of USAG-1 and RUNX2 during Tooth Development	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL INTERACTIONS; RECOMBINANT ECTODYSPLASIN; STEM-CELLS; MOUSE; TEETH; EXPRESSION; CBFA1; ABNORMALITIES; ACTIVATOR; PREVENTS	Supernumerary teeth and tooth agenesis are common morphological anomalies in humans. We previously obtained evidence that supernumerary maxillary incisors form as a result of the successive development of the rudimentary maxillary incisor tooth germ in Usag-1 null mice. The development of tooth germs is arrested in Runx2 null mice, and such mice also exhibit lingual epithelial buds associated with the upper molars and incisors. The aim of this study is to investigate the potential crosstalk between Usag-1 and Runx2 during tooth development. In the present study, three interesting phenomena were observed in double null Usag-1(-/-)/Runx2(-/-) mice: the prevalence of supernumerary teeth was lower than in Usag-1 null mice; tooth development progressed further compared than in Runx2 null mice; and the frequency of molar lingual buds was lower than in Runx2 null mice. Therefore, we suggest that RUNX2 and USAG-1 act in an antagonistic manner. The lingual bud was completely filled with odontogenic epithelial Sox2-positive cells in the Usag-1(+/+)/Runx2(-/-) mice, whereas almost no odontogenic epithelial Sox2-positive cells contributed to supernumerary tooth formation in the rudimentary maxillary incisors of the Usag-1(-/-)/Runx2(+/+) mice. Our findings suggest that RUNX2 directly or indirectly prevents the differentiation and/or proliferation of odontogenic epithelial Sox2-positive cells. We hypothesize that RUNX2 inhibits the bone morphogenetic protein (BMP) and/ or Wnt signaling pathways regulated by USAG-1, whereas RUNX2 expression is induced by BMP signaling independently of USAG-1.	[Togo, Yumiko; Takahashi, Katsu; Saito, Kazuyuki; Kiso, Honoka; Tsukamoto, Hiroko; Bessho, Kazuhisa] Kyoto Univ, Grad Sch Med, Dept Oral & Maxillofacial Surg, Sakyo Ku, 54 Shogoin Kawahara Cho, Kyoto 6068507, Japan; [Huang, Boyen] Charles Sturt Univ, Sch Dent & Hlth Sci, Fac Sci, Orange, NSW 2800, Australia; [Yanagita, Motoko] Kyoto Univ, Grad Sch Med, Dept Nephrol, Sakyo Ku, 54 Shogoin Kawahara Cho, Kyoto 6068507, Japan; [Sugai, Manabu] Univ Fukui, Dept Mol Genet, Div Med, Fac Med Sci, Eiheiji, Fukui 9101193, Japan; [Harada, Hidemitsu] Iwate Med Univ, Div Dev Biol & Regenerat Med, Dept Anat, 2-1-1 Nishitokuta, Yahaba, Iwate 0283694, Japan; [Komori, Toshihisa] Nagasaki Univ, Dept Cell Biol, Unit Basic Med Sci, Grad Sch Biomed Sci, 1-7-1 Sakamoto, Nagasaki 8528588, Japan; [Shimizu, Akira] Kyoto Univ Hosp, Inst Adv Clin & Translat Sci, Dept Expt Therapeut, Sakyo Ku, 54 Shogoin Kawahara Cho, Kyoto 6068507, Japan; [MacDougall, Mary] Univ Alabama Birmingham, Sch Dent, Dept Oral & Maxillofacial Surg, Inst Oral Hlth Res, Birmingham, AL 35294 USA	Kyoto University; Charles Sturt University; Kyoto University; University of Fukui; Iwate Medical University; Nagasaki University; Kyoto University; University of Alabama System; University of Alabama Birmingham	Takahashi, K (corresponding author), Kyoto Univ, Grad Sch Med, Dept Oral & Maxillofacial Surg, Sakyo Ku, 54 Shogoin Kawahara Cho, Kyoto 6068507, Japan.	takahask@kuhp.kyoto-u.ac.jp	Huang, Boyen/I-7768-2014; Huang, Boyen/GRE-5912-2022; Yanagita, Motoko/AAJ-7731-2021; Huang, Boyen/AAR-3348-2020; Harada, Hidemitsu/P-5692-2017; MacDougall, Mary/ABG-8212-2021	Huang, Boyen/0000-0002-1246-7447; Huang, Boyen/0000-0002-1246-7447; Huang, Boyen/0000-0002-1246-7447; Harada, Hidemitsu/0000-0002-9724-8568; Yanagita, Motoko/0000-0002-0339-9008; Sugai, Manabu/0000-0003-1668-7647	A-STEP (Adaptable & Seamless Technology Transfer Program through Target-driven R D) FS stage [AS231Z01061G, AS242Z02645Q];  [22592213];  [25463081]; Grants-in-Aid for Scientific Research [24390073, 25293069] Funding Source: KAKEN	A-STEP (Adaptable & Seamless Technology Transfer Program through Target-driven R D) FS stage; ; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by Grants-in-Aid for Scientific Research(C) Nos. 22592213 and 25463081 and A-STEP (Adaptable & Seamless Technology Transfer Program through Target-driven R& D) FS stage: AS231Z01061G and AS242Z02645Q. KT received all of the above funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberg T, 2004, J HISTOCHEM CYTOCHEM, V52, P131, DOI 10.1177/002215540405200113; Callea M, 2012, BMJ CASE REP, V5; Camilleri S, 2006, EUR J ORAL SCI, V114, P361, DOI 10.1111/j.1600-0722.2006.00399.x; Casal ML, 2007, AM J HUM GENET, V81, P1050, DOI 10.1086/521988; Chen S, 2002, CONNECT TISSUE RES, V43, P338, DOI 10.1080/03008200290000691; Chen S, 2009, J DENT RES, V88, P904, DOI 10.1177/0022034509342873; D'Souza RN, 1999, DEVELOPMENT, V126, P2911; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; FITZGERALD LR, 1973, ARCH ORAL BIOL, V18, P381, DOI 10.1016/0003-9969(73)90162-3; Fleischmannova J, 2008, EUR J ORAL SCI, V116, P1, DOI 10.1111/j.1600-0722.2007.00504.x; Gaide O, 2003, NAT MED, V9, P614, DOI 10.1038/nm861; Huang B, 2013, ORAL DIS, V19, P144, DOI 10.1111/j.1601-0825.2012.01963.x; Itasaki N, 2003, DEVELOPMENT, V130, P4295, DOI 10.1242/dev.00674; Jarvinen E, 2006, P NATL ACAD SCI USA, V103, P18627, DOI 10.1073/pnas.0607289103; Jiang HP, 1999, MECH DEVELOP, V81, P169, DOI 10.1016/S0925-4773(98)00232-9; Juuri E, 2013, DEVELOPMENT, V140, P1424, DOI 10.1242/dev.089599; Juuri E, 2012, DEV CELL, V23, P317, DOI 10.1016/j.devcel.2012.05.012; Kassai Y, 2005, SCIENCE, V309, P2067, DOI 10.1126/science.1116848; KAUFMAN MH, 1995, J ANAT, V186, P607; Kiso H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096938; Klein OD, 2006, DEV CELL, V11, P181, DOI 10.1016/j.devcel.2006.05.014; Kobayashi I, 2006, BONE, V38, P836, DOI 10.1016/j.bone.2005.10.026; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Kowalczyk C, 2011, J BIOL CHEM, V286, P30769, DOI 10.1074/jbc.M111.267997; Kurosaka H, 2011, STEM CELLS, V29, P1792, DOI 10.1002/stem.722; Lagronova-Churava S, 2013, J EXP ZOOL PART B, V320B, P307, DOI 10.1002/jez.b.22502; Laurikkala J, 2003, DEV BIOL, V264, P91, DOI 10.1016/j.ydbio.2003.08.011; Mauldin EA, 2009, AM J MED GENET A, V149A, P2045, DOI 10.1002/ajmg.a.32916; Mundlos S, 1997, CELL, V89, P773, DOI 10.1016/S0092-8674(00)80260-3; Murashima-Suginami A, 2008, BIOCHEM BIOPH RES CO, V369, P1012, DOI 10.1016/j.bbrc.2008.02.135; Murashima-Suginami A, 2007, BIOCHEM BIOPH RES CO, V359, P549, DOI 10.1016/j.bbrc.2007.05.148; Mustonen T, 2003, DEV BIOL, V259, P123, DOI 10.1016/S0012-1606(03)00157-X; Nakamura T, 2008, J BIOL CHEM, V283, P4825, DOI 10.1074/jbc.M708388200; Ohazama A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004092; Otsu K, 2011, J CELL PHYSIOL, V226, P2527, DOI 10.1002/jcp.22597; Peters H, 1998, GENE DEV, V12, P2735, DOI 10.1101/gad.12.17.2735; Pispa J, 2004, DEV DYNAM, V231, P432, DOI 10.1002/dvdy.20138; SATOKATA I, 1994, NAT GENET, V6, P348, DOI 10.1038/ng0494-348; Takahashi K, 2013, GENE THERAPY TOOLS P, P727; Tucker AS, 2004, DEV BIOL, V268, P185, DOI 10.1016/j.ydbio.2003.12.019; VANGENDEREN C, 1994, GENE DEV, V8, P2691, DOI 10.1101/gad.8.22.2691; Wang XP, 2007, PLOS BIOL, V5, P1324, DOI 10.1371/journal.pbio.0050159; Wang XP, 2009, DEVELOPMENT, V136, P1939, DOI 10.1242/dev.033803; Wang XP, 2005, J DENT RES, V84, P138, DOI 10.1177/154405910508400206; Yamamoto H, 2005, ARCH ORAL BIOL, V50, P189, DOI 10.1016/j.archoralbio.2004.11.010; Yanagita M, 2006, KIDNEY INT, V70, P989, DOI 10.1038/sj.ki.5001731; Yanagita M, 2006, J CLIN INVEST, V116, P70, DOI 10.1172/JCI25445; Yanagita M, 2004, BIOCHEM BIOPH RES CO, V316, P490, DOI 10.1016/j.bbrc.2004.02.075; Zhang L, 2012, GENE EXPR PATTERNS, V12, P273, DOI 10.1016/j.gep.2012.07.001; Zhang QH, 2003, DEV DYNAM, V227, P78, DOI 10.1002/dvdy.10289; Zhang ZY, 2009, SCIENCE, V323, P1232, DOI 10.1126/science.1167418; ZHOU PB, 1995, GENE DEV, V9, P700, DOI 10.1101/gad.9.6.700	52	12	12	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2016	11	8							e0161067	10.1371/journal.pone.0161067	http://dx.doi.org/10.1371/journal.pone.0161067			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3LI	27518316	Green Submitted, gold, Green Published			2022-12-27	WOS:000381382100042
J	Goupil, S; Marechal, L; El Hajj, H; Tremblay, ME; Richard, FJ; Leclerc, P				Goupil, Serge; Marechal, Loize; El Hajj, Hassan; Tremblay, Marie-Eve; Richard, Francois J.; Leclerc, Pierre			Identification and Localization of the Cyclic Nucleotide Phosphodiesterase 10A in Bovine Testis and Mature Spermatozoa	PLOS ONE			English	Article							PROTEIN-TYROSINE PHOSPHORYLATION; SOLUBLE ADENYLYL-CYCLASE; HUMAN SPERM CAPACITATION; CAMP-DEPENDENT PATHWAY; ACROSOME REACTION; SIGNALING PATHWAYS; MAMMALIAN SPERM; INTRACELLULAR PARAMETERS; POLYACRYLAMIDE-GELS; MOUSE SPERMATOZOA	In mammals, adenosine 3', 5'-cyclic monophosphate (cAMP) is known to play highly important roles in sperm motility and acrosomal exocytosis. It is known to act through protein phosphorylation via PRKA and through the activation of guanine nucleotide exchange factors like EPAC. Sperm intracellular cAMP levels depend on the activity of adenylyl cyclases, mostly SACY, though transmembrane-containing adenylyl cyclases are also present, and on the activity of cyclic nucleotide phosphodiesterases (PDE) whose role is to degrade cAMP into 5'-AMP. The PDE superfamily is subdivided into 11 families (PDE1 to 11), which act on either cAMP or cGMP, or on both cAMP and cGMP although with different enzymatic properties. PDE10, which is more effective on cAMP than cGMP, has been known for almost 15 years and is mostly studied in the brain where it is associated with neurological disorders. Although a high level of PDE10A gene expression is observed in the testis, information on the identity of the isoforms or on the cell type that express the PDE10 protein is lacking. The objective of this study was to identify the PDE10A isoforms expressed in the testis and germ cells, and to determine the presence and localization of PDE10A in mature spermatozoa. As a sub-objective, since PDE10A transcript variants were reported strictly through analyses of bovine genomic sequence, we also wanted to determine the nucleotide and amino acid sequences by experimental evidence. Using RT-PCR, 5'-and 3'-RACE approaches we clearly show that PDE10A transcript variants X3 and X5 are expressed in bovine testis as well as in primary spermatocytes and spermatids. We also reveal using a combination of immunological techniques and proteomics analytical tools that the PDE10A isoform X4 is present in the area of the developing acrosome of spermatids and of the acrosome of mature spermatozoa.	[Goupil, Serge; Marechal, Loize; Leclerc, Pierre] Univ Laval, Dept Obstet Gynecol & Reprod, Quebec City, PQ G1K 7P4, Canada; [Goupil, Serge; Marechal, Loize; El Hajj, Hassan; Tremblay, Marie-Eve; Richard, Francois J.; Leclerc, Pierre] Univ Laval, CHU Quebec, Ctr Rech, Quebec City, PQ G1V 4G2, Canada; [El Hajj, Hassan; Tremblay, Marie-Eve] Univ Laval, Dept Mol Med, Quebec City, PQ G1K 7P4, Canada; [Richard, Francois J.] Univ Laval, Dept Sci Anim, Quebec City, PQ G1K 7P4, Canada; [Leclerc, Pierre] Univ Laval, CRDSI, Quebec City, PQ G1K 7P4, Canada	Laval University; Laval University; Laval University; Laval University; Laval University	Leclerc, P (corresponding author), Univ Laval, Dept Obstet Gynecol & Reprod, Quebec City, PQ G1K 7P4, Canada.; Leclerc, P (corresponding author), Univ Laval, CRDSI, Quebec City, PQ G1K 7P4, Canada.	pierre.leclerc@crchudequebec.ulaval.ca		Tremblay, Marie-Eve/0000-0003-2863-9626; Richard, Francois J./0000-0003-0226-2971; Leclerc, Pierre/0000-0003-2053-3958	Natural Science and Engineering Research Council of Canada (NSERC) [435507]	Natural Science and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was funded by the Natural Science and Engineering Research Council of Canada (NSERC; Collaborative Research & Development grant, project #435507; http://www.nserc-crsng.gc.ca) to FJR and PL. This funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work was also supported by L'Alliance Boviteq Inc (St- Hyacinthe, QC, Canada; http://www.boviteq.com) to FJR and PL. This funder had no role in study	Bajpai M, 2006, BIOL REPROD, V74, P109, DOI 10.1095/biolreprod.105.043588; Baker MA, 2006, J CELL SCI, V119, P3182, DOI 10.1242/jcs.03055; Baxendale RW, 2005, MOL REPROD DEV, V71, P495, DOI 10.1002/mrd.20265; Bisht K, 2016, JOVE-J VIS EXP, DOI 10.3791/54060; Branham MT, 2009, J BIOL CHEM, V284, P24825, DOI 10.1074/jbc.M109.015362; Branham MAT, 2006, J BIOL CHEM, V281, P8656, DOI 10.1074/jbc.M508854200; Buck J, 1999, P NATL ACAD SCI USA, V96, P79, DOI 10.1073/pnas.96.1.79; Buffone MG, 2014, BBA-MOL BASIS DIS, V1842, P2610, DOI 10.1016/j.bbadis.2014.07.013; Charych EI, 2010, J NEUROSCI, V30, P9027, DOI 10.1523/JNEUROSCI.1635-10.2010; Conti M, 2007, ANNU REV BIOCHEM, V76, P481, DOI 10.1146/annurev.biochem.76.060305.150444; Coskran TM, 2006, J HISTOCHEM CYTOCHEM, V54, P1205, DOI 10.1369/JHC.6A6930.2006; DEJONGE CJ, 1991, J EXP ZOOL, V258, P113, DOI 10.1002/jez.1402580113; DOHERTY CM, 1995, J ANDROL, V16, P36; Ebner T, 2011, FERTIL STERIL, V96, P1331, DOI 10.1016/j.fertnstert.2011.08.041; Fisch JD, 1998, HUM REPROD, V13, P1248, DOI 10.1093/humrep/13.5.1248; Fournier V, 2003, J ANDROL, V24, P104; FRASER LR, 1979, J REPROD FERTIL, V57, P377, DOI 10.1530/jrf.0.0570377; FRASER LR, 1981, J REPROD FERTIL, V62, P63, DOI 10.1530/jrf.0.0620063; Fujishige K, 1999, EUR J BIOCHEM, V266, P1118, DOI 10.1046/j.1432-1327.1999.00963.x; Fujishige K, 2000, EUR J BIOCHEM, V267, P5943, DOI 10.1046/j.1432-1327.2000.01661.x; Fujishige K, 1999, J BIOL CHEM, V274, P18438, DOI 10.1074/jbc.274.26.18438; GARBERS DL, 1971, BIOL REPROD, V5, P336, DOI 10.1093/biolreprod/5.3.336; Havlis J, 2003, ANAL CHEM, V75, P1300, DOI 10.1021/ac026136s; Herrero MB, 2000, FREE RADICAL BIO MED, V29, P522, DOI 10.1016/S0891-5849(00)00339-7; HOSKINS DD, 1975, BIOL REPROD, V13, P168, DOI 10.1095/biolreprod13.2.168; HYNE RV, 1979, P NATL ACAD SCI USA, V76, P5699, DOI 10.1073/pnas.76.11.5699; Kehler J, 2011, BIOORG MED CHEM LETT, V21, P3738, DOI 10.1016/j.bmcl.2011.04.067; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kleiman RJ, 2011, J PHARMACOL EXP THER, V336, P64, DOI 10.1124/jpet.110.173294; Kotera J, 2004, J BIOL CHEM, V279, P4366, DOI 10.1074/jbc.M308471200; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lalancette C, 2006, MOL REPROD DEV, V73, P520, DOI 10.1002/mrd.20422; Lawson C, 2008, BIOL REPROD, V79, P657, DOI 10.1095/biolreprod.108.070367; Leclerc P, 1999, J ANDROL, V20, P126; LECLERC P, 1995, BIOL REPROD, V52, P1227, DOI 10.1095/biolreprod52.6.1227; Leclerc P, 1996, BIOL REPROD, V55, P684, DOI 10.1095/biolreprod55.3.684; Leclerc P, 2002, BIOL REPROD, V67, P301, DOI 10.1095/biolreprod67.1.301; Lefievre L, 2002, BIOL REPROD, V67, P423, DOI 10.1095/biolreprod67.2.423; Livera G, 2005, MOL ENDOCRINOL, V19, P1277, DOI 10.1210/me.2004-0318; McPartlin LA, 2011, BIOL REPROD, V85, P179, DOI 10.1095/biolreprod.110.085555; Melo RCN, 2014, NAT PROTOC, V9, P2382, DOI 10.1038/nprot.2014.163; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; PARRISH JJ, 1995, THERIOGENOLOGY, V44, P859, DOI 10.1016/0093-691X(95)00271-9; Pons-Rejraji H, 2009, REPROD FERT DEVELOP, V21, P525, DOI 10.1071/RD07170; Pons-Rejraji H, 2009, REPROD FERT DEVELOP, V21, P511, DOI 10.1071/RD07169; Richter W, 1999, MOL HUM REPROD, V5, P732, DOI 10.1093/molehr/5.8.732; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Sinclair ML, 2000, MOL REPROD DEV, V56, P6, DOI 10.1002/(SICI)1098-2795(200005)56:1&lt;6::AID-MRD2&gt;3.0.CO;2-M; Siuciak JA, 2006, NEUROPHARMACOLOGY, V51, P386, DOI 10.1016/j.neuropharm.2006.04.013; Siuciak JA, 2008, CNS DRUGS, V22, P983, DOI 10.2165/0023210-200822120-00002; Soderling SH, 1999, P NATL ACAD SCI USA, V96, P7071, DOI 10.1073/pnas.96.12.7071; TASH JS, 1976, J REPROD FERTIL, V47, P63, DOI 10.1530/jrf.0.0470063; Thundathil J, 2002, MOL HUM REPROD, V8, P811, DOI 10.1093/molehr/8.9.811; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Visconti PE, 1999, BIOL REPROD, V61, P76, DOI 10.1095/biolreprod61.1.76; VISCONTI PE, 1995, DEVELOPMENT, V121, P1139; WASCO WM, 1984, BIOCHEM BIOPH RES CO, V118, P636, DOI 10.1016/0006-291X(84)91350-0; Wayman C, 2005, INT J IMPOT RES, V17, P216, DOI 10.1038/sj.ijir.3901307; Wertheimer E, 2013, J BIOL CHEM, V288, P35307, DOI 10.1074/jbc.M113.489476	59	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2016	11	8							e0161035	10.1371/journal.pone.0161035	http://dx.doi.org/10.1371/journal.pone.0161035			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT8TP	27548062	gold, Green Submitted, Green Published			2022-12-27	WOS:000381768400028
J	Hirai, T; Yoshii, T; Iwanami, A; Takeuchi, K; Mori, K; Yamada, T; Wada, K; Koda, M; Matsuyama, Y; Takeshita, K; Abematsu, M; Haro, H; Watanabe, M; Watanabe, K; Ozawa, H; Kanno, H; Imagama, S; Fujibayashi, S; Yamazaki, M; Matsumoto, M; Nakamura, M; Okawa, A; Kawaguchi, Y				Hirai, Takashi; Yoshii, Toshitaka; Iwanami, Akio; Takeuchi, Kazuhiro; Mori, Kanji; Yamada, Tsuyoshi; Wada, Kanichiro; Koda, Masao; Matsuyama, Yukihiro; Takeshita, Katsushi; Abematsu, Masahiko; Haro, Hirotaka; Watanabe, Masahiko; Watanabe, Kei; Ozawa, Hiroshi; Kanno, Haruo; Imagama, Shiro; Fujibayashi, Shunsuke; Yamazaki, Masashi; Matsumoto, Morio; Nakamura, Masaya; Okawa, Atsushi; Kawaguchi, Yoshiharu			Prevalence and Distribution of Ossified Lesions in the Whole Spine of Patients with Cervical Ossification of the Posterior Longitudinal Ligament A Multicenter Study (JOSL CT study)	PLOS ONE			English	Article							THORACIC SPINE; FOLLOW-UP; POPULATION; MYELOPATHY; JAPANESE; FUSION; COL6A1; CELLS	Ossification of the posterior longitudinal ligament (OPLL) can cause severe and irreversible paralysis in not only the cervical spine but also the thoracolumbar spine. To date, however, the prevalence and distribution of OPLL in the whole spine has not been precisely evaluated in patients with cervical OPLL. Therefore, we conducted a multi-center study to comprehensively evaluate the prevalence and distribution of OPLL using multi-detector computed tomography (CT) images in the whole spine and to analyze what factors predict the presence of ossified lesions in the thoracolumbar spine in patients who were diagnosed with cervical OPLL by plain X-ray. Three hundred and twenty-two patients with a diagnosis of cervical OPLL underwent CT imaging of the whole spine. The sum of the levels in which OPLL was present in the whole spine was defined as the OP-index and used to evaluate the extent of ossification. The distribution of OPLL in the whole spine was compared between male and female subjects. In addition, a multiple regression model was used to ascertain related factors that affected the OP-index. Among patients with cervical OPLL, women tended to have more ossified lesions in the thoracolumbar spine than did men. A multiple regression model revealed that the OP-index was significantly correlated with the cervical OP-index, sex (female), and body mass index. Furthermore, the prevalence of thoracolumbar OPLL in patients with a cervical OP-index >= 10 was 7.8 times greater than that in patients with a cervical OP-index <= 5. The results of this study reveal that the extent of OPLL in the whole spine is significantly associated with the extent of cervical OPLL, female sex, and obesity.	[Hirai, Takashi; Yoshii, Toshitaka; Yamada, Tsuyoshi; Okawa, Atsushi] Tokyo Med & Dent Univ, Dept Orthoped Surg, Bunkyo Ward, 1-5-45 Yushima, Tokyo 1138519, Japan; [Iwanami, Akio; Matsumoto, Morio; Nakamura, Masaya] Keio Univ, Dept Orthoped Surg, Sch Med, Shinjuku Ward, 35 Shinanomachi, Tokyo 1608582, Japan; [Takeuchi, Kazuhiro] Natl Hosp Org Okayama Med Ctr, Dept Orthoped Surg, 1711-1 Tamasu, Okayama, Okayama 7011154, Japan; [Mori, Kanji] Shiga Univ Med Sci, Dept Orthoped Surg, Tsukinowa Cho, Otsu, Shiga 5202192, Japan; [Wada, Kanichiro] Hirosaki Univ, Grad Sch Med, Dept Orthoped Surg, 53 Honcho, Hirosaki, Aomori 0368203, Japan; [Koda, Masao] Chiba Univ, Grad Sch Med, Dept Orthoped Surg, Chuo Ward, 1-8-1 Inohana, Chiba, Chiba 2600856, Japan; [Matsuyama, Yukihiro] Hamamatsu Univ, Sch Med, Dept Orthoped Surg, 1-20-1 Handayama, Hamamatsu, Shizuoka 4313125, Japan; [Takeshita, Katsushi] Jichi Med Univ, Dept Orthoped, 3311-1 Yakushiji, Shimotsuke, Tochigi 3290498, Japan; [Abematsu, Masahiko] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Orthoped Surg, 8-35-1 Sakuragaoka, Kagoshima, Kagoshima 8908520, Japan; [Haro, Hirotaka] Univ Yamanashi, Dept Orthoped Surg, Chuo Ward, 1110 Shimokato, Kofu, Yamanashi 4093898, Japan; [Watanabe, Masahiko] Tokai Univ, Dept Orthoped Surg, Sch Med, Surg Sci, 143 Shimokasuya, Isehara, Kanagawa 2591143, Japan; [Watanabe, Kei] Niigata Univ Med & Dent Gen Hosp, Dept Orthoped Surg, Chuo Ward, 1-754 Asahimachidori, Niigata, Niigata 9518520, Japan; [Ozawa, Hiroshi] Tohoku Med & Pharmaceut Univ, Dept Orthopaed Surg, 1-12-1 Fukumuro Miyaginoku, Sendai, Miyagi 9838512, Japan; [Kanno, Haruo] Tohoku Univ, Dept Orthopaed Surg, Sch Med, Aoba Ward, 1-1 Seiryomachi, Sendai, Miyagi 9808574, Japan; [Imagama, Shiro] Nagoya Univ, Grad Sch Med, Dept Orthoped Surg, Showa Ward, 65 Tsurumaicho, Nagoya, Aichi 4660065, Japan; [Fujibayashi, Shunsuke] Kyoto Univ, Grad Sch Med, Dept Orthoped Surg, Sakyo Ward, 54 Kawaharacho, Kyoto, Kyoto 6068507, Japan; [Yamazaki, Masashi] Univ Tsukuba, Dept Orthoped Surg, Fac Med, 2-1-1 Amakubo, Tsukuba, Ibaraki 3058576, Japan; [Kawaguchi, Yoshiharu] Toyama Univ, Dept Orthoped Surg, Fac Med, 2630 Sugitani, Toyama, Toyama 9300194, Japan; [Hirai, Takashi; Yoshii, Toshitaka; Iwanami, Akio; Takeuchi, Kazuhiro; Mori, Kanji; Yamada, Tsuyoshi; Wada, Kanichiro; Koda, Masao; Matsuyama, Yukihiro; Takeshita, Katsushi; Abematsu, Masahiko; Haro, Hirotaka; Watanabe, Masahiko; Watanabe, Kei; Ozawa, Hiroshi; Kanno, Haruo; Imagama, Shiro; Fujibayashi, Shunsuke; Yamazaki, Masashi; Matsumoto, Morio; Nakamura, Masaya; Okawa, Atsushi; Kawaguchi, Yoshiharu] Japanese Multictr Res Org Ossificat Spinal Ligame, Working Grp CT Study, Tokyo, Japan	Tokyo Medical & Dental University (TMDU); Keio University; Shiga University of Medical Science; Hirosaki University; Chiba University; Hamamatsu University School of Medicine; Jichi Medical University; Kagoshima University; University of Yamanashi; Tokai University; Niigata University; Tohoku Medical & Pharmaceutical University; Tohoku University; Nagoya University; Kyoto University; University of Tsukuba; University of Toyama	Yoshii, T (corresponding author), Tokyo Med & Dent Univ, Dept Orthoped Surg, Bunkyo Ward, 1-5-45 Yushima, Tokyo 1138519, Japan.; Yoshii, T (corresponding author), Japanese Multictr Res Org Ossificat Spinal Ligame, Working Grp CT Study, Tokyo, Japan.	yoshii.orth@tmd.ac.jp	Nakamura, Masaya/K-4111-2013; Kanno, Haruo/AAA-2187-2020	Kanno, Haruo/0000-0003-1985-2257	Japanese Health Labor Sciences Research Grant	Japanese Health Labor Sciences Research Grant	This work was supported by a Japanese Health Labor Sciences Research Grant.	ERIKSEN EF, 1988, SCIENCE, V241, P84, DOI 10.1126/science.3388021; FIROOZNIA H, 1982, NEW YORK STATE J MED, V82, P1193; Fujimori T, 2016, SPINE PHILA PA 1976, V23; Ijiri K, 1996, EPIDEMIOLOGICAL STUD, P24; Ikeda Y, 2011, EUR SPINE J, V20, P1450, DOI 10.1007/s00586-011-1688-7; IZAWA K, 1980, Journal of the Japanese Orthopaedic Association, V54, P461; Karanicolas PJ, 2009, J BONE JOINT SURG AM, V91A, P99, DOI 10.2106/JBJS.H.01624; Kawaguchi Y, 2003, SPINE, V28, P1424, DOI 10.1097/00007632-200307010-00013; Kawaguchi Y, 2013, SPINE, V38, pE1477, DOI 10.1097/BRS.0b013e3182a54f00; Key GA., 1838, GUY HOSP REP, V638, P17; Koga H, 1998, AM J HUM GENET, V62, P1460, DOI 10.1086/301868; KOMM BS, 1988, SCIENCE, V241, P81, DOI 10.1126/science.3164526; Kong QQ, 2007, SPINE, V32, P2834, DOI 10.1097/BRS.0b013e31815b761c; Liu Y, 2010, CLIN ORTHOP RELAT R, V468, P3333, DOI 10.1007/s11999-010-1511-5; Matsumoto M, 2008, SPINE, V33, P1034, DOI 10.1097/BRS.0b013e31816c913b; Matsumoto M, 2011, J NEUROSURG-SPINE, V15, P380, DOI 10.3171/2011.6.SPINE10816; Matsunaga S, 2008, SPINE, V33, P2648, DOI 10.1097/BRS.0b013e31817f988c; Matsunaga S, 2012, SPINE, V37, pE309, DOI 10.1097/BRS.0b013e318241ad33; Mori K, 2014, SPINE, V39, P394, DOI 10.1097/BRS.0000000000000153; Ohtsuka K, 1986, Nihon Seikeigeka Gakkai Zasshi, V60, P1087; ONO M, 1982, RADIOLOGY, V143, P469, DOI 10.1148/radiology.143.2.7071349; Pham MH, 2011, NEUROSURG FOCUS, V30, DOI 10.3171/2011.1.FOCUS10273; RESNICK D, 1978, SEMIN ARTHRITIS RHEU, V7, P153, DOI 10.1016/0049-0172(78)90036-7; Sakai K, 2012, SPINE, V37, P367, DOI 10.1097/BRS.0b013e31821f4a51; Stetler WR, 2011, NEUROSURG FOCUS, V30, DOI 10.3171/2010.12.FOCUS10275; Tanaka T, 2003, AM J HUM GENET, V73, P812, DOI 10.1086/378593; TERAYAMA K, 1989, SPINE, V14, P1184, DOI 10.1097/00007632-198911000-00009; Wang PN, 1999, SPINE, V24, P142, DOI 10.1097/00007632-199901150-00010; Yoshimura N, 2014, OSTEOPOROSIS INT, V25, P1089, DOI 10.1007/s00198-013-2489-0	29	47	52	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2016	11	8							e0160117	10.1371/journal.pone.0160117	http://dx.doi.org/10.1371/journal.pone.0160117			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT8TP	27548354	Green Published, gold, Green Submitted			2022-12-27	WOS:000381768400012
J	Silva, VL; Ferreira, D; Nobrega, FL; Martins, IM; Kluskens, LD; Rodrigues, LR				Silva, Vera L.; Ferreira, Debora; Nobrega, Franklin L.; Martins, Ivone M.; Kluskens, Leon D.; Rodrigues, Ligia R.			Selection of Novel Peptides Homing the 4T1 CELL Line: Exploring Alternative Targets for Triple Negative Breast Cancer	PLOS ONE			English	Article							PHAGE DISPLAY; MOUSE MODELS; IDENTIFICATION; LIBRARIES; METASTASIS; DIVERSITY; DELIVERY; DATABASE; FUTURE; TUMORS	The use of bacteriophages to select novel ligands has been widely explored for cancer therapy. Their application is most warranted in cancer subtypes lacking knowledge on how to target the cancer cells in question, such as the triple negative breast cancer, eventually leading to the development of alternative nanomedicines for cancer therapeutics. Therefore, the following study aimed to select and characterize novel peptides for a triple negative breast cancer murine mammary carcinoma cell line-4T1. Using phage display, 7 and 12 amino acid random peptide libraries were screened against the 4T1 cell line. A total of four rounds, plus a counter-selection round using the 3T3 murine fibroblast cell line, was performed. The enriched selective peptides were characterized and their binding capacity towards 4T1 tissue samples was confirmed by immunofluorescence and flow cytometry analysis. The selected peptides (4T1pep1 -CPTASNTSC and 4T1pep2-EVQSSKF-PAHVS) were enriched over few rounds of selection and exhibited specific binding to the 4T1 cell line. Interestingly, affinity to the human MDA-MB-231 cell line was also observed for both peptides, promoting the translational application of these novel ligands between species. Additionally, bioinformatics analysis suggested that both peptides target human Mucin-16. This protein has been implicated in different types of cancer, as it is involved in many important cellular functions. This study strongly supports the need of finding alternative targeting systems for TNBC and the peptides herein selected exhibit promising future application as novel homing peptides for breast cancer therapy.	[Silva, Vera L.; Ferreira, Debora; Nobrega, Franklin L.; Martins, Ivone M.; Kluskens, Leon D.; Rodrigues, Ligia R.] Univ Minho, CEB, Campus Gualtar, Braga, Portugal; [Silva, Vera L.] Univ East Anglia, Sch Pharm, Norwich Res Pk, Norwich, Norfolk, England	Universidade do Minho; University of East Anglia	Rodrigues, LR (corresponding author), Univ Minho, CEB, Campus Gualtar, Braga, Portugal.	lrmr@deb.uminho.pt	Ferreira, Débora/AAA-6991-2022; Nobrega, Franklin L./J-3094-2019; Ferreira, Débora/T-1353-2017; Martins, Ivone M/G-1752-2012; Rodrigues, Ligia R/C-3151-2009	Ferreira, Débora/0000-0002-0937-4047; Nobrega, Franklin L./0000-0002-8238-1083; Ferreira, Débora/0000-0002-0937-4047; Martins, Ivone M/0000-0002-3412-9377; Rodrigues, Ligia R/0000-0001-9265-0630	Portuguese Foundation for Science and Technology (FCT) [SFRH/BD/86462/2012]; FCT; European Community fund FEDER, through Program COMPETE [FCOMP-01-0124-FEDER-021053 (PTDC/SAU-BMA/121028/2010), RECI/BBB-EBI/0179/2012 (FCOMP-01-0124-FEDER-027462), UID/BIO/04469/2013]; Programa Operacional Regional do Norte (ON.2 - O Novo Norte), QREN, FEDER; Fundação para a Ciência e a Tecnologia [PTDC/SAU-BMA/121028/2010] Funding Source: FCT	Portuguese Foundation for Science and Technology (FCT)(Portuguese Foundation for Science and Technology); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); European Community fund FEDER, through Program COMPETE; Programa Operacional Regional do Norte (ON.2 - O Novo Norte), QREN, FEDER; Fundação para a Ciência e a Tecnologia	Franklin L. Nobrega acknowledges the Portuguese Foundation for Science and Technology (FCT) for the grant SFRH/BD/86462/2012. This study was supported by FCT and the European Community fund FEDER, through Program COMPETE, under the scope of the Projects FCOMP-01-0124-FEDER-021053 (PTDC/SAU-BMA/121028/2010), RECI/BBB-EBI/0179/2012 (FCOMP-01-0124-FEDER-027462), the strategic funding of UID/BIO/04469/2013 unit, co-funded by the Programa Operacional Regional do Norte (ON.2 - O Novo Norte), QREN, FEDER.	Adochite RC, 2014, MOL PHARMACEUT, V11, P2896, DOI 10.1021/mp5002526; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; [Anonymous], 2014, IHC PARAFFIN STAININ; Bar H, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-37; Bedi D, 2011, NANOMED-NANOTECHNOL, V7, P315, DOI 10.1016/j.nano.2010.10.004; Bignone PA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058200; Budynek P, 2010, ARCH MICROBIOL, V192, P315, DOI 10.1007/s00203-010-0559-7; Dai XY, 2014, BIOCHEM BIOPH RES CO, V445, P795, DOI 10.1016/j.bbrc.2014.02.022; Derda R, 2011, MOLECULES, V16, P1776, DOI 10.3390/molecules16021776; Dong J, 2008, CHINESE SCI BULL, V53, P860, DOI 10.1007/s11434-008-0162-3; Eckhardt BL, 2005, MOL CANCER RES, V3, P1; Fantozzi A, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1530; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Filfil R, 2012, INT J CANCER, V131, pE681, DOI 10.1002/ijc.27368; Francia G, 2011, NAT REV CANCER, V11, P135, DOI 10.1038/nrc3001; Fu B, 2014, BIOTECHNOL LETT, V36, P2291, DOI 10.1007/s10529-014-1608-0; Giordano RJ, 2001, NAT MED, V7, P1249, DOI 10.1038/nm1101-1249; Gluz O, 2009, ANN ONCOL, V20, P1913, DOI 10.1093/annonc/mdp492; Gray BP, 2014, CHEM REV, V114, P1020, DOI 10.1021/cr400166n; Gray BP, 2013, BIOCONJUGATE CHEM, V24, P85, DOI 10.1021/bc300498d; Hong HY, 2008, J CELL MOL MED, V12, P2003, DOI 10.1111/j.1582-4934.2008.00189.x; Huang J, 2012, NUCLEIC ACIDS RES, V40, pD271, DOI 10.1093/nar/gkr922; Huang J, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/101932; Ismail-Khan R, 2010, CANCER CONTROL, V17, P173, DOI 10.1177/107327481001700305; Jiao QL, 2014, J THORAC DIS, V6, P1329, DOI 10.3978/j.issn.2072-1439.2014.08.13; Kau P, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-120; Kong M., 2013, CHIN GER J CLIN ONCO, V12, P246, DOI [10.1007/s10330-013-1141-y, DOI 10.1007/S10330-013-1141-Y]; Krag DN, 2006, CANCER RES, V66, P7724, DOI 10.1158/0008-5472.CAN-05-4441; Kufe DW, 2009, NAT REV CANCER, V9, P874, DOI 10.1038/nrc2761; Lakshmanan I, 2012, ONCOGENE, V31, P805, DOI 10.1038/onc.2011.297; Le Du F, 2015, ONCOTARGET, V6, P12890, DOI 10.18632/oncotarget.3849; Lehmann BD, 2011, J CLIN INVEST, V121, P2750, DOI 10.1172/JCI45014; Li X, 2014, METHODS MOL BIOL, V1108, P57, DOI 10.1007/978-1-62703-751-8_4; Lu RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066128; Matochko WL, 2012, METHODS, V58, P47, DOI 10.1016/j.ymeth.2012.07.006; Mendes TFS, 2015, ADV SCI, V2, DOI 10.1002/advs.201500053; Menendez A, 2005, ANAL BIOCHEM, V336, P145, DOI 10.1016/j.ab.2004.09.048; Molek P, 2011, MOLECULES, V16, P857, DOI 10.3390/molecules16010857; Nowakowski GS, 2004, STEM CELLS, V22, P1030, DOI 10.1634/stemcells.22-6-1030; Petrenko VA, 2014, FEBS LETT, V588, P341, DOI 10.1016/j.febslet.2013.11.011; Reinartz S, 2012, EUR J CANCER, V48, P1558, DOI 10.1016/j.ejca.2011.07.004; Shtatland T, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-280; Smith Temple F., 2008, V48, P20, DOI 10.1007/978-0-387-09595-0_3; 't Hoen PAC, 2012, ANAL BIOCHEM, V421, P622, DOI 10.1016/j.ab.2011.11.005; Tao K, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-228; Umlauf BJ, 2015, BIOTECHNIQUES, V58, P81, DOI 10.2144/000114256; Vodnik M, 2011, MOLECULES, V16, P790, DOI 10.3390/molecules16010790; Yildiz I, 2011, CURR OPIN BIOTECH, V22, P901, DOI 10.1016/j.copbio.2011.04.020; Zhang BH, 2007, MOL MED, V13, P246, DOI 10.2119/2006-00115.Zhang	50	16	16	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2016	11	8							e0161290	10.1371/journal.pone.0161290	http://dx.doi.org/10.1371/journal.pone.0161290			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT8TP	27548261	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000381768400038
J	Deng, LT; Wu, YL; Li, JC; OuYang, KX; Ding, MM; Zhang, JJ; Li, SQ; Lin, MF; Chen, HB; Hu, XS; Chen, XY				Deng, Li-Ting; Wu, Yu-Ling; Li, Jun-Cheng; OuYang, Kun-Xi; Ding, Mei-Mei; Zhang, Jun-Jie; Li, Shu-Qi; Lin, Meng-Fei; Chen, Han-Bin; Hu, Xin-Sheng; Chen, Xiao-Yang			Screening Reliable Reference Genes for RT-qPCR Analysis of Gene Expression in Moringa oleifera	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; HOUSEKEEPING GENES; SUPEROXIDE-DISMUTASE; PCR NORMALIZATION; OXIDATIVE STRESS; QUANTITATIVE-PCR; RNA EXPRESSION; SELECTION; IDENTIFICATION; VALIDATION	Moringa oleifera is a promising plant species for oil and forage, but its genetic improvement is limited. Our current breeding program in this species focuses on exploiting the functional genes associated with important agronomical traits. Here, we screened reliable reference genes for accurately quantifying the expression of target genes using the technique of real-time quantitative polymerase chain reaction (RT-qPCR) in M. oleifera. Eighteen candidate reference genes were selected from a transcriptome database, and their expression stabilities were examined in 90 samples collected from the pods in different developmental stages, various tissues, and the roots and leaves under different conditions (low or high temperature, sodium chloride (NaCl)-or polyethyleneglycol (PEG)-simulated water stress). Analyses with geNorm, NormFinder and BestKeeper algorithms revealed that the reliable reference genes differed across sample designs and that ribosomal protein L1 (RPL1) and acyl carrier protein 2 (ACP2) were the most suitable reference genes in all tested samples. The experiment results demonstrated the significance of using the properly validated reference genes and suggested the use of more than one reference gene to achieve reliable expression profiles. In addition, we applied three isotypes of the superoxide dismutase (SOD) gene that are associated with plant adaptation to abiotic stress to confirm the efficacy of the validated reference genes under NaCl and PEG water stresses. Our results provide a valuable reference for future studies on identifying important functional genes from their transcriptional expressions via RT-qPCR technique in M. oleifera.	[Deng, Li-Ting; Wu, Yu-Ling; Li, Jun-Cheng; OuYang, Kun-Xi; Ding, Mei-Mei; Zhang, Jun-Jie; Li, Shu-Qi; Lin, Meng-Fei; Chen, Han-Bin; Hu, Xin-Sheng; Chen, Xiao-Yang] South China Agr Univ, State Key Lab Conservat & Utilizat Subtrop Agrobi, Guangzhou 510642, Guangdong, Peoples R China; [Deng, Li-Ting; Wu, Yu-Ling; Li, Jun-Cheng; OuYang, Kun-Xi; Ding, Mei-Mei; Zhang, Jun-Jie; Li, Shu-Qi; Lin, Meng-Fei; Chen, Han-Bin; Hu, Xin-Sheng; Chen, Xiao-Yang] South China Agr Univ, Guangdong Key Lab Innovat Dev & Utilizat Forest P, Guangzhou 510642, Guangdong, Peoples R China; [Deng, Li-Ting; Wu, Yu-Ling; Li, Jun-Cheng; OuYang, Kun-Xi; Ding, Mei-Mei; Zhang, Jun-Jie; Li, Shu-Qi; Lin, Meng-Fei; Chen, Han-Bin; Hu, Xin-Sheng; Chen, Xiao-Yang] South China Agr Univ, Guangdong Prov Res Ctr Woody Forage Engn Technol, Guangzhou 510642, Guangdong, Peoples R China; [Deng, Li-Ting; Wu, Yu-Ling; Li, Jun-Cheng; OuYang, Kun-Xi; Ding, Mei-Mei; Zhang, Jun-Jie; Li, Shu-Qi; Lin, Meng-Fei; Chen, Han-Bin; Hu, Xin-Sheng; Chen, Xiao-Yang] South China Agr Univ, Coll Forestry & Landscape Architecture, Guangzhou 510642, Guangdong, Peoples R China	South China Agricultural University; South China Agricultural University; South China Agricultural University; South China Agricultural University	Hu, XS; Chen, XY (corresponding author), South China Agr Univ, State Key Lab Conservat & Utilizat Subtrop Agrobi, Guangzhou 510642, Guangdong, Peoples R China.; Hu, XS; Chen, XY (corresponding author), South China Agr Univ, Guangdong Key Lab Innovat Dev & Utilizat Forest P, Guangzhou 510642, Guangdong, Peoples R China.; Hu, XS; Chen, XY (corresponding author), South China Agr Univ, Guangdong Prov Res Ctr Woody Forage Engn Technol, Guangzhou 510642, Guangdong, Peoples R China.; Hu, XS; Chen, XY (corresponding author), South China Agr Univ, Coll Forestry & Landscape Architecture, Guangzhou 510642, Guangdong, Peoples R China.	xinsheng@scau.edu.cn; xychen@scau.edu.cn			Forestry Sciences and Technology Innovation Project in Guangdong Province, P.R. China [2015KJCX009]; Department of Tropical crops, State Bureau for Land-Reclamation, P.R. China [15RZNJ-62]	Forestry Sciences and Technology Innovation Project in Guangdong Province, P.R. China; Department of Tropical crops, State Bureau for Land-Reclamation, P.R. China	This work was supported by the Forestry Sciences and Technology Innovation Project in Guangdong Province (2015KJCX009) and the Department of Tropical crops, State Bureau for Land-Reclamation (15RZNJ-62), P.R. China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We appreciate the Academic Editor and two anonymous reviewers for helpful comments on an earlier version of this article. We would like to thank Yong-shun Gao, Ai-min Wu and Chang-Cao Peng for helpful advices on this research work. This work was supported by the Forestry Sciences and Technology Innovation Project in Guangdong Province (2015KJCX009) and the Department of Tropical crops, State Bureau for Land-Reclamation (15RZNJ-62), P.R. China.	Alscher RG, 2002, J EXP BOT, V53, P1331, DOI 10.1093/jexbot/53.372.1331; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Ando H, 2016, J PHARMACOL SCI, V131, P138, DOI 10.1016/j.jphs.2016.03.002; Anwar F, 2007, PHYTOTHER RES, V21, P17, DOI 10.1002/ptr.2023; Artico S, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-49; Buckland PR, 2006, BBA-MOL BASIS DIS, V1762, P17, DOI 10.1016/j.bbadis.2005.10.004; Bustin SA, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290023; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chen L, 2011, PLANTA, V234, P377, DOI 10.1007/s00425-011-1410-3; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; Dheda K, 2004, BIOTECHNIQUES, V37, P112, DOI 10.2144/04371RR03; Die JV, 2010, PLANTA, V232, P145, DOI 10.1007/s00425-010-1158-1; Ellis Danielle R., 2004, BMC Plant Biology, V4, P1, DOI 10.1186/1471-2229-4-1; Exposito-Rodriguez M, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-131; Foidl N., 2001, WHAT DEV POTENTIAL M, V20, P1; Gill SS, 2015, ENVIRON SCI POLLUT R, V22, P10375, DOI 10.1007/s11356-015-4532-5; Gismondi A, 2013, INT J ONCOL, V43, P956, DOI 10.3892/ijo.2013.2001; Gomez JM, 2004, J EXP BOT, V55, P119, DOI 10.1093/jxb/erh013; Gutierrez L, 2008, PLANT BIOTECHNOL J, V6, P609, DOI 10.1111/j.1467-7652.2008.00346.x; Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190; Kim BR, 2003, BIOTECHNOL LETT, V25, P1869, DOI 10.1023/A:1026298032009; KIMURA M, 1974, P NATL ACAD SCI USA, V71, P2848, DOI 10.1073/pnas.71.7.2848; Kumar V, 2011, AUST J CROP SCI, V5, P1455; Lee PD, 2002, GENOME RES, V12, P292, DOI 10.1101/gr.217802; Libault M, 2008, PLANT GENOME-US, V1, P44, DOI 10.3835/plantgenome2008.02.0091; Lovdal T, 2009, ANAL BIOCHEM, V387, P238, DOI 10.1016/j.ab.2009.01.024; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; Mohamed E, 2015, PLANT CELL REP, V34, P2099, DOI 10.1007/s00299-015-1854-1; Neuvians TAP, 2005, J BIOTECHNOL, V117, P163, DOI 10.1016/j.jbiotec.2005.01.011; Nicot N, 2005, J EXP BOT, V56, P2907, DOI 10.1093/jxb/eri285; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Radonic A, 2004, BIOCHEM BIOPH RES CO, V313, P856, DOI 10.1016/j.bbrc.2003.11.177; Reid KE, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-27; Saini RK, 2014, ACTA PHYSIOL PLANT, V36, P2695, DOI 10.1007/s11738-014-1640-7; Schmid H, 2003, KIDNEY INT, V64, P356, DOI 10.1046/j.1523-1755.2003.00074.x; Schmidt GW, 2010, MOL GENET GENOMICS, V283, P233, DOI 10.1007/s00438-010-0511-1; Shivhare R, 2016, SCI REP-UK, V6, DOI 10.1038/srep23036; Silver N, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-33; Smit R, 2013, S AFR J BOT, V86, P182, DOI 10.1016/j.sajb.2013.02.162; Suzuki T, 2000, BIOTECHNIQUES, V29, P332, DOI 10.2144/00292rv02; Tian Y, 2015, SCI CHINA LIFE SCI, V58, P627, DOI 10.1007/s11427-015-4872-x; Tricarico C, 2002, ANAL BIOCHEM, V309, P293, DOI 10.1016/S0003-2697(02)00311-1; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Verma AR, 2009, FOOD CHEM TOXICOL, V47, P2196, DOI 10.1016/j.fct.2009.06.005; Volkov RA, 2003, J EXP BOT, V54, P2343, DOI 10.1093/jxb/erg244; Wan HJ, 2010, ANAL BIOCHEM, V399, P257, DOI 10.1016/j.ab.2009.12.008; Xu M, 2011, ANAL BIOCHEM, V408, P337, DOI 10.1016/j.ab.2010.08.044; Zhang L, 2013, INT J MOL SCI, V14, P24338, DOI 10.3390/ijms141224338; Zhu XF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033013	49	73	84	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2016	11	8							e0159458	10.1371/journal.pone.0159458	http://dx.doi.org/10.1371/journal.pone.0159458			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6UQ	27541138	Green Published, Green Submitted, gold			2022-12-27	WOS:000381620200001
J	Jonsson, U; Bertilsson, G; Allard, P; Gyllensvard, H; Soderlund, A; Tham, A; Andersson, G				Jonsson, Ulf; Bertilsson, Goran; Allard, Per; Gyllensvard, Harald; Soderlund, Anne; Tham, Anne; Andersson, Gerhard			Psychological Treatment of Depression in People Aged 65 Years and Over: A Systematic Review of Efficacy, Safety, and Cost-Effectiveness	PLOS ONE			English	Review							COGNITIVE-BEHAVIORAL THERAPY; PROBLEM-SOLVING THERAPY; PROBLEM ADAPTATION THERAPY; OLDER-ADULTS; HEALTH-CARE; MAJOR DEPRESSION; HOME-CARE; LIFE; INTERVENTIONS; ACTIVATION	Objectives Depression in elderly people is a major public health concern. As response to antidepressants is often unsatisfactory in this age group, there is a need for evidence-based non-pharmacological treatment options. Our objectives were twofold: firstly, to synthesize published trials evaluating efficacy, safety and cost-effectiveness of psychological treatment of depression in the elderly and secondly, to assess the quality of evidence. Method The electronic databases PubMed, EMBASE, Cochrane Library, CINAL, Scopus, and Psyc-INFO were searched up to 23 May 2016 for randomized controlled trials (RCTs) of psychological treatment for depressive disorders or depressive symptoms in people aged 65 years and over. Two reviewers independently assessed relevant studies for risk of bias. Where appropriate, the results were synthesized in meta-analyses. The quality of the evidence was graded according to GRADE (Grading of Recommendations Assessment, Development and Evaluation). Results Twenty-two relevant RCTs were identified, eight of which were excluded from the synthesis due to a high risk of bias. Of the remaining trials, six evaluated problem-solving therapy (PST), five evaluated other forms of cognitive behavioural therapy (CBT), and three evaluated life review/reminiscence therapy. In frail elderly with depressive symptoms, the evidence supported the efficacy of PST, with large but heterogeneous effect sizes compared with treatment as usual. The results for life-review/reminiscence therapy and CBT were also promising, but because of the limited number of trials the quality of evidence was rated as very low. Safety data were not reported in any included trial. The only identified cost-effectiveness study estimated an incremental cost per additional point reduction in Beck Depression Inventory II score for CBT compared with talking control and treatment as usual. Conclusion Psychological treatment is a feasible option for frail elderly with depressive symptoms. However, important questions about efficacy, generalizability, safety and cost-effectiveness remain.	[Jonsson, Ulf] Karolinska Inst, Div Insurance Med, Dept Clin Neurosci, Stockholm, Sweden; [Jonsson, Ulf] Uppsala Univ, Dept Neurosci, Child & Adolescent Psychiat, Uppsala, Sweden; [Jonsson, Ulf] Natl Board Hlth & Welf, Stockholm, Sweden; [Bertilsson, Goran; Gyllensvard, Harald] Swedish Agcy Hlth Technol Assessment & Assessment, Stockholm, Sweden; [Allard, Per] Umea Univ, Div Psychiat, Dept Clin Sci, Umea, Sweden; [Gyllensvard, Harald] Linkoping Univ, Dept Med & Hlth Sci, Linkoping, Sweden; [Soderlund, Anne] Malardalen Univ, Sch Hlth Care & Social Welf, Physiotherapy, Malardalen, Vasteras, Sweden; [Tham, Anne; Andersson, Gerhard] Karolinska Inst, Psychiat Sect, Dept Clin Neurosci, Stockholm, Sweden; [Andersson, Gerhard] Linkoping Univ, Dept Behav Sci & Learning, Linkoping, Sweden	Karolinska Institutet; Uppsala University; National Board of Health & Welfare; Umea University; Linkoping University; Malardalen University; Karolinska Institutet; Linkoping University	Jonsson, U (corresponding author), Karolinska Inst, Div Insurance Med, Dept Clin Neurosci, Stockholm, Sweden.; Jonsson, U (corresponding author), Uppsala Univ, Dept Neurosci, Child & Adolescent Psychiat, Uppsala, Sweden.; Jonsson, U (corresponding author), Natl Board Hlth & Welf, Stockholm, Sweden.	ulf.jonsson@ki.se	Andersson, Gerhard/J-8529-2012	Andersson, Gerhard/0000-0003-4753-6745; Soderlund, Anne/0000-0002-4537-030X	Swedish Agency for Health Technology Assessment and Assessment of Social Services, SBU; Swedish Agency for Health Technology Assessment and Assessment of Social Services	Swedish Agency for Health Technology Assessment and Assessment of Social Services, SBU; Swedish Agency for Health Technology Assessment and Assessment of Social Services	This study was funded by and conducted within the framework of the Swedish Agency for Health Technology Assessment and Assessment of Social Services, SBU (www.sbu.se/en/), a public agency conducting health technology assessments. The study design, data collection and analysis were completed within this framework. SBU had no role in the decision to publish, or the preparation of the manuscript.; Dr Per Allard passed away before the submission of the final version of this manuscript. Ulf Jonsson accepts responsibility for the integrity and validity of the data collected and analysed. This systematic review was funded by and carried out within the framework of a public agency, the Swedish Agency for Health Technology Assessment and Assessment of Social Services. We would like to thank Therese Kedebring for excellent technical support, Hanna Olofsson and Carl Gornitzki for diligent assistance with the literature search, and Pia Johansson for assistance with the quality appraisal of the health economic study.	ABRAHAM IL, 1992, NURS RES, V41, P196; Alexopoulos GS, 2003, AM J GERIAT PSYCHIAT, V11, P46, DOI 10.1176/appi.ajgp.11.1.46; Alexopoulos GS, 2002, BIOL PSYCHIAT, V52, P164, DOI 10.1016/S0006-3223(02)01381-1; Balshem H, 2011, J CLIN EPIDEMIOL, V64, P401, DOI 10.1016/j.jclinepi.2010.07.015; Beck A. S. R., 1996, BDI 2 MANUAL; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; BEUTLER LE, 1987, J CONSULT CLIN PSYCH, V55, P550, DOI 10.1037/0022-006X.55.4.550; Bhattarai N, 2013, PSYCHOL MED, V43, P1423, DOI 10.1017/S0033291712002498; Bock JO, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091973; Bower P, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f540; Brink TL., 1982, CLIN GERON, V1, P37, DOI [10.1300/J018v01n01_06, DOI 10.1300/J018V01N01_06]; Brooks R, 1996, HEALTH POLICY, V37, P53, DOI 10.1016/0168-8510(96)00822-6; Choi S, 2014, J MENT HEALTH, V23, P140, DOI 10.3109/09638237.2014.910643; Copeland John R M, 2004, World Psychiatry, V3, P45; Cuijpers P, 2010, PSYCHOL MED, V40, P211, DOI 10.1017/S0033291709006114; Cuijpers P, 2014, MATURITAS, V79, P160, DOI 10.1016/j.maturitas.2014.05.027; Cuijpers P, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002542; Cuijpers P, 2013, CAN J PSYCHIAT, V58, P376, DOI 10.1177/070674371305800702; Cuijpers P, 2011, NORD J PSYCHIAT, V65, P354, DOI 10.3109/08039488.2011.596570; Ekkers W, 2011, BEHAV RES THER, V49, P588, DOI 10.1016/j.brat.2011.05.010; Ferrari AJ, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001547; Gellis ZD, 2007, AM J GERIAT PSYCHIAT, V15, P968, DOI 10.1097/JGP.0b013e3180cc2bd7; Gellis ZD, 2014, J AM GERIATR SOC, V62, P889, DOI 10.1111/jgs.12776; Gellis ZD, 2010, AM J GERIAT PSYCHIAT, V18, P464, DOI 10.1097/JGP.0b013e3181b21442; Goncalves DC, 2009, AGING CLIN EXP RES, V21, P369; HAMILTON M, 1980, J CLIN PSYCHIAT, V41, P21; Holman AJ, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-33; Hsu YC, 2009, NURS RES, V58, P294, DOI 10.1097/NNR.0b013e3181a308ee; Huang TT, 2015, INT J NURS STUD, V52, P1542, DOI 10.1016/j.ijnurstu.2015.05.013; Hyer L, 2008, AM J ALZHEIMERS DIS, V23, P528, DOI 10.1177/1533317508323571; Joling KJ, 2011, AM J GERIAT PSYCHIAT, V19, P256, DOI 10.1097/JGP.0b013e3181ec8859; Jonsson U, 2014, CONTEMP CLIN TRIALS, V38, P1, DOI 10.1016/j.cct.2014.02.005; Kiosses DN, 2015, JAMA PSYCHIAT, V72, P22, DOI 10.1001/jamapsychiatry.2014.1305; Kiosses DN, 2010, AM J GERIAT PSYCHIAT, V18, P988, DOI 10.1097/JGP.0b013e3181d6947d; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Meeks S, 2008, GERONTOLOGIST, V48, P105, DOI 10.1093/geront/48.1.105; MONTGOMERY SA, 1979, BRIT J PSYCHIAT, V134, P382, DOI 10.1192/bjp.134.4.382; Moss K, 2012, AGING MENT HEALTH, V16, P625, DOI 10.1080/13607863.2011.651435; NEUGARTEN BL, 1961, J GERONTOL, V16, P134, DOI 10.1093/geronj/16.2.134; OECD, 2013, PENS GLANC 2013 OECD, DOI 10.1787/pension_glance-2013-en; Preschl B, 2012, AGING MENT HEALTH, V16, P964, DOI 10.1080/13607863.2012.702726; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Reinhardt JP, 2014, CLIN THER, V36, P1531, DOI 10.1016/j.clinthera.2014.10.005; Serfaty MA, 2009, ARCH GEN PSYCHIAT, V66, P1332, DOI 10.1001/archgenpsychiatry.2009.165; Serrano JP, 2004, PSYCHOL AGING, V19, P272, DOI 10.1037/0882-7974.19.2.272; Selva JPS, 2012, PSICOTHEMA, V24, P224; Simon SS, 2015, INT J GERIATR PSYCH, V30, P223, DOI 10.1002/gps.4239; SPITZER WO, 1981, J CHRON DIS, V34, P585, DOI 10.1016/0021-9681(81)90058-8; Strandberg TE, 2007, LANCET, V369, P1328, DOI 10.1016/S0140-6736(12)62167-9; Swedish Agency for Health Technology Assessment and Assessment of Social Services, 2016, ASS METH HLTH CAR HD; Tham A, 2016, J AFFECT DISORDERS, V205, P1, DOI 10.1016/j.jad.2016.06.013; Tsai YF, 2008, J ADV NURS, V64, P488, DOI 10.1111/j.1365-2648.2008.04804.x; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Wilson KCM, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004853.pub2	54	41	45	2	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0160859	10.1371/journal.pone.0160859	http://dx.doi.org/10.1371/journal.pone.0160859			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DT6ES	27537217	Green Published, Green Submitted, gold			2022-12-27	WOS:000381577000035
J	Marini, F; Squeri, V; Morasso, P; Konczak, J; Masia, L				Marini, Francesca; Squeri, Valentina; Morasso, Pietro; Konczak, Juergen; Masia, Lorenzo			Robot-Aided Mapping of Wrist Proprioceptive Acuity across a 3D Workspace	PLOS ONE			English	Article							JOINT POSITION SENSE; SENSORIMOTOR SYSTEM; UPPER EXTREMITY; MUSCLE; SHOULDER; RELIABILITY; MOVEMENT; RECOVERY; STROKE; MECHANORECEPTORS	Proprioceptive signals from peripheral mechanoreceptors form the basis for bodily perception and are known to be essential for motor control. However we still have an incomplete understanding of how proprioception differs between joints, whether it differs among the various degrees-of-freedom (DoFs) within a particular joint, and how such differences affect motor control and learning. We here introduce a robot-aided method to objectively measure proprioceptive function: specifically, we systematically mapped wrist proprioceptive acuity across the three DoFs of the wrist/hand complex with the aim to characterize the wrist position sense. Thirty healthy young adults performed an ipsilateral active joint position matching task with their dominant wrist using a haptic robotic exoskeleton. Our results indicate that the active wrist position sense acuity is anisotropic across the joint, with the abduction/adduction DoF having the highest acuity (the error of acuity for flexion/extension is 4.64 +/- 0.24 degrees; abduction/adduction: 3.68 +/- 0.32 degrees; supination/pronation: 5.15 +/- 0.37 degrees) and they also revealed that proprioceptive acuity decreases for smaller joint displacements. We believe this knowledge is imperative in a clinical scenario when assessing proprioceptive deficits and for understanding how such sensory deficits relate to observable motor impairments.	[Marini, Francesca; Squeri, Valentina; Morasso, Pietro] Ist Italiano Tecnol, Dept Robot Brain & Cognit Sci, Motor Learning & Robot Rehabil Lab, Genoa, Italy; [Konczak, Juergen] Univ Minnesota, Human Sensorimotor Control Lab, Sch Kinesiol, Minneapolis, MN USA; [Konczak, Juergen] Univ Minnesota, Ctr Clin Movement Sci, Minneapolis, MN USA; [Masia, Lorenzo] Nanyang Technol Univ, Sch Mech & Aerosp Engn, Singapore, Singapore	Istituto Italiano di Tecnologia - IIT; University of Genoa; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Masia, L (corresponding author), Nanyang Technol Univ, Sch Mech & Aerosp Engn, Singapore, Singapore.	lorenzo.masia@ntu.edu.sg	Konczak, Jürgen/J-4001-2019	Konczak, Jürgen/0000-0002-4422-5610	RBCS Dept. of the Istituto Italiano di Tecnologia	RBCS Dept. of the Istituto Italiano di Tecnologia	This research was supported by the RBCS Dept. of the Istituto Italiano di Tecnologia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEGRUCCI M, 1995, J ORTHOP SPORT PHYS, V21, P220, DOI 10.2519/jospt.1995.21.4.220; Brindle TJ, 2004, J ORTHOP SPORT PHYS, V34, P468, DOI 10.2519/jospt.2004.34.8.468; BURKE D, 1988, J PHYSIOL-LONDON, V402, P347, DOI 10.1113/jphysiol.1988.sp017208; Cappello L, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00198; Coupar F, 2012, CLIN REHABIL, V26, P291, DOI 10.1177/0269215511420305; De Santis D, 2015, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.01037; Debert CT, 2012, J NEUROL PHYS THER, V36, P58, DOI 10.1097/NPT.0b013e318254bd4f; Domingo A, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-167; Dukelow SP, 2012, J NEUROENG REHABIL, V9, DOI 10.1186/1743-0003-9-72; Dukelow SP, 2010, NEUROREHAB NEURAL RE, V24, P178, DOI 10.1177/1545968309345267; Elangovan N, 2014, PHYS THER, V94, P553, DOI 10.2522/ptj.20130103; Erickson RIC, 2012, J ORTHOP RES, V30, P787, DOI 10.1002/jor.22007; Fuentes CT, 2010, J NEUROPHYSIOL, V103, P164, DOI 10.1152/jn.00494.2009; Gay A, 2010, J NEUROENG REHABIL, V7, DOI 10.1186/1743-0003-7-5; Goble DJ, 2012, EXP BRAIN RES, V216, P35, DOI 10.1007/s00221-011-2904-8; Goble DJ, 2010, PHYS THER, V90, P1176, DOI 10.2522/ptj.20090399; Goble DJ, 2009, BEHAV BRAIN RES, V200, P7, DOI 10.1016/j.bbr.2008.11.034; Hagert E, 2005, J ORTHOP RES, V23, P757, DOI 10.1016/j.orthres.2005.01.011; Hagert E., 2008, WRIST LIGAMENTS INNE; Herter TM, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-43; Hospod V, 2007, J NEUROSCI, V27, P5172, DOI 10.1523/JNEUROSCI.0572-07.2007; Janwantanakul P, 2001, ARCH PHYS MED REHAB, V82, P840, DOI 10.1053/apmr.2001.21865; JOHANSSON H, 1991, J ELECTROMYOGR KINES, V1, P158, DOI 10.1016/1050-6411(91)90032-Z; King J, 2013, J MOTOR BEHAV, V45, P479, DOI 10.1080/00222895.2013.832136; Knoop J, 2011, OSTEOARTHR CARTILAGE, V19, P381, DOI 10.1016/j.joca.2011.01.003; Konczak J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002625; Langhorne P, 2009, LANCET NEUROL, V8, P741, DOI 10.1016/S1474-4422(09)70150-4; Lephart S M, 1994, J Shoulder Elbow Surg, V3, P371, DOI 10.1016/S1058-2746(09)80022-0; Lincoln NB, 1998, PHYSIOTHERAPY, V84, P358, DOI [10.1016/S0031-9406(05)61454-X, DOI 10.1016/S0031-9406(05)61454-X]; Lonn J, 2000, CLIN PHYSIOL, V20, P30; Masia L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007004; MATTHEWS PBC, 1988, CAN J PHYSIOL PHARM, V66, P430, DOI 10.1139/y88-073; MCCLOSKEY DI, 1978, PHYSIOL REV, V58, P763, DOI 10.1152/physrev.1978.58.4.763; NEUFELD SD, 1981, PHYS THER, V61, P1147, DOI 10.1093/ptj/61.8.1147; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Petrie S, 1997, J BONE JOINT SURG BR, V79B, P494, DOI 10.1302/0301-620X.79B3.7439; Proske U, 2012, PHYSIOL REV, V92, P1651, DOI 10.1152/physrev.00048.2011; PRUDHOMME MJL, 1994, J NEUROPHYSIOL, V72, P2280, DOI 10.1152/jn.1994.72.5.2280; Rand D, 1999, NEUROREHAB NEURAL RE, V13, P15, DOI 10.1177/154596839901300104; Riemann BL, 2002, J ATHL TRAINING, V37, P85; Riemann BL, 2002, J ATHL TRAINING, V37, P71; SANES JN, 1985, HUM NEUROBIOL, V4, P101; Schabrun SM, 2009, CLIN REHABIL, V23, P27, DOI 10.1177/0269215508098897; Schmidt RA, 1988, MOTOR CONTROL AND LE; Sjolander Per, 2002, J Electromyogr Kinesiol, V12, P167, DOI 10.1016/S1050-6411(02)00017-2; Squeri Valentina, 2011, IEEE Int Conf Rehabil Robot, V2011, P5975500, DOI 10.1109/ICORR.2011.5975500; Swinkels A, 2000, SPINE, V25, P98, DOI 10.1097/00007632-200001010-00017; WEI JY, 1986, BRAIN RES, V370, P108; Wilson ET, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011851; Windhorst U, 2007, BRAIN RES BULL, V73, P155, DOI 10.1016/j.brainresbull.2007.03.010; Winward CE, 2002, CLIN REHABIL, V16, P523, DOI 10.1191/0269215502cr522oa	51	24	24	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0161155	10.1371/journal.pone.0161155	http://dx.doi.org/10.1371/journal.pone.0161155			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27536882	Green Submitted, Green Published, gold			2022-12-27	WOS:000381577000061
J	Shu, XM; Peng, QL; Lu, X; Wang, GC				Shu, Xiaoming; Peng, Qinglin; Lu, Xin; Wang, Guochun			HMGB1 May Be a Biomarker for Predicting the Outcome in Patients with Polymyositis/Dermatomyositis with Interstitial Lung Disease	PLOS ONE			English	Article							IDIOPATHIC INFLAMMATORY MYOPATHIES; GROUP BOX PROTEIN-1; MYOCARDIAL-INFARCTION; MUSCLE REGENERATION; DERMATOMYOSITIS; POLYMYOSITIS; MYOSITIS; ANTIBODY; EXPRESSION; RECEPTOR	Objective To investigate the significance of high mobility group box 1 (HMGB1) levels in polymyositis (PM) and dermatomyositis (DM) patients with interstitial lung disease and whether HMGB1 levels could predict disease outcome. Methods HMGB1 levels were measured in sera from 34 patients with PM/DM and from 34 healthy controls by ELISA. Results Significantly higher serum levels of HMGB1 were found in patients with PM [12.75 ng/ml (4.34-25.07 ng/ml), p < 0.001] and DM [20.75 ng/ml (3.80-124.88 ng/ml), p < 0.001] than in healthy controls [5.64 ng/ml (2.71-8.71 ng/ml)]. Importantly, the average HMGB1 level in PM/DM patients with interstitial lung disease (ILD) was 25.84 ng/ml, which is significantly higher than that in PM/DM patients without ILD [12.68 ng/ml] (p < 0.05). A receiver operating characteristic (ROC) curve analysis revealed that the serum HMGB1 cutoff value that best discriminated PM/DM patients with ILD from those without ILD was 14.5ng/ml. The area under the curve was 0.87 +/- 0.05, and the 95% Confidence interval (CI) was 0.77-0.98. The diagnostic sensitivity and specificity of this serum HMGB1 cutoff level was 84.6% and 89% respectively. Patients with higher levels of HMGB1 expression had lower overall survival rates and disease-free survival rates, whereas patients with lower levels of HMGB1 expression had higher survival rates. Conclusion Multivariate analysis showed that HMGB1 expression is a prognostic indicator for patient survival. These data support the notion that HMGB1 overexpression is involved in PM/DM progression for patients with ILD and is relative to its poor clinical outcomes.	[Shu, Xiaoming; Peng, Qinglin; Lu, Xin; Wang, Guochun] China Japan Friendship Hosp, Dept Rheumatol, YingHua East Rd, Beijing 100029, Peoples R China	China-Japan Friendship Hospital	Wang, GC (corresponding author), China Japan Friendship Hosp, Dept Rheumatol, YingHua East Rd, Beijing 100029, Peoples R China.	guochunwang@hotmail.com	Ming, Shu Xiao/AAF-3356-2019	Shu, Xiao ming/0000-0001-5425-6157	General Program of the National Natural Science Foundation of China [81571603]; Major Research Plan of the National Natural Science of China [91542121]; Youth Program of the National Natural Science Foundation of China [81401363]; Capital Health Research and Development of Special Programs [2014-4-4062]; International Cooperation Project from State Ministry of Science and Technology of China [2014DFA31490]	General Program of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major Research Plan of the National Natural Science of China(National Natural Science Foundation of China (NSFC)); Youth Program of the National Natural Science Foundation of China; Capital Health Research and Development of Special Programs; International Cooperation Project from State Ministry of Science and Technology of China	This study was funded by the General Program of the National Natural Science Foundation of China (Grant No. 81571603), the Major Research Plan of the National Natural Science of China (Grant No. 91542121), the Youth Program of the National Natural Science Foundation of China (Grant No. 81401363), the Capital Health Research and Development of Special Programs (Grant No. 2014-4-4062), and the International Cooperation Project from State Ministry of Science and Technology of China (Grant No. 2014DFA31490).	Abdulahad DA, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3332; Abeyama K, 2005, J CLIN INVEST, V115, P1267, DOI 10.1172/JCI200522782; Andersson U, 2011, ANNU REV IMMUNOL, V29, P139, DOI 10.1146/annurev-immunol-030409-101323; ARAHATA K, 1986, ANN NEUROL, V19, P112, DOI 10.1002/ana.410190203; Barnay-Verdier S, 2011, INTENS CARE MED, V37, P957, DOI 10.1007/s00134-011-2192-6; BOHAN A, 1975, NEW ENGL J MED, V292, P403, DOI 10.1056/NEJM197502202920807; Chauhan AK, 2015, J BIOL CHEM; Cseri K, 2015, J MUSCLE RES CELL M, V36, P255, DOI 10.1007/s10974-015-9411-7; Dalakas MC, 2003, LANCET, V362, P971, DOI 10.1016/S0140-6736(03)14368-1; DALAKAS MC, 1991, NEW ENGL J MED, V325, P1487, DOI 10.1056/NEJM199111213252107; De Mori R, 2007, ARTERIOSCL THROM VAS, V27, P2377, DOI 10.1161/ATVBAHA.107.153429; EMSLIESMITH AM, 1990, ANN NEUROL, V27, P343, DOI 10.1002/ana.410270402; Gono T, 2010, RHEUMATOLOGY, V49, P1713, DOI 10.1093/rheumatology/keq149; Grundtman C, 2010, FASEB J, V24, P570, DOI 10.1096/fj.09-144782; Harris HE, 2012, NAT REV RHEUMATOL, V8, P195, DOI 10.1038/nrrheum.2011.222; Hoshino K, 2010, RHEUMATOLOGY, V49, P1726, DOI 10.1093/rheumatology/keq153; Huh JW, 2007, RESP MED, V101, P1761, DOI 10.1016/j.rmed.2007.02.017; Ichikado K, 1997, AM J ROENTGENOL, V168, P333, DOI 10.2214/ajr.168.2.9016201; Kang R, 2011, AUTOPHAGY, V7, P904, DOI 10.4161/auto.7.8.15704; KISSEL JT, 1991, ARCH NEUROL-CHICAGO, V48, P26, DOI 10.1001/archneur.1991.00530130034016; Li CKC, 2004, J RHEUMATOL, V31, P605; Lotze MT, 2005, NAT REV IMMUNOL, V5, P331, DOI 10.1038/nri1594; Marie I, 2002, ARTHRIT RHEUM-ARTHR, V47, P614, DOI 10.1002/art.10794; Marie I, 2011, ARTHRITIS RHEUM-US, V63, P3439, DOI 10.1002/art.30513; Muller S, 2001, EMBO J, V20, P4337, DOI 10.1093/emboj/20.16.4337; Nakamura Y, 2015, J ATHEROSCLER THROMB, V22, P570, DOI 10.5551/jat.27235; Nakashima R, 2010, RHEUMATOLOGY, V49, P433, DOI 10.1093/rheumatology/kep375; Pisetsky DS, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2440; Sundaram C, 2008, NEUROL INDIA, V56, P363, DOI 10.4103/0028-3886.43457; Takahashi M, 2015, J ATHEROSCLER THROMB, V22, P553, DOI 10.5551/jat.ED008; Tanizawa K, 2013, RESP MED, V107, P745, DOI 10.1016/j.rmed.2013.01.014; Vincze M, 2012, BEST PRACT RES CL RH, V26, P25, DOI 10.1016/j.berh.2012.01.013; Vitadello M, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2963; Wang HC, 1999, SCIENCE, V285, P248, DOI 10.1126/science.285.5425.248; Zong M, 2013, ANN RHEUM DIS, V72, P1390, DOI 10.1136/annrheumdis-2012-202207	35	12	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0161436	10.1371/journal.pone.0161436	http://dx.doi.org/10.1371/journal.pone.0161436			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27537498	Green Published, Green Submitted, gold			2022-12-27	WOS:000381577000107
J	Wang, XF; Wang, Y; Feng, LF; Tong, Y; Chen, ZJ; Ying, SB; Chen, TH; Li, T; Xia, HL; Jiang, ZQ; Shang, Q; Lou, XM; Lou, JL				Wang, Xiaofeng; Wang, Yu; Feng, Lingfang; Tong, Yan; Chen, Zhijian; Ying, Shibo; Chen, Tianhui; Li, Tao; Xia, Hailing; Jiang, Zhaoqiang; Shang, Qi; Lou, Xiaoming; Lou, Jianlin			Application of the Benchmark Dose (BMD) Method to Identify Thresholds of Cadmium-Induced Renal Effects in Non-Polluted Areas in China	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; URINARY CADMIUM; HYBRID APPROACH; REFERENCE LEVEL; EXPOSURE; DYSFUNCTION; BETA(2)-MICROGLOBULIN; POPULATION; EXCRETION; REGIONS	The benchmark dose (BMD) method has been increasingly used to assess the health risks of cadmium (Cd) in epidemiological studies. The aim of our study was to estimate the threshold levels of urinary Cd (UCd) using the BMD method in a general population of Jiangshan City, Zhejiang Province of China. In our study, a total of 934 people (469 men, 465 women) were recruited and morning urine samples were collected from all the participants. Levels of Cd, creatinine, and renal dysfunction indicators such as retinol binding protein (RBP), beta 2-microglobulin (beta 2-MG), and N-acetyl-b-glucosaminidase (NAG) in urine were detected for analysis of BMD and BMD low (BMDL) of UCd. RBP, beta 2-MG, and NAG in urine all correlated significantly (P < 0.001) with UCd except of age (P = 0.767). When the benchmark response (BMR) was 5%, the BMD/BMDL of UCd for RBP, beta 2-MG, and NAG was 1.69/0.89, 1.24/0.62, 0.85/0.49 mu g/g Cr in men and 1.70/0.76, 1.35/0.64, 1.36/0.65 mu g/g Cr in women, respectively. If the BMR was set at 10%, the BMD/BMDL of UCd for RBP, beta 2-MG, and NAG was 2.44/1.59, 2.09/1.30, 1.80/1.04 mu g/g Cr in men and 2.43/1.53, 2.10/1.34, 2.31/1.37 mu g/g Cr in women, respectively. Our results provided evidence for Cd-induced tubular effects in cadmium non-polluted areas in China. Both beta 2-MG and NAG were more sensitive than RBP in response to Cd exposure. But beta 2-MG was the most sensitive indicator in women, and NAG was the most sensitive one in men.	[Wang, Xiaofeng; Lou, Xiaoming] Zhejiang Prov Ctr Dis Control & Prevent, Dept Environm & Occupat Hlth, Hangzhou 310051, Zhejiang, Peoples R China; [Wang, Yu; Feng, Lingfang; Tong, Yan; Chen, Zhijian; Ying, Shibo; Chen, Tianhui; Li, Tao; Xia, Hailing; Jiang, Zhaoqiang; Lou, Jianlin] Zhejiang Acad Med Sci, Inst Occupat Dis, Hangzhou 310013, Zhejiang, Peoples R China; [Shang, Qi] Chinese Ctr Dis Control & Prevent, Inst Environm Hlth & Related Prod Safety, Beijing 100050, Peoples R China	Zhejiang Provincial Center for Disease Control & Prevention; Zhejiang Academy of Medical Sciences; Chinese Center for Disease Control & Prevention; National Institute of Environmental Health, Chinese Center for Disease Control & Prevention	Lou, XM (corresponding author), Zhejiang Prov Ctr Dis Control & Prevent, Dept Environm & Occupat Hlth, Hangzhou 310051, Zhejiang, Peoples R China.; Lou, JL (corresponding author), Zhejiang Acad Med Sci, Inst Occupat Dis, Hangzhou 310013, Zhejiang, Peoples R China.	xmlou@cdc.zj.cn; jianlinlou@163.com	Chen, Tianhui/Y-3500-2018; Ying, Shibo/K-2514-2016	Chen, Tianhui/0000-0003-4677-0361; Ying, Shibo/0000-0001-5275-9383	National Natural Science Foundation of China [81472960, 81001242]; Medical Scientific Research of Zhejiang Province [2009A044]; Zhejiang Provincial Natural Science [LQ14H260003]; Zhejiang Provincial Program for the Cultivation of High-level Innovative Health talents; Zhejiang Committee of Science and Technology [2015F10013]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Medical Scientific Research of Zhejiang Province; Zhejiang Provincial Natural Science; Zhejiang Provincial Program for the Cultivation of High-level Innovative Health talents; Zhejiang Committee of Science and Technology	The authors acknowledge funding by the National Natural Science Foundation of China (81472960, 81001242), the Medical Scientific Research of Zhejiang Province (2009A044), the Zhejiang Provincial Natural Science (LQ14H260003), the Zhejiang Provincial Program for the Cultivation of High-level Innovative Health talents (2014), and the Zhejiang Committee of Science and Technology (2015F10013).	Akesson AA, 2005, ENVIRON HEALTH PERSP, V113, P1627, DOI 10.1289/ehp.8033; BERNARD A, 1995, OCCUP ENVIRON MED, V52, P177, DOI 10.1136/oem.52.3.177; BERNARD AM, 1987, CLIN CHEM, V33, P775; Boonprasert K, 2011, ENVIRON TOXICOL PHAR, V31, P416, DOI 10.1016/j.etap.2011.02.003; Chen L, 2006, TOXICOL APPL PHARM, V215, P93, DOI 10.1016/j.taap.2006.01.013; Chen X, 2013, FOOD CHEM TOXICOL, V55, P592, DOI 10.1016/j.fct.2013.01.044; CRUMP KS, 1984, FUND APPL TOXICOL, V4, P854, DOI 10.1016/0272-0590(84)90107-6; EFSA, 2009, SCI OP PAN CONT FOOD, V980; El Nahas AM, 2005, LANCET, V365, P331, DOI 10.1016/S0140-6736(05)17789-7; Environmental Protection Administration of China (EPAC), 1995, GB156181995 EPAC; *EPA, 1995, US BENCHM DOS APPR H; Ferguson MA, 2008, TOXICOLOGY, V245, P182, DOI 10.1016/j.tox.2007.12.024; Filipsson AF, 2003, CRIT REV TOXICOL, V33, P505, DOI 10.1080/10408440390242360; Hong F, 2004, BIOMETALS, V17, P573, DOI 10.1023/B:BIOM.0000045741.22924.d8; Ikeda M, 1992, IARC Sci Publ, P65; Jarup L, 2000, OCCUP ENVIRON MED, V57, P668, DOI 10.1136/oem.57.10.668; Jarup Lars, 1998, Scandinavian Journal of Work Environment and Health, V24, P1; Jha V, 2013, LANCET, V382, P260, DOI 10.1016/S0140-6736(13)60687-X; Jin TY, 2004, BIOMETALS, V17, P525, DOI 10.1023/B:BIOM.0000045732.91261.e2; Kim NH, 2015, J KOREAN MED SCI, V30, P272, DOI 10.3346/jkms.2015.30.3.272; Kobayashi E, 2008, TOXICOL LETT, V179, P108, DOI 10.1016/j.toxlet.2008.04.013; Kobayashi E, 2006, J APPL TOXICOL, V26, P351, DOI 10.1002/jat.1147; Liang YH, 2012, ENVIRON HEALTH PERSP, V120, P223, DOI 10.1289/ehp.1103699; Ministry of Health of the People's Republic of China (MOHC), 2012, GB27622012 MOHC; Miyata T, 1998, J AM SOC NEPHROL, V9, P1723; Moriguchi J, 2004, TOXICOL LETT, V148, P11, DOI 10.1016/j.toxlet.2003.11.009; Moriguchi J, 2003, TOXICOL LETT, V143, P279, DOI 10.1016/S0378-4274(03)00181-4; Moriguchi Jiro, 2005, Toxicological and Environmental Chemistry, V87, P119, DOI 10.1080/02772240400010389; Moriguchi J, 2009, TOXICOL LETT, V190, P1, DOI 10.1016/j.toxlet.2009.05.009; Oo YK, 2000, ARCH ENVIRON HEALTH, V55, P98, DOI 10.1080/00039890009603394; Rong Li-Ping, 2014, Zhongguo Dang Dai Er Ke Za Zhi, V16, P325; Sakuragi S, 2012, INT ARCH OCC ENV HEA, V85, P941, DOI 10.1007/s00420-012-0734-z; Sand S, 2008, J APPL TOXICOL, V28, P405, DOI 10.1002/jat.1298; Shao B, 2007, BIOMED ENVIRON SCI, V20, P460; Shimizu A, 2006, INT J ENVIRON HEAL R, V16, P329, DOI 10.1080/09603120600869174; Soderland P, 2010, ADV CHRONIC KIDNEY D, V17, P254, DOI 10.1053/j.ackd.2010.03.011; Suwazono Y, 2006, ENVIRON HEALTH PERSP, V114, P1072, DOI 10.1289/ehp.9028; Suwazono Y, 2011, INT J HYG ENVIR HEAL, V214, P175, DOI 10.1016/j.ijheh.2010.09.002; Suwazono Y, 2011, ENVIRON RES, V111, P312, DOI 10.1016/j.envres.2010.11.013; Suwazono Y, 2010, TOXICOL LETT, V198, P40, DOI 10.1016/j.toxlet.2010.04.015; TREVISAN A, 1994, INT ARCH OCC ENV HEA, V65, P373, DOI 10.1007/BF00383246; Van Vleet TR, 2003, SEMIN NEPHROL, V23, P500, DOI 10.1016/S0270-9295(03)00094-9; Wang Q, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087817; Woo HD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126680; Zheng Laura, 2014, Curr Environ Health Rep, V1, P192	45	9	11	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0161240	10.1371/journal.pone.0161240	http://dx.doi.org/10.1371/journal.pone.0161240			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27537182	Green Published, Green Submitted, gold			2022-12-27	WOS:000381577000074
J	Niegowska, M; Rapini, N; Biet, F; Piccinini, S; Bay, S; Lidano, R; Bitti, MLM; Sechi, LA				Niegowska, Magdalena; Rapini, Novella; Biet, Frank; Piccinini, Simona; Bay, Sylvie; Lidano, Roberta; Bitti, Maria Luisa Manca; Sechi, Leonardo A.			Seroreactivity against Specific L5P Antigen from Mycobacterium avium subsp. paratuberculosis in Children at Risk for T1D (vol 11, e0157962, 2016)	PLOS ONE			English	Correction									[Niegowska, Magdalena; Sechi, Leonardo A.] Univ Sassari, Dept Biomed Sci, I-07100 Sassari, Italy; [Rapini, Novella; Piccinini, Simona; Lidano, Roberta; Bitti, Maria Luisa Manca] Univ Roma Tor Vergata, Policlin Tor Vergata, Pediat Diabetol Unit, I-00133 Rome, Italy; [Biet, Frank] INRA Ctr Val Loire, ISP 311, UMR1282, F-37380 Nouzilly, France; [Bay, Sylvie] Inst Pasteur, Unite Chim Biomol, Dept Biol Struct & Chim, Paris, France	University of Sassari; University of Rome Tor Vergata; Policlin Tor Vergata; INRAE; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Sechi, LA (corresponding author), Univ Sassari, Dept Biomed Sci, I-07100 Sassari, Italy.		Biet, Franck/ABA-4151-2021; Sechi, Leonardo Antonio/Y-3109-2018	Biet, Franck/0000-0001-8425-6158; 				Niegowska M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157962	1	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2016	11	8							e0161516	10.1371/journal.pone.0161516	http://dx.doi.org/10.1371/journal.pone.0161516			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4UN	27529779	gold, Green Submitted, Green Published			2022-12-27	WOS:000381476700072
J	Liu, K; Lv, JL; Dai, YC; Zhang, H; Cao, YF				Liu, Ke; Lv, Jialong; Dai, Yunchao; Zhang, Hong; Cao, Yingfei			Cross-Species Extrapolation of Models for Predicting Lead Transfer from Soil to Wheat Grain	PLOS ONE			English	Article							TRITICUM-AESTIVUM; HEAVY-METAL; SENSITIVITY DISTRIBUTION; BIOAVAILABILITY MODEL; ACUTE TOXICITY; CADMIUM; NICKEL; ACCUMULATION; PLANT; ZINC	The transfer of Pb from the soil to crops is a serious food hygiene security problem in China because of industrial, agricultural, and historical contamination. In this study, the characteristics of exogenous Pb transfer from 17 Chinese soils to a popular wheat variety (Xiaoyan 22) were investigated. In addition, bioaccumulation prediction models of Pb in grain were obtained based on soil properties. The results of the analysis showed that pH and OC were the most important factors contributing to Pb uptake by wheat grain. Using a cross-species extrapolation approach, the Pb uptake prediction models for cultivar Xiaoyan 22 in different soil Pb levels were satisfactorily applied to six additional non-modeled wheat varieties to develop a prediction model for each variety. Normalization of the bioaccumulation factor (BAF) to specific soil physico-chemistry is essential, because doing so could significantly reduce the intra-species variation of different wheat cultivars in predicted Pb transfer and eliminate the influence of soil properties on ecotoxicity parameters for organisms of interest. Finally, the prediction models were successfully verified against published data (including other wheat varieties and crops) and used to evaluate the ecological risk of Pb for wheat in contaminated agricultural soils.	[Liu, Ke; Lv, Jialong; Dai, Yunchao; Zhang, Hong; Cao, Yingfei] Northwest A&F Univ, Coll Nat Resources & Environm, Minist Agr, Key Lab Plant Nutr & Agrienvironm Northwest China, Yangling, Peoples R China	Ministry of Agriculture & Rural Affairs; Northwest A&F University - China	Lv, JL (corresponding author), Northwest A&F Univ, Coll Nat Resources & Environm, Minist Agr, Key Lab Plant Nutr & Agrienvironm Northwest China, Yangling, Peoples R China.	ljlll@nwsuaf.edu.cn			Ministry of Agriculture of the People's Republic of China [200903015]	Ministry of Agriculture of the People's Republic of China(Ministry of Agriculture & Rural Affairs)	This research was supported by the Ministry of Agriculture of the People's Republic of China (No. 200903015); http://www.moa.gov.cn/, Chinese special fund.; We would like to express our gratitude to Professor Wenxiang HE and Dongli LIANG for assistance with this paper. We declare that there is no conflict of interest. This research was supported by the Ministry of Agriculture of the People's Republic of China (No. 200903015).	Ahmed AB, 2010, AFR J AGR RES, V5, P2795; Antoniadis V, 2008, CHEMOSPHERE, V71, P759, DOI 10.1016/j.chemosphere.2007.10.015; Baize D, 2009, AGRON SUSTAIN DEV, V29, P297, DOI 10.1051/agro:2008057; Bermudez GMA, 2011, J HAZARD MATER, V193, P264, DOI 10.1016/j.jhazmat.2011.07.058; Boussen S, 2013, GEODERMA, V192, P227, DOI 10.1016/j.geoderma.2012.08.029; Castaldi P, 2009, GEODERMA, V151, P241, DOI 10.1016/j.geoderma.2009.04.009; CHAMBERLAIN AC, 1983, ATMOS ENVIRON, V17, P693, DOI 10.1016/0004-6981(83)90416-X; Chlopecka A, 1996, WATER AIR SOIL POLL, V87, P297, DOI 10.1007/BF00696843; Deleebeeck NME, 2008, ECOTOX ENVIRON SAFE, V70, P67, DOI 10.1016/j.ecoenv.2007.05.002; Deleebeeck NME, 2007, ECOTOX ENVIRON SAFE, V67, P1, DOI 10.1016/j.ecoenv.2006.10.001; Deleebeeck NME, 2009, WATER RES, V43, P1935, DOI 10.1016/j.watres.2009.01.019; Ding CF, 2016, J HAZARD MATER, V303, P21, DOI 10.1016/j.jhazmat.2015.10.027; Feng JF, 2012, ENVIRON GEOCHEM HLTH, V34, P605, DOI 10.1007/s10653-012-9454-2; Huang ML, 2008, SCI TOTAL ENVIRON, V405, P54, DOI 10.1016/j.scitotenv.2008.07.004; Jamali MK, 2009, J HAZARD MATER, V164, P1386, DOI 10.1016/j.jhazmat.2008.09.056; James K, 2009, ENVIRON TOXICOL CHEM, V23, P691; Krauss M, 2002, J PLANT NUTR SOIL SC, V165, P3, DOI 10.1002/1522-2624(200202)165:1<3::AID-JPLN3>3.0.CO;2-B; Li YK, 1983, ANAL METHODS AGR CHE; Li ZL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103633; Liang ZF, 2013, ECOTOX ENVIRON SAFE, V93, P180, DOI 10.1016/j.ecoenv.2013.04.003; Liu K, 2015, ECOTOX ENVIRON SAFE, V113, P207, DOI 10.1016/j.ecoenv.2014.12.005; Liu W., 2014, ENVIRON SCI POLLUT R, V22, P8432; Liu WX, 2009, B ENVIRON CONTAM TOX, V82, P343, DOI 10.1007/s00128-008-9575-6; Liu WT, 2010, J ENVIRON MANAGE, V91, P781, DOI 10.1016/j.jenvman.2009.10.009; Martinez E, 2008, SOIL TILL RES, V99, P232, DOI 10.1016/j.still.2008.02.001; Nan ZR, 2002, WATER AIR SOIL POLL, V133, P205, DOI 10.1023/A:1012962604095; Raimondo S, 2008, ENVIRON TOXICOL CHEM, V27, P2599, DOI 10.1897/08-157.1; Rodrigues SM, 2012, PLANT SOIL, V361, P329, DOI 10.1007/s11104-012-1249-9; Rooney CP, 2007, ENVIRON POLLUT, V145, P596, DOI 10.1016/j.envpol.2006.04.008; Schlekat CE, 2010, SCI TOTAL ENVIRON, V408, P6148, DOI 10.1016/j.scitotenv.2010.09.012; Tlustos P, 2006, PLANT SOIL ENVIRON, V52, P16, DOI 10.17221/3341-PSE; Van Sprang PA, 2009, SCI TOTAL ENVIRON, V407, P5373, DOI 10.1016/j.scitotenv.2009.06.029; Wang XQ, 2012, ECOLOGICAL THRESHOLD; Wang ZW, 2011, J SCI FOOD AGR, V91, P377, DOI 10.1002/jsfa.4196; Yang H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080855; Zhang Hong-zhen, 2010, Huanjing Kexue, V31, P488; Zhang ZW, 1998, SCI TOTAL ENVIRON, V220, P137, DOI 10.1016/S0048-9697(98)00252-6; Zhao FJ, 2004, ENVIRON POLLUT, V131, P461, DOI 10.1016/j.envpol.2004.02.011	38	13	15	2	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2016	11	8							e0160552	10.1371/journal.pone.0160552	http://dx.doi.org/10.1371/journal.pone.0160552			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3LI	27518712	Green Published, Green Submitted, gold			2022-12-27	WOS:000381382100017
J	Tanaka, Y; Sasaki, M; Ito, F; Aoyama, T; Sato-Okamoto, M; Takahashi-Nakaguchi, A; Chibana, H; Shibata, N				Tanaka, Yutaka; Sasaki, Masato; Ito, Fumie; Aoyama, Toshio; Sato-Okamoto, Michiyo; Takahashi-Nakaguchi, Azusa; Chibana, Hiroji; Shibata, Nobuyuki			KRE5 Suppression Induces Cell Wall Stress and Alternative ER Stress Response Required for Maintaining Cell Wall Integrity in Candida glabrata	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; PROTEIN-KINASE; GLYCOPROTEIN-GLUCOSYLTRANSFERASE; BETA-1,6-GLUCAN SYNTHESIS; FUNGAL-INFECTIONS; CALCOFLUOR WHITE; IN-VITRO; ALBICANS; CHITIN; CASPOFUNGIN	The maintenance of cell wall integrity in fungi is required for normal cell growth, division, hyphae formation, and antifungal tolerance. We observed that endoplasmic reticulum stress regulated cell wall integrity in Candida glabrata, which possesses uniquely evolved mechanisms for unfolded protein response mechanisms. Tetracycline-mediated suppression of KRE5, which encodes a predicted UDP-glucose: glycoprotein glucosyltransferase localized in the endoplasmic reticulum, significantly increased cell wall chitin content and decreased cell wall beta-1,6-glucan content. KRE5 repression induced endoplasmic reticulum stressrelated gene expression and MAP kinase pathway activation, including Slt2p and Hog1p phosphorylation, through the cell wall integrity signaling pathway. Moreover, the calcineurin pathway negatively regulated cell wall integrity, but not the reduction of beta-1,6-glucan content. These results indicate that KRE5 is required for maintaining both endoplasmic reticulum homeostasis and cell wall integrity, and that the calcineurin pathway acts as a regulator of chitin-glucan balance in the cell wall and as an alternative mediator of endoplasmic reticulum stress in C. glabrata.	[Tanaka, Yutaka; Sasaki, Masato; Ito, Fumie; Shibata, Nobuyuki] Tohoku Med & Pharmaceut Univ, Dept Infect & Host Def, Sendai, Miyagi, Japan; [Aoyama, Toshio] Suzuka Natl Coll Technol, Dept Elect & Informat Engn, Suzuka, Japan; [Sato-Okamoto, Michiyo; Takahashi-Nakaguchi, Azusa; Chibana, Hiroji] Chiba Univ, Med Mycol Res Ctr, Chiba, Japan	Tohoku Medical & Pharmaceutical University; Chiba University	Shibata, N (corresponding author), Tohoku Med & Pharmaceut Univ, Dept Infect & Host Def, Sendai, Miyagi, Japan.	nshibata@tohoku-mpu.ac.jp		tanaka, yutaka/0000-0003-2944-8485				AGATEP R, 1998, TECH TIPS ONLINE, V3, P133, DOI DOI 10.1016/S1366-2120(08)70121-1; Ahmad KM, 2014, FEMS YEAST RES, V14, P529, DOI 10.1111/1567-1364.12145; Back SH, 2005, METHODS, V35, P395, DOI 10.1016/j.ymeth.2005.03.001; Barchiesi F, 2007, ANTIMICROB AGENTS CH, V51, P941, DOI 10.1128/AAC.00880-06; Bermejo C, 2008, MOL BIOL CELL, V19, P1113, DOI 10.1091/mbc.E07-08-0742; Birkaya B, 2009, EUKARYOT CELL, V8, P1118, DOI 10.1128/EC.00006-09; Borah S, 2011, J BIOL CHEM, V286, P34311, DOI 10.1074/jbc.M111.264671; Buzzi LI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027025; Cao SS, 2012, CURR BIOL, V22, pR622, DOI 10.1016/j.cub.2012.07.004; Chamilos G, 2007, ANTIMICROB AGENTS CH, V51, P2257, DOI 10.1128/AAC.00095-07; Chavan M, 2003, P NATL ACAD SCI USA, V100, P15381, DOI 10.1073/pnas.2536561100; Chen RE, 2007, BBA-MOL CELL RES, V1773, P1311, DOI 10.1016/j.bbamcr.2007.05.003; Chen YL, 2012, G3-GENES GENOM GENET, V2, P675, DOI 10.1534/g3.112.002279; Cid VJ, 1998, MICROBIOL-SGM, V144, P25, DOI 10.1099/00221287-144-1-25; Clancy CJ, 2006, ANTIMICROB AGENTS CH, V50, P2569, DOI 10.1128/AAC.00291-06; Cota J, 2006, ANTIMICROB AGENTS CH, V50, P3926, DOI 10.1128/AAC.00538-06; Cota JM, 2008, ANTIMICROB AGENTS CH, V52, P1144, DOI 10.1128/AAC.01542-07; de Groot PWJ, 2008, EUKARYOT CELL, V7, P1951, DOI 10.1128/EC.00284-08; Denardi LB, 2015, BRAZ J MICROBIOL, V46, P125, DOI 10.1590/S1517-838246120120442; ELORZA MV, 1983, J GEN MICROBIOL, V129, P1577; Fanchiotti S, 1998, J CELL BIOL, V143, P625, DOI 10.1083/jcb.143.3.625; Feng XZ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002330; Francois JM, 2006, NAT PROTOC, V1, P2995, DOI 10.1038/nprot.2006.457; Frost A, 2012, CELL, V149, P1339, DOI 10.1016/j.cell.2012.04.028; Garcia R, 2009, J BIOL CHEM, V284, P10901, DOI 10.1074/jbc.M808693200; Gardner BM, 2011, SCIENCE, V333, P1891, DOI 10.1126/science.1209126; Gebbie L, 2014, METHODS MOL BIOL, V1099, P159, DOI 10.1007/978-1-62703-715-0_14; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Herrero AB, 2004, EUKARYOT CELL, V3, P1423, DOI 10.1128/EC.3.6.1423-1432.2004; Hurtado-Guerrero R, 2009, J BIOL CHEM, V284, P8461, DOI 10.1074/jbc.M807990200; Jandric Z, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00350; Jung K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089324; Jung US, 1999, MOL MICROBIOL, V34, P1049, DOI 10.1046/j.1365-2958.1999.01667.x; Katiyar S, 2006, ANTIMICROB AGENTS CH, V50, P2892, DOI 10.1128/AAC.00349-06; Kollar R, 1997, J BIOL CHEM, V272, P17762, DOI 10.1074/jbc.272.28.17762; Krysan Damian J, 2009, Commun Integr Biol, V2, P233; Kurita T, 2012, J BIOL CHEM, V287, P17415, DOI 10.1074/jbc.M111.321018; Lagorce A, 2002, EUR J BIOCHEM, V269, P1697, DOI 10.1046/j.1432-1327.2002.02814.x; Levin DE, 2005, MICROBIOL MOL BIOL R, V69, P262, DOI 10.1128/MMBR.69.2.262-291.2005; Levinson JN, 2002, YEAST, V19, P1243, DOI 10.1002/yea.908; Maesaki S, 1998, J ANTIMICROB CHEMOTH, V42, P747, DOI 10.1093/jac/42.6.747; Martin H, 2000, J BIOL CHEM, V275, P1511, DOI 10.1074/jbc.275.2.1511; MEADEN P, 1990, MOL CELL BIOL, V10, P3013, DOI 10.1128/MCB.10.6.3013; Miyazaki T, 2014, VIRULENCE, V5, P365, DOI 10.4161/viru.27373; Miyazaki T, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003160; Miyazaki T, 2011, FEMS YEAST RES, V11, P621, DOI 10.1111/j.1567-1364.2011.00751.x; Miyazaki T, 2010, FEMS YEAST RES, V10, P343, DOI 10.1111/j.1567-1364.2010.00611.x; Munro CA, 2001, MOL MICROBIOL, V39, P1414, DOI 10.1046/j.1365-2958.2001.02347.x; Nakayama H, 1998, MICROBIOL-UK, V144, P2407, DOI 10.1099/00221287-144-9-2407; Neofytos D, 2010, TRANSPL INFECT DIS, V12, P220, DOI 10.1111/j.1399-3062.2010.00492.x; Nett JE, 2011, EUKARYOT CELL, V10, P1660, DOI 10.1128/EC.05126-11; Niimi K, 2012, J ANTIMICROB CHEMOTH, V67, P1666, DOI 10.1093/jac/dks112; NIKAWA JI, 1992, MOL MICROBIOL, V6, P1441, DOI 10.1111/j.1365-2958.1992.tb00864.x; Proia L, 2009, AM J TRANSPLANT, V9, pS199, DOI 10.1111/j.1600-6143.2009.02912.x; Ram R, 2009, BONE MARROW TRANSPL, V43, P643, DOI 10.1038/bmt.2008.373; Roetzer A, 2011, FEMS MICROBIOL LETT, V314, P1, DOI 10.1111/j.1574-6968.2010.02102.x; RONCERO C, 1985, J BACTERIOL, V163, P1180, DOI 10.1128/JB.163.3.1180-1185.1985; Scrimale T, 2009, MOL BIOL CELL, V20, P164, DOI 10.1091/mbc.E08-08-0809; Selvakumar D, 2006, ANTIMICROB AGENTS CH, V50, P3090, DOI 10.1128/AAC.01435-05; Shahinian S, 2000, MOL MICROBIOL, V35, P477, DOI 10.1046/j.1365-2958.2000.01713.x; Shahinian S, 1998, GENETICS, V149, P843; Skeens M, 2012, BONE MARROW TRANSPL, V47, P1415, DOI 10.1038/bmt.2012.59; Stevens DA, 2006, ANTIMICROB AGENTS CH, V50, P3160, DOI 10.1128/AAC.00563-06; Sugita T, 2005, J CLIN MICROBIOL, V43, P2824, DOI 10.1128/JCM.43.6.2824-2829.2005; Taylor SC, 2004, NAT STRUCT MOL BIOL, V11, P128, DOI 10.1038/nsmb715; Ueno K, 2007, EUKARYOT CELL, V6, P1239, DOI 10.1128/EC.00414-06; Urano F, 2000, J CELL SCI, V113, P3697; Valiante V, 2009, FUNGAL GENET BIOL, V46, P909, DOI 10.1016/j.fgb.2009.08.005; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038	69	5	5	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2016	11	8							e0161371	10.1371/journal.pone.0161371	http://dx.doi.org/10.1371/journal.pone.0161371			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT8TP	27548283	Green Published, gold, Green Submitted			2022-12-27	WOS:000381768400048
J	Petrova, MI; Imholz, NCE; Verhoeven, TLA; Balzarini, J; Van Damme, EJM; Schols, D; Vanderleyden, J; Lebeer, S				Petrova, Mariya I.; Imholz, Nicole C. E.; Verhoeven, Tine L. A.; Balzarini, Jan; Van Damme, Els J. M.; Schols, Dominique; Vanderleyden, Jos; Lebeer, Sarah			Lectin-Like Molecules of Lactobacillus rhamnosus GG Inhibit Pathogenic Escherichia coli and Salmonella Biofilm Formation	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA; FUNCTIONAL-ANALYSIS; STAPHYLOCOCCUS-AUREUS; CARBOHYDRATE-BINDING; REFERENCE COLLECTION; COMMON THEMES; GENE; TYPHIMURIUM; PLANTARUM; BACTERIA	Objectives Increased antibiotic resistance has catalyzed the research on new antibacterial molecules and alternative strategies, such as the application of beneficial bacteria. Since lectin molecules have unique sugar-recognizing capacities, and pathogens are often decorated with sugars that affect their survival and infectivity, we explored whether lectins from the probiotic strain Lactobacillus rhamnosus GG have antipathogenic properties. Methods The genome sequence of L. rhamnosus GG was screened for the presence of lectin-like proteins. Two genes, LGG_RS02780 and LGG_RS02750, encoding for polypeptides with an N-terminal conserved L-type lectin domain were detected and designated Llp1 (lectinlike protein 1) and Llp2. The capacity of Llp1 and Llp2 to inhibit biofilm formation of various pathogens was investigated. Sugar specificity was determined by Sepharose beads assays and glycan array screening. Results The isolated lectin domains of Llp1 and Llp2 possess pronounced inhibitory activity against biofilm formation by various pathogens, including clinical Salmonella species and uropathogenic E. coli, with Llp2 being more active than Llp1. In addition, sugar binding assays with Llp1 and Llp2 indicate specificity for complex glycans. Both proteins are also involved in the adhesion capacity of L. rhamnosus GG to gastrointestinal and vaginal epithelial cells. Conclusions Lectins isolated from or expressed by beneficial lactobacilli could be considered promising bio-active ingredients for improved prophylaxis of urogenital and gastrointestinal infections.	[Petrova, Mariya I.; Imholz, Nicole C. E.; Verhoeven, Tine L. A.; Vanderleyden, Jos; Lebeer, Sarah] Katholieke Univ Leuven, Ctr Microbial & Plant Genet, Kasteelpk Arenberg 20,Box 2460, B-3001 Leuven, Belgium; [Petrova, Mariya I.; Lebeer, Sarah] Univ Antwerp, Dept Biosci Engn, Groenenborgerlaan 171, B-2020 Antwerp, Belgium; [Balzarini, Jan; Schols, Dominique] Katholieke Univ Leuven, Rega Inst Med Res, Minderbroedersstr 10, B-3000 Leuven, Belgium; [Van Damme, Els J. M.] Univ Ghent, Dept Mol Biotechnol, Lab Biochem & Glycobiol, Coupure Links 653, B-9000 Ghent, Belgium	KU Leuven; University of Antwerp; KU Leuven; Ghent University	Petrova, MI; Lebeer, S (corresponding author), Katholieke Univ Leuven, Ctr Microbial & Plant Genet, Kasteelpk Arenberg 20,Box 2460, B-3001 Leuven, Belgium.; Petrova, MI; Lebeer, S (corresponding author), Univ Antwerp, Dept Biosci Engn, Groenenborgerlaan 171, B-2020 Antwerp, Belgium.	mariyapetrova3@gmail.com; sarah.lebeer@uantwerpen.be	Petrova, Mariya/U-8087-2019; Van Damme, Els J/B-4410-2015; Schols, Dominique/AAC-1309-2021; Lebeer, Sarah/S-9951-2019; Schols, Dominique/S-9057-2017; Van Damme, Els/U-3904-2019; Lebeer, Sarah/D-5156-2014	Schols, Dominique/0000-0003-3256-5850; Lebeer, Sarah/0000-0002-9400-6918; Schols, Dominique/0000-0003-3256-5850; Van Damme, Els/0000-0001-9848-766X; Lebeer, Sarah/0000-0002-9400-6918	Fund for Scientific Research (FWO Vlaanderen) [12Q0115N]; FWO Vlaanderen [1520114N]; BOF program from the KU Leuven [PF/10/018];  [R24 GM098791]	Fund for Scientific Research (FWO Vlaanderen)(FWO); FWO Vlaanderen(FWO); BOF program from the KU Leuven; 	Mariya Petrova holds a postdoctoral grant from the Fund for Scientific Research (FWO Vlaanderen, http://www.fwo.be/en/) with postdoctoral grant 12Q0115N. Sarah Lebeer was supported from the FWO Vlaanderen with a postdoctoral grant and research grant 1520114N. Work at KU Leuven was supported by BOF program financing from the KU Leuven (PF/10/018). We thank the Protein-glycan Interaction Resource of the CFG and the supporting grant R24 GM098791 for conducting the glycan array analysis. The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.	Arndt NX, 2011, J CELL BIOCHEM, V112, P2230, DOI 10.1002/jcb.23139; Balcazar JL, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01216; BELTRAN P, 1991, J GEN MICROBIOL, V137, P601, DOI 10.1099/00221287-137-3-601; Berendonk TU, 2015, NAT REV MICROBIOL, V13, P310, DOI 10.1038/nrmicro3439; BOYD EF, 1993, J GEN MICROBIOL, V139, P1125, DOI 10.1099/00221287-139-6-1125; Cash HL, 2006, SCIENCE, V313, P1126, DOI 10.1126/science.1127119; Clarke SR, 2002, INFECT IMMUN, V70, P6680, DOI 10.1128/IAI.70.12.6680-6687.2002; Dias RD, 2015, MOLECULES, V20, P519, DOI 10.3390/molecules20010519; Diggle SP, 2006, ENVIRON MICROBIOL, V8, P1095, DOI 10.1111/j.1462-2920.2006.001001.x; FIELDS PI, 1986, P NATL ACAD SCI USA, V83, P5189, DOI 10.1073/pnas.83.14.5189; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; FORNSTEDT N, 1975, FEBS LETT, V57, P187, DOI 10.1016/0014-5793(75)80713-7; Francois KO, 2012, MED RES REV, V32, P349, DOI 10.1002/med.20216; Gardiner GE, 2002, CLIN DIAGN LAB IMMUN, V9, P92, DOI 10.1128/CDLI.9.1.92-96.2002; GASSER F, 1970, J GEN MICROBIOL, V62, P219, DOI 10.1099/00221287-62-2-219; Hobley L, 2015, FEMS MICROBIOL REV, V39, P649, DOI 10.1093/femsre/fuv015; Hofberger JA, 2015, GENOME BIOL EVOL, V7, P720, DOI 10.1093/gbe/evv020; HOISETH SK, 1981, NATURE, V291, P238, DOI 10.1038/291238a0; Horsburgh MJ, 2002, J BACTERIOL, V184, P5457, DOI 10.1128/JB.184.19.5457-5467.2002; Hunstad DA, 2005, INFECT IMMUN, V73, P3999, DOI 10.1128/IAI.73.7.3999-4006.2005; Imberty A, 2008, CURR OPIN STRUC BIOL, V18, P567, DOI 10.1016/j.sbi.2008.08.001; JOSSON K, 1989, PLASMID, V21, P9, DOI 10.1016/0147-619X(89)90082-6; Kankainen M, 2009, P NATL ACAD SCI USA, V106, P17193, DOI 10.1073/pnas.0908876106; Lannoo N, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00397; Lasa I, 2006, RES MICROBIOL, V157, P99, DOI 10.1016/j.resmic.2005.11.003; Lebeer S, 2007, J BACTERIOL, V189, P860, DOI 10.1128/JB.01394-06; Lebeer S, 2012, APPL ENVIRON MICROB, V78, P185, DOI 10.1128/AEM.06192-11; Lebeer S, 2009, APPL ENVIRON MICROB, V75, P3554, DOI 10.1128/AEM.02919-08; Malik S, 2014, GENOME ANNOUNC, V2; Malik S, 2013, APPL ENVIRON MICROB, V79, P4576, DOI 10.1128/AEM.00926-13; MARINUS MG, 1983, MOL GEN GENET, V192, P288, DOI 10.1007/BF00327681; MOORE WEC, 1980, APPL ENVIRON MICROB, V39, P900, DOI 10.1128/AEM.39.4.900-907.1980; Nagy Z, 2004, MOL MICROBIOL, V54, P478, DOI 10.1111/j.1365-2958.2004.04279.x; Petrova MI, 2013, J ANTIMICROB CHEMOTH, V68, P2026, DOI 10.1093/jac/dkt152; Pieters RJ, 2011, ADV EXP MED BIOL, V715, P227, DOI 10.1007/978-94-007-0940-9_14; Pretzer G, 2005, J BACTERIOL, V187, P6128, DOI 10.1128/JB.187.17.6128-6136.2005; RAHME LG, 1995, SCIENCE, V268, P1899, DOI 10.1126/science.7604262; Reid G, 1999, APPL ENVIRON MICROB, V65, P3763; Reid G, 2001, FEMS IMMUNOL MED MIC, V30, P49, DOI 10.1111/j.1574-695X.2001.tb01549.x; Robijns SCA, 2014, BIOFOULING, V30, P605, DOI 10.1080/08927014.2014.907401; Sambrook J., 1989, MOLECULAR CLONING A; Segers ME, 2014, MICROB CELL FACT, V13, DOI 10.1186/1475-2859-13-S1-S7; Sharon N, 2007, LECTINS; Siezen R, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-126; Steenackers H, 2012, FOOD RES INT, V45, P502, DOI 10.1016/j.foodres.2011.01.038; Steenackers HPL, 2011, J MED CHEM, V54, P472, DOI 10.1021/jm1011148; Tielker D, 2005, MICROBIOL-SGM, V151, P1313, DOI 10.1099/mic.0.27701-0; Topin J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071149; Tytgat HLP, 2014, MICROBIOL MOL BIOL R, V78, P372, DOI 10.1128/MMBR.00007-14; Damme EJM, 2011, ADV EXP MED BIOL, V705, P757, DOI 10.1007/978-1-4419-7877-6_39; Van Houdt R, 2005, RES MICROBIOL, V156, P626, DOI 10.1016/j.resmic.2005.02.005; Wei Q, 2013, INT J MOL SCI, V14, P20983, DOI 10.3390/ijms141020983; Wu H, 2015, INT J ORAL SCI, V7, P1, DOI 10.1038/ijos.2014.65; Yang YH, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004169	54	47	52	1	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0161337	10.1371/journal.pone.0161337	http://dx.doi.org/10.1371/journal.pone.0161337			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27537843	Green Published, gold, Green Submitted			2022-12-27	WOS:000381577000089
J	Saggio, ML; Ritter, P; Jirsa, VK				Saggio, Maria Luisa; Ritter, Petra; Jirsa, Viktor K.			Analytical Operations Relate Structural and Functional Connectivity in the Brain	PLOS ONE			English	Article							VIRTUAL BRAIN; CEREBRAL-CORTEX; NETWORKS; DYNAMICS; MRI; ARCHITECTURE; REGIONS; MODELS; SYSTEM	Resting-state large-scale brain models vary in the amount of biological elements they incorporate and in the way they are being tested. One might expect that the more realistic the model is, the closer it should reproduce real functional data. It has been shown, instead, that when linear correlation across long BOLD fMRI time-series is used as a measure for functional connectivity (FC) to compare simulated and real data, a simple model performs just as well, or even better, than more sophisticated ones. The model in question is a simple linear model, which considers the physiological noise that is pervasively present in our brain while it diffuses across the white-matter connections, that is structural connectivity (SC). We deeply investigate this linear model, providing an analytical solution to straightforwardly compute FC from SC without the need of computationally costly simulations of time-series. We provide a few examples how this analytical solution could be used to perform a fast and detailed parameter exploration or to investigate resting-state non-stationarities. Most importantly, by inverting the analytical solution, we propose a method to retrieve information on the anatomical structure directly from functional data. This simple method can be used to complement or guide DTI/DSI and tractography results, especially for a better assessment of inter-hemispheric connections, or to provide an estimate of SC when only functional data are available.	[Saggio, Maria Luisa; Jirsa, Viktor K.] Aix Marseille Univ, Fac Med, Inst Neurosci Syst, Marseille, France; [Saggio, Maria Luisa; Jirsa, Viktor K.] Aix Marseille Univ, INSERM, UMR 1106, Marseille, France; [Ritter, Petra] Max Planck Inst Human Cognit & Brain Sci, Minerva Res Grp BrainModes, Leipzig, Germany; [Ritter, Petra] Charite, Dept Neurol, Berlin, Germany; [Ritter, Petra] Bernstein Focus State Dependencies Learning & Ber, Berlin, Germany; [Ritter, Petra] Humboldt Univ, Berlin Sch Mind & Brain & Mind, Berlin, Germany; [Ritter, Petra] Humboldt Univ, Inst Brain, Berlin, Germany	UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Max Planck Society; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Humboldt University of Berlin; Humboldt University of Berlin	Jirsa, VK (corresponding author), Aix Marseille Univ, Fac Med, Inst Neurosci Syst, Marseille, France.; Jirsa, VK (corresponding author), Aix Marseille Univ, INSERM, UMR 1106, Marseille, France.	viktor.jirsa@univ-amu.fr	Jirsa, Viktor/M-4630-2016; Ritter, Petra/B-6953-2008	Jirsa, Viktor/0000-0002-8251-8860; Ritter, Petra/0000-0002-4643-4782	Brain Network Recovery Group through the James S. McDonnell Foundation; European Union Seventh Framework Programme (FP7-ICT BrainScales and Human Brain Project) [60402]; James S. McDonnell Foundation (Brain Network Recovery Group) [JSMF22002082]; German Ministry of Education and Research (Bernstein Focus State Dependencies of Learning) [01GQ0971]; Max-Planck Society (Minerva Program)	Brain Network Recovery Group through the James S. McDonnell Foundation; European Union Seventh Framework Programme (FP7-ICT BrainScales and Human Brain Project); James S. McDonnell Foundation (Brain Network Recovery Group); German Ministry of Education and Research (Bernstein Focus State Dependencies of Learning); Max-Planck Society (Minerva Program)	VJ acknowledges the support of the Brain Network Recovery Group through the James S. McDonnell Foundation and funding from the European Union Seventh Framework Programme (FP7-ICT BrainScales and Human Brain Project [grant no. 60402]). PR acknowledges the support of the James S. McDonnell Foundation (Brain Network Recovery Group JSMF22002082), the German Ministry of Education and Research (Bernstein Focus State Dependencies of Learning 01GQ0971) and the Max-Planck Society (Minerva Program). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelnour F, 2014, NEUROIMAGE, V90, P335, DOI 10.1016/j.neuroimage.2013.12.039; Anderson JS, 2011, AM J NEURORADIOL, V32, P548, DOI 10.3174/ajnr.A2330; Banerjee A, 2008, NEUROIMAGE, V42, P663, DOI 10.1016/j.neuroimage.2008.04.260; Barnett L, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.051914; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Chang C, 2010, NEUROIMAGE, V50, P81, DOI 10.1016/j.neuroimage.2009.12.011; Daffertshofer Andreas, 2011, Front Neuroinform, V5, P6, DOI 10.3389/fninf.2011.00006; Deco G, 2014, J NEUROSCI, V34, P7910, DOI 10.1523/JNEUROSCI.4423-13.2014; Deco G, 2013, J NEUROSCI, V33, P11239, DOI 10.1523/JNEUROSCI.1091-13.2013; Deco G, 2012, J NEUROSCI, V32, P3366, DOI 10.1523/JNEUROSCI.2523-11.2012; Deco G, 2011, NAT REV NEUROSCI, V12, P43, DOI 10.1038/nrn2961; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Dhamala M, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.074104; Dominguez LG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061493; Feng JF, 2006, CHAOS, V16, DOI 10.1063/1.2180690; Friston KJ, 2011, BRAIN CONNECT, V1, P13, DOI 10.1089/brain.2011.0008; Galan RF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002148; Ghosh A, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000196; Goni J, 2014, P NATL ACAD SCI USA, V111, P833, DOI 10.1073/pnas.1315529111; Hansen ECA, 2015, NEUROIMAGE, V105, P525, DOI 10.1016/j.neuroimage.2014.11.001; Hindriks R, 2015, NEUROIMAGE; Hlinka J, 2012, EUR J NEUROSCI, V36, P2137, DOI 10.1111/j.1460-9568.2012.08081.x; Hlinka J, 2011, NEUROIMAGE, V54, P2218, DOI 10.1016/j.neuroimage.2010.08.042; Honey CJ, 2009, P NATL ACAD SCI USA, V106, P2035, DOI 10.1073/pnas.0811168106; Honey CJ, 2007, P NATL ACAD SCI USA, V104, P10240, DOI 10.1073/pnas.0701519104; Jirsa VK, 2010, ARCH ITAL BIOL, V148, P189; Jirsa VK, 2009, PHILOS T R SOC A, V367, P1131, DOI 10.1098/rsta.2008.0260; Jirsa VK, 2008, COGN NEURODYNAMICS, V2, P29, DOI 10.1007/s11571-007-9030-0; Jirsa VK, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.070602; Lauritzen S.L.., 1996, GRAPHICAL MODELS; Leonardi N, 2015, NEUROIMAGE, V104, P430, DOI 10.1016/j.neuroimage.2014.09.007; Li LC, 2012, NEUROIMAGE, V61, P1017, DOI 10.1016/j.neuroimage.2012.03.071; Liptrot MG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096247; Marrelec G, 2009, HUM BRAIN MAPP, V30, P941, DOI 10.1002/hbm.20555; Marrelec G, 2006, NEUROIMAGE, V32, P228, DOI 10.1016/j.neuroimage.2005.12.057; Masuda H, 2004, BERNOULLI, V10, P97, DOI 10.3150/bj/1077544605; McIntosh AR, 2010, ARCH ITAL BIOL, V148, P323; Messe A, 2015, SCI REP-UK, V5, DOI 10.1038/srep07870; Messe A, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003530; Mueller S, 2013, NEURON, V77, P586, DOI 10.1016/j.neuron.2012.12.028; Murphy K, 2009, NEUROIMAGE, V44, P893, DOI 10.1016/j.neuroimage.2008.09.036; Park HJ, 2013, SCIENCE, V342, P579, DOI 10.1126/science.1238411; Qubbaj MR, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.238102; Rho YA, 2011, BRAIN CONNECT, V1, P73, DOI 10.1089/brain.2011.0009; Ritter P, 2006, NEUROSCI BIOBEHAV R, V30, P823, DOI 10.1016/j.neubiorev.2006.06.008; Ritter P, 2013, BRAIN CONNECT, V3, P121, DOI 10.1089/brain.2012.0120; Ritter P, 2010, EEG-FMRI: PHYSIOLOGICAL BASIS, TECHNIQUE AND APPLICATIONS, P153, DOI 10.1007/978-3-540-87919-0_9; Robinson PA, 2014, PHYS REV E, V90, DOI 10.1103/PhysRevE.90.012707; Robinson PA, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.011912; Rosazza C, 2011, NEUROL SCI, V32, P773, DOI 10.1007/s10072-011-0636-y; Roy D, 2014, BRAIN CONNECT, V4, P791, DOI 10.1089/brain.2014.0252; Schirner M, 2015, NEUROIMAGE, V117, P343, DOI 10.1016/j.neuroimage.2015.03.055; Smith SM, 2011, NEUROIMAGE, V54, P875, DOI 10.1016/j.neuroimage.2010.08.063; Stam C, 2015, INT J PSYCHOPHYSIOLO; Steinke GK, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002207; Sutera A, 2014, ARXIV14067865; TONONI G, 1994, P NATL ACAD SCI USA, V91, P5033, DOI 10.1073/pnas.91.11.5033; Tournier JD, 2007, NEUROIMAGE, V35, P1459, DOI 10.1016/j.neuroimage.2007.02.016; Tournier JD, 2004, NEUROIMAGE, V23, P1176, DOI 10.1016/j.neuroimage.2004.07.037; Uddin LQ, 2011, J NEUROSCI, V31, P18578, DOI 10.1523/JNEUROSCI.4465-11.2011; Uhlenbeck GE, 1930, PHYS REV, V36, P0823, DOI 10.1103/PhysRev.36.823; Watanabe T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2388	62	26	26	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0157292	10.1371/journal.pone.0157292	http://dx.doi.org/10.1371/journal.pone.0157292			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27536987	Green Published, Green Submitted, gold			2022-12-27	WOS:000381577000003
J	Taylor, JM; Ptomey, L; Hamilton-Reeves, JM; Sullivan, DK; Creed, C; Carlson, SE; Wesson, DE; Grantham, JJ; Gibson, CA				Taylor, Jacob M.; Ptomey, Lauren; Hamilton-Reeves, Jill M.; Sullivan, Debra K.; Creed, Catherine; Carlson, Susan E.; Wesson, Donald E.; Grantham, Jared J.; Gibson, Cheryl A.			Experiences and Perspectives of Polycystic Kidney Disease Patients following a Diet of Reduced Osmoles, Protein, and Acid Precursors Supplemented with Water: A Qualitative Study	PLOS ONE			English	Article							GLOMERULAR-FILTRATION-RATE; BLOOD-PRESSURE; PROGRESSION; AMELIORATION; ENDOTHELIN; REDUCTION; DECLINE; INJURY; LOAD; SALT	Background Salt, protein, acid precursors, and fluid intake have been identified as factors that influence cyst growth in ADPKD. Unfortunately, the feasibility of following these dietary restrictions/enhancements from a patient's point-of-view has yet to be studied. The purpose of this study is to understand better the experiences of patients following a relatively complex dietary prescription targeting these factors. Methods Twelve adults with ADPKD and kidney function >30ml/min/1.73m(2) were recruited from the University of Kansas Medical Center Polycystic Kidney Disease clinic. In a qualitative design, semi-structured interviews of participants were conducted following a four week dietary intervention (experimental diet lower in sodium, protein, and acid precursors, and supplemented with water) either face-to-face or by telephone. All interviews were recorded, transcribed verbatim, and checked for accuracy. Transcripts were analyzed thematically for emerging themes. Results Participants reported that eating less meat and more fruits and vegetables were the easiest components of the diet, whereas reaching the daily goal amount of fruits and vegetables and tracking the diet constantly were the most difficult components. Participants had little difficulty with fluid intake and reported the prescribed fluid goal as achievable. The tracking system for fruits and vegetables and protein was reported to be both helpful and intuitive, but tracking their intake on paper was tedious. Eating out was the most significant barrier to following the diet with some individuals avoiding restaurants in order to comply with the dietary prescription. Conclusion Participants on the experimental diet heightened their awareness of the consumption of dietary salt, protein, acid precursors, and fluid intake. Additionally, most participants believed adherence to the prescribed diet was feasible. However, participants wanted less cumbersome ways to track and monitor the diet, especially given that the prescribed diet is designed for lifelong adherence. Future studies should focus on targeting these specific dietary factors in larger groups of more ethnically and culturally diverse populations to help inform clinicians and how best to help diverse populations adhere to the dietary intervention.	[Taylor, Jacob M.; Hamilton-Reeves, Jill M.; Sullivan, Debra K.; Carlson, Susan E.] Univ Kansas, Med Ctr, Dept Nutr & Dietet, Sch Hlth Profess, Kansas City, KS 66103 USA; [Taylor, Jacob M.] Childrens Mercy Hosp & Clin, Dept Nutr Serv, Kansas City, MO 64108 USA; [Ptomey, Lauren] Univ Kansas, Med Ctr, Sch Med, Div Cardiovasc Dis, Kansas City, KS 66103 USA; [Creed, Catherine; Grantham, Jared J.] Univ Kansas, Med Ctr, Sch Med, Dept Med Nephrol,Kidney Inst, Kansas City, KS 66103 USA; [Wesson, Donald E.] Texas A&M Hlth Sci Ctr Coll Med, Baylor Scott & White Hlth, Dept Internal Med, Temple, TX USA; [Gibson, Cheryl A.] Univ Kansas, Med Ctr, Sch Med, Dept Internal Med,Div Gen Med, Kansas City, KS 66103 USA; [Taylor, Jacob M.] Univ Groningen, Univ Med Ctr Groningen, Dept Nephrol, Groningen, Netherlands	University of Kansas; University of Kansas Medical Center; Children's Mercy Hospital; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; Baylor Health Care System; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Kansas; University of Kansas Medical Center; University of Groningen	Taylor, JM (corresponding author), Univ Kansas, Med Ctr, Dept Nutr & Dietet, Sch Hlth Profess, Kansas City, KS 66103 USA.; Taylor, JM (corresponding author), Childrens Mercy Hosp & Clin, Dept Nutr Serv, Kansas City, MO 64108 USA.; Taylor, JM (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Nephrol, Groningen, Netherlands.	jacobtaylor.ms_rd@yahoo.com		Ptomey, Lauren/0000-0002-1705-1643	Frontiers Pilot and Collaborative Studies Funding Program; University of Kansas Medical Center Research Institute Clinical Pilots Program; Abbott Nutrition Award through the Academy of Nutrition and Dietetics; University of Kansas Medical Center Kidney Institute's Research and Development fund; NCATS [KL2TR000119]	Frontiers Pilot and Collaborative Studies Funding Program; University of Kansas Medical Center Research Institute Clinical Pilots Program; Abbott Nutrition Award through the Academy of Nutrition and Dietetics; University of Kansas Medical Center Kidney Institute's Research and Development fund; NCATS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported by the Frontiers Pilot and Collaborative Studies Funding Program and the University of Kansas Medical Center Research Institute Clinical Pilots Program (JJG, JMHR, DKS), the Abbott Nutrition Award funded through the Academy of Nutrition and Dietetics (JMT), and the University of Kansas Medical Center Kidney Institute's Research and Development fund (JJG). Support for J. Hamilton-Reeves was provided by KL2 training grant KL2TR000119 a CTSA grant from NCATS awarded to the University of Kansas Medical Center for Frontiers: The Heartland Institute for Clinical and Translational Research (JMHR). The contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH or NCATS. The sponsors were not involved in the study design, in the collection, analysis and interpretation of data; in the writing of the manuscript; and in the decision to submit the manuscript for publication.	Banerjee T, 2015, J AM SOC NEPHROL, V26, P1693, DOI 10.1681/ASN.2014040332; Banerjee T, 2014, BMC NEPHROL, V15, DOI 10.1186/1471-2369-15-137; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Brindal E, 2013, J TELEMED TELECARE, V19, P166, DOI 10.1177/1357633X13479702; Cianciaruso B, 2008, NEPHROL DIAL TRANSPL, V23, P636, DOI 10.1093/ndt/gfm576; Colin-Ramirez E, 2015, J CARDIOVASC NURS, V30, P58, DOI 10.1097/JCN.0000000000000124; Cowley BD, 1996, AM J KIDNEY DIS, V27, P865, DOI 10.1016/S0272-6386(96)90525-9; Ecder T, 2000, AM J KIDNEY DIS, V36, P266, DOI 10.1053/ajkd.2000.8970; Frassetto LA, 2007, J NUTR, V137, P1491, DOI 10.1093/jn/137.6.1491; Gattone VH, 2003, NAT MED, V9, P1323, DOI 10.1038/nm935; Goraya N, 2014, AM J NEPHROL, V39, P142, DOI 10.1159/000358602; Goraya N, 2012, CURR OPIN NEPHROL HY, V21, P552, DOI 10.1097/MNH.0b013e328356233b; Goraya N, 2012, KIDNEY INT, V81, P86, DOI 10.1038/ki.2011.313; Grantham JJ, 2008, NEW ENGL J MED, V359, P1477, DOI 10.1056/NEJMcp0804458; Grantham JJ, 2015, PEDIATR NEPHROL, V30, P1053, DOI 10.1007/s00467-014-2882-8; Hadziabdic MO, 2015, J HUM NUTR DIET, V28, P24, DOI 10.1111/jhn.12270; He FJ, 2009, J HUM HYPERTENS, V23, P363, DOI 10.1038/jhh.2008.144; Mahajan A, 2010, KIDNEY INT, V78, P303, DOI 10.1038/ki.2010.129; McCauley LR, 2012, J UROLOGY, V187, P1282, DOI 10.1016/j.juro.2011.11.111; McMahon EJ, 2012, INT J NEPHROL, V2012, DOI 10.1155/2012/720429; MILAS NC, 1995, J AM DIET ASSOC, V95, P1295, DOI 10.1016/S0002-8223(95)00340-1; Miles M. B., 2019, SAGE, DOI DOI 10.1080/1034912X.2016.1228856; Nagao S, 2006, J AM SOC NEPHROL, V17, P2220, DOI 10.1681/ASN.2006030251; Ogborn MR, 1995, J AM SOC NEPHROL, V6, P1649; Phisitkul S, 2010, KIDNEY INT, V77, P617, DOI 10.1038/ki.2009.519; Ritchie J., 2013, QUALITATIVE RES PRAC; Schakel SF, 2001, J FOOD COMPOS ANAL, V14, P315, DOI 10.1006/jfca.2001.0992; Schrier RW, 2014, NEW ENGL J MED, V371, P2255, DOI 10.1056/NEJMoa1402685; Shenton A.K., 2004, ED INF, V22, P63, DOI DOI 10.3233/EFI-2004-22201; Tanner GA, 2000, KIDNEY INT, V58, P1859, DOI 10.1046/j.1523-1755.2000.00357.x; Taylor JM, 2017, CLIN NUTR, V36, P458, DOI 10.1016/j.clnu.2016.01.003; Torres VE, 2011, CLIN J AM SOC NEPHRO, V6, P640, DOI 10.2215/CJN.03250410; Wang CJ, 2011, CLIN J AM SOC NEPHRO, V6, P192, DOI 10.2215/CJN.03950510; Wang XF, 2008, J AM SOC NEPHROL, V19, P102, DOI 10.1681/ASN.2007060688; Wesson DE, 2010, KIDNEY INT, V78, P1128, DOI 10.1038/ki.2010.348	35	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0161043	10.1371/journal.pone.0161043	http://dx.doi.org/10.1371/journal.pone.0161043			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27537328	Green Published, gold, Green Submitted			2022-12-27	WOS:000381577000045
J	Ballhorn, DJ; Rakotoarivelo, FP; Kautz, S				Ballhorn, Daniel J.; Rakotoarivelo, Fanny Patrika; Kautz, Stefanie			Coevolution of Cyanogenic Bamboos and Bamboo Lemurs on Madagascar	PLOS ONE			English	Article							PLANT SECONDARY COMPOUNDS; GENERALIST MAMMALIAN FOLIVORE; BEAN PHASEOLUS-LUNATUS; SOUTHEASTERN MADAGASCAR; TRICHOSURUS-VULPECULA; PHYLOGENETIC ANALYSIS; HERBIVOROUS INSECTS; FEEDING PATTERNS; BETA-GLUCOSIDASE; TROPICAL FORESTS	Feeding strategies of specialist herbivores often originate from the coevolutionary arms race of plant defenses and counter-adaptations of herbivores. The interaction between bamboo lemurs and cyanogenic bamboos on Madagascar represents a unique system to study diffuse coevolutionary processes between mammalian herbivores and plant defenses. Bamboo lemurs have different degrees of dietary specialization while bamboos show different levels of chemical defense. In this study, we found variation in cyanogenic potential (HCNp) and nutritive characteristics among five sympatric bamboo species in the Ranomafana area, southeastern Madagascar. The HCNp ranged from 209 +/- 72 mu mol cyanide*g(-1) dwt in Cathariostachys madagascariensis to no cyanide in Bambusa madagascariensis. Among three sympatric bamboo lemur species, the greater bamboo lemur (Prolemur simus) has the narrowest food range as it almost exclusively feeds on the highly cyanogenic C. madagascariensis. Our data suggest that high HCNp is the derived state in bamboos. The ancestral state of lemurs is most likely "generalist" while the ancestral state of bamboo lemurs was determined as equivocal. Nevertheless, as recent bamboo lemurs comprise several "facultative specialists" and only one "obligate specialist" adaptive radiation due to increased flexibility is likely. We propose that escaping a strict food plant specialization enabled facultative specialist bamboo lemurs to inhabit diverse geographical areas.	[Ballhorn, Daniel J.; Kautz, Stefanie] Portland State Univ, Dept Biol, 1719 SW 10th Ave, Portland, OR 97201 USA; [Rakotoarivelo, Fanny Patrika] Univ La Reunion, UMR PVBMT, 15 Ave Rene Cassin, St Denis 97715, Reunion, France	Portland State University; University of La Reunion	Ballhorn, DJ (corresponding author), Portland State Univ, Dept Biol, 1719 SW 10th Ave, Portland, OR 97201 USA.	ballhorn@pdx.edu			Deutsche Forschungsgemeinschaft (DFG) [Ba 3966/1-1]; National Science Foundation (NSF) [1457369]; German Academy of Sciences Leopoldina [LPDS 2009-29]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); National Science Foundation (NSF)(National Science Foundation (NSF)); German Academy of Sciences Leopoldina	DJB gratefully acknowledges funding from the Deutsche Forschungsgemeinschaft (DFG grant Ba 3966/1-1) and the National Science Foundation (NSF grant 1457369). SK acknowledges financial support from the German Academy of Sciences Leopoldina (grant LPDS 2009-29). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali JG, 2012, TRENDS PLANT SCI, V17, P293, DOI 10.1016/j.tplants.2012.02.006; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; [Anonymous], 2006, THESIS U TEXAS AUSTI; Ball JP, 2000, J APPL ECOL, V37, P247, DOI 10.1046/j.1365-2664.2000.00487.x; Ballhorn DJ, 2007, J CHEM ECOL, V33, P2195, DOI 10.1007/s10886-007-9380-4; Ballhorn DJ, 2010, ENTOMOL EXP APPL, V134, P245, DOI 10.1111/j.1570-7458.2009.00961.x; Ballhorn DJ, 2008, J ECOL, V96, P971, DOI 10.1111/j.1365-2745.2008.01404.x; Ballhorn DJ, 2006, J CHEM ECOL, V32, P1861, DOI 10.1007/s10886-006-9114-z; Ballhorn DJ, 2011, J ECOL, V99, P313, DOI 10.1111/j.1365-2745.2010.01747.x; Ballhorn DJ, 2009, AM J PRIMATOL, V71, P305, DOI 10.1002/ajp.20653; Ballhorn DJ, 2006, J CHEM ECOL, V32, P261, DOI 10.1007/s10886-005-9001-z; Ballhorn DJ, 2005, J CHEM ECOL, V31, P1445, DOI 10.1007/s10886-005-5791-2; Banea-Mayambu JP, 2000, ANN TROP PAEDIATR, V20, P34, DOI 10.1080/02724930092048; BELOVSKY GE, 1984, AM NAT, V124, P97, DOI 10.1086/284254; BELOVSKY GE, 1984, THEOR POPUL BIOL, V25, P235, DOI 10.1016/0040-5809(84)90009-1; BELOVSKY GE, 1994, J MAMMAL, V75, P816, DOI 10.2307/1382464; BERENBAUM M, 1981, SCIENCE, V212, P927, DOI 10.1126/science.212.4497.927; Berenbaum MR, 1998, P NATL ACAD SCI USA, V95, P13743, DOI 10.1073/pnas.95.23.13743; BERENBAUM MR, 1990, ANNU REV ENTOMOL, V35, P319, DOI 10.1146/annurev.en.35.010190.001535; BERNAYS E, 1988, ECOLOGY, V69, P886, DOI 10.2307/1941237; Bernays E. A., 1994, Host-plant selection by phytophagous insects.; Bernays EA, 1997, ECOLOGY, V78, P1157, DOI 10.1890/0012-9658(1997)078[1157:IHDRFB]2.0.CO;2; Biesmeijer JC, 2006, SCIENCE, V313, P351, DOI 10.1126/science.1127863; Boyle R, 1999, AM ZOOL, V39, p120A; Braby MF, 2012, BIOL J LINN SOC, V107, P697, DOI 10.1111/j.1095-8312.2012.01970.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brooks D.R., 2002, NATURE DIVERSITY; BROWN JH, 1984, AM NAT, V124, P255, DOI 10.1086/284267; Bryant JP, 2009, AM NAT, V174, P13, DOI 10.1086/599304; BRYANT JP, 1980, ANNU REV ECOL SYST, V11, P261, DOI 10.1146/annurev.es.11.110180.001401; Carmona D, 2011, FUNCT ECOL, V25, P358, DOI 10.1111/j.1365-2435.2010.01794.x; Chatterjee HJ, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-259; CHUNG TK, 1991, J NUTR, V121, P979, DOI 10.1093/jn/121.7.979; Clark Lynn G., 2007, Aliso, V23, P315; Colles A, 2009, ECOL LETT, V12, P849, DOI 10.1111/j.1461-0248.2009.01336.x; COOPER SM, 1988, OECOLOGIA, V75, P336, DOI 10.1007/BF00376934; CRAWLEY MJ, 1983, STUDIES ECOLOGY, V10; Dearing MD, 2000, OECOLOGIA, V123, P397, DOI 10.1007/s004420051027; Dearing MD, 1999, J CHEM ECOL, V25, P1205, DOI 10.1023/A:1020958221803; DEARING MD, 1992, ECOLOGY, V73, P845, DOI 10.2307/1940162; Degabriel JL, 2009, ECOLOGY, V90, P711, DOI 10.1890/08-0940.1; DIRZO R, 1982, J ECOL, V70, P119, DOI 10.2307/2259868; Dolch Rainer, 2004, Lemur News, V9, P24; Dolch Rainer, 2008, Lemur News, V13, P14; Drummond A., 2011, GENEIOUS V5 5; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; EDWARDS AWF, 1972, LIKELIHOOD; EHRLICH PR, 1964, EVOLUTION, V18, P586, DOI 10.2307/2406212; Engler HS, 2000, NATURE, V406, P144, DOI 10.1038/35018159; Eppley TM, 2011, PRIMATES, V52, P7, DOI 10.1007/s10329-010-0225-3; Evans LM, 2008, EVOLUTION, V62, P3027, DOI 10.1111/j.1558-5646.2008.00497.x; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Feng ZL, 2009, ECOSYSTEMS, V12, P534, DOI 10.1007/s10021-009-9240-x; FREELAND WJ, 1974, AM NAT, V108, P269, DOI 10.1086/282907; FUTUYMA DJ, 1988, ANNU REV ECOL SYST, V19, P207, DOI 10.1146/annurev.es.19.110188.001231; GANZHORN JU, 1992, OECOLOGIA, V91, P540, DOI 10.1007/BF00650329; Garshelis DL, 2008, URSUS, V19, P168, DOI 10.2192/07PER011.1; GLANDER KE, 1989, AM J PRIMATOL, V19, P119, DOI 10.1002/ajp.1350190205; Gleadow RM, 2000, AUST J PLANT PHYSIOL, V27, P693, DOI 10.1071/PP00004; Godfrey LR, 1986, PRIMATE CONSERVATION, V7, P92; GOODMAN SM, 2001, INVENTAIRE BIOL PARC, P231; Guglielmo CG, 1996, ECOLOGY, V77, P1103, DOI 10.2307/2265579; Haley SL, 2007, COMP BIOCHEM PHYS C, V146, P552, DOI 10.1016/j.cbpc.2007.06.007; Handasyde, 1999, KOALA NATURAL HIST C; HILLIS DM, 1993, SYST BIOL, V42, P182, DOI 10.2307/2992540; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Isaacson T, 2006, NAT PROTOC, V1, P769, DOI 10.1038/nprot.2006.102; JAENIKE J, 1990, ANNU REV ECOL SYST, V21, P243, DOI 10.1146/annurev.es.21.110190.001331; JAKUBAS WJ, 1993, PHYSIOL ZOOL, V66, P580, DOI 10.1086/physzool.66.4.30163809; JANZEN DH, 1980, EVOLUTION, V34, P611, DOI 10.1111/j.1558-5646.1980.tb04849.x; Johansson J, 2007, J INSECT SCI, V7, DOI 10.1673/031.007.0301; Jordan WC, 1996, AM J BOT, V83, P430, DOI 10.2307/2446212; Julliard R, 2004, GLOBAL CHANGE BIOL, V10, P148, DOI 10.1111/j.1365-2486.2003.00723.x; Kareiva P, 1999, P NATL ACAD SCI USA, V96, P8, DOI 10.1073/pnas.96.1.8; Kautz S, 2009, EVOLUTION, V63, P839, DOI 10.1111/j.1558-5646.2008.00594.x; Kelchner SA, 1997, MOL PHYLOGENET EVOL, V8, P385, DOI 10.1006/mpev.1997.0432; LANYON SM, 1992, SCIENCE, V255, P77, DOI 10.1126/science.1553533; Lawler IR, 1998, OECOLOGIA, V116, P160, DOI 10.1007/s004420050575; LEESON S, 1991, POULTRY SCI, V70, P1739, DOI 10.3382/ps.0701739; Lehman Shawn M., 2000, Lemur News, V5, P23; Li RQ, 2010, NATURE, V463, P311, DOI 10.1038/nature08696; Li WM, 2003, P NATL ACAD SCI USA, V100, P14593, DOI 10.1073/pnas.1934643100; LOBEL PS, 1981, MAR BIOL, V64, P173, DOI 10.1007/BF00397106; Maddison D.R., 2007, MESQUITE 2 MODULAR S; Magalhaes CP, 2000, PHYTOCHEM ANALYSIS, V11, P57, DOI 10.1002/(SICI)1099-1565(200001/02)11:1&lt;57::AID-PCA489&gt;3.0.CO;2-E; Marsh KJ, 2006, ECOLOGY, V87, P2103, DOI 10.1890/0012-9658(2006)87[2103:CDODPI]2.0.CO;2; Marsh KJ, 2003, AUST J ZOOL, V51, P31, DOI 10.1071/ZO02055; MASON JR, 1983, PHARMACOL BIOCHEM BE, V19, P857, DOI 10.1016/0091-3057(83)90093-X; McArthur Clare, 1991, P103; McKinney ML, 1997, ANNU REV ECOL SYST, V28, P495, DOI 10.1146/annurev.ecolsys.28.1.495; MEIER B, 1987, FOLIA PRIMATOL, V48, P211, DOI 10.1159/000156299; Mittermeier RA, 1994, LEMURS PALEARCTIC AN; Mittermeier RA, 1992, LEMURS MADAGASCAR AC; Mittermeier R, 2008, INT J PRIMATOL, V29, P1607, DOI 10.1007/s10764-008-9317-y; MONTGOMERY RD, 1969, TOXIC CONSTITUENTS P; Moore BD, 2000, AUST J ZOOL, V48, P317, DOI 10.1071/ZO99034; Muller A, 1996, ECOL MONOGR, V66, P235, DOI 10.2307/2963476; NAHRSTEDT A, 1985, PLANT SYST EVOL, V150, P35, DOI 10.1007/BF00985566; Novotny V, 2007, NATURE, V448, P692, DOI 10.1038/nature06021; Novotny V, 2006, SCIENCE, V313, P1115, DOI 10.1126/science.1129237; Nylander J. A. A., 2004, MRMODELTEST V2; Nylander JAA, 2004, SYST BIOL, V53, P47, DOI 10.1080/10635150490264699; Overdorff DJ, 1997, AM J PRIMATOL, V43, P211, DOI 10.1002/(SICI)1098-2345(1997)43:3<211::AID-AJP2>3.3.CO;2-V; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; PAGEL M, 1994, P ROY SOC B-BIOL SCI, V255, P37, DOI 10.1098/rspb.1994.0006; Palo R.T., 1991, PLANT DEFENSES MAMMA; Papachristou TG, 2007, APPL ANIM BEHAV SCI, V108, P68, DOI 10.1016/j.applanim.2006.11.015; PELLMYR O, 1992, P NATL ACAD SCI USA, V89, P2927, DOI 10.1073/pnas.89.7.2927; Pentzold S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091337; Rakotondravony Daniel, 2004, Lemur News, V9, P28; Rakotosamimanana Berthe, 2004, Lemur News, V9, P19; Rasmann S, 2011, AM NAT, V177, P728, DOI 10.1086/659948; Robbins C. T., 1993, WILDLIFE FEEDING NUT; Robinson BW, 1998, AM NAT, V151, P223, DOI 10.1086/286113; Rodriguez-Saona CR, 2010, J CHEM ECOL, V36, P1043, DOI 10.1007/s10886-010-9854-7; Schaller G.B., 1985, GIANT PANDAS WOLONG; Shipley LA, 2006, J CHEM ECOL, V32, P2455, DOI 10.1007/s10886-006-9156-2; Shipley LA, 2009, INTEGR COMP BIOL, V49, P274, DOI 10.1093/icb/icp051; Skopec MM, 2011, COMP BIOCHEM PHYS C, V154, P383, DOI 10.1016/j.cbpc.2011.07.010; Sorensen JS, 2006, J CHEM ECOL, V32, P1181, DOI 10.1007/s10886-006-9079-y; Sorensen JS, 2005, OECOLOGIA, V146, P415, DOI 10.1007/s00442-005-0236-8; Sorensen JS, 2005, ECOLOGY, V86, P125, DOI 10.1890/03-0627; Sorensen JS, 2003, OECOLOGIA, V134, P88, DOI 10.1007/s00442-002-1085-3; Stephens PR, 2003, BIOL J LINN SOC, V79, P577, DOI 10.1046/j.1095-8312.2003.00211.x; Swofford D.L., 2002, PHYLOGENETIC ANAL US; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Tan CL, 1999, INT J PRIMATOL, V20, P547, DOI 10.1023/A:1020390723639; Tattersall I., 1982, PRIMATES MADAGASCAR, DOI 10.1002/ajpa.1330590417; Thompson JD., 1994, COEVOLUTIONARY PROCE; vanderMeijden E, 1996, ENTOMOL EXP APPL, V80, P307, DOI 10.1007/BF00194780; Villalba JJ, 2004, OIKOS, V107, P100, DOI 10.1111/j.0030-1299.2004.12983.x; Wiggins NL, 2006, J CHEM ECOL, V32, P1133, DOI 10.1007/s10886-006-9076-1; Wiggins NL, 2006, OECOLOGIA, V147, P650, DOI 10.1007/s00442-005-0305-z; Wiggins NL, 2003, J CHEM ECOL, V29, P1447, DOI 10.1023/A:1024221705354; Wissing F., 1981, CYANIDE BIOL; Wright Patricia C., 2008, Primate Conservation, V23, P5, DOI 10.1896/052.023.0102; WRIGHT PC, 1989, AM J PHYS ANTHROPOL, V78, P327; Xin Xia, 2007, Scientia Silvae Sinicae, V43, P26; Yamashita N, 2010, AM J PRIMATOL, V72, P56, DOI 10.1002/ajp.20751; Zentek J, 1997, DEUT TIERARZTL WOCH, V104, P153; Zhang WP, 2000, MOL PHYLOGENET EVOL, V15, P135, DOI 10.1006/mpev.1999.0729	141	12	14	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2016	11	8							e0158935	10.1371/journal.pone.0158935	http://dx.doi.org/10.1371/journal.pone.0158935			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4YN	27532127	Green Published, gold, Green Submitted			2022-12-27	WOS:000381487600004
J	Gon, G; Restrepo-Mendez, MC; Campbell, OMR; Barros, AJD; Woodd, S; Benova, L; Graham, WJ				Gon, Giorgia; Restrepo-Mendez, Maria Clara; Campbell, Oona M. R.; Barros, Aluisio J. D.; Woodd, Susannah; Benova, Lenka; Graham, Wendy J.			Who Delivers without Water? A Multi Country Analysis of Water and Sanitation in the Childbirth Environment	PLOS ONE			English	Article							INFECTION	Background and Objectives Hygiene during childbirth is essential to the health of mothers and newborns, irrespective of where birth takes place. This paper investigates the status of water and sanitation in both the home and facility childbirth environments, and for whom and where this is a more significant problem. Methods We used three datasets: a global dataset, with information on the home environment from 58 countries, and two datasets for each of four countries in Eastern Africa: a healthcare facility dataset, and a dataset that incorporated information on facilities and the home environment to create a comprehensive description of birth environments in those countries. We constructed indices of improved water, and improved water and sanitation combined (WATSAN), for the home and healthcare facilities. The Joint Monitoring Program was used to construct indices for household; we tailored them to the facility context-household and facility indices include different components. We described what proportion of women delivered in an environment with improved WATSAN. For those women who delivered at home, we calculated what proportion had improved WATSAN by socio-economic status, education and rural-urban status. Results Among women delivering at home (58 countries), coverage of improved WATSAN by region varied from 9% to 53%. Fewer than 15% of women who delivered at home in Sub-Saharan Africa, had access to water and sanitation infrastructure (range 0.1% to 37%). This was worse among the poorest, the less educated and those living in rural areas. In Eastern Africa, where we looked at both the home and facility childbirth environment, a third of women delivered in an environment with improved water in Uganda and Rwanda; whereas, 18% of women in Kenya and 7% in Tanzania delivered with improved water and sanitation. Across the four countries, less than half of the facility deliveries had improved water, or improved water and sanitation in the childbirth environment. Conclusions Access to water and sanitation during childbirth is poor across low and middle-income countries. Even when women travel to health facilities for childbirth, they are not guaranteed access to basic WATSAN infrastructure. These indicators should be measured routinely in order to inform improvements.	[Gon, Giorgia; Campbell, Oona M. R.; Woodd, Susannah; Benova, Lenka; Graham, Wendy J.] London Sch Hyg & Trop Med, Infect Dis Epidemiol Dept, London, England; [Restrepo-Mendez, Maria Clara; Barros, Aluisio J. D.] Univ Fed Pelotas, Int Ctr Equ Hlth, Pelotas, Brazil	University of London; London School of Hygiene & Tropical Medicine; Universidade Federal de Pelotas	Gon, G (corresponding author), London Sch Hyg & Trop Med, Infect Dis Epidemiol Dept, London, England.	giorgia.gon@lshtm.ac.uk	Gon, Giorgia/GRJ-9198-2022; Barros, Aluisio JD/A-7417-2008	Barros, Aluisio JD/0000-0002-2022-8729; Gon, Giorgia/0000-0002-9741-7712; Campbell, Oona/0000-0002-9311-0115; Restrepo-Mendez, Maria Clara/0000-0001-7714-7340; Graham, Wendy/0000-0003-1473-5342	U.S. Fund for UNICEF under the Bill & Melinda Gates Foundation; Scottish Charity; UNICEF; Soapbox Collaborative	U.S. Fund for UNICEF under the Bill & Melinda Gates Foundation; Scottish Charity; UNICEF; Soapbox Collaborative	This work was funded through a sub-grant from the U.S. Fund for UNICEF under the Countdown to 2015 for Maternal, Newborn and Child Survival grant from the Bill & Melinda Gates Foundation; and by funding provided by a Scottish Charity, the Soapbox Collaborative.; We thank Prof Cesar Victora<SUP>1</SUP>, Dr. Sandra Virgo<SUP>2</SUP>, Dr. Clara Calvert<SUP>2</SUP>, and Oliver Cumming<SUP>2</SUP> for their technical input to this paper, and Deepthi Wickremasinghe<SUP>2</SUP> for her editorial contribution. We also thank Countdown to 2015, UNICEF and the Soapbox Collaborative for the financial contribution to the project.	Allegranzi B, 2011, LANCET, V377, P228, DOI 10.1016/S0140-6736(10)61458-4; Bain R, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001644; Barros AJD, 2012, LANCET, V379, P1225, DOI 10.1016/S0140-6736(12)60113-5; Benova L, 2014, TROP MED INT HLTH; Benova L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106738; Blencowe H, 2011, BMC PUBLIC HEALTH, V11, DOI [10.1186/1471-2458-11-S3-S9, 10.1186/1471-2458-11-S3-S11]; Campbell OMR, 2014, TROP MED INT HLTH TM, DOI [10.1111/tmi.12439, DOI 10.1111/TMI.2439]; Chambers V, 2012, DELIVERING MATERNAL; Fink G, 2011, INT J EPIDEMIOL, V40, P1196, DOI 10.1093/ije/dyr102; Gon G, 2014, TROP MED INT HEALTH, V19, P1488, DOI 10.1111/tmi.12394; Gordon AA., 1795, TREATISE EPIDEMIC PU; Gould IM, 2010, LANCET INFECT DIS, V10, P275, DOI 10.1016/S1473-3099(09)70304-4; Johnson K, 2004, DHS COMP REPORTS; Kassebaum NJ, 2014, LANCET, V384, P980, DOI 10.1016/S0140-6736(14)60696-6; Luangasanatip N, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h3728; Makaka A, 2012, LANCET S2, V380, pS7, DOI DOI 10.1016/S0140-6736(13)60293-7; Padhi BK, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001851; Restrepo-Mendez MC, 2014, PUBLIC HEALTH NUTR, V18; Rheingans R, 2014, TROP MED INT HEALTH, V19, P2, DOI 10.1111/tmi.12220; Seale AC, 2014, LANCET INFECT DIS, V14, P731, DOI 10.1016/S1473-3099(14)70804-7; Semmelweis I., 1983, ETIOLOGY CONCEPT PRO; Shamba DD, 2013, J HEALTH POPUL NUTR, V31, P110; Skiles MP, 2013, POPUL HEALTH METR, V11, DOI 10.1186/1478-7954-11-14; UN DESA, SUST DEV KNOWL PLATF; UNICEF and World Health Organization, 2015, 25 YEARS PROGR SAN D; Velleman Y, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001771; WHO, 2015, WATER SANITATION HYG; Wolf J, 2014, TROP MED INT HEALTH, V19, P928, DOI 10.1111/tmi.12331; Zaidi AKM, 2005, LANCET, V365, P1175, DOI 10.1016/S0140-6736(05)71881-X	29	20	20	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2016	11	8							e01605720	10.1371/journal.pone.0160572	http://dx.doi.org/10.1371/journal.pone.0160572			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4YN	27532291	Green Published, Green Accepted, gold			2022-12-27	WOS:000381487600037
J	Gu, L; Qu, JX; Sun, B; Yu, XM; Li, H; Cao, B				Gu, Li; Qu, Jiuxin; Sun, Bing; Yu, Xiaomin; Li, Hui; Cao, Bin			Sustained Viremia and High Viral Load in Respiratory Tract Secretions Are Predictors for Death in Immunocompetent Adults with Adenovirus Pneumonia	PLOS ONE			English	Article							DISEASE	The predictors for fatal adenovirus (AdV) pneumonia among immunocompetent adults are unclear. Laboratory-confirmed, hospitalized AdV pneumonia adults were prospectively enrolled in Beijing Chao-Yang hospital from March to June 2013. Clinical data and serial whole blood and respiratory tract secretions from such patients were collected. Quantitative real-time polymerase chain reaction was performed to quantify the viral load. A total of 14 AdV pneumonia cases were consecutively enrolled, and four of them were fatal. Ten cases were caused by AdV-55, three by AdV-7 and one by AdV-3. There were no differences in age, gender or underlying diseases between the patients in the fatal cases and surviving cases. At admission (on day 5-7 after illness onset), the patients in fatal cases presented higher initial viral loads in respiratory tract secretions (8.578 +/- 2.115 vs 6.263 +/- 1.225 Log(10) copies/ml, p = 0.023). All patients in fatal cases presented with viremia on day 12-14 (100% vs 66.7%, p = 0.017). A higher initial viral load in the respiratory tract and sustained viremia (more than 2 weeks) may be predictors for fatal clinical outcomes.	[Gu, Li; Qu, Jiuxin; Yu, Xiaomin; Li, Hui; Cao, Bin] Capital Med Univ, Beijing Chao Yang Hosp, Beijing Inst Resp Med, Dept Infect Dis & Clin Microbiol, Beijing, Peoples R China; [Sun, Bing] Capital Med Univ, Beijing Chao Yang Hosp, Beijing Inst Resp Med, Dept Pulm & Crit Care, Beijing, Peoples R China; [Cao, Bin] China Japan Friendship Hosp, Clin Microbiol & Infect Dis Lab, Dept Resp & Crit Care Med, Beijing, Peoples R China	Capital Medical University; Capital Medical University; China-Japan Friendship Hospital	Cao, B (corresponding author), Capital Med Univ, Beijing Chao Yang Hosp, Beijing Inst Resp Med, Dept Infect Dis & Clin Microbiol, Beijing, Peoples R China.; Cao, B (corresponding author), China Japan Friendship Hosp, Clin Microbiol & Infect Dis Lab, Dept Resp & Crit Care Med, Beijing, Peoples R China.	caobin_ben@163.com		Gu, Li/0000-0002-3318-3902	Beijing Science and Technology Project [D101100049810002, Z131100002613001]; Ministry of Health, P.R. China [20130217]; Beijing Municipal Administration of Hospitals' Youth Programme [20150306]; National Natural Science Foundation of China [81070005/H0104, 81030032/H19, 81271840, 81400005/H0104]	Beijing Science and Technology Project; Ministry of Health, P.R. China; Beijing Municipal Administration of Hospitals' Youth Programme; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Beijing Science and Technology Project [grant numbers D101100049810002, Z131100002613001], Ministry of Health, P.R. China [grant number 20130217], Beijing Municipal Administration of Hospitals' Youth Programme [grant number 20150306], and the National Natural Science Foundation of China [grant numbers 81070005/H0104, 81030032/H19, 81271840 and 81400005/H0104].	Cao B, 2010, EUR J CLIN MICROBIOL, V29, P1443, DOI 10.1007/s10096-010-1003-2; Cao B, 2014, CHEST, V145, P79, DOI 10.1378/chest.13-1186; Centers for Disease Control and Prevention (CDC), 2001, MMWR Morb Mortal Wkly Rep, V50, P553; Gu L, 2012, J CLIN VIROL, V54, P295, DOI 10.1016/j.jcv.2012.04.018; Hakim FA, 2008, EUR J CLIN MICROBIOL, V27, P153, DOI 10.1007/s10096-007-0416-z; Lee YJ, 2013, BIOL BLOOD MARROW TR, V19, P387, DOI 10.1016/j.bbmt.2012.10.014; Louie JK, 2008, CLIN INFECT DIS, V46, P421, DOI 10.1086/525261; Shike H, 2005, PEDIATR INFECT DIS J, V24, P29, DOI 10.1097/01.inf.0000148882.97399.79; Zhu Z, 2009, J CLIN MICROBIOL, V47, P697, DOI 10.1128/JCM.01769-08	9	24	26	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2016	11	8							e0160777	10.1371/journal.pone.0160777	http://dx.doi.org/10.1371/journal.pone.0160777			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4YN	27532864	Green Published, gold, Green Submitted			2022-12-27	WOS:000381487600042
J	Guan, TP; Owens, JR; Gong, MH; Liu, G; Ouyang, ZY; Song, YL				Guan, Tian-Pei; Owens, Jacob R.; Gong, Ming-Hao; Liu, Gang; Ouyang, Zhi-Yun; Song, Yan-Ling			Role of New Nature Reserve in Assisting Endangered Species Conservation - Case Study of Giant Pandas in the Northern Qionglai Mountains, China	PLOS ONE			English	Article							WOLONG NATURE-RESERVE; WENCHUAN EARTHQUAKE; HABITAT; DISPERSAL; DIVERSITY; NETWORK; MINSHAN	The creation of nature reserves is the most direct way to save endangered species populations and their habitat. Development of the giant panda (Ailuropoda melanoleuca) nature reserve network in China was initiated in the 1960s, though the effort to create new reserves boomed considerably after the year 2000. Given this rapid development of protected areas in panda habitats, and the potential conflicting interests between conservation administrations and local economic development, it is essential to assess the role of new nature reserves in the overall giant panda conservation effort and reserve network. We utilized data from national giant panda surveys conducted in 2000 and 2012 to compare the size, spatial use, and distribution of panda populations, as well as the habitat suitability and connectivity in the Northern Qionglai Mountains between the two survey years. Our results show that although the total giant panda population in the study area did not change remarkably, local changes did occur. Most notably, the population in Wolong Nature Reserve declined by 27.3% (N = 39) and the population in Caopo Nature Reserve increased by 71.4% (N = 29) over the 12-year study period. We also found habitat suitability and availability decreased in both Wolong (12.4%) and Caopo (7.4%), but that the relative density of giant pandas declined (19.2%) and increased (84.6%) at each site, respectively. The distance between centers of high IUA were more distant in 2012 (14.1 +/- 1.9km) than that in 2000 (6.1 +/- 0.9km; t = -7.4, df = 5, p = 0.001), showing a scattered spatial pattern. Habitat availability decreased by 42% within the corridor between the two reserves, however panda occurrences in the corridor increased 24.6%. Compared to the total number of encounters, the proportion of the corridor increased 45.76%. Our results show the importance and success of the newly established Caopo to the conservation of giant pandas, and how crucial it is to identify and repair reserve corridors. Furthermore, we propose criteria for future nature reserve network management and investment, which is applicable for other endangered species conservation practices.	[Guan, Tian-Pei] Mianyang Normal Univ, Ecol Secur & Protect Key Lab Sichuan Prov, Mianyang, Peoples R China; [Owens, Jacob R.] Chengdu Res Base Giant Panda Breeding, Chengdu, Peoples R China; [Gong, Ming-Hao; Liu, Gang] Chinese Acad Forestry, Res Inst Wetland, Beijing, Peoples R China; [Ouyang, Zhi-Yun] Chinese Acad Sci, Ecoenvironm Sci Res Ctr, Beijing, Peoples R China; [Song, Yan-Ling] Chinese Acad Sci, Inst Zool, Beijing, Peoples R China	Mianyang Teachers' College; Chinese Academy of Forestry; Chinese Academy of Sciences; Research Center for Eco-Environmental Sciences (RCEES); Chinese Academy of Sciences; Institute of Zoology, CAS	Gong, MH (corresponding author), Chinese Acad Forestry, Res Inst Wetland, Beijing, Peoples R China.	gongmh2005@hotmail.com	Liu, Gang/AAE-4197-2022; guan, tianpei/ABG-4874-2020	Liu, Gang/0000-0002-3614-0561; Owens, Jacob/0000-0003-1528-650X	Fourth National Giant Panda Survey; Chinese State Forestry Administration (SFA); National Natural Science Foundation of China [31300319]; Chinese State Forestry Administration [CM1423]; WWF-China [10002980]; Mianyang Normal University [QD2014A001, QD2012A12]	Fourth National Giant Panda Survey; Chinese State Forestry Administration (SFA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese State Forestry Administration; WWF-China; Mianyang Normal University	This study was funded by the Fourth National Giant Panda Survey initiated by the Chinese State Forestry Administration (SFA). National Natural Science Foundation of China (31300319) Chinese State Forestry Administration (No. CM1423), WWF-China (No. 10002980), Mianyang Normal University (QD2014A001, QD2012A12) also provided financial support for this study. We thank Jiansheng Jia, Director of Wildlife Conservation Department at SFA, for providing supporting during our study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was funded by the Fourth National Giant Panda Survey initiated by the Chinese State Forestry Administration (SFA). National Natural Science Foundation of China (31300319) Chinese State Forestry Administration (No. CM1423), WWF-China (No. 10002980), Mianyang Normal University (QD2014A001, QD2012A12) also provided financial support for this study. We thank Jiansheng Jia, Director of Wildlife Conservation Department at SFA, for providing supporting during our study. We are grateful toWeihua Xu, Zhichen Wang, Baocheng Yu, Ximing Zhang, Qiang Jiu and Youde Chang for comments and assistance. Especially, we appreciate the contributions of all field survey teams. We also acknowledge comments and suggestions from anonymous reviewers and Dr. William J McShea in improving the manuscript.	Boitani L, 2008, PLOS BIOL, V6, P436, DOI 10.1371/journal.pbio.0060066; Brooks TM, 2009, CONSERV BIOL, V23, P1448, DOI 10.1111/j.1523-1739.2009.01334.x; Burgess ND, 2007, ORYX, V41, P151, DOI 10.1017/S0030605307001895; Campbell D, 2004, J APPL ECOL, V41, P1185, DOI 10.1111/j.0021-8901.2004.00964.x; Dai FC, 2011, J ASIAN EARTH SCI, V40, P883, DOI 10.1016/j.jseaes.2010.04.010; Efford MG, 2013, OIKOS, V122, P918, DOI 10.1111/j.1600-0706.2012.20440.x; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Forestry Department of Sichuan Province, 2016, PAND SICH 4 SURV REP; Gaston KJ, 2008, ANNU REV ECOL EVOL S, V39, P93, DOI 10.1146/annurev.ecolsys.39.110707.173529; Hu JC, 2001, RES GIANT PANDA; Li HL, 2010, ECOL MODEL, V221, P944, DOI 10.1016/j.ecolmodel.2009.12.006; Li RQ, 2015, BIOL CONSERV, V182, P93, DOI 10.1016/j.biocon.2014.11.037; Liu JG, 2001, SCIENCE, V292, P98, DOI 10.1126/science.1058104; Liu XH, 2015, ENVIRON SCI POLLUT R, V22, P1175, DOI 10.1007/s11356-014-3412-8; Liu XH, 2013, ECOL INDIC, V33, P121, DOI 10.1016/j.ecolind.2012.09.022; Matthysen E, 2005, ECOGRAPHY, V28, P403, DOI 10.1111/j.0906-7590.2005.04073.x; Morris DW, 2006, NATURE, V443, P645, DOI 10.1038/443645a; [欧阳志云 OUYANG ZhiYun], 2008, [生态学报, Acta Ecologica Sinica], V28, P5801; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Qi DW, 2015, FOLIA ZOOL, V64, P56; Qi DW, 2011, J ZOOL, V285, P205, DOI 10.1111/j.1469-7998.2011.00831.x; Rebelo H, 2010, GLOBAL CHANGE BIOL, V16, P561, DOI 10.1111/j.1365-2486.2009.02021.x; Schaller G.B., 1985, GIANT PANDAS WOLONG; Smart LS, 2012, FOREST ECOL MANAG, V281, P100, DOI 10.1016/j.foreco.2012.06.020; State Forestry Administration of Peoples Republic of China, 2006, BEIJ 3 NAT SURV REP; Teel TL, 2010, CONSERV BIOL, V24, P128, DOI 10.1111/j.1523-1739.2009.01374.x; Western D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006140; Wu RD, 2011, FRONT ECOL ENVIRON, V9, P383, DOI 10.1890/100093; Xu JL, 2012, ORYX, V46, P554, DOI 10.1017/S0030605311000810; Xu WH, 2009, FRONT ECOL ENVIRON, V7, P353, DOI 10.1890/080192; Yang B, 2015, CONSERV LETT, V8, P251, DOI 10.1111/conl.12143; Zheng W, 2012, BIOL CONSERV, V145, P241, DOI 10.1016/j.biocon.2011.11.016	32	7	8	1	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2016	11	8							e0159738	10.1371/journal.pone.0159738	http://dx.doi.org/10.1371/journal.pone.0159738			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4YN	27532870	Green Published, Green Submitted, gold			2022-12-27	WOS:000381487600011
J	Rhodes, D; Di Luca, M				Rhodes, Darren; Di Luca, Massimiliano			Temporal Regularity of the Environment Drives Time Perception (vol 11, e0159842, 2016)	PLOS ONE			English	Correction													Di Luca, Massimiliano/A-7850-2012	Di Luca, Massimiliano/0000-0003-3085-7251; Rhodes, Darren/0000-0001-5859-4567				Rhodes D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159842	1	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2016	11	8							e0161677	10.1371/journal.pone.0161677	http://dx.doi.org/10.1371/journal.pone.0161677			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4YN	27532631	Green Published, gold			2022-12-27	WOS:000381487600099
J	Yu, ZY; Huang, P; Yu, YH; Zheng, Z; Huang, ZC; Guo, CY; Lin, DH				Yu, Ziyao; Huang, Pei; Yu, Yuanhui; Zheng, Zhen; Huang, Zicheng; Guo, Chenyun; Lin, Donghai			Unique Properties of the Rabbit Prion Protein Oligomer	PLOS ONE			English	Article							PHYSICAL-PROPERTIES; SOLUBLE OLIGOMERS; AMYLOID FIBRILS; TOXICITY; DISEASE; NEURODEGENERATION; TRANSITION; STABILITY; INFECTION; NEUROTOXICITY	Prion diseases, also known as transmissible spongiform encephalopathies (TSEs), are a group of fatal neurodegenerative disorders infecting both humans and animals. Recent works have demonstrated that the soluble prion protein oligomer (PrPO), the intermediate of the conformational transformation from the host-derived cellular form (PrPC) to the disease-associated Scrapie form (PrPSc), exerts the major neurotoxicity in vitro and in vivo. Rabbits show strong resistance to TSEs, the underlying mechanism is unclear to date. It is expected that the relative TSEs-resistance of rabbits is closely associated with the unique properties of rabbit prion protein oligomer which remain to be addressed in detail. In the present work, we prepared rabbit prion protein oligomer (recRaPrP(O)) and human prion protein oligomer (recHuPrP(O)) under varied conditions, analyzed the effects of pH, NaCl concentration and incubation temperature on the oligomerization, and compared the properties of recRaPrP(O) and recHuPrP(O). We found that several factors facilitated the formation of prion protein oligomers, including low pH, high NaCl concentration, high incubation temperature and low conformational stability of monomeric prion protein. RecRaPrPO was formed more slowly than recHuPrP(O) at physiological-like conditions (< 57 degrees C, < 150 mM NaCl). Furthermore, recRaPrP(O) possessed higher susceptibility to proteinase K and lower cytotoxicity in vitro than recHuPrP(O). These unique properties of recRaPrP(O) might substantially contribute to the TSEs-resistance of rabbits. Our work sheds light on the oligomerization of prion proteins and is of benefit to mechanistic understanding of TSEs-resistance of rabbits.	[Yu, Ziyao; Huang, Pei; Yu, Yuanhui; Zheng, Zhen; Huang, Zicheng; Guo, Chenyun; Lin, Donghai] Xiamen Univ, Coll Chem & Chem Engn, Key Lab Chem Biol Fujian Prov, MOE Key Lab Spectrochem Anal & Instrumentat, Xiamen 361005, Peoples R China	Xiamen University	Lin, DH (corresponding author), Xiamen Univ, Coll Chem & Chem Engn, Key Lab Chem Biol Fujian Prov, MOE Key Lab Spectrochem Anal & Instrumentat, Xiamen 361005, Peoples R China.	dhlin@xmu.edu.cn			National Natural Science Foundation of China [31170717, 31470034]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by funds from the National Natural Science Foundation of China (Nos. 31170717, 31470034, https://isisn.nsfc.gov.cn/egrantweb/).	Apetri AC, 2003, J BIOL CHEM, V278, P22187, DOI 10.1074/jbc.M302130200; Ballard C, 2011, LANCET, V377, P1019, DOI 10.1016/S0140-6736(10)61349-9; Baskakov IV, 2002, J BIOL CHEM, V277, P21140, DOI 10.1074/jbc.M111402200; Baskakov IV, 2000, BIOCHEMISTRY-US, V39, P2792, DOI 10.1021/bi9923353; Baskakov IV, 2001, J BIOL CHEM, V276, P19687, DOI 10.1074/jbc.C100180200; Bitel Claudine L., 2010, BMC Physiology, V10, P18, DOI 10.1186/1472-6793-10-18; Bocharova OV, 2005, J MOL BIOL, V346, P645, DOI 10.1016/j.jmb.2004.11.068; Carrell RW, 2008, FEBS LETT, V582, P2537, DOI 10.1016/j.febslet.2008.06.021; Carrell RW, 2005, TRENDS CELL BIOL, V15, P574, DOI 10.1016/j.tcb.2005.09.005; Caughey B, 2003, ANNU REV NEUROSCI, V26, P267, DOI 10.1146/annurev.neuro.26.010302.081142; Cheon M, 2007, PLOS COMPUT BIOL, V3, P1727, DOI 10.1371/journal.pcbi.0030173; Chianini F, 2012, P NATL ACAD SCI USA, V109, P5080, DOI 10.1073/pnas.1120076109; Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; Eghiaian F, 2007, P NATL ACAD SCI USA, V104, P7414, DOI 10.1073/pnas.0607745104; Fernandez-Borges N, 2012, PRION, V6, DOI 10.4161/pri.22057; Gerber R, 2007, J BIOL CHEM, V282, P6300, DOI 10.1074/jbc.M608926200; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Horiuchi M, 1999, STRUCTURE, V7, pR231, DOI 10.1016/S0969-2126(00)80049-0; Horwich AL, 1997, CELL, V89, P499, DOI 10.1016/S0092-8674(00)80232-9; Huang P, 2013, ACTA BIOCH BIOPH SIN, V45, P442, DOI 10.1093/abbs/gmt037; Kudo W, 2012, HUM MOL GENET, V21, P1138, DOI 10.1093/hmg/ddr542; Lansbury PT, 1997, NEURON, V19, P1151, DOI 10.1016/S0896-6273(00)80406-7; Loftus B, 1997, GENE, V184, P215, DOI 10.1016/S0378-1119(96)00598-7; Ma JY, 2002, SCIENCE, V298, P1781, DOI 10.1126/science.1073725; Ma Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036288; Martins SM, 2006, J BIOL CHEM, V281, P26121, DOI 10.1074/jbc.M605367200; MEYER RK, 1986, P NATL ACAD SCI USA, V83, P2310, DOI 10.1073/pnas.83.8.2310; Mindell JA, 2012, ANNU REV PHYSIOL, V74, P69, DOI 10.1146/annurev-physiol-012110-142317; Morillas M, 2001, BIOCHEMISTRY-US, V40, P6982, DOI 10.1021/bi010232q; Pauli Georg, 2005, Cell and Tissue Banking, V6, P191, DOI 10.1007/s10561-005-0336-z; PRUSINER SB, 1984, SCI AM, V251, P50, DOI 10.1038/scientificamerican1084-50; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Rezaei H, 2005, J MOL BIOL, V347, P665, DOI 10.1016/j.jmb.2005.01.043; Rezaei H, 2002, J MOL BIOL, V322, P799, DOI 10.1016/S0022-2836(02)00856-2; Sasaki K, 2008, PRION, V2, P118, DOI 10.4161/pri.2.3.7148; Sigurdson CJ, 2006, J VIROL, V80, P12303, DOI 10.1128/JVI.01120-06; Silveira JR, 2005, NATURE, V437, P257, DOI 10.1038/nature03989; Simoneau S, 2007, PLOS PATHOG, V3, P1175, DOI 10.1371/journal.ppat.0030125; Sokolowski F, 2003, J BIOL CHEM, V278, P40481, DOI 10.1074/jbc.M304391200; Stefani M, 2003, J MOL MED, V81, P678, DOI 10.1007/s00109-003-0464-5; Swietnicki W, 1997, J BIOL CHEM, V272, P27517, DOI 10.1074/jbc.272.44.27517; Vorberg I, 2003, J VIROL, V77, P2003, DOI 10.1128/JVI.77.3.2003-2009.2003; Wen Y, 2010, J BIOL CHEM, V285, P31682, DOI 10.1074/jbc.M110.118844; Wen Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013273; Yan X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113238; Yin SM, 2003, PROTEIN EXPRES PURIF, V32, P104, DOI 10.1016/S1046-5928(03)00195-5; Yuan Z, 2015, J NEUROCHEM, V133, P722, DOI 10.1111/jnc.13098; Yuan Z, 2013, ACTA BIOCH BIOPH SIN, V45, P899, DOI 10.1093/abbs/gmt093; Zhang JP, 2011, J THEOR BIOL, V269, P88, DOI 10.1016/j.jtbi.2010.10.020; Zhou Z, 2011, BIOPHYS J, V101, P1483, DOI 10.1016/j.bpj.2011.08.018	50	5	6	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2016	11	8							e0160874	10.1371/journal.pone.0160874	http://dx.doi.org/10.1371/journal.pone.0160874			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4UN	27529173	gold, Green Submitted, Green Published			2022-12-27	WOS:000381476700029
J	Zylstra, P; Bradstock, RA; Bedward, M; Penman, TD; Doherty, MD; Weber, RO; Gill, AM; Cary, GJ				Zylstra, Philip; Bradstock, Ross A.; Bedward, Michael; Penman, Trent D.; Doherty, Michael D.; Weber, Rodney O.; Gill, A. Malcolm; Cary, Geoffrey J.			Biophysical Mechanistic Modelling Quantifies the Effects of Plant Traits on Fire Severity: Species, Not Surface Fuel Loads, Determine Flame Dimensions in Eucalypt Forests	PLOS ONE			English	Article							SOUTH-EASTERN AUSTRALIA; MOISTURE-CONTENT; LITTER FLAMMABILITY; TEMPERATE FOREST; LEAF TRAITS; CROWN FIRE; BEHAVIOR; SPREAD; LIDAR; PERFORMANCE	The influence of plant traits on forest fire behaviour has evolutionary, ecological and management implications, but is poorly understood and frequently discounted. We use a process model to quantify that influence and provide validation in a diverse range of eucalypt forests burnt under varying conditions. Measured height of consumption was compared to heights predicted using a surface fuel fire behaviour model, then key aspects of our model were sequentially added to this with and without species-specific information. Our fully specified model had a mean absolute error 3.8 times smaller than the otherwise identical surface fuel model (p < 0.01), and correctly predicted the height of larger (>= 1 m) flames 12 times more often (p < 0.001). We conclude that the primary endogenous drivers of fire severity are the species of plants present rather than the surface fuel load, and demonstrate the accuracy and versatility of the model for quantifying this.	[Zylstra, Philip; Bradstock, Ross A.; Bedward, Michael] Univ Wollongong, Ctr Environm Risk Management Bushfires, Biol Sci, Wollongong, NSW, Australia; [Penman, Trent D.] Univ Melbourne, Sch Ecosyst & Forest Sci, Creswick, Vic, Australia; [Doherty, Michael D.; Gill, A. Malcolm; Cary, Geoffrey J.] Australian Natl Univ, Fenner Sch Environm & Soc, Acton, ACT, Australia; [Weber, Rodney O.] Univ NSW ADFA, Phys Environm & Math Sci, Canberra, ACT, Australia	University of Wollongong; University of Melbourne; Australian National University; University of New South Wales Sydney	Zylstra, P (corresponding author), Univ Wollongong, Ctr Environm Risk Management Bushfires, Biol Sci, Wollongong, NSW, Australia.	pzylstra@uow.edu.au	Cary, Geoffrey J./AAX-1964-2021; Zylstra, Philip/O-2587-2016; Penman, Trent D/A-7242-2012; Bedward, Michael/ABB-6905-2021; Doherty, Michael D/E-9700-2010	Zylstra, Philip/0000-0002-6946-866X; Penman, Trent D/0000-0002-5203-9818; Bedward, Michael/0000-0002-9986-1286; Doherty, Michael D/0000-0001-7671-880X; Cary, Geoffrey J./0000-0002-6386-1751	NSW Office of Environment and Heritage; University of Wollongong Centre for Environmental Risk Management of Bushfires	NSW Office of Environment and Heritage; University of Wollongong Centre for Environmental Risk Management of Bushfires	All work was funded by the NSW Office of Environment and Heritage (http://www.environment.nsw.gov.au) as part of an ongoing contract with the University of Wollongong Centre for Environmental Risk Management of Bushfires. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander ME, 2013, INT J WILDLAND FIRE, V22, P415, DOI 10.1071/WF12008; Alexander ME, 2012, INT J WILDLAND FIRE, V21, P95, DOI 10.1071/WF11001; Andersen HE, 2005, REMOTE SENS ENVIRON, V94, P441, DOI 10.1016/j.rse.2004.10.013; Anderson H. E., 1970, Fire Technology, V6, P312, DOI 10.1007/BF02588932; [Anonymous], 2021, LANG ENV STAT COMP; [Anonymous], 1996, IGNITABILITY LEAVES; Barrett TW, 2006, BUSHF C 2006 LIF FIR; Belcher CM, 2010, NAT GEOSCI, V3, P426, DOI 10.1038/NGEO871; Bowman DMJS, 2015, TRENDS ECOL EVOL, V30, P255, DOI 10.1016/j.tree.2015.03.005; Bradstock RA, 2010, LANDSCAPE ECOL, V25, P607, DOI 10.1007/s10980-009-9443-8; Burrows N. D., 1999, CALMScience, V3, P31; Burrows N. D., 1999, CALMScience, V3, P57; Butler BW, 2004, MON SCI TECHN S UN K, P595; Caccamo G, 2012, INT J WILDLAND FIRE, V21, P257, DOI 10.1071/WF11024; Cassiani M, 2008, BOUND-LAY METEOROL, V126, P433, DOI 10.1007/s10546-007-9242-1; Cheney NP, 2012, FOREST ECOL MANAG, V280, P120, DOI 10.1016/j.foreco.2012.06.012; Chuvieco E, 2004, REMOTE SENS ENVIRON, V92, P322, DOI 10.1016/j.rse.2004.01.019; CIONCO R M, 1972, Boundary-Layer Meteorology, V3, P255, DOI 10.1007/BF02033923; Collins L, 2013, INT J WILDL FIRE; Cornwell WK, 2015, NEW PHYTOL, V206, P672, DOI 10.1111/nph.13317; Cruz MG, 2005, CAN J FOREST RES, V35, P1626, DOI 10.1139/X05-085; de Magalhaes RMQ, 2012, J ECOL, V100, P1153, DOI 10.1111/j.1365-2745.2012.01987.x; DICKINSON KJM, 1985, J BIOGEOGR, V12, P121, DOI 10.2307/2844836; Doherty MD, 1998, VEGETATION SURVEY MA; Doherty MD, 1997, VEGETATION SURVEY MA; Fernandes PM, 2012, NEW PHYTOL, V194, P606, DOI 10.1111/j.1469-8137.2012.04065.x; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Gill A. M., 1975, Australian Forestry, V38, P4; Gill A. M., 2005, Australian Forestry, V68, P87; Gill AM, 2012, FLAMMABLE AUSTRALIA: FIRE REGIMES, BIODIVERSITY AND ECOSYSTEMS IN A CHANGING WORLD, P235; Gill AM, 2012, FLAMMABLE AUSTR FIRE, P351; Gill AM, 1994, P 2 INT C FOR FIR RE, P63; Gould J.S., 2007, FIELD GUIDE FUEL ASS; Grootemaat S, 2015, MODELS LEAF IGNITABI, P130, DOI [10.1017/CBO9781107415324.004, DOI 10.1017/CBO9781107415324.004]; Grootemaat S, 2015, FUNCT ECOL, V29, P1486, DOI 10.1111/1365-2435.12449; Higgins SI, 2014, BIOGEOSCIENCES, V11, P4357, DOI 10.5194/bg-11-4357-2014; Hintze JL, 1998, AM STAT, V52, P181, DOI 10.2307/2685478; Jensen JLR, 2008, REMOTE SENS ENVIRON, V112, P3947, DOI 10.1016/j.rse.2008.07.001; Kattge J, 2011, GLOBAL CHANGE BIOL, V17, P2905, DOI 10.1111/j.1365-2486.2011.02451.x; Keeley J. E., 2012, FIRE MEDITERRANEAN E; Keeley JE, 2009, INT J WILDLAND FIRE, V18, P116, DOI 10.1071/WF07049; Korhonen L, 2011, REMOTE SENS ENVIRON, V115, P1065, DOI 10.1016/j.rse.2010.12.011; Lindenmayer DB, 2013, BIOL CONSERV, V167, P137, DOI 10.1016/j.biocon.2013.07.028; Little JK, 2012, AUSTRAL ECOL, V37, P915, DOI 10.1111/j.1442-9993.2011.02350.x; Lovell JL, 2003, CAN J REMOTE SENS, V29, P607, DOI 10.5589/m03-026; Madrigal J, 2012, ANN FOREST SCI, V69, P387, DOI 10.1007/s13595-011-0165-0; Matthews S, 2014, INT J WILDLAND FIRE, V23, P78, DOI 10.1071/WF13005; Mccaw WL, 2012, FOREST ECOL MANAG, V271, P170, DOI 10.1016/j.foreco.2012.02.003; NOBLE IR, 1980, AUST J ECOL, V5, P201, DOI 10.1111/j.1442-9993.1980.tb01243.x; Olsen TS, 1963, ECOLOGY, V44, P322; Onoda Y, 2011, ECOL LETT, V14, P301, DOI 10.1111/j.1461-0248.2010.01582.x; Perez-Harguindeguy N, 2013, AUST J BOT, V61, P167, DOI 10.1071/BT12225; PHILPOT CW, 1970, FOREST SCI, V16, P461; Plucinski MP, 2010, INT J WILDLAND FIRE, V19, P512, DOI 10.1071/WF09038; Price OF, 2012, J ENVIRON MANAGE, V113, P146, DOI 10.1016/j.jenvman.2012.08.041; Rothermel RC, 1972, INT115; Scarff FR, 2006, FUNCT ECOL, V20, P745, DOI 10.1111/j.1365-2435.2006.01174.x; Scarff FR, 2012, INT J WILDLAND FIRE, V21, P1042, DOI 10.1071/WF09065; Schwilk DW, 2015, NEW PHYTOL, V206, P486, DOI 10.1111/nph.13372; Schwilk DW, 2011, J ECOL, V99, P970, DOI 10.1111/j.1365-2745.2011.01828.x; Sharples JJ, 2010, ENVIRON MODELL SOFTW, V25, P1099, DOI 10.1016/j.envsoft.2010.03.016; Simpson KJ, 2016, J ECOL, V104, P138, DOI 10.1111/1365-2745.12503; Taylor C, 2014, CONSERV LETT, V7, P355, DOI 10.1111/conl.12122; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; van Bodegom PM, 2014, P NATL ACAD SCI USA, V111, P13733, DOI 10.1073/pnas.1304551110; Van Wagner CE, 1973, CAN J FOREST RES, V3, P373, DOI DOI 10.1139/X73-055; Viegas DX, 2014, ADV FOREST FIRE RES, P326; Wagner C. E. van, 1977, Canadian Journal of Forest Research, V7, P23, DOI 10.1139/x77-004; Weber R. O., 1995, Landscape Fires '93: Proceedings of an Australian Bushfire Conference, Perth, Western Australia, 27-29 September 1993., P23; Williams RJ, 1998, INT J WILDLAND FIRE, V8, P227, DOI 10.1071/WF9980227; Willmott CJ, 2005, CLIMATE RES, V30, P79, DOI 10.3354/cr030079; Wright GT, 2004, PRELIMINARY ASSESSME; Wright GT, 2005, CONTINUING ASSESSMEN; Yebra M, 2013, REMOTE SENS ENVIRON, V136, P455, DOI 10.1016/j.rse.2013.05.029; Yebra M, 2009, REMOTE SENS ENVIRON, V113, P2403, DOI 10.1016/j.rse.2009.07.001; Zylstra P., 2006, FOREST ECOL MANAG, V234, pS81, DOI [10.1016/j.foreco.2006.08.117, DOI 10.1016/J.FORECO.2006.08.117]; Zylstra P., 2011, FOREST FLAMMABILITY, DOI DOI 10.13140/2.1.3722.0166; Zylstra P., 2014, GEOPH RES ABSTR, V16; Zylstra Philip, 2013, Victorian Naturalist (Blackburn), V130, P232	80	74	76	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2016	11	8							e0160715	10.1371/journal.pone.0160715	http://dx.doi.org/10.1371/journal.pone.0160715			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4UN	27529789	Green Published, gold, Green Submitted			2022-12-27	WOS:000381476700018
J	Arnon, S; Dahan, N; Koren, A; Radiano, O; Ronen, M; Yannay, T; Giron, J; Ben-Ami, L; Amir, Y; Hel-Or, Y; Friedman, D; Bachelet, I				Arnon, Shachar; Dahan, Nir; Koren, Amir; Radiano, Oz; Ronen, Matan; Yannay, Tal; Giron, Jonathan; Ben-Ami, Lee; Amir, Yaniv; Hel-Or, Yacov; Friedman, Doron; Bachelet, Ido			Thought-Controlled Nanoscale Robots in a Living Host	PLOS ONE			English	Article							BRAIN-COMPUTER INTERFACE; DNA; NANOPARTICLES; SHAPES	We report a new type of brain-machine interface enabling a human operator to control nanometer-size robots inside a living animal by brain activity. Recorded EEG patterns are recognized online by an algorithm, which in turn controls the state of an electromagnetic field. The field induces the local heating of billions of mechanically-actuating DNA origami robots tethered to metal nanoparticles, leading to their reversible activation and subsequent exposure of a bioactive payload. As a proof of principle we demonstrate activation of DNA robots to cause a cellular effect inside the insect Blaberus discoidalis, by a cognitively straining task. This technology enables the online switching of a bioactive molecule on and off in response to a subject's cognitive state, with potential implications to therapeutic control in disorders such as schizophrenia, depression, and attention deficits, which are among the most challenging conditions to diagnose and treat.	[Arnon, Shachar; Dahan, Nir; Koren, Amir; Radiano, Oz; Ronen, Matan; Yannay, Tal; Hel-Or, Yacov] Interdisciplinary Ctr, Efi Arazi Sch Comp Sci, Herzliyya, Israel; [Giron, Jonathan; Friedman, Doron] Interdisciplinary Ctr, Adv Virtual Lab, Sammy Ofer Sch Commun, Herzliyya, Israel; [Giron, Jonathan; Ben-Ami, Lee; Amir, Yaniv; Bachelet, Ido] Bar Ilan Univ, Fac Life Sci, Ramat Gan, Israel; [Giron, Jonathan; Ben-Ami, Lee; Amir, Yaniv; Bachelet, Ido] Bar Ilan Univ, Nanoctr, Ramat Gan, Israel	Reichman University; Reichman University; Bar Ilan University; Bar Ilan University	Bachelet, I (corresponding author), Bar Ilan Univ, Fac Life Sci, Ramat Gan, Israel.; Bachelet, I (corresponding author), Bar Ilan Univ, Nanoctr, Ramat Gan, Israel.	Dogbach@gmail.com			Europoean Research Council Starting Grant [335332]; Marie Curie Career Reintegration Grant [321772]	Europoean Research Council Starting Grant; Marie Curie Career Reintegration Grant	This work was supported by grants from the Europoean Research Council Starting Grant (no. 335332) and a Marie Curie Career Reintegration Grant (no. 321772) to I.B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors wish to thank all the members of the Bachelet lab for technical assistance and valuable discussions. This work was supported by grants from the Europoean Research Council Starting Grant and a Marie Curie Career Reintegration Grant to I.B.	Amir Y, 2014, NAT NANOTECHNOL, V9, P353, DOI [10.1038/NNANO.2014.58, 10.1038/nnano.2014.58]; Barenholz Y, 2012, J CONTROL RELEASE, V160, P117, DOI 10.1016/j.jconrel.2012.03.020; Bell CJ, 2008, J NEURAL ENG, V5, P214, DOI 10.1088/1741-2560/5/2/012; Christa N, 1993, CLIN NEUROPHYSIOL, V87, pS56; Coppage R, 2012, ACS NANO, V6, P1625, DOI 10.1021/nn204600d; Decharms RC, 2008, NAT REV NEUROSCI, V9, P720, DOI 10.1038/nrn2414; Douglas SM, 2012, SCIENCE, V335, P831, DOI 10.1126/science.1214081; Douglas SM, 2009, NUCLEIC ACIDS RES, V37, P5001, DOI 10.1093/nar/gkp436; Hamad-Schifferli K, 2002, NATURE, V415, P152, DOI 10.1038/415152a; Hochberg LR, 2012, NATURE, V485, P372, DOI 10.1038/nature11076; Isaacs RE, 2000, IEEE T REHABIL ENG, V8, P196, DOI 10.1109/86.847814; Kobayashi Y, 2011, J NANOPART RES, V13, P5365, DOI 10.1007/s11051-011-0522-9; Leeb R, 2008, IEEE T NEUR SYS REH, V16, P119, DOI 10.1109/TNSRE.2008.918082; Russell-Chapin LA, 2013, NEUROTHERAPY AND NEU; Sengupta S, 2005, NATURE, V436, P568, DOI 10.1038/nature03794; Shih JJ, 2012, MAYO CLIN PROC, V87, P268, DOI 10.1016/j.mayocp.2011.12.008; Sobczak JPJ, 2012, SCIENCE, V338, P1458, DOI 10.1126/science.1229919; Stanley SA, 2012, SCIENCE, V336, P604, DOI 10.1126/science.1216753; Vaughan TM, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/2/020201; WOLPAW JR, 1991, ELECTROEN CLIN NEURO, V78, P252, DOI 10.1016/0013-4694(91)90040-B	20	26	27	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2016	11	8							e0161227	10.1371/journal.pone.0161227	http://dx.doi.org/10.1371/journal.pone.0161227			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4SL	27525806	Green Published, gold, Green Submitted			2022-12-27	WOS:000381471100045
J	Ha, SJ; Kim, BG; Lee, YA; Kim, YH; Kim, BJ; Jung, SE; Pang, MG; Ryu, BY				Ha, Seung-Jung; Kim, Byung-Gak; Lee, Yong-An; Kim, Yong-Hee; Kim, Bang-Jin; Jung, Sang-Eun; Pang, Myeong-Geol; Ryu, Buom-Yong			Effect of Antioxidants and Apoptosis Inhibitors on Cryopreservation of Murine Germ Cells Enriched for Spermatogonial Stem Cells	PLOS ONE			English	Article							SILK PROTEIN SERICIN; FREE FREEZING MEDIUM; MOUSE TESTES; HEMATOPOIETIC STEM; MAMMALIAN-CELLS; TRANSPLANTATION; SERUM; TREHALOSE; PRESERVATION; EMBRYOS	Spermatogonial stem cells (SSCs) are germline stem cells that serve as the foundation of spermatogenesis to maintain fertility throughout a male's lifetime. To treat male infertility using stem cell banking systems and transplantation, it is important to be able to preserve SSCs for long periods of time. Therefore, this study was conducted to develop an optimal cryopreservation protocol for SSCs using antioxidants and apoptosis inhibitors in freezing medium. No differences were observed compared to controls when SSCs were cryopreserved in the presence of apoptosis inhibitors by themselves. However, mouse germ cells cryopreserved in basal medium containing the antioxidant hypotaurine (14 mM) resulted in significantly greater proliferation potential and mitochondrial activity. Furthermore, treatment groups with combinations containing 200 mM trehalose and 14 mM hypotaurine showed higher proliferation rates compared to controls. In addition, several serum free conditions were evaluated for SSC cryopreservation. Treatment media containing 10% or 20% knockout serum replacement resulted in similar cryopreservation results compared to media containing FBS. SSC transplantation was also performed to confirm the functionality of SSCs frozen in 14 mM hypotaurine. Donor SSCs formed normal spermatogenic colonies and sperm in the recipient testis. These data indicate that inclusion of 14 mM hypotaurine in cryopreservation media is an effective way to efficiently cryopreserve germ cells enriched for SSCs and that knockout serum replacement can replace FBS in germ cell cryopreservation media.	[Ha, Seung-Jung; Kim, Yong-Hee; Kim, Bang-Jin; Jung, Sang-Eun; Pang, Myeong-Geol; Ryu, Buom-Yong] Chung Ang Univ, Dept Anim Sci & Technol, Anseong, Gyeonggi Do, South Korea; [Kim, Byung-Gak] Chung Ang Univ, Bio Environm Technol Res Inst, Anseong, Gyeonggi Do, South Korea; [Lee, Yong-An] Agcy Sci Technol & Res, Singapore Bioimaging Consortium, Lab Bioimaging Probe Dev, Singapore, Singapore; [Kim, Bang-Jin] Univ Penn, Perelman Sch Med, Dept Canc Biol, Philadelphia, PA 19104 USA	Chung Ang University; Chung Ang University; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Bioengineering & Bioimaging (IBB); A*STAR - Singapore Bioimaging Consortium (SBIC); University of Pennsylvania; Pennsylvania Medicine	Ryu, BY (corresponding author), Chung Ang Univ, Dept Anim Sci & Technol, Anseong, Gyeonggi Do, South Korea.	byryu@cau.ac.kr		Lee, Yong-An/0000-0001-7253-2397	Korean Health Technology R&D Project, Ministry of Health and Welfare [HI12C0055]; Next-Generation BioGreen 21 Program, Republic of Korea [PJ011347]	Korean Health Technology R&D Project, Ministry of Health and Welfare; Next-Generation BioGreen 21 Program, Republic of Korea	This work was supported by the Korean Health Technology R&D Project, Ministry of Health and Welfare (HI12C0055), and Next-Generation BioGreen 21 Program (PJ011347), Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboagla EME, 2003, BIOL REPROD, V69, P1245, DOI 10.1095/biolreprod.103.017889; Brinster RL, 1998, SEMIN CELL DEV BIOL, V9, P401, DOI 10.1006/scdb.1998.0205; BRINSTER RL, 1994, P NATL ACAD SCI USA, V91, P11298, DOI 10.1073/pnas.91.24.11298; Brook PF, 2001, FERTIL STERIL, V75, P269, DOI 10.1016/S0015-0282(00)01721-0; Bucak MN, 2013, CRYOBIOLOGY, V67, P34, DOI 10.1016/j.cryobiol.2013.04.007; CHEN Y, 1993, CRYOBIOLOGY, V30, P423, DOI 10.1006/cryo.1993.1042; CROWE JH, 1984, SCIENCE, V223, P701, DOI 10.1126/science.223.4637.701; Cryns V, 1998, GENE DEV, V12, P1551, DOI 10.1101/gad.12.11.1551; Dalcin L, 2013, CRYOBIOLOGY, V67, P137, DOI 10.1016/j.cryobiol.2013.05.012; Desjardins C, 1993, CELL MOL BIOL TESTIS; Dobrinski I, 1999, BIOL REPROD, V61, P1331, DOI 10.1095/biolreprod61.5.1331; Dobrinski I, 2000, MOL REPROD DEV, V57, P270, DOI 10.1002/1098-2795(200011)57:3&lt;270::AID-MRD9&gt;3.0.CO;2-Z; Dohle GR, 2010, INT J UROL, V17, P327, DOI 10.1111/j.1442-2042.2010.02484.x; Duchez P, 2013, TRANSFUSION, V53, P2012, DOI 10.1111/trf.12015; Eroglu A, 2000, NAT BIOTECHNOL, V18, P163, DOI 10.1038/72608; Fellman J H, 1985, Prog Clin Biol Res, V179, P71; Gao D, 2000, ILAR J, V41, P187; GEORGE MA, 1992, HUM REPROD, V7, P408, DOI 10.1093/oxfordjournals.humrep.a137659; GRILLI G, 1980, CRYOBIOLOGY, V17, P516, DOI 10.1016/0011-2240(80)90063-2; Hagedorn M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039397; Isobe T, 2013, CRYOBIOLOGY, V67, P184, DOI 10.1016/j.cryobiol.2013.06.010; Izadyar F, 2002, J ANDROL, V23, P537; Kanatsu-Shinohara M, HUMAN REPROD; Kim GA, 2010, FERTIL STERIL, V94, P2409, DOI 10.1016/j.fertnstert.2010.01.073; Kubota H, 2004, P NATL ACAD SCI USA, V101, P16489, DOI 10.1073/pnas.0407063101; Lee YA, 2014, FERTIL STERIL, V101, P1165, DOI 10.1016/j.fertnstert.2013.12.033; Lee YA, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.111195; Lee YA, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0063255, 10.1371/journal.pone.0054889]; LEIBO SP, 1971, CRYOBIOLOGY, V8, P447, DOI 10.1016/0011-2240(71)90035-6; Limaye LS, 2001, J HEMATOTH STEM CELL, V10, P709, DOI 10.1089/152581601753193931; Memon AA, 2012, ANIM REPROD SCI, V136, P55, DOI 10.1016/j.anireprosci.2012.10.020; Miyamoto Y, 2012, CELL TRANSPLANT, V21, P617, DOI 10.3727/096368911X605556; Nagano M, 1999, BIOL REPROD, V60, P1429, DOI 10.1095/biolreprod60.6.1429; Oatley JM, 2006, METHOD ENZYMOL, V419, P259, DOI 10.1016/S0076-6879(06)19011-4; Ogawa T, 1997, INT J DEV BIOL, V41, P111; Ogawa T, 1999, BIOL REPROD, V60, P515, DOI 10.1095/biolreprod60.2.515; Ohnishi K, 2012, J HEPATO-BIL-PAN SCI, V19, P354, DOI 10.1007/s00534-011-0415-4; Pegg David E, 2007, Methods Mol Biol, V368, P39; Piwkham Duangjai, 2015, Asian Pac J Cancer Prev, V16, P4727; Ryu BY, 2004, DEV BIOL, V274, P158, DOI 10.1016/j.ydbio.2004.07.004; Sasaki M, 2005, BIOTECHNOL APPL BIOC, V42, P183, DOI 10.1042/BA20050019; Seo JM, 2011, CRYOBIOLOGY, V62, P167, DOI 10.1016/j.cryobiol.2011.02.003; Siriboon C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118165; Stroh C, 2002, FASEB J, V16, P1651, DOI 10.1096/fj.02-0034fje; Thibier M, 2006, REPROD DOMEST ANIM, V41, P260, DOI 10.1111/j.1439-0531.2006.00721.x; WRIGHT CE, 1986, ANNU REV BIOCHEM, V55, P427, DOI 10.1146/annurev.bi.55.070186.002235; Wu X, 2012, HUM REPROD, V27, P1249, DOI 10.1093/humrep/des077; Zeng W, 2009, REPROD FERT DEVELOP, V21, P489, DOI 10.1071/RD08235	48	40	43	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2016	11	8							e0161372	10.1371/journal.pone.0161372	http://dx.doi.org/10.1371/journal.pone.0161372			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT8TP	27548381	gold, Green Published, Green Submitted			2022-12-27	WOS:000381768400049
J	Montana, S; Schramm, STJ; Traglia, GM; Chiem, K; Di Noto, GP; Almuzara, M; Barberis, C; Vay, C; Quiroga, C; Tolmasky, ME; Iriarte, A; Ramirez, MS				Montana, Sabrina; Schramm, Sareda T. J.; Matias Traglia, German; Chiem, Kevin; Parmeciano Di Noto, Gisela; Almuzara, Marisa; Barberis, Claudia; Vay, Carlos; Quiroga, Cecilia; Tolmasky, Marcelo E.; Iriarte, Andres; Soledad Ramirez, Maria			The Genetic Analysis of an Acinetobacter johnsonii Clinical Strain Evidenced the Presence of Horizontal Genetic Transfer	PLOS ONE			English	Article							ANTIBIOTIC-RESISTANCE; BAUMANNII; IDENTIFICATION; BACTEREMIA; EXPRESSION; ANNOTATIONS; BLA(OXA-58); PHYLOGENIES; ALGORITHMS; INFECTION	Acinetobacter johnsonii rarely causes human infections. While most A. johnsonii isolates are susceptible to virtually all antibiotics, strains harboring a variety of beta-lactamases have recently been described. An A. johnsonii Aj2199 clinical strain recovered from a hospital in Buenos Aires produces PER-2 and OXA-58. We decided to delve into its genome by obtaining the whole genome sequence of the Aj2199 strain. Genome comparison studies on Aj2199 revealed 240 unique genes and a close relation to strain WJ10621, isolated from the urine of a patient in China. Genomic analysis showed evidence of horizontal genetic transfer (HGT) events. Forty-five insertion sequences and two intact prophages were found in addition to several resistance determinants such as bla(PER-2), bla(OXA-58), bla(TEM-1), strA, strB, ereA, sul1, aacC2 and a new variant of bla(OXA-211), called bla(OXA-498). In particular, bla(PER-2) and bla(TEM- 1) are present within the typical contexts previously described in the Enterobacteriaceae family. These results suggest that A. johnsonii actively acquires exogenous DNA from other bacterial species and concomitantly becomes a reservoir of resistance genes.	[Montana, Sabrina; Matias Traglia, German; Chiem, Kevin; Parmeciano Di Noto, Gisela; Quiroga, Cecilia; Soledad Ramirez, Maria] UBA CONICET, Inst Invest Microbiol & Parasitol Med IMPaM, Buenos Aires, DF, Argentina; [Schramm, Sareda T. J.; Chiem, Kevin; Tolmasky, Marcelo E.; Soledad Ramirez, Maria] Calif State Univ Fullerton, Dept Biol Sci, Fullerton, CA 92634 USA; [Almuzara, Marisa; Barberis, Claudia; Vay, Carlos] Hosp Clin Jose San Martin, Dept Bioquim Clin, Lab Bacteriol Clin, Fac Farm & Bioquim, Buenos Aires, DF, Argentina; [Iriarte, Andres] UdelaR, Fac Med, Inst Higiene, Dept Desarrollo Biotecnol, Montevideo, Uruguay	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; California State University System; California State University Fullerton; University of Buenos Aires; Hospital de Clinicas Jose de San Martin; Universidad de la Republica, Uruguay	Ramirez, MS (corresponding author), UBA CONICET, Inst Invest Microbiol & Parasitol Med IMPaM, Buenos Aires, DF, Argentina.; Ramirez, MS (corresponding author), Calif State Univ Fullerton, Dept Biol Sci, Fullerton, CA 92634 USA.	msramirez@fullerton.edu	Quiroga, Cecilia/AAK-2933-2020; Tolmasky, Marcelo/AAC-5316-2020	Tolmasky, Marcelo/0000-0002-6298-7811; Traglia, German Matias/0000-0002-4780-5311; Quiroga, Cecilia/0000-0002-5552-3349; Iriarte, Andres/0000-0002-5862-0152	"Secretaria de Ciencia y Tecnica de la Universidad de Buenos Aires" (UBACyT); Buenos Aires, Argentina [PICT 0120]; CONICET; National Institute on Minority Health and Health Disparities, National Institute of Health [MHIRT 2T37MD001368]; Science, Technology, and Productive Innovation office (Mincyt) Argentina [AECID A1/041041/11, D/024562/09]; National Institute on Minority Health and Health Disparities [T37MD001368] Funding Source: NIH RePORTER	"Secretaria de Ciencia y Tecnica de la Universidad de Buenos Aires" (UBACyT)(Secretaria de Ciencia y Tecnologia (SECYT)); Buenos Aires, Argentina; CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); National Institute on Minority Health and Health Disparities, National Institute of Health; Science, Technology, and Productive Innovation office (Mincyt) Argentina; National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported by grants from the "Secretaria de Ciencia y Tecnica de la Universidad de Buenos Aires" (UBACyT) and PICT 0120 to MSR, Buenos Aires, Argentina. MSR and CQ is a member of the CONICET research career and SM, GMT, and GPDN have a Doctoral Fellowship from CONICET. KC was supported by grant MHIRT 2T37MD001368 from the National Institute on Minority Health and Health Disparities, National Institute of Health. AI is a researcher from the Sistema Nacional de Investigadores (ANII), Uruguay.; We want to acknowledge the Argentinian Consortium of Genomic Technology ( ACGT), which is funded by the PPL project of the Science, Technology, and Productive Innovation office (Mincyt) Argentina AECID A1/041041/11, D/024562/09, and INTA, for technical support.	Antipov D, 2016, BIORXIV, P1; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Bailey JK, 2011, J ANTIMICROB CHEMOTH, V66, P745, DOI 10.1093/jac/dkq529; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Basmaci R, 2014, ANTIMICROB AGENTS CH, V58, P6258, DOI 10.1128/AAC.03562-14; Carattoli A, 2014, ANTIMICROB AGENTS CH, V58, P3895, DOI 10.1128/AAC.02412-14; CHIOU CS, 1993, J BACTERIOL, V175, P732, DOI 10.1128/JB.175.3.732-740.1993; Cho BK, 2014, BMC BIOL, V12, DOI 10.1186/1741-7007-12-4; Chusri S, 2014, ANTIMICROB AGENTS CH, V58, P4172, DOI 10.1128/AAC.02992-14; Contreras-Moreira B, 2013, APPL ENVIRON MICROB, V79, P7696, DOI 10.1128/AEM.02411-13; Fehlberg LCC, 2014, ANTIMICROB AGENTS CH, V58, P1831, DOI 10.1128/AAC.01260-13; Di Nocera PP, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-224; Endo S, 2014, J CLIN MICROBIOL, V52, P911, DOI 10.1128/JCM.03009-13; Espinal P, 2011, FUTURE MICROBIOL, V6, P495, DOI [10.2217/fmb.11.30, 10.2217/FMB.11.30]; Feng Y, 2016, J ANTIMICROB CHEMOTH, V71, P71, DOI 10.1093/jac/dkv324; Fu YQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084680; Goris J, 2007, INT J SYST EVOL MICR, V57, P81, DOI 10.1099/ijs.0.64483-0; Guardabassi L, 1999, J APPL MICROBIOL, V87, P659, DOI 10.1046/j.1365-2672.1999.00905.x; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Gupta SK, 2014, ANTIMICROB AGENTS CH, V58, P212, DOI 10.1128/AAC.01310-13; Hare JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093861; Hare JM, 2012, MICROBIOL-SGM, V158, P601, DOI 10.1099/mic.0.054668-0; Harmer CJ, 2015, MBIO, V6, DOI 10.1128/mBio.01866-15; Huerta-Cepas J, 2016, NUCLEIC ACIDS RES, V44, pD286, DOI 10.1093/nar/gkv1248; Iacono M, 2008, ANTIMICROB AGENTS CH, V52, P2616, DOI 10.1128/AAC.01643-07; Imperi F, 2011, IUBMB LIFE, V63, P1068, DOI 10.1002/iub.531; Karah N, 2011, J ANTIMICROB CHEMOTH, V66, P738, DOI 10.1093/jac/dkq521; Krizova L, 2015, INT J SYST EVOL MICR, V65, P3905, DOI 10.1099/ijsem.0.000511; Krizova L, 2015, INT J SYST EVOL MICR, V65, P857, DOI 10.1099/ijs.0.000028; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Liebert CA, 1999, MICROBIOL MOL BIOL R, V63, P507, DOI 10.1128/MMBR.63.3.507-522.1999; Liu ZR, 2015, J CHEMOTHERAPY, V27, P207, DOI 10.1179/1973947814Y.0000000190; Lopes BS, 2012, J MED MICROBIOL, V61, P1103, DOI 10.1099/jmm.0.044156-0; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Mammeri H, 2003, ANTIMICROB AGENTS CH, V47, P1536, DOI 10.1128/AAC.47.5.1536-1542.2003; Traglia GM, 2014, J INFECT DEV COUNTR, V8, P666, DOI 10.3855/jidc.3747; Mazauric MH, 2008, J BIOL CHEM, V283, P20421, DOI 10.1074/jbc.M802829200; Menouni R, 2015, FEMS MICROBIOL LETT, V362, DOI 10.1093/femsle/fnu022; Mugnier PD, 2009, J BACTERIOL, V191, P2414, DOI 10.1128/JB.01258-08; Nawrocki EP, 2013, BIOINFORMATICS, V29, P2933, DOI 10.1093/bioinformatics/btt509; Overbeek R, 2014, NUCLEIC ACIDS RES, V42, pD206, DOI 10.1093/nar/gkt1226; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Perichon B, 2014, ANTIMICROB AGENTS CH, V58, P936, DOI 10.1128/AAC.01261-13; Poirel L, 2006, ANTIMICROB AGENTS CH, V50, P1442, DOI 10.1128/AAC.50.4.1442-1448.2006; Poirel L, 2008, ANTIMICROB AGENTS CH, V52, P1252, DOI 10.1128/AAC.01304-07; Power P, 2007, ANTIMICROB AGENTS CH, V51, P2359, DOI 10.1128/AAC.01395-06; Rapa RA, 2015, ENVIRON MICROBIOL, V17, P1090, DOI 10.1111/1462-2920.12512; Ravasi P, 2011, ANTIMICROB AGENTS CH, V55, P917, DOI 10.1128/AAC.00491-10; Renda BA, 2015, J BACTERIOL, V197, P872, DOI 10.1128/JB.02263-14; Roca I, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00148; Rodriguez CH, 2014, DIAGN MICR INFEC DIS, V80, P341, DOI 10.1016/j.diagmicrobio.2014.09.013; Schilling D, 2010, ARCH MICROBIOL, V192, P691, DOI 10.1007/s00203-010-0592-6; SEIFERT H, 1993, CLIN INFECT DIS, V17, P632, DOI 10.1093/clinids/17.4.632; Seifert H, 1997, J CLIN MICROBIOL, V35, P2819, DOI 10.1128/JCM.35.11.2819-2825.1997; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Siguier P, 2006, NUCLEIC ACIDS RES, V34, pD32, DOI 10.1093/nar/gkj014; Ramirez MS, 2010, J CLIN MICROBIOL, V48, P1488, DOI 10.1128/JCM.01264-09; Sousa C, 2014, EUR J CLIN MICROBIOL, V33, P1345, DOI 10.1007/s10096-014-2078-y; Sousa C, 2014, INT J MED MICROBIOL, V304, P669, DOI 10.1016/j.ijmm.2014.04.014; Storz G, 2011, MOL CELL, V43, P880, DOI 10.1016/j.molcel.2011.08.022; Sukumaran J, 2010, BIOINFORMATICS, V26, P1569, DOI 10.1093/bioinformatics/btq228; TOLMASKY ME, 1984, J BACTERIOL, V160, P860, DOI 10.1128/JB.160.3.860-866.1984; Touchon M, 2014, GENOME BIOL EVOL, V6, P2866, DOI 10.1093/gbe/evu225; Tsai HY, 2012, EUR J CLIN MICROBIOL, V31, P2737, DOI 10.1007/s10096-012-1622-x; Turton JF, 2010, J CLIN MICROBIOL, V48, P1445, DOI 10.1128/JCM.02467-09; van den Broek PJ, 2009, J CLIN MICROBIOL, V47, P3593, DOI 10.1128/JCM.00967-09; Vogel J, 2011, NAT REV MICROBIOL, V9, P578, DOI 10.1038/nrmicro2615; Yamamoto M, 2009, ADV EXP MED BIOL, V667, P59, DOI 10.1007/978-1-4419-1603-7_6; Yildirim S, 2016, SCI REP-UK, V6, DOI 10.1038/srep22110; Zarrilli R, 2008, ANTIMICROB AGENTS CH, V52, P4115, DOI 10.1128/AAC.00366-08; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhou Y, 2011, NUCLEIC ACIDS RES, V39, pW347, DOI 10.1093/nar/gkr485; Zimbler DL, 2013, INFECT IMMUN, V81, P3382, DOI 10.1128/IAI.00540-13; Zong ZY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090046	75	21	21	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2016	11	8							e0161528	10.1371/journal.pone.0161528	http://dx.doi.org/10.1371/journal.pone.0161528			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT8TP	27548264	gold, Green Published, Green Submitted			2022-12-27	WOS:000381768400065
J	Costello, MJ; Brennan, LA; Mohamed, A; Gilliland, KO; Johnsen, S; Kantorow, M				Costello, M. Joseph; Brennan, Lisa A.; Mohamed, Ashik; Gilliland, Kurt O.; Johnsen, Soenke; Kantorow, Marc			Identification and Ultrastructural Characterization of a Novel Nuclear Degradation Complex in Differentiating Lens Fiber Cells	PLOS ONE			English	Article							MOUSE EYE LENS; TERMINAL DIFFERENTIATION; VERTEBRATE LENS; OCULAR LENS; AUTOPHAGY; CATARACT; MECHANISMS; EXPRESSION; BREAKDOWN; DNASE	An unresolved issue in structural biology is how the encapsulated lens removes membranous organelles to carry out its role as a transparent optical element. In this ultrastructural study, we establish a mechanism for nuclear elimination in the developing chick lens during the formation of the organelle-free zone. Day 12-15 chick embryo lenses were examined by high-resolution confocal light microscopy and thin section transmission electron microscopy (TEM) following fixation in 10% formalin and 4% paraformaldehyde, and then processing for confocal or TEM as described previously. Examination of developing fiber cells revealed normal nuclei with dispersed chromatin and clear nucleoli typical of cells in active ribosome production to support protein synthesis. Early signs of nuclear degradation were observed about 300 mu m from the lens capsule in Day 15 lenses where the nuclei display irregular nuclear stain and prominent indentations that sometimes contained a previously undescribed macromolecular aggregate attached to the nuclear envelope. We have termed this novel structure the nuclear excisosome. This complex by confocal is closely adherent to the nuclear envelope and by TEM appears to degrade the outer leaflet of the nuclear envelope, then the inner leaflet up to 500 mu m depth. The images suggest that the nuclear excisosome separates nuclear membrane proteins from lipids, which then form multilamellar assemblies that stain intensely in confocal and in TEM have 5 nm spacing consistent with pure lipid bilayers. The denuded nucleoplasm then degrades by condensation and loss of structure in the range 600 to 700 mu m depth producing pyknotic nuclear remnants. None of these stages display any classic autophagic vesicles or lysosomes associated with nuclei. Uniquely, the origin of the nuclear excisosome is from filopodial-like projections of adjacent lens fiber cells that initially contact, and then appear to fuse with the outer nuclear membrane. These filopodial-like projections appear to be initiated with a clathrin-like coat and driven by an internal actin network. In summary, a specialized cellular organelle, the nuclear excisosome, generated in part by adjacent fiber cells degrades nuclei during fiber cell differentiation and maturation.	[Costello, M. Joseph; Gilliland, Kurt O.] Univ N Carolina, Dept Cell Biol & Physiol, Chapel Hill, NC 27599 USA; [Brennan, Lisa A.; Kantorow, Marc] Florida Atlantic Univ, Dept Biomed Sci, Boca Raton, FL 33431 USA; [Mohamed, Ashik] LV Prasad Eye Inst, Ophthalm Biophys, Hyderabad, Andhra Pradesh, India; [Johnsen, Soenke] Duke Univ, Dept Biol, Durham, NC USA	University of North Carolina; University of North Carolina Chapel Hill; State University System of Florida; Florida Atlantic University; L. V. Prasad Eye Institute; Duke University	Costello, MJ (corresponding author), Univ N Carolina, Dept Cell Biol & Physiol, Chapel Hill, NC 27599 USA.	mjc@med.unc.edu	Mohamed, Ashik/D-5105-2014; Core UNC, Hooker Imaging/AAE-1484-2022	Mohamed, Ashik/0000-0001-5520-4930; Gilliland, Kurt/0000-0002-9000-2119	NIH/NEI grant [R01EY008148, R01EY026478, P30EY005722]; NATIONAL EYE INSTITUTE [R01EY008148, R01EY026478] Funding Source: NIH RePORTER	NIH/NEI grant; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by NIH/NEI grants R01EY008148 (MJC), R01EY026478 (MK) and P30EY005722 (Duke Core Grant). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bassnett S, 1997, J CELL BIOL, V137, P37, DOI 10.1083/jcb.137.1.37; BASSNETT S, 1992, DEV DYNAM, V194, P85, DOI 10.1002/aja.1001940202; Bassnett S, 2011, PHILOS T R SOC B, V366, P1250, DOI 10.1098/rstb.2010.0302; Bassnett S, 2009, EXP EYE RES, V88, P133, DOI 10.1016/j.exer.2008.08.017; Basu S, 2014, AUTOPHAGY, V10, P1193, DOI 10.4161/auto.28768; Brennan LA, 2012, MOL VIS, V18, P1773; Caceres A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013331; Chaffee BR, 2014, DEVELOPMENT, V141, P3388, DOI 10.1242/dev.106005; Chen K, 2014, MOL BIOL EVOL, V31, P2194, DOI 10.1093/molbev/msu181; Costello MJ, 2013, EXP EYE RES, V116, P141, DOI 10.1016/j.exer.2013.08.017; Costello MJ, 2010, EXP EYE RES, V91, P881, DOI 10.1016/j.exer.2010.09.013; Cvekl A, 2014, DEVELOPMENT, V141, P4432, DOI 10.1242/dev.107953; De Maria A, 2007, INVEST OPHTH VIS SCI, V48, P5638, DOI 10.1167/iovs.07-0782; Girao H, 2005, INVEST OPHTH VIS SCI, V46, P1386, DOI 10.1167/iovs.04-0563; Kuszak JR, 2004, INT J DEV BIOL, V48, P889, DOI 10.1387/ijdb.041880jk; KUSZAK JR, 2004, DEV OCULAR LENS, P71; KUSZAK JR, 1994, PRINCIPLES PRACTICE, P82; KUWABARA T, 1974, INVEST OPHTH VISUAL, V13, P973; Lovicu FJ, 2005, DEV BIOL, V280, P1, DOI 10.1016/j.ydbio.2005.01.020; Mochizuki T, 2014, DEV GROWTH DIFFER, V56, P387, DOI 10.1111/dgd.12128; MODAK SP, 1970, EXP CELL RES, V59, P43, DOI 10.1016/0014-4827(70)90622-1; Mohamed A, 2013, MOL VIS, V19, P2352; Nakahara M, 2007, FEBS J, V274, P3055, DOI 10.1111/j.1742-4658.2007.05836.x; Nishimoto S, 2003, NATURE, V424, P1071, DOI 10.1038/nature01895; Rabl C., 1899, Z WISS ZOOL, V67, P1; Robinson ML, 2006, SEMIN CELL DEV BIOL, V17, P726, DOI 10.1016/j.semcdb.2006.10.002; SANWAL M, 1986, EXP CELL RES, V167, P429, DOI 10.1016/0014-4827(86)90183-7; Vrensen GFJM, 2004, EXP EYE RES, V78, P661, DOI 10.1016/j.exer.2003.07.004; VRENSEN GFJM, 1991, EXP EYE RES, V52, P647, DOI 10.1016/0014-4835(91)90017-9; Wignes JA, 2013, EXP EYE RES, V115, P263, DOI 10.1016/j.exer.2013.06.026; WILLEKENS B, 1985, TISSUE CELL, V17, P359, DOI 10.1016/0040-8166(85)90055-2; Wride MA, 2011, PHILOS T R SOC B, V366, P1219, DOI 10.1098/rstb.2010.0324; Zandy AJ, 2005, J BIOL CHEM, V280, P30263, DOI 10.1074/jbc.M504007200; Zandy AJ, 2007, INVEST OPHTH VIS SCI, V48, P293, DOI 10.1167/iovs.06-0656; Zhou CJ, 2003, EXP EYE RES, V77, P423, DOI 10.1016/S0014-4835(03)00171-4	35	8	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0160785	10.1371/journal.pone.0160785	http://dx.doi.org/10.1371/journal.pone.0160785			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27536868	Green Submitted, Green Published, gold			2022-12-27	WOS:000381577000031
J	Han, D; Shim, H; Jeon, B; Jang, Y; Hong, Y; Jung, S; Ha, S; Chang, HJ				Han, Dongjin; Shim, Hackjoon; Jeon, Byunghwan; Jang, Yeonggul; Hong, Youngtaek; Jung, Sunghee; Ha, Seongmin; Chang, Hyuk-Jae			Automatic Coronary Artery Segmentation Using Active Search for Branches and Seemingly Disconnected Vessel Segments from Coronary CT Angiography	PLOS ONE			English	Article							COMPUTED-TOMOGRAPHY; EXTRACTION; TRACKING	We propose a Bayesian tracking and segmentation method of coronary arteries on coronary computed tomographic angiography (CCTA). The geometry of coronary arteries including lumen boundary is estimated in Maximum A Posteriori (MAP) framework. Three consecutive sphere based filtering is combined with a stochastic process that is based on the similarity of the consecutive local neighborhood voxels and the geometric constraint of a vessel. It is also founded on the prior knowledge that an artery can be seen locally disconnected and consist of branches which may be seemingly disconnected due to plaque build up. For such problem, an active search method is proposed to find branches and seemingly disconnected but actually connected vessel segments. Several new measures have been developed for branch detection, disconnection check and planar vesselness measure. Using public domain Rotterdam CT dataset, the accuracy of extracted centerline is demonstrated and automatic reconstruction of coronary artery mesh is shown.	[Han, Dongjin; Shim, Hackjoon; Jeon, Byunghwan; Jang, Yeonggul; Hong, Youngtaek; Jung, Sunghee; Ha, Seongmin; Chang, Hyuk-Jae] Yonsei Univ, Coll Med, 134 Sinchon, Seoul, South Korea	Yonsei University; Yonsei University Health System	Chang, HJ (corresponding author), Yonsei Univ, Coll Med, 134 Sinchon, Seoul, South Korea.	ross.djhan@gmail.com	Shim, Hackjoon/AAA-3027-2021; Han, Dongjin/A-7554-2010; Jung, Sunghee/AAL-1636-2021	Han, Dongjin/0000-0003-1093-1741; Chang, Hyuk-Jae/0000-0002-6139-7545	ICT R&D program of MSIP/IITP (Development of Multi-modality Imaging and 3D Simulation-Based Integrative Diagnosis-Treatment Support Software System for Cardiovascular Diseases) Korea [10044910]; Institute for Information & communications Technology Promotion(IITP) grant - Korea government(MSIP) [R0101-16-0171]	ICT R&D program of MSIP/IITP (Development of Multi-modality Imaging and 3D Simulation-Based Integrative Diagnosis-Treatment Support Software System for Cardiovascular Diseases) Korea; Institute for Information & communications Technology Promotion(IITP) grant - Korea government(MSIP)	This work was supported by the ICT R&D program of MSIP/IITP (10044910, Development of Multi-modality Imaging and 3D Simulation-Based Integrative Diagnosis-Treatment Support Software System for Cardiovascular Diseases) Korea.; This work was supported by Institute for Information & communications Technology Promotion(IITP) grant funded by the Korea government(MSIP) (No. R0101-16-0171, Development of Multi-modality Imaging and 3D Simulation-Based Integrative Diagnosis-Treatment Support Software System for Cardiovascular Diseases).	Bahler, 2008, INSIGHT J, V4; Barzohar M, 1996, IEEE T PATTERN ANAL, V18, P707, DOI 10.1109/34.506793; Bauer C, 2008, INSIGHT J; Boskamp T, 2005, MEDICAL IMAGING SYSTEMS TECHNOLOGY: METHODS IN CARDIOVASCULAR AND BRAIN SYSTEMS, VOL 5, P1; Ciresan D., 2012, ADV NEURAL INF PROCE, V25, P2843; Frangi AF, 1998, LECT NOTES COMPUT SC, V1496, P130, DOI 10.1007/BFb0056195; grand-challenge org, 2009, ROTTERDAM CORONARY A; HARTIGAN JA, 1985, ANN STAT, V13, P70, DOI 10.1214/aos/1176346577; Jiang S, 2013, JOURNAL OF COMPUTATI, V9, P9833; Kirbas C, 2004, ACM COMPUT SURV, V36, P81, DOI 10.1145/1031120.1031121; Kitamura Y, 2012, 2012 9TH IEEE INTERNATIONAL SYMPOSIUM ON BIOMEDICAL IMAGING (ISBI), P234, DOI 10.1109/ISBI.2012.6235527; Kitslaar P, 2008, MIDAS J; Lesage D, 2009, LECT NOTES COMPUT SC, V5761, P222, DOI 10.1007/978-3-642-04268-3_28; Lesage D, 2009, MED IMAGE ANAL, V13, P819, DOI 10.1016/j.media.2009.07.011; Marquering HA, 2005, INT J CARDIOVAS IMAG, V21, P73, DOI 10.1007/s10554-004-5341-y; Marquering HA, 2008, MED IMAGING; Schaap M, 2009, MED IMAGE ANAL, V13, P701, DOI 10.1016/j.media.2009.06.003; Serruys PW, 2009, NEW ENGL J MED, V360, P961, DOI 10.1056/NEJMoa0804626; Shim H, 2006, COMPUT METH PROG BIO, V84, P135, DOI 10.1016/j.cmpb.2006.09.001; Strandmark P, 2013, IEEE I CONF COMP VIS, P2024, DOI 10.1109/ICCV.2013.253; Struik D. J., 1961, LECTURES ON CLASSICA; Szymczak A, 2006, MED IMAGE ANAL, V10, P548, DOI 10.1016/j.media.2006.05.002; Taylor CA, 2013, J AM COLL CARDIOL, V61, P2233, DOI 10.1016/j.jacc.2012.11.083; Tek H., 2008, THE MIDAS JOURNAL GR; Ulen J, 2015, IEEE T PATTERN ANAL, V37, P2588, DOI 10.1109/TPAMI.2015.2409869; van der Giessen AG, 2010, INT J CARDIOVAS IMAG, V26, P781, DOI 10.1007/s10554-009-9546-y; Wesarg S, 2006, J DIGIT IMAGING, V19, P249, DOI 10.1007/s10278-006-9947-6; Yang GY, 2012, INT J CARDIOVAS IMAG, V28, P921, DOI 10.1007/s10554-011-9894-2; Yang Q, 2002, INT C PATT RECOG, P282, DOI 10.1109/ICPR.2002.1048295; Zhao F, 2011, I S BIOMED IMAGING, P2066, DOI 10.1109/ISBI.2011.5872819; Zheng YF, 2013, LECT NOTES COMPUT SC, V8151, P74, DOI 10.1007/978-3-642-40760-4_10; Zhou C, 2012, COMPUT MED IMAG GRAP, V36, P1, DOI 10.1016/j.compmedimag.2011.04.001	32	15	17	8	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0156837	10.1371/journal.pone.0156837	http://dx.doi.org/10.1371/journal.pone.0156837			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27536939	Green Published, Green Submitted, gold			2022-12-27	WOS:000381577000002
J	Montefusco, F; Akman, OE; Soyer, OS; Bates, DG				Montefusco, Francesco; Akman, Ozgur E.; Soyer, Orkun S.; Bates, Declan G.			Ultrasensitive Negative Feedback Control: A Natural Approach for the Design of Synthetic Controllers	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; COVALENT MODIFICATION; YEAST OSMOREGULATION; OSMOTIC-STRESS; GENE NETWORKS; ADAPTATION; NOISE; SYSTEMS; MODEL; GLYCEROL	Many of the most important potential applications of Synthetic Biology will require the ability to design and implement high performance feedback control systems that can accurately regulate the dynamics of multiple molecular species within the cell. Here, we argue that the use of design strategies based on combining ultrasensitive response dynamics with negative feedback represents a natural approach to this problem that fully exploits the strongly nonlinear nature of cellular information processing. We propose that such feedback mechanisms can explain the adaptive responses observed in one of the most widely studied biomolecular feedback systems-the yeast osmoregulatory response network. Based on our analysis of such system, we identify strong links with a well-known branch of mathematical systems theory from the field of Control Engineering, known as Sliding Mode Control. These insights allow us to develop design guidelines that can inform the construction of feedback controllers for synthetic biological systems.	[Montefusco, Francesco] Univ Padua, Dept Informat Engn, Padua, Italy; [Akman, Ozgur E.] Univ Exeter, Coll Engn Math & Phys Sci, Exeter, Devon, England; [Soyer, Orkun S.] Univ Warwick, Sch Life Sci, Coventry, W Midlands, England; [Bates, Declan G.] Univ Warwick, Sch Engn, Coventry, W Midlands, England	University of Padua; University of Exeter; University of Warwick; University of Warwick	Montefusco, F (corresponding author), Univ Padua, Dept Informat Engn, Padua, Italy.	montefusco@dei.unipd.it	MONTEFUSCO, FRANCESCO/ABI-7613-2020	MONTEFUSCO, FRANCESCO/0000-0002-3264-9686	UK Engineering and Physical Sciences Research Council (EPSRC) [EP/I017445/1]; EPSRC [EP/I017445/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/I017445/1] Funding Source: researchfish	UK Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was funded by the UK Engineering and Physical Sciences Research Council (EPSRC), grant number EP/I017445/1.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Amin M, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003890; Amin M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002949; Ang J, 2013, BIOPHYS J, V104, P505, DOI 10.1016/j.bpj.2012.12.015; Arpino JAJ, 2013, MICROBIOL-SGM, V159, P1236, DOI 10.1099/mic.0.067975-0; Bashor CJ, 2008, SCIENCE, V319, P1539, DOI 10.1126/science.1151153; Becskei A, 2000, NATURE, V405, P590, DOI 10.1038/35014651; Behar M, 2007, BIOPHYS J, V93, P806, DOI 10.1529/biophysj.107.107516; Bluthgen N, 2006, FEBS J, V273, P895, DOI 10.1111/j.1742-4658.2006.05105.x; Bruggeman FJ, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000506; Buchler NE, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.30; Cluzel P, 2000, SCIENCE, V287, P1652, DOI 10.1126/science.287.5458.1652; Cosentino C., 2011, FEEDBACK CONTROL SYS; Csikasz-Nagy A, 2008, J R SOC INTERFACE, V5, pS41, DOI 10.1098/rsif.2008.0099.focus; de Godoy LMF, 2008, NATURE, V455, P1251, DOI 10.1038/nature07341; Del Vecchio D, 2013, ANNU REV CONTROL, V37, P333, DOI 10.1016/j.arcontrol.2013.09.011; Dorf R., 2000, MODERN CONTROL SYSTE; Drengstig T, 2012, BIOPHYS J, V103, P2000, DOI 10.1016/j.bpj.2012.09.033; Dublanche Y, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100081; Fan SS, 2014, INTERFACE FOCUS, V4, DOI 10.1098/rsfs.2014.0002; Fleming PJ, 2002, CONTROL ENG PRACT, V10, P1223, DOI 10.1016/S0967-0661(02)00081-3; Franklin GF, 1994, EMANI NAEINI FEEDBAC; Gennemark Peter, 2006, In Silico Biology, V6, P193; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Goldberg D.E., 1996, GENETIC ALGORITHMS S; GOLDBETER A, 1984, J BIOL CHEM, V259, P14441; GOLDBETER A, 1981, P NATL ACAD SCI-BIOL, V78, P6840, DOI 10.1073/pnas.78.11.6840; Gomez-Uribe C, 2007, PLOS COMPUT BIOL, V3, P2487, DOI 10.1371/journal.pcbi.0030246; Huang CYF, 1996, P NATL ACAD SCI USA, V93, P10078, DOI 10.1073/pnas.93.19.10078; Khalil HK, 2002, NONLINEAR SYSTENS; Klipp E, 2005, NAT BIOTECHNOL, V23, P975, DOI 10.1038/nbt1114; Kothamachu VB, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003322; LEVIN RL, 1979, J MEMBRANE BIOL, V46, P91, DOI 10.1007/BF01961376; Ljung L., 1999, SYSTEM IDENTIFICATIO; Lobo FG, 1996, ILLIGAL REPORT NO 96; MATLAB, 2004, GLOB OPT TOOLB US GU; MATLAB, 1990, OPT TOOLB US GUID; Mettetal JT, 2008, SCIENCE, V319, P482, DOI 10.1126/science.1151582; Muzzey D, 2009, CELL, V138, P160, DOI 10.1016/j.cell.2009.04.047; Newman JRS, 2006, NATURE, V441, P840, DOI 10.1038/nature04785; O'Shaughnessy EC, 2011, CELL, V144, P119, DOI 10.1016/j.cell.2010.12.014; Oyarzun DA, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0671; Peisajovich SG, 2010, SCIENCE, V328, P368, DOI 10.1126/science.1182376; Rao CV, 2002, NATURE, V420, P231, DOI 10.1038/nature01258; REED RH, 1987, APPL ENVIRON MICROB, V53, P2119, DOI 10.1128/AEM.53.9.2119-2123.1987; Schaber J, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.53; Schaber J, 2010, EUR BIOPHYS J BIOPHY, V39, P1547, DOI 10.1007/s00249-010-0612-0; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Shin YJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012785; Shtessel Y., 2013, SLIDING MODE CONTROL; Singh A, 2009, BIOPHYS J, V96, P4013, DOI 10.1016/j.bpj.2009.02.064; Skogestad S, 1996, MULTIVARIABLE FEEDBA; Sourjik V, 2002, P NATL ACAD SCI USA, V99, P123, DOI 10.1073/pnas.011589998; Sunder S, 1996, MOL CELL BIOCHEM, V158, P121; Tamas MJ, 1999, MOL MICROBIOL, V31, P1087, DOI 10.1046/j.1365-2958.1999.01248.x; Thattai M, 2001, P NATL ACAD SCI USA, V98, P8614, DOI 10.1073/pnas.151588598; Tiwari A, 2011, MATH BIOSCI, V231, P76, DOI 10.1016/j.mbs.2011.03.004; Tsimring LS, 2014, REP PROG PHYS, V77, DOI 10.1088/0034-4885/77/2/026601; Utkin VI, 1992, SLIDING MODES IN CON, P1992; Ventura AC, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000041; Zi ZK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009522	61	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0161605	10.1371/journal.pone.0161605	http://dx.doi.org/10.1371/journal.pone.0161605			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27537373	gold, Green Published			2022-12-27	WOS:000381577000126
J	Puce, S; Pica, D; Schiaparelli, S; Negrisolo, E				Puce, Stefania; Pica, Daniela; Schiaparelli, Stefano; Negrisolo, Enrico			Integration of Morphological Data into Molecular Phylogenetic Analysis: Toward the Identikit of the Stylasterid Ancestor	PLOS ONE			English	Article							GENERIC REVISION; HYDROZOA; CNIDARIA; EVOLUTION; COELENTERATA; TREE; NOV	Stylasteridae is a hydroid family including 29 worldwide-distributed genera, all provided with a calcareous skeleton. They are abundant in shallow and deep waters and represent an important component of marine communities. In the present paper, we studied the evolution of ten morphological characters, currently used in stylasterid taxonomy, using a phylogenetic approach. Our results indicate that stylasterid morphology is highly plastic and that many events of independent evolution and reversion have occurred. Our analysis also allows sketching a possible identikit of the stylasterid ancestor. It had calcareous skeleton, reticulate-granular coenosteal texture, polyps randomly arranged, gastrostyle, and dactylopore spines, while lacking a gastropore lip and dactylostyles. If the ancestor had single or double/multiple chambered gastropore tube is uncertain. These data suggest that the ancestor was similar to the extant genera Cyclohelia and Stellapora. Our investigation is the first attempt to integrate molecular and morphological information to clarify the stylasterid evolutionary scenario and represents the first step to infer the stylasterid ancestor morphology.	[Puce, Stefania; Pica, Daniela] Univ Politecn Marche, Dipartimento Sci Vita & Ambiente, Ancona, Italy; [Schiaparelli, Stefano] Univ Genoa, Dipartimento Sci Terra Ambiente & Vita, Genoa, Italy; [Schiaparelli, Stefano] Museo Nazl Antartide, Sede Genova, Genoa, Italy; [Negrisolo, Enrico] Univ Padua, Agripolis, Dipartimento Biomed Comparata & Alimentaz, Padua, Italy	Marche Polytechnic University; University of Genoa; University of Padua	Puce, S (corresponding author), Univ Politecn Marche, Dipartimento Sci Vita & Ambiente, Ancona, Italy.	s.puce@univpm.it	Schiaparelli, Stefano/AAI-4024-2020	Schiaparelli, Stefano/0000-0002-0137-3605; Pica, Daniela/0000-0001-7823-0488	SYNTHESYS Project; European Community Research Infrastructure Action under the FP7 Integrating Activities Programme; Universita Politecnica delle Marche - Ricerca Scientifica di Ateneo	SYNTHESYS Project; European Community Research Infrastructure Action under the FP7 Integrating Activities Programme; Universita Politecnica delle Marche - Ricerca Scientifica di Ateneo	This work was supported by a grant to SP (Universita Politecnica delle Marche - Ricerca Scientifica di Ateneo). DP visited the Natural History Museum in London and Natural History Museum in Leiden receiving support from the SYNTHESYS Project, which is financed by European Community Research Infrastructure Action under the FP7 Integrating Activities Programme (www.synthesys.info). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Broch H., 1942, SKRIFTER UTGITT N MN, V3, P1; Minh BQ, 2013, MOL BIOL EVOL, V30, P1188, DOI 10.1093/molbev/mst024; Cairns S.D., 1987, P257; Cairns S.D., 1983, Antarctic Research Series, V38, P61; Cairns S.D., 1998, Zoologische Verhandelingen (Leiden), V323, P311; Cairns S.D., 1991, New Zealand Oceanographic Institute Memoir, P1; CAIRNS S D, 1986, Smithsonian Contributions to Zoology, P1; CAIRNS S D, 1988, Records of the Western Australian Museum, V14, P105; CAIRNS SD, 1984, B MAR SCI, V35, P38; CAIRNS SD, 1983, B MAR SCI, V33, P427; Cairns SD., 1986, SMITHSONIAN CONTRIB, V426, P1, DOI [10.5479/si.00810282.426, DOI 10.5479/SI.00810282.426]; Cairns SD, 1983, P BIOL SOC WASH, V96, P158; Cairns Stephen D., 2015, V207, P5; Cairns SD, 2011, ZOOKEYS, P1, DOI 10.3897/zookeys.158.1910; Cairns SD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021670; Cairns Stephen D., 2005, Pacific Science, V59, P439, DOI 10.1353/psc.2005.0034; Deng Z., 1982, P184; Felsenstein J., 2004, INFERRING PHYLOGENIE; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Kennedy M, 2005, SYST BIOL, V54, P620, DOI 10.1080/106351591007462; Nguyen LT, 2015, MOL BIOL EVOL, V32, P268, DOI 10.1093/molbev/msu300; LANAVE C, 1984, J MOL EVOL, V20, P86, DOI 10.1007/BF02101990; Leclere L, 2007, ZOOL SCR, V36, P371, DOI 10.1111/j.1463-6409.2007.00283.x; Leclere L, 2009, SYST BIOL, V58, P509, DOI 10.1093/sysbio/syp044; Lewis PO, 2001, SYST BIOL, V50, P913, DOI 10.1080/106351501753462876; Lindner A, 2004, J MAR BIOL ASSOC UK, V84, P943, DOI 10.1017/S0025315404010239h; Lindner A, 2014, ZOOTAXA, V3900, P581, DOI 10.11646/zootaxa.3900.4.8; Lindner A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002429; Maddison WP., 2021, MESQUITE MODULAR SYS; Mendoza-Becerril MA, 2016, ZOOLOGICAL J LINNEAN; Miglietta MP, 2010, INTEGR COMP BIOL, V50, P428, DOI 10.1093/icb/icq102; Miglietta MP, 2012, EVOLUTION, V66, P3876, DOI 10.1111/j.1558-5646.2012.01717.x; Moseley HN., 1881, REPORT SCI RESULTS V, V2, P1; Moseley HN., 1881, REP SCI RES VOYAGE C, V2, P209; Puce S, 2012, CORAL REEFS, V31, P715, DOI 10.1007/s00338-012-0885-0; Puce S, 2010, J MAR BIOL ASSOC UK, V90, P1145, DOI 10.1017/S0025315409991433; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Royer-Carenzi M, 2013, MATH BIOSCI, V242, P95, DOI 10.1016/j.mbs.2012.12.003; Shimodaira H, 2002, SYST BIOL, V51, P492, DOI 10.1080/10635150290069913; Stylasteridae Broch H., 1914, DAN INGOLF EXPED, V5, P1; ZIBROWIUS H, 1981, BIJDR DIERKD, V51, P268	41	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0161423	10.1371/journal.pone.0161423	http://dx.doi.org/10.1371/journal.pone.0161423			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27537333	Green Published, gold, Green Submitted			2022-12-27	WOS:000381577000105
J	Segre, H; DeMalach, N; Henkin, Z; Kadmon, R				Segre, Hila; DeMalach, Niv; Henkin, Zalmen; Kadmon, Ronen			Quantifying Competitive Exclusion and Competitive Release in Ecological Communities: A Conceptual Framework and a Case Study	PLOS ONE			English	Article							GRASSLAND PLANT DIVERSITY; SPECIES RICHNESS; INTERMEDIATE DISTURBANCE; INTERTIDAL COMMUNITY; BIODIVERSITY LOSS; PREDATION; PRODUCTIVITY; HERBIVORES; MAINTENANCE; MECHANISMS	A fundamental notion in community ecology is that local species diversity reflects some balance between the contrasting forces of competitive exclusion and competitive release. Quantifying this balance is not trivial, and requires data on the magnitude of both processes in the same system, as well as appropriate methodology to integrate and interpret such data. Here we present a novel framework for empirical studies of the balance between competitive exclusion and competitive release and demonstrate its applicability using data from a Mediterranean annual grassland where grazing is a major mechanism of competitive release. Empirical data on the balance between competitive exclusion and competitive release are crucial for understanding observed patterns of variation in local species diversity and the proposed approach provides a simple framework for the collection, interpretation, and synthesis of such data.	[Segre, Hila; DeMalach, Niv; Kadmon, Ronen] Hebrew Univ Jerusalem, Dept Ecol Evolut & Behav, Jerusalem, Israel; [Henkin, Zalmen] Agr Res Org, Dept Nat Resources, Beef Cattle Sect, Newe Yaar Res Ctr, Ramat Yishay, Israel	Hebrew University of Jerusalem	DeMalach, N (corresponding author), Hebrew Univ Jerusalem, Dept Ecol Evolut & Behav, Jerusalem, Israel.	Nivdemalach@gmail.com	DeMalach, niv/AAW-8339-2020; Segre, Hila/AAJ-3995-2021	DeMalach, niv/0000-0002-4509-5387; Segre, Hila/0000-0002-3354-4675	Nature and Parks Authority; Ministry of Science and Technology TASHTIOT program; Israeli Science Foundation [454/11, 1026/11]	Nature and Parks Authority; Ministry of Science and Technology TASHTIOT program; Israeli Science Foundation(Israel Science Foundation)	This work was supported by the Nature and Parks Authority, the Ministry of Science and Technology TASHTIOT program, and the Israeli Science Foundation grants no. 454/11 and 1026/11.	Bakker ES, 2006, ECOL LETT, V9, P780, DOI 10.1111/j.1461-0248.2006.00925.x; BELSKY JA, 1992, J VEG SCI, V3, P187, DOI 10.2307/3235679; Borer ET, 2014, NATURE, V508, P517, DOI 10.1038/nature13144; Chase JM, 2002, ECOL LETT, V5, P302, DOI 10.1046/j.1461-0248.2002.00315.x; Chesson P, 2008, NATURE, V456, P235, DOI 10.1038/nature07248; Cingolani AM, 2005, ECOL APPL, V15, P757, DOI 10.1890/03-5272; Collins SL, 1998, SCIENCE, V280, P745, DOI 10.1126/science.280.5364.745; CONNELL JH, 1978, SCIENCE, V199, P1302, DOI 10.1126/science.199.4335.1302; Craine JM, 2005, J ECOL, V93, P1041, DOI 10.1111/j.1365-2745.2005.01043.x; De Bello F, 2007, J VEG SCI, V18, P25, DOI 10.1111/j.1654-1103.2007.tb02512.x; DeMalach N, 2016, J ECOL, V104, P899, DOI 10.1111/1365-2745.12557; Diaz S, 2001, J APPL ECOL, V38, P497, DOI 10.1046/j.1365-2664.2001.00635.x; Fox JW, 2013, TRENDS ECOL EVOL, V28, P86, DOI 10.1016/j.tree.2012.08.014; Gallet R, 2007, AM NAT, V170, P143, DOI 10.1086/518567; GOLDBERG DE, 1995, FOLIA GEOBOT PHYTOTX, V30, P231, DOI 10.1007/BF02812101; Goldberg DE, 1999, ECOLOGY, V80, P1118, DOI 10.2307/177059; GRIME JP, 1973, NATURE, V242, P344, DOI 10.1038/242344a0; Harrison S, 2010, ECOLOGY, V91, P2141, DOI 10.1890/09-0742.1; Hautier Y, 2009, SCIENCE, V324, P636, DOI 10.1126/science.1169640; HIXON MA, 1983, SCIENCE, V220, P511, DOI 10.1126/science.220.4596.511; HUSTON M, 1979, AM NAT, V113, P81, DOI 10.1086/283366; Isbell F, 2013, P NATL ACAD SCI USA, V110, P11911, DOI 10.1073/pnas.1310880110; KADMON R, 1990, ISRAEL J BOT, V39, P403; Kadmon R, 2006, AM NAT, V167, P939, DOI 10.1086/504602; May F, 2009, OIKOS, V118, P1830, DOI 10.1111/j.1600-0706.2009.17724.x; McWethy DB, 2010, LANDSCAPE ECOL, V25, P533, DOI 10.1007/s10980-009-9437-6; MENGE BA, 1976, ECOL MONOGR, V46, P355, DOI 10.2307/1942563; MENGE BA, 1987, AM NAT, V130, P730, DOI 10.1086/284741; MILCHUNAS DG, 1988, AM NAT, V132, P87, DOI 10.1086/284839; Munson SM, 2009, J VEG SCI, V20, P224, DOI 10.1111/j.1654-1103.2009.05556.x; NEWMAN EI, 1973, NATURE, V244, P310, DOI 10.1038/244310a0; NOYMEIR I, 1989, J ECOL, V77, P290, DOI 10.2307/2260930; NOYMEIR I, 1995, J VEG SCI, V6, P701, DOI 10.2307/3236441; Osem Y, 2002, J ECOL, V90, P936, DOI 10.1046/j.1365-2745.2002.00730.x; PAINE RT, 1966, AM NAT, V100, P65, DOI 10.1086/282400; PETRAITIS PS, 1989, Q REV BIOL, V64, P393, DOI 10.1086/416457; Rueda M, 2013, OECOLOGIA, V172, P449, DOI 10.1007/s00442-012-2501-y; Segre H, 2014, ECOL LETT, V17, P1400, DOI 10.1111/ele.12343; Shea K, 2004, ECOL LETT, V7, P491, DOI 10.1111/j.1461-0248.2004.00600.x; Shurin JB, 2001, AM NAT, V158, P624, DOI 10.1086/323589; SOUSA WP, 1979, ECOLOGY, V60, P1225, DOI 10.2307/1936969; Sternberg M, 2000, J APPL ECOL, V37, P224, DOI 10.1046/j.1365-2664.2000.00491.x; Sternberg M, 2001, ECOL RES, V16, P335, DOI 10.1046/j.1440-1703.2001.00393.x; Suding KN, 2001, ECOLOGY, V82, P2133, DOI 10.2307/2680221; Wilson SD, 2002, ECOLOGY, V83, P492, DOI 10.1890/0012-9658(2002)083[0492:QVIOFS]2.0.CO;2; WOOTTON JT, 1993, AM NAT, V141, P71, DOI 10.1086/285461; Yang ZL, 2015, OECOLOGIA, V179, P261, DOI 10.1007/s00442-015-3313-7	47	20	20	4	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0160798	10.1371/journal.pone.0160798	http://dx.doi.org/10.1371/journal.pone.0160798			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27536943	Green Published, gold, Green Submitted			2022-12-27	WOS:000381577000032
J	Wong, YH; Yu, L; Zhang, G; He, LS; Qian, PY				Wong, Yue Him; Yu, Li; Zhang, Gen; He, Li-Sheng; Qian, Pei-Yuan			In Silico Prediction of Neuropeptides/Peptide Hormone Transcripts in the Cheilostome Bryozoan Bugula neritina	PLOS ONE			English	Article							LARVAL NERVOUS-SYSTEM; PEDAL PEPTIDE; BRAIN; IDENTIFICATION; METAMORPHOSIS; MECHANISMS; ORCOKININ; EVOLUTION; DISCOVERY; SITES	The bryozoan Bugula neritina has a biphasic life cycle that consists of a planktonic larval stage and a sessile juvenile/adult stage. The transition between these two stages is crucial for the development and recruitment of B. neritina. Metamorphosis in B. neritina is mediated by both the nervous system and the release of developmental signals. However, no research has been conducted to investigate the expression of neuropeptides (NP)/peptide hormones in B. neritina larvae. Here, we report a comprehensive study of the NP/peptide hormones in the marine bryozoan B. neritina based on in silico identification methods. We recovered 22 transcripts encompassing 11 NP/peptide hormone precursor transcript sequences. The transcript sequences of the 11 isolated NP precursors were validated by cDNA cloning using gene-specific primers. We also examined the expression of three peptide hormone precursor transcripts (BnFDSIG, BnILP1, BnGPB) in the coronate larvae of B. neritina, demonstrating their distinct expression patterns in the larvae. Overall, our findings serve as an important foundation for subsequent investigations of the peptidergic control of bryozoan larval behavior and settlement.	[Wong, Yue Him; Yu, Li; Zhang, Gen; He, Li-Sheng; Qian, Pei-Yuan] Hong Kong Univ Sci & Technol, Div Life Sci, Hong Kong, Hong Kong, Peoples R China; [He, Li-Sheng; Qian, Pei-Yuan] Chinese Acad Sci, Sanya Inst Deep Sea Sci & Engn, San Ya, Hai Nan, Peoples R China; [Wong, Yue Him] Akita Prefectural Univ, Dept Biotechnol, Akita, Japan	Hong Kong University of Science & Technology; Chinese Academy of Sciences; Institute of Deep-Sea Science & Engineering, CAS; Akita Prefectural University	Qian, PY (corresponding author), Hong Kong Univ Sci & Technol, Div Life Sci, Hong Kong, Hong Kong, Peoples R China.; Qian, PY (corresponding author), Chinese Acad Sci, Sanya Inst Deep Sea Sci & Engn, San Ya, Hai Nan, Peoples R China.	boqianpy@ust.hk	Zhang/L-6428-2017	Zhang/0000-0001-8619-3285; Qian, Pei-Yuan/0000-0003-4074-9078	Research Grant Council of HKSAR [662313, 16101015]	Research Grant Council of HKSAR(Hong Kong Research Grants Council)	This work was supported by the grants from Research Grant Council of HKSAR (662313 and 16101015) to PY Qian.; This work was supported by grants from the Research Grant Council of HKSAR (662313 and 16101015) to PY Qian.	Behrens HL, 2008, ANAL CHEM, V80, P6949, DOI 10.1021/ac800798h; Boonen K, 2008, J SEP SCI, V31, P427, DOI 10.1002/jssc.200700450; Brown MR, 1999, PEPTIDES, V20, P1035, DOI 10.1016/S0196-9781(99)00097-2; Burbach JPH, 2011, METHODS MOL BIOL, V789, P1, DOI 10.1007/978-1-61779-310-3_1; Chen ZF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022913; Christie AE, 2015, GEN COMP ENDOCR, V213, P90, DOI 10.1016/j.ygcen.2015.02.003; Christie AE, 2010, CELL MOL LIFE SCI, V67, P4135, DOI 10.1007/s00018-010-0482-8; Conzelmann M, 2011, P NATL ACAD SCI USA, V108, pE1174, DOI 10.1073/pnas.1109085108; CRUZ LJ, 1987, J BIOL CHEM, V262, P15821; DUVIGNEAUD V, 1953, J AM CHEM SOC, V75, P4880; DUVIGNEAUD V, 1953, J BIOL CHEM, V205, P949; EBBERINK RHM, 1989, BIOL BULL, V177, P176, DOI 10.2307/1541928; Ferre F, 2005, NUCLEIC ACIDS RES, V33, pW230, DOI 10.1093/nar/gki412; Fricker L.D., 2012, C SERIES NEUROPEPTID, V1, P1, DOI DOI 10.4199/C00058ED1V01Y201205NPE003; Gruhl A, 2009, ZOOMORPHOLOGY, V128, P135, DOI 10.1007/s00435-009-0084-x; HALL JD, 1990, J NEUROBIOL, V21, P858, DOI 10.1002/neu.480210604; Heyland A, 2006, INTEGR COMP BIOL, V46, P743, DOI 10.1093/icb/icl023; Hofer S, 2006, J EXP BIOL, V209, P2794, DOI 10.1242/jeb.02307; Hummon AB, 2006, MASS SPECTROM REV, V25, P77, DOI 10.1002/mas.20055; Huybrechts J, 2010, INSECT MOL BIOL, V19, P87, DOI 10.1111/j.1365-2583.2009.00951.x; Liu F, 2006, MOL CELL PROTEOMICS, V5, P510, DOI 10.1074/mcp.M400114-MCP200; LLOYD PE, 1989, J NEUROSCI, V9, P312; Ma MM, 2010, PEPTIDES, V31, P27, DOI 10.1016/j.peptides.2009.10.007; MAULE AG, 1991, PARASITOLOGY, V102, P309, DOI 10.1017/S0031182000062648; Metzker Michael L, 2010, Nat Rev Genet, V11, P31, DOI 10.1038/nrg2626; Monigatti F, 2002, BIOINFORMATICS, V18, P769, DOI 10.1093/bioinformatics/18.5.769; Morozova O, 2008, GENOMICS, V92, P255, DOI 10.1016/j.ygeno.2008.07.001; Okajima Y, 2008, REGUL PEPTIDES, V148, P62, DOI 10.1016/j.regpep.2008.03.002; Okano K, 1996, J EXP ZOOL, V276, P138, DOI 10.1002/(SICI)1097-010X(19961001)276:2<138::AID-JEZ7>3.0.CO;2-P; Ostrovsky A, 2013, EVOLUTION OF SEXUAL REPRODUCTION IN MARINE INVERTEBRATES: EXAMPLE OF GYMNOLAEMATE BRYOZOANS, P229, DOI 10.1007/978-94-007-7146-8_3; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pettersson E, 2009, GENOMICS, V93, P105, DOI 10.1016/j.ygeno.2008.10.003; Pires A, 1997, BIOL BULL-US, V192, P399, DOI 10.2307/1542749; REED CG, 1988, J MORPHOL, V197, P127, DOI 10.1002/jmor.1051970202; REED CG, 1983, J MORPHOL, V177, P127, DOI 10.1002/jmor.1051770202; Roch GJ, 2014, GENOME BIOL EVOL, V6, P1466, DOI 10.1093/gbe/evu118; Rotwein P, 1991, Growth Factors, V5, P3, DOI 10.3109/08977199109000267; Salio C, 2011, METHODS MOL BIOL, V789, P57, DOI 10.1007/978-1-61779-310-3_3; Santagata S, 2008, BIOL BULL-US, V215, P3, DOI 10.2307/25470679; Shimizu K, 2000, MAR BIOL, V136, P1, DOI 10.1007/s002270050001; Siuzdak G, 2004, J AM SOC MASS SPECTR, V15, P625; Smit AB, 1996, NEUROSCIENCE, V70, P589, DOI 10.1016/0306-4522(95)00378-9; Soehler S, 2011, CELL TISSUE RES, V343, P559, DOI 10.1007/s00441-010-1091-4; Spittaels K, 1996, INSECT BIOCHEM MOLEC, V26, P375, DOI 10.1016/0965-1748(95)00104-2; Stafflinger E, 2008, P NATL ACAD SCI USA, V105, P3262, DOI 10.1073/pnas.0710897105; STANGIER J, 1992, PEPTIDES, V13, P859, DOI 10.1016/0196-9781(92)90041-Z; STEINER DF, 1985, ANNU REV GENET, V19, P463, DOI 10.1146/annurev.ge.19.120185.002335; Strand FL, 1999, NEUROPEPTIDES REGULA; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Taylor PD, 1988, HIST BIOL, V1, P209; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Toullec JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071609; Veenstra JA, 2000, ARCH INSECT BIOCHEM, V43, P49, DOI 10.1002/(SICI)1520-6327(200002)43:2&lt;49::AID-ARCH1&gt;3.0.CO;2-M; Veenstra JA, 2011, GEN COMP ENDOCR, V171, P160, DOI 10.1016/j.ygcen.2011.01.005; Veenstra JA, 2010, GEN COMP ENDOCR, V167, P86, DOI 10.1016/j.ygcen.2010.02.010; Ventura T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097323; Wanninger A, 2005, ZOOMORPHOLOGY, V124, P161, DOI 10.1007/s00435-005-0004-7; Wei HY, 2011, J BIOL RHYTHM, V26, P507, DOI 10.1177/0748730411419968; WITTEN JL, 1984, BIOCHEM BIOPH RES CO, V124, P350, DOI 10.1016/0006-291X(84)91560-2; Wong YH, 2014, SCI REP-UK, V4, DOI 10.1038/srep06534; WOOLLACOTT RM, 1971, J MORPHOL, V134, P351, DOI 10.1002/jmor.1051340307; Wu Q, 2006, ANNU REV ENTOMOL, V51, P1, DOI 10.1146/annurev.ento.51.110104.151011; Yamanaka N, 2011, J COMP NEUROL, V519, P238, DOI 10.1002/cne.22517; Yan XC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046513; YANG HYT, 1985, P NATL ACAD SCI USA, V82, P7757, DOI 10.1073/pnas.82.22.7757	65	3	4	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0160271	10.1371/journal.pone.0160271	http://dx.doi.org/10.1371/journal.pone.0160271			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27537380	gold, Green Submitted, Green Published			2022-12-27	WOS:000381577000016
J	Zhuo, CJ; Liu, M; Wang, LN; Tian, HJ; Tang, JS				Zhuo, Chuanjun; Liu, Mei; Wang, Lina; Tian, Hongjun; Tang, Jinsong			Diffusion Tensor MR Imaging Evaluation of Callosal Abnormalities in Schizophrenia: A Meta-Analysis	PLOS ONE			English	Article							WHITE-MATTER INTEGRITY; CORPUS-CALLOSUM; 1ST-EPISODE SCHIZOPHRENIA; FRACTIONAL ANISOTROPY; MAGNETIC-RESONANCE; DTI; INDIVIDUALS; VOLUME	Widespread white matter (WM) abnormalities have been found in patients with schizophrenia. Corpus callosum (CC) is the key area that connects the left and right brain hemispheres. However, the results of studies considering different subregions of the CC as regions of interest in patients with schizophrenia have been inconsistent. To obtain a more consistent evaluation of the diffusion characteristics change of the corpus callosum (CC) related to schizophrenia. A meta-analysis involving fractional anisotropy (FA) values in the CC of 729 schizophrenic subjects and 682 healthy controls from 22 studies was conducted. Overall FA values in the CC of the schizophrenic group were less than that of the healthy control group [weighted mean difference (WMD) = -0.021, P<0.001]. So were the FA values in the genus region (WMD = -0.019, P<0.001) and the splenium region (WMD = -0.020, P<0.001) of the CC respectively. The FA reduction was also significant in subjects with chronic schizophrenia (WMD = -0.032, P<0.001) and first-episode schizophrenia (WMD = -0.014, P = 0.001). In present study, we demonstrated an overall FA decrease in the CC of schizophrenic patients. In the two subgroup analyses of the genu vs splenium region and chronic vs first-episode schizophrenia, the decrease of all groups was significant. Further studies with more homogenous populations and standardized DTI protocols are needed to confirm and extend these findings.	[Zhuo, Chuanjun; Liu, Mei; Wang, Lina; Tian, Hongjun] Tianjin Anding Hosp, Dept Psychiat Funct Neuroimaging Lab, Tianjin Mental Hlth Ctr, Tianjin, Peoples R China; [Tang, Jinsong] Cent S Univ, Xiangya Hosp 2, Inst Mental Hlth, Changsha, Hunan, Peoples R China; [Tang, Jinsong] Natl Clin Res Ctr Psychiat & Psychol Dis, Key Lab Psychiat & Mental Hlth Hunan Prov, Changsha, Hunan, Peoples R China	Central South University	Zhuo, CJ (corresponding author), Tianjin Anding Hosp, Dept Psychiat Funct Neuroimaging Lab, Tianjin Mental Hlth Ctr, Tianjin, Peoples R China.; Tang, JS (corresponding author), Cent S Univ, Xiangya Hosp 2, Inst Mental Hlth, Changsha, Hunan, Peoples R China.; Tang, JS (corresponding author), Natl Clin Res Ctr Psychiat & Psychol Dis, Key Lab Psychiat & Mental Hlth Hunan Prov, Changsha, Hunan, Peoples R China.	chuanjunzhuotjmh@163.com; tangjinsonghn@gmail.com			China Postdoctoral Science Foundation [2012M520585]	China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported by grants from China Postdoctoral Science Foundation (2012M520585). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnone D, 2008, SCHIZOPHR RES, V101, P124, DOI 10.1016/j.schres.2008.01.005; Asami T, 2014, PSYCHIAT RES-NEUROIM, V222, P52, DOI 10.1016/j.pscychresns.2014.02.007; Cheung V, 2008, PSYCHOL MED, V38, P877, DOI 10.1017/S0033291707001808; Collinson SL, 2014, BRIT J PSYCHIAT, V204, P55, DOI 10.1192/bjp.bp.113.127886; Foong J, 2000, J NEUROL NEUROSUR PS, V68, P242, DOI 10.1136/jnnp.68.2.242; Friedman JI, 2008, AM J PSYCHIAT, V165, P1024, DOI 10.1176/appi.ajp.2008.07101640; Gasparotti R, 2009, SCHIZOPHR RES, V108, P41, DOI 10.1016/j.schres.2008.11.015; Harms MP, 2015, PSYCHIAT RES-NEUROIM, V231, P87, DOI 10.1016/j.pscychresns.2014.10.009; Henze R, 2012, NEUROSCI LETT, V513, P178, DOI 10.1016/j.neulet.2012.02.032; Hwang EJ, 2014, INVESTIGATIVE RADIOL; Kanaan R, 2009, BRIT J PSYCHIAT, V194, P236, DOI 10.1192/bjp.bp.108.054320; Kitis O, 2011, TURK PSIKIYATR DERG, V22, P213; Klauss M, 2015, EUROPEAN RADIOLOGY; Knoche C, 2012, NEUROIMAGE, V59, P926, DOI 10.1016/j.neuroimage.2011.07.088; Kochunov P, 2014, PSYCHIAT RES-NEUROIM, V223, P148, DOI 10.1016/j.pscychresns.2014.05.004; Kong XJ, 2011, J PSYCHIATR NEUROSCI, V36, P120, DOI 10.1503/jpn.100041; Kubicki M, 2005, NEUROIMAGE, V26, P1109, DOI 10.1016/j.neuroimage.2005.03.026; Kunimatsu N, 2012, PSYCHIAT RES-NEUROIM, V201, P136, DOI 10.1016/j.pscychresns.2011.07.010; Lee SH, 2013, SCHIZOPHR RES, V143, P231, DOI 10.1016/j.schres.2012.11.029; Lemke A, 2009, INVEST RADIOL, V44, P769, DOI 10.1097/RLI.0b013e3181b62271; Li L., 2015, STUDY DWI PANCREAS 3; Mandl RCW, 2010, SCHIZOPHRENIA BULL, V36, P778, DOI 10.1093/schbul/sbn161; Mihrshahi R, 2006, J EXP ZOOL PART B, V306B, P8, DOI 10.1002/jez.b.21067; Nugent KL, 2015, PSYCHOSOM MED, V77, P733, DOI 10.1097/PSY.0000000000000215; Patel S, 2011, SCHIZOPHR RES, V129, P149, DOI 10.1016/j.schres.2011.03.014; Peters BD, 2008, NEUROPSYCHOBIOLOGY, V58, P19, DOI 10.1159/000154476; Price G, 2005, J NEUROL NEUROSUR PS, V76, P585, DOI 10.1136/jnnp.2004.042952; Re TJ, 2011, MAGN RESON MED, V66, P1327, DOI 10.1002/mrm.22931; Rotarska-Jagiela A, 2008, NEUROIMAGE, V39, P1522, DOI 10.1016/j.neuroimage.2007.10.063; Samartzis L, 2014, J NEUROIMAGING, V24, P101, DOI 10.1111/j.1552-6569.2012.00779.x; Sivagnanasundaram S, 2007, PROTEOM CLIN APPL, V1, P1291, DOI 10.1002/prca.200700230; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Soares JM, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00031; Sun ZG, 2003, NEUROREPORT, V14, P1833, DOI 10.1097/00001756-200310060-00015; Viswanath H, 2015, ALTERATIONS INTERHEM, V9, DOI [10.3389/fnhum.2015.00116, DOI 10.3389/FNHUM.2015.00116]; Whitford TJ, 2011, NEUROIMAGE, V54, P2318, DOI 10.1016/j.neuroimage.2010.10.048; Wu CH, 2015, SCHIZOPHR RES, V169, P54, DOI 10.1016/j.schres.2015.09.023	37	19	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0161406	10.1371/journal.pone.0161406	http://dx.doi.org/10.1371/journal.pone.0161406			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DT6ES	27536773	Green Published, Green Submitted, gold			2022-12-27	WOS:000381577000100
J	Glaister, M; Williams, BH; Muniz-Pumares, D; Balsalobre-Fernandez, C; Foley, P				Glaister, Mark; Williams, Benjamin Henley; Muniz-Pumares, Daniel; Balsalobre-Fernandez, Carlos; Foley, Paul			The Effects of Caffeine Supplementation on Physiological Responses to Submaximal Exercise in Endurance-Trained Men	PLOS ONE			English	Article							FLUID-ELECTROLYTE BALANCE; 2000-M ROWING PERFORMANCE; CYCLING PERFORMANCE; FAT-METABOLISM; HEART-RATE; INGESTION; CARBOHYDRATE; MUSCLE; TIME; VARIABILITY	Objectives The aim of this study was to evaluate the effects of caffeine on physiological responses to submaximal exercise, with a focus on blood lactate concentration ([BLa]). Methods Using a randomised, single-blind, crossover design; 16 endurance-trained, male cyclists (age: 38 +/- 8 years; height: 1.80 +/- 0.05 m; body mass: 76.6 +/- 7.8 kg; (V) over dotO(2max) : 4.3 +/- 0.6 L . min(-1)) completed four trials on an electromagnetically-braked cycle ergometer. Each trial consisted of a six-stage incremental test (3 minute stages) followed by 30 minutes of passive recovery. One hour before trials 2-4, participants ingested a capsule containing 5 mg . kg(-1) of either caffeine or placebo (maltodextrin). Trials 2 and 3 were designed to evaluate the effects of caffeine on various physiological responses during exercise and recovery. In contrast, Trial 4 was designed to evaluate the effects of caffeine on [BLa] during passive recovery from an end-exercise concentration of 4 mmol . L-1. Results Relative to placebo, caffeine increased [BLa] during exercise, independent of exercise intensity (mean difference: 0.33 +/- 0.41 mmol . L-1; 95% likely range: 0.11 to 0.55 mmol . L-1), but did not affect the time-course of [BLa] during recovery (p = 0.604). Caffeine reduced ratings of perceived exertion (mean difference: 0.5 +/- 0.7; 95% likely range: 0.1 to 0.9) and heart rate (mean difference: 3.6 +/- 4.2 b . min(-1); 95% likely range: 1.3 to 5.8 b . min(-1)) during exercise, with the effect on the latter dissipating as exercise intensity increased. Supplement x exercise intensity interactions were observed for respiratory exchange ratio (p = 0.004) and minute ventilation (p = 0.034). Conclusions The results of the present study illustrate the clear, though often subtle, effects of caffeine on physiological responses to submaximal exercise. Researchers should be aware of these responses, particularly when evaluating the physiological effects of various experimental interventions.	[Glaister, Mark; Williams, Benjamin Henley; Muniz-Pumares, Daniel] St Marys Univ, Sch Sport Hlth & Appl Sci, Strawberry Hill, Twickenham, England; [Balsalobre-Fernandez, Carlos] Autonomous Univ Madrid, Dept Phys Educ Sport & Human Movement, Madrid, Spain; [Foley, Paul] Cardiff Metropolitan Univ, Cardiff Sch Hlth Sci, Cardiff, S Glam, Wales	Autonomous University of Madrid; Cardiff Metropolitan University; Cardiff University	Glaister, M (corresponding author), St Marys Univ, Sch Sport Hlth & Appl Sci, Strawberry Hill, Twickenham, England.	mark.glaister@stmarys.ac.uk	/J-1248-2019	/0000-0002-8329-1581; Muniz-Pumares, Daniel/0000-0002-6748-9870				Acker-Hewitt TL, 2012, APPL PHYSIOL NUTR ME, V37, P276, DOI [10.1139/h11-160, 10.1139/H11-160]; Adamo KB, 1998, J APPL PHYSIOL, V84, P908, DOI 10.1152/jappl.1998.84.3.908; Anderson ME, 2000, INT J SPORT NUTR EXE, V10, P464, DOI 10.1123/ijsnem.10.4.464; Armstrong LE, 2007, EXERC SPORT SCI REV, V35, P135; BEAVER WL, 1986, J APPL PHYSIOL, V60, P2020, DOI 10.1152/jappl.1986.60.6.2020; Bergman BC, 2000, AM J PHYSIOL-ENDOC M, V278, pE244, DOI 10.1152/ajpendo.2000.278.2.E244; Black CD, 2015, MED SCI SPORT EXER, V47, P1145, DOI 10.1249/MSS.0000000000000513; BORG G, 1970, Scandinavian Journal of Rehabilitation Medicine, V2, P92; Bridge CA, 2006, J SPORT SCI, V24, P433, DOI 10.1080/02640410500231496; Bruce CR, 2000, MED SCI SPORT EXER, V32, P1958, DOI 10.1097/00005768-200011000-00021; Burke L.M., 2013, CAFFEINE SPORTS PERF; Burke LM, 2008, APPL PHYSIOL NUTR ME, V33, P1319, DOI 10.1139/H08-130; Cheuvront SN, 2009, AM J PHYSIOL-REG I, V296, pR394, DOI 10.1152/ajpregu.90812.2008; De Pauw K, 2013, INT J SPORT PHYSIOL, V8, P111, DOI 10.1123/ijspp.8.2.111; Del Coso J, 2009, MED SCI SPORT EXER, V41, P164, DOI 10.1249/MSS.0b013e318184f45e; DODD SL, 1991, EUR J APPL PHYSIOL O, V62, P424, DOI 10.1007/BF00626615; Doherty M, 2005, SCAND J MED SCI SPOR, V15, P69, DOI 10.1111/j.1600-0838.2005.00445.x; DURNIN JVGA, 1974, BRIT J NUTR, V32, P77, DOI 10.1079/BJN19740060; Faude O, 2009, SPORTS MED, V39, P469, DOI 10.2165/00007256-200939060-00003; Fredholm BB, 1999, PHARMACOL REV, V51, P83; Ganio MS, 2011, EUR J APPL PHYSIOL, V111, P1135, DOI 10.1007/s00421-010-1734-x; Glaister M, 2015, J STRENGTH COND RES, V29, P165, DOI 10.1519/JSC.0000000000000596; Goedecke JH, 2000, AM J PHYSIOL-ENDOC M, V279, pE1325, DOI 10.1152/ajpendo.2000.279.6.E1325; Graham TE, 2000, J PHYSIOL-LONDON, V529, P837, DOI 10.1111/j.1469-7793.2000.00837.x; Graham TE, 2001, SPORTS MED, V31, P785, DOI 10.2165/00007256-200131110-00002; Graham TE, 2008, APPL PHYSIOL NUTR ME, V33, P1311, DOI 10.1139/H08-129; Hodgson AB, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0059561, 10.1371/journal.pone.0079556]; Howell LL, 1997, PSYCHOPHARMACOLOGY, V129, P1, DOI 10.1007/s002130050155; Irwin C, 2011, J SPORT SCI, V29, P509, DOI 10.1080/02640414.2010.541480; Jacobson TL, 2001, EXP PHYSIOL, V86, P137, DOI 10.1113/eph8602072; Jenkins NT, 2008, INT J SPORT NUTR EXE, V18, P328, DOI 10.1123/ijsnem.18.3.328; Kalmar JM, 2005, MED SCI SPORT EXER, V37, P2113, DOI 10.1249/01.mss.0000178219.18086.9e; Koupenova Milka, 2013, J Cell Physiol, DOI 10.1002/jcp.24352; Kovacs EMR, 1998, J APPL PHYSIOL, V85, P709, DOI 10.1152/jappl.1998.85.2.709; MACINTOSH BR, 1995, CAN J APPL PHYSIOL, V20, P168, DOI 10.1139/h95-012; McClaran SR, 2007, J INT SOC SPORT NUTR, V4, DOI 10.1186/1550-2783-4-11; Newell J, 2007, J SPORT SCI, V25, P1403, DOI 10.1080/02640410601128922; Roelands B, 2011, EUR J APPL PHYSIOL, V111, P3089, DOI 10.1007/s00421-011-1945-9; Rongen GA, 1999, CLIN SCI, V96, P597, DOI 10.1042/CS19980348; Ryan EJ, 2013, J STRENGTH COND RES, V27, P259, DOI 10.1519/JSC.0b013e3182541d03; Simmonds MJ, 2010, EUR J APPL PHYSIOL, V109, P287, DOI 10.1007/s00421-009-1351-8; Skinner TL, 2010, MED SCI SPORT EXER, V42, P571, DOI 10.1249/MSS.0b013e3181b6668b; Stadheim HK, 2013, MED SCI SPORT EXER, V45, P2175, DOI 10.1249/MSS.0b013e3182967948; Stadheim HK, 2014, MED SCI SPORT EXER, V46, P1787, DOI 10.1249/MSS.0000000000000288; TARNOPOLSKY MA, 1989, MED SCI SPORT EXER, V21, P418; Tarnopolsky MA, 2008, APPL PHYSIOL NUTR ME, V33, P1284, DOI 10.1139/H08-121; Vercruyssen F, 2005, BRIT J SPORT MED, V39, P267, DOI 10.1136/bjsm.2004.011668; Wiles J D, 1992, Br J Sports Med, V26, P116	48	13	14	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2016	11	8							e0161375	10.1371/journal.pone.0161375	http://dx.doi.org/10.1371/journal.pone.0161375			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4YN	27532605	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000381487600089
J	Jarczok, MN; Koenig, J; Li, J; Mauss, D; Hoffmann, K; Schmidt, B; Fischer, JE; Thayer, JF				Jarczok, Marc N.; Koenig, Julian; Li, Jian; Mauss, Daniel; Hoffmann, Kristina; Schmidt, Burkhard; Fischer, Joachim E.; Thayer, Julian F.			The Association of Work Stress and Glycemic Status Is Partially Mediated by Autonomic Nervous System Function: Cross-Sectional Results from the Mannheim Industrial Cohort Study (MICS)	PLOS ONE			English	Article							EFFORT-REWARD IMBALANCE; HEART-RATE-VARIABILITY; PSYCHOSOCIAL FACTORS; HEALTHY POPULATIONS; DIABETES-MELLITUS; NEURAL REGULATION; HEMOGLOBIN A1C; RISK-FACTORS; VAGUS NERVE; GLUCOSE	Background Work stress is associated with an increased risk of pre-diabetes, Type 2 diabetes, and inflammation, as well as decreased autonomic nervous system function as measured, for example, via heart rate variability. We investigated the extent to which the association between work stress and glycemic status is mediated by vagally-mediated heart rate variability (vmHRV) and/or inflammation. Methods Cross-sectional data from the Mannheim Industrial Cohort Study (MICS) with 9,937 participants were analyzed. The root mean squared successive differences (RMSSD) from long-term heart rate monitoring during work and night time periods was used to index vmHRV. Fasting plasma glucose and glycosylated hemoglobin were assessed to determine glycemic status. High sensitive C-reactive protein levels were observed as a measure of systemic inflammation and the Effort-Reward-Imbalance scale was used to evaluate work stress. Mediation models were adjusted for age, sex, and occupational status, and estimations were bootstrapped (5,000 replications). Results Effort-Reward-Imbalance was significantly negatively associated with RMSSD and both glycosylated hemoglobin and fasting plasma glucose during both work and night time periods. Effort-Reward-Imbalance was observed to have a significant direct effect on glycosylated hemoglobin and significant indirect effects, through RMSSD, on both glycemic measures during both time periods. Introducing C-reactive protein as a further mediator to the model did not alter the indirect effects observed. C-reactive protein, as an exclusive mediator, was observed to have smaller direct and indirect effects on the glycemic measures as compared to when Effort-Reward-Imbalance was included in the model. Conclusions Our results suggest that the association between work stress and glycemic status is partially mediated through vmHRV independent of systemic inflammation as measured by C-reactive protein. We conclude that work stress may be an additional factor that promotes development of hyperglycemic-metabolic states. If supported by prospective evidence, these results may lead to new approaches for primary prevention of hyperglycemia in the workplace.	[Jarczok, Marc N.; Hoffmann, Kristina; Schmidt, Burkhard; Fischer, Joachim E.] Heidelberg Univ, Mannheim Inst Publ Hlth Social & Prevent Med, Mannheim Med Fac, Ludolf Krehl Str 7-11, D-68167 Mannheim, Germany; [Jarczok, Marc N.] UniversityHosp Heidelberg, Ctr Psychosocial Med, Inst Med Psychol, Bergheimer Str 20, D-69115 Heidelberg, Germany; [Koenig, Julian; Thayer, Julian F.] Ohio State Univ, Dept Psychol, 1835 Neil Ave, Columbus, OH 43210 USA; [Li, Jian] Univ Dusseldorf, Inst Occupat Social & Environm Med, Ctr Hlth & Soc, Fac Med, Univ Str 1, D-40225 Dusseldorf, Germany; [Mauss, Daniel] Allianz SE, Dept Occupat Med, Koniginstr 28, D-80802 Munich, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; University System of Ohio; Ohio State University; Heinrich Heine University Dusseldorf; Allianz SE	Jarczok, MN (corresponding author), Heidelberg Univ, Mannheim Inst Publ Hlth Social & Prevent Med, Mannheim Med Fac, Ludolf Krehl Str 7-11, D-68167 Mannheim, Germany.; Jarczok, MN (corresponding author), UniversityHosp Heidelberg, Ctr Psychosocial Med, Inst Med Psychol, Bergheimer Str 20, D-69115 Heidelberg, Germany.	marc.jarczok@gmail.com	Koenig, Julian/J-8863-2017; Jarczok, Marc N/A-2383-2014; Thayer, Julian/AAA-1161-2020; Jarczok, M/GZN-2543-2022	Koenig, Julian/0000-0003-1009-9625; Jarczok, Marc N/0000-0002-6055-385X; Thayer, Julian/0000-0001-9385-3421; Schmidt, Burkhard/0000-0001-7394-2742	Mannheim Institute of Public Health; Humboldt Senior Research Award; Deutsche Forschungsgemeinschaft; Ruprecht-Karls-Universitat Heidelberg	Mannheim Institute of Public Health; Humboldt Senior Research Award; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Ruprecht-Karls-Universitat Heidelberg	This work was funded through internal funds of the Mannheim Institute of Public Health. Julian F. Thayer was supported by a Humboldt Senior Research Award. Julian Koenig, Jian Li and Daniel Mauss received no specific funding for this work. We acknowledge additional financial support by Deutsche Forschungsgemeinschaft and Ruprecht-Karls-Universitat Heidelberg within the funding programme Open Access Publishing.	Abadie JM, 2008, ANN CLIN LAB SCI, V38, P31; Backe EM, 2012, INT ARCH OCC ENV HEA, V85, P67, DOI 10.1007/s00420-011-0643-6; Borovikova LV, 2000, NATURE, V405, P458, DOI 10.1038/35013070; Cameron OG, 2001, PSYCHOSOM MED, V63, P697, DOI 10.1097/00006842-200109000-00001; Camm AJ, 1996, CIRCULATION, V93, P1043; Chandola T, 2006, BMJ-BRIT MED J, V332, P521, DOI 10.1136/bmj.38693.435301.80; Chandola T, 2008, EUR HEART J, V29, P640, DOI 10.1093/eurheartj/ehm584; Chida Y, 2008, PSYCHOL BULL, V134, P829, DOI 10.1037/a0013342; Daniele G, 2014, ACTA DIABETOL, V51, P123, DOI 10.1007/s00592-013-0543-1; Darwin C., 1872, P374; Ditlevsen S, 2005, EPIDEMIOLOGY, V16, P114, DOI 10.1097/01.ede.0000147107.76079.07; Eskesen K, 2013, J INTERN MED, V273, P94, DOI 10.1111/j.1365-2796.2012.02594.x; Federici M, 2005, J CLIN INVEST, V115, P3494, DOI 10.1172/JCI26052; Fujihara K, 2012, EXP CLIN ENDOCR DIAB, V120, P560, DOI 10.1055/s-0032-1314873; Groves DA, 2005, NEUROSCI BIOBEHAV R, V29, P493, DOI 10.1016/j.neubiorev.2005.01.004; Hayes AF, 2009, COMMUN MONOGR, V76, P408, DOI 10.1080/03637750903310360; Heraclides A, 2009, DIABETES CARE, V32, P2230, DOI 10.2337/dc09-0132; Heraclides AM, 2012, OBESITY, V20, P428, DOI 10.1038/oby.2011.95; Houtman I., 2007, RAISING AWARENESS ST; Jarczok MN, 2013, INT J CARDIOL, V168, P3025, DOI 10.1016/j.ijcard.2013.04.147; Jarczok MN, 2013, NEUROSCI BIOBEHAV R, V37, P1810, DOI 10.1016/j.neubiorev.2013.07.004; Jarczok MN, 2013, INT J CARDIOL, V167, P855, DOI 10.1016/j.ijcard.2012.02.002; Jarczok MN, 2015, PLOS ONE, P1, DOI [10.1371/journal, DOI 10.1371/JOURNAL]; JOSE AD, 1970, CARDIOVASC RES, V4, P160, DOI 10.1093/cvr/4.2.160; Juster RP, 2010, NEUROSCI BIOBEHAV R, V35, P2, DOI 10.1016/j.neubiorev.2009.10.002; Kawakami N, 2000, OCCUP ENVIRON MED, V57, P805, DOI 10.1136/oem.57.12.805; Kivimaki M, 2015, CURR CARDIOL REP, V17, DOI 10.1007/s11886-015-0630-8; Koenig J, 2014, EUR J PAIN, V18, P301, DOI 10.1002/j.1532-2149.2013.00379.x; Kogler L, 2015, NEUROIMAGE, V119, P235, DOI 10.1016/j.neuroimage.2015.06.059; Kornitzer M, 2001, EUR HEART J, V22, P109, DOI 10.1053/euhj.2000.2375; Lane RD, 2009, NEUROIMAGE, V47, P1135, DOI 10.1016/j.neuroimage.2009.06.013; Lane RD, 2009, PSYCHOSOM MED, V71, P117, DOI 10.1097/PSY.0b013e31819783be; Li J, 2013, INT J BEHAV MED, V20, P495, DOI 10.1007/s12529-012-9255-0; Li J, 2012, AM J IND MED, V55, P808, DOI 10.1002/ajim.22018; Liao DP, 1995, DIABETES RES CLIN PR, V30, P211, DOI 10.1016/0168-8227(95)01190-0; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Luft FC, 2012, J AM SOC HYPERTENS, V6, P23, DOI 10.1016/j.jash.2011.09.006; Marty N, 2007, PHYSIOLOGY, V22, P241, DOI 10.1152/physiol.00010.2007; Matteoli G, 2013, GUT, V62, P1214, DOI 10.1136/gutjnl-2012-302550; Mauss D, 2015, IND HEALTH, V53, P5, DOI 10.2486/indhealth.2014-0122; MCEWEN BS, 1993, ARCH INTERN MED, V153, P2093, DOI 10.1001/archinte.153.18.2093; Monroy A, 2009, DIABETOLOGIA, V52, P2169, DOI 10.1007/s00125-009-1451-3; Niedhammer I, 2004, SOC SCI MED, V58, P1531, DOI 10.1016/S0277-9536(03)00346-0; Page KA, 2011, J CLIN INVEST, V121, P4161, DOI 10.1172/JCI57873; Pavlov VA, 2012, NAT REV ENDOCRINOL, V8, P743, DOI 10.1038/nrendo.2012.189; Pocai A, 2005, CELL METAB, V1, P53, DOI 10.1016/j.cmet.2004.11.001; POMERANZ B, 1985, AM J PHYSIOL, V248, pH151, DOI 10.1152/ajpheart.1985.248.1.H151; Pouwer F, 2010, DISCOV MED, V9, P112; Roy M, 2012, TRENDS COGN SCI, V16, P147, DOI 10.1016/j.tics.2012.01.005; Sternberg EM, 2006, NAT REV IMMUNOL, V6, P318, DOI 10.1038/nri1810; Sun Y, 2013, CELL RES, V23, P1270, DOI 10.1038/cr.2013.116; Tamashiro KLK, 2011, ANN NY ACAD SCI, V1231, P46, DOI 10.1111/j.1749-6632.2011.06134.x; Thayer JF, 2005, PSYCHONEUROENDOCRINO, V30, P1050, DOI 10.1016/j.psyneuen.2005.04.014; Thayer JF, 2012, NEUROSCI BIOBEHAV R, V36, P747, DOI 10.1016/j.neubiorev.2011.11.009; Thayer JF, 2011, RESP PHYSIOL NEUROBI, V178, P387, DOI 10.1016/j.resp.2011.05.016; Thayer JF, 2010, BRAIN BEHAV IMMUN, V24, P1223, DOI 10.1016/j.bbi.2010.07.247; Thayer JF, 2010, INT J CARDIOL, V141, P122, DOI 10.1016/j.ijcard.2009.09.543; Thayer JF, 2009, ANN BEHAV MED, V37, P141, DOI 10.1007/s12160-009-9101-z; Thayer JF, 2009, NEUROSCI BIOBEHAV R, V33, P81, DOI 10.1016/j.neubiorev.2008.08.004; Toker S, 2012, J OCCUP HEALTH PSYCH, V17, P259, DOI 10.1037/a0028401; Toshihiro M, 2008, DIABETIC MED, V25, P1211, DOI 10.1111/j.1464-5491.2008.02566.x; Tracey KJ, 2010, NAT IMMUNOL, V11, P561, DOI 10.1038/ni0710-561; Tracey KJ, 2002, NATURE, V420, P853, DOI 10.1038/nature01321; Tripathy D, 2013, DIABETOLOGIA, V56, P2153, DOI 10.1007/s00125-013-2976-z; Tukey JW, 1977, EXPLORATORY DATA ANA; WARNER HR, 1962, J APPL PHYSIOL, V17, P349, DOI 10.1152/jappl.1962.17.2.349; Weippert M, 2010, EUR J APPL PHYSIOL, V109, P779, DOI 10.1007/s00421-010-1415-9; Wittling W., 2012, HERZSCHLAGVARIABILIT; World Health Organization (WHO), 2000, WHO TECHN REP SER, P256, DOI DOI 10.1007/978-0-387-71799-9_454; Xu WX, 2012, INT ARCH OCC ENV HEA, V85, P215, DOI 10.1007/s00420-011-0650-7	70	16	16	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2016	11	8							e0160743	10.1371/journal.pone.0160743	http://dx.doi.org/10.1371/journal.pone.0160743			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DT4YN	27532642	Green Published, gold, Green Submitted			2022-12-27	WOS:000381487600041
J	van Beurden, YH; Dekkers, OM; Bomers, MK; Kaiser, AM; van Houdt, R; Knetsch, CW; Girbes, ARJ; Mulder, CJJ; Vandenbroucke-Grauls, CMJE				van Beurden, Yvette H.; Dekkers, Olaf M.; Bomers, Marije K.; Kaiser, Annie M.; van Houdt, Robin; Knetsch, Cornelis W.; Girbes, Armand R. J.; Mulder, Chris J. J.; Vandenbroucke-Grauls, Christina M. J. E.			An Outbreak of Clostridium difficile Ribotype 027 Associated with Length of Stay in the Intensive Care Unit and Use of Selective Decontamination of the Digestive Tract: A Case Control Study	PLOS ONE			English	Article							INFECTION; MORTALITY; METAANALYSIS; RESISTANCE; MICROBIOTA; MORBIDITY; EXPOSURE; DIARRHEA; RISK; TIME	Background An outbreak of Clostridium difficile ribotype 027 infection (CDI) occurred at an university hospital, involving 19 departments. To determine what hospital-associated factors drove the outbreak of this particular strain we performed a case-control study. Methods Cases (n = 79), diagnosed with CDI due to C. difficile ribotype 027 were matched for age and treating medical specialty to four control patients (n = 316). Patients diagnosed with CDI due to other ribotypes were included as a second control group. A random selection of C. difficile ribotype 027 strains (n = 10) was genotyped by Whole Genome Sequencing (WGS). Findings WGS showed the outbreak was likely caused by a single strain of C. difficile (two or less single-nucleotide variants between isolates). Ninety-five percent of cases had used antibiotics, compared to 56% of controls. Previous admission to the intensive care unit (ICU) (OR: 2.4, 95% CI 1.0-5.6), longer length of stay (LOS), and recent hospital admission were associated with CDI ribotype 027. Cases were less likely to have been admitted to a ward with a known isolated CDI patient (OR: 0.2, 95% CI 0.1-0.6). Analysis of patients who stayed at the ICU (35 cases; 51 controls), indicated that the use of selective decontamination of the digestive tract (SDD) and a longer LOS in the ICU were associated with CDI risk. Interpretation In this large outbreak, any antibiotic use, including SDD use, appeared as a prerequisite for acquisition of the outbreak strain. The role of use of SDD and prolonged stay on the ICU could not be disentangled, but both factors can play a biologically plausible role in C. difficile acquisition and infection.	[van Beurden, Yvette H.; Kaiser, Annie M.; van Houdt, Robin; Vandenbroucke-Grauls, Christina M. J. E.] Vrije Univ Amsterdam, Med Ctr, Dept Med Microbiol & Infect Control, Amsterdam, Netherlands; [van Beurden, Yvette H.; Mulder, Chris J. J.] Vrije Univ Amsterdam, Med Ctr, Dept Gastroenterol & Hepatol, Amsterdam, Netherlands; [Dekkers, Olaf M.] Leiden Univ, Med Ctr, Dept Clin Epidemiol, Leiden, Netherlands; [Dekkers, Olaf M.] Leiden Univ, Med Ctr, Dept Endocrinol & Metab Dis, Leiden, Netherlands; [Bomers, Marije K.] Vrije Univ Amsterdam, Med Ctr, Dept Internal Med, Amsterdam, Netherlands; [Knetsch, Cornelis W.] Leiden Univ, Med Ctr, Dept Med Microbiol, Leiden, Netherlands; [Girbes, Armand R. J.] Vrije Univ Amsterdam, Med Ctr, Dept Intens Care, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Vrije Universiteit Amsterdam; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Vrije Universiteit Amsterdam	van Beurden, YH (corresponding author), Vrije Univ Amsterdam, Med Ctr, Dept Med Microbiol & Infect Control, Amsterdam, Netherlands.; van Beurden, YH (corresponding author), Vrije Univ Amsterdam, Med Ctr, Dept Gastroenterol & Hepatol, Amsterdam, Netherlands.	y.vanbeurden@vumc.nl	Vandenbroucke-Grauls, Christina/AAO-7953-2020	Vandenbroucke-Grauls, Christina/0000-0003-2074-1597; Bomers, Marije/0000-0003-0399-6926; Knetsch, Wilco/0000-0001-8569-3456; Dekkers, Olaf/0000-0002-1333-7580				Ananthakrishnan AN, 2011, NAT REV GASTRO HEPAT, V8, P17, DOI 10.1038/nrgastro.2010.190; Archibald LK, 2004, J INFECT DIS, V189, P1585, DOI 10.1086/383045; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Bruijnesteijn van Coppenraet LES, 2009, CLIN MICROBIOL INFEC, V15, P924, DOI 10.1111/j.1469-0691.2009.02798.x; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Daneman N, 2013, LANCET INFECT DIS, V13, P328, DOI 10.1016/S1473-3099(12)70322-5; Dethlefsen L, 2008, PLOS BIOL, V6, P2383, DOI 10.1371/journal.pbio.0060280; Ghose C, 2013, EMERG MICROBES INFEC, V2, DOI 10.1038/emi.2013.62; Hensgens MPM, 2011, EUR J CLIN MICROBIOL, V30, P587, DOI 10.1007/s10096-010-1127-4; Hensgens MPM, 2012, J ANTIMICROB CHEMOTH, V67, P742, DOI 10.1093/jac/dkr508; Janarthanan S, 2012, AM J GASTROENTEROL, V107, P1001, DOI 10.1038/ajg.2012.179; Jernberg C, 2010, MICROBIOL-SGM, V156, P3216, DOI 10.1099/mic.0.040618-0; Knetsch CW, 2014, EUROSURVEILLANCE, V19, P30, DOI 10.2807/1560-7917.ES2014.19.45.20954; Lawrence SJ, 2007, INFECT CONT HOSP EP, V28, P123, DOI 10.1086/511793; Leffler DA, 2015, NEW ENGL J MED, V372, P1539, DOI 10.1056/NEJMra1403772; Lofgren ET, 2014, EPIDEMIOLOGY, V25, P570, DOI 10.1097/EDE.0000000000000119; Loo VG, 2005, NEW ENGL J MED, V353, P2442, DOI 10.1056/NEJMoa051639; Miller M, 2010, CLIN INFECT DIS, V50, P194, DOI 10.1086/649213; Oostdijk EAN, 2014, JAMA-J AM MED ASSOC, V312, P1429, DOI 10.1001/jama.2014.7247; Stevens V, 2011, CLIN INFECT DIS, V53, P42, DOI 10.1093/cid/cir301; Stevens VW, 2015, INFECT CONT HOSP EP, V36, P1024, DOI 10.1017/ice.2015.132; van Prehn J, 2015, EUR J CLIN MICROBIOL; Zimmerman JE, 2006, CRIT CARE MED, V34, P1297, DOI 10.1097/01.CCM.0000215112.84523.F0	23	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2016	11	8							e0160778	10.1371/journal.pone.0160778	http://dx.doi.org/10.1371/journal.pone.0160778			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4YN	27533048	Green Submitted, Green Published, gold			2022-12-27	WOS:000381487600043
J	Waeber, PO; Wilme, L; Mercier, JR; Camara, C; Lowry, PP				Waeber, Patrick O.; Wilme, Lucienne; Mercier, Jean-Roger; Camara, Christian; Lowry, Porter P., II			How Effective Have Thirty Years of Internationally Driven Conservation and Development Efforts Been in Madagascar?	PLOS ONE			English	Article							FOREST FRAGMENTATION; GLOBAL BIODIVERSITY; DEFORESTATION; MALNUTRITION; DIVERSITY; GROWTH	Conservation and development are intricately linked. The international donor community has long provided aid to tropical countries in an effort to alleviate poverty and conserve bio-diversity. While hundreds of millions of $ have been invested in over 500 environmental-based projects in Madagascar during the period covered by a series of National Environmental Action Plans (1993-2008) and the protected areas network has expanded threefold, deforestation remains unchecked and none of the eight Millennium Development Goals (MDGs) established for 2000-2015 were likely be met. Efforts to achieve sustainable development had failed to reduce poverty or deliver progress toward any of the MDGs. Cross-sectorial policy adjustments are needed that (i) enable and catalyze Madagascar's capacities rather than deepening dependency on external actors such as the World Bank, the International Monetary Fund and donor countries, and that (ii) deliver improvements to the livelihoods and wellbeing of the country's rural poor.	[Waeber, Patrick O.] Swiss Fed Inst Technol Zurich, Dept Environm Sci, Forest Management & Dev, Zurich, Switzerland; [Waeber, Patrick O.] Madagascar Wildlife Conservat, Ambatondrazaka, Madagascar; [Wilme, Lucienne] Univ Antananarivo, Sch Agron, Water & Forest Dept, Antananarivo, Madagascar; [Wilme, Lucienne; Camara, Christian] Madagascar Res & Conservat Program, Missouri Bot Garden, Antananarivo, Madagascar; [Lowry, Porter P., II] Africa & Madagascar Program, Missouri Bot Garden, St Louis, MO USA; [Lowry, Porter P., II] Sorbonne Univ, Univ Paris 06, Inst Systemat Evolut & Biodivers,UMR 7205,CNRS, Museum Natl Hist Nat,Ecole Prat Hautes Etud, Paris, France	Swiss Federal Institutes of Technology Domain; ETH Zurich; University Antananarivo; Missouri Botanical Gardens; Missouri Botanical Gardens; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Sorbonne Universite	Waeber, PO (corresponding author), Swiss Fed Inst Technol Zurich, Dept Environm Sci, Forest Management & Dev, Zurich, Switzerland.; Waeber, PO (corresponding author), Madagascar Wildlife Conservat, Ambatondrazaka, Madagascar.	patrick.waeber@usys.ethz.ch	Wilmé, Lucienne/AAQ-6653-2020; Wilmé, Lucienne/A-3818-2016; Waeber, Patrick O./A-3649-2016	Wilmé, Lucienne/0000-0002-8344-1957; Wilmé, Lucienne/0000-0002-8344-1957; Waeber, Patrick O./0000-0002-3229-0124	Swiss Programme for Research on Global Issues for Development [IZ01Z0_146852]	Swiss Programme for Research on Global Issues for Development	This work was funded by the Swiss Programme for Research on Global Issues for Development under research grant IZ01Z0_146852 (http://www.snf.ch/en/funding/programmes/r4dprogramme/Pages/default.aspx).	[Anonymous], 2007, ENERG ENVIRON-UK; [Anonymous], 2016, IUCN RED LIST CAT CR; Balmford A, 2002, SCIENCE, V297, P950, DOI 10.1126/science.1073947; Bodin O, 2006, ECOL APPL, V16, P440, DOI 10.1890/1051-0761(2006)016[0440:TVOSSL]2.0.CO;2; Bolo P, 2002, ED TRAINING MADAGASC; Boyd C, 2008, CONSERV LETT, V1, P37, DOI 10.1111/j.1755-263X.2008.00002.x; Brimont L, 2015, ECOSYST SERV, V14, P113, DOI 10.1016/j.ecoser.2015.04.003; Brummitt NA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135152; Butchart SHM, 2004, PLOS BIOL, V2, P2294, DOI 10.1371/journal.pbio.0020383; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; Corson C, 2011, J PEASANT STUD, V38, P703, DOI 10.1080/03066150.2011.607696; Devine CM, 2003, SOC SCI MED, V56, P617, DOI 10.1016/S0277-9536(02)00058-8; [DGF Direction Generale des Forets MEF Ministere de lEnvironnement et des Forets CI Conservation International-Madagascar FTM Foiben-Taosarintanini Madagasikara MNP Madagascar National Parks ONE Office National pour lEnvironnement], 2013, EV COUV FOR NAT MAD; Duffy R, 2006, ENVIRON POLIT, V15, P731, DOI 10.1080/09644010600937173; Easterly W, 2009, WORLD DEV, V37, P26, DOI 10.1016/j.worlddev.2008.02.009; FAO, 2013, LOC PLAG THREAT TRIG; Francken N, 2009, WORLD DEV, V37, P242, DOI 10.1016/j.worlddev.2008.01.005; Froger G, 2012, ENVIRON POLICY GOV, V22, P369, DOI 10.1002/eet.1595; Ganzhorn JU, 2001, ORYX, V35, P346, DOI 10.1046/j.1365-3008.2001.00201.x; Geist HJ, 2002, BIOSCIENCE, V52, P143, DOI 10.1641/0006-3568(2002)052[0143:PCAUDF]2.0.CO;2; Gilbert N, 2012, NATURE, V483, P525, DOI 10.1038/483525a; Gore ML, 2013, CONSERV LETT, V6, P430, DOI 10.1111/conl.12032; GREEN GM, 1990, SCIENCE, V248, P212, DOI 10.1126/science.248.4952.212; Hannah L, 2008, BIOL LETTERS, V4, P590, DOI 10.1098/rsbl.2008.0270; Hanushek EA, 2016, SCIENCE, V351, P344, DOI 10.1126/science.aad7796; Hardoon D., 2015, WEALTH HAVING IT ALL; Harper GJ, 2007, ENVIRON CONSERV, V34, P325, DOI 10.1017/S0376892907004262; Harvey CA, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0089; Heino M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138918; Horning NR, 2008, AFR AFFAIRS, V107, P405, DOI 10.1093/afraf/adn036; Innes J. L., 2010, Madagascar Conservation and Development, V5, P6; JAROSZ L, 1993, ECON GEOGR, V69, P366, DOI 10.2307/143595; Kreft S., 2010, MILLENNIUM DEV GOALS; Kull C., 2004, ISLE FIRE POLITICAL; Kull CA, 2014, EARTH CONSERV DEV, P146; Mace GM, 2014, SCIENCE, V345, P1558, DOI 10.1126/science.1254704; Madagascar Government, 2015, DEV COOP REP MAD 201; Malherbe J, 2013, CLIM DYNAM, V40, P2867, DOI 10.1007/s00382-012-1635-2; MEFT USAID CI, 2009, EV COUV FOR NAT MAD; Mercier JR, 2009, MADAG CONSERV DEV, V1, P50; Moat J., 2007, ATLAS VEGETATION MAD; Moyo Dambisa., 2009, DEAD AID WHY AID IS; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Newbold T, 2015, NATURE, V520, P45, DOI 10.1038/nature14324; Nori J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125055; Pereira HM, 2010, SCIENCE, V330, P1496, DOI 10.1126/science.1196624; Poudyal M, 2016, GLOBAL ENVIRON CHANG, V37, P31, DOI 10.1016/j.gloenvcha.2016.01.004; Pouzols FM, 2014, NATURE, V516, P383, DOI 10.1038/nature14032; Radelet S., 2006, 92 CTR GLOB DEV; Rakotosamimanana VR, 2015, APPETITE, V95, P533, DOI 10.1016/j.appet.2015.08.011; Rakotosamimanana VR, 2014, APPETITE, V81, P67, DOI 10.1016/j.appet.2014.05.032; Randriamalala H., 2010, Madagascar Conservation and Development, V5, P11; Randrianja S, 2012, COUP ETAT MARS 2009; Riemann JC, 2015, BIOL CONSERV, V191, P707, DOI 10.1016/j.biocon.2015.08.020; Rockstrom J, 2009, NATURE, V461, P472, DOI 10.1038/461472a; Rodrigues ASL, 2006, TRENDS ECOL EVOL, V21, P71, DOI 10.1016/j.tree.2005.10.010; Samoff Joel, 2004, AFR STUD REV, V47, P67, DOI DOI 10.1017/S0002020600027001; Sukhdev P., 2014, NATURE BALANCE EC BI; Tattersall Ian, 2013, Madagascar Conservation & Development, V8, P7; Tulloch AIT, 2016, J APPL ECOL, V53, P418, DOI 10.1111/1365-2664.12547; Urech Z. L., 2015, Madagascar Conservation and Development, V10, P67, DOI 10.4314/mcd.v10i2.5; Waeber PO, 2015, INT FOREST REV, V17, P127, DOI 10.1505/146554815815834822; WAEBER PO, 2013, MADAG CONSERV DEV, V8, P52, DOI DOI 10.4314/mcd.v8i2.1; Watson JEM, 2004, BIOL CONSERV, V120, P311, DOI 10.1016/j.biocon.2004.03.004; Wilme Lucienne, 2012, Madagascar Conservation &  Development, V7, P30, DOI 10.4314/mcd.v7i1.6; World Bank, 2002, POV SOC DEV 1993 199; Zinner D, 2014, REG ENVIRON CHANGE, V14, P157, DOI 10.1007/s10113-013-0475-x	67	56	56	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2016	11	8							e0161115	10.1371/journal.pone.0161115	http://dx.doi.org/10.1371/journal.pone.0161115			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DT4YN	27532499	Green Submitted, Green Published, gold			2022-12-27	WOS:000381487600059
J	Keating, SJ; Gariboldi, MI; Patrick, WG; Sharma, S; Kong, DS; Oxman, N				Keating, Steven J.; Gariboldi, Maria Isabella; Patrick, William G.; Sharma, Sunanda; Kong, David S.; Oxman, Neri			3D Printed Multimaterial Microfluidic Valve	PLOS ONE			English	Article							LARGE-SCALE INTEGRATION; DEVICES; AUTOMATION; CHIP	We present a novel 3D printed multimaterial microfluidic proportional valve. The microfluidic valve is a fundamental primitive that enables the development of programmable, automated devices for controlling fluids in a precise manner. We discuss valve characterization results, as well as exploratory design variations in channel width, membrane thickness, and membrane stiffness. Compared to previous single material 3D printed valves that are stiff, these printed valves constrain fluidic deformation spatially, through combinations of stiff and flexible materials, to enable intricate geometries in an actuated, functionally graded device. Research presented marks a shift towards 3D printing multi-property programmable fluidic devices in a single step, in which integrated multimaterial valves can be used to control complex fluidic reactions for a variety of applications, including DNA assembly and analysis, continuous sampling and sensing, and soft robotics.	[Keating, Steven J.; Gariboldi, Maria Isabella; Patrick, William G.; Sharma, Sunanda; Oxman, Neri] MIT, Media Lab, Cambridge, MA 02139 USA; [Kong, David S.] MIT, Lincoln Lab, 244 Wood St, Lexington, MA 02173 USA	Massachusetts Institute of Technology (MIT); Lincoln Laboratory; Massachusetts Institute of Technology (MIT)	Oxman, N (corresponding author), MIT, Media Lab, Cambridge, MA 02139 USA.	neri@mit.edu	Sharma, Sunanda/AAD-5093-2021	Gariboldi, Maria Isabella/0000-0003-2020-6885				Anderson KB, 2013, ANAL CHEM, V85, P5622, DOI 10.1021/ac4009594; Au AK, 2015, LAB CHIP, V15, P1934, DOI 10.1039/c5lc00126a; Au AK, 2014, LAB CHIP, V14, P1294, DOI 10.1039/c3lc51360b; Bader C, 2015, MUSHTARI; Bhargava KC, 2014, P NATL ACAD SCI USA, V111, P15013, DOI 10.1073/pnas.1414764111; Chen CP, 2014, ANALYST, V139, P3219, DOI 10.1039/c3an02357e; Dragone V, 2013, BEILSTEIN J ORG CHEM, V9, P951, DOI 10.3762/bjoc.9.109; Easley C, 2007, HDB CAPILLARY MICROC, P1153; Erkal JL, 2014, LAB CHIP, V14, P2023, DOI 10.1039/c4lc00171k; i. materialise, 2016, ONL 3D PRINT SERV; Kartalov EP, 2006, P NATL ACAD SCI USA, V103, P12280, DOI 10.1073/pnas.0602890103; Keating S, 2014, BEYOND 3D PRINTING T, P379; Kitson PJ, 2012, LAB CHIP, V12, P3267, DOI 10.1039/c2lc40761b; Krejcova L, 2014, BIOSENS BIOELECTRON, V54, P421, DOI 10.1016/j.bios.2013.10.031; Lee A, 2013, LAB CHIP, V13, P1660, DOI 10.1039/c3lc90031b; Lee KG, 2014, RSC ADV, V4, P32876, DOI 10.1039/c4ra05072j; Melin J, 2007, ANNU REV BIOPH BIOM, V36, P213, DOI 10.1146/annurev.biophys.36.040306.132646; Oxman N, 2011, VIRTUAL PHYS PROTOTY, V6, P3, DOI 10.1080/17452759.2011.558588; Patrick WG, 2015, THESIS; Rogers CI, 2015, BIOMICROFLUIDICS, V9, DOI 10.1063/1.4905840; Shallan AI, 2014, ANAL CHEM, V86, P3124, DOI 10.1021/ac4041857; Shapeways, 2016, SHAP 3D PRINT SERV M; Song H, 2014, J APPL PHYS, V115, DOI 10.1063/1.4863168; Stratasys Ltd, 2015, DIG MAT DAT SHEET; Stratasys Ltd, 2015, POL PRIC LIST; TechShop Inc, 2016, TECHSHOP LOC; Thorsen T, 2002, SCIENCE, V298, P580, DOI 10.1126/science.1076996; Tseng Peter, 2014, Lab Chip, V14, P1491, DOI 10.1039/c4lc90023e; Unger MA, 2000, SCIENCE, V288, P113, DOI 10.1126/science.288.5463.113; Velders A, ADV SCI, V2	30	48	48	8	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2016	11	8							e0160624	10.1371/journal.pone.0160624	http://dx.doi.org/10.1371/journal.pone.0160624			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4SL	27525809	Green Published, gold			2022-12-27	WOS:000381471100017
J	Kouwenberg, M; Jacobs, CWM; van der Vlag, J; Hilbrands, LB				Kouwenberg, M.; Jacobs, C. W. M.; van der Vlag, J.; Hilbrands, L. B.			Allostimulatory Effects of Dendritic Cells with Characteristic Features of a Regulatory Phenotype	PLOS ONE			English	Article							GLYCOGEN-SYNTHASE KINASE-3; NF-KAPPA-B; T-CELLS; IL-10 PRODUCTION; IN-VITRO; DIFFERENTIATION; ACTIVATION; EXPRESSION; LITHIUM; LIPOPOLYSACCHARIDE	Introduction Tolerogenic dendritic cells (DCs) have the potential to prolong graft survival after transplantation. Tolerogenic DCs are in general characterized by a low expression of co-stimulatory molecule and a high IL-10: IL-12 production ratio. Based on promising results with earlier used alternatively activated DCs, we aimed to generate in culture potentially tolerogenic DC by simultaneously blocking GSK3 by lithium chloride (LiCl) and stimulating TLR2 by PAM(3)CysSerLys(4). Materials and Methods Bone marrow-derived LiClPAM(3) DCs were generated by the addition of LiCl 24 hours before harvesting, and one hour later PAM(3)CysSerLys(4). The phenotype of the DCs was assessed by determining the expression of co-stimulatory molecules in flow cytometry and cytokine production in ELISA, whereas their functional properties were tested in a mixed lymphocyte reaction. A fully MHC mismatched heterotopic heart transplant preceded by infusion of donor-derived LiClPAM(3) DC was performed to assess the tolerogenic potential of LiClPAM(3) DCs in vivo. Results LiClPAM(3) DCs displayed a tolerogenic phenotype accompanied with a low expression of co-stimulatory molecules and a high IL-10:IL-12 production ratio. However, in mixed lymphocyte reaction, LiClPAM(3) DCs appeared superior in T cell stimulation, and induced Th1 and Th17 differentiation. Moreover, mice pretreated with LiClPAM(3) DC displayed a reduced graft survival. Analysis of LiClPAM(3) DC culture supernatant revealed high levels of CXCL-1, which was also found in supernatants of co-cultures of LiClPAM(3) DC and T cells. Nevertheless, we could not show a role for CXCL-1 in T cell proliferation or activation in vitro. Discussion LiClPAM(3) DCs display in vitro a tolerogenic phenotype with a high IL-10:IL-12 ratio, but appeared to be highly immunogenic, since allograft rejection was accelerated. As yet unidentified LiClPAM(3) DC-derived factors, may explain the immunogenic character of LiCl-PAM(3) DCs in vivo.	[Kouwenberg, M.; Jacobs, C. W. M.; van der Vlag, J.; Hilbrands, L. B.] Radboud Univ Nijmegen, Med Ctr, Dept Nephrol, Nijmegen, Netherlands	Radboud University Nijmegen	Hilbrands, LB (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Nephrol, Nijmegen, Netherlands.	luuk.hilbrands@radboudumc.nl	Hilbrands, Luuk/B-4921-2011; Van der Vlag, Johan/E-4636-2010; Kouwenberg, Margreet/P-8827-2015	Hilbrands, Luuk/0000-0002-4935-9765; Van der Vlag, Johan/0000-0001-7843-5918; Kouwenberg, Margreet/0000-0003-1992-920X	NWO ZonMw AGIKO Radboud PhD programm [92003567]	NWO ZonMw AGIKO Radboud PhD programm	Funding provided by NWO ZonMw AGIKO 92003567 Radboud PhD programm 2010. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal S, 2003, J IMMUNOL, V171, P4984, DOI 10.4049/jimmunol.171.10.4984; Albayrak A, 2013, INT IMMUNOPHARMACOL, V16, P35, DOI 10.1016/j.intimp.2013.03.018; Ben-Sasson SZ, 2009, P NATL ACAD SCI USA, V106, P7119, DOI 10.1073/pnas.0902745106; Benwell RK, 2010, CLIN IMMUNOL, V134, P178, DOI 10.1016/j.clim.2009.09.013; Beurel E, 2010, TRENDS IMMUNOL, V31, P24, DOI 10.1016/j.it.2009.09.007; CORRY RJ, 1973, TRANSPLANT P, V5, P733; Cortes-Vieyra R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132867; Daniel V, 2015, BMC IMMUNOL, V16, DOI 10.1186/s12865-015-0111-2; Diehl JA, 1998, GENE DEV, V12, P3499, DOI 10.1101/gad.12.22.3499; Dieker J, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0617-2; Dillon S, 2006, J CLIN INVEST, V116, P916, DOI 10.1172/JCI27203; Emmer PM, 2006, TRANSPLANTATION, V81, P1451, DOI 10.1097/01.tp.0000208801.51222.bd; Ferreira GB, 2011, DIABETES-METAB RES, V27, P933, DOI 10.1002/dmrr.1275; Fransen JH, 2009, ARTHRITIS RHEUM-US, V60, P2304, DOI 10.1002/art.24719; FREVERT CW, 1995, J IMMUNOL, V154, P335; Giambelluca MS, 2014, FASEB J, V28, P3679, DOI 10.1096/fj.14-251900; Guha S, 2011, BASIC RES CARDIOL, V106, P773, DOI 10.1007/s00395-011-0189-5; Hill EV, 2015, EUR J IMMUNOL, V45, P1103, DOI 10.1002/eji.201444661; Hoeflich KP, 2000, NATURE, V406, P86, DOI 10.1038/35017574; Hu XY, 2006, IMMUNITY, V24, P563, DOI 10.1016/j.immuni.2006.02.014; Jiga LP, 2004, TRANSPLANTATION, V77, P1761, DOI 10.1097/01.TP.0000131165.37177.6E; Kalantari T, 2014, CLIN EXP IMMUNOL, V176, P180, DOI 10.1111/cei.12266; Katancik JA, 2000, CYTOKINE, V12, P1480, DOI 10.1006/cyto.2000.0742; Kim GY, 2005, J IMMUNOL, V174, P8116, DOI 10.4049/jimmunol.174.12.8116; Koenen HJPM, 2008, BLOOD, V112, P2340, DOI 10.1182/blood-2008-01-133967; Leuenberger T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100871; Lu LN, 1997, TRANSPLANTATION, V64, P1808, DOI 10.1097/00007890-199712270-00031; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Martin M, 2005, NAT IMMUNOL, V6, P777, DOI 10.1038/ni1221; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Morelli AE, 2007, NAT REV IMMUNOL, V7, P610, DOI 10.1038/nri2132; Morelli AE, 2014, CURR OPIN ORGAN TRAN, V19, P348, DOI 10.1097/MOT.0000000000000097; Noh KJ, 2012, J NANOMATER, V2012, DOI 10.1155/2012/475430; Owen JL, 2011, CELL IMMUNOL, V270, P172, DOI 10.1016/j.cellimm.2011.05.004; Penna G, 2000, J IMMUNOL, V164, P2405, DOI 10.4049/jimmunol.164.5.2405; Rogers NC, 2005, IMMUNITY, V22, P507, DOI 10.1016/j.immuni.2005.03.004; Salazar L, 2007, EUR CYTOKINE NETW, V18, P78, DOI 10.1684/ecn.2007.0089; Shin S, 2011, P NATL ACAD SCI USA, V108, pE1204, DOI 10.1073/pnas.1110195108; Slack EC, 2007, EUR J IMMUNOL, V37, P1600, DOI 10.1002/eji.200636830; Stroopinsky D, 2009, EUR J IMMUNOL, V39, P2703, DOI 10.1002/eji.200839097; Tai NW, 2011, CLIN IMMUNOL, V139, P336, DOI 10.1016/j.clim.2011.03.003; Torres-Aguilar H, 2010, J IMMUNOL, V184, P1765, DOI 10.4049/jimmunol.0902133; Tsao NN, 2015, ANTIMICROB AGENTS CH, V59, P1530, DOI 10.1128/AAC.04261-14; Van Brussel I, 2014, AUTOIMMUN REV, V13, P138, DOI 10.1016/j.autrev.2013.09.008; Wang HZ, 2011, J IMMUNOL, V186, P675, DOI 10.4049/jimmunol.1001473; Wang Y, 2009, BRIT J PHARMACOL, V157, P1004, DOI 10.1111/j.1476-5381.2009.00284.x; Woltman AM, 2000, EUR J IMMUNOL, V30, P1807, DOI 10.1002/1521-4141(200007)30:7<1807::AID-IMMU1807>3.0.CO;2-N; Xia CQ, 2005, SCAND J IMMUNOL, V62, P45, DOI 10.1111/j.1365-3083.2005.01640.x; Yung Raymond, 2007, Immun Ageing, V4, P8, DOI 10.1186/1742-4933-4-8; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212; Zhu ZF, 2010, BRAIN RES BULL, V83, P272, DOI 10.1016/j.brainresbull.2010.07.008	51	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2016	11	8							e0159986	10.1371/journal.pone.0159986	http://dx.doi.org/10.1371/journal.pone.0159986			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4SL	27525971	Green Submitted, Green Published, gold			2022-12-27	WOS:000381471100010
J	Brecko, J; Mathys, A; Dekoninck, W; De Ceukelaire, M; VandenSpiegel, D; Semal, P				Brecko, Jonathan; Mathys, Aurore; Dekoninck, Wouter; De Ceukelaire, Marleen; VandenSpiegel, Didier; Semal, Patrick			Revealing Invisible Beauty, Ultra Detailed: The Influence of Low Cost UV Exposure on Natural History Specimens in 2D+Digitization	PLOS ONE			English	Article							ULTRAVIOLET REFLECTANCE; CARNIVOROUS PLANTS; PATTERNS; SPIDERS; TRAPS; LIGHT	Digitization of the natural history specimens usually occurs by taking detailed pictures from different sides or producing 3D models. Additionally this is normally limited to imaging the specimen while exposed by light of the visual spectrum. However many specimens can see in or react to other spectra as well. Fluorescence is a well known reaction to the ultraviolet (UV) spectrum by animals, plants, minerals etc. but rarely taken into account while examining natural history specimens. Our tests show that museum specimens still fluoresce when exposed to UV light of 395 nm and 365 nm, even after many years of preservation. When the UV exposure is used in the digitization of specimens using our low cost focus stacking (2D+) setup, the resulting pictures reveal more detail than the conventional 2D+ images. Differences in fluorescence using 395 nm or 365 nm UV lights were noticed, however there isn't a preferred wavelength as some specimens react more to the first, while others have better results with the latter exposure. Given the increased detail and the low cost of the system, UV exposure should be considered while digitizing natural history museum collections.	[Brecko, Jonathan; Mathys, Aurore; Dekoninck, Wouter; De Ceukelaire, Marleen; Semal, Patrick] Royal Belgian Inst Nat Sci, Sci Heritage Serv, Vautierstr 29, B-1000 Brussels, Belgium; [Brecko, Jonathan; Mathys, Aurore; VandenSpiegel, Didier] Royal Museum Cent Africa, Biol Collect & Data Management, Leuvensesteenweg 13, B-3080 Tervuren, Belgium	Royal Belgian Institute of Natural Sciences; Royal Museum for Central Africa	Brecko, J (corresponding author), Royal Belgian Inst Nat Sci, Sci Heritage Serv, Vautierstr 29, B-1000 Brussels, Belgium.; Brecko, J (corresponding author), Royal Museum Cent Africa, Biol Collect & Data Management, Leuvensesteenweg 13, B-3080 Tervuren, Belgium.	jonathan.brecko@naturalsciences.be	Mathys, Aurore/AAA-3835-2022	Semal, Patrick/0000-0002-4048-7728	Belgian Science Policy [DIGIT-03]; "Synthesys of systematic resources" (FP7-CP-CSA-INFRA) [312253]	Belgian Science Policy(Belgian Federal Science Policy Office); "Synthesys of systematic resources" (FP7-CP-CSA-INFRA)	The research is funded by the DIGIT-03 program of the Belgian Science Policy and the "Synthesys of systematic resources" (FP7-CP-CSA-INFRA, no 312253). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Alvarez C, 2004, BEHAV ECOL, V15, P805, DOI 10.1093/beheco/arh083; Altshuler DL, 2001, EVOL ECOL RES, V3, P767; Andrews K, 2007, BIOL LETTERS, V3, P265, DOI 10.1098/rsbl.2007.0016; Bok MJ, 2015, J EXP BIOL, V218, P2055, DOI 10.1242/jeb.122036; Brecko J, 2014, ZOOKEYS, P1, DOI 10.3897/zookeys.464.8615; Croft DA, 2004, PALAEONTOLOGY, V47, P795, DOI 10.1111/j.0031-0239.2004.00398.x; Eaton MD, 2003, P ROY SOC B-BIOL SCI, V270, P1721, DOI 10.1098/rspb.2003.2431; Holovachov SD, PHOTOGRAPHY ARTICLES; Honkavaara J, 2002, OIKOS, V98, P505, DOI 10.1034/j.1600-0706.2002.980315.x; Hunt S, 1998, P ROY SOC B-BIOL SCI, V265, P451, DOI 10.1098/rspb.1998.0316; JOEL DM, 1985, NEW PHYTOL, V101, P585, DOI 10.1111/j.1469-8137.1985.tb02864.x; Knuttel H, 2001, J EXP BIOL, V204, P2447; Kurup R, 2013, PLANT BIOLOGY, V15, P611, DOI 10.1111/j.1438-8677.2012.00709.x; Loria SF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112913; Mazza CA, 2010, P ROY SOC B-BIOL SCI, V277, P367, DOI 10.1098/rspb.2009.1565; Meadows MG, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1211; Molina-Borja M, 2006, J ZOOL, V268, P193, DOI 10.1111/j.1469-7998.2005.00008.x; Rorslett B., FLOWERS ULTRAVIOLET; Tischlinger Helmut, 2013, P549; Volschenk ES, 2005, J ARACHNOL, V33, P820, DOI 10.1636/S03-047.1; Welch VL, 2012, PROC SPIE, V8480, DOI 10.1117/12.929547; Wiesenborn William D., 2011, Psyche (Cambridge), V2011; Yang XF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055125; Zschokke S, 2002, J ARACHNOL, V30, P246, DOI 10.1636/0161-8202(2002)030[0246:UROSAW]2.0.CO;2	24	3	3	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0161572	10.1371/journal.pone.0161572	http://dx.doi.org/10.1371/journal.pone.0161572			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27536993	Green Published, gold, Green Submitted			2022-12-27	WOS:000381577000123
J	Haasum, Y; Fastbom, J; Johnell, K				Haasum, Ylva; Fastbom, Johan; Johnell, Kristina			Use of Fall-Risk Inducing Drugs in Patients Using Anti-Parkinson Drugs (APD): A Swedish Register-Based Study	PLOS ONE			English	Article							POPULATION-BASED COHORT; INCREASING DRUGS; NONMOTOR SYMPTOMS; ELDERLY-PEOPLE; MEDICATION USE; HIP FRACTURE; OLDER-PEOPLE; DISEASE; PREVALENCE; METAANALYSIS	Objectives Many drugs increase the risk of falls in old age. Although persons with Parkinson's disease (PD) are at increased risk of experiencing falls and fractures, the use of fall-risk inducing drugs (FRIDs) in this population has not previously been investigated. The objective of this study was to investigate the burden of use of FRIDs in older persons treated with anti-Parkinson drugs (APD; used as a proxy for PD), compared to persons without APD. Methods We analyzed individual data on age, sex, type of housing and drug use in 1 346 709 persons aged >= 65 years in the Swedish Prescribed Drug Register on the date of 30 September 2008. Main outcome measure was the use of FRIDs. Results FRIDs were used by 79% of persons with APD and 75% of persons without APD. Persons with APD were more likely to use >= 1 FRIDs compared to persons without APD (adjusted OR: 1.09; 95% CI: 1.06-1-12). The association was stronger for concomitant use of >= 5 FRIDS (adjusted OR: 1.49; 95% CI: 1.44-1.55). Conclusions The high use of FRIDs among persons with APD indicates that these patients may be at increased risk of drug-induced falls. Further studies are needed to investigate how these drugs affect the risk of falling in persons with PD.	[Haasum, Ylva] Karolinska Inst, Dept Neurobiol Care Sci & Soc, Aging Res Ctr, Stockholm, Sweden; Stockholm Univ, Stockholm, Sweden	Karolinska Institutet; Stockholm University	Haasum, Y (corresponding author), Karolinska Inst, Dept Neurobiol Care Sci & Soc, Aging Res Ctr, Stockholm, Sweden.	Ylva.Haasum@ki.se			Swedish Research Council; Strategic Research Program in Epidemiology at Karolinska Institutet	Swedish Research Council(Swedish Research CouncilEuropean Commission); Strategic Research Program in Epidemiology at Karolinska Institutet	This study was supported financially by grants from the Swedish Research Council and the Strategic Research Program in Epidemiology at Karolinska Institutet. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarsland D, 2000, J AM GERIATR SOC, V48, P938, DOI 10.1111/j.1532-5415.2000.tb06891.x; Ahlskog JE, 2014, MAYO CLIN PROC, V89, P997, DOI 10.1016/j.mayocp.2014.02.018; Allen NE, 2013, PARKINSONS DIS-US, V2013, DOI 10.1155/2013/906274; Baranzini F, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-228; Bennett A, 2014, DRUG AGING, V31, P225, DOI 10.1007/s40266-013-0151-3; BLAKE AJ, 1988, AGE AGEING, V17, P365, DOI 10.1093/ageing/17.6.365; Bloem BR, 2001, J NEUROL, V248, P950, DOI 10.1007/s004150170047; Brandt-Christensen M, 2006, MOVEMENT DISORD, V21, P1221, DOI 10.1002/mds.20907; Canning CG, 2014, NEURODEGENER DIS MAN, V4, P203, DOI [10.2217/nmt.14.22, 10.2217/NMT.14.22]; Chaudhuri KR, 2015, MOVEMENT DISORD, V30, P1623, DOI 10.1002/mds.26270; Chou KL, 2011, PARKINSONISM RELAT D, V17, P440, DOI 10.1016/j.parkreldis.2011.03.002; Comella Cynthia L, 2003, Curr Neurol Neurosci Rep, V3, P173, DOI 10.1007/s11910-003-0073-2; Crispo JAG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150621; Dissanayaka NNNW, 2014, MOVEMENT DISORD, V29, P967, DOI 10.1002/mds.25937; Ehrt U, 2010, J NEUROL NEUROSUR PS, V81, P160, DOI 10.1136/jnnp.2009.186239; Fastbom J, 2010, SWEDISH NATL BORD HL, V6; Grimbergen YAM, 2004, CURR OPIN NEUROL, V17, P405, DOI 10.1097/01.wco.0000137530.68867.93; Harris MA, 2011, PARKINSONISM RELAT D, V17, P464, DOI 10.1016/j.parkreldis.2011.04.007; Hartikainen S, 2007, J GERONTOL A-BIOL, V62, P1172, DOI 10.1093/gerona/62.10.1172; Hausdorff JM, 2003, EXP BRAIN RES, V149, P187, DOI 10.1007/s00221-002-1354-8; Huang AR, 2012, DRUG AGING, V29, P359, DOI 10.2165/11599460-000000000-00000; Johnell K, 2011, EUR J CLIN PHARMACOL, V67, P1069, DOI 10.1007/s00228-011-1051-2; Kannus P, 2005, LANCET, V366, P1885, DOI 10.1016/S0140-6736(05)67604-0; Kojima G, 2015, J AM MED DIR ASSOC, V16, P940, DOI 10.1016/j.jamda.2015.06.025; Kojima T, 2011, GERIATR GERONTOL INT, V11, P438, DOI 10.1111/j.1447-0594.2011.00703.x; Kragh A, 2011, J AM GERIATR SOC, V59, P863, DOI 10.1111/j.1532-5415.2011.03372.x; Laflamme L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123390; Leipzig RM, 1999, J AM GERIATR SOC, V47, P40, DOI 10.1111/j.1532-5415.1999.tb01899.x; Leipzig RM, 1999, J AM GERIATR SOC, V47, P30, DOI 10.1111/j.1532-5415.1999.tb01898.x; Lieberman A, 2006, ACTA NEUROL SCAND, V113, P1, DOI 10.1111/j.1600-0404.2006.00536.x; Masud T, 2001, AGE AGEING, V30, P3, DOI 10.1093/ageing/30.suppl_4.3; Milos V, 2014, BMC GERIATR, V14, DOI 10.1186/1471-2318-14-40; Modugno N, 2013, ARCH ITAL BIOL, V151, P148; Nilson F, 2016, INT J INJ CONTROL SA, V23, P277, DOI 10.1080/17457300.2015.1032980; Payne RA, 2014, BRIT J CLIN PHARMACO, V77, P1073, DOI 10.1111/bcp.12292; Perez-Lloret S, 2012, PARKINSONISM RELAT D, V18, P501, DOI 10.1016/j.parkreldis.2012.01.012; Richardson K, 2015, J AM GERIATR SOC, V63, P1561, DOI 10.1111/jgs.13543; Rossini M, 2014, DRUG AGING, V31, P547, DOI 10.1007/s40266-014-0184-2; Seppi K, 2011, MOVEMENT DISORD, V26, pS42, DOI 10.1002/mds.23884; Stevens JA, 2006, INJURY PREV, V12, P290, DOI 10.1136/ip.2005.011015; Stolze H, 2005, MOVEMENT DISORD, V20, P89, DOI 10.1002/mds.20266; Stolze H, 2004, J NEUROL, V251, P79, DOI 10.1007/s00415-004-0276-8; TANDBERG E, 1995, MOVEMENT DISORD, V10, P541, DOI 10.1002/mds.870100503; The Swedish National Board of Health and Welfare, 2008, CAR SERV ELD PERS 30; Van der Velde N, 2007, BRIT J CLIN PHARMACO, V63, P232, DOI 10.1111/j.1365-2125.2006.02736.x; Wenning GK, 2000, J NEUROL NEUROSUR PS, V68, P434, DOI 10.1136/jnnp.68.4.434; Wettermark B, 2007, PHARMACOEPIDEM DR S, V16, P726, DOI 10.1002/pds.1294; WHO Collaborating Centre for Drug Statistics Methodology, 2015, GUIDELINES ATC CLASS; Wood BH, 2002, J NEUROL NEUROSUR PS, V72, P721, DOI 10.1136/jnnp.72.6.721	49	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0161246	10.1371/journal.pone.0161246	http://dx.doi.org/10.1371/journal.pone.0161246			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DT6ES	27537366	Green Published, gold, Green Submitted			2022-12-27	WOS:000381577000076
J	Zitt, E; Pscheidt, C; Concin, H; Kramar, R; Lhotta, K; Nagel, G				Zitt, Emanuel; Pscheidt, Constanze; Concin, Hans; Kramar, Reinhard; Lhotta, Karl; Nagel, Gabriele			Anthropometric and Metabolic Risk Factors for ESRD Are Disease-Specific: Results from a Large Population-Based Cohort Study in Austria	PLOS ONE			English	Article							STAGE RENAL-DISEASE; CHRONIC KIDNEY-DISEASE; GAMMA-GLUTAMYL-TRANSFERASE; BODY-MASS INDEX; BLOOD-PRESSURE; MICROVASCULAR COMPLICATIONS; MULTIFACTORIAL INTERVENTION; FOLLOW-UP; PROGRESSION; MORTALITY	Background Anthropometric and metabolic risk factors for all-cause end-stage renal disease (ESRD) may vary in their impact depending on the specific primary renal disease. Methods In this Austrian population-based prospective cohort study (n = 185,341; 53.9% women) the following data were collected between 1985 and 2005: age, sex, body mass index (BMI), fasting blood glucose (FBG) from 1988, blood pressure, total cholesterol (TC), triglycerides (TG), gamma-glutamyl transferase (GGT) and smoking status. These data were merged with the Austrian Dialysis and Transplant Registry to identify ESRD patients. Cox proportional hazards models were applied to calculate hazard ratios (HR) for all-cause ESRD as well as for cause-specific ESRD due to the following primary renal diseases: autosomal dominant polycystic kidney disease (ADPKD), vascular nephropathy (VN), diabetic nephropathy (DN) and other diseases (OD). Results During a mean follow-up of 17.5 years 403 participants developed ESRD (ADPKD 36, VN 97, DN 86, and OD 184). All parameters except TG and GGT were significantly associated with all-cause ESRD risk. Particular cause-specific ESRD risk factor patterns were found: for ADPKD increased risk from hypertension (HR 11.55); for VN from smoking (HR 1.81), hypertension (HR 2.37), TG (>= 5.70 vs. <1.17 mmol/L: HR 9.27); for DN from smoking (HR 1.77), BMI (>= 30 vs. 18.5-24.9 kg/m(2): HR 7.55), FBG (>= 6.94 vs. <5.55 mmol/L: HR 7.67), hypertension (HR 1.08), TG (>= 5.70 vs. <1.17 mmol/L: HR 2.02), GGT (HR 2.14); and for OD from hypertension (HR 2.29), TG (>= 5.70 vs. <1.17 mmol/L: HR 6.99) and TC (>= 6.22 vs. <5.18 mmol/L: HR 1.56). Conclusions Particular anthropometric and metabolic ESRD risk factors differ in importance depending on the primary renal disease. This needs to be considered for future preventive and therapeutic strategies addressing cause-specific ESRD.	[Zitt, Emanuel; Lhotta, Karl] Acad Teaching Hosp Feldkirch, Dept Nephrol & Dialysis, Feldkirch, Austria; [Zitt, Emanuel; Lhotta, Karl] Acad Teaching Hosp Feldkirch, VIVIT, Feldkirch, Austria; [Pscheidt, Constanze; Concin, Hans; Nagel, Gabriele] Agcy Prevent & Social Med, Bregenz, Austria; [Pscheidt, Constanze; Nagel, Gabriele] Univ Ulm, Inst Epidemiol & Med Biometry, Ulm, Germany; [Kramar, Reinhard] Austrian Dialysis & Transplant Registry, Rohr Im Kremstal, Austria	Ulm University	Nagel, G (corresponding author), Agcy Prevent & Social Med, Bregenz, Austria.; Nagel, G (corresponding author), Univ Ulm, Inst Epidemiol & Med Biometry, Ulm, Germany.	hans.concin@aks.or.at; gabriele.nagel@uni-ulm.de	vhmpp, aks/F-9756-2012; Nagel, Gabriele/C-3635-2012; Zitt, Emanuel/ABE-1926-2020	Nagel, Gabriele/0000-0001-6185-8535; Zitt, Emanuel/0000-0001-6944-6041				Adler AI, 2000, BMJ-BRIT MED J, V321, P412, DOI 10.1136/bmj.321.7258.412; Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS11, DOI 10.2337/dc13-S011; Amer Diabet Assoc, 2012, DIABETES CARE, V35, pS64, DOI [10.2337/dc12-S064, 10.2337/dc09-S062, 10.2337/dc11-S011]; [Anonymous], 2013, N 1, V17, DOI DOI 10.1093/NDT/GFV100; Bangalore S, 2011, CIRCULATION, V123, P2799, DOI 10.1161/CIRCULATIONAHA.110.016337; Brenner BM, 2001, NEW ENGL J MED, V345, P861, DOI 10.1056/NEJMoa011161; Carter BD, 2015, NEW ENGL J MED, V372, P631, DOI 10.1056/NEJMsa1407211; Chang TI, 2013, AM J KIDNEY DIS, V61, pS4, DOI 10.1053/j.ajkd.2012.12.016; Charlton J, 2008, DIABETES CARE, V31, P1761, DOI 10.2337/dc08-0137; Cooper CJ, 2014, NEW ENGL J MED, V370, P13, DOI 10.1056/NEJMoa1310753; Cornec-Le Gall E, 2013, J AM SOC NEPHROL, V24, P1006, DOI 10.1681/ASN.2012070650; Dialysis Austrian and Registry Transplantation (OEDTR), 2014, ANNUAL REPORT 2014; Ejerblad E, 2006, J AM SOC NEPHROL, V17, P1695, DOI 10.1681/ASN.2005060638; Eriksen BO, 2006, KIDNEY INT, V69, P375, DOI 10.1038/sj.ki.5000058; Gaede P, 2003, NEW ENGL J MED, V348, P383, DOI 10.1056/NEJMoa021778; Gaede P, 2008, NEW ENGL J MED, V358, P580, DOI 10.1056/NEJMoa0706245; Gregg EW, 2014, NEW ENGL J MED, V370, P1514, DOI 10.1056/NEJMoa1310799; Gross O, 2012, KIDNEY INT, V81, P494, DOI 10.1038/ki.2011.407; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Hallan SI, 2011, KIDNEY INT, V80, P516, DOI 10.1038/ki.2011.157; Hecking M, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001750; Hsu CY, 2009, ARCH INTERN MED, V169, P342, DOI 10.1001/archinternmed.2008.605; Hsu CY, 2005, ARCH INTERN MED, V165, P923, DOI 10.1001/archinte.165.8.923; Iseki K, 2004, KIDNEY INT, V65, P1870, DOI 10.1111/j.1523-1755.2004.00582.x; Kastarinen M, 2010, J INTERN MED, V267, P612, DOI 10.1111/j.1365-2796.2009.02197.x; Klag MJ, 1996, NEW ENGL J MED, V334, P13, DOI 10.1056/NEJM199601043340103; Klenk J, 2009, EUR J EPIDEMIOL, V24, P83, DOI 10.1007/s10654-009-9312-4; Lee DH, 2005, CLIN CHEM, V51, P1185, DOI 10.1373/clinchem.2004.045872; McMahon GM, 2014, J AM SOC NEPHROL, V25, P2633, DOI 10.1681/ASN.2013070750; Muntner P, 2000, KIDNEY INT, V58, P293, DOI 10.1046/j.1523-1755.2000.00165.x; Nagel G, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-177; Neugarten J, 2000, J AM SOC NEPHROL, V11, P319, DOI 10.1681/ASN.V112319; Ozkok A, 2013, CLIN EXP NEPHROL, V17, P345, DOI 10.1007/s10157-012-0706-3; Panwar B, 2015, KIDNEY INT, V87, P1216, DOI 10.1038/ki.2014.384; Parving HH, 2001, NEW ENGL J MED, V345, P870, DOI 10.1056/NEJMoa011489; Prischl FC, 2015, NEPHROL DIAL TRANSPL, V30, P1920, DOI 10.1093/ndt/gfv113; Pscheidt C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135052; Rahman M, 2014, CLIN J AM SOC NEPHRO, V9, P1190, DOI 10.2215/CJN.09320913; Ruggenenti P, 2004, NEW ENGL J MED, V351, P1941, DOI 10.1056/NEJMoa042167; Ruggenenti P, 1998, LANCET, V352, P1252, DOI 10.1016/S0140-6736(98)04433-X; Schrier RW, 2014, NEW ENGL J MED, V371, P2255, DOI 10.1056/NEJMoa1402685; Schrier RW, 2014, J AM SOC NEPHROL, V25, P2399, DOI 10.1681/ASN.2013111184; SILBIGER SR, 1995, AM J KIDNEY DIS, V25, P515, DOI 10.1016/0272-6386(95)90119-1; Spithoven EM, 2014, KIDNEY INT, V86, P1244, DOI 10.1038/ki.2014.120; Stratton IM, 2000, BMJ-BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405; Sundin PO, 2014, AM J KIDNEY DIS, V64, P723, DOI 10.1053/j.ajkd.2014.06.019; Targher G, 2010, CLIN CHEM LAB MED, V48, P147, DOI 10.1515/CCLM.2010.031; Thomas G, 2011, CLIN J AM SOC NEPHRO, V6, P2364, DOI 10.2215/CJN.02180311; Torres VE, 2014, NEW ENGL J MED, V371, P2267, DOI 10.1056/NEJMoa1402686; Tozawa M, 2003, HYPERTENSION, V41, P1341, DOI 10.1161/01.HYP.0000069699.92349.8C; Ulmer H, 2003, EUR HEART J, V24, P1004, DOI 10.1016/S0195-668X(03)00170-2; US Renal Data System, 2014, 2014 ANNUAL DATA REP; Vivante A, 2012, ARCH INTERN MED, V172, P1644, DOI 10.1001/2013.jamainternmed.85; Wimmer F, 2003, NEPHROL DIAL TRANSPL, V18, P1562, DOI 10.1093/ndt/gfg184	54	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0161376	10.1371/journal.pone.0161376	http://dx.doi.org/10.1371/journal.pone.0161376			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27537361	Green Published, gold, Green Submitted			2022-12-27	WOS:000381577000095
J	Gim, J; Won, S; Park, T				Gim, Jungsoo; Won, Sungho; Park, Taesung			LPEseq: Local-Pooled-Error Test for RNA Sequencing Experiments with a Small Number of Replicates	PLOS ONE			English	Article							DIFFERENTIAL EXPRESSION ANALYSIS; SEQ; NORMALIZATION	RNA-Sequencing (RNA-Seq) provides valuable information for characterizing the molecular nature of the cells, in particular, identification of differentially expressed transcripts on a genome-wide scale. Unfortunately, cost and limited specimen availability often lead to studies with small sample sizes, and hypothesis testing on differential expression between classes with a small number of samples is generally limited. The problem is especially challenging when only one sample per each class exists. In this case, only a few methods among many that have been developed are applicable for identifying differentially expressed transcripts. Thus, the aim of this study was to develop a method able to accurately test differential expression with a limited number of samples, in particular non-replicated samples. We propose a local-pooled-error method for RNA-Seq data (LPEseq) to account for non-replicated samples in the analysis of differential expression. Our LPEseq method extends the existing LPE method, which was proposed for microarray data, to allow examination of non-replicated RNA-Seq experiments. We demonstrated the validity of the LPEseq method using both real and simulated datasets. By comparing the results obtained using the LPEseq method with those obtained from other methods, we found that the LPEseq method outperformed the others for non-replicated datasets, and showed a similar performance with replicated samples; LPEseq consistently showed high true discovery rate while not increasing the rate of false positives regardless of the number of samples. Our proposed LPEseq method can be effectively used to conduct differential expression analysis as a preliminary design step or for investigation of a rare specimen, for which a limited number of samples is available.	[Gim, Jungsoo] Seoul Natl Univ, Inst Hlth & Environm, 1 Gwanak Ro, Seoul, South Korea; [Won, Sungho] Seoul Natl Univ, Grad Sch Publ Hlth, 1 Gwanak Ro, Seoul, South Korea; [Park, Taesung] Seoul Natl Univ, Dept Stat, 1 Gwanak Ro, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Park, T (corresponding author), Seoul Natl Univ, Dept Stat, 1 Gwanak Ro, Seoul, South Korea.	tspark@stats.snu.ac.kr			National Research Foundation of Korea (NRF) grants - Korea government (MSIP) [2012R1A3A2026438]; Bio-Synergy Research Project of the Ministry of Science, ICT and Future Planning through the NRF [2013M3A9C4078158]	National Research Foundation of Korea (NRF) grants - Korea government (MSIP); Bio-Synergy Research Project of the Ministry of Science, ICT and Future Planning through the NRF	This work is supported by the National Research Foundation of Korea (NRF) grants funded by the Korea government (MSIP) (no. 2012R1A3A2026438) and by the Bio-Synergy Research Project (2013M3A9C4078158) of the Ministry of Science, ICT and Future Planning through the NRF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Thanks to Yoav Benjamini (Tel Aviv University) and Nancy Cox (University of Chicago) for invaluable comments and helpful discussions. This work is supported by the National Research Foundation of Korea (NRF) grants funded by the Korea government (MSIP) (No. 2012R1A3A2026438) and by the Bio-Synergy Research Project (2013M3A9C4078158) of the Ministry of Science, ICT and Future Planning through the NRF.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bullard JH, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-94; CASSIE RM, 1962, J ANIM ECOL, V31, P65, DOI 10.2307/2333; Di YM, 2011, STAT APPL GENET MOL, V10, DOI 10.2202/1544-6115.1637; Frazee AC, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-449; Gregg C, 2010, SCIENCE, V329, P643, DOI 10.1126/science.1190830; Hammer P, 2010, GENOME RES, V20, P847, DOI 10.1101/gr.101204.109; Henningsen A, 2011, COMPUTATION STAT, V26, P443, DOI 10.1007/s00180-010-0217-1; Hoaglin DC, 1993, HOW TO DETECT AND HA, Vix; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jain N, 2003, BIOINFORMATICS, V19, P1945, DOI 10.1093/bioinformatics/btg264; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Li J, 2013, STAT METHODS MED RES, V22, P519, DOI 10.1177/0962280211428386; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Maher CA, 2009, NATURE, V458, P97, DOI 10.1038/nature07638; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; McCarthy DJ, 2012, NUCLEIC ACIDS RES, V40, P4288, DOI 10.1093/nar/gks042; Montgomery SB, 2010, NATURE, V464, P773, DOI 10.1038/nature08903; Rapaport F, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-9-r95; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Robles JA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-484; Seyednasrollah F, 2015, BRIEF BIOINFORM, V16, P59, DOI 10.1093/bib/bbt086; Soneson C, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-91; Sultan M, 2008, SCIENCE, V321, P956, DOI 10.1126/science.1160342	27	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2016	11	8							e0159182	10.1371/journal.pone.0159182	http://dx.doi.org/10.1371/journal.pone.0159182			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4YN	27532300	Green Published, gold, Green Submitted			2022-12-27	WOS:000381487600006
J	Fani, S; Dehghan, F; Karimian, H; Lo, KM; Nigjeh, SE; Keong, YS; Soori, R; Chow, KM; Kamalidehghan, B; Ali, HM; Hashim, NM				Fani, Somayeh; Dehghan, Firouzeh; Karimian, Hamed; Lo, Kong Mun; Nigjeh, Siyamak Ebrahimi; Keong, Yeap Swee; Soori, Rahman; Chow, Kit May; Kamalidehghan, Behnam; Ali, Hapipah Mohd; Hashim, Najihah Mohd			Monobenzyltin Complex C1 Induces Apoptosis in MCF-7 Breast Cancer Cells through the Intrinsic Signaling Pathway and through the Targeting of MCF-7-Derived Breast Cancer Stem Cells via the Wnt/beta Catenin Signaling Pathway	PLOS ONE			English	Article							IN-VITRO CYTOTOXICITY; BETA-CATENIN; STRUCTURAL-CHARACTERIZATION; PROSPECTIVE IDENTIFICATION; ALDEHYDE DEHYDROGENASE; ANTITUMOR-ACTIVITY; ACTIVATION; THERAPY; DEATH; DERIVATIVES	Monobenzyltin Schiff base complex, [N-(3,5-dichloro-2-oxidobenzylidene)-4-chlorobenzyhy-drazidato](o-methylbenzyl) aquatin(IV) chloride, C1, is an organotin non-platinum metal-based agent. The present study was conducted to investigate its effects on MCF-7 cells with respect to the induction of apoptosis and its inhibitory effect against MCF-7 breast cancer stem cells. As determined in a previous study, compound C1 revealed strong antiproliferative activity on MCF-7 cells with an IC50 value of 2.5 mu g/mL. Annexin V/propidium iodide staining coupled with flow cytometry indicated the induction of apoptosis in treated cells. Compound C1 induced apoptosis in MCF-7 cells and was mediated through the intrinsic pathway with a reduction in mitochondrial membrane potential and mitochondrial cytochrome c release to cytosol. Complex C1 activated caspase 9 as a result of cytochrome c release. Subsequently, western blot and real time PCR revealed a significant increase in Bax and Bad expression and a significant decrease in the expression levels of Bcl2 and HSP70. Furthermore, a flow cytometric analysis showed that treatment with compound C1 caused a significant arrest of MCF-7 cells in G0/G1 phase. The inhibitory analysis of compound C1 against derived MCF-7 stem cells showed a significant reduction in the aldehyde dehydrogenase-positive cell population and a significant reduction in the population of MCF-7 cancer stem cells in primary, secondary, and tertiary mammospheres. Moreover, treatment with C1 down-regulated the Wnt/beta-catenin self-renewal pathway. These findings indicate that complex C1 is a suppressive agent of MCF-7 cells that functions through the induction of apoptosis, cell cycle arrest, and the targeting of MCF-7-derived cancer stem cells. This work may lead to a better treatment strategy for the reduction of breast cancer recurrence.	[Fani, Somayeh; Karimian, Hamed; Hashim, Najihah Mohd] Univ Malaya, Dept Pharm, Fac Med, Kuala Lumpur 50603, Malaysia; [Dehghan, Firouzeh; Soori, Rahman] Univ Tehran, Fac Phys Educ & Sport Sci, Dept Exercise Physiol, Tehran 14174, Iran; [Dehghan, Firouzeh] Univ Malaya, Dept Exercise Sci, Sports Ctr, Kuala Lumpur 50603, Malaysia; [Lo, Kong Mun; Chow, Kit May; Ali, Hapipah Mohd] Univ Malaya, Dept Chem, Fac Sci, Kuala Lumpur 50603, Malaysia; [Nigjeh, Siyamak Ebrahimi; Keong, Yeap Swee] Univ Putra Malaysia, Inst Biosci, Serdang 43400, Malaysia; [Kamalidehghan, Behnam] NIGEB, Dept Med Genet, Tehran Karaj Highway, Tehran, Iran; [Ali, Hapipah Mohd; Hashim, Najihah Mohd] Univ Malaya, Ctr Nat Prod & Drug Discovery CENAR, Dept Chem, Fac Sci, Kuala Lumpur, Malaysia	Universiti Malaya; University of Tehran; Universiti Malaya; Universiti Malaya; Universiti Putra Malaysia; Universiti Malaya	Fani, S; Hashim, NM (corresponding author), Univ Malaya, Dept Pharm, Fac Med, Kuala Lumpur 50603, Malaysia.; Hashim, NM (corresponding author), Univ Malaya, Ctr Nat Prod & Drug Discovery CENAR, Dept Chem, Fac Sci, Kuala Lumpur, Malaysia.	somi.fani@gmail.com; najihahmh@um.edu.my	Soori, Rahman/AAM-8873-2020; Kamalidehghan, Behnam/B-5401-2013; Hashim, Najihah Mohd/J-5508-2015; Yeap, Swee Keong/H-9285-2013	Soori, Rahman/0000-0002-4661-7204; Kamalidehghan, Behnam/0000-0001-8530-8124; Hashim, Najihah Mohd/0000-0003-1133-7998; Yeap, Swee Keong/0000-0002-4736-0674	University of Malaya Research Grant [RG084-13BIO]; IPPP grant [PG082-2013B];  [UM.0000104/HIR.C1]	University of Malaya Research Grant; IPPP grant; 	The authors would like to express their greatest appreciation to the University of Malaya Research Grant (RG084-13BIO), IPPP grant (PG082-2013B), and UM.0000104/HIR.C1 for providing partial financial support to conduct this study.	Ahmadipour F, 2015, DRUG DES DEV THER, V9, P1193, DOI 10.2147/DDDT.S72127; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Alama A, 2009, DRUG DISCOV TODAY, V14, P500, DOI 10.1016/j.drudis.2009.02.002; Arbab IA, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/856029; Awang N, 2011, Pak J Biol Sci, V14, P768; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; CARUSO F, 1994, J ORGANOMET CHEM, V466, P69, DOI 10.1016/0022-328X(94)88030-1; Chan CK, 2012, MOLECULES, V17, P6633, DOI 10.3390/molecules17066633; Charafe-Jauffret E, 2009, CANCER RES, V69, P1302, DOI 10.1158/0008-5472.CAN-08-2741; Chen SP, 2009, MUTAT RES-FUND MOL M, V666, P68, DOI 10.1016/j.mrfmmm.2009.04.006; Chute JP, 2006, P NATL ACAD SCI USA, V103, P11707, DOI 10.1073/pnas.0603806103; Clevers H, 2011, NAT MED, V17, P313, DOI 10.1038/nm.2304; Collins AT, 2005, CANCER RES, V65, P10946, DOI 10.1158/0008-5472.CAN-05-2018; Cragg GM, 2005, J ETHNOPHARMACOL, V100, P72, DOI 10.1016/j.jep.2005.05.011; Croker AK, 2009, J CELL MOL MED, V13, P2236, DOI 10.1111/j.1582-4934.2008.00455.x; Csuk R, 2012, EUR J MED CHEM, V56, P237, DOI 10.1016/j.ejmech.2012.08.032; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Eramo A, 2008, CELL DEATH DIFFER, V15, P504, DOI 10.1038/sj.cdd.4402283; Fani S, 2015, DRUG DES DEV THER, V9, P6191, DOI 10.2147/DDDT.S87064; Fantozzi A, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1530; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Fulda S, 2010, INT J BIOCHEM CELL B, V42, P31, DOI 10.1016/j.biocel.2009.06.010; Gielen M, 2000, J INORG BIOCHEM, V79, P139, DOI 10.1016/S0162-0134(99)00161-0; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Gomez E, 2006, CHEM PHARM BULL, V54, P54, DOI 10.1248/cpb.54.54; Gu Q, 2005, CARCINOGENESIS, V26, P541, DOI 10.1093/carcin/bgh345; Gupta SC, 2010, CANCER METAST REV, V29, P405, DOI 10.1007/s10555-010-9235-2; Hadjikakou SK, 2009, COORDIN CHEM REV, V253, P235, DOI 10.1016/j.ccr.2007.12.026; Hajrezaie M, 2014, SCI WORLD J, DOI 10.1155/2014/540463; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; He YC, 2014, INT J MOL SCI, V15, P8335, DOI 10.3390/ijms15058335; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Hunter AM, 2007, APOPTOSIS, V12, P1543, DOI 10.1007/s10495-007-0087-3; Ikeda S, 1998, EMBO J, V17, P1371, DOI 10.1093/emboj/17.5.1371; Jin ZY, 2009, CELL, V137, P721, DOI 10.1016/j.cell.2009.03.015; Joo JH, 2010, CANCER LETT, V287, P123, DOI 10.1016/j.canlet.2009.05.015; Kakarala M, 2008, J CLIN ONCOL, V26, P2813, DOI 10.1200/JCO.2008.16.3931; Kanagesan S, 2013, ADV MATER SCI ENG, V2013, DOI 10.1155/2013/710432; Karimian H, 2015, CELL PHYSIOL BIOCHEM, V36, P988, DOI 10.1159/000430273; Karimian H, 2014, DRUG DES DEV THER, V8, P1481, DOI 10.2147/DDDT.S68818; Kennedy SG, 1997, GENE DEV, V11, P701, DOI 10.1101/gad.11.6.701; Kim BM, 2007, BIOCHEM BIOPH RES CO, V363, P745, DOI 10.1016/j.bbrc.2007.09.024; Kizlink J, 2001, CHEM PAP, V55, P53; Korkaya H, 2008, ONCOGENE, V27, P6120, DOI 10.1038/onc.2008.207; Korkaya H, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000121; Lee SM, 2013, INORG CHIM ACTA, V406, P272, DOI 10.1016/j.ica.2013.04.036; Liu ZB, 2009, J CELL BIOCHEM, V108, P195, DOI 10.1002/jcb.22241; Luo W, 2007, EMBO J, V26, P1511, DOI 10.1038/sj.emboj.7601607; Ma S, 2008, ONCOGENE, V27, P1749, DOI 10.1038/sj.onc.1210811; Mohan S, 2010, J ETHNOPHARMACOL, V131, P592, DOI 10.1016/j.jep.2010.07.043; Molenaar M, 1996, CELL, V86, P391, DOI 10.1016/S0092-8674(00)80112-9; Monica C, 1998, ANTI-CANCER DRUG, V9, P603; Morrison BJ, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2111; Ngai P, 2008, HEPATOLOGY, V47, P919, DOI [10.1002/hep.22082, DOI 10.1002/HEP.22082]; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Ocker M, 2012, EUR SURG RES, V48, P111, DOI 10.1159/000336875; Pahlke G, 2006, J AGR FOOD CHEM, V54, P7075, DOI 10.1021/jf0612530; Pham PV, 2012, ISOLATION BREAST CAN, DOI DOI 10.5772/3071; Pham TD, 2003, AM J PHYSIOL-REG I, V285, pR962, DOI 10.1152/ajpregu.00201.2003; Ponti D, 2005, CANCER RES, V65, P5506, DOI 10.1158/0008-5472.CAN-05-0626; Rehman W, 2008, EUR J MED CHEM, V43, P2380, DOI 10.1016/j.ejmech.2008.01.019; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Rossi DJ, 2008, CELL, V132, P681, DOI 10.1016/j.cell.2008.01.036; Rubinfeld B, 1996, SCIENCE, V272, P1023, DOI 10.1126/science.272.5264.1023; Sachlos E, 2012, CELL, V149, P1284, DOI 10.1016/j.cell.2012.03.049; Schatton T, 2008, NATURE, V451, P345, DOI 10.1038/nature06489; Schwartz GK, 2005, J CLIN ONCOL, V23, P9408, DOI 10.1200/JCO.2005.01.5594; Shim HY, 2007, MOL CELLS, V24, P95; Shpakovsky DB, 2012, DALTON T, V41, P14568, DOI 10.1039/c2dt31527k; Siddiqi ZA, 2009, J ORGANOMET CHEM, V694, P3768, DOI 10.1016/j.jorganchem.2009.07.030; Siegel R, 2012, CA-CANCER J CLIN, V62, P220, DOI 10.3322/caac.21149; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Tait SWG, 2010, NAT REV MOL CELL BIO, V11, P621, DOI 10.1038/nrm2952; Takahashi-Yanaga F, 2010, CLIN CANCER RES, V16, P3153, DOI 10.1158/1078-0432.CCR-09-2943; Thoonen SHL, 2004, J ORGANOMET CHEM, V689, P2145, DOI 10.1016/j.jorganchem.2004.03.027; Vakkala M, 1999, CLIN CANCER RES, V5, P319; Vermeulen L, 2008, P NATL ACAD SCI USA, V105, P13427, DOI 10.1073/pnas.0805706105; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Weinl C, 2005, PLANT CELL, V17, P1704, DOI 10.1105/tpc.104.030486; Wu XZ, 2006, MED HYPOTHESES, V66, P883, DOI 10.1016/j.mehy.2005.11.036; Xanthopoulou MN, 2003, J INORG BIOCHEM, V96, P425, DOI 10.1016/S0162-0134(03)00178-8; Xiang JL, 1996, P NATL ACAD SCI USA, V93, P14559, DOI 10.1073/pnas.93.25.14559; Yun HR, 2009, J ACUPUNCT MERIDIAN, V2, P210, DOI 10.1016/S2005-2901(09)60057-1; Zhang H, 2013, P NATL ACAD SCI USA, V110, P5606, DOI 10.1073/pnas.1302352110; Zhou JB, 2008, BREAST CANCER RES TR, V111, P419, DOI 10.1007/s10549-007-9798-y	86	15	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2016	11	8							e0160836	10.1371/journal.pone.0160836	http://dx.doi.org/10.1371/journal.pone.0160836			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4UN	27529753	Green Published, gold, Green Submitted			2022-12-27	WOS:000381476700027
J	Ivleva, NB; Groat, J; Staub, JM; Stephens, M				Ivleva, Natalia B.; Groat, Jeanna; Staub, Jeffrey M.; Stephens, Michael			Expression of Active Subunit of Nitrogenase via Integration into Plant Organelle Genome	PLOS ONE			English	Article							PSBA MESSENGER-RNA; NIF-GENE-TRANSFER; AZOTOBACTER-VINELANDII; KLEBSIELLA-PNEUMONIAE; TOBACCO PLASTIDS; FIXATION; CEREALS; PROTEIN; CHLOROPLASTS; TRANSFORMATION	Nitrogen availability is crucial for crop yield with nitrogen fertilizer accounting for a large percentage of farmers' expenses. However, an untimely or excessive application of fertilizer can increase risks of negative environmental effects. These factors, along with the environmental and energy costs of synthesizing nitrogen fertilizer, led us to seek out novel biotechnology-driven approaches to supply nitrogen to plants. The strategy we focused on involves transgenic expression of nitrogenase, a bacterial multi-subunit enzyme that can capture atmospheric nitrogen. Here we report expression of the active Fe subunit of nitrogenase via integration into the tobacco plastid genome of bacterial gene sequences modified for expression in plastid. Our study suggests that it will be possible to engineer plants that are able to produce their own nitrogen fertilizer by expressing nitrogenase genes in plant plastids.	[Ivleva, Natalia B.; Groat, Jeanna; Staub, Jeffrey M.; Stephens, Michael] Monsanto Co, 700 Chesterfield Village Pkwy, Chesterfield, MO USA	Monsanto	Ivleva, NB (corresponding author), Monsanto Co, 700 Chesterfield Village Pkwy, Chesterfield, MO USA.	natalia.ivleva@monsanto.com			Monsanto Company	Monsanto Company	Monsanto Company provided support in the form of salaries for authors N.B.I., J.G., J.M.S., M.S., but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Aronsson H, 2002, FEBS LETT, V529, P215, DOI 10.1016/S0014-5793(02)03342-2; Beatty PH, 2011, SCIENCE, V333, P416, DOI 10.1126/science.1209467; Bock R, 2015, ANNU REV PLANT BIOL, V66, P211, DOI 10.1146/annurev-arplant-050213-040212; Bock R, 2013, PLANT MOL BIOL, V83, P21, DOI 10.1007/s11103-013-0045-0; Cazetta JO, 1999, ANN BOT-LONDON, V84, P747, DOI 10.1006/anbo.1999.0976; Charles Dan, 2013, National Geographic, V223, P96; Cheng Q, 2005, BIOCHEM BIOPH RES CO, V329, P966, DOI 10.1016/j.bbrc.2005.02.064; Curatti L, 2014, PLANT SCI, V225, P130, DOI 10.1016/j.plantsci.2014.06.003; Dixon R, 1997, PLANT SOIL, V194, P193, DOI 10.1023/A:1004296703638; DIXON RA, 1972, NATURE, V237, P102, DOI 10.1038/237102a0; Dos Santos PC, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-162; DU D, 1990, Chinese Journal of Oceanology and Limnology, V8, P378; Geddes BA, 2015, CURR OPIN BIOTECH, V32, P216, DOI 10.1016/j.copbio.2015.01.004; Hamilton TL, 2011, J BACTERIOL, V193, P4534, DOI 10.1128/JB.05100-11; Hamilton TL, 2011, J BACTERIOL, V193, P4477, DOI 10.1128/JB.05099-11; HARDY RWF, 1975, SCIENCE, V188, P633, DOI 10.1126/science.188.4188.633; HYMAN MR, 1987, APPL ENVIRON MICROB, V53, P298, DOI 10.1128/AEM.53.2.298-303.1987; Lu YH, 2013, P NATL ACAD SCI USA, V110, pE623, DOI 10.1073/pnas.1216898110; Ludden PW, ANNUAL REVIEW OF MIC, P93; Maliga P, 2011, PLANT PHYSIOL, V155, P1501, DOI 10.1104/pp.110.170969; Maliga P, 2011, METHODS MOL BIOL, V701, P37, DOI 10.1007/978-1-61737-957-4_2; Millar AH, 2007, METHOD CELL BIOL, V80, P65, DOI 10.1016/S0091-679X(06)80003-8; Mueller ND, 2012, NATURE, V490, P254, DOI 10.1038/nature11420; Oldroyd GED, 2014, CURR OPIN BIOTECH, V26, P19, DOI 10.1016/j.copbio.2013.08.006; POSTGATE J, 1992, PHILOS T ROY SOC B, V338, P409, DOI 10.1098/rstb.1992.0158; Poza-Carrion C, 2014, J BACTERIOL, V196, P595, DOI 10.1128/JB.00942-13; Preuss SB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030717; Raymond J, 2004, MOL BIOL EVOL, V21, P541, DOI 10.1093/molbev/msh047; Ritchie JT., 1998, CEREAL GROWTH DEV YI, P79; Rogers C, 2014, J EXP BOT, V65, P1939, DOI 10.1093/jxb/eru098; Rubio LM, 2005, J BACTERIOL, V187, P405, DOI 10.1128/JB.187.2.405-414.2005; SHAH VK, 1973, BIOCHIM BIOPHYS ACTA, V305, P445, DOI 10.1016/0005-2728(73)90190-4; Sidorov VA, 1999, PLANT J, V19, P209, DOI 10.1046/j.1365-313X.1999.00508.x; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; STAUB JM, 1994, PLANT J, V6, P547, DOI 10.1046/j.1365-313X.1994.6040547.x; Staub JM, 2000, NAT BIOTECHNOL, V18, P333, DOI 10.1038/73796; STAUB JM, 1993, EMBO J, V12, P601, DOI 10.1002/j.1460-2075.1993.tb05692.x; Sutton MA, 2011, NATURE, V472, P159, DOI 10.1038/472159a; SVAB Z, 1993, P NATL ACAD SCI USA, V90, P913, DOI 10.1073/pnas.90.3.913; Temme K, 2012, P NATL ACAD SCI USA, V109, P7085, DOI 10.1073/pnas.1120788109; Uribelarrea M, 2004, CROP SCI, V44, P1593, DOI 10.2135/cropsci2004.1593; Wang LY, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003865; Wang X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068677; Zhang J, 2012, PLANT J, V72, P115, DOI 10.1111/j.1365-313X.2012.05065.x	44	51	54	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2016	11	8							e0160951	10.1371/journal.pone.0160951	http://dx.doi.org/10.1371/journal.pone.0160951			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4UN	27529475	Green Submitted, Green Published, gold			2022-12-27	WOS:000381476700032
J	Donner, J; Kaukonen, M; Anderson, H; Moller, F; Kyostila, K; Sankari, S; Hytonen, M; Giger, U; Lohi, H				Donner, Jonas; Kaukonen, Maria; Anderson, Heidi; Moller, Fredrik; Kyostila, Kaisa; Sankari, Satu; Hytonen, Marjo; Giger, Urs; Lohi, Hannes			Genetic Panel Screening of Nearly 100 Mutations Reveals New Insights into the Breed Distribution of Risk Variants for Canine Hereditary Disorders	PLOS ONE			English	Article							PRIMARY LENS LUXATION; FACTOR-VII DEFICIENCY; DOG BREEDS; HYPERURICOSURIA; CATALASE; DISEASES; TERRIERS; MODEL	Background The growing number of identified genetic disease risk variants across dog breeds challenges the current state-of-the-art of population screening, veterinary molecular diagnostics, and genetic counseling. Multiplex screening of such variants is now technologically feasible, but its practical potential as a supportive tool for canine breeding, disease diagnostics, pet care, and genetics research is still unexplored. Results To demonstrate the utility of comprehensive genetic panel screening, we tested nearly 7000 dogs representing around 230 breeds for 93 disease-associated variants using a custom-designed genotyping microarray (the MyDogDNA1panel test). In addition to known breed disease-associated mutations, we discovered 15 risk variants in a total of 34 breeds in which their presence was previously undocumented. We followed up on seven of these genetic findings to demonstrate their clinical relevance. We report additional breeds harboring variants causing factor VII deficiency, hyperuricosuria, lens luxation, von Willebrand's disease, multifocal retinopathy, multidrug resistance, and rod-cone dysplasia. Moreover, we provide plausible molecular explanations for chondrodysplasia in the Chinook, cerebellar ataxia in the Norrbottenspitz, and familiar nephropathy in the Welsh Springer Spaniel. Conclusions These practical examples illustrate how genetic panel screening represents a comprehensive, efficient and powerful diagnostic and research discovery tool with a range of applications in veterinary care, disease research, and breeding. We conclude that several known disease alleles are more widespread across different breeds than previously recognized. However, careful follow up studies of any unexpected discoveries are essential to establish genotype-phenotype correlations, as is readiness to provide genetic counseling on their implications for the dog and its breed.	[Donner, Jonas; Anderson, Heidi; Moller, Fredrik; Lohi, Hannes] Genoscoper Labs Oy, Helsinki, Finland; [Kaukonen, Maria; Kyostila, Kaisa; Hytonen, Marjo; Lohi, Hannes] Univ Helsinki, Res Programs Unit Mol Neurol, Helsinki, Finland; [Kaukonen, Maria; Kyostila, Kaisa; Hytonen, Marjo; Lohi, Hannes] Univ Helsinki, Dept Vet Biosci, Helsinki, Finland; [Kaukonen, Maria; Kyostila, Kaisa; Hytonen, Marjo; Lohi, Hannes] Folkhalsan Inst Genet, Helsinki, Finland; [Sankari, Satu] Univ Helsinki, Dept Equine & Small Anim Med, Helsinki, Finland; [Giger, Urs] Univ Penn, Med Genet Sect, Philadelphia, PA 19104 USA	University of Helsinki; University of Helsinki; University of Helsinki; University of Pennsylvania	Donner, J (corresponding author), Genoscoper Labs Oy, Helsinki, Finland.	jonas.donner@genoscoper.com	Lohi, Hannes/F-4596-2011	Lohi, Hannes/0000-0003-1087-5532; Hytonen, Marjo/0000-0003-1976-5874; Kaukonen, Maria/0000-0002-2146-4694; Donner, Jonas/0000-0002-9874-8484	Jane and Aatos Erkko Foundation; Biocentrum Helsinki; Finnish Cultural Foundation; Academy of Finland; National Institutes of Health [OD010939]	Jane and Aatos Erkko Foundation; Biocentrum Helsinki; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Academy of Finland(Academy of Finland); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was partly supported by the Jane and Aatos Erkko Foundation (http://www.jaes.fi/; to HL), Biocentrum Helsinki (http://www.helsinki.fi/biocentrum/; to HL), the Finnish Cultural Foundation (http://www.skr.fi; to KK), the Academy of Finland (http://www.aka.fi/fi/; to HL), and National Institutes of Health grant number OD010939 - Animal Models of Human Genetic Disease (http://www.nih.gov; to UG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bannasch D, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000246; Brons AK, 2013, J VET INTERN MED, V27, P1400, DOI 10.1111/jvim.12176; Callan MB, 2006, J THROMB HAEMOST, V4, P2616, DOI 10.1111/j.1538-7836.2006.02203.x; Davidson AG, 2007, J VET INTERN MED, V21, P394, DOI 10.1892/0891-6640(2007)21[394:GCOARH]2.0.CO;2; Farias FHG, 2010, INVEST OPHTH VIS SCI, V51, P4716, DOI 10.1167/iovs.09-5142; Farrell Lindsay L, 2015, Canine Genet Epidemiol, V2, P3, DOI 10.1186/s40575-015-0014-9; Finnigan DF, 2007, J VET INTERN MED, V21, P458, DOI 10.1892/0891-6640(2007)21[458:ANMOTC]2.0.CO;2; Forman OP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064627; FUKUDA K, 1982, ACTA HISTOCHEM CYTOC, V15, P685, DOI 10.1267/ahc.15.685; Genoscoper Laboratories Oy, MYDOGDNA TECHN SHEET; Gilliam D, 2014, J VET INTERN MED, V28, P871, DOI 10.1111/jvim.12355; Gould D, 2011, VET OPHTHALMOL, V14, P378, DOI 10.1111/j.1463-5224.2011.00892.x; Gultekin GI, 2012, J VET INTERN MED, V26, P935, DOI 10.1111/j.1939-1676.2012.00958.x; Guziewicz KE, 2007, INVEST OPHTH VIS SCI, V48, P1959, DOI 10.1167/iovs.06-1374; Hytonen MK, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006037; Kaae JA, 2007, J VET INTERN MED, V21, P976, DOI 10.1892/0891-6640(2007)21[976:HFVDIT]2.0.CO;2; Karmi N, 2010, J VET INTERN MED, V24, P1337, DOI 10.1111/j.1939-1676.2010.0631.x; Karmi N, 2010, AM J VET RES, V71, P909, DOI 10.2460/ajvr.71.8.909; Kramer JW, 2004, VET PATHOL, V41, P221, DOI 10.1354/vp.41-3-221; Kyostila K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075621; Kyostila K, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002759; Mealey KL, 2001, PHARMACOGENETICS, V11, P727, DOI 10.1097/00008571-200111000-00012; Miyadera K, 2012, MAMM GENOME, V23, P40, DOI 10.1007/s00335-011-9361-3; Nakamura K, 2000, INT J BIOCHEM CELL B, V32, P1183, DOI 10.1016/S1357-2725(00)00057-1; Parker HG, 2007, GENOME RES, V17, P1562, DOI 10.1101/gr.6772807; Petersen-Jones SM, 1999, INVEST OPHTH VIS SCI, V40, P1637; [School of Veterinary Medicine University of Pennsylvania PennGen-Section of Medical Genetics], LIST CAN FEL HER DIS; Slutsky J, 2013, VET J, V197, P182, DOI 10.1016/j.tvjl.2013.02.021; Suomen Kennelliitto ry, KOIRANET JAL; [University of Sydney Faculty of Veterinary Science], ONL MEND INH AN; Zangerl B, 2010, MOL VIS, V16, P2791; Zeng R, 2014, J VET INTERN MED, V28, P515, DOI 10.1111/jvim.12317	32	27	27	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2016	11	8							e0161005	10.1371/journal.pone.0161005	http://dx.doi.org/10.1371/journal.pone.0161005			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4SL	27525650	Green Submitted, Green Published, gold			2022-12-27	WOS:000381471100029
J	Sowa-Staszczak, A; Trofimiuk-Muldner, M; Stefanska, A; Tomaszuk, M; Buziak-Bereza, M; Gilis-Januszewska, A; Jabrocka-Hybel, A; Glowa, B; Malecki, M; Bednarczuk, T; Kaminski, G; Kowalska, A; Mikolajczak, R; Janota, B; Hubalewska-Dydejczyk, A				Sowa-Staszczak, Anna; Trofimiuk-Muldner, Malgorzata; Stefanska, Agnieszka; Tomaszuk, Monika; Buziak-Bereza, Monika; Gilis-Januszewska, Aleksandra; Jabrocka-Hybel, Agata; Glowa, Boguslaw; Malecki, Maciej; Bednarczuk, Tomasz; Kaminski, Grzegorz; Kowalska, Aldona; Mikolajczak, Renata; Janota, Barbara; Hubalewska-Dydejczyk, Alicja			Tc-99m Labeled Glucagon-Like Peptide-1-Analogue (Tc-99m-GLP1) Scintigraphy in the Management of Patients with Occult Insulinoma	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; DEPENDENT DIABETIC-PATIENTS; NEUROENDOCRINE TUMORS; HYPERINSULINEMIC HYPOGLYCEMIA; RECEPTOR; LOCALIZATION; SECRETION; RESPONSES; FORMS; AMIDE	Introduction The aim of this study was to assess the utility of [Lys(40)(Ahx-HYNIC-Tc-99m/EDDA)NH2]-exendin-4 scintigraphy in the management of patients with hypoglycemia, particularly in the detection of occult insulinoma. Materials and Methods Forty patients with hypoglycemia and increased/confusing results of serum insulin and C-peptide concentration and negative/inconclusive results of other imaging examinations were enrolled in the study. In all patients GLP-1 receptor imaging was performed to localise potential pancreatic lesions. Results Positive results of GLP-1 scintigraphy were observed in 28 patients. In 18 patients postsurgical histopathological examination confirmed diagnosis of insulinoma. Two patients had contraindications to the surgery, one patient did not want to be operated. One patient, who presented with postprandial hypoglycemia, with positive result of GLP-1 imaging was not qualified for surgery and is in the observational group. Eight patients were lost for follow up, among them 6 patients with positive GLP-1 scintigraphy result. One patient with negative scintigraphy was diagnosed with malignant insulinoma. In two patients with negative scintigraphy Munchausen syndrome was diagnosed (patients were taking insulin). Other seven patients with negative results of (99m)TcGLP-1 scintigraphy and postprandial hypoglycemia with C-peptide and insulin levels within the limits of normal ranges are in the observational group. We would like to mention that Tc-99m-GLP1-SPECT/CT was also performed in 3 pts with nesidioblastosis (revealing diffuse tracer uptake in two and a focal lesion in one case) and in two patients with malignant insulinoma (with the a focal uptake in the localization of a removed pancreatic headin one case and negative GLP-1 1 scintigraphy in the other patient). Conclusions Tc-99m-GLP1-SPECT/CT could be helpful examination in the management of patients with hypoglycemia enabling proper localization of the pancreatic lesion and effective surgical treatment. This imaging technique may eliminate the need to perform invasive procedures in case of occult insulinoma.	[Sowa-Staszczak, Anna; Trofimiuk-Muldner, Malgorzata; Stefanska, Agnieszka; Tomaszuk, Monika; Buziak-Bereza, Monika; Gilis-Januszewska, Aleksandra; Jabrocka-Hybel, Agata; Hubalewska-Dydejczyk, Alicja] Jagiellonian Univ, Dept Endocrinol, Coll Med, Krakow, Poland; [Glowa, Boguslaw] Univ Hosp, Dept Endocrinol, Krakow, Poland; [Malecki, Maciej] Jagiellonian Univ, Dept Metab Dis, Coll Med, Krakow, Poland; [Bednarczuk, Tomasz] Med Univ Warsaw, Dept Endocrinol, Warsaw, Poland; [Kaminski, Grzegorz] Mil Inst Med, Dept Endocrinol & Radioisotop Therapy, Warsaw, Poland; [Kowalska, Aldona] Holycross Canc Ctr, Dept Endocrinol & Nucl Med, Kielce, Poland; [Mikolajczak, Renata; Janota, Barbara] Natl Ctr Nucl Res, Radioisotope Ctr POLATOM, Otwock, Poland	Jagiellonian University; Collegium Medicum Jagiellonian University; Jagiellonian University; Collegium Medicum Jagiellonian University; Medical University of Warsaw; Military Institute of Aviation Medicine; National Centre for Nuclear Research	Hubalewska-Dydejczyk, A (corresponding author), Jagiellonian Univ, Dept Endocrinol, Coll Med, Krakow, Poland.	alahub@cm-uj.krakow.pl	KAMINSKI, GRZEGORZ/AAH-9765-2020; Mikolajczak, Renata/S-2978-2019; Kielce, SCO/O-6702-2016; Trofimiuk-Muldner, Malgorzata/AFV-2722-2022; Bednarczuk, Tomasz/AFQ-8418-2022	KAMINSKI, GRZEGORZ/0000-0002-2357-0634; Mikolajczak, Renata/0000-0002-6882-751X; Tulik, Monika/0000-0002-6725-6575; KOWALSKA, ALDONA/0000-0001-5647-5898	Polish Ministry of Science [N402 445039]	Polish Ministry of Science(Ministry of Science and Higher Education, Poland)	This study was supported by the Polish Ministry of Science within Research Project No N402 445039. The costs of the publication of the manuscript are covered by KNOW 2012-2017 Leading National Research Center, Polish Ministry of Science and Higher Education.	Christ E, 2013, LANCET DIABETES ENDO, V1, P115, DOI 10.1016/S2213-8587(13)70049-4; Christ E, 2009, J CLIN ENDOCR METAB, V94, P4398, DOI 10.1210/jc.2009-1082; Christesen HBT, 2008, CLIN ENDOCRINOL, V68, P747, DOI 10.1111/j.1365-2265.2008.03184.x; Cryer PE., 2008, WILLIAMS TXB ENDOCRI, P1503; Cryer PE, 2009, J CLIN ENDOCR METAB, V94, P709, DOI 10.1210/jc.2008-1410; de Herder WW, 2016, BEST PRACT RES CL EN, V30, P3, DOI 10.1016/j.beem.2015.10.004; Eriksson O, 2014, J CLIN ENDOCR METAB, V99, P1519, DOI 10.1210/jc.2013-3541; Haubner R, 2010, RADIOTHER ONCOL, V96, P280, DOI 10.1016/j.radonc.2010.07.022; Kann PH, 2016, FRONT HORM RES, V45, P46, DOI 10.1159/000442277; Kauhanen S, 2007, J CLIN ENDOCR METAB, V92, P1237, DOI 10.1210/jc.2006-1479; Lerche S, 2009, CLIN ENDOCRINOL, V71, P500, DOI 10.1111/j.1365-2265.2008.03510.x; Morera J, 2016, J ENDOCRINOL INVEST, V39, P455, DOI 10.1007/s40618-015-0406-4; Nauck MA, 1997, HORM METAB RES, V29, P411, DOI 10.1055/s-2007-979067; Nauck MA, 2002, J CLIN ENDOCR METAB, V87, P1239, DOI 10.1210/jc.87.3.1239; NAUCK MA, 1993, DIABETOLOGIA, V36, P741, DOI 10.1007/BF00401145; Nauck MA, 1997, AM J PHYSIOL-ENDOC M, V273, pE981, DOI 10.1152/ajpendo.1997.273.5.E981; Noone TC, 2005, BEST PRACT RES CL EN, V19, P195, DOI 10.1016/j.beem.2004.11.013; Pach D, 2012, RADIOTHER ONCOL, V102, P45, DOI 10.1016/j.radonc.2011.08.006; Placzkowski KA, 2009, J CLIN ENDOCR METAB, V94, P1069, DOI DOI 10.1210/JC.2008-2031); Raffel A, 2007, SURGERY, V141, P179, DOI 10.1016/j.surg.2006.04.015; Reubi JC, 2003, EUR J NUCL MED MOL I, V30, P781, DOI 10.1007/s00259-003-1184-3; Reubi JC, 2008, J NUCL MED, V49, P1735, DOI 10.2967/jnumed.108.053041; Sempoux C, 2004, ENDOCR PATHOL, V15, P241, DOI 10.1385/EP:15:3:241; SERVICE FJ, 1991, MAYO CLIN PROC, V66, P711, DOI 10.1016/S0025-6196(12)62083-7; Shantavasinkul PC, 2016, CLIN ENDOCRINOL, V85, P3, DOI 10.1111/cen.13033; Siegel EG, 1999, REGUL PEPTIDES, V79, P93, DOI 10.1016/S0167-0115(98)00155-4; Sowa-Staszczak A, 2013, EUR J NUCL MED MOL I, V40, P524, DOI 10.1007/s00259-012-2299-1; Toumpanakis C, 2014, NEUROENDOCRINOLOGY, V99, P63, DOI 10.1159/000358727; Whipple AO, 1938, J INT CHIR, V3, P237; WIDMANN C, 1995, BIOCHEM J, V310, P203, DOI 10.1042/bj3100203; Wild D, 2008, NEW ENGL J MED, V359, P766, DOI 10.1056/NEJMc0802045; Wild D, 2006, J NUCL MED, V47, P2025; Wild D, 2011, J NUCL MED, V52, P1073, DOI 10.2967/jnumed.110.085142; Wild D, 2010, J NUCL MED, V51, P1059, DOI 10.2967/jnumed.110.074914; Willms B, 1996, J CLIN ENDOCR METAB, V81, P327, DOI 10.1210/jc.81.1.327	35	30	32	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2016	11	8							e0160714	10.1371/journal.pone.0160714	http://dx.doi.org/10.1371/journal.pone.0160714			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4SL	27526057	Green Published, gold, Green Submitted			2022-12-27	WOS:000381471100019
J	Banica, T; Schwarzkopf, DS				Banica, Theodora; Schwarzkopf, D. Samuel			Induction of Kanizsa Contours Requires Awareness of the Inducing Context	PLOS ONE			English	Article							ILLUSORY CONTOURS; SUBJECTIVE CONTOURS; PHANTOM SURFACE; VISUAL-CORTEX; PERCEPTION; DEPTH; ORIENTATION; ATTENTION; SHAPE; REAL	It remains unknown to what extent the human visual system interprets information about complex scenes without conscious analysis. Here we used visualmasking techniques to assess whether illusory contours (Kanizsa shapes) are perceived when the inducing context creating this illusion does not reach awareness. In the first experiment we tested perception directly by having participants discriminate the orientation of an illusory contour. In the second experiment, we exploited the fact that the presence of an illusory contour enhances performance on a spatial localization task. Moreover, in the latter experiment we also used a different masking method to rule out the effect of stimulus duration. Our results suggest that participants do not perceive illusory contours when they are unaware of the inducing context. This is consistent with theories of a multistage, recurrent process of perceptual integration. Our findings thus challenge some reports, including those fromneurophysiological experiments in anaesthetized animals. Furthermore, we discuss the importance to test the presence of the phenomenal percept directly with appropriatemethods.	[Banica, Theodora; Schwarzkopf, D. Samuel] UCL, Expt Psychol, 26 Bedford Way, London, England; [Schwarzkopf, D. Samuel] UCL, Inst Cognit Neurosci, 17 Queen Sq, London, England	University of London; University College London; University of London; University College London	Schwarzkopf, DS (corresponding author), UCL, Expt Psychol, 26 Bedford Way, London, England.; Schwarzkopf, DS (corresponding author), UCL, Inst Cognit Neurosci, 17 Queen Sq, London, England.	s.schwarzkopf@ucl.ac.uk			European Research Council [310829]	European Research Council(European Research Council (ERC)European Commission)	This work was supported by the European Research Council, 310829 (https://erc.europa.eu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson BL, 2007, PSYCHOL REV, V114, P470, DOI 10.1037/0033-295X.114.2.470; Axelrod V, 2014, CONSCIOUS COGN, V27, P233, DOI 10.1016/j.concog.2014.05.004; Bahrami B, 2008, PERCEPTION, V37, P1520, DOI 10.1068/p5999; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Clifford CWG, 2005, CURR BIOL, V15, P574, DOI 10.1016/j.cub.2005.01.055; Conci M, 2009, NEUROPSYCHOLOGIA, V47, P726, DOI 10.1016/j.neuropsychologia.2008.11.029; Cox MA, 2013, P NATL ACAD SCI USA, V110, P17095, DOI 10.1073/pnas.1310806110; Falconbridge M, 2010, J VISION, V10, DOI 10.1167/10.8.21; Ffytche DH, 1996, NEUROIMAGE, V3, P104, DOI 10.1006/nimg.1996.0012; FRISBY JP, 1975, PERCEPTION, V4, P349, DOI 10.1068/p040349; GELLATLY ARH, 1980, PERCEPTION, V9, P599, DOI 10.1068/p090599; Gillam B, 1999, VISION RES, V39, P109, DOI 10.1016/S0042-6989(98)00052-2; GROSOF DH, 1993, NATURE, V365, P550, DOI 10.1038/365550a0; Hakkinen J, 2001, VISION RES, V41, P187, DOI 10.1016/S0042-6989(00)00231-5; HALPERN DF, 1981, PERCEPTION, V10, P199, DOI 10.1068/p100199; Harris JJ, 2011, PSYCHOL SCI, V22, P399, DOI 10.1177/0956797611399293; Haynes JD, 2005, NEURON, V46, P811, DOI 10.1016/j.neuron.2005.05.012; Haynes JD, 2005, NAT NEUROSCI, V8, P686, DOI 10.1038/nn1445; Heider B, 2000, EUR J NEUROSCI, V12, P4117, DOI 10.1046/j.1460-9568.2000.00293.x; Hesselmann G, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00584; Koch C, 2007, TRENDS COGN SCI, V11, P16, DOI 10.1016/j.tics.2006.10.012; Kogo N, 2010, PSYCHOL REV, V117, P406, DOI 10.1037/a0019076; Kok P, 2014, CURR BIOL, V24, P1531, DOI 10.1016/j.cub.2014.05.042; Lau JSF, 2012, J VISION, V12, DOI 10.1167/12.6.15; Lee TS, 2001, P NATL ACAD SCI USA, V98, P1907, DOI 10.1073/pnas.031579998; Ling S, 2009, PSYCHOL SCI, V20, P1348, DOI 10.1111/j.1467-9280.2009.02446.x; LIU L, 1994, NATURE, V367, P66, DOI 10.1038/367066a0; Mattingley JB, 1997, SCIENCE, V275, P671, DOI 10.1126/science.275.5300.671; Mendola JD, 1999, J NEUROSCI, V19, P8560; Montaser-Kouhsari L, 2007, J NEUROSCI, V27, P2186, DOI 10.1523/JNEUROSCI.4173-06.2007; Moore CM, 1997, J EXP PSYCHOL HUMAN, V23, P339, DOI 10.1037/0096-1523.23.2.339; Moors P, 2016, PSYCHOL SCI, V27, P945, DOI 10.1177/0956797616642525; Moors P, 2016, ATTEN PERCEPT PSYCHO, V78, P902, DOI 10.3758/s13414-015-1043-x; Moutoussis K, 2002, P NATL ACAD SCI USA, V99, P9527, DOI 10.1073/pnas.142305699; Mudrik L, 2011, PSYCHOL SCI, V22, P764, DOI 10.1177/0956797611408736; MUISE JG, 1993, PERCEPTION, V22, P623, DOI 10.1068/p220623; Newell BR, 2014, BEHAV BRAIN SCI, V37, P1, DOI 10.1017/S0140525X12003214; Pan YX, 2012, J NEUROSCI, V32, P6760, DOI 10.1523/JNEUROSCI.6140-11.2012; PARKS TE, 1994, PERCEPTION, V23, P857, DOI 10.1068/p230857; Pearson J, 2005, CURR BIOL, V15, P2142, DOI 10.1016/j.cub.2005.10.066; PETERHANS E, 1991, TRENDS NEUROSCI, V14, P112, DOI 10.1016/0166-2236(91)90072-3; Ramsden BM, 2001, CEREB CORTEX, V11, P648, DOI 10.1093/cercor/11.7.648; REYNOLDS RI, 1981, PERCEPTION, V10, P107, DOI 10.1068/p100107; Ringach DL, 1996, VISION RES, V36, P3037, DOI 10.1016/0042-6989(96)00062-4; Rouder JN, 2009, PSYCHON B REV, V16, P225, DOI 10.3758/PBR.16.2.225; Rubin N, 2001, PERCEPTION, V30, P339, DOI 10.1068/p3173; Schurger A, 2015, P NATL ACAD SCI USA, V112, pE2083, DOI 10.1073/pnas.1418730112; Schurger A, 2010, SCIENCE, V327, P97, DOI 10.1126/science.1180029; Schwarzkopf DS, 2011, P ROY SOC B-BIOL SCI, V278, P2207, DOI 10.1098/rspb.2010.1909; Sklar AY, 2012, P NATL ACAD SCI USA, V109, P19614, DOI 10.1073/pnas.1211645109; Sobel KV, 2003, VISION RES, V43, P1533, DOI 10.1016/S0042-6989(03)00178-0; Stanley DA, 2003, NEURON, V37, P323, DOI 10.1016/S0896-6273(02)01148-0; Sterzer P, 2008, J VISION, V8, DOI 10.1167/8.15.10; Stewart LH, 2012, J EXP PSYCHOL GEN, V141, P715, DOI 10.1037/a0027950; Tsuchiya N, 2005, NAT NEUROSCI, V8, P1096, DOI 10.1038/nn1500; Vandenbroucke ARE, 2014, J COGNITIVE NEUROSCI, V26, P955, DOI 10.1162/jocn_a_00530; Varin D., 1971, RIV PSICOL, V65, P101; VONDERHEYDT R, 1984, SCIENCE, V224, P1260, DOI 10.1126/science.6539501; VONDERHEYDT R, 1989, J NEUROSCI, V9, P1731; Vuilleumier P, 1998, NEUROREPORT, V9, P2481, DOI 10.1097/00001756-199808030-00010; Vuilleumier P, 2001, NEUROPSYCHOLOGIA, V39, P597, DOI 10.1016/S0028-3932(00)00148-2; Vul E, 2006, NAT NEUROSCI, V9, P873, DOI 10.1038/nn1723; Wang LH, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0039845, 10.1371/journal.pone.0051769, 10.1371/journal.pone.0045491, 10.1371/journal.pone.0044596]; Wokke ME, 2013, PSYCHOL SCI, V24, P63, DOI 10.1177/0956797612449175; Yang JK, 2015, J VISION, V15, DOI 10.1167/15.14.6; Zhan CA, 2008, CEREB CORTEX, V18, P1029, DOI 10.1093/cercor/bhm139; Zhaoping L, 2008, J VISION, V8, DOI 10.1167/8.5.1	67	13	13	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2016	11	8							e0161177	10.1371/journal.pone.0161177	http://dx.doi.org/10.1371/journal.pone.0161177			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DT3LI	27518569	gold, Green Published, Green Submitted			2022-12-27	WOS:000381382100058
J	Carpio, VH; Opata, MM; Montanez, ME; Banerjee, PP; Dent, AL; Stephens, R				Carpio, Victor H.; Opata, Michael M.; Montanez, Marelle E.; Banerjee, Pinaki P.; Dent, Alexander L.; Stephens, Robin			IFN-gamma and IL-21 Double Producing T Cells Are Bcl6-Independent and Survive into the Memory Phase in Plasmodium chabaudi Infection (vol 10, e0144654, 2015)	PLOS ONE			English	Correction															NIAID NIH HHS [R01 AI089953] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI089953] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Carpio VH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144654	1	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2016	11	8							e0155570	10.1371/journal.pone.0155570	http://dx.doi.org/10.1371/journal.pone.0155570			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT8TP	27548065	Green Published, gold			2022-12-27	WOS:000381768400001
J	Igarashi, Y; Ohnishi, K; Irie, K; Murakami, A				Igarashi, Yoko; Ohnishi, Kohta; Irie, Kazuhiro; Murakami, Akira			Possible Contribution of Zerumbone-Induced Proteo-Stress to Its Anti-Inflammatory Functions via the Activation of Heat Shock Factor 1	PLOS ONE			English	Article							TROPICAL GINGER SESQUITERPENE; MOLECULAR CHAPERONES; IN-VITRO; TRANSCRIPTION; HSP70; SUPPRESSES; EXPRESSION; DISEASE; MICE; HSF1	Zerumbone is a sesquiterpene present in Zinger zerumbet. Many studies have demonstrated its marked anti-inflammatory and anti-carcinogenesis activities. Recently, we showed that zerumbone binds to numerous proteins with scant selectivity and induces the expression of heat shock proteins (HSPs) in hepatocytes. To dampen proteo-toxic stress, organisms have a stress-responsive molecular machinery, known as heat shock response. Heat shock factor 1 (HSF1) plays a key role in this protein quality control system by promoting activation of HSPs. In this study, we investigated whether zerumbone-induced HSF1 activation contributes to its anti-inflammatory functions in stimulated macrophages. Our findings showed that zerumbone increased cellular protein aggregates and promoted nuclear translocation of HSF1 for HSP expression. Interestingly, HSF1 down-regulation attenuated the suppressive effects of zerumbone on mRNA and protein expressions of pro-inflammatory genes, including inducible nitric oxide synthase and interlukin-1 beta. These results suggest that proteo-stress induced by zerumbone activates HSF1 for exhibiting its anti-inflammatory functions.	[Igarashi, Yoko; Ohnishi, Kohta; Irie, Kazuhiro; Murakami, Akira] Kyoto Univ, Grad Sch Agr, Div Food Sci & Biotechnol, Kyoto, Japan; [Ohnishi, Kohta] Univ Tokushima, Inst Biomed Sci, Dept Food Sci, Tokushima, Japan; [Murakami, Akira] Univ Hyogo, Sch Human Sci & Environm, Dept Food Sci & Nutr, Kobe, Hyogo, Japan	Kyoto University; Tokushima University; University of Hyogo	Murakami, A (corresponding author), Kyoto Univ, Grad Sch Agr, Div Food Sci & Biotechnol, Kyoto, Japan.; Murakami, A (corresponding author), Univ Hyogo, Sch Human Sci & Environm, Dept Food Sci & Nutr, Kobe, Hyogo, Japan.	akira@shse.u-hyogo.ac.jp	Irie, Kazuhiro/A-6121-2014	Irie, Kazuhiro/0000-0001-7109-8568	Japan Society for the Promotion of Science [26450156, 22.3355]; Urakami Foundation for Food and Food Culture Promotion	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Urakami Foundation for Food and Food Culture Promotion	This study was partly supported by a Grant-in-Aid for Scientific Research (C) (No. 26450156 to AM) from the Japan Society for the Promotion of Science (https://www.jsps.go.jp/english/index.html), the Urakami Foundation for Food and Food Culture Promotion (https://www.urakamizaidan.or.jp/) (AM), and a Grant-in-Aid for JSPS Fellows (No. 22.3355 to KO) from the Japan Society for the Promotion of Science.; This study was partly supported by a Grant-in-Aid for Scientific Research (C) (No. 26450156 to A.M.), Urakami Foundation for Food and Food Culture Promotion, and a Grant-in-Aid for JSPS Fellows (No. 22.3355 to K.O.) from the Japan Society for the Promotion of Science.	Anckar J, 2011, ANNU REV BIOCHEM, V80, P1089, DOI 10.1146/annurev-biochem-060809-095203; Camacho LH, 2007, INVEST NEW DRUG, V25, P131, DOI 10.1007/s10637-006-9017-4; Chen Y, 2006, CARDIOVASC RES, V69, P66, DOI 10.1016/j.cardiores.2005.07.004; Ciocca DR, 2013, ARCH TOXICOL, V87, P19, DOI 10.1007/s00204-012-0918-z; Cortez L, 2014, PRION, V8, P197, DOI 10.4161/pri.28938; Cuadrado-Tejedor M, 2011, CURR MED CHEM, V18, P5545, DOI 10.2174/092986711798347315; Dinkova-Kostova AT, 2005, P NATL ACAD SCI USA, V102, P4584, DOI 10.1073/pnas.0500815102; Gardian G, 2005, J BIOL CHEM, P280; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Kacimi R, 2015, GLIA, V63, P1200, DOI 10.1002/glia.22811; Kim M, 2009, INT J CANCER, V124, P264, DOI 10.1002/ijc.23923; Lee CT, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00140; McLean PJ, 2004, BIOCHEM BIOPH RES CO, V321, P665, DOI 10.1016/j.bbrc.2004.07.021; Murakami A, 2005, J NUTR, V135, p2987S, DOI 10.1093/jn/135.12.2987S; Murakami A, 2004, BIOFACTORS, V21, P95, DOI 10.1002/biof.552210118; Murakami A, 2004, INT J CANCER, V110, P481, DOI 10.1002/ijc.20175; Murakami A, 2002, CARCINOGENESIS, V23, P795, DOI 10.1093/carcin/23.5.795; Murakami A, 1999, BIOSCI BIOTECH BIOCH, V63, P1811, DOI 10.1271/bbb.63.1811; Muralidharan S, 2014, J IMMUNOL, V193, P1975, DOI 10.4049/jimmunol.1303468; Murata S, 2001, EMBO REP, V2, P1133, DOI 10.1093/embo-reports/kve246; Myeku N, 2011, METHODS MOL BIOL, V793, P273, DOI 10.1007/978-1-61779-328-8_18; Nakamura Y, 2004, FEBS LETT, V572, P245, DOI 10.1016/j.febslet.2004.07.042; Ohnishi K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058641; Ohnishi K, 2013, BIOCHEM BIOPH RES CO, V430, P616, DOI 10.1016/j.bbrc.2012.11.104; Ohnishi K, 2009, BIOSCI BIOTECH BIOCH, V73, P1905, DOI 10.1271/bbb.90265; Rahman HS, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/563930; Rappa F, 2012, ANTICANCER RES, V32, P5139; Salminen A, 2008, IMMUNOL LETT, V117, P9, DOI 10.1016/j.imlet.2007.12.017; SARGE KD, 1993, MOL CELL BIOL, V13, P1392, DOI 10.1128/MCB.13.3.1392; Sha YB, 2009, MOL CELL BIOL, V29, P116, DOI 10.1128/MCB.00829-08; Shen HY, 2005, J BIOL CHEM, V280, P39962, DOI 10.1074/jbc.M505524200; Shim S, 2011, FOOD CHEM TOXICOL, V49, P2734, DOI 10.1016/j.fct.2011.08.012; Shin JW, 2011, CANCER PREV RES, V4, P860, DOI 10.1158/1940-6207.CAPR-10-0354; Singh IS, 2002, J BIOL CHEM, V277, P4981, DOI 10.1074/jbc.M108154200; Sittler A, 2001, HUM MOL GENET, V10, P1307, DOI 10.1093/hmg/10.12.1307; Takii R, 2010, J IMMUNOL, V184, P1041, DOI 10.4049/jimmunol.0902579; Teiten MH, 2009, CANCER LETT, V279, P145, DOI 10.1016/j.canlet.2009.01.031; Turturici G, 2011, BIOCHEM RES INT, V2011, DOI 10.1155/2011/618127; van Eden W, 2005, NAT REV IMMUNOL, V5, P318, DOI 10.1038/nri1593; Vihervaara A, 2014, J CELL SCI, V127, P261, DOI 10.1242/jcs.132605; Voellmy R, 2007, ADV EXP MED BIOL, V594, P89; Wang XJ, 2013, J MOL CELL CARDIOL, V55, P73, DOI 10.1016/j.yjmcc.2012.09.012; Westerheide SD, 2012, CURR PROTEIN PEPT SC, V13, P86; Xie Y, 2002, J BIOL CHEM, V277, P11802, DOI 10.1074/jbc.M109296200; Yao XY, 2012, INT IMMUNOPHARMACOL, V14, P138, DOI 10.1016/j.intimp.2012.06.017; Zhou WB, 2011, J BIOL CHEM, V286, P14941, DOI 10.1074/jbc.M110.211029; Zou J, 1998, CELL	48	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0161282	10.1371/journal.pone.0161282	http://dx.doi.org/10.1371/journal.pone.0161282			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27536885	Green Published, gold, Green Submitted			2022-12-27	WOS:000381577000081
J	Kazui, H; Yoshiyama, K; Kanemoto, H; Suzuki, Y; Sato, S; Hashimoto, M; Ikeda, M; Tanaka, H; Hatada, Y; Matsushita, M; Nishio, Y; Mori, E; Tanimukai, S; Komori, K; Yoshida, T; Shimizu, H; Matsumoto, T; Mori, T; Kashibayashi, T; Yokoyama, K; Shimomura, T; Kabeshita, Y; Adachi, H; Tanaka, T				Kazui, Hiroaki; Yoshiyama, Kenji; Kanemoto, Hideki; Suzuki, Yukiko; Sato, Shunsuke; Hashimoto, Mamoru; Ikeda, Manabu; Tanaka, Hibiki; Hatada, Yutaka; Matsushita, Masateru; Nishio, Yoshiyuki; Mori, Etsuro; Tanimukai, Satoshi; Komori, Kenjiro; Yoshida, Taku; Shimizu, Hideaki; Matsumoto, Teruhisa; Mori, Takaaki; Kashibayashi, Tetsuo; Yokoyama, Kazumasa; Shimomura, Tatsuo; Kabeshita, Yasunobu; Adachi, Hiroyoshi; Tanaka, Toshihisa			Differences of Behavioral and Psychological Symptoms of Dementia in Disease Severity in Four Major Dementias	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; LEWY BODIES; VASCULAR DEMENTIA; NEUROPSYCHIATRIC INVENTORY; PSYCHOTIC SYMPTOMS; DOUBLE-BLIND; POOLED DATA; DONEPEZIL; DIAGNOSIS; RECOMMENDATIONS	Background/Aims Behavioral and psychological symptoms of dementia (BPSDs) negatively impact the prognosis of dementia patients and increase caregiver distress. The aims of this study were to clarify the differences of trajectories of 12 kinds of BPSDs by disease severity in four major dementias and to develop charts showing the frequency, severity, and associated caregiver distress (ACD) of BPSDs using the data of a Japan multicenter study (J-BIRD). Methods We gathered Neuropsychiatric Inventory (NPI) data of patients with Alzheimer's disease (AD; n = 1091), dementia with Lewy bodies (DLB; n = 249), vascular dementia (VaD; n = 156), and frontotemporal lobar degeneration (FTLD; n = 102) collected during a 5-year period up to July 31, 2013 in seven centers for dementia in Japan. The NPI composite scores (frequency x severity) of 12 kinds of items were analyzed using a principal component analysis (PCA) in each dementia. The factor scores of the PCA were compared in each dementia by disease severity, which was determined with Clinical Dementia Rating (CDR). Results Significant increases with higher CDR scores were observed in 1) two of the three factor scores which were loaded for all items except euphoria in AD, 2) two of the four factor scores for apathy, aberrant motor behavior (AMB), sleep disturbances, agitation, irritability, disinhibition, and euphoria in DLB, and 3) one of the four factor scores for apathy, depression, anxiety, and sleep disturbances in VaD. However, no increases were observed in any of the five factor scores in FTLD. Conclusions As dementia progresses, several BPSDs become more severe, including 1) apathy and sleep disturbances in AD, DLB, and VaD, 2) all of the BPSDs except euphoria in AD, 3) AMB, agitation, irritability, disinhibition, and euphoria in DLB, and 4) depression and anxiety in VaD. Trajectories of BPSDs in FTLD were unclear.	[Kazui, Hiroaki; Yoshiyama, Kenji; Kanemoto, Hideki; Suzuki, Yukiko; Sato, Shunsuke; Ikeda, Manabu; Kashibayashi, Tetsuo; Kabeshita, Yasunobu; Adachi, Hiroyoshi; Tanaka, Toshihisa] Osaka Univ, Grad Sch Med, Dept Psychiat, Suita, Osaka, Japan; [Hashimoto, Mamoru; Ikeda, Manabu; Tanaka, Hibiki; Hatada, Yutaka; Matsushita, Masateru] Kumamoto Univ, Fac Life Sci, Dept Neuropsychiat, Kumamoto, Kumamoto, Japan; [Nishio, Yoshiyuki; Mori, Etsuro] Tohoku Univ, Sch Med, Dept Behav Neurol & Cognit Neurosci, Sendai, Miyagi, Japan; [Tanimukai, Satoshi; Komori, Kenjiro; Yoshida, Taku; Shimizu, Hideaki; Matsumoto, Teruhisa; Mori, Takaaki] Ehime Univ, Grad Sch Med, Dept Neuropsychiat, Toon, Ehime, Japan; [Tanimukai, Satoshi] Ehime Univ, Grad Sch Med, Comprehens Community Care Elderly Nursing & Hlth, Toon, Ehime, Japan; [Komori, Kenjiro] Zaidan Niihama Hosp, Niihama, Ehime, Japan; [Kashibayashi, Tetsuo; Yokoyama, Kazumasa] Hyogo Prefectural Rehabil Ctr Nishi Harima, Dept Neurol, Tatsuno, Hyogo, Japan; [Kashibayashi, Tetsuo; Yokoyama, Kazumasa] Hyogo Prefectural Rehabil Ctr Nishi Harima, Dept Cognit Disorders, Tatsuno, Hyogo, Japan; [Shimomura, Tatsuo] Akita Prefectural Ctr Rehabil & Psychiat Med, Dept Dementia Res, Akita, Japan; [Kabeshita, Yasunobu; Adachi, Hiroyoshi] Osaka Univ Hosp, Sleep Med Ctr, Suita, Osaka, Japan; [Kabeshita, Yasunobu; Adachi, Hiroyoshi] Osaka Univ, Hlth Care Ctr, Dept Psychiat, Toyonaka, Osaka, Japan	Osaka University; Kumamoto University; Tohoku University; Ehime University; Ehime University; Osaka University; Osaka University	Kazui, H (corresponding author), Osaka Univ, Grad Sch Med, Dept Psychiat, Suita, Osaka, Japan.	kazui@psy.med.osaka-u.ac.jp	Kanemoto, Hideki/AAH-1720-2020	Kanemoto, Hideki/0000-0003-3662-1469	Ministry of Health, Labour and Welfare [H25-27-Dementia-General-003]; Grants-in-Aid for Scientific Research [26461750] Funding Source: KAKEN	Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The present study was undertaken with the support of grants provided by the Ministry of Health, Labour and Welfare (Research on Dementia; H25-27-Dementia-General-003) for Hiroaki Kazui. http://www.mhlw.go.jp/seisakunitsuite/bunya/hokabunya/kenkyujigyou/hojokin-koubo-h26/gaiyo/16.html.	Allegri Ricardo F, 2006, Neuropsychiatr Dis Treat, V2, P105; American Psychiatric Association, 2008, DIAGN STAT MAN MENT; [Anonymous], 2007, AM J PSYCHIAT, V164, P5; Bullock R, 2006, CURR MED RES OPIN, V22, P483, DOI 10.1185/030079906X89685; Chow TW, 2012, J ALZHEIMERS DIS, V31, P143, DOI 10.3233/JAD-2012-111916; CHUI HC, 1992, NEUROLOGY, V42, P473, DOI 10.1212/WNL.42.3.473; CUMMINGS JL, 1994, NEUROLOGY, V44, P2308, DOI 10.1212/WNL.44.12.2308; Feldman H, 2001, NEUROLOGY, V57, P613, DOI 10.1212/WNL.57.4.613; Gauthier S, 2008, INT J GERIATR PSYCH, V23, P537, DOI 10.1002/gps.1949; Hashimoto M, 2015, DEMENT GER COGN D EX, V5, P244, DOI 10.1159/000381800; Herrmann N, 2005, AM J GERIAT PSYCHIAT, V13, P527, DOI 10.1176/appi.ajgp.13.6.527; Hirono N, 1999, J NEUROPSYCH CLIN N, V11, P498; Ikejima C, 2012, PSYCHOGERIATRICS, V12, P120, DOI 10.1111/j.1479-8301.2012.00415.x; Johnson DK, 2011, ALZ DIS ASSOC DIS, V25, P326, DOI 10.1097/WAD.0b013e31820d89b6; Kales HC, 2014, J AM GERIATR SOC, V62, P762, DOI 10.1111/jgs.12730; Kaufer DI, 1998, J AM GERIATR SOC, V46, P210, DOI 10.1111/j.1532-5415.1998.tb02542.x; LERNER AJ, 1994, NEUROLOGY, V44, P523, DOI 10.1212/WNL.44.3_Part_1.523; Livingston G, 2014, BRIT J PSYCHIAT, V205, P436, DOI 10.1192/bjp.bp.113.141119; Magni E, 1996, J GERIATR PSYCH NEUR, V9, P123, DOI 10.1177/089198879600900303; Matsui Y, 2009, J NEUROL NEUROSUR PS, V80, P366, DOI 10.1136/jnnp.2008.155481; McKeith I, 2000, LANCET, V356, P2031, DOI 10.1016/S0140-6736(00)03399-7; McKeith IG, 2005, NEUROLOGY, V65, P1863, DOI 10.1212/01.wnl.0000187889.17253.b1; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Mori E, 2012, ANN NEUROL, V72, P41, DOI 10.1002/ana.23557; Mori S, 2006, PSYCHIAT CLIN NEUROS, V60, P190, DOI 10.1111/j.1440-1819.2006.01485.x; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; MORRISS RK, 1990, AM J PSYCHIAT, V147, P299; Neary D, 1998, NEUROLOGY, V51, P1546, DOI 10.1212/WNL.51.6.1546; Leung P, 2015, INT J GERIATR PSYCH, V30, P1, DOI 10.1002/gps.4166; Piguet O, 2011, J MOL NEUROSCI, V45, P589, DOI 10.1007/s12031-011-9547-x; Quaranta D, 2015, DEMENT GERIATR COGN, V39, P194, DOI 10.1159/000369161; Raglio A, 2012, MATURITAS, V72, P305, DOI 10.1016/j.maturitas.2012.05.016; ROMAN GC, 1993, NEUROLOGY, V43, P250, DOI 10.1212/WNL.43.2.250; Rosen HJ, 2005, BRAIN, V128, P2612, DOI 10.1093/brain/awh628; Sarkamo T, 2014, GERONTOLOGIST, V54, P634, DOI 10.1093/geront/gnt100; Shigenobu Kazue, 2008, Brain and Nerve (Tokyo), V60, P1463; Srikanth S, 2005, J NEUROL SCI, V236, P43, DOI 10.1016/j.jns.2005.04.014; Stanley MA, 2013, AM J GERIAT PSYCHIAT, V21, P696, DOI 10.1016/j.jagp.2013.01.007; STEELE C, 1990, AM J PSYCHIAT, V147, P1049; STERN Y, 1987, NEUROLOGY, V37, P1649, DOI 10.1212/WNL.37.10.1649; Vetter PH, 1999, J GERONTOL B-PSYCHOL, V54, pS93, DOI 10.1093/geronb/54B.2.S93; Waldo ML, 2015, INT PSYCHOGERIATR, V27, P531, DOI 10.1017/S1041610214002580	42	71	73	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0161092	10.1371/journal.pone.0161092	http://dx.doi.org/10.1371/journal.pone.0161092			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DT6ES	27536962	Green Published, Green Submitted, gold			2022-12-27	WOS:000381577000052
J	Koh, J; Hogue, JA; Sosa, JA				Koh, James; Hogue, Joyce A.; Sosa, Julie A.			A Novel Ex Vivo Method for Visualizing Live-Cell Calcium Response Behavior in Intact Human Tumors	PLOS ONE			English	Article							PRIMARY HYPERPARATHYROIDISM; SENSING RECEPTOR; PARATHYROID ADENOMAS; SECONDARY HYPERPARATHYROIDISM; DECREASED EXPRESSION; COLOCALIZATION; PATHOGENESIS; PHYSIOLOGY; MUTATIONS	The functional impact of intratumoral heterogeneity has been difficult to assess in the absence of a means to interrogate dynamic, live-cell biochemical events in the native tissue context of a human tumor. Conventional histological methods can reveal morphology and static biomarker expression patterns but do not provide a means to probe and evaluate tumor functional behavior and live-cell responsiveness to experimentally controlled stimuli. Here, we describe an approach that couples vibratome-mediated viable tissue sectioning with live-cell confocal microscopy imaging to visualize human parathyroid adenoma tumor cell responsiveness to extracellular calcium challenge. Tumor sections prepared as 300 micron-thick tissue slices retain viability throughout a >24 hour observation period and retain the native architecture of the parental tumor. Live-cell observation of biochemical signaling in response to extracellular calcium challenge in the intact tissue slices reveals discrete, heterogeneous kinetic waveform categories of calcium agonist reactivity within each tumor. Plotting the proportion of maximally responsive tumor cells as a function of calcium concentration yields a sigmoid dose-response curve with a calculated calcium EC50 value significantly elevated above published reference values for wild-type calcium-sensing receptor (CASR) sensitivity. Subsequent fixation and immunofluorescence analysis of the functionally evaluated tissue specimens allows alignment and mapping of the physical characteristics of individual cells within the tumor to specific calcium response behaviors. Evaluation of the relative abundance of intracellular PTH in tissue slices challenged with variable calcium concentrations demonstrates that production of the hormone can be dynamically manipulated ex vivo. The capability of visualizing live human tumor tissue behavior in response to experimentally controlled conditions opens a wide range of possibilities for personalized ex vivo therapeutic testing. This highly adaptable system provides a unique platform for live-cell ex vivo provocative testing of human tumor responsiveness to a range of physiological agonists or candidate therapeutic compounds.	[Koh, James; Hogue, Joyce A.; Sosa, Julie A.] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA; [Sosa, Julie A.] Duke Univ, Med Ctr, Duke Canc Inst, Durham, NC USA; [Sosa, Julie A.] Duke Univ, Med Ctr, Duke Clin Res Inst, Durham, NC USA	Duke University; Duke University; Duke University	Koh, J (corresponding author), Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA.	james.koh@dm.duke.edu		Hogue, Joyce A/0000-0003-0848-3484	NIH [1R21CA192004-02]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by NIH grant 1R21CA192004-02 to JK and JAS.	Arnold A, 2002, J BONE MINER RES, V17, pN30; Avlani VA, 2013, AM J PHYSIOL-ENDOC M, V304, pE1097, DOI 10.1152/ajpendo.00054.2013; Brennan SC, 2015, ENDOCRINOLOGY, V156, P1330, DOI 10.1210/en.2014-1771; Brennan SC, 2013, BBA-MOL CELL RES, V1833, P1732, DOI 10.1016/j.bbamcr.2012.12.011; Brown EM, 2013, BEST PRACT RES CL EN, V27, P333, DOI 10.1016/j.beem.2013.02.006; Brown EM, 2002, J BONE MINER RES, V17, pN24; Brown EM, 2001, PHYSIOL REV, V81, P239, DOI 10.1152/physrev.2001.81.1.239; Carneiro DM, 2003, SURGERY, V134, P973, DOI 10.1016/j.surg.2003.06.001; Chen RA, 2004, AM J PHYSIOL-RENAL, V286, pF1005, DOI 10.1152/ajprenal.00013.2004; Costa-Guda J, 2014, MOL CELL ENDOCRINOL, V386, P46, DOI 10.1016/j.mce.2013.09.005; Costes SV, 2004, BIOPHYS J, V86, P3993, DOI [10.1529/biophysj.103.038422, 10.1529/biophysi.103.038422]; Cromer MK, 2012, J CLIN ENDOCR METAB, V97, pE1774, DOI 10.1210/jc.2012-1743; DeLellis RA, 2008, ARCH PATHOL LAB MED, V132, P1251, DOI 10.1043/1543-2165(2008)132[1251:PHACP]2.0.CO;2; Dissing-Olesen L, 2015, CURR PROTOC NEUROSCI, V71, p1 23 1, DOI 10.1002/0471142301.ns0123s71; Dunn KW, 2011, AM J PHYSIOL-CELL PH, V300, pC723, DOI 10.1152/ajpcell.00462.2010; Farnebo F, 1998, SURGERY, V124, P1094, DOI 10.1067/msy.1998.91828; Farnebo F, 1997, J CLIN ENDOCR METAB, V82, P3481, DOI 10.1210/jc.82.10.3481; Goodman WG, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V1341017; Kifor O, 1996, J CLIN ENDOCR METAB, V81, P1598, DOI 10.1210/jc.81.4.1598; Koh J, 2016, J CELL MOL MED, V20, P351, DOI 10.1111/jcmm.12732; Koh J, 2011, MOL ENDOCRINOL, V25, P867, DOI 10.1210/me.2010-0277; Nemeth EF, 2004, CELL CALCIUM, V35, P283, DOI 10.1016/j.ceca.2003.10.020; Nesbit MA, 2013, NEW ENGL J MED, V368, P2476, DOI 10.1056/NEJMoa1300253; Nesbit MA, 2013, NAT GENET, V45, P93, DOI 10.1038/ng.2492; Newey PJ, 2012, J CLIN ENDOCR METAB, V97, pE1995, DOI 10.1210/jc.2012-2303; Roman SA, 2011, ANN SURG, V253, P131, DOI 10.1097/SLA.0b013e3181f66720; Shi YH, 2014, P NATL ACAD SCI USA, V111, P3092, DOI 10.1073/pnas.1319742111; Silverberg SJ, 2009, J CLIN ENDOCR METAB, V94, P351, DOI 10.1210/jc.2008-1760; Silverberg SJ, 1997, NEW ENGL J MED, V337, P1506, DOI 10.1056/NEJM199711203372104; Spohn D, 2010, MOL PHARMACOL, V78, P865, DOI 10.1124/mol.110.067637; Verma A, 2011, CELL CALCIUM, V50, P510, DOI 10.1016/j.ceca.2011.08.007; Wettschureck N, 2007, MOL ENDOCRINOL, V21, P274, DOI 10.1210/me.2006-0110	32	3	4	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0161134	10.1371/journal.pone.0161134	http://dx.doi.org/10.1371/journal.pone.0161134			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27537691	Green Published, gold, Green Submitted			2022-12-27	WOS:000381577000058
J	Kumar, V; Jha, P				Kumar, Vipan; Jha, Prashant			Differences in Germination, Growth, and Fecundity Characteristics of Dicamba-Fluroxypyr-Resistant and Susceptible Kochia scoparia	PLOS ONE			English	Article							AUXINIC HERBICIDE RESISTANCE; LOLIUM-RIGIDUM POPULATION; WILD MUSTARD; SULFONYLUREA-RESISTANT; MANAGEMENT-PRACTICES; SEEDLING EMERGENCE; ECOLOGICAL FITNESS; DOSE-RESPONSE; GLYPHOSATE; EVOLUTION	The widespread occurrence of herbicide-resistant (HR) Kochia scoparia is an increasing concern for growers in the US Great Plains and Canada. K. scoparia populations resistant to dicamba have been reported in six US states. Populations cross-resistant to dicamba and fluroxypyr have been reported from wheat fields in Montana, USA. It is unclear whether resistance to the auxinic herbicides (dicamba and/or fluroxypyr), can alter the fitness traits of K. scoparia. The objectives of this research were to compare the germination dynamics in response to thermal environment, vegetative growth and fecundity characteristics, and the relative competitive ability of dicamba-fluroxypyr-susceptible (S) vs.-resistant (R) K. scoparia selected from within a single segregating population (collected from wheat-fallow field in MT). S and R selected lines were developed after three generations of recurrent group selection. Compared to the S selected line, the R selected line had lower cumulative germination at all constant temperatures except 25 degrees C, and at all alternating temperatures except 30/35 degrees C. Also, the R selected line had delayed germination relative to the S selected line. The R had lower plant height, plant width, primary branches, total leaf area, stem diameter, and shoot dry weight compared with the S plants in the absence of competition. The reduction in seed production per plant resulted in a 39% fitness cost. The 1000-seed weight of R (1.6 g) was also less than that of S (2.6 g). When grown in an intraspecific competition at different mixture proportions, replacement series indices for the growth parameters further indicated that the R was less competitive than the S. Evident from this research, the dicamba-fluroxypyr-resistant R selected line is less likely to persist in a field population in the absence of the auxinic herbicides.	[Kumar, Vipan; Jha, Prashant] Montana State Univ Bozeman, Dept Res Ctr, Southern Agr Res Ctr, Huntley, MT 59037 USA	Montana State University System; Montana State University Bozeman	Jha, P (corresponding author), Montana State Univ Bozeman, Dept Res Ctr, Southern Agr Res Ctr, Huntley, MT 59037 USA.	pjha@montana.edu	Kumar, Vipan/N-1879-2019	Kumar, Vipan/0000-0002-8301-5878	Montana Agricultural Experiment Station [923658]	Montana Agricultural Experiment Station	The authors acknowledge Montana Agricultural Experiment Station for funding this research, Grant # 923658. The grant was obtained by PJ. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was funded by Montana Agricultural Experiment Station- Award # 923658. We greatly appreciate extension agents and growers from Choteau County, Montana for their valuable assistance in auxinic-herbicide-resistant K. scoparia seed collection. We also thank Dr. Aruna Varanasi, Ms. Anjani, Mr. Charlemagne A. Lim, and Mr. Shane Leland for their technical assistance in conducting this research.	Bagavathiannan MV, 2011, WEED SCI, V59, P353, DOI 10.1614/WS-D-10-00151.1; Baker DV, 2010, INVAS PLANT SCI MANA, V3, P301, DOI 10.1614/IPSM-D-09-00016.1; Bourdot GW, 1996, J APPL ECOL, V33, P151, DOI 10.2307/2405024; Christoffoleti PJ, 1997, WEED SCI, V45, P691; Cranston HJ, 2001, WEED SCI, V49, P164, DOI 10.1614/0043-1745(2001)049[0164:DRIK]2.0.CO;2; Debreuil DJ, 1996, WEED SCI, V44, P871, DOI 10.1017/S0043174500094856; Delye C, 2013, ANN BOT-LONDON, V111, P681, DOI 10.1093/aob/mct018; Eberlein C. V., 1984, Weeds Today, V15, P5; EVERITT JH, 1983, J RANGE MANAGE, V36, P646, DOI 10.2307/3898360; Friesen LF, 2009, CAN J PLANT SCI, V89, P141, DOI 10.4141/CJPS08057; Giacomini D, 2014, WEED SCI, V62, P29, DOI 10.1614/WS-D-13-00066.1; Goh SS, 2016, PEST MANAG SCI, V72, P67, DOI 10.1002/ps.4005; Goss GA, 2003, WEED SCI, V51, P839, DOI 10.1614/P2002-164; HALL JC, 1995, PESTIC BIOCHEM PHYS, V52, P149, DOI 10.1006/pest.1995.1039; Hall LM, 2014, CAN J PLANT SCI, V94, P127, DOI [10.4141/CJPS2013-204, 10.4141/cjps2013-204]; Harper J. L, 1977, POPULATION BIOL PLAN; Heap I, INT SURVEY HERBICIDE; Hoffman ML, 2002, WEED SCI, V50, P466, DOI 10.1614/0043-1745(2002)050[0466:USAAFM]2.0.CO;2; JASIENIUK M, 1994, PHYTOPROTECTION, V75, P25, DOI 10.7202/706069ar; Jha P, 2015, CAN J PLANT SCI, V95, P965, DOI [10.4141/cjps-2015-019, 10.4141/CJPS-2015-019]; Kern AJ, 2005, WEED SCI, V53, P139, DOI 10.1614/WS-04-090R; Knezevic SZ, 2007, WEED TECHNOL, V21, P840, DOI 10.1614/WT-06-161.1; Kumar V, 2015, WEED TECHNOL, V29, P24, DOI 10.1614/WT-D-14-00026.1; Kumar V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142675; Kumar V, 2015, WEED SCI, V63, P758, DOI 10.1614/WS-D-15-00021.1; Kumar V, 2015, CROP PROT, V76, P39, DOI 10.1016/j.cropro.2015.06.010; Kumar V, 2014, WEED TECHNOL, V28, P122, DOI 10.1614/WT-D-13-00115.1; Legere A, 2013, WEED SCI, V61, P267, DOI 10.1614/WS-D-12-00116.1; MAXWELL BD, 1990, WEED TECHNOL, V4, P2, DOI 10.1017/S0890037X0002488X; Menalled FD, 2007, WEED BIOL MANAG, V7, P115, DOI 10.1111/j.1445-6664.2007.00244.x; Mengistu LW, 2002, WEED SCI, V50, P498, DOI 10.1614/0043-1745(2002)050[0498:GDOK]2.0.CO;2; Mithila J, 2011, WEED SCI, V59, P445, DOI 10.1614/WS-D-11-00062.1; Mithila J, 2012, PEST MANAG SCI, V68, P548, DOI 10.1002/ps.2289; Norsworthy JK, 2012, WEED SCI, V60, P31, DOI 10.1614/WS-D-11-00155.1; Sbatella GM, 2010, WEED TECHNOL, V24, P392, DOI 10.1614/WT-D-09-00023.1; Schwinghamer TD, 2008, WEED SCI, V56, P37, DOI 10.1614/WS-07-098.1; SEEFELDT SS, 1995, WEED TECHNOL, V9, P218, DOI 10.1017/S0890037X00023253; STALLINGS GP, 1995, WEED SCI, V43, P63, DOI 10.1017/S0043174500080838; STALLINGS GP, 1995, WEED SCI, V43, P95, DOI 10.1017/S0043174500080887; Steadman KJ, 2006, AUST J AGR RES, V57, P133, DOI 10.1071/AR05122; Vila-Aiub MM, 2015, J EXP BOT, V66, P4711, DOI 10.1093/jxb/erv248; Vila-Aiub MM, 2015, WEED SCI, V63, P203, DOI 10.1614/WS-D-14-00062.1; Vila-Aiub MM, 2009, NEW PHYTOL, V184, P751, DOI 10.1111/j.1469-8137.2009.03055.x; Vila-Aiub MM, 2005, NEW PHYTOL, V167, P787, DOI 10.1111/j.1469-8137.2005.01465.x; Vila-Aiub MM, 2005, J APPL ECOL, V42, P288, DOI 10.1111/j.1365-2664.2005.01017.x; Weinberg T, 2006, J AGR FOOD CHEM, V54, P9126, DOI 10.1021/jf061803u; Yanniccari M, 2016, WEED SCI, V64, P71, DOI 10.1614/WS-D-15-00065.1; YOUNG JA, 1981, AGRON J, V73, P957, DOI 10.2134/agronj1981.00021962007300060012x; Zheng HG, 2001, WEED SCI, V49, P276, DOI 10.1614/0043-1745(2001)049[0276:UAHRIW]2.0.CO;2	49	28	29	3	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0161533	10.1371/journal.pone.0161533	http://dx.doi.org/10.1371/journal.pone.0161533			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27537419	gold, Green Published, Green Submitted			2022-12-27	WOS:000381577000117
J	Polimanti, R; Yang, BZ; Zhao, HY; Gelernter, J				Polimanti, Renato; Yang, Bao Zhu; Zhao, Hongyu; Gelernter, Joel			Evidence of Polygenic Adaptation in the Systems Genetics of Anthropometric Traits	PLOS ONE			English	Article							LOW-FREQUENCY VARIANTS; NATURAL-SELECTION; SEXUAL-DIMORPHISM; ASSOCIATION; COMMON; LOCI; VARIABILITY; EVOLUTION; HEIGHT; SWEEPS	Many signals of natural selection have been identified in the human genome. However, except for some single-locus mechanisms, most molecular processes generating these adaptation signals are still unknown. We developed an approach that integrates datasets related to genome-wide association studies (GWAS) with information about systems biology and genetic signatures of natural selection to identify evidence of polygenic adaptation. Specifically, we focused on five anthropometric measurements: body mass index (BMI), height, waist-to-hip ratio adjusted for BMI (WHR), and waist circumference adjusted for BMI (WC), and sex differences for WHR and WC. We performed an enrichment analysis for signals of natural selection in protein interaction networks associated with anthropometric traits in European populations. The adaptation signals-enriched gene networks associated highlighted epistatic interactions in the context of polygenic selection for the investigated traits. These polygenic mechanisms indicated intriguing selective mechanisms related to the anthropometric traits: adult locomotory behavior for BMI, infection resistance for height, interplay between lipid transport and immune systems forWHR, and female-specific polygenic adaptation forWHR and WC. In conclusion, we observed evidence of polygenic adaptation in the context of systems genetics of anthropometric traits that indicates polygenic mechanisms related to the natural selection in European populations.	[Polimanti, Renato; Yang, Bao Zhu; Gelernter, Joel] Yale Univ, Sch Med, Dept Psychiat, West Haven, CT 06516 USA; [Polimanti, Renato; Yang, Bao Zhu; Gelernter, Joel] VA CT Healthcare Ctr, West Haven, CT USA; [Zhao, Hongyu] Yale Univ, Sch Publ Hlth, Dept Biostat, New Haven, CT USA; [Zhao, Hongyu; Gelernter, Joel] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA; [Gelernter, Joel] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT USA	Yale University; Yale University; Yale University; Yale University	Polimanti, R (corresponding author), Yale Univ, Sch Med, Dept Psychiat, West Haven, CT 06516 USA.; Polimanti, R (corresponding author), VA CT Healthcare Ctr, West Haven, CT USA.	renato.polimanti@yale.edu		Gelernter, Joel/0000-0002-4067-1859; Polimanti, Renato/0000-0003-0745-6046	National Institutes of Health grants [R01 DA030976, R01 DA12690, R01 DA12849, R01 AA11330, R01 AA017535]; VA Connecticut MIRECC; NATIONAL CANCER INSTITUTE [P30CA016359] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001863] Funding Source: NIH RePORTER	National Institutes of Health grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VA Connecticut MIRECC; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This study was supported by National Institutes of Health grants [R01 DA030976, R01 DA12690, R01 DA12849, R01 AA11330, and R01 AA017535] and the VA Connecticut MIRECC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Babin PJ, 2009, PROG LIPID RES, V48, P73, DOI 10.1016/j.plipres.2008.11.002; Berg JJ, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004412; Berndt SI, 2013, NAT GENET, V45, P501, DOI 10.1038/ng.2606; Chan YL, 2014, AM J HUM GENET, V94, P437, DOI 10.1016/j.ajhg.2014.02.006; Choudhury A, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-437; Colonna V, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-6-r88; Courtiol A, 2013, CURR BIOL, V23, P884, DOI 10.1016/j.cub.2013.04.006; Cowley MJ, 2012, NUCLEIC ACIDS RES, V40, pD862, DOI 10.1093/nar/gkr967; Daub JT, 2013, MOL BIOL EVOL, V30, P1544, DOI 10.1093/molbev/mst080; Ding KY, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-55; Ferrer-Admetlla A, 2014, MOL BIOL EVOL, V31, P1275, DOI 10.1093/molbev/msu077; Festi D, 2014, WORLD J GASTROENTERO, V20, P16079, DOI 10.3748/wjg.v20.i43.16079; Fumagalli M, 2014, CURR OPIN IMMUNOL, V30, P9, DOI 10.1016/j.coi.2014.05.001; GOLDSTEIN MS, 1984, HUM BIOL, V56, P35; Gragnoli C, 2014, APPL CLIN GENET, V7, P43, DOI 10.2147/TACG.S39993; Heid IM, 2010, NAT GENET, V42, P949, DOI 10.1038/ng.685; Henderson GC, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00162; Hou Lin, 2013, Frontiers in Genetics, V4, P280, DOI 10.3389/fgene.2013.00280; Houser Brandy L., 2012, Yale Journal of Biology and Medicine, V85, P105; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jablonski NG, 2012, J ROY COLL PHYS EDIN, V42, P58, DOI 10.4997/JRCPE.2012.114; Janani C, 2014, DIABETES METAB SYNDR; Jeong C, 2014, CURR OPIN GENET DEV, V29, P1, DOI 10.1016/j.gde.2014.06.011; Jia PL, 2011, BIOINFORMATICS, V27, P95, DOI 10.1093/bioinformatics/btq615; Joel Dipesalema R, 2014, J Int Assoc Provid AIDS Care, V13, P529, DOI 10.1177/2325957414531621; Lachance J, 2013, ANNU REV ECOL EVOL S, V44, P123, DOI 10.1146/annurev-ecolsys-110512-135833; Legein B, 2013, CELL MOL LIFE SCI, V70, P3847, DOI 10.1007/s00018-013-1289-1; Limou S, 2009, J INFECT DIS, V199, P419, DOI 10.1086/596067; Liu JZ, 2010, AM J HUM GENET, V87, P139, DOI 10.1016/j.ajhg.2010.06.009; Loria AS, 2014, PHYSIOL REP, V2, DOI 10.14814/phy2.12125; Mortensen HM, 2011, PHARMACOGENOMICS, V12, P1545, DOI [10.2217/PGS.11.88, 10.2217/pgs.11.88]; Piwoz E, 2012, ADV NUTR, V3, P234, DOI 10.3945/an.111.001164; Polimanti R, 2015, ADDICT BIOL; Polimanti R, 2015, PHARMACOGENOMICS, V16, P1487, DOI [10.2217/PGS.15.91, 10.2217/pgs.15.91]; Polimanti R, 2012, PHARMACOGENOMICS, V13, P1951, DOI [10.2217/PGS.12.163, 10.2217/pgs.12.163]; Pritchard JK, 2010, NAT REV GENET, V11, P665, DOI 10.1038/nrg2880; Pritchard JK, 2010, CURR BIOL, V20, pR208, DOI 10.1016/j.cub.2009.11.055; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Randall JC, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003500; Rivadeneira F, 2009, NAT GENET, V41, P1199, DOI 10.1038/ng.446; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Sakkou M, 2007, CELL METAB, V5, P450, DOI 10.1016/j.cmet.2007.05.007; Southam L, 2009, DIABETOLOGIA, V52, P1846, DOI 10.1007/s00125-009-1419-3; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Taal HR, 2012, NAT GENET, V44, P532, DOI 10.1038/ng.2238; Tsalik EL, 2003, J NEUROBIOL, V56, P178, DOI 10.1002/neu.10245; Turchin MC, 2012, NAT GENET, V44, P1015, DOI 10.1038/ng.2368; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Wells JCK, 2012, AM J PHYS ANTHROPOL, V147, P169, DOI 10.1002/ajpa.21591; Wheeler E, 2013, NAT GENET, V45, P513, DOI 10.1038/ng.2607; Wood AR, 2014, NAT GENET, V46, P1173, DOI 10.1038/ng.3097; Wuren T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088252; Xing JC, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003634; Yang J, 2012, NATURE, V490, P267, DOI 10.1038/nature11401; Zahra K., 2014, NEUROL SCI; Zoumakis E, 2009, CURR MED CHEM, V16, P4230, DOI 10.2174/092986709789578204; Zuloaga KL, 2014, AM J PHYSIOL-HEART C, V306, pH929, DOI 10.1152/ajpheart.00698.2013	59	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0160654	10.1371/journal.pone.0160654	http://dx.doi.org/10.1371/journal.pone.0160654			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27537407	gold, Green Published, Green Submitted			2022-12-27	WOS:000381577000027
J	Zhang, CW; Tatham, AJ; Abe, RY; Hammel, N; Belghith, A; Weinreb, RN; Medeiros, FA; Liebmann, JM; Girkin, CA; Zangwill, LM				Zhang, Chunwei; Tatham, Andrew J.; Abe, Ricardo Y.; Hammel, Na'ama; Belghith, Akram; Weinreb, Robert N.; Medeiros, Felipe A.; Liebmann, Jeffrey M.; Girkin, Christopher A.; Zangwill, Linda M.			Macular Ganglion Cell Inner Plexiform Layer Thickness in Glaucomatous Eyes with Localized Retinal Nerve Fiber Layer Defects	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; AFRICAN DESCENT; DAMAGE; PARAMETERS; DIAGNOSIS; HISTOLOGY; ATROPHY; ABILITY; COUNTS; MAPS	Purpose To investigate macular ganglion cell-inner plexiform layer (mGCIPL) thickness in glaucomatous eyes with visible localized retinal nerve fiber layer (RNFL) defects on stereophotographs. Methods 112 healthy and 149 glaucomatous eyes from the Diagnostic Innovations in Glaucoma Study (DIGS) and the African Descent and Glaucoma Evaluation Study (ADAGES) subjects had standard automated perimetry (SAP), optical coherence tomography (OCT) imaging of the macula and optic nerve head, and stereoscopic optic disc photography. Masked observers identified localized RNFL defects by grading of stereophotographs. Result 47 eyes had visible localized RNFL defects on stereophotographs. Eyes with visible localized RNFL defects had significantly thinner mGCIPL thickness compared to healthy eyes (68.3 +/- 11.4 mu m versus 79.2 +/- 6.6 mu m respectively, P<0.001) and similar mGCIPL thickness to glaucomatous eyes without localized RNFL defects (68.6 +/- 11.2 mu m, P = 1.000). The average mGCIPL thickness in eyes with RNFL defects was 14% less than similarly aged healthy controls. For 29 eyes with a visible RNFL defect in just one hemiretina (superior or inferior) mGCIPL was thinnest in the same hemiretina in 26 eyes (90%). Eyes with inferior-temporal RNFL defects also had significantly thinner inferior-temporal mGCIPL (P<0.001) and inferior mGCIPL (P = 0.030) compared to glaucomatous eyes without a visible RNFL defect. Conclusion The current study indicates that presence of a localized RNFL defect is likely to indicate significant macular damage, particularly in the region of the macular that topographically corresponds to the location of the RNFL defect.	[Zhang, Chunwei] Harbin Med Univ, Affiliated Hosp 1, Dept Ophthalmol, Harbin, Peoples R China; [Zhang, Chunwei; Tatham, Andrew J.; Abe, Ricardo Y.; Hammel, Na'ama; Belghith, Akram; Weinreb, Robert N.; Medeiros, Felipe A.; Zangwill, Linda M.] Univ Calif San Diego, Dept Ophthalmol, Hamilton Glaucoma Ctr, San Diego, CA 92103 USA; [Zhang, Chunwei; Tatham, Andrew J.; Abe, Ricardo Y.; Hammel, Na'ama; Belghith, Akram; Weinreb, Robert N.; Medeiros, Felipe A.; Zangwill, Linda M.] Univ Calif San Diego, Shiley Eye Inst, San Diego, CA 92103 USA; [Tatham, Andrew J.] Univ Edinburgh, Princess Alexandra Eye Pavil, Edinburgh, Midlothian, Scotland; [Tatham, Andrew J.] Univ Edinburgh, Dept Ophthalmol, Edinburgh, Midlothian, Scotland; [Abe, Ricardo Y.] Univ Estadual Campinas, Dept Ophthalmol, Campinas, SP, Brazil; [Liebmann, Jeffrey M.] Columbia Univ, Harkness Eye Inst, Med Ctr, New York, NY USA; [Girkin, Christopher A.] Univ Alabama Birmingham, Dept Ophthalmol, Birmingham, AL 35294 USA	Harbin Medical University; University of California System; University of California San Diego; University of California System; University of California San Diego; University of Edinburgh; University of Edinburgh; Universidade Estadual de Campinas; Columbia University; University of Alabama System; University of Alabama Birmingham	Zangwill, LM (corresponding author), Univ Calif San Diego, Dept Ophthalmol, Hamilton Glaucoma Ctr, San Diego, CA 92103 USA.; Zangwill, LM (corresponding author), Univ Calif San Diego, Shiley Eye Inst, San Diego, CA 92103 USA.	lzangwill@ucsd.edu	Abe, Ricardo Y/L-1965-2018	Abe, Ricardo Y/0000-0002-7023-2144; Girkin, Christopher/0000-0002-5781-7682; Tatham, Andrew/0000-0003-0372-3100	National Institutes of Health/National Eye Institute [EY021818, EY11008, EY14267, EY019869, P30EY022589]; NHS Scotland Career Researcher Grant; Research to Prevent Blindness (New York, NY); Alcon; Allergan; Pfizer; Merck; Santen; Natural Science Foundation of Heilongjiang Province for Returned Scholars, China [LC2012C21]; Innovation research special fund of the Science and Technology of Harbin of Heilong Jiang Province, China [2011RFLYS029]; Research fund of the First Affiliated Hospital of Harbin Medical University, China [2007021]; Scientific and technical research fund of Education Bureau of Heilongjiang Province, China [12511311]	National Institutes of Health/National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NHS Scotland Career Researcher Grant; Research to Prevent Blindness (New York, NY)(Research to Prevent Blindness (RPB)); Alcon(Novartis); Allergan(AbbVieAllergan); Pfizer(Pfizer); Merck(Merck & Company); Santen; Natural Science Foundation of Heilongjiang Province for Returned Scholars, China; Innovation research special fund of the Science and Technology of Harbin of Heilong Jiang Province, China; Research fund of the First Affiliated Hospital of Harbin Medical University, China; Scientific and technical research fund of Education Bureau of Heilongjiang Province, China	This work was supported in part by National Institutes of Health/National Eye Institute grants EY021818 (FAM), EY11008 (LMZ), EY14267 (LMZ), EY019869 (LMZ), core grant P30EY022589; NHS Scotland Career Researcher Grant (AJT); an unrestricted grant from Research to Prevent Blindness (New York, NY); grants for participants' glaucoma medications from Alcon, Allergan, Pfizer, Merck and Santen; Natural Science Foundation of Heilongjiang Province for Returned Scholars, China. No. LC2012C21 (CZ); Innovation research special fund of the Science and Technology of Harbin of Heilong Jiang Province, China. No. 2011RFLYS029 (CZ). Research fund of the First Affiliated Hospital of Harbin Medical University, China No. 2007021(CZ). Scientific and technical research fund of Education Bureau of Heilongjiang Province, China. No. 12511311 (CZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIRAKSINEN PJ, 1984, AM J OPHTHALMOL, V98, P566, DOI 10.1016/0002-9394(84)90242-3; Akashi A, 2013, INVEST OPHTH VIS SCI, V54, P6025, DOI 10.1167/iovs.13-12630; CURCIO CA, 1990, J COMP NEUROL, V300, P5, DOI 10.1002/cne.903000103; Hood DC, 2014, INVEST OPHTH VIS SCI, V55, P632, DOI 10.1167/iovs.13-13130; Hood DC, 2013, PROG RETIN EYE RES, V32, P1, DOI 10.1016/j.preteyeres.2012.08.003; Hood DC, 2011, INVEST OPHTH VIS SCI, V52, P940, DOI 10.1167/iovs.10-5803; HOYT WF, 1972, LANCET, V1, P692; JONAS JB, 1994, GRAEF ARCH CLIN EXP, V232, P759, DOI 10.1007/BF00184280; Kim KE, 2014, INVEST OPHTH VIS SCI, V55, P3501, DOI 10.1167/iovs.14-13925; Kim MJ, 2015, ACTA OPHTHALMOL, V93, pE22, DOI 10.1111/aos.12485; Kim TW, 2007, OPHTHALMOLOGY, V114, P1053, DOI 10.1016/j.ophtha.2006.09.015; Knighton RW, 2012, INVEST OPHTH VIS SCI, V53, P3653, DOI 10.1167/iovs.12-9719; Kotowski J, 2012, BRIT J OPHTHALMOL, V96, P1420, DOI 10.1136/bjophthalmol-2011-301021; Leung CKS, 2010, OPHTHALMOLOGY, V117, P2337, DOI 10.1016/j.ophtha.2010.04.002; Leung CKS, 2012, OPHTHALMOLOGY, V119, P1858, DOI 10.1016/j.ophtha.2012.03.044; Lu ATH, 2008, OPHTHALMOLOGY, V115, P1352, DOI 10.1016/j.ophtha.2008.01.011; Medeiros FA, 2005, ARCH OPHTHALMOL-CHIC, V123, P1351, DOI 10.1001/archopht.123.10.1351; Medeiros FA, 2004, ARCH OPHTHALMOL-CHIC, V122, P827, DOI 10.1001/archopht.122.6.827; Medeiros FA, 2008, OPHTHALMOLOGY, V115, P1340, DOI 10.1016/j.ophtha.2007.11.008; Medeiros FA, 2007, INVEST OPHTH VIS SCI, V48, P3146, DOI 10.1167/iovs.06-1139; Mwanza JC, 2012, OPHTHALMOLOGY, V119, P1151, DOI 10.1016/j.ophtha.2011.12.014; Mwanza JC, 2011, INVEST OPHTH VIS SCI, V52, P8323, DOI 10.1167/iovs.11-7962; Quigley H A, 1986, Trans Am Ophthalmol Soc, V84, P920; QUIGLEY HA, 1979, OPHTHALMOLOGY, V86, P1803; QUIGLEY HA, 1987, EYE, V1, P318, DOI 10.1038/eye.1987.51; Racette L, 2010, ARCH OPHTHALMOL-CHIC, V128, P551, DOI 10.1001/archophthalmol.2010.58; RADIUS RL, 1979, ARCH OPHTHALMOL-CHIC, V97, P948; Sample PA, 2009, ARCH OPHTHALMOL-CHIC, V127, P1136, DOI 10.1001/archophthalmol.2009.187; Shah NN, 2006, OPHTHALMOLOGY, V113, P1593, DOI 10.1016/j.ophtha.2006.06.004; SOMMER A, 1977, ARCH OPHTHALMOL-CHIC, V95, P2149; SOMMER A, 1991, ARCH OPHTHALMOL-CHIC, V109, P77, DOI 10.1001/archopht.1991.01080010079037; Tatham AJ, 2013, AM J OPHTHALMOL, V156, P578, DOI 10.1016/j.ajo.2013.04.015; Tham YC, 2013, BRIT J OPHTHALMOL, V97, P1592, DOI 10.1136/bjophthalmol-2013-303660; TUULONEN A, 1993, OPHTHALMOLOGY, V100, P587; Ueda K, 2016, J GLAUCOMA, V25, P383, DOI 10.1097/IJG.0000000000000216; Weinreb RN, 2014, JAMA-J AM MED ASSOC, V311, P1901, DOI 10.1001/jama.2014.3192; Yang ZY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125957; Yang ZY, 2015, AM J OPHTHALMOL, V159, P193, DOI 10.1016/j.ajo.2014.10.019; Zhang CW, 2014, OPHTHALMOLOGY, V121, P2371, DOI 10.1016/j.ophtha.2014.06.047	39	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0160549	10.1371/journal.pone.0160549	http://dx.doi.org/10.1371/journal.pone.0160549			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27537107	Green Published, gold, Green Submitted			2022-12-27	WOS:000381577000024
J	Mendsaikhan, N; Begzjav, T; Lundeg, G; Brunauer, A; Dunser, MW				Mendsaikhan, Naranpurev; Begzjav, Tsolmon; Lundeg, Ganbold; Brunauer, Andreas; Duenser, Martin W.			A Nationwide Census of ICU Capacity and Admissions in Mongolia	PLOS ONE			English	Article							CRITICAL-CARE RESOURCES; INTENSIVE-CARE; UNIT; AVAILABILITY; SERVICES; AFRICA; SEPSIS	In Mongolia, a Central Asian lower-middle income country, intensive care medicine is an under-resourced and-developed medical specialty. The burden of critical illness and capacity of intensive care unit (ICU) services in the country is unknown. In this nationwide census, we collected data on adult and pediatric/neonatal ICU capacities and the number of ICU admissions in 2014. All hospitals registered to run an ICU service in Mongolia were surveyed. Data on the availability of an adult and/or pediatric/neonatal ICU service, the number of available ICU beds, the number of available functional mechanical ventilators, the number of patients admitted to the ICU, and the number of patients admitted to the study hospital were collected. In total, 70 ICUs with 349 ICU beds were counted in Mongolia (11.7 ICU beds/100,000 inhabitants; 1.7 ICU beds/100 hospital beds). Of these, 241 (69%) were adult and 108 (31%) pediatric/neonatal ICU beds. Functional mechanical ventilators were available for approximately half of the ICU beds (5.1 mechanical ventilators/100,000 inhabitants). While all provincial hospitals ran a pediatric/neonatal ICU, only dedicated pediatric hospitals in Ulaanbaatar did so. The number of adult and pediatric/neonatal ICU admissions varied between provinces. The number of adult ICU beds and adult ICU admissions per 100,000 inhabitants correlated (r = 0.5; p = 0.02), while the number of pediatric/neonatal ICU beds and pediatric/neonatal ICU admissions per 100,000 inhabitants did not (r = 0.25; p = 0.26). In conclusion, with 11.7 ICU beds per 100,000 inhabitants the ICU capacity in Mongolia is higher than in other low-and lower-middle-income countries. Substantial heterogeneities in the standardized ICU capacity and ICU admissions exist between Mongolian provinces. Functional mechanical ventilators are available for only half of the ICU beds. Pediatric/neonatal ICU beds make up one third of the national ICU capacity and appear to meet or even exceed the demand of pediatric/neonatal critical care.	[Mendsaikhan, Naranpurev; Begzjav, Tsolmon] Intermed Hosp, Dept Intens Care, Ulaanbaatar, Mongolia; [Lundeg, Ganbold] Hlth Sci Univ Mongolia, Div Emergency Med & Anesthesia, Ulaanbaatar, Mongolia; [Brunauer, Andreas; Duenser, Martin W.] Salzburg Univ Hosp, Dept Anesthesiol Perioperat Med & Gen Intens Care, Salzburg, Austria; [Brunauer, Andreas; Duenser, Martin W.] Paracelsus Private Med Univ, Salzburg, Austria	Mongolian National University of Medical Sciences; Paracelsus Private Medical University	Mendsaikhan, N (corresponding author), Intermed Hosp, Dept Intens Care, Ulaanbaatar, Mongolia.	m-naran@hotmail.com	GANBOLD, Lundeg/AAL-4966-2021	GANBOLD, Lundeg/0000-0001-8470-7342				Adhikari NKJ, 2010, LANCET, V376, P1339, DOI 10.1016/S0140-6736(10)60446-1; Baelani I, 2011, CRIT CARE, V15, DOI 10.1186/cc9410; Baker T, 2009, PEDIATR ANESTH, V19, P23, DOI 10.1111/j.1460-9592.2008.02868.x; Bataar O, 2010, B WORLD HEALTH ORGAN, V88, P839, DOI 10.2471/BLT.10.077073; Bhagwanjee S, 2007, SAMJ S AFR MED J, V97, P1311; Campos-Mino S, 2012, MED INTENSIVA, V36, P3, DOI 10.1016/j.medin.2011.07.004; Celis E, 2002, CRIT CARE, V6, P405; Dondorp AM, 2016, JAMA-J AM MED ASSOC, V315, P753, DOI 10.1001/jama.2016.0976; Du B, 2010, CRIT CARE, V14, DOI 10.1186/cc8222; Dunser MW, 2009, J CRIT CARE, V24, DOI 10.1016/j.jcrc.2008.06.014; Dunser MW, 2008, WIEN KLIN WOCHENSCHR, V120, P600, DOI 10.1007/s00508-008-1064-8; Frikha Nabil, 2005, Tunis Med, V83, P320; Geok JTM, MALAYSIAN REGISTRY I; Haniffa R, 2014, J CRIT CARE, V29, P764, DOI 10.1016/j.jcrc.2014.04.021; Hariharan S, 2007, W INDIAN MED J, V56, P144; Jochberger S, 2010, J CLIN ANESTH, V22, P443, DOI 10.1016/j.jclinane.2009.12.005; Kwizera A, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/2015251; Kwizera Arthur, 2012, BMC Res Notes, V5, P475, DOI 10.1186/1756-0500-5-475; Odetola FO, 2005, PEDIATRICS, V115, DOI 10.1542/peds.2004-1920; Rhodes A, 2012, INTENS CARE MED, V38, P1647, DOI 10.1007/s00134-012-2627-8; Wunsch H, 2008, CRIT CARE MED, V36, P2787, DOI 10.1097/CCM.0b013e318186aec8	21	14	14	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2016	11	8							e0160921	10.1371/journal.pone.0160921	http://dx.doi.org/10.1371/journal.pone.0160921			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4YN	27532338	Green Published, Green Submitted, gold			2022-12-27	WOS:000381487600048
J	Neyrinck, AM; Pachikian, B; Taminiau, B; Daube, G; Frederick, R; Cani, PD; Bindels, LB; Delzenne, NM				Neyrinck, Audrey M.; Pachikian, Barbara; Taminiau, Bernard; Daube, Georges; Frederick, Raphael; Cani, Patrice D.; Bindels, Laure B.; Delzenne, Nathalie M.			Intestinal Sucrase as a Novel Target Contributing to the Regulation of Glycemia by Prebiotics	PLOS ONE			English	Article							RAT LARGE-BOWEL; GUT MICROBIOTA; AKKERMANSIA-MUCINIPHILA; CELL-PROLIFERATION; PEPTIDE-1 RECEPTOR; LIPID-METABOLISM; MICE; GLUCOSE; OBESITY; FIBER	Inulin-type fructans (ITF) are known for their capacity to modulate gut microbiota, energy metabolism and to improve glycemia in several animal models of obesity, and in humans. The potential contribution of ITF as modulators of sugar digestion by host enzymes has not been evaluated yet. A sucrose challenge has been performed on naive mice fed a standard diet supplemented with or without native chicory inulin (Fibruline 5%) for 3 weeks. The area under the curve of glycemia as well as sucrase activity in the small intestine were lowered after inulin treatment. Pyrosequencing of the 16S rRNA gene confirmed important changes in gut microbiota (mostly in favor of Blautia genus) due to inulin extract supplementation. Interestingly, the suppressive effect of inulin extract on postprandial glycemia also occurred when inulin was directly added to the sucrose solution, suggesting that the effect on sucrose digestion did not require chronic inulin administration. In vitro tests confirmed a direct inhibition of sucrase enzyme by the inulin extract, thereby suggesting that native chicory inulin, in addition to its well-known prebiotic effect, is also able to decrease the digestibility of carbohydrates, a phenomenon that can contribute in the control of post prandial glycemia. We may not exclude that the sucrose escaping the digestion could also contribute to the changes in the gut microbiota after a chronic treatment with inulin.	[Neyrinck, Audrey M.; Pachikian, Barbara; Cani, Patrice D.; Bindels, Laure B.; Delzenne, Nathalie M.] Catholic Univ Louvain, Metab & Nutr Res Grp, Louvain Drug Res Inst, Brussels, Belgium; [Taminiau, Bernard; Daube, Georges] Univ Liege, Fac Vet Med, FARAH, Liege, Belgium; [Frederick, Raphael] Catholic Univ Louvain, Med Chem Res Grp, Louvain Drug Res Inst, Brussels, Belgium; [Cani, Patrice D.] UCL, Louvain Drug Res Inst, Walloon Excellence Life Sci & BIOtechnol WELBIO, B-1200 Brussels, Belgium	Universite Catholique Louvain; University of Liege; Universite Catholique Louvain; Universite Catholique Louvain; WELBIO	Delzenne, NM (corresponding author), Catholic Univ Louvain, Metab & Nutr Res Grp, Louvain Drug Res Inst, Brussels, Belgium.	nathalie.delzenne@uclouvain.be	Delzenne, Nathalie/AAC-4628-2019; D., Cani Patrice/M-8055-2016; Taminiau, Bernard/E-8008-2017; Bindels, Laure/T-7846-2019; Neyrinck, Audrey/AAE-7929-2019	Delzenne, Nathalie/0000-0003-2115-6082; D., Cani Patrice/0000-0003-2040-2448; Taminiau, Bernard/0000-0001-6456-329X; Bindels, Laure/0000-0003-3747-3234; Neyrinck, Audrey/0000-0002-9435-3338; Daube, Georges/0000-0002-9282-8408; Frederick, Raphael/0000-0001-8119-1272	FRS-FNRS grants; Wallonia (FOOD4GUT project) [1318148]; Wallonia - competitive cluster Wagralim (NUTRIGUTIOR project) [6918]; ERC Starting Grant (European Research Council) [336452-ENIGMO]; PDR (Fonds de la Recherche Scientifique, Belgium) [T0.138.14]; ARC (Concerted Research Activities-French Community of Belgium) [12/17-047]; FRS-FNRS via the FRFS-WELBIO [WELBIO-CR-2012S-02R]	FRS-FNRS grants(Fonds de la Recherche Scientifique - FNRS); Wallonia (FOOD4GUT project); Wallonia - competitive cluster Wagralim (NUTRIGUTIOR project); ERC Starting Grant (European Research Council); PDR (Fonds de la Recherche Scientifique, Belgium); ARC (Concerted Research Activities-French Community of Belgium); FRS-FNRS via the FRFS-WELBIO(Fonds de la Recherche Scientifique - FNRS)	LBB is Postdoctoral Researcher from the FRS-FNRS (Fond National de la Recherche Scientifique, Belgium). NMD is a recipient of FRS-FNRS grants and of grant from the Wallonia (FOOD4GUT project, convention 1318148). NMD and GD are recipients of grant from Wallonia supported by the competitive cluster Wagralim (NUTRIGUTIOR project, convention 6918). PDC, a research associate at the FRS-FNRS (Belgium), is a recipient of an ERC Starting Grant 2013 (European Research Council, Starting Grant 336452-ENIGMO), PDR subsidies (Projet de recherches T0.138.14; Fonds de la Recherche Scientifique, Belgium) and ARC subsidies (Concerted Research Activities-French Community of Belgium convention: 12/17-047) and is supported by the FRS-FNRS via the FRFS-WELBIO under Grant number WELBIO-CR-2012S-02R.; We thank Remi Selleslagh and Bouazza Es Saadi for skillful technical assistance and Carine Nezer, Quality Partner s.a., Herstal, Belgium, for performing metagenetic analysis. LBB is Post-doctoral Researcher from the FRS-FNRS (Fond National de la Recherche Scientifique, Belgium). NMD is a recipient of FRS-FNRS grants and of grant from the Wallonia (FOOD4GUT project, convention 1318148). NMD and GD are recipients of grant from Wallonia supported by the competitive cluster Wagralim (NUTRIGUTIOR project, convention 6918). PDC, a research associate at the FRS-FNRS (Belgium), is a recipient of an ERC Starting Grant 2013 (European Research Council, Starting Grant 336452-ENIGMO), PDR subsidies (Projet de recherches T0.138.14; Fonds de la Recherche Scientifique, Belgium) and ARC subsidies (Concerted Research Activities-French Community of Belgium convention: 12/17-047) and is supported by the FRS-FNRS via the FRFS-WELBIO under Grant number WELBIO-CR-2012S-02R.	Barlow GM, 2015, NUTR CLIN PRACT, V30, P787, DOI 10.1177/0884533615609896; Bindels LB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131009; Bindels LB, 2015, NAT REV GASTRO HEPAT, V12, P303, DOI 10.1038/nrgastro.2015.47; Brownlee IA, 2003, P NUTR SOC, V62, P245, DOI 10.1079/PNS2003206; Cani PD, 2009, GUT, V58, P1091, DOI 10.1136/gut.2008.165886; Cani PD, 2006, DIABETES, V55, P1484, DOI 10.2337/db05-1360; CANI PD, 2007, BR J NUTR, P1; DAHLQVIST A, 1968, ANAL BIOCHEM, V22, P99, DOI 10.1016/0003-2697(68)90263-7; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; Delzenne NM, 2015, DIABETOLOGIA, V58, P2206, DOI 10.1007/s00125-015-3712-7; Delzenne NM, 2011, NAT REV ENDOCRINOL, V7, P639, DOI 10.1038/nrendo.2011.126; Devkota S, 2012, NATURE, V487, P104, DOI 10.1038/nature11225; Everard A, 2014, ISME J, V8, P2116, DOI 10.1038/ismej.2014.45; Everard A, 2013, P NATL ACAD SCI USA, V110, P9066, DOI 10.1073/pnas.1219451110; Everard A, 2011, DIABETES, V60, P2775, DOI 10.2337/db11-0227; Fletcher MM, 2016, BIOCHEM SOC T, V44, P582, DOI 10.1042/BST20150244; Fukunaga T, 2003, DIGESTION, V67, P42, DOI 10.1159/000069705; Hedemann MS, 2006, J ANIM SCI, V84, P1375, DOI 10.2527/2006.8461375x; Hutkins RW, 2016, CURR OPIN BIOTECH, V37, P1, DOI 10.1016/j.copbio.2015.09.001; JACOBS LR, 1984, AM J PHYSIOL, V246, pG378, DOI 10.1152/ajpgi.1984.246.4.G378; Junicke H, 2016, BIOTECHNOL BIOENG, V113, P560, DOI 10.1002/bit.25816; KAWAI Y, 1978, INFECT IMMUN, V19, P771, DOI 10.1128/IAI.19.3.771-778.1978; Liu CX, 2008, INT J SYST EVOL MICR, V58, P1896, DOI 10.1099/ijs.0.65208-0; LUPTON JR, 1988, J NUTR, V118, P840, DOI 10.1093/jn/118.7.840; Martinez I, 2013, ISME J, V7, P269, DOI 10.1038/ismej.2012.104; Maurer AD, 2009, J PHYSIOL-LONDON, V587, P679, DOI 10.1113/jphysiol.2008.161844; Nakamura N, 2010, ANNU REV FOOD SCI T, V1, P363, DOI 10.1146/annurev.food.102308.124101; Oki T, 1999, J AGR FOOD CHEM, V47, P550, DOI 10.1021/jf980788t; Oku T, 2014, NUTR RES, V34, P961, DOI 10.1016/j.nutres.2014.09.009; Quintero M, 2011, CURR MICROBIOL, V62, P1448, DOI 10.1007/s00284-011-9882-8; Roberfroid M, 2010, BRIT J NUTR, V104, pS1, DOI 10.1017/S0007114510003363; Salonen A, 2014, ISME J, V8, P2218, DOI 10.1038/ismej.2014.63; Schneeberger M, 2015, SCI REP-UK, V5, DOI 10.1038/srep16643; Sim L, 2010, J BIOL CHEM, V285, P17763, DOI 10.1074/jbc.M109.078980; Tannock GW, 2014, APPL ENVIRON MICROB, V80, P2240, DOI 10.1128/AEM.03799-13; Urias-Silvas JE, 2008, BRIT J NUTR, V99, P254, DOI 10.1017/S0007114507795338; WHITT DD, 1981, APPL ENVIRON MICROB, V42, P513, DOI 10.1128/AEM.42.3.513-520.1981; Williamson G, 2013, MOL NUTR FOOD RES, V57, P48, DOI 10.1002/mnfr.201200511; Yang JY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146144; Zenhom M, 2011, J NUTR, V141, P971, DOI 10.3945/jn.110.136176	40	18	20	4	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2016	11	8							e0160488	10.1371/journal.pone.0160488	http://dx.doi.org/10.1371/journal.pone.0160488			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4YN	27532866	gold, Green Published			2022-12-27	WOS:000381487600032
J	Khalil, AA; Hohenhaus, M; Kunze, C; Schmidt, W; Brunecker, P; Villringer, K; Merboldt, KD; Frahm, J; Fiebach, JB				Khalil, Ahmed A.; Hohenhaus, Marc; Kunze, Claudia; Schmidt, Wolf; Brunecker, Peter; Villringer, Kersten; Merboldt, Klaus-Dietmar; Frahm, Jens; Fiebach, Jochen B.			Sensitivity of Diffusion-Weighted STEAM MRI and EPI-DWI to Infratentorial Ischemic Stroke	PLOS ONE			English	Article							REAL-TIME MRI; RADIAL FLASH; RECONSTRUCTION; RESOLUTION; BRAIN; COEFFICIENT; VARIABILITY; AGREEMENT	Objectives To assess the sensitivity of stimulated echo acquisition mode diffusion weighted imaging (STEAM-DWI) to ischemic stroke in comparison to echo-planar imaging diffusion weighted imaging (EPI-DWI) in the infratentorial compartment. Methods Fifty-seven patients presenting with clinical features of infratentorial stroke underwent STEAM-DWI, high-resolution EPI-DWI (HR-DWI, 2.5 mm slice thickness) and low-resolution EPI-DWI (LR-DWI, 5 mm slice thickness). Four readers assessed the presence of ischemic lesions and artifacts. Agreement between sequences and interobserver agreement on the presence of ischemia were calculated. The sensitivities of the DWI sequences were calculated in 45 patients with a confirmed diagnosis of infratentorial stroke. Results Median time from symptom onset to imaging was 24 hours. STEAM-DWI agreed with LR-DWI in 89.5% of cases (kappa = 0.72, p<0.0001) and with HR-DWI in 89.5% of cases (kappa = 0.68, p<0.0001). STEAM-DWI showed fewer intraparenchymal artifacts (1/57) than HR-DWI (44/57) and LR-DWI (41/57). Ischemia was visible in 87% of cases for LR-DWI, 93% of cases for HR-DWI, and 89% of cases for STEAM-DWI. Interobserver agreement was good for STEAM-DWI (kappa = 0.62, p<0.0001). Conclusions Compared to the best currently available MR sequence for detecting ischemia (HR-DWI), STEAM-DWI shows fewer artifacts and a similar sensitivity to infratentorial stroke.	[Khalil, Ahmed A.; Kunze, Claudia; Schmidt, Wolf; Brunecker, Peter; Villringer, Kersten; Fiebach, Jochen B.] Charite, Ctr Stroke Res Berlin, Berlin, Germany; [Khalil, Ahmed A.] Charite, NeuroCure Cluster Excellence, Berlin, Germany; [Khalil, Ahmed A.] Charite, Int Grad Program Med Neurosci, Berlin, Germany; [Hohenhaus, Marc] Univ Klinikum Freiburg, Klin Neurochirurg, Freiburg, Germany; [Merboldt, Klaus-Dietmar; Frahm, Jens] Max Planck Inst Biophys Chem, Biomed NMR Forsch GmbH, Gottingen, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Freiburg; Max Planck Society	Khalil, AA (corresponding author), Charite, Ctr Stroke Res Berlin, Berlin, Germany.; Khalil, AA (corresponding author), Charite, NeuroCure Cluster Excellence, Berlin, Germany.; Khalil, AA (corresponding author), Charite, Int Grad Program Med Neurosci, Berlin, Germany.	ahmed-abdelrahim.khalil@charite.de	Khalil, Ahmed/I-3251-2019	Khalil, Ahmed/0000-0003-1752-4305; Fiebach, Jochen B./0000-0002-7936-6958; Frahm, Jens/0000-0002-8279-884X	German Federal Ministry of Education and Research via the grant Center for Stroke Research Berlin [01EO0801, 01EO01301]	German Federal Ministry of Education and Research via the grant Center for Stroke Research Berlin	This study received funding from the German Federal Ministry of Education and Research (https://www.bmbf.de/en/index.html) via the grant Center for Stroke Research Berlin (01EO0801 and 01EO01301). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEAM CA, 1992, AM J ROENTGENOL, V159, P631, DOI 10.2214/ajr.159.3.1503041; Benameur K, 2006, AM J NEURORADIOL, V27, P1987; Caso V, 2005, J NEUROL NEUROSUR PS, V76, P514, DOI 10.1136/jnnp.2004.046383; Chalela JA, 2007, LANCET, V369, P293, DOI 10.1016/S0140-6736(07)60151-2; CICCHETTI DV, 1990, J CLIN EPIDEMIOL, V43, P551, DOI 10.1016/0895-4356(90)90159-M; FRAHM J, 1985, J MAGN RESON, V64, P81, DOI 10.1016/0022-2364(85)90033-2; Gonzalez RG, 1999, RADIOLOGY, V210, P155, DOI 10.1148/radiology.210.1.r99ja02155; Hand PJ, 2006, STROKE, V37, P776, DOI 10.1161/01.STR.0000204042.41695.a1; HATANO S, 1976, B WORLD HEALTH ORGAN, V54, P533; Hotter B, 2013, STROKE, V44, P2598, DOI 10.1161/STROKEAHA.113.001594; Hotter B, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-60; Lansberg MG, 2001, AM J NEURORADIOL, V22, P637; Lovblad KO, 1998, AM J NEURORADIOL, V19, P1061; Makin SDJ, 2015, STROKE, V46, P3142, DOI 10.1161/STROKEAHA.115.010665; MERBOLDT KD, 1992, MAGNET RESON MED, V23, P179, DOI 10.1002/mrm.1910230119; Molyneux PD, 1998, AM J NEURORADIOL, V19, P1715; Nalleballe K, 2015, NEUROLOGY, V84; Nolte UG, 2000, MAGNET RESON MED, V44, P731, DOI 10.1002/1522-2594(200011)44:5<731::AID-MRM11>3.0.CO;2-1; Oppenheim C, 2000, AM J NEURORADIOL, V21, P1434; Parikh PT, 2011, AM J NEURORADIOL, V32, P365, DOI 10.3174/ajnr.A2297; Rieseberg S, 2005, MAGN RESON MED, V54, P486, DOI 10.1002/mrm.20572; Schlaug G, 1997, NEUROLOGY, V49, P113, DOI 10.1212/WNL.49.1.113; SHINAR D, 1985, ARCH NEUROL-CHICAGO, V42, P557, DOI 10.1001/archneur.1985.04060060059010; Uecker M, 2008, MAGN RESON MED, V60, P674, DOI 10.1002/mrm.21691; Uecker M, 2010, NMR BIOMED, V23, P986, DOI 10.1002/nbm.1585; Uecker M, 2010, MAGN RESON MED, V63, P1456, DOI 10.1002/mrm.22453; WARACH S, 1992, NEUROLOGY, V42, P1717, DOI 10.1212/WNL.42.9.1717; Warach S, 1996, J CEREBR BLOOD F MET, V16, P53, DOI 10.1097/00004647-199601000-00006; Watts Jennifer, 2013, Neurol Clin Pract, V3, P186, DOI 10.1212/CPJ.0b013e318296f288; Zhang S, 2010, J MAGN RESON IMAGING, V31, P101, DOI 10.1002/jmri.21987	30	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2016	11	8							e0161416	10.1371/journal.pone.0161416	http://dx.doi.org/10.1371/journal.pone.0161416			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4UN	27529697	gold, Green Published, Green Submitted			2022-12-27	WOS:000381476700071
J	Thiery, T; Lajnef, T; Jerbi, K; Arguin, M; Aubin, M; Jolicoeur, P				Thiery, Thomas; Lajnef, Tarek; Jerbi, Karim; Arguin, Martin; Aubin, Mercedes; Jolicoeur, Pierre			Decoding the Locus of Covert Visuospatial Attention from EEG Signals	PLOS ONE			English	Article							TERM-MEMORY EVIDENCE; CLASSIFICATION; CAPTURE; P300; N2PC; REPRESENTATIONS; TOP	Visuospatial attention can be deployed to different locations in space independently of ocular fixation, and studies have shown that event-related potential (ERP) components can effectively index whether such covert visuospatial attention is deployed to the left or right visual field. However, it is not clear whether we may obtain a more precise spatial localization of the focus of attention based on the EEG signals during central fixation. In this study, we used a modified Posner cueing task with an endogenous cue to determine the degree to which information in the EEG signal can be used to track visual spatial attention in presentation sequences lasting 200 ms. We used a machine learning classification method to evaluate how well EEG signals discriminate between four different locations of the focus of attention. We then used a multi-class support vector machine (SVM) and a leave-one-out cross-validation framework to evaluate the decoding accuracy (DA). We found that ERP-based features from occipital and parietal regions showed a statistically significant valid prediction of the location of the focus of visuospatial attention (DA = 57%, p<.001, chance-level 25%). The mean distance between the predicted and the true focus of attention was 0.62 letter positions, which represented a mean error of 0.55 degrees of visual angle. In addition, ERP responses also successfully predicted whether spatial attention was allocated or not to a given location with an accuracy of 79% (p<.001). These findings are discussed in terms of their implications for visuospatial attention decoding and future paths for research are proposed.	[Thiery, Thomas; Jerbi, Karim; Arguin, Martin; Aubin, Mercedes; Jolicoeur, Pierre] Univ Montreal, Montreal, PQ, Canada; [Jerbi, Karim; Arguin, Martin; Aubin, Mercedes; Jolicoeur, Pierre] Ctr Rech Neuropsychol & Cognit CERNEC, Montreal, PQ, Canada; [Jerbi, Karim; Jolicoeur, Pierre] Int Lab Brain Mus & Sound Res BRAMS, Montreal, PQ, Canada; [Jolicoeur, Pierre] CRIUGM, Quebec City, PQ, Canada; [Lajnef, Tarek] Univ Sfax, LETI Lab, Sfax Natl Engn Sch ENIS, Sfax, Tunisia	Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Sfax; Ecole Nationale dIngenieurs de Sfax (ENIS)	Thiery, T (corresponding author), Univ Montreal, Montreal, PQ, Canada.	thomas.thiery@umontreal.ca		Arguin, Martin/0000-0002-1036-2932	FRQNT; Natural Sciences and Engineering Research Council of Canada; FRQS; PhysNum Lab, part of the Centre de Recherche en Mathematiques (CRM) at Universite de Montreal; Fonds de la Recherche du Quebec Nature et Technologies [2015-PR-182822]; Canada Research Chairs program; Fonds de Recherche du Quebec Sante	FRQNT; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); FRQS; PhysNum Lab, part of the Centre de Recherche en Mathematiques (CRM) at Universite de Montreal; Fonds de la Recherche du Quebec Nature et Technologies; Canada Research Chairs program(Canada Research Chairs); Fonds de Recherche du Quebec Sante(Fonds de la Recherche en Sante du Quebec)	This work was supported by FRQNT (http://www.frqnt.gouv.qc.ca/en/accueil); Natural Sciences and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca/index_eng.asp); and FRQS (http://www.frqs.gouv.qc.ca/en/accueil). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to Nicolas Dupuis-Roy suggestions and help in conducting decoding analysis. Support to TL was provided by a fellowship from the PhysNum Lab, part of the Centre de Recherche en Mathematiques (CRM) at Universite de Montreal.; This research was funded by grants from the Natural Sciences and Engineering Research Council of Canada to MA and PJ, from infrastructure support from the Fonds de Recherche du Quebec Sante, from research grant 2015-PR-182822 from the Fonds de la Recherche du Quebec Nature et Technologies to MA, and from the Canada Research Chairs program to PJ.	Agrawal RK, 2011, INFORMATICA; ARGUIN M, 1993, PSYCHOBIOLOGY, V21, P307; Benabdeslem K., 2006, CIT J COMPUTING; Bishop C. M, 2006, PATTERN RECOGNITION; Blankertz B, 2010, NEUROIMAGE, V51, P1303, DOI 10.1016/j.neuroimage.2010.03.022; Brouwer GJ, 2009, J NEUROSCI, V29, P13992, DOI 10.1523/JNEUROSCI.3577-09.2009; Brunner P, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/5/056013; Combrisson E, 2015, J NEUROSCI METH, V250, P126, DOI 10.1016/j.jneumeth.2015.01.010; DeHaan M., 2007, INFANT EEG EVENT REL; Doyle LMF, 2005, CLIN NEUROPHYSIOL, V116, P1879, DOI 10.1016/j.clinph.2005.03.017; Eimer M, 1996, ELECTROEN CLIN NEURO, V99, P225, DOI 10.1016/0013-4694(96)95711-9; EIMER M, 1993, ELECTROEN CLIN NEURO, V88, P408, DOI 10.1016/0168-5597(93)90017-J; FARWELL LA, 1988, ELECTROEN CLIN NEURO, V70, P510, DOI 10.1016/0013-4694(88)90149-6; Freeman J, 2011, NAT NEUROSCI, V14, P1195, DOI 10.1038/nn.2889; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; Hickey C, 2006, J COGNITIVE NEUROSCI, V18, P604, DOI 10.1162/jocn.2006.18.4.604; Huang C, 2002, INT J REMOTE SENS, V23, P725, DOI 10.1080/01431160110040323; Jolicoeur P, 2008, BRAIN RES, V1215, P160, DOI 10.1016/j.brainres.2008.03.059; Jonides J., 1981, VOLUNTARY VERSUS AUT; Kaper M, 2004, IEEE T BIO-MED ENG, V51, P1073, DOI 10.1109/TBME.2004.826698; Kiss M, 2008, PSYCHOPHYSIOLOGY, V45, P1013, DOI 10.1111/j.1469-8986.2008.00700.x; Klaver P, 1999, NEUROREPORT, V10, P2001, DOI 10.1097/00001756-199907130-00002; Krusienski DJ, 2008, J NEUROSCI METH, V167, P15, DOI 10.1016/j.jneumeth.2007.07.017; Krusienski DJ, 2006, J NEURAL ENG, V3, P299, DOI 10.1088/1741-2560/3/4/007; Lajnef T, 2015, J NEUROSCI METH, V250, P94, DOI 10.1016/j.jneumeth.2015.01.022; Leblanc E, 2008, J COGNITIVE NEUROSCI, V20, P657, DOI 10.1162/jocn.2008.20051; Lotte F, 2007, J NEURAL ENG, V4, pR1, DOI 10.1088/1741-2560/4/2/R01; LUCK SJ, 1994, J EXP PSYCHOL HUMAN, V20, P1000, DOI 10.1037/0096-1523.20.5.1000; Luck SJ, 2014, INTRODUCTION TO THE EVENT-RELATED POTENTIAL TECHNIQUE, 2ND EDITION, P1; Madzarov G, 2009, INFORMATICA; MANGUN GR, 1995, PSYCHOPHYSIOLOGY, V32, P4, DOI 10.1111/j.1469-8986.1995.tb03400.x; McCollough AW, 2007, CORTEX, V43, P77, DOI 10.1016/S0010-9452(08)70447-7; Melgani F, 2004, IEEE T GEOSCI REMOTE, V42, P1778, DOI 10.1109/TGRS.2004.831865; Muller KR, 2008, J NEUROSCI METH, V167, P82, DOI 10.1016/j.jneumeth.2007.09.022; MULLER HJ, 1989, J EXP PSYCHOL HUMAN, V15, P315, DOI 10.1037/0096-1523.15.2.315; Perron R, 2009, PSYCHOL RES-PSYCH FO, V73, P222, DOI 10.1007/s00426-008-0214-y; Picton TW, 2000, PSYCHOPHYSIOLOGY, V37, P127, DOI 10.1111/1469-8986.3720127; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; Predovan D, 2009, PSYCHOPHYSIOLOGY, V46, P191, DOI 10.1111/j.1469-8986.2008.00753.x; Serences JT, 2012, J VISION, V12, P126, DOI [10.1167/12.9.126, DOI 10.1167/12.9.126]; Sharbrough F, 1991, J CLIN NEUROPHYSIOL; Takahashi F, 2002, ICONIP'02: PROCEEDINGS OF THE 9TH INTERNATIONAL CONFERENCE ON NEURAL INFORMATION PROCESSING, P1418; Theodoridis S, 2009, PATTERN RECOGNITION, 4RTH EDITION, P1; van Gerven M, 2009, J NEUROSCI METH, V179, P78, DOI 10.1016/j.jneumeth.2009.01.016; Vogel EK, 2004, NATURE, V428, P748, DOI 10.1038/nature02447; Woodman GF, 2003, PSYCHOL SCI, V14, P605, DOI 10.1046/j.0956-7976.2003.psci_1472.x	47	7	7	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2016	11	8							e0160304	10.1371/journal.pone.0160304	http://dx.doi.org/10.1371/journal.pone.0160304			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4UN	27529476	Green Submitted, gold, Green Published			2022-12-27	WOS:000381476700005
J	Xie, SS; Spelmink, L; Codemo, M; Subramanian, K; Putsep, K; Henriques-Normark, B; Olliver, M				Xie, Shanshan; Spelmink, Laura; Codemo, Mario; Subramanian, Karthik; Putsep, Katrin; Henriques-Normark, Birgitta; Olliver, Marie			Cinobufagin Modulates Human Innate Immune Responses and Triggers Antibacterial Activity	PLOS ONE			English	Article							STREPTOCOCCUS-PNEUMONIAE INFECTION; PLASMACYTOID DENDRITIC CELLS; GINGIVAL EPITHELIAL-CELLS; PROSTATE-CANCER CELLS; NF-KAPPA-B; HUMAN BETA-DEFENSIN-2; ANTIMICROBIAL PEPTIDES; PROTECTIVE IMMUNITY; HUMAN-NEUTROPHILS; HOST-DEFENSE	The traditional Chinese medicine Chan-Su is widely used for treatment of cancer and cardiovascular diseases, but also as a remedy for infections such as furunculosis, tonsillitis and acute pharyngitis. The clinical use of Chan-Su suggests that it has anti-infective effects, however, the mechanism of action is incompletely understood. In particular, the effect on the human immune system is poorly defined. Here, we describe previously unrecognized immunomodulatory activities of cinobufagin (CBG), a major bioactive component of ChanSu. Using human monocyte-derived dendritic cells (DCs), we show that LPS-induced maturation and production of a number of cytokines was potently inhibited by CBG, which also had a pro-apoptotic effect, associated with activation of caspase-3. Interestingly, CBG triggered caspase-1 activation and significantly enhanced IL-1 beta production in LPS-stimulated cells. Finally, we demonstrate that CBG upregulates gene expression of the antimicrobial peptides (AMPs) hBD-2 and hBD-3 in DCs, and induces secretion of HNP1-3 and hCAP-18/LL-37 from neutrophils, potentiating neutrophil antibacterial activity. Taken together, our data indicate that CBG modulates the inflammatory phenotype of DCs in response to LPS, and triggers an antibacterial innate immune response, thus proposing possible mechanisms for the clinical effects of Chan-Su in anti-infective therapy.	[Xie, Shanshan; Spelmink, Laura; Codemo, Mario; Subramanian, Karthik; Putsep, Katrin; Henriques-Normark, Birgitta; Olliver, Marie] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, SE-17177 Stockholm, Sweden; [Xie, Shanshan] Jilin Univ, Dept Clin Vet Med, Coll Vet Med, Changchun, Jilin, Peoples R China; [Henriques-Normark, Birgitta] Karolinska Univ Hosp, Dept Clin Microbiol, SE-17176 Stockholm, Sweden	Karolinska Institutet; Jilin University; Karolinska Institutet; Karolinska University Hospital	Henriques-Normark, B (corresponding author), Karolinska Inst, Dept Microbiol Tumor & Cell Biol, SE-17177 Stockholm, Sweden.; Henriques-Normark, B (corresponding author), Karolinska Univ Hosp, Dept Clin Microbiol, SE-17176 Stockholm, Sweden.	birgitta.henriques@ki.se	Subramanian, Karthik/N-3587-2019; xie, shanshan/GSM-8999-2022	Subramanian, Karthik/0000-0002-4381-5037; Olliver, Marie/0000-0003-4115-2716	Swedish Research Council; Knut and Alice Wallenberg Foundation; Swedish Foundation for Strategic research; ALF-grant from Stockholm City Council; EU commission EIMID-ITN Project; China Scholarship Council	Swedish Research Council(Swedish Research CouncilEuropean Commission); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Swedish Foundation for Strategic research(Swedish Foundation for Strategic Research); ALF-grant from Stockholm City Council; EU commission EIMID-ITN Project; China Scholarship Council(China Scholarship Council)	Financial support was received from the Swedish Research Council www.vr.se (BHN), Knut and Alice Wallenberg Foundation www.wallenberg.com/kaw (BHN), the Swedish Foundation for Strategic research www.stratresearch.se (BHN), ALF-grant from Stockholm City Council (BHN), the EU commission EIMID-ITN Project (BHN), and by China Scholarship Council (SX). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ardeshna KM, 2000, BLOOD, V96, P1039, DOI 10.1182/blood.V96.3.1039.015k04_1039_1046; Ayabe T, 2000, NAT IMMUNOL, V1, P113, DOI 10.1038/77783; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Beiter K, 2006, CURR BIOL, V16, P401, DOI 10.1016/j.cub.2006.01.056; BENTWOOD BJ, 1980, J IMMUNOL, V124, P855; Bick RJ, 2002, LIFE SCI, V72, P699, DOI 10.1016/S0024-3205(02)02302-0; Biragyn A, 2002, SCIENCE, V298, P1025, DOI 10.1126/science.1075565; Broz P, 2010, CELL HOST MICROBE, V8, P471, DOI 10.1016/j.chom.2010.11.007; CHEN KK, 1967, J PHARM SCI-US, V56, P1535, DOI 10.1002/jps.2600561202; Chen QY, 2006, J IMMUNOL, V177, P6044, DOI 10.4049/jimmunol.177.9.6044; Clarke BT, 1997, BIOL REV, V72, P365, DOI 10.1017/S0006323197005045; Cookson BT, 2001, TRENDS MICROBIOL, V9, P113, DOI 10.1016/S0966-842X(00)01936-3; Dommisch H, 2012, J CLIN PERIODONTOL, V39, P913, DOI 10.1111/j.1600-051X.2012.01933.x; Fang RD, 2011, J IMMUNOL, V187, P4890, DOI 10.4049/jimmunol.1100381; Fernebro J, 2004, J INFECT DIS, V189, P328, DOI 10.1086/380564; Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180; Greer A, 2013, PERIODONTOL 2000, V63, P67, DOI 10.1111/prd.12028; Han GW, 2012, INT J BIOL SCI, V8, P228, DOI 10.7150/ijbs.8.228; Harder J, 2000, AM J RESP CELL MOL, V22, P714, DOI 10.1165/ajrcmb.22.6.4023; Horowitz MA, 2015, INT J NEUROPSYCHOPH, V18, DOI 10.1093/ijnp/pyu076; Kafka D, 2008, INT IMMUNOL, V20, P1139, DOI 10.1093/intimm/dxn071; Kanda N, 2007, AM J PHYSIOL-CELL PH, V293, pC1916, DOI 10.1152/ajpcell.00293.2007; Kim C, 2006, TRENDS MICROBIOL, V14, P428, DOI 10.1016/j.tim.2006.08.001; Krisanaprakornkit S, 1998, INFECT IMMUN, V66, P4222; Ku CL, 2007, J EXP MED, V204, P2407, DOI 10.1084/jem.20070628; Li C, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/849054; Lu CX, 2008, ANTI-CANCER DRUG, V19, P931, DOI 10.1097/CAD.0b013e3283139100; Meyer-Hoffert U, 2008, GUT, V57, P764, DOI 10.1136/gut.2007.141481; MORISHITA S, 1992, AM J CHINESE MED, V20, P245, DOI 10.1142/S0192415X92000254; Oppenheim JJ, 2005, CURR OPIN IMMUNOL, V17, P359, DOI 10.1016/j.coi.2005.06.002; Oppenheim JJ, 2007, ADV EXP MED BIOL, V601, P185; Prassas I, 2008, NAT REV DRUG DISCOV, V7, P926, DOI 10.1038/nrd2682; Qi FH, 2011, CANCER SCI, V102, P951, DOI 10.1111/j.1349-7006.2011.01900.x; Qi FH, 2010, BIOSCI TRENDS, V4, P297; Ren K, 2009, BRAIN RES REV, V60, P57, DOI 10.1016/j.brainresrev.2008.12.020; Rescigno M, 2001, NAT IMMUNOL, V2, P361, DOI 10.1038/86373; Ryan LK, 2011, J LEUKOCYTE BIOL, V90, P343, DOI 10.1189/jlb.0209079; Sheshachalam A, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00448; Stockinger S, 2014, J INNATE IMMUN, V6, P530, DOI 10.1159/000357644; TERRITO MC, 1989, J CLIN INVEST, V84, P2017, DOI 10.1172/JCI114394; Tettelin H, 2001, SCIENCE, V293, P498, DOI 10.1126/science.1061217; Tewary P, 2013, J IMMUNOL, V191, P865, DOI 10.4049/jimmunol.1201648; Tsutsumi-Ishii Y, 2003, J IMMUNOL, V170, P4226, DOI 10.4049/jimmunol.170.8.4226; van de Laar L, 2010, J IMMUNOL, V185, P7252, DOI 10.4049/jimmunol.1000672; Xie XF, 2013, MED HYPOTHESES, V81, P243, DOI 10.1016/j.mehy.2013.04.038; Yamamoto-Furusho JK, 2010, INFLAMM BOWEL DIS, V16, P736, DOI 10.1002/ibd.21144; Yang D, 2009, TRENDS IMMUNOL, V30, P531, DOI 10.1016/j.it.2009.07.004; Yang H, 2013, J INFECT DIS, V207, P50, DOI 10.1093/infdis/jis651; Ye Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep11685; Yeh JY, 2003, PROSTATE, V54, P112, DOI 10.1002/pros.10172; Yin L, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-37; Yu CH, 2008, CANCER SCI, V99, P2467, DOI 10.1111/j.1349-7006.2008.00966.x; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; Zwijnenburg PJG, 2003, J IMMUNOL, V170, P4724, DOI 10.4049/jimmunol.170.9.4724	54	11	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2016	11	8							e0160734	10.1371/journal.pone.0160734	http://dx.doi.org/10.1371/journal.pone.0160734			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4UN	27529866	Green Submitted, Green Published, gold			2022-12-27	WOS:000381476700019
J	Zweiker, D; Lambert, T; Steinwender, C; Weber, T; Suppan, M; Brussee, H; Koppelstatter, C; Kerschbaum, J; Watschinger, B; Hohenstein-Scheibenecker, K; Reindl-Schwaighofer, R; Sturmberger, T; Kindslehner, C; Weiss, TW; Rohla, M; Gruener, P; Maister, P; Auer, J; Dechant, C; Sykora, J; Krismer, C; Glaser, S; Zweiker, R				Zweiker, David; Lambert, Thomas; Steinwender, Clemens; Weber, Thomas; Suppan, Markus; Brussee, Helmut; Koppelstaetter, Christian; Kerschbaum, Julia; Watschinger, Bruno; Hohenstein-Scheibenecker, Katharina; Reindl-Schwaighofer, Roman; Sturmberger, Thomas; Kindslehner, Claudia; Weiss, Thomas Werner; Rohla, Miklos; Gruener, Peter; Maister, Petra; Auer, Johann; Dechant, Cornelia; Sykora, Josef; Krismer, Christoph; Glaser, Stefan; Zweiker, Robert			Effects of Renal Denervation Documented in the Austrian National Multicentre Renal Denervation Registry	PLOS ONE			English	Article							BLOOD-PRESSURE CHANGES; RESISTANT HYPERTENSION; SYMPATHETIC DENERVATION; SYMPLICITY HTN-3; PROGNOSTIC VALUE; GUIDELINES; TRIAL; MANAGEMENT; STANDARD	Renal denervation (RDN) is a new procedure for treatment-resistant hypertensive patients. In order to monitor all procedures undergone in Austria, the Austrian Society of Hypertension established the investigator-initiated Austrian Transcatheter Renal Denervation (TREND) Registry. From April 2011 to September 2014, 407 procedures in 14 Austrian centres were recorded. At baseline, office and mean 24-h ambulatory blood pressure (ABP) were 171/94 and 151/89 mmHg, respectively, and patients were taking a median of 4 antihypertensive medications. Mean 24-h ABP changes after 2-6 weeks, 3, 6 and 12 months were -11/-6, -8/-4, -8/-5 and -10/-6 mmHg (p< 0.05 at all measurements), respectively. The periprocedural complication rate was 2.5%. Incidence of long-term complications during follow-up (median 1 year) was 0.5%. Office BP and ABP responses showed only a weak correlation (Pearson coefficient 0.303). Based on the data from the TREND registry, ambulatory blood pressure monitoring in addition to office BP should be used for patient selection as well as for monitoring response to RDN. Furthermore, criteria for optimal patient selection are suggested.	[Zweiker, David; Brussee, Helmut; Zweiker, Robert] Med Univ Graz, Dept Internal Med, Div Cardiol, Graz, Austria; [Lambert, Thomas; Steinwender, Clemens] Kepler Univ Hosp, Dept Internal Med 1, Linz, Austria; [Weber, Thomas; Suppan, Markus] Klinikum Wels Grieskirchen, Dept Internal Med 2, Wels, Austria; [Koppelstaetter, Christian] Med Univ Innsbruck, Dept Internal Med 3, Innsbruck, Austria; [Kerschbaum, Julia] Med Univ Innsbruck, Dept Internal Med 4, Innsbruck, Austria; [Watschinger, Bruno; Hohenstein-Scheibenecker, Katharina; Reindl-Schwaighofer, Roman] Med Univ Vienna, Dept Internal Med 3, Div Nephrol, Vienna, Austria; [Reindl-Schwaighofer, Roman; Sturmberger, Thomas] Krankenhaus Elisabethinen Linz, Dept Internal Med 2, Linz, Austria; [Kindslehner, Claudia] Landeskrankenhaus Waidhofen Ybbs, Dept Internal Med, Waidhofen Ybbs, Austria; [Weiss, Thomas Werner; Rohla, Miklos] Sigmund Freud Univ, Wilhelminenspital & Med Fac, Dept Internal Med 3, Vienna, Austria; [Weiss, Thomas Werner] Sigmund Freud Univ, Fac Med, Vienna, Austria; [Steinwender, Clemens; Gruener, Peter] Paracelsus Med Univ Salzburg, Dept Internal Med 2, Salzburg, Austria; [Maister, Petra; Auer, Johann] Krankenhaus St Josef Braunau, Dept Internal Med 1, Braunau, Austria; [Dechant, Cornelia] Kaiser Franz Josef Spital, Med Dept 5, Vienna, Austria; [Sykora, Josef] Privatklin Mariahilf, Dept Internal Med, Klagenfurt, Austria; [Krismer, Christoph] Krankenhaus St Vinzenz, Dept Internal Med, Zams, Austria; [Glaser, Stefan] Landesklinikum Wiener Neustadt, Dept Internal Med 2, Wiener Neustadt, Austria	Medical University of Graz; Kepler University Hospital; Medical University of Innsbruck; Medical University of Innsbruck; Medical University of Vienna; Ordensklinikum Linz Elisabethinen; Paracelsus Private Medical University; Kaiser-Franz-Josef Hospital	Zweiker, D (corresponding author), Med Univ Graz, Dept Internal Med, Div Cardiol, Graz, Austria.	david.zweiker@medunigraz.at	Zweiker, David/W-3375-2019; Auer, Johann/AAJ-6895-2021	Zweiker, David/0000-0002-7479-7767; Rohla, Miklos/0000-0002-8967-0806	Austrian Society of Hypertension	Austrian Society of Hypertension	The Austrian Society of Hypertension funded this registry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], J HYPERTONIE; Azizi M, 2015, LANCET, V385, P1957, DOI 10.1016/S0140-6736(14)61942-5; Bakris GL, 2014, J AM COLL CARDIOL, V64, P1071, DOI 10.1016/j.jacc.2014.05.012; Bhatt DL, 2014, NEW ENGL J MED, V370, P1393, DOI 10.1056/NEJMoa1402670; Bohm M, 2015, HYPERTENSION, V65, P766, DOI 10.1161/HYPERTENSIONAHA.114.05010; Clement DL, 2003, NEW ENGL J MED, V348, P2407, DOI 10.1056/NEJMoa022273; Daemen J, 2013, EUROINTERVENTION, V9, pR75, DOI 10.4244/EIJV9SRA13; Daugherty SL, 2012, CIRCULATION, V125, P1635, DOI 10.1161/CIRCULATIONAHA.111.068064; Elmula FEMF, 2014, HYPERTENSION, V63, P991, DOI 10.1161/HYPERTENSIONAHA.114.03246; Esler MD, 2014, EUR HEART J, V35, P1752, DOI 10.1093/eurheartj/ehu209; Esler MD, 2012, CIRCULATION, V126, P2976, DOI 10.1161/CIRCULATIONAHA.112.130880; Esler MD, 2010, LANCET, V376, P1903, DOI 10.1016/S0140-6736(10)62039-9; Ewen S, 2015, CLIN RES CARDIOL, V104, P1097, DOI 10.1007/s00392-015-0905-5; Ewen S, 2015, HYPERTENSION, V65, P193, DOI 10.1161/HYPERTENSIONAHA.114.04336; Gitt AK, 2010, EUR HEART J, V31, P525, DOI 10.1093/eurheartj/ehp596; Gu YM, 2012, SWISS MED WKLY, V142, DOI 10.4414/smw.2012.13638; Head GA, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1104; Kandzari DE, 2015, EUR HEART J, V36, P219, DOI 10.1093/eurheartj/ehu441; KRAUSE T, 2011, BRIT MED J, V343, DOI DOI 10.1136/BMJ.D4891; Krum H, 2014, LANCET, V383, P622, DOI 10.1016/S0140-6736(13)62192-3; Krum H, 2009, LANCET, V373, P1275, DOI 10.1016/S0140-6736(09)60566-3; Lambert T, 2014, CLIN CARDIOL, V37, P307, DOI 10.1002/clc.22269; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Mahfoud F, 2015, EUR HEART J, V36, P2219, DOI 10.1093/eurheartj/ehv192; Mahfoud F, 2013, CIRCULATION, V128, P132, DOI 10.1161/CIRCULATIONAHA.112.000949; Mancia G, 2007, EUR HEART J, V28, P1462, DOI [10.1093/eurheartj/eht151, 10.1093/eurheartj/ehm236]; Myers MG, 2012, J HYPERTENS, V30, P1894, DOI 10.1097/HJH.0b013e3283577b05; Ott C, 2015, EUROINTERVENTION, V11, P110, DOI 10.4244/EIJV11I1A19; Ott C, 2015, J HYPERTENS, V33, P1261, DOI 10.1097/HJH.0000000000000556; Parati G, 2014, J HYPERTENS, V32, P1359, DOI 10.1097/HJH.0000000000000221; Persu A, 2014, J HUM HYPERTENS, V28, P150, DOI 10.1038/jhh.2013.88; Persu A, 2014, J HYPERTENS, V32, P2101, DOI 10.1097/HJH.0000000000000323; Persu A, 2014, CURR HYPERTENS REP, V16, DOI 10.1007/s11906-014-0460-x; Persu A, 2012, HYPERTENSION, V60, P596, DOI 10.1161/HYPERTENSIONAHA.112.195263; Raphael Claire E, 2014, Clin Med (Lond), V14 Suppl 6, ps38, DOI 10.7861/clinmedicine.14-6-s38; Redon J, 1998, HYPERTENSION, V31, P712, DOI 10.1161/01.HYP.31.2.712; Sadowski J, 2011, HYPERTENSION, V57, P911, DOI 10.1161/HYPERTENSIONAHA.110.163014; Schmieder RE, 2013, EUROINTERVENTION, V9, pR58, DOI 10.4244/EIJV9SRA11; SPRINT Research Group, 2015, N Engl J Med, V373, P2103, DOI 10.1056/NEJMoa1511939; Stergiou GS, 2002, AM J HYPERTENS, V15, P101, DOI 10.1016/S0895-7061(01)02324-X; Vink EE, 2014, J HYPERTENS, V32, P2045, DOI 10.1097/HJH.0000000000000282; Weber T, 2014, J HYPERTON, V18, P54; Weber T, 2012, WIEN KLIN WOCHENSCHR, V124, P789, DOI 10.1007/s00508-012-0257-3; Worthley SG, 2013, EUR HEART J, V34, P2132, DOI 10.1093/eurheartj/eht197; Zuern CS, 2013, J AM COLL CARDIOL, V62, P2124, DOI 10.1016/j.jacc.2013.07.046; Zweiker R, 2012, J HYPERTON, V16, P18	46	12	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2016	11	8							e0161250	10.1371/journal.pone.0161250	http://dx.doi.org/10.1371/journal.pone.0161250			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4UN	27529426	Green Submitted, Green Published, gold			2022-12-27	WOS:000381476700058
J	Ikeda, K; Shiraishi, K; Yoshida, A; Shinchi, Y; Sanada, M; Motooka, Y; Fujino, K; Mori, T; Suzuki, M				Ikeda, Koei; Shiraishi, Kenji; Yoshida, Ayaka; Shinchi, Yusuke; Sanada, Mune; Motooka, Yamato; Fujino, Kosuke; Mori, Takeshi; Suzuki, Makoto			Synchronous Multiple Lung Adenocarcinomas: Estrogen Concentration in Peripheral Lung	PLOS ONE			English	Article							CANCER; EXPRESSION; CARCINOMA; AROMATASE; MUTATIONS; WOMEN; RISK	Background The detection rate of synchronous multiple lung adenocarcinomas (SMLA), which display multiple ground glass opacity nodules in the peripheral lung, is increasing due to advances in high resolution computed tomography. The backgrounds of multicentric development of adenocarcinoma are unknown. In this study, we quantitated estrogen concentration in the peripheral lungs of postmenopausal female patients with SMLA. Methods The tissue concentration of estrogens (estrone [E1] and estdadiol [E2]) in the noncancerous peripheral lung were measured with liquid chromatography/electrospray tandem mass spectrometry in postmenopausal female patients with lung adenocarcinoma. The expression levels of CYP19A1 in the normal lung were also quantitated with real-time PCR. Thirty patients with SMLA and 79 cases of control patients with single lung adenocarcinoma were analyzed. Results The concentrations of E1 and E2 in the noncancerous tissue were significantly higher in SMLA cases than control cases (P = 0.004 and P = 0.02, respectively). The minor allele (A) of single nucleotide polymorphism rs3764221 were significantly associated with higher concentration of E1 and E2 (P = 0.002 and P = 0.01, respectively) and higher CYP19A1 mRNA expression (P = 0.03). Conclusion The tissue estrogen concentration of peripheral lung was significantly higher in SMLA than control cases. The high concentration of estrogen may be one of the causes of multicentric development of peripheral lung adenocarcinomas.	[Ikeda, Koei; Shiraishi, Kenji; Yoshida, Ayaka; Shinchi, Yusuke; Sanada, Mune; Motooka, Yamato; Fujino, Kosuke; Mori, Takeshi; Suzuki, Makoto] Kumamoto Univ, Grad Sch Med Sci, Dept Thorac Surg, 1-1-1 Honjo, Kumamoto 8608556, Japan	Kumamoto University	Ikeda, K (corresponding author), Kumamoto Univ, Grad Sch Med Sci, Dept Thorac Surg, 1-1-1 Honjo, Kumamoto 8608556, Japan.	koei@cg7.so-net.ne.jp	Suzuki, Makoto/AAE-5248-2020		Ministry of Education, Science, Sports, Culture and Technology of Japan [23592069, 24592096]; Smoking Research Foundation	Ministry of Education, Science, Sports, Culture and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Smoking Research Foundation	This study was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Science, Sports, Culture and Technology of Japan (23592069) (24592096) and by a grant from the Smoking Research Foundation (2012-2015). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Science, Sports, Culture and Technology of Japan (23592069) (24592096) and by a grant from the Smoking Research Foundation (2012-2015). We thank ASKA Pharma Medical (Kawasaki, Japan) for the skillful technical assistance.	BARSKY SH, 1994, MODERN PATHOL, V7, P633; Bouchardy C, 2011, CANCER-AM CANCER SOC, V117, P1288, DOI 10.1002/cncr.25638; Chlebowski RT, 2009, LANCET, V374, P1243, DOI 10.1016/S0140-6736(09)61526-9; Clague J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103735; GUINEE DG, 1995, CARCINOGENESIS, V16, P993, DOI 10.1093/carcin/16.5.993; Hammoud Z, 2008, ENDOCR-RELAT CANCER, V15, P475, DOI 10.1677/ERC-08-0002; Ikeda K, 2008, J THORAC ONCOL, V3, P467, DOI 10.1097/JTO.0b013e31816b4b14; Ikeda K, 2014, ANN SURG ONCOL, V21, P939, DOI 10.1245/s10434-013-3362-2; Kim HK, 2010, J THORAC ONCOL, V5, P206, DOI 10.1097/JTO.0b013e3181c422be; Koutras A, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-109; Marquez-Garban DC, 2009, ANN NY ACAD SCI, V1155, P194, DOI 10.1111/j.1749-6632.2009.04116.x; MARTINI N, 1975, J THORAC CARDIOV SUR, V70, P606; Niikawa H, 2008, CLIN CANCER RES, V14, P4417, DOI 10.1158/1078-0432.CCR-07-1950; Omoto Y, 2001, BIOCHEM BIOPH RES CO, V285, P340, DOI 10.1006/bbrc.2001.5158; Pesatori AC, 2013, INT J CANCER, V132, P2630, DOI 10.1002/ijc.27926; Shen H, 2010, BIOMED PHARMACOTHER, V64, P88, DOI 10.1016/j.biopha.2009.06.010; Taniuchi S, 2014, MOL CELL ENDOCRINOL, V392, P136, DOI 10.1016/j.mce.2014.05.016; Toyoda Y, 2008, JPN J CLIN ONCOL, V38, P534, DOI 10.1093/jjco/hyn072; Travis WD, 2013, ARCH PATHOL LAB MED, V137, P668, DOI 10.5858/arpa.2012-0263-RA; Traynor AM, 2009, LUNG CANCER, V64, P51, DOI 10.1016/j.lungcan.2008.07.002; Wang HZ, 2009, ENDOCRINOLOGY, V150, P3301, DOI 10.1210/en.2008-1812; Zang EA, 1996, JNCI-J NATL CANCER I, V88, P183, DOI 10.1093/jnci/88.3-4.183	22	10	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2016	11	8							e0160910	10.1371/journal.pone.0160910	http://dx.doi.org/10.1371/journal.pone.0160910			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4SL	27526096	gold, Green Published, Green Submitted			2022-12-27	WOS:000381471100026
J	Ng-Sueng, LF; Vargas-Matos, I; Mayta-Tristan, P; Pereyra-Elias, R; Montenegro-Idrogo, JJ; Inga-Berrospi, F; Ancalli, F; Bonilla-Escobar, F; Diaz-Velez, C; Gutierrez-Quezada, E; Gomez-Alhach, J; Munoz-Medina, CE; Sanchez-Pozo, A; Vidal, M				Fernando Ng-Sueng, Luis; Vargas-Matos, Ivan; Mayta-Tristan, Percy; Pereyra-Elias, Renee; Jose Montenegro-Idrogo, Juan; Inga-Berrospi, Fiorella; Ancalli, Felix; Bonilla-Escobar, Francisco; Diaz-Velez, Cristian; Gutierrez-Quezada, Erick; Gomez-Alhach, Jennifer; Munoz-Medina, Carlos E.; Sanchez-Pozo, Adriana; Vidal, Milisen		Red LIRHUS	Gender Associated with the Intention to Choose a Medical Specialty in Medical Students: A Cross-Sectional Study in 11 Countries in Latin America	PLOS ONE			English	Article							CAREER CHOICE; FEMALE PHYSICIANS; HEALTH-CARE; WOMEN; SURGERY; TRENDS; IMPACT; SCHOOL; PREFERENCES; FEMINIZATION	Introduction The selection of a medical specialty has been associated with multiple factors, such as personal preferences, academic exposure, motivational factors and sociodemographic factors, such as gender. The number of women in the medical field has increased in recent years. In Latin America, we have not found any studies that explore this relationship. Objective To determine whether there is an association between gender and the intention to choose a medical specialty in medical students from 11 countries in Latin America. Methods Secondary analysis of the Collaborative Working Group for the Research of Human Resources for Health (Red-LIRHUS) data; a multi-country project of students in their first year and fifth year of study, from 63 medical schools in 11 Latin American countries. All students who referred intention to choose a certain medical specialty were considered as participants. Results Of the 11073 surveyed students, 9235 indicated the name of a specific specialty. The specialties chosen most often in the fifth year were General Surgery (13.0%), Pediatrics (11.0%), Internal Medicine (10.3%) and Obstetrics/Gynecology (9.0%). For women, the top choices were Pediatrics (15.8%), Obstetrics/Gynecology (11.0%), Cardiology (8.7%), General Surgery (8.6%), and Oncology (6.4%). In the adjusted analysis, the female gender was associated with the choice of Obstetrics/Gynecology (RP: 2.75; IC95%: 2.24-3.39); Pediatric Surgery (RP: 2.19; IC95%: 1.19-4.00), Dermatology (RP: 1.91; IC95%: 1.24-2.93), Pediatrics (RP: 1.83; IC95%: 1.56-2.17), and Oncology (RP: 1.37; IC95%: 1.10-1.71). Conclusions There is an association between the female gender and the intention to choose Obstetrics/ Gynecology, Pediatrics, Pediatric Surgery, Dermatology, and Oncology. We recommend conducting studies that consider other factors that can influence the choice of a medical specialty.	[Fernando Ng-Sueng, Luis; Vargas-Matos, Ivan; Mayta-Tristan, Percy; Pereyra-Elias, Renee] Univ Peruana Ciencias Aplicadas, Escuela Med, Lima, Peru; [Fernando Ng-Sueng, Luis] Soc Cient Estudiantes Med UPC, Lima, Peru; [Jose Montenegro-Idrogo, Juan; Inga-Berrospi, Fiorella] Univ Nacl Mayor San Marcos, Lima, Peru; [Ancalli, Felix] Univ Nacl Jorge Basadre Grohmann, Tacna, Peru; [Bonilla-Escobar, Francisco] Univ Valle, Escuela Salud Publ, Inst Cisalva, Cali, Colombia; [Diaz-Velez, Cristian] Univ San Martin de Porres, Chiclayo, Peru; [Gutierrez-Quezada, Erick] Univ Autonoma Nayarit, Tepic, Nayarit, Mexico; [Gomez-Alhach, Jennifer] Univ San Martin Cali, Cali, Colombia; [Munoz-Medina, Carlos E.] Univ Oriente Nucl Bolivar, Ciudad Bolivar, Venezuela; [Sanchez-Pozo, Adriana] Univ Nuestra Senora La Paz, La Paz, Bolivia; [Vidal, Milisen] Univ Concepcion, Concepcion, Chile	Universidad Peruana de Ciencias Aplicadas (UPC); Universidad Nacional Mayor de San Marcos; Universidad Nacional Jorge Basadre Grohmann; Universidad del Valle; Universidad de San Martin de Porres; Universidad de Concepcion	Mayta-Tristan, P (corresponding author), Univ Peruana Ciencias Aplicadas, Escuela Med, Lima, Peru.	percy.mayta@upc.edu.pe	Mayta-Tristan, Percy/D-8587-2011; Inga-Berrospi, Fiorella/AAB-1293-2020; Moya, Geovanna/H-5601-2017; Montenegro-Idrogo, Juan José/AAT-9476-2021; Bonilla-Escobar, Francisco Javier/AAK-8367-2020; Pereyra-Elías, Reneé/AAP-5975-2021; Díaz-Vélez, Cristian/A-7675-2016; moreno-loaiza, oscar oml/L-3959-2016	Mayta-Tristan, Percy/0000-0002-0861-6606; Inga-Berrospi, Fiorella/0000-0002-9778-1557; Moya, Geovanna/0000-0003-1555-7904; Montenegro-Idrogo, Juan José/0000-0002-3874-1432; Bonilla-Escobar, Francisco Javier/0000-0002-0224-3482; Díaz-Vélez, Cristian/0000-0003-4593-2509; moreno-loaiza, oscar oml/0000-0001-6675-6562; daSilva-deAbreu, Adrian/0000-0002-6739-5946; Mogollon Correa, Cesar Alonso/0000-0003-3155-6020; Ng-Sueng, Luis Fernando/0000-0001-9835-2669				Adams TL, 2010, SOCIOL COMPASS, V4, P454, DOI 10.1111/j.1751-9020.2010.00294.x; Ahmed SMM, 2011, ADV MED EDUC PRACT, V2, P51, DOI 10.2147/AMEP.S13451; Are C, 2011, AM J SURG, V202, P352, DOI 10.1016/j.amjsurg.2010.08.007; Arrizabalaga P, 2014, GAC SANIT, V28, P363, DOI 10.1016/j.gaceta.2014.03.014; Arrizabalaga P, 2009, MED CLIN-BARCELONA, V133, P184, DOI 10.1016/j.medcli.2009.01.027; Astor A, 2005, SOC SCI MED, V61, P2492, DOI 10.1016/j.socscimed.2005.05.003; Azizzadeh Ali, 2003, Curr Surg, V60, P210, DOI 10.1016/S0149-7944(02)00679-7; Baecher-Lind L, 2012, OBSTET GYNECOL, V120, P1415, DOI [10.1097/AOG.0b013e318275679d, http://10.1097/AOG.0b013e318275679d]; Barzansky Barbara, 2013, JAMA, V310, P2319, DOI 10.1001/jama.2013.278345; Baxter N, 1996, AM J SURG, V172, P373, DOI 10.1016/S0002-9610(96)00185-7; Bedoya R., 2015, THESIS; Bittaye M, 2012, BMC MED EDUC, V12, DOI 10.1186/1472-6920-12-72; Boulis AK, 2008, CHANGING FACE MED WO; Boyle E, 2013, IRISH J MED SCI, V182, P337, DOI 10.1007/s11845-012-0882-x; Burton KR, 2004, CAN MED ASSOC J, V170, P1385, DOI 10.1503/cmaj.1040354; Chang PY, 2006, J FORMOS MED ASSOC, V105, P489, DOI 10.1016/S0929-6646(09)60189-3; Cooper RA, 2003, ACAD MED, V78, P855, DOI 10.1097/00001888-200309000-00003; Corona T, 2014, MUJER SALUD MEXICO; Coulston C, 2012, PSYCHIAT RES, V200, P457, DOI 10.1016/j.psychres.2012.06.019; Creed PA, 2010, SOC SCI MED, V71, P1084, DOI 10.1016/j.socscimed.2010.06.027; Deedar-Ali-Khawaja R, 2010, J SURG EDUC, V67, P237, DOI 10.1016/j.jsurg.2010.05.006; Dhalla IA, 2002, CAN MED ASSOC J, V166, P1029; Diderichsen S, 2013, BMC MED EDUC, V13, DOI 10.1186/1472-6920-13-39; Elston MA, 2009, WOMEN MED FUTURE; Evers A, 2014, PSYCHOL WOMEN QUART, V38, P93, DOI 10.1177/0361684313498071; Ferrinho P, 2011, HUM RESOUR HEALTH, V9, DOI 10.1186/1478-4491-9-9; Fukuda Y, 2010, BMC MED EDUC, V10, DOI 10.1186/1472-6920-10-15; Garcia JC, 1969, CARACTERISTICAS GEN; Gargiulo DA, 2006, ARCH SURG-CHICAGO, V141, P405, DOI 10.1001/archsurg.141.4.405; Gibis B, 2012, DTSCH ARZTEBL INT, V109, P327, DOI 10.3238/arztebl.2012.0327; Gill D, 2001, NEW ZEAL MED J, V114, P461; Girasek E, 2011, CENT EUR J MED, V6, P502, DOI 10.2478/s11536-011-0034-0; Haklai Z, 2013, ISR J HEALTH POLICY, V2, DOI 10.1186/2045-4015-2-37; Hall JA, 2002, PATIENT EDUC COUNS, V48, P217, DOI 10.1016/S0738-3991(02)00174-X; Harris JE, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002051; Heiligers PJM, 2012, BMC MED EDUC, V12, DOI 10.1186/1472-6920-12-82; Hojat M, 2002, AM J PSYCHIAT, V159, P1563, DOI 10.1176/appi.ajp.159.9.1563; Jeffrey J, 2011, FAM MED, V43, P21; Jena AB, 2016, JAMA INTERN MED, V176, P1294, DOI 10.1001/jamainternmed.2016.3284; Khader Y, 2008, BMC MED EDUC, V8, DOI 10.1186/1472-6920-8-32; Kilminster S, 2007, MED EDUC, V41, P39, DOI 10.1111/j.1365-2929.2006.02645.x; Kiolbassa K, 2011, BMC FAM PRACT, V12, DOI 10.1186/1471-2296-12-25; Koike S, 2010, HEALTH POLICY, V98, P236, DOI 10.1016/j.healthpol.2010.06.021; Kumar R, 2011, NATL MED J INDIA, V24, P166; Lefevre JH, 2010, MED EDUC, V44, P603, DOI 10.1111/j.1365-2923.2010.03707.x; Levine RB, 2013, ACAD MED, V88, P527, DOI 10.1097/ACM.0b013e31828578bb; Mariolis Anargiros, 2007, BMC Med Educ, V7, P15; Masanet E, 2010, OBETS-REV CIENC SOC, V5, P243; Mayta-Tristan P, 2016, BMC RES NOT IN PRESS; Mehmood SI, 2012, MED TEACH, V34, pS51, DOI 10.3109/0142159X.2012.656753; Mullan F, 2005, NEW ENGL J MED, V353, P1810, DOI 10.1056/NEJMsa050004; Newton DA, 2003, JAMA-J AM MED ASSOC, V290, P1179, DOI 10.1001/jama.290.9.1179; Nieves M, 2006, MUJER EMPLEO REFORMA; Pamo-Reyna O., 2007, REV, V20, P109; Park J, 2005, AM J SURG, V190, P141, DOI 10.1016/j.amjsurg.2005.04.008; Pelley E, 2016, J CLIN ENDOCR METAB, V101, P16, DOI 10.1210/jc.2015-3436; Ranta M, 2002, J LARYNGOL OTOL, V116, P839, DOI 10.1258/00222150260293673; Riska E, 2011, MATURITAS, V68, P264, DOI 10.1016/j.maturitas.2010.09.010; Rosenblatt RA, 2005, ACAD MED, V80, P815, DOI 10.1097/00001888-200509000-00006; Ruiz F, 2009, RECURSOS HUMANOS SAL; Schnuth RL, 2003, AM J OBSTET GYNECOL, V189, P639, DOI 10.1067/S0002-9378(03)00886-X; SIERRA ESCALONA ROSAURA, 2005, CDC, V22, P47; Tomizawa Y, 2015, TOHOKU J EXP MED, V235, P97, DOI 10.1620/tjem.235.97; Weissman C, 2012, ISR J HEALTH POLICY, V1, DOI 10.1186/2045-4015-1-13; Wendel TM, 2003, SURGERY, V134, P591, DOI 10.1016/S0039-6060(03)00304-0; Willett Lisa L, 2015, Am J Med, V128, P659, DOI 10.1016/j.amjmed.2015.02.002; Williams GC, 1997, SOC SCI MED, V45, P1705, DOI 10.1016/S0277-9536(97)00103-2; Zevallos Leslie, 2011, Rev. perú. med. exp. salud publica, V28, P177, DOI 10.1590/s1726-46342011000200003	68	18	21	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2016	11	8							e0161000	10.1371/journal.pone.0161000	http://dx.doi.org/10.1371/journal.pone.0161000			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DT3LI	27519055	Green Submitted, gold, Green Published			2022-12-27	WOS:000381382100034
J	Paes, J; de Oliveira, L; Pereira, MG; David, I; Souza, GGL; Sobral, AP; Machado-Pinheiro, W; Mocaiber, I				Paes, Juliana; de Oliveira, Leticia; Pereira, Mirtes Garcia; David, Isabel; Leal Souza, Gabriela Guerra; Sobral, Ana Paula; Machado-Pinheiro, Walter; Mocaiber, Izabela			The Perception of Aversiveness of Surgical Procedure Pictures Is Modulated by Personal/Occupational Relevance	PLOS ONE			English	Article							INDIVIDUAL-DIFFERENCES; BRAIN REACTIVITY; EMOTION; EMPATHY; AMYGDALA; SAFETY; PAIN; STIMULI; STRESS; DANGER	It is well established that emotions are organized around two motivational systems: the defensive and the appetitive. Individual differences are relevant factors in emotional reactions, making them more flexible and less stereotyped. There is evidence that health professionals have lower emotional reactivity when viewing scenes of situations involving pain. The objective of this study was to investigate whether the rating of pictures of surgical procedure depends on their personal/occupational relevance. Fifty-two female Nursing (health discipline) and forty-eight Social Work (social science discipline) students participated in the experiment, which consisted of the presentation of 105 images of different categories (e.g., neutral, food), including 25 images of surgical procedure. Volunteers judged each picture according to its valence (pleasantness) and arousal using the Self-Assessment Manikin scale (dimensional approach). Additionally, the participants chose the word that best described what they felt while viewing each image (discrete emotion perspective). The average valence score for surgical procedure pictures for the Nursing group (M = 4.57; SD = 1.02) was higher than the score for the Social Work group (M = 3.31; SD = 1.05), indicating that Nursing students classified those images as less unpleasant than the Social Work students did. Additionally, the majority of Nursing students (65.4%) chose "neutral" as the word that best described what they felt while viewing the pictures. In the Social Work group, disgust (54.2%) was the emotion that was most frequently chosen. The evaluation of emotional stimuli differed according to the groups' personal/occupational relevance: Nursing students judged pictures of surgical procedure as less unpleasant than the Social Work students did, possibly reflecting an emotional regulation skill or some type of habituation that is critically relevant to their future professional work.	[Paes, Juliana; Machado-Pinheiro, Walter; Mocaiber, Izabela] Univ Fed Fluminense, Inst Humanities & Hlth, Dept Nat Sci, Lab Cognit Psychophysiol, Rio Das Ostras, RJ, Brazil; [Paes, Juliana; de Oliveira, Leticia; Pereira, Mirtes Garcia; David, Isabel] Univ Fed Fluminense, Inst Biomed, Dept Physiol & Pharmacol, Lab Neurophysiol Behav, Niteroi, RJ, Brazil; [Leal Souza, Gabriela Guerra] Univ Fed Ouro Preto, Dept Biol Sci, Psychophysiol Lab, Ouro Preto, MG, Brazil; [Sobral, Ana Paula] Univ Fed Fluminense, Inst Sci & Technol, Dept Engn, Rio Das Ostras, RJ, Brazil	Universidade Federal Fluminense; Universidade Federal Fluminense; Universidade Federal de Ouro Preto; Universidade Federal Fluminense	Mocaiber, I (corresponding author), Univ Fed Fluminense, Inst Humanities & Hlth, Dept Nat Sci, Lab Cognit Psychophysiol, Rio Das Ostras, RJ, Brazil.	izabelamocaiber@yahoo.com.br	David, Isabel A/I-6090-2012; Pereira, Mirtes Garcia/J-6222-2016; Souza, Gabriela Guerra Leal/AAY-1045-2021	David, Isabel A/0000-0003-3894-8043; Pereira, Mirtes Garcia/0000-0003-4682-223X; Oliveira, Leticia/0000-0002-8450-2264	Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) [E26/110.418/2012]; CNPq [442878/2014-8]; CAPES [88881.030326/2013-01]	Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This project was supported by Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) (E26/110.418/2012), CNPq (442878/2014-8) and CAPES (88881.030326/2013-01).	Alves RDS, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01514; Ap Dijksterhuis, 2002, EMOTION, V2, P203, DOI 10.1037/1528-3542.2.3.203; Barke Stahl J., 2001, J BEHAV THER EXP PSY, V43, P565; Barrett HC, 2006, PSYCHOL REV, V113, P628, DOI 10.1037/0033-295X.113.3.628; Bradley MM, 2001, EMOTION, V1, P276, DOI 10.1037//1528-3542.1.3.276; Bradley MM, 2009, PSYCHOPHYSIOLOGY, V46, P1, DOI 10.1111/j.1469-8986.2008.00702.x; BRADLEY MM, 1994, J BEHAV THER EXP PSY, V25, P49, DOI 10.1016/0005-7916(94)90063-9; DAVIS MH, 1983, J PERS SOC PSYCHOL, V44, P113, DOI 10.1037/0022-3514.44.1.113; Decety J, 2009, SOCIAL NEUROSCIENCE OF EMPATHY, P1; Decety J, 2010, NEUROIMAGE, V50, P1676, DOI 10.1016/j.neuroimage.2010.01.025; Drabant EM, 2009, BIOL PSYCHIAT, V65, P367, DOI 10.1016/j.biopsych.2008.09.007; Ekman Paul, 1972, NEBRASKA S MOTIVATIO, V19, P207, DOI DOI 10.1037/0022-3514.53.4.712; Erthal FS, 2005, COGN AFFECT BEHAV NE, V5, P388, DOI 10.3758/CABN.5.4.388; Fernandes O, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00632; Figley CR, 2002, J CLIN PSYCHOL, V58, P1433, DOI 10.1002/jclp.10090; Frijda N. H., 1986, EMOTIONS STUDIES EMO; Giuliani NR, 2011, BIOL PSYCHOL, V86, P379, DOI 10.1016/j.biopsycho.2010.11.010; Goubert L, 2005, PAIN, V118, P285, DOI 10.1016/j.pain.2005.10.025; Greenwald M. K., 1989, J PSYCHOPHYSIOL, V3, P51; Grissom N, 2009, NEUROBIOL LEARN MEM, V92, P215, DOI 10.1016/j.nlm.2008.07.001; Hojat M, 2009, ACAD MED, V84, P1182, DOI 10.1097/ACM.0b013e3181b17e55; Izard C. E., 1977, HUMAN EMOTIONS; Kashdan TB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090651; Lang P.J., 2008, A8 U FLOR; Lang P. J., 2005, INT AFFECTIVE PICTUR; Lang PJ, 2013, EMOT REV, V5, P230, DOI 10.1177/1754073913477511; Lang PJ, 1997, ATTENTION AND ORIENTING: SENSORY AND MOTIVATIONAL PROCESSES, P97; Lapate RC, 2012, J COGNITIVE NEUROSCI, V24, P148, DOI 10.1162/jocn_a_00125; Larson EB, 2005, JAMA-J AM MED ASSOC, V293, P1100, DOI 10.1001/jama.293.9.1100; Souza GGL, 2013, STRESS, V16, P377, DOI 10.3109/10253890.2013.767326; LEVENSON RW, 1992, J PERS SOC PSYCHOL, V63, P234, DOI 10.1037/0022-3514.63.2.234; Lobo I, 2014, BIOL PSYCHOL, V103, P233, DOI 10.1016/j.biopsycho.2014.09.002; Lohr JM, 2007, CLIN PSYCHOL REV, V27, P114, DOI 10.1016/j.cpr.2006.07.005; LUMLEY MA, 1992, BEHAV RES THER, V30, P425, DOI 10.1016/0005-7967(92)90026-D; Mocaiber I, 2011, NEUROSCIENCE, V193, P241, DOI 10.1016/j.neuroscience.2011.07.003; Mocaiber I, 2011, INT J PSYCHOPHYSIOL, V81, P299, DOI 10.1016/j.ijpsycho.2011.07.014; Mocaiber Izabela, 2009, Psychol. Neurosci., V2, P211, DOI 10.3922/j.psns.2009.2.014; Nascimento BEM, 2008, TOB CONTROL, V17, P405, DOI 10.1136/tc.2008.025643; Oliveira LAS, 2009, PSYCHOPHYSIOLOGY, V46, P870, DOI 10.1111/j.1469-8986.2009.00812.x; Oliveira L, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00364; Pereira MG, 2010, COGN AFFECT BEHAV NE, V10, P94, DOI 10.3758/CABN.10.1.94; Rogan MT, 2005, NEURON, V46, P309, DOI 10.1016/j.neuron.2005.02.017; ROZIN P, 1987, PSYCHOL REV, V94, P23, DOI 10.1037/0033-295X.94.1.23; Sabo Brenda M, 2006, Int J Nurs Pract, V12, P136, DOI 10.1111/j.1440-172X.2006.00562.x; Sanchez TA, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00107; Schneider IK, 2016, EMOTION, V16, P426, DOI 10.1037/emo0000164; SHAVER P, 1987, J PERS SOC PSYCHOL, V52, P1061, DOI 10.1037//0022-3514.52.6.1061; Sun YB, 2015, SCI REP-UK, V5, DOI 10.1038/srep16988; Tempesta D, 2010, BRAIN RES BULL, V82, P104, DOI 10.1016/j.brainresbull.2010.01.014; Tolin DF, 1997, BEHAV RES THER, V35, P949, DOI 10.1016/S0005-7967(97)00048-X; Tulsky J. A., 2008, RESULTS SCOPE TRIAL; Tybur JM, 2009, J PERS SOC PSYCHOL, V97, P103, DOI 10.1037/a0015474	52	7	7	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2016	11	8							e0160582	10.1371/journal.pone.0160582	http://dx.doi.org/10.1371/journal.pone.0160582			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DT3LI	27518897	Green Published, Green Submitted, gold			2022-12-27	WOS:000381382100019
J	Toljamo, A; Blande, D; Karenlampi, S; Kokko, H				Toljamo, Anna; Blande, Daniel; Karenlampi, Sirpa; Kokko, Harri			Reprogramming of Strawberry (Fragaria vesca) Root Transcriptome in Response to Phytophthora cactorum	PLOS ONE			English	Article							LECTIN RECEPTOR KINASES; CELL-WALL DEVELOPMENT; SALICYLIC-ACID; X ANANASSA; CROWN ROT; PLANT DEFENSE; ISOCHORISMATE SYNTHASE; AUXIN BIOSYNTHESIS; GENETIC-VARIATION; BOTRYTIS-CINEREA	Crown rot (Phytophthora cactorum) causes significant economic losses in strawberry production. The best control strategy would be to use resistant cultivars, but polygenically inherited resistance makes the breeding of the garden strawberry (Fragaria x ananassa) challenging. The diploid wild strawberry Fragaria vesca Hawaii 4 genotype was shown previously to have resistance against crown rot. To explore the resistance mechanisms, we inoculated the roots of Hawaii 4 with P. cactorum in a novel in vitro hydroponic system to minimize interference caused by other microbes. Major reprogramming of the root transcriptome occurred, involving 30% of the genes. The surveillance system of the plant shifted from the development mode to the defense mode. Furthermore, the immune responses as well as many genes involved in the biosynthesis of the defense hormones jasmonic acid, ethylene and salicylic acid were up-regulated. Several major allergen-like genes encoding PR-10 proteins were highly expressed in the inoculated plants, suggesting that they also have a crucial role in the defense responses against P. cactorum. Additionally, flavonoids and terpenoids may be of vital importance, as several genes involved in their biosynthesis were up-regulated. The cell wall biosynthesis and developmental processes were downregulated, possibly as a result of the down-regulation of the key genes involved in the biosynthesis of growth-promoting hormones brassinosteroids and auxin. Of particular interest was the expression of potential resistance genes in the recently identified P. cactorum resistance locus RPc-1. These new findings help to target the breeding efforts aiming at more resistant strawberry cultivars.	[Toljamo, Anna; Blande, Daniel; Karenlampi, Sirpa; Kokko, Harri] Univ Eastern Finland, Dept Environm & Biol Sci, Kuopio, Finland	University of Eastern Finland	Toljamo, A; Kokko, H (corresponding author), Univ Eastern Finland, Dept Environm & Biol Sci, Kuopio, Finland.	anna.toljamo@uef.fi; harri.kokko@uef.fi			University of Eastern Finland	University of Eastern Finland	This research was supported by the strategic funding of the University of Eastern Finland (Innovative Research Initiatives). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal P, 2014, MOL BIOL REP, V41, P599, DOI 10.1007/s11033-013-2897-4; Albrecht C, 2012, P NATL ACAD SCI USA, V109, P303, DOI 10.1073/pnas.1109921108; Amil-Ruiz F, 2011, PLANT CELL PHYSIOL, V52, P1873, DOI 10.1093/pcp/pcr136; Antolin-Llovera M, 2014, CURR BIOL, V24, P422, DOI 10.1016/j.cub.2013.12.053; Augustin JM, 2011, PHYTOCHEMISTRY, V72, P435, DOI 10.1016/j.phytochem.2011.01.015; Belkhadir Y, 2012, P NATL ACAD SCI USA, V109, P297, DOI 10.1073/pnas.1112840108; Bhat RG, 2006, PLANT DIS, V90, P161, DOI 10.1094/PD-90-0161; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bourdais G, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005373; Bouwmeester K, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001327; Breitfellner F, 2002, EUR FOOD RES TECHNOL, V215, P28, DOI 10.1007/s00217-002-0536-8; Caarls L, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00170; Cano-Delgado A, 2003, PLANT J, V34, P351, DOI 10.1046/j.1365-313X.2003.01729.x; Casado-Diaz A, 2006, PHYSIOL PLANTARUM, V128, P633, DOI 10.1111/j.1399-3054.2006.00798.x; Casanal A, 2013, J BIOL CHEM, V288, P35322, DOI 10.1074/jbc.M113.501528; Chen XR, 2011, CURR GENET, V57, P297, DOI 10.1007/s00294-011-0348-0; Davik J, 2015, MOL BREEDING, V35, DOI 10.1007/s11032-015-0405-3; De Vleesschauwer D, 2012, PLANT PHYSIOL, V158, P1833, DOI 10.1104/pp.112.193672; Denance N, 2013, PLANT J, V73, P225, DOI 10.1111/tpj.12027; Ding XH, 2008, PLANT CELL, V20, P228, DOI 10.1105/tpc.107.055657; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Eikemo H, 2004, MYCOL RES, V108, P317, DOI 10.1017/S0953756204009244; Eikemo H, 2003, PLANT DIS, V87, P345, DOI 10.1094/PDIS.2003.87.4.345; Eikemo H, 2003, ANN APPL BIOL, V142, P83, DOI 10.1111/j.1744-7348.2003.tb00232.x; Eikemo H, 2000, ANN APPL BIOL, V137, P237, DOI 10.1111/j.1744-7348.2000.tb00064.x; Eikemo H, 2010, HORTSCIENCE, V45, P193, DOI 10.21273/HORTSCI.45.2.193; Eshraghi L, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-68; Fang XL, 2013, J PROTEOME RES, V12, P1772, DOI 10.1021/pr301117a; Feys BJ, 2005, PLANT CELL, V17, P2601, DOI 10.1105/tpc.105.033910; Glazebrook J, 2005, ANNU REV PHYTOPATHOL, V43, P205, DOI 10.1146/annurev.phyto.43.040204.135923; Gonzalez G, 2013, PHYSIOL MOL PLANT P, V82, P73, DOI 10.1016/j.pmpp.2013.02.001; Guidarelli M, 2011, PLANT PATHOL, V60, P685, DOI 10.1111/j.1365-3059.2010.02423.x; HAMM PB, 1991, PACIF FOR C, V331, P169; Hanhineva K, 2008, PHYTOCHEMISTRY, V69, P2463, DOI 10.1016/j.phytochem.2008.07.009; Hirai N, 2000, BIOSCI BIOTECH BIOCH, V64, P1707, DOI 10.1271/bbb.64.1707; Hok S, 2011, PLANT CELL ENVIRON, V34, P1944, DOI 10.1111/j.1365-3040.2011.02390.x; Hukkanen AT, 2007, J AGR FOOD CHEM, V55, P1862, DOI 10.1021/jf063452p; Huot B, 2014, MOL PLANT, V7, P1267, DOI 10.1093/mp/ssu049; Hussey SG, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-173; Jambagi S., 2015, TRANSCRIPTOMICS, V3, DOI [10.4172/2329-8936.1000106, DOI 10.4172/2329-8936.1000106]; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Karlund A, 2014, J AGR FOOD CHEM, V62, P4592, DOI 10.1021/jf405589f; Kazan K, 2009, TRENDS PLANT SCI, V14, P373, DOI 10.1016/j.tplants.2009.04.005; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kim YT, 2010, MOL BIOL REP, V37, P717, DOI 10.1007/s11033-009-9570-y; Kohorn Bruce D, 2015, Plant Signal Behav, V10, pe1035854, DOI 10.1080/15592324.2015.1035854; Koistinen KM, 2005, PHYTOCHEMISTRY, V66, P2524, DOI 10.1016/j.phytochem.2005.09.007; Koskinen P, 2015, BIOINFORMATICS, V31, P1544, DOI 10.1093/bioinformatics/btu851; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Le MH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102245; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Liu H, 2014, J INTEGR PLANT BIOL, V56, P350, DOI 10.1111/jipb.12150; Lorenzo O, 2003, PLANT CELL, V15, P165, DOI 10.1105/tpc.007468; Lozano-Duran R, 2015, TRENDS PLANT SCI, V20, P12, DOI 10.1016/j.tplants.2014.09.003; Maas JL, 1998, COMPENDIUM OF STRAWB; MacMillan CP, 2010, PLANT J, V62, P689, DOI 10.1111/j.1365-313X.2010.04181.x; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; MASHIGUCHI K, 2011, NATL ACAD SCI US, V108, P18512, DOI DOI 10.1073/PNAS.1108434108; Merchante C, 2013, CURR OPIN PLANT BIOL, V16, P554, DOI 10.1016/j.pbi.2013.08.001; Mewalal R, 2014, PLANT CELL PHYSIOL, V55, P1031, DOI 10.1093/pcp/pcu050; Miedes E, 2015, FRONT PLANT SCI, P78; Munoz C, 2010, MOL PLANT, V3, P113, DOI 10.1093/mp/ssp087; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Mutka AM, 2013, PLANT J, V74, P746, DOI 10.1111/tpj.12157; Nasrallah JB, 2014, BIOCHEM SOC T, V42, P313, DOI 10.1042/BST20130222; Nissen KS, 2016, TRENDS PLANT SCI; Nomura T, 2001, PHYTOCHEMISTRY, V57, P171, DOI 10.1016/S0031-9422(00)00440-4; Pandey SP, 2010, PLANT J, V64, P912, DOI 10.1111/j.1365-313X.2010.04387.x; Parikka P, 2003, ACTA HORTIC, P183, DOI 10.17660/ActaHortic.2003.626.24; Puhl I, 2008, J PLANT DIS PROTECT, V115, P247, DOI 10.1007/BF03356272; Ranocha P, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3625; Robert-Seilaniantz A, 2011, ANNU REV PHYTOPATHOL, V49, P317, DOI 10.1146/annurev-phyto-073009-114447; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rytkonen A, 2012, CAN J PLANT PATHOL, V34, P255, DOI 10.1080/07060661.2012.686455; Saubeau G, 2016, PLANT PATHOL, V65, P342, DOI 10.1111/ppa.12420; SHAH J, 2013, FRONT PLANT SCI, V4; Shaw DV, 2008, PLANT PATHOL, V57, P210, DOI 10.1111/j.1365-3059.2007.01773.x; Shaw DV, 2006, J AM SOC HORTIC SCI, V131, P687, DOI 10.21273/JASHS.131.5.687; Shulaev V, 2011, NAT GENET, V43, P109, DOI 10.1038/ng.740; Stracke S, 2002, NATURE, V417, P959, DOI 10.1038/nature00841; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Thimmappa R, 2014, ANNU REV PLANT BIOL, V65, P225, DOI 10.1146/annurev-arplant-050312-120229; Thompson JR, 2003, J VIROL METHODS, V111, P85, DOI 10.1016/S0166-0934(03)00164-2; VANDENHEUVEL JFJM, 1989, PHYTOPATHOLOGY, V79, P963, DOI 10.1094/Phyto-79-963; Vlot AC, 2009, ANNU REV PHYTOPATHOL, V47, P177, DOI 10.1146/annurev.phyto.050908.135202; Vranova E, 2012, MOL PLANT, V5, P318, DOI 10.1093/mp/sss015; Wang Y, 2015, J EXP BOT, V66, P6731, DOI 10.1093/jxb/erv379; Wang Y, 2014, MOL PLANT MICROBE IN, V27, P1390, DOI 10.1094/MPMI-06-14-0191-R; Wildermuth MC, 2001, NATURE, V414, P562, DOI 10.1038/35107108; Wulf JS, 2008, J AGR FOOD CHEM, V56, P2875, DOI 10.1021/jf072495i; Yamamoto M, 2000, PHYTOPATHOLOGY, V90, P595, DOI 10.1094/PHYTO.2000.90.6.595; Yan JB, 2009, PLANT CELL, V21, P2220, DOI 10.1105/tpc.109.065730; Yuan YA, 2009, P NATL ACAD SCI USA, V106, P22020, DOI 10.1073/pnas.0906869106; Zentmyer GA., 1969, CALIFORNIA AVOCADO S, P103; Zhao YD, 2001, SCIENCE, V291, P306, DOI 10.1126/science.291.5502.306; Zheng ZY, 2006, PLANT J, V48, P592, DOI 10.1111/j.1365-313X.2006.02901.x; Zhong R, 2007, PLANT CELL, V19, P2776, DOI 10.1105/tpc.107.053678; Zhou J, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0084724, 10.1371/journal.pone.0096989, 10.1371/journal.pone.0087161]; Zipfel C, 2014, TRENDS IMMUNOL, V35, P345, DOI 10.1016/j.it.2014.05.004	100	34	35	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2016	11	8							e0161078	10.1371/journal.pone.0161078	http://dx.doi.org/10.1371/journal.pone.0161078			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3LI	27518577	Green Submitted, Green Published, gold			2022-12-27	WOS:000381382100044
J	Hoonakker, ME; Verhagen, LM; Pupo, E; de Haan, A; Metz, B; Hendriksen, CFM; Han, WGH; Sloots, A				Hoonakker, Marieke E.; Verhagen, Lisa M.; Pupo, Elder; de Haan, Alex; Metz, Bernard; Hendriksen, Coenraad F. M.; Han, Wanda G. H.; Sloots, Arjen			Vaccine-Mediated Activation of Human TLR4 Is Affected by Modulation of Culture Conditions during Whole-Cell Pertussis Vaccine Preparation	PLOS ONE			English	Article							BORDETELLA-PERTUSSIS; PHOSPHATE GROUPS; ACYL-CHAIN; LIPOPOLYSACCHARIDE BIOSYNTHESIS; HAEMOPHILUS-INFLUENZAE; IMMUNE-RESPONSES; KDO KINASE; INFECTION; GLUCOSAMINE; PROTECTION	The potency of whole-cell pertussis (wP) vaccines is still determined by an intracerebral mouse protection test. To allow development of suitable in vitro alternatives to this test, insight into relevant parameters to monitor the consistency of vaccine quality is essential. To this end, a panel of experimental wP vaccines of varying quality was prepared by sulfate- mediated suppression of the BvgASR master virulence regulatory system of Bordetella pertussis during cultivation. This system regulates the transcription of a range of virulence proteins, many of which are considered important for the induction of effective host immunity. The protein compositions and in vivo potencies of the vaccines were BvgASR dependent, with the vaccine containing the highest amount of virulence proteins having the highest in vivo potency. Here, the capacities of these vaccines to stimulate human Toll-like receptors (hTLR) 2 and 4 and the role these receptors play in wP vaccine-mediated activation of antigen-presenting cells in vitro were studied. Prolonged BvgASR suppression was associated with a decreased capacity of vaccines to activate hTLR4. In contrast, no significant differences in hTLR2 activation were observed. Similarly, vaccine-induced activation of MonoMac-6 and monocyte-derived dendritic cells was strongest with the highest potency vaccine. Blocking of TLR2 and TLR4 showed that differences in antigen-presenting cell activation could be largely attributed to vaccine-dependent variation in hTLR4 signalling. Interestingly, this BvgASR-dependent decrease in hTLR4 activation coincided with a reduction in GlcN-modified lipopolysaccharides in these vaccines. Accordingly, expression of the lgmA-C genes, required for this glucosamine modification, was significantly reduced in bacteria exposed to sulfate. Together, these findings demonstrate that the BvgASR status of bacteria during wP vaccine preparation is critical for their hTLR4 activation capacity and suggest that including such parameters to assess consistency of newly produced vaccines could bring in vitro testing of vaccine quality a step closer.	[Hoonakker, Marieke E.; Verhagen, Lisa M.; Pupo, Elder; de Haan, Alex; Metz, Bernard; Hendriksen, Coenraad F. M.; Sloots, Arjen] Inst Translat Vaccinol Intravacc, Bilthoven, Netherlands; [Hoonakker, Marieke E.; Hendriksen, Coenraad F. M.] Univ Utrecht, Dept Anim Sci & Soc, Fac Vet Med, Utrecht, Netherlands; [Verhagen, Lisa M.; Han, Wanda G. H.] Natl Inst Publ Hlth & Environm, Ctr Immunol Infect Dis & Vaccines, Bilthoven, Netherlands	Utrecht University; Netherlands National Institute for Public Health & the Environment	Hoonakker, ME (corresponding author), Inst Translat Vaccinol Intravacc, Bilthoven, Netherlands.; Hoonakker, ME (corresponding author), Univ Utrecht, Dept Anim Sci & Soc, Fac Vet Med, Utrecht, Netherlands.	Marieke.Hoonakker@intravacc.nl		Verhagen, Lisa/0000-0002-4130-580X				Allen A, 1996, MOL MICROBIOL, V19, P37, DOI 10.1046/j.1365-2958.1996.354877.x; Allen AG, 1998, J BACTERIOL, V180, P35, DOI 10.1128/JB.180.1.35-40.1998; Allen AG, 1998, MOL MICROBIOL, V29, P27, DOI 10.1046/j.1365-2958.1998.00878.x; [Anonymous], 2014, WKLY EPIDEMIOL REC, V21, P230; Baart GJE, 2008, BIOTECHNOL BIOENG, V101, P1022, DOI 10.1002/bit.22016; BELLALOU J, 1984, ANN INST PASTEUR MIC, VB135, P101, DOI 10.1016/S0769-2609(84)80047-2; Caroff M, 2000, FEBS LETT, V477, P8, DOI 10.1016/S0014-5793(00)01720-8; de Gouw D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084523; de Gouw D, 2011, FEMS MICROBIOL REV, V35, P441, DOI 10.1111/j.1574-6976.2010.00257.x; de Tejada GM, 1998, INFECT IMMUN, V66, P2762, DOI 10.1128/IAI.66.6.2762-2768.1998; Decker KB, 2012, MICROBIOL-SGM, V158, P1665, DOI 10.1099/mic.0.058941-0; Dunne A, 2015, MUCOSAL IMMUNOL, V8, P607, DOI 10.1038/mi.2014.93; Fedele G, 2008, J IMMUNOL, V181, P208, DOI 10.4049/jimmunol.181.1.208; Fedele G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008734; Flo TH, 2001, J LEUKOCYTE BIOL, V69, P474; Fransen F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015692; Geurtsen J, 2007, J BIOL CHEM, V282, P37875, DOI 10.1074/jbc.M706391200; Geurtsen J, 2009, INFECT IMMUN, V77, P2602, DOI 10.1128/IAI.00033-09; HAMSTRA HJ, 1995, VACCINE, V13, P747, DOI 10.1016/0264-410X(94)00040-T; Harvill ET, 2000, INFECT IMMUN, V68, P6720, DOI 10.1128/IAI.68.12.6720-6728.2000; Hendriksen C F, 2000, ILAR J, V41, P105; Higgins SC, 2006, J IMMUNOL, V177, P7980, DOI 10.4049/jimmunol.177.11.7980; Higgs R, 2012, MUCOSAL IMMUNOL, V5, P485, DOI 10.1038/mi.2012.54; Hoonakker ME, 2015, BIOLOGICALS, V43, P100, DOI 10.1016/j.biologicals.2014.12.002; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Kondakov A, 2005, EUR J MASS SPECTROM, V11, P535, DOI 10.1255/ejms.721; LeBouder E, 2006, J IMMUNOL, V176, P3742, DOI 10.4049/jimmunol.176.6.3742; Libster R, 2012, EXPERT REV VACCINES, V11, P1331, DOI [10.1586/erv.12.118, 10.1586/ERV.12.118]; Liko J, 2013, NEW ENGL J MED, V368, P581, DOI 10.1056/NEJMc1212006; Marr N, 2008, J BACTERIOL, V190, P4281, DOI 10.1128/JB.01875-07; Marr N, 2010, INFECT IMMUN, V78, P2060, DOI 10.1128/IAI.01346-09; Mattoo S, 2005, CLIN MICROBIOL REV, V18, P326, DOI 10.1128/CMR.18.2.326-382.2005; Merkel TJ, 1998, INFECT IMMUN, V66, P4367; Mills KHG, 1998, INFECT IMMUN, V66, P594, DOI 10.1128/IAI.66.2.594-602.1998; Nakamura MM, 2006, INFECT IMMUN, V74, P5537, DOI 10.1128/IAI.00781-06; Parkhill J, 2003, NAT GENET, V35, P32, DOI 10.1038/ng1227; Pharmacopeia E, 2013, ASSAY PERTUSSIS VACC, P242; Preston A, 2002, MICROB PATHOGENESIS, V33, P91, DOI 10.1006/mpat.2002.0511; ROBERTS M, 1992, VACCINE, V10, P43, DOI 10.1016/0264-410X(92)90418-J; Robins LI, 2009, BIOCHEMISTRY-US, V48, P6191, DOI 10.1021/bi900629e; ROBINSON A, 1989, VACCINE, V7, P321, DOI 10.1016/0264-410X(89)90193-X; Shah NR, 2014, ANTIMICROB AGENTS CH, V58, P4931, DOI 10.1128/AAC.02590-14; Shah NR, 2013, J BIOL CHEM, V288, P11751, DOI 10.1074/jbc.M112.434365; Sheridan SL, 2012, JAMA-J AM MED ASSOC, V308, P454, DOI 10.1001/jama.2012.6364; Thalen M, 1999, J BIOTECHNOL, V75, P147, DOI 10.1016/S0168-1656(99)00155-8; Thalen M, 2006, BIOLOGICALS, V34, P213, DOI 10.1016/j.biologicals.2005.11.002; Trent MS, 2001, J BIOL CHEM, V276, P43122, DOI 10.1074/jbc.M106961200; van de Waterbeemd B, 2009, BIOTECHNOL BIOENG, V103, P900, DOI 10.1002/bit.22326; vanStraatenvandeKappelle I, 1997, BIOLOGICALS, V25, P41, DOI 10.1006/biol.1996.0059; WEISS AA, 1984, INFECT IMMUN, V43, P263, DOI 10.1128/IAI.43.1.263-269.1984; WESTPHAL O., 1965, METHOD CARBOHYD CHEM, V5, P83; Weyrich LS, 2014, J INFECT DIS, V209, P913, DOI 10.1093/infdis/jit597; White KA, 1997, J BIOL CHEM, V272, P16555, DOI 10.1074/jbc.272.26.16555; White KA, 1999, J BIOL CHEM, V274, P31391, DOI 10.1074/jbc.274.44.31391; WHO, 2007, WHO TECHN REP SER, V941, P301; WILM MS, 1994, INT J MASS SPECTROM, V136, P167, DOI 10.1016/0168-1176(94)04024-9; Witt MA, 2013, CLIN INFECT DIS, V56, P1248, DOI 10.1093/cid/cit046; Xing D, 2001, VACCINE, V20, P342, DOI 10.1016/S0264-410X(01)00372-3; ZIEGLERHEITBROCK HWL, 1988, INT J CANCER, V41, P456, DOI 10.1002/ijc.2910410324	59	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2016	11	8							e0161428	10.1371/journal.pone.0161428	http://dx.doi.org/10.1371/journal.pone.0161428			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT8TP	27548265	Green Submitted, Green Published, gold			2022-12-27	WOS:000381768400056
J	Walter, JM; Tschoeke, DA; Meirelles, PM; de Oliveira, L; Leomil, L; Tenorio, M; Valle, R; Salomon, PS; Thompson, CC; Thompson, FL				Walter, Juline M.; Tschoeke, Diogo A.; Meirelles, Pedro M.; de Oliveira, Louisi; Leomil, Luciana; Tenorio, Marcio; Valle, Rogerio; Salomon, Paulo S.; Thompson, Cristiane C.; Thompson, Fabiano L.			Taxonomic and Functional Metagenomic Signature of Turfs in the Abrolhos Reef System (Brazil)	PLOS ONE			English	Article							CORAL; BACTERIA; CYANOBACTERIA; ACQUISITION; ECOLOGY; DAMAGE; MATS; DMSP	Turfs are widespread assemblages (consisting of microbes and algae) that inhabit reef systems. They are the most abundant benthic component in the Abrolhos reef system (Brazil), representing greater than half the coverage of the entire benthic community. Their presence is associated with a reduction in three-dimensional coral reef complexity and decreases the habitats available for reef biodiversity. Despite their importance, the taxonomic and functional diversity of turfs remain unclear. We performed a metagenomics and pigments profile characterization of turfs from the Abrolhos reefs. Turf microbiome primarily encompassed Proteobacteria (mean 40.57% +/- s.d. 10.36, N = 1.548,192), Cyanobacteria (mean 35.04% +/- s.d. 15.5, N = 1.337,196), and Bacteroidetes (mean 11.12% +/- s.d. 4.25, N = 424,185). Oxygenic and anoxygenic phototrophs, chemolithotrophs, and aerobic anoxygenic phototrophic (AANP) bacteria showed a conserved functional trait of the turf microbiomes. Genes associated with oxygenic photosynthesis, AANP, sulfur cycle (S oxidation, and DMSP consumption), and nitrogen metabolism (N-2 fixation, ammonia assimilation, dissimilatory nitrate and nitrite ammonification) were found in the turf microbiomes. Principal component analyses of the most abundant taxa and functions showed that turf microbiomes differ from the other major Abrolhos benthic microbiomes (i.e., corals and rhodoliths) and seawater. Taken together, these features suggest that turfs have a homogeneous functional core across the Abrolhos Bank, which holds diverse microbial guilds when comparing with other benthic organisms.	[Walter, Juline M.; Tschoeke, Diogo A.; Meirelles, Pedro M.; de Oliveira, Louisi; Leomil, Luciana; Thompson, Cristiane C.; Thompson, Fabiano L.] Univ Fed Rio de Janeiro, Inst Biol, Microbiol Lab, Rio De Janeiro, Brazil; [Walter, Juline M.; Tschoeke, Diogo A.; de Oliveira, Louisi; Leomil, Luciana; Salomon, Paulo S.; Thompson, Fabiano L.] Univ Fed Rio de Janeiro, Ctr Technol CT2, SAGE COPPE, Rio De Janeiro, Brazil; [Tenorio, Marcio; Salomon, Paulo S.] Univ Fed Rio de Janeiro, Inst Biol, Rio De Janeiro, Brazil; [Valle, Rogerio] Univ Fed Rio de Janeiro, COPPE Prod Engn Program, Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro	Thompson, FL (corresponding author), Univ Fed Rio de Janeiro, Inst Biol, Microbiol Lab, Rio De Janeiro, Brazil.; Thompson, FL (corresponding author), Univ Fed Rio de Janeiro, Ctr Technol CT2, SAGE COPPE, Rio De Janeiro, Brazil.	fabianothompson1@gmail.com	Salomon, Paulo Sergio/D-3310-2011; Tschoeke, Diogo A/F-9913-2019; Meirelles, Pedro/GRY-0806-2022; Meirelles, Pedro/AAK-5942-2021; Leomil, Luciana/O-4860-2019; Tschoeke, Diogo/AAB-4739-2021; Meirelles, Pedro/AAL-4542-2020	Salomon, Paulo Sergio/0000-0002-0037-6011; Tschoeke, Diogo A/0000-0001-8134-4259; Meirelles, Pedro/0000-0002-1306-0331; Walter, Juline/0000-0002-8073-2142; Thompson, Fabiano/0000-0002-7562-1683	National Counsel of Technological and Scientific Development (CNPq); Coordination for the Improvement of Higher Education Personnel (CAPES); Rio de Janeiro Research Foundation (FAPERJ)	National Counsel of Technological and Scientific Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordination for the Improvement of Higher Education Personnel (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Rio de Janeiro Research Foundation (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	The authors received funding from National Counsel of Technological and Scientific Development (CNPq), Coordination for the Improvement of Higher Education Personnel (CAPES), Rio de Janeiro Research Foundation (FAPERJ) for this work.	Ainsworth TD, 2015, ISME J, V9, P2261, DOI 10.1038/ismej.2015.39; Amado GM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035171; Andrews S., 2010, FASTQC QUALITY CONTR; Barott KL, 2012, TRENDS MICROBIOL, V20, P621, DOI 10.1016/j.tim.2012.08.004; Barott KL, 2012, MAR ECOL PROG SER, V460, P1, DOI 10.3354/meps09874; Barott KL, 2012, P ROY SOC B-BIOL SCI, V279, P1655, DOI 10.1098/rspb.2011.2155; Barott KL, 2011, ENVIRON MICROBIOL, V13, P1192, DOI 10.1111/j.1462-2920.2010.02419.x; Behrendt L, 2011, ISME J, V5, P1072, DOI 10.1038/ismej.2010.195; BENNETT A, 1973, J CELL BIOL, V58, P419, DOI 10.1083/jcb.58.2.419; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Bruce T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036687; BRYANT DA, 1979, ARCH MICROBIOL, V123, P113, DOI 10.1007/BF00446810; Casadevall A, 2015, INFECT IMMUN, V83, P2, DOI 10.1128/IAI.02627-14; Cavalcanti GS, 2013, CONT SHELF RES, V70, P126, DOI 10.1016/j.csr.2013.05.011; Cavalcanti GS, 2014, ISME J, V8, P52, DOI 10.1038/ismej.2013.133; Chen M, 2010, SCIENCE, V329, P1318, DOI 10.1126/science.1191127; Connell SD, 2014, MAR ECOL PROG SER, V495, P299, DOI 10.3354/meps10513; Cordero OX, 2012, P NATL ACAD SCI USA, V109, P20059, DOI 10.1073/pnas.1213344109; Cordero OX, 2012, SCIENCE, V337, P1228, DOI 10.1126/science.1219385; Costa TRD, 2015, NAT REV MICROBIOL, V13, P343, DOI 10.1038/nrmicro3456; Dinsdale EA, 2008, NATURE, V455, P830, DOI 10.1038/nature07346; Dinsdale EA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001584; Dinsdale Elizabeth A., 2013, Frontiers in Genetics, V4, P41, DOI 10.3389/fgene.2013.00041; Echenique-Subiabre I, 2015, MICROB ECOL, V69, P234, DOI 10.1007/s00248-014-0496-0; Egan S, 2014, ENVIRON MICROBIOL, V16, P925, DOI 10.1111/1462-2920.12288; Egan S, 2013, FEMS MICROBIOL REV, V37, P462, DOI 10.1111/1574-6976.12011; Faraldo-Gomez JD, 2003, NAT REV MOL CELL BIO, V4, P105, DOI 10.1038/nrm1015; Fernandes N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027387; Fierer N, 2012, P NATL ACAD SCI USA, V109, P21390, DOI 10.1073/pnas.1215210110; Francini RB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054260; Garcia GD, 2013, MICROB ECOL, V65, P1076, DOI 10.1007/s00248-012-0161-4; Goldberg WM., 2013, BIOL REEFS REEF ORGA, DOI 10.7208/chicago/9780226925370.001.0001; Haas AF, 2013, PEERJ, V1, DOI 10.7717/peerj.108; Haas AF, 2013, PEERJ, V1, DOI 10.7717/peerj.106; Haas AF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027973; Hester ER, 2016, ISME J, V10, P1157, DOI 10.1038/ismej.2015.190; Hollants J, 2013, FEMS MICROBIOL ECOL, V83, P1, DOI 10.1111/j.1574-6941.2012.01446.x; Knowlton N, 2008, PLOS BIOL, V6, P215, DOI 10.1371/journal.pbio.0060054; Lesser MP, 2004, SCIENCE, V305, P997, DOI 10.1126/science.1099128; Mason OU, 2012, ISME J, V6, P1715, DOI 10.1038/ismej.2012.59; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Moran NA, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002311; Nelson CE, 2013, ISME J, V7, P962, DOI 10.1038/ismej.2012.161; NEVEUX J, 1993, DEEP-SEA RES PT I, V40, P1747, DOI 10.1016/0967-0637(93)90030-7; Oksanen J., 2005, VEGAN R FUNCTIONS VE; Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866; R Core Team, 2021, R LANGUAGE ENV STAT; Raina JB, 2013, NATURE, V502, P677, DOI 10.1038/nature12677; Raina JB, 2010, TRENDS MICROBIOL, V18, P101, DOI 10.1016/j.tim.2009.12.002; Richardson LL, 2009, DIS AQUAT ORGAN, V87, P79, DOI 10.3354/dao02083; Rodrigue S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011840; Roff G, 2012, TRENDS ECOL EVOL, V27, P404, DOI 10.1016/j.tree.2012.04.007; Rosenberg E, 2007, NAT REV MICROBIOL, V5, P355, DOI 10.1038/nrmicro1635; Sandin SA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001548; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Sheppard CRC, 2009, BIO HABIT, P1, DOI 10.1093/acprof:oso/9780198566359.001.0001; STAL LJ, 1995, NEW PHYTOL, V131, P1, DOI 10.1111/j.1469-8137.1995.tb03051.x; Steunou AS, 2006, P NATL ACAD SCI USA, V103, P2398, DOI 10.1073/pnas.0507513103; Sweet M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062580; Tenorio MMB, 2005, ESTUAR COAST SHELF S, V64, P531, DOI 10.1016/j.ecss.2005.02.030; Teske A, 1998, APPL ENVIRON MICROB, V64, P2943; Weber M, 2012, P NATL ACAD SCI USA, V109, pE1558, DOI 10.1073/pnas.1100715109; Welker M, 2006, FEMS MICROBIOL REV, V30, P530, DOI 10.1111/j.1574-6976.2006.00022.x; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wickham H, 2007, J STAT SOFTW, V21, P1; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Yoon S, 2015, ISME J, V9, P1093, DOI 10.1038/ismej.2014.201	67	17	17	5	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2016	11	8							e0161168	10.1371/journal.pone.0161168	http://dx.doi.org/10.1371/journal.pone.0161168			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT8TP	27548380	gold, Green Published, Green Submitted			2022-12-27	WOS:000381768400031
J	Wrzesniak, M; Kepinska, M; Krolik, M; Milnerowicz, H				Wrzesniak, Marta; Kepinska, Marta; Krolik, Malgorzata; Milnerowicz, Halina			The Influence of Tobacco Smoke on Protein and Metal Levels in the Serum of Women during Pregnancy	PLOS ONE			English	Article							CIGARETTE-SMOKING; TRANSFERRIN MICROHETEROGENEITY; OXIDATIVE STRESS; MATERNAL SMOKING; TRACE-ELEMENTS; CADMIUM; ALPHA-1-ANTITRYPSIN; GLYCOPROTEIN; INFLAMMATION; TRANSPORT	Background Tobacco smoking by pregnant women has a negative effect on fetal development and increases pregnancy risk by changing the oxidative balance and microelements level. Smoking affects the concentration, structure and function of proteins, potentially leading to various negative effects on pregnancy outcomes. Methodology/Principal Findings The influence of tobacco smoke on key protein fractions in smoking and non-smoking healthy pregnant women was determined by capillary electrophoresis (CE). Concentrations of the proteins alpha 1-antitrypsin, alpha 1-acid glycoprotein, alpha 2-macroglobulin and transferrin were determined by ELISA tests. Total protein concentration was measured by the Biuretmethod. Smoking status was established by cotinine levels. Cadmium (Cd) and Zinc (Zn) concentrations were determined by flame atomic absorption spectrometry and the Zn/Cd ratio was calculated based on these numbers. Smoking women had a 3.7 times higher level of Cd than non-smoking women. Zn levels decreased during pregnancy for all women. The Zn/Cd ratio was three times lower in smoking women. The differences between the changes in the protein profile for smoking and non-smoking women were noted. Regarding proteins, alpha 1-antitrypsin and alpha 2-macroglobulin levels were lower in the non-smoking group than in the smoking group and correlated with Cd levels (r = -0.968, p = 0.032 for non-smokers; r = -0.835, p = 0.019 for smokers). Zn/Cd ratios correlated negatively with alpha 1-, alpha 2-and beta-globulins. Conclusions/Significance Exposure to tobacco smoke increases the concentration of Cd in the blood of pregnant women and may lead to an elevated risk of pregnancy disorders. During pregnancy alter concentrations of some proteins. The correlation of Cd with proteins suggests that it is one of the causes of protein aberrations.	[Wrzesniak, Marta; Kepinska, Marta; Milnerowicz, Halina] Wroclaw Med Univ, Dept Biomed & Environm Anal, Fac Pharm, Wroclaw, Poland; [Krolik, Malgorzata] Early Pregnancy Pathol Clin, Ctr Gynaecol Obstet & Neonatol, Opole, Poland	Wroclaw Medical University	Wrzesniak, M; Milnerowicz, H (corresponding author), Wroclaw Med Univ, Dept Biomed & Environm Anal, Fac Pharm, Wroclaw, Poland.	krolikm87@gmail.com; halina.milnerowicz@umed.wroc.pl	Kepinska, Marta/C-8354-2011	Wrzesniak, Marta/0000-0003-1388-2594; Milnerowicz, Halina/0000-0002-0772-9852; Kepinska, Marta/0000-0002-0935-5663	National Science Centre in Poland [DEC-2012/07/N/NZ7/02387]	National Science Centre in Poland(National Science Centre, Poland)	The project was financed by the National Science Centre in Poland granted on the basis of the decision DEC-2012/07/N/NZ7/02387 number (https://www.ncn.gov.pl/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bizon A, 2011, REPROD TOXICOL, V32, P360, DOI 10.1016/j.reprotox.2011.08.007; Catarino C, 2012, J PREGNANCY, V2012, DOI 10.1155/2012/684384; Cetin I, 2011, ANN NUTR METAB, V59, P55, DOI 10.1159/000332133; CHIBA M, 1992, B WORLD HEALTH ORGAN, V70, P269; CHU CYT, 1981, CLIN CHIM ACTA, V112, P235, DOI 10.1016/0009-8981(81)90382-X; Cogswell ME, 2003, J NUTR, V133, p1722S; Colombo G, 2012, ANTIOXID REDOX SIGN, V17, P1515, DOI 10.1089/ars.2012.4702; Fenzl V, 2013, ARCH GYNECOL OBSTET, V287, P19, DOI 10.1007/s00404-012-2502-4; Fournier T, 2000, BBA-PROTEIN STRUCT M, V1482, P157, DOI 10.1016/S0167-4838(00)00153-9; GOLDENBERG RL, 1991, OBSTET GYNECOL, V78, P594; Harmon AC, 2016, CLIN SCI, V130, P409, DOI 10.1042/CS20150702; Hendrick DJ, 2004, THORAX, V59, P184, DOI 10.1136/thx.2003.018432; Janciauskiene SM, 2011, RESP MED, V105, P1129, DOI 10.1016/j.rmed.2011.02.002; Jang ES, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-145; Kippler M, 2010, TOXICOL LETT, V192, P162, DOI 10.1016/j.toxlet.2009.10.018; Kowalska K, 2015, J TRACE ELEM MED BIO, V29, P99, DOI 10.1016/j.jtemb.2014.05.001; KUHNERT BR, 1988, J AM COLL NUTR, V7, P309, DOI 10.1080/07315724.1988.10720248; Kwon Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147065; LEGGE M, 1984, J CLIN PATHOL, V37, P867, DOI 10.1136/jcp.37.8.867; Lisowska-Myjak B, 2003, EUR J OBSTET GYN R B, V106, P31, DOI 10.1016/S0301-2115(02)00201-4; Mattsson K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144207; Milnerowicz H, 2000, Int J Occup Med Environ Health, V13, P185; Milnerowicz H, 2000, Ginekol Pol, V71, P311; Milnerowicz H, 1993, ACTA POLONIAE TOXICO, V1, P25; Milnerowicz-Nabzdyk E, 2015, REPROD TOXICOL, V58, P79, DOI 10.1016/j.reprotox.2015.08.003; Milnerowicz-Nabzdyk E, 2014, REPROD TOXICOL, V50, P27, DOI 10.1016/j.reprotox.2014.10.002; Nafstad P, 1996, EUR RESPIR J, V9, P2623, DOI 10.1183/09031936.96.09122623; PARVIN R, 1965, ANAL BIOCHEM, V12, P219, DOI 10.1016/0003-2697(65)90085-0; PATEL AB, 1992, IND HEALTH, V30, P97, DOI 10.2486/indhealth.30.97; RAMCHARAN S, 1976, OBSTET GYNECOL, V48, P211; Rollin HB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142455; Rogers JM, 2009, REPROD TOXICOL, V28, P152, DOI 10.1016/j.reprotox.2009.03.012; Rom O, 2013, RESP PHYSIOL NEUROBI, V187, P5, DOI 10.1016/j.resp.2013.01.013; Sciskalska M, 2014, BIOL TRACE ELEM RES, V159, P59, DOI 10.1007/s12011-014-9984-9; Shaper AG, 2004, J CLIN EPIDEMIOL, V57, P195, DOI 10.1016/j.jclinepi.2003.07.001; Shiels MS, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju294; Staff AC, 2014, J REPROD IMMUNOL, V101, P120, DOI 10.1016/j.jri.2013.09.001; Suriyaprom Kanjana, 2007, Southeast Asian Journal of Tropical Medicine and Public Health, V38, P918; Tayade C, 2005, MOL CELL ENDOCRINOL, V245, P60, DOI 10.1016/j.mce.2005.10.004; Tekin D, 2012, J APPL TOXICOL, V32, P270, DOI 10.1002/jat.1661; Tong VT, 2013, SITES, V40, P2000; Twina G, 2012, J MATERN-FETAL NEO M, V25, P2667, DOI 10.3109/14767058.2012.705397; Wallin M, 2014, OCCUP ENVIRON MED, V71, P848, DOI 10.1136/oemed-2014-102279; Wang J, 2016, PHYS CHEM CHEM PHYS, V18, P3536, DOI 10.1039/c5cp06100h; Wen QJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065571; WINGERD J, 1977, CLIN CHEM, V23, P1310; Wrzesniak M, 2015, FETAL PEDIATR PATHOL, V34, P391, DOI 10.3109/15513815.2015.1095260; Wu Y, 2004, BIOL NEONATE, V86, P98, DOI 10.1159/000078311; Wu YH, 2003, CLIN CHIM ACTA, V332, P103, DOI 10.1016/S0009-8981(03)00134-7; Zalewska M, 2014, INT J ENVIRON AN CH, V94, P1422, DOI 10.1080/03067319.2014.962530	50	8	8	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2016	11	8							e0161342	10.1371/journal.pone.0161342	http://dx.doi.org/10.1371/journal.pone.0161342			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT8TP	27548057	gold, Green Published, Green Submitted			2022-12-27	WOS:000381768400046
J	Chan, AW; Hamblin, MT; Jannink, JL				Chan, Ariel W.; Hamblin, Martha T.; Jannink, Jean-Luc			Evaluating Imputation Algorithms for Low-Depth Genotyping-By-Sequencing (GBS) Data	PLOS ONE			English	Article							GENOMIC SELECTION; ASSOCIATION; MODELS	Well-powered genomic studies require genome-wide marker coverage across many individuals. For non-model species with few genomic resources, high-throughput sequencing (HTS) methods, such as Genotyping-By-Sequencing (GBS), offer an inexpensive alternative to array-based genotyping. Although affordable, datasets derived from HTS methods suffer from sequencing error, alignment errors, and missing data, all of which introduce noise and uncertainty to variant discovery and genotype calling. Under such circumstances, meaningful analysis of the data is difficult. Our primary interest lies in the issue of how one can accurately infer or impute missing genotypes in HTS-derived datasets. Many of the existing genotype imputation algorithms and software packages were primarily developed by and optimized for the human genetics community, a field where a complete and accurate reference genome has been constructed and SNP arrays have, in large part, been the common genotyping platform. We set out to answer two questions: 1) can we use existing imputation methods developed by the human genetics community to impute missing genotypes in datasets derived from non-human species and 2) are these methods, which were developed and optimized to impute ascertained variants, amenable for imputation of missing genotypes at HTS-derived variants? We selected Beagle v.4, a widely used algorithm within the human genetics community with reportedly high accuracy, to serve as our imputation contender. We performed a series of cross-validation experiments, using GBS data collected from the species Manihot esculenta by the Next Generation (NEXTGEN) Cassava Breeding Project. NEXTGEN currently imputes missing genotypes in their datasets using a LASSO-penalized, linear regression method (denoted 'glmnet'). We selected glmnet to serve as a benchmark imputation method for this reason. We obtained estimates of imputation accuracy by masking a subset of observed genotypes, imputing, and calculating the sample Pearson correlation between observed and imputed genotype dosages at the site and individual level; computation time served as a second metric for comparison. We then set out to examine factors affecting imputation accuracy, such as levels of missing data, read depth, minor allele frequency (MAF), and reference panel composition.	[Chan, Ariel W.; Jannink, Jean-Luc] Cornell Univ, Sch Integrat Plant Sci, Sect Plant Breeding & Genet, Ithaca, NY 14850 USA; [Hamblin, Martha T.] Cornell Univ, Inst Genom Div, Ithaca, NY USA; [Jannink, Jean-Luc] ARS, USDA, RW Holley Ctr Agr & Hlth, Ithaca, NY USA	Cornell University; Cornell University; United States Department of Agriculture (USDA)	Chan, AW (corresponding author), Cornell Univ, Sch Integrat Plant Sci, Sect Plant Breeding & Genet, Ithaca, NY 14850 USA.	ac2278@cornell.edu		Jannink, Jean-Luc/0000-0003-4849-628X	Bill & Melinda Gates Foundation; Department for International Development of the United Kingdom; National Science Foundation	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); Department for International Development of the United Kingdom; National Science Foundation(National Science Foundation (NSF))	The Next Generation (NEXTGEN) Cassava Breeding Project is supported by a grant from the Bill & Melinda Gates Foundation and the Department for International Development of the United Kingdom. JLJ and MTH received funding from the Bill & Melinda Gates Foundation and the Department for International Development of the United Kingdom. AWC received funding from the National Science Foundation. The funders had no role in study design, data analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Browning BL, 2009, AM J HUM GENET, V85, P847, DOI 10.1016/j.ajhg.2009.11.004; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Browning SR, 2006, AM J HUM GENET, V78, P903, DOI 10.1086/503876; Calus MPL, 2014, ANIMAL, V8, P1743, DOI 10.1017/S1751731114001803; Ceballos H, 2004, PLANT MOL BIOL, V56, P503, DOI 10.1007/s11103-004-5010-5; Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Endelman JB, 2012, G3-GENES GENOM GENET, V2, P1405, DOI 10.1534/g3.112.004259; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Glaubitz JC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090346; Hastie T, 2005, ELEMENTS STAT LEARNI, V27; Howie B, 2011, G3-GENES GENOM GENET, V1, P457, DOI 10.1534/g3.111.001198; Li Y, 2011, GENOME RES, V21, P940, DOI 10.1101/gr.117259.110; Poland J, 2012, PLANT GENOME-US, V5, P103, DOI 10.3835/plantgenome2012.06.0006; RABINER LR, 1989, P IEEE, V77, P257, DOI 10.1109/5.18626; Rutkoski JE, 2013, G3-GENES GENOM GENET, V3, P427, DOI 10.1534/g3.112.005363; Wolf M. M., 2016, 2016 IEEE HIGH PERFO, P1, DOI [DOI 10.3835/PLANTGEN0ME2015.11.0118, 10.1109/HPEC.2016.7761649, DOI 10.1109/HPEC.2016.7761649]	20	21	21	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0160733	10.1371/journal.pone.0160733	http://dx.doi.org/10.1371/journal.pone.0160733			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27537694	gold, Green Submitted, Green Published			2022-12-27	WOS:000381577000029
J	Helfenstein, J; Muller, I; Gruter, R; Bhullar, G; Mandloi, L; Papritz, A; Siegrist, M; Schulin, R; Frossard, E				Helfenstein, Julian; Mueller, Isabel; Gruter, Roman; Bhullar, Gurbir; Mandloi, Lokendra; Papritz, Andreas; Siegrist, Michael; Schulin, Rainer; Frossard, Emmanuel			Organic Wheat Farming Improves Grain Zinc Concentration	PLOS ONE			English	Article							HEAVY-METALS; SOILS; BIOFORTIFICATION; INDIA; DEFICIENCY; NUTRITION; PLAINS; ZN	Zinc (Zn) nutrition is of key relevance in India, as a large fraction of the population suffers from Zn malnutrition and many soils contain little plant available Zn. In this study we compared organic and conventional wheat cropping systems with respect to DTPA (diethylene triamine pentaacetic acid)-extractable Zn as a proxy for plant available Zn, yield, and grain Zn concentration. We analyzed soil and wheat grain samples from 30 organic and 30 conventional farms in Madhya Pradesh (central India), and conducted farmer interviews to elucidate sociological and management variables. Total and DTPA-extractable soil Zn concentrations and grain yield (3400 kg ha(-1)) did not differ between the two farming systems, but with 32 and 28 mg kg(-1) respectively, grain Zn concentrations were higher on organic than conventional farms (t = -2.2, p = 0.03). Furthermore, multiple linear regression analyses revealed that (a) total soil zinc and sulfur concentrations were the best predictors of DTPA-extractable soil Zn, (b) Olsen phosphate taken as a proxy for available soil phosphorus, exchangeable soil potassium, harvest date, training of farmers in nutrient management, and soil silt content were the best predictors of yield, and (c) yield, Olsen phosphate, grain nitrogen, farmyard manure availability, and the type of cropping system were the best predictors of grain Zn concentration. Results suggested that organic wheat contained more Zn despite same yield level due to higher nutrient efficiency. Higher nutrient efficiency was also seen in organic wheat for P, N and S. The study thus suggests that appropriate farm management can lead to competitive yield and improved Zn concentration in wheat grains on organic farms.	[Helfenstein, Julian; Mueller, Isabel; Frossard, Emmanuel] Swiss Fed Inst Technol, Inst Agr Sci, CH-8315 Lindau, Switzerland; [Gruter, Roman; Papritz, Andreas; Schulin, Rainer] Swiss Fed Inst Technol, Inst Terr Ecosyst, CH-8092 Zurich, Switzerland; [Bhullar, Gurbir] Res Inst Organ Agr FiBL, Int Cooperat Dept, CH-5070 Frick, Switzerland; [Mandloi, Lokendra] bioRe Assoc, Div Res, Kasrawad, Madhya Pradesh, India; [Siegrist, Michael] Swiss Fed Inst Technol, Inst Environm Decis, CH-8092 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Helfenstein, J (corresponding author), Swiss Fed Inst Technol, Inst Agr Sci, CH-8315 Lindau, Switzerland.	julian.helfenstein@usys.ethz.ch	Siegrist, Michael/A-1032-2008	Siegrist, Michael/0000-0002-6139-7190; Helfenstein, Julian/0000-0002-5012-2589; Bhullar, Gurbir S./0000-0001-7311-2562	WFSC Mercator Research Program; Biovision Foundation for Ecological Development; Coop Sustainability Fund; Liechtenstein Development Service (LED); Swiss Agency for Development and Cooperation (SDC)	WFSC Mercator Research Program; Biovision Foundation for Ecological Development; Coop Sustainability Fund; Liechtenstein Development Service (LED); Swiss Agency for Development and Cooperation (SDC)	The project was funded by WFSC Mercator Research Program (http://www.worldfoodsystem.ethz.ch/research.html) and was conducted in the framework of long-term farming systems comparison in the tropics (SysCom) program, which is financially supported by Biovision Foundation for Ecological Development, Coop Sustainability Fund, Liechtenstein Development Service (LED) and the Swiss Agency for Development and Cooperation (SDC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AACC, 1999, 461901 AACC; Aghili F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101487; Andres C, 2016, FRONT ENV SCI-SWITZ, V4, DOI 10.3389/fenvs.2016.00005; [Anonymous], 2011, THE EC; BANSAL RL, 1990, FERT RES, V21, P163, DOI 10.1007/BF01087426; Bhullar GS, 2014, P FAO INT S; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Bulluck LR, 2002, APPL SOIL ECOL, V19, P147, DOI 10.1016/S0929-1393(01)00187-1; Cakmak I, 2002, PLANT SOIL, V247, P3, DOI 10.1023/A:1021194511492; Cakmak I, 2008, PLANT SOIL, V302, P1, DOI 10.1007/s11104-007-9466-3; Cakmak I, 2010, CEREAL CHEM, V87, P10, DOI 10.1094/CCHEM-87-1-0010; Crowder DW, 2015, P NATL ACAD SCI USA, V112, P7611, DOI 10.1073/pnas.1423674112; de Ponti T, 2012, AGR SYST, V108, P1, DOI 10.1016/j.agsy.2011.12.004; Diesing WE, 2008, EUR J SOIL SCI, V59, P716, DOI 10.1111/j.1365-2389.2008.01032.x; Dijkstra JJ, 2009, ENVIRON SCI TECHNOL, V43, P6196, DOI 10.1021/es900555g; Eyhorn F., 2007, International Journal of Agricultural Sustainability, V5, P25; Eyhorn F., 2007, ORGANIC FARMING SUST, DOI [10.3218/3152-2, DOI 10.3218/3152-2]; FAL RAC FAW, 1996, EXTR ABF KON GESCHL, P3; FAL RAC FAW, 1996, BEST KORN MIN ANT FE; FAL RAC FAW, 1996, PH WERT WASS 1 2 5 P; FAOSTAT, 2013, FOOD AGR COMM PROD; Forster D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081039; Frossard E, 2011, HDB SOIL SCI PROPERT; Guttieri MJ, 2015, CROP SCI, V55, P1035, DOI 10.2135/cropsci2014.07.0506; HarvestPlus, 2014, BIOF PROGR BRIEFS; Helfenstein J, 2015, J PLANT NUTR SOIL SC, V178, P896, DOI 10.1002/jpln.201500146; Helmke P. A., 1996, Methods of soil analysis. Part 3 - chemical methods., P551; Joshi AK, 2010, FIELD CROP RES, V116, P268, DOI 10.1016/j.fcr.2010.01.004; Karami M, 2009, J AGR FOOD CHEM, V57, P10876, DOI 10.1021/jf902074f; KATYAL JC, 1991, GEODERMA, V49, P165, DOI 10.1016/0016-7061(91)90099-F; Lehmann A, 2014, SOIL BIOL BIOCHEM, V69, P123, DOI 10.1016/j.soilbio.2013.11.001; Mader P, 2002, SCIENCE, V296, P1694, DOI 10.1126/science.1071148; Mader P, 2007, J SCI FOOD AGR, V87, P1826, DOI 10.1002/jsfa.2866; Marschner, 1995, MINERAL NUTR HIGHER, P596, DOI DOI 10.1016/B978-012473542-2/50018-3; Nicholson FA, 2003, SCI TOTAL ENVIRON, V311, P205, DOI 10.1016/S0048-9697(03)00139-6; Ova EA, 2015, PLANT SOIL, V393, P147, DOI 10.1007/s11104-015-2483-8; Ozer M, 2010, ENVIRON ENG GEOSCI, V16, P163, DOI 10.2113/gseegeosci.16.2.163; Pace NJ, 2014, BIOMOLECULES, V4, P419, DOI 10.3390/biom4020419; Persson DP, 2016, NEW PHYTOL, V211, P1255, DOI 10.1111/nph.13989; Ram H, 2015, CURR SCI INDIA, V109, P1171, DOI 10.18520/v109/i6/1171-1176; RCoreTeam, 2015, R LANG ENV STAT COMP; Reed S. T., 1996, Methods of soil analysis. Part 3 - chemical methods., P703; Ryan MH, 2004, J SCI FOOD AGR, V84, P207, DOI 10.1002/jsfa.1634; Sakamoto Y., 1986, AKAIKE INFORM CRITER; Schoenau J.J., 2007, SOIL SAMPLING METHOD; Schulin R, 2008, DEV USE BIOFORTIFIED, P95; Stein AJ, 2007, PUBLIC HEALTH NUTR, V10, P492, DOI 10.1017/S1368980007223857; Syers J.K., 2008, FAO FERTILIZER PLANT, V18, P5; unicefIndia, 2013, WHAT WE DO STUNT; van Groenigen JW, 2015, SOIL-GERMANY, V1, P235, DOI 10.5194/soil-1-235-2015; World Health Organisation, 2010, GLOB DAT CHILD GROWT; Zou CQ, 2012, PLANT SOIL, V361, P119, DOI 10.1007/s11104-012-1369-2	52	11	11	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0160729	10.1371/journal.pone.0160729	http://dx.doi.org/10.1371/journal.pone.0160729			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27537548	Green Published, gold, Green Submitted			2022-12-27	WOS:000381577000028
J	Na, HN; Hegde, V; Dubuisson, O; Dhurandhar, NV				Na, Ha-Na; Hegde, Vijay; Dubuisson, Olga; Dhurandhar, Nikhil V.			E4orf1 Enhances Glucose Uptake Independent of Proximal Insulin Signaling	PLOS ONE			English	Article							SENSITIVITY; PROTEIN; RESISTANCE; ADIPOSITY; SYSTEM; CELLS; FAT	Impaired proximal insulin signaling is often present in diabetes. Hence, approaches to enhance glucose disposal independent of proximal insulin signaling are desirable. Evidence indicates that Adenovirus-derived E4orf1 protein may offer such an approach. This study determined if E4orf1 improves insulin sensitivity and downregulates proximal insulin signaling in vivo and enhances cellular glucose uptake independent of proximal insulin signaling in vitro. High fat fed mice were injected with a retrovirus plasmid expressing E4orf1, or a null vector. E4orf1 significantly improved insulin sensitivity in response to a glucose load. Yet, their proximal insulin signaling in fat depots was impaired, as indicated by reduced tyrosine phosphorylation of insulin receptor (IR), and significantly increased abundance of ectonucleotide pyrophosphatase/phosphodiesterase- 1 (ENPP1). In 3T3-L1 pre-adipocytes E4orf1 expression impaired proximal insulin signaling. Whereas, treatment with rosiglitazone reduced ENPP1 abundance. Unaffected by IR-KD (insulin receptor knockdown) with siRNA, E4orf1 significantly up-regulated distal insulin signaling pathway and enhanced cellular glucose uptake. In vivo, E4orf1 impairs proximal insulin signaling in fat depots yet improves glycemic control. This is probably explained by the ability of E4orf1 to promote cellular glucose uptake independent of proximal insulin signaling. E4orf1 may provide a therapeutic template to enhance glucose disposal in the presence of impaired proximal insulin signaling.	[Na, Ha-Na; Hegde, Vijay; Dubuisson, Olga; Dhurandhar, Nikhil V.] Louisiana State Univ Syst, Pennington Biomed Res Ctr, Infect & Obes Lab, Baton Rouge, LA 70803 USA	Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center	Dhurandhar, NV (corresponding author), Louisiana State Univ Syst, Pennington Biomed Res Ctr, Infect & Obes Lab, Baton Rouge, LA 70803 USA.	Nikhil.Dhurandhar@TTU.EDU			Vital Health Interventions; COBRE center grant from National Institutes of Health [NIH 8 P20-GM103528]; NORC center grant from National Institutes of Health [NIH 2P30-DK072476]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072476] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103528] Funding Source: NIH RePORTER	Vital Health Interventions; COBRE center grant from National Institutes of Health; NORC center grant from National Institutes of Health; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by Vital Health Interventions. The funders had no role in data collection and analysis, decision to publish, or preparation of the manuscript.; This work utilized the facilities of the Cell Biology and Bioimaging Core that are supported in part by COBRE (NIH 8 P20-GM103528) and NORC (NIH 2P30-DK072476) center grants from the National Institutes of Health.	Anderson MS, 2005, EFFECTS ACUTE HYPERI; CHANDALIA M, 2012, J CLIN ENDOCR METAB, V97, P4663, DOI [DOI 10.1210/jc.2012-2018, DOI 10.1210/JC.2012-2018]; Czech MP, 1999, J BIOL CHEM, V274, P1865, DOI 10.1074/jbc.274.4.1865; Dhurandhar EJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047813; Dhurandhar EJ, 2011, OBESITY, V19, pS86; Dhurandhar EJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023394; Dhurandhar NV, 2013, J DIABETES COMPLICAT, V27, P191, DOI 10.1016/j.jdiacomp.2012.09.006; Dubuisson O, 2011, ENDOCRINOLOGY, V152, P3648, DOI 10.1210/en.2011-0225; DUNCAN MH, 1995, LANCET, V346, P120, DOI 10.1016/S0140-6736(95)92143-5; Farese RV, 2001, INSULIN SENSITIVE PH; GOODYEAR LJ, 1995, J CLIN INVEST, V95, P2195, DOI 10.1172/JCI117909; Hegde V, 2016, BIOCHIMIE, V121, P140, DOI 10.1016/j.biochi.2015.12.002; Krishnapuram R, 2013, INT J OBESITY, V37, P146, DOI 10.1038/ijo.2012.6; Krishnapuram R, 2011, AM J PHYSIOL-ENDOC M, V300, pE779, DOI 10.1152/ajpendo.00703.2010; Kusminski CM, 2015, MOL METAB, V4, P653, DOI 10.1016/j.molmet.2015.07.004; Legro RS, 1998, J CLIN ENDOCR METAB, V83, P2694, DOI 10.1210/jc.83.8.2694; Pan Wentong, 2012, J Metabonomics Metab, V1, DOI 10.4172/2325-9736.1000e103; Pasarica M, 2006, OBESITY, V14, P1905, DOI 10.1038/oby.2006.222; Pessin JE, 2000, J CLIN INVEST, V106, P165, DOI 10.1172/JCI10582; Rogers PM, 2008, INT J OBESITY, V32, P397, DOI 10.1038/sj.ijo.0803748; Sesti G, 2001, FASEB J, V15, P2099, DOI 10.1096/fj.01-0009rev; Wang ZQ, 2008, DIABETES, V57, P1805, DOI 10.2337/db07-1313; White MF, 1998, CURR TOP MICROBIOL, V228, P179; Zhou HH, 2009, EUR J PHARMACOL, V616, P346, DOI 10.1016/j.ejphar.2009.06.057	24	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0161275	10.1371/journal.pone.0161275	http://dx.doi.org/10.1371/journal.pone.0161275			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27537838	Green Submitted, gold, Green Published			2022-12-27	WOS:000381577000079
J	Brugnara, L; Murillo, S; Novials, A; Rojo-Martinez, G; Soriguer, F; Goday, A; Calle-Pascual, A; Castano, L; Gaztambide, S; Valdes, S; Franch, J; Castell, C; Vendrell, J; Casamitjana, R; Bosch-Comas, A; Bordiu, E; Carmena, R; Catala, M; Delgado, E; Girbes, J; Lopez-Alba, A; Martinez-Larrad, MT; Menendez, E; Mora-Peces, I; Pascual-Manich, G; Serrano-Rios, M; Gomis, R; Ortega, E				Brugnara, Laura; Murillo, Serafin; Novials, Anna; Rojo-Martinez, Gemma; Soriguer, Federico; Goday, Albert; Calle-Pascual, Alfonso; Castano, Luis; Gaztambide, Sonia; Valdes, Sergio; Franch, Josep; Castell, Conxa; Vendrell, Joan; Casamitjana, Roser; Bosch-Comas, Anna; Bordiu, Elena; Carmena, Rafael; Catala, Miguel; Delgado, Elias; Girbes, Juan; Lopez-Alba, Alfonso; Teresa Martinez-Larrad, Maria; Menendez, Edelmiro; Mora-Peces, Inmaculada; Pascual-Manich, Gemma; Serrano-Rios, Manuel; Gomis, Ramon; Ortega, Emilio			Low Physical Activity and Its Association with Diabetes and Other Cardiovascular Risk Factors: A Nationwide, Population-Based Study	PLOS ONE			English	Article							INSULIN-RESISTANCE; ADULTS; PREVENTION; PREVALENCE; OBESITY; DIET; ADHERENCE; EXERCISE	Low physical activity (PA), or sedentary lifestyle, is associated with the development of several chronic diseases. We aimed to investigate current prevalence of sedentariness and its association with diabetes and other cardiovascular risk factors. PA was evaluated in a population-based, cross-sectional, randomly sampled study conducted in 2009-2010 in Spain. International Physical Activity Questionnaire (SF-IPAQ) was used to assess PA. 4991 individuals (median age 50 years, 57% women) were studied. Prevalence of sedentariness was 32.3% for men and 39% for women (p < 0.0001). Sex differences were particularly notable (age*sex interaction, p = 0.0024) at early and older ages. Sedentary individuals had higher BMI (28 vs. 27 kg/m(2)) and obesity prevalence (37 vs. 26%). Low PA was present in 44, 43, and 38% of individuals with known diabetes (KDM), prediabetes/unknown-diabetes (PREDM/UKDM), and normal glucose regulation (p = 0.0014), respectively. No difference between KDM and PREDM/UKDM (p = 0.72) was found. Variables independently associated (p < 0.05) with sedentariness were age, sex, BMI, central obesity, Mediterranean diet adherence, smoking habit, HDL-cholesterol, triglycerides and dyslipidemia. Low PA is on the rise in Spain, especially among women. Sedentariness is associated with several cardiovascular risk factors and may be responsible for the increasing prevalence of obesity and diabetes in this country.	[Brugnara, Laura; Murillo, Serafin; Novials, Anna; Rojo-Martinez, Gemma; Soriguer, Federico; Castano, Luis; Gaztambide, Sonia; Valdes, Sergio; Vendrell, Joan; Casamitjana, Roser; Bosch-Comas, Anna; Carmena, Rafael; Catala, Miguel; Teresa Martinez-Larrad, Maria; Pascual-Manich, Gemma; Serrano-Rios, Manuel; Gomis, Ramon] CIBERDEM Spanish Biomed Res Ctr Diabet & Associat, Madrid, Spain; [Brugnara, Laura; Murillo, Serafin; Novials, Anna; Casamitjana, Roser; Bosch-Comas, Anna; Pascual-Manich, Gemma; Gomis, Ramon] Hosp Clin Barcelona, IDIBAPS August Pi & Sunyer Biomed Res Inst, Barcelona, Spain; [Rojo-Martinez, Gemma; Soriguer, Federico; Valdes, Sergio] Hosp Univ Carlos Haya, Dept Endocrinol & Nutr, Malaga, Spain; [Goday, Albert] Hosp Mar, Dept Endocrinol & Nutr, Barcelona, Spain; [Calle-Pascual, Alfonso; Bordiu, Elena] Hosp Univ San Carlos, Madrid, Spain; [Castano, Luis; Gaztambide, Sonia] Univ Basque Country, Hosp Univ Cruces, Diabet Res Grp, Baracaldo, Spain; [Franch, Josep] IDIAP, Red GEDAPS, Inst Catala Salut, EAP Raval Sud, Barcelona, Spain; [Castell, Conxa] Autonomous Govt Catalonia, Publ Hlth Div, Barcelona, Spain; [Vendrell, Joan] Hosp Univ Joan XXIII, Dept Endocrinol & Nutr, Tarragona, Spain; [Carmena, Rafael; Catala, Miguel] Hosp Clin Univ Valencia, Dept Med & Endocrinol, Valencia, Spain; [Delgado, Elias; Menendez, Edelmiro] Univ Oviedo, Hosp Univ Cent Asturias, Fac Med & Ciencias Salud, Dept Endocrinol & Nutr, Oviedo, Spain; [Girbes, Juan] Hosp Arnau Vilanova, Valencia, Spain; [Lopez-Alba, Alfonso] Fdn Hosp Jove, Gijon, Spain; [Serrano-Rios, Manuel] Hosp Clin San Carlos IdISSC, Inst Invest Sanitaria, Madrid, Spain; [Mora-Peces, Inmaculada] Canarian Hlth Serv, Tenerife, Spain; [Teresa Martinez-Larrad, Maria; Ortega, Emilio] CIBEROBN Spanish Biomed Res Ctr Physiopathol Obes, Pamplona, Spain; [Ortega, Emilio] Hosp Clin Barcelona, ICMDM, Dept Endocrinol & Nutr, Barcelona, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Hospital Carlos Haya; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Hospital Universitario Cruces; University of Basque Country; Hospital Clinic Universitari de Valencia; Central University Hospital Asturias; University of Oviedo; Hospital Clinico San Carlos; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; University of Barcelona; Hospital Clinic de Barcelona	Ortega, E (corresponding author), CIBEROBN Spanish Biomed Res Ctr Physiopathol Obes, Pamplona, Spain.; Ortega, E (corresponding author), Hosp Clin Barcelona, ICMDM, Dept Endocrinol & Nutr, Barcelona, Spain.	eortega1@clinic.ub.es	Vendrell, Joan j/V-4034-2018; Menendez Torre, Edelmiro Luis/AFR-2604-2022; Ortega Martínez de V, Emilio/AAB-2072-2022; Torre, Edelmiro Menéndez/G-1547-2013; Franch-Nadal, Josep/AAC-1945-2019; Serrano Ríos, Manuel/E-4625-2019; Rojo-martínez, Gemma/E-3351-2010; Delgado, Elias/B-2634-2013; Stefanadis, Christodoulos/ABH-2232-2020	Vendrell, Joan j/0000-0002-6994-6115; Menendez Torre, Edelmiro Luis/0000-0002-9548-7821; Ortega Martínez de V, Emilio/0000-0002-2217-8905; Torre, Edelmiro Menéndez/0000-0002-9548-7821; Franch-Nadal, Josep/0000-0002-5175-1555; Serrano Ríos, Manuel/0000-0002-3214-1444; Rojo-martínez, Gemma/0000-0003-2179-2134; Delgado, Elias/0000-0001-6114-9712; Stefanadis, Christodoulos/0000-0001-5974-6454; GAZTAMBIDE, SONIA/0000-0003-3569-2265; Castano, Luis/0000-0003-0437-9401; Novials, Anna/0000-0003-0465-2949	Spanish Biomedical Research Centre in Diabetes and Associated Metabolic Disorders (CIBERDEM; ISCIII Ministerio de Ciencia e Innovacion); Ministerio de Sanidad y Consumo; Spanish Diabetes Society (SED)	Spanish Biomedical Research Centre in Diabetes and Associated Metabolic Disorders (CIBERDEM; ISCIII Ministerio de Ciencia e Innovacion); Ministerio de Sanidad y Consumo(Instituto de Salud Carlos III); Spanish Diabetes Society (SED)	This work was supported by the Spanish Biomedical Research Centre in Diabetes and Associated Metabolic Disorders (CIBERDEM; ISCIII Ministerio de Ciencia e Innovacion), Ministerio de Sanidad y Consumo and the Spanish Diabetes Society (SED). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baudrand R, 2010, REV MED CHILE, V138, P1294, DOI [10.4067/S0034-98872010001100015, /S0034-98872010001100015]; Egede LE, 2002, ARCH INTERN MED, V162, P427, DOI 10.1001/archinte.162.4.427; Estruch R, 2013, NEW ENGL J MED, V368, P1279, DOI 10.1056/NEJMoa1200303; Guthold R, 2008, AM J PREV MED, V34, P486, DOI 10.1016/j.amepre.2008.02.013; Felix-Redondo FJ, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-542; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Larsson CA, 2012, METABOLISM, V61, P590, DOI 10.1016/j.metabol.2011.09.010; Lee PH, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-115; Lee PG, 2013, DIABETES CARE, V36, P3076, DOI 10.2337/dc13-0412; Lindstrom J, 2003, DIABETES CARE, V26, P3230, DOI 10.2337/diacare.26.12.3230; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Murillo S, 2008, AV DIABETOL, V24, P320; Navarro-Vidal B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061549; Nelson KM, 2002, DIABETES CARE, V25, P1722, DOI 10.2337/diacare.25.10.1722; Ortega E, 2013, ANN NUTR METAB, V62, P339, DOI 10.1159/000346553; Panagiotakos DB, 2007, PREV MED, V44, P335, DOI 10.1016/j.ypmed.2006.12.009; Paulweber B, 2010, HORM METAB RES, V42, pS3, DOI 10.1055/s-0029-1240928; Pitel L, 2010, PUBLIC HEALTH, V124, P512, DOI 10.1016/j.puhe.2010.05.005; Schneider KL, 2014, MED SCI SPORT EXER, V46, P84, DOI 10.1249/MSS.0b013e3182a33010; Sjostrom M, 2006, J PUBLIC HEALTH-HEID, V14, P291, DOI 10.1007/s10389-006-0031-y; Soriguer F, 2008, EUR J CLIN INVEST, V38, P126, DOI 10.1111/j.1365-2362.2007.01910.x; Soriguer F, 2012, DIABETOLOGIA, V55, P88, DOI 10.1007/s00125-011-2336-9; Strath SJ, 2013, CIRCULATION, V128, P2259, DOI 10.1161/01.cir.0000435708.67487.da; Varo JJ, 2003, INT J EPIDEMIOL, V32, P138, DOI 10.1093/ije/dyg116; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; WHO, 2010, GLOB REC PHYS ACT HL, V1st, P15; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Wing R, 2013, NEW ENGL J MED, V369, P145, DOI 10.1056/NEJMoa1212914; World Health Organization, 1999, WHONCDNCS992	29	33	36	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2016	11	8							e0160959	10.1371/journal.pone.0160959	http://dx.doi.org/10.1371/journal.pone.0160959			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4YN	27532610	Green Published, Green Submitted, gold			2022-12-27	WOS:000381487600050
J	Chen, YL; Reese, DH				Chen, Yanling; Reese, David H.			Disruption of Retinol (Vitamin A) Signaling by Phthalate Esters: SAR and Mechanism Studies	PLOS ONE			English	Article							MALE REPRODUCTIVE DEVELOPMENT; HOMOZYGOUS HOXA1 MUTATIONS; MALE-RAT; SEXUAL-DIFFERENTIATION; EXTERNAL GENITALIA; ACID BIOSYNTHESIS; AXIAL SKELETON; IN-UTERO; EXPRESSION; EXPOSURE	A spectrum of reproductive system anomalies (cryptorchidism, hypospadias, dysgenesis of Wolffian duct-derived tissues and prostate, and reduced sperm production) in male rats exposed in utero to phthalate esters (PEs) are thought to be caused by PE inhibition of fetal testosterone production. Recently, dibutyl and dipentyl phthalate (DBuP, DPnP) were shown to disrupt the retinol signaling pathway (RSP) in mouse pluripotent P19 embryonal carcinoma cells in vitro. The RSP regulates the synthesis and cellular levels of retinoic acid (RA), the active metabolite of retinol (vitamin A). In this new study, a total of 26 di- and mono-esters were screened to identify additional phthalate structures that disrupt the RSP and explore their mechanisms of action. The most potent PEs, those causing >50% inhibition, contained aryl and cycloalkane groups or C4-C6 alkyl ester chains and were the same PEs reported to cause malformations in utero. They shared similar lipid solubility; logP values were between 4 and 6 and, except for PEs with butyl and phenyl groups, were stable for prolonged periods in culture. Mono-and cognate di-esters varied in ability to disrupt the RSP; e.g., DEHP was inactive but its monoester was active while DBuP was active yet its monoester was inactive. DBuP and dibenzyl phthalate both disrupted the synthesis of RA from retinol but not the ability of RA to activate gene transcription. Both PEs also disrupted the RSP in C3H10T1/2 multipotent mesenchymal stem cells. Based on this in vitro study showing that some PEs disrupt retinol signaling and previous in vivo studies that vitamin A/RA deficiency and PEs both cause strikingly similar anomalies in the male rat reproductive system, we propose that PE-mediated inhibition of testosterone and RA synthesis in utero are both causes of malformations in male rat offspring.	[Chen, Yanling; Reese, David H.] US FDA, Div Mol Biol, Off Appl Res & Safety Assessment, Ctr Food Safety & Appl Nutr, 8301 Muirkirk Rd, Laurel, MD 20708 USA	US Food & Drug Administration (FDA)	Reese, DH (corresponding author), US FDA, Div Mol Biol, Off Appl Res & Safety Assessment, Ctr Food Safety & Appl Nutr, 8301 Muirkirk Rd, Laurel, MD 20708 USA.	dhreeseret@gmail.com	chen, yanling/GRE-8287-2022					Alexander T, 2009, ANNU REV CELL DEV BI, V25, P431, DOI 10.1146/annurev.cellbio.042308.113423; Balmer JE, 2002, J LIPID RES, V43, P1773, DOI 10.1194/jlr.R100015-JLR200; Bay K, 2011, NAT REV UROL, V8, P187, DOI 10.1038/nrurol.2011.23; Bosley TM, 2008, AM J MED GENET A, V146A, P1235, DOI 10.1002/ajmg.a.32262; Cammas L, 2007, DEV DYNAM, V236, P2899, DOI 10.1002/dvdy.21312; Cao XL, 2010, COMPR REV FOOD SCI F, V9, P21, DOI 10.1111/j.1541-4337.2009.00093.x; Cawley S, 2004, CELL, V116, P499, DOI 10.1016/S0092-8674(04)00127-8; Chen YL, 2013, BIRTH DEFECTS RES B, V98, P276, DOI 10.1002/bdrb.21062; Chen YL, 2011, J CELL BIOCHEM, V112, P2865, DOI 10.1002/jcb.23200; Clagett-Dame M, 2011, NUTRIENTS, V3, P385, DOI 10.3390/nu3040385; Cobb J, 2005, DEVELOPMENT, V132, P3055, DOI 10.1242/dev.01885; Davie JR, 2003, J NUTR, V133, p2485S, DOI 10.1093/jn/133.7.2485S; Ema M, 1997, J APPL TOXICOL, V17, P223, DOI 10.1002/(SICI)1099-1263(199707)17:4<223::AID-JAT433>3.0.CO;2-H; Farjo KM, 2011, DEV BIOL, V357, P347, DOI 10.1016/j.ydbio.2011.07.011; Feng CW, 2014, MOL CELL ENDOCRINOL, V382, P488, DOI 10.1016/j.mce.2013.09.026; Foster PMD, 2006, INT J ANDROL, V29, P140, DOI 10.1111/j.1365-2605.2005.00563.x; Foster PMD, 2005, CRIT REV TOXICOL, V35, P713, DOI 10.1080/10408440591007395; Gray LE, 2000, TOXICOL SCI, V58, P350, DOI 10.1093/toxsci/58.2.350; Hannas BR, 2011, TOXICOL SCI, V120, P184, DOI 10.1093/toxsci/kfq386; Hernandez-Diaz S, 2013, REPROD TOXICOL, V37, P1, DOI 10.1016/j.reprotox.2013.01.001; Kaiser ME, 2003, DEV BIOL, V257, P14, DOI 10.1016/S0012-1606(03)00044-7; Kelley KE, 2012, ENVIRON HEALTH PERSP, V120, P379, DOI 10.1289/ehp.1103998; KESSEL M, 1991, CELL, V67, P89, DOI 10.1016/0092-8674(91)90574-I; Klonisch T, 2005, INT J ONCOL, V27, P307; Liu LQ, 2012, BIRTH DEFECTS RES B, V95, P79, DOI 10.1002/bdrb.20344; LUFKIN T, 1991, CELL, V66, P1105, DOI 10.1016/0092-8674(91)90034-V; MCBURNEY MW, 1993, INT J DEV BIOL, V37, P135; Millard CJ, 2013, J MOL ENDOCRINOL, V51, pT23, DOI 10.1530/JME-13-0227; Miyagawa S, 2011, ENDOCRINOLOGY, V152, P2894, DOI 10.1210/en.2011-0263; Mylchreest E, 2000, TOXICOL SCI, V55, P143, DOI 10.1093/toxsci/55.1.143; Napoli JL, 2012, BBA-MOL CELL BIOL L, V1821, P152, DOI 10.1016/j.bbalip.2011.05.004; Nicholls PK, 2013, MOL CELL ENDOCRINOL, V377, P33, DOI 10.1016/j.mce.2013.06.034; Niederreither K, 1999, NAT GENET, V21, P444, DOI 10.1038/7788; Niederreither K, 1997, MECH DEVELOP, V62, P67, DOI 10.1016/S0925-4773(96)00653-3; Niederreither K, 2008, NAT REV GENET, V9, P541, DOI 10.1038/nrg2340; NOY N, 1990, BIOCHEMISTRY-US, V29, P3888, DOI 10.1021/bi00468a014; Ogino Y, 2001, ANN NY ACAD SCI, V948, P13; Parks LG, 2000, TOXICOL SCI, V58, P339, DOI 10.1093/toxsci/58.2.339; Pierzchalski K, 2014, BIOL REPROD, V91, DOI 10.1095/biolreprod.114.119677; Raverdeau M, 2012, P NATL ACAD SCI USA, V109, P16582, DOI 10.1073/pnas.1214936109; REESE DH, 1992, J CELL PHYSIOL, V151, P239, DOI 10.1002/jcp.1041510204; REZNIKOFF CA, 1973, CANCER RES, V33, P3231; Saillenfait AM, 2008, REPROD TOXICOL, V26, P107, DOI 10.1016/j.reprotox.2008.07.006; See AWM, 2008, DEV BIOL, V316, P171, DOI 10.1016/j.ydbio.2007.10.018; Serrano SE, 2014, ENVIRON HEALTH-GLOB, V13, DOI 10.1186/1476-069X-13-43; Serrano T, 2013, HUM REPROD, V28, P1974, DOI 10.1093/humrep/det111; Silva MJ, 2004, ENVIRON HEALTH PERSP, V112, P331, DOI 10.1289/ehp.6723; TAYLOR SM, 1979, CELL, V17, P771, DOI 10.1016/0092-8674(79)90317-9; Tischfield MA, 2005, NAT GENET, V37, P1035, DOI 10.1038/ng1636; van der Zanden LFM, 2012, HUM REPROD UPDATE, V18, P260, DOI 10.1093/humupd/dms002; Watson PJ, 2012, MOL CELL ENDOCRINOL, V348, P440, DOI 10.1016/j.mce.2011.08.033; WILSON JG, 1948, AM J ANAT, V83, P357, DOI 10.1002/aja.1000830303; WILSON JG, 1953, AM J ANAT, V92, P189, DOI 10.1002/aja.1000920202; Wolbach SB, 1925, J EXP MED, V42, P753, DOI 10.1084/jem.42.6.753; Yamasaki K, 2009, TOXICOL LETT, V189, P14, DOI 10.1016/j.toxlet.2009.04.023; Zhao XL, 2009, CURR BIOL, V19, P1050, DOI 10.1016/j.cub.2009.04.059	56	10	13	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2016	11	8							e0161167	10.1371/journal.pone.0161167	http://dx.doi.org/10.1371/journal.pone.0161167			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4YN	27532513	Green Published, Green Submitted, gold			2022-12-27	WOS:000381487600069
J	Costa, MD; de Paula, SO; Martins, GF; Zanuncio, JC; Santana, AEG; Serrao, JE				Costa, Marilza da Silva; de Paula, Sergio Oliveira; Martins, Gustavo Ferreira; Zanuncio, Jose Cola; Goulart Santana, Antonio Euzebio; Serrao, Jose Eduardo			Multiple Modes of Action of the Squamocin in the Midgut Cells of Aedes aegypti Larvae	PLOS ONE			English	Article							ATG1 KINASE COMPLEX; PROTEIN ATG8; FAT-BODY; AUTOPHAGY; DIPTERA; ATPASE; INSECTICIDES; ACETOGENINS; MECHANISMS	Annonaceous acetogenins are botanical compounds with good potential for use as insecticides. In the vector, Aedes aegypti (L.) (Diptera: Culicidae), squamocin (acetogenin) has been reported to be a larvicide and cytotoxic, but the modes of action of this molecule are still poorly understood. This study evaluated the changes in the cell morphology, and in the expression of genes, for autophagy (Atg1 and Atg8), for membrane ion transporter V-ATPase, and for water channel aquaporin-4 (Aqp4) in the midgut of A. aegypti larvae exposed to squamocin from Annona mucosa Jacq. (Annonaceae). Squamocin showed cytotoxic action with changes in the midgut epithelium and digestive cells of A. aegypti larvae, increase in the expression for autophagy gene Atg1 and Atg8, decrease in the expression of V-ATPase, decrease in the expression of Aqp4 gene in LC20 and inhibition of Apq4 genes in the midgut of this vector in LC50. These multiple modes of action for squamocin are described for the first time in insects, and they are important because different sites of action of squamocin from A. mucosa may reduce the possibility of resistance of A. aegypti to this molecule.	[Costa, Marilza da Silva; Zanuncio, Jose Cola] Univ Fed Vicosa, Dept Entomol, Vicosa, MG, Brazil; [de Paula, Sergio Oliveira; Martins, Gustavo Ferreira; Serrao, Jose Eduardo] Univ Fed Vicosa, Dept Gen Biol, Vicosa, MG, Brazil; [Goulart Santana, Antonio Euzebio] Univ Fed Alagoas, Inst Chem & Biotechnol, Maceio, Alagoas, Brazil	Universidade Federal de Vicosa; Universidade Federal de Vicosa; Universidade Federal de Alagoas	Serrao, JE (corresponding author), Univ Fed Vicosa, Dept Gen Biol, Vicosa, MG, Brazil.	jeserrao@ufv.br	De Paula, Sergio/N-2609-2018; Sant'Ana, Antonio/AAP-6955-2021; Martins, Gustavo Ferreira/AAL-7744-2020	De Paula, Sergio/0000-0002-2275-5768; Santana, Antonio/0000-0002-3750-438X; Martins, Gustavo/0000-0003-0614-8551	Conselho Nacional de Pesquisa grants reagents; Fundacao de Amparo a Pesquisa do estado de Minas Gerais; Brazilian research agency CNPq; Brazilian research agency FAPEMIG	Conselho Nacional de Pesquisa grants reagents; Fundacao de Amparo a Pesquisa do estado de Minas Gerais(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Brazilian research agency CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Brazilian research agency FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	The funding from Conselho Nacional de Pesquisa grants reagents for JES. The funding from Fundacao de Amparo a Pesquisa do estado de Minas Gerais grants fellowship and reagents for MSC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by Brazilian research agencies CNPq and FAPEMIG. Authors are grateful to Nucleus of Microscopy and Microanalysis, UFV, for technical support.	AHAMMADSAHIB KI, 1993, LIFE SCI, V53, P1113, DOI 10.1016/0024-3205(93)90547-G; Almeida GD, 2014, ISJ-INVERT SURVIV J, V11, P79; Alves SN, 2010, MICRON, V41, P592, DOI 10.1016/j.micron.2010.04.004; [Anonymous], 2012, PESTICIDES ADV CHEM, DOI DOI 10.5772/46225; Arruda W, 2008, REV PATOLOGIA TROPIC, V37; Bermejo A, 2005, NAT PROD REP, V22, P269, DOI 10.1039/b500186m; BOORMAN J. P. T., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P238, DOI 10.1016/0035-9203(56)90029-3; BRAGA I. A., 2007, REV EPIDEMIOLOGIA SA, V16, P179, DOI DOI 10.5123/S1679-49742007000400006; Bryant B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025502; Cheong H, 2008, MOL BIOL CELL, V19, P668, DOI 10.1091/mbc.E07-08-0826; COCKE J, 1979, LIFE SCI, V24, P817, DOI 10.1016/0024-3205(79)90366-7; Cooper S, 2009, AM J POTATO RES, V86, P24, DOI 10.1007/s12230-008-9057-8; Correia AA, 2009, NEOTROP ENTOMOL, V38, P83, DOI 10.1590/S1519-566X2009000100008; Costa MS, 2012, NEOTROP ENTOMOL, V41, P311, DOI 10.1007/s13744-012-0050-z; Costa MS, 2014, TOXINS, V6, P1169, DOI 10.3390/toxins6041169; DAVIDSON EW, 1979, CAN J MICROBIOL, V25, P178, DOI 10.1139/m79-028; Desneux N, 2007, ANNU REV ENTOMOL, V52, P81, DOI 10.1146/annurev.ento.52.110405.091440; Drake LL, 2015, SCI REP-UK, V5, DOI 10.1038/srep07795; Fernandes KM, 2015, MED VET ENTOMOL, V29, P245, DOI 10.1111/mve.12122; Finn RN, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8814; Furtado RF, 2005, NEOTROP ENTOMOL, V34, P843, DOI 10.1590/S1519-566X2005000500018; Ginzinger DG, 2002, EXP HEMATOL, V30, P503, DOI 10.1016/S0301-472X(02)00806-8; Halstead SB, 2008, ANNU REV ENTOMOL, V53, P273, DOI 10.1146/annurev.ento.53.103106.093326; Hariri M, 2000, MOL BIOL CELL, V11, P255, DOI 10.1091/mbc.11.1.255; He K, 1997, PESTIC SCI, V49, P372, DOI 10.1002/(SICI)1096-9063(199704)49:4&lt;372::AID-PS543&gt;3.0.CO;2-K; Hu C, 2010, ACTA CRYSTALLOGR F, V66, P787, DOI 10.1107/S1744309110018464; Ichimura Y, 2000, NATURE, V408, P488, DOI 10.1038/35044114; Isman MB, 2006, ANNU REV ENTOMOL, V51, P45, DOI 10.1146/annurev.ento.51.110104.151146; Kamada Y, 2010, MOL CELL BIOL, V30, P1049, DOI 10.1128/MCB.01344-09; Klionsky DJ, 2014, NAT STRUCT MOL BIOL, V21, P336, DOI 10.1038/nsmb.2787; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Ligon B Lee, 2006, Semin Pediatr Infect Dis, V17, P99, DOI 10.1053/j.spid.2006.04.009; Luna JED, 2004, REV SAUDE PUBL, V38, P842, DOI 10.1590/S0034-89102004000600013; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Nakatogawa H, 2012, J BIOL CHEM, V287, P28503, DOI 10.1074/jbc.C112.387514; Patramool S, 2012, PROTEOMICS, V12, P3510, DOI 10.1002/pmic.201200300; Patrick ML, 2006, J EXP BIOL, V209, P4638, DOI 10.1242/jeb.02551; Perumalsamy H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080226; Rattan RS, 2010, CROP PROT, V29, P913, DOI 10.1016/j.cropro.2010.05.008; Regis L, 2008, MEM I OSWALDO CRUZ, V103, P50, DOI 10.1590/S0074-02762008000100008; Rost-Roszkowska MM, 2012, ARTHROPOD STRUCT DEV, V41, P271, DOI 10.1016/j.asd.2012.01.001; Santos DE, 2015, PROTOPLASMA, V252, P619, DOI 10.1007/s00709-014-0707-z; Souza W, 2007, TECNICAS MICROSCOPI, P20; von Schwarzenberg K, 2013, J BIOL CHEM, V288, P1385, DOI 10.1074/jbc.M112.412007; Whalon M, 2006, DATABASE ARTHROPOD R; Wieczorek H, 1999, J BIOENERG BIOMEMBR, V31, P67, DOI 10.1023/A:1005448614450; Wink M, 2000, STUD NAT PROD CHEM, V21, P3; Zhuang ZP, 1999, J EXP BIOL, V202, P2449	48	24	25	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2016	11	8							e0160928	10.1371/journal.pone.0160928	http://dx.doi.org/10.1371/journal.pone.0160928			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4YN	27532504	Green Submitted, Green Published, gold			2022-12-27	WOS:000381487600049
J	Kim, YB; Kim, JG; Kim, W; Im, JH; Kim, TH; Kang, SJ; Kim, CH				Kim, Young Bin; Kim, Jun Gi; Kim, Wook; Im, Jae Ho; Kim, Tae Hyeong; Kang, Shin Jin; Kim, Chang Hun			Predicting Fluctuations in Cryptocurrency Transactions Based on User Comments and Replies	PLOS ONE			English	Article							CLASSIFICATION; PATTERNS	This paper proposes a method to predict fluctuations in the prices of cryptocurrencies, which are increasingly used for online transactions worldwide. Little research has been conducted on predicting fluctuations in the price and number of transactions of a variety of cryptocurrencies. Moreover, the few methods proposed to predict fluctuation in currency prices are inefficient because they fail to take into account the differences in attributes between real currencies and cryptocurrencies. This paper analyzes user comments in online cryptocurrency communities to predict fluctuations in the prices of cryptocurrencies and the number of transactions. By focusing on three cryptocurrencies, each with a large market size and user base, this paper attempts to predict such fluctuations by using a simple and efficient method.	[Kim, Young Bin; Kim, Tae Hyeong] Korea Univ, Interdisciplinary Program Visual Informat Proc, Seoul, South Korea; [Kim, Jun Gi; Kang, Shin Jin] Hongik Univ, Sch Games, Seoul, South Korea; [Kim, Wook; Im, Jae Ho; Kim, Chang Hun] Korea Univ, Dept Comp & Radio Commun Engn, Seoul, South Korea	Korea University; Hongik University; Korea University	Kim, CH (corresponding author), Korea Univ, Dept Comp & Radio Commun Engn, Seoul, South Korea.	chkim@korea.ac.kr			Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science, ICT and future Planning [NRF-2014R1A2A2A01007143, NRF-2015R1C1A2A01053543, NRF-2015R1A2A1A16074940, NRF-2015R1A1A1A05001196]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science, ICT and future Planning	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF), funded by the Ministry of Education, Science, ICT and future Planning (NRF-2014R1A2A2A01007143, NRF-2015R1C1A2A01053543, NRF-2015R1A2A1A16074940, and NRF-2015R1A1A1A05001196).	Abbasi A, 2008, ACM T INFORM SYST, V26, DOI [10.1145/1344411.1344413, 10.1145/1361684.1361685]; Agarwal A., 2011, P WORKSH LANG SOC ME; Ahamad S., 2013, 4 INT C ADV COMP SCI; [Anonymous], 2011, SCIENCE, DOI [DOI 10.21055/0370-1069-2020-1-51-60, DOI 10.1016/j.jocs.2010.12.007]; [Anonymous], P INT C LANG RES EV; Baccianella Stefano, 2010, LREC; Bernstein Michael S, 2011, ICWSM; Bifet A., 2010, DISCOVERY SCI; Bo Pang, 2008, Foundations and Trends in Information Retrieval, V2, P1, DOI 10.1561/1500000001; Bohme R, 2015, J ECON PERSPECT, V29, P213, DOI 10.1257/jep.29.2.213; Cohen-Charash Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072031; Garcia D, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0623; Glorot X, 2011, P 28 INT C MACH LEAR, P513; Granger C.W., 2000, Q REV ECON FINANC, V40, P337, DOI DOI 10.1016/S1062-9769(00)00042-9; Grinberg R., 2012, HASTINGS SCI TECH L, V4, P159; Hau YS, 2011, COMPUT HUM BEHAV, V27, P956, DOI 10.1016/j.chb.2010.11.022; Hutto C.J., 2014, PROC INT AAAI C WEB; Kim S-H, 2008, J KOREAN I INTELLIGE, V18, P781; Kim YB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132944; Kondor D, 2014, NEW J PHYS, V16, DOI 10.1088/1367-2630/16/12/125003; Kondor D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086197; Kouloumpis E, 2011, ICWSM, V11, P164; Kristoufek L., 2013, SCI REPORTS, V3; Kristoufek L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123923; Lahmiri S., 2011, INT J COMPUTER APPL, V29, P24; Manning C. D., 2014, STANFORD CORENLP NAT; Matta M., 2015, P DECAT; Maurer B, 2013, SOC SEMIOT, V23, P261, DOI 10.1080/10350330.2013.777594; McCord M., 2011, Autonomic and Trusted Computing. Proceedings 8th International Conference (ATC 2011), P175, DOI 10.1007/978-3-642-23496-5_13; Nakamoto S., 2019, BITCOIN PEER TO PEER, P21260; Pang Bo, 2002, P ACL 02 C EMP METH, V10; Panzarasa P, 2009, J AM SOC INF SCI TEC, V60, P911, DOI 10.1002/asi.21015; Read J., 2005, P ACL STUD RES WORKS; Reid F, 2013, ANAL ANONYMITY BITCO; Ron D., LNCS, V7859, P6, DOI DOI 10.1007/978-3-642-39884-1; Shah D., 2014, COMM CONTR COMP ALL; Sing CC, 2006, EDUC TECHNOL SOC, V9, P250; Song J, 2011, RECENT ADV INTRUSION; Tang HF, 2009, EXPERT SYST APPL, V36, P10760, DOI 10.1016/j.eswa.2009.02.063; Thelwall M, 2012, J AM SOC INF SCI TEC, V63, P163, DOI 10.1002/asi.21662; Thomas K, 2011, P 2011 ACM SIGCOMM C, P243; van Rossum G., 2010, PYTHON LANGUAGE REFE, V3rd ed; Wang A. H., 2010, SEC CRYPT SECRYPT P; Webb GI, 2005, MACH LEARN, V58, P5, DOI 10.1007/s10994-005-4258-6; Yardi S, 2010, 1 MONDAY, V15, DOI [10.5210/fm.v15i1.2793, DOI 10.5210/FM.V15I1.2793]; Ye Q, 2009, EXPERT SYST APPL, V36, P6527, DOI 10.1016/j.eswa.2008.07.035; YELOWITZ A, 2015, APPL ECON LETT, V22, P1030, DOI DOI 10.1080/13504851.2014.995359	47	46	47	0	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2016	11	8							e0161197	10.1371/journal.pone.0161197	http://dx.doi.org/10.1371/journal.pone.0161197			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DT4YN	27533113	gold, Green Published, Green Submitted			2022-12-27	WOS:000381487600073
J	Ortiz, F; Gelpi, R; Helantera, I; Melilli, E; Honkanen, E; Bestard, O; Grinyo, JM; Cruzado, JM				Ortiz, Fernanda; Gelpi, Rosana; Helantera, Ilkka; Melilli, Edoardo; Honkanen, Eero; Bestard, Oriol; Grinyo, Josep M.; Cruzado, Josep M.			Decreased Kidney Graft Survival in Low Immunological Risk Patients Showing Inflammation in Normal Protocol Biopsies	PLOS ONE			English	Article							EARLY SUBCLINICAL REJECTION; RENAL-ALLOGRAFT REJECTION; TUBULAR ATROPHY; TRANSPLANT RECIPIENTS; INTERSTITIAL FIBROSIS; SURVEILLANCE BIOPSIES; PROTEINURIA; CLASSIFICATION; CONSEQUENCES; MANAGEMENT	Introduction The pros and cons for implementing protocol biopsies (PB) after kidney transplantation are still a matter of debate. We aimed to address the frequency of pathological findings in PB, to analyze their impact on long-term graft survival (GS) and to analyze the risk factors predicting an abnormal histology. Methods We analyzed 946 kidney PB obtained at a median time of 6.5 (+/- 2.9) months after transplantation. Statistics included comparison between groups, Kaplan-Meier and multinomial logistic regression analysis. Results and Discussion PB diagnosis were: 53.4% normal; 46% IFTA; 12.3% borderline and 4.9% had subclinical acute rejection (SCAR). Inflammation had the strongest negative impact on GS. Therefore we split the cases into: "normal without inflammation", "normal with inflammation", "IFTA without inflammation", "IFTA with inflammation" and "rejection" (including SCAR and borderline). 15-year GS in PB diagnosed normal with inflammation was significantly decreased in a similar fashion as in rejection cases. Among normal biopsies, inflammation increased significantly the risk of 15-y graft loss (P = 0.01). Variables that predicted an abnormal biopsy were proteinuria, previous AR and DR-mismatch. Conclusion We conclude that inflammation in normal PB is associated with a significantly lower 15-y GS, comparable to rejection or IFTA with inflammation.	[Ortiz, Fernanda; Honkanen, Eero] Helsinki Univ Hosp, Nephrol, Helsinki, Finland; [Gelpi, Rosana; Melilli, Edoardo; Bestard, Oriol; Grinyo, Josep M.; Cruzado, Josep M.] Bellvitge Univ Hosp, Dept Nephrol, Barcelona, Spain; [Helantera, Ilkka] Helsinki Univ Hosp, Transplantat & Liver Surg, Helsinki, Finland	University of Helsinki; Helsinki University Central Hospital; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; University of Helsinki; Helsinki University Central Hospital	Ortiz, F (corresponding author), Helsinki Univ Hosp, Nephrol, Helsinki, Finland.	fernanda.ortiz@hus.fi		Melilli, Edoardo/0000-0001-6965-3745; Ortiz, Fernanda/0000-0003-0462-4833	 [TYH2015108];  [PI12/01427]	; 	The work was supported by the following: http://www.med.helsinki.fi/english/research/, Grant number TYH2015108; and http://redinren.org/, Grant Number PI12/01427.	Amer H, 2007, AM J TRANSPLANT, V7, P2748, DOI 10.1111/j.1600-6143.2007.02006.x; Buchmann TN, 2012, TRANSPLANTATION, V93, P908, DOI 10.1097/TP.0b013e318248cab0; Cosio FG, 2005, AM J TRANSPLANT, V5, P2464, DOI 10.1111/j.1600-6143.2005.01050.x; de Freitas DG, 2012, AM J TRANSPLANT, V12, P191, DOI 10.1111/j.1600-6143.2011.03784.x; de Freitas DG, 2011, AM J TRANSPLANT, V11, P56; Gago M, 2012, AM J TRANSPLANT, V12, P1199, DOI 10.1111/j.1600-6143.2011.03911.x; Halimi JM, 2007, AM J TRANSPLANT, V7, P2775, DOI 10.1111/j.1600-6143.2007.02010.x; Halimi JM, 2005, AM J TRANSPLANT, V5, P2281, DOI 10.1111/j.1600-6143.2005.01020.x; Heilman RL, 2010, AM J TRANSPLANT, V10, P563, DOI 10.1111/j.1600-6143.2009.02966.x; ISONIEMI H, 1994, TRANSPLANTATION, V58, P1195, DOI 10.1097/00007890-199412270-00010; Jenni F, 2013, KIDNEY BLOOD PRESS R, V37, P116, DOI 10.1159/000350065; Kee TYS, 2006, TRANSPLANTATION, V82, P36, DOI 10.1097/01.tp.0000225783.86950.c2; Legendre C, 2014, TRANSPL INT, V27, P19, DOI 10.1111/tri.12217; Mannon RB, 2010, AM J TRANSPLANT, V10, P2066, DOI 10.1111/j.1600-6143.2010.03240.x; Matsushita K, 2012, JAMA-J AM MED ASSOC, V307, P1941, DOI 10.1001/jama.2012.3954; Mengel M, 2007, AM J TRANSPLANT, V7, P512, DOI 10.1111/j.1600-6143.2006.01677.x; Mengel M, 2007, AM J TRANSPLANT, V7, P356, DOI 10.1111/j.1600-6143.2006.01635.x; Moreso F, 2012, TRANSPLANTATION, V93, P41, DOI 10.1097/TP.0b013e31823bb647; Nankivell BJ, 2006, AM J TRANSPLANT, V6, P2006, DOI 10.1111/j.1600-6143.2006.01436.x; Oblak M, 2013, TRANSPL P, V45, P1453, DOI 10.1016/j.transproceed.2013.02.106; Ponticelli C, 2012, TRANSPL INT, V25, P909, DOI 10.1111/j.1432-2277.2012.01500.x; Racusen LC, 2003, AM J TRANSPLANT, V3, P708, DOI 10.1034/j.1600-6143.2003.00072.x; Racusen LC, 1999, KIDNEY INT, V55, P713, DOI 10.1046/j.1523-1755.1999.00299.x; Roberts ISD, 2004, TRANSPLANTATION, V77, P1194, DOI 10.1097/01.TP.0000118905.98469.91; Rush D, 2007, AM J TRANSPLANT, V7, P2538, DOI 10.1111/j.1600-6143.2007.01979.x; Rush D, 1998, J AM SOC NEPHROL, V9, P2129; Rush DN, 2015, CURR OPIN NEPHROL HY, V24, P582, DOI 10.1097/MNH.0000000000000170; RUSH DN, 1995, TRANSPLANT P, V27, P1017; RUSH DN, 1994, TRANSPLANTATION, V57, P208, DOI 10.1097/00007890-199401001-00009; Scholten EM, 2006, J AM SOC NEPHROL, V17, P2622, DOI 10.1681/ASN.2006030227; Seron D, 2009, TRANSPL P, V41, P769, DOI 10.1016/j.transproceed.2008.12.027; Shamseddin MK, 2011, CLIN J AM SOC NEPHRO, V6, P1786, DOI 10.2215/CJN.01310211; Solez K, 2007, AM J TRANSPLANT, V7, P518, DOI 10.1111/j.1600-6143.2006.01688.x; Thierry A, 2011, AM J TRANSPLANT, V11, P2153, DOI 10.1111/j.1600-6143.2011.03695.x	34	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2016	11	8							e0159717	10.1371/journal.pone.0159717	http://dx.doi.org/10.1371/journal.pone.0159717			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4YN	27532630	Green Submitted, Green Published, gold			2022-12-27	WOS:000381487600009
J	Zhang, C; Wu, JM; Hu, ZW; Yan, C; Gao, X; Liang, WT; Liu, DG; Li, F; Wang, ZG				Zhang, Chao; Wu, Jimin; Hu, Zhiwei; Yan, Chao; Gao, Xiang; Liang, Weitao; Liu, Diangang; Li, Fei; Wang, Zhonggao			Diagnosis and Anti-Reflux Therapy for GERD with Respiratory Symptoms: A Study Using Multichannel Intraluminal Impedance-pH Monitoring	PLOS ONE			English	Article							GASTROESOPHAGEAL-REFLUX DISEASE; LAPAROSCOPIC NISSEN FUNDOPLICATION; INVASIVE ENDOSCOPIC PROCEDURE; EXTRAESOPHAGEAL MANIFESTATIONS; STRETTA RADIOFREQUENCY; TOUPET FUNDOPLICATION; RANDOMIZED-TRIAL; ASSOCIATION; MANAGEMENT; STANDARD	Background/Aims Respiratory symptoms are often associated with gastroesophageal reflux disease (GERD). Although the role of multichannel intraluminal impedance-pH (MII-pH) monitoring in GERD is clear, little is known regarding the characteristics of patients with respiratory symptoms based on MII-pH monitoring and anti-reflux therapy. We evaluated a cohort of GERD patients to identify the MII-pH parameters of GERD-related respiratory symptoms and to assess the anti-reflux therapy outcomes. Methods We undertook a prospective study of patients who were referred for GERD evaluation from January 2011 to January 2012. One hundred ninety-five patients underwent MII-pH monitoring and esophageal manometry, and one hundred sixty-five patients underwent invasive anti-reflux therapy that included laparoscopic Toupet fundoplication (LTF) and the Stretta procedure. The patient characteristics and MII-pH parameters were analyzed, and the symptom scores were assessed at baseline and at 1- and 3-year follow-up evaluations. Results Of the 195 patients, 96 (49.2%) exhibited respiratory symptoms and significantly more reflux episodes (70.7 +/- 29.3) than patients without respiratory symptoms (64.7 +/- 24.4, p = 0.044) based on the MII-pH monitoring results. Moreover, the group of patients with respiratory symptoms exhibited more proximal reflux episodes (35.2 +/- 21.3) than the non-respiratory symptomatic group (28.3 +/- 17.9, p = 0.013). One hundred twenty-five patients following the Stretta procedure (n = 60, 31 with respiratory symptoms) or LTF (n = 65, 35 with respiratory symptoms) completed the designated 3-year follow-up period and were included in the final analysis. The symptom scores after anti-reflux therapy all decreased relative to the corresponding baseline values (p<0.05), and there were no significant differences in the control of respiration between the Stretta procedure and LTF (p>0.05). However, LTF significantly reduced the recurrence (re-operation) rate compared with the Stretta procedure (0 vs. 19.4%, p = 0.006). Conclusions MII-pH monitoring effectively detected respiratory-related predictive parameters, including total/proximal reflux episodes and symptom correlations. We found that GERD patients with respiratory symptoms exhibited more proximal and total reflux episodes but not more acid-related episodes, as determined by MII-pH monitoring. Thus, such monitoring could be useful for diagnosing atypical GERD patients with respiratory symptoms. Furthermore, LTF exhibited a more significant effect on controlling typical symptoms in all GERD patients and reducing the recurrence rate than the Stretta procedure in patients with respiratory symptoms.	[Zhang, Chao; Yan, Chao; Gao, Xiang; Liang, Weitao; Liu, Diangang; Li, Fei; Wang, Zhonggao] Capital Med Univ, Xuanwu Hosp, Dept Gen Surg, 45 Changchun St, Beijing 100053, Peoples R China; [Zhang, Chao; Wu, Jimin; Hu, Zhiwei; Wang, Zhonggao] Chinese Peoples Liberat Army, Dept Gastroesophageal Reflux Dis, Artillery Gen Hosp 2, 16 Xinjiekou St, Beijing 100088, Peoples R China	Capital Medical University	Li, F; Wang, ZG (corresponding author), Capital Med Univ, Xuanwu Hosp, Dept Gen Surg, 45 Changchun St, Beijing 100053, Peoples R China.; Wang, ZG (corresponding author), Chinese Peoples Liberat Army, Dept Gastroesophageal Reflux Dis, Artillery Gen Hosp 2, 16 Xinjiekou St, Beijing 100088, Peoples R China.	feili36@ccmu.edu.cn; wangzg35@126.com			National High Technology Research and Development Program 863 of China [2007AAOZ4Z6]	National High Technology Research and Development Program 863 of China(National High Technology Research and Development Program of China)	This work was supported by the National High Technology Research and Development Program 863 of China (2007AAOZ4Z6 to Z.G. Wang).	Aanen MC, 2008, J CLIN GASTROENTEROL, V42, P441, DOI 10.1097/MCG.0b013e318074dd62; Aziz AMA, 2010, SURG ENDOSC, V24, P818, DOI 10.1007/s00464-009-0671-4; Blonski W, 2008, J CLIN GASTROENTEROL, V42, P776, DOI 10.1097/MCG.0b013e31806daf77; Cho Yu Kyung, 2010, Korean J Gastroenterol, V55, P279; Cicala M, 2013, WORLD J GASTROENTERO, V19, P6529, DOI 10.3748/wjg.v19.i39.6529; Comay D, 2008, CAN J GASTROENTEROL, V22, P552, DOI 10.1155/2008/765458; de Bortoli N, 2012, WORLD J GASTROENTERO, V18, P4363, DOI 10.3748/wjg.v18.i32.4363; Gislason T, 2002, CHEST, V121, P158, DOI 10.1378/chest.121.1.158; Katz PO, 2013, AM J GASTROENTEROL, V108, P308, DOI 10.1038/ajg.2012.444; Khan MQ, 2014, J NEUROGASTROENTEROL, V20, P497, DOI 10.5056/jnm14038; Kirschniak A, 2013, ZBL CHIR, V138, P397, DOI [10.1055/s-1350636, 10.1055/s-0033-1350636]; Koch OO, 2012, SURG LAPARO ENDO PER, V22, P387, DOI 10.1097/SLE.0b013e31825efb5b; Kohata Y, 2012, J GASTROEN HEPATOL, V27, P58, DOI 10.1111/j.1440-1746.2012.07074.x; Lee Bong Eun, 2010, J Neurogastroenterol Motil, V16, P157, DOI 10.5056/jnm.2010.16.2.157; Lee JH, 2012, GUT LIVER, V6, P197, DOI 10.5009/gnl.2012.6.2.197; Liang WT, 2014, MINERVA CHIR, V69, P293; Liang WT, 2014, MINERVA CHIR, V69, P217; Liang WT, 2015, J LAPAROENDOSC ADV S, V25, P657, DOI 10.1089/lap.2015.0188; Liang WT, 2014, BMC GASTROENTEROL, V14, DOI 10.1186/1471-230X-14-178; Loots CM, 2009, J PEDIATR-US, V154, P248, DOI 10.1016/j.jpeds.2008.08.019; Madan K, 2005, J GASTROEN HEPATOL, V20, P30, DOI 10.1111/j.1440-1746.2004.03530.x; Moraes-Filho Joaquim Prado P., 2012, Arq. Gastroenterol., V49, P296, DOI 10.1590/S0004-28032012000400012; Morehead RS, 2009, EUR RESPIR REV, V18, P233, DOI 10.1183/09059180.00002509; Napierkowski J, 2003, AM J MED SCI, V326, P285, DOI 10.1097/00000441-200311000-00005; Patel A, 2015, CLIN GASTROENTEROL H, V13, P884, DOI 10.1016/j.cgh.2014.08.029; Qin MF, 2013, J LAPAROENDOSC ADV S, V23, P601, DOI 10.1089/lap.2012.0485; Rosen R, 2011, J PEDIATR GASTR NUTR, V52, P404, DOI 10.1097/MPG.0b013e3182078081; Rothenberg SS, 2013, J LAPAROENDOSC ADV S, V23, P791, DOI 10.1089/lap.2013.0299; Savarino E, 2008, AM J GASTROENTEROL, V103, P2685, DOI 10.1111/j.1572-0241.2008.02119.x; Shaw JM, 2010, SURG ENDOSC, V24, P924, DOI 10.1007/s00464-009-0700-3; Soyer T, 2007, EUR J PEDIATR SURG, V17, P158, DOI 10.1055/s-2007-965393; Thoman DS, 2002, J GASTROINTEST SURG, V6, P17, DOI 10.1016/S1091-255X(01)00013-0; Tutuian R., 2006, GI MOTILITY ONLINE, DOI [10.1038/gimo31, DOI 10.1038/GIMO31]; Vakil N, 2006, AM J GASTROENTEROL, V101, P1900, DOI 10.1111/j.1572-0241.2006.00630.x; Varannes SBD, 2010, BEST PRACT RES CL GA, V24, P905, DOI 10.1016/j.bpg.2010.09.004; Wang ZG, 2015, FRONT MED-PRC, V9, P117, DOI 10.1007/s11684-014-0343-1; Wu JCY, 2008, J GASTROEN HEPATOL, V23, P1785, DOI 10.1111/j.1440-1746.2008.05684.x; Zerbib F, 2006, AM J GASTROENTEROL, V101, P1956, DOI 10.1111/j.1572-0241.2006.00711.x; Zhu GC, 2014, CHIN J EXP SURG, V31, P3330	39	13	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2016	11	8							e0160139	10.1371/journal.pone.0160139	http://dx.doi.org/10.1371/journal.pone.0160139			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4YN	27532103	Green Published, gold, Green Submitted			2022-12-27	WOS:000381487600024
J	Dietz, S; Schirmer, U; Merce, C; von Bubnoff, N; Dahl, E; Meister, M; Muley, T; Thomas, M; Sultmann, H				Dietz, Steffen; Schirmer, Uwe; Merce, Clementine; von Bubnoff, Nikolas; Dahl, Edgar; Meister, Michael; Muley, Thomas; Thomas, Michael; Sueltmann, Holger			Low Input Whole-Exome Sequencing to Determine the Representation of the Tumor Exome in Circulating DNA of Non-Small Cell Lung Cancer Patients	PLOS ONE			English	Article							PLASMA DNA; GENOME; MUTATIONS; BLOOD; EVOLUTION; ORIGIN; QUANTIFICATION; HETEROGENEITY; CAPTURE; FORMAT	Circulating cell-free DNA (cfDNA) released from cancerous tissues has been found to harbor tumor-associated alterations and to represent the molecular composition of the tumor. Recent advances in technologies, especially in next-generation sequencing, enable the analysis of low amounts of cfDNA from body fluids. We analyzed the exomes of tumor tissue and matched serum samples to investigate the molecular representation of the tumor exome in cfDNA. To this end, we implemented a workflow for sequencing of cfDNA from low serum volumes (200 mu l) and performed whole-exome sequencing (WES) of serum and matched tumor tissue samples from six non-small cell lung cancer (NSCLC) patients and two control sera. Exomes, including untranslated regions (UTRs) of cfDNA were sequenced with an average coverage of 68.5x. Enrichment efficiency, target coverage, and sequencing depth of cfDNA reads were comparable to those from matched tissues. Discovered variants were compared between serum and tissue as well as to the COSMIC database of known mutations. Although not all tissue variants could be confirmed in the matched serum, up to 57% of the tumor variants were reflected in matched cfDNA with mutations in PIK3CA, ALK, and PTEN as well as variants at COSMIC annotated sites in all six patients analyzed. Moreover, cfDNA revealed a mutation in MTOR, which was not detected in the matched tissue, potentially from an untested region of the heterogeneous primary tumor or from a distant metastatic clone. WES of cfDNA may provide additional complementary molecular information about clinically relevant mutations and the clonal heterogeneity of the tumors.	[Dietz, Steffen; Schirmer, Uwe; Merce, Clementine; Sueltmann, Holger] German Canc Res Ctr, Canc Genome Res Grp, Neuenheimer Feld 460, Heidelberg, Germany; [Dietz, Steffen; Schirmer, Uwe; Merce, Clementine; Sueltmann, Holger] Natl Ctr Tumor Dis NCT, Neuenheimer Feld 460, Heidelberg, Germany; [Dietz, Steffen; Schirmer, Uwe; Merce, Clementine; Meister, Michael; Muley, Thomas; Thomas, Michael; Sueltmann, Holger] German Ctr Lung Res DZL, TLRC, Heidelberg, Germany; [von Bubnoff, Nikolas] Univ Med Ctr Freiburg, Dept Hematol Oncol & Stem Cell Transplantat, Freiburg, Germany; [von Bubnoff, Nikolas; Sueltmann, Holger] German Canc Consortium DKTK, Heidelberg, Germany; [Dahl, Edgar] Rhein Westfal TH Aachen, Inst Pathol, Mol Oncol Grp, Aachen, Germany; [Meister, Michael; Muley, Thomas] Univ Heidelberg Hosp, Translat Res Unit, Thoraxklin, Heidelberg, Germany; [Thomas, Michael] Univ Heidelberg Hosp, Dept Oncol, Thoraxklin, Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; University of Freiburg; Helmholtz Association; German Cancer Research Center (DKFZ); RWTH Aachen University; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Sultmann, H (corresponding author), German Canc Res Ctr, Canc Genome Res Grp, Neuenheimer Feld 460, Heidelberg, Germany.; Sultmann, H (corresponding author), Natl Ctr Tumor Dis NCT, Neuenheimer Feld 460, Heidelberg, Germany.; Sultmann, H (corresponding author), German Ctr Lung Res DZL, TLRC, Heidelberg, Germany.; Sultmann, H (corresponding author), German Canc Consortium DKTK, Heidelberg, Germany.	h.sueltmann@dkfz.de	von Bubnoff, Nikolas/F-2351-2017; Muley, Thomas/AAY-9200-2020; von Bubnoff, Nikolas/AAG-1845-2021; Sültmann, Holger/E-4534-2013	von Bubnoff, Nikolas/0000-0001-9593-8947; Sültmann, Holger/0000-0002-5257-8600				Aird D, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-r18; Alexandrov LB, 2014, CURR OPIN GENET DEV, V24, P52, DOI 10.1016/j.gde.2013.11.014; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Belkadi A, 2015, P NATL ACAD SCI USA, V112, P5473, DOI 10.1073/pnas.1418631112; Bettegowda C, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007094; Butler TM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136407; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Collisson EA, 2014, NATURE, V511, P543, DOI 10.1038/nature13385; Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330; Dawson SJ, 2013, NEW ENGL J MED, V368, P1199, DOI 10.1056/NEJMoa1213261; de Bruin EC, 2014, SCIENCE, V346, P251, DOI 10.1126/science.1253462; De Mattos-Arruda L, 2014, ANN ONCOL, V25, P1729, DOI 10.1093/annonc/mdu239; Diaz LA, 2014, J CLIN ONCOL, V32, P579, DOI 10.1200/JCO.2012.45.2011; Diehl F, 2005, P NATL ACAD SCI USA, V102, P16368, DOI 10.1073/pnas.0507904102; Diehl F, 2008, NAT MED, V14, P985, DOI 10.1038/nm.1789; Fan HC, 2008, P NATL ACAD SCI USA, V105, P16266, DOI 10.1073/pnas.0808319105; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Forshew T, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003726; Frenel JS, 2015, CLIN CANCER RES, V21, P4586, DOI 10.1158/1078-0432.CCR-15-0584; Frumkin D, 2005, PLOS COMPUT BIOL, V1, P382, DOI 10.1371/journal.pcbi.0010050; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Gomez-Ramos A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101412; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Heitzer E, 2013, INT J CANCER, V133, P346, DOI 10.1002/ijc.28030; Holstege H, 2014, GENOME RES, V24, P733, DOI 10.1101/gr.162131.113; Hummel M, 2011, BIOINFORMATICS, V27, P1316, DOI 10.1093/bioinformatics/btr122; Jahr S, 2001, CANCER RES, V61, P1659; Jiang PY, 2015, P NATL ACAD SCI USA, V112, pE1317, DOI 10.1073/pnas.1500076112; Kane MD, 2000, NUCLEIC ACIDS RES, V28, P4552, DOI 10.1093/nar/28.22.4552; Klevebring D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104417; Kozarewa I, 2009, NAT METHODS, V6, P291, DOI [10.1038/nmeth.1311, 10.1038/NMETH.1311]; Lawrence MS, 2014, NATURE, V505, P495, DOI 10.1038/nature12912; Leary RJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004742; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lo YMD, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001720; Lupski JR, 2013, SCIENCE, V341, P358, DOI 10.1126/science.1239503; McBride DJ, 2010, GENE CHROMOSOME CANC, V49, P1062, DOI 10.1002/gcc.20815; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mohan S, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004271; Murtaza M, 2013, NATURE, V497, P108, DOI 10.1038/nature12065; Newman AM, 2014, NAT MED, V20, P552, DOI 10.1038/nm.3519; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Rykalina VN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101154; Snyder MW, 2016, CELL, V164, P57, DOI 10.1016/j.cell.2015.11.050; SORENSON GD, 1994, CANCER EPIDEM BIOMAR, V3, P67; Tennessen JA, 2012, SCIENCE, V337, P64, DOI 10.1126/science.1219240; Thierry AR, 2014, NAT MED, V20, P430, DOI 10.1038/nm.3511; Thierry AR, 2010, NUCLEIC ACIDS RES, V38, P6159, DOI 10.1093/nar/gkq421; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Wang ZT, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0097907, 10.1371/journal.pone.0114792, 10.1371/journal.pone.0103645, 10.1371/journal.pone.0089948, 10.1371/journal.pone.0087381, 10.1371/journal.pone.0091755, 10.1371/journal.pone.0109571, 10.1371/journal.pone.0104657]	52	30	31	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2016	11	8							e0161012	10.1371/journal.pone.0161012	http://dx.doi.org/10.1371/journal.pone.0161012			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4UN	27529345	gold, Green Submitted, Green Published			2022-12-27	WOS:000381476700039
J	Hatae, R; Hata, N; Yoshimoto, K; Kuga, D; Akagi, Y; Murata, H; Suzuki, SO; Mizoguchi, M; Iihara, K				Hatae, Ryusuke; Hata, Nobuhiro; Yoshimoto, Koji; Kuga, Daisuke; Akagi, Yojiro; Murata, Hideki; Suzuki, Satoshi O.; Mizoguchi, Masahiro; Iihara, Koji			Precise Detection of IDH1/2 and BRAF Hotspot Mutations in Clinical Glioma Tissues by a Differential Calculus Analysis of High-Resolution Melting Data	PLOS ONE			English	Article							IDH2 MUTATIONS; CURVE ANALYSIS; GLIOBLASTOMA; INHIBITOR; SUBSET; ASSAY	High resolution melting (HRM) is a simple and rapid method for screening mutations. It offers various advantages for clinical diagnostic applications. Conventional HRM analysis often yields equivocal results, especially for surgically obtained tissues. We attempted to improve HRM analyses for more effective applications to clinical diagnostics. HRM analyses were performed for IDH1R132 and IDH2R172 mutations in 192 clinical glioma samples in duplicate and these results were compared with sequencing results. BRAFV600E mutations were analyzed in 52 additional brain tumor samples. The melting profiles were used for differential calculus analyses. Negative second derivative plots revealed additional peaks derived from heteroduplexes in PCR products that contained mutations; this enabled unequivocal visual discrimination of the mutations. We further developed a numerical expression, the HRM-mutation index (MI), to quantify the heteroduplex-derived peak of the mutational curves. Using this expression, all IDH1 mutation statuses matched those ascertained by sequencing, with the exception of three samples. These discordant results were all derived from the misinterpretation of sequencing data. The effectiveness of our approach was further validated by analyses of IDH2R172 and BRAFV600E mutations. The present analytical method enabled an unequivocal and objective HRM analysis and is suitable for reliable mutation scanning in surgically obtained glioma tissues. This approach could facilitate molecular diagnostics in clinical environments.	[Hatae, Ryusuke; Hata, Nobuhiro; Yoshimoto, Koji; Kuga, Daisuke; Akagi, Yojiro; Murata, Hideki; Mizoguchi, Masahiro; Iihara, Koji] Kyushu Univ, Grad Sch Med Sci, Dept Neurosurg, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan; [Hata, Nobuhiro] Kyushu Med Ctr, Natl Hosp Org, Clin Res Inst, Dept Neurosurg, Fukuoka, Japan; [Suzuki, Satoshi O.] Kyushu Univ, Grad Sch Med Sci, Dept Neuropathol, Fukuoka, Japan; [Mizoguchi, Masahiro] Kitakyushu Municipal Med Ctr, Dept Neurosurg, Kitakyushu, Fukuoka, Japan	Kyushu University; Kyushu University	Hata, N (corresponding author), Kyushu Univ, Grad Sch Med Sci, Dept Neurosurg, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.; Hata, N (corresponding author), Kyushu Med Ctr, Natl Hosp Org, Clin Res Inst, Dept Neurosurg, Fukuoka, Japan.	hatanobu@kyumed.jp	Suzuki, Satoshi O/H-8367-2019; Hata, Nobuhiro/AAF-3034-2021	Suzuki, Satoshi O/0000-0002-0742-5680; Hata, Nobuhiro/0000-0002-5523-7166; Hatae, Ryusuke/0000-0001-5636-8064	JSPS KAKENHI [26462185, 25293311, 15K15529, 16K10779]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI, https://www.jsps.go.jp/english/index.html. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Ms. Fumie Doi for technical assistance. This work was supported by JSPS KAKENHI Grant Number 26462185, 25293311, 15K15529 and 16K10779.	Adachi JI, 2014, JSM NEUROSURG SPINE, V2, P1028; Arita H, 2015, BRAIN TUMOR PATHOL, V32, P22, DOI 10.1007/s10014-014-0186-0; Carbonell P, 2011, J MOL DIAGN, V13, P467, DOI 10.1016/j.jmoldx.2011.03.009; Chi AS, 2013, J CLIN ONCOL, V31, pE233, DOI 10.1200/JCO.2012.46.0220; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Dang L, 2010, NATURE, V465, P966, DOI 10.1038/nature09132; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Duncan CG, 2012, GENOME RES, V22, P2339, DOI 10.1101/gr.132738.111; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Garritano S, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-5; Gonzalez-Bosquet J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014522; Gundry CN, 2003, CLIN CHEM, V49, P396, DOI 10.1373/49.3.396; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hata N, 2006, CLIN CHEM, V52, P370, DOI 10.1373/clinchem.2005.060954; Herrmann MG, 2006, CLIN CHEM, V52, P494, DOI 10.1373/clinchem.2005.063438; Horbinski C, 2010, J MOL DIAGN, V12, P487, DOI 10.2353/jmoldx.2010.090228; Ihle MA, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-13; Kanamori M, 2014, J NEUROSURG, V120, P1288, DOI 10.3171/2014.3.JNS131505; Li M, 2014, CLIN CHEM, V60, P864, DOI 10.1373/clinchem.2013.220160; Mengel M, 2002, J PATHOL, V198, P292, DOI 10.1002/path.1218; Milbury CA, 2009, CLIN CHEM, V55, P2130, DOI 10.1373/clinchem.2009.131029; Nicolaides TP, 2011, CLIN CANCER RES, V17, P7595, DOI 10.1158/1078-0432.CCR-11-1456; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Reed GH, 2004, CLIN CHEM, V50, P1748, DOI 10.1373/clinchem.2003.029751; Rohle D, 2013, SCIENCE, V340, P626, DOI 10.1126/science.1236062; Schiffman JD, 2010, CANCER RES, V70, P512, DOI 10.1158/0008-5472.CAN-09-1851; Schindler G, 2011, ACTA NEUROPATHOL, V121, P397, DOI 10.1007/s00401-011-0802-6; Setty P, 2010, J MOL DIAGN, V12, P750, DOI 10.2353/jmoldx.2010.090237; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Sturm D, 2012, CANCER CELL, V22, P425, DOI 10.1016/j.ccr.2012.08.024; Tsiatis AC, 2010, J MOL DIAGN, V12, P425, DOI 10.2353/jmoldx.2010.090188; Turcan S, 2012, NATURE, V483, P479, DOI 10.1038/nature10866; Vossen RHAM, 2009, HUM MUTAT, V30, P860, DOI 10.1002/humu.21019; Wittwer CT, 2003, CLIN CHEM, V49, P853, DOI 10.1373/49.6.853; Xu W, 2011, CANCER CELL, V19, P17, DOI 10.1016/j.ccr.2010.12.014; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710; Zhang JH, 2013, NAT GENET, V45, P602, DOI 10.1038/ng.2611; Zhou LM, 2005, CLIN CHEM, V51, P1770, DOI 10.1373/clinchem.2005.054924	38	33	34	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2016	11	8							e0160489	10.1371/journal.pone.0160489	http://dx.doi.org/10.1371/journal.pone.0160489			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4UN	27529619	Green Published, Green Submitted, gold			2022-12-27	WOS:000381476700007
J	Meertens, JH; Nienhuis, HL; Lefrandt, JD; Schalkwijk, CG; Nyyssonen, K; Ligtenberg, JJM; Smit, AJ; Zijlstra, JG; Mulder, DJ				Meertens, John H.; Nienhuis, Hans L.; Lefrandt, Joop D.; Schalkwijk, Casper G.; Nyyssonen, Kristiina; Ligtenberg, Jack J. M.; Smit, Andries J.; Zijlstra, Jan G.; Mulder, D. J.			The Course of Skin and Serum Biomarkers of Advanced Glycation Endproducts and Its Association with Oxidative Stress, Inflammation, Disease Severity, and Mortality during ICU Admission in Critically Ill Patients: Results from a Prospective Pilot Study	PLOS ONE			English	Article							IMPAIRED RENAL-FUNCTION; ACUTE LUNG INJURY; END-PRODUCTS; ORGAN FAILURE; ENDOTHELIAL DYSFUNCTION; HEMODIALYSIS-PATIENTS; N-EPSILON-(CARBOXYMETHYL)LYSINE LEVELS; PREDICTS MORTALITY; SOLUBLE RECEPTOR; PLASMA-LEVELS	Background Advanced glycation end products (AGEs) have been implicated in multiple organ failure, predominantly via their cellular receptor (RAGE) in preclinical studies. Little is known about the time course and prognostic relevance of AGEs in critically ill human patients, including those with severe sepsis. Objective 1) To explore the reliability of Skin Autofluorescence (AF) as an index of tissue AGEs in ICU patients, 2) to compare its levels to healthy controls, 3) to describe the time course of AGEs and influencing factors during ICU admission, and 4) to explore their association with disease severity, outcome, and markers of oxidative stress and inflammation. Methods Skin AF, serum N ''-(carboxyethyl) lysine (CEL), N ''-(carboxymethyl) lysine (CML), and soluble RAGE (sRAGE) were serially measured for a maximum of 7 days in critically ill ICU patients with multiple organ failure and compared to age-matched healthy controls. Correlations with (changes in) clinical parameters of disease severity, LDL dienes, and CRP were studied and survival analysis for in-hospital mortality was performed. Results Forty-five ICU patients (age: 59 +/- 15 years; 60% male), and 37 healthy controls (59 +/- 14; 68%) were included. Skin AF measurements in ICU patients were reproducible (CV right-left arm: 13%, day-to-day: 10%), with confounding effects of skin reflectance and plasma bilirubin levels. Skin AF was higher in ICU patients vs healthy controls (2.7 +/- 0.7 vs 1.8 +/- 0.3 au; p < 0.001). Serum CEL (23 +/- 10 vs, 16 +/- 3 nmol/gr protein; p < 0.001), LDL dienes (19 (15-23) vs. 9 (8-11) mu mol/mmol cholesterol; < 0.001), and sRAGE (1547 (998-2496) vs. 1042 (824-1388) pg/ml; p = 0.003) were significantly higher in ICU patients compared to healthy controls, while CML was not different (27 (20-39) vs 29 (25-33) nmol/gr protein). While CRP and LDL dienes decreased significantly, Skin AF and serum AGEs and sRAGE did not change significantly during the first 7 days of ICU admission. CML and CEL were strongly correlated with SOFA scores and CML above the median at baseline was associated with increased risk for mortality (Hazard ratio 3.3 (1.3-8.3); p = 0.01). All other markers did not correlate with disease severity and did not predict mortality. Conclusions This study demonstrates that markers for the AGE-RAGE axis are elevated in critically ill patients compared to healthy controls but remain stable for at least 7 days despite clearly fading inflammation and oxidative stress. Circulating AGEs may be associated with disease severity and outcome. Further research should be conducted to elucidate the role of the AGE-RAGE axis in the exaggerated inflammatory response leading to multiple organ failure and death, and whether or not this may be a target for treatment.	[Meertens, John H.; Zijlstra, Jan G.] Univ Groningen, Univ Med Ctr Groningen, Dept Crit Care, Groningen, Netherlands; [Nienhuis, Hans L.; Lefrandt, Joop D.; Ligtenberg, Jack J. M.; Smit, Andries J.; Mulder, D. J.] Univ Groningen, Univ Med Ctr Groningen, Dept Internal Med, Groningen, Netherlands; [Schalkwijk, Casper G.] Maastricht Univ, Dept Internal Med, Lab Metab & Vasc Med, Med Ctr, Maastricht, Netherlands; [Nyyssonen, Kristiina] Univ Eastern Finland, Inst Publ Hlth & Clin Nutr, Dept Clin Chem, Kuopio, Finland; [Nyyssonen, Kristiina] Eastern Finland Lab Ctr, Kuopio, Finland	University of Groningen; University of Groningen; Maastricht University; University of Eastern Finland	Meertens, JH (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Crit Care, Groningen, Netherlands.	j.h.j.m.meertens@umcg.nl	Zijlstra, Jan/E-6782-2011	Zijlstra, Jan/0000-0001-9079-0795; Schalkwijk, Casper G/0000-0003-0190-2690; Nienhuis, Hans/0000-0003-3974-6830				Anderson MM, 1999, J CLIN INVEST, V104, P103, DOI 10.1172/JCI3042; Andrades ME, 2012, EUR J CLIN INVEST, V42, P1055, DOI 10.1111/j.1365-2362.2012.02694.x; Basta G, 2008, CORONARY ARTERY DIS, V19, P299, DOI 10.1097/MCA.0b013e3282fec058; BONE RC, 1992, CRIT CARE MED, V20, P864, DOI 10.1097/00003246-199206000-00025; Bopp C, 2008, J SURG RES, V147, P79, DOI 10.1016/j.jss.2007.07.014; Brodska H, 2013, SCAND J CLIN LAB INV, V73, P650, DOI 10.3109/00365513.2013.849357; Bryland A, 2010, INTENS CARE MED, V36, P1213, DOI 10.1007/s00134-010-1873-x; Calfee CS, 2008, THORAX, V63, P1083, DOI 10.1136/thx.2008.095588; Cnossen TT, 2011, PERITON DIALYSIS INT, V31, P679, DOI 10.3747/pdi.2010.00004; Corstjens AM, 2006, CRIT CARE, V10, DOI 10.1186/cc5048; de Vega JMA, 2000, CRIT CARE MED, V28, P1812, DOI 10.1097/00003246-200006000-00021; den Hollander NC, 2007, J INHERIT METAB DIS, V30, P916, DOI 10.1007/s10545-007-0507-0; Dullaart RPF, 2012, CLIN CHIM ACTA, V414, P161, DOI 10.1016/j.cca.2012.08.029; DYER DG, 1993, J CLIN INVEST, V91, P2463, DOI 10.1172/JCI116481; DYER DG, 1991, Z ERNAHRUNGSWISS, V30, P29, DOI 10.1007/BF01910730; Ehrhardt C, 2010, RECEPTOR ADV GLYCATI, V2010, DOI [10.1155/2010/917108, DOI 10.1155/2010/917108]; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Fu MX, 1996, J BIOL CHEM, V271, P9982, DOI 10.1074/jbc.271.17.9982; Gaens KHJ, 2015, ARTERIOSCL THROM VAS, V35, P2707, DOI 10.1161/ATVBAHA.115.306106; Gaens KHJ, 2012, J HEPATOL, V56, P647, DOI 10.1016/j.jhep.2011.07.028; Gerrits EG, 2009, NEPHROL DIAL TRANSPL, V24, P710, DOI 10.1093/ndt/gfn634; Graaff R, 2005, P SOC PHOTO-OPT INS, V5692, P111, DOI 10.1117/12.588984; Graaff R, 2014, ARTIF ORGANS, V38, P515, DOI 10.1111/aor.12205; Greven WL, 2010, BMC CLIN PATHOL, V10, DOI 10.1186/1472-6890-10-4; Grune T, 2007, CURR OPIN CLIN NUTR, V10, P712, DOI 10.1097/MCO.0b013e3282f0c97c; Halliwell B, 2007, BIOCHEM J, V401, P1, DOI 10.1042/BJ20061131; Hanssen NMJ, 2013, J CLIN ENDOCR METAB, V98, pE1369, DOI 10.1210/jc.2013-1068; Hartog JWL, 2007, EUR HEART J, V28, P2879, DOI 10.1093/eurheartj/ehm486; Humpert PM, 2009, J LEUKOCYTE BIOL, V86, P589, DOI 10.1189/jlb.1008646; Kalousova M, 2005, CELL MOL BIOL, V51, P387, DOI 10.1170/T642; Kalousova M, 2006, AM J KIDNEY DIS, V47, P406, DOI 10.1053/j.ajkd.2005.12.028; Karppi J, 2010, ATHEROSCLEROSIS, V209, P565, DOI 10.1016/j.atherosclerosis.2009.10.007; Lieuw-A-Fa MLM, 2004, NEPHROL DIAL TRANSPL, V19, P631, DOI 10.1093/ndt/gfg619; Liliensiek B, 2004, J CLIN INVEST, V113, P1641, DOI 10.1172/JCI200418704; Lobo SMA, 2003, CHEST, V123, P2043, DOI 10.1378/chest.123.6.2043; Meerwaldt R, 2005, ANN NY ACAD SCI, V1043, P290, DOI 10.1196/annals.1333.036; Meerwaldt R, 2005, J AM SOC NEPHROL, V16, P3687, DOI 10.1681/ASN.2005020144; Meerwaldt R, 2004, DIABETOLOGIA, V47, P1324, DOI 10.1007/s00125-004-1451-2; Meisner M, 1999, CRIT CARE, V3, P45, DOI 10.1186/cc306; Motoyama T, 2003, CRIT CARE MED, V31, P1048, DOI 10.1097/01.CCM.0000055371.27268.36; Mulder DJ, 2009, NETH HEART J, V17, P162, DOI 10.1007/BF03086239; Mulder DJ, 2004, INTENS CARE MED, V30; Mulder DJ, 2006, DIABETES TECHNOL THE, V8, P523, DOI 10.1089/dia.2006.8.523; Nakamura T, 2009, PHARMACOL RES, V60, P515, DOI 10.1016/j.phrs.2009.05.002; Price CL, 2010, J CELL MOL MED, V14, P1806, DOI 10.1111/j.1582-4934.2009.00803.x; Schalkwijk CG, 2005, ANN NY ACAD SCI, V1043, P662, DOI 10.1196/annals.1333.075; Schmidt AM, 1999, CIRC RES, V84, P489, DOI 10.1161/01.RES.84.5.489; Schwedler SB, 2002, KIDNEY INT, V62, P301, DOI 10.1046/j.1523-1755.2002.00423.x; Smit AJ, 2004, CURR MED CHEM, V11, P2767, DOI 10.2174/0929867043364342; Stam F, 2006, NEPHROL DIAL TRANSPL, V21, P677, DOI 10.1093/ndt/gfi309; Uchida T, 2006, AM J RESP CRIT CARE, V173, P1008, DOI 10.1164/rccm.200509-1477OC; van Zoelen MAD, 2008, CRIT CARE, V12, DOI 10.1186/cc6187; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; Wagner Z, 2006, AM J KIDNEY DIS, V47, P294, DOI 10.1053/j.ajkd.2005.10.010; Wagner Z, 2001, AM J KIDNEY DIS, V38, P785, DOI 10.1053/ajkd.2001.27695; Ware LB, 2011, SHOCK, V36, P12, DOI 10.1097/SHK.0b013e318217025a	56	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2016	11	8							e0160893	10.1371/journal.pone.0160893	http://dx.doi.org/10.1371/journal.pone.0160893			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4UN	27529340	Green Submitted, Green Published, gold			2022-12-27	WOS:000381476700030
J	Sheikh, AM; Small, HY; Currie, G; Delles, C				Sheikh, Adam M.; Small, Heather Yvonne; Currie, Gemma; Delles, Christian			Systematic Review of Micro-RNA Expression in Pre-Eclampsia Identifies a Number of Common Pathways Associated with the Disease	PLOS ONE			English	Review							ENDOTHELIAL GROWTH-FACTOR; TROPHOBLAST CELL-PROLIFERATION; PLACENTA-SPECIFIC MICRORNAS; MESENCHYMAL STEM-CELLS; REAL-TIME PCR; DIFFERENTIAL EXPRESSION; CIRCULATING MICRORNAS; ANGIOGENIC FACTORS; RISK-FACTOR; NORMALIZATION METHODS	Background Pre-eclampsia (PE) is a complex, multi-systemic condition of pregnancy which greatly impacts maternal and perinatal morbidity and mortality. MicroRNAs (miRs) are differentially expressed in PE and may be important in helping to understand the condition and its pathogenesis. Methods Case-control studies investigating expression of miRs in PE were collected through a systematic literature search. Data was extracted and compared from 58 studies to identify the most promising miRs associated with PE pathogenesis and identify areas of methodology which could account for often conflicting results. Results Some of the most frequently differentially expressed miRs in PE include miR-210, miR-223 and miR-126/126* which associate strongly with the etiological domains of hypoxia, immunology and angiogenesis. Members of the miR-515 family belonging to the imprinted chromosome 19 miR cluster with putative roles in trophoblast invasion were also found to be differentially expressed. Certain miRs appear to associate with more severe forms of PE such as miR-210 and the immune-related miR-181a and miR-15 families. Patterns of miR expression may help pinpoint key pathways (e.g. IL-6/miR-223/STAT3) and aid in untangling the heterogeneous nature of PE. The detectable presence of many PE-associated miRs in antenatal circulatory samples suggests their usefulness as predictive biomarkers. Further progress in ascertaining the clinical value of miRs and in understanding how they might contribute to pathogenesis is predicated upon resolving current methodological challenges in studies. These include differences in diagnostic criteria, cohort characteristics, sampling technique, RNA isolation and platform-dependent variation in miR profiling. Conclusion Reviewing studies of PE-associated miRs has revealed their potential as informants of underlying target genes and pathways relating to PE pathogenesis. However, the incongruity in results across current studies hampers their capacity to be useful biomarkers of the condition.	[Sheikh, Adam M.; Small, Heather Yvonne; Currie, Gemma; Delles, Christian] Univ Glasgow, Inst Cardiovasc & Med Sci, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland	University of Glasgow	Small, HY (corresponding author), Univ Glasgow, Inst Cardiovasc & Med Sci, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland.	h.small.1@research.gla.ac.uk			European Commission [278249, 603288]; British Heart Foundation Centre of Excellence Award [RE/13/5/30177]	European Commission(European CommissionEuropean Commission Joint Research Centre); British Heart Foundation Centre of Excellence Award	This work has been supported by the European Commission (http://ec.europa.eu/research/index.cfm) (grant agreement 278249 "EU-MASCARA" and grant agreement 603288 "sysVASC") and a British Heart Foundation Centre of Excellence Award RE/13/5/30177. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accerbi M, 2010, METHODS MOL BIOL, V592, P31, DOI 10.1007/978-1-60327-005-2_3; Akehurst C, 2015, J HYPERTENS, V33, P2068, DOI 10.1097/HJH.0000000000000656; Anton L, 2015, PLOS ONE, P10, DOI [10. 1371/ journal. pone. 0122707, DOI 10.1371/J0URNAL.P0NE.0122707]; Anton L, 2013, AM J PATHOL, V183, P1437, DOI 10.1016/j.ajpath.2013.07.021; Bai Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038875; Baumann MU, 2007, MOL ASPECTS MED, V28, P227, DOI 10.1016/j.mam.2007.04.002; Betoni JS, 2013, HYPERTENS PREGNANCY, V32, P321, DOI 10.3109/10641955.2013.807819; Blair JD, 2013, MOL HUM REPROD, V19, P697, DOI 10.1093/molehr/gat044; Bravo V, 2007, BIOCHEM BIOPH RES CO, V353, P1052, DOI 10.1016/j.bbrc.2006.12.135; Brosens JJ, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.11.037; Burton GJ, 2014, PLACENTA, V35, P9, DOI 10.1016/j.placenta.2013.11.005; Cascio S, 2010, J CELL PHYSIOL, V224, P242, DOI 10.1002/jcp.22126; Caughey AB, 2005, OBSTET GYNECOL, V106, P156, DOI 10.1097/01.AOG.0000164478.91731.06; Chaiworapongsa T, 2005, J MATERN-FETAL NEO M, V17, P3, DOI 10.1080/14767050400028816; Chaiworapongsa T, 2014, NAT REV NEPHROL, V10, P531, DOI 10.1038/nrneph.2014.103; Chaiworapongsa T, 2014, NAT REV NEPHROL, V10, P466, DOI 10.1038/nrneph.2014.102; Chen LM, 2010, PLACENTA, V31, P75, DOI 10.1016/j.placenta.2009.11.005; Chen QY, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0037149, 10.1371/journal.pone.0042971]; Chen YX, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-407; Choi SY, 2013, PLACENTA, V34, P799, DOI 10.1016/j.placenta.2013.06.006; Cicchillitti L, 2012, J BIOL CHEM, V287, P44761, DOI 10.1074/jbc.M112.421255; Coffer PJ, 2004, NAT REV IMMUNOL, V4, P889, DOI 10.1038/nri1488; Cross CE, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/257090; Cunningham FG, 2010, WILLIAMS OBSTET; D'haene Barbara, 2012, Methods Mol Biol, V822, P261, DOI 10.1007/978-1-61779-427-8_18; Dedeoglu BG, 2014, METHODS MOL BIOL, V1107, P91, DOI 10.1007/978-1-62703-748-8_6; Ding J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120321; Doleshal M, 2008, J MOL DIAGN, V10, P203, DOI 10.2353/jmoldx.2008.070153; Donker RB, 2012, MOL HUM REPROD, V18, P417, DOI 10.1093/molehr/gas013; Donker RB, 2007, MOL HUM REPROD, V13, P273, DOI 10.1093/molehr/gam006; DOUGLAS KA, 1994, BMJ-BRIT MED J, V309, P1395, DOI 10.1136/bmj.309.6966.1395; Duley L, 2009, SEMIN PERINATOL, V33, P130, DOI 10.1053/j.semperi.2009.02.010; Enquobahrie DA, 2016, REPROD SCI, V23, P731, DOI 10.1177/1933719115612925; Enquobahrie Daniel A, 2011, Am J Obstet Gynecol, V204, DOI 10.1016/j.ajog.2010.09.004; Enquobahrie DA, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.04.020; Farrokhnia F, 2014, J BIOL CHEM, V289, P30404, DOI 10.1074/jbc.M114.587295; Fasanaro P, 2008, J BIOL CHEM, V283, P15878, DOI 10.1074/jbc.M800731200; Fehniger TA, 2010, GENOME RES, V20, P1590, DOI 10.1101/gr.107995.110; Fish JE, 2008, DEV CELL, V15, P272, DOI 10.1016/j.devcel.2008.07.008; Fu GD, 2013, HYPERTENSION, V61, P864, DOI 10.1161/HYPERTENSIONAHA.111.203489; Gao WL, 2012, RNA BIOL, V9, P1002, DOI 10.4161/rna.20807; Garmire LX, 2012, RNA, V18, P1279, DOI 10.1261/rna.030916.111; Git A, 2010, RNA, V16, P991, DOI 10.1261/rna.1947110; Goldman-Wohl DS, 2000, MOL HUM REPROD, V6, P535, DOI 10.1093/molehr/6.6.535; Goodwin AA, 2005, AM J OBSTET GYNECOL, V193, P973, DOI 10.1016/j.ajog.2005.05.047; Gray MJ, 2005, ONCOGENE, V24, P3110, DOI 10.1038/sj.onc.1208513; Griffiths-Jones S, 2011, EMBO REP, V12, P172, DOI 10.1038/embor.2010.191; Guo L, 2013, PLACENTA, V34, P599, DOI 10.1016/j.placenta.2013.04.007; Guo L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021072; Guo Yan, 2014, International Journal of Computational Biology and Drug Design, V7, P102, DOI 10.1504/IJCBDD.2014.061642; Ha M, 2014, NAT REV MOL CELL BIO, V15, P509, DOI 10.1038/nrm3838; Hammerle-Fickinger A, 2010, BIOTECHNOL LETT, V32, P35, DOI 10.1007/s10529-009-0130-2; Haneklaus M, 2013, J INTERN MED, V274, P215, DOI 10.1111/joim.12099; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Hempstock J, 2003, PLACENTA, V24, P517, DOI 10.1053/plac.2002.0955; Herrera JA, 2001, MED HYPOTHESES, V57, P393, DOI 10.1054/mehy.2001.1378; Hoefig KP, 2008, ANTICANCER RES, V28, P119; Hong FZ, 2014, J INT MED RES, V42, P1243, DOI 10.1177/0300060514540627; Hromadnikova I, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/186041; Hromadnikova I, 2012, J MOL DIAGN, V14, P160, DOI 10.1016/j.jmoldx.2011.11.003; Hu YL, 2009, CLIN CHEM LAB MED, V47, P923, DOI 10.1515/CCLM.2009.228; Hua YJ, 2008, GENOMICS, V92, P122, DOI 10.1016/j.ygeno.2008.04.002; Huang RS, 2011, RNA BIOL, V8, P692, DOI 10.4161/rna.8.4.16029; Huppertz B, 2008, HYPERTENSION, V51, P970, DOI 10.1161/HYPERTENSIONAHA.107.107607; Ishibashi O, 2012, HYPERTENSION, V59, P265, DOI 10.1161/HYPERTENSIONAHA.111.180232; Jiang F, 2015, MOL MED REP, V12, P5383, DOI 10.3892/mmr.2015.4018; Jobe SO, 2013, HYPERTENSION, V61, P480, DOI 10.1161/HYPERTENSIONAHA.111.201624; Jung JE, 2005, FASEB J, V19, P1296, DOI 10.1096/fj.04-3099fje; Kaaja R, 2008, Minerva Ginecol, V60, P421; Kamanu TKK, 2013, SCI REP-UK, V3, DOI 10.1038/srep02940; Kanasaki K, 2008, NATURE, V453, P1117, DOI 10.1038/nature06951; Kang K, 2012, J ANIM SCI BIOTECHNO, V3, DOI 10.1186/2049-1891-3-4; Kopriva SE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067760; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Kulshreshtha R, 2007, MOL CELL BIOL, V27, P1859, DOI 10.1128/MCB.01395-06; Kuo WP, 2006, NAT BIOTECHNOL, V24, P832, DOI 10.1038/nbt1217; Kushwaha R, 2014, STEM CELLS DEV, V23, P1149, DOI 10.1089/scd.2013.0262; Lappas M, 2009, PLACENTA, V30, P256, DOI 10.1016/j.placenta.2008.12.008; Lee DC, 2011, AM J PATHOL, V179, P590, DOI 10.1016/j.ajpath.2011.04.035; Levine RJ, 2006, NEW ENGL J MED, V355, P992, DOI 10.1056/NEJMoa055352; Levine RJ, 2004, NEW ENGL J MED, V350, P672, DOI 10.1056/NEJMoa031884; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li HL, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/970265; Li JH, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-36; Li QJ, 2007, CELL, V129, P147, DOI 10.1016/j.cell.2007.03.008; Li QH, 2014, BIOCHEM BIOPH RES CO, V453, P57, DOI 10.1016/j.bbrc.2014.09.059; Liang WN, 2014, INT J ONCOL, V44, P91, DOI 10.3892/ijo.2013.2155; Lin S, 2010, COMPUT BIOL CHEM, V34, P232, DOI 10.1016/j.compbiolchem.2010.08.001; Liu L, 2012, STEM CELLS, V30, P1756, DOI 10.1002/stem.1156; Liu Q, 2015, INT J CLIN EXP MED, V8, P15731; Liu SC, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.453; Lockwood CJ, 2008, AM J PATHOL, V172, P1571, DOI 10.2353/ajpath.2008.070629; Luo RC, 2014, HYPERTENSION, V64, P839, DOI 10.1161/HYPERTENSIONAHA.114.03530; Luque A, 2014, SCI REP-UK, V4, DOI 10.1038/srep04882; MacKay AP, 2001, OBSTET GYNECOL, V97, P533, DOI 10.1016/S0029-7844(00)01223-0; Martinelli R, 2010, OBESITY, V18, P2170, DOI 10.1038/oby.2009.474; Maynard SE, 2003, J CLIN INVEST, V111, P649, DOI 10.1172/JCI200317189; Maynard SE, 2011, SEMIN NEPHROL, V31, P33, DOI 10.1016/j.semnephrol.2010.10.004; Mayor-Lynn K, 2011, REPROD SCI, V18, P46, DOI 10.1177/1933719110374115; Mestdagh P, 2014, NAT METHODS, V11, P809, DOI [10.1038/NMETH.3014, 10.1038/nmeth.3014]; Mincheva-Nilsson L, 2010, AM J REPROD IMMUNOL, V63, P520, DOI 10.1111/j.1600-0897.2010.00822.x; Miura K, 2015, J OBSTET GYNAECOL RE, V41, P1526, DOI 10.1111/jog.12749; Miura K, 2010, CLIN CHEM, V56, P1767, DOI 10.1373/clinchem.2010.147660; Morales-Prieto DM, 2012, PLACENTA, V33, P725, DOI 10.1016/j.placenta.2012.05.009; Mouillet JF, 2014, INT J DEV BIOL, V58, P281, DOI 10.1387/ijdb.130349ys; Muralimanoharan S, 2012, PLACENTA, V33, P816, DOI 10.1016/j.placenta.2012.07.002; Murphy MSQ, 2015, AM J OBSTET GYNECOL, V213, DOI 10.1016/j.ajog.2015.05.013; National Institute for Health and Care Excellence, 2010, AM J OBSTET GYNECOL, V77, pS1; Nicoli S, 2010, NATURE, V464, P1196, DOI 10.1038/nature08889; Noack F, 2011, J PERINAT MED, V39, P267, DOI [10.1515/JPM.2011.012, 10.1515/jpm.2011.012]; Noris M, 2005, NAT CLIN PRACT NEPHR, V1, P98, DOI 10.1038/ncpneph0035; O'Brien M, 2000, HUM IMMUNOL, V61, P1126, DOI 10.1016/S0198-8859(00)00193-2; Okamura K, 2009, MOL CELL, V36, P431, DOI 10.1016/j.molcel.2009.09.027; Pan M, 2012, J NANOSCI NANOTECHNO, V12, P4035, DOI 10.1166/jnn.2012.6196; Pennington KA, 2012, DIS MODEL MECH, V5, P9, DOI 10.1242/dmm.008516; Pijnenborg R, 2011, PLACENTA, V32, P586, DOI 10.1016/j.placenta.2011.05.007; Pineles BL, 2007, AM J OBSTET GYNECOL, V196, P261, DOI 10.1016/j.ajog.2007.01.008; Podolska A, 2011, ACTA BIOCHIM POL, V58, P535; Puissegur MP, 2011, CELL DEATH DIFFER, V18, P465, DOI 10.1038/cdd.2010.119; Rajakumar A, 2004, PLACENTA, V25, P763, DOI 10.1016/j.placenta.2004.02.011; Ramkissoon SH, 2006, LEUKEMIA RES, V30, P643, DOI 10.1016/j.leukres.2005.09.001; Redman CWG, 2010, AM J REPROD IMMUNOL, V63, P534, DOI 10.1111/j.1600-0897.2010.00831.x; Risso D, 2014, NAT BIOTECHNOL, V32, P896, DOI 10.1038/nbt.2931; Roberts JM, 2013, OBSTET GYNECOL, V122, P1122, DOI 10.1097/01.AOG.0000437382.03963.88; Rodrigues M. N., 2013, Open Journal of Animal Sciences, V3, P138, DOI 10.4236/ojas.2013.32021; Sabapatha A, 2006, AM J REPROD IMMUNOL, V56, P345, DOI 10.1111/j.1600-0897.2006.00435.x; Sah Sachin, 2010, BMC Res Notes, V3, P80, DOI 10.1186/1756-0500-3-80; Sato F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005540; Schjenken J, 2015, PLACENTA, V36, pA9, DOI 10.1016/j.placenta.2015.07.212; Schober A, 2014, NAT MED, V20, P368, DOI 10.1038/nm.3487; Seifeddine R, 2008, CANCER RES, V68, P2158, DOI 10.1158/0008-5472.CAN-07-1190; Sheridan R, 2015, HISTOL HISTOPATHOL, V30, P213, DOI 10.14670/HH-30.213; Shi L, 2013, CIRC RES, V113, P1320, DOI 10.1161/CIRCRESAHA.113.301824; Shi R, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/981841; Silva LM, 2008, J HYPERTENS, V26, P1200, DOI 10.1097/HJH.0b013e3282fcc36e; Simas TAM, 2014, J MATERN-FETAL NEO M, V27, P1038, DOI 10.3109/14767058.2013.847415; Simon C, 2010, DIVERSE EFFECTS HYPO; Snydal S, 2014, J MIDWIFERY WOM HEAL, V59, P596, DOI 10.1111/jmwh.12260; Soto E, 2012, J MATERN-FETAL NEO M, V25, P498, DOI 10.3109/14767058.2011.591461; Steegers EAP, 2010, LANCET, V376, P631, DOI 10.1016/S0140-6736(10)60279-6; Suarez Y, 2009, CIRC RES, V104, P442, DOI 10.1161/CIRCRESAHA.108.191270; Sun MN, 2015, BMC CELL BIOL, V16, DOI 10.1186/s12860-015-0068-2; Tabet F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4292; Taibi F, 2014, BBA-MOL BASIS DIS, V1842, P88, DOI 10.1016/j.bbadis.2013.10.005; Taylor CM, 1997, PLACENTA, V18, P451, DOI 10.1016/S0143-4004(97)80047-1; Than NG, 2008, PLACENTA, V29, pS83, DOI 10.1016/j.placenta.2007.10.008; Tian G, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-64; Tranquilli AL, 2013, PREGNANCY HYPERTENS, V3, P44, DOI [10.1016/j.preghy.2012.11.001, 10.1016/j.preghy.2013.04.006]; Tripathi R, 2008, ANN ANAT, V190, P477, DOI 10.1016/j.aanat.2008.08.002; Tsai KW, 2009, EPIGENETICS-US, V4, P587, DOI 10.4161/epi.4.8.10230; Ura B, 2014, TAIWAN J OBSTET GYNE, V53, P232, DOI 10.1016/j.tjog.2014.03.001; Vlachos IS, 2015, NUCLEIC ACIDS RES, V43, pW460, DOI 10.1093/nar/gkv403; von Dadelszen P, 2003, HYPERTENS PREGNANCY, V22, P143, DOI 10.1081/PRG-120021060; Wang D, 2012, AUST NZ J OBSTET GYN, V52, P565, DOI 10.1111/j.1479-828X.2012.01481.x; Wang HP, 2014, NAT IMMUNOL, V15, P393, DOI 10.1038/ni.2846; Wang K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041561; Wang SS, 2008, DEV CELL, V15, P261, DOI 10.1016/j.devcel.2008.07.002; Wang W, 2012, J CLIN ENDOCR METAB, V97, pE1051, DOI 10.1210/jc.2011-3131; Wang Y, 1998, PLACENTA, V19, P581, DOI 10.1016/S0143-4004(98)90018-2; Wang YP, 2012, FEBS J, V279, P4510, DOI 10.1111/febs.12037; Wang Y, 2014, INT J BIOL SCI, V10, P973, DOI 10.7150/ijbs.9088; Weedon-Fekjaer MS, 2014, PLACENTA, V35, P709, DOI 10.1016/j.placenta.2014.07.002; Winger EE, 2015, J REPROD IMMUNOL, V110, P22, DOI 10.1016/j.jri.2015.03.005; Winger EE, 2014, AM J REPROD IMMUNOL, V72, P515, DOI 10.1111/aji.12287; Wu L, 2012, REPRODUCTION, V143, P389, DOI 10.1530/REP-11-0304; Wu LH, 2012, FEBS LETT, V586, P1038, DOI 10.1016/j.febslet.2012.02.050; Wuchty S, 2012, NUCLEIC ACIDS RES, V40, P8219, DOI 10.1093/nar/gks627; Wyatt SM, 2005, PLACENTA, V26, P372, DOI 10.1016/j.placenta.2004.07.003; Xiao J, 2014, J HUM HYPERTENS, V28, P694, DOI 10.1038/jhh.2013.148; Xie L, 2014, ENDOCRINOLOGY, V155, P4975, DOI 10.1210/en.2014-1501; Xu P, 2014, HYPERTENSION, V63, P1276, DOI 10.1161/HYPERTENSIONAHA.113.02647; Yan T, 2014, PLACENTA, V35, P23, DOI 10.1016/j.placenta.2013.10.017; Yan T, 2013, J CELL BIOCHEM, V114, P2148, DOI 10.1002/jcb.24563; Yang Q, 2011, CLIN CHIM ACTA, V412, P2167, DOI 10.1016/j.cca.2011.07.029; Yang S, 2015, MOL MED REP, V12, P527, DOI 10.3892/mmr.2015.3414; Yang WJ, 2005, J BIOL CHEM, V280, P9330, DOI 10.1074/jbc.M413394200; Ye PP, 2014, INT J MED SCI, V11, P17, DOI 10.7150/ijms.7329; Young BC, 2010, ANNU REV PATHOL-MECH, V5, P173, DOI 10.1146/annurev-pathol-121808-102149; Young WF, 2006, ADV THERAPY HYPERTEN, P309; Zeisler H, 2016, NEW ENGL J MED, V374, P13, DOI 10.1056/NEJMoa1414838; Zhang C, 2015, PLACENTA, V36, P250, DOI 10.1016/j.placenta.2014.11.020; Zhang Y, 2012, J CELL MOL MED, V16, P249, DOI 10.1111/j.1582-4934.2011.01291.x; Zhao GF, 2014, J BIOMED SCI, V21, DOI 10.1186/s12929-014-0081-3; Zhu XM, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.12.045	184	54	56	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2016	11	8							e0160808	10.1371/journal.pone.0160808	http://dx.doi.org/10.1371/journal.pone.0160808			36	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4UN	27529341	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000381476700021
J	Binder, D; Probst, C; Grunberger, A; Hilgers, F; Loeschcke, A; Jaeger, KE; Kohlheyer, D; Drepper, T				Binder, Dennis; Probst, Christopher; Gruenberger, Alexander; Hilgers, Fabienne; Loeschcke, Anita; Jaeger, Karl-Erich; Kohlheyer, Dietrich; Drepper, Thomas			Comparative Single-Cell Analysis of Different E. coli Expression Systems during Microfluidic Cultivation	PLOS ONE			English	Article							BACTERIOPHAGE-T7 RNA-POLYMERASE; HIGH-LEVEL EXPRESSION; ESCHERICHIA-COLI; GENE-EXPRESSION; PROTEIN-PRODUCTION; PROMOTER; ARABINOSE; MUTAGENESIS; INDUCTION; REPRESSOR	Recombinant protein production is mostly realized with large-scale cultivations and monitored at the level of the entire population. Detailed knowledge of cell-to-cell variations with respect to cellular growth and product formation is limited, even though phenotypic heterogeneity may distinctly hamper overall production yields, especially for toxic or difficult-to-express proteins. Unraveling phenotypic heterogeneity is thus a key aspect in understanding and optimizing recombinant protein production in biotechnology and synthetic biology. Here, microfluidic single-cell analysis serves as the method of choice to investigate and unmask population heterogeneities in a dynamic and spatiotemporal fashion. In this study, we report on comparative microfluidic single-cell analyses of commonly used E. coli expression systems to uncover system-inherent specifications in the synthetic M9CA growth medium. To this end, the P-T7lac/LacI, the P-BAD/AraC and the Pm/XylS system were systematically analyzed in order to gain detailed insights into variations of growth behavior and expression phenotypes and thus to uncover individual strengths and deficiencies at the single-cell level. Specifically, we evaluated the impact of different system-specific inducers, inducer concentrations as well as genetic modifications that affect inducer-uptake and regulation of target gene expression on responsiveness and phenotypic heterogeneity. Interestingly, the most frequently applied expression system based on E. coli strain BL21(DE3) clearly fell behind with respect to expression homogeneity and robustness of growth. Moreover, both the choice of inducer and the presence of inducer uptake systems proved crucial for phenotypic heterogeneity. Conclusively, microfluidic evaluation of different inducible E. coli expression systems and setups identified the modified lacY-deficient P-T7lac/LacI as well as the Pm/XylS system with conventional m-toluic acid induction as key players for precise and robust triggering of bacterial gene expression in E. coli in a homogeneous fashion.	[Binder, Dennis; Hilgers, Fabienne; Loeschcke, Anita; Jaeger, Karl-Erich; Drepper, Thomas] Univ Dusseldorf, Inst Mol Enzyme Technol, Forschungszentrum Julich, Julich, Germany; [Probst, Christopher; Gruenberger, Alexander; Jaeger, Karl-Erich; Kohlheyer, Dietrich] Forschungszentrum Julich, Inst Bio & Geosci IBG 1, Julich, Germany	Heinrich Heine University Dusseldorf; Helmholtz Association; Research Center Julich; Helmholtz Association; Research Center Julich	Drepper, T (corresponding author), Univ Dusseldorf, Inst Mol Enzyme Technol, Forschungszentrum Julich, Julich, Germany.	t.drepper@fz-juelich.de	drepper, thomas/ABB-4717-2020; Drepper, Thomas/ABA-8291-2020; Kohlheyer, Dietrich/A-9645-2012; Knapp, Fabienne/AAD-5729-2022; jaeger, karl/ABB-1955-2020	drepper, thomas/0000-0002-0096-8084; Drepper, Thomas/0000-0002-0096-8084; Kohlheyer, Dietrich/0000-0001-6215-1857; Knapp, Fabienne/0000-0002-8749-284X; Grunberger, Alexander/0000-0002-7564-4957	Federal Ministry of Education and Research (OptoSys) [FKZ 031A16]; Ministry of Innovation, Science and Research of North-Rhine Westphalia; German Research Foundation [INST 208/654-1 FUGG]; Helmholtz Association [VH-NG-1029, PD-311]	Federal Ministry of Education and Research (OptoSys); Ministry of Innovation, Science and Research of North-Rhine Westphalia; German Research Foundation(German Research Foundation (DFG)); Helmholtz Association(Helmholtz Association)	Supported by grants from the Federal Ministry of Education and Research (OptoSys, FKZ 031A16), Ministry of Innovation, Science and Research of North-Rhine Westphalia and German Research Foundation (INST 208/654-1 FUGG). Moreover, the Helmholtz Association (VH-NG-1029 and PD-311) is gratefully acknowledged for funding. This work was partly performed at the Helmholtz Nanoelectronic Facility (HNF) of Forschungszentrum Julich. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakke I, 2009, APPL ENVIRON MICROB, V75, P2002, DOI 10.1128/AEM.02315-08; Balzer S, 2013, MICROB CELL FACT, V12, DOI 10.1186/1475-2859-12-26; Binder D, 2016, CHEMBIOCHEM, V17, P296, DOI 10.1002/cbic.201500609; Binder D, 2014, INTEGR BIOL-UK, V6, P755, DOI 10.1039/c4ib00027g; Brautaset T, 2009, MICROB BIOTECHNOL, V2, P15, DOI 10.1111/j.1751-7915.2008.00048.x; Daber R, 2007, J MOL BIOL, V370, P609, DOI 10.1016/j.jmb.2007.04.028; Dai J, 2013, ANAL CHEM, V85, P5892, DOI 10.1021/ac400648z; Diederichs S, 2014, MICROB CELL FACT, V13, DOI 10.1186/s12934-014-0149-5; Dumon-Seignovert L, 2004, PROTEIN EXPRES PURIF, V37, P203, DOI 10.1016/j.pep.2004.04.025; Dusny C, 2015, LAB CHIP, V15, P1822, DOI 10.1039/c4lc01270d; Eldar A, 2010, NATURE, V467, P167, DOI 10.1038/nature09326; Fernandez-Castane A, 2012, J BIOTECHNOL, V157, P391, DOI 10.1016/j.jbiotec.2011.12.007; Fritz G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089532; Graslund S, 2008, NAT METHODS, V5, P135, DOI 10.1038/nmeth.f.202; Grunberger A, 2015, CYTOM PART A, V87A, P1101, DOI 10.1002/cyto.a.22779; Gruenberger A, 2013, JOVE-J VIS EXP, DOI 10.3791/50560; Grunberger A, 2014, CURR OPIN BIOTECH, V29, P15, DOI 10.1016/j.copbio.2014.02.008; Grunberger A, 2013, BIOTECHNOL BIOENG, V110, P220, DOI 10.1002/bit.24616; Grunberger A, 2012, LAB CHIP, V12, P2060, DOI [10.1039/c2lc40156h, 10.1039/c21c40156h]; Guan L, 2006, ANNU REV BIOPH BIOM, V35, P67, DOI 10.1146/annurev.biophys.35.040405.102005; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Haldimann A, 1998, J BACTERIOL, V180, P1277, DOI 10.1128/JB.180.5.1277-1286.1998; HENDERSON PJF, 1977, BIOCHEM J, V162, P309, DOI 10.1042/bj1620309; IOST I, 1992, J BACTERIOL, V174, P619, DOI 10.1128/jb.174.2.619-622.1992; JACOB F, 1961, J MOL BIOL, V3, P318, DOI 10.1016/S0022-2836(61)80072-7; Katzke N, 2010, PROTEIN EXPRES PURIF, V69, P137, DOI 10.1016/j.pep.2009.08.008; Khlebnikov A, 2002, BIOTECHNOL PROGR, V18, P672, DOI 10.1021/bp010141k; Khlebnikov A, 2001, MICROBIOL-SGM, V147, P3241, DOI 10.1099/00221287-147-12-3241; Khlebnikov A, 2000, J BACTERIOL, V182, P7029, DOI 10.1128/JB.182.24.7029-7034.2000; Lee SK, 2005, APPL ENVIRON MICROB, V71, P6856, DOI 10.1128/AEM.71.11.6856-6862.2005; Lee SK, 2007, APPL ENVIRON MICROB, V73, P5711, DOI 10.1128/AEM.00791-07; Lee SK, 2006, BIOTECHNOL PROGR, V22, P1547, DOI 10.1021/bp060193f; Lewis M, 1996, SCIENCE, V271, P1247, DOI 10.1126/science.271.5253.1247; Marbach A, 2012, J BIOTECHNOL, V157, P82, DOI 10.1016/j.jbiotec.2011.10.009; Mather W, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.208101; Morgan-Kiss RM, 2002, P NATL ACAD SCI USA, V99, P7373, DOI 10.1073/pnas.122227599; Mustafi N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085731; Ozbudak EM, 2004, NATURE, V427, P737, DOI 10.1038/nature02298; RAMOS JL, 1986, P NATL ACAD SCI USA, V83, P8467, DOI 10.1073/pnas.83.22.8467; RAMOS JL, 1990, J MOL BIOL, V211, P373, DOI 10.1016/0022-2836(90)90358-S; Ramos JL, 1997, ANNU REV MICROBIOL, V51, P341, DOI 10.1146/annurev.micro.51.1.341; Robert L, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.12; Rosano GL, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00172; Saida F, 2006, CURR PROTEIN PEPT SC, V7, P47, DOI 10.2174/138920306775474095; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Samuelson JC, 2011, METHODS MOL BIOL, V705, P195, DOI 10.1007/978-1-61737-967-3_11; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SKERRA A, 1994, GENE, V151, P131, DOI 10.1016/0378-1119(94)90643-2; Sleight Sean C, 2010, J Biol Eng, V4, P12, DOI 10.1186/1754-1611-4-12; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; Terpe K, 2006, APPL MICROBIOL BIOT, V72, P211, DOI 10.1007/s00253-006-0465-8; Ullman G, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0025; Urban A, 1997, NUCLEIC ACIDS RES, V25, P2227, DOI 10.1093/nar/25.11.2227; Veening JW, 2008, ANNU REV MICROBIOL, V62, P193, DOI 10.1146/annurev.micro.62.081307.163002; Wagner S, 2008, P NATL ACAD SCI USA, V105, P14371, DOI 10.1073/pnas.0804090105; Wang Y, 2013, APPL MECH MATER, V377, P69, DOI 10.4028/www.scientific.net/AMM.377.69; Xu JL, 2012, PROTEIN EXPRES PURIF, V83, P30, DOI 10.1016/j.pep.2012.02.014	57	22	22	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2016	11	8							e0160711	10.1371/journal.pone.0160711	http://dx.doi.org/10.1371/journal.pone.0160711			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4SL	27525986	Green Published, Green Submitted, gold			2022-12-27	WOS:000381471100018
J	Cao, LL; Zhang, LJ; Zhao, X; Zhang, Y				Cao, Lili; Zhang, Lijun; Zhao, Xiang; Zhang, Ye			A Hybrid Chalcone Combining the Trimethoxyphenyl and Isatinyl Groups Targets Multiple Oncogenic Proteins and Pathways in Hepatocellular Carcinoma Cells	PLOS ONE			English	Article							CANCER-CELLS; TUBULIN POLYMERIZATION; BIOLOGICAL EVALUATION; MUTATIONAL LANDSCAPE; MOLECULAR THERAPIES; ANTITUBULIN AGENTS; NUCLEOLIN; KINASE; IDENTIFICATION; DERIVATIVES	Small molecule inhibitors that can simultaneously inhibit multiple oncogenic proteins in essential pathways are promising therapeutic chemicals for hepatocellular carcinoma (HCC). To combine the anticancer effects of combretastatins, chalcones and isatins, we synthesized a novel hybrid molecule 3', 4', 5'-trimethoxy-5-chloro-isatinylchalcone (3MCIC). 3MCIC inhibited proliferation of cultured HepG2 cells, causing rounding-up of the cells and massive vacuole accumulation in the cytoplasm. Paxillin and focal adhesion plaques were downregulated by 3MCIC. Surprisingly, unlike the microtubule (MT)-targeting agent CA-4 that inhibits tubulin polymerization, 3MCIC stabilized tubulin polymers both in living cells and in cell lysates. 3MCIC treatment reduced cyclin B1, CDK1, p-CDK1/2, and Rb, but increased p53 and p21. Moreover, 3MCIC caused GSK3 beta degradation by promoting GSK3 beta-Ser9 phosphorylation. Nevertheless, 3MCIC inhibited the Wnt/beta-catenin pathway by downregulating beta-catenin, c-Myc, cyclin D1 and E2F1. 3MCIC treatment not only activated the caspase-3-dependent apoptotic pathway, but also caused massive autophagy evidenced by rapid and drastic changes of LC3 and p62. 3MCIC also promoted cleavage and maturation of the lysosomal protease cathepsin D. Using ligand-affinity chromatography (LAC), target proteins captured onto the Sephacryl S1000-C-12-3MCIC resins were isolated and analyzed by mass spectrometry (MS). Some of the LAC-MS identified targets, i.e., septin-2, vimentin, pan-cytokeratin, nucleolin, EF1 alpha 1/2, EBP1 (PA2G4), cyclin B1 and GSK3 beta, were further detected by Western blotting. Moreover, both septin-2 and HIF-1 alpha decreased drastically in 3MCIC-treated HepG2 cells. Our data suggest that 3MCIC is a promising anticancer lead compound with novel targeting mechanisms, and also demonstrate the efficiency of LAC-MS based target identification in anticancer drug development.	[Cao, Lili; Zhao, Xiang; Zhang, Ye] Peking Univ, Sch Basic Med Sci, Dept Cell Biol, Beijing, Peoples R China; [Zhang, Lijun] Peking Univ, Sch Life Sci, Beijing, Peoples R China	Peking University; Peking University	Zhang, Y (corresponding author), Peking Univ, Sch Basic Med Sci, Dept Cell Biol, Beijing, Peoples R China.	zhangye@bjmu.edu.cn			National Natural Science Foundation of China [31171296]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The work was supported by the National Natural Science Foundation of China (No. 31171296). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas W, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00075; Angelis D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096390; Bai Y, 2009, NEUROSCIENCE, V160, P371, DOI 10.1016/j.neuroscience.2009.01.076; Bai Y, 2009, NEUROREPORT, V20, P918, DOI 10.1097/WNR.0b013e32832c92d7; Benes P, 2008, CRIT REV ONCOL HEMAT, V68, P12, DOI 10.1016/j.critrevonc.2008.02.008; Berger CM, 2015, BIOCHIMIE, V113, P78, DOI 10.1016/j.biochi.2015.03.023; Beurel E, 2015, PHARMACOL THERAPEUT, V148, P114, DOI 10.1016/j.pharmthera.2014.11.016; Bilsland AE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006459; Bupathi M, 2014, ONCOTARGETS THER, V7, P1927, DOI 10.2147/OTT.S46457; Chen C, 2015, WORLD J HEPATOL, V7, P1964, DOI 10.4254/wjh.v7.i15.1964; Cheng DD, 2014, BIOCHEM BIOPH RES CO, V443, P598, DOI 10.1016/j.bbrc.2013.12.020; Cinghu S, 2014, P NATL ACAD SCI USA, V111, pE1581, DOI 10.1073/pnas.1318598111; Cleary SP, 2013, HEPATOLOGY, V58, P1693, DOI 10.1002/hep.26540; Delire B, 2015, EUR J CLIN INVEST, V45, P609, DOI 10.1111/eci.12441; Deng GL, 2015, WORLD J HEPATOL, V7, P787, DOI 10.4254/wjh.v7.i5.787; Dolat L, 2014, J CELL BIOL, V207, P225, DOI 10.1083/jcb.201405050; Dolat L, 2014, BIOL CHEM, V395, P123, DOI 10.1515/hsz-2013-0233; Galuppo R, 2014, DIGEST DIS SCI, V59, P1688, DOI 10.1007/s10620-014-3058-x; Gangjee A, 2014, ACS MED CHEM LETT, V5, P480, DOI 10.1021/ml4004793; Germano D, 2014, WORLD J GASTROENTERO, V20, P3087, DOI 10.3748/wjg.v20.i12.3087; Giannakakou P, 1997, J BIOL CHEM, V272, P17118, DOI 10.1074/jbc.272.27.17118; Guo XD, 2014, DIAGN PATHOL, V9, DOI 10.1186/s13000-014-0175-y; Kamal A, 2015, ORG BIOMOL CHEM, V13, P3963, DOI 10.1039/c4ob02606c; Kan ZY, 2013, GENOME RES, V23, P1422, DOI 10.1101/gr.154492.113; Kanda M, 2015, WORLD J GASTROENTERO, V21, P10584, DOI 10.3748/wjg.v21.i37.10584; Karaman MW, 2008, NAT BIOTECHNOL, V26, P127, DOI 10.1038/nbt1358; Karim MR, 2014, ANAL BIOCHEM, V465, P28, DOI 10.1016/j.ab.2014.07.007; Komatsu M, 2012, PHARMACOL RES, V66, P457, DOI 10.1016/j.phrs.2012.07.004; Kremer BE, 2005, MOL BIOL CELL, V16, P4648, DOI 10.1091/mbc.E05-03-0267; Krishnegowda G, 2011, BIOORGAN MED CHEM, V19, P6006, DOI 10.1016/j.bmc.2011.08.044; Kuo CC, 2004, CANCER RES, V64, P4621, DOI 10.1158/0008-5472.CAN-03-3474; Kuzuya T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138776; Lee WC, 2015, EJSO-EUR J SURG ONC, V41, P1144, DOI 10.1016/j.ejso.2015.05.024; Li J, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0090225, 10.1371/journal.pone.0105508]; Liu M, 2010, MOL BIOL REP, V37, P3601, DOI 10.1007/s11033-010-0009-2; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Llovet JM, 2015, NAT REV CLIN ONCOL, V12, P408, DOI [10.1038/nrclinonc.2015.103, 10.1038/nrclinonc.2015.121]; Lomenick B, 2011, ACS CHEM BIOL, V6, P34, DOI 10.1021/cb100294v; Mahapatra DM, 2015, EUR J MED CHEM, V98, P69, DOI 10.1016/j.ejmech.2015.05.004; Marks EI, 2016, CURR CANCER DRUG TAR, V16, P53, DOI 10.2174/1568009615666150916092903; McCubrey JA, 2014, ONCOTARGET, V5, P2881, DOI 10.18632/oncotarget.2037; Mostowy S, 2012, NAT REV MOL CELL BIO, V13, P183, DOI 10.1038/nrm3284; Mukhtar E, 2014, MOL CANCER THER, V13, P275, DOI 10.1158/1535-7163.MCT-13-0791; Nault JC, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3218; Negi AS, 2015, BIOORGAN MED CHEM, V23, P373, DOI 10.1016/j.bmc.2014.12.027; Nepali K, 2014, EUR J MED CHEM, V77, P422, DOI 10.1016/j.ejmech.2014.03.018; Ookata K, 1997, BIOCHEMISTRY-US, V36, P15873, DOI 10.1021/bi971251w; Pakravan P, 2013, PHARMACOL REP, V65, P313, DOI 10.1016/S1734-1140(13)71007-7; Palmer DH, 2015, CANCER METAST REV, V34, P497, DOI 10.1007/s10555-015-9580-2; Palmieri D, 2015, P NATL ACAD SCI USA, V112, P9418, DOI 10.1073/pnas.1507087112; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Patel A, 2014, CURR TREAT OPTION ON, V15, P380, DOI 10.1007/s11864-014-0291-7; Poruchynsky MS, 2015, P NATL ACAD SCI USA, V112, P1571, DOI 10.1073/pnas.1416418112; Renz C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148340; Satelli A, 2011, CELL MOL LIFE SCI, V68, P3033, DOI 10.1007/s00018-011-0735-1; Sato S, 2010, CHEM BIOL, V17, P616, DOI 10.1016/j.chembiol.2010.05.015; Siemann DW, 2011, CANCER TREAT REV, V37, P63, DOI 10.1016/j.ctrv.2010.05.001; Singh P, 2014, EUR J MED CHEM, V85, P758, DOI 10.1016/j.ejmech.2014.08.033; Smith C, 2015, J MOL BIOL, V427, P3273, DOI 10.1016/j.jmb.2015.07.026; Sperandio S, 2000, P NATL ACAD SCI USA, V97, P14376, DOI 10.1073/pnas.97.26.14376; Taelman VF, 2010, CELL, V143, P1136, DOI 10.1016/j.cell.2010.11.034; Toivola DM, 2015, CURR OPIN CELL BIOL, V32, P73, DOI 10.1016/j.ceb.2014.12.008; Totoki Y, 2014, NAT GENET, V46, P1267, DOI 10.1038/ng.3126; Tsubota A, 2010, CARCINOGENESIS, V31, P504, DOI 10.1093/carcin/bgp313; Ursu A, 2015, BIOORG MED CHEM LETT, V25, P3079, DOI 10.1016/j.bmcl.2015.06.023; Vardi-Oknin D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073179; Villanueva A, 2014, NAT REV CLIN ONCOL, V11, P73, DOI [10.1038/nrclinonc.2013.227, 10.1038/nrclinonc.2013.243]; Villanueva A, 2013, J HEPATOL, V59, P392, DOI 10.1016/j.jhep.2013.03.025; Vine KL, 2009, ANTI-CANCER AGENT ME, V9, P397; Wei H, 2016, RSC ADV, V6, P10846, DOI 10.1039/c5ra26294a; Yang F, 2011, ACS CHEM BIOL, V6, P252, DOI 10.1021/cb100287q; Yang J, 2010, J CELL SCI, V123, P861, DOI 10.1242/jcs.060475; Yang TT, 1996, ANAL BIOCHEM, V241, P103, DOI 10.1006/abio.1996.0383; Zhang L, 2000, J CELL BIOL, V151, P1; Zhang L, 2015, RSC ADV, V5, P97816, DOI 10.1039/c5ra21217k; Zhao P, 2014, EUR J MED CHEM, V86, P165, DOI 10.1016/j.ejmech.2014.08.049	76	6	6	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2016	11	8							e0161025	10.1371/journal.pone.0161025	http://dx.doi.org/10.1371/journal.pone.0161025			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4SL	27525972	Green Submitted, Green Published, gold			2022-12-27	WOS:000381471100031
J	Nemska, S; Monassier, L; Gassmann, M; Frossard, N; Tavakoli, R				Nemska, Simona; Monassier, Laurent; Gassmann, Max; Frossard, Nelly; Tavakoli, Reza			Kinetic mRNA Profiling in a Rat Model of Left-Ventricular Hypertrophy Reveals Early Expression of Chemokines and Their Receptors	PLOS ONE			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; CARDIAC-HYPERTROPHY; MYOCARDIAL FIBROSIS; DIASTOLIC DYSFUNCTION; INFLAMMATORY CELLS; OXIDATIVE STRESS; CXC CHEMOKINE; CC-CHEMOKINE; KAPPA-B; RECRUITMENT	Left-ventricular hypertrophy (LVH), a risk factor for heart failure and death, is characterized by cardiomyocyte hypertrophy, interstitial cell proliferation, and leukocyte infiltration. Chemokines interacting with G protein-coupled chemokine receptors may play a role in LVH development by promoting recruitment of activated leukocytes or modulating left-ventricular remodeling. Using a pressure overload-induced kinetic model of LVH in rats, we examined during 14 days the expression over time of chemokine and chemokine receptor mRNAs in left ventricles from aortic-banded vs sham-operated animals. Two phases were clearly distinguished: an inflammatory phase (D3-D5) with overexpression of inflammatory genes such as il-1 beta, tnfa, nlrp3, and the rela subunit of nf-kb, and a hypertrophic phase (D7-D14) where anp overexpression was accompanied by a heart weight/body weight ratio that increased by more than 20% at D14. No cardiac dysfunction was detectable by echocardiography at the latter time point. Of the 36 chemokines and 20 chemokine receptors analyzed by a Taqman Low Density Array panel, we identified at D3 (the early inflammatory phase) overexpression of mRNAs for the monocyte chemotactic proteins CCL2 (12-fold increase), CCL7 (7-fold increase), and CCL12 (3-fold increase), for the macrophage inflammatory proteins CCL3 (4-fold increase), CCL4 (2-fold increase), and CCL9 (2-fold increase), for their receptors CCR2 (4-fold increase), CCR1 (3-fold increase), and CCR5 (3-fold increase), and for CXCL1 (8-fold increase) and CXCL16 (2-fold increase). During the hypertrophic phase mRNA expression of chemokines and receptors returned to the baseline levels observed at D0. Hence, this first exhaustive study of chemokine and chemokine receptor mRNA expression kinetics reports early expression of monocyte/macrophage-related chemokines and their receptors during the development of LVH in rats, followed by regulation of inflammation as LVH progresses.	[Nemska, Simona; Gassmann, Max; Tavakoli, Reza] Univ Zurich, Inst Vet Physiol, Zurich, Switzerland; [Nemska, Simona; Gassmann, Max; Tavakoli, Reza] Univ Zurich, Zurich Ctr Integrat Human Physiol, Zurich, Switzerland; [Nemska, Simona; Frossard, Nelly] Univ Strasbourg, CNRS, Lab Innovat Therapeut, UMR7200, Strasbourg, France; [Monassier, Laurent] Univ Strasbourg, Federat Med Translat, Lab Neurobiol & Pharmacol Cardiovasc, EA7296, Strasbourg, France; [Tavakoli, Reza] Canton Hosp Lucerne, Dept Cardiac Surg, Luzern, Switzerland	University of Zurich; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Lucerne Cantonal Hospital	Tavakoli, R (corresponding author), Univ Zurich, Inst Vet Physiol, Zurich, Switzerland.; Tavakoli, R (corresponding author), Univ Zurich, Zurich Ctr Integrat Human Physiol, Zurich, Switzerland.; Frossard, N (corresponding author), Univ Strasbourg, CNRS, Lab Innovat Therapeut, UMR7200, Strasbourg, France.; Tavakoli, R (corresponding author), Canton Hosp Lucerne, Dept Cardiac Surg, Luzern, Switzerland.	nelly.frossard@unistra.fr; reza.tavakoli@uzh.ch	Nemska, Simona/Y-1105-2019; Monassier, Laurent/AAE-4446-2022; /AAD-1664-2020; Frossard, Nelly/F-8301-2013	Nemska, Simona/0000-0002-6969-6494; Gassmann, Max/0000-0003-2750-8878	University of Zurich (Switzerland); St Jude Medical (Switzerland)	University of Zurich (Switzerland); St Jude Medical (Switzerland)(St. Jude Medical)	The study was funded by the University of Zurich and St Jude Medical (Switzerland) (RT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altara R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141394; Aukrust P, 1998, CIRCULATION, V97, P1136, DOI 10.1161/01.CIR.97.12.1136; Bechara C, 2007, AM J PHYSIOL-HEART C, V293, pH3088, DOI 10.1152/ajpheart.00473.2007; Berahovich RD, 2005, J IMMUNOL, V174, P7341, DOI 10.4049/jimmunol.174.11.7341; Bettink SI, 2010, BIOCHEM BIOPH RES CO, V397, P208, DOI 10.1016/j.bbrc.2010.05.086; Castellani C, 2010, HUM PATHOL, V41, P1566, DOI 10.1016/j.humpath.2009.12.017; Cole KE, 1998, J EXP MED, V187, P2009, DOI 10.1084/jem.187.12.2009; Dahl CP, 2009, CIRC-HEART FAIL, V2, P624, DOI 10.1161/CIRCHEARTFAILURE.108.821074; Daryadel A, 2014, J CARDIOTHORAC SURG, V9, DOI 10.1186/1749-8090-9-81; Duerr GD, 2013, LIFE SCI, V92, P976, DOI 10.1016/j.lfs.2013.03.014; Fang L, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000270; Finsen AV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112172; Frangogiannis NG, 2007, CIRCULATION, V115, P584, DOI 10.1161/CIRCULATIONAHA.106.646091; Fujiu K, 2014, CARDIOVASC RES, V102, P232, DOI 10.1093/cvr/cvu059; Gupta S, 2002, J CELL BIOL, V159, P1019, DOI 10.1083/jcb.200207149; Gupta S, 2007, ANTIOXID REDOX SIGN, V9, P623, DOI 10.1089/ars.2007.1474; Hayashidani S, 2003, CIRCULATION, V108, P2134, DOI 10.1161/01.CIR.0000092890.29552.22; Heymans S, 2013, CIRCULATION, V128, P1420, DOI 10.1161/CIRCULATIONAHA.112.001357; Hill JA, 2008, NEW ENGL J MED, V358, P1370, DOI 10.1056/NEJMra072139; Hill JA, 2012, J ELECTROCARDIOL, V45, P624, DOI 10.1016/j.jelectrocard.2012.08.003; HINGLAIS N, 1994, LAB INVEST, V70, P286; Homey B, 2002, NAT MED, V8, P157, DOI 10.1038/nm0202-157; Husberg C, 2008, J MOL CELL CARDIOL, V45, P261, DOI 10.1016/j.yjmcc.2008.05.009; Jia GQ, 1996, J EXP MED, V184, P1939, DOI 10.1084/jem.184.5.1939; Kai H, 2006, HYPERTENS RES, V29, P711, DOI 10.1291/hypres.29.711; Kang YJ, 2006, TOXICOL PATHOL, V34, P58, DOI 10.1080/01926230500419421; Kao J, 2003, CIRCULATION, V107, P1958, DOI 10.1161/01.CIR.0000069270.16498.75; Kolattukudy PE, 1998, AM J PATHOL, V152, P101; Kuwahara F, 2002, CIRCULATION, V106, P130, DOI 10.1161/01.CIR.0000020689.12472.E0; Kuwahara F, 2004, HYPERTENSION, V43, P739, DOI 10.1161/01.HYP.0000118584.33350.7d; Kuwahara F, 2003, HYPERTENSION, V41, P819, DOI 10.1161/01.HYP.0000056108.73219.0A; Ludwig A, 2008, J NEUROIMMUNOL, V198, P92, DOI 10.1016/j.jneuroim.2008.04.024; Moore BB, 2006, AM J RESP CELL MOL, V35, P175, DOI 10.1165/rcmb.2005-0239OC; Morimoto H, 2006, CIRC RES, V99, P891, DOI 10.1161/01.RES.0000246113.82111.2d; Nicoletti A, 1996, CARDIOVASC RES, V32, P1096, DOI 10.1016/S0008-6363(96)00158-7; Nicoletti A, 1999, CARDIOVASC RES, V41, P532, DOI 10.1016/S0008-6363(98)00305-8; Nishimura M, 2009, ANN NY ACAD SCI, V1173, P350, DOI 10.1111/j.1749-6632.2009.04738.x; Opie LH, 2006, LANCET, V367, P356, DOI 10.1016/S0140-6736(06)68074-4; Purcell NH, 2001, P NATL ACAD SCI USA, V98, P6668, DOI 10.1073/pnas.111155798; Velazquez JR, 2011, CLIN REV ALLERG IMMU, V41, P76, DOI 10.1007/s12016-010-8202-6; Ruwhof C, 2000, CARDIOVASC RES, V47, P23, DOI 10.1016/S0008-6363(00)00076-6; Sarafi MN, 1997, J EXP MED, V185, P99, DOI 10.1084/jem.185.1.99; Sato E, 2001, ANTIMICROB AGENTS CH, V45, P401, DOI 10.1128/AAC.8.2.401-406.2001; Schultz MJ, 2000, J ANTIMICROB CHEMOTH, V46, P235, DOI 10.1093/jac/46.2.235; Shen JZ, 2014, ENDOCRINOLOGY, V155, P1057, DOI 10.1210/en.2013-1772; Shi C, 2011, NAT REV IMMUNOL, V11, P762, DOI 10.1038/nri3070; Soehnlein O, 2010, NAT REV IMMUNOL, V10, P427, DOI 10.1038/nri2779; Takeda N, 2010, J CLIN INVEST, V120, P254, DOI 10.1172/JCI40295; Tarzami ST, 2005, BIOCHEM BIOPH RES CO, V335, P1008, DOI 10.1016/j.bbrc.2005.07.168; Tarzami ST, 2002, J MOL CELL CARDIOL, V34, P209, DOI 10.1006/jmcc.2001.1503; Tsou CL, 2007, J CLIN INVEST, V117, P902, DOI 10.1172/JCI29919; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Velten M, 2012, CARDIOVASC RES, V96, P422, DOI 10.1093/cvr/cvs280; Waehre A, 2012, J APPL PHYSIOL, V112, P1372, DOI 10.1152/japplphysiol.01350.2011; Wang X.D., 2014, J APPL MATH, V2014, P9; Weeks KL, 2011, PHYSIOLOGY, V26, P97, DOI 10.1152/physiol.00043.2010; Weisheit C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112710; White GE, 2013, PHARMACOL REV, V65, P47, DOI 10.1124/pr.111.005074; Xuan WL, 2011, CARDIOVASC RES, V92, P385, DOI 10.1093/cvr/cvr221; Younce CW, 2014, J MOL CELL CARDIOL, V76, P172, DOI 10.1016/j.yjmcc.2014.08.022; Zernecke A, 2010, CARDIOVASC RES, V86, P192, DOI 10.1093/cvr/cvp391	61	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2016	11	8							e0161273	10.1371/journal.pone.0161273	http://dx.doi.org/10.1371/journal.pone.0161273			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4SL	27525724	Green Accepted, Green Published, gold			2022-12-27	WOS:000381471100051
J	Laranjeira, A; Schulz, J; Dotti, CG				Laranjeira, Antnio; Schulz, Joachim; Dotti, Carlos G.			Genes Related to Fatty Acid beta-Oxidation Play a Role in the Functional Decline of the Drosophila Brain with Age	PLOS ONE			English	Article							LIFE-SPAN; CARNITINE BIOSYNTHESIS; DIETARY RESTRICTION; ADULT DROSOPHILA; INSULIN-RECEPTOR; LIPID DROPLETS; NERVOUS-SYSTEM; AGING PROCESS; LONGEVITY; PROTEIN	In living organisms, ageing is widely considered to be the result of a multifaceted process consisting of the progressive accumulation of damage over time, having implications both in terms of function and survival. The study of ageing presents several challenges, from the different mechanisms implicated to the great diversity of systems affected over time. In the current study, we set out to identify genes involved in the functional decline of the brain with age and study its relevance in a tissue dependent manner using Drosophila melanogaster as a model system. Here we report the age-dependent upregulation of genes involved in the metabolic process of fatty acid -oxidation in the nervous tissue of female wild-type flies. Downregulation of CG10814, dHNF4 and lipid mobilizing genes bmm and dAkh rescues the functional decline of the brain with age, both at the cellular and behaviour level, while over-expression worsens performance. Our data proposes the occurrence of a metabolic alteration in the fly brain with age, whereby the process of beta-oxidation of fatty acids experiences a genetic gain-of-function. This event proved to be one of the main causes contributing to the functional decline of the brain with age.	[Laranjeira, Antnio; Schulz, Joachim] Univ Leuven, Ctr Human Genet, VIB Ctr Biol Dis, B-3000 Leuven, Belgium; [Dotti, Carlos G.] UAM, CSIC, Ctr Biol Mol Severo Ochoa, Campus Univ Autonoma Madrid, Madrid 28049, Spain	Flanders Institute for Biotechnology (VIB); KU Leuven; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM)	Dotti, CG (corresponding author), UAM, CSIC, Ctr Biol Mol Severo Ochoa, Campus Univ Autonoma Madrid, Madrid 28049, Spain.	cdotti@cbm.csic.es			OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD018537] Funding Source: NIH RePORTER; NIH HHS [P40 OD018537] Funding Source: Medline	OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Bailey AP, 2015, CELL, V163, P340, DOI 10.1016/j.cell.2015.09.020; BEAL MF, 1993, TRENDS NEUROSCI, V16, P125, DOI 10.1016/0166-2236(93)90117-5; BERNARDES DJB, 2012, EMBO MOL MED, V4, P691, DOI DOI 10.1002/EMMM.201200245; Bishop NA, 2010, NATURE, V464, P529, DOI 10.1038/nature08983; Bluher M, 2003, SCIENCE, V299, P572, DOI 10.1126/science.1078223; BRAND AH, 1993, DEVELOPMENT, V118, P401; Bross TG, 2005, AGING CELL, V4, P309, DOI 10.1111/j.1474-9726.2005.00181.x; Broughton S, 2009, BIOCHEM J, V418, P1, DOI 10.1042/BJ20082102; Clancy DJ, 2001, SCIENCE, V292, P104, DOI 10.1126/science.1057991; Demontis F, 2010, CELL, V143, P813, DOI 10.1016/j.cell.2010.10.007; EDGECOMB RS, 1994, J EXP BIOL, V197, P215; Gargano JW, 2005, EXP GERONTOL, V40, P386, DOI 10.1016/j.exger.2005.02.005; Gems D, 2013, ANNU REV PHYSIOL, V75, P621, DOI 10.1146/annurev-physiol-030212-183712; Giannakou ME, 2004, SCIENCE, V305, P361, DOI 10.1126/science.1098219; Girardot F, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-69; Gronke S, 2007, PLOS BIOL, V5, P1248, DOI 10.1371/journal.pbio.0050137; Grotewiel MS, 2005, AGEING RES REV, V4, P372, DOI 10.1016/j.arr.2005.04.001; Holzenberger M, 2003, NATURE, V421, P182, DOI 10.1038/nature01298; Houten S.M., 2015, ANN REV PHYSL; Hwangbo DS, 2004, NATURE, V429, P562, DOI 10.1038/nature02549; KLASS MR, 1983, MECH AGEING DEV, V22, P279, DOI 10.1016/0047-6374(83)90082-9; Koh K, 2006, P NATL ACAD SCI USA, V103, P13843, DOI 10.1073/pnas.0605903103; Koubova J, 2003, GENE DEV, V17, P313, DOI 10.1101/gad.1052903; Libert S, 2008, MOL IMMUNOL, V45, P810, DOI 10.1016/j.molimm.2007.06.353; Liu L, 2015, CELL, V160, P177, DOI 10.1016/j.cell.2014.12.019; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Mackay TFC, 2012, NATURE, V482, P173, DOI 10.1038/nature10811; Mannaerts GP, 1996, ANN NY ACAD SCI, V804, P99, DOI 10.1111/j.1749-6632.1996.tb18611.x; Moskalev AA, 2013, AGEING RES REV, V12, P661, DOI 10.1016/j.arr.2012.02.001; Mourikis P, 2006, P NATL ACAD SCI USA, V103, P1307, DOI 10.1073/pnas.0510564103; Navarro A, 2008, AM J PHYSIOL-REG I, V294, pR501, DOI 10.1152/ajpregu.00492.2007; Navarro A, 2007, AM J PHYSIOL-CELL PH, V292, pC670, DOI 10.1152/ajpcell.00213.2006; Osterwalder T, 2001, P NATL ACAD SCI USA, V98, P12596, DOI 10.1073/pnas.221303298; Palanker L, 2009, CELL METAB, V9, P228, DOI 10.1016/j.cmet.2009.01.009; Pandi-Perumal SR, 2002, AGEING RES REV, V1, P559, DOI 10.1016/S1568-1637(02)00014-4; Powers ET, 2009, ANNU REV BIOCHEM, V78, P959, DOI 10.1146/annurev.biochem.052308.114844; Rigault C, 2013, BBA-MOL CELL BIOL L, V1831, P370, DOI 10.1016/j.bbalip.2012.10.007; Simonsen A, 2008, AUTOPHAGY, V4, P176, DOI 10.4161/auto.5269; Sohal RS, 2002, FREE RADICAL BIO MED, V33, P37, DOI 10.1016/S0891-5849(02)00856-0; Strijbis K, 2010, IUBMB LIFE, V62, P357, DOI 10.1002/iub.323; Sun XP, 2014, CELL REP, V8, P1781, DOI 10.1016/j.celrep.2014.08.022; Taguchi A, 2007, SCIENCE, V317, P369, DOI 10.1126/science.1142179; Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517; Tsai L, 1998, P NATL ACAD SCI USA, V95, P7975, DOI 10.1073/pnas.95.14.7975; Vaz FM, 2002, BIOCHEM J, V361, P417, DOI 10.1042/0264-6021:3610417; Vijg J, 2005, ANNU REV MED, V56, P193, DOI 10.1146/annurev.med.56.082103.104617; Vijg J, 2008, NATURE, V454, P1065, DOI 10.1038/nature07216; Wisely GB, 2002, STRUCTURE, V10, P1225, DOI 10.1016/S0969-2126(02)00829-8; Wong R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006063	49	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2016	11	8							e0161143	10.1371/journal.pone.0161143	http://dx.doi.org/10.1371/journal.pone.0161143			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3LI	27518101	gold, Green Published, Green Submitted			2022-12-27	WOS:000381382100054
J	Castillo, M; Astudillo, A; Clavero, O; Velasco, J; Ibanez, R; de Sanjose, S				Castillo, Marta; Astudillo, Aurora; Clavero, Omar; Velasco, Julio; Ibanez, Raquel; de Sanjose, Silvia			Poor Cervical Cancer Screening Attendance and False Negatives. A Call for Organized Screening	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS; HISTORY; WOMEN; CARCINOMA; PROGRAM; ADENOCARCINOMA; NETHERLANDS; PREVENTION; CYTOLOGY; AUDIT	Objective The objective of this study was to describe prior negative screening history and symptoms around the time of diagnosis of incident cervical cancer (CC) cases diagnosed between 2000 and 2010 within the Asturias public health system. Methods Records from 374 women diagnosed with CC between 2000 and 2010 from all public hospitals in Asturias were retrieved. Clinical information, FIGO stage and all previous cytological data were extracted from clinical and histopathological records. Proportional differences were assessed using chi-square tests. Logistic regression analysis was used to estimate odds ratios (OR) and 95% confidence intervals (CI). Inter-observer agreement in cytology was checked by comparing concordance values using k-statistics. Results No prior screening history was recorded in 60.7% of CC cases and its absence increased with age and advanced stage. Advanced stage (e.g., >= II) at diagnosis was associated with age (> 50 years) and adenocarcinoma (ADC) compared to younger women and those with a squamous cell carcinoma (SCC). False negative smears were identified in 27.1% of women with CC (ADC 52.6% vs. SCC 16.2%, p< 0.05). Conclusions Absence of prior screening history was common among CC cases. Organized actions to reduce "under screening"and the use of highly sensitive HPV-based tests could be useful strategies in reducing the burden of CC in Asturias.	[Castillo, Marta] SESPA, Jarrio Hosp, Dept Obstet & Gynecol, Coana, Asturias, Spain; [Astudillo, Aurora] Univ Oviedo, SESPA, Asturias Cent Univ Hosp, Dept Pathol, Oviedo, Asturias, Spain; [Clavero, Omar; Ibanez, Raquel; de Sanjose, Silvia] Inst Catala Oncol IDIBELL, Canc Epidemiol Res Programme, Infect & Canc Unit, Barcelona, Spain; [Velasco, Julio] Med Ctr Asturias, Dept Pathol, Oviedo, Asturias, Spain; [de Sanjose, Silvia] CIBER Epidemiol & Publ Hlth CIBERESP, Barcelona, Spain	Central University Hospital Asturias; University of Oviedo; Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); CIBER - Centro de Investigacion Biomedica en Red; CIBERESP	Castillo, M (corresponding author), SESPA, Jarrio Hosp, Dept Obstet & Gynecol, Coana, Asturias, Spain.	mamacasnu@gmail.com		Castillo Nunez, Marta/0000-0003-1565-9652; Ibanez, Raquel/0000-0003-3324-8312; Clavero, Omar/0000-0001-9721-6382; Astudillo Gonzalez, Maria Aurora/0000-0001-8947-8809	Agencia de Gestiio d'Ajuts Universitaris i de Recerca (Catalan Government) [SGR_14_756]; Instituto de Salud Carlos III CIBERESP [36]	Agencia de Gestiio d'Ajuts Universitaris i de Recerca (Catalan Government); Instituto de Salud Carlos III CIBERESP(Instituto de Salud Carlos III)	This study has been partially supported by Agencia de Gestiio d'Ajuts Universitaris i de Recerca (Catalan Government, grants SGR_14_756) and from the Instituto de Salud Carlos III CIBERESP, group 36. Silvia de Sanjose, Omar Clavero, Raquel Ibanez.	Blade A.T., 2014, REV ESP PATOL, V57, P1, DOI [10.1016/S0304-5013(14)73068-7, DOI 10.1016/S0304-5013(14)73068-7]; Bofin AM, 2007, CANCER CYTOPATHOL, V111, P210, DOI 10.1002/cncr.22865; Bos AB, 2006, INT J CANCER, V119, P2372, DOI 10.1002/ijc.22114; Boulanger JC, 2007, GYNECOL OBSTET FERTI, V35, P764, DOI 10.1016/j.gyobfe.2007.07.019; Bruni L, 2014, PAPILLOMAVIRUS RELAT; Castanon A, 2013, BRIT J CANCER, V109, P35, DOI 10.1038/bjc.2013.322; Castanon A, 2012, CYTOPATHOLOGY, V23, P13, DOI 10.1111/j.1365-2303.2011.00948.x; Marqueta PC, 2011, MED CLIN-BARCELONA, V136, P192, DOI 10.1016/j.medcli.2010.07.010; Castro P, 2004, PROG OBSTET GINECOL, V47, P214; CIATTO S, 1993, TUMORI, V79, P311, DOI 10.1177/030089169307900505; Sanjosé Silvia de, 2006, Gac Sanit, V20, P166; Franco EL, 2012, VACCINE, V30, pF175, DOI 10.1016/j.vaccine.2012.06.092; Gispert Rosa, 2006, Gac Sanit, V20, P184, DOI 10.1157/13088849; Herbert A, 2009, BJOG-INT J OBSTET GY, V116, P854, DOI 10.1111/j.1471-0528.2008.01989.x; Herbert A, 2009, BJOG-INT J OBSTET GY, V116, P845, DOI 10.1111/j.1471-0528.2008.01990.x; Ibanez R, 2014, J CLIN MICROBIOL, V52, P1511, DOI 10.1128/JCM.00100-14; Ibanez R, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/605375; Kirschner B, 2011, GYNECOL ONCOL, V120, P68, DOI 10.1016/j.ygyno.2010.09.021; LANDIS JR, 1977, BIOMETRICS, V33, P363, DOI 10.2307/2529786; Margolles M., 2009, ENCUESTA SALUD ASTUR; Mubiayi N, 2002, Gynecol Obstet Fertil, V30, P210, DOI 10.1016/S1297-9589(02)00297-7; Mulvany NJ, 2009, PATHOLOGY, V41, P411, DOI 10.1080/00313020903042604; Pirog EC, 2014, MODERN PATHOL, V27, P1559, DOI 10.1038/modpathol.2014.55; RATIMA K, 1993, NEW ZEAL MED J, V106, P519; Ronco G, 2014, LANCET, V383, P524, DOI 10.1016/S0140-6736(13)62218-7; Skaznik-Wikiel ME, 2012, ACTA CYTOL, V56, P388, DOI 10.1159/000338555; Spayne J, 2008, EUR J PUBLIC HEALTH, V18, P162, DOI 10.1093/eurpub/ckm043; Spence AR, 2007, PREV MED, V45, P93, DOI 10.1016/j.ypmed.2007.06.007; Stuart GCE, 1997, CAN MED ASSOC J, V157, P513; van der Aa MA, 2008, EUR J OBSTET GYN R B, V139, P204, DOI 10.1016/j.ejogrb.2007.10.017; Wright JD, 2005, CANCER-AM CANCER SOC, V103, P85, DOI 10.1002/cncr.20751	31	11	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2016	11	8							e0161403	10.1371/journal.pone.0161403	http://dx.doi.org/10.1371/journal.pone.0161403			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT8TP	27547971	Green Published, Green Submitted, gold			2022-12-27	WOS:000381768400054
J	Sauvageot, N; Leite, S; Alkerwi, A; Sisanni, L; Zannad, F; Saverio, S; Donneau, AF; Albert, A; Guillaume, M				Sauvageot, Nicolas; Leite, Sonia; Alkerwi, Ala'a; Sisanni, Leila; Zannad, Faiez; Saverio, Stranges; Donneau, Anne-Francoise; Albert, Adelin; Guillaume, Michele			Association of Empirically Derived Dietary Patterns with Cardiovascular Risk Factors: A Comparison of PCA and RRR Methods	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; BODY-MASS INDEX; EATING PATTERNS; PRINCIPAL-COMPONENTS; MEDITERRANEAN DIET; METABOLIC SYNDROME; CLINICAL-PRACTICE; CLUSTER-ANALYSIS; TASK-FORCE; FAT	Introduction Principal component analysis is used to determine dietary behaviors of a population whereas reduced rank regression is used to construct disease-related dietary patterns. This study aimed to compare both types of DP and theirs associations with cardiovascular risk factors (CVRF). Materiel and Methods Data were derived from the cross sectional NESCAV (Nutrition, Environment and Cardiovascular Health) study, aiming to describe the cardiovascular health of the Greater region's population (Grand duchy of Luxembourg, Wallonia (Belgium), Lorraine (France)). 2298 individuals were included for this study and dietary intake was assessed using a 134-item food frequency questionnaire. Results We found that CVRF-related patterns also reflect eating behaviours of the population. Comparing concordant food groups between both dietary pattern methods, a diet high in fruits, oleaginous and dried fruits, vegetables, olive oil, fats rich in omega 6 and tea and low in fried foods, lean and fatty meat, processed meat, ready meal, soft drink and beer was associated with lower prevalence of CVRF. In the opposite, a pattern characterized by high intakes of fried foods, meat, offal, beer, wine and aperitifs and spirits, and low intakes of cereals, sugar and sweets and soft drinks was associated with higher prevalence of CVRF. Conclusion In sum, we found that a "Prudent" and "Animal protein and alcohol" patterns were both associated with CVRF and behaviourally meaningful. Moreover, the relationships of those dietary patterns with lifestyle characteristics support the theory that food choices are part of a larger pattern of healthy lifestyle.	[Sauvageot, Nicolas; Leite, Sonia; Alkerwi, Ala'a; Saverio, Stranges] LIH, Strassen, Luxembourg; [Sisanni, Leila] Univ Paris Diderot, Sorbonne Paris Cite, AP HP, Dept Neurol, Paris, France; [Sisanni, Leila] Univ Paris Diderot, Sorbonne Paris Cite, Stroke Ctr, Bichat Hosp,INSERM,LVTS,U1148,DHU FIRE, Paris, France; [Zannad, Faiez] CHU, Dept Malad Cardiovasc, Hypertens Unit, Vandoeuvre Les Nancy, France; [Donneau, Anne-Francoise; Albert, Adelin; Guillaume, Michele] Univ Liege, Ecole Sante Publ, Liege, Belgium	Luxembourg Institute of Health; Assistance Publique Hopitaux Paris (APHP); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; CHU de Nancy; University of Liege	Sauvageot, N (corresponding author), LIH, Strassen, Luxembourg.	nicolas.sauvageot@lih.lu	Zannad, Faiez/K-4649-2019	Alkerwi, Ala'a/0000-0002-7448-3936	European Regional Development Fund; National Fund of Research of Luxembourg	European Regional Development Fund(European Commission); National Fund of Research of Luxembourg	Funding was provided by the European Regional Development Fund and National Fund of Research of Luxembourg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkerwi A, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-698; Alkerwi A, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-468; Barbaresko J, 2014, BRIT J NUTR, V112, P1364, DOI 10.1017/S0007114514002098; BARKER ME, 1990, BRIT J NUTR, V64, P319, DOI 10.1079/BJN19900034; Centritto F, 2009, NUTR METAB CARDIOVAS, V19, P697, DOI 10.1016/j.numecd.2008.11.009; Costacou T, 2003, EUR J CLIN NUTR, V57, P1378, DOI 10.1038/sj.ejcn.1601699; De Backer G, 2003, EUR J CARDIOV PREV R, V10, pS1, DOI 10.1097/01.hjr.0000087913.96265.e2; DiBello JR, 2008, AM J EPIDEMIOL, V168, P1433, DOI 10.1093/aje/kwn274; Fung TT, 2001, AM J CLIN NUTR, V73, P61; Heidemann C, 2005, DIABETOLOGIA, V48, P1126, DOI 10.1007/s00125-005-1743-1; Hercberg S., 2006, Annales Pharmaceutiques Francaises, V64, P397, DOI 10.1016/S0003-4509(06)75335-4; Hoffmann K, 2005, BRIT J NUTR, V93, P709, DOI 10.1079/BJN20051399; Hoffmann K, 2004, AM J CLIN NUTR, V80, P633; Hoffmann K, 2004, AM J EPIDEMIOL, V159, P935, DOI 10.1093/aje/kwh134; Hu FB, 2000, AM J CLIN NUTR, V72, P912; Hu FB, 2002, CURR OPIN LIPIDOL, V13, P3, DOI 10.1097/00041433-200202000-00002; Hu FB, 2001, J AM COLL NUTR, V20, P5, DOI 10.1080/07315724.2001.10719008; Hu FB, 2003, NEW ENGL J MED, V348, P2595, DOI 10.1056/NEJMp030069; Hulshof K F, 2001, Public Health Nutr, V4, P667; Kastorini CM, 2009, CURR DIABETES REV, V5, P221, DOI 10.2174/157339909789804341; Kerver JM, 2003, AM J CLIN NUTR, V78, P1103, DOI 10.1093/ajcn/78.6.1103; Kipnis V, 2003, AM J EPIDEMIOL, V158, P14, DOI 10.1093/aje/kwg091; Mancia G, 2007, J HYPERTENS, V25, P1751, DOI 10.1097/HJH.0b013e3282f0580f; Manios Y, 2010, EUR J CLIN NUTR, V64, P1407, DOI 10.1038/ejcn.2010.168; Maskarinec G, 2000, J NUTR, V130, P3068, DOI 10.1093/jn/130.12.3068; Mullie P, 2010, EUR J CLIN NUTR, V64, P231, DOI 10.1038/ejcn.2009.145; Nettleton JA, 2007, AM J CLIN NUTR, V85, P1615, DOI 10.1093/ajcn/85.6.1615; Newby P, 2003, AM J CLIN NUTR, V77, P1417, DOI 10.1093/ajcn/77.6.1417; Newby PK, 2004, NUTR REV, V62, P177, DOI [10.1111/j.1753-4887.2004.tb00040.x, 10.1301/rn.2004.may.177-203]; Newby PK, 2004, AM J CLIN NUTR, V80, P759; Newby PK, 2004, AM J CLIN NUTR, V80, P504, DOI 10.1093/ajcn/80.2.504; Nolan CC, 1995, CAN J PUBLIC HEALTH, V86, P389; Organization WH, 2011, GLOBAL STATUS REPORT; Panagiotakos DB, 2004, AM HEART J, V147, P106, DOI 10.1016/S0002-8703(03)00442-3; Pi-Sunyer FX, 1998, OBES RES, V6, p51S; Rosamond W, 2008, CIRCULATION, V117, pE25, DOI 10.1161/CIRCULATIONAHA.107.187998; Ryden L, 2007, EUR HEART J, V28, P88, DOI [10.1093/eurheartj/ehl260, 10.1093/eurheartj/ehm124]; Sadakane A, 2008, J EPIDEMIOL, V18, P58, DOI 10.2188/jea.18.58; Sauvageot N, 2013, J NUTR FOOD SCI, V3, P2; Sauvageot N, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-143; Schulze MB, 2003, BRIT J NUTR, V89, P409, DOI 10.1079/BJN2002778; Slattery ML, 1998, AM J EPIDEMIOL, V148, P4, DOI 10.1093/aje/148.1.4-a; WILLETT W, 1986, AM J EPIDEMIOL, V124, P17, DOI 10.1093/oxfordjournals.aje.a114366; Williams DEM, 2000, BRIT J NUTR, V83, P257, DOI 10.1017/S0007114500000337; Wirfalt E, 2013, FOOD NUTR RES, V57, DOI 10.3402/fnr.v57i0.20523; Wosje KS, 2010, AM J CLIN NUTR, V92, P294, DOI 10.3945/ajcn.2009.28925	46	17	18	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2016	11	8							e0161298	10.1371/journal.pone.0161298	http://dx.doi.org/10.1371/journal.pone.0161298			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT8TP	27548287	Green Published, gold, Green Submitted			2022-12-27	WOS:000381768400039
J	Aunger, R; Greenland, K; Ploubidis, G; Schmidt, W; Oxford, J; Curtis, V				Aunger, Robert; Greenland, Katie; Ploubidis, George; Schmidt, Wolf; Oxford, John; Curtis, Valerie			The Determinants of Reported Personal and Household Hygiene Behaviour: A Multi-Country Study	PLOS ONE			English	Article							INFLUENZA TRANSMISSION; RESPIRATORY ILLNESS; VALIDITY; HEALTH; RISK; HOME; CONTAMINATION; INTERVENTION; SANITATION; VARIABLES	A substantial proportion of the total infectious disease burden world-wide is due to person-to-person spread of pathogens within households. A questionnaire-based survey on the determinants of hand-washing with soap and cleaning of household surfaces was conducted in at least 1000 households in each of twelve countries across the world (N = 12,239). A structural equation model of hygiene behaviour and its consequences derived from theory was then estimated on this dataset for both behaviours, using a maximum likelihood procedure. The analysis showed that the frequency of hand washing with soap is significantly related to how automatically it is performed, and whether or not someone is busy, or tired. Surface cleaning was strongly linked to possessing a cleaning routine, the perception that one is living in a dirty environment and that others are doing the behaviour, whether one has a strong sense of contamination, as well as a felt need to keep one's surroundings tidy. Being concerned with good manners is also linked to the performance of both behaviours. This study is the first to identify the role of manners, orderliness and routine on hygiene behaviours globally. Such findings should prove helpful in designing programs to improve domestic hygiene practices.	[Aunger, Robert; Greenland, Katie; Schmidt, Wolf; Curtis, Valerie] London Sch Hyg & Trop Med, Environm Hlth Grp, London, England; [Ploubidis, George] UCL, Inst Educ, London, England; [Oxford, John] Queen Mary Univ London, Sch Med, London, England	University of London; London School of Hygiene & Tropical Medicine; University of London; University College London; UCL Institute of Education; University of London; Queen Mary University London	Aunger, R (corresponding author), London Sch Hyg & Trop Med, Environm Hlth Grp, London, England.	robert.aunger@lshtm.ac.uk	Ploubidis, George B/G-9531-2011	Ploubidis, George B/0000-0002-8198-5790; Schmidt, Wolf-Peter/0000-0001-7449-4152	Hygiene Council	Hygiene Council	The Hygiene Council approached the LSHTM team to conduct a global study; they paid for some LSHTM staff time, all data collection but played no role in study design, data collection, analysis, decision to publish, or preparation of the manuscript.; We would like to thank Oliver Parsons, Lee-Ann Cameron, Ann Walters and Claire Leggott of Tonic Plc for their help in coordinating the study; Kate Norfolk and her staff from Opinion Matters for supervising the data collection, providing details about their methods, and conducting preliminary statistical analyses; and the Hygiene Council for funding the research.	AJZEN I, 1973, J PERS SOC PSYCHOL, V27, P41, DOI 10.1037/h0034440; [Anonymous], 1974, Health Education Monograph, V2, P324; Aunger R, 2014, APPL EVOLUTIONARY AN; Aunger R, 2010, SOC SCI MED, V70, P383, DOI 10.1016/j.socscimed.2009.10.038; Bandura A., 1986, SOCIAL FDN THOUGHT A; Bloomfield S.F., 2007, AM J INFECT SUPPL 1, V35, P1; Bollen KA, 1989, STRUCTURAL EQUATIONS; Buss A. R., 1979, PERSONALITY SOCIAL P, V5, P191; Cairncross S, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000365; Cogan TA, 2002, J APPL MICROBIOL, V92, P885, DOI 10.1046/j.1365-2672.2002.01598.x; Cole EC, 2012, S AFR J CHILD HEALTH, V6, P109, DOI 10.7196/SAJCH.459; Costa P.T., 1992, PSYCHOL ASSESSMENT, V4, P5, DOI [https://doi.org/10.1037/1040-3590.4.1.5, DOI 10.1037/1040-3590.4.1.5, 10.1037/1040-3590.4.1.5]; Cowling BJ, 2009, ANN INTERN MED, V151, P437, DOI 10.7326/0003-4819-151-7-200910060-00142; CURTIS V, 1993, B WORLD HEALTH ORGAN, V71, P23; Curtis V, 2003, LANCET INFECT DIS, V3, P275, DOI 10.1016/S1473-3099(03)00606-6; Curtis V, 2003, SOC SCI MED, V57, P657, DOI 10.1016/S0277-9536(02)00409-4; Curtis V, 2004, P ROY SOC B-BIOL SCI, V271, pS131, DOI 10.1098/rsbl.2003.0144; Curtis V, 2000, TROP MED INT HEALTH, V5, P22, DOI 10.1046/j.1365-3156.2000.00512.x; Curtis V, 2011, LANCET INFECT DIS, V11, P312, DOI 10.1016/S1473-3099(10)70224-3; Curtis V, 2011, PHILOS T R SOC B, V366, P389, DOI 10.1098/rstb.2010.0117; Curtis VA, 2009, HEALTH EDUC RES, V24, P655, DOI 10.1093/her/cyp002; Denham S.A., 2003, J FAMILY NURSING, V9, P305, DOI DOI 10.1177/1074840703255447; Dodou D, 2014, COMPUT HUM BEHAV, V36, P487, DOI 10.1016/j.chb.2014.04.005; Douglas M., 1985, RISK ACCEPTABILITY A; Douglas Mary., 1966, PURITY DANGER ANAL C; Duncan LA, 2009, PERS INDIV DIFFER, V47, P541, DOI 10.1016/j.paid.2009.05.001; Ejemot-Nwadiaro RI, 2015, COCHRANE DATABASE SY, P9; EPSTEIN S, 1985, PSYCHOL BULL, V98, P513, DOI 10.1037/0033-2909.98.3.513; Exner M, 2004, J HOSP INFECT, V56, pS70, DOI 10.1016/j.jhin.2003.12.037; Exner M., 2007, GMS KRANKENHAUSHYGIE, V2, P1; Falsey AR, 1999, INFECT CONT HOSP EP, V20, P200, DOI 10.1086/501612; Fishbein M, 1992, FACT INFL BEH BEH CH; Fleeson W, 2008, SOC PERSONAL PSYCHOL, V2, P1667, DOI 10.1111/j.1751-9004.2008.00122.x; Foddy W., 1994, CONSTRUCTING QUESTIO; Grayson ML, 2009, CLIN INFECT DIS, V48, P285, DOI 10.1086/595845; Halder AK, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-545; Horner KL, 1996, PERS INDIV DIFFER, V21, P195, DOI 10.1016/0191-8869(96)00067-0; House T, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-117; Inglis D., 2000, SOCIOLOGICAL HIST EX; Jackson JJ, 2010, J RES PERS, V44, P501, DOI 10.1016/j.jrp.2010.06.005; Jones E. E., 1971, ACTOR OBSERVER DIVER; Judah G, 2012, BRIT J HLTH PSYCHOL; Judah G, 2009, AM J PUBLIC HEALTH, V99, pS405, DOI 10.2105/AJPH.2009.164160; Kaiser FG, 2001, EUR J PSYCHOL ASSESS, V17, P212, DOI 10.1027//1015-5759.17.3.212; Klesges LM, 2004, PREV MED, V38, pS78, DOI 10.1016/j.ypmed.2003.07.003; Kline R.B., 2005, PRINCIPLES PRACTICE, V2, DOI DOI 10.1038/156278A0; Knapp H, 2003, COMPUT HUM BEHAV, V19, P117, DOI 10.1016/S0747-5632(02)00008-0; KNIGHT GP, 1981, DEV PSYCHOL, V17, P430; Lamont Michele, 1992, MONEY MORALS MANNERS; Largo TW, 2011, PUBLIC HEALTH REP, V126, P14, DOI 10.1177/00333549111260S104; Larson E, 2001, PUBLIC HEALTH NURS, V18, P116, DOI 10.1046/j.1525-1446.2001.00116.x; Lee A, 2006, J EPIDEMIOL COMMUN H, V60, P530, DOI 10.1136/jech.2005.040121; Lewis M.A., 2002, HLTH BEHAV HLTH ED T, Vthird, P240; Lopez-Quintero C, 2009, AM J PUBLIC HEALTH, V99, P94, DOI 10.2105/AJPH.2007.129759; MacCann C, 2009, LEARN INDIVID DIFFER, V19, P451, DOI 10.1016/j.lindif.2009.03.007; Mattioli MC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084939; MISCHEL W, 1995, PSYCHOL REV, V102, P246, DOI 10.1037/0033-295X.102.2.246; Nickmilder M, 2007, PEDIAT ALLERG IMM-UK, V18, P27, DOI 10.1111/j.1399-3038.2006.00487.x; Oxford JS, 2012, ENCY GLOBAL STUDIES, P838; Podsakoff PM, 2003, J APPL PSYCHOL, V88, P879, DOI 10.1037/0021-9010.88.5.879; Rabie T, 2006, TROP MED INT HEALTH, V11, P258, DOI 10.1111/j.1365-3156.2006.01568.x; Rabie T, 2006, TROP MED INT HEALTH, V11, P1; Rose E, 2009, ARCH PEDIAT ADOL MED, V163, P61, DOI 10.1001/archpediatrics.2008.509; Sobsey M. D., 2002, MANAGING WATER HOME; Stange KC, 1998, MED CARE, V36, P851, DOI 10.1097/00005650-199806000-00009; Stauber CE, 2013, INT J ENV RES PUB HE, V10, P1586, DOI 10.3390/ijerph10041586; Sutton S., 2012, SAGE HDB HLTH PSYCHO, P94, DOI DOI 10.4135/9781848608153.N4; Viboud C, 2004, INT CONGR SER, V1263, P291, DOI 10.1016/j.ics.2004.01.013; Vickers R, 1989, PSYCHOSOCIAL RISK FA; Vujcic J, 2014, TROP MED INT HEALTH, V19, P528, DOI 10.1111/tmi.12292; WARNER LG, 1969, AM SOCIOL REV, V34, P153, DOI 10.2307/2092174	71	22	22	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2016	11	8							e0159551	10.1371/journal.pone.0159551	http://dx.doi.org/10.1371/journal.pone.0159551			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DT6UQ	27541259	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000381620200002
J	Petrola, KAF; Bezerra, IB; de Menezes, EAV; Calvasina, P; Saintrain, MVD; Vieira-Meyer, APGF				Feitosa Petrola, Krishna Andreia; Bezerra, Italo Barroso; Vasconcelos de Menezes, Erico Alexandro; Calvasina, Paola; de Lima Saintrain, Maria Vieira; Vieira-Meyer, Anya Pimentel G. F.			Provision of Oral Health Care to Children under Seven Covered by Bolsa Familia Program. Is This a Reality?	PLOS ONE			English	Article							CASH TRANSFER PROGRAMS; SERVICES	Over the last decade, there has been a great improvement in the oral health of Brazilians. However, such a trend was not observed among five-year-old children. Dental caries are determined by the interplay between biological and behavioral factors that are shaped by broader socioeconomic determinants. It is well established that dental disease is concentrated in socially disadvantaged populations. To reduce social and health inequalities, the Brazilian government created Family Health Program (ESF), and the Bolsa Familia Program, the Brazilian conditional cash transfer program (Bolsa Familia Program). The aim of this study was to examine the oral health care and promotion provided by the Family Health Teams to children and caregivers covered by the Bolsa Familia Program. Data was collected through interviews with three groups of participants: 1) dentists working for the Family Health Program; 2) Family Health Program professionals supervising the Bolsa Familia Program health conditionalities (Bolsa Familia Program supervisors); and 3) parents/caregivers of children covered by the Bolsa Familia Program. A pretested questionnaire included socio-demographic, Bolsa Familia Program, oral health promotion, dental prevention and dental treatment questions. The results showed that most dentists performed no systematic efforts to promote oral health care to children covered by the Bolsa Familia Program (93.3%; n = 69) or to their parents/caregivers (74.3%; n = 55). Many dentists (33.8%) did not provide oral health care to children covered by the Bolsa Familia Program because they felt it was beyond their responsibilities. Nearly all Bolsa Familia Program supervisors (97.3%; n = 72) supported the inclusion of oral health care in the health conditionality of the Bolsa Familia Program, but 82.4% (n = 61) stated they did not promote oral health activities to children covered by the Bolsa Familia Program. Children in the routine care setting were more often referred to dentists than children covered by the Bolsa Familia Program (p <= 0.001). Parents/caregivers (99.2%; n = 381) agreed that oral health care is important and 99.5% (n = 382) would like their children to be seen regularly. Conclusions: No collaboration was observed between the Bolsa Familia Program and the Family Health Program with regard to the provision of oral health care. Making oral health care a Bolsa Familia Program conditionality may reduce oral health care inequalities for extreme poor children under seven in Brazil.	[Feitosa Petrola, Krishna Andreia] Municipal Dept Hlth, Fortaleza, Ceara, Brazil; [Bezerra, Italo Barroso; Vasconcelos de Menezes, Erico Alexandro] Univ Fortaleza UNIFOR, Fortaleza, Ceara, Brazil; [Calvasina, Paola; Vieira-Meyer, Anya Pimentel G. F.] Oswaldo Cruz Fdn FIOCRUZ, Fortaleza, Ceara, Brazil; [de Lima Saintrain, Maria Vieira] Univ Fortaleza, Publ Hlth Masters Program, Fortaleza, Ceara, Brazil; [Vieira-Meyer, Anya Pimentel G. F.] Fiocruz MS, Family Hlth Masters Program, Fortaleza, Ceara, Brazil	Universidade Fortaleza; Fundacao Oswaldo Cruz; Universidade Fortaleza; Fundacao Oswaldo Cruz	Vieira-Meyer, APGF (corresponding author), Oswaldo Cruz Fdn FIOCRUZ, Fortaleza, Ceara, Brazil.; Vieira-Meyer, APGF (corresponding author), Fiocruz MS, Family Hlth Masters Program, Fortaleza, Ceara, Brazil.	anya@fiocruz.br	Bezerra, Italo/GYU-8016-2022	Vieira-Meyer, Anya Pimentel Gomes Fernandes/0000-0003-4237-8995				Adato M, 2011, SOC SCI MED, V72, P1921, DOI 10.1016/j.socscimed.2010.09.032; American Academy of Paediatric Dentistry-Council on Clinical Affairs, 2012, GUID INF OR HLTH CAR, V34, P132; [Anonymous], 1988, CONS FED REP BRAZ; Benjamin RM, 2010, PUBLIC HEALTH REP, V125, P158, DOI 10.1177/003335491012500202; BRASIL M da S., 2012, DEP AT BAS; Currie J, 2007, HEALTH AFFAIR, V26, P331, DOI 10.1377/hlthaff.26.2.331; Fernald LCH, 2008, LANCET, V371, P828, DOI 10.1016/S0140-6736(08)60382-7; Fernald LCH, 2013, LANCET, V382, P7, DOI 10.1016/S0140-6736(13)61035-1; Forde I, 2011, AM J PUBLIC HEALTH, V101, P1365, DOI 10.2105/AJPH.2011.300140; Lemos LVFM, 2014, EINSTEIN-SAO PAULO, V12, P6, DOI 10.1590/S1679-45082014AO2895; Gaarder MM, 2010, J DEV EFFECT, V2, P6, DOI 10.1080/19439341003646188; Instituto de Pesquisa Economica Aplicada-Ipea (BR), 2011, REV DESAFIOS DESENVO, V8, P19; Kranz AM, 2012, J HEALTH CARE POOR U, V23, P1205, DOI 10.1353/hpu.2012.0090; Lagarde M, 2009, COCHRANE DATABASE SY, V4; Martin Amy Brock, 2012, Pediatr Dent, V34, P107; Ministerio da Saude, 2001, PROGR SAUD FAM; Ministerio da Saude (BR), 2004, DIR POL NAC SAUD BUC; Ministerio da Saude (BR) Portal Brasil, NUM EQ QUE AT AT BAS; Ministerio da Saude (BR) Secretaria de Atencao a Saude Departamento de Atencao Basica, 2005, PROJ SB BRAS 2003 CO; Ministerio da Saude (BR) Secretaria de Atencao a Saude Departamento de Atencao Basica, 2007, MAN OR BOLS FAM SAUD; Ministerio da Saude (BR) Secretaria de Atencao a Saude Secretaria de Vigilancia em Saude, 2011, SB BRAS 2010 PESQ NA; Ministerio do Desenvolvimento Social e Combate a Fome (BR), 2014, BOLS FAM MAIS 98 CRI; Ministerio do Desenvolvimento Social e Combate a fome (BR), BOLS FAM; Ministerio do Planejamento Orcamento e Gestao (BR) Instituto Brasileiro de Geografia e Estatistica, 2011, CENS 2010 PRIM RES D; Moyses SJ, 2008, SAUDE BUCAL FAMILIAS, P47; Munoz A, 2015, OXFORD TXB GLOBAL PU, V1, P467; Oliveira L., 2013, REV SAUDE PUBLICA, V47, P1039, DOI DOI 10.1590/S0034-8910.2013047004688; Ramos CI, 2012, CIENC SAUDE COLETIVA, V17, P2159, DOI 10.1590/S1413-81232012000800026; Ranganathan M, 2012, PREV MED, V55, pS95, DOI 10.1016/j.ypmed.2011.11.015; Rasella D, 2013, LANCET, V382, P57, DOI 10.1016/S0140-6736(13)60715-1; Roncalli AG, 2011, CAD SAUDE PUBLICA, V27, P5; Rugg-Gunn Andrew, 2013, Acta Med Acad, V42, P117, DOI 10.5644/ama2006-124.80; Santos VE, 2013, REV FACULDADE ODONTO, V18, P61; UN-Habitat, 2010, STAT WORLD CIT 2010	34	6	6	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0161244	10.1371/journal.pone.0161244	http://dx.doi.org/10.1371/journal.pone.0161244			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DT6ES	27537330	Green Submitted, Green Published, gold			2022-12-27	WOS:000381577000075
J	Ha, JH; Doguer, C; Wang, XY; Flores, SR; Collins, JF				Ha, Jung-Heun; Doguer, Caglar; Wang, Xiaoyu; Flores, Shireen R.; Collins, James F.			High-Iron Consumption Impairs Growth and Causes Copper-Deficiency Anemia in Weanling Sprague-Dawley Rats	PLOS ONE			English	Article							TRANSFERRIN RECEPTOR 2; AIN-93 PURIFIED DIETS; ATPASE ATP7A GENE; HEREDITARY HEMOCHROMATOSIS; PHOSPHATE BINDER; FERRIC CITRATE; OVERLOAD; CERULOPLASMIN; EXPRESSION; HEPCIDIN	Iron-copper interactions were described decades ago; however, molecular mechanisms linking the two essential minerals remain largely undefined. Investigations in humans and other mammals noted that copper levels increase in the intestinal mucosa, liver and blood during iron deficiency, tissues all important for iron homeostasis. The current study was undertaken to test the hypothesis that dietary copper influences iron homeostasis during iron deficiency and iron overload. We thus fed weanling, male Sprague-Dawley rats (n = 611/group) AIN-93G-based diets containing high (similar to 8800 ppm), adequate (similar to 80) or low (similar to 11) iron in combination with high (similar to 183), adequate (similar to 8) or low (similar to 0.9) copper for 5 weeks. Subsequently, the iron-and copper-related phenotype of the rats was assessed. Rats fed the low-iron diets grew slower than controls, with changes in dietary copper not further influencing growth. Unexpectedly, however, high-iron (HFe) feeding also impaired growth. Furthermore, consumption of the HFe diet caused cardiac hypertrophy, anemia, low serum and tissue copper levels and decreased circulating ceruloplasmin activity. Intriguingly, these physiologic perturbations were prevented by adding extra copper to the HFe diet. Furthermore, higher copper levels in the HFe diet increased serum nonheme iron concentration and transferrin saturation, exacerbated hepatic nonheme iron loading and attenuated splenic nonheme iron accumulation. Moreover, serum erythropoietin levels, and splenic erythroferrone and hepatic hepcidin mRNA levels were altered by the dietary treatments in unanticipated ways, providing insight into how iron and copper influence expression of these hormones. We conclude that high-iron feeding of weanling rats causes systemic copper deficiency, and further, that copper influences the iron-overload phenotype.	[Ha, Jung-Heun; Doguer, Caglar; Wang, Xiaoyu; Flores, Shireen R.; Collins, James F.] Univ Florida, Dept Food Sci & Human Nutr, Gainesville, FL 32611 USA	State University System of Florida; University of Florida	Collins, JF (corresponding author), Univ Florida, Dept Food Sci & Human Nutr, Gainesville, FL 32611 USA.	jfcollins@ufl.edu	Doguer, Caglar/ABA-3152-2020	Doguer, Caglar/0000-0003-0059-1819	National Institute of Diabetes and Digestive and Kidney Diseases [R01 DK074867]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK074867] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by R01 DK074867 (JFC) (www.niddk.nih.gov) National Institute of Diabetes and Digestive and Kidney Diseases.	BABSON AL, 1967, CLIN CHEM, V13, P163; BACON BR, 1983, J CLIN INVEST, V71, P429, DOI 10.1172/JCI110787; Coffey R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086019; COHEN NL, 1985, J NUTR, V115, P710, DOI 10.1093/jn/115.6.710; Collins JF, 2008, AM J PHYSIOL-GASTR L, V294, pG948, DOI 10.1152/ajpgi.00274.2007; Collins JF, 2005, AM J PHYSIOL-GASTR L, V288, pG964, DOI 10.1152/ajpgi.00489.2004; DELMEZ JA, 1992, AM J KIDNEY DIS, V19, P303, DOI 10.1016/S0272-6386(12)80446-X; Dongiovanni P, 2013, AM J PATHOL, V182, P2254, DOI 10.1016/j.ajpath.2013.02.019; FIELDS M, 1995, J AM COLL NUTR, V14, P399; Floege J, 2016, J NEPHROL, V29, P329, DOI 10.1007/s40620-016-0266-9; Fox PL, 2003, BIOMETALS, V16, P9, DOI 10.1023/A:1020799512190; Gao JW, 2009, CELL METAB, V9, P217, DOI 10.1016/j.cmet.2009.01.010; Gehrke SG, 2003, BLOOD, V102, P371, DOI 10.1182/blood-2002-11-3610; Gulec S, 2014, ANNU REV NUTR, V34, P95, DOI 10.1146/annurev-nutr-071812-161215; Gulec S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066010; Jiang LL, 2013, J NUTR, V143, P1927, DOI 10.3945/jn.113.181867; Kautz L, 2014, BLOOD, V124, P2569, DOI 10.1182/blood-2014-06-584607; Kautz L, 2014, NAT GENET, V46, P678, DOI 10.1038/ng.2996; Klevay LM, 2016, NUTR RES REV, V29, P172, DOI 10.1017/S0954422416000093; Klevay LM, 2001, J TRACE ELEM MED BIO, V14, P237, DOI 10.1016/S0946-672X(01)80009-2; LINDER MC, 1979, ENZYME, V24, P23, DOI 10.1159/000458625; MACKINNON M, 1995, HEPATOLOGY, V21, P1083; Matak P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059538; Matsuo A, 2014, RENAL FAILURE, V36, P1291, DOI 10.3109/0886022X.2014.930491; Merza H, 2015, CLIN CASE REP, V3, P819, DOI 10.1002/ccr3.344; Nam H, 2012, BIOMETALS, V25, P115, DOI 10.1007/s10534-011-9487-5; Pai AB, 2016, EXPERT OPIN DRUG MET, V12, pV, DOI 10.1517/17425255.2016.1127670; PARK CH, 1987, LAB INVEST, V57, P555; Prasad Rakesh, 2015, BMJ Case Rep, V2015, DOI 10.1136/bcr-2015-211390; PROHASKA JR, 1982, J NUTR, V112, P2142; RAMSAY WNM, 1957, CLIN CHIM ACTA, V2, P221, DOI 10.1016/0009-8981(57)90106-7; Ranganathan PN, 2012, BIOMETALS, V25, P687, DOI 10.1007/s10534-012-9527-9; Ranganathan PN, 2011, BLOOD, V118, P3146, DOI 10.1182/blood-2011-05-352112; Ravia JJ, 2005, J BIOL CHEM, V280, P36221, DOI 10.1074/jbc.M506727200; REEVES PG, 1993, J NUTR, V123, P1923, DOI 10.1093/jn/123.11.1923; REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939; ROESER HP, 1970, J CLIN INVEST, V49, P2408, DOI 10.1172/JCI106460; SEMENZA GL, 1992, MOL CELL BIOL, V12, P5447, DOI 10.1128/MCB.12.12.5447; SHERMAN AR, 1981, J NUTR, V111, P266, DOI 10.1093/jn/111.2.266; SUNDERMAN FW, 1970, CLIN CHEM, V16, P903; TORRANCE J D, 1968, South African Journal of Medical Sciences, V33, P9; Van Buren PN, 2015, AM J KIDNEY DIS, V66, P479, DOI 10.1053/j.ajkd.2015.03.013; Wallace DF, 2005, GUT, V54, P980, DOI 10.1136/gut.2004.062018; WANG GL, 1993, BLOOD, V82, P3610; Wilkins SJ, 2006, BLOOD, V107, P1659, DOI 10.1182/blood-2005-07-2614; Xie LW, 2013, J BIOL CHEM, V288, P23943, DOI 10.1074/jbc.M113.489500; Xie LW, 2011, AM J PHYSIOL-CELL PH, V300, pC1298, DOI 10.1152/ajpcell.00023.2011; YOUNG DS, 1965, J CLIN PATHOL, V18, P98, DOI 10.1136/jcp.18.1.98; Yu F, 2015, NEUROSCI LETT, V597, P183, DOI 10.1016/j.neulet.2015.04.049	49	24	25	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0161033	10.1371/journal.pone.0161033	http://dx.doi.org/10.1371/journal.pone.0161033			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27537180	Green Submitted, Green Published, gold			2022-12-27	WOS:000381577000044
J	Romo-Romo, A; Aguilar-Salinas, CA; Brito-Cordova, GX; Diaz, RAG; Valentin, DV; Almeda-Valdes, P				Romo-Romo, Alonso; Aguilar-Salinas, Carlos A.; Brito-Cordova, Griselda X.; Gomez Diaz, Rita A.; Vilchis Valentin, David; Almeda-Valdes, Paloma			Effects of the Non-Nutritive Sweeteners on Glucose Metabolism and Appetite Regulating Hormones: Systematic Review of Observational Prospective Studies and Clinical Trials	PLOS ONE			English	Review							TYPE-2 DIABETES-MELLITUS; BLOOD-GLUCOSE; DIET SODA; ARTIFICIAL SWEETENER; HEALTHY-SUBJECTS; WEIGHT-GAIN; SOFT DRINK; SHORT-TERM; CONSUMPTION; SUCRALOSE	Background The effects of non-nutritive sweeteners (NNS) on glucose metabolism and appetite regulating hormones are not clear. There is an ongoing debate concerning NNS use and deleterious changes in metabolism. Objectives The aim of this review is to analyze the scientific available evidence regarding the effects of NNS on glucose metabolism and appetite regulating hormones. Data Sources and Study Eligibility Criteria We identified human observational studies evaluating the relation between NNS consumption and obesity, diabetes, and metabolic syndrome, in addition to clinical trials evaluating the effects of NNS in glucose metabolism and appetite regulating hormones. Results Fourteen observational studies evaluating the association between NNS consumption and the development of metabolic diseases and twenty-eight clinical trials studying the effects of NNS on metabolism were included. Finally, two meta-analyses evaluating the association between the consumption of NNS-containing beverages and the development of type 2 diabetes were identified. Conclusions Some observational studies suggest an association between NNS consumption and development of metabolic diseases; however, adiposity is a confounder frequently found in observational studies. The effects of the NNS on glucose metabolism are not clear. The results of the identified clinical trials are contradictory and are not comparable because of the major existing differences between them. Studies evaluating specific NNS, with an adequate sample size, including a homogeneous study group, identifying significant comorbidities, with an appropriate control group, with an appropriate exposure time, and considering adjustment for confounder variables such as adiposity are needed.	[Romo-Romo, Alonso; Aguilar-Salinas, Carlos A.; Brito-Cordova, Griselda X.; Vilchis Valentin, David; Almeda-Valdes, Paloma] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Endocrinol & Metab, Mexico City, DF, Mexico; [Gomez Diaz, Rita A.] UMAE Hosp Especialidades, IMSS, Ctr Med Nacl Siglo 21, Med Res Unit Clin Epidemiol, Mexico City, DF, Mexico	Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico; Instituto Mexicano del Seguro Social	Almeda-Valdes, P (corresponding author), Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Endocrinol & Metab, Mexico City, DF, Mexico.	paloma.almedav@incmnsz.mx	Salinas, Carlos A Aguilar/AAL-4491-2020; Almeda-Valdes, Paloma/AAJ-8023-2020	Almeda-Valdes, Paloma/0000-0002-9701-5879; Romo-Romo, Alonso/0000-0001-7719-0234				[Anonymous], ADD INF HIGH INT SWE; Anton SD, 2010, APPETITE, V55, P37, DOI 10.1016/j.appet.2010.03.009; Barquera S, 2008, J NUTR, V138, P2454, DOI 10.3945/jn.108.092163; Barriocanal LA, 2008, REGUL TOXICOL PHARM, V51, P37, DOI 10.1016/j.yrtph.2008.02.006; Bhupathiraju SN, 2013, AM J CLIN NUTR, V97, P155, DOI 10.3945/ajcn.112.048603; Brown AW, 2011, NUTR RES, V31, P882, DOI 10.1016/j.nutres.2011.10.004; Brown RJ, 2012, DIABETES CARE, V35, P959, DOI 10.2337/dc11-2424; Bryant CE, 2014, EUR J CLIN NUTR, V68, P629, DOI 10.1038/ejcn.2014.19; COLAGIURI S, 1989, AM J CLIN NUTR, V50, P474, DOI 10.1093/ajcn/50.3.474; COOPER PL, 1988, DIABETIC MED, V5, P676, DOI 10.1111/j.1464-5491.1988.tb01079.x; de Koning L, 2011, AM J CLIN NUTR, V93, P1321, DOI 10.3945/ajcn.110.007922; Dhingra R, 2007, CIRCULATION, V116, P480, DOI 10.1161/CIRCULATIONAHA.107.689935; Duffey KJ, 2012, AM J CLIN NUTR, V95, P909, DOI 10.3945/ajcn.111.026682; European Food Safety Authority, SWEETN; Fagherazzi G, 2013, AM J CLIN NUTR, V97, P517, DOI 10.3945/ajcn.112.050997; Ford HE, 2011, EUR J CLIN NUTR, V65, P508, DOI 10.1038/ejcn.2010.291; Fowler SP, 2008, OBESITY, V16, P1894, DOI 10.1038/oby.2008.284; Greenwood DC, 2014, BRIT J NUTR, V112, P725, DOI 10.1017/S0007114514001329; Gregersen S, 2004, METABOLISM, V53, P73, DOI 10.1016/j.metabol.2003.07.013; Grotz VL, 2003, J AM DIET ASSOC, V103, P1607, DOI 10.1016/j.jada.2003.09.021; Hall WL, 2003, PHYSIOL BEHAV, V78, P557, DOI 10.1016/S0031-9384(03)00034-9; HARTEL B, 1993, ERNAHRUNGS-UMSCHAU, V40, P152; HORWITZ DL, 1988, DIABETES CARE, V11, P230, DOI 10.2337/diacare.11.3.230; Imamura F, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h3576; Liliana OM, 2013, ARCH LATINOAM NUTR, V63, P142; Lutsey PL, 2008, CIRCULATION, V117, P754, DOI 10.1161/CIRCULATIONAHA.107.716159; Ma J, 2010, BRIT J NUTR, V104, P803, DOI 10.1017/S0007114510001327; Ma J, 2009, AM J PHYSIOL-GASTR L, V296, pG735, DOI 10.1152/ajpgi.90708.2008; Maersk M, 2012, EUR J CLIN NUTR, V66, P523, DOI 10.1038/ejcn.2011.223; Maki KC, 2008, FOOD CHEM TOXICOL, V46, pS47, DOI 10.1016/j.fct.2008.05.007; Melanson KJ, 1999, BRIT J NUTR, V82, P437, DOI 10.1017/S0007114599001695; Mezitis NHE, 1996, DIABETES CARE, V19, P1004, DOI 10.2337/diacare.19.9.1004; NEHRLING JK, 1985, DIABETES CARE, V8, P415, DOI 10.2337/diacare.8.5.415; Nettleton JA, 2009, DIABETES CARE, V32, P688, DOI 10.2337/dc08-1799; O'Connor L, 2015, DIABETOLOGIA, V58, P1474, DOI 10.1007/s00125-015-3572-1; OKUNO G, 1986, Diabetes Research and Clinical Practice, V2, P23, DOI 10.1016/S0168-8227(86)80025-0; Palmer JR, 2008, ARCH INTERN MED, V168, P1487, DOI 10.1001/archinte.168.14.1487; Pepino MY, 2015, PHYSIOL BEHAV, V152, P450, DOI 10.1016/j.physbeh.2015.06.024; Pepino MY, 2013, DIABETES CARE, V36, P2530, DOI 10.2337/dc12-2221; Qurrat-ul-Ain, 2015, J PAK MED ASSOC, V65, P225; RODIN J, 1990, AM J CLIN NUTR, V51, P428, DOI 10.1093/ajcn/51.3.428; Romaguera D, 2013, DIABETOLOGIA, V56, P1520, DOI 10.1007/s00125-013-2899-8; Sakurai M, 2014, EUR J NUTR, V53, P1137, DOI 10.1007/s00394-014-0681-4; Schulze MB, 2004, JAMA-J AM MED ASSOC, V292, P927, DOI 10.1001/jama.292.8.927; Shankar P, 2013, NUTRITION, V29, P1293, DOI 10.1016/j.nut.2013.03.024; Steinert RE, 2011, BRIT J NUTR, V105, P1320, DOI 10.1017/S000711451000512X; Suez J, 2014, NATURE, V514, P181, DOI 10.1038/nature13793; Temizkan S, 2015, EUR J CLIN NUTR, V69, P162, DOI 10.1038/ejcn.2014.208; Wu TZ, 2012, AM J CLIN NUTR, V95, P78, DOI 10.3945/ajcn.111.021543	49	62	63	2	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0161264	10.1371/journal.pone.0161264	http://dx.doi.org/10.1371/journal.pone.0161264			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27537496	Green Published, gold, Green Submitted			2022-12-27	WOS:000381577000077
J	Topaz, CM; Sen, S				Topaz, Chad M.; Sen, Shilad			Gender Representation on Journal Editorial Boards in the Mathematical Sciences	PLOS ONE			English	Article							ROLE-MODELS; WOMEN; DIVERSITY	We study gender representation on the editorial boards of 435 journals in the mathematical sciences. Women are known to comprise approximately 15% of tenure-stream faculty positions in doctoral-granting mathematical sciences departments in the United States. Compared to this group, we find that 8.9% of the 13067 editorships in our study are held by women. We describe group variations within the editorships by identifying specific journals, subfields, publishers, and countries that significantly exceed or fall short of this average. To enable our study, we develop a semi-automated method for inferring gender that has an estimated accuracy of 97.5%. Our findings provide the first measure of gender distribution on editorial boards in the mathematical sciences, offer insights that suggest future studies in the mathematical sciences, and introduce new methods that enable large-scale studies of gender distribution in other fields.	[Topaz, Chad M.; Sen, Shilad] Macalester Coll, Dept Math Stat & Comp Sci, St Paul, MN 55105 USA	Macalester College	Topaz, CM (corresponding author), Macalester Coll, Dept Math Stat & Comp Sci, St Paul, MN 55105 USA.	ctopaz@macalester.edu		Topaz, Chad/0000-0001-9977-3414	Wallace Scholarly Research Activities Grant from Macalester College; Experiment.com; Div Of Information & Intelligent Systems [1527173] Funding Source: National Science Foundation	Wallace Scholarly Research Activities Grant from Macalester College; Experiment.com; Div Of Information & Intelligent Systems(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	This work was supported by a Wallace Scholarly Research Activities Grant from Macalester College. Additional funding came from a crowdfunding campaign via Experiment.com. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addis E, 2003, FEM ECON, V9, P75, DOI 10.1080/1354570032000057062; American Mathematical Society, ANN SURV MATH SCI; Amrein K, 2011, GENDER MED, V8, P378, DOI 10.1016/j.genm.2011.10.007; Bettinger EP, 2005, AM ECON REV, V95, P152, DOI 10.1257/000282805774670149; Brisbin A, 2015, WOMEN S REPRESENTATI; Buhrmester M, 2011, PERSPECT PSYCHOL SCI, V6, P3, DOI 10.1177/1745691610393980; Cho AH, 2014, PEERJ, V2, DOI 10.7717/peerj.542; Fox CW, 2016, FUNCT ECOL, V30, P140, DOI 10.1111/1365-2435.12529; Gersick CJG, 2000, ACAD MANAGE J, V43, P1026, DOI 10.2307/1556333; Hill C., 2010, WOMEN SCI TECHNOLOGY, DOI [10.1002/sce.21007, DOI 10.1002/SCE.21007]; HOLM S, 1979, SCAND J STAT, V6, P65; Leslie SJ, 2015, SCIENCE, V347, P262, DOI 10.1126/science.1261375; Lincoln AE, 2012, SOC STUD SCI, V42, P307, DOI 10.1177/0306312711435830; Lindsey LindaL., 2020, GENDER SOCIOLOGICAL, V7th ed.; Loyd DL, 2013, ORGAN SCI, V24, P757, DOI 10.1287/orsc.1120.0761; Mauleon E, 2013, SCIENTOMETRICS, V95, P87, DOI 10.1007/s11192-012-0824-4; Metz I, 2009, ACAD MANAG LEARN EDU, V8, P540, DOI 10.5465/AMLE.2009.47785472; Morton MJ, 2007, J NATL MED ASSOC, V99, P764; Moss-Racusin CA, 2012, P NATL ACAD SCI USA, V109, P16474, DOI 10.1073/pnas.1211286109; National Science Foundation, SURV EARN DOCT; Niculescu-Mizil A., 2005, MACH LEARN P 22 INT, P625, DOI 10.1145/1102351.1102430; Pierson E., 2014, SCI IT MATTERS WOMEN; Popejoy A.B., 2012, J MATH SYST SCI, V2, P292; Sen S, 2015, PROCEEDINGS OF THE 2015 ACM INTERNATIONAL CONFERENCE ON COMPUTER-SUPPORTED COOPERATIVE WORK AND SOCIAL COMPUTING (CSCW'15), P826, DOI 10.1145/2675133.2675285; Hyde JS, 2006, SCIENCE, V314, P599, DOI 10.1126/science.1132154; SMITH WS, 1986, J RES SCI TEACH, V23, P667, DOI 10.1002/tea.3660230802; Spelke ES, 2005, AM PSYCHOL, V60, P950, DOI 10.1037/0003-066X.60.9.950; Stegmaier M, 2011, PS-POLIT SCI POLIT, V44, P799, DOI 10.1017/S1049096511001284; Stewart A, 2015, GENDER ROLES SOCIOLO; Storage D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150194; US Census Bureau, 2016, AM FACTFINDER; US Department of Education Institute of Education Sciences National Center for Education Statistics., INT POSTS ED DAT SYS; Way SF, 2016, PROCEEDINGS OF THE 25TH INTERNATIONAL CONFERENCE ON WORLD WIDE WEB (WWW'16), P1169	33	51	51	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0161357	10.1371/journal.pone.0161357	http://dx.doi.org/10.1371/journal.pone.0161357			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DT6ES	27536970	Green Published, Green Submitted, gold			2022-12-27	WOS:000381577000092
J	Allahverdyan, AE; Galstyan, A				Allahverdyan, Armen E.; Galstyan, Aram			Emergence of Leadership in Communication	PLOS ONE			English	Article							NETWORKS; DYNAMICS; MODEL; BEHAVIOR; POPULATIONS	We study a neuro-inspired model that mimics a discussion (or information dissemination) process in a network of agents. During their interaction, agents redistribute activity and network weights, resulting in emergence of leader(s). The model is able to reproduce the basic scenarios of leadership known in nature and society: laissez-faire (irregular activity, weak leadership, sizable inter-follower interaction, autonomous sub-leaders); participative or democratic (strong leadership, but with feedback from followers); and autocratic (no feedback, one-way influence). Several pertinent aspects of these scenarios are found as well-e.g., hidden leadership (a hidden clique of agents driving the official autocratic leader), and successive leadership (two leaders influence followers by turns). We study how these scenarios emerge from inter-agent dynamics and how they depend on behavior rules of agents-in particular, on their inertia against state changes.	[Allahverdyan, Armen E.] Yerevan Phys Inst, Alikhanian Bros St 2, Yerevan 375036, Armenia; [Galstyan, Aram] USC Informat Sci Inst, 4676 Admiralty Way, Marina Del Rey, CA 90292 USA	Yerevan Physics Institute; University of Southern California	Allahverdyan, AE (corresponding author), Yerevan Phys Inst, Alikhanian Bros St 2, Yerevan 375036, Armenia.	armen.allahverdyan@gmail.com		Galstyan, Aram/0000-0003-4215-0886	Yerevan Physics Institute (Armenia); DARPA grant [W911NF-12-1-0034]	Yerevan Physics Institute (Armenia); DARPA grant(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA))	This research was funded by Yerevan Physics Institute (Armenia) to AEA and DARPA grant No. W911NF-12-1-0034 to AG. AEA was also partially funded by the above DARPA grant.; This research was supported by DARPA grant No. W911NF-12-1-0034.	Allahverdyan AE, 2006, EUROPHYS LETT, V75, P908, DOI 10.1209/epl/i2006-10212-8; Allahverdyan AE, 2015, PHYS REV E, V92, DOI 10.1103/PhysRevE.92.062824; Allahverdyan AE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099557; Anghel M, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.058701; Aronson E, 2007, SOCIAL ANIMAL; BECKMAN MD, 1967, J MARKETING, V31, P34, DOI 10.2307/1249027; Ben-Naim E, 2005, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2005/11/L11002; Blondel VD, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.036114; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; BONABEAU E, 1995, PHYSICA A, V217, P373, DOI 10.1016/0378-4371(95)00064-E; Borgatti SP, 1999, SOC NETWORKS, V21, P375; Bornholdt S, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.066118; Burt RS, 1999, ANN AM ACAD POLIT SS, V566, P37, DOI 10.1177/0002716299566001004; Caldarelli G, 2008, EUR PHYS J B, V64, P585, DOI 10.1140/epjb/e2008-00243-5; Caldarelli G, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.258702; Castellano C, 2009, REV MOD PHYS, V81, P591, DOI 10.1103/RevModPhys.81.591; Cheng J., 2016, DO CASCADES RECUR, P11; Cholvi V, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.035103; COLOMER JM, 1995, RATION SOC, V7, P225, DOI 10.1177/1043463195007002008; COREY LG, 1971, J MARKETING, V35, P48, DOI 10.2307/1250457; Debanne D, 1998, J PHYSIOL-LONDON, V507, P237, DOI 10.1111/j.1469-7793.1998.237bu.x; DEUTSCH KW, 1961, BEHAV SCI, V6, P72; Dodds PS, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.218701; Durlauf SN, 2001, SOCIOL METHODOL, V31, P47, DOI 10.1111/0081-1750.00089; Eguiluz VM, 2005, AM J SOCIOL, V110, P977, DOI 10.1086/428716; EMELYANOVYAROSLAVSKY LB, 1992, BIOL CYBERN, V67, P67, DOI 10.1007/BF00201803; EMELYANOVYAROSLAVSKY LB, 1992, BIOL CYBERN, V67, P73, DOI 10.1007/BF00201804; Fiedler F. E., 1967, THEORY LEADERSHIP EF; FREEMAN LC, 1979, SOC NETWORKS, V1, P215, DOI 10.1016/0378-8733(78)90021-7; Galster GC, 2000, HOUS POLICY DEBATE, V11, P701; Galstyan A., 2013, P 6 ACM INT C WEB SE, P3, DOI [10.1145/2433396.2433400, DOI 10.1145/2433396.2433400, /10.1145 /2433396.2433400]; Galstyan A, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.036109; Godreche S, 2010, J STAT MECH-THEORY E; Goethals G.R., 2004, ENCY LEADERSHIP; Gomez-Rodriguez M, 2012, ACM T KNOWL DISCOV D, V5, DOI 10.1145/2086737.2086741; Goncalves B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022656; GRANOVETTER M, 1978, AM J SOCIOL, V83, P1420, DOI 10.1086/226707; Granovetter M., 1988, SOCIOL METHODOL, V18, P69, DOI [10.2307/271045, DOI 10.2307/271045]; Greene MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052219; Gross T, 2008, J R SOC INTERFACE, V5, P259, DOI 10.1098/rsif.2007.1229; Guttenberg N, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.046111; Hazy JK, 2007, LEADERSHIP QUART, V18, P391, DOI 10.1016/j.leaqua.2007.04.007; Hodas N., 2012, SOCIALCOM; Hogg MA, 2007, HDB BASIC PRINCIPLES; Huberman BA, 2004, LECT NOTES PHYS, V650, P371; Huberman BA, 2008, 1 MONDAY, V14, P1, DOI [DOI 10.5210/FM.V14I1.2317, 10.2139/ssrn.1313405]; Huberman BA, 2008, ADV COMPLEX SYST, V11, P487, DOI 10.1142/S0219525908001830; Jost J, 2009, PHYSICA A, V388, P1959, DOI 10.1016/j.physa.2008.12.073; Katz E., 1955, PERSONAL INFLUENCE P; Kianercy A, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.012815; Larson-Prior LJ, 2013, HDB HUMAN COMPUTATIO; Lewin K, 1939, J SOC PSYCHOL, V10, P271, DOI 10.1080/00224545.1939.9713366; Lipowski A, 2014, PHYS REV E, V90, DOI 10.1103/PhysRevE.90.032817; MALSBURG CV, 1973, KYBERNETIK, V14, P85, DOI 10.1007/BF00288907; Morris S, 2000, REV ECON STUD, V67, P57, DOI 10.1111/1467-937X.00121; MULLEN B, 1989, J EXP SOC PSYCHOL, V25, P545, DOI 10.1016/0022-1031(89)90005-X; Nowak A., 1998, COMPUTER MODELLING S, P97; Peretto P, 1994, INTRO MODELLING NEUR; Piedrahita P, 2013, EPL-EUROPHYS LETT, V104, DOI 10.1209/0295-5075/104/48004; Pugliese F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137234; RASHEVSKY N., 1955, BULL MATH BIOPHYS, V17, P229, DOI 10.1007/BF02477860; RASHEVSKY N., 1954, BULL MATH BIOPHYS, V16, P317, DOI 10.1007/BF02484495; RASHEVSKY N., 1955, BULL MATH BIOPHYS, V17, P207, DOI 10.1007/BF02477858; Rashevsky N., 1949, B AM MATH SOC, V55, P722, DOI [10.1090/S0002-9904-1949-09260-1, DOI 10.1090/S0002-9904-1949-09260-1]; Rombach MP, 2014, SIAM J APPL MATH, V74, P167, DOI 10.1137/120881683; Shvyrkov VB, 1985, ADV PSYCH, V25, P47, DOI [10.1016/S0166-4115(08)61596-4, DOI 10.1016/S0166-4115(08)61596-4]; Simaan M, 1973, J OPTIMIZ THEORY APP, V11, P533, DOI 10.1007/BF00935665; Sole R. V., 2002, Complexity, V8, P20, DOI 10.1002/cplx.10055; SORRENTINO RM, 1975, J EXP SOC PSYCHOL, V11, P403, DOI 10.1016/0022-1031(75)90044-X; Stogdill RM, 1948, J PSYCHOL, V25, P35, DOI 10.1080/00223980.1948.9917362; SUTTON RS, 1981, PSYCHOL REV, V88, P135, DOI 10.1037/0033-295X.88.2.135; TROLDAHL VC, 1966, PUBLIC OPIN QUART, V30, P609, DOI 10.1086/267459; USHER M, 1993, NEURAL COMPUT, V5, P570, DOI 10.1162/neco.1993.5.4.570; Valente TW, 1999, ANN AM ACAD POLIT SS, V566, P55, DOI 10.1177/0002716299566001005; Van Vugt M, 2006, PERS SOC PSYCHOL REV, V10, P354, DOI 10.1207/s15327957pspr1004_5; VANVREESWIJK C, 1993, SIAM J APPL MATH, V53, P253, DOI 10.1137/0153015; Venkatasubramanian V, 2004, COMPUT CHEM ENG, V28, P1789, DOI 10.1016/j.compchemeng.2004.02.028; Ver Steeg G., 2012, P 21 INT C WORLD WID, P509, DOI DOI 10.1145/2187836.2187906; Vidal JM, 2003, HDB BRAIN THEORY NEU; Watts DJ, 2002, P NATL ACAD SCI USA, V99, P5766, DOI 10.1073/pnas.082090499; WEIMANN G, 1982, AM SOCIOL REV, V47, P764, DOI 10.2307/2095212; Winkler I., 2010, CONT LEADERSHIP THEO; Zhang LS, 2014, CHINESE PHYS B, V23, DOI 10.1088/1674-1056/23/10/108902	85	3	3	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2016	11	8							e0159301	10.1371/journal.pone.0159301	http://dx.doi.org/10.1371/journal.pone.0159301			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DT4YN	27532484	Green Published, Green Submitted, gold			2022-12-27	WOS:000381487600007
J	Frilander, H; Lallukka, T; Viikari-Juntura, E; Heliovaara, M; Solovieva, S				Frilander, Heikki; Lallukka, Tea; Viikari-Juntura, Eira; Heliovaara, Markku; Solovieva, Svetlana			Health Problems during Compulsory Military Service Predict Disability Retirement: A Register-Based Study on Secular Trends during 40 Years of Follow-Up	PLOS ONE			English	Article							COMMON MENTAL-DISORDERS; POPULATION-BASED COHORT; MUSCULOSKELETAL DISORDERS; YOUNG MEN; FINLAND; PENSION; AWARDS	Disability retirement causes a significant burden on the society and affects the well-being of individuals. Early health problems as determinants of disability retirement have received little attention. The objective was to study, whether interrupting compulsory military service is an early indicator of disability retirement among Finnish men and whether seeking medical advice during military service increases the risk of all-cause disability retirement and disability retirement due to mental disorders and musculoskeletal diseases. We also looked at secular trends in these associations. We examined a nationally representative sample of 2069 men, who had entered military service during 1967-1996. We linked military service health records with cause-specific register data on disability retirement from 1968 to 2008. Secular trends were explored in three service time strata. We used the Cox regression model to estimate proportional hazard ratios and their 95% confidence intervals. During the follow-up time altogether 140 ( 6.8%) men retired due to disability, mental disorders being the most common cause. The men who interrupted service had a remarkably higher cumulative incidence of disability retirement ( 18.9%). The associations between seeking medical advice during military service and all-cause disability retirement were similar across the three service time cohorts ( overall hazard ratio 1.40 per one standard deviation of the number of visits; 95% confidence interval 1.26-1.56). Visits due to mental problems predicted disability retirement due to mental disorders in the men who served between 1987 and 1996 and a tendency for a similar cause-specific association was seen for musculoskeletal diseases in the men who served in 1967-1976. In conclusion, health problems-in particular mental problems-during late adolescence are strong determinants of disability retirement. Call-up examinations and military service provide access to the entire age cohort of men, where persons at risk for work disability can be identified and early preventive measures initiated.	[Frilander, Heikki; Lallukka, Tea; Solovieva, Svetlana] Finnish Inst Occupat Hlth, Ctr Expertise Hlth & Work Abil, Helsinki, Finland; [Frilander, Heikki; Lallukka, Tea; Viikari-Juntura, Eira; Solovieva, Svetlana] Finnish Inst Occupat Hlth, Disabil Prevent Res Ctr, Helsinki, Finland; [Heliovaara, Markku] Natl Inst Hlth & Welf, Dept Hlth, Helsinki, Finland	Finnish Institute of Occupational Health; Finnish Institute of Occupational Health; Finland National Institute for Health & Welfare	Frilander, H (corresponding author), Finnish Inst Occupat Hlth, Ctr Expertise Hlth & Work Abil, Helsinki, Finland.; Frilander, H (corresponding author), Finnish Inst Occupat Hlth, Disabil Prevent Res Ctr, Helsinki, Finland.	heikki.frilander@ttl.fi		Lallukka, Tea/0000-0003-3841-3129	Academy of Finland [129475, 287488]; Centre for Military Medicine, Helsinki, Finland	Academy of Finland(Academy of Finland); Centre for Military Medicine, Helsinki, Finland	This work was supported by the Academy of Finland (www.aka.fi/en/) grants #129475 (HF), #287488 (TL) and the Centre for Military Medicine, Helsinki, Finland (HF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2015, STAT DAT FINN CTR PE; Appelqvist-Schmidlechner K, 2010, SCAND J PUBLIC HEALT, V38, P168, DOI 10.1177/1403494809357103; Aromaa A., 2004, HLTH FUNCTIONAL CAPA; Brown J, 2009, J PUBLIC HEALTH-UK, V31, P74, DOI 10.1093/pubmed/fdn098; Buist-Bouwman MA, 2005, ACTA PSYCHIAT SCAND, V111, P436, DOI 10.1111/j.1600-0447.2005.00513.x; Cattrell A, 2011, OCCUP MED-OXFORD, V61, P148, DOI 10.1093/occmed/kqr008; Finnish Centre for Pensions, 2014, STAT YB PENS FINL 20; Frilander H, 2012, MIL MED, V177, P1069, DOI 10.7205/MILMED-D-11-00327; Gould R, 2003, EUROPEAN DISABILITY, V26, P165; Heistaro S., 2008, METHODOLOGY REPORT H; Jarvisalo J, 2005, SOCIAL SECURITY HLTH, P27; Kaila-Kangas L, 2014, J AFFECT DISORDERS, V165, P38, DOI 10.1016/j.jad.2014.04.036; Knudsen AK, 2010, J PSYCHOSOM RES, V69, P59, DOI 10.1016/j.jpsychores.2010.03.007; Lahelma E, 2015, OCCUP ENVIRON MED, V72, P181, DOI 10.1136/oemed-2014-102432; Leboeuf-Yde C, 1998, SPINE, V23, P228, DOI 10.1097/00007632-199801150-00015; Li RL, 2007, ANN EPIDEMIOL, V17, P227, DOI 10.1016/j.annepidem.2006.10.009; Mittendorfer-Rutz E, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-75; Murphy L, 2008, ARTHRIT RHEUM-ARTHR, V59, P1207, DOI 10.1002/art.24021; Mykletun A, 2006, AM J PSYCHIAT, V163, P1412, DOI 10.1176/appi.ajp.163.8.1412; Organisation for economic Co-operation and development, 2010, SICKN DIS WORK BREAK; Parkkola K, 1999, THESIS; Salminen JK, 1997, ACTA PSYCHIAT SCAND, V95, P242, DOI 10.1111/j.1600-0447.1997.tb09626.x; Santtila M, 2006, MED SCI SPORT EXER, V38, P1990, DOI 10.1249/01.mss.0000232023.28984.78; Suvisaari J, 2009, PSYCHOL MED, V39, P287, DOI 10.1017/S0033291708003632; Upmark M, 1999, SOC PSYCH PSYCH EPID, V34, P533, DOI 10.1007/s001270050172; van Rijn RM, 2014, OCCUP ENVIRON MED, V71, P295, DOI 10.1136/oemed-2013-101591	26	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2016	11	8							e0159786	10.1371/journal.pone.0159786	http://dx.doi.org/10.1371/journal.pone.0159786			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DT4YN	27533052	gold, Green Published, Green Submitted			2022-12-27	WOS:000381487600012
J	Hoarau, M; Malbert, Y; Irague, R; Hureau, C; Faller, P; Gras, E; Andre, I; Remaud-Simeon, M				Hoarau, Marie; Malbert, Yannick; Irague, Romain; Hureau, Christelle; Faller, Peter; Gras, Emmanuel; Andre, Isabelle; Remaud-Simeon, Magali			A Robust and Efficient Production and Purification Procedure of Recombinant Alzheimers Disease Methionine-Modified Amyloid-beta Peptides	PLOS ONE			English	Article							STRUCTURAL-ANALYSIS; INCLUSION-BODIES; FACILE METHOD; EXPRESSION; N-15; AGGREGATION; A-BETA-42; COLI	An improved production and purification method for Alzheimer's disease related methionine-modified amyloid-beta 1-40 and 1-42 peptides is proposed, taking advantage of the formation of inclusion body in Escherichia coli. A Thioflavin-S assay was set-up to evaluate inclusion body formation during growth and optimize culture conditions for amyloid-beta peptides production. A simple and fast purification protocol including first the isolation of the inclusion bodies and second, two cycles of high pH denaturation/neutralization combined with an ultrafiltration step on 30-kDa cut-off membrane was established. Special attention was paid to purity monitoring based on a rational combination of UV spectrophotometry and SDS-PAGE analyses at the various stages of the process. It revealed that this chromatography-free protocol affords good yield of high quality peptides in term of purity. The resulting peptides were fully characterized and are appropriate models for highly reproducible in vitro aggregation studies.	[Hoarau, Marie; Malbert, Yannick; Irague, Romain; Andre, Isabelle; Remaud-Simeon, Magali] Univ Toulouse, CNRS, INRA, Lab Ingn Syst Biol & Proc,INSA, Toulouse, France; [Hoarau, Marie; Hureau, Christelle; Faller, Peter; Gras, Emmanuel] Univ Toulouse, CNRS, INPT, Chim Coordinat Lab, Toulouse, France; [Irague, Romain] Univ Nantes, CNRS, Unite Fonct & Ingn Prot, Nantes, France; [Faller, Peter] Univ Strasbourg, Inst Chim, UMR 7177, Strasbourg, France	INRAE; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite de Toulouse; Institut National Polytechnique de Toulouse; Centre National de la Recherche Scientifique (CNRS); Nantes Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Remaud-Simeon, M (corresponding author), Univ Toulouse, CNRS, INRA, Lab Ingn Syst Biol & Proc,INSA, Toulouse, France.	remaud@insa-toulouse.fr	HUREAU, Christelle/AAM-1642-2021; Faller, Peter/B-9614-2018	HUREAU, Christelle/0000-0003-3339-0239; Faller, Peter/0000-0001-8013-0806; GRAS, Emmanuel/0000-0002-1178-3579; Hoarau, Marie/0000-0002-5758-3556	APR-PRES	APR-PRES	This work was funded within the frame of APR-PRES 2013, project EVOLCAT.	Alies B, 2012, INORG CHEM, V51, P7897, DOI 10.1021/ic300972j; ALLEN SP, 1992, J BACTERIOL, V174, P6938, DOI 10.1128/JB.174.21.6938-6947.1992; BEAVEN GH, 1952, ADV PROTEIN CHEM, V7, P319, DOI 10.1016/S0065-3233(08)60022-4; Bockhorn JJ, 2010, BIOPOLYMERS, V94, P511, DOI 10.1002/bip.21391; Chang YJ, 2014, FEBS J, V281, P2674, DOI 10.1111/febs.12813; Chhetri G, 2015, PROTEIN EXPRES PURIF, V114, P71, DOI 10.1016/j.pep.2015.05.015; Delrieu J, 2014, REV NEUROL-FRANCE, V170, P739, DOI 10.1016/j.neurol.2014.10.003; Espargaro A, 2012, MOL BIOSYST, V8, P2839, DOI 10.1039/c2mb25214g; Finder VH, 2010, J MOL BIOL, V396, P9, DOI 10.1016/j.jmb.2009.12.016; Fu Z, 2015, BIOCHEMISTRY-US, V54, P4197, DOI 10.1021/acs.biochem.5b00467; Garai K, 2009, PROTEIN EXPRES PURIF, V66, P107, DOI 10.1016/j.pep.2009.02.009; Hamley IW, 2012, CHEM REV, V112, P5147, DOI 10.1021/cr3000994; Henderson VW, 2014, J STEROID BIOCHEM, V142, P99, DOI 10.1016/j.jsbmb.2013.05.010; Kim EK, 2012, PROTEIN EXPRES PURIF, V86, P53, DOI 10.1016/j.pep.2012.08.021; Lee EK, 2005, PROTEIN EXPRES PURIF, V40, P183, DOI 10.1016/j.pep.2004.12.014; Liao YH, 2015, PROTEIN EXPRES PURIF, V113, P63, DOI 10.1016/j.pep.2015.05.002; Long F, 2011, PROTEIN EXPRES PURIF, V79, P16, DOI 10.1016/j.pep.2011.05.012; Neerathilingam M, 2014, BIOCHEM BIOPH RES CO, V448, P45, DOI 10.1016/j.bbrc.2014.04.049; SATO C, 1995, NEUROSCI LETT, V200, P105, DOI 10.1016/0304-3940(95)12089-M; Schneider LS, 2014, J INTERN MED, V275, P251, DOI 10.1111/joim.12191; Sharma SC, 2015, PROTEIN EXPRES PURIF, V116, P82, DOI 10.1016/j.pep.2015.07.012; Shen M, 2009, PROTEIN EXPRES PURIF, V63, P84, DOI 10.1016/j.pep.2008.09.015; Szczepankiewicz O, 2015, J AM CHEM SOC, V137, P14673, DOI 10.1021/jacs.5b07849; Tong LM, 2015, EXP MOL MED, V47, DOI 10.1038/emm.2014.124; Villar-Pique A, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-55; Walsh DM, 2009, FEBS J, V276, P1266, DOI 10.1111/j.1742-4658.2008.06862.x; Wiesehan K, 2007, J CHROMATOGR B, V856, P229, DOI 10.1016/j.jchromb.2007.06.003; Zagorski MG, 1999, METHOD ENZYMOL, V309, P189	28	8	8	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2016	11	8							e0161209	10.1371/journal.pone.0161209	http://dx.doi.org/10.1371/journal.pone.0161209			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4YN	27532547	Green Published, gold, Green Submitted			2022-12-27	WOS:000381487600076
J	Kantar, MB; Anderson, JE; Lucht, SA; Mercer, K; Bernau, V; Case, KA; Le, NC; Frederiksen, MK; DeKeyser, HC; Wong, ZZ; Hastings, JC; Baumler, DJ				Kantar, Michael B.; Anderson, Justin E.; Lucht, Sarah A.; Mercer, Kristin; Bernau, Vivian; Case, Kyle A.; Le, Nina C.; Frederiksen, Matthew K.; DeKeyser, Haley C.; Wong, Zen-Zi; Hastings, Jennifer C.; Baumler, David J.			Vitamin Variation in Capsicum Spp. Provides Opportunities to Improve Nutritional Value of Human Diets	PLOS ONE			English	Article							ANNUUM L.; SWEET-PEPPERS; BELL PEPPERS; DEVELOPING-COUNTRIES; GENETIC DIVERSITY; ASCORBIC-ACID; CHILE PEPPER; C CONTENT; CAROTENOIDS; COLLECTION	Chile peppers, native to the Americas, have spread around the world and have been integrated into the diets of many cultures. Much like their heat content, nutritional content can vary dramatically between different pepper types. In this study, a diverse set of chile pepper types were examined for nutrient content. Some pepper types were found to have high levels of vitamin A, vitamin C, or folate. Correlations between nutrient content, species, cultivation status, or geographic region were limited. Varietal selection or plant breeding offer tools to augment nutrient content in peppers. Integration of nutrient rich pepper types into diets that already include peppers could help combat nutrient deficiencies by providing a significant portion of recommended daily nutrients.	[Kantar, Michael B.; Anderson, Justin E.] Univ Hawaii Manoa, Dept Trop Plant & Soil Sci, Honolulu, HI 96822 USA; [Lucht, Sarah A.] Harvard Univ, Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Mercer, Kristin; Bernau, Vivian] Ohio State Univ, Dept Hort & Crop Sci, Columbus, OH 43210 USA; [Case, Kyle A.; Le, Nina C.; Frederiksen, Matthew K.; DeKeyser, Haley C.; Wong, Zen-Zi; Hastings, Jennifer C.; Baumler, David J.] Univ Minnesota Twin Cities, Dept Food Sci & Nutr, St Paul, MN 55108 USA; [Baumler, David J.] Univ Minnesota Twin Cities, Microbial & Plant Genome Inst, St Paul, MN 55108 USA; [Baumler, David J.] Univ Minnesota Twin Cities, Inst Biotechnol, St Paul, MN 55108 USA	University of Hawaii System; University of Hawaii Manoa; Harvard University; Harvard T.H. Chan School of Public Health; University System of Ohio; Ohio State University; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Baumler, DJ (corresponding author), Univ Minnesota Twin Cities, Dept Food Sci & Nutr, St Paul, MN 55108 USA.; Baumler, DJ (corresponding author), Univ Minnesota Twin Cities, Microbial & Plant Genome Inst, St Paul, MN 55108 USA.; Baumler, DJ (corresponding author), Univ Minnesota Twin Cities, Inst Biotechnol, St Paul, MN 55108 USA.	dbaumler@umn.edu	Anderson, Justin/R-3007-2016	Anderson, Justin/0000-0001-7642-4641; Bernau, Vivian/0000-0002-2393-8101; Lucht, Sarah/0000-0001-5904-2844; Kantar, Michael/0000-0001-5542-0975				[Agricultural Research Service Nutrient Data Laboratory US Department of Agriculture], 2015, NUTRIENT DATA USDA N; Akhtar S, 2013, J HEALTH POPUL NUTR, V31, P413; [Anonymous], 2014, J INFECT DIS THER; Asnin L, 2015, CRIT REV FOOD SCI, V55, P254, DOI 10.1080/10408398.2011.652316; Bassett T.J., 2010, ATLAS WORLD HUNGER; Black MM, 2008, FOOD NUTR BULL, V29, pS126, DOI 10.1177/15648265080292S117; Black RE, 2013, LANCET, V382, P427, DOI 10.1016/S0140-6736(13)60937-X; Blancquaert D, 2014, J EXP BOT, V65, P895, DOI 10.1093/jxb/ert483; Bosland PW, 2007, HORTSCIENCE, V42, P222, DOI 10.21273/HORTSCI.42.2.222; Bosland PW, 2012, HORTTECHNOLOGY, V22, P534, DOI 10.21273/HORTTECH.22.4.534; Cichewicz RH, 1996, J ETHNOPHARMACOL, V52, P61, DOI 10.1016/0378-8741(96)01384-0; Crider KS, 2011, NUTRIENTS, V3, P370, DOI 10.3390/nu3030370; Cunningham SA, 2014, NEW ENGL J MED, V370, P403, DOI [10.1056/NEJMoa1309753, 10.1056/NEJMc1402397]; Dary O, 2002, J NUTR, V132, p2927S, DOI 10.1093/jn/132.9.2927S; Deepa N, 2007, LWT-FOOD SCI TECHNOL, V40, P121, DOI 10.1016/j.lwt.2005.09.016; Diepvens K, 2007, AM J PHYSIOL-REG I, V292, pR77, DOI 10.1152/ajpregu.00832.2005; Estrada B, 1999, SCI HORTIC-AMSTERDAM, V81, P385, DOI 10.1016/S0304-4238(99)00029-1; FDA, 2013, LAB NUTR GUID IND FO; Frank CA, 2001, HORTSCIENCE, V36, P795, DOI 10.21273/HORTSCI.36.4.795; Geleta LF, 2006, J SCI FOOD AGR, V86, P1317, DOI 10.1002/jsfa.2494; Guil-Guerrero JL, 2006, EUR FOOD RES TECHNOL, V224, P1, DOI 10.1007/s00217-006-0281-5; Hayano-Kanashiro C, 2016, CROP SCI, V56, P1, DOI 10.2135/cropsci2014.11.0789; HURTADOHERNANDEZ H, 1985, J HERED, V76, P211, DOI 10.1093/oxfordjournals.jhered.a110070; *I MED FOOD NUTR B, 2001, DIET REF INT VIT A V; Kraft KH, 2014, P NATL ACAD SCI USA, V111, P6165, DOI 10.1073/pnas.1308933111; Lejeune MP, 2009, BR J NUTR, V90, P651; Li Z, 2013, PLOS ONE, V18; Martinez S, 2005, INT J FOOD SCI NUTR, V56, P45, DOI 10.1080/09637480500081936; Martínez-Sánchez David, 2010, Rev. Chapingo Ser.Hortic, V16, P169; Martins KC, 2015, CROP BREED APPL BIOT, V15, P139, DOI 10.1590/1984-70332015v15n3a25; Naegele RP, 2015, PHYTOPATHOLOGY, V105, P110, DOI 10.1094/PHYTO-02-14-0031-R; Perez-Lopez AJ, 2007, J AGR FOOD CHEM, V55, P8158, DOI 10.1021/jf071534n; Perla V, 2016, FOOD CHEM, V202, P189, DOI 10.1016/j.foodchem.2016.01.135; Phillips KM, 2006, J AGR FOOD CHEM, V54, P9998, DOI 10.1021/jf062327a; PICKERSGILL B, 1971, EVOLUTION, V25, P683, DOI 10.1111/j.1558-5646.1971.tb01926.x; Popkin BM, 2012, NUTR REV, V70, P3, DOI 10.1111/j.1753-4887.2011.00456.x; Pugliese A, 2013, FOOD CHEM, V141, P2606, DOI 10.1016/j.foodchem.2013.05.046; Qin C, 2014, P NATL ACAD SCI USA, V111, P5135, DOI 10.1073/pnas.1400975111; R Core Team, 2013, R LANG ENV STAT COMP; Rodriguez Gustavo R, 2010, J Vis Exp, DOI 10.3791/1856; Scholl TO, 2000, AM J CLIN NUTR, V71, p1295S, DOI 10.1093/ajcn/71.5.1295s; Sherman PW, 1999, BIOSCIENCE, V49, P453, DOI 10.2307/1313553; Smith SH, 2015, J ETHNOPHARMACOL, V167, P64, DOI 10.1016/j.jep.2014.10.048; Sun T, 2007, J FOOD SCI, V72, pS98, DOI 10.1111/j.1750-3841.2006.00245.x; Topuz A, 2007, J FOOD COMPOS ANAL, V20, P596, DOI 10.1016/j.jfca.2007.03.007; van Jaarsveld PJ, 2005, AM J CLIN NUTR, V81, P1080; van Zonneveld M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134663; Varela-Silva MI, 2012, COLLEGIUM ANTROPOL, V36, P39; Wahyuni Y, 2013, J NAT PROD, V76, P783, DOI 10.1021/np300898z; Wahyuni Y, 2011, PHYTOCHEMISTRY, V72, P1358, DOI 10.1016/j.phytochem.2011.03.016; [WHO] World Health Organization, 2016, MICR DEF; Zhang DL, 2003, J FOOD AGRIC ENVIRON, V1, P22	52	60	61	4	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2016	11	8							e0161464	10.1371/journal.pone.0161464	http://dx.doi.org/10.1371/journal.pone.0161464			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4YN	27532495	gold, Green Submitted, Green Published			2022-12-27	WOS:000381487600097
J	Kaufman, DJ; Baker, R; Milner, LC; Devaney, S; Hudson, KL				Kaufman, David J.; Baker, Rebecca; Milner, Lauren C.; Devaney, Stephanie; Hudson, Kathy L.			A Survey of U.S Adults' Opinions about Conduct of a Nationwide Precision Medicine Initiative (R) Cohort Study of Genes and Environment	PLOS ONE			English	Article							DATABASE; BIOBANK; HEART	Objectives A survey of a population-based sample of U.S adults was conducted to measure their attitudes about, and inform the design of the Precision Medicine Initiative's planned national cohort study. Methods An online survey was conducted by GfK between May and June of 2015. The influence of different consent models on willingness to share data was examined by randomizing participants to one of eight consent scenarios. Results Of 4,777 people invited to take the survey, 2,706 responded and 2,601 (54% response rate) provided valid responses. Most respondents (79%) supported the proposed study, and 54% said they would definitely or probably participate if asked. Support for and willingness to participate in the study varied little among demographic groups; younger respondents, LGBT respondents, and those with more years of education were significantly more likely to take part if asked. The most important study incentive that the survey asked about was learning about one's own health information. Willingness to share data and samples under broad, study-by-study, menu and dynamic consent models was similar when a statement about transparency was included in the consent scenarios. Respondents were generally interested in taking part in several governance functions of the cohort study. Conclusions A large majority of the U.S. adults who responded to the survey supported a large national cohort study. Levels of support for the study and willingness to participate were both consistent across most demographic groups. The opportunity to learn health information about one's self from the study appears to be a strong motivation to participate.	[Kaufman, David J.] NHGRI, Div Genom & Soc, NIH, Rockville, MD 20852 USA; [Baker, Rebecca; Milner, Lauren C.; Devaney, Stephanie; Hudson, Kathy L.] NIH, Off Director, Bldg 10, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA	Kaufman, DJ (corresponding author), NHGRI, Div Genom & Soc, NIH, Rockville, MD 20852 USA.	dave.kaufman@nih.gov			Foundation for the National Institutes of Health	Foundation for the National Institutes of Health	The authors wish to thank the Foundation for the National Institutes of Health, which funded this survey. The authors would also like to thank Vence Bonham, Laura Rodriguez, Alex Lee and the members of the Consent, Education, Regulation and Consultation Working Group of the eMERGE research consortium for their contributions to the survey and manuscript development.; The Foundation for National Institutes of Health directly paid for GfK to field the survey. The authors themselves received no specific funding for the work. FNIH did not participate in data collection, analysis, decisions to publish or preparation of the manuscript. They were involved in discussions about the logistics of study design but did not influence survey content.	BAKER LC, VALIDITY SURVEY HLTH; Bollinger JM, 2014, GENET MED, V16, P932, DOI 10.1038/gim.2014.50; Collins FS, 2015, NEW ENGL J MED, V372, P793, DOI 10.1056/NEJMp1500523; Collins FS, 2004, NATURE, V429, P475, DOI 10.1038/nature02628; Genomeweb.com, REG LAUNCH 100K PAT; GfK, 2015, GFK 2015; Gulcher J, 1999, NAT BIOTECHNOL, V17, P620, DOI 10.1038/10796; Hudson K., 2015, PRECISION MED INITIA; Kaufman D, 2009, GENET MED, V11, P329, DOI 10.1097/GIM.0b013e31819994f8; Kaufman D, 2008, GENET MED, V10, P331, DOI 10.1097/GIM.0b013e31818bb3ab; Mathews AW, 2015, WALL STREET J; McQuillan GM, 2003, GENET MED, V5, P35, DOI 10.1097/00125817-200301000-00006; National Human Genome Research Institute, 2005, DES CONS POT US POP; National Institutes of Health, 2015, SUMM RESP REQ INF BU; National Institutes of Health, 2015, MOB PERS TECHN PREC; National Institutes of Health, 2015, ACD PREC MED IN WORK; NIH, 2015, REQ INF NIH PREC MED; North KE, 2003, AM J EPIDEMIOL, V157, P303, DOI 10.1093/aje/kwf208; Oh SS, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001918; Palmer LJ, 2007, LANCET, V369, P1980, DOI 10.1016/S0140-6736(07)60924-6; Roden DM, 2008, CLIN PHARMACOL THER, V84, P362, DOI 10.1038/clpt.2008.89; Sanger David, 2015, NEW YORK TIMES; Splansky GL, 2007, AM J EPIDEMIOL, V165, P1328, DOI 10.1093/aje/kwm021; SPSS Inc, 2012, SPSS WIND REL 21 0; The White House, 2015, PREC MED IN PROP PRI	25	63	63	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2016	11	8							e0160461	10.1371/journal.pone.0160461	http://dx.doi.org/10.1371/journal.pone.0160461			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4YN	27532667	Green Published, Green Submitted, gold			2022-12-27	WOS:000381487600031
J	El-Sayed, MA				El-Sayed, Mahmoud Ahmed			The Behaviour of Bifilm Defects in Cast Al-7Si-Mg Alloy	PLOS ONE			English	Article							DOUBLE-OXIDE-FILM; MECHANICAL-PROPERTIES; ALUMINUM; HYDROGEN	Double oxide films (bifilms) are significant defects in the casting of light alloys, and have been shown to decrease tensile and fatigue properties, and also to increase their scatter, making casting properties unreproducible and unreliable. A bifilm consists of doubled-over oxide films containing a gas-filled crevice and is formed due to surface turbulence of the liquid metal during handling and/or pouring. Previous studies has shown that the nature of oxide film defects may change with time, as the atmosphere inside the bifilm could be consumed by reaction with the surrounding melt, which may enhance the mechanical properties of Al alloy castings. As a proxy for a bifilm, an air bubble was trapped within an Al-7wt.% Si-0.3wt.% Mg (2L99) alloy melt, subjected to stirring. The effect of different parameters such as the holding time, stirring velocity and melt temperature on the change in gas composition of the bubble was investigated, using a design of experiments (DoE) approach. Also, the solid species inside the bubbles solidified in the melt were examined using SEM. The results suggested that both oxygen and nitrogen inside the bifilm would be consumed by reaction with the surrounding melt producing MgAl2O4 and AlN, respectively. Also, hydrogen was suggested to consistently diffuse into the defect. The reaction rates and the rate of H diffusion were shown to increase upon increasing the holding time and temperature, and stirring velocity. Such significant effect of the process parameters studied on the gaseous content of the bubble suggesting that a careful control of such parameters might lead to the deactivation of bifilm defects, or at least elimination of their deteriorous effect in light alloy castings.	[El-Sayed, Mahmoud Ahmed] Arab Acad Sci Technol Maritime Transport Abu Qir, Dept Ind & Management Engn, Alexandria, Egypt	Egyptian Knowledge Bank (EKB); Arab Academy for Science, Technology & Maritime Transport	El-Sayed, MA (corresponding author), Arab Acad Sci Technol Maritime Transport Abu Qir, Dept Ind & Management Engn, Alexandria, Egypt.	m_elsayed@aast.edu	El-Sayed, Mahmoud Ahmed/Q-7425-2016	El-Sayed, Mahmoud Ahmed/0000-0003-3086-0872	Arab Academy for Science and Technology and Maritime Transport, Egypt	Arab Academy for Science and Technology and Maritime Transport, Egypt(Arab Academy for Science, Technology & Maritime Transport)	This work has been funded by The Arab Academy for Science and Technology and Maritime Transport, Egypt (www.aast.edu). The funder role was the financial support of the research fellowship by the author (ME) at The University of Birmingham from June 1st 2015 to September 30th 2015. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brandes E.A., 1999, SMITHELLS METALS REF; Campbell J, 2006, MATER SCI TECH-LOND, V22, P127, DOI 10.1179/174328406X74248; CAMPBELL J, 1993, J PHYS IV, V3, P861, DOI 10.1051/jp4:19937135; Chase M.W., 1985, JANAF THERMOCHEMICAL; El-Sayed, 2012, DOUBLE OXIDE FILM DE; El-Sayed M, 2013, MATER SCI FORUM, V765, P260, DOI 10.4028/www.scientific.net/MSF.765.260; El-Sayed M, 2016, INT J CAST IN PRESS; El-Sayed MA, 2014, INT J CAST METAL RES, V27, P282, DOI 10.1179/1743133614Y.0000000113; El-Sayed MA., 2015, INT REV MECH ENG, V9, P252; El-Sayed MA, 2014, METALL MATER TRANS B, V45, P1398, DOI 10.1007/s11663-014-0035-x; El-Sayed MA, 2011, METALL MATER TRANS B, V42, P1104, DOI 10.1007/s11663-011-9571-9; Griffiths W., 2013, P 2013 INT S LIQ MET, P187; Griffiths William D., 2014, Materials Science Forum, V783-786, P142, DOI 10.4028/www.scientific.net/MSF.783-786.142; Griffiths WD, 2009, J MATER SCI, V44, P3402, DOI 10.1007/s10853-009-3450-7; Griffiths WD, 2007, EFFECT HOLDING TIME; Halvaee A., 1997, AFS T, V105, P35; Nyahumwa C., 1998, J MECH BEHAV MAT, V9, P227; Raiszadeh R, 2006, METALL MATER TRANS B, V37, P865, DOI 10.1007/BF02735007; RANSLEY CE, 1948, J I MET, V74, P599; SLEPPY WC, 1961, J ELECTROCHEM SOC, V108, P1097, DOI 10.1149/1.2427963	20	13	13	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2016	11	8							e0160633	10.1371/journal.pone.0160633	http://dx.doi.org/10.1371/journal.pone.0160633			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4UN	27529350	Green Published, Green Submitted, gold			2022-12-27	WOS:000381476700012
J	Prevosto, C; Usmani, MF; McDonald, S; Gumienny, AM; Key, T; Goodman, RS; Gaston, JSH; Deery, MJ; Busch, R				Prevosto, Claudia; Usmani, M. Farooq; McDonald, Sarah; Gumienny, Aleksandra M.; Key, Tim; Goodman, Reyna S.; Gaston, J. S. Hill; Deery, Michael J.; Busch, Robert			Allele-Independent Turnover of Human Leukocyte Antigen (HLA) Class I alpha Molecules	PLOS ONE			English	Article							MHC CLASS-I; HUMAN DENDRITIC CELLS; DIFFERENTIAL EXPRESSION; RECOGNITION; ACTIVATION; HLA-B27; TAPASIN; GENES; TAP; MECHANISMS	Major histocompatibility complex class I (MHCI) glycoproteins present cytosolic peptides to CD8+ T cells and regulate NK cell activity. Their heavy chains (HC) are expressed from up to three MHC gene loci (human leukocyte antigen [HLA]-A, -B, and -C in humans), whose extensive polymorphism maps predominantly to the antigen-binding groove, diversifying the bound peptide repertoire. Codominant expression of MHCI alleles is thus functionally critical, but how it is regulated is not fully understood. Here, we have examined the effect of polymorphism on the turnover rates of MHCI molecules in cell lines with functional MHCI peptide loading pathways and in monocyte-derived dendritic cells (MoDCs). Proteins were labeled biosynthetically with heavy water ((H2O)-H-2), folded MHCI molecules immunoprecipitated, and tryptic digests analysed by mass spectrometry. MHCI-derived peptides were assigned to specific alleles and isotypes, and turnover rates quantified by H-2 incorporation, after correcting for cell growth. MHCI turnover half-lives ranged from undetectable to a few hours, depending on cell type, activation state, donor, and MHCI isotype. However, in all settings, the turnover half-lives of alleles of the same isotype were similar. Thus, MHCI protein turnover rates appear to be allele-independent in normal human cells. We propose that this is an important feature enabling the normal function and codominant expression of MHCI alleles.	[Prevosto, Claudia; Usmani, M. Farooq; McDonald, Sarah; Gumienny, Aleksandra M.; Gaston, J. S. Hill; Busch, Robert] Univ Cambridge, Dept Med, Cambridge, England; [Key, Tim; Goodman, Reyna S.] Addenbrookes Hosp, Tissue Typing Lab, Cambridge, England; [Deery, Michael J.] Univ Cambridge, Cambridge Ctr Prote, Cambridge, England; [Busch, Robert] Univ Roehampton, Dept Life Sci, London, England; [Key, Tim] NHS Blood & Transplant, Histocompatibil & Immunogenet Lab, Sheffield, S Yorkshire, England	University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Cambridge; Roehampton University	Busch, R (corresponding author), Univ Cambridge, Dept Med, Cambridge, England.; Busch, R (corresponding author), Univ Roehampton, Dept Life Sci, London, England.	robert.busch@roehampton.ac.uk		Busch, Robert/0000-0002-4132-0751	Arthritis Research UK [18543, 20648]; Cambridge Arthritis Research Endeavour (CARE); Cambridge Commonwealth, European and International Trust; Cancer Research UK [16491] Funding Source: researchfish; Versus Arthritis [20648] Funding Source: researchfish	Arthritis Research UK(Versus Arthritis); Cambridge Arthritis Research Endeavour (CARE); Cambridge Commonwealth, European and International Trust; Cancer Research UK(Cancer Research UK); Versus Arthritis(Versus Arthritis)	This work was funded primarily by a Senior Research Fellowship and a Research Progression Award from Arthritis Research UK (refs. 18543 and 20648; http://www.arthritisresearchuk.org/), with start-up funding from Cambridge Arthritis Research Endeavour (CARE; http://www.cambridge-arthritis.org.uk/; all to RB). MFU was supported by an International Scholarship from the Cambridge Commonwealth, European and International Trust (https://www.cambridgetrust.org/). The authors also gratefully acknowledge support for core facilities by the Cambridge Biomedical Research Centre of the National Institute for Health Research, and support from the Tissue Typing Laboratory at Addenbrooke's Hospital, Cambridge, for HLA typing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman AL, 2003, J IMMUNOL, V170, P4178, DOI 10.4049/jimmunol.170.8.4178; Andres AM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001157; Apps R, 2015, J IMMUNOL, V194, P3594, DOI 10.4049/jimmunol.1403234; Barel MT, 2006, INT IMMUNOL, V18, P173, DOI 10.1093/intimm/dxh362; BARNSTABLE CJ, 1978, CELL, V14, P9, DOI 10.1016/0092-8674(78)90296-9; BJORKMAN PJ, 1987, NATURE, V329, P512, DOI 10.1038/329512a0; Blum JS, 2013, ANNU REV IMMUNOL, V31, P443, DOI 10.1146/annurev-immunol-032712-095910; Bowness P, 2011, J IMMUNOL, V186, P2672, DOI 10.4049/jimmunol.1002653; Cano F, 2013, MOL IMMUNOL, V55, P135, DOI 10.1016/j.molimm.2012.10.015; Cella M, 1997, NATURE, V388, P782, DOI 10.1038/42030; Chapman DC, 2010, SEMIN CELL DEV BIOL, V21, P512, DOI 10.1016/j.semcdb.2009.12.013; Chazara O, 2011, J LEUKOCYTE BIOL, V90, P703, DOI 10.1189/jlb.0511227; De Riva A, 2013, J IMMUNOL, V190, P5961, DOI 10.4049/jimmunol.1300551; De Riva A, 2010, ANAL BIOCHEM, V403, P1, DOI 10.1016/j.ab.2010.04.018; Delay ML, 2009, ARTHRITIS RHEUM-US, V60, P2633, DOI 10.1002/art.24763; DOBBE LME, 1988, IMMUNOGENETICS, V27, P203, DOI 10.1007/BF00346587; Duncan LM, 2010, J IMMUNOL, V184, P6978, DOI 10.4049/jimmunol.0904154; Evans DM, 2011, NAT GENET, V43, P761, DOI 10.1038/ng.873; Falk CS, 1997, IMMUNOL RES, V16, P203, DOI 10.1007/BF02786363; Garstka MA, 2011, FASEB J, V25, P3989, DOI 10.1096/fj.11-190249; Grandea AG, 1997, IMMUNOGENETICS, V46, P477, DOI 10.1007/s002510050308; Gras S, 2012, IMMUNOL REV, V250, P61, DOI 10.1111/j.1600-065X.2012.01159.x; Gromme M, 1999, P NATL ACAD SCI USA, V96, P10326, DOI 10.1073/pnas.96.18.10326; Hammer GE, 2007, NAT IMMUNOL, V8, P101, DOI 10.1038/ni1409; HAMMER RE, 1990, CELL, V63, P1099, DOI 10.1016/0092-8674(90)90512-D; Hellerstein MK, 1999, AM J PHYSIOL-ENDOC M, V276, pE1146, DOI 10.1152/ajpendo.1999.276.6.E1146; Hermann C, 2015, ELIFE, V4, DOI 10.7554/eLife.09617; Holmes WE, 2015, METHOD ENZYMOL, V561, P219, DOI 10.1016/bs.mie.2015.05.018; Hou Tieying, 2013, Methods Mol Biol, V960, P411, DOI 10.1007/978-1-62703-218-6_31; Johnson DR, 2000, HUM IMMUNOL, V61, P389, DOI 10.1016/S0198-8859(99)00186-X; Jones EY, 1997, CURR OPIN IMMUNOL, V9, P75, DOI 10.1016/S0952-7915(97)80162-8; Jorgensen KW, 2014, IMMUNOLOGY, V141, P18, DOI 10.1111/imm.12160; Karre K, 2002, SCAND J IMMUNOL, V55, P221, DOI 10.1046/j.1365-3083.2002.01053.x; Kim TY, 2012, MOL CELL PROTEOMICS, V11, P1586, DOI 10.1074/mcp.M112.021162; KOEFFLER HP, 1978, SCIENCE, V200, P1153, DOI 10.1126/science.306682; Kulkarni S, 2011, NATURE, V472, P495, DOI 10.1038/nature09914; Lanier LL, 2008, NAT IMMUNOL, V9, P495, DOI 10.1038/ni1581; Li L, 2012, MOL CELL PROTEOMICS, V11, DOI [10.1074/mcp.M111.010025, 10.1074/mcp.M111.014209]; McLaren JE, 2009, J GEN VIROL, V90, P2239, DOI 10.1099/vir.0.011627-0; MOMBURG F, 1994, NATURE, V367, P648, DOI 10.1038/367648a0; Murphy K, 2008, JANEWAYS IMMUNOBIOLO; Neefjes J, 2011, NAT REV IMMUNOL, V11, P823, DOI 10.1038/nri3084; NEEFJES JJ, 1988, EUR J IMMUNOL, V18, P801, DOI 10.1002/eji.1830180522; NEEFJES JJ, 1986, IMMUNOGENETICS, V23, P164, DOI 10.1007/BF00373817; Neisig A, 1998, J IMMUNOL, V160, P171; Obst R, 2005, J EXP MED, V201, P1555, DOI 10.1084/jem.20042521; ORR HT, 1983, NATURE, V302, P534, DOI 10.1038/302534a0; Peh CA, 1998, IMMUNITY, V8, P531, DOI 10.1016/S1074-7613(00)80558-0; Prevosto C, 2012, J RHEUMATOL, V39, P1918, DOI 10.3899/jrheum.120208; Rabenstein H, 2014, J IMMUNOL, V192, P3507, DOI 10.4049/jimmunol.1302725; Rachdaoui N, 2009, MOL CELL PROTEOMICS, V8, P2653, DOI 10.1074/mcp.M900026-MCP200; RAMMENSEE HG, 1995, IMMUNOGENETICS, V41, P178, DOI 10.1007/BF00172063; Reeves E, 2014, P NATL ACAD SCI USA, V111, P17594, DOI 10.1073/pnas.1408882111; Rene C, 2015, EUR J IMMUNOL, V45, P3454, DOI 10.1002/eji.201545927; Ridley A, 2015, ARTHRITIS RHEUM; Rivas HG, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8040102; Robinson J, 2016, HUM IMMUNOL; Rowe M, 2007, P NATL ACAD SCI USA, V104, P3366, DOI 10.1073/pnas.0611128104; Sadasivan B, 1996, IMMUNITY, V5, P103, DOI 10.1016/S1074-7613(00)80487-2; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; SALTER RD, 1985, IMMUNOGENETICS, V21, P235, DOI 10.1007/BF00375376; Santos SG, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2492; Schaefer MR, 2008, J IMMUNOL, V180, P7804, DOI 10.4049/jimmunol.180.12.7804; SHIMIZU Y, 1988, P NATL ACAD SCI USA, V85, P227, DOI 10.1073/pnas.85.1.227; Spiliotis ET, 2002, MOL BIOL CELL, V13, P1566, DOI 10.1091/mbc.01-07-0322; Spurgin LG, 2010, P ROY SOC B-BIOL SCI, V277, P979, DOI 10.1098/rspb.2009.2084; Teobald I, 2008, IMMUNOBIOLOGY, V213, P75, DOI 10.1016/j.imbio.2007.06.001; Thammavongsa V, 2009, IMMUNOGENETICS, V61, P703, DOI 10.1007/s00251-009-0399-2; Thammavongsa V, 2006, J IMMUNOL, V177, P3150, DOI 10.4049/jimmunol.177.5.3150; Usmani MF, 2012, THESIS; van de Weijer ML, 2015, SEMIN IMMUNOL, V27, P125, DOI 10.1016/j.smim.2015.03.010; van den Elsen PJ, 2004, CURR OPIN IMMUNOL, V16, P67, DOI 10.1016/j.coi.2003.11.015; WEI ML, 1992, NATURE, V356, P443, DOI 10.1038/356443a0; Wilkins MR, 1997, ELECTROPHORESIS, V18, P403, DOI 10.1002/elps.1150180314	74	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2016	11	8							e0161011	10.1371/journal.pone.0161011	http://dx.doi.org/10.1371/journal.pone.0161011			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4UN	27529174	Green Submitted, Green Published, gold			2022-12-27	WOS:000381476700038
J	Ng, TH; Tan, SK; Wong, WH; Meier, R; Chan, SY; Tan, HH; Yeo, DCJ				Ng, Ting Hui; Tan, Siong Kiat; Wong, Wing Hing; Meier, Rudolf; Chan, Sow-Yan; Tan, Heok Hui; Yeo, Darren C. J.			Molluscs for Sale: Assessment of Freshwater Gastropods and Bivalves in the Ornamental Pet Trade	PLOS ONE			English	Article							NONNATIVE APPLE SNAILS; MALILI LAKE SYSTEM; OXIDASE SUBUNIT-I; AQUARIUM TRADE; MUSSELS MOLLUSCA; GLOBAL DIVERSITY; DNA; FISH; TAXONOMY; CERITHIOIDEA	The ornamental pet trade is often considered a key culprit for conservation problems such as the introduction of invasive species (including infectious diseases) and overharvesting of rare species. Here, we present the first assessment of the biodiversity of freshwater molluscs in the ornamental pet trade in Singapore, one of the most important global hubs of the ornamental aquarium trade, and discuss associated conservation concerns. We recorded freshwater molluscs from ornamental pet shops and major exporters including non-ornamental species (e.g., hitchhikers, molluscs sold as fish feed). We recorded an unexpectedly high diversity-59 species-of freshwater bivalves and gastropods, with the majority (38 species or 64%) being from the Oriental region. In addition to morphological examination, we sequenced the DNA barcode region of mitochondrial CO1 and 16S genes to provide molecular data for the confirmation of the identification and for future re-identification. DNA barcodes were obtained for 50 species, and all but four were separated by > 3% uncorrected pairwise distances. The trade has been considered a main introduction pathway for non-native species to Singapore, and we found that out of 15 species in the trade as well as in the wild in Singapore, 12 are either introduced or of unknown origin, representing almost half of the known non-native freshwater molluscs in Singapore. Particularly prevalent are non-ornamental species: six hitchhikers on aquarium plants and six species sold as fish feed. We found that a quarter of the trade species have a history of introduction, which includes 11 known or potentially invasive species. We conclude that potential overharvesting is difficult to assess because only half of the trade species have been treated by IUCN. Of these, 21 species are of Least Concern and three are Data Deficient. Our checklist, with accompanying DNA barcodes, images, and museum vouchers, provides an important reference library for future monitoring, and constitutes a step toward creating a more sustainable ornamental pet trade.	[Ng, Ting Hui; Meier, Rudolf; Yeo, Darren C. J.] Natl Univ Singapore, Dept Biol Sci, Singapore, Singapore; [Tan, Siong Kiat; Meier, Rudolf; Tan, Heok Hui] Natl Univ Singapore, Lee Kong Chian Nat Hist Museum, Singapore, Singapore; [Wong, Wing Hing] Washington Univ, Div Biol & Biomed Sci, St Louis, MO USA; [Chan, Sow-Yan] VBox 888313, Singapore, Singapore	National University of Singapore; National University of Singapore; Washington University (WUSTL)	Ng, TH (corresponding author), Natl Univ Singapore, Dept Biol Sci, Singapore, Singapore.	ng.tinghui@u.nus.edu	Ng, Ting Hui/E-8339-2011; Yeo, Darren CJ/H-9790-2012; Wong, Hing/J-2307-2019; Meier, Rudolf/A-7099-2011; Meier, Rudolf/AAB-3848-2021	Ng, Ting Hui/0000-0002-5123-0039; Meier, Rudolf/0000-0002-4452-2885; Meier, Rudolf/0000-0002-4452-2885; Wong, Wing Hing/0000-0003-2494-1721	Department of Biological Sciences of the National University of Singapore; Singapore National Research Foundation; Economic Development Board, SPORE [COY-15-EWI-RCFSA/N197-1]; Wildlife Reserves Singapore Ah Meng Memorial Conservation Fund, National University of Singapore [R-154-000-617-720]	Department of Biological Sciences of the National University of Singapore(National University of Singapore); Singapore National Research Foundation(National Research Foundation, Singapore); Economic Development Board, SPORE(Singapore Economic Development Board); Wildlife Reserves Singapore Ah Meng Memorial Conservation Fund, National University of Singapore(National University of Singapore)	The authors acknowledge financial support from the Department of Biological Sciences of the National University of Singapore, the Singapore National Research Foundation and the Economic Development Board, SPORE, COY-15-EWI-RCFSA/N197-1, http://www.nrf.gov.sg/, THN; and Wildlife Reserves Singapore Ah Meng Memorial Conservation Fund, National University of Singapore grant number R-154-000-617-720, http://www.wrscf.org.sg/index.html, to DCJY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank colleagues and friends, particularly: Kelvin KP Lim for assistance in obtaining molluscs from the trade and providing important references; Swee Hee Tan for first suggesting the idea for an earlier version of this study; Thomas Eichhorst, Matthias Glaubrecht, Frank Kohler, and Thomas von Rintelen for help in species identifications; Kenneth Hayes and Ravindra C Joshi for photographs and information of Pomacea maculata; Wendy Y Wang, Darren Yeo and other members of the Evolutionary Biology Laboratory, members of the Freshwater and Invasion Biology Laboratory, and Amanda Windsor of the Smithsonian Institution, for assistance in various aspects of the molecular work and data collection process. We acknowledge financial support from the Department of Biological Sciences of the National University of Singapore, the Singapore National Research Foundation and the Economic Development Board, SPORE, COY-15-EWI-RCFSA/N197-1, and Wildlife Reserves Singapore Ah Meng Memorial Conservation Fund, National University of Singapore grant number R-154-000-617-720. Finally, we would like to thank three anonymous reviewers and the academic editor for their helpful recommendations that have greatly improved the manuscript.	Alacs E, 2008, AUST J FORENSIC SCI, V40, P147, DOI 10.1080/00450610802491382; Anderson R, 2008, ANNOTATED LIST NONMA; ANDREWS C, 1990, J FISH BIOL, V37, P53, DOI 10.1111/j.1095-8649.1990.tb05020.x; Appleton CC, 2015, AFR INVERTEBR, V56, P1, DOI 10.5733/afin.056.0102; Appleton C. C., 2003, African Journal of Aquatic Science, V28, P69, DOI 10.2989/16085914.2003.9626602; Areekijseree M, 2004, AQUACULTURE, V234, P575, DOI 10.1016/j.aquaculture.2003.12.008; Arias A, 2014, LIMNETICA, V33, P65; AVA (Agri-Food and Veterinary Authority of Singapore), 2011, ORN FISH NEWSL, V2, P1; Bastert J, 1998, DERMATOLOGY, V197, P84, DOI 10.1159/000017965; Becker S, 2011, MITOCHONDR DNA, V22, P3, DOI 10.3109/19401736.2010.535528; Benson AJ, 2016, SINANODONTA WOODIANA; Blaxter ML, 2004, PHILOS T R SOC B, V359, P669, DOI 10.1098/rstb.2003.1447; Bogan AE, 2008, HYDROBIOLOGIA, V595, P139, DOI 10.1007/s10750-007-9011-7; Bortolus A, 2008, AMBIO, V37, P114, DOI 10.1579/0044-7447(2008)37[114:ECITBS]2.0.CO;2; BRANDT R A M, 1974, Archiv fuer Molluskenkunde, V105, P1; BROWN DS, 1983, J MOLLUS STUD, V49, P77, DOI 10.1093/oxfordjournals.mollus.a065687; Brown DS, 1998, J AFRICAN ZOOLOGY, V112, P1; Bunje PMJ, 2004, THESIS; BUTOT L. J. M., 1954, BASTERIA, V18, P65; Chan SY, 2008, ELLIPSARIA, V10, P10; Charoenchai A, 1997, Southeast Asian J Trop Med Public Health, V28 Suppl 1, P209; Chee SY, 2016, MITOCHONDRIAL DNA A, V27, P2282, DOI 10.3109/19401736.2014.987237; Cianfanelli Simone, 2007, V2, P103, DOI 10.1007/978-1-4020-6029-8_5; Clausen JH, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001945; Clements R, 2006, BIOL CONSERV, V128, P136, DOI 10.1016/j.biocon.2005.09.023; Cohen J, 2007, FRONT ECOL ENVIRON, V5, P528, DOI 10.1890/1540-9295(2007)5[528:TIATAP]2.0.CO;2; Collins RA, 2013, MOL ECOL RESOUR, V13, P969, DOI 10.1111/1755-0998.12046; Collins RA, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0028381, 10.1371/journal.pone.0030581]; Courchamp F, 2006, PLOS BIOL, V4, P2405, DOI 10.1371/journal.pbio.0040415; Cowie Robert H., 2003, P93; Cowie RH, 2012, HANDBOOK OF GLOBAL FRESHWATER INVASIVE SPECIES, P207; Cowie RH, 2009, AM MALACOL BULL, V27, P113, DOI 10.4003/006.027.0210; de Carvalho MR, 2007, EVOL BIOL, V34, P140, DOI 10.1007/s11692-007-9011-6; Deng ZH, 2011, SE ASIAN J TROP MED, V42, P1047; DJAJASASMITA M, 1982, VELIGER, V25, P175; Do VT, 2013, IUCN RED LIST THREAT; Douda K, 2012, BIOL INVASIONS, V14, P127, DOI 10.1007/s10530-011-9989-7; DUDGEON D, 1983, Malacological Review, V16, P93; Duggan IC, 2010, BIOL INVASIONS, V12, P3757, DOI 10.1007/s10530-010-9768-x; Eichhorst TE, 2016, NERITIDAE WORLD, V1; European Commission, 2012, OFFICIAL J EUROPEA L, V311, P14; Evans BB, 2001, BULL EUR ASSN FISH P, V21, P51; FAO (Food and Agriculture Organization of the United Nations), 2005, FISH AQ TOP ORN FISH; FAO (Food and Agricutural Organization of the United Nations), 2011, FAO YB FISH AQ STAT, P127; Filipova L, 2011, KNOWL MANAG AQUAT EC, DOI 10.1051/kmae/2011025; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Foster AM, 2015, CORBICULA FLUMINEA G; Geller J, 2013, MOL ECOL RESOUR, V13, P851, DOI 10.1111/1755-0998.12138; Glaubrecht M, 2004, BIOL J LINN SOC, V82, P275, DOI 10.1111/j.1095-8312.2004.00361.x; Glaubrecht M, 2003, MALACOLOGIA, V45, P1; Glaubrecht Matthias, 2010, Zoosystematics and Evolution, V86, P185, DOI 10.1002/zoos.201000002; Gupta S., 2012, FISHING CHIMES, V32, P61; Habe T., 1964, Nat & Life in SW Asia, V3, P45; HALWART M, 1994, INT J PEST MANAGE, V40, P199, DOI 10.1080/09670879409371882; Hayes KA, 2008, DIVERS DISTRIB, V14, P701, DOI 10.1111/j.1472-4642.2008.00483.x; Hayes KA, 2012, ZOOL J LINN SOC-LOND, V166, P723, DOI 10.1111/j.1096-3642.2012.00867.x; Haynes A, 2001, FRESHWATER SNAILS TR; Hummel S, 2012, PRACTICAL FISHKEEPIN, V6, P30; Iglesias SP, 2010, AQUAT CONSERV, V20, P319, DOI 10.1002/aqc.1083; Ilarri MI, 2012, HANDBOOK OF GLOBAL FRESHWATER INVASIVE SPECIES, P173; International Enterprise Singapore, 2016, SING TRAD STAT SING; Ishibashi Ryo, 2003, Venus (Tokyo), V62, P65; IUCN Red list, 2022, ZOOL, Patent No. [eT158085A760192, 158085760192]; Joshi R. C., 2006, GLOBAL ADV; Jutting W. S. S. v. B., 1959, Beaufortia, V7, P41; Jutting W. S. S. v. B., 1956, Treubia, V23, P259; Jutting W. S. S.v. B., 1953, Treubia, V22, P19; Karatayev AY, 2009, HYDROBIOLOGIA, V619, P181, DOI 10.1007/s10750-008-9639-y; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Keller RP, 2007, BIOSCIENCE, V57, P428, DOI 10.1641/B570509; Kim KC, 2006, ECOL RES, V21, P794, DOI 10.1007/s11284-006-0035-7; Kohler F, 2009, MOLLUSCAN RES, V29, P121; Kohler F, 2006, MALACOLOGIA, V48, P159; Kohler F, 2001, J MOLLUS STUD, V67, P281, DOI 10.1093/mollus/67.3.281; Kohler F, STATUS DISTRIBUTION, P67; KRISTENSEN TK, 1987, J MOLLUS STUD, V53, P245, DOI 10.1093/mollus/53.2.245; Kulsantiwong J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079144; Lajtner J, 2011, AQUAT INVASIONS, V6, pS119, DOI 10.3391/ai.2011.6.S1.027; Layton KKS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095003; Lee S., 2008, THESIS; Leray M, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-34; Liang Shih-Hisung, 2006, Taiwania, V51, P93; Ling K.H., 2005, SINGAPORE J PRI IND, V32, P59; Liu Y.Y., 1979, EC FAUNA CHINA FRESH; Lukhaup C., 2009, PRACTICAL FISHKEEPIN, V2009, P31; Lydeard C, 2004, BIOSCIENCE, V54, P321, DOI 10.1641/0006-3568(2004)054[0321:TGDONM]2.0.CO;2; Maceda-Veiga A, 2013, BIOL INVASIONS, V15, P2707, DOI 10.1007/s10530-013-0485-0; Mackie GL, 2000, NONINDIGENOUS FRESHWATER ORGANISMS, P135; MADSEN H, 1989, ACTA TROP, V46, P139, DOI 10.1016/0001-706X(89)90030-2; Maki K, 2004, BIOL CONSERV, V118, P389, DOI 10.1016/j.biocon.2003.09.015; Marwoto Ristiyanti M., 2011, Biotropia, V18, P123; McDowall RM, 2004, NEW ZEAL J MAR FRESH, V38, P503, DOI 10.1080/00288330.2004.9517256; MCMAHON RF, 1982, NAUTILUS, V96, P134; Meier R, 2008, SYST BIOL, V57, P809, DOI 10.1080/10635150802406343; Meier R, 2008, SYST ASSOC SPEC VOL, V76, P95; Meier R, 2006, SYST BIOL, V55, P715, DOI 10.1080/10635150600969864; Meier R, 2016, CLADISTICS, V32, P100, DOI 10.1111/cla.12115; Mienis HK, 1973, BASTERIA, V37, P1; Mitchell AJ, 2007, N AM J FISH MANAGE, V27, P1287, DOI 10.1577/M06-252.1; Naylor R, 1996, AMBIO, V25, P443; Ng HH, 2010, COSMOS, V6, P95, DOI [10.1142/S0219607710000504, DOI 10.1142/S0219607710000504]; Ng Peter K.L., 1997, Aquarium Sciences and Conservation, V1, P79, DOI 10.1023/A:1018335617835; NG PKL, 1993, BIOL CONSERV, V64, P19, DOI 10.1016/0006-3207(93)90379-F; Ng TH, 2015, BIOINVASIONS REC, V4, P189, DOI 10.3391/bir.2015.4.3.06; Ng Ting Hui, 2014, Nature in Singapore, V7, P31; Padilla DK, 2004, FRONT ECOL ENVIRON, V2, P131, DOI 10.1890/1540-9295(2004)002[0131:BBWAAO]2.0.CO;2; Palumbi S, 2002, THE SIMPLE FOOLS GUI; Pecnikar ZF, 2014, J APPL GENET, V55, P43, DOI 10.1007/s13353-013-0180-y; Petney T, 2012, PARASITOL INT, V61, P38, DOI 10.1016/j.parint.2011.07.019; Pigneur LM, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-147; Pointier JP, 2001, MEM I OSWALDO CRUZ, V96, P67, DOI 10.1590/S0074-02762001000900009; Pointier JP, 1999, MALACOLOGIA, V41, P403; Posch H, 2013, J MOLLUS STUD, V79, P383, DOI 10.1093/mollus/eyt034; Poulin R, 2011, FRESHWATER BIOL, V56, P676, DOI 10.1111/j.1365-2427.2010.02425.x; Raghavan R, 2013, BIOL CONSERV, V164, P158, DOI 10.1016/j.biocon.2013.04.019; Raut SK, 1999, CURR SCI INDIA, V77, P1389; Rawlings TA, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-97; Regnier C, 2009, CONSERV BIOL, V23, P1214, DOI 10.1111/j.1523-1739.2009.01245.x; Rhyne A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008413; Rhyne AL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035808; Robinson DG, 1999, MALACOLOGIA, V41, P413; Roll U, 2009, BIOL INVASIONS, V11, P1963, DOI 10.1007/s10530-008-9373-4; SALISBURY JR, 1976, AUST VET J, V52, P487, DOI 10.1111/j.1751-0813.1976.tb05413.x; Sarasin F, 1898, MAT NATURGESCHICHTE, P62; Sarasin P., 1897, ZOOL ANZ, V539, P308; Shea Michael, 1994, Molluscan Research, V15, P3; Shokralla S, 2014, MOL ECOL RESOUR, V14, P892, DOI 10.1111/1755-0998.12236; Simonis J, IUCN RED LIST THREAT; Singh K. Inder, 1997, Southeast Asian Journal of Tropical Medicine and Public Health, V28, P303; Smith KF, 2008, CONSERV LETT, V1, P103, DOI 10.1111/j.1755-263X.2008.00014.x; Sousa R, 2009, BIOL INVASIONS, V11, P2367, DOI 10.1007/s10530-009-9422-7; SRI-AROON P., 2010, FRESHWATER SNAILS ME; Srivathsan A, 2012, CLADISTICS, V28, P190, DOI 10.1111/j.1096-0031.2011.00370.x; Steinke D, 2011, MITOCHONDR DNA, V22, P10, DOI 10.3109/19401736.2010.536538; Steinke D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006300; Strecker AL, 2011, FISHERIES, V36, P74, DOI 10.1577/03632415.2011.10389070; Strong EE, 2008, HYDROBIOLOGIA, V595, P149, DOI 10.1007/s10750-007-9012-6; Subba NV., 1989, ZOOLOGICAL SURVEY IN, P1; Tan SK, 2008, ZOOL STUD, V47, P481; Tan SK, 2012, GUID SNAILS OTHER NO; Teem John L, 2013, Hawaii J Med Public Health, V72, P11; Ng TH, 2014, MALACOLOGIA, V57, P401, DOI 10.4002/040.057.0211; Van Damme D., 2014, IUCN RED LIST THREAT; van Jutting WSS Benthem, 1946, J CONCHOL, V22, P221; Vences Miguel, 2005, Front Zool, V2, P5, DOI 10.1186/1742-9994-2-5; Vink CJ, 2012, BIOSCIENCE, V62, P451, DOI 10.1525/bio.2012.62.5.3; Von Rintelen T, 2003, J MOLLUS STUD, V69, P3; Von Rintelen T, 2008, ZOOTAXA, P37; von Rintelen T, 2007, HYDROBIOLOGIA, V592, P11, DOI 10.1007/s10750-007-0765-8; von Rintelen T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098917; Watters GT, 1997, VELIGER, V40, P152; Weese DA, 2009, ANIM CONSERV, V12, P13, DOI 10.1111/j.1469-1795.2008.00215.x; Welton LJ, 2013, BIOL CONSERV, V159, P7, DOI 10.1016/j.biocon.2012.10.013; Wethington AR, 2007, J MOLLUS STUD, V73, P241, DOI 10.1093/mollus/eym021; Whelan NV, 2011, MOL PHYLOGENET EVOL, V61, P504, DOI 10.1016/j.ympev.2011.07.016; WINNEPENNINCKX B, 1993, TRENDS GENET, V9, P407; Wong WH, 2014, MOL ECOL RESOUR, V14, P1271, DOI 10.1111/1755-0998.12275; Wong YT, 2011, BIOL INVASIONS, V13, P341, DOI 10.1007/s10530-010-9825-5; Wong YT, 2011, A GUIDE TO FRESHWATE, P11; Yang L, 2014, SCI REP-UK, V4, DOI 10.1038/srep04089; Yang SL, 1990, RAFFLES B ZOOL, V38, P1; YEO D. C. J., 2010, COSMOS, V6, P23, DOI DOI 10.1142/S0219607710000486; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478; Zilch A., 1955, ARCH MOLLUSKENKD, V64, P1	164	56	61	3	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2016	11	8							e0161130	10.1371/journal.pone.0161130	http://dx.doi.org/10.1371/journal.pone.0161130			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4SL	27525660	gold, Green Published, Green Submitted			2022-12-27	WOS:000381471100036
J	Marshall, J; Booth, T; Devane, N; Galliers, J; Greenwood, H; Hilari, K; Talbot, R; Wilson, S; Woolf, C				Marshall, Jane; Booth, Tracey; Devane, Niamh; Galliers, Julia; Greenwood, Helen; Hilari, Katerina; Talbot, Richard; Wilson, Stephanie; Woolf, Celia			Evaluating the Benefits of Aphasia Intervention Delivered in Virtual Reality: Results of a Quasi-Randomised Study	PLOS ONE			English	Article							COGNITIVE-BEHAVIOR THERAPY; PUBLIC-SPEAKING ANXIETY; QUALITY-OF-LIFE; SENTENCE PRODUCTION; LEXICAL RETRIEVAL; STROKE; PEOPLE; COMMUNICATION; LANGUAGE; EFFICACY	Introduction This study evaluated an intervention for people with aphasia delivered in a novel virtual reality platform called EVA Park. EVA Park contains a number of functional and fantastic locations and allows for interactive communication between multiple users. Twenty people with aphasia had 5 weeks' intervention, during which they received daily language stimulation sessions in EVA Park from a support worker. The study employed a quasi randomised design, which compared a group that received immediate intervention with a waitlist control group. Outcome measures explored the effects of intervention on communication and language skills, communicative confidence and feelings of social isolation. Compliance with the intervention was also explored through attrition and usage data. Results There was excellent compliance with the intervention, with no participants lost to follow up and most (18/20) receiving at least 88% of the intended treatment dose. Intervention brought about significant gains on a measure of functional communication. Gains were achieved by both groups of participants, once intervention was received, and were well maintained. Changes on the measures of communicative confidence and feelings of social isolation were not achieved. Results are discussed with reference to previous aphasia therapy findings.	[Marshall, Jane; Devane, Niamh; Greenwood, Helen; Hilari, Katerina; Talbot, Richard; Woolf, Celia] City Univ London, Div Language & Commun Sci, London, England; [Booth, Tracey; Galliers, Julia; Wilson, Stephanie] City Univ London, Ctr Human Comp Interact Design, London, England	City University London; City University London	Marshall, J (corresponding author), City Univ London, Div Language & Commun Sci, London, England.	J.Marshall@city.ac.uk	Wilson, Stephanie/AAX-1579-2020; Talbot, Richard/GYR-1597-2022	Wilson, Stephanie/0000-0001-6445-654X; Devane, Niamh/0000-0001-8448-1478; Hilari, Katerina/0000-0003-2091-4849	Stroke Association [TSA 2011/10]; Stroke Association [TSA2011/10] Funding Source: researchfish	Stroke Association; Stroke Association	This work was funded by a research grant to JM, SW, and CW from The Stroke Association https://www.stroke.org.uk/ Award Number: TSA 2011/10. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali M, 2015, INT J STROKE, V10, P400, DOI 10.1111/ijs.12067; Anderson P, 2003, COGN BEHAV PRACT, V10, P240, DOI 10.1016/S1077-7229(03)80036-6; Anderson PL, 2005, DEPRESS ANXIETY, V22, P156, DOI 10.1002/da.20090; ANTONUCCI TC, 1987, J GERONTOL, V42, P519, DOI 10.1093/geronj/42.5.519; Archibald Lisa M D, 2009, Ther Adv Neurol Disord, V2, P299, DOI 10.1177/1756285609336548; Babbitt E, 2010, TOP STROKE REHABIL, V17, P197; Babbitt EM, 2011, APHASIOLOGY, V25, P727, DOI 10.1080/02687038.2010.537347; Berndt R. S., 2000, QUANTITATIVE PRODUCT; Booth V, 2014, CLIN REHABIL, V28, P419, DOI 10.1177/0269215513509389; Boyle M, 2004, AM J SPEECH-LANG PAT, V13, P236, DOI 10.1044/1058-0360(2004/025); Boyle M., 1995, AM J SPEECH-LANG PAT, V4, P94, DOI [10.1044/1058-0360.0404.94, DOI 10.1044/1058-0360.0404.94]; Bozzacchi C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047783; Brady MC, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000425.pub4; Bruce C, 2003, INT J LANG COMM DIS, V38, P131, DOI 10.1080/1368282021000048258; Brundage SB, 2015, AM J SPEECH-LANG PAT, V24, P139, DOI 10.1044/2014_AJSLP-14-0087; Carragher M, 2013, NEUROPSYCHOL REHABIL, V23, P846, DOI 10.1080/09602011.2013.832335; Caute A, 2016, APHASIOLOGY, V30, P245, DOI 10.1080/02687038.2015.1041095; Chapey R., 2008, LANGUAGE INTERVENTIO, Vedition; Cherney LR, 2014, AM J SPEECH-LANG PAT, V23, P343, DOI 10.1044/2014_AJSLP-13-0097; Cherney LR, 2012, SEMIN SPEECH LANG, V33, P243, DOI 10.1055/s-0032-1320044; Cherney LR, 2011, TOP STROKE REHABIL, V18, P352, DOI 10.1310/tsr1804-352; Cherney LR, 2011, J COMMUN DISORD, V44, P493, DOI 10.1016/j.jcomdis.2011.04.002; Cherney LR, 2010, TOP STROKE REHABIL, V17, P423, DOI 10.1310/tsr1706-423; Conroy P, 2009, APHASIOLOGY, V23, P707, DOI 10.1080/02687030802165574; Cruice M, 2010, APHASIOLOGY, V24, P327, DOI 10.1080/02687030802565849; Doesborgh S, 2004, APHASIOLOGY, V18, P213, DOI 10.1080/02687030344000580; Doesborgh SJC, 2004, STROKE, V35, P141, DOI 10.1161/01.STR.0000105460.52928.A6; Estes C, 2011, APHASIOLOGY, V25, P366, DOI 10.1080/02687038.2010.493294; Furnas DW, 2014, APHASIOLOGY, V28, P401, DOI 10.1080/02687038.2013.869304; Fernandes ABGS, 2014, NEUROREHABILITATION, V35, P39, DOI 10.3233/NRE-141105; Greenwood A, 2010, APHASIOLOGY, V24, P991, DOI 10.1080/02687030903168220; Harris SR, 2002, CYBERPSYCHOL BEHAV, V5, P543, DOI 10.1089/109493102321018187; Hawthorne G, 2006, SOC INDIC RES, V77, P521, DOI 10.1007/s11205-005-7746-y; Herbert R., 2013, PROFILE WORD ERRORS; Herbert R, 2008, APHASIOLOGY, V22, P184, DOI 10.1080/02687030701262613; Hilari K, 2003, STROKE, V34, P1944, DOI 10.1161/01.STR.0000081987.46660.ED; Hill AJ, 2009, APHASIOLOGY, V23, P627, DOI 10.1080/02687030801909659; Hinckley JJ, 2001, APHASIOLOGY, V15, P463, DOI 10.1080/02687040042000340; Holland A. L., 1999, COMMUNICATION ACTIVI; Kempler D, 2011, APHASIOLOGY, V25, P1327, DOI 10.1080/02687038.2011.599364; Klinger E, 2005, CYBERPSYCHOL BEHAV, V8, P76, DOI 10.1089/cpb.2005.8.76; Lam JMC, 2010, MED CARE, V48, P380, DOI 10.1097/MLR.0b013e3181ca2647; Laufer Y., 2011, J PHYS THER ED, V25, P59, DOI [10.1097/00001416-201110000-00011, DOI 10.1097/00001416-201110000-00011]; Laver K., 2012, STROKE, V43, pe20, DOI DOI 10.1161/STROKEAHA.111.642439; Lee JB, 2009, APHASIOLOGY, V23, P885, DOI 10.1080/02687030802669534; Lee S, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000269; Linebarger M, 2007, BRAIN LANG, V100, P53, DOI 10.1016/j.bandl.2006.09.001; Lohse KR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093318; Marshall J, 2013, APHASIOLOGY, V27, P1128, DOI 10.1080/02687038.2013.786803; Maskey M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100374; McCall D, 2009, APHASIOLOGY, V23, P438, DOI 10.1080/02687030701818000; Moreira MC, 2013, DISABIL REHABIL-ASSI, V8, P357, DOI 10.3109/17483107.2012.749428; Motraghi TE, 2014, J CLIN PSYCHOL, V70, P197, DOI 10.1002/jclp.22051; Nickels L, 2002, REHABILITATION SPOKE; Northcott S, 2011, INT J LANG COMM DIS, V46, P524, DOI 10.1111/j.1460-6984.2011.00079.x; Palmer R, 2013, INT J LANG COMM DIS, V48, P508, DOI 10.1111/1460-6984.12024; Palmer R, 2012, STROKE, V43, P1904, DOI 10.1161/STROKEAHA.112.650671; Proffitt R, 2015, PHYS THER, V95, P441, DOI 10.2522/ptj.20130571; Rochon E, 2005, NEUROPSYCHOL REHABIL, V15, P1, DOI 10.1080/09602010343000327; Rochon E, 2000, BRAIN LANG, V72, P193, DOI 10.1006/brln.1999.2285; Safir MP, 2012, BEHAV MODIF, V36, P235, DOI 10.1177/0145445511429999; Sickert A, 2014, J NEUROL NEUROSUR PS, V85, P51, DOI 10.1136/jnnp-2012-304297; Simmons-Mackie N, 2010, ARCH PHYS MED REHAB, V91, P1814, DOI 10.1016/j.apmr.2010.08.026; Stark J, 2013, INT C VIRT REAL PHIL; Swinburn K., 2004, COMPREHENSIVE APHASI; Theodoros D, 2008, TELEMED J E-HEALTH, V14, P552, DOI 10.1089/tmj.2007.0091; Thompson CK, 2010, APHASIOLOGY, V24, P1242, DOI 10.1080/02687030903474255; Triberti S, 2014, CYBERPSYCH BEH SOC N, V17, P335, DOI 10.1089/cyber.2014.0054; van de Sandt-Koenderman WME, 2011, INT J SPEECH-LANG PA, V13, P21, DOI 10.3109/17549507.2010.502973; van Vuuren S, 2014, LECT NOTES ARTIF INT, V8637, P438, DOI 10.1007/978-3-319-09767-1_55; Wade J, 2003, APHASIOLOGY, V17, P1031, DOI 10.1080/02687030344000373; Wallace SJ, 2014, APHASIOLOGY, V28, P1364, DOI 10.1080/02687038.2014.930262; Wallach HS, 2009, BEHAV MODIF, V33, P314, DOI 10.1177/0145445509331926; Wambaugh JL, 2014, APHASIOLOGY, V28, P1, DOI 10.1080/02687038.2013.845739; Wang M, 2011, NEUROEPIDEMIOLOGY, V36, P2, DOI 10.1159/000320847; Wilson S, 2015, CODESIGN, V11, P21, DOI 10.1080/15710882.2014.997744; Woolf C, 2016, CLIN REHABIL, V30, P359, DOI 10.1177/0269215515582074; Worrall L, 2013, APHASIA RELATED NEUR, P93	78	43	44	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2016	11	8							e0160381	10.1371/journal.pone.0160381	http://dx.doi.org/10.1371/journal.pone.0160381			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DT3LI	27518188	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000381382100013
J	Wang, LJ; Yang, KC; Lee, SY; Yang, CJ; Huang, TS; Lee, TL; Yuan, SS; Shyu, YC				Wang, Liang-Jen; Yang, Kang-Chung; Lee, Sheng-Yu; Yang, Chun-Ju; Huang, Ting-Shuo; Lee, Tung-Liang; Yuan, Shin-Sheng; Shyu, Yu-Chiau			Initiation and Persistence of Pharmacotherapy for Youths with Attention Deficit Hyperactivity Disorder in Taiwan	PLOS ONE			English	Article							DEFICIT/HYPERACTIVITY DISORDER; PHARMACOLOGICAL-TREATMENT; MEDICATION ADHERENCE; TREATMENT PATTERNS; SURVIVAL ANALYSIS; PUBLIC-ATTITUDES; DRUG-USE; CHILDREN; ADHD; ADOLESCENTS	Background Pharmacotherapy is an effective therapeutic option for attention deficit hyperactivity disorder (ADHD). Understanding the patterns of medication treatment is crucial for clinical practice. This study employed nationwide population-based data to elucidate the initiation and persistence of pharmacotherapy (immediate-release methylphenidate [IR-MPH], osmotic controlled-release formulations of methylphenidate [OROS-MPH] and atomoxetine [ATX]) for youths with ADHD in Taiwan. Methods Patients first receiving an ADHD diagnosis at age 18 or younger between January 2000 and December 2009 (n = 112,140; mean age at ADHD diagnosis: 7.7 years) were selected from Taiwan's National Health Insurance database. All patients were monitored through December 31, 2011, with an average follow-up time of 5.8 years. The initiation of ADHD drug therapy was defined as the first patient prescription, and discontinuation was defined as the cessation of ADHD medication for 180 days or longer. Results Within the first year after ADHD diagnosis, 47.3%, 14.4%, and 0.8% of the patients were prescribed IR-MPH, OROS-MPH, and ATX, respectively. Regarding the patients prescribed IR-MPH, OROS-MPH, and ATX, 17.8%, 12.6%, and 18.8%, respectively, received the prescription only once and never returned for a drug refill, and 51.0%, 38.9%, and 58.8%, respectively, discontinued drug therapy within 1 year after the first prescription. Male sex and neuropsychiatric comorbidities were associated with higher probabilities of being prescribed one of the medications. An older age at first prescription and a higher daily dose of prescription were significant predictors of early discontinuation of ADHD medication. Conclusions The current findings suggest that IR-MPH is the most frequently prescribed drug for ADHD treatment in Taiwan. Patients treated with OROS-MPH possessed the highest persistence rate, whereas those treated with ATX had the lowest persistence rate. The results provide insight into the delivery of pediatric mental health services and have crucial implications for ADHD medication treatment in real clinical settings.	[Wang, Liang-Jen] Kaohsiung Chang Gung Mem Hosp, Dept Child & Adolescent Psychiat, Kaohsiung, Taiwan; [Wang, Liang-Jen] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan; [Yang, Kang-Chung] Natl Taiwan Univ, Genome & Syst Biol Degree Program, Taipei, Taiwan; [Yang, Kang-Chung] Acad Sinica, Taipei, Taiwan; [Yang, Kang-Chung; Yuan, Shin-Sheng] Acad Sinica, Inst Stat Sci, Taipei, Taiwan; [Lee, Sheng-Yu] Kaohsiung Vet Gen Hosp, Dept Psychiat, Kaohsiung, Taiwan; [Lee, Sheng-Yu] Natl Cheng Kung Univ, Coll Med & Hosp, Dept Psychiat, Tainan, Taiwan; [Yang, Chun-Ju] Natl Yang Ming Univ, Inst Biopharmaceut Sci, Taipei, Taiwan; [Yang, Chun-Ju; Huang, Ting-Shuo; Shyu, Yu-Chiau] Keelung Chang Gung Mem Hosp, Community Med Res Ctr, Keelung, Taiwan; [Huang, Ting-Shuo] Keelung Chang Gung Mem Hosp, Dept Gen Surg, Keelung, Taiwan; [Huang, Ting-Shuo] Chang Gung Univ, Coll Med, Dept Chinese Med, Taoyuan, Taiwan; [Lee, Tung-Liang] Univ Texas MD Anderson Canc Ctr, Dept Expt Radiat Oncol, Houston, TX 77030 USA; [Shyu, Yu-Chiau] Acad Sinica, Inst Mol Biol, Taipei, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; National Taiwan University; Academia Sinica - Taiwan; Academia Sinica - Taiwan; Kaohsiung Veterans General Hospital; National Cheng Kung University; National Yang Ming Chiao Tung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University; University of Texas System; UTMD Anderson Cancer Center; Academia Sinica - Taiwan	Yuan, SS (corresponding author), Acad Sinica, Inst Stat Sci, Taipei, Taiwan.; Shyu, YC (corresponding author), Keelung Chang Gung Mem Hosp, Community Med Res Ctr, Keelung, Taiwan.; Shyu, YC (corresponding author), Acad Sinica, Inst Mol Biol, Taipei, Taiwan.	shinshengyuan@gmail.com; yuchiaushyu@gmail.com	Huang, Ting-Shuo/ABD-3205-2021; Wang, Liang-Jen/AAR-1089-2020; Yuan, Shinsheng/AAP-4855-2021	Huang, Ting-Shuo/0000-0002-2932-6878; Wang, Liang-Jen/0000-0002-5320-1151; Shyu, Yu-Chiau/0000-0003-1747-2226; Lee, Tung Liang/0000-0003-1913-1652	Chang Gung Memorial Hospital Research Projects [CMRPG8D0581, CLRPG2C0021, CLRPG2C0022, CMRPG2B0113]	Chang Gung Memorial Hospital Research Projects	This study was sponsored by the Chang Gung Memorial Hospital Research Projects (CMRPG8D0581, CLRPG2C0021, CLRPG2C0022 and CMRPG2B0113).	Ahmed R, 2013, EXPERT REV PHARM OUT, V13, P791, DOI 10.1586/14737167.2013.841544; Ahmed R, 2013, J CHILD ADOL PSYCHOP, V23, P163, DOI 10.1089/cap.2012.0087; ALLGULANDER C, 1986, ACTA PSYCHIAT SCAND, V74, P529, DOI 10.1111/j.1600-0447.1986.tb06279.x; American Psychiatric Association, 2000, DIAGNOSTIC AND STATI; Atzori P, 2009, J CHILD ADOL PSYCHOP, V19, P673, DOI 10.1089/cap.2008.0146; Ayaz M, 2014, J CHILD ADOL PSYCHOP, V24, P442, DOI 10.1089/cap.2014.0002; Charach A, 2013, CURR PSYCHIAT REP, V15, DOI 10.1007/s11920-013-0371-6; Chen CY, 2012, PSYCHIAT SERV, V63, P1011, DOI 10.1176/appi.ps.201100473; Chen CY, 2011, J CHILD ADOL PSYCHOP, V21, P265, DOI 10.1089/cap.2010.0107; Chien IC, 2012, SOC PSYCH PSYCH EPID, V47, P1885, DOI 10.1007/s00127-012-0501-1; Clavenna A, 2014, ARCH DIS CHILD, V99, P866, DOI 10.1136/archdischild-2013-304170; Didoni A, 2011, EUR J CLIN PHARMACOL, V67, P1061, DOI 10.1007/s00228-011-1050-3; Feldman HM, 2014, NEW ENGL J MED, V370, P838, DOI 10.1056/NEJMcp1307215; Findling RL, 2008, CLIN THER, V30, P942, DOI 10.1016/j.clinthera.2008.05.006; Gajria K, 2014, NEUROPSYCH DIS TREAT, V10, P1543, DOI 10.2147/NDT.S65721; Garbe E, 2012, J CHILD ADOL PSYCHOP, V22, P452, DOI 10.1089/cap.2012.0022; Gau SSF, 2005, AM J PSYCHIAT, V162, P1344, DOI 10.1176/appi.ajp.162.7.1344; Gau SSF, 2008, J CLIN PSYCHIAT, V69, P131, DOI 10.4088/JCP.v69n0118; Hammerness P, 2009, NEUROPSYCH DIS TREAT, V5, P215; Hodgkins P, 2011, CLIN THER, V33, P188, DOI 10.1016/j.clinthera.2011.03.001; Hong JH, 2013, PATIENT PREFER ADHER, V7, P987, DOI 10.2147/PPA.S50628; Hong M, 2014, J CHILD ADOL PSYCHOP, V24, P341, DOI 10.1089/cap.2013.0090; Huang CLC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095014; Karam R. G., 2015, PSYCHOL MED, P1; Katzman M, 2014, CNS DRUGS, V28, P1005, DOI 10.1007/s40263-014-0175-1; Lambert MC, 2015, J CHILD ADOL PSYCHOP, V25, P475, DOI 10.1089/cap.2014.0151; Lang HC, 2010, HEALTH POLICY, V97, P71, DOI 10.1016/j.healthpol.2010.03.005; Lien YT, 2015, PSYCHIAT SERV, V66, P177, DOI 10.1176/appi.ps.201300501; Marcus SC, 2005, ARCH PEDIAT ADOL MED, V159, P572, DOI 10.1001/archpedi.159.6.572; McCarthy S, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-78; McLeod JD, 2004, J HEALTH SOC BEHAV, V45, P53, DOI 10.1177/002214650404500104; Palli SR, 2012, J CHILD ADOL PSYCHOP, V22, P139, DOI 10.1089/cap.2011.0028; Partridge B, 2012, AUST NZ J PSYCHIAT, V46, P958, DOI 10.1177/0004867412450755; Polanczyk G, 2007, AM J PSYCHIAT, V164, P942, DOI 10.1176/appi.ajp.164.6.942; Polanczyk GV, 2014, INT J EPIDEMIOL, V43, P434, DOI 10.1093/ije/dyt261; Pottegard A, 2013, EUR J CLIN PHARMACOL, V69, P589, DOI 10.1007/s00228-012-1344-0; Rapoport JL, 2013, WORLD PSYCHIATRY, V12, P118, DOI 10.1002/wps.20028; Reddy DS, 2013, DRUG TODAY, V49, P647, DOI 10.1358/dot.2013.49.10.2008996; Spencer TJ, 2007, J PEDIATR PSYCHOL, V32, P631, DOI 10.1093/jpepsy/jsm005; Treuer T, 2013, J CHILD ADOL PSYCHOP, V23, P179, DOI 10.1089/cap.2012.0093; van de Loo-Neus GHH, 2011, EUR NEUROPSYCHOPHARM, V21, P584, DOI 10.1016/j.euroneuro.2011.03.008; Vaughan BS, 2012, INT J NEUROPSYCHOPH, V15, P27, DOI 10.1017/S1461145711000095; Willoughby MT, 2003, J CHILD PSYCHOL PSYC, V44, P88, DOI 10.1111/1469-7610.t01-1-00104; Winterstein AG, 2008, ANN PHARMACOTHER, V42, P24, DOI 10.1345/aph.1K143; Wong ICK, 2009, HEALTH TECHNOL ASSES, V13, P1, DOI 10.3310/hta13490; Wu CS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112257; Zetterqvist J, 2013, ACTA PSYCHIAT SCAND, V128, P70, DOI 10.1111/acps.12004; Zoega H, 2011, ACTA PSYCHIAT SCAND, V123, P360, DOI 10.1111/j.1600-0447.2010.01607.x	48	27	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2016	11	8							e0161061	10.1371/journal.pone.0161061	http://dx.doi.org/10.1371/journal.pone.0161061			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DT3LI	27518196	Green Published, gold, Green Submitted			2022-12-27	WOS:000381382100041
J	Elkalaf, M; Tuma, P; Weiszenstein, M; Polak, J; Trnka, J				Elkalaf, Moustafa; Tuma, Petr; Weiszenstein, Martin; Polak, Jan; Trnka, Jan			Mitochondrial Probe Methyltriphenylphosphonium (TPMP) Inhibits the Krebs Cycle Enzyme 2-Oxoglutarate Dehydrogenase	PLOS ONE			English	Article							TRIPHENYLPHOSPHONIUM CATIONS; TARGETED ANTIOXIDANT; RESPIRATORY-CHAIN; CULTURED-CELLS; COMPLEX-I; BIOENERGETICS; ASSAY; UBIQUINONE; SAMPLES; ENERGY	Methyltriphenylphosphonium (TPMP) salts have been widely used to measure the mitochondrial membrane potential and the triphenylphosphonium (TPP+) moiety has been attached to many bioactive compounds including antioxidants to target them into mitochondria thanks to their high affinity to accumulate in the mitochondrial matrix. The adverse effects of these compounds on cellular metabolism have been insufficiently studied and are still poorly understood. Micromolar concentrations of TPMP cause a progressive inhibition of cellular respiration in adherent cells without a marked effect on mitochondrial coupling. In permeabilized cells the inhibition was limited to NADH-linked respiration. We found a mixed inhibition of the Krebs cycle enzyme 2-oxoglutarate dehydrogenase complex (OGDHC) with an estimated IC50 3.93 [3.70-4.17] mM, which is pharmacologically plausible since it corresponds to micromolar extracellular concentrations. Increasing the lipophilic character of the used TPP+ compound further potentiates the inhibition of OGDHC activity. This effect of TPMP on the Krebs cycle ought to be taken into account when interpreting observations on cells and mitochondria in the presence of TPP+ derivatives. Compounds based on or similar to TPP+ derivatives may also be used to alter OGDHC activity for experimental or therapeutic purposes.	[Elkalaf, Moustafa; Trnka, Jan] Charles Univ Prague, Fac Med 3, Lab Metab & Bioenerget, Prague, Czech Republic; [Tuma, Petr; Trnka, Jan] Charles Univ Prague, Fac Med 3, Dept Biochem Cell & Mol Biol, Prague, Czech Republic; [Weiszenstein, Martin; Polak, Jan] Charles Univ Prague, Fac Med 3, Dept Sport Med, Prague, Czech Republic; [Elkalaf, Moustafa; Tuma, Petr; Weiszenstein, Martin; Polak, Jan; Trnka, Jan] Charles Univ Prague, Fac Med 3, Ctr Res Diabet Metab & Nutr, Prague, Czech Republic	Charles University Prague; Charles University Prague; Charles University Prague; Charles University Prague	Trnka, J (corresponding author), Charles Univ Prague, Fac Med 3, Lab Metab & Bioenerget, Prague, Czech Republic.; Trnka, J (corresponding author), Charles Univ Prague, Fac Med 3, Dept Biochem Cell & Mol Biol, Prague, Czech Republic.; Trnka, J (corresponding author), Charles Univ Prague, Fac Med 3, Ctr Res Diabet Metab & Nutr, Prague, Czech Republic.	jan.trnka@lf3.cuni.cz	Tuma, Petr/B-7868-2014; Trnka, Jan/B-8951-2012; Elkalaf, Moustafa/AAL-4938-2020; Polak, Jan/J-3404-2014	Tuma, Petr/0000-0003-3489-9547; Trnka, Jan/0000-0002-1786-7562; Elkalaf, Moustafa/0000-0002-0418-2732; Polak, Jan/0000-0001-9964-652X	Charles University in Prague (Univerzita Karlova v Praze) [PRVOUK-P31, UNCE 204015/2012, 260042/SVV/2014, 260165/SVV/2015]	Charles University in Prague (Univerzita Karlova v Praze)	This work was supported by grants PRVOUK-P31, UNCE 204015/2012, 260042/SVV/2014 and 260165/SVV/2015 from Charles University in Prague (Univerzita Karlova v Praze). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonenko YN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061902; Asin-Cayuela J, 2004, FEBS LETT, V571, P9, DOI 10.1016/j.febslet.2004.06.045; Brand M. D., 1995, BIOENERGETICS, V154, P62; BROWN GC, 1985, BIOCHEM J, V225, P399, DOI 10.1042/bj2250399; CHEN FR, 1963, BIOCHEMISTRY-US, V2, P1023, DOI 10.1021/bi00905a020; Cocheme HM, 2012, NAT PROTOC, V7, P946, DOI 10.1038/nprot.2012.035; COOPERSTEIN SJ, 1951, J BIOL CHEM, V189, P665; Elkalaf M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070772; Floryk D, 1999, BIOSCIENCE REP, V19, P27, DOI 10.1023/A:1020193906974; FRICKE W, 1992, J EXP BOT, V43, P1515, DOI 10.1093/jxb/43.11.1515; Goncalves S, 2010, BMC BIOCHEM, V11, DOI 10.1186/1471-2091-11-5; GRINIUS LL, 1970, BIOCHIM BIOPHYS ACTA, V216, P1, DOI 10.1016/0005-2728(70)90153-2; HECKERT LL, 1989, J GEN MICROBIOL, V135, P155; Janssen AJM, 2007, CLIN CHEM, V53, P729, DOI 10.1373/clinchem.2006.078873; Johnson G, 2006, AM J PHYSIOL-ENDOC M, V291, pE460, DOI 10.1152/ajpendo.00258.2005; Kelso GF, 2012, CHEM BIOL, V19, P1237, DOI 10.1016/j.chembiol.2012.08.005; Kelso GF, 2001, J BIOL CHEM, V276, P4588, DOI 10.1074/jbc.M009093200; Lee I, 2001, BIOL CHEM, V382, P1629, DOI 10.1515/BC.2001.198; Leo S, 2008, ANN NY ACAD SCI, V1147, P264, DOI 10.1196/annals.1427.019; LIBERMAN EA, 1969, NATURE, V222, P1076, DOI 10.1038/2221076a0; Luo C, 2008, CLIN CHIM ACTA, V395, P38, DOI 10.1016/j.cca.2008.04.025; Murphy MP, 1997, TRENDS BIOTECHNOL, V15, P326, DOI 10.1016/S0167-7799(97)01068-8; Nicholls DG, 2012, METHODS MOL BIOL, V810, P119, DOI 10.1007/978-1-61779-382-0_8; O'Malley Y, 2006, J BIOL CHEM, V281, P39766, DOI 10.1074/jbc.M608268200; Ojovan SM, 2011, J BIOENERG BIOMEMBR, V43, P175, DOI 10.1007/s10863-011-9345-8; Plecita-Hlavata L, 2009, INT J BIOCHEM CELL B, V41, P1697, DOI 10.1016/j.biocel.2009.02.015; Qi F, 2011, BMC BIOCHEM, V12, DOI 10.1186/1471-2091-12-53; Rasmussen UF, 2000, MOL CELL BIOCHEM, V208, P37, DOI 10.1023/A:1007046028132; Reily C, 2013, REDOX BIOL, V1, P86, DOI 10.1016/j.redox.2012.11.009; Robinson KM, 2006, P NATL ACAD SCI USA, V103, P15038, DOI 10.1073/pnas.0601945103; Ross MF, 2008, BIOCHEM J, V411, P633, DOI 10.1042/BJ20080063; Ross MF, 2005, BIOCHEMISTRY-MOSCOW+, V70, P222, DOI 10.1007/s10541-005-0104-5; Salabei JK, 2014, NAT PROTOC, V9, P421, DOI 10.1038/nprot.2014.018; Sauer SW, 2005, J BIOL CHEM, V280, P21830, DOI 10.1074/jbc.M502845200; Scaduto RC, 1999, BIOPHYS J, V76, P469, DOI 10.1016/S0006-3495(99)77214-0; Severin FF, 2010, P NATL ACAD SCI USA, V107, P663, DOI 10.1073/pnas.0910216107; Sheu KFR, 1999, ANN NY ACAD SCI, V893, P61; Smith RAJ, 1999, EUR J BIOCHEM, V263, P709, DOI 10.1046/j.1432-1327.1999.00543.x; Smith RAJ, 2012, TRENDS PHARMACOL SCI, V33, P341, DOI 10.1016/j.tips.2012.03.010; Spinazzi M, 2012, NAT PROTOC, V7, P1235, DOI 10.1038/nprot.2012.058; Trendeleva TA, 2012, BIOCHEMISTRY-MOSCOW+, V77, P1021, DOI 10.1134/S000629791209009X; Trnka J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121837; Trnka J, 2009, FREE RADICAL RES, V43, P4, DOI 10.1080/10715760802582183; Trounce I A, 1996, Methods Enzymol, V264, P484, DOI 10.1016/S0076-6879(96)64044-0; Tuma P, 2011, ANAL CHIM ACTA, V685, P84, DOI 10.1016/j.aca.2010.11.007; Tuma P, 2010, J SEP SCI, V33, P2394, DOI 10.1002/jssc.201000137; Wu M, 2007, AM J PHYSIOL-CELL PH, V292, pC125, DOI 10.1152/ajpcell.00247.2006	47	7	7	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0161413	10.1371/journal.pone.0161413	http://dx.doi.org/10.1371/journal.pone.0161413			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27537184	Green Published, Green Submitted, gold			2022-12-27	WOS:000381577000104
J	He, L; Yuan, J; Xu, QY; Chen, RX; Chen, LG; Fang, MX				He, Ling; Yuan, Jing; Xu, Qingyun; Chen, Ruixue; Chen, Liguo; Fang, Meixia			miRNA-1283 Regulates the PERK/ATF4 Pathway in Vascular Injury by Targeting ATF4	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; CIRCULATING ENDOTHELIAL-CELLS; UNFOLDED PROTEIN RESPONSE; VON-WILLEBRAND-FACTOR; INFLAMMATION; HYPERTENSION; EXPRESSION	Background In our previous study, we found significant differences in the mRNA and microRNA (miRNA) levels among hypertensive patients with different degrees of vascular endothelial cells damage. These differences were closely associated with endoplasmic reticulum stress (ERS)-related proteins. Moreover, compared to the control group, the expression of transcription factor activating factor 4 (ATF4) was also found to be significantly different in the hypertensive patients with different degrees of vascular endothelial cells damage groups. These results were confirmed using gene prediction software, which showed synergistic effects between ATF4 and miR-1283. ATF4 is a key molecule in ERS. Three ERS pathways exist: protein kinase RNA-like ER kinase (PERK), activating transcription factor 6 (ATF6) and inositol-requiring enzyme-1 (IRE-1)-induced apoptosis. The PERK pathway is the most important and also includes the phosphorylation of eukaryotic translation initiation factor 2 alpha (eIF2 alpha) and ATF4. In this report, we studied the regulatory effects of miR-1283 and ATF4 on the PERK-eIF2 alpha-ATF4 signaling pathway using human umbilical vein endothelial cells (HUVECs) and mice. Methodology/Principal Findings We verified the relationship between miR-1283 and ATF4 using a luciferase activity assay and observed the regulatory effects of miR-1283 and ATF4 on the PERK-eIF2 alpha-ATF4 signaling pathway in vivo and in vitro. Conclusions/Significance ATF4 is a target gene of miR-1283, which regulates the PERK-eIF2 alpha-ATF4 signaling pathway by inhibiting ATF4, and it plays a critical role in inducing injury in HUVECs and mouse heart tissue.	[He, Ling; Yuan, Jing; Xu, Qingyun; Chen, Ruixue; Chen, Liguo] Jinan Univ, Dept Chinese Med, Coll Med, Guangzhou 510632, Guangdong, Peoples R China; [Fang, Meixia] Jinan Univ, Inst Lab Anim, Guangzhou 510632, Guangdong, Peoples R China	Jinan University; Jinan University	Chen, LG (corresponding author), Jinan Univ, Dept Chinese Med, Coll Med, Guangzhou 510632, Guangdong, Peoples R China.; Fang, MX (corresponding author), Jinan Univ, Inst Lab Anim, Guangzhou 510632, Guangdong, Peoples R China.	tchenly@jnu.edu.cn; fangmx1979@163.com		Chen, Ruixue/0000-0003-3347-2584	National Natural Science Foundation of China [81173157]; National Natural Science Foundation of Guangdong [10151063201000045]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of Guangdong(National Natural Science Foundation of Guangdong Province)	This study was supported by the National Natural Science Foundation of China (No. 81173157), and the National Natural Science Foundation of Guangdong (No. 10151063201000045).; This study was supported by the National Natural Science Foundation of China (Nos. 81173157), and the National Natural Science Foundation of Guangdong (Nos. 10151063201000045). The fund certificates are showed in S1 File.	Behrman S, 2011, J CELL BIOL, V192, P919, DOI 10.1083/jcb.201010055; Byrd AE, 2012, J CELL BIOL, V196, P689, DOI 10.1083/jcb.201201077; Chong AY, 2006, EUR J HEART FAIL, V8, P167, DOI 10.1016/j.ejheart.2005.06.010; Dai RY, 2010, BIOL CHEM, V391, P791, DOI 10.1515/BC.2010.072; Ding J, 2010, J APPLIDCLINICAL PED, V31, P1013; Fernandez JA, 2006, J IMMUNOL METHODS, V314, P174, DOI 10.1016/j.jim.2006.05.004; Guan HS, 2010, ADV CARDIOVASCULAR D, V5, P669; He L, 2016, J TRADIT CHIN MED, V36, P173; [何铃 He Ling], 2015, [中国病理生理杂志, Chinese Journal of Pathophysiology], V31, P817; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Kang EB, 2013, APOPTOSIS, V18, P1332, DOI 10.1007/s10495-013-0884-9; Lee KW, 2006, INT J CARDIOL, V111, P302, DOI 10.1016/j.ijcard.2005.10.014; [李载权 Li Zaiquan], 2004, [中国生物化学与分子生物学报, Chinese Journal of Biochemistry and Molecular Biology], V20, P283; Liu XH, 2010, CHINESE J PATHOPHYSI, V26, P1964; Mei Y, 2013, PHARM BIOMED ANAL, V1, P1; [秦明春 Qin Mingchun], 2014, [时珍国医国药, Lishizhen Medicine and Materia Medica Research], V25, P2016; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Simioni P, 2006, THROMB RES, V117, P523, DOI 10.1016/j.thromres.2005.04.029; Wu Q, 2014, CELL BIOL INT, V38, P881, DOI 10.1002/cbin.10272; Yang SB, 2015, FEBS LETT, V589, P2087, DOI 10.1016/j.febslet.2015.06.029; Zeng W, 2014, LIFE SCI, V103, P15, DOI 10.1016/j.lfs.2014.03.007; Zhang JG, 2014, BIOMED REP, V2, P233, DOI 10.3892/br.2014.225	22	22	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0159171	10.1371/journal.pone.0159171	http://dx.doi.org/10.1371/journal.pone.0159171			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27537404	Green Published, gold, Green Submitted			2022-12-27	WOS:000381577000007
J	Latasa, C; Echeverz, M; Garcia, B; Gil, C; Garcia-Ona, E; Burgui, S; Casares, N; Hervas-Stubbs, S; Lasarte, JJ; Lasa, I; Solano, C				Latasa, Cristina; Echeverz, Maite; Garcia, Begona; Gil, Carmen; Garcia-Ona, Enrique; Burgui, Saioa; Casares, Noelia; Hervas-Stubbs, Sandra; Jose Lasarte, Juan; Lasa, Inigo; Solano, Cristina			Evaluation of a Salmonella Strain Lacking the Secondary Messenger C-di-GMP and RpoS as a Live Oral Vaccine	PLOS ONE			English	Article							ENTERICA SEROVAR TYPHIMURIUM; ESCHERICHIA-COLI; BIOFILM FORMATION; IMMUNE-RESPONSE; CYCLIC DIGUANYLATE; MARKER VACCINE; IFN-GAMMA; VIRULENCE; BACTERIAL; CELLULOSE	Salmonellosis is one of the most important bacterial zoonotic diseases transmitted through the consumption of contaminated food, with chicken and pig related products being key reservoirs of infection. Although numerous studies on animal vaccination have been performed in order to reduce Salmonella prevalence, there is still a need for an ideal vaccine. Here, with the aim of constructing a novel live attenuated Salmonella vaccine candidate, we firstly analyzed the impact of the absence of cyclic-di-GMP (c-di-GMP) in Salmonella virulence. C-di-GMP is an intracellular second messenger that controls a wide range of bacterial processes, including biofilm formation and synthesis of virulence factors, and also modulates the host innate immune response. Our results showed that a Salmonella multiple mutant in the twelve genes encoding diguanylate cyclase proteins that, as a consequence, cannot synthesize c-di-GMP, presents a moderate attenuation in a systemic murine infection model. An additional mutation of the rpoS gene resulted in a synergic attenuating effect that led to a highly attenuated strain, referred to as Delta XIII, immunogenic enough to protect mice against a lethal oral challenge of a S. Typhimurium virulent strain. Delta XIII immunogenicity relied on activation of both antibody and cell mediated immune responses characterized by the production of opsonizing antibodies and the induction of significant levels of IFN-gamma, TNF-alpha, IL-2, IL-17 and IL-10. Delta XIII was unable to form a biofilm and did not survive under desiccation conditions, indicating that it could be easily eliminated from the environment. Moreover, Delta XIII shows DIVA features that allow differentiation of infected and vaccinated animals. Altogether, these results show Delta XIII as a safe and effective live DIVA vaccine.	[Latasa, Cristina; Echeverz, Maite; Garcia, Begona; Gil, Carmen; Garcia-Ona, Enrique; Burgui, Saioa; Lasa, Inigo; Solano, Cristina] Univ Publ Navarra CSIC Gobierno Navarra, Lab Microbial Biofilms, Inst Agrobiotecnol Idab, Pamplona, Spain; [Latasa, Cristina] Recombina SL Mutilva, Navarra, Spain; [Casares, Noelia; Hervas-Stubbs, Sandra; Jose Lasarte, Juan] Univ Navarra, Inst Invest Sanitaria Navarra IdISNA, Program Immunol & Immunotherapy, Ctr Appl Med Res CIMA, Pamplona, Spain; [Lasa, Inigo] Navarrabiomed Univ Publ Navarra, Inst Invest Sanitaria Navarra IdISNA, Pamplona, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-GN-UPNA - Instituto de Agrobiotecnologia (IDAB); Universidad Publica de Navarra; University of Navarra; Navarrabiomed	Lasa, I; Solano, C (corresponding author), Univ Publ Navarra CSIC Gobierno Navarra, Lab Microbial Biofilms, Inst Agrobiotecnol Idab, Pamplona, Spain.; Lasa, I (corresponding author), Navarrabiomed Univ Publ Navarra, Inst Invest Sanitaria Navarra IdISNA, Pamplona, Spain.	ilasa@unavarra.es; cristina.solano@unavarra.es	Lasa, Iñigo/F-2947-2011; Echeverz, Maite/H-6471-2017; Solano, Cristina/ABG-8407-2020; Lasarte, Juan José/AAN-6548-2020; Garcia, Begoña/I-8051-2012; Burgui, Saioa/V-5868-2019; Solano, Cristina/F-9607-2011; Gil, Carmen/K-3759-2017; Casares, Noelia/AAA-5568-2019; Hervas-Stubbs, Sandra/C-9053-2018	Lasa, Iñigo/0000-0002-6625-9221; Echeverz, Maite/0000-0002-4153-4549; Solano, Cristina/0000-0002-6207-1766; Lasarte, Juan José/0000-0003-1641-3881; Garcia, Begoña/0000-0002-0476-4900; Burgui, Saioa/0000-0002-3601-7221; Solano, Cristina/0000-0002-6207-1766; Gil, Carmen/0000-0002-8867-4442; Casares, Noelia/0000-0003-3817-6434; Hervas-Stubbs, Sandra/0000-0003-3391-1516	Departamento de Innovacion, Empresa y Empleo, Government of Navarra [IIM 13329.RI1]; Spanish Ministry of Economy and Competitiveness [BIO2011-30503-C02-02, BIO2014-53530-R]	Departamento de Innovacion, Empresa y Empleo, Government of Navarra; Spanish Ministry of Economy and Competitiveness(Spanish Government)	SB is a predoctoral fellow from the Public University of Navarra. CG and BG are recipients of a postdoctoral contract under Grants IIM 13329.RI1 and BIO2011-30503-C02-02, respectively. This work was supported by grant IIM 13329.RI1 from the Departamento de Innovacion, Empresa y Empleo, Government of Navarra and grants BIO2011-30503-C02-02 and BIO2014-53530-R from the Spanish Ministry of Economy and Competitiveness. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Recombina S.L. provided support in the form of salaries for author CL, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Ahmad I, 2013, MOL MICROBIOL, V90, P1216, DOI 10.1111/mmi.12428; Ahmad I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028351; Allombert J, 2014, INFECT IMMUN, V82, P1222, DOI 10.1128/IAI.01077-13; Argello H, 2012, SALMONELLA - DISTRIBUTION, ADAPTATION, CONTROL MEASURES AND MOLECULAR TECHNOLOGIES, P99; Bohez L, 2008, VET MICROBIOL, V126, P216, DOI 10.1016/j.vetmic.2007.06.025; Burdette DL, 2011, NATURE, V478, P515, DOI 10.1038/nature10429; Chaveroche MK, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.22.e97; Cyktor JC, 2011, INFECT IMMUN, V79, P2964, DOI 10.1128/IAI.00047-11; Denagamage TN, 2007, FOODBORNE PATHOG DIS, V4, P539, DOI 10.1089/fpd.2007.0013; Desin TS, 2013, EXPERT REV VACCINES, V12, P87, DOI [10.1586/ERV.12.138, 10.1586/erv.12.138]; Dougan G, 2011, IMMUNOL REV, V240, P196, DOI 10.1111/j.1600-065X.2010.00999.x; Doyle ME, 2015, FOODBORNE PATHOG DIS, V12, P261, DOI 10.1089/fpd.2014.1865; FANG FC, 1992, P NATL ACAD SCI USA, V89, P11978, DOI 10.1073/pnas.89.24.11978; Figueira R, 2013, MBIO, V4, DOI 10.1128/mBio.00065-13; Flo TH, 2004, NATURE, V432, P917, DOI 10.1038/nature03104; Garcia B, 2004, MOL MICROBIOL, V54, P264, DOI 10.1111/j.1365-2958.2004.04269.x; Goetz DH, 2002, MOL CELL, V10, P1033, DOI 10.1016/S1097-2765(02)00708-6; Gonzalez-Zorn B, 2012, INT MICROBIOL, V15, P101, DOI 10.2436/20.1501.01.163; Henderson LM, 2005, BIOLOGICALS, V33, P203, DOI 10.1016/j.biologicals.2005.08.006; Jouanguy E, 1999, CURR OPIN IMMUNOL, V11, P346, DOI 10.1016/S0952-7915(99)80055-7; Karasova D, 2009, VACCINE, V27, P5265, DOI 10.1016/j.vaccine.2009.06.060; Kong W, 2012, P NATL ACAD SCI USA, V109, P19414, DOI 10.1073/pnas.1217554109; Kulesekara H, 2006, P NATL ACAD SCI USA, V103, P2839, DOI 10.1073/pnas.0511090103; Leyman B, 2012, VET J, V194, P250, DOI 10.1016/j.tvjl.2012.04.011; Leyman B, 2011, VACCINE, V29, P3679, DOI 10.1016/j.vaccine.2011.03.004; Li WH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9330; Lo WF, 2004, INFECT IMMUN, V72, P2843, DOI 10.1128/IAI.72.5.2843-2849.2004; Mastroeni P, 2003, J MED MICROBIOL, V52, P453, DOI 10.1099/jmm.0.05173-0; MASTROENI P, 1993, INFECT IMMUN, V61, P3981, DOI 10.1128/IAI.61.9.3981-3984.1993; Mastroeni P, 2000, INFECT IMMUN, V68, P46, DOI 10.1128/IAI.68.1.46-53.2000; Matulova M, 2012, VACCINE, V30, P2090, DOI 10.1016/j.vaccine.2012.01.050; MCKENNA AJ, 1995, MICROBIOL-UK, V141, P1993, DOI 10.1099/13500872-141-8-1993; Methner U, 2011, ZOONOSES PUBLIC HLTH, V58, P540, DOI 10.1111/j.1863-2378.2011.01400.x; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; Moe-Behrens GG, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00005; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; MUOTIALA A, 1990, MICROB PATHOGENESIS, V8, P135, DOI 10.1016/0882-4010(90)90077-4; OCALLAGHAN D, 1990, IMMUNOLOGY, V69, P184; Parvatiyar K, 2012, NAT IMMUNOL, V13, P1155, DOI 10.1038/ni.2460; Pontes MH, 2015, P NATL ACAD SCI USA, V112, P5183, DOI 10.1073/pnas.1500989112; Povolotsky TL, 2012, J BIOTECHNOL, V160, P10, DOI 10.1016/j.jbiotec.2011.12.024; Raffatellu M, 2008, NAT MED, V14, P421, DOI 10.1038/nm1743; Romling U, 1998, J BACTERIOL, V180, P722; Romling U, 2013, MICROBIOL MOL BIOL R, V77, P1, DOI 10.1128/MMBR.00043-12; Rubino SJ, 2012, TRENDS IMMUNOL, V33, P112, DOI 10.1016/j.it.2012.01.003; Schulte LN, 2011, EMBO J, V30, P1977, DOI 10.1038/emboj.2011.94; Selke M, 2007, INFECT IMMUN, V75, P2476, DOI 10.1128/IAI.01908-06; Shang F, 2009, INFECT IMMUN, V77, P2849, DOI 10.1128/IAI.01405-08; Simon R, 2011, VACCINE, V29, P5094, DOI 10.1016/j.vaccine.2011.05.022; Singh BR, 2009, OPEN VAC J, V2, P100, DOI DOI 10.2174/1875035400902010100; Solano C, 2002, MOL MICROBIOL, V43, P793, DOI 10.1046/j.1365-2958.2002.02802.x; Solano C, 1998, J CLIN MICROBIOL, V36, P674, DOI 10.1128/JCM.36.3.674-678.1998; Solano C, 2009, P NATL ACAD SCI USA, V106, P7997, DOI 10.1073/pnas.0812573106; Spurbeck RR, 2013, J BACTERIOL, V195, P3156, DOI 10.1128/JB.02254-12; Stewart MK, 2011, P NATL ACAD SCI USA, V108, P20742, DOI 10.1073/pnas.1108963108; Tamayo R, 2007, ANNU REV MICROBIOL, V61, P131, DOI 10.1146/annurev.micro.61.080706.093426; Valle J, 2013, TRENDS MICROBIOL, V21, P364, DOI 10.1016/j.tim.2013.05.008; VanCott JL, 1998, NAT MED, V4, P1247, DOI 10.1038/3227; Voinnet O, 2011, EMBO J, V30, P1877, DOI 10.1038/emboj.2011.134; White AP, 2006, J BACTERIOL, V188, P3219, DOI 10.1128/JB.188.9.3219-3227.2006; Woodward JJ, 2010, SCIENCE, V328, P1703, DOI 10.1126/science.1189801; Yang FH, 2014, MOL PLANT MICROBE IN, V27, P578, DOI 10.1094/MPMI-12-13-0371-R; Zorraquino V, 2013, J BACTERIOL, V195, P417, DOI 10.1128/JB.01789-12	63	8	8	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0161216	10.1371/journal.pone.0161216	http://dx.doi.org/10.1371/journal.pone.0161216			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27537839	Green Published, Green Submitted, gold			2022-12-27	WOS:000381577000069
J	Dourado, PM; Bacalhau, FB; Amado, D; Carvalho, RA; Martinelli, S; Head, GP; Omoto, C				Dourado, Patrick M.; Bacalhau, Fabiana B.; Amado, Douglas; Carvalho, Renato A.; Martinelli, Samuel; Head, Graham P.; Omoto, Celso			High Susceptibility to Cry1Ac and Low Resistance Allele Frequency Reduce the Risk of Resistance of Helicoverpa armigers to Bt Soybean in Brazil	PLOS ONE			English	Article							PUNCTIGERA WALLENGREN LEPIDOPTERA; FIELD-EVOLVED RESISTANCE; BASE-LINE-SUSCEPTIBILITY; BACILLUS-THURINGIENSIS; INSECT RESISTANCE; HUBNER LEPIDOPTERA; TRANSGENIC CROPS; NOCTUIDAE; COTTON; MANAGEMENT	The Old World bollworm, Helicoverpa armigera (Hubner), was recently introduced into Brazil, where it has caused extensive damage to cotton and soybean crops. MON 87701 x MON 89788 soybean, which expresses the Bt protein Cry1Ac, was recently deployed in Brazil, providing high levels of control against H. armigera. To assess the risk of resistance to the Cry1Ac protein expressed by MON 87701 x MON 89788 soybean in Brazil, we conducted studies to evaluate the baseline susceptibility of H. armigera to Cry1Ac, in planta efficacy including the assessment of the high-dose criterion, and the initial resistance allele frequency based on an F-2 screen. The mean Cry1Ac lethal concentration (LC50) ranged from 0.11 to 1.82 mu g.mL(-1) of diet among all H. armigera field populations collected from crop seasons 2013/14 to 2014/15, which indicated about 16.5-fold variation. MON 87701 x MON 89788 soybean exhibited a high level of efficacy against H. armigera and most likely met the high dose criterion against this target species in leaf tissue dilution bioassays up to 50 times. A total of 212 F2 family lines of H. armigera were established from field collections sampled from seven locations across Brazil and were screened for the presence of MON 87701 x MON 89788 soybean resistance alleles. None of the 212 families survived on MON 87701 x MON 89788 soybean leaf tissue (estimated allele frequency = 0.0011). The responses of H. armigera to Cry1Ac protein, high susceptibility to MON 87701 x MON 89788 soybean, and low frequency of resistance alleles across the main soybean-producing regions support the assumptions of a high-dose/refuge strategy. However, maintenance of reasonable compliance with the refuge recommendation will be essential to delay the evolution of resistance in H. armigera to MON 87701 x MON 89788 soybean in Brazil.	[Dourado, Patrick M.; Amado, Douglas; Omoto, Celso] Univ Sao Paulo, Escola Super Agr Luiz de Queiroz, Dept Entomol & Acarol, Sao Paulo, Brazil; [Dourado, Patrick M.; Bacalhau, Fabiana B.; Carvalho, Renato A.] Monsanto Brasil Ltda, Sao Paulo, Brazil; [Martinelli, Samuel; Head, Graham P.] Monsanto LLC, St Louis, MO USA	Universidade de Sao Paulo; Monsanto; Monsanto	Dourado, PM (corresponding author), Univ Sao Paulo, Escola Super Agr Luiz de Queiroz, Dept Entomol & Acarol, Sao Paulo, Brazil.; Dourado, PM (corresponding author), Monsanto Brasil Ltda, Sao Paulo, Brazil.	patrick.m.dourado@monsanto.com	Omoto, Celso/D-9794-2012; Amado, Douglas/U-9426-2018	Omoto, Celso/0000-0002-6432-830X; Amado, Douglas/0000-0003-2982-5404; Dourado, Patrick/0000-0001-8587-3561; Head, Graham/0000-0003-0521-0616	Monsanto	Monsanto	Monsanto provided support in the form of salaries for PMD, FBB, RAC, SM and GPH, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albernaz KC, 2013, J ECON ENTOMOL, V106, P1819, DOI 10.1603/EC12222; Ali MI, 2009, J ECON ENTOMOL, V102, P1935, DOI 10.1603/029.102.0526; Andow DA, 1998, J ECON ENTOMOL, V91, P572, DOI 10.1093/jee/91.3.572; [Anonymous], 2015, OLD WORLD BOLLWORM F, V20, P18; Azambuja R, 2015, EFFECT BT SOYBEAN LA, V7; Barros Ricardo, 2012, Cientifica (Jaboticabal), V40, P117; Behere GT, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-117; Bernardi O, 2014, PEST MANAG SCI, V70, P588, DOI 10.1002/ps.3581; Bernardi O, 2012, PEST MANAG SCI, V68, P1083, DOI 10.1002/ps.3271; Bird LJ, 2007, J INVERTEBR PATHOL, V94, P84, DOI 10.1016/j.jip.2006.08.005; Blanco CA, 2009, J ECON ENTOMOL, V102, P381, DOI 10.1603/029.102.0149; Brevault T, 2009, J ECON ENTOMOL, V102, P2301, DOI 10.1603/029.102.0636; Comissao Tecnica Nacional de Biosseguranca (CTNBio), TECHN OP 2542 2010; Conte L, 2006, THESIS; Cunningham JP, 2014, J ECON ENTOMOL, V107, P881, DOI 10.1603/EC14036; Czepak Cecília, 2013, Pesqui. Agropecu. Trop., V43, P110, DOI 10.1590/S1983-40632013000100015; Dhurua S, 2011, PEST MANAG SCI, V67, P898, DOI 10.1002/ps.2127; Downes Sharon, 2012, GM Crops Food, V3, P228, DOI 10.4161/gmcr.20194; Downes S, 2012, J INVERTEBR PATHOL, V110, P281, DOI 10.1016/j.jip.2012.04.005; Farias JR, 2014, CROP PROT, V64, P150, DOI 10.1016/j.cropro.2014.06.019; Fathipour Y., 2013, SOYBEAN PEST RESISTA, P231, DOI DOI 10.5772/54522; Ffrench-Constant R.H., 1990, PESTICIDE RESISTANCE, P4, DOI [10.1007/978-1-4684-6429-0_2, DOI 10.1007/978-1-4684-6429-0_2]; FITT GP, 1989, ANNU REV ENTOMOL, V34, P17, DOI 10.1146/annurev.en.34.010189.000313; Gassmann AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022629; Gould F, 1998, ANNU REV ENTOMOL, V43, P701, DOI 10.1146/annurev.ento.43.1.701; Greenplate JT, 2003, J APPL ENTOMOL, V127, P340, DOI 10.1046/j.1439-0418.2003.00766.x; Gujar GT, 2007, J INVERTEBR PATHOL, V95, P214, DOI 10.1016/j.jip.2007.03.011; HALLIDAY WR, 1990, J ECON ENTOMOL, V83, P1151, DOI 10.1093/jee/83.4.1151; Head G, 2010, J APPL ECOL, V47, P583, DOI 10.1111/j.1365-2664.2010.01796.x; Head Graham P, 2012, GM Crops Food, V3, P144, DOI 10.4161/gmcr.20743; Huang FN, 2011, PEST MANAG SCI, V67, P1269, DOI 10.1002/ps.2182; Huang FN, 2011, ENTOMOL EXP APPL, V140, P1, DOI 10.1111/j.1570-7458.2011.01138.x; Jalali SK, 2004, CROP PROT, V23, P53, DOI 10.1016/S0261-2194(03)00170-4; Jin L, 2015, NAT BIOTECHNOL, V33, P169, DOI 10.1038/nbt.3100; Kasten Jr P., 1978, REV AGR, V53, P69; Kranthi K. R., 2001, International Journal of Pest Management, V47, P141, DOI 10.1080/09670870151130651; Kranthi KR, 2002, CROP PROT, V21, P449, DOI 10.1016/S0261-2194(01)00131-4; Kriticos DJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119618; Leite NA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113286; Llewellyn DJ, 2007, AGR FOREST ENTOMOL, V9, P93, DOI 10.1111/j.1461-9563.2007.00332.x; Luttrell RG, 1999, J ECON ENTOMOL, V92, P21, DOI 10.1093/jee/92.1.21; Macrae TC, 2005, J ECON ENTOMOL, V98, P577, DOI 10.1603/0022-0493-98.2.577; Mastrangelo T, 2014, J ECON ENTOMOL, V107, P970, DOI 10.1603/EC13403; McPherson RM, 2009, J ECON ENTOMOL, V102, P1640, DOI 10.1603/029.102.0431; NAPPO. North American Plant Protection Organizations Phytosanitary Alert System, 2014, DET OLD WORLD BOLLW; Omoto C, 2016, PEST MANAG SCI; Pogue MG, 2004, ANN ENTOMOL SOC AM, V97, P1222, DOI 10.1603/0013-8746(2004)097[1222:ANSOHZ]2.0.CO;2; Producao Agriola Municipal, 2012, QUANT PROD VAL PROD; Robertson J.L., 2007, BIOASSAYS ARTHROPODS, V2nd; Roush RT, 1997, PESTIC SCI, V51, P328, DOI 10.1002/(SICI)1096-9063(199711)51:3&lt;328::AID-PS650&gt;3.0.CO;2-B; ROUSH RT, 1986, J ECON ENTOMOL, V79, P293, DOI 10.1093/jee/79.2.293; Sosa-Gomez DR, REV BRASILEIRA ENTOM; Specht A, 2013, PESQUI AGROPECU BRAS, V48, P689, DOI 10.1590/S0100-204X2013000600015; Storer NP, 2010, J ECON ENTOMOL, V103, P1031, DOI 10.1603/EC10040; Tabashnik BE, 2004, J EVOLUTION BIOL, V17, P904, DOI 10.1111/j.1420-9101.2004.00695.x; Tabashnik BE, 2013, NAT BIOTECHNOL, V31, P510, DOI 10.1038/nbt.2597; Tabashnik BE, 2009, J ECON ENTOMOL, V102, P2011, DOI 10.1603/029.102.0601; TAY WT, 2013, PLOS ONE, V8; van Rensburg J. B. J., 2007, South African Journal of Plant and Soil, V24, P147; WILSON FD, 1992, J ECON ENTOMOL, V85, P1516, DOI 10.1093/jee/85.4.1516; Wu KM, 1999, J ECON ENTOMOL, V92, P273, DOI 10.1093/jee/92.2.273; Wu KM, 2005, ANNU REV ENTOMOL, V50, P31, DOI 10.1146/annurev.ento.50.071803.130349; Wu KM, 2002, J ECON ENTOMOL, V95, P832, DOI 10.1603/0022-0493-95.4.832; Wu KM, 2008, SCIENCE, V321, P1676, DOI 10.1126/science.1160550; Yang YH, 2013, J ECON ENTOMOL, V106, P375, DOI 10.1603/EC12286; Yano SA, 2015, PEST MANAG SCI; Yu HL, 2013, PEST MANAG SCI, V69, P1326, DOI 10.1002/ps.3508; ZALUCKI MP, 1986, AUST J ZOOL, V34, P779, DOI 10.1071/ZO9860779; Zalucki Myron P., 2005, Insect Science, V12, P45, DOI 10.1111/j.1672-9609.2005.00007.x; Zhang HN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022874	70	27	28	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2016	11	8							e0161388	10.1371/journal.pone.0161388	http://dx.doi.org/10.1371/journal.pone.0161388			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4YN	27532632	gold, Green Published			2022-12-27	WOS:000381487600090
J	Riedl, R; Robausch, M; Berghold, A				Riedl, Regina; Robausch, Martin; Berghold, Andrea			The Evaluation of the Effectiveness of Austrians Disease Management Program in Patients with Type 2 Diabetes Mellitus - A Population-Based Retrospective Cohort Study	PLOS ONE			English	Article							MULTIDISCIPLINARY RISK-ASSESSMENT; PRIMARY-CARE; PROPENSITY-SCORE; RAMP-DM; OUTCOMES; BENEFIT; EFFICIENCY	Aim To evaluate the effectiveness of the Austrian Disease Management Program (DMP) 'Therapie aktiv-Diabetes im Griff' for patients with type 2 diabetes mellitus concerning patient-relevant outcomes (mortality, myocardial infarction and stroke) and costs. Methods Based on routine health insurance data, we conducted a population-based retrospective cohort study using a propensity score (PS) matched control group design. The DMP-group consists of participants enrolled in the program during 2008 and 2009 (n = 7181). Out of 208.532 patients with no participation in the DMP up to 2013, PS-matched controls were selected with a matching ratio 1:3. In the PS-model, patient's characteristics, form of antidiabetic drug therapy, several prescriptions, the number of hospital admissions and days, main discharge diagnoses and costs at baseline were included. Results Over a follow-up period of four years, we observed a significantly lower mortality rate in the DMP-group (9.4%) in comparison with the control group (15.9%, p<0.001). The cumulative number of hospital days and mean annual hospital costs were lower for DMP-participants resulting in significantly lower mean annual total costs, amounting to (sic) 8226.80 per patient in the DMP-group and (sic) 9231.10 in the control group respectively (p<0.001). Conclusions The evaluation shows a survival benefit and an average reduction of costs for participants in the DMP compared with the control-group. Despite we took great effort to ensure comparable groups, we cannot entirely rule out an influence by residual and unmeasured confounding due to the observational study design and the use of routine data. However, the results indicate that the disease management program implemented in Austria improves quality of care for patients with type 2 diabetes mellitus.	[Riedl, Regina; Berghold, Andrea] Med Univ Graz, Inst Med Informat Stat & Documentat, Graz, Austria; [Robausch, Martin] Lower Austria Hlth Insurance Fund, Controlling Dept AIRCON, St Polten, Austria	Medical University of Graz	Berghold, A (corresponding author), Med Univ Graz, Inst Med Informat Stat & Documentat, Graz, Austria.	andrea.berghold@medunigraz.at			Styrian Health Insurance Fund for the DMP "Therapie aktiv - Diabetes im Griff"	Styrian Health Insurance Fund for the DMP "Therapie aktiv - Diabetes im Griff"	This study was funded by the Styrian Health Insurance Fund which is in charge for the DMP "Therapie aktiv - Diabetes im Griff". The funder provided support in the form of salaries for data extraction [MR] and for statistical analyses [RR], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of these authors is articulated in the 'author contributions' section.	Austin PC, 2014, STAT MED, V33, P4306, DOI 10.1002/sim.6276; Austin PC, 2009, STAT MED, V28, P3083, DOI 10.1002/sim.3697; Coca-Perraillon M, 2007, 1852007 SAS GLOB FOR; Conklin A, 2011, DIS MANAGEMENT EVALU; Drabik A, 2012, POPUL HEALTH MANAG, V15, P241, DOI 10.1089/pop.2011.0063; Efron Bradley, 1993, INTRO BOOTSTRAP, V57; Elissen AMJ, 2013, J EVAL CLIN PRACT, V19, P753, DOI 10.1111/j.1365-2753.2012.01817.x; Filzmoser P, 2009, ATC ICD DETERMINATIO; Flamm M, 2012, WIEN KLIN WOCHENSCHR, V124, P639, DOI 10.1007/s00508-012-0226-x; Fuchs S, 2014, DTSCH ARZTEBL INT, V111, P453, DOI 10.3238/arztebl.2014.0453; Fullerton B, 2012, DISMEVAL DEV VALIDAT, P69; Griebler R, 2013, ZIVILISATIONSKHEIT D; International Diabetes Federation, 2014, IDF DIAB ATL UPD POS; International Diabetes Federation, 2013, IDF DIABETES ATLAS; Jiao FF, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/s12933-014-0127-6; Jiao FF, 2015, CARDIOVASC DIABETOL, V14, DOI 10.1186/s12933-015-0267-3; Jonsson B, 2002, DIABETOLOGIA, V45, pS5, DOI 10.1007/s00125-002-0858-x; Kane R, 2000, HEALTH EDUC, V100, P33, DOI 10.1108/09654280010309030; Laxy M, 2015, DIABETOL METAB SYNDR, V7, DOI 10.1186/s13098-015-0065-9; LIN DY, 1989, J AM STAT ASSOC, V84, P1074, DOI 10.2307/2290085; Linder R, 2011, DTSCH ARZTEBL INT, V108, P155, DOI 10.3238/arztebl.2011.0155; Manning WG, 2005, J HEALTH ECON, V24, P465, DOI 10.1016/j.jhealeco.2004.09.011; Miksch A, 2010, AM J MANAG CARE, V16, P49; Nolte E, 2012, DEV VALIDATING DIS M; Ostermann H, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-490; Pimouguet C, 2011, CAN MED ASSOC J, V183, pE115, DOI 10.1503/cmaj.091786; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Schafer I, 2010, BMC HEALTH SERV RES, V10, DOI [10.1186/1472-6963-10-351, 10.1186/1472-6963-10-55]; Schang L, 2013, STRENGTHERING CARE C; Seuring T, 2015, PHARMACOECONOMICS, V33, P811, DOI 10.1007/s40273-015-0268-9; Sonnichsen AC, 2010, BMC FAM PRACT, V11, DOI 10.1186/1471-2296-11-86; Stock S, 2010, HEALTH AFFAIR, V29, P2197, DOI 10.1377/hlthaff.2009.0799; Tang TS, 2012, PREV CHRONIC DIS, V9, DOI 10.5888/pcd9.110313; Tang TS, 2010, PATIENT EDUC COUNS, V79, P178, DOI 10.1016/j.pec.2009.09.029; Wong CKH, 2015, DIABETES OBES METAB, V17, P128, DOI 10.1111/dom.12397; Wong CKH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095328; Zoungas S, 2014, DIABETOLOGIA, V57, P2465, DOI 10.1007/s00125-014-3369-7	37	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2016	11	8							e0161429	10.1371/journal.pone.0161429	http://dx.doi.org/10.1371/journal.pone.0161429			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DT4YN	27532885	Green Submitted, Green Published, gold			2022-12-27	WOS:000381487600093
J	Robert, MA; Christofferson, RC; Silva, NJB; Vasquez, C; Mores, CN; Wearing, HJ				Robert, Michael A.; Christofferson, Rebecca C.; Silva, Noah J. B.; Vasquez, Chalmers; Mores, Christopher N.; Wearing, Helen J.			Modeling Mosquito-Borne Disease Spread in US Urbanized Areas: The Case of Dengue in Miami	PLOS ONE			English	Article							AEDES-AEGYPTI DIPTERA; HUMAN MOVEMENT; HABITAT SEGREGATION; AIR-TRAVEL; VIRUS; CULICIDAE; ALBOPICTUS; DISPERSAL; TRANSMISSION; DYNAMICS	Expansion of mosquito-borne pathogens into more temperate regions of the world necessitates tools such as mathematical models for understanding the factors that contribute to the introduction and emergence of a disease in populations naive to the disease. Often, these models are not developed and analyzed until after a pathogen is detected in a population. In this study, we develop a spatially explicit stochastic model parameterized with publicly available U.S. Census data for studying the potential for disease spread in Urbanized Areas of the United States. To illustrate the utility of the model, we specifically study the potential for introductions of dengue to lead to autochthonous transmission and outbreaks in a population representative of the Miami Urbanized Area, where introductions of dengue have occurred frequently in recent years. We describe seasonal fluctuations in mosquito populations by fitting a population model to trap data provided by the Miami-Dade Mosquito Control Division. We show that the timing and location of introduced cases could play an important role in determining both the probability that local transmission occurs as well as the total number of cases throughout the entire region following introduction. We show that at low rates of clinical presentation, small outbreaks of dengue could go completely undetected during a season, which may confound mitigation efforts that rely upon detection. We discuss the sensitivity of the model to several critical parameter values that are currently poorly characterized and motivate the collection of additional data to strengthen the predictive power of this and similar models. Finally, we emphasize the utility of the general structure of this model in studying mosquito-borne diseases such as chikungunya and Zika virus in other regions.	[Robert, Michael A.; Silva, Noah J. B.; Wearing, Helen J.] Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA; [Robert, Michael A.; Wearing, Helen J.] Univ New Mexico, Dept Math & Stat, Albuquerque, NM 87131 USA; [Christofferson, Rebecca C.; Mores, Christopher N.] Louisiana State Univ, Dept Pathobiol Sci, Baton Rouge, LA 70803 USA; [Vasquez, Chalmers] Miami Dade Cty Mosquito Control Div, Miami, FL USA	University of New Mexico; University of New Mexico; Louisiana State University System; Louisiana State University	Robert, MA (corresponding author), Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA.; Robert, MA (corresponding author), Univ New Mexico, Dept Math & Stat, Albuquerque, NM 87131 USA.	marobert@unm.edu		Mores, Christopher/0000-0001-6678-9049; Wearing, Helen/0000-0002-9837-9797; Robert, Michael/0000-0003-3705-0952	National Institutes of Health/NIGMS program for Models of Infectious Disease Agent Study (MIDAS) [U01GM097661]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM097661] Funding Source: NIH RePORTER	National Institutes of Health/NIGMS program for Models of Infectious Disease Agent Study (MIDAS); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project was supported by the National Institutes of Health/NIGMS program for Models of Infectious Disease Agent Study (MIDAS) grant U01GM097661. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBEY HELEN, 1952, HUMAN BIOL, V24, P201; Adalja AA, 2012, EMERG INFECT DIS, V18, P608, DOI 10.3201/eid1804.110968; Adams B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006763; Altizer S, 2006, ECOL LETT, V9, P467, DOI 10.1111/j.1461-0248.2005.00879.x; ANDERSON R M, 1991; Bacaer N, 2007, B MATH BIOL, V69, P1067, DOI 10.1007/s11538-006-9166-9; Becker B, 2014, INT J ENV RES PUB HE, V11, P3256, DOI 10.3390/ijerph110303256; Benedict MQ, 2007, VECTOR-BORNE ZOONOT, V7, P76, DOI 10.1089/vbz.2006.0562; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Bhoomiboonchoo P, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003138; Braks MAH, 2003, J MED ENTOMOL, V40, P785, DOI 10.1603/0022-2585-40.6.785; Carrington LB, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002190; Cauchemez S., 2004, EUROSURVEILLANCE, V19; Christofferson RC, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-282; de Jong M, 1995, EPIDEMIC MODELS THEI, P84; Dowling Z, 2013, J MED ENTOMOL, V50, P764, DOI 10.1603/ME12250; Drake JM, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002056; Erlander Sven, 1990, GRAVITY MODEL TRANSP, V3; Feldstein LR, 2015, T ROY SOC TROP MED H, P1; Florida Department of Health, 2015, WEEKL SURV INF MOSQ; Fouque F, 2006, J VECTOR ECOL, V31, P390, DOI 10.3376/1081-1710(2006)31[390:AASADT]2.0.CO;2; Guagliardo SA, 2015, J MED ENTOMOL, V52, P726, DOI 10.1093/jme/tjv048; Guagliardo SA, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003648; Guagliardo SA, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003033; Gubler DJ, 2009, REV SCI TECH OIE, V28, P583, DOI 10.20506/rst.28.2.1904; GUBLER DJ, 1981, B WORLD HEALTH ORGAN, V59, P623; Gubler DJ, 1998, EMERG INFECT DIS, V4, P442, DOI 10.3201/eid0403.980326; Gubler DJ, 2011, ASIA PACIFIC J MOL B, V19, P111; Gubler Duane J., 2002, Trends in Microbiology, V10, P100, DOI 10.1016/S0966-842X(01)02288-0; Harrington LC, 2005, AM J TROP MED HYG, V72, P209, DOI 10.4269/ajtmh.2005.72.209; Heesterbeek JAP, 2007, MATH BIOSCI, V206, P3, DOI 10.1016/j.mbs.2004.10.013; Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1; Hufnagel L, 2004, P NATL ACAD SCI USA, V101, P15124, DOI 10.1073/pnas.0308344101; Johansson MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104915; Johansson MA, 2012, AM J TROP MED HYG, V86, P349, DOI 10.4269/ajtmh.2012.11-0432; Johansson MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022151; Juliano SA, 2002, OECOLOGIA, V130, P458, DOI 10.1007/s004420100811; Juliano SA, 2004, OECOLOGIA, V139, P583, DOI 10.1007/s00442-004-1532-4; Knudsen A. B., 1995, Parassitologia (Rome), V37, P91; Lourenco J, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003083; MACDONALD G, 1952, Trop Dis Bull, V49, P813; Mackenzie JS, 2004, NAT MED, V10, pS98, DOI 10.1038/nm1144; Martinez JC., 2013, PREDICTION MUTATIONS; Messenger AM, 2014, VECTOR-BORNE ZOONOT, V14, P783, DOI 10.1089/vbz.2014.1665; Nasci RS, 2014, EMERG INFECT DIS, V20, P1394, DOI 10.3201/eid2008.140333; OMEARA GF, 1995, J MED ENTOMOL, V32, P554, DOI 10.1093/jmedent/32.4.554; Poletti P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018860; Read JM, 2003, P ROY SOC B-BIOL SCI, V270, P699, DOI 10.1098/rspb.2002.2305; Reiner RC, 2014, EPIDEMICS-NETH, V6, P30, DOI 10.1016/j.epidem.2013.12.003; Reiskind MH, 2013, MED VET ENTOMOL, V27, P421, DOI 10.1111/mve.12000; Rey JR, 2006, J MED ENTOMOL, V43, P1134, DOI 10.1603/0022-2585(2006)43[1134:HSOMAV]2.0.CO;2; Rey Jorge R, 2014, Insects, V5, P991, DOI 10.3390/insects5040991; Rezza G, 2014, PATHOG GLOB HEALTH, V108, P349, DOI 10.1179/2047773214Y.0000000163; Rochlin I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060874; Ross R, 1911, NATURE, V87, P466, DOI 10.1038/087466a0; Ross R., 1910, PREVENTION MALARIA; Rudolph KE, 2014, AM J TROP MED HYG, V90, P882, DOI 10.4269/ajtmh.13-0403; Ruiz-Moreno D, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001918; Scott TW, 2000, J MED ENTOMOL, V37, P89, DOI 10.1603/0022-2585-37.1.89; Semenza JC, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003278; Stoddard ST, 2013, P NATL ACAD SCI USA, V110, P994, DOI 10.1073/pnas.1213349110; Suk JE, 2014, EUR J PUBLIC HEALTH, V24, P531, DOI 10.1093/eurpub/cku041; Tatem AJ, 2012, PARASITOLOGY, V139, P1816, DOI 10.1017/S0031182012000352; The Bureau of Transportation Statistics, 2015, STATE TRANSPORTATION; Trout A., 2010, Morbidity and Mortality Weekly Report, V59, P577; TRPIS M, 1986, AM J TROP MED HYG, V35, P1263, DOI 10.4269/ajtmh.1986.35.1263; U. S. Census Bureau, 2010, 2010 CENS POP HOUS T; U. S. Census Bureau, 2010, TIG LIN SHAP TIG LIN; U. S. Centers for Disease Control and Prevention, 2016, ZIK VIR DIS US 2015; U. S. Centers for Disease Control and Prevention, 2014, CHIK VIR US 2014; U. S. Department of Transportation Bureau of Transportation Statistics, 2012, CRUIS SHIP STAT; Vaughn DW, 2000, J INFECT DIS, V181, P2, DOI 10.1086/315215; Vazquez-Prokopec GM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058802; Viboud C, 2006, SCIENCE, V312, P447, DOI 10.1126/science.1125237; Wesolowski A, 2015, P NATL ACAD SCI USA, V112, P11887, DOI 10.1073/pnas.1504964112; World Health Organization (WHO), 2015, DENG SEV DENG FACT S; Xia YC, 2004, AM NAT, V164, P267, DOI 10.1086/422341	78	21	21	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2016	11	8							e0161365	10.1371/journal.pone.0161365	http://dx.doi.org/10.1371/journal.pone.0161365			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4YN	27532496	Green Published, Green Submitted, gold			2022-12-27	WOS:000381487600088
J	Dantas, FFO; Brasileiro-Santos, MD; Batista, RMF; do Nascimento, LS; Castellano, LRC; Ritti-Dias, RM; Lima, KC; Santos, AD				Oliveira Dantas, Filipe Fernandes; Brasileiro-Santos, Maria do Socorro; Falcao Batista, Rafael Marinho; do Nascimento, Leone Severino; Cancado Castellano, Lucio Roberto; Ritti-Dias, Raphael Mendes; Lima, Kenio Costa; Santos, Amilton da Cruz			Effect of Strength Training on Oxidative Stress and the Correlation of the Same with Forearm Vasodilatation and Blood Pressure of Hypertensive Elderly Women: A Randomized Clinical Trial	PLOS ONE			English	Article							RESISTANCE EXERCISE; ASCORBIC-ACID; BAROREFLEX SENSITIVITY; LIPID-PEROXIDATION; OLDER; MECHANISMS; RESPONSES; HUMANS; REFLEX; ANTIOXIDANTS	The aim of the study was to evaluate the effect of strength training on oxidative stress and the correlation of the same with forearm vasodilatation and mean blood pressure of hypertensive elderly women, at rest (basal) and during a static handgrip exercise. Insufficiently active hypertensive elderly women (N = 25; mean age = 66.1 years) were randomized into a 10 week strength training group (n = 13) or control (n = 12) group. Plasma malondialdehyde (MDA), total antioxidant capacity (TAC), plasma nitrite (NO2-), forearm blood flow (FBF), mean blood pressure (MBP) and vascular conductance ([FBF / MBP] x 100) were evaluated before and after the completion of the interventions. The strength training group increased the TAC (pre: Median = 39.0; Interquartile range = 34.0-41.5% vs post: Median = 44.0; Interquartile range = 38.0-51.5%; p = 0.006) and reduced the MDA (pre: 4.94 +/- 1.10 mu M vs post: 3.90 +/- 1.35 mu M; p = 0.025; CI-95%: -1.92 - -0.16 mu M). The strength training group increased basal vascular conductance (VC) (pre: 3.56 +/- 0.88 units vs post: 5.21 +/- 1.28 units; p = 0.001; CI-95%: 0.93-2.38 units) and decreased basal MBP (pre: 93.1 +/- 6.3 mmHg vs post: 88.9 +/- 5.4 mmHg; p = 0.035; CI-95%: -8.0 - -0.4 mmHg). Such changes were also observed during static handgrip exercise. A moderate correlation was observed between changes in basal VC and MBP with changes in NO2 -(Delta VC -> r = -0.56, p = 0.047; Delta MBP -> r = -0.41, p = 0.168) and MDA (Delta VC -> r = 0.64, p = 0.019; Delta MBP -> r = 0.31, p = 0.305). The strength training program reduced the oxidative stress of the hypertensive elderly women and this reduction was moderately correlated with their cardiovascular benefits.	[Oliveira Dantas, Filipe Fernandes; Brasileiro-Santos, Maria do Socorro; Falcao Batista, Rafael Marinho; do Nascimento, Leone Severino; Santos, Amilton da Cruz] Univ Fed Paraiba, Grad Associate Program Phys Educ, Joao Pessoa, Paraiba, Brazil; [Oliveira Dantas, Filipe Fernandes; Brasileiro-Santos, Maria do Socorro; Falcao Batista, Rafael Marinho; do Nascimento, Leone Severino; Santos, Amilton da Cruz] Univ Fed Paraiba, Res Lab Phys Training Appl Performance & Hlth, Joao Pessoa, Paraiba, Brazil; [Cancado Castellano, Lucio Roberto] Univ Fed Paraiba, Human Immunol Res & Educ Grp, Hlth Tech Sch, Joao Pessoa, Paraiba, Brazil; [Ritti-Dias, Raphael Mendes] Hosp Israelita Albert Einstein, Sao Paulo, Brazil; [Lima, Kenio Costa] Univ Fed Rio Grande do Norte, Postgrad Program Publ Hlth, Natal, RN, Brazil	Universidade Federal da Paraiba; Universidade Federal da Paraiba; Universidade Federal da Paraiba; Hospital Israelita Albert Einstein; Universidade Federal do Rio Grande do Norte	Dantas, FFO (corresponding author), Univ Fed Paraiba, Grad Associate Program Phys Educ, Joao Pessoa, Paraiba, Brazil.; Dantas, FFO (corresponding author), Univ Fed Paraiba, Res Lab Phys Training Appl Performance & Hlth, Joao Pessoa, Paraiba, Brazil.	filipepersonal@hotmail.com	Ritti-Dias, Raphael/G-4200-2013; Brasileiro-Santos, Maria/AAI-1662-2021; Castellano, Lucio/D-8887-2015	Ritti-Dias, Raphael/0000-0001-7883-6746; Castellano, Lucio/0000-0003-0851-5298; Dantas, Filipe Fernandes Oliveira/0000-0001-8257-876X; Lima, Kenio Costa/0000-0002-5668-4398				Aagaard P, 2010, SCAND J MED SCI SPOR, V20, P49, DOI 10.1111/j.1600-0838.2009.01084.x; American College of Sports Medicine, 2009, Med Sci Sports Exerc, V41, P1510, DOI 10.1249/MSS.0b013e3181a0c95c; Barodka VM, 2011, ANESTH ANALG, V112, P1048, DOI 10.1213/ANE.0b013e3182147e3c; BRAND-WILLIAMS W, 1995, FOOD SCI TECHNOL-LEB, V28, P25; Caballero B, 2014, AGE, V36, P851, DOI 10.1007/s11357-013-9607-y; Cerqueira Nereide Freire, 2002, Acta Cir. Bras., V17, P417, DOI 10.1590/S0102-86502002000600011; Collier Scott R, 2011, Biol Sex Differ, V2, P9, DOI 10.1186/2042-6410-2-9; Del Rio D, 2005, NUTR METAB CARDIOVAS, V15, P316, DOI 10.1016/j.numecd.2005.05.003; Delaney EP, 2010, AM J PHYSIOL-HEART C, V299, pH1318, DOI 10.1152/ajpheart.00556.2010; Dinenno FA, 1999, CIRCULATION, V100, P164, DOI 10.1161/01.CIR.100.2.164; dos Santos ES, 2014, J STRENGTH COND RES, V28, P3073, DOI 10.1519/JSC.0000000000000537; Eskurza I, 2004, J PHYSIOL-LONDON, V556, P315, DOI 10.1113/jphysiol.2003.057042; Fisher JP, 2015, COMPR PHYSIOL, V5, P475, DOI 10.1002/cphy.c140022; FOLKOW B, 1993, PHYSIOL REV, V73, P725, DOI 10.1152/physrev.1993.73.4.725; Greaney JL, 2014, AM J PHYSIOL-HEART C, V306, pH132, DOI 10.1152/ajpheart.00575.2013; Hawkins MN, 2009, MEDICINE SCIENCE IN, V41, P331; Higashi Y, 2012, HYPERTENS RES, V35, P1039, DOI 10.1038/hr.2012.138; Kennis E, 2013, ARCH PHYS MED REHAB, V94, P2054, DOI 10.1016/j.apmr.2013.06.018; Koba S, 2014, J PHYSIOL-LONDON, V592, P3917, DOI 10.1113/jphysiol.2014.272377; Kokkinos Peter F, 2002, J Cardiopulm Rehabil, V22, P178, DOI 10.1097/00008483-200205000-00009; Kraemer W, 1995, PHYSL ASSESSMENT HUM, P115; Kumar Arun, 2014, Asian Pacific Journal of Tropical Biomedicine, V4, pS189, DOI 10.12980/APJTB.4.2014D153; LAKATTA EG, 1993, PHYSIOL REV, V73, P413, DOI 10.1152/physrev.1993.73.2.413; Leal AK, 2008, AM J PHYSIOL-HEART C, V295, pH1429, DOI 10.1152/ajpheart.01365.2007; Lekakis J, 2011, EUR J CARDIOV PREV R, V18, P775, DOI 10.1177/1741826711398179; Liang Nan, 2016, Am J Physiol Heart Circ Physiol, V310, pH123, DOI 10.1152/ajpheart.00479.2015; MARK AL, 1985, CIRC RES, V57, P461, DOI 10.1161/01.RES.57.3.461; Masson GS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094927; Monahan KD, 2004, AM J PHYSIOL-HEART C, V286, pH2113, DOI 10.1152/ajpheart.01054.2003; Moreau KL, 2005, HYPERTENSION, V45, P1107, DOI 10.1161/01.HYP.0000165678.63373.8c; Moreira S. R., 2014, CLIN PHYSL FUNCTIONA, V36, P242, DOI [10.1111/cpf.1222125524237, DOI 10.1111/CPF.12221]; Mota MR, 2013, INT J GEN MED, V6, P581, DOI 10.2147/IJGM.S40628; Mukhtar O, 2013, BRIT J CLIN PHARMACO, V75, P36, DOI 10.1111/j.1365-2125.2012.04375.x; Nagai Y, 1998, CIRCULATION, V98, P1504, DOI 10.1161/01.CIR.98.15.1504; O'Mahony D, 2000, CLIN SCI, V98, P103, DOI 10.1042/CS19990106; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006; Parise G, 2005, FREE RADICAL BIO MED, V39, P289, DOI 10.1016/j.freeradbiomed.2005.03.024; Parslow RA, 2005, J HUM HYPERTENS, V19, P219, DOI 10.1038/sj.jhh.1001809; Powers SK, 2008, PHYSIOL REV, V88, P1243, DOI 10.1152/physrev.00031.2007; Reckelhoff JF, 2001, HYPERTENSION, V37, P1199, DOI 10.1161/01.HYP.37.5.1199; Richardson CA, 2015, J GERONTOL A-BIOL, V70, P487, DOI 10.1093/gerona/glu146; Robertson RJ, 2003, MED SCI SPORT EXER, V35, P333, DOI 10.1249/01.MSS.0000048831.15016.2A; Schaur RJ, 2015, BIOMOLECULES, V5, P2247, DOI 10.3390/biom5042247; Schottker B, 2015, J GERONTOL A-BIOL, V70, P518, DOI 10.1093/gerona/glu111; Sidhu SK, 2015, AM J PHYSIOL-HEART C, V309, pH1479, DOI 10.1152/ajpheart.00433.2015; Smith SA, 2006, J PHYSIOL-LONDON, V577, P1009, DOI 10.1113/jphysiol.2006.121558; Sullivan Gail M, 2012, J Grad Med Educ, V4, P279, DOI 10.4300/JGME-D-12-00156.1; Victor RG, 2008, CURR HYPERTENS REP, V10, P241, DOI 10.1007/s11906-008-0045-7; Vincent HK, 2006, OBESITY, V14, P1921, DOI 10.1038/oby.2006.224; Vincent KR, 2002, EUR J APPL PHYSIOL, V87, P416, DOI 10.1007/s00421-002-0640-2; Vincent KR, 2002, MED SCI SPORT EXER, V34, P17, DOI 10.1097/00005768-200201000-00004; Virdis A, 2012, MATURITAS, V71, P326, DOI 10.1016/j.maturitas.2012.01.010	53	23	26	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2016	11	8							e0161178	10.1371/journal.pone.0161178	http://dx.doi.org/10.1371/journal.pone.0161178			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4UN	27529625	Green Published, gold, Green Submitted			2022-12-27	WOS:000381476700052
J	Sakwinska, O; Moine, D; Delley, M; Combremont, S; Rezzonico, E; Descombes, P; Vinyes-Pares, G; Zhang, YM; Wang, PY; Thakkar, SK				Sakwinska, Olga; Moine, Deborah; Delley, Michele; Combremont, Severine; Rezzonico, Enea; Descombes, Patrick; Vinyes-Pares, Gerard; Zhang, Yumei; Wang, Peiyu; Thakkar, Sagar K.			Microbiota in Breast Milk of Chinese Lactating Mothers	PLOS ONE			English	Article							REAL-TIME PCR; BACTERIAL DIVERSITY; MATERNAL WEIGHT; HEALTHY WOMEN; BIFIDOBACTERIA; DELIVERY; FECES; MODE; OLIGOSACCHARIDES; COLLECTION	The microbiota of breast milk from Chinese lactating mothers at different stages of lactation was examined in the framework of a Maternal Infant Nutrition Growth (MING) study investigating the dietary habits and breast milk composition in Chinese urban mothers. We used microbiota profiling based on the sequencing of fragments of 16S rRNA gene and specific qPCR for bifidobacteria, lactobacilli and total bacteria to study microbiota of the entire breast milk collected using standard protocol without aseptic cleansing (n = 60), and the microbiota of the milk collected aseptically (n = 30). We have also investigated the impact of the delivery mode and the stage of lactation on the microbiota composition. The microbiota of breast milk was dominated by streptococci and staphylococci for both collection protocols and, in the case of standard collection protocol, Acinetobacter sp. While the predominance of streptococci and staphylococci was consistently reported previously for other populations, the abundance of Acinetobacter sp. was reported only once before in a study where milk collection was done without aseptic cleansing of the breast and rejection of foremilk. Higher bacterial counts were found in the milk collected using standard protocol. Bifidobacteria and lactobacilli were present in few samples with low abundance. We observed no effect of the stage of lactation or the delivery mode on microbiota composition. Methodological and geographical differences likely explain the variability in microbiota composition reported to date.	[Sakwinska, Olga; Delley, Michele; Combremont, Severine; Rezzonico, Enea; Thakkar, Sagar K.] Nestle Res Ctr, Lausanne, Switzerland; [Moine, Deborah; Descombes, Patrick] Nestle Inst Hlth Sci, Lausanne, Switzerland; [Vinyes-Pares, Gerard] Nestle Res Ctr Beijing, Beijing, Peoples R China; [Zhang, Yumei; Wang, Peiyu] Peking Univ, Sch Publ Hlth, Dept Nutr & Food Hyg, Beijing, Peoples R China; [Rezzonico, Enea] Le Grand Chemin 58, CH-1066 Epalinges, Switzerland	Nestle SA; Nestle SA; Peking University	Sakwinska, O (corresponding author), Nestle Res Ctr, Lausanne, Switzerland.	olga.sakwinska@rdls.nestle.com		Sakwinska, Olga/0000-0002-3142-9542	Nestle Research Center; Nestle Nutrition Institute China	Nestle Research Center(Nestle SA); Nestle Nutrition Institute China(Nestle SA)	OS, GVP, MD, SC, and ST are employees of Nestec Ltd. PD and DM are employees of Nestle Institute of Health Sciences SA. Nestle Research Center and Nestle Nutrition Institute China sponsored the study. We would like to confirm that the funders of the study, Nestle Research Center and Nestle Nutrition Institute China, provided support in the form of salaries for authors (OS, GVP, MD, SC, and ST are employees of Nestec Ltd. and PD and DM are employees of Nestle Institute of Health Sciences SA), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Albesharat R, 2011, SYST APPL MICROBIOL, V34, P148, DOI 10.1016/j.syapm.2010.12.001; Austin S, 2016, NUTRIENTS, V8, DOI 10.3390/nu8060346; Biesbroek G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032942; Cabrera-Rubio R, 2016, J DEV ORIG HLTH DIS, V7, P54, DOI 10.1017/S2040174415001397; Cabrera-Rubio R, 2012, AM J CLIN NUTR, V96, P544, DOI 10.3945/ajcn.112.037382; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Collado MC, 2012, PEDIATR RES, V72, P77, DOI 10.1038/pr.2012.42; CARROLL L, 1979, LANCET, V2, P1186; Collado MC, 2009, LETT APPL MICROBIOL, V48, P523, DOI 10.1111/j.1472-765X.2009.02567.x; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; EIDELMAN AI, 1979, OBSTET GYNECOL, V53, P550; ELMOHANDES AE, 1993, AM J INFECT CONTROL, V21, P226, DOI 10.1016/0196-6553(93)90413-X; Gronlund MM, 2007, CLIN EXP ALLERGY, V37, P1764, DOI 10.1111/j.1365-2222.2007.02849.x; Gueimonde M, 2007, NEONATOLOGY, V92, P64, DOI 10.1159/000100088; Heikkila MP, 2003, J APPL MICROBIOL, V95, P471, DOI 10.1046/j.1365-2672.2003.02002.x; Hunt KM, 2012, APPL ENVIRON MICROB, V78, P4763, DOI 10.1128/AEM.00477-12; Huse SM, 2010, ENVIRON MICROBIOL, V12, P1889, DOI 10.1111/j.1462-2920.2010.02193.x; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Jimenez E, 2008, RES MICROBIOL, V159, P595, DOI 10.1016/j.resmic.2008.09.001; Jimenez E, 2015, J HUM LACT, V31, P406, DOI 10.1177/0890334415585078; Jost T, 2013, BRIT J NUTR, V110, P1253, DOI 10.1017/S0007114513000597; Khodayar-Pardo P, 2014, J PERINATOL, V34, P599, DOI 10.1038/jp.2014.47; Kozich JJ, 2013, APPL ENVIRON MICROB, V79, P5112, DOI 10.1128/AEM.01043-13; LIEBHABER M, 1978, J PEDIATR-US, V92, P236, DOI 10.1016/S0022-3476(78)80014-6; Makino H, 2015, BENEF MICROBES, V6, P563, DOI 10.3920/BM2014.0082; Martin R, 2009, APPL ENVIRON MICROB, V75, P965, DOI 10.1128/AEM.02063-08; Martin V, 2012, J HUM LACT, V28, P36, DOI 10.1177/0890334411424729; Matsuki T, 2002, APPL ENVIRON MICROB, V68, P5445, DOI 10.1128/AEM.68.11.5445-5451.2002; Nadkarni MA, 2002, MICROBIOL-SGM, V148, P257, DOI 10.1099/00221287-148-1-257; Penders J, 2006, PEDIATRICS, V118, P511, DOI 10.1542/peds.2005-2824; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Solis G, 2010, ANAEROBE, V16, P307, DOI 10.1016/j.anaerobe.2010.02.004; Soto A, 2014, J PEDIATR GASTR NUTR, V59, P78, DOI 10.1097/MPG.0000000000000347; Urbaniak C, 2016, MICROBIOME, V4, DOI 10.1186/s40168-015-0145-y; Urbaniak C, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-24; Ward TL, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-116; WEST PA, 1979, J APPL BACTERIOL, V46, P269, DOI 10.1111/j.1365-2672.1979.tb00820.x	37	64	68	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2016	11	8							e0160856	10.1371/journal.pone.0160856	http://dx.doi.org/10.1371/journal.pone.0160856			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4UN	27529821	Green Published, Green Submitted, gold			2022-12-27	WOS:000381476700028
J	Simionescu, N; Niculescu, LS; Carnuta, MG; Sanda, GM; Stancu, CS; Popescu, AC; Popescu, MR; Vlad, A; Dimulescu, DR; Simionescu, M; Sima, AV				Simionescu, Natalia; Niculescu, Loredan S.; Carnuta, Mihaela G.; Sanda, Gabriela M.; Stancu, Camelia S.; Popescu, Andreea C.; Popescu, Mihaela R.; Vlad, Adelina; Dimulescu, Doina R.; Simionescu, Maya; Sima, Anca V.			Hyperglycemia Determines Increased Specific MicroRNAs Levels in Sera and HDL of Acute Coronary Syndrome Patients and Stimulates MicroRNAs Production in Human Macrophages	PLOS ONE			English	Article							CIRCULATING MICRORNAS; CARDIOVASCULAR-DISEASE; INFLAMMATORY RESPONSE; ATHEROSCLEROSIS; BIOGENESIS; BIOMARKERS; MIR-223; OBESITY; PLASMA; CELLS	We aimed to determine the levels of microRNAs (miRNAs) in sera and HDL of acute coronary syndrome (ACS) compared to stable angina (SA) patients with/ without hyperglycemia, and evaluate comparatively the functional effect of these sera on the processing machinery proteins (Drosha, DGCR8, Dicer) and miRNAs production in human macrophages. MiRNAs levels in sera and HDL from 35 SA and 72 ACS patients and 30 healthy subjects were measured by using microRNA TaqMan assays. MiR-223, miR-92a, miR-486, miR-122, miR125a and miR-146a levels were higher in the hyperglycemic ACS compared to normoglycemic sera. MiR-223 and miR-486 prevailed in HDL2, while miR-92a predominated in HDL3, all three miRNAs discriminating between ACS and SA patients; their levels were increased in HDL from hyperglycemic ACS patients versus normoglycemic ones. The incubation of human macrophages with sera from ACS and SA patients showed that all patients' sera induced an increase of Drosha, DGCR8 and Dicer expressions and of selected miRNAs levels compared to control sera, the effect being higher in the case of hyperglycemic versus normoglycemic ACS sera. The addition of glucose to SA and ACS sera increased Drosha, DGCR8 and Dicer expression and miRNAs levels in the exposed macrophages. In conclusion, hyperglycemia is associated with increased miR-223, miR-92a, miR-486 levels in HDL, which discriminate between ACS and SA patients. Exposure of human macrophages to ACS compared to SA sera determines the upregulation of Drosha, DGCR8 and Dicer expression and the increase of selected miRNAs production, the effect being augmented by an increased glucose concentration.	[Simionescu, Natalia; Niculescu, Loredan S.; Carnuta, Mihaela G.; Sanda, Gabriela M.; Stancu, Camelia S.; Simionescu, Maya; Sima, Anca V.] Romanian Acad, Lipid Dept, Inst Cellular Biol & Pathol Nicolae Simionescu, Bucharest, Romania; [Simionescu, Natalia] Petru Poni Inst Macromol Chem, Ctr Adv Res Bionanoconjugates & Biopolymers, Iasi, Romania; [Popescu, Andreea C.; Popescu, Mihaela R.; Vlad, Adelina; Dimulescu, Doina R.] Elias Univ Emergency Hosp, Cardiol Clin, Bucharest, Romania; [Vlad, Adelina] Carol Davila Univ Med & Pharm, Dept Physiol, Bucharest, Romania	Romanian Academy of Sciences; Nicolae Simionescu Institute of Cellular Biology & Pathology; Romanian Academy of Sciences; Petru Poni Institute of Macromolecular Chemistry; Carol Davila University of Medicine & Pharmacy	Sima, AV (corresponding author), Romanian Acad, Lipid Dept, Inst Cellular Biol & Pathol Nicolae Simionescu, Bucharest, Romania.	anca.sima@icbp.ro	Sanda, Gabriela Maria/C-2561-2011; Sima, Anca Volumnia/C-3904-2011; Niculescu, Loredan Stefan/F-2591-2010; Simionescu, Maya/C-4794-2011; Simionescu, Natalia/N-6574-2015; Popescu, Mihaela Roxana/AAD-6433-2019; Turtoi, Mihaela/AAP-2061-2021; Stancu, Camelia Sorina/C-3882-2011; Vlad, Adelina/C-6288-2012	Niculescu, Loredan Stefan/0000-0002-1394-9085; Simionescu, Natalia/0000-0001-5581-4624; Popescu, Mihaela Roxana/0000-0002-4539-5259; Turtoi, Mihaela/0000-0001-6418-3406; Stancu, Camelia Sorina/0000-0002-2988-9961; Sanda, Gabriela Maria/0000-0001-5368-4264; Vlad, Adelina/0000-0002-2282-6802; Sima, Anca V./0000-0003-1932-8965; Simionescu, Maya/0000-0003-2077-0400	Romanian Academy; Romanian Ministry of National Education [PN-II-PT-PCCA-2011-3.1-0184, PCCA-127/2012, PN-II-RU-TE-2014-4-0290, RUTE-17/2015]	Romanian Academy(Romanian Academy of Sciences); Romanian Ministry of National Education(Ministry of Education and Research - Romania)	This work was supported by the Romanian Academy, the Romanian Ministry of National Education PN-II-PT-PCCA-2011-3.1-0184 project (grant number PCCA-127/2012, http://uefiscdi.gov.ro), and the Romanian Ministry of National Education PN-II-RU-TE-2014-4-0290 project (grant number RUTE-17/2015, http://uefiscdi.gov.ro). The funders had no role in study design, data collection and	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Boon RA, 2013, ARTERIOSCL THROM VAS, V33, P186, DOI 10.1161/ATVBAHA.112.300139; Chen QY, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0037149, 10.1371/journal.pone.0042971]; Chen T, 2009, CARDIOVASC RES, V83, P131, DOI 10.1093/cvr/cvp121; Creemers EE, 2012, CIRC RES, V110, P483, DOI 10.1161/CIRCRESAHA.111.247452; Davis BN, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-18; Denli AM, 2004, NATURE, V432, P231, DOI 10.1038/nature03049; Graves Paul, 2012, Genomics Proteomics & Bioinformatics, V10, P239, DOI 10.1016/j.gpb.2012.06.004; Guay C, 2013, NAT REV ENDOCRINOL, V9, P513, DOI 10.1038/nrendo.2013.86; Ortega FJ, 2013, CLIN CHEM, V59, P781, DOI 10.1373/clinchem.2012.195776; Karunakaran D, 2016, BBA-MOL CELL BIOL L, V1861, P2087, DOI 10.1016/j.bbalip.2016.02.006; Lai LH, 2013, J BIOL CHEM, V288, P7956, DOI 10.1074/jbc.M112.445429; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Li K, 2015, CIRC RES, V117, pe1, DOI 10.1161/CIRCRESAHA.117.305844; Liu FQ, 2014, MEDICINE, V93, DOI 10.1097/MD.0000000000000098; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; Manduteanu I, 2012, J CELL MOL MED, V16, P1978, DOI 10.1111/j.1582-4934.2012.01552.x; MARKWELL MAK, 1978, ANAL BIOCHEM, V87, P206, DOI 10.1016/0003-2697(78)90586-9; Michell DL, 2016, BBA-MOL CELL BIOL L, V1861, P2069, DOI 10.1016/j.bbalip.2016.01.011; Niculescu LS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140958; Oerlemans MIFJ, 2012, EMBO MOL MED, V4, P1176, DOI 10.1002/emmm.201201749; Ofstad AP, 2016, SCAND J CLIN LAB INV, V76, P271, DOI 10.3109/00365513.2016.1155230; Ono K, 2011, FEBS J, V278, P1619, DOI 10.1111/j.1742-4658.2011.08090.x; Raitoharju E, 2011, ATHEROSCLEROSIS, V219, P211, DOI 10.1016/j.atherosclerosis.2011.07.020; Rayner KJ, 2012, THROMB HAEMOSTASIS, V107, P642, DOI 10.1160/TH11-10-0694; Ren JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080738; Rozenberg O, 2005, ATHEROSCLEROSIS, V181, P9, DOI 10.1016/j.atherosclerosis.2004.12.030; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schulte C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145930; Simionescu M, 2009, CELL TISSUE RES, V335, P27, DOI 10.1007/s00441-008-0688-3; Simionescu N, 2014, MOL BIOL REP, V41, P5765, DOI 10.1007/s11033-014-3449-2; van Empel VPM, 2012, CURR HYPERTENS REP, V14, P498, DOI 10.1007/s11906-012-0310-7; Vickers KC, 2011, NAT CELL BIOL, V13, P423, DOI 10.1038/ncb2210; Wagner J, 2013, ARTERIOSCL THROM VAS, V33, P1392, DOI 10.1161/ATVBAHA.112.300741; Wang H, 2012, ZHONGGUO WEI ZHONG B, V24, P215; Wang J, 2015, INT J MOL SCI, V16, P24965, DOI 10.3390/ijms161024965; Yi R, 2003, GENE DEV, V17, P3011, DOI 10.1101/gad.1158803; Zhuang GQ, 2012, CIRCULATION, V125, P2892, DOI 10.1161/CIRCULATIONAHA.111.087817	38	30	32	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2016	11	8							e0161201	10.1371/journal.pone.0161201	http://dx.doi.org/10.1371/journal.pone.0161201			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3LI	27519051	Green Published, gold, Green Submitted			2022-12-27	WOS:000381382100062
J	Shen, FC; Lee, Y				Shen, Feichen; Lee, Yugyung			Knowledge Discovery from Biomedical Ontologies in Cross Domains	PLOS ONE			English	Article							DRUG DISCOVERY; FRAMEWORK; PATTERNS; NETWORKS; SYSTEMS; MODELS; MAP	In recent years, there is an increasing demand for sharing and integration of medical data in biomedical research. In order to improve a health care system, it is required to support the integration of data by facilitating semantic interoperability systems and practices. Semantic interoperability is difficult to achieve in these systems as the conceptual models underlying datasets are not fully exploited. In this paper, we propose a semantic framework, called Medical Knowledge Discovery and Data Mining (MedKDD), that aims to build a topic hierarchy and serve the semantic interoperability between different ontologies. For the purpose, we fully focus on the discovery of semantic patterns about the association of relations in the heterogeneous information network representing different types of objects and relationships in multiple biological ontologies and the creation of a topic hierarchy through the analysis of the discovered patterns. These patterns are used to cluster heterogeneous information networks into a set of smaller topic graphs in a hierarchical manner and then to conduct cross domain knowledge discovery from the multiple biological ontologies. Thus, patterns made a greater contribution in the knowledge discovery across multiple ontologies. We have demonstrated the cross domain knowledge discovery in the MedKDD framework using a case study with 9 primary biological ontologies from Bio2RDF and compared it with the cross domain query processing approach, namely SLAP. We have confirmed the effectiveness of the MedKDD framework in knowledge discovery from multiple medical ontologies.	[Shen, Feichen] Mayo Clin, Dept Hlth Sci Res, Rochester, MN USA; [Lee, Yugyung] Univ Missouri, Sch Comp & Engn, Kansas City, MO 64110 USA	Mayo Clinic; University of Missouri System; University of Missouri Kansas City	Lee, Y (corresponding author), Univ Missouri, Sch Comp & Engn, Kansas City, MO 64110 USA.	leeyu@umkc.edu						Ananiadou S., 2000, P 18 C COMP LING, V1, P530, DOI DOI 10.1186/2041-1480-1-S1-S1; Baorto D, 2009, J BIOMED INFORM, V42, P494, DOI 10.1016/j.jbi.2009.03.005; Belleau F, 2008, J BIOMED INFORM, V41, P706, DOI 10.1016/j.jbi.2008.03.004; Campillos M, 2008, SCIENCE, V321, P263, DOI 10.1126/science.1158140; Chen B, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002574; Chen B, 2012, J CHEMINFORMATICS, V4, DOI 10.1186/1758-2946-4-6; Chen B, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-255; Croset S, 2012, INTEGRATION ANATOMIC; Demartin G., 2009, ACM SIGIR FORUM, V43, P17, DOI [DOI 10.1145/1670598.1670603, 10.1145/1670598.1670603]; Doing-Harris K, 2015, J BIOMED SEMANT, V6, DOI 10.1186/s13326-015-0011-7; Dos Reis JC, 2015, EXPERT SYST APPL, V42, P1465, DOI 10.1016/j.eswa.2014.08.047; Drouin Patrick, 2004, DETECTION DOMAIN SPE; Dumontier M, 2014, J BIOMED SEMANT, V5, DOI 10.1186/2041-1480-5-14; Dumontier M, 2012, IEEE INTERNET COMPUT, V16, P68, DOI 10.1109/MIC.2012.122; Duy Dinh, 2014, The Semantic Web: Trends and Challenges. 11th International Conference (ESWC 2014). Proceedings: LNCS 8465, P768, DOI 10.1007/978-3-319-07443-6_51; Euzenat J., 2007, ONTOLOGY MATCHING; Friedman C, 2001, Bioinformatics, V17 Suppl 1, pS74; Fundel K, 2007, BIOINFORMATICS, V23, P365, DOI 10.1093/bioinformatics/btl616; Garcia-Serna R, 2010, BIOINFORMATICS, V26, P985, DOI 10.1093/bioinformatics/btq061; Ghoting A, 2011, PROC INT CONF DATA, P231, DOI 10.1109/ICDE.2011.5767930; Gombocz E., 2011, NCBO WEBINAR SERIES; Gotz D, 2014, J BIOMED INFORM, V48, P148, DOI 10.1016/j.jbi.2014.01.007; Hassanzadeh O., 2009, ARXIV09080567; Hastings J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025513; Huang ZX, 2014, J BIOMED INFORM, V47, P39, DOI 10.1016/j.jbi.2013.09.003; Ivanovic M, 2014, EXPERT SYST APPL, V41, P5158, DOI 10.1016/j.eswa.2014.02.045; Jain AK, 2010, PATTERN RECOGN LETT, V31, P651, DOI 10.1016/j.patrec.2009.09.011; JI Q, 2011, THE SEMANTIC WEB RES, P497; Kinnings SL, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000423; Kitamura Yoshinobu, 2008, Semantic Web. Proceedings 3rd Asian Semantic Web Conference, ASWC 2008, P137, DOI 10.1007/978-3-540-89704-0_10; Kolling J, 2012, BIOINFORMATICS, V28, P1143, DOI 10.1093/bioinformatics/bts104; Kong XN, 2013, PROCEEDINGS OF THE 22ND ACM INTERNATIONAL CONFERENCE ON INFORMATION & KNOWLEDGE MANAGEMENT (CIKM'13), P179, DOI 10.1145/2505515.2505531; Kuhn M, 2012, NUCLEIC ACIDS RES, V40, pD876, DOI 10.1093/nar/gkr1011; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Lambrix P, 2009, LECT NOTES COMPUT SC, V5500, P343, DOI 10.1007/978-3-642-04581-3_8; Lasko TA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066341; Luciano Joanne S, 2011, J Biomed Semantics, V2 Suppl 2, pS1, DOI 10.1186/2041-1480-2-S2-S1; Mate S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116656; McBride B, 2001, P 2 INT WORKSH SEM W, V40, P23; Momtchev Vassil, 2009, P INT SEM WEB CHALL; Oprea TI, 2011, MOL INFORM, V30, P100, DOI 10.1002/minf.201100023; Papadimitriou S, 2008, IEEE DATA MINING, P512, DOI 10.1109/ICDM.2008.142; Pesquita C, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000443; Rafiq MI, 2005, 2005 IEEE COMPUTATIONAL SYSTEMS BIOINFORMATICS CONFERENCE, PROCEEDINGS, P362, DOI 10.1109/CSB.2005.25; Ray S., 2001, P 17 INT JOINT C ART, P1273; Sabou M., 2008, J DATA SEMANTICS, V11, P156, DOI DOI 10.1007/978-3-540-92148-66; Samwald M, 2011, J CHEMINFORMATICS, V3, DOI 10.1186/1758-2946-3-19; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shen F, 2016, THESIS; Shi B., 2015, ARXIV151005911; Shi C, 2014, IEEE T KNOWL DATA EN, V26, P2479, DOI 10.1109/TKDE.2013.2297920; Shotton D, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000361; Smith B, 2007, NAT BIOTECHNOL, V25, P1251, DOI 10.1038/nbt1346; Srinivasan P, 2002, AMIA 2002 SYMPOSIUM, PROCEEDINGS, P722; Sun Y, 2012, ACM SIGKDD EXPLORATI; Taboureau O, 2011, NUCLEIC ACIDS RES, V39, pD367, DOI 10.1093/nar/gkq906; Tartir S, 2010, THEORY AND APPLICATIONS OF ONTOLOGY: COMPUTER APPLICATIONS, P115, DOI 10.1007/978-90-481-8847-5_5; van Leeuwen Matthijs, 2014, Interactive Knowledge Discovery and Data Mining in Biomedical Informatics. State-of-the-Art and Future Challenges: LNCS 8401, P169, DOI 10.1007/978-3-662-43968-5_9; Wang HY, 2004, IEEE T INF TECHNOL B, V8, P16, DOI 10.1109/TITB.2004.824727; Wang P, 2015, SCI CHINA INFORM SCI, V58, DOI 10.1007/s11432-014-5237-y; Warrender JD, 2013, ARXIV13120465; Whetzel PL, 2011, NUCLEIC ACIDS RES, V39, pW541, DOI 10.1093/nar/gkr469; Williams AJ, 2012, DRUG DISCOV TODAY, V17, P1188, DOI 10.1016/j.drudis.2012.05.016; Willighagen EL, 2013, J CHEMINFORMATICS, V5, DOI 10.1186/1758-2946-5-23; Zepeda-Mendoza M.L., 2013, ENCY SYSTEMBIOL, P886; Zhou Y, 2015, KDD'15: PROCEEDINGS OF THE 21ST ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P1563, DOI 10.1145/2783258.2783328; Ziegler P, 2004, INT FED INFO PROC, V156, P3	67	17	17	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2016	11	8							e0160005	10.1371/journal.pone.0160005	http://dx.doi.org/10.1371/journal.pone.0160005			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT8TP	27548262	Green Published, gold, Green Submitted			2022-12-27	WOS:000381768400011
J	Thibault, K; Riviere, S; Lenkei, Z; Ferezou, I; Pezet, S				Thibault, Karine; Riviere, Sebastien; Lenkei, Zsolt; Ferezou, Isabelle; Pezet, Sophie			Orofacial Neuropathic Pain Leads to a Hyporesponsive Barrel Cortex with Enhanced Structural Synaptic Plasticity	PLOS ONE			English	Article							PRIMARY SOMATOSENSORY CORTEX; CORTICAL REORGANIZATION; NEURONAL-ACTIVITY; SPINAL-CORD; PERIPHERAL MONONEUROPATHY; TRIGEMINAL NEURALGIA; CONSTRICTION INJURY; INFRAORBITAL NERVE; MOUSE MODEL; RAT MODEL	Chronic pain is a long-lasting debilitating condition that is particularly difficult to treat due to the lack of identified underlying mechanisms. Although several key contributing processes have been described at the level of the spinal cord, very few studies have investigated the supraspinal mechanisms underlying chronic pain. Using a combination of approaches (cortical intrinsic imaging, immunohistochemical and behavioural analysis), our study aimed to decipher the nature of functional and structural changes in a mouse model of orofacial neuropathic pain, focusing on cortical areas involved in various pain components. Our results show that chronic neuropathic orofacial pain is associated with decreased haemodynamic responsiveness to whisker stimulation in the barrel field cortex. This reduced functional activation is likely due to the increased basal neuronal activity (measured indirectly using cFos and phospho-ERK immunoreactivity) observed in several cortical areas, including the contralateral barrel field, motor and cingulate cortices. In the same animals, immunohistochemical analysis of markers for active pre-or postsynaptic elements (Piccolo and phosphoCofilin, respectively) revealed an increased immunofluorescence in deep cortical layers of the contralateral barrel field, motor and cingulate cortices. These results suggest that longlasting orofacial neuropathic pain is associated with exacerbated neuronal activity and synaptic plasticity at the cortical level.	[Thibault, Karine; Riviere, Sebastien; Lenkei, Zsolt; Ferezou, Isabelle; Pezet, Sophie] PSL Res Univ, ESPCI, Brain Plast Unit, 10 Rue Vauquelin, F-75005 Paris, France; [Thibault, Karine; Riviere, Sebastien; Lenkei, Zsolt; Ferezou, Isabelle; Pezet, Sophie] CNRS, UMR 8249, F-75005 Paris, France; [Riviere, Sebastien] Univ Bourgogne, UMR INRA 1324, UMR CNRS 6265, Ctr Sci Gout & Alimentat, 9E Blvd Jeanne Arc, F-21000 Dijon, France; [Ferezou, Isabelle] CNRS, FRE 3693, Unit Neurosci Informat & Complex, Gif Sur Yvette, France	UDICE-French Research Universities; PSL Research University Paris; Ecole Superieure de Physique et de Chimie Industrielles de la Ville de Paris (ESPCI); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); INRAE; Institut Agro; AgroSup Dijon; Centre National de la Recherche Scientifique (CNRS); Universite de Bourgogne; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay	Pezet, S (corresponding author), PSL Res Univ, ESPCI, Brain Plast Unit, 10 Rue Vauquelin, F-75005 Paris, France.; Pezet, S (corresponding author), CNRS, UMR 8249, F-75005 Paris, France.	sophie.pezet@espci.fr	Lenkei, Zsolt/G-4369-2013; PEZET, sophie/AAR-1239-2021	Lenkei, Zsolt/0000-0002-1142-5931; PEZET, sophie/0000-0002-3305-3315; Ferezou, Isabelle/0000-0001-7602-1295	Centre National pour la Recherche Scientifique (CNRS); Ecole Superieure de Physique et Chimie Industrielles de la mairie de Paris, ParisTech	Centre National pour la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Ecole Superieure de Physique et Chimie Industrielles de la mairie de Paris, ParisTech	This work was supported by the Centre National pour la Recherche Scientifique (CNRS) and the Ecole Superieure de Physique et Chimie Industrielles de la mairie de Paris, ParisTech. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work has been supported by the Centre National pour la Recherche Scientifique (CNRS) and the Ecole Superieure de Physique et Chimie Industrielles de la mairie de Paris, ParisTech. The authors thank Mr. Marcel Leopoldie for animal husbandry and Brandon Loveall of Improvence for English proofreading of the manuscript.	ABBADIE C, 1992, NEUROSCIENCE, V48, P985, DOI 10.1016/0306-4522(92)90287-C; Abbadie C, 2009, BRAIN RES REV, V60, P125, DOI 10.1016/j.brainresrev.2008.12.002; Anderson EM, 2013, JOVE-J VIS EXP, DOI 10.3791/50336; Apkarian AV, 2005, EUR J PAIN, V9, P463, DOI 10.1016/j.ejpain.2004.11.001; Apkarian AV, 2004, J NEUROSCI, V24, P10410, DOI 10.1523/JNEUROSCI.2541-04.2004; Baliki MN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026010; Bamburg JR, 1999, TRENDS CELL BIOL, V9, P364, DOI 10.1016/S0962-8924(99)01619-0; Becerra L, 2006, J NEUROSCI, V26, P10646, DOI 10.1523/JNEUROSCI.2305-06.2006; BENNETT GJ, 1988, PAIN, V33, P87, DOI 10.1016/0304-3959(88)90209-6; Bennetto L, 2007, BMJ-BRIT MED J, V334, P201, DOI 10.1136/bmj.39085.614792.BE; Benoist JM, 1999, EXP BRAIN RES, V126, P383, DOI 10.1007/s002210050745; Braz JM, 2010, PAIN, V150, P290, DOI 10.1016/j.pain.2010.05.005; Cha MH, 2009, NEUROSCI LETT, V464, P117, DOI 10.1016/j.neulet.2009.08.024; Cha M, 2012, BEHAV BRAIN RES, V234, P82, DOI 10.1016/j.bbr.2012.06.020; Chen LY, 2007, J NEUROSCI, V27, P5363, DOI 10.1523/JNEUROSCI.0164-07.2007; CLAVELOU P, 1995, PAIN, V62, P295, DOI 10.1016/0304-3959(94)00273-H; Costigan M, 2009, ANNU REV NEUROSCI, V32, P1, DOI 10.1146/annurev.neuro.051508.135531; DaSilva AF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003396; De Gois S, 2005, J NEUROSCI, V25, P7121, DOI 10.1523/JNEUROSCI.5221-04.2005; DeSouza DD, 2014, PAIN, V155, P37, DOI 10.1016/j.pain.2013.08.029; Fenster SD, 2000, NEURON, V25, P203, DOI 10.1016/S0896-6273(00)80883-1; Flor H, 1997, NEUROSCI LETT, V224, P5, DOI 10.1016/S0304-3940(97)13441-3; FLOR H, 1995, NATURE, V375, P482, DOI 10.1038/375482a0; Frangeul L, 2014, EUR J NEUROSCI, V39, P1455, DOI 10.1111/ejn.12524; FROSTIG RD, 1990, P NATL ACAD SCI USA, V87, P6082, DOI 10.1073/pnas.87.16.6082; Gracely RH, 2004, BRAIN, V127, P835, DOI 10.1093/brain/awh098; Gu JP, 2010, NAT NEUROSCI, V13, P1208, DOI 10.1038/nn.2634; Guo D, 2014, NEUROSCIENCE, V283, P95, DOI 10.1016/j.neuroscience.2014.09.032; Gustin RM, 2010, NEUROBIOL DIS, V39, P283, DOI 10.1016/j.nbd.2010.04.012; Gustin SM, 2014, PLOS ONE, P9, DOI [10.1371/ journal.none.0109664, DOI 10.1371/J0URNAL.P0NE.0109664]; Gustin SM, 2013, J PAIN, V14, P1642, DOI 10.1016/j.jpain.2013.08.005; Gustin SM, 2012, J NEUROSCI, V32, P14874, DOI 10.1523/JNEUROSCI.1733-12.2012; Gustin SM, 2011, J NEUROSCI, V31, P5956, DOI 10.1523/JNEUROSCI.5980-10.2011; Hayes DJ, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-60; Hu HJ, 2007, J NEUROSCI, V27, P13181, DOI 10.1523/JNEUROSCI.0269-07.2007; Hubbard CS, 2015, NEUROIMAGE, V107, P333, DOI 10.1016/j.neuroimage.2014.12.024; Imamura Y, 1997, EXP BRAIN RES, V116, P97, DOI 10.1007/PL00005748; Ji RR, 1999, NAT NEUROSCI, V2, P1114, DOI 10.1038/16040; Ji RR, 2003, TRENDS NEUROSCI, V26, P696, DOI 10.1016/j.tins.2003.09.017; Jones EG, 2009, ANN NY ACAD SCI, V1157, P10, DOI 10.1111/j.1749-6632.2009.04534.x; Juottonen K, 2002, PAIN, V98, P315, DOI 10.1016/S0304-3959(02)00119-7; KAJANDER KC, 1992, J NEUROPHYSIOL, V68, P734, DOI 10.1152/jn.1992.68.3.734; Karim F, 2001, J NEUROSCI, V21, P3771, DOI 10.1523/JNEUROSCI.21-11-03771.2001; Kawai HD, 2013, SYNAPSE, V67, P455, DOI 10.1002/syn.21647; Kim SK, 2011, J NEUROSCI, V31, P5477, DOI 10.1523/JNEUROSCI.0328-11.2011; Kitagawa J, 2006, EUR J NEUROSCI, V24, P1976, DOI 10.1111/j.1460-9568.2006.05065.x; Krzyzanowska A, 2011, J NEUROSCI METH, V201, P46, DOI 10.1016/j.jneumeth.2011.07.006; Lam David K, 2005, Pain Res Manag, V10, P145; LAMOUR Y, 1983, EXP BRAIN RES, V49, P46; Lazarevic V, 2011, J NEUROSCI, V31, P10189, DOI 10.1523/JNEUROSCI.2088-11.2011; LEE SM, 2015, FRONT HUM NEUROSCI, V9, DOI DOI 10.3389/FNINS.2015.00462; Lin CS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094300; Ma F, 2012, MOL BRAIN, V5, DOI 10.1186/1756-6606-5-44; Maihofner C, 2004, NEUROLOGY, V63, P693, DOI 10.1212/01.WNL.0000134661.46658.B0; MAO JR, 1993, J NEUROSCI, V13, P2689, DOI 10.1523/JNEUROSCI.13-06-02689.1993; Marchand F, 2005, NAT REV NEUROSCI, V6, P521, DOI 10.1038/nrn1700; Moulder KL, 2004, NEURON, V42, P423, DOI 10.1016/S0896-6273(04)00184-9; Nemoto M, 2004, J NEUROSCI; Neubert JK, 2005, PAIN, V116, P386, DOI 10.1016/j.pain.2005.05.011; Nolan TA, 2011, BEHAV BRAIN RES, V217, P477, DOI 10.1016/j.bbr.2010.10.022; O'Brien RJ, 1998, NEURON, V21, P1067, DOI 10.1016/S0896-6273(00)80624-8; Pattany PM, 2002, AM J NEURORADIOL, V23, P901; Paulson PE, 2002, PAIN, V95, P31, DOI 10.1016/S0304-3959(01)00370-0; Paxinos G, 2012, PAXINOS FRANKLINS MO; Pelissier T, 2002, PAIN, V96, P81, DOI 10.1016/S0304-3959(01)00432-8; Pezet S, 2002, MOL CELL NEUROSCI, V21, P684, DOI 10.1006/mcne.2002.1205; Pirttimaki TM, 2011, J NEUROSCI, V31, P7637, DOI 10.1523/JNEUROSCI.5783-10.2011; Pleger B, 2006, NEUROIMAGE, V32, P503, DOI 10.1016/j.neuroimage.2006.03.045; Pontrello CG, 2012, P NATL ACAD SCI USA, V109, pE442, DOI 10.1073/pnas.1118803109; Pozo K, 2010, NEURON, V66, P337, DOI 10.1016/j.neuron.2010.04.028; Rex CS, 2007, J NEUROSCI, V27, P3017, DOI 10.1523/JNEUROSCI.4037-06.2007; Rossi HL, 2012, NEUROSCIENCE, V224, P294, DOI 10.1016/j.neuroscience.2012.08.015; Scholz J, 2007, NAT NEUROSCI, V10, P1361, DOI 10.1038/nn1992; Sheth S, 2003, NEUROIMAGE, V19, P884, DOI 10.1016/S1053-8119(03)00086-7; Staiger JF, 2000, NEUROSCIENCE, V99, P7, DOI 10.1016/S0306-4522(00)00166-4; Swart CMA, 2009, EUR J PAIN, V13, P902, DOI 10.1016/j.ejpain.2008.11.010; Thiagarajan TC, 2005, NEURON, V47, P725, DOI 10.1016/j.neuron.2005.06.037; Thibault K, 2014, J NEUROSCI, V34, P14739, DOI 10.1523/JNEUROSCI.0860-14.2014; Tracey I, 2005, CURR OPIN NEUROBIOL, V15, P478, DOI 10.1016/j.conb.2005.06.010; Treede RD, 1999, PAIN, V79, P105, DOI 10.1016/S0304-3959(98)00184-5; Tsubota T, 2015, COFILIN1 CONTROLS TR, P1, DOI [10.1371/journal.pbio.1002070content/23/6/901.short, DOI 10.1371/JOURNAL.PBIO.1002070CONTENT/23/6/901.SHORT]; Tsujino H, 2000, MOL CELL NEUROSCI, V15, P170, DOI 10.1006/mcne.1999.0814; Vartiainen N, 2009, J PAIN, V10, P854, DOI 10.1016/j.jpain.2009.02.006; Vogt BA, CYTOARCHITECTURE MOU, DOI [10.1007/s00429-012-0493-3, DOI 10.1007/S00429-012-0493-3]; VOS BP, 1994, J NEUROSCI, V14, P2708; Wierenga CJ, 2005, J NEUROSCI, V25, P2895, DOI 10.1523/JNEUROSCI.5217-04.2005; Xu M, 2008, J PAIN, V9, P1036, DOI 10.1016/j.jpain.2008.06.006; Zakrzewska JM, 2011, POSTGRAD MED J, V87, P410, DOI 10.1136/pgmj.2009.080473; Zhang ZW, 1997, J NEUROSCI, V17, P6365	89	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2016	11	8							e0160786	10.1371/journal.pone.0160786	http://dx.doi.org/10.1371/journal.pone.0160786			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT8TP	27548330	Green Published, Green Submitted, gold			2022-12-27	WOS:000381768400021
J	Urano-Tashiro, Y; Takahashi, Y; Oguchi, R; Konishi, K				Urano-Tashiro, Yumiko; Takahashi, Yukihiro; Oguchi, Riyo; Konishi, Kiyoshi			Two Arginine Residues of Streptococcus gordonii Sialic Acid-Binding Adhesin Hsa Are Essential for Interaction to Host Cell Receptors (vol 11, e0154098, 2016)	PLOS ONE			English	Correction													TASHIRO, Yumiko/AAV-2054-2020	Tashiro, Yumiko/0000-0002-8328-2634				Patel N, 1999, J BIOL CHEM, V274, P22729, DOI 10.1074/jbc.274.32.22729; Urano-Tashiro Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154098	2	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2016	11	8							e0161900	10.1371/journal.pone.0161900	http://dx.doi.org/10.1371/journal.pone.0161900			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT8TP	27548255	Green Published, Green Submitted, gold			2022-12-27	WOS:000381768400083
J	Xiong, L; Lu, YJ; Zhang, YF; Zhang, XG; Gupta, P				Xiong, Li; Lu, Yan-Jun; Zhang, Yong-Fang; Zhang, Xin-Guo; Gupta, Parag			Design and Hardware Implementation of a New Chaotic Secure Communication Technique	PLOS ONE			English	Article							NONLINEAR-SYSTEMS; SYNCHRONIZATION; CIRCUIT; OSCILLATORS; REALIZATION; HYPERCHAOS; STATE	In this paper, a scheme for chaotic modulation secure communication is proposed based on chaotic synchronization of an improved Lorenz system. For the first time, the intensity limit and stability of the transmitted signal, the characteristics of broadband and the requirements for accuracy of electronic components are presented by Multisim simulation. In addition, some improvements are made on the measurement method and the proposed experimental circuit in order to facilitate the experiments of chaotic synchronization, chaotic non-synchronization, experiment without signal and experiment with signal. To illustrate the effectiveness of the proposed scheme, some numerical simulations are presented. Then, the proposed chaotic secure communication circuit is implemented through analog electronic circuit, which is characterized by its high accuracy and good robustness.	[Xiong, Li; Lu, Yan-Jun] Xian Univ Technol, Sch Mech & Precis Instrument Engn, Xian 710048, Peoples R China; [Xiong, Li] Hexi Univ, Sch Phys & Electromech Engn, Zhangye 734000, Peoples R China; [Zhang, Yong-Fang] Xian Univ Technol, Sch Printing Packaging Engn & Digital Media, Xian 710048, Peoples R China; [Zhang, Xin-Guo] Lanzhou Univ, Sch Informat Sci & Engn, Lanzhou 730000, Peoples R China; [Gupta, Parag] Northwestern Univ, Robert R McCormick Sch Engn & Appl Sci, Evanston, IL 60208 USA	Xi'an University of Technology; Hexi University; Xi'an University of Technology; Lanzhou University; Northwestern University	Lu, YJ (corresponding author), Xian Univ Technol, Sch Mech & Precis Instrument Engn, Xian 710048, Peoples R China.	yanjunlu@xaut.edu.cn	Gupta, Parag/P-8425-2017	Gupta, Parag/0000-0001-6618-2132	National Natural Science Foundation of China [51505375]; Open Project of State Key Laboratory of Mechanical Transmission [SKLMT-KFKT-201510]; Scientific Research Program of Shanxi Provincial Education Department of China [15JS068, 15JK1549]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Open Project of State Key Laboratory of Mechanical Transmission; Scientific Research Program of Shanxi Provincial Education Department of China	The authors are greatly thankful for the help and support from the National Natural Science Foundation of China (Grant No. 51505375), Open Project of State Key Laboratory of Mechanical Transmission (Grant No. SKLMT-KFKT-201510), Scientific Research Program of Shanxi Provincial Education Department of China (15JS068, 15JK1549).	Boutayeb M, 2002, IEEE T CIRCUITS-I, V49, P345, DOI 10.1109/81.989169; Carbajal-Gomez VH, 2013, APPL MATH COMPUT, V219, P8163, DOI 10.1016/j.amc.2013.01.072; Chen G., 2003, DYNAMICAL ANAL CONTR; Chen HC, 2013, SENSORS-BASEL, V13, P2494, DOI 10.3390/s130202494; CUOMO KM, 1993, PHYS REV LETT, V71, P65, DOI 10.1103/PhysRevLett.71.65; CUOMO KM, 1993, IEEE T CIRCUITS-II, V40, P626, DOI 10.1109/82.246163; El-Sayed AMA, 2014, APPL MATH COMPUT, V239, P333, DOI 10.1016/j.amc.2014.04.109; Feng CW, 2015, J COMPUT NONLIN DYN, V10, DOI 10.1115/1.4029227; Filali RL, 2014, COMMUN NONLINEAR SCI, V19, P1424, DOI 10.1016/j.cnsns.2013.09.005; Galias Z, 2001, IEEE T CIRCUITS-I, V48, P1510, DOI 10.1109/TCSI.2001.972858; Garza-Gonzalez E, 2016, REV MEX FIS, V62, P51; Ge SS, 2014, IEEE T AUTOMAT CONTR, V59, P1624, DOI 10.1109/TAC.2013.2294826; de la Fraga LG, 2014, NONLINEAR DYNAM, V76, P1503, DOI 10.1007/s11071-013-1224-x; Halimi M, 2014, APPL MATH INFORM SCI, V8, P1509, DOI 10.12785/amis/080404; Kiani-B A, 2009, COMMUN NONLINEAR SCI, V14, P863, DOI 10.1016/j.cnsns.2007.11.011; Li F, 2016, NONLINEAR DYNAM, V84, P2305, DOI 10.1007/s11071-016-2646-z; Li F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154282; Li SJ, 2005, CHAOS SOLITON FRACT, V25, P109, DOI 10.1016/j.chaos.2004.09.077; Lin TC, 2015, INT J FUZZY SYST, V17, P206, DOI 10.1007/s40815-015-0024-5; [刘玉民 LIU Yu-min], 2009, [电路与系统学报, Journal of Circuits and Systems], V14, P116; Lu JH, 2002, INT J BIFURCAT CHAOS, V12, P2917, DOI 10.1142/S021812740200631X; Mbe ESK, 2014, CHAOS SOLITON FRACT, V61, P27, DOI 10.1016/j.chaos.2014.02.004; Merah L., 2013, APPL MATH SCI, V7, P237; Milanovic V, 1996, ELECTRON LETT, V32, P11, DOI 10.1049/el:19960004; Munoz-Pacheco JM, 2014, INT J ELECTRON, V101, P1559, DOI 10.1080/00207217.2014.880999; Muthuswamy B, 2010, INT J BIFURCAT CHAOS, V20, P1567, DOI 10.1142/S0218127410027076; Ni W., 2005, COMPUTER MODERNIZATI, V64, P96; Nunez JC, 2015, IEEE LAT AM T, V13, P2865, DOI 10.1109/TLA.2015.7350032; PECORA LM, 1990, PHYS REV LETT, V64, P821, DOI 10.1103/PhysRevLett.64.821; Pehlivan I, 2014, J SOUND VIB, V333, P5077, DOI 10.1016/j.jsv.2014.05.025; Rahul Ekhande, 2014, INT J ENG RES, V3, P458; Rui WB, 2014, CHINESE PHYS B, V23, DOI 10.1088/1674-1056/23/10/107502; Sanchez-Lopez C, 2010, NONLINEAR DYNAM, V61, P331, DOI 10.1007/s11071-009-9652-3; Sira-Ramirez H, 2001, INT J BIFURCAT CHAOS, V11, P1381, DOI 10.1142/S0218127401002778; Soriano-Sanchez AG, 2016, APPL MATH COMPUT, V275, P305, DOI 10.1016/j.amc.2015.11.081; Swathy PS, 2014, NONLINEAR DYNAM, V78, P2639, DOI 10.1007/s11071-014-1615-7; Tlelo-Cuautle E, 2015, NONLINEAR DYNAM, V82, P1879, DOI 10.1007/s11071-015-2284-x; Tlelo-Cuautle E, 2015, COMMUN NONLINEAR SCI, V27, P66, DOI 10.1016/j.cnsns.2015.03.003; Trejo-Guerra R, 2013, INT J CIRC THEOR APP, V41, P831, DOI 10.1002/cta.821; Trejo-Guerra R, 2012, COMMUN NONLINEAR SCI, V17, P4328, DOI 10.1016/j.cnsns.2012.01.029; Trejo-Guerra R, 2009, INT J BIFURCAT CHAOS, V19, P4217, DOI 10.1142/S0218127409025304; Yan XG, 2002, T I MEAS CONTROL, V24, P263, DOI 10.1191/0142331202tm06loa; Yan XG, 2008, IEEE T IND ELECTRON, V55, P4029, DOI 10.1109/TIE.2008.2003367; Zapateiro M, 2014, COMMUN NONLINEAR SCI, V19, P991, DOI 10.1016/j.cnsns.2013.07.029; Zhang X., 2011, NONLINEAR CIRCUIT BA; Zhang X. G., 2014, ACTA PHYS SINICA, V63, P1	46	24	24	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2016	11	8							e0158348	10.1371/journal.pone.0158348	http://dx.doi.org/10.1371/journal.pone.0158348			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT8TP	27548385	Green Published, Green Submitted, gold			2022-12-27	WOS:000381768400004
J	Chen, SM; Li, YY; Tu, CH; Salazar, N; Tseng, YY; Huang, SF; Hsieh, LL; Lui, TN				Chen, Shu-Mei; Li, Ying-Ying; Tu, Chiao-Hui; Salazar, Nicole; Tseng, Yuan-Yun; Huang, Shiang-Fu; Hsieh, Ling-Ling; Lui, Tai-Ngar			Blockade of Inhibitors of Apoptosis Proteins in Combination with Conventional Chemotherapy Leads to Synergistic Antitumor Activity in Medulloblastoma and Cancer Stem-Like Cells	PLOS ONE			English	Article							MALIGNANT GLIOMA-CELLS; NERVOUS-SYSTEM TUMORS; ADJUVANT CHEMOTHERAPY; RISK MEDULLOBLASTOMA; PEDIATRIC-ONCOLOGY; RADIATION-THERAPY; RANDOMIZED-TRIAL; IN-VITRO; AUTOPHAGY; RADIOTHERAPY	Background Medulloblastoma (MB) is the most common pediatric primary malignant brain tumor. Approximately one-third of MB patients succumb to treatment failure and some survivors suffer detrimental side effects. Hence, the purpose of this study is to explore new therapeutic regimens to overcome chemotherapeutic agent resistance or reduce chemotherapy-induced toxicity. Methods We detected the expression of inhibitors of apoptosis proteins (IAPs) in MB and CD133+MB cell lines and MB tissues using immunoblotting and immunohistochemical staining. The antitumor effects of inhibitors against IAPs on MB or CD133+ MB cells were evaluated by MTT assay, Annexin V/PI analysis, and caspase-3/7 activity. Autophagy was assessed by the conversion of light chain (LC) 3-I to LC3-II and Cyto-ID autophagy detection kit. Results MB cells showed higher expression of IAPs compared to normal astrocytes and normal brain tissues. Conventional chemotherapeutic agents combined with small-molecule IAP inhibitors (LCL161 or LBW242) showed a synergistic effect in MB cells. Combined treatments triggered apoptosis in MB cells through activation of caspase-3/7 and autophagic flux simultaneously. In addition, we found that CD133+ MB cells with features of cancer stem cells displayed higher levels of X-linked inhibitor of apoptosis (XIAP) and cellular inhibitor of apoptosis 1/2 (cIAP1/2), and were hypersensitive to treatment with IAP inhibitors. Conclusions These results shed light on the biological effects of combination therapy on MB cells and illustrate that IAP inhibitors are more effective for CD133+ stem-like MB cells.	[Chen, Shu-Mei] Chang Gung Univ, Coll Med, Grad Inst Clin Med Sci, Taoyuan, Taiwan; [Chen, Shu-Mei; Tu, Chiao-Hui; Lui, Tai-Ngar] Taipei Med Univ, Wan Fang Hosp, Dept Neurosurg, Taipei, Taiwan; [Li, Ying-Ying; Salazar, Nicole] Univ Miami, Miller Sch Med, Sheila & David Fuente Grad Program Canc Biol, Miami, FL USA; [Tseng, Yuan-Yun] Taipei Med Univ, Shuang Ho Hosp, Dept Neurosurg, Taipei, Taiwan; [Tseng, Yuan-Yun; Lui, Tai-Ngar] Taipei Med Univ, Coll Med, Sch Med, Dept Surg, Taipei, Taiwan; [Huang, Shiang-Fu; Hsieh, Ling-Ling] Chang Gung Univ, Coll Med, Dept Publ Hlth, Taoyuan, Taiwan; [Huang, Shiang-Fu] Chang Gung Univ, Chang Gung Mem Hosp, Dept Otolaryngol Head & Neck Surg, Taoyuan, Taiwan	Chang Gung University; Taipei Medical University; Taipei Municipal WanFang Hospital; University of Miami; Taipei Medical University; Shuang Ho Hospital; Taipei Medical University; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University	Lui, TN (corresponding author), Taipei Med Univ, Wan Fang Hosp, Dept Neurosurg, Taipei, Taiwan.; Lui, TN (corresponding author), Taipei Med Univ, Coll Med, Sch Med, Dept Surg, Taipei, Taiwan.; Hsieh, LL (corresponding author), Chang Gung Univ, Coll Med, Dept Publ Hlth, Taoyuan, Taiwan.	aaanray@yahoo.com.tw; 99318@w.tmu.edu.tw	Salazar, Nicole/I-6467-2019	Salazar, Nicole/0000-0002-8658-6553; Tseng, Yuan Yun/0000-0003-4968-3298	Wan Fang Hospital, Taipei Medical University, Taiwan [100-wf-phd-02, 101-wf-phd-04]; Taipei Medical University, Taiwan [TMU99-AE1-B24]	Wan Fang Hospital, Taipei Medical University, Taiwan; Taipei Medical University, Taiwan	This work was supported by Wan Fang Hospital, Taipei Medical University, Taiwan (grant no. 100-wf-phd-02 and 101-wf-phd-04) and Taipei Medical University, Taiwan (grant no. TMU99-AE1-B24). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baehrecke EH, 2005, NAT REV MOL CELL BIO, V6, P505, DOI 10.1038/nrm1666; Blazek ER, 2007, INT J RADIAT ONCOL, V67, P1, DOI 10.1016/j.ijrobp.2006.09.037; Brown JM, 2005, NAT REV CANCER, V5, P231, DOI 10.1038/nrc1560; Chauhan D, 2007, BLOOD, V109, P1220, DOI 10.1182/blood-2006-04-015149; Chawla-Sarkar M, 2004, CELL DEATH DIFFER, V11, P915, DOI 10.1038/sj.cdd.4401416; Chen YJ, 2008, SITIS 2008: 4TH INTERNATIONAL CONFERENCE ON SIGNAL IMAGE TECHNOLOGY AND INTERNET BASED SYSTEMS, PROCEEDINGS, P3, DOI 10.1109/SITIS.2008.31; Elmore SP, 2001, FASEB J, V15, P2286, DOI 10.1096/fj.01-0206fje; Frasson C, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/973912; Gaither A, 2007, CANCER RES, V67, P11493, DOI 10.1158/0008-5472.CAN-07-5173; Gidding CEM, 1999, CRIT REV ONCOL HEMAT, V29, P267, DOI 10.1016/S1040-8428(98)00023-7; Gurney JG, 2001, CURR OPIN ONCOL, V13, P160, DOI 10.1097/00001622-200105000-00005; He W, 2014, ONCOGENE, V33, P3004, DOI 10.1038/onc.2013.256; Huang X, 2013, EMBO J, V32, P2204, DOI 10.1038/emboj.2013.133; Johnstone RW, 2002, CELL, V108, P153, DOI 10.1016/S0092-8674(02)00625-6; Jozwiak J, 2007, MED RES REV, V27, P869, DOI 10.1002/med.20088; Kanzawa T, 2003, CANCER RES, V63, P2103; Kanzawa T, 2004, CELL DEATH DIFFER, V11, P448, DOI 10.1038/sj.cdd.4401359; Keating J, 2012, MOL CANCER THER, V11, P2654, DOI 10.1158/1535-7163.MCT-12-0352; Kortmann RD, 2000, INT J RADIAT ONCOL, V46, P269, DOI 10.1016/S0360-3016(99)00369-7; Kumar D, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-171; Lannering B, 2012, J CLIN ONCOL, V30, P3187, DOI 10.1200/JCO.2011.39.8719; LEGHA SS, 1986, MED TOXICOL ADV DRUG, V1, P421, DOI 10.1007/BF03259853; Lin F, 2015, HUM MOL GENET, V24, P2899, DOI 10.1093/hmg/ddv052; LOEHRER PJ, 1984, ANN INTERN MED, V100, P704, DOI 10.7326/0003-4819-100-5-704; Lum JJ, 2005, CELL, V120, P237, DOI 10.1016/j.cell.2004.11.046; Massimino M, 2012, J NEURO-ONCOL, V108, P163, DOI 10.1007/s11060-012-0822-7; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Odagiri K, 2014, RADIAT ONCOL, V9, DOI 10.1186/1748-717X-9-201; Onodera J, 2005, J BIOL CHEM, V280, P31582, DOI 10.1074/jbc.M506736200; PACKER RJ, 1994, J NEUROSURG, V81, P690, DOI 10.3171/jns.1994.81.5.0690; Packer RJ, 1999, J CLIN ONCOL, V17, P2127, DOI 10.1200/JCO.1999.17.7.2127; Packer RJ, 2013, NEURO-ONCOLOGY, V15, P97, DOI 10.1093/neuonc/nos267; Paglin S, 2001, CANCER RES, V61, P439; Pui CH, 2011, NAT REV CLIN ONCOL, V8, P540, DOI 10.1038/nrclinonc.2011.95; Raso A, 2008, NEUROPATH APPL NEURO, V34, P306, DOI 10.1111/j.1365-2990.2007.00896.x; Rood BR, 2004, SEMIN ONCOL, V31, P666, DOI 10.1053/j.seminoncol.2004.07.009; Rutkauskiene Giedre, 2005, Medicina (Kaunas), V41, P1026; Shu Q, 2008, STEM CELLS, V26, P1414, DOI 10.1634/stemcells.2007-1009; Singh SK, 2003, CANCER RES, V63, P5821; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Talloczy Z, 2002, P NATL ACAD SCI USA, V99, P190, DOI 10.1073/pnas.012485299; Tarbell NJ, 2013, J CLIN ONCOL, V31, P2936, DOI 10.1200/JCO.2012.43.9984; Taylor RE, 2005, EUR J CANCER, V41, P727, DOI 10.1016/j.ejca.2004.12.017; Tian AP, 2014, CANCER LETT, V351, P232, DOI 10.1016/j.canlet.2014.06.006; Tsujimoto Y, 2005, CELL DEATH DIFFER, V12, P1528, DOI 10.1038/sj.cdd.4401777; Vogler M, 2008, CANCER RES, V68, P7956, DOI 10.1158/0008-5472.CAN-08-1296; Wan F, 2010, BRAIN PATHOL, V20, P877, DOI 10.1111/j.1750-3639.2010.00379.x; Weisberg E, 2007, MOL CANCER THER, V6, P1951, DOI 10.1158/1535-7163.MCT-06-0810; Yao X, 2007, AM J MED SCI, V334, P115, DOI 10.1097/MAJ.0b013e31812dfe1e; Yu CC, 2010, CHILD NERV SYST, V26, P897, DOI 10.1007/s00381-010-1087-0; Zanini C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063748; Ziegler DS, 2008, J CLIN INVEST, V118, P3109, DOI 10.1172/JCI34120; Ziegler DS, 2011, NEURO-ONCOLOGY, V13, P820, DOI 10.1093/neuonc/nor066	53	16	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0161299	10.1371/journal.pone.0161299	http://dx.doi.org/10.1371/journal.pone.0161299			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27537345	Green Submitted, Green Published, gold			2022-12-27	WOS:000381577000085
J	Eadie, LN; Hughes, TP; White, DL				Eadie, Laura N.; Hughes, Timothy P.; White, Deborah L.			ABCB1 Overexpression Is a Key Initiator of Resistance to Tyrosine Kinase Inhibitors in CML Cell Lines	PLOS ONE			English	Article							CHRONIC MYELOID-LEUKEMIA; CHRONIC MYELOGENOUS LEUKEMIA; BCR-ABL INHIBITORS; IMATINIB MESYLATE; CHRONIC-PHASE; LYN KINASE; CLINICAL RESISTANCE; TRANSPORTERS ABCB1; GENE-EXPRESSION; P-GLYCOPROTEIN	The tyrosine kinase inhibitor (TKI) imatinib has resulted in excellent responses in the majority of Chronic Myeloid Leukaemia (CML) patients; however, resistance is observed in 20-30% of patients. More recently, resistance to the second generation TKIs, nilotinib and dasatinib, has also been observed albeit at a lower incidence. ABCB1 has previously been implicated in TKI export and its overexpression linked to TKI resistance. In this study the dynamics of nilotinib resistance was studied in CML cell lines with particular focus on ABCB1 expression levels during development of resistance. Results revealed ABCB1 overexpression is likely an important initiator of nilotinib resistance in vitro. ABCB1 overexpression was also observed in cell lines as an intermediate step during development of resistance to imatinib and dasatinib in vitro. We conclude that ABCB1 overexpression may provide an initial platform to facilitate development of additional mechanisms for resistance to TKIs. This provides a rationale for investigating this phenomenon in patients undergoing TKI therapy.	[Eadie, Laura N.; Hughes, Timothy P.; White, Deborah L.] South Australian Hlth & Med Res Inst, Canc Theme, Adelaide, SA, Australia; [Eadie, Laura N.; Hughes, Timothy P.; White, Deborah L.] Univ Adelaide, Dept Med, Adelaide, SA, Australia; [White, Deborah L.] Univ Adelaide, Dept Paediat, Adelaide, SA, Australia; [Hughes, Timothy P.] SA Pathol, Div Haematol, Adelaide, SA, Australia; [Hughes, Timothy P.] Ctr Canc Biol, Adelaide, SA, Australia	South Australian Health & Medical Research Institute (SAHMRI); University of Adelaide; University of Adelaide; SA Pathology; Centre for Cancer Biology	White, DL (corresponding author), South Australian Hlth & Med Res Inst, Canc Theme, Adelaide, SA, Australia.; White, DL (corresponding author), Univ Adelaide, Dept Med, Adelaide, SA, Australia.; White, DL (corresponding author), Univ Adelaide, Dept Paediat, Adelaide, SA, Australia.	deborah.white@sahmri.com	Hughes, Tim/AAO-9975-2021; Eadie, Laura N/P-9385-2016	Eadie, Laura N/0000-0003-1912-7602; Hughes, Timothy/0000-0002-0910-3730; White, Deborah/0000-0003-4844-333X	Leukaemia Foundation of Australia	Leukaemia Foundation of Australia	This research was supported by the Leukaemia Foundation of Australia. LNE received a PhD scholarship to support these studies. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Barnes DJ, 2005, CANCER RES, V65, P8912, DOI 10.1158/0008-5472.CAN-05-0076; Branford S, 2003, BLOOD, V102, P276, DOI 10.1182/blood-2002-09-2896; Burger H, 2005, CANCER BIOL THER, V4, P747, DOI 10.4161/cbt.4.7.1826; Camgoz A, 2013, LEUKEMIA LYMPHOMA, V54, P1279, DOI 10.3109/10428194.2012.737919; Campbell LJ, 2002, CANCER GENET CYTOGEN, V139, P30, DOI 10.1016/S0165-4608(02)00615-5; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Dai Y, 2004, J BIOL CHEM, V279, P34227, DOI 10.1074/jbc.M402290200; De Braekeleer E, 2007, CANCER GENET CYTOGEN, V179, P159, DOI 10.1016/j.cancergencyto.2007.09.003; Donato NJ, 2003, BLOOD, V101, P690, DOI 10.1182/blood.V101.2.690; Druker BJ, 1996, NAT MED, V2, P561, DOI 10.1038/nm0596-561; Eadie LN, 2017, LEUKEMIA, V31, P75, DOI 10.1038/leu.2016.179; Eadie LN, 2014, CLIN PHARMACOL THER, V95, P294, DOI 10.1038/clpt.2013.208; Eadie LN, 2015, BLOOD, V126, DOI 10.1182/blood.V126.23.348.348; Eadie LN, 2013, LEUKEMIA LYMPHOMA, V54, P569, DOI 10.3109/10428194.2012.715345; Giles FJ, 2013, LEUKEMIA, V27, P107, DOI 10.1038/leu.2012.181; Goldman JM, 2003, NEW ENGL J MED, V349, P1451, DOI 10.1056/NEJMra020777; Gorre ME, 2001, SCIENCE, V293, P876, DOI 10.1126/science.1062538; Gromicho M, 2011, LEUKEMIA LYMPHOMA, V52, P1980, DOI 10.3109/10428194.2011.584005; Grosso S, 2009, MOL CANCER THER, V8, P1924, DOI 10.1158/1535-7163.MCT-09-0168; Hantschel O, 2008, LEUKEMIA LYMPHOMA, V49, P615, DOI 10.1080/10428190801896103; Hirayama C, 2008, PHARM RES, V25, P827, DOI 10.1007/s11095-007-9376-3; Hochhaus A, 2002, LEUKEMIA, V16, P2190, DOI 10.1038/sj.leu.2402741; Hochhaus A, 2013, BLOOD, V121, P3703, DOI 10.1182/blood-2012-04-423418; Hughes T, 2009, J CLIN ONCOL, V27, P4204, DOI 10.1200/JCO.2009.21.8230; Hughes TP, 2003, NEW ENGL J MED, V349, P1423, DOI 10.1056/NEJMoa030513; Illmer T, 2004, LEUKEMIA, V18, P401, DOI 10.1038/sj.leu.2403257; Kantarjian H, 2010, NEW ENGL J MED, V362, P2260, DOI 10.1056/NEJMoa1002315; Khorashad JS, 2013, BLOOD, V121, P489, DOI 10.1182/blood-2012-05-431379; le Coutre P, 2000, BLOOD, V95, P1758, DOI 10.1182/blood.V95.5.1758.005a41_1758_1766; Lombardo LJ, 2004, J MED CHEM, V47, P6658, DOI 10.1021/jm049486a; Mahon FX, 2008, CANCER RES, V68, P9809, DOI 10.1158/0008-5472.CAN-08-1008; Mahon FX, 2000, BLOOD, V96, P1070, DOI 10.1182/blood.V96.3.1070.015k17_1070_1079; Mahon FX, 2003, BLOOD, V101, P2368, DOI 10.1182/blood.V101.6.2368; Manley PW, 2004, BIOORG MED CHEM LETT, V14, P5793, DOI 10.1016/j.bmcl.2004.09.042; Meyn MA, 2006, J BIOL CHEM, V281, P30907, DOI 10.1074/jbc.M605902200; Muller MC, 2009, BLOOD, V114, P4944, DOI 10.1182/blood-2009-04-214221; NICHOLS GL, 1994, BLOOD, V84, P2912; NOWELL PC, 1960, SCIENCE, V132, P1497; Okabe S, 2013, BIOCHEM BIOPH RES CO, V435, P506, DOI 10.1016/j.bbrc.2013.05.022; Okabe S, 2011, J HEMATOL ONCOL, V4, DOI 10.1186/1756-8722-4-32; ROWLEY JD, 1973, NATURE, V243, P290, DOI 10.1038/243290a0; Scappini B, 2004, CANCER-AM CANCER SOC, V100, P1459, DOI 10.1002/cncr.20131; Tanaka C, 2010, CLIN PHARMACOL THER, V87, P197, DOI 10.1038/clpt.2009.208; Tang C, 2011, LEUKEMIA LYMPHOMA, V52, P2139, DOI 10.3109/10428194.2011.591013; Warmuth M, 1997, J BIOL CHEM, V272, P33260, DOI 10.1074/jbc.272.52.33260; Weisberg E, 2000, BLOOD, V95, P3498, DOI 10.1182/blood.V95.11.3498.011k27_3498_3505; White D, 2005, BLOOD, V106, P2520, DOI 10.1182/blood-2005-03-1103; White D, 2006, BLOOD, V108, p608A, DOI 10.1182/blood.V108.11.2144.2144; Wu J, 2008, J NATL CANCER I, V100, P926, DOI 10.1093/jnci/djn188; Wu J, 2008, BLOOD, V111, P3821, DOI 10.1182/blood-2007-08-109330; Yuan HF, 2010, J BIOL CHEM, V285, P5085, DOI 10.1074/jbc.M109.039206; Zhao F, 2010, ONCOGENE, V29, P2962, DOI 10.1038/onc.2010.67	52	24	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0161470	10.1371/journal.pone.0161470	http://dx.doi.org/10.1371/journal.pone.0161470			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27536777	Green Submitted, Green Published, gold			2022-12-27	WOS:000381577000110
J	Kochi, M; Kohagura, K; Shiohira, Y; Iseki, K; Ohya, Y				Kochi, Masako; Kohagura, Kentaro; Shiohira, Yoshiki; Iseki, Kunitoshi; Ohya, Yusuke			Inflammation as a Risk of Developing Chronic Kidney Disease in Rheumatoid Arthritis	PLOS ONE			English	Article							C-REACTIVE PROTEIN; SUBCLINICAL RENAL DYSFUNCTION; CARDIOVASCULAR EVENTS; FOLLOW-UP; POPULATION; GLOMERULONEPHRITIS; METHOTREXATE; MARKERS; DAMAGE; METAANALYSIS	Objective The relationship between chronic inflammation and the incidence of chronic kidney disease (CKD) remained not-clear in patients with rheumatoid arthritis (RA). This study aims to examine the relationship between persistently high C-reactive protein (CRP), a marker of inflammation, and the incidence of CKD in RA. Methods We retrospectively examined the relationship between the levels of CRP and incidence of CKD in 345 RA patients. The outcome of interest was incidence of CKD, defined as an estimated glomerular filtration rate (eGFR) < 60 mL/min/1.73 m(2) and/or positive dipstick testing for proteinuria for >= 3 months. We defined high CRP, as > 3.0 mg/L. On the basis of three measurements of CRP for 6-months period, patients were divided into three groups: group 1, including patients with no high CRP values; group 2, patients with transient high CRP values (once or twice) and group 3, patients with persistently high CRP values. Results During a median follow-up period of 89 months, 14% of all patients developed CKD. The cumulative incidence of CKD was 7% in group 1, 14% in group 2 and 22% in group 3 (P = 0.008, log-rank test). In a multivariate analysis, including classical risk factors for CKD, persistently high CRP was an independent predictor of the incidence of CKD (hazard ratio, 3.00; 95% confidence interval, 1.23-8.53; P = 0.01). Conclusions Persistently high CRP was a significant risk factor for the incidence of CKD. Results suggest that persistent inflammation is a marker for the high risk of CKD in RA.	[Kochi, Masako] Univ Ryukyus, Sch Med, Dept Cardiovasc Med Nephrol & Neurol, Nishihara, Okinawa, Japan; [Kochi, Masako; Ohya, Yusuke] Yuuaikai Nanbu Hosp, Itoman, Okinawa, Japan; [Kohagura, Kentaro] Univ Hosp Ryukyus, Dialysis Unit, Nishihara, Okinawa, Japan; [Shiohira, Yoshiki; Iseki, Kunitoshi] Yuuaikai Tomishiro Cent Hosp, Tomigusuku, Okinawa, Japan; [Iseki, Kunitoshi] Okinawa Heart & Renal Assoc, Naha, Okinawa, Japan	University of the Ryukyus; University of the Ryukyus	Kohagura, K (corresponding author), Univ Hosp Ryukyus, Dialysis Unit, Nishihara, Okinawa, Japan.	kohagura@med.u-ryukyu.ac.jp		Kohagura, Kentaro/0000-0003-1636-7889				ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Azzi JR, 2013, J IMMUNOL, V191, P5785, DOI 10.4049/jimmunol.1390055; Bash LD, 2009, AM J KIDNEY DIS, V53, P596, DOI 10.1053/j.ajkd.2008.10.044; BERTANI T, 1989, AM J PATHOL, V134, P419; BOERS M, 1990, ARTHRITIS RHEUM, V33, P95, DOI 10.1002/art.1780330113; Bulgarelli A, 2012, J CARDIOVASC PHARM, V59, P308, DOI 10.1097/FJC.0b013e318241c385; Combe B, 2001, ARTHRITIS RHEUM, V44, P1736, DOI 10.1002/1529-0131(200108)44:8<1736::AID-ART308>3.0.CO;2-I; DAWES PT, 1986, BRIT J RHEUMATOL, V25, P44; de Wit MPT, 2011, ANN RHEUM DIS, V70, P891, DOI 10.1136/ard.2010.146662; Galarraga B, 2008, RHEUMATOLOGY, V47, P1780, DOI 10.1093/rheumatology/ken386; GLENNER GG, 1980, NEW ENGL J MED, V302, P1283, DOI 10.1056/NEJM198006053022305; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Hall C L, 1989, Adv Exp Med Biol, V252, P247; Haroon M, 2011, INT J RHEUM DIS, V14, P255, DOI 10.1111/j.1756-185X.2011.01594.x; HELIN HJ, 1995, ARTHRITIS RHEUM, V38, P242, DOI 10.1002/art.1780380213; Hickson LJ, 2014, AM J KIDNEY DIS, V63, P206, DOI 10.1053/j.ajkd.2013.08.010; Hiramoto JS, 2012, AM J KIDNEY DIS, V60, P225, DOI 10.1053/j.ajkd.2012.02.335; Iseki K, 2003, KIDNEY INT, V63, P1468, DOI 10.1046/j.1523-1755.2003.00868.x; Iseki K, 2011, NEPHRON CLIN PRACT, V117, pC51, DOI 10.1159/000319647; Karie S, 2008, RHEUMATOLOGY, V47, P350, DOI 10.1093/rheumatology/kem370; Karkar AM, 2001, NEPHROL DIAL TRANSPL, V16, P518, DOI 10.1093/ndt/16.3.518; Karstila K, 2007, CLIN RHEUMATOL, V26, P2089, DOI 10.1007/s10067-007-0625-y; Keith DS, 2004, ARCH INTERN MED, V164, P659, DOI 10.1001/archinte.164.6.659; Koseki Y, 2001, ANN RHEUM DIS, V60, P327, DOI 10.1136/ard.60.4.327; Lachmann HJ, 2007, NEW ENGL J MED, V356, P2361, DOI 10.1056/NEJMoa070265; Levey AS, 2011, KIDNEY INT, V80, P17, DOI 10.1038/ki.2010.483; Levy L, 2008, CLIN EXP RHEUMATOL, V26, P673; Li Z, 2011, LAB INVEST, V91, P837, DOI 10.1038/labinvest.2011.42; Maradit-Kremers H, 2005, ARTHRITIS RHEUM-US, V52, P722, DOI 10.1002/art.20878; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; MATTHEWS JNS, 1990, BRIT MED J, V300, P230, DOI 10.1136/bmj.300.6719.230; McInnes IB, 2011, NEW ENGL J MED, V365, P2205, DOI 10.1056/NEJMra1004965; Meune C, 2009, RHEUMATOLOGY, V48, P1309, DOI 10.1093/rheumatology/kep252; Micha R, 2011, AM J CARDIOL, V108, P1362, DOI 10.1016/j.amjcard.2011.06.054; Moller B, 2015, ANN RHEUM DIS, V74, P718, DOI 10.1136/annrheumdis-2013-204078; Mustonen J, 1985, Duodecim, V101, P1549; Nakahara C, 2001, CLIN NEPHROL, V55, P365; Nakano M, 1998, CLIN NEPHROL, V50, P154; Ninomiya T, 2005, KIDNEY INT, V68, P228, DOI 10.1111/j.1523-1755.2005.00397.x; Paisley KE, 2003, KIDNEY INT, V63, P624, DOI 10.1046/j.1523-1755.2003.00768.x; Perazella MA, 2009, CLIN J AM SOC NEPHRO, V4, P1275, DOI 10.2215/CJN.02050309; Peters MJL, 2010, ANN RHEUM DIS, V69, P325, DOI 10.1136/ard.2009.113696; Plant MJ, 2000, ARTHRITIS RHEUM, V43, P1473, DOI 10.1002/1529-0131(200007)43:7<1473::AID-ANR9>3.0.CO;2-N; Remuzzi G, 1998, NEW ENGL J MED, V339, P1448, DOI 10.1056/NEJM199811123392007; Roubille C, 2015, ANN RHEUM DIS, V74, P480, DOI 10.1136/annrheumdis-2014-206624; Schwedler SB, 2003, NEPHROL DIAL TRANSPL, V18, P2300, DOI 10.1093/ndt/gfg407; Shankar A, 2011, KIDNEY INT, V80, P1231, DOI 10.1038/ki.2011.283; Smolen JS, 2014, ANN RHEUM DIS, V73, P492, DOI 10.1136/annrheumdis-2013-204573; Stuveling EM, 2003, KIDNEY INT, V63, P654, DOI 10.1046/j.1523-1755.2003.00762.x; Tapia E, 2008, AM J PHYSIOL-RENAL, V295, pF1431, DOI 10.1152/ajprenal.90201.2008; Teramoto T, 2007, J ATHEROSCLER THROMB, V14, P155, DOI 10.5551/jat.E537; TIPPING PG, 1991, LAB INVEST, V65, P272; van Sijl AM, 2012, ANN RHEUM DIS, V71, P341, DOI 10.1136/annrheumdis-2011-200051; VANLEEUWEN MA, 1994, J RHEUMATOL, V21, P425; YOSHIDA A, 1994, CLIN THER, V16, P1000	55	30	31	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0160225	10.1371/journal.pone.0160225	http://dx.doi.org/10.1371/journal.pone.0160225			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27537204	Green Published, Green Submitted, gold			2022-12-27	WOS:000381577000014
J	Montes, A; Regueiro, C; Perez-Pampin, E; Boveda, MD; Gomez-Reino, JJ; Gonzalez, A				Montes, Ariana; Regueiro, Cristina; Perez-Pampin, Eva; Dolores Boveda, Maria; Gomez-Reino, Juan J.; Gonzalez, Antonio			Anti-Carbamylated Protein Antibodies as a Reproducible Independent Type of Rheumatoid Arthritis Autoantibodies	PLOS ONE			English	Article							CARP ANTIBODIES; SHARED EPITOPE; SMOKING; HLA-DRB1; ASSOCIATION; SUBSETS; PREDICT; PTPN22	A large fraction of the patients with rheumatoid arthritis (RA) develop specific autoantibodies, which until recently were only of two types, rheumatoid factor (RF) and anti-citrullinated protein antibodies (ACPA). We aimed to replicate important findings about a recently described third type of specific autoantibodies, anti-carbamylated protein (anti-CarP) antibodies, because they have been described based only in the homemade ELISA from a single laboratory. Our study included 520 patients with established RA and 278 healthy controls of Spanish ancestry and it was done with an independently performed ELISA. The prevalence and pattern of environmental, clinical and genetic associations of the anti-CarP antibodies were similar to the previously described. Notably, the presence and titers of anti-CarP correlated with the presence and titers of ACPA, but the anti-CarP antibodies did not share the known genetic and exposure risk factors of the ACPA. In addition, anti-CarP antibodies were independently associated with a higher (10.5%) prevalence of bone erosions. The reproducibility of these characteristics across laboratories and European subpopulations, indicates the wide validity of the results and suggests that determination of anti-CarP antibodies could contribute to explain RA pathogenesis and identify clinically relevant patient subgroups.	[Montes, Ariana; Regueiro, Cristina; Perez-Pampin, Eva; Gomez-Reino, Juan J.; Gonzalez, Antonio] Inst Invest Sanitaria Hosp Clin Univ Santiago, Lab Invest 10, Santiago De Compostela, Spain; [Montes, Ariana; Regueiro, Cristina; Perez-Pampin, Eva; Gomez-Reino, Juan J.; Gonzalez, Antonio] Inst Invest Sanitaria Hosp Clin Univ Santiago, Rheumatol Unit, Santiago De Compostela, Spain; [Dolores Boveda, Maria] Inst Invest Sanitaria Hosp Clin Univ Santiago, Dept Pediat, Unit Diag & Treatment Congenital Metab Dis, Santiago De Compostela, Spain; [Gomez-Reino, Juan J.] Univ Santiago de Compostela, Dept Med, Santiago De Compostela, Spain	Universidade de Santiago de Compostela	Gonzalez, A (corresponding author), Inst Invest Sanitaria Hosp Clin Univ Santiago, Lab Invest 10, Santiago De Compostela, Spain.; Gonzalez, A (corresponding author), Inst Invest Sanitaria Hosp Clin Univ Santiago, Rheumatol Unit, Santiago De Compostela, Spain.	agmartinezp@ser.es	Gonzalez, Antonio/C-4444-2008; Perez-Pampin, Eva/ABF-7200-2020; Gomez-Reino, Juan/ABI-2853-2020; Expósito, Cristina Regueiro/AAC-1405-2021	Gonzalez, Antonio/0000-0002-2624-0606; Perez-Pampin, Eva/0000-0003-0319-4456; Regueiro, Cristina/0000-0002-8567-6784; Gomez-Reino, Juan/0000-0001-5229-6294	Instituto de Salud Carlos III [PI14/01651, RD12/0009/0008]; Instituto de Salud Carlos III (Spain) - European Regional Development Fund of the EU (FEDER) [PI14/01651, RD12/0009/0008]	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Instituto de Salud Carlos III (Spain) - European Regional Development Fund of the EU (FEDER)	Funding was provided by the Instituto de Salud Carlos III, PI14/01651; and Instituto de Salud Carlos III, RD12/0009/0008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors are indebted to the patients that generously have contributed the samples and time to this work. They also thank Camen Pena for her excellent technical support. Funding was provided by the Instituto de Salud Carlos III (Spain) through grants PI14/01651 and RD12/0009/0008, which are partially financed by the European Regional Development Fund of the EU (FEDER).	ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Bax M, 2014, SEMIN IMMUNOPATHOL, V36, P313, DOI 10.1007/s00281-014-0429-5; Brink M, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0536-2; Catrina AI, 2014, NAT REV RHEUMATOL, V10, P645, DOI 10.1038/nrrheum.2014.115; Gan RW, 2015, J RHEUMATOL, V42, P572, DOI 10.3899/jrheum.140767; Harre U, 2012, J CLIN INVEST, V122, P1791, DOI 10.1172/JCI60975; Hecht C, 2015, ANN RHEUM DIS, V74, P2151, DOI 10.1136/annrheumdis-2014-205428; Holoshitz J, 2010, CURR OPIN RHEUMATOL, V22, P293, DOI 10.1097/BOR.0b013e328336ba63; Jiang X, 2014, ANN RHEUM DIS, V73, P1761, DOI 10.1136/annrheumdis-2013-205109; Kallberg H, 2007, AM J HUM GENET, V80, P867, DOI 10.1086/516736; Lee HS, 2007, ARTHRITIS RHEUM-US, V56, P1745, DOI 10.1002/art.22703; McInnes IB, 2011, NEW ENGL J MED, V365, P2205, DOI 10.1056/NEJMra1004965; Micallef L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101717; Montes A, 2012, ARTHRITIS RHEUM-US, V64, P3102, DOI 10.1002/art.34569; Montes A, 2011, ARTHRITIS RHEUM-US, V63, P654, DOI 10.1002/art.30186; Morgan AW, 2009, ARTHRITIS RHEUM-US, V60, P2565, DOI 10.1002/art.24752; Mydel P, 2010, J IMMUNOL, V184, P6882, DOI 10.4049/jimmunol.1000075; Scinocca M, 2014, J RHEUMATOL, V41, P270, DOI 10.3899/jrheum.130742; Shi J, 2014, ANN RHEUM DIS, V73, P780, DOI 10.1136/annrheumdis-2013-204154; Shi J, 2013, ARTHRITIS RHEUM-US, V65, P911, DOI 10.1002/art.37830; Shi J, 2011, P NATL ACAD SCI USA, V108, P17372, DOI 10.1073/pnas.1114465108; Smolen JS, 2014, ANN RHEUM DIS, V73, P492, DOI 10.1136/annrheumdis-2013-204573; Townsend MJ, 2014, BEST PRACT RES CL RH, V28, P539, DOI 10.1016/j.berh.2014.10.024; van Heemst J, 2014, ANN MED, V46, P304, DOI 10.3109/07853890.2014.907097	24	31	33	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0161141	10.1371/journal.pone.0161141	http://dx.doi.org/10.1371/journal.pone.0161141			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27537849	Green Published, Green Submitted, gold			2022-12-27	WOS:000381577000059
J	Sun, J; Hinton, MG; Webster, DG				Sun, Jenny; Hinton, Michael G.; Webster, D. G.			Modeling the Spatial Dynamics of International Tuna Fleets	PLOS ONE			English	Article							FISHING LOCATION CHOICE; KATSUWONUS-PELAMIS; TRAWL FISHERIES; BEHAVIOR; HETEROGENEITY; GOVERNANCE; PACIFIC; SHRIMP; OCEAN	We developed an iterative sequential random utility model to investigate the social and environmental determinants of the spatiotemporal decision process of tuna purse-seine fishery fishing effort in the eastern Pacific Ocean. Operations of the fishing gear mark checkpoints in a continuous complex decision-making process. Individual fisher behavior is modeled by identifying diversified choices over decision-space for an entire fishing trip, which allows inclusion of prior and current vessel locations and conditions among the explanatory variables. Among these factors are vessel capacity; departure and arrival port; duration of the fishing trip; daily and cumulative distance travelled, which provides a proxy for operation costs; expected revenue; oceanographic conditions; and tons of fish on board. The model uses a two-step decision process to capture the probability of a vessel choosing a specific fishing region for the first set and the probability of switching to ( or staying in) a specific region to fish before returning to its landing port. The model provides a means to anticipate the success of marine resource management, and it can be used to evaluate fleet diversity in fisher behavior, the impact of climate variability, and the stability and resilience of complex coupled human and natural systems.	[Sun, Jenny] Gulf Maine Res Inst, Portland, ME 04101 USA; [Hinton, Michael G.] Interamer Trop Tuna Commiss, La Jolla, CA 92037 USA; [Webster, D. G.] Dartmouth Coll, Environm Studies, Hanover, NH 03755 USA	Gulf of Maine Research Institute; Dartmouth College	Hinton, MG (corresponding author), Interamer Trop Tuna Commiss, La Jolla, CA 92037 USA.	mghinton@uw.edu		Webster, D.G./0000-0002-8368-983X; Hinton, Michael Gene/0000-0003-4508-4335	National Science Foundation; Coupled Natural and Human systems project called Fishscape under NSF [CNH-1010280]; Directorate For Geosciences [1010280] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Coupled Natural and Human systems project called Fishscape under NSF; Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This study is sponsored by the National Science Foundation and is funded through Coupled Natural and Human systems project called Fishscape under NSF Grant No. CNH-1010280 (DGW JS) (http://www.nsf.gov/funding/pgm_summ.jsp?pims_id=13681). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen BS, 2012, ICES J MAR SCI, V69, P131, DOI 10.1093/icesjms/fsr181; Andersen BS, 2010, FISH RES, V102, P26, DOI 10.1016/j.fishres.2009.10.004; BARKLEY RA, 1978, FISH B-NOAA, V76, P653; BOCKSTAEL NE, 1983, J ENVIRON ECON MANAG, V10, P125, DOI 10.1016/0095-0696(83)90021-9; Branch TA, 2006, CAN J FISH AQUAT SCI, V63, P1647, DOI 10.1139/F06-072; Brill Richard W., 1994, Fisheries Oceanography, V3, P204, DOI 10.1111/j.1365-2419.1994.tb00098.x; Crowder LB, 2006, SCIENCE, V313, P617, DOI 10.1126/science.1129706; Cumming GS, 2013, LANDSCAPE ECOL, V28, P1139, DOI 10.1007/s10980-012-9725-4; Curtis R, 2000, AM J AGR ECON, V82, P1191, DOI 10.1111/0002-9092.00119; Davies TK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114037; Deriso, 1998, NOAA TECHNICAL REPOR, P161; Eales James, 1986, MAR RESOUR ECON, V2, P331, DOI [10.1086/mre.2.4.42628909, DOI 10.1086/MRE.2.4.42628909]; EVANS RH, 1981, MAR FISH REV, V43, P1; Hicks RL, 2008, J ENVIRON ECON MANAG, V56, P103, DOI 10.1016/j.jeem.2008.01.001; HILBORN R, 1985, CAN J FISH AQUAT SCI, V42, P2, DOI 10.1139/f85-001; Holland DS, 1999, CAN J FISH AQUAT SCI, V56, P253, DOI 10.1139/cjfas-56-2-253; Hutton T, 2004, ICES J MAR SCI, V61, P1443, DOI 10.1016/j.icesjms.2004.08.016; IATTC, 2012, IATTC CONVENTION ARE; IATTC, 2013, IATTC REPORT FOR THE; Joyner CC, 2000, OCEAN DEV INT LAW, V31, P127, DOI 10.1080/009083200276094; Larson DM, 1999, CONTEMP ECON POLICY, V17, P267, DOI 10.1111/j.1465-7287.1999.tb00681.x; Liu JG, 2007, AMBIO, V36, P639, DOI 10.1579/0044-7447(2007)36[639:CHANS]2.0.CO;2; McFadden D., 1978, MODELING THE CHOICE; McFadden D., 1974, J PUBLIC ECON, V3, P303, DOI [10.1016/0047-2727(74)90003-6, DOI 10.1016/0047-2727(74)90003-6]; NOAA, 2015, MULTIVARIATE EL NINO; Salas S, 2004, FISH FISH, V5, P153, DOI 10.1111/j.1467-2979.2004.00146.x; Schaefer KM, 2009, REV-METHODS TECHNOL, V9, P121, DOI 10.1007/978-1-4020-9640-2_8; Schnier KE, 2011, LAND ECON, V87, P382, DOI 10.3368/le.87.3.382; Smith MD, 2005, J ENVIRON ECON MANAG, V50, P319, DOI 10.1016/j.jeem.2005.04.001; Swait J, 2004, J ENVIRON ECON MANAG, V47, P94, DOI 10.1016/S0095-0696(03)00077-9; van Putten IE, 2012, FISH FISH, V13, P216, DOI 10.1111/j.1467-2979.2011.00430.x; Vermard Y, 2008, CAN J FISH AQUAT SCI, V65, P2444, DOI 10.1139/F08-147; WARD JM, 1994, AM J AGR ECON, V76, P916, DOI 10.2307/1243751; Wilson J, 2007, P NATL ACAD SCI USA, V104, P15212, DOI 10.1073/pnas.0702241104	34	20	20	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0159626	10.1371/journal.pone.0159626	http://dx.doi.org/10.1371/journal.pone.0159626			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DT6ES	27537545	Green Published, Green Submitted, gold			2022-12-27	WOS:000381577000008
J	Yoon, HI; Koom, WS; Kim, TH; Ahn, JB; Jung, M; Kim, TI; Kim, H; Shin, SJ; Kim, NK				Yoon, Hong In; Koom, Woong Sub; Kim, Tae Hyung; Ahn, Joong Bae; Jung, Minkyu; Kim, Tae Il; Kim, Hoguen; Shin, Sang Joon; Kim, Nam Kyu			Upfront Systemic Chemotherapy and Short-Course Radiotherapy with Delayed Surgery for Locally Advanced Rectal Cancer with Distant Metastases: Outcomes, Compliance, and Favorable Prognostic Factors	PLOS ONE			English	Article							COURSE PREOPERATIVE RADIOTHERAPY; COLORECTAL LIVER METASTASES; CIRCUMFERENTIAL MARGIN; LUNG METASTASECTOMY; RANDOMIZED-TRIAL; PHASE-II; CHEMORADIOTHERAPY; CHEMORADIATION; METAANALYSIS; MULTICENTER	Purpose/Objective(s) Optimal treatment for locally advanced rectal cancer (LARC) with distant metastasis remains elusive. We aimed to evaluate upfront systemic chemotherapy and short-course radiotherapy (RT) followed by delayed surgery for such patients, and to identify favorable prognostic factors. Materials/Methods We retrospectively reviewed 50 LARC patients (cT4 or cT3, < 2 mm from the mesorectal fascia) with synchronous metastatic disease. The primary endpoint was progression-free survival (PFS). The secondary endpoints were overall survival, treatment-related toxicity, and compliance. We considered P values < 0.05 significant. Results At 22 months median follow-up, the median PFS time was 16 months and the 2-year PFS rate was 34.8%. Thirty-five patients who received radical surgery for primary and metastatic tumors were designated the curable group. Six patients with clinical complete response (ypCR) of metastases who underwent radical surgery for only the primary tumor were classified as potentially curable. Nine patients who received no radical surgery (3 received palliative surgery) were deemed the palliative group. The ypCR rate among surgery patients was 13.6%. PFS rates for the curable or potentially curable groups were significantly longer than that of the palliative group (P<0.001). On multivariate analysis, solitary organ metastasis and R0 status were independent prognostic factors for PFS. Conclusions These findings demonstrated that a strong possibility that upfront chemotherapy and short-course RT with delayed surgery are an effective alternative treatment for LARC with potentially resectable distant metastasis, owing to achievement of pathologic down-staging, R0 resection, and favorable compliance and toxicity, despite the long treatment duration.	[Yoon, Hong In; Koom, Woong Sub; Kim, Tae Hyung] Yonsei Univ Hlth Syst, Yonsei Univ, Dept Radiat Oncol, Yonsei Canc Ctr,Coll Med, Seoul, South Korea; [Ahn, Joong Bae; Jung, Minkyu; Shin, Sang Joon] Yonsei Univ Hlth Syst, Yonsei Univ, Div Med Oncol, Dept Internal Med,Yonsei Canc Ctr,Coll Med, Seoul, South Korea; [Kim, Tae Il] Yonsei Univ Hlth Syst, Yonsei Univ, Div Gastroenterol, Dept Internal Med,Coll Med, Seoul, South Korea; [Kim, Hoguen] Yonsei Univ Hlth Syst, Yonsei Univ, Coll Med, Dept Pathol, Seoul, South Korea; [Kim, Hoguen; Kim, Nam Kyu] Yonsei Univ Hlth Syst, Yonsei Univ, Dept Surg, Div Colorectal Surg,Coll Med, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Shin, SJ (corresponding author), Yonsei Univ Hlth Syst, Yonsei Univ, Div Med Oncol, Dept Internal Med,Yonsei Canc Ctr,Coll Med, Seoul, South Korea.; Kim, NK (corresponding author), Yonsei Univ Hlth Syst, Yonsei Univ, Dept Surg, Div Colorectal Surg,Coll Med, Seoul, South Korea.	SSJ338@yuhs.ac; NAMKYUK@yuhs.ac		Koom, Woong Sub/0000-0002-9435-7750; Shin, Sang Joon/0000-0001-5350-7241; Jung, Minkyu/0000-0001-8281-3387; Kim, Nam-Kyu/0000-0003-0639-5632; Ahn, Joong Bae/0000-0001-6787-1503; Yoon, Hong In/0000-0002-2106-6856; Kim, Tae Il/0000-0003-4807-890X	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning [2015R1C1A1A01053547]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (2015R1C1A1A01053547).	Beppu N, 2014, INT J COLORECTAL DIS, V29, P1459, DOI 10.1007/s00384-014-1997-5; Blazer DG, 2008, J CLIN ONCOL, V26, P5344, DOI 10.1200/JCO.2008.17.5299; Bonney GK, 2015, J SURG ONCOL, V111, P716, DOI 10.1002/jso.23899; Bujko K, 2006, BRIT J SURG, V93, P1215, DOI 10.1002/bjs.5506; Ciliberto D, 2012, ONCOL REP, V27, P1849, DOI 10.3892/or.2012.1740; Glimelius B, 2003, ACTA ONCOL, V42, P476, DOI 10.1080/02841860310012301; Gonzalez M, 2013, ANN SURG ONCOL, V20, P572, DOI 10.1245/s10434-012-2726-3; Hatfield P, 2009, RADIOTHER ONCOL, V92, P210, DOI 10.1016/j.radonc.2009.04.007; He Yi-Fu, 2006, Ai Zheng, V25, P1153; Kim KH, 2016, RADIOTHER ONCOL, V118, P369, DOI 10.1016/j.radonc.2015.11.029; MANDARD AM, 1994, CANCER, V73, P2680, DOI 10.1002/1097-0142(19940601)73:11<2680::AID-CNCR2820731105>3.0.CO;2-C; Marijnen CAM, 2003, INT J RADIAT ONCOL, V55, P1311, DOI 10.1016/S0360-3016(02)04291-8; Nagtegaal ID, 2002, AM J SURG PATHOL, V26, P350, DOI 10.1097/00000478-200203000-00009; Nagtegaal ID, 2008, J CLIN ONCOL, V26, P303, DOI 10.1200/JCO.2007.12.7027; Network NCC, 2015, NCCN CLIN PRACTICE G; Nordlinger B, 2008, LANCET, V371, P1007, DOI 10.1016/S0140-6736(08)60455-9; Pettersson D, 2012, BRIT J SURG, V99, P577, DOI 10.1002/bjs.7796; Poultsides GA, 2012, ANN SURG ONCOL, V19, P2797, DOI 10.1245/s10434-012-2335-1; Radu C, 2008, RADIOTHER ONCOL, V87, P343, DOI 10.1016/j.radonc.2007.11.025; Rama N, 2009, EUR J CARDIO-THORAC, V35, P444, DOI 10.1016/j.ejcts.2008.10.047; Salah S, 2012, ANN ONCOL, V23, P2649, DOI 10.1093/annonc/mds100; Sauer R, 2004, NEW ENGL J MED, V351, P1731, DOI 10.1056/NEJMoa040694; Shin SJ, 2011, RADIAT ONCOL, V6, DOI 10.1186/1748-717X-6-99; Tyc-Szczepaniak D, 2013, ANN ONCOL, V24, P2829, DOI 10.1093/annonc/mdt363; van der Pool AE, 2010, BRIT J SURG, V97, P383, DOI 10.1002/bjs.6947; van Dijk TH, 2013, ANN ONCOL, V24, P1762, DOI 10.1093/annonc/mdt124; van Gijn W, 2011, LANCET ONCOL, V12, P575, DOI 10.1016/S1470-2045(11)70097-3; Wong RKS, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002102.pub2; Yeo SG, 2013, INT J RADIAT ONCOL, V86, P34, DOI 10.1016/j.ijrobp.2012.11.018; Zhou ZR, 2014, SURG ONCOL, V23, P211, DOI 10.1016/j.suronc.2014.10.003; Zhu DX, 2012, ANN SURG ONCOL, V19, P2860, DOI 10.1245/s10434-012-2356-9	31	34	34	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0161475	10.1371/journal.pone.0161475	http://dx.doi.org/10.1371/journal.pone.0161475			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27536871	Green Submitted, Green Published, gold			2022-12-27	WOS:000381577000111
J	Zhu, XQ; Lu, W; Chen, Y; Cheng, XF; Qiu, JY; Xu, Y; Sun, Y				Zhu, Xiang-qing; Lu, Wei; Chen, Yang; Cheng, Xiao-fan; Qiu, Jia-ying; Xu, Yan; Sun, Ying			Effects of Porphyromonas gingivalis Lipopolysaccharide Tolerized Monocytes on Inflammatory Responses in Neutrophils	PLOS ONE			English	Article							EXPRESSION; TOLERANCE; APOPTOSIS; RECEPTOR; ACTIVATION; CHEMOKINES; CELLS; IL-10; LPS; PHOSPHORYLATION	Periodontitis is a chronic inflammatory disease induced by bacteria. Exposure of the host to periodontal pathogens and their virulence factors induces a state of hyporesponsiveness to subsequent stimulations, which is termed endotoxin tolerance. The role and mechanism of lipopolysaccharide (LPS)-tolerized monocytes in inflammatory responses in neutrophils are currently unclear. Here, conditioned supernatants were collected from THP-1 cells treated with or without repeated 1 mu g/ml Porphyromonas gingivalis (P. gingivalis) LPS. The chemotactic response of freshly isolated neutrophils recruited by supernatants was determined by a transwell migration assay, which demonstrated a reduced migration of neutrophils stimulated with supernatants from tolerized THP-1 cells in comparison to non-tolerized THP-1 cells. In addition, there was a marked increase in reactive oxygen species (ROS) generation and a significant decrease in Caspase 3 activities in neutrophils treated with supernatants from THP-1 cells that were treated repeatedly with P. gingivalis LPS in comparison to single treatment. A cytokine antibody array was then used to assess cytokine expression patterns in THP-1 cells. In tolerized THP-1 cells, 43 cytokine (43/170) expression levels were decreased, including chemokine ligand 23 (CCL23) and IFN-gamma, while 11 cytokine (11/170) expression levels were increased, such as death receptor 6 (DR6). Furthermore, there was decreased production of IFN-gamma and epithelial neutrophil activating peptide-78 (ENA-78) in THP-1 cells after stimulation with repeated P. gingivalis LPS in comparison to single challenge, which was confirmed by ELISA. Therefore, P. gingivalis LPS-tolerized THP-1 cells were able to depress neutrophil chemotaxis and apoptosis, and contribute to respiratory burst, which might be related to the changes in cytokine expression patterns in THP-1 cells.	[Zhu, Xiang-qing; Lu, Wei; Chen, Yang; Cheng, Xiao-fan; Qiu, Jia-ying; Xu, Yan; Sun, Ying] Nanjing Med Univ, Jiangsu Key Lab Oral Dis, Nanjing, Jiangsu, Peoples R China; [Zhu, Xiang-qing; Lu, Wei; Chen, Yang; Cheng, Xiao-fan; Qiu, Jia-ying; Xu, Yan; Sun, Ying] Nanjing Med Univ, Affiliated Hosp Stomatol, Dept Periodontol, Nanjing, Jiangsu, Peoples R China; [Zhu, Xiang-qing] Nanjing First Hosp, Dept Stomatol, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University	Sun, Y (corresponding author), Nanjing Med Univ, Jiangsu Key Lab Oral Dis, Nanjing, Jiangsu, Peoples R China.; Sun, Y (corresponding author), Nanjing Med Univ, Affiliated Hosp Stomatol, Dept Periodontol, Nanjing, Jiangsu, Peoples R China.	ebolasun@njmu.edu.cn			Natural Science Foundation of Jiangsu Province [BK20161565];  [81370025];  [2014-37]	Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); ; 	Grant BK20161565 (http://www.jstd.gov.cn/) from Natural Science Foundation of Jiangsu Province was received by YS. This funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Then, there were 3 funds (Grant 81370025, Grant 2014-37, Grant BK20161565) that subsidized this paper now.	Al-Shibani NK, 2011, J PERIODONTOL, V82, P1504, DOI 10.1902/jop.2011.100757; Bliss CM, 1998, INFECT IMMUN, V66, P5357, DOI 10.1128/IAI.66.11.5357-5363.1998; Borregaard N, 2010, IMMUNITY, V33, P657, DOI 10.1016/j.immuni.2010.11.011; Bosmann M, 2014, J IMMUNOL, V193, P5668, DOI 10.4049/jimmunol.1302280; Bratton DL, 2011, TRENDS IMMUNOL, V32, P350, DOI 10.1016/j.it.2011.04.009; CHENG JH, 1994, SCIENCE, V263, P1759, DOI 10.1126/science.7510905; Cole TS, 2012, IMMUNOL LETT, V144, P49, DOI 10.1016/j.imlet.2012.03.006; El-Benna J, 2008, SEMIN IMMUNOPATHOL, V30, P279, DOI 10.1007/s00281-008-0118-3; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Galli SJ, 2011, NAT IMMUNOL, V12, P1035, DOI 10.1038/ni.2109; Golz L, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/986264; Gong J, 2015, SHOCK, V44, P371, DOI 10.1097/SHK.0000000000000434; Griffith JW, 2014, ANNU REV IMMUNOL, V32, P659, DOI 10.1146/annurev-immunol-032713-120145; Grosse-Steffen T, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/720768; Haute GV, 2015, TOXICOL IN VITRO, V30, P309, DOI 10.1016/j.tiv.2015.10.005; Huang G, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.378; Jain S, 2010, PERIODONTOL 2000, V54, P53, DOI 10.1111/j.1600-0757.2009.00333.x; Kang SW, 2015, GENET MOL RES, V14, P18069, DOI 10.4238/2015.December.22.33; Kaplanski G, 2003, TRENDS IMMUNOL, V24, P25, DOI 10.1016/S1471-4906(02)00013-3; Kathariya R, 2014, J INVESTIG CLIN DENT, V5, P23, DOI 10.1111/jicd.12009; Keglowich L, 2014, J ALLERGY CAIRO, V2014; Kovacs I, 2014, FREE RADICAL RES, V48, P1190, DOI 10.3109/10715762.2014.938234; Ling MR, 2015, INNATE IMMUN-LONDON, V21, P714, DOI 10.1177/1753425915589387; Mathy-Hartert M, 2003, INFLAMM RES, V52, P111; Medvedev AE, 2006, J ENDOTOXIN RES, V12, P133, DOI 10.1179/096805106X102255; Melo ES, 2010, MOL IMMUNOL, V47, P2587, DOI 10.1016/j.molimm.2010.06.011; Morozumi T, 2016, J PERIODONTAL RES, V51, P768, DOI 10.1111/jre.12353; Muniz FWMG, 2015, ARCH ORAL BIOL, V60, P1203, DOI 10.1016/j.archoralbio.2015.05.007; Muthukuru M, 2005, INFECT IMMUN, V73, P687, DOI 10.1128/IAI.73.2.687-694.2005; Patel VP, 1997, J EXP MED, V185, P1163, DOI 10.1084/jem.185.7.1163; Poposki JA, 2011, J ALLERGY CLIN IMMUN, V128, P73, DOI 10.1016/j.jaci.2011.03.017; Searles S, 2013, J IMMUNOL, V191, P3884, DOI 10.4049/jimmunol.1301344; Shih CH, 2005, EXP HEMATOL, V33, P1101, DOI 10.1016/j.exphem.2005.06.028; Sugaya M, 2015, ARCH IMMUNOL THER EX, V63, P109, DOI 10.1007/s00005-014-0313-y; Sun Y, 2014, INFLAMMATION, V37, P268, DOI 10.1007/s10753-013-9737-5; Sun Y, 2010, J PERIODONTOL, V81, P1488, DOI 10.1902/jop.2010.100004; Ribeiro ALT, 2011, TOXICOLOGY, V288, P1, DOI 10.1016/j.tox.2011.05.009; Tonetti MS, 1997, J PERIODONTAL RES, V32, P104, DOI 10.1111/j.1600-0765.1997.tb01389.x; Varghese Sheeja S, 2015, Contemp Clin Dent, V6, pS152, DOI 10.4103/0976-237X.166816; Wall DM, 2014, CELL MICROBIOL, V16, P1746, DOI 10.1111/cmi.12368; Wang L, 2014, INT ENDOD J, V47, P271, DOI 10.1111/iej.12143; Wei SQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077519; Xiong YB, 2016, J INNATE IMMUN, V8, P171, DOI 10.1159/000440838; Zeng LL, 2012, J BIOL CHEM, V287, P29125, DOI 10.1074/jbc.M112.362038; Zhou HF, 2013, J IMMUNOL, V190, P5078, DOI 10.4049/jimmunol.1203228; Zhu CL, 2010, SCAND J IMMUNOL, V72, P469, DOI 10.1111/j.1365-3083.2010.02460.x; Zhu XJ, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4377; Zizzo G, 2013, J IMMUNOL, V190, P5237, DOI 10.4049/jimmunol.1203017	48	11	13	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0161482	10.1371/journal.pone.0161482	http://dx.doi.org/10.1371/journal.pone.0161482			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27536946	gold, Green Submitted, Green Published			2022-12-27	WOS:000381577000112
J	Bohn, B; Karges, B; Vogel, C; Otto, KP; Marg, W; Hofer, SE; Frohlich-Reiterer, E; Holder, M; Plamper, M; Wabitsch, M; Kerner, W; Holl, RW				Bohn, Barbara; Karges, Beate; Vogel, Christian; Otto, Klaus-Peter; Marg, Wolfgang; Hofer, Sabine E.; Froehlich-Reiterer, Elke; Holder, Martin; Plamper, Michaela; Wabitsch, Martin; Kerner, Wolfgang; Holl, Reinhard W.		DPV Initiative	20 Years of Pediatric Benchmarking in Germany and Austria: Age-Dependent Analysis of Longitudinal Follow-Up in 63,967 Children and Adolescents with Type 1 Diabetes	PLOS ONE			English	Article							CONSENSUS STATEMENT; INSULIN THERAPY; MANAGEMENT; ENDOCRINOLOGY; KETOACIDOSIS; ASSOCIATION; DISEASE; TRENDS; CARE	Background To investigate changes in diabetes treatment over the last two decades in three age-groups of children and adolescents with type 1 diabetes (T1D) from Germany and Austria. Methods 63,967 subjects (< 18yr) with T1D documented between 1995 and 2014 from the DPV-database were included and stratified according to age (0.5-<6, 6-<12, 12-<18yr). Regression models were applied for insulin regimens (< 3 and >= 4 injection time points/day, or continuous subcutaneous insulin infusion (CSII)), use of rapid-and long acting insulin analogues, NPH insulin, and frequency of self-monitoring of blood glucose (SMBG)/day. Models were adjusted for sex, diabetes duration, and migration background. P-value for trend was given. Findings The number of subjects with <3 injection time points/day decreased from 1995 to 2014 to <5% in all age-groups (p<0.0001). Proportion of patients with >= 4 injections/day increased until the early 2000s, and then declined until 2014. This trend was not found in 6-<12yr olds (p = 0.3403). CSII increased in all age-groups (p<0.0001) with the highest increase in children <6 years (from 0.4% to 79.2%), and the lowest increase in 12-<18 year olds (from 1.0% to 38.9%). NPH insulin decreased in all age-groups (p<0.0001). Insulin analogues, especially rapid-acting, became more frequent in all age-groups (p<0.0001), accounting for 78.4% in 2014 for all subjects. The highest use was found in the youngest children (in 2014: 85.6%), the lowest use in 6-<12 year olds (in 2014: 72.9%). The number of SMBG/day increased from 2.2 to 6.4 with a similar rise in all age-groups (p<0.0001). Frequency was highest in subjects <6yr. Conclusions In all age-groups, T1D treatment was intensified over the last 20 years. Age-specific differences in trends were particularly observed in the number of patients on CSII, in the number of patients with 4 or more injections/day, and in the frequency of SMBG/day.	[Bohn, Barbara; Holl, Reinhard W.] Univ Ulm, ZIBMT, Inst Epidemiol & Med Biometry, Ulm, Germany; [Bohn, Barbara; Holl, Reinhard W.] German Ctr Diabet Res DZD, Munich, Germany; [Karges, Beate] Rhein Westfal TH Aachen, German Ctr Diabet Res DZD, Fac Med, Div Endocrinol & Diabet, Aachen, Germany; [Karges, Beate] Rhein Westfal TH Aachen, German Ctr Diabet Res DZD, Fac Med, Dept Gynecol Endocrinol & Reprod Med, Aachen, Germany; [Karges, Beate] Bethlehem Hosp, Dept Pediat, Stolberg, Germany; [Vogel, Christian] Clin Chemnitz, Dept Pediat Endocrinol & Diabetol, Chemnitz, Germany; [Otto, Klaus-Peter] Clin Itzehoe, Ctr Pediat & Adolescents Med Neonatol & Pediat In, Itzehoe, Germany; [Marg, Wolfgang] Bremen Mitte Hosp, Ctr Pediat & Adolescent Med, Bremen, Germany; [Hofer, Sabine E.] Med Univ Innsbruck, Dept Paediat, Innsbruck, Austria; [Froehlich-Reiterer, Elke] Med Univ Graz, Dept Pediat, Graz, Austria; [Holder, Martin] Olgahospital, Stuttgart Clin Ctr, Dept Pediat Endocrinol & Diabetol, Stuttgart, Germany; [Plamper, Michaela] Univ Hosp Bonn, Dept Pediat Endocrinol & Diabetol, Bonn, Germany; [Wabitsch, Martin] Univ Hosp Children & Adolescents, Div Pediat Endocrinol & Diabet, Ulm, Germany; [Kerner, Wolfgang] Ctr Diabet & Metab Disorders, Karlsburg, Germany	Ulm University; RWTH Aachen University; RWTH Aachen University; Chemnitz Clinic; Klinikum Bremen-Mitte; Medical University of Innsbruck; Medical University of Graz; Klinikum Stuttgart; University of Bonn	Bohn, B (corresponding author), Univ Ulm, ZIBMT, Inst Epidemiol & Med Biometry, Ulm, Germany.; Bohn, B (corresponding author), German Ctr Diabet Res DZD, Munich, Germany.	barbara.bohn@uni-ulm.de	Plamper, Michaela/AAG-4445-2020	Holl, Reinhard/0000-0003-1395-4842	German Competence Network Diabetes mellitus - Federal Ministry of Education and Research [FKZ 01GI1106]; European Foundation for the Study of Diabetes (EFSD); German Diabetes Association (DDG); European Foundation for the Study of Diabetes [AZ Macrov 2014_2] Funding Source: researchfish	German Competence Network Diabetes mellitus - Federal Ministry of Education and Research; European Foundation for the Study of Diabetes (EFSD); German Diabetes Association (DDG); European Foundation for the Study of Diabetes	The study was supported by the German Competence Network Diabetes mellitus (diabetes meta-database) funded by the Federal Ministry of Education and Research (FKZ 01GI1106) (https://www.bmbf.de/), now integrated into the German Center for Diabetes Research (DZD) (https://www.dzd-ev.de/) as of January 2015. Further financial support was provided by the European Foundation for the Study of Diabetes (EFSD) (http://www.europeandiabetesfoundation.org/), and by the German Diabetes Association (DDG) (http://www.deutsche-diabetes-gesellschaft.de/home.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altobelli E, 2000, ACTA DIABETOL, V37, P173, DOI 10.1007/s005920070001; Amer Diabet Assoc, 2014, DIABETES CARE, V37, pS14, DOI 10.2337/dc14-S014; Bangstad HJ, 2009, PEDIATR DIABETES, V10, P82, DOI 10.1111/j.1399-5448.2009.00578.x; Blum RW, 2002, PEDIATRICS, V110, P1304; Cameron FJ, 2015, LANCET, V385, P2096, DOI 10.1016/S0140-6736(15)60971-0; Carstensen B, 2008, DIABETOLOGIA, V51, P2187, DOI 10.1007/s00125-008-1156-z; Cengiz E, 2013, PEDIATR DIABETES, V14, P447, DOI 10.1111/pedi.12030; Danne T, 2007, ARCH DIS CHILD, V92, P1015, DOI 10.1136/adc.2006.094904; de Beaufort CE, 2007, DIABETES CARE, V30, P2245, DOI 10.2337/dc07-0475; Grabert M, 2002, COMPUT METH PROG BIO, V69, P115, DOI 10.1016/S0169-2607(02)00035-4; Grunberger G, 2014, ENDOCR PRACT, V20, P463, DOI 10.4158/EP14145.PS; Hattersley AT, 2014, LANCET DIABETES ENDO, V2, P194, DOI 10.1016/S2213-8587(13)70179-7; Hofer S, 2012, MINERVA PEDIATR, V64, P433; Hofer SE, 2014, J PEDIAT, V165, pe1; Icks A, 2013, EXP CLIN ENDOCR DIAB, V121, P58, DOI 10.1055/s-0032-1312639; Karges B, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001742; Margeirsdottir HD, 2010, PEDIATR DIABETES, V11, P88, DOI 10.1111/j.1399-5448.2009.00542.x; Miller KM, 2015, DIABETES CARE, V38, P971, DOI 10.2337/dc15-0078; Neu A, 2015, DIABETOL STOFFWECHS, V10, pS181; Otto T, 2014, GESUNDH QUAL, V19, P126, DOI 10.1055/s-0033-1355963; Phillip M, 2007, DIABETES CARE, V30, P1653, DOI 10.2337/dc07-9922; Prinz N, 2016, DIABETES TECHNOL THE, V18, P34, DOI 10.1089/dia.2015.0180; Redon I, 2014, PEDIATR DIABETES, V15, P329, DOI 10.1111/pedi.12062; Rohrer TR, 2015, DIABETES CARE, V38, P801, DOI 10.2337/dc14-0683; Rosario AS, 2010, EUR J CLIN NUTR, V64, P341, DOI 10.1038/ejcn.2010.8; Rosenbauer J, 2012, DIABETES CARE, V35, P80, DOI 10.2337/dc11-0993; Svensson J, 2009, PEDIATR DIABETES, V10, P461, DOI 10.1111/j.1399-5448.2008.00460.x; Svoren BM, 2007, J PEDIATR-US, V150, P279, DOI 10.1016/j.jpeds.2006.12.009; Waite P, 2015, J ABNORM CHILD PSYCH, V43, P1079, DOI 10.1007/s10802-015-0005-z	29	41	44	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2016	11	8							e0160971	10.1371/journal.pone.0160971	http://dx.doi.org/10.1371/journal.pone.0160971			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4YN	27532627	Green Published, gold			2022-12-27	WOS:000381487600051
J	Casonato, A; Cattini, MG; Daidone, V; Pontara, E; Bertomoro, A; Prandoni, P				Casonato, Alessandra; Cattini, Maria Grazia; Daidone, Viviana; Pontara, Elena; Bertomoro, Antonella; Prandoni, Paolo			Diagnostic Value of Measuring Platelet Von Willebrand Factor in Von Willebrand Disease	PLOS ONE			English	Article							ABO BLOOD-GROUP; BONE-MARROW-TRANSPLANTATION; VONWILLEBRAND-FACTOR; MULTIMERIC STRUCTURE; BINDING-ACTIVITY; FACTOR MUTATION; PLASMA; PROTEOLYSIS; ADAMTS13; SURVIVAL	Von Willebrand disease (VWD) may be caused by an impaired von Willebrand factor (VWF) synthesis, its increased clearance or abnormal function, or combinations of these factors. It may be difficult to recognize the different contributions of these anomalies. Here we demonstrate that VWD diagnostics gains from measuring platelet VWF, which can reveal a defective VWF synthesis. Measuring platelet VWF revealed that: severe type 1 VWD always coincided with significantly lower platelet and plasma VWF levels, whereas mild forms revealed low plasma VWF levels associated with low or normal platelet VWF levels, and the latter were associated with a slightly shorter VWF survival; type Vicenza (the archetype VWD caused by a reduced VWF survival) featured normal platelet VWF levels despite significantly reduced plasma VWF levels; type 2B patients could have either normal platelet VWF levels associated with abnormal multimer patterns, or reduced platelet VWF levels associated with normal multimer patterns; type 2A patients could have reduced or normal platelet VWF levels, the former associated mainly with type 2A-I, the latter with type 2A-II; plasma and platelet VWF levels were normal in type 2N, except when the defect was associated with a quantitative VWF mutation. Our findings show that measuring platelet VWF helps to characterize VWD, especially the ambiguous phenotypes, shedding light on the mechanisms underlying the disorder.	[Casonato, Alessandra; Bertomoro, Antonella] Univ Padua, Sch Med, Dept Med, Padua, Italy; [Cattini, Maria Grazia; Daidone, Viviana; Pontara, Elena; Prandoni, Paolo] Univ Padua, Sch Med, Dept Cardiol Thorac & Vasc Sci, Padua, Italy	University of Padua; University of Padua	Casonato, A (corresponding author), Univ Padua, Sch Med, Dept Med, Padua, Italy.	andra.casonato@unipd.it			Ministero dell'Universita e della Ricerca Scientifica e Tecnologica	Ministero dell'Universita e della Ricerca Scientifica e Tecnologica(Ministry of Education, Universities and Research (MIUR))	This work was supported by a grant from the Ministero dell'Universita e della Ricerca Scientifica e Tecnologica (60%, 2013). AC received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bowen DJ, 2003, J THROMB HAEMOST, V1, P33, DOI 10.1046/j.1538-7836.2003.00007.x; BOWIE EJW, 1986, J CLIN INVEST, V78, P26, DOI 10.1172/JCI112560; Brown SA, 2002, THROMB HAEMOSTASIS, V87, P990; Casonato A, 2015, THROMB RES, V136, P682, DOI 10.1016/j.thromres.2015.07.014; Casonato A, 2002, BLOOD, V99, P180, DOI 10.1182/blood.V99.1.180; Casonato A, 1997, J LAB CLIN MED, V129, P251, DOI 10.1016/S0022-2143(97)90147-5; CASONATO A, 1989, BLOOD, V74, P2028; CASONATO A, 1992, BLOOD COAGUL FIBRIN, V3, P149, DOI 10.1097/00001721-199204000-00003; Casonato A, 1998, AM J CLIN PATHOL, V109, P347, DOI 10.1093/ajcp/109.3.347; Casonato A, 2007, THROMB HAEMOSTASIS, V98, P1182, DOI 10.1160/TH07-05-0347; Casonato A, 2010, TRANSL RES, V155, P200, DOI 10.1016/j.trsl.2009.12.003; CASTILLO R, 1991, BLOOD, V77, P1901; Eikenboom JCJ, 2002, THROMB HAEMOSTASIS, V87, P252; Eikenboom J, 2013, BLOOD, V121, P2336, DOI 10.1182/blood-2012-09-455089; FERNANDEZ MFL, 1982, BLOOD, V60, P1132; FOSTER PA, 1987, J BIOL CHEM, V262, P8443; FRESSINAUD E, 1994, BRIT J HAEMATOL, V86, P327, DOI 10.1111/j.1365-2141.1994.tb04734.x; Gallinaro L, 2008, BLOOD, V111, P3540, DOI 10.1182/blood-2007-11-122945; Gallinaro L, 2006, THROMB HAEMOSTASIS, V96, P711, DOI 10.1160/TH06-07-0417; GRALNICK HR, 1986, BLOOD, V68, P58; Kagami K, 2000, Nagoya J Med Sci, V63, P51; LYONS SE, 1992, J BIOL CHEM, V267, P4424; MANCUSO DJ, 1989, J BIOL CHEM, V264, P19514; MANNUCCI PM, 1985, BLOOD, V66, P796; Matsui T, 1999, BLOOD, V94, P2895, DOI 10.1182/blood.V94.8.2895.420a03_2895_2900; MAYADAS TN, 1991, ANN NY ACAD SCI, V614, P153, DOI 10.1111/j.1749-6632.1991.tb43700.x; McGrath RT, 2013, BLOOD, V122, P4107, DOI 10.1182/blood-2013-04-496851; NACHMAN RL, 1975, J EXP MED, V141, P1101, DOI 10.1084/jem.141.5.1101; NICHOLS TC, 1995, P NATL ACAD SCI USA, V92, P2455, DOI 10.1073/pnas.92.7.2455; Sadler JE, 2006, J THROMB HAEMOST, V4, P2103, DOI 10.1111/j.1538-7836.2006.02146.x; Sadler JE, 1998, ANNU REV BIOCHEM, V67, P395, DOI 10.1146/annurev.biochem.67.1.395; Schneppenheim R, 2000, THROMB HAEMOSTASIS, V83, P136; SWEENEY JD, 1992, THROMB RES, V68, P393, DOI 10.1016/0049-3848(92)90097-T; TSAI HM, 1991, BRIT J HAEMATOL, V79, P239, DOI 10.1111/j.1365-2141.1991.tb04528.x; WEISS HJ, 1983, J LAB CLIN MED, V101, P411; WILLIAMS SB, 1994, BRIT J HAEMATOL, V88, P582, DOI 10.1111/j.1365-2141.1994.tb05077.x	36	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2016	11	8							e0161310	10.1371/journal.pone.0161310	http://dx.doi.org/10.1371/journal.pone.0161310			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4YN	27532107	Green Submitted, Green Published, gold			2022-12-27	WOS:000381487600084
J	Guo, WH; Chen, YY; Wei, N; Feng, XY				Guo, Weihua; Chen, Yingying; Wei, Na; Feng, Xueyang			Investigate the Metabolic Reprogramming of Saccharomyces cerevisiae for Enhanced Resistance to Mixed Fermentation Inhibitors via C-13 Metabolic Flux Analysis	PLOS ONE			English	Article							ACETIC-ACID; TOLERANCE; YEAST; STRESS; ADAPTATION; ACETATE; GENES	The fermentation inhibitors from the pretreatment of lignocellulosic materials, e.g., acetic acid and furfural, are notorious due to their negative effects on the cell growth and chemical production. However, the metabolic reprogramming of the cells under these stress conditions, especially metabolic response for resistance to mixed inhibitors, has not been systematically investigated and remains mysterious. Therefore, in this study, C-13 metabolic flux analysis (C-13-MFA), a powerful tool to elucidate the intracellular carbon flux distributions, has been applied to two Saccharomyces cerevisiae strains with different tolerances to the inhibitors under acetic acid, furfural, and mixed (i.e., acetic acid and furfural) stress conditions to unravel the key metabolic responses. By analyzing the intracellular carbon fluxes as well as the energy and cofactor utilization under different conditions, we uncovered varied metabolic responses to different inhibitors. Under acetate stress, ATP and NADH production was slightly impaired, while NADPH tended towards overproduction. Under furfural stress, ATP and cofactors (including both NADH and NADPH) tended to be overproduced. However, under dual-stress condition, production of ATP and cofactors was severely impaired due to synergistic stress caused by the simultaneous addition of two fermentation inhibitors. Such phenomenon indicated the pivotal role of the energy and cofactor utilization in resisting the mixed inhibitors of acetic acid and furfural. Based on the discoveries, valuable insights are provided to improve the tolerance of S. cerevisiae strain and further enhance lignocellulosic fermentation.	[Guo, Weihua; Feng, Xueyang] Virginia Polytech Inst & State Univ, Dept Biol Syst Engn, Blacksburg, VA 24061 USA; [Chen, Yingying; Wei, Na] Univ Notre Dame, Dept Civil & Environm Engn & Earth Sci, Notre Dame, IN 46556 USA	Virginia Polytechnic Institute & State University; University of Notre Dame	Feng, XY (corresponding author), Virginia Polytech Inst & State Univ, Dept Biol Syst Engn, Blacksburg, VA 24061 USA.; Wei, N (corresponding author), Univ Notre Dame, Dept Civil & Environm Engn & Earth Sci, Notre Dame, IN 46556 USA.	nwei@nd.edu; xueyang@vt.edu	Guo, Weihua/AGF-9090-2022; chen, ying/HHS-8254-2022	Feng, Xueyang/0000-0003-4426-5732	Institute for Critical Technology and Applied Science from Virginia Polytechnic Institute and State University [175323, J0663185]; University of Notre Dame; Institute for Critical Technology and Applied Science from Virginia Tech [175323, J0663185]	Institute for Critical Technology and Applied Science from Virginia Polytechnic Institute and State University; University of Notre Dame; Institute for Critical Technology and Applied Science from Virginia Tech	This study was supported by a start-up fund (#175323) and Junior Faculty Award of Institute for Critical Technology and Applied Science (#J0663185 to XYF) from Virginia Polytechnic Institute and State University, and a start-up fund from the University of Notre Dame.; We thank the writing center in Virginia Tech for improving the language of the paper. This study was supported by a start-up fund (#175323) and Junior Faculty Award of Institute for Critical Technology and Applied Science (#J0663185) from Virginia Tech and a start-up fund from the University of Notre Dame.	Almeida JRM, 2007, J CHEM TECHNOL BIOT, V82, P340, DOI 10.1002/jctb.1676; BANERJEE N, 1981, EUR J APPL MICROBIOL, V11, P226, DOI 10.1007/BF00505872; Bauer BE, 2003, EUR J BIOCHEM, V270, P3189, DOI 10.1046/j.1432-1033.2003.03701.x; Cakir T, 2004, BIOTECHNOL BIOENG, V86, P251, DOI 10.1002/bit.20020; Casal M, 1996, MICROBIOL-UK, V142, P1385, DOI 10.1099/13500872-142-6-1385; Chen Y, 2016, APPLIED AND ENVIRONM; Chen YY, 2016, APPL ENVIRON MICROB, V82, P2156, DOI 10.1128/AEM.03718-15; Chen YY, 2016, BIOTECHNOL BIOFUELS, V9, DOI 10.1186/s13068-015-0418-5; Cvijovic M, 2010, NUCLEIC ACIDS RES, V38, pW144, DOI 10.1093/nar/gkq404; Feng XY, 2013, MICROB CELL FACT, V12, DOI 10.1186/1475-2859-12-114; Feng Xueyang, 2012, Methods Mol Biol, V881, P309, DOI 10.1007/978-1-61779-827-6_11; Giannattasio S, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00033; Gorsich SW, 2006, APPL MICROBIOL BIOT, V71, P339, DOI 10.1007/s00253-005-0142-3; Guo Weihua, 2016, Bioengineering-Basel, V3, P3, DOI 10.3390/bioengineering3010003; Hasunuma T, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-2; Heer D, 2009, APPL ENVIRON MICROB, V75, P7631, DOI 10.1128/AEM.01649-09; Heer D, 2008, MICROB BIOTECHNOL, V1, P497, DOI 10.1111/j.1751-7915.2008.00050.x; Hohmann S, 2003, YEAST STRESS RESPONS; Horvath IS, 2003, APPL ENVIRON MICROB, V69, P4076, DOI 10.1128/AEM.69.7.4076-4086.2003; Jarboe LR, 2011, CURR OPIN CHEM ENG, V1, P38, DOI 10.1016/j.coche.2011.08.003; Jonsson LJ, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-16; Keating JD, 2006, BIOTECHNOL BIOENG, V93, P1196, DOI 10.1002/bit.20838; Kim SR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057048; KREBS HA, 1952, BIOCHEM J, V51, P614, DOI 10.1042/bj0510614; Lambert RJ, 1999, J APPL MICROBIOL, V86, P157, DOI 10.1046/j.1365-2672.1999.00646.x; Lee YJ, 2011, YEAST, V28, P153, DOI 10.1002/yea.1828; Li BZ, 2010, APPL MICROBIOL BIOT, V86, P1915, DOI 10.1007/s00253-010-2518-2; Lin FM, 2009, APPL ENVIRON MICROB, V75, P3765, DOI 10.1128/AEM.02594-08; Liu ZL, 2011, APPL MICROBIOL BIOT, V90, P809, DOI 10.1007/s00253-011-3167-9; MAIORELLA B, 1983, BIOTECHNOL BIOENG, V25, P103, DOI 10.1002/bit.260250109; Martin C, 2007, BIORESOURCE TECHNOL, V98, P1767, DOI 10.1016/j.biortech.2006.07.021; Mira NP, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-79; Mira NP, 2010, OMICS, V14, P525, DOI 10.1089/omi.2010.0072; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; NIKAWA J, 1991, J BIOL CHEM, V266, P11184; Palmqvist E, 1999, BIOTECHNOL BIOENG, V63, P46, DOI 10.1002/(SICI)1097-0290(19990405)63:1<46::AID-BIT5>3.0.CO;2-J; Palmqvist E, 1999, BIOTECHNOL BIOENG, V62, P447, DOI 10.1002/(SICI)1097-0290(19990220)62:4<447::AID-BIT7>3.3.CO;2-S; Palmqvist E, 2000, BIORESOURCE TECHNOL, V74, P17, DOI 10.1016/S0960-8524(99)00160-1; Semchyshyn HM, 2011, REDOX REP, V16, P15, DOI 10.1179/174329211X12968219310954; Sousa MJ, 2012, STRESS CELL DEATH YE, DOI [10.1179/174329211X12968219310954, DOI 10.1179/174329211X12968219310954]; Taherzadeh MJ, 2000, J BIOSCI BIOENG, V90, P374, DOI 10.1263/jbb.90.374; Wahl SA, 2004, BIOTECHNOL BIOENG, V85, P259, DOI 10.1002/bit.10909; Zamboni N, 2009, NAT PROTOC, V4, P878, DOI 10.1038/nprot.2009.58; Zhang JG, 2011, BIOTECHNOL LETT, V33, P277, DOI 10.1007/s10529-010-0433-3; Zheng DQ, 2011, J IND MICROBIOL BIOT, V38, P415, DOI 10.1007/s10295-010-0784-8	45	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2016	11	8							e0161448	10.1371/journal.pone.0161448	http://dx.doi.org/10.1371/journal.pone.0161448			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4YN	27532329	Green Published, gold, Green Submitted			2022-12-27	WOS:000381487600096
J	Kano, Y; Dudgeon, D; Nam, S; Samejima, H; Watanabe, K; Grudpan, C; Grudpan, J; Magtoon, W; Musikasinthorn, P; Nguyen, PT; Praxaysonbath, B; Sato, T; Shibukawa, K; Shimatani, Y; Suvarnaraksha, A; Tanaka, W; Thach, P; Tran, DD; Yamashita, T; Utsugi, K				Kano, Yuichi; Dudgeon, David; Nam, So; Samejima, Hiromitsu; Watanabe, Katsutoshi; Grudpan, Chaiwut; Grudpan, Jarungjit; Magtoon, Wichan; Musikasinthorn, Prachya; Phuong Thanh Nguyen; Praxaysonbath, Bounthob; Sato, Tomoyuki; Shibukawa, Koichi; Shimatani, Yukihiro; Suvarnaraksha, Apinun; Tanaka, Wataru; Thach, Phanara; Dac Dinh Tran; Yamashita, Tomomi; Utsugi, Kenzo			Impacts of Dams and Global Warming on Fish Biodiversity in the Indo-Burma Hotspot	PLOS ONE			English	Article							FRESH-WATER BIODIVERSITY; CLIMATE-CHANGE; FUTURE; FLOW; HYDROPOWER; SCENARIOS; SECURITY; PATTERNS; THREATS; WORLDS	Both hydropower dams and global warming pose threats to freshwater fish diversity. While the extent of global warming may be reduced by a shift towards energy generation by large dams in order to reduce fossil-fuel use, such dams profoundly modify riverine habitats. Furthermore, the threats posed by dams and global warming will interact: for example, dams constrain range adjustments by fishes that might compensate for warming temperatures. Evaluation of their combined or synergistic effects is thus essential for adequate assessment of the consequences of planned water-resource developments. We made projections of the responses of 363 fish species within the Indo-Burma global biodiversity hotspot to the separate and joint impacts of dams and global warming. The hotspot encompasses the Lower Mekong Basin, which is the world's largest freshwater capture fishery. Projections for 81 dam-building scenarios revealed progressive impacts upon projected species richness, habitable area, and the proportion of threatened species as generating capacity increased. Projections from 126 global-warming scenarios included a rise in species richness, a reduction in habitable area, and an increase in the proportion of threatened species; however, there was substantial variation in the extent of these changes among warming projections. Projections from scenarios that combined the effects of dams and global warming were derived either by simply adding the two threats, or by combining them in a synergistic manner that took account of the likelihood that habitat shifts under global warming would be constrained by river fragmentation. Impacts on fish diversity under the synergistic projections were 10-20% higher than those attributable to additive scenarios, and were exacerbated as generating capacity increased-particularly if CO2 emissions remained high. The impacts of dams, especially those on river mainstreams, are likely to be greater, more predictable and more immediately pressing for fishes than the consequences of global warming. Limits upon dam construction should therefore be a priority action for conserving fish biodiversity in the Indo-Burma hotspot. This would minimize synergistic impacts attributable to dams plus global warming, and help ensure the continued provision of ecosystem services represented by the Lower Mekong fishery.	[Kano, Yuichi; Shimatani, Yukihiro; Yamashita, Tomomi] Kyushu Univ, Inst Decis Sci Sustainable Soc, Fukuoka, Fukuoka, Japan; [Dudgeon, David] Univ Hong Kong, Sch Biol Sci, Hong Kong, Hong Kong, Peoples R China; [Nam, So; Thach, Phanara] Inland Fisheries Res & Dev Inst Fisheries Adm, Phnom Penh, Cambodia; [Samejima, Hiromitsu] Inst Global Environm Strategies, Hayama, Kanagawa, Japan; [Samejima, Hiromitsu; Shimatani, Yukihiro] Kyushu Univ, Dept Urban & Environm Engn, Fukuoka, Fukuoka, Japan; [Watanabe, Katsutoshi] Kyoto Univ, Dept Zool, Kyoto, Kyoto, Japan; [Grudpan, Chaiwut; Grudpan, Jarungjit] Ubon Ratchathani Univ, Dept Fisheries, Ubon Ratchathani, Thailand; [Magtoon, Wichan] Mahasakham Univ, Dept Biol, Maha Sarakham, Thailand; [Musikasinthorn, Prachya] Kasetsart Univ, Fac Fisheries, Bangkok, Thailand; [Phuong Thanh Nguyen; Dac Dinh Tran] Can Tho Univ, Dept Fisheries Management & Econ, Chan Tho, Vietnam; [Praxaysonbath, Bounthob] Natl Univ Laos, Fac Sci, Viangchan, Laos; [Sato, Tomoyuki] Siem Reap Freshwater Fishes Lab, Siem Reap, Cambodia; [Shibukawa, Koichi; Utsugi, Kenzo] Nagao Nat Environm Fdn, Tokyo, Japan; [Shibukawa, Koichi] Museum Nat & Environm Hist, Shizuoka, Shizuoka, Japan; [Suvarnaraksha, Apinun] Maejo Univ, Fac Fisheries Technol & Aquat Resources, Chiang Mai, Thailand; [Tanaka, Wataru] Kyushu Univ, Grad Educ & Res Training Program Decis Sci Sustai, Fukuoka, Fukuoka, Japan	Kyushu University; University of Hong Kong; Kyushu University; Kyoto University; Ubon Ratchathani University; Kasetsart University; Can Tho University; Maejo University; Kyushu University	Kano, Y (corresponding author), Kyushu Univ, Inst Decis Sci Sustainable Soc, Fukuoka, Fukuoka, Japan.	kano@species.jp		Kano, Yuichi/0000-0001-7158-753X	Environment Research and Technology Development Fund of the Ministry of the Environment, Japan [S9-4-7]; JSPS KAKENHI Grant [26304007]; JSPS Program for Leading Graduate Schools (Graduate Education and Research Training Program in Decision Science for a Sustainable Society)	Environment Research and Technology Development Fund of the Ministry of the Environment, Japan(Ministry of the Environment, Japan); JSPS KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); JSPS Program for Leading Graduate Schools (Graduate Education and Research Training Program in Decision Science for a Sustainable Society)	This research was financially supported, in part, by grants from the Environment Research and Technology Development Fund (S9-4-7) of the Ministry of the Environment, Japan, JSPS KAKENHI Grant Number 26304007, and JSPS Program for Leading Graduate Schools (Graduate Education and Research Training Program in Decision Science for a Sustainable Society). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study. We declare all the funding or sources of support received during this study.	Akin S, 2005, ESTUAR COAST SHELF S, V64, P671, DOI 10.1016/j.ecss.2005.03.019; Allan JD, 2005, BIOSCIENCE, V55, P1041, DOI 10.1641/0006-3568(2005)055[1041:OOIW]2.0.CO;2; Allen D.J., 2012, STATUS DISTRIBUTION; Baran E, 2009, AQUAT ECOSYST HEALTH, V12, P227, DOI 10.1080/14634980903149902; Baran E, 2010, MEKONG RIVER COMMISS, P1; Bellard C, 2012, ECOL LETT, V15, P365, DOI 10.1111/j.1461-0248.2011.01736.x; Besnard AG, 2013, DIVERS DISTRIB, V19, P955, DOI 10.1111/ddi.12047; Beven K.J., 1979, HYDROL SCI B, V24, P43, DOI [10.1080/02626667909491834, DOI 10.1080/02626667909491834]; Bezuijen MR, 2011, WETLAND BIODIVERSITY; CEPF (Critical Ecosystem Partnership Fund), 2012, EC PROF IND BIOD HOT; CGIAR Research Program on Water Land and Ecosystems, 2015, MEK DAM MAP; Comte L, 2013, DIVERS DISTRIB, V19, P996, DOI 10.1111/ddi.12078; Comte L, 2013, FRESHWATER BIOL, V58, P625, DOI 10.1111/fwb.12081; Conti L, 2015, ECOGRAPHY, V38, P510, DOI 10.1111/ecog.00753; Deutsch CA, 2008, P NATL ACAD SCI USA, V105, P6668, DOI 10.1073/pnas.0709472105; Dormann CF, 2013, ECOGRAPHY, V36, P27, DOI 10.1111/j.1600-0587.2012.07348.x; Dudgeon D, 2007, WA SCI TECHNOL, V7, P69, DOI 10.2166/ws.2007.042; Dudgeon D, 2000, ANNU REV ECOL SYST, V31, P239, DOI 10.1146/annurev.ecolsys.31.1.239; Dudgeon D, 2006, BIOL REV, V81, P163, DOI 10.1017/S1464793105006950; Dugan PJ, 2010, AMBIO, V39, P344, DOI 10.1007/s13280-010-0036-1; Edenhofer O., 2014, CONTRIBUTION WORKING; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Fitzpatrick MC, 2013, ECOSPHERE, V4, DOI 10.1890/ES13-00066.1; Fourcade Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097122; Grill G, 2014, ECOL INDIC, V45, P148, DOI 10.1016/j.ecolind.2014.03.026; Heino J, 2009, BIOL REV, V84, P39, DOI 10.1111/j.1469-185X.2008.00060.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hortle KG, 2009, AQUAT ECOL-SAN DIEGO, P197, DOI 10.1016/B978-0-12-374026-7.00009-7; Institute for Global Environmental Strategies (IGES), 2013, IGES MARK MECH COUNT; IUCN, 2012, IUCN RED LIST CATEGO, VSecond edition; Junk WJ, 2006, AQUAT SCI, V68, P400, DOI 10.1007/s00027-006-0856-z; Jutagate Tuantong, 2003, Kasetsart Journal Natural Sciences, V37, P101; Kano Y, 2013, ICHTHYOL RES, V60, P293, DOI 10.1007/s10228-013-0349-8; Kramer-Schadt S, 2013, DIVERS DISTRIB, V19, P1366, DOI 10.1111/ddi.12096; Kummu M, 2007, GEOMORPHOLOGY, V85, P275, DOI 10.1016/j.geomorph.2006.03.024; Lao PDR, 2015, INTENDED NATL DETERM; Lehner B, 2011, FRONT ECOL ENVIRON, V9, P494, DOI 10.1890/100125; Markovic D, 2014, DIVERS DISTRIB, V20, P1097, DOI 10.1111/ddi.12232; Mekong River Commission (MRC), 2009, HYDR PROJ DAT; Moss RH, 2010, NATURE, V463, P747, DOI 10.1038/nature08823; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nagao Natural Environment Foundation (NEF), 2011, REP RES WIS US CONS; NASA Socioeconomic Data and Applications Center (SEDAC), 2011, GLOB RES DAM GRAND V; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Ormerod SJ, 2010, FRESHWATER BIOL, V55, P1, DOI 10.1111/j.1365-2427.2009.02395.x; Orr S, 2012, GLOBAL ENVIRON CHANG, V22, P925, DOI 10.1016/j.gloenvcha.2012.06.002; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Poulsen A.F., 2002, MRC TECH PAP; Roberts Tyson R., 2001, Natural History Bulletin of the Siam Society, V49, P189; Roberts Tyson R., 2002, Natural History Bulletin of the Siam Society, V50, P135; Royle JA, 2012, METHODS ECOL EVOL, V3, P545, DOI 10.1111/j.2041-210X.2011.00182.x; Strayer DL, 2010, J N AM BENTHOL SOC, V29, P344, DOI 10.1899/08-171.1; Syvitski JPM, 2009, NAT GEOSCI, V2, P681, DOI 10.1038/NGEO629; Tedesco PA, 2013, J APPL ECOL, V50, P1105, DOI 10.1111/1365-2664.12125; UNEP (United Nations Environment Programme), 2010, BLUE HARVEST INLAND; United States Geological Survey (USGS), 1997, HYDRO1K; USGS, 1996, GLOB 30 ARC 2 EL GTO; Vorosmarty CJ, 2010, NATURE, V467, P555, DOI 10.1038/nature09440; WCD, 2000, PAK MUN DAN MEK RIV; WCS, 2005, LAST WILD PROJ VERS; Winemiller KO, 2016, SCIENCE, V351, P128, DOI 10.1126/science.aac7082; World Commission on Dams, 2000, DAMS DEV NEW FRAMEWO; World Wide Fund for Nature (WWF), 2001, TERR EC WORLD; Xenopoulos MA, 2005, GLOBAL CHANGE BIOL, V11, P1557, DOI 10.1111/j.1365-2486.2005.001008.x; Xu JC, 2009, CONSERV BIOL, V23, P520, DOI 10.1111/j.1523-1739.2009.01237.x; Ziv G, 2012, P NATL ACAD SCI USA, V109, P5609, DOI 10.1073/pnas.1201423109	66	27	28	4	97	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2016	11	8							e0160151	10.1371/journal.pone.0160151	http://dx.doi.org/10.1371/journal.pone.0160151			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4YN	27532150	Green Published, gold, Green Submitted			2022-12-27	WOS:000381487600025
J	Li, ZY; Wang, H				Li, Zhongyi; Wang, Hao			Interactive Tooth Separation from Dental Model Using Segmentation Field	PLOS ONE			English	Article							MESH SEGMENTATION	Tooth segmentation on dental model is an essential step of computer-aided-design systems for orthodontic virtual treatment planning. However, fast and accurate identifying cutting boundary to separate teeth from dental model still remains a challenge, due to various geometrical shapes of teeth, complex tooth arrangements, different dental model qualities, and varying degrees of crowding problems. Most segmentation approaches presented before are not able to achieve a balance between fine segmentation results and simple operating procedures with less time consumption. In this article, we present a novel, effective and efficient framework that achieves tooth segmentation based on a segmentation field, which is solved by a linear system defined by a discrete Laplace-Beltrami operator with Dirichlet boundary conditions. A set of contour lines are sampled from the smooth scalar field, and candidate cutting boundaries can be detected from concave regions with large variations of field data. The sensitivity to concave seams of the segmentation field facilitates effective tooth partition, as well as avoids obtaining appropriate curvature threshold value, which is unreliable in some case. Our tooth segmentation algorithm is robust to dental models with low quality, as well as is effective to dental models with different levels of crowding problems. The experiments, including segmentation tests of varying dental models with different complexity, experiments on dental meshes with different modeling resolutions and surface noises and comparison between our method and the morphologic skeleton segmentation method are conducted, thus demonstrating the effectiveness of our method.	[Li, Zhongyi; Wang, Hao] Huazhong Univ Sci & Technol, Sch Hydropower & Informat Engn, Wuhan, Hubei Province, Peoples R China	Huazhong University of Science & Technology	Wang, H (corresponding author), Huazhong Univ Sci & Technol, Sch Hydropower & Informat Engn, Wuhan, Hubei Province, Peoples R China.	wanghao4110@hust.edu.cn		Wang, Hao/0000-0001-9355-1319				Attene M, 2006, VISUAL COMPUT, V22, P181, DOI 10.1007/s00371-006-0375-x; Au OKC, 2007, ACM T GRAPHIC, V26, DOI 10.1145/1239451.1239534; Au OKC, 2012, IEEE T VIS COMPUT GR, V18, P1125, DOI 10.1109/TVCG.2011.131; Axler Sheldon, 2001, GRAD TEXT M, V137, DOI 10.1007/978-1-4757-8137-3; Barnfather KDP, 2007, BRIT DENT J, V202, P731, DOI 10.1038/bdj.2007.534; Bell RB, 2010, ORAL MAXIL SURG CLIN, V22, P135, DOI 10.1016/j.coms.2009.10.010; Cignoni P, 2008, ERCIM NEWS, V73, P47; Grauer D, 2012, J ESTHET RESTOR DENT, V24, P3, DOI 10.1111/j.1708-8240.2011.00500.x; Grzegorzek M, 2010, LECT NOTES COMPUT SC, V6134, P521, DOI 10.1007/978-3-642-13681-8_61; Hoffman DD, 1997, COGNITION, V63, P29, DOI 10.1016/S0010-0277(96)00791-3; HOFFMAN DD, 1984, COGNITION, V18, P65, DOI 10.1016/0010-0277(84)90022-2; Katz S., 2003, HIERARCHICAL MESH DE, V22; Kihara T, 2012, AM J ORTHOD DENTOFAC, V141, P806, DOI 10.1016/j.ajodo.2011.10.027; Kobbelt L., 1998, Computer Graphics. Proceedings. SIGGRAPH 98 Conference Proceedings, P105, DOI 10.1145/280814.280831; Kondo T, 2004, IEEE T MED IMAGING, V23, P350, DOI 10.1109/TMI.2004.824235; Kronfeld T., 2010, COMPUT AIDED APPL, V7, P221, DOI [10.3722/cadaps.2010.221-233, DOI 10.3722/CADAPS.2010.221-233]; Kumar Y., 2012, COMPUT AIDED APPL, V9, P747, DOI [10.3722/cadaps.2012.747-769, DOI 10.3722/CADAPS.2012.747-769]; Kumar Y., 2011, COMPUT AIDED APPL, V8, P211, DOI [10.3722/cadaps.2011.211-224, DOI 10.3722/CADAPS.2011.211-224, DOI 10.3722/cadaps.2011.211-224]; Lai YK, 2008, SPM 2008: PROCEEDINGS OF THE ACM SOLID AND PHYSICAL MODELING SYMPOSIUM, P183; Lai YK, 2009, COMPUT AIDED GEOM D, V26, P665, DOI 10.1016/j.cagd.2008.09.007; Li ZL, 2007, 2007 IEEE/ICME INTERNATIONAL CONFERENCE ON COMPLEX MEDICAL ENGINEERING, VOLS 1-4, P163, DOI 10.1109/ICCME.2007.4381713; Meng M, 2008, INTERACTIVE MESH SEG; Meng M, 2011, COMPUT ANIMAT VIRT W, V22, P334, DOI 10.1002/cav.422; Meng Min, 2008, Journal of Computer Aided Design & Computer Graphics, V20, P1146; Mortara M., 2004, P 9 ACM S SOL MOD AP, P339; Mouritsen D. A., 2013, AUTOMATIC SEGMENTATI; Pinkall U., 1993, EXP MATH, V2, P15, DOI DOI 10.1080/10586458.1993.10504266; Reniers D, 2007, IEEE INTERNATIONAL CONFERENCE ON SHAPE MODELING AND APPLICATIONS 2007, PROCEEDINGS, P179, DOI 10.1109/SMI.2007.33; Shapira L, 2008, VISUAL COMPUT, V24, P249, DOI 10.1007/s00371-007-0197-5; Shlafman S, 2002, COMPUT GRAPH FORUM, V21, P219, DOI 10.1111/1467-8659.00581; Sorkine O, 2005, IEEE T VIS COMPUT GR, V11, P171, DOI 10.1109/TVCG.2005.33; Tai Chiew-Lan, 2005, P S GEOM PROC; Wang H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104023; Wu K, 2014, COMPUT GRAPH-UK, V38, P199, DOI 10.1016/j.cag.2013.10.028; Yamany SM, 1999, PROC SPIE, V3640, P115, DOI 10.1117/12.341053; Yuan T., 2010, J BIOMED IMAGING, V2010, P9; Zayer R, 2005, COMPUT GRAPH FORUM, V24, P601, DOI 10.1111/j.1467-8659.2005.00885.x; Zhang H., 2005, PROC VISION MODELING, P429; Zhang JY, 2010, COMPUT GRAPH FORUM, V29, P517, DOI 10.1111/j.1467-8659.2009.01621.x; Zhao MX, 2005, P ANN INT IEEE EMBS, P654; Zheng YY, 2010, COMPUT GRAPH FORUM, V29, P527, DOI 10.1111/j.1467-8659.2009.01622.x	41	13	17	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2016	11	8							e0161159	10.1371/journal.pone.0161159	http://dx.doi.org/10.1371/journal.pone.0161159			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4YN	27532266	Green Published, gold			2022-12-27	WOS:000381487600067
J	Chung, SJ; Lee, JJ; Ham, JH; Ye, BS; Lee, PH; Sohn, YH				Chung, Su Jin; Lee, Jae Jung; Ham, Jee Hyun; Ye, Byoung Seok; Lee, Phil Hyu; Sohn, Young H.			Striatal Dopamine Depletion Patterns and Early Non-Motor Burden in Parkinsons Disease	PLOS ONE			English	Article							SYMPTOMS SCALE; PATHOLOGY; PET	Background The mechanism underlying non-motor symptoms in Parkinson's disease has not yet been elucidated. In this study, we hypothesized that Parkinson patients with more non-motor symptoms have a different pattern of striatal dopamine depletion, particularly in areas other than the sensorimotor striatum, compared to those with fewer non-motor symptoms. Methods We conducted a prospective survey of the degree of non-motor symptoms (using the Korean version of the Non-Motor Symptoms Scale; K-NMSS) in 151 patients with early-stage Parkinson's disease who had undergone a dopamine transporter PET scan as an initial diagnostic procedure. We classified the patients into two groups; high non-motor patients (HNM-PD; K-NMSS score >= 41) and low non-motor patients (LNM-PD). Results Patients in the HNM-PD group (n = 71) were older, had longer symptom duration, exhibited more severe motor deficits, and had been prescribed higher levodopa-equivalent doses at follow-up than those in the LNM-PD group. However, dopamine transporter binding to the striatal sub-regions and inter-sub-regional binding ratios were comparable between the two groups. A general linear model showed that the HNM-PD group had significantly more severe motor deficits than the LNM-PD group after controlling for age, gender, symptom duration, and dopamine transporter binding to the sensorimotor striatum. Conclusions This study demonstrated that the pattern of striatal dopamine depletion does not contribute to early non-motor burden in Parkinson's disease. Our results suggest that LNM-PD patients may have a more benign course of motor symptom progression than HNM-PD patients.	[Chung, Su Jin; Lee, Jae Jung; Ham, Jee Hyun; Ye, Byoung Seok; Lee, Phil Hyu; Sohn, Young H.] Yonsei Univ, Dept Neurol, Coll Med, Seoul, South Korea; [Lee, Jae Jung] Inje Univ, Dept Neurol, Ilsan Paik Hosp, Goyang, South Korea; [Lee, Phil Hyu] Yonsei Univ, Coll Med, Severance Biomed Sci Inst, Seoul, South Korea	Yonsei University; Yonsei University Health System; Inje University; Yonsei University; Yonsei University Health System	Sohn, YH (corresponding author), Yonsei Univ, Dept Neurol, Coll Med, Seoul, South Korea.	yhsohn62@yuhs.ac	Chung, Su Jin/G-5382-2019	Chung, Su Jin/0000-0002-9324-3284; Lee, Phil Hyu/0000-0001-9931-8462; Sohn, Young H./0000-0001-6533-2610; Ye, Byoung Seok/0000-0003-0187-8440				Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Chaudhuri KR, 2009, LANCET NEUROL, V8, P464, DOI 10.1016/S1474-4422(09)70068-7; Chaudhuri KR, 2007, MOVEMENT DISORD, V22, P1901, DOI 10.1002/mds.21596; Chaudhuri KR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057221; Chaudhuri KR, 2006, LANCET NEUROL, V5, P235, DOI 10.1016/S1474-4422(06)70373-8; Erro R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070244; GIBB WRG, 1988, J NEUROL NEUROSUR PS, V51, P745, DOI 10.1136/jnnp.51.6.745; Haber SN, 2000, J NEUROSCI, V20, P2369; Jellinger KA, 2012, MOVEMENT DISORD, V27, P8, DOI 10.1002/mds.23795; Kingsbury AE, 2010, MOVEMENT DISORD, V25, P2508, DOI 10.1002/mds.23305; Koh SB, 2012, J CLIN NEUROL, V8, P276, DOI 10.3988/jcn.2012.8.4.276; Lee DH, 2015, NEUROLOGY, V85, P1270, DOI 10.1212/WNL.0000000000001999; Oh M, 2012, J NUCL MED, V53, P399, DOI 10.2967/jnumed.111.095224; PARENT A, 1995, BRAIN RES REV, V20, P91, DOI 10.1016/0165-0173(94)00007-C; Politis M, 2008, EXP NEUROL, V214, P112, DOI 10.1016/j.expneurol.2008.07.021; Tomlinson CL, 2010, MOVEMENT DISORD, V25, P2649, DOI 10.1002/mds.23429; Wang J, 2007, J NEUROL, V254, P185, DOI 10.1007/s00415-006-0322-9; Wolters EC, 2006, J NEURAL TRANSM-SUPP, P309; Yoo K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125455	19	9	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2016	11	8							e0161316	10.1371/journal.pone.0161316	http://dx.doi.org/10.1371/journal.pone.0161316			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4UN	27529171	Green Published, gold, Green Submitted			2022-12-27	WOS:000381476700065
J	Hou, ZF; Sun, GX; Guo, Y				Hou, Zhifei; Sun, Guoxiang; Guo, Yong			Linear Quantitative Profiling Method Fast Monitors Alkaloids of Sophora Flavescens That Was Verified by Tri-Marker Analyses	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; UP-REGULATION; MAST-CELLS; IN-VITRO; MATRINE; RADIX; EXTRACT; MICE; OXYMATRINE; INJECTION	The present study demonstrated the use of the Linear Quantitative Profiling Method (LQPM) to evaluate the quality of Alkaloids of Sophora flavescens (ASF) based on chromatographic fingerprints in an accurate, economical and fast way. Both linear qualitative and quantitative similarities were calculated in order to monitor the consistency of the samples. The results indicate that the linear qualitative similarity (LQLS) is not sufficiently discriminating due to the predominant presence of three alkaloid compounds (matrine, sophoridine and oxymatrine) in the test samples; however, the linear quantitative similarity (LQTS) was shown to be able to obviously identify the samples based on the difference in the quantitative content of all the chemical components. In addition, the fingerprint analysis was also supported by the quantitative analysis of three marker compounds. The LQTS was found to be highly correlated to the contents of the marker compounds, indicating that quantitative analysis of the marker compounds may be substituted with the LQPM based on the chromatographic fingerprints for the purpose of quantifying all chemicals of a complex sample system. Furthermore, once reference fingerprint (RFP) developed from a standard preparation in an immediate detection way and the composition similarities calculated out, LQPM could employ the classical mathematical model to effectively quantify the multiple components of ASF samples without any chemical standard.	[Hou, Zhifei; Sun, Guoxiang] Shenyang Pharmaceut Univ, Sch Pharm, Shenyang, Peoples R China; [Hou, Zhifei] Hebei Chem & Pharmaceut Coll, Dept Pharmaceut Engn, Shijiazhuang, Peoples R China; [Guo, Yong] Fairleigh Dickinson Univ, Sch Pharm, Florham Pk, NJ USA	Shenyang Pharmaceutical University; Hebei Chemical & Pharmaceutical College; Fairleigh Dickinson University	Sun, GX (corresponding author), Shenyang Pharmaceut Univ, Sch Pharm, Shenyang, Peoples R China.	gxswmwys@163.com		Guo, Yong/0000-0003-0488-3093				Araujo-Leon JA, 2015, J SEP SCI; Guo CR, 2014, PHYTOMEDICINE, V21, P807, DOI 10.1016/j.phymed.2014.02.007; Ho-sub L, 2001, AM J CHINESE MED, V29, P129; Huang XY, 2013, PHYTOMEDICINE, V20, P202, DOI 10.1016/j.phymed.2012.10.012; Ji Rui, 2013, Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi, V31, P275; Ji Rui, 2013, Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi, V25, P280; Kan QC, 2015, EXP MOL PATHOL, V98, P124, DOI 10.1016/j.yexmp.2015.01.001; Kan QC, 2013, IMMUNOL RES, V56, P189, DOI 10.1007/s12026-013-8393-z; Kim BJ, 2012, J PHARMACOPUNCT, V15, P31, DOI 10.3831/KPI.2012.15.003; Kim HY, 2010, ANTIVIR THER, V15, P697, DOI 10.3851/IMP1615; Kim H, 2012, J ETHNOPHARMACOL, V142, P253, DOI 10.1016/j.jep.2012.04.053; Kim MC, 2012, J PHARMACOPUNCT, V15, P15, DOI 10.3831/KPI.2012.15.2.015; Ko E, 2007, LUPUS, V16, P335, DOI 10.1177/0961203307078228; Kwon KB, 2004, CLIN CHIM ACTA, V348, P79, DOI 10.1016/j.cccn.2004.05.003; Li Yan-qun, 2005, Weishengwu Xuebao, V45, P643; Liang YZ, 2010, PLANTA MED, V76, P1997, DOI 10.1055/s-0030-1250541; Liu JP, 2003, AM J CHINESE MED, V31, P337, DOI 10.1142/S0192415X03001107; Liu N, 2014, EXP MOL PATHOL, V97, P470, DOI 10.1016/j.yexmp.2014.10.004; Liu YC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118223; Long G, 2009, PLANTA MED, V75, P1293, DOI 10.1055/s-0029-1185602; Lu J, 2013, MOL MED REP, V8, P227, DOI 10.3892/mmr.2013.1491; Sun Guo-xiang, 2009, Yaoxue Xuebao, V44, P401; Sun GX, 2014, ANAL METHODS-UK, V6, P838, DOI 10.1039/c3ay41670d; The State Commission of Chinese Pharmacopoeia, 2015, PHARMACOPOEIA OF PEO, V1, P202; The State Commission of Chinese Pharmacopoeia, 2002, THE STATE DRUG STAND, P27; Wang HY, 2012, J PHARMACEUT BIOMED, V58, P146, DOI 10.1016/j.jpba.2011.09.014; Wang W, 2015, ACTA PHARMACOL SIN, V36, P676, DOI 10.1038/aps.2015.24; Wang YZ, 2013, J TRADIT CHIN MED, V33, P218; Xiao ZM, 2013, AFR J TRADIT COMPLEM, V10, P352, DOI 10.4314/ajtcam.v10i5.22; Xu GP, 2015, TUMOR BIOL, V36, P1653, DOI 10.1007/s13277-014-2764-5; Yong JP, 2015, CURR PHARM DESIGN, V21, P3673, DOI 10.2174/1381612821666150122123748; Zeng XY, 2015, BRIT J PHARMACOL, V172, P4303, DOI 10.1111/bph.13209; Zhang L, 2015, INT J CLIN EXP MED, V8, P5591; Zhang S, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/736085; Zhang X, 2003, J ASIAN NAT PROD RES, V5, P171, DOI 10.1080/1028602031000082043; Zhao Feng-chun, 2015, Zhongguo Zhong Yao Za Zhi, V40, P245; Zhao P, 2015, INT J MOL MED, V36, P633, DOI 10.3892/ijmm.2015.2260; Zhao XY, 2011, AM J CHINESE MED, V39, P933, DOI 10.1142/S0192415X11009317; Zhao Y, 2015, J PHARMACEUT BIOMED, V107, P251, DOI 10.1016/j.jpba.2014.12.035	39	6	6	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2016	11	8							e0161146	10.1371/journal.pone.0161146	http://dx.doi.org/10.1371/journal.pone.0161146			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4UN	27529425	gold, Green Published			2022-12-27	WOS:000381476700049
J	Augusto, I; Monteiro, D; Girard-Dias, W; dos Santos, TO; Belmonte, SLR; de Oliveira, JP; Mauad, H; Pacheco, MD; Lenz, D; Bittencourt, AS; Nogueira, BV; dos Santos, JRL; Miranda, K; Guimaraes, MCC				Augusto, Ingrid; Monteiro, Douglas; Girard-Dias, Wendell; dos Santos, Thaisa Oliveira; Rosa Belmonte, Simone Leticia; de Oliveira, Jairo Pinto; Mauad, Helder; Pacheco, Marcos da Silva; Lenz, Dominik; Bittencourt, Athelson Stefanon; Nogueira, Breno Valentim; Lopes dos Santos, Jorge Roberto; Miranda, Kildare; Cunegundes Guimaraes, Marco Cesar			Virtual Reconstruction and Three-Dimensional Printing of Blood Cells as a Tool in Cell Biology Education	PLOS ONE			English	Article							ELECTRON-MICROSCOPY; TOMOGRAPHY; ORGANIZATION	The cell biology discipline constitutes a highly dynamic field whose concepts take a long time to be incorporated into the educational system, especially in developing countries. Amongst the main obstacles to the introduction of new cell biology concepts to students is their general lack of identification with most teaching methods. The introduction of elaborated figures, movies and animations to textbooks has given a tremendous contribution to the learning process and the search for novel teaching methods has been a central goal in cell biology education. Some specialized tools, however, are usually only available in advanced research centers or in institutions that are traditionally involved with the development of novel teaching/learning processes, and are far from becoming reality in the majority of life sciences schools. When combined with the known declining interest in science among young people, a critical scenario may result. This is especially important in the field of electron microscopy and associated techniques, methods that have greatly contributed to the current knowledge on the structure and function of different cell biology models but are rarely made accessible to most students. In this work, we propose a strategy to increase the engagement of students into the world of cell and structural biology by combining 3D electron microscopy techniques and 3D prototyping technology (3D printing) to generate 3D physical models that accurately and realistically reproduce a close-to-the native structure of the cell and serve as a tool for students and teachers outside the main centers. We introduce three strategies for 3D imaging, modeling and prototyping of cells and propose the establishment of a virtual platform where different digital models can be deposited by EM groups and subsequently downloaded and printed in different schools, universities, research centers and museums, thereby modernizing teaching of cell biology and increasing the accessibility to modern approaches in basic science.	[Augusto, Ingrid; dos Santos, Thaisa Oliveira; de Oliveira, Jairo Pinto; Nogueira, Breno Valentim; Cunegundes Guimaraes, Marco Cesar] Univ Fed Espirito Santo, Lab Ultraestrutura Celular Carlos Alberto Redins, Biotecnol, Vitoria, Brazil; [Mauad, Helder] Univ Fed Espirito Santo, Dept Fisiol, Vitoria, Brazil; [Pacheco, Marcos da Silva] Univ Fed Espirito Santo, Dept Morfol, Vitoria, Brazil; [Lenz, Dominik] Univ Vila Velha, Ciencias Farmaceut, Vila Velha, Brazil; [Bittencourt, Athelson Stefanon] Museu Ciencias Vida, Vitoria, Brazil; [Rosa Belmonte, Simone Leticia; Lopes dos Santos, Jorge Roberto] Pontificia Univ Catolica Rio de Janeiro, Rio de Janeiro, Brazil; [Augusto, Ingrid; Monteiro, Douglas; Girard-Dias, Wendell; Miranda, Kildare] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Rio De Janeiro, Brazil; [Augusto, Ingrid; Monteiro, Douglas; Girard-Dias, Wendell; Miranda, Kildare] Univ Fed Rio de Janeiro, Ctr Nacl Biol Estrutural & Bioimagem, Rio De Janeiro, Brazil	Universidade Federal do Espirito Santo; Universidade Federal do Espirito Santo; Universidade Federal do Espirito Santo; Centro Universitario Vila Velha; Pontificia Universidade Catolica do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro	Guimaraes, MCC (corresponding author), Univ Fed Espirito Santo, Lab Ultraestrutura Celular Carlos Alberto Redins, Biotecnol, Vitoria, Brazil.; Miranda, K (corresponding author), Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Rio De Janeiro, Brazil.; Miranda, K (corresponding author), Univ Fed Rio de Janeiro, Ctr Nacl Biol Estrutural & Bioimagem, Rio De Janeiro, Brazil.	kmiranda@biof.ufrj.br; marco.guimaraes@ufes.br	OLIVEIRA, JAIRO/I-7147-2019; NOGUEIRA, BRENO VALENTIM/O-7459-2016; Monteiro, Douglas/W-9011-2019; NOGUEIRA, BRENO/X-7418-2019; Monteiro, Douglas/AAZ-1859-2021; Guimarães, Marco Cesar C/O-3917-2018	OLIVEIRA, JAIRO/0000-0001-7595-1183; NOGUEIRA, BRENO VALENTIM/0000-0002-2199-0635; NOGUEIRA, BRENO/0000-0002-2199-0635; Monteiro, Douglas/0000-0002-1407-6685; Guimarães, Marco Cesar C/0000-0003-2146-0180; Lenz, Dominik/0000-0001-6932-401X; AUGUSTO, INGRID/0000-0003-0651-0899	Ministry of Science and Technology CNPq [483036/2011-0]; Ministry of Education (MEC-PROEXT Grant); CAPES; FAPERJ; FAPES [018/2012]; FINEP (MCTI/FINEP/CT-INFRA); Instituto Nacional de Ciencia e Tecnologia em Biologia Estrutural e Bioimagens (INBEB)	Ministry of Science and Technology CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Ministry of Education (MEC-PROEXT Grant); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); FAPES(Fundacao de Amparo a Pesquisa do Estado de Espiritu Santo (FAPES)); FINEP (MCTI/FINEP/CT-INFRA); Instituto Nacional de Ciencia e Tecnologia em Biologia Estrutural e Bioimagens (INBEB)	This work was supported by grants from the following organizations and agencies to KM and MCG: Ministry of Science and Technology CNPq (Grant 483036/2011-0), Ministry of Education (MEC-PROEXT Grant 04/2011), CAPES, FAPERJ, FAPES (Grant 018/2012), FINEP (MCTI/FINEP/CT-INFRA), and the Instituto Nacional de Ciencia e Tecnologia em Biologia Estrutural e Bioimagens (INBEB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Mr. Helio Santos and Mr. Paulo Crepaldi for their help with the figures and movies. We are also very grateful for the copyediting work of Catherine Thorpe. This work was supported by grants from the following Brazilian organization and agencies to KM and MCG: Ministry of Science and Technology CNPq (Grant 483036/2011-0), Ministry of Education (MEC-PROEXT Grant 04/2011), CAPES, FAPERJ, FAPES (Grant 018/2012) and FINEP (MCTI/FINEP/CT-INFRA). The authors also acknowledge support from Instituto Nacional de Ciencia e Tecnologia em Biologia Estrutural e Bioimagens (INBEB) and declare no conflicts of interest.	[Anonymous], 2015, ENCY BRITANNICA; Baumeister W, 2002, CURR OPIN STRUC BIOL, V12, P679, DOI 10.1016/S0959-440X(02)00378-0; Braga SDMC, 2009, NAT M RES SCI ED NOV; Buabeng-Andoh C., 2012, INT J ED DEV USING I, V8, P136; Connell JL, 2013, P NATL ACAD SCI USA, V110, P18380, DOI 10.1073/pnas.1309729110; Denk W, 2004, PLOS BIOL, V2, P1900, DOI 10.1371/journal.pbio.0020329; Dorey E., 2014, CHEM IND, V78, P7; ELLIOTT DA, 2007, MICROSCOPY TODAY, V15, P30; FAHRENBACH WH, 1984, J ELECTRON MICR TECH, V1, P387, DOI 10.1002/jemt.1060010407; Girard-Dias W, 2012, HISTOCHEM CELL BIOL, V138, P821, DOI 10.1007/s00418-012-1002-8; Hajdu SI, 2003, ANN CLIN LAB SCI, V33, P237; Hooke R, 1665, SOME PHYSL DESCRIPTI; Horstmann H., 2012, PLOS ONE, V7, P1; Irving K. E., 2006, TEACHING SCI 21 CENT, P3; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; McIntosh JR, 2001, ELECTRON MICROS, V153, P25; Micheva KD, 2007, NEURON, V55, P25, DOI 10.1016/j.neuron.2007.06.014; Miranda K, 2015, MOL REPROD DEV, V82, P530, DOI 10.1002/mrd.22455; OECD, 2006, EV STUD INT SCI TECH; Oppenheimer DM, 2006, APPL COGNITIVE PSYCH, V20, P139, DOI 10.1002/acp.1178; PALADE GEORGE E., 1956, JOUR BIOPHYS AND BIOCHEM CYTOL, V2, P85, DOI 10.1083/jcb.2.4.85; Price TR, BRIEF HIST 3D PRINTI; RUSKA E, 1987, BIOSCIENCE REP, V7, P607, DOI 10.1007/BF01127674; SAXTON WO, 1984, ULTRAMICROSCOPY, V13, P57, DOI 10.1016/0304-3991(84)90057-3; Medeiros LCS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033445; van Leeuwenhoek A., 1677, PHILOS T, V12, P821, DOI DOI 10.1098/RSTL.1677.0003; Wendt C, 2016, J STRUCT BIOL, V194, P171, DOI 10.1016/j.jsb.2016.02.014	27	4	4	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2016	11	8							e0161184	10.1371/journal.pone.0161184	http://dx.doi.org/10.1371/journal.pone.0161184			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4SL	27526196	Green Submitted, gold, Green Published			2022-12-27	WOS:000381471100040
J	Bach, LT; Taucher, J; Boxhammer, T; Ludwig, A; Achterberg, EP; Alguero-Muniz, M; Anderson, LG; Bellworthy, J; Budenbender, J; Czerny, J; Ericson, Y; Esposito, M; Fischer, M; Haunost, M; Hellemann, D; Horn, HG; Hornick, T; Meyer, J; Sswat, M; Zark, M; Riebesell, U				Bach, Lennart T.; Taucher, Jan; Boxhammer, Tim; Ludwig, Andrea; Achterberg, Eric P.; Alguero-Muniz, Maria; Anderson, Leif G.; Bellworthy, Jessica; Buedenbender, Jan; Czerny, Jan; Ericson, Ylva; Esposito, Mario; Fischer, Matthias; Haunost, Mathias; Hellemann, Dana; Horn, Henriette G.; Hornick, Thomas; Meyer, Jana; Sswat, Michael; Zark, Maren; Riebesell, Ulf		Kristineberg KOSMOS Consortium	Influence of Ocean Acidification on a Natural Winter-to-Summer Plankton Succession: First Insights from a Long-Term Mesocosm Study Draw Attention to Periods of Low Nutrient Concentrations	PLOS ONE			English	Article							TECHNICAL NOTE; MARINE-PHYTOPLANKTON; ION CONCENTRATION; GULLMAR-FJORD; CARBON; SEAWATER; WATER; CO2; DIVERSITY; VIRUSES	Every year, the oceans absorb about 30% of anthropogenic carbon dioxide (CO2) leading to a re-equilibration of the marine carbonate system and decreasing seawater pH. Today, there is increasing awareness that these changes-summarized by the term ocean acidification (OA)-could differentially affect the competitive ability of marine organisms, thereby provoking a restructuring of marine ecosystems and biogeochemical element cycles. In winter 2013, we deployed ten pelagic mesocosms in the Gullmar Fjord at the Swedish west coast in order to study the effect of OA on plankton ecology and biogeochemistry under close to natural conditions. Five of the ten mesocosms were left unperturbed and served as controls (similar to 380 mu atm pCO(2)), whereas the others were enriched with CO2-saturated water to simulate realistic end-of-the-century carbonate chemistry conditions (mu 760 mu atm pCO(2)). We ran the experiment for 113 days which allowed us to study the influence of high CO2 on an entire winter-to-summer plankton succession and to investigate the potential of some plankton organisms for evolutionary adaptation to OA in their natural environment. This paper is the first in a PLOS collection and provides a detailed overview on the experimental design, important events, and the key complexities of such a "long-term mesocosm" approach. Furthermore, we analyzed whether simulated end-of-the-century carbonate chemistry conditions could lead to a significant restructuring of the plankton community in the course of the succession. At the level of detail analyzed in this overview paper we found that CO2-induced differences in plankton community composition were non-detectable during most of the succession except for a period where a phytoplankton bloom was fueled by remineralized nutrients. These results indicate: (1) Long-term studies with pelagic ecosystems are necessary to uncover OA-sensitive stages of succession. (2) Plankton communities fueled by regenerated nutrients may be more responsive to changing carbonate chemistry than those having access to high inorganic nutrient concentrations and may deserve particular attention in future studies.	[Bach, Lennart T.; Taucher, Jan; Boxhammer, Tim; Ludwig, Andrea; Achterberg, Eric P.; Bellworthy, Jessica; Buedenbender, Jan; Czerny, Jan; Esposito, Mario; Fischer, Matthias; Haunost, Mathias; Hellemann, Dana; Meyer, Jana; Sswat, Michael; Riebesell, Ulf] GEOMAR Helmholtz Ctr Ocean Res Kiel, Kiel, Germany; [Alguero-Muniz, Maria] Biol Anstalt Helgoland, Alfred Wegener Inst Helmholtz Zentrum Polar & Mee, Helgoland, Germany; [Anderson, Leif G.] Univ Gothenburg, Dept Marine Sci, Gothenburg, Sweden; [Bellworthy, Jessica; Esposito, Mario] Univ Southampton, Ocean & Earth Sci, Southampton, Hants, England; [Ericson, Ylva] Univ Ctr Svalbard UNIS, Longyearbyen, Norway; [Hellemann, Dana] Univ Helsinki, Dept Environm Sci, Helsinki, Finland; [Hornick, Thomas] Leibniz Inst Freshwater Ecol & Inland Fisheries I, Expt Limnol, Stechlin, Germany; [Zark, Maren] Carl von Ossietzky Univ Oldenburg, Inst Chem & Biol Marine Environm ICBM, Res Grp Marine Geochem, ICBM MPI Bridging Grp, Oldenburg, Germany	Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; University of Gothenburg; University of Southampton; University Centre Svalbard (UNIS); University of Helsinki; Leibniz Institut fur Gewasserokologie und Binnenfischerei (IGB); Carl von Ossietzky Universitat Oldenburg	Bach, LT (corresponding author), GEOMAR Helmholtz Ctr Ocean Res Kiel, Kiel, Germany.	lbach@geomar.de	Boersma, Maarten/A-5475-2013; Jutfelt, Fredrik/B-6988-2014; Mark, Felix Christopher/P-4759-2016; Schulz, Kai/AEZ-9073-2022; Algueró-Muñiz, María/AAA-9748-2020; Sswat, Michael/B-7944-2019; Pansch, Christian/I-9170-2012; Schartau, Markus/A-5918-2017; Boxhammer, Tim/AAE-6416-2020; Boxhammer, Tim/GLN-6190-2022; Bellworthy, Jessica/ABG-6390-2020; Riebesell, Ulf/AAC-9717-2020; Achterberg, Eric P/C-5820-2009; Dittmar, Thorsten/L-7796-2013; Taucher, Jan/AAA-9195-2019; Thor, Peter/A-7522-2009; Hoffmann, Linn/J-3761-2019; Horn, Henriette G./R-7667-2016; Stiasny, Martina/O-4988-2018	Boersma, Maarten/0000-0003-1010-026X; Jutfelt, Fredrik/0000-0001-9838-3991; Mark, Felix Christopher/0000-0002-5586-6704; Schulz, Kai/0000-0002-8481-4639; Algueró-Muñiz, María/0000-0001-8064-6212; Sswat, Michael/0000-0002-5957-4792; Pansch, Christian/0000-0001-8442-4502; Schartau, Markus/0000-0003-1114-0415; Boxhammer, Tim/0000-0002-9632-5947; Boxhammer, Tim/0000-0002-9632-5947; Achterberg, Eric P/0000-0002-3061-2767; Dittmar, Thorsten/0000-0002-3462-0107; Thor, Peter/0000-0002-2603-2284; Hoffmann, Linn/0000-0003-0242-4686; Horn, Henriette G./0000-0002-4020-5559; Ericson, Ylva/0000-0002-5162-373X; Reusch, Thorsten B. H./0000-0002-8961-4337; Taucher, Jan/0000-0001-9944-0775; Storch, Daniela/0000-0003-3090-7554; Stiasny, Martina/0000-0001-6365-2610; Bach, Lennart/0000-0003-0202-3671; Hornick, Thomas/0000-0003-0280-9260; Riebesell, Ulf/0000-0002-9442-452X; Wohlrab, Sylke/0000-0003-3190-0880	German Federal Ministry of Science and Education (BMBF) in the framework of the BIOACID II project [FKZ 03F06550]; Leibniz Award, German Science Foundation (DFG); Hasselblad Foundation; association of European marine biological laboratories (ASSEMBLE) [227799]; UK Ocean Acidification research programme [NE/H017348/1]	German Federal Ministry of Science and Education (BMBF) in the framework of the BIOACID II project(Federal Ministry of Education & Research (BMBF)); Leibniz Award, German Science Foundation (DFG)(German Research Foundation (DFG)); Hasselblad Foundation; association of European marine biological laboratories (ASSEMBLE); UK Ocean Acidification research programme	Support was provided by the German Federal Ministry of Science and Education (BMBF) in the framework of the BIOACID II project (FKZ 03F06550). U. Riebesell received funding from the Leibniz Award 2012 by the German Science Foundation (DFG). The carbonate chemistry measurements were supported by a grant from the Hasselblad Foundation. M. Zark and T. Hornick were supported by the association of European marine biological laboratories (ASSEMBLE, grant no. 227799). E. P. Achterberg received funding from the UK Ocean Acidification research programme (grant no. NE/H017348/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the Sven Loven Centre for Marine Sciences, Kristineberg for giving us access to their facilities and the warm hospitality. We also gratefully acknowledge the captain and crew of RV ALKOR for their work transporting, deploying and recovering the mesocosms during cruises AL406 and AL420. This project was funded by the German Federal Ministry of Science and Education (BMBF) in the framework of the BIOACID II project (FKZ 03F06550). U. Riebesell received additional funding from the Leibniz Award 2012 by the German Science Foundation (DFG). The carbonate chemistry measurements were supported by a grant from the Hasselblad Foundation. M. Zark and T. Hornick were supported by the association of European marine biological laboratories (ASSEMBLE, grant no. 227799), M. Alguero-Muniz and H. G. Horn by the Swedish Academy of Sciences, and E. P. Achterberg received funding from the UK Ocean Acidification research programme (grant no. NE/H017348/1). This manuscript profited from the helpful comments of four anonymous reviewers.	Arneborg L, 2004, LIMNOL OCEANOGR, V49, P768, DOI 10.4319/lo.2004.49.3.0768; Arneborg L, 2004, CONT SHELF RES, V24, P443, DOI 10.1016/j.csr.2003.12.005; Arneborg L, 2001, J PHYS OCEANOGR, V31, P2549, DOI 10.1175/1520-0485(2001)031<2549:TISIGF>2.0.CO;2; Bach LT, 2015, BIOGEOSCIENCES, V12, P4939, DOI 10.5194/bg-12-4939-2015; Barlow RG, 1997, MAR ECOL PROG SER, V161, P303, DOI 10.3354/meps161303; Boxhammer T, 2016, BIOGEOSCIENCES, V13, P2, DOI DOI 10.5194/BGD-12-18693-2015; Brussaard CPD, 2004, APPL ENVIRON MICROB, V70, P1506, DOI 10.1128/AEM.70.3.1506-1513.2004; Caldeira K, 2003, NATURE, V425, P365, DOI 10.1038/425365a; Calliari D, 2009, ESTUAR COAST SHELF S, V85, P107, DOI 10.1016/j.ecss.2009.06.016; Calosi P, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0444; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; CLAYTON TD, 1993, DEEP-SEA RES PT I, V40, P2115, DOI 10.1016/0967-0637(93)90048-8; Collins S, 2014, EVOL APPL, V7, P140, DOI 10.1111/eva.12120; Czerny J, 2013, BIOGEOSCIENCES, V10, P1937, DOI 10.5194/bg-10-1937-2013; Czerny J, 2013, BIOGEOSCIENCES, V10, P1379, DOI 10.5194/bg-10-1379-2013; Dam HG, 2013, ANNU REV MAR SCI, V5, P349, DOI 10.1146/annurev-marine-121211-172229; Dorey N, 2013, GLOBAL CHANGE BIOL, V19, P3355, DOI 10.1111/gcb.12276; Fabricius KE, 2011, NAT CLIM CHANGE, V1, P165, DOI 10.1038/NCLIMATE1122; Hall-Spencer JM, 2008, NATURE, V454, P96, DOI 10.1038/nature07051; Hansen H.P., 2007, METHODS SEAWATER ANA, P159, DOI [10.1002/9783527613984.ch10, DOI 10.1002/9783527613984, DOI 10.1002/9783527613984.CH10]; Hansen H.P., 1983, METHODS SEAWATER ANA, V2nd ed., P347; Holmes RM, 1999, CAN J FISH AQUAT SCI, V56, P1801, DOI 10.1139/cjfas-56-10-1801; JOHNSON KM, 1987, MAR CHEM, V21, P117, DOI 10.1016/0304-4203(87)90033-8; Jones D. L, 2015, FATHOM TOOLBOX MATLA; Kilnas M, 2006, SJOMATNING GULLMARSF, P1; Kroeker KJ, 2010, ECOL LETT, V13, P1419, DOI 10.1111/j.1461-0248.2010.01518.x; Larsen A, 2001, MAR ECOL PROG SER, V221, P47, DOI 10.3354/meps221047; Le Quere C, 2009, NAT GEOSCI, V2, P831, DOI 10.1038/ngeo689; Lindahl O, 1998, ICES J MAR SCI, V55, P723, DOI 10.1006/jmsc.1998.0379; Lueker TJ, 2000, MAR CHEM, V70, P105, DOI 10.1016/S0304-4203(00)00022-0; Mackey MD, 1996, MAR ECOL PROG SER, V144, P265, DOI 10.3354/meps144265; Marie D, 1999, CURR PROTOCOLS CYTOM, V11, P1, DOI [DOI 10.1002/0471142956.CY1111S10, 10.1002/0471142956.cy1111s10, 10.1002/0471142956.cy1112s11]; MURPHY J, 1962, ANAL CHIM ACTA, V26, P31; Patey MD, 2008, TRAC-TREND ANAL CHEM, V27, P169, DOI 10.1016/j.trac.2007.12.006; Paul AJ, 2015, BIOGEOSCIENCES, V12, P6181, DOI 10.5194/bg-12-6181-2015; Pettit LR, 2013, MAR POLLUT BULL, V73, P452, DOI 10.1016/j.marpolbul.2013.02.011; Pierrot D, 2006, ORNLCDIAC105A US DOE; Riebesell U, 2013, BIOGEOSCIENCES, V10, P1835, DOI 10.5194/bg-10-1835-2013; Riebesell U., 2011, OCEAN ACIDIFICATION, P99, DOI [10.1093/oso/9780199591091.003.0011, DOI 10.1093/OSO/9780199591091.003.0011]; Riebesell U, 2015, NAT CLIM CHANGE, V5, P12; Sala MM, 2016, ICES J MAR SCI, V73, P670, DOI 10.1093/icesjms/fsv130; Schaum E, 2013, NAT CLIM CHANGE, V3, P298, DOI 10.1038/NCLIMATE1774; Scheinin M, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2015.0056; Schulz KG, 2013, MAR BIOL, V160, P1889, DOI 10.1007/s00227-012-1965-y; SHARP JH, 1974, LIMNOL OCEANOGR, V19, P984, DOI 10.4319/lo.1974.19.6.0984; Sswat M, 2015, VIDEO PLANKTON COMMU, DOI [10.3289/KOSMOS_PLANKTONBSWEDENB2013, DOI 10.3289/K0SM0S_PLANKT0NBSWEDENB]; Stocker T.F., 2013, PHYS SCI BASIS, P1535, DOI [10.1017/CBO9781107415324, DOI 10.1017/CB09781107415324, DOI 10.1017/CBO9781107415324]; Veldhuis MJW, 2000, SCI MAR, V64, P121, DOI 10.3989/scimar.2000.64n2121; Wolf-Gladrow DA, 1999, TELLUS B, V51, P461, DOI 10.1034/j.1600-0889.1999.00023.x; Zark M, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500531; Ziveri P, 2014, BIOL BULL-US, V226, P282, DOI 10.1086/BBLv226n3p282	51	49	49	3	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2016	11	8							e0159068	10.1371/journal.pone.0159068	http://dx.doi.org/10.1371/journal.pone.0159068			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4SL	27525979	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000381471100003
J	Kromer, R; Buhmann, C; Hidding, U; Keseru, M; Keseru, D; Hassenstein, A; Stemplewitz, B				Kromer, Robert; Buhmann, Carsten; Hidding, Ute; Keserue, Matthias; Keserue, Diana; Hassenstein, Andrea; Stemplewitz, Birthe			Evaluation of Retinal Vessel Morphology in Patients with Parkinson's Disease Using Optical Coherence Tomography	PLOS ONE			English	Article							AUTOMATED LAYER SEGMENTATION; LEVODOPA USE; RISK-FACTOR; HOMOCYSTEINE; NERVE; POLYNEUROPATHY; PROGRESSION; NEUROPATHY; DIAGNOSIS; DETECT	Purpose The retina has been found affected in Parkinson's disease (PD). It is unclear if this is due to neurodegeneration of local dopamine-dependent retinal cells, a result of central nervous degeneration including the optic nerve or retinal small vessel disease. This study aimed to detect changes of the retinal vasculature in PD patients compared to controls. Methods We examined 49 PD patients and 49 age- and sex-matched healthy controls by spectral domain optical coherence tomography (SD-OCT) with a circular scan centred at the optic disc. Vessels within the retinal nerve fibre layer were identified by an automated algorithm and thereafter manually labelled as artery or vein. Layer segmentation, vessel lumen and direct surrounding tissue were marked automatically with a grey value and the contrast between both values in relation to the surrounding tissue was calculated. The differences in these grey value ratios among subjects were determined and used as an indicator for differences in vessel morphology. Furthermore, the diameters of the veins and arteries were measured and then compared between the groups. Results The contrast of retinal veins was significantly lower in PD patients compared to controls, which indicates changes in vessel morphology in PD. The contrast of arteries was not significantly different. Disease duration, disease stage according to Hoehn and Yahr or age did not influence the grey value ratios in PD patients. Vessel diameter in either veins or arteries did not differ between subject groups. The contrast of retinal veins contralateral to the clinically predominant and first affected side was significantly lower compared to the ipsilateral side. Conclusion Our data show a potential difference of the retinal vasculature in PD patients compared to controls. Vascular changes in the retina of PD patients might contribute to vision-related complaints in PD.	[Kromer, Robert; Keserue, Matthias; Keserue, Diana; Hassenstein, Andrea; Stemplewitz, Birthe] Hamburg Med Ctr Hamburg Eppendorf, Dept Ophthalmol, Hamburg, Germany; [Buhmann, Carsten; Hidding, Ute] Hamburg Med Ctr Hamburg Eppendorf, Dept Neurol, Hamburg, Germany		Kromer, R (corresponding author), Hamburg Med Ctr Hamburg Eppendorf, Dept Ophthalmol, Hamburg, Germany.	rkromer@me.com	Keserü, Matthias/AAM-7020-2020; Kromer, Robert/G-4239-2017	Kromer, Robert/0000-0002-5986-5047				Aaker GD, 2010, CLIN OPHTHALMOL, V4, P1427, DOI 10.2147/OPTH.S15136; Ajith TA, 2015, CLIN CHIM ACTA, V450, P316, DOI 10.1016/j.cca.2015.09.007; Albrecht P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034891; Alten F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112311; Archibald NK, 2009, BRAIN, V132, P1128, DOI 10.1093/brain/awp068; Berganzo K, 2013, J NEUROL, V260, P1752, DOI 10.1007/s00415-013-6859-5; Bittersohl D, 2015, ACTA OPHTHALMOL, V93, pE578, DOI 10.1111/aos.12757; Braak H, 2002, J NEUROL, V249, DOI [1007/s00415-002-1301-4, 10.1007/s00415-002-1301-4, DOI 10.1007/S00415-002-1301-4]; Cense B, 2004, OPT EXPRESS, V12, P2435, DOI 10.1364/OPEX.12.002435; Chaudhuri KR, 2006, LANCET NEUROL, V5, P235, DOI 10.1016/S1474-4422(06)70373-8; Choi J, 2006, INVEST OPHTH VIS SCI, V47, P831, DOI 10.1167/iovs.05-1053; Chung HS, 1999, BRIT J OPHTHALMOL, V83, P466, DOI 10.1136/bjo.83.4.466; de Jong FJ, 2011, NEUROLOGY, V76, P816, DOI 10.1212/WNL.0b013e31820e7baa; DeBuc D.C., 2011, IMAGE SEGMENTATION; Ding Y, 2014, J NEURAL TRANSM, V121, P1367, DOI 10.1007/s00702-014-1214-2; Fraz MM, 2012, COMPUT METH PROG BIO, V108, P407, DOI 10.1016/j.cmpb.2012.03.009; Garcia-Martin E, 2012, OPHTHALMOLOGY, V119, P2161, DOI 10.1016/j.ophtha.2012.05.003; Gupta S, 2016, EXPERT REV NEUROTHER, V16, P765, DOI 10.1080/14737175.2016.1180978; Hajee ME, 2009, ARCH OPHTHALMOL-CHIC, V127, P737, DOI 10.1001/archophthalmol.2009.106; Hassan A, 2004, BRAIN, V127, P212, DOI 10.1093/brain/awh023; Hawkes CH, 2010, PARKINSONISM RELAT D, V16, P79, DOI 10.1016/j.parkreldis.2009.08.007; Herzog A, 2004, LECT NOTES COMPUT SC, V3117, P395; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; HUGHES AJ, 1993, ARCH NEUROL-CHICAGO, V50, P140, DOI 10.1001/archneur.1993.00540020018011; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Jaffe GJ, 2004, AM J OPHTHALMOL, V137, P156, DOI 10.1016/S0002-9394(03)00792-X; Jimenez B, 2014, MOVEMENT DISORD, V29, P68, DOI 10.1002/mds.25747; Kimber T, 2013, PARKINSONISM RELAT D, V19, P847, DOI 10.1016/j.parkreldis.2013.05.002; Kloppenborg RP, 2014, NEUROLOGY, V82, P777, DOI 10.1212/WNL.0000000000000168; Kolar P, 2014, J OPHTHALMOL, V2014, DOI 10.1155/2014/724780; Kwa VIH, 2002, NEUROLOGY, V59, P1536, DOI 10.1212/01.WNL.0000033093.16450.5C; La Morgia C, 2013, EUR J NEUROL, V20, P198, DOI 10.1111/j.1468-1331.2012.03701.x; Lee JY, 2014, J PARKINSON DIS, V4, P197, DOI 10.3233/JPD-130306; Lee P, 2010, APPL OPTICS, V49, P3538, DOI 10.1364/AO.49.003538; Liew G, 2008, CIRC-CARDIOVASC IMAG, V1, P156, DOI 10.1161/CIRCIMAGING.108.784876; Lu SJ, 2010, IEEE T BIO-MED ENG, V57, P2605, DOI 10.1109/TBME.2010.2055057; Maresca A, 2013, MOL CELL NEUROSCI, V55, P62, DOI 10.1016/j.mcn.2012.08.004; Marnane M, 2016, CURR ALZHEIMER RES, V13, P750, DOI 10.2174/1567205013666160222112634; Merola A, 2016, EUR J NEUROL, V23, P501, DOI 10.1111/ene.12846; Montastruc JL, 2010, MOVEMENT DISORD, V25, P660, DOI 10.1002/mds.22878; Motte J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102034; Muller T, 2002, J NEURAL TRANSM, V109, P175, DOI 10.1007/s007020200013; Nanhoe-Mahabier W, 2009, NAT REV NEUROL, V5, P533, DOI 10.1038/nrneurol.2009.136; Nolano M, 2011, ANN NEUROL, V69, P427, DOI 10.1002/ana.22330; Parkinson Study Group, 2000, JAMA, V284, P1931; Bambo MP, 2014, PARKINSONS DIS-US, V2014, DOI 10.1155/2014/946540; Pirker W, 2003, MOVEMENT DISORD, V18, pS43, DOI 10.1002/mds.10579; Rascol O, 2000, NEW ENGL J MED, V342, P1484, DOI 10.1056/NEJM200005183422004; Rehak J, 2008, CURR EYE RES, V33, P111, DOI 10.1080/02713680701851902; Roth NM, 2014, MOVEMENT DISORD, V29, P1163, DOI 10.1002/mds.25896; Schneider M, 2014, J NEURAL TRANSM, V121, P41, DOI 10.1007/s00702-013-1072-3; Schwartz RS, 2012, MOVEMENT DISORD, V27, P1506, DOI 10.1002/mds.25112; Shahrizaila N, 2013, PARKINSONISM RELAT D, V19, P391, DOI 10.1016/j.parkreldis.2012.08.002; Staurenghi G, 2014, PROPOSED LEXICON ANA, P1572, DOI [10.1016/j.ophtha.2014.02.023, DOI 10.1016/J.OPHTHA.2014.02.023]; Stemplewitz B, 2015, ACTA OPHTHALMOL, V93, pE672, DOI 10.1111/aos.12764; Tatsch K, 1997, EUR J NUCL MED, V24, P415, DOI 10.1007/BF00881814; Tewarie P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034823; van der Holst HM, 2015, NEUROLOGY, V85, P1569, DOI 10.1212/WNL.0000000000002082; Wojtkowski M, 2003, OPT LETT, V28, P1745, DOI 10.1364/OL.28.001745; Yang Q, 2010, OPT EXPRESS, V18, P21293, DOI 10.1364/OE.18.021293; Zucco GM, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01020	61	25	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2016	11	8							e0161136	10.1371/journal.pone.0161136	http://dx.doi.org/10.1371/journal.pone.0161136			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4SL	27525728	Green Submitted, gold, Green Published			2022-12-27	WOS:000381471100037
J	Richie, DL; Takeoka, KT; Bojkovic, J; Metzger, LE; Rath, CM; Sawyer, WS; Wei, JR; Dean, CR				Richie, Daryl L.; Takeoka, Kenneth T.; Bojkovic, Jade; Metzger, Louis E.; Rath, Christopher M.; Sawyer, William S.; Wei, Jun-Rong; Dean, Charles R.			Toxic Accumulation of LPS Pathway Intermediates Underlies the Requirement of LpxH for Growth of Acinetobacter baumannii ATCC 19606	PLOS ONE			English	Article							ZINC-DEPENDENT DEACETYLASE; ACYL-CHAIN SPECIFICITY; COLISTIN RESISTANCE; ESCHERICHIA-COLI; ANTIBIOTIC-ACTIVITY; LIPOPOLYSACCHARIDE; BIOSYNTHESIS; ACYLTRANSFERASES; INHIBITION; DEFICIENT	The lipid A moiety of lipopolysaccharide (LPS) is the main constituent of the outer leaflet of the Gram-negative bacterial outer membrane (OM) and is essential in many Gram-negative pathogens. An exception is Acinetobacter baumannii ATCC 19606, where mutants lacking enzymes occurring early in lipid A biosynthesis (LpxA, LpxC or LpxD), and correspondingly lacking LPS, can grow. In contrast, we show here that LpxH, an enzyme that occurs downstream of LpxD in the lipid A biosynthetic pathway, is essential for growth in this strain. Multiple attempts to disrupt lpxH on the genome were unsuccessful, and when LpxH expression was controlled by an isopropyl beta-D-1-thiogalactopyranoside (IPTG) inducible promoter, cell growth under typical laboratory conditions required IPTG induction. Mass spectrometry analysis of cells shifted from LpxH-induced to uninduced (and whose growth was correspondingly slowing as LpxH was depleted) showed a large cellular accumulation of UDP2,3- diacyl-GlcN (substrate of LpxH), a C14: 0(3-OH) acyl variant of the LpxD substrate (UDP-3-O-[(R)-3-OH-C-14]-GlcN), and disaccharide 1-monophosphate (DSMP). Furthermore, the viable cell counts of the LpxH depleted cultures dropped modestly, and electron microscopy revealed clear defects at the cell (inner) membrane, suggesting lipid A intermediate accumulation was toxic. Consistent with this, blocking the synthesis of these intermediates by inhibition of the upstream LpxC enzyme using CHIR-090 abrogated the requirement for IPTG induction of LpxH. Taken together, these data indicate that LpxH is essential for growth in A. baumannii ATCC19606, because, unlike earlier pathway steps like LpxA or LpxC, blockage of LpxH causes accumulation of detergent-like pathway intermediates that prevents cell growth.	[Richie, Daryl L.; Takeoka, Kenneth T.; Bojkovic, Jade; Metzger, Louis E.; Rath, Christopher M.; Sawyer, William S.; Wei, Jun-Rong; Dean, Charles R.] Novartis Inst BioMed Res, Emeryville, CA USA	Novartis	Dean, CR (corresponding author), Novartis Inst BioMed Res, Emeryville, CA USA.	charlesr.dean@novartis.com		Sawyer, William/0000-0002-7593-1972	Novartis organization; Novartis	Novartis organization; Novartis(Novartis)	Funding of this research was provided solely within the Novartis organization as per standard research activities. The Novartis funders provided support in the form of salaries for authors [DLR, KTT, JB, LEMIV, CMR, WSS, J-RW, CRD], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Adams MD, 2009, ANTIMICROB AGENTS CH, V53, P3628, DOI 10.1128/AAC.00284-09; Babinski KJ, 2002, J BIOL CHEM, P277; Bainbridge BW, 2008, J BACTERIOL, V190, P4549, DOI 10.1128/JB.00234-08; Barb AW, 2008, CURR PHARM BIOTECHNO, V9, P9; Barb AW, 2007, P NATL ACAD SCI USA, V104, P18433, DOI 10.1073/pnas.0709412104; Barb AW, 2007, BIOCHEMISTRY-US, V46, P3793, DOI 10.1021/bi6025165; Bartling CM, 2008, BIOCHEMISTRY-US, V47, P5290, DOI 10.1021/bi800240r; Beceiro A, 2014, ANTIMICROB AGENTS CH, V58, P518, DOI 10.1128/AAC.01597-13; Beceiro A, 2011, ANTIMICROB AGENTS CH, V55, P3370, DOI 10.1128/AAC.00079-11; Bojkovic J, 2015, J BACTERIOLOGY; Bos MP, 2005, INFECT IMMUN, V73, P6194, DOI 10.1128/IAI.73.9.6194-6197.2005; Cai Y, 2012, J ANTIMICROB CHEMOTH, V67, P1607, DOI 10.1093/jac/dks084; Clements JM, 2002, ANTIMICROB AGENTS CH, V46, P1793, DOI 10.1128/AAC.46.6.1793-1799.2002; de Berardinis V, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.10; DeLucia AM, 2011, MBIO, V2, DOI 10.1128/mBio.00142-11; Dijkshoorn L, 2007, NAT REV MICROBIOL, V5, P939, DOI 10.1038/nrmicro1789; Emiola A, 2016, P NATL ACAD SCI US; Emiola A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121216; Garcia-Quintanilla M, 2016, ANTIMICROBIAL AGENTS; Garrett TA, 1997, J BIOL CHEM, V272, P21855, DOI 10.1074/jbc.272.35.21855; HORTON RM, 1990, BIOTECHNIQUES, V8, P528; Jackman JE, 1999, BIOCHEMISTRY-US, V38, P1902, DOI 10.1021/bi982339s; Jenkins RJ, 2014, J BIOL CHEM, V289, P15527, DOI 10.1074/jbc.M114.564278; Jenkins RJ, 2012, ACS CHEM BIOL, V7, P1170, DOI 10.1021/cb300094a; Klein G, 2009, J BIOL CHEM, V284, P15369, DOI 10.1074/jbc.M900490200; Lin L, 2012, MBIO, V3, DOI 10.1128/mBio.00312-12; Manchanda V, 2010, J GLOB INFECT DIS, V2, P291, DOI 10.4103/0974-777X.68538; McClerren AL, 2005, BIOCHEMISTRY-US, V44, P16574, DOI 10.1021/bi0518186; Metzger LE, 2012, NAT STRUCT MOL BIOL, V19, P1132, DOI 10.1038/nsmb.2393; Metzger LE, 2010, BIOCHEMISTRY-US, V49, P6715, DOI 10.1021/bi1008744; Moffatt JH, 2011, ANTIMICROB AGENTS CH, V55, P3022, DOI 10.1128/AAC.01732-10; Moffatt JH, 2010, ANTIMICROB AGENTS CH, V54, P4971, DOI 10.1128/AAC.00834-10; Montgomery JI, 2012, J MED CHEM, V55, P1662, DOI 10.1021/jm2014875; Nayar AS, 2015, J BACTERIOL, V197, P1726, DOI 10.1128/JB.02552-14; Peng DX, 2005, INFECT IMMUN, V73, P7569, DOI 10.1128/IAI.73.11.7569-7577.2005; Piet JR, 2014, J INFECTION, V69, P352, DOI 10.1016/j.jinf.2014.06.005; Quan JY, 2011, NAT PROTOC, V6, P242, DOI 10.1038/nprot.2010.181; RADIKA K, 1988, J BIOL CHEM, V263, P14859; Raetz CRH, 2009, J LIPID RES, V50, pS103, DOI 10.1194/jlr.R800060-JLR200; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Srinivas N, 2010, SCIENCE, V327, P1010, DOI 10.1126/science.1182749; Steeghs L, 2001, EMBO J, V20, P6937, DOI 10.1093/emboj/20.24.6937; Steeghs L, 1998, NATURE, V392, P449, DOI 10.1038/33046; Sweet CR, 2002, J BIOL CHEM, V277, P18281, DOI 10.1074/jbc.M201057200; Sweet CR, 2001, J BIOL CHEM, V276, P19565, DOI 10.1074/jbc.M101868200; Walsh AG, 2000, MOL MICROBIOL, V35, P718, DOI 10.1046/j.1365-2958.2000.01741.x; Wang XY, 2010, PROG LIPID RES, V49, P97, DOI 10.1016/j.plipres.2009.06.002; Whitfield C, 2014, ANNU REV BIOCHEM, V83, P99, DOI 10.1146/annurev-biochem-060713-035600; Young HE, 2016, MBIO, V7, DOI 10.1128/mBio.00090-16; Young HE, 2013, J BIOL CHEM, V288, P26987, DOI 10.1074/jbc.M113.497636; Zhang G, 2013, CURR OPIN MICROBIOL, V16, P779, DOI 10.1016/j.mib.2013.09.007; Zhao X, 2002, J BIOL CHEM, V277, P4722, DOI 10.1074/jbc.M107803200	52	22	22	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2016	11	8							e0160918	10.1371/journal.pone.0160918	http://dx.doi.org/10.1371/journal.pone.0160918			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4SL	27526195	Green Published, gold, Green Submitted			2022-12-27	WOS:000381471100027
J	Harizanova, J; Fermin, Y; Malik-Sheriff, RS; Wieczorek, J; Ickstadt, K; Grecco, HE; Zamir, E				Harizanova, Jana; Fermin, Yessica; Malik-Sheriff, Rahuman S.; Wieczorek, Jakob; Ickstadt, Katja; Grecco, Hernan E.; Zamir, Eli			Highly Multiplexed Imaging Uncovers Changes in Compositional Noise within Assembling Focal Adhesions	PLOS ONE			English	Article							MATRIX ADHESIONS; CELLS; TOPONOMICS; PROTEOMICS; DYNAMICS; KINETICS; PAXILLIN	Integrin adhesome proteins bind each other in alternative manners, forming within the cell diverse cell-matrix adhesion sites with distinct properties. An intriguing question is how such modular assembly of adhesion sites is achieved correctly solely by self-organization of their components. Here we address this question using high-throughput multiplexed imaging of eight proteins and two phosphorylation sites in a large number of single focal adhesions. We found that during the assembly of focal adhesions the variances of protein densities decrease while the correlations between them increase, suggesting reduction in the noise levels within these structures. These changes correlate independently with the area and internal density of focal adhesions, but not with their age or shape. Artificial neural network analysis indicates that a joint consideration of multiple components improves the predictability of paxillin and zyxin levels in internally dense focal adhesions. This suggests that paxillin and zyxin densities in focal adhesions are fine-tuned by integrating the levels of multiple other components, thus averaging-out stochastic fluctuations. Based on these results we propose that increase in internal protein densities facilitates noise suppression in focal adhesions, while noise suppression enables their stable growth and further density increase-hence forming a feedback loop giving rise to a quality-controlled assembly.	[Harizanova, Jana; Malik-Sheriff, Rahuman S.; Grecco, Hernan E.; Zamir, Eli] Max Planck Inst Mol Physiol, Dept System Cell Biol, Dortmund, Germany; [Fermin, Yessica; Wieczorek, Jakob; Ickstadt, Katja] TU Dortmund Univ, Fac Stat, Dortmund, Germany; [Malik-Sheriff, Rahuman S.] European Bioinformat Inst, European Mol Biol Lab, Cambridge, England; [Malik-Sheriff, Rahuman S.] Imperial Coll London, MRC Clin Sci Ctr, London, England; [Grecco, Hernan E.] Univ Buenos Aires, FCEN, Dept Phys, Buenos Aires, DF, Argentina; [Grecco, Hernan E.] Consejo Nacl Invest Cient & Tecn, IFIBA, Buenos Aires, DF, Argentina	Max Planck Society; Dortmund University of Technology; European Molecular Biology Laboratory (EMBL); Imperial College London; University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Grecco, HE; Zamir, E (corresponding author), Max Planck Inst Mol Physiol, Dept System Cell Biol, Dortmund, Germany.; Grecco, HE (corresponding author), Univ Buenos Aires, FCEN, Dept Phys, Buenos Aires, DF, Argentina.; Grecco, HE (corresponding author), Consejo Nacl Invest Cient & Tecn, IFIBA, Buenos Aires, DF, Argentina.	grecco@mpi-dortmund.mpg.de; eli.zamir@mpi-dortmund.mpg.de	Sheriff, Rahuman/ABB-9034-2020	Sheriff, Rahuman/0000-0003-0705-9809; Fermin Ruiz, Yessica Yulieth/0000-0002-6336-4042; Zamir, Eli/0000-0001-8226-5480	BMBF (Federal Ministry of Education and Research, Germany) [0315507]; German academic exchange service (DAAD) fellowship; BMBF [0315507]	BMBF (Federal Ministry of Education and Research, Germany)(Federal Ministry of Education & Research (BMBF)); German academic exchange service (DAAD) fellowship(Deutscher Akademischer Austausch Dienst (DAAD)); BMBF(Federal Ministry of Education & Research (BMBF))	This work was supported by BMBF (Federal Ministry of Education and Research, Germany) grant number 0315507. YF was supported by a German academic exchange service (DAAD) fellowship.; This work was supported by BMBF grant no. 0315507. YF was supported by a German academic exchange service (DAAD) fellowship. We thank Philippe Bastiaens for additional support.	BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Deakin NO, 2008, J CELL SCI, V121, P2435, DOI 10.1242/jcs.018044; Friedenberger M, 2007, NAT PROTOC, V2, P2285, DOI 10.1038/nprot.2007.320; Geiger T, 2012, CURR OPIN CELL BIOL, V24, P562, DOI 10.1016/j.ceb.2012.05.004; Grecco HE, 2016, CYTOM PART A, V89A, P761, DOI 10.1002/cyto.a.22876; Guizar-Sicairos M, 2008, OPT LETT, V33, P156, DOI 10.1364/OL.33.000156; Hirata Hiroaki, 2008, Commun Integr Biol, V1, P192; Hoffmann JE, 2014, ELIFE, V3, DOI 10.7554/eLife.02257; Kam Z, 2001, TRENDS CELL BIOL, V11, P329, DOI 10.1016/S0962-8924(01)02067-0; Kanchanawong P, 2010, NATURE, V468, P580, DOI 10.1038/nature09621; Katz BZ, 2000, MOL BIOL CELL, V11, P1047, DOI 10.1091/mbc.11.3.1047; Lavelin I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073549; Lele TP, 2006, J CELL PHYSIOL, V207, P187, DOI 10.1002/jcp.20550; Lin JR, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9390; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Robertson J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7265; Rompp A, 2013, HISTOCHEM CELL BIOL, V139, P759, DOI 10.1007/s00418-013-1097-6; Rossier O, 2012, NAT CELL BIOL, V14, P1057, DOI 10.1038/ncb2588; Schubert W, 2006, CYTOM PART A, V69A, P109, DOI 10.1002/cyto.a.20234; Schubert W, 2003, ADV BIOCHEM ENG BIOT, V83, P189; Schubert W, 2006, NAT BIOTECHNOL, V24, P1270, DOI 10.1038/nbt1250; Schubert W, 2015, CYTOM PART A, V87A, P696, DOI 10.1002/cyto.a.22671; Schubert W, 2014, J MOL RECOGNIT, V27, P3, DOI 10.1002/jmr.2326; Tukey JW, 1977, EXPLORATORY DATA ANA; Turner CE, 2000, J CELL SCI, V113, P4139; Wolfenson H, 2011, J CELL SCI, V124, P1425, DOI 10.1242/jcs.077388; Zaidel-Bar R, 2004, BIOCHEM SOC T, V32, P416, DOI 10.1042/BST0320416; Zaidel-Bar R, 2003, J CELL SCI, V116, P4605, DOI 10.1242/jcs.00792; Zaidel-Bar R, 2007, NAT CELL BIOL, V9, P858, DOI 10.1038/ncb0807-858; Zaidel-Bar R, 2010, J CELL SCI, V123, P1385, DOI 10.1242/jcs.066183; Zamir E, 2000, NAT CELL BIOL, V2, P191, DOI 10.1038/35008607; Zamir E, 2001, J CELL SCI, V114, P3583; Zamir E, 1999, J CELL SCI, V112, P1655; Zamir E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001901; Zrazhevskiy P, 2013, NAT PROTOC, V8, P1852, DOI 10.1038/nprot.2013.112	37	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2016	11	8							e0160591	10.1371/journal.pone.0160591	http://dx.doi.org/10.1371/journal.pone.0160591			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3LI	27519053	gold, Green Published, Green Submitted			2022-12-27	WOS:000381382100020
J	Yang, XF; Zhu, YR; Hong, J; Yang, LX; Wu, YB; Tang, YY				Yang, Xiaofan; Zhu, Yuanrui; Hong, Jing; Yang, Lu-Xing; Wu, Yingbo; Tang, Yuan Yan			The Rationality of Four Metrics of Network Robustness: A Viewpoint of Robust Growth of Generalized Meshes	PLOS ONE			English	Article							ALGEBRAIC CONNECTIVITY; TOPOLOGICAL PROPERTIES; CENTRALITY; ALGORITHM	There are quite a number of different metrics of network robustness. This paper addresses the rationality of four metrics of network robustness (the algebraic connectivity, the effective resistance, the average edge betweenness, and the efficiency) by investigating the robust growth of generalized meshes (GMs). First, a heuristic growth algorithm (the Proximity-Growth algorithm) is proposed. The resulting proximity-optimal GMs are intuitively robust and hence are adopted as the benchmark. Then, a generalized mesh (GM) is grown up by stepwise optimizing a given measure of network robustness. The following findings are presented: (1) The algebraic connectivity-optimal GMs deviate quickly from the proximity-optimal GMs, yielding a number of less robust GMs. This hints that the rationality of the algebraic connectivity as a measure of network robustness is still in doubt. (2) The effective resistace-optimal GMs and the average edge betweenness-optimal GMs are in line with the proximity-optimal GMs. This partly justifies the two quantities as metrics of network robustness. (3) The efficiency-optimal GMs deviate gradually from the proximity-optimal GMs, yielding some less robust GMs. This suggests the limited utility of the efficiency as a measure of network robustness.	[Yang, Xiaofan; Zhu, Yuanrui; Yang, Lu-Xing; Wu, Yingbo] Chongqing Univ, Sch Software Engn, Chongqing 400044, Peoples R China; [Hong, Jing] Georgia Inst Technol, Dept Comp Sci, Atlanta, GA 30309 USA; [Yang, Lu-Xing] Delft Univ Technol, Fac Elect Engn Math & Comp Sci, NL-2600 GA Delft, Netherlands; [Tang, Yuan Yan] Univ Macau, Dept Comp & Informat Sci, Ave Univ, Taipa, Macau, Peoples R China	Chongqing University; University System of Georgia; Georgia Institute of Technology; Delft University of Technology; University of Macau	Yang, LX (corresponding author), Chongqing Univ, Sch Software Engn, Chongqing 400044, Peoples R China.; Yang, LX (corresponding author), Delft Univ Technol, Fac Elect Engn Math & Comp Sci, NL-2600 GA Delft, Netherlands.	ylx910920@gmail.com		Yang, Lu-Xing/0000-0002-9229-5787	National Natural Science Foundation of China [61572006, 71301177]; National Sci-Tech Support Plan [2015BAF05B03]; Natural Science Foundation of Chongqing [cstc2013jcyjA40011]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Sci-Tech Support Plan; Natural Science Foundation of Chongqing(Natural Science Foundation of Chongqing)	This work is supported by National Natural Science Foundation of China (Grant Nos. 61572006 [XY], 71301177 [YW]), National Sci-Tech Support Plan (Grant No. 2015BAF05B03 [YW]), and Natural Science Foundation of Chongqing (Grant No. cstc2013jcyjA40011 [YW]). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas W., 2012, 3 IFAC WORKSH DISTR, V45, P85, DOI DOI 10.3182/20120914-2-US-4030.00052; [Anonymous], THESIS; Cuzzocrea A, 2012, J NETW COMPUT APPL, V35, P1210, DOI 10.1016/j.jnca.2011.06.001; de Abreu NMM, 2007, LINEAR ALGEBRA APPL, V423, P53, DOI 10.1016/j.laa.2006.08.017; Decayeux C, 2005, IEEE T PARALL DISTR, V16, P875, DOI 10.1109/TPDS.2005.100; Domanski Z, 2005, SCI RES I MATH COMPU, V4, P34; Dong Q, 2008, INFORM SCIENCES, V178, P2396, DOI 10.1016/j.ins.2007.12.010; Dong Q, 2010, COMPUT ELECTR ENG, V36, P1021, DOI 10.1016/j.compeleceng.2010.03.003; Ellens W, 2011, LINEAR ALGEBRA APPL, V435, P2491, DOI 10.1016/j.laa.2011.02.024; Ellens W, 2013, ARXIV, V18, P359; FIEDLER M, 1973, CZECH MATH J, V23, P298; Ghosh A, 2006, IEEE DECIS CONTR P, P6605, DOI 10.1109/CDC.2006.377282; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Grimmett G. R., 1999, PERCOLATION; Holub P, 2014, DISCRETE APPL MATH, V179, P139, DOI 10.1016/j.dam.2014.07.012; KLEIN DJ, 1993, J MATH CHEM, V12, P81, DOI 10.1007/BF01164627; Kresch E, 2015, PROCEEDINGS OF THE 2015 INTERNATIONAL CONFERENCE ON HIGH PERFORMANCE COMPUTING & SIMULATION (HPCS 2015), P371, DOI 10.1109/HPCSim.2015.7237064; Lal AK, 2011, GRAPH COMBINATOR, V27, P215, DOI 10.1007/s00373-010-0975-0; Latora V, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/6/188; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Li C, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.039901; Liu W, 2009, I C DES RELIABL COMM, P131, DOI 10.1109/DRCN.2009.5340016; Lu L, ENCY SYSTEMBIOL, P647; Martin-Hernandez J, 2014, PHYSICA A, V404, P92, DOI 10.1016/j.physa.2014.02.043; Mosk-Aoyama D, 2008, OPER RES LETT, V36, P677, DOI 10.1016/j.orl.2008.09.001; Nocetti FG, 2002, IEEE T PARALL DISTR, V13, P963, DOI 10.1109/TPDS.2002.1036069; Pradhan AK, 2014, J OPT-INDIA, V43, P330, DOI 10.1007/s12596-014-0211-z; Stojmenovic I, 1997, IEEE T PARALL DISTR, V8, P1036, DOI 10.1109/71.629486; [Tian Guixian 田贵贤], 2012, [数学进展, Advances in Mathematics], V41, P217; van de Bovenkamp R, 2014, 10TH INTERNATIONAL CONFERENCE ON SIGNAL-IMAGE TECHNOLOGY AND INTERNET-BASED SYSTEMS SITIS 2014, P347, DOI 10.1109/SITIS.2014.82; Wang H, 2008, ALGEBRAIC CONNECTIVI, P25; Wang XR, 2014, EUR PHYS J B, V87, DOI 10.1140/epjb/e2014-50276-0; Xiang D, 2009, IEEE T COMPUT, V58, P620, DOI 10.1109/TC.2008.211; Xu DC, 2013, INFORM SCIENCES, V240, P184, DOI 10.1016/j.ins.2013.03.044; Xu JM, 2015, 1 COURSE GRAPH THEOR; Yang LX, 2016, PHYSICA A, V450, P403, DOI 10.1016/j.physa.2016.01.026; Yang LX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134507; Yang LX, MATH METHODS APPL SC; Yang XF, 2008, INT J COMPUT MATH, V85, P201, DOI 10.1080/00207160701421144; Yang XF, 2006, APPL MATH COMPUT, V182, P1696, DOI 10.1016/j.amc.2006.06.009; Yang XF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155580; Yang XF, 2010, INFORM PROCESS LETT, V110, P559, DOI 10.1016/j.ipl.2010.04.007; Yoon J, 2006, BIOINFORMATICS, V22, P3106, DOI 10.1093/bioinformatics/btl533	43	6	6	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2016	11	8							e0161077	10.1371/journal.pone.0161077	http://dx.doi.org/10.1371/journal.pone.0161077			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3LI	27518448	Green Submitted, Green Published, gold			2022-12-27	WOS:000381382100043
J	Ruiz, C; Kustermann, S; Pietilae, E; Vlajnic, T; Baschiera, B; Arabi, L; Lorber, T; Oeggerli, M; Savic, S; Obermann, E; Singer, T; Rothschild, SI; Zippelius, A; Roth, AB; Bubendorf, L				Ruiz, Christian; Kustermann, Stefan; Pietilae, Elina; Vlajnic, Tatjana; Baschiera, Betty; Arabi, Leila; Lorber, Thomas; Oeggerli, Martin; Savic, Spasenija; Obermann, Ellen; Singer, Thomas; Rothschild, Sacha I.; Zippelius, Alfred; Roth, Adrian B.; Bubendorf, Lukas			Culture and Drug Profiling of Patient Derived Malignant Pleural Effusions for Personalized Cancer Medicine	PLOS ONE			English	Article							CELL LUNG CANCERS; KINASE INHIBITION; RESISTANCE; ALK; CRIZOTINIB; GENERATION; CHEMOSENSITIVITY; MECHANISMS; THERAPIES; DIAGNOSIS	Introduction The use of patients' own cancer cells for in vitro selection of the most promising treatment is an attractive concept in personalized medicine. Human carcinoma cells from malignant pleural effusions (MPEs) are suited for this purpose since they have already adapted to the liquid environment in the patient and do not depend on a stromal cell compartment. Aim of this study was to develop a systematic approach for the in-vitro culture of MPEs to analyze the effect of chemotherapeutic as well as targeted drugs. Methods MPEs from patients with solid tumors were selected for this study. After morphological and molecular characterization, they were cultured in medium supplemented with patientderived sterile-filtered effusion supernatant. Growth characteristics were monitored in realtime using the xCELLigence system. MPEs were treated with a targeted therapeutic (erlotinib) according to the mutational status or chemotherapeutics based on the recommendation of the oncologists. Results We have established a robust system for the ex-vivo culture of MPEs and the application of drug tests in-vitro. The use of an antibody based magnetic cell separation system for epithelial cells before culture allowed treatment of effusions with only moderate tumor cell proportion. Experiments using drugs and drug-combinations revealed dose-dependent and specific growth inhibitory effects of targeted drugs. Conclusions We developed a new approach for the ex-vivo culture of MPEs and the application of drug tests in-vitro using real-time measuring of cell growth, which precisely reproduced the effect of clinically established treatments by standard chemotherapy and targeted drugs. This sets the stage for future studies testing agents against specific targets from genomic profiling of metastatic tumor cells and multiple drug-combinations in a personalized manner.	[Ruiz, Christian; Vlajnic, Tatjana; Baschiera, Betty; Arabi, Leila; Lorber, Thomas; Oeggerli, Martin; Savic, Spasenija; Obermann, Ellen; Bubendorf, Lukas] Univ Basel Hosp, Inst Pathol, Basel, Switzerland; [Kustermann, Stefan; Pietilae, Elina; Singer, Thomas; Roth, Adrian B.] Roche Innovat Ctr Basel, Pharmaceut Sci, Basel, Switzerland; [Rothschild, Sacha I.; Zippelius, Alfred] Univ Basel Hosp, Dept Med Oncol, Basel, Switzerland; [Arabi, Leila] Mashhad Univ Med Sci, Sch Pharm, Nanotechnol Res Ctr, Mashhad, Iran	University of Basel; Roche Holding; University of Basel; Mashhad University Medical Science	Ruiz, C (corresponding author), Univ Basel Hosp, Inst Pathol, Basel, Switzerland.	christian.ruiz@unibas.ch	Bubendorf, Lukas/G-5299-2015; Bubendorfl, Lukas/H-5880-2011; Rothschild, Sacha/AAV-4003-2020; Arabi, Leila/H-2312-2018	Bubendorf, Lukas/0000-0001-5970-1803; Rothschild, Sacha/0000-0003-1304-9340; Arabi, Leila/0000-0003-1623-3346; Pietila, Elina/0000-0003-0209-9369	Basel Translational Medicine Hub and the Swiss National Science Foundation (SNF) [310030_138513]	Basel Translational Medicine Hub and the Swiss National Science Foundation (SNF)	This study was supported by the Basel Translational Medicine Hub and the Swiss National Science Foundation (SNF 310030_138513, www.snf.ch). The funders provided support in the form of salaries for authors [LA, TL and MO], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Basak SK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005884; Bergethon K, 2012, J CLIN ONCOL, V30, P863, DOI 10.1200/JCO.2011.35.6345; Buttitta F, 2013, CLIN CANCER RES, V19, P691, DOI 10.1158/1078-0432.CCR-12-1958; Camidge DR, 2014, NAT REV CLIN ONCOL, V11, P473, DOI 10.1038/nrclinonc.2014.104; Camidge DR, 2012, LANCET ONCOL, V13, P1011, DOI 10.1016/S1470-2045(12)70344-3; Castellarin M, 2013, J PATHOL, V229, P515, DOI 10.1002/path.4105; Chong CR, 2013, NAT MED, V19, P1389, DOI 10.1038/nm.3388; Cree IA, 2009, CURR OPIN OBSTET GYN, V21, P39, DOI 10.1097/GCO.0b013e32832210ff; Davidson B, 2004, DIAGN CYTOPATHOL, V31, P246, DOI 10.1002/dc.20133; Dienstmann R, 2013, J CLIN ONCOL, V31, P1874, DOI 10.1200/JCO.2012.45.2268; Dinu M, 2012, ROM J MORPHOL EMBRYO, V53, P817; Domcke S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3126; Katayama R, 2011, P NATL ACAD SCI USA, V108, P7535, DOI 10.1073/pnas.1019559108; Kelm JM, 2003, BIOTECHNOL BIOENG, V83, P173, DOI 10.1002/bit.10655; Kustermann S, 2013, TOXICOL IN VITRO, V27, P1589, DOI 10.1016/j.tiv.2012.08.019; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Maniwa Y, 2010, ONCOL LETT, V1, P345, DOI 10.3892/ol_00000061; Masters JR, 2007, NAT PROTOC, V2, P2276, DOI 10.1038/nprot.2007.319; McDermott U, 2011, NEW ENGL J MED, V364, P340, DOI 10.1056/NEJMra0907178; Melosky B, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00244; Niederst MJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004652; Ohara Tatsuru, 2005, Hum Cell, V18, P171; Ou SHI, 2011, J THORAC ONCOL, V6, P942, DOI 10.1097/JTO.0b013e31821528d3; Pall G, 2015, CURR OPIN ONCOL, V27, P118, DOI 10.1097/CCO.0000000000000165; Rolfo C, 2014, TRANSL LUNG CANCER R, V3, P250, DOI 10.3978/j.issn.2218-6751.2014.03.01; Rosfjord E, 2014, BIOCHEM PHARMACOL, V91, P135, DOI 10.1016/j.bcp.2014.06.008; Ruiz Christian, 2012, Swiss Med Wkly, V142, pw13587, DOI 10.4414/smw.2012.13587; Saleh HA, 2009, DIAGN CYTOPATHOL, V37, P324, DOI 10.1002/dc.21006; Samson DJ, 2004, J CLIN ONCOL, V22, P3618, DOI 10.1200/JCO.2004.04.077; Savic S, 2013, J THORAC ONCOL, V8, P1004, DOI 10.1097/JTO.0b013e3182936ca9; Tapia C, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1676; Wendt D, 2006, BIORHEOLOGY, V43, P481; Wetterauer C, 2015, PROSTATE, V75, P585, DOI 10.1002/pros.22939	33	9	10	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2016	11	8							e0160807	10.1371/journal.pone.0160807	http://dx.doi.org/10.1371/journal.pone.0160807			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT8TP	27548442	gold, Green Published, Green Submitted			2022-12-27	WOS:000381768400022
J	Chung, HJ; Lin, ATL; Lin, CC; Chen, TJ; Chen, KK				Chung, Hsiao-Jen; Lin, Alex Tong-Long; Lin, Chih-Chieh; Chen, Tzeng-Ji; Chen, Kuang-Kuo			Patients with Urinary Incontinence Appear More Likely to Develop Upper Urinary Tract Stones: A Nationwide, Population-Based Study with 8-Year Follow-Up	PLOS ONE			English	Article							METABOLIC SYNDROME; PREVALENCE; OBESITY; RISK; NEPHROLITHIASIS; EPIDEMIOLOGY; DISORDERS; DISEASE	This study aimed to investigate associations between primary urinary incontinence and development of upper urinary tract stones in a nationwide population in Taiwan. Data of 1,777 adults with primary urinary incontinence and 26,655 controls (groups A, B, and C) without urinary incontinence at study inception were retrieved from the National Health Insurance System database in Taiwan and were analyzed retrospectively. No enrolled subjects had previous diagnosis of upper urinary tract stones or spinal cord injury. All subjects were followed through end of 2009, with a minimum follow-up of 8 years. A greater percentage of study subjects (334/1777, 18.8%) developed upper urinary tract stones than that of control groups A (865/8885, 9.7%) and B (888/8885, 10%), and C (930/8885, 10.5%) (all p-values < 0.0001). Urinary incontinence was associated with significantly increased risk of developing urinary tract stones (HR 1.99, 95% CI, 1.70-2.34, p < 0.001). Age and metabolic syndrome status were both associated with developing upper urinary tract stones (both p-values < 0.0001). After adjusting for metabolic syndrome, regression analysis showed that urinary incontinence was still associated with a significantly increased risk of developing upper urinary tract stones (HR 1.99, 95% CI = 1.76-2.26, p < 0.0001). Long-term follow-up of Taiwanese patients with primary urinary incontinence suggests that urinary incontinence is associated with a significantly increased risk of developing upper urinary tract stones. Study findings suggest that physicians treating patients with urinary incontinence should give attention to early detection of upper urinary tract stones.	[Chung, Hsiao-Jen; Lin, Alex Tong-Long; Lin, Chih-Chieh; Chen, Kuang-Kuo] Taipei Vet Gen Hosp, Dept Urol, Taipei, Taiwan; [Chen, Tzeng-Ji] Taipei Vet Gen Hosp, Dept Family Med, Taipei, Taiwan; [Chen, Tzeng-Ji] Natl Yang Ming Univ, Div Family Med, Dept Med, Taipei, Taiwan; [Chung, Hsiao-Jen; Lin, Alex Tong-Long; Lin, Chih-Chieh; Chen, Kuang-Kuo] Natl Yang Ming Univ, Sch Med, Dept Urol, Shu Tien Urol Res Ctr, Taipei, Taiwan	Taipei Veterans General Hospital; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Chung, HJ (corresponding author), Taipei Vet Gen Hosp, Dept Urol, Taipei, Taiwan.; Chung, HJ (corresponding author), Natl Yang Ming Univ, Sch Med, Dept Urol, Shu Tien Urol Res Ctr, Taipei, Taiwan.	hjchung@vghtpe.gov.tw	Chen, TJ/AAH-8430-2021					Amarenco G, 2012, PROG UROL, V22, P207, DOI 10.1016/j.purol.2012.01.005; BORGHI L, 1990, BRIT J UROL, V65, P231, DOI 10.1111/j.1464-410X.1990.tb14716.x; Boudokhane S, 2013, PROG UROL, V23, P256, DOI 10.1016/j.purol.2012.10.009; Chiu AF, 2012, TZU CHI MED J, V24, P56, DOI 10.1016/j.tcmj.2012.03.002; Curhan GC, 2007, UROL CLIN N AM, V34, P287, DOI 10.1016/j.ucl.2007.04.003; CURHAN GC, 1994, J UROLOGY, V151, P838, DOI 10.1016/S0022-5347(17)35101-7; Gorbachinsky Ilya, 2010, Rev Urol, V12, pe157; Gustafson B, 2007, ARTERIOSCL THROM VAS, V27, P2276, DOI 10.1161/ATVBAHA.107.147835; Huang PL, 2009, DIS MODEL MECH, V2, P231, DOI 10.1242/dmm.001180; Huang WY, 2013, J UROLOGY, V189, P2158, DOI 10.1016/j.juro.2012.12.105; Janssen I, 2007, OBESITY, V15, P1827, DOI 10.1038/oby.2007.217; Lawrence JM, 2007, DIABETES CARE, V30, P2536, DOI 10.2337/dc07-0262; Lee RK, 2012, BJU INT, V110, P540, DOI 10.1111/j.1464-410X.2011.10819.x; Lee YH, 2002, UROL INT, V68, P172, DOI 10.1159/000048445; Otunctemur A, 2014, INT UROL NEPHROL, V46, P1501, DOI 10.1007/s11255-014-0680-7; ROBERTSON WG, 1990, UROL RES, V18, pS3, DOI 10.1007/BF00301521; Saigal CS, 2005, KIDNEY INT, V68, P1808, DOI 10.1111/j.1523-1755.2005.00599.x; Taylor EN, 2005, JAMA-J AM MED ASSOC, V293, P455, DOI 10.1001/jama.293.4.455; Tsai YC, 2009, INT UROL NEPHROL, V41, P795, DOI 10.1007/s11255-009-9523-3; West B, 2008, AM J KIDNEY DIS, V51, P741, DOI 10.1053/j.ajkd.2007.12.030; Zuo L, 2014, J UROLOGY, V191, P1906, DOI 10.1016/j.juro.2014.01.013	21	1	1	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0161223	10.1371/journal.pone.0161223	http://dx.doi.org/10.1371/journal.pone.0161223			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27536881	gold, Green Submitted, Green Published			2022-12-27	WOS:000381577000071
J	Kellom, M; Raymond, J				Kellom, Matthew; Raymond, Jason			Using Dendritic Heat Maps to Simultaneously Display Genotype Divergence with Phenotype Divergence	PLOS ONE			English	Article							KEY INNOVATION; MICROBIOME; KINGDOMS; PATTERNS; GENOMES; SEARCH; LENGTH; BLAST; TOOL	The advancement of techniques to visualize and analyze large-scale sequencing datasets is an area of active research and is rooted in traditional techniques such as heat maps and dendrograms. We introduce dendritic heat maps that display heat map results over aligned DNA sequence clusters for a range of clustering cutoffs. Dendritic heat maps aid in visualizing the effects of group differences on clustering hierarchy and relative abundance of sampled sequences. Here, we artificially generate two separate datasets with simplified mutation and population growth procedures with GC content group separation to use as example phenotypes. In this work, we use the term phenotype to represent any feature by which groups can be separated. These sequences were clustered in a fractional identity range of 0.75 to 1.0 using agglomerative minimum-, maximum-, and average-linkage algorithms, as well as a divisive centroid-based algorithm. We demonstrate that dendritic heat maps give freedom to scrutinize specific clustering levels across a range of cutoffs, track changes in phenotype inequity across multiple levels of sequence clustering specificity, and easily visualize how deeply rooted changes in phenotype inequity are in a dataset. As genotypes diverge in sample populations, clusters are shown to break apart into smaller clusters at higher identity cutoff levels, similar to a dendrogram. Phenotype divergence, which is shown as a heat map of relative abundance bin response, may or may not follow genotype divergences. This joined view highlights the relationship between genotype and phenotype divergence for treatment groups. We discuss the minimum-, maximum-, average-, and centroid-linkage algorithm approaches to building dendritic heat maps and make a case for the divisive "top-down" centroid-based clustering methodology as being the best option visualize the effects of changing factors on clustering hierarchy and relative abundance.	[Kellom, Matthew; Raymond, Jason] Arizona State Univ, Sch Earth & Space Explorat, Tempe, AZ 85281 USA	Arizona State University; Arizona State University-Tempe	Raymond, J (corresponding author), Arizona State Univ, Sch Earth & Space Explorat, Tempe, AZ 85281 USA.	jason.raymond@asu.edu	Kellom, Matthew/GNP-5389-2022		National Aeronautics and Space Administration Exobiology and Evolutionary Biology Program [NNX08AP61G]; National Aeronautics and Space Administration Astrobiology Institute at Arizona State University [08-NAI5-0018]	National Aeronautics and Space Administration Exobiology and Evolutionary Biology Program; National Aeronautics and Space Administration Astrobiology Institute at Arizona State University	The authors acknowledge support from the National Aeronautics and Space Administration Exobiology and Evolutionary Biology Program (NNX08AP61G) (https://astrobiology.nasa.gov/exobiology/) as well as the National Aeronautics and Space Administration Astrobiology Institute at Arizona State University (08-NAI5-0018) (https://astrobiology.nasa.gov/nai/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blount ZD, 2012, NATURE, V489, P513, DOI 10.1038/nature11514; BRAY JR, 1957, ECOL MONOGR, V27, P326, DOI 10.2307/1942268; Brewer C.A., 2003, CARTOGR GEOGR INF SC, V30, P159, DOI [10.1559/152304003100011126, DOI 10.1559/152304003100011126]; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Cho I, 2012, NATURE, V488, P621, DOI 10.1038/nature11400; Cole JR, 2014, NUCLEIC ACIDS RES, V42, pD633, DOI 10.1093/nar/gkt1244; Darling AE, 2014, PEERJ, V2, DOI 10.7717/peerj.243; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Elser JJ, 2014, APPL ENV MICROBIOLOG; Florek K, 1951, COLLOQ MATH-WARSAW, V2, P282, DOI 10.4064/cm-2-3-4-282-285; Getz G, 2013, NATURE, V497, P67, DOI 10.1038/nature12113; Goll J, 2010, BIOINFORMATICS, V26, P2631, DOI 10.1093/bioinformatics/btq455; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Koenig JE, 2011, P NATL ACAD SCI USA, V108, P4578, DOI 10.1073/pnas.1000081107; Krebs JE, 2011, LEWINS GENES 10; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; MACNAUGHTONSMIT.P, 1964, NATURE, V202, P1034, DOI 10.1038/2021034a0; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Meyer JR, 2012, SCIENCE, V335, P428, DOI 10.1126/science.1214449; Mitchell-Olds T, 2007, NAT REV GENET, V8, P845, DOI 10.1038/nrg2207; Nodine MD, 2012, NATURE, V482, P94, DOI 10.1038/nature10756; Ondov BD, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-385; Schloissnig S, 2013, NATURE, V493, P45, DOI 10.1038/nature11711; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; SNEATH PHA, 1957, J GEN MICROBIOL, V17, P201, DOI 10.1099/00221287-17-1-201; SOKAL ROBERT R., 1958, UNIV KANSAS SCI BULL, V38, P1409; Wang DY, 2005, MOL BIOL EVOL, V22, P142, DOI 10.1093/molbev/msh263; Wilkinson L, 2009, AM STAT, V63, P179, DOI 10.1198/tas.2009.0033; WILLIAMS WT, 1966, J ECOL, V54, P427, DOI 10.2307/2257960; Williams WT, 1967, COMPUT J, V9, P373; Wooley JC, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000667; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344; Xu L, 2006, MOL BIOL EVOL, V23, P1107, DOI 10.1093/molbev/msk019; Zhao YA, 2012, BIOINFORMATICS, V28, P125, DOI 10.1093/bioinformatics/btr595	35	6	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0161292	10.1371/journal.pone.0161292	http://dx.doi.org/10.1371/journal.pone.0161292			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27536963	Green Published, gold, Green Submitted			2022-12-27	WOS:000381577000082
J	Browne, JL; Klipstein-Grobusch, K; Koster, MPH; Ramamoorthy, D; Antwi, E; Belmouden, I; Franx, A; Grobbee, DE; Schielen, PCJI				Browne, Joyce L.; Klipstein-Grobusch, Kerstin; Koster, Maria P. H.; Ramamoorthy, Dhivya; Antwi, Edward; Belmouden, Idder; Franx, Arie; Grobbee, Diederick E.; Schielen, Peter C. J. I.			Pregnancy Associated Plasma Protein-A and Placental Growth Factor in a Sub-Saharan African Population: A Nested Cross-Sectional Study	PLOS ONE			English	Article							HUMAN CHORIONIC-GONADOTROPIN; FREE BETA-HCG; PAPP-A; 1ST-TRIMESTER; SERUM; WOMEN; TRISOMY-21; BIOMARKERS; ETHNICITY; MARKERS	Background Baseline distributions of pregnancy disorders' biomarkers PlGF and PAPP-A levels are primarily based on Western European populations of Caucasian ethnicity. Differences in PAPP-A and PlGF concentrations by ethnicity have been observed, with increased levels in Afro-Caribbean, East Asian, and South Asian women. Baseline concentrations of sub-Saharan African women have not been evaluated. Objectives To investigate PlGF and PAPP-A in a sub-Saharan African population and assess the performance of existing reference values of PAPP-A and PlGF. Methods A nested cross-sectional study was conducted in two public hospitals in Accra, Ghana. Out of the original 1010 women enrolled in the cohort, 398 participants were eligible for inclusion with a normotensive singleton gestation and serum samples taken between 56-97 days of pregnancy. PAPP-A and PlGF concentrations were measured with an automated immunoassay. Multiple of the median (MoM) values corrected for gestation and maternal weight for PAPP-A and PlGF were calculated using reference values of a Dutch perinatal screening laboratory based on over 10.000 samples, and PlGF manufacturer reference values, respectively. Results The PAPP-A median MoM was 2.34 (interquartile range (IQR) 1.24-3.97). Median PlGF MoM was 1.25 (IQR 0.95-1.80). Median MoM values for PAPP-A and PlGF tended to be slightly different for various Ghanaian ethnic subgroups. Conclusions PAPP-A and PlGF MoM values appear to be substantially higher in a sub-Saharan African population compared to the Caucasian or Afro-Caribbean MoM values previously reported. The difference suggests the need for a specific correction factor for this population to avoid underestimation of risk for fetal aneuploidies or placental disorders when using PAPP-A and PlGF MoM for screening purposes.	[Browne, Joyce L.; Klipstein-Grobusch, Kerstin; Ramamoorthy, Dhivya; Antwi, Edward; Grobbee, Diederick E.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Julius Global Hlth, Utrecht, Netherlands; [Klipstein-Grobusch, Kerstin] Univ Witwatersrand, Sch Publ Hlth, Div Obstet & Gynecol, Fac Hlth Sci, Johannesburg, South Africa; [Koster, Maria P. H.; Franx, Arie] Univ Med Ctr Utrecht, Dept Obstet & Gynecol, Utrecht, Netherlands; [Antwi, Edward] Greater Accra Reg Hlth Directorate, Ghana Hlth Serv, Accra, Ghana; [Belmouden, Idder; Schielen, Peter C. J. I.] Natl Inst Publ Hlth & Environm RIVM, Ctr Infect Dis Res Diagnost & Screening IDS, Bilthoven, Netherlands	Utrecht University; Utrecht University Medical Center; University of Witwatersrand; Utrecht University; Utrecht University Medical Center; Ghana Health Service; Netherlands National Institute for Public Health & the Environment	Browne, JL (corresponding author), Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Julius Global Hlth, Utrecht, Netherlands.	J.L.Browne@umcutrecht.nl	Klipstein-Grobusch, Kerstin/F-5555-2016; Franx, Arie/AAA-1739-2021; Antwi, Edward/GQH-0788-2022; Schielen, Peter/AAP-4539-2020	Klipstein-Grobusch, Kerstin/0000-0002-5462-9889; Antwi, Edward/0000-0002-4143-3254; 				Agyemang C, 2005, J EPIDEMIOL COMMUN H, V59, P1014, DOI 10.1136/jech.2005.035964; [Anonymous], 2006, OPP AFR NEWB; Ball S, 2013, ULTRASOUND OBST GYN, V41, P33, DOI 10.1002/uog.11209; Ball S, 2012, FETAL DIAGN THER, V31, P162, DOI 10.1159/000336252; Bhutta ZA, 2014, LANCET, V384, P347, DOI 10.1016/S0140-6736(14)60792-3; Bujold E, 2014, PRENATAL DIAG, V34, P642, DOI 10.1002/pd.4403; Cowans NJ, 2011, PRENATAL DIAG, V31, P1193, DOI 10.1002/pd.2894; Cowans NJ, 2013, PRENATAL DIAG, V33, P56, DOI 10.1002/pd.4010; Cowans NJ, 2010, PRENATAL DIAG, V30, P127, DOI 10.1002/pd.2423; Cox NJ, 2011, AAPLOT; Cruz J, 2010, ULTRASOUND OBST GYN, V36, P141, DOI 10.1002/uog.7688; Darling AM, 2014, AM J OBSTET GYNECOL, V211, DOI 10.1016/j.ajog.2014.05.032; DOMBROWSKI MP, 1994, ARCH PEDIAT ADOL MED, V148, P508, DOI 10.1001/archpedi.1994.02170050066012; Gagnon AJ, 2016, BEST PRACT RES CL OB, V32, P3, DOI 10.1016/j.bpobgyn.2016.01.005; Geerts L, 2008, INT J GYNECOL OBSTET, V103, P16, DOI 10.1016/j.ijgo.2008.05.028; Govender L, 2012, CARDIOVASC J AFR, V23, P153, DOI 10.5830/CVJA-2012-003; Govender N, 2013, CARDIOVASC J AFR, V24, P174, DOI 10.5830/CVJA-2013-029; Hofmeyr GJ, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001059.pub4; Inhorn MC, 2015, HUM REPROD UPDATE, V21, P411, DOI 10.1093/humupd/dmv016; JACKSON MR, 1987, J ANAT, V152, P173; Kagan KO, 2008, ULTRASOUND OBST GYN, V31, P493, DOI 10.1002/uog.5332; Kassebaum NJ, 2014, LANCET, V384, P980, DOI 10.1016/S0140-6736(14)60696-6; Kuc S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063546; Kuc S, 2011, OBSTET GYNECOL SURV, V66, P225, DOI 10.1097/OGX.0b013e3182227027; Lawn JE, 2014, LANCET, V384, P189, DOI 10.1016/S0140-6736(14)60496-7; Leung TY, 2006, FETAL DIAGN THER, V21, P140, DOI 10.1159/000089064; Manotaya S, 2015, PRENATAL DIAG, V35, P735, DOI 10.1002/pd.4602; Molteno C, 1997, PAEDIATR PERINAT EP, V11, P428, DOI 10.1046/j.1365-3016.1997.d01-25.x; Muy-Rivera M, 2005, PHYSIOL RES, V54, P611, DOI 10.33549/physiolres.930000.54.611; Nicolaides KH, 2005, ULTRASOUND OBST GYN, V25, P221, DOI 10.1002/uog.1860; Odibo AO, 2014, J PERINATOL, V34, P186, DOI 10.1038/jp.2013.176; Owusu-Dabo E, 2009, TOB CONTROL, V18, P365, DOI 10.1136/tc.2009.030635; Pandya P, 2012, FETAL DIAGN THER, V31, P87, DOI 10.1159/000335684; PERRY IJ, 1995, BMJ-BRIT MED J, V310, P436, DOI 10.1136/bmj.310.6977.436; Poon LC, 2014, PRENATAL DIAG, V34, P618, DOI 10.1002/pd.4397; Powis KM, 2013, JAIDS-J ACQ IMM DEF, V62, P517, DOI 10.1097/QAI.0b013e318286d77e; Sivarao S, 2002, PLACENTA, V23, P691, DOI 10.1053/plac.2002.0817; Spencer K, 2005, PRENATAL DIAG, V25, P365, DOI 10.1002/pd.1153; Spencer K, 2000, PRENATAL DIAG, V20, P491, DOI 10.1002/1097-0223(200006)20:6<491::AID-PD844>3.0.CO;2-3; Tishkoff SA, 2009, SCIENCE, V324, P1035, DOI 10.1126/science.1172257; Tsiakkas A, 2015, ULTRASOUND OBST GYN, V45, P591, DOI 10.1002/uog.14811; Williams LA, 1997, BRIT MED J, V314, P1864, DOI 10.1136/bmj.314.7098.1864; Wright D, 2015, ULTRASOUND OBST GYN, V46, P42, DOI 10.1002/uog.14870; Wright D, 2010, ULTRASOUND OBST GYN, V36, P404, DOI 10.1002/uog.7755	44	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2016	11	8							e0159592	10.1371/journal.pone.0159592	http://dx.doi.org/10.1371/journal.pone.0159592			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4YN	27532602	gold, Green Published, Green Submitted			2022-12-27	WOS:000381487600008
J	Hu, SB; Wong, DJL; Correa, A; Li, N; Deng, JC				Hu, Scott B.; Wong, Deborah J. L.; Correa, Aditi; Li, Ning; Deng, Jane C.			Prediction of Clinical Deterioration in Hospitalized Adult Patients with Hematologic Malignancies Using a Neural Network Model	PLOS ONE			English	Article							INTENSIVE-CARE-UNIT; EARLY WARNING SCORE; CARDIORESPIRATORY INSTABILITY; INCREASED MORTALITY; VALIDATION; ALARMS; OUTCOMES; VIEWS; ADMISSIONS; TRANSFERS	Introduction Clinical deterioration (ICU transfer and cardiac arrest) occurs during approximately 5-10% of hospital admissions. Existing prediction models have a high false positive rate, leading to multiple false alarms and alarm fatigue. We used routine vital signs and laboratory values obtained from the electronic medical record (EMR) along with a machine learning algorithm called a neural network to develop a prediction model that would increase the predictive accuracy and decrease false alarm rates. Design Retrospective cohort study. Setting The hematologic malignancy unit in an academic medical center in the United States. Patient Population Adult patients admitted to the hematologic malignancy unit from 2009 to 2010. Intervention None. Measurements and Main Results Vital signs and laboratory values were obtained from the electronic medical record system and then used as predictors (features). A neural network was used to build a model to predict clinical deterioration events (ICU transfer and cardiac arrest). The performance of the neural network model was compared to the VitalPac Early Warning Score (ViEWS). Five hundred sixty five consecutive total admissions were available with 43 admissions resulting in clinical deterioration. Using simulation, the neural network outperformed the ViEWS model with a positive predictive value of 82% compared to 24%, respectively. Conclusion We developed and tested a neural network-based prediction model for clinical deterioration in patients hospitalized in the hematologic malignancy unit. Our neural network model outperformed an existing model, substantially increasing the positive predictive value, allowing the clinician to be confident in the alarm raised. This system can be readily implemented in a real-time fashion in existing EMR systems.	[Hu, Scott B.; Deng, Jane C.] Univ Calif Los Angeles, Div Pulm Crit Care, Los Angeles, CA 90095 USA; [Wong, Deborah J. L.] Univ Calif Los Angeles, Div Hematol Oncol, Los Angeles, CA USA; [Correa, Aditi] SUNY Albany, Downstate Coll Med, Albany, NY USA; [Li, Ning] Univ Calif Los Angeles, Dept Biomath, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; State University of New York (SUNY) System; State University of New York (SUNY) Albany; University of California System; University of California Los Angeles	Hu, SB (corresponding author), Univ Calif Los Angeles, Div Pulm Crit Care, Los Angeles, CA 90095 USA.	scotthu@mednet.ucla.edu			NIH [5T32HL072752]; NIH/National Center for Advancing Translational Science (NCATS) UCLA CTSI Grant [UL1TR000124]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL072752] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/National Center for Advancing Translational Science (NCATS) UCLA CTSI Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The research was supported by NIH 5T32HL072752 (SBH) and NIH/National Center for Advancing Translational Science (NCATS) UCLA CTSI Grant Number UL1TR000124.; The research was supported by NIH 5T32HL072752 (S.B.H.) and NIH/National Center for Advancing Translational Science (NCATS) UCLA CTSI Grant Number UL1TR000124	Alam N, 2014, RESUSCITATION, V85, P587, DOI 10.1016/j.resuscitation.2014.01.013; [Anonymous], 2005, BIOINFORMATICS, V21, P7881; Bergmeir C, 2012, J STAT SOFTW, V46, P1; Bliss JP, 2007, APPL ERGON, V38, P191, DOI 10.1016/j.apergo.2006.03.004; Bliss JP, 2000, ERGONOMICS, V43, P1283, DOI 10.1080/001401300421743; Chambrin MC, 1999, INTENS CARE MED, V25, P1360, DOI 10.1007/s001340051082; Churpek MM, 2014, CRIT CARE MED, V42, P841, DOI 10.1097/CCM.0000000000000038; Churpek MM, 2013, CHEST, V143, P1758, DOI 10.1378/chest.12-1605; Churpek MM, 2013, RESUSCITATION, V84, P564, DOI 10.1016/j.resuscitation.2012.09.024; Cvach Maria, 2012, Biomed Instrum Technol, V46, P268, DOI 10.2345/0899-8205-46.4.268; Edworthy J, 2005, QUAL SAF HEALTH CARE, V14, P212, DOI 10.1136/qshc.2004.013052; Finlay GD, 2014, J HOSP MED, V9, P116, DOI 10.1002/jhm.2132; Hravnak M, 2008, ARCH INTERN MED, V168, P1300, DOI 10.1001/archinte.168.12.1300; Hravnak M, 2011, CRIT CARE MED, V39, P65, DOI 10.1097/CCM.0b013e3181fb7b1c; Kellett J, 2012, RESUSCITATION, V83, P297, DOI 10.1016/j.resuscitation.2011.08.022; LAWLESS ST, 1994, CRIT CARE MED, V22, P981, DOI 10.1097/00003246-199406000-00017; Lengline E, 2012, LEUKEMIA LYMPHOMA, V53, P1352, DOI 10.3109/10428194.2011.649752; Liu V, 2012, J HOSP MED, V7, P224, DOI 10.1002/jhm.964; Manning T, 2013, BIOENGINEERED, V5; Mardini L, 2012, J CRIT CARE, V27, P688, DOI 10.1016/j.jcrc.2012.04.011; Mokart D, 2013, LEUKEMIA LYMPHOMA, V54, P1724, DOI 10.3109/10428194.2012.753446; Morgan R., 1997, CLIN INTENSIVE CARE, V8, P100, DOI DOI 10.3109/TCIC.8.2.93.110; Motta S, 2013, BRIEF BIOINFORM, V14, P411, DOI 10.1093/bib/bbs061; Opio MO, 2013, RESUSCITATION, V84, P743, DOI 10.1016/j.resuscitation.2013.02.007; Pappalardo AP F., 2012, MATH MODELLING NATUR, V7; Penny W, 1996, MED DECIS MAKING, V16, P386, DOI 10.1177/0272989X9601600409; Prytherch DR, 2010, RESUSCITATION, V81, P932, DOI 10.1016/j.resuscitation.2010.04.014; Rothman MJ, 2013, J BIOMED INFORM, V46, P837, DOI 10.1016/j.jbi.2013.06.011; Sendelbach S, 2013, AACN ADV CRIT CARE, V24, P378, DOI 10.1097/NCI.0b013e3182a903f9; Siebig S, 2010, CRIT CARE MED, V38, P451, DOI 10.1097/CCM.0b013e3181cb0888; Smith GB, 2008, RESUSCITATION, V77, P170, DOI 10.1016/j.resuscitation.2007.12.004; Smith GB, 2013, RESUSCITATION, V84, P465, DOI 10.1016/j.resuscitation.2012.12.016; Subbe CP, 2001, QJM-MON J ASSOC PHYS, V94, P521, DOI 10.1093/qjmed/94.10.521; Thiel SW, 2010, J HOSP MED, V5, P19, DOI 10.1002/jhm.530; Tsien CL, 1997, CRIT CARE MED, V25, P614, DOI 10.1097/00003246-199704000-00010; Young MP, 2003, J GEN INTERN MED, V18, P77, DOI 10.1046/j.1525-1497.2003.20441.x; Yousef K, 2012, AM J CRIT CARE, V21, P344, DOI 10.4037/ajcc2012797	37	25	26	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2016	11	8							e0161401	10.1371/journal.pone.0161401	http://dx.doi.org/10.1371/journal.pone.0161401			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4YN	27532679	Green Published, gold, Green Submitted			2022-12-27	WOS:000381487600092
J	Wang, P; Goggins, WB; Chan, EYY				Wang, Pin; Goggins, William B.; Chan, Emily Y. Y.			Hand, Foot and Mouth Disease in Hong Kong: A Time-Series Analysis on Its Relationship with Weather	PLOS ONE			English	Article							ENTEROVIRUS 71; METEOROLOGICAL FACTORS; TEMPERATURE; GUANGZHOU; INFECTIONS; SURVIVAL; HUMIDITY; OUTBREAK; PATTERNS; CHILDREN	Background Hand, foot and mouth disease (HFMD) is an emerging enterovirus-induced infectious disease for which the environmental risk factors promoting disease circulation remain inconclusive. This study aims to quantify the association of daily weather variation with hospitalizations for HFMD in Hong Kong, a subtropical city in China. Methods A time series of daily counts of HFMD public hospital admissions from 2008 through 2011 in Hong Kong was regressed on daily mean temperature, relative humidity, wind speed, solar radiation and total rainfall, using a combination of negative binomial generalized additive models and distributed lag non-linear models, adjusting for trend, season, and day of week. Results There was a positive association between temperature and HFMD, with increasing trends from 8 to 20 degrees C and above 25 degrees C with a plateau in between. A hockey-stick relationship of relative humidity with HFMD was found, with markedly increasing risks over 80%. Moderate rainfall and stronger wind and solar radiation were also found to be associated with more admissions. Conclusions The present study provides quantitative evidence that short-term meteorological variations could be used as early indicators for potential HFMD outbreaks. Climate change is likely to lead to a substantial increase in severe HFMD cases in this subtropical city in the absence of further interventions.	[Wang, Pin; Goggins, William B.] Chinese Univ Hong Kong, Fac Med, Sch Publ Hlth & Primary Care, Hong Kong, Hong Kong, Peoples R China; [Chan, Emily Y. Y.] Chinese Univ Hong Kong, Fac Med, Sch Publ Hlth & Primary Care, Collaborating Ctr Oxford Univ & CUHK Disaster & M, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong	Goggins, WB (corresponding author), Chinese Univ Hong Kong, Fac Med, Sch Publ Hlth & Primary Care, Hong Kong, Hong Kong, Peoples R China.	wgoggins@cuhk.edu.hk	Chan, Emily Ying Yang/H-6849-2017; Wang, Pin/S-6226-2016; Ibrahim, Essam Hassan/G-1960-2018	Wang, Pin/0000-0002-8031-8494; Ibrahim, Essam Hassan/0000-0003-0130-2257; Chan, Emily Ying Yang/0000-0002-8854-5093	Health and Medical Research Fund of the Food and Health Bureau of the government of Hong Kong SAR [08090261]	Health and Medical Research Fund of the Food and Health Bureau of the government of Hong Kong SAR	This work was supported by the Health and Medical Research Fund of the Food and Health Bureau of the government of Hong Kong SAR (ref: 08090261) (website: https://rfs1.fhb.gov.hk/english/funds/funds_hmrf/funds_hmrf_abt/funds_hmrf_abt.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ang LW, 2009, ANN ACAD MED SINGAP, V38, P106; Atkinson J, 2010, NATURAL VENTILATION; Belanger M, 2009, ANN EPIDEMIOL, V19, P180, DOI 10.1016/j.annepidem.2008.12.008; Blomqvist S, 2010, J CLIN VIROL, V48, P49, DOI 10.1016/j.jcv.2010.02.002; Centre for Health Protection, 2016, EV SCAN 2016; Chan EYY, 2013, B WORLD HEALTH ORGAN, V91, P576, DOI 10.2471/BLT.12.113035; Chen C, 2014, INT J BIOMETEOROL, V58, P1605, DOI 10.1007/s00484-013-0764-6; Chen KT, 2007, PEDIATRICS, V120, pE244, DOI 10.1542/peds.2006-3331; Cheng J, 2014, SCI TOTAL ENVIRON, V497, P484, DOI 10.1016/j.scitotenv.2014.08.006; Chong KC, 2015, INT J ENV RES PUB HE, V12, P1560, DOI 10.3390/ijerph120201560; Chua Kaw Bing, 2011, Virologica Sinica, V26, P221, DOI 10.1007/s12250-011-3195-8; DUFF MF, 1968, BMJ-BRIT MED J, V2, P661, DOI 10.1136/bmj.2.5606.661; Fan J, 2014, EPIDEMIOL INFECT, V142, P634, DOI 10.1017/S0950268813001519; Fares A, 2013, INT J PREVENTIVE MED, V4, P128; Feng HF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087916; Gasparrini A, 2011, J STAT SOFTW, V43, P1, DOI 10.18637/jss.v043.i08; Guo B, 2015, EXPERT REV VACCINES, V14, P561, DOI 10.1586/14760584.2014.990387; Hii YL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016796; Kramer A, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-130; Kung YH, 2010, VIROLOGY, V396, P1, DOI 10.1016/j.virol.2009.10.017; Li T, 2014, EPIDEMIOL INFECT, V142, P1741, DOI 10.1017/S0950268813002938; Lin HL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065585; Ma E, 2010, EPIDEMIOL INFECT, V138, P1779, DOI 10.1017/S0950268810002256; Ma E, 2010, JPN J INFECT DIS, V63, P422; Nguyen NTB, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-341; Onozuka D, 2011, SCI TOTAL ENVIRON, V410, P119, DOI 10.1016/j.scitotenv.2011.09.055; Rzezutka A, 2004, FEMS MICROBIOL REV, V28, P441, DOI 10.1016/j.femsre.2004.02.001; SATTAR SA, 1988, J MED VIROL, V25, P289, DOI 10.1002/jmv.1890250306; Ventarola D, 2015, CLIN DERMATOL, V33, P340, DOI 10.1016/j.clindermatol.2014.12.011; Wang Y, 2011, EPIDEMIOLOGY, V22, P781, DOI 10.1097/EDE.0b013e318231d67a; Wong SSY, 2010, EPIDEMIOL INFECT, V138, P1071, DOI 10.1017/S0950268809991555; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; World Health Organization Western Pacific Region, 2015, HAND FOOT MOUTH DIS; World Health Organization Western Pacific Region, 2012, GUID CLIN MAN PUBL H; World Health Organization Western Pacific Region, 2014, HAND FOOT MOUTH DIS; Wu HX, 2014, GLOBAL HEALTH ACTION, V7, P1, DOI 10.3402/gha.v7.24664; Wu XN, 2014, JPN J INFECT DIS, V67, P95, DOI 10.7883/yoken.67.95; Wu Y, 2010, INT J INFECT DIS, V14, pE1076, DOI 10.1016/j.ijid.2010.07.006; Zhang T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067157; Zou XN, 2012, BRAZ J INFECT DIS, V16, P457, DOI 10.1016/j.bjid.2012.08.001	40	54	56	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2016	11	8							e0161006	10.1371/journal.pone.0161006	http://dx.doi.org/10.1371/journal.pone.0161006			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4YN	27532865	Green Published, gold, Green Submitted			2022-12-27	WOS:000381487600053
J	Lin, CC; Lin, ATL; Yang, AH; Chen, KK				Lin, Chih-Chieh; Lin, Alex Tong-Long; Yang, An-Hang; Chen, Kuang-Kuo			Microvascular Injury in Ketamine-Induced Bladder Dysfunction	PLOS ONE			English	Article							TO-MESENCHYMAL TRANSITION; NMDA RECEPTOR; INTERSTITIAL CYSTITIS; PROXIMITY LIGATION; INDUCED APOPTOSIS; INDUCED UROPATHY; CLINICAL ENTITY; IN-SITU; DETRUSOR; FIBROSIS	The pathogenesis of ketamine-induced cystitis (KC) remains unclear. In this study, bladder microvascular injury was investigated as a possible contributing mechanism. A total of 36 KC patients with exposure to ketamine for more than 6 months, and 9 control subjects, were prospectively recruited. All participants completed questionnaires, including the O'Leary-Sant interstitial cystitis symptom index (ICSI) and the interstitial cystitis problem index (ICPI). All KC patients received a urodynamic study and radiological exams. Bladder tissues were obtained from cystoscopic biopsies in the control group and after hydrodistention in the KC group. Double-immunofluorescence staining of N-methyl-D-aspartate receptor subunit 1 (NMDAR1) and the endothelial marker, cluster of differentiation 31 (CD31), was performed to reveal the existence of NMDAR1 on the endothelium. Electron microscopy (EM) was applied to assess the microvascular change in the urinary bladder and to measure the thickening of the basement membrane (BM). A proximity ligation assay (PLA) was used to quantify the co-localization of the endothelial CD31 receptor and the mesenchymal marker [fibroblast-specific protein 1 (FSP-1)]. The Mann-Whitney U test and Spearman's correlation coefficient were used for statistical analysis. The mean ICSI [14.38 (+/- 4.16)] and ICPI [12.67 (+/- 3.54)] scores of the KC group were significantly higher than those (0 and 0, respectively) of the control group (both p < 0.001). The KC patients had decreasing cystometric bladder capacity (CBC) with a mean volume of 65.38 (+/- 48.67) mL. NMDAR1 was expressed on endothelial cells in both groups under immunofluorescence staining. Moreover, KC patients had significant BM duplication of microvessels in the mucosa of the urinary bladder under EM. The co-expression of the endothelial marker CD31 and mesenchymal marker FSP1 was significantly stained and calculated under PLA. In conclusion, microvascular injury and mesenchymal phenotypic alteration of endothelial cells can potentially contribute to KC-induced bladder dysfunction.	[Lin, Chih-Chieh; Yang, An-Hang] Natl Yang Ming Univ, Inst Clin Med, Taipei, Taiwan; [Lin, Chih-Chieh; Lin, Alex Tong-Long; Chen, Kuang-Kuo] Natl Yang Ming Univ, Sch Med, Dept Urol, Taipei, Taiwan; [Lin, Chih-Chieh; Lin, Alex Tong-Long; Chen, Kuang-Kuo] Taipei Vet Gen Hosp, Dept Urol, Taipei, Taiwan; [Yang, An-Hang] Taipei Vet Gen Hosp, Dept Pathol & Lab Med, Taipei, Taiwan; [Yang, An-Hang] Natl Yang Ming Univ, Sch Med, Dept Pathol, Taipei, Taiwan; [Yang, An-Hang] Taipei Vet Gen Hosp, Dept Pathol, Taipei, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital	Yang, AH (corresponding author), Natl Yang Ming Univ, Inst Clin Med, Taipei, Taiwan.; Yang, AH (corresponding author), Taipei Vet Gen Hosp, Dept Pathol & Lab Med, Taipei, Taiwan.; Yang, AH (corresponding author), Natl Yang Ming Univ, Sch Med, Dept Pathol, Taipei, Taiwan.; Yang, AH (corresponding author), Taipei Vet Gen Hosp, Dept Pathol, Taipei, Taiwan.	ahyang@vghtpe.gov.tw			Taipei Veterans General Hospital [V100B-024, V105C-014]; Ministry of Science and Technology [MOST-102-2320-B-075-001-MY3]	Taipei Veterans General Hospital(Taipei Veterans General Hospital); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea)	This work was partially supported by Taipei Veterans General Hospital (V100B-024 and V105C-014) and Ministry of Science and Technology (MOST-102-2320-B-075-001-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asosingh K, 2013, J IMMUNOL, V190, P3458, DOI 10.4049/jimmunol.1202095; Baker SC, 2016, AM J PATHOL, V186, P1267, DOI 10.1016/j.ajpath.2015.12.014; Baker SC, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-64; Chang T, 2012, LUTS, V4, P19, DOI 10.1111/j.1757-5672.2011.00101.x; Chu PSK, 2008, BJU INT, V102, P1616, DOI 10.1111/j.1464-410X.2008.07920.x; Cristofaro V, 2012, J UROLOGY, V188, P1017, DOI 10.1016/j.juro.2012.04.100; Cryan JF, 2010, SCIENCE, V329, P913, DOI 10.1126/science.1194313; Diazgranados N, 2010, ARCH GEN PSYCHIAT, V67, P793, DOI 10.1001/archgenpsychiatry.2010.90; Gonzalez-Cadavid NF, 2000, J ANDROL, V21, P566; Homma Y, 2009, INT J UROL, V16, P597, DOI 10.1111/j.1442-2042.2009.02326.x; Huang LK, 2014, POSTGRAD MED J, V90, P185, DOI 10.1136/postgradmedj-2013-131776; Jarvius M, 2007, MOL CELL PROTEOMICS, V6, P1500, DOI 10.1074/mcp.M700166-MCP200; Jhang JF, 2014, J UROLOGY, V192, P1249, DOI 10.1016/j.juro.2014.05.084; Jiang XG, 2014, J MOL MED, V92, P797, DOI 10.1007/s00109-014-1173-y; Kushner L, 2006, J UROLOGY, V176, P587, DOI 10.1016/j.juro.2006.03.035; Lee CL, 2013, BJU INT, V112, P1156, DOI 10.1111/bju.12256; Li JH, 2009, AM J PATHOL, V175, P1380, DOI 10.2353/ajpath.2009.090096; Li NX, 2010, SCIENCE, V329, P959, DOI 10.1126/science.1190287; Miodonski AJ, 1999, ANAT REC, V254, P375, DOI 10.1002/(SICI)1097-0185(19990301)254:3<375::AID-AR8>3.3.CO;2-I; Piera-Velazquez S, 2011, AM J PATHOL, V179, P1074, DOI 10.1016/j.ajpath.2011.06.001; Reijerkerk A, 2010, J NEUROCHEM, V113, P447, DOI 10.1111/j.1471-4159.2010.06598.x; Shahani R, 2007, UROLOGY, V69, P810, DOI 10.1016/j.urology.2007.01.038; Smith KM, 2002, AM J HEALTH-SYST PH, V59, P1067, DOI 10.1093/ajhp/59.11.1067; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Takadera T, 2006, TOXICOL APPL PHARM, V210, P100, DOI 10.1016/j.taap.2005.10.005; Tang HC, 2014, INT UROL NEPHROL, V46, P1563, DOI 10.1007/s11255-014-0690-5; Tang JJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep13573; Tsai TH, 2009, INT J UROL, V16, P826, DOI 10.1111/j.1442-2042.2009.02361.x; Xu-Dubois YC, 2015, J AM SOC NEPHROL; Zeisberg EM, 2007, NAT MED, V13, P952, DOI 10.1038/nm1613; Zeisberg EM, 2008, J AM SOC NEPHROL, V19, P2282, DOI 10.1681/ASN.2008050513; Zeisberg M, 2009, J CLIN INVEST, V119, P1429, DOI 10.1172/JCI36183	32	11	12	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2016	11	8							e0160578	10.1371/journal.pone.0160578	http://dx.doi.org/10.1371/journal.pone.0160578			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4UN	27529746	Green Published, gold, Green Submitted			2022-12-27	WOS:000381476700009
J	Umeda, S; Miyagawa, S; Fukushima, S; Oda, N; Saito, A; Sakai, Y; Sawa, Y; Okuyama, H				Umeda, Satoshi; Miyagawa, Shigeru; Fukushima, Satsuki; Oda, Noriko; Saito, Atsuhiro; Sakai, Yoshiki; Sawa, Yoshiki; Okuyama, Hiroomi			Enhanced Pulmonary Vascular and Alveolar Development via Prenatal Administration of a Slow-Release Synthetic Prostacyclin Agonist in Rat Fetal Lung Hypoplasia	PLOS ONE			English	Article							CONGENITAL DIAPHRAGMATIC-HERNIA; ENDOSCOPIC TRACHEAL OCCLUSION; ARTERY STRUCTURAL-CHANGES; HYPERTENSION; MODEL; THERAPY; GROWTH; GLUCOCORTICOIDS; ANGIOGENESIS; HYPEROXIA	Lung hypoplasia and pulmonary hypertension are the major causes of mortality in neonates with congenital diaphragmatic hernia (CDH). Although the prostaglandin pathway plays a pivotal role in lung development, the reported efficacy of postnatal prostaglandin agonist treatment is suboptimal. We hypothesized that prenatal treatment with ONO-1301SR, a slow-release form of a novel synthetic prostacyclin agonist with thromboxane inhibitory activity, might enhance the development of lungs exhibiting hypoplasia in the fetal period. On embryonic day (E) 9.5, nitrofen was given to pregnant Sprague-Dawley rats to establish a CDH-related lung hypoplasia model, whereas normal rats received the vehicle only. The same day, either ONO-1301SR or a placebo was also randomly administered. On E21.5, the fetuses of the normal group and those exhibiting CDH were analyzed. Prenatal ONO-1301SR administration had no influence on the incidence of nitrofen-induced CDH. The lung-to-body weight ratio in the CDH+ONO group was greater than that in the CDH group. Histologically, the medial wall in the CDH+ONO group was two-thirds thinner than that in the CDH group. In addition, the number of Ttf-1-positive cells and the capillary density were >= 1.5 times greater in the CDH+ONO group than in the CDH group, and this increase was associated with higher expression of vascular endothelial growth factor and stromal cell-derived factor in the CDH+ONO group, suggesting enhanced development of the alveolar and capillary networks. Thus, prenatal ONO-1301SR was protective against the progression of lung hypoplasia associated with CDH in a nitrofen-induced rat model, indicating the potential of this treatment for pathologies exhibiting lung hypoplasia.	[Umeda, Satoshi; Okuyama, Hiroomi] Osaka Univ, Grad Sch Med, Dept Pediat Surg, Osaka, Japan; [Miyagawa, Shigeru; Fukushima, Satsuki; Oda, Noriko; Saito, Atsuhiro; Sakai, Yoshiki; Sawa, Yoshiki] Osaka Univ, Grad Sch Med, Dept Cardiovasc Surg, Osaka, Japan	Osaka University; Osaka University	Okuyama, H (corresponding author), Osaka Univ, Grad Sch Med, Dept Pediat Surg, Osaka, Japan.	okuyama@pedsurg.med.osaka-u.ac.jp	Fukushima, Satsuki/ABE-6582-2020	Fukushima, Satsuki/0000-0002-9481-8860; Miyagawa, Shigeru/0000-0003-0015-6569	JSPS KAKENHI [16K20343]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was financially supported by JSPS KAKENHI Grant Number 16K20343 (SU). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Budhiraja R, 2004, CIRCULATION, V109, P159, DOI 10.1161/01.CIR.0000102381.57477.50; Chang YT, 2012, AM J PHYSIOL-LUNG C, V302, pL1159, DOI 10.1152/ajplung.00325.2010; Garne E, 2002, ULTRASOUND OBST GYN, V19, P329, DOI 10.1046/j.1469-0705.2002.00635.x; HISLOP A, 1976, THORAX, V31, P450, DOI 10.1136/thx.31.4.450; Imanishi Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069302; Ishimaru K, 2013, J THORAC CARDIOV SUR, V146, P1516, DOI 10.1016/j.jtcvs.2013.02.045; Jakkula M, 2000, AM J PHYSIOL-LUNG C, V279, pL600, DOI 10.1152/ajplung.2000.279.3.L600; Jani JC, 2009, ULTRASOUND OBST GYN, V34, P304, DOI 10.1002/uog.6450; Kamiyama M, 2005, J PEDIATR SURG, V40, P1562, DOI 10.1016/j.jpedsurg.2005.06.005; Kanai M, 2001, J PEDIATR SURG, V36, P839, DOI 10.1053/jpsu.2001.23950; Kataoka M, 2005, AM J RESP CRIT CARE, V172, P1575, DOI 10.1164/rccm.200501-102OC; Kunig AM, 2005, AM J PHYSIOL-LUNG C, V289, pL529, DOI 10.1152/ajplung.00336.2004; Kunig AM, 2006, AM J PHYSIOL-LUNG C, V291, pL1068, DOI 10.1152/ajplung.00093.2006; Langham MR, 1996, CLIN PERINATOL, V23, P671, DOI 10.1016/S0095-5108(18)30201-X; Leeuwen L, 2014, J PAEDIATR CHILD H, V50, P667, DOI 10.1111/jpc.12508; Lemus-Varela MDL, 2014, WORLD J PEDIATR, V10, P354, DOI 10.1007/s12519-014-0512-y; Luong C, 2011, CIRCULATION, V123, P2120, DOI 10.1161/CIRCULATIONAHA.108.845909; Obata H, 2008, AM J RESP CRIT CARE, V177, P195, DOI 10.1164/rccm.200703-349OC; Okoye BO, 1998, J PEDIATR SURG, V33, P76, DOI 10.1016/S0022-3468(98)90366-9; Ruano R, 2012, ULTRASOUND OBST GYN, V39, P20, DOI 10.1002/uog.10142; Sakai K, 2014, J PEDIATR SURG, V49, P1749, DOI 10.1016/j.jpedsurg.2014.09.015; Schmidt AF, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.04.025; Taira Y, 1998, J PEDIATR SURG, V33, P1052, DOI 10.1016/S0022-3468(98)90530-9; Thebaud B, 2005, CIRCULATION, V112, P2477, DOI 10.1161/CIRCULATIONAHA.105.541524; Thebaud B, 1998, BIOL NEONATE, V74, P323, DOI 10.1159/000014050; Thebaud B, 2007, AM J RESP CRIT CARE, V175, P978, DOI 10.1164/rccm.200611-1660PP; THURLBEC.WM, 1967, THORAX, V22, P483, DOI 10.1136/thx.22.6.483; Wharton J, 2000, CIRCULATION, V102, P3130; Yamataka T, 1997, J PEDIATR SURG, V32, P387, DOI 10.1016/S0022-3468(97)90587-X	29	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2016	11	8							e0161334	10.1371/journal.pone.0161334	http://dx.doi.org/10.1371/journal.pone.0161334			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4UN	27529478	Green Submitted, Green Published, gold			2022-12-27	WOS:000381476700068
J	Magini, D; Giovani, C; Mangiavacchi, S; Maccari, S; Cecchi, R; Ulmer, JB; De Gregorio, E; Geall, AJ; Brazzoli, M; Bertholet, S				Magini, Diletta; Giovani, Cinzia; Mangiavacchi, Simona; Maccari, Silvia; Cecchi, Raffaella; Ulmer, Jeffrey B.; De Gregorio, Ennio; Geall, Andrew J.; Brazzoli, Michela; Bertholet, Sylvie			Self-Amplifying mRNA Vaccines Expressing Multiple Conserved Influenza Antigens Confer Protection against Homologous and Heterosubtypic Viral Challenge	PLOS ONE			English	Article							CD8(+) T-CELLS; A VIRUS; SEASONAL INFLUENZA; PANDEMIC INFLUENZA; NONVIRAL DELIVERY; ANTIBODY-RESPONSE; YOUNG-CHILDREN; M-GENE; MICE; DNA	Current hemagglutinin (HA)-based seasonal influenza vaccines induce vaccine strain-specific neutralizing antibodies that usually fail to provide protection against mismatched circulating viruses. Inclusion in the vaccine of highly conserved internal proteins such as the nucleoprotein (NP) and the matrix protein 1 (M1) was shown previously to increase vaccine efficacy by eliciting cross-reactive T-cells. However, appropriate delivery systems are required for efficient priming of T-cell responses. In this study, we demonstrated that administration of novel self-amplifying mRNA (SAM (R)) vectors expressing influenza NP (SAM (NP)), M1 (SAM(M1)), and NP and M1 (SAM(M1-NP)) delivered with lipid nanoparticles (LNP) induced robust polyfunctional CD4 T helper 1 cells, while NP-containing SAM also induced cytotoxic CD8 T cells. Robust expansions of central memory (T-CM) and effector memory (T-EM) CD4 and CD8 T cells were also measured. An enhanced recruitment of NP-specific cytotoxic CD8 T cells was observed in the lungs of SAM(NP)-immunized mice after influenza infection that paralleled with reduced lung viral titers and pathology, and increased survival after homologous and heterosubtypic influenza challenge. Finally, we demonstrated for the first time that the co-administration of RNA (SAM(M1-NP)) and protein (monovalent inactivated influenza vaccine (MIIV)) was feasible, induced simultaneously NP-, M1- and HA-specific T cells and HA-specific neutralizing antibodies, and enhanced MIIV efficacy against a heterologous challenge. In conclusion, systemic administration of SAM vectors expressing conserved internal influenza antigens induced protective immune responses in mice, supporting the SAM (R) platform as another promising strategy for the development of broad-spectrum universal influenza vaccines.	[Magini, Diletta; Giovani, Cinzia; Mangiavacchi, Simona; Maccari, Silvia; Cecchi, Raffaella; De Gregorio, Ennio; Brazzoli, Michela; Bertholet, Sylvie] Novartis Vaccines Srl, Siena, Italy; [Magini, Diletta] Univ Siena, Dipartimento Biotecnol Chim & Farm, Siena, Italy; [Ulmer, Jeffrey B.; Geall, Andrew J.] Novartis Vaccines Inc, Cambridge, MA USA; [Magini, Diletta] IRCCS San Raffaele Sci Inst, Div Immunol Transplantat & Infect Dis, Milan, Italy; [Giovani, Cinzia; Mangiavacchi, Simona; Maccari, Silvia; Cecchi, Raffaella; De Gregorio, Ennio; Brazzoli, Michela; Bertholet, Sylvie] GSK Vaccines Srl, Siena, Italy; [Ulmer, Jeffrey B.] GSK Vaccines Inc, Cambridge, MA USA; [Geall, Andrew J.] Avid NanoMed LLC, San Diego, CA USA	Novartis; University of Siena; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; GlaxoSmithKline; GlaxoSmithKline	Brazzoli, M (corresponding author), Novartis Vaccines Srl, Siena, Italy.; Brazzoli, M (corresponding author), GSK Vaccines Srl, Siena, Italy.	michela.x.brazzoli@gsk.com		Magini, Diletta/0000-0002-2257-9979	Defense Advanced Research Project Agency [HR0011-12-3-0001]	Defense Advanced Research Project Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA))	This work is supported by the Defense Advanced Research Project Agency (HR0011-12-3-0001). AJG received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. All the authors were employed or affiliated with Novartis Vaccines S.r.l. at the time of the study conduct.	Altenburg AF, 2014, VIRUSES-BASEL, V6, P2735, DOI 10.3390/v6072735; Altstein AD, 2006, ARCH VIROL, V151, P921, DOI 10.1007/s00705-005-0676-9; Ansaldi F, 2010, VACCINE, V28, P4123, DOI 10.1016/j.vaccine.2010.04.030; Antrobus RD, 2014, MOL THER, V22, P233, DOI 10.1038/mt.2013.162; Belshe RB, 2007, NEW ENGL J MED, V356, P685, DOI 10.1056/NEJMoa065368; Berthoud TK, 2011, CLIN INFECT DIS, V52, P1, DOI 10.1093/cid/ciq015; Bogers WM, 2015, J INFECT DIS, V211, P947, DOI 10.1093/infdis/jiu522; Brazzoli M, 2016, J VIROL, V90, P332, DOI 10.1128/JVI.01786-15; Brito LA, 2014, MOL THER, V22, P2118, DOI 10.1038/mt.2014.133; Carragher DM, 2008, J IMMUNOL, V181, P4168, DOI 10.4049/jimmunol.181.6.4168; Chen QJ, 2009, VIRUS GENES, V38, P30, DOI 10.1007/s11262-008-0305-2; Cowling BJ, 2010, CLIN INFECT DIS, V51, P1370, DOI 10.1086/657311; Cukalac T, 2014, J IMMUNOL, V192, P4061, DOI 10.4049/jimmunol.1301403; de Jong JC, 2000, J MED VIROL, V61, P94, DOI 10.1002/(SICI)1096-9071(200005)61:1&lt;94::AID-JMV15&gt;3.0.CO;2-C; Deering RP, 2014, EXPERT OPIN DRUG DEL, V11, P885, DOI 10.1517/17425247.2014.901308; Del Giudice G, 2013, EXPERT OPIN BIOL TH, V13, P121, DOI 10.1517/14712598.2013.748030; Donnelly JJ, 1997, VACCINE, V15, P865, DOI 10.1016/S0264-410X(96)00268-X; Epstein SL, 2005, VACCINE, V23, P5404, DOI 10.1016/j.vaccine.2005.04.047; Epstein SL, 2002, EMERG INFECT DIS, V8, P796; Furuya Y, 2012, IMMUNOL CELL BIOL, V90, P571, DOI 10.1038/icb.2011.70; Geall AJ, 2012, P NATL ACAD SCI USA, V109, P14604, DOI 10.1073/pnas.1209367109; Gerhard W, 1997, IMMUNOL REV, V159, P95, DOI 10.1111/j.1600-065X.1997.tb01009.x; Gianfrani C, 2000, HUM IMMUNOL, V61, P438, DOI 10.1016/S0198-8859(00)00105-1; Grebe KM, 2008, MICROBES INFECT, V10, P1024, DOI 10.1016/j.micinf.2008.07.002; Hamm S, 2007, INT IMMUNOL, V19, P297, DOI 10.1093/intimm/dxl146; Hekele A, 2013, EMERG MICROBES INFEC, V2, DOI 10.1038/emi.2013.54; Hessel A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088340; Hoft DF, 2011, J INFECT DIS, V204, P845, DOI 10.1093/infdis/jir436; Jameson J, 1998, J VIROL, V72, P8682, DOI 10.1128/JVI.72.11.8682-8689.1998; Jelinek I, 2011, J IMMUNOL, V186, P2422, DOI 10.4049/jimmunol.1002845; Jeon SH, 2002, VACCINE, V20, P2772, DOI 10.1016/S0264-410X(02)00187-1; Jimenez GS, 2007, HUM VACCINES, V3, P157, DOI 10.4161/hv.3.5.4175; Jin HL, 2005, BIOCHEM BIOPH RES CO, V328, P979, DOI 10.1016/j.bbrc.2005.01.048; Johansson DX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029732; Jungblut M, 2009, JOVE-J VIS EXP, DOI [10.3791/1266, DOI 10.3791/1266]; Kalams SA, 1998, J EXP MED, V188, P2199, DOI 10.1084/jem.188.12.2199; La Gruta NL, 2008, P NATL ACAD SCI USA, V105, P2034, DOI 10.1073/pnas.0711682102; Lambe T, 2013, SCI REP-UK, V3, DOI 10.1038/srep01443; Lazzaro S, 2015, IMMUNOLOGY, V146, P312, DOI 10.1111/imm.12505; LEHNER PJ, 1995, J EXP MED, V181, P79, DOI 10.1084/jem.181.1.79; LIACOPOULOS P, 1975, PROG ALLERGY, V18, P97; Lillie PJ, 2012, CLIN INFECT DIS, V55, P19, DOI 10.1093/cid/cis327; Maisonneuve C, 2014, P NATL ACAD SCI USA, V111, P12294, DOI 10.1073/pnas.1400478111; Manoj S, 2003, VIROLOGY, V313, P296, DOI 10.1016/S0042-6822(03)00325-8; MCMICHAEL AJ, 1983, NEW ENGL J MED, V309, P13, DOI 10.1056/NEJM198307073090103; Molinari NAM, 2007, VACCINE, V25, P5086, DOI 10.1016/j.vaccine.2007.03.046; Monto AS, 2009, NEW ENGL J MED, V361, P1260, DOI 10.1056/NEJMoa0808652; MORRISON J, 1992, EUR J IMMUNOL, V22, P903, DOI 10.1002/eji.1830220404; Mullarkey CE, 2013, EUR J IMMUNOL, V43, P1940, DOI 10.1002/eji.201242922; Okuda K, 2001, VACCINE, V19, P3681, DOI 10.1016/S0264-410X(01)00078-0; Orsi A, 2013, HUM VACC IMMUNOTHER, V9, P582, DOI 10.4161/hv.23239; Perri S, 2003, J VIROL, V77, P10394, DOI 10.1128/JVI.77.19.10394-10403.2003; Petsch B, 2012, NAT BIOTECHNOL, V30, P1210, DOI 10.1038/nbt.2436; Plotnicky H, 2003, VIROLOGY, V309, P320, DOI 10.1016/S0042-6822(03)00072-2; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Soema PC, 2015, EUROPEAN J PHARM BIO; Sridhar S, 2013, NAT MED, V19, P1305, DOI 10.1038/nm.3350; Sun JC, 2004, NAT IMMUNOL, V5, P927, DOI 10.1038/ni1105; Szewczyk B, 2014, ACTA BIOCHIM POL, V61, P397; Tamura S, 1996, J IMMUNOL, V156, P3892; Uematsu Y, 2012, CLIN VACCINE IMMUNOL, V19, P991, DOI 10.1128/CVI.00031-12; ULMER JB, 1993, SCIENCE, V259, P1745, DOI 10.1126/science.8456302; Ulmer JB, 1998, J VIROL, V72, P5648, DOI 10.1128/JVI.72.7.5648-5653.1998; Wang WL, 2015, CLIN VACCINE IMMUNOL, V22, P618, DOI 10.1128/CVI.00091-15; Wilkinson TM, 2012, NAT MED, V18, P274, DOI 10.1038/nm.2612; Zaritskaya L, 2010, EXPERT REV VACCINES, V9, P601, DOI [10.1586/erv.10.49, 10.1586/ERV.10.49]; Zhirnov OP, 2007, INFLUENZA OTHER RESP, V1, P71, DOI 10.1111/j.1750-2659.2007.00010.x	67	70	104	5	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2016	11	8							e0161193	10.1371/journal.pone.0161193	http://dx.doi.org/10.1371/journal.pone.0161193			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4SL	27525409	Green Submitted, Green Published, gold			2022-12-27	WOS:000381471100042
J	Dilg, D; Saleh, RNM; Phelps, SEL; Rose, Y; Dupays, L; Murphy, C; Mohun, T; Anderson, RH; Scambler, PJ; Chapgier, ALA				Dilg, Daniel; Saleh, Rasha Noureldin M.; Phelps, Sarah Elizabeth Lee; Rose, Yoann; Dupays, Laurent; Murphy, Cian; Mohun, Timothy; Anderson, Robert H.; Scambler, Peter J.; Chapgier, Ariane L. A.			HIRA Is Required for Heart Development and Directly Regulates Tnni2 and Tnnt3	PLOS ONE			English	Article							SYNDROME CANDIDATE GENE; HISTONE CHAPERONE; CHROMATIN; H3.3; TRANSCRIPTION; SKELETAL; NKX2-5; SUPPRESSION; DEFECTS; COMPLEX	Chromatin remodelling is essential for cardiac development. Interestingly, the role of histone chaperones has not been investigated in this regard. HIRA is a member of the HUCA (HIRA/ UBN1/CABIN1/ASF1a) complex that deposits the variant histone H3.3 on chromatin independently of replication. Lack of HIRA has general effects on chromatin and gene expression dynamics in embryonic stem cells and mouse oocytes. Here we describe the conditional ablation of Hira in the cardiogenic mesoderm of mice. We observed surface oedema, ventricular and atrial septal defects and embryonic lethality. We identified dysregulation of a subset of cardiac genes, notably upregulation of troponins Tnni2 and Tnnt3, involved in cardiac contractility and decreased expression of Epha3, a gene necessary for the fusion of the muscular ventricular septum and the atrioventricular cushions. We found that HIRA binds GAGA rich DNA loci in the embryonic heart, and in particular a previously described enhancer of Tnni2/Tnnt3 (TTe) bound by the transcription factor NKX2.5. HIRA-dependent H3.3 enrichment was observed at the TTe in embryonic stem cells (ESC) differentiated toward cardiomyocytes in vitro. Thus, we show here that HIRA has locus-specific effects on gene expression and that histone chaperone activity is vital for normal heart development, impinging on pathways regulated by an established cardiac transcription factor.	[Dilg, Daniel; Saleh, Rasha Noureldin M.; Phelps, Sarah Elizabeth Lee; Rose, Yoann; Scambler, Peter J.; Chapgier, Ariane L. A.] UCL, Inst Child Hlth, Dev Biol Birth Defects Sect, 30 Guilford St, London WC1N 1EH, England; [Saleh, Rasha Noureldin M.; Mohun, Timothy] Univ Alexandria, Fac Med, El Gaish Rd, Alexandria, Egypt; [Dupays, Laurent] Francis Crick Inst, Mill Hill Lab, Mill Hill, London NW7 1AA, England; [Murphy, Cian] UCL, UGI, Dept Genet Environm & Evolut, Gower St, London WC1E 6BT, England; [Anderson, Robert H.] Newcastle Univ, Inst Med Genet, Int Ctr Life, Cent Pkwy, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England	University of London; University College London; Egyptian Knowledge Bank (EKB); Alexandria University; University of London; University College London; Newcastle University - UK	Scambler, PJ (corresponding author), UCL, Inst Child Hlth, Dev Biol Birth Defects Sect, 30 Guilford St, London WC1N 1EH, England.	p.scambler@ucl.ac.uk	Scambler, Peter/AAZ-6026-2020; Dupays, Laurent/HGU-2621-2022; Murphy, Cian/N-4343-2019	Scambler, Peter/0000-0002-1487-4628; Murphy, Cian/0000-0003-1356-959X; Chapgier, Ariane/0000-0002-1734-0744	British Heart Foundation [RG/15/14/31880, FS/11/83/29333, FS/10/031/28395]; Fondation Leducq (FR) [TNE 15CVD01]; National Institute for Health Research Biomedical Research Centre at Great Ormond Street Hospital for Children NHS Foundation Trust; National Institute for Health Research Biomedical Research Centre at University College London; Biotechnology and Biological Sciences Research Council [BB/E009603/1] Funding Source: researchfish; British Heart Foundation [PG/15/6/31211, FS/10/31/28395] Funding Source: researchfish; The Francis Crick Institute [10117] Funding Source: researchfish; BBSRC [BB/E009603/1] Funding Source: UKRI	British Heart Foundation(British Heart Foundation); Fondation Leducq (FR)(Leducq Foundation); National Institute for Health Research Biomedical Research Centre at Great Ormond Street Hospital for Children NHS Foundation Trust; National Institute for Health Research Biomedical Research Centre at University College London; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Heart Foundation(British Heart Foundation); The Francis Crick Institute; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This research was funded by British Heart Foundation (grants RG/15/14/31880; FS/11/83/29333 (PJS); and FS/10/031/28395 (ALAC)), Fondation Leducq (FR) grant TNE 15CVD01 (PJS), and supported by the National Institute for Health Research Biomedical Research Centre at Great Ormond Street Hospital for Children NHS Foundation Trust and University College London. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkins NL, 2006, BIOCHEM CELL BIOL, V84, P559, DOI 10.1139/O06-062; Ahmad A, 2003, BIOCHEM BIOPH RES CO, V312, P1266, DOI 10.1016/j.bbrc.2003.11.073; Anderson HE, 2009, MOL CELL BIOL, V29, P5158, DOI 10.1128/MCB.00698-09; Anderson RH, 2016, CLIN ANAT, V29, P290, DOI 10.1002/ca.22627; Banaszynski LA, 2013, CELL, V155, P107, DOI 10.1016/j.cell.2013.08.061; Barriga EH, 2015, DEVELOPMENT, V142, P1555, DOI 10.1242/dev.121590; Bergemann AD, 2005, TRENDS GENET, V21, P188, DOI 10.1016/j.tig.2005.01.008; Bible PW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127285; Blow MJ, 2010, NAT GENET, V42, P806, DOI 10.1038/ng.650; Bonnefoy E, 2007, PLOS GENET, V3, P1991, DOI 10.1371/journal.pgen.0030182; Bouveret R, 2015, ELIFE, V4, DOI 10.7554/eLife.06942; Chang CP, 2012, ANNU REV PHYSIOL, V74, P41, DOI 10.1146/annurev-physiol-020911-153242; Dupays L, 2015, CELL REP, V13, P183, DOI 10.1016/j.celrep.2015.08.065; Dutta D, 2010, J BIOL CHEM, V285, P41567, DOI 10.1074/jbc.M110.190025; Farrell MJ, 1999, CIRC RES, V84, P127, DOI 10.1161/01.RES.84.2.127; Franco D, 1998, CARDIOVASC RES, V38, P25, DOI 10.1016/S0008-6363(97)00321-0; Goldberg AD, 2010, CELL, V140, P678, DOI 10.1016/j.cell.2010.01.003; Huang QQ, 2008, AM J PHYSIOL-CELL PH, V294, pC213, DOI 10.1152/ajpcell.00146.2007; Kisanuki YY, 2001, DEV BIOL, V230, P230, DOI 10.1006/dbio.2000.0106; Lin CJ, 2014, DEV CELL, V30, P268, DOI 10.1016/j.devcel.2014.06.022; Ma Q, 2008, DEV BIOL, V323, P98, DOI 10.1016/j.ydbio.2008.08.013; Moorman A, 2003, HEART, V89, P806, DOI 10.1136/heart.89.7.806; Moses Kelvin A., 2001, Genesis The Journal of Genetics and Development, V31, P176, DOI 10.1002/gene.10022; Nakayama T, 2012, DEVELOPMENT, V139, P4582, DOI 10.1242/dev.083246; Nimura K, 2009, NATURE, V460, P287, DOI 10.1038/nature08086; Ochala J, 2008, J MOL MED-JMM, V86, P1197, DOI 10.1007/s00109-008-0380-9; Pchelintsev NA, 2013, CELL REP, V3, P1012, DOI 10.1016/j.celrep.2013.03.026; Peng X, 2008, P NATL ACAD SCI USA, V105, P6638, DOI 10.1073/pnas.0802319105; Phelps-Durr TL, 2005, PLANT CELL, V17, P2886, DOI 10.1105/tpc.105.035477; Rai TS, 2014, GENE DEV, V28, P2712, DOI 10.1101/gad.247528.114; Ramsbottom SA, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004871; Risebro CA, 2009, DEVELOPMENT, V136, P495, DOI 10.1242/dev.030007; Roberts C, 2002, MOL CELL BIOL, V22, P2318, DOI 10.1128/MCB.22.7.2318-2328.2002; Sarai N, 2013, EMBO J, V32, P2392, DOI 10.1038/emboj.2013.176; Stephen LJ, 2007, DEV BIOL, V302, P66, DOI 10.1016/j.ydbio.2006.08.058; StoneO MR, 2007, J CELL SCI, V120, P3999, DOI 10.1242/jcs.009241; Trainor PA, 2010, AM J MED GENET A, V152A, P2984, DOI 10.1002/ajmg.a.33454; Venkatesh S, 2015, NAT REV MOL CELL BIO, V16, P178, DOI 10.1038/nrm3941; Wamstad JA, 2012, CELL, V151, P206, DOI 10.1016/j.cell.2012.07.035; Wang H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137797; Wang Xiang, 2008, J Vis Exp, DOI 10.3791/825; Wang Xiaohua, 2014, Zhonghua Yi Xue Za Zhi, V94, P1223; Watanabe Y, 2006, DEVELOPMENT, V133, P1625, DOI 10.1242/dev.02344; Wilming LG, 1997, HUM MOL GENET, V6, P247, DOI 10.1093/hmg/6.2.247; Zhang L, 2014, DEV BIOL, V390, P68, DOI 10.1016/j.ydbio.2014.02.023	45	15	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2016	11	8							e0161096	10.1371/journal.pone.0161096	http://dx.doi.org/10.1371/journal.pone.0161096			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3LI	27518902	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000381382100047
J	Benoit, J; Manger, PR; Fernandez, V; Rubidge, BS				Benoit, Julien; Manger, Paul R.; Fernandez, Vincent; Rubidge, Bruce S.			Cranial Bosses of Choerosaurus dejageri (Therapsida, Therocephalia): Earliest Evidence of Cranial Display Structures in Eutheriodonts	PLOS ONE			English	Article							BURNETIAMORPH THERAPSIDA; TEEKLOOF FORMATION; COLLAGEN ARRAYS; SOUTH-AFRICA; EVOLUTION; BIARMOSUCHIA; MORPHOLOGY; PATTERNS; RECONSTRUCTION; ORNITHISCHIA	Choerosaurus dejageri, a non-mammalian eutheriodont therapsid from the South African late Permian (similar to 259 Ma), has conspicuous hemispheric cranial bosses on the maxilla and the mandible. These bosses, the earliest of this nature in a eutheriodont, potentially make C. dejageri a key species for understanding the evolutionary origins of sexually selective behaviours (intraspecific competition, ritualized sexual and intimidation displays) associated with cranial outgrowths at the root of the clade that eventually led to extant mammals. Comparison with the tapinocephalid dinocephalian Moschops capensis, a therapsid in which head butting is strongly supported, shows that the delicate structure of the cranial bosses and the gracile structure of the skull of Choerosaurus would be more suitable for display and low energy combat than vigorous head butting. Thus, despite the fact that Choerosaurus is represented by only one skull (which makes it impossible to address the question of sexual dimorphism), its cranial bosses are better interpreted as structures involved in intraspecific selection, i.e. low-energy fighting or display. Display structures, such as enlarged canines and cranial bosses, are widespread among basal therapsid clades and are also present in the putative basal therapsid Tetraceratops insignis. This suggests that sexual selection may have played a more important role in the distant origin and evolution of mammals earlier than previously thought. Sexual selection may explain the subsequent independent evolution of cranial outgrowths and pachyostosis in different therapsid lineages (Biarmosuchia, Dinocephalia, Gorgonopsia and Dicynodontia).	[Benoit, Julien; Rubidge, Bruce S.] Univ Witwatersrand, Sch Geosci, ESI, ZA-2050 Johannesburg, South Africa; [Benoit, Julien; Manger, Paul R.] Univ Witwatersrand, Sch Anat Sci, 7 York Rd, ZA-2193 Johannesburg, South Africa; [Fernandez, Vincent] European Synchrotron Radiat Facil, 71 Rue Martyrs, F-38000 Grenoble, France	University of Witwatersrand; University of Witwatersrand; European Synchrotron Radiation Facility (ESRF)	Benoit, J (corresponding author), Univ Witwatersrand, Sch Geosci, ESI, ZA-2050 Johannesburg, South Africa.; Benoit, J (corresponding author), Univ Witwatersrand, Sch Anat Sci, 7 York Rd, ZA-2193 Johannesburg, South Africa.	julien.benoit@wits.ac.za	Rubidge, Bruce/AAE-7021-2019	Rubidge, Bruce/0000-0003-2477-1873; Benoit, Julien/0000-0001-5378-3940; Fernandez, Vincent/0000-0002-8315-1458	Palaeontological Scientific Trust (PAST); NRF African Origins Platform; DST-NRF Centre of Excellence in Palaeosciences; European Synchrotron Radiation Facility grant	Palaeontological Scientific Trust (PAST); NRF African Origins Platform; DST-NRF Centre of Excellence in Palaeosciences; European Synchrotron Radiation Facility grant	This research was conducted with financial support from the Palaeontological Scientific Trust (PAST) and its scatterlings projects; the NRF African Origins Platform; the DST-NRF Centre of Excellence in Palaeosciences; and the European Synchrotron Radiation Facility grant.	Angielczyk KD, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1642; BARGHUSEN H R, 1975, Paleobiology, V1, P295; Benoit J, 2016, SCI REP-UK, V6, DOI 10.1038/srep25604; Benoit J, 2013, GEOBIOS-LYON, V46, P357, DOI 10.1016/j.geobios.2013.07.002; Boonstra L. D., 1968, Annals of the South African Museum, V50, P195; BOONSTRA LIEUWE D., 1934, ANN S AFRICAN MUS, V31, P215; Boucot AJ., 1990, EVOLUTIONARY PALEOBI; Brink A. S., 1958, Palaeontologia Africana, V5, P39; Broom, 1932, MAMMAL LIKE REPTILES; Camp C.L., 1956, MEM U CALIF, V13, P255; Carlson KJ, 2011, SCIENCE, V333, P1402, DOI 10.1126/science.1203922; Cisneros JC, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.150090; de Margerie E, 2004, J EXP BIOL, V207, P869, DOI 10.1242/jeb.00841; Emlen DJ, 2008, ANNU REV ECOL EVOL S, V39, P387, DOI 10.1146/annurev.ecolsys.39.110707.173502; Evans DC, 2009, ANAT REC, V292, P1315, DOI 10.1002/ar.20984; Farke AA, 2008, J EXP BIOL, V211, P3085, DOI 10.1242/jeb.019042; Fernandez V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064978; Fiorelli LE, 2013, SCI REP-UK, V3, DOI 10.1038/srep03348; Gand Georges, 2000, Palaeovertebrata (Montpellier), V29, P1; GEIST V, 1972, Zeitschrift fuer Saeugetierkunde, V37, P1; GEIST V, 1966, BEHAVIOUR, V27, P175, DOI 10.1163/156853966X00155; Goodwin MB, 2004, PALEOBIOLOGY, V30, P253, DOI 10.1666/0094-8373(2004)030<0253:CHOPOM>2.0.CO;2; GOW CE, 1986, S AFR J ZOOL, V21, P136; GRINE F E, 1979, Palaeontologia Africana, V22, P35; HAUGHTON S. H., 1929, ANN SOUTH AFRICAN MUS, V28, P55; Hieronymus TL, 2009, ANAT REC, V292, P1370, DOI 10.1002/ar.20985; Hopkins SSB, 2005, P ROY SOC B-BIOL SCI, V272, P1705, DOI 10.1098/rspb.2005.3171; Hopson J.A., 1979, P39; Horner JR, 2011, CR PALEVOL, V10, P439, DOI 10.1016/j.crpv.2011.04.006; Horner JR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007626; Huttenlocker AK, 2016, J VERTEBR PALEONTOL, V36, DOI 10.1080/02724634.2016.1111897; Huttenlocker AK, 2015, J VERTEBR PALEONTOL, V35, DOI 10.1080/02724634.2015.969400; Huttenlocker AK, 2014, PEERJ, V2, DOI 10.7717/peerj.325; Ivachnenko M.F., 2000, PALEONTOL J, V34, P189; Ivakhnenko M, 2008, PALEONTOL J+, V42, P859, DOI 10.1134/S0031030108090013; Jasinoski SC, ANAT REC IN PRESS; JASLOW CR, 1995, J ZOOL, V235, P193; Jerison HJ., 1973, EVOLUTION BRAIN INTE; Kammerer CF, 2015, FOSS REC, V18, P43, DOI 10.5194/fr-18-43-2015; Kammerer CF, 2016, J VERTEBR PALEONTOL, V36, DOI 10.1080/02724634.2015.1030408; Kammerer CF, 2016, PEERJ, V4, DOI 10.7717/peerj.1608; Kammerer CF, 2011, J VERTEBR PALEONTOL, V31, P1, DOI 10.1080/02724634.2011.627074; Kammerer CF, 2011, J SYST PALAEONTOL, V9, P261, DOI 10.1080/14772019.2010.492645; Kammerer CF, 2009, ZOOTAXA, P1; KEMP TS, 2005, ORIGIN EVOLUTION MAM; Kielan-Jaworowska Z, 2004, ACTA PALAEONTOL POL, V49, P177; Krapovickas V, 2013, LETHAIA, V46, P154, DOI 10.1111/j.1502-3931.2012.00329.x; Kruger A, 2015, J VERTEBR PALEONTOL, V35, DOI 10.1080/02724634.2015.1008698; LAURIN M, 1990, NATURE, V345, P249, DOI 10.1038/345249a0; Liu J, 2013, J VERTEBR PALEONTOL, V33, P1394, DOI 10.1080/02724634.2013.781505; Liu J, 2009, ACTA PALAEONTOL POL, V54, P393, DOI 10.4202/app.2008.0071; Margerie E., 2002, CR BIOL, V325, P221, DOI DOI 10.1016/S1631-0691(02)01429-4; Mirone A, 2014, NUCL INSTRUM METH B, V324, P41, DOI 10.1016/j.nimb.2013.09.030; Nasterlack T, 2012, J VERTEBR PALEONTOL, V32, P1396, DOI 10.1080/02724634.2012.697410; Olson E. C., 1962, Transactions of the American Philosophical Society NS, V52, P1, DOI 10.2307/1005904; Paganin D, 2002, J MICROSC-OXFORD, V206, P33, DOI 10.1046/j.1365-2818.2002.01010.x; Perez-Barberia FJ, 2005, OECOLOGIA, V145, P41, DOI 10.1007/s00442-005-0067-7; Peterson JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068620; Piveteau J, 1961, TRAITE PALEONTOLOGIE, VVI; PRUM RO, 1994, J MORPHOL, V222, P61, DOI 10.1002/jmor.1052220107; Prum RO, 1999, J EXP BIOL, V202, P3507; Rehorek SJ, 2005, CHEM SIGNAL, V10, P152, DOI 10.1007/0-387-25160-X_19; Reichel M, 2009, PALAEONTOLOGY, V52, P229, DOI 10.1111/j.1475-4983.2008.00824.x; Rodrigues PG, 2014, PALAEONTOL Z, V88, P329, DOI 10.1007/s12542-013-0200-6; Romer A. S., 1940, GEOLOGICAL SOC AM SP, V28, P1, DOI DOI 10.1130/SPE28-P1; Rubidge BS, 2006, J PALEONTOL, V80, P740, DOI 10.1666/0022-3360(2006)80[740:ANBTBF]2.0.CO;2; RUBIDGE BS, 1991, PALAEONTOLOGY, V34, P547; RUBIDGE BS, 1994, PALAEONTOLOGY, V37, P579; Rubidge BS, 2003, PALAEONTOLOGY, V46, P199, DOI 10.1111/1475-4983.00294; Rubidge BS, 2002, J VERTEBR PALEONTOL, V22, P257, DOI 10.1671/0272-4634(2002)022[0257:OTCMOT]2.0.CO;2; Rubidge BS, 2001, ANNU REV ECOL SYST, V32, P449, DOI 10.1146/annurev.ecolsys.32.081501.114113; Ruta M, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1865; Sidor CA, 2004, J VERTEBR PALEONTOL, V24, P938, DOI 10.1671/0272-4634(2004)024[0938:ANBTFT]2.0.CO;2; Sidor CA, 2003, J VERTEBR PALEONTOL, V23, P631, DOI 10.1671/0272-4634(2003)023[0631:ASSOLP]2.0.CO;2; Sidor CA, 2007, J VERTEBR PALEONTOL, V27, P420, DOI 10.1671/0272-4634(2007)27[420:ASBTFT]2.0.CO;2; SIGOGNEAU D, 1970, Palaeontologia Africana, V13, P25; Sigogneau D., 1970, REVISION SYSTEMATIQU; Sigurdsen T, 2012, J VERTEBR PALEONTOL, V32, P1113, DOI 10.1080/02724634.2012.688693; Simmons RE, 1996, AM NAT, V148, P771, DOI 10.1086/285955; Smith RMH, 2006, J VERTEBR PALEONTOL, V26, P331, DOI 10.1671/0272-4634(2006)26[331:ANBTBF]2.0.CO;2; STANLEY SM, 1974, EVOLUTION, V28, P447, DOI 10.1111/j.1558-5646.1974.tb00766.x; Sues H.-D., 1978, Neues Jahrbuch fuer Geologie und Palaeontologie Monatshefte, V1978, P459; Sullivan C, 2003, P ROY SOC B-BIOL SCI, V270, P173, DOI 10.1098/rspb.2002.2189; Tatarinov LP., 1976, MORPHOLOGICAL EVOLUT; TCHUDINOV PK, 1960, PALEONTOL ZH, V4, P81; Thackeray J. F., 1998, Annals of the Transvaal Museum, V36, P413; TOLLMAN S M, 1980, Annals of the South African Museum, V81, P159; Tomkins JL, 2010, AM NAT, V176, P141, DOI 10.1086/653001; Viglietti PA, 2013, PALAEOGEOGR PALAEOCL, V392, P9, DOI 10.1016/j.palaeo.2013.08.015; Vjuschkov BP, 1964, FUNDAMENTALS PALEONT, P275	90	17	20	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2016	11	8							e0161457	10.1371/journal.pone.0161457	http://dx.doi.org/10.1371/journal.pone.0161457			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT8TP	27548428	Green Published, gold, Green Submitted			2022-12-27	WOS:000381768400058
J	Heurich, M; Zeis, K; Kuchenhoff, H; Muller, J; Belotti, E; Bufka, L; Woelfing, B				Heurich, Marco; Zeis, Klara; Kuechenhoff, Helmut; Mueller, Joerg; Belotti, Elisa; Bufka, Ludek; Woelfing, Benno			Selective Predation of a Stalking Predator on Ungulate Prey	PLOS ONE			English	Article							LYNX LYNX-LYNX; DEER CAPREOLUS-CAPREOLUS; ROE DEER; EURASIAN LYNX; TEMPORAL VARIATION; RED DEER; HABITAT SELECTION; NATIONAL-PARK; RISK; POPULATION	Prey selection is a key factor shaping animal populations and evolutionary dynamics. An optimal forager should target prey that offers the highest benefits in terms of energy content at the lowest costs. Predators are therefore expected to select for prey of optimal size. Stalking predators do not pursue their prey long, which may lead to a more random choice of prey individuals. Due to difficulties in assessing the composition of available prey populations, data on prey selection of stalking carnivores are still scarce. We show how the stalking predator Eurasian lynx (Lynx lynx) selects prey individuals based on species identity, age, sex and individual behaviour. To address the difficulties in assessing prey population structure, we confirm inferred selection patterns by using two independent data sets: (1) data of 387 documented kills of radio-collared lynx were compared to the prey population structure retrieved from systematic camera trapping using Manly's standardized selection ratio alpha and (2) data on 120 radio-collared roe deer were analysed using a Cox proportional hazards model. Among the larger red deer prey, lynx selected against adult males-the largest and potentially most dangerous prey individuals. In roe deer lynx preyed selectively on males and did not select for a specific age class. Activity during high risk periods reduced the risk of falling victim to a lynx attack. Our results suggest that the stalking predator lynx actively selects for size, while prey behaviour induces selection by encounter and stalking success rates.	[Heurich, Marco; Mueller, Joerg; Woelfing, Benno] Bavarian Forest Natl Pk, Dept Conservat & Res, Freyunger Str 2, D-94481 Grafenau, Germany; [Heurich, Marco] Univ Freiburg, Chair Wildlife Ecol & Management, Tennenbacher Str 4, D-79106 Freiburg, Germany; [Zeis, Klara; Kuechenhoff, Helmut] Univ Munich, Dept Stat, Stat Consulting Unit, Ludwigstr 33, D-80539 Munich, Germany; [Belotti, Elisa] Czech Univ Life Sci Prague, Fac Forestry & Wood Sci, Kamycka 1176, CZ-16521 Prague 6, Czech Republic; [Belotti, Elisa; Bufka, Ludek] Sumava Natl Pk Adm, Dept Res & Nat Protect, Susicka 399, CZ-34192 Kasperske Hory, Czech Republic; [Mueller, Joerg] Univ Wurzburg, Bioctr, Dept Anim Ecol & Trop Biol, Field Stn Fabrikschleichach, Rauhenebrach, Germany	University of Freiburg; University of Munich; Czech University of Life Sciences Prague; University of Wurzburg	Heurich, M (corresponding author), Bavarian Forest Natl Pk, Dept Conservat & Res, Freyunger Str 2, D-94481 Grafenau, Germany.; Heurich, M (corresponding author), Univ Freiburg, Chair Wildlife Ecol & Management, Tennenbacher Str 4, D-79106 Freiburg, Germany.	Marco.heurich@npv-bw.bayern.de	Heurich, Marco/O-4653-2014	Heurich, Marco/0000-0003-0051-2930; Muller, Jorg/0000-0002-1409-1586; Kuchenhoff, Helmut/0000-0002-6372-2487	EU Programme INTERREG IV (EFREZiel 3) [18]; Bavarian Forest National Park Administration	EU Programme INTERREG IV (EFREZiel 3); Bavarian Forest National Park Administration	Financial support was provided by the EU Programme INTERREG IV (EFREZiel 3) Project Nr. 18 (http://www.stmwi.bayern.de/EFRE/Interreg_IV/) and the Bavarian Forest National Park Administration.; This study is part of a project on the predator-prey relationship of Eurasian lynx, red deer and roe deer carried out by the Bavarian Forest National Park Administration, Department of Research and Documentation. Financial support was provided by the EU Programme INTERREG IV (EFREZiel 3) and the Bavarian Forest National Park Administration. We thank Horst Burghart, Martin Gahbauer, Oldrich Vojtech, Jan Mokry, Helmut Penn, Michael Penn, Rudiger Fischer, and Lothar Ertl for technical support and Karen A. Brune for language editing.	Aanes R, 1996, CAN J ZOOL, V74, P1857, DOI 10.1139/z96-209; Abrams PA, 2000, ANNU REV ECOL SYST, V31, P79, DOI 10.1146/annurev.ecolsys.31.1.79; Andersen R., 1998, EUROPEAN ROE DEER BI; Andersen R, 2007, WILDLIFE BIOL, V13, P467, DOI 10.2981/0909-6396(2007)13[467:SOELLL]2.0.CO;2; Apollonio M., 2010, EUROPEAN UNGULATES T; Belotti E, 2014, EUR J WILDLIFE RES, V60, P441, DOI 10.1007/s10344-014-0801-8; Boon AK, 2008, OIKOS, V117, P1321, DOI 10.1111/j.0030-1299.2008.16567.x; Borkowski J, 2008, FOREST ECOL MANAG, V255, P468, DOI 10.1016/j.foreco.2007.09.013; Creel S, 2005, ANIM BEHAV, V69, P1181, DOI 10.1016/j.anbehav.2004.07.022; Creel S., 2002, AFRICAN WILD DOG BEH; Creel S, 2011, ECOLOGY, V92, P2190, DOI 10.1890/11-0327.1; Danilkin A, 1995, BEHAV ECOLOGY SIBERI; Davis ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047894; DiRienzo N, 2013, ANIM BEHAV, V86, P317, DOI 10.1016/j.anbehav.2013.05.020; Dorai-Raj S., 2014, BINOM BINOMIAL CONFI; Efron B, 2000, J AM STAT ASSOC, V95, P1293, DOI 10.2307/2669773; Ellenberg H, 1978, POPULATIONSOKOLOGIE; Ewald M, 2014, FORESTS, V5, P1374, DOI 10.3390/f5061374; Fellows I, 2012, J STAT SOFTW, V49, P1; Festa-Bianchet M, 2006, P ROY SOC B-BIOL SCI, V273, P1537, DOI 10.1098/rspb.2006.3467; Festetics A, 1980, WIEDEREINBURGERUNG L, P89; FITZGIBBON CD, 1990, ANIM BEHAV, V39, P1116, DOI 10.1016/S0003-3472(05)80784-5; FITZGIBBON CD, 1989, J ZOOL, V218, P99, DOI 10.1111/j.1469-7998.1989.tb02528.x; FITZGIBBON CD, 1990, ANIM BEHAV, V40, P837, DOI 10.1016/S0003-3472(05)80984-4; GEIGER C, 1974, Zeitschrift fuer Jagdwissenschaft, V20, P53, DOI 10.1007/BF01901849; Gervasi V, 2012, J ANIM ECOL, V81, P443, DOI 10.1111/j.1365-2656.2011.01928.x; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Griffin PC, 2005, BEHAV ECOL, V16, P938, DOI 10.1093/beheco/ari074; Hagen R, 2014, ECOL COMPLEX, V20, P43, DOI 10.1016/j.ecocom.2014.07.006; Haglund B., 1966, Viltrevy, V4, P81; Hayward MW, 2006, J ZOOL, V270, P298, DOI 10.1111/j.1469-7998.2006.00139.x; Hayward MW, 2012, J ZOOL, V286, P221, DOI 10.1111/j.1469-7998.2011.00871.x; Hayward MW, 2006, J MAMMAL, V87, P1122, DOI 10.1644/05-MAMM-A-304R2.1; Hayward MW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023607; Hayward MW, 2005, J ZOOL, V267, P309, DOI 10.1017/S0952836905007508; Hebblewhite M, 2002, CAN J ZOOL, V80, P800, DOI 10.1139/Z02-059; Heurich M, 2012, EUROPEAN J WILDLIFE, P1; Heurich M, 2011, 12 INT FACHT FRAG VE, P142; Heurich M, 2012, ACTA THERIOL, P1; Heurich M, 2005, WALDER NATIONALPARKS; Heurich M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120960; Heurich M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114143; Hornocker M.G., 1970, WILDLIFE MONOGR, V21, P3; Husseman JS, 2003, OIKOS, V101, P591, DOI 10.1034/j.1600-0706.2003.12230.x; Jarnemo A, 2004, CAN J ZOOL, V82, P416, DOI 10.1139/z04-011; JEDRZEJEWSKI W, 1993, ACTA THERIOL, V38, P385; Jobin A, 2000, ACTA THERIOL, V45, P243, DOI 10.4098/AT.arch.00-26; Kamler JF, 2012, J MAMMAL, V93, P627, DOI 10.1644/11-MAMM-A-241.1; KARANTH KU, 1995, J ANIM ECOL, V64, P439, DOI 10.2307/5647; KITCHENER A., 1991, NATURAL HIST WILD CA; KLEIMAN DG, 1973, ANIM BEHAV, V21, P637, DOI 10.1016/S0003-3472(73)80088-0; Koubek P., 1996, LYNX CZECH SLOVAK RE; Krivan V, 1996, THEOR POPUL BIOL, V49, P265, DOI 10.1006/tpbi.1996.0014; Krivan V, 2003, THEOR POPUL BIOL, V63, P269, DOI 10.1016/S0040-5809(03)00012-1; Krofel M, 2014, EUR J WILDLIFE RES, V60, P11, DOI 10.1007/s10344-013-0745-4; Kunkel KE, 1999, J WILDLIFE MANAGE, V63, P901, DOI 10.2307/3802804; Lausch A, 2013, ECOL INDIC, V31, P73, DOI 10.1016/j.ecolind.2012.07.026; Lima SL, 1999, AM NAT, V153, P649, DOI 10.1086/303202; Lottker P, 2009, WILDLIFE BIOL, V15, P425, DOI 10.2981/08-014; MAGNHAGEN C, 1991, TRENDS ECOL EVOL, V6, P183, DOI 10.1016/0169-5347(91)90210-O; MANLY BFJ, 1972, AM NAT, V106, P719, DOI 10.1086/282808; MCNAMARA JM, 1992, B MATH BIOL, V54, P355; Mech L. David, 2003, P131; Mejlgaard T, 2013, J ZOOL, V289, P222, DOI 10.1111/j.1469-7998.2012.00980.x; Melis C, 2009, GLOBAL ECOL BIOGEOGR, V18, P724, DOI 10.1111/j.1466-8238.2009.00480.x; Molinari-Jobin A, 2004, ECOGRAPHY, V27, P323, DOI 10.1111/j.0906-7590.2004.03862.x; Morellet N, 2007, J APPL ECOL, V44, P634, DOI 10.1111/j.1365-2664.2007.01307.x; Muller J, 2014, BIOL CONSERV, V177, P210, DOI 10.1016/j.biocon.2014.07.007; MYSTERUD A, 1995, CAN J ZOOL, V73, P924, DOI 10.1139/z95-108; Mysterud A, 1997, WILDLIFE BIOL, V3, P27, DOI 10.2981/wlb.1997.004; Nahlik A., 2005, Wildlife Biology in Practice, V1, P47; Necas J, 1986, BEITRAGE JAGD WILDFO, VVI, P27; Nilsen EB, 2009, J ANIM ECOL, V78, P741, DOI 10.1111/j.1365-2656.2009.01547.x; Okarma H, 1997, ACTA THERIOL, V42, P203, DOI 10.4098/AT.arch.97-22; Pettorelli N, 2011, OECOLOGIA, V167, P305, DOI 10.1007/s00442-011-2069-y; Pierce BM, 2000, J MAMMAL, V81, P462, DOI 10.1644/1545-1542(2000)081<0462:SOMDBM>2.0.CO;2; Podolski I, 2013, WILDLIFE BIOL, V19, P69, DOI 10.2981/12-049; Preisser EL, 2005, ECOLOGY, V86, P501, DOI 10.1890/04-0719; Quinn JL, 2012, P ROY SOC B-BIOL SCI, V279, P1919, DOI 10.1098/rspb.2011.2227; R Core Team, 2021, R LANGUAGE ENV STAT; Reale D, 2003, ANIM BEHAV, V65, P463, DOI 10.1006/anbe.2003.2100; Reale D, 2010, PHILOS T R SOC B, V365, P3937, DOI 10.1098/rstb.2010.0222; Rowcliffe JM, 2008, J APPL ECOL, V45, P1228, DOI 10.1111/j.1365-2664.2008.01473.x; Ruckstuhl K.E., 2005, SEXUAL SEGREGATION V; SCHEEL D, 1991, ANIM BEHAV, V41, P697, DOI 10.1016/S0003-3472(05)80907-8; Siebert U, 2012, REHWILDZAHLUNG NP BA; Sih A, 2002, ANIM BEHAV, V63, P437, DOI 10.1006/anbe.2001.1921; Sinclair ARE, 2003, NATURE, V425, P288, DOI 10.1038/nature01934; Sokal R.R., 2012, BIOMETRY; Stache A, 2013, FOLIA ZOOL, P62; Stubbe C., 1997, REHWILD BIOL OKOLOGI, Vfourth; Sunquist ME, 1989, ECOLOGICAL CONSTRAIN, P283; Sunquist ME, 2002, WILD CATS WORLD; Therneau T. M., 2015, PACKAGE SURVIVAL ANA; Weilnbock G., 2012, CURRENT RES APPL ETH, P22; Weingarth K, 2012, ANIM BIODIV CONSERV, V35, P197; Wickham H, 2007, J STAT SOFTW, V21, P1; Winnie J, 2007, ANIM BEHAV, V73, P215, DOI 10.1016/j.anbehav.2006.07.007; Wolfl M, 2001, ACTA THERIOL, V46, P181, DOI 10.1007/BF03192427; Yearsley IM, 2005, ANIM BEHAV, V69, P257, DOI 10.1016/j.anbehav.2004.04.010	100	15	16	1	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2016	11	8							e0158449	10.1371/journal.pone.0158449	http://dx.doi.org/10.1371/journal.pone.0158449			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT8TP	27548478	gold, Green Published, Green Submitted			2022-12-27	WOS:000381768400005
J	Sundqvist, S; Larson, T; Cauliez, B; Bauer, F; Dumont, A; Le Roy, F; Hanoy, M; Freguin-Bouilland, C; Godin, M; Guerrot, D				Sundqvist, Sofia; Larson, Thomas; Cauliez, Bruno; Bauer, Fabrice; Dumont, Audrey; Le Roy, Frank; Hanoy, Melanie; Freguin-Bouilland, Caroline; Godin, Michel; Guerrot, Dominique			Clinical Value of Natriuretic Peptides in Predicting Time to Dialysis in Stage 4 and 5 Chronic Kidney Disease Patients	PLOS ONE			English	Article							AMINO-TERMINAL PROBNP; PROGNOSTIC VALUE; CARDIOVASCULAR EVENTS; HEART-FAILURE; HEMODIALYSIS; STRATIFICATION; FRAGMENT; ACCESS; DEATH; RISK	Background Anticipating the time to renal replacement therapy (RRT) in chronic kidney disease (CKD) patients is an important but challenging issue. Natriuretic peptides are biomarkers of ventricular dysfunction related to poor outcome in CKD. We comparatively investigated the value of B-type natriuretic peptide (BNP) and N-terminal pro-B-type natriuretic peptide (NT-proBNP) as prognostic markers for the risk of RRT in stage 4 and 5 CKD patients, and in foretelling all-cause mortality and major cardiovascular events within a 5-year follow-up period. Methods Baseline plasma BNP (Triage, Biosite) and NT-proBNP (Elecsys, Roche) were measured at inclusion. Forty-three patients were followed-up during 5 years. Kaplan-Meier analysis, with log-rank testing and hazard ratios (HR), were calculated to evaluate survival without RRT, cardiovascular events or mortality. The independent prognostic value of the biomarkers was estimated in separate Cox multivariate analysis, including estimated glomerular filtration rate (eGFR), creatininemia and comorbidities. Results During the first 12-month follow-up period, 16 patients started RRT. NT-proBNP concentration was higher in patients who reached endpoint (3221 ng/L vs 777 ng/L, p = 0.02). NT-proBNP concentration >1345 ng/L proved significant predictive value on survival analysis for cardiovascular events (p = 0.04) and dialysis within 60 months follow-up (p = 0.008). BNP concentration >140 ng/L was an independent predictor of RRT after 12 months follow-up (p<0.005), and of significant predictive value for initiation of dialysis within 60 months follow-up. Conclusions Our results indicate a prognostic value for BNP and NT-proBNP in predicting RRT in stage 4 and 5 CKD patients, regarding both short- and long-term periods. NT-proBNP also proved a value in predicting cardiovascular events. Natriuretic peptides could be useful predictive biomarkers for therapeutic guidance in CKD.	[Sundqvist, Sofia; Dumont, Audrey; Le Roy, Frank; Hanoy, Melanie; Freguin-Bouilland, Caroline; Godin, Michel; Guerrot, Dominique] CHU Hop Rouen, Serv Nephrol, Rouen, France; [Sundqvist, Sofia] Norwegian Univ Sci & Technol, Trondheim, Norway; [Larson, Thomas; Cauliez, Bruno] CHU Hop Rouen, Serv Biochim, Rouen, France; [Bauer, Fabrice] CHU Hop Rouen, Serv Cardiol, Rouen, France; [Bauer, Fabrice; Godin, Michel; Guerrot, Dominique] Univ Med Pharm Rouen, INSERM Unite 1096, Rouen, France	CHU de Rouen; Norwegian University of Science & Technology (NTNU); CHU de Rouen; CHU de Rouen; Institut National de la Sante et de la Recherche Medicale (Inserm)	Guerrot, D (corresponding author), CHU Hop Rouen, Serv Nephrol, Rouen, France.; Guerrot, D (corresponding author), Univ Med Pharm Rouen, INSERM Unite 1096, Rouen, France.	dominique.guerrot@chu-rouen.fr	Guerrot, Dominique/N-7769-2019	Guerrot, Dominique/0000-0002-5953-5785; Guerrot, Dominique/0000-0001-9562-530X				Austin WJ, 2006, AM J CLIN PATHOL, V126, P506, DOI 10.1309/M7AAXA0J1THMNCDF; Avorn J, 2002, J CLIN EPIDEMIOL, V55, P711, DOI 10.1016/S0895-4356(02)00415-8; Chae CU, 2003, AM J CARDIOL, V92, P682, DOI 10.1016/S0002-9149(03)00822-1; DeFilippi C, 2008, AM J CARDIOL, V101, p82A, DOI 10.1016/j.amjcard.2007.11.029; Defilippi CR, 2007, CLIN CHEM, V53, P1511, DOI 10.1373/clinchem.2006.084533; Fagugli RM, 2003, NEPHRON CLIN PRACT, V95, pC60, DOI 10.1159/000073669; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Hiremath S, 2010, NEPHROL DIAL TRANSPL, V25, P2656, DOI 10.1093/ndt/gfq081; Horii M, 2013, J CARDIOL, V61, P410, DOI 10.1016/j.jjcc.2013.01.015; JUNGERS P, 1993, NEPHROL DIAL TRANSPL, V8, P1089; Kalra PR, 2001, CARDIOVASC RES, V51, P495, DOI 10.1016/S0008-6363(01)00297-8; Khan SS, 2005, KIDNEY INT, V67, P1038, DOI 10.1111/j.1523-1755.2005.00168.x; Levin A, 2001, AM J KIDNEY DIS, V38, P1398, DOI 10.1053/ajkd.2001.29275; Levin ER, 1998, NEW ENGL J MED, V339, P321; Mallamaci F, 2001, KIDNEY INT, V59, P1559, DOI 10.1046/j.1523-1755.2001.0590041559.x; Pippias M, 2015, CLIN KIDNEY J, V8, P248, DOI 10.1093/ckj/sfv014; Rosansky SJ, 2011, ARCH INTERN MED, V171, P396, DOI 10.1001/archinternmed.2010.415; Salahi H, 2006, TRANSPL P, V38, P1261, DOI 10.1016/j.transproceed.2006.02.066; Saran R, 2015, AM J KIDNEY DIS, V66, pS1, DOI 10.1053/j.ajkd.2015.05.001; Schiffrin EL, 2007, CIRCULATION, V116, P85, DOI 10.1161/CIRCULATIONAHA.106.678342; Stein B, 1998, AM HEART J, V135, P914, DOI 10.1016/S0002-8703(98)70054-7; Sumida K, 2016, NEPHROL DIAL TRANSPL; Tagore R, 2008, CLIN J AM SOC NEPHRO, V3, P1644, DOI 10.2215/CJN.00850208; Takami Y, 2004, AM J KIDNEY DIS, V44, P420, DOI 10.1053/j.ajkd.2004.05.023; van de Pol Anouk C M, 2007, Hemodial Int, V11, P51, DOI 10.1111/j.1542-4758.2007.00154.x; Vickery S, 2005, AM J KIDNEY DIS, V46, P610, DOI 10.1053/j.ajkd.2005.06.017; Vickery S, 2008, NEPHROL DIAL TRANSPL, V23, P3546, DOI 10.1093/ndt/gfn341; Weber M, 2006, HEART, V92, P843, DOI 10.1136/hrt.2005.071233; Yoshimura M, 2000, METABOLISM, V49, P1228, DOI 10.1053/meta.2000.8602	29	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2016	11	8							e0159914	10.1371/journal.pone.0159914	http://dx.doi.org/10.1371/journal.pone.0159914			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT8TP	27548064	gold, Green Published, Green Submitted			2022-12-27	WOS:000381768400010
J	Hollo, G				Hollo, Gabor			Intrasession and Between-Visit Variability of Sector Peripapillary Angioflow Vessel Density Values Measured with the Angiovue Optical Coherence Tomograph in Different Retinal Layers in Ocular Hypertension and Glaucoma	PLOS ONE			English	Article							OCT ANGIOGRAPHY; PERFUSION; DISC; EYES	Purpose To evaluate intrasession and between-visit reproducibility of sector peripapillary angioflow vessel-density (PAFD, %) values in the optic nerve head (ONH) and radial peripapillary capillaries (RPC) layers, respectively, and to analyze the influence of the corresponding sector retinal nerve fiber layer thickness (RNFLT) on the results. Methods High quality images acquired with the Angiovue/RTVue-XR Avanti optical coherence tomograph (Optovue Inc., Fremont, USA) on 1 eye of 18 stable glaucoma and ocular hypertension patients were analyzed using the Optovue 2015.100.0.33 software version. Three images were acquired in one visit and 1 image 3 months later. Results PAFD image quality for all images necessary to calculate reproducibility was sufficient to analysis only in 18 of the 83 participants (21.7%) who were successfully imaged for RNFLT. Intrasession coefficient of variation (CV) ranged between 2.30 and 3.89%, and 3.51 and 5.12% for the peripapillary sectors in the ONH and RPC layers, respectively. The corresponding between-visit CV values ranged between 3.05 and 4.26%, and 4.99 and 6.90%, respectively. Intrasession SD did not correlate with the corresponding RNFLT in any sector in either layer (P >= 0.170). In the ONH layer sector PAFD values did not correlate with the corresponding RNFLT values (P >= 0.100). In contrast, in the RPC layer a significant positive correlation between the corresponding sector PAFD and RNFLT values was found for all but one peripapillary sectors (Pearson-r range: 0.652 to 0.771, P <= 0.0046). Conclusion Though in several patients routine use of PAFD measurement may be limited by suboptimal image quality, in the successfully imaged cases (21.7% of the study eyes in the current investigation) reproducibility of sector PAFD values seems to be sufficient for clinical research. In stable patients intrasession variability explains most of the between-visit variability. Sector PAFD variability is independent from sector RNFLT, a marker of glaucoma severity. In the RPC layer sector PAFD and RNFLT show strong to very strong positive correlation.	[Hollo, Gabor] Semmelweis Univ, Dept Ophthalmol, Budapest, Hungary	Semmelweis University	Hollo, G (corresponding author), Semmelweis Univ, Dept Ophthalmol, Budapest, Hungary.	hollo.gabor@med.semmelweis-univ.hu						Carpineto P, 2016, BRIT J OPHTHALMOL, V100, P671, DOI 10.1136/bjophthalmol-2015-307330; Coscas F, 2016, AM J OPHTHALMOL, V161, P160, DOI 10.1016/j.ajo.2015.10.008; Garas A, 2010, OPHTHALMOLOGY, V117, P738, DOI 10.1016/j.ophtha.2009.08.039; Garway-Heath DF, 2000, OPHTHALMOLOGY, V107, P1809, DOI 10.1016/S0161-6420(00)00284-0; Hollo G, 2016, EUR J OPHTHALMOL, V26, pE42, DOI 10.5301/ejo.5000717; Kuehlewein L, 2015, EYE, V29, P932, DOI 10.1038/eye.2015.80; Liu L, 2015, JAMA OPHTHALMOL, V133, P1045, DOI 10.1001/jamaophthalmol.2015.2225; Pechauer AD, 2015, INVEST OPHTH VIS SCI, V56, P3287, DOI 10.1167/iovs.15-16655; Quaranta L, 2013, SURV OPHTHALMOL, V58, P26, DOI 10.1016/j.survophthal.2012.05.003; Wang XL, 2015, GRAEF ARCH CLIN EXP, V253, P1557, DOI 10.1007/s00417-015-3095-y	10	42	43	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0161631	10.1371/journal.pone.0161631	http://dx.doi.org/10.1371/journal.pone.0161631			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27537500	gold, Green Published, Green Submitted			2022-12-27	WOS:000381577000127
J	Ladapo, JA; Blecker, S; O'Donnell, M; Jumkhawala, SA; Douglas, PS				Ladapo, Joseph A.; Blecker, Saul; O'Donnell, Michael; Jumkhawala, Saahil A.; Douglas, Pamela S.			Appropriate Use of Cardiac Stress Testing with Imaging: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							COMPUTED-TOMOGRAPHY SESTAMIBI; CORONARY-ARTERY-DISEASE; ACADEMIC-MEDICAL-CENTER; USE CRITERIA; TEMPORAL TRENDS; NUCLEAR-CARDIOLOGY; ORIGINAL CRITERIA; AMERICAN-SOCIETY; PROGNOSTIC VALUE; DECISION-MAKING	Background Appropriate use criteria (AUC) for cardiac stress tests address concerns about utilization growth and patient safety. We systematically reviewed studies of appropriateness, including within physician specialties; evaluated trends over time and in response to AUC updates; and characterized leading indications for inappropriate/rarely appropriate testing. Methods We searched PubMed (2005-2015) for English-language articles reporting stress echocardiography or myocardial perfusion imaging (MPI) appropriateness. Data were pooled using random-effects meta-analysis and meta-regression. Results Thirty-four publications of 41,578 patients were included, primarily from academic centers. Stress echocardiography appropriate testing rates were 53.0% (95% CI, 45.3%-60.7%) and 50.9% (42.6%-59.2%) and inappropriate/rarely appropriate rates were 19.1% (11.4%-26.8%) and 28.4% (23.9%-32.8%) using 2008 and 2011 AUC, respectively. Stress MPI appropriate testing rates were 71.1% (64.5%-77.7%) and 72.0% (67.6%-76.3%) and inappropriate/rarely appropriate rates were 10.7% (7.2%-14.2%) and 15.7% (12.4%-19.1%) using 2005 and 2009 AUC, respectively. There was no significant temporal trend toward rising rates of appropriateness for stress echocardiography or MPI. Unclassified stress echocardiograms fell by 79% (p = 0.04) with updated AUC. There were no differences between cardiac specialists and internists. Conclusions Rates of appropriate use tend to be lower for stress echocardiography compared to MPI, and updated AUC reduced unclassified stress echocardiograms. There is no conclusive evidence that AUC improved appropriate use over time. Further research is needed to determine if integration of appropriateness guidelines in academic and community settings is an effective approach to optimizing inappropriate/rarely appropriate use of stress testing and its associated costs and patient harms.	[Ladapo, Joseph A.] Univ Calif Los Angeles, David Geffen Sch Med, Div Gen Internal Med & Hlth Serv Res, Los Angeles, CA 90095 USA; [Blecker, Saul] NYU, Sch Med, Dept Populat Hlth & Med, New York, NY USA; [O'Donnell, Michael] NYU, Sch Med, New York, NY USA; [Jumkhawala, Saahil A.] NYU, New York, NY USA; [Douglas, Pamela S.] Duke Univ, Sch Med, Dept Med, Durham, NC 27706 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; New York University; New York University; New York University; Duke University	Ladapo, JA (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Div Gen Internal Med & Hlth Serv Res, Los Angeles, CA 90095 USA.	JLadapo@mednet.ucla.edu		Douglas, Pamela/0000-0001-9876-4049; Ladapo, Joseph/0000-0002-8518-4800	National Heart, Lung, and Blood Institute (NHLBI) [K23 HL116787]; Agency for Healthcare Research and Quality [K08 HS23683]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K08HS023683] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL116787] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Dr. Joseph Ladapo had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. Dr. Ladapo's work is supported by a K23 Career Development Award (K23 HL116787) from the National Heart, Lung, and Blood Institute (NHLBI) and he serves as a consultant to CardioDx, Inc. Dr. Blecker's work is supported by a K08 Career Development Award (K08 HS23683) from the Agency for Healthcare Research and Quality.; Dr. Joseph Ladapo had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. Dr. Ladapo's work is supported by a K23 Career Development Award (K23 HL116787) from the National Heart, Lung, and Blood Institute (NHLBI) and he serves as a consultant to CardioDx, Inc. Dr. Blecker's work is supported by a K08 Career Development Award (K08 HS23683) from the Agency for Healthcare Research and Quality.	Aldweib N, 2013, AM HEART J, V166, P581, DOI 10.1016/j.ahj.2013.06.003; Bhatia RS, 2013, J AM SOC ECHOCARDIOG, V26, P339, DOI 10.1016/j.echo.2012.12.001; Bhattacharyya S, 2014, HEART, V100, P370, DOI 10.1136/heartjnl-2013-304949; Bohossian HB, 2015, J HOSP MED, V10, P190, DOI 10.1002/jhm.2288; Brenner DJ, 2010, NEW ENGL J MED, V362, P943, DOI 10.1056/NEJMe1000802; Brindis RG, 2005, J AM COLL CARDIOL, V46, P1587, DOI 10.1016/j.jacc.2005.08.029; Carryer DJ, 2010, AM HEART J, V160, P244, DOI 10.1016/j.ahj.2010.06.008; Cortigiani L, 2012, CIRC-CARDIOVASC IMAG, V5, P298, DOI 10.1161/CIRCIMAGING.111.971242; de Oliveira A, 2014, ARQ BRAS CARDIOL, V103, P375, DOI 10.5935/abc.20140140; Douglas PS, 2015, NEW ENGL J MED, V372, P1291, DOI 10.1056/NEJMoa1415516; Doukky R, 2014, INT J CARDIOL, V176, P285, DOI 10.1016/j.ijcard.2014.06.087; Doukky R, 2013, CIRCULATION, V128, P1634, DOI 10.1161/CIRCULATIONAHA.113.002744; Druz Regina S, 2011, ISRN Cardiol, V2011, P798318, DOI 10.5402/2011/798318; Elgendy IY, 2016, J NUCL CARDIOL, V23, P680, DOI 10.1007/s12350-015-0240-2; Fonseca R, 2015, J AM COLL CARDIOL, V65, P763, DOI 10.1016/j.jacc.2014.11.057; Gertz ZM, 2015, CLIN CARDIOL, V38, P8, DOI 10.1002/clc.22340; Gholamrezanezhad A, 2011, J NUCL CARDIOL, V18, P1044, DOI 10.1007/s12350-011-9419-3; Gibbons RJ, 2008, J AM COLL CARDIOL, V51, P1283, DOI 10.1016/j.jacc.2007.10.064; Gibbons RJ, 2011, CIRCULATION, V123, P499, DOI 10.1161/CIRCULATIONAHA.110.975995; Gibbons RJ, 2010, AM HEART J, V159, P484, DOI 10.1016/j.ahj.2009.12.004; Gupta A, 2011, J NUCL CARDIOL, V18, P588, DOI 10.1007/s12350-011-9368-x; Hendel RC, 2010, J AM COLL CARDIOL, V55, P156, DOI 10.1016/j.jacc.2009.11.004; Iglehart JK, 2009, NEW ENGL J MED, V360, P1030, DOI 10.1056/NEJMhpr0808703; Johnson TV, 2014, J AM SOC ECHOCARDIOG, V27, P749, DOI 10.1016/j.echo.2014.03.002; Koh AS, 2011, J NUCL CARDIOL, V18, P324, DOI 10.1007/s12350-010-9317-0; Ladapo JA, 2014, ANN INTERN MED, V161, P482, DOI 10.7326/M14-0296; Ladapo JA, 2009, J AM COLL CARDIOL, V54, P2409, DOI 10.1016/j.jacc.2009.10.012; Lalude OO, 2014, J NUCL CARDIOL, V21, P544, DOI 10.1007/s12350-014-9881-9; Lin FY, 2013, J AM COLL CARDIOL, V62, P308, DOI 10.1016/j.jacc.2013.04.059; Mahajan A, 2015, J NUCL CARDIOL, V22, P66, DOI 10.1007/s12350-014-9995-0; Mansour IN, 2012, J AM SOC ECHOCARDIOG, V25, P1153, DOI 10.1016/j.echo.2012.08.008; Mansour IN, 2010, J AM SOC ECHOCARDIOG, V23, P1199, DOI 10.1016/j.echo.2010.07.008; McCully RB, 2009, CIRC-CARDIOVASC IMAG, V2, P213, DOI 10.1161/CIRCIMAGING.108.798082; Medolago G, 2014, EUR J NUCL MED MOL I, V41, P1695, DOI 10.1007/s00259-014-2743-5; Mehta R, 2008, J NUCL CARDIOL, V15, P337, DOI 10.1016/j.nuclcard.2007.10.010; Miller TD, 2001, J AM COLL CARDIOL, V38, P690, DOI 10.1016/S0735-1097(01)01413-9; Moralidis E, 2013, J NUCL CARDIOL, V20, P275, DOI 10.1007/s12350-012-9664-0; Nelson KH, 2012, J NUCL CARDIOL, V19, P37, DOI 10.1007/s12350-011-9467-8; Saifi S, 2013, JACC-CARDIOVASC IMAG, V6, P823, DOI 10.1016/j.jcmg.2013.01.012; Schmitz L, 2013, INT J CARDIOL, V165, P387, DOI 10.1016/j.ijcard.2012.08.060; Shaw LJ, 2010, JACC-CARDIOVASC IMAG, V3, P789, DOI 10.1016/j.jcmg.2010.05.004; Shreibati JB, 2011, JAMA-J AM MED ASSOC, V306, P2128, DOI 10.1001/jama.2011.1652; Singh M, 2014, CLIN CARDIOL, V37, P67, DOI 10.1002/clc.22240; Soine LA, 2012, J AM ACAD NURSE PRAC, V24, P200, DOI 10.1111/j.1745-7599.2011.00679.x; Thompson SG, 2002, STAT MED, V21, P1559, DOI 10.1002/sim.1187; Willens HJ, 2013, JACC-CARDIOVASC IMAG, V6, P297, DOI 10.1016/j.jcmg.2012.11.009; Winchester DE, 2014, J NUCL CARDIOL, V21, P598, DOI 10.1007/s12350-014-9887-3	47	22	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0161153	10.1371/journal.pone.0161153	http://dx.doi.org/10.1371/journal.pone.0161153			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27536775	Green Published, Green Submitted, gold			2022-12-27	WOS:000381577000060
J	Rokunuzzaman, M; Islam, MT; Rowe, WST; Kibria, S; Singh, MJ; Misran, N				Rokunuzzaman, Md.; Islam, Mohammad Tariqul; Rowe, Wayne S. T.; Kibria, Salehin; Singh, Mandeep Jit; Misran, Norbahiah			Design of a Miniaturized Meandered Line Antenna for UHF RFID Tags	PLOS ONE			English	Article								A semi-circle looped vertically omnidirectional radiation (VOR) patterned tag antenna for UHF (919-923 MHz for Malaysia) frequency is designed to overcome the impedance mismatch issue in this paper. Two impedance matching feeding strips are used in the antenna structure to tune the input impedance of the antenna. Two dipole shaped meandered lines are used to achieve a VOR pattern. The proposed antenna is designed for 23-j224 O chip impedance. The antenna is suitable for 'place and tag' application. A small size of 77.68x35.5 mm(2) is achieved for a read range performance of 8.3 meters using Malaysia regulated maximum power transfer of 2.0 W effective radiated power (ERP).	[Rokunuzzaman, Md.; Rowe, Wayne S. T.] RMIT Univ, Sch Engn, Melbourne, Vic, Australia; [Rokunuzzaman, Md.; Islam, Mohammad Tariqul; Kibria, Salehin; Singh, Mandeep Jit; Misran, Norbahiah] Univ Kebangsaan Malaysia, Dept Elect Elect & Syst Engn, Ukm Bangi, Malaysia	Royal Melbourne Institute of Technology (RMIT); Universiti Kebangsaan Malaysia	Islam, MT (corresponding author), Univ Kebangsaan Malaysia, Dept Elect Elect & Syst Engn, Ukm Bangi, Malaysia.	tariqul@ukm.edu.my	Rowe, Wayne/A-6457-2018; Islam, Mohammad Tariqul/M-7377-2016; Singh, Mandeep/AAC-8680-2020; Misran, Norbahiah/U-1666-2019; singh, mandeep/W-7242-2019	Rowe, Wayne/0000-0002-0947-2341; Islam, Mohammad Tariqul/0000-0002-4929-3209; Misran, Norbahiah/0000-0002-6142-8591; Zaman, M. R./0000-0001-9715-4652	University Research Grant [DIP-2015-014, AP-2015-007]	University Research Grant	This work is supported by a University Research Grant under grant numbers DIP-2015-014 and AP-2015-007. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work is supported by a University Research Grant under grant number DIP-2015-014 and AP-2015-007.	Abdulhadi AE, 2012, IEEE ANTENN WIREL PR, V11, P248, DOI 10.1109/LAWP.2012.2187632; Braaten BD, 2009, IEEE ANTENN WIREL PR, V8, P1158, DOI 10.1109/LAWP.2009.2034990; Casula GA, 2013, IEEE ANTENN WIREL PR, V12, P1400, DOI 10.1109/LAWP.2013.2287307; Chen HD, 2013, IEEE ANTENN WIREL PR, V12, P1460, DOI 10.1109/LAWP.2013.2288138; Cho C, 2009, IEEE T ANTENN PROPAG, V57, P3418, DOI 10.1109/TAP.2009.2028707; Deavours D.D., 2009, IEEE INT C RFID, P265; Kibria S, 2014, IEEE T ANTENN PROPAG, V62, P2795, DOI 10.1109/TAP.2014.2309136; Koski E, 2013, IEEE T ANTENN PROPAG, V61, P4026, DOI 10.1109/TAP.2013.2261448; Liang L, 2013, IEEE ANTENN WIREL PR, V12, P210, DOI 10.1109/LAWP.2013.2245393; Liu Q, 2013, IEEE ANTENN WIREL PR, V12, P1161, DOI 10.1109/LAWP.2013.2281070; NXP, UCODE G2IL AND G2IL; Qing XM, 2009, IEEE T MICROW THEORY, V57, P1268, DOI 10.1109/TMTT.2009.2017288; Zhang J, 2013, IEEE ANTENN WIREL PR, V12, P1184, DOI 10.1109/LAWP.2013.2281842	13	11	11	3	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2016	11	8							e0161293	10.1371/journal.pone.0161293	http://dx.doi.org/10.1371/journal.pone.0161293			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4YN	27533470	gold, Green Submitted, Green Published			2022-12-27	WOS:000381487600083
J	Somerville, AD; Sugiyama, N; Manzanilla, LR; Schoeninger, MJ				Somerville, Andrew D.; Sugiyama, Nawa; Manzanilla, Linda R.; Schoeninger, Margaret J.			Animal Management at the Ancient Metropolis of Teotihuacan, Mexico: Stable Isotope Analysis of Leporid (Cottontail and Jackrabbit) Bone Mineral	PLOS ONE			English	Article							OXYGEN ISOTOPES; CARBON ISOTOPES; MAMMALIAN BONE; HOME-RANGE; PHOSPHATE; PATTERNS; PLANTS; DOMESTICATION; DIAGENESIS; ENRICHMENT	Human-animal interactions have played crucial roles in the development of complex societies across the globe. This study examines the human-leporid (cottontail and jackrabbit) relationship at the pre-Hispanic (AD 1-550) city of Teotihuacan in the Basin of Mexico and tests the hypothesis that leporids were managed or bred for food and secondary products within the urban core. We use stable isotope analysis (delta C-13(apatite) and delta O-18(apatite)) of 134 leporid specimens from five archaeological contexts within the city and 13 modern specimens from across central Mexico to quantify aspects of leporid diet and ecology. The results demonstrate that leporids from Oztoyahualco, a residential complex associated with a unique rabbit sculpture and archaeological traces of animal butchering, exhibit the highest delta C-13(apatite) values of the sample. These results imply greater consumption of human-cultivated foods, such as maize (Zea mays), by cottontails and jackrabbits at this complex and suggest practices of human provisioning. A lack of significant differences in delta O-18(apatite) values between ancient and modern leporids and between Oztoyahualco and other locations within Teotihuacan indicates generally similar relative humidity from sampled contexts. Results of this study support the notion that residents provisioned, managed, or bred leporids during the height of the city, and provide new evidence for mammalian animal husbandry in the ancient New World.	[Somerville, Andrew D.; Schoeninger, Margaret J.] Univ Calif San Diego, Dept Anthropol, 9500 Gilman Dr, La Jolla, CA 92093 USA; [Sugiyama, Nawa] George Mason Univ, Dept Sociol & Anthropol, SOAN, MSN 3G5, Fairfax, VA 22030 USA; [Manzanilla, Linda R.] Univ Nacl Autonoma Mexico, Inst Invest Antropol, Ciudad Univ, Mexico City 04510, DF, Mexico	University of California System; University of California San Diego; George Mason University; Universidad Nacional Autonoma de Mexico	Somerville, AD (corresponding author), Univ Calif San Diego, Dept Anthropol, 9500 Gilman Dr, La Jolla, CA 92093 USA.	asomervi@ucsd.edu	Somerville, Andrew/AAC-9253-2022	Somerville, Andrew/0000-0003-4839-2739	National Science Foundation Doctoral Dissertation Research Improvement Grant (NSF) [1262186]; National Science Foundation Integrated Graduate Education and Research Traineeship Fellowship (NSF) [0903551]; NSF-IGERT Fellowship (NSF) [0903551]	National Science Foundation Doctoral Dissertation Research Improvement Grant (NSF); National Science Foundation Integrated Graduate Education and Research Traineeship Fellowship (NSF); NSF-IGERT Fellowship (NSF)	Funding was provided by a National Science Foundation Doctoral Dissertation Research Improvement Grant (NSF# 1262186; PIs: MJS and ADS) and a National Science Foundation Integrated Graduate Education and Research Traineeship Fellowship (ADS; NSF# 0903551).; We thank Doctor Maria de los Angeles Olay Barrientos, the Consejo Nacional de Mexico, and the Instituto Nacional de Antropologia e Historia for supporting the study. Sample selection was approved and facilitated by Dr. Raul Valadez Azua and Dr. Bernardo Rodriguez Galicia, coordinators of the Laboaratorio de Paleozoologia Instituto de Investigaciones Antropologicas, de la Universidad Nacional Autonoma de Mexico. Funding was provided by a National Science Foundation Doctoral Dissertation Research Improvement Grant (NSF# 1262186; PIs: MJS and ADS), and a NSF-IGERT Fellowship (ADS; NSF# 0903551). We thank the volunteers of the Paleodiet Laboratory, including Janell Bryant, Cheyenne Butcher, Amanda Edwards, Adrienne Koh, Hollie Lappin, Sean Lee, Christi Menger, Tykie Paxton, Kelsie Telson, Sandra Victorini, Jonathan Wong, Jason Kjolsing, Mikael Fauvelle, Sarah Baitzel, Matthew Sitek, and Misha Miller Sisson for their assistance in sample preparation. Additionally, we thank Melanie Beasley for laboratory support. Constructive comments by Dr. Jessica Z. Metcalfe and an anonymous reviewer greatly improved the quality of the manuscript. Any remaining errors, however, are the fault of the authors.	Ambrose S. H., 1993, PREHISTORIC HUMAN BO, P1; AYLIFFE LK, 1990, GEOCHIM COSMOCHIM AC, V54, P2603, DOI 10.1016/0016-7037(90)90246-H; Beramendi LEO, 2012, ESTUDIOS ARQUEOMETRI; Best Troy L., 1996, Mammalian Species, V530, P1; Bond BT, 2001, J WILDLIFE MANAGE, V65, P1004, DOI 10.2307/3803049; BURK RL, 1981, SCIENCE, V211, P1417, DOI 10.1126/science.211.4489.1417; Chapman J. A., 2003, WILD MAMMALS N AM BI, P101; Cowgill George L, 2015, ANCIENT TEOTIHUACAN; DENIRO MJ, 1978, GEOCHIM COSMOCHIM AC, V42, P495, DOI 10.1016/0016-7037(78)90199-0; Diamond J, 2002, NATURE, V418, P700, DOI 10.1038/nature01019; DONGMANN G, 1974, RADIAT ENVIRON BIOPH, V11, P41, DOI 10.1007/BF01323099; DONKIN RA, 1977, T AM PHILOS SOC, V67, P5; DRENNAN RD, 1984, AM ANTIQUITY, V49, P27, DOI 10.2307/280510; EHLERINGER JR, 1978, OECOLOGIA, V31, P255, DOI 10.1007/BF00346246; Flinders J. T., 2003, WILD MAMMALS N AM, P126; FORSTEL H, 1978, RADIAT ENVIRON BIOPH, V15, P323, DOI 10.1007/BF01323459; Francey RJ, 1999, TELLUS B, V51, P170, DOI 10.1034/j.1600-0889.1999.t01-1-00005.x; Froehle AW, 2010, J ARCHAEOL SCI, V37, P2662, DOI 10.1016/j.jas.2010.06.003; Fry B, 2007, STABLE ISOTOPE ECOLO; Gifford-Gonzalez D, 2011, J WORLD PREHIST, V24, P1, DOI DOI 10.1007/s10963-010-9042-2; Gonzalez-Porter GP, 2011, CONSERV GENET, V12, P1229, DOI 10.1007/s10592-011-0225-x; Gu ZY, 2003, CHINESE SCI BULL, V48, P1271, DOI 10.1360/03wd0200; Harner M., 1977, AM ETHNOL, V4, P117, DOI DOI 10.1525/AE.1977.4.1.02A00070; Harris M., 1977, CANNIBALS AND KINGS; Helliker BR, 2002, FUNCT PLANT BIOL, V29, P435, DOI 10.1071/PP01122; Hernandez Cynthia, 1993, ANATOMIA CONJUNTO RE, V1, P388; Hijmans RJ, 2001, PLANT GENETIC RESOUR, P15, DOI DOI 10.1007/s10344-011-0563-5; Hollund HI, 2013, ARCHAEOMETRY, V55, P507, DOI 10.1111/j.1475-4754.2012.00695.x; HUERTAS AD, 1995, GEOCHIM COSMOCHIM AC, V59, P4299; Keeling CD, 1979, ENVIRON INT, V2, P229, DOI [10.1016/0160-4120(79)90005-9, DOI 10.1016/0160-4120(79)90005-9]; Kellner CM, 2007, AM J PHYS ANTHROPOL, V133, P1112, DOI 10.1002/ajpa.20618; Kent R, 1984, J CULT GEOGR, V4, P14, DOI DOI 10.1080/08873638409478571; Kohn MJ, 2010, P NATL ACAD SCI USA, V107, P19691, DOI 10.1073/pnas.1004933107; Larson G, 2007, P NATL ACAD SCI USA, V104, P15276, DOI 10.1073/pnas.0703411104; LECHLEITNER R. R., 1959, JOUR MAMMAL, V40, P63, DOI 10.2307/1376117; Levin NE, 2006, P NATL ACAD SCI USA, V103, P11201, DOI 10.1073/pnas.0604719103; LINARES OF, 1976, HUM ECOL, V4, P331, DOI 10.1007/BF01557917; LONGINELLI A, 1984, GEOCHIM COSMOCHIM AC, V48, P385, DOI 10.1016/0016-7037(84)90259-X; LUZ B, 1984, GEOCHIM COSMOCHIM AC, V48, P1689, DOI 10.1016/0016-7037(84)90338-7; Manzanilla L., 1993, ANATOMIA CONJUNTO RE; Manzanilla L., 1996, ANCIENT MESOAM, V7, P245, DOI [DOI 10.1017/S0956536100001450, 10.1017/S0956536100001450]; Manzanilla Linda, 1994, ARCHAEOMETRY, V36, P141; Manzanilla Linda, 1994, ANTROPOLOGICAS, V11, P53; Manzanilla Linda, 1996, LAT AM ANTIQ, V7, P228, DOI DOI 10.2307/971576; Manzanilla LR, 2007, LA MEMORIA, P485; Manzanilla LR, 2012, ESTUDIOS ARQUEOMETRI; McClung de Tapia E, 2003, REV MEXICANA CIENCIA, V20, P270; MILLON R, 1961, AM ANTIQUITY, V26, P516, DOI 10.2307/278739; Millon R, 1973, TEOTIHUACAN MAP 1; Moragas Segura N, 1994, SALVAMENTO ARQUEOLOG; Moragas Segura N, 2002, B AM, P165; Munoz C.M., 2011, TEX J SCI, V63, P113; Nations J. D., 1980, Journal of Anthropological Research, V36, P1; Neusius SW, 2008, INTERD CONTRIB ARCH, P297, DOI 10.1007/978-0-387-71303-8_15; OLEARY MH, 1988, BIOSCIENCE, V38, P328, DOI 10.2307/1310735; Ortiz Butron A, 1993, ANATOMIA CONJUNTO RE, P617; Parsons JR, 2010, PRE-COLUMBIAN FOODWAYS: INTERDISCIPLINARY APPROACHES TO FOOD, CULTURE, AND MARKETS IN ANCIENT MESOAMERICA, P109, DOI 10.1007/978-1-4419-0471-3_4; Rawlings TA, 2010, J ARCHAEOL SCI, V37, P2433, DOI 10.1016/j.jas.2010.05.004; Redman C.L., 1999, HUMAN IMPACT ANCIENT; ROSE GB, 1977, J WILDLIFE MANAGE, V41, P511, DOI 10.2307/3800524; Schmitt J, 2012, SCIENCE, V336, P711, DOI 10.1126/science.1217161; Schollmeyer KG, 2013, J ARCHAEOL METHOD TH, V20, P448, DOI 10.1007/s10816-012-9160-5; SHEMESH A, 1990, GEOCHIM COSMOCHIM AC, V54, P2433, DOI 10.1016/0016-7037(90)90230-I; SMITH BN, 1971, PLANT PHYSIOL, V47, P380, DOI 10.1104/pp.47.3.380; Smith CI, 2007, J ARCHAEOL SCI, V34, P1485, DOI 10.1016/j.jas.2006.11.006; Smith S, 2010, OPEN J ARCHAEOMETRY; Somerville AD, 2010, J ANTHROPOL ARCHAEOL, V29, P125, DOI 10.1016/j.jaa.2009.09.003; Starbuck DR, 1975, THESIS; Starbuck DR, 1987, TEOTIHUACAN NUEVOS D, P75; STOWE LG, 1978, AM NAT, V112, P609, DOI 10.1086/283301; Sugiyama N, 2012, ARQUEOLOGIA MEXICANA, V19, P20; Sugiyama N, 2013, CULTURAL SYMBIOSIS R, V8, P169; Sugiyama N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135635; Sugiyama S, 2007, ANCIENT MESOAM, V18, P109, DOI 10.1017/S0956536107000053; SWIHART RK, 1986, ACTA THERIOL, V31, P139, DOI 10.4098/AT.arch.86-13; Szuter C. R., 1991, HUNTING PREHISTORIC; Taylor WP, 1933, U ARIZONA TECHNICAL, V49; Thornton EK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042630; TRENT TT, 1974, J WILDLIFE MANAGE, V38, P459, DOI 10.2307/3800877; TURKOWSKI FJ, 1975, J WILDLIFE MANAGE, V39, P748, DOI 10.2307/3800237; VALADEZ AZUA R, 1993, ANATOMIA CONJUNTO RE, P729; VALADEZ R., 2003, DOMESTICACION ANIMAL; VANDERMERWE NJ, 1982, AM SCI, V70, P596; Warinner C, 2013, J ARCHAEOL SCI, V40, P868, DOI 10.1016/j.jas.2012.07.003; White CD, 2001, J ARCHAEOL SCI, V28, P89, DOI 10.1006/jasc.1999.0560; Williams DG, 2005, J ARCHAEOL SCI, V32, P931, DOI 10.1016/j.jas.2005.01.008; Williamson T., 2006, ARCHAEOLOGY RABBIT W; Wright LE, 1996, J ARCHAEOL SCI, V23, P933, DOI 10.1006/jasc.1996.0087; Zeder MA, 2006, EVOL ANTHROPOL, V15, P105, DOI 10.1002/evan.20101; Zuria I, 2006, HUM ECOL, V34, P53, DOI 10.1007/s10745-005-9002-0	90	25	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2016	11	8							e0159982	10.1371/journal.pone.0159982	http://dx.doi.org/10.1371/journal.pone.0159982			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DT4YN	27532515	Green Published, Green Submitted, gold			2022-12-27	WOS:000381487600019
J	Tribouillois, H; Durr, C; Demilly, D; Wagner, MH; Justes, E				Tribouillois, Helene; Durr, Carolyne; Demilly, Didier; Wagner, Marie-Helene; Justes, Eric			Determination of Germination Response to Temperature and Water Potential for a Wide Range of Cover Crop Species and Related Functional Groups	PLOS ONE			English	Article							HELIANTHUS-ANNUUS L.; SEED-GERMINATION; CARDINAL TEMPERATURES; TIME-COURSE; EMERGENCE; REQUIREMENTS; MITIGATION; MODEL; PEA	A wide range of species can be sown as cover crops during fallow periods to provide various ecosystem services. Plant establishment is a key stage, especially when sowing occurs in summer with high soil temperatures and low water availability. The aim of this study was to determine the response of germination to temperature and water potential for diverse cover crop species. Based on these characteristics, we developed contrasting functional groups that group species with the same germination ability, which may be useful to adapt species choice to climatic sowing conditions. Germination of 36 different species from six botanical families was measured in the laboratory at eight temperatures ranging from 4.5-43 degrees C and at four water potentials. Final germination percentages, germination rate, cardinal temperatures, base temperature and base water potential were calculated for each species. Optimal temperatures varied from 21.3-37.2 degrees C, maximum temperatures at which the species could germinate varied from 27.7-43.0 degrees C and base water potentials varied from -0.1 to -2.6 MPa. Most cover crops were adapted to summer sowing with a relatively high mean optimal temperature for germination, but some Fabaceae species were more sensitive to high temperatures. Species mainly from Poaceae and Brassicaceae were the most resistant to water deficit and germinated under a low base water potential. Species were classified, independent of family, according to their ability to germinate under a range of temperatures and according to their base water potential in order to group species by functional germination groups. These groups may help in choosing the most adapted cover crop species to sow based on climatic conditions in order to favor plant establishment and the services provided by cover crops during fallow periods. Our data can also be useful as germination parameters in crop models to simulate the emergence of cover crops under different pedoclimatic conditions and crop management practices.	[Tribouillois, Helene; Justes, Eric] INRA, UMR AGIR 1248, 24 Chemin Borderouge Auzeville, F-31320 Castanet Tolosan, France; [Durr, Carolyne] INRA, IRHS 1345, 42 Rue George Morel, F-49071 Beaucouze, France; [Demilly, Didier; Wagner, Marie-Helene] GEVES, Stn Natl Essais Semences, 42 Rue George Morel, F-49071 Beaucouze, France	INRAE; INRAE	Justes, E (corresponding author), INRA, UMR AGIR 1248, 24 Chemin Borderouge Auzeville, F-31320 Castanet Tolosan, France.	eric.justes@toulouse.inra.fr	Justes, Eric/GLT-6299-2022	Justes, Eric/0000-0001-7390-7058; WAGNER, Marie-Helene/0000-0001-6224-5271	Arvalis-Institut du Vegetal; Midi-Pyrenees Region; CASDAR-CTPS project [C2011-2013]; ADEME project CiCC; UMR AGIR INRA	Arvalis-Institut du Vegetal; Midi-Pyrenees Region(Region Occitanie); CASDAR-CTPS project; ADEME project CiCC; UMR AGIR INRA	This study was financed by Arvalis-Institut du Vegetal, the Midi-Pyrenees Region, the CASDAR-CTPS project C2011-2013, the ADEME project CiCC and UMR AGIR INRA.; This study was financed by Arvalis-Institut du Vegetal, the Midi-Pyrenees Region, the CASDAR-CTPS project C2011-2013, the ADEME project CiCC and UMR AGIR INRA. The authors would like to thank L. Ledroit, E. Chardon and M. Labarrere for their efficient technical help. We thank M. L. and M. S. Corson for improving the English in the text.	Allen BL, 2014, AGRON J, V106, P940, DOI 10.2134/agronj13.0469; ANGUS JF, 1981, FIELD CROP RES, V3, P365; BASKIN CC, 1988, AM J BOT, V75, P286, DOI 10.2307/2443896; Bewley JD., 1994, SEEDS PHYSL DEV GERM, DOI [10.1007/978-1-4899-1002-8_1, DOI 10.1007/978-1-4899-1002-8]; Brisson N, 2003, EUR J AGRON, V18, P309, DOI 10.1016/S1161-0301(02)00110-7; Brisson N., 2008, CONCEPTUAL BASIS FOR; Constantin J, 2012, AGR ECOSYST ENVIRON, V147, P36, DOI 10.1016/j.agee.2011.06.006; Constantin J, 2015, EUR J AGRON, V69, P75, DOI 10.1016/j.eja.2015.06.002; Constantin J, 2015, FIELD CROP RES, V176, P22, DOI 10.1016/j.fcr.2015.02.017; Dahal P, 1994, SEED SCI RES, V4, P71, DOI 10.1017/S096025850000204X; Dayrell RL, 2016, ANN BOT IN PRESS; Demilly D, 2014, PLANT IMAGE IN PRESS; Demilly D, 1995, DIGITAL IMAGING SEED; Dorsainvil F, 2005, EUR J AGRON, V23, P146, DOI 10.1016/j.eja.2004.11.002; Dorsainvil F., 2002, THESIS; DRACUP M, 1993, AUST J EXP AGR, V33, P759, DOI 10.1071/EA9930759; Ducournau S, 2005, SEED SCI TECHNOL, V33, P329, DOI 10.15258/sst.2005.33.2.06; Ducournau S, 2004, COMPUT ELECTRON AGR, V44, P189, DOI 10.1016/j.compag.2004.04.005; Durr C, 2015, AGR FOREST METEOROL, V200, P222, DOI 10.1016/j.agrformet.2014.09.024; DUMUR D, 1990, J EXP BOT, V41, P1423, DOI 10.1093/jxb/41.11.1423; Durr C, 2003, BIOLOGY OF SEEDS: RECENT RESEARCH ADVANCES, P225, DOI 10.1079/9780851996530.0225; GUMMERSON RJ, 1986, J EXP BOT, V37, P729, DOI 10.1093/jxb/37.6.729; HARDEGREE SP, 1994, SEED SCI TECHNOL, V22, P1; Iannucci A, 2008, FIELD CROP RES, V106, P156, DOI 10.1016/j.fcr.2007.11.005; Jacobsen KL, 2010, AGRON J, V102, P1346, DOI 10.2134/agronj2010.0002n; Justes E, 2009, PLANT SOIL, V325, P171, DOI 10.1007/s11104-009-9966-4; Justes E., 2012, INT FERT SOC M CAMBR, P4; Kamkar B., 2006, Asian Journal of Plant Sciences, V5, P316; Lee JiHyun, 2009, Korean Journal of Crop Science / Hanguk Jakmul Hakhoe Chi, V54, P218; Marshall B, 1996, J EXP BOT, V47, P1369, DOI 10.1093/jxb/47.9.1369; MICHEL BE, 1983, PLANT PHYSIOL, V72, P66, DOI 10.1104/pp.72.1.66; Mwale SS, 2003, SEED SCI TECHNOL, V31, P199, DOI 10.15258/sst.2003.31.1.21; Olivier FC, 1998, FIELD CROP RES, V56, P301, DOI 10.1016/S0378-4290(97)00097-X; Parent B, 2012, NEW PHYTOL, V194, P760, DOI 10.1111/j.1469-8137.2012.04086.x; Raveneau MP, 2011, SEED SCI RES, V21, P205, DOI 10.1017/S0960258511000067; ROBERTS EH, 1988, SYM SOC EXP BIOL, V42, P109; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; SCHOPFER P, 1979, PLANT PHYSIOL, V64, P822, DOI 10.1104/pp.64.5.822; Thorup-Kristensen K, 2003, ADV AGRON, V79, P227, DOI 10.1016/S0065-2113(02)79005-6; Tosti G, 2014, EUR J AGRON, V54, P34, DOI 10.1016/j.eja.2013.11.012; Tribouillois H, 2016, PLANT SOIL, V401, P347, DOI 10.1007/s11104-015-2734-8; Tribouillois H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122156; Uzun F., 2004, Asian Journal of Plant Sciences, V3, P714; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; Wilke BJ, 2008, J SCI FOOD AGR, V88, P551, DOI 10.1002/jsfa.3149; YIN XY, 1995, AGR FOREST METEOROL, V77, P1, DOI 10.1016/0168-1923(95)02236-Q; Yusoff MM, 2012, CROP PASTURE SCI, V63, P1097, DOI 10.1071/CP12305	47	47	48	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2016	11	8							e0161185	10.1371/journal.pone.0161185	http://dx.doi.org/10.1371/journal.pone.0161185			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4YN	27532825	Green Published, Green Submitted, gold			2022-12-27	WOS:000381487600071
J	You, JZ; Wang, HR; Huang, XJ; Qin, Z; Deng, ZM; Luo, J; Wang, BN; Li, MY				You, Jiangzhou; Wang, Hongren; Huang, Xiaojun; Qin, Zhen; Deng, Zhaomin; Luo, Jun; Wang, Baoning; Li, Mingyuan			Therapy-Emergent Drug Resistance to Integrase Strand Transfer Inhibitors in HIV-1 Patients: A Subgroup Meta-Analysis of Clinical Trials	PLOS ONE			English	Article							TREATMENT-EXPERIENCED PATIENTS; ANTIRETROVIRAL-NAIVE ADULTS; NON-INFERIORITY TRIAL; BOOSTED PROTEASE INHIBITOR; TWICE-DAILY RALTEGRAVIR; ONCE-DAILY DOLUTEGRAVIR; DOUBLE-BLIND; INFECTION; EFFICACY; ELVITEGRAVIR	Background Integrase strand transfer inhibitors (INSTIs) are a novel class of anti-HIV agents that show high activity in inhibiting HIV-1 replication. Currently, licensed INSTIs include raltegravir (RAL), elvitegravir (EVG) and dolutegravir (DTG); these drugs have played a critical role in AIDS therapy, serving as additional weapons in the arsenal for treating patients infected with HIV-1. To date, long-term data regarding clinical experience with INSTI use and the emergence of resistance remain scarce. However, the literature is likely now sufficiently comprehensive to warrant a meta-analysis of resistance to INSTIs. Methods Our team implemented a manuscript retrieval protocol using Medical Subject Headings (MeSH) via the Web of Science, MEDLINE, EMBASE, and Cochrane Central Register of Controlled Trials databases. We screened the literature based on inclusion and exclusion criteria and then performed a quality analysis and evaluation using RevMan software, Stata software, and the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE). We also performed a subgroup analysis. Finally, we calculated resistance rates and risk ratios (RRs) for the three types of drugs. Results We identified 26 references via the database search. A meta-analysis of the RAL data revealed that the resistance rate was 3.9% (95% CI = 2.9%-4.9%) for the selected randomized controlled trials (RCTs). However, the RAL resistance rate reached 40.9%(95% CI = 8.8%-72.9%) for the selected observational studies (OBSs). The rates of resistance to RAL that were associated with HIV subtypes A, B, and C as well as with more complex subtypes were 0.1% (95% CI = -0.7%-0.9%), 2.5% (95% CI = 0.5%-4.5%), 4.6% (95% CI = 2.7%-6.6%) and 2.2% (95% CI = 0.7%-3.7%), respectively. The rates of resistance to EVG and DTG were 1.2% (95% CI = 0.2%-2.2%) and 0.1% (95% CI = -0.2%-0.5%), respectively. Furthermore, we found that the RRs for antiviral resistance were 0.414 (95% CI = 0.210-0.816) between DTG and RAL and 0.499 (95% CI = 0.255-0.977) between EVG and RAL. When RAL was separately co-administered with nuclear nucleoside reverse transcriptase inhibitors (NRTIs) or protease inhibitors (PIs), the rates of resistance to RAL were 0.2% (95% CI = -0.1%-0.5%) and 0.2% (95% CI = -0.2%-0.6%), respectively. The ten major integrase mutations (including N155H, Y143C/R, Q148H/R, Y143Y/H, L74L/M, E92Q, E138E/A, Y143C, Q148Q and Y143S) can reduce the sensitivity of RAL and EVG. The resistance of DTG is mainly shown in 13 integrase mutations (including T97T/A, E138E/D, V151V/I, N155H, Q148, Y143C/H/R, T66A and E92Q). Conclusions Our results reveal that the DTG resistance rate was lower than the RAL resistance rate in a head-to-head comparison. Moreover, we confirmed that the EVG resistance rate was lower than the RAL resistance rate. In addition, our results revealed that the resistance rate of RAL was lower than that of efavirenz. The rates of resistance to RAL, EVG and DTG were specifically 3.9%, 1.2% and 0.1%, respectively. Compared with other types of antiviral drugs, the rates of resistance to INSTIs are generally lower. Unfortunately, the EVG and DTG resistance rates could not be compared because of a lack of data.	[You, Jiangzhou; Wang, Hongren; Huang, Xiaojun; Qin, Zhen; Deng, Zhaomin; Luo, Jun; Wang, Baoning; Li, Mingyuan] Sichuan Univ, West China Sch Preclin & Forens Med, Dept Microbiol, Chengdu, Sichuan, Peoples R China	Sichuan University	Li, MY (corresponding author), Sichuan Univ, West China Sch Preclin & Forens Med, Dept Microbiol, Chengdu, Sichuan, Peoples R China.	lmy3985@sina.com						Ananworanich J, 2012, ANTIMICROB AGENTS CH, V56, P1892, DOI 10.1128/AAC.05694-11; Armenia D, 2012, J INFECT DIS, V205, P557, DOI 10.1093/infdis/jir821; Arribas JR, 2014, LANCET INFECT DIS, V14, P581, DOI 10.1016/S1473-3099(14)70782-0; Bessong PO, 2013, INT J MOL SCI, V14, P5013, DOI 10.3390/ijms14035013; Burrell QL, 2004, J ROY STAT SOC A STA, V167, P184, DOI 10.1111/j.1467-985X.2004.298_3.x; Butler SL, 2002, J VIROL, V76, P3739, DOI 10.1128/JVI.76.8.3739-3747.2002; Caby F, 2010, SCAND J INFECT DIS, V42, P527, DOI 10.3109/00365541003621502; Cahn P, 2013, LANCET, V382, P700, DOI 10.1016/S0140-6736(13)61221-0; Capetti A, 2014, INT J ANTIMICROB AG, V43, P189, DOI 10.1016/j.ijantimicag.2013.10.013; Castagna A, 2014, J INFECT DIS, V210, P354, DOI 10.1093/infdis/jiu051; Cohen C, 2011, AIDS, V25, pF7, DOI 10.1097/QAD.0b013e328345766f; Cooper DA, 2008, NEW ENGL J MED, V359, P355, DOI 10.1056/NEJMoa0708978; Eron JJ, 2013, LANCET INFECT DIS, V13, P587, DOI 10.1016/S1473-3099(13)70093-8; Eron JJ, 2013, J INFECT DIS, V207, P740, DOI 10.1093/infdis/jis750; Eron JJ, 2010, LANCET, V375, P396, DOI 10.1016/S0140-6736(09)62041-9; German P, 2010, JAIDS-J ACQ IMM DEF, V55, P323, DOI 10.1097/QAI.0b013e3181eb376b; Grinsztejn B, 2007, LANCET, V369, P1261, DOI 10.1016/S0140-6736(07)60597-2; Gu WG, 2014, BIOMED PHARMACOTHER, V68, P917, DOI 10.1016/j.biopha.2014.09.013; Hazuda DJ, 2000, SCIENCE, V287, P646, DOI 10.1126/science.287.5453.646; Hughes A, 2008, J INFECTION, V57, P1, DOI 10.1016/j.jinf.2008.05.006; Hurt CB, 2014, CLIN INFECT DIS, V58, P423, DOI 10.1093/cid/cit697; Jayaweera D, 2012, EXPERT OPIN PHARMACO, V13, P2601, DOI 10.1517/14656566.2012.742506; Kinger M, 2012, ARCH PHARM RES, V35, P633, DOI 10.1007/s12272-012-0406-2; Lennox JL, 2009, LANCET, V374, P786; Lopez-Cortes LF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097262; Malet I, 2012, CURR OPIN VIROL, V2, P580, DOI 10.1016/j.coviro.2012.08.005; Manfredi R, 2006, CURR MED CHEM, V13, P2369, DOI 10.2174/092986706777935069; Metifiot M, 2010, VIRUSES-BASEL, V2, P1347, DOI 10.3390/v2071347; Molina JM, 2012, LANCET INFECT DIS, V12, P27, DOI 10.1016/S1473-3099(11)70249-3; Raffi F, 2014, LANCET, V384, P1942, DOI 10.1016/S0140-6736(14)61170-3; Raffi F, 2013, LANCET INFECT DIS, V13, P927, DOI 10.1016/S1473-3099(13)70257-3; Raffi F, 2013, LANCET, V381, P735, DOI 10.1016/S0140-6736(12)61853-4; Rockstroh JK, 2011, AIDS, V25, P1365, DOI 10.1097/QAD.0b013e328348065a; Rucker G, 2009, STAT MED, V28, P721, DOI 10.1002/sim.3511; Sax PE, 2012, LANCET, V380, P730; Serrao E, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-25; Summa V, 2008, J MED CHEM, V51, P5843, DOI 10.1021/jm800245z; Taiwo B, 2011, AIDS, V25, P2113, DOI 10.1097/QAD.0b013e32834bbaa9; Vandenbroucke JP, 2014, INT J SURG, V12, P1500, DOI 10.1016/j.ijsu.2014.07.014; Vets S, 2012, MOL THER, V20, P908, DOI 10.1038/mt.2012.6; Weller S, 2014, EUR J CLIN PHARMACOL, V70, P29, DOI 10.1007/s00228-013-1590-9; Wood L, 2008, BMJ-BRIT MED J, V336, P601, DOI 10.1136/bmj.39465.451748.AD; Yazdanpanah Y, 2009, CLIN INFECT DIS, V49, P1441, DOI 10.1086/630210; Zolopa AR, 2010, J INFECT DIS, V201, P814, DOI 10.1086/650698	44	17	18	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2016	11	8							e0160087	10.1371/journal.pone.0160087	http://dx.doi.org/10.1371/journal.pone.0160087			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4YN	27532886	Green Published, gold, Green Submitted			2022-12-27	WOS:000381487600023
J	Park, B; Kim, SI; Seo, SS; Kang, S; Park, SY; Lim, MC				Park, Boyoung; Kim, Se Ik; Seo, Sang-Soo; Kang, Sokbom; Park, Sang-Yoon; Lim, Myong Cheol			Health Behaviors and Associated Sociodemographic Factors in Cervical Cancer Survivors Compared with Matched Non-Cancer Controls	PLOS ONE			English	Article							RISK-FACTORS; LIFE-STYLE; PREVALENCE; SMOKING; KOREA	We explored the prevalence of smoking, alcohol consumption, physical activity, and obesity in cervical cancer survivors and examined associations between sociodemographic factors and each health behavior. We studied 448 cervical cancer survivors >= 2 years after their initial diagnosis who had completed treatment. The total sample consisted of these survivors, and 4,480 cancer-free controls who were grouped into 5-year age cohorts and matched to the survivors in terms of both education and monthly household income. The prevalence of current smoking, current alcohol consumption, physical inactivity, and obesity in cervical cancer survivors (2.68, 23.88, 62.02, and 32.81%, respectively) did not differ significantly from those of matched non-cancer controls. Age (younger), marital status (married), and education (>= college) were associated with lower probabilities of current alcohol consumption (odds ratio [ OR] = 0.91, 95% confidence interval [ CI] = 0.88-0.95; OR = 0.42, 95% CI = 0.23-0.78; OR = 0.49, 95% CI = 0.25-0.97, respectively). A monthly household income >=$2,000, being employed, and self-rated health status (less healthy) were associated with physical inactivity (OR = 0.61, 95% CI = 0.37-0.99; OR = 2.16, 95% CI = 1.36-3.42; OR = 1.94, 95% CI = 1.23-3.05, respectively). Both age and number of years since diagnosis were associated with obesity (OR = 1.04, 95% CI = 1.01-1.08; OR = 0.38; 95% CI = 0.20-0.72, respectively). The health behaviors of cervical cancer survivors did not differ from those of matched cancer-free controls. As health behaviors are modifiable, identification of cervical cancer survivors who are at risk of an unhealthy lifestyle would allow individual-and population-based intervention programs to more effectively use their limited resources.	[Park, Boyoung; Kang, Sokbom; Lim, Myong Cheol] Natl Canc Ctr, Grad Sch Canc Sci & Policy, Dept Canc Control & Policy, Goyang Si, South Korea; [Park, Boyoung] Natl Canc Ctr, Natl Canc Control Inst, Canc Early Detect Branch, Goyang Si, South Korea; [Kim, Se Ik] Seoul Natl Univ, Dept Obstet & Gynecol, Coll Med, Seoul, South Korea; [Seo, Sang-Soo; Kang, Sokbom; Park, Sang-Yoon; Lim, Myong Cheol] Natl Canc Ctr, Hosp, Ctr Uterine Canc, Goyang Si, South Korea; [Kang, Sokbom; Park, Sang-Yoon; Lim, Myong Cheol] Natl Canc Ctr, Gynecol Canc Branch, Res Inst, Goyang Si, South Korea	National Cancer Center - Korea (NCC); National Cancer Center - Korea (NCC); Seoul National University (SNU); National Cancer Center - Korea (NCC); National Cancer Center - Korea (NCC)	Lim, MC (corresponding author), Natl Canc Ctr, Grad Sch Canc Sci & Policy, Dept Canc Control & Policy, Goyang Si, South Korea.; Lim, MC (corresponding author), Natl Canc Ctr, Hosp, Ctr Uterine Canc, Goyang Si, South Korea.; Lim, MC (corresponding author), Natl Canc Ctr, Gynecol Canc Branch, Res Inst, Goyang Si, South Korea.	mclim@ncc.re.kr		Kang, Sokbom/0000-0002-8428-9555	National Cancer Center of Korea [1410692-2, 1630950-1]; Korea Health Industry Development Institute [HI16C1127]	National Cancer Center of Korea; Korea Health Industry Development Institute(Korea Health Industry Development Institute (KHIDI))	This study was supported by a Grant-in-Aid for Cancer Research and Control from the National Cancer Center of Korea (No. 1410692-2, No. 1630950-1 MD Boyoung Park) and Korea Health Industry Development Institute (No. HI16C1127). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armenian SH, 2012, BONE MARROW TRANSPL, V47, P283, DOI 10.1038/bmt.2011.60; Beesley VL, 2008, CANCER CAUSE CONTROL, V19, P775, DOI 10.1007/s10552-008-9140-y; Bellizzi KM, 2005, J CLIN ONCOL, V23, P8884, DOI 10.1200/JCO.2005.02.2343; Bergmann MM, 1998, AM J EPIDEMIOL, V147, P556; Bull F.C., 2010, PHYS ACTIVITY GUIDEL; Coups EJ, 2005, PREV MED, V40, P702, DOI 10.1016/j.ypmed.2004.09.011; Day NE, 2016, IARC SCI PUBLICATION, V32; Demark-Wahnefried W, 2008, HEMATOL ONCOL CLIN N, V22, P319, DOI 10.1016/j.hoc.2008.01.012; Demark-Wahnefried W, 2006, J CLIN ONCOL, V24, P5125, DOI 10.1200/JCO.2006.06.6175; Duska LR, 2015, CLIN THER, V37, P6, DOI 10.1016/j.clinthera.2014.12.003; Eakin EG, 2007, CANCER CAUSE CONTROL, V18, P881, DOI 10.1007/s10552-007-9033-5; Emmons KM, 2005, PREV MED, V40, P527, DOI 10.1016/j.ypmed.2004.10.001; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Gallicchio Lisa, 2008, J Cancer Surviv, V2, P12, DOI 10.1007/s11764-008-0046-1; Group HES, 2014, ASIAN PAC J CANCER P, V16, P1591; Hausdorf K, 2008, CANCER CAUSE CONTROL, V19, P1339, DOI 10.1007/s10552-008-9205-y; Jung KW, 2015, CANCER RES TREAT, V47, P127, DOI 10.4143/crt.2015.060; Kim RB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057598; Kwon S, 2012, J CANCER SURVIV, V6, P54, DOI 10.1007/s11764-011-0204-8; Lim MC, 2016, CANCER RES TREAT, V48, P641, DOI 10.4143/crt.2014.326; Lim MC, 2013, J GYNECOL ONCOL, V24, P298, DOI 10.3802/jgo.2013.24.4.298; Linsky A, 2011, J CANCER SURVIV, V5, P27, DOI 10.1007/s11764-010-0162-6; McBride CM, 2003, HEALTH EDUC RES, V18, P156, DOI 10.1093/her/18.2.156; Oh CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072012; Oh MG, 2013, JPN J CLIN ONCOL, V43, P981, DOI 10.1093/jjco/hyt118; Palma MD, 2008, CANCER RES, V68, P7006, DOI 10.1158/0008-5472.CAN-08-0599; Park B, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001214; Pekmezi DW, 2011, ACTA ONCOL, V50, P167, DOI 10.3109/0284186X.2010.529822; Schlumbrecht MP, 2014, INT J GYNECOL CANCER, V24, P570, DOI 10.1097/IGC.0000000000000081; Shin DW, 2008, ONCOLOGY-BASEL, V74, P207, DOI 10.1159/000151368; U.S. Department of Health and Human Services, 2008, 2008 PHYS ACT GUID A; Underwood JM, 2012, CANCER CAUSE CONTROL, V23, P1009, DOI 10.1007/s10552-012-9957-2; WHO, 2010, GLOB REC PHYS ACT HL, V1st, P15; Yabroff KR, 2004, JNCI-J NATL CANCER I, V96, P1322, DOI 10.1093/jnci/djh255	34	7	7	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2016	11	8							e0160682	10.1371/journal.pone.0160682	http://dx.doi.org/10.1371/journal.pone.0160682			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4UN	27529704	Green Published, Green Submitted, gold			2022-12-27	WOS:000381476700017
J	Keczer, Z; File, B; Orosz, G; Zimbardo, PG				Keczer, Zsolt; File, Balint; Orosz, Gabor; Zimbardo, Philip G.			Social Representations of Hero and Everyday Hero: A Network Study from Representative Samples	PLOS ONE			English	Article							COMMUNITY STRUCTURE; CONSTRUCTION; ORGANIZATION	The psychological investigation of heroism is relatively new. At this stage, inductive methods can shed light on its main aspects. Therefore, we examined the social representations of Hero and Everyday Hero by collecting word associations from two separate representative samples in Hungary. We constructed two networks from these word associations. The results show that the social representation of Hero is more centralized and it cannot be divided into smaller units. The network of Everyday Hero is divided into five units and the significance moves from abstract hero characteristics to concrete social roles and occupations exhibiting pro-social values. We also created networks from the common associations of Hero and Everyday Hero. The structures of these networks show a moderate similarity and the connections are more balanced in case of Everyday Hero. While heroism in general can be the source of inspiration, the promotion of everyday heroism can be more successful in encouraging ordinary people to recognize their own potential for heroic behavior.	[Orosz, Gabor] Eotvos Lorand Univ, Fac Educ & Psychol, Inst Psychol, Budapest, Hungary; [File, Balint; Orosz, Gabor] MTA Res Ctr Nat Sci, Inst Cognit Neurosci & Psychol, Budapest, Hungary; [File, Balint] Pazmany Peter Catholic Univ, Fac Informat Technol & Bion, Budapest, Hungary; [Keczer, Zsolt] Univ Szeged, Inst Psychol, Szeged, Hungary; [Zimbardo, Philip G.] Stanford Univ, Dept Psychol, Stanford, CA USA	Eotvos Lorand University; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences; Szeged University; Stanford University	Orosz, G (corresponding author), Eotvos Lorand Univ, Fac Educ & Psychol, Inst Psychol, Budapest, Hungary.; Orosz, G (corresponding author), MTA Res Ctr Nat Sci, Inst Cognit Neurosci & Psychol, Budapest, Hungary.	orosz.gabor@ttk.mta.hu		Orosz, Gabor/0000-0001-5883-6861	Hungarian Research Fund (NKFI PD) [106027, 116686];  [0183-13 502]	Hungarian Research Fund (NKFI PD)(National Research, Development & Innovation Office (NRDIO) - Hungary); 	Gyorgyi Orosz gave a personal donation for data gathering 500 USD. The third author (GO) was supported by the Hungarian Research Fund (NKFI PD 106027, 116686) and Momentum (0183-13 502) during the period of time he was working on this study. There was no additional funding received for this study.; We would like to thank Monika Eva Fekete for the fruitful discussions which significantly improved the paper. We are also grateful to Zoltan Somogyvari for carefully reading the manuscript. We also thank Elaine L. Kinsella and a second anonymous referee for all their corrections and suggestions. We thank Gyorgyi Orosz for the financial support. The third author (GO) was supported by the Hungarian Research Fund (NKFI PD 106027, 116686) and Momentum (0183-13 502).	Abric J. -C., 1994, PRATIQUES SOCIALES R, P11; Abric J.-C., 1987, COOPERATION COMPETIT; Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; [Anonymous], [No title captured]; [Anonymous], [No title captured]; [Anonymous], [No title captured]; [Anonymous], [No title captured]; [Anonymous], [No title captured]; [Anonymous], [No title captured]; [Anonymous], 1994, PRATIQUES SOCIALES R; [Anonymous], [No title captured]; [Anonymous], 2005, J CULTURAL EVOLUTION, DOI DOI 10.1556/JCEP.3.2005.3-4.2; [Anonymous], 2007, THE LUCIFER EFFECT; [Anonymous], [No title captured]; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Belanger JJ, 2014, J PERS SOC PSYCHOL, V107, P494, DOI 10.1037/a0036855; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Bode C, 2007, FEBS LETT, V581, P2776, DOI 10.1016/j.febslet.2007.05.021; Burt RS, 2013, ANNU REV PSYCHOL, V64, P527, DOI 10.1146/annurev-psych-113011-143828; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Davis JL, 2011, SOC PSYCHOL EDUC, V14, P331, DOI 10.1007/s11218-010-9147-6; De Deyne S, 2008, BEHAV RES METHODS, V40, P198, DOI 10.3758/BRM.40.1.198; Eagly AH, 2005, AM PSYCHOL, V60, P343, DOI 10.1037/0003-066X.60.4.343; Erdi P, 2013, SCIENTOMETRICS, V95, P225, DOI 10.1007/s11192-012-0796-4; Farley F., 2012, PSYCHOL TODAY; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Franco ZE, 2011, REV GEN PSYCHOL, V15, P99, DOI 10.1037/a0022672; Goethals GR, 2012, ADV EXP SOC PSYCHOL, V46, P183, DOI 10.1016/B978-0-12-394281-4.00004-0; Gonzalez MC, 2007, PHYSICA A, V379, P307, DOI 10.1016/j.physa.2007.01.002; Guimera R, 2005, NATURE, V433, P895, DOI 10.1038/nature03288; Jacomy M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098679; Johnson RC, 1996, ETHOL SOCIOBIOL, V17, P355, DOI 10.1016/S0162-3095(96)00059-3; Jonsson PF, 2006, BIOINFORMATICS, V22, P2291, DOI 10.1093/bioinformatics/btl390; Karypis G., 2001, Proceedings of the 2001 ACM CIKM. Tenth International Conference on Information and Knowledge Management, P247, DOI 10.1145/502585.502627; Kinsella EL, 2015, J PERS SOC PSYCHOL, V108, P114, DOI 10.1037/a0038463; Kirchler E, 2003, J ECON PSYCHOL, V24, P535, DOI 10.1016/S0167-4870(02)00164-2; Knyazev GG, 2015, NEUROBIOL AGING, V36, P1849, DOI 10.1016/j.neurobiolaging.2015.02.007; Li L, 2005, INTERNET MATH, V2, P431, DOI 10.1080/15427951.2005.10129111; Meunier D, 2009, NEUROIMAGE, V44, P715, DOI 10.1016/j.neuroimage.2008.09.062; Morales AJ, 2014, SOC NETWORKS, V39, P1, DOI 10.1016/j.socnet.2014.03.007; Moscovici S., 1961, PSYCHANALYSE; Nagarajan R, 2013, J BIOMED INFORM, V46, P40, DOI 10.1016/j.jbi.2012.08.002; Nelson DL, 2000, MEM COGNITION, V28, P887, DOI 10.3758/BF03209337; Newman MEJ, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.066133; Palla G, 2005, NATURE, V435, P814, DOI 10.1038/nature03607; Rankin LE, 2008, PSYCHOL WOMEN QUART, V32, P414, DOI 10.1111/j.1471-6402.2008.00455.x; Wachelke JFR, 2009, PSICOL-REFLEX CRIT, V22, P102, DOI 10.1590/S0102-79722009000100014; Rubinov M, 2011, NEUROIMAGE, V56, P2068, DOI 10.1016/j.neuroimage.2011.03.069; Smith SF, 2013, J RES PERS, V47, P634, DOI 10.1016/j.jrp.2013.05.006; Spears N., 2013, J PROMOTION MANAGEME, V19, P17, DOI DOI 10.1080/10496491.2012.715126; Staats S, 2009, ETHICS BEHAV, V19, P171, DOI 10.1080/10508420802623716; Stam CJ, 2012, CLIN NEUROPHYSIOL, V123, P1067, DOI 10.1016/j.clinph.2012.01.011; Steyvers M, 2005, COGNITIVE SCI, V29, P41, DOI 10.1207/s15516709cog2901_3; Sullivan MP, 2005, SELF IDENTITY, V4, P101, DOI 10.1080/13576500444000191; Sullivan MP, 2010, J SOC PSYCHOL, V150, P471, DOI 10.1080/00224540903366602; Sun Y, 2009, EPL-EUROPHYS LETT, V86, DOI 10.1209/0295-5075/86/28004; Uhlmann EL, 2013, COGNITION, V126, P326, DOI 10.1016/j.cognition.2012.10.005; Verges P, 1994, STRUCTURES TRANSFORM, V277, P233; Wachelke J, 2012, NEW IDEAS PSYCHOL, V30, P259, DOI 10.1016/j.newideapsych.2011.12.001; Wansink B, 2008, LEADERSHIP QUART, V19, P547, DOI 10.1016/j.leaqua.2008.07.010; Wilkinson DM, 2004, P NATL ACAD SCI USA, V101, P5241, DOI 10.1073/pnas.0307740100; Zeng A, 2013, PHYS LETT A, V377, P1031, DOI 10.1016/j.physleta.2013.02.039	62	12	12	3	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2016	11	8							e0159354	10.1371/journal.pone.0159354	http://dx.doi.org/10.1371/journal.pone.0159354			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DT4SL	27525418	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000381471100007
J	Rivet, CA; Kniss-James, AS; Gran, MA; Potnis, A; Hill, A; Lu, H; Kemp, ML				Rivet, Catherine A.; Kniss-James, Ariel S.; Gran, Margaret A.; Potnis, Anish; Hill, Abby; Lu, Hang; Kemp, Melissa L.			Calcium Dynamics of Ex Vivo Long-Term Cultured CD8(+) T Cells Are Regulated by Changes in Redox Metabolism	PLOS ONE			English	Article							OPERATED CA2+ ENTRY; INOSITOL 1,4,5-TRISPHOSPHATE RECEPTOR; AGE-RELATED ALTERATIONS; GENE-EXPRESSION; KINETIC-MODEL; LYMPHOCYTE-ACTIVATION; ENDOPLASMIC-RETICULUM; MEMBRANE CA2+-ATPASE; SIGNAL-TRANSDUCTION; CARDIAC MYOCYTES	T cells reach a state of replicative senescence characterized by a decreased ability to proliferate and respond to foreign antigens. Calcium release associated with TCR engagement is widely used as a surrogate measure of T cell response. Using an ex vivo culture model that partially replicates features of organismal aging, we observe that while the amplitude of Ca2+ signaling does not change with time in culture, older T cells exhibit faster Ca2+ rise and a faster decay. Gene expression analysis of Ca2+ channels and pumps expressed in T cells by RT-qPCR identified overexpression of the plasma membrane CRAC channel subunit ORAI1 and PMCA in older T cells. To test whether overexpression of the plasma membrane Ca2+ channel is sufficient to explain the kinetic information, we adapted a previously published computational model by Maurya and Subramaniam to include additional details on the store-operated calcium entry (SOCE) process to recapitulate Ca2+ dynamics after T cell receptor stimulation. Simulations demonstrated that upregulation of ORAI1 and PMCA channels is not sufficient to explain the observed alterations in Ca2+ signaling. Instead, modeling analysis identified kinetic parameters associated with the IP3R and STIM1 channels as potential causes for alterations in Ca2+ dynamics associated with the long term ex vivo culturing protocol. Due to these proteins having known cysteine residues susceptible to oxidation, we subsequently investigated and observed transcriptional remodeling of metabolic enzymes, a shift to more oxidized redox couples, and post-translational thiol oxidation of STIM1. The model-directed findings from this study highlight changes in the cellular redox environment that may ultimately lead to altered T cell calcium dynamics during immunosenescence or organismal aging.	[Rivet, Catherine A.] Georgia Inst Technol, Sch Elect & Comp Engn, Atlanta, GA 30332 USA; [Kniss-James, Ariel S.; Gran, Margaret A.; Potnis, Anish; Hill, Abby; Lu, Hang; Kemp, Melissa L.] Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA; [Kniss-James, Ariel S.; Gran, Margaret A.; Potnis, Anish; Hill, Abby; Lu, Hang; Kemp, Melissa L.] Emory Univ, Atlanta, GA 30322 USA; [Lu, Hang] Georgia Inst Technol, Sch Chem & Biomol Engn, Atlanta, GA 30332 USA; [Lu, Hang; Kemp, Melissa L.] Parker H Petit Inst Bioengn & Biosci, Atlanta, GA USA; [Hill, Abby] MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA	University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; Emory University; University System of Georgia; Georgia Institute of Technology; Massachusetts Institute of Technology (MIT)	Kemp, ML (corresponding author), Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA.; Kemp, ML (corresponding author), Emory Univ, Atlanta, GA 30322 USA.; Kemp, ML (corresponding author), Parker H Petit Inst Bioengn & Biosci, Atlanta, GA USA.	melissa.kemp@bme.gatech.edu		Kemp, Melissa/0000-0003-3781-8802	NIAID [R01AI088023A]; NIH New Innovator award [DP2OD006483]; NSF Graduate Research Fellowship [DGE-1148903]; NIH T32 Pre-Doctoral Training Grant [32GM105490]; National Institutes of Health [R01AI088023A, DP2OD006483]; P.E.O. Scholar Award; NIH Training Grant [32GM105490]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI088023, R01AI088023] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM105490] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD006483] Funding Source: NIH RePORTER	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH New Innovator award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF Graduate Research Fellowship(National Science Foundation (NSF)); NIH T32 Pre-Doctoral Training Grant; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); P.E.O. Scholar Award; NIH Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The work was supported by the following: NIAID, www.niaid.nih.gov, R01AI088023A (awarded to MLK and HL); NIH New Innovator award, Office of Director, www.commonfund.nih.gov/newinnovator/, DP2OD006483 (to MLK); NSF Graduate Research Fellowship, www.nsfgrfp.org, DGE-1148903 (to AK); and NIH T32 Pre-Doctoral Training Grant, www.nigms.nih.gov/Training/InstPredoc, 32GM105490 (to AK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r The authors would like to acknowledge invaluable assistance in parameter optimization from Gaurav Dwivedi. Support for this work was provided by the National Institutes of Health awards R01AI088023A and DP2OD006483. Financial support to AK provided through NSF Graduate Research Fellowship Grant DGE-1148903, P.E.O. Scholar Award, and NIH Training Grant 32GM105490.	Abell E, 2011, P NATL ACAD SCI USA, V108, P14485, DOI 10.1073/pnas.1018266108; Ahnadi CE, 1996, CELL CALCIUM, V19, P509, DOI 10.1016/S0143-4160(96)90060-3; Arrol HP, 2008, CLIN EXP IMMUNOL, V153, P86, DOI 10.1111/j.1365-2249.2008.03677.x; ATRI A, 1993, BIOPHYS J, V65, P1727, DOI 10.1016/S0006-3495(93)81191-3; BEZPROZVANNY I, 1991, NATURE, V351, P751, DOI 10.1038/351751a0; Bogeski I, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000672; BOOTMAN MD, 1992, J BIOL CHEM, V267, P25113; Cao JN, 2010, AGING CELL, V9, P19, DOI 10.1111/j.1474-9726.2009.00534.x; Chay TR, 1996, NEURAL COMPUT, V8, P951, DOI 10.1162/neco.1996.8.5.951; Chen JL, 2010, J IMMUNOL, V184, P1829, DOI 10.4049/jimmunol.0902103; Chen XF, 2008, BIOPHYS CHEM, V136, P87, DOI 10.1016/j.bpc.2008.04.010; Chung KH, 2011, ANAL CHEM, V83, P7044, DOI 10.1021/ac2011153; Csordas G, 2009, BBA-BIOENERGETICS, V1787, P1352, DOI 10.1016/j.bbabio.2009.06.004; Cui JJ, 2009, FEMS YEAST RES, V9, P1137, DOI 10.1111/j.1567-1364.2009.00552.x; Dadsetan S, 2008, J BIOL CHEM, V283, P12512, DOI 10.1074/jbc.M709330200; DEYOUNG GW, 1992, P NATL ACAD SCI USA, V89, P9895, DOI 10.1073/pnas.89.20.9895; Esser MT, 1998, J EXP MED, V187, P1057, DOI 10.1084/jem.187.7.1057; Feske S, 2007, NAT REV IMMUNOL, V7, P690, DOI 10.1038/nri2152; Fulop T, 2003, ARTHRITIS RES THER, V5, P290, DOI 10.1186/ar1019; Galan C, 2010, MOLECULES, V15, P7167, DOI 10.3390/molecules15107167; Gautam N, 2010, OXID MED CELL LONGEV, V3, P275, DOI 10.4161/oxim.3.4.12860; Groenendaal W, 2008, IET SYST BIOL, V2, P411, DOI 10.1049/iet-syb:20070050; GROSSMANN A, 1991, CELL IMMUNOL, V135, P118, DOI 10.1016/0008-8749(91)90259-E; GROSSMANN A, 1989, EXP CELL RES, V180, P367, DOI 10.1016/0014-4827(89)90064-5; Grupe M, 2010, CELL CALCIUM, V48, P1, DOI 10.1016/j.ceca.2010.05.005; GUPTA S, 1989, ANN NY ACAD SCI, V568, P277; GUSE AH, 1993, BIOCHEM J, V291, P447, DOI 10.1042/bj2910447; Hake J, 2012, J PHYSL; Hawkins BJ, 2010, J CELL BIOL, V190, P391, DOI 10.1083/jcb.201004152; He L, 2013, AUTOMATED HIGH THROU; Holcman D, 2005, SIAM J APPL MATH, V65, P1006, DOI 10.1137/S003613990342894X; Hoth M, 1997, J CELL BIOL, V137, P633, DOI 10.1083/jcb.137.3.633; Jones DP, 2008, AM J PHYSIOL-CELL PH, V295, pC849, DOI 10.1152/ajpcell.00283.2008; Jones DP, 2002, METHOD ENZYMOL, V348, P93, DOI 10.1016/S0076-6879(02)48630-2; Kang S, 2008, J BIOL CHEM, V283, P25567, DOI 10.1074/jbc.M803321200; Kaplan P, 2007, MOL CELL BIOCHEM, V301, P219, DOI 10.1007/s11010-007-9414-9; KENNES B, 1981, IMMUNOL LETT, V2, P231, DOI 10.1016/0165-2478(81)90048-1; Kim S, 2001, ANN BIOMED ENG, V29, P373, DOI 10.1114/1.1366671; Kniss A, 2013, METHOD ENZYMOL, V526, P219, DOI 10.1016/B978-0-12-405883-5.00013-2; Kowalewski JM, 2006, MATH BIOSCI, V204, P232, DOI 10.1016/j.mbs.2006.03.001; Kwon YW, 2003, BIOL CHEM, V384, P991, DOI 10.1515/BC.2003.111; LEJEMTEL TH, 1993, CIRC RES, V72, P341, DOI 10.1161/01.RES.72.2.341; Lewis RS, 2001, ANNU REV IMMUNOL, V19, P497, DOI 10.1146/annurev.immunol.19.1.497; LI YX, 1994, J THEOR BIOL, V166, P461, DOI 10.1006/jtbi.1994.1041; Liu WJ, 2010, MATH BIOSCI, V228, P110, DOI 10.1016/j.mbs.2010.08.013; Lushington GH, 2005, J MOL GRAPH MODEL, V24, P175, DOI 10.1016/j.jmgm.2005.07.003; Marhl M, 2000, BIOSYSTEMS, V57, P75, DOI 10.1016/S0303-2647(00)00090-3; Maul-Pavicic A, 2011, P NATL ACAD SCI USA, V108, P3324, DOI 10.1073/pnas.1013285108; Maurya MR, 2007, BIOPHYS J, V93, P709, DOI 10.1529/biophysj.106.097469; Maurya MR, 2007, BIOPHYS J, V93, P729, DOI 10.1529/biophysj.106.097501; Miller RA, 1996, LIFE SCI, V59, P469, DOI 10.1016/0024-3205(96)00326-8; Mirza N, 2011, AGING CELL, V10, P853, DOI 10.1111/j.1474-9726.2011.00730.x; Newrzela S, 2008, T CELL CULTURE GAMMA, P71; Nunes P, 2014, ANTIOXID REDOX SIGN, V21, P915, DOI 10.1089/ars.2013.5615; Oh-Hora M, 2008, CURR OPIN IMMUNOL, V20, P250, DOI 10.1016/j.coi.2008.04.004; PETRZILKA GE, 1979, CELL TISSUE RES, V201, P101; PHILOSOPHE B, 1989, EUR J IMMUNOL, V19, P695, DOI 10.1002/eji.1830190419; Politi A, 2006, BIOPHYS J, V90, P3120, DOI 10.1529/biophysj.105.072249; Pottorf WJ, 2001, BRAIN RES, V914, P57, DOI 10.1016/S0006-8993(01)02773-1; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; Quintana A, 2011, EMBO J, V30, P3895, DOI 10.1038/emboj.2011.289; Redondo PC, 2004, BIOCHEM PHARMACOL, V67, P491, DOI 10.1016/j.bcp.2003.09.031; Remondini D, 2010, MOL BIOSYST, V6, P1983, DOI 10.1039/c004635c; Rice JJ, 2001, PHILOS T R SOC A, V359, P1143, DOI 10.1098/rsta.2001.0822; Rink L, 1998, MECH AGEING DEV, V102, P199, DOI 10.1016/S0047-6374(97)00153-X; Ritchie MF, 2012, EMBO J, V31, P1123, DOI 10.1038/emboj.2011.495; Rivet CA, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.003921; Roussel C, 2006, CELL CALCIUM, V39, P455, DOI 10.1016/j.ceca.2006.01.004; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Sneyd J, 2002, P NATL ACAD SCI USA, V99, P2398, DOI 10.1073/pnas.032281999; Sulger J, 1999, BIOL PSYCHIAT, V45, P737, DOI 10.1016/S0006-3223(98)00218-2; Swietach P, 2010, FRONT BIOSCI-LANDMRK, V15, P661, DOI 10.2741/3639; Thakur P, 2012, BIOPHYS J, V102, p315A, DOI 10.1016/j.bpj.2011.11.1735; Thompson JA, 2003, CLIN CANCER RES, V9, P3562; Utzny C, 2005, BIOPHYS J, V88, P1, DOI 10.1529/biophysj.103.038216; Watson WH, 2003, FEBS LETT, V543, P144, DOI 10.1016/S0014-5793(03)00430-7; WONG AYK, 1993, CELL CALCIUM, V14, P227, DOI 10.1016/0143-4160(93)90070-M; Zaidi A, 1998, NEUROBIOL AGING, V19, P487, DOI 10.1016/S0197-4580(98)00078-5; Zhang SYL, 2005, NATURE, V437, P902, DOI 10.1038/nature04147; Zhao XL, 2008, AGING CELL, V7, P561, DOI 10.1111/j.1474-9726.2008.00408.x; Zhong F, 2006, J CELL BIOL, V172, P127, DOI 10.1083/jcb.200506189	81	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2016	11	8							e0159248	10.1371/journal.pone.0159248	http://dx.doi.org/10.1371/journal.pone.0159248			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4SL	27526200	Green Published, Green Submitted, gold			2022-12-27	WOS:000381471100006
J	van der Linden, M; Falkenhorst, G; Perniciaro, S; Fitzner, C; Imohl, M				van der Linden, Mark; Falkenhorst, Gerhard; Perniciaro, Stephanie; Fitzner, Christina; Imoehl, Matthias			Effectiveness of Pneumococcal Conjugate Vaccines (PCV7 and PCV13) against Invasive Pneumococcal Disease among Children under Two Years of Age in Germany	PLOS ONE			English	Article							LOGISTIC-REGRESSION; VACCINATION; EVENTS; IMPACT	Background In this study we calculate the effectiveness of pneumococcal conjugate vaccines (PCV) against invasive pneumococcal disease (IPD) among children under the age of two years using the indirect cohort method. We also discuss the timeliness of vaccination and the residual cases of vaccine type IPD. Methods and Findings From July 2006 until June 2015, 921 IPD cases were reported and for 618 children (67.1%), the vaccination status at the time of infection could be accurately determined. Of these, 379 (61.3%) were vaccinated and 239 (38.7%) were not vaccinated. The adjusted vaccine effectiveness (VE) of PCV7 for all included serotypes + 6A was 80% (95% CI: 63-89) for at least one dose, 97% (89-100) after three primary doses (post primary) and 95% (57-100) post booster. The adjusted overall VE of PCV13 was 86% (74-93) for at least one dose, 85% (62-94) post primary and 91% (61-99) post booster. For the additional serotypes included in PCV13, the adjusted VE was 82% (66-91), 80% (46-93) and 90% (54-98) respectively. The serotype specific VE for at least one dose was high for serotypes 1 (83%; 15-97), 3 (74%; 2-93), 7F (84%; 18-98) and 19A (77%; 47-90). Only 39.5% of children with IPD obtained their first dose of PCV7 according to schedule (2nd dose: 32.9%, 3rd dose: 22.0%, booster dose: 63.6%). For children vaccinated with PCV13 values were slightly better: 43.8%, 33.5%, 26.3% and 74.3% respectively. Among 90 residual cases with PCV7 serotypes, 73 (81.1%) were in unvaccinated children, and 15 (16.7%) in children who had not obtained the number of doses recommended for their age, and only two (2.2%) in children vaccinated according to age. Of 82 cases with PCV13 serotypes occurring after the switch from PCV7 to PCV13, 56 (68.3%) were not vaccinated, 22 (26.8%) were incompletely vaccinated, and four (4.9%) were vaccinated according to age. Conclusions Our data show a high effectiveness of pneumococcal conjugate vaccination in Germany. However, the administration of vaccine doses among children with IPD is often delayed, resulting in many vaccine type cases in non- or incompletely-vaccinated children. Whether the recently-implemented change to a 2+1 schedule will improve the timeliness of vaccination should be subject to careful monitoring.	[van der Linden, Mark; Perniciaro, Stephanie; Imoehl, Matthias] Univ Hosp RWTH, Dept Med Microbiol, Natl Reference Ctr Streptococci, Aachen, Germany; [Falkenhorst, Gerhard] Robert Koch Inst, Dept Infect Dis Epidemiol, Berlin, Germany; [Fitzner, Christina] Univ Hosp RWTH, Dept Med Stat, Aachen, Germany	RWTH Aachen University; RWTH Aachen University Hospital; Robert Koch Institute; RWTH Aachen University; RWTH Aachen University Hospital	van der Linden, M (corresponding author), Univ Hosp RWTH, Dept Med Microbiol, Natl Reference Ctr Streptococci, Aachen, Germany.	mlinden@ukaachen.de	van der Linden, Mark/B-9305-2009; Imöhl, Matthias/P-5014-2014; Perniciaro, Stephanie R/J-3669-2017; Fitzner, Christina/H-6431-2013	van der Linden, Mark/0000-0002-6574-4313; Imöhl, Matthias/0000-0002-8372-0251; Perniciaro, Stephanie R/0000-0002-3146-2182; 	investigator initiated research grant from Pfizer Pharma GmbH [IRR WI 172072]; Robert Koch Institut, Berlin, Germany	investigator initiated research grant from Pfizer Pharma GmbH; Robert Koch Institut, Berlin, Germany	This study was in part funded by investigator initiated research grant IRR WI 172072 from Pfizer Pharma GmbH. PneumoWeb is maintained and supported by the Robert Koch Institut, Berlin, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028435; Andrews NJ, 2014, LANCET INFECT DIS, V14, P839, DOI 10.1016/S1473-3099(14)70822-9; [Anonymous], EPIDEMIOL B; BROOME CV, 1980, NEW ENGL J MED, V303, P549, DOI 10.1056/NEJM198009043031003; Camilli R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076309; [Centre HaSCI Screening and Immunisations team], 2014, NHS IMM STAT 2014; De Serres G, 2012, VACCINE, V30, P4067, DOI 10.1016/j.vaccine.2012.04.017; Deceuninck G, 2015, VACCINE, V33, P2684, DOI 10.1016/j.vaccine.2015.04.005; Harboe ZB, 2014, CLIN INFECT DIS, V59, P1066, DOI 10.1093/cid/ciu524; Heinze G, 2006, STAT MED, V25, P4216, DOI 10.1002/sim.2687; Hussain M, 2005, EPIDEMIOL INFECT, V133, P891, DOI 10.1017/S0950268805004012; Kunze W, 2010, PADIATR PRAX, V75, P249; Moore MR, 2015, LANCET INFECT DIS, V15, P301, DOI 10.1016/S1473-3099(14)71081-3; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; Picon T, 2013, VACCINE, V31, pC109, DOI 10.1016/j.vaccine.2013.01.059; Ruckinger S, 2010, VACCINE, V28, P5012, DOI 10.1016/j.vaccine.2010.05.021; Ruckinger S, 2009, VACCINE, V27, P4136, DOI 10.1016/j.vaccine.2009.04.057; Schmitt HJ, 2003, LANCET INFECT DIS, V3, P103, DOI 10.1016/S1473-3099(03)00519-X; Standige Impfkommission (STIKO), 2006, EPIDEMIOL B, P255; Standige Impfkommission (STIKO), 2015, EPIDEMIOL B, P339; Steens A, 2013, VACCINE, V31, P6232, DOI 10.1016/j.vaccine.2013.10.032; Theidel U, 2013, GESUNDHEITSWESEN, V75, P309, DOI 10.1055/s-0032-1321747; van der Linden M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131494; van der Linden M, 2015, EUR J PEDIATR, V174, P355, DOI 10.1007/s00431-014-2409-0; Vittinghoff E, 2007, AM J EPIDEMIOL, V165, P710, DOI 10.1093/aje/kwk052; Weiss S, 2015, EUROSURVEILLANCE, V20, DOI 10.2807/1560-7917.ES2015.20.10.21057	26	55	60	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2016	11	8							e0161257	10.1371/journal.pone.0161257	http://dx.doi.org/10.1371/journal.pone.0161257			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4SL	27526117	Green Published, gold			2022-12-27	WOS:000381471100048
J	Lange, N; Tontsa, AT; Wegscheid, C; Mkounga, P; Nkengfack, AE; Loscher, C; Sass, G; Tiegs, G				Lange, Nicole; Tontsa, Armelle Tsamo; Wegscheid, Claudia; Mkounga, Pierre; Nkengfack, Augustin Ephrem; Loscher, Christine; Sass, Gabriele; Tiegs, Gisa			The Limonoids TS3 and Rubescin E Induce Apoptosis in Human Hepatoma Cell Lines and Interfere with NF-kappa B Signaling	PLOS ONE			English	Article							CASPASE-DEPENDENT APOPTOSIS; HEPATOCELLULAR-CARCINOMA; DOWN-REGULATION; CANCER; LIVER; EXPRESSION; NIMBOLIDE; GROWTH; PROTEINS; 5-FLUOROURACIL	Hepatocellular carcinoma (HCC) is extremely resistant towards pharmacological therapy. To date, the multi-kinase inhibitor Sorafenib is the only available therapeutic agent with the potential to prolong patient survival. Using the human hepatoma cell lines HepG2 and Huh7, we analyzed anti-cancer activities of 6 purified havanensin type limonoids isolated from the traditional African medicinal plant Trichilia rubescens Oliv. Our results show that two of the compounds, TR4 (TS3) and TR9 (Rubescin E) reduced hepatoma cell viability, but not primary hepatocyte viability, at TC50s of 5 to 10 mu M. These were significantly lower than the TC50s for Sorafenib, the histone deacetylase inhibitor SAHA or 5-Fluoruracil. In comparison, TR3 (Rubescin D), a limonoid isolated in parallel and structurally highly similar to TR4 and TR9, did not interfere with hepatoma cell viability. Both, TR4 and TR9, but not TR3, induced apoptosis in hepatoma cells and interfered with NF-kappa B activation. TR4 as well as TR9 significantly supported anti-cancer activities of Sorafenib. In summary, the limonoids TR4 and TR9 exhibit anti-cancer activities and support Sorafenib effects in vitro, having the potential to support future HCC therapy.	[Lange, Nicole; Wegscheid, Claudia; Loscher, Christine; Sass, Gabriele; Tiegs, Gisa] Univ Med Ctr Hamburg Eppendorf, Inst Expt Immunol & Hepatol, Hamburg, Germany; [Tontsa, Armelle Tsamo; Mkounga, Pierre; Nkengfack, Augustin Ephrem] Univ Yaounde I, Dept Organ Chem, POB 812, Yaounde, Cameroon; [Sass, Gabriele] Calif Inst Med Res, San Jose, CA 95128 USA	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Yaounde I	Tiegs, G (corresponding author), Univ Med Ctr Hamburg Eppendorf, Inst Expt Immunol & Hepatol, Hamburg, Germany.	g.tiegs@uke.de		Armelle, Tsamo Tontsa/0000-0001-5672-046X	Else-Kroner-Fresenius-Stiftung, Bad Homburg, Germany [2013_A199]	Else-Kroner-Fresenius-Stiftung, Bad Homburg, Germany	This work was supported by Else-Kroner-Fresenius-Stiftung, Bad Homburg, Germany, Grant No 2013_A199 (www.ekfs.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADEN DP, 1979, NATURE, V282, P615, DOI 10.1038/282615a0; Alao JP, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-24; Armelle TT PN, 2016, MED CHEM; Babykutty S, 2012, MOL CARCINOGEN, V51, P475, DOI 10.1002/mc.20812; Balsells J, 1996, BRIT J SURG, V83, P758, DOI 10.1002/bjs.1800830610; Busia K, 2005, PHYTOTHER RES, V19, P919, DOI 10.1002/ptr.1775; Cauchy F, 2012, LANGENBECK ARCH SURG, V397, P681, DOI 10.1007/s00423-012-0911-2; CHAMPAGNE DE, 1992, PHYTOCHEMISTRY, V31, P377, DOI 10.1016/0031-9422(92)90003-9; Cheng AL, 2009, LANCET ONCOL, V10, P25, DOI 10.1016/S1470-2045(08)70285-7; DARLINGTON GJ, 1980, J NATL CANCER I, V64, P809; deCarvalho ACV, 2002, MOL MED, V8, P75, DOI 10.1007/BF03402077; Elumalai P, 2012, TOXICOL LETT, V215, P131, DOI 10.1016/j.toxlet.2012.10.008; Finnin MS, 1999, NATURE, V401, P188, DOI 10.1038/43710; Fong YM, 1999, ANN SURG, V229, P790, DOI 10.1097/00000658-199906000-00005; Gonzalez-Vallinas M, 2013, NUTR REV, V71, P585, DOI 10.1111/nure.12051; Gouvea CF, 2008, ANN BOT-LONDON, V101, P39, DOI 10.1093/aob/mcm279; Gupta SC, 2011, J BIOL CHEM, V286, P1134, DOI 10.1074/jbc.M110.191379; Gupta SC, 2010, J BIOL CHEM, V285, P35406, DOI 10.1074/jbc.M110.161984; Hirchaud F, 2013, PLANTA MED, V79, P1628, DOI 10.1055/s-0033-1350956; Huang XH, 2014, ONCOTARGET, V5, P5570, DOI 10.18632/oncotarget.2141; Johnson PJ, 2002, GUT, V51, P459, DOI 10.1136/gut.51.4.459; Joshi P, 2014, STEROIDS, V79, P19, DOI 10.1016/j.steroids.2013.10.008; Karou Simplice D, 2011, Pak J Biol Sci, V14, P149, DOI 10.3923/pjbs.2011.149.169; Kavitha K, 2012, EUR J PHARMACOL, V681, P6, DOI 10.1016/j.ejphar.2012.01.024; Krief S, 2004, ANTIMICROB AGENTS CH, V48, P3196, DOI 10.1128/AAC.48.8.3196-3199.2004; Lee HH, 1999, P NATL ACAD SCI USA, V96, P9136, DOI 10.1073/pnas.96.16.9136; Li Y, 2013, TOXICOL APPL PHARM, V272, P37, DOI 10.1016/j.taap.2013.05.031; Liu ZL, 2014, J INTEGR MED-JIM, V12, P346, DOI 10.1016/S2095-4964(14)60034-0; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Longley DB, 2003, NAT REV CANCER, V3, P330, DOI 10.1038/nrc1074; Louppe D., 2008, Bois d'oeuvre 1; Luedde T, 2011, NAT REV GASTRO HEPAT, V8, P108, DOI 10.1038/nrgastro.2010.213; Mann BS, 2007, CLIN CANCER RES, V13, P2318, DOI 10.1158/1078-0432.CCR-06-2672; Mehnert JM, 2007, CANCER J, V13, P23, DOI 10.1097/PPO.0b013e31803c72ba; Mulholland DA, 2000, CURR ORG CHEM, V4, P1011, DOI 10.2174/1385272003375941; NAKABAYASHI H, 1982, CANCER RES, V42, P3858; Nakatani M., 2004, LIMONOIDS MELIACEAE; Nishiumi Shin, 2011, Front Biosci (Schol Ed), V3, P1332; Nowak AK, 2004, EUR J CANCER, V40, P1474, DOI 10.1016/j.ejca.2004.02.027; Ocker M, 2005, J CANCER RES CLIN, V131, P385, DOI 10.1007/s00432-004-0664-6; Ozturk S, 2012, EXP CELL RES, V318, P1324, DOI 10.1016/j.yexcr.2012.01.019; Ortiz LMG, 2014, MOLECULES, V19, P12349, DOI 10.3390/molecules190812349; Parkin DM, 2001, INT J CANCER, V94, P153, DOI 10.1002/ijc.1440; Pratheeshkumar P, 2012, INTEGR CANCER THER, V11, P48, DOI 10.1177/1534735411403307; Premratanachai Pongsathon, 2014, Asian Pacific Journal of Tropical Biomedicine, V4, P337, DOI 10.12980/APJTB.4.2014C1262; Sass G, 2007, J IMMUNOL, V179, P7042, DOI 10.4049/jimmunol.179.10.7042; SEGLEN PO, 1973, EXP CELL RES, V82, P391, DOI 10.1016/0014-4827(73)90357-1; Shirley S, 2013, CANCER LETT, V332, P141, DOI 10.1016/j.canlet.2010.10.009; Sieber S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029993; Tian QG, 2001, NUTR CANCER, V40, P180, DOI 10.1207/S15327914NC402_15; Tsai SC, 2012, INT J ONCOL, V41, P1431, DOI 10.3892/ijo.2012.1579; Tsamo TA MP, 2013, CHEM PHARM BULL, V61, P1; Uddin SJ, 2007, PHYTOTHER RES, V21, P757, DOI 10.1002/ptr.2159; Venturelli S, 2007, CANCER, V109, P2132, DOI 10.1002/cncr.22652; Wullaert A, 2007, ENDOCR REV, V28, P365, DOI 10.1210/er.2006-0031; Yamashita T, 2011, ONCOLOGY-BASEL, V81, P281, DOI 10.1159/000334439; Yip KW, 2008, ONCOGENE, V27, P6398, DOI 10.1038/onc.2008.307; Zhang HP, 2007, PHYTOTHER RES, V21, P731, DOI 10.1002/ptr.2148; Zhang LY, 2010, HEPATOLOGY, V51, P690, DOI 10.1002/hep.23384; Zhou J, 2014, J TRADIT CHIN MED, V34, P100, DOI 10.1016/S0254-6272(14)60062-5	60	7	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2016	11	8							e0160843	10.1371/journal.pone.0160843	http://dx.doi.org/10.1371/journal.pone.0160843			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3LI	27518192	Green Submitted, Green Published, gold			2022-12-27	WOS:000381382100027
J	Scholte, M; Neeleman-van der Steen, CWM; van der Wees, PJ; Nijhuis-van der Sanden, MWG; Braspenning, J				Scholte, Marijn; Neeleman-van der Steen, Catherina W. M.; van der Wees, Philip J.; Nijhuis-van der Sanden, Maria W. G.; Braspenning, Joze			The Reasons behind the (Non)Use of Feedback Reports for Quality Improvement in Physical Therapy: A Mixed-Method Study	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; PRIMARY-CARE; INTRINSIC MOTIVATION; HEALTH-CARE; OF-CARE; IMPACT; CIRCLES	Objectives To explain the use of feedback reports for quality improvements by the reasons to participate in quality measuring projects and to identify barriers and facilitators. Design Mixed methods design. Methods In 2009-2011 a national audit and feedback system for physical therapy (Qualiphy) was initiated in the Netherlands. After each data collection round, an evaluation survey was held amongst its participants. The evaluation survey data was used to explain the use of feedback reports by studying the reasons to participate with Qualiphy with correlation measures and logistic regression. Semi-structured interviews with PTs served to seek confirmation and disentangle barriers and facilitators. Results Analysis of 257 surveys (response rate: 42.8%) showed that therapists with only financial reasons were less likely to use feedback reports (OR = 0.24; 95% CI = 0.11-0.52) compared to therapists with a mixture of reasons. PTs in 2009 and 2010 were more likely to use the feedback reports for quality improvement than PTs in 2011 (OR = 2.41; 95% CI = 1.25-4.64 respectively OR = 3.28; 95% CI = 1.51-7.10). Changing circumstances in 2011, i. e. using EHRs and financial incentives, had a negative effect on the use of feedback reports (OR = 0.40, 95% CI = 0.20-0.78). Interviews with 12 physical therapists showed that feedback reports could serve as a tool to support and structure quality improvement plans. Barriers were distrust and perceived self-reporting bias on indicator scores. Conclusions Implementing financial incentives that are not well-specified and well-targeted can have an adverse effect on using feedback reports to improve quality of care. Distrust is a major barrier to implementing quality systems.	[Scholte, Marijn; van der Wees, Philip J.; Nijhuis-van der Sanden, Maria W. G.; Braspenning, Joze] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Hlth Sci, Sci Inst Qual Healthcare, Nijmegen, Netherlands; [Neeleman-van der Steen, Catherina W. M.] ROS Caransscoop, Beekbergen, Netherlands; [Scholte, Marijn] Radboud Univ Nijmegen, Dept Social Sci, Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen	Scholte, M (corresponding author), Radboud Univ Nijmegen, Med Ctr, Radboud Inst Hlth Sci, Sci Inst Qual Healthcare, Nijmegen, Netherlands.; Scholte, M (corresponding author), Radboud Univ Nijmegen, Dept Social Sci, Nijmegen, Netherlands.	m.scholte@maw.ru.nl	van der Wees, Philip Jan/L-4748-2015; der Sanden, Maria WG Nijhuis-van/B-3463-2012; Braspenning, Jozé/AAG-7612-2021; Braspenning, Jozé CC/D-4268-2009	der Sanden, Maria WG Nijhuis-van/0000-0003-2637-6877; Braspenning, Jozé/0000-0003-0800-0630; Braspenning, Jozé CC/0000-0003-0800-0630				Beyer M, 2003, FAM PRACT, V20, P443, DOI 10.1093/fampra/cmg420; Bijlsma-Frankema K, 2005, INT SOCIOL, V20, P259, DOI 10.1177/0268580905055477; Chassin MR, 2010, NEW ENGL J MED, V363, P683, DOI 10.1056/NEJMsb1002320; Christianson JB, 2008, MED CARE RES REV, V65, p5S, DOI 10.1177/1077558708324236; Deci EL, 1985, INTRINSIC MOTIVATION; Dekker HC, 2004, ACCOUNT ORG SOC, V29, P27, DOI 10.1016/S0361-3682(02)00056-9; Friedberg MW, 2011, J GEN INTERN MED, V26, P498, DOI 10.1007/s11606-010-1597-1; Fung CH, 2008, ANN INTERN MED, V148, P111, DOI 10.7326/0003-4819-148-2-200801150-00006; Geissler KH, 2013, MED CARE RES REV, V70, P621, DOI 10.1177/1077558713496319; Giuffrida A, 2000, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858; Gneezy U, 2011, J ECON PERSPECT, V25, P191, DOI 10.1257/jep.25.4.191; Gosden T, 2000, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD002215; Grimshaw JM, 2004, HEALTH TECHNOL ASSES, V8, P1, DOI 10.3310/hta8060; Grol R, 2011, IMPROVING PATIENT CA; Grol R, 1995, BR J GEN PRACT, V5, P506; Ivers N, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000259.pub3; Kaplan HC, 2012, BMJ QUAL SAF, V21, P13, DOI 10.1136/bmjqs-2011-000010; Kiefe CI, 2001, JAMA-J AM MED ASSOC, V285, P2871, DOI 10.1001/jama.285.22.2871; Kirschner K, 2010, QUAL SAF HEALTH CARE, V19, P248, DOI 10.1136/qshc.2008.031526; Marshall MN, 2004, INT J QUAL HEALTH C, V16, pI57, DOI 10.1093/intqhc/mzh013; Neeleman-van der Steen CWM, 2009, PRESTATIE INDICATORE; Palinkas LA, 2011, ADM POLICY MENT HLTH, V38, P44, DOI 10.1007/s10488-010-0314-z; Pope C, 2000, BMJ-BRIT MED J, V320, P114, DOI 10.1136/bmj.320.7227.114; Promberger M, 2013, HEALTH PSYCHOL, V32, P950, DOI 10.1037/a0032727; Rasbash J, 2009, USERS GUIDE MLWIN V2, V2, P10; Ryan RM, 2000, AM PSYCHOL, V55, P68, DOI 10.1037/0003-066X.55.1.68; Schneider A, 2008, J EVAL CLIN PRACT, V14, P185, DOI 10.1111/j.1365-2753.2007.00827.x; Scholte M, 2014, INT J QUAL HEALTH C, V26, P261, DOI 10.1093/intqhc/mzu031; Scott A, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008451.pub2; Smith MA, 2012, HEALTH AFFAIR, V31, P570, DOI 10.1377/hlthaff.2011.0853; Wensing M, 2004, J EVAL CLIN PRACT, V10, P457, DOI 10.1111/j.1365-2753.2004.00517.x; Wensing M, 2009, PHARMACOEPIDEM DR S, V18, P763, DOI 10.1002/pds.1778	32	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2016	11	8							e0161056	10.1371/journal.pone.0161056	http://dx.doi.org/10.1371/journal.pone.0161056			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DT3LI	27518113	Green Published, Green Submitted, gold			2022-12-27	WOS:000381382100040
J	Zahin, M; Joh, J; Khanal, S; Husk, A; Mason, H; Warzecha, H; Ghim, SJ; Miller, DM; Matoba, N; Jenson, AB				Zahin, Maryam; Joh, Joongho; Khanal, Sujita; Husk, Adam; Mason, Hugh; Warzecha, Heribert; Ghim, Shin-je; Miller, Donald M.; Matoba, Nobuyuki; Jenson, Alfred Bennett			Scalable Production of HPV16 L1 Protein and VLPs from Tobacco Leaves	PLOS ONE			English	Article							VIRUS-LIKE PARTICLES; CAPSID PROTEIN; PAPILLOMAVIRUS; EXPRESSION; VACCINES; PLANTS; EPITOPES; BIOPHARMACEUTICALS; GENE; STEP	Cervical cancer is the most common malignancy among women particularly in developing countries, with human papillomavirus (HPV) 16 causing 50% of invasive cervical cancers. A plant-based HPV vaccine is an alternative to the currently available virus-like particle (VLP) vaccines, and would be much less expensive. We optimized methods to express HPV16 L1 protein and purify VLPs from tobacco (Nicotiana benthamiana) leaves transfected with the magnICON deconstructed viral vector expression system. L1 proteins were extracted from agro-infiltrated leaves using a series of pH and salt mediated buffers. Expression levels of L1 proteins and VLPs were verified by immunoblot and ELISA, which confirmed the presence of sequential and conformational epitopes, respectively. Among three constructs tested (16L1d22, TPL1d22, and TPL1F), TPL1F, containing a full-length L1 and chloroplast transit peptide, was best. Extraction of HPV16 L1 from leaf tissue was most efficient (> 2.5% of total soluble protein) with a low-salt phosphate buffer. VLPs were purified using both cesium chloride (CsCl) density gradient and size exclusion chromatography. Electron microscopy studies confirmed the presence of assembled forms of HPV16 L1 VLPs. Collectively; our results indicated that chloroplast-targeted transient expression in tobacco plants is promising for the production of a cheap, efficacious HPV16 L1 VLP vaccine. Studies are underway to develop plant VLPs for the production of a cervical cancer vaccine.	[Zahin, Maryam; Joh, Joongho; Khanal, Sujita; Husk, Adam; Ghim, Shin-je; Miller, Donald M.; Matoba, Nobuyuki; Jenson, Alfred Bennett] Univ Louisville, James Graham Brown Canc Ctr, Louisville, KY 40292 USA; [Joh, Joongho; Miller, Donald M.] Univ Louisville, Dept Med, Louisville, KY 40292 USA; [Khanal, Sujita] Univ Louisville, Dept Biochem & Mol Genet, Louisville, KY 40292 USA; [Husk, Adam; Matoba, Nobuyuki] Owensboro Canc Res Program, Owensboro, KY USA; [Mason, Hugh] Arizona State Univ, Biodesign Inst, Tempe, AZ USA; [Mason, Hugh] Arizona State Univ, Sch Life Sci, Tempe, AZ USA; [Warzecha, Heribert] Tech Univ Darmstadt, Plant Biotechnol & Metab Engn, Schnittspahnstr 3-5, D-64287 Darmstadt, Germany; [Matoba, Nobuyuki] Univ Louisville, Dept Pharmacol & Toxicol, Louisville, KY 40292 USA	University of Louisville; University of Louisville; University of Louisville; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; Technical University of Darmstadt; University of Louisville	Joh, J (corresponding author), Univ Louisville, James Graham Brown Canc Ctr, Louisville, KY 40292 USA.; Joh, J (corresponding author), Univ Louisville, Dept Med, Louisville, KY 40292 USA.	j0joh001@louisville.edu		Matoba, Nobuyuki/0000-0001-7231-3004	Helmsley Trust Foundation; James Graham Brown Cancer Center, School of Medicine, University of Louisville	Helmsley Trust Foundation; James Graham Brown Cancer Center, School of Medicine, University of Louisville	This study was supported by Helmsley Trust Foundation and James Graham Brown Cancer Center, School of Medicine, University of Louisville to MZ, JJ and ABJ.; This study was supported by Helmsley Trust Foundation and James Graham Brown Cancer Center, School of Medicine, University of Louisville to MZ, JJ and ABJ. We thank M. Clarke Miller, University of North Georgia, Georgia for his help with the chromatographic purification of HPV16 VLPs from tobacco plants. We would also like to thank ICON genetics GmbH, Germany for providing us the (pICH26212) vector.	Ahmad I, 2008, DRUG FUTURE, V33, P329, DOI 10.1358/dof.2008.033.04.1186159; Baldauf KJ, 2015, TOXINS, V7, P974, DOI 10.3390/toxins7030974; Biemelt S, 2003, J VIROL, V77, P9211, DOI 10.1128/JVI.77.17.9211-9220.2003; Chebolu S, 2009, CURR TOP MICROBIOL, V332, P33, DOI 10.1007/978-3-540-70868-1_3; Chen Q, 2013, HUM VACC IMMUNOTHER, V9, P26, DOI 10.4161/hv.22218; Chen XJS, 2000, MOL CELL, V5, P557, DOI 10.1016/S1097-2765(00)80449-9; CHRISTENSEN ND, 1994, VIROLOGY, V205, P329, DOI 10.1006/viro.1994.1649; GHIM SJ, 1992, VIROLOGY, V190, P548, DOI 10.1016/0042-6822(92)91251-O; Hefferon K, 2013, BIOTECHNOL J, V8, P1193, DOI 10.1002/biot.201300162; HINES JF, 1994, GYNECOL ONCOL, V55, P13, DOI 10.1006/gyno.1994.1239; Joh J, 2012, EXP MOL PATHOL, V93, P416, DOI 10.1016/j.yexmp.2012.07.001; Kessans SA, 2013, PLANT BIOTECHNOL J, V11, P681, DOI 10.1111/pbi.12058; Kim HJ, 2010, PROTEIN EXPRES PURIF, V70, P68, DOI 10.1016/j.pep.2009.08.005; Knappe M, 2007, J BIOL CHEM, V282, P27913, DOI 10.1074/jbc.M705127200; Komarova TV, 2010, EXPERT REV VACCINES, V9, P859, DOI [10.1586/erv.10.85, 10.1586/ERV.10.85]; Lenzi P, 2008, TRANSGENIC RES, V17, P1091, DOI 10.1007/s11248-008-9186-3; Liu HL, 2005, ACTA BIOCH BIOPH SIN, V37, P153, DOI 10.1093/abbs/37.3.153; Lossl AG, 2011, PLANT BIOTECHNOL J, V9, P527, DOI 10.1111/j.1467-7652.2011.00615.x; Ma JKC, 2003, NAT REV GENET, V4, P794, DOI 10.1038/nrg1177; Maclean J, 2007, J GEN VIROL, V88, P1460, DOI 10.1099/vir.0.82718-0; Maliga P, 2002, CURR OPIN PLANT BIOL, V5, P164, DOI 10.1016/S1369-5266(02)00248-0; Mason HS, 1998, VACCINE, V16, P1336, DOI 10.1016/S0264-410X(98)80020-0; Millan AFS, 2008, PLANT BIOTECHNOL J, V6, P427, DOI 10.1111/j.1467-7652.2008.00338.x; Millan AFS, 2007, J BIOTECHNOL, V127, P593, DOI 10.1016/j.jbiotec.2006.08.010; Neeper MP, 1996, GENE, V180, P1, DOI 10.1016/S0378-1119(96)00388-5; Olcese VA, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-29; Rybicki EP, 2014, VIROL J, V11, DOI 10.1186/s12985-014-0205-0; Shen W. J., 1989, NUCLEIC ACIDS RES, V25, P83; Shi L, 2005, J PHARM SCI-US, V94, P1538, DOI 10.1002/jps.20377; Stanley M, 2008, BRIT MED BULL, V88, P59, DOI 10.1093/bmb/ldn037; Waheed MT, 2011, TRANSGENIC RES, V20, P271, DOI 10.1007/s11248-010-9415-4; Waheed MT, 2011, PLANT BIOTECHNOL J, V9, P651, DOI 10.1111/j.1467-7652.2011.00612.x; Warzecha H, 2003, J VIROL, V77, P8702, DOI 10.1128/JVI.77.16.8702-8711.2003; Wu Xiaocheng, 2012, Morbidity and Mortality Weekly Report, V61, P258	34	19	24	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2016	11	8							e0160995	10.1371/journal.pone.0160995	http://dx.doi.org/10.1371/journal.pone.0160995			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3LI	27518899	Green Published, Green Submitted, gold			2022-12-27	WOS:000381382100033
J	Perez, C; Perez-Zuniga, FJ; Garrido, F; Reytor, E; Portillo, F; Pajares, MA				Perez, Claudia; Perez-Zuniga, Francisco J.; Garrido, Francisco; Reytor, Edel; Portillo, Francisco; Pajares, Maria A.			The Oncogene PDRG1 Is an Interaction Target of Methionine Adenosyltransferases	PLOS ONE			English	Article							S-ADENOSYLMETHIONINE SYNTHETASE; IMPAIRED LIVER-REGENERATION; CRYSTAL-STRUCTURES; GENE-EXPRESSION; CANCER; GROWTH; MICE; METHYLATION; INJURY; METABOLISM	Methionine adenosyltransferases MAT I and MAT III (encoded by Mat1a) catalyze S-adenosylmethionine synthesis in normal liver. Major hepatic diseases concur with reduced levels of this essential methyl donor, which are primarily due to an expression switch from Mat1a towards Mat2a. Additional changes in the association state and even in subcellular localization of these isoenzymes are also detected. All these alterations result in a reduced content of the moderate (MAT I) and high V-max] (MAT III) isoenzymes, whereas the low Vmax (MAT II) isoenzyme increases and nuclear accumulation of MAT I is observed. These changes derive in a reduced availability of cytoplasmic S-adenosylmethionine, together with an effort to meet its needs in the nucleus of damaged cells, rendering enhanced levels of certain epigenetic modifications. In this context, the putative role of protein-protein interactions in the control of S-adenosylmethionine synthesis has been scarcely studied. Using yeast two hybrid and a rat liver library we identified PDRG1 as an interaction target for MAT alpha 1 (catalytic subunit of MAT I and MAT III), further confirmation being obtained by immunoprecipitation and pull-down assays. Nuclear MAT alpha interacts physically and functionally with the PDRG1 oncogene, resulting in reduced DNA methylation levels. Increased Pdrg1 expression is detected in acute liver injury and hepatoma cells, together with decreased Mat1a expression and nuclear accumulation of MATa1. Silencing of Pdrg1 expression in hepatoma cells alters their steady-state expression profile on microarrays, downregulating genes associated with tumor progression according to GO pathway analysis. Altogether, the results unveil the role of PDRG1 in the control of the nuclear methylation status through methionine adenosyltransferase binding and its putative collaboration in the progression of hepatic diseases.	[Perez, Claudia; Perez-Zuniga, Francisco J.; Garrido, Francisco; Reytor, Edel; Portillo, Francisco; Pajares, Maria A.] CSIC UAM, Inst Invest Biomed Alberto Sols, Arturo Duperier 4, Madrid 28029, Spain; [Portillo, Francisco; Pajares, Maria A.] Inst Invest Sanitaria La Paz IdiPAZ, Paseo Castellana 261, Madrid 28046, Spain; [Portillo, Francisco] Univ Autonoma Madrid, Fac Med, Dept Bioquim, Arzobispo Morcillo 4, E-28029 Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); Autonomous University of Madrid	Pajares, MA (corresponding author), CSIC UAM, Inst Invest Biomed Alberto Sols, Arturo Duperier 4, Madrid 28029, Spain.; Pajares, MA (corresponding author), Inst Invest Sanitaria La Paz IdiPAZ, Paseo Castellana 261, Madrid 28046, Spain.	mapajares@iib.uam.es	Pajares, Maria Angeles/I-5952-2012	Pajares, Maria Angeles/0000-0002-4714-9051; Portillo Perez, Francisco/0000-0003-4922-346X	RCMN [C03/08, PI05/056]; Ministerio de Economia y Competitividad [BFU2005-00050, BFU2008-00666, BFU2009-08977]; Institute de Salud Carlos III (RCMN) [C03/08, PI05/0563]	RCMN; Ministerio de Economia y Competitividad(Spanish Government); Institute de Salud Carlos III (RCMN)(Instituto de Salud Carlos III)	CP was a postdoctoral fellow of the UNAM-CSIC program and ER was supported by RCMN C03/08 and PI05/056. This work was supported by grants of the Ministerio de Economia y Competitividad (BFU2005-00050, BFU2008-00666, BFU2009-08977), and the Institute de Salud Carlos III (RCMN C03/08 and PI05/0563). The authors declare that there are no competing interests. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	ALVAREZ L, 1994, BIOCHEM J, V301, P557, DOI 10.1042/bj3010557; Ansorena E, 2002, HEPATOLOGY, V35, P274, DOI 10.1053/jhep.2002.30419; Antonov AV, 2011, NUCLEIC ACIDS RES, V39, pW323, DOI 10.1093/nar/gkr372; Avila MA, 2000, J HEPATOL, V33, P907, DOI 10.1016/S0168-8278(00)80122-1; Avila MA, 1998, BIOFACTORS, V8, P27, DOI 10.1002/biof.5520080106; Avila MA, 1997, HEPATOLOGY, V25, P391; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boulon S, 2010, MOL CELL, V39, P912, DOI 10.1016/j.molcel.2010.08.023; CABRERO C, 1988, HEPATOLOGY, V8, P1530, DOI 10.1002/hep.1840080610; CANTONI GL, 1975, ANNU REV BIOCHEM, V44, P435, DOI 10.1146/annurev.bi.44.070175.002251; Chen LX, 2004, FASEB J, V18, P914, DOI 10.1096/fj.03-1204fje; Chen NC, 2010, FASEB J, V24, P2804, DOI 10.1096/fj.09-143651; CHRISTMAN JK, 1980, J CELL BIOL, V86, P366, DOI 10.1083/jcb.86.2.366; CORRALES F, 1991, HEPATOLOGY, V14, P528, DOI 10.1002/hep.1840140320; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Delgado M, 2008, CELL MOL LIFE SCI, V65, P2080, DOI 10.1007/s00018-008-8201-4; Delgado M, 2014, ANTIOXID REDOX SIGN, V20, P2541, DOI 10.1089/ars.2013.5342; Derfoul A, 2011, CARCINOGENESIS, V32, P1607, DOI 10.1093/carcin/bgr184; Feinberg AP, 2004, NAT REV CANCER, V4, P143, DOI 10.1038/nrc1279; GILLIES RJ, 1986, ANAL BIOCHEM, V159, P109, DOI 10.1016/0003-2697(86)90314-3; Gonzalez B, 2000, J MOL BIOL, V300, P363, DOI 10.1006/jmbi.2000.3858; Gonzalez B, 2003, BIOCHEM J, V370, P945, DOI 10.1042/BJ20021510; Gonzalez B, 2003, J MOL BIOL, V331, P407, DOI 10.1016/s0022-2836(03)00728-9; Gonzalez B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050329; Halim AB, 1999, J BIOL CHEM, V274, P29720, DOI 10.1074/jbc.274.42.29720; Jeronimo C, 2007, MOL CELL, V27, P262, DOI 10.1016/j.molcel.2007.06.027; Jiang LY, 2011, CANCER BIOL THER, V11, P567, DOI 10.4161/cbt.11.6.14412; Katoh Y, 2011, MOL CELL, V41, P554, DOI 10.1016/j.molcel.2011.02.018; Kebebew E, 2004, J CLIN ENDOCR METAB, V89, P6105, DOI 10.1210/jc.2004-1234; LeGros HL, 2000, J BIOL CHEM, V275, P2359, DOI 10.1074/jbc.275.4.2359; LeGros L, 2001, J BIOL CHEM, V276, P24918, DOI 10.1074/jbc.M102816200; Liu SP, 2007, HEPATOLOGY, V46, P1413, DOI 10.1002/hep.21863; Lu SC, 2001, P NATL ACAD SCI USA, V98, P5560, DOI 10.1073/pnas.091016398; Lu SC, 2012, PHYSIOL REV, V92, P1515, DOI 10.1152/physrev.00047.2011; Luo XQ, 2003, ONCOGENE, V22, P7247, DOI 10.1038/sj.onc.1207010; Markham GD, 2009, CELL MOL LIFE SCI, V66, P636, DOI 10.1007/s00018-008-8516-1; Martin-Benito J, 2002, EMBO J, V21, P6377, DOI 10.1093/emboj/cdf640; Martinez-Chantar ML, 2008, HEPATOLOGY, V47, P1191, DOI 10.1002/hep.22159; Martinez-Chantar ML, 2002, FASEB J, V16, P1292, DOI 10.1096/fj.02-0078fje; Martinez-Chantar ML, 2000, EUR J BIOCHEM, V267, P132, DOI 10.1046/j.1432-1327.2000.00974.x; Martinez-Una M, 2015, J HEPATOL, V62, P673, DOI 10.1016/j.jhep.2014.10.019; Martinez-Una M, 2013, HEPATOLOGY, V58, P1296, DOI 10.1002/hep.26399; MartinezChantar ML, 1996, FEBS LETT, V397, P293, DOI 10.1016/S0014-5793(96)01201-X; Mato JM, 1997, PHARMACOL THERAPEUT, V73, P265, DOI 10.1016/S0163-7258(96)00197-0; Mingorance J, 1996, BIOCHEM J, V315, P761, DOI 10.1042/bj3150761; Mita P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063879; Miyato H, 2012, CANCER SCI, V103, P1961, DOI 10.1111/cas.12003; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; PAJARES MA, 1992, J BIOL CHEM, V267, P17598; Pajares MA, 2013, FEBS LETT, V587, P1711, DOI 10.1016/j.febslet.2013.04.034; Pajares Maria A, 2011, Adv Enzymol Relat Areas Mol Biol, V78, P449; Peng H, 2015, AM J PATHOL, V185, P1135, DOI 10.1016/j.ajpath.2014.12.016; Peng H, 2013, HEPATOLOGY, V57, P2299, DOI 10.1002/hep.26258; Petrossian TC, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.000976; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Reytor E, 2009, FASEB J, V23, P3347, DOI 10.1096/fj.09-130187; Saigusa S, 2012, ONCOL REP, V28, P855, DOI 10.3892/or.2012.1863; Sanchez-Perez GF, 2004, J MOL BIOL, V335, P693, DOI 10.1016/j.jmb.2003.11.022; Sanchez-Perez GF, 2003, J BIOL CHEM, V278, P7285, DOI 10.1074/jbc.M210177200; SanchezGongora E, 1996, BIOCHEM J, V319, P767, DOI 10.1042/bj3190767; Sardiu ME, 2008, P NATL ACAD SCI USA, V105, P1454, DOI 10.1073/pnas.0706983105; Schroder PC, 2011, FUNCT INTEGR GENOMIC, V11, P419, DOI 10.1007/s10142-011-0230-7; Shafqat N, 2013, BIOCHEM J, V452, P27, DOI 10.1042/BJ20121580; Shilatifard A, 2006, ANNU REV BIOCHEM, V75, P243, DOI 10.1146/annurev.biochem.75.103004.142422; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Tolwani RJ, 2005, PLOS GENET, V1, P205, DOI 10.1371/journal.pgen.0010023; Torres L, 2000, INT J BIOCHEM CELL B, V32, P397, DOI 10.1016/S1357-2725(99)00140-5; Vainberg IE, 1998, CELL, V93, P863, DOI 10.1016/S0092-8674(00)81446-4; Varela-Rey M, 2009, HEPATOLOGY, V50, P443, DOI 10.1002/hep.23033; Vire E, 2006, NATURE, V439, P871, DOI 10.1038/nature04431; [王俊岭 Wang Junling], 2015, [环境工程, Environment Engineering], V33, P1; Wei ZW, 2015, CANCER LETT, V359, P335, DOI 10.1016/j.canlet.2015.01.033; Welch MD, 2013, BRIT J HAEMATOL, V162, P537, DOI 10.1111/bjh.12417; Yang HP, 2008, GASTROENTEROLOGY, V134, P281, DOI 10.1053/j.gastro.2007.10.027; Yang HP, 2013, J BIOL CHEM, V288, P23161, DOI 10.1074/jbc.M113.487157; Yang HP, 2013, J CLIN INVEST, V123, P285, DOI 10.1172/JCI63861	77	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2016	11	8							e0161672	10.1371/journal.pone.0161672	http://dx.doi.org/10.1371/journal.pone.0161672			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT8TP	27548429	Green Published, Green Submitted, gold			2022-12-27	WOS:000381768400076
J	Torkamaneh, D; Laroche, J; Belzile, F				Torkamaneh, Davoud; Laroche, Jerome; Belzile, Francois			Genome-Wide SNP Calling from Genotyping by Sequencing (GBS) Data: A Comparison of Seven Pipelines and Two Sequencing Technologies	PLOS ONE			English	Article							RAD MARKERS; DISCOVERY	Next-generation sequencing (NGS) has revolutionized plant and animal research in many ways including new methods of high throughput genotyping. Genotyping-by-sequencing (GBS) has been demonstrated to be a robust and cost-effective genotyping method capable of producing thousands to millions of SNPs across a wide range of species. Undoubtedly, the greatest barrier to its broader use is the challenge of data analysis. Herein we describe a comprehensive comparison of seven GBS bioinformatics pipelines developed to process raw GBS sequence data into SNP genotypes. We compared five pipelines requiring a reference genome (TASSEL-GBS v1&v2, Stacks, IGST, and Fast-GBS) and two de novo pipelines that do not require a reference genome (UNEAK and Stacks). Using Illumina sequence data from a set of 24 re-sequenced soybean lines, we performed SNP calling with these pipelines and compared the GBS SNP calls with the re-sequencing data to assess their accuracy. The number of SNPs called without a reference genome was lower (13k to 24k) than with a reference genome (25k to 54k SNPs) while accuracy was high (92.3 to 98.7%) for all but one pipeline (TASSEL-GBSv1, 76.1%). Among pipelines offering a high accuracy (> 95%), Fast-GBS called the greatest number of polymorphisms (close to 35,000 SNPs + Indels) and yielded the highest accuracy (98.7%). Using Ion Torrent sequence data for the same 24 lines, we compared the performance of Fast-GBS with that of TASSEL-GBSv2. It again called more polymorphisms (25.8K vs 22.9K) and these proved more accurate (95.2 vs 91.1%). Typically, SNP catalogues called from the same sequencing data using different pipelines resulted in highly overlapping SNP catalogues (79-92% overlap). In contrast, overlap between SNP catalogues obtained using the same pipeline but different sequencing technologies was less extensive (similar to 50-70%).	[Torkamaneh, Davoud; Belzile, Francois] Univ Laval, Dept Phytol, Quebec City, PQ, Canada; [Torkamaneh, Davoud; Laroche, Jerome; Belzile, Francois] Univ Laval, IBIS, Quebec City, PQ, Canada	Laval University; Laval University	Belzile, F (corresponding author), Univ Laval, Dept Phytol, Quebec City, PQ, Canada.; Belzile, F (corresponding author), Univ Laval, IBIS, Quebec City, PQ, Canada.	francois.belzile@fsaa.ulaval.ca		Torkamaneh, Davoud/0000-0002-9782-5695; Belzile, Francois/0000-0001-6893-4529	Agriculture and AgriFood Canada; Canadian Field Crop Research Alliance [AIP-CL23]	Agriculture and AgriFood Canada(Agriculture & Agri Food Canada); Canadian Field Crop Research Alliance	Funding for this research was provided by Agriculture and AgriFood Canada and the Canadian Field Crop Research Alliance (Grant no. AIP-CL23).	Andolfatto P, 2011, GENOME RES, V21, P610, DOI 10.1101/gr.115402.110; Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Catchen J, 2013, MOL ECOL, V22, P3124, DOI 10.1111/mec.12354; Danecek P., 2011, BIOINFORMATICS; Davey JW, 2011, NAT REV GENET, V12, P499, DOI 10.1038/nrg3012; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Glaubitz JC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090346; Herten K, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0514-3; Kumar S., 2012, INT J COMP APP IRAFI, V5, P1; Larson WA, 2014, EVOL APPL, V7, P355, DOI 10.1111/eva.12128; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lu F, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003215; Mascher M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076925; McCormack JE, 2013, MOL PHYLOGENET EVOL, V66, P526, DOI 10.1016/j.ympev.2011.12.007; Miller MR, 2007, GENOME RES, V17, P240, DOI 10.1101/gr.5681207; Nielsen R, 2011, NAT REV GENET, V12, P443, DOI 10.1038/nrg2986; Parchman TL, 2012, MOL ECOL, V21, P2991, DOI 10.1111/j.1365-294X.2012.05513.x; Peterson BK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037135; Poland JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032253; Rothberg JM, 2011, NATURE, V475, P348, DOI 10.1038/nature10242; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Sehgal D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132112; Sonah H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054603; Torkamaneh D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131533; Truong HT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037565; van Orsouw NJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001172	28	67	72	5	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2016	11	8							e0161333	10.1371/journal.pone.0161333	http://dx.doi.org/10.1371/journal.pone.0161333			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT8TP	27547936	Green Published, Green Submitted, gold			2022-12-27	WOS:000381768400045
J	Mannan, T; Ahmed, S; Akhtar, E; Roy, AK; Haq, MA; Roy, A; Kippler, M; Ekstrom, EC; Wagatsuma, Y; Raqib, R				Mannan, Tania; Ahmed, Sultan; Akhtar, Evana; Roy, Anjan Kumar; Haq, Md Ahsanul; Roy, Adity; Kippler, Maria; Ekstrom, Eva-Charlotte; Wagatsuma, Yukiko; Raqib, Rubhana			Maternal Micronutrient Supplementation and Long Term Health Impact in Children in Rural Bangladesh	PLOS ONE			English	Article							UTERO ARSENIC EXPOSURE; VITAMIN-A; PREGNANCY OUTCOMES; OXIDATIVE STRESS; AGED CHILDREN; ANEMIA; DETERMINANTS; ASSOCIATION; PREVALENCE; MORTALITY	Background Limited data is available on the role of prenatal nutritional status on the health of school-age children. We aimed to determine the impact of maternal micronutrient supplementation on the health status of Bangladeshi children. Methods Children (8.6-9.6 years; n = 540) were enrolled from a longitudinal mother-child cohort, where mothers were supplemented daily with either 30mg iron and 400 mu g folic acid (Fe30F), or 60mg iron and 400 mu g folic acid (Fe60F), or Fe30F including 15 micronutrients (MM), in rural Matlab. Blood was collected from children to determine the concentration of hemoglobin (Hb) and several micronutrients. Anthropometric and Hb data from these children were also available at 4.5 years of age and mothers at gestational week (GW) 14 and 30. Results MM supplementation significantly improved (p <= 0.05) body mass index-for-age z-score (BAZ), but not Hb levels, in 9 years old children compared to the Fe30F group. MM supplementation also reduced markers of inflammation (p <= 0.05). About 28%, 35% and 23% of the women were found to be anemic at GW14, GW30 and both time points, respectively. The prevalence of anemia was 5% and 15% in 4.5 and 9 years old children, respectively. The adjusted odds of having anemia in 9 year old children was 3-fold higher if their mothers were anemic at both GW14 and GW30 [ Odds Ratio (OR) = 3.05; 95% Confidence Interval (CI) 1.42, 6.14, P = 0.002] or even higher if they were also anemic at 4.5 years of age [OR = 5.92; 95% CI 2.64, 13.25; P<0.001]. Conclusion Maternal micronutrient supplementation imparted beneficial effects on child health. Anemia during pregnancy and early childhood are important risk factors for the occurrence of anemia in school-age children.	[Mannan, Tania; Ahmed, Sultan; Akhtar, Evana; Roy, Anjan Kumar; Haq, Md Ahsanul; Roy, Adity; Raqib, Rubhana] Icddr b, Div Infect Dis, Immunobiol Nutr & Toxicol Lab, Dhaka, Bangladesh; [Mannan, Tania] Bangladesh Univ Hlth Sci, Dept Immunol, Dhaka, Bangladesh; [Kippler, Maria] Karolinska Inst, Inst Environm Med, Stockholm, Sweden; [Ekstrom, Eva-Charlotte] Uppsala Univ, Dept Womens & Childrens Hlth, IMCH, Uppsala, Sweden; [Wagatsuma, Yukiko] Univ Tsukuba, Fac Med, Dept Clin Epidemiol, Tsukuba, Ibaraki, Japan	International Centre for Diarrhoeal Disease Research (ICDDR); Bangladesh University of Health Sciences (BUHS); Karolinska Institutet; Uppsala University; University of Tsukuba	Raqib, R (corresponding author), Icddr b, Div Infect Dis, Immunobiol Nutr & Toxicol Lab, Dhaka, Bangladesh.	rubhana@icddrb.org	Wagatsuma, Yukiko/AAE-5881-2020	Wagatsuma, Yukiko/0000-0002-8056-9998; Kippler, Maria/0000-0002-9010-9821; Haq, Ahsanul/0000-0002-4408-6104	Japan Society for the Promotion of Science (JSPS) [18256005]; Karolinska Institutet [00933]; icddrb [384, SWE-2008-065]; Government of the People's Republic of Bangladesh; Global Affairs Canada (GAC); Swedish International Development Cooperation Agency (Sida); Department for International Development, (UKAid)	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Karolinska Institutet(Karolinska Institutet); icddrb; Government of the People's Republic of Bangladesh; Global Affairs Canada (GAC)(CGIAR); Swedish International Development Cooperation Agency (Sida); Department for International Development, (UKAid)(CGIAR)	This work was supported by the Japan Society for the Promotion of Science (JSPS; Grant No. 18256005), Karolinska Institutet (Grant No. 00933), and icddrb (Grant 384, SWE-2008-065). icddr, b also gratefully acknowledges the following donors who provide unrestricted support: Government of the People's Republic of Bangladesh; Global Affairs Canada (GAC); Swedish International Development Cooperation Agency (Sida) and the Department for International Development, (UKAid).	Abioye AI, 2016, J NUTR, V146, P1162, DOI 10.3945/jn.115.225482; Ahmed S, 2014, TOXICOL SCI, V141, P166, DOI 10.1093/toxsci/kfu113; Ahmed S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081530; Ahmed S, 2012, TOXICOL SCI, V129, P305, DOI 10.1093/toxsci/kfs202; Ahmed S, 2011, ENVIRON HEALTH PERSP, V119, P258, DOI 10.1289/ehp.1002086; Akcam M, 2007, DIGEST DIS SCI, V52, P405, DOI 10.1007/s10620-006-9422-8; [Anonymous], 2001, WHO TECHN REP SER; [Anonymous], 2008, WORLDW PREV AN 1993; Capra L, 2013, ITAL J PEDIATR, V39, DOI 10.1186/1824-7288-39-7; de Onis M, 2007, B WORLD HEALTH ORGAN, V85, P660, DOI 10.2471/BLT.07.043497; Demirchyan A, 2016, PUBLIC HEALTH NUTR, V19, P1260, DOI 10.1017/S1368980015002451; Doi M, 2011, BRIT J NUTR, V106, P1398, DOI 10.1017/S0007114511001747; Faruque ASG, 2008, J HEALTH POPUL NUTR, V26, P325; GWATKIN DR, 2000, SOCIOECONOMIC DIFFER; Haider BA, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004905.pub4; Hawlader Mohammad D H, 2014, Trop Med Health, V42, P77, DOI 10.2149/tmh.2013-19; Hawlader MDH, 2014, PUBLIC HEALTH NUTR, V17, P1570, DOI 10.1017/S1368980013001262; Henriksson H, 2015, PREVALENCE ANEMIA IT; IZiNCG, 2007, ASS POP ZINC STAT SE; Janus J, 2010, AM FAM PHYSICIAN, V81, P1462; Khan AI, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-134; Khan JR, 2016, BMC PEDIATR, V16, DOI 10.1186/s12887-015-0536-z; Khavari N, 2014, INT HEALTH, V6, P298, DOI 10.1093/inthealth/ihu061; Kolbe-Busch S, 2002, CLIN CHEM LAB MED, V40, P529, DOI 10.1515/CCLM.2002.091; Lu WP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088496; Luo RF, 2011, J HEALTH POPUL NUTR, V29, P471; NCCLS, REF SEL PROC ER SED; NMS, 2013, NAT MICR STAT SURV 2; Ozaltin E, 2010, JAMA-J AM MED ASSOC, V303, P1507, DOI 10.1001/jama.2010.450; Palmer AC, 2015, NUTRITION, V31, P813, DOI 10.1016/j.nut.2014.11.016; Pasricha SR, 2010, PEDIATRICS, V126, pE140, DOI 10.1542/peds.2009-3108; Persson LA, 2012, JAMA-J AM MED ASSOC, V307, P2050, DOI 10.1001/jama.2012.4061; Raqib R, 2009, TOXICOL LETT, V185, P197, DOI 10.1016/j.toxlet.2009.01.001; Rosales FJ, 1999, J NUTR, V129, P1223, DOI 10.1093/jn/129.6.1223; Sanou D., 2012, RISK FACTORS ANEMIA; Sdogou T, 2015, J CLIN LAB ANAL, V29, P10, DOI 10.1002/jcla.21719; Semba RD, 2002, EUR J CLIN NUTR, V56, P271, DOI 10.1038/sj.ejcn.1601320; Shamim AA, 2013, PUBLIC HEALTH NUTR, V16, P1354, DOI 10.1017/S1368980013000475; Subramanian SV, 2009, JAMA-J AM MED ASSOC, V301, P1691, DOI 10.1001/jama.2009.548; WHO, 2011, WHO GLOBAL DATABASE; WHO, 2006, WHO CHILD GROWTH STA; World Health Organization, 2011, SER FERR CONC ASS IR; Zerfu TA, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-20; Zhao A, 2012, AM J TROP MED HYG, V87, P306, DOI 10.4269/ajtmh.2012.11-0660	44	11	11	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0161294	10.1371/journal.pone.0161294	http://dx.doi.org/10.1371/journal.pone.0161294			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27537051	gold, Green Published, Green Submitted			2022-12-27	WOS:000381577000083
J	Mekuria, Y; Yilma, D; Mekonnen, Z; Kassa, T; Gedefaw, L				Mekuria, Yewulsew; Yilma, Daniel; Mekonnen, Zeleke; Kassa, Tesfaye; Gedefaw, Lealem			Renal Function Impairment and Associated Factors among HAART Naive and Experienced Adult HIV Positive Individuals in Southwest Ethiopia: A Comparative Cross Sectional Study	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; HUMAN-IMMUNODEFICIENCY-VIRUS; CHRONIC KIDNEY-DISEASE; INFECTED PATIENTS; PREVALENCE; DYSFUNCTION; GUIDELINES	Background Human immunodeficiency virus (HIV) infection and its treatment cause renal diseases. Renal disease is associated with an increasing cause of morbidity and mortality in HIV positive individuals than in the general population. It has been also associated with adverse outcomes, such as complications of decreased renal functions and progression to renal failure. Objective To determine the prevalence and factors associated with renal function impairment among highly active antiretroviral therapy (HAART) naive and HAART experienced adult HIV positive individuals. Methods A facility based comparative cross-sectional study was conducted in Jimma University Specialized Hospital (JUSH) from June to September 2014. HIV positive individuals who visited JUSH during the study period were included in the study. Sociodemographic and clinical data were collected using a structured questionnaire. Blood specimen was analyzed for renal function tests. Descriptive statistics, Mann-Whitney U test and logistic regression analysis were done using SPSS version 16 software. Results A total of 446 HIV positive individuals, 223 HAART naive and 223 HAART experienced, were recruited. The overall prevalence of renal function impairment was 18.2%[95% 14.6-21.7]. The prevalence of renal impairment in HAART naive and HAART experienced persons was 28.7%[95% CI: 23.1-34.4] and 7.6% [95% CI: 4.6-11.6], respectively. Age >= 50 years (AOR = 3.6; 95% CI 1.4, 9.6), advanced WHO stage (AOR = 2.3; 95% CI 1.1, 4.7), and CD4 count <200 (AOR = 6.9; 95% CI 3.3, 14.2) were independent risk factors among HAART naive participants. Female gender (AOR = 6.6; 95 CI % 1.2, 34), age >= 50 years (AOR = 12.1; 95% CI 1.7, 84) and CD4 count <200 (AOR = 17; 95% CI 5.2, 58) were independent risk factors among HAART experienced participants. Conclusion The prevalence of renal function impairment was higher among HAART naive than HAART experienced HIV positive individuals. Renal function impairment was associated with disease advancement and old age.	[Mekuria, Yewulsew] Jimma Univ Specialized Hosp, Dept Clin Lab Sci, Jimma, Ethiopia; [Yilma, Daniel] Jimma Univ, Coll Hlth Sci, Dept Internal Med, Jimma, Ethiopia; [Mekonnen, Zeleke; Kassa, Tesfaye; Gedefaw, Lealem] Jimma Univ, Coll Hlth Sci, Dept Med Lab Sci & Pathol, Jimma, Ethiopia	Jimma University; Jimma University	Gedefaw, L (corresponding author), Jimma Univ, Coll Hlth Sci, Dept Med Lab Sci & Pathol, Jimma, Ethiopia.	lealem.gedefaw@ju.edu.et	Yilma, Daniel/AAJ-2072-2021; Mekonnen, Zeleke/AAF-3877-2020	Yilma, Daniel/0000-0001-6058-2696; Mekonnen, Zeleke/0000-0003-3418-7291	Jimma University	Jimma University	The study was funded by Jimma University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansari Naheed, KIDNEY INVOLVEMENT H; BERNS JS, 1991, J AM SOC NEPHROL, V1, P1061; Bygrave H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017609; Cailhol J, 2011, BMC NEPHROL, V12, DOI 10.1186/1471-2369-12-40; Cheung CY, 2007, NEPHROL DIAL TRANSPL, V22, P3186, DOI 10.1093/ndt/gfm350; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Crum-Cianflone N, 2010, AIDS PATIENT CARE ST, V24, P353, DOI 10.1089/apc.2009.0326; DAVIES DF, 1950, J CLIN INVEST, V29, P496, DOI 10.1172/JCI102286; Deti EK, 2007, 4 IAS C HIV PATH TRE; FolefackKaze Francois, 2013, Saudi J Kidney Dis Transpl, V24, P1291, DOI 10.4103/1319-2442.121280; Gupta SK, 2005, CLIN INFECT DIS, V40, P1559, DOI 10.1086/430257; Jeff Dubin, 2002, E MED            FEB; Kahsu G, 2013, J INTERDISCIPL HISTO, V1; Levin A, 2013, KIDNEY INT SUPPL, V3, P5, DOI 10.1038/kisup.2012.77; Mpondo BCT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089573; Msango L, 2011, AIDS, V25, P1421, DOI 10.1097/QAD.0b013e328348a4b1; Mugyenyi P, 2010, LANCET, V375, P123, DOI 10.1016/S0140-6736(09)62067-5; Mulenga LB, 2008, AIDS, V22, P1821, DOI 10.1097/QAD.0b013e328307a051; National renal foundation, HIV CHRON REN DIS; Owiredu WKBA, 2013, AFR HEALTH SCI, V13, P101, DOI 10.4314/ahs.v13i1.14; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Peters PJ, 2008, KIDNEY INT, V74, P925, DOI 10.1038/ki.2008.305; Petersen PH, 1996, EUR J CLIN CHEM CLIN, V34, P983; Plebani M, 2006, CLIN CHEM LAB MED, V44, P750, DOI 10.1515/CCLM.2006.123; Post FA, 2009, CURR OPIN INFECT DIS, V22, P43, DOI 10.1097/QCO.0b013e328320ffec; Scarpino M, 2013, EUR REV MED PHARMACO, V17, P2660; Schwartz EJ, 2005, J AM SOC NEPHROL, V16, P2412, DOI 10.1681/ASN.2005040340; Struik GM, 2011, INT J STD AIDS, V22, P457, DOI 10.1258/ijsa.2011.010521; Torre D, 2005, HIV MED, V6, P66, DOI 10.1111/j.1468-1293.2005.00268.x; Wools-Kaloustian K, 2007, NEPHROL DIAL TRANSPL, V22, P2208, DOI 10.1093/ndt/gfm223; World Health Organization, 2014, POL BRIEF CONS GUID; Wyatt Christina M, 2012, Top Antivir Med, V20, P106; Yusuf R, 2011, NIGER J PHARM SCI, V10	33	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0161180	10.1371/journal.pone.0161180	http://dx.doi.org/10.1371/journal.pone.0161180			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27537338	Green Submitted, Green Published, gold			2022-12-27	WOS:000381577000065
J	Min, JJ; Lee, JH; Kang, SH; Kim, E; Lee, SM; Cho, JH; Kim, HK				Min, Jeong Jin; Lee, Jong-Hwan; Kang, Se Hee; Kim, Eunhee; Lee, Sangmin M.; Cho, Jong Ho; Kim, Hong Kwan			The Fast and Easy Way for Double-Lumen Tube Intubation: Individual Angle-Modification	PLOS ONE			English	Article							DIFFICULT TRACHEAL INTUBATION; RANDOMIZED CONTROLLED-TRIAL; MACINTOSH LARYNGOSCOPE; ENDOTRACHEAL-TUBE; VIDEOLARYNGOSCOPE; GLIDESCOPE(R); STYLET	To find the faster and easier way than the existing intubating technique for double-lumen tube, we modified the angle of double-lumen tube according to an individual's upper airway anatomy and compared the time needed and the number of attempts for successful intubation between individually angle-modified and non-modified double-lumen tubes. Adult patients undergoing elective thoracic surgery were randomly allocated in either non-angle-modified (Group N, n = 54) or angle-modified (Group M, n = 54) groups. During mask ventilation in the sniffing position, angle-modification was performed in Group M as follows: the distal tip of the tube was placed at the level of the cricoid cartilage and the shaft was bent at the intersection of the oral and pharyngeal axes estimated from the patient's surface anatomy. The time needed and the number of attempts for successful intubation and Cormack and Lehane (C-L) grade were recorded. Overall median intubation time (sec) was significantly shorter in Group M than in Group N [10.2 vs. 15.1, P< 0.001]. In addition, Group M showed the shorter median intubation time (sec) in C-L grades I-III [8.2 vs. 11.1 in C-L grade I, (P = 0.003), 10.3 vs. 15.3 in II, (P = 0.001), and 11.8 vs. 27.9 in III, (P< 0.001), respectively]. Moreover, all intubation was successfully performed at the first attempt in patients with C-L grades I-III in Group M (P = 0.027). Our study showed an individual angle-modification would be useful for the fast and easy intubation of double-lumen tube in patients with C-L grades I-III.	[Min, Jeong Jin; Lee, Jong-Hwan; Kang, Se Hee; Kim, Eunhee; Lee, Sangmin M.] Sungkyunkwan Univ, Dept Anesthesiol & Pain Med, Samsung Med Ctr, Sch Med, Seoul, South Korea; [Cho, Jong Ho; Kim, Hong Kwan] Sungkyunkwan Univ, Dept Thorac & Cardiovasc Surg, Samsung Med Ctr, Sch Med, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center	Lee, JH (corresponding author), Sungkyunkwan Univ, Dept Anesthesiol & Pain Med, Samsung Med Ctr, Sch Med, Seoul, South Korea.	jonghwanlee75@gmail.com	Kim, Hong Kwan/AAR-4892-2020	Kim, Hong Kwan/0000-0002-7815-3336; Cho, Jong Ho/0000-0003-3362-4621				Adnet F, 1997, ANESTHESIOLOGY, V87, P1290, DOI 10.1097/00000542-199712000-00005; Adnet F, 2001, ANESTHESIOLOGY, V94, P83, DOI 10.1097/00000542-200101000-00017; Arino JJ, 2003, CAN J ANAESTH, V50, P501, DOI 10.1007/BF03021064; Brodsky J B, 2009, Br J Anaesth, V103 Suppl 1, pi66, DOI 10.1093/bja/aep262; Campos JH, 2007, CURR OPIN ANESTHESIO, V20, P27, DOI 10.1097/ACO.0b013e3280111e2a; Cook TM, 2000, ANAESTHESIA, V55, P274, DOI 10.1046/j.1365-2044.2000.01270.x; Cooper RM, 2005, CAN J ANAESTH, V52, P191, DOI 10.1007/BF03027728; CORMACK RS, 1984, ANAESTHESIA, V39, P1105, DOI 10.1111/j.1365-2044.1984.tb08932.x; Greenland KB, 2010, BRIT J ANAESTH, V105, P683, DOI 10.1093/bja/aeq239; Hsu HT, 2014, BMC ANESTHESIOL, V14, DOI 10.1186/1471-2253-14-72; Lee JH, 2005, ANESTH ANALG, V101, P1226, DOI 10.1213/01.ane.0000169293.59514.28; Levitan RM, 2006, ACAD EMERG MED, V13, P1255, DOI 10.1197/j.aem.2006.06.058; Levitan RM, 2011, ANN EMERG MED, V57, P240, DOI 10.1016/j.annemergmed.2010.05.035; Lin W, 2012, ANAESTHESIA, V67, P771, DOI 10.1111/j.1365-2044.2012.07137.x; MALLAMPATI SR, 1985, CAN ANAESTH SOC J, V32, P429, DOI 10.1007/BF03011357; Mort TC, 2004, ANESTH ANALG, V99, P607, DOI 10.1213/01.ANE.0000122825.04923.15; Russell T, 2013, ANAESTHESIA, V68, P1253, DOI 10.1111/anae.12322; Stasiuk RBP, 2001, CAN J ANAESTH, V48, P911, DOI 10.1007/BF03017359; Takahata O, 1997, ANESTH ANALG, V84, P419, DOI 10.1097/00000539-199702000-00033; Walker L, 2009, BRIT J ANAESTH, V103, P440, DOI 10.1093/bja/aep191; Wasem S, 2013, EUR J ANAESTH, V30, P180, DOI 10.1097/EJA.0b013e32835fe574; Yang M, 2013, BRIT J ANAESTH, V111, P990, DOI 10.1093/bja/aet281	22	3	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0161434	10.1371/journal.pone.0161434	http://dx.doi.org/10.1371/journal.pone.0161434			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27537372	gold, Green Published, Green Submitted			2022-12-27	WOS:000381577000106
J	Ingargiola, A; Lerner, E; Chung, S; Weiss, S; Michalet, X				Ingargiola, Antonino; Lerner, Eitan; Chung, SangYoon; Weiss, Shimon; Michalet, Xavier			FRETBursts: An Open Source Toolkit for Analysis of Freely-Diffusing Single-Molecule FRET	PLOS ONE			English	Article							ALTERNATING-LASER EXCITATION; RESONANCE ENERGY-TRANSFER; STRUCTURAL HETEROGENEITIES; CORRELATION SPECTROSCOPY; CONFORMATIONAL DYNAMICS; DISTRIBUTIONS; EFFICIENCY; IDENTIFICATION; PROTEIN	Single-molecule Forster Resonance Energy Transfer (smFRET) allows probing intermolecular interactions and conformational changes in biomacromolecules, and represents an invaluable tool for studying cellular processes at the molecular scale. smFRET experiments can detect the distance between two fluorescent labels (donor and acceptor) in the 3-10 nm range. In the commonly employed confocal geometry, molecules are free to diffuse in solution. When a molecule traverses the excitation volume, it emits a burst of photons, which can be detected by single-photon avalanche diode (SPAD) detectors. The intensities of donor and acceptor fluorescence can then be related to the distance between the two fluorophores. While recent years have seen a growing number of contributions proposing improvements or new techniques in smFRET data analysis, rarely have those publications been accompanied by software implementation. In particular, despite the widespread application of smFRET, no complete software package for smFRET burst analysis is freely available to date. In this paper, we introduce FRETBursts, an open source software for analysis of freely-diffusing smFRET data. FRETBursts allows executing all the fundamental steps of smFRET bursts analysis using state-of-the-art as well as novel techniques, while providing an open, robust and well-documented implementation. Therefore, FRETBursts represents an ideal platform for comparison and development of new methods in burst analysis. We employ modern software engineering principles in order to minimize bugs and facilitate long-term maintainability. Furthermore, we place a strong focus on reproducibility by relying on Jupyter notebooks for FRETBursts execution. Notebooks are executable documents capturing all the steps of the analysis (including data files, input parameters, and results) and can be easily shared to replicate complete smFRET analyzes. Notebooks allow beginners to execute complex workflows and advanced users to customize the analysis for their own needs. By bundling analysis description, code and results in a single document, FRETBursts allows to seamless share analysis workflows and results, encourages reproducibility and facilitates collaboration among researchers in the single-molecule community.	[Ingargiola, Antonino; Lerner, Eitan; Chung, SangYoon; Weiss, Shimon; Michalet, Xavier] Univ Calif Los Angeles, Dept Chem & Biochem, 405 Hilgard Ave, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles	Ingargiola, A (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, 405 Hilgard Ave, Los Angeles, CA 90024 USA.	ingargiola.antonino@gmail.com	Michalet, Xavier/A-9704-2009; Lerner, Eitan/S-5576-2018; weiss, shimon/B-4164-2009	Michalet, Xavier/0000-0001-6602-7693; Lerner, Eitan/0000-0002-3791-5277; weiss, shimon/0000-0002-0720-5426; Ingargiola, Antonino/0000-0002-9348-1397; Chung, SangYoon/0000-0002-0592-4099	National Institutes of Health [R01-GM95904, R01-GM069709]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095904, R01GM069709] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by National Institutes of Health (http://www.nih.gov/) grant R01-GM95904 awarded to XM and SW and grant R01-GM069709 awarded to SW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. Eyal Nir and Dr. Toma Tomov for support in the implementation of the 2CDE method and Dr. Achillefs Kapanidis and Dr. Nicole Robb for providing experimental data for testing the BVA implementation. This work was supported by National Institutes of Health (NIH) grant R01-GM95904 and R01-GM069709. Dr. Weiss discloses equity in Nesher Technologies and intellectual property used in the research reported here. The work at UCLA was conducted in Dr. Weiss's Laboratory.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Antonik M, 2006, J PHYS CHEM B, V110, P6970, DOI 10.1021/jp057257+; Blischak JD, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004668; Bronson JE, 2009, BIOPHYS J, V97, P3196, DOI 10.1016/j.bpj.2009.09.031; Buckheit JB., 1995, WAVELETS STAT, P55, DOI [DOI 10.1007/978-1-4612-2544-7_5, 10.1007/978-1-4612-2544-7_5]; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Camley BA, 2009, J CHEM PHYS, V131, DOI 10.1063/1.3230974; Dahan M, 1999, CHEM PHYS, V247, P85, DOI 10.1016/S0301-0104(99)00132-9; Deniz AA, 1999, P NATL ACAD SCI USA, V96, P3670, DOI 10.1073/pnas.96.7.3670; DeVore MS, 2012, J PHYS CHEM B, V116, P4006, DOI 10.1021/jp209861u; Droettboom M, 2016, MATPLOTLIB MATPLOTLI; Edman L, 1996, P NATL ACAD SCI USA, V93, P6710, DOI 10.1073/pnas.93.13.6710; Eggeling C, 2001, J BIOTECHNOL, V86, P163, DOI 10.1016/S0168-1656(00)00412-0; Eggeling C, 1998, P NATL ACAD SCI USA, V95, P1556, DOI 10.1073/pnas.95.4.1556; Eglen S, 2016, BIORXIV; Fries JR, 1998, J PHYS CHEM A, V102, P6601, DOI 10.1021/jp980965t; Gopich I, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1812746; Gopich IV, 2008, J PHYS CHEM B, V112, P6214, DOI 10.1021/jp0764182; Gopich IV, 2007, J PHYS CHEM B, V111, P12925, DOI 10.1021/jp075255e; Gopich IV, 2012, ADV CHEM PHYS, V146, P245; Gopich IV, 2010, J PHYS CHEM B, V114, P15221, DOI 10.1021/jp105359z; Gopich IV, 2009, J PHYS CHEM B, V113, P10965, DOI 10.1021/jp903671p; Greenfeld M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030024; Haran G, 2012, CURR OPIN STRUC BIOL, V22, P14, DOI 10.1016/j.sbi.2011.10.005; Hoffmann A, 2011, PHYS CHEM CHEM PHYS, V13, P1857, DOI 10.1039/c0cp01911a; Hohlbein J, 2014, CHEM SOC REV, V43, P1156, DOI 10.1039/c3cs60233h; Ince DC, 2012, NATURE, V482, P485, DOI 10.1038/nature10836; Ingargiola A, 2016, PROC SPIE, V9714, DOI 10.1117/12.2212085; Ingargiola A, 2016, BIOPHYS J, V110, P26, DOI 10.1016/j.bpj.2015.11.013; Ingargiola A, 2013, PROC SPIE, V8590, DOI 10.1117/12.2003704; Kalinin S, 2007, J PHYS CHEM B, V111, P10253, DOI 10.1021/jp072293p; Kalinin S, 2010, J PHYS CHEM B, V114, P6197, DOI 10.1021/jp100025v; Kapanidis AN, 2004, P NATL ACAD SCI USA, V101, P8936, DOI 10.1073/pnas.0401690101; Kapanidis AN, 2005, ACCOUNTS CHEM RES, V38, P523, DOI 10.1021/ar0401348; Konig SLB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084157; Kou SC, 2005, J R STAT SOC C-APPL, V54, P469, DOI 10.1111/j.1467-9876.2005.00509.x; Laurence TA, 2005, P NATL ACAD SCI USA, V102, P17348, DOI 10.1073/pnas.0508584102; Laurence TA, 2007, BIOPHYS J, V92, P2184, DOI 10.1529/biophysj.106.093591; Lee NK, 2005, BIOPHYS J, V88, P2939, DOI 10.1529/biophysj.104.054114; Lerner E, 2014, BIOPHYS J, V106, P667, DOI 10.1016/j.bpj.2013.11.4500; McKinney SA, 2006, BIOPHYS J, V91, P1941, DOI 10.1529/biophysj.106.082487; Merali Z, 2010, NATURE, V467, P775, DOI 10.1038/467775a; Michalet X, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0035; Muller BK, 2005, BIOPHYS J, V89, P3508, DOI 10.1529/biophysj.105.064766; Murphy RR, 2014, ANAL CHEM, V86, P8603, DOI 10.1021/ac501188r; Murphy RR, 2014, PYFRET PYTHON LIB SI; Nettels D, 2008, J PHYS CHEM B, V112, P6137, DOI 10.1021/jp076971j; Newville M, 2016, IMFIT PY RELEASE 0 9; Nir E, 2006, J PHYS CHEM B, V110, P22103, DOI 10.1021/jp063483n; Prlic A, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002802; Rahamim G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143732; Robb NC, 2013, J MOL BIOL, V425, P875, DOI 10.1016/j.jmb.2012.12.015; Roy R, 2008, NAT METHODS, V5, P507, DOI 10.1038/NMETH.1208; Santoso Y, 2010, CHEMPHYSCHEM, V11, P2209, DOI 10.1002/cphc.201000129; Santoso Y, 2009, ANAL CHEM, V81, P9561, DOI 10.1021/ac901423e; Schuler B, 2008, CURR OPIN STRUC BIOL, V18, P16, DOI 10.1016/j.sbi.2007.12.003; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Selvin PR, 2000, NAT STRUCT BIOL, V7, P730, DOI 10.1038/78948; Shen H, 2014, NATURE, V515, P151, DOI 10.1038/515151a; Sisamakis E, 2010, METHOD ENZYMOL, V475, P455, DOI 10.1016/S0076-6879(10)75018-7; Soergel DAW, 2015, RAMPANT SOFTWARE ERR; Tomov TE, 2012, BIOPHYS J, V102, P1163, DOI 10.1016/j.bpj.2011.11.4025; Torella JP, 2011, BIOPHYS J, V100, P1568, DOI 10.1016/j.bpj.2011.01.066; Torres T, 2007, J PHYS CHEM B, V111, P7392, DOI 10.1021/jp070659s; Tsukanov R, 2013, J PHYS CHEM B, V117, P11932, DOI 10.1021/jp4059214; van de Meent JW, 2014, BIOPHYS J, V106, P1327, DOI 10.1016/j.bpj.2013.12.055; Vihinen M, 2015, NATURE, V521, P261, DOI 10.1038/521261a; Weiss S, 1999, SCIENCE, V283, P1676, DOI 10.1126/science.283.5408.1676; Wilson G, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001745; Zhang K, 2005, J PHYS CHEM B, V109, P21930, DOI 10.1021/jp0546047	70	36	36	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2016	11	8							e0160716	10.1371/journal.pone.0160716	http://dx.doi.org/10.1371/journal.pone.0160716			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4YN	27532626	Green Published, Green Submitted, gold			2022-12-27	WOS:000381487600040
J	Montes-Torres, J; Subirats, JL; Ribelles, N; Urda, D; Franco, L; Alba, E; Jerez, JM				Montes-Torres, Julio; Luis Subirats, Jose; Ribelles, Nuria; Urda, Daniel; Franco, Leonardo; Alba, Emilio; Manuel Jerez, Jose			Advanced Online Survival Analysis Tool for Predictive Modelling in Clinical Data Science	PLOS ONE			English	Article							DISTRIBUTIONS; CANCER; TESTS	One of the prevailing applications of machine learning is the use of predictive modelling in clinical survival analysis. In this work, we present our view of the current situation of computer tools for survival analysis, stressing the need of transferring the latest results in the field of machine learning to biomedical researchers. We propose a web based software for survival analysis called OSA (Online Survival Analysis), which has been developed as an open access and user friendly option to obtain discrete time, predictive survival models at individual level using machine learning techniques, and to perform standard survival analysis. OSA employs an Artificial Neural Network (ANN) based method to produce the predictive survival models. Additionally, the software can easily generate survival and hazard curves with multiple options to personalise the plots, obtain contingency tables from the uploaded data to perform different tests, and fit a Cox regression model from a number of predictor variables. In the Materials and Methods section, we depict the general architecture of the application and introduce the mathematical background of each of the implemented methods. The study concludes with examples of use showing the results obtained with public datasets.	[Montes-Torres, Julio; Luis Subirats, Jose; Urda, Daniel; Franco, Leonardo; Manuel Jerez, Jose] Univ Malaga, Dept Comp Sci, Malaga, Spain; [Luis Subirats, Jose] Yachay Tech Univ, Urcuqui, Imbabura, Ecuador; [Ribelles, Nuria; Alba, Emilio] Virgen de la Victoria Univ Hosp, Malaga, Spain; [Montes-Torres, Julio; Luis Subirats, Jose; Ribelles, Nuria; Urda, Daniel; Franco, Leonardo; Alba, Emilio; Manuel Jerez, Jose] Malaga Biomed Res Inst IBIMA, Malaga, Spain	Universidad de Malaga; Hospital Virgen de la Victoria	Montes-Torres, J (corresponding author), Univ Malaga, Dept Comp Sci, Malaga, Spain.; Montes-Torres, J (corresponding author), Malaga Biomed Res Inst IBIMA, Malaga, Spain.	julmontor@uma.es	Franco, Leonardo/AAD-9050-2020; Jerez, José/GYV-4500-2022; Muñoz, Daniel Urda/B-2040-2017; Ribelles, Nuria/ABH-2617-2020; Alba, Emilio/S-1435-2019; Franco, Leonardo/C-3929-2008; Jerez Aragones, Jose Manuel/L-1801-2014	Franco, Leonardo/0000-0003-0012-5914; Muñoz, Daniel Urda/0000-0003-2662-798X; Ribelles, Nuria/0000-0003-3194-7398; Alba, Emilio/0000-0002-3364-2603; Franco, Leonardo/0000-0003-0012-5914; Jerez Aragones, Jose Manuel/0000-0002-7858-2966; Montes Torres, Julio/0000-0001-8708-7847	MICINN-SPAIN (Spanish Government) [TIN2010-16556]; Andalusia Regional Government, Spain [P08-TIC-4026]; MICINN-SPAIN [TIN2010-16556, TIN2014-58516-c2-1-R]; Junta de Andalucia [P08-TIC-4026]; FEDER funds (European Union); FEDER funds	MICINN-SPAIN (Spanish Government); Andalusia Regional Government, Spain; MICINN-SPAIN(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Junta de Andalucia(Junta de Andalucia); FEDER funds (European Union)(European Commission); FEDER funds(European Commission)	This work was supported by grants TIN2010-16556 from MICINN-SPAIN (Spanish Government) and P08-TIC-4026 (Andalusia Regional Government, Spain). All of them include FEDER funds (European Union). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors acknowledge support through grants TIN2014-58516-c2-1-R and TIN2010-16556 from MICINN-SPAIN, and P08-TIC-4026 (Junta de Andalucia), all of which include FEDER funds.	AALEN O, 1978, ANN STAT, V6, P701, DOI 10.1214/aos/1176344247; [Anonymous], 2012, CANS VERS 1 1 STAT M; Ansari D, 2013, AM J SURG, V205, P1, DOI 10.1016/j.amjsurg.2012.05.032; Arsene CTC, 2011, LECT NOTES COMPUT SC, V6692, P210, DOI 10.1007/978-3-642-21498-1_27; BRESLOW N, 1974, BIOMETRICS, V30, P89, DOI 10.2307/2529620; COX DR, 1972, J R STAT SOC B, V34, P187; Crowther MJ, 2013, J STAT SOFTW, V53, P1; EFRON B, 1977, J AM STAT ASSOC, V72, P557, DOI 10.2307/2286217; Goswami Chirayu Pankaj, 2013, J Clin Bioinforma, V3, P22, DOI 10.1186/2043-9113-3-22; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Gyorffy B, 2010, BREAST CANCER RES TR, V123, P725, DOI 10.1007/s10549-009-0674-9; Hertzberg AM, 1985, COLLECTION PROBLEMS; Hess KR, 1999, STAT MED, V18, P3075, DOI 10.1002/(SICI)1097-0258(19991130)18:22<3075::AID-SIM244>3.3.CO;2-Y; Jozwiak K, 2013, COMPUT METH PROG BIO, V111, P115, DOI 10.1016/j.cmpb.2013.02.005; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; LOPRINZI CL, 1994, J CLIN ONCOL, V12, P601, DOI 10.1200/JCO.1994.12.3.601; Mani DR, 1999, P 5 ACM SIGKDD INT C, P94; MANTEL NATHAN, 1966, CANCERCHEMOTHERAP REP, V50, P163; McNemar Q, 1947, PSYCHOMETRIKA, V12, P153, DOI 10.1007/BF02295996; MULLER HG, 1994, BIOMETRICS, V50, P61, DOI 10.2307/2533197; Muller HG, 1979, LECT NOTES MATH, V757; NELSON W, 1972, TECHNOMETRICS, V14, P945, DOI 10.2307/1267144; PETO R, 1972, J R STAT SOC SER A-G, V135, P185, DOI 10.2307/2344317; TARONE RE, 1977, BIOMETRIKA, V64, P156, DOI 10.1093/biomet/64.1.156; Venables WN., 2002, MODERN APPL STAT S 4; WEI LJ, 1989, J AM STAT ASSOC, V84, P1065, DOI 10.2307/2290084; Yang JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023525; Zhang X, 2012, COMPUT METH PROG BIO, V108, P310, DOI 10.1016/j.cmpb.2012.01.003	28	2	3	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2016	11	8							e0161135	10.1371/journal.pone.0161135	http://dx.doi.org/10.1371/journal.pone.0161135			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4YN	27532883	Green Submitted, gold, Green Published			2022-12-27	WOS:000381487600062
J	Scheepbouwer, C; Meyer, S; Burggraaf, MJ; Jose, J; Molthoff, CFM				Scheepbouwer, Chantal; Meyer, Sandra; Burggraaf, Maroeska J.; Jose, Jithin; Molthoff, Carla F. M.			A Multimodal Imaging Approach for Longitudinal Evaluation of Bladder Tumor Development in an Orthotopic Murine Model	PLOS ONE			English	Article							OVARIAN-CANCER DETECTION; IN-VIVO; MICRO-ULTRASOUND; GENE-EXPRESSION; NUDE-MICE; CARCINOMA; BCG; COMBINATION; METASTASIS; LUCIFERASE	Bladder cancer is the fourth most common malignancy amongst men in Western industrialized countries with an initial response rate of 70% for the non-muscle invasive type, and improving therapy efficacy is highly needed. For this, an appropriate, reliable animal model is essential to gain insight into mechanisms of tumor growth for use in response monitoring of (new) agents. Several animal models have been described in previous studies, but so far success has been hampered due to the absence of imaging methods to follow tumor growth non-invasively over time. Recent developments of multimodal imaging methods for use in animal research have substantially strengthened these options of in vivo visualization of tumor growth. In the present study, a multimodal imaging approach was addressed to investigate bladder tumor proliferation longitudinally. The complementary abilities of Bioluminescence, High Resolution Ultrasound and Photo-acoustic Imaging permit a better understanding of bladder tumor development. Hybrid imaging modalities allow the integration of individual strengths to enable sensitive and improved quantification and understanding of tumor biology, and ultimately, can aid in the discovery and development of new therapeutics.	[Scheepbouwer, Chantal; Burggraaf, Maroeska J.; Molthoff, Carla F. M.] Vrije Univ Amsterdam, Med Ctr, Dept Radiol & Nucl Med, Amsterdam, Netherlands; [Meyer, Sandra; Jose, Jithin] FUJIFILM VisualSon Inc, Amsterdam, Netherlands; [Burggraaf, Maroeska J.] Dept Med Microbiol & Infect Control, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; Fujifilm Corporation	Molthoff, CFM (corresponding author), Vrije Univ Amsterdam, Med Ctr, Dept Radiol & Nucl Med, Amsterdam, Netherlands.	cfm.molthoff@vumc.nl		Scheepbouwer, Chantal/0000-0003-4243-0095; Meyer, Sandra/0000-0002-1778-8768	FUJIFILM VisualSonics Inc.	FUJIFILM VisualSonics Inc.	Fujifilm VisualSonics Inc. did not play a role in the study design, decision to publish, or preparation of the manuscript. FujiFilm VisualSonics Inc. did not provide any salary to the authors CS, MJB and CFMM. FUJIFILM VisualSonics Inc. only provided access and use of their equipment and both co-author's (SM, JJ) helped with operating the system, explaining the system, how to collect the data without further interest related to the outcome of the data. The funder provided support in the form of salaries for authors SM and JJ, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre A, 2011, TRANSL ONCOL, V4, P29, DOI 10.1593/tlo.10187; Anastasiadis A, 2012, THER ADV UROL, V4, P13, DOI 10.1177/1756287211431976; Arnold J, 2004, J IMMUNOTHER, V27, P116, DOI 10.1097/00002371-200403000-00005; Babjuk M, 2008, EUR UROL, V54, P303, DOI 10.1016/j.eururo.2008.04.051; Benedict WF, 2004, MOL THER, V10, P525, DOI 10.1016/j.ymthe.2004.05.027; Bhaumik S, 2002, P NATL ACAD SCI USA, V99, P377, DOI 10.1073/pnas.012611099; Botteman MF, 2003, PHARMACOECONOMICS, V21, P1315, DOI 10.1007/BF03262330; Chan E, 2009, BJU INT, V104, P1286, DOI 10.1111/j.1464-410X.2009.08577.x; Chan ESY, 2009, J UROLOGY, V182, P2926, DOI 10.1016/j.juro.2009.08.020; Chen FH, 2009, J UROLOGY, V182, P2932, DOI 10.1016/j.juro.2009.08.018; Contag CH, 1997, PHOTOCHEM PHOTOBIOL, V66, P523, DOI 10.1111/j.1751-1097.1997.tb03184.x; Foster FS, 2011, INTERFACE FOCUS, V1, P576, DOI 10.1098/rsfs.2011.0037; FU XY, 1992, INT J CANCER, V51, P989; FU XY, 1991, INT J CANCER, V49, P938, DOI 10.1002/ijc.2910490623; Gerling M, 2014, THERANOSTICS, V4, P604, DOI 10.7150/thno.7996; Gunther JH, 1999, CANCER RES, V59, P2834; Hadaschik BA, 2007, BJU INT, V100, P1377, DOI 10.1111/j.1464-410X.2007.07165.x; Hoffman RM, 2005, NAT REV CANCER, V5, P796, DOI 10.1038/nrc1717; Inoue Y, 2009, EUR J NUCL MED MOL I, V36, P771, DOI 10.1007/s00259-008-1022-8; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jokerst JV, 2012, ACS NANO, V6, P10366, DOI 10.1021/nn304347g; Jose J, 2012, MED PHYS, V39, P7262, DOI 10.1118/1.4764911; Jurczok A, 2008, BJU INT, V101, P120, DOI 10.1111/j.1464-410X.2007.07193.x; Kamaya A, 2013, J ULTRAS MED, V32, P1245, DOI 10.7863/ultra.32.7.1245; Keyaerts M, 2012, TRENDS MOL MED, V18, P164, DOI 10.1016/j.molmed.2012.01.005; Kirkali Z, 2005, UROLOGY, V66, P4, DOI 10.1016/j.urology.2005.07.062; Kolkman RGM, 2008, J BIOMED OPT, V13, DOI 10.1117/1.3005421; Lerner SP, 2015, CANCER-AM CANCER SOC, V121, P169, DOI 10.1002/cncr.28905; Liu JJ, 2012, J UROLOGY, V188, P361, DOI 10.1016/j.juro.2012.03.127; Luke GP, 2012, ANN BIOMED ENG, V40, P422, DOI 10.1007/s10439-011-0449-4; Needles A, 2015, NAT METHODS, V12; Needles A, 2013, IEEE T ULTRASON FERR, V60, P888, DOI 10.1109/TUFFC.2013.2646; Newton MR, 2014, CLIN EXP IMMUNOL, V177, P261, DOI 10.1111/cei.12315; Scanga CA, 2014, PATHOG DIS, V71, P205, DOI 10.1111/2049-632X.12186; van Rijn S, 2013, SCI REP-UK, V3, DOI 10.1038/srep01046; Wirtzfeld LA, 2005, CANCER RES, V65, P6337, DOI 10.1158/0008-5472.CAN-05-0414; Witjes JA, 2006, EUR UROL, V49, P790, DOI 10.1016/j.eururo.2006.01.017; Wurdinger T, 2008, NAT METHODS, V5, P171, DOI 10.1038/NMETH.1177; Xiao ZW, 2011, CLIN MED INSIGHTS-ON, V5, P315, DOI 10.4137/CMO.S7658; Xie ZX, 2011, OPT LETT, V36, P4815, DOI 10.1364/OL.36.004815; Yang Xi-hua, 2012, Cancer Biology Medicine, V9, P261, DOI 10.7497/j.issn.2095-3941.2012.04.007; Zhou JH, 2002, CANCER GENE THER, V9, P681, DOI 10.1038/sj.cgt.7700489	42	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2016	11	8							e0161284	10.1371/journal.pone.0161284	http://dx.doi.org/10.1371/journal.pone.0161284			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4YN	27533303	Green Submitted, gold, Green Published			2022-12-27	WOS:000381487600082
J	Kim, SM; Shu, AD; Long, J; Montez-Rath, ME; Leonard, MB; Norton, JA; Chertow, GM				Kim, Sun Moon; Shu, Aimee D.; Long, Jin; Montez-Rath, Maria E.; Leonard, Mary B.; Norton, Jeffrey A.; Chertow, Glenn M.			Declining Rates of Inpatient Parathyroidectomy for Primary Hyperparathyroidism in the US	PLOS ONE			English	Article							ASYMPTOMATIC PRIMARY HYPERPARATHYROIDISM; 3RD INTERNATIONAL WORKSHOP; CLINICAL-TRIAL; POSTMENOPAUSAL WOMEN; SERUM-CALCIUM; SURGERY; MANAGEMENT; MILD; GUIDELINES; STATEMENT	Parathyroidectomy is the only curative therapy for patients with primary hyperparathyroidism. However, the incidence, correlates and consequences of parathyroidectomy for primary hyperparathyroidism across the entire US population are unknown. We evaluated temporal trends in rates of inpatient parathyroidectomy for primary hyperparathyroidism, and associated in-hospital mortality, length of stay, and costs. We used the Healthcare Cost and Utilization Project Nationwide Inpatient Sample (NIS) from 2002-2011. Parathyroidectomies for primary hyperparathyroidism were identified using International Classification of Diseases, Ninth Revision codes. Unadjusted and age-and sex-adjusted rates of inpatient parathyroidectomy for primary hyperparathyroidism were derived from the NIS and the annual US Census. We estimated 109,583 parathyroidectomies for primary hyperparathyroidism between 2002 and 2011. More than half (55.4%) of patients were younger than age 65, and more than three-quarters (76.8%) were female. The overall rate of inpatient parathyroidectomy was 32.3 cases per million person-years. The adjusted rate decreased from 2004 (48.3 cases/million person-years) to 2007 (31.7 cases/million person-years) and was sustained thereafter. Although inpatient parathyroidectomy rates declined over time across all geographic regions, a steeper decline was observed in the South compared to other regions. Overall in-hospital mortality rates were 0.08%: 0.02% in patients younger than 65 years and 0.14% in patients 65 years and older. Inpatient parathyroidectomy rates for primary hyperparathyroidism have declined in recent years.	[Kim, Sun Moon; Long, Jin; Montez-Rath, Maria E.; Leonard, Mary B.; Chertow, Glenn M.] Stanford Univ, Dept Med, Sch Med, Div Nephrol, Stanford, CA 94305 USA; [Shu, Aimee D.] Stanford Univ, Sch Med, Div Endocrinol Gerontol & Metab, Stanford, CA 94305 USA; [Leonard, Mary B.] Stanford Univ, Dept Pediat, Sch Med, Div Pediat Nephrol, Stanford, CA 94305 USA; [Norton, Jeffrey A.] Stanford Univ, Dept Surg, Sch Med, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University	Chertow, GM (corresponding author), Stanford Univ, Dept Med, Sch Med, Div Nephrol, Stanford, CA 94305 USA.	gchertow@stanford.edu		Chertow, Glenn/0000-0002-7599-0534	Amgen	Amgen(Amgen)	JL and GC have received research support from Amgen, the manufacturer of cinacalcet, an oral calcimimetic approved for the treatment of primary hyperparathyroidism. The authors did not receive any support from Amgen for this project. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrogini E, 2007, J CLIN ENDOCR METAB, V92, P3114, DOI 10.1210/jc.2007-0219; Anderson R. C., 2000, Navigation. Journal of the Institute of Navigation, V47, P1; [Anonymous], 1991, J BONE MINER RES SUP, V6, pS1; Bilezikian JP, 2014, J CLIN ENDOCR METAB, V99, P3561, DOI 10.1210/jc.2014-1413; Bilezikian JP, 2009, J CLIN ENDOCR METAB, V94, P335, DOI 10.1210/jc.2008-1763; Bilezikian JP, 2002, J CLIN ENDOCR METAB, V87, P5353, DOI 10.1210/jc.2002-021370; Bilezikian JP, 2004, NEW ENGL J MED, V350, P1746, DOI 10.1056/NEJMcp032200; Flynn MB, 2015, AM SURGEON, V81, P472; Griebeler ML, 2015, BONE, V73, P1, DOI 10.1016/j.bone.2014.12.003; Haas JS, 2004, ANN INTERN MED, V140, P184, DOI 10.7326/0003-4819-140-3-200402030-00009; HEATH H, 1980, NEW ENGL J MED, V302, P189, DOI 10.1056/NEJM198001243020402; Jha S, 2015, J BONE MINER RES; Khan A, 2009, J CLIN ENDOCR METAB, V94, P373, DOI 10.1210/jc.2008-1762; Kim SM, 2016, CLIN J AM SOC NEPHRO, V11, P1260, DOI 10.2215/CJN.10370915; Marcocci C, 2009, J CLIN ENDOCR METAB, V94, P2766, DOI 10.1210/jc.2008-2640; MARCUS R, 1984, ANN INTERN MED, V100, P633, DOI 10.7326/0003-4819-100-5-633; MCDERMOTT MT, 1994, J BONE MINER RES, V9, P509; Mollerup CL, 2002, BMJ-BRIT MED J, V325, P807, DOI 10.1136/bmj.325.7368.807; Niederle B, 2015, EUR J ENDOCRINOL, V173, pD13, DOI 10.1530/EJE-15-0277; Peacock M, 2005, J CLIN ENDOCR METAB, V90, P135, DOI 10.1210/jc.2004-0842; Rao DS, 2004, J CLIN ENDOCR METAB, V89, P5415, DOI 10.1210/jc.2004-0028; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Sattar N, 2012, LANCET, V379, P95, DOI 10.1016/S0140-6736(11)61816-3; Shoback DM, 2003, J CLIN ENDOCR METAB, V88, P5644, DOI 10.1210/jc.2002-021597; Silverberg SJ, 1997, NEW ENGL J MED, V337, P1506, DOI 10.1056/NEJM199711203372104; Silverberg SJ, 1999, NEW ENGL J MED, V341, P1249, DOI 10.1056/NEJM199910213411701; Silverberg SJ, 1996, J CLIN ENDOCR METAB, V81, P2036, DOI 10.1210/jc.81.6.2036; Stack BC, 2012, OTOLARYNG HEAD NECK, V147, P438, DOI 10.1177/0194599812445551; [The Healthcare cost and utilization project Agency for Healthcare Research and Quality], 2011, INTRODUCTION TO THE; Thomas DC, 2011, J SURG RES, V170, P240, DOI 10.1016/j.jss.2011.03.014; Udell JA, 2006, J BONE MINER RES, V21, P765, DOI 10.1359/JBMR.060119; US Census Bureau, CURR POPP SURV AG SE; Wermers RA, 2006, J BONE MINER RES, V21, P171, DOI 10.1359/JBMR.050910; Wermers RA, 1997, ANN INTERN MED, V126, P433, DOI 10.7326/0003-4819-126-6-199703150-00003; Wu BA, 2010, J CLIN ENDOCR METAB, V95, P4324, DOI 10.1210/jc.2009-2819; Yeh MW, 2013, J CLIN ENDOCR METAB, V98, P1122, DOI 10.1210/jc.2012-4022; Yeh MW, 2012, ANN SURG, V255, P1179, DOI 10.1097/SLA.0b013e31824dad7d	37	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2016	11	8							e0161192	10.1371/journal.pone.0161192	http://dx.doi.org/10.1371/journal.pone.0161192			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4UN	27529699	Green Published, Green Submitted, gold			2022-12-27	WOS:000381476700053
J	Torres, MA; Diaz, R; Boguen, R; Martins, SMMK; Ravagnani, GM; Leal, DF; Oliveira, MD; Muro, BBD; Parra, BM; Meirelles, FV; Papa, FO; Dell'Aqua, JA; Alvarenga, MA; Moretti, AD; Sepulveda, N; de Andrade, AFC				Torres, Mariana Andrade; Diaz, Rommy; Boguen, Rodrigo; Massami Kitamura Martins, Simone Maria; Ravagnani, Gisele Mouro; Leal, Diego Feitosa; Oliveira, Melissa de Lima; Donatelli Muro, Bruno Bracco; Parra, Beatriz Martins; Meirelles, Flavio Vieira; Papa, Frederico Ozanan; Dell'Aqua, Jose Antonio, Jr.; Alvarenga, Marco Antonio; Moretti, Anibal de Sant'Anna; Sepulveda, Nestor; Cesar de Andrade, Andre Furugen			Novel Flow Cytometry Analyses of Boar Sperm Viability: Can the Addition of Whole Sperm-Rich Fraction Seminal Plasma to Frozen-Thawed Boar Sperm Affect It?	PLOS ONE			English	Article							PORCINE LUTEINIZING-HORMONE; TYROSINE PHOSPHORYLATION; SURFACE-PROTEINS; IN-VITRO; MITOCHONDRIAL-FUNCTION; SPERMATOZOA; CAPACITATION; SEMEN; MEMBRANE; POSTTHAW	Boar semen cryopreservation remains a challenge due to the extension of cold shock damage. Thus, many alternatives have emerged to improve the quality of frozen-thawed boar sperm. Although the use of seminal plasma arising from boar sperm-rich fraction (SP-SRF) has shown good efficacy; however, the majority of actual sperm evaluation techniques include a single or dual sperm parameter analysis, which overrates the real sperm viability. Within this context, this work was performed to introduce a sperm flow cytometry fourfold stain technique for simultaneous evaluation of plasma and acrosomal membrane integrity and mitochondrial membrane potential. We then used the sperm flow cytometry fourfold stain technique to study the effect of SP-SRF on frozen-thawed boar sperm and further evaluated the effect of this treatment on sperm movement, tyrosine phosphorylation and fertility rate (FR). The sperm fourfold stain technique is accurate (R-2 = 0.9356, p > 0.01) for simultaneous evaluation of plasma and acrosomal membrane integrity and mitochondrial membrane potential (IPIAH cells). Centrifugation pre-cryopreservation was not deleterious (p > 0.05) for any analyzed variables. Addition of SP-SRF after cryopreservation was able to improve total and progressive motility (p < 0.05) when boar semen was cryopreserved without SP-SRF; however, it was not able to decrease tyrosine phosphorylation (p > 0.05) or improve IPIAH cells (p > 0.05). FR was not (p > 0.05) statistically increased by the addition of seminal plasma, though females inseminated with frozen-thawed boar semen plus SP-SRF did perform better than those inseminated with sperm lacking seminal plasma. Thus, we conclude that sperm fourfold stain can be used to simultaneously evaluate plasma and acrosomal membrane integrity and mitochondrial membrane potential, and the addition of SP-SRF at thawed boar semen cryopreserved in absence of SP-SRF improve its total and progressive motility.	[Torres, Mariana Andrade; Massami Kitamura Martins, Simone Maria; Ravagnani, Gisele Mouro; Leal, Diego Feitosa; Oliveira, Melissa de Lima; Donatelli Muro, Bruno Bracco; Parra, Beatriz Martins; Cesar de Andrade, Andre Furugen] Univ Sao Paulo, Sch Vet Med & Anim Sci, Dept Anim Reprod, Lab Androl & Technol Swine Embryos, Sao Paulo, Brazil; [Diaz, Rommy; Boguen, Rodrigo; Sepulveda, Nestor] Univ La Frontera, Ctr Excellence Biotechnol Reprod, Temuco, Araucania, Chile; [Massami Kitamura Martins, Simone Maria; Moretti, Anibal de Sant'Anna] Univ Sao Paulo, Lab Swine Res, Dept Anim Nutr & Prod, Sch Vet Med & Anim Sci, Sao Paulo, Brazil; [Meirelles, Flavio Vieira] Univ Sao Paulo, Sch Anim Sci & Food Engn, Dept Vet Med, Sao Paulo, Brazil; [Papa, Frederico Ozanan; Dell'Aqua, Jose Antonio, Jr.; Alvarenga, Marco Antonio] Sao Paulo State Univ UNESP, Sch Vet Med & Anim Sci, Dept Anim Reprod & Vet Radiol, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidad de La Frontera; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Estadual Paulista	de Andrade, AFC (corresponding author), Univ Sao Paulo, Sch Vet Med & Anim Sci, Dept Anim Reprod, Lab Androl & Technol Swine Embryos, Sao Paulo, Brazil.	andrefc@usp.br	Torres, Mariana Andrade/AAC-2471-2020; de Andrade, André Furugen Cesar/C-5092-2012; Meirelles, Flavio V/B-5048-2010; Díaz, Rommy/I-3255-2018; Sepulveda, Nestor/H-8699-2018; Torres, Mariana Andrade MAT/W-9214-2018; Martins, Simone Maria Massami Kitamura/M-7538-2013; CTC USP, CEPID 13 18/J-8951-2014	de Andrade, André Furugen Cesar/0000-0002-0148-4372; Meirelles, Flavio V/0000-0003-0372-4920; Sepulveda, Nestor/0000-0001-8321-604X; Torres, Mariana Andrade MAT/0000-0003-0222-0544; Martins, Simone Maria Massami Kitamura/0000-0002-5895-3678; Diaz, Rommy/0000-0002-6209-6728; CTC USP, CEPID 13 18/0000-0002-7123-9524; Boguen, Rodrigo/0000-0002-0325-743X; Leal, Diego/0000-0001-9205-2382; Dell'Aqua Jr., Jose Antonio/0000-0001-8758-3605	FUNDACAO DE AMPARO A PESQUISA DO ESTADO DE SAO PAULO [2011/23484-8, 2013/08070-8, 2014/22972-7]	FUNDACAO DE AMPARO A PESQUISA DO ESTADO DE SAO PAULO(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by FUNDACAO DE AMPARO A PESQUISA DO ESTADO DE SAO PAULO; grant numbers and author who received the funding: 2011/23484-8 AFCA, 2013/08070-8 MAT, 2014/22972-7 MAT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade AFC, 2008, ANIM REPROD SCI, V107, P304, DOI 10.1016/j.anireprosci.2008.05.082; [Anonymous], 1983, BIOL TRACE ELEM RES; Baker MA, 2004, J CELL SCI, V117, P211, DOI 10.1242/jcs.00842; Braundmeier AG, 2001, J DAIRY SCI, V84, P1915, DOI 10.3168/jds.S0022-0302(01)74633-4; Caballero I, 2008, THERIOGENOLOGY, V70, P1352, DOI 10.1016/j.theriogenology.2008.07.013; Caballero I, 2012, REPROD DOMEST ANIM, V47, P12, DOI 10.1111/j.1439-0531.2012.02028.x; Cai K, 2005, ARCH ANDROLOGY, V51, P371, DOI 10.1080/014850190924485; Candini P. H., 2004, Brazilian Journal of Veterinary Research and Animal Science, V41, P124; Carvajal G, 2004, J ANDROL, V25, P389; Celeghini ECC, 2007, REPROD DOMEST ANIM, V42, P479, DOI 10.1111/j.1439-0531.2006.00810.x; de Andrade AFC, 2012, THERIOGENOLOGY, V77, P1866, DOI 10.1016/j.theriogenology.2012.01.003; Cremades T, 2005, J ANDROL, V26, P610, DOI 10.2164/jandrol.05028; CROSS NL, 1989, BIOL REPROD, V41, P635, DOI 10.1095/biolreprod41.4.635; de Andrade AFC, 2007, REPROD DOMEST ANIM, V42, P190, DOI 10.1111/j.1439-0531.2006.00751.x; de Andrade AFC, 2011, REPROD DOMEST ANIM, V46, P682, DOI 10.1111/j.1439-0531.2010.01729.x; Degenstein KL, 2008, THERIOGENOLOGY, V70, P1075, DOI 10.1016/j.theriogenology.2008.06.027; DOSTALOVA Z, 1994, BIOL CHEM H-S, V375, P457, DOI 10.1515/bchm3.1994.375.7.457; EISERT WG, 1981, CYTOMETRY, V1, P254, DOI 10.1002/cyto.990010403; Ekhlasi-Hundrieser M, 2005, BIOL REPROD, V73, P536, DOI 10.1095/biolreprod.105.040824; Flesch FM, 1999, BIOCHEM BIOPH RES CO, V262, P787, DOI 10.1006/bbrc.1999.1300; Gama RD, 2005, REPROD DOMEST ANIM, V40, P433, DOI 10.1111/j.1439-0531.2005.00605.x; Garcia JC, 2010, ANIM REPROD SCI, V119, P160, DOI 10.1016/j.anireprosci.2009.11.001; Garner DL, 1997, BIOL REPROD, V57, P1401, DOI 10.1095/biolreprod57.6.1401; Garner DL, 1996, THERIOGENOLOGY, V45, P1103, DOI 10.1016/0093-691X(96)00067-2; GARNER DL, 1994, J ANDROL, V15, P620; GARNER DL, 1995, BIOL REPROD, V53, P276, DOI 10.1095/biolreprod53.2.276; Gomez-Fernandez J, 2013, REPROD DOMEST ANIM, V48, P177, DOI 10.1111/j.1439-0531.2012.02126.x; Gonzalez-Cadavid V, 2014, THERIOGENOLOGY, V82, P697, DOI [10.1016/j.theriogenology.2014.05.024, 10.1016/j.theriogen]; GRAHAM JK, 1990, BIOL REPROD, V43, P55, DOI 10.1095/biolreprod43.1.55; Hernandez M, 2007, J ANDROL, V28, P689, DOI 10.2164/jandrol.107.002725; Hossain MS, 2011, ANIM REPROD SCI, V128, P37, DOI 10.1016/j.anireprosci.2011.08.006; Hossain MS, 2011, ASIAN J ANDROL, V13, P406, DOI 10.1038/aja.2011.15; Johnson LA, 2000, ANIM REPROD SCI, V62, P143, DOI 10.1016/S0378-4320(00)00157-3; Jonakova V, 2000, MOL REPROD DEV, V56, P275, DOI 10.1002/(SICI)1098-2795(200006)56:2+&lt;275::AID-MRD13&gt;3.0.CO;2-G; Martinez-Pastor F, 2010, REPROD DOMEST ANIM, V45, P67, DOI 10.1111/j.1439-0531.2010.01622.x; Maxwell WMC, 1997, THERIOGENOLOGY, V48, P209, DOI 10.1016/S0093-691X(97)84068-X; Nagy S, 2003, BIOL REPROD, V68, P1828, DOI 10.1095/biolreprod.102.011445; Okazaki T, 2009, THERIOGENOLOGY, V71, P491, DOI 10.1016/j.theriogenology.2008.08.014; Okazaki T, 2012, J ANDROL, V33, P990, DOI 10.2164/jandrol.111.015115; Oura C., 1990, International Review of Cytology, V122, P105, DOI 10.1016/S0074-7696(08)61207-3; Petrunkina AM, 2013, REPROD DOMEST ANIM, V48, P11, DOI 10.1111/rda.12202; Petrunkina AM, 2010, THERIOGENOLOGY, V73, P995, DOI 10.1016/j.theriogenology.2009.12.006; Piehler E, 2006, CYTOM PART A, V69A, P1062, DOI 10.1002/cyto.a.20338; Rath D, 2009, Soc Reprod Fertil Suppl, V66, P51; Rieseberg M, 2001, APPL MICROBIOL BIOT, V56, P350, DOI 10.1007/s002530100673; Roca J, 2003, THERIOGENOLOGY, V60, P77, DOI 10.1016/S0093-691X(02)01330-4; Rodriguez-Martinez H, 2006, REPROD DOMEST ANIM, V41, P2, DOI 10.1111/j.1439-0531.2006.00764.x; Rodriguez-Martinez Heriberto, 2010, Vet Med Int, V2010, DOI 10.4061/2011/396181; Saravia F, 2007, INT J ANDROL, V30, P485, DOI 10.1111/j.1365-2605.2006.00741.x; Saravia F, 2010, ANIM REPROD SCI, V117, P279, DOI 10.1016/j.anireprosci.2009.04.014; Saravia F, 2009, THERIOGENOLOGY, V71, P662, DOI 10.1016/j.theriogenology.2008.09.037; Schmidt H, 2004, REPRODUCTION, V128, P171, DOI 10.1530/rep.1.00153; Sidhu KS, 2004, REPRODUCTION, V127, P95, DOI 10.1530/rep.1.00073; Siqueira AP, 2011, THERIOGENOLOGY, V75, P1175, DOI 10.1016/j.theriogenology.2010.11.024; Talevi R, 2010, THERIOGENOLOGY, V73, P796, DOI 10.1016/j.theriogenology.2009.07.005; Tartaglione CM, 2004, THERIOGENOLOGY, V62, P1245, DOI 10.1016/j.theriogenology.2004.01.012; Topfer-Petersen E, 2008, INT J DEV BIOL, V52, P717, DOI 10.1387/ijdb.072536et; Vadnais ML, 2010, REPROD FERT DEVELOP, V22, P893, DOI 10.1071/RD09274; Vadnais ML, 2005, ANIM REPROD SCI, V90, P347, DOI 10.1016/j.anireprosci.2005.02.007; Yaniz JL, 2013, REPROD DOMEST ANIM, V48, P598, DOI 10.1111/rda.12132; Zasiadczyk L, 2015, THERIOGENOLOGY, V83, P1287, DOI 10.1016/j.theriogenology.2015.01.015	61	18	18	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2016	11	8							e0160988	10.1371/journal.pone.0160988	http://dx.doi.org/10.1371/journal.pone.0160988			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4UN	27529819	gold, Green Published, Green Submitted			2022-12-27	WOS:000381476700037
J	Winther, JA; Brynildsen, J; Hoiseth, AD; Folling, I; Brekke, PH; Christensen, G; Hagve, TA; Verbalis, JG; Omland, T; Rosjo, H				Winther, Jacob A.; Brynildsen, Jon; Hoiseth, Arne Didrik; Folling, Ivar; Brekke, Pal H.; Christensen, Geir; Hagve, Tor-Arne; Verbalis, Joseph G.; Omland, Torbjorn; Rosjo, Helge			Prevalence and Prognostic Significance of Hyponatremia in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease: Data from the Akershus Cardiac Examination (ACE) 2 Study	PLOS ONE			English	Article							CHRONIC HEART-FAILURE; SERUM SODIUM CONCENTRATION; HOSPITALIZED-PATIENTS; EMERGENCY-DEPARTMENT; NATRIURETIC PEPTIDE; PROSPECTIVE COHORT; OPTIMIZE-HF; MORTALITY; OUTCOMES; ASSOCIATION	Background Hyponatremia is prevalent and associated with mortality in patients with heart failure (HF). The prevalence and prognostic implications of hyponatremia in acute exacerbation of chronic obstructive pulmonary (AECOPD) have not been established. Method We included 313 unselected patients with acute dyspnea who were categorized by etiology of dyspnea according to established guidelines (derivation cohort). Serum Na+ was determined on hospital admission and corrected for hyperglycemia, and hyponatremia was defined as [Na+]< 137 mmol/L. Survival was ascertained after a median follow-up of 816 days and outcome was analyzed in acute HF (n = 143) and AECOPD (n = 83) separately. Results were confirmed in an independent AECOPD validation cohort (n = 99). Results In the derivation cohort, median serum Na+ was lower in AECOPD vs. acute HF (138.5 [135.9-140.5] vs. 139.2 [136.7-141.3] mmol/L, p = 0.02), while prevalence of hyponatremia (27% [22/83] vs. 20% [29/143], p = 0.28) and mortality rate (42% [35/83] vs. 46% [66/143], p = 0.56) were similar. By univariate Cox regression analysis, hyponatremia was associated with increased mortality in acute HF (HR 1.85 [95% CI 1.08, 3.16], p = 0.02), but not in AECOPD (HR 1.00 [0.47, 2.15], p = 1.00). Analogous to the results of the derivation cohort, hyponatremia was prevalent also in the AECOPD validation cohort (25% [25/99]), but not associated with mortality. The diverging effect of hyponatremia on outcome between AECOPD and acute HF was statistically significant (p = 0.04). Conclusion Hyponatremia is prevalent in patients with acute HF and AECOPD, but is associated with mortality in patients with acute HF only.	[Winther, Jacob A.; Brynildsen, Jon; Hoiseth, Arne Didrik; Folling, Ivar; Brekke, Pal H.; Omland, Torbjorn; Rosjo, Helge] Akershus Univ Hosp, Div Med, Lorenskog, Norway; [Winther, Jacob A.; Brynildsen, Jon; Hoiseth, Arne Didrik; Folling, Ivar; Brekke, Pal H.; Christensen, Geir; Hagve, Tor-Arne; Omland, Torbjorn; Rosjo, Helge] Univ Oslo, Inst Clin Med, Oslo, Norway; [Christensen, Geir] Oslo Univ Hosp, Expt Med Res Inst, Oslo, Norway; [Hagve, Tor-Arne] Akershus Univ Hosp, Div Diagnost & Technol, Lorenskog, Norway; [Verbalis, Joseph G.] Georgetown Univ, Med Ctr, Div Endocrinol & Metab, Washington, DC 20007 USA; [Brekke, Pal H.] Oslo Univ Hosp, Div Med, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo; University of Oslo; Georgetown University; University of Oslo	Winther, JA (corresponding author), Akershus Univ Hosp, Div Med, Lorenskog, Norway.; Winther, JA (corresponding author), Univ Oslo, Inst Clin Med, Oslo, Norway.	j.a.winther@medisin.uio.no		Brekke, Pal/0000-0003-4875-9633	Akershus University Hospital; Research Council of Norway	Akershus University Hospital; Research Council of Norway(Research Council of Norway)	The ACE 2 Study was funded by Akershus University Hospital (http://www.ahus.no) and the Research Council of Norway (http://www.forskningsradet.no). The sponsors had no role in any of the following: design and conduct of the study, collection, management, analysis and interpretation of the data, or preparation, review and approval of the manuscript.	Abraham WT, 2008, J AM COLL CARDIOL, V52, P347, DOI 10.1016/j.jacc.2008.04.028; Balling L, 2011, EUR J HEART FAIL, V13, P968, DOI 10.1093/eurjhf/hfr086; BAUER FK, 1965, AM J MED SCI, V250, P245, DOI 10.1097/00000441-196509000-00001; Bettari L, 2012, J CARD FAIL, V18, P74, DOI 10.1016/j.cardfail.2011.09.005; Borroni G, 2000, DIGEST LIVER DIS, V32, P605, DOI 10.1016/S1590-8658(00)80844-0; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Corona G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124105; Corona G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080451; Deubner N, 2012, EUR J HEART FAIL, V14, P1147, DOI 10.1093/eurjhf/hfs115; Filippatos TD, 2013, WORLD J CARDIOL, V5, P317, DOI [10.4330/wjc.v5.i9.317, 10.4330/wjc.v5.i7.210]; Gheorghiade M, 2007, ARCH INTERN MED, V167, P1998, DOI 10.1001/archinte.167.18.1998; Gheorghiade M, 2007, EUR HEART J, V28, P980, DOI 10.1093/eurheartj/ehl542; GOLD, GLOB STRAT DIAGN MAN; Hawkins RC, 2003, CLIN CHIM ACTA, V337, P169, DOI 10.1016/j.cccn.2003.08.001; Hillier TA, 1999, AM J MED, V106, P399, DOI 10.1016/S0002-9343(99)00055-8; Hoiseth AD, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-97; Hoiseth AD, 2012, BMC PULM MED, V12, DOI 10.1186/1471-2466-12-22; Januzzi JL, 2005, AM J CARDIOL, V95, P948, DOI 10.1016/j.amjcard.2004.12.032; Karadag F, 2004, RESPIROLOGY, V9, P481, DOI 10.1111/j.1440-1843.2004.00614.x; Kim WR, 2008, NEW ENGL J MED, V359, P1018, DOI 10.1056/NEJMoa0801209; Lainscak M, 2011, J CACHEXIA SARCOPENI, V2, P81, DOI 10.1007/s13539-011-0023-9; Landbo C, 1999, AM J RESP CRIT CARE, V160, P1856, DOI 10.1164/ajrccm.160.6.9902115; Levine M, 2001, PHARMACOTHERAPY, V21, P405, DOI 10.1592/phco.21.5.405.34503; Lim WS, 2000, THORAX, V55, P219, DOI 10.1136/thorax.55.3.219; Madan VD, 2011, CIRC-HEART FAIL, V4, P637, DOI 10.1161/CIRCHEARTFAILURE.111.961011; McCullough PA, 2002, CIRCULATION, V106, P416, DOI 10.1161/01.CIR.0000025242.79963.4C; McMurray JJV, 2012, EUR HEART J, V33, P1787, DOI 10.1093/eurheartj/ehs104; Mohan S, 2013, AM J MED, V126, P1127, DOI 10.1016/j.amjmed.2013.07.021; Porcel A, 2002, ARCH INTERN MED, V162, P323, DOI 10.1001/archinte.162.3.323; Rosjo H, 2015, CLIN CHEM, V61, P1087, DOI 10.1373/clinchem.2015.239673; Rustad P, 2004, SCAND J CLIN LAB INV, V64, P271, DOI 10.1080/00365510410006324; SCHRIER RW, 1981, J LAB CLIN MED, V98, P1; SONNENBLICK M, 1993, CHEST, V103, P601, DOI 10.1378/chest.103.2.601; STEVENSON LW, 1989, JAMA-J AM MED ASSOC, V261, P884, DOI 10.1001/jama.261.6.884; TANG WW, 1993, AM J MED, V94, P169, DOI 10.1016/0002-9343(93)90179-S; Tribouilloy C, 2008, EUR HEART J, V29, P339, DOI 10.1093/eurheartj/ehm554; Upadhyay A, 2006, AM J MED, V119, pS30, DOI 10.1016/j.amjmed.2006.05.005; Vazquez R, 2009, EUR HEART J, V30, P1088, DOI 10.1093/eurheartj/ehp032; Verbalis JG, 2013, AM J MED, V126, pS5, DOI 10.1016/j.amjmed.2013.07.006; Wald R, 2010, ARCH INTERN MED, V170, P294, DOI 10.1001/archinternmed.2009.513; Wang CS, 2005, JAMA-J AM MED ASSOC, V294, P1944, DOI 10.1001/jama.294.15.1944; WOOD CE, 1989, AM J PHYSIOL, V257, pR344, DOI 10.1152/ajpregu.1989.257.2.R344	42	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2016	11	8							e0161232	10.1371/journal.pone.0161232	http://dx.doi.org/10.1371/journal.pone.0161232			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4UN	27529844	Green Published, gold, Green Submitted			2022-12-27	WOS:000381476700055
J	Xia, WW; Morch, CD; Andersen, OK				Xia, Weiwei; Morch, Carsten Dahl; Andersen, Ole Kaeseler			Test-Retest Reliability of 10 Hz Conditioning Electrical Stimulation Inducing Long-Term Potentiation (LTP)-Like Pain Amplification in Humans	PLOS ONE			English	Article							SPINAL DORSAL-HORN; FIBER-EVOKED POTENTIALS; PRIMARY AFFERENT-FIBERS; C-FIBER; HUMAN SKIN; SECONDARY HYPERALGESIA; CENTRAL SENSITIZATION; PERCEPTUAL CORRELATE; INFLAMMATORY PAIN; HEAT HYPERALGESIA	Background 10 Hz conditioning electrical stimulation (CES) has been shown to induce long-term potentiation (LTP)-like pain amplification similar to traditional 100 Hz CES in healthy humans. The aim of this study was to assess the test-retest reliability and to estimate sample sizes required for future crossover and parallel study designs. Methods The 10 Hz paradigm (500 rectangular pulses lasting 50 s) was repeated on two separate days with one week interval in twenty volunteers. Perceptual intensities to single electrical stimulation (SES) at the conditioned skin site and to mechanical stimuli (pinprick and light stroking) in immediate vicinity to the conditioned skin site were recorded. Superficial blood flow (SBF) was assessed as indicator of neurogenic inflammation. All outcome measures were assessed with 10 min interval three times before and six times after the CES. The coefficient of variation and intra-class correlation coefficient were calculated within session and between sessions. Sample sizes were estimated for future crossover (Ncr) and parallel (Np) drug testing studies expected to detect a 30% decrease for the individual outcome measure following 10 Hz CES. Results Perceptual intensity ratings to light stroking (Ncr = 2, Np = 33) and pinprick stimulation (491 mN) (Ncr = 6, Np = 54) increased after CES and showed better reliability in crossover than parallel design. The SBF increased after CES, and then declined until reaching a plateau 20 minutes postCES. SBF showed acceptable reliability both in crossover and parallel designs (Ncr = 3, Np = 13). Pain ratings to SES were reliable, but with large estimated sample sizes (Ncr = 634, Np = 11310) due to the minor pain amplification. Conclusions The reliability of 10 Hz CES was acceptable in inducing LTP-like effects in the assessments of superficial blood flow, heterotopic mechanical hyperalgesia, and dysesthesia in terms of sample sizes for future crossover study designs.	[Xia, Weiwei; Morch, Carsten Dahl; Andersen, Ole Kaeseler] Aalborg Univ, Dept Hlth Sci & Technol, SMI, CNAP, Fredrik Bajers Vej 7 D3, DK-9220 Aalborg, Denmark; [Xia, Weiwei] Jilin Univ, China Japan Union Hosp, Changchun, Jilin Province, Peoples R China	Aalborg University; Jilin University	Xia, WW (corresponding author), Aalborg Univ, Dept Hlth Sci & Technol, SMI, CNAP, Fredrik Bajers Vej 7 D3, DK-9220 Aalborg, Denmark.; Xia, WW (corresponding author), Jilin Univ, China Japan Union Hosp, Changchun, Jilin Province, Peoples R China.	wx@hst.aau.dk	Mørch, Carsten Dahl/J-5639-2019; Andersen, Ole Kæseler/J-7825-2013	Mørch, Carsten Dahl/0000-0001-6693-2028; Andersen, Ole Kæseler/0000-0001-6307-8786	Danish National Research Foundation [DNRF121]; China Scholarship Council [2011617176]	Danish National Research Foundation(Danmarks Grundforskningsfond); China Scholarship Council(China Scholarship Council)	This study was supported by the Danish National Research Foundation (DNRF121) (O.K.A.) URL:http://dg.dk/en/ and China Scholarship Council (FILE NO.2011617176) (W.X.) URL:http://www.csc.edu.cn. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1989, MEASUREMENT CONCEPTS; Benrath J, 2005, BRIT J ANAESTH, V95, P518, DOI 10.1093/bja/aei215; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Button KS, 2013, NAT REV NEUROSCI, V14, P365, DOI 10.1038/nrn3475; Chizh BA, 2007, PAIN, V132, P132, DOI 10.1016/j.pain.2007.06.006; Dawson A, 2012, J OROFAC PAIN, V26, P39; De Col R, 2008, PAIN, V138, P556, DOI 10.1016/j.pain.2008.02.005; Djouhri L, 2006, J NEUROSCI, V26, P1281, DOI 10.1523/JNEUROSCI.3388-05.2006; Drdla R, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-18; Dusch M, 2007, NEUROREPORT, V18, P1101, DOI 10.1097/WNR.0b013e3281e72cff; Gazerani P, 2006, PAIN, V122, P315, DOI 10.1016/j.pain.2006.04.014; Han HC, 2000, PAIN, V84, P253; HANDWERKER HO, 1987, EXP BRAIN RES, V65, P493; Hansen N, 2007, J NEUROPHYSIOL, V97, P2559, DOI 10.1152/jn.01125.2006; Hathway GJ, 2009, PAIN, V144, P110, DOI 10.1016/j.pain.2009.03.022; Henrich F, 2015, BRAIN, V138, P2505, DOI 10.1093/brain/awv108; Hopkins WG, 2000, SPORTS MED, V30, P1, DOI 10.2165/00007256-200030010-00001; Ikeda H, 2006, SCIENCE, V312, P1659, DOI 10.1126/science.1127233; Jensen MP, 2003, J PAIN, V4, P2, DOI 10.1054/jpai.2003.1; Jurgens TP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099507; Julious SA, 2004, STAT MED, V23, P1921, DOI 10.1002/sim.1783; Kim HY, 2015, PAIN, V156, P618, DOI 10.1097/01.j.pain.0000460354.09622.ec; Klein T, 2004, J NEUROSCI, V24, P964, DOI 10.1523/JNEUROSCI.1222-03.2004; Klein T, 2007, NEUROPHARMACOLOGY, V52, P655, DOI 10.1016/j.neuropharm.2006.09.008; Klein T, 2006, J NEUROPHYSIOL, V96, P3551, DOI 10.1152/jn.00755.2006; Lang S, 2007, PAIN, V128, P254, DOI 10.1016/j.pain.2006.09.026; LIU XG, 1995, NEUROSCI LETT, V191, P43, DOI 10.1016/0304-3940(95)11553-0; Liu XG, 1997, J NEUROPHYSIOL, V78, P1973, DOI 10.1152/jn.1997.78.4.1973; Lynn B, 1996, PROG BRAIN RES, V113, P361, DOI 10.1016/S0079-6123(08)61098-5; MAGERL W, 1987, NEUROSCI LETT, V82, P349, DOI 10.1016/0304-3940(87)90281-3; Magerl W, 2006, HAND CLINIC, V81, P503, DOI 10.1016/S0072-9752(06)80037-0; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Manresa JAB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100241; Manresa JAB, 2010, EUR J PAIN, V14, P822, DOI 10.1016/j.ejpain.2009.12.008; Matre D, 2006, J NEUROSCI, V26, P559, DOI 10.1523/JNEUROSCI.4218-05.2006; Matre D, 2013, BRAIN RES, V1491, P54, DOI 10.1016/j.brainres.2012.10.045; Morch Carsten Dahl, 2013, Int J Physiol Pathophysiol Pharmacol, V5, P203; Pfau DB, 2011, PAIN, V152, P1532, DOI 10.1016/j.pain.2011.02.037; Portney LG, 2009, FDN CLIN RES APPL PR, V3rd, DOI DOI 10.1016/S0039-6257(02)00362-4; Price TJ, 2015, PROG MOL BIOL TRANSL, V131, P409, DOI 10.1016/bs.pmbts.2014.11.010; Puig S, 1996, PAIN, V64, P345, DOI 10.1016/0304-3959(95)00121-2; Rankin CH, 2009, NEUROBIOL LEARN MEM, V92, P135, DOI 10.1016/j.nlm.2008.09.012; Rankin G, 1998, CLIN REHABIL, V12, P187, DOI 10.1191/026921598672178340; RAYMOND SA, 1990, BRAIN RES, V526, P318, DOI 10.1016/0006-8993(90)91239-D; Sandkuhler J, 2012, CURR OPIN PHARMACOL, V12, P18, DOI 10.1016/j.coph.2011.10.018; Sauerstein K, 2000, J PHYSIOL-LONDON, V529, P803, DOI 10.1111/j.1469-7793.2000.00803.x; Schaible H. -G., 2007, V177, P3; Schaible HG, 2005, RHEUM DIS CLIN N AM, V31, P77, DOI 10.1016/j.rdc.2004.09.004; SIMONE DA, 1991, J NEUROPHYSIOL, V66, P228, DOI 10.1152/jn.1991.66.1.228; Sumikura H, 2003, PAIN, V105, P285, DOI 10.1016/S0304-3959(03)00243-4; Sumikura H, 2003, NEUROSCI LETT, V337, P147, DOI 10.1016/S0304-3940(02)01325-3; Svendsen F, 1998, NEUROREPORT, V9, P1185, DOI 10.1097/00001756-199804200-00041; Terman GW, 2001, J NEUROPHYSIOL, V85, P485, DOI 10.1152/jn.2001.85.2.485; TREEDE RD, 1992, PROG NEUROBIOL, V38, P397, DOI 10.1016/0301-0082(92)90027-C; van den Broeke EN, 2014, J NEUROPHYSIOL, V112, P2059, DOI 10.1152/jn.00342.2014; van den Broeke EN, 2014, J NEUROPHYSIOL, V111, P1564, DOI 10.1152/jn.00651.2013; Van den Broeke EN, 2012, J NEUROPHYSIOL, V108, P2276, DOI 10.1152/jn.00391.2012; Weir JP, 2005, J STRENGTH COND RES, V19, P231, DOI 10.1519/15184.1; Woolf CJ, 2011, PAIN, V152, pS2, DOI 10.1016/j.pain.2010.09.030; Xia WW, 2016, EXP BRAIN RES, V234, P2479, DOI 10.1007/s00221-016-4653-1; Xiao WH, 2007, ANESTHESIOLOGY, V107, P813, DOI 10.1097/01.anes.0000286983.33184.9c; Yang HW, 2004, J NEUROPHYSIOL, V91, P1122, DOI 10.1152/jn.00735.2003; Yucel A, 2002, EUR J PAIN, V6, P357, DOI 10.1016/S1090-3801(02)00022-8	63	7	7	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2016	11	8							e0161117	10.1371/journal.pone.0161117	http://dx.doi.org/10.1371/journal.pone.0161117			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4UN	27529175	Green Published, gold, Green Submitted			2022-12-27	WOS:000381476700047
J	Danna, SM; Graham, E; Burns, RJ; Deschenes, SS; Schmitz, N				Danna, Sofia M.; Graham, Eva; Burns, Rachel J.; Deschenes, Sonya S.; Schmitz, Norbert			Association between Depressive Symptoms and Cognitive Function in Persons with Diabetes Mellitus: A Systematic Review	PLOS ONE			English	Review							OLDER MEXICAN-AMERICANS; RISK-FACTOR; COMORBID DEPRESSION; TYPE-2; ADULTS; PREVALENCE; METAANALYSIS; DEMENTIA; COMPLICATIONS; DISABILITY	Depression and diabetes are independent risk factors for one another, and both are associated with increased risk of cognitive decline. Diabetes patients with lower cognitive function are more likely to suffer poorer health outcomes. However, the role of depression in cognitive decline among people with diabetes is not well understood. This systematic review assessed whether adults with comorbid diabetes and depression or depressive symptoms exhibit greater cognitive decline relative to individuals with diabetes alone. Searches were run in CINAHL, the Cochrane Central Register of Controlled Trials, EMBASE, PsycINFO, and PubMed (MEDLINE) with no time or language restrictions. Studies were eligible for inclusion if they were of any quantitative study design, included participants aged 18 years or older with diabetes mellitus of which some must have presented with current depression, and measured cognition as an outcome. The Cochrane Collaboration's Risk Of Bias In Non-randomized Studies-of Interventions tool was used for quality assessment of each study and its collected outcome. Fifteen articles were included in the final analysis. The high degree of heterogeneity in exposures, outcomes, and participant characteristics precluded a meta-analysis of any of the studies, and the risk of bias observed in these studies limits the strength of the evidence. Nonetheless, this review found the presence of comorbid depression was associated with poorer cognitive outcomes than for persons with diabetes alone. While large-scale preventive efforts must address epidemic levels of diabetes and its comorbidities, on the patient level healthcare professionals must be cognizant of the added difficulties that depression poses to patients and the extra support required to management diabetes in these cases. This systematic review is registered with the University of York Centre for Reviews and Dissemination under registration number 2015:CRD42015025122.	[Danna, Sofia M.; Graham, Eva; Schmitz, Norbert] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada; [Danna, Sofia M.; Graham, Eva; Burns, Rachel J.; Deschenes, Sonya S.; Schmitz, Norbert] Douglas Mental Hlth Univ Inst, Montreal, PQ, Canada; [Burns, Rachel J.; Deschenes, Sonya S.; Schmitz, Norbert] McGill Univ, Dept Psychiat, Montreal, PQ, Canada; [Schmitz, Norbert] Montreal Diabet Res Ctr, Montreal, PQ, Canada	McGill University; McGill University; Universite de Montreal	Schmitz, N (corresponding author), McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada.; Schmitz, N (corresponding author), Douglas Mental Hlth Univ Inst, Montreal, PQ, Canada.; Schmitz, N (corresponding author), McGill Univ, Dept Psychiat, Montreal, PQ, Canada.; Schmitz, N (corresponding author), Montreal Diabet Res Ctr, Montreal, PQ, Canada.	norbert.schmitz@mcgill.ca	Schmitz, Norbert/A-5177-2010; Schmitz, Norbert/AAH-3624-2020; Deschenes, Sonya/G-6341-2017	Schmitz, Norbert/0000-0001-7777-6323; Danna, Sofia/0000-0003-4861-8400; Burns, Rachel/0000-0002-5337-7878	Canadian Institutes of Health Research; Canadian Institutes of Health Research (CIHR) fellowship [201411MFE-338860 FRN-142923]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Institutes of Health Research (CIHR) fellowship(Canadian Institutes of Health Research (CIHR))	This work was funded by a grant from the Canadian Institutes of Health Research. RJB is supported by a Canadian Institutes of Health Research (CIHR) fellowship (201411MFE-338860 FRN-142923). The funder had no role in the study design, data collection, data analysis, interpretation, writing of the report, or the choice to submit for publication.r Funding was provided by a grant from the Canadian Institutes of Health Research. RJB is supported by a Canadian Institutes of Health Research (CIHR) fellowship (201411MFE-338860 FRN-142923). The funder had no role in the study design, data collection, data analysis, interpretation, writing of the report, or the choice to submit for publication.	Ali S, 2006, DIABETIC MED, V23, P1165, DOI 10.1111/j.1464-5491.2006.01943.x; Anderson RJ, 2001, DIABETES CARE, V24, P1069, DOI 10.2337/diacare.24.6.1069; Black SA, 2003, DIABETES CARE, V26, P2822, DOI 10.2337/diacare.26.10.2822; Bruce DG, 2003, DIABETES RES CLIN PR, V61, P59, DOI 10.1016/S0168-8227(03)00084-6; Burcusa SL, 2007, CLIN PSYCHOL REV, V27, P959, DOI 10.1016/j.cpr.2007.02.005; Byers AL, 2011, NAT REV NEUROL, V7, P323, DOI 10.1038/nrneurol.2011.60; Capoccia K, 2016, DIABETES EDUCATOR, V42, P34, DOI 10.1177/0145721715619038; Danna S, 2015, ASS DEPRESSION COGNI; de Groot M, 2001, PSYCHOSOM MED, V63, P619, DOI 10.1097/00006842-200107000-00015; Egede LE, 2016, J GEN INTERN MED, V31, P615, DOI 10.1007/s11606-016-3650-1; Iype T, 2009, ANN INDIAN ACAD NEUR, V12, P25, DOI 10.4103/0972-2327.48848; Jorm AF, 2001, AUST NZ J PSYCHIAT, V35, P776, DOI 10.1046/j.1440-1614.2001.00967.x; Katon W, 2012, ARCH GEN PSYCHIAT, V69, P410, DOI 10.1001/archgenpsychiatry.2011.154; Katon WJ, 2010, J GEN INTERN MED, V25, P423, DOI 10.1007/s11606-009-1248-6; Klunder CM, 2005, SCI ENG, V65, P6657; Knol MJ, 2006, DIABETOLOGIA, V49, P837, DOI 10.1007/s00125-006-0159-x; Koekkoek PS, 2013, PSYCHONEUROENDOCRINO, V38, P376, DOI 10.1016/j.psyneuen.2012.06.014; Li CY, 2008, DIABETES CARE, V31, P105, DOI 10.2337/dc07-1154; Lin EHB, 2010, DIABETES CARE, V33, P264, DOI 10.2337/dc09-1068; Lu FP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004144; Lustman PJ, 2005, J DIABETES COMPLICAT, V19, P113, DOI 10.1016/j.jdiacomp.2004.01.002; McFall GP, 2010, NEUROPSYCHOLOGY, V24, P547, DOI 10.1037/a0019246; Mejia-Arango S, 2011, REV NEUROLOGIA, V53, P397, DOI 10.33588/rn.5307.2010628; Mezuk B, 2008, DIABETES CARE, V31, P2383, DOI 10.2337/dc08-0985; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Monette MCE, 2014, CAN J DIABETES, V38, P401, DOI 10.1016/j.jcjd.2014.01.014; Moulton CD, 2016, AGING MENT HEALTH, V20, P840, DOI 10.1080/13607863.2015.1040723; Munshi MN, 2012, DIABETIC MED, V29, P1171, DOI 10.1111/j.1464-5491.2012.03606.x; NCD Risk Factor Collaboration (NCD-RisC), 2016, Lancet, V387, P1513, DOI 10.1016/S0140-6736(16)00618-8; Nichols GA, 2003, DIABETES CARE, V26, P744, DOI 10.2337/diacare.26.3.744; Ownby RL, 2006, ARCH GEN PSYCHIAT, V63, P530, DOI 10.1001/archpsyc.63.5.530; Rock PL, 2014, PSYCHOL MED, V44, P2029, DOI 10.1017/S0033291713002535; Rotella F, 2013, DIABETES RES CLIN PR, V99, P98, DOI 10.1016/j.diabres.2012.11.022; Rotella F, 2013, J CLIN PSYCHIAT, V74, P32, DOI 10.4088/JCP.12r07922; Rotkiewicz-Piorun AM, 2006, J NATL MED ASSOC, V98, P1840; Sterne JAC., 2014, COCHRANE RISK BIAS A; Sullivan MD, 2013, JAMA PSYCHIAT, V70, P1041, DOI 10.1001/jamapsychiatry.2013.1965; Sumlin LL, 2014, DIABETES EDUCATOR, V40, P731, DOI 10.1177/0145721714538925; Trento M, 2012, ACTA DIABETOL, V49, P199, DOI 10.1007/s00592-011-0275-z; Umegaki H, 2008, NEUROBIOL AGING, V29, P1022, DOI 10.1016/j.neurobiolaging.2007.02.004; Vos T, 2015, LANCET, V386, P743, DOI 10.1016/S0140-6736(15)60692-4; Wang Y, 2012, EURASIP J IMAGE VIDE, DOI 10.1186/1687-5281-2012-16; Watari K, 2006, ARCH CLIN NEUROPSYCH, V21, P787, DOI 10.1016/j.acn.2006.06.014; World Health Organization, 1999, DEF DIAGN CLASS DI 1; World Health Organization, 2016, DEPR FACT SHEET WHO; World Health Organization, 2016, DEM FACT SHEET WHO M; World Health Organization, 2016, GLOB REP DIAB	47	40	41	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2016	11	8							e0160809	10.1371/journal.pone.0160809	http://dx.doi.org/10.1371/journal.pone.0160809			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4SL	27526176	gold, Green Submitted, Green Published			2022-12-27	WOS:000381471100020
J	Coletta, DK; Campbell, LE; Weil, J; Kaplan, B; Clarkson, M; Finlayson, J; Mandarino, LJ; Chakkera, HA				Coletta, Dawn K.; Campbell, Latoya E.; Weil, Jennifer; Kaplan, Bruce; Clarkson, Marie; Finlayson, Jean; Mandarino, Lawrence J.; Chakkera, Harini A.			Changes in Pre- and Post-Exercise Gene Expression among Patients with Chronic Kidney Disease and Kidney Transplant Recipients	PLOS ONE			English	Article							ENCODED MITOCHONDRIAL GENES; INSULIN-RESISTANCE; SKELETAL-MUSCLE; EXTRACELLULAR-MATRIX; DIABETES-MELLITUS; DISUSE ATROPHY; CYCLOSPORINE-A; EXERCISE; GLUCOSE; MECHANISMS	Introduction Decreased insulin sensitivity blunts the normal increase in gene expression from skeletal muscle after exercise. In addition, chronic inflammation decreases insulin sensitivity. Chronic kidney disease (CKD) is an inflammatory state. How CKD and, subsequently, kidney transplantation affects skeletal muscle gene expression after exercise are unknown. Methods Study cohort: non-diabetic male/female 4/1, age 52 +/- 2 years, with end-stage CKD who underwent successful kidney transplantation. The following were measured both pre-transplant and post-transplant and compared to normals: Inflammatory markers, euglycemic insulin clamp studies determine insulin sensitivity, and skeletal muscle biopsies performed before and within 30 minutes after an acute exercise protocol. Microarray analyses were performed on the skeletal muscle using the 4x44K Whole Human Genome Microarrays. Since nuclear factor of activated T cells (NFAT) plays an important role in T cell activation and calcineurin inhibitors are mainstay immunosuppression, calcineurin/NFAT pathway gene expression was compared at rest and after exercise. Log transformation was performed to prevent skewing of data and regression analyses comparing measures pre- and post-transplant performed. Result Markers of inflammation significantly improved post-transplantation. Insulin infusion raised glucose disposal slightly lower post-transplant compared to pre-transplant, but not significantly, thus concluding differences in insulin sensitivity were similar. The overall pattern of gene expression in response to exercise was reduced both pre- and post- transplant compared to healthy volunteers. Although significant changes were observed among NFAT/Calcineurin gene at rest and after exercise in normal cohort, there were no significant differences comparing NFAT/calcineurin pathway gene expression pre- and post-transplant. Conclusions Despite an improvement in serum inflammatory markers, no significant differences in glucose disposal were observed post- transplant. The reduced skeletal muscle gene expression, including NFAT/calcineurin gene expression, in response to a single bout of exercise was not improved post- transplant. This study suggests that the improvements in inflammatory mediators post- transplant are unrelated to changes of NFAT/calcineurin gene expression.	[Kaplan, Bruce; Clarkson, Marie; Chakkera, Harini A.] Mayo Clin, Div Nephrol & Hypertens, Phoenix, AZ 85054 USA; [Campbell, Latoya E.] Arizona State Univ, Phoenix, AZ USA; [Coletta, Dawn K.; Finlayson, Jean; Mandarino, Lawrence J.] Arizona State Univ, Sch Sci Hlth Care Delivery, Phoenix, AZ USA; [Coletta, Dawn K.; Mandarino, Lawrence J.] Mayo Clin Arizona, Scottsdale, AZ USA; [Coletta, Dawn K.] Univ Arizona, Dept Basic Med Sci, Coll Med Phoenix, Phoenix, AZ USA; [Weil, Jennifer] NIH NIDDK, Phoenix, AZ USA	Mayo Clinic; Mayo Clinic Phoenix; Arizona State University; Arizona State University-Downtown Phoenix; Arizona State University; Arizona State University-Downtown Phoenix; Mayo Clinic; Mayo Clinic Phoenix; University of Arizona	Chakkera, HA (corresponding author), Mayo Clin, Div Nephrol & Hypertens, Phoenix, AZ 85054 USA.	chakkera.harini@mayo.edu		Chakkera, Harini/0000-0002-9456-0863	National Institutes of Health [R01 DK094013, R01 DK047936, R01 DK066483]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK094013] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported in part by National Institutes of Health Grants R01 DK094013 (DKC), R01 DK047936 (LJM) and R01 DK066483 (LJM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beddhu S, 2009, CLIN J AM SOC NEPHRO, V4, P1901, DOI 10.2215/CJN.01970309; Chakkera HA, 2013, DIABETES CARE, V36, P1406, DOI 10.2337/dc12-2067; Chen YW, 2007, PHYSIOL GENOMICS, V31, P510, DOI 10.1152/physiolgenomics.00115.2006; Coletta DK, 2011, AM J PHYSIOL-ENDOC M, V301, pE749, DOI 10.1152/ajpendo.00363.2011; Cosio FG, 2002, KIDNEY INT, V62, P1440, DOI 10.1111/j.1523-1755.2002.kid582.x; Cusi K, 2000, J CLIN INVEST, V105, P311, DOI 10.1172/JCI7535; de Boer IH, 2016, J AM SOC NEPHROL; De Filippis E, 2008, AM J PHYSIOL-ENDOC M, V294, pE607, DOI 10.1152/ajpendo.00729.2007; DEFRONZO RA, 1981, J CLIN INVEST, V67, P563, DOI 10.1172/JCI110067; DEFRONZO RA, 1979, AM J PHYSIOL, V237, pE214; Dungey M, 2013, INT J ENDOCRINOL, V2013, DOI 10.1155/2013/569831; Ferris HA, 2012, J CLIN INVEST, V122, P3854, DOI 10.1172/JCI66180; Fuhrmann A, 2014, BIOCHEM PHARMACOL, V88, P216, DOI 10.1016/j.bcp.2014.01.020; Goodyear LJ, 1998, ANNU REV MED, V49, P235, DOI 10.1146/annurev.med.49.1.235; Hargreaves M, 2002, MED SCI SPORT EXER, V34, P1505, DOI 10.1097/00005768-200209000-00017; Hwang H, 2010, DIABETES, V59, P33, DOI 10.2337/db09-0214; Jones SW, 2004, FASEB J, V18, P1025, DOI 10.1096/fj.03-1228fje; Kasiske BL, 2003, AM J TRANSPLANT, V3, P178, DOI 10.1034/j.1600-6143.2003.00010.x; McLean CS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127089; Painter Patrick, 2005, Ann Transplant, V10, P28; Palepu S, 2015, WORLD J DIABETES, V6, P445, DOI 10.4239/wjd.v6.i3.445; Richardson DK, 2005, J BIOL CHEM, V280, P10290, DOI 10.1074/jbc.M408985200; Rodrigo E, 2006, J AM SOC NEPHROL, V17, pS291, DOI 10.1681/ASN.2006080929; Sakuma K, 2008, ACTA NEUROPATHOL, V115, P663, DOI 10.1007/s00401-008-0371-5; Wei YZ, 2008, AM J PHYSIOL-REG I, V294, pR673, DOI 10.1152/ajpregu.00561.2007	25	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2016	11	8							e0160327	10.1371/journal.pone.0160327	http://dx.doi.org/10.1371/journal.pone.0160327			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3LI	27518102	Green Published, Green Submitted, gold			2022-12-27	WOS:000381382100012
J	Waight, AB; Bargsten, K; Doronina, S; Steinmetz, MO; Sussman, D; Prota, AE				Waight, Andrew B.; Bargsten, Katja; Doronina, Svetlana; Steinmetz, Michel O.; Sussman, Django; Prota, Andrea E.			Structural Basis of Microtubule Destabilization by Potent Auristatin Anti-Mitotics	PLOS ONE			English	Article							VINCA-DOMAIN; DYNAMIC INSTABILITY; BETA-TUBULIN; BINDING; SITE; DOLASTATIN-10; COLCHICINE; INSIGHT; AGENTS; PHARMACOPHORE	The auristatin class of microtubule destabilizers are highly potent cytotoxic agents against several cancer cell types when delivered as antibody drug conjugates. Here we describe the high resolution structures of tubulin in complex with both monomethyl auristatin E and F and unambiguously define the trans-configuration of both ligands at the Val-Dil amide bond in their tubulin bound state. Moreover, we illustrate how peptidic vinca-site agents carrying terminal carboxylate residues may exploit an observed extended hydrogen bond network with the M-loop Arg278 to greatly improve the affinity of the corresponding analogs and to maintain the M-loop in an incompatible conformation for productive lateral tubulin-tubulin contacts in microtubules. Our results highlight a potential, previously undescribed molecular mechanism by which peptidic vinca-site agents maintain unparalleled potency as microtubule- destabilizing agents.	[Waight, Andrew B.; Doronina, Svetlana; Sussman, Django] Seattle Genet Inc, Dept Prot Sci, Bothell, WA 98021 USA; [Bargsten, Katja; Steinmetz, Michel O.; Prota, Andrea E.] Paul Scherrer Inst, Dept Biol & Chem, Lab Biomol Res, Villigen, Switzerland; [Bargsten, Katja] Univ Zurich, Dept Biochem, Zurich, Switzerland	Seattle Genetics; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; University of Zurich	Sussman, D (corresponding author), Seattle Genet Inc, Dept Prot Sci, Bothell, WA 98021 USA.; Prota, AE (corresponding author), Paul Scherrer Inst, Dept Biol & Chem, Lab Biomol Res, Villigen, Switzerland.	dsussman@seagen.com; andrea.prota@psi.ch	Steinmetz, Michel O/AAA-3349-2022; Prota, Andrea Enrico/R-9526-2019	Steinmetz, Michel O/0000-0001-6157-3687; Prota, Andrea Enrico/0000-0003-0875-5339	Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy [DE-AC02-05CH11231]; Swiss National Science Foundation [310030B_138659]; Seattle Genetics Inc.	Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy(United States Department of Energy (DOE)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Seattle Genetics Inc.	The Advanced Light Source is supported by the Director, Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy under Contract No. DE-AC02-05CH11231. This work was supported by a grant from the Swiss National Science Foundation (310030B_138659 to MOS). Portions of this work were done under a Sponsored Research Agreement funded by Seattle Genetics Inc., which is developing antibody-drug conjugate technology including Monomethylauristatin E based ADCs like ADCETRIS1 (Brentuximab Vedotin). ABW, SD and DS are current full-time employees of Seattle Genetics and did play a role in our study design, data collection and analysis, decision to publish and preparation of the manuscript. All other authors of this manuscript declare no financial interest related to this work.	Alushin GM, 2014, CELL, V157, P1117, DOI 10.1016/j.cell.2014.03.053; Andreu Jose Manuel, 2007, Methods Mol Med, V137, P17, DOI 10.1007/978-1-59745-442-1_2; BAI R, 1990, J BIOL CHEM, V265, P17141; BAI R, 1990, BIOCHEM PHARMACOL, V39, P1941, DOI 10.1016/0006-2952(90)90613-P; Cormier A, 2008, EMBO REP, V9, P1101, DOI 10.1038/embor.2008.171; CURMI PA, 1994, BIOCHEM J, V300, P331, DOI 10.1042/bj3000331; de Claro RA, 2012, CLIN CANCER RES, V18, P5845, DOI 10.1158/1078-0432.CCR-12-1803; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; Dorleans A, 2009, P NATL ACAD SCI USA, V106, P13775, DOI 10.1073/pnas.0904223106; Doronina SO, 2006, BIOCONJUGATE CHEM, V17, P114, DOI 10.1021/bc0502917; Doronina SO, 2003, NAT BIOTECHNOL, V21, P778, DOI 10.1038/nbt832; Francisco JA, 2003, BLOOD, V102, P1458, DOI 10.1182/blood-2003-01-0039; Gigant B, 2005, NATURE, V435, P519, DOI 10.1038/nature03566; HAMEL E, 1992, PHARMACOL THERAPEUT, V55, P31, DOI 10.1016/0163-7258(92)90028-X; HYMAN AA, 1992, MOL BIOL CELL, V3, P1155, DOI 10.1091/mbc.3.10.1155; JOHNSON IS, 1963, CANCER RES, V23, P1390; Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nrc1317; Komlodi-Pasztor E, 2011, NAT REV CLIN ONCOL, V8, DOI 10.1038/nrclinonc.2010.228-c2; Maderna A, 2014, J MED CHEM, V57, P10527, DOI 10.1021/jm501649k; MITCHISON T, 1984, NATURE, V312, P237, DOI 10.1038/312237a0; Nawrotek A, 2011, J MOL BIOL, V412, P35, DOI 10.1016/j.jmb.2011.07.029; Pecqueur L, 2012, P NATL ACAD SCI USA, V109, P12011, DOI 10.1073/pnas.1204129109; Pettit G R, 1997, Fortschr Chem Org Naturst, V70, P1; Pettit GR, 1998, ANTI-CANCER DRUG DES, V13, P243; Phillips GDL, 2008, CANCER RES, V68, P9280, DOI 10.1158/0008-5472.CAN-08-1776; Prota AE, 2014, P NATL ACAD SCI USA, V111, P13817, DOI 10.1073/pnas.1408124111; Prota AE, 2014, J MOL BIOL, V426, P1848, DOI 10.1016/j.jmb.2014.02.005; Prota AE, 2014, ANGEW CHEM INT EDIT, V53, P1621, DOI 10.1002/anie.201307749; Prota AE, 2013, J CELL BIOL, V200, P259, DOI 10.1083/jcb.201211017; Prota AE, 2013, SCIENCE, V339, P587, DOI 10.1126/science.1230582; PURICH DL, 1984, ADV PROTEIN CHEM, V36, P133, DOI 10.1016/S0065-3233(08)60297-1; Ranaivoson FM, 2012, ACTA CRYSTALLOGR D, V68, P927, DOI 10.1107/S0907444912017143; Ravelli RBG, 2004, NATURE, V428, P198, DOI 10.1038/nature02393; Snyder JP, 2001, P NATL ACAD SCI USA, V98, P5312, DOI 10.1073/pnas.051309398; Wang YX, 2016, MOL PHARMACOL, V89, P233, DOI 10.1124/mol.115.100149; Zhang R, 2015, CELL, V162, P849, DOI 10.1016/j.cell.2015.07.012	36	84	84	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2016	11	8							e0160890	10.1371/journal.pone.0160890	http://dx.doi.org/10.1371/journal.pone.0160890			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3LI	27518442	Green Published, gold, Green Submitted			2022-12-27	WOS:000381382100029
J	Zaman, A; Ali, N; Sajid, M; Hayat, T				Zaman, Akbar; Ali, Nasir; Sajid, M.; Hayat, Tasawar			Numerical and Analytical Study of Two-Layered Unsteady Blood Flow through Catheterized Artery	PLOS ONE			English	Article							PERIODIC BODY ACCELERATION; PULSATILE FLOW; STENOSED ARTERY; MAGNETIC-FIELD; FLUID-FLOW; MODEL; VISCOSITY; VISCOELASTICITY; RESISTANCE; TUBES	The pulsatile flow of blood in a catheterized blood vessel is analyzed. The flow of blood in vessel is modeled as the flow of two immiscible fluids. The fluid in the core region is characterized as a non-Newtonian viscoelastic fluid satisfying the constitutive equation of an Oldroyd-B fluid. The fluid in the peripheral region is treated as a Newtonian fluid. The catheter inside the vessel is modeled as a rigid tube of very small radius. The resulting differential system for velocity in each region is computed numerically by finite-difference scheme and analytically by Laplace transform. A comparison of numerical solution with Laplace transform solution is carried out. Various physical quantities of interest through the computed velocity are also analyzed.	[Zaman, Akbar; Ali, Nasir; Sajid, M.] Int Islamic Univ, Fac Basic & Appl Sci, Dept Math & Stat, Islamabad 44000, Pakistan; [Hayat, Tasawar] Quaid I Azam Univ, Dept Math, Islamabad 4400, Pakistan; [Hayat, Tasawar] King Abdulaziz Univ, Dept Math, Nonlinear Anal & Appl Math NAAM Res Grp, Fac Sci, Jeddah 21589, Saudi Arabia	International Islamic University, Pakistan; King Abdulaziz University	Zaman, A (corresponding author), Int Islamic Univ, Fac Basic & Appl Sci, Dept Math & Stat, Islamabad 44000, Pakistan.	akbarzaman75@yahoo.com	Hayat, Tasawar/Y-2524-2019; Ali, Nasir/ABB-1446-2021					Abdullah I, 2011, INT J NUMER METH FL, V67, P1624, DOI 10.1002/fld.2436; AKAY G, 1985, INT J ENG SCI, V23, P265, DOI 10.1016/0020-7225(85)90047-3; [Anonymous], [No title captured]; BACK LH, 1994, J BIOMECH, V27, P169, DOI 10.1016/0021-9290(94)90205-4; BUGLIARELLO G, 1970, Biorheology, V7, P85; Burton A. C., 1966, INTRO TEXT YB; Canic S, 2006, SIAM J APPL MATH, V67, P164, DOI 10.1137/060651562; CHATURANI P, 1990, BIORHEOLOGY, V27, P747; CHATURANI P, 1991, INT J ENG SCI, V29, P113, DOI 10.1016/0020-7225(91)90081-D; CHIEN S, 1975, BIORHEOLOGY, V12, P341; Dash RK, 1996, J BIOMECH, V29, P917, DOI 10.1016/0021-9290(95)00153-0; Dash RK, 1999, J BIOMECH, V32, P49, DOI 10.1016/S0021-9290(98)00142-0; Fung YC, 1997, BIOMECHANICS CIRCULA, P571; Hoffmann K. A., 2000, COMPUTATIONAL FLUID, V1, P67208; Ikbal MA, 2009, J COMPUT APPL MATH, V230, P243, DOI 10.1016/j.cam.2008.11.010; JAYARAMAN G, 1995, MED BIOL ENG COMPUT, V33, P720, DOI 10.1007/BF02510793; KARAHALIOS GT, 1990, MED PHYS, V17, P922, DOI 10.1118/1.596448; MACDONALD DA, 1986, J BIOMECH, V19, P239, DOI 10.1016/0021-9290(86)90156-9; MAJHI SN, 1994, INT J ENG SCI, V32, P839, DOI 10.1016/0020-7225(94)90064-7; Mandal PK, 2005, INT J NONLIN MECH, V40, P151, DOI 10.1016/j.ijnonlinmec.2004.07.007; Massoudi M, 2008, COMPUT MATH APPL, V56, P199, DOI 10.1016/j.camwa.2007.07.018; Mekheimer KS, 2008, APPL MATH MECH-ENGL, V29, P1093, DOI 10.1007/s10483-008-0813-x; Mustapha N., 2009, NUM METH PARTIAL DIF, V27, P960; Mustapha N, 2009, COMPUT BIOL MED, V39, P896, DOI 10.1016/j.compbiomed.2009.07.004; Mustapha N, 2008, J MECH MED BIOL, V8, P395, DOI 10.1142/S0219519408002723; Muthu P, 2008, J MECH MED BIOL, V8, P561, DOI 10.1142/S0219519408002541; PRALHAD RN, 1988, BIORHEOLOGY, V25, P715; Reddy JVR, 2014, EUR J MECH B-FLUID, V48, P236, DOI 10.1016/j.euromechflu.2014.07.001; Sajid M, 2015, INT J NONLIN SCI NUM, V16, P197, DOI 10.1515/ijnsns-2013-0133; Sankar DS, 2007, APPL MATH MODEL, V31, P1847, DOI 10.1016/j.apm.2006.06.009; Sankar DS, 2007, APPL MATH MODEL, V31, P1497, DOI 10.1016/j.apm.2006.04.012; Sarkar A, 1998, J BIOMECH, V31, P781, DOI 10.1016/S0021-9290(98)00053-0; Shahed SR, 2014, PROCEDIA ENGINEER, V90, P339, DOI 10.1016/j.proeng.2014.11.859; SHUKLA JB, 1980, B MATH BIOL, V42, P797, DOI 10.1016/S0092-8240(80)80003-6; Srivastava VP, 2010, COMPUT MATH APPL, V59, P1377, DOI 10.1016/j.camwa.2009.12.007; SRIVASTAVA VP, 1994, J BIOMECH, V27, P921, DOI 10.1016/0021-9290(94)90264-X; Thurston G. B., 1992, THEORETICAL APPL RHE, V112, P17; THURSTON GB, 1979, BIORHEOLOGY, V16, P149; THURSTON GB, 1972, BIOPHYS J, V12, P1205, DOI 10.1016/S0006-3495(72)86156-3; Yeleswarapu K, 1996, THESIS; Yeleswarapu KK, 1998, MECH RES COMMUN, V25, P257, DOI 10.1016/S0093-6413(98)00036-6; Yilmaz F, 2008, KOREA-AUST RHEOL J, V20, P197	42	7	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2016	11	8							e0161377	10.1371/journal.pone.0161377	http://dx.doi.org/10.1371/journal.pone.0161377			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT8TP	27548476	Green Submitted, Green Published, gold			2022-12-27	WOS:000381768400050
J	Coronado, LM; Montealegre, S; Chaverra, Z; Mojica, L; Espinosa, C; Almanza, A; Correa, R; Stoute, JA; Gittens, RA; Spadafora, C				Coronado, Lorena M.; Montealegre, Stephania; Chaverra, Zumara; Mojica, Luis; Espinosa, Carlos; Almanza, Alejandro; Correa, Ricardo; Stoute, Jose A.; Gittens, Rolando A.; Spadafora, Carmenza			Blood Stage Plasmodium falciparum Exhibits Biological Responses to Direct Current Electric Fields	PLOS ONE			English	Article							CHLOROQUINE RESISTANCE; PARASITES; BONE; TRANSPORT; REVERSAL	The development of resistance to insecticides by the vector of malaria and the increasingly faster appearance of resistance to antimalarial drugs by the parasite can dangerously hamper efforts to control and eradicate the disease. Alternative ways to treat this disease are urgently needed. Here we evaluate the in vitro effect of direct current (DC) capacitive coupling electrical stimulation on the biology and viability of Plasmodium falciparum. We designed a system that exposes infected erythrocytes to different capacitively coupled electric fields in order to evaluate their effect on P. falciparum. The effect on growth of the parasite, replication of DNA, mitochondrial membrane potential and level of reactive oxygen species after exposure to electric fields demonstrate that the parasite is biologically able to respond to stimuli from DC electric fields involving calcium signaling pathways.	[Coronado, Lorena M.; Almanza, Alejandro; Correa, Ricardo; Spadafora, Carmenza] City Knowledge, Inst Invest Cient & Serv Alta Tecnol INDICASAT AI, Ctr Cellular & Mol Biol Dis CBCMe, Clayton, Ancon, Panama; [Coronado, Lorena M.; Correa, Ricardo] Acharya Nagarjuna Univ, Dept Biotechnol, Guntur 522510, Andhra Pradesh, India; [Montealegre, Stephania; Chaverra, Zumara] Univ Latina, Sch Biotechnol, Fac Ciencias Salud William C Gorgas, Panama City, Panama; [Mojica, Luis; Espinosa, Carlos] City Knowledge, Natl Ctr Metrol Panama CENAMEP AIP, Clayton, Ancon, Panama; [Stoute, Jose A.] Penn State Univ, Dept Med, Div Infect Dis & Epidemiol, Coll Med, Hershey, PA USA; [Gittens, Rolando A.] City Knowledge, INDICASAT AIP, CBDD, Clayton, Ancon, Panama	Instituto de Investigacion Cientificas y Servicios de Alta Tecnologia (INDICASAT-AIP); Acharya Nagarjuna University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Instituto de Investigacion Cientificas y Servicios de Alta Tecnologia (INDICASAT-AIP)	Spadafora, C (corresponding author), City Knowledge, Inst Invest Cient & Serv Alta Tecnol INDICASAT AI, Ctr Cellular & Mol Biol Dis CBCMe, Clayton, Ancon, Panama.	cspadafora@indicasat.org.pa	Spadafora, Carmenza/ABE-8973-2020	Spadafora, Carmenza/0000-0002-3002-9467; Mojica Ovalle, Luis/0000-0001-5594-9166; Gittens, Rolando A./0000-0002-0286-3956; Correa, Ricardo/0000-0001-5475-5407; Coronado, Lorena/0000-0001-6755-3118	Bill & Melinda Gates Foundation, Seattle, WA [51797]; Secretaria Nacional de Ciencia, Tecnologia e Innovacion, Panama; National System of Investigators, Panama [38-2014, 91-2015]	Bill & Melinda Gates Foundation, Seattle, WA(Bill & Melinda Gates Foundation); Secretaria Nacional de Ciencia, Tecnologia e Innovacion, Panama; National System of Investigators, Panama	This work was supported by the Bill & Melinda Gates Foundation, Seattle, WA, www.gatesfoundation.org [grant number 51797] to CS and JAS; the Secretaria Nacional de Ciencia, Tecnologia e Innovacion, Panama, www.senacyt.gob.pa [Ph.D. scholarships] to LMC and RC; and National System of Investigators, Panama, www.senacyt.gob.pa [grant numbers 38-2014, 91-2015] to CS and RG.	Almanza A., 2011, Current Trends in Biotechnology and Pharmacy, V5, P1130; [Anonymous], 2008, MOL MECH PARASITE IN; Asadi MR, 2014, ADV WOUND CARE, V3, P91, DOI 10.1089/wound.2012.0410; ATAMNA H, 1993, MOL BIOCHEM PARASIT, V61, P231, DOI 10.1016/0166-6851(93)90069-A; Bacarin CC, 2015, CNS NEUROL DISORD-DR, V14, P400, DOI 10.2174/1871527314666150225125232; BASSETT CAL, 1962, SCIENCE, V137, P1063, DOI 10.1126/science.137.3535.1063; Bonnet S, 2007, CANCER CELL, V11, P37, DOI 10.1016/j.ccr.2006.10.020; Brighton CT, 2001, J BONE JOINT SURG AM, V83A, P1514, DOI 10.2106/00004623-200110000-00009; Cakmak AS, 2016, TURK J BIOL, V40, P462, DOI 10.3906/biy-1505-114; Corbett Y, 2004, AM J TROP MED HYG, V70, P119, DOI 10.4269/ajtmh.2004.70.119; Draz EI, 2015, PHARMACOL REP, V67, P317, DOI 10.1016/j.pharep.2014.10.007; FUKADA E, 1957, J PHYS SOC JPN, V12, P1158, DOI 10.1143/JPSJ.12.1158; Gan JC, 2006, EUR SPINE J, V15, P1301, DOI 10.1007/s00586-006-0087-y; Gittens RA, 2011, J DENT RES, V90, P1389, DOI 10.1177/0022034511408428; Gittens RA, 2013, BIOELECTROMAGNETICS, V34, P599, DOI 10.1002/bem.21810; Golberg A, 2013, BIOTECHNOL BIOENG, V110, P1759, DOI 10.1002/bit.24831; Gopalakrishnan AM, 2015, ANTIMICROB AGENTS CH, V59, P317, DOI 10.1128/AAC.03663-14; HAYNES JD, 1976, NATURE, V263, P767, DOI 10.1038/263767a0; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Jakubowski W, 2000, CELL BIOL INT, V24, P757, DOI 10.1006/cbir.2000.0556; Keitany GJ, 2014, HUM VACC IMMUNOTHER, V10, P2903, DOI 10.4161/21645515.2014.972764; Khan SI, 2016, BIOTECHNOL BIOENG, V113, P643, DOI 10.1002/bit.25818; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; MARTIN SK, 1987, SCIENCE, V235, P899, DOI 10.1126/science.3544220; MARTINEY JA, 1995, J BIOL CHEM, V270, P22393, DOI 10.1074/jbc.270.38.22393; McCaig CD, 2005, PHYSIOL REV, V85, P943, DOI 10.1152/physrev.00020.2004; Nelson FRT, J AM ACAD ORTHOP SUR, V11, P344; Nuccitelli R, 2003, CURR TOP DEV BIOL, V58, P1, DOI 10.1016/S0070-2153(03)58001-2; Pak O, 2013, AM J RESP CELL MOL, V49, P358, DOI 10.1165/rcmb.2012-0361OC; Prole DL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026218; Rotmann A, 2010, MOL MICROBIOL, V76, P1591, DOI 10.1111/j.1365-2958.2010.07187.x; Shanks GD, 2015, T ROY SOC TROP MED H, V109, P182, DOI 10.1093/trstmh/tru199; TANABE K, 1982, J CELL BIOL, V93, P680, DOI 10.1083/jcb.93.3.680; Titushkin IA, 2009, IEEE ENG MED BIO, P2090, DOI 10.1109/IEMBS.2009.5333949; van Schalkwyk DA, 2016, J INFECT DIS, V213, P800, DOI 10.1093/infdis/jiv509; *WHO, 2013, WORLD MAL REP 2014 W; Williams GSB, 2013, P NATL ACAD SCI USA, V110, P10479, DOI 10.1073/pnas.1300410110; Zangeneh M, 2015, RADIAT ENVIRON BIOPH, V54, P175, DOI 10.1007/s00411-015-0586-5; Zhao HP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129625	39	2	2	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0161207	10.1371/journal.pone.0161207	http://dx.doi.org/10.1371/journal.pone.0161207			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27537497	Green Published, Green Submitted, gold			2022-12-27	WOS:000381577000067
J	Maina, AN; Fogarty, C; Krueger, L; Macaluso, KR; Odhiambo, A; Nguyen, K; Farris, CM; Luce-Fedrow, A; Bennett, S; Jiang, J; Sun, S; Cummings, RF; Richards, AL				Maina, Alice N.; Fogarty, Carrie; Krueger, Laura; Macaluso, Kevin R.; Odhiambo, Antony; Kiet Nguyen; Farris, Christina M.; Luce-Fedrow, Alison; Bennett, Stephen; Jiang, Ju; Sun, Sokanary; Cummings, Robert F.; Richards, Allen L.			Rickettsial Infections among Ctenocephalides felis and Host Animals during a Flea-Borne Rickettsioses Outbreak in Orange County, California	PLOS ONE			English	Article							LOS-ANGELES-COUNTY; MURINE TYPHUS; XENOPSYLLA-CHEOPIS; CAT FLEAS; ENDEMIC TYPHUS; IDENTIFICATION; BARTONELLA; TRANSMISSION; SIPHONAPTERA; ASSOCIATION	Due to a resurgence of flea-borne rickettsioses in Orange County, California, we investigated the etiologies of rickettsial infections of Ctenocephalides felis, the predominant fleas species obtained from opossums (Didelphis virginiana) and domestic cats (Felis catus), collected from case exposure sites and other areas in Orange County. In addition, we assessed the prevalence of IgG antibodies against spotted fever group (SFGR) and typhus group (TGR) rickettsiae in opossum sera. Of the 597 flea specimens collected from opossums and cats, 37.2% tested positive for Rickettsia. PCR and sequencing of rickettsial genes obtained from C. felis flea DNA preparations revealed the presence of R. typhi (1.3%), R. felis (28.0%) and R. felislike organisms (7.5%). Sera from opossums contained TGR-specific (40.84%), but not SFGR-specific antibodies. The detection of R. felis and R. typhi in the C. felis fleas in Orange County highlights the potential risk for human infection with either of these pathogens, and underscores the need for further investigations incorporating specimens from humans, animal hosts, and invertebrate vectors in endemic areas. Such studies will be essential for establishing a link in the ongoing flea-borne rickettsioses outbreaks.	[Maina, Alice N.; Odhiambo, Antony; Farris, Christina M.; Luce-Fedrow, Alison; Jiang, Ju; Richards, Allen L.] Naval Med Res Ctr, Silver Spring, MD 20910 USA; [Fogarty, Carrie; Krueger, Laura; Kiet Nguyen; Bennett, Stephen; Cummings, Robert F.] Orange Cty Mosquito & Vector Control Dist, Garden Grove, CA USA; [Macaluso, Kevin R.] Louisiana State Univ, Baton Rouge, LA 70803 USA; [Luce-Fedrow, Alison] Shippensburg Univ, Shippensburg, PA 17257 USA; [Sun, Sokanary] West Valley Mosquito & Vector Control Dist, Ontario, CA USA	Naval Medical Research Center (NMRC); Louisiana State University System; Louisiana State University; Pennsylvania State System of Higher Education (PASSHE); Shippensburg University of Pennsylvania	Maina, AN (corresponding author), Naval Med Res Ctr, Silver Spring, MD 20910 USA.	alice.n.maina.ctr@mail.mil		Farris, Christina/0000-0002-4004-410X	Global Emerging Infections Surveillance and Response System, a Division of the Armed Forces Health Surveillance Center [847705.82000.25GB.A0074]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI122672] Funding Source: NIH RePORTER	Global Emerging Infections Surveillance and Response System, a Division of the Armed Forces Health Surveillance Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Global Emerging Infections Surveillance and Response System, a Division of the Armed Forces Health Surveillance Center, work unit number 847705.82000.25GB.A0074 (https://www.afhsc.mil/Home/Sections/GEIS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdad Mohammad Yazid, 2011, Emerg Health Threats J, V4, P7168, DOI 10.3402/ehtj.v4i0.7168; Abramowicz KF, 2012, MED VET ENTOMOL, V26, P458, DOI 10.1111/j.1365-2915.2012.01017.x; Abramowicz KF, 2011, VECTOR-BORNE ZOONOT, V11, P979, DOI 10.1089/vbz.2010.0117; ADAMS JR, 1990, AM J TROP MED HYG, V43, P400, DOI 10.4269/ajtmh.1990.43.400; ADAMS WH, 1970, AM J TROP MED HYG, V19, P311, DOI 10.4269/ajtmh.1970.19.311; Adjemian J, 2010, EMERG INFECT DIS, V16, P412, DOI 10.3201/eid1603.091028; American Veterinary Medical Association (AVMA), 2013, AVMA GUID EUTH AN 20; Azad AF, 1997, EMERG INFECT DIS, V3, P319, DOI 10.3201/eid0303.970308; Billeter SA, 2016, VECTOR-BORNE ZOONOT, V16, P151, DOI 10.1089/vbz.2015.1869; Boostrom A, 2002, EMERG INFECT DIS, V8, P549, DOI 10.3201/eid0806.010350; Borchert JN, 2012, J MED ENTOMOL, V49, P210, DOI 10.1603/ME11045; CDPH, 1950, TYPH FEV CAL 1916 19; CDPH-VBDS, 2008, CDPH VBDS 2007 ANN R; CDPH-VBDS, 2014, CDPH VBDS 2013 ANN R; Christou C, 2010, AM J TROP MED HYG, V83, P1301, DOI 10.4269/ajtmh.2010.10-0118; Civen R, 2008, CLIN INFECT DIS, V46, P913, DOI 10.1086/527443; Eremeeva ME, 2008, EMERG INFECT DIS, V14, P1613, DOI 10.3201/eid1410.080571; Eremeeva ME, 2012, J MED ENTOMOL, V49, P1485, DOI 10.1603/ME11291; Fang R, 2003, CLIN DIAGN LAB IMMUN, V10, P221, DOI 10.1128/CDLI.10.2.221-228.2003; Graf PCF, 2008, CLIN INFECT DIS, V46, P70, DOI 10.1086/524018; Green JS, 2011, PEDIATR INFECT DIS J, V30, P163, DOI 10.1097/INF.0b013e3181f4cc25; Henry KM, 2007, MOL CELL PROBE, V21, P17, DOI 10.1016/j.mcp.2006.06.002; Hirunkanokpun S, 2011, MOL ECOL, V20, P4577, DOI 10.1111/j.1365-294X.2011.05289.x; Horta MC, 2010, VECTOR-BORNE ZOONOT, V10, P959, DOI 10.1089/vbz.2009.0149; Houhamdi L, 2003, ANN NY ACAD SCI, V990, P617, DOI 10.1111/j.1749-6632.2003.tb07436.x; Irons J. V., 1944, AMER JOUR TROP MED, V24, P359; Jiang J, 2006, EMERG INFECT DIS, V12, P1281, DOI 10.3201/eid1708.060327; Jiang J, 2013, VECTOR-BORNE ZOONOT, V13, P550, DOI 10.1089/vbz.2012.1123; Jiang J, 2012, VECTOR-BORNE ZOONOT, V12, P175, DOI 10.1089/vbz.2011.0614; Jima DD, 2015, GENOME ANNOUNCEMENTS, V3, DOI 10.1128/genomeA.00018-15; Karpathy SE, 2009, CLIN MICROBIOL INFEC, V15, P218, DOI 10.1111/j.1469-0691.2008.02140.x; Leulmi H, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003152; Mediannikov O., 2015, New Microbes and New Infections, V3, P24, DOI 10.1016/j.nmni.2014.10.005; Meleney H E, 1945, Cal West Med, V62, P116; Nogueras MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071386; Noden BH, 1998, J MED ENTOMOL, V35, P410, DOI 10.1093/jmedent/35.4.410; Odhiambo AM, 2014, VECTOR-BORNE ZOONOT, V14, P476, DOI 10.1089/vbz.2013.1518; Oteo JA, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0455-0; Parola P, 2011, CLIN MICROBIOL INFEC, V17, P996, DOI 10.1111/j.1469-0691.2011.03516.x; Parola P, 2003, ANN NY ACAD SCI, V990, P173, DOI 10.1111/j.1749-6632.2003.tb07359.x; Reeves WK, 2005, J VECTOR ECOL, V30, P310; Reif KE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002805; SCHRIEFER ME, 1994, J CLIN MICROBIOL, V32, P949, DOI 10.1128/JCM.32.4.949-954.1994; SORVILLO FJ, 1993, AM J TROP MED HYG, V48, P269, DOI 10.4269/ajtmh.1993.48.269; Sunyakumthorn P, 2008, APPL ENVIRON MICROB, V74, P3151, DOI 10.1128/AEM.00025-08; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tay ST, 2015, EMERG INFECT DIS, V21, P545, DOI 10.3201/eid2103.141457; WILLIAMS SG, 1992, J CLIN MICROBIOL, V30, P1758, DOI 10.1128/JCM.30.7.1758-1762.1992; Znazen A, 2006, EMERG INFECT DIS, V12, P138, DOI 10.3201/eid1201.050876	49	47	48	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0160604	10.1371/journal.pone.0160604	http://dx.doi.org/10.1371/journal.pone.0160604			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27537367	Green Published, gold, Green Submitted			2022-12-27	WOS:000381577000026
J	Salem, J; Borgmann, H; Bultitude, M; Fritsche, HM; Haferkamp, A; Heidenreich, A; Miernik, A; Neisius, A; Knoll, T; Thomas, C; Tsaur, I				Salem, Johannes; Borgmann, Hendrik; Bultitude, Matthew; Fritsche, Hans-Martin; Haferkamp, Axel; Heidenreich, Axel; Miernik, Arkadiusz; Neisius, Andreas; Knoll, Thomas; Thomas, Christian; Tsaur, Igor			Online Discussion on #KidneyStones: A Longitudinal Assessment of Activity, Users and Content	PLOS ONE			English	Article							SOCIAL MEDIA; CALCIUM NEPHROLITHIASIS; RECURRENCE RATE; RISK-FACTORS; STONE; UROLITHIASIS; PROPHYLAXIS; PREVALENCE; OBESITY; CALCULI	Introduction Twitter is a popular microblogging platform for the rapid dissemination of information and reciprocal exchange in the urological field. We aimed to assess the activity, users and content of the online discussion, #KidneyStones, on Twitter. Methods We investigated the Symplur Signals analytics tool for Twitter data distributed via the #KidneyStones hashtag over a one year period. Activity analysis reflected overall activity and tweet enhancements. We assessed users' geolocations and performed an influencer analysis. Content analysis included the most frequently used words, tweet sentiment and shares for top tweets. Results 3,426 users generated over 10,333 tweets, which were frequently accompanied by links (49%), mentions (30%) and photos (13%). Users came from 106 countries across the globe and were most frequently from North America (63%) and Europe (16%). Individual and organisational healthcare professionals made up 56% of the influencers of the Twitter discussion on #KidneyStones. Besides the words 'kidney' (used 4,045 times) and 'stones' (3,335), 'pain' (1,233), 'urine' (1,158), and 'risk' (1,023) were the most frequently used words. 56% of tweets had a positive sentiment. The median (range) number of shares was 85 (62-587) for the top 10 links, 45.5 (17-94) for the top 10 photos, and 44 (22-95) for the top 10 retweets. Conclusion The rapidly growing Twitter discussion on #KidneyStones engaged multiple stakeholders in the healthcare sector on a global scale and reached both professionals and laypeople. When used effectively and responsibly, the Twitter platform could improve prevention and medical care of kidney stone patients.	[Salem, Johannes; Heidenreich, Axel] Univ Hosp, Dept Urol, Cologne, Germany; [Borgmann, Hendrik; Haferkamp, Axel; Neisius, Andreas; Thomas, Christian; Tsaur, Igor] Univ Med, Dept Urol, Mainz, Germany; [Bultitude, Matthew] Guys & St Thomas NHS Fdn Trust, Stone Unit, London, England; [Fritsche, Hans-Martin] Univ Regensburg, Caritas St Josef Hosp, Dept Urol, Regensburg, Germany; [Miernik, Arkadiusz] Univ Med Ctr, Dept Urol, Freiburg, Germany; [Knoll, Thomas] Klinikum Sindelfingen Boblingen, Dept Urol, Sindelfingen, Germany	University of Cologne; Guy's & St Thomas' NHS Foundation Trust; University of Regensburg; University of Freiburg	Salem, J (corresponding author), Univ Hosp, Dept Urol, Cologne, Germany.	j.salem@gesru.de	Miernik, Arkadiusz/AAF-1226-2020; Tsaur, Igor/ACG-6445-2022; Borgmann, Hendrik/F-4658-2015	Tsaur, Igor/0000-0001-5107-3523; Borgmann, Hendrik/0000-0002-3955-564X; Salem, Johannes/0000-0002-0528-9291				Antonelli JA, 2014, EUR UROL, V66, P724, DOI 10.1016/j.eururo.2014.06.036; Attai DJ, 2015, J MED INTERNET RES, V17, DOI 10.2196/jmir.4721; BARCELO P, 1993, J UROLOGY, V150, P1761, DOI 10.1016/S0022-5347(17)35888-3; Borghi L, 1996, J UROLOGY, V155, P839, DOI 10.1016/S0022-5347(01)66321-3; Borgmann HD, 2015, CUAJ, V9; Borgmann H, 2016, UROL ONCOL-SEMIN ORI, V34, P377, DOI 10.1016/j.urolonc.2016.02.021; Canvasser NE, 2015, J ENDOUROL, V29, P615, DOI 10.1089/end.2014.0329; Cardona-Grau D SI, 2016, EUR UROL FO IN PRESS, P138; Chung A, 2016, ANZ J SURG, V86, P224, DOI 10.1111/ans.13393; Dauw CA, 2016, J UROLOGY, V195, P648, DOI 10.1016/j.juro.2015.10.082; Dauw CA, 2015, J UROLOGY, V193, P885, DOI 10.1016/j.juro.2014.09.111; Davies N, 2015, BJU INT, V116, P984, DOI 10.1111/bju.13159; ETTINGER B, 1986, NEW ENGL J MED, V315, P1386, DOI 10.1056/NEJM198611273152204; Kocvara R, 1999, BJU INT, V84, P393; Kutikov A, 2016, EUR UROL, V69, P183, DOI 10.1016/j.eururo.2015.09.034; LAERUM E, 1984, ACTA MED SCAND, V215, P383; Leveridge MJ, 2016, WORLD J UROL, V34, P57, DOI 10.1007/s00345-015-1725-y; Loeb S, 2014, BJU INT, V113, P993, DOI 10.1111/bju.12586; Lotan Y, 2012, BJU INT, V110, pE1060, DOI 10.1111/j.1464-410X.2012.11212.x; Robillard JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069861; Scales CD, 2012, EUR UROL, V62, P160, DOI 10.1016/j.eururo.2012.03.052; Siener R, 2004, OBES RES, V12, P106, DOI 10.1038/oby.2004.14; Signals S., HEALTHC CAT DEF; Sun BYC, 1996, J UROLOGY, V156, P903, DOI 10.1016/S0022-5347(01)65657-X; Symplur, HEALTHC HASHT PROJ; Tasian GE, 2016, CLIN J AM SOC NEPHRO, V11, P488, DOI 10.2215/CJN.07610715; Thackeray R, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.3002; Thangasamy IA, 2014, EUR UROL, V66, P112, DOI 10.1016/j.eururo.2014.01.034; Trinchieri A, 1999, J UROLOGY, V162, P27, DOI 10.1097/00005392-199907000-00007; Weeg Christopher, 2015, JMIR Public Health Surveill, V1, pe6, DOI 10.2196/publichealth.3953	30	19	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0160863	10.1371/journal.pone.0160863	http://dx.doi.org/10.1371/journal.pone.0160863			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27537406	Green Submitted, Green Published, gold			2022-12-27	WOS:000381577000037
J	Venkatesh, J; Jahn, M; Kang, BC				Venkatesh, Jelli; Jahn, Molly; Kang, Byoung-Cheorl			Genome-Wide Analysis and Evolution of the Pto-Like Protein Kinase (PLPK) Gene Family in Pepper	PLOS ONE			English	Article							DISEASE RESISTANCE GENE; BACTERIAL SPECK DISEASE; AVIRULENCE GENE; SUBCELLULAR-LOCALIZATION; RECOGNITION SPECIFICITY; PHYLOGENETIC ANALYSIS; FUNCTIONAL-ANALYSIS; TOMATO CULTIVARS; MOLECULAR-BASIS; AVRPTO	The tomato Pto gene, which encodes a serine/threonine kinase (STK) domain-containing protein, confers resistance to bacterial speck disease caused by Pseudomonas syringae pv. tomato (Pst). In this study, in vivo recognition assays using PVX constructs showed that AvrPto was specifically recognized in the pepper genotypes. This AvrPto recognition caused a nonhost hypersensitive response (HR) and localization of the PVX::AvrPto fusion protein to inoculated pepper leaf tissues, which indicates the presence of a similar Pto recognition mechanism in pepper as in tomato. However, genome-wide analysis in pepper revealed no Pto clade corresponding to that in tomato, suggesting an alternative system for Pto recognition in pepper. Nevertheless, 25 Pto-like protein kinases (PLPKs) with a highly conserved STK domain have been identified in the pepper genome. For the majority of the amino acid sites in the STK domain of Ptos and PLPKs, nonsynonymous (dN) to synonymous (dS) nucleotide substitution ratios (omega) were less than one, suggesting that purifying selection played a predominant role in the evolutionary process. However, some amino acid sites were found to be subjected to episodic positive selection in the course of evolution of Pto homologs, and, thus, different evolutionary processes might have shaped the Pto gene family in plants. Based on RNA-seq data, PLPK genes and other Pto pathway genes, such as Prf, Pti1, Pti5, and Pti6 were expressed in all tested pepper genotypes. Therefore, the nonhost HR against Pst in pepper may be due to the recognition of the AvrPto effector by a PLPK homolog, and subsequent action of downstream components of the Pto signaling pathway. However, the possibility remains that the recognition of AvrPto in pepper plants may involve activities of other receptor like kinases (RLKs). The identification of the PLPKs in this study will serve as a foundation for further efforts to understand the roles of PLPKs in nonhost resistance.	[Venkatesh, Jelli; Kang, Byoung-Cheorl] Seoul Natl Univ, Dept Plant Sci, Vegetable Breeding Res Ctr, Seoul 151921, South Korea; [Venkatesh, Jelli; Kang, Byoung-Cheorl] Seoul Natl Univ, Plant Genom & Breeding Inst, Vegetable Breeding Res Ctr, Seoul 151921, South Korea; [Jahn, Molly] Univ Wisconsin, Madison, WI 53706 USA	Seoul National University (SNU); Seoul National University (SNU); University of Wisconsin System; University of Wisconsin Madison	Kang, BC (corresponding author), Seoul Natl Univ, Dept Plant Sci, Vegetable Breeding Res Ctr, Seoul 151921, South Korea.; Kang, BC (corresponding author), Seoul Natl Univ, Plant Genom & Breeding Inst, Vegetable Breeding Res Ctr, Seoul 151921, South Korea.	bk54@snu.ac.kr	Kang, Byoung-Cheorl/Q-6174-2019; Venkatesh, Jelli/O-8942-2019; Venkatesh, Jelli/E-7887-2018	Venkatesh, Jelli/0000-0002-8896-0385; Venkatesh, Jelli/0000-0002-8896-0385; Jahn, Molly/0000-0003-0181-0374	Vegetable Breeding Research Center through the R&D Convergence Center Support Program, Ministry for Food, Agriculture, Forestry and Fisheries [710001-03]; Next-Generation BioGreen 21 Program (Plant Molecular Breeding Center), Rural Development Administration [PJ00906501]	Vegetable Breeding Research Center through the R&D Convergence Center Support Program, Ministry for Food, Agriculture, Forestry and Fisheries; Next-Generation BioGreen 21 Program (Plant Molecular Breeding Center), Rural Development Administration	This research was funded by a grant (Project No. 710001-03) from the Vegetable Breeding Research Center through the R&D Convergence Center Support Program, Ministry for Food, Agriculture, Forestry and Fisheries. This work was also supported by a grant from the Next-Generation BioGreen 21 Program (Plant Molecular Breeding Center No. PJ00906501), Rural Development Administration. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was funded by a grant (Project No. 710001-03) from the Vegetable Breeding Research Center through the R&D Convergence Center Support Program, Ministry for Food, Agriculture, Forestry and Fisheries. This work was also supported by a grant from the Next-Generation BioGreen 21 Program (Plant Molecular Breeding Center No. PJ00906501), Rural Development Administration. We would like to thank Dr. Marco van Schriek at KeyGene for microarray analysis. We thank G.B. Martin, D. Baulcombe, A.R. Collmer, Y.-J. Kim, B. Riely, R. Stall, X. Tang, and S.D. Tanksley for providing experimental materials.	Abramovitch RB, 2003, EMBO J, V22, P60, DOI 10.1093/emboj/cdg006; Balmuth A, 2007, PLANT J, V51, P978, DOI 10.1111/j.1365-313X.2007.03199.x; BAULCOMBE DC, 1995, PLANT J, V7, P1045, DOI 10.1046/j.1365-313X.1995.07061045.x; Belkhadir Y, 2004, CURR OPIN PLANT BIOL, V7, P391, DOI 10.1016/j.pbi.2004.05.009; Bogdanove AJ, 2000, P NATL ACAD SCI USA, V97, P8836, DOI 10.1073/pnas.97.16.8836; Chang JH, 2002, MOL PLANT MICROBE IN, V15, P281, DOI 10.1094/MPMI.2002.15.3.281; Chang JH, 2001, MOL PLANT MICROBE IN, V14, P451, DOI 10.1094/MPMI.2001.14.4.451; Chang TH, 2013, J COMPUT AID MOL DES, V27, P91, DOI 10.1007/s10822-012-9628-0; Chen QH, 2010, J MOL EVOL, V70, P137, DOI 10.1007/s00239-009-9316-4; Chisholm ST, 2006, CELL, V124, P803, DOI 10.1016/j.cell.2006.02.008; Collier SM, 2009, TRENDS PLANT SCI, V14, P521, DOI 10.1016/j.tplants.2009.08.001; Collmer A, 2000, P NATL ACAD SCI USA, V97, P8770, DOI 10.1073/pnas.97.16.8770; Cui HT, 2015, ANNU REV PLANT BIOL, V66, P487, DOI 10.1146/annurev-arplant-050213-040012; Cui HT, 2009, CELL MICROBIOL, V11, P1453, DOI 10.1111/j.1462-5822.2009.01359.x; Delport W, 2010, BIOINFORMATICS, V26, P2455, DOI 10.1093/bioinformatics/btq429; Deng Z, 2003, THEOR APPL GENET, V108, P53, DOI 10.1007/s00122-003-1410-1; Di Gaspero G, 2003, MOL GENET GENOMICS, V269, P612, DOI 10.1007/s00438-003-0884-5; Frederick RD, 1998, MOL CELL, V2, P241, DOI 10.1016/S1097-2765(00)80134-3; Gilardi P, 1998, MOL PLANT MICROBE IN, V11, P1253, DOI 10.1094/MPMI.1998.11.12.1253; Gimenez-Ibanez S, 2009, CURR BIOL, V19, P423, DOI 10.1016/j.cub.2009.01.054; Gohre V, 2008, ANNU REV PHYTOPATHOL, V46, P189, DOI 10.1146/annurev.phyto.46.120407.110050; Grube RC, 2000, PLANT DIS, V84, P885, DOI 10.1094/PDIS.2000.84.8.885; Gu YQ, 2002, PLANT CELL, V14, P817, DOI 10.1105/tpc.000794; Gururani MA, 2012, PHYSIOL MOL PLANT P, V78, P51, DOI 10.1016/j.pmpp.2012.01.002; Gutierrez JR, 2010, PLANT J, V61, P507, DOI 10.1111/j.1365-313X.2009.04078.x; Hammond-Kosack KE, 2003, CURR OPIN BIOTECH, V14, P177, DOI 10.1016/S0958-1669(03)00035-1; Hardie DG, 1999, ANNU REV PLANT PHYS, V50, P97, DOI 10.1146/annurev.arplant.50.1.97; He P, 2001, MOL PLANT MICROBE IN, V14, P1453, DOI 10.1094/MPMI.2001.14.12.1453; Hok S, 2011, PLANT CELL ENVIRON, V34, P1944, DOI 10.1111/j.1365-3040.2011.02390.x; Hulbert SH, 2001, ANNU REV PHYTOPATHOL, V39, P285, DOI 10.1146/annurev.phyto.39.1.285; Jia YL, 1997, PLANT CELL, V9, P61, DOI 10.1105/tpc.9.1.61; Kang JH, 2014, KOREAN J HORTIC SCI, V32, P535, DOI 10.7235/hort.2014.14109; Kang L, 2004, MOL PLANT MICROBE IN, V17, P1328, DOI 10.1094/MPMI.2004.17.12.1328; Kim YJ, 2002, CELL, V109, P589, DOI 10.1016/S0092-8674(02)00743-2; Pond SLK, 2006, MOL BIOL EVOL, V23, P1891, DOI 10.1093/molbev/msl051; Lin NC, 2007, MOL PLANT MICROBE IN, V20, P806, DOI 10.1094/MPMI-20-7-0806; Livingstone KD, 1999, GENETICS, V152, P1183; LOH YT, 1995, PLANT PHYSIOL, V108, P1735, DOI 10.1104/pp.108.4.1735; MARTIN GB, 1993, SCIENCE, V262, P1432, DOI 10.1126/science.7902614; MARTIN GB, 1994, PLANT CELL, V6, P1543, DOI 10.1105/tpc.6.11.1543; Martin GB, 1999, CURR OPIN PLANT BIOL, V2, P273, DOI 10.1016/S1369-5266(99)80049-1; Zamora MGM, 2008, J MOL EVOL, V67, P211, DOI 10.1007/s00239-008-9134-0; Mathieu J, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004227; Michelmore RW, 1998, GENOME RES, V8, P1113, DOI 10.1101/gr.8.11.1113; Oh CS, 2011, TRENDS PLANT SCI, V16, P132, DOI 10.1016/j.tplants.2010.11.001; Pan QL, 2000, J MOL EVOL, V50, P203, DOI 10.1007/s002399910023; Pedley KF, 2003, ANNU REV PHYTOPATHOL, V41, P215, DOI 10.1146/annurev.phyto.41.121602.143032; Peraza-Echeverria S, 2007, MOL GENET GENOMICS, V278, P443, DOI 10.1007/s00438-007-0262-9; Pflieger S, 1999, GENOME, V42, P1100, DOI 10.1139/gen-42-6-1100; Pond SLK, 2011, MOL BIOL EVOL; Rathjen JP, 1999, EMBO J, V18, P3232, DOI 10.1093/emboj/18.12.3232; Richter TE, 2000, PLANT MOL BIOL, V42, P195, DOI 10.1023/A:1006388223475; Riely BK, 2001, P NATL ACAD SCI USA, V98, P2059, DOI 10.1073/pnas.98.4.2059; RONALD PC, 1992, J BACTERIOL, V174, P1604, DOI 10.1128/jb.174.5.1604-1611.1992; Rose LE, 2007, GENETICS, V175, P1307, DOI 10.1534/genetics.106.063602; Saur IML, 2015, J BIOL CHEM, V290, P11258, DOI 10.1074/jbc.M114.616532; Scofield SR, 1996, SCIENCE, V274, P2063, DOI 10.1126/science.274.5295.2063; Sessa G, 2000, EMBO J, V19, P2257, DOI 10.1093/emboj/19.10.2257; Shan LB, 2000, PLANT CELL, V12, P2323, DOI 10.1105/tpc.12.12.2323; Shan LB, 2008, CELL HOST MICROBE, V4, P17, DOI 10.1016/j.chom.2008.05.017; Speth EB, 2009, PLANT PHYSIOL, V149, P1824, DOI 10.1104/pp.108.132092; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tanksley SD, 1997, REPT TOMATO GENET CO, V47, P35; Tobias CM, 1999, PLANT J, V17, P41, DOI 10.1046/j.1365-313X.1999.00350.x; Vallad G, 2001, THEOR APPL GENET, V103, P1046, DOI 10.1007/s001220100705; van der Hoorn RAL, 2008, PLANT CELL, V20, P2009, DOI 10.1105/tpc.108.060194; Vleeshouwers VGAA, 2001, MOL PLANT MICROBE IN, V14, P996, DOI 10.1094/MPMI.2001.14.8.996; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Wan HJ, 2013, PLANT MOL BIOL REP, V31, P901, DOI 10.1007/s11105-013-0564-5; Wan HJ, 2010, FUNCT PLANT BIOL, V37, P513, DOI 10.1071/FP09205; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; White FF, 2000, CURR OPIN PLANT BIOL, V3, P291, DOI 10.1016/S1369-5266(00)00082-0; Xiang TT, 2008, CURR BIOL, V18, P74, DOI 10.1016/j.cub.2007.12.020; Yeam I, 2010, PLANT J, V61, P16, DOI 10.1111/j.1365-313X.2009.04028.x; Yuan M, 2009, PLANT CELL PHYSIOL, V50, P947, DOI 10.1093/pcp/pcp046	75	4	5	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0161545	10.1371/journal.pone.0161545	http://dx.doi.org/10.1371/journal.pone.0161545			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27536870	gold, Green Published, Green Submitted			2022-12-27	WOS:000381577000121
J	Hasche, D; Stephan, S; Savelyeva, L; Westermann, F; Rosl, F; Vinzon, SE				Hasche, Daniel; Stephan, Sonja; Savelyeva, Larissa; Westermann, Frank; Roesl, Frank; Vinzon, Sabrina E.			Establishment of an Immortalized Skin Keratinocyte Cell Line Derived from the Animal Model Mastomys coucha	PLOS ONE			English	Article							NATALENSIS; CANCER; P53; DIFFERENTIATION; VACCINATION; DOXORUBICIN; EXPRESSION; PREVENTION; MUTATIONS; BINDING	In the present report we describe the establishment of a spontaneous immortalized skin keratinocyte cell line derived from the skin of the multimammate rodent Mastomys coucha. These animals are used in preclinical studies for a variety of human diseases such as infections with nematodes, bacteria and papillomaviruses, especially regarding cutaneous manifestations such as non-melanoma skin cancer. Here we characterize the cells in terms of their origin and cytogenetic features. Searching for genomic signatures, a spontaneous mutation in the splicing donor sequence of Trp53 (G to A transition at the first position of intron 7) could be detected. This point mutation leads to alternative splicing and to a premature stop codon, resulting in a truncated and, in turn, undetectable form of p53, probably contributing to the process of immortalization. Mastomys coucha-derived skin keratinocytes can be used as an in vitro system to investigate molecular and immunological aspects of infectious agent interactions with their host cells.	[Hasche, Daniel; Stephan, Sonja; Roesl, Frank; Vinzon, Sabrina E.] German Canc Res Ctr, Div Viral Transformat Mech F030, Heidelberg, Germany; [Savelyeva, Larissa; Westermann, Frank] German Canc Res Ctr, Div Neuroblastoma Genom B087, Heidelberg, Germany; [Vinzon, Sabrina E.] IIBBA CONICET, Fdn Inst Leloir, Lab Mol & Cellular Therapy, Buenos Aires, DF, Argentina	Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Leloir Institute	Rosl, F; Vinzon, SE (corresponding author), German Canc Res Ctr, Div Viral Transformat Mech F030, Heidelberg, Germany.; Vinzon, SE (corresponding author), IIBBA CONICET, Fdn Inst Leloir, Lab Mol & Cellular Therapy, Buenos Aires, DF, Argentina.	f.roesl@dkfz.de; s.vinzon@dkfz.de	Vinzon, Sabrina/HFZ-9144-2022; Westermann, Frank/F-7509-2013; Vinzón, Sabrina/Q-1631-2019; Hasche, Daniel/ABC-3206-2020	Vinzón, Sabrina/0000-0002-1330-9125; Hasche, Daniel/0000-0001-9306-3059	Eurostars Project [E! 6872 TOSCA, 01QE1203C]	Eurostars Project	This study was supported by the "Eurostars Project" E! 6872 TOSCA (01QE1203C). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ast G, 2004, NAT REV GENET, V5, P773, DOI 10.1038/nrg1451; Boccellino M, 2010, TOXICOL LETT, V197, P61, DOI 10.1016/j.toxlet.2010.04.026; Borowiec AS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077507; Caldelari R, 2010, METHODS MOL BIOL, V633, P125, DOI 10.1007/978-1-59745-019-5_10; Cavallo F, 2006, ADV IMMUNOL, V90, P175, DOI 10.1016/S0065-2776(06)90005-4; Chapman S, 2010, J CLIN INVEST, V120, P2619, DOI 10.1172/JCI42297; Diederichs S, 2016, EMBO MOL MED, V8, P442, DOI 10.15252/emmm.201506055; Doorbar J, 2016, J PATHOL, V238, P166, DOI 10.1002/path.4656; ELDEIRY WS, 1992, NAT GENET, V1, P45, DOI 10.1038/ng0492-45; Golunski G, 2016, BIOCHIMIE, V123, P95, DOI 10.1016/j.biochi.2016.02.003; Goodpaster T, 2008, J HISTOCHEM CYTOCHEM, V56, P347, DOI 10.1369/jhc.7A7287.2007; Hanel W, 2012, J CELL BIOCHEM, V113, P433, DOI 10.1002/jcb.23400; Hodivala-Dilke Kairbaan, 2002, Methods Mol Biol, V188, P139; Khoury MP, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000927; Koga T, 2002, J MED MICROBIOL, V51, P777, DOI 10.1099/0022-1317-51-9-777; KRUPPA TF, 1990, TROP MED PARASITOL, V41, P219; Kushwaha S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072585; Kvac M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147090; Larmour LI, 2015, INT J GYNECOL CANCER, V25, P1345, DOI 10.1097/IGC.0000000000000525; Le Hir H, 2016, NAT REV MOL CELL BIO, V17, DOI 10.1038/nrm.2015.7; LEHMAN TA, 1993, CARCINOGENESIS, V14, P833, DOI 10.1093/carcin/14.5.833; Leibiger C, 2013, J HISTOCHEM CYTOCHEM, V61, P306, DOI 10.1369/0022155413476868; Lutzner N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032590; Macville M, 1999, CANCER RES, V59, P141; Matt S, 2016, CELL MOL LIFE SCI, V73, P2829, DOI 10.1007/s00018-016-2130-4; Moll R, 2008, HISTOCHEM CELL BIOL, V129, P705, DOI 10.1007/s00418-008-0435-6; MOMPARLER RL, 1976, CANCER RES, V36, P2891; MULLER H, 1978, J GEN VIROL, V41, P315, DOI 10.1099/0022-1317-41-2-315; MURPHY GF, 1984, J INVEST DERMATOL, V82, P453, DOI 10.1111/1523-1747.ep12260945; Nafz J, 2008, VIROLOGY, V374, P186, DOI 10.1016/j.virol.2007.12.012; Ng G, 2006, J MOL DIAGN, V8, P449, DOI 10.2353/jmoldx.2006.060033; Niebler M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003536; Ojok L, 2002, VET PARASITOL, V105, P327, DOI 10.1016/S0304-4017(02)00017-1; Olayemi A, 2016, SCI REP-UK, V6, DOI 10.1038/srep25280; Olivier M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001008; Pandit SK, 2013, TRENDS CELL BIOL, V23, P556, DOI 10.1016/j.tcb.2013.06.002; Reizner W, 2014, EUR CELLS MATER, V27, P196, DOI 10.22203/eCM.v027a15; Salvermoser M, 2016, J GEN VIROL, V97, P1658, DOI 10.1099/jgv.0.000471; Schoenfelder KP, 2015, J CELL BIOL, V209, P485, DOI 10.1083/jcb.201502016; STRICKLAND JE, 1988, CANCER RES, V48, P165; Verma SK, 2015, VACCINE, V33, P527, DOI 10.1016/j.vaccine.2014.11.041; Vinzon SE, 2015, HUM VACC IMMUNOTHER, V11, P353, DOI 10.4161/21645515.2014.983858; Vinzon SE, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003924; Weiss J., 2008, TIERPFLEGE FORSCHUNG; YUSPA SH, 1989, J CELL BIOL, V109, P1207, DOI 10.1083/jcb.109.3.1207	45	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2016	11	8							e0161283	10.1371/journal.pone.0161283	http://dx.doi.org/10.1371/journal.pone.0161283			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4YN	27533138	gold, Green Published, Green Submitted			2022-12-27	WOS:000381487600081
J	Tokushima, Y; Uehara, T; Yamaguchi, T; Arikawa, K; Kainoh, Y; Shimoda, M				Tokushima, Yoshiaki; Uehara, Takuya; Yamaguchi, Terumi; Arikawa, Kentaro; Kainoh, Yooichi; Shimoda, Masami			Broadband Photoreceptors Are Involved in Violet Light Preference in the Parasitoid Fly Exorista Japonica	PLOS ONE			English	Article							COLOR-VISION; PHOTOTACTIC BEHAVIOR; SPECTRAL PREFERENCE; DROSOPHILA-MELANOGASTER; TSETSE-FLY; HOST; TACHINIDAE; GREEN; ORIENTATION; SENSITIVITY	Phototaxis has been described in many insects, which are often attracted to specific wavelengths of light. However, little is known about phototaxis in parasitoid insect species that are potentially useful for integrated pest management. In this study, we investigated the wavelength dependency of the phototactic behavior of the parasitoid fly Exorista japonica and its possible mechanism. Multiple-choice tests with six monochromatic stimuli revealed that the flies were specifically attracted to violet light peaking at 405 nm, which was unexpected because insects are generally attracted to ultraviolet or green light. We measured the spectral sensitivity of the compound eye, and found that the sensitivity peaked at 340 nm, as in other brachyceran flies. We used statistical modeling and optimization of the process parameters to predict the type of photoreceptor contributing to the violet preference. The analysis revealed that the wavelength preference could be explained by linear models of the quanta received by photoreceptors, including the R1-6 broadband receptors. The broadband receptors appear to contribute positively, whereas the R7-8 narrowband receptors contribute negatively to achieve the violet preference; i.e., spectral opponency might be involved.	[Tokushima, Yoshiaki; Uehara, Takuya; Yamaguchi, Terumi; Shimoda, Masami] NARO, Inst Agrobil Sci, Tsukuba, Ibaraki, Japan; [Tokushima, Yoshiaki] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 305, Japan; [Arikawa, Kentaro] SOKENDAI, Lab Neuroethol, Hayama, Japan; [Kainoh, Yooichi] Univ Tsukuba, Fac Life & Environm Sci, Tsukuba, Ibaraki 305, Japan	National Agriculture & Food Research Organization - Japan; University of Tsukuba; Graduate University for Advanced Studies - Japan; University of Tsukuba	Shimoda, M (corresponding author), NARO, Inst Agrobil Sci, Tsukuba, Ibaraki, Japan.; Kainoh, Y (corresponding author), Univ Tsukuba, Fac Life & Environm Sci, Tsukuba, Ibaraki 305, Japan.	kainoh.yooichi.gf@u.tsukuba.ac.jp; shimoda1@affrc.go.jp	Uehara, Takuya/I-4880-2019; Kainoh, Yooichi/AAF-5717-2020	Uehara, Takuya/0000-0002-4871-0197; Kainoh, Yooichi/0000-0002-7183-2483; Arikawa, Kentaro/0000-0002-4365-0762	Cross-ministerial Strategic Innovation Promotion Program (SIP), "Technologies for creating next-generation agriculture, forestry, and fisheries" (funding agency: Bio-oriented Technology Research Advancement Institution, NARO); JSPS KAKENHI grant [25660268, 16K14868]	Cross-ministerial Strategic Innovation Promotion Program (SIP), "Technologies for creating next-generation agriculture, forestry, and fisheries" (funding agency: Bio-oriented Technology Research Advancement Institution, NARO); JSPS KAKENHI grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was partially supported by the Cross-ministerial Strategic Innovation Promotion Program (SIP), "Technologies for creating next-generation agriculture, forestry, and fisheries" (funding agency: Bio-oriented Technology Research Advancement Institution, NARO) and by JSPS KAKENHI grant numbers 25660268 and 16K14868 to MS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auguie B, 2017, GRIDEXTRA MISCELLANE; BUCHSBAUM G, 1983, PROC R SOC SER B-BIO, V220, P89, DOI 10.1098/rspb.1983.0090; COOMBE PE, 1982, PHYSIOL ENTOMOL, V7, P243, DOI 10.1111/j.1365-3032.1982.tb00297.x; Crawley MJ, 2005, STAT INTRO USING R; Dobson AJ., 2008, INTRO GEN LINEAR MOD, DOI 10.1201/9780367807849; GREEN CH, 1983, J INSECT PHYSIOL, V29, P795, DOI 10.1016/0022-1910(83)90009-4; Ichiki RT, 2008, J CHEM ECOL, V34, P614, DOI 10.1007/s10886-008-9459-6; Ichiki RT, 2011, ENTOMOL EXP APPL, V138, P175, DOI 10.1111/j.1570-7458.2010.01091.x; JACOB KG, 1977, J COMP PHYSIOL, V116, P209, DOI 10.1007/BF00605403; JANDER R, 1963, ANNU REV ENTOMOL, V8, P95, DOI 10.1146/annurev.en.08.010163.000523; Kanda K., 1991, REARING METHOD INSEC, P206; Karuppudurai T, 2014, NEURON, V81, P603, DOI 10.1016/j.neuron.2013.12.010; Kelber A, 2003, BIOL REV, V78, P81, DOI 10.1017/S1464793102005985; Kelber A, 2001, ENTOMOL EXP APPL, V99, P231, DOI 10.1023/A:1019244619503; Kelber A, 1999, J EXP BIOL, V202, P2619; Kinoshita M, 1999, J EXP BIOL, V202, P95; Kinoshita M, 2014, J COMP PHYSIOL A, V200, P513, DOI 10.1007/s00359-014-0903-5; Kishi M, 2014, JPN J APPL ENTOMOL Z, V58, P13, DOI 10.1303/jjaez.2014.13; Lunau K, 2014, J COMP PHYSIOL A, V200, P497, DOI 10.1007/s00359-014-0895-1; Menzel R., 1979, COMP PHYSL EVOLUTION, P503; Moller R, 2002, J THEOR BIOL, V214, P619, DOI 10.1006/jtbi.2001.2484; Nakamura S, 1997, APPL ENTOMOL ZOOL, V32, P189, DOI 10.1303/aez.32.189; Ogino T, 2015, JPN J APPL ENTOMOL Z, V59, P10, DOI 10.1303/jjaez.2015.10; Ohashi K, 2015, FUNCT ECOL, V29, P1144, DOI 10.1111/1365-2435.12420; Otalora-Luna F, 2011, ENTOMOL EXP APPL, V138, P93, DOI 10.1111/j.1570-7458.2010.01081.x; Otani Y, 2014, JPN J APPL ENTOMOL Z, V58, P177, DOI 10.1303/jjaez.2014.177; Otsuna H, 2015, NEURAL CIRCUITS JPN, V99; Ottoson D, 1985, PROGR SENSORY PHYSL, P1; PROKOPY RJ, 1983, ANNU REV ENTOMOL, V28, P337, DOI 10.1146/annurev.en.28.010183.002005; ROBERTS AE, 1992, ENTOMOL EXP APPL, V64, P259, DOI 10.1007/BF00341089; Santer RD, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004121; Santer RD, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003360; Schnaitmann C, 2013, CURR BIOL, V23, P2375, DOI 10.1016/j.cub.2013.10.037; SCHUMPERLI RA, 1973, J COMP PHYSIOL, V86, P77, DOI 10.1007/BF00694480; Shimoda M, 2013, APPL ENTOMOL ZOOL, V48, P413, DOI 10.1007/s13355-013-0219-x; Stireman JO, 2006, ANNU REV ENTOMOL, V51, P525, DOI 10.1146/annurev.ento.51.110104.151133; Tanaka C, 1999, APPL ENTOMOL ZOOL, V34, P91, DOI 10.1303/aez.34.91; Uehara T, 2014, JPN J APPL ENTOMOL Z, V58, P36, DOI 10.1303/jjaez.2014.36; Wakakuwa M, 2014, J COMP PHYSIOL A, V200, P527, DOI 10.1007/s00359-014-0892-4; Yamaguchi S, 2010, P NATL ACAD SCI USA, V107, P5634, DOI 10.1073/pnas.0809398107; Yamawaki Y, 2002, J EXP BIOL, V205, P485; Yamawaki Y, 2005, ZOOL SCI, V22, P563, DOI 10.2108/zsj.22.563	42	15	16	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2016	11	8							e0160441	10.1371/journal.pone.0160441	http://dx.doi.org/10.1371/journal.pone.0160441			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4YN	27532635	Green Published, gold, Green Submitted			2022-12-27	WOS:000381487600030
J	Vanselow, J; Vernunft, A; Koczan, D; Spitschak, M; Kuhla, B				Vanselow, Jens; Vernunft, Andreas; Koczan, Dirk; Spitschak, Marion; Kuhla, Bjoern			Exposure of Lactating Dairy Cows to Acute Pre-Ovulatory Heat Stress Affects Granulosa Cell-Specific Gene Expression Profiles in Dominant Follicles	PLOS ONE			English	Article							HUMAN CHORIONIC-GONADOTROPIN; ACTIVIN-BINDING PROTEIN; DEVELOPMENTAL COMPETENCE; FOLLICULAR DEVELOPMENT; HYALURONAN SYNTHESIS; OOCYTE COMPETENCE; CORPUS-LUTEUM; HOLSTEIN COWS; RAT OVARY; FOLLISTATIN	High environmental temperatures induce detrimental effects on various reproductive processes in cattle. According to the predicted global warming the number of days with unfavorable ambient temperatures will further increase. The objective of this study was to investigate effects of acute heat stress during the late pre-ovulatory phase on morphological, physiological and molecular parameters of dominant follicles in cycling cows during lactation. Eight German Holstein cows in established lactation were exposed to heat stress (28 degrees C) or thermoneutral conditions (15 degrees C) with pair-feeding for four days. After hormonal heat induction growth of the respective dominant follicles was monitored by ultrasonography for two days, then an ovulatory GnRH dose was given and follicular steroid hormones and granulosa cell-specific gene expression profiles were determined 23 hrs thereafter. The data showed that the pre-ovulatory growth of dominant follicles and the estradiol, but not the progesterone concentrations tended to be slightly affected. mRNA microarray and hierarchical cluster analysis revealed distinct expression profiles in granulosa cells derived from heat stressed compared to pair-fed animals. Among the 255 affected genes heatstress-, stress- or apoptosis associated genes were not present. But instead, we found upregulation of genes essentially involved in G-protein coupled signaling pathways, extracellular matrix composition, and several members of the solute carrier family as well as up-regulation of FST encoding follistatin. In summary, the data of the present study show that acute pre-ovulatory heat stress can specifically alter gene expression profiles in granulosa cells, however without inducing stress related genes and pathways and suggestively can impair follicular growth due to affecting the activin-inhibin-follistatin system.	[Vanselow, Jens; Vernunft, Andreas] Leibniz Inst Farm Anim Biol FBN, Inst Reprod Biol, D-18196 Dummerstorf, Germany; [Kuhla, Bjoern] Leibniz Inst Farm Anim Biol FBN, Inst Nutr Physiol, D-18196 Dummerstorf, Germany; [Spitschak, Marion] Leibniz Inst Farm Anim Biol FBN, Inst Genome Biol, D-18196 Dummerstorf, Germany; [Koczan, Dirk] Univ Rostock, Inst Immunol, D-18055 Rostock, Germany	Forschungsinstitut fur Nutztierbiologie (FBN); Forschungsinstitut fur Nutztierbiologie (FBN); Forschungsinstitut fur Nutztierbiologie (FBN); University of Rostock	Vanselow, J (corresponding author), Leibniz Inst Farm Anim Biol FBN, Inst Reprod Biol, D-18196 Dummerstorf, Germany.; Kuhla, B (corresponding author), Leibniz Inst Farm Anim Biol FBN, Inst Nutr Physiol, D-18196 Dummerstorf, Germany.	vanselow@fbn-dummerstorf.de; b.kuhla@fbn-dummerstorf.de	Vanselow, Jens/ABU-1095-2022		core budget of the Leibniz Institute for Farm Animals (FBN); Open Access fund of the Leibniz Association; core budget of the FBN	core budget of the Leibniz Institute for Farm Animals (FBN); Open Access fund of the Leibniz Association; core budget of the FBN	This study was supported by the core budget of the Leibniz Institute for Farm Animals (FBN) and the publication of this article was funded by the Open Access fund of the Leibniz Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We express our gratitude to the staff of the Tiertechnikum at the FBN and we thank M. Anders and V. Schreiter (all Leibniz Institute for Farm Animal Biology) for excellent technical assistance with sampling and analysis. This study was supported by the core budget of the FBN.	Abdoon AS, 2014, THERIOGENOLOGY, V82, P1055, DOI 10.1016/j.theriogenology.2014.07.008; Al-Katanani YM, 1999, J DAIRY SCI, V82, P2611, DOI 10.3168/jds.S0022-0302(99)75516-5; Aroyo A, 2007, THERIOGENOLOGY, V67, P1013, DOI 10.1016/j.theriogenology.2006.12.001; Baddela VS, 2014, REPROD BIOL ENDOCRIN, V12, P1, DOI 10.1186/1477-7827-12-118; BADINGA L, 1993, THERIOGENOLOGY, V39, P797, DOI 10.1016/0093-691X(93)90419-6; Baufeld A, 2013, CELL TISSUE RES, V354, P869, DOI 10.1007/s00441-013-1712-9; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bharadwaj AG, 2009, AM J PATHOL, V174, P1027, DOI 10.2353/ajpath.2009.080501; Chebel RC, 2004, ANIM REPROD SCI, V84, P239, DOI 10.1016/j.anireprosci.2003.12.012; Chong ZL, 2015, ANIM REPROD SCI, V155, P80, DOI 10.1016/j.anireprosci.2015.02.003; Christenson LK, 2013, MOL ENDOCRINOL, V27, P1153, DOI 10.1210/me.2013-1093; De Rensis F, 2003, THERIOGENOLOGY, V60, P1139, DOI 10.1016/S0093-691X(03)00126-2; ESCH FS, 1987, MOL ENDOCRINOL, V1, P849, DOI 10.1210/mend-1-11-849; Eslamizad M, 2015, PHYSIOL BEHAV, V145, P64, DOI 10.1016/j.physbeh.2015.03.044; Fu Y, 2014, INT J MOL SCI, V15, P21090, DOI 10.3390/ijms151121090; Gendelman M, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.092882; Glister C, 2011, REPRODUCTION, V142, P581, DOI 10.1530/REP-11-0150; Gregory SJ, 2004, SEMIN REPROD MED, V 22, P253, DOI 10.1055/s-2004-831901; Guzeloglu A, 2001, ANIM REPROD SCI, V66, P15, DOI 10.1016/S0378-4320(01)00082-3; Hansen PJ, 1999, J ANIM SCI, V77, P36; Hunter RHF, 2005, J ANIM PHYSIOL AN N, V89, P240, DOI 10.1111/j.1439-0396.2005.00509.x; Hunter RHF, 2000, HUM REPROD, V15, P273, DOI 10.1093/humrep/15.2.273; Itano N, 2002, IUBMB LIFE, V54, P195, DOI 10.1080/15216540214929; Kussano NR, 2016, THERIOGENOLOGY, V85, P1167, DOI 10.1016/j.theriogenology.2015.11.033; Lamp O, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125264; Li L, 2016, CELL STRESS CHAPERON, V21, P467, DOI 10.1007/s12192-016-0673-9; Lin CC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4551; Miro F, 1996, ENDOCRINOLOGY, V137, P464, DOI 10.1210/en.137.2.464; NAKAMURA T, 1990, SCIENCE, V247, P836, DOI 10.1126/science.2106159; Nimz M, 2009, DOMEST ANIM ENDOCRIN, V37, P45, DOI 10.1016/j.domaniend.2009.02.002; Pennarossa G, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.104018; Phillips DJ, 1998, FRONT NEUROENDOCRIN, V19, P287, DOI 10.1006/frne.1998.0169; Ploutarchou P, 2015, REPRODUCTION, V149, P533, DOI 10.1530/REP-14-0503; PUTNEY DJ, 1988, BIOL REPROD, V39, P717, DOI 10.1095/biolreprod39.3.717; Rhoads ML, 2009, J DAIRY SCI, V92, P1986, DOI 10.3168/jds.2008-1641; Rodgers RJ, 2010, BIOL REPROD, V82, P1021, DOI 10.1095/biolreprod.109.082941; Rodgers RJ, 2003, REPRODUCTION, V126, P415, DOI 10.1530/rep.0.1260415; Romero JJ, 2013, PHYSIOL GENOMICS, V45, P1095, DOI 10.1152/physiolgenomics.00082.2013; Roth Z, 2000, J REPROD FERTIL, V120, P83, DOI 10.1530/reprod/120.1.83; Schmahl J, 2008, GENE DEV, V22, P3255, DOI 10.1101/gad.1723908; Schoenfelder M, 2003, BIOL REPROD, V69, P269, DOI 10.1095/biolreprod.102.011577; Shehab-El-Deen MAMM, 2010, ANIM REPROD SCI, V117, P189, DOI 10.1016/j.anireprosci.2009.04.013; Sirois J, 2004, HUM REPROD UPDATE, V10, P373, DOI 10.1093/humupd/dmh032; SIROIS J, 1994, ENDOCRINOLOGY, V135, P841, DOI 10.1210/en.135.3.841; Sirotkin AV, 2011, CELL STRESS CHAPERON, V16, P379, DOI 10.1007/s12192-010-0252-4; Sirotkin AV, 2010, J EXP BIOL, V213, P2125, DOI 10.1242/jeb.040626; Soto P, 2009, MOL REPROD DEV, V76, P637, DOI 10.1002/mrd.20986; Spitschak M, 2012, GEN COMP ENDOCR, V178, P37, DOI 10.1016/j.ygcen.2012.04.001; Stangaferro ML, 2014, ANIM REPROD SCI, V148, P97, DOI 10.1016/j.anireprosci.2014.06.005; Stock AE, 2002, ENDOCRINOLOGY, V143, P4375, DOI 10.1210/en.2002-220563; Takahashi N, 2014, REPRODUCTION, V147, P189, DOI 10.1530/REP-13-0464; Torres-Junior JRD, 2008, THERIOGENOLOGY, V69, P155, DOI 10.1016/j.theriogenology.2007.06.023; Vernunft A, 2013, VET MED-CZECH, V58, P221, DOI 10.17221/6760-VETMED; Vitoratos N, 2006, ANN NY ACAD SCI, V1092, P310, DOI 10.1196/annals.1365.029; Wang SH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125816; Wolfenson D, 1997, ANIM REPROD SCI, V47, P9, DOI 10.1016/S0378-4320(96)01638-7; Xu J, 2006, J CLIN ENDOCR METAB, V91, P1544, DOI 10.1210/jc.2005-2776; Xu J, 2007, ENDOCRINOLOGY, V148, P5385, DOI 10.1210/en.2007-0541; Yamada K, 2004, BIOL REPROD, V70, P76, DOI 10.1095/biolreprod.103.020107; Yan KQ, 2013, MOL CELL ENDOCRINOL, V372, P73, DOI 10.1016/j.mce.2013.03.027; Yenuganti VR, 2016, GEN COMP ENDOCR, V232, P134, DOI 10.1016/j.ygcen.2016.04.020	61	10	10	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2016	11	8							e0160600	10.1371/journal.pone.0160600	http://dx.doi.org/10.1371/journal.pone.0160600			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4YN	27532452	Green Submitted, Green Published, gold			2022-12-27	WOS:000381487600038
J	Wang, K; Langevin, S; O'Hern, CS; Shattuck, MD; Ogle, S; Forero, A; Morrison, J; Slayden, R; Katze, MG; Kirby, M				Wang, Kun; Langevin, Stanley; O'Hern, Corey S.; Shattuck, Mark D.; Ogle, Serenity; Forero, Adriana; Morrison, Juliet; Slayden, Richard; Katze, Michael G.; Kirby, Michael			Anomaly Detection in Host Signaling Pathways for the Early Prognosis of Acute Infection	PLOS ONE			English	Article							ACUTE INFLAMMATORY RESPONSE; REDUCED MATHEMATICAL-MODEL; GENE-EXPRESSION; INFLUENZA-VIRUS; TNF-ALPHA; LPS; LIPOPOLYSACCHARIDE; CELLS; INTERLEUKIN-10; INDUCTION	Clinical diagnosis of acute infectious diseases during the early stages of infection is critical to administering the appropriate treatment to improve the disease outcome. We present a data driven analysis of the human cellular response to respiratory viruses including influenza, respiratory syncytia virus, and human rhinovirus, and compared this with the response to the bacterial endotoxin, Lipopolysaccharides (LPS). Using an anomaly detection framework we identified pathways that clearly distinguish between asymptomatic and symptomatic patients infected with the four different respiratory viruses and that accurately diagnosed patients exposed to a bacterial infection. Connectivity pathway analysis comparing the viral and bacterial diagnostic signatures identified host cellular pathways that were unique to patients exposed to LPS endotoxin indicating this type of analysis could be used to identify host biomarkers that can differentiate clinical etiologies of acute infection. We applied the Multivariate State Estimation Technique (MSET) on two human influenza (H1N1 and H3N2) gene expression data sets to define host networks perturbed in the asymptomatic phase of infection. Our analysis identified pathways in the respiratory virus diagnostic signature as prognostic biomarkers that triggered prior to clinical presentation of acute symptoms. These early warning pathways correctly predicted that almost half of the subjects would become symptomatic in less than forty hours post-infection and that three of the 18 subjects would become symptomatic after only 8 hours. These results provide a proof-of-concept for utility of anomaly detection algorithms to classify host pathway signatures that can identify presymptomatic signatures of acute diseases and differentiate between etiologies of infection. On a global scale, acute respiratory infections cause a significant proportion of human co-morbidities and account for 4.25 million deaths annually. The development of clinical diagnostic tools to distinguish between acute viral and bacterial respiratory infections is critical to improve patient care and limit the overuse of antibiotics in the medical community. The identification of prognostic respiratory virus biomarkers provides an early warning system that is capable of predicting which subjects will become symptomatic to expand our medical diagnostic capabilities and treatment options for acute infectious diseases. The host response to acute infection may be viewed as a deterministic signaling network responsible for maintaining the health of the host organism. We identify pathway signatures that reflect the very earliest perturbations in the host response to acute infection. These pathways provide a monitor the health state of the host using anomaly detection to quantify and predict health outcomes to pathogens.	[Wang, Kun; Kirby, Michael] Colorado State Univ, Dept Math, Ft Collins, CO 80523 USA; [Wang, Kun; O'Hern, Corey S.; Shattuck, Mark D.] Yale Univ, Dept Mech Engn & Mat Sci, New Haven, CT USA; [Langevin, Stanley; Forero, Adriana; Morrison, Juliet; Katze, Michael G.] Univ Washington, Sch Med, Dept Microbiol, Seattle, WA 98195 USA; [O'Hern, Corey S.] Yale Univ, Dept Appl Phys, New Haven, CT 06520 USA; [O'Hern, Corey S.] Yale Univ, Dept Phys, New Haven, CT USA; [O'Hern, Corey S.] Yale Univ, Grad Program Computat Biol & Bioinformat, New Haven, CT USA; [Shattuck, Mark D.] CUNY City Coll, Dept Phys, New York, NY 10031 USA; [Shattuck, Mark D.] CUNY City Coll, Benjamin Levich Inst, New York, NY 10031 USA; [Slayden, Richard] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA; [Ogle, Serenity] Colorado State Univ, Dept Biomed Sci, Ft Collins, CO 80523 USA; [Kirby, Michael] Colorado State Univ, Dept Comp Sci, Ft Collins, CO 80523 USA	Colorado State University; Yale University; University of Washington; University of Washington Seattle; Yale University; Yale University; Yale University; City University of New York (CUNY) System; City College of New York (CUNY); City University of New York (CUNY) System; City College of New York (CUNY); Colorado State University; Colorado State University; Colorado State University	Kirby, M (corresponding author), Colorado State Univ, Dept Math, Ft Collins, CO 80523 USA.; Kirby, M (corresponding author), Colorado State Univ, Dept Comp Sci, Ft Collins, CO 80523 USA.	Michael.Kirby@Colostate.edu	Slayden, Richard/O-8626-2016; Slayden, Richard/AAV-2582-2021; Shattuck, Mark D/F-5680-2015; O'Hern, Corey/I-3459-2014	Slayden, Richard/0000-0001-6857-7277; Slayden, Richard/0000-0001-6857-7277; Shattuck, Mark D/0000-0001-8473-2505; Morrison, Juliet/0000-0001-7387-6351; O'Hern, Corey/0000-0002-8272-5640	National Science Foundation [DMS-1513633]; Federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health; National Institutes of Health [P51OD010425]; Department of Health and Human Services, under CEIRS Contract [HHSN272201400005C]	National Science Foundation(National Science Foundation (NSF)); Federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Health and Human Services, under CEIRS Contract	This research was partially supported by the National Science Foundation under award DMS-1513633. Any opinions, findings and conclusions or recommendations expressed in this material are those of the authors and do not necessarily reflect the views of the National Science Foundation. This project has been funded in whole or in part with Federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services, under CEIRS Contract No. HHSN272201400005C, and the National Institutes of Health, Office of the Director under grant No. P51OD010425.	Arbour NC, 2000, NAT GENET, V25, P187, DOI 10.1038/76048; BERG DJ, 1995, J CLIN INVEST, V96, P2339, DOI 10.1172/JCI118290; BLANCHARD DK, 1986, J IMMUNOL, V136, P963; Calvano SE, 2005, NATURE, V437, P1032, DOI 10.1038/nature03985; Cheng Shunfeng, 2007, PARAMETERS, V1, px2; Csardi G., 2005, INTERJ COMPLEX SYST, P1695; Curtis RK, 2005, TRENDS BIOTECHNOL, V23, P429, DOI 10.1016/j.tibtech.2005.05.011; Day J, 2006, J THEOR BIOL, V242, P237, DOI 10.1016/j.jtbi.2006.02.015; Day J, 2010, MATH BIOSCI ENG, V7, P739, DOI 10.3934/mbe.2010.7.739; Derlindati E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119751; Gee K, 2002, J IMMUNOL, V169, P5660, DOI 10.4049/jimmunol.169.10.5660; Ghosh M, 2014, J IMMUNOL S, V192, P180; Ginsburg GS, 2012, CRIT CARE, V16, DOI 10.1186/cc11685; GOTSCH U, 1994, CELL ADHES COMMUN, V2, P7, DOI 10.3109/15419069409014198; Guha M, 2001, CELL SIGNAL, V13, P85, DOI 10.1016/S0898-6568(00)00149-2; Guo HL, 2010, J VIROL, V84, P7750, DOI 10.1128/JVI.00187-10; Gutzeit C, 2014, IMMUNOL REV, V260, P76, DOI 10.1111/imr.12189; Guyon I, 2002, MACH LEARN, V46, P389, DOI 10.1023/A:1012487302797; HUANG K, 1995, INFLAMMATION, V19, P389, DOI 10.1007/BF01534395; Huschak G, 2003, CLIN EXP IMMUNOL, V134, P491, DOI 10.1111/j.1365-2249.2003.02302.x; Iyer SS, 2010, J IMMUNOL, V185, P6599, DOI 10.4049/jimmunol.1002041; Jaai R, 2009, P REL MAINT S, P100; Jin SQ, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-105; KAMADA T, 1989, INFORM PROCESS LETT, V31, P7, DOI 10.1016/0020-0190(89)90102-6; Khatri P, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002375; Kim ID, 2010, ARCH PHARM RES, V33, P959, DOI 10.1007/s12272-010-0620-8; Kirby M., 2000, GEOMETRIC DATA ANAL, V1st ed.; Lettau M, 2011, EUR J CELL BIOL, V90, P456, DOI 10.1016/j.ejcb.2010.10.006; Liu G, 2009, J IMMUNOL, V182, P5063, DOI 10.4049/jimmunol.0803526; Lunardi Andrea, 2011, Genes Cancer, V2, P10, DOI 10.1177/1947601911402682; Mei B, 2014, GENE, V551, P255, DOI 10.1016/j.gene.2014.08.062; Mejias A, 2014, CURR OPIN INFECT DIS, V27, P228, DOI [10.1097/QCO.0000000000000065, 10.1097/QCO.0000000000000063]; Morrison J, 2014, J VIROL, V88, P10556, DOI 10.1128/JVI.00570-14; Negishi M, 2011, AM J REPROD IMMUNOL, V65, P20, DOI 10.1111/j.1600-0897.2010.00856.x; Nikoopour E, 2014, CYTOKINE; O'Hara S, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-832; Oh JZ, 2014, IMMUNITY, V41, P478, DOI 10.1016/j.immuni.2014.08.009; Openshaw PJ, 2009, MUCOSAL IMMUNOL, V2, P100, DOI 10.1038/mi.2008.79; Parnell GP, 2012, CRIT CARE, V16, DOI 10.1186/cc11477; Pociask DA, 2013, AM J PATHOL, V182, P1286, DOI 10.1016/j.ajpath.2012.12.007; Reynolds A, 2006, J THEOR BIOL, V242, P220, DOI 10.1016/j.jtbi.2006.02.016; Rui YX, 2007, J IMMUNOL, V179, P7344, DOI 10.4049/jimmunol.179.11.7344; Sawa Y, 2008, J HISTOCHEM CYTOCHEM, V56, P97, DOI 10.1369/jhc.7A7299.2007; Scholz G, 2000, J BIOL CHEM, V275, P14615, DOI 10.1074/jbc.275.19.14615; Shi YZ, 2006, SHOCK, V26, P277, DOI 10.1097/01.shk.0000223134.17877.ad; Shouval DS, 2014, ADV IMMUNOL, V122, P177, DOI 10.1016/B978-0-12-800267-4.00005-5; Storey JD, 2005, P NATL ACAD SCI USA, V102, P12837, DOI 10.1073/pnas.0504609102; Sun K, 2010, J VIROL, V84, P5007, DOI 10.1128/JVI.02408-09; Sun YJ, 2007, IEEE T PATTERN ANAL, V29, P1035, DOI 10.1109/TPAMI.2007.1093; Thompson J., 2010, 2010 International Conference on Dependable Systems and Networks Workshops (DSN-W), P8, DOI 10.1109/DSNW.2010.5542626; Tuyt LML, 1996, BRIT J HAEMATOL, V92, P521, DOI 10.1046/j.1365-2141.1996.00378.x; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Wang YH, 2005, BIOINFORMATICS, V21, P1530, DOI 10.1093/bioinformatics/bti192; Wang Y, 2011, CELL BIOL INT, V35, P677, DOI 10.1042/CBI20100625; Weber GF, 2007, INFECT IMMUN, V75, P1690, DOI 10.1128/IAI.01564-06; Whisnant K, 2005, CDES '05: Proceedings of the 2005 International Conference on Computer Design, P3; Woods CW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052198; Wu CX, 2012, J SURG RES, V175, P88, DOI 10.1016/j.jss.2011.02.026; Xaus J, 2000, BLOOD, V95, P3823; Xing E.P., 2001, ICML CITESEER, V1, P601; Yao ZY, 2014, J BIOL CHEM, V289, P9372, DOI 10.1074/jbc.M113.533992; Yeung KY, 2005, BIOINFORMATICS, V21, P2394, DOI 10.1093/bioinformatics/bti319; Yu L., 2004, P 10 ACM SIGKDD INT, P737, DOI DOI 10.1145/1014052.1014149; Zaas AK, 2014, TRENDS MOL MED, V20, P579, DOI 10.1016/j.molmed.2014.08.001; Zaas AK, 2009, CELL HOST MICROBE, V6, P207, DOI 10.1016/j.chom.2009.07.006; Zavaljevski N, 1999, P MC, V99; Zavaljevski N, 2001, P YUG NUCL SOC I NUC; Zhong J, 2009, J IMMUNOL, V182, P91	68	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2016	11	8							e0160919	10.1371/journal.pone.0160919	http://dx.doi.org/10.1371/journal.pone.0160919			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4YN	27532264	Green Published, gold			2022-12-27	WOS:000381487600047
J	Trickey, A; May, MT; Vehreschild, J; Obel, N; Gill, MJ; Crane, H; Boesecke, C; Samji, H; Grabar, S; Cazanave, C; Cavassini, M; Shepherd, L; Monforte, AD; Smit, C; Saag, M; Lampe, F; Hernando, V; Montero, M; Zangerle, R; Justice, AC; Sterling, T; Miro, J; Ingle, S; Sterne, JAC				Trickey, Adam; May, Margaret T.; Vehreschild, Janne; Obel, Niels; Gill, Michael John; Crane, Heidi; Boesecke, Christoph; Samji, Hasina; Grabar, Sophie; Cazanave, Charles; Cavassini, Matthias; Shepherd, Leah; Monforte, Antonella d'Arminio; Smit, Colette; Saag, Michael; Lampe, Fiona; Hernando, Vicky; Montero, Marta; Zangerle, Robert; Justice, Amy C.; Sterling, Timothy; Miro, Jose; Ingle, Suzanne; Sterne, Jonathan A. C.		Antiretroviral Therapy Cohort Coll	Cause-Specific Mortality in HIV-Positive Patients Who Survived Ten Years after Starting Antiretroviral Therapy	PLOS ONE			English	Article							CD4 CELL COUNT; HIV-1-INFECTED PATIENTS; COLLABORATIVE ANALYSIS; INFECTED INDIVIDUALS; PROPORTIONAL-HAZARDS; CLINICAL-PRACTICE; RISK-FACTORS; DRUG-USE; DEATH; COHORT	Objectives To estimate mortality rates and prognostic factors in HIV-positive patients who started combination antiretroviral therapy between 1996-1999 and survived for more than ten years. Methods We used data from 18 European and North American HIV cohort studies contributing to the Antiretroviral Therapy Cohort Collaboration. We followed up patients from ten years after start of combination antiretroviral therapy. We estimated overall and cause-specific mortality rate ratios for age, sex, transmission through injection drug use, AIDS, CD4 count and HIV-1 RNA. Results During 50,593 person years 656/13,011 (5%) patients died. Older age, male sex, injecting drug use transmission, AIDS, and low CD4 count and detectable viral replication ten years after starting combination antiretroviral therapy were associated with higher subsequent mortality. CD4 count at ART start did not predict mortality in models adjusted for patient characteristics ten years after start of antiretroviral therapy. The most frequent causes of death (among 340 classified) were non-AIDS cancer, AIDS, cardiovascular, and liver-related disease. Older age was strongly associated with cardiovascular mortality, injecting drug use transmission with non-AIDS infection and liver-related mortality, and low CD4 and detectable viral replication ten years after starting antiretroviral therapy with AIDS mortality. Five-year mortality risk was <5% in 60% of all patients, and in 30% of those aged over 60 years. Conclusions Viral replication, lower CD4 count, prior AIDS, and transmission via injecting drug use continue to predict higher all-cause and AIDS-related mortality in patients treated with combination antiretroviral therapy for over a decade. Deaths from AIDS and non-AIDS infection are less frequent than deaths from other non-AIDS causes.	[Trickey, Adam; May, Margaret T.; Ingle, Suzanne; Sterne, Jonathan A. C.] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England; [Vehreschild, Janne] German Ctr Infect Res, Partner Site Bonn Cologne, Cologne, Germany; [Vehreschild, Janne] Univ Hosp Cologne, Dept Internal Med 1, Cologne, Germany; [Obel, Niels] Copenhagen Univ Hosp, Dept Infect Dis, Copenhagen, Denmark; [Gill, Michael John] Univ Calgary, Div Infect Dis, Calgary, AB, Canada; [Crane, Heidi] Univ Washington, Ctr AIDS Res, Seattle, WA 98195 USA; [Boesecke, Christoph] Univ Bonn, Dept Internal Med, Bonn, Germany; [Samji, Hasina] British Columbia Ctr Excellence HIV AIDS, Epidemiol & Populat Hlth Program, Vancouver, BC, Canada; [Samji, Hasina] Simon Fraser Univ, Fac Hlth Sci, Burnaby, BC, Canada; [Grabar, Sophie] Univ Paris 06, Sorbonne Univ, Inst Pierre Louis Epidemiol & Sante Publ, UMR S 1136, F-75013 Paris, France; [Grabar, Sophie] Inst Pierre Louis Epidemiol & Sante Publ, INSERM, UMR S 1136, F-75013 Paris, France; [Grabar, Sophie] Univ Paris 05, Paris, France; [Grabar, Sophie] Grp Hosp Cochin Hotel Dieu, AP HP, Paris, France; [Cazanave, Charles] Ctr Hosp Univ Bordeaux, Hop Pellegrin, F-33000 Bordeaux, France; [Cavassini, Matthias] Univ Lausanne Hosp, Infect Dis Serv, Lausanne, Switzerland; [Cavassini, Matthias] Univ Lausanne, Lausanne, Switzerland; [Shepherd, Leah; Lampe, Fiona] UCL Med Sch, Res Dept Infect & Populat Hlth, London, England; [Monforte, Antonella d'Arminio] Univ Milan, Clin Infect Dis & Trop Med, San Paolo Hosp, Milan, Italy; [Smit, Colette] Stichting HIV Monitoring, Amsterdam, Netherlands; [Saag, Michael] Univ Alabama Birmingham, Dept Med, Div Infect Dis, Birmingham, AL 35294 USA; [Hernando, Vicky] Inst Salud Carlos III, Ctr Nacl Epidemiol, Red Invest Sida, Avda Monforte de Lemos 5, Madrid 28029, Spain; [Montero, Marta] Hosp La Fe, Valencia, Spain; [Zangerle, Robert] Med Univ Innsbruck, Innsbruck, Austria; [Justice, Amy C.] Yale Univ, Sch Med, New Haven, CT USA; [Justice, Amy C.] VA Connecticut Healthcare Syst, West Haven, CT USA; [Sterling, Timothy] Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA; [Miro, Jose] Univ Barcelona, Hosp Clin IDIBAPS, Barcelona, Spain	University of Bristol; German Center for Infection Research; University of Cologne; University of Cologne; University of Copenhagen; University of Calgary; University of Washington; University of Washington Seattle; University of Bonn; B.C. Centre for Excellence in HIV/AIDS; Simon Fraser University; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU Bordeaux; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; University of London; University College London; San Paolo-Polo Universitaria Hospital; University of Milan; University of Alabama System; University of Alabama Birmingham; Instituto de Salud Carlos III; Centro Nacional de Epidemiologia (CNE); Hospital Universitari i Politecnic La Fe; Medical University of Innsbruck; Yale University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System; Vanderbilt University; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Trickey, A (corresponding author), Univ Bristol, Sch Social & Community Med, Bristol, Avon, England.	adam.trickey@bristol.ac.uk; Niels.Obel@regionh.dk; Matthias.Cavassini@chuv.ch; leah.shepherd@ucl.ac.uk; antonella.darminio@unimi.it; c.smith@ucl.ac.uk; robert.zangerle@uki.at; amy.justice2@va.gov; timothy.sterling@vanderbilt.edu; miro97@fundsoriano.es	Montero, Marta/H-7555-2017; Cazanave, Charles/AHE-5492-2022; Hernando, Victoria/E-1740-2015; Lampe, Fiona/I-5826-2019; Sterne, Jonathan/Z-3106-2019; Dodsley, Maria/G-7083-2016; Grabar, Sophie/AAM-9857-2020; cavassini, matthias/F-8987-2017; Gill, Michael John/G-7083-2016; Boulle, Andrew/C-1413-2008; Vehreschild, Jorg Janne/G-6764-2013	Montero, Marta/0000-0002-3432-5394; Hernando, Victoria/0000-0003-2762-4924; Lampe, Fiona/0000-0001-6851-5471; Sterne, Jonathan/0000-0001-8496-6053; Dodsley, Maria/0000-0001-7587-558X; cavassini, matthias/0000-0003-0933-7833; Trickey, Adam/0000-0003-3462-2898; Obel, Niels/0000-0002-5031-0045; Gill, Michael John/0000-0002-8546-8790; Boulle, Andrew/0000-0002-7713-8062; Vehreschild, Jorg Janne/0000-0002-5446-7170; Samji, Hasina/0000-0002-4555-7609	UK Medical Research Council (MRC) [MR/J002380/1]; UK Department for International Development (DFID) under the MRC/DFID Concordat agreement; European Union; National Institute for Health Research [NF-SI-0611-10168]; Agence Nationale de Recherche sur le SIDA et les hepatites virales (ANRS); Institut National de la Sante et de la Recherche Medicale (INSERM); French Ministry of Health; Italian Ministry of Health; Spanish Ministry of Health; Swiss National Science Foundation [33CS30_134277]; Ministry of Science and Innovation; Spanish Network for AIDS Research (RIS) [ISCIII-RETIC RD06/006]; Stichting HIV Monitoring; European Commission (EuroCoord grant) [260694]; British Columbia Government; Alberta Government; National Institutes of Health (NIH) [UW Center for AIDS Research (CFAR) (NIH)] [P30 AI027757]; National Institutes of Health (NIH) [UAB CFAR (NIH)] [P30 AI027767]; National Institutes of Health (NIH) [Vanderbilt-Meharry CFAR (NIH grant)] [P30 AI54999]; National Institute on Alcohol Abuse and Alcoholism [U10-AA13566, U24-AA020794]; US Department of Veterans Affairs; Michael Smith Foundation for Health Research; Canadian Institutes of Health Research; VHA Office of Research and Development; Abbott; Gilead; Tibotec-Upjohn; ViiV Healthcare; MSD; GlaxoSmithKline; Pfizer; Bristol Myers Squibb; Roche; Boehringer-Ingelheim; European Union Seventh Framework Programme (FP7) under EuroCoord grant [260694]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [U24AA020794, U01AA020790] Funding Source: NIH RePORTER; Medical Research Council [G0100221, MR/J002380/1, G0700820] Funding Source: researchfish; MRC [MR/J002380/1, G0100221, G0700820] Funding Source: UKRI	UK Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK Department for International Development (DFID) under the MRC/DFID Concordat agreement(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Union(European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Agence Nationale de Recherche sur le SIDA et les hepatites virales (ANRS)(ANRSFrench National Research Agency (ANR)); Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); French Ministry of Health; Italian Ministry of Health(Ministry of Health, Italy); Spanish Ministry of Health(Instituto de Salud Carlos IIISpanish Government); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Spanish Network for AIDS Research (RIS); Stichting HIV Monitoring; European Commission (EuroCoord grant)(European Commission); British Columbia Government; Alberta Government; National Institutes of Health (NIH) [UW Center for AIDS Research (CFAR) (NIH)]; National Institutes of Health (NIH) [UAB CFAR (NIH)](United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health (NIH) [Vanderbilt-Meharry CFAR (NIH grant)](United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); US Department of Veterans Affairs(US Department of Veterans Affairs); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); VHA Office of Research and Development; Abbott(Abbott Laboratories); Gilead(Gilead Sciences); Tibotec-Upjohn; ViiV Healthcare; MSD; GlaxoSmithKline(GlaxoSmithKline); Pfizer(Pfizer); Bristol Myers Squibb(Bristol-Myers Squibb); Roche(Roche Holding); Boehringer-Ingelheim(Boehringer Ingelheim); European Union Seventh Framework Programme (FP7) under EuroCoord grant; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the UK Medical Research Council (MRC) MR/J002380/1-http://www.mrc.ac.uk/-and the UK Department for International Development (DFID) under the MRC/DFID Concordat agreement and is also part of the EDCTP2 programme supported by the European Union. Jonathan Sterne is funded by National Institute for Health Research Senior Investigator award NF-SI-0611-10168. Sources of funding of individual cohorts include the Agence Nationale de Recherche sur le SIDA et les hepatites virales (ANRS), the Institut National de la Sante et de la Recherche Medicale (INSERM), the French, Italian and Spanish Ministries of Health, the Swiss National Science Foundation (grant 33CS30_134277), the Ministry of Science and Innovation and the "Spanish Network for AIDS Research (RIS; ISCIII-RETIC RD06/006), the Stichting HIV Monitoring, the European Commission (EuroCoord grant 260694), the British Columbia and Alberta Governments, the National Institutes of Health (NIH) [UW Center for AIDS Research (CFAR) (NIH grant P30 AI027757), UAB CFAR (NIH grant P30 AI027767), The Vanderbilt-Meharry CFAR (NIH grant P30 AI54999), National Institute on Alcohol Abuse and Alcoholism (U10-AA13566, U24-AA020794), the US Department of Veterans Affairs, the Michael Smith Foundation for Health Research, the Canadian Institutes of Health Research, the VHA Office of Research and Development and unrestricted grants from Abbott, Gilead, Tibotec-Upjohn, ViiV Healthcare, MSD, GlaxoSmithKline, Pfizer, Bristol Myers Squibb, Roche and Boehringer-Ingelheim. The Danish HIV Cohort Study is founded by Preben and Anne Simonsens Foundation. Data from 11 European cohorts were pooled in June 2014 within COHERE in EuroCoord (www.cohere.org and www.EuroCoord.net). COHERE receives funding from the European Union Seventh Framework Programme (FP7/2007-2013) under EuroCoord grant agreement no 260694. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Astuti N, 2014, INFECT DIS THER, V3, P1, DOI 10.1007/s40121-014-0024-z; Bartlett JA, 2001, AIDS, V15, P1369, DOI 10.1097/00002030-200107270-00006; Egger M, 2002, LANCET, V360, P119, DOI 10.1016/S0140-6736(02)09411-4; Ehren K, 2014, INFECTION, V42, P135, DOI 10.1007/s15010-013-0535-7; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Gill J, 2010, CLIN INFECT DIS, V50, P1387, DOI 10.1086/652283; Ingle SM, 2014, CLIN INFECT DIS, V59, P287, DOI 10.1093/cid/ciu261; Kim HY, 2001, RADIOGRAPHICS, V21, P839, DOI 10.1148/radiographics.21.4.g01jl06839; Kowalska JD, 2010, HIV MED, V11, P200, DOI 10.1111/j.1468-1293.2009.00763.x; Kowalska JD, 2012, AIDS, V26, P315, DOI 10.1097/QAD.0b013e32834e8805; Kowalska JD, 2011, EPIDEMIOLOGY, V22, P516, DOI 10.1097/EDE.0b013e31821b5332; Kowalska JD, 2011, HIV CLIN TRIALS, V12, P109, DOI 10.1310/hct1202-109; Lanoy E, 2009, AIDS, V23, P2199, DOI 10.1097/QAD.0b013e3283305a00; Laut KG, 2014, J INT AIDS SOC, V17, P11, DOI 10.7448/IAS.17.4.19504; Legarth RA, 2016, JAIDS-J ACQ IMM DEF, V71, P213, DOI 10.1097/QAI.0000000000000825; Leone S, 2011, INFECTION, V39, P13, DOI 10.1007/s15010-010-0079-z; Lewden C, 2008, JAIDS-J ACQ IMM DEF, V48, P590, DOI 10.1097/QAI.0b013e31817efb54; Lewden C, 2007, JAIDS-J ACQ IMM DEF, V46, P72; Lewden C, 2012, INT J EPIDEMIOL, V41, P433, DOI 10.1093/ije/dyr164; Lima VD, 2015, LANCET HIV, V2, pE92, DOI 10.1016/S2352-3018(15)00017-X; Blanco JL, 2015, EXPERT OPIN PHARMACO, V16, P1313, DOI 10.1517/14656566.2015.1044436; May M, 2005, J CLIN EPIDEMIOL, V58, P1033, DOI 10.1016/j.jclinepi.2005.02.015; May M, 2007, AIDS, V21, P1185, DOI 10.1097/QAD.0b013e328133f285; May MT, 2015, JAIDS-J ACQ IMM DEF, V69, P348, DOI 10.1097/QAI.0000000000000603; May MT, 2014, AIDS, V28, P1193, DOI 10.1097/QAD.0000000000000243; May MT, 2012, INT J EPIDEMIOL, V41, P1807, DOI 10.1093/ije/dys164; May MT, 2013, IJE, V12; McManus H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048839; Mocroft A, 2014, INFECTION, V42, P757, DOI 10.1007/s15010-014-0630-4; Monforte AD, 2008, AIDS, V22, P2143, DOI 10.1097/QAD.0b013e3283112b77; Obel N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022698; Palella FJ, 2006, JAIDS-J ACQ IMM DEF, V43, P27, DOI 10.1097/01.qai.0000233310.90484.16; Phillips AN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055312; Phillips AN, 2010, AIDS, V24, P1561, DOI 10.1097/QAD.0b013e32833a6056; Royston P, 2002, STAT MED, V21, P2175, DOI 10.1002/sim.1203; Shubber Z, 2013, AIDS, V27, P1403, DOI 10.1097/QAD.0b013e32835f1db0; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Sigel Keith, 2011, Curr HIV/AIDS Rep, V8, P142, DOI 10.1007/s11904-011-0085-5; Smith CJ, 2014, LANCET, V384, P241, DOI 10.1016/S0140-6736(14)60604-8; Swain SD, 2007, AM J PATHOL, V171, P790, DOI 10.2353/ajpath.2007.070178; Tate JP, 2013, AIDS, V27, P563, DOI 10.1097/QAD.0b013e32835b8c7f; Thorsteinsson K, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-256; Weber R, 2015, HIV MED, V16, P137, DOI 10.1111/hiv.12184; Weber R, 2009, HIV MED, V10, P407, DOI 10.1111/j.1468-1293.2009.00701.x; Wells JS, 2014, AIDS PATIENT CARE ST, V28, P350, DOI 10.1089/apc.2013.0358; Young J, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001194	46	58	61	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2016	11	8							e0160460	10.1371/journal.pone.0160460	http://dx.doi.org/10.1371/journal.pone.0160460			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4SL	27525413	Green Published, gold, Green Submitted			2022-12-27	WOS:000381471100014
J	Yang, PY; Miao, NF; Lin, CW; Chou, YE; Yang, SF; Huang, HC; Chang, HJ; Tsai, HT				Yang, Po-Yu; Miao, Nae-Fang; Lin, Chiao-Wen; Chou, Ying-Erh; Yang, Shun-Fa; Huang, Hui-Chuan; Chang, Hsiu-Ju; Tsai, Hsiu-Ting			Impact of Maspin Polymorphism rs2289520 G/C and Its Interaction with Gene to Gene, Alcohol Consumption Increase Susceptibility to Oral Cancer Occurrence	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; EXTRACELLULAR-MATRIX; IN-VITRO; SUPPRESSOR; EXPRESSION; PROGRESSION; METASTASIS; ADHESION; MUCOSA; TONGUE	Background The purpose of this study was to identify gene polymorphisms of mammary serine protease inhibitor (Maspin) specific to patients with oral cancer susceptibility and clinicopathological status. Methodology/Principal Findings Three single-nucleotide polymorphisms (SNPs) of the Maspin gene from 741 patients with oral cancer and 601 non-cancer controls were analyzed by real-time PCR. The participants with G/G homozygotes or with G/C heterozygotes of Maspin rs2289520 polymorphism had a 2.07-fold (p = 0.01) and a 2.01-fold (p = 0.02) risk of developing oral cancer compared to those with C/C homozygotes. Moreover, gene-gene interaction increased the risk of oral cancer susceptibility among subjects expose to oral cancer related risk factors, including areca, alcohol, and tobacco consumption. Conclusion G allele of Maspin rs2289520 polymorphism may be a factor that increases the susceptibility to oral cancer. The interactions of gene to oral cancer-related environmental risk factors have a synergetic effect that can further enhance oral cancer development.	[Yang, Po-Yu] Chung Shan Med Univ, Sch Dent, Taichung, Taiwan; [Yang, Po-Yu; Lin, Chiao-Wen] Chung Shan Med Univ Hosp, Dept Dent, Taichung, Taiwan; [Miao, Nae-Fang; Huang, Hui-Chuan; Tsai, Hsiu-Ting] Taipei Med Univ, Coll Nursing, Accelerated Bachelor Sci Nursing, Taipei, Taiwan; [Lin, Chiao-Wen] Chung Shan Med Univ, Inst Oral Sci, Taichung, Taiwan; [Chou, Ying-Erh] Chung Shan Med Univ, Sch Med, Taichung, Taiwan; [Chou, Ying-Erh; Yang, Shun-Fa] Chung Shan Med Univ Hosp, Dept Med Res, Taichung, Taiwan; [Yang, Shun-Fa] Chung Shan Med Univ, Inst Med, Taichung, Taiwan; [Chang, Hsiu-Ju; Tsai, Hsiu-Ting] Taipei Med Univ, Sch Nursing, Coll Nursing, Taipei, Taiwan; [Tsai, Hsiu-Ting] Taipei Med Univ Hosp, Dept Nursing, Taipei, Taiwan	Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; Taipei Medical University; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; Taipei Medical University; Taipei Medical University; Taipei Medical University Hospital	Tsai, HT (corresponding author), Taipei Med Univ, Coll Nursing, Accelerated Bachelor Sci Nursing, Taipei, Taiwan.; Tsai, HT (corresponding author), Taipei Med Univ, Sch Nursing, Coll Nursing, Taipei, Taiwan.; Tsai, HT (corresponding author), Taipei Med Univ Hosp, Dept Nursing, Taipei, Taiwan.	tsaihsiuting@yahoo.com.tw	Yang, Shun-Fa/AAN-1519-2020	Yang, Shun-Fa/0000-0002-0365-7927; Tsai, Hsiu Ting/0000-0003-1137-9274; Chang, Hsiu-Ju/0000-0002-8544-0712	Ministry of Science and Technology, Taiwan [MOST 102-2314-B-040-002, MOST 103-2314-B-040-005-MY3]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	This study was financially supported by grants from Ministry of Science and Technology, Taiwan (MOST 102-2314-B-040-002) & (MOST 103-2314-B-040-005-MY3). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham S, 2003, J UROLOGY, V169, P1157, DOI 10.1097/01.ju.0000040245.70349.37; Al-Mamun MA, 2016, J THEOR BIOL, V388, P37, DOI 10.1016/j.jtbi.2015.10.007; Lopes CFB, 2012, ARCH ORAL BIOL, V57, P1026, DOI 10.1016/j.archoralbio.2012.05.006; Chen MK, 2009, ORAL ONCOL, V45, pE222, DOI 10.1016/j.oraloncology.2009.07.015; Department of Health, 2012, REP CHIN HLTH STAT 2; Gupta B, 2013, INT DENT J, V63, P12, DOI 10.1111/j.1875-595x.2012.00131.x; HARVEY W, 1986, ARCH ORAL BIOL, V31, P45, DOI 10.1016/0003-9969(86)90112-3; Jang HL, 2008, INT J MOL MED, V22, P333, DOI 10.3892/ijmm_00000027; Kim M, 2012, CARCINOGENESIS, V33, P2344, DOI 10.1093/carcin/bgs280; Loyha K, 2012, ASIAN PAC J CANCER P, V13, P5087, DOI 10.7314/APJCP.2012.13.10.5087; Meng H, 2015, TUMOR BIOL, V36, P6231, DOI 10.1007/s13277-015-3308-3; MUIR C, 1995, CANCER, V75, P147, DOI 10.1002/1097-0142(19950101)75:1+<147::AID-CNCR2820751304>3.0.CO;2-U; Ngamkitidechakul C, 2001, INVEST OPHTH VIS SCI, V42, P3135; Ramot Y, 2012, TOXICOL PATHOL, V40, P40, DOI 10.1177/0192623311424169; Ray Jay Gopal, 2013, J Oral Maxillofac Pathol, V17, P45, DOI 10.4103/0973-029X.110720; Schwartz J, 2012, J ORAL MAXIL SURG, V70, P1867, DOI 10.1016/j.joms.2011.08.005; Semenzati GD, 2012, INHAL TOXICOL, V24, P723, DOI 10.3109/08958378.2012.715317; Shpitzer T, 2009, BRIT J CANCER, V101, P1194, DOI 10.1038/sj.bjc.6605290; Smith SL, 2003, ONCOGENE, V22, P8677, DOI 10.1038/sj.onc.1207127; Teng YH, 2009, HEAD NECK-J SCI SPEC, V31, P1282, DOI 10.1002/hed.21094; Tsai HT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083572; Umekita Y, 1997, CANCER LETT, V113, P87, DOI 10.1016/S0304-3835(97)04600-4; Wang CC, 2011, J ORAL PATHOL MED, V40, P769, DOI 10.1111/j.1600-0714.2011.01043.x; Xia WY, 2000, ONCOGENE, V19, P2398, DOI 10.1038/sj.onc.1203535; Yang SF, 2010, FOOD CHEM TOXICOL, V48, P1052, DOI 10.1016/j.fct.2010.01.019; Yasumatsu R, 2001, HEAD NECK-J SCI SPEC, V23, P962, DOI 10.1002/hed.1139; Yoshizawa K, 2009, J ORAL PATHOL MED, V38, P535, DOI 10.1111/j.1600-0714.2009.00762.x	27	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2016	11	8							e0160841	10.1371/journal.pone.0160841	http://dx.doi.org/10.1371/journal.pone.0160841			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4SL	27525723	gold, Green Submitted, Green Published			2022-12-27	WOS:000381471100023
J	Meghji, J; Simpson, H; Squire, SB; Mortimer, K				Meghji, Jamilah; Simpson, Hope; Squire, S. Bertel; Mortimer, Kevin			A Systematic Review of the Prevalence and Pattern of Imaging Defined Post-TB Lung Disease	PLOS ONE			English	Review							OBSTRUCTIVE PULMONARY-DISEASE; AIR-FLOW OBSTRUCTION; CHRONIC RESPIRATORY-DISEASE; RESOLUTION CHEST CT; RADIOLOGICAL SEQUELAE; TUBERCULOUS PLEURISY; RISK-FACTOR; COPD; PREDICTORS; HIV	Background Tuberculosis is an important risk factor for chronic respiratory disease in resource poor settings. The persistence of abnormal spirometry and symptoms after treatment are well described, but the structural abnormalities underlying these changes remain poorly defined, limiting our ability to phenotype post-TB lung disease in to meaningful categories for clinical management, prognostication, and ongoing research. The relationship between post-TB lung damage and patient-centred outcomes including functional impairment, respiratory symptoms, and health related quality of life also remains unclear. Methods We performed a systematic literature review to determine the prevalence and pattern of imaging-defined lung pathology in adults after medical treatment for pleural, miliary, or pulmonary TB disease. Data were collected on study characteristics, and the modality, timing, and findings of thoracic imaging. The proportion of studies relating imaging findings to spirometry results and patient morbidity was recorded. Study quality was assessed using a modified Newcastle-Ottowa score. (Prospero Registration number CRD42015027958) Results We identified 37 eligible studies. The principle features seen on CXR were cavitation (8.383.7%), bronchiectasis (4.3-11.2%), and fibrosis (25.0-70.4%), but prevalence was highly variable. CT imaging identified a wider range of residual abnormalities than CXR, including nodules (25.0-55.8%), consolidation (3.7-19.2%), and emphysema (15.0-45.0%). The prevalence of cavitation was generally lower (7.4-34.6%) and bronchiectasis higher (35.086.0%) on CT vs. CXR imaging. A paucity of prospective data, and data from HIV-infected adults and sub-Saharan Africa (sSA) was noted. Few studies related structural damage to physiological impairment, respiratory symptoms, or patient morbidity. Conclusions Post-TB structural lung pathology is common. Prospective data are required to determine the evolution of this lung damage and its associated morbidity over time. Further data are required from HIV-infected groups and those living in sSA.	[Meghji, Jamilah] Malawi Liverpool Wellcome Clin Res Programme, Blantyre, Malawi; [Meghji, Jamilah; Simpson, Hope; Squire, S. Bertel; Mortimer, Kevin] Univ Liverpool Liverpool Sch Trop Med, Dept Clin Sci, Liverpool, Merseyside, England	Liverpool School of Tropical Medicine	Meghji, J (corresponding author), Malawi Liverpool Wellcome Clin Res Programme, Blantyre, Malawi.; Meghji, J (corresponding author), Univ Liverpool Liverpool Sch Trop Med, Dept Clin Sci, Liverpool, Merseyside, England.	jmeghji@doctors.org.uk	Simpson, Hope/ADW-8396-2022	Mortimer, Kevin/0000-0002-8118-8871; Meghji, Jamilah/0000-0002-4693-8884; Squire, Stephen/0000-0001-7173-9038; Simpson, Hope/0000-0002-2956-5342	Wellcome Trust Clinical PhD Fellowship Grant [106065/Z/14/A]	Wellcome Trust Clinical PhD Fellowship Grant	This study was supported by a Wellcome Trust Clinical PhD Fellowship Grant, awarded to Dr Jamilah Meghji (106065/Z/14/A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajjaj MS, 2000, ACTA RADIOL, V41, P533, DOI 10.1080/028418500127346153; Allwood BW, 2013, RESPIRATION, V86, P76, DOI 10.1159/000350917; Angthong W, 2011, JPN J RADIOL, V29, P554, DOI 10.1007/s11604-011-0597-3; Baez-Saldana R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078926; Banu Rekha V V, 2009, Indian J Tuberc, V56, P132; BARBAS CSV, 1991, CHEST, V100, P1264, DOI 10.1378/chest.100.5.1264; Beran D, 2015, LANCET RESP MED, V3, P159, DOI 10.1016/S2213-2600(15)00004-1; Bishwakarma R, 2015, RESPIROLOGY, V20, P556, DOI 10.1111/resp.12515; Bombarda Sidney, 2003, Sao Paulo Med. J., V121, P198, DOI 10.1590/S1516-31802003000500004; Buist AS, 2007, LANCET, V370, P741, DOI 10.1016/S0140-6736(07)61377-4; Buyukoglan H, 2007, MEDIAT INFLAMM, V2007, DOI 10.1155/2007/64859; Byrne AL, 2015, INT J INFECT DIS, V32, P138, DOI 10.1016/j.ijid.2014.12.016; Caballero A, 2008, CHEST, V133, P343, DOI 10.1378/chest.07-1361; Chen YC, 2011, DIS MARKERS, V31, P101, DOI [10.3233/DMA-2011-0808, 10.1155/2011/938794]; Chung KP, 2011, CLINICS, V66, P549, DOI 10.1590/S1807-59322011000400005; Cohen C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117716; Corlan E, 1997, RESP MED, V91, P21, DOI 10.1016/S0954-6111(97)90133-5; Crothers K, 2007, CLIN CHEST MED, V28, P575, DOI 10.1016/j.ccm.2007.06.004; de la Mora IL, 2015, INT J TUBERC LUNG D, V19, P808, DOI 10.5588/ijtld.14.0983; de Valliere S, 2004, INT J TUBERC LUNG D, V8, P767; dePablo A, 1997, CHEST, V112, P1293, DOI 10.1378/chest.112.5.1293; Dheda K, 2005, J INFECT DIS, V192, P1201, DOI 10.1086/444545; Dickson RP, 2014, LANCET, V384, P691, DOI 10.1016/S0140-6736(14)61136-3; Drummond MB, 2014, LANCET RESP MED, V2, P583, DOI 10.1016/S2213-2600(14)70017-7; Drummond MB, 2010, QUAL LIFE RES, V19, P1295, DOI 10.1007/s11136-010-9701-x; Ehrlich RI, 2011, INT J TUBERC LUNG D, V15, P886, DOI 10.5588/ijtld.10.0526; Ehrlich RI, 2004, INT J TUBERC LUNG D, V8, P369; Elkington PTG, 2006, THORAX, V61, P259, DOI 10.1136/thx.2005.051979; Feikin DR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043656; Finney LJ, 2013, INT J TUBERC LUNG D, V17, P583, DOI 10.5588/ijtld.12.0619; Fitzpatrick M, 2013, CLIN CHEST MED, V34, P325, DOI 10.1016/j.ccm.2013.01.010; Frye MD, 1997, CHEST, V112, P393, DOI 10.1378/chest.112.2.393; GALARZA I, 1995, THORAX, V50, P1305, DOI 10.1136/thx.50.12.1305; Godoy MDP, 2012, RESP CARE, V57, P1949, DOI 10.4187/respcare.01532; Haines A, 2009, LANCET, V374, P2104, DOI 10.1016/S0140-6736(09)61759-1; Hamilton CD, 2008, INT J TUBERC LUNG D, V12, P1059; Han MK, 2010, AM J RESP CRIT CARE, V182, P598, DOI 10.1164/rccm.200912-1843CC; How SH, 2014, MALAYS J PATHOL, V36, P91; KALLAN B M, 1988, Indian Journal of Medical Sciences, V42, P4; Kenangalem E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076077; Kunter E, 2002, INT J TUBERC LUNG D, V6, P516; Lam KBH, 2010, CHEST, V137, P593, DOI 10.1378/chest.09-1435; Lee JJ, 2008, EUR J RADIOL, V67, P100, DOI 10.1016/j.ejrad.2007.07.009; Lin HH, 2014, INT J TUBERC LUNG D, V18, P613, DOI 10.5588/ijtld.13.0765; Lisha P V, 2012, Indian J Tuberc, V59, P83; Long R, 1998, CHEST, V113, P933, DOI 10.1378/chest.113.4.933; Marks GB, 2014, INT J TUBERC LUNG D, V18, P1261, DOI 10.5588/ijtld.14.0707; Meghji J, 2016, AM J RESP CRIT CARE, V194, P67, DOI 10.1164/rccm.201509-1807OC; Menezes AMB, 2007, EUR RESPIR J, V30, P1180, DOI 10.1183/09031936.00083507; Menon B, 2015, LUNG INDIA, V32, P241, DOI 10.4103/0970-2113.156233; Munthali L, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-107; National Tuberculosis Association of the USA, 1961, DIAGN STAND CLASS TU; Pasteur MC, 2000, AM J RESP CRIT CARE, V162, P1277, DOI 10.1164/ajrccm.162.4.9906120; Poey C, 1997, J COMPUT ASSIST TOMO, V21, P601, DOI 10.1097/00004728-199707000-00014; Ralph AP, 2010, THORAX, V65, P863, DOI 10.1136/thx.2010.136242; Rufino RL, 2015, AM J RESP CRIT CARE, V191; Ryu YJ, 2011, INT J TUBERC LUNG D, V15, P246; Salvi S, 2010, CHEST, V138, P3, DOI 10.1378/chest.10-0645; Seiscento M, 2007, RESPIROLOGY, V12, P660, DOI 10.1111/j.1440-1843.2007.01135.x; Singla Neeta, 2009, Indian J Tuberc, V56, P206; Small P M, 1994, J Thorac Imaging, V9, P74, DOI 10.1097/00005382-199421000-00003; Stocks J, 2013, LANCET RESP MED, V1, P728, DOI 10.1016/S2213-2600(13)70118-8; Swaminathan S, 2007, J POSTGRAD MED, V53, P228, DOI 10.4103/0022-3859.37509; Tuberculosis Chemotherapy Centre, 1973, BMJ-BRIT MED J, V2, P7; Uskul B, 2005, Monaldi Arch Chest Dis, V63, P101; Wang CH, 2010, INT J TUBERC LUNG D, V14, P627; Wardlaw AJ, 2005, CLIN EXP ALLERGY, V35, P1254, DOI 10.1111/j.1365-2222.2005.02344.x; Wells GA, NEWCASTLE OTTOWA SCA; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; WILLCOX PA, 1989, RESP MED, V83, P195, DOI 10.1016/S0954-6111(89)80031-9; Wong CF, 2005, RESPIROLOGY, V10, P515, DOI 10.1111/j.1440-1843.2005.00743.x; World Health Organisation, 2013, GLOB TUB REP POST 20; World Health Organization, 2020, GLOBAL TUBERCULOSIS; World Health Organization, 2013, GLOBAL ACTION PLAN F; Wyser C, 1996, CHEST, V110, P333, DOI 10.1378/chest.110.2.333; YU CT, 1995, THORAX, V50, P869, DOI 10.1136/thx.50.8.869; Zhou Yu-min, 2013, Zhonghua Nei Ke Za Zhi, V52, P379	77	45	47	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2016	11	8							e0161176	10.1371/journal.pone.0161176	http://dx.doi.org/10.1371/journal.pone.0161176			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3LI	27518438	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000381382100057
J	Mortensen, AN; Ellis, JD				Mortensen, Ashley N.; Ellis, James D.			Managed European-Derived Honey Bee, Apis mellifera sspp, Colonies Reduce African-Matriline Honey Bee, A-m. scutellata, Drones at Regional Mating Congregations	PLOS ONE			English	Article							MITOCHONDRIAL-DNA; GENETIC-STRUCTURE; HYMENOPTERA; SPREAD; POPULATIONS; HISTORY; QUEEN; RACES	African honey bees (Apis mellifera scutellata) dramatically changed the South American beekeeping industry as they rapidly spread through the Americas following their introduction into Brazil. In the present study, we aimed to determine if the management of European- derived honey bees (A. mellifera sspp.) could reduce the relative abundance of African-matriline drones at regional mating sites known as drone congregation areas (DCAs). We collected 2,400 drones at six DCAs either 0.25 km or >2.8 km from managed European-derived honey bee apiaries. The maternal ancestry of each drone was determined by Bgl II enzyme digestion of an amplified portion of the mitochondrial Cytochrome b gene. Furthermore, sibship reconstruction via nuclear microsatellites was conducted for a subset of 1,200 drones to estimate the number of colonies contributing drones to each DCA. Results indicate that DCAs distant to managed European apiaries (>2.8 km) had significantly more African-matriline drones (34.33% of the collected drones had African mitochondrial DNA) than did DCAs close (0.25 km) to managed European apiaries (1.83% of the collected drones had African mitochondrial DNA). Furthermore, nuclear sibship reconstruction demonstrated that the reduction in the proportion of African matriline drones at DCAs near apiaries was not simply an increase in the number of European matriline drones at the DCAs but also the result of fewer African matriline colonies contributing drones to the DCAs. Our data demonstrate that the management of European honey bee colonies can dramatically influence the proportion of drones with African matrilines at nearby drone congregation areas, and would likely decreasing the probability that virgin European queens will mate with African drones at those drone congregation areas.	[Mortensen, Ashley N.; Ellis, James D.] Univ Florida, Dept Entomol & Nematol, Gainesville, FL 32611 USA	State University System of Florida; University of Florida	Mortensen, AN; Ellis, JD (corresponding author), Univ Florida, Dept Entomol & Nematol, Gainesville, FL 32611 USA.	mortensena@ufl.edu; jdellis@ufl.edu	Mortensen, Ashley/B-8058-2018; Ellis, James/L-7985-2013	Mortensen, Ashley/0000-0002-4560-0574; Ellis, James/0000-0003-0318-8646	Florida Department of Agricultural and Consumer Services under the advisement of the Honey Bee Technical Counsel [00113280]	Florida Department of Agricultural and Consumer Services under the advisement of the Honey Bee Technical Counsel	Funding for this research was awarded to JDE and ANM (project number: 00113280) by the Florida Department of Agricultural and Consumer Services under the advisement of the Honey Bee Technical Counsel [http://www.freshfromflorida.com]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ascunce MS, 2009, MOL ECOL RESOUR, V9, P1476, DOI 10.1111/j.1755-0998.2009.02688.x; CROZIER YC, 1991, EXPERIENTIA, V47, P968, DOI 10.1007/BF01929894; Diniz NM, 2003, GENET MOL BIOL, V26, P47, DOI 10.1590/S1415-47572003000100008; ESTOUP A, 1995, GENETICS, V140, P679; GARY NE, 1962, SCIENCE, V136, P773, DOI 10.1126/science.136.3518.773; Gries M, 1996, J COMP PHYSIOL A, V179, P539, DOI 10.1007/BF00192319; HALL HG, 1989, NATURE, V339, P211, DOI 10.1038/339211a0; HALL HG, 1992, FLA ENTOMOL, V75, P51, DOI 10.2307/3495480; Human H, 2013, J APICULT RES, V52, DOI 10.3896/IBRA.1.52.4.10; Jean-Prost P., 1985, 17 INT BEEK C, P404; Jensen AB, 2005, CONSERV GENET, V6, P527, DOI 10.1007/s10592-005-9007-7; Jones OR, 2010, MOL ECOL RESOUR, V10, P551, DOI 10.1111/j.1755-0998.2009.02787.x; Kerr W.E., 1957, BRASIL APICOLA, V3, P211; Kerr W.E., 1967, S AFR BEE J, V39, P3; KERR WE, 1970, EVOLUTION, V24, P145, DOI 10.1111/j.1558-5646.1970.tb01747.x; Kraus FB, 2005, APIDOLOGIE, V36, P223, DOI 10.1051/apido:2005010; LOPER GM, 1991, J APICULT RES, V30, P119, DOI 10.1080/00218839.1991.11101245; MICHENER CD, 1975, ANNU REV ENTOMOL, V20, P399, DOI 10.1146/annurev.en.20.010175.002151; Michener CD, 1972, FINAL REPORT COMMITT; Mortensen AN, 2014, J APICULT RES, V53, P424, DOI 10.3896/IBRA.1.53.4.12; Pinto MA, 2005, GENETICS, V170, P1653, DOI 10.1534/genetics.104.035030; Pinto MA, 2003, ANN ENTOMOL SOC AM, V96, P679, DOI 10.1603/0013-8746(2003)096[0679:IOAHBH]2.0.CO;2; Quezada-Euan JJG, 2001, ANN ENTOMOL SOC AM, V94, P540, DOI 10.1603/0013-8746(2001)094[0540:PSIOAA]2.0.CO;2; Ratnieks F.L.W., 1991, P119; ROWELL GA, 1992, J KANSAS ENTOMOL SOC, V65, P218; RUTTNER F, 1985, FORTS ZOOL, V31, P225; Scheiner R, 2013, J APICULT RES, V52, DOI 10.3896/IBRA.1.52.4.04; Schneider SS, 2004, ANNU REV ENTOMOL, V49, P351, DOI 10.1146/annurev.ento.49.061802.123359; Shaibi T, 2008, MOL ECOL RESOUR, V8, P1034, DOI 10.1111/j.1755-0998.2008.02146.x; SHEPPARD WS, 1989, AM BEE J, V129, P664; SHEPPARD WS, 1989, AM BEE J, V129, P617; TAYLOR O R JR, 1985, Bulletin of the Entomological Society of America, V31, P15; TAYLOR OR, 1984, BEE WORLD, V65, P38, DOI 10.1080/0005772X.1984.11098769; TAYLOR OR, 1977, BEE WORLD, V58, P19, DOI 10.1080/0005772X.1977.11097632; Tribe G. D., 1982, South African Bee Journal, V54, P99; WALSH PS, 1991, BIOTECHNIQUES, V10, P506, DOI 10.2144/000114018; Wang JL, 2004, GENETICS, V166, P1963, DOI 10.1534/genetics.166.4.1963; WILLIAMS JL, 1987, J ECON ENTOMOL, V80, P532, DOI 10.1093/jee/80.2.532	38	3	3	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2016	11	8							e0161331	10.1371/journal.pone.0161331	http://dx.doi.org/10.1371/journal.pone.0161331			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3LI	27518068	gold, Green Submitted, Green Published			2022-12-27	WOS:000381382100068
J	Baghirov, H; Karaman, D; Viitala, T; Duchanoy, A; Lou, YR; Mamaeva, V; Pryazhnikov, E; Khiroug, L; Davies, CD; Sahlgren, C; Rosenholm, JM				Baghirov, Habib; Karaman, Didem; Viitala, Tapani; Duchanoy, Alain; Lou, Yan-Ru; Mamaeva, Veronika; Pryazhnikov, Evgeny; Khiroug, Leonard; Davies, Catharina de Lange; Sahlgren, Cecilia; Rosenholm, Jessica M.			Feasibility Study of the Permeability and Uptake of Mesoporous Silica Nanoparticles across the Blood-Brain Barrier	PLOS ONE			English	Article							BIOMEDICAL APPLICATIONS; IN-VITRO; CELLS; EXOCYTOSIS; NANOCARRIERS; ENDOCYTOSIS; DETERMINES; ABSORPTION; MECHANISM; TRANSPORT	Drug delivery into the brain is impeded by the blood-brain-barrier (BBB) that filters out the vast majority of drugs after systemic administration. In this work, we assessed the transport, uptake and cytotoxicity of promising drug nanocarriers, mesoporous silica nanoparticles (MSNs), in in vitro models of the BBB. RBE4 rat brain endothelial cells and Madin-Darby canine kidney epithelial cells, strain II, were used as BBB models. We studied spherical and rod-shaped MSNs with the following modifications: bare MSNs and MSNs coated with a poly (ethylene glycol)-poly(ethylene imine) (PEG-PEI) block copolymer. In transport studies, MSNs showed low permeability, whereas the results of the cellular uptake studies suggest robust uptake of PEG-PEI-coated MSNs. None of the MSNs showed significant toxic effects in the cell viability studies. While the shape effect was detectable but small, especially in the real-time surface plasmon resonance measurements, coating with PEG-PEI copolymers clearly facilitated the uptake of MSNs. Finally, we evaluated the in vivo detectability of one of the best candidates, i.e. the copolymer-coated rod-shaped MSNs, by two-photon in vivo imaging in the brain vasculature. The particles were clearly detectable after intravenous injection and caused no damage to the BBB. Thus, when properly designed, the uptake of MSNs could potentially be utilized for the delivery of drugs into the brain via transcellular transport.	[Baghirov, Habib; Mamaeva, Veronika; Sahlgren, Cecilia] Univ Turku, Turku Ctr Biotechnol, Turku, Finland; [Baghirov, Habib; Mamaeva, Veronika; Sahlgren, Cecilia] Abo Akad Univ, Turku, Finland; [Baghirov, Habib; Karaman, Didem; Duchanoy, Alain; Rosenholm, Jessica M.] Abo Akad Univ, Fac Sci & Engn, Phys Chem Lab, Turku, Finland; [Baghirov, Habib; Sahlgren, Cecilia] Abo Akad Univ, Fac Sci & Engn, Cell Biol, Turku, Finland; [Baghirov, Habib; Davies, Catharina de Lange] Norwegian Univ Sci & Technol, Dept Phys, Trondheim, Norway; [Karaman, Didem; Rosenholm, Jessica M.] Abo Akad Univ, Fac Sci & Engn, Pharmaceut Sci Lab, Turku, Finland; [Viitala, Tapani; Lou, Yan-Ru] Univ Helsinki, Div Pharmaceut Biosci, Ctr Drug Res, Helsinki, Finland; [Pryazhnikov, Evgeny; Khiroug, Leonard] Neurotar LtD, Helsinki, Finland; [Sahlgren, Cecilia] Eindhoven Univ Technol, Eindhoven, Netherlands	University of Turku; Abo Akademi University; Abo Akademi University; Abo Akademi University; Norwegian University of Science & Technology (NTNU); Abo Akademi University; University of Helsinki; Eindhoven University of Technology	Sahlgren, C (corresponding author), Univ Turku, Turku Ctr Biotechnol, Turku, Finland.; Sahlgren, C (corresponding author), Abo Akad Univ, Turku, Finland.; Rosenholm, JM (corresponding author), Abo Akad Univ, Fac Sci & Engn, Phys Chem Lab, Turku, Finland.; Sahlgren, C (corresponding author), Abo Akad Univ, Fac Sci & Engn, Cell Biol, Turku, Finland.; Rosenholm, JM (corresponding author), Abo Akad Univ, Fac Sci & Engn, Pharmaceut Sci Lab, Turku, Finland.; Sahlgren, C (corresponding author), Eindhoven Univ Technol, Eindhoven, Netherlands.	csahlgre@btk.fi; jerosenh@abo.fi	Karaman, Didem Sen/AAA-4738-2020; Lou, Yan-Ru/K-4348-2012; Viitala, Tapani/N-1434-2014; Rosenholm, Jessica Marianne/H-2542-2012; Lou, Yan-Ru/AAX-4008-2020	Karaman, Didem Sen/0000-0002-2368-9598; Lou, Yan-Ru/0000-0001-7717-6010; Viitala, Tapani/0000-0001-9074-9450; Rosenholm, Jessica Marianne/0000-0001-6085-1112; Lou, Yan-Ru/0000-0001-7717-6010; Baghirov, Habib/0000-0002-3441-9825; Sahlgren, Cecilia/0000-0003-3350-4937	Academy of Finland [140193, 137101, 260599, 137053, 263861]; Norwegian Research Council [Biotek2021 226159, Nano2021 220005]; Center for Functional Materials; Graduate School of Materials Research; Neurotar LtD	Academy of Finland(Academy of Finland); Norwegian Research Council(Research Council of NorwayEuropean Commission); Center for Functional Materials; Graduate School of Materials Research; Neurotar LtD	Funding for this research work was provided by the Academy of Finland project #140193: "Targeting of cancer cells by design - Nanoparticles as theranostic agents" (JR). Other supporting funding sources the authors acknowledge are Norwegian Research Council projects (Biotek2021 226159 and Nano2021 220005), Academy of Finland projects (#137101, #260599, #137053 and #263861) (CD), Center for Functional Materials (DSK) and Graduate School of Materials Research (AD). Neurotar LtD provided support in the form of salaries for authors EP and LK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Abbott NJ, 2010, NEUROBIOL DIS, V37, P13, DOI 10.1016/j.nbd.2009.07.030; ARTURSSON P, 1991, BIOCHEM BIOPH RES CO, V175, P880, DOI 10.1016/0006-291X(91)91647-U; Barandeh F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029424; Chabot V, 2009, BIOSENS BIOELECTRON, V24, P1667, DOI 10.1016/j.bios.2008.08.025; Chen Y, 2014, EXPERT OPIN DRUG DEL, V11, P917, DOI 10.1517/17425247.2014.908181; Chithrani BD, 2007, NANO LETT, V7, P1542, DOI 10.1021/nl070363y; Desai D, 2014, MESOPOROUS BIOMATERI, V1, P28; Fazlollahi F, 2011, NANOMED-NANOTECHNOL, V7, P588, DOI 10.1016/j.nano.2011.01.008; Gratton SEA, 2008, P NATL ACAD SCI USA, V105, P11613, DOI 10.1073/pnas.0801763105; Gu J, 2007, SMALL, V3, P1740, DOI 10.1002/smll.200700311; Hanada S, 2014, INT J MOL SCI, V15, P1812, DOI 10.3390/ijms15021812; Harush-Frenkel O, 2008, BIOMACROMOLECULES, V9, P435, DOI 10.1021/bm700535p; He QJ, 2009, SMALL, V5, P2722, DOI 10.1002/smll.200900923; Huang XL, 2010, BIOMATERIALS, V31, P438, DOI 10.1016/j.biomaterials.2009.09.060; Jain KK, 2012, NANOMEDICINE-UK, V7, P1225, DOI 10.2217/nnm.12.86; Jiang XE, 2010, ACS NANO, V4, P6787, DOI 10.1021/nn101277w; Jin H, 2008, NANO LETT, V8, P1577, DOI 10.1021/nl072969s; Kim JS, 2006, TOXICOL SCI, V89, P338, DOI 10.1093/toxsci/kfj027; Koch AM, 2005, CHEMBIOCHEM, V6, P337, DOI 10.1002/cbic.200400174; Ku ST, 2010, BIOCHEM BIOPH RES CO, V394, P871, DOI 10.1016/j.bbrc.2010.03.006; Kumar R, 2010, ACS NANO, V4, P699, DOI 10.1021/nn901146y; Lee CM, 2014, INT J NANOMED, V9, P243, DOI 10.2147/IJN.S57938; Limnell T., 2011, MESOPOROUS SILICA SI; Liu D, 2014, ACS APPL MATER INTER, V6, P2131, DOI 10.1021/am405219u; Meng H, 2011, ACS NANO, V5, P4434, DOI 10.1021/nn103344k; Panyam J, 2003, PHARM RES-DORDR, V20, P212, DOI 10.1023/A:1022219003551; Pardridge WM, 2002, DRUG DISCOV TODAY, V7, P5, DOI 10.1016/S1359-6446(01)02082-7; Ragnaill MN, 2011, EUR J PHARM BIOPHARM, V77, P360, DOI 10.1016/j.ejpb.2010.12.024; Rosenholm JM, 2011, CURR DRUG TARGETS, V12, P1166; Salvati A, 2011, NANOMED-NANOTECHNOL, V7, P818, DOI 10.1016/j.nano.2011.03.005; Santra S, 2004, CHEM COMMUN, P2810, DOI 10.1039/b411916a; Schulze C, 2011, EURO NANOTOX LETT, V1, P0001; Sen Karaman D, 2014, J COLLOID INTERF SCI, V418, P300, DOI 10.1016/j.jcis.2013.11.080; Sen Karaman D, 2012, NANOSCALE RES LETT, V7, DOI 10.1186/1556-276X-7-358; Shim KH, 2014, INT J NANOMED, V9, P225, DOI 10.2147/IJN.S58205; Veiseh O, 2005, NANO LETT, V5, P1003, DOI 10.1021/nl0502569; Viitala T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072192; Wang Y, 2015, NANOMED-NANOTECHNOL, V11, P313, DOI 10.1016/j.nano.2014.09.014; Wong HL, 2012, ADV DRUG DELIVER REV, V64, P686, DOI 10.1016/j.addr.2011.10.007; Wu SH, 2011, CHEM COMMUN, V47, P9972, DOI 10.1039/c1cc11760b; Xia TA, 2009, ACS NANO, V3, P3273, DOI 10.1021/nn900918w; Yashunsky V, 2010, BIOPHYS J, V99, P4028, DOI 10.1016/j.bpj.2010.10.017	42	55	55	2	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2016	11	8							e0160705	10.1371/journal.pone.0160705	http://dx.doi.org/10.1371/journal.pone.0160705			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT8TP	27547955	Green Published, Green Submitted, gold			2022-12-27	WOS:000381768400018
J	Orfei, CP; Lovati, AB; Vigano, M; Stanco, D; Bottagisio, M; Di Giancamillo, A; Setti, S; de Girolamo, L				Orfei, Carlotta Perucca; Lovati, Arianna B.; Vigano, Marco; Stanco, Deborah; Bottagisio, Marta; Di Giancamillo, Alessia; Setti, Stefania; de Girolamo, Laura			Dose-Related and Time-Dependent Development of Collagenase-Induced Tendinopathy in Rats	PLOS ONE			English	Article							LEVEL LASER THERAPY; INDUCED ACHILLES TENDINITIS; INDUCED TENDON INJURY; PLATELET-RICH PLASMA; ANIMAL-MODELS; CELLS; EXPRESSION; DEGENERATION; INFLAMMATION; CYTOKINES	Tendinopathy is a big burden in clinics and it represents 45% of musculoskeletal lesions. Despite the relevant social impact, both pathogenesis and development of the tendinopathy are still under-investigated, thus limiting the therapeutic advancement in this field. The purpose of this study was to evaluate the dose-dependent and time-related tissue-level changes occurring in a collagenase-induced tendinopathy in rat Achilles tendons, in order to establish a standardized model for future pre-clinical studies. With this purpose, 40 Sprague Dawley rats were randomly divided into two groups, treated by injecting collagenase type I within the Achilles tendon at 1 mg/mL (low dose) or 3 mg/mL (high dose). Tendon explants were histologically evaluated at 3, 7, 15, 30 and 45 days. Our results revealed that both the collagenase doses induced a disorganization of collagen fibers and increased the number of rounded resident cells. In particular, the high dose treatment determined a greater neovascularization and fatty degeneration with respect to the lower dose. These changes were found to be time-dependent and to resemble the features of human tendinopathy. Indeed, in our series, the acute phase occurred from day 3 to day 15, and then progressed towards the proliferative phase from day 30 to day 45 displaying a degenerative appearance associated with a very precocious and mild remodeling process. The model represents a good balance between similarity with histological features of human tendinopathy and feasibility, in terms of tendon size to create lesions and costs when compared to other animal models. Moreover, this model could contribute to improve the knowledge in this field, and it could be useful to properly design further pre-clinical studies to test innovative treatments for tendinopathy.	[Orfei, Carlotta Perucca; Vigano, Marco; Stanco, Deborah; de Girolamo, Laura] IRCCS Galeazzi Orthopaed Inst, Orthopaed Biotechnol Lab, Milan, Italy; [Orfei, Carlotta Perucca] Univ Pavia, Dept Drug Sci, Pavia, Italy; [Lovati, Arianna B.; Bottagisio, Marta] IRCCS Galeazzi Orthopaed Inst, Cell & Tissue Engn Lab, Milan, Italy; [Vigano, Marco] Univ Milano Bicocca, Dept Biotechnol & Biosci, Milan, Italy; [Bottagisio, Marta] Univ Milan, Dept Vet Med DiMeVet, Milan, Italy; [Di Giancamillo, Alessia] Univ Milan, Dept Hlth Anim Sci & Food Safety, Milan, Italy; [Setti, Stefania] IGEA SpA Clin Biophys, Carpi, MO, Italy	IRCCS Istituto Ortopedico Galeazzi; University of Pavia; IRCCS Istituto Ortopedico Galeazzi; University of Milano-Bicocca; University of Milan; University of Milan	Lovati, AB (corresponding author), IRCCS Galeazzi Orthopaed Inst, Cell & Tissue Engn Lab, Milan, Italy.	arianna.lovati@grupposadonato.it	Di Giancamillo, Alessia/Z-1477-2019; Orfei, Carlotta Perucca/B-1436-2017; Orfei, Carlotta Perucca/N-4262-2019; Bottagisio, Marta/J-8212-2016; Stanco, Deborah/AAV-6387-2021; Lovati, Arianna Barbara/J-8213-2016; Viganò, Marco/H-2559-2013; DE GIROLAMO, LAURA/C-6274-2011	Di Giancamillo, Alessia/0000-0003-1674-3020; Orfei, Carlotta Perucca/0000-0001-6162-8668; Bottagisio, Marta/0000-0001-8105-5959; Lovati, Arianna Barbara/0000-0002-5230-9718; Viganò, Marco/0000-0002-6463-6564; STANCO, DEBORAH/0000-0001-6973-1555; DE GIROLAMO, LAURA/0000-0002-9979-3092	IGEA Clinical Biophysics SpA	IGEA Clinical Biophysics SpA	This work was funded by IGEA Clinical Biophysics SpA, and the authors have no competing financial interests to declare. The funder provided support in the form of salaries for the author SS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the "author contributions."	Abbott A, 2004, NATURE, V428, P464, DOI 10.1038/428464a; [Anonymous], 2005, BASIC ORTHOPAEDIC BI; Bagnaninchi PO, 2007, BRIT J SPORT MED, V41, DOI 10.1136/bjsm.2006.030643; Battery L, 2011, SPORTS MED ARTHROSC, V19, P213, DOI 10.1097/JSA.0b013e31820e6a92; Bi YM, 2007, NAT MED, V13, P1219, DOI 10.1038/nm1630; Burssens A, 2013, KNEE SURG SPORT TR A, V21, P1459, DOI 10.1007/s00167-012-2203-3; Casalechi HL, 2013, LASER MED SCI, V28, P989, DOI 10.1007/s10103-012-1189-x; CHARD MD, 1994, ANN RHEUM DIS, V53, P30, DOI 10.1136/ard.53.1.30; Chen L, 2014, CELL PHYSIOL BIOCHEM, V34, P2153, DOI 10.1159/000369659; Cook JL, 2009, BRIT J SPORT MED, V43, P409, DOI 10.1136/bjsm.2008.051193; de Girolamo L, 2013, CELL BIOCHEM BIOPHYS, V66, P697, DOI 10.1007/s12013-013-9514-y; De Girolamo L, 2014, ULTRASOUND MED BIOL, V40, P1204, DOI 10.1016/j.ultrasmedbio.2013.12.003; Dirks RC, 2011, J MUSCULOSKEL NEURON, V11, P141; Fleiss J. L., 1981, STAT METHODS RATES P, V2; Hast MW, 2014, BONE JOINT RES, V3, P193, DOI 10.1302/2046-3758.36.2000281; Hildebrand KA, 2002, MICROSC RES TECHNIQ, V58, P34, DOI 10.1002/jemt.10114; Kamineni S, 2015, J ORTHOP SURG RES, V10, DOI 10.1186/s13018-015-0207-7; Lake SP, 2008, DISABIL REHABIL, V30, P1530, DOI 10.1080/09638280701785460; Lovati AB, 2011, J BIOL REGUL HOMEOST, V25, P75; Lui PPY, 2011, SCAND J MED SCI SPOR, V21, P3, DOI 10.1111/j.1600-0838.2010.01164.x; Lui PPY, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-248; Lui PPY, 2010, AM J SPORT MED, V38, P757, DOI 10.1177/0363546509355402; Lui PPY, 2009, J HISTOCHEM CYTOCHEM, V57, P91, DOI 10.1369/jhc.2008.952143; Maffulli N, 1998, ARTHROSCOPY, V14, P840, DOI 10.1016/S0749-8063(98)70021-0; Maffulli N, 2003, CLIN SPORT MED, V22, P675, DOI 10.1016/S0278-5919(03)00004-8; Maffulli N, 2002, J BONE JOINT SURG BR, V84B, P1, DOI 10.1302/0301-620X.84B1.12792; Maffulli N, 2006, CLIN J SPORT MED, V16, P329, DOI 10.1097/00042752-200607000-00008; Marcos RL, 2012, J ORTHOP RES, V30, P1945, DOI 10.1002/jor.22156; Pires D, 2011, LASER MED SCI, V26, P85, DOI 10.1007/s10103-010-0811-z; Rees JD, 2014, BRIT J SPORT MED, V48, P1553, DOI 10.1136/bjsports-2012-091957; Rui YF, 2012, KNEE SURG SPORT TR A, V20, P1409, DOI 10.1007/s00167-011-1685-8; Scott AM, 2015, J MOL MODEL, V21, DOI 10.1007/s00894-015-2577-5; Sharma P., 2006, Journal of Musculoskeletal & Neuronal Interactions, V6, P181; Shepherd JH, 2013, INT J EXP PATHOL, V94, P260, DOI 10.1111/iep.12037; Solchaga LA, 2014, J ORTHOP RES, V32, P145, DOI 10.1002/jor.22483; Soslowsky L J, 1996, J Shoulder Elbow Surg, V5, P383; Stanco D, 2015, REGEN MED, V10, P729, DOI 10.2217/rme.14.92; Tsai YP, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/402692; Urdzikova LM, 2014, BIOMED ENG ONLINE, V13, DOI 10.1186/1475-925X-13-42; Warden SJ, 2007, BRIT J SPORT MED, V41, P232, DOI 10.1136/bjsm.2006.032342; WILLIAMS IF, 1984, RES VET SCI, V36, P326, DOI 10.1016/S0034-5288(18)31954-4; Yoo SD, 2012, LASER MED SCI, V27, P1195, DOI 10.1007/s10103-011-1049-0; Yuan T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148557	43	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2016	11	8							e0161590	10.1371/journal.pone.0161590	http://dx.doi.org/10.1371/journal.pone.0161590			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT8TP	27548063	Green Published, gold, Green Submitted			2022-12-27	WOS:000381768400073
J	Kamisugi, Y; Whitaker, JW; Cuming, AC				Kamisugi, Yasuko; Whitaker, John W.; Cuming, Andrew C.			The Transcriptional Response to DNA-Double-Strand Breaks in Physcomitrella patens	PLOS ONE			English	Article							HOMOLOGOUS RECOMBINATION; SEQUENCE-ANALYSIS; EARLY EVOLUTION; ARABIDOPSIS; MOSS; END; ACTIVATION; MECHANISM; HELICASE; STRESS	The model bryophyte Physcomitrella patens is unique among plants in supporting the generation of mutant alleles by facile homologous recombination-mediated gene targeting (GT). Reasoning that targeted transgene integration occurs through the capture of transforming DNA by the homology-dependent pathway for DNA double-strand break (DNA-DSB) repair, we analysed the genome-wide transcriptomic response to bleomycin-induced DNA damage and generated mutants in candidate DNA repair genes. Massively parallel (Illumina) cDNA sequencing identified potential participants in gene targeting. Transcripts encoding DNA repair proteins active in multiple repair pathways were significantly up-regulated. These included Rad51, CtIP, DNA ligase 1, Replication protein A and ATR in homology-dependent repair, Xrcc4, DNA ligase 4, Ku70 and Ku80 in non-homologous end-joining and Rad1, Tebichi/polymerase theta, PARP in microhomology-mediated end-joining. Differentially regulated cell-cycle components included up-regulated Rad9 and Hus1 DNA-damage-related checkpoint proteins and down-regulated D-type cyclins and B-type CDKs, commensurate with the imposition of a checkpoint at G2 of the cell cycle characteristic of homology-dependent DNA-DSB repair. Candidate genes, including ATP-dependent chromatin remodelling helicases associated with repair and recombination, were knocked out and analysed for growth defects, hypersensitivity to DNA damage and reduced GT efficiency. Targeted knockout of PpCtIP, a cell-cycle activated mediator of homology-dependent DSB resection, resulted in bleomycin-hypersensitivity and greatly reduced GT efficiency.	[Kamisugi, Yasuko; Cuming, Andrew C.] Univ Leeds, Fac Biol Sci, Ctr Plant Sci, Leeds LS2 9JT, W Yorkshire, England; [Whitaker, John W.] Univ Leeds, Sch Mol & Cellular Biol, Bioinformat Res Grp, Leeds LS2 9JT, W Yorkshire, England; [Whitaker, John W.] Janssen R&D Johnson & Johnson, Discovery Sci, San Diego, CA USA	University of Leeds; University of Leeds	Cuming, AC (corresponding author), Univ Leeds, Fac Biol Sci, Ctr Plant Sci, Leeds LS2 9JT, W Yorkshire, England.	a.c.cuming@leeds.ac.uk		Whitaker, John W./0000-0002-0585-9119; Cuming, Andrew/0000-0003-2562-2052	UK Biotechnology and Biological Sciences Research Council [BB/I006710/1]; BBSRC [BB/I006710/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/I006710/1] Funding Source: researchfish	UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The authors are grateful to the UK Biotechnology and Biological Sciences Research Council (http://www.bbsrc.ac.uk) for its support through BBSRC Research Grant BB/I006710/1. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors are grateful to the UK Biotechnology and Biological Sciences Research Council for its support through BBSRC Research Grant BB/I006710/1. We are grateful to Dr. Fabien Nogue (INRA, Versailles) and Dr. Didier Schaefer (Univ. Neuchatel) for providing us with the mismatched PpAPT targeting vectors. We also thank Stefan Rensing, Daniel Lang and Andreas Zimmer (Freiburg University) for integrating the sequence reads into the Cosmoss Physcomitrella genome browser.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Ahel D, 2009, SCIENCE, V325, P1240, DOI 10.1126/science.1177321; Antony E, 2009, MOL CELL, V35, P105, DOI 10.1016/j.molcel.2009.05.026; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Britt AB, 2003, TRENDS PLANT SCI, V8, P90, DOI 10.1016/S1360-1385(03)00002-5; Charlot F, 2014, NUCLEIC ACIDS RES, V42, P11965, DOI 10.1093/nar/gku890; Chen IP, 2003, PLANT J, V35, P771, DOI 10.1046/j.1365-313X.2003.01847.x; Clerici M, 2005, J BIOL CHEM, V280, P38631, DOI 10.1074/jbc.M508339200; Colaiacovo MP, 1999, GENETICS, V151, P1409; Colavito S, 2009, NUCLEIC ACIDS RES, V37, P6754, DOI 10.1093/nar/gkp748; Cosgrove DJ, 2005, NAT REV MOL CELL BIO, V6, P850, DOI 10.1038/nrm1746; Culligan KM, 2006, PLANT J, V48, P947, DOI 10.1111/j.1365-313X.2006.02931.x; Cuming AC, 2007, NEW PHYTOL, V176, P275, DOI 10.1111/j.1469-8137.2007.02187.x; DIXON RA, 1995, PLANT CELL, V7, P1085, DOI 10.1105/tpc.7.7.1085; Dubest S, 2002, EMBO REP, V3, P1049, DOI 10.1093/embo-reports/kvf211; Feng JX, 2005, PLANT MOL BIOL, V59, P853, DOI 10.1007/s11103-005-1511-0; Frank W, 2005, PLANTA, V220, P384, DOI 10.1007/s00425-004-1351-1; FUTERS TS, 1993, PLANT MOL BIOL, V23, P1067, DOI 10.1007/BF00021821; Gottschalk AJ, 2012, J BIOL CHEM, V287, P43527, DOI 10.1074/jbc.M112.401141; Hartmann U, 2005, PLANT MOL BIOL, V57, P155, DOI 10.1007/s11103-004-6910-0; Hu ZB, 2015, PLANT CELL, V27, P149, DOI 10.1105/tpc.114.134312; Huertas P, 2009, J BIOL CHEM, V284, P9558, DOI 10.1074/jbc.M808906200; Inagaki S, 2006, PLANT CELL, V18, P879, DOI 10.1105/tpc.105.036798; Inagaki S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000613; Jazayeri A, 2006, NAT CELL BIOL, V8, P37, DOI 10.1038/ncb1337; Jin HL, 1999, PLANT MOL BIOL, V41, P577, DOI 10.1023/A:1006319732410; Kai M, 2013, BIOMOLECULES, V3, P75, DOI 10.3390/biom3010075; Kamisugi Y, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni172; Kamisugi Y, 2008, PLANT J, V56, P855, DOI 10.1111/j.1365-313X.2008.03637.x; Kamisugi Y, 2009, ANNU PLANT REV, V36, P76, DOI 10.1111/b.9781405181891.2009.00004.x; Kamisugi Y, 2012, NUCLEIC ACIDS RES, V40, P3496, DOI 10.1093/nar/gkr1272; Kamisugi Y, 2006, NUCLEIC ACIDS RES, V34, P6205, DOI 10.1093/nar/gkl832; Kenrick P, 1997, NATURE, V389, P33, DOI 10.1038/37918; Kim DG, 2005, J PLANT BIOL, V48, P298, DOI 10.1007/BF03030526; Knight CD, 2002, PRACT APPROACH SER, V259, P285; Krogh BO, 2004, ANNU REV GENET, V38, P233, DOI 10.1146/annurev.genet.38.072902.091500; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Mannuss A, 2010, PLANT CELL, V22, P3318, DOI 10.1105/tpc.110.078568; Markmann-Mulisch U, 2007, PLANT CELL, V19, P3080, DOI 10.1105/tpc.107.054049; Ogas J, 1999, P NATL ACAD SCI USA, V96, P13839, DOI 10.1073/pnas.96.24.13839; ORRWEAVER TL, 1981, P NATL ACAD SCI-BIOL, V78, P6354, DOI 10.1073/pnas.78.10.6354; Peterson SE, 2013, MOL CELL, V49, P657, DOI 10.1016/j.molcel.2012.11.020; PLESSIS A, 1993, GENE, V134, P41, DOI 10.1016/0378-1119(93)90172-Y; Recker J, 2014, PLANT CELL, V26, P4889, DOI 10.1105/tpc.114.132472; Rensing SA, 2008, SCIENCE, V319, P64, DOI 10.1126/science.1150646; Roerink SF, 2014, GENOME RES, V24, P954, DOI 10.1101/gr.170431.113; Sartori AA, 2007, NATURE, V450, P509, DOI 10.1038/nature06337; Schaefer DG, 2010, DNA REPAIR, V9, P526, DOI 10.1016/j.dnarep.2010.02.001; Schaefer DG, 2002, ANNU REV PLANT BIOL, V53, P477, DOI 10.1146/annurev.arplant.53.100301.135202; Schaefer DG, 1997, PLANT J, V11, P1195, DOI 10.1046/j.1365-313X.1997.11061195.x; Schiml S, 2016, PLANT METHODS, V12, DOI 10.1186/s13007-016-0103-0; Sfeir A, 2015, TRENDS BIOCHEM SCI, V40, P701, DOI 10.1016/j.tibs.2015.08.006; Shaked H, 2006, GENETICS, V173, P985, DOI 10.1534/genetics.105.051664; TAYLOR RM, 1993, FEBS LETT, V331, P71, DOI 10.1016/0014-5793(93)80299-A; Terada R, 2007, PLANT PHYSIOL, V144, P846, DOI 10.1104/pp.107.095992; Thompson JE, 2001, PLANT J, V26, P23, DOI 10.1046/j.1365-313x.2001.01005.x; Townsend JA, 2009, NATURE, V459, P442, DOI 10.1038/nature07845; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Trouiller B, 2006, NUCLEIC ACIDS RES, V34, P232, DOI 10.1093/nar/gkj423; von Stackelberg M, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-9; West CE, 2004, BIOCHEM SOC T, V32, P964, DOI 10.1042/BST0320964; Woodhouse BC, 2008, DNA REPAIR, V7, P1077, DOI 10.1016/j.dnarep.2008.03.009; Yun MH, 2009, NATURE, V459, P460, DOI 10.1038/nature07955; Zimmer A, 2007, MOL GENET GENOMICS, V278, P393, DOI 10.1007/s00438-007-0257-6	66	22	23	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0161204	10.1371/journal.pone.0161204	http://dx.doi.org/10.1371/journal.pone.0161204			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27537368	Green Published, gold			2022-12-27	WOS:000381577000066
J	Sukseree, S; Chen, YT; Laggner, M; Gruber, F; Petit, V; Nagelreiter, IM; Mlitz, V; Rossiter, H; Pollreisz, A; Schmidt-Erfurth, U; Larue, L; Tschachler, E; Eckhart, L				Sukseree, Supawadee; Chen, Ying-Ting; Laggner, Maria; Gruber, Florian; Petit, Valerie; Nagelreiter, Ionela-Mariana; Mlitz, Veronika; Rossiter, Heidemarie; Pollreisz, Andreas; Schmidt-Erfurth, Ursula; Larue, Lionel; Tschachler, Erwin; Eckhart, Leopold			Tyrosinase-Cre-Mediated Deletion of the Autophagy Gene Atg7 Leads to Accumulation of the RPE65 Variant M450 in the Retinal Pigment Epithelium of C57BL/6 Mice	PLOS ONE			English	Article							VISUAL CYCLE; OXIDATIVE STRESS; EPIDERMAL-KERATINOCYTES; MACULAR DEGENERATION; STEM-CELLS; EXPRESSION; A2E; DIFFERENTIATION; AGGREGATION; INHIBITION	Targeted gene knockout mouse models have helped to identify roles of autophagy in many tissues. Here, we investigated the retinal pigment epithelium (RPE) of Atg7(f/f) Tyr-Cre mice (on a C57BL/6 background), in which Cre recombinase is expressed under the control of the tyrosinase promoter to delete the autophagy gene Atg7. In line with pigment cell-directed blockade of autophagy, the RPE and the melanocytes of the choroid showed strong accumulation of the autophagy adaptor and substrate, sequestosome 1 (Sqstm1)/p62, relative to the levels in control mice. Immunofluorescence and Western blot analysis demonstrated that the RPE, but not the choroid melanocytes, of Atg7(f/f) Tyr-Cre mice also had strongly increased levels of retinoid isomerohydrolase RPE65, a pivotal enzyme for the maintenance of visual perception. In contrast to Sqstm1, genes involved in retinal regeneration, i.e. Lrat, Rdh5, Rgr, and Rpe65, were expressed at higher mRNA levels. Sequencing of the Rpe65 gene showed that Atg7(f/f) and Atg7(f/f) Tyr-Cre mice carry a point mutation (L450M) that is characteristic for the C57BL/6 mouse strain and reportedly causes enhanced degradation of the RPE65 protein by an as-yet unknown mechanism. These results suggest that the increased abundance of RPE65 M450 in the RPE of Atg7(f/f) Tyr-Cre mice is, at least partly, mediated by upregulation of Rpe65 transcription; however, our data are also compatible with the hypothesis that the RPE65 M450 protein is degraded by Atg7-dependent autophagy in Atg7(f/f) mice. Further studies in mice of different genetic backgrounds are necessary to determine the relative contributions of these mechanisms.	[Sukseree, Supawadee; Gruber, Florian; Nagelreiter, Ionela-Mariana; Mlitz, Veronika; Rossiter, Heidemarie; Tschachler, Erwin; Eckhart, Leopold] Med Univ Vienna, Dept Dermatol, Res Div Biol & Pathobiol Skin, Vienna, Austria; [Chen, Ying-Ting; Laggner, Maria; Pollreisz, Andreas; Schmidt-Erfurth, Ursula] Med Univ Vienna, Dept Ophthalmol, Vienna, Austria; [Gruber, Florian; Nagelreiter, Ionela-Mariana] Christian Doppler Lab Biotechnol Skin Aging, Vienna, Austria; [Petit, Valerie; Larue, Lionel] PSL Res Univ, Inst Curie, CNRS UMR3347, INSERM U1021,Normal & Pathol Dev Melanocytes, Orsay, France; [Petit, Valerie; Larue, Lionel] INSERM, Orsay, France; [Petit, Valerie; Larue, Lionel] Univ Paris 11, Equipe Labellisee Ligue Natl Canc, Orsay, France	Medical University of Vienna; Medical University of Vienna; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Eckhart, L (corresponding author), Med Univ Vienna, Dept Dermatol, Res Div Biol & Pathobiol Skin, Vienna, Austria.	leopold.eckhart@meduniwien.ac.at	Pollreisz, Andreas/AAJ-1538-2021; Sukseree, Supawadee/AAT-6545-2020; Larue, Lionel/I-6532-2016	PETIT, Valerie/0000-0003-1645-9396; Sukseree, Supawadee/0000-0002-7011-9352; Eckhart, Leopold/0000-0002-5645-2036; Gruber, Florian/0000-0003-1094-5641; Chen, Ying-Ting/0000-0002-8606-2418; Nagelreiter, Ionela Mariana/0000-0003-4684-7947; Schmidt-Erfurth, Ursula/0000-0002-7788-7311; Tschachler, Erwin/0000-0002-0248-1798				Choi AMK, 2013, NEW ENGL J MED, V368, P651, DOI [10.1056/NEJMra1205406, 10.1056/NEJMc1303158]; Choi SW, 2015, STEM CELL REV REP, V11, P376, DOI 10.1007/s12015-014-9568-2; Colombo S, 2007, PIGM CELL RES, V20, P305, DOI 10.1111/j.1600-0749.2007.00387.x; Danciger M, 2000, MAMM GENOME, V11, P422, DOI 10.1007/s003350010081; Delmas V, 2003, GENESIS, V36, P73, DOI 10.1002/gene.10197; Eckhart L, 2008, J DERMATOL SCI, V50, P209, DOI 10.1016/j.jdermsci.2007.12.009; Ferrington DA, 2016, PROG RETIN EYE RES, V51, P69, DOI 10.1016/j.preteyeres.2015.09.002; Fischer H, 2014, J INVEST DERMATOL, V134, P2579, DOI 10.1038/jid.2014.197; Frost LS, 2015, MOL NEUROBIOL, V52, P1135, DOI 10.1007/s12035-014-8920-5; Galluzzi L, 2014, CELL, V159, P1263, DOI 10.1016/j.cell.2014.11.006; Garcia TY, 2015, INVEST OPHTH VIS SCI, V56, P7480, DOI 10.1167/iovs.15-17251; Ildefonso CJ, 2016, INVEST OPHTH VIS SCI, V57, P372, DOI 10.1167/iovs.15-17703; Jacobson SG, 2015, NEW ENGL J MED, V372, P1920, DOI 10.1056/NEJMoa1412965; Kaarniranta K, 2013, AUTOPHAGY, V9, P973, DOI 10.4161/auto.24546; Katsuragi Y, 2015, FEBS J, V282, P4672, DOI 10.1111/febs.13540; Kim JY, 2013, CELL, V154, P365, DOI 10.1016/j.cell.2013.06.012; Kim SR, 2004, P NATL ACAD SCI USA, V101, P11668, DOI 10.1073/pnas.0403499101; Kole C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150758; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Lorenz B, 2008, INVEST OPHTH VIS SCI, V49, P5235, DOI 10.1167/iovs.07-1671; Maeda T, 2009, INVEST OPHTH VIS SCI, V50, P322, DOI 10.1167/iovs.08-2301; Marlhens F, 1997, NAT GENET, V17, P139, DOI 10.1038/ng1097-139; Masuda T, 2014, J BIOL CHEM, V289, P12908, DOI 10.1074/jbc.M114.556738; Mattapallil MJ, 2012, INVEST OPHTH VIS SCI, V53, P2921, DOI 10.1167/iovs.12-9662; Mehalow AK, 2003, HUM MOL GENET, V12, P2179, DOI 10.1093/hmg/ddg232; Mitter SK, 2014, AUTOPHAGY, V10, P1989, DOI 10.4161/auto.36184; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Moiseyev G, 2005, P NATL ACAD SCI USA, V102, P12413, DOI 10.1073/pnas.0503460102; Perusek L, 2015, J BIOL CHEM, V290, P29035, DOI 10.1074/jbc.M115.682310; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Radu RA, 2008, J BIOL CHEM, V283, P19730, DOI 10.1074/jbc.M801288200; Redmond TM, 2007, MOL VIS, V13, P1813; Rossiter H, 2013, J DERMATOL SCI, V71, P67, DOI 10.1016/j.jdermsci.2013.04.015; Saadat KASM, 2014, FEBS OPEN BIO, V4, P1007, DOI 10.1016/j.fob.2014.11.003; Sachdeva MM, 2014, EXP EYE RES, V119, P111, DOI 10.1016/j.exer.2013.10.024; Sukseree Supawadee, 2013, Front Biosci (Elite Ed), V5, P1000; Sukseree S, 2013, BIOCHEM BIOPH RES CO, V430, P689, DOI 10.1016/j.bbrc.2012.11.090; Sukseree S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038933; Tang PH, 2013, PROG RETIN EYE RES, V32, P48, DOI 10.1016/j.preteyeres.2012.09.002; Valapala M, 2014, AUTOPHAGY, V10, P480, DOI 10.4161/auto.27292; Viiri J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069563; Wang AL, 2009, AUTOPHAGY, V5, P1190, DOI 10.4161/auto.5.8.10087; Wang L, 2014, BBA-MOL CELL RES, V1843, P1248, DOI 10.1016/j.bbamcr.2014.03.016; Wavre-Shapton ST, 2015, HUM MOL GENET, V24, P7060, DOI 10.1093/hmg/ddv406; Wavre-Shapton ST, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057769; Wenzel A, 2001, J NEUROSCI, V21, P53, DOI 10.1523/JNEUROSCI.21-01-00053.2001; Yao JY, 2015, AUTOPHAGY, V11, P939, DOI 10.1080/15548627.2015.1041699; Zatloukal K, 2002, AM J PATHOL, V160, P255, DOI 10.1016/S0002-9440(10)64369-6; Zhang CF, 2015, J INVEST DERMATOL, V135, P1348, DOI 10.1038/jid.2014.439; Zhang J, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.330; Zhao ZY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019456	51	13	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0161640	10.1371/journal.pone.0161640	http://dx.doi.org/10.1371/journal.pone.0161640			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27537685	Green Submitted, gold, Green Published			2022-12-27	WOS:000381577000128
J	Thome, J; Koppe, G; Hauschild, S; Liebke, L; Schmahl, C; Lis, S; Bohus, M				Thome, Janine; Koppe, Georgia; Hauschild, Sophie; Liebke, Lisa; Schmahl, Christian; Lis, Stefanie; Bohus, Martin			Modification of Fear Memory by Pharmacological and Behavioural Interventions during Reconsolidation	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; CONDITIONED FEAR; POTENTIATED STARTLE; TRIGGER RECONSOLIDATION; NORADRENERGIC BLOCKADE; INDIVIDUAL-DIFFERENCES; IMPAIRS EXTINCTION; ERASING FEAR; HUMANS; MECHANISMS	Background Dysfunctional fear responses play a central role in many mental disorders. New insights in learning and memory suggest that pharmacological and behavioural interventions during the reconsolidation of reactivated fear memories may increase the efficacy of therapeutic interventions. It has been proposed that interventions applied during reconsolidation may modify the original fear memory, and thus prevent the spontaneous recovery and reinstatement of the fear response. Methods We investigated whether pharmacological (propranolol) and behavioural (reappraisal, multisensory stimulation) interventions reduce fear memory, and prevent reinstatement of fear in comparison to a placebo control group. Eighty healthy female subjects underwent a differential fear conditioning procedure with three stimuli (CS). Two of these (CS+) were paired with an electric shock on day 1. On day 2, 20 subjects were pseudo-randomly assigned to either the propranolol or placebo condition, or underwent one of the two behavioural interventions after one of the two CS+ was reactivated. On day 3, all subjects underwent an extinction phase, followed by a reinstatement test. Dependent variables were US expectancy ratings, fear-potentiated startle, and skin conductance response. Results Differential fear responses to the reactivated and non-reactivated CS+ were observed only in the propranolol condition. Here, the non-reactivated CS+ evoked stronger fear-potentiated startle-responses compared to the placebo group. None of the interventions prevented the return of the extinguished fear response after re-exposure to the unconditioned stimulus. Conclusions Our data are in line with an increasing body of research stating that the occurrence of re-consolidation may be constrained by boundary conditions such as subtle differences in experimental manipulations and instructions. In conclusion, our findings do not support a beneficial effect in using reconsolidation processes to enhance effects of psychotherapeutic interventions. This implies that more research is required before therapeutic interventions may benefit from a combination with reconsolidation processes.	[Thome, Janine; Hauschild, Sophie; Liebke, Lisa; Lis, Stefanie; Bohus, Martin] Heidelberg Univ, Med Fac Mannheim, Cent Inst Mental Hlth, Inst Psychiat & Psychosomat Psychotherapy, Mannheim, Germany; [Schmahl, Christian] Heidelberg Univ, Med Fac Mannheim, Cent Inst Mental Hlth, Clin Psychosomat Med & Psychotherapy, Mannheim, Germany; [Koppe, Georgia] Heidelberg Univ, Med Fac Mannheim, Cent Inst Mental Hlth, Dept Theoret Neurosci, Mannheim, Germany; [Schmahl, Christian] Western Univ, Schulich Sch Med & Dent, Dept Psychiat, London, ON, Canada; [Bohus, Martin] Univ Antwerp, Fac Hlth, Antwerp, Belgium	Central Institute of Mental Health; Ruprecht Karls University Heidelberg; Central Institute of Mental Health; Ruprecht Karls University Heidelberg; Central Institute of Mental Health; Ruprecht Karls University Heidelberg; Western University (University of Western Ontario); University of Antwerp	Thome, J (corresponding author), Heidelberg Univ, Med Fac Mannheim, Cent Inst Mental Hlth, Inst Psychiat & Psychosomat Psychotherapy, Mannheim, Germany.	janine.thome@zi-mannheim.de	Koppe, Georgia/ABD-4179-2020; Schmahl, Christian/E-8760-2012	Koppe, Georgia/0000-0003-2941-9238; Thome, Janine/0000-0002-0215-2097; Schmahl, Christian/0000-0003-0141-0821	German Research Foundation [SFB636/ C5]; International Graduate Program in Translational Neuroscience [SFB 636]	German Research Foundation(German Research Foundation (DFG)); International Graduate Program in Translational Neuroscience	This study was supported by the German Research Foundation (SFB636/ C5 to MB and CS) [http://www.sfb636.de/29.html]. JT, GK, and HS were supported by a scholarship of the SFB 636 International Graduate Program in Translational Neuroscience founded by the German Research Foundation (DFG).; This study was supported by the German Research Foundation (SFB636/ C5 to MB and CS). JT, GK, and HS were supported by a scholarship of the SFB 636 International Graduate Program in Translational Neuroscience founded by the German Research Foundation (DFG).	Agren T, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.5; Agren T, 2012, SCIENCE, V337, P1550, DOI 10.1126/science.1223006; Blumenthal TD, 2005, PSYCHOPHYSIOLOGY, V42, P1, DOI 10.1111/j.1469-8986.2005.00271.x; Bohus M, 2013, PSYCHOTHER PSYCHOSOM, V82, P221, DOI 10.1159/000348451; Bos MGN, 2012, BIOL PSYCHOL, V89, P598, DOI 10.1016/j.biopsycho.2012.01.007; Bos MGN, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00412; Bouton ME, 2004, LEARN MEMORY, V11, P485, DOI 10.1101/lm.78804; Bouton ME, 2002, BIOL PSYCHIAT, V52, P976, DOI 10.1016/S0006-3223(02)01546-9; Choi JH, 2010, MOL BRAIN, V3, DOI 10.1186/1756-6606-3-1; Corlett PR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065088; Davis M, 2006, AM PSYCHOL, V61, P741, DOI 10.1037/0003-066X.61.8.741; Debiec J, 2002, NEURON, V36, P527, DOI 10.1016/S0896-6273(02)01001-2; Debiec J, 2011, DEPRESS ANXIETY, V28, P186, DOI 10.1002/da.20803; Dunsmoor JE, 2015, TRENDS COGN SCI, V19, P73, DOI 10.1016/j.tics.2014.12.003; Dymond S, 2015, BEHAV THER, V46, P561, DOI 10.1016/j.beth.2014.10.001; Finnie PSB, 2012, NEUROSCI BIOBEHAV R, V36, P1667, DOI 10.1016/j.neubiorev.2012.03.008; Ford JD., 2009, TREATING COMPLEX TRA; Frewen PA, 2014, J TRAUMA DISSOCIATIO, V15, P436, DOI 10.1080/15299732.2013.873377; Gazendam FJ, 2013, BIOL PSYCHOL, V92, P342, DOI 10.1016/j.biopsycho.2012.11.006; Geschwind N, 2015, J PAIN, V16, P258, DOI 10.1016/j.jpain.2014.12.003; Ghirlanda S, 2006, ANIM BEHAV, V66, P15; Golkar A, 2012, BIOL PSYCHOL, V91, P292, DOI 10.1016/j.biopsycho.2012.07.007; Hamm AO, 2005, INT J PSYCHOPHYSIOL, V57, P5, DOI 10.1016/j.ijpsycho.2005.01.006; Harris JA, 2000, J EXP PSYCHOL-ANIM B, V26, P174, DOI 10.1037//0097-7403.26.2.174; Hofmann SG, 2008, J CLIN PSYCHIAT, V69, P621, DOI 10.4088/jcp.v69n0415; Hou Y, 2015, NEUROSCI LETT, V594, P1, DOI 10.1016/j.neulet.2015.03.030; Huang YY, 2007, LEARN MEMORY, V14, P497, DOI 10.1101/lm.593407; Hurlemann R, 2010, PSYCHOL MED, V40, P1839, DOI 10.1017/S0033291709992376; James EL, 2015, PSYCHOL SCI, V26, P1201, DOI 10.1177/0956797615583071; Jeffries FW, 2013, BEHAV COGN PSYCHOTH, V41, P290, DOI 10.1017/S1352465812000793; Kindt M, 2014, JOVE-J VIS EXP, DOI 10.3791/52151; Kindt M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086462; Kindt M, 2013, BIOL PSYCHOL, V92, P43, DOI 10.1016/j.biopsycho.2011.09.016; Kindt M, 2009, NAT NEUROSCI, V12, P256, DOI 10.1038/nn.2271; KLORMAN R, 1974, BEHAV THER, V5, P401, DOI 10.1016/S0005-7894(74)80008-0; Klucken T, 2016, CORTEX, V79, P112, DOI 10.1016/j.cortex.2016.03.015; LaBar KS, 1998, NEURON, V20, P937, DOI 10.1016/S0896-6273(00)80475-4; Lane RD, 2015, BEHAV BRAIN SCI, V38, DOI 10.1017/S0140525X14000041; Lang PJ, 2008, INT AFFECTIVE PICTUR; Laux L., 1981, STATE TRAIT ANGSTINV; Lee JLC, 2008, NAT NEUROSCI, V11, P1264, DOI 10.1038/nn.2205; Lissek S, 2008, BEHAV RES THER, V46, P678, DOI 10.1016/j.brat.2008.02.005; Lissek S, 2010, AM J PSYCHIAT, V167, P47, DOI 10.1176/appi.ajp.2009.09030410; Milad MR, 2002, NATURE, V420, P70, DOI 10.1038/nature01138; Myers KM, 2006, LEARN MEMORY, V13, P216, DOI 10.1101/lm.119806; Norrholm SD, 2006, LEARN MEMORY, V13, P681, DOI 10.1101/lm.393906; Norton PJ, 2007, J NERV MENT DIS, V195, P521, DOI 10.1097/01.nmd.0000253843.70149.9a; Ochsner KN, 2002, J COGNITIVE NEUROSCI, V14, P1215, DOI 10.1162/089892902760807212; Olatunji BO, 2010, CLIN PSYCHOL REV, V30, P642, DOI 10.1016/j.cpr.2010.04.008; Onat S, 2015, NAT NEUROSCI, V18, P1811, DOI 10.1038/nn.4166; Oyarzun JP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038849; Powers A, 2015, J PSYCHIATR RES, V61, P174, DOI 10.1016/j.jpsychires.2014.12.011; Ray RD, 2005, COGN AFFECT BEHAV NE, V5, P156, DOI 10.3758/CABN.5.2.156; Ray RD, 2008, J PERS SOC PSYCHOL, V94, P133, DOI 10.1037/0022-3514.94.1.133; Rescorla RA, 2001, HANDBOOK OF CONTEMPORARY LEARNING THEORIES, P119; Rescorla RA, 2004, LEARN BEHAV, V32, P401; Rinck M, 2002, DIAGNOSTICA, V48, P141, DOI 10.1026//0012-1924.48.3.141; Schiller D, 2013, P NATL ACAD SCI USA, V110, P20040, DOI 10.1073/pnas.1320322110; Schiller D, 2010, NATURE, V463, P49, DOI 10.1038/nature08637; Schwabe L, 2014, BIOL PSYCHIAT, V76, P274, DOI 10.1016/j.biopsych.2014.03.008; Sevenster D, 2014, LEARN MEMORY, V21, P580, DOI 10.1101/lm.035493.114; Sevenster D, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00032; Sevenster D, 2013, SCIENCE, V339, P830, DOI 10.1126/science.1231357; Sevenster D, 2012, NEUROBIOL LEARN MEM, V97, P338, DOI 10.1016/j.nlm.2012.01.009; SHEPARD RN, 1987, SCIENCE, V237, P1317, DOI 10.1126/science.3629243; Soeter M, 2015, BIOL PSYCHIAT, V78, P880, DOI 10.1016/j.biopsych.2015.04.006; Soeter M, 2015, FRONT BEHAV NEUROSCI, V9, DOI [10.3389/fnbeh.2015.00122, 10.3389/fnbeh.2015.001]; Soeter M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075239; Soeter M, 2012, PSYCHONEUROENDOCRINO, V37, P1769, DOI 10.1016/j.psyneuen.2012.03.011; Soeter M, 2012, NEUROPSYCHOPHARMACOL, V37, P1204, DOI 10.1038/npp.2011.307; Soeter M, 2011, LEARN MEMORY, V18, P357, DOI 10.1101/lm.2148511; Soeter M, 2010, NEUROBIOL LEARN MEM, V94, P30, DOI 10.1016/j.nlm.2010.03.004; Spielberger CD, 1999, USE PSYCHOL TESTING, P993; Steinfurth ECK, 2014, LEARN MEMORY, V21, P338, DOI 10.1101/lm.033589.113; Suzuki A, 2004, J NEUROSCI, V24, P4787, DOI 10.1523/JNEUROSCI.5491-03.2004; Tian SW, 2011, NEUROSCI LETT, V487, P368, DOI 10.1016/j.neulet.2010.10.058; van Heugten-van der Kloet D, 2015, J BEHAV THER EXP PSY, V47, P9, DOI 10.1016/j.jbtep.2014.11.002; van Well S, 2012, COGN AFFECT BEHAV NE, V12, P499, DOI 10.3758/s13415-012-0089-7; Vervoort E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096569; Wang SH, 2005, J NEUROSCI, V25, P830, DOI 10.1523/JNEUROSCI.4716-04.2005; Warren VT, 2014, NEUROBIOL LEARN MEM, V113, P165, DOI 10.1016/j.nlm.2013.10.014	81	16	17	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0161044	10.1371/journal.pone.0161044	http://dx.doi.org/10.1371/journal.pone.0161044			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DT6ES	27537364	Green Published, Green Submitted, gold			2022-12-27	WOS:000381577000046
J	Vassilev, I; Rogers, A; Kennedy, A; Wensing, M; Koetsenruijter, J; Orlando, R; Portillo, MC; Culliford, D				Vassilev, Ivaylo; Rogers, Anne; Kennedy, Anne; Wensing, Michel; Koetsenruijter, Jan; Orlando, Rosanna; Portillo, Maria Carmen; Culliford, David			Social Network Type and Long-Term Condition Management Support: A Cross-Sectional Study in Six European Countries	PLOS ONE			English	Article							SELF-MANAGEMENT; WELL; ILLNESS; PEOPLE; HEALTH; LAY	Background Network types and characteristics have been linked to the capacity of inter-personal environments to mobilise and share resources. The aim of this paper is to examine personal network types in relation to long-term condition management in order to identify the properties of network types most likely to provide support for those with a long-term condition. Method A cross-sectional observational survey of people with type 2 diabetes using interviews and questionnaires was conducted between April and October 2013 in six European countries: Greece, Spain, Bulgaria, Norway, United Kingdom, and Netherlands. 1862 people with predominantly lower socio-economic status were recruited from each country. We used k-means clustering analysis to derive the network types, and one-way analysis of variance and multivariate logistic regression analysis to explore the relationship between network type socio-economic characteristics, self-management monitoring and skills, well-being, and network member work. Results Five network types of people with long-term conditions were identified: restricted, minimal family, family, weak ties, and diverse. Restricted network types represented those with the poorest self-management skills and were associated with limited support from social network members. Restricted networks were associated with poor indicators across self-management capacity, network support, and well-being. Diverse networks were associated with more enhanced self-management skills amongst those with a long-term condition and high level of emotional support. It was the three network types which had a large number of network members (diverse, weak ties, and family) where healthcare utilisation was most likely to correspond to existing health needs. Discussion Our findings suggest that type of increased social involvement is linked to greater self-management capacity and potentially lower formal health care costs indicating that diverse networks constitute the optimal network type as a policy in terms of the design of LTCM interventions and building support for people with LTCs.	[Vassilev, Ivaylo; Rogers, Anne; Kennedy, Anne; Orlando, Rosanna; Portillo, Maria Carmen; Culliford, David] Univ Southampton, NIHR Collaborat Leadership Appl Hlth Res CLAHRC W, Hlth Sci, Highfield Campus, Southampton, Hants, England; [Wensing, Michel] Univ Heidelberg Hosp, Dept Gen Practice & Hlth Serv Res, Heidelberg, Germany; [Koetsenruijter, Jan] Aarhus Univ, Dept Publ Hlth, Bartholins Alee 2, DK-8000 Aarhus C, Denmark	University of Southampton; Ruprecht Karls University Heidelberg; Aarhus University	Vassilev, I (corresponding author), Univ Southampton, NIHR Collaborat Leadership Appl Hlth Res CLAHRC W, Hlth Sci, Highfield Campus, Southampton, Hants, England.	I.I.Vassilev@soton.ac.uk	Wensing, Michel/H-8113-2014	Wensing, Michel/0000-0001-6569-8137; Koetsenruijter, Jan/0000-0003-4632-5129; Vassilev, Ivaylo/0000-0002-2206-8247; Orlando, Rosa/0000-0002-7097-5431	NIHR Collaboration for Leadership in Applied Health Research and Care (CLAHRC) Wessex; EU FP7 Collaborative Research Grant-EU-WISE; National Institute for Health Research [NF-SI-0513-10103] Funding Source: researchfish	NIHR Collaboration for Leadership in Applied Health Research and Care (CLAHRC) Wessex; EU FP7 Collaborative Research Grant-EU-WISE; National Institute for Health Research(National Institute for Health Research (NIHR))	This research has been funded by the NIHR Collaboration for Leadership in Applied Health Research and Care (CLAHRC) Wessex and EU FP7 Collaborative Research Grant-EU-WISE. CLAHRC Wessex is a partnership between Wessex NHS organisations and partners and the University of Southampton and is part of the National Institute for Health Research. EU-WISE is an integrated project under the 7th Framework Programme of the European Commission. The views expressed in this article are those of the authors and not necessarily those of the NIHR.	ADAMS RG, 1995, AM BEHAV SCI, V39, P209, DOI 10.1177/0002764295039002008; Berkman LF, 2000, SOC SCI MED, V51, P843, DOI 10.1016/S0277-9536(00)00065-4; Bossy D, 2016, HEALTH SOC CARE COMM, V24, pE191, DOI 10.1111/hsc.12277; Carstensen L.L., 2001, FAMILIES LATER LIFE, P265; Christakis NA., 2010, CONNECTED AMAZING PO; Fiori KL, 2007, J GERONTOL B-PSYCHOL, V62, pP322, DOI 10.1093/geronb/62.6.P322; Gallant MP, 2003, HEALTH EDUC BEHAV, V30, P170, DOI 10.1177/1090198102251030; GRANOVETTER MS, 1973, AM J SOCIOL, V78, P1360, DOI 10.1086/225469; Holt-Lunstad J, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000316; Jeffries M, 2015, HEALTH SOC CARE COMM, V23, P252, DOI 10.1111/hsc.12138; Kalmijn M, 2001, SOC FORCES, V79, P1289, DOI 10.1353/sof.2001.0044; Kennedy A., 2015, IMPLEMENT SCI, V11, P1; Kennedy A, 2010, IMPLEMENT SCI, V5, DOI 10.1186/1748-5908-5-7; Knutsen IR, 2017, QUAL HEALTH RES, V27, P299, DOI 10.1177/1049732315610318; Koetsenruijter J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135079; Koetsenruijter J, 2014, HEALTH QUAL LIFE OUT, V12, DOI 10.1186/1477-7525-12-29; Laumann E.O., 1966, PRESTIGE ASS URBAN C; Li T, 2015, SOC SCI MED, V130, P59, DOI 10.1016/j.socscimed.2015.02.007; Litwin H, 1997, J Cross Cult Gerontol, V12, P45, DOI 10.1023/A:1006593025061; Litwin H, 2001, GERONTOLOGIST, V41, P516, DOI 10.1093/geront/41.4.516; Litwin H, 2011, GERONTOLOGIST, V51, P379, DOI 10.1093/geront/gnq094; Litwin H, 2010, J GERONTOL B-PSYCHOL, V65, P599, DOI 10.1093/geronb/gbp104; Miller RJ, 2002, J COMMUNITY PSYCHOL, V30, P461, DOI 10.1002/jcop.10023; Osborne Richard H., W KATHRYN HLTH ED IM; Pahl R., 2004, CURR SOCIOL, V52, P199, DOI DOI 10.1177/0011392104041808; Portillo MC, 2015, DIABETES EDUCATOR, V41, P550, DOI 10.1177/0145721715594026; Reeves D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098340; Rogers A, 1998, BRIT MED J, V316, P1816, DOI 10.1136/bmj.316.7147.1816; Rogers A., 2014, IMPLEMENTATION SCI; Rogers A, 2011, IMPLEMENTATION SCI, V6; Scott A., 1995, CONNECTING GENDER AG, P158; Steinhaus H., 1956, B ACAD POLONAISE SCI; Stoller EP, 2003, J AGING HEALTH, V15, P482, DOI 10.1177/0898264303253504; Vassilev I, 2014, CHRONIC ILLNESS; Vassilev I, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-719; Vassilev I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059723; Ware J.E., 2009, USERS MANUAL SF 12V2; WELLMAN B, 1990, AM J SOCIOL, V96, P558, DOI 10.1086/229572; Wenger GC, 1997, AGING MENT HEALTH, V1, P311, DOI 10.1080/13607869757001	39	30	32	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0161027	10.1371/journal.pone.0161027	http://dx.doi.org/10.1371/journal.pone.0161027			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DT6ES	27536988	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000381577000043
J	Audet, JN; Ducatez, S; Lefebvre, L				Audet, Jean-Nicolas; Ducatez, Simon; Lefebvre, Louis			Bajan Birds Pull Strings: Two Wild Antillean Species Enter the Select Club of String-Pullers	PLOS ONE			English	Article							CALEDONIAN CROWS; END; PERFORMANCE; RADIATION; COGNITION; INSIGHT; RAVENS	String-pulling is one of the most popular tests in animal cognition because of its apparent complexity, and of its potential to be applied to very different taxa. In birds, the basic procedure involves a food reward, suspended from a perch by a string, which can be reached by a series of coordinated pulling actions with the beak and holding actions of the pulled lengths of string with the foot. The taxonomic distribution of species that pass the test includes several corvids, parrots and parids, but in other families, data are much spottier and the number of individuals per species that succeed is often low. To date, the association between string-pulling ability and other cognitive traits was never tested. It is generally assumed that string-pulling is a complex form of problem-solving, suggesting that performance on string-pulling and other problem-solving tasks should be correlated. Here, we show that individuals of two innovative species from Barbados, the bullfinch Loxigilla barbadensis and the Carib grackle Quiscalus lugubris fortirostris, pass the string-pulling test. Eighteen of the 42 bullfinches tested succeeded, allowing us to correlate performance on this test to that on several other behavioral measurements. Surprisingly, string-pulling in bullfinches was unrelated to shyness, neophobia, problem-solving, discrimination and reversal learning performance. Only two of 31 grackles tested succeeded, precluding correlational analyses with other measures but still, the two successful birds largely differed in their other behavioral traits.	[Audet, Jean-Nicolas; Ducatez, Simon; Lefebvre, Louis] McGill Univ, Dept Biol, Montreal, PQ, Canada	McGill University	Audet, JN (corresponding author), McGill Univ, Dept Biol, Montreal, PQ, Canada.	jean-nicolas.audet@mail.mcgill.ca	Audet, Jean-Nicolas/P-2535-2014; Ducatez, Simon/AAA-5378-2020	Audet, Jean-Nicolas/0000-0002-0511-183X; Ducatez, Simon/0000-0003-2865-4674	Fond de Recherche du Quebec Nature et Technologies; Fondation Fyssen; Natural Sciences and Engineering Research Council of Canada	Fond de Recherche du Quebec Nature et Technologies; Fondation Fyssen; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by a Fond de Recherche du Quebec Nature et Technologies doctoral scholarship to JNA, a post-doctoral fellowship from the Fondation Fyssen to SD and a Natural Sciences and Engineering Research Council of Canada Discovery grant to LL.	Audet JN, 2016, BEHAV ECOL, V27, P637, DOI 10.1093/beheco/arv201; Bagotskaya M.S., 2012, NEUROSCI BEHAV PHYSL, V42, P36, DOI DOI 10.1007/S11055-011-9529-Z; Bird CD, 2009, CURR BIOL, V19, P1410, DOI 10.1016/j.cub.2009.07.033; Burns KJ, 2014, MOL PHYLOGENET EVOL, V75, P41, DOI 10.1016/j.ympev.2014.02.006; Ducatez S, 2015, ANIM COGN, V18, P485, DOI 10.1007/s10071-014-0817-1; DUCKER G, 1977, BEHAVIOUR, V62, P164, DOI 10.1163/156853977X00081; Ellison AM, 2015, ANIM COGN, V18, P111, DOI 10.1007/s10071-014-0782-8; Emery NJ, 2004, SCIENCE, V306, P1903, DOI 10.1126/science.1098410; Graves GR, 2006, J CARIB ORNITHOL, V19, P56; Griffin AS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084907; Heinrich B, 2005, ETHOLOGY, V111, P962, DOI 10.1111/j.1439-0310.2005.01133.x; Heinrich B, 1995, AUK, V112, P994, DOI 10.2307/4089030; Isden J, 2013, ANIM BEHAV, V86, P829, DOI 10.1016/j.anbehav.2013.07.024; Jacobs IF, 2015, J COMP PSYCHOL, V129, P89, DOI 10.1037/a0038746; Kayello L., 2013, OPPORTUNISM COGNITIO; Krasheninnikova A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085499; Lefebvre L, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0188; MILLIKAN GEORGE C., 1967, LIVING BIRD, V6, P23; Osthaus B, 2005, ANIM COGN, V8, P37, DOI 10.1007/s10071-004-0230-2; Pepperberg IM, 2004, ANIM COGN, V7, P263, DOI 10.1007/s10071-004-0218-y; Schuck-Paim C, 2009, ANIM COGN, V12, P287, DOI 10.1007/s10071-008-0190-z; Seed AM, 2013, CURR BIOL, V23, pR67, DOI 10.1016/j.cub.2012.11.043; Seibt U, 2006, ETHOLOGY, V112, P493, DOI 10.1111/j.1439-0310.2005.01172.x; Shaw RC, 2015, ANIM BEHAV, V109, P101, DOI 10.1016/j.anbehav.2015.08.001; Taylor AH, 2009, P R SOC B, V276, P247, DOI 10.1098/rspb.2008.1107; Taylor AH, 2012, P ROY SOC B-BIOL SCI, V279, P4977, DOI 10.1098/rspb.2012.1998; Taylor AH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009345; Tebbich S, 2010, PHILOS T R SOC B, V365, P1099, DOI 10.1098/rstb.2009.0291; Teschke I, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0418; Teschke I, 2011, ANIM BEHAV, V82, P945, DOI 10.1016/j.anbehav.2011.07.032; VINCE M. A., 1961, BEHAVIOUR, V17, P103, DOI 10.1163/156853961X00033; Volter CJ, 2012, ANIM COGN, V15, P923, DOI 10.1007/s10071-012-0519-5; Werdenich D, 2006, ANIM BEHAV, V71, P855, DOI 10.1016/j.anbehav.2005.06.018; West-Eberhard Mary Jane, 2003, pi; Whitt E, 2009, ANIM COGN, V12, P739, DOI 10.1007/s10071-009-0228-x	35	6	6	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2016	11	8							e0156112	10.1371/journal.pone.0156112	http://dx.doi.org/10.1371/journal.pone.0156112			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4YN	27533282	Green Published, Green Submitted, gold			2022-12-27	WOS:000381487600001
J	Descamps, S; Tarroux, A; Cherel, Y; Delord, K; Godo, OR; Kato, A; Krafft, BA; Lorentsen, SH; Ropert-Coudert, Y; Skaret, G; Varpe, O				Descamps, Sebastien; Tarroux, Arnaud; Cherel, Yves; Delord, Karine; Godo, Olaf Rune; Kato, Akiko; Krafft, Bjorn A.; Lorentsen, Svein-Hakon; Ropert-Coudert, Yan; Skaret, Georg; Varpe, Oystein			At-Sea Distribution and Prey Selection of Antarctic Petrels and Commercial Krill Fisheries	PLOS ONE			English	Article							SOUTH-SHETLAND-ISLANDS; DRONNING-MAUD LAND; EUPHAUSIA-SUPERBA; THALASSOICA-ANTARCTICA; FUR SEALS; SEABIRD COMMUNITIES; CHINSTRAP PENGUINS; FOOD SECURITY; MINKE WHALES; INDIAN-OCEAN	Commercial fisheries may impact marine ecosystems and affect populations of predators like seabirds. In the Southern Ocean, there is an extensive fishery for Antarctic krill Euphausia superba that is projected to increase further. Comparing distribution and prey selection of fishing operations versus predators is needed to predict fishery-related impacts on krill-dependent predators. In this context, it is important to consider not only predators breeding near the fishing grounds but also the ones breeding far away and that disperse during the non-breeding season where they may interact with fisheries. In this study, we first quantified the overlap between the distribution of the Antarctic krill fisheries and the distribution of a krill dependent seabird, the Antarctic petrel Thalassoica antarctica, during both the breeding and non-breeding season. We tracked birds from the world biggest Antarctic petrel colony (Svarthamaren, Dronning Maud Land), located >1000 km from the main fishing areas, during three consecutive seasons. The overall spatial overlap between krill fisheries and Antarctic petrels was limited but varied greatly among and within years, and was high in some periods during the non-breeding season. In a second step, we described the length frequency distribution of Antarctic krill consumed by Antarctic petrels, and compared this with results from fisheries, as well as from diet studies in other krill predators. Krill taken by Antarctic petrels did not differ in size from that taken by trawls or from krill taken by most Antarctic krill predators. Selectivity for specific Antarctic krill stages seems generally low in Antarctic predators. Overall, our results show that competition between Antarctic petrels and krill fisheries is currently likely negligible. However, if krill fisheries are to increase in the future, competition with the Antarctic petrel may occur, even with birds breeding thousands of kilometers away.	[Descamps, Sebastien; Tarroux, Arnaud] Norwegian Polar Res Inst, Fram Ctr, N-9296 Tromso, Norway; [Cherel, Yves; Delord, Karine; Kato, Akiko; Ropert-Coudert, Yan] Univ La Rochelle, CNRS, UMR 7372, Ctr Etud Biol Chize, F-79360 Villiers En Bois, France; [Godo, Olaf Rune; Krafft, Bjorn A.; Skaret, Georg] Inst Marine Res, POB 1870 Nordnes, N-5817 Bergen, Norway; [Lorentsen, Svein-Hakon] Norwegian Inst Nat Res, N-7485 Trondheim, Norway; [Kato, Akiko; Ropert-Coudert, Yan] CNRS, UMR7178, F-67037 Strasbourg, France; [Kato, Akiko; Ropert-Coudert, Yan] Univ Strasbourg, IPHC, 23 Rue Becquerel, F-67087 Strasbourg, France; [Varpe, Oystein] Univ Ctr Svalbard, N-9171 Longyearbyen, Norway; [Varpe, Oystein] Akvaplan Niva, Fram Ctr, N-9296 Tromso, Norway	Norwegian Polar Institute; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); La Rochelle Universite; Institute of Marine Research - Norway; Norwegian Institute Nature Research; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University Centre Svalbard (UNIS); Akvaplan-niva	Descamps, S (corresponding author), Norwegian Polar Res Inst, Fram Ctr, N-9296 Tromso, Norway.	Sebastien.descamps@npolar.no	Tarroux, Arnaud/AAE-5173-2021; Kato, Akiko/W-2447-2019; Varpe, Øystein/B-9693-2008	Tarroux, Arnaud/0000-0001-8306-6694; Varpe, Øystein/0000-0002-5895-6983; Kato, Akiko/0000-0002-8947-3634; Godo, Olav Rune/0000-0001-8826-8068	Norwegian Research Council (program NARE-Norwegian Antarctic Research Expedition); Norwegian Research Council (Norwegian Antarctic Research Expedition program)	Norwegian Research Council (program NARE-Norwegian Antarctic Research Expedition); Norwegian Research Council (Norwegian Antarctic Research Expedition program)	The study was funded by a grant from the Norwegian Research Council (program NARE-Norwegian Antarctic Research Expedition).; This study was funded by the Norwegian Research Council (Norwegian Antarctic Research Expedition program). We are very grateful to H. Weimerskirch, T. Nordstad, S. Haaland, E. Soininen, G. Mabille and J. Sward for their help in the field, to all the personnel from the logistics department at the Norwegian Polar Institute and the Troll summer and overwintering teams. We also extend our gratitude to CCAMLR Secretariat and Members for providing the krill fishery data, to C. Trouve for her help in the analysis of food samples from Antarctic petrels, and to F. Crenner and N. Chatelain who customized the GPS units at the IPHC-CNRS UMR7178.	Afanasyev Vsevolod, 2004, Memoirs of National Institute of Polar Research Special Issue, V58, P227; Ainley D.G., 1984, MARINE ECOLOGY BIRDS; AINLEY DG, 1992, MAR ECOL PROG SER, V90, P207, DOI 10.3354/meps090207; AINLEY DG, 1994, J ANIM ECOL, V63, P347, DOI 10.2307/5553; ARNOULD JPY, 1991, ANTARCT SCI, V3, P19, DOI 10.1017/S0954102091000056; Atkinson A, 2008, MAR ECOL PROG SER, V362, P1, DOI 10.3354/meps07498; Atkinson A, 2004, NATURE, V432, P100, DOI 10.1038/nature02996; Baker AC, 1990, PRACTICAL GUIDE EUPH; Belda EJ, 2001, BIOL CONSERV, V98, P357, DOI 10.1016/S0006-3207(00)00178-6; Bocher P, 2001, MAR ECOL PROG SER, V223, P261, DOI 10.3354/meps223261; Boyd IL, 2001, J ANIM ECOL, V70, P747, DOI 10.1046/j.0021-8790.2001.00534.x; Calenge C, 2006, ECOL MODEL, V197, P516, DOI 10.1016/j.ecolmodel.2006.03.017; CHEREL Y, 1992, IBIS, V134, P118, DOI 10.1111/j.1474-919X.1992.tb08388.x; Cherel Y, 2002, MAR ECOL PROG SER, V228, P263, DOI 10.3354/meps228263; Constable AJ, 2002, CCAMLR SCI, V9, P117; Cornejo-Donoso J, 2008, ECOL MODEL, V218, P1, DOI 10.1016/j.ecolmodel.2008.06.011; Croll DA, 2006, J ZOOL, V269, P506, DOI 10.1111/j.1469-7998.2006.00090.x; Croll DA, 1998, POLAR BIOL, V19, P365, DOI 10.1007/s003000050261; Croxall J.P., 1985, P516; Descamps S, 2016, ECOGRAPHY, V39, P496, DOI 10.1111/ecog.01659; Duffy DC, 1994, SEABIRD FISHERY INTE; EVERSON I, 1996, CCAMLR SCI, V3, P1; Fauchald P, 2006, OECOLOGIA, V149, P383, DOI 10.1007/s00442-006-0463-7; Fraser WR, 2003, MAR ECOL PROG SER, V265, P1, DOI 10.3354/meps265001; Freeman AND, 1998, EMU, V98, P36, DOI 10.1071/MU98005; Friedlaender AS, 2009, MAR MAMMAL SCI, V25, P402, DOI 10.1111/j.1748-7692.2008.00263.x; Furness RW, 2003, SCI MAR, V67, P33, DOI 10.3989/scimar.2003.67s233; Garcia SM, 2010, PHILOS T R SOC B, V365, P2869, DOI 10.1098/rstb.2010.0171; Garthe S, 1996, MAR ECOL PROG SER, V136, P1, DOI 10.3354/meps136001; Gremillet D, 2008, P R SOC B, V275, P1149, DOI 10.1098/rspb.2007.1763; Hill HJ, 1996, MAR ECOL PROG SER, V140, P1, DOI 10.3354/meps140001; Hinke JT, 2007, OECOLOGIA, V153, P845, DOI 10.1007/s00442-007-0781-4; Hjermann DO, 2004, P NATL ACAD SCI USA, V101, P11679, DOI 10.1073/pnas.0402904101; Ichii T, 1996, POLAR BIOL, V16, P63, DOI 10.1007/BF02388736; ICHII T, 1991, POLAR BIOL, V11, P479; JOIRIS CR, 1991, POLAR BIOL, V11, P415; Krafft BA, 2013, 8 I MAR RES; Krafft BA, 2014, 8 I MAR RES; LORENTSEN SH, 1995, IBIS, V137, P345, DOI 10.1111/j.1474-919X.1995.tb08031.x; Lorentsen SH, 1998, POLAR BIOL, V19, P414, DOI 10.1007/s003000050267; Lynnes AS, 2004, POLAR BIOL, V27, P544, DOI 10.1007/s00300-004-0617-1; Marchant S., 1990, HDB AUSTR NZ ANTARCT, V1; MEHLUM F, 1988, Polar Research, V6, P1, DOI 10.1111/j.1751-8369.1988.tb00576.x; Miller AK, 2007, POLAR BIOL, V30, P1615, DOI 10.1007/s00300-007-0326-7; MONTAGUE TL, 1984, EMU, V84, P244, DOI 10.1071/MU9840244; Morris D. J., 1988, BR ANTARCT SURV B, V79, P27; Murphy EJ, 2007, PHILOS T R SOC B, V362, P113, DOI 10.1098/rstb.2006.1957; Myers RA, 2007, CURR BIOL, V17, pR10, DOI 10.1016/j.cub.2006.11.045; Nicol S, 2006, BIOSCIENCE, V56, P111, DOI 10.1641/0006-3568(2006)056[0111:KCASIE]2.0.CO;2; NICOL S, 1993, POLAR BIOL, V13, P399, DOI 10.1007/BF01681981; Nicol S, 2012, FISH FISH, V13, P30, DOI 10.1111/j.1467-2979.2011.00406.x; Olsen EM, 2004, NATURE, V428, P932, DOI 10.1038/nature02430; Pauly D, 2005, PHILOS T R SOC B, V360, P5, DOI 10.1098/rstb.2004.1574; Phillips RA, 2004, MAR ECOL PROG SER, V266, P265, DOI 10.3354/meps266265; Phillips RA, 2006, EMU, V106, P305, DOI 10.1071/MU06035; Pichegru L, 2010, BIOL LETTERS, V6, P498, DOI 10.1098/rsbl.2009.0913; Quetin LB, 2003, MAR ECOL PROG SER, V259, P185, DOI 10.3354/meps259185; R Development Core Team, 2014, R LANG ENV STAT COMP; Ratcliffe N, 2015, DIVERS DISTRIB, V21, P1339, DOI 10.1111/ddi.12366; Reid K, 2004, DEEP-SEA RES PT II, V51, P1383, DOI 10.1016/j.dsr2.2004.06.007; Reid K, 1996, POLAR BIOL, V16, P105, DOI 10.1007/BF02390431; Reid K, 1996, MAR ECOL PROG SER, V140, P13, DOI 10.3354/meps140013; Santora JA, 2014, POLAR BIOL, V37, P1083, DOI 10.1007/s00300-014-1502-1; Santora JA, 2010, MAR ECOL PROG SER, V405, P255, DOI 10.3354/meps08513; Schmidt K, 2014, LIMNOL OCEANOGR, V59, P17, DOI 10.4319/lo.2014.59.1.0017; Shelton AO, 2013, MAR ECOL PROG SER, V481, P53, DOI 10.3354/meps10245; SIEGEL V, 1995, MAR ECOL PROG SER, V123, P45, DOI 10.3354/meps123045; Skaret G, 2013, 9 I MAR RES; Smith WO, 2007, PHILOS T R SOC B, V362, P95, DOI 10.1098/rstb.2006.1956; Tarroux A, 2016, ANIM BEHAV, V113, P99, DOI 10.1016/j.anbehav.2015.12.021; Tierney M, 2009, MAR BIOL; Torres LG, 2013, MAR ECOL PROG SER, V473, P275, DOI 10.3354/meps10071; Tuck GN, 2003, BIOL CONSERV, V114, P1, DOI 10.1016/S0006-3207(02)00378-6; Urbanek S., PROJ4 SIMPLE INTERFA; van Franeker JA, 1999, WATERBIRDS, V22, P14, DOI 10.2307/1521989; vanFraneker JA, 1996, POLAR BIOL, V16, P565, DOI 10.1007/s003000050090; VEIT RR, 1993, J ANIM ECOL, V62, P551, DOI 10.2307/5204; Verity PG, 2002, ENVIRON CONSERV, V29, P207, DOI 10.1017/S0376892902000139; Votier SC, 2004, NATURE, V427, P727, DOI 10.1038/nature02315; WATKINS JL, 1986, MAR ECOL PROG SER, V31, P67, DOI 10.3354/meps031067; WHITEHOUSE MJ, 1994, POLAR BIOL, V14, P325; Williams R., 1990, ANARE RES NOTES, V75, P1; WILSON RP, 1984, J FIELD ORNITHOL, V55, P109; Wilson RP, 1992, WILDLIFE TELEMETRY R; Wing SR, 2014, MAR ECOL PROG SER, V510, P1, DOI 10.3354/meps10923; Winship AJ, 2012, METHODS ECOL EVOL, V3, P291, DOI 10.1111/j.2041-210X.2011.00161.x; Xavier J. C, 2009, CEPHALOPOD BEAK GUID	87	19	20	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2016	11	8							e0156968	10.1371/journal.pone.0156968	http://dx.doi.org/10.1371/journal.pone.0156968			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4YN	27533327	Green Submitted, gold, Green Published			2022-12-27	WOS:000381487600002
J	Emmert, K; Zoller, D; Preti, MG; Van De Ville, D; Giannakopoulos, P; Haller, S				Emmert, Kirsten; Zoller, Daniela; Preti, Maria Giulia; Van De Ville, Dimitri; Giannakopoulos, Panteleimon; Haller, Sven			Influence of Vascular Variant of the Posterior Cerebral Artery (PCA) on Cerebral Blood Flow, Vascular Response to CO2 and Static Functional Connectivity	PLOS ONE			English	Article							BRAIN; FMRI; ACTIVATION; REACTIVITY; MRI	Introduction The fetal origin of the posterior cerebral artery (fPCA) is a frequent vascular variant in 11-29% of the population. For the fPCA, blood flow in the PCA originates from the anterior instead of the posterior circulation. We tested whether this blood supply variant impacts the cerebral blood flow assessed by arterial spin labeling (ASL), cerebrovascular reserve as well as resting-state static functional connectivity (sFC) in the sense of a systematic confound. Methods The study included 385 healthy, elderly subjects (mean age: 74.18 years [range: 68.9-90.4]; 243 female). Participants were classified into normal vascular supply (n = 296, 76.88%), right fetal origin (n = 23, 5.97%), left fetal origin (n = 16, 4.16%), bilateral fetal origin (n = 4, 1.04%), and intermediate (n = 46, 11.95%, excluded from further analysis) groups. ASL-derived relative cerebral blood flow (relCBF) maps and cerebrovascular reserve (CVR) maps derived from a CO2 challenge with blocks of 7% CO2 were compared. Additionally, sFC between 90 regions of interest (ROIs) was compared between the groups. Results CVR was significantly reduced in subjects with ipsilateral fPCA, most prominently in the temporal lobe. ASL yielded a non-significant trend towards reduced relCBF in bilateral posterior watershed areas. In contrast, conventional atlas-based sFC did not differ between groups. Conclusions In conclusion, fPCA presence may bias the assessment of cerebrovascular reserve by reducing the response to CO2. In contrast, its effect on ASL-assessed baseline perfusion was marginal. Moreover, fPCA presence did not systematically impact resting-state sFC. Taken together, this data implies that perfusion variables should take into account the vascularization patterns.	[Emmert, Kirsten; Preti, Maria Giulia; Van De Ville, Dimitri; Haller, Sven] Univ Geneva, Fac Med, Geneva, Switzerland; [Emmert, Kirsten; Zoller, Daniela; Preti, Maria Giulia; Van De Ville, Dimitri] Ecole Polytech Fed Lausanne, Inst Bioengn, Med Image Proc Lab, Geneva, Switzerland; [Zoller, Daniela] Univ Geneva, Dept Psychiat, Off Medicopedag, Geneva, Switzerland; [Giannakopoulos, Panteleimon] Univ Geneva, Dept Psychiat, Geneva, Switzerland; [Haller, Sven] Affidea Ctr Diagnost Radiol Carouge CDRC, Carouge, Switzerland; [Haller, Sven] Uppsala Univ, Dept Surg Sci, Radiol, Uppsala, Sweden	University of Geneva; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Geneva; University of Geneva; Uppsala University	Haller, S (corresponding author), Univ Geneva, Fac Med, Geneva, Switzerland.; Haller, S (corresponding author), Affidea Ctr Diagnost Radiol Carouge CDRC, Carouge, Switzerland.; Haller, S (corresponding author), Uppsala Univ, Dept Surg Sci, Radiol, Uppsala, Sweden.	sven.haller@me.com	Haller, Sven/AAY-2564-2020; Zöller, Daniela/D-7452-2019; Van De Ville, Dimitri/A-5364-2008; Preti, Maria Giulia/X-9430-2019	Haller, Sven/0000-0001-7433-0203; Zöller, Daniela/0000-0002-7049-0696; Van De Ville, Dimitri/0000-0002-2879-3861; Preti, Maria Giulia/0000-0002-5323-5327	Swiss National Science Foundation [SNF 320030-147126, 3200B0-1161193, SPUM 33CM30-124111]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by the Swiss National Science Foundation (Grant SNF 320030-147126, 3200B0-1161193 and SPUM 33CM30-124111). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleman-Gomez Y., 2006, 12 ANN M ORG HUM BRA; Bartynski WS, 2007, AM J NEURORADIOL, V28, P1320, DOI 10.3174/ajnr.A0549; Caplan LR, 1998, ARCH NEUROL-CHICAGO, V55, P1475, DOI 10.1001/archneur.55.11.1475; Haller S, 2008, RADIOLOGY, V249, P251, DOI 10.1148/radiol.2491071644; Haller S, 2006, EUR J NEUROSCI, V24, P2672, DOI 10.1111/j.1460-9568.2006.05147.x; Hinchey J, 1996, NEW ENGL J MED, V334, P494, DOI 10.1056/NEJM199602223340803; Jiang Z, 2010, NEUROIMAGE, V52, P538, DOI 10.1016/j.neuroimage.2010.04.194; Khalili-Mahani N, 2014, HUM BRAIN MAPP, V35, P929, DOI 10.1002/hbm.22224; Kohn JC, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00112; Krainik A, 2013, Diagn Interv Imaging, V94, P1259, DOI 10.1016/j.diii.2013.08.004; Park SY, 2015, AM J PHYSL HEART CIR; Richiardi J, 2015, NEUROBIOL AGING, V36, P33, DOI 10.1016/j.neurobiolaging.2014.07.020; Richiardi J, 2012, NEUROIMAGE, V62, P2021, DOI 10.1016/j.neuroimage.2012.05.078; Richiardi J, 2011, NEUROIMAGE, V56, P616, DOI 10.1016/j.neuroimage.2010.05.081; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Tak S, 2014, NEUROIMAGE, V84, P672, DOI 10.1016/j.neuroimage.2013.09.057; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; van Raamt AF, 2006, CEREBROVASC DIS, V22, P217, DOI 10.1159/000094007; VILLRINGER A, 1995, CEREBROVAS BRAIN MET, V7, P240; Wentland AL, 2010, AM J NEURORADIOL, V31, P448, DOI 10.3174/ajnr.A1858; Yan CG, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00013; Ziyeh S, 2005, STROKE, V36, P751, DOI 10.1161/01.STR.0000157593.03470.3d	22	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2016	11	8							e0161121	10.1371/journal.pone.0161121	http://dx.doi.org/10.1371/journal.pone.0161121			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4YN	27532633	Green Published, gold, Green Submitted			2022-12-27	WOS:000381487600061
J	Martin, C; Bideau, B; Delamarche, P; Kulpa, R				Martin, Caroline; Bideau, Benoit; Delamarche, Paul; Kulpa, Richard			Influence of a Prolonged Tennis Match Play on Serve Biomechanics	PLOS ONE			English	Article							FATIGUE; MUSCLE; PERFORMANCE; KINEMATICS; STRENGTH; INERTIA	The aim of this study was to quantify kinematic, kinetic and performance changes that occur in the serve throughout a prolonged tennis match play. Serves of eight male advanced tennis players were recorded with a motion capture system before, at mid-match, and after a 3-hour tennis match. Before and after each match, electromyographic data of 8 upper limb muscles obtained during isometric maximal voluntary contraction were compared to determine the presence of muscular fatigue. Vertical ground reaction forces, rating of perceived exertion, ball speed, and ball impact height were measured. Kinematic and upper limb kinetic variables were computed. The results show decrease in mean power frequency values for several upper limb muscles that is an indicator of local muscular fatigue. Decreases in serve ball speed, ball impact height, maximal angular velocities and an increase in rating of perceived exertion were also observed between the beginning and the end of the match. With fatigue, the majority of the upper limb joint kinetics decreases at the end of the match. No change in timing of maximal angular velocities was observed between the beginning and the end of the match. A prolonged tennis match play may induce fatigue in upper limb muscles, which decrease performance and cause changes in serve maximal angular velocities and joint kinetics. The consistency in timing of maximal angular velocities suggests that advanced tennis players are able to maintain the temporal pattern of their serve technique, in spite of the muscular fatigue development.	[Martin, Caroline; Bideau, Benoit; Delamarche, Paul; Kulpa, Richard] Univ Rennes 2, Lab M2S, UFR APS, ENS Rennes, Campus Ker Lann,Ave Robert Schuman, F-35170 Bruz, France	Ecole Normale Superieure de Rennes (ENS Rennes); Universite Rennes 2	Martin, C (corresponding author), Univ Rennes 2, Lab M2S, UFR APS, ENS Rennes, Campus Ker Lann,Ave Robert Schuman, F-35170 Bruz, France.	caromartin@numericable.fr	Martin, Caroline/J-6385-2019; Bideau, Benoit/AAD-2052-2020	MARTIN, CAROLINE/0000-0002-4114-8947	Society of Tennis Medicine and Science (STMS); Sport Court Tennis	Society of Tennis Medicine and Science (STMS); Sport Court Tennis	The Society of Tennis Medicine and Science (STMS) and Sport Court Tennis have supported our work with an STMS Tennis Medicine Research Grant 2013 (2500 $); http://www.stms-web.org/additional_info.html; http://www.sportcourt.com. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, ARCH SEX BEHAV, DOI DOI 10.1007/s10508-008-9314-4; Apriantono T, 2006, J SPORT SCI, V24, P951, DOI 10.1080/02640410500386050; Aune TK, 2008, PERCEPT MOTOR SKILL, V106, P371, DOI 10.2466/PMS.106.2.371-386; Bahamonde RE, 2000, J SPORT SCI, V18, P579, DOI 10.1080/02640410050082297; Borg G., 1985, INTRO BORGS RPE SCAL; Brody H, 2006, BRIT J SPORT MED, V40, P397, DOI 10.1136/bjsm.2005.023432; BRODY H, 1985, PHYS TEACH, V23, P213, DOI 10.1119/1.2341781; Brotherhood J.R., 2005, MED SCI TENNIS, V10, P12; Cairns SP, 2005, EXERC SPORT SCI REV, V33, P9; Chow John W, 2009, Sports Med Arthrosc Rehabil Ther Technol, V1, P24, DOI 10.1186/1758-2555-1-24; Cifrek M, 2009, CLIN BIOMECH, V24, P327, DOI 10.1016/j.clinbiomech.2009.01.010; Davey PR, 2002, J SPORT SCI, V20, P311, DOI 10.1080/026404102753576080; de Leva P, 1996, J BIOMECH, V29, P1223, DOI 10.1016/0021-9290(95)00178-6; Donatelli R, 2000, J ORTHOP SPORT PHYS, V30, P544, DOI 10.2519/jospt.2000.30.9.544; Ebaugh DD, 2006, J ELECTROMYOGR KINES, V16, P224, DOI 10.1016/j.jelekin.2005.06.015; Elliott B, 2003, J SCI MED SPORT, V6, P76, DOI 10.1016/S1440-2440(03)80011-7; Elliott B., 2009, TECHNIQUE DEV TENNIS; Escamilla RF, 2007, AM J SPORT MED, V35, P23, DOI 10.1177/0363546506293025; Escamilla RF, 2009, SPORTS MED, V39, P569, DOI 10.2165/00007256-200939070-00004; FELTNER M, 1986, INT J SPORT BIOMECH, V2, P235, DOI 10.1123/ijsb.2.4.235; Fleisig Glenn, 2003, Sports Biomech, V2, P51, DOI 10.1080/14763140308522807; Gescheit DT, 2015, INT J SPORT PHYSIOL, V10, P913, DOI 10.1123/ijspp.2014-0329; Girard O, 2006, BRIT J SPORT MED, V40, P521, DOI 10.1136/bjsm.2005.023754; Girard O, 2011, SCAND J MED SCI SPOR, V21, P455, DOI 10.1111/j.1600-0838.2009.01032.x; Girard O, 2012, ITF COACH SPORT SCI, V20, P18; Girard O, 2007, J STRENGTH COND RES, V21, P950; Gordon BJ, 2006, J SPORT SCI, V24, P31, DOI 10.1080/02640410400022045; Hermens HJ, 2000, J ELECTROMYOGR KINES, V10, P361, DOI 10.1016/S1050-6411(00)00027-4; Hornery DJ, 2007, BRIT J SPORT MED, V41, P531, DOI 10.1136/bjsm.2006.031351; Hornery DJ, 2007, SPORTS MED, V37, P199, DOI 10.2165/00007256-200737030-00002; Kendall F, 1993, MUSCLE TESTING FUNCT; Kovacs MS, 2006, BRIT J SPORT MED, V40, P381, DOI 10.1136/bjsm.2005.023309; Manary, 1999, SAE T J PASSENGERS C, V108, P1; Martin C, 2014, SCAND J MED SCI SPOR, V24, P700, DOI 10.1111/sms.12043; Martin C, 2013, SPORT BIOMECH, V12, P2, DOI 10.1080/14763141.2012.734321; Martin C, 2011, J STRENGTH COND RES, V25, P163, DOI 10.1519/JSC.0b013e3181fb459b; Murray TA, 2001, AM J SPORT MED, V29, P137, DOI 10.1177/03635465010290020501; OBERG T, 1990, EUR J APPL PHYSIOL, V61, P362, DOI 10.1007/BF00236054; Reid M, 2014, BRIT J SPORT MED, V48, DOI 10.1136/bjsports-2013-093196; Reid M, 2011, SPORT BIOMECH, V10, P407, DOI 10.1080/14763141.2011.629206; RODOSKY MW, 1994, AM J SPORT MED, V22, P121, DOI 10.1177/036354659402200119; Rota S, 2014, J ELECTROMYOGR KINES, V24, P90, DOI 10.1016/j.jelekin.2013.10.007; RYU RKN, 1988, AM J SPORT MED, V16, P481, DOI 10.1177/036354658801600509; USRSA, 2010, RACQUET SPORTS IND M, V38, P29; Vergauwen L, 1998, MED SCI SPORT EXER, V30, P1289, DOI 10.1097/00005768-199808000-00017; Winter D. A., 2009, BIOMECHANICS MOTOR C, DOI DOI 10.1002/9780470549148; Zatsiorsky VM, 1990, CONT PROBLEMS BIOMEC, P272; ZIPP P, 1982, EUR J APPL PHYSIOL O, V50, P41, DOI 10.1007/BF00952243	49	9	9	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2016	11	8							e0159979	10.1371/journal.pone.0159979	http://dx.doi.org/10.1371/journal.pone.0159979			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4YN	27532421	Green Published, Green Submitted, gold			2022-12-27	WOS:000381487600018
J	Sharabi, S; Drori, Y; Micheli, M; Friedman, N; Orzitzer, S; Bassal, R; Glatman-Freedman, A; Shohat, T; Mendelson, E; Hindiyeh, M; Mandelboim, M				Sharabi, Sivan; Drori, Yaron; Micheli, Michal; Friedman, Nehemya; Orzitzer, Sara; Bassal, Ravit; Glatman-Freedman, Aharona; Shohat, Tamar; Mendelson, Ella; Hindiyeh, Musa; Mandelboim, Michal			Epidemiological and Virological Characterization of Influenza B Virus Infections	PLOS ONE			English	Article							CHILDREN; LINEAGES; VACCINE; DYNAMICS; SEASON; DIFFERENTIATION; YAMAGATA; VICTORIA; EFFICACY; ISRAEL	While influenza A viruses comprise a heterogeneous group of clinically relevant influenza viruses, influenza B viruses form a more homogeneous cluster, divided mainly into two lineages: Victoria and Yamagata. This divergence has complicated seasonal influenza vaccine design, which traditionally contained two seasonal influenza A virus strains and one influenza B virus strain. We examined the distribution of the two influenza B virus lineages in Israel, between 2011-2014, in hospitalized and in non-hospitalized (community) influenza B virus-infected patients. We showed that influenza B virus infections can lead to hospitalization and demonstrated that during some winter seasons, both influenza B virus lineages circulated simultaneously in Israel. We further show that the influenza B virus Yamagata lineage was dominant, circulating in the county in the last few years of the study period, consistent with the anti-Yamagata influenza B virus antibodies detected in the serum samples of affected individuals residing in Israel in the year 2014. Interestingly, we found that elderly people were particularly vulnerable to Yamagata lineage influenza B virus infections.	[Sharabi, Sivan; Drori, Yaron; Micheli, Michal; Friedman, Nehemya; Orzitzer, Sara; Mendelson, Ella; Hindiyeh, Musa; Mandelboim, Michal] Chaim Sheba Med Ctr, Minist Hlth, Cent Virol Lab, IL-52621 Ramat Gan, Israel; [Sharabi, Sivan; Drori, Yaron; Friedman, Nehemya; Shohat, Tamar; Mendelson, Ella; Hindiyeh, Musa; Mandelboim, Michal] Tel Aviv Univ, Sackler Fac Med, Sch Publ Hlth, Dept Epidemiol & Prevent Med, Tel Aviv, Israel; [Bassal, Ravit; Glatman-Freedman, Aharona; Shohat, Tamar] Israel Minist Hlth, Israel Ctr Dis Control, IL-52621 Tel Hashomer, Israel; [Glatman-Freedman, Aharona] New York Med Coll, Dept Family & Community Med, Valhalla, NY 10595 USA	Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; New York Medical College	Mandelboim, M (corresponding author), Chaim Sheba Med Ctr, Minist Hlth, Cent Virol Lab, IL-52621 Ramat Gan, Israel.; Mandelboim, M (corresponding author), Tel Aviv Univ, Sackler Fac Med, Sch Publ Hlth, Dept Epidemiol & Prevent Med, Tel Aviv, Israel.	michalman@sheba.health.gov.il						Ambrose CS, 2012, HUM VACC IMMUNOTHER, V8, P81, DOI 10.4161/hv.8.1.17623; Belshe RB, 2010, VACCINE, V28, P2149, DOI 10.1016/j.vaccine.2009.11.068; Beran J, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-2; Biere B, 2010, J CLIN MICROBIOL, V48, P1425, DOI 10.1128/JCM.02116-09; Chen RB, 2008, J MOL EVOL, V66, P655, DOI 10.1007/s00239-008-9119-z; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Heikkinen T, 2014, CLIN INFECT DIS, V59, P1519, DOI 10.1093/cid/ciu664; Hindiyeh M, 2005, J CLIN MICROBIOL, V43, P589, DOI 10.1128/JCM.43.2.589-595.2005; KANEGAE Y, 1990, J VIROL, V64, P2860, DOI 10.1128/JVI.64.6.2860-2865.1990; Kim YH, 2009, VIRAL IMMUNOL, V22, P423, DOI 10.1089/vim.2009.0045; Langley JM, 2013, J INFECT DIS, V208, P544, DOI 10.1093/infdis/jit263; Mandelboim M, 2016, ONCOTARGET, V7, P1185, DOI 10.18632/oncotarget.6746; Meningher T, 2014, INFLUENZA OTHER RESP, V8, P422, DOI 10.1111/irv.12249; Nelson MI, 2006, PLOS PATHOG, V2, P1144, DOI 10.1371/journal.ppat.0020125; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; Nicholson KG, 2003, LANCET, V362, P1733, DOI 10.1016/S0140-6736(03)14854-4; Osterhaus ADME, 2000, SCIENCE, V288, P1051, DOI 10.1126/science.288.5468.1051; ROTA PA, 1990, VIROLOGY, V175, P59, DOI 10.1016/0042-6822(90)90186-U; Rowe T, 1999, J CLIN MICROBIOL, V37, P937, DOI 10.1128/JCM.37.4.937-943.1999; Skowronski DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038929; Skowronski DM, 2011, PEDIATR INFECT DIS J, V30, P833, DOI 10.1097/INF.0b013e31822db4dc; Socan M, 2014, J CLIN VIROL, V61, P156, DOI 10.1016/j.jcv.2014.06.018; Tan Y, 2013, J VIROL, V87, P12447, DOI 10.1128/JVI.01039-13; Taubenberger JK, 2008, ANNU REV PATHOL-MECH, V3, P499, DOI 10.1146/annurev.pathmechdis.3.121806.154316; Weil M, 2013, INFLUENZA OTHER RESP, V7, P838, DOI 10.1111/irv.12071; WRIGHT PF, 1980, J INFECT DIS, V141, P430, DOI 10.1093/infdis/141.4.430; WRIGHT PF, 2006, FIELDS VIROLOGY, P1691; Wu CT, 2010, ACTA PAEDIATR, V99, P1701, DOI 10.1111/j.1651-2227.2009.01595.x	28	21	23	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2016	11	8							e0161195	10.1371/journal.pone.0161195	http://dx.doi.org/10.1371/journal.pone.0161195			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4YN	27533045	Green Published, Green Submitted, gold			2022-12-27	WOS:000381487600072
J	Sugihara, T; Nagata, T; Mason, B; Koyanagi, M; Terakita, A				Sugihara, Tomohiro; Nagata, Takashi; Mason, Benjamin; Koyanagi, Mitsumasa; Terakita, Akihisa			Absorption Characteristics of Vertebrate Non-Visual Opsin, Opn3	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTOR; VISUAL CELLS; PHOTORECEPTOR-MEMBRANES; SPECTRAL SENSITIVITY; BINDING PROTEIN; RHODOPSIN; PIGMENT; GENE; MELANOPSIN; TISSUE	Most animals possess multiple opsins which sense light for visual and non-visual functions. Here, we show spectral characteristics of non-visual opsins, vertebrate Opn3s, which are widely distributed among vertebrates. We successfully expressed zebrafish Opn3 in mammalian cultured cells and measured its absorption spectrumspectroscopically. When incubated with 11-cis retinal, zebrafish Opn3 formed a blue-sensitive photopigment with an absorption maximum around 465 nm. The Opn3 converts to an all-trans retinal-bearing photoproduct with an absorption spectrum similar to the dark state following brief blue-light irradiation. The photoproduct experienced a remarkable blue-shift, with changes in position of the isosbestic point, during further irradiation. We then used a cAMP-dependent luciferase reporter assay to investigate light-dependent cAMP responses in cultured cells expressing zebrafish, pufferfish, anole and chicken Opn3. The wild type opsins did not produce responses, but cells expressing chimera mutants (WT Opn3s in which the third intracellular loops were replaced with the third intracellular loop of a Gs-coupled jellyfish opsin) displayed light-dependent changes in cAMP. The results suggest that Opn3 is capable of activating G protein(s) in a light-dependent manner. Finally, we used this assay to measure the relative wavelength-dependent response of cells expressing Opn3 chimeras to multiple quantally-matched stimuli. The inferred spectral sensitivity curve of zebrafish Opn3 accurately matched the measured absorption spectrum. We were unable to estimate the spectral sensitivity curve ofmouse or anole Opn3, but, like zebrafish Opn3, the chicken and pufferfish Opn3-JiL3 chimeras also formed blue-sensitive pigments. These findings suggest that vertebrate Opn3s may form blue-sensitive G protein-coupled pigments. Further, we suggest that the method described here, combining a cAMPdependent luciferase reporter assay with chimeric opsins possessing the third intracellular loop of jellyfish opsin, is a versatile approach for estimating absorption spectra of opsins with unknown signaling cascades or for which absorption spectra are difficult to obtain.	[Sugihara, Tomohiro; Nagata, Takashi; Koyanagi, Mitsumasa; Terakita, Akihisa] Osaka City Univ, Grad Sch Sci, Dept Biol & Geosci, Sumiyoshi Ku, Osaka, Japan; [Mason, Benjamin] Stanford Univ, Dept Genet, Stanford Sch Med, Stanford, CA 94305 USA; [Koyanagi, Mitsumasa] Japan Sci & Technol Agcy JST, Precursory Res Embryon Sci & Technol PRESTO, Kawaguchi, Saitama, Japan	Osaka Metropolitan University; Stanford University; Japan Science & Technology Agency (JST)	Koyanagi, M; Terakita, A (corresponding author), Osaka City Univ, Grad Sch Sci, Dept Biol & Geosci, Sumiyoshi Ku, Osaka, Japan.; Koyanagi, M (corresponding author), Japan Sci & Technol Agcy JST, Precursory Res Embryon Sci & Technol PRESTO, Kawaguchi, Saitama, Japan.	koyanagi@sci.osaka-cu.ac.jp; terakita@sci.osaka-cu.ac.jp	Nagata, Takashi/ABB-1780-2020	Nagata, Takashi/0000-0001-5379-2951; Terakita, Akihisa/0000-0002-8379-8913; Koyanagi, Mitsumasa/0000-0002-7741-918X	Japanese Ministry of Education, Culture, Sports, Science and Technology [23247011, 15H05777, 20770057, 22687005, 15K14568]; Human Frontier Science Program; PRESTO from the Japan Science and Technology Agency (JST); National Science Foundation [1158967]; Grants-in-Aid for Scientific Research [26291070, 16K14778, 15H05777] Funding Source: KAKEN	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Human Frontier Science Program(Human Frontier Science Program); PRESTO from the Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)); National Science Foundation(National Science Foundation (NSF)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-aid for Scientific Research from the Japanese Ministry of Education, Culture, Sports, Science and Technology (nos 23247011, 15H05777 to AT and nos 20770057, 22687005, 15K14568 to MK), http://www.jsps.go.jp/english/e-grants/, Human Frontier Science Program (to AT), http://www.hfsp.org/, PRESTO from the Japan Science and Technology Agency (JST) (to MK), http://www.jst.go.jp/kisoken/en/, and the National Science Foundation (no 1158967 to BM), http://www.nsf.gov/.	Airan RD, 2009, NATURE, V458, P1025, DOI 10.1038/nature07926; Arendt D, 2004, SCIENCE, V306, P869, DOI 10.1126/science.1099955; Arikawa K, 2003, J NEUROSCI, V23, P4527; Bailes HJ, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2987; Blackshaw S, 1999, J NEUROSCI, V19, P3681; Davies WIL, 2015, GENOME RES, V25, P1666, DOI 10.1101/gr.189886.115; Fischer RM, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001585; Govardovskii VI, 2000, VISUAL NEUROSCI, V17, P509, DOI 10.1017/S0952523800174036; Halford S, 2001, GENOMICS, V72, P203, DOI 10.1006/geno.2001.6469; Hao WS, 1999, J BIOL CHEM, V274, P6085, DOI 10.1074/jbc.274.10.6085; HARA T, 1968, NATURE, V219, P450, DOI 10.1038/219450a0; Kasper G, 2002, GENE, V295, P27, DOI 10.1016/S0378-1119(02)00799-0; Kikkawa S, 1996, BIOCHEMISTRY-US, V35, P15857, DOI 10.1021/bi961360v; Kojima D, 1997, J BIOL CHEM, V272, P22979, DOI 10.1074/jbc.272.37.22979; Kojima D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026388; Koyanagi M, 2005, CURR BIOL, V15, P1065, DOI 10.1016/j.cub.2005.04.063; Koyanagi M, 2004, P NATL ACAD SCI USA, V101, P6687, DOI 10.1073/pnas.0400819101; Koyanagi M, 2002, FEBS LETT, V531, P525, DOI 10.1016/S0014-5793(02)03616-5; Koyanagi M, 2008, P NATL ACAD SCI USA, V105, P15576, DOI 10.1073/pnas.0806215105; Koyanagi M, 2008, PHOTOCHEM PHOTOBIOL, V84, P1024, DOI 10.1111/j.1751-1097.2008.00369.x; Koyanagi M, 2015, BMC BIOL, V13, DOI 10.1186/s12915-015-0174-9; Koyanagi M, 2014, BBA-BIOENERGETICS, V1837, P710, DOI 10.1016/j.bbabio.2013.09.003; Koyanagi M, 2013, P NATL ACAD SCI USA, V110, P4998, DOI 10.1073/pnas.1219416110; KUHN H, 1980, NATURE, V283, P587, DOI 10.1038/283587a0; LEE YJ, 1994, NEURON, V13, P1143, DOI 10.1016/0896-6273(94)90052-3; MOLDAY RS, 1983, BIOCHEMISTRY-US, V22, P653, DOI 10.1021/bi00272a020; Moutsaki P, 2003, MOL BRAIN RES, V112, P135, DOI 10.1016/S0169-328X(03)00059-7; Nagata T, 2012, SCIENCE, V335, P469, DOI 10.1126/science.1211667; Nagata T, 2010, J COMP PHYSIOL A, V196, P51, DOI 10.1007/s00359-009-0493-9; Sakai K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141238; Sun L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108209; Terakita A, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-3-213; Terakita A, 2002, J BIOL CHEM, V277, P40, DOI 10.1074/jbc.M104960200; TERAKITA A, 1993, FEBS LETT, V330, P197, DOI 10.1016/0014-5793(93)80272-V; TERAKITA A, 1989, VISION RES, V29, P639, DOI 10.1016/0042-6989(89)90026-6; Terakita A, 2008, J NEUROCHEM, V105, P883, DOI 10.1111/j.1471-4159.2007.05184.x; Terakita A, 2014, ZOOL SCI, V31, P653, DOI 10.2108/zs140094; Tsukamoto H, 2013, J BIOL CHEM, V288, P28207, DOI 10.1074/jbc.M113.472464; White JH, 2008, HUM MOL GENET, V17, P1890, DOI 10.1093/hmg/ddn087; Yamashita T, 2010, P NATL ACAD SCI USA, V107, P22084, DOI 10.1073/pnas.1012498107	40	40	41	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2016	11	8							e0161215	10.1371/journal.pone.0161215	http://dx.doi.org/10.1371/journal.pone.0161215			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4YN	27532629	gold, Green Published, Green Submitted			2022-12-27	WOS:000381487600077
J	Langenberg, JCM; Thomas, AR; Donker, JMW; van Rijen, MML; Kluytmans, JAJW; van der Laan, L				Langenberg, J. C. M.; Thomas, A. R.; Donker, J. M. W.; van Rijen, M. M. L.; Kluytmans, J. A. J. W.; van der Laan, L.			Evaluation of Staphylococcus aureus Eradication Therapy in Vascular Surgery	PLOS ONE			English	Article							SURGICAL-SITE INFECTIONS; WOUND INFECTIONS; NASAL CARRIAGE; METHICILLIN-RESISTANT; BLOOD CULTURES; GENEXPERT	Introduction Surgical site infections (SSI) are a serious complication in vascular surgery which may lead to severe morbidity and mortality. Staphylococcus aureus nasal carriage is associated with increased risk for development of SSIs in central vascular surgery. The risk for SSI can be reduced by perioperative eradication of S. aureus carriage in cardiothoracic and orthopedic surgery. This study analyzes the relation between S. aureus eradication therapy and SSI in a vascular surgery population. Methods A prospective cohort study was performed, including all patients undergoing vascular surgery between February 2013 and April 2015. Patients were screened for S. aureus nasal carriage and, when tested positive, were subsequently treated with eradication therapy. The presence of SSI was recorded based on criteria of the CDC. The control group consisted of a cohort of vascular surgery patients in 2010, who were screened, but received no treatment. Results A total of 444 patients were screened. 104 nasal swabs were positive for S. aureus, these patients were included in the intervention group. 204 patients were screened in the 2010 cohort. 51 tested positive and were included in the control group. The incidence of S. aureus infection was 5 out of 51 (9.8%) in the control group versus 3 out of 104 in the eradication group (2.2%; 95% confidence interval 0.02-1.39; P = 0.13). A subgroup analysis showed that the incidence of S. aureus infection was 3 out of 23 (13.0%) in the control group in central reconstructive surgery versus 0 out of 44 in the intervention group (P = 0.074). The reduction of infection pressure by S. aureus was stronger than the reduction of infection pressure by other pathogens (exact maximum likelihood estimation; OR = 0.0724; 95% CI: 0.001-0.98; p = 0.0475). Conclusion S. aureus eradication therapy reduces the infection pressure of S. aureus, resulting in a reduction of SSIs caused by S. aureus.	[Langenberg, J. C. M.; Thomas, A. R.; Donker, J. M. W.; van der Laan, L.] Amphia Hosp, Dept Surg, Breda, Netherlands; [van Rijen, M. M. L.; Kluytmans, J. A. J. W.] Amphia Hosp, Lab Microbiol & Infect Control, Breda, Netherlands; [Kluytmans, J. A. J. W.] UMCU, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands	Amphia Hospital; Amphia Hospital; Unilever; Utrecht University; Utrecht University Medical Center	van der Laan, L (corresponding author), Amphia Hosp, Dept Surg, Breda, Netherlands.	lvanderlaan@amphia.nl	van der Laan, Luc/M-5495-2019	van der Laan, Luc/0000-0002-0651-5334; van der laan, lijckle/0000-0001-5631-594X				Baser O., 2013, VASC DIS MANAG, V10, pE26, DOI 10.1016/j.jval.2011.02.194; Bode LG, 2015, ANN SURG; Bode LGM, 2010, NEW ENGL J MED, V362, P9, DOI 10.1056/NEJMoa0808939; Cookson BD, 1998, J ANTIMICROB CHEMOTH, V41, P11, DOI 10.1093/jac/41.1.11; Donker JMW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038127; Gernaat-van der Sluis AJ, 1998, ACTA ORTHOP SCAND, V69, P412; HORAN TC, 1992, AM J INFECT CONTROL, V20, P271, DOI 10.1016/S0196-6553(05)80201-9; KLUYTMANS JAJW, 1995, J INFECT DIS, V171, P216, DOI 10.1093/infdis/171.1.216; Laurent C, 2010, EUR J CLIN MICROBIOL, V29, P995, DOI 10.1007/s10096-010-0958-3; Lipsky BA, 2004, DIABETES-METAB RES, V20, pS68, DOI 10.1002/dmrr.453; LUZAR MA, 1990, NEW ENGL J MED, V322, P505, DOI 10.1056/NEJM199002223220804; Parta M, 2009, J CLIN MICROBIOL, V47, P1609, DOI 10.1128/JCM.00351-09; Spencer DH, 2011, AM J CLIN PATHOL, V136, P690, DOI 10.1309/AJCP07UGYOKBVVNC; van der Slegt J, 2015, INT J SURG, V14, P85, DOI 10.1016/j.ijsu.2015.01.011; van der Slegt J, 2014, SURG INFECT, V15, P752, DOI 10.1089/sur.2013.253; van der Slegt J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071566; van Rijen MML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043065; Wassenberg MWM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014815; WENZEL RP, 1995, J HOSP INFECT, V31, P13, DOI 10.1016/0195-6701(95)90079-9; Wolk DM, 2009, J CLIN MICROBIOL, V47, P823, DOI 10.1128/JCM.01884-08	20	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2016	11	8							e0161058	10.1371/journal.pone.0161058	http://dx.doi.org/10.1371/journal.pone.0161058			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4UN	27529551	Green Published, gold			2022-12-27	WOS:000381476700042
J	Penailillo, J; Olivares, G; Moncada, X; Payacan, C; Chang, CS; Chung, KF; Matthews, PJ; Seelenfreund, A; Seelenfreund, D				Penailillo, Johany; Olivares, Gabriela; Moncada, Ximena; Payacan, Claudia; Chang, Chi-Shan; Chung, Kuo-Fang; Matthews, Peter J.; Seelenfreund, Andrea; Seelenfreund, Daniela			Sex Distribution of Paper Mulberry (Broussonetia papyrifera) in the Pacific	PLOS ONE			English	Article							AIRBORNE POLLEN; ANCIENT DNA; NEW-ZEALAND; L. VENT.; IDENTIFICATION; MIGRATIONS; SETTLEMENT; MORACEAE; MARKERS; REGION	Background Paper mulberry (Broussonetia papyrifera (L.) L'Her. ex Vent) is a dioecious tree native to East Asia and mainland Southeast-Asia, introduced prehistorically to Polynesia as a source of bark fiber by Austronesian-speaking voyagers. In Oceania, trees are coppiced and harvested for production of bark-cloth, so flowering is generally unknown. A survey of botanical records of paper mulberry revealed a distributional disjunction: the tree is apparently absent in Borneo and the Philippines. A subsequent study of chloroplast haplotypes linked paper mulberry of Remote Oceania directly to a population in southern Taiwan, distinct from known populations in mainland Southeast-Asia. Methodology We describe the optimization and use of a DNA marker designed to identify sex in paper mulberry. We used this marker to determine the sex distribution in selected localities across Asia, Near and Remote Oceania. We also characterized all samples using the ribosomal internal transcribed spacer sequence (ITS) in order to relate results to a previous survey of ITS diversity. Results In Near and Remote Oceania, contemporary paper mulberry plants are all female with the exception of Hawaii, where plants of both sexes are found. In its natural range in Asia, male and female plants are found, as expected. Male plants in Hawaii display an East Asian ITS genotype, consistent with modern introduction, while females in Remote Oceania share a distinctive variant. Conclusions Most paper mulberry plants now present in the Pacific appear to be descended from female clones introduced prehistorically. In Hawaii, the presence of male and female plants is thought to reflect a dual origin, one a prehistoric female introduction and the other a modern male introduction by Japanese/Chinese immigrants. If only female clones were dispersed from a source-region in Taiwan, this may explain the absence of botanical records and breeding populations in the Philippines and Borneo, and Remote Oceania.	[Penailillo, Johany; Olivares, Gabriela; Payacan, Claudia; Seelenfreund, Daniela] Univ Chile, Fac Ciencias Quim & Farmaceut, Dept Bioquim & Biol Mol, Santiago, Chile; [Moncada, Ximena] CEAZA, La Serena, Chile; [Chang, Chi-Shan] Natl Museum Prehist, Taitung 95060, Taiwan; [Chung, Kuo-Fang] Acad Sinica, Biodivers Res Ctr, Taipei 11529, Taiwan; [Matthews, Peter J.] Natl Museum Ethnol, Osaka, Japan; [Seelenfreund, Andrea] Univ Acad Humanismo Cristiano, Escuela Antropol, Santiago, Chile	Universidad de Chile; Academia Sinica - Taiwan; Universidad Academia de Humanismo Cristiano	Seelenfreund, D (corresponding author), Univ Chile, Fac Ciencias Quim & Farmaceut, Dept Bioquim & Biol Mol, Santiago, Chile.	dseelen@ciq.uchile.cl	Matthews, Peter J./AID-1290-2022	Matthews, Peter/0000-0003-2563-0976	Fondo Nacional de Desarrollo Cientifico y Tecnologico from the Government of Chile [1080061, 1120175]; National Science Council, Taiwan [NSC-102-2621-B-002-007]	Fondo Nacional de Desarrollo Cientifico y Tecnologico from the Government of Chile; National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This project was funded by the Fondo Nacional de Desarrollo Cientifico y Tecnologico (www.conicyt.cl/fondecyt/) grants 1080061 and 1120175 from the Government of Chile to AS, and National Science Council, Taiwan (www.most.gov.tw/) Grant NSC-102-2621-B-002-007 to KFC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas S, 2012, WORLD ALLERGY ORGAN, V5, P103, DOI 10.1097/WOX.0b013e31826421c8; Adhikari Sinchan, 2014, ScientificWorldJournal, V2014, P216896, DOI 10.1155/2014/216896; Anderson E., 1952, PLANTS MAN AND LIFE; Bachtrog D, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001899; Barker Christine, 2002, Curtis's Botanical Magazine, V19, P8, DOI 10.1111/1467-8748.00324; Bellwood P, 1993, ASIAN PERSPECT, V32, P37; Blattner FR, 1999, BIOTECHNIQUES, V27, P1180, DOI 10.2144/99276st04; Brown, 1996, OCEANIC CULTURE HIST, P117; Chang CS, 2015, P NATL ACAD SCI USA, V112, P13537, DOI 10.1073/pnas.1503205112; de Witte LC, 2010, ANN BOT-LONDON, V106, P859, DOI 10.1093/aob/mcq191; Deputy JC, 2002, THEOR APPL GENET, V106, P107, DOI 10.1007/s00122-002-0995-0; Dubois A., 2013, PLANTAS RAPA NUI GUI; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Elevitch CR, 2006, TRADITIONAL TREES PA; FLENLEY JR, 1991, J QUATERNARY SCI, V6, P85, DOI 10.1002/jqs.3390060202; Florece LM, 2006, JESAM, V9, P54; Florence J, 1997, FLORE POLYNESIE FRAN, V1; Ghersa CM, 2002, AGR ECOSYST ENVIRON, V88, P271, DOI 10.1016/S0167-8809(01)00209-2; Gonzalez-Lorca J, 2015, NEW ZEAL J BOT, V53, P75, DOI 10.1080/0028825X.2015.1010546; Horrocks M, 2008, J ARCHAEOL SCI, V35, P2446, DOI 10.1016/j.jas.2008.03.011; Howard M, 2006, STUDIES MAT CULTURES, V10; Howe KR, 2007, VAKA MOANA VOYAGES A, P94; Jacomb C, 2014, J ARCHAEOL SCI, V50, P24, DOI 10.1016/j.jas.2014.05.023; Kafkas S, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1326-6; Kahn JG, 2014, ECON BOT, V68, P246, DOI 10.1007/s12231-014-9274-7; KIRCH PV, 2000, ROAD WINDS ARCHAEOLO; Lebot V, 2002, J SOC OCEANISTES, V114-115, P46; Lepofsky D, 2003, ECON BOT, V57, P73, DOI 10.1663/0013-0001(2003)057[0073:TEOCPO]2.0.CO;2; Ling SS, 1962, 2 BIENN C INT ASS HI; Lodhi M. A., 1994, Plant Molecular Biology Reporter, V12, P6, DOI 10.1007/BF02668658; Malik RN, 2007, PAK J BOT, V39, P1045; Matisoo-Smith E, 2015, J HUM EVOL, V79, P93, DOI 10.1016/j.jhevol.2014.10.017; Matthews PJ, 2002, VEGECULTURE E ASIA O; McKey D, 2010, NEW PHYTOL, V186, P318, DOI 10.1111/j.1469-8137.2010.03210.x; Merrill ED, 1954, BOT COOKS VOYAGES IT, P384; Moncada X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056549; Orliac C, 1998, J SOC OCEANISTES, V107, P135, DOI DOI 10.3406/JSO.1998.2053; Orliac C, 2000, EASTER ISLAND ARCHAE, P199; Overholt WA, 2013, ONE SERIES ENTOMOLOG; Prebble M, 2008, TERRA AUSTRALIS, V29, P227; Primack RB, 1987, PEOPLE TROPICAL FORE, P45; Rodriguez W., 2000, Agronomia Mesoamericana, V11, P133; Seelenfreund D, 2011, NEW ZEAL J BOT, V49, P413, DOI 10.1080/0028825X.2011.579135; Seelenfreund D, 2010, NEW ZEAL J BOT, V48, P1; Sieveking G de G, 1956, J MALAYAN BRANCH ROY, V29, P78; Singh AB, 2003, GRANA, V42, P168, DOI 10.1080/00173130310016149; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Wang DW, 2011, INT J MOL SCI, V12, P857, DOI 10.3390/ijms12010857; Wang L, 2012, CHINESE HLTH EC, V11, P11; Whistler W, 2009, PLANTS CANOE PEOPLE; Wilmshurst JM, 2011, P NATL ACAD SCI USA, V108, P1815, DOI 10.1073/pnas.1015876108; Yang YL, 1998, J PLANT RES, V111, P501, DOI 10.1007/BF02507785; Zerega NJC, 2005, MOL PHYLOGENET EVOL, V37, P402, DOI 10.1016/j.ympev.2005.07.004; Zerega NJC, 2004, AM J BOT, V91, P760, DOI 10.3732/ajb.91.5.760; Zizka G, 1991, FLOWERING PLANTS E I	55	24	25	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2016	11	8							e0161148	10.1371/journal.pone.0161148	http://dx.doi.org/10.1371/journal.pone.0161148			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4UN	27529483	Green Published, gold, Green Submitted			2022-12-27	WOS:000381476700050
J	Wilkes-Gillan, S; Bundy, A; Cordier, R; Lincoln, M; Chen, YW				Wilkes-Gillan, Sarah; Bundy, Anita; Cordier, Reinie; Lincoln, Michelle; Chen, Yu-Wei			A Randomised Controlled Trial of a Play-Based Intervention to Improve the Social Play Skills of Children with Attention Deficit Hyperactivity Disorder (ADHD)	PLOS ONE			English	Article							EVALUATING COMPLEX INTERVENTIONS; DEFICIT/HYPERACTIVITY DISORDER; TREATMENT FIDELITY; PARENTAL INFLUENCE; FRIENDSHIPS; PREVALENCE; FRAMEWORK; EMPATHY; SCHOOL	There is a need for effective interventions to address the social difficulties of children with ADHD. This randomised controlled trial examined the effectiveness of a play-based intervention for improving the social play skills of children with ADHD in peer-to-peer interactions. Children with ADHD (5 to 11 years) were randomised to an intervention-first (n = 15) or waitlist control-first group (n = 14). Participants allocated to the control-first group received the intervention after a 10-week wait period. Children invited a typically-developing playmate and parents of children with ADHD participated. The intervention involved: six clinic play-sessions, weekly home-modules and a one-month home follow up. The Test of Playfulness (ToP) was scored by a blinded rater. Parent reported treatment adherence was used to assess treatment fidelity. Between group statistics were used to compare the change of the intervention-first (10-week intervention period) and control-first (10-week wait period) groups. Once all children had received the intervention, repeated measures ANOVA, post hoc Least Significance Difference tests and Cohen's-d were used to measure effect. Changes in ToP social items were analysed using Friedman's ANOVA. Linear regression analyses were used to identify variables that predicted change. The control-first group did not change during the wait period. The change in the intervention-first group was significantly greater than the change in the control-first group (during the wait period). When the data from the two groups were combined, the mean ToP scores of the children with ADHD (n = 29) improved significantly following the intervention, with a large effect from pre to post intervention and from pre intervention to follow up. Children maintained treatment gains at follow up. All ToP social items improved significantly following the intervention. The findings support the use of play involving parent and peer mediated components to enhance the social play skills of children with ADHD.	[Wilkes-Gillan, Sarah] Australian Catholic Univ, Sch Allied Hlth, Sydney, NSW, Australia; [Bundy, Anita; Cordier, Reinie; Lincoln, Michelle; Chen, Yu-Wei] Univ Sydney, Fac Hlth Sci, Sydney, NSW, Australia; [Cordier, Reinie] Curtin Univ, Sch Occupat Therapy & Social Work, Perth, WA, Australia	Australian Catholic University; University of Sydney; Curtin University	Wilkes-Gillan, S (corresponding author), Australian Catholic Univ, Sch Allied Hlth, Sydney, NSW, Australia.	Sarah.WilkesGillan@acu.edu.au	Cordier, Reinie/AAH-6290-2019; Chen, Yu-Wei Ryan/AFN-1975-2022; Lincoln, Michelle/AAV-8839-2020	Cordier, Reinie/0000-0002-9906-5300; Chen, Yu-Wei Ryan/0000-0001-5965-1279; Lincoln, Michelle/0000-0001-7536-5993; Wilkes-Gillan, Sarah/0000-0001-5670-2974; Bundy, Anita/0000-0003-4743-9144	Rotary Club of Mosman; University of Sydney's Postgraduate Research Support Scheme; Australian Government	Rotary Club of Mosman; University of Sydney's Postgraduate Research Support Scheme; Australian Government(Australian GovernmentCGIAR)	The authors would like to acknowledge financial contributions from the Rotary Club of Mosman and the University of Sydney's Postgraduate Research Support Scheme. The authors would also like to acknowledge the provision of the Australian Postgraduate Award scholarship from the Australian Government. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abikoff H, 2009, J ATTEN DISORD, V13, P207, DOI 10.1177/1087054709333385; BARKLEY RA, 1990, J AM ACAD CHILD PSY, V29, P546, DOI 10.1097/00004583-199007000-00007; Barkley RA, 1997, PSYCHOL BULL, V121, P65, DOI 10.1037/0033-2909.121.1.65; Bellg AJ, 2004, HEALTH PSYCHOL, V23, P443, DOI 10.1037/0278-6133.23.5.443; Borrelli B, 2005, J CONSULT CLIN PSYCH, V73, P852, DOI 10.1037/0022-006X.73.5.852; Braaten EB, 2000, J CONSULT CLIN PSYCH, V68, P313, DOI [10.1037/0022-006X.68.2.313, 10.1037//0022-006X.68.2.313]; Brentnall J, 2008, OTJR-OCCUP PART HEAL, V28, P133, DOI 10.3928/15394492-20080601-02; Bundy A., 2012, KIDS CAN BE KIDS CHI, P28; Bundy A, 2004, TEST PLAYFULNESS TOP; Bundy AC, 2001, OCCUP THER J RES, V21, P276, DOI 10.1177/153944920102100405; Campbell M, 2000, BRIT MED J, V321, P694, DOI 10.1136/bmj.321.7262.694; Campbell NC, 2007, BMJ-BRIT MED J, V334, P455, DOI 10.1136/bmj.39108.379965.BE; Charman T., 2001, EMOT BEHAV DIFFICULT, V6, P31, DOI [10.1080/13632750100507654, DOI 10.1080/13632750100507654]; Cohen J.E., 1988, STAT POWER ANAL BEHA; Conners C.K., 1997, CONNERS RATING SCALE; Cordier R., 2009, PLAY THERAPY ASSESSM, P45; Cordier R, 2012, ULTIMATE GUIDE MAKIN; Cordier R, 2010, OTJR-OCCUP PART HEAL, V30, P122, DOI 10.3928/15394492-20090518-02; Cordier R, 2009, AUST OCCUP THER J, V56, P332, DOI 10.1111/j.1440-1630.2009.00796.x; Craig Peter, 2008, BMJ, V337, pa1655, DOI 10.1136/bmj.a1655; Cunningham JA, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-150; Czajkowski SM, 2011, J PUBLIC HEALTH DENT, V71, pS67, DOI 10.1111/j.1752-7325.2011.00219.x; Domanski  M., 2009, SUCCESSFUL RANDOMIZE; DuPaul GJ, 2012, SCHOOL PSYCHOL REV, V41, P387; Evans D, 2003, J CLIN NURS, V12, P77, DOI 10.1046/j.1365-2702.2003.00662.x; Frankel F, 1997, J AM ACAD CHILD PSY, V36, P1056, DOI 10.1097/00004583-199708000-00013; Fritz CO, 2012, J EXP PSYCHOL GEN, V141, P2, DOI 10.1037/a0024338; Gifford-Smith ME, 2003, J SCHOOL PSYCHOL, V41, P235, DOI 10.1016/S0022-4405(03)00048-7; Hoza B, 2003, J Atten Disord, V6, P87, DOI 10.1177/108705470300600301; Hsu J, 1996, MULTIPLE COMP PROCED; Kasari C, 2012, J CHILD PSYCHOL PSYC, V53, P431, DOI 10.1111/j.1469-7610.2011.02493.x; Linacre JM., 2022, WINSTEPS RASCH MEASU; Marton I, 2009, J ABNORM CHILD PSYCH, V37, P107, DOI 10.1007/s10802-008-9262-4; Mikami AY, 2013, J CONSULT CLIN PSYCH, V81, P100, DOI 10.1037/a0029654; Mikami AY, 2010, J ABNORM CHILD PSYCH, V38, P737, DOI 10.1007/s10802-010-9403-4; Mikami AY, 2010, J ABNORM CHILD PSYCH, V38, P721, DOI 10.1007/s10802-010-9393-2; Mikami AY, 2010, CLIN CHILD FAM PSYCH, V13, P181, DOI 10.1007/s10567-010-0067-y; Moher David, 2012, Int J Surg, V10, P28, DOI 10.1016/j.ijsu.2011.10.001; Mrug S, 2012, J ABNORM CHILD PSYCH, V40, P1013, DOI 10.1007/s10802-012-9610-2; Nijmeijer JS, 2008, CLIN PSYCHOL REV, V28, P692, DOI 10.1016/j.cpr.2007.10.003; Normand S, 2013, J ABNORM CHILD PSYCH, V41, P1161, DOI 10.1007/s10802-013-9753-9; Normand S, 2011, J ABNORM CHILD PSYCH, V39, P293, DOI 10.1007/s10802-010-9450-x; Parham L.D., 2008, PLAY OCCUPATIONAL TH, P3, DOI DOI 10.1016/B978-032302954-4.10001-7; Pelham WE, 2007, J PEDIATR PSYCHOL, V32, P711, DOI 10.1093/jpepsy/jsm022; Pelham WE, 2008, J CLIN CHILD ADOLESC, V37, P184, DOI 10.1080/15374410701818681; Polanczyk GV, 2014, INT J EPIDEMIOL, V43, P434, DOI 10.1093/ije/dyt261; Quay HC, 1997, J ABNORM CHILD PSYCH, V25, P7, DOI 10.1023/A:1025799122529; Skaines N., 2006, BRIT J OCCUP THER, V69, P505, DOI [10.1177/030802260606901104, DOI 10.1177/030802260606901104]; Spillane V, 2007, J ADV NURS, V60, P343, DOI 10.1111/j.1365-2648.2007.04386.x; Storebo O., 2011, COCHRANE DB SYST REV, V12, P1; Thabane L, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-92; Tur-Kaspa H, 2005, CONTEMPORARY CLIN NE, P317; Uekermann J, 2010, NEUROSCI BIOBEHAV R, V34, P734, DOI 10.1016/j.neubiorev.2009.10.009; Wilkes S, 2011, AUST OCCUP THER J, V58, P231, DOI 10.1111/j.1440-1630.2011.00928.x; Wilkes-Gillan S, 2016, DEV NEUROREHABIL, V19, P238, DOI 10.3109/17518423.2014.948639; Wilkes-Gillan S, 2015, BRIT J OCCUP THER, V78, P644, DOI 10.1177/0308022615573453; Wilkes-Gillan S, 2014, AM J OCCUP THER, V68, P700, DOI 10.5014/ajot.2014.012450; Wilkes-Gillan S, 2014, AUST OCCUP THER J, V61, P299, DOI 10.1111/1440-1630.12124; Willcutt E, 2012, NEUROTHERAPEUTICS, V9, P490, DOI 10.1007/s13311-012-0135-8; Young S, 2010, J CHILD PSYCHOL PSYC, V51, P116, DOI 10.1111/j.1469-7610.2009.02191.x	60	37	39	2	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2016	11	8							e0160558	10.1371/journal.pone.0160558	http://dx.doi.org/10.1371/journal.pone.0160558			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DT4UN	27529693	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000381476700008
J	Lahiri, P; Schmidt, V; Smole, C; Kufferath, I; Denk, H; Strnad, P; Rulicke, T; Frohlich, LF; Zatloukal, K				Lahiri, Pooja; Schmidt, Volker; Smole, Claudia; Kufferath, Iris; Denk, Helmut; Strnad, Pavel; Ruelicke, Thomas; Froehlich, Leopold F.; Zatloukal, Kurt			p62/Sequestosome-1 Is Indispensable for Maturation and Stabilization of Mallory-Denk Bodies	PLOS ONE			English	Article							INTRACELLULAR HYALINE BODIES; TRANSCRIPTION FACTOR NRF2; CUL3-BASED E3 LIGASE; OXIDATIVE STRESS; BODY FORMATION; PROTEIN; P62; AUTOPHAGY; MOUSE; LIVER	Mallory-Denk bodies (MDBs) are hepatocytic protein aggregates found in steatohepatitis and several other chronic liver diseases as well as hepatocellular carcinoma. MDBs are mainly composed of phosphorylated keratins and stress protein p62/Sequestosome-1 (p62), which is a common component of cytoplasmic aggregates in a variety of protein aggregation diseases. In contrast to the well-established role of keratins, the role of p62 in MDB pathogenesis is still elusive. We have generated total and hepatocyte-specific p62 knockout mice, fed them with 3,5-diethoxycarbonyl-1,4-dihydrocollidine (DDC) to induce MDBs and allowed the mice to recover from DDC intoxication on a standard diet to investigate the role of p62 in MDB formation and elimination. In the absence of p62, smaller, granular and less distinct MDBs appeared, which failed to mature to larger and compact inclusions. Moreover, p62 deficiency impaired the binding of other proteins such as NBR1 and Hsp25 to MDBs and altered the cellular defense mechanism by downregulation of Nrf2 target genes. Upon recovery from DDC intoxication on a standard diet, there was an enhanced reduction of p62-deficient MDBs, which was accompanied by a pronounced decrease in ubiquitinated proteins. Our data provide strong evidence that keratin aggregation is the initial step in MDB formation in steatohepatitis-related mouse models. Interaction of p62 with keratin aggregates then leads to maturation i.e., enlargement and stabilization of the MDBs as well as recruitment of other MDB-associated proteins.	[Lahiri, Pooja; Smole, Claudia; Kufferath, Iris; Denk, Helmut; Froehlich, Leopold F.; Zatloukal, Kurt] Med Univ Graz, Inst Pathol, Graz, Austria; [Schmidt, Volker; Ruelicke, Thomas] Univ Vet Med Vienna, Inst Lab Anim Sci, Vienna, Austria; [Strnad, Pavel] IZKF, Aachen, Germany; [Strnad, Pavel] Dept Internal Med 3, Aachen, Germany	Medical University of Graz; University of Veterinary Medicine Vienna	Zatloukal, K (corresponding author), Med Univ Graz, Inst Pathol, Graz, Austria.	kurt.zatloukal@medunigraz.at	Lahiri, Pooja/AAE-6663-2019	Lahiri, Pooja/0000-0002-6305-9451	Doctoral College of Metabolic and Cardiovascular Diseases, Medical University of Graz; FWF Austrian Science Fund [DK-MCD W1226]; Emmy Noether program of the German Research Foundation [STR 1095/2-1]; Interdisciplinary Center for Clinical Research (IZKF) within the faculty of medicine at the RWTH Aachen University; GEN-AU programme Austromouse	Doctoral College of Metabolic and Cardiovascular Diseases, Medical University of Graz; FWF Austrian Science Fund(Austrian Science Fund (FWF)); Emmy Noether program of the German Research Foundation(German Research Foundation (DFG)); Interdisciplinary Center for Clinical Research (IZKF) within the faculty of medicine at the RWTH Aachen University; GEN-AU programme Austromouse	This project was supported by the Doctoral College of Metabolic and Cardiovascular Diseases, Medical University of Graz and FWF Austrian Science Fund DK-MCD W1226 (to KZ), the Emmy Noether program of the German Research Foundation STR 1095/2-1 and the Interdisciplinary Center for Clinical Research (IZKF) within the faculty of medicine at the RWTH Aachen University (to PS) and the GEN-AU programme Austromouse (to TR).	Aguzzi A, 2010, NAT REV DRUG DISCOV, V9, P237, DOI 10.1038/nrd3050; Copple IM, 2010, J BIOL CHEM, V285, P16782, DOI 10.1074/jbc.M109.096545; Cullinan SB, 2004, MOL CELL BIOL, V24, P8477, DOI 10.1128/MCB.24.19.8477-8486.2004; DENK H, 1979, P NATL ACAD SCI USA, V76, P4112, DOI 10.1073/pnas.76.8.4112; DENK H, 1981, EUR J CELL BIOL, V23, P241; Denk H, 2006, J PATHOL, V208, P653, DOI 10.1002/path.1946; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; FRANKE WW, 1979, LAB INVEST, V40, P207; Harada M, 2008, HEPATOLOGY, V47, P2026, DOI 10.1002/hep.22294; Jain A, 2010, J BIOL CHEM, V285, P22576, DOI 10.1074/jbc.M110.118976; Janig E, 2005, EUR J CELL BIOL, V84, P329, DOI 10.1016/j.ejcb.2004.12.018; Jin ZY, 2009, CELL, V137, P721, DOI 10.1016/j.cell.2009.03.015; Kim J, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/2746457; Kirkin V, 2009, MOL CELL, V33, P505, DOI 10.1016/j.molcel.2009.01.020; Kobayashi A, 2004, MOL CELL BIOL, V24, P7130, DOI 10.1128/MCB.24.16.7130-7139.2004; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Komatsu M, 2010, NAT CELL BIOL, V12, P213, DOI 10.1038/ncb2021; Kraft C, 2010, NAT CELL BIOL, V12, P836, DOI 10.1038/ncb0910-836; Ku NO, 2004, METHOD CELL BIOL, V78, P489; Leneuve P, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng021; Mahajan V, 2011, GASTROENTEROLOGY, V141, P1080, DOI 10.1053/j.gastro.2011.05.039; Moscat J, 2007, TRENDS BIOCHEM SCI, V32, P95, DOI 10.1016/j.tibs.2006.12.002; Moscat J, 2009, EMBO REP, V10, P804, DOI 10.1038/embor.2009.172; Moscat J, 2009, CELL, V137, P1001, DOI 10.1016/j.cell.2009.05.023; Muller TD, 2013, J CLIN INVEST, V123, P469, DOI 10.1172/JCI64209; Muller T, 2004, HEPATOLOGY, V39, P963, DOI 10.1002/hep.20108; Naeem A, 2011, CELL BIOCHEM BIOPHYS, V61, P237, DOI 10.1007/s12013-011-9200-x; Nezis IP, 2008, J CELL BIOL, V180, P1065, DOI 10.1083/jcb.200711108; Nikam A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066094; Odagiri S, 2012, ACTA NEUROPATHOL, V124, P173, DOI 10.1007/s00401-012-0975-7; Osburn WO, 2008, MUTAT RES-REV MUTAT, V659, P31, DOI 10.1016/j.mrrev.2007.11.006; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Postic C, 1999, J BIOL CHEM, V274, P305, DOI 10.1074/jbc.274.1.305; PREISEGGER KH, 1992, LAB INVEST, V66, P193; Reynaud E., 2010, NAT ED, V3, P28; Richter-Landsberg C, 2003, CELL MOL LIFE SCI, V60, P337, DOI 10.1007/s000180300028; Singla A, 2012, HEPATOLOGY, V56, P322, DOI 10.1002/hep.25664; Strnad P, 2007, GASTROENTEROLOGY, V132, P1515, DOI 10.1053/j.gastro.2007.02.020; Stumptner C, 2002, HEPATOLOGY, V35, P1053, DOI 10.1053/jhep.2002.32674; Stumptner C, 2001, J HEPATOL, V34, P665, DOI 10.1016/S0168-8278(00)00099-4; Stumptner C, 2007, HEPATOLOGY, V46, P851, DOI 10.1002/hep.21744; Umemura A, 2016, CANCER CELL, V29, P935, DOI 10.1016/j.ccell.2016.04.006; Yao Tso-Pang, 2010, Genes Cancer, V1, P779; YOKOO H, 1982, GASTROENTEROLOGY, V83, P109; Yuan QX, 1995, EXP MOL PATHOL, V63, P63, DOI 10.1006/exmp.1995.1031; Zatloukal B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096690; ZATLOUKAL K, 1990, HEPATOLOGY, V11, P652, DOI 10.1002/hep.1840110419; ZATLOUKAL K, 1990, LAB INVEST, V62, P427; ZATLOUKAL K, 1992, LAB INVEST, V66, P774; Zatloukal K, 2002, AM J PATHOL, V160, P255, DOI 10.1016/S0002-9440(10)64369-6; Zatloukal K, 2007, EXP CELL RES, V313, P2033, DOI 10.1016/j.yexcr.2007.04.024	51	21	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2016	11	8							e0161083	10.1371/journal.pone.0161083	http://dx.doi.org/10.1371/journal.pone.0161083			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4SL	27526095	gold, Green Published, Green Submitted			2022-12-27	WOS:000381471100033
J	Onorato, I; D'Alessandro, G; Di Castro, MA; Renzi, M; Dobrowolny, G; Musaro, A; Salvetti, M; Limatola, C; Crisanti, A; Grassi, F				Onorato, Irene; D'Alessandro, Giuseppina; Di Castro, Maria Amalia; Renzi, Massimiliano; Dobrowolny, Gabriella; Musaro, Antonio; Salvetti, Marco; Limatola, Cristina; Crisanti, Andrea; Grassi, Francesca			Noise Enhances Action Potential Generation in Mouse Sensory Neurons via Stochastic Resonance	PLOS ONE			English	Article							ROOT GANGLION NEURONS; SUBTHRESHOLD OSCILLATIONS; ION CHANNELS; MEMBRANE; MECHANORECEPTORS; CONDUCTION; CURRENTS; SYSTEMS	Noise can enhance perception of tactile and proprioceptive stimuli by stochastic resonance processes. However, the mechanisms underlying this general phenomenon remain to be characterized. Here we studied how externally applied noise influences action potential firing in mouse primary sensory neurons of dorsal root ganglia, modelling a basic process in sensory perception. Since noisy mechanical stimuli may cause stochastic fluctuations in receptor potential, we examined the effects of sub-threshold depolarizing current steps with superimposed random fluctuations. We performed whole cell patch clamp recordings in cultured neurons of mouse dorsal root ganglia. Noise was added either before and during the step, or during the depolarizing step only, to focus onto the specific effects of external noise on action potential generation. In both cases, step + noise stimuli triggered significantly more action potentials than steps alone. The normalized power norm had a clear peak at intermediate noise levels, demonstrating that the phenomenon is driven by stochastic resonance. Spikes evoked in step + noise trials occur earlier and show faster rise time as compared to the occasional ones elicited by steps alone. These data suggest that external noise enhances, via stochastic resonance, the recruitment of transient voltage-gated Na channels, responsible for action potential firing in response to rapid step-wise depolarizing currents.	[Onorato, Irene; D'Alessandro, Giuseppina; Di Castro, Maria Amalia; Renzi, Massimiliano; Limatola, Cristina; Grassi, Francesca] Sapienza Univ, Inst Pasteur, Dept Physiol & Pharmacol, Cenci Bolognetti Fdn, Rome, Italy; [Dobrowolny, Gabriella; Musaro, Antonio] Sapienza Univ Rome, Inst Pasteur, DAHFMO Unit Histol & Med Embryol, IIM,Cenci Bolognetti Fdn, Rome, Italy; [Dobrowolny, Gabriella; Musaro, Antonio] Ist Italiano Tecnol, Ctr Life Nano Sci Sapienza, Rome, Italy; [Salvetti, Marco] Sapienza Univ, Dept Neurosci Mental Hlth & Sensory Organs, Rome, Italy; [Limatola, Cristina] NeuroMed, Pozzilli, IS, Italy; [Crisanti, Andrea] Sapienza Univ, Dept Phys, Rome, Italy	Fondazione Cenci Bolognetti; Sapienza University Rome; Fondazione Cenci Bolognetti; Sapienza University Rome; Istituto Italiano di Tecnologia - IIT; Sapienza University Rome; IRCCS Neuromed; Sapienza University Rome	Grassi, F (corresponding author), Sapienza Univ, Inst Pasteur, Dept Physiol & Pharmacol, Cenci Bolognetti Fdn, Rome, Italy.	francesca.grassi@uniroma1.it	D'ALESSANDRO, GIUSEPPINA/L-6726-2019; Crisanti, Andrea/C-1705-2016; Musarò, Antonio/K-9598-2016; Di Castro, Maria Amalia/AGY-9938-2022; Grassi, Francesca/D-3963-2009; D'Alessandro, Giuseppina/K-7825-2016; Musaro, Antonio/P-2953-2019; Salvetti, Marco/K-3836-2016	D'ALESSANDRO, GIUSEPPINA/0000-0001-7220-6065; Crisanti, Andrea/0000-0002-9869-4420; Musarò, Antonio/0000-0002-2944-9739; Di Castro, Maria Amalia/0000-0001-7480-1087; Grassi, Francesca/0000-0002-0169-8397; D'Alessandro, Giuseppina/0000-0001-7220-6065; Musaro, Antonio/0000-0002-2944-9739; RENZI, MASSIMILIANO/0000-0001-6973-3569; Crisanti, Andrea/0000-0002-2406-4426; Dobrowolny, Gabriella/0000-0001-8693-0724; limatola, cristina/0000-0001-7504-8197	Ministero Istruzione Universita Ricerca grant [2010R8JK2X_003]; Telethon grant [GGP14066]; Fondazione Roma grant; ASI grant; NeuroMed (Pozzilli, Italy)	Ministero Istruzione Universita Ricerca grant(Ministry of Education, Universities and Research (MIUR)); Telethon grant(Fondazione Telethon); Fondazione Roma grant(Fondazione Roma); ASI grant; NeuroMed (Pozzilli, Italy)	This work was supported by Ministero Istruzione Universita Ricerca grant n. 2010R8JK2X_003 (www.miur.it) to FG; ASI, Telethon (GGP14066), and Fondazione Roma grants to AM. NeuroMed (Pozzilli, Italy) provided support in the form of ancillary salary for CL, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section.	Amir R, 2003, BIOPHYS J, V84, P2181, DOI 10.1016/S0006-3495(03)75024-3; Bean BP, 2007, NAT REV NEUROSCI, V8, P451, DOI 10.1038/nrn2148; BENZI R, 1982, TELLUS, V34, P10, DOI 10.1111/j.2153-3490.1982.tb01787.x; BENZI R, 1981, J PHYS A-MATH GEN, V14, pL453, DOI 10.1088/0305-4470/14/11/006; BEZRUKOV SM, 1995, NATURE, V378, P362, DOI 10.1038/378362a0; Breen PP, 2014, MED ENG PHYS, V36, P1088, DOI 10.1016/j.medengphy.2014.04.010; Collins JJ, 1996, J NEUROPHYSIOL, V76, P642, DOI 10.1152/jn.1996.76.1.642; COLLINS JJ, 1995, PHYS REV E, V52, pR3321, DOI 10.1103/PhysRevE.52.R3321; Cordo P, 1996, NATURE, V383, P769, DOI 10.1038/383769a0; Djouhri L, 1998, J PHYSIOL-LONDON, V513, P857, DOI 10.1111/j.1469-7793.1998.857ba.x; Dong H, 2008, PHYSIOL RES, V57, P639, DOI 10.33549/physiolres.931164; Dorval AD, 2005, J NEUROSCI, V25, P10025, DOI 10.1523/JNEUROSCI.3557-05.2005; England S, 1996, J PHYSIOL-LONDON, V495, P429, DOI 10.1113/jphysiol.1996.sp021604; Faisal AA, 2008, NAT REV NEUROSCI, V9, P292, DOI 10.1038/nrn2258; HARPER AA, 1985, J PHYSIOL-LONDON, V359, P31, DOI 10.1113/jphysiol.1985.sp015573; Hu J, 2006, J PHYSIOL-LONDON, V577, P815, DOI 10.1113/jphysiol.2006.117648; Matsumoto M., 1998, ACM Transactions on Modeling and Computer Simulation, V8, P3, DOI 10.1145/272991.272995; McDonnell MD, 2011, NAT REV NEUROSCI, V12, P415, DOI 10.1038/nrn3061; McDonnell MD, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000348; Momin A, 2008, J PHYSIOL-LONDON, V586, P5911, DOI 10.1113/jphysiol.2008.163154; Motomura H, 1995, PFLUG ARCH EUR J PHY, V431, P221, DOI 10.1007/BF00410194; NICOLIS C, 1981, TELLUS, V33, P225, DOI 10.1111/j.2153-3490.1981.tb01746.x; Reinker S, 2004, J COMPUT NEUROSCI, V16, P15, DOI 10.1023/B:JCNS.0000004838.67584.77; Richardson KA, 1998, CHAOS, V8, P599, DOI 10.1063/1.166341; RITCHIE JM, 1977, P NATL ACAD SCI USA, V74, P211, DOI 10.1073/pnas.74.1.211; Schmid G, 2001, EUROPHYS LETT, V56, P22, DOI 10.1209/epl/i2001-00482-6; Sejdic E, 2013, COMPUT METH PROG BIO, V111, P459, DOI 10.1016/j.cmpb.2013.03.014; Stacey WC, 2001, J NEUROPHYSIOL, V86, P1104, DOI 10.1152/jn.2001.86.3.1104; WADDELL PJ, 1990, NEUROSCIENCE, V36, P811, DOI 10.1016/0306-4522(90)90024-X; WALL PD, 1983, PAIN, V17, P321, DOI 10.1016/0304-3959(83)90164-1; Wang YY, 2011, NEUROSIGNALS, V19, P54, DOI 10.1159/000324519; White JA, 1998, J NEUROPHYSIOL, V80, P262, DOI 10.1152/jn.1998.80.1.262; Xing JL, 2001, BRAIN RES, V901, P128, DOI 10.1016/S0006-8993(01)02329-0	36	12	13	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2016	11	8							e0160950	10.1371/journal.pone.0160950	http://dx.doi.org/10.1371/journal.pone.0160950			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4SL	27525414	Green Submitted, Green Published, gold			2022-12-27	WOS:000381471100028
J	Han, W; Shi, CT; Cao, FY; Cao, F; Chen, MB; Lu, RZ; Wang, HB; Yu, M; He, DW; Wang, QH; Wang, JF; Xu, XX; Ding, HZ				Han, Wei; Shi, Chun-tao; Cao, Fei-yun; Cao, Fang; Chen, Min-bin; Lu, Rong-zhu; Wang, Hua-bing; Yu, Min; He, Da-wei; Wang, Qing-hua; Wang, Jie-feng; Xu, Xuan-xuan; Ding, Hou-zhong			Prognostic Value of NME1 (NM23-H1) in Patients with Digestive System Neoplasms: A Systematic Review and Meta-Analysis	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; GASTRIC-CANCER; COLORECTAL CARCINOMAS; METASTASIS SUPPRESSOR; GENE-PRODUCT; COLON-CANCER; HEPATOCELLULAR-CARCINOMA; DIPHOSPHATE KINASE; TUMOR PROGRESSION; EXPRESSION	Objective There is a heated debate on whether the prognostic value of NME1 is favorable or unfavorable. Thus, we carried out a meta-analysis to evaluate the relationship between NME1 expression and the prognosis of patients with digestive system neoplasms. Methods We searched PubMed, EMBASE and Web of Science for relevant articles. The pooled odd ratios (ORs) and corresponding 95% CI were calculated to evaluate the prognostic value of NME1 expression in patients with digestive system neoplasms, and the association between NME1 expression and clinicopathological factors. We also performed subgroup analyses to find out the source of heterogeneity. Results 2904 patients were pooled from 28 available studies in total. Neither the incorporative OR combined by 17 studies with overall survival (OR = 0.65, 95% CI: 0.41-1.03, P = 0.07) nor the pooled OR with disease-free survival (OR = 0.75, 95% CI: 0.17-3.36, P = 0.71) in statistics showed any significance. Although we couldn't find any significance in TNM stage (OR = 0.78, 95% CI: 0.44-1.36, P = 0.38), elevated NME1 expression was related to well tumor differentiation (OR = 0.59, 95% CI: 0.47-0.73, P< 0.00001), negative N status (OR = 0.54, 95% CI: 0.36-0.82, P = 0.003) and Dukes' stage (OR = 0.43, 95% CI: 0.24-0.77, P = 0.004). And in the subgroup analyses, we only find the "years" which might be the source of heterogeneity of overall survival in gastric cancer. Conclusions The results showed that statistically significant association was found between NME1 expression and the tumor differentiation, N status and Dukes' stage of patients with digestive system cancers, while no significance was found in overall survival, disease-free survival and TNM stage. More and further researches should be conducted to reveal the prognostic value of NME1.	[Han, Wei; Shi, Chun-tao; Cao, Fang; Wang, Hua-bing; Yu, Min; Ding, Hou-zhong] Jiangsu Univ, Kunshan Peoples Hosp 1, Dept Gen Surg, Kunshan 215300, Jiangsu, Peoples R China; [Shi, Chun-tao] Xishan Peoples Hosp, Dept Gen Surg, Wuxi 215300, Jiangsu, Peoples R China; [Cao, Fei-yun; Lu, Rong-zhu] Jiangsu Univ, Sch Med, Zhenjiang 212001, Jiangsu, Peoples R China; [Chen, Min-bin] Jiangsu Univ, Kunshan Peoples Hosp 1, Dept Radiotherapy & Oncol, Kunshan 215300, Jiangsu, Peoples R China; [He, Da-wei; Xu, Xuan-xuan] Jiangsu Univ, Kunshan Peoples Hosp 1, Dept Lab, Kunshan 215300, Jiangsu, Peoples R China; [Wang, Qing-hua] Jiangsu Univ, Kunshan Peoples Hosp 1, Digest Syst Dept, Kunshan 215300, Jiangsu, Peoples R China; [Wang, Jie-feng] Qiandeng Hosp, Dept Gen Surg, Kunshan 215300, Jiangsu, Peoples R China	Jiangsu University; Jiangsu University; Jiangsu University; Jiangsu University; Jiangsu University	Ding, HZ (corresponding author), Jiangsu Univ, Kunshan Peoples Hosp 1, Dept Gen Surg, Kunshan 215300, Jiangsu, Peoples R China.	dinghouzhong@163.com	Wang, Qinghua/GVT-3252-2022; he, dawei/GZK-8280-2022	Lu, Rongzhu/0000-0002-8633-8453; He, Dawei/0000-0002-9334-2354				Abad A., 1996, European Journal of Cancer, V32A, pS26, DOI 10.1016/0959-8049(96)84887-8; Boissan M, 2010, CANCER RES, V70, P7710, DOI 10.1158/0008-5472.CAN-10-1887; Cai YYC, 2007, INT J ONCOL, V30, P1059; Caligo MA, 2000, ONCOL REP, V7, P1371; Cheah PY, 1998, BRIT J CANCER, V77, P1164, DOI 10.1038/bjc.1998.193; Chen WC, 2007, WORLD J GASTROENTERO, V13, P699, DOI 10.3748/wjg.v13.i5.699; Dursun A, 2002, PATHOLOGY, V34, P427, DOI 10.1080/0031302021000009342; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Gao Qing-Lei, 2004, Ai Zheng, V23, P650; Han Wei, 2015, PROSPERO; Hari DM, 2013, J AM COLL SURGEONS, V217, P181, DOI 10.1016/j.jamcollsurg.2013.04.018; Iizuka N, 1999, BRIT J CANCER, V81, P469, DOI 10.1038/sj.bjc.6690717; Iizuka N, 1999, CANCER LETT, V138, P139, DOI 10.1016/S0304-3835(98)00387-5; Iizuka N, 2001, CANCER LETT, V174, P65, DOI 10.1016/S0304-3835(01)00684-X; Jensen SL, 1996, WORLD J UROL, V14, pS21; Kapitanovic S, 2004, J CLIN PATHOL, V57, P1312, DOI 10.1136/jcp.2004.017954; Khan MH, 2001, AM J PATHOL, V158, P1785, DOI 10.1016/S0002-9440(10)64134-X; Kim Kyoung-Mee, 1995, Journal of Korean Medical Science, V10, P406; Lee CS, 1996, PATHOLOGY, V28, P220, DOI 10.1080/00313029600169014; Lee JC, 2001, J SURG ONCOL, V76, P58, DOI 10.1002/1096-9098(200101)76:1<58::AID-JSO1010>3.0.CO;2-D; LEONE A, 1991, CELL, V65, P25, DOI 10.1016/0092-8674(91)90404-M; Li J, 2006, CANCER GENE THER, V13, P266, DOI 10.1038/sj.cgt.7700899; Lin Xing Qiu, 2005, Shi Yan Sheng Wu Xue Bao, V38, P148; Lindmark G, 1996, BRIT J CANCER, V74, P1413, DOI 10.1038/bjc.1996.557; Liu YB, 2005, WORLD J GASTROENTERO, V11, P1378, DOI 10.3748/wjg.v11.i9.1378; Lu Hai Ying, 2006, Fen Zi Xi Bao Sheng Wu Xue Bao, V39, P249; Marshall JC, 2010, EUR J CANCER, V46, P1278, DOI 10.1016/j.ejca.2010.02.042; MARTINEZ JA, 1995, GUT, V37, P712, DOI 10.1136/gut.37.5.712; Mccorkle JR, 2014, CANCER GENOM PROTEOM, V11, P175; Monig SP, 2007, ANTICANCER RES, V27, P3029; Muller W, 1998, CANCER-AM CANCER SOC, V83, P2481, DOI 10.1002/(SICI)1097-0142(19981215)83:12<2481::AID-CNCR11>3.0.CO;2-P; Nesi G, 2001, ANTICANCER RES, V21, P3643; Ng L, 2013, CELL MOL LIFE SCI, V70, P3631, DOI 10.1007/s00018-013-1266-8; Ogino S, 2016, EPIDEMIOLOGY, V27, P602, DOI 10.1097/EDE.0000000000000471; Ohshio G, 1997, INT J PANCREATOL, V22, P59, DOI 10.1007/BF02803906; Oue N, 2007, CANCER SCI, V98, P1198, DOI 10.1111/j.1349-7006.2007.00515.x; Qin ZQ, 2011, J VIROL, V85, P3596, DOI 10.1128/JVI.01596-10; Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z; STEEG PS, 1988, J NATL CANCER I, V80, P200, DOI 10.1093/jnci/80.3.200; Su ZH, 2004, WORLD J GASTROENTERO, V10, P2800; Tabuchi Y, 1999, SURG TODAY, V29, P116; Takadate Tatsuyuki, 2012, Clin Proteomics, V9, P8, DOI 10.1186/1559-0275-9-8; TANNAPFEL A, 1995, DIS COLON RECTUM, V38, P651, DOI 10.1007/BF02054128; Terada R, 2002, MED ONCOL, V19, P239, DOI 10.1385/MO:19:4:239; TOKUNAGA Y, 1993, INT J CANCER, V55, P66, DOI 10.1002/ijc.2910550113; Tomita M, 2001, BMC CANCER, V1, DOI 10.1186/1471-2407-1-3; Wang CS, 1998, CANCER LETT, V128, P23, DOI 10.1016/S0304-3835(98)00043-3; Wang LS, 2004, EUR J CARDIO-THORAC, V26, P419, DOI 10.1016/j.ejcts.2004.03.045; Wong WCW, 2008, EMERG THEMES EPIDEMI, V5, DOI 10.1186/1742-7622-5-23; YAMAGUCHI A, 1993, BRIT J CANCER, V68, P1020, DOI 10.1038/bjc.1993.473; YAMAGUCHI A, 1994, CANCER, V73, P2280, DOI 10.1002/1097-0142(19940501)73:9<2280::AID-CNCR2820730908>3.0.CO;2-3; Yang YQ, 2008, WORLD J GASTROENTERO, V14, P5549, DOI 10.3748/wjg.14.5549; Yoo CH, 1999, J SURG ONCOL, V71, P22, DOI 10.1002/(SICI)1096-9098(199905)71:1<22::AID-JSO5>3.0.CO;2-I; 苏向前, 2001, Chinese Journal of Cancer Research, V13, P302, DOI 10.1007/s11670-001-0053-5	54	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2016	11	8							e0160547	10.1371/journal.pone.0160547	http://dx.doi.org/10.1371/journal.pone.0160547			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3LI	27518571	gold, Green Published, Green Submitted			2022-12-27	WOS:000381382100016
J	Mema, SC; Yang, HM; Vaska, M; Elnitsky, S; Jiang, ZC				Mema, Silvina C.; Yang, Huiming; Vaska, Marcus; Elnitsky, Sherry; Jiang, Zhichang			Integrated Cancer Screening Performance Indicators: A Systematic Review	PLOS ONE			English	Review							LOW-INCOME WOMEN; CARE; INTERVENTION; ADHERENCE	Cancer screening guidelines recommend that women over 50 years regularly be screened for breast, cervical and colorectal cancers. Population-based screening programs use performance indicators to monitor uptake for each type of cancer screening, but integrated measures of adherence across multiple screenings are rarely reported. Integrated measures of adherence that combine the three cancers cannot be inferred from measures of screening uptake of each cancer alone; nevertheless, they can help discern the proportion of women who, having received one or two types of screening, may be more amenable to receiving one additional screen, compared to those who haven't had any screening and may experience barriers to access screening such as distance, language, and so on. The focus of our search was to identify indicators of participation in the three cancers, therefore our search strategy included synonyms of integrated screening, cervical, breast and colorectal cancer screening. Additionally, we limited our search to studies published between 2000 and 2015, written in English, and pertaining to females over 50 years of age. The following databases were searched: MEDLINE, EMBASE, EBM Reviews, PubMed, PubMed Central, CINAHL, and Nursing Reference Center, as well as grey literature resources. Of the 78 initially retrieved articles, only 7 reported summary measures of screening across the three cancers. Overall, adherence to cervical, breast and colorectal cancer screening ranged from around 8% to 43%. Our review confirms that reports of screening adherence across breast, cervical and colorectal cancers are rare. This is surprising, as integrated cancer screening measures can provide additional insight into the needs of the target population that can help craft strategies to improve adherence to all three screenings.	[Mema, Silvina C.] Interior Hlth Author, Kelowna, BC, Canada; [Yang, Huiming; Vaska, Marcus; Elnitsky, Sherry; Jiang, Zhichang] Alberta Hlth Serv, Calgary, AB, Canada	Alberta Health Services (AHS); University of Calgary	Mema, SC (corresponding author), Interior Hlth Author, Kelowna, BC, Canada.	Silvina.Mema@interiorhealth.ca	Mema, Silvina/J-5416-2019	Mema, Silvina/0000-0001-5895-9159				Allen JD, 2014, J CANCER EDUC, V29, P136, DOI 10.1007/s13187-013-0560-3; Bray F, 2012, LANCET ONCOL, V13, P790, DOI 10.1016/S1470-2045(12)70211-5; Canadian Partnership Against Cancer (CPAC), 2012, QUAL DET IND MEAS CO; Canadian Partnership Against Cancer (CPAC), 2013, ORG BREAST CANC SCRE; Canadian Task Force on Preventive Health Care, 2001, CMAJ, V165, P206; Cancer Quality Council of Ontario (CQCO), INT CANC SCREEN PART; Carlos Ruth C, 2004, J Am Coll Radiol, V1, P769, DOI 10.1016/j.jacr.2004.05.018; Commission on Chronic Illness, 1957, PREV CHRON ILLN; de Villemeur AB, 2007, EUR J CANCER PREV, V16, P26, DOI 10.1097/01.cej.0000228399.30235.bc; Dietrich AJ, 2006, ANN INTERN MED, V144, P563, DOI 10.7326/0003-4819-144-8-200604180-00006; Dietrich AJ, 2007, ANN FAM MED, V5, P320, DOI 10.1370/afm.701; Emmons KM, 2011, CANCER CAUSE CONTROL, V22, P1343, DOI 10.1007/s10552-011-9807-7; Forte T, 2012, CURR ONCOL, V19, P269, DOI 10.3747/co.19.1188; Hiatt RA, 2002, JNCI-J NATL CANCER I, V94, P1837, DOI 10.1093/jnci/94.24.1837; Katz ML, 2014, CANCER EPIDEM BIOMAR, V23, P564, DOI 10.1158/1055-9965.EPI-14-0069; Mai V., 2006, CHALLENGES IMPLEMENT; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; O'Malley AS, 2002, J GEN INTERN MED, V17, P144, DOI 10.1046/j.1525-1497.2002.10431.x; Schwartz LM, 2004, JAMA-J AM MED ASSOC, V291, P71, DOI 10.1001/jama.291.1.71; Singh Harminder, 2015, CMAJ Open, V3, pE149, DOI 10.9778/cmajo.20140073; Suter E, 2007, HEALTH CARE MANAGE R, V32, P226, DOI 10.1097/01.HMR.0000281624.43611.dd; US Preventive Services Task Force, 1996, SCREEN COL CANC GUID, P89; Waddington C, 2008, 1 WHO; Yost A, 2013, 1209120315 NEW YORK; Zoorob R, 2001, AM FAM PHYSICIAN, V63, P1101	25	8	8	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2016	11	8							e0161187	10.1371/journal.pone.0161187	http://dx.doi.org/10.1371/journal.pone.0161187			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3LI	27518708	Green Published, Green Submitted, gold			2022-12-27	WOS:000381382100059
J	Welter, M; Fredrich, T; Rinneberg, H; Rieger, H				Welter, Michael; Fredrich, Thierry; Rinneberg, Herbert; Rieger, Heiko			Computational Model for Tumor Oxygenation Applied to Clinical Data on Breast Tumor Hemoglobin Concentrations Suggests Vascular Dilatation and Compression	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; INTERSTITIAL FLUID PRESSURE; SCANNING OPTICAL MAMMOGRAPHY; BLOOD-FLOW; MICROVASCULAR NETWORKS; CAPILLARY NETWORKS; SOLID STRESS; VESSEL COOPTION; TRANSPORT; TISSUE	We present a computational model for trans-vascular oxygen transport in synthetic tumor and host tissue blood vessel networks, aiming at qualitatively explaining published data of optical mammography, which were obtained from 87 breast cancer patients. The data generally show average hemoglobin concentration to be higher in tumors versus host tissue whereas average oxy-to total hemoglobin concentration (vascular segment RBC-volume-weighted blood oxygenation) can be above or below normal. Starting from a synthetic arterio-venous initial network the tumor vasculature was generated by processes involving cooption, angiogenesis, and vessel regression. Calculations of spatially resolved blood flow, hematocrit, oxy- and total hemoglobin concentrations, blood and tissue oxygenation were carried out for ninety tumor and associated normal vessel networks starting from various assumed geometries of feeding arteries and draining veins. Spatial heterogeneity in the extra-vascular partial oxygen pressure distribution can be related to various tumor compartments characterized by varying capillary densities and blood flow characteristics. The reported higher average hemoglobin concentration of tumors is explained by growth and dilatation of tumor blood vessels. Even assuming sixfold metabolic rate of oxygen consumption in tumorous versus host tissue, the predicted oxygen hemoglobin concentrations are above normal. Such tumors are likely associated with high tumor blood flow caused by high-caliber blood vessels crossing the tumor volume and hence oxygen supply exceeding oxygen demand. Tumor oxy- to total hemoglobin concentration below normal could only be achieved by reducing tumor vessel radii during growth by a randomly selected factor, simulating compression caused by intra-tumoral solid stress due to proliferation of cells and extracellular matrix. Since compression of blood vessels will impede chemotherapy we conclude that tumors with oxy- to total hemoglobin concentration below normal are less likely to respond to chemotherapy. Such behavior was recently reported for neo-adjuvant chemotherapy of locally advanced breast tumors.	[Welter, Michael; Fredrich, Thierry; Rieger, Heiko] Univ Saarland, Theoret Phys, Saarbrucken, Germany; [Rinneberg, Herbert] Phys Tech Bundesanstalt PTB Berlin, Div Med Phys & Metrol Informat Technol, Berlin, Germany	Saarland University; Physikalisch-Technische Bundesanstalt (PTB)	Rieger, H (corresponding author), Univ Saarland, Theoret Phys, Saarbrucken, Germany.	h.rieger@mx.uni-saarland.de	Rieger, Heiko/C-3298-2012	Fredrich, Thierry/0000-0001-7030-3048; Rieger, Heiko/0000-0003-0205-3678	German Research Foundation (DFG) within the Collaborative Research Center [SFB 1027]	German Research Foundation (DFG) within the Collaborative Research Center(German Research Foundation (DFG))	This work was supported by the German Research Foundation (DFG) within the Collaborative Research Center SFB 1027. The funders had no influence on this work.	An Hongyu, 2011, Open Neuroimag J, V5, P120, DOI 10.2174/1874440001105010120; Anderson PG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117322; Bartha K, 2006, J THEOR BIOL, V241, P903, DOI 10.1016/j.jtbi.2006.01.022; BEANEY RP, 1984, SEMIN NUCL MED, V14, P324, DOI 10.1016/S0001-2998(84)80006-9; Beard DA, 2001, ANN BIOMED ENG, V29, P837, DOI 10.1114/1.1408920; Brown JM, 2004, NAT REV CANCER, V4, P437, DOI 10.1038/nrc1367; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Carp SA, 2008, OPT EXPRESS, V16, P16064, DOI 10.1364/OE.16.016064; CHARY SR, 1989, P NATL ACAD SCI USA, V86, P5385, DOI 10.1073/pnas.86.14.5385; Chauhan VP, 2014, CANCER CELL, V26, P14, DOI 10.1016/j.ccr.2014.06.003; Chauhan VP, 2011, ANNU REV CHEM BIOMOL, V2, P281, DOI 10.1146/annurev-chembioeng-061010-114300; Choe R, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3103325; Christen T, 2013, AM J NEURORADIOL, V34, P1113, DOI 10.3174/ajnr.A3070; Coppola G, 2008, J R SOC INTERFACE, V5, P1067, DOI 10.1098/rsif.2007.1338; D'Angelo C, 2012, SIAM J NUMER ANAL, V50, P194, DOI 10.1137/100813853; Dafni H, 2002, CANCER RES, V62, P6731; Dasu A, 2003, PHYS MED BIOL, V48, P2829, DOI 10.1088/0031-9155/48/17/307; DelGiorno KE, 2014, CANCER CELL, V26, P16, DOI 10.1016/j.ccr.2014.06.004; Dewhirst MW, 2008, NAT REV CANCER, V8, P425, DOI 10.1038/nrc2397; Dhakal HP, 2009, HISTOL HISTOPATHOL, V24, P1049, DOI 10.14670/HH-24.1049; Dome B, 2002, J PATHOL, V197, P355, DOI 10.1002/path.1124; Espinoza I, 2013, MED PHYS, V40, DOI 10.1118/1.4812431; Fernandez-Guinea O, 2013, INT J CLIN ONCOL, V18, P629, DOI 10.1007/s10147-012-0428-2; Fleming IN, 2015, BRIT J CANCER, V112, P238, DOI 10.1038/bjc.2014.610; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; Fraser GM, 2013, MICROCIRCULATION, V20, P748, DOI 10.1111/micc.12075; Godde R, 2001, DEV DYNAM, V220, P387, DOI 10.1002/dvdy.1118; Goldman D, 1999, ADV EXP MED BIOL, V471, P555; Goldman D, 2008, MICROCIRCULATION, V15, P795, DOI 10.1080/10739680801938289; Griffon-Etienne G, 1999, CANCER RES, V59, P3776; Grimes DR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153692; Grimes DR, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2013.1124; Grosenick D, 2005, PHYS MED BIOL, V50, P2429, DOI 10.1088/0031-9155/50/11/001; Grosenick D, 2005, PHYS MED BIOL, V50, P2451, DOI 10.1088/0031-9155/50/11/002; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Hartmann P, 2006, MELANOMA RES, V16, P479, DOI 10.1097/01.cmr.0000222605.03675.1d; Hellums JD, 1996, ANN BIOMED ENG, V24, P1, DOI 10.1007/BF02770991; Heroux MA, 2005, ACM T MATH SOFTWARE, V31, P397, DOI 10.1145/1089014.1089021; Holash J, 1999, SCIENCE, V284, P1994, DOI 10.1126/science.284.5422.1994; HSU R, 1989, MATH BIOSCI, V96, P61, DOI 10.1016/0025-5564(89)90083-7; Ito H, 2004, EUR J NUCL MED MOL I, V31, P635, DOI 10.1007/s00259-003-1430-8; Ito M, 2006, ACAD RADIOL, V13, P598, DOI 10.1016/j.acra.2006.01.007; Jain RK, 1999, ANNU REV BIOMED ENG, V1, P241, DOI 10.1146/annurev.bioeng.1.1.241; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; KALLINOWSKI F, 1989, INT J CANCER, V44, P266, DOI 10.1002/ijc.2910440214; KALLINOWSKI F, 1989, CANCER RES, V49, P3759; Kelly CJ, 2006, PHYS MED BIOL, V51, P5859, DOI 10.1088/0031-9155/51/22/009; Kesmarky G, 2008, CLIN HEMORHEOL MICRO, V39, P243, DOI 10.3233/CH-2008-1088; Kim E, 2013, MAGN RESON MED, V70, P1106, DOI 10.1002/mrm.24530; Kim E, 2012, ANN BIOMED ENG, V40, P2425, DOI 10.1007/s10439-012-0585-5; Kirkpatrick JP, 2003, RADIAT RES, V159, P336, DOI 10.1667/0033-7587(2003)159[0336:AMMOTO]2.0.CO;2; Knabner P., 2000, NUMERIK PARTIELLER D; Krogh A, 1919, J PHYSIOL-LONDON, V52, P409, DOI 10.1113/jphysiol.1919.sp001839; Lagerlof JH, 2014, MED PHYS, V41, DOI 10.1118/1.4866887; Lee DS, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.058104; Less J R, 1992, EXS, V61, P74; LEU AJ, 1994, AM J PHYSIOL-HEART C, V267, pH1507, DOI 10.1152/ajpheart.1994.267.4.H1507; LeVeque RJ, 2007, OTHER TITL APPL MATH, V98, P1, DOI 10.1137/1.9780898717839; Mankoff DA, 2002, J NUCL MED, V43, P500; Marieb E.N., 2013, HUMAN ANATOMY PHYSL; Monnich D, 2011, PHYS MED BIOL, V56, P2045, DOI 10.1088/0031-9155/56/7/009; Moschandreou TE, 2011, MATH BIOSCI, V232, P1, DOI 10.1016/j.mbs.2011.03.010; Nagy JA, 2009, BRIT J CANCER, V100, P865, DOI 10.1038/sj.bjc.6604929; NAIR PK, 1990, MICROVASC RES, V39, P203, DOI 10.1016/0026-2862(90)90070-8; Neri D, 2005, NAT REV CANCER, V5, P436, DOI 10.1038/nrc1627; Ntziachristos V, 2002, NEOPLASIA, V4, P347, DOI 10.1038/sj.neo.7900244; Padera TP, 2004, NATURE, V427, P695, DOI 10.1038/427695a; PRIES AR, 1990, CIRC RES, V67, P826, DOI 10.1161/01.RES.67.4.826; PRIES AR, 1994, CIRC RES, V75, P904, DOI 10.1161/01.RES.75.5.904; Provenzano PP, 2012, CANCER CELL, V21, P418, DOI 10.1016/j.ccr.2012.01.007; Quarto G, 2014, BIOMED OPT EXPRESS, V5, P3684, DOI 10.1364/BOE.5.003684; Rieger H, 2015, WIRES SYST BIOL MED, V7, P113, DOI 10.1002/wsbm.1295; Safaeian N, 2012, COMPUTATIONAL MODELL; Safaeian N, 2013, J CEREBR BLOOD F MET, V33, P1633, DOI 10.1038/jcbfm.2013.119; Safaeian N, 2011, J THEOR BIOL, V271, P145, DOI 10.1016/j.jtbi.2010.11.038; Secomb TW, 2004, ANN BIOMED ENG, V32, P1519, DOI 10.1114/B:ABME.0000049036.08817.44; Sharan M, 2008, J CEREBR BLOOD F MET, V28, P1597, DOI 10.1038/jcbfm.2008.51; Skeldon AC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038597; Sourbron SP, 2012, PHYS MED BIOL, V57, pR1, DOI 10.1088/0031-9155/57/2/R1; Spinelli L, 2005, PHYS MED BIOL, V50, P2489, DOI 10.1088/0031-9155/50/11/004; Stamatelos SK, 2014, MICROVASC RES, V91, P8, DOI 10.1016/j.mvr.2013.12.003; Stylianopoulos T, 2013, CANCER RES, V73, P3833, DOI 10.1158/0008-5472.CAN-12-4521; Stylianopoulos T, 2012, P NATL ACAD SCI USA, V109, P15101, DOI 10.1073/pnas.1213353109; Taroni P, 2005, PHYS MED BIOL, V50, P2469, DOI 10.1088/0031-9155/50/11/003; Taroni Paola, 2012, Photochem Photobiol Sci, V11, P241, DOI 10.1039/c1pp05230f; Thomas H, 2009, INTRODUCTION TO ALGO; Ueda S, 2012, CANCER RES, V72, P4318, DOI 10.1158/0008-5472.CAN-12-0056; VAUPEL P, 1991, CANCER RES, V51, P3316; Viacava P, 2004, J PATHOL, V204, P140, DOI 10.1002/path.1626; Walocha JA, 2003, HUM REPROD, V18, P1088, DOI 10.1093/humrep/deg213; Wang Y, C SERIES INTEGRATED, P1; Welter M, 2008, J THEOR BIOL, V250, P257, DOI 10.1016/j.jtbi.2007.09.031; Welter M, 2010, EUR PHYS J E, V33, P149, DOI 10.1140/epje/i2010-10611-6; Welter M, 2009, J THEOR BIOL, V259, P405, DOI 10.1016/j.jtbi.2009.04.005; Welter M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070395; WILSON CBJH, 1992, CANCER RES, V52, P1592; Yaseen MA, 2011, J CEREBR BLOOD F MET, V31, P1051, DOI 10.1038/jcbfm.2010.227; Zubieta-Calleja G, 2015, NEW HUMAN PHYSL	98	23	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2016	11	8							e0161267	10.1371/journal.pone.0161267	http://dx.doi.org/10.1371/journal.pone.0161267			42	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT8TP	27547939	gold, Green Submitted, Green Published			2022-12-27	WOS:000381768400036
J	Capoor, MN; Ruzicka, F; Machackova, T; Jancalek, R; Smrcka, M; Schmitz, JE; Hermanova, M; Sana, J; Michu, E; Baird, JC; Ahmed, FS; Maca, K; Lipina, R; Alamin, TF; Coscia, MF; Stonemetz, JL; Witham, T; Ehrlich, GD; Gokaslan, ZL; Mavrommatis, K; Birkenmaier, C; Fischetti, VA; Slaby, O				Capoor, Manu N.; Ruzicka, Filip; Machackova, Tana; Jancalek, Radim; Smrcka, Martin; Schmitz, Jonathan E.; Hermanova, Marketa; Sana, Jiri; Michu, Elleni; Baird, John C.; Ahmed, Fahad S.; Maca, Karel; Lipina, Radim; Alamin, Todd F.; Coscia, Michael F.; Stonemetz, Jerry L.; Witham, Timothy; Ehrlich, Garth D.; Gokaslan, Ziya L.; Mavrommatis, Konstantinos; Birkenmaier, Christof; Fischetti, Vincent A.; Slaby, Ondrej			Prevalence of Propionibacterium acnes in Intervertebral Discs of Patients Undergoing Lumbar Microdiscectomy: A Prospective Cross-Sectional Study	PLOS ONE			English	Article							BACTERIAL-INFECTION; BIOFILM FORMATION; ASSOCIATION; SCIATICA; SAMPLES; SKIN; DNA	Background The relationship between intervertebral disc degeneration and chronic infection by Propionibacterium acnes is controversial with contradictory evidence available in the literature. Previous studies investigating these relationships were under-powered and fraught with methodical differences; moreover, they have not taken into consideration P. acnes' ability to form biofilms or attempted to quantitate the bioburden with regard to determining bacterial counts/genome equivalents as criteria to differentiate true infection from contamination. The aim of this prospective cross-sectional study was to determine the prevalence of P. acnes in patients undergoing lumbar disc microdiscectomy. Methods and Findings The sample consisted of 290 adult patients undergoing lumbar microdiscectomy for symptomatic lumbar disc herniation. An intraoperative biopsy and pre-operative clinical data were taken in all cases. One biopsy fragment was homogenized and used for quantitative anaerobic culture and a second was frozen and used for real-time PCR-based quantification of P. acnes genomes. P. acnes was identified in 115 cases (40%), coagulase-negative staphylococci in 31 cases (11%) and alpha-hemolytic streptococci in 8 cases (3%). P. acnes counts ranged from 100 to 9000 CFU/ml with a median of 400 CFU/ml. The prevalence of intervertebral discs with abundant P. acnes (>= 1x10(3) CFU/ml) was 11% (39 cases). There was significant correlation between the bacterial counts obtained by culture and the number of P. acnes genomes detected by real-time PCR (r = 0.4363, p<0.0001). Conclusions In a large series of patients, the prevalence of discs with abundant P. acnes was 11%. We believe, disc tissue homogenization releases P. acnes from the biofilm so that they can then potentially be cultured, reducing the rate of false-negative cultures. Further, quantification study revealing significant bioburden based on both culture and real-time PCR minimize the likelihood that observed findings are due to contamination and supports the hypothesis P. acnes acts as a pathogen in these cases of degenerative disc disease.	[Capoor, Manu N.; Fischetti, Vincent A.] Rockefeller Univ, Lab Bacterial Pathogenesis & Immunol, 1230 York Ave, New York, NY 10021 USA; [Ruzicka, Filip] Masaryk Univ, St Annes Fac Hosp, Dept Microbiol, Fac Med, Brno, Czech Republic; [Capoor, Manu N.; Machackova, Tana; Sana, Jiri; Michu, Elleni; Baird, John C.; Ahmed, Fahad S.; Slaby, Ondrej] Masaryk Univ, Dept Mol Oncol, Cent European Inst Technol CEITEC, Brno, Czech Republic; [Jancalek, Radim] Masaryk Univ, St Annes Univ Hosp, Dept Neurosurg, Brno, Czech Republic; [Smrcka, Martin; Maca, Karel] Masaryk Univ, Univ Hosp Brno, Dept Neurosurg, Brno, Czech Republic; [Schmitz, Jonathan E.] Vanderbilt Univ, Sch Med, Dept Pathol Microbiol & Immunol, Nashville, TN 37212 USA; [Hermanova, Marketa] Masaryk Univ, St Annes Univ Hosp, Dept Pathol Anat 1, Brno, Czech Republic; [Lipina, Radim] Univ Ostrava, Univ Hosp Ostrava, Dept Neurosurg, Ostrava, Czech Republic; [Alamin, Todd F.] Stanford Univ, Dept Orthoped Surg, Stanford Univ Med Ctr, Stanford, CA 94305 USA; [Coscia, Michael F.] OrthoIndy Hosp, Dept Orthoped Surg, Indianapolis, IN USA; [Stonemetz, Jerry L.] Johns Hopkins Univ Hosp, Dept Anesthesia, Baltimore, MD 21287 USA; [Witham, Timothy] Johns Hopkins Univ Hosp, Dept Neurosurg, Baltimore, MD 21287 USA; [Ehrlich, Garth D.] Drexel Univ, Ctr Genom Sci, Coll Med, Philadelphia, PA 19104 USA; [Ehrlich, Garth D.] Drexel Univ, Coll Med, Dept Microbiol & Immunol, Philadelphia, PA 19104 USA; [Ehrlich, Garth D.] Drexel Univ, Dept Otolaryngol Head & Neck Surg, Coll Med, Philadelphia, PA 19104 USA; [Ehrlich, Garth D.] Drexel Univ, Inst Mol Med & Infect Dis, Coll Med, Philadelphia, PA 19104 USA; [Gokaslan, Ziya L.] Brown Univ, Rhode Isl Hosp, Warren Alpert Med Sch, Dept Neurosurg, Providence, RI 02903 USA; [Mavrommatis, Konstantinos] Celgene Corp, Informat Knowledge & Utilizat, San Francisco, CA USA; [Birkenmaier, Christof] Univ Munich LMU, Dept Orthoped Phys Med & Rehabil, Munich, Germany	Rockefeller University; Masaryk University Brno; St Anne's University Hospital Brno (FNUSA-ICRC); Masaryk University Brno; Masaryk University Brno; St Anne's University Hospital Brno (FNUSA-ICRC); Masaryk University Brno; University Hospital Brno; Vanderbilt University; Masaryk University Brno; St Anne's University Hospital Brno (FNUSA-ICRC); University Hospital Ostrava; University of Ostrava; Stanford University; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Drexel University; Drexel University; Drexel University; Drexel University; Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; Bristol-Myers Squibb; Celgene Corporation; University of Munich	Capoor, MN (corresponding author), Rockefeller Univ, Lab Bacterial Pathogenesis & Immunol, 1230 York Ave, New York, NY 10021 USA.; Capoor, MN; Slaby, O (corresponding author), Masaryk Univ, Dept Mol Oncol, Cent European Inst Technol CEITEC, Brno, Czech Republic.	mcapoor@mail.rockefeller.edu; ondrej.slaby@ceitec.muni.cz	Jancalek, Radim/AAP-9193-2020; Smrčka, Martin/AAM-8872-2021; Růžička, Filip/K-6360-2015; capoor, manu/AAI-2709-2021	Jancalek, Radim/0000-0001-6834-6567; Smrčka, Martin/0000-0002-9191-8700; Hermanova, Marketa/0000-0002-3889-0905; Capoor, Manu/0000-0002-0861-4993; Mavrommatis, Konstantinos/0000-0003-4549-385X; Ehrlich, Garth/0000-0003-1140-6594; Witham, Timothy/0000-0002-9397-8344; Ruzicka, Filip/0000-0001-5679-0513; Machackova, Tana/0000-0001-5055-7147	DiscitisDx	DiscitisDx	DiscitisDx provided support in the form of a research grant which was used to pay for culturing and PCR reagents and materials. Neither DiscitiDX, Inc. nor any other commercial organization provided any support in the form of salaries for authors and did not have any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Achermann Y, 2014, CLIN MICROBIOL REV, V27, P419, DOI 10.1128/CMR.00092-13; Adams MA, 2006, SPINE, V31, P2151, DOI 10.1097/01.brs.0000231761.73859.2c; Agarwal V, 2011, J SPINAL DISORD TECH, V24, P397, DOI 10.1097/BSD.0b013e3182019f3a; Albert HB, 2013, EUR SPINE J, V22, P690, DOI 10.1007/s00586-013-2674-z; Arndt J, 2012, J SPINAL DISORD TECH, V25, pE211, DOI 10.1097/BSD.0b013e318269851a; Bae Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090324; Bayston R, 2007, J BIOMED MATER RES A, V81A, P705, DOI 10.1002/jbm.a.31145; Ben-Galim P, 2006, SPINE, V31, P2507, DOI 10.1097/01.brs.0000238657.13263.b2; Brzuszkiewicz E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021581; Carricajo A, 2007, J HOSP INFECT, V66, P275, DOI 10.1016/j.jhin.2007.04.007; Chen Z, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/9612437; Coenye T, 2007, RES MICROBIOL, V158, P386, DOI 10.1016/j.resmic.2007.02.001; Colina M, 2007, CLIN EXP RHEUMATOL, V25, P457; Coscia M, 2003, SCOL RES SOC SRS ANN; Eishi Y, 2002, J CLIN MICROBIOL, V40, P198, DOI 10.1128/JCM.40.1.198-204.2002; Portillo ME, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/804391; Ganko R, 2015, SPINE, V40, pE587, DOI 10.1097/BRS.0000000000000832; Iulia L, 2013, ROM BIOTECH LETT, V18, P8007; Jahns AC, 2014, EXP DERMATOL, V23, P687, DOI 10.1111/exd.12482; Kadler BK, 2015, INT J SHOULDER SURG, V9, P139, DOI 10.4103/0973-6042.167957; Kassis C, 2009, J CLIN MICROBIOL, V47, P3255, DOI 10.1128/JCM.01045-09; Lee MJ, 2014, J BONE JOINT SURG AM, V96A, P1447, DOI 10.2106/JBJS.M.01474; Liu PF, 2015, CURR DRUG METAB, V16, P245, DOI 10.2174/1389200216666150812124801; MARSHALL BJ, 1988, SCAND J GASTROENTERO, V23, P58, DOI 10.3109/00365528809099131; Matsen FA, 2013, J BONE JOINT SURG AM, V95A, P1126, DOI [10.2106/JBJS.L.01104, 10.2106/JBJS.L.01733]; Miura Yuriko, 2010, Journal of Medical and Dental Sciences, V57, P65; Mollerup S, 2016, J CLIN MICROBIOL, V54, P980, DOI 10.1128/JCM.02723-15; Perry A, 2011, EXPERT REV ANTI-INFE, V9, P1149, DOI [10.1586/ERI.11.137, 10.1586/eri.11.137]; Rigal J, 2016, EUR SPINE J, V25, P1000, DOI 10.1007/s00586-016-4396-5; Scholz CFP, 2016, SCI REP-UK, V6, DOI 10.1038/srep20662; Stirling A, 2001, LANCET, V357, P2024, DOI 10.1016/S0140-6736(00)05109-6; Urquhart DM, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0267-x; Zhou Y, 2013, SARCOIDOSIS VASC DIF, V30, P262; Zhou ZZ, 2015, EUR SPINE J, V24, P2496, DOI 10.1007/s00586-015-4180-y	34	48	49	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0161676	10.1371/journal.pone.0161676	http://dx.doi.org/10.1371/journal.pone.0161676			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27536784	Green Published, gold, Green Submitted			2022-12-27	WOS:000381577000130
J	Fournier, J; Mueller, CM; Shein-Idelson, M; Hemberger, M; Laurent, G				Fournier, Julien; Mueller, Christian M.; Shein-Idelson, Mark; Hemberger, Mike; Laurent, Gilles			Consensus-Based Sorting of Neuronal Spike Waveforms	PLOS ONE			English	Article							RECORDINGS	Optimizing spike-sorting algorithms is difficult because sorted clusters can rarely be checked against independently obtained "ground truth" data. In most spike-sorting algorithms in use today, the optimality of a clustering solution is assessed relative to some assumption on the distribution of the spike shapes associated with a particular single unit (e.g., Gaussianity) and by visual inspection of the clustering solution followed by manual validation. When the spatiotemporal waveforms of spikes from different cells overlap, the decision as to whether two spikes should be assigned to the same source can be quite subjective, if it is not based on reliable quantitative measures. We propose a new approach, whereby spike clusters are identified from the most consensual partition across an ensemble of clustering solutions. Using the variability of the clustering solutions across successive iterations of the same clustering algorithm (template matching based on K-means clusters), we estimate the probability of spikes being clustered together and identify groups of spikes that are not statistically distinguishable from one another. Thus, we identify spikes that are most likely to be clustered together and therefore correspond to consistent spike clusters. This method has the potential advantage that it does not rely on any model of the spike shapes. It also provides estimates of the proportion of misclassified spikes for each of the identified clusters. We tested our algorithm on several datasets for which there exists a ground truth (simultaneous intracellular data), and show that it performs close to the optimum reached by a support vector machine trained on the ground truth. We also show that the estimated rate of misclassification matches the proportion of misclassified spikes measured from the ground truth data.	[Fournier, Julien; Mueller, Christian M.; Shein-Idelson, Mark; Hemberger, Mike; Laurent, Gilles] Max Planck Inst Brain Res, Dept Neural Syst, Max von Laue Str 4, D-60438 Frankfurt, Germany	Max Planck Society	Fournier, J; Laurent, G (corresponding author), Max Planck Inst Brain Res, Dept Neural Syst, Max von Laue Str 4, D-60438 Frankfurt, Germany.	julien.fournier@brain.mpg.de; gilles.laurent@brain.mpg.de	Shein, Mark/M-9170-2018	Shein, Mark/0000-0001-8132-2826	Max Planck Society; European Research Council; Human Frontiers Science Program; HFSP	Max Planck Society(Max Planck SocietyFoundation CELLEX); European Research Council(European Research Council (ERC)European Commission); Human Frontiers Science Program(Human Frontier Science Program); HFSP(Human Frontier Science Program)	This work was funded by the Max Planck Society, the European Research Council, and the Human Frontiers Science Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The Max Planck Society paid the salaries of GL and CMM. The HFSP and the Max Planck Society paid the salary of JF.	Achtert E, 2006, P ADV KNOWL DISC DAT; Ankerst M, 1999, P SIGMOD; Ayad HG, 2008, IEEE T PATTERN ANAL, V30, P160, DOI 10.1109/TPAMI.2007.1138; Barnett AH, 2016, J NEUROSCI METH, V264, P65, DOI 10.1016/j.jneumeth.2016.02.022; Buzsaki G, 2015, NEURON, V86, P92, DOI 10.1016/j.neuron.2015.01.028; Connors BW, 1984, CELLULAR PHYSL TURTL, V6, P164; Einevoll GT, 2012, CURR OPIN NEUROBIOL, V22, P11, DOI 10.1016/j.conb.2011.10.001; Fee S, 1996, VARIABILITY EXTRACEL, V76; Franke F, 2010, J COMPUT NEUROSCI, V29, P127, DOI 10.1007/s10827-009-0163-5; Fred A, 2001, P 3 INT WORK MULT CL; Fred ALN, 2005, IEEE T PATTERN ANAL, V27, P835, DOI 10.1109/TPAMI.2005.113; Gibson S, 2012, IEEE SIGNAL PROC MAG, V29, P124, DOI 10.1109/MSP.2011.941880; Gold C, 2006, J NEUROPHYSIOL, V95, P3113, DOI 10.1152/jn.00979.2005; Harris KD, 2000, J NEUROPHYSIOL, V84, P401, DOI 10.1152/jn.2000.84.1.401; Henze DA, 2000, J NEUROPHYSIOL, V84, P390, DOI 10.1152/jn.2000.84.1.390; Hill DN, 2011, J NEUROSCI, V31, P8699, DOI 10.1523/JNEUROSCI.0971-11.2011; Jain AK., 1988, TECHNOMETRICS; Kadir SN, 2014, NEURAL COMPUT, V26, P2379, DOI 10.1162/NECO_a_00661; Khodagholy D, 2015, NAT NEUROSCI, V18, P310, DOI 10.1038/nn.3905; Lewicki MS, 1999, NETW COMPUT NEURAL S, V9; Marre O, 2012, J NEUROSCI, V32, P14859, DOI 10.1523/JNEUROSCI.0723-12.2012; Monti S, 2003, MACH LEARN, V52, P91, DOI 10.1023/A:1023949509487; Pillow JW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062123; Pouzat C, 2002, J NEUROSCI METH, V122, P43, DOI 10.1016/S0165-0270(02)00276-5; Prentice JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019884; Quiroga RQ, 2004, NEURAL COMPUT, V16, P1661, DOI 10.1162/089976604774201631; Raftery AE, 2006, J AM STAT ASS; Segev R, 2004, NAT NEUROSCI, V7, P1155, DOI 10.1038/nn1323; Senbabaoglu Y, 2014, SCI REP-UK, V4, DOI 10.1038/srep06207	29	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0160494	10.1371/journal.pone.0160494	http://dx.doi.org/10.1371/journal.pone.0160494			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27536990	Green Submitted, Green Published, gold			2022-12-27	WOS:000381577000023
J	Halmai, M; Frittmann, O; Szabo, Z; Daraba, A; Gali, VK; Balint, E; Unk, I				Halmai, Miklos; Frittmann, Orsolya; Szabo, Zoltan; Daraba, Andreea; Gali, Vamsi K.; Balint, Eva; Unk, Ildiko			Mutations at the Subunit Interface of Yeast Proliferating Cell Nuclear Antigen Reveal a Versatile Regulatory Domain	PLOS ONE			English	Article							NUCLEOTIDE EXCISION-REPAIR; DNA-POLYMERASE-DELTA; REPLICATION FACTOR-C; SACCHAROMYCES-CEREVISIAE; CRYSTAL-STRUCTURE; IN-VITRO; FUNCTIONAL INTERACTIONS; ERROR-PRONE; PCNA; UBIQUITIN	Proliferating cell nuclear antigen (PCNA) plays a key role in many cellular processes and due to that it interacts with a plethora of proteins. The main interacting surfaces of Saccharomyces cerevisiae PCNA have been mapped to the interdomain connecting loop and to the carboxy-terminal domain. Here we report that the subunit interface of yeast PCNA also has regulatory roles in the function of several DNA damage response pathways. Using sitedirected mutagenesis we engineered mutations at both sides of the interface and investigated the effect of these alleles on DNA damage response. Genetic experiments with strains bearing the mutant alleles revealed that mutagenic translesion synthesis, nucleotide excision repair, and homologous recombination are all regulated through residues at the subunit interface. Moreover, genetic characterization of one of our mutants identifies a new sub-branch of nucleotide excision repair. Based on these results we conclude that residues at the subunit boundary of PCNA are not only important for the formation of the trimer structure of PCNA, but they constitute a regulatory protein domain that mediates different DNA damage response pathways, as well.	[Halmai, Miklos; Frittmann, Orsolya; Szabo, Zoltan; Daraba, Andreea; Gali, Vamsi K.; Balint, Eva; Unk, Ildiko] Hungarian Acad Sci, Biol Res Ctr, Inst Genet, Szeged, Hungary; [Gali, Vamsi K.] Univ Aberdeen, Inst Med Sci Foresterhill, Aberdeen, Scotland	Hungarian Academy of Sciences; Hungarian Biological Research Center; University of Aberdeen	Unk, I (corresponding author), Hungarian Acad Sci, Biol Res Ctr, Inst Genet, Szeged, Hungary.	unk.ildiko@brc.mta.hu	Balint, Eva/B-8695-2008	Balint, Eva/0000-0002-1258-6892; Gali, Vamsi Krishna/0000-0001-7048-4133	Hungarian Science Foundation [OTKA 109521]; National Research Development and Innovation Office [GINOP-2.3.2-15-2016-00001]	Hungarian Science Foundation(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); National Research Development and Innovation Office(National Research, Development & Innovation Office (NRDIO) - Hungary)	This work was supported by Hungarian Science Foundation Grant OTKA 109521 and National Research Development and Innovation Office GINOP-2.3.2-15-2016-00001. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Szilvia Minorits for technical assistance. I.U. conceived and designed the project and wrote the manuscript. All authors participated in designing and performing the experiments, and analyzing the results. The authors declare no competing financial interests. This work was also supported by a grant from the National Research, Development and Innovation Office GINOP-2.3.2-15-2016-00001.	Amin NS, 1996, GENETICS, V144, P479; AYYAGARI R, 1995, MOL CELL BIOL, V15, P4420; BAILLY V, 1994, GENE DEV, V8, P811, DOI 10.1101/gad.8.7.811; BAUER GA, 1990, NUCLEIC ACIDS RES, V18, P261, DOI 10.1093/nar/18.2.261; Bienko M, 2005, SCIENCE, V310, P1821, DOI 10.1126/science.1120615; BOHR VA, 1985, CELL, V40, P359, DOI 10.1016/0092-8674(85)90150-3; BRAVO R, 1987, NATURE, V326, P515, DOI 10.1038/326515a0; BURGERS PMJ, 1991, J BIOL CHEM, V266, P22698; Burgess RC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082630; Carlile CM, 2009, J BIOL CHEM, V284, P29326, DOI 10.1074/jbc.M109.043885; Clark AB, 2000, J BIOL CHEM, V275, P36498, DOI 10.1074/jbc.C000513200; Daraba A, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001771; Dovrat D, 2014, P NATL ACAD SCI USA, V111, P14118, DOI 10.1073/pnas.1321349111; Eissenberg JC, 1997, MOL CELL BIOL, V17, P6367, DOI 10.1128/MCB.17.11.6367; FIEN K, 1992, MOL CELL BIOL, V12, P155, DOI 10.1128/MCB.12.1.155; Flores-Rozas H, 2000, NAT GENET, V26, P375, DOI 10.1038/81708; Fridman Y, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000507; Gomes XV, 2000, EMBO J, V19, P3811, DOI 10.1093/emboj/19.14.3811; Guzder SN, 1997, J BIOL CHEM, V272, P21665, DOI 10.1074/jbc.272.35.21665; Haracska L, 2004, MOL CELL BIOL, V24, P4267, DOI 10.1128/MCB.24.10.4267-4274.2004; Haracska L, 2001, P NATL ACAD SCI USA, V98, P14256, DOI 10.1073/pnas.261560798; Haracska L, 2001, MOL CELL BIOL, V21, P7199, DOI 10.1128/MCB.21.21.7199-7206.2001; Haracska L, 2001, MOL CELL, V8, P407, DOI 10.1016/S1097-2765(01)00319-7; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Johnson RE, 2006, METHOD ENZYMOL, V408, P390, DOI 10.1016/S0076-6879(06)08024-4; Kang MS, 2010, YEAST, V27, P399, DOI 10.1002/yea.1764; Krejci L, 2003, NATURE, V423, P305, DOI 10.1038/nature01577; KRISHNA TSR, 1994, CELL, V79, P1233, DOI 10.1016/0092-8674(94)90014-0; LEE SH, 1991, J BIOL CHEM, V266, P22707; Li SS, 2002, EMBO J, V21, P5921, DOI 10.1093/emboj/cdf589; LI XY, 1995, J BIOL CHEM, V270, P22109, DOI 10.1074/jbc.270.38.22109; Ling H, 2001, CELL, V107, P91, DOI 10.1016/S0092-8674(01)00515-3; MELLON I, 1987, CELL, V51, P241, DOI 10.1016/0092-8674(87)90151-6; MIYACHI K, 1978, J IMMUNOL, V121, P2228; Nair DT, 2004, NATURE, V430, P377, DOI 10.1038/nature02692; Pfander B, 2005, NATURE, V436, P428, DOI 10.1038/nature03665; Prakash S, 2005, ANNU REV BIOCHEM, V74, P317, DOI 10.1146/annurev.biochem.74.082803.133250; PRELICH G, 1987, NATURE, V326, P517, DOI 10.1038/326517a0; Reed SH, 1998, J BIOL CHEM, V273, P29481, DOI 10.1074/jbc.273.45.29481; Sharma NM, 2011, J BIOL CHEM, V286, P33557, DOI 10.1074/jbc.M110.206680; Silvian LF, 2001, NAT STRUCT BIOL, V8, P984, DOI 10.1038/nsb1101-984; Stelter P, 2003, NATURE, V425, P188, DOI 10.1038/nature01965; Torres-Ramos CA, 2002, MOL CELL BIOL, V22, P2419, DOI 10.1128/MCB.22.7.2419-2426.2002; Trincao J, 2001, MOL CELL, V8, P417, DOI 10.1016/S1097-2765(01)00306-9; TSURIMOTO T, 1991, J BIOL CHEM, V266, P1950; Uijon SN, 2004, STRUCTURE, V12, P1395, DOI 10.1016/j.str.2004.05.011; Umar A, 1996, CELL, V87, P65, DOI 10.1016/S0092-8674(00)81323-9; Unk I, 2002, MOL CELL BIOL, V22, P6480, DOI 10.1128/MCB.22.18.6480-6486.2002; VANGOOL AJ, 1994, EMBO J, V13, P5361, DOI 10.1002/j.1460-2075.1994.tb06871.x; Veaute X, 2003, NATURE, V423, P309, DOI 10.1038/nature01585; Vijayakumar S, 2007, NUCLEIC ACIDS RES, V35, P1624, DOI 10.1093/nar/gkm006; Wang ZG, 1997, MOL CELL BIOL, V17, P635, DOI 10.1128/MCB.17.2.635; Zhang HS, 2005, P NATL ACAD SCI USA, V102, P15954, DOI 10.1073/pnas.0504586102; Zhang XP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082184; Zhou BL, 2001, MOL CELL, V8, P427, DOI 10.1016/S1097-2765(01)00310-0	55	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0161307	10.1371/journal.pone.0161307	http://dx.doi.org/10.1371/journal.pone.0161307			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27537501	Green Submitted, Green Published, gold			2022-12-27	WOS:000381577000087
J	Qin, Y; Liu, CZ; Jiang, SS; Cao, JM; Xiong, L; Sun, QJ				Qin, Yang; Liu, Chengzhen; Jiang, Suisui; Cao, Jinmiao; Xiong, Liu; Sun, Qingjie			Functional Properties of Glutinous Rice Flour by Dry-Heat Treatment	PLOS ONE			English	Article							MOISTURE TREATMENT; PHYSICOCHEMICAL PROPERTIES; RHEOLOGICAL PROPERTIES; STRUCTURAL-PROPERTIES; THERMAL-PROPERTIES; AMYLOSE CONTENT; IONIC GUMS; STARCH; XANTHAN; CORN	Glutinous rice flour (GRF) and glutinous rice starch (GRS) were modified by dry-heat treatment and their rheological, thermal properties and freeze-thaw stability were evaluated. Compared with the native GRF and GRS, the water-holding ability of modified GRF and GRS were enhanced. Both the onset and peak temperatures of the modified samples increased while the endothermic enthalpy change decreased significantly (p < 0.05). Meanwhile, dry heating remarkably increased the apparent viscosities of both GRF and GRS. Importantly, compared with GRS samples, the storage modulus (G') and loss modulus (G") values of modified GRF increased more greatly and the tan delta values decreased more remarkably, indicating that the dry-heat treatment showed more impact on the GRF and a higher viscoelasticity compared with GRS. Our results suggest the dry-heat treatment of GRF is a more effective method than that of GRS, which omits the complex and tedious process for purifying GRS, and thereby has more practical applications in the food industry.	[Qin, Yang; Liu, Chengzhen; Jiang, Suisui; Cao, Jinmiao; Xiong, Liu; Sun, Qingjie] Qingdao Agr Univ, Coll Food Sci & Engn, Qingdao 266109, Shandong, Peoples R China	Qingdao Agricultural University	Sun, QJ (corresponding author), Qingdao Agr Univ, Coll Food Sci & Engn, Qingdao 266109, Shandong, Peoples R China.	phdsun@163.com						Achayuthakan P, 2008, CARBOHYD POLYM, V71, P9, DOI 10.1016/j.carbpol.2007.05.006; Ahmed J, 2014, J FOOD ENG, V124, P43, DOI 10.1016/j.jfoodeng.2013.09.030; Akesowan A., 2009, J APPL SCI RES, V5, P2477; [Anonymous], 2000, OFFICIAL METHODS ANA, DOI DOI 10.1007/978-3-642-31241-0; Arns B, 2014, INT J FOOD SCI TECH, V49, P1939, DOI 10.1111/ijfs.12580; Arunyanart T, 2008, CARBOHYD POLYM, V74, P514, DOI 10.1016/j.carbpol.2008.04.002; Chen X, 2015, J CEREAL SCI, V63, P109, DOI 10.1016/j.jcs.2015.03.003; Chung HJ, 2007, J APPL POLYM SCI, V105, P2280, DOI 10.1002/app.26237; Falade KO, 2015, FOOD HYDROCOLLOID, V44, P478, DOI 10.1016/j.foodhyd.2014.10.005; Falade KO, 2012, FOOD BIOPROCESS TECH, V5, P879, DOI 10.1007/s11947-010-0383-8; Gonzalez-Tomas L, 2008, INT DAIRY J, V18, P858, DOI 10.1016/j.idairyj.2007.09.010; Dias ARG, 2010, FOOD CHEM, V123, P711, DOI 10.1016/j.foodchem.2010.05.040; Gujral HS, 2003, J AGR FOOD CHEM, V51, P3814, DOI 10.1021/jf034112w; Hasjim J, 2013, CARBOHYD POLYM, V92, P682, DOI 10.1016/j.carbpol.2012.09.023; Ji Y, 2007, FOOD CHEM, V104, P53, DOI 10.1016/j.foodchem.2006.10.072; Ju ZY, 2001, J FOOD SCI, V66, P229, DOI 10.1111/j.1365-2621.2001.tb11322.x; Khunae P, 2007, STARCH-STARKE, V59, P593, DOI 10.1002/star.200700618; Kim WW, 2009, INT J FOOD SCI TECH, V44, P503, DOI 10.1111/j.1365-2621.2008.01760.x; Kim YL, 2013, INT J BIOL MACROMOL, V60, P422, DOI 10.1016/j.ijbiomac.2013.04.032; Lai HM, 2001, FOOD CHEM, V72, P455, DOI 10.1016/S0308-8146(00)00261-2; Lawal OS, 2011, FOOD HYDROCOLLOID, V25, P1785, DOI 10.1016/j.foodhyd.2011.04.010; Lee MH, 2002, FOOD HYDROCOLLOID, V16, P345, DOI 10.1016/S0268-005X(01)00107-2; Li Y, 2013, CARBOHYD POLYM, V92, P1647, DOI 10.1016/j.carbpol.2012.11.002; Lim ST, 2002, CEREAL CHEM, V79, P601, DOI 10.1094/CCHEM.2002.79.5.601; Lopez ACB, 2004, BRAZ ARCH BIOL TECHN, V47, P63, DOI 10.1590/S1516-89132004000100009; Loubes MA, 2014, LWT-FOOD SCI TECHNOL, V57, P320, DOI 10.1016/j.lwt.2013.12.048; Noriko O, 2003, J COOKERY SCI JAPAN, V36, P210; Pramodrao KS, 2014, FOOD HYDROCOLLOID, V35, P613, DOI 10.1016/j.foodhyd.2013.08.006; Puncha-arnon S, 2013, CARBOHYD POLYM, V91, P85, DOI 10.1016/j.carbpol.2012.08.006; Qiu C, 2015, STARCH-STARKE, V67, P756, DOI 10.1002/star.201500016; Qiu C, 2015, FOOD HYDROCOLLOID, V48, P1, DOI 10.1016/j.foodhyd.2015.01.030; Salgado S. M., 2005, Ciencia e Tecnologia de Alimentos, V25, P525, DOI 10.1590/S0101-20612005000300022; Satmalee P, 2011, INT J FOOD SCI TECH, V46, P2628, DOI 10.1111/j.1365-2621.2011.02793.x; Singh N, 2006, FOOD HYDROCOLLOID, V20, P532, DOI 10.1016/j.foodhyd.2005.05.003; Sopade PA, 2008, J FOOD ENG, V84, P553, DOI 10.1016/j.jfoodeng.2007.06.024; Sun D, 2015, LWT-FOOD SCI TECHNOL, V64, P205, DOI 10.1016/j.lwt.2015.05.062; Sun QJ, 2014, INT J BIOL MACROMOL, V68, P86, DOI 10.1016/j.ijbiomac.2014.04.032; Sun QJ, 2014, CARBOHYD POLYM, V110, P128, DOI 10.1016/j.carbpol.2014.03.090; Sun QJ, 2013, FOOD CHEM, V136, P1421, DOI 10.1016/j.foodchem.2012.09.061; Zavareze ED, 2010, FOOD CHEM, V121, P358, DOI 10.1016/j.foodchem.2009.12.036; Zhang L, 2015, COLLOID POLYM SCI, V293, P229, DOI 10.1007/s00396-014-3407-5; Zhang YY, 2011, STARCH-STARKE, V63, P11, DOI 10.1002/star.200900255; Zhu LJ, 2010, FOOD CHEM, V120, P94, DOI 10.1016/j.foodchem.2009.09.076; Zieba T, 2014, CARBOHYD POLYM, V99, P687, DOI 10.1016/j.carbpol.2013.08.064; 이기정, 2004, [Korean Journal of Food Science and Technology, 한국식품과학회지], V36, P568	45	15	15	3	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0160371	10.1371/journal.pone.0160371	http://dx.doi.org/10.1371/journal.pone.0160371			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27537844	Green Submitted, Green Published, gold			2022-12-27	WOS:000381577000019
J	Sarva, ST; Waldo, RH; Belland, RJ; Klose, KE				Sarva, Siva T.; Waldo, Robert H.; Belland, Robert J.; Klose, Karl E.			Comparative Transcriptional Analyses of Francisella tularensis and Francisella novicida	PLOS ONE			English	Article							LIVE VACCINE STRAIN; VIRULENCE GENE-EXPRESSION; INTRAMACROPHAGE SURVIVAL; ACID-PHOSPHATASE; SUBSPECIES TULARENSIS; RESPIRATORY BURST; GENOME SEQUENCE; FULL VIRULENCE; IDENTIFICATION; TULAREMIA	Francisella tularensis is composed of a number of subspecies with varied geographic distribution, host ranges, and virulence. In view of these marked differences, comparative functional genomics may elucidate some of the molecular mechanism(s) behind these differences. In this study a shared probe microarray was designed that could be used to compare the transcriptomes of Francisella tularensis subsp. tularensis Schu S4 (Ftt), Francisella tularensis subsp. holarctica OR960246 (Fth), Francisella tularensis subsp. holarctica LVS (LVS), and Francisella novicida U112 (Fn). To gain insight into expression differences that may be related to the differences in virulence of these subspecies, transcriptomes were measured from each strain grown in vitro under identical conditions, utilizing a shared probe microarray. The human avirulent Fn strain exhibited high levels of transcription of genes involved in general metabolism, which are pseudogenes in the human virulent Ftt and Fth strains, consistent with the process of genome decay in the virulent strains. Genes encoding an efflux system (emrA2 cluster of genes), siderophore (fsl operon), acid phosphatase, LPS synthesis, polyamine synthesis, and citrulline ureidase were all highly expressed in Ftt when compared to Fn, suggesting that some of these may contribute to the relative high virulence of Ftt. Genes expressed at a higher level in Ftt when compared to the relatively less virulent Fth included genes encoding isochorismatases, cholylglycine hydrolase, polyamine synthesis, citrulline ureidase, Type IV pilus subunit, and the Francisella Pathogenicity Island protein PdpD. Fth and LVS had very few expression differences, consistent with the derivation of LVS from Fth. This study demonstrated that a shared probe microarray designed to detect transcripts in multiple species/subspecies of Francisella enabled comparative transcriptional analyses that may highlight critical differences that underlie the relative pathogenesis of these strains for humans. This strategy could be extended to other closelyrelated bacterial species for inter-strain and inter-species analyses.	[Sarva, Siva T.; Waldo, Robert H.; Belland, Robert J.] Univ Tennessee, Hlth Sci Ctr, Memphis, TN USA; [Klose, Karl E.] Univ Texas San Antonio, South Texas Ctr Emerging Infect Dis, San Antonio, TX 78249 USA; [Klose, Karl E.] Univ Texas San Antonio, Dept Biol, San Antonio, TX 78249 USA	University of Tennessee System; University of Tennessee Health Science Center; University of Texas System; University of Texas at San Antonio (UTSA); University of Texas System; University of Texas at San Antonio (UTSA)	Klose, KE (corresponding author), Univ Texas San Antonio, South Texas Ctr Emerging Infect Dis, San Antonio, TX 78249 USA.; Klose, KE (corresponding author), Univ Texas San Antonio, Dept Biol, San Antonio, TX 78249 USA.	Karl.Klose@utsa.edu			NIH [AI057986, NIH-NIAID-DMID-05-22]; NIAID [AI059642]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Portions of the study were funded by NIH AI057986 and NIH-NIAID-DMID-05-22 (P.I. Lyons) to Karl E. Klose. Portions of the study were also funded by NIAID grant AI059642 to Dr. George M. Hilliard. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbdelRahman YM, 2011, NUCLEIC ACIDS RES, V39, P1843, DOI 10.1093/nar/gkq1065; Barker JR, 2009, MOL MICROBIOL, V74, P1459, DOI 10.1111/j.1365-2958.2009.06947.x; Beckstrom-Sternberg SM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000947; Bina XR, 2008, FEMS MICROBIOL LETT, V279, P226, DOI 10.1111/j.1574-6968.2007.01033.x; Brotcke A, 2006, INFECT IMMUN, V74, P6642, DOI 10.1128/IAI.01250-06; Buchan BW, 2008, APPL ENVIRON MICROB, V74, P2637, DOI 10.1128/AEM.02882-07; Carlson PE, 2009, J BACTERIOL, V191, P6855, DOI 10.1128/JB.00995-09; CHAMBERL.RE, 1965, APPL MICROBIOL, V13, P232, DOI 10.1128/AEM.13.2.232-235.1965; Charity JC, 2007, PLOS PATHOG, V3, P770, DOI 10.1371/journal.ppat.0030084; Chaudhuri RR, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000352; Child R, 2010, INFECT IMMUN, V78, P59, DOI 10.1128/IAI.00965-09; Dai SP, 2012, INFECT IMMUN, V80, P1088, DOI 10.1128/IAI.06245-11; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; Deng K, 2006, INFECT IMMUN, V74, P4224, DOI 10.1128/IAI.01975-05; Di Martino ML, 2013, INT J MED MICROBIOL, V303, P484, DOI 10.1016/j.ijmm.2013.06.008; Dussurget O, 2002, MOL MICROBIOL, V45, P1095, DOI 10.1046/j.1365-2958.2002.03080.x; Ellis J, 2002, CLIN MICROBIOL REV, V15, P631, DOI 10.1128/CMR.15.4.631-646.2002; Forslund AL, 2006, MOL MICROBIOL, V59, P1818, DOI 10.1111/j.1365-2958.2006.05061.x; Gil H, 2006, P NATL ACAD SCI USA, V103, P12897, DOI 10.1073/pnas.0602582103; Golovliov I, 1997, INFECT IMMUN, V65, P2183, DOI 10.1128/IAI.65.6.2183-2189.1997; Marchesini MI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028480; Johansson A, 2010, INT J SYST EVOL MICR, V60, P1717, DOI 10.1099/ijs.0.022830-0; Kingry LC, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00035; Kiss K, 2008, FEMS MICROBIOL LETT, V285, P270, DOI 10.1111/j.1574-6968.2008.01237.x; Konecna K, 2010, PROTEOMICS, V10, P4501, DOI 10.1002/pmic.201000248; Kraemer PS, 2009, INFECT IMMUN, V77, P232, DOI 10.1128/IAI.00978-08; Larsson P, 2005, NAT GENET, V37, P153, DOI 10.1038/ng1499; Lauriano CM, 2004, P NATL ACAD SCI USA, V101, P4246, DOI 10.1073/pnas.0307690101; Li XZ, 2015, CLIN MICROBIOL REV, V28, P337, DOI 10.1128/CMR.00117-14; Ludu JS, 2008, J BACTERIOL, V190, P4584, DOI 10.1128/JB.00198-08; Ma Z, 2014, MOL MICROBIOL, V91, P976, DOI 10.1111/mmi.12509; Maier TA, 2007, INFECT IMMUN, V75, P5376, DOI 10.1128/IAI.00238-07; Miyashiro T, 2011, MOL MICROBIOL, V82, P894, DOI 10.1111/j.1365-2958.2011.07858.x; Mohapatra NP, 2008, INFECT IMMUN, V76, P3690, DOI 10.1128/IAI.00262-08; Mohapatra NP, 2007, INFECT IMMUN, V75, P3305, DOI 10.1128/IAI.00351-07; Mohapatra NP, 2007, INFECT IMMUN, V75, P390, DOI 10.1128/IAI.01226-06; Mohapatra NP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056834; Nallaparaju KC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018201; Nano FE, 2004, J BACTERIOL, V186, P6430, DOI 10.1128/JB.186.19.6430-6436.2004; Oyston PCF, 2004, NAT REV MICROBIOL, V2, P967, DOI 10.1038/nrmicro1045; Perez NM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093558; Petersen JM, 2005, VET RES, V36, P455, DOI 10.1051/vetres:2005006; Petrosino JF, 2006, J BACTERIOL, V188, P6977, DOI 10.1128/JB.00506-06; Qin AP, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-69; Ramakrishnan G, 2012, J BIOL CHEM, V287, P25191, DOI 10.1074/jbc.M112.371856; Ratledge C, 2000, ANNU REV MICROBIOL, V54, P881, DOI 10.1146/annurev.micro.54.1.881; Reilly TJ, 1996, J BIOL CHEM, V271, P10973, DOI 10.1074/jbc.271.18.10973; RODIONOV.IV, 1968, DOKL AKAD NAUK SSSR+, V179, P457; Rodionova I V, 1970, Lab Delo, V1, P42; Rohlfing AE, 2014, J BACTERIOL, V196, P3516, DOI 10.1128/JB.01700-14; Rohmer L, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r102; Rohmer L, 2006, INFECT IMMUN, V74, P6895, DOI 10.1128/IAI.01006-06; Salomonsson E, 2009, INFECT IMMUN, V77, P3424, DOI 10.1128/IAI.00196-09; SANDSTROM G, 1992, J CLIN MICROBIOL, V30, P172; Schulert GS, 2009, INFECT IMMUN, V77, P1324, DOI 10.1128/IAI.01318-08; Su JL, 2007, INFECT IMMUN, V75, P3089, DOI 10.1128/IAI.01865-06; Sullivan JT, 2006, J BACTERIOL, V188, P3785, DOI 10.1128/JB.00027-06; Symmons MF, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00513; Tarnvik A, 2003, EUR RESPIR J, V21, P361, DOI 10.1183/09031936.03.00088903; Twine S, 2005, INFECT IMMUN, V73, P8345, DOI 10.1128/IAI.73.12.8345-8352.2005; Waldo RH, 2007, J PROTEOME RES, V6, P3484, DOI 10.1021/pr070107m; Weiss DS, 2007, P NATL ACAD SCI USA, V104, P6037, DOI 10.1073/pnas.0609675104; Whitworth T, 2005, INFECT IMMUN, V73, P6668, DOI 10.1128/IAI.73.10.6668-6673.2005; Zgurskaya HI, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00100; Zogaj X, 2008, MICROBIOL-SGM, V154, P2139, DOI 10.1099/mic.0.2008/018077-0	65	3	3	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0158631	10.1371/journal.pone.0158631	http://dx.doi.org/10.1371/journal.pone.0158631			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27537327	Green Published, Green Submitted, gold			2022-12-27	WOS:000381577000005
J	Tominaga, K; Lee, A; Altenmuller, E; Miyazaki, F; Furuya, S				Tominaga, Kenta; Lee, Andre; Altenmueller, Eckart; Miyazaki, Fumio; Furuya, Shinichi			Kinematic Origins of Motor Inconsistency in Expert Pianists	PLOS ONE			English	Article							HUMAN FINGER MOVEMENTS; TASK-SPECIFIC TREMOR; INDEPENDENT CONTROL; COMMON INPUT; MUSICIANS; COORDINATION; ACQUISITION; PERFORMANCE; MODULATION	For top performers, including athletes and musicians, even subtle inconsistencies in rhythm and force during movement production decrease the quality of performance. However, extensive training over many years beginning in childhood is unable to perfect dexterous motor performance so that it is without any error. To gain insight into the biological mechanisms underlying the subtle defects of motor actions, the present study sought to identify the kinematic origins of inconsistency of dexterous finger movements in musical performance. Seven highly-skilled pianists who have won prizes at international piano competitions played a short sequence of tones with the right hand at a predetermined tempo. Time-varying joint angles of the fingers were recorded using a custom-made data glove, and the timing and velocity of the individual keystrokes were recorded from a digital piano. Both ridge and stepwise multiple regression analyses demonstrated an association of the inter-trial variability of the inter-keystroke interval (i.e., rhythmic inconsistency) with both the rotational velocity of joints of the finger used for a keystroke (i.e., striking finger) and the movement independence between the striking and non-striking fingers. This indicates a relationship between rhythmic inconsistency in musical performance and the dynamic features of movements in not only the striking finger but also the non-striking fingers. In contrast, the inter-trial variability of the key-descending velocity (i.e., loudness inconsistency) was associated mostly with the kinematic features of the striking finger at the moment of the keystroke. Furthermore, there was no correlation between the rhythmic and loudness inconsistencies. The results suggest distinct kinematic origins of inconsistencies in rhythm and loudness in expert musical performance.	[Tominaga, Kenta; Miyazaki, Fumio] Osaka Univ, Dept Engn Sci, 1-3 Machikaneyama, Toyonaka, Osaka 5608531, Japan; [Lee, Andre] Tech Univ Munich, Klinikum Rechts Isar, Neurol Klin & Poliklin, Munich, Germany; [Lee, Andre; Altenmueller, Eckart; Furuya, Shinichi] Hannover Univ Mus Drama & Media, Inst Mus Physiol & Musicians Med, Emmichpl 1, D-30175 Hannover, Germany; [Furuya, Shinichi] Sophia Univ, Mus Skill & Injury Ctr MuSIC, Tokyo, Japan	Osaka University; Technical University of Munich; University of Hamburg; University Medical Center Hamburg-Eppendorf; Sophia University	Furuya, S (corresponding author), Hannover Univ Mus Drama & Media, Inst Mus Physiol & Musicians Med, Emmichpl 1, D-30175 Hannover, Germany.; Furuya, S (corresponding author), Sophia Univ, Mus Skill & Injury Ctr MuSIC, Tokyo, Japan.	sfuruya@sophia.ac.jp	Altenmuller, Eckart/AAB-9948-2021	Furuya, Shinichi/0000-0003-1387-6645	YAMAHA music foundation	YAMAHA music foundation	The study was supported by YAMAHA music foundation to SF (http://www.yamaha-mf.or.jp/english/index.html). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The present study was partly supported by the YAMAHA Music Foundation.	Bella SD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020518; Brown RM, 2015, PROG BRAIN RES, V217, P57, DOI 10.1016/bs.pbr.2014.11.021; Faisal AA, 2008, NAT REV NEUROSCI, V9, P292, DOI 10.1038/nrn2258; Furuya S, 2008, NEUROSCIENCE, V156, P390, DOI 10.1016/j.neuroscience.2008.07.028; Furuya S, 2014, NEUROSCIENCE, V275, P444, DOI 10.1016/j.neuroscience.2014.06.031; Furuya S, 2013, NEUROSCIENCE, V247, P152, DOI 10.1016/j.neuroscience.2013.05.025; Furuya S, 2015, SCI REP-UK, V5, DOI 10.1038/srep13360; Furuya S, 2015, ANN NY ACAD SCI, V1337, P118, DOI 10.1111/nyas.12659; Furuya S, 2012, J NEUROPHYSIOL, V108, P2060, DOI 10.1152/jn.00378.2012; Furuya S, 2011, J NEUROPHYSIOL, V106, P2849, DOI 10.1152/jn.00378.2011; Furuya S, 2010, EXP BRAIN RES, V204, P223, DOI 10.1007/s00221-010-2307-2; Gentner R, 2009, J NEUROSCI METH, V178, P138, DOI 10.1016/j.jneumeth.2008.11.005; Goebl W, 2008, EXP BRAIN RES, V186, P471, DOI 10.1007/s00221-007-1252-1; Goebl W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0050901; Gordon AM, 1995, EXP BRAIN RES, V107, P281; Hager-Ross C, 2000, J NEUROSCI, V20, P8542, DOI 10.1523/JNEUROSCI.20-22-08542.2000; Hore J, 1996, J NEUROPHYSIOL, V75, P1013, DOI 10.1152/jn.1996.75.3.1013; Jabusch HC, 2009, HUM MOVEMENT SCI, V28, P74, DOI 10.1016/j.humov.2008.08.001; Konczak J, 2009, J MOTOR BEHAV, V41, P243, DOI 10.3200/JMBR.41.3.243-252; LACQUANITI F, 1992, J NEUROSCI, V12, P1750; Lang CE, 2004, J NEUROPHYSIOL, V92, P2802, DOI 10.1152/jn.00480.2004; Lee A, 2015, J NEURAL TRANSM, V122, P393, DOI 10.1007/s00702-014-1275-2; Lee A, 2013, MOVEMENT DISORD, V28, P1890, DOI 10.1002/mds.25569; Leijnse JNAL, 1997, J BIOMECH, V30, P659, DOI 10.1016/S0021-9290(97)00008-0; Osborne LC, 2005, NATURE, V437, P412, DOI 10.1038/nature03961; Repp BH, 1999, PERCEPT PSYCHOPHYS, V61, P529, DOI 10.3758/BF03211971; SCHIEBER MH, 1993, SCIENCE, V261, P489, DOI 10.1126/science.8332915; Schoonderwaldt E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106615; Sims SEG, 2015, J HAND SURG-AM, V40, P1996, DOI 10.1016/j.jhsa.2015.06.009; van Beers RJ, 2007, J NEUROSCI, V27, P8757, DOI 10.1523/JNEUROSCI.2311-07.2007; Van der Steen MCM, 2014, NEUROSCIENCE, V269, P290, DOI 10.1016/j.neuroscience.2014.03.058; van Duinen H, 2011, J PHYSIOL-LONDON, V589, P5583, DOI 10.1113/jphysiol.2011.217810; van Vugt FT, 2014, EXP BRAIN RES, V232, P3555, DOI 10.1007/s00221-014-4036-4; van Vugt FT, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00495; Venkadesan M, 2008, J NEUROSCI, V28, P1366, DOI 10.1523/JNEUROSCI.4993-07.2008; Verrel J, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00157; Verrel J, 2013, EXP BRAIN RES, V224, P323, DOI 10.1007/s00221-012-3314-2; WING AM, 1973, PERCEPT PSYCHOPHYS, V13, P455, DOI 10.3758/BF03205802; Winges SA, 2008, J NEUROPHYSIOL, V99, P1119, DOI 10.1152/jn.01059.2007; Winges SA, 2006, J NEUROPHYSIOL, V96, P1258, DOI 10.1152/jn.00327.2006; Zatsiorsky VM, 2000, EXP BRAIN RES, V131, P187, DOI 10.1007/s002219900261	41	8	8	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0161324	10.1371/journal.pone.0161324	http://dx.doi.org/10.1371/journal.pone.0161324			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27537686	gold, Green Submitted, Green Published			2022-12-27	WOS:000381577000088
J	Wang, DY; Chun, RKM; Liu, ML; Lee, RPK; Sun, Y; Zhang, T; Lam, C; Liu, Q; To, CH				Wang, Danyang; Chun, Rachel Ka Man; Liu, Manli; Lee, Roger Pak Kin; Sun, Yuan; Zhang, Ting; Lam, Chuen; Liu, Quan; To, Chi Ho			Optical Defocus Rapidly Changes Choroidal Thickness in Schoolchildren	PLOS ONE			English	Article							RANDOMIZED CLINICAL-TRIAL; KONG CHINESE SCHOOLCHILDREN; AXIAL LENGTH; MYOPIA PROGRESSION; COHERENCE TOMOGRAPHY; HYPEROPIC DEFOCUS; EYE GROWTH; CHILDREN; RECOVERY; CHICKS	The current study aimed to examine the short-term choroidal response to optical defocus in schoolchildren. Myopic schoolchildren aged 8-16 were randomly allocated to control group (CG), myopic defocus group (MDG) and hyperopic defocus group (HDG) (n = 17 per group). Children in MDG and HDG received additional +3D and -3D lenses, respectively, to their full corrections on the right eyes. Full correction was given to their left eyes, and on both eyes in the CG. Axial length (AXL) and subfoveal choroidal thickness (SFChT) were then measured by spectral domain optical coherence tomography. Children wore their group-specific correction for 2 hours after which any existing optical defocus was removed, and subjects wore full corrections for another 2 hours. Both the AXL and SFChT were recorded hourly for 4 hours. The mean refraction of all subjects was -3.41 +/- 0.37D (+/- SEM). SFChT thinned when exposed to hyperopic defocus for 2 hours but less thinning was observed in response to myopic defocus compared to the control group (p < 0.05, two-way ANOVA). Removal of optical defocus significantly decreased SFChT in the MDG and significantly increased SFChT in the HDG after 1 and 2 hours (mean percentage change at 2hour; control vs. hyperopic defocus vs. myopic defocus; -0.33 +/- 0.59% vs. 3.04 +/- 0.60% vs. -1.34 +/- 0.74%, p < 0.01). Our results showed short-term exposure to myopic defocus induced relative choroidal thickening while hyperopic defocus led to choroidal thinning in children. This rapid and reversible choroidal response may be an important clinical parameter in gauging retinal response to optical defocus in human myopia.	[Wang, Danyang; Liu, Manli; Sun, Yuan; Zhang, Ting; Liu, Quan; To, Chi Ho] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou, Guangdong, Peoples R China; [Wang, Danyang; Chun, Rachel Ka Man; Lee, Roger Pak Kin; Lam, Chuen; Liu, Quan; To, Chi Ho] Hong Kong Polytech Univ, Sch Optometry, Ctr Myopia Res, Lab Expt Optometry, Hong Kong, Hong Kong, Peoples R China; [Wang, Danyang] Sun Yat Sen Univ, Hainan Eye Hosp, Zhongshan Ophthalm Ctr, Haikou, Peoples R China	Sun Yat Sen University; Hong Kong Polytechnic University; Sun Yat Sen University	Liu, Q; To, CH (corresponding author), Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou, Guangdong, Peoples R China.; Liu, Q; To, CH (corresponding author), Hong Kong Polytech Univ, Sch Optometry, Ctr Myopia Res, Lab Expt Optometry, Hong Kong, Hong Kong, Peoples R China.	drliuquan@163.com; chi-ho.to@polyu.edu.hk	Lam, Chuen/AAI-4020-2021	Lam, Chuen/0000-0002-3511-5620; Chun, Rachel Ka Man/0000-0001-6978-0963; To, Chi-ho/0000-0002-1938-8397	Hong Kong Polytechnic University [GUA32, GYZ29]; Health and Medical Research Fund(HMRF, K-ZJHZ); Henry G Leong Professorship in Elderly Vision Health	Hong Kong Polytechnic University(Hong Kong Polytechnic University); Health and Medical Research Fund(HMRF, K-ZJHZ); Henry G Leong Professorship in Elderly Vision Health	The work was supported by The Hong Kong Polytechnic University (GUA32, GYZ29), Health and Medical Research Fund(HMRF, K-ZJHZ) and Henry G Leong Professorship in Elderly Vision Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chakraborty R, 2013, OPTOMETRY VISION SCI, V90, P1187, DOI 10.1097/OPX.0000000000000035; Chakraborty R, 2012, EXP EYE RES, V103, P47, DOI 10.1016/j.exer.2012.08.002; Cheng D, 2014, JAMA OPHTHALMOL, V132, P258, DOI 10.1001/jamaophthalmol.2013.7623; Chiang STH, 2015, OPHTHAL PHYSL OPT, V35, P405, DOI 10.1111/opo.12218; Cho P, 2012, INVEST OPHTH VIS SCI, V53, P7077, DOI 10.1167/iovs.12-10565; Dirani M, 2010, INVEST OPHTH VIS SCI, V51, P1348, DOI 10.1167/iovs.09-3587; Donovan L, 2012, OPTOMETRY VISION SCI, V89, P1196, DOI 10.1097/OPX.0b013e3182640996; Fitzgerald MEC, 2002, EXP EYE RES, V74, P561, DOI 10.1006/exer.2002.1142; Grajciar B, 2008, OPT EXPRESS, V16, P2405, DOI 10.1364/OE.16.002405; Guo YH, 2012, EYE, V26, P684, DOI 10.1038/eye.2012.9; Hammond DS, 2013, OPHTHAL PHYSL OPT, V33, P215, DOI 10.1111/opo.12056; Howlett MHC, 2009, VISION RES, V49, P219, DOI 10.1016/j.visres.2008.10.008; Hung LF, 2000, INVEST OPHTH VIS SCI, V41, P1259; Lam CSY, 2014, BRIT J OPHTHALMOL, V98, P40, DOI 10.1136/bjophthalmol-2013-303914; Lam CSY, 2012, OPHTHAL PHYSL OPT, V32, P17, DOI 10.1111/j.1475-1313.2011.00886.x; Liang H, 2004, INVEST OPHTH VIS SCI, V45, P2463, DOI 10.1167/iovs.03-1009; LOVASIK JV, 1986, AM J OPTOM PHYS OPT, V63, P787; McFadden SA, 2014, INVEST OPHTH VIS SCI, V55, P908, DOI 10.1167/iovs.13-11724; Mitchell P, 1999, OPHTHALMOLOGY, V106, P2010, DOI 10.1016/S0161-6420(99)90416-5; MUTTI DO, 1994, INVEST OPHTH VIS SCI, V35, P515; Mwanza JC, 2013, INT OPHTHALMOL, V33, P335, DOI 10.1007/s10792-012-9689-z; Nickla DL, 2010, PROG RETIN EYE RES, V29, P144, DOI 10.1016/j.preteyeres.2009.12.002; Pendrak K, 2000, EXP EYE RES, V70, P629, DOI 10.1006/exer.2000.0825; PIERRO L, 1992, RETINA-J RET VIT DIS, V12, P12, DOI 10.1097/00006982-199212010-00003; Rada JAS, 2007, INVEST OPHTH VIS SCI, V48, P2957, DOI 10.1167/iovs.06-1051; Read SA, 2015, INVEST OPHTH VIS SCI, V56, P3103, DOI 10.1167/iovs.15-16446; Read SA, 2013, INVEST OPHTH VIS SCI, V54, P3586, DOI 10.1167/iovs.13-11732; Read SA, 2010, INVEST OPHTH VIS SCI, V51, P6262, DOI 10.1167/iovs.10-5457; Sander BP, 2014, EXP EYE RES, V128, P181, DOI 10.1016/j.exer.2014.10.003; Saw SM, 2002, BRIT J OPHTHALMOL, V86, P1306, DOI 10.1136/bjo.86.11.1306; Tan CS, 2012, INVEST OPHTH VIS SCI, V53, P261, DOI 10.1167/iovs.11-8782; Tse DY, 2011, INVEST OPHTH VIS SCI, V52, P8056, DOI 10.1167/iovs.10-5207; WILDSOET C, 1995, VISION RES, V35, P1175, DOI 10.1016/0042-6989(94)00233-C; Woodman EC, 2012, VISION RES, V72, P34, DOI 10.1016/j.visres.2012.09.009; Woodman-Pieterse EC, 2015, INVEST OPHTH VIS SCI, V56, P6414, DOI 10.1167/iovs.15-17102; Yuvaci I, 2015, J OPHTHALMOL, V2015, DOI 10.1155/2015/981274; Zhu XY, 2005, INVEST OPHTH VIS SCI, V46, P2238, DOI 10.1167/iovs.04-0956	37	61	65	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0161535	10.1371/journal.pone.0161535	http://dx.doi.org/10.1371/journal.pone.0161535			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27537606	Green Published, Green Submitted, gold			2022-12-27	WOS:000381577000118
J	Katayama, K; Narimatsu, H				Katayama, Kayoko; Narimatsu, Hiroto			Prediction of Female Breast Cancer Incidence among the Aging Society in Kanagawa, Japan	PLOS ONE			English	Article							UNITED-KINGDOM PROJECTIONS; PASSIVE SMOKING; FUTURE BURDEN; RISK; POPULATION; COHORT; TRENDS; RATES	Owing to the increasing number of elderly "baby boomers" in Japan, the number of cancer patients is also expected to increase. Approximately 2 million baby boomers from nearby local areas are residing in metropolitan areas; hence, the geographical distribution of cancer patients will probably markedly change. We assessed the expected number of breast cancer (BC) patients in different regions (urban, outer city, town, rural) using estimates of the nation's population and Kanagawa Cancer Registry data. To estimate future BC incidence for each region, we multiplied the 2010 rate by the predicted female population for each region according to age group. The incidence cases of BC in those aged >= 65 years is expected to increase in all areas; in particular, compared to rates in 2010, the BC incidence in urban areas was predicted to increase by 82.6% in 2035 and 102.2% in 2040. Although the incidence in all BC cases in urban areas showed an increasing trend, until peaking in 2040 (increasing 31.2% from 2010), the number of BC patients would continue to decrease in other areas. The number of BC patients per capita BC specialist was 64.3 patients in 2010; this value would increase from 59.3 in 2010 to 77.7 in 2040 in urban areas, but would decrease in other areas. Our findings suggest that the number of elderly BC patients is expected to increase rapidly in urban areas and that the demand for BC treatment would increase in the elderly population in urban areas.	[Katayama, Kayoko; Narimatsu, Hiroto] Kanagawa Canc Ctr Res Inst, Canc Prevent & Control Div, Yokohama, Kanagawa, Japan	Kanagawa Prefectural Cancer Center	Narimatsu, H (corresponding author), Kanagawa Canc Ctr Res Inst, Canc Prevent & Control Div, Yokohama, Kanagawa, Japan.	hiroto-narimatsu@umin.org	片山, 佳代子/HGA-9604-2022; Narimatsu, Hiroto/ABC-9150-2021	Narimatsu, Hiroto/0000-0002-5302-5872; Narimatsu, Hiroto/0000-0002-0383-4911				[Anonymous], 2006, ANN REP INT MIGR JAP; [Anonymous], 2015, ANN REP KAN CANC REG, P114; [Anonymous], 2014, ANN REP AG SOC IMPL; [Anonymous], 2015, ANN REP AG SOC CURR; [Anonymous], 2007, SURV RES HOUS DANK J; [Anonymous], 2006, WHITE PAPER NATL CAP, P1; [Anonymous], 2015, CANC STAT JAP 2014; [Anonymous], 2013, WORLD POP PROSP 2012; ARMSTRONG BK, 1992, CANCER CAUSE CONTROL, V3, P569, DOI 10.1007/BF00052754; Bray F, 2006, NAT REV CANCER, V6, P63, DOI 10.1038/nrc1781; CLAYTON D, 1987, STAT MED, V6, P449, DOI 10.1002/sim.4780060405; Cooper RA, 2002, HEALTH AFFAIR, V21, P140, DOI 10.1377/hlthaff.21.1.140; Extermann Martine, 2004, Curr Treat Options Oncol, V5, P161, DOI 10.1007/s11864-004-0048-9; Ferlay J, GLOBOCAN 2012 V1 0; FIELD NA, 1992, INT J EPIDEMIOL, V21, P842, DOI 10.1093/ije/21.5.842; Foundation High Life Insutitute, RET SEN RES SER FY20; Hanaoka T, 2005, INT J CANCER, V114, P317, DOI 10.1002/ijc.20709; Hori M, 2015, JPN J CLIN ONCOL, V45, P884, DOI 10.1093/jjco/hyv088; Institute of Population Based Cancer Research, NORDPRED SOFTW PACK; Keyes KM, 2010, SOC SCI MED, V70, P1100, DOI 10.1016/j.socscimed.2009.12.018; Kohno K, 2014, J BLOOD MED, V5, P31, DOI 10.2147/JBM.S57944; Lin Y, 2008, J EPIDEMIOL, V18, P77, DOI 10.2188/jea.18.77; Matsuda A, 2014, JPN J CLIN ONCOL, V44, P388, DOI 10.1093/jjco/hyu003; Mistry M, 2011, BRIT J CANCER, V105, P1795, DOI 10.1038/bjc.2011.430; Moller B, 2005, EUR J CANCER PREV, V14, P117, DOI 10.1097/00008469-200504000-00007; Moller B, 2002, EUR J CANCER PREV, V11, pS1; Moller H, 2007, BRIT J CANCER, V96, P1484, DOI 10.1038/sj.bjc.6603746; Nagata C, 2006, JPN J CLIN ONCOL, V36, P387, DOI 10.1093/jjco/hyl031; National Institute of Population and Social Security Research, 2013, EST NAT POP TRENDS R; Olsen AH, 2008, BRIT J CANCER, V99, P1549, DOI 10.1038/sj.bjc.6604710; Ross JS, 2002, EINSTEIN Q, V19, P129; TANGO T, 1995, STAT MED, V14, P2323, DOI 10.1002/sim.4780142105; Virani S, 2014, CANCER EPIDEMIOL, V38, P235, DOI 10.1016/j.canep.2014.03.003; Wada K, 2014, ANN ONCOL, V25, P519, DOI 10.1093/annonc/mdt542	34	3	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2016	11	8							e0159913	10.1371/journal.pone.0159913	http://dx.doi.org/10.1371/journal.pone.0159913			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4YN	27532126	gold, Green Published, Green Submitted			2022-12-27	WOS:000381487600015
J	McIsaac, KE; MacDonald, SF; Chong, N; Moser, A; Moineddin, R; Colantonio, A; Nathens, A; Matheson, FI				McIsaac, Kathryn E.; MacDonald, Shanna Farrell; Chong, Nelson; Moser, Andrea; Moineddin, Rahim; Colantonio, Angela; Nathens, Avery; Matheson, Flora I.			Creating a Powerful Platform to Explore Health in a Correctional Population: A Record Linkage Study	PLOS ONE			English	Article							PRISONERS; CARE; DEPENDENCE; DISPARITIES; PREVALENCE; MORTALITY; OUTCOMES; ABUSE; BIAS; TOOL	We used record linkage to create a data repository of health information of persons who were federally incarcerated in Ontario and Canada. We obtained records from 56,867 adults who were federally incarcerated between January 1, 1998 and December 31, 2011 from the Correctional Service of Canada; 15,248 records belonged to individuals residing in Ontario, Canada. We linked these records to the Registered Persons Database (RPDB) which contained records from 18,116,996 individuals eligible for health care in Ontario. Out of 56,867 OMS records, 22,844 (40.2%) were linked to the RPDB. Looking only at those incarcerated in Ontario, 98%, (14 953 of 15248) records were linked to RPDB. Most records of persons in Ontario-based facilities were linked deterministically. Linkage rates were lower for women, minority groups, and substance users. In conclusion, record linkage enabled the creation of a valuable data repository: there are no electronic medical records for correctional populations in Canada, making it more difficult to profile their health.	[McIsaac, Kathryn E.; Moineddin, Rahim; Colantonio, Angela; Matheson, Flora I.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [McIsaac, Kathryn E.; Matheson, Flora I.] St Michaels Hosp, Ctr Urban Hlth Solut, Toronto, ON, Canada; [MacDonald, Shanna Farrell; Moser, Andrea] Correct Serv Canada, Ottawa, ON, Canada; [Chong, Nelson; Moineddin, Rahim; Colantonio, Angela; Nathens, Avery; Matheson, Flora I.] Sunnybrook Med Ctr, Inst Clin Evaluat Sci, Toronto, ON, Canada; [Moineddin, Rahim] Univ Toronto, Dept Family & Community Med, Toronto, ON, Canada; [Colantonio, Angela] Univ Toronto, Rehabil Sci Inst, Toronto, ON, Canada; [Colantonio, Angela] Univ Toronto, Dept Occupat Sci & Occupat Therapy, Toronto, ON, Canada; [Nathens, Avery] Univ Toronto, Dept Surg, Toronto, ON, Canada; [McIsaac, Kathryn E.] Nova Scotia Hlth Author, Res Serv, Halifax, NS, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University of Toronto; University of Toronto; University of Toronto	Matheson, FI (corresponding author), Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada.; Matheson, FI (corresponding author), St Michaels Hosp, Ctr Urban Hlth Solut, Toronto, ON, Canada.; Matheson, FI (corresponding author), Sunnybrook Med Ctr, Inst Clin Evaluat Sci, Toronto, ON, Canada.	mathesonf@smh.ca		Colantonio, Angela/0000-0003-2094-4765	Institute for Clinical Evaluative Sciences (ICES) - Ontario Ministry of Health and Long-Term Care (MOHLTC); Dalla Lana School of Public Health at the University of Toronto; Social Sciences and Humanities Research Council Partnership Grant [890-2011-0027]; Research Chair in Gender, Work and Health from the Canadian Institutes of Health Research Institute of Gender and Health [CGW-126-580]	Institute for Clinical Evaluative Sciences (ICES) - Ontario Ministry of Health and Long-Term Care (MOHLTC)(Ministry of Health and Long-Term Care, Ontario); Dalla Lana School of Public Health at the University of Toronto; Social Sciences and Humanities Research Council Partnership Grant; Research Chair in Gender, Work and Health from the Canadian Institutes of Health Research Institute of Gender and Health(Canadian Institutes of Health Research (CIHR))	This study was supported by the Institute for Clinical Evaluative Sciences (ICES), which is funded by an annual grant from the Ontario Ministry of Health and Long-Term Care (MOHLTC) and also supported by the Dalla Lana School of Public Health at the University of Toronto. This research is also supported by a Social Sciences and Humanities Research Council Partnership Grant (#890-2011-0027). Dr. McIsaac is a Canadian Institutes of Health Research Strategic Training Fellow in the ACHIEVE Research Partnership: Action for Health Equity Interventions (#96566). Dr. Colantonio received support through a Research Chair in Gender, Work and Health from the Canadian Institutes of Health Research Institute of Gender and Health (#CGW-126-580). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The Centre for Urban Health Solutions is part of the Li Ka Shing Knowledge Institute of ST. Michael's Hospital. This study was supported by the Institute for Clinical Evaluative Sciences (ICES), which is funded by an annual grant from the Ontario Ministry of Health and Long-Term Care (MOHLTC) and also supported by the Dalla Lana School of Public Health at the University of Toronto. The opinions, results and conclusions reported in this paper are those of the authors and are independent from the funding sources. No endorsement by ICES or the Ontario MOHLTC is intended or should be inferred. Parts of this material are based on data and information compiled and provided by CIHI. However, the analyses, conclusions, opinions and statements expressed herein are those of the author, and not necessarily those of CIHI.	Ahalt C, 2013, J AM GERIATR SOC, V61, P2013, DOI 10.1111/jgs.12510; Ahalt C, 2012, J GEN INTERN MED, V27, P160, DOI 10.1007/s11606-011-1858-7; ANDREWS DA, 1990, CRIM JUSTICE BEHAV, V17, P19, DOI 10.1177/0093854890017001004; Baussano I, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000381; Binswanger IA, 2012, J URBAN HEALTH, V89, P98, DOI 10.1007/s11524-011-9614-1; Bohensky MA, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-346; Bonta J., 2007, REHABILITATION; Correctional Services Program, 2015, AD CORR STAT CAN 201; Draper GK, 2009, AUST NZ J PUBL HEAL, V33, P325, DOI 10.1111/j.1753-6405.2009.00403.x; Fazel S, 2006, ADDICTION, V101, P181, DOI 10.1111/j.1360-0443.2006.01316.x; Fazel S, 2002, LANCET, V359, P545, DOI 10.1016/S0140-6736(02)07740-1; Harron K, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-36; Harry B, 1986, J FORENSIC SCIENCES, V31, P8; Hawton K, 2014, LANCET, V383, P1147, DOI 10.1016/S0140-6736(13)62118-2; HODGINS DC, 1989, INT J OFFENDER THER, V33, P59, DOI 10.1177/0306624X8903300107; Iron K, 2008, LIVING DYING ONTARIO; JARO MA, 1995, STAT MED, V14, P491, DOI 10.1002/sim.4780140510; Jutte DP, 2011, ANNU REV PUBL HEALTH, V32, P91, DOI 10.1146/annurev-publhealth-031210-100700; Kinner SA, 2013, ADDICTION, V108, P38, DOI 10.1111/add.12010; Kinner SA, 2012, DRUG ALCOHOL DEPEN, V126, P156, DOI 10.1016/j.drugalcdep.2012.05.008; Kouyoumdjian FG, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1758-6; Kunic D., 2006, COMPUTERIZED ASSESSM; Larney S, 2011, EVALUATION REV, V35, P118, DOI 10.1177/0193841X11401695; Li B, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-48; Martin RE, 2005, BRIT MED J, V331, P335, DOI 10.1136/bmj.331.7512.335; Merrall ELC, 2010, ADDICTION, V105, P1545, DOI 10.1111/j.1360-0443.2010.02990.x; Motiuk L. L., 1997, FORUM CORRECTIONS RE, V9, P18; O'Reilly D, 2008, J CLIN EPIDEMIOL, V61, P380, DOI 10.1016/j.jclinepi.2007.05.012; Schmidlin K, 2013, BMC MED INFORM DECIS, V13, DOI 10.1186/1472-6947-13-1; SELZER ML, 1971, AM J PSYCHIAT, V127, P1653, DOI 10.1176/ajp.127.12.1653; SKINNER HA, 1982, ADDICT BEHAV, V7, P363, DOI 10.1016/0306-4603(82)90005-3; SKINNER HA, 1982, J ABNORM PSYCHOL, V91, P199, DOI 10.1037/0021-843X.91.3.199; Spaulding AC, 2009, PLOS ONE, V4, pA16, DOI 10.1371/journal.pone.0007558; Wang EA, 2011, JAMA-J AM MED ASSOC, V305, P1708, DOI 10.1001/jama.2011.532; Wilper AP, 2009, AM J PUBLIC HEALTH, V99, P666, DOI 10.2105/AJPH.2008.144279; Zlodre Jakov, 2012, Am J Public Health, V102, pe67, DOI 10.2105/AJPH.2012.300764	36	6	6	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2016	11	8							e0161173	10.1371/journal.pone.0161173	http://dx.doi.org/10.1371/journal.pone.0161173			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DT4YN	27532612	gold, Green Published, Green Submitted			2022-12-27	WOS:000381487600070
J	Pinto, P; Peixoto, A; Santos, C; Rocha, P; Pinto, C; Pinheiro, M; Leca, L; Martins, AT; Ferreira, V; Bartosch, C; Teixeira, MR				Pinto, Pedro; Peixoto, Ana; Santos, Catarina; Rocha, Patricia; Pinto, Carla; Pinheiro, Manuela; Leca, Luis; Martins, Ana Teresa; Ferreira, Veronica; Bartosch, Carla; Teixeira, Manuel R.			Analysis of Founder Mutations in Rare Tumors Associated With Hereditary Breast/Ovarian Cancer Reveals a Novel Association of BRCA2 Mutations with Ampulla of Vater Carcinomas	PLOS ONE			English	Article							BREAST-CANCER; PANCREATIC ADENOCARCINOMA; INHERITED PREDISPOSITION; GERMLINE MUTATIONS; PROSTATE-CANCER; GENE-MUTATIONS; OVARIAN-CANCER; FAMILIES; FREQUENCY; REPAIR	BRCA1 and BRCA2 mutations are responsible for hereditary breast and ovarian cancer, but they also confer an increased risk for the development of rarer cancers associated with this syndrome, namely, cancer of the pancreas, male breast, peritoneum, and fallopian tube. The objective of this work was to quantify the contribution of the founder mutations BRCA2 c.156_157insAlu and BRCA1 c.3331_3334del for cancer etiology in unselected hospital-based cohorts of Portuguese patients diagnosed with these rarer cancers, by using a strategy that included testing of archival tumor tissue. A total of 102 male breast, 68 pancreatic and 33 peritoneal/fallopian tube carcinoma cases were included in the study. The BRCA2 c.156_157insAlu mutation was observed with a frequency of 7.8% in male breast cancers, 3.0% in peritoneal/fallopian tube cancers, and 1.6% in pancreatic cancers, with estimated total contributions of germline BRCA2 mutations of 14.3%, 5.5%, and 2.8%, respectively. No carriers of the BRCA1 c.3331_3334del mutation were identified. During our study, a patient with an ampulla of Vater carcinoma was incidentally found to carry the BRCA2 c.156_157insAlu mutation, so we decided to test a consecutive series of additional 15 ampullary carcinomas for BRCA1/BRCA2 mutations using a combination of direct founder mutation testing and full gene analysis with next generation sequencing. BRCA2 mutations were observed with a frequency of 14.3% in ampulla of Vater carcinomas. In conclusion, taking into account the implications for both the individuals and their family members, we recommend that patients with these neoplasias should be offered BRCA1/BRCA2 genetic testing and we here show that it is feasible to test for founder mutations in archival tumor tissue. Furthermore, we identified for the first time a high frequency of germline BRCA2 mutations in ampullary cancers.	[Pinto, Pedro; Peixoto, Ana; Santos, Catarina; Rocha, Patricia; Pinto, Carla; Pinheiro, Manuela; Teixeira, Manuel R.] Portuguese Oncol Inst Porto IPO Porto, Dept Genet, Porto, Portugal; [Leca, Luis; Martins, Ana Teresa; Ferreira, Veronica; Bartosch, Carla] Portuguese Oncol Inst Porto IPO Porto, Dept Pathol, Porto, Portugal; [Teixeira, Manuel R.] Univ Porto, Inst Biomed Sci Abel Salazar ICBAS, Porto, Portugal	Portuguese Institute of Oncology; Portuguese Institute of Oncology; Universidade do Porto	Teixeira, MR (corresponding author), Portuguese Oncol Inst Porto IPO Porto, Dept Genet, Porto, Portugal.; Teixeira, MR (corresponding author), Univ Porto, Inst Biomed Sci Abel Salazar ICBAS, Porto, Portugal.	manuel.teixeira@ipoporto.min-saude.pt	Pinheiro, Manuela/AAG-2543-2021; Teixeira, Manuel António Rodrigues/E-4885-2011; Teixeira, Manuel AC/AAZ-7251-2020; Pinheiro, Manuela/AAV-4114-2020	Teixeira, Manuel António Rodrigues/0000-0002-4896-5982; Teixeira, Manuel AC/0000-0002-1959-0624; Pinheiro, Manuela/0000-0001-8228-3435; Bartosch, Carla/0000-0003-0646-7667; Pinto, Carla/0000-0001-8689-3388; Santos, Catarina/0000-0002-9102-757X; Peixoto, Ana/0000-0002-1404-5897; Rocha, Patricia/0000-0001-6275-026X; Pinto, Pedro/0000-0001-6289-5792	Fundacao para a Ciencia e a Tecnologia [SFRH/BD/73719/2010]	Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission)	PP was awarded a PhD grant (SFRH/BD/73719/2010) by the Fundacao para a Ciencia e a Tecnologia (http://www.fct.pt/). PP and MP are research fellows of the Nucleo Regional do Norte da Liga Portuguesa Contra o Cancro (http://www.ligacontracancro.pt/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aburjania Nana, 2014, J Gastrointest Cancer, V45, P87, DOI 10.1007/s12029-013-9479-5; Albores-Saavedra J, 2009, J SURG ONCOL, V100, P598, DOI 10.1002/jso.21374; Alsop K, 2012, J CLIN ONCOL, V30, P2654, DOI 10.1200/JCO.2011.39.8545; Ashworth A, 2008, J CLIN ONCOL, V26, P3785, DOI 10.1200/JCO.2008.16.0812; Besic N, 2008, GENET TEST, V12, P203, DOI 10.1089/gte.2007.0071; Bjork J, 2001, GASTROENTEROLOGY, V121, P1127, DOI 10.1053/gast.2001.28707; Bryant HE, 2005, NATURE, V434, P913, DOI 10.1038/nature03443; Chodick G, 2008, EUR J MED GENET, V51, P141, DOI 10.1016/j.ejmg.2007.11.001; Ding YC, 2011, BREAST CANCER RES TR, V126, P771, DOI 10.1007/s10549-010-1195-2; Durocher F, 1996, J MED GENET, V33, P814, DOI 10.1136/jmg.33.10.814; Evans DGR, 2010, J MED GENET, V47, P710, DOI 10.1136/jmg.2009.075176; Ferla R, 2007, ANN ONCOL, V18, P93, DOI 10.1093/annonc/mdm234; Hahn SA, 2003, JNCI-J NATL CANCER I, V95, P214, DOI 10.1093/jnci/95.3.214; Holter S, 2015, J CLIN ONCOL, V33, P3124, DOI 10.1200/JCO.2014.59.7401; Lal G, 2000, CANCER RES, V60, P409; Ledermann J, 2014, LANCET ONCOL, V15, P852, DOI 10.1016/S1470-2045(14)70228-1; Machado PM, 2007, J CLIN ONCOL, V25, P2027, DOI 10.1200/JCO.2006.06.9443; Maia S, 2016, FAM CANCER, V15, P111, DOI 10.1007/s10689-015-9832-x; Mateo J, 2015, NEW ENGL J MED, V373, P1697, DOI 10.1056/NEJMoa1506859; Mavaddat N, 2013, JNCI-J NATL CANCER I, V105, P812, DOI 10.1093/jnci/djt095; Mersch J, 2015, CANCER-AM CANCER SOC, V121, P269, DOI 10.1002/cncr.29041; Moreira MAM, 2012, FAM CANCER, V11, P657, DOI 10.1007/s10689-012-9551-5; Murphy KM, 2002, CANCER RES, V62, P3789; Narod SA, 2004, NAT REV CANCER, V4, P665, DOI 10.1038/nrc1431; National Comprehensive Cancer Network, 2015, GENETIC FAMILIAL HIG; Ottini L, 2009, BREAST CANCER RES TR, V116, P577, DOI 10.1007/s10549-008-0194-z; Peixoto A, 2015, CLIN GENET, V88, P41, DOI 10.1111/cge.12441; Peixoto A, 2011, BREAST CANCER RES TR, V127, P671, DOI 10.1007/s10549-010-1036-3; Peixoto A, 2009, BREAST CANCER RES TR, V114, P31, DOI 10.1007/s10549-008-9978-4; Blesa JR, 2000, HUM MUTAT, V15, P381, DOI 10.1002/(SICI)1098-1004(200004)15:4<381::AID-HUMU14>3.0.CO;2-H; Robson M, 2007, NEW ENGL J MED, V357, P154, DOI 10.1056/NEJMcp071286; Stadler ZK, 2012, CANCER-AM CANCER SOC, V118, P493, DOI 10.1002/cncr.26191; Teugels E, 2005, HUM MUTAT, V26, DOI 10.1002/humu.9366; Thorlacius S, 1997, AM J HUM GENET, V60, P1079; Torres D, 2007, BREAST CANCER RES TR, V103, P225, DOI 10.1007/s10549-006-9370-1; Vicus D, 2010, GYNECOL ONCOL, V118, P299, DOI 10.1016/j.ygyno.2010.05.011; Walsh T, 2011, P NATL ACAD SCI USA, V108, P18032, DOI 10.1073/pnas.1115052108	37	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2016	11	8							e0161438	10.1371/journal.pone.0161438	http://dx.doi.org/10.1371/journal.pone.0161438			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4YN	27532258	gold, Green Published, Green Submitted			2022-12-27	WOS:000381487600095
J	Tjiurutue, MC; Palmer-Young, EC; Adler, LS				Tjiurutue, Muvari Connie; Palmer-Young, Evan C.; Adler, Lynn S.			Parasite Removal, but Not Herbivory, Deters Future Parasite Attachment on Tomato	PLOS ONE			English	Article							HOST-PLANT GENOTYPE; HEMIPARASITIC PLANT; INSECT HERBIVORES; LYCOPERSICON-ESCULENTUM; DEFENSE; POLLINATION; COMMUNITIES; MECHANISMS; RESISTANCE; RESPONSES	Plants face many antagonistic interactions that occur sequentially. Often, plants employ defense strategies in response to the initial damage that are highly specific and can affect interactions with subsequent antagonists. In addition to herbivores and pathogens, plants face attacks by parasitic plants, but we know little about how prior herbivory compared to prior parasite attachment affects subsequent host interactions. If host plants can respond adaptively to these different damage types, we predict that prior parasitism would have a greater deterrent effect on subsequent parasites than would prior herbivory. To test the effects of prior parasitism and prior herbivory on subsequent parasitic dodder (Cuscuta spp.) preference, we conducted two separate greenhouse studies with tomato hosts (Solanum lycopersicum). In the first experiment, we tested the effects of previous dodder attachment on subsequent dodder preference on tomato hosts using three treatments: control plants that had no previous dodder attachment; dodder-removed plants that had an initial dodder seedling attached, removed and left in the same pot to simulate parasite death; and dodder-continuous plants with an initial dodder seedling that remained attached. In the second experiment, we tested the effects of previous caterpillar damage (Spodoptera exigua) and mechanical damage on future dodder attachment on tomato hosts. Dodder attached most slowly to tomato hosts that had dodder plants previously attached and then removed, compared to control plants or plants with continuous dodder attachment. In contrast, herbivory did not affect subsequent dodder attachment rate. These results indicate that dodder preference depended on the identity and the outcome of the initial attack, suggesting that early-season interactions have the potential for profound impacts on subsequent community dynamics.	[Tjiurutue, Muvari Connie; Palmer-Young, Evan C.; Adler, Lynn S.] Univ Massachusetts, Dept Biol, Morrill Sci Ctr South 221, 611 North Pleasant St, Amherst, MA 01003 USA; [Tjiurutue, Muvari Connie] Univ Namibia, Dept Chem & Biochem, Windhoek, Namibia	University of Massachusetts System; University of Massachusetts Amherst; University of Namibia	Tjiurutue, MC (corresponding author), Univ Massachusetts, Dept Biol, Morrill Sci Ctr South 221, 611 North Pleasant St, Amherst, MA 01003 USA.; Tjiurutue, MC (corresponding author), Univ Namibia, Dept Chem & Biochem, Windhoek, Namibia.	connie.muv@gmail.com	Palmer-Young, Evan/AFL-1225-2022	Palmer-Young, Evan/0000-0002-9258-2073	Fulbright Fellowship [15101429]; Schlumberger Faculty for the Future Fellowship; Plant Biology Graduate program; USDA NIFA predoctoral fellowship [2016-67011-24698]; USDA/CSREES (Hatch) [MAS000411]; USDA [NRI 2008-02346]	Fulbright Fellowship; Schlumberger Faculty for the Future Fellowship(Schlumberger); Plant Biology Graduate program; USDA NIFA predoctoral fellowship; USDA/CSREES (Hatch)(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); USDA(United States Department of Agriculture (USDA))	This work is supported by: MCT: Fulbright Fellowship (15101429), Schlumberger Faculty for the Future Fellowship and the Plant Biology Graduate program; EPY: USDA NIFA predoctoral fellowship, Award number 2016-67011-24698; LSA: USDA/CSREES (Hatch) MAS000411 and USDA NRI 2008-02346. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler LS, 2000, AM NAT, V156, P92, DOI 10.1086/303374; Agrawal AA, 2011, FUNCT ECOL, V25, P420, DOI 10.1111/j.1365-2435.2010.01796.x; Ali JG, 2012, TRENDS PLANT SCI, V17, P293, DOI 10.1016/j.tplants.2012.02.006; [Anonymous], 2014, A LANGUAGE AND ENVIR; BELL RA, 1976, ANN ENTOMOL SOC AM, V69, P365, DOI 10.1093/aesa/69.2.365; Cronin JT, 1999, OECOLOGIA, V121, P392, DOI 10.1007/s004420050944; Dawson JH, 1984, WEED SCI, V6, P265; De Moraes CM, 1998, NATURE, V393, P570, DOI 10.1038/31219; Dicke M, 2010, TRENDS PLANT SCI, V15, P167, DOI 10.1016/j.tplants.2009.12.002; Ghantous KM, 2012, WEED TECHNOL, V26, P485, DOI 10.1614/WT-D-11-00077.1; Ghantous KM, 2012, PROC NORTHEAST WEED; Glazebrook J, 2005, ANNU REV PHYTOPATHOL, V43, P205, DOI 10.1146/annurev.phyto.43.040204.135923; Goldwasser Y, 2001, WEED SCI, V49, P520, DOI 10.1614/0043-1745(2001)049[0520:TOTVTL]2.0.CO;2; Hartley SE, 2015, ECOLOGY, V96, P2408, DOI 10.1890/14-1244.1; Hopkins RJ, 1998, J CHEM ECOL, V24, P2003, DOI 10.1023/A:1020729524818; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; IHL B, 1988, FLORA, V181, P383; Irving LJ, ADVANCES IN BOTANICA, V50, P87; Johnson MTJ, 2007, OIKOS, V116, P941, DOI 10.1111/j.0030-1299.2007.15773.x; Kahl J, 2000, PLANTA, V210, P336, DOI 10.1007/PL00008142; Kant MR, 2015, ANN BOT-LONDON, V115, P1015, DOI 10.1093/aob/mcv054; KARBAN R, 1997, INDUCED RESPONSES TO; Korth KL, 1997, PLANT PHYSIOL, V115, P1299, DOI 10.1104/pp.115.4.1299; Matthies D, 1996, OIKOS, V75, P118, DOI 10.2307/3546328; McCall AC, 2006, ECOL LETT, V9, P1351, DOI 10.1111/j.1461-0248.2006.00975.x; Moraes MCB, 2005, ENTOMOL EXP APPL, V115, P227, DOI 10.1111/j.1570-7458.2005.00290.x; Morandin LA, 2001, J ECON ENTOMOL, V94, P172, DOI 10.1603/0022-0493-94.1.172; Niemela M, 2008, BASIC APPL ECOL, V9, P117, DOI 10.1016/j.baae.2007.01.001; Pennings SC, 1996, ECOLOGY, V77, P1410, DOI 10.2307/2265538; Pennings SC, 2002, OECOLOGIA, V131, P479, DOI 10.1007/s00442-002-0923-7; Press M.C., 1995, PARASITIC PLANTS; Press MC, 2005, NEW PHYTOL, V166, P737, DOI 10.1111/j.1469-8137.2005.01358.x; Prider JN, 2011, AUSTRAL ECOL, V36, P167, DOI 10.1111/j.1442-9993.2010.02132.x; Puustinen S, 1999, CAN J BOT, V77, P523, DOI 10.1139/cjb-77-4-523; Runyon JB, 2008, PLANT PHYSIOL, V146, P987, DOI 10.1104/pp.107.112219; Runyon JB, 2006, SCIENCE, V313, P1964, DOI 10.1126/science.1131371; Runyon JB, 2010, PLANT CELL ENVIRON, V33, P290, DOI 10.1111/j.1365-3040.2009.02082.x; Runyon JB, 2009, SUSTAIN AGR REV, V1, P123, DOI 10.1007/978-1-4020-9654-9_8; Sandler Hilary A., 2010, Sustainability, V2, P660, DOI 10.3390/su2020660; Sandler HA, 2008, CRANBERRY PRODUCTION, P11; Schadler M, 2010, ENTOMOL EXP APPL, V135, P162, DOI 10.1111/j.1570-7458.2010.00976.x; Schwartzberg EG, 2014, FUNCT ECOL, V28, P386, DOI 10.1111/1365-2435.12182; Schwartzberg EG, 2011, J CHEM ECOL, V37, P1055, DOI 10.1007/s10886-011-0006-5; Siemens DH, 1996, ENVIRON ENTOMOL, V25, P1344, DOI 10.1093/ee/25.6.1344; Stam JM, 2014, ANNU REV PLANT BIOL, V65, P689, DOI 10.1146/annurev-arplant-050213-035937; Sui XL, 2015, J PLANT RES, V128, P563, DOI 10.1007/s10265-015-0727-6; Tedeschi P, 2011, J FOOD COMPOS ANAL, V24, P131, DOI 10.1016/j.jfca.2010.06.008; Thaler JS, 2012, TRENDS PLANT SCI, V17, P260, DOI 10.1016/j.tplants.2012.02.010; Thaler JS, 2010, ECOLOGY, V91, P1075, DOI 10.1890/08-2347.1; Thaler JS, 1996, J CHEM ECOL, V22, P1767, DOI 10.1007/BF02028503; Thaler JS, 2001, ECOL ENTOMOL, V26, P312, DOI 10.1046/j.1365-2311.2001.00324.x; Therneau T.M., 2015, R PACKAGE COXME MIXE; Tjiurutue MC, 2016, J CHEM ECOL, V42, P95, DOI 10.1007/s10886-016-0671-5; Uesugi A, 2013, OECOLOGIA, V173, P1387, DOI 10.1007/s00442-013-2717-5; Underwood N, 2009, J ANIM ECOL, V78, P839, DOI 10.1111/j.1365-2656.2009.01540.x; Van Zandt PA, 2004, OIKOS, V104, P401, DOI 10.1111/j.0030-1299.2004.12964.x	56	0	0	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2016	11	8							e0161076	10.1371/journal.pone.0161076	http://dx.doi.org/10.1371/journal.pone.0161076			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4UN	27529694	gold, Green Submitted, Green Published			2022-12-27	WOS:000381476700044
J	Bednarski, C; Tomczak, K; vom Hoevel, B; Weber, WM; Cathomen, T				Bednarski, Christien; Tomczak, Katja; vom Hoevel, Beate; Weber, Wolf-Michael; Cathomen, Toni			Targeted Integration of a Super-Exon into the CFTR Locus Leads to Functional Correction of a Cystic Fibrosis Cell Line Model	PLOS ONE			English	Article							ZINC-FINGER NUCLEASES; CONDUCTANCE REGULATOR GENE; EXPRESSION; IDENTIFICATION; COMBINATION; GENERATION; DELTA-F508; MUTATIONS; TRANSPORT; DISEASE	In vitro disease models have enabled insights into the pathophysiology of human disease as well as the functional evaluation of new therapies, such as novel genome engineering strategies. In the context of cystic fibrosis (CF), various cellular disease models have been established in recent years, including organoids based on induced pluripotent stem cell technology that allowed for functional readouts of CFTR activity. Yet, many of these in vitro CF models require complex and expensive culturing protocols that are difficult to implement and may not be amenable for high throughput screens. Here, we show that a simple cellular CF disease model based on the bronchial epithelial Delta F508 cell line CFBE41o-can be used to validate functional CFTR correction. We used an engineered nuclease to target the integration of a super-exon, encompassing the sequences of CFTR exons 11 to 27, into exon 11 and re-activated endogenous CFTR expression by treating CFBE41o-cells with a demethylating agent. We demonstrate that the integration of this super-exon resulted in expression of a corrected mRNA from the endogenous CFTR promoter and used short-circuit current measurements in Ussing chambers to corroborate restored ion transport of the repaired CFTR channels. In conclusion, this study proves that the targeted integration of a large super-exon in CFTR exon 11 leads to functional correction of CFTR, suggesting that this strategy can be used to functionally correct all CFTR mutations located downstream of the 5' end of exon 11.	[Bednarski, Christien; vom Hoevel, Beate; Cathomen, Toni] Univ Freiburg, Med Ctr, Inst Cell & Gene Therapy, Freiburg, Germany; [Bednarski, Christien; vom Hoevel, Beate; Cathomen, Toni] Univ Freiburg, Med Ctr, Ctr Chron Immunodeficiency, Freiburg, Germany; [Tomczak, Katja; Weber, Wolf-Michael] Univ Munster, Inst Anim Physiol, Munster, Germany; [Cathomen, Toni] Univ Freiburg, Fac Med, Freiburg, Germany	University of Freiburg; University of Freiburg; University of Munster; University of Freiburg	Cathomen, T (corresponding author), Univ Freiburg, Med Ctr, Inst Cell & Gene Therapy, Freiburg, Germany.; Cathomen, T (corresponding author), Univ Freiburg, Med Ctr, Ctr Chron Immunodeficiency, Freiburg, Germany.; Cathomen, T (corresponding author), Univ Freiburg, Fac Med, Freiburg, Germany.	toni.cathomen@uniklinik-freiburg.de	Cathomen, Toni/ABG-8410-2021; Cathomen, Toni/GZL-2702-2022	Cathomen, Toni/0000-0002-7757-4630; Cathomen, Toni/0000-0002-7757-4630	Bundesministerium fur Bildung und Forschung [BMBF-01EO0803, GALENUS-01GM1106F]; Mukoviszidose Institut GmbH [S03/11]	Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Mukoviszidose Institut GmbH	This study was supported by Bundesministerium fur Bildung und Forschung, (BMBF-01EO0803 and GALENUS-01GM1106F to TC), http://www.bmbf.de/; and Mukoviszidose Institut GmbH (S03/11 to TC), https://muko.info/mukoviszidose-institut/mukoviszidose-institut.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alton EWFW, 2015, LANCET RESP MED, V3, P684, DOI 10.1016/S2213-2600(15)00245-3; Alton EWFW, 2013, THORAX; Amaral MD, 2013, CURR PHARM DESIGN, V19, P3497; Bartoszewski R, 2008, AM J RESP CELL MOL, V39, P448, DOI 10.1165/rcmb.2008-0065OC; BEAR CE, 1992, CELL, V68, P809, DOI 10.1016/0092-8674(92)90155-6; Bobadilla JL, 2002, HUM MUTAT, V19, P575, DOI 10.1002/humu.10041; Botelho HM, 2015, SCI REP-UK, V5, DOI 10.1038/srep09038; CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8; CHU CS, 1993, NAT GENET, V3, P151, DOI 10.1038/ng0293-151; Cormet-Boyaka E, 2009, FASEB J, V23, P3743, DOI 10.1096/fj.08-127878; Cystic Fibrosis Genetic Anal Consortium, 1990, AM J HUM GENET, V47, P354; Dekkers JF, 2013, NAT MED, V19, P939, DOI 10.1038/nm.3201; Dreyer AK, 2015, BIOMATERIALS, V69, P191, DOI 10.1016/j.biomaterials.2015.07.057; Ehrhardt C, 2006, CELL TISSUE RES, V323, P405, DOI 10.1007/s00441-005-0062-7; Gellhaus K, 2010, HUM GENE THER, V21, P543, DOI 10.1089/hum.2009.167; Gosalia N, 2015, GENES-BASEL, V6, P543, DOI 10.3390/genes6030543; Gruenert D C, 2004, J Cyst Fibros, V3 Suppl 2, P191, DOI 10.1016/j.jcf.2004.05.040; Heda GD, 2000, BIOCHEM BIOPH RES CO, V271, P659, DOI 10.1006/bbrc.2000.2684; Hockemeyer D, 2011, NAT BIOTECHNOL, V29, P731, DOI 10.1038/nbt.1927; Holt N, 2010, NAT BIOTECHNOL, V28, P839, DOI 10.1038/nbt.1663; Iiizumi S, 2008, NUCLEIC ACIDS RES, V36, P6333, DOI 10.1093/nar/gkn649; Kass EM, 2010, FEBS LETT, V584, P3703, DOI 10.1016/j.febslet.2010.07.057; Kerbiriou M, 2007, BBA-MOL BASIS DIS, V1772, P1236, DOI 10.1016/j.bbadis.2007.10.004; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; Kleinstiver BP, 2016, NATURE, V529, P490, DOI 10.1038/nature16526; Landry JJM, 2013, G3-GENES GENOM GENET, V3, P1213, DOI 10.1534/g3.113.005777; Lee CM, 2016, MOL THER, V24, P645, DOI 10.1038/mt.2016.8; Lee CM, 2012, BIORESEARCH OPEN ACC, V1, P99, DOI 10.1089/biores.2012.0218; Li HJ, 2011, NATURE, V475, P217, DOI 10.1038/nature10177; Maeder ML, 2008, MOL CELL, V31, P294, DOI 10.1016/j.molcel.2008.06.016; Maier DA, 2013, HUM GENE THER, V24, P245, DOI 10.1089/hum.2012.172; Molinski S, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00160; Muller M, 2016, MOL THER, V24, P636, DOI 10.1038/mt.2015.218; Mussolino C, 2014, NUCL ACIDS RES; Mussolino C, 2014, NUCLEIC ACIDS RES, V42, P6762, DOI 10.1093/nar/gku305; Mussolino C, 2011, NUCLEIC ACIDS RES, V39, P9283, DOI 10.1093/nar/gkr597; Ott CJ, 2009, P NATL ACAD SCI USA, V106, P19934, DOI 10.1073/pnas.0900946106; Pattanayak V, 2011, NAT METHODS, V8, P765, DOI 10.1038/nmeth.1670; Rahman SH, 2013, HUM GENE THER, V24, P67, DOI 10.1089/hum.2012.168; Ramalingam S, 2013, STEM CELLS DEV, V22, P595, DOI 10.1089/scd.2012.0245; Randell SH, 2011, METHODS MOL BIOL, V742, P285, DOI 10.1007/978-1-61779-120-8_18; RICH DP, 1990, NATURE, V347, P358, DOI 10.1038/347358a0; Riordan JR, 1989, SCIENCE, P245; Robert R, 2010, MOL PHARMACOL, V77, P922, DOI 10.1124/mol.109.062679; ROMMENS JM, 1989, SCIENCE, V245, P1059, DOI 10.1126/science.2772657; Schwank G, 2013, CELL STEM CELL, V13, P653, DOI 10.1016/j.stem.2013.11.002; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227; Sollu C, 2010, NUCLEIC ACIDS RES, V38, P8269, DOI 10.1093/nar/gkq720; Sosnay PR, 2013, NAT GENET, V45, P1160, DOI 10.1038/ng.2745; Suzuki S, 2016, MOL THER-NUCL ACIDS, V5, DOI 10.1038/mtna.2015.43; Swiatecka-Urban A, 2005, J BIOL CHEM, V280, P36762, DOI 10.1074/jbc.M508944200; Szczepek M, 2007, NAT BIOTECHNOL, V25, P786, DOI 10.1038/nbt1317; Tebas P, 2014, NEW ENGL J MED, V370, P901, DOI 10.1056/NEJMoa1300662; TRAPNELL BC, 1991, P NATL ACAD SCI USA, V88, P6565, DOI 10.1073/pnas.88.15.6565; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Yang R, 2016, NUCLEIC ACIDS RES, V44, P3082, DOI 10.1093/nar/gkv1358; Yigit E, 2013, NUCLEIC ACIDS RES, V41, P2857, DOI 10.1093/nar/gks1462; ZABNER J, 1993, CELL, V75, P207, DOI 10.1016/0092-8674(93)80063-K	58	31	33	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2016	11	8							e0161072	10.1371/journal.pone.0161072	http://dx.doi.org/10.1371/journal.pone.0161072			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4SL	27526025	Green Published, Green Submitted, gold			2022-12-27	WOS:000381471100032
J	Desai, A; Krynitsky, J; Pohida, TJ; Zhao, HY; Schuck, P				Desai, Abhiksha; Krynitsky, Jonathan; Pohida, Thomas J.; Zhao, Huaying; Schuck, Peter			3D-Printing for Analytical Ultracentrifugation	PLOS ONE			English	Article							VELOCITY ANALYTICAL ULTRACENTRIFUGATION; SEDIMENTATION EQUILIBRIUM; PROTEIN INTERACTIONS; QUANTITATION; PRECISION; ACCURACY; DENSITY; SIZE	Analytical ultracentrifugation (AUC) is a classical technique of physical biochemistry providing information on size, shape, and interactions of macromolecules from the analysis of their migration in centrifugal fields while free in solution. A key mechanical element in AUC is the centerpiece, a component of the sample cell assembly that is mounted between the optical windows to allow imaging and to seal the sample solution column against high vacuum while exposed to gravitational forces in excess of 300,000 g. For sedimentation velocity it needs to be precisely sector-shaped to allow unimpeded radial macromolecular migration. During the history of AUC a great variety of centerpiece designs have been developed for different types of experiments. Here, we report that centerpieces can now be readily fabricated by 3D printing at low cost, from a variety of materials, and with customized designs. The new centerpieces can exhibit sufficient mechanical stability to withstand the gravitational forces at the highest rotor speeds and be sufficiently precise for sedimentation equilibrium and sedimentation velocity experiments. Sedimentation velocity experiments with bovine serum albumin as a reference molecule in 3D printed centerpieces with standard double-sector design result in sedimentation boundaries virtually indistinguishable from those in commercial double-sector epoxy centerpieces, with sedimentation coefficients well within the range of published values. The statistical error of the measurement is slightly above that obtained with commercial epoxy, but still below 1%. Facilitated by modern open-source design and fabrication paradigms, we believe 3D printed centerpieces and AUC accessories can spawn a variety of improvements in AUC experimental design, efficiency and resource allocation.	[Desai, Abhiksha; Zhao, Huaying; Schuck, Peter] Natl Inst Biomed Imaging & Bioengn, Dynam Macromol Assembly Sect, Lab Cellular Imaging & Macromol Biophys, NIH, Bethesda, MD 20892 USA; [Krynitsky, Jonathan; Pohida, Thomas J.] NIH, Div Computat Biosci, Ctr Informat Technol, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Biomedical Imaging & Bioengineering (NIBIB); National Institutes of Health (NIH) - USA; NIH Center for Information Technology (CIT)	Schuck, P (corresponding author), Natl Inst Biomed Imaging & Bioengn, Dynam Macromol Assembly Sect, Lab Cellular Imaging & Macromol Biophys, NIH, Bethesda, MD 20892 USA.	schuckp@mail.nih.gov	Schuck, Peter/AAA-6888-2020	Schuck, Peter/0000-0002-8859-6966	Intramural Research Program of the National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health, United States [ZIA EB000051-09 LCIM]; CENTER FOR INFORMATION TECHNOLOGY [ZIACT000261] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [ZIAEB000051] Funding Source: NIH RePORTER	Intramural Research Program of the National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health, United States; CENTER FOR INFORMATION TECHNOLOGY(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Center for Information Technology (CIT)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by the Intramural Research Program of the National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health, United States (ZIA EB000051-09 LCIM to PS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANSEVIN AT, 1970, ANAL BIOCHEM, V34, P237, DOI 10.1016/0003-2697(70)90103-X; Aragon SR, 2011, METHODS, V54, P101, DOI 10.1016/j.ymeth.2010.10.005; Aragon SR, 2016, ANAL ULTRAC IN PRESS, DOI [10.1007/978-4-431-55985-6_12, DOI 10.1007/978-4-431-55985-6]; Baden T, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002086; Balbo A, 2005, P NATL ACAD SCI USA, V102, P81, DOI 10.1073/pnas.0408399102; BENDET IJ, 1960, ARCH BIOCHEM BIOPHYS, V88, P280, DOI 10.1016/0003-9861(60)90236-8; Berkowitz SA, 2015, BIOPHYSICAL CHARACTERIZATION OF PROTEINS IN DEVELOPING BIOPHARMACEUTICALS, P211, DOI 10.1016/B978-0-444-59573-7.00009-9; Boestad G, 1938, REV SCI INSTRUM, V9, P346, DOI 10.1063/1.1752364; Brautigam CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062694; Carney RP, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1338; de la Torre JG, 2000, BIOPHYS J, V78, P719, DOI 10.1016/S0006-3495(00)76630-6; Ebel C, 2011, METHODS, V54, P56, DOI 10.1016/j.ymeth.2010.11.003; Fagan JA, 2013, ACS NANO, V7, P3373, DOI 10.1021/nn4002165; Flossdorf J, 1978, DOUBLE SECTOR CELL U; Gabrielson JP, 2007, ANAL BIOCHEM, V361, P24, DOI 10.1016/j.ab.2006.11.012; Gabrielson JP, 2011, METHODS, V54, P83, DOI 10.1016/j.ymeth.2010.12.030; Ghirlando R, 2014, ANAL BIOCHEM, V458, P37, DOI 10.1016/j.ab.2014.04.029; Ghirlando R, 2013, ANAL BIOCHEM, V440, P81, DOI 10.1016/j.ab.2013.05.011; Giebeler R, 1992, ANAL ULTRACENTRIFUGA, P16; Gillis RB, 2013, EUR BIOPHYS J BIOPHY, V42, P777, DOI 10.1007/s00249-013-0924-y; Harding SE, 2011, METHODS, V54, P136, DOI 10.1016/j.ymeth.2011.01.009; Harding SE, 2010, BIOCHEM SOC T, V38, P901, DOI 10.1042/BST0380901; HEARST JE, 1968, ANAL BIOCHEM, V24, P70, DOI 10.1016/0003-2697(68)90060-2; Karabudak E, 2010, EUR BIOPHYS J BIOPHY, V39, P397, DOI 10.1007/s00249-009-0412-6; LEWIS MS, 1994, MODERN ANAL ULTRACEN, P94; Liu J, 2006, AAPS J, V8, pE580, DOI 10.1208/aapsj080367; Ma J, 2015, BIOPHYS J, V109, P827, DOI 10.1016/j.bpj.2015.07.015; MacGregor IK, 2004, BIOPHYS CHEM, V108, P165, DOI 10.1016/j.bpc.2003.10.018; Moore DH, 1943, REV SCI INSTRUM, V14, P295, DOI 10.1063/1.1770090; Padrick SB, 2010, ANAL BIOCHEM, V407, P89, DOI 10.1016/j.ab.2010.07.017; Pearce JM, 2012, SCIENCE, V337, P1303, DOI 10.1126/science.1228183; Pekar A, 2007, ANAL BIOCHEM, V367, P225, DOI 10.1016/j.ab.2007.04.035; PICKELS EG, 1952, P NATL ACAD SCI USA, V38, P943, DOI 10.1073/pnas.38.11.943; Pickels EG, 1942, REV SCI INSTRUM, V13, P426, DOI 10.1063/1.1769940; Rai N, 2005, STRUCTURE, V13, P723, DOI 10.1016/j.str.2005.02.012; Rasa M, 2006, MACROMOL CHEM PHYS, V207, P2029, DOI 10.1002/macp.200600235; Rowe AJ, 2011, METHODS, V54, P157, DOI 10.1016/j.ymeth.2011.02.006; Schachman H.K., 1959, ULTRACENTRIFUGATION; SCHUCK P, 1994, PROG COLL POL SCI S, V94, P1; Schuck P., 2015, BASIC PRINCIPLES ANA; Schuck Peter, 2013, Biophys Rev, V5, P159, DOI 10.1007/s12551-013-0106-2; Schuck P, 2010, BIOPHYS J, V98, P2005, DOI 10.1016/j.bpj.2009.12.4336; Scott DJ, 2015, ANAL BIOCHEM, V490, P20, DOI 10.1016/j.ab.2015.08.017; SCOTT DJ, 2005, MODERN ANAL ULTRACEN; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Svedberg T, 1924, J AM CHEM SOC, V46, P2677, DOI 10.1021/ja01677a011; Svedberg T, 1940, THE ULTRACENTRIFUGE; Tombs M., 1997, INTRO POLYSACCHARIDE; VINOGRAD J, 1963, P NATL ACAD SCI USA, V49, P902, DOI 10.1073/pnas.49.6.902; VINOGRAD J, 1965, BIOPOLYMERS, V3, P481, DOI 10.1002/bip.1965.360030409; Vistica J, 2004, ANAL BIOCHEM, V326, P234, DOI 10.1016/j.ab.2003.12.014; Walter J, 2015, ANAL CHEM, V87, P3396, DOI 10.1021/ac504649c; Wandrey C, 2011, METHODS, V54, P92, DOI 10.1016/j.ymeth.2010.12.003; YPHANTIS DA, 1960, ANN NY ACAD SCI, V88, P586, DOI 10.1111/j.1749-6632.1960.tb20055.x; Zhang CL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059840; Zhao H., 2013, Curr. Protoc. Protein Sci., DOI [10.1002/0471140864.ps2012s71, DOI 10.1002/0471140864.PS2012S71]; Zhao HY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126420; Zhao HY, 2014, ANAL CHEM, V86, P3181, DOI 10.1021/ac500093m; Zhao HY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083439; Zhao HY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077245; Zhao HY, 2011, METHODS, V54, P16, DOI 10.1016/j.ymeth.2011.01.010	61	18	18	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2016	11	8							e0155201	10.1371/journal.pone.0155201	http://dx.doi.org/10.1371/journal.pone.0155201			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4SL	27525659	Green Submitted, gold, Green Published			2022-12-27	WOS:000381471100001
J	Curran, AM; Ryan, MF; Drummond, E; Gibney, ER; Gibney, MJ; Roche, HM; Brennan, L				Curran, Aoife M.; Ryan, Miriam F.; Drummond, Elaine; Gibney, Eileen R.; Gibney, Michael J.; Roche, Helen M.; Brennan, Lorraine			Uncovering Factors Related to Pancreatic Beta-Cell Function	PLOS ONE			English	Article							BODY-MASS INDEX; INSULIN-RESISTANCE; GLUCOSE-TOLERANCE; AMPLIFYING PATHWAYS; ADIPONECTIN RECEPTORS; METABOLIC SYNDROME; SECRETION; RISK; SENSITIVITY; DYSFUNCTION	Aim The incidence of type 2 diabetes has increased rapidly on a global scale. Beta-cell dysfunction contributes to the overall pathogenesis of type 2 diabetes. However, factors contributing to beta-cell function are not clear. The aims of this study were (i) to identify factors related to pancreatic beta-cell function and (ii) to perform mechanistic studies in vitro. Methods Three specific measures of beta-cell function were assessed for 110 participants who completed an oral glucose tolerance test as part of the Metabolic Challenge Study. Anthropometric and biochemical parameters were assessed as potential modulators of beta-cell function. Subsequent in vitro experiments were performed using the BRIN-BD11 pancreatic beta-cell line. Validation of findings were performed in a second human cohort. Results Waist-to-hip ratio was the strongest anthropometric modulator of beta-cell function, with beta-coefficients of -0.33 (p = 0.001) and -0.30 (p = 0.002) for beta-cell function/homeostatic model assessment of insulin resistance (HOMA-IR), and disposition index respectively. Additionally, the resistin-to-adiponectin ratio (RA index) emerged as being strongly associated with beta-cell function, with beta-coefficients of -0.24 (p = 0.038) and -0.25 (p = 0.028) for beta-cell function/HOMA-IR, and disposition index respectively. Similar results were obtained using a third measure for beta-cell function. In vitro experiments revealed that the RA index was a potent regulator of acute insulin secretion where a high RA index (20ng ml(-1) resistin, 5nmol l(-1) g-adiponectin) significantly decreased insulin secretion whereas a low RA index (10ng ml(-1) resistin, 10nmol l(-1) g-adiponectin) significantly increased insulin secretion. The RA index was successfully validated in a second human cohort with beta-coefficients of -0.40 (p = 0.006) and -0.38 (p = 0.008) for beta-cell function/HOMA-IR, and disposition index respectively. Conclusions Waist-to- hip ratio and RA index were identified as significant modulators of beta-cell function. The ability of the RA index to modulate insulin secretion was confirmed in mechanistic studies. Future work should identify strategies to alter the RA index.	[Curran, Aoife M.; Ryan, Miriam F.; Drummond, Elaine; Gibney, Eileen R.; Gibney, Michael J.; Roche, Helen M.; Brennan, Lorraine] Univ Coll Dublin, Sch Agr & Food Sci, Inst Food & Hlth, Dublin, Ireland; [Roche, Helen M.] Univ Coll Dublin, UCD Conway Inst Biomol & Biomed Res, Nutrigen Res Grp, Dublin 4, Ireland; [Roche, Helen M.] Univ Coll Dublin, UCD Inst Food & Hlth, Sch Publ Hlth Physiotherapy & Sports Sci, Dublin 4, Ireland	University College Dublin; University College Dublin; University College Dublin	Brennan, L (corresponding author), Univ Coll Dublin, Sch Agr & Food Sci, Inst Food & Hlth, Dublin, Ireland.	lorraine.brennan@ucd.ie	Roche, Helen M/AAF-4164-2019	Roche, Helen M/0000-0002-0628-3318; Brennan, Lorraine/0000-0002-7711-7499	Food for Health Ireland, through Enterprise Ireland [TC20130001]; Irish department of Agriculture, Food and the Marine [07FHRIUCD1, 13F407-ENPADASI]; Science Foundation Ireland Principal Investigator Award (SFI PI) [11/PI/1119]; SFI [14/JP-HDHL/B3075]; ERC Consolidator grants [647783]	Food for Health Ireland, through Enterprise Ireland; Irish department of Agriculture, Food and the Marine; Science Foundation Ireland Principal Investigator Award (SFI PI)(Science Foundation Ireland); SFI(Science Foundation Ireland); ERC Consolidator grants	This work was supported by Food for Health Ireland, through Enterprise Ireland Grant No. TC20130001. This work was conducted as part of a clinical trial (NCT01172951), funded by the Irish department of Agriculture, Food and the Marine through the grants 07FHRIUCD1 and 13F407-ENPADASI www.ucd.ie/jingo. H.M.R is supported by the Science Foundation Ireland Principal Investigator Award (SFI PI 11/PI/1119). L.B was supported by SFI (14/JP-HDHL/B3075) and ERC Consolidator grants 647783). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arita Y, 1999, BIOCHEM BIOPH RES CO, V257, P79, DOI 10.1006/bbrc.1999.0255; Arnlov J, 2011, DIABETES CARE, V34, P61, DOI 10.2337/dc10-0955; Bardini G, 2011, DIABETIC MED, V28, P1229, DOI 10.1111/j.1464-5491.2011.03332.x; Bardini G, 2013, ACTA DIABETOL, V50, P277, DOI 10.1007/s00592-011-0339-0; Benomar Y, 2013, DIABETES, V62, P102, DOI 10.2337/db12-0237; Boslem E, 2012, ISLETS, V4, P177, DOI 10.4161/isl.20102; Breda E, 2001, DIABETES, V50, P150, DOI 10.2337/diabetes.50.1.150; Brown JEP, 2007, FEBS LETT, V581, P3273, DOI 10.1016/j.febslet.2007.06.031; Brown JEP, 2010, PEPTIDES, V31, P944, DOI 10.1016/j.peptides.2010.02.004; Carr DB, 2004, DIABETES, V53, P2087, DOI 10.2337/diabetes.53.8.2087; Cheng CH, 2010, NUTR RES, V30, P585, DOI 10.1016/j.nutres.2010.08.007; Donin AS, 2014, DIABETES CARE, V37, P116, DOI 10.2337/dc13-1263; Elbein SC, 2000, DIABETES CARE, V23, P221, DOI 10.2337/diacare.23.2.221; Flehmig G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099785; Heidemann C, 2008, ANN INTERN MED, V149, P307, DOI 10.7326/0003-4819-149-5-200809020-00005; Henquin JC, 2000, DIABETES, V49, P1751, DOI 10.2337/diabetes.49.11.1751; Hermans MP, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-132; Holland WL, 2011, NAT MED, V17, P55, DOI 10.1038/nm.2277; Jamaluddin MS, 2012, BRIT J PHARMACOL, V165, P622, DOI 10.1111/j.1476-5381.2011.01369.x; Kahn SE, 2003, DIABETOLOGIA, V46, P3, DOI 10.1007/s00125-002-1009-0; Khaldi MZ, 2004, AM J PHYSIOL-ENDOC M, V287, pE207, DOI 10.1152/ajpendo.00426.2003; Kharroubi I, 2003, BIOCHEM BIOPH RES CO, V312, P1118, DOI 10.1016/j.bbrc.2003.11.042; Kruit JK, 2010, CURR OPIN LIPIDOL, V21, P178, DOI 10.1097/MOL.0b013e328339387b; Kuo TY, 2016, J BIOL CHEM, V291, P9648, DOI 10.1074/jbc.M115.702183; Lau CH, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-8; Lim EL, 2011, DIABETOLOGIA, V54, P2506, DOI 10.1007/s00125-011-2204-7; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; McClenaghan NH, 1996, DIABETES, V45, P1132, DOI 10.2337/diabetes.45.8.1132; Morris C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072890; Nakata M, 2007, BIOCHEM BIOPH RES CO, V353, P1046, DOI 10.1016/j.bbrc.2006.12.134; Narayan KMV, 2007, DIABETES CARE, V30, P1562, DOI 10.2337/dc06-2544; Nenquin M, 2004, J BIOL CHEM, V279, P32316, DOI 10.1074/jbc.M402076200; O'Gorman A, 2014, J CHROMATOGR B, V966, P140, DOI [10.1016/j.jchromb.2014.01.032, 10.1016/]; Okamoto M, 2008, DIABETOLOGIA, V51, P827, DOI 10.1007/s00125-008-0944-9; Park HK, 2013, DIABETES METAB J, V37, P404, DOI [10.4093/dmj.2013.37.6.404, 10.4093/dmj.2013.37.2.113]; Ryan MF, 2013, AM J CLIN NUTR, V97, P261, DOI 10.3945/ajcn.112.047936; Schienkiewitz A, 2006, AM J CLIN NUTR, V84, P427; Steppan CM, 2001, NATURE, V409, P307, DOI 10.1038/35053000; Tao C, 2014, BEST PRACT RES CL EN, V28, P43, DOI 10.1016/j.beem.2013.11.003; Utzschneider KM, 2009, DIABETES CARE, V32, P335, DOI 10.2337/dc08-1478; Wallace M, 2014, MOL BIOSYST, V10, P1586, DOI 10.1039/c3mb70529c; Wallace M, 2013, BBA-GEN SUBJECTS, V1830, P2583, DOI 10.1016/j.bbagen.2012.10.025; Weir GC, 2004, DIABETES, V53, pS16, DOI 10.2337/diabetes.53.suppl_3.S16; Wen JP, 2008, BIOCHEM BIOPH RES CO, V371, P756, DOI 10.1016/j.bbrc.2008.04.146; Whiting DR, 2011, DIABETES RES CLIN PR, V94, P311, DOI 10.1016/j.diabres.2011.10.029; Winzell MS, 2004, BIOCHEM BIOPH RES CO, V321, P154, DOI 10.1016/j.bbrc.2004.06.130; Yamauchi T, 2003, NATURE, V423, P762, DOI 10.1038/nature01705	47	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0161350	10.1371/journal.pone.0161350	http://dx.doi.org/10.1371/journal.pone.0161350			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27536890	Green Published, Green Submitted, gold			2022-12-27	WOS:000381577000091
J	Rochford, K; Chen, F; Waguespack, Y; Figliozzi, RW; Kharel, MK; Zhang, QJ; Martin-Caraballo, M; Hsia, SV				Rochford, Kevin; Chen, Feng; Waguespack, Yan; Figliozzi, Robert W.; Kharel, Madan K.; Zhang, Qiaojuan; Martin-Caraballo, Miguel; Hsia, S. Victor			Volatile Organic Compound Gamma-Butyrolactone Released upon Herpes Simplex Virus Type-1 Acute Infection Modulated Membrane Potential and Repressed Viral Infection in Human Neuron-Like Cells	PLOS ONE			English	Article							PROSTATE-CANCER CELLS; HYDROXYBUTYRIC ACID; NEUROENDOCRINE DIFFERENTIATION; AMINOBUTYRIC-ACID; CHANNEL ACTIVITY; LNCAP CELLS; IN-VITRO; REPLICATION; METABOLISM; EXPRESSION	Herpes Simplex Virus Type-1 (HSV-1) infections can cause serious complications such as keratitis and encephalitis. The goal of this study was to identify any changes in the concentrations of volatile organic compounds (VOCs) produced during HSV-1 infection of epithelial cells that could potentially be used as an indicator of a response to stress. An additional objective was to study if any VOCs released from acute epithelial infection may influence subsequent neuronal infection to facilitate latency. To investigate these hypotheses, Vero cells were infected with HSV-1 and the emission of VOCs was analyzed using two-dimensional gas chromatograph/mass spectrometry (2D GC/MS). It was observed that the concentrations of gamma-butyrolactone (GBL) in particular changed significantly after a 24-hour infection. Since HSV-1 may establish latency in neurons after the acute infection, GBL was tested to determine if it exerts neuronal regulation of infection. The results indicated that GBL altered the resting membrane potential of differentiated LNCaP cells and promoted a non-permissive state of HSV-1 infection by repressing viral replication. These observations may provide useful clues towards understanding the complex signaling pathways that occur during the HSV-1 primary infection and establishment of viral latency.	[Rochford, Kevin; Chen, Feng; Figliozzi, Robert W.; Kharel, Madan K.; Zhang, Qiaojuan; Martin-Caraballo, Miguel; Hsia, S. Victor] Univ Maryland, Sch Pharm & Hlth Profess, Dept Pharmaceut Sci, Princess Anne, MD 21853 USA; [Rochford, Kevin; Waguespack, Yan; Figliozzi, Robert W.] Univ Maryland, Sch Agr & Nat Sci, Dept Nat Sci, Princess Anne, MD 21853 USA	University System of Maryland; University of Maryland Eastern Shore; University System of Maryland; University of Maryland Eastern Shore	Hsia, SV (corresponding author), Univ Maryland, Sch Pharm & Hlth Profess, Dept Pharmaceut Sci, Princess Anne, MD 21853 USA.	vhsia@umes.edu		Hsia, Victor/0000-0001-7623-2842	NINDS/NIH [R01NS081109]; NIH [R01NS081109]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS081109] Funding Source: NIH RePORTER	NINDS/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This project is in part supported by R01NS081109 to SVH from NINDS/NIH and the content is solely the responsibility of the authors and does not necessarily represent the official views of the NINDS/NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors are grateful for the support in part from NIH grant R01NS081109 to SVH. We thank Dr. Peter Wang from the University of Maryland Eastern Shore for his assistance in statistical analyses. The authors appreciate the editorial assistance from UMES staff.	Aghi MK, 2009, MOL THER, V17, P51, DOI 10.1038/mt.2008.232; [Anonymous], 2016, J NEUROVIROL; [Anonymous], 2016, VIROL SIN; Berard AR, 2015, J PROTEOME RES, V14, P2121, DOI 10.1021/pr5012284; Biarnes-Carrera M, 2015, CURR OPIN CHEM BIOL, V28, P91, DOI 10.1016/j.cbpa.2015.06.024; Biswas A, 2014, J PHYS CHEM B, V118, P10035, DOI 10.1021/jp503589h; Bony G, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2820; Dahlen J, 2011, FORENSIC SCI INT, V210, P247, DOI 10.1016/j.forsciint.2011.03.016; Derouiche S, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-54; Dizeyi N, 2011, UROL ONCOL-SEMIN ORI, V29, P436, DOI 10.1016/j.urolonc.2009.09.013; Dodson AW, 2007, VIROLOGY, V366, P340, DOI 10.1016/j.virol.2007.05.001; Du YL, 2011, APPL ENVIRON MICROB, V77, P8415, DOI 10.1128/AEM.05898-11; Figliozzi RW, 2014, J NEUROL SCI, V346, P164, DOI 10.1016/j.jns.2014.08.017; Foster TP, 1998, J VIROL METHODS, V75, P151, DOI 10.1016/S0166-0934(98)00107-4; Friedman GK, 2012, TRANSL ONCOL, V5, P200, DOI 10.1593/tlo.12115; HOLLAND KD, 1995, MOL PHARMACOL, V47, P1217; Hsia SC, 2011, CELL BIOSCI, V1, DOI 10.1186/2045-3701-1-24; Knipe D.M.H., 2013, PETER FIELDS VIROLOG, V6th; Laniado ME, 2001, PROSTATE, V46, P262, DOI 10.1002/1097-0045(20010301)46:4<262::AID-PROS1032>3.0.CO;2-F; Laviv T, 2011, J NEUROSCI, V31, P12523, DOI 10.1523/JNEUROSCI.1527-11.2011; Moritz T, 2016, TUMOUR BIOL; Munshi T, 2013, DRUG TEST ANAL, V5, P678, DOI 10.1002/dta.1438; Murmu MS, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-105; Ottani A, 2003, BRAIN RES, V986, P181, DOI 10.1016/S0006-8993(03)03252-9; Pawliszyn J, 2000, J CHROMATOGR SCI, V38, P270, DOI 10.1093/chromsci/38.7.270; Sano R, 2013, BBA-MOL CELL RES, V1833, P3460, DOI 10.1016/j.bbamcr.2013.06.028; SCHOLZ D, 1983, HEPATO-GASTROENTEROL, V30, P102; Scorey N, 2006, PROSTATE CANCER P D, V9, P399, DOI 10.1038/sj.pcan.4500894; Skryma RN, 1997, PROSTATE, V33, P112, DOI 10.1002/(SICI)1097-0045(19971001)33:2<112::AID-PROS5>3.0.CO;2-M; SNEAD OC, 1989, BIOCHEM PHARMACOL, V38, P4375, DOI 10.1016/0006-2952(89)90645-X; Wang L, 2003, MICROBIOL-SGM, V149, P1991, DOI 10.1099/mic.0.26209-0; Watson S, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-130; Weaver EM, 2015, EUR J PHARMACOL, V749, P20, DOI 10.1016/j.ejphar.2014.12.021; Yuan TC, 2006, ENDOCR-RELAT CANCER, V13, P151, DOI 10.1677/erc.1.01043; Zhang CX, 2005, J NEUROVIROL, V11, P256, DOI 10.1080/13550280590952781; Zhu YZ, 2014, PROSTATE, V74, P1086, DOI 10.1002/pros.22819	37	3	3	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0161119	10.1371/journal.pone.0161119	http://dx.doi.org/10.1371/journal.pone.0161119			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27537375	gold, Green Submitted, Green Published			2022-12-27	WOS:000381577000056
J	Sasaki, T; Hashimoto, K; Oda, Y; Ishima, T; Yakita, M; Kurata, T; Kunou, M; Takahashi, J; Kamata, Y; Kimura, A; Niitsu, T; Komatsu, H; Hasegawa, T; Shiina, A; Hashimoto, T; Kanahara, N; Shimizu, E; Iyo, M				Sasaki, Tsuyoshi; Hashimoto, Kenji; Oda, Yasunori; Ishima, Tamaki; Yakita, Madoka; Kurata, Tsutomu; Kunou, Masaru; Takahashi, Jumpei; Kamata, Yu; Kimura, Atsushi; Niitsu, Tomihisa; Komatsu, Hideki; Hasegawa, Tadashi; Shiina, Akihiro; Hashimoto, Tasuku; Kanahara, Nobuhisa; Shimizu, Eiji; Iyo, Masaomi			Increased Serum Levels of Oxytocin in 'Treatment Resistant Depression in Adolescents (TRDIA)' Group	PLOS ONE			English	Article							BIPOLAR DISORDER; RATING-SCALE; VALIDITY; OUTCOMES; CHILDREN; TORDIA; RELIABILITY; VASOPRESSIN; BEHAVIOR	Objective 'Treatment-resistant depression' is depression that does not respond to an adequate regimen of evidence-based treatment. Treatment-resistant depression frequently becomes chronic. Children with treatment-resistant depression might also develop bipolar disorder (BD). The objective of this study was to determine whether serum levels of oxytocin (OXT) in treatment-resistant depression in adolescents (TRDIA) differ from non-treatment-resistant depression in adolescents (non-TRDIA) or controls. We also investigated the relationships between serum OXT levels and the clinical symptoms, severity, and familial histories of adolescent depressive patients. Methods We measured serum OXT levels: TRDIA (n = 10), non-TRDIA (n = 27), and age-and sex-matched, neurotypical controls (n = 25). Patients were evaluated using the Children's Depression Rating Scale-Revised (CDRS-R) and the Depression Self-Rating Scale for Children-Japanese Version (DSRS-C-J). The patients were also assessed retrospectively using the following variables: familial history of major depressive disorder and BD (1st degree or 2nd degree), history of disruptive mood dysregulation disorder, recurrent depressive disorder (RDD), history of antidepressant activation. Results Serum levels of OXT among the TRDIA and non-TRDIA patients and controls differed significantly. Interestingly, the rates of a family history of BD (1st or 2nd degree), RDD and a history of antidepressant activation in our TRDIA group were significantly higher than those of the non-TRDIA group. Conclusions Serum levels of OXT may play a role in the pathophysiology of TRDIA.	[Sasaki, Tsuyoshi; Yakita, Madoka; Kurata, Tsutomu; Kunou, Masaru; Takahashi, Jumpei; Iyo, Masaomi] Chiba Univ Hosp, Dept Child Psychiat, Chiba, Japan; [Sasaki, Tsuyoshi; Oda, Yasunori; Kamata, Yu; Kimura, Atsushi; Niitsu, Tomihisa; Komatsu, Hideki; Hasegawa, Tadashi; Shiina, Akihiro; Hashimoto, Tasuku; Iyo, Masaomi] Chiba Univ, Grad Sch Med, Dept Psychiat, Chiba, Japan; [Hashimoto, Kenji; Ishima, Tamaki; Iyo, Masaomi] Chiba Univ, Ctr Forens Mental Hlth, Div Clin Neurosci, Chiba, Japan; [Kanahara, Nobuhisa; Iyo, Masaomi] Chiba Univ, Ctr Forens Mental Hlth, Div Med Treatment & Rehabil, Chiba, Japan; [Kunou, Masaru; Shimizu, Eiji] Chiba Univ, Grad Sch Med, Dept Cognit Behav Physiol, Chiba, Japan	Chiba University; Chiba University; Chiba University; Chiba University; Chiba University	Sasaki, T (corresponding author), Chiba Univ Hosp, Dept Child Psychiat, Chiba, Japan.; Sasaki, T (corresponding author), Chiba Univ, Grad Sch Med, Dept Psychiat, Chiba, Japan.	sasaki@faculty.chiba-u.jp	Shimizu, Eiji/K-4637-2017; Hashimoto, Kenji/I-5800-2015	Shimizu, Eiji/0000-0002-6741-9338; Hashimoto, Kenji/0000-0002-8892-0439; KUNO, Masaru/0000-0002-4153-280X; Sasaki, Tsuyoshi/0000-0001-8502-6469	Health Labour Sciences Research Grant [KAKENHI 201419072A]; Astellas; Dainippon Sumitomo; Eli Lilly; Janssen; Mochida; Otsuka; Shionogi; Taisho; Yoshitomi; Novartis; Abbvie; Ministry of Health, Labour and Welfare; Non-Profit Organization of dependence research; General Association for Justice; Sumitomo Dainippon Phama; Chiba-ken Bengoshi-kai (Chiba Lawyers Association); Chugai; Pfizer; Daiichi-Sankyo; Eizai; Glaxosmithkline; MSD; Takeda; Asahi Kasei; Sanofi	Health Labour Sciences Research Grant(Ministry of Health, Labour and Welfare, Japan); Astellas(Astellas Pharmaceuticals); Dainippon Sumitomo(Dainippon Sumitomo Pharma Co., Ltd.); Eli Lilly(Eli Lilly); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Mochida; Otsuka(Otsuka Pharmaceutical); Shionogi; Taisho; Yoshitomi(Mitsubishi Tanabe Pharma Corporation); Novartis(Novartis); Abbvie(AbbVie); Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan); Non-Profit Organization of dependence research; General Association for Justice; Sumitomo Dainippon Phama; Chiba-ken Bengoshi-kai (Chiba Lawyers Association); Chugai; Pfizer(Pfizer); Daiichi-Sankyo(Daiichi Sankyo Company Limited); Eizai; Glaxosmithkline(GlaxoSmithKline); MSD; Takeda(Takeda Pharmaceutical Company Ltd); Asahi Kasei(Asahi Kasei Corporation); Sanofi	This study was supported in part by a Health Labour Sciences Research Grant [KAKENHI 201419072A] (https://mhlw-grants.niph.go.jp/niph/search/NIDD00.do?resrchNum=201419072A). TS has received research support or speakers' honoraria from Astellas, Dainippon Sumitomo, Eli Lilly, Janssen, Mochida, Otsuka, Shionogi, Taisho, and Yoshitomi and he has also received research support from Novartis, Otsuka, and Taisho. KH has served as a scientific consultant to Taisho, and he has also received research support from Abbvie, Dainippon Sumitomo, Mochida, Otsuka, and Taisho. TK has received speakers' honoraria from Astellas, Eli Lilly, Janssen, Takeda, and Otsuka. MK has received speakers' honoraria from Eli Lilly. YK has received speakers' honoraria from Dainippon Sumitomo and Otsuka. TN has received honoraria from Eli Lilly and Dainippon Sumitomo. HK has received research support or speakers' honoraria from Dainippon Sumitomo, Eli Lilly, and Novartis. T. Hasegawa has received speakers' honoraria from Astellas, Dainippon Sumitomo, Eli Lilly, Mochida, Otsuka, and Shionogi. AS has received research support from Ministry of Health, Labour and Welfare, Non-Profit Organization of dependence research and General Association for Justice, a lecture fee from Sumitomo Dainippon Phama and Chiba-ken Bengoshi-kai (Chiba Lawyers Association). T. Hashimoto has received honoraria as speaker/consultant from Astellas, Glaxosmithkline, Meiji Seika, Mochida, Otsuka, Tanabe Mitsubishi, Yoshitomiyakuhin, and received research/grant support from Astellas, Chugai, Otsuka, Pfizer, and Shionogi. NK has received honoraria from Eli Lilly, Janssen, and Otsuka. ES has received speaking honoraria from MSD, Meiji Seika, Mochida, Eli Lilly, Janssen, and Yoshitomi. MI has received research support and honoraria from Astellas, Daiichi-Sankyo, Dainippon Sumitomo, Eizai, Glaxosmithkline, Janssen, Mochida, MSD, Novartis, Otsuka, Takeda, and Yoshitomi, and received research support from Asahi Kasei, Pfizer, Sanofi, Shionogi, Taisho, and received honoraria from Chugai-Nissin Pharmaceutical, Eli Lilly, Hisamitsu, Kyowa-Hakko Kirin, Meiji, Ono, and Tsumura. YO, TI, MY, JT, and AK, report no biomedical financial interests or potential conflicts of interest. The funders along with any other relevant declarations relating to employment, consultancy, patents, products in development, marketed products had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	American Psychiatric Association, 2013, DIAGNOSTIC AND STATI; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; [Anonymous], 2011, OPEN CLIN CHEM J, DOI DOI 10.2174/1874241601104010028; BIRLESON P, 1981, J CHILD PSYCHOL PSYC, V22, P73, DOI 10.1111/j.1469-7610.1981.tb00533.x; Birmaher B, 2007, J AM ACAD CHILD PSY, V46, P1503, DOI 10.1097/chi.0b013e318145ae1c; Brent D., TREATMENT RESISTANT; Brent DA, 2009, J CHILD PSYCHOL PSYC, V50, P143, DOI 10.1111/j.1469-7610.2008.02037.x; Emslie GJ, 2010, AM J PSYCHIAT, V167, P782, DOI 10.1176/appi.ajp.2010.09040552; Green LA, 2001, BIOL PSYCHIAT, V50, P609, DOI 10.1016/S0006-3223(01)01139-8; Kennard BD, 2009, J AM ACAD CHILD PSY, V48, P186, DOI 10.1097/CHI.0b013e31819176f9; Lee HJ, 2009, PROG NEUROBIOL, V88, P127, DOI 10.1016/j.pneurobio.2009.04.001; Maalouf FT, 2012, J AFFECT DISORDERS, V138, P86, DOI 10.1016/j.jad.2011.12.021; MacDonald K, 2012, ACTA NEUROPSYCHIATR, V24, P130, DOI 10.1111/j.1601-5215.2011.00634.x; March J, 2004, JAMA-J AM MED ASSOC, V292, P807; Meyer-Lindenberg A, 2011, NAT REV NEUROSCI, V12, P524, DOI 10.1038/nrn3044; Modahl C, 1998, BIOL PSYCHIAT, V43, P270, DOI 10.1016/S0006-3223(97)00439-3; Murata T., 1996, SAISHIN SEISHIN IGAK, V1, P131; Pitchot W, 2008, J PSYCHIATR RES, V42, P684, DOI 10.1016/j.jpsychires.2007.07.007; POZNANSKI EO, 1984, J AM ACAD CHILD PSY, V23, P191, DOI 10.1097/00004583-198403000-00011; Reid JM, 2010, CHILD YOUTH CARE FOR, V39, P113, DOI 10.1007/s10566-010-9095-5; Sakolsky DJ, 2011, J CLIN PSYCHOPHARM, V31, P92, DOI 10.1097/JCP.0b013e318204b117; Sasaki T, 2015, PSYCHIAT RES, V228, P746, DOI 10.1016/j.psychres.2015.05.029; Sheehan DV, 2010, J CLIN PSYCHIAT, V71, P313, DOI 10.4088/JCP.09m05305whi; Smith Donald F, 2013, Front Psychiatry, V4, P57, DOI 10.3389/fpsyt.2013.00057; Stavropoulos KKM, 2013, J CHILD PSYCHOL PSYC, V54, P603, DOI 10.1111/jcpp.12061; Striepens N, 2011, FRONT NEUROENDOCRIN, V32, P426, DOI 10.1016/j.yfrne.2011.07.001; Turan T, 2013, PSYCHONEUROENDOCRINO, V38, P2890, DOI 10.1016/j.psyneuen.2013.07.017; World Health Organization, ICD 10 CLASS MENT BE; Yamasue H, 2012, J NEUROSCI, V32, P14109, DOI 10.1523/JNEUROSCI.3327-12.2012; Youngstrom EA, 2012, ISR J PSYCHIATR REL, V49, P15	30	14	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0160767	10.1371/journal.pone.0160767	http://dx.doi.org/10.1371/journal.pone.0160767			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DT6ES	27536785	Green Published, Green Submitted, gold			2022-12-27	WOS:000381577000030
J	Shteingart, H; Loewenstein, Y				Shteingart, Hanan; Loewenstein, Yonatan			Heterogeneous Suppression of Sequential Effects in Random Sequence Generation, but Not in Operant Learning	PLOS ONE			English	Article							INFORMATION; DECISIONS; CORTEX	There is a long history of experiments in which participants are instructed to generate a long sequence of binary random numbers. The scope of this line of research has shifted over the years from identifying the basic psychological principles and/or the heuristics that lead to deviations from randomness, to one of predicting future choices. In this paper, we used generalized linear regression and the framework of Reinforcement Learning in order to address both points. In particular, we used logistic regression analysis in order to characterize the temporal sequence of participants' choices. Surprisingly, a population analysis indicated that the contribution of the most recent trial has only a weak effect on behavior, compared to more preceding trials, a result that seems irreconcilable with standard sequential effects that decay monotonously with the delay. However, when considering each participant separately, we found that the magnitudes of the sequential effect are a monotonous decreasing function of the delay, yet these individual sequential effects are largely averaged out in a population analysis because of heterogeneity. The substantial behavioral heterogeneity in this task is further demonstrated quantitatively by considering the predictive power of the model. We show that a heterogeneous model of sequential dependencies captures the structure available in random sequence generation. Finally, we show that the results of the logistic regression analysis can be interpreted in the framework of reinforcement learning, allowing us to compare the sequential effects in the random sequence generation task to those in an operant learning task. We show that in contrast to the random sequence generation task, sequential effects in operant learning are far more homogenous across the population. These results suggest that in the random sequence generation task, different participants adopt different cognitive strategies to suppress sequential dependencies when generating the "random" sequences.	[Shteingart, Hanan; Loewenstein, Yonatan] Hebrew Univ Jerusalem, Edmond & Lily Safra Ctr Brain Sci, Jerusalem, Israel; [Loewenstein, Yonatan] Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, Dept Neurobiol, Jerusalem, Israel; [Loewenstein, Yonatan] Hebrew Univ Jerusalem, Federmann Ctr Study Rat, Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hebrew University of Jerusalem	Shteingart, H (corresponding author), Hebrew Univ Jerusalem, Edmond & Lily Safra Ctr Brain Sci, Jerusalem, Israel.	hanan@shteingart.com			Israel Science Foundation [868/08, 757/16]; Israeli Ministry of Science and Technology; Israeli Ministry of Foreign and European Affairs; French Ministry of Higher Education and Research; Gatsby Charitable Foundation; Ministry of Science and Technology, Israel; Ministry of Higher Education and Research, France	Israel Science Foundation(Israel Science Foundation); Israeli Ministry of Science and Technology(Ministry of Science, Technology and Space (MOST), Israel); Israeli Ministry of Foreign and European Affairs; French Ministry of Higher Education and Research; Gatsby Charitable Foundation; Ministry of Science and Technology, Israel(Ministry of Science, Technology and Space (MOST), Israel); Ministry of Higher Education and Research, France(Ministry of Higher Education & Scientific Research (MHESR))	This work was supported by the Israel Science Foundation (Grant No. 868/08 and No. 757/16), by a grant from the Israeli Ministry of Science and Technology, the Israeli Ministry of Foreign and European Affairs, the French Ministry of Higher Education and Research, and the Gatsby Charitable Foundation.; This work was supported by the Israel Science Foundation (Grant No. 868/08), grant from the Ministry of Science and Technology, Israel; The Ministry of Foreign and European Affairs; The Ministry of Higher Education and Research, France; and the Gatsby Charitable Foundation.	Agranov M, 2013, STOCHASTIC CHOICE HE; Ashourian P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019551; Baddeley A, 1998, Q J EXP PSYCHOL-A, V51, P819, DOI 10.1080/027249898391413; BADDELEY AD, 1966, Q J EXP PSYCHOL, V18, P119, DOI 10.1080/14640746608400019; BARHILLEL M, 1991, ADV APPL MATH, V12, P428, DOI 10.1016/0196-8858(91)90029-I; Barraclough DJ, 2004, NAT NEUROSCI, V7, P404, DOI 10.1038/nn1209; Barron G, 2013, J ECON PSYCHOL, V39, P278, DOI 10.1016/j.joep.2013.09.002; Blanchard TC, 2015, NEURON, V85, P602, DOI 10.1016/j.neuron.2014.12.050; Brugger P, 1997, PERCEPT MOTOR SKILL, V84, P627, DOI 10.2466/pms.1997.84.2.627; BUDESCU DV, 1987, J EXP PSYCHOL HUMAN, V13, P25, DOI 10.1037/0096-1523.13.1.25; COVER TM, 1967, IEEE T INFORM THEORY, V13, P21, DOI 10.1109/TIT.1967.1053964; Daw N. D., 2011, DECISION MAKING AFFE, VXXIII, P555; Doya K, 2007, HFSP J, V1, P30, DOI [10.2976/1.2732246/10.2976/1, 10.2976/1.2732246]; Dutt V, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00177; Erev I, 2005, J MATH PSYCHOL, V49, P357, DOI 10.1016/j.jmp.2005.06.009; Erev I, 2010, J BEHAV DECIS MAKING, V23, P15, DOI 10.1002/bdm.683; Glimcher PW, 2009, NEUROECONOMICS: DECISION MAKING AND THE BRAIN, P503, DOI 10.1016/B978-0-12-374176-9.00032-4; GREEN DR, 1982, TEACHING MATH ITS AP, V0001; HOSMER DW, 2000, WILEY PS TX, P1; KAREEV Y, 1992, J EXP PSYCHOL HUMAN, V18, P1189, DOI 10.1037/0096-1523.18.4.1189; Klein JT, 2008, CURR BIOL, V18, P419, DOI 10.1016/j.cub.2008.02.047; Lages M, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00056; Laquitaine S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080683; Lau B, 2005, J EXP ANAL BEHAV, V84, P555, DOI 10.1901/jeab.2005.110-04; Loewenstein Y, 2009, NEURAL COMPUT, V21, P2755, DOI 10.1162/neco.2009.09-08-854; Mongillo G, 2014, P IEEE, V102, P528, DOI 10.1109/JPROC.2014.2307022; Neiman T, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1580; NEURINGER A, 1986, J EXP PSYCHOL GEN, V115, P62, DOI 10.1037/0096-3445.115.1.62; Neuringer A, 2002, PSYCHON B REV, V9, P672, DOI 10.3758/BF03196324; Nickerson RS, 2009, AM J PSYCHOL, V122, P141; Nickerson RS, 2002, PSYCHOL REV, V109, P330, DOI 10.1037//0033-295X.109.2.330; Oskarsson AT, 2009, PSYCHOL BULL, V135, P262, DOI 10.1037/a0014821; Poulton E.C., 1989, BIAS QUANTIFYING JUD; Rapoport A, 1997, PSYCHOL REV, V104, P603, DOI 10.1037/0033-295X.104.3.603; Raviv O, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002731; Rubin J, 2012, INTEL SYST REF LIBR, V28, P57; Schulz MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041531; Shteingart H, 2014, CURR OPIN NEUROBIOL, V25, P93, DOI 10.1016/j.conb.2013.12.004; Shteingart H, 2013, J EXP PSYCHOL GEN, V142, P476, DOI 10.1037/a0029550; Stahl DO, 2006, ENCY COGNITIVE SCI, DOI [10.1002/0470018860, DOI 10.1002/0470018860]; Sutton R. S., 1998, INTRO REINFORCEMENT; Trommershauser J, 2003, SPATIAL VISION, V16, P255, DOI 10.1163/156856803322467527; TUNE GS, 1964, PERCEPT MOTOR SKILL, V19, P551, DOI 10.2466/pms.1964.19.2.551; TUNE GS, 1964, PSYCHOL BULL, V61, P286, DOI 10.1037/h0048618; WAGENAAR WA, 1972, PSYCHOL BULL, V77, P65, DOI 10.1037/h0032060	46	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0157643	10.1371/journal.pone.0157643	http://dx.doi.org/10.1371/journal.pone.0157643			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DT6ES	27537177	Green Published, gold, Green Submitted			2022-12-27	WOS:000381577000004
J	Sozanski, K; Wisniewska, A; Kalwarczyk, T; Sznajder, A; Holyst, R				Sozanski, Krzysztof; Wisniewska, Agnieszka; Kalwarczyk, Tomasz; Sznajder, Anna; Holyst, Robert			Motion of Molecular Probes and Viscosity Scaling in Polyelectrolyte Solutions at Physiological Ionic Strength	PLOS ONE			English	Article							POLYMER-SOLUTIONS; COMPLEX LIQUIDS; DIFFUSION; MOBILITY; DYNAMICS; MACROMOLECULES; CYTOPLASM; CHAIN; VISCOELASTICITY; NANOPARTICLES	We investigate transport properties of model polyelectrolyte systems at physiological ionic strength (0.154 M). Covering a broad range of flow length scales-from diffusion of molecular probes to macroscopic viscous flow-we establish a single, continuous function describing the scale dependent viscosity of high-salt polyelectrolyte solutions. The data are consistent with the model developed previously for electrically neutral polymers in a good solvent. The presented approach merges the power-law scaling concepts of de Gennes with the idea of exponential length scale dependence of effective viscosity in complex liquids. The result is a simple and applicable description of transport properties of high-salt polyelectrolyte solutions at all length scales, valid for motion of single molecules as well as macroscopic flow of the complex liquid.	[Sozanski, Krzysztof; Wisniewska, Agnieszka; Kalwarczyk, Tomasz; Sznajder, Anna; Holyst, Robert] Polish Acad Sci, Inst Phys Chem, Kasprzaka 44-52, PL-01224 Warsaw, Poland	Polish Academy of Sciences; Institute of Physical Chemistry of the Polish Academy of Sciences	Holyst, R (corresponding author), Polish Acad Sci, Inst Phys Chem, Kasprzaka 44-52, PL-01224 Warsaw, Poland.	rholyst@ichf.edu.pl	Kalwarczyk, Tomasz/V-5262-2018; Wiśniewska, Agnieszka/HCI-1785-2022	Kalwarczyk, Tomasz/0000-0003-1136-9789; Wiśniewska, Agnieszka/0000-0001-5317-757X; Holyst, Robert/0000-0002-3211-4286; Sozanski, Krzysztof/0000-0002-4514-3836	National Science Centre [2011/02/A/ST3/00143]	National Science Centre(National Science Centre, Poland)	The authors acknowledge the National Science Centre (https://www.ncn.gov.pl/) for funding the project from the funds granted on the basis of the decision number 2011/02/A/ST3/00143 (Maestro grant).	Amsden B, 2002, POLYMER, V43, P1623, DOI 10.1016/S0032-3861(01)00749-2; Bielejewska A, 2010, ANAL CHEM, V82, P5463, DOI 10.1021/ac1008207; Boris DC, 1998, MACROMOLECULES, V31, P5746, DOI 10.1021/ma971884i; Cai LH, 2011, MACROMOLECULES, V44, P7853, DOI 10.1021/ma201583q; Carrillo JMY, 2010, J PHYS CHEM B, V114, P9391, DOI 10.1021/jp101978k; COHEN J, 1988, J CHEM PHYS, V88, P7111, DOI 10.1063/1.454361; Colby RH, 2010, RHEOL ACTA, V49, P425, DOI 10.1007/s00397-009-0413-5; COLBY RH, 1991, MACROMOLECULES, V24, P3873, DOI 10.1021/ma00013a021; COOPER EC, 1991, POLYMER, V32, P2815, DOI 10.1016/0032-3861(91)90114-X; CUKIER RI, 1984, MACROMOLECULES, V17, P252, DOI 10.1021/ma00132a023; de Gennes PG, 1979, SCALING CONCEPTS IN; de Kort DW, 2015, MACROMOLECULES, V48, P7585, DOI 10.1021/acs.macromol.5b01530; DEGENNES PG, 1976, J PHYS-PARIS, V37, P1461, DOI 10.1051/jphys:0197600370120146100; Dobrynin AV, 2005, PROG POLYM SCI, V30, P1049, DOI 10.1016/j.progpolymsci.2005.07.006; DOBRYNIN AV, 1995, MACROMOLECULES, V28, P1859, DOI 10.1021/ma00110a021; Doi M, 1986, THE THEORY OF POLYME; Dou SC, 2006, J POLYM SCI POL PHYS, V44, P2001, DOI 10.1002/polb.20853; Elowitz MB, 1999, J BACTERIOL, V181, P197, DOI 10.1128/JB.181.1.197-203.1999; Gelbart WM, 2000, PHYS TODAY, V53, P38, DOI 10.1063/1.1325230; Heo Y, 2005, J RHEOL, V49, P1117, DOI 10.1122/1.1993595; Holyst R, 2009, PHYS CHEM CHEM PHYS, V11, P9025, DOI 10.1039/b908386c; Izzo D, 2014, SOFT MATTER, V10, P1714, DOI 10.1039/c3sm52630e; Janmey PA, 2014, SOFT MATTER, V10, P1439, DOI 10.1039/c3sm50854d; Jonsson B, 2003, LANGMUIR, V19, P9914, DOI 10.1021/la034850e; Kalwarczyk T, 2014, NANOSCALE, V6, P10340, DOI 10.1039/c4nr00647j; Kalwarczyk T, 2015, ADV COLLOID INTERFAC, V223, P55, DOI 10.1016/j.cis.2015.06.007; Kalwarczyk T, 2011, NANO LETT, V11, P2157, DOI 10.1021/nl2008218; Khorasani FB, 2014, MACROMOLECULES, V47, P5328, DOI 10.1021/ma501248u; KIRKWOOD JG, 1948, J CHEM PHYS, V16, P565, DOI 10.1063/1.1746947; Konop AJ, 1999, MACROMOLECULES, V32, P2803, DOI 10.1021/ma9818174; Lakowicz JR, 2007, PRINCIPLES OF FLUORE; LANGEVIN D, 1978, POLYMER, V19, P875, DOI 10.1016/0032-3861(78)90191-X; Liu J, 2008, J PHYS CHEM C, V112, P6653, DOI 10.1021/jp800474t; Lukacs GL, 2000, J BIOL CHEM, V275, P1625, DOI 10.1074/jbc.275.3.1625; Majcher A, 2015, ANAL CHIM ACTA, V855, P51, DOI 10.1016/j.aca.2014.12.008; MANNING GS, 1969, J CHEM PHYS, V51, P924, DOI 10.1063/1.1672157; Miyazaki K, 2004, J CHEM PHYS, V121, P8120, DOI 10.1063/1.1797193; Moulay S, 2006, J APPL POLYM SCI, V100, P954, DOI 10.1002/app.23002; Nishida K, 2002, POLYMER, V43, P1295, DOI 10.1016/S0032-3861(01)00682-6; Nystrom B, 1982, PROG POLYM SCI, V8, P333, DOI [10.1016/0079-6700(82)90003-X, DOI 10.1016/0079-6700(82)90003-X]; ODIJK T, 1979, MACROMOLECULES, V12, P688, DOI 10.1021/ma60070a028; Odijk T, 2000, BIOPHYS J, V79, P2314, DOI 10.1016/S0006-3495(00)76477-0; Pecora R, 2005, MACROMOL SYMP, V229, P18, DOI 10.1002/masy.200551103; PHILLIES GDJ, 1987, MACROMOLECULES, V20, P2280, DOI 10.1021/ma00175a037; PHILLIES GDJ, 1985, J CHEM PHYS, V82, P5242, DOI 10.1063/1.448969; PHILLIES GDJ, 1992, MACROMOLECULES, V25, P4948, DOI 10.1021/ma00045a021; PHILLIES GDJ, 1989, MACROMOLECULES, V22, P4068, DOI 10.1021/ma00200a044; PHILLIES GDJ, 1986, MACROMOLECULES, V19, P2367, DOI 10.1021/ma00163a006; PHILLIES GDJ, 1988, MACROMOLECULES, V21, P214, DOI 10.1021/ma00179a041; PHILLIES GDJ, 1995, MACROMOLECULES, V28, P8198, DOI 10.1021/ma00128a033; RABIN Y, 1988, J POLYM SCI POL LETT, V26, P397, DOI 10.1002/pol.1988.140260904; Rapoport DH, 2007, J PHYS CHEM C, V111, P5726, DOI 10.1021/jp066735t; RUBINSTEIN M, 1994, PHYS REV LETT, V73, P2776, DOI 10.1103/PhysRevLett.73.2776; Rubinstein M, 2012, SOFT MATTER, V8, P9265, DOI 10.1039/c2sm90104h; Saenger W., 1984, PRINCILPES OF NUCLEI; SCHACHMAN HK, 1952, J AM CHEM SOC, V74, P3965, DOI 10.1021/ja01135a533; Sozanski K, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.228301; STONEMASUI J, 1968, J COLLOID INTERF SCI, V28, P187, DOI 10.1016/0021-9797(68)90120-3; Szymanski J, 2006, J PHYS CHEM B, V110, P25593, DOI 10.1021/jp0666784; TAKAHASHI Y, 1985, MACROMOLECULES, V18, P1002, DOI 10.1021/ma00147a033; Teraoka I., 2002, POLYMER SOLUTIONS AN; Tuteja A, 2007, NANO LETT, V7, P1276, DOI 10.1021/nl070192x; Uzum C, 2011, MACROMOLECULES, V44, P7782, DOI 10.1021/ma201466a; UTRACKI LA, 1981, J RHEOL, V25, P329, DOI 10.1122/1.549646; Weiller GF, 2004, PROTEOMICS, V4, P943, DOI 10.1002/pmic.200200648; Wisniewska A, 2014, POLYMER, V55, P4651, DOI 10.1016/j.polymer.2014.07.029; Wyart FB, 2000, EUR PHYS J E, V1, P93, DOI 10.1007/s101890050011; YING QC, 1987, MACROMOLECULES, V20, P362, DOI 10.1021/ma00168a023; Zustiak SP, 2011, BIOPHYS J, V101, P255, DOI 10.1016/j.bpj.2011.05.035	69	6	6	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0161409	10.1371/journal.pone.0161409	http://dx.doi.org/10.1371/journal.pone.0161409			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27536866	Green Submitted, gold, Green Published			2022-12-27	WOS:000381577000101
J	Staines, K; Batra, A; Mwangi, W; Maier, HJ; Van Borm, S; Young, JR; Fife, M; Butter, C				Staines, Karen; Batra, Ambalika; Mwangi, William; Maier, Helena J.; Van Borm, Steven; Young, John R.; Fife, Mark; Butter, Colin			A Versatile Panel of Reference Gene Assays for the Measurement of Chicken mRNA by Quantitative PCR	PLOS ONE			English	Article							RT-PCR; IDENTIFICATION; PUBLICATION; MODEL; MIQE	Quantitative real-time PCR assays are widely used for the quantification of mRNA within avian experimental samples. Multiple stably-expressed reference genes, selected for the lowest variation in representative samples, can be used to control random technical variation. Reference gene assays must be reliable, have high amplification specificity and efficiency, and not produce signals from contaminating DNA. Whilst recent research papers identify specific genes that are stable in particular tissues and experimental treatments, here we describe a panel of ten avian gene primer and probe sets that can be used to identify suitable reference genes in many experimental contexts. The panel was tested with TaqMan and SYBR Green systems in two experimental scenarios: a tissue collection and virus infection of cultured fibroblasts. GeNorm and NormFinder algorithms were able to select appropriate reference gene sets in each case. We show the effects of using the selected genes on the detection of statistically significant differences in expression. The results are compared with those obtained using 28s ribosomal RNA, the present most widely accepted reference gene in chicken work, identifying circumstances where its use might provide misleading results. Methods for eliminating DNA contamination of RNA reduced, but did not completely remove, detectable DNA. We therefore attached special importance to testing each qPCR assay for absence of signal using DNA template. The assays and analyses developed here provide a useful resource for selecting reference genes for investigations of avian biology.	[Staines, Karen; Batra, Ambalika; Mwangi, William; Maier, Helena J.; Young, John R.; Fife, Mark; Butter, Colin] Pirbright Inst, Pirbright, Surrey, England; [Van Borm, Steven] CODA CERVA Vet & Agrochem Res Ctr, Brussels, Belgium; [Staines, Karen; Butter, Colin] Lincoln Univ, Sch Life Sci, Joseph Banks Labs, Lincoln, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Pirbright Institute; University of Lincoln	Butter, C (corresponding author), Pirbright Inst, Pirbright, Surrey, England.; Butter, C (corresponding author), Lincoln Univ, Sch Life Sci, Joseph Banks Labs, Lincoln, England.	colin.butter@avianimmunology.org	Maier, Helena J/D-6517-2012	batra, ambalika/0000-0001-6798-6714	BBSRC (Biotechnology and Biological Sciences Research Council), Institute Strategic Programme Grant [BBS/E/I/00001423, BB/J016837/1]; BBSRC [BBS/E/I/00002535, BB/J016837/1, BBS/E/I/00001423, BBS/E/I/00001712, BBS/E/I/00001758, BB/L003996/1, BBS/E/I/00001707] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/I/00001712, BBS/E/I/00001707, BBS/E/I/00002535, BB/J016837/1, BBS/E/I/00001758, 1524044, BBS/E/I/00001423, BB/L003996/1] Funding Source: researchfish	BBSRC (Biotechnology and Biological Sciences Research Council), Institute Strategic Programme Grant; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by the BBSRC (Biotechnology and Biological Sciences Research Council) under grant number BBS/E/I/00001423 as part of the Institute Strategic Programme Grant to the Avian Viral Diseases Programme at the Pirbright Institute (KAS, CB, MF, WM, JRY) and grant number BB/J016837/1 (MF, AB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Boggy GJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012355; Borowska D, 2016, VET IMMUNOL IMMUNOP, V170, P20, DOI 10.1016/j.vetimm.2016.01.001; Bustin SA, 2013, NAT METHODS, V10, P1063, DOI 10.1038/nmeth.2697; Bustin SA, 2010, METHODS, V50, P217, DOI 10.1016/j.ymeth.2009.12.006; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; De Boever S, 2008, VET IMMUNOL IMMUNOP, V122, P312, DOI 10.1016/j.vetimm.2007.12.002; Edmunds Richard C, 2014, J Biomol Tech, V25, P54, DOI 10.7171/jbt.14-2502-003; Fan WQ, 2012, BIOSCI BIOTECH BIOCH, V76, P2255, DOI 10.1271/bbb.120521; Khaperskyy DA, 2015, J VIROL, V89, P6528, DOI 10.1128/JVI.00386-15; Moody A, 2000, J VIROL METHODS, V85, P55, DOI 10.1016/S0166-0934(99)00156-1; Olias P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099678; Perkins JR, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-296; Reddy SK, 2008, DEV COMP IMMUNOL, V32, P1076, DOI 10.1016/j.dci.2008.02.004; Rutledge RG, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-96; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034	16	20	20	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0160173	10.1371/journal.pone.0160173	http://dx.doi.org/10.1371/journal.pone.0160173			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27537060	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000381577000013
J	Franzini, PZN; Ramond, JB; Scholtz, CH; Sole, CL; Ronca, S; Cowan, DA				Franzini, Philippa Z. N.; Ramond, Jean-Baptiste; Scholtz, Clarke H.; Sole, Catherine L.; Ronca, Sandra; Cowan, Don A.			The Gut Microbiomes of Two Pachysoma MacLeay Desert Dung Beetle Species (Coleoptera: Scarabaeidae: Scarabaeinae) Feeding on Different Diets	PLOS ONE			English	Article							BACTERIAL COMMUNITY; RETICULITERMES-FLAVIPES; FUNCTIONAL-ANALYSIS; SYMBIOTIC BACTERIA; HIGHER TERMITES; DIVERSITY; HINDGUT; INSECTS; LARVAE; HOST	Micro-organisms inhabiting animal guts benefit from a protected and nutrient-rich environment while assisting the host with digestion and nutrition. In this study we compare, for the first time, the bacterial and fungal gut communities of two species of the small desert dung beetle genus Pachysoma feeding on different diets: the detritivorous P. endroedyi and the dry-dung-feeding P. striatum. Whole-gut microbial communities from 5 individuals of each species were assessed using 454 pyrosequencing of the bacterial 16S rRNA gene and fungal ITS gene regions. The two bacterial communities were significantly different, with only 3.7% of operational taxonomic units shared, and displayed intra-specific variation. The number of bacterial phyla present within the guts of P. endroedyi and P. striatum individuals ranged from 6-11 and 4-7, respectively. Fungal phylotypes could only be detected within the gut of P. striatum. Although the role of host phylogeny in Pachysoma microbiome assembly remains unknown, evidence presented in this study suggests that host diet may be a deterministic factor.	[Franzini, Philippa Z. N.; Ramond, Jean-Baptiste; Ronca, Sandra; Cowan, Don A.] Univ Pretoria, Dept Genet, Genom Res Inst, Ctr Microbial Ecol & Genom, Pretoria, South Africa; [Scholtz, Clarke H.; Sole, Catherine L.] Univ Pretoria, Dept Zool & Entomol, Scarab Res Grp, Pretoria, South Africa	University of Pretoria; University of Pretoria	Cowan, DA (corresponding author), Univ Pretoria, Dept Genet, Genom Res Inst, Ctr Microbial Ecol & Genom, Pretoria, South Africa.	don.cowan@up.ac.za	Sole, Catherine/AAB-3095-2020; Sole, Catherine L/A-9200-2012; Ramond, Jean-Baptiste/AAI-8087-2020; Cowan, Don/E-3991-2012	Sole, Catherine/0000-0002-1578-0973; Sole, Catherine L/0000-0002-1578-0973; Ramond, Jean-Baptiste/0000-0003-4790-6232; Cowan, Don/0000-0001-8059-861X				Ahn JH, 2012, J MICROBIOL, V50, P735, DOI 10.1007/s12275-012-2188-0; Anderson KE, 2012, MOL ECOL, V21, P2282, DOI 10.1111/j.1365-294X.2011.05464.x; Andert J, 2010, FEMS MICROBIOL ECOL, V74, P439, DOI 10.1111/j.1574-6941.2010.00950.x; Andongma AA, 2015, SCI REP-UK, V5, DOI 10.1038/srep09470; Arias-Cordero E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051557; Bell TH, 2014, ISME J, V8, P331, DOI 10.1038/ismej.2013.149; Bertino-Grimaldi D, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-609; Billiet A, 2015, INSECT SCI; Boissiere Anne, 2012, PLoS Pathog, V8, pe1002742, DOI 10.1371/journal.ppat.1002742; Boucias DG, 2013, MOL ECOL, V22, P1836, DOI 10.1111/mec.12230; BRAY J. ROGER, 1957, ECOL MONOGR, V27, P325, DOI 10.2307/1942268; Broderick NA, 2012, GUT MICROBES, V3, P307, DOI 10.4161/gmic.19896; Brune A, 2000, CURR OPIN MICROBIOL, V3, P263, DOI 10.1016/S1369-5274(00)00087-4; Brune A., 2013, PROKARYOTES, P545; Calderon-Cortes N, 2012, ANNU REV ECOL EVOL S, V43, P45, DOI 10.1146/annurev-ecolsys-110411-160312; Calderon-Cortes N, 2010, INT J MOL SCI, V11, P5057, DOI 10.3390/ijms11125056; Chandler JA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002272; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Colman DR, 2012, MOL ECOL, V21, P5124, DOI 10.1111/j.1365-294X.2012.05752.x; Coon KL, 2014, MOL ECOL, V23, P2727, DOI 10.1111/mec.12771; Correa VR, 2012, APPL ENVIRON MICROB, V78, P6327, DOI 10.1128/AEM.00892-12; Dillon RJ, 2004, ANNU REV ENTOMOL, V49, P71, DOI 10.1146/annurev.ento.49.061802.123416; Dillon RJ, 2002, J APPL MICROBIOL, V92, P759, DOI 10.1046/j.1365-2672.2002.01581.x; Diouf M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140014; Douglas AE, 2009, FUNCT ECOL, V23, P38, DOI 10.1111/j.1365-2435.2008.01442.x; Douglas AE, 2015, ANNU REV ENTOMOL, V60, P17, DOI 10.1146/annurev-ento-010814-020822; Douglas AE, 2013, J CHEM ECOL, V39, P952, DOI 10.1007/s10886-013-0308-x; Douglas AE, 2011, CELL HOST MICROBE, V10, P359, DOI 10.1016/j.chom.2011.09.001; Engel P, 2013, FEMS MICROBIOL REV, V37, P699, DOI 10.1111/1574-6976.12025; Fierer N, 2008, P NATL ACAD SCI USA, V105, P17994, DOI 10.1073/pnas.0807920105; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; Gibson CM, 2010, ECOL LETT, V13, P223, DOI 10.1111/j.1461-0248.2009.01416.x; Hamady M, 2009, GENOME RES, V19, P1141, DOI 10.1101/gr.085464.108; Hamdi C, 2011, J APPL ENTOMOL, V135, P524, DOI 10.1111/j.1439-0418.2010.01609.x; Harrison JDG, 2003, J NAT HIST, V37, P305, DOI 10.1080/713834683; He SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061126; Holter P, 2013, J MORPHOL, V274, P657, DOI 10.1002/jmor.20123; Holter P, 2011, J MORPHOL, V272, P1007, DOI 10.1002/jmor.10968; Hooper LV, 2002, ANNU REV NUTR, V22, P283, DOI 10.1146/annurev.nutr.22.011602.092259; Huang SW, 2010, INSECT SCI, V17, P175, DOI 10.1111/j.1744-7917.2010.01320.x; Huang XF, 2013, MICROB ECOL, V65, P531, DOI 10.1007/s00248-013-0219-y; Husseneder C, 2010, ENVIRON ENTOMOL, V39, P378, DOI 10.1603/EN09006; Ihrmark K, 2012, FEMS MICROBIOL ECOL, V82, P666, DOI 10.1111/j.1574-6941.2012.01437.x; Jones RT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061218; Karasov WH, 2011, ANNU REV PHYSIOL, V73, P69, DOI 10.1146/annurev-physiol-012110-142152; KAUFMAN MG, 1991, COMP BIOCHEM PHYS A, V98, P117, DOI 10.1016/0300-9629(91)90588-4; Koch H, 2011, P NATL ACAD SCI USA, V108, P19288, DOI 10.1073/pnas.1110474108; Kohler T, 2012, APPL ENVIRON MICROB, V78, P4691, DOI 10.1128/AEM.00683-12; Lagisz M, 2010, INSECT SCI, V17, P465, DOI 10.1111/j.1744-7917.2010.01318.x; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI [DOI 10.4135/9781446279281.N7, DOI 10.1271/BBB.67.1048]; Lim YW, 2010, J MICROBIOL, V48, P284, DOI 10.1007/s12275-010-9369-5; Loy A, 2007, NUCLEIC ACIDS RES, V35, pD800, DOI 10.1093/nar/gkl856; Meeus I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125152; Meriweather M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061465; Miyata R, 2007, BIOSCI BIOTECH BIOCH, V71, P1244, DOI 10.1271/bbb.60672; Montagna M, 2015, INSECT SCI, V22, P340, DOI 10.1111/1744-7917.12143; Montagna M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117439; Moran NA, 2015, CURR OPIN INSECT SCI, V10, P22, DOI 10.1016/j.cois.2015.04.003; Nardi JB, 2002, J INSECT PHYSIOL, V48, P751, DOI 10.1016/S0022-1910(02)00105-1; Nguyen NH, 2007, MYCOLOGIA, V99, P842, DOI 10.3852/mycologia.99.6.842; Nichols E, 2008, BIOL CONSERV, V141, P1461, DOI 10.1016/j.biocon.2008.04.011; Ohkuma M, 2003, APPL MICROBIOL BIOT, V61, P1, DOI 10.1007/s00253-002-1189-z; Osei-Poku J, 2012, MOL ECOL, V21, P5138, DOI 10.1111/j.1365-294X.2012.05759.x; Pandey N, 2016, INSECT SCI, V23, P704, DOI 10.1111/1744-7917.12220; Park DS, 2007, J MICROBIOL, V45, P394; Petti S, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0078999, 10.1371/journal.pone.0073827]; Poulsen M, 2015, ENVIRON MICROBIOL, V17, P2562, DOI 10.1111/1462-2920.12765; Pramono AK, 2015, INT J SYST EVOL MICR, V65, P681, DOI 10.1099/ijs.0.070391-0; Priya NG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030768; Reid NM, 2011, APPL ENVIRON MICROB, V77, P7000, DOI 10.1128/AEM.05609-11; Sabree ZL, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-138; Santana RH, 2015, MICROB ECOL, V70, P545, DOI 10.1007/s00248-015-0581-z; Santo Domingo JW, 1998, MOL ECOL, V7, P761, DOI 10.1046/j.1365-294x.1998.00390.x; Schauer C, 2014, PYROTAG SEQUENCING G; Schauer C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085861; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; SCHOLTZ CH, 1989, J ARID ENVIRON, V16, P305, DOI 10.1016/S0140-1963(18)30946-7; Shao MW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134542; Shi ZH, 2012, INT J MOL SCI, V13, P6266, DOI 10.3390/ijms13056266; Soininen EM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115335; Sole CL, 2005, J BIOGEOGR, V32, P75, DOI 10.1111/j.1365-2699.2004.01124.x; Suh SO, 2005, MYCOL RES, V109, P261, DOI 10.1017/S0953756205002388; Suh SO, 2004, INT J SYST EVOL MICR, V54, P2409, DOI 10.1099/ijs.0.63246-0; Suh SO, 2008, FEMS YEAST RES, V8, P88, DOI 10.1111/j.1567-1364.2007.00320.x; Tagliavia M, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-136; Tsuchida T, 2010, SCIENCE, V330, P1102, DOI 10.1126/science.1195463; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Vasanthakumar A, 2008, ENVIRON ENTOMOL, V37, P1344, DOI 10.1603/0046-225X(2008)37[1344:GMOAIS]2.0.CO;2; Waite DW, 2015, ARCH MICROBIOL, V197, P603, DOI 10.1007/s00203-015-1094-3; Wang AL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106988; Wang SB, 2012, P NATL ACAD SCI USA, V109, P12734, DOI 10.1073/pnas.1204158109; Wang Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024767; Warnecke F, 2007, NATURE, V450, P560, DOI 10.1038/nature06269; Wong ACN, 2013, ISME J, V7, P1922, DOI 10.1038/ismej.2013.86; Yang YJ, 2014, INT J SYST EVOL MICR, V64, P2956, DOI 10.1099/ijs.0.061739-0; Yun JH, 2014, APPL ENVIRON MICROB, V80, P5254, DOI 10.1128/AEM.01226-14; Zhang ML, 2014, MICROB ECOL, V68, P416, DOI 10.1007/s00248-014-0388-3; Zhang N, 2003, J INVERTEBR PATHOL, V84, P226, DOI 10.1016/j.jip.2003.10.002; Zouache K, 2012, MOL ECOL, V21, P2297, DOI 10.1111/j.1365-294X.2012.05526.x	100	26	28	4	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2016	11	8							e0161118	10.1371/journal.pone.0161118	http://dx.doi.org/10.1371/journal.pone.0161118			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4YN	27532606	Green Submitted, gold, Green Published			2022-12-27	WOS:000381487600060
J	Hoffmann, J; Thomassen, K; Stumpp, P; Grothoff, M; Engel, C; Kahn, T; Stepan, H				Hoffmann, Janine; Thomassen, Katrin; Stumpp, Patrick; Grothoff, Matthias; Engel, Christoph; Kahn, Thomas; Stepan, Holger			New MRI Criteria for Successful Vaginal Breech Delivery in Primiparae	PLOS ONE			English	Article							PLANNED CESAREAN-SECTION; TERM BREECH; PELVIMETRY; MANAGEMENT; TRIAL; BIRTH; NETHERLANDS; OUTCOMES; WOMEN; STILL	Background Even if lower vaginal delivery success rates and impaired neonatal short-term outcomes have been reported for primiparous women with breech presentation, vaginal breech delivery remains an option for carefully selected patients. Because Magnetic resonance imaging (MRI) pelvimetry can provide additional information on maternal pelvic morphology, we sought to identify new MRI parameters that predict successful vaginal breech delivery. Methods In this retrospective unicentre study, 240 primiparous women with breech presentation at term underwent MRI pelvimetry. For all patients vaginal delivery was planned, according to German guidelines and if the conjugata vera (CV) was >= 12 cm. The patients with uneventful vaginal deliveries and the patients who underwent a secondary caesarean section were compared according to pelvimetric parameters and outcomes. Regression analyses were performed. Results In the vaginal delivery group (n = 162, (67.5%)), the distance between the spinae ischiadicae (interspinous diameter, ISD) was significantly enlarged. The ISD significantly influenced the mode of delivery in the regression analyses. The CV did not significantly differ between the groups. The patients with successful vaginal deliveries were significantly younger than the patients who underwent caesarean section. In the receiver operating characteristic (ROC) analysis, the area under the curve (AUC) for ISD was 67.7% (p<0.001, 95% CI [0.303-0.642]) and was higher considering the mother's age (AUC = 73.1%, p<0.001, 95% CI [0.662-0.800]). The neonatal short-term outcomes were comparable in both groups. Conclusion The additional use of ISD may predict successful vaginal breech delivery and may be superior to the CV, which is more commonly used.	[Hoffmann, Janine; Thomassen, Katrin; Stepan, Holger] Univ Leipzig, Dept Obstet, Liebigstr 20a, D-04103 Leipzig, Germany; [Stumpp, Patrick; Kahn, Thomas] Univ Leipzig, Dept Radiol, Liebigstr 20, D-04103 Leipzig, Germany; [Grothoff, Matthias] Univ Leipzig, Ctr Heart, Dept Radiol, Struempellstr 39, D-04289 Leipzig, Germany; [Engel, Christoph] Univ Leipzig, Inst Med Informat Stat & Epidemiol, Haertelstr 16-18, D-04107 Leipzig, Germany	Leipzig University; Leipzig University; Heart Center Leipzig GMBH; Leipzig University; University of Hamburg; University Medical Center Hamburg-Eppendorf; Leipzig University	Hoffmann, J (corresponding author), Univ Leipzig, Dept Obstet, Liebigstr 20a, D-04103 Leipzig, Germany.	janine.hoffmann@medizin.uni-leipzig.de	Hoffmann, Janine/AAZ-1828-2020	Engel, Christoph/0000-0002-7247-282X				ACOG Committee on Obstetric Practice, 2006, Obstet Gynecol, V108, P235; Alarab M, 2004, OBSTET GYNECOL, V103, P407, DOI 10.1097/01.AOG.0000113625.29073.4c; Azria E, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.08.027; BERGER R, 1994, EUR J OBSTET GYN R B, V55, P97, DOI 10.1016/0028-2243(94)90061-2; BINGHAM P, 1987, OBSTET GYNECOL, V69, P965; Burgos J, 2015, J PERINATOL, V35, P803, DOI 10.1038/jp.2015.75; Burke G, 2006, BJOG-INT J OBSTET GY, V113, P969, DOI 10.1111/j.1471-0528.2006.00997.x; DIEHL J, 1968, ACTA OBSTET GYN SCAN, VS 47, P5, DOI 10.3109/00016346809156614; Diro M, 1999, AM J OBSTET GYNECOL, V181, P247, DOI 10.1016/S0002-9378(99)70543-0; Ghosh MK, 2005, J REPROD MED, V50, P108; Gilbert WM, 2003, OBSTET GYNECOL, V102, P911, DOI 10.1016/S0029-7844(03)00809-3; GIMOVSKY ML, 1994, J REPROD MED, V39, P489; Glezerman M, 2006, AM J OBSTET GYNECOL, V194, P20, DOI 10.1016/j.ajog.2005.08.039; Goffinet F, 2006, AM J OBSTET GYNECOL, V194, P1002, DOI 10.1016/j.ajog.2005.10.817; Hannah ME, 2004, AM J OBSTET GYNECOL, V191, P917, DOI 10.1016/j.ajog.2004.08.004; Hannah ME, 2000, LANCET, V356, P1375, DOI 10.1016/S0140-6736(00)02840-3; Huerta-Enochian GS, 2006, AM J OBSTET GYNECOL, V194, P1689, DOI 10.1016/j.ajog.2006.03.008; Impey LWM, 2006, MANAGEMENT BREECH PR; JOYCE DN, 1975, BMJ-BRIT MED J, V4, P505, DOI 10.1136/bmj.4.5995.505; Keller TM, 2003, RADIOLOGY, V227, P37, DOI 10.1148/radiol.2271011658; Korhonen U, 2010, EUR J RADIOL, V75, pE56, DOI 10.1016/j.ejrad.2009.11.018; MERZ E, 1988, ULTRASCHALL MED, V9, P15, DOI 10.1055/s-2007-1011588; Michel SCA, 2002, AM J ROENTGENOL, V179, DOI 10.2214/ajr.179.4.1791063; OLEARY JA, 1979, OBSTET GYNECOL, V53, P341; PFAMMATTER T, 1990, ROFO FORTSCHR RONTG, V153, P706, DOI 10.1055/s-2008-1033469; Reitter A, 2014, AM J OBSTET GYNECOL, V211, DOI 10.1016/j.ajog.2014.06.029; Rietberg CCT, 2005, BJOG-INT J OBSTET GY, V112, P205, DOI 10.1111/j.1471-0528.2004.00317.x; Sporri S, 2002, AM J ROENTGENOL, V179, P137; STARK DD, 1985, AM J ROENTGENOL, V144, P947, DOI 10.2214/ajr.144.5.947; van Loon AJ, 1997, LANCET, V350, P1799, DOI 10.1016/S0140-6736(97)05431-7; van Roosmalen J, 2014, LANCET, V383, P1863, DOI 10.1016/S0140-6736(14)60618-8; Vlemmix F, 2014, ACTA OBSTET GYN SCAN, V93, P888, DOI 10.1111/aogs.12449; WATSON WJ, 1984, OBSTET GYNECOL, V64, P638; WENTZ KU, 1994, GEBURTSH FRAUENHEILK, V54, P204, DOI 10.1055/s-2007-1023583; Whyte H, 2004, AM J OBSTET GYNECOL, V191, P864, DOI 10.1016/j.ajog.2004.06.056	35	12	14	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2016	11	8							e0161028	10.1371/journal.pone.0161028	http://dx.doi.org/10.1371/journal.pone.0161028			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4YN	27532122	gold, Green Submitted, Green Published			2022-12-27	WOS:000381487600055
J	Kim, M; Song, KH; Kim, CJ; Song, M; Choe, PG; Park, WB; Bang, JH; Hwang, H; Kim, ES; Park, SW; Kim, NJ; Oh, MD; Kim, HB				Kim, Moonsuk; Song, Kyoung-Ho; Kim, Chung-Jong; Song, Minkyo; Choe, Pyoeng Gyun; Park, Wan Beom; Bang, Ji Hwan; Hwang, Hee; Kim, Eu Suk; Park, Sang-Won; Kim, Nam Joong; Oh, Myoung-don; Kim, Hong Bin			Electronic Alerts with Automated Consultations Promote Appropriate Antimicrobial Prescriptions	PLOS ONE			English	Article							BLOOD-STREAM INFECTIONS; STEWARDSHIP PROGRAMS; STAPHYLOCOCCUS-AUREUS; ANTIBIOTIC-THERAPY; IMPACT; BACTEREMIA; MORTALITY; TRIAL; INTERVENTION; SPECIALISTS	Background To promote appropriate antimicrobial use in bloodstream infections (BSIs), we initiated an intervention program consisting of electronic alerts and automated infectious diseases consultations in which the identification and antimicrobial susceptibility test (ID/AST) results were reported. Methods We compared the appropriateness of antimicrobial prescriptions and clinical outcomes in BSIs before and after initiation of the program. Appropriateness was assessed in terms of effective therapy, optimal therapy, de-escalation therapy, and intravenous to oral switch therapy. Results There were 648 BSI episodes in the pre-program period and 678 in the program period. The proportion of effective, optimal, and de-escalation therapies assessed 24 hours after the reporting of the ID/AST results increased from 87.8% (95% confidence interval [CI] 85.590.5), 64.4% (95% CI 60.8-68.1), and 10.0% (95% CI 7.5-12.6) in the pre-program period, respectively, to 94.4% (95% CI 92.7-96.1), 81.4% (95% CI 78.4-84.3), and 18.6% (95% CI 15.3-21.9) in the program period, respectively. Kaplan-Meier analyses and log-rank tests revealed that the time to effective (p<0.001), optimal (p<0.001), and de-escalation (p = 0.017) therapies were significantly different in the two periods. Segmented linear regression analysis showed the increase in the proportion of effective (p = 0.015), optimal (p<0.001), and de-escalation (p = 0.010) therapies at 24 hours after reporting, immediately after program initiation. No significant baseline trends or changes in trends were identified. There were no significant differences in time to intravenous to oral switch therapy, length of stay, and 30-day mortality rate. Conclusion This novel form of stewardship program based on intervention by infectious disease specialists and information technology improved antimicrobial prescriptions in BSIs.	[Kim, Moonsuk; Song, Kyoung-Ho; Kim, Chung-Jong; Kim, Eu Suk; Kim, Hong Bin] Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Songnam, South Korea; [Song, Kyoung-Ho; Choe, Pyoeng Gyun; Park, Wan Beom; Bang, Ji Hwan; Kim, Eu Suk; Park, Sang-Won; Kim, Nam Joong; Oh, Myoung-don; Kim, Hong Bin] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Song, Minkyo] Seoul Natl Univ, Coll Med, Dept Prevent Med, Seoul, South Korea; [Hwang, Hee] Seoul Natl Univ, Bundang Hosp, Med Informat Ctr, Songnam, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Song, KH (corresponding author), Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Songnam, South Korea.; Song, KH (corresponding author), Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea.	khsongmd@gmail.com	Park, Wan Beom/GLU-9886-2022; Park, Wan Beom/AGO-0374-2022; Song, Minkyo/AAE-9095-2020; Kim, Hong Bin/J-5452-2012	Park, Wan Beom/0000-0003-0022-9625; Song, Minkyo/0000-0002-9412-2871; Kim, Hong Bin/0000-0001-6262-372X; Song, Kyoung-Ho/0000-0002-4517-3840; Kim, Moonsuk/0000-0001-8640-939X				[Anonymous], 2015, HLTH GLANCE 2015; ARBO MDJ, 1994, ARCH INTERN MED, V154, P2641, DOI 10.1001/archinte.1994.00420230024004; Avdic E, 2014, INFECT DIS CLIN N AM, V28, P215, DOI 10.1016/j.idc.2014.01.002; Bauer KA, 2014, CLIN INFECT DIS, V59, pS134, DOI 10.1093/cid/ciu547; Bouza E, 2004, CLIN INFECT DIS, V39, P1161, DOI 10.1086/424520; Byl B, 1999, CLIN INFECT DIS, V29, P60, DOI 10.1086/520182; CHARLSON M, 1994, J CLIN EPIDEMIOL, V47, P1245, DOI 10.1016/0895-4356(94)90129-5; Forrest GN, 2014, CLIN INFECT DIS, V59, pS122, DOI 10.1093/cid/ciu565; Friedman ND, 2002, ANN INTERN MED, V137, P791, DOI 10.7326/0003-4819-137-10-200211190-00007; Hamilton-Miller J. M. T., 1996, Clin Microbiol Infect, V2, P12, DOI 10.1111/j.1469-0691.1996.tb00194.x; Harbarth S, 1998, ARCH INTERN MED, V158, P182, DOI 10.1001/archinte.158.2.182; Harbarth S, 2003, AM J MED, V115, P529, DOI 10.1016/j.amjmed.2003.07.005; Jenkins TC, 2008, CLIN INFECT DIS, V46, P1000, DOI 10.1086/529190; Kullar R, 2014, INFECT DIS CLIN N AM, V28, P291, DOI 10.1016/j.idc.2014.01.009; Lesprit P, 2013, CLIN MICROBIOL INFEC, V19, pE91, DOI 10.1111/1469-0691.12062; McGregor JC, 2007, CLIN INFECT DIS, V45, P329, DOI 10.1086/519283; Paul M, 2010, ANTIMICROB AGENTS CH, V54, P4851, DOI 10.1128/AAC.00627-10; Pogue JM, 2014, INFECT CONT HOSP EP, V35, P132, DOI 10.1086/674849; Pollack LA, 2014, CLIN INFECT DIS, V59, pS97, DOI 10.1093/cid/ciu542; Pulcini C, 2014, CLIN MICROBIOL INFEC, V20, P963, DOI 10.1111/1469-0691.12751; Retamar P, 2012, ANTIMICROB AGENTS CH, V56, P472, DOI 10.1128/AAC.00462-11; RINTALA E, 1991, SCAND J INFECT DIS, V23, P341, DOI 10.3109/00365549109024321; Shardell M, 2007, CLIN INFECT DIS, V45, P901, DOI 10.1086/521255; Tissot F, 2014, J INFECTION, V69, P226, DOI 10.1016/j.jinf.2014.05.004	24	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2016	11	8							e0160551	10.1371/journal.pone.0160551	http://dx.doi.org/10.1371/journal.pone.0160551			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4YN	27532125	Green Published, gold			2022-12-27	WOS:000381487600035
J	Liu, M; Jing, HJ; Zhang, JJ; Che, G; Zhou, M; Gao, Z; Li, SS; Ren, ZZ; Hao, L; Liu, Y; Jia, L				Liu, Min; Jing, Huijuan; Zhang, Jianjun; Che, Gen; Zhou, Meng; Gao, Zheng; Li, Shangshang; Ren, Zhenzhen; Hao, Long; Liu, Yu; Jia, Le			Optimization of Mycelia Selenium Polysaccharide Extraction from Agrocybe cylindracea SL-02 and Assessment of their Antioxidant and Anti-Ageing Activities	PLOS ONE			English	Article							IN-VITRO; PLEUROTUS-OSTREATUS; D-GALACTOSE; MUSHROOMS; PURIFICATION; SENESCENCE; HEALTH; ZINC; RATS; MICE	The aim of the present study was to optimize the purification of mycelia selenium polysaccharides (MSPS) from Agrocybe cylindracea SL-02 and characterize their in vitro antioxidant and in vivo anti-ageing activities. The Box-Behnken experimental design (BBD) was evaluated, which showed that the optimum conditions included an extraction temperature of 94.99 degrees C, a pH of 9 and a precipitation temperature of 12 degrees C, and the predicted yield was 11.036 +/- 0.31%. The in vitro antioxidant assay demonstrated that MSPS had potential effects on scavenging and enhanced the reducing power of reactive oxygen species. The in vivo anti-ageing evaluation showed that MSPS significantly reduced the malonaldehyde (MDA) contents and total cholesterol (CHOL) levels, and remarkably improved the activities of superoxide dismutase (SOD), glutathione peroxidase (GSH-Px), and total antioxidant capacity (T-AOC) in mice in response to D-galactose-induced ageing. Furthermore, the characteristic analysis of MSPS indicated a selenium content of 1.76 +/- 0.10 mg/g at a concentration of 6 mu g/mL in liquid media and a monosaccharide composition of rhamnose, arabinose, mannose, glucose and galactose at a molar ratio of 29:3:1:18.8:2.7. These results suggest that MSPS might be suitable for functional foods and natural drugs on preventing the ageing progress induced by toxic chemicals.	[Liu, Min; Liu, Yu] Beijing Acad Agr & Forestry Sci, Beijing Engn Res Ctr Edible Mushroom, Key Lab Urban Agr North, Inst Plant & Environm Protect,Minist Agr, Beijing, Peoples R China; [Liu, Min; Jing, Huijuan; Zhang, Jianjun; Gao, Zheng; Li, Shangshang; Ren, Zhenzhen; Hao, Long; Jia, Le] Shandong Agr Univ, Coll Life Sci, Tai An, Shandong, Peoples R China; [Che, Gen] Shandong Acad Agr Sci, Jinan, Peoples R China; [Zhou, Meng] Qual & Safety Monitoring Ctr Anim Prod, Jinan, Peoples R China	Beijing Academy of Agriculture & Forestry; Ministry of Agriculture & Rural Affairs; Shandong Agricultural University; Shandong Academy of Agricultural Sciences	Liu, Y (corresponding author), Beijing Acad Agr & Forestry Sci, Beijing Engn Res Ctr Edible Mushroom, Key Lab Urban Agr North, Inst Plant & Environm Protect,Minist Agr, Beijing, Peoples R China.; Jia, L (corresponding author), Shandong Agr Univ, Coll Life Sci, Tai An, Shandong, Peoples R China.	ly6828@sina.com; jiale0525@163.com			Mushroom Technology System of Shandong Province [SDAIT-07-05]	Mushroom Technology System of Shandong Province	This work was funded by Mushroom Technology System of Shandong Province (SDAIT-07-05), Le Jia, Presenter.	[Anonymous], 1994, CARBOHYDRATE ANAL PR; Balaban H, 2017, MOL NEUROBIOL, V54, P2852, DOI 10.1007/s12035-016-9835-0; Capek P, 2009, INT J BIOL MACROMOL, V44, P75, DOI 10.1016/j.ijbiomac.2008.10.007; da Silva MCS, 2012, FOOD CHEM, V131, P558, DOI 10.1016/j.foodchem.2011.09.023; Dong CH, 2008, LWT-FOOD SCI TECHNOL, V41, P669, DOI 10.1016/j.lwt.2007.05.002; Falandysz J, 2013, APPL MICROBIOL BIOT, V97, P477, DOI 10.1007/s00253-012-4552-8; Falandysz J, 2013, FOOD CHEM, V138, P242, DOI 10.1016/j.foodchem.2012.10.046; Farage MA, 2008, AGING CLIN EXP RES, V20, P195; Figlas D, 2010, J MED FOOD, V13, P469, DOI 10.1089/jmf.2008.0284; Gan D, 2011, CARBOHYD POLYM, V84, P997, DOI 10.1016/j.carbpol.2010.12.058; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; Hifney AF, 2016, FOOD HYDROCOLLOID, V54, P77, DOI 10.1016/j.foodhyd.2015.09.022; Hsieh HM, 2009, FOOD CHEM TOXICOL, V47, P625, DOI 10.1016/j.fct.2008.12.026; Huang SJ, 2006, LWT-FOOD SCI TECHNOL, V39, P379, DOI 10.1016/j.lwt.2005.02.012; Jain RB, 2015, J TRACE ELEM MED BIO, V30, P142, DOI 10.1016/j.jtemb.2014.12.004; Jayakumar T, 2011, FOOD RES INT, V44, P851, DOI 10.1016/j.foodres.2011.03.015; Johnson FB, 1999, CELL, V96, P291, DOI 10.1016/S0092-8674(00)80567-X; Kacurakova M, 2000, CARBOHYD POLYM, V43, P195, DOI 10.1016/S0144-8617(00)00151-X; Kim HO, 2005, BIORESOURCE TECHNOL, V96, P1175, DOI 10.1016/j.biortech.2004.09.021; Kumar A, 2011, J ASIAN NAT PROD RES, V13, P42, DOI 10.1080/10286020.2010.544253; Li B, 2013, CARBOHYD POLYM, V92, P1991, DOI 10.1016/j.carbpol.2012.11.088; Luo AX, 2010, CARBOHYD POLYM, V79, P1014, DOI 10.1016/j.carbpol.2009.10.033; Maseko T, 2013, FOOD CHEM, V141, P3681, DOI 10.1016/j.foodchem.2013.06.027; Naziroglu M, 2004, TOXICOLOGY, V195, P221, DOI 10.1016/j.tox.2003.10.012; NOHL H, 1993, BRIT MED BULL, V49, P653, DOI 10.1093/oxfordjournals.bmb.a072638; OYAIZU M, 1986, Japanese Journal of Nutrition, V44, P307; Rayman MP, 2000, LANCET, V356, P233, DOI 10.1016/S0140-6736(00)02490-9; Sheng JC, 2007, FOOD CHEM, V105, P533, DOI 10.1016/j.foodchem.2007.04.018; SMIRNOFF N, 1989, PHYTOCHEMISTRY, V28, P1057, DOI 10.1016/0031-9422(89)80182-7; Soares JR, 1997, FREE RADICAL RES, V26, P469, DOI 10.3109/10715769709084484; Sun T, 2005, FOOD CHEM, V90, P743, DOI 10.1016/j.foodchem.2004.04.035; Thomet U, 1999, EUR FOOD RES TECHNOL, V209, P317, DOI 10.1007/s002170050502; Tsai SY, 2007, LWT-FOOD SCI TECHNOL, V40, P1392, DOI 10.1016/j.lwt.2006.10.001; Tsai SY, 2006, FOOD CHEM, V98, P670, DOI 10.1016/j.foodchem.2005.07.003; Wu Z, 2015, INT J BIOL MACROMOL, V74, P224, DOI 10.1016/j.ijbiomac.2014.12.010; Xiao N, 2004, SHOCK, V21, P276; Ye CL, 2012, CARBOHYD POLYM, V89, P1131, DOI 10.1016/j.carbpol.2012.03.084; Ye M, 2012, FOOD CHEM, V132, P338, DOI 10.1016/j.foodchem.2011.10.087; You QH, 2014, CARBOHYD POLYM, V99, P1, DOI 10.1016/j.carbpol.2013.07.088; Zelko IN, 2002, FREE RADICAL BIO MED, V33, P337, DOI 10.1016/S0891-5849(02)00905-X; Zhang P, 2014, J BASIC MICROB, V54, P866, DOI 10.1002/jobm.201200757; Zheng L, 2015, J SCI FOOD AGR, V95, P3117, DOI 10.1002/jsfa.7048; Zhong WQ, 2013, INT J BIOL MACROMOL, V60, P355, DOI 10.1016/j.ijbiomac.2013.06.018; ZHOU YC, 1991, BIOCHEM PHARMACOL, V42, P1177	44	29	32	3	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2016	11	8							e0160799	10.1371/journal.pone.0160799	http://dx.doi.org/10.1371/journal.pone.0160799			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4YN	27532123	Green Published, gold, Green Submitted			2022-12-27	WOS:000381487600045
J	Matanda, DJ; Urke, HB; Mittelmark, MB				Matanda, Dennis Juma; Urke, Helga Bjornoy; Mittelmark, Maurice B.			Changes in Optimal Childcare Practices in Kenya: Insights from the 2003, 2008-9 and 2014 Demographic and Health Surveys	PLOS ONE			English	Article							ORAL REHYDRATION THERAPY; INFLUENZAE TYPE-B; NET USE; DEVELOPING-COUNTRIES; COVERAGE; URBAN; IMMUNIZATION; SERVICES; DIARRHEA; EQUITY	Objective(s) Using nationally representative surveys conducted in Kenya, this study examined optimal health promoting childcare practices in 2003, 2008-9 and 2014. This was undertaken in the context of continuous child health promotion activities conducted by government and non-government organizations throughout Kenya. It was the aim of such activities to increase the prevalence of health promoting childcare practices; to what extent have there been changes in optimal childcare practices in Kenya during the 11-year period under study? Methods Cross-sectional data were obtained from the Kenya Demographic and Health Surveys conducted in 2003, 2008-9 and 2014. Women 15-49 years old with children 0-59 months were interviewed about a range of childcare practices. Logistic regression analysis was used to examine changes in, and correlates of, optimal childcare practices using the 2003, 2008-9 and 2014 data. Samples of 5949, 6079 and 20964 women interviewed in 2003, 2008-9 and 2014 respectively were used in the analysis. Results Between 2003 and 2014, there were increases in all health facility-based childcare practices with major increases observed in seeking medical treatment for diarrhoea and complete child vaccination. Mixed results were observed in home-based care where increases were noted in the use of insecticide treated bed nets, sanitary stool disposal and use of oral rehydration solutions, while decreases were observed in the prevalence of urging more fluid/food during diarrhoea and consumption of a minimum acceptable diet. Logit models showed that area of residence (region), household wealth, maternal education, parity, mother's age, child's age and pregnancy history were significant determinants of optimal childcare practices across the three surveys. Conclusions The study observed variation in the uptake of the recommended optimal childcare practices in Kenya. National, regional and local child health promotion activities, coupled with changes in society and in living conditions between 2003 and 2014, could have influenced uptake of certain recommended childcare practices in Kenya. Decreases in the prevalence of children who were offered same/more fluid/food when they had diarrhea and children who consumed the minimum acceptable diet is alarming and perhaps a red flag to stakeholders who may have focused more on health facility-based care at the expense of homebased care. Concerted efforts are needed to address the consistent inequities in the uptake of the recommended childcare practices. Such efforts should be cognizant of the underlying factors that affect childcare in Kenya, herein defined as region, household wealth, maternal education, parity, mother's age, child's age and pregnancy history.	[Matanda, Dennis Juma] Populat Council, Nairobi, Kenya; [Matanda, Dennis Juma; Urke, Helga Bjornoy; Mittelmark, Maurice B.] Univ Bergen, Multicultural Venues Hlth Gender & Social Justice, Bergen, Norway; [Urke, Helga Bjornoy; Mittelmark, Maurice B.] Univ Bergen, Fac Psychol, Dept Hlth Promot & Dev, Bergen, Norway	University of Bergen; University of Bergen	Urke, HB (corresponding author), Univ Bergen, Multicultural Venues Hlth Gender & Social Justice, Bergen, Norway.; Urke, HB (corresponding author), Univ Bergen, Fac Psychol, Dept Hlth Promot & Dev, Bergen, Norway.	helga.urke@uib.no						Abou-Zahr CL, 2003, ANTENATAL CARE DEV C; Abuya BA, 2011, MATERN CHILD HLTH J, V15, P1389, DOI 10.1007/s10995-010-0670-z; Akumu AO, 2007, B WORLD HEALTH ORGAN, V85, P511, DOI 10.2471/BLT.06.034686; [Anonymous], 2015, ANN EVALUATION ABOLI; Arimond M, 2004, J NUTR, V134, P2579, DOI 10.1093/jn/134.10.2579; Baume CA, 2007, AM J TROP MED HYG, V77, P963, DOI 10.4269/ajtmh.2007.77.963; Bell A, 2013, SOC SCI MED, V93, P163, DOI 10.1016/j.socscimed.2013.04.029; Blum LS, 2011, AM J TROP MED HYG, V85, P1126, DOI 10.4269/ajtmh.2011.11-0171; Boerma J T, 1993, World Health Stat Q, V46, P222; Boerma JT, 2008, LANCET, V371, P1259, DOI 10.1016/S0140-6736(08)60560-7; Bwibo NO, 2003, J NUTR, V133, p3936S, DOI 10.1093/jn/133.11.3936S; Cho HY, 2007, J COMMUN, V57, P293, DOI 10.1111/j.1460-2466.2007.00344.x; Chuma J, 2013, FREE MATERNAL CARE R; Chuma J, 2007, TROP MED INT HEALTH, V12, P673, DOI 10.1111/j.1365-3156.2007.01825.x; Clarke PM, 2008, J HEALTH ECON, V27, P1275, DOI 10.1016/j.jhealeco.2008.05.012; Clasen TF, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007180.pub2; COUGHLIN SS, 1990, J CLIN EPIDEMIOL, V43, P87, DOI 10.1016/0895-4356(90)90060-3; Engle P.L., 1997, CARE NUTR CONCEPTS M; Engle PL, 1997, ENVIRON URBAN, V9, P253, DOI 10.1177/095624789700900213; Fotso JC, 2007, HEALTH PLACE, V13, P205, DOI 10.1016/j.healthplace.2006.01.004; Government of Kenya, 2011, RAPID QUALITATIVE AS; Graft-Johnson J, 2006, CONTINUUM CARE MATER; Grantham-McGregor S, 2007, LANCET, V369, P60, DOI 10.1016/S0140-6736(07)60032-4; Hawley WA, 2003, AM J TROP MED HYG, V68, P121, DOI 10.4269/ajtmh.2003.68.121; HILL Z, 2004, FAMILY COMMUNITY PRA; [ICF International KNBS], 2014, KEN DEM HLT SURV 201; Kenya national Bureau of statistics (KNBS) and ICF macro, 2010, KEN DEM HLTH SURV 20; Kenya National Bureau of Statistics; Ministry of Health; National AIDS Control Council; The DHS Program ICF International KDHS, 2003, KEN DEM HLTH SURV 20; Kerber KJ, 2007, LANCET, V370, P1358, DOI 10.1016/S0140-6736(07)61578-5; Kreps GL, 2015, J NATURE SCI, V1, P35; Magadi MA, 2000, SOC SCI MED, V51, P551, DOI 10.1016/S0277-9536(99)00495-5; Magadi MA, 2007, SOC SCI MED, V64, P1311, DOI 10.1016/j.socscimed.2006.11.004; Marston C, 2003, POP STUD-J DEMOG, V57, P77, DOI 10.1080/0032472032000061749; Masmalai A., 2010, Journal of Population and Social Studies, V19, P123; Matanda DJ, 2014, NUTR RES, V34, P507, DOI 10.1016/j.nutres.2014.05.004; Matanda DJ, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-5; Matanda DJ, 2015, CHILD PHYS GROWTH CA; Menon Purnima, 2000, Food and Nutrition Bulletin, V21, P282; Ministry of Health, 2001, NAT MAL STRAT 2001 2; Ministry of Planning and National Development, 2003, KEN EC REC STRAT WEA; Ministry of Public Health and Sanitation, 2010, POL GUID CONTR MAN D; Ministry of Public Health and Sanitation, 2007, NAT STRAT INF YOUNG; Moisi JC, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-142; Munos MK, 2010, INT J EPIDEMIOL, V39, P75, DOI 10.1093/ije/dyq025; Ndiritu M, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-132; Noor AM, 2007, PLOS MED, V4, P1341, DOI 10.1371/journal.pmed.0040255; Noor AM, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-5; Okeke TA, 2010, HEALTH POLICY, V95, P62, DOI 10.1016/j.healthpol.2009.11.005; Olson CK, 2011, AM J TROP MED HYG, V85, P1134, DOI 10.4269/ajtmh.2011.11-0178; Pagnini DL, 2000, FAM PLANN PERSPECT, V32, P56, DOI 10.2307/2648213; Rutstein S. O., 2004, DHS COMP REPORTS; Say L, 2007, B WORLD HEALTH ORGAN, V85, P812, DOI 10.2471/BLT.06.035659; Smith L.C., 2000, EXPLAINING CHILD MAL; Smith LC, 2005, WORLD DEV, V33, P1285, DOI 10.1016/j.worlddev.2005.03.002; Stephenson K, 2010, NUTR J, V9, DOI 10.1186/1475-2891-9-9; Taffa N, 2005, TROP MED INT HEALTH, V10, P240, DOI 10.1111/j.1365-3156.2004.01381.x; UNICEF, 2008, STAT WORLDS CHILDR 2, V9; Van de Poel E, 2007, SOC SCI MED, V65, P1986, DOI 10.1016/j.socscimed.2007.06.032; van Eijk Anna M, 2006, Reprod Health, V3, P2, DOI 10.1186/1742-4755-3-2; Vijayaraghavan M, 2007, HEALTH POLICY, V83, P27, DOI 10.1016/j.healthpol.2006.11.008; Wamae A, 2009, KENYA WORKING PAPERS; World Health Organization, 2010, IND ASS INF YOUNG CH; Yawn BP, 1998, J CLIN EPIDEMIOL, V51, P399, DOI 10.1016/S0895-4356(97)00304-1; Yeager BAC, 1999, SOC SCI MED, V49, P531, DOI 10.1016/S0277-9536(99)00119-7; Yesuf EA, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-131	66	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2016	11	8							e0161221	10.1371/journal.pone.0161221	http://dx.doi.org/10.1371/journal.pone.0161221			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DT4YN	27532665	Green Published, gold, Green Submitted			2022-12-27	WOS:000381487600078
J	Yasmin, S; Zaka, A; Imran, A; Zahid, MA; Yousaf, S; Rasul, G; Arif, M; Mirza, MS				Yasmin, Sumera; Zaka, Abha; Imran, Asma; Zahid, Muhammad Awais; Yousaf, Sumaira; Rasul, Ghulam; Arif, Muhammad; Mirza, Muhammad Sajjad			Plant Growth Promotion and Suppression of Bacterial Leaf Blight in Rice by Inoculated Bacteria	PLOS ONE			English	Article							SYSTEMIC RESISTANCE; XANTHOMONAS-ORYZAE; FLUORESCENT PSEUDOMONADS; BIOCONTROL AGENTS; INDUCTION; STRAIN; RHIZOBACTERIA; PEROXIDASE; RHIZOSPHERE; DIVERSITY	The present study was conducted to evaluate the potential of rice rhizosphere associated antagonistic bacteria for growth promotion and disease suppression of bacterial leaf blight (BLB). A total of 811 rhizospheric bacteria were isolated and screened against 3 prevalent strains of BLB pathogen Xanthomonas oryzae pv. oryzae (Xoo) of which five antagonistic bacteria, i.e., Pseudomonas spp. E227, E233, Rh323, Serratia sp. Rh269 and Bacillus sp. Rh219 showed antagonistic potential (zone of inhibition 1-19 mm). Production of siderophores was found to be the common biocontrol determinant and all the strains solubilized inorganic phosphate (82-116 mu g mL(-1)) and produced indole acetic acid (0.48-1.85 mg L-1) in vitro. All antagonistic bacteria were non-pathogenic to rice, and their co-inoculation significantly improved plant health in terms of reduced diseased leaf area (80%), improved shoot length (31%), root length (41%) and plant dry weight (60%) as compared to infected control plants. Furthermore, under pathogen pressure, bacterial inoculation resulted in increased activity of defense related enzymes including phenylalanine ammonia-lyase and polyphenol oxidase, along with 86% increase in peroxidase and 53% increase in catalase enzyme activities in plants inoculated with Pseudomonas sp. Rh323 as well as co-inoculated plants. Bacterial strains showed good colonization potential in the rice rhizosphere up to 21 days after seed inoculation. Application of bacterial consortia in the field resulted in an increase of 31% in grain yield and 10% in straw yield over non-inoculated plots. Although, yield increase was statistically non-significant but was accomplished with overall saving of 20% chemical fertilizers. The study showed that Pseudomonas sp. Rh323 can be used to develop dual-purpose inoculum which can serve not only to suppress BLB but also to promote plant growth in rice.	[Yasmin, Sumera; Zaka, Abha; Imran, Asma; Zahid, Muhammad Awais; Rasul, Ghulam; Arif, Muhammad; Mirza, Muhammad Sajjad] NIBGE, Faisalabad, Pakistan; [Zahid, Muhammad Awais] Univ Sargodha, Univ Coll Agr, Dept Plant Pathol, Sargodha, Pakistan; [Yousaf, Sumaira] NIAB, Faisalabad, Pakistan; [Zahid, Muhammad Awais] Univ Hohenheim, Inst Phytomed, Stuttgart, Germany	Pakistan Institute of Engineering & Applied Science; Bahauddin Zakariya University; University of Sargodha; Nuclear Institute for Agriculture & Biology - Pakistan; University Hohenheim	Yasmin, S (corresponding author), NIBGE, Faisalabad, Pakistan.	sumeraimran2012@gmail.com	Arif, Dr Muhammad/HGB-3451-2022	Zahid, Muhammad Awais/0000-0001-7065-5369; Yasmin, Sumera/0000-0002-9744-6257	grant of PSF	grant of PSF	The research work (few chemicals, sequencing charges) was only partially supported by the grant of PSF funded project. There was no additional external funding received for this study.	Adesemoye AO, 2009, MICROB ECOL, V58, P921, DOI 10.1007/s00248-009-9531-y; Adhikari TB, 1999, PHYTOPATHOLOGY, V89, P687, DOI 10.1094/PHYTO.1999.89.8.687; Ahirwar N, 2015, J MICROBIOL BIOTECHN, V7, P96; Ali S, 2014, MICROB CELL FACT, V13, DOI 10.1186/s12934-014-0144-x; Arshad HMI, 2015, ADVAN LIFE SCI, V2, P125; Cappuccino J.G., 2004, MICROBIOLOGY LAB MAN; Chen L, 2013, J EXP BOT, V64, P1565, DOI 10.1093/jxb/ert031; Choodamani MS, 2009, INT J PEST MANAGE, V55, P121, DOI 10.1080/09670870802601076; Copping LG, 2000, PEST MANAG SCI, V56, P651, DOI 10.1002/1526-4998(200008)56:8<651::AID-PS201>3.0.CO;2-U; Couillerot O, 2009, LETT APPL MICROBIOL, V48, P505, DOI 10.1111/j.1472-765X.2009.02566.x; Das B, 2014, BMC GENET, V15, DOI 10.1186/1471-2156-15-82; Denizci AA, 2004, J APPL MICROBIOL, V96, P320, DOI 10.1046/j.1365-2672.2003.02153.x; EDWARDS A, 1991, AM J HUM GENET, V49, P746; Fravel DR, 2005, ANNU REV PHYTOPATHOL, V43, P337, DOI 10.1146/annurev.phyto.43.032904.092924; GLICK BR, 1995, CAN J MICROBIOL, V41, P109, DOI 10.1139/m95-015; Cabanas CGL, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00427; Gustavo S.M., 2012, BIOCONTROL SCI TECHN, V22, P8558; Hafeez FY, 2004, AUST J EXP AGR, V44, P617, DOI 10.1071/EA03074; Hafeez FY., 2009, P INT S MICR TECHN S, P279; Hallmann J, 1997, CAN J MICROBIOL, V43, P895, DOI 10.1139/m97-131; Hameed A, 2014, CEREAL RES COMMUN, V42, P450, DOI 10.1556/CRC.2013.0066; HAMMERSCHMIDT R, 1982, PHYSIOL PLANT PATHOL, V20, P73, DOI 10.1016/0048-4059(82)90025-X; HammondKosack KE, 1996, PLANT CELL, V8, P1773, DOI 10.1105/tpc.8.10.1773; Hanif MK, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00583; Hassan TU, 2015, J SOIL SCI PLANT NUT, V15, P190, DOI 10.4067/S0718-95162015005000016; Hemm MR, 2004, PLANT J, V38, P765, DOI 10.1111/j.1365-313X.2004.02089.x; Hewitt W, 1989, THEORY APPL MICROBIO, P39; Hiddink GA, 2005, PHYTOPATHOLOGY, V95, P1325, DOI 10.1094/PHYTO-95-1325; Hoagland DR, 1950, CAL AGR EXP STN CIRC, V347, DOI [DOI 10.1016/S0140-6736(00)73482-9, 10.1016/S0140-6736(00)73482-9]; Jabeen R, 2011, PAK J BOT, V43, P111; Jayaraj J, 2004, Z PFLANZENK PFLANZEN, V111, P115; Jetiyanon K, 2002, BIOL CONTROL, V24, P285, DOI 10.1016/S1049-9644(02)00022-1; Ji GH, 2008, BIOL CONTROL, V45, P288, DOI 10.1016/j.biocontrol.2008.01.004; JOCKUSCH H., 1966, Phytopathologische Zeitschrift, V55, P185, DOI 10.1111/j.1439-0434.1966.tb02222.x; KAUFFMAN HE, 1973, PLANT DIS REP, V57, P537; Khan M S, PHOSPHATE SOLUBILIZI, P297; Lavania M, 2006, CURR MICROBIOL, V52, P363, DOI 10.1007/s00284-005-5578-2; Liang JG, 2011, AFR J BIOTECHNOL, V10, P6920; Maksimov IV, 2014, APPL BIOCHEM MICRO+, V50, P82, DOI 10.1134/S0003683813060124; Marten P, 2000, J APPL MICROBIOL, V89, P463, DOI 10.1046/j.1365-2672.2000.01136.x; Mathivanan S, 2014, INT J CURRENT RES AC, V2, P187; Mehmood MA, 2009, WORLD J MICROB BIOT, V25, P1955, DOI 10.1007/s11274-009-0094-3; Molina J, 2011, P NATL ACAD SCI USA, V108, P8351, DOI 10.1073/pnas.1104686108; Muhammad Tahir, 2013, Australian Journal of Crop Science, V7, P1284; MURPHY J, 1962, ANAL CHIM ACTA, V26, P31; Nascimento FX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099168; Naureen Z, 2009, CROP PROT, V28, P1052, DOI 10.1016/j.cropro.2009.08.007; Oke O L, 1969, World Rev Nutr Diet, V11, P170; Ou SH, 1985, RICE DIS; Panhwar QA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097241; Patten CL, 2002, APPL ENVIRON MICROB, V68, P3795, DOI 10.1128/AEM.68.8.3795-3801.2002; Perez-Montano F, 2014, MICROBIOL RES, V169, P325, DOI 10.1016/j.micres.2013.09.011; PIKOVSKAIA R. I., 1948, Mikrobiologiya, V17, P362; Qing F., 2002, CHINESE SCI BULL, V47, P292, DOI [10.1360/02tb9070, DOI 10.1360/02TB9070]; Ramette A, 2003, MOL PLANT MICROBE IN, V16, P525, DOI 10.1094/MPMI.2003.16.6.525; Rasul G, 1998, DEV PLANT SOIL SCI, V79, P25; Saikia Ratul, 2006, The Plant Pathology Journal, V22, P339; Schiliro E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048646; SCHWYN B, 1987, ANAL BIOCHEM, V160, P47, DOI 10.1016/0003-2697(87)90612-9; Shanti R., 2014, INT J CURR RES ACTA, V2, P74; Shoebitz M, 2009, SOIL BIOL BIOCHEM, V41, P1768, DOI 10.1016/j.soilbio.2007.12.031; Sofo A, 2015, INT J MOL SCI, V16, P13561, DOI 10.3390/ijms160613561; Tahir M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130030; Tahsili J, 2014, J PLANT INTERACT, V9, P412, DOI 10.1080/17429145.2013.846419; Tariq M, 2007, PAK J BOT, V39, P245; TIEN TM, 1979, APPL ENVIRON MICROB, V37, P1016, DOI 10.1128/AEM.37.5.1016-1024.1979; Vanitha SC, 2011, BIOL PLANTARUM, V55, P317, DOI 10.1007/s10535-011-0045-3; Velusamy P, 2013, RICE SCI, V20, P356, DOI 10.1016/S1672-6308(13)60143-2; Vincent JM, 1970, IBP HDB; Wang ChunLian, 2001, Chinese Journal of Rice Science, V15, P131; Wartiainen I, 2008, APPL SOIL ECOL, V39, P65, DOI 10.1016/j.apsoil.2007.11.008; Weisany W, 2012, PLANT OMICS, V5, P60; Wimberly JE., 1983, TECHNICAL HDB PADDY, P147; Worthington C.C., 1988, WORTHINGTON ENZYME M; Xie JJ, 2007, J MICROBIOL, V45, P219; Yang JH, 2008, J APPL MICROBIOL, V104, P91, DOI 10.1111/j.1365-2672.2007.03534.x; Yao T, 2008, J AGR SCI-CAMBRIDGE, V146, P49, DOI 10.1017/S0021859607007356; Yoshida K, 2003, APPL MICROBIOL BIOT, V60, P665, DOI 10.1007/s00253-002-1157-7; Zhang Y, 2006, CAN J MICROBIOL, V52, P476, DOI 10.1139/W05-152; ZUCKER M, 1965, PLANT PHYSIOL, V40, P779, DOI 10.1104/pp.40.5.779	80	51	53	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2016	11	8							e0160688	10.1371/journal.pone.0160688	http://dx.doi.org/10.1371/journal.pone.0160688			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4YN	27532545	gold, Green Published, Green Submitted			2022-12-27	WOS:000381487600039
J	Hong, L; Sharp, T; Khorsand, B; Fischer, C; Eliason, S; Salem, A; Akkouch, A; Brogden, K; Amendt, BA				Hong, Liu; Sharp, Thad; Khorsand, Behnoush; Fischer, Carol; Eliason, Steven; Salem, Ali; Akkouch, Adil; Brogden, Kim; Amendt, Brad A.			MicroRNA-200c Represses IL-6, IL-8, and CCL-5 Expression and Enhances Osteogenic Differentiation	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; BONE-FORMATION; SUPPRESSION; MIR-200C; NOGGIN; MIRNA	MicroRNAs (miRs) regulate inflammation and BMP antagonists, thus they have potential uses as therapeutic reagents. However, the molecular function of miR-200c in modulating proinflammatory and bone metabolic mediators and osteogenic differentiation is not known. After miR-200c was transduced into a human embryonic palatal mesenchyme (HEPM) (a cell line of preosteoblasts), using lentiviral vectors, the resulting miR-200c overexpression increased osteogenic differentiation biomarkers, including osteocalcin (OCN) transcripts and calcium content. miR-200c expression also down-regulated interleukin (IL)-6, IL-8, and chemokine (C-C motif) ligand (CCL)-5 under lipopolysaccharide (LPS) stimulation and increased osteoprotegerin (OPG) in these cells. miR-200c directly regulates the expression of IL-6, IL-8 and CCL-5 transcripts by binding to their 3' UTRs. A plasmid-based miR-200c inhibitor effectively reduces their binding activities. Additionally, miR-200c delivered using polyethylenimine (PEI) nanoparticles effectively inhibits IL-6, IL-8 and CCL-5 in primary human periodontal ligament fibroblasts and increases the biomarkers of osteogenic differentiation in human bone marrow mesenchymal stem cells (MSCs), including calcium content, ALP, and Runx2. These data demonstrate that miR-200c represses IL-6, IL-8 and CCL-5 and improves osteogenic differentiation. miR-200c may potentially be used as an effective means to prevent periodontitis-associated bone loss by arresting inflammation and osteoclastogenesis and enhancing bone regeneration.	[Hong, Liu; Fischer, Carol; Akkouch, Adil; Brogden, Kim; Amendt, Brad A.] Univ Iowa, Coll Dent, Dows Inst Dent Res, Iowa City, IA 52242 USA; [Hong, Liu; Eliason, Steven; Amendt, Brad A.] Univ Iowa, Carver Coll Med, Ctr Craniofacial Anomalies Res, Iowa City, IA USA; [Sharp, Thad; Eliason, Steven; Amendt, Brad A.] Univ Iowa, Carver Coll Med, Dept Anat & Cell Biol, Iowa City, IA USA; [Khorsand, Behnoush; Salem, Ali] Univ Iowa, Coll Pharm, Dept Pharmaceut Sci & Expt Therapeut, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; University of Iowa; University of Iowa	Hong, L; Amendt, BA (corresponding author), Univ Iowa, Coll Dent, Dows Inst Dent Res, Iowa City, IA 52242 USA.; Hong, L; Amendt, BA (corresponding author), Univ Iowa, Carver Coll Med, Ctr Craniofacial Anomalies Res, Iowa City, IA USA.; Amendt, BA (corresponding author), Univ Iowa, Carver Coll Med, Dept Anat & Cell Biol, Iowa City, IA USA.	liu-hong@uiowa.edu; brad-amendt@uiowa.edu	Akkouch, Adil/AAW-1531-2020	Akkouch, Adil/0000-0001-8816-1885; Amendt, Brad A./0000-0001-6524-1006; hong, liu/0000-0003-0308-5049; Fischer, Carol/0000-0002-9050-5170	NIDCR NIH HHS [R21 DE024799] Funding Source: Medline; NIEHS NIH HHS [P30 ES005605] Funding Source: Medline; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R21DE024799] Funding Source: NIH RePORTER	NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Armas Joshe, 2013, Dent Update, V40, P472; Borgwardt DS, 2014, SCI REP-UK, V4, DOI 10.1038/srep03904; Cao H, 2016, GENE THER, V23, P527, DOI 10.1038/gt.2016.22; Cao HJ, 2013, DEVELOPMENT, V140, P3348, DOI 10.1242/dev.089193; Chang J, 2013, P NATL ACAD SCI USA, V110, P9469, DOI 10.1073/pnas.1300532110; Chang J, 2009, NAT MED, V15, P682, DOI 10.1038/nm.1954; Chuang TD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095370; Darveau RP, 2010, NAT REV MICROBIOL, V8, P481, DOI 10.1038/nrmicro2337; Di Benedetto A, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/503754; Eke PI, 2012, J DENT RES, V91, P914, DOI 10.1177/0022034512457373; Elangovan S, 2014, BIOMATERIALS, V35, P737, DOI 10.1016/j.biomaterials.2013.10.021; Graves Dana T, 2011, J Oral Microbiol, V3, DOI 10.3402/jom.v3i0.5304; Hajishengallis G, 2012, ADV EXP MED BIOL, V946, P69, DOI 10.1007/978-1-4614-0106-3_5; Heliotis M, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2467; Herath TDK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058496; Hikiji H, 2000, AM J PHYSIOL-ENDOC M, V278, pE1031, DOI 10.1152/ajpendo.2000.278.6.E1031; Holpuch AS, 2010, PHARM RES-DORDR, V27, P1224, DOI 10.1007/s11095-010-0121-y; Howe EN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049987; Huang HN, 2014, STEM CELL RES, V12, P338, DOI 10.1016/j.scr.2013.11.009; Jeffcoat M K, 1998, Ann Periodontol, V3, P312, DOI 10.1902/annals.1998.3.1.312; Katoh Y, 2008, INT J MOL MED, V22, P271, DOI 10.3892/ijmm_00000019; Khosla S, 2012, J CLIN ENDOCR METAB, V97, P2272, DOI 10.1210/jc.2012-1027; Lacey DC, 2009, OSTEOARTHR CARTILAGE, V17, P735, DOI 10.1016/j.joca.2008.11.011; Lian JB, 2012, NAT REV ENDOCRINOL, V8, P212, DOI 10.1038/nrendo.2011.234; Mogensen TH, 2009, CLIN MICROBIOL REV, V22, P240, DOI 10.1128/CMR.00046-08; Muller HP, 2005, CLIN ORAL INVEST, V9, P98, DOI 10.1007/s00784-005-0303-x; Papapanou PN, 2000, PERIODONTOL 2000, V22, P8, DOI 10.1034/j.1600-0757.2000.2220102.x; Plank M, 2013, CLIN EXP ALLERGY, V43, P981, DOI [10.1111/cea.12135, 10.1111/cea.12170]; Rokavec M, 2012, MOL CELL, V45, P777, DOI 10.1016/j.molcel.2012.01.015; Sidiropoulou-Chatzigiannis Sossani, 2007, J Int Acad Periodontol, V9, P77; Singh RP, 2013, AUTOIMMUN REV, V12, P1160, DOI 10.1016/j.autrev.2013.07.003; Stoecklin-Wasmer C, 2012, J DENT RES, V91, P934, DOI 10.1177/0022034512456551; Stottmann RW, 2001, DEV BIOL, V240, P457, DOI 10.1006/dbio.2001.0479; Wang L, 2012, J DENT RES, V91, P1003, DOI 10.1177/0022034512460404; Wendlandt EB, 2012, INNATE IMMUN-LONDON, V18, P846, DOI 10.1177/1753425912443903; Yang N, 2013, J BONE MINER RES, V28, P559, DOI 10.1002/jbmr.1798	36	43	46	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2016	11	8							e0160915	10.1371/journal.pone.0160915	http://dx.doi.org/10.1371/journal.pone.0160915			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4UN	27529418	Green Published, gold, Green Submitted			2022-12-27	WOS:000381476700031
J	Karaman, E; Cheng, H; Firat, MZ; Garrick, DJ; Fernando, RL				Karaman, Emre; Cheng, Hao; Firat, Mehmet Z.; Garrick, Dorian J.; Fernando, Rohan L.			An Upper Bound for Accuracy of Prediction Using GBLUP	PLOS ONE			English	Article							GENETIC-RELATIONSHIP INFORMATION; GENOMIC BREEDING VALUES; QUANTITATIVE TRAITS; SELECTION; IMPACT; PERFORMANCE; REGRESSION	This study aims at characterizing the asymptotic behavior of genomic prediction R-2 as the size of the reference population increases for common or rare QTL alleles through simulations. Haplotypes derived from whole-genome sequence of 85 Caucasian individuals from the 1,000 Genomes Project were used to simulate random mating in a population of 10,000 individuals for at least 100 generations to create the LD structure in humans for a large number of individuals. To reduce computational demands, only SNPs within a 0.1M region of each of the first 5 chromosomes were used in simulations, and therefore, the total genome length simulated was 0.5M. When the genome length is 30M, to get the same genomic prediction R-2 as with a 0.5M genome would require a reference population 60 fold larger. Three scenarios were considered varying in minor allele frequency distributions of markers and QTL, for h(2) = 0.8 resembling height in humans. Total number of markers was 4,200 and QTL were 70 for each scenario. In this study, we considered the prediction accuracy in terms of an estimability problem, and thereby provided an upper bound for reliability of prediction, and thus, for prediction R-2. Genomic prediction methods GBLUP, BayesB and BayesC were compared. Our results imply that for human height variable selection methods BayesB and BayesC applied to a 30M genome have no advantage over GBLUP when the size of reference population was small (<6,000 individuals), but are superior as more individuals are included in the reference population. All methods become asymptotically equivalent in terms of prediction R-2, which approaches genomic heritability when the size of the reference population reaches 480,000 individuals.	[Karaman, Emre; Firat, Mehmet Z.] Akdeniz Univ, Dept Anim Sci, Fac Agr, TR-07059 Antalya, Turkey; [Cheng, Hao; Garrick, Dorian J.; Fernando, Rohan L.] Iowa State Univ, Dept Anim Sci, Ames, IA 50011 USA; [Cheng, Hao] Iowa State Univ, Dept Stat, Ames, IA 50011 USA; [Garrick, Dorian J.] Massey Univ, Inst Vet Anim & Biomed Sci, Palmerston North, New Zealand	Akdeniz University; Iowa State University; Iowa State University; Massey University	Karaman, E (corresponding author), Akdeniz Univ, Dept Anim Sci, Fac Agr, TR-07059 Antalya, Turkey.	emrkaraman@gmail.com	Karaman, Emre/AAW-8742-2020; Garrick, Dorian/P-9628-2019; Garrick, Dorian/Q-3239-2019; FIRAT, Mehmet Ziya/C-5503-2016; FIRAT, Mehmet Ziya/AAV-2691-2020	Karaman, Emre/0000-0003-1010-683X; Garrick, Dorian/0000-0001-8640-5372; FIRAT, Mehmet Ziya/0000-0002-0091-4713; FIRAT, Mehmet Ziya/0000-0002-0091-4713; Cheng, Hao/0000-0001-5146-7231	NIH [R01GM099992]; Akdeniz University, Turkey	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Akdeniz University, Turkey(Akdeniz University)	RLF acknowledges funding from NIH (http://www.nih.gov/) grant R01GM099992. EK was funded by the Akdeniz University (http://www.akdeniz.edu.tr), Turkey. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Angeles Perez-Cabal M., 2012, Frontiers in Genetics, V3, P27, DOI 10.3389/fgene.2012.00027; [Anonymous], 1999, ANAL VARIANCE; Bernardo R, 2007, CROP SCI, V47, P1082, DOI 10.2135/cropsci2006.11.0690; Calus MPL, 2010, ANIMAL, V4, P157, DOI 10.1017/S1751731109991352; Cheng H, 2015, G3-GENES GENOM GENET, V5, P1415, DOI 10.1534/g3.115.016683; Clark SA, 2012, GENET SEL EVOL, V44, DOI 10.1186/1297-9686-44-4; Clark SA, 2011, GENET SEL EVOL, V43, DOI 10.1186/1297-9686-43-18; Daetwyler HD, 2010, GENETICS, V185, P1021, DOI 10.1534/genetics.110.116855; Daetwyler HD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003395; de los Campos G, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003608; de los Campos G, 2013, GENETICS, V193, P327, DOI 10.1534/genetics.112.143313; Fernando R., 2013, GENOME WIDE ASS STUD; Fernando RL, 2013, GENOME WIDE ASS STUD; Fernando RL, 1998, 6 WCGALP; Goddard ME, 2011, J ANIM BREED GENET, V128, P409, DOI 10.1111/j.1439-0388.2011.00964.x; GODDARD ME, 2007, J ANIM BREED GENET, V124, P323; Goddard M, 2009, GENETICA, V136, P245, DOI 10.1007/s10709-008-9308-0; Habier D, 2007, GENETICS, V177, P2389, DOI 10.1534/genetics.107.081190; Habier D, 2010, BMC BIOINFORMATICS, V12; Habier D, 2010, GENET SEL EVOL, V42, DOI 10.1186/1297-9686-42-5; Hayes B, 2001, GENET SEL EVOL, V33, P209, DOI 10.1051/gse:2001117; Hayes BJ, 2009, GENET SEL EVOL, P41, DOI DOI 10.1186/1297-9686-1141-1151; Heffner EL, 2009, CROP SCI, V49, P1, DOI 10.2135/cropsci2008.08.0512; Henderson C. R, 1984, APPL LINEAR MODELS A; Jannink JL, 2010, BRIEF FUNCT GENOMICS, V9, P166, DOI 10.1093/bfgp/elq001; Kizilkaya K, 2010, J ANIM SCI, V88, P544, DOI 10.2527/jas.2009-2064; Legarra A, 2008, GENETICS, V180, P611, DOI 10.1534/genetics.108.088575; Luan T, 2009, GENETICS, V183, P1119, DOI 10.1534/genetics.109.107391; Makowsky R, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002051; McCarthy JJ, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005785; Meuwissen THE, 2001, GENETICS, V157, P1819; Meuwissen T, 2010, GENETICS, V185, P623, DOI 10.1534/genetics.110.116590; Meuwissen THE, 2009, GENET SEL EVOL, V41, DOI 10.1186/1297-9686-41-35; NejatiJavaremi A, 1997, J ANIM SCI, V75, P1738; Ober U, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002685; Pszczola M, 2012, J DAIRY SCI, V95, P389, DOI 10.3168/jds.2011-4338; Stranden I, 2009, J DAIRY SCI, V92, P2971, DOI 10.3168/jds.2008-1929; TAKAHATA N, 1993, MOL BIOL EVOL, V10, P2; VanRaden PM, 2008, J DAIRY SCI, V91, P4414, DOI 10.3168/jds.2007-0980; Wolc A, 2013, POULTRY SCI, V92, P1486, DOI 10.3382/ps.2012-02882; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Zhang Z, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012648	43	41	41	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2016	11	8							e0161054	10.1371/journal.pone.0161054	http://dx.doi.org/10.1371/journal.pone.0161054			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4UN	27529480	Green Published, Green Submitted, gold			2022-12-27	WOS:000381476700041
J	Ying, GX; Gerstner, CD; Frederick, JM; Boye, SL; Hauswirth, WW; Baehr, W				Ying, Guoxin; Gerstner, Cecilia D.; Frederick, Jeanne M.; Boye, Sanford L.; Hauswirth, William W.; Baehr, Wolfgang			Small GTPases Rab8a and Rab11a Are Dispensable for Rhodopsin Transport in Mouse Photoreceptors	PLOS ONE			English	Article							ROD OUTER SEGMENTS; DROSOPHILA PHOTORECEPTORS; PRIMARY CILIOGENESIS; MEMBRANE-TRANSPORT; CRE RECOMBINASE; TRANSGENIC MICE; EXCHANGE FACTOR; MYOSIN-VB; IN-VIVO; CELLS	Rab11a and Rab8a are ubiquitous small GTPases shown as required for rhodopsin transport in Xenopus laevis and zebrafish photoreceptors by dominant negative (dn) disruption of function. Here, we generated retina-specific Rab11a ((ret)Rab11a) and Rab8a ((ret)Rab8a) single and double knockout mice to explore the consequences in mouse photoreceptors. Rhodopsin and other outer segment (OS) membrane proteins targeted correctly to OS and electroretinogram (ERG) responses in all three mutant mouse lines were indistinguishable from wild-type (WT). Further, AAV (adeno-associated virus)-mediated expression of dnRab11b in (ret)Rab11a(-/-) retina, or expression of dnRab8b in (ret)Rab8a(-/-) retina did not cause OS protein mislocalization. Finally, a (ret)Rab8a(-/-) retina injected at one month of age with AAVs expressing dnRab11a, dnRab11b, dnRab8b, and dnRab10 (four dn viruses on Rab8a(-/-) background) and harvested three months later exhibited normal OS protein localization. In contrast to results obtained with dnRab GTPases in Xenopus and zebrafish, mouse Rab11a and Rab8a are dispensable for proper rhodopsin and outer segment membrane protein targeting. Absence of phenotype after expression of four dn Rab GTPases in a Rab8a(-/-) retina suggests that Rab8b and Rab11b paralogsmaybe dispensable as well. Our data thus demonstrate significant interspecies variation in photoreceptor membrane protein and rhodopsin trafficking.	[Ying, Guoxin; Gerstner, Cecilia D.; Frederick, Jeanne M.; Baehr, Wolfgang] Univ Utah, Hlth Sci Ctr, Dept Ophthalmol & Visual Sci, Salt Lake City, UT 84132 USA; [Boye, Sanford L.; Hauswirth, William W.] Univ Florida, Dept Ophthalmol, 1600 SW Archer Rd, Gainesville, FL 32610 USA; [Baehr, Wolfgang] Univ Utah, Sch Med, Dept Neurobiol & Anat, Salt Lake City, UT 84132 USA; [Baehr, Wolfgang] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah; State University System of Florida; University of Florida; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Ying, GX; Baehr, W (corresponding author), Univ Utah, Hlth Sci Ctr, Dept Ophthalmol & Visual Sci, Salt Lake City, UT 84132 USA.; Baehr, W (corresponding author), Univ Utah, Sch Med, Dept Neurobiol & Anat, Salt Lake City, UT 84132 USA.; Baehr, W (corresponding author), Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA.	g.ying@utah.edu; wbaehr@hsc.utah.edu		hauswirth, william/0000-0002-3244-4947	NIH [EY08123, EY019298]; NEI core grants [EY014800, 039003, 021721]; Research to Prevent Blindness, Inc. (RPB; New York); RPB Senior Investigator award; RPB Nelson Trust Award	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NEI core grants; Research to Prevent Blindness, Inc. (RPB; New York)(Research to Prevent Blindness (RPB)); RPB Senior Investigator award; RPB Nelson Trust Award	work was supported by NIH grants EY08123, EY019298 (WB); by NEI core grants EY014800 (Utah), 039003 and 021721 (UF); by an unrestricted grant to the University of Utah Department of Ophthalmology and to the University of Florida Department of Ophthalmology from Research to Prevent Blindness, Inc. (RPB; New York). WB is the recipient of an RPB Senior Investigator award and an RPB Nelson Trust Award.	Babbey CM, 2006, MOL BIOL CELL, V17, P3156, DOI 10.1091/mbc.E05-08-0799; Bachmann-Gagescu R, 2011, HUM MOL GENET, V20, P4041, DOI 10.1093/hmg/ddr332; Best JM, 2011, AM J PHYSIOL-CELL PH, V300, pC1023, DOI 10.1152/ajpcell.00288.2010; BOK D, 1971, J CELL BIOL, V49, P664, DOI 10.1083/jcb.49.3.664; Butterworth MB, 2012, AM J PHYSIOL-RENAL, V302, pF581, DOI 10.1152/ajprenal.00304.2011; Chen S, 2001, J BIOL CHEM, V276, P13209, DOI 10.1074/jbc.M010798200; DERETIC D, 1995, J CELL SCI, V108, P215; Deretic D, 1996, J BIOL CHEM, V271, P2279, DOI 10.1074/jbc.271.4.2279; FARNSWORTH CC, 1994, P NATL ACAD SCI USA, V91, P11963, DOI 10.1073/pnas.91.25.11963; Feng SS, 2012, J BIOL CHEM, V287, P15602, DOI 10.1074/jbc.M111.333245; Furuta Y, 2000, GENESIS, V26, P130, DOI 10.1002/(SICI)1526-968X(200002)26:2<130::AID-GENE9>3.0.CO;2-I; Guo W, 1999, EMBO J, V18, P1071, DOI 10.1093/emboj/18.4.1071; Hattula K, 2002, MOL BIOL CELL, V13, P3268, DOI 10.1091/mbc.E02-03-0143; Jiang L, 2011, P NATL ACAD SCI USA, V108, P18476, DOI 10.1073/pnas.1112758108; Kelly EE, 2012, BIOCHEM SOC T, V40, P1360, DOI 10.1042/BST20120157; Knodler A, 2010, P NATL ACAD SCI USA, V107, P6346, DOI 10.1073/pnas.1002401107; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; Lapierre LA, 2001, MOL BIOL CELL, V12, P1843, DOI 10.1091/mbc.12.6.1843; Le YZ, 2004, MOL VIS, V10, P1011; Li BX, 2007, J CELL BIOL, V177, P659, DOI 10.1083/jcb.200610157; Li S, 2005, GENESIS, V41, P73, DOI 10.1002/gene.20097; Mattapallil MJ, 2012, INVEST OPHTH VIS SCI, V53, P2921, DOI 10.1167/iovs.12-9662; Mazelova J, 2009, J CELL SCI, V122, P2003, DOI 10.1242/jcs.039982; Mazelova J, 2009, EMBO J, V28, P183, DOI 10.1038/emboj.2008.267; Moritz OL, 2001, MOL BIOL CELL, V12, P2341, DOI 10.1091/mbc.12.8.2341; Mukhopadhyay S, 2008, DEV CELL, V14, P762, DOI 10.1016/j.devcel.2008.03.002; Murga-Zamalloa CA, 2010, MOL VIS, V16, P1373; Nachury MV, 2007, CELL, V129, P1201, DOI 10.1016/j.cell.2007.03.053; Nickell S, 2007, J CELL BIOL, V177, P917, DOI 10.1083/jcb.200612010; Omori Y, 2008, NAT CELL BIOL, V10, P437, DOI 10.1038/ncb1706; Pearring JN, 2013, PROG RETIN EYE RES, V36, P24, DOI 10.1016/j.preteyeres.2013.03.002; Peranen J, 2011, CYTOSKELETON, V68, P527, DOI 10.1002/cm.20529; Reish NJ, 2014, J NEUROSCI, V34, P14854, DOI 10.1523/JNEUROSCI.1943-14.2014; Riveiro-Alvarez R, 2015, JAMA OPHTHALMOL, V133, P133, DOI 10.1001/jamaophthalmol.2014.4266; Roland JT, 2007, MOL BIOL CELL, V18, P2828, DOI 10.1091/mbc.E07-02-0169; Roosing S, 2013, AM J HUM GENET, V93, P110, DOI 10.1016/j.ajhg.2013.05.005; Sato T, 2007, NATURE, V448, P366, DOI 10.1038/nature05929; Sato T, 2014, J CELL SCI, V127, P422, DOI 10.1242/jcs.136903; Satoh AK, 2005, DEVELOPMENT, V132, P1487, DOI 10.1242/dev.01704; SEABRA MC, 1995, J BIOL CHEM, V270, P24420, DOI 10.1074/jbc.270.41.24420; Silvis MR, 2009, MOL BIOL CELL, V20, P2337, DOI 10.1091/mbc.E08-01-0084; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Tai AW, 1999, CELL, V97, P877, DOI 10.1016/S0092-8674(00)80800-4; TROUTT LL, 1988, J NEUROSCI, V8, P2371; Wang J, 2015, J CELL SCI, V128, P1375, DOI 10.1242/jcs.162925; Wang J, 2014, PROG RETIN EYE RES, V38, P1, DOI 10.1016/j.preteyeres.2013.08.004; Wang J, 2012, EMBO J, V31, P4057, DOI 10.1038/emboj.2012.253; Welz T, 2014, TRENDS CELL BIOL, V24, P407, DOI 10.1016/j.tcb.2014.02.004; Westfall JE, 2010, J NEUROSCI, V30, P8759, DOI 10.1523/JNEUROSCI.5229-09.2010; Westlake CJ, 2011, P NATL ACAD SCI USA, V108, P2759, DOI 10.1073/pnas.1018823108; Wu SY, 2005, NAT STRUCT MOL BIOL, V12, P879, DOI 10.1038/nsmb987; Yoshimura S, 2007, J CELL BIOL, V178, P363, DOI 10.1083/jcb.200703047; Yoshimura S, 2010, J CELL BIOL, V191, P367, DOI 10.1083/jcb.201008051; YOUNG RW, 1967, J CELL BIOL, V33, P61, DOI 10.1083/jcb.33.1.61; Yu SY, 2014, J BIOL CHEM, V289, P32030, DOI 10.1074/jbc.M113.538223; Zolotukhin S, 2002, METHODS, V28, P158, DOI 10.1016/S1046-2023(02)00220-7	56	21	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2016	11	8							e0161236	10.1371/journal.pone.0161236	http://dx.doi.org/10.1371/journal.pone.0161236			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4UN	27529348	Green Published, gold, Green Submitted			2022-12-27	WOS:000381476700057
J	Hain, EG; Klein, C; Munder, T; Braun, J; Riek, K; Mueller, S; Sack, I; Steiner, B				Hain, Elisabeth G.; Klein, Charlotte; Munder, Tonia; Braun, Juergen; Riek, Kerstin; Mueller, Susanne; Sack, Ingolf; Steiner, Barbara			Dopaminergic Neurodegeneration in the Mouse Is Associated with Decrease of Viscoelasticity of Substantia Nigra Tissue	PLOS ONE			English	Article							MAGNETIC-RESONANCE ELASTOGRAPHY; PRECURSOR CELL-PROLIFERATION; PARKINSONS-DISEASE; MR ELASTOGRAPHY; BRAIN VISCOELASTICITY; MODEL; 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE; STIFFNESS	The biomechanical properties of brain tissue are altered by histopathological changes due to neurodegenerative diseases like Parkinson's disease (PD). Such alterations can be measured by magnetic resonance elastography (MRE) as a non-invasive technique to determine viscoelastic parameters of the brain. Until now, the correlation between histopathological mechanisms and observed alterations in tissue viscoelasticity in neurodegenerative diseases is still not completely understood. Thus, the objective of this study was to evaluate (1) the validity of MRE to detect viscoelastic changes in small and specific brain regions: the substantia nigra (SN), midbrain and hippocampus in a mouse model of PD, and (2) if the induced dopaminergic neurodegeneration and inflammation in the SN is reflected by local changes in viscoelasticity. Therefore, MRE measurements of the SN, midbrain and hippocampus were performed in adult female mice before and at five time points after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridin hydrochloride (MPTP) treatment specifically lesioning dopaminergic neurons in the SN. At each time point, additional mice were utilized for histological analysis of the SN. After treatment cessation, we observed opposed viscoelastic changes in the midbrain, hippocampus and SN with the midbrain showing a gradual rise and the hippocampus a distinct transient increase of viscous and elastic parameters, while viscosity and-to a lesser extent-elasticity in the SN decreased over time. The decrease in viscosity and elasticity in the SN was paralleled by a reduced number of neurons due to the MPTP-induced neurodegeneration. In conclusion, MRE is highly sensitive to detect local viscoelastic changes in specific and even small brain regions. Moreover, we confirmed that neuronal cells likely constitute the backbone of the adult brain mainly accounting for its viscoelasticity. Therefore, MRE could be established as a new potential instrument for clinical evaluation and diagnostics of neurodegenerative diseases.	[Hain, Elisabeth G.; Klein, Charlotte; Munder, Tonia; Steiner, Barbara] Charite, Dept Neurol, Berlin, Germany; [Braun, Juergen] Charite, Inst Med Informat, Berlin, Germany; [Riek, Kerstin; Sack, Ingolf] Charite, Dept Radiol, Berlin, Germany; [Mueller, Susanne] Ctr Stroke Res Berlin, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Steiner, B (corresponding author), Charite, Dept Neurol, Berlin, Germany.	barbara.steiner@charite.de		Hain, Elisabeth G./0000-0001-5755-5339; Mueller, Susanne/0000-0002-5053-2211; Steiner, Barbara/0000-0003-2106-4532; Munder, Tonia/0000-0001-5995-6275; Braun, Jurgen/0000-0001-5183-7546	German Research Foundation [STE 1450/8, SA901/17]	German Research Foundation(German Research Foundation (DFG))	This study was funded by the German Research Foundation (www.dfg.de) to Barbara Steiner: STE 1450/8, and Ingolf Sack: SA901/17. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annese V, 2015, BRAIN STRUCT FUNCT, V220, P703, DOI 10.1007/s00429-014-0718-8; Araki T, 2001, EUR J PHARM SCI, V12, P231, DOI 10.1016/S0928-0987(00)00170-6; Arani A, 2015, NEUROIMAGE, V111, P59, DOI 10.1016/j.neuroimage.2015.02.016; Clayton EH, 2011, PHYS MED BIOL, V56, P2391, DOI 10.1088/0031-9155/56/8/005; Freimann FB, 2013, NMR BIOMED, V26, P1534, DOI 10.1002/nbm.2987; HIRSCH E, 1988, NATURE, V334, P345, DOI 10.1038/334345a0; Hoglinger GU, 2004, NAT NEUROSCI, V7, P726, DOI 10.1038/nn1265; Huston J, 2016, J MAGN RESON IMAGING, V43, P474, DOI 10.1002/jmri.24977; Jackson-Lewis V, 2007, NAT PROTOC, V2, P141, DOI 10.1038/nprot.2006.342; JACKSONLEWIS V, 1995, NEURODEGENERATION, V4, P257, DOI 10.1016/1055-8330(95)90015-2; Klaissle P, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-132; Klein C, 2016, BEHAV BRAIN RES, V307, P227, DOI 10.1016/j.bbr.2016.02.040; Klein C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092582; Kruse SA, 2008, NEUROIMAGE, V39, P231, DOI 10.1016/j.neuroimage.2007.08.030; Lesemann A, 2012, BRAIN RES, V1457, P51, DOI 10.1016/j.brainres.2012.03.046; Lipp A, 2013, NEUROIMAGE-CLIN, V3, P381, DOI 10.1016/j.nicl.2013.09.006; Lu YB, 2011, FASEB J, V25, P624, DOI 10.1096/fj.10-163790; Mariappan YK, 2010, CLIN ANAT, V23, P497, DOI 10.1002/ca.21006; McCracken PJ, 2005, MAGN RESON MED, V53, P628, DOI 10.1002/mrm.20388; McGeer PL, 2008, MOVEMENT DISORD, V23, P474, DOI 10.1002/mds.21751; Millward JM, 2015, NMR BIOMED, V28, P831, DOI 10.1002/nbm.3319; Murphy MC, 2012, MAGN RESON IMAGING, V30, P535, DOI 10.1016/j.mri.2011.12.019; Murphy MC, 2011, J MAGN RESON IMAGING, V34, P494, DOI 10.1002/jmri.22707; MUTHUPILLAI R, 1995, SCIENCE, V269, P1854, DOI 10.1126/science.7569924; Papazoglou S, 2008, PHYS MED BIOL, V53, P3147, DOI 10.1088/0031-9155/53/12/005; Phani S, 2010, BRAIN RES, V1343, P1, DOI 10.1016/j.brainres.2010.04.061; Przedborski S, 2003, ANN NY ACAD SCI, V991, P189; Riek K, 2012, NEUROIMAGE-CLIN, V1, P81, DOI 10.1016/j.nicl.2012.09.003; Sack I, 2009, NEUROIMAGE, V46, P652, DOI 10.1016/j.neuroimage.2009.02.040; Schregel K, 2012, P NATL ACAD SCI USA, V109, P6650, DOI 10.1073/pnas.1200151109; Streitberger KJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110588; Streitberger KJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029888; Streitberger KJ, 2011, NMR BIOMED, V24, P385, DOI 10.1002/nbm.1602; Wuerfel J, 2010, NEUROIMAGE, V49, P2520, DOI 10.1016/j.neuroimage.2009.06.018	34	23	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2016	11	8							e0161179	10.1371/journal.pone.0161179	http://dx.doi.org/10.1371/journal.pone.0161179			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4SL	27526042	Green Submitted, Green Published, gold			2022-12-27	WOS:000381471100039
J	Li, YH; Xu, JY; Tao, L; Li, XF; Li, S; Zeng, X; Chen, SY; Zhang, P; Qin, C; Zhang, C; Chen, Z; Zhu, F; Chen, YZ				Li, Ying Hong; Xu, Jing Yu; Tao, Lin; Li, Xiao Feng; Li, Shuang; Zeng, Xian; Chen, Shang Ying; Zhang, Peng; Qin, Chu; Zhang, Cheng; Chen, Zhe; Zhu, Feng; Chen, Yu Zong			SVM-Prot 2016: A Web-Server for Machine Learning Prediction of Protein Functional Families from Sequence Irrespective of Similarity	PLOS ONE			English	Article							AMINO-ACID-COMPOSITION; SUPPORT VECTOR MACHINE; DNA-BINDING PROTEINS; SECONDARY STRUCTURE; PHYSICOCHEMICAL FEATURES; CLASSIFICATION; IDENTIFICATION; UPDATE; RESOURCE; DATABASE	Knowledge of protein function is important for biological, medical and therapeutic studies, but many proteins are still unknown in function. There is a need for more improved functional prediction methods. Our SVM-Prot web-server employed a machine learning method for predicting protein functional families from protein sequences irrespective of similarity, which complemented those similarity-based and other methods in predicting diverse classes of proteins including the distantly-related proteins and homologous proteins of different functions. Since its publication in 2003, we made major improvements to SVM-Prot with (1) expanded coverage from 54 to 192 functional families, (2) more diverse protein descriptors protein representation, (3) improved predictive performances due to the use of more enriched training datasets and more variety of protein descriptors, (4) newly integrated BLAST analysis option for assessing proteins in the SVM-Prot predicted functional families that were similar in sequence to a query protein, and (5) newly added batch submission option for supporting the classification of multiple proteins. Moreover, 2 more machine learning approaches, K nearest neighbor and probabilistic neural networks, were added for facilitating collective assessment of protein functions by multiple methods. SVM-Prot can be accessed at http://bidd2.nus.edu.sg/cgi-bin/svmprot/svmprot.cgi.	[Li, Ying Hong; Xu, Jing Yu; Tao, Lin; Li, Xiao Feng; Li, Shuang; Zhu, Feng] Chongqing Univ, Innovat Drug Res & Bioinformat Grp, Innovat Drug Res Ctr, Chongqing 401331, Peoples R China; [Li, Ying Hong; Xu, Jing Yu; Tao, Lin; Li, Xiao Feng; Li, Shuang; Zhu, Feng] Chongqing Univ, Sch Pharmaceut Sci, Chongqing 401331, Peoples R China; [Tao, Lin; Zeng, Xian; Chen, Shang Ying; Zhang, Peng; Qin, Chu; Zhang, Cheng; Chen, Yu Zong] Natl Univ Singapore, Dept Pharm, Bioinformat & Drug Discovery Grp, Singapore 117543, Singapore; [Chen, Zhe] Zhejiang Chinese Med Univ, Zhejiang Hosp Tradit Chinese Med, Zhejiang Key Lab Gastrointestinal Pathophysiol, Hangzhou, Zhejiang, Peoples R China; [Xu, Jing Yu] Beijing Inst Technol, Sch Math & Stat, Beijing, Peoples R China	Chongqing University; Chongqing University; National University of Singapore; Zhejiang Chinese Medical University; Beijing Institute of Technology	Zhu, F (corresponding author), Chongqing Univ, Innovat Drug Res & Bioinformat Grp, Innovat Drug Res Ctr, Chongqing 401331, Peoples R China.; Zhu, F (corresponding author), Chongqing Univ, Sch Pharmaceut Sci, Chongqing 401331, Peoples R China.	zhufeng@cqu.edu.cn	Zeng, Xian/AAL-8713-2020; ZHU, Feng/ABF-5843-2021; Zhang, Peng/I-4665-2019; Li, Ying Hong/U-4004-2017; ZHU, Feng/X-2659-2018; Zeng, Xian/O-8750-2018	Zeng, Xian/0000-0002-1397-554X; ZHU, Feng/0000-0001-8069-0053; Zhang, Peng/0000-0002-6129-567X; Li, Ying Hong/0000-0003-3629-519X; ZHU, Feng/0000-0001-8069-0053; Zeng, Xian/0000-0002-1397-554X; Zhang, Cheng/0000-0003-3843-1562; Chen, Yu Zong/0000-0002-5473-8022; Tao, Lin/0000-0001-7494-4758; Zhu, Feng/0000-0001-6661-0002	Fundamental Research Funds for the Central Universities [CDJZR14468801, CDJKXB14011, 2015CDJXY]; Ministry of Science and Technology, 863 Hi-Tech Program [2007AA02Z160]; Key Special Project China [2009ZX09501-004]; Singapore Academic Research Fund [R-148-000-208-112]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Ministry of Science and Technology, 863 Hi-Tech Program; Key Special Project China; Singapore Academic Research Fund(Ministry of Education, Singapore)	FZ is supported by grants from the Fundamental Research Funds for the Central Universities (CDJZR14468801, CDJKXB14011, 2015CDJXY); Ministry of Science and Technology, 863 Hi-Tech Program (2007AA02Z160); Key Special Project Grant 2009ZX09501-004 China; and Singapore Academic Research Fund grant R-148-000-208-112. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was funded by the Fundamental Research Funds for the Central Universities (CDJZR14468801, CDJKXB14011, 2015CDJXY); Ministry of Science and Technology, 863 Hi-Tech Program (2007AA02Z160); Key Special Project Grant 2009ZX09501-004 China; and Singapore Academic Research Fund grant R-148-000-208-112.	Bateman A, 2002, NUCLEIC ACIDS RES, V30, P276, DOI 10.1093/nar/30.1.276; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; Bernardes Juliana S, 2013, Recent Pat Biotechnol, V7, P122; Boratyn GM, 2013, NUCLEIC ACIDS RES, V41, pW29, DOI 10.1093/nar/gkt282; Bork P, 2000, GENOME RES, V10, P398, DOI 10.1101/gr.10.4.398; BROTO P, 1984, EUR J MED CHEM, V19, P79; Cai CZ, 2004, PROTEINS, V55, P66, DOI 10.1002/prot.20045; Cai CZ, 2003, NUCLEIC ACIDS RES, V31, P3692, DOI 10.1093/nar/gkg600; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Cao P, 2013, IEEE ENG MED BIO, P3981, DOI 10.1109/EMBC.2013.6610417; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Cheng XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038979; Cui J, 2007, MOL IMMUNOL, V44, P514, DOI 10.1016/j.molimm.2006.02.010; Dai HL, 2015, IEEE T NANOBIOSCI, V14, P350, DOI 10.1109/TNB.2015.2431292; Date SV, 2005, BIOINFORMATICS, V21, P2558, DOI 10.1093/bioinformatics/bti313; Dobson PD, 2005, J MOL BIOL, V345, P187, DOI 10.1016/j.jmb.2004.10.024; DUBCHAK I, 1995, P NATL ACAD SCI USA, V92, P8700, DOI 10.1073/pnas.92.19.8700; Garg A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-62; Garg Aarti, 2008, In Silico Biology, V8, P129; Gene Ontology Consortium, 2015, Nucleic Acids Res, V43, pD1049, DOI 10.1093/nar/gku1179; Grassmann J, 1999, Proc Int Conf Intell Syst Mol Biol, P106; Guan YF, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-s1-s3; Guermeur Y, 1999, BIOINFORMATICS, V15, P413, DOI 10.1093/bioinformatics/15.5.413; Han LY, 2004, NUCLEIC ACIDS RES, V32, P6437, DOI 10.1093/nar/gkh984; Han LY, 2004, RNA, V10, P355, DOI 10.1261/rna.5890304; Heffernan R, 2015, SCI REP-UK, V5, DOI 10.1038/srep11476; Hodges J. L., 1951, DISCRIMINATORY ANAL, P261; Horn F, 2001, NUCLEIC ACIDS RES, V29, P346, DOI 10.1093/nar/29.1.346; Hu PZ, 2009, PLOS BIOL, V7, P929, DOI 10.1371/journal.pbio.1000096; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Jones P, 2014, BIOINFORMATICS, V30, P1236, DOI 10.1093/bioinformatics/btu031; Karchin R, 2002, BIOINFORMATICS, V18, P147, DOI 10.1093/bioinformatics/18.1.147; Khan ZU, 2015, J THEOR BIOL, V365, P197, DOI 10.1016/j.jtbi.2014.10.014; Kotlyar M, 2015, NAT METHODS, V12, P79, DOI [10.1038/NMETH.3178, 10.1038/nmeth.3178]; Le Novere N, 2001, NUCLEIC ACIDS RES, V29, P294, DOI 10.1093/nar/29.1.294; Li ZR, 2006, NUCLEIC ACIDS RES, V34, pW32, DOI 10.1093/nar/gkl305; Lin C, 2014, NEUROCOMPUTING, V123, P424, DOI 10.1016/j.neucom.2013.08.004; Lin C, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0056499, 10.1371/journal.pone.0080883, 10.1371/journal.pone.0065734, 10.1371/journal.pone.0070187]; Lin HT, 2007, MACH LEARN, V68, P267, DOI 10.1007/s10994-007-5018-6; Liu B, 2015, BIOINFORMATICS, V31, P3492, DOI 10.1093/bioinformatics/btv413; Liu B, 2015, SCI REP-UK, V5, DOI 10.1038/srep15479; Liu B, 2015, NUCLEIC ACIDS RES, V43, pW65, DOI 10.1093/nar/gkv458; Liu B, 2014, BIOINFORMATICS, V30, P472, DOI 10.1093/bioinformatics/btt709; Lobley AE, 2008, NUCLEIC ACIDS RES, V36, pW297, DOI 10.1093/nar/gkn193; Lyons J, 2014, J COMPUT CHEM, V35, P2040, DOI 10.1002/jcc.23718; Majid A, 2014, COMPUT METH PROG BIO, V113, P792, DOI 10.1016/j.cmpb.2014.01.001; Minneci F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063754; Mitchell A, 2015, NUCLEIC ACIDS RES, V43, pD213, DOI 10.1093/nar/gku1243; Nath N, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-60; Naveed M, 2012, AMINO ACIDS, V42, P1809, DOI 10.1007/s00726-011-0902-6; Needham CJ, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-405; Nelson KJ, 2011, PROTEINS, V79, P947, DOI 10.1002/prot.22936; Ong SAK, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-300; Piovesan D, 2015, NUCLEIC ACIDS RES, V43, pW134, DOI 10.1093/nar/gkv523; Radivojac P, 2013, NAT METHODS, V10, P221, DOI [10.1038/NMETH.2340, 10.1038/nmeth.2340]; Rao HB, 2011, NUCLEIC ACIDS RES, V39, pW385, DOI 10.1093/nar/gkr284; Rentzsch R, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S3-S5; Reynolds SM, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000213; Rose PW, 2015, NUCLEIC ACIDS RES, V43, pD345, DOI 10.1093/nar/gku1214; Sahraeian SM, 2015, NUCLEIC ACIDS RES, V43, pW141, DOI 10.1093/nar/gkv461; Saier MH, 2000, MICROBIOL MOL BIOL R, V64, P354, DOI 10.1128/MMBR.64.2.354-411.2000; Schomburg I, 2002, NUCLEIC ACIDS RES, V30, P47, DOI 10.1093/nar/30.1.47; Song L, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-298; SPECHT DF, 1990, NEURAL NETWORKS, V3, P109, DOI 10.1016/0893-6080(90)90049-Q; Spencer M, 2015, IEEE ACM T COMPUT BI, V12, P103, DOI 10.1109/TCBB.2014.2343960; Tang H, 2016, MOL BIOSYST, V12, P1269, DOI 10.1039/c5mb00883b; Wang M, 2004, PROTEIN ENG DES SEL, V17, P509, DOI 10.1093/protein/gzh061; Wang P, 2015, EVID-BASED COMPL ALT, V2015, DOI 10.1155/2015/767136; Wass MN, 2012, NUCLEIC ACIDS RES, V40, pW466, DOI 10.1093/nar/gks489; Wei LY, 2016, COMB CHEM HIGH T SCR, V19, P144, DOI 10.2174/1386207319666151110122621; Wei LY, 2015, IEEE T NANOBIOSCI, V14, P649, DOI 10.1109/TNB.2015.2450233; Wei LY, 2015, IEEE T NANOBIOSCI, V14, P339, DOI 10.1109/TNB.2014.2352454; Weinberg SE, 2015, NAT CHEM BIOL, V11, P9, DOI 10.1038/nchembio.1712; Xu RF, 2015, BMC SYST BIOL, V9, DOI 10.1186/1752-0509-9-S1-S10; Xue WW, 2016, PHYS CHEM CHEM PHYS, V18, P3260, DOI 10.1039/c5cp05771j; Yang H, 2016, NUCLEIC ACIDS RES, V44, pD1069, DOI 10.1093/nar/gkv1230; Zhu F, 2012, NUCLEIC ACIDS RES, V40, pD1128, DOI 10.1093/nar/gkr797; Zhu F, 2010, NUCLEIC ACIDS RES, V38, pD787, DOI 10.1093/nar/gkp1014; Zou Q, 2013, BIOMED RES INT, V2013, DOI [10.1155/2013/686090, 10.1155/2013/608430]	80	132	136	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2016	11	8							e0155290	10.1371/journal.pone.0155290	http://dx.doi.org/10.1371/journal.pone.0155290			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4SL	27525735	gold, Green Submitted, Green Published			2022-12-27	WOS:000381471100002
J	Maughan-Brown, B; Evans, M; George, G				Maughan-Brown, Brendan; Evans, Meredith; George, Gavin			Sexual Behaviour of Men and Women within Age-Disparate Partnerships in South Africa: Implications for Young Women's HIV Risk	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; TRANSACTIONAL SEX; CONCURRENT PARTNERSHIPS; ECONOMIC ASYMMETRIES; REPRODUCTIVE HEALTH; ADOLESCENT GIRLS; ALCOHOL-USE; CONDOM USE; URBAN; PREVALENCE	Background Age-disparate partnerships are hypothesized to increase HIV-risk for young women. However, the evidence base remains mixed. Most studies have focused only on unprotected sex among women in the partnership. Consequently, little is known about other risky behaviours, such as transactional sex, alcohol use, and concurrency, as well as the behaviours of the men who partner with young women. We therefore examined differences in various sexual behaviours of both young women and their male partners by partnership age difference. Methods We used nationally representative data from South Africa (2012) on partnerships reported by 16-24 year old black African women (n = 818) and by black African men in partnerships with 16-24 year old women (n = 985). We compared sexual behaviours in age-disparate partnerships and age-similar partnerships, using multiple logistic regression to control for potential confounders and to assess rural/urban differences. Results Young women in age-disparate partnerships were more likely to report unprotected sex than young women in similar-aged partnerships (aOR: 1.51; p = 0.014; 95% CI: 1.09-2.11). Men in partnerships with young women were more likely to report unprotected sex (aOR: 1.92; p<0.01; 95% CI: 1.31-2.81), transactional sex (aOR: 2.73; p< 0.01; 95% CI: 1.64-4.56), drinking alcohol before sex (aOR:1.60; p = 0.062; 95%CI:0.98-2.61), and concurrency (aOR: 1.39; p = 0.097; 95%CI:0.94-2.07) when their partners were five or more years younger. The association between age-disparate partnerships and transactional sex (aOR: 4.14; p< 0.01; 95% CI: 2.03-8.46) and alcohol use (aOR:2.24; p< 0.013; 95% CI:1.20-4.19) was only found in urban areas. Conclusions Results provide evidence that young women's age-disparate partnerships involve greater sexual risk, particularly through the risky behaviours of their male partners, with the risk amplified for young women in urban areas.	[Maughan-Brown, Brendan] Univ Cape Town, Southern Africa Labour & Dev Res Unit, Dept Econ, Cape Town, South Africa; [Evans, Meredith] Univ Cape Town, Dept Sociol, Inst Humanities Africa HUMA, Cape Town, South Africa; [George, Gavin] Univ KwaZulu Natal, Hlth Econ & HIV & AIDS Res Div HEARD, Durban, South Africa	University of Cape Town; University of Cape Town; University of Kwazulu Natal	Maughan-Brown, B (corresponding author), Univ Cape Town, Southern Africa Labour & Dev Res Unit, Dept Econ, Cape Town, South Africa.	brendan.maughanbrown@gmail.com	George, Gavin L/N-5756-2013; Evans, Meredith/HHN-7716-2022; Maughan-Brown, Brendan/AAH-4254-2019	George, Gavin L/0000-0001-7258-8470; Evans, Meredith/0000-0002-9986-3185; 	National Research Foundation, South Africa, through the Research Career Advancement Fellowship; Department of Health, the United States Agency for International Development (USAID) through the President's Emergency Plan for AIDS Relief (PEPFAR); Global Fund	National Research Foundation, South Africa, through the Research Career Advancement Fellowship; Department of Health, the United States Agency for International Development (USAID) through the President's Emergency Plan for AIDS Relief (PEPFAR)(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Global Fund	Brendan Maughan-Brown acknowledges support from the National Research Foundation, South Africa, through the Research Career Advancement Fellowship. The National Research Foundation had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r The authors thank Atheendar Venkataramani and David Maughan Brown for helpful comments and suggestions on previous versions of this manuscript. The data used in this paper are from the Third National HIV Communication Survey (NCS). The NCS is a collaborative survey undertaken by Johns Hopkins Health and Education in South Africa (JHHESA), loveLife and Soul City. The survey was managed by Health and Development Africa (HDA). The Johns Hopkins Bloomberg School of Public Health Center for Communication Programs (JHUCCP) provided technical support and oversight at all stages of the study. Data were gathered by Freshly Ground Insights (FGI). The NCS was funded by the Department of Health, the United States Agency for International Development (USAID) through the President's Emergency Plan for AIDS Relief (PEPFAR) and the Global Fund.	Baird SJ, 2012, LANCET, V379, P1320, DOI 10.1016/S0140-6736(11)61709-1; Balkus JE, 2015, JAIDS-J ACQ IMM DEF, V70, P212, DOI 10.1097/QAI.0000000000000715; Bankole Akinrinola, 2007, Afr J Reprod Health, V11, P197, DOI 10.2307/25549740; Bauman LJ, 2005, AIDS BEHAV, V9, P211, DOI 10.1007/s10461-005-3902-2; Beauclair R, 2012, EUR J CONTRACEP REPR, V17, P30, DOI 10.3109/13625187.2011.644841; Britton A, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0273-z; Cameron AC, 2015, J HUM RESOUR, V50, P317, DOI 10.3368/jhr.50.2.317; Chapman R, 2010, TROP MED INT HEALTH, V15, P554, DOI 10.1111/j.1365-3156.2010.02483.x; Choudhry V, 2014, GLOBAL HEALTH ACTION, V8, P27249; Darj E, 2010, SEX REPROD HEALTHC, V1, P111, DOI 10.1016/j.srhc.2010.03.001; Dodoo FNA, 2007, SOC SCI MED, V64, P1019, DOI 10.1016/j.socscimed.2006.10.007; Dunkle KL, 2004, SOC SCI MED, V59, P1581, DOI 10.1016/j.socscimed.2004.02.003; Dunkle KL, 2010, PUBLIC HEALTH REP, V125, P90, DOI 10.1177/00333549101250S413; Dupas P, 2009, AM ECON J-APPL ECON; Dupas P., 2009, BOTSWANA J EC, V3, P1; Fisher JC, 2008, SEX TRANSM DIS, V35, P537, DOI 10.1097/OLQ.0b013e3181677547; Gregson S, 2002, LANCET, V359, P1896, DOI 10.1016/S0140-6736(02)08780-9; Harling G, 2014, J ACQ IMMUN DEF SYND, V66, P433; Harling G, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-005638; Hope Ruth, 2007, ADDRESSING CROSS GEN; Hunter Mark., 2002, AFR STUD-UK, V61, P99, DOI [DOI 10.1080/00020180220140091, 10.1080/00020180220140091]; Jewkes R., 2012, Journal of AIDS and Clinical Research, V3, P158; Jewkes R, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-325; Jewkes R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040821; Jewkes R, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-6; Johnson S, 2013, 3 NATL HIV COMMUNICA; Kalichman SC, 2007, PREV SCI, V8, P141, DOI 10.1007/s11121-006-0061-2; Karlyn AS, 2005, CULT HEALTH SEX, V7, P279, DOI 10.1080/13691050412331334362; Katz I, 2008, SEX TRANSM DIS, V35, P837, DOI 10.1097/OLQ.0b013e31817c0be5; Kaufman CE, 2004, CULT HEALTH SEX, V6, P377, DOI 10.1080/13691050410001680492; Kelly RJ, 2003, JAIDS-J ACQ IMM DEF, V32, P446, DOI 10.1097/00126334-200304010-00016; Kenyon C, 2013, INT J STD AIDS, V24, P211, DOI 10.1177/0956462412472455; KNAUB JR, 1987, AM STAT, V41, P246; KwaZulu-Natal Department of Health, 2012, SUG DADD CAMP; Lamb MR, 2014, AIDS, V28, P559, DOI 10.1097/QAD.0000000000000054; Langeni T, 2007, AJAR-AFR J AIDS RES, V6, P261, DOI 10.2989/16085900709490422; Leclerc-Madlala S, 2003, SOC DYNAMICS, V29, P213, DOI 10.1080/02533950308628681; Leclerc-Madlala S, 2008, AIDS, V22, pS17, DOI 10.1097/01.aids.0000341774.86500.53; Longfield K, 2004, STUD FAMILY PLANN, V35, P125, DOI 10.1111/j.1728-4465.2004.00014.x; Luke N, 2005, INT FAM PLAN PERSPEC, V31, P6, DOI 10.1363/3100605; Luke N, 2003, STUD FAMILY PLANN, V34, P67, DOI 10.1111/j.1728-4465.2003.00067.x; Lurie M, 2008, JAIDS-J ACQ IMM DEF, V47, P484, DOI 10.1097/QAI.0b013e3181648de8; MacPhail C, 2001, SOC SCI MED, V52, P1613, DOI 10.1016/S0277-9536(00)00272-0; Mantell JE, 2015, GLOB PUBLIC HEALTH, V10, P947, DOI 10.1080/17441692.2015.1045918; Masvawure T, 2010, CULT HEALTH SEX, V12, P857, DOI 10.1080/13691050903471441; Maughan-Brown B, 2014, AIDS BEHAV, V18, P2469, DOI 10.1007/s10461-014-0828-6; Maughan-Brown B, 2011, AIDS, V25, P1549, DOI 10.1097/QAD.0b013e32834905c4; Mavhandu-Mudzusi AH, 2014, MEDITERRANEAN J SOCI, V5, DOI [10.5901/mjss.2014.v5n20p2876, DOI 10.5901/MJSS.2014.V5N20P2876]; Miller KS, 1997, FAM PLANN PERSPECT, V29, P212, DOI 10.2307/2953397; Morris M, 2010, AIDS BEHAV, V14, P31, DOI 10.1007/s10461-009-9639-6; Nyanzi S, 2001, AIDS CARE, V13, P83, DOI 10.1080/09540120020018206; Ott MQ, 2011, AIDS, V25, P861, DOI 10.1097/QAD.0b013e32834344c9; Papo JK, 2011, AIDS, V25, P247, DOI 10.1097/QAD.0b013e328341b9b8; Pettifor AE, 2005, AIDS, V19, P1525, DOI 10.1097/01.aids.0000183129.16830.06; Pettifor AE, 2005, TROP MED INT HEALTH, V10, P971, DOI 10.1111/j.1365-3156.2005.01483.x; PSI, 2014, CROSS GEN SEX; Robinson J, 2011, AM ECON J-APPL ECON, V3, P35, DOI 10.1257/app.3.1.35; Schroder KEE, 2003, ANN BEHAV MED, V26, P76, DOI 10.1207/S15324796ABM2602_02; Shisana O, 2009, S AFRICAN NATL PREVA; Shisana O, 2014, S AFRICAN NATL HIV P; Silberschmidt M, 2001, SOC SCI MED, V52, P1815, DOI 10.1016/S0277-9536(00)00299-9; Stephenson R, 2013, AIDS CARE, V25, P784, DOI 10.1080/09540121.2012.748161; Tumwesigye NM, 2013, AFR HEALTH SCI, V13, P407, DOI 10.4314/ahs.v13i2.30; UNAIDS, 2020, UNAIDS 2020 GLOB REP; Voeten HACM, 2007, TROP MED INT HEALTH, V12, P174, DOI 10.1111/j.1365-3156.2006.01776.x; Voeten HACM, 2004, SEX TRANSM DIS, V31, P481, DOI 10.1097/01.olq.0000135989.14131.9d; Volpe EM, 2013, J INTERPERS VIOLENCE, V28, P2068, DOI 10.1177/0886260512471082; Wamoyi J, 2011, ARCH SEX BEHAV, V40, P5, DOI 10.1007/s10508-010-9646-8; Wood K, 1998, SOC SCI MED, V47, P233, DOI 10.1016/S0277-9536(98)00057-4; Zembe YZ, 2013, GLOBALIZATION HEALTH, V9, DOI 10.1186/1744-8603-9-28	70	47	47	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2016	11	8							e0159162	10.1371/journal.pone.0159162	http://dx.doi.org/10.1371/journal.pone.0159162			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DT4SL	27526116	Green Published, gold			2022-12-27	WOS:000381471100005
J	Baack, ML; Forred, BJ; Larsen, TD; Jensen, DN; Wachal, AL; Khan, MA; Vitiello, PF				Baack, Michelle L.; Forred, Benjamin J.; Larsen, Tricia D.; Jensen, Danielle N.; Wachal, Angela L.; Khan, Muhammad Ali; Vitiello, Peter F.			Consequences of a Maternal High-Fat Diet and Late Gestation Diabetes on the Developing Rat Lung	PLOS ONE			English	Article							FETAL LUNG; PULMONARY-HYPERTENSION; MOLECULAR-MECHANISMS; VASCULAR INJURY; PREGNANCY; OBESITY; MATURATION; MELLITUS; INFANTS; GROWTH	Rationale Infants born to diabetic or obese mothers are at risk of respiratory distress and persistent pulmonary hypertension of the newborn (PPHN), conceivably through fuel-mediated pathogenic mechanisms. Prior research and preventative measures focus on controlling maternal hyperglycemia, but growing evidence suggests a role for additional circulating fuels including lipids. Little is known about the individual or additive effects of a maternal high-fat diet on fetal lung development. Objective The objective of this study was to determine the effects of a maternal high-fat diet, alone and alongside late-gestation diabetes, on lung alveologenesis and vasculogenesis, as well as to ascertain if consequences persist beyond the perinatal period. Methods A rat model was used to study lung development in offspring from control, diabetes-exposed, high-fat diet-exposed and combination-exposed pregnancies via morphometric, histologic (alveolarization and vasculogenesis) and physiologic (echocardiography, pulmonary function) analyses at birth and 3 weeks of age. Outcomes were interrogated for diet, diabetes and interaction effect using ANOVA with significance set at p <= 0.05. Findings prompted additional mechanistic inquiry of key molecular pathways. Results Offspring exposed to maternal diabetes or high-fat diet, alone and in combination, had smaller lungs and larger hearts at birth. High-fat diet-exposed, but not diabetes-exposed offspring, had a higher perinatal death rate and echocardiographic evidence of PPHN at birth. Alveolar mean linear intercept, septal thickness, and airspace area (D-2) were not significantly different between the groups; however, markers of lung maturity were. Both diabetes-exposed and diet-exposed offspring expressed more T1 alpha protein, a marker of type I cells. Diet-exposed newborn pups expressed less surfactant protein B and had fewer pulmonary vessels enumerated. Mechanistic inquiry revealed alterations in AKT activation, higher endothelin-1 expression, and an impaired Txnip/VEGF pathway that are important for vessel growth and migration. After 3 weeks, mortality remained highest and static lung compliance and hysteresis were lowest in combination-exposed offspring. Conclusion This study emphasizes the effects of a maternal high-fat diet, especially alongside late-gestation diabetes, on pulmonary vasculogenesis, demonstrates adverse consequences beyond the perinatal period and directs attention to mechanistic pathways of interest. Findings provide a foundation for additional investigation of preventative and therapeutic strategies aimed at decreasing pulmonary morbidity in at-risk infants.	[Baack, Michelle L.; Forred, Benjamin J.; Larsen, Tricia D.; Jensen, Danielle N.; Wachal, Angela L.; Vitiello, Peter F.] Sanford Res, Childrens Hlth Res Ctr, Sioux Falls, SD 57104 USA; [Baack, Michelle L.; Khan, Muhammad Ali] Univ South Dakota, Sanford Sch Med, Dept Internal Med, Sioux Falls, SD 57105 USA; [Baack, Michelle L.; Vitiello, Peter F.] Univ South Dakota, Sanford Sch Med, Dept Pediat, Sioux Falls, SD 57105 USA; [Baack, Michelle L.] Sanford Childrens Hosp, Childrens Hlth Specialty Clin, Sioux Falls, SD 57117 USA	Sanford Health; University of South Dakota; University of South Dakota; Sanford Health	Baack, ML (corresponding author), Sanford Res, Childrens Hlth Res Ctr, Sioux Falls, SD 57104 USA.; Baack, ML (corresponding author), Univ South Dakota, Sanford Sch Med, Dept Internal Med, Sioux Falls, SD 57105 USA.; Baack, ML (corresponding author), Univ South Dakota, Sanford Sch Med, Dept Pediat, Sioux Falls, SD 57105 USA.; Baack, ML (corresponding author), Sanford Childrens Hosp, Childrens Hlth Specialty Clin, Sioux Falls, SD 57117 USA.	michelle.baack@sanfordhealth.org	Baack, Michelle/T-4645-2019	Baack, Michelle/0000-0001-5966-669X; Forred, Benjamin/0000-0002-5340-6886	Eunice Kennedy Shriver National Institute of Child Health and Human Development [K08D078504, R25HD072596]; National Institutes of Health General Medical Sciences [P20GM103620, P20GM103548]; National Science Foundation-Research Experiences for Undergraduates [DBI-1262744]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K08HD078504, R25HD072596] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103620] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institutes of Health General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Science Foundation-Research Experiences for Undergraduates(National Science Foundation (NSF)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding was provided by the Eunice Kennedy Shriver National Institute of Child Health and Human Development, K08D078504 MLB; https://www.nichd.nih.gov/Pages/index.aspx; National Institutes of Health General Medical Sciences, P20GM103620 COBRE PFV BJF, https://www.nigms.nih.gov/Pages/default.aspx; National Institutes of Health General Medical Sciences, P20GM103548 COBRE the Sanford Research Molecular Pathology Core, https://www.nigms.nih.gov/Pages/default.aspx; National Science Foundation-Research Experiences for Undergraduates, DBI-1262744 funds Sanford Program for Undergraduate Research (SPUR) DNJ, http://www.nsf.gov/funding/pgm_summ.jsp?pims_id=5517& and Eunice Kennedy Shriver National Institute of Child Health and Human Development, R25HD072596 funds Sanford Science Educator Research Fellowship (SERF) ALW, https://www.nichd.nih.gov/Pages/index.aspx. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Black MH, 2013, DIABETES CARE, V36, P56, DOI 10.2337/dc12-0741; Blagosklonny MV, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.506; Boucherat O, 2014, DEVELOPMENT, V141, P3197, DOI 10.1242/dev.110254; BOURBON JR, 1985, PEDIATR RES, V19, P253, DOI 10.1203/00006450-198503000-00001; Catalano PM, 2012, DIABETES CARE, V35, P780, DOI 10.2337/dc11-1790; Catalano PM, 2011, AM J OBSTET GYNECOL, V204, P479, DOI 10.1016/j.ajog.2010.11.039; COLPAERT C, 1995, PEDIATR PATHOL LAB M, V15, P689, DOI 10.3109/15513819509027006; Cundy T, 2000, DIABETIC MED, V17, P33, DOI 10.1046/j.1464-5491.2000.00215.x; Dabelea D, 2005, DIABETES CARE, V28, P579, DOI 10.2337/diacare.28.3.579; DABESTANI A, 1987, AM J CARDIOL, V59, P662, DOI 10.1016/0002-9149(87)91189-1; Deng FT, 2015, J HUAZHONG U SCI-MED, V35, P122, DOI 10.1007/s11596-015-1400-y; Dennedy M C, 2012, Ir Med J, V105, P23; Everaert BR, 2010, INT J CARDIOL, V144, P350, DOI 10.1016/j.ijcard.2010.04.018; Fan L, 2013, INT J OBESITY, V37, P254, DOI 10.1038/ijo.2012.42; Feng XS, 2010, DEVELOPMENT, V137, P4191, DOI 10.1242/dev.052043; Floen MJ, 2014, FREE RADICAL BIO MED, V75, P167, DOI 10.1016/j.freeradbiomed.2014.07.023; Fung GPG, 2014, EARLY HUM DEV, V90, P527, DOI 10.1016/j.earlhumdev.2014.04.006; Gewolb IH, 1996, EXP LUNG RES, V22, P201, DOI 10.3109/01902149609050847; Grover TR, 2005, AM J PHYSIOL-LUNG C, V288, pL648, DOI 10.1152/ajplung.00288.2004; Haberg SE, 2009, PAEDIATR PERINAT EP, V23, P352, DOI 10.1111/j.1365-3016.2009.01034.x; Hernandez-Diaz S, 2007, PEDIATRICS, V120, pE272, DOI 10.1542/peds.2006-3037; Herrera E, 2010, BEST PRACT RES CL EN, V24, P515, DOI 10.1016/j.beem.2010.05.006; Hsia CCW, 2010, AM J RESP CRIT CARE, V181, P394, DOI 10.1164/rccm.200809-1522ST; Huang LT, 2016, PEDIATR NEONATOL, V57, P508, DOI 10.1016/j.pedneo.2016.03.003; Ikeda H, 2011, MOL CELL BIOL, V31, P1054, DOI 10.1128/MCB.00732-10; Jacob RE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006670; KITABATAKE A, 1983, CIRCULATION, V68, P302, DOI 10.1161/01.CIR.68.2.302; Knudsen L, 2010, J APPL PHYSIOL, V108, P412, DOI 10.1152/japplphysiol.01100.2009; Koskinen A, 2012, PEDIATR PULM, V47, P275, DOI 10.1002/ppul.21541; Langer O, 2015, J MATERN-FETAL NEO M, P1, DOI DOI 10.3109/14767058; Lock M, 2013, CLIN EXP PHARMACOL P, V40, P803, DOI 10.1111/1440-1681.12166; Madonna R, 2011, VASC PHARMACOL, V54, P68, DOI 10.1016/j.vph.2011.03.005; Madonna R, 2011, VASC PHARMACOL, V54, P75, DOI 10.1016/j.vph.2011.03.007; Mayor RS, 2015, AM J PHYSIOL-LUNG C, V309, pL360, DOI 10.1152/ajplung.00105.2015; Mdaki KS, 2016, AM J PHYSIOL-HEART C, V310, pH681, DOI 10.1152/ajpheart.00795.2015; Mitzner W, 2008, J APPL PHYSIOL, V105, P1980, DOI 10.1152/japplphysiol.90968.2008; Park SY, 2013, ARTERIOSCL THROM VAS, V33, P737, DOI 10.1161/ATVBAHA.112.300386; Perez MK, 2014, IMMUNOL ALLERGY CLIN, V34, P777, DOI 10.1016/j.iac.2014.07.002; Piazze JJ, 1999, EUR J OBSTET GYN R B, V83, P145, DOI 10.1016/S0301-2115(98)90333-5; PIPER JM, 1993, AM J OBSTET GYNECOL, V168, P783, DOI 10.1016/S0002-9378(12)90819-4; Rayani HH, 1999, EXP LUNG RES, V25, P69, DOI 10.1080/019021499270439; Satwiko MG, 2015, BIOCHEM BIOPH RES CO, V465, P356, DOI 10.1016/j.bbrc.2015.08.002; SOSENKO IRS, 1980, AM REV RESPIR DIS, V122, P687, DOI 10.1164/arrd.1980.122.5.687; Sutton L, 2001, ACTA OBSTET GYN SCAN, V80, P917, DOI 10.1080/791200707; Thebaud B, 2007, AM J RESP CRIT CARE, V175, P978, DOI 10.1164/rccm.200611-1660PP; Trevino-Alanis M, 2009, ANAT HISTOL EMBRYOL, V38, P169, DOI 10.1111/j.1439-0264.2008.00902.x; USDA, 2010, DIET GUID AM, DOI DOI 10.HTTP://WWW.CNPP.USDA.G0V/PUBLICATI0NS/DIETARYGUIDELINES/2010/P0LICYD0C/P0LICYD0C.PDF; Vela-Huerta M, 2007, ACTA PAEDIATR, V96, P1303, DOI 10.1111/j.1651-2227.2007.00414.x; Wieck MM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148323; World C, 2011, ARTERIOSCL THROM VAS, V31, P1890, DOI 10.1161/ATVBAHA.111.226340; Yared K, 2011, J AM SOC ECHOCARDIOG, V24, P687, DOI 10.1016/j.echo.2011.03.008	51	23	24	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2016	11	8							e0160818	10.1371/journal.pone.0160818	http://dx.doi.org/10.1371/journal.pone.0160818			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3LI	27518105	Green Submitted, Green Published, gold			2022-12-27	WOS:000381382100026
J	Gaddam, RR; Fraser, R; Badiei, A; Chambers, S; Cogger, VC; Le Couteur, DG; Ishii, I; Bhatia, M				Gaddam, Ravinder Reddy; Fraser, Robin; Badiei, Alireza; Chambers, Stephen; Cogger, Victoria C.; Le Couteur, David G.; Ishii, Isao; Bhatia, Madhav			Cystathionine-Gamma-Lyase Gene Deletion Protects Mice against Inflammation and Liver Sieve Injury following Polymicrobial Sepsis	PLOS ONE			English	Article							SINUSOIDAL ENDOTHELIAL-CELLS; PUNCTURE-INDUCED SEPSIS; HYDROGEN-SULFIDE; CECAL LIGATION; KUPFFER CELLS; LUNG INJURY; RAT-LIVER; PROPARGYLGLYCINE; INACTIVATION; PATHOGENESIS	Background Hydrogen sulfide (H2S), produced by the activity of cystathionine-gamma-lyase (CSE), is a key mediator of inflammation in sepsis. The liver sinusoidal endothelial cells (LSECs) are important target and mediator of sepsis. The aim of this study was to investigate the role of CSE-derived H2S on inflammation and LSECs fenestrae in caecal-ligation and puncture (CLP)-induced sepsis using CSE KO mice. Methods Sepsis was induced by CLP, and mice (C57BL/6J, male) were sacrificed after 8 hours. Liver, lung, and blood were collected and processed to measure CSE expression, H2S synthesis, MPO activity, NF-.B p65, ERK1/2, and cytokines/chemokines levels. Diameter, frequency, porosity and gap area of the liver sieve were calculated from scanning electron micrographs of the LSECs. Results An increased CSE expression and H2S synthesizing activity in the liver and lung of wildtype mice following CLP-induced sepsis. This was associated with an increased liver and lung MPO activity, and increased liver and lung and plasma levels of the pro-inflammatory cytokines TNF-alpha, IL-6, and IL-1 beta, and the chemokines MCP-1 and MIP-2 alpha. Conversely, CSE KO mice had less liver and lung injury and reduced inflammation following CLPinduced sepsis as evidenced by decreased levels of H2S synthesizing activity, MPO activity, and pro-inflammatory cytokines/chemokines production. Extracellular-regulated kinase (ERK1/2) and nuclear factor-kappa B p65 (NF-kappa B) became significantly activated after the CLP in WT mice but not in CSE KO mice. In addition, CLP-induced damage to the LSECs, as indicated by increased defenestration and gaps formation in the LSECs compared toWT sham control. CSE KO mice showed decreased defenestration and gaps formation following sepsis. Conclusions Mice with CSE (an H2S synthesising enzyme) gene deletion are less susceptible to CLPinduced sepsis and associated inflammatory response through ERK1/ 2-NF-kappa B p65 pathway as evidenced by reduced inflammation, tissue damage, and LSECs defenestration and gaps formation.	[Gaddam, Ravinder Reddy; Fraser, Robin; Badiei, Alireza; Chambers, Stephen; Bhatia, Madhav] Univ Otago, Dept Pathol, Christchurch, New Zealand; [Cogger, Victoria C.; Le Couteur, David G.] Univ Sydney, Alzheimers & Ageing Inst, ANZAC Res Inst, Ctr Educ & Res Ageing,Biogerentol, Sydney, NSW, Australia; [Cogger, Victoria C.; Le Couteur, David G.] Concord Hosp, Sydney, NSW, Australia; [Ishii, Isao] Keio Univ, Grad Sch Pharmaceut Sci, Dept Biochem, Tokyo, Japan	University of Otago; University of Sydney; ANZAC Research Institute; Concord Repatriation General Hospital; Keio University	Bhatia, M (corresponding author), Univ Otago, Dept Pathol, Christchurch, New Zealand.	madhav.bhatia@otago.ac.nz	Ekanayake, Kanchana/P-8817-2016; Gaddam, Ravinder Reddy/I-5703-2019; Research Institute, ANZAC/CAE-9030-2022	Gaddam, Ravinder Reddy/0000-0003-1062-5082; Le Couteur, David/0000-0002-4227-5817; Ishii, Isao/0000-0002-5367-205X; Chambers, Stephen/0000-0002-0698-3285	University of Otago; Canterbury Medical Research Foundation (CMRF, New Zealand); Aging and Alzheimers Institute (Australia)	University of Otago; Canterbury Medical Research Foundation (CMRF, New Zealand); Aging and Alzheimers Institute (Australia)	Support was provided by the University of Otago, Canterbury Medical Research Foundation (CMRF, New Zealand), and the Aging and Alzheimers Institute (Australia). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the University of Otago, and Canterbury Medical Research Foundation (CMRF), New Zealand and the Aging and Alzheimers Institute, Australia. We thank Katie Saunders, Aaron Dyer, and Abel Ang for their technical assistance. We would like to thank Dr. John Pearson, Department of Population Health, University of Otago, Christchurch for advice with statistics.	Ang SF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024535; Ang SF, 2010, CRIT CARE MED, V38, P619, DOI 10.1097/CCM.0b013e3181c0df00; Bhatia M, 2005, BRIT J PHARMACOL, V145, P141, DOI 10.1038/sj.bjp.0706186; Brown AP, 1997, SHOCK, V7, P186, DOI 10.1097/00024382-199703000-00006; Brunt EM, 2000, HEPATOLOGY, V31, P241, DOI 10.1002/hep.510310136; BURNETT G, 1980, J BIOL CHEM, V255, P3487; Cheluvappa R, 2010, INT J INFECT DIS, V14, pE857, DOI 10.1016/j.ijid.2010.02.2263; Cogger VC, 2004, J HEPATOL, V41, P370, DOI 10.1016/j.jhep.2004.04.034; Cogger VC, 2015, JOVE-J VIS EXP, DOI 10.3791/52698; Collin M, 2005, BRIT J PHARMACOL, V146, P498, DOI 10.1038/sj.bjp.0706367; Dal-Secco D, 2008, J IMMUNOL, V181, P4287, DOI 10.4049/jimmunol.181.6.4287; DOBBS BR, 1994, LIVER, V14, P230; Francescato HD, 2011, NEPHROL DIAL TRANSPL, V26, P479, DOI 10.1093/ndt/gfq447; Fry DE, 2012, AM SURGEON, V78, P1; Huang CW, 2015, HANDB EXP PHARMACOL, V230, P3, DOI 10.1007/978-3-319-18144-8_1; Ishii I, 2010, J BIOL CHEM, V285, P26358, DOI 10.1074/jbc.M110.147439; Kabil O, 2011, ANTIOXID REDOX SIGN, V15, P363, DOI 10.1089/ars.2010.3781; KNODELL RG, 1981, HEPATOLOGY, V1, P431, DOI 10.1002/hep.1840010511; Knolle PA, 1997, CLIN EXP IMMUNOL, V107, P555, DOI 10.1046/j.1365-2249.1997.d01-959.x; Kolios G, 2008, MOL CELL BIOCHEM, V319, P91, DOI 10.1007/s11010-008-9881-7; Li L, 2005, FASEB J, V19, P1196, DOI 10.1096/fj.04-3583fje; MARCOTTE P, 1976, BIOCHEMISTRY-US, V15, P3070, DOI 10.1021/bi00659a021; Marshall JC, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001341; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Matute-Bello G, 2011, AM J RESP CELL MOL, V44, P725, DOI 10.1165/rcmb.2009-0210ST; Niwano M, 1997, J SURG RES, V72, P36, DOI 10.1006/jsre.1997.5162; Remick DG, 2007, AM J PATHOL, V170, P1435, DOI 10.2353/ajpath.2007.060872; Sarphie TG, 1996, HEPATOLOGY, V23, P788, DOI 10.1053/jhep.1996.v23.pm0008666333; Sen N, 2012, MOL CELL, V45, P13, DOI 10.1016/j.molcel.2011.10.021; Sidhapuriwala JN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032574; Sorensen KK, 2015, COMPR PHYSIOL, V5, P1751, DOI 10.1002/cphy.c140078; Streetz KL, 2001, CELL MOL BIOL, V47, P661; Wang G, 2013, APOPTOSIS, V18, P28, DOI 10.1007/s10495-012-0770-x; Warren A, 2010, MICROCIRCULATION, V17, P32, DOI 10.1111/j.1549-8719.2009.00004.x; Whiteman Matthew, 2011, Expert Rev Clin Pharmacol, V4, P13, DOI 10.1586/ecp.10.134; Whiteman M, 2010, ANN NY ACAD SCI, V1203, P146, DOI 10.1111/j.1749-6632.2010.05556.x; WICHTERMAN KA, 1980, J SURG RES, V29, P189, DOI 10.1016/0022-4804(80)90037-2; Zhang CY, 2003, BIOCHEM BIOPH RES CO, V302, P810, DOI 10.1016/S0006-291X(03)00256-0; Zhang HL, 2006, AM J PHYSIOL-LUNG C, V290, pL1193, DOI 10.1152/ajplung.00489.2005; Zhang HL, 2008, J IMMUNOL, V181, P4320, DOI 10.4049/jimmunol.181.6.4320; Zhang HL, 2007, J LEUKOCYTE BIOL, V82, P894, DOI 10.1189/jlb.0407237; Zhang HL, 2007, J IMMUNOL, V179, P4153, DOI 10.4049/jimmunol.179.6.4153; Zhang L, 2010, MOL MED, V16, P417, DOI 10.2119/molmed.2010.00027; Zhi L, 2007, J LEUKOCYTE BIOL, V81, P1322, DOI 10.1189/jlb.1006599; Zhou HX, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154483	45	27	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2016	11	8							e0160521	10.1371/journal.pone.0160521	http://dx.doi.org/10.1371/journal.pone.0160521			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3LI	27518439	Green Published, gold, Green Submitted			2022-12-27	WOS:000381382100015
J	Wang, YQ; Wang, YD; Wang, ZY; Bravo, A; Soberon, M; He, KL				Wang, Yueqin; Wang, Yidong; Wang, Zhenying; Bravo, Alejandra; Soberon, Mario; He, Kanglai			Genetic Basis of Cry1F-Resistance in a Laboratory Selected Asian Corn Borer Strain and Its Cross-Resistance to Other Bacillus thuringiensis Toxins	PLOS ONE			English	Article							FRUGIPERDA LEPIDOPTERA-NOCTUIDAE; OSTRINIA-NUBILALIS LEPIDOPTERA; HELICOVERPA-ARMIGERA HUBNER; BORDER MEMBRANE-VESICLES; FIELD-EVOLVED RESISTANCE; SPODOPTERA-FRUGIPERDA; DIAMONDBACK MOTH; INSECT RESISTANCE; CRY1F RESISTANCE; DELTA-ENDOTOXINS	The Asian corn borer (ACB), Ostrinia furnacalis (Guenee) (Lepidoptera: Crambidae), is the most destructive insect pest of corn in China. Susceptibility to the Cry1F toxin derived from Bacillus thuringiensis has been demonstrated for ACB, suggesting the potential for Cry1F inclusion as part of an insect pest management program. Insects can develop resistance to Cry toxins, which threatens the development and use of Bt formulations and Bt crops in the field. To determine possible resistance mechanisms to Cry1F, a Cry1F-resistant colony of ACB (ACB-FR) that exhibited more than 1700-fold resistance was established through selection experiments after 49 generations of selection under laboratory conditions. The ACB-FR strain showed moderate cross-resistance to Cry1Ab and Cry1Ac of 22.8-and 26.9-fold, respectively, marginally cross-resistance to Cry1Ah (3.7-fold), and no cross-resistance to Cry1Ie (0.6-fold). The bioassay responses of progeny from reciprocal F-1 crosses to different Cry1 toxin concentrations indicated that the resistance trait to Cry1Ab, Cry1Ac and Cry1F has autosomal inheritance with no maternal effect or sex linked. The effective dominance (h) of F-1 offspring was calculated at different concentrations of Cry1F, showing that h decreased as concentration of Cry1F increased. Finally, the analysis of actual and expected mortality of the progeny from a backcross (F-1 x resistant strain) indicated that the inheritance of the resistance to Cry1F in ACB-FR was due to more than one locus. The present study provides an understanding of the genetic basis of Cry1F resistance in ACB-FR and also shows that pyramiding Cry1F with Cry1Ah or Cry1Ie could be used as a strategy to delay the development of ACB resistance to Bt proteins.	[Wang, Yueqin; Wang, Yidong; Wang, Zhenying; He, Kanglai] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China; [Bravo, Alejandra; Soberon, Mario] Univ Nacl Autonoma Mexico, Inst Biotecnol, Apdo Postal 510-3, Cuernavaca 62250, Morelos, Mexico	Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS; Universidad Nacional Autonoma de Mexico	He, KL (corresponding author), Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China.	klhe@ippcaas.cn	de la Parra, Maria Alejandra Bravo/R-6740-2017	Bravo, Alejandra/0000-0002-7573-7475; Wang, Yidong/0000-0001-6939-1490	Genetically Modified Organisms Breeding Major Project [2014ZX08011-003]; National Science and Technology Major Project of China	Genetically Modified Organisms Breeding Major Project; National Science and Technology Major Project of China	This work was funded by Genetically Modified Organisms Breeding Major Project (2014ZX08011-003), National Science and Technology Major Project of China. Dow AgroSciences provided Cry1F protein.	Alves AP, 2006, J ECON ENTOMOL, V99, P494, DOI 10.1603/0022-0493-99.2.494; Bates SL, 2005, NAT BIOTECHNOL, V23, P57, DOI 10.1038/nbt1056; Bourguet D, 2000, J ECON ENTOMOL, V93, P1588, DOI 10.1603/0022-0493-93.6.1588; Bravo A, 2008, TRENDS BIOTECHNOL, V26, P573, DOI 10.1016/j.tibtech.2008.06.005; CHAMBERS JA, 1991, J BACTERIOL, V173, P3966, DOI 10.1128/jb.173.13.3966-3976.1991; Crespo ALB, 2009, PEST MANAG SCI, V65, P1071, DOI 10.1002/ps.1793; Dhurua S, 2011, PEST MANAG SCI, V67, P898, DOI 10.1002/ps.2127; Farias JR, 2016, PEST MANAG SCI, V72, P974, DOI 10.1002/ps.4077; Farias JR, 2014, CROP PROT, V64, P150, DOI 10.1016/j.cropro.2014.06.019; Gahan LJ, 2005, J ECON ENTOMOL, V98, P1357, DOI 10.1603/0022-0493-98.4.1357; Gassmann AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022629; Gonzalez-Cabrera J, 2001, APPL ENVIRON MICROB, V67, P5043, DOI 10.1128/AEM.67.11.5043-5048.2001; Gould F, 1998, ANNU REV ENTOMOL, V43, P701, DOI 10.1146/annurev.ento.43.1.701; GOULD F, 1994, BIOCONTROL SCI TECHN, V4, P451, DOI 10.1080/09583159409355357; He K, 2005, J APPL ENTOMOL, V129, P407, DOI 10.1111/j.1439-0418.2005.00989.x; He KL, 2003, J ECON ENTOMOL, V96, P935, DOI 10.1603/0022-0493-96.3.935; Hernandez CS, 2005, APPL ENVIRON MICROB, V71, P5627, DOI 10.1128/AEM.71.9.5627-5629.2005; Hua G, 2001, APPL ENVIRON MICROB, V67, P872, DOI 10.1128/AEM.67.2.872-879.2001; Huang F, 1999, SCIENCE, V284, P965, DOI 10.1126/science.284.5416.965; Huang JK, 2005, SCIENCE, V308, P688, DOI 10.1126/science.1108972; JAMES C, 2003, GLOBAL REV COMMERCIA; Janmaat AF, 2004, APPL ENVIRON MICROB, V70, P5859, DOI 10.1128/AEM.70.10.5859-5867.2004; Jurat-Fuentes JL, 2001, APPL ENVIRON MICROB, V67, P323, DOI 10.1128/AEM.67.1.323-329.2001; Kranthi KR, 2006, CROP PROT, V25, P119, DOI 10.1016/j.cropro.2005.03.011; Krishna VV, 2012, AGR SYST, V107, P47, DOI 10.1016/j.agsy.2011.11.005; Liang GM, 2008, J INVERTEBR PATHOL, V97, P142, DOI 10.1016/j.jip.2007.09.007; Liu YB, 1997, APPL ENVIRON MICROB, V63, P2218, DOI 10.1128/AEM.63.6.2218-2223.1997; Luo K, 1999, APPL ENVIRON MICROB, V65, P457; Mahon RJ, 2007, J ECON ENTOMOL, V100, P894, DOI 10.1603/0022-0493(2007)100[894:RTBTTC]2.0.CO;2; MCGAUGHEY WH, 1985, SCIENCE, V229, P193, DOI 10.1126/science.229.4709.193; Monnerat R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119544; Pereira EJG, 2008, B ENTOMOL RES, V98, P621, DOI 10.1017/S0007485308005920; Pereira EJG, 2008, ENTOMOL EXP APPL, V126, P115, DOI 10.1111/j.1570-7458.2007.00642.x; ROUSH RT, 1989, PESTIC SCI, V26, P423, DOI 10.1002/ps.2780260409; Roush RT, 1998, PHILOS T R SOC B, V353, P1777, DOI 10.1098/rstb.1998.0330; Santos-Amaya OF, 2016, CROP PROT, V81, P154, DOI 10.1016/j.cropro.2015.12.014; Hernandez-Rodriguez CS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068164; Sayyed AH, 2000, PEST MANAG SCI, V56, P743, DOI 10.1002/1526-4998(200009)56:9<743::AID-PS195>3.0.CO;2-8; SIMS SR, 1991, J INVERTEBR PATHOL, V57, P206, DOI 10.1016/0022-2011(91)90118-A; Siqueira HAA, 2004, J ECON ENTOMOL, V97, P1049, DOI 10.1603/0022-0493(2004)097[1049:COCONL]2.0.CO;2; Storer NP, 2010, J ECON ENTOMOL, V103, P1031, DOI 10.1603/EC10040; Tabashnik BE, 2003, J ECON ENTOMOL, V96, P1031, DOI 10.1603/0022-0493-96.4.1031; TABASHNIK BE, 1991, J ECON ENTOMOL, V84, P703, DOI 10.1093/jee/84.3.703; TABASHNIK BE, 1989, J ECON ENTOMOL, V82, P1263, DOI 10.1093/jee/82.5.1263; Tabashnik BE, 1997, P NATL ACAD SCI USA, V94, P1640, DOI 10.1073/pnas.94.5.1640; TABASHNIK BE, 1990, J ECON ENTOMOL, V83, P1671, DOI 10.1093/jee/83.5.1671; Tabashnik BE, 2002, J ECON ENTOMOL, V95, P1018, DOI 10.1603/0022-0493-95.5.1018; Tan SY, 2013, J INVERTEBR PATHOL, V114, P234, DOI 10.1016/j.jip.2013.08.007; van Rensburg J. B. J., 2007, South African Journal of Plant and Soil, V24, P147; Wirth MC, 2012, J MED ENTOMOL, V49, P886, DOI 10.1603/ME11192; Xu L, 2010, J APPL ENTOMOL, V134, P429, DOI 10.1111/j.1439-0418.2010.01517.x; Xue J, 2008, FEMS MICROBIOL LETT, V280, P95, DOI 10.1111/j.1574-6968.2007.01053.x; Zhang TT, 2014, TOXINS, V6, P2694, DOI 10.3390/toxins6092694; Zhou DR, 1992, ADV INSECT REARING R, P230; Zhou DR, 1995, ASIAN CORN BORER ITS	55	18	23	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2016	11	8							e0161189	10.1371/journal.pone.0161189	http://dx.doi.org/10.1371/journal.pone.0161189			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3LI	27518813	Green Published, Green Submitted, gold			2022-12-27	WOS:000381382100060
J	van Galen, LS; Struik, PW; Driesen, BEJM; Merten, H; Ludikhuize, J; van der Spoel, JI; Kramer, MHH; Nanayakkara, PWB				van Galen, Louise S.; Struik, Patricia W.; Driesen, Babiche E. J. M.; Merten, Hanneke; Ludikhuize, Jeroen; van der Spoel, Johannes I.; Kramer, Mark H. H.; Nanayakkara, Prabath W. B.			Delayed Recognition of Deterioration of Patients in General Wards Is Mostly Caused by Human Related Monitoring Failures: A Root Cause Analysis of Unplanned ICU Admissions	PLOS ONE			English	Article							INTENSIVE-CARE; ADVERSE EVENTS; INTERNATIONAL CLASSIFICATION; HOSPITALIZED-PATIENTS; ACUTE PHYSIOLOGY; QUALITY; SYSTEM; SAFETY; RISK; IMPLEMENTATION	Background An unplanned ICU admission of an inpatient is a serious adverse event (SAE). So far, no in depth-study has been performed to systematically analyse the root causes of unplanned ICU-admissions. The primary aim of this study was to identify the healthcare worker-, organisational-, technical,- disease- and patient- related causes that contribute to acute unplanned ICU admissions from general wards using a Root-Cause Analysis Tool called PRISMA-medical. Although a Track and Trigger System (MEWS) was introduced in our hospital a few years ago, it was implemented without a clear protocol. Therefore, the secondary aim was to assess the adherence to a Track and Trigger system to identify deterioration on general hospital wards in patients eventually transferred to the ICU. Methods Retrospective observational study in 49 consecutive adult patients acutely admitted to the Intensive Care Unit from a general nursing ward. 1. PRISMA-analysis on root causes of unplanned ICU admissions 2. Assessment of protocol adherence to the early warning score system. Results Out of 49 cases, 156 root causes were identified. The most frequent root causes were healthcare worker related (46%), which were mainly failures in monitoring the patient. They were followed by disease-related (45%), patient-related causes (7, 5%), and organisational root causes (3%). In only 40% of the patients vital parameters were monitored as was instructed by the doctor. 477 vital parameter sets were found in the 48 hours before ICU admission, in only 1% a correct MEWS was explicitly documented in the record. Conclusions This in-depth analysis demonstrates that almost half of the unplanned ICU admissions from the general ward had healthcare worker related root causes, mostly due to monitoring failures in clinically deteriorating patients. In order to reduce unplanned ICU admissions, improving the monitoring of patients is therefore warranted.	[van Galen, Louise S.; Struik, Patricia W.; Driesen, Babiche E. J. M.; Kramer, Mark H. H.; Nanayakkara, Prabath W. B.] Vrije Univ Amsterdam Med Ctr, Sect Acute Med, Dept Internal Med, Amsterdam, Netherlands; [Merten, Hanneke] Vrije Univ Amsterdam Med Ctr, EMGO Inst Hlth & Care Res, Dept Publ & Occupat Hlth, Amsterdam, Netherlands; [Ludikhuize, Jeroen] Acad Med Ctr, Dept Anaesthesiol, Amsterdam, Netherlands; [van der Spoel, Johannes I.] Vrije Univ Amsterdam Med Ctr, Dept Intens Care, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Nanayakkara, PWB (corresponding author), Vrije Univ Amsterdam Med Ctr, Sect Acute Med, Dept Internal Med, Amsterdam, Netherlands.	p.nanayakkara@vumc.nl	Zixuan, Huang/ABI-3557-2020; Kramer, Mark/GWQ-3502-2022					Alam N, 2015, RESUSCITATION, V90, P111, DOI 10.1016/j.resuscitation.2015.02.011; Arts D, 2002, INTENS CARE MED, V28, P656, DOI 10.1007/s00134-002-1272-z; Bapoje SR, 2011, J HOSP MED, V6, P68, DOI 10.1002/jhm.812; Chan PS, 2008, JAMA-J AM MED ASSOC, V300, P2506, DOI 10.1001/jama.2008.715; Darchy B, 1999, ARCH INTERN MED, V159, P71, DOI 10.1001/archinte.159.1.71; de Vries EN, 2008, QUAL SAF HEALTH CARE, V17, P216, DOI 10.1136/qshc.2007.023622; Fluitman KS, 2016, EUR J INTERN MED; Frost SA, 2009, RESUSCITATION, V80, P224, DOI 10.1016/j.resuscitation.2008.10.030; Hillman K, 2001, RESUSCITATION, V48, P105, DOI 10.1016/S0300-9572(00)00334-8; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; LEAPE LL, 1991, NEW ENGL J MED, V324, P377, DOI 10.1056/NEJM199102073240605; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; Ludikhuize J, 2014, RESUSCITATION, V85, P676, DOI 10.1016/j.resuscitation.2014.02.009; McGaughey J, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005529; McGloin H, 1999, J ROY COLL PHYS LOND, V33, P255; Mercier E, 2010, INTENS CARE MED, V36, P1033, DOI 10.1007/s00134-010-1793-9; Moon A, 2011, RESUSCITATION, V82, P150, DOI 10.1016/j.resuscitation.2010.09.480; Quinn T. D., 2015, J INTENSIVE CARE MED; Ranji SR, 2007, J HOSP MED, V2, P422, DOI 10.1002/jhm.238; RASMUSSEN J, 1983, IEEE T SYST MAN CYB, V13, P257, DOI 10.1109/TSMC.1983.6313160; Reason J., 1991, HUMAN ERROR, DOI 10.1017/cbo9781139062367; Reason J.T., 1997, ACTOOLKIT UNPRME ORG, V43, P147; RIDLEY S, 1990, BRIT MED J, V301, P1127, DOI 10.1136/bmj.301.6761.1127; Runciman WB, 2006, QUAL SAF HEALTH CARE, V15, pI82, DOI 10.1136/qshc.2005.017467; Runciman W, 2009, INT J QUAL HEALTH C, V21, P18, DOI 10.1093/intqhc/mzn057; Sherman H, 2009, INT J QUAL HEALTH C, V21, P2, DOI 10.1093/intqhc/mzn054; Storm-Versloot MN, 2014, J NURS SCHOLARSHIP, V46, P39, DOI 10.1111/jnu.12048; Subbe CP, 2007, INTENS CARE MED, V33, P619, DOI 10.1007/s00134-006-0516-8; van der Schaaf TW HM, 2005, PRISM MED BRIEF DESC; van Galen LS, 2016, PLOS O IN PRESS 0627; van Vuuren W, 1997, DEV INCIDENT ANAL TO, DOI 10.1519/8706&reprep1&typepdf; van Wagtendonk I, 2010, BRIT J SURG, V97, P1730, DOI 10.1002/bjs.7201; Vlayen A, 2012, J EVAL CLIN PRACT, V18, P485, DOI 10.1111/j.1365-2753.2010.01612.x; Wilson RM, 1995, MED J AUSTRALIA, V163, P458, DOI 10.5694/j.1326-5377.1995.tb124691.x; Zegers M, 2009, QUAL SAF HEALTH CARE, V18, P297, DOI 10.1136/qshc.2007.025924; Zimmerman JE, 2006, CRIT CARE MED, V34, P1297, DOI 10.1097/01.CCM.0000215112.84523.F0	36	32	32	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0161393	10.1371/journal.pone.0161393	http://dx.doi.org/10.1371/journal.pone.0161393			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DT6ES	27537689	Green Published, Green Submitted, gold			2022-12-27	WOS:000381577000098
J	Yagi-Yaguchi, Y; Yamaguchi, T; Okuyama, Y; Satake, Y; Tsubota, K; Shimazaki, J				Yagi-Yaguchi, Yukari; Yamaguchi, Takefumi; Okuyama, Yumi; Satake, Yoshiyuki; Tsubota, Kazuo; Shimazaki, Jun			Corneal Higher Order Aberrations in Granular, Lattice and Macular Corneal Dystrophies	PLOS ONE			English	Article							LASER PHOTOTHERAPEUTIC KERATECTOMY; AUTOMATED ENDOTHELIAL KERATOPLASTY; OPTICAL COHERENCE TOMOGRAPHY; EXCIMER-LASER; SURFACE IRREGULARITY; CATARACT-SURGERY; VISUAL-ACUITY; ANTERIOR; EYES; AGE	Purpose To evaluate the corneal higher-order aberrations (HOAs) in granular, lattice and macular corneal dystrophies. Methods This retrospective study includes consecutive patients who were diagnosed as granular corneal dystrophy type2 (GCD2; 121 eyes), lattice corneal dystrophies type 1, type 3A (LCDI; 20 eyes, LCDIIIA; 32 eyes) and macular corneal dystrophies (MCD; 13 eyes), and 18 healthy control eyes. Corneal HOAs were calculated using anterior segment optical coherence tomography, and the correlations between HOAs and visual acuity were analyzed. Results HOAs of the total cornea within 4 mm diameter were significantly larger in GCD2 (0.17 +/- 0.35 mu m), in LCDI (0.33 +/- 0.27), LCDIIIA (0.61 +/- 1.56) and in MCD (0.23 +/- 0.18), compared with healthy controls (0.09 +/- 0.02 mu m, all P < 0.01). HOAs of the total cornea within 6 mm diameter were significantly larger in GCD2 (0.32 +/- 0.48), in LCDI (0.60 +/- 0.46), LCDIIIA (0.83 +/- 2.29) and in MCD (0.44 +/- 0.24), compared with healthy controls (0.19 +/- 0.06, all P < 0.001). In GCD2, there was no significant correlation between logMAR and HOAs (r = 0.113, P = 0.227). In MCD, LCDI and LCDIIIA, logMAR was positively significantly correlated with HOAs (r = 0.620 and P = 0.028, r = 0.587 and P = 0.007, r = 0.614 and P < 0.001, respectively). Conclusions Increased HOAs occur in eyes with corneal dystrophies, especially in eye with LCD and MCD. Larger amount corneal HOAs are associated with poorer visual acuity in patients with LCD and MCD.	[Yagi-Yaguchi, Yukari; Yamaguchi, Takefumi; Okuyama, Yumi; Satake, Yoshiyuki; Shimazaki, Jun] Tokyo Dent Coll, Ichikawa Gen Hosp, Dept Ophthalmol, Chiba, Japan; [Tsubota, Kazuo] Keio Univ, Sch Med, Dept Ophthalmol, Tokyo, Japan	Tokyo Dental College; Keio University	Yamaguchi, T (corresponding author), Tokyo Dent Coll, Ichikawa Gen Hosp, Dept Ophthalmol, Chiba, Japan.	tym.i.eye.i@gmail.com	Yamaguchi, Takefumi/AEV-4169-2022; YAMAGUCHI, Takefumi/AAY-6964-2020; Jun, Shimazaki/K-5976-2019	Yamaguchi, Takefumi/0000-0002-2546-2813				Applegate RA, 2003, J CATARACT REFR SURG, V29, P1487, DOI 10.1016/S0886-3350(03)00334-1; Applegate RA, 2003, OPTOMETRY VISION SCI, V80, P97, DOI 10.1097/00006324-200302000-00005; Dang XH, 2009, MOL VIS, V15, P700; Das S, 2005, J REFRACT SURG, V21, P727; Dighiero P, 2000, OPHTHALMOLOGY, V107, P1353, DOI 10.1016/S0161-6420(00)00149-4; Dinh R, 1999, OPHTHALMOLOGY, V106, P1490, DOI 10.1016/S0161-6420(99)90441-4; FANTES FE, 1990, ARCH OPHTHALMOL-CHIC, V108, P665, DOI 10.1001/archopht.1990.01070070051034; Fukuda S, 2010, J CATARACT REFR SURG, V36, P1867, DOI 10.1016/j.jcrs.2010.05.024; Hafner A, 2005, AM J OPHTHALMOL, V140, P392, DOI 10.1016/j.ajo.2005.03.052; Hayashi K, 2015, AM J OPHTHALMOL, V160, P171, DOI 10.1016/j.ajo.2015.04.015; Lakshminarayanan R, 2014, OCUL SURF, V12, P234, DOI 10.1016/j.jtos.2013.12.002; Maeda N, 2010, EYE CONTACT LENS, V36, P254, DOI 10.1097/ICL.0b013e3181ef0dbb; McLellan JS, 2001, INVEST OPHTH VIS SCI, V42, P1390; Montes-Mico R, 2005, INVEST OPHTH VIS SCI, V46, P1615, DOI 10.1167/iovs.05-0017; Musch DC, 2011, INVEST OPHTH VIS SCI, V52, P6959, DOI 10.1167/iovs.11-7771; Nassaralla BA, 1996, J REFRACT SURG, V12, P795; Nowinska AK, 2014, BRIT J OPHTHALMOL, V98, P1514, DOI 10.1136/bjophthalmol-2014-305098; Okamoto F, 2008, OPHTHALMOLOGY, V115, P1216, DOI 10.1016/j.ophtha.2007.09.016; Oshika T, 2006, OPHTHALMOLOGY, V113, P1807, DOI 10.1016/j.ophtha.2006.03.061; Pepose JS, 2005, AM J OPHTHALMOL, V139, P335, DOI 10.1016/j.ajo.2004.11.010; Radhakrishnan S, 2014, CURR OPIN OPHTHALMOL, V25, P98, DOI 10.1097/ICU.0000000000000026; Rudolph M, 2012, OPHTHALMOLOGY, V119, P528, DOI 10.1016/j.ophtha.2011.08.034; Seitz B, 2004, CORNEA, V23, P380, DOI 10.1097/00003226-200405000-00013; Seitz B, 2011, DEV OPHTHALMOL, V48, P116, DOI 10.1159/000324081; Thibos LN, 2002, J REFRACT SURG, V18, pS652; Tomida D, 2015, JPN J OPHTHALMOL, V59, P216, DOI 10.1007/s10384-015-0388-y; Wang L, 2007, J CATARACT REFR SURG, V33, P1713, DOI 10.1016/j.jcrs.2007.07.010; Weiss JS, 2015, CORNEA, V34, P117, DOI 10.1097/ICO.0000000000000307; Yamaguchi T, 2011, INVEST OPHTH VIS SCI, V52, P6222, DOI 10.1167/iovs.11-7647; Yamaguchi T, 2010, CORNEA, V29, P1086, DOI 10.1097/ICO.0b013e3181d0092c; Yamaguchi TD, 2009, J CATARACT REFR SURG, V35, P688, DOI 10.1016/j.jcrs.2008.11.062; Yamaguchi T, 2009, J CATARACT REFR SURG, V35, P57, DOI 10.1016/j.jcrs.2008.09.012	32	21	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0161075	10.1371/journal.pone.0161075	http://dx.doi.org/10.1371/journal.pone.0161075			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27536778	Green Published, gold, Green Submitted			2022-12-27	WOS:000381577000050
J	Ahn, JJ; Son, Y; He, Y; Lee, E; Park, YL				Ahn, Jeong Joon; Son, Youngsoo; He, Yaqian; Lee, Eungul; Park, Yong-Lak			Effects of Temperature on Development and Voltinism of Chaetodactylus krombeini (Acari: Chaetodactylidae): Implications for Climate Change Impacts	PLOS ONE			English	Article							VAPOR-PRESSURE DEFICIT; MITE NEOSEIULUS-CALIFORNICUS; HIGH RELATIVE-HUMIDITY; PREDATORY MITE; AIR-TEMPERATURE; DEPENDENT DEVELOPMENT; AMBLYSEIUS-CUCUMERIS; DEVELOPMENT RATES; FALLACIS ACARINA; COLD-STORAGE	Temperature plays an important role in the growth and development of arthropods, and thus the current trend of climate change will alter their biology and species distribution. We used Chaetodactylus krombeini (Acari: Chaetodactylidae), a cleptoparasitic mite associated with Osmia bees (Hymenoptera: Megachilidae), as a model organism to investigate how temperature affects the development and voltinism of C. krombeini in the eastern United States. The effects of temperature on the stage-specific development of C. krombeini were determined at seven constant temperatures (16.1, 20.2, 24.1, 27.5, 30.0, 32.4 and 37.8 degrees C). Parameters for stage-specific development, such as threshold temperatures and thermal constant, were determined by using empirical models. Results of this study showed that C. krombeini eggs developed successfully to adult at all temperatures tested except 37.8 degrees C. The nonlinear and linear empirical models were applied to describe quantitatively the relationship between temperature and development of each C. krombeini stage. The nonlinear Lactin model estimated optimal temperatures as 31.4, 32.9, 32.6 and 32.5 degrees C for egg, larva, nymph, and egg to adult, respectively. In the linear model, the lower threshold temperatures were estimated to be 9.9, 14.7, 13.0 and 12.4 degrees C for egg, larva, nymph, and egg to adult, respectively. The thermal constant for each stage completion were 61.5, 28.1, 64.8 and 171.1 degree days for egg, larva, nymph, and egg to adult, respectively. Under the future climate scenarios, the number of generations (i.e., voltinism) would increase more likely by 1.5 to 2.0 times by the year of 2100 according to simulation. The findings herein firstly provided comprehensive data on thermal development of C. krombeini and implications for the management of C. krombeini populations under global warming were discussed.	[Ahn, Jeong Joon; Park, Yong-Lak] West Virginia Univ, Div Plant & Soil Sci, Entomol Program, Morgantown, WV 26506 USA; [Ahn, Jeong Joon] RDA, NIHHS, Res Inst Climate Change & Agr, 281 Ayeonno, Jeju 63240, South Korea; [Son, Youngsoo] Calif Dept Food & Agr, Pierces Dis Control Program, Arvin, CA 93203 USA; [He, Yaqian; Lee, Eungul] West Virginia Univ, Dept Geol & Geog, Morgantown, WV 26506 USA	West Virginia University; National Institute of Horticultural & Herbal Science (NIHHS), Republic of Korea; Rural Development Administration (RDA), Republic of Korea; California Department of Food & Agriculture; West Virginia University	Park, YL (corresponding author), West Virginia Univ, Div Plant & Soil Sci, Entomol Program, Morgantown, WV 26506 USA.	yopark@mail.wvu.edu	He, Yaqian/AAB-6147-2021; Lee, Eungul/AAJ-2993-2020; Park, Yong-Lak/ABH-2225-2020	Park, Yong-Lak/0000-0002-6995-8212; Lee, Eungul/0000-0002-1887-1870	USDA National Institute of Food & Agriculture (NIFA) Grant NIFA Award [2014-67004-21631]	USDA National Institute of Food & Agriculture (NIFA) Grant NIFA Award	The study was supported by the USDA National Institute of Food & Agriculture (NIFA) Grant NIFA Award: 2014-67004-21631 (http://nifa.usda.gov/program/agriculture-and-food-research-initiative-afri). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are very grateful to Dr. Pavel Klimov (University of Michigan) for confirming that Chaetodactylus krombeini used in this study was correctly identified. The study was supported by the USDA National Institute of Food & Agriculture (NIFA) Grant (NIFA Award: 2014-67004-21631). We acknowledge the World Climate Research Programme's Working Group on Coupled Modelling, which is responsible for CMIP, and we thank the climate modeling groups, especially the CESM groups, for producing and making available their model output. For CMIP the United States Department of Energy's Program for Climate Model Diagnosis and Intercomparison provides coordinating support and led development of software infrastructure in partnership with the Global Organization for Earth System Science Portals.	ALLEN JC, 1995, ENVIRON ENTOMOL, V24, P996, DOI 10.1093/ee/24.5.996; Angilletta MJ, 2009, BIO HABIT, P1, DOI 10.1093/acprof:oso/9780198570875.001.1; Batra SWT, 1998, AM BEE J, V138, P361; Boina DR, 2009, J ECON ENTOMOL, V102, P685, DOI 10.1603/029.102.0229; BOSCH J, 2001, SUSTAINABLE AGR NETW, V5; Bosch J, 2010, J INSECT PHYSIOL, V56, P1949, DOI 10.1016/j.jinsphys.2010.08.017; Briere JF, 1999, ENVIRON ENTOMOL, V28, P22, DOI 10.1093/ee/28.1.22; CAMPBELL A, 1974, J APPL ECOL, V11, P431, DOI 10.2307/2402197; Cook BI, 2014, CLIM DYNAM, V43, P2607, DOI 10.1007/s00382-014-2075-y; Danilevskii A.S., 1965, PHOTOPERIODISM SEASO; Eaton M, 2009, EXP APPL ACAROL, V47, P201, DOI 10.1007/s10493-008-9206-2; Field CB, 2007, ANNU REV ENV RESOUR, V32, P1, DOI 10.1146/annurev.energy.32.053006.141119; Gadino AN, 2012, EXP APPL ACAROL, V58, P1, DOI 10.1007/s10493-012-9562-9; Ghazy NA, 2014, PEST MANAG SCI, V70, P483, DOI 10.1002/ps.3599; Ghazy NA, 2012, BIOCONTROL, V57, P635, DOI 10.1007/s10526-012-9441-7; Ghazy NA, 2012, EXP APPL ACAROL, V58, P111, DOI 10.1007/s10493-012-9556-7; Ghazy NA, 2012, BIOL CONTROL, V60, P241, DOI 10.1016/j.biocontrol.2011.12.006; Gotoh T, 2014, EXP APPL ACAROL, V64, P465, DOI 10.1007/s10493-014-9841-8; Gutierrez AP, 2008, CLIMATIC CHANGE, V87, pS167, DOI 10.1007/s10584-007-9379-4; Hance T, 2007, ANNU REV ENTOMOL, V52, P107, DOI 10.1146/annurev.ento.52.110405.091333; Hart AJ, 2002, PHYSIOL ENTOMOL, V27, P112, DOI 10.1046/j.1365-3032.2002.00276.x; Hatherly IS, 2005, BIOCONTROL, V50, P687, DOI 10.1007/s10526-005-6758-5; IMS RA, 1990, TRENDS ECOL EVOL, V5, P135, DOI 10.1016/0169-5347(90)90218-3; IPCC (Intergovernmental Panel on Climate Change), 2013, CLIMATE CHANGE 2013; Johnson RM, 2010, APIDOLOGIE, V41, P312, DOI 10.1051/apido/2010018; Klimov PB, 2007, EVOLUTION, V61, P1368, DOI 10.1111/j.1558-5646.2007.00119.x; KLIMOV PB, 2008, MISCELLANEOUS PUBLIC, V199; KRAMER DA, 1989, ENVIRON ENTOMOL, V18, P741, DOI 10.1093/ee/18.5.743; KROMBEIN KARL V., 1962, PROC BIOL SOC WASHINGTON, V75, P237; Krunic Miloje, 2005, Bulletin of Insectology, V58, P141; LACTIN DJ, 1995, ENVIRON ENTOMOL, V24, P68, DOI 10.1093/ee/24.1.68; LOGAN JA, 1976, ENVIRON ENTOMOL, V5, P1133, DOI 10.1093/ee/5.6.1133; Lutterschmidt WI, 1997, CAN J ZOOL, V75, P1561, DOI 10.1139/z97-783; MANGINI AC, 1991, ENVIRON ENTOMOL, V20, P823, DOI 10.1093/ee/20.3.823; McKinney MI, 2013, EXP APPL ACAROL, V60, P153, DOI 10.1007/s10493-012-9629-7; Meehl GA, 2013, J CLIMATE, V26, P6287, DOI 10.1175/JCLI-D-12-00572.1; Mills N, 2005, BIOL CONTROL, V34, P274, DOI 10.1016/j.biocontrol.2005.02.012; Moss RH, 2010, NATURE, V463, P747, DOI 10.1038/nature08823; Park HH, 2011, J ASIA-PAC ENTOMOL, V14, P497, DOI 10.1016/j.aspen.2011.07.010; Park YL, 2009, J APPL ENTOMOL, V133, P174, DOI 10.1111/j.1439-0418.2008.01351.x; Pautasso M, 2010, BIOL REV, V85, P729, DOI 10.1111/j.1469-185X.2010.00123.x; Qu Da-cai, 2002, Japanese Journal of Entomology (New Series), V5, P121; Radmacher S, 2011, APIDOLOGIE, V42, P711, DOI 10.1007/s13592-011-0078-9; REGNIERE J, 1984, CAN ENTOMOL, V116, P1367, DOI 10.4039/Ent1161367-10; SAS Institute, 1995, SAS US GUID STAT VER; Schweiger O, 2008, ECOLOGY, V89, P3472, DOI 10.1890/07-1748.1; Scientific Jandel, 1996, TABLECURVE US MAN SA; Shi PJ, 2011, J ASIA-PAC ENTOMOL, V14, P15, DOI 10.1016/j.aspen.2010.11.008; Shipp JL, 1996, ENTOMOL EXP APPL, V78, P31, DOI 10.1007/BF00304454; Shipp JL, 1997, ENVIRON ENTOMOL, V26, P106, DOI 10.1093/ee/26.1.106; Son Y, 2012, BIOL CONTROL, V60, P233, DOI 10.1016/j.biocontrol.2011.04.008; SUGIURA N, 1989, Japanese Journal of Entomology, V57, P861; UCIPM, 2014, UC IPM STAT INT PEST; WAGNER TL, 1984, ANN ENTOMOL SOC AM, V77, P208, DOI 10.1093/aesa/77.2.208; WEIBULL W, 1951, J APPL MECH-T ASME, V18, P293; White J, 2009, J ECON ENTOMOL, V102, P2026, DOI 10.1603/029.102.0602; White JB, 2009, J ECON ENTOMOL, V102, P2090, DOI 10.1603/029.102.0611; YAMAGUCHI M, 1990, BIOENERGETICS, P39	58	9	10	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2016	11	8							e0161319	10.1371/journal.pone.0161319	http://dx.doi.org/10.1371/journal.pone.0161319			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4YN	27532151	gold, Green Published, Green Submitted			2022-12-27	WOS:000381487600085
J	Gusscott, S; Jenkins, CE; Lam, SH; Giambra, V; Pollak, M; Weng, AP				Gusscott, Samuel; Jenkins, Catherine E.; Lam, Sonya H.; Giambra, Vincenzo; Pollak, Michael; Weng, Andrew P.			IGF1R Derived PI3K/AKT Signaling Maintains Growth in a Subset of Human T-Cell Acute Lymphoblastic Leukemias	PLOS ONE			English	Article							OF-FUNCTION MUTATIONS; FACTOR-I RECEPTOR; FOLLICULAR LYMPHOMA; INSULIN; INHIBITION; NOTCH1; ACTIVATION; PATHWAYS; THERAPY; PTEN	Insulin-like growth factor 1 receptor (IGF1R) is a prevalent signaling pathway in human cancer that supports cell growth/survival and thus contributes to aggressive biological behavior. Much work has gone into development of IGF1R inhibitors; however, candidate agents including small molecule tyrosine kinase inhibitors and blocking antibodies have yet to fulfill their promise clinically. Understanding cellular features that define sensitivity versus resistance are important for effective patient selection and anticipation of outgrowth of a resistant clone. We previously identified an important role for IGF signaling in T-cell acute lymphoblastic leukemia (T-ALL) relying primarily upon genetically defined mouse models. We present here an assessment of IGF1R dependence in human T-ALL using a broad panel of 27 established cell lines that capture a spectrum of the genetic variation that might be encountered in clinical practice. We observed that a subset of cell lines are sensitive to IGF1R inhibition and are characterized by high levels of surface IGF1R expression and PTEN positivity. Interestingly, lentiviral expression or knock-down of PTEN in PTEN-negative/positive cell lines, respectively, had limited effects on their response to IGF1R inhibition, suggesting that PTEN contributes to, but does not define IGF dependence. Additionally, we characterize downstream PI3K/AKT signaling as dominant over RAS/RAF/MEK/ERK in mediating growth and/or survival in this context. Finally, we demonstrate that IGF and interleukin-7 (IL-7) fulfill non-overlapping roles in supporting T-ALL growth. These findings are significant in that they reveal cellular features and downstream mechanisms that may determine the response of an individual patient's tumor to IGF1R inhibitor therapy.	[Gusscott, Samuel; Jenkins, Catherine E.; Lam, Sonya H.; Giambra, Vincenzo; Weng, Andrew P.] BC Canc Agcy, Terry Fox Lab, Vancouver, BC V5Z 1L3, Canada; [Pollak, Michael] McGill Univ, Dept Oncol, Montreal, PQ, Canada	British Columbia Cancer Agency; McGill University	Weng, AP (corresponding author), BC Canc Agcy, Terry Fox Lab, Vancouver, BC V5Z 1L3, Canada.	aweng@bccrc.ca	Giambra, Vincenzo/ABG-8306-2021	Giambra, Vincenzo/0000-0003-2607-2080; Pollak, Michael/0000-0003-3047-0604	Canadian Institutes of Health Research; Terry Fox Foundation; Leukemia and Lymphoma Society of Canada	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Terry Fox Foundation; Leukemia and Lymphoma Society of Canada	This work was supported by Canadian Institutes of Health Research, http://cihr-irsc.gc.ca/e/193.html, APW; Terry Fox Foundation, http://www.terryfox.org/TerryFox/The_Terry_Fox_Foundation.html, APW; and Leukemia and Lymphoma Society of Canada, http://www.llscanada.org/, APW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandapalli OR, 2014, THE ACTIVATING STAT5, pe188; Barata JT, 2004, HAEMATOLOGICA, V89, P1459; Barata JT, 2004, J EXP MED, V200, P659, DOI 10.1084/jem.20040789; Britten CD, 2013, CANCER CHEMOTH PHARM, V71, P1395, DOI 10.1007/s00280-013-2121-1; Camps M, 2005, NAT MED, V11, P936, DOI 10.1038/nm1284; Carboni JM, 2005, CANCER RES, V65, P3781, DOI 10.1158/0008-5472.CAN-04-4602; Carboni JM, 2009, MOL CANCER THER, V8, P3341, DOI 10.1158/1535-7163.MCT-09-0499; Castillo JJ, 2014, ONCOTARGETS THER, V7, P333, DOI 10.2147/OTT.S34641; Chapuis N, 2010, HAEMATOL-HEMATOL J, V95, P415, DOI 10.3324/haematol.2009.010785; Chiang MY, 2008, J CLIN INVEST, V118, P3181, DOI 10.1172/JCI35090; Clappier E, 2007, BLOOD, V110, P1251, DOI 10.1182/blood-2006-12-064683; Cohen BD, 2005, CLIN CANCER RES, V11, P2063, DOI 10.1158/1078-0432.CCR-04-1070; Doepfner KT, 2007, LEUKEMIA, V21, P1921, DOI 10.1038/sj.leu.2404813; Fingar DC, 2002, GENE DEV, V16, P1472, DOI 10.1101/gad.995802; Forbes SA, 2015, NUCLEIC ACIDS RES, V43, pD805, DOI 10.1093/nar/gku1075; Giambra V, 2012, NAT MED, V18, P1693, DOI 10.1038/nm.2960; Gombos A, 2012, INVEST NEW DRUG, V30, P2433, DOI 10.1007/s10637-012-9811-0; Gusscott S, 2012, LEUKEMIA RES, V36, P905, DOI 10.1016/j.leukres.2012.02.013; Gutierrez A, 2009, BLOOD, V114, P647, DOI 10.1182/blood-2009-02-206722; Haluska P, 2011, J CLIN ONCOL S, V29; Holmfeldt L, 2013, NAT GENET, V45, P242, DOI 10.1038/ng.2532; Jin MZ, 2013, ONCOL REV, V7, P12, DOI 10.4081/oncol.2013.e3; Kawamura M, 1999, LEUKEMIA RES, V23, P115, DOI 10.1016/S0145-2126(98)00146-5; Lahortiga I, 2007, NAT GENET, V39, P593, DOI 10.1038/ng2025; Maser RS, 2007, NATURE, V447, P966, DOI 10.1038/nature05886; McCubrey JA, 2012, ONCOTARGET, V3, P1068, DOI 10.18632/oncotarget.659; Medyouf H, 2011, J EXP MED, V208, P1809, DOI 10.1084/jem.20110121; Meier F, 2007, BRIT J DERMATOL, V156, P1204, DOI 10.1111/j.1365-2133.2007.07821.x; Mendoza MC, 2011, TRENDS BIOCHEM SCI, V36, P320, DOI 10.1016/j.tibs.2011.03.006; Miller WT, 2012, J SIGNAL TRANSDUCTIO, V2012, P7; Mitsiades CS, 2004, CANCER CELL, V5, P221, DOI 10.1016/S1535-6108(04)00050-9; MYAL Y, 1984, CANCER RES, V44, P5486; Palomero T, 2006, LEUKEMIA, V20, P1279, DOI 10.1038/sj.leu.2404258; Palomero T, 2007, NAT MED, V13, P1203, DOI 10.1038/nm1636; Pavlicek A, 2013, MOL CANCER THER, V12, P2929, DOI 10.1158/1535-7163.MCT-13-0442-T; Perentesis JP, 2004, LEUKEMIA, V18, P685, DOI 10.1038/sj.leu.2403272; Pollak M, 2012, NAT REV CANCER, V12, P159, DOI 10.1038/nrc3215; Porcu M, 2012, BLOOD, V119, P4476, DOI 10.1182/blood-2011-09-379958; Renshaw J, 2013, CLIN CANCER RES, V19, P5940, DOI 10.1158/1078-0432.CCR-13-0850; Sabnis AJ, 2009, PLOS BIOL, V7, P537, DOI 10.1371/journal.pbio.1000059; SELL C, 1993, P NATL ACAD SCI USA, V90, P11217, DOI 10.1073/pnas.90.23.11217; Shochat C, 2011, J EXP MED, V208, P901, DOI 10.1084/jem.20110580; Silva A, 2008, J CLIN INVEST, V118, P3762, DOI 10.1172/JCI34616; Silva A, 2011, CANCER RES, V71, P4780, DOI 10.1158/0008-5472.CAN-10-3606; Solal-Celigny P, 2004, BLOOD, V104, P1258, DOI 10.1182/blood-2003-12-4434; Staffas A, 2015, LEUKEMIA, V29, P1032, DOI 10.1038/leu.2014.315; Stengel C, 2013, BRIT J HAEMATOL, V162, P285, DOI 10.1111/bjh.12353; Subramaniam PS, 2012, CANCER CELL, V21, P459, DOI 10.1016/j.ccr.2012.02.029; Tamiya T, 2011, ARTERIOSCL THROM VAS, V31, P980, DOI 10.1161/ATVBAHA.110.207464; Thorpe LM, 2015, NAT REV CANCER, V15, P7, DOI 10.1038/nrc3860; Treanor LM, 2014, J EXP MED, V211, P701, DOI 10.1084/jem.20122727; Trimarchi T, 2014, CELL, V158, P593, DOI 10.1016/j.cell.2014.05.049; Vanhaesebroeck B, 2012, NAT REV MOL CELL BIO, V13, P195, DOI 10.1038/nrm3290; von Lintig FC, 2000, CLIN CANCER RES, V6, P1804; Wagner-Johnston ND, 2015, BLOOD, V126, P851, DOI 10.1182/blood-2015-01-621375; Wan XL, 2015, NEOPLASIA, V17, P358, DOI 10.1016/j.neo.2015.03.001; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Yaktapour N, 2013, BLOOD, V122, P1621, DOI 10.1182/blood-2013-02-484386; Yamada H, 2013, INT J HEMATOL, V97, P73, DOI 10.1007/s12185-012-1234-3; Yang XF, 1996, CANCER RES, V56, P1509; Yee D, 2012, JOURNAL OF THE NATIO, V104, P982; Yokoyama K, 2013, BLOOD, V122, P4259, DOI 10.1182/blood-2012-08-451278; Yost AJ, 2013, LEUKEMIA, V27, P1437, DOI 10.1038/leu.2012.337; Zenatti PP, 2011, NAT GENET, V43, P932, DOI 10.1038/ng.924; Zhang JH, 2012, NATURE, V481, P157, DOI 10.1038/nature10725; Zhao JJ, 2006, P NATL ACAD SCI USA, V103, P16296, DOI 10.1073/pnas.0607899103; Zhao L, 2008, ONCOGENE, V27, P5486, DOI 10.1038/onc.2008.244	67	30	32	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2016	11	8							e0161158	10.1371/journal.pone.0161158	http://dx.doi.org/10.1371/journal.pone.0161158			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4YN	27532210	gold, Green Published			2022-12-27	WOS:000381487600066
J	Peffers, MJ; Goljanek-Whysall, K; Collins, J; Fang, YX; Rushton, M; Loughlin, J; Proctor, C; Clegg, PD				Peffers, Mandy Jayne; Goljanek-Whysall, Katarzyna; Collins, John; Fang, Yongxiang; Rushton, Michael; Loughlin, John; Proctor, Carole; Clegg, Peter David			Decoding the Regulatory Landscape of Ageing in Musculoskeletal Engineered Tissues Using Genome-Wide DNA Methylation and RNASeq	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; AGE-RELATED-CHANGES; NERVE GROWTH-FACTOR; GENE-EXPRESSION; NONCODING RNAS; STROMAL CELLS; ARTICULAR CHONDROCYTES; TENDON; DIFFERENTIATION; SENESCENCE	Mesenchymal stem cells (MSC) are capable of multipotent differentiation into connective tissues and as such are an attractive source for autologous cell-based regenerative medicine and tissue engineering. Epigenetic mechanisms, like DNA methylation, contribute to the changes in gene expression in ageing. However there was a lack of sufficient knowledge of the role that differential methylation plays during chondrogenic, osteogenic and tenogenic differentiation from ageing MSCs. This study undertook genome level determination of the effects of DNA methylation on expression in engineered tissues from chronologically aged MSCs. We compiled unique DNA methylation signatures from chondrogenic, osteogenic, and tenogenic engineered tissues derived from young; n = 4 (21.8 years +/- 2.4 SD) and old; n = 4 (65.5 years +/- 8.3SD) human MSCs donors using the Illumina Human-Methylation 450 Beadchip arrays and compared these to gene expression by RNA sequencing. Unique and common signatures of global DNA methylation were identified. There were 201, 67 and 32 chondrogenic, osteogenic and tenogenic age-related DE protein-coding genes respectively. Findings inferred the nature of the transcript networks was predominantly for 'cell death and survival', 'cell morphology', and 'cell growth and proliferation'. Further studies are required to validate if this gene expression effect translates to cell events. Alternative splicing (AS) was dysregulated in ageing with 119, 21 and 9 differential splicing events identified in chondrogenic, osteogenic and tenogenic respectively, and enrichment in genes associated principally with metabolic processes. Gene ontology analysis of differentially methylated loci indicated age-related enrichment for all engineered tissue types in 'skeletal system morphogenesis', 'regulation of cell proliferation' and 'regulation of transcription' suggesting that dynamic epigenetic modifications may occur in genes associated with shared and distinct pathways dependent upon engineered tissue type. An altered phenotype in engineered tissues was observed with ageing at numerous levels. These changes represent novel insights into the ageing process, with implications for stem cell therapies in older patients. In addition we have identified a number of tissue-dependant pathways, which warrant further studies.	[Peffers, Mandy Jayne; Goljanek-Whysall, Katarzyna; Clegg, Peter David] Univ Liverpool, Inst Ageing & Chron Dis, Chester High Rd, Wirral CH64 7TE, Merseyside, England; [Collins, John] Univ N Carolina, Sch Med, Thurston Arthrit Res Ctr, Chapel Hill, NC 27599 USA; [Fang, Yongxiang] Univ Liverpool, Ctr Genom Res, Inst Integrat Biol, Biosci Bldg,Crown St, Liverpool L69 7ZB, Merseyside, England; [Rushton, Michael; Loughlin, John; Proctor, Carole] Newcastle Univ, Inst Cellular Med, Musculoskeletal Res Grp, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Proctor, Carole] Newcastle Univ, Inst Ageing, Campus Ageing & Vital, Newcastle Upon Tyne NE4 5PL, Tyne & Wear, England	University of Liverpool; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of Liverpool; Newcastle University - UK; Newcastle University - UK	Peffers, MJ (corresponding author), Univ Liverpool, Inst Ageing & Chron Dis, Chester High Rd, Wirral CH64 7TE, Merseyside, England.	peffs@liv.ac.uk	Whysall, Kasia/P-2070-2019; Peffers, Mandy Jayne/AAV-9411-2020	Whysall, Kasia/0000-0001-8166-8800; Peffers, Mandy Jayne/0000-0001-6979-0440; Clegg, Peter/0000-0003-0632-0032; Loughlin, John/0000-0003-2018-3361	Wellcome Trust [WT088557MA]; Medical Research Council (MRC); Arthritis Research UK as part of the MRC-Arthritis Research UK Centre for Integrated research into Musculoskeletal Ageing (CIMA); BBSRC [BB/L021668/1] Funding Source: UKRI; MRC [MR/K006312/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/L021668/1] Funding Source: researchfish; Medical Research Council [MR/K006312/1] Funding Source: researchfish; Versus Arthritis [20771, 20028] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Arthritis Research UK as part of the MRC-Arthritis Research UK Centre for Integrated research into Musculoskeletal Ageing (CIMA)(Versus Arthritis); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Versus Arthritis(Versus Arthritis)	This work was supported by the Wellcome Trust www.welccometrust.ac.uk (WT088557MA) to MJP, Medical Research Council (MRC) and Arthritis Research UK as part of the MRC-Arthritis Research UK Centre for Integrated research into Musculoskeletal Ageing (CIMA) www.cimauk.org to MJP, JC, KW, CP, JL, MR, PDC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelmohsen K, 2013, AGING CELL, V12, P890, DOI 10.1111/acel.12115; Ackema KB, 2008, STEM CELLS DEV, V17, P979, DOI 10.1089/scd.2007.0220; ALOE L, 1992, ARTHRITIS RHEUM, V35, P351, DOI 10.1002/art.1780350315; Alt EU, 2012, STEM CELL RES, V8, P215, DOI 10.1016/j.scr.2011.11.002; Bancroft JD, 2008, HEORY PRACTICE HISTO, DOI DOI 10.1186/GM444; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bergman RJ, 1996, J BONE MINER RES, V11, P568; Blakeley P, 2015, DEVELOPMENT, V142, P3613, DOI 10.1242/dev.131235; Bork S, 2010, AGING CELL, V9, P54, DOI 10.1111/j.1474-9726.2009.00535.x; Brady K, 2014, STEM CELLS DEV, V23, P541, DOI 10.1089/scd.2013.0301; Buitrago DH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121521; Calvanese V, 2009, AGEING RES REV, V8, P268, DOI 10.1016/j.arr.2009.03.004; Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010; Chang JW, 2012, J CELL MOL MED, V16, P2935, DOI 10.1111/j.1582-4934.2012.01610.x; Chen L, 2015, BONE, V71, P210, DOI 10.1016/j.bone.2014.11.001; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Collins JA, 2016, J BIOL CHEM, V291, P6641, DOI 10.1074/jbc.M115.693523; David CJ, 2010, GENE DEV, V24, P2343, DOI 10.1101/gad.1973010; Delgado-Calle Jesus, 2012, Biology (Basel), V1, P698, DOI 10.3390/biology1030698; Dexheimer V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022980; Ding W, 2015, CARDIOVASC RES, V106, P131, DOI 10.1093/cvr/cvv030; Docheva D, 2015, ADV DRUG DELIVER REV, V84, P222, DOI 10.1016/j.addr.2014.11.015; Duque G, 2002, BIOCHEM BIOPH RES CO, V299, P446, DOI 10.1016/S0006-291X(02)02657-8; Fickert S, 2011, J BONE MINER METAB, V29, P224, DOI 10.1007/s00774-010-0215-y; Gang HY, 2015, J CELL BIOL, V210, P1101, DOI 10.1083/jcb.201504047; Gerstenfeld LC, 1996, ENDOCRINOLOGY, V137, P3957, DOI 10.1210/en.137.9.3957; Giorda K, 2014, J FEDERATION AM SO S, V28, pLB211, DOI DOI 10.1002/ART.38713; Goltzman D, 2002, NAT REV DRUG DISCOV, V1, P784, DOI 10.1038/nrd916; Gomez-Barrena E, 2015, BONE, V70, P93, DOI 10.1016/j.bone.2014.07.033; Grammatikakis I, 2014, AGING-US, V6, P992, DOI 10.18632/aging.100710; Grimsholm O, 2008, CELLS TISSUES ORGANS, V188, P299, DOI 10.1159/000121432; Guan YF, 2002, DRUG NEWS PERSPECT, V15, P147, DOI 10.1358/dnp.2002.15.3.840011; Hanzelmann S, 2015, CLIN EPIGENETICS, V7, DOI 10.1186/s13148-015-0057-5; Harries LW, 2011, AGING CELL, V10, P868, DOI 10.1111/j.1474-9726.2011.00726.x; Haussler MR, 1998, J BONE MINER RES, V13, P325, DOI 10.1359/jbmr.1998.13.3.325; Henrotin YE, 2003, OSTEOARTHR CARTILAGE, V11, P747, DOI 10.1016/S1063-4584(03)00150-X; HORST RL, 1990, ENDOCRINOLOGY, V126, P1053, DOI 10.1210/endo-126-2-1053; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Iannone F, 2002, RHEUMATOLOGY, V41, P1413, DOI 10.1093/rheumatology/41.12.1413; Jjingo D, 2012, ONCOTARGET, V3, P462, DOI 10.18632/oncotarget.497; Kanawa M, 2013, CYTOTHERAPY, V15, P1062, DOI 10.1016/j.jcyt.2013.03.015; Kapacee Z, 2010, MATRIX BIOL, V29, P668, DOI 10.1016/j.matbio.2010.08.005; Katoh-Semba R, 1998, NEUROSCI RES, V31, P227, DOI 10.1016/S0168-0102(98)00040-6; Kawase Y, 2003, J BONE MINER RES, V18, P975, DOI 10.1359/jbmr.2003.18.6.975; Kharaz YA, 2016, PROTEOMICS, V16, P1547, DOI 10.1002/pmic.201500459; Knuth CA, 2013, STEM CELL REV REP, V9, P599, DOI 10.1007/s12015-013-9446-3; Kohler J, 2013, AGING CELL, V12, P988, DOI 10.1111/acel.12124; Kretlow JD, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-60; Laine SK, 2012, J CELL BIOCHEM, V113, P2687, DOI 10.1002/jcb.24144; Le LTT, 2016, J MOL MED, V94, P583, DOI 10.1007/s00109-015-1374-z; Leskela HV, 2003, BIOCHEM BIOPH RES CO, V311, P1008, DOI 10.1016/j.bbrc.2003.10.095; Li CR, 2015, J APPL REMOTE SENS, V8, DOI 10.1117/1.JRS.8.083498; Liu-Bryan R, 2015, NAT REV RHEUMATOL, V11, P35, DOI 10.1038/nrrheum.2014.162; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loeser RF, 2014, ARTHRITIS RHEUMATOL, V66, P2201, DOI 10.1002/art.38641; Martin I, 2001, OSTEOARTHR CARTILAGE, V9, P112, DOI 10.1053/joca.2000.0366; McAlinden A, 2014, CONNECT TISSUE RES, V55, P165, DOI 10.3109/03008207.2014.908860; McCauley BS, 2014, BBA-GENE REGUL MECH, V1839, P1454, DOI 10.1016/j.bbagrm.2014.05.008; Mendias CL, 2012, J APPL PHYSIOL, V113, P56, DOI 10.1152/japplphysiol.00301.2012; Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521; Mi HY, 2013, NUCLEIC ACIDS RES, V41, pD377, DOI 10.1093/nar/gks1118; Millar NL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7774; Mueller AM, 2015, A SYSTEMS BIOLOGY AP; Nakamura Y, 2011, MOL CELL BIOL, V31, P3019, DOI 10.1128/MCB.05178-11; Natsu K, 2004, TISSUE ENG, V10, P1093, DOI 10.1089/1076327041887754; Nockher WA, 2005, CLIN CHIM ACTA, V352, P49, DOI 10.1016/j.cccn.2004.10.002; O'Loughlin A, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-250; Oh J, 2014, NAT MED, V20, P870, DOI 10.1038/nm.3651; Orth P, 2014, STEM CELLS CLONING, V7, P1, DOI 10.2147/SCCAA.S42880; PAUL H, 1983, ARTHRITIS RHEUM, V26, P191, DOI 10.1002/art.1780260211; Paxton JZ, 2012, TISSUE ENG PT A, V18, P277, DOI [10.1089/ten.tea.2011.0336, 10.1089/ten.TEA.2011.0336]; Payne KA, 2010, OSTEOARTHR CARTILAGE, V18, P705, DOI 10.1016/j.joca.2010.01.011; Peffers MJ, 2016, EUR CELLS MATER, V31, P136, DOI 10.22203/eCM.v031a10; Peffers MJ, 2016, J ORTHOP RES, V34, P106, DOI 10.1002/jor.22963; Peffers MJ, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0544-2; Peffers MJ, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4278; Pidsley R, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-293; Pivetta E, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3047; Poulsen RC, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.52; Prinos P, 2011, NAT STRUCT MOL BIOL, V18, P673, DOI 10.1038/nsmb.2040; Robertson KD, 2000, CARCINOGENESIS, V21, P461, DOI 10.1093/carcin/21.3.461; Robertson KD, 2005, NAT REV GENET, V6, P597, DOI 10.1038/nrg1655; Roura S, 2006, EUR J HEART FAIL, V8, P555, DOI 10.1016/j.ejheart.2005.11.006; Rushton MD, 2014, ARTHRITIS RHEUMATOL, V66, P2450, DOI 10.1002/art.38713; Scharstuhl A, 2007, STEM CELLS, V25, P3244, DOI 10.1634/stemcells.2007-0300; Sethe S, 2006, AGEING RES REV, V5, P91, DOI 10.1016/j.arr.2005.10.001; Shargunov AV, 2014, J PROTEOME RES, V13, P173, DOI 10.1021/pr400808u; Sheng JJ, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00165; Stelnicki EJ, 1998, J INVEST DERMATOL, V110, P110, DOI 10.1046/j.1523-1747.1998.00092.x; Stenderup K, 2003, BONE, V33, P919, DOI 10.1016/j.bone.2003.07.005; Stolzing A, 2008, MECH AGEING DEV, V129, P163, DOI 10.1016/j.mad.2007.12.002; Sun HJ, 2006, J ORTHOP RES, V24, P2059, DOI 10.1002/jor.20273; Tan JL, 2015, BONE RES, V3, DOI 10.1038/boneres.2015.3; Tazi J, 2009, BBA-MOL BASIS DIS, V1792, P14, DOI 10.1016/j.bbadis.2008.09.017; Tollervey JR, 2011, GENOME RES, V21, P1572, DOI 10.1101/gr.122226.111; Venkataraman K, 2002, FEBS LETT, V528, P3, DOI 10.1016/S0014-5793(02)03248-9; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang HJ, 2012, J VIROL, V86, P6286, DOI 10.1128/JVI.00205-12; Wang JM, 2014, ARTERIOSCL THROM VAS, V34, P99, DOI 10.1161/ATVBAHA.113.302104; Wang Y, 2015, ARTHRITIS RHEUMATOL, V67, P2141, DOI 10.1002/art.39182; Wei JF, 2014, STEM CELLS DEV, V23, P1452, DOI 10.1089/scd.2013.0600; Whitaker JW, 2013, GENOME MED, V5, DOI 10.1186/gm444; Wu TT, 2015, STEM CELLS, V33, P3281, DOI 10.1002/stem.2081; Yang KC, 2014, CIRCULATION, V129, P1009, DOI 10.1161/CIRCULATIONAHA.113.003863; Zaim M, 2012, ANN HEMATOL, V91, P1175, DOI 10.1007/s00277-012-1438-x; Zhang YP, 2012, BIOMED ENVIRON SCI, V25, P311, DOI 10.3967/0895-3988.2012.03.009; Zhao YS, 2015, HAEMATOLOGICA, V100, P194, DOI 10.3324/haematol.2014.109769; Zimmermann P, 2008, ARTHRITIS RHEUM, V58, P2743, DOI 10.1002/art.23736	108	17	17	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2016	11	8							e0160517	10.1371/journal.pone.0160517	http://dx.doi.org/10.1371/journal.pone.0160517			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4YN	27533049	Green Submitted, Green Published, gold			2022-12-27	WOS:000381487600033
J	Headey, D; Hirvonen, K				Headey, Derek; Hirvonen, Kalle			Is Exposure to Poultry Harmful to Child Nutrition? An Observational Analysis for Rural Ethiopia	PLOS ONE			English	Article							ANIMAL SOURCE FOODS; ENVIRONMENTAL ENTEROPATHY; FECAL CONTAMINATION; MILK; DIARRHEA; HYGIENE; WATER; UNDERNUTRITION; SANITATION; REGRESSION	Although strategic thinking on water, sanitation and hygiene (WASH) has prioritized reducing exposure to human feces in order to limit diarrheal infections, recent research suggests that elevated exposure to livestock-particularly poultry and poultry feces-may be an important risk factor for diarrhea, environmental enteric disorder (EED) and respiratory infections, all of which may seriously retard linear growth in young children. Yet a very different literature on nutrition-sensitive agriculture suggests that livestock ownership is highly beneficial for child growth outcomes through its importance for increasing consumption of nutrient-rich animal sourced foods, such as eggs. Together, these two literatures suggest that the net nutritional benefit of poultry ownership is particularly ambiguous and potentially mediated by whether or not children are highly exposed to poultry. We test this novel hypothesis using a large agricultural survey of rural Ethiopian households that includes measures of child height-for-age Z-scores (HAZ), ownership of poultry and other types of livestock, and an indicator of whether livestock are kept within the main household dwelling overnight. We used least squares regression analysis to estimate unadjusted and adjusted models that control for a wide range of potentially confounding factors. We find that while poultry ownership is positively associated with child HAZ [beta = 0.291, s.e. = 0.094], the practice of corralling poultry in the household dwelling overnight is negatively associated with HAZ [beta = -0.250, s.e. = 0.118]. Moreover, we find no negative associations between HAZ and corralling other livestock species indoors. These results suggest that while poultry ownership can be beneficial to child growth, overly close exposure to poultry poses a concurrent risk factor for undernutrition, most likely because of increased risk of infection.	[Headey, Derek] Int Food Policy Res Inst, Washington, DC 20036 USA; [Hirvonen, Kalle] Int Food Policy Res Inst, Addis Ababa, Ethiopia	CGIAR; International Food Policy Research Institute (IFPRI); CGIAR; International Food Policy Research Institute (IFPRI)	Hirvonen, K (corresponding author), Int Food Policy Res Inst, Addis Ababa, Ethiopia.	k.hirvonen@cgiar.org		Hirvonen, Kalle/0000-0003-2057-1612	Feed-the-Future project - United States Agency for International Development; Advancing Research on Nutrition and Agriculture (AReNA) project - Bill and Melinda Gates Foundation	Feed-the-Future project - United States Agency for International Development(United States Agency for International Development (USAID)); Advancing Research on Nutrition and Agriculture (AReNA) project - Bill and Melinda Gates Foundation	Funding for this work was received through the Feed-the-Future project funded by the United States Agency for International Development, and the Advancing Research on Nutrition and Agriculture (AReNA) project funded by the Bill and Melinda Gates Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Funding for this work was received through the Feed-the-Future project funded by the United States Agency for International Development, and the Advancing Research on Nutrition and Agriculture (AReNA) project funded by the Bill and Melinda Gates Foundation. We thank Dan Gilligan and Marie Ruel for useful comments on an earlier version of the paper, as well as Rebecca Stolzfus and other members of the SHINE project.	Abebe Z, 2016, FOOD NUTR BULL, V37, P353, DOI 10.1177/0379572116651209; Azzarri C, 2015, J DEV STUD, V51, P1034, DOI 10.1080/00220388.2015.1018905; Bachewe F, 2014, FEED FUTURE FTF ETHI; Block SA, 2012, J DEV STUD, V48, P1699, DOI 10.1080/00220388.2012.700399; BUTZ WP, 1984, AM J EPIDEMIOL, V119, P516, DOI 10.1093/oxfordjournals.aje.a113769; CSA ICF, 2012, ETH DEM HLTH SURV 20; Curtis V, 2000, TROP MED INT HEALTH, V5, P22, DOI 10.1046/j.1365-3156.2000.00512.x; Dangour AD, 2013, COCHRANE DATABASE SY, V1; Dessie T, 2001, TROP ANIM HEALTH PRO, V33, P521, DOI 10.1023/A:1012740832558; Dessie T, 2013, VILLAGE CHICKEN PROD; ESREY SA, 1986, EPIDEMIOL REV, V8, P117, DOI 10.1093/oxfordjournals.epirev.a036290; [Ethiopia The-Manoff-Group-Inc Save-the-Children], 2014, WATER HYGIENE SANITA; FAO, 2013, MILK AND DAIRY PRODU; George CM, 2015, AM J TROP MED HYG, V93, P269, DOI 10.4269/ajtmh.14-0694; George CM, 2015, AM J TROP MED HYG, V92, P1117, DOI 10.4269/ajtmh.14-0672; Headey D., 2014, 70 ESSP TIFPRII; Headey D, 2014, FOOD POLICY, V48, P129, DOI 10.1016/j.foodpol.2014.01.008; Hirvonen K, 2015, 43 IFPRI ETH STRAT S; Hirvonen K., 2016, RURAL URBAN DIFFEREN, P89; Hoddinott J, 2015, J DEV STUD, V51, P958, DOI 10.1080/00220388.2015.1018903; Hoppe C, 2006, ANNU REV NUTR, V26, P131, DOI 10.1146/annurev.nutr.26.010506.103757; Humphrey JH, 2009, LANCET, V374, P1032, DOI 10.1016/S0140-6736(09)60950-8; Iannotti L, 2013, J DEV EFFECT, V5, P82, DOI 10.1080/19439342.2012.758165; Iannotti LL, 2014, NUTR REV, V72, P355, DOI 10.1111/nure.12107; Korpe PS, 2012, TRENDS MOL MED, V18, P328, DOI 10.1016/j.molmed.2012.04.007; Lanata CF, 1998, PEDIATR INFECT DIS J, V17, P7, DOI 10.1097/00006454-199801000-00003; Leroy JL, 2007, J NUTR, V137, P2311, DOI 10.1093/jn/137.10.2311; MacKinnon D P, 2000, Prev Sci, V1, P173, DOI 10.1023/A:1026595011371; Mara D, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000363; MARQUIS GS, 1990, AM J PUBLIC HEALTH, V80, P146, DOI 10.2105/AJPH.80.2.146; Mbuya MNN, 2016, MATERN CHILD NUTR, V12, P106, DOI 10.1111/mcn.12220; McDermott J, 2015, FOOD SECUR, V7, P593, DOI 10.1007/s12571-015-0462-9; Murphy SP, 2003, J NUTR, V133, p3932S, DOI 10.1093/jn/133.11.3932S; Neumann C, 2002, NUTR RES, V22, P193, DOI 10.1016/S0271-5317(01)00374-8; Ngure FM, 2013, AM J TROP MED HYG, V89, P709, DOI 10.4269/ajtmh.12-0568; Nguyen PH, 2013, J NUTR, V143, P1176, DOI 10.3945/jn.112.172247; Onyango AW, 2006, ACTA PAEDIATR, V95, P38, DOI 10.1080/08035320500494464; Rawlins R, 2014, FOOD POLICY, V44, P202, DOI 10.1016/j.foodpol.2013.12.003; Royston P, 2006, STAT MED, V25, P127, DOI 10.1002/sim.2331; Schenker MB, 1998, AM J RESP CRIT CARE, V158, pS1; Schriewer A, 2015, AM J TROP MED HYG, V93, P509, DOI 10.4269/ajtmh.14-0824; Sebastian K, 2014, ATLAS AFRICAN AGR RE; SUITS DB, 1978, REV ECON STAT, V60, P132, DOI 10.2307/1924341; Turner R, 2013, FOOD NUTR BULL, V34, P369, DOI 10.1177/156482651303400401; WHO & UNICEF, 2014, PROGR SAN DRINK WAT; Zambrano LD, 2014, T ROY SOC TROP MED H, V108, P313, DOI 10.1093/trstmh/tru056	46	51	52	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2016	11	8							e0160590	10.1371/journal.pone.0160590	http://dx.doi.org/10.1371/journal.pone.0160590			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DT4UN	27529178	Green Published, Green Submitted, gold			2022-12-27	WOS:000381476700011
J	Tsai, MH; Chou, CM; Lan, KC				Tsai, Meng-Hsun; Chou, Chien-Ming; Lan, Kun-chan			Avoiding Biased-Feeding in the Scheduling of Collaborative Multipath TCP	PLOS ONE			English	Article								Smartphones have become the major communication and portable computing devices that access the Internet throughWi-Fi or mobile networks. Unfortunately, users without a mobile data subscription can only access the Internet at limited locations, such as hotspots. In this paper, we propose a collaborative bandwidth sharing protocol (CBSP) built on top of MultiPath TCP (MPTCP). CBSP enables users to buy bandwidth on demand from neighbors (called Helpers) and uses virtual interfaces to bind the subflows of MPTCP to avoid modifying the implementation of MPTCP. However, although MPTCP provides the required multi-homing functionality for bandwidth sharing, the current packet scheduling in collaborative MPTCP (e.g., Co-MPTCP) leads to the so-called biased-feeding problem. In this problem, the fastest link might always be selected to send packets whenever it has available cwnd, which results in other links not being fully utilized. In this work, we set out to design an algorithm, called Scheduled Window-based Transmission Control (SWTC), to improve the performance of packet scheduling in MPTCP, and we perform extensive simulations to evaluate its performance.	[Tsai, Meng-Hsun; Chou, Chien-Ming; Lan, Kun-chan] Natl Cheng Kung Univ, Dept Comp Sci & Informat Engn, Tainan, Taiwan	National Cheng Kung University	Lan, KC (corresponding author), Natl Cheng Kung Univ, Dept Comp Sci & Informat Engn, Tainan, Taiwan.	klan@csie.ncku.edu.tw	Tsai, Meng-Hsun/M-1058-2018	Tsai, Meng-Hsun/0000-0001-7549-5245	Ministry of Science and Technology, Taiwan, R.O.C. [MOST 104-2221-E-006-041-, MOST 104-2221-E-006-024-]	Ministry of Science and Technology, Taiwan, R.O.C.(Ministry of Science and Technology, Taiwan)	This research was partially supported by the Ministry of Science and Technology, Taiwan, R.O.C., under the grant numbers: MOST 104-2221-E-006-041- and MOST 104-2221-E-006-024-, https://www.most.gov.tw. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no specific funding for the rest of this project. There was no additional external funding received for this study.	Adhari H, P IEEE WAINA2011; Allman M., 2009, TCP CONGESTION CONTR; Ameigeiras P, 2012, T EMERG TELECOMMUN T, V23, P360, DOI 10.1002/ett.2546; Barre S, 2011, MULTIPATH TCP GUIDEL; Chen LJ, 2009, WIREL NETW, V15, P111, DOI 10.1007/s11276-007-0047-4; Chen Y-C, P IMC2013; Cui Y, 2014, IEEE ACM T NETWORKIN; D'Orazio C, 2016, COMPUT SECUR, V56, P94, DOI 10.1016/j.cose.2015.06.009; De Cicco L, 2014, IEEE ACM T NETWORK, V22, P526, DOI 10.1109/TNET.2013.2253797; Do Q, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138449; Do Q, 2015, COMPUT SECUR, V48, P74, DOI 10.1016/j.cose.2014.10.016; Erman J, P IMC2011, P127; Ford A., 2011, RFC6182 IETF; Ford A., 2020, RFC 8684; Gaddam VR, 2015, 2015 PICTURE CODING SYMPOSIUM (PCS) WITH 2015 PACKET VIDEO WORKSHOP (PV), P204, DOI 10.1109/PCS.2015.7170076; Giruka VC, 2005, I S WORLD WIREL MOBI, P354, DOI 10.1109/WOWMOM.2005.50; Helgason O, 2014, IEEE T MOBILE COMPUT, V13, P1597, DOI 10.1109/TMC.2013.160; Huang CM, 2011, INT C PAR DISTRIB SY, P436, DOI 10.1109/ICPADS.2011.1; Imgraben J, 2014, BEHAV INFORM TECHNOL, V33, P1347, DOI 10.1080/0144929X.2014.934286; Kandula S., 2008, P 5 USENIX S NETW SY, V8, P89; Kim K-H, 2005, P MOBISYSJUNE; Lan K-C, P IEEE WCNC2012; Lan K-C, 2012, IEEE VTC 2012; Leung KC, 2007, IEEE T PARALL DISTR, V18, P522, DOI 10.1109/TPDS.2007.1011; Liu Y, P PAM2013, P104; Mascolo S, 2001, P ACM MOBIQUITOUS RO; Paasch C, P ACM CSWS2014, P27; Paxson V, 1997, THESIS; Postel J, 1981, RFC793; Prokkola J, 2009, IEEE ICC, P1152; Sastry N, P HOTNETS 62007; Seenivasan TV, 2010, THESIS; Spyropoulos T, 2008, IEEE ACM T NETWORK, V16, P77, DOI 10.1109/TNET.2007.897964; Srinivasan K, 2010, CS201006 U WAT; Su W., 2001, International Journal of Network Management, V11, P3, DOI 10.1002/nem.386; Wallace TD, P IWCMC2012, P27; Yang F, P ICCCN2013, P1; Yao J, 2012, IEEE T MOBILE COMPUT, V11, P603, DOI 10.1109/TMC.2011.97; Yoon H, 2010, IEEE T CONSUM ELECTR, V56, P2193, DOI 10.1109/TCE.2010.5681090; Zhou DZ, 2013, 2013 IEEE CONSUMER COMMUNICATIONS AND NETWORKING CONFERENCE (CCNC), P508, DOI 10.1109/CCNC.2013.6488491; Zhou DZ, 2012, 2012 IEEE 23RD INTERNATIONAL SYMPOSIUM ON PERSONAL INDOOR AND MOBILE RADIO COMMUNICATIONS (PIMRC), P1371, DOI 10.1109/PIMRC.2012.6362561	41	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2016	11	8							e0161213	10.1371/journal.pone.0161213	http://dx.doi.org/10.1371/journal.pone.0161213			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4UN	27529783	gold, Green Submitted, Green Published			2022-12-27	WOS:000381476700054
J	Yang, J; Song, W; Wei, QQ; Ou, RW; Cao, B; Liu, WL; Shao, N; Shang, HF				Yang, Jing; Song, Wei; Wei, Qianqian; Ou, Ruwei; Cao, Bei; Liu, Wanglin; Shao, Na; Shang, Hui-Fang			Screening for Cognitive Impairments in Primary Blepharospasm	PLOS ONE			English	Article							CRANIAL-CERVICAL DYSTONIA; MINI-MENTAL-STATE; REVISED ACE-R; DISEASE; DISORDERS; DEMENTIA; TOXIN; FMRI	Backgrounds Studies have reported that non-motor symptoms are an important component of primary dystonia. However, evidence supporting cognitive impairment in primary dystonia is limited and contradictory. Methods We applied the Chinese version of the Addenbrooke's Cognitive Examination-Revised and the Mini-Mental State Examination (MMSE) to screen for cognitive impairment in patients with primary blepharospasm. In addition, we investigated the relationship between performance on the Addenbrooke's Cognitive Examination-Revised and quality of life as measured by the Medical Outcomes Study 36-item Short-Form (SF36). Results The study included 68 primary blepharospasm patients and 68 controls matched by age, sex and education. The prevalence of cognitive deficits was 22.0% and 32.3% in primary blepharospasm patients group, as measured by the MMSE and the Addenbrooke's Cognitive Examination-Revised, respectively. Primary blepharospasm patents had a broad range of cognitive deficits, with the most frequently affected domains being visuospatial function (30.9%) and language (30.9%), followed by memory (27.9%), orientation/attention (26.4%) and verbal fluency (22.0%). Patients with cognitive deficits had lower total SF36 scores, especially in the subdomains of physical functioning, role-physical and social functioning, compared to those without cognitive deficits. Scores on the Addenbrooke's Cognitive Examination-Revised were significantly correlated with both the SF36 scores and the scores on the subdomains of physical functioning and social functioning. Conclusions Some patients with primary blepharospasm have cognitive deficits. Poor performance on the Addenbrooke's Cognitive Examination-Revised is related to poorer quality of life.	[Yang, Jing; Song, Wei; Wei, Qianqian; Ou, Ruwei; Cao, Bei; Liu, Wanglin; Shao, Na; Shang, Hui-Fang] Sichuan Univ, West China Hosp, Dept Neurol, Chengdu, Sichuan, Peoples R China	Sichuan University	Shang, HF (corresponding author), Sichuan Univ, West China Hosp, Dept Neurol, Chengdu, Sichuan, Peoples R China.	hfshang2002@163.com			National Science Fund of China [81371394, 81500971]	National Science Fund of China(National Natural Science Foundation of China (NSFC))	This study was founded by the National Science Fund of China (Grant No. 81371394, 81500971).	Albanese A, 2013, MOVEMENT DISORD, V28, P863, DOI 10.1002/mds.25475; Allam N, 2007, ACTA NEUROL SCAND, V116, P196, DOI 10.1111/j.1600-0404.2007.00862.x; Amaral-Carvalho V, 2012, COGN BEHAV NEUROL, V25, P72, DOI 10.1097/WNN.0b013e318259594b; CRUM RM, 1993, JAMA-J AM MED ASSOC, V269, P2386, DOI 10.1001/jama.269.18.2386; Fang R, 2014, DEMENT GERIATR COGN, V37, P223, DOI 10.1159/000353541; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Aleman GG, 2009, MOVEMENT DISORD, V24, P2112, DOI 10.1002/mds.22736; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; HAMILTON M, 1959, BRIT J MED PSYCHOL, V32, P50, DOI 10.1111/j.2044-8341.1959.tb00467.x; Hinse P, 1996, J NEUROL, V243, P29; Jahanshahi M, 2003, MOVEMENT DISORD, V18, P1470, DOI 10.1002/mds.10595; JANKOVIC J, 1987, NEUROLOGY, V37, P616, DOI 10.1212/WNL.37.4.616; Kawata KHD, 2012, DEMENT GER COGN D EX, V2, P29, DOI 10.1159/000336909; Kerrison JB, 2003, AM J OPHTHALMOL, V136, P846, DOI 10.1016/S0002-9394(03)00895-X; Komadina NC, 2011, DEMENT GERIATR COGN, V31, P349, DOI 10.1159/000328165; Laisney M, 2009, J NEUROL, V256, P1083, DOI 10.1007/s00415-009-5073-y; Larner AJ, 2014, INT PSYCHOGERIATR, V26, P555, DOI 10.1017/S1041610213002329; Mioshi E, 2006, INT J GERIATR PSYCH, V21, P1078, DOI 10.1002/gps.1610; Page D, 2007, MOVEMENT DISORD, V22, P341, DOI 10.1002/mds.21234; Pillon B, 2006, NEUROLOGY, V66, P1556, DOI 10.1212/01.wnl.0000216131.41563.24; Redondo-Verge L, 2001, REV NEUROLOGIA, V32, P82, DOI 10.33588/rn.3201.2000085; Rittman T, 2013, J NEUROL NEUROSUR PS, V84, P544, DOI 10.1136/jnnp-2012-303618; Romano R, 2014, PARKINSONISM RELAT D, V20, P162, DOI 10.1016/j.parkreldis.2013.10.008; Schmidt KE, 2003, NEUROLOGY, V60, P1738, DOI 10.1212/01.WNL.0000063306.67984.8C; Scott RB, 2003, MOVEMENT DISORD, V18, P539, DOI 10.1002/mds.10399; Stamelou M, 2012, BRAIN, V135, P1668, DOI 10.1093/brain/awr224; TAYLOR AE, 1991, CLIN NEUROPHARMACOL, V14, P62, DOI 10.1097/00002826-199102000-00005; van Tricht MJ, 2012, J NEUROL NEUROSUR PS, V83, P814, DOI 10.1136/jnnp-2011-301386; Dias FMV, 2009, ARQ NEURO-PSIQUIAT, V67, P12, DOI 10.1590/S0004-282X2009000100004; Walterfang M, 2014, MOVEMENT DISORD, V29, P694, DOI 10.1002/mds.25849; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Yang J, 2013, J NEUROL, V260, P2754, DOI 10.1007/s00415-013-7042-8; Zoons E, 2011, NEUROIMAGE, V56, P1011, DOI 10.1016/j.neuroimage.2011.02.045	33	13	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2016	11	8							e0160867	10.1371/journal.pone.0160867	http://dx.doi.org/10.1371/journal.pone.0160867			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4SL	27526026	Green Published, gold, Green Submitted			2022-12-27	WOS:000381471100025
J	Faksri, K; Tan, JH; Disratthakit, A; Xia, EY; Prammananan, T; Suriyaphol, P; Khor, CC; Teo, YY; Ong, RTH; Chaiprasert, A				Faksri, Kiatichai; Tan, Jun Hao; Disratthakit, Areeya; Xia, Eryu; Prammananan, Therdsak; Suriyaphol, Prapat; Khor, Chiea Chuen; Teo, Yik-Ying; Ong, Rick Twee-Hee; Chaiprasert, Angkana			Whole-Genome Sequencing Analysis of Serially Isolated Multi-Drug and Extensively Drug Resistant Mycobacterium tuberculosis from Thai Patients	PLOS ONE			English	Article							PREDICTION; STABILITY; SPOLIGOTYPES; KANAMYCIN; OUTBREAK; PATTERNS; GENES	Multi-drug and extensively drug-resistant tuberculosis (MDR and XDR-TB) are problems that threaten public health worldwide. Only some genetic markers associated with drug-resistant TB are known. Whole-genome sequencing (WGS) is a promising tool for distinguishing between re-infection and persistent infection in isolates taken at different times from a single patient, but has not yet been applied in MDR and XDR-TB. We aim to detect genetic markers associated with drug resistance and distinguish between reinfection and persistent infection from MDR and XDR-TB patients based on WGS analysis. Samples of Mycobacterium tuberculosis (n = 7), serially isolated from 2 MDR cases and 1 XDR-TB case, were retrieved from Siriraj Hospital, Bangkok. TheWGS analysis used an Illumina Miseq sequencer. In cases of persistent infection, MDR-TB isolates differed at an average of 2 SNPs across the span of 2-9 months whereas in the case of reinfection, isolates differed at 61 SNPs across 2 years. Known genetic markers associated with resistance were detected from strains susceptible to streptomycin (2/7 isolates), p-aminosalicylic acid (3/7 isolates) and fluoroquinolone drugs. Among fluoroquinolone drugs, ofloxacin had the highest phenotype-genotype concordance (6/7 isolates), whereas gatifloxcain had the lowest (3/7 isolates). A putative candidate SNP in Rv2477c associated with kanamycin and amikacin resistance was suggested for further validation. WGS provided comprehensive results regarding molecular epidemiology, distinguishing between persistent infection and reinfection in M/XDR-TB and potentially can be used for detection of novel mutations associated with drug resistance.	[Faksri, Kiatichai] Khon Kaen Univ, Fac Med, Dept Microbiol, Khon Kaen, Thailand; [Faksri, Kiatichai] Khon Kaen Univ, Res & Diagnost Ctr Emerging Infect Dis RCEID, Khon Kaen, Thailand; [Tan, Jun Hao; Teo, Yik-Ying; Ong, Rick Twee-Hee] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore, Singapore; [Disratthakit, Areeya; Chaiprasert, Angkana] Mahidol Univ, Siriraj Hosp, Fac Med, Dept Microbiol, Bangkok, Thailand; [Xia, Eryu; Teo, Yik-Ying] Natl Univ Singapore, NUS Grad Sch Integrat Sci & Engn, Singapore, Singapore; [Prammananan, Therdsak] Natl Sci & Technol Dev Agcy, Minist Sci & Technol, Natl Ctr Genet Engn & Biotechnol, Pathum Thani, Thailand; [Suriyaphol, Prapat] Mahidol Univ, Siriraj Hosp, Bioinformat & Data Management Res Unit, Off Res & Dev,Fac Med, Bangkok, Thailand; [Khor, Chiea Chuen; Teo, Yik-Ying] Genome Inst Singapore, Singapore, Singapore; [Teo, Yik-Ying] Natl Univ Singapore, Dept Stat & Appl Probabil, Singapore, Singapore; [Teo, Yik-Ying] Natl Univ Singapore, Inst Life Sci, Singapore, Singapore	Khon Kaen University; Khon Kaen University; National University of Singapore; Mahidol University; National University of Singapore; National Science & Technology Development Agency - Thailand; National Center Genetic Engineering & Biotechnology (BIOTEC); Mahidol University; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); National University of Singapore; National University of Singapore	Faksri, K (corresponding author), Khon Kaen Univ, Fac Med, Dept Microbiol, Khon Kaen, Thailand.; Faksri, K (corresponding author), Khon Kaen Univ, Res & Diagnost Ctr Emerging Infect Dis RCEID, Khon Kaen, Thailand.; Chaiprasert, A (corresponding author), Mahidol Univ, Siriraj Hosp, Fac Med, Dept Microbiol, Bangkok, Thailand.	kiatichai@kku.ac.th; angkana.cha@mahidol.ac.th		Khor, Chiea Chuen/0000-0002-1128-4729; Faksri, Kiatichai/0000-0001-5022-4182	Faculty of Medicine, Siriraj Hospital, Mahidol University [R015833003]; JST/NSTDA [P-12-01777]; National University of Singapore Yong Loo Lin School of Medicine Aspiration Fund [NUHSRO/2014/069/AF-New Idea/04]; Genome Institute of Singapore (GIS), A-STAR, Singapore	Faculty of Medicine, Siriraj Hospital, Mahidol University; JST/NSTDA; National University of Singapore Yong Loo Lin School of Medicine Aspiration Fund(National University of Singapore); Genome Institute of Singapore (GIS), A-STAR, Singapore	This study was partially supported by Faculty of Medicine, Siriraj Hospital, Mahidol University grant No. R015833003, JST/NSTDA, grant no. P-12-01777, and the National University of Singapore Yong Loo Lin School of Medicine Aspiration Fund (NUHSRO/2014/069/AF-New Idea/04). The authors thank Genome Institute of Singapore (GIS), A-STAR, Singapore, for supporting of NGS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was partially supported by Faculty of Medicine, Siriraj Hospital, Mahidol University grant No. R015833003, JST/NSTDA grant No. P-12-01777 and the National University of Singapore Yong Loo Lin School of Medicine Aspiration Fund (NUHSRO/2014/069/AF-New Idea/04). We thanks for Genome Institute of Singapore (GIS), A-STAR, Singapore for supporting of NGS. We would like to acknowledge Prof. David Blair for editing the manuscript via Publication Clinic KKU. The author declared that they have no competing interests.	Andrews S., 2010, FASTQC QUALITY CONTR; Banu S, 2014, J CLIN MICROBIOL, V52, P156, DOI 10.1128/JCM.02378-13; Benavente ED, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0603-3; Blower TR, 2016, P NATL ACAD SCI USA, V113, P1706, DOI 10.1073/pnas.1525047113; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Braibant M, 2000, FEMS MICROBIOL REV, V24, P449, DOI 10.1111/j.1574-6976.2000.tb00550.x; Brown AC, 2015, J CLIN MICROBIOL, V53, P2230, DOI 10.1128/JCM.00486-15; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Coll F, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0164-0; Coll F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5812; Coll F, 2012, BIOINFORMATICS, V28, P2991, DOI 10.1093/bioinformatics/bts544; de Boer AS, 1999, J INFECT DIS, V180, P1238, DOI 10.1086/314979; Disratthakit A, 2015, INFECT GENET EVOL, V32, P432, DOI 10.1016/j.meegid.2015.03.038; Eldholm V, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0490-3; Feuerriegel S, 2015, J CLIN MICROBIOL, V53, P1908, DOI 10.1128/JCM.00025-15; Ford CB, 2013, NAT GENET, V45, P784, DOI 10.1038/ng.2656; Griffin JE, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002251; Guerra-Assuncao JA, 2015, J INFECT DIS, V211, P1154, DOI 10.1093/infdis/jiu574; Gupta AK, 2010, MICROB DRUG RESIST, V16, P21, DOI 10.1089/mdr.2009.0054; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Kato-Maeda M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058235; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Koser CU, 2013, NEW ENGL J MED, V369, P290, DOI 10.1056/NEJMc1215305; Larsen Michelle H, 2007, Curr Protoc Microbiol, VChapter 10, DOI 10.1002/9780471729259.mc10a02s6; Li H., 2013, ARXIV, DOI DOI 10.48550/ARXIV.1303.3997; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Luo T, 2014, TUBERCULOSIS, V94, P434, DOI 10.1016/j.tube.2014.04.005; Mazandu GK, 2012, INT J MOL SCI, V13, P7283, DOI 10.3390/ijms13067283; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Niemann S, 1999, J CLIN MICROBIOL, V37, P3078, DOI 10.1128/JCM.37.2.409-412.1999; Perez-Lago L, 2014, J INFECT DIS, V209, P98, DOI 10.1093/infdis/jit439; Regmi SM, 2015, MOL GENET GENOMICS, V290, P1933, DOI 10.1007/s00438-015-1048-0; Robertson D, 2007, TUBERCULOSIS, V87, P450, DOI 10.1016/j.tube.2007.05.015; Roetzer A, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001387; Salamon H, 2015, J INFECT DIS, V211, pS50, DOI 10.1093/infdis/jiu816; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Saunders NJ, 2011, J INFECTION, V62, P212, DOI 10.1016/j.jinf.2011.01.003; Savine E, 2002, J CLIN MICROBIOL, V40, P4561, DOI 10.1128/JCM.40.12.4561-4566.2002; Sharma D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139414; Sowajassatakul A, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-165; Steiner A, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-881; Stucki D, 2015, J INFECT DIS, V211, P1306, DOI 10.1093/infdis/jiu601; Sun G, 2012, J INFECT DIS, V206, P1724, DOI 10.1093/infdis/jis601; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Vishnoi A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-373; Walker TM, 2015, LANCET INFECT DIS; Wand ME, 2015, J ANTIMICROB CHEMOTH, V70, P2209, DOI 10.1093/jac/dkv097; WHO, 1998, INT J TUBERC LUNG D, V2, P71; Willby M, 2015, ANTIMICROB AGENTS CH, V59, P5427, DOI 10.1128/AAC.00662-15; Xia E, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0270-7; Zaunbrecher MA, 2009, P NATL ACAD SCI USA, V106, P20004, DOI 10.1073/pnas.0907925106; Zhang Y, 2005, NUCLEIC ACIDS RES, V33, P2302, DOI 10.1093/nar/gki524	52	10	10	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2016	11	8							e0160992	10.1371/journal.pone.0160992	http://dx.doi.org/10.1371/journal.pone.0160992			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3LI	27518818	Green Submitted, gold, Green Published			2022-12-27	WOS:000381382100032
J	Iversen, MM; Nefs, G; Tell, GS; Espehaug, B; Midthjell, K; Graue, M; Pouwer, F				Iversen, Marjolein M.; Nefs, Giesje; Tell, Grethe S.; Espehaug, Birgitte; Midthjell, Kristian; Graue, Marit; Pouwer, Frans			Anxiety and Depressive Symptoms as Predictors of All-Cause Mortality among People with Insulin-Naive Type 2 Diabetes: 17-Year Follow-Up of the Second Nord-Trondelag Health Survey (HUNT2), Norway	PLOS ONE			English	Article							POOR GLYCEMIC CONTROL; HOSPITAL ANXIETY; SCALE; METAANALYSIS; PREVALENCE; RISK; HYPOGLYCEMIA; POPULATION; RESISTANCE; COHORT	Aim To examine whether elevated anxiety and/or depressive symptoms are related to all-cause mortality in people with Type 2 diabetes, not using insulin. Methods 948 participants in the community-wide Nord-Trondelag Health Survey conducted during 1995-97 completed the Hospital Anxiety and Depression Scale with subscales of anxiety (HADS-A) and depression (HADS-D). Elevated symptoms were defined as HADS-A or HADS-D >= 8. Participants with type 2 diabetes, not using insulin, were followed until November 21, 2012 or death. Cox regression analyses were used to estimate associations between baseline elevated anxiety symptoms, elevated depressive symptoms and mortality, adjusting for sociodemographic factors, HbA(1c), cardiovascular disease and microvascular complications. Results At baseline, 8% (n = 77/948) reported elevated anxiety symptoms, 9% (n = 87/948) elevated depressive symptoms and 10% (n = 93/948) reported both. After a mean follow-up of 12 years (SD 5.1, range 0-17), 541 participants (57%) had died. Participants with elevated anxiety symptoms only had a decreased mortality risk (unadjusted HR 0.66, 95% CI 0.46-0.96). Adjustment for HbA(1c) attenuated this relation (HR 0.73, 95% CI 0.50-1.07). Those with elevated depression symptoms alone had an increased mortality risk (fully adjusted model HR 1.39, 95% CI 1.05-1.84). Having both elevated anxiety and depressive symptoms was not associated with increased mortality risk (adjusted HR 1.30, 95% CI 0.96-1.74). Conclusions Elevated depressive symptoms were associated with excess mortality risk in people with Type 2 diabetes not using insulin. No significant association with mortality was found among people with elevated anxiety symptoms. Having both elevated anxiety and depressive symptoms was not associated with mortality. The hypothesis that elevated levels of anxiety symptoms leads to behavior that counteracts the adverse health effects of Type 2 diabetes needs further investigation.	[Iversen, Marjolein M.; Espehaug, Birgitte; Graue, Marit] Bergen Univ Coll, Dept Hlth & Social Sci, Ctr Evidence Based Practice, Bergen, Norway; [Iversen, Marjolein M.] Stavanger Univ Hosp, Endocrinol Sect, Dept Med, Stavanger, Norway; [Nefs, Giesje; Pouwer, Frans] Tilburg Univ, Dept Med & Clin Psychol, Ctr Res Psychol & Somat Disorders CoRPS, Tilburg, Netherlands; [Tell, Grethe S.] Univ Bergen, Dept Global Publ Hlth & Primary Care, Bergen, Norway; [Midthjell, Kristian] Norwegian Univ Sci & Technol, Dept Community Med & Gen Practice, HUNT Res Ctr, Levanger, Norway	Western Norway University of Applied Sciences; Stavanger University Hospital; Tilburg University; University of Bergen; Norwegian University of Science & Technology (NTNU)	Iversen, MM (corresponding author), Bergen Univ Coll, Dept Hlth & Social Sci, Ctr Evidence Based Practice, Bergen, Norway.; Iversen, MM (corresponding author), Stavanger Univ Hosp, Endocrinol Sect, Dept Med, Stavanger, Norway.	marjolein.iversen@hib.no	Nefs, Giesje/C-9992-2018; Tell, Grethe/G-5639-2015	Tell, Grethe/0000-0003-1386-1638; Espehaug, Birgitte/0000-0002-7287-8643; Pouwer, Frans/0000-0002-8172-9818; Iversen, Marjolein Memelink/0000-0001-9954-171X				Ali S, 2006, DIABETIC MED, V23, P1165, DOI 10.1111/j.1464-5491.2006.01943.x; Amer Diabet Assoc, 2009, DIABETES CARE, V32, pS13, DOI 10.2337/dc09-S013; Anderbro T, 2015, ACTA DIABETOL, V52, P581, DOI 10.1007/s00592-014-0694-8; Anderson RJ, 2002, INT J PSYCHIAT MED, V32, P235, DOI 10.2190/KLGD-4H8D-4RYL-TWQ8; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; Coyne JC, 2012, J PSYCHOSOM RES, V72, P173, DOI 10.1016/j.jpsychores.2011.12.003; Cuijpers P, 2014, AM J PSYCHIAT, V171, P453, DOI 10.1176/appi.ajp.2013.13030325; Damak R., 2013, DEPRESS RES TREAT, V2013; Doering LV, 2010, INT J CARDIOL, V145, P188, DOI 10.1016/j.ijcard.2009.05.025; Drivsholm T, 2006, SCAND J PUBLIC HEALT, V34, P623, DOI 10.1080/14034940600607616; Grigsby AB, 2002, J PSYCHOSOM RES, V53, P1053, DOI 10.1016/S0022-3999(02)00417-8; Hermanns N, 2005, DIABETIC MED, V22, P293, DOI 10.1111/j.1464-5491.2005.01414.x; Holmen J, 2003, NORSK EPIDEMIOLOGI, V13, P19, DOI DOI 10.1093/eurheartj/eht019; Iversen MM, 2015, J PSYCHOSOM RES, V79, P309, DOI 10.1016/j.jpsychores.2015.07.004; Lin EHB, 2010, DIABETES CARE, V33, P264, DOI 10.2337/dc09-1068; Lou PA, 2014, COPD, V11, P444, DOI 10.3109/15412555.2013.822856; Lustman PJ, 2000, DIABETES CARE, V23, P934, DOI 10.2337/diacare.23.7.934; Mykletun A, 2001, BRIT J PSYCHIAT, V179, P540, DOI 10.1192/bjp.179.6.540; Nam S, 2010, DIABETES CARE, V33, P1747, DOI 10.2337/dc10-0099; Nefs G, 2012, DIABETOLOGIA, V55, P608, DOI 10.1007/s00125-011-2411-2; Nefs G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078865; Norton S, 2012, J PSYCHOSOM RES, V73, P75, DOI 10.1016/j.jpsychores.2012.04.005; Nouwen A, 2010, DIABETOLOGIA, V53, P2480, DOI 10.1007/s00125-010-1874-x; Park JH, 2015, J CARDIOVASC NURS, V30, P351, DOI 10.1097/JCN.0000000000000143; Polonsky WH, 2005, DIABETES CARE, V28, P2543, DOI 10.2337/diacare.28.10.2543; Pouwer F, 2013, ENDOCRIN METAB CLIN, V42, P529, DOI 10.1016/j.ecl.2013.05.002; Rutledge T, 2009, PSYCHOSOM MED, V71, P958, DOI 10.1097/PSY.0b013e3181bd6062; Saleh N, 2012, DIABETOLOGIA, V55, P2109, DOI 10.1007/s00125-012-2565-6; Smith KJ, 2013, J PSYCHOSOM RES, V74, P89, DOI 10.1016/j.jpsychores.2012.11.013; Strandberg RB, 2014, J PSYCHOSOM RES, V77, P174, DOI 10.1016/j.jpsychores.2014.06.015; Tovilla-Zarate C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036887; Vallis M, 2014, CURR DIABETES REV, V10, P364, DOI 10.2174/1573399810666141113115026; van Dooren FEP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057058; Watkins LL, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.112.000068; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	35	11	12	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0160861	10.1371/journal.pone.0160861	http://dx.doi.org/10.1371/journal.pone.0160861			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DT6ES	27537359	Green Published, gold, Green Submitted			2022-12-27	WOS:000381577000036
J	Metwally, DM; Al-Olayan, EM; El-Khadragy, MF; Alkathiri, B				Metwally, Dina M.; Al-Olayan, Ebtesam M.; El-Khadragy, Manal F.; Alkathiri, Badriah			Anti-Leishmanial Activity (In Vitro and In Vivo) of Allicin and Allicin Cream Using Leishmania major (Sub-strain Zymowme LON4) and Balb/c Mice	PLOS ONE			English	Article							CUTANEOUS LEISHMANIASIS; L. INFANTUM; DONOVANI; INTERLEUKIN-12; PROMASTIGOTES; APOPTOSIS; PROTEINS; ASSAY	Background Leishmania is a unicellular protozoan parasite that produces several human diseases, ranging from localized self-healing cutaneous lesions to deadly visceral infections. Objective The effect of allicin on the growth of Leishmania major (L. major) promastigotes was evaluated under in vitro conditions. Moreover, the efficacy of a topical allicin cream was examined in BALB/c (Bagg albino, laboratory-bred strain of the House Mouse) mice with cutaneous leishmanial lesions compared to the currently used drug, sodiumstibogluconate (pentostam). Methods Cytotoxiciy and promastigote proliferation were measured. Different concentrations (50, 100, 150, and 200 mu M) of liquid allicin were tested on L. major promastigotes twice: after 24 and 48 hours using an MTT colorimetric assay. In the in vivo condition, the efficacies of allicin cream and liquid allicin at two concentrations (0.15 mu M/mouse and 0.30 mu M/mouse) were evaluated. Serum factors of the control and treated groups were tested to evaluate the toxic effects of allicin on the liver and kidney. Results Allicin at a concentration of 50 mu M inhibited the growth of Leishmania promastigotes. Topical application of allicin cream reduced lesion sizes in mice. No significant differences in biochemical analysis were observed between the control and treated groups. Conclusions Allicin has antileishmanial effects under in vitro and in vivo conditions and may be used in clinical applications.	[Metwally, Dina M.; Al-Olayan, Ebtesam M.; El-Khadragy, Manal F.; Alkathiri, Badriah] King Saud Univ, Fac Sci, Dept Zool, Riyadh, Saudi Arabia; [Metwally, Dina M.] Zagazig Univ, Fac Vet Med, Dept Parasitol, Zagazig, Egypt; [El-Khadragy, Manal F.] Helwan Univ, Fac Sci, Dept Zool & Entomol, Cairo, Egypt	King Saud University; Egyptian Knowledge Bank (EKB); Zagazig University; Egyptian Knowledge Bank (EKB); Helwan University	Metwally, DM (corresponding author), King Saud Univ, Fac Sci, Dept Zool, Riyadh, Saudi Arabia.; Metwally, DM (corresponding author), Zagazig Univ, Fac Vet Med, Dept Parasitol, Zagazig, Egypt.	mdbody7@yahoo.com		Metwally, Dina M./0000-0001-6042-4137	research center of the Center for Female Scientific and Medical Colleges in King Saud University	research center of the Center for Female Scientific and Medical Colleges in King Saud University	This research project was supported by a grant from the research center of the Center for Female Scientific and Medical Colleges in King Saud University.	Acardi SA, 2010, MEM I OSWALDO CRUZ, V105, P796, DOI 10.1590/S0074-02762010000600011; Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671; Ankri S, 1999, MICROBES INFECT, V1, P125, DOI 10.1016/S1286-4579(99)80003-3; [Anonymous], 2016, FACT SHEET WHO STAND; Anthony JP, 2005, TRENDS PARASITOL, V21, P462, DOI 10.1016/j.pt.2005.08.004; City B, 2014, J COASTAL LIFE MED, V2, P319; Corral MJ, 2014, ANTIMICROB AGENTS CH, V58, P1596, DOI 10.1128/AAC.00710-13; Fuertes MA, 2008, CURR MED CHEM, V15, P433; Gharavi MJ, 2011, IRAN J PUBLIC HEALTH, V40, P105; Hepburn NC, 2000, CLIN EXP DERMATOL, V25, P363, DOI 10.1046/j.1365-2230.2000.00664.x; Corral-Caridad MJ, 2012, EXP PARASITOL, V132, P475, DOI 10.1016/j.exppara.2012.08.016; Marfurt J, 2003, J CLIN MICROBIOL, V41, P3147, DOI 10.1128/JCM.41.7.3147-3153.2003; Markle WH, 2004, AM FAM PHYSICIAN, V69, P1455; Miron T, 2010, EUR J MED CHEM, V45, P1912, DOI 10.1016/j.ejmech.2010.01.031; Mohammadzadeh M, 2013, J INFECT PUBLIC HEAL, V6, P120, DOI 10.1016/j.jiph.2012.11.003; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; NABORS GS, 1995, P NATL ACAD SCI USA, V92, P3142, DOI 10.1073/pnas.92.8.3142; NEI M, 1979, P NATL ACAD SCI USA, V76, P5269, DOI 10.1073/pnas.76.10.5269; Oommen S, 2004, EUR J PHARMACOL, V485, P97, DOI 10.1016/j.ejphar.2003.11.059; Rabinkov A, 1998, BBA-GEN SUBJECTS, V1379, P233, DOI 10.1016/S0304-4165(97)00104-9; Sambrook J., 2001, MOL CLONING LAB MANU; Verma NK, 2007, EXP PARASITOL, V116, P1, DOI 10.1016/j.exppara.2006.10.007; Zaghloul IY, 2004, ANN TROP MED PARASIT, V98, P793, DOI 10.1179/000349804X3171	23	9	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0161296	10.1371/journal.pone.0161296	http://dx.doi.org/10.1371/journal.pone.0161296			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27537199	Green Published, gold, Green Submitted			2022-12-27	WOS:000381577000084
J	Rubbenstroth, D; Schmidt, V; Rinder, M; Legler, M; Twietmeyer, S; Schwemmer, P; Corman, VM				Rubbenstroth, Dennis; Schmidt, Volker; Rinder, Monika; Legler, Marko; Twietmeyer, Soenke; Schwemmer, Phillip; Corman, Victor M.			Phylogenetic Analysis Supports Horizontal Transmission as a Driving Force of the Spread of Avian Bornaviruses	PLOS ONE			English	Article							PROVENTRICULAR DILATATION DISEASE; COCKATIELS NYMPHICUS-HOLLANDICUS; EXPERIMENTALLY INFECTED COCKATIELS; GEESE BRANTA-CANADENSIS; PSITTACINE BIRDS; BORNA-DISEASE; VERTICAL TRANSMISSION; MUTE SWANS; VIRUS; RESERVOIR	Background Avian bornaviruses are a genetically diverse group of viruses initially discovered in 2008. They are known to infect several avian orders. Bornaviruses of parrots and related species (Psittaciformes) are causative agents of proventricular dilatation disease, a chronic and often fatal neurologic disease widely distributed in captive psittacine populations. Although knowledge has considerably increased in the past years, many aspects of the biology of avian bornaviruses are still undiscovered. In particular, the precise way of transmission remains unknown. Aims and Methods In order to collect further information on the epidemiology of bornavirus infections in birds we collected samples from captive and free-ranging aquatic birds (n = 738) and Passeriformes (n = 145) in Germany and tested them for the presence of bornaviruses by PCR assays covering a broad range of known bornaviruses. We detected aquatic bird bornavirus 1 (ABBV-1) in three out of 73 sampled free-ranging mute swans (Cygnus olor) and one out of 282 free-ranging Eurasian oystercatchers (Haematopus ostralegus). Canary bornavirus 1 (CnBV-1), CnBV-2 and CnBV-3 were detected in four, six and one out of 48 captive common canaries (Serinus canaria forma domestica), respectively. In addition, samples originating from 49 bornavirus-positive captive Psittaciformes were used for determination of parrot bornavirus 2 (PaBV-2) and PaBV-4 sequences. Bornavirus sequences compiled during this study were used for phylogenetic analysis together with all related sequences available in GenBank. Results of the Study Within ABBV-1, PaBV-2 and PaBV-4, identical or genetically closely related bornavirus sequences were found in parallel in various different avian species, suggesting that interspecies transmission is frequent relative to the overall transmission of these viruses. Our results argue for an important role of horizontal transmission, but do not exclude the additional possibility of vertical transmission. Furthermore we defined clearly separated sequence clusters within several avian bornaviruses, providing a basis for an improved interpretation of transmission events within and between wild bird populations and captive bird collections.	[Rubbenstroth, Dennis] Univ Freiburg, Med Ctr, Inst Virol, Fac Med, Herrmann Herder Str 11, D-79104 Freiburg, Germany; [Schmidt, Volker] Univ Leipzig, Clin Birds & Reptiles, Tierkliniken 17, D-04103 Leipzig, Germany; [Rinder, Monika] Univ Ludwig Maximilian Munich, Ctr Clin Vet Med, Clin Birds Reptiles Amphibians & Ornamental Fish, Sonnenstr 18, D-85764 Oberschleissheim, Germany; [Legler, Marko] Univ Vet Med Hannover, Clin Pets Reptiles & Pet & Feral Birds, Bunteweg 9, D-30559 Hannover, Germany; [Twietmeyer, Soenke] Eifel Natl Pk, Dept Res & Documentat, Urftseestr 34, D-53937 Schleiden Gemund, Germany; [Schwemmer, Phillip] Univ Kiel, Res & Technol Ctr Busum, Hafentorn 1, D-25761 Busum, Germany; [Corman, Victor M.] Univ Bonn, Inst Virol, Sigmund Freud Str 25, D-53127 Bonn, Germany; [Corman, Victor M.] German Ctr Infect Res DZIF, Partner Site Bonn Cologne, Bonn, Germany	University of Freiburg; Leipzig University; University of Munich; University of Veterinary Medicine Hannover, Foundation; University of Kiel; University of Bonn; German Center for Infection Research	Rubbenstroth, D (corresponding author), Univ Freiburg, Med Ctr, Inst Virol, Fac Med, Herrmann Herder Str 11, D-79104 Freiburg, Germany.	Dennis.Rubbenstroth@uniklinik-freiburg.de	Corman, Victor M/K-1319-2019; Schmidt, Volker/I-7708-2019	Corman, Victor M/0000-0002-3605-0136; Schmidt, Volker/0000-0002-6001-9542	German Research Foundation (Deutsche Forschungsgemeinschaft, DFG) [RU-1923/2-1]	German Research Foundation (Deutsche Forschungsgemeinschaft, DFG)(German Research Foundation (DFG))	DR obtained funding from the German Research Foundation (Deutsche Forschungsgemeinschaft, DFG; grant RU-1923/2-1), http://www.dfg.de/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors like to thank Rebecca Eberhardt, Sabine Muller, Andreas Narr, Felix Rottele, Solveig Runge, Lukas Walther and Stefan Weiel for excellent technical assistance. Dennis Rubbenstroth obtained funding from the German Research Foundation (Deutsche Forschungsgemeinschaft, DFG; grant RU-1923/2-1).	Berg M, 2001, EPIDEMIOL INFECT, V127, P173, DOI 10.1017/S0950268801005702; Bourg M, 2013, EMERG INFECT DIS, V19, P2064, DOI 10.3201/eid1912.131076; Delnatte P, 2014, AVIAN PATHOL, V43, P301, DOI 10.1080/03079457.2014.921279; Delnatte P, 2014, J VET DIAGN INVEST, V26, P266, DOI 10.1177/1040638713519641; Delnatte P, 2013, AVIAN PATHOL, V42, P114, DOI 10.1080/03079457.2013.769669; Durrwald R, 2006, MICROBES INFECT, V8, P917, DOI 10.1016/j.micinf.2005.08.013; Durrwald R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093659; Encinas-Nagel N, 2014, EMERG INFECT DIS, V20, P2103, DOI 10.3201/eid2012.140920; Gray P, 2010, EMERG INFECT DIS, V16, P473, DOI 10.3201/eid1603.091257; Gregory Christopher R., 1994, Journal of the Association of Avian Veterinarians, V8, P69; Guo JH, 2015, J WILDLIFE DIS, V51, P754, DOI 10.7589/2015-01-001; Guo JH, 2014, VIROL J, V11, DOI 10.1186/s12985-014-0197-9; Guo J, 2012, VET MED-RES REP, V3, P49, DOI 10.2147/VMRR.S33353; Heatley JJ, 2012, VET MED-RES REP, V3, P19, DOI 10.2147/VMRR.S31336; Heffels-Redmann U, 2012, AVIAN DIS, V56, P153, DOI 10.1637/9844-062811-Reg.1; Heffels-Redmann U, 2011, AVIAN PATHOL, V40, P419, DOI 10.1080/03079457.2011.589825; Hilbe M, 2006, EMERG INFECT DIS, V12, P675, DOI 10.3201/eid1204.051418; Hoffmann B, 2015, NEW ENGL J MED, V373, P154, DOI 10.1056/NEJMoa1415627; Honkavuori KS, 2008, EMERG INFECT DIS, V14, P1883, DOI 10.3201/eid1412.080984; Kerski A, 2012, AVIAN DIS, V56, P471, DOI 10.1637/9879-080511-Reg.1; Kistler AL, 2010, J VIROL, V84, P2176, DOI 10.1128/JVI.02191-09; Kistler AL, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-88; Kolodziejek J, 2005, J GEN VIROL, V86, P385, DOI 10.1099/vir.0.80587-0; Kuhn JH, 2015, ARCH VIROL, V160, P621, DOI 10.1007/s00705-014-2276-z; Lierz M, 2011, EMERG INFECT DIS, V17, P2390, DOI 10.3201/eid1712.111317; Mirhosseini N, 2011, J AVIAN MED SURG, V25, P199, DOI 10.1647/2010-030.1; Monaco E, 2012, J AVIAN MED SURG, V26, P144, DOI 10.1647/2011-049R1.1; Nobach D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137018; Payne S, 2011, AVIAN PATHOL, V40, P15, DOI 10.1080/03079457.2010.536978; Payne S, 2011, J VIROL, V85, P12053, DOI 10.1128/JVI.05700-11; Philadelpho NA, 2014, VET MICROBIOL, V174, P584, DOI 10.1016/j.vetmic.2014.10.020; Piepenbring AK, 2012, EMERG INFECT DIS, V18, P234, DOI 10.3201/eid1802.111525; Puorger ME, 2010, VET PATHOL, V47, P236, DOI 10.1177/0300985809351849; Raghav R, 2010, J VET DIAGN INVEST, V22, P495, DOI 10.1177/104063871002200402; Rinder M, 2009, J VIROL, V83, P5401, DOI 10.1128/JVI.00133-09; Rubbenstroth D, 2012, VET MICROBIOL, V161, P36, DOI 10.1016/j.vetmic.2012.07.004; Rubbenstroth D, 2015, 2 NEW SPECIES FAMILY; Rubbenstroth D, 2014, VET MICROBIOL, V172, P146, DOI 10.1016/j.vetmic.2014.05.011; Rubbenstroth D, 2014, VET MICROBIOL, V168, P318, DOI 10.1016/j.vetmic.2013.11.032; Rubbenstroth D, 2013, VET MICROBIOL, V165, P287, DOI 10.1016/j.vetmic.2013.03.024; Sassa Y, 2015, VIRUS GENES, V51, P234, DOI 10.1007/s11262-015-1240-7; Schwemmer P, 2014, WATERBIRDS, V37, P319, DOI 10.1675/063.037.0310; Staeheli P, 2010, J VIROL, V84, P6269, DOI 10.1128/JVI.02567-09; Thomsen AF, 2015, EMERG INFECT DIS, V21, P2201, DOI 10.3201/eid2112.150650; Weissenbock H, 2009, J VIROL, V83, P11367, DOI 10.1128/JVI.01343-09; Weissenbock H, 2009, EMERG INFECT DIS, V15, P1453, DOI 10.3201/eid1509.090353	46	21	22	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0160936	10.1371/journal.pone.0160936	http://dx.doi.org/10.1371/journal.pone.0160936			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27537693	Green Submitted, gold, Green Published			2022-12-27	WOS:000381577000039
J	Yan, I; Bendavid, E; Korenromp, EL				Yan, Isabel; Bendavid, Eran; Korenromp, Eline L.			Antiretroviral Treatment Scale-Up and Tuberculosis Mortality in High TB/HIV Burden Countries: An Econometric Analysis	PLOS ONE			English	Article							ISONIAZID PREVENTIVE THERAPY; RIO-DE-JANEIRO; SOUTH-AFRICA; COTRIMOXAZOLE PROPHYLAXIS; POSITIVE ADULTS; HIV; SURVIVAL; TARGETS; DEATHS; TRENDS	Introduction Antiretroviral therapy (ART) reduces mortality in patients with active tuberculosis (TB), but the population-level relationship between ART coverage and TB mortality is untested. We estimated the reduction in population-level TB mortality that can be attributed to increasing ART coverage across 41 high HIV-TB burden countries. Methods We compiled TB mortality trends between 1996 and 2011 from two sources: (1) national program-reported TB death notifications, adjusted for annual TB case detection rates, and (2) WHO TB mortality estimates. National coverage with ART, as proportion of HIV-infected people in need, was obtained from UNAIDS. We applied panel linear regressions controlling for HIV prevalence (5-year lagged), coverage of TB interventions (estimated by WHO and UNAIDS), gross domestic product per capita, health spending from domestic sources, urbanization, and country fixed effects. Results Models suggest that that increasing ART coverage was followed by reduced TB mortality, across multiple specifications. For death notifications at 2 to 5 years following a given ART scale-up, a 1% increase in ART coverage predicted 0.95% faster mortality rate decline (p = 0.002); resulting in 27% fewer TB deaths in 2011 alone than would have occurred without ART. Based on WHO death estimates, a 1% increase in ART predicted a 1.0% reduced TB death rate (p<0.001), and 31% fewer deaths in 2011. TB mortality was higher at higher HIV prevalence (p<0.001), but not related to coverage of isoniazid preventive therapy, cotrimoxazole preventive therapy, or other covariates. Conclusion This econometric analysis supports a substantial impact of ART on population-level TB mortality realized already within the first decade of ART scale-up, that is apparent despite variable-quality mortality data.	[Yan, Isabel] City Univ Hong Kong, Dept Econ & Finance, Kowloon, Hong Kong, Peoples R China; [Bendavid, Eran] Stanford Univ, Div Gen Med Disciplines, Stanford, CA 94305 USA; [Bendavid, Eran] Stanford Univ, Ctr Hlth Policy, Stanford, CA 94305 USA; [Bendavid, Eran] Stanford Univ, Ctr Primary Care & Outcomes Res, Stanford, CA 94305 USA; [Korenromp, Eline L.] Univ Med Ctr, Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands; [Korenromp, Eline L.] Avenir Hlth, Geneva, Switzerland	City University of Hong Kong; Stanford University; Stanford University; Stanford University; Erasmus University Rotterdam; Erasmus MC	Korenromp, EL (corresponding author), Univ Med Ctr, Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands.; Korenromp, EL (corresponding author), Avenir Hlth, Geneva, Switzerland.	ekorenromp@AvenirHealth.org			National Institute for Drug Abuse [DA015612]; Doris Duke Charitable Foundation; National Natural Science Foundation [71403061]; Global Research Unit (GRU) at the City University of Hong Kong; NATIONAL INSTITUTE ON AGING [P30AG017253] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA015612, R37DA015612] Funding Source: NIH RePORTER	National Institute for Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Global Research Unit (GRU) at the City University of Hong Kong; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	EB was supported by the National Institute for Drug Abuse (DA015612) and by the Doris Duke Charitable Foundation. IY acknowledges support by the National Natural Science Foundation (project no. 71403061) and by the Global Research Unit (GRU) at the City University of Hong Kong. The funders of the study had no role in study design, data collection and analysis, data interpretation, decision to publish, or preparation of the manuscript.	[Anonymous], 2015, GLOBAL TUBERCULOSIS; [Anonymous], 2011, INDICATOR AND MEASUR; Au-Yeung Christopher, 2011, Clin Epidemiol, V3, P21, DOI 10.2147/CLEP.S15574; Badri M, 2002, LANCET, V359, P2059, DOI 10.1016/S0140-6736(02)08904-3; Bendavid E, 2012, JAMA-J AM MED ASSOC, V307, P2060, DOI 10.1001/jama.2012.2001; Bendavid E, 2009, ANN INTERN MED, V150, P688, DOI 10.7326/0003-4819-150-10-200905190-00117; Blok L, 2014, INT HEALTH, V6, P181, DOI 10.1093/inthealth/ihu055; Bor J, 2013, SCIENCE, V339, P961, DOI 10.1126/science.1230413; Charalambous S, 2010, AIDS, V24, pS5, DOI 10.1097/01.aids.0000391010.02774.6f; Cohen T, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000296; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; Creswell J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094465; Dieleman JL, 2013, JOURNAL OF DEVELOPME, P1; Dowdy DW, 2014, JAIDS-J ACQ IMM DEF, V66, P552, DOI 10.1097/QAI.0000000000000219; Duber HC, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-21; Durovni B, 2013, LANCET INFECT DIS, V13, P852, DOI 10.1016/S1473-3099(13)70187-7; Fazito E, 2012, SEX TRANSM INFECT, V88, pI86, DOI 10.1136/sextrans-2012-050632; Floyd S, 2012, TROP MED INT HEALTH, V17, pe84, DOI 10.1111/j.1365-3156.2012.03032.x; Floyd S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013499; Glaziou P, 2011, B WORLD HEALTH ORGAN, V89, P573, DOI [10.2471/BLT.11.087510, DOI 10.2471/BLT.11.O87510]; Glaziou P, 2016, EPRINT ARXIV 2016 16; Glaziou P, 2011, B WORLD HEALTH ORGAN, V89, P573, DOI 10.2471/BLT.11.087510; Harries AD, 2015, LANCET INFECT DIS, V15, P1492, DOI 10.1016/S1473-3099(15)00242-X; Kabali C, 2011, INT J TUBERC LUNG D, V15, P1515, DOI 10.5588/ijtld.10.0788; Kasamba I, 2012, TROP MED INT HEALTH, V17, pe66, DOI 10.1111/j.1365-3156.2012.02841.x; Korenromp EL, 2009, INT J TUBERC LUNG D, V13, P283; Korenromp EL, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-18; Korenromp EL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038816; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Maher D, 2005, INT J TUBERC LUNG D, V9, P123; Manosuthi W, 2006, JAIDS-J ACQ IMM DEF, V43, P42, DOI 10.1097/01.qai.0000230521.86964.86; Nunn AJ, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a257; Organisation for Economic Co-operation and Development, 2014, DEVELOPMENT ASSISTAN; Pretorius C, 2014, AIDS, V28, pS25, DOI 10.1097/QAD.0000000000000085; Samandari T, 2011, LANCET, V377, P1588, DOI 10.1016/S0140-6736(11)60204-3; Stoneburner R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100431; Suthar AB, 2015, LANCET HIV, V2, pE137, DOI 10.1016/S2352-3018(15)00005-3; The Global Fund to Fight AIDS Tuberculosis and Malaria, 2011, THE GLOBAL FUND RESU; UNAIDS, 2014, FAST TRACK ENDING TH; UNAIDS, 2013, REPORT ON THE GLOBAL; Uyei J, 2011, LANCET INFECT DIS, V11, P855, DOI 10.1016/S1473-3099(11)70145-1; van der Werf MJ, 2007, B WORLD HEALTH ORGAN, V85, P370, DOI 10.2471/BLT.06.039941; Vapattanawong P, 2011, B WORLD HEALTH ORGAN, V89, P806, DOI 10.2471/BLT.10.083931; Watera C, 2006, JAIDS-J ACQ IMM DEF, V42, P373, DOI 10.1097/01.qai.0000221679.14445.1b; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; WHO, 2013, CONSOLIDATED GUIDELI; Williams BG, 2010, P NATL ACAD SCI USA, V107, P19485, DOI [10.1073.pnas.1005660107, DOI 10.1073/PANS.1005660107]; Williams BG, 2011, TUBERCULOSIS AMONG P; World Health Organization, 2013, CARTOGRAPHER GLOBAL, P104; World Health Organization, 2011, STOP TB PARTNERSHIP; Yan I, 2014, TUBERCULOSIS AND MAL; Yassin MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063174	52	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0160481	10.1371/journal.pone.0160481	http://dx.doi.org/10.1371/journal.pone.0160481			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27536864	Green Published, Green Submitted, gold			2022-12-27	WOS:000381577000021
J	Chunga, RM; Ensink, JHJ; Jenkins, MW; Brown, J				Chunga, Richard M.; Ensink, Jeroen H. J.; Jenkins, Marion W.; Brown, Joe			Adopt or Adapt: Sanitation Technology Choices in Urbanizing Malawi	PLOS ONE			English	Article							SUSTAINABLE SANITATION; ECOLOGICAL SANITATION; ENVIRONMENTAL-CHANGE; PERCEIVED EASE; CLIMATE-CHANGE; VULNERABILITY; STRATEGIES; ACCEPTANCE	This paper presents the results of a mixed-methods study examining adaptation strategies that property owners in low-income, rapidly urbanizing areas in Malawi adopt to address the limitations of pit latrines, the most common method of disposing human excreta. A particular challenge is lack of space for constructing new latrines as population density increases: traditional practice has been to cap full pits and simply move to a new site, but increasing demands on space require new approaches to extend the service life of latrines. In this context, we collected data on sanitation technology choices from January to September 2013 through 48 in-depth interviews and a stated preference survey targeting 1,300 property owners from 27 low-income urban areas. Results showed that property owners with concern about space for replacing pit latrines were 1.8 times more likely to select pit emptying service over the construction of new pit latrines with a slab floor (p = 0.02) but there was no significant association between concern about space for replacing pit latrines and intention to adopt locally promoted, novel sanitation technology known as ecological sanitation (ecosan). Property owners preferred to adapt existing, known technology by constructing replacement pit latrines on old pit latrine locations, reducing the frequency of replacing pit latrines, or via emptying pit latrines when full. This study highlights potential challenges to adoption of wholly new sanitation technologies, even when they present clear advantages to end users. To scale, alternative sanitation technologies for rapidly urbanising cities should offer clear advantages, be affordable, be easy to use when shared among multiple households, and their design should be informed by existing adaptation strategies and local knowledge.	[Chunga, Richard M.; Ensink, Jeroen H. J.; Jenkins, Marion W.] London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London, England; [Jenkins, Marion W.] Univ Calif Davis, Dept Civil & Environm Engn, Davis, CA 95616 USA; [Brown, Joe] Georgia Inst Technol, Sch Civil & Environm Engn, Atlanta, GA 30332 USA	University of London; London School of Hygiene & Tropical Medicine; University of California System; University of California Davis; University System of Georgia; Georgia Institute of Technology	Chunga, RM (corresponding author), London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London, England.	Richard.Chunga@btinternet.com						Abraham B., 2011, ALTERNATIVE SOLUTION; [Anonymous], 2014, STAT AFR CIT REIM SU; Blackett I., 2014, MISSING LINK SANITAT; Bostoen K, 2006, INT J EPIDEMIOL, V35, P751, DOI 10.1093/ije/dyl019; Collender G, 2011, WATERLINES, V30, P289; DAVIS FD, 1989, MIS QUART, V13, P319, DOI 10.2307/249008; Eriksen SH, 2005, GEOGR J, V171, P287, DOI 10.1111/j.1475-4959.2005.00174.x; Esrey SA, 2001, WATER SCI TECHNOL, V43, P177; Fazey I, 2010, FRONT ECOL ENVIRON, V8, P414, DOI 10.1890/080215; Hosmer D. W., 2013, APPL LOGISTIC REGRES; Isunju JB, 2011, PUBLIC HEALTH, V125, P368, DOI 10.1016/j.puhe.2011.03.008; Jenkins MW, 2015, INT J ENV RES PUB HE, V12, P2588, DOI 10.3390/ijerph120302588; Jenkins MW, 2005, SOC SCI MED, V61, P2446, DOI 10.1016/j.socscimed.2005.04.036; Kates RW, 2012, P NATL ACAD SCI USA, V109, P7156, DOI 10.1073/pnas.1115521109; Katukiza AY, 2012, BIOTECHNOL ADV, V30, P964, DOI 10.1016/j.biotechadv.2012.02.007; Kelly PM, 2000, CLIMATIC CHANGE, V47, P325, DOI 10.1023/A:1005627828199; Matsebe G., 2011, REV ECOSAN TOILETS M; Morgan P., 2013, PAVING WAY SCALING F; Nelson DR, 2007, ANNU REV ENV RESOUR, V32, P395, DOI 10.1146/annurev.energy.32.051807.090348; NSO, 2011, 3 INT HOUS SURV; NSO, 2008, POP HOUS CENS PREL R; NSO, 2011, SOC WELF MON SURV; Nyong A., 2007, Mitigation and Adaptation Strategies for Global Change, V12, P787, DOI 10.1007/s11027-007-9099-0; Peal A, 2014, J WATER SANITATION H, V4; Ritchie J., 2003, GUIDE SOCIAL SCI STU, P77; Rogers E.M., 1995, DIFFUSION INNOVATION; Roma E, 2013, WATER SA, V39, P305, DOI 10.4314/wsa.v39i2.15; Silverman D., 2010, DOING QUALITATIVE RE, V3; Smit B, 2006, GLOBAL ENVIRON CHANG, V16, P282, DOI 10.1016/j.gloenvcha.2006.03.008; Thye YP, 2011, CRIT REV ENV SCI TEC, V41, P1793, DOI 10.1080/10643389.2010.481593; Tsinda A, 2013, INT J ENV RES PUB HE, V10, P6939, DOI 10.3390/ijerph10126939; Tumwebaze IK, 2011, ECOLOGICAL SANITATIO; UN-Habitat, 2003, CHALL SLUMS GLOB REP; UNICEF and WHO, 2010, PROGR SAN DRINK WAT; Venkatesh V, 2000, INFORM SYST RES, V11, P342, DOI 10.1287/isre.11.4.342.11872; Werner C, 2009, DESALINATION, V248, P392, DOI 10.1016/j.desal.2008.05.080; WHO/UNICEF(WHO/UnitedNationsInternationalChildren's Fund), 2014, PROGR DRINK WAT SAN; Wilson A., 2012, MARKETING RES INTEGR	38	26	26	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2016	11	8							e0161262	10.1371/journal.pone.0161262	http://dx.doi.org/10.1371/journal.pone.0161262			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DT4YN	27532871	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000381487600079
J	Song, B; An, LX; Han, YJ; Gao, HX; Ren, HB; Zhao, X; Wei, XS; Krishnan, HB; Liu, SS				Song, Bo; An, Lixin; Han, Yanjing; Gao, Hongxiu; Ren, Hongbo; Zhao, Xue; Wei, Xiaoshuang; Krishnan, Hari B.; Liu, Shanshan			Transcriptome Profile of Near-Isogenic Soybean Lines for beta-Conglycinin alpha-Subunit Deficiency during Seed Maturation	PLOS ONE			English	Article							STORAGE-PROTEIN GENES; GLYCINE-MAX L; ATOPIC-DERMATITIS; 7S GLOBULIN; RNA-SEQ; SUPERFAMILY; INHERITANCE; EXPRESSION; IDENTIFICATION; ALLERGENS	Crossing, backcrossing, and molecular marker-assisted background selection produced a soybean (Glycine max) near-isogenic line (cgy-2-NIL) containing the cgy-2 allele, which is responsible for the absence of the allergenic alpha-subunit of beta-conglycinin. To identify alpha-null-related transcriptional changes, the gene expressions of cgy-2-NIL and its recurrent parent DN47 were compared using Illumina high-throughput RNA-sequencing of samples at 25, 35, 50, and 55 days after flowering (DAF). Seeds at 18 DAF served as the control. Comparison of the transcript profiles identified 3,543 differentially expressed genes (DEGs) between the two genotypes, with 2,193 genes downregulated and 1,350 genes upregulated. The largest numbers of DEGs were identified at 55 DAF. The DEGs identified at 25 DAF represented a unique pattern of GO category distributions. KEGG pathway analyses identified 541 altered metabolic pathways in cgy-2-NIL. At 18DAF, 12 DEGs were involved in arginine and proline metabolism. The cgy-2 allele in the homozygous form modified the expression of several Cupin allergen genes. The cgy-2 allele is an alteration of a functional allele that is closely related to soybean protein amino acid quality, and is useful for hypoallergenic soybean breeding programs that aim to improve seed protein quality.	[Song, Bo; Han, Yanjing; Gao, Hongxiu; Zhao, Xue; Wei, Xiaoshuang; Liu, Shanshan] Northeast Agr Univ, Chinese Agr Minist, Key Lab Soybean Biol & Breeding Genet, Key Lab Soybean Biol, Harbin 150030, Peoples R China; [Ren, Hongbo] Minist Agr China, Inspect & Testing Ctr Qual Cereals & Their Prod, Harbin 150030, Peoples R China; [Krishnan, Hari B.] Univ Missouri, USDA ARS, Plant Genet Res Unit, Columbia, MO USA; [An, Lixin] Harbin Med Univ, Affiliated Hosp 1, Dept Allergy, Harbin, Peoples R China	Northeast Agricultural University - China; Ministry of Agriculture & Rural Affairs; United States Department of Agriculture (USDA); University of Missouri System; University of Missouri Columbia; Harbin Medical University	Liu, SS (corresponding author), Northeast Agr Univ, Chinese Agr Minist, Key Lab Soybean Biol & Breeding Genet, Key Lab Soybean Biol, Harbin 150030, Peoples R China.	ars336699@aliyun.com		SHANSHAN, LIU/0000-0001-7273-735X	National Natural Science Foundation of China [31071440, 31371650]; Northeast Agricultural University Innovation Foundation [yjscx14042]; ARS [ARS-0424526] Funding Source: Federal RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Northeast Agricultural University Innovation Foundation; ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	The work was supported by the National Natural Science Foundation of China (31071440 and 31371650) and Northeast Agricultural University Innovation Foundation for Postgraduates (yjscx14042). The study is part of the PhD research of the first author.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Asakura T, 2012, PLANT PHYSIOL BIOCH, V52, P147, DOI 10.1016/j.plaphy.2011.12.007; Beilinson V, 2002, THEOR APPL GENET, V104, P1132, DOI 10.1007/s00122-002-0884-6; BURKS AW, 1988, J ALLERGY CLIN IMMUN, V81, P1135, DOI 10.1016/0091-6749(88)90881-0; Cho YB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076954; DAVIES CS, 1985, THEOR APPL GENET, V71, P351, DOI 10.1007/BF00252079; Dunwell JM, 2004, PHYTOCHEMISTRY, V65, P7, DOI 10.1016/j.phytochem.2003.08.016; Dunwell JM, 2001, TRENDS BIOCHEM SCI, V26, P740, DOI 10.1016/S0968-0004(01)01981-8; Dunwell JM, 1998, BIOTECHNOL GENET ENG, V15, P1; Dunwell JM, 1998, J MOL EVOL, V46, P147, DOI 10.1007/PL00006289; FAO/WHO, 1991, PROT QUAL EV, P51; Fu CJJ, 2007, J AGR FOOD CHEM, V55, P4014, DOI 10.1021/jf070211o; Guo QQ, 2013, CROPS, V5, P80; Hajika M., 2009, Bulletin of the National Institute of Crop Science, P1; Hajika M, 1998, BREEDING SCI, V48, P383; Hajika M, 1996, BREEDING SCI, V46, P385; HARADA K, 1983, JPN J BREED, V33, P23; Harada K., 2013, AGR RES, V5, P101; Hidvegi M., 1984, P INT ASS CER CHEM S, P205; Holzhauser T, 2009, J ALLERGY CLIN IMMUN, V123, P452, DOI 10.1016/j.jaci.2008.09.034; Jones SI, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-136; Kita Y, 2010, PLANT CELL REP, V29, P87, DOI 10.1007/s00299-009-0800-5; KITAMURA K, 1981, JPN J BREED, V31, P353; KITAMURA K, 1984, THEOR APPL GENET, V68, P253, DOI 10.1007/BF00266899; KOSHIYAMA I, 1968, CEREAL CHEM, V45, P394; Krishnan HB, 2009, J AGR FOOD CHEM, V57, P938, DOI 10.1021/jf802451g; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Leitner A, 1998, ALLERGY, V53, P36, DOI 10.1111/j.1398-9995.1998.tb03771.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MEINKE DW, 1981, PLANTA, V153, P130, DOI 10.1007/BF00384094; Mitchell HH, 1964, WASTAGE NUTR METABOL, P567; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; MUEHLBAUER GJ, 1988, CROP SCI, V28, P729, DOI 10.2135/cropsci1988.0011183X002800050002x; Narikawa T, 2010, BIOSCI BIOTECH BIOCH, V74, P1976, DOI 10.1271/bbb.100479; NIELSEN NC, 1989, PLANT CELL, V1, P313, DOI 10.1105/tpc.1.3.313; Niselsen NC, 1997, CELLULAR MOL BIOL PL, P151; ODANAKA H, 1989, JPN J BREED S1, V39, P430; OGAWA T, 1989, JPN J BREED, V39, P137; OGAWA T, 1995, BIOSCI BIOTECH BIOCH, V59, P831, DOI 10.1271/bbb.59.831; Ogawa T, 2000, J NUTR SCI VITAMINOL, V46, P271, DOI 10.3177/jnsv.46.271; Oser B.L., 1959, PROTEIN AMINO ACID N, P281, DOI DOI 10.1016/B978-0-12-395683-5.50014-6; Rabjohn P, 1999, J CLIN INVEST, V103, P535, DOI 10.1172/JCI5349; SCALLON B, 1985, THEOR APPL GENET, V70, P510, DOI 10.1007/BF00305984; Song B, 2014, PLANT BREEDING, V133, P638, DOI 10.1111/pbr.12203; TAKAHASHI K, 1994, BREEDING SCI, V44, P65; Takahashi K., 2004, Bulletin of the National Agricultural Research Center for Tohoku Region, P23; Takahashi K, 1996, BREEDING SCI, V46, P251; Takahashi M, 2003, PLANTA, V217, P577, DOI 10.1007/s00425-003-1026-3; THANH VH, 1978, J AGR FOOD CHEM, V26, P692, DOI 10.1021/jf60217a026; TSUKADA Y, 1986, JPN J BREED, V36, P390; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14	51	11	11	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2016	11	8							e0159723	10.1371/journal.pone.0159723	http://dx.doi.org/10.1371/journal.pone.0159723			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4YN	27532666	Green Published, Green Submitted, gold			2022-12-27	WOS:000381487600010
J	Svalbring, E; Fredriksson, A; Eriksson, J; Dyverfeldt, P; Ebbers, T; Bolger, AF; Engvall, J; Carlhall, CJ				Svalbring, Emil; Fredriksson, Alexandru; Eriksson, Jonatan; Dyverfeldt, Petter; Ebbers, Tino; Bolger, Ann F.; Engvall, Jan; Carlhall, Carl-Johan			Altered Diastolic Flow Patterns and Kinetic Energy in Subtle Left Ventricular Remodeling and Dysfunction Detected by 4D Flow MRI	PLOS ONE			English	Article							CARDIOVASCULAR MAGNETIC-RESONANCE; MAIN PULMONARY-ARTERY; BLOOD-FLOW; QUANTIFICATION; PRESSURE; DISEASE; HEART	Aims 4D flow magnetic resonance imaging (MRI) allows quantitative assessment of left ventricular (LV) function according to characteristics of the dynamic flow in the chamber. Marked abnormalities in flow components' volume and kinetic energy (KE) have previously been demonstrated in moderately dilated and depressed LV's compared to healthy subjects. We hypothesized that these 4D flow-based measures would detect even subtle LV dysfunction and remodeling. Methods and Results We acquired 4D flow and morphological MRI data from 26 patients with chronic ischemic heart disease with New York Heart Association (NYHA) class I and II and with no to mild LV systolic dysfunction and remodeling, and from 10 healthy controls. A previously validated method was used to separate the LV end-diastolic volume (LVEDV) into functional components: direct flow, which passes directly to ejection, and non-ejecting flow, which remains in the LV for at least 1 cycle. The direct flow and non-ejecting flow proportions of end-diastolic volume and KE were assessed. The proportions of direct flow volume and KE fell with increasing LVEDV-index (LVEDVI) and LVESV-index (LVESVI) (direct flow volume r = -0.64 and r = -0.74, both P<0.001; direct flow KE r = -0.48, P = 0.013, and r = -0.56, P = 0.003). The proportions of non-ejecting flow volume and KE rose with increasing LVEDVI and LVESVI (non-ejecting flow volume: r = 0.67 and r = 0.76, both P<0.001; non-ejecting flow KE: r = 0.53, P = 0.005 and r = 0.52, P = 0.006). The proportion of direct flow volume correlated moderately to LVEF (r = 0.68, P < 0.001) and was higher in a sub-group of patients with LVEDVI > 74 ml/m(2) compared to patients with LVEDVI < 74 ml/m(2) and controls (both P<0.05). Conclusion Direct flow volume and KE proportions diminish with increased LV volumes, while non-ejecting flow proportions increase. A decrease in direct flow volume and KE at end-diastole proposes that alterations in these novel 4D flow-specific markers may detect LV dysfunction even in subtle or subclinical LV remodeling.	[Svalbring, Emil; Fredriksson, Alexandru; Eriksson, Jonatan; Dyverfeldt, Petter; Ebbers, Tino; Bolger, Ann F.; Engvall, Jan; Carlhall, Carl-Johan] Linkoping Univ, Div Cardiovasc Med, Dept Med & Hlth Sci, Linkoping, Sweden; [Eriksson, Jonatan; Dyverfeldt, Petter; Ebbers, Tino; Engvall, Jan; Carlhall, Carl-Johan] Linkoping Univ, Ctr Med Image Sci & Visualizat CMIV, Linkoping, Sweden; [Bolger, Ann F.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Engvall, Jan; Carlhall, Carl-Johan] Linkoping Univ, Dept Med & Hlth Sci, Dept Clin Physiol, Linkoping, Sweden	Linkoping University; Linkoping University; University of California System; University of California San Francisco; Linkoping University	Carlhall, CJ (corresponding author), Linkoping Univ, Div Cardiovasc Med, Dept Med & Hlth Sci, Linkoping, Sweden.; Carlhall, CJ (corresponding author), Linkoping Univ, Ctr Med Image Sci & Visualizat CMIV, Linkoping, Sweden.; Carlhall, CJ (corresponding author), Linkoping Univ, Dept Med & Hlth Sci, Dept Clin Physiol, Linkoping, Sweden.	carljohan.carlhall@liu.se	Engvall, Jan Edvin/I-5019-2019; Dyverfeldt, Petter/AAO-4923-2021; Ebbers, Tino/ABB-8488-2021	Engvall, Jan Edvin/0000-0002-5716-5098; Dyverfeldt, Petter/0000-0002-3051-661X; Ebbers, Tino/0000-0003-1395-8296; Carlhall, Carl-Johan/0000-0003-2198-9690	Swedish Heart Lung foundation [20140398]; Swedish Research Council [2014-6191]; European Union FP7 [223615]; Medical Research Council of Southeast Sweden [FORSS-35141, FORSS-88731, FORSS-157921]; County Council of Ostergotland/Heart and Medicine Center [20090120]	Swedish Heart Lung foundation(Swedish Heart-Lung Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); European Union FP7(European Commission); Medical Research Council of Southeast Sweden(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); County Council of Ostergotland/Heart and Medicine Center	This work was funded by Swedish Heart Lung foundation (grant number: 20140398) [https://www.hjart-lungfonden.se/HLF/Om-Hjart-lungfonden/About-HLF/], Receiver: CJC; Swedish Research Council (grant number: 2014-6191) [http://www.vr.se], Receiver: TE; European Union FP7 (grant number: 223615) [https://ec.europa.eu/research/fp7/index_en.cfm], Receiver: TE; Medical Research Council of Southeast Sweden (grant number: FORSS-35141, FORSS-88731, FORSS-157921) [http://www.fou.nu/is/forss/], Receiver: JE; County Council of Ostergotland/Heart and Medicine Center (grant number: 20090120) [http://www.regionostergotland.se/hmc/], Receiver: JE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arvidsson PM, 2013, J APPL PHYSIOL, V114, P1472, DOI 10.1152/japplphysiol.00932.2012; Bolger AF, 2007, J CARDIOVASC MAGN R, V9, P741, DOI 10.1080/10976640701544530; Carlhall CJ, 2010, CIRC-HEART FAIL, V3, P326, DOI 10.1161/CIRCHEARTFAILURE.109.911867; Carlsson M, 2012, AM J PHYSIOL-HEART C, V302, pH893, DOI 10.1152/ajpheart.00942.2011; Dyverfeldt P, 2015, J CARDIOVASC MAGN R, V17, DOI 10.1186/s12968-015-0174-5; Elbaz MSM, 2014, J CARDIOVASC MAGN R, V16, DOI 10.1186/s12968-014-0078-9; Eriksson J, 2013, EUR HEART J-CARD IMG, V14, P417, DOI 10.1093/ehjci/jes159; Eriksson J, 2010, J CARDIOVASC MAGN R, V12, DOI 10.1186/1532-429X-12-9; Foll D, 2013, EUR HEART J-CARD IMG, V14, P366, DOI 10.1093/ehjci/jes196; FRANCIS GS, 2001, AM J MED, V110, P37; Francois CJ, 2012, J CARDIOVASC MAGN R, V14, DOI 10.1186/1532-429X-14-16; Fredriksson AG, 2016, J MAGN RESON IMAGING, V43, P558, DOI 10.1002/jmri.25015; Fyrenius A, 2001, HEART, V86, P448, DOI 10.1136/heart.86.4.448; Geiger J, 2011, EUR RADIOL, V21, P1651, DOI 10.1007/s00330-011-2108-4; Han QJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138365; Harloff A, 2009, MAGN RESON MED, V61, P65, DOI 10.1002/mrm.21774; Heiberg Einar, 2010, BMC Med Imaging, V10, P1, DOI 10.1186/1471-2342-10-1; Hope MD, 2011, JACC-CARDIOVASC IMAG, V4, P781, DOI 10.1016/j.jcmg.2011.05.004; Maceira AM, 2006, J CARDIOVASC MAGN R, V8, P417, DOI 10.1080/10976640600572889; Rademakers F, 2013, SCAND CARDIOVASC J, V47, P329, DOI 10.3109/14017431.2013.857039; Reiter G, 2008, CIRC-CARDIOVASC IMAG, V1, P23, DOI 10.1161/CIRCIMAGING.108.780247; Stoll V, 2015, J CARDIOVASC MAGN S1, V17, pP7; Yiallourou TI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052284	23	46	46	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2016	11	8							e0161391	10.1371/journal.pone.0161391	http://dx.doi.org/10.1371/journal.pone.0161391			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4YN	27532640	gold, Green Published, Green Submitted			2022-12-27	WOS:000381487600091
J	Vedelek, V; Laurinyecz, B; Kovacs, AL; Juhasz, G; Sinka, R				Vedelek, Viktor; Laurinyecz, Barbara; Kovacs, Attila L.; Juhasz, Gabor; Sinka, Rita			Testis-Specific Bb8 Is Essential in the Development of Spermatid Mitochondria	PLOS ONE			English	Article							DROSOPHILA-MELANOGASTER; GLUTAMATE-DEHYDROGENASE; POSTMEIOTIC TRANSCRIPTION; MALE-FERTILITY; GENE; INDIVIDUALIZATION; PROTEIN; ELONGATION; CONFLICT; DYNAMICS	Mitochondria are essential organelles of developing spermatids in Drosophila, which undergo dramatic changes in size and shape after meiotic division, where mitochondria localized in the cytoplasm, migrate near the nucleus, aggregate, fuse and create the Nebenkern. During spermatid elongation the two similar mitochondrial derivatives of the Nebenkern start to elongate parallel to the axoneme. One of the elongated mitochondrial derivatives starts to lose volume and becomes the minor mitochondrial derivative, while the other one accumulates paracrystalline and becomes the major mitochondrial derivative. Proteins and intracellular environment that are responsible for cyst elongation and paracrystalline formation in the major mitochondrial derivative need to be identified. In this work we investigate the function of the testis specific big bubble 8 (bb8) gene during spermatogenesis. We show that a Minos element insertion in bb8 gene, a predicted glutamate dehydrogenase, causes recessive male sterility. We demonstrate bb8 mRNA enrichment in spermatids and the mitochondrial localisation of Bb8 protein during spermatogenesis. We report that megamitochondria develop in the homozygous mutant testes, in elongating spermatids. Ultrastructural analysis of the cross section of elongated spermatids shows enlarged mitochondria and the production of paracrystalline in both major and minor mitochondrial derivatives. Our results suggest that the Bb8 protein and presumably glutamate metabolism has a crucial role in the normal development and establishment of the identity of the mitochondrial derivatives during spermatid elongation.	[Vedelek, Viktor; Laurinyecz, Barbara; Sinka, Rita] Univ Szeged, Dept Genet, Szeged, Hungary; [Kovacs, Attila L.; Juhasz, Gabor] Eotvos Lorand Univ, Dept Anat Cell & Dev Biol, Budapest, Hungary	Szeged University; Eotvos Lorand University	Sinka, R (corresponding author), Univ Szeged, Dept Genet, Szeged, Hungary.	rsinka@bio.u-szeged.hu	Sinka, Rita/ABA-8767-2021; Laurinyecz, Barbara/L-8322-2018; Juhasz, Gabor/G-5622-2013	Laurinyecz, Barbara/0000-0003-0620-2239; Juhasz, Gabor/0000-0001-8548-8874; Sinka, Rita/0000-0003-4040-4184	European Molecular Biology Organization (EMBO) [1825]; Hungarian Scientific Research funds [OTKA: NF101001]; Hungarian Academy of Science's Bolyai Scholarship	European Molecular Biology Organization (EMBO)(European Molecular Biology Organization (EMBO)); Hungarian Scientific Research funds(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Hungarian Academy of Science's Bolyai Scholarship	This work was supported by grants from the European Molecular Biology Organization (EMBO)(Installation Grant (No1825)(http://www.embo.org) to RS and the Hungarian Scientific Research funds (OTKA: NF101001)(http://nkfih.gov.hu/) to RS. RS also thanks the Hungarian Academy of Science's Bolyai Scholarship for funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Ferenc Jankovics, and Tibor Kalmar for discussion and critical reading of the manuscript. We are indebted to Attila Gacser for helping to carry out Q-RT-PCR experiments. This work was supported by grants from EMBO (Installation Grant (No1825)), the Hungarian Scientific Research funds (OTKA: NF101001). RS also thanks the Hungarian Academy of Science's Bolyai Scholarship for funding.	Aldridge AC, 2007, FLY, V1, P38, DOI 10.4161/fly.3913; Aram L, 2016, DEV CELL, V37, P15, DOI 10.1016/j.devcel.2016.02.025; Arama E, 2006, EMBO J, V25, P232, DOI 10.1038/sj.emboj.7600920; Barreau C, 2008, DEVELOPMENT, V135, P1897, DOI 10.1242/dev.021949; Bre MH, 1996, J CELL SCI, V109, P727; Brosnan JT, 2013, AMINO ACIDS, V45, P413, DOI 10.1007/s00726-012-1280-4; Chintapalli VR, 2007, NAT GENET, V39, P715, DOI 10.1038/ng2049; Chintapalli VR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078066; Dorogova NV, 2013, PROTOPLASMA, V250, P515, DOI 10.1007/s00709-012-0434-2; Fabrizio JJ, 1998, DEVELOPMENT, V125, P1833; Gallach M, 2011, TRENDS ECOL EVOL, V26, P222, DOI 10.1016/j.tree.2011.02.004; Gallach M, 2010, GENOME BIOL EVOL, V2, P835, DOI 10.1093/gbe/evq069; Hales KG, 1997, CELL, V90, P121, DOI 10.1016/S0092-8674(00)80319-0; Kriventseva EV, 2015, NUCLEIC ACIDS RES, V43, pD250, DOI 10.1093/nar/gku1220; Larkin EK, 2007, BMC P, V6, P1; Laurinyecz B, 2016, OPEN BIOL, V6, DOI 10.1098/rsob.150169; LEVINE RL, 1983, J BIOL CHEM, V258, P1823; Mastorodemos V, 2005, J NEUROSCI RES, V79, P65, DOI 10.1002/jnr.20353; Mastorodemos V, 2009, BIOCHEM CELL BIOL, V87, P505, DOI [10.1139/O09-008, 10.1139/o09-008]; Metaxakis A, 2005, GENETICS, V171, P571, DOI 10.1534/genetics.105.041848; Metzendorf C, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-68; Morris CA, 2009, NAT PROTOC, V4, P1807, DOI 10.1038/nprot.2009.192; NEWSHOLME EA, 1985, BIOSCIENCE REP, V5, P393, DOI 10.1007/BF01116556; Noguchi T, 2008, MOL BIOL CELL, V19, P2363, DOI 10.1091/mbc.E07-08-0840; Noguchi T, 2011, CURR BIOL, V21, P805, DOI 10.1016/j.cub.2011.04.016; OLSON GE, 1990, J STRUCT BIOL, V103, P13, DOI 10.1016/1047-8477(90)90081-M; Rathke C, 2010, EUR J CELL BIOL, V89, P326, DOI 10.1016/j.ejcb.2009.09.001; REERS M, 1991, BIOCHEMISTRY-US, V30, P4480, DOI 10.1021/bi00232a015; Riparbelli MG, 2007, DEV BIOL, V303, P108, DOI 10.1016/j.ydbio.2006.10.038; Santel A, 1997, MECH DEVELOP, V64, P19, DOI 10.1016/S0925-4773(97)00031-2; Santel A, 1998, J CELL SCI, V111, P3299; Shim MS, 2011, BIOCHEM J, V439, P277, DOI 10.1042/BJ20110582; Shim MS, 2009, J BIOL CHEM, V284, P32881, DOI 10.1074/jbc.M109.026492; Spanaki C, 2014, NEUROCHEM RES, V39, P500, DOI 10.1007/s11064-013-1235-5; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Timakov B, 2001, CELL STRESS CHAPERON, V6, P71, DOI 10.1379/1466-1268(2001)006<0071:THGODM>2.0.CO;2; Tiwari AK, 2014, ACTA HISTOCHEM, V116, P297, DOI 10.1016/j.acthis.2013.08.007; TOKUYASU KT, 1972, Z ZELLFORSCH MIK ANA, V124, P479, DOI 10.1007/BF00335253; Vibranovski MD, 2010, GENETICS, V186, P431, DOI 10.1534/genetics.110.118919; Vibranovski MD, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000731; Wakimoto BT, 2004, GENETICS, V167, P207, DOI 10.1534/genetics.167.1.207; White-Cooper H, 2004, METH MOL B, V247, P45; White-Cooper H, 2010, PHILOS T R SOC B, V365, P1465, DOI 10.1098/rstb.2009.0323; Wilson KL, 2006, DEVELOPMENT, V133, P4871, DOI 10.1242/dev.02671	44	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2016	11	8							e0161289	10.1371/journal.pone.0161289	http://dx.doi.org/10.1371/journal.pone.0161289			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4UN	27529784	Green Accepted, Green Published, gold			2022-12-27	WOS:000381476700063
J	Garthe, S; Schwemmer, P; Paiva, VH; Corman, AM; Fock, HO; Voigt, CC; Adler, S				Garthe, Stefan; Schwemmer, Philipp; Paiva, Vitor H.; Corman, Anna-Marie; Fock, Heino O.; Voigt, Christian C.; Adler, Sven			Terrestrial and Marine Foraging Strategies of an Opportunistic Seabird Species Breeding in the Wadden Sea	PLOS ONE			English	Article							AREA-RESTRICTED SEARCH; LARUS-FUSCUS; 1ST-PASSAGE TIME; FEEDING ECOLOGY; STABLE-ISOTOPES; FISHERIES; GULLS; DISCARDS; TRACKING; BLOOD	Lesser black-backed gulls Larus fuscus are considered to be mainly pelagic. We assessed the importance of different landscape elements (open sea, tidal flats and inland) by comparing marine and terrestrial foraging behaviours in lesser black-backed gulls breeding along the coast of the southern North Sea. We attached GPS data loggers to eight incubating birds and collected information on diet and habitat use. The loggers recorded data for 10-19 days to allow flight-path reconstruction. Lesser black-backed gulls foraged in both offshore and inland areas, but rarely on tidal flats. Targets and directions were similar among all eight individuals. Foraging trips (n = 108) lasted 0.5-26.4 h (mean 8.7 h), and ranges varied from 3.0-79.9 km (mean 30.9 km). The total distance travelled per foraging trip ranged from 7.5-333.6 km (mean 97.9 km). Trips out to sea were significantly more variable in all parameters than inland trips. Presence in inland areas was closely associated with daylight, whereas trips to sea occurred at day and night, but mostly at night. The most common items in pellets were grass (48%), insects (38%), fish (28%), litter (26%) and earthworms (20%). There was a significant relationship between the carbon and nitrogen isotope signals in blood and the proportional time each individual spent foraging at sea/land. On land, gulls preferentially foraged on bare ground, with significantly higher use of potato fields and significantly less use of grassland. The flight patterns of lesser black-backed gulls at sea overlapped with fishing-vessel distribution, including small beam trawlers fishing for shrimps in coastal waters close to the colony and large beam-trawlers fishing for flatfish at greater distances. Our data show that individuals made intensive use of the anthropogenic landscape and seascape, indicating that lesser black-backed gulls are not a predominantly marine species during the incubation period.	[Garthe, Stefan; Schwemmer, Philipp; Corman, Anna-Marie; Adler, Sven] Univ Kiel, Res & Technol Ctr FTZ, Hafentorn 1, D-25761 Busum, Germany; [Paiva, Vitor H.] Univ Coimbra, Inst Marine Res IMAR, P-3004517 Coimbra, Portugal; [Paiva, Vitor H.] Univ Coimbra, Marine & Environm Sci Ctr MARE, Dept Life Sci, P-3004517 Coimbra, Portugal; [Fock, Heino O.] Thunen Inst Sea Fisheries, Palmaille 9, D-22767 Hamburg, Germany; [Voigt, Christian C.] Leibniz Inst Zoo & Wildlife Res, Dept Evolutionary Ecol, Alfred Kowalke Str 17, D-10315 Berlin, Germany; [Adler, Sven] Swedish Univ Agr Sci, Umea, Sweden	University of Kiel; Universidade de Coimbra; Universidade de Coimbra; Johann Heinrich von Thunen Institute; Leibniz Institut fur Zoo und Wildtierforschung; Swedish University of Agricultural Sciences	Garthe, S (corresponding author), Univ Kiel, Res & Technol Ctr FTZ, Hafentorn 1, D-25761 Busum, Germany.	garthe@ftz-west.uni-kiel.de	Paiva, Vitor H./J-1092-2019; Adler, Sven/GLU-0860-2022; Paiva, Vitor Hugo/GRX-9179-2022	Paiva, Vitor H./0000-0001-6368-9579; Garthe, Stefan/0000-0003-0548-9346	Niedersachsische Wattenmeerstiftung (NWS) [04/09]	Niedersachsische Wattenmeerstiftung (NWS)	Grants were provided by the Niedersachsische Wattenmeerstiftung (NWS 04/09) to SG. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida PJAL, 2010, ZOOLOGIA-CURITIBA, V27, P674, DOI 10.1590/S1984-46702010000500002; Barnett PR, 2004, AGR ECOSYST ENVIRON, V102, P49, DOI 10.1016/S0167-8809(03)00278-0; Barrett RT, 2007, ICES J MAR SCI, V64, P1675, DOI 10.1093/icesjms/fsm152; Bates D., 2011, PACKAGE LME4 LINEAR, V1; Batschelet E, 1981, CIRCULAR STAT BIOL; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Butler SJ, 2004, IBIS, V146, P123, DOI 10.1111/j.1474-919X.2004.00352.x; Camphuysen CJ, 1995, ARDEA, V83, P365; Camphuysen CJ, 1993, SULA, V7, P81; Camphuysen KCJ, 2015, MAR BIOL, V162, P1417, DOI 10.1007/s00227-015-2678-9; Ceia FR, 2014, MAR ECOL PROG SER, V497, P273, DOI 10.3354/meps10586; Ceia FR, 2012, MAR BIOL, V159, P1581, DOI 10.1007/s00227-012-1946-1; Cherel Y, 2014, MAR ECOL PROG SER, V505, P267, DOI 10.3354/meps10795; Corman AM, 2016, ECOL EVOL, V6, P974, DOI 10.1002/ece3.1884; Coulson JC, 2008, BIRD STUDY, V55, P297, DOI 10.1080/00063650809461535; Cuendet G., 1983, P415; Faraway J, 2006, EXTENDING LINEAR MOD; Fauchald P, 1999, AM NAT, V153, P603, DOI 10.1086/303203; Fauchald P, 2003, ECOLOGY, V84, P282, DOI 10.1890/0012-9658(2003)084[0282:UFPTIT]2.0.CO;2; Fauchald P, 2011, ECOLOGY, V92, P228, DOI 10.1890/10-0818.1; Fock HO, 2008, MAR POLICY, V32, P728, DOI 10.1016/j.marpol.2007.12.010; Garthe S, 2004, J APPL ECOL, V41, P724, DOI 10.1111/j.0021-8901.2004.00918.x; Garthe S, 1997, ARCH FISH MAR RES, V45, P223; Garthe S, 1996, COLON WATERBIRD, V19, P232, DOI 10.2307/1521861; Glutz von Blotzheim U.N., 1982, HDB VOGEL MITTELEURO, V8; HOBSON KA, 1993, AUK, V110, P638, DOI 10.2307/4088430; Inger R, 2008, IBIS, V150, P447, DOI 10.1111/j.1474-919X.2008.00839.x; KAREIVA P, 1987, AM NAT, V130, P233, DOI 10.1086/284707; Kubetzki U, 2003, MAR BIOL, V143, P199, DOI 10.1007/s00227-003-1036-5; Kuznetsova A., 2013, CHRISTENSEN RHB LMER; Lavoie RA, 2012, WATERBIRDS, V35, P402, DOI 10.1675/063.035.0305; Miramontes O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034317; Pinaud D, 2008, J APPL ECOL, V45, P91, DOI 10.1111/j.1365-2664.2007.01370.x; Post DM, 2007, OECOLOGIA, V152, P179, DOI 10.1007/s00442-006-0630-x; Quillfeldt P, 2008, MAR BIOL, V155, P593, DOI 10.1007/s00227-008-1048-2; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Schneider DC, 2002, ECOSYSTEMS, V5, P736, DOI 10.1007/s10021-002-0156-y; Schwemmer H, 2013, ESTUAR COAST SHELF S, V119, P71, DOI 10.1016/j.ecss.2012.12.021; Schwemmer P, 2005, MAR ECOL PROG SER, V285, P245, DOI 10.3354/meps285245; Schwemmer P, 2008, ESTUAR COAST SHELF S, V77, P12, DOI 10.1016/j.ecss.2007.08.017; Schwemmer P, 2008, LANDSCAPE ECOL, V23, P355, DOI 10.1007/s10980-008-9194-y; Sommerfeld J, 2016, MAR BIOL, V163, DOI 10.1007/s00227-016-2889-8; Sumner M, 2013, TRIP SPATIAL ANAL AN; Tiedemann R, 1997, J ORNITHOL, V138, P183, DOI 10.1007/BF01651622; Tyson C, 2015, ICES J MAR SCI, V72, P1882, DOI 10.1093/icesjms/fsv021; Ulleweit J, 2010, J APPL ICHTHYOL, V26, P54, DOI 10.1111/j.1439-0426.2010.01449.x; Vickery JA, 2001, J APPL ECOL, V38, P647, DOI 10.1046/j.1365-2664.2001.00626.x; Votier SC, 2010, J APPL ECOL, V47, P487, DOI 10.1111/j.1365-2664.2010.01790.x; Walter U, 1997, ARCH FISH MAR RES, V45, P61; Weimerskirch H, 2007, AM NAT, V170, P734, DOI 10.1086/522059; Wilson RP, 2012, MAR ECOL PROG SER, V451, P245, DOI 10.3354/meps09608; Zydelis R, 2013, BIOL CONSERV, V162, P76, DOI 10.1016/j.biocon.2013.04.002	52	30	32	1	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2016	11	8							e0159630	10.1371/journal.pone.0159630	http://dx.doi.org/10.1371/journal.pone.0159630			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4SL	27525661	gold, Green Submitted, Green Published			2022-12-27	WOS:000381471100008
J	Kim, M; Park, KY; Lee, MK; Jin, T; Seo, SJ				Kim, MinJeong; Park, Kui Young; Lee, Mi-Kyung; Jin, Taewon; Seo, Seong Jun			Adiponectin Suppresses UVB-Induced Premature Senescence and hBD2 Overexpression in Human Keratinocytes	PLOS ONE			English	Article							BETA-DEFENSIN 2; ANTIMICROBIAL PEPTIDES; HUMAN SKIN; IN-VIVO; CELLS; EXPRESSION; ACTIVATION; GROWTH; LIPOPOLYSACCHARIDE; BETA-DEFENSIN-2	Recent studies have revealed that adiponectin can suppress cellular inflammatory signaling pathways. This study aimed to elucidate the effect of adiponectin on the unregulated production of hBD2 in UVB-induced premature senescent keratinocytes. We constructed an in vitro model of premature senescent keratinocytes through repeated exposure to low energy UVB. After repeated low energy UVB exposure, there was significant generation of reactive oxygen species (ROS) and induction of senescence-associated markers, including senescence associated beta-galactosidase activity and expression of p16(INK4a) and histone H2AX. In addition, the present clinical study showed higher expression of hBD2 in sun-exposed skin of elderly group, and the overexpression of hBD2 was observed by c-Fos activation in vitro. Adiponectin has the ability to scavenge ROS and consequently inhibit MAPKs and SA-markers in UVB-exposed keratinocytes. An inhibitor study demonstrated that adiponectin downregulated hBD2 mRNA expression through suppression of the AP-1 transcription factor components c-Fos via inactivation of p38 MAPK. Collectively, the dysregulated production of hBD2 by the induction of oxidative stress was attenuated by adiponectin through the suppression of p38 and JNK/SAPK MAPK signaling in UVB-mediated premature senescent inducible conditions. These results suggest the feasibility of adiponectin as an anti-photoaging and anti-inflammatory agent in the skin.	[Kim, MinJeong; Park, Kui Young; Jin, Taewon; Seo, Seong Jun] Chung Ang Univ, Coll Med, Chung Ang Univ Hosp, Dept Dermatol, Seoul, South Korea; [Lee, Mi-Kyung] Chung Ang Univ, Coll Med, Chung Ang Univ Hosp, Dept Lab Med, Seoul, South Korea	Chung Ang University; Chung Ang University Hospital; Chung Ang University; Chung Ang University Hospital	Seo, SJ (corresponding author), Chung Ang Univ, Coll Med, Chung Ang Univ Hosp, Dept Dermatol, Seoul, South Korea.	drseo@hanafos.com		Kim, MinJeong/0000-0002-0524-9281	Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea [HI14C1379]	Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea	This study was supported by a grant of the Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea. (Grant No. HI14C1379), https://www.htdream.kr/.; This study was supported by a grant of the Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea. (Grant No. HI14C1379)	Ali RS, 2001, J INVEST DERMATOL, V117, P106; Arita Y, 1999, BIOCHEM BIOPH RES CO, V257, P79, DOI 10.1006/bbrc.1999.0255; Bakkenist CJ, 2004, CANCER RES, V64, P3748, DOI 10.1158/0008-5472.CAN-04-0453; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Barnes L, 2010, PHOTOCHEM PHOTOBIOL, V86, P933, DOI 10.1111/j.1751-1097.2010.00744.x; Bertrand-Vallery V, 2010, BIOGERONTOLOGY, V11, P167, DOI 10.1007/s10522-009-9238-y; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Campisi J, 2005, CELL, V120, P513, DOI 10.1016/j.cell.2005.02.003; Castaneda-Delgado JE, 2013, CLIN IMMUNOL, V148, P198, DOI 10.1016/j.clim.2013.05.015; CERIMELE D, 1990, BRIT J DERMATOL, V122, P13, DOI 10.1111/j.1365-2133.1990.tb16120.x; Chen WX, 1999, ONCOGENE, V18, P7469, DOI 10.1038/sj.onc.1203210; Chertov O, 1996, J BIOL CHEM, V271, P2935, DOI 10.1074/jbc.271.6.2935; Debacq-Chainiaux F, 2009, NAT PROTOC, V4, P1798, DOI 10.1038/nprot.2009.191; Fahlgren A, 2003, CLIN EXP IMMUNOL, V131, P90, DOI 10.1046/j.1365-2249.2003.02035.x; Gambichler T, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-163; Gandarillas A, 2000, EXP GERONTOL, V35, P53, DOI 10.1016/S0531-5565(99)00088-1; Garcia JRC, 2001, CELL TISSUE RES, V306, P257, DOI 10.1007/s004410100433; Glasser R, 2009, J ALLERGY CLIN IMMUN, V123, P1117, DOI 10.1016/j.jaci.2009.01.043; HANSEN MB, 1989, J IMMUNOL METHODS, V119, P203, DOI 10.1016/0022-1759(89)90397-9; Hess J, 2004, J CELL SCI, V117, P5965, DOI 10.1242/jcs.01589; Hibbert SA, POTENTIAL ROLE ENDOG, P2213; Kadowaki T, 2005, ENDOCR REV, V26, P439, DOI 10.1210/er.2005-0005; Kang S, 2003, J INVEST DERMATOL, V120, P835, DOI 10.1046/j.1523-1747.2003.12122.x; Kim EJ, 2015, J INVEST DERMATOL, V135, P2331, DOI 10.1038/jid.2015.150; Krtolica A, 2002, INT J BIOCHEM CELL B, V34, P1401, DOI 10.1016/S1357-2725(02)00053-5; Lai YP, 2009, TRENDS IMMUNOL, V30, P131, DOI 10.1016/j.it.2008.12.003; Lewis DA, 2008, MOL BIOL CELL, V19, P1346, DOI 10.1091/mbc.E07-10-1041; Li RC, 2014, CLIN EXP DERMATOL, V39, P19, DOI 10.1111/ced.12250; Masaki H, 2009, J INVEST DERM SYMP P, V14, P50, DOI 10.1038/jidsymp.2009.12; Mineshiba J, 2005, FEMS IMMUNOL MED MIC, V45, P37, DOI 10.1016/j.femsim.2005.01.008; Niyonsaba F, 2007, J INVEST DERMATOL, V127, P594, DOI 10.1038/sj.jid.5700599; Rajapakse N, 2008, IMMUNOLOGY, V123, P348, DOI 10.1111/j.1365-2567.2007.02683.x; Ressler S, 2006, AGING CELL, V5, P379, DOI 10.1111/j.1474-9726.2006.00231.x; Rohrl J, 2010, J IMMUNOL, V184, P6688, DOI 10.4049/jimmunol.0903984; Seo SJ, 2001, J DERMATOL SCI, V27, P183, DOI 10.1016/S0923-1811(01)00135-9; Shay JW, 2005, CARCINOGENESIS, V26, P867, DOI 10.1093/carcin/bgh296; Shi N, 2014, ONCOTARGET, V5, P11333, DOI 10.18632/oncotarget.2416; Shibata S, 2012, J IMMUNOL, V189, P3231, DOI 10.4049/jimmunol.1101739; Soroka Y, 2008, EXP GERONTOL, V43, P947, DOI 10.1016/j.exger.2008.08.003; Syed DN, 2012, PHOTOCHEM PHOTOBIOL, V88, P1184, DOI 10.1111/j.1751-1097.2012.01115.x; Takahashi A, 2005, CANCER LETT, V229, P171, DOI 10.1016/j.canlet.2005.07.016; Tomizawa A, 2008, DIABETES VASC DIS RE, V5, P123, DOI 10.3132/dvdr.2008.020; Villarreal-Molina MT, 2012, BIOCHIMIE, V94, P2143, DOI 10.1016/j.biochi.2012.06.030; Whitehead JP, 2006, DIABETES OBES METAB, V8, P264, DOI 10.1111/j.1463-1326.2005.00510.x; Wittersheim M, 2013, EXP DERMATOL, V22, P364, DOI 10.1111/exd.12133; Yamaguchi N, 2005, FEBS LETT, V579, P6821, DOI 10.1016/j.febslet.2005.11.019; Yang D, 1999, SCIENCE, V286, P525, DOI 10.1126/science.286.5439.525	47	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2016	11	8							e0161247	10.1371/journal.pone.0161247	http://dx.doi.org/10.1371/journal.pone.0161247			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4SL	27526049	Green Published, gold			2022-12-27	WOS:000381471100047
J	Qiu, PY; Caine, ED; Hou, FS; Cerulli, C; Wittink, MN; Li, J				Qiu, Peiyuan; Caine, Eric D.; Hou, Fengsu; Cerulli, Catherine; Wittink, Marsha N.; Li, Jin			The Prevalence of Distress and Depression among Women in Rural Sichuan Province	PLOS ONE			English	Article							SUICIDE; VALIDITY; STIGMA; SCALE; RELIABILITY; CHINESE	Background In this paper, we report findings regarding the prevalence of expressed distress and depressive conditions among women living in a rural region of Sichuan Province. As well, we know of no data among women in rural China that examine whether "depression," as categorically defined in classifications such as the DSM, adequately captures the expressed distress and symptomatic complaints of women in rural China. Methods A multistage sampling method was employed to recruit the target population. The Center for Epidemiologic Studies Depression Scale (CES-D) was used to measure distress symptoms, and MINI International Neuropsychiatric Interview (MINI) was employed to determine the prevalence of diagnosable depression and other disorders. Results Among 1898 rural women, 12.4%(236) scored >= 16 on the CES-D, indicative of distress, and a subset of 7.7% (146) had scores >= 21, highly suggestive of a clinically significant disorder. We found that 49.8% women with >= 16 CES-D score were identified as showing features consistent with a current major depressive episode (MDE) vs. 1.9% in a sample of randomly selected women with <16 CES-D score. Among respondents, 30 of 84 (35.7%) scoring 16-20 and 83 of 143 (58.0%) scoring >= 21 reported symptoms consistent with MDE. 25.1% of women with a positive CES-D score did not describe symptoms consistent with any DSM-IV disorder. Conclusions We found a higher portion of women reporting significant distress than previously described. Among them, there was a clear gradient, such that 41.7% of women with moderate distress did not have a psychiatric diagnosis, and even among those with more severe symptoms, 15.4% did not manifest a DSM-specific psychiatric condition.	[Qiu, Peiyuan] Sichuan Univ, West China Sch Publ Hlth, Chengdu, Peoples R China; [Qiu, Peiyuan; Caine, Eric D.; Hou, Fengsu; Cerulli, Catherine; Wittink, Marsha N.] Univ Rochester, Med Ctr, Dept Psychiat, Rochester, NY 14642 USA; [Hou, Fengsu] Sun Yat Sen Univ, Sch Publ Hlth, Guangzhou, Guangdong, Peoples R China; [Hou, Fengsu] Sun Yat Sen Univ, Sun Yat Sen Global Hlth Inst, Inst State Governance, Guangzhou, Guangdong, Peoples R China; [Li, Jin] Sichuan Univ, West China Hosp, Dept Psychiat, Chengdu, Peoples R China	Sichuan University; University of Rochester; Sun Yat Sen University; Sun Yat Sen University; Sichuan University	Qiu, PY (corresponding author), Sichuan Univ, West China Sch Publ Hlth, Chengdu, Peoples R China.; Qiu, PY (corresponding author), Univ Rochester, Med Ctr, Dept Psychiat, Rochester, NY 14642 USA.	qiupeiyuan@scu.edu.cn	Hou, Fengsu/ABD-4947-2020; Hou, Fengsu/AAE-8544-2020; Hou, Fengsu/AAJ-2004-2020	Hou, Fengsu/0000-0001-5869-4365	National Institutes of Health [D43 TW009101, TW009101-01S1]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funded by National Institutes of Health, Grant D43 TW009101 and TW009101-01S1 (E.D. Caine, PI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Center TMoHSI, 2009, AN REP NAT HLTH SERV; Cheng ST, 2005, INT J GERIATR PSYCH, V20, P465, DOI 10.1002/gps.1314; Chin WY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135131; Chiu HFK, 2004, ACTA PSYCHIAT SCAND, V109, P299, DOI 10.1046/j.1600-0447.2003.00263.x; Corrigan PW, 2010, CLIN PSYCHOL REV, V30, P907, DOI 10.1016/j.cpr.2010.06.004; FABREGA H, 1991, COMPR PSYCHIAT, V32, P534, DOI 10.1016/0010-440X(91)90033-9; Fountoulakis K, 2001, BMC PSYCHIATRY, V1, DOI 10.1186/1471-244X-1-3; Gu L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065356; Hu TW, 2007, SOC PSYCH PSYCH EPID, V42, P110, DOI 10.1007/s00127-006-0151-2; Intranet GS, 2012, STAT COMMUNIQUE 2012; Jackson S.W., 1986, MELANCHOLIA DEPRESSI; Jones AR, 2011, J AFFECT DISORDERS, V134, P145, DOI 10.1016/j.jad.2011.05.013; Kleinman A., 2011, DEEPCHINA MORAL LIFE; Kleinman A., 1988, RETHINKING PSYCHIAT; KLEINMAN AM, 1977, SOC SCI MED, V11, P3, DOI 10.1016/0037-7856(77)90138-X; Lee DTS, 2007, HARVARD REV PSYCHIAT, V15, P1, DOI 10.1080/10673220601183915; Lee S, 2007, ACTA PSYCHIAT SCAND, V116, P429, DOI 10.1111/j.1600-0447.2007.01064.x; Lee S, 2009, PSYCHOL MED, V39, P735, DOI 10.1017/S0033291708004091; Lee S, 2010, PSYCHIAT SERV, V61, P1260, DOI 10.1176/ps.2010.61.12.1260; Lu J, 2008, J AFFECT DISORDERS, V111, P221, DOI 10.1016/j.jad.2008.02.018; Lv Y, 2013, GEN HOSP PSYCHIAT, V35, P83, DOI 10.1016/j.genhosppsych.2012.07.007; Murray C.J.L., 1997, GLOBAL BURDEN DIS CO; O'Connor EA, 2009, ANN INTERN MED, V151, P793, DOI 10.7326/0003-4819-151-11-200912010-00007; Phillips MR, 2009, LANCET, V373, P2041, DOI 10.1016/S0140-6736(09)60660-7; Pignone MP, 2002, ANN INTERN MED, V136, P765, DOI 10.7326/0003-4819-136-10-200205210-00013; Sheehan DV, 1997, EUR PSYCHIAT, V12, P232, DOI 10.1016/S0924-9338(97)83297-X; SHEEHAN TJ, 1995, J PERS ASSESS, V64, P507, DOI 10.1207/s15327752jpa6403_9; [司天梅 SI Tian-Mei], 2009, [中国心理卫生杂志, Chinese Mental Health Journal], V23, P493; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; Wang CW, 2014, SOC PSYCH PSYCH EPID, V49, P929, DOI 10.1007/s00127-013-0789-5; Yang L, 2015, BMC PSYCHIATRY, V15, DOI 10.1186/s12888-015-0458-1; Zhang J, 2012, COMPR PSYCHIAT, V53, P1243, DOI 10.1016/j.comppsych.2012.03.015; [章婕 ZHANG Jie], 2010, [中国心理卫生杂志, Chinese Mental Health Journal], V24, P139	33	13	14	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2016	11	8							e0161097	10.1371/journal.pone.0161097	http://dx.doi.org/10.1371/journal.pone.0161097			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DT4SL	27526182	Green Submitted, gold, Green Published			2022-12-27	WOS:000381471100034
J	Villa, P; Soriano, S; Grun, R; Marra, F; Nomade, S; Pereira, A; Boschian, G; Pollarolo, L; Fang, F; Bahain, JJ				Villa, Paola; Soriano, Sylvain; Grun, Rainer; Marra, Fabrizio; Nomade, Sebastien; Pereira, Alison; Boschian, Giovanni; Pollarolo, Luca; Fang, Fang; Bahain, Jean-Jacques			The Acheulian and Early Middle Paleolithic in Latium (Italy): Stability and Innovation	PLOS ONE			English	Article							TIBER RIVER; SEA-LEVEL; AGGRADATIONAL SECTIONS; AGE CONSTRAINTS; MONTI SABATINI; TOOTH ENAMEL; PLEISTOCENE; ROME; STRATIGRAPHY; 40AR/39AR	We present here the results of a technological and typological analysis of the Acheulian and early Middle Paleolithic assemblages from Torre in Pietra (Latium, Italy) together with comparisons with the Acheulian small tools of Castel di Guido. The assemblages were never chronometrically dated before. We have now 40Ar/39Ar dates and ESR-U-series dates, within a geomorphological framework, which support correlations to marine isotope stages. The Acheulian (previously correlated to MIS 9) is now dated to MIS 10 while the Middle Paleolithic is dated to MIS 7. Lithic analyses are preceded by taphonomic evaluations. The Levallois method of the Middle Paleolithic assemblage is an innovation characterized by the production of thin flake blanks without cortex. In contrast, the small tool blanks of the Acheulian were either pebbles or thick flakes with some cortex. They provided a relatively easy manual prehension. The choice of Levallois thin flake blanks in the Middle Paleolithic assemblage suggest that the new technology is most likely related to the emergence of hafting. Accordingly, the oldest direct evidence of hafting technology is from the site of Campitello Quarry in Tuscany (Central Italy) where birch-bark tar, found on the proximal part of two flint flakes, is dated to the end of MIS 7. Nevertheless, a peculiar feature of the Middle Paleolithic at Torre in Pietra is the continuous presence of small tool blanks on pebbles and cores and on thick flake albeit at a much lower frequency than in the older Acheulian industries. The adoption of the new technology is thus characterized by innovation combined with a degree of stability. The persistence of these habits in spite of the introduction of an innovative technique underlies the importance of cultural transmission and conformity in the behavior of Neandertals.	[Villa, Paola] Univ Colorado Museum, Boulder, CO 80309 USA; [Villa, Paola] Ist Italiano Paleontol Umana, Rome, Italy; [Villa, Paola; Pollarolo, Luca] Univ Witwatersrand, Sch Geog Archaeol & Environm Studies, Johannesburg, South Africa; [Soriano, Sylvain] Univ Paris Ouest, CNRS, ArScAn, AnTET, F-92023 Nanterre, France; [Grun, Rainer; Fang, Fang] Australian Natl Univ, Res Sch Earth Sci, Canberra, ACT 2601, Australia; [Grun, Rainer; Fang, Fang] Griffith Univ, Res Ctr Human Evolut, Nathan, Qld 4111, Australia; [Marra, Fabrizio] Ist Nazl Geofis & Vulcanol, I-00147 Rome, Italy; [Nomade, Sebastien; Pereira, Alison] UVSQ, Lab Sci Climat & Environm, CEA Saclay, UMR 8212, F-91198 Gif Sur Yvette, France; [Nomade, Sebastien; Pereira, Alison] Univ Paris Saclay, F-91198 Gif Sur Yvette, France; [Pereira, Alison; Bahain, Jean-Jacques] Museum Natl Hist Nat, UMR 7194, Dept Prehist, F-75013 Paris, France; [Pereira, Alison] Univ Ferrara, Sez Sci Preist & Antropol, Dipartimento Studi Umanistici, Ferrara, Italy; [Pereira, Alison] Ecole Francaise, Rome, Italy; [Boschian, Giovanni] Univ Pisa, Dipartimento Biol, I-56126 Pisa, Italy; [Pollarolo, Luca] Univ Geneva, Dept Genet & Evolut, Lab Archeol & Peuplement Afr, CH-1211 Geneva, Switzerland	University of Colorado System; University of Colorado Boulder; University of Witwatersrand; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Australian National University; Griffith University; Istituto Nazionale Geofisica e Vulcanologia (INGV); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Universite Paris Saclay; CEA; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); University of Ferrara; University of Pisa; University of Geneva	Villa, P (corresponding author), Univ Colorado Museum, Boulder, CO 80309 USA.; Villa, P (corresponding author), Ist Italiano Paleontol Umana, Rome, Italy.; Villa, P (corresponding author), Univ Witwatersrand, Sch Geog Archaeol & Environm Studies, Johannesburg, South Africa.	villap@colorado.edu	MARRA, Fabrizio/AAB-9514-2019; Bahain, Jean-Jacques/AAB-8910-2019; Grun, Rainer/A-1437-2012	MARRA, Fabrizio/0000-0002-4881-9563; Grun, Rainer/0000-0003-1366-3674; Bahain, Jean-Jacques/0000-0002-1446-5568; POLLAROLO, LUCA/0000-0001-9449-5937; Soriano, Sylvain/0000-0002-4288-9763; Villa, Paola/0000-0002-9831-5443; BOSCHIAN, Giovanni/0000-0003-4324-6353; nomade, sebastien/0000-0001-7373-0571	National Science Foundation [BCS 1118143]; CNRS, UMR, ArScAn/AnTET, Nanterre	National Science Foundation(National Science Foundation (NSF)); CNRS, UMR, ArScAn/AnTET, Nanterre	This work is funded by the National Science Foundation, BCS 1118143, grant to PV, SS. CNRS, UMR 7041, ArScAn/AnTET, Nanterre, grant to SS.; Research at Torre in Pietra and on the Castel di Guido lithics was funded by National Science Foundation Grant BCS 1118143 to PV and SS and by a travel grant from CNRS, UMR 7041, ArSca/AnTET, Nanterre to SS. We thank the Pigorini Museum, the Italian Institute of Human Paleontology and the Dipartimento di Biologia of the University of Pisa for access to the Torre in Pietra and Castel di Guido collections and facilities during analysis. We are grateful to Anna Maria Moretti, Alfonsina Russo and Flavia Trucco of the Soprintendenza of Lazio and Etruria Meridionale for access to the Torre in Pietra archeological site, allowing us to clean the two preserved sections and take sediment samples for dating. Salvatore Milli and Maria Rita Palombo have provided us with very valuable information on the Torre in Pietra stratigraphy. Throughout our analysis we valued the very informative paper on the Torre in Pietra lithic assemblages by Marcello Piperno and Italo Biddittu. Fabio Parenti, President of the Italian Institute of Human Paleontology and Luciano Bruni very graciously allowed us complete access to the lithic material of Torre in Pietra and its transport from the town of Anagni to the Zoology Museum in Rome and keep it there for the duration of this study. We thank Francesco di Gennaro and Mario Mineo of the Pigorini Museum in Rome for permission to take photos of the materials and allowing us to use the skills of Fabio Naccari for photography. We thanks Luca Galletti for conceiving and making Fig D of the S1 File. Antonio Tagliacozzo of the Paleontology Section in the Pigorini Museum and Fabio Parenti provided us with faunal materials (teeth and bones) from Torre in Pietra for ESR-U-series dating. PV, SS and LP are particularly grateful to Mario Amore of the Pigorini Museum and the staff of the Zoology Museum in Rome for the good humor and quick access to the Museum facilities (including the indispensable coffee machines). We thank two anonymous reviewers for their insightful and helpful comments. We also wish to thank the University of Colorado Interlibrary Loan Service for their effcient and rapid deliveries and the University of Colorado Museum of Natural History for covering the publication cost.	Beyries S., 1983, BULL SOC PREHIST FR, V80, P275, DOI [DOI 10.3406/BSPF.1983.5455, 10.3406/bspf.1983.5455]; Biddittu I, 1984, I PRIMI ABITANTI DEU, P168; Bietti A., 2009, PERCUSSION ENCLUME I, P143; Boeda E, 2004, APPROCHES FONCTIONNE, P293; Boeda E., 1993, BULL SOC PREHIST FR, V90, P392, DOI [10.3406/bspf.1993.9669, DOI 10.3406/BSPF.1993.9669]; Boeda E., 1994, CONCEPT LEVALLOIS VA; Boeda E., 1995, PALEO, P57, DOI [10.3406/pal.1995.1380, DOI 10.3406/PAL.1995.1380]; Boeda E, 1997, TECHNOGENESE SYSTEME; Boeda E., 1991, TECHNIQUES CULTURE, V17-18, P37, DOI DOI 10.4000/TC.685; Boeda E., 2001, IND OUTILS BIFACIAUX, P51; Boeda E., 2013, TECHNO LOGIQUE TECHN; BORDES F, 1968, OLD STONE AGE; Bordes F, 1971, MUNIBE, P5; Boschian G, 2015, QUATERN INT, V361, P288, DOI 10.1016/j.quaint.2014.04.030; Boschian G, 2010, QUATERN INT, V214, P3, DOI 10.1016/j.quaint.2009.10.016; Bourguignon L, 2008, SOC PALEOLITHIQUE GR, P41; Bradley B, 1986, STONE AGE PREHISTORY, P29; Cahen D., 1986, CHRONOSTRATIGRAPHIE, V26, P89; Caloi L., 1978, Quaternaria, V20, P315; Caloi L, 1998, QUATERN INT, V47-8, P77, DOI 10.1016/S1040-6182(97)00073-6; Childe VG, 1932, ANTIQUITY, V6, P185; Cioni R., 1993, B SOC GEOL ITAL, V112, P251; Cliquet D, 2001, IND OUTILS BIFACIAUX, P141; Conato V., 1980, QUATERNARIA, V22, P131; Connet N, 2014, LGV SEA GRANDE OCCUP, P215; DEINO A, 1990, J GEOPHYS RES-SOLID, V95, P8453, DOI 10.1029/JB095iB06p08453; Dutton A, 2009, NAT GEOSCI, V2, P355, DOI 10.1038/NGEO470; Duval M, 2016, QUAT GEOCHRONOL, V31, P19, DOI 10.1016/j.quageo.2015.09.007; EVERNDEN JF, 1965, CURR ANTHROPOL, V6, P343; Faivre JPh, 2009, FRACTURATION SPLIT T, P133, DOI DOI 10.4000/PALEO.1944; Florindo F, 2007, EARTH PLANET SC LETT, V256, P61, DOI 10.1016/j.epsl.2007.01.014; Folgado M, 2009, RIV SCI PREISTORICHE, V59, P49; Forestier H., 1993, PALEO, V5, P53, DOI [DOI 10.3406/PAL.1993.1104, 10.3406/pal.1993.1104]; Gliozzi E, 1997, RIV ITAL PALEONTOL S, V103, P369, DOI 10.13130/2039-4942/5299; Gran R., 2000, ANCIENT TL, V18, P1; Grant KM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6076; Green HS, 1983, STUDIA PRAEHISTORICA, V3, P29; Grimaldi S., 1998, PALEO, V10, P109, DOI DOI 10.3406/PAL.1998.1132; GRUN R, 1988, NUCL TRACKS RAD MEAS, V14, P237; Guibert P, 2008, SOC PALEOLITHIQUE GR, P41; Harding P., 1987, HUMAN USES FLINT CHE, P115; Herisson D, 2012, PALEO, V23, P137, DOI DOI 10.4000/PALEO.2329; Jarry M, 2007, BOSSES 1 LAMAGDELAIN, P7; Jaubert J, 1990, CHASSEURS AUROCHS BO; Jaubert J., 1996, QUATERNARIA NOVA, V6, P313; Joris O., 2006, AXE AGE ACHEULIAN TO, P287; Karner DB, 1998, GEOL SOC AM BULL, V110, P748, DOI 10.1130/0016-7606(1998)110<0748:COFASW>2.3.CO;2; Karner DB, 1998, GEOL SOC AM BULL, V110, P740, DOI 10.1130/0016-7606(1998)110<0740:AAGORV>2.3.CO;2; Karner DB, 2001, J VOLCANOL GEOTH RES, V107, P185, DOI 10.1016/S0377-0273(00)00258-4; Karner DB, 2001, EARTH PLANET SC LETT, V188, P135, DOI 10.1016/S0012-821X(01)00325-9; Koehler H, 2008, BULL SOC PREHIST FR, V105, P709, DOI 10.3406/bspf.2008.13781; Kotsakis T., 2008, Memorie Descrittive della Carta Geologica d'Italia, V80, P115; Kuhn SL., 1995, MOUSTERIAN LITHIC TE, DOI [10.1515/9781400864034, DOI 10.1515/9781400864034]; Lai Pannocchia F, 1950, RIV SCI PREISTORICHE, V1950, P67; Lamotte A, 1999, B SOC PREHISTORIQUE, V96, P117; Lhomme V, 2007, ANTIQUITY, V81, P536, DOI 10.1017/S0003598X00095570; LISIECKI LE, 2005, PALEOCEANOGRAPHY, V0020; Ludwig K.R, 2003, BERKELEY GEOCHRONOLO; Malatesta A., 1978, QUATERNARIA, V20, P237; Malatesta A., 1978, QUATERNARIA, V20, P537; Marcy J.-L., 1993, B SOCI T PR HISTORIQ, V90, P251; Marra F, 2016, EARTH PLANET SC LETT, V449, P105, DOI 10.1016/j.epsl.2016.05.037; Marra F, 2014, EARTH-SCI REV, V139, P104, DOI 10.1016/j.earscirev.2014.08.014; Marra F, 2014, QUATERNARY SCI REV, V94, P74, DOI 10.1016/j.quascirev.2014.04.010; Marra F, 1998, EARTH PLANET SC LETT, V159, P147, DOI 10.1016/S0012-821X(98)00071-5; Marra F., 1995, GEOLOGIA ROMA CTR ST, VVolume 50, P49; Marra F, 2015, QUATERNARY SCI REV, V129, P260, DOI 10.1016/j.quascirev.2015.10.027; Marra F, 2014, EARTH-SCI REV, V136, P1, DOI 10.1016/j.earscirev.2014.05.001; Marra F, 2008, PALEOCEANOGRAPHY, V23, DOI 10.1029/2007PA001543; Mazza PPA, 2006, J ARCHAEOL SCI, V33, P1310, DOI 10.1016/j.jas.2006.01.006; Michel V., 2009, ARCHEOSCIENCES, V32, P51; Milli S, 2005, QUATERN INT, V126, P251, DOI 10.1016/j.quaint.2004.04.025; Milli S., 2008, GEOACTA SPECIAL PUBL, V1, P667; Milli S, 2001, POST SESS 1 INT C WO; Monnier J.-L., 1985, REV ARCHEOLOGIQUE OU, V2, P7; NEWCOMER MH, 1971, WORLD ARCHAEOL, V3, P85, DOI 10.1080/00438243.1971.9979493; Nicoud E, 2013, PARADOXE ACHEULEEN; Nomade S, 2014, 27 WORLD UISPP C BUR; Palombo M.R., 2004, GEOL ROMANA, V37, P135; Peretto C, 2015, QUAT INT IN PRESS; Perpere M, 1999, ANTHROPOLOGIE, V103, P43; Pike AWG, 2002, GEOCHIM COSMOCHIM AC, V66, P4273, DOI 10.1016/S0016-7037(02)00997-3; Piperno M, 1978, QUATERNARIA, V20, P441; Radmilli AM, 1996, SCAVI CASTEL GUIDO P; Roe DA, 1981, LOWER MIDDLE PALAEOL; Roebroeks W, 2011, P NATL ACAD SCI USA, V108, P5209, DOI 10.1073/pnas.1018116108; Sacca D., 2012, RIV SCI PREISTORICHE, VLXII, P13; Sacca D, 2012, QUATERN INT, V276, P27, DOI 10.1016/j.quaint.2012.03.055; Sambridge M, 2012, QUAT GEOCHRONOL, V9, P42, DOI 10.1016/j.quageo.2012.02.010; Santucci E, 2016, QUATERN INT, V406, P169, DOI 10.1016/j.quaint.2015.08.042; Shea JJ, 2015, LITHIC TECHNOL, V40, P231, DOI 10.1179/2051618515Y.0000000011; Shimelmitz R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106293; Soressi M, 2002, THESIS, P1; Sorgi C., 1994, THESIS; Soriano S, 2000, THESIS, P10; Soriano S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131127; Tavoso A, 1986, PALEOLITHIQUE INFERI, V5; Teheux E, 2000, ARCHEOPAGES, V1, P30; Tuffreau A, 2008, ANTHROPOLOGIE, V112, P104, DOI 10.1016/j.anthro.2008.01.003; Turq A, 2010, QUATERN INT, V223, P383, DOI 10.1016/j.quaint.2010.03.012; Vallin L, 2006, PALEO, V18, P237, DOI DOI 10.4000/PALEO.347; VALLOIS H, 1956, AM J PHYS ANTHROPOL, V14, P319, DOI 10.1002/ajpa.1330140224; Villa P, 1983, TERRA AMATA MIDDLE P; Villa P, 2009, J ARCHAEOL SCI, V36, P441, DOI 10.1016/j.jas.2008.09.028; White M, 2003, CURR ANTHROPOL, V44, P598, DOI 10.1086/377653; White M, 2006, J QUATERNARY SCI, V21, P525, DOI 10.1002/jqs.1034	106	39	39	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2016	11	8							e0160516	10.1371/journal.pone.0160516	http://dx.doi.org/10.1371/journal.pone.0160516			54	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4SL	27525705	Green Published, gold, Green Submitted			2022-12-27	WOS:000381471100016
J	Bharti, PK; Chandel, HS; Ahmad, A; Krishna, S; Udhayakumar, V; Singh, N				Bharti, Praveen Kumar; Chandel, Himanshu Singh; Ahmad, Amreen; Krishna, Sri; Udhayakumar, Venkatachalam; Singh, Neeru			Prevalence of pfhrp2 and/or pfhrp3 Gene Deletion in Plasmodium falciparum Population in Eight Highly Endemic States in India	PLOS ONE			English	Article							RAPID DIAGNOSTIC-TESTS; SEQUENCE VARIATION; MALARIA; HRP2; CHLOROQUINE; PERFORMANCE; MANAGEMENT; DIVERSITY; SENEGAL; REGION	Background Plasmodium falciparum encoded histidine rich protein (HRP2) based malaria rapid diagnostic tests (RDTs) are used in India. Deletion of pfhrp2 and pfhrp3 genes contributes to false negative test results, and large numbers of such deletions have been reported from South America, highlighting the importance of surveillance to detect such deletions. Methods This is the first prospective field study carried out at 16 sites located in eight endemic states of India to assess the performance of PfHRP2 based RDT kits used in the national malaria control programme. In this study, microscopically confirmed P. falciparum but RDT negative samples were assessed for presence of pfhrp2, pfhrp3, and their flanking genes using PCR. Results Among 1521 microscopically positive P. falciparum samples screened, 50 were negative by HRP2 based RDT test. Molecular testing was carried out using these 50 RDT negative samples by assuming that 1471 RDT positive samples carried pfhrp2 gene. It was found that 2.4% (36/1521) and 1.8% (27/1521) of samples were negative for pfhrp2 and pfhrp3 genes, respectively. However, the frequency of pfhrp2 deletions varied between the sites ranging from 0-25% (2.4, 95% CI; 1.6-3.3). The frequency of both pfhrp2 and pfhrp3 gene deletion varied from 0-8% (1.6, 95% CI; 1.0-2.4). Conclusion This study provides evidence for low level presence of pfhrp2 and pfhrp3 deleted P. falciparum parasites in different endemic regions of India, and periodic surveillance is warranted for reliable use of PfHRP2 based RDTs.	[Bharti, Praveen Kumar; Chandel, Himanshu Singh; Ahmad, Amreen; Krishna, Sri; Singh, Neeru] NIRTH, Jabalpur 482003, Madhya Pradesh, India; [Udhayakumar, Venkatachalam] Ctr Dis Control & Prevent, Div Parasit Dis & Malaria, Malaria Branch, Ctr Global Hlth, Atlanta, GA 30333 USA	Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Tribal Health (NIRTH); Centers for Disease Control & Prevention - USA	Singh, N (corresponding author), NIRTH, Jabalpur 482003, Madhya Pradesh, India.	neeru.singh@gmail.com			Indian Council of Medical Research, India	Indian Council of Medical Research, India(Indian Council of Medical Research (ICMR))	This work was funded by Indian Council of Medical Research, India.	Abdallah JF, 2015, MALARIA J, V14, DOI 10.1186/s12936-014-0537-7; [Anonymous], 2015, PLOS ONE, DOI DOI 10.1371/journal.pone.0131576; Baker J, 2005, J INFECT DIS, V192, P870, DOI 10.1086/432010; Baker J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-129; Bharti PK, 2010, TROP MED INT HEALTH, V15, P33, DOI 10.1111/j.1365-3156.2009.02425.x; Deme AB, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-34; Diagnosis and Treatment of Malaria, 2013, DIAGN TREATM MAL 201; Gamboa D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008091; Hendriksen ICE, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001297; HOWARD RJ, 1986, J CELL BIOL, V103, P1269, DOI 10.1083/jcb.103.4.1269; Jain V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115266; Koita OA, 2012, AM J TROP MED HYG, V86, P194, DOI 10.4269/ajtmh.2012.10-0665; Krishna S, 2015, EMERG INFECT DIS, V21, P1853, DOI 10.3201/eid2110.150678; Kumar N, 2013, ACTA TROP, V125, P119, DOI 10.1016/j.actatropica.2012.09.015; Lee N, 2006, J CLIN MICROBIOL, V44, P2773, DOI 10.1128/JCM.02557-05; Luchavez J, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-286; Maltha J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043094; National Vector Borne Diseases Control programme, 2014, MAL SIT IND 2014; Okoth SA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126805; Ramutton T, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-276; Singh J., 1944, Indian Medical Gazette, V79, P102; Singh N, 1997, AM J TROP MED HYG, V56, P188, DOI 10.4269/ajtmh.1997.56.188; Singh N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058080; Singh N, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-191; Sinha I, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0900-3; SNOUNOU G, 1993, MOL BIOCHEM PARASIT, V58, P283, DOI 10.1016/0166-6851(93)90050-8; WELLEMS TE, 1987, CELL, V49, P633, DOI 10.1016/0092-8674(87)90539-3; WELLEMS TE, 1991, P NATL ACAD SCI USA, V88, P3382, DOI 10.1073/pnas.88.8.3382; WHO, 2013, WORLD MALARIA REPORT 2013, P1; Wurtz N, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-34	30	94	94	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2016	11	8							e0157949	10.1371/journal.pone.0157949	http://dx.doi.org/10.1371/journal.pone.0157949			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3LI	27518538	Green Published, Green Submitted, gold			2022-12-27	WOS:000381382100002
J	Li, H; Zheng, HL; Li, LH; Shen, XG; Zang, WJ; Sun, YS				Li, Hui; Zheng, Huiling; Li, Lihui; Shen, Xingai; Zang, Wenjuan; Sun, Yongsen			The Effects of Matrix Metalloproteinase-9 on Dairy Goat Mastitis and Cell Survival of Goat Mammary Epithelial Cells	PLOS ONE			English	Article							BOVINE MASTITIS; GROWTH-FACTORS; SOMATIC-CELLS; UP-REGULATION; MMP-9; METALLOPROTEINASE-9; ANGIOGENESIS; REDUCTION; APOPTOSIS; MODEL	Matrix metalloproteinase-9 (MMP-9) is a zinc-dependent enzyme, and plays a crucial role in extracellular matrix degeneration, inflammation and tissue remodeling. However, the relationship between MMP-9 and somatic cell count (SCC) in goat milk and the role of MMP-9 in the regulation of mastitis are still unknown. In this study, we found MMP-9 was predominantly expressed in the spleen, intestine and mammary gland. The SCC in goat milk was positively correlated with MMP-9 expression, and staphylococcus aureus could markedly increase MMP-9 expression in goat mammary epithelial cells (GMEC) in dosage and time dependent manner. We also demonstrated that SB-3CT, an inhibitor of MMP-9, promoted apoptosis and inhibited proliferation in GMEC. Thus, MMP-9 may emerge as an easily measurable and sensitive parameter that reflects the number of somatic cells present in milk and a regulatory factor of apoptosis in GMEC.	[Li, Hui; Zheng, Huiling; Li, Lihui; Shen, Xingai; Zang, Wenjuan; Sun, Yongsen] Northwest A&F Univ, Coll Anim Sci & Technol, Key Lab Mol Biol Agr, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China	Zheng, HL (corresponding author), Northwest A&F Univ, Coll Anim Sci & Technol, Key Lab Mol Biol Agr, Yangling, Shaanxi, Peoples R China.	zhenghuiling@nwsuaf.edu.cn		Li, Hui/0000-0002-5604-0592	National Natural Science Foundation of China, China [31572368]; Natural Science Basic Research Plan in Shaanxi Province of China [2016JM3029]; National Natural Science Foundation of China [31572368]	National Natural Science Foundation of China, China(National Natural Science Foundation of China (NSFC)); Natural Science Basic Research Plan in Shaanxi Province of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (No. 31572368), China, and the Natural Science Basic Research Plan in Shaanxi Province of China (No. 2016JM3029). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by the National Natural Science Foundation of China (No. 31572368), and the Natural Science Basic Research Plan in Shaanxi Province of China (No. 2016JM3029).	Aalinkeel R, 2004, CANCER RES, V64, P5311, DOI 10.1158/0008-5472.CAN-2506-2; Barkema HW, 1998, J DAIRY SCI, V81, P411, DOI 10.3168/jds.S0022-0302(98)75591-2; Bauvois B, 2012, BBA-REV CANCER, V1825, P29, DOI 10.1016/j.bbcan.2011.10.001; Bergers G, 2000, NAT CELL BIOL, V2, P737, DOI 10.1038/35036374; Bergonier D, 2014, VET RES, V45, DOI 10.1186/s13567-014-0097-4; Blankenberg S, 2003, CIRCULATION, V107, P1579, DOI 10.1161/01.CIR.0000058700.41738.12; Bond M, 1998, FEBS LETT, V435, P29, DOI 10.1016/S0014-5793(98)01034-5; Boutinaud M, 2002, REPROD NUTR DEV, V42, P133, DOI 10.1051/rnd:2002013; Cortes-Reynosa P, 2008, MATRIX BIOL, V27, P220, DOI 10.1016/j.matbio.2007.11.003; Coussens LM, 2000, CELL, V103, P481, DOI 10.1016/S0092-8674(00)00139-2; d'Angelo F, 2007, J DAIRY SCI, V90, P3550, DOI 10.3168/jds.2007-0149; DULIN AM, 1983, J DAIRY SCI, V66, P2426, DOI 10.3168/jds.S0022-0302(83)82101-8; Fernandez CA, 2005, CLIN CANCER RES, V11, P5390, DOI 10.1158/1078-0432.CCR-04-2391; GEARING AJH, 1994, NATURE, V370, P555, DOI 10.1038/370555a0; Hampel D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149479; HARMON RJ, 1994, J DAIRY SCI, V77, P2103, DOI 10.3168/jds.S0022-0302(94)77153-8; Kawasaki Y, 2008, NAT MED, V14, P331, DOI 10.1038/nm1723; Krieglstein K, 2000, NAT NEUROSCI, V3, P1085, DOI 10.1038/80598; Leverson JD, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa4642; Li H., 2015, TUMOR BIOL, P1; Li N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0146071; Paape MJ, 1997, FLEMISH VET J, V66, P93; Pu WX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088134; Raulo SM, 2002, VET IMMUNOL IMMUNOP, V85, P137, DOI 10.1016/S0165-2427(01)00423-8; Schorr K, 1999, J MAMMARY GLAND BIOL, V4, P153, DOI 10.1023/A:1018773123899; Scoditti E, 2012, ARCH BIOCHEM BIOPHYS, V527, P81, DOI 10.1016/j.abb.2012.05.003; Shi HB, 2014, J DAIRY SCI, V97, P5437, DOI 10.3168/jds.2013-7863; Silanikove N, 2014, J DAIRY SCI, V97, P3449, DOI 10.3168/jds.2013-7334; Simonetti O, 2012, J ANTIMICROB CHEMOTH, V67, P191, DOI 10.1093/jac/dkr440; Taponen S, 2009, VET MICROBIOL, V134, P29, DOI 10.1016/j.vetmic.2008.09.011; Vaillant C, 2003, MOL CELL NEUROSCI, V24, P395, DOI 10.1016/S1044-7431(03)00196-9; Van den Steen PE, 2002, CRIT REV BIOCHEM MOL, V37, P375, DOI 10.1080/10409230290771546; Vu TH, 1998, CELL, V93, P411, DOI 10.1016/S0092-8674(00)81169-1; Wang H, 2015, J DAIRY SCI, V98, P9001, DOI 10.3168/jds.2015-9418; Wang Zhen, 2010, Sheng Wu Gong Cheng Xue Bao, V26, P1123; Wang ZF, 2011, J CEREBR BLOOD F MET, V31, P52, DOI 10.1038/jcbfm.2010.195; Wellnitz O, 2004, VET IMMUNOL IMMUNOP, V101, P191, DOI 10.1016/j.vetimm.2004.04.019; Yu TC, 2011, VET IMMUNOL IMMUNOP, V144, P210, DOI 10.1016/j.vetimm.2011.09.006; Zhao X, 2008, J ANIM SCI, V86, P57, DOI 10.2527/jas.2007-0302; Zhao YQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134797	40	14	14	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2016	11	8							e0160989	10.1371/journal.pone.0160989	http://dx.doi.org/10.1371/journal.pone.0160989			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3LI	27518717	Green Published, Green Submitted, gold			2022-12-27	WOS:000381382100031
J	Voller, D; Linck, L; Bruckmann, A; Hauptmann, J; Deutzmann, R; Meister, G; Bosserhoff, AK				Voeller, Daniel; Linck, Lisa; Bruckmann, Astrid; Hauptmann, Judith; Deutzmann, Rainer; Meister, Gunter; Bosserhoff, Anja Katrin			Argonaute Family Protein Expression in Normal Tissue and Cancer Entities	PLOS ONE			English	Article							TARGET GENES; MICRORNAS; MELANOMA; DICER; MIRNA; PROGRESSION; RNA	Themembers of the Argonaute (AGO) protein family are key players inmiRNA-guided gene silencing. They enable the interaction between small RNAs and their respective target mRNA (s) and support the catalytic destruction of the gene transcript or recruit additional proteins for downstream gene silencing. The human AGO family consists of four AGO proteins (AGO1-AGO4), but only AGO2 harbors nuclease activity. In this study, we characterized the expression of the four AGO proteins in cancer cell lines and normal tissues with a new mass spectrometry approach called AGO-APP (AGO Affinity Purification by Peptides). In all analyzed normal tissues, AGO1 and AGO2 were most prominent, but marked tissue-specific differences were identified. Furthermore, considerable changes during development were observed by comparing fetal and adult tissues. We also identified decreased overall AGO expression in melanoma derived cell lines compared to other tumor cell lines and normal tissues, with the largest differences in AGO2 expression. The experiments described in this study suggest that reduced amounts of AGO proteins, as key players in miRNA processing, have impact on several cellular processes. Deregulated miRNA expression has been attributed to chromosomal aberrations, promoter regulation and it is known to have a major impact on tumor development and progression. Our findings will further increase our basic understanding of the molecular basis ofmiRNA processing and its relevance for disease.	[Voeller, Daniel; Linck, Lisa; Bosserhoff, Anja Katrin] Univ Erlangen Nurnberg, Emil Fischer Zentrum, Inst Biochem, Erlangen, Germany; [Bruckmann, Astrid; Hauptmann, Judith; Deutzmann, Rainer; Meister, Gunter] Univ Regensburg, Biochem Ctr Regensburg, Regensburg, Germany	University of Erlangen Nuremberg; University of Regensburg	Bosserhoff, AK (corresponding author), Univ Erlangen Nurnberg, Emil Fischer Zentrum, Inst Biochem, Erlangen, Germany.	anja.bosserhoff@fau.de	Bosserhoff, Anja/GNH-4801-2022	Bosserhoff, Anja/0000-0001-8147-394X; Linck-Paulus, Lisa/0000-0001-8581-684X; Hauptmann, Judith/0000-0001-9098-6763	DFG [SFB960]; Bavarian Ministry for education and science (BioSysNet); German Cancer Aid; Wilhelm Sander Foundation; Bavarian Ministry for education and science (BayGene); European Union (ERC starting grant 'sRNAs', FP7 project 'ONCOMIRs')	DFG(German Research Foundation (DFG)); Bavarian Ministry for education and science (BioSysNet); German Cancer Aid(Deutsche Krebshilfe); Wilhelm Sander Foundation; Bavarian Ministry for education and science (BayGene); European Union (ERC starting grant 'sRNAs', FP7 project 'ONCOMIRs')	This work was supported by the DFG (SFB960, grants to AB and GM) and the Bavarian Ministry for education and science (BioSysNet). AB is supported by grants from the German Cancer Aid and the Wilhelm Sander Foundation. GM is supported by grants from the Bavarian Ministry for education and science (BayGene) and the European Union (ERC starting grant 'sRNAs', FP7 project 'ONCOMIRs').	Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Beitzinger M, 2007, RNA BIOL, V4, P76, DOI 10.4161/rna.4.2.4640; Bosserhoff A, 2011, MELANOMA DEVELOPMENT: MOLECULAR BIOLOGY, GENETICS AND CLINICAL APPLICATION, P1, DOI 10.1007/978-3-7091-0371-5_1; Caramuta S, 2010, J INVEST DERMATOL, V130, P2062, DOI 10.1038/jid.2010.63; Cheloufi S, 2010, NATURE, V465, P584, DOI 10.1038/nature09092; Diederichs S, 2007, CELL, V131, P1097, DOI 10.1016/j.cell.2007.10.032; Dueck A, 2014, BIOL CHEM, V395, P611, DOI 10.1515/hsz-2014-0116; Dueck A, 2012, NUCLEIC ACIDS RES, V40, P9850, DOI 10.1093/nar/gks705; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Frohn A, 2012, MOL CELL PROTEOMICS, V11, P1442, DOI 10.1074/mcp.M112.017756; Ha M, 2014, NAT REV MOL CELL BIO, V15, P509, DOI 10.1038/nrm3838; Hauptmann J, 2015, P NATL ACAD SCI USA, V112, P11841, DOI 10.1073/pnas.1506116112; Hauptmann J, 2013, DEV CELL, V25, P553, DOI 10.1016/j.devcel.2013.06.009; Hutvagner G, 2008, NAT REV MOL CELL BIO, V9, P22, DOI 10.1038/nrm2321; Jacob K, 1998, MELANOMA RES, V8, P211, DOI 10.1097/00008390-199806000-00003; JACOB K, 1995, INT J CANCER, V60, P668, DOI 10.1002/ijc.2910600517; Jafarnejad SM, 2013, ONCOGENE, V32, P2131, DOI 10.1038/onc.2012.239; Jafarnejad SM, 2013, PIGM CELL MELANOMA R, V26, P147, DOI 10.1111/pcmr.12039; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kappelmann M, 2013, ONCOGENE, V32, P2984, DOI 10.1038/onc.2012.307; Kunz M, 2013, ADV EXP MED BIOL, V774, P103, DOI 10.1007/978-94-007-5590-1_6; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Luo CL, 2014, EUR J CELL BIOL, V93, P11, DOI 10.1016/j.ejcb.2014.02.001; Ma ZH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020494; MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054; Muller DW, 2008, ONCOGENE, V27, P6698, DOI 10.1038/onc.2008.282; Mueller DW, 2009, BRIT J CANCER, V101, P551, DOI 10.1038/sj.bjc.6605204; Mueller DW, 2009, J INVEST DERMATOL, V129, P1740, DOI 10.1038/jid.2008.452; Nazarov PV, 2013, NUCLEIC ACIDS RES, V41, P2817, DOI 10.1093/nar/gks1471; Pellegrino L, 2013, EXPERT REV ANTICANC, V13, P21, DOI [10.1586/era.12.150, 10.1586/ERA.12.150]; Peters L, 2007, MOL CELL, V26, P611, DOI 10.1016/j.molcel.2007.05.001; Petri S, 2011, RNA, V17, P737, DOI 10.1261/rna.2348111; Philippidou D, 2010, CANCER RES, V70, P4163, DOI 10.1158/0008-5472.CAN-09-4512; Sand M, 2011, EUR J DERMATOL, V21, P18, DOI [10.1684/ejd.2011.1210, 10.1684/ejd.2010.1210]; Shoo BA, 2009, SEMIN CUTAN MED SURG, V28, P96, DOI 10.1016/j.sder.2009.04.005; Voller D, 2013, BRIT J CANCER, V109, P3116, DOI 10.1038/bjc.2013.646; Voller D, 2013, CLIN BIOCHEM, V46, P909, DOI 10.1016/j.clinbiochem.2013.01.008; Wang DM, 2012, GENE DEV, V26, P693, DOI 10.1101/gad.182758.111; Winter J, 2013, RNA BIOL, P10; Xu Y, 2012, BRIT J CANCER, V106, P553, DOI 10.1038/bjc.2011.568	40	32	33	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2016	11	8							e0161165	10.1371/journal.pone.0161165	http://dx.doi.org/10.1371/journal.pone.0161165			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3LI	27518285	Green Submitted, gold, Green Published			2022-12-27	WOS:000381382100056
J	Augustinos, AA; Rajamohan, A; Kyritsis, GA; Zacharopoulou, A; ul Haq, I; Targovska, A; Caceres, C; Bourtzis, K; Abd-Alla, AMM				Augustinos, Antonios A.; Rajamohan, Arun; Kyritsis, Georgios A.; Zacharopoulou, Antigone; ul Haq, Ihsan; Targovska, Asya; Caceres, Carlos; Bourtzis, Kostas; Abd-Alla, Adly M. M.			Cryopreservation of Embryos of the Mediterranean Fruit Fly Ceratitis capitata Vienna 8 Genetic Sexing Strain	PLOS ONE			English	Article							DIPTERA-TEPHRITIDAE; STERILE; DOMESTICATION; LEPIDOPTERA; ERADICATION; SUPPRESSION; MUTATIONS; POLYTENE; QUALITY; FLIES	The Mediterranean fruit fly, Ceratitis capitata, is one of the most serious pests of fruit crops world-wide. During the last decades, area-wide pest management (AW-IPM) approaches with a sterile insect technique (SIT) component have been used to control populations of this pest in an effective and environment-friendly manner. The development of genetic sexing strains (GSS), such as the Vienna 8 strain, has been played a major role in increasing the efficacy and reducing the cost of SIT programs. However, mass rearing, extensive inbreeding, possible bottleneck phenomena and hitch-hiking effects might pose major risks for deterioration and loss of important genetic characteristics of domesticated insect. In the present study, we present a modified procedure to cryopreserve the embryos of the medfly Vienna 8 GSS based on vitrification and used this strain as insect model to assess the impact of the cryopreservation process on the genetic structure of the cryopreserved insects. Forty-eight hours old embryos, incubated at 24 degrees C, were found to be the most suitable developmental stage for cryopreservation treatment for high production of acceptable hatch rate (38%). Our data suggest the absence of any negative impact of the cryopreservation process on egg hatch rate, pupation rates, adult emergence rates and stability of the temperature sensitive lethal (tsl) character on two established cryopreserved lines (flies emerged from cryopreserved embryos), named V8-118 and V8-228. Taken together, our study provides an optimized procedure to cryopreserve the medfly Vienna 8 GSS and documents the absence of any negative impact on the genetic structure and quality of the strain. Benefits and sceneries for utilization of this technology to support operational SIT projects are discussed in this paper.	[Augustinos, Antonios A.; Kyritsis, Georgios A.; ul Haq, Ihsan; Targovska, Asya; Caceres, Carlos; Bourtzis, Kostas; Abd-Alla, Adly M. M.] Joint FAO IAEA Div Nucl Tech Food & Agr, Insect Pest Control Lab, Vienna, Austria; [Rajamohan, Arun] USDA, Insect Genet & Biochem Unit, Biosci Res Lab, Fargo, ND 58105 USA; [Zacharopoulou, Antigone] Univ Patras, Dept Biol, Patras, Greece	Food & Agriculture Organization of the United Nations (FAO); International Atomic Energy Agency; United States Department of Agriculture (USDA); University of Patras	Abd-Alla, AMM (corresponding author), Joint FAO IAEA Div Nucl Tech Food & Agr, Insect Pest Control Lab, Vienna, Austria.	a.m.m.abd-alla@iaea.org	Augustinos, Antonios/C-1318-2019	Augustinos, Antonios/0000-0003-3682-6077; ABD-ALLA, Adly/0000-0001-7540-4462; Rajamohan, Arun/0000-0003-1587-2891	ARS [ARS-0428476] Funding Source: Federal RePORTER	ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)		[Anonymous], 1979, BASIC PRINCIPLES INS; BEDO DG, 1987, GENOME, V29, P598, DOI 10.1139/g87-101; BEDO DG, 1986, CAN J GENET CYTOL, V28, P180, DOI 10.1139/g86-025; Cayol J.P., 2000, P657; Cayol JP, 2000, FRUIT FLIES (TEPHRITIDAE): PHYLOGENY AND EVOLUTION OF BEHAVIOR, P843; CHRISTENSON LD, 1960, ANNU REV ENTOMOL, V5, P171, DOI 10.1146/annurev.en.05.010160.001131; COX BD, 1975, MUTAT RES, V28, P421, DOI 10.1016/0027-5107(75)90236-5; Enkerlin W, 2015, FLA ENTOMOL, V98, P665, DOI 10.1653/024.098.0242; Franz G, 2005, STERILE INSECT TECHNIQUE: PRINCIPLES AND PRACTICE IN AREA-WIDE INTEGRATED PEST MANAGEMENT, P427, DOI 10.1007/1-4020-4051-2_16; FRANZ G, 1995, MACROMOL SYMP, V99, P187, DOI 10.1002/masy.19950990120; Franz G, 2011, GENETICA, V139, P1, DOI 10.1007/s10709-010-9543-z; Gilchrist AS, 2012, J ECON ENTOMOL, V105, P1051, DOI 10.1603/EC11421; Hendrichs J, 2005, STERILE INSECT TECHNIQUE: PRINCIPLES AND PRACTICE IN AREA-WIDE INTEGRATED PEST MANAGEMENT, P563, DOI 10.1007/1-4020-4051-2_22; Hendrichs J, 2002, FLA ENTOMOL, V85, P1, DOI 10.1653/0015-4040(2002)085[0001:MASITP]2.0.CO;2; IAEA, 2001, ENTOMOLOGY; Isasawin S, 2014, BMC GENET, V15, DOI 10.1186/1471-2156-15-S2-S2; Juan-Blasco M, 2014, B ENTOMOL RES, V104, P233, DOI 10.1017/S0007485313000692; Klassen W, 2005, STERILE INSECT TECHNIQUE: PRINCIPLES AND PRACTICE IN AREA-WIDE INTEGRATED PEST MANAGEMENT, P3, DOI 10.1007/1-4020-4051-2_1; Lance DR, 2005, STERILE INSECT TECHNIQUE: PRINCIPLES AND PRACTICE IN AREA-WIDE INTEGRATED PEST MANAGEMENT, P69, DOI 10.1007/1-4020-4051-2_3; Lance DR, 2000, ANN ENTOMOL SOC AM, V93, P1179, DOI 10.1603/0013-8746(2000)093[1179:CASAWC]2.0.CO;2; Leopold R. A., 2007, P149, DOI 10.1007/978-1-4020-6059-5_13; Leopold RA, 1999, CRYO-LETT, V20, P37; Leopold RA, 2000, ANN ENTOMOL SOC AM, V93, P884, DOI 10.1603/0013-8746(2000)093[0884:STCSOH]2.0.CO;2; Leopold RA, 2001, ANN ENTOMOL SOC AM, V94, P695, DOI 10.1603/0013-8746(2001)094[0695:COEOTN]2.0.CO;2; Leopold RA, 1993, MANAGEMENT INSECT PE, P63; Leopold RA, 2010, ANN ENTOMOL SOC AM, V103, P264, DOI 10.1603/AN09094; Mavragani-Tsipidou P, 2014, PROTOCOLS CYTOGENETI, P1; MAZUR P, 1992, SCIENCE, V258, P1932, DOI 10.1126/science.1470915; MCINNIS DO, 1994, ANN ENTOMOL SOC AM, V87, P231, DOI 10.1093/aesa/87.2.231; McInnis DO, 1993, EVALUATION IAEAS TSL, P1; NUNAMAKER RA, 1993, J MED ENTOMOL, V30, P913, DOI 10.1093/jmedent/30.5.913; Paranhos B. J., 2008, Fruit Flies of Economic Importance to Applied Knowledge. Proceedings of the 7th International Symposium on Fruit Flies of Economic Importance, 10-15 September 2006, Salvador, Brazil, P313; Parreno MA, 2014, BMC GENET, V15, DOI 10.1186/1471-2156-15-S2-S14; Rajamohan A, 2007, CRYOBIOLOGY, V54, P44, DOI 10.1016/j.cryobiol.2006.10.192; Rajamohan A, 2003, CRYOLETTERS, V24, P125; Rajamohan A, 2014, J MED ENTOMOL, V51, P360, DOI 10.1603/ME13188; Rajamohan A, 2013, J ECON ENTOMOL, V106, P855, DOI 10.1603/EC12485; Rempoulakis P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157679; Rendon P, 2004, J ECON ENTOMOL, V97, P1547, DOI 10.1603/0022-0493-97.5.1547; Rendon P., 2000, Area-wide control of fruit flies and other insect pests. Joint proceedings of the international conference on area-wide control of insect pests, 28 May-2 June, 1998 and the Fifth International Symposium on Fruit Flies of Economic Importance, Penang, Malaysia, 1-5 June, 1998, P517; Rendon P.A, 1996, DEV EVALUATION TEMPE; RHODE RH, 1971, J ECON ENTOMOL, V64, P708, DOI 10.1093/jee/64.3.708; Robinson AS, 2002, MUTAT RES-REV MUTAT, V511, P113, DOI 10.1016/S1383-5742(02)00006-6; Robinson AS, 2002, GENETICA, V116, P1, DOI 10.1023/A:1020943122999; Robinson DE, 2000, USE STERILE INSECT T, P213; Roversi PF, 2008, CRYOBIOLOGY, V56, P1, DOI 10.1016/j.cryobiol.2007.09.002; Zepeda-Cisneros CS, 2014, BMC GENET, V15, DOI 10.1186/1471-2156-15-S2-S1; Tanaka N, 1970, P PANEL STERILE MALE, P19, DOI DOI 10.1007/978-1-4615-9585-4_12; Vargas R., 1989, WORLD CROP PESTS FRU, V3, P141; Vreysen M., 2005, Bulletin OILB/SROP, V28, P65; Wang WB, 2000, CRYOBIOLOGY, V41, P153, DOI 10.1006/cryo.2000.2278; Wyss JH, 2000, ANN NY ACAD SCI, V916, P186, DOI 10.1111/j.1749-6632.2000.tb05289.x; Zacharopoulou A, 2013, J ECON ENTOMOL, V106, P995, DOI 10.1603/EC12379; Zygouridis NE, 2014, J APPL ENTOMOL, V138, P423, DOI 10.1111/jen.12042	54	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0160232	10.1371/journal.pone.0160232	http://dx.doi.org/10.1371/journal.pone.0160232			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27537351	Green Published, Green Submitted, gold			2022-12-27	WOS:000381577000015
J	Choi, SJ; Lee, SI; Joo, EY				Choi, Su Jung; Lee, Sung Ik; Joo, Eun Yeon			Habitual Alcohol Consumption and Metabolic Syndrome in Patients with Sleep Disordered Breathing	PLOS ONE			English	Article							NUTRITION EXAMINATION SURVEY; KOREAN NATIONAL-HEALTH; MODERATE ALCOHOL; INSPIRATORY RESISTANCE; OXYGEN DESATURATION; RESPIRATORY DRIVE; BEDTIME ETHANOL; NONSNORING MEN; RISK-FACTORS; APNEA	To investigate the associations between amount of habitual alcohol consumption (HAC) and prevalence of metabolic syndrome (MetS), sleep, and sleep-disordered breathing (SDB). We enrolled 683 untreated SDB male patients (age: 54.4 +/- 7.80 y, apnea-hypopnea index (AHI): 29.0 +/- 21.53/h). HAC was assessed as the average number of drinks consumed per week during the past 12 months. Anthropometric and biochemical markers were used to diagnose MetS. Clinical data and MetS components were compared according to the reported amounts of HAC (no drinking, light drinking <13, heavy drinking >= 13 drinks/week). As reported, 78.9% of the participants (n = 539) were regular drinkers; 33.7% (n = 230) were habitually heavy drinkers (mean: 30.7 drinks/week), and 45.2% (n = 309) were light drinkers (5.1 drinks/week). The overall prevalence of MetS was 36.9% (n = 252) and was most common in heavy drinkers (40.5%). Compared to non-drinkers and light drinkers, heavy drinkers had the greatest body mass index (BMI) and waist circumference. Central obesity, hypertension, and hyperglycemia were most prevalent in heavy drinkers. Sleep quality and severity of SDB were the worst in heavy drinkers. After adjusting for age, AHI, and BMI, heavy drinkers had a 1.71 times greater risk of MetS when compared with nondrinkers, and light and heavy drinkers had a 2.06 and 2.11 times higher risk of severe SDB than non-drinkers. HAC may increase the prevalence of MetS and deteriorate sleep in relation to amount of alcohol intake. Even light drinkers had more than twice higher risk of severe SDB than non-drinkers.	[Choi, Su Jung; Joo, Eun Yeon] Sungkyunkwan Univ, Dept Neurol, Neurosci Ctr, Samsung Med Ctr,Sch Med, Seoul, South Korea; [Choi, Su Jung] Sungkyunkwan Univ, Grad Sch Clin Nursing Sci, Dept Clin Nursing Sci, Dept Nursing,Samsung Med Ctr, Seoul, South Korea; [Joo, Eun Yeon] Sungkyunkwan Univ, SAIHST, Dept Hlth Sci & Technol, Seoul, South Korea; [Lee, Sung Ik] Wonkwang Univ, Sch Med, Sanbon Hosp, Dept Neurol,Inam NeuroSci Res Ctr, Gunpo Si, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Wonkwang University	Joo, EY (corresponding author), Sungkyunkwan Univ, Dept Neurol, Neurosci Ctr, Samsung Med Ctr,Sch Med, Seoul, South Korea.; Joo, EY (corresponding author), Sungkyunkwan Univ, SAIHST, Dept Hlth Sci & Technol, Seoul, South Korea.	ejoo@skku.edu		Choi, Su Jung/0000-0003-2171-7441				Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Alkerwi A, 2009, ATHEROSCLEROSIS, V204, P624, DOI 10.1016/j.atherosclerosis.2008.10.036; Baik I, 2008, AM J CLIN NUTR, V87, P1455, DOI 10.1093/ajcn/87.5.1455; Barreiro Bienvenido, 2013, Open Respir Med J, V7, P71, DOI 10.2174/1874306401307010071; BEARPARK H, 1995, AM J RESP CRIT CARE, V151, P1459, DOI 10.1164/ajrccm.151.5.7735600; BERRY RB, 1992, AM REV RESPIR DIS, V145, P445, DOI 10.1164/ajrccm/145.2_Pt_1.445; Bixler EO, 1998, AM J RESP CRIT CARE, V157, P144, DOI 10.1164/ajrccm.157.1.9706079; CHAN AWK, 1986, ALCOHOL ALCOHOLISM, V21, P93; Dawson A, 1997, ALCOHOL CLIN EXP RES, V21, P183, DOI 10.1111/j.1530-0277.1997.tb03747.x; DAWSON A, 1993, ALCOHOL CLIN EXP RES, V17, P256, DOI 10.1111/j.1530-0277.1993.tb00759.x; Djousse L, 2004, OBES RES, V12, P1375, DOI 10.1038/oby.2004.174; DOLLY FR, 1983, CHEST, V83, P469, DOI 10.1378/chest.83.3.469; Freiberg MS, 2004, DIABETES CARE, V27, P2954, DOI 10.2337/diacare.27.12.2954; Gastaldelli A, 2010, CURR PHARM DESIGN, V16, P2526, DOI 10.2174/138161210792062858; Iber C., 2007, AASM MANUAL SCORING; ISSA FG, 1982, J NEUROL NEUROSUR PS, V45, P353, DOI 10.1136/jnnp.45.4.353; Joe KH, 2009, J KOREAN ACAD ADDICT, V13, P34; Kato I, 2003, J CLIN EPIDEMIOL, V56, P196, DOI 10.1016/S0895-4356(02)00578-4; Keyes KM, 2012, EPIDEMIOL REV, V34, P89, DOI 10.1093/epirev/mxr018; Kim BJ, 2012, CIRC J, V76, P2363, DOI 10.1253/circj.CJ-12-0315; Kim J, 2004, AM J RESP CRIT CARE, V170, P1108, DOI 10.1164/rccm.200404-519OC; Koppes LLJ, 2005, DIABETES CARE, V28, P719, DOI 10.2337/diacare.28.3.719; Lee K, 2012, PUBLIC HEALTH NUTR, V15, P1917, DOI 10.1017/S136898001100365X; Lee SJ, 2015, NEUROLOGY, V85, P1950, DOI 10.1212/WNL.0000000000002165; Lim S, 2011, DIABETES CARE, V34, P1323, DOI 10.2337/dc10-2109; MITLER MM, 1988, ALCOHOL CLIN EXP RES, V12, P801, DOI 10.1111/j.1530-0277.1988.tb01349.x; Nolen-Hoeksema S, 2004, CLIN PSYCHOL REV, V24, P981, DOI 10.1016/j.cpr.2004.08.003; OLSON LG, 1995, AM J RESP CRIT CARE, V152, P711, DOI 10.1164/ajrccm.152.2.7633731; Pan Yue, 2014, Int J High Risk Behav Addict, V3, pe19088, DOI 10.5812/ijhrba.19088; Peppard PE, 2007, J CLIN SLEEP MED, V3, P265; Redline S, 2004, ARCH INTERN MED, V164, P406, DOI 10.1001/archinte.164.4.406; Reid MC, 1999, ARCH INTERN MED, V159, P1681, DOI 10.1001/archinte.159.15.1681; Rosell M, 2003, EUR J CLIN NUTR, V57, P227, DOI 10.1038/sj.ejcn.1601548; Scanlan MF, 2000, EUR RESPIR J, V16, P909, DOI 10.1183/09031936.00.16590900; SCHMIDTNOWARA WW, 1990, ARCH INTERN MED, V150, P597, DOI 10.1001/archinte.150.3.597; Seo S, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-007914; TAASAN VC, 1981, AM J MED, V71, P240; Tanigawa T, 2004, JAMA-J AM MED ASSOC, V292, P923, DOI 10.1001/jama.292.8.923-b; TCHAI BS, 1993, ANN NY ACAD SCI, V676, P279, DOI 10.1111/j.1749-6632.1993.tb38741.x; THOMASSON HR, 1991, AM J HUM GENET, V48, P677; Vgontzas AN, 2005, SLEEP MED REV, V9, P211, DOI 10.1016/j.smrv.2005.01.006; World Health Organization, 1992, ICD 10 CLASSIFICATIO; Wu WT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130279; Xin X, 2001, HYPERTENSION, V38, P1112, DOI 10.1161/hy1101.093424; Yoon YS, 2004, AM J CLIN NUTR, V80, P217; Young T, 2005, J APPL PHYSIOL, V99, P1592, DOI 10.1152/japplphysiol.00587.2005; Zito A, 2011, EUR RESPIR J, V37, P717, DOI 10.1183/09031936.00120510	47	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0161276	10.1371/journal.pone.0161276	http://dx.doi.org/10.1371/journal.pone.0161276			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27536782	Green Published, Green Submitted, gold			2022-12-27	WOS:000381577000080
J	Jamal, SN; Moy, FM; Mohamed, MNA; Mukhtar, F				Jamal, Siti Noraida; Moy, Foong Ming; Mohamed, Mohd Nahar Azmi; Mukhtar, Firdaus			Effectiveness of a Group Support Lifestyle Modification (GSLiM) Programme among Obese Adults in Workplace: A Randomised Controlled Trial	PLOS ONE			English	Article							DIABETES PREVENTION PROGRAM; PHYSICAL-ACTIVITY QUESTIONNAIRE; WEIGHT-LOSS; RISK-FACTORS; INTERVENTIONS; HEALTH; OVERWEIGHT; EFFICACY; DIET; METAANALYSIS	Background There was an increasing trend in the prevalence of obesity and its comorbidities over the past decades in Malaysia. Effective intervention for obesity remains limited. This study aimed to compare the effectiveness of a group based lifestyle modification programme amongst obese individuals with an existing dietary counseling programme. Methods We recruited one hundred and ninety four overweight and obese (BMI>27.5kg/m(2)) employees from a local university. They were randomly allocated to either Group Support Lifestyle Modification (GSLiM) (intervention)(n = 97) or dietary counseling (comparison)(n = 97). The GSLIM activities included self monitoring, cognitive-behaviour sessions, exercise as well as dietary change advocacy, which were conducted through seminars and group sessions over 24 weeks. The comparison group was given dietary counselling once in 12 weeks. Both groups were followed up for additional 12 weeks to check for intervention effect sustenance. Anthropometric and biochemical parameters were measured at baseline, 12, 24 and 36 weeks; while dietary intake, physical activities, psychological measures and quality of life measured at baseline, 24 and 36 weeks. Data analysis was conducted using ANOVA repeated measures with intention to treat principle. Results The participants were predominantly women with mean (standard deviation) age of 40.5 (9.3) years. A total of 19.6% of the participants in GSLiM achieved 6% weight loss compared to 4.1% in the comparison group (Risk Ratio 4.75; 95% CI: 1.68, 13.45). At 24 weeks, the retention rate was 83.5% for GSLiM and 82.5% for comparison group. GSLiM participants also achieved significant improvement in total weight self-efficacy score, negative emotions and physical discomfort subscales, MDPSS friend subscale and all domains in quality of life. Participants in the comparison group experienced reduction in negative self-thoughts. Conclusion The GSLiM programme proved to be more effective in achieving targeted weight loss, improving weight self-efficacy, friend social support, and quality of life compared to dietary counseling.	[Jamal, Siti Noraida; Moy, Foong Ming] Univ Malaya, Fac Med, Dept Social & Prevent Med, Julius Ctr, Kuala Lumpur 50603, Malaysia; [Mohamed, Mohd Nahar Azmi] Univ Malaya, Fac Med, Dept Sports Med, Kuala Lumpur 50603, Malaysia; [Mukhtar, Firdaus] Univ Putra Malaysia, Fac Med, Dept Psychiat, Serdang 43400, Malaysia	Universiti Malaya; Universiti Malaya; Universiti Putra Malaysia	Jamal, SN (corresponding author), Univ Malaya, Fac Med, Dept Social & Prevent Med, Julius Ctr, Kuala Lumpur 50603, Malaysia.	snoraidaj@gmail.com	Moy, Foong Ming/B-7899-2010; Mohamed, Mohd Nahar Azmi/J-9930-2014	Moy, Foong Ming/0000-0002-0306-4419; Mohamed, Mohd Nahar Azmi/0000-0002-8480-3788	University Malaya Post graduate research fund [PV065-2011A]; High Impact Research Grant, Ministry of Higher Education, Malaysia [H-20001-00-E00069]	University Malaya Post graduate research fund; High Impact Research Grant, Ministry of Higher Education, Malaysia	This work was supported by University Malaya Post graduate research fund No. PV065-2011A, http://www.ips.um.edu.my/ by FM Moy; and by High Impact Research Grant, Ministry of Higher Education, Malaysia (No: H-20001-00-E00069), http://hir.um.edu.my/ by FM Moy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali MK, 2012, HEALTH AFFAIR, V31, P67, DOI 10.1377/hlthaff.2011.1009; Ariffin FD, 2014, ASIAN BIOMED, V8, P185, DOI 10.5372/1905-7415.0802.278; Bandura A, 2001, ANNU REV PSYCHOL, V52, P1, DOI 10.1146/annurev.psych.52.1.1; BANDURA A, 1989, AM PSYCHOL, V44, P1175, DOI 10.1037/0003-066X.44.9.1175; Bilger M, 2013, MED CARE, V51, P471, DOI 10.1097/MLR.0b013e318286e437; Blokstra A, 2012, EUR J CARDIOVASC NUR, V11, P97, DOI 10.1016/j.ejcnurse.2010.10.005; Byrne S, 2015, APPETITE, V95, P593, DOI 10.1016/j.appet.2015.08.028; Carmienke S, 2013, EUR J CLIN NUTR, V67, P573, DOI 10.1038/ejcn.2013.61; Chang C T, 2007, Rural Remote Health, V7, P864; Chen Y, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5446; Chu AHY, 2012, ASIA PACIFIC J PUBLI; CLARK MM, 1991, J CONSULT CLIN PSYCH, V59, P739, DOI 10.1037/0022-006X.59.5.739; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Dalle Grave R, 2013, PSYCHOL RES BEHAV MA, V6, P101, DOI 10.2147/PRBM.S40460; Deurenberg P, 2002, Obes Rev, V3, P141, DOI 10.1046/j.1467-789X.2002.00065.x; Dunkley AJ, 2014, DIABETES CARE, V37, P922, DOI 10.2337/dc13-2195; Ellsworth DL, 2015, OBESITY, V23, P1312, DOI 10.1002/oby.21079; Giese KK, 2014, WORKPLACE HEALTH SAF, V62, P136, DOI 10.3928/21650799-20140305-02; Groeneveld IF, 2010, SCAND J WORK ENV HEA, V36, P202, DOI 10.5271/sjweh.2891; Hallal PC, 2012, LANCET, V380, P247, DOI 10.1016/S0140-6736(12)60646-1; Hasanah C I, 2003, Med J Malaysia, V58, P79; Hasanah C I, 1999, Malays J Med Sci, V6, P21; Hays Laura M, 2014, Diabetes Spectr, V27, P270, DOI 10.2337/diaspect.27.4.270; HOLLON SD, 1980, COGNITIVE THER RES, V4, P383, DOI 10.1007/BF01178214; Hu T, 2016, OBES SCI PRACT, V2, P24, DOI 10.1002/osp4.23; Huang I-C, QUALITY LIFE RES, V15, P15; Johns DJ, 2014, J ACAD NUTR DIET, V114, P1557, DOI 10.1016/j.jand.2014.07.005; Johnson F, 2012, INT J OBESITY, V36, P665, DOI 10.1038/ijo.2011.156; Katterman SN, 2014, EAT BEHAV, V15, P197, DOI 10.1016/j.eatbeh.2014.01.005; Khambalia AZ, 2010, OBES REV, V11, P403, DOI 10.1111/j.1467-789X.2010.00728.x; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Kramer MK, 2015, J OCCUP ENVIRON MED, V57, P284, DOI 10.1097/JOM.0000000000000350; Kramer MK, 2009, AM J PREV MED, V37, P505, DOI 10.1016/j.amepre.2009.07.020; Leahey TM, 2011, OBESITY, V19, P1157, DOI 10.1038/oby.2010.301; Lee PH, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-115; Li R, 2010, DIABETES CARE, V33, P1872, DOI 10.2337/dc10-0843; Liu YL, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000916; Ma J, 2013, JAMA INTERN MED, V173, P113, DOI 10.1001/2013.jamainternmed.987; Ministry of Health M, 2008, MAN HYP; Ministry of Health M Committee, 2015, NATIONAL HEALTH MORB; Mobbs O, 2010, PATIENT EDUC COUNS, V79, P372, DOI 10.1016/j.pec.2010.03.003; Moore CJ, 2012, J ACAD NUTR DIET, V112, P518, DOI 10.1016/j.jand.2011.12.001; Moroshko I, 2011, OBES REV, V12, P912, DOI 10.1111/j.1467-789X.2011.00915.x; Moy FM, 2008, ASIA PACIFIC JPURNAL, V20, P5; Moy F, 2006, HEALTH PROMOT INT, V21, P301, DOI 10.1093/heapro/dal031; Mustapha FI, 2014, INCREASING BURDEN NO; Ng CG, 2010, ASIAN J PSYCHIATR, V3, P3, DOI 10.1016/j.ajp.2009.12.001; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; OEI TPS, 2008, HONG KONG J PSYCHIAT, V18, P92; Pagoto SL, 2013, JAMA-J AM MED ASSOC, V310, P687, DOI 10.1001/jama.2013.8601; Pan CY, 2004, DIABETIC MED, V21, P1007, DOI 10.1111/j.1464-5491.2004.01287.x; Proper KI, 2011, AM J PREV MED, V40, P174, DOI 10.1016/j.amepre.2010.10.015; Rejeski WJ, 2011, J GERONTOL B-PSYCHOL, V66, P279, DOI 10.1093/geronb/gbq104; Salinardi TC, 2013, AM J CLIN NUTR, V97, P667, DOI 10.3945/ajcn.112.046995; Sallit J, 2009, J AM DIET ASSOC, V109, P1398, DOI 10.1016/j.jada.2009.05.009; Schwarzer R., 2014, SELF EFFICACY THOUGH; Seidel MC, 2008, DIABETES CARE, V31, P684, DOI 10.2337/dc07-1869; Soon HK, 2013, SE ASIAN J TROP MED, V44, P295; Ul-Haq Z, 2013, OBESITY, V21, pE322, DOI 10.1002/oby.20107; Verweij LM, 2011, OBES REV, V12, P406, DOI 10.1111/j.1467-789X.2010.00765.x; Wadden TA, 2012, CIRCULATION, V125, P1157, DOI 10.1161/CIRCULATIONAHA.111.039453; Wadden TA, 2011, OBESITY, V19, P1987, DOI 10.1038/oby.2011.230; Wang ML, 2014, OBESITY, V22, P1973, DOI 10.1002/oby.20814; WHO, 2008, NONC DIS COUNTR PROF; WHO, 2008, WAIST CIRCUMFERENCE; Wyatt HR, 2013, J CLIN ENDOCR METAB, V98, P1299, DOI 10.1210/jc.2012-3115; ZIMET GD, 1988, J PERS ASSESS, V52, P30, DOI 10.1207/s15327752jpa5201_2	67	15	15	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0160343	10.1371/journal.pone.0160343	http://dx.doi.org/10.1371/journal.pone.0160343			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DT6ES	27537687	Green Submitted, Green Published, gold			2022-12-27	WOS:000381577000018
J	Jamal, WY; Rotimi, VO				Jamal, Wafaa Y.; Rotimi, Vincent O.			Surveillance of Antibiotic Resistance among Hospital- and Community-Acquired Toxigenic Clostridium difficile Isolates over 5-Year Period in Kuwait	PLOS ONE			English	Article							PCR RIBOTYPE; ANTIMICROBIAL SUSCEPTIBILITY; INFECTION; EMERGENCE; METRONIDAZOLE; EPIDEMIOLOGY; TUBERCULOSIS; GUIDELINES; OUTBREAK; AMERICA	Clostridium difficile infection (CDI) is a leading and an important cause of diarrhea in a healthcare setting especially in industrialized countries. Community-associated CDI appears to add to the burden on healthcare setting problems. The aim of the study was to investigate the antimicrobial resistance of healthcare-associated and community-acquired C. difficile infection over 5 years (2008-2012) in Kuwait. A total of 111 hospital-acquired (HA-CD) and 35 community-acquired Clostridium difficile (CA-CD) clinical isolates from stool of patients with diarrhoea were studied. Antimicrobial susceptibility testing of 15 antimicrobial agents against these pathogens was performed using E test method. There was no evidence of resistance to amoxicillin-clavulanic acid, daptomycin, linezolid, piperacillin-tazobactam, teicoplanin and vancomycin by both HA-CD and CA-CD isolates. Metronidazole had excellent activity against CA-CD but there was a 2.9% resistance rate against HA-CD isolates. Ampicillin, clindamycin, levofloxacin and imipenem resistance rates among the HC-CD vs. CA-CD isolates were 100 vs. 47.4%; 43 vs. 47.4%; 100 vs. 100% and 100 vs. 89%, respectively. An unexpected high rifampicin resistance rate of 15.7% emerged amongst the HA-CD isolates. In conclusion, vancomycin resistance amongst the HA-CD and CA-CD isolates was not encountered in this series but few metronidazole resistant hospital isolates were isolated. High resistance rates of ampicillin, clindamycin, levofloxacin, and imipenem resistance were evident among both CA-CD and HA-CD isolates. Rifampicin resistance is emerging among the HA-CD isolates.	[Jamal, Wafaa Y.] Kuwait Univ, Fac Med, Anaerobe Reference Lab, Jabriya, Kuwait; Kuwait Univ, Fac Med, Dept Microbiol, Jabriya, Kuwait	Kuwait University; Kuwait University	Jamal, WY (corresponding author), Kuwait Univ, Fac Med, Anaerobe Reference Lab, Jabriya, Kuwait.	wjamal@hsc.edu.kw			Kuwait University Research Grant [MI 05/10]	Kuwait University Research Grant	This work was supported by Kuwait University Research Grant no. MI 05/10. The funder had no role in study design, data collection, and analysis, decision to publish or preparation of the manuscript.	Areeshi MY, 2014, J INFECT DEV COUNTR, V8, P1137, DOI 10.3855/jidc.4053; Baines SD, 2008, J ANTIMICROB CHEMOTH, V62, P1046, DOI 10.1093/jac/dkn313; Barbut F, 1999, ANTIMICROB AGENTS CH, V43, P2607, DOI 10.1128/AAC.43.11.2607; CLSI Clinical Laboratory and Standards Institute, 2014, MI00S24 CLSI; CLSI Clinical Laboratory and Standards Institute, 2007, MI00S17 CLSI; Cohen SH, 2010, INFECT CONT HOSP EP, V31, P431, DOI 10.1086/651706; Debast SB, 2014, CLIN MICROBIOL INFEC, V20, P1, DOI 10.1111/1469-0691.12418; Freeman J, 2015, CLIN MICROBIOL INFEC, V21, DOI 10.1016/j.cmi.2014.09.017; Freeman J, 2010, CLIN MICROBIOL REV, V23, P529, DOI 10.1128/CMR.00082-09; Gonzales M, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-363; Goorhuis Abraham, 2008, Infection Control and Hospital Epidemiology, V29, P1162, DOI 10.1086/592257; Jamal WY, 2002, INT J ANTIMICROB AG, V20, P270, DOI 10.1016/S0924-8579(02)00180-2; Knight DR, 2015, J ANTIMICROB CHEMOTH, V70, P2992, DOI 10.1093/jac/dkv220; Kuijper EJ, 2006, CLIN MICROBIOL INFEC, V12, P2, DOI 10.1111/j.1469-0691.2006.01580.x; Kuijper EJ, 2008, CAN MED ASSOC J, V179, P747, DOI 10.1503/cmaj.081211; Lachowicz D, 2015, ANAEROBE, V31, P37, DOI 10.1016/j.anaerobe.2014.09.004; Lee JH, 2014, J MED MICROBIOL, V63, P819, DOI 10.1099/jmm.0.072082-0; Loo VG, 2005, NEW ENGL J MED, V353, P2442, DOI 10.1056/NEJMoa051639; Muto CA, 2005, INFECT CONT HOSP EP, V26, P273, DOI 10.1086/502539; Norman KN, 2014, FOODBORNE PATHOG DIS, V11, P257, DOI 10.1089/fpd.2013.1648; O'Connor JR, 2009, GASTROENTEROLOGY, V136, P1913, DOI 10.1053/j.gastro.2009.02.073; Obuch-Woszczatynski P, 2013, EUR J CLIN MICROBIOL, V32, P1027, DOI 10.1007/s10096-013-1845-5; ONeill GL, 1996, ANAEROBE, V2, P205, DOI 10.1006/anae.1996.0028; Owens RC, 2008, CLIN INFECT DIS, V46, pS19, DOI 10.1086/521859; Pelaez T, 2008, J CLIN MICROBIOL, V46, P3028, DOI 10.1128/JCM.00524-08; Pelaez T, 2002, ANTIMICROB AGENTS CH, V46, P1647, DOI 10.1128/AAC.46.6.1647-1650.2002; Riley TV, 2009, MED J AUSTRALIA, V190, P706, DOI 10.5694/j.1326-5377.2009.tb02644.x; Rouphael NG, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2008.01.062; Spigaglia P, 2011, J ANTIMICROB CHEMOTH, V66, P2227, DOI 10.1093/jac/dkr292; Surawicz CM, 2013, AM J GASTROENTEROL, V108, P478, DOI 10.1038/ajg.2013.4; Udo EE, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-168	31	16	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0161411	10.1371/journal.pone.0161411	http://dx.doi.org/10.1371/journal.pone.0161411			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27536994	Green Published, Green Submitted, gold			2022-12-27	WOS:000381577000103
J	Martinez-Hervas, S; Navarro, I; Real, JT; Artero, A; Peiro, M; Gonzalez-Navarro, H; Carmena, R; Ascaso, JF				Martinez-Hervas, Sergio; Navarro, Inmaculada; Real, Jose T.; Artero, Ana; Peiro, Marta; Gonzalez-Navarro, Herminia; Carmena, Rafael; Ascaso, Juan F.			Unsaturated Oral Fat Load Test Improves Glycemia, Insulinemia and Oxidative Stress Status in Nondiabetic Subjects with Abdominal Obesity	PLOS ONE			English	Article							MITOCHONDRIAL BIOENERGETICS; PROTEIN CARBONYLATION; POSTPRANDIAL LIPEMIA; ENDOTHELIAL FUNCTION; RESISTANCE; ACIDS; GLUCOSE; HUMANS; INFLAMMATION; SENSITIVITY	Aims To evaluate the changes in glycemia, insulinemia, and oxidative stress markers during an oral fat load test in nondiabetic subjects with abdominal obesity and to analyze the association between postprandial oxidative stress markers and postprandial glucose and insulin responses. Methods We included 20 subjects with abdominal obesity (waist circumference > 102 cm for men and > 88 cm for women) and 20 healthy lean controls (waist circumference < 102 cm for men and < 88 cm for women). After 12 hours of fasting we performed a standardized fat load test (0-8 hours) with supracal (R) (50 g/m(2)). We determined metabolic parameters, oxidized and reduced glutathione, and malondialdehyde. Results In both groups, insulin, HOMA, oxidized/reduced glutathione ratio, and malondialdehyde significantly decreased in the postprandial state after the OFLT. All these parameters were significantly higher in the abdominal obesity group at baseline and during all the postprandial points, but the reduction from the baseline levels was significantly higher in the abdominal obesity group. Conclusion Unsaturated fat improves insulin resistance and oxidative stress status. It is possible that a consumption of unsaturated fat could be beneficial even in subjects with abdominal obesity in postprandial state.	[Martinez-Hervas, Sergio; Navarro, Inmaculada; Real, Jose T.; Artero, Ana; Ascaso, Juan F.] Hosp Clin Univ Valencia, Serv Endocrinol & Nutr Hosp, Valencia, Spain; [Martinez-Hervas, Sergio; Real, Jose T.; Carmena, Rafael; Ascaso, Juan F.] Univ Valencia, Dept Med, Valencia, Spain; [Martinez-Hervas, Sergio; Real, Jose T.; Peiro, Marta; Gonzalez-Navarro, Herminia; Carmena, Rafael; Ascaso, Juan F.] ISCIII, CIBER Diabet & Associated Metab Dis CIBERDEM, Madrid, Spain; [Peiro, Marta; Gonzalez-Navarro, Herminia; Carmena, Rafael] Hosp Clin Res Fdn INCLIVA, Valencia, Spain	University of Valencia; CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; Instituto de Salud Carlos III	Real, JT (corresponding author), Hosp Clin Univ Valencia, Serv Endocrinol & Nutr Hosp, Valencia, Spain.; Real, JT (corresponding author), Univ Valencia, Dept Med, Valencia, Spain.; Real, JT (corresponding author), ISCIII, CIBER Diabet & Associated Metab Dis CIBERDEM, Madrid, Spain.	jtreal@uv.es	Martinez-Hervas, Sergio/K-2829-2014	Martinez-Hervas, Sergio/0000-0002-6775-2034; Gonzalez-Navarro, Herminia/0000-0001-6883-3808	Fondo de Investigaciones Sanitarias [FIS 10/0051, FIS 05/0348, FIS 12/01978]; Valencian Government [GE-010/09]	Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III); Valencian Government	This work has been supported by grants from Fondo de Investigaciones Sanitarias to Juan F. Ascaso T (FIS 10/0051), Jose T. Real (FIS 05/0348, FIS 12/01978) and CIBER de Diabetes y Enfermedades Metabolicas Asociadas, and from the Valencian Government to Sergio Martinez-Hervas (GE-010/09).	Anderson EJ, 2009, J CLIN INVEST, V119, P573, DOI 10.1172/JCI37048; Belfort R, 2005, DIABETES, V54, P1640, DOI 10.2337/diabetes.54.6.1640; Berlett BS, 1997, J BIOL CHEM, V272, P20313, DOI 10.1074/jbc.272.33.20313; BORKMAN M, 1993, NEW ENGL J MED, V328, P238, DOI 10.1056/NEJM199301283280404; CABEZAS MC, 1993, J CLIN INVEST, V92, P160, DOI 10.1172/JCI116544; Capurso C, 2012, VASC PHARMACOL, V57, P91, DOI 10.1016/j.vph.2012.05.003; Ceriello A, 2004, ARTERIOSCL THROM VAS, V24, P816, DOI 10.1161/01.ATV.0000122852.22604.78; Chen LJ, 2008, AGING CELL, V7, P866, DOI 10.1111/j.1474-9726.2008.00432.x; Cocco T, 1999, FREE RADICAL BIO MED, V27, P51, DOI 10.1016/S0891-5849(99)00034-9; Cortes B, 2006, J AM COLL CARDIOL, V48, P1666, DOI 10.1016/j.jacc.2006.06.057; Curtis JM, 2010, DIABETES, V59, P1132, DOI 10.2337/db09-1105; Delarue J, 1996, AM J PHYSIOL-ENDOC M, V270, pE353, DOI 10.1152/ajpendo.1996.270.2.E353; Eckel RH, 2005, CIRCULATION, V111, pE257, DOI 10.1161/01.CIR.0000163653.38992.E5; El-Assaad W, 2003, ENDOCRINOLOGY, V144, P4154, DOI 10.1210/en.2003-0410; Espinosa A, 2009, J BIOL CHEM, V284, P2568, DOI 10.1074/jbc.M804249200; Fernandez-Sanchez A, 2011, INT J MOL SCI, V12, P3117, DOI 10.3390/ijms12053117; Fisher-Wellman KH, 2012, TRENDS ENDOCRIN MET, V23, P142, DOI 10.1016/j.tem.2011.12.008; Frohnert BI, 2011, OBESITY, V19, P1735, DOI 10.1038/oby.2011.115; Iggman D, 2010, DIABETOLOGIA, V53, P850, DOI 10.1007/s00125-010-1669-0; Koves TR, 2008, CELL METAB, V7, P45, DOI 10.1016/j.cmet.2007.10.013; Le KA, 2006, CURR OPIN CLIN NUTR, V9, P469, DOI 10.1097/01.mco.0000232910.61612.4d; Lozano A, 2013, NUTR RES, V33, P1012, DOI 10.1016/j.nutres.2013.08.010; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; MayerDavis EJ, 1997, AM J CLIN NUTR, V65, P79, DOI 10.1093/ajcn/65.1.79; Navarro J, 1997, FREE RADICAL BIO MED, V22, P1203, DOI 10.1016/S0891-5849(96)00554-0; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Oltra AM, 2001, FREE RADICAL BIO MED, V30, P1286, DOI 10.1016/S0891-5849(01)00521-4; Paglialunga S, 2007, APPL PHYSIOL NUTR ME, V32, P61, DOI 10.1139/h06-100; Pedro T, 2013, TRANSL RES, V161, P50, DOI 10.1016/j.trsl.2012.09.002; Pou KM, 2007, CIRCULATION, V116, P1234, DOI 10.1161/CIRCULATIONAHA.107.710509; Ruggiero C, 2011, AM J PHYSIOL-ENDOC M, V300, pE1047, DOI 10.1152/ajpendo.00666.2010; Salas-Salvado J, 2011, DIABETES CARE, V34, P14, DOI 10.2337/dc10-1288; Stein DT, 1997, J CLIN INVEST, V100, P398, DOI 10.1172/JCI119546; Stocker R, 2004, PHYSIOL REV, V84, P1381, DOI 10.1152/physrev.00047.2003; Thomsen C, 1999, AM J CLIN NUTR, V69, P1135; Tsai WC, 2004, CLIN SCI, V106, P315, DOI 10.1042/CS20030227; Vessby B, 2001, DIABETOLOGIA, V44, P312, DOI 10.1007/s001250051620; Vincent HK, 2006, INT J OBESITY, V30, P400, DOI 10.1038/sj.ijo.0803177; Wang XF, 2015, J ENDOCRINOL, V224, pR97, DOI 10.1530/JOE-14-0581; Wassmann S, 2004, HYPERTENSION, V44, P381, DOI 10.1161/01.HYP.0000142232.29764.a7; Weinbrenner T, 2004, J NUTR, V134, P2314, DOI 10.1093/jn/134.9.2314	42	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0161400	10.1371/journal.pone.0161400	http://dx.doi.org/10.1371/journal.pone.0161400			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27537847	gold, Green Submitted, Green Published			2022-12-27	WOS:000381577000099
J	Tawfik, S; El Koofy, N; Moawad, EMI				Tawfik, Safaa; El Koofy, Nehal; Moawad, Eman Mohamed Ibraheim			Patterns of Nutrition and Dietary Supplements Use in Young Egyptian Athletes: A Community-Based Cross-Sectional Survey	PLOS ONE			English	Article							CREATINE USE; TEAM SPORTS; KNOWLEDGE; ADOLESCENTS; STRENGTH; CHILDREN; COACHES; PLAYERS; DRINKS; NEEDS	The aim of this study was to investigate the pattern of basic and sport nutrition as well as perspectives of young Egyptian athletes. Structured interview survey measuring knowledge, attitudes, beliefs and behaviors about basic and sport nutrition was administered to adolescent athletes recruited from 4 sport clubs and 2 fitness centers in Greater Cairo governorate. A total of 358 participants aged 13-18 years completed questionnaires. Basic nutrition knowledge was reasonable in almost all domains except fast food. Fixed breakfast (78.5%), home meals (lunch, 70.7%), and healthy snacks (55.8%) were the most positive features of the basic dietary pattern. More than 70% perceived themselves as knowledgeable about sport nutrition. The prevalence rate of sport supplement intake was (48.9%, n = 175), predominantly sport drinks (66.9%) and creatine (54.3%). Coaches were the primary source of sport nutrition information. Forty-four percent of participants (n = 77/175) reported supplement consumption during competition seasons only. Better physical appearance and enhancement of athletic performance were the major motivations for supplement intake. These findings indicate the necessity of a comprehensive nutrition education program targeting not only athletes and parents, but also coaching staff, health trainers and all sport team officials.	[Tawfik, Safaa] Minist Hlth Cairo, Natl Inst Nutr, Cairo, Egypt; [El Koofy, Nehal; Moawad, Eman Mohamed Ibraheim] Cairo Univ, Dept Pediat, Fac Med, Cairo, Egypt	Egyptian Knowledge Bank (EKB); Ministry of Health & Population - Egypt; Egyptian Knowledge Bank (EKB); Cairo University	Moawad, EMI (corresponding author), Cairo Univ, Dept Pediat, Fac Med, Cairo, Egypt.	eimanmoawad@yahoo.com						Aljaloud SO, 2013, J NUTR METAB, V2013, DOI 10.1155/2013/245349; [Anonymous], [No title captured]; Braun H, 2009, INT J SPORT NUTR EXE, V19, P97, DOI 10.1123/ijsnem.19.1.97; Buergel NS, 2002, J AM DIET ASSOC, V102, P1283, DOI 10.1016/S0002-8223(02)90282-8; Burkhart SJ, 2009, ANN C NUTR SOC NZ, P45; Calfee R, 2006, PEDIATRICS, V117, pE577, DOI 10.1542/peds.2005-1429; Corrigan B, 2003, CLIN J SPORT MED, V13, P33, DOI 10.1097/00042752-200301000-00007; Croll JK, 2006, J AM DIET ASSOC, V106, P709, DOI 10.1016/j.jada.2006.02.010; Dawson WJ, 2002, MED PROBL PERFORM AR, V17, P50; de Silva A, 2010, INT J SPORT NUTR EXE, V20, P15, DOI 10.1123/ijsnem.20.1.15; Dunford, 2018, NUTR SPORT EXERCISE; Erdman KA, 2007, CLIN J SPORT MED, V17, P458, DOI 10.1097/JSM.0b013e31815aed33; Etchison WC, 2011, SPORTS HEALTH, V3, P249, DOI 10.1177/1941738111404655; Galanti G, 2015, TRANSL MED UNISA, V11, P44; Giannopoulou I, 2013, J SPORT SCI MED, V12, P190; Golshanraz A., 2012, INT J SPORT HLTH SCI, V6, P2480; Grete R.H., 2011, FOOD NUTR SCI, V2011; Hassan-Wassef H, 2004, E MEDITERR HEALTH J, V10, P899; Herbold NH, 2004, INT J SPORT NUTR EXE, V14, P586, DOI 10.1123/ijsnem.14.5.586; HICKSON JF, 1987, J AM DIET ASSOC, V87, P1656; Jacobson BH, 2001, J STRENGTH COND RES, V15, P63; Lachheb M, IDENTITY NATION AFRI, P99; Lazic JS, 2011, SCAND J MED SCI SPOR, V21, P260, DOI 10.1111/j.1600-0838.2009.01026.x; LOOSLI AR, 1990, PEDIATR CLIN N AM, V37, P1143; Metzl JD, 2001, PEDIATRICS, V108, P421, DOI 10.1542/peds.108.2.421; Nazni Peerkhan, 2010, Asian J Sports Med, V1, P93; Nemet Dan, 2007, Harefuah, V146, P794; Nieper A, 2005, BRIT J SPORT MED, V39, P645, DOI 10.1136/bjsm.2004.015842; Parmenter K, 1999, EUR J CLIN NUTR, V53, P298, DOI 10.1038/sj.ejcn.1600726; Petrie HJ, 2004, NUTRITION, V20, P620, DOI 10.1016/j.nut.2004.04.002; Purcell LK, 2013, PAED CHILD HEALT-CAN, V18, P200, DOI 10.1093/pch/18.4.200; Rash C, 2008, SPORT J, V11, P48; Rosenbloom CA, 2002, J AM DIET ASSOC, V102, P418, DOI 10.1016/S0002-8223(02)90098-2; Salamon Lester M, 1998, NONPROFIT SECTOR DEV, V5; Sartorius N., 1994, QUALITY LIFE ASSESSM, P3, DOI [10.1007/978-3-642-79123-9_1, DOI 10.1007/978-3-642-79123-9_1]; Sawka MN, 2007, MED SCI SPORT EXER, V39, P377, DOI 10.1249/mss.0b013e31802ca597; Seifert SM, 2011, PEDIATRICS, V127, P511, DOI 10.1542/peds.2009-3592; Shifflett B, 2002, RES Q EXERCISE SPORT, V73, P357, DOI 10.1080/02701367.2002.10609032; Singhal V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100218; Slater G, 2011, J SPORT SCI, V29, pS67, DOI 10.1080/02640414.2011.574722; Smith JW, 2015, J SPORTS MED, V2015, P1, DOI 10.1155/2015/734649; SOBAL J, 1994, INT J SPORT NUTR, V4, P320, DOI 10.1123/ijsn.4.4.320; Stafford I., 2005, COACHWISE BUSINESS S; Sundgot-Borgen J, 2004, CLIN J SPORT MED, V14, P25, DOI 10.1097/00042752-200401000-00005; Sundgot-Borgen J, 2003, SCAND J MED SCI SPOR, V13, P138, DOI 10.1034/j.1600-0838.2003.10288.x; Torres-McGehee TM, 2012, J ATHL TRAINING, V47, P205; Unnithan VB, 2001, J STRENGTH COND RES, V15, P524; Viell B, 1996, Z ERNAHRUNGSWISS, V35, P378, DOI 10.1007/BF01610556; Walsh M, 2011, INT J SPORT NUTR EXE, V21, P365, DOI 10.1123/ijsnem.21.5.365; Zinn C, 2005, J SCI MED SPORT, V8, P346, DOI 10.1016/S1440-2440(05)80045-3	50	25	26	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2016	11	8							e0161252	10.1371/journal.pone.0161252	http://dx.doi.org/10.1371/journal.pone.0161252			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4UN	27529492	Green Published, gold, Green Submitted			2022-12-27	WOS:000381476700059
J	Wei, Y; Xu, J; Zhou, GQ; Chen, SW; Ouyang, P; Liu, SW				Wei, Yong; Xu, Juan; Zhou, Genqing; Chen, Songwen; Ouyang, Ping; Liu, Shaowen			Renal Denervation Suppresses the Inducibility of Atrial Fibrillation in a Rabbit Model for Atrial Fibrosis	PLOS ONE			English	Article							SYMPATHETIC DENERVATION; NERVE ACTIVITY; MECHANISMS; SYSTEM; IMPACT	Renal denervation (RD) was reported to reduce the susceptibility of atrial fibrillation (AF), but the underlying mechanism has not been well understood. This study was performed to investigate the effect of RD on the inducibility of AF in a rabbit model for atrial fibrosis and to explore the potential mechanisms. Thirty-five rabbits were randomly assigned into sham-operated group (n = 12), abdominal aortic constriction (AAC) group (n = 12) and AAC with RD (AAC-RD) group (n = 11). The incidence of AF induced by burst pacing in atriums was determined. Blood was collected to measure the levels of rennin, angiotensin II and aldosterone. Atrial samples were preserved to evaluate protein and gene expression of collagen, connective tissue growth factor (CTGF) and transforming growth factor-beta 1 (TGF-beta 1). Our data suggested cardiac structure remodeling and atrial fibrosis were successfully induced by AAC. Compared with the AAC group, the AAC-RD rabbits had smaller ascending aortic diameter and left ventricular end-systolic diameter. For burst pacing at the left atrium (LA), AF was induced in two of the 12 rabbits in the sham-operated group, 10 of the 12 rabbits in the AAC group, and 2 of the 11 rabbits in the AAC-RD group, with great difference among the three groups (P = 0.001). The percentage of LA burst stimulations with induced AF achieved 47.2% in the AAC group, which was higher than those in both the AAC-RD (12.1%) and the Sham-operated (5.6%) groups. Significantly increasing intercellular space in the AAC group (P<0.001) compared with the sham-operated rabbits. RD clearly decreased the volume fraction of collagen in LA and right atrium compared with that of the AAC group (P<0.01). AAC-induced elevation of collagen I, CTGF and TGF-beta 1 was suppressed by RD. In conclusion, RD suppressed the inducibility of AF in a rabbit model for pressure associated atrial fibrosis, potentially by modulating renin-angiotensin-aldosterone system and decreasing pro-fibrotic factors.	[Wei, Yong; Ouyang, Ping] Shanghai Songjiang Cent Hosp, Dept Cardiol, Shanghai 201600, Peoples R China; [Wei, Yong; Xu, Juan; Zhou, Genqing; Chen, Songwen; Liu, Shaowen] Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 1, Dept Cardiol, Shanghai 200800, Peoples R China	Shanghai Jiao Tong University	Liu, SW (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 1, Dept Cardiol, Shanghai 200800, Peoples R China.	shaowen.liu@hotmail.com	Liu, Shaowen/AAJ-4121-2020; Chen, Songwen/AAI-4389-2020	Chen, Songwen/0000-0002-6492-5702; Zhou, Genqing/0000-0003-4506-7658	Youth Project of the National Natural Science Fund of China [81300137, 81400245]; Shanghai Municipal Commission of Health and Family Planning [20134Y182]	Youth Project of the National Natural Science Fund of China; Shanghai Municipal Commission of Health and Family Planning	This work was supported by Youth Project of the National Natural Science Fund of China (grant number 81300137 and 81400245) and a grant from Shanghai Municipal Commission of Health and Family Planning (grant number: 20134Y182).	Anand K, 2006, AM HEART J, V152, P217, DOI 10.1016/j.ahj.2006.01.007; Bakris GL, 2014, J AM COLL CARDIOL, V64, P1071, DOI 10.1016/j.jacc.2014.05.012; Bhatt DL, 2014, NEW ENGL J MED, V370, P1393, DOI 10.1056/NEJMoa1402670; Booth LC, 2012, AM J PHYSIOL-REG I, V303, pR30, DOI 10.1152/ajpregu.00063.2012; de Vos CB, 2008, EUR HEART J, V29, P632, DOI 10.1093/eurheartj/ehn025; Dias LD, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-33; Doltra A, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.001353; Ducharme A, 2006, AM HEART J, V152, P86, DOI 10.1016/j.ahj.2005.06.036; Dzeshka MS, 2015, J AM COLL CARDIOL, V66, P943, DOI 10.1016/j.jacc.2015.06.1313; Esler MD, 2012, CIRCULATION, V126, P2976, DOI 10.1161/CIRCULATIONAHA.112.130880; Krum H, 2014, LANCET, V383, P622, DOI 10.1016/S0140-6736(13)62192-3; Krum H, 2009, LANCET, V373, P1275, DOI 10.1016/S0140-6736(09)60566-3; Levy S, 2006, NAT CLIN PRACT CARD, V3, P220, DOI 10.1038/ncpcardio0480; Liang Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105974; Linz D, 2015, CIRC-ARRHYTHMIA ELEC, V8, P466, DOI 10.1161/CIRCEP.114.002453; Linz D, 2012, HYPERTENSION, V60, P172, DOI 10.1161/HYPERTENSIONAHA.112.191965; Ogawa M, 2007, J AM COLL CARDIOL, V50, P335, DOI 10.1016/j.jacc.2007.03.045; Patel BM, 2012, EUR J PHARMACOL, V697, P1, DOI 10.1016/j.ejphar.2012.09.034; Pokushalov E, 2012, J AM COLL CARDIOL, V60, P1163, DOI 10.1016/j.jacc.2012.05.036; Redpath CJ, 2006, J MOL CELL CARDIOL, V40, P717, DOI 10.1016/j.yjmcc.2006.01.012; Sadowski J, 2011, HYPERTENSION, V57, P911, DOI 10.1161/HYPERTENSIONAHA.110.163014; Schotten U, 2011, PHYSIOL REV, V91, P265, DOI 10.1152/physrev.00031.2009; Sobotka PA, 2011, CLIN RES CARDIOL, V100, P1049, DOI 10.1007/s00392-011-0335-y; Takahashi N, 2012, CIRC J, V76, P2318, DOI 10.1253/circj.CJ-12-1099; Tan AY, 2008, CIRCULATION, V118, P916, DOI 10.1161/CIRCULATIONAHA.108.776203; Wang XL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064611; Watanabe H, 2016, HYPERTENS RES, V39, P217, DOI 10.1038/hr.2015.133; Witkowski A, 2011, HYPERTENSION, V58, P559, DOI 10.1161/HYPERTENSIONAHA.111.173799; Zhao QY, 2012, J INTERV CARD ELECTR, V35, P119, DOI 10.1007/s10840-012-9717-y	29	10	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2016	11	8							e0160634	10.1371/journal.pone.0160634	http://dx.doi.org/10.1371/journal.pone.0160634			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4UN	27529427	Green Submitted, Green Published, gold			2022-12-27	WOS:000381476700013
J	Gao, GW; Yang, J; Jing, XY; Huang, P; Hua, JL; Yue, D				Gao, Guangwei; Yang, Jian; Jing, Xiaoyuan; Huang, Pu; Hua, Juliang; Yue, Dong			Robust Face Recognition via Multi-Scale Patch-Based Matrix Regression	PLOS ONE			English	Article							COLLABORATIVE REPRESENTATION; SPARSE REPRESENTATION; IMAGE; ALGORITHM; SAMPLE	In many real-world applications such as smart card solutions, law enforcement, surveillance and access control, the limited training sample size is the most fundamental problem. By making use of the low-rank structural information of the reconstructed error image, the socalled nuclear norm-based matrix regression has been demonstrated to be effective for robust face recognition with continuous occlusions. However, the recognition performance of nuclear norm-based matrix regression degrades greatly in the face of the small sample size problem. An alternative solution to tackle this problem is performing matrix regression on each patch and then integrating the outputs from all patches. However, it is difficult to set an optimal patch size across different data-bases. To fully utilize the complementary information from different patch scales for the final decision, we propose a multi-scale patch-based matrix regression scheme based on which the ensemble of multi-scale outputs can be achieved optimally. Extensive experiments on benchmark face databases validate the effectiveness and robustness of our method, which outperforms several state-of-the-art patch-based face recognition algorithms.	[Gao, Guangwei; Yue, Dong] Nanjing Univ Posts & Telecommun, Inst Adv Technol, Nanjing 210023, Jiangsu, Peoples R China; [Yang, Jian; Hua, Juliang] Nanjing Univ Sci & Technol, Sch Comp Sci & Engn, Nanjing 210094, Jiangsu, Peoples R China; [Jing, Xiaoyuan] Nanjing Univ Posts & Telecommun, Sch Automat, Nanjing 210023, Jiangsu, Peoples R China; [Huang, Pu] Nanjing Univ Posts & Telecommun, Sch Comp Sci & Technol, Nanjing 210023, Jiangsu, Peoples R China	Nanjing University of Posts & Telecommunications; Nanjing University of Science & Technology; Nanjing University of Posts & Telecommunications; Nanjing University of Posts & Telecommunications	Gao, GW (corresponding author), Nanjing Univ Posts & Telecommun, Inst Adv Technol, Nanjing 210023, Jiangsu, Peoples R China.	csggao@gmail.com			National Science Fund for Distinguished Young Scholars [61125305, 91420201, 61472187, 61233011, 61373063]; National Natural Science Foundation of China [61502245, 61503188, 61503195]; NUPTSF [NY214204, NY214165]; China Postdoctoral Science Foundation [2015M571786]; Natural Science Fund for Colleges and Universities in Jiangsu Province [15KJB520026]; Natural Science Foundation of Jiangsu Province [BK20150849, BK20150982]; Key Project of Chinese Ministry of Education [313030]; 973 Program [2014CB349303]; Fundamental Research Funds for the Central Universities [30920140121005]; Program for Changjiang Scholars and Innovative Research Team in University [IRT13072]	National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NUPTSF; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Natural Science Fund for Colleges and Universities in Jiangsu Province; Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Key Project of Chinese Ministry of Education(Ministry of Education, China); 973 Program(National Basic Research Program of China); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	This work was partially supported by the National Science Fund for Distinguished Young Scholars under Grant Nos. 61125305, 91420201, 61472187, 61233011 and 61373063, the National Natural Science Foundation of China under Grant Nos. 61502245, 61503188 and 61503195, the NUPTSF under Grant Nos. NY214204 and NY214165, the China Postdoctoral Science Foundation No. 2015M571786, the Natural Science Fund for Colleges and Universities in Jiangsu Province No. 15KJB520026, the Natural Science Foundation of Jiangsu Province under Grant Nos. BK20150849 and BK20150982, the Key Project of Chinese Ministry of Education under Grant No. 313030, the 973 Program No. 2014CB349303, Fundamental Research Funds for the Central Universities No. 30920140121005, and Program for Changjiang Scholars and Innovative Research Team in University No. IRT13072.	Beveridge JR, 2001, 3 WORKSH EMP EV COMP, P1; Cai JF, 2010, SIAM J OPTIMIZ, V20, P1956, DOI 10.1137/080738970; Chen BJ, 2015, J MATH IMAGING VIS, V51, P124, DOI 10.1007/s10851-014-0511-6; Chen SC, 2004, PATTERN RECOGN, V37, P1553, DOI 10.1016/j.patcog.2003.12.010; Deng ZH, 2014, IEEE T CYBERNETICS, V44, P2585, DOI 10.1109/TCYB.2014.2311014; Gao GW, 2015, APPL SOFT COMPUT, V37, P48, DOI 10.1016/j.asoc.2015.07.034; Gao GW, 2014, NEUROCOMPUTING, V134, P92, DOI 10.1016/j.neucom.2012.12.059; Gu B, 2016, IEEE T NEUR NET LEAR, DOI [DOI 10.1109/TNNLS.2016.2527796, 10.1109/TNNLS.2016.2527796]; Gu B, 2017, IEEE T NEUR NET LEAR, V28, P1646, DOI 10.1109/TNNLS.2016.2544779; Gu B, 2015, IEEE T NEUR NET LEAR, V26, P1403, DOI 10.1109/TNNLS.2014.2342533; Gu B, 2015, NEURAL NETWORKS, V67, P140, DOI 10.1016/j.neunet.2015.03.013; Guillaumin M, 2009, IEEE I CONF COMP VIS, P498, DOI 10.1109/ICCV.2009.5459197; Guo ZH, 2016, IEEE T IMAGE PROCESS, V25, P687, DOI 10.1109/TIP.2015.2507408; He R, 2014, IEEE T PATTERN ANAL, V36, P261, DOI 10.1109/TPAMI.2013.102; Huang G. B., 2007, 0749 U MASS; Jain AK, 2004, IEEE T CIRC SYST VID, V14, P4, DOI 10.1109/TCSVT.2003.818349; Jiang JJ, 2014, IEEE T MULTIMEDIA, V16, P1268, DOI 10.1109/TMM.2014.2311320; Jiang YZ, 2015, IEEE T CYBERNETICS, V45, P548, DOI 10.1109/TCYB.2014.2330844; Juang CF, 2007, IEEE T SYST MAN CY A, V37, P1077, DOI 10.1109/TSMCA.2007.904579; Kim SJ, 2007, IEEE J-STSP, V1, P606, DOI 10.1109/JSTSP.2007.910971; Kumar R, 2011, IEEE I CONF COMP VIS, P2375, DOI 10.1109/ICCV.2011.6126520; Kumar R, 2009, PROC CVPR IEEE, P150, DOI 10.1109/CVPRW.2009.5206837; Lai ZH, 2014, IEEE T CIRC SYST VID, V24, P1651, DOI 10.1109/TCSVT.2014.2305495; Lai ZH, 2014, IEEE T NEUR NET LEAR, V25, P1942, DOI 10.1109/TNNLS.2013.2297381; Lee KC, 2005, IEEE T PATTERN ANAL, V27, P684, DOI 10.1109/TPAMI.2005.92; Lin D., 2006, 2006 IEEE COMP SOC C, P1355; Lin Z., 2013, J STRUCT BIOL, V181, P116, DOI [10.1016/j.jsb.2012.10.010, DOI 10.1016/J.JSB.2012.10.010]; Luo L, 2014, INT C PATT RECOG, P1834, DOI 10.1109/ICPR.2014.321; Martinez A., 1998, AR FACE DATABASE CVC; Naseem I, 2010, IEEE T PATTERN ANAL, V32, P2106, DOI 10.1109/TPAMI.2010.128; Ou WH, 2014, PATTERN RECOGN, V47, P1559, DOI 10.1016/j.patcog.2013.10.017; Qian JJ, 2015, PATTERN RECOGN, V48, P3145, DOI 10.1016/j.patcog.2015.04.017; Shawe-Taylor J., 1999, 4 EUR C COMP LEARN T; Shen CH, 2010, IEEE T PATTERN ANAL, V32, P2216, DOI 10.1109/TPAMI.2010.47; Su Y, 2009, IEEE T IMAGE PROCESS, V18, P1885, DOI 10.1109/TIP.2009.2021737; Tan XY, 2006, PATTERN RECOGN, V39, P1725, DOI 10.1016/j.patcog.2006.03.013; Tan XY, 2005, IEEE T NEURAL NETWOR, V16, P875, DOI 10.1109/TNN.2005.849817; Tawari A, 2013, IEEE T MULTIMEDIA, V15, P1543, DOI 10.1109/TMM.2013.2266635; Wagner A, 2012, IEEE T PATTERN ANAL, V34, P372, DOI 10.1109/TPAMI.2011.112; Wen XZ, 2015, INFORM SCIENCES, V295, P395, DOI 10.1016/j.ins.2014.10.040; Wolf L, 2011, IEEE T PATTERN ANAL, V33, P1978, DOI 10.1109/TPAMI.2010.230; Wong WK, 2015, IEEE T CYBERNETICS, V45, P2425, DOI 10.1109/TCYB.2014.2374452; Wright J, 2009, IEEE T PATTERN ANAL, V31, P210, DOI 10.1109/TPAMI.2008.79; Yang J, 2017, IEEE T PATTERN ANAL, V39, P156, DOI 10.1109/TPAMI.2016.2535218; Yang J, 2012, PATTERN RECOGN, V45, P1104, DOI 10.1016/j.patcog.2011.08.022; Yang M, 2015, NEUROCOMPUTING, V168, P70, DOI 10.1016/j.neucom.2015.06.013; Yang M, 2014, PATTERN RECOGN, V47, P535, DOI 10.1016/j.patcog.2013.08.003; Yang M, 2011, PROC CVPR IEEE, P625, DOI 10.1109/CVPR.2011.5995393; Yang WK, 2015, PATTERN RECOGN, V48, P20, DOI 10.1016/j.patcog.2014.07.009; Zhang FL, 2015, IEEE T IMAGE PROCESS, V24, P1956, DOI 10.1109/TIP.2015.2400213; Zhang L, 2011, IEEE I CONF COMP VIS, P471, DOI 10.1109/ICCV.2011.6126277; Zhu PF, 2012, LECT NOTES COMPUT SC, V7572, P822, DOI 10.1007/978-3-642-33718-5_59	52	4	4	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2016	11	8							e0159945	10.1371/journal.pone.0159945	http://dx.doi.org/10.1371/journal.pone.0159945			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4SL	27525734	Green Published, Green Submitted, gold			2022-12-27	WOS:000381471100009
J	Saeed, I; Bachir, DG; Chen, L; Hu, YG				Saeed, Iqbal; Bachir, Daoura Goudia; Chen, Liang; Hu, Yin-Gang			The Expression of TaRca2-alpha Gene Associated with Net Photosynthesis Rate, Biomass and Grain Yield in Bread Wheat (Triticum aestivum L.) under Field Conditions	PLOS ONE			English	Article							RUBISCO ACTIVASE; GROWTH; MAIZE; PRODUCTIVITY; CAPACITY; ISOFORMS; PROTEIN	Improvement in activation of Rubisco by Rubisco activase can potentially enhance CO2 assimilation and photosynthetic efficiency in plants. The three homoeologous copies of TaRca2-alpha were identified on chromosomes 4AL, 4BS and 4DS (TaRca2-alpha-4AL, TaRca2-alpha-4BS, and TaRca2-alpha-4DS) in bread wheat. Expression patterns of the three copies at heading (Z55), anthesis (Z67) and grain-filling (Z73) stages were investigated through qRT-PCR analyses in a panel of 59 bread wheat genotypes and their effects on net photosynthesis rate (Pn), biomass plant(-1) (BMPP) and grain yield plant(-1) (GYPP) were further explored. Different but similar expression patterns were observed for the three copies of TaRca2-alpha at the three growth stages with highest expression at grain-filling stage. TaRca2-alpha-4BS expressed higher at the three stages than TaRca2-alpha-4AL and TaRca2-alpha-4DS. The 59 genotypes could be clustered into three groups as high (7 genotypes), intermediate (41 genotypes) and low (11 genotypes) expression based on the expression of the three copies of TaRca2-alpha at three growth stages. Significant variations (P<0.01) were observed among the three groups of bread wheat genotypes for Pn, BMPP and GYPP. Generally, the genotypes with higher TaRca2-alpha expression also showed higher values for Pn, BMPP and GYPP. The expressions of the three copies of TaRca2-alpha at heading, anthesis and grain-filling stages were positively correlated with Pn, BMPP and GYPP (P<0.01) with stronger association for TaRca2 alpha- 4BS at grain-filling stage. These results revealed that the expression of TaRca2-alpha contribute substantially to Pn, BMPP and GYPP, and suggested that manipulating TaRca-alpha expression may efficiently improve Pn, BMPP and GYPP in bread wheat and detecting TaRca-a expression levels with emphasis on TaRca2-alpha-4BS may be a positive strategy for selection in improving photosynthetic efficiency and grain yield of bread wheat.	[Saeed, Iqbal; Bachir, Daoura Goudia; Chen, Liang; Hu, Yin-Gang] Northwest A&F Univ, Coll Agron, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China; [Saeed, Iqbal] NIFA, POB 446, Peshawar, KP, Pakistan; [Hu, Yin-Gang] Inst Water Saving Agr Arid Reg China, Yangling 712100, Shaanxi, Peoples R China	Northwest A&F University - China; Nuclear Institute for Food & Agriculture - Pakistan	Hu, YG (corresponding author), Northwest A&F Univ, Coll Agron, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China.; Hu, YG (corresponding author), Inst Water Saving Agr Arid Reg China, Yangling 712100, Shaanxi, Peoples R China.	huyingang@nwsuaf.edu.cn			863 Program of the Ministry of Science and Technology [2013AA102902]; China 111 Project, P. R. China [B12007]	863 Program of the Ministry of Science and Technology; China 111 Project, P. R. China	This work is supported by sub-project of the 863 Program (2013AA102902) of the Ministry of Science and Technology, and the China 111 Project (B12007), P. R. China. YGH received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carmo-Silva E, 2013, PLANT PHYSIOL, V161, P1645, DOI [10. 1104/pp.112.213348, DOI 10.1104/PP9112.213348]; Carmo-Silva E, 2015, PLANT CELL ENVIRON, V38, P1817, DOI 10.1111/pce.12425; Chao M, 2013, J EXP BOT, V65, P47, DOI [10.1093/ jeb/e9346, DOI 10.1093/JEB/E9346]; Chen Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140934; Edae EA, 2013, PLANT GEN, V6, P2, DOI DOI 10.3835/PLANTGEN0ME2013.04.0010; Evenson RE, 2003, SCIENCE, V300, P758, DOI 10.1126/science.1078710; Fischer RA, 1998, CROP SCI, V38, P1467, DOI 10.2135/cropsci1998.0011183X003800060011x; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Huang Xiu-Qiang, 2010, BMC Res Notes, V3, P140, DOI 10.1186/1756-0500-3-140; Kruger EL, 2006, FUNCT PLANT BIOL, V33, P421, DOI 10.1071/FP05310; Kumar A, 2009, PHOTOSYNTH RES, V100, P143, DOI 10.1007/s11120-009-9438-y; Kurek I, 2007, PLANT CELL, V19, P3230, DOI 10.1105/tpc.107.054171; MartinezBarajas E, 1997, J AGR SCI-CAMBRIDGE, V128, P155, DOI 10.1017/S002185969600408X; McNevin D, 2006, J EXP BOT, V57, P3883, DOI 10.1093/jxb/erl156; Morales A, 1999, J EXP BOT, V50, P823; Neuwald AF, 1999, GENOME RES, V9, P27; PORTIS AR, 1995, J EXP BOT, V46, P1285, DOI 10.1093/jxb/46.special_issue.1285; Portis AR, 2003, PHOTOSYNTH RES, V75, P11, DOI 10.1023/A:1022458108678; Portis AR, 2008, J EXP BOT, V59, P1597, DOI 10.1093/jxb/erm240; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Raven JA, 2013, NEW PHYTOL, V198, P1, DOI 10.1111/nph.12197; Reynolds M, 2011, J EXP BOT, V62, P439, DOI 10.1093/jxb/erq311; Rieu I, 2009, PLANT CELL, V21, P1031, DOI 10.1105/tpc.109.066001; Ristic Z, 2009, J EXP BOT, V60, P4003, DOI 10.1093/jxb/erp241; Rosegrant MW., 2010, GLOBAL FOOD DEMAND S; Salvucci ME, 1996, PHOTOSYNTH RES, V47, P1, DOI 10.1007/BF00017748; SHEN JB, 1991, J BIOL CHEM, V266, P8963; Shinmachi F, 2010, PLANT PHYSIOL, V153, P327, DOI 10.1104/pp.110.153759; Spreitzer RJ, 2002, ANNU REV PLANT BIOL, V53, P449, DOI 10.1146/annurev.arplant.53.100301.135233; VERWOERD TC, 1989, NUCLEIC ACIDS RES, V17, P2362, DOI 10.1093/nar/17.6.2362; Wang D, 2010, PHYSIOL PLANTARUM, V139, P55, DOI 10.1111/j.1399-3054.2009.01344.x; Whitney SM, 2011, PLANT PHYSIOL, V155, P27, DOI 10.1104/pp.110.164814; Yin ZT, 2014, PLANT PHYSIOL, V164, P2096, DOI 10.1104/pp.113.230854; Yin ZT, 2010, PLANT PHYSIOL, V152, P1625, DOI 10.1104/pp.109.148312; Zhang N, 2002, P NATL ACAD SCI USA, V99, P3330, DOI 10.1073/pnas.042529999; Zheng JC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128415	36	8	9	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2016	11	8							e0161308	10.1371/journal.pone.0161308	http://dx.doi.org/10.1371/journal.pone.0161308			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT8TP	27548477	Green Published, Green Submitted, gold			2022-12-27	WOS:000381768400041
J	Busche, T; Winkler, A; Wedderhoff, I; Ruckert, C; Kalinowski, J; Lucana, DOD				Busche, Tobias; Winkler, Anika; Wedderhoff, Ina; Rueckert, Christian; Kalinowski, Joern; Lucana, Dario Ortiz de Orue			Deciphering the Transcriptional Response Mediated by the Redox-Sensing System HbpS-SenS-SenR from Streptomycetes	PLOS ONE			English	Article							HEME-BINDING PROTEIN; CATALASE-PEROXIDASE CPEB; MOLECULAR-WEIGHT THIOLS; ESCHERICHIA-COLI; DNA-BINDING; CORYNEBACTERIUM-GLUTAMICUM; CONFORMATIONAL-CHANGES; ANTIOXIDANT DEFENSE; HYDROGEN-PEROXIDE; COELICOLOR A3(2)	The secreted protein HbpS, the membrane-embedded sensor kinase SenS and the cytoplasmic response regulator SenR from streptomycetes have been shown to form a novel type of signaling pathway. Based on structural biology as well as different biochemical and biophysical approaches, redox stress-based post-translational modifications in the three proteins were shown to modulate the activity of this signaling pathway. In this study, we show that the homologous system, named here HbpSc-SenSc-SenRc, from the model species Streptomyces coelicolor A3(2) provides this bacterium with an efficient defense mechanism under conditions of oxidative stress. Comparative analyses of the transcriptomes of the Streptomyces coelicolor A3(2) wild-type and the generated hbpSc-senSc-senRc mutant under native and oxidative-stressing conditions allowed to identify differentially expressed genes, whose products may enhance the anti-oxidative defense of the bacterium. Amongst others, the results show an up-regulated transcription of genes for biosynthesis of cysteine and vitamin B-12, transport of methionine and vitamin B-12, and DNA synthesis and repair. Simultaneously, transcription of genes for degradation of an anti-oxidant compound is down-regulated in a HbpSc-SenSc-SenRc-dependent manner. It appears that HbpSc-SenSc-SenRc controls the non-enzymatic response of Streptomyces coelicolor A3(2) to counteract the hazardous effects of oxidative stress. Binding of the response regulator SenRc to regulatory regions of some of the studied genes indicates that the regulation is direct. The results additionally suggest that HbpSc-SenSc-SenRc may act in concert with other regulatory modules such as a transcriptional regulator, a two-component system and the Streptomyces B-12 riboswitch. The transcriptomics data, together with our previous in vitro results, enable a profound characterization of the HbpS-SenS-SenR system from streptomycetes. Since homologues to HbpS-SenS-SenR are widespread in different actinobacteria with ecological and medical relevance, the data presented here will serve as a basis to elucidate the biological role of these homologues.	[Busche, Tobias; Winkler, Anika; Rueckert, Christian; Kalinowski, Joern] Univ Bielefeld, Ctr Biotechnol, Microbial Genom & Biotechnol, Univ Str 27, D-33615 Bielefeld, Germany; [Wedderhoff, Ina; Lucana, Dario Ortiz de Orue] Univ Osnabruck, Dept Biol & Chem, Appl Genet Microorganisms, Barbarastr 13, D-49076 Osnabruck, Germany	University of Bielefeld; University Osnabruck	Lucana, DOD (corresponding author), Univ Osnabruck, Dept Biol & Chem, Appl Genet Microorganisms, Barbarastr 13, D-49076 Osnabruck, Germany.	ortiz@biologie.uni-osnabrueck.de		Ruckert-Reed, Christian/0000-0002-9722-4435	Deutsche Forschungsgemeinschaft (DFG) [OR 224/2-1, OR 224/4-1]; European Union Seventh Programme for Research, Technological Development and Demonstration under the grant agreement STREPSYNTH [613877]; DFG; Open Access Publishing Fund of the University of Osnabrueck	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); European Union Seventh Programme for Research, Technological Development and Demonstration under the grant agreement STREPSYNTH; DFG(German Research Foundation (DFG)); Open Access Publishing Fund of the University of Osnabrueck	DOOL acknowledges support of the Deutsche Forschungsgemeinschaft (DFG), grants OR 224/2-1 and OR 224/4-1. TB, CR and JK acknowledge support by the European Union Seventh Programme for Research, Technological Development and Demonstration under the grant agreement STREPSYNTH (project No. 613877). The authors acknowledge support by DFG and Open Access Publishing Fund of the University of Osnabrueck.; We are very grateful to Prof. Dr. A. Torda (Hamburg University, Germany) and Prof. Dr. H. Schrempf (University of Osnabrueck, Germany) for comments. DOOL acknowledges support of the Deutsche Forschungsgemeinschaft (DFG), grants OR 224/2-1 and OR 224/4-1. TB, CR and JK acknowledge support by the European Union Seventh Programme for Research, Technological Development and Demonstration under the grant agreement STREPSYNTH (project No. 613877). We acknowledge support by DFG and Open Access Publishing Fund of the University of Osnabrueck.	AHARONOWITZ Y, 1977, ARCH MICROBIOL, V115, P169, DOI 10.1007/BF00406371; Allen KD, 2014, ARCH BIOCHEM BIOPHYS, V543, P67, DOI 10.1016/j.abb.2013.12.004; AMES BN, 1981, P NATL ACAD SCI-BIOL, V78, P6858, DOI 10.1073/pnas.78.11.6858; Barka EA, 2016, MICROBIOL MOL BIOL R, V80, P1, DOI 10.1128/MMBR.00019-15; Bentley SD, 2002, NATURE, V417, P141, DOI 10.1038/417141a; Birch CS, 2009, FREE RADICAL BIO MED, V47, P184, DOI 10.1016/j.freeradbiomed.2009.04.023; Blom J, 2011, BIOINFORMATICS, V27, P1351, DOI 10.1093/bioinformatics/btr151; BlondeletRouault MH, 1997, GENE, V190, P315, DOI 10.1016/S0378-1119(97)00014-0; Bogel G, 2007, FEBS J, V274, P3900, DOI 10.1111/j.1742-4658.2007.05923.x; Bogel G, 2009, AMINO ACIDS, V37, P681, DOI 10.1007/s00726-008-0188-5; Borovok I, 2006, J BACTERIOL, V188, P2512, DOI 10.1128/JB.188.7.2512-2520.2006; Borovok I, 2002, MICROBIOL-SGM, V148, P391, DOI 10.1099/00221287-148-2-391; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Buelow DR, 2010, MOL MICROBIOL, V75, P547, DOI 10.1111/j.1365-2958.2009.06982.x; Carrondo MA, 2003, EMBO J, V22, P1959, DOI 10.1093/emboj/cdg215; Casino P, 2010, CURR OPIN STRUC BIOL, V20, P763, DOI 10.1016/j.sbi.2010.09.010; Chater KF, 2010, FEMS MICROBIOL REV, V34, P171, DOI 10.1111/j.1574-6976.2009.00206.x; Chekabab SM, 2014, VIRULENCE, V5, P786, DOI 10.4161/viru.29307; Cheng Z, 2014, MOL MICROBIOL, V91, P649, DOI 10.1111/mmi.12491; Chiancone E, 2010, BBA-GEN SUBJECTS, V1800, P798, DOI 10.1016/j.bbagen.2010.01.013; Cho HY, 2009, J BIOL CHEM, V284, P13057, DOI 10.1074/jbc.M808905200; Cooke MS, 2003, FASEB J, V17, P1195, DOI 10.1096/fj.02-0752rev; Crawford MA, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00444; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Darbon E, 2012, APPL MICROBIOL BIOT, V95, P1553, DOI 10.1007/s00253-012-3995-2; de la Riva L, 2008, J BACTERIOL, V190, P7892, DOI 10.1128/JB.01022-08; DebRoy S, 2014, SCIENCE, V345, P937, DOI 10.1126/science.1255091; Fischer M, 2012, RES MICROBIOL, V163, P340, DOI 10.1016/j.resmic.2012.05.004; Flardh K, 2009, NAT REV MICROBIOL, V7, P36, DOI 10.1038/nrmicro1968; Flinspach K, 2010, BIOPOLYMERS, V93, P823, DOI 10.1002/bip.21493; HALL HH, 1953, APPL MICROBIOL, V1, P124, DOI 10.1128/AEM.1.3.124-129.1953; Harrison J, 2014, MICROB BIOTECHNOL, V7, P373, DOI 10.1111/1751-7915.12143; Hilker R, 2014, BIOINFORMATICS, V30, P2247, DOI 10.1093/bioinformatics/btu205; Hopwood D. A., 1985, GENETIC MANIPULATION; Hullo MF, 2007, J BACTERIOL, V189, P187, DOI 10.1128/JB.01273-06; Imlay JA, 2013, NAT REV MICROBIOL, V11, P443, DOI 10.1038/nrmicro3032; Jacques S, 2013, PROTEOMICS, V13, P932, DOI 10.1002/pmic.201200237; Jothivasan VK, 2008, NAT PROD REP, V25, P1091, DOI 10.1039/b616489g; Kim JN, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1311-0; Klare JP, 2012, ANTIOXID REDOX SIGN, V16, P639, DOI 10.1089/ars.2011.4080; Krautler B, 2005, BIOCHEM SOC T, V33, P806; Krell T, 2010, ANNU REV MICROBIOL, V64, P539, DOI 10.1146/annurev.micro.112408.134054; Lee EJ, 2005, MOL MICROBIOL, V57, P1252, DOI 10.1111/j.1365-2958.2005.04761.x; Levine RL, 2000, IUBMB LIFE, V50, P301, DOI 10.1080/15216540051081056; Lu M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109660; Lucana DOD, 2014, J BIOL CHEM, V289, P34214, DOI 10.1074/jbc.M114.585489; Lucana DOD, 2010, J BIOL CHEM, V285, P28086, DOI 10.1074/jbc.M110.127506; Lucana DOD, 2009, AMINO ACIDS, V37, P479, DOI 10.1007/s00726-009-0260-9; Lucana DODO, 2009, J MOL BIOL, V386, P1108, DOI 10.1016/j.jmb.2009.01.017; Lucana DOD, 2000, MOL GEN GENET, V264, P341; Lucana DOD, 2005, MICROBIOL-SGM, V151, P3603, DOI 10.1099/mic.0.28298-0; Lucana DOD, 2004, MICROBIOL-SGM, V150, P2575, DOI 10.1099/mic.0.27091-0; Ortiz-Guerrero JM, 2011, P NATL ACAD SCI USA, V108, P7565, DOI 10.1073/pnas.1018972108; Martin JF, 2012, APPL MICROBIOL BIOT, V95, P61, DOI 10.1007/s00253-012-4129-6; Mellin JR, 2014, SCIENCE, V345, P940, DOI 10.1126/science.1255083; Merlin C, 2002, J BACTERIOL, V184, P5513, DOI 10.1128/JB.184.19.5513-5517.2002; Merrick BA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061768; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; MUTH G, 1989, MOL GEN GENET, V219, P341, DOI 10.1007/BF00259605; NEWTON GL, 1993, J BACTERIOL, V175, P2734, DOI 10.1128/JB.175.9.2734-2742.1993; Ortiz de Orue Lucana Dario, 2012, J Signal Transduct, V2012, P605905, DOI 10.1155/2012/605905; Park JH, 2008, MOL MICROBIOL, V68, P861, DOI 10.1111/j.1365-2958.2008.06191.x; Pfeifer-Sancar K, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-888; Podust LM, 2008, BIOCHEMISTRY-US, V47, P12523, DOI 10.1021/bi8012356; Rodriguez H, 2013, MICROB CELL FACT, V12, DOI 10.1186/1475-2859-12-127; Rodriguez-Garcia A, 2007, PROTEOMICS, V7, P2410, DOI 10.1002/pmic.200600883; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Santos-Beneit F, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00402; Savige W E, 1977, Methods Enzymol, V47, P453; Schneider TD, 1996, METHOD ENZYMOL, V274, P445; Schrempf H, 1995, INT J BIOL MACROMOL, V17, P353, DOI 10.1016/0141-8130(96)81845-9; Sevvana M, 2008, J MOL BIOL, V377, P512, DOI 10.1016/j.jmb.2008.01.024; Si MR, 2014, APPL ENVIRON MICROB, V80, P1750, DOI 10.1128/AEM.03654-13; Siedenburg G, 2012, ANTIOXID REDOX SIGN, V16, P668, DOI 10.1089/ars.2011.4290; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Sola-Landa A, 2005, MOL MICROBIOL, V56, P1373, DOI 10.1111/j.1365-2958.2005.04631.x; Sola-Landa A, 2008, NUCLEIC ACIDS RES, V36, P1358, DOI 10.1093/nar/gkm1150; Solomon LR, 2007, BLOOD REV, V21, P113, DOI 10.1016/j.blre.2006.05.001; Song SG, 1997, J BACTERIOL, V179, P7025, DOI 10.1128/jb.179.22.7025-7032.1997; STAUDENMAIER H, 1989, J BACTERIOL, V171, P2626, DOI 10.1128/jb.171.5.2626-2633.1989; Suarez-Moreira E, 2009, J AM CHEM SOC, V131, P15078, DOI 10.1021/ja904670x; Taylor BL, 1999, MICROBIOL MOL BIOL R, V63, P479, DOI 10.1128/MMBR.63.2.479-506.1999; Torda AE, 2013, FEMS MICROBIOL LETT, V342, P106, DOI 10.1111/1574-6968.12093; TRZEBIATOWSKI JR, 1994, J BACTERIOL, V176, P3568, DOI 10.1128/JB.176.12.3568-3575.1994; Van Laer K, 2013, ANTIOXID REDOX SIGN, V18, P1642, DOI 10.1089/ars.2012.4964; Vermeulen AJ, 2015, J BACTERIOL, V197, P2694, DOI 10.1128/JB.00374-15; VIEIRA J, 1982, GENE, V19, P259, DOI 10.1016/0378-1119(82)90015-4; WARREN MJ, 1990, BIOCHEM J, V265, P725, DOI 10.1042/bj2650725; Wedderhoff I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071579; Winterbourn CC, 1995, TOXICOL LETT, V82-3, P969, DOI 10.1016/0378-4274(95)03532-X; Zhou Z, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S10-S8; Zou P, 2008, ACTA CRYSTALLOGR F, V64, P386, DOI 10.1107/S1744309108008348; Zou PJ, 1999, MICROBIOL-SGM, V145, P549, DOI 10.1099/13500872-145-3-549	93	4	4	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2016	11	8							e0159873	10.1371/journal.pone.0159873	http://dx.doi.org/10.1371/journal.pone.0159873			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6UQ	27541358	Green Published, Green Submitted, gold			2022-12-27	WOS:000381620200003
J	Gobel, A; Heldmann, M; Gottlich, M; Dirk, AL; Brabant, G; Munte, TF				Goebel, Anna; Heldmann, Marcus; Gottlich, Martin; Dirk, Anna-Luise; Brabant, Georg; Muente, Thomas F.			Effect of Mild Thyrotoxicosis on Performance and Brain Activations in a Working Memory Task	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; ANTERIOR CINGULATE CORTEX; SYMPTOM RATING-SCALE; N-BACK TASK; COGNITIVE FUNCTION; SUBCLINICAL HYPOTHYROIDISM; ASSESSING HYPERTHYROIDISM; INTELLECTUAL IMPAIRMENT; HEALTHY-INDIVIDUALS; CEREBELLAR LESIONS	Aims Disturbed levels of thyroid hormones are associated with neuropsychiatric disorders, including memory impairments. The aim of this study was to evaluate effects of mild induced thyrotoxicosis on working memory and its neural correlates. Methods Twenty-nine healthy, male subjects with normal thyroid state participated in the study. Functional MRI was acquired during a working memory task (n-back task) before and after ingesting 250 mu g L-thyroxin per day for a period of eight weeks. In addition, neuropsychological tests were performed. Results In the hyperthyroid condition the subjects showed slower reaction times, but a higher accuracy in the 0-back version of the memory tasks. Fewer differences between euthyroid and hyperthyroid state were seen for the more difficult conditions of the n-back task. FMRI revealed effects of difficulty in the parahippocampal gyrus, supplementary motor area, prefrontal cortex, anterior cingulate cortex, posterior cerebellum, rolandic operculum and insula (p<0.05, FWE corrected). When comparing euthyroid and hyperthyroid condition in relation to task-induced activation, differences of activation were found in the right prefrontal cortex as well as in the right parahippocampal area. In the psychological assessment, the alerting effect in the Attention Network Task (ANT) and four out of five parameters of the auditory verbal learning test (AVLT) showed an increase from euthyroid to hyperthyroid state. Conclusions It can be concluded that even a short-term intake of thyroid hormones leads to an activation of brain areas associated with working memory and to an improvement of accuracy of working memory tasks.	[Goebel, Anna; Heldmann, Marcus; Gottlich, Martin; Muente, Thomas F.] Univ Lubeck, Dept Neurol, D-23538 Lubeck, Germany; [Dirk, Anna-Luise; Brabant, Georg] Univ Lubeck, Dept Internal Med 1, D-23538 Lubeck, Germany	University of Lubeck; University of Lubeck	Munte, TF (corresponding author), Univ Lubeck, Dept Neurol, D-23538 Lubeck, Germany.	Thomas.muente@neuro.uni-luebeck.de		Gottlich, Martin/0000-0002-7668-0730	Deutsche Forschungsgemeinschaft [MU 3811 / 16-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Funded by Deutsche Forschungsgemeinschaft, www.dfg.de, grant number MU 3811 / 16-1.	Alvarez JA, 2006, NEUROPSYCHOL REV, V16, P17, DOI 10.1007/s11065-006-9002-x; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Baethge C, 2002, PSYCHIAT RES, V110, P117, DOI 10.1016/S0165-1781(02)00101-4; Barbey AK, 2013, CORTEX, V49, P1195, DOI 10.1016/j.cortex.2012.05.022; Bauer M, 2008, J NEUROENDOCRINOL, V20, P1101, DOI 10.1111/j.1365-2826.2008.01774.x; Boelaert K, 2005, J ENDOCRINOL, V187, P1, DOI 10.1677/joe.1.06131; Braver TS, 1997, NEUROIMAGE, V5, P49, DOI 10.1006/nimg.1996.0247; Burmeister LA, 2001, THYROID, V11, P1177, DOI 10.1089/10507250152741037; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Callicott JH, 1999, CEREB CORTEX, V9, P20, DOI 10.1093/cercor/9.1.20; Cools R, 2011, BIOL PSYCHIAT, V69, pE113, DOI 10.1016/j.biopsych.2011.03.028; Courtney SM, 1996, CEREB CORTEX, V6, P39, DOI 10.1093/cercor/6.1.39; CRUSIO WE, 1991, PHYSIOL BEHAV, V50, P259, DOI 10.1016/0031-9384(91)90530-2; D'Esposito M, 1998, COGNITIVE BRAIN RES, V7, P1, DOI 10.1016/S0926-6410(98)00004-4; Dalbert C., 1992, Z DIFFERENTIELLE DIA, V13, P207; DANEMAN D, 1980, J PEDIATR-US, V97, P257, DOI 10.1016/S0022-3476(80)80487-2; de Jongh RT, 2011, EUR J ENDOCRINOL, V165, P545, DOI 10.1530/EJE-11-0430; de Ribaupierre S, 2008, ACTA NEUROCHIR, V150, P545, DOI 10.1007/s00701-008-1562-5; DENICOFF KD, 1990, AM J PSYCHIAT, V147, P94; DEVINSKY O, 1995, BRAIN, V118, P279, DOI 10.1093/brain/118.1.279; Dugbartey AT, 1998, ARCH INTERN MED, V158, P1413, DOI 10.1001/archinte.158.13.1413; ERICSSON KA, 1980, SCIENCE, V208, P1181, DOI 10.1126/science.7375930; Exner C, 2004, NEUROLOGY, V63, P2132, DOI 10.1212/01.WNL.0000146197.44568.CD; Fahrenfort JJ, 2000, PSYCHONEUROENDOCRINO, V25, P201, DOI 10.1016/S0306-4530(99)00050-5; Fernandez M, 2004, P NATL ACAD SCI USA, V101, P16363, DOI 10.1073/pnas.0407262101; Fiez JA, 1996, J NEUROSCI, V16, P808; GEFFNER DL, 1989, ARCH INTERN MED, V149, P1466, DOI 10.1001/archinte.149.6.1466; GEVINS A, 1993, ELECTROEN CLIN NEURO, V87, P128, DOI 10.1016/0013-4694(93)90119-G; Glickstein M, 2009, NEUROSCIENCE, V162, P549, DOI 10.1016/j.neuroscience.2009.02.054; Helmstaedter C, 2001, VERBALER LERN MERKFA, V1; Hutzler F, 2014, NEUROIMAGE, V84, P1061, DOI 10.1016/j.neuroimage.2012.12.075; Jablkowska K, 2008, PSYCHIATR POL, V42, P249; Jansma JM, 2000, NEUROIMAGE, V12, P688, DOI 10.1006/nimg.2000.0645; JONIDES J, 1993, NATURE, V363, P623, DOI 10.1038/363623a0; KATHMANN N, 1994, NEUROPSYCHOBIOLOGY, V29, P136, DOI 10.1159/000119076; KIRCHNER WK, 1958, J EXP PSYCHOL, V55, P352, DOI 10.1037/h0043688; KLEIN I, 1988, ARCH INTERN MED, V148, P387, DOI 10.1001/archinte.148.2.387; Kuhner C, 2007, NERVENARZT, V78, P651, DOI 10.1007/s00115-006-2098-7; Kurth F, 2010, BRAIN STRUCT FUNCT, V214, P519, DOI 10.1007/s00429-010-0255-z; Lebedev MA, 2004, PLOS BIOL, V2, P1919, DOI 10.1371/journal.pbio.0020365; Lee D, 2003, J NEUROPHYSIOL, V89, P1039, DOI 10.1152/jn.00638.2002; MANCIET G, 1995, AGE AGEING, V24, P235, DOI 10.1093/ageing/24.3.235; Manoach DS, 1997, NEUROREPORT, V8, P545, DOI 10.1097/00001756-199701200-00033; MCCARTHY G, 1994, P NATL ACAD SCI USA, V91, P8690, DOI 10.1073/pnas.91.18.8690; MENNEMEIER M, 1993, J CLIN EXP NEUROPSYC, V15, P822, DOI 10.1080/01688639308402598; Meyer-Lindenberg A, 2006, NAT REV NEUROSCI, V7, P818, DOI 10.1038/nrn1993; Miao Q, 2011, AM J NEURORADIOL, V32, P1034, DOI 10.3174/ajnr.A2449; Munte TF, 2004, PSYCHONEUROENDOCRINO, V29, P1109, DOI 10.1016/j.psyneuen.2003.12.001; Munte TF, 2001, THYROID, V11, P385, DOI 10.1089/10507250152039145; OSTERWEIL D, 1992, J AM GERIATR SOC, V40, P325, DOI 10.1111/j.1532-5415.1992.tb02130.x; Owen AM, 2005, HUM BRAIN MAPP, V25, P46, DOI 10.1002/hbm.20131; Owen AM, 2000, EXP BRAIN RES, V133, P33, DOI 10.1007/s002210000398; Perlstein WM, 2001, AM J PSYCHIAT, V158, P1105, DOI 10.1176/appi.ajp.158.7.1105; PERRILD H, 1986, ACTA ENDOCRINOL-COP, V112, P185, DOI 10.1530/acta.0.1120185; PETRIDES M, 1993, P NATL ACAD SCI USA, V90, P878, DOI 10.1073/pnas.90.3.878; Pilhatsch M, 2011, THYROID RES, V4, DOI 10.1186/1756-6614-4-S1-S3; Plichta MM, 2012, NEUROIMAGE, V60, P1746, DOI 10.1016/j.neuroimage.2012.01.129; Poldrack RA, 2006, TRENDS COGN SCI, V10, P59, DOI 10.1016/j.tics.2005.12.004; Poldrack RA, 2011, NEURON, V72, P692, DOI 10.1016/j.neuron.2011.11.001; Ragland JD, 2002, NEUROPSYCHOLOGY, V16, P370, DOI 10.1037//0894-4105.16.3.370; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Rey A., 1958, LEXAMEN CLINIQUE PSY; Roberts LM, 2006, ANN INTERN MED, V145, P573, DOI 10.7326/0003-4819-145-8-200610170-00006; Samuels MH, 2008, J CLIN ENDOCR METAB, V93, P1730, DOI 10.1210/jc.2007-1957; Samuels MH, 2014, ENDOCRIN METAB CLIN, V43, P529, DOI 10.1016/j.ecl.2014.02.006; Schmidt H, 2009, HUM BRAIN MAPP, V30, P3609, DOI 10.1002/hbm.20783; Schmitz N, 2000, QUAL LIFE RES, V9, P185, DOI 10.1023/A:1008931926181; Schreckenberger MF, 2006, J CLIN ENDOCR METAB, V91, P4786, DOI 10.1210/jc.2006-0573; Sokoloff L, 1966, Res Publ Assoc Res Nerv Ment Dis, V43, P371; Steer RA, 1999, BEHAV RES THER, V37, P183, DOI 10.1016/S0005-7967(98)00087-4; SWARTZ BE, 1995, CEREB CORTEX, V5, P205, DOI 10.1093/cercor/5.3.205; WHYBROW PC, 1969, ARCH GEN PSYCHIAT, V20, P48; Zhang W, 2013, EUR J RADIOL; Zhu DF, 2006, BRAIN, V129, P2923, DOI 10.1093/brain/awl215; Zimmermann P, 2007, TESTBATTERIE AUFMERK	76	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0161552	10.1371/journal.pone.0161552	http://dx.doi.org/10.1371/journal.pone.0161552			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DT6ES	27536945	Green Published, Green Submitted, gold			2022-12-27	WOS:000381577000122
J	Prinja, S; Gupta, A; Verma, R; Bahuguna, P; Kumar, D; Kaur, M; Kumar, R				Prinja, Shankar; Gupta, Aditi; Verma, Ramesh; Bahuguna, Pankaj; Kumar, Dinesh; Kaur, Manmeet; Kumar, Rajesh			Cost of Delivering Health Care Services in Public Sector Primary and Community Health Centres in North India	PLOS ONE			English	Article							HOSPITALS; HARYANA	Background With the commitment of the national government to provide universal healthcare at cheap and affordable prices in India, public healthcare services are being strengthened in India. However, there is dearth of cost data for provision of health services through public system like primary & community health centres. In this study, we aim to bridge this gap in evidence by assessing the total annual and per capita cost of delivering the package of health services at PHC and CHC level. Secondly, we determined the per capita cost of delivering specific health services like cost per antenatal care visit, per institutional delivery, per outpatient consultation, per bed-day hospitalization etc. Methods We undertook economic costing of fourteen public health facilities (seven PHCs and CHCs each) in three North-Indian states viz., Haryana, Himachal Pradesh and Punjab. Bottom-up costing method was adopted for collection of data on all resources spent on delivery of health services in selected health facilities. Analysis was undertaken using a health system perspective. The joint costs like human resource, capital, and equipment were apportioned as per the time value spent on a particular service. Capital costs were discounted and annualized over the estimated life of the item. Mean annual costs and unit costs were estimated along with their 95% confidence intervals using bootstrap methodology. Results The overall annual cost of delivering services through public sector primary and community health facilities in three states of north India were INR 8.8 million (95% CI: 7,365,630-10,294,065) and INR 26.9 million (95% CI: 22,225,159.3-32,290,099.6), respectively. Human resources accounted for more than 50% of the overall costs at both the level of PHCs and CHCs. Per capita per year costs for provision of complete package of preventive, curative and promotive services at PHC and CHC were INR 170.8 (95% CI: 131.6-208.3) and INR162.1 (95% CI: 112-219.1), respectively. Conclusion The study estimates can be used for financial planning of scaling up of similar health services in the urban areas under the aegis of National Health Mission. The estimates would be also useful in undertaking equity analysis and full economic evaluations of the health systems.	[Prinja, Shankar; Gupta, Aditi; Bahuguna, Pankaj; Kaur, Manmeet; Kumar, Rajesh] Postgrad Inst Med Educ & Res, Sch Publ Hlth, Chandigarh, India; [Verma, Ramesh] Pt BD Sharma Post Grad Inst Med Sci, Dept Community Med, Rohtak, Haryana, India; [Kumar, Dinesh] Dr Rajendra Prasad Govt Med Coll, Dept Community Med, Kangra, Himachal Prades, India	Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; Pt. B.D. Sharma Post Graduate Institute of Medical Sciences (PGIMS), Rohtak	Prinja, S (corresponding author), Postgrad Inst Med Educ & Res, Sch Publ Hlth, Chandigarh, India.	shankarprinja@gmail.com	KUMAR, DINESH/GRJ-5448-2022	KUMAR, DINESH/0000-0002-9641-6662; Bahuguna, Pankaj/0000-0001-9952-6077	Intramural Research Grant of Post Graduate Institute of Medical Education and Research, Chandigarh, India	Intramural Research Grant of Post Graduate Institute of Medical Education and Research, Chandigarh, India	The study was funded by the Intramural Research Grant of Post Graduate Institute of Medical Education and Research, Chandigarh - 160012, India (http://pgimer.edu.in/PGIMER_PORTAL/PGIMERPORTAL/home.jsp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand K, 1993, Natl Med J India, V6, P160; [Anonymous], 2013, BOOTSTRAP EDGEWORTH; Balasubramanian D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125202; Chatterjee S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069728; DGHS, 2012, IND PUBL HLTH STAND; Edlin R., 2015, COST EFFECTIVENESS M; Fox-Rushby J, 2006, EC EVALUATION; Good P.I., 2013, RESAMPLING METHODS P; Hox JJ., 2017, MULTILEVEL ANAL TECH, DOI DOI 10.4324/9781315650982; ISPOR, 2014, PHARM GUID IND; Johns Benjamin, 2003, Cost Eff Resour Alloc, V1, P1, DOI 10.1186/1478-7547-1-1; Krishnan Anand, 2005, Indian Journal of Pediatrics, V72, P657, DOI 10.1007/BF02724072; Kumar R, 2015, INDAN J COMMUNITY HE, V27, P197; Kumar R, 2014, INDIAN J PEDIATR, V81, P1347, DOI 10.1007/s12098-014-1495-3; Library Parliament And Reference R Documentation And Information Service (Larrdis), 2013, LIB PARL REF R DOC I; Mathur Neeta, 2010, Indian J Community Med, V35, P153, DOI 10.4103/0970-0218.62585; Mini PP, 2013, RASHTRIYA SWASTHYA B; Ministry of Health & Family Welfare (MoHFW), 2013, NAT URB HLTH MISS FR; MoHFW, 2005, NAT HLTH ACC 2004 05; Palacios R, 2011, NEW APPROACH PROVIDI; Prinja S, 2015, BMC PHARMACOL TOXICO, V16, DOI 10.1186/s40360-015-0043-8; Prinja S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137315; Prinja S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091781; Prinja S, 2013, INDIAN J MED RES, V138, P1003; Prinja S, 2013, J TROP PEDIATRICS, V59, P489, DOI 10.1093/tropej/fmt057; Prinja S, 2013, INDIAN PEDIATR, V50, P839, DOI 10.1007/s13312-013-0234-6; Prinja S, 2012, INDIAN J MED RES, V136, P868; Prinja S, 2012, INDIAN J MED RES, V136, P421; Reddy K.S., 2011, PUBLIC HLTH FDN INDI, V4, P1; Rural Health Statistics, 2015, RUR HLTH STAT 2015 D; Rural Health Statistics in India, 2014, RUR HLTH STAT IND 20; Sur D, 2009, J HEALTH POPUL NUTR, V27, P725; Tabachnick B. G., 2006, USING MULTIVARIATE S; UNICEF, 2009, NAT FACT SHEET COV E; WHO, 2003, MAKING CHOICES HLTH; Yung Y-F, 1999, STAT STRATEGIES SMAL, P81	36	52	52	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0160986	10.1371/journal.pone.0160986	http://dx.doi.org/10.1371/journal.pone.0160986			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27536781	Green Published, Green Submitted, gold			2022-12-27	WOS:000381577000040
J	Jiang, H; Liu, W; Zhan, SK; Pan, YX; Bian, LG; Sun, BM; Sun, QF; Pan, SJ				Jiang, Hong; Liu, Wei; Zhan, Shi-Kun; Pan, Yi-Xin; Bian, Liu-Guan; Sun, Bomin; Sun, Qing-Fang; Pan, Si-Jian			GSK621 Targets Glioma Cells via Activating AMP-Activated Protein Kinase Signalings	PLOS ONE			English	Article							CANCER CELLS; APOPTOSIS; GROWTH; CYTOTOXICITY; INHIBITION; EXPRESSION; METFORMIN	Here, we studied the anti-glioma cell activity by a novel AMP-activated protein kinase (AMPK) activator GSK621. We showed that GSK621 was cytotoxic to human glioma cells (U87MG and U251MG lines), possibly via provoking caspase-dependent apoptotic cell death. Its cytotoxicity was alleviated by caspase inhibitors. GSK621 activated AMPK to inhibit mammalian target of rapamycin (mTOR) and downregulate Tetraspanin 8 (Tspan8) in glioma cells. AMPK inhibition, through shRNA knockdown of AMPK alpha or introduction of a dominant negative (T172A) AMPK alpha, almost reversed GSK621-induced AMPK activation, mTOR inhibition and Tspan8 degradation. Consequently, GSK621's cytotoxicity in glioma cells was also significantly attenuated by AMPKa knockdown or mutation. Further studies showed that GSK621, at a relatively low concentration, significantly potentiated temozolomide (TMZ)'s sensitivity and lethality against glioma cells. We summarized that GSK621 inhibits human glioma cells possibly via activating AMPK signaling. This novel AMPK activator could be a novel and promising anti-glioma cell agent.	[Jiang, Hong; Bian, Liu-Guan; Sun, Qing-Fang; Pan, Si-Jian] Shanghai Jiao Tong Univ, Sch Med, Rui Jin Hosp, Dept Neurosurg, Shanghai 200025, Peoples R China; [Liu, Wei; Zhan, Shi-Kun; Pan, Yi-Xin; Sun, Bomin] Shanghai Jiao Tong Univ, Sch Med, Rui Jin Hosp, Dept Stereotact & Funct Neurosurg, Shanghai 200025, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Sun, QF; Pan, SJ (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Rui Jin Hosp, Dept Neurosurg, Shanghai 200025, Peoples R China.	sunqingfang11@163.com; swordspan163@163.com	Pan, Yi/AAJ-2341-2021		National Natural Science Foundation of China [81441072, 81502140]; Fund of Shanghai Municipal Health Bureau [20124295]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fund of Shanghai Municipal Health Bureau	This project was supported by the National Natural Science Foundation of China (81441072) to S.P., the Fund of Shanghai Municipal Health Bureau (20124295) to S.P., and the National Natural Science Foundation of China (81502140) to W.L. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ailane N, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00364; Averous J, 2008, ONCOGENE, V27, P1106, DOI 10.1038/sj.onc.1210715; Brunn GJ, 1996, EMBO J, V15, P5256, DOI 10.1002/j.1460-2075.1996.tb00911.x; Charrin S, 2009, BIOCHEM J, V420, P133, DOI 10.1042/BJ20082422; Chen MB, 2011, J CELL PHYSIOL, V226, P1915, DOI 10.1002/jcp.22522; Chen MB, 2011, CELL BIOCHEM BIOPHYS, V60, P311, DOI 10.1007/s12013-011-9153-0; Choi YK, 2013, MOL CELLS, V36, P279, DOI 10.1007/s10059-013-0169-8; Cui Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156915; Faubert B, 2015, CANCER LETT, V356, P165, DOI 10.1016/j.canlet.2014.01.018; Hardie DG, 2012, CHEM BIOL, V19, P1222, DOI 10.1016/j.chembiol.2012.08.019; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; He XY, 2013, BIOCHEM BIOPH RES CO, V435, P397, DOI 10.1016/j.bbrc.2013.04.099; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Ji C, 2010, ONCOGENE, V29, P6557, DOI 10.1038/onc.2010.379; Jiang G, 2011, BIOCHEM BIOPH RES CO, V406, P311, DOI 10.1016/j.bbrc.2011.02.042; Khasraw M, 2009, NAT REV NEUROL, V5, P646, DOI 10.1038/nrneurol.2009.194; Kim IY, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00175; Lefranc F, 2009, ADV TECH STAND NEURO, V34, P3, DOI 10.1007/978-3-211-78741-0_1; Levy S, 2005, NAT REV IMMUNOL, V5, P136, DOI 10.1038/nri1548; Lo Hui-Wen, 2010, Curr Mol Pharmacol, V3, P37; Luo ZJ, 2005, TRENDS PHARMACOL SCI, V26, P69, DOI 10.1016/j.tips.2004.12.011; Pan SJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep11066; Pan SJ, 2015, BIOCHEM BIOPH RES CO, V458, P476, DOI 10.1016/j.bbrc.2015.01.128; Rocha GZ, 2011, CLIN CANCER RES, V17, P3993, DOI 10.1158/1078-0432.CCR-10-2243; Shackelford DB, 2009, NAT REV CANCER, V9, P563, DOI 10.1038/nrc2676; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; Su RY, 2007, MOL CANCER THER, V6, P1562, DOI 10.1158/1535-7163.MCT-06-0800; Sujobert P, 2015, CELL REP, V11, P1446, DOI 10.1016/j.celrep.2015.04.063; Sun H, 2011, CANCER LETT, V310, P118, DOI 10.1016/j.canlet.2011.06.010; Wang YZ, 2013, CANCER LETT, V331, P139, DOI 10.1016/j.canlet.2012.12.024; Westphal M, 2011, NAT REV NEUROSCI, V12, P495, DOI 10.1038/nrn3060; Yue SJ, 2013, EUR J CANCER, V49, P2934, DOI 10.1016/j.ejca.2013.03.032; Zhang WB, 2010, J BIOL CHEM, V285, P40461, DOI 10.1074/jbc.M110.164046	34	16	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2016	11	8							e0161017	10.1371/journal.pone.0161017	http://dx.doi.org/10.1371/journal.pone.0161017			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4YN	27532105	gold, Green Submitted, Green Published			2022-12-27	WOS:000381487600054
J	Pathak, A; Chauhan, A; Blom, J; Indest, KJ; Jung, CM; Stothard, P; Bera, G; Green, SJ; Ogram, A				Pathak, Ashish; Chauhan, Ashvini; Blom, Jochen; Indest, Karl J.; Jung, Carina M.; Stothard, Paul; Bera, Gopal; Green, Stefan J.; Ogram, Andrew			Comparative Genomics and Metabolic Analysis Reveals Peculiar Characteristics of Rhodococcus opacus Strain M213 Particularly for Naphthalene Degradation	PLOS ONE			English	Article							POLYCYCLIC AROMATIC-HYDROCARBONS; HORIZONTAL GENE-TRANSFER; DEGRADING BACTERIUM; PSEUDOMONAS; SEQUENCE; ISLAND; SOIL; EVOLUTION; BIODEGRADATION; CATABOLISM	The genome of Rhodococcus opacus strain M213, isolated from a fuel-oil contaminated soil, was sequenced and annotated which revealed a genome size of 9,194,165 bp encoding 8680 putative genes and a G+ C content of 66.72%. Among the protein coding genes, 71.77% were annotated as clusters of orthologous groups of proteins (COGs); 55% of the COGs were present as paralog clusters. Pulsed field gel electrophoresis (PFGE) analysis of M213 revealed the presence of three different sized replicons-a circular chromosome and two megaplasmids (pNUO1 and pNUO2) estimated to be of 750Kb 350Kb in size, respectively. Conversely, using an alternative approach of optical mapping, the plasmid replicons appeared as a circular similar to 1.2 Mb megaplasmid and a linear, similar to 0.7 Mb megaplasmid. Genome-wide comparative analysis of M213 with a cohort of sequenced Rhodococcus species revealed low syntenic affiliation with other R. opacus species including strains B4 and PD630. Conversely, a closer affiliation of M213, at the functional (COG) level, was observed with the catabolically versatile R. jostii strain RHA1 and other Rhodococcii such as R. wratislaviensis strain IFP 2016, R. imtechensis strain RKJ300, Rhodococcus sp. strain JVH1, and Rhodococcus sp. strain DK17, respectively. An in-depth, genome-wide comparison between these functional relatives revealed 971 unique genes in M213 representing 11% of its total genome; many associating with catabolic functions. Of major interest was the identification of as many as 154 genomic islands (GEIs), many with duplicated catabolic genes, in particular for PAHs; a trait that was confirmed by PCR-based identification of naphthalene dioxygenase (NDO) as a representative gene, across PFGE-resolved replicons of strain M213. Interestingly, several plasmid/ GEI-encoded genes, that likely participate in degrading naphthalene (NAP) via a peculiar pathway, were also identified in strain M213 using a combination of bioinformatics, metabolic analysis and gene expression measurements of selected catabolic genes by RT-PCR. Taken together, this study provides a comprehensive understanding of the genome plasticity and ecological competitiveness of strain M213 likely facilitated by horizontal gene transfer (HGT), bacteriophage attacks and genomic reshuffling-aspects that continue to be understudied and thus poorly understood, in particular for the soil-borne Rhodococcii.	[Pathak, Ashish; Chauhan, Ashvini] Florida A&M Univ, Sch Environm, Tallahassee, FL 32307 USA; [Blom, Jochen] Univ Giessen, Bioinformat & Syst Biol, Giessen, Germany; [Indest, Karl J.; Jung, Carina M.] US Army Engn Res & Dev Ctr, Environm Proc Branch, Vicksburg, MS USA; [Stothard, Paul] Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada; [Bera, Gopal] Texas A&M Univ, Geochem & Environm Res Grp, College Stn, TX USA; [Green, Stefan J.] Univ Illinois, DNA Serv Facil, Chicago, IL USA; [Ogram, Andrew] Univ Florida, Soil & Water Sci Dept, Gainesville, FL USA	State University System of Florida; Florida A&M University; Justus Liebig University Giessen; United States Department of Defense; United States Army; U.S. Army Corps of Engineers; U.S. Army Engineer Research & Development Center (ERDC); University of Alberta; Texas A&M University System; Texas A&M University College Station; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; State University System of Florida; University of Florida	Chauhan, A (corresponding author), Florida A&M Univ, Sch Environm, Tallahassee, FL 32307 USA.	ashvini.chauhan@famu.edu	Pathak, Ashish/N-2303-2019; Chauhan, Ashvini/AAU-3285-2020; Bera, Gopal/J-1201-2018	Bera, Gopal/0000-0002-9426-3148; Jung, Carina/0000-0002-3171-7341; Green, Stefan/0000-0003-2781-359X	School of Graduate Studies, Florida AM University; Department of Defense (DoD) [W911NF-10-1-0146, W911NF-10-R-0006]; Savannah River Nuclear Solutions [0000217620]	School of Graduate Studies, Florida AM University; Department of Defense (DoD)(United States Department of Defense); Savannah River Nuclear Solutions	The authors acknowledge the support provide by the School of Graduate Studies, Florida A&M University and funding obtained from two grants funded by the Department of Defense (DoD)-W911NF-10-1-0146 and W911NF-10-R-0006. This study was also funded partly by the Savannah River Nuclear Solutions under subcontract #0000217620.	Alvarez HM, 2010, MICROBIOL MONOGR, V16, P263, DOI 10.1007/978-3-642-12937-7_10; Andreoni V, 2000, ENVIRON MICROBIOL, V2, P572, DOI 10.1046/j.1462-2920.2000.00134.x; Annweiler E, 2000, APPL ENVIRON MICROB, V66, P518, DOI 10.1128/AEM.66.2.518-523.2000; [Anonymous], [No title captured]; Auffret M, 2009, APPL ENVIRON MICROB, V75, P7774, DOI 10.1128/AEM.01117-09; Barcellos FG, 2007, APPL ENVIRON MICROB, V73, P2635, DOI 10.1128/AEM.01823-06; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Basu A, 2008, BIODEGRADATION, V19, P83, DOI 10.1007/s10532-007-9117-7; Bell KS, 1999, J APPL MICROBIOL, V87, P472, DOI 10.1046/j.1365-2672.1999.00824.x; Blom J, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-154; Bostrom CE, 2002, ENVIRON HEALTH PERSP, V110, P451, DOI 10.1289/ehp.02110s3451; Bubinas A, 2008, CENT EUR J BIOL, V3, P61, DOI 10.2478/s11535-007-0042-x; Chao L, 2015, ANN MICROBIOL, P1, DOI [10.1007/s13213-015-1132-z, DOI 10.1007/S13213-015-1132-Z]; Choi KY, 2007, BIOCHEM BIOPH RES CO, V357, P766, DOI 10.1016/j.bbrc.2007.04.009; Creason Allison L, 2014, Front Plant Sci, V5, P406, DOI 10.3389/fpls.2014.00406; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Dhillon BK, 2015, NUCLEIC ACIDS RES, V43, pW104, DOI 10.1093/nar/gkv401; Di Gennaro P, 2001, RES MICROBIOL, V152, P641, DOI 10.1016/S0923-2508(01)01243-8; Dobrindt U, 2001, CURR OPIN MICROBIOL, V4, P550, DOI 10.1016/S1369-5274(00)00250-2; Duarte M, 2014, DATABASE-OXFORD, DOI 10.1093/database/bau118; Ferrero M, 2002, APPL ENVIRON MICROB, V68, P957, DOI 10.1128/AEM.68.2.957-962.2002; Filonov AE, 2006, J CHEM TECHNOL BIOT, V81, P216, DOI 10.1002/jctb.1391; Fonger GC, 2014, TOXICOLOGY, V325, P209, DOI 10.1016/j.tox.2014.09.003; Gaillard M, 2006, J BACTERIOL, V188, P1999, DOI 10.1128/JB.188.5.1999-2013.2006; Gibson D.T., 1984, MICROBIAL DEGRADATIO, P182; Grant JR, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-202; GRUND E, 1992, APPL ENVIRON MICROB, V58, P1874, DOI 10.1128/AEM.58.6.1874-1877.1992; Gurtler V, 2004, FEMS MICROBIOL REV, V28, P377, DOI 10.1016/j.femsre.2004.01.001; Hacker J, 2001, EMBO REP, V2, P376, DOI 10.1093/embo-reports/kve097; Haft DH, 2005, PLOS COMPUT BIOL, V1, P474, DOI 10.1371/journal.pcbi.0010060; Hickey WJ, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00125; Husemann P, 2010, BIOINFORMATICS, V26, P570, DOI 10.1093/bioinformatics/btp690; Jin HM, 2011, J BACTERIOL, V193, P4292, DOI 10.1128/JB.05252-11; Juhas M, 2009, FEMS MICROBIOL REV, V33, P376, DOI 10.1111/j.1574-6976.2008.00136.x; Kapustka LA, 2004, HUM ECOL RISK ASSESS, V10, P185, DOI 10.1080/10807030490438166; Kim D, 2002, APPL ENVIRON MICROB, V68, P3270, DOI 10.1128/AEM.68.7.3270-3278.2002; Kimura N, 2006, APPL MICROBIOL BIOT, V73, P474, DOI 10.1007/s00253-006-0481-8; Krizova L, 2010, J ANTIMICROB CHEMOTH, V65, P1915, DOI 10.1093/jac/dkq223; Kulakov LA, 2005, APPL ENVIRON MICROB, V71, P1754, DOI 10.1128/AEM.71.4.1754-1764.2005; Kulakova AN, 1996, FEMS MICROBIOL LETT, V145, P227, DOI 10.1111/j.1574-6968.1996.tb08582.x; Kuyukina MS, 2010, MICROBIOL MONOGR, V16, P231, DOI 10.1007/978-3-642-12937-7_9; Laemmli CM, 2000, J BACTERIOL, V182, P4165, DOI 10.1128/JB.182.15.4165-4172.2000; Lalucat J, 2006, MICROBIOL MOL BIOL R, V70, P510, DOI 10.1128/MMBR.00047-05; Lane DJ, 1991, NUCL ACID TECHNIQUES, P115; Larkin MJ, 2006, ADV APPL MICROBIOL, V59, P1, DOI 10.1016/S0065-2164(06)59001-X; Larkin MJ, 2005, CURR OPIN BIOTECH, V16, P282, DOI 10.1016/j.copbio.2005.04.007; Larkin MJ, 1999, J BACTERIOL, V181, P6200, DOI 10.1128/JB.181.19.6200-6204.1999; Lin CL, 2012, MICROBIOL RES, V167, P395, DOI 10.1016/j.micres.2011.12.002; Liu TT, 2011, APPL MICROBIOL BIOT, V90, P671, DOI 10.1007/s00253-010-3033-1; Markowitz VM, 2014, NUCLEIC ACIDS RES, V42, pD560, DOI 10.1093/nar/gkt963; MASAI E, 1995, APPL ENVIRON MICROB, V61, P2079, DOI 10.1128/AEM.61.6.2079-2085.1995; McLeod MP, 2006, P NATL ACAD SCI USA, V103, P15582, DOI 10.1073/pnas.0607048103; Nishi A, 2000, J BACTERIOL, V182, P1949, DOI 10.1128/JB.182.7.1949-1955.2000; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; Pathak A., 2012, THESIS; Pathak A, 2011, STRAT ENV RES DEV PR; Pathak A, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00144-12; Phale PS, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00234-12; Pierre B, 1999, ENV PHOTOCHEMISTRY; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Salinero KK, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-351; Schuhle K, 2001, J BACTERIOL, V183, P5268, DOI 10.1128/JB.183.18.5268-5278.2001; SETO M, 1995, APPL ENVIRON MICROB, V61, P3353, DOI 10.1128/AEM.61.9.3353-3358.1995; Soares SC, 2015, J BIOTECHNOL; Suzuki K, 2002, J BACTERIOL, V184, P5714, DOI 10.1128/JB.184.20.5714-5722.2002; Tian L, 2003, PROCESS BIOCHEM, V38, P1125, DOI 10.1016/S0032-9592(02)00245-5; Tomas-Gallardo L, 2014, MICROB BIOTECHNOL, V7, P100, DOI 10.1111/1751-7915.12096; Toussaint A, 2003, APPL ENVIRON MICROB, V69, P4837, DOI 10.1128/AEM.69.8.4837-4845.2003; Tumapa S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-190; Uz I, 2000, FEMS MICROBIOL LETT, V185, P231, DOI 10.1111/j.1574-6968.2000.tb09067.x; van der Geize R, 2004, CURR OPIN MICROBIOL, V7, P255, DOI 10.1016/j.mib.2004.04.001; van Herwijnen R, 2006, FEMS MICROBIOL ECOL, V55, P122, DOI 10.1111/j.1574-6941.2005.00001.x; van Herwijnen R, 2003, APPL ENVIRON MICROB, V69, P186, DOI 10.1128/AEM.69.1.186-190.2003; Vikram S, 2012, J BACTERIOL, V194, P3543, DOI 10.1128/JB.00532-12; Yagi JM, 2009, ENVIRON MICROBIOL, V11, P2253, DOI 10.1111/j.1462-2920.2009.01947.x; Yoo M, 2012, J BACTERIOL, V194, P4440, DOI 10.1128/JB.00844-12	76	13	15	3	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2016	11	8							e0161032	10.1371/journal.pone.0161032	http://dx.doi.org/10.1371/journal.pone.0161032			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4YN	27532207	Green Published, Green Submitted, gold			2022-12-27	WOS:000381487600056
J	Sasic, L; Acanski, J; Vujic, A; Stahls, G; Radenkovic, S; Milic, D; Vidakovic, DO; Dan, M				Sasic, Ljiljana; Acanski, Jelena; Vujic, Ante; Stahls, Gunilla; Radenkovic, Snezana; Milic, Dubravka; Vidakovic, Dragana Obreht; Dan, Mihajla			Molecular and Morphological Inference of Three Cryptic Species within the Merodon aureus Species Group (Diptera: Syrphidae)	PLOS ONE			English	Article							ENVIRONMENTAL NICHE; TAXONOMY; COMPLEX; DELIMITATION; DIVERGENCE; MEIGEN; CONSERVATION; SYSTEMATICS; POPULATIONS; EXTENSIONS	The Merodon aureus species group (Diptera: Syrphidae: Eristalinae) comprises a number of different sub-groups and species complexes. In this study we focus on resolving the taxonomic status of the entity previously identified as M. cinereus B, here identified as M. atratus species complex. We used an integrative approach based on morphological descriptions, combined with supporting characters that were obtained from molecular analyses of the mitochondrial cytochrome c oxidase I gene as well as from geometric morphometry of wing and surstylus shapes and environmental niche comparisons. All applied data and methods distinguished and supported three morphologically cryptic species: M. atratus stat. nov., M. virgatus sp. nov. and M. balkanicus sp. nov., which constitute the M. atratus species complex. We present an identification key for the sub-groups and species complexes of the M. aureus species group occurring in Europe, describe the taxa and discuss the utility of the applied methods for species delimitation. The estimated divergence times for the species splits of these taxa coincide with the Pleistocene Gunz-Mindel interglaciation and the Great interglaciation (between the Ris and Mindel glacial periods).	[Sasic, Ljiljana; Vujic, Ante; Radenkovic, Snezana; Milic, Dubravka; Vidakovic, Dragana Obreht; Dan, Mihajla] Univ Novi Sad, Dept Biol & Ecol, Fac Sci, Novi Sad, Serbia; [Acanski, Jelena] Univ Novi Sad, BioSense Inst, Lab Biosyst Res, Res Inst Informat Technol Biosyst, Novi Sad, Serbia; [Stahls, Gunilla] Univ Helsinki, Zool Unit, Finnish Museum Nat Hist, Helsinki, Finland	University of Novi Sad; University of Novi Sad; University of Helsinki	Sasic, L (corresponding author), Univ Novi Sad, Dept Biol & Ecol, Fac Sci, Novi Sad, Serbia.	ljiljana.sasic@dbe.uns.ac.rs	Ačanski, Jelena/S-5383-2017; Vujic, Ante/AAG-2996-2020	Ačanski, Jelena/0000-0003-1745-6410; Sasic Zoric, Ljiljana/0000-0003-1616-2701; Stahls, Gunilla/0000-0003-0505-0691; Milic, Dubravka/0000-0002-8828-1489; Vujic, Ante/0000-0002-8819-8079	Ministry of Education, Science and Technological Development of Serbia [173002]	Ministry of Education, Science and Technological Development of Serbia(Ministry of Education, Science & Technological Development, Serbia)	This work was supported by the Ministry of Education, Science and Technological Development of Serbia (http://www.mpn.gov.rs/), Grant Number 173002 (Conservation strategies for the preservation of protected and strictly protected species in Serbia-hoverflies (Insecta: Diptera: Syrphidae) as model organisms); AV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acanski J, 2016, ARCH BIOL S IN PRESS; Acanski J, 2016, EUR J TAXON IN PRESS; Aguirre-Gutierrez J, 2015, DIVERS DISTRIB, V21, P245, DOI 10.1111/ddi.12268; Andric A, 2014, ACTA ENT MUS NAT PRA, V54, P741; Marcos-Garcia MA, 2011, CAN ENTOMOL, V143, P332, DOI 10.4039/n11-013; [Anonymous], 2014, TRACER V1 6; Avise JC, 2000, PHYLOGEOGRAPHY HIST, DOI 10.2307/j.ctv1nzfgj7; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Bookstein FL, 1997, MED IMAGE ANAL, V1, P225, DOI DOI 10.1016/S1361-8415(97)85012-8; BROWER AVZ, 1994, P NATL ACAD SCI USA, V91, P6491, DOI 10.1073/pnas.91.14.6491; Burns John M., 2007, Journal of the Lepidopterists' Society, V61, P138; Chen H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011963; Cognato AI, 2006, J ECON ENTOMOL, V99, P1037, DOI 10.1603/0022-0493-99.4.1037; Debandi G, 2012, AUSTRAL ECOL, V37, P392, DOI 10.1111/j.1442-9993.2011.02295.x; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Francuski L, 2011, J INSECT CONSERV, V15, P379, DOI 10.1007/s10841-010-9311-5; Goloboff P. A, 1999, NONA COMPUTER PROGRA; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hasson Esteban, 2009, P89; Hawlitschek O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016662; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hewitt GM, 1996, BIOL J LINN SOC, V58, P247, DOI 10.1111/j.1095-8312.1996.tb01434.x; Hijmans RJ, 2006, GLOBAL CHANGE BIOL, V12, P2272, DOI 10.1111/j.1365-2486.2006.01256.x; Hippa Heikki, 2005, Acta Zoologica Fennica, V215, P1; House CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063807; Kambhampati S, 2007, BIOL J LINN SOC, V90, P457, DOI 10.1111/j.1095-8312.2006.00734.x; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Klingenberg CP, 2011, MOL ECOL RESOUR, V11, P353, DOI 10.1111/j.1755-0998.2010.02924.x; Knowles LL, 2000, EVOLUTION, V54, P1337, DOI 10.1111/j.0014-3820.2000.tb00566.x; Kukla G, 2005, QUATERNARY SCI REV, V24, P1573, DOI 10.1016/j.quascirev.2004.08.023; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; MANTEL N, 1967, CANCER RES, V27, P209; Marcos-Garcia MA, 2007, EUR J ENTOMOL, V104, P531, DOI 10.14411/eje.2007.073; Masetti A, 2006, EUR J ENTOMOL, V103, P459, DOI 10.14411/eje.2006.059; Mengual Ximo, 2006, Zootaxa, V1377, P1; Milankov V, 2008, CONSERV GENET, V9, P1125, DOI 10.1007/s10592-007-9426-8; Milankov V, 2013, BIOL J LINN SOC, V110, P257, DOI 10.1111/bij.12127; Milankovitch M., 1941, CANON INSOLATION ICE, V133, P633; Miller M.A., 2010, P GAT COMP ENV WORKS; Montgomery D. C., 1992, INTRO LINEAR REGRESS; Mutanen M, 2007, SYST ENTOMOL, V32, P371, DOI 10.1111/j.1365-3113.2006.00372.x; Naimi B., 2015, R PACKAGE VERSION, P1; Nedeljkovic Z, 2015, CONTRIB ZOOL, V84, P285, DOI 10.1163/18759866-08404002; Nedeljkovic Z, 2013, ZOOL J LINN SOC-LOND, V169, P84, DOI 10.1111/zoj.12052; Nixon K.C., 2002, WINCLADA VER 1 00 08; Oldenberg L., 1919, DTSCH ENTOMOL Z, P387; Padial JM, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-16; Penman TD, 2005, J BIOGEOGR, V32, P397, DOI 10.1111/j.1365-2699.2005.01205.x; Perez-Banon C, 2003, EUR J ENTOMOL, V100, P417, DOI 10.14411/eje.2003.064; Petersen MJ, 2013, BIOL INVASIONS, V15, P885, DOI 10.1007/s10530-012-0337-3; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Popovic D, 2015, EUR J ENTOMOL, V112, P790, DOI 10.14411/eje.2015.100; Puillandre N, 2012, MOL ECOL, V21, P1864, DOI 10.1111/j.1365-294X.2011.05239.x; R Core Team, 2021, R LANGUAGE ENV STAT; Radenkovic S, 2011, ZOOTAXA, P35, DOI 10.11646/zootaxa.2735.1.5; RAMBAUT A., 2014, FIGTREE 1 4 4 SOFTWA; Rissler LJ, 2007, SYST BIOL, V56, P924, DOI 10.1080/10635150701703063; RODRIGUEZ F, 1990, J THEOR BIOL, V142, P485, DOI 10.1016/S0022-5193(05)80104-3; ROHLF FJ, 1990, SYST ZOOL, V39, P40, DOI 10.2307/2992207; Rohlf FJ., 2006, TPSDIG DIGITIZE LAND; Rosenberg MS, 2011, METHODS ECOL EVOL, V2, P229, DOI 10.1111/j.2041-210X.2010.00081.x; Rutschmann F, 2006, DIVERS DISTRIB, V12, P35, DOI 10.1111/j.1366-9516.2006.00210.x; Schmitt T, 2009, VYVOJ PRIRODY SLOVEN, P143; Schmitt T, 2009, FRONT ZOOL, V6, DOI 10.1186/1742-9994-6-9; SCHOENER TW, 1968, ECOLOGY, V49, P704, DOI 10.2307/1935534; Sheets HD, 2012, IMP SOFTW SER; Sheffield CS, 2009, MOL ECOL RESOUR, V9, P196, DOI 10.1111/j.1755-0998.2009.02645.x; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Speight MCD., 2014, SYRPH NET DATABASE E, V78; Stahls G, 2009, MOL ECOL RESOUR, V9, P1431, DOI 10.1111/j.1755-0998.2009.02592.x; Stahls G, 2008, ANN ZOOL FENN, V45, P149, DOI 10.5735/086.045.0206; Stamatakis A., 2014, BIOINFORMATICS, V21; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Vujic A, 2007, ANN SOC ENTOMOL FR, V43, P319, DOI 10.1080/00379271.2007.10697527; Vujic A, 2015, ZOOTAXA, V4006, P439, DOI 10.11646/zootaxa.4006.3.2; Vujic A, 2013, ZOOL SCR, V42, P288, DOI 10.1111/zsc.12005; Vujic A, 2012, SYST ENTOMOL, V37, P578, DOI 10.1111/j.1365-3113.2012.00631.x; Warren DL, 2008, EVOLUTION, V62, P2868, DOI 10.1111/j.1558-5646.2008.00482.x; Warren DL, 2010, ECOGRAPHY, V33, P607, DOI 10.1111/j.1600-0587.2009.06142.x; Zelditch ML, 2004, GEOMETRIC MORPHOMETR; Zhu GP, 2013, J INSECT SCI, V13, DOI 10.1673/031.013.10201	86	37	41	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2016	11	8							e0160001	10.1371/journal.pone.0160001	http://dx.doi.org/10.1371/journal.pone.0160001			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4YN	27532618	Green Published, Green Submitted, gold			2022-12-27	WOS:000381487600020
J	Wu, YH; Lee, WJ; Chen, YH; Chang, MH; Lin, CH				Wu, Yu-Hsuan; Lee, Wei-Ju; Chen, Yi-Huei; Chang, Ming-Hong; Lin, Ching-Heng			Premotor Symptoms as Predictors of Outcome in Parkinsons Disease: A Case-Control Study	PLOS ONE			English	Article							SLEEP BEHAVIOR DISORDER; SUBTHALAMIC NUCLEUS; STIMULATION; PREVALENCE; TAIWAN; RISK	Background To evaluate the association between the premotor symptoms and the prognosis of PD. Methods A total of 1213 patients who were diagnosed of PD from January 2001 to December 2008 were selected from the Taiwan's National Health Insurance Research Database. Patients were traced back to determine the presence of premotor symptoms, including rapid eye movement sleep behavior disorder (RBD), depression, and constipation. Cox's regression analysis was used to detect the risks between the occurrence of premotor symptoms and the outcome (including death, psychosis, accidental injury, dementia and aspiration pneumonia). In addition, the association between premotor symptoms and levodopa equivalent dosage (LED) was examined. Results Higher occurrence of death, dementia and aspiration pneumonia were identified in PD patients with premotor symptoms than without premotor symptoms (HR 1.69, 95% CI 1.342 .14, p < 0.001 for death; HR 1.63, 95% CI 1.20-2.22, p = 0.002 for dementia; HR 2.45, 95% CI 1.42-4.21, p = 0.001 for aspiration pneumonia). In a comorbidities-stratified analysis, PD patients with premotor symptoms showed significantly high risks of mortality and morbidity (dementia and aspiration pneumonia), especially in the absence of comorbidities. Independent predictors of mortality in PD were found to be higher age, male sex, constipation, RBD, RBD with constipation and depression, and diabetes. Furthermore, no significant differences of LED and subsequent accidental injury were noted between PD patient with or without premotor symptoms. Conclusion Premotor symptoms seem to be not merely risk factors, but also prognostic factors of PD.	[Wu, Yu-Hsuan; Lee, Wei-Ju; Chang, Ming-Hong] Taichung Vet Gen Hosp, Neurol Sect, Taichung, Taiwan; [Lee, Wei-Ju; Chang, Ming-Hong] Natl Yang Ming Univ, Sch Med, Dept Neurol, Taipei, Taiwan; [Chen, Yi-Huei; Lin, Ching-Heng] Taichung Vet Gen Hosp, Dept Med Educ & Res, Taichung, Taiwan	Taichung Veterans General Hospital; National Yang Ming Chiao Tung University; Taichung Veterans General Hospital	Chang, MH (corresponding author), Taichung Vet Gen Hosp, Neurol Sect, Taichung, Taiwan.; Chang, MH (corresponding author), Natl Yang Ming Univ, Sch Med, Dept Neurol, Taipei, Taiwan.; Lin, CH (corresponding author), Taichung Vet Gen Hosp, Dept Med Educ & Res, Taichung, Taiwan.	cmh50@ms10.hinet.net; joelin99@gmail.com		Lee, Wei-Ju/0000-0002-3720-4539	Taichung Veterans General Hospital [TCVGH-1053402C, TCVGH-1053404D]	Taichung Veterans General Hospital	Full financial support for all authors came from the Taichung Veterans General Hospital (TCVGH-1053402C and TCVGH-1053404D). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhidayasiri R, 2012, PARKINSONISM RELAT D, V18, P694, DOI 10.1016/j.parkreldis.2012.01.010; Chen RC, 2001, NEUROLOGY, V57, P1679, DOI 10.1212/WNL.57.9.1679; de Lau LML, 2014, PARKINSONISM RELAT D, V20, P613, DOI 10.1016/j.parkreldis.2014.02.030; Guo YJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107465; Hely MA, 2005, MOVEMENT DISORD, V20, P190, DOI 10.1002/mds.20324; Hsieh LP, 2011, EPILEPSY RES, V96, P81, DOI 10.1016/j.eplepsyres.2011.05.003; Jennum P, 2013, SLEEP MED, V14, P782, DOI 10.1016/j.sleep.2012.11.002; Kang SH, 2013, SLEEP, V36, P1147, DOI 10.5665/sleep.2874; Krack P, 2003, NEW ENGL J MED, V349, P1925, DOI 10.1056/NEJMoa035275; Lang AE, 2011, MOVEMENT DISORD, V26, P775, DOI 10.1002/mds.23609; Lebouvier T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012728; Lin CH, 2014, PARKINSONISM RELAT D, V20, P1371, DOI 10.1016/j.parkreldis.2014.09.026; Morgan JC, 2014, PARKINSONS DIS-US, V2014, DOI 10.1155/2014/426976; O'Sullivan SS, 2008, MOVEMENT DISORD, V23, P101, DOI 10.1002/mds.21813; Romenets Silvia Rios, 2012, Mov Disord, V27, P996, DOI 10.1002/mds.25086; Shen CC, 2013, NEUROLOGY, V81, P1538, DOI 10.1212/WNL.0b013e3182a956ad; Wu YH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130282; Yamada K, 2008, ACTA NEUROCHIR, V150, P15, DOI 10.1007/s00701-007-1451-3	18	8	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2016	11	8							e0161271	10.1371/journal.pone.0161271	http://dx.doi.org/10.1371/journal.pone.0161271			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4YN	27533053	Green Published, gold, Green Submitted			2022-12-27	WOS:000381487600080
J	Mahamoud, YS; Aite, M; Martin, C; Zhadobov, M; Sauleau, R; Le Drean, Y; Habauzit, D				Mahamoud, Yonis Soubere; Aite, Meziane; Martin, Catherine; Zhadobov, Maxim; Sauleau, Ronan; Le Drean, Yves; Habauzit, Denis			Additive Effects of Millimeter Waves and 2-Deoxyglucose Co-Exposure on the Human Keratinocyte Transcriptome	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; CHEMICAL GENOMICS; GENE-EXPRESSION; B-CELL; T-CELL; 2-DEOXY-D-GLUCOSE; DOSIMETRY; STRESS; CYCLOPHOSPHAMIDE; APOPTOSIS	Millimeter Waves (MMW) will be used in the next-generation of high-speed wireless technologies, especially in future Ultra-Broadband small cells in 5G cellular networks. Therefore, their biocompatibilities must be evaluated prior to their massive deployment. Using a micro-array-based approach, we analyzed modifications to the whole genome of a human keratinocyte model that was exposed at 60.4 GHz-MMW at an incident power density (IPD) of 20 mW/cm(2) for 3 hours in athermic conditions. No keratinocyte transcriptome modifications were observed. We tested the effects of MMWs on cell metabolism by co-treating MMW-exposed cells with a glycolysis inhibitor, 2-deoxyglucose (2dG, 20 mM for 3 hours), and whole genome expression was evaluated along with the ATP content. We found that the 2dG treatment decreased the cellular ATP content and induced a high modification in the transcriptome (632 coding genes). The affected genes were associated with transcriptional repression, cellular communication and endoplasmic reticulum homeostasis. The MMW/2dG co-treatment did not alter the keratinocyte ATP content, but it did slightly alter the transcriptome, which reflected the capacity of MMWto interfere with the bioenergetic stress response. The RT-PCR-based validation confirmed 6 MMW-sensitive genes (SOCS3, SPRY2, TRIB1, FAM46A, CSRNP1 and PPP1R15A) during the 2dG treatment. These 6 genes encoded transcription factors or inhibitors of cytokine pathways, which raised questions regarding the potential impact of long-term or chronic MMW exposure on metabolically stressed cells.	[Mahamoud, Yonis Soubere; Aite, Meziane; Martin, Catherine; Le Drean, Yves; Habauzit, Denis] INSERM, UMR 1085, Irset, Transcript Environm & Canc Grp TREC, Rennes, France; [Mahamoud, Yonis Soubere; Aite, Meziane; Martin, Catherine; Zhadobov, Maxim; Sauleau, Ronan; Le Drean, Yves; Habauzit, Denis] Univ Rennes 1, Rennes, France; [Zhadobov, Maxim; Sauleau, Ronan] CNRS, UMR 6164, IETR, Rennes, France; [Mahamoud, Yonis Soubere] Univ Djibouti, Djibouti City, Djibouti	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); University Djibouti	Habauzit, D (corresponding author), INSERM, UMR 1085, Irset, Transcript Environm & Canc Grp TREC, Rennes, France.; Habauzit, D (corresponding author), Univ Rennes 1, Rennes, France.	denis.habauzit@univ-rennes1.fr	Habauzit, Denis/K-1779-2015; Zhadobov, Maxim/P-6492-2016	Habauzit, Denis/0000-0001-8101-3839; Zhadobov, Maxim/0000-0002-3809-110X; Sauleau, Ronan/0000-0001-7510-9762	French National Research Agency (Agence Nationale de la Recherche, ANR) [10-CESA-017-01]; French Agency for Food, Environmental and Occupational Health Safety (ANSES) [EST-2014/2 RF/012]	French National Research Agency (Agence Nationale de la Recherche, ANR)(French National Research Agency (ANR)); French Agency for Food, Environmental and Occupational Health Safety (ANSES)	This work was supported by the French National Research Agency (Agence Nationale de la Recherche, ANR), under grant number 10-CESA-017-01 (BioREF project) and by the French Agency for Food, Environmental and Occupational Health & Safety (ANSES), under grant number EST-2014/2 RF/012 (BEMAM project). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alekseev SI, 2008, BIOELECTROMAGNETICS, V29, P65, DOI 10.1002/bem.20363; [Anonymous], 1998, HEALTH PHYS, V74, P494; Caraglia M, 2005, J CELL PHYSIOL, V204, P539, DOI 10.1002/jcp.20327; Cojocari D, 2013, RADIOTHER ONCOL, V108, P541, DOI 10.1016/j.radonc.2013.06.005; FORNACE AJ, 1988, P NATL ACAD SCI USA, V85, P8800, DOI 10.1073/pnas.85.23.8800; Frank MJ, 2009, BLOOD, V113, P2478, DOI 10.1182/blood-2008-05-156943; Gapeyev AB, 2009, BIOELECTROMAGNETICS, V30, P454, DOI 10.1002/bem.20499; Ha YT, 2010, INT J RADIAT BIOL, V86, P27, DOI 10.3109/09553000903264507; Habauzit D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109435; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2013, IARC Monogr Eval Carcinog Risks Hum, V102, P1; Ikeda J, 1997, BIOCHEM BIOPH RES CO, V230, P94, DOI 10.1006/bbrc.1996.5890; Jing W, WEB BASED GENE SET A; Joshi MB, 2013, FEBS LETT, V587, P2241, DOI 10.1016/j.febslet.2013.05.053; Ke XQ, 2008, INT J RADIAT BIOL, V84, P413, DOI 10.1080/09553000801998875; Kunz S, 2006, EXP DERMATOL, V15, P991, DOI 10.1111/j.1600-0625.2006.00516.x; Le Drean Y, 2013, CR PHYS, V14, P402, DOI 10.1016/j.crhy.2013.02.005; Le Quement C, 2014, BIOELECTROMAGNETICS, V35, P444, DOI 10.1002/bem.21864; Li YM, 2014, ACTA BIOCH BIOPH SIN, V46, P629, DOI 10.1093/abbs/gmu048; Logani MK, 2012, IMMUNOPHARM IMMUNOT, V34, P107, DOI 10.3109/08923973.2011.583252; Lu YH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108318; Makar VR, 2006, BIOELECTROMAGNETICS, V27, P458, DOI 10.1002/bem.20230; Maschek G, 2004, CANCER RES, V64, P31, DOI 10.1158/0008-5472.CAN-03-3294; Pelicano H, 2006, ONCOGENE, V25, P4633, DOI 10.1038/sj.onc.1209597; Puigdecanet E, 2008, LEUKEMIA, V22, P1368, DOI 10.1038/leu.2008.112; Radzievsky AA, 2008, BIOELECTROMAGNETICS, V29, P284, DOI 10.1002/bem.20389; Rainard P, 2008, MOL IMMUNOL, V45, P4020, DOI 10.1016/j.molimm.2008.06.010; Rojavin MA, 1998, QJM-MON J ASSOC PHYS, V91, P57, DOI 10.1093/qjmed/91.1.57; Saito S, 2011, METHOD ENZYMOL, V491, P327, DOI 10.1016/B978-0-12-385928-0.00018-3; Saito S, 2009, CANCER RES, V69, P4225, DOI 10.1158/0008-5472.CAN-08-2689; Shefler I, 2014, J ALLERGY CLIN IMMUN, V133, P217, DOI 10.1016/j.jaci.2013.04.035; Simons AL, 2007, INT J RADIAT ONCOL, V69, P1222, DOI 10.1016/j.ijrobp.2007.07.2343; Simons AL, 2009, J CANCER RES THER, V5, P2, DOI 10.4103/0973-1482.55133; Skobowiat C, 2011, AM J PHYSIOL-ENDOC M, V301, pE484, DOI [10.1152/ajpendo.00217.2011, 10.1152/ajpendo.00217.2011.]; Slominski A, 2000, ENDOCR REV, V21, P457, DOI 10.1210/er.21.5.457; SLOMINSKI A, 2013, J STEROID BIOCHEM, V137, P107, DOI [10.1016/.jsbmb.2013.02.006, DOI 10.1016/J.JSBMB.2013.02.006]; Usichenko TI, 2006, EVID-BASED COMPL ALT, V3, P201, DOI 10.1093/ecam/nel012; van Galen P, 2014, NATURE, V510, P268, DOI 10.1038/nature13228; WARBURG O, 1956, SCIENCE, V124, P269; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Winer J, 1999, ANAL BIOCHEM, V270, P41, DOI 10.1006/abio.1999.4085; Wu M, 2007, AM J PHYSIOL-CELL PH, V292, pC125, DOI 10.1152/ajpcell.00247.2006; Yang XS, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-54; Zhadobov M, 2012, BIOELECTROMAGNETICS, V33, P55, DOI 10.1002/bem.20685; Zhadobov M, 2008, IEEE T MICROW THEORY, V56, P2998, DOI 10.1109/TMTT.2008.2006797; Zhang Hua, 2008, Zhonghua Fu Chan Ke Za Zhi, V43, P356; Zhang XD, 2006, ANTICANCER RES, V26, P3561; Zheng YZ, 2014, BREAST CANCER RES TR, V145, P349, DOI 10.1007/s10549-014-2967-x; Zhong DS, 2009, J BIOL CHEM, V284, P23225, DOI 10.1074/jbc.M109.005280	49	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2016	11	8							e0160810	10.1371/journal.pone.0160810	http://dx.doi.org/10.1371/journal.pone.0160810			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4UN	27529420	gold, Green Published, Green Submitted			2022-12-27	WOS:000381476700022
J	Dew-Budd, K; Jarnigan, J; Reed, LK				Dew-Budd, Kelly; Jarnigan, Julie; Reed, Laura K.			Genetic and Sex-Specific Transgenerational Effects of a High Fat Diet in Drosophila melanogaster	PLOS ONE			English	Article							EPIGENETIC INHERITANCE; METABOLIC STATE; REFERENCE PANEL; EGG SIZE; GENERATIONS; PHENOTYPES; GROWTH; FLIES; TRIACYLGLYCEROL; REPRODUCTION	An organism's phenotype is the product of its environment and genotype, but an ancestor's environment can also be a contributing factor. The recent increase in caloric intake and decrease in physical activity of developed nations' populations is contributing to deteriorating health and making the study of the longer term impacts of a changing lifestyle a priority. The dietary habits of ancestors have been shown to affect phenotype in several organisms, including humans, mice, and the fruit fly. Whether the ancestral dietary effect is purely environmental or if there is a genetic interaction with the environment passed down for multiple generations, has not been determined previously. Here we used the fruit fly, Drosophila melanogaster, to investigate the genetic, sex-specific, and environmental effects of a high fat diet for three generations' on pupal body weights across ten genotypes. We also tested for genotype-specific transgenerational effects on metabolic pools and egg size across three genotypes. We showed that there were substantial differences in transgenerational responses to ancestral diet between genotypes and sexes through both first and second descendant generations. Additionally, there were differences in phenotypes between maternally and paternally inherited dietary effects. We also found a treated organism's reaction to a high fat diet was not a consistent predictor of its untreated descendants' phenotype. The implication of these results is that, given our interest in understanding and preventing metabolic diseases like obesity, we need to consider the contribution of ancestral environmental experiences. However, we need to be cautious when drawing population-level generalization from small studies because transgenerational effects are likely to exhibit substantial sex and genotype specificity.	[Dew-Budd, Kelly; Jarnigan, Julie; Reed, Laura K.] Univ Alabama, Dept Biol Sci, Tuscaloosa, AL 35487 USA; [Dew-Budd, Kelly] Univ Arizona, Sch Plant Sci, Tucson, AZ USA	University of Alabama System; University of Alabama Tuscaloosa; University of Arizona	Reed, LK (corresponding author), Univ Alabama, Dept Biol Sci, Tuscaloosa, AL 35487 USA.	lreed1@ua.edu		Reed, Laura/0000-0002-4381-494X; Dew-Budd, Kelly/0000-0003-3791-2241	National Institutes of General Medical Sciences [R01GM098856]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098856] Funding Source: NIH RePORTER	National Institutes of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by grant R01GM098856 from National Institutes of General Medical Sciences, [www.nigms.nih.gov]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Competing	Aldrich JC, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005148; Azevedo RBR, 1997, AM NAT, V150, P250, DOI 10.1086/286065; Baker KD, 2007, CELL METAB, V6, P257, DOI 10.1016/j.cmet.2007.09.002; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Branco AT, 2014, GENETICS, V197, P147, DOI 10.1534/genetics.114.163170; Broderick NA, 2012, GUT MICROBES, V3, P307, DOI 10.4161/gmic.19896; Brookheart RT, 2016, MOL CELL ENDOCRINOL, V435, P20, DOI 10.1016/j.mce.2015.12.003; Buchon N, 2013, NAT REV MICROBIOL, V11, P615, DOI 10.1038/nrmicro3074; Buescher JL, 2013, DIS MODEL MECH, V6, P1123, DOI 10.1242/dmm.011924; Charroux B, 2012, SEMIN IMMUNOL, V24, P17, DOI 10.1016/j.smim.2011.11.003; CHURCH RB, 1966, J EXP ZOOL, V162, P337, DOI 10.1002/jez.1401620309; CLARK AG, 1988, GENETICS, V119, P595; Crill WD, 1996, EVOLUTION, V50, P1205, DOI [10.2307/2410661, 10.1111/j.1558-5646.1996.tb02361.x]; De Luca M, 2005, OBES RES, V13, P1596, DOI 10.1038/oby.2005.196; Dias BG, 2014, NAT NEUROSCI, V17, P89, DOI 10.1038/nn.3594; Donkin I, 2016, CELL METAB, V23, P369, DOI 10.1016/j.cmet.2015.11.004; Fullston T, 2013, FASEB J, V27, P4226, DOI 10.1096/fj.12-224048; Gapp K, 2014, NAT NEUROSCI, V17, P667, DOI 10.1038/nn.3695; Ho DH, 2010, J EXP BIOL, V213, P3, DOI 10.1242/jeb.019752; Huang W, 2014, GENOME RES, V24, P1193, DOI 10.1101/gr.171546.113; Jablonka E, 2009, Q REV BIOL, V84, P131, DOI 10.1086/598822; Kaati G, 2002, EUR J HUM GENET, V10, P682, DOI 10.1038/sj.ejhg.5200859; King EG, 2012, GENETICS, V191, P935, DOI 10.1534/genetics.112.138537; Lecomte V, 2013, BIOESSAYS, V35, P787, DOI 10.1002/bies.201300051; Linder JE, 2009, FLY, V3, P143, DOI 10.4161/fly.8051; Macdonald SJ, 2007, GENETICS, V176, P1261, DOI 10.1534/genetics.106.069641; Mackay TFC, 2012, NATURE, V482, P173, DOI 10.1038/nature10811; Matzkin LM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059530; McPherson NO, 2014, FERTIL STERIL, V101, P865, DOI 10.1016/j.fertnstert.2013.12.007; Nystrand M, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1242; Paoloni-Giacobino A, 2014, VITAM HORM, V94, P211, DOI 10.1016/B978-0-12-800095-3.00008-0; Pembrey ME, 2006, EUR J HUM GENET, V14, P159, DOI 10.1038/sj.ejhg.5201538; Prasad NG, 2003, EVOL ECOL RES, V5, P903; Reed LK, 2014, GENETICS, V197, P781, DOI 10.1534/genetics.114.163857; Reed LK, 2010, GENETICS, V185, P1009, DOI 10.1534/genetics.109.113571; Rockman MV, 2012, EVOLUTION, V66, P1, DOI 10.1111/j.1558-5646.2011.01486.x; Rulifson EJ, 2002, SCIENCE, V296, P1118, DOI 10.1126/science.1070058; Schiffer M, 2013, J EXP BIOL, V216, P3790, DOI 10.1242/jeb.085126; Skinner MK, 2008, REPROD TOXICOL, V25, P2, DOI 10.1016/j.reprotox.2007.09.001; Somer RA, 2014, CURR OPIN GENET DEV, V27, P43, DOI 10.1016/j.gde.2014.03.008; Staubach F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070749; Stern S, 2014, J PHYSIOL-LONDON, V592, P2343, DOI 10.1113/jphysiol.2014.271445; Tadros W, 2005, DEV DYNAM, V232, P593, DOI 10.1002/dvdy.20297; Valtonen TM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031611; Vijendravarma RK, 2010, BIOL LETTERS, V6, P238, DOI 10.1098/rsbl.2009.0754; Wei YC, 2015, HUM REPROD UPDATE, V21, P194, DOI 10.1093/humupd/dmu061; Williams S, 2015, G3-GENES GENOM GENET, V5, P2817, DOI 10.1534/g3.115.023564; Xia B, 2016, AGING-US, V8, P1115, DOI 10.18632/aging.100932; Youngson NA, 2008, ANNU REV GENOM HUM G, V9, P233, DOI 10.1146/annurev.genom.9.081307.164445; Zhu JM, 2014, J NEUROSCI, V34, P2768, DOI 10.1523/JNEUROSCI.4402-13.2014	50	18	18	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2016	11	8							e0160857	10.1371/journal.pone.0160857	http://dx.doi.org/10.1371/journal.pone.0160857			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3LI	27518304	gold, Green Published			2022-12-27	WOS:000381382100028
J	Dennison, TJ; Smith, J; Hofmann, MP; Bland, CE; Badhan, RK; Al-Khattawi, A; Mohammed, AR				Dennison, Thomas J.; Smith, Julian; Hofmann, Michael P.; Bland, Charlotte E.; Badhan, Raj K.; Al-Khattawi, Ali; Mohammed, Afzal R.			Design of Experiments to Study the Impact of Process Parameters on Droplet Size and Development of Non-Invasive Imaging Techniques in Tablet Coating	PLOS ONE			English	Article							NON-NEWTONIAN LIQUIDS; ROUND WATER-JET; ANNULAR AIR-JET; AIRBLAST ATOMIZATION; COATED TABLETS; SPRAY DRYER; SCALE-UP; THICKNESS; COMPRESSION; MICROSCOPY	Atomisation of an aqueous solution for tablet film coating is a complex process with multiple factors determining droplet formation and properties. The importance of droplet size for an efficient process and a high quality final product has been noted in the literature, with smaller droplets reported to produce smoother, more homogenous coatings whilst simultaneously avoiding the risk of damage through over-wetting of the tablet core. In this work the effect of droplet size on tablet film coat characteristics was investigated using X-ray microcomputed tomography (X mu CT) and confocal laser scanning microscopy (CLSM). A quality by design approach utilising design of experiments (DOE) was used to optimise the conditions necessary for production of droplets at a small (20 mu m) and large (70 mu m) droplet size. Droplet size distribution was measured using real-time laser diffraction and the volume median diameter taken as a response. DOE yielded information on the relationship three critical process parameters: pump rate, atomisation pressure and coating-polymer concentration, had upon droplet size. The model generated was robust, scoring highly for model fit (R-2 = 0.977), predictability (Q(2) = 0.837), validity and reproducibility. Modelling confirmed that all parameters had either a linear or quadratic effect on droplet size and revealed an interaction between pump rate and atomisation pressure. Fluidised bed coating of tablet cores was performed with either small or large droplets followed by CLSM and X mu CT imaging. Addition of commonly used contrast materials to the coating solution improved visualisation of the coating by X mu CT, showing the coat as a discrete section of the overall tablet. Imaging provided qualitative and quantitative evidence revealing that smaller droplets formed thinner, more uniform and less porous film coats.	[Dennison, Thomas J.; Badhan, Raj K.; Al-Khattawi, Ali; Mohammed, Afzal R.] Aston Univ, Aston Sch Pharm, Birmingham, W Midlands, England; [Smith, Julian] Viridian Pharma Ltd, Newport, Shrops, England; [Hofmann, Michael P.] Univ Birmingham, Sch Dent, Biomat Unit, Birmingham, W Midlands, England; [Bland, Charlotte E.] Aston Univ, Aston Res Ctr Hlth Ageing, Birmingham, W Midlands, England; [Al-Khattawi, Ali] De Montfort Univ, Leicester Sch Pharm, Leicester, Leics, England	Aston University; University of Birmingham; Aston University; De Montfort University	Mohammed, AR (corresponding author), Aston Univ, Aston Sch Pharm, Birmingham, W Midlands, England.	a.u.r.mohammed@aston.ac.uk	Hofmann, Michael P/B-8636-2008	Al-khattawi, Ali/0000-0002-2498-2817; Badhan, Raj/0000-0002-0904-9324; Mohammed, Afzal-Ur-Rahman/0000-0002-5212-3040	MRC CASE award [MR/J01236X/1]; Viridian Pharma Ltd.; Viridian Pharma Ltd; Medical Research Council [1264674] Funding Source: researchfish	MRC CASE award(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Viridian Pharma Ltd.; Viridian Pharma Ltd; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Financial support was provided by a joint funded MRC CASE award (Grant No. MR/J01236X/1) with Viridian Pharma Ltd. The kind use of equipment and expertise provided by Malvern Instruments and Michelle Holder of the University of Birmingham School of Dentistry is very much appreciated. Malvern Instruments had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Author Julian Smith is employed by Viridian Pharma Ltd. Viridian Pharma Ltd provided support in the form of salary for author JS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.; Financial support was provided by a joint funded MRC CASE award (Grant No. MR/J01236X/1) with Viridian Pharma Ltd. The kind use of equipment and expertise provided by Malvern Instruments and Michelle Holder of the University of Birmingham School of Dentistry is very much appreciated. Julian Smith (Viridian Pharma Ltd.) was involved in study design, decision to publish and preparation of the manuscript and this contribution is also greatly acknowledged.	Aguilar G, 2001, INT J HEAT MASS TRAN, V44, P3201, DOI 10.1016/S0017-9310(00)00363-X; Aliseda A, 2008, INT J MULTIPHAS FLOW, V34, P161, DOI 10.1016/j.ijmultiphaseflow.2007.09.003; Aulton ME, 1995, PHARM COATING TECHNO, P65; Beaulieu LY, 2002, MICROSC MICROANAL, V8, P422, DOI 10.1017/S1431927602010309; Christensen FN, 1997, DRUG DEV IND PHARM, V23, P451, DOI 10.3109/03639049709148494; Coomaraswamy KS, 2007, J ENDODONT, V33, P295, DOI 10.1016/j.joen.2006.11.018; Depypere F, 2009, EUR J PHARM BIOPHARM, V73, P179, DOI 10.1016/j.ejpb.2009.04.007; Dumouchel C, 2008, EXP FLUIDS, V45, P371, DOI 10.1007/s00348-008-0526-0; Felton LA, 2013, EXPERT OPIN DRUG DEL, V10, P421, DOI 10.1517/17425247.2013.763792; FRASER RP, 1963, CHEM ENG SCI, V18, P339, DOI 10.1016/0009-2509(63)80027-5; Funada T, 2004, INT J MULTIPHAS FLOW, V30, P1279, DOI 10.1016/j.ijmultiphaseflow.2004.07.001; Gauno MH, 2013, PHARM DEV TECHNOL, V18, P926, DOI 10.3109/10837450.2011.619542; Ginebra MP, 2002, BIOMATERIALS, V23, P1873, DOI 10.1016/S0142-9612(01)00314-3; Hede PD, 2008, CHEM ENG SCI, V63, P3821, DOI 10.1016/j.ces.2008.04.014; Hemati A, 2003, POWDER TECHNOL, V130, P18; Hildebrand T, 1997, J MICROSC-OXFORD, V185, P67, DOI 10.1046/j.1365-2818.1997.1340694.x; Jiang DJ, 2012, CHEM ENG RES DES, V90, P185, DOI 10.1016/j.cherd.2011.07.006; Kemp IC, 2013, DRY TECHNOL, V31, P930, DOI 10.1080/07373937.2012.710693; Lasheras JC, 1998, J FLUID MECH, V357, P351, DOI 10.1017/S0022112097008070; Lecomte F, 2004, PHARM RES-DORDR, V21, P882, DOI 10.1023/B:PHAM.0000026443.71935.cb; LEFEBVRE AH, 1980, PROG ENERG COMBUST, V6, P233, DOI 10.1016/0360-1285(80)90017-9; LEWIS HC, 1948, IND ENG CHEM, V40, P67, DOI 10.1021/ie50457a020; Lorck CA, 1997, EUR J PHARM BIOPHARM, V43, P149, DOI 10.1016/S0939-6411(96)00035-5; MANSOUR A, 1995, J NON-NEWTON FLUID, V58, P161, DOI 10.1016/0377-0257(95)01356-Z; MANSOUR A, 1990, PHYS FLUIDS A-FLUID, V2, P706, DOI 10.1063/1.857724; Marmottant PH, 2004, J FLUID MECH, V498, P73, DOI 10.1017/S0022112003006529; Missaghi S, 2004, AAPS PHARMSCITECH, V5, DOI 10.1208/pt050229; Ozeki Y, 2003, INT J PHARM, V259, P69, DOI 10.1016/S0378-5173(03)00208-4; Pandey P, 2014, AAPS PHARMSCITECH, V15, P296, DOI 10.1208/s12249-013-0060-0; Perfetti G, 2010, ADV POWDER TECHNOL, V21, P663, DOI 10.1016/j.apt.2010.08.002; Prpich A, 2010, COMPUT CHEM ENG, V34, P1092, DOI 10.1016/j.compchemeng.2010.03.006; Rambali B, 2001, INT J PHARMACEUT, V220, P149, DOI 10.1016/S0378-5173(01)00658-5; RANZ WE, 1952, CHEM ENG PROG, V48, P141; RIZKALLA AA, 1975, J FLUID ENG-T ASME, V97, P316, DOI 10.1115/1.3447309; Roy S., 2012, INT J PHARM BIOMEDIC, V3, P100; Ruotsalainen M, 2003, EUR J PHARM BIOPHARM, V56, P381, DOI 10.1016/S0939-6411(03)00118-8; Russe IS, 2012, MOL PHARMACEUT, V9, P3551, DOI 10.1021/mp300383y; Saleh K, 1999, ADV POWDER TECHNOL, V10, P255, DOI 10.1163/156855299X00334; Sander A, 2014, CHEM ENG TECHNOL, V37, P2073, DOI 10.1002/ceat.201400185; Schmidt D.P., 1999, SAE TECHNICAL PAPER; SCHMIDT PC, 1994, DRUG DEV IND PHARM, V20, P2899, DOI 10.3109/03639049409042687; Suyari M, 1986, DROP SIZE MEASUREMEN; Thybo P, 2008, PHARM DEV TECHNOL, V13, P93, DOI [10.1080/10837450701830957, 10.1080/10837450701830957 ]; Wang J, 2012, INT J PHARMACEUT, V427, P163, DOI 10.1016/j.ijpharm.2012.01.033	44	8	9	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2016	11	8							e0157267	10.1371/journal.pone.0157267	http://dx.doi.org/10.1371/journal.pone.0157267			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT8TP	27548263	Green Accepted, Green Published, gold			2022-12-27	WOS:000381768400002
J	Ortiz-Fernandez, L; Carmona, FD; Montes-Cano, MA; Garcia-Lozano, JR; Conde-Jaldon, M; Ortego-Centeno, N; Castillo, MJ; Espinosa, G; Grana-Gil, G; Sanchez-Burson, J; Julia, MR; Solans, R; Blanco, R; Barnosi-Marin, AC; de la Torre, RG; Fanlo, P; Rodriguez-Carballeira, M; Rodriguez-Rodriguez, L; Camps, T; Castaneda, S; Alegre-Sancho, JJ; Martin, J; Gonzalez-Escribano, MF				Ortiz-Fernandez, Lourdes; Carmona, Francisco-David; Montes-Cano, Marco-Antonio; Garcia-Lozano, Jose-Raul; Conde-Jaldon, Marta; Ortego-Centeno, Norberto; Jesus Castillo, Maria; Espinosa, Gerard; Grana-Gil, Genaro; Sanchez-Burson, Juan; Rosa Julia, Maria; Solans, Roser; Blanco, Ricardo; Barnosi-Marin, Ana-Celia; Gomez de la Torre, Ricardo; Fanlo, Patricia; Rodriguez-Carballeira, Monica; Rodriguez-Rodriguez, Luis; Camps, Teresa; Castaneda, Santos; Alegre-Sancho, Juan-Jose; Martin, Javier; Francisca Gonzalez-Escribano, Maria			Genetic Analysis with the Immunochip Platform in Behcet Disease. Identification of Residues Associated in the HLA Class I Region and New Susceptibility Loci	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; MHC CLASS-I; RHEUMATOID-ARTHRITIS; POPULATION; PEPTIDE; BINDING; RISK; IL23R-IL12RB2; IMPUTATION; SCLEROSIS	Behcet's disease (BD) is an immuno-mediated vasculitis in which knowledge of its etiology and genetic basis is limited. To improve the current knowledge, a genetic analysis performed with the Immunochip platform was carried out in a population from Spain. A discovery cohort comprising 278 BD cases and 1,517 unaffected controls were genotyped using the Immunochip platform. The validation step was performed on an independent replication cohort composed of 130 BD cases and 600 additional controls. The strongest association signals were observed in the HLA class I region, being HLA-B*51 the highest peak (overall P = 6.82E-32, OR = 3.82). A step-wise conditional logistic regression with classical alleles identified HLA-B*57 and HLA-A*03 as additional independent markers. The amino acid model that best explained the association, includes the position 97 of the HLA-B molecule and the position 66 of the HLA-A. Among the non-HLA loci, the most significant in the discovery analysis were: IL23R (rs10889664: P = 3.81E-12, OR = 2.00), the JRKL/CNTN5 region (rs2848479: P = 5.00E-08, OR = 1.68) and IL12A (rs1874886: P = 6.67E-08, OR = 1.72), which were confirmed in the validation phase (JRKL/CNTN5 rs2848479: P = 3.29E10, OR = 1.66; IL12A rs1874886: P = 1.62E-08, OR = 1.61). Our results confirm HLA-B*51 as a primary-association marker in predisposition to BD and suggest additional independent signals within the class I region, specifically in the genes HLA-A and HLA-B. Regarding the non-HLA genes, in addition to IL-23R, previously reported in our population; IL12A, described in other populations, was found to be a BD susceptibility factor also in Spaniards; finally, a new associated locus was found in the JRKL/CNTN5 region.	[Ortiz-Fernandez, Lourdes; Montes-Cano, Marco-Antonio; Garcia-Lozano, Jose-Raul; Conde-Jaldon, Marta; Francisca Gonzalez-Escribano, Maria] Hosp Univ Virgen Rocio IBiS CSIC US, Dept Immunol, Seville 41013, Spain; [Carmona, Francisco-David; Martin, Javier] PTS Granada, CSIC, Inst Parasitol & Biomed Lopez Neyra, Granada 18016, Spain; [Ortego-Centeno, Norberto] Hosp Clin San Cecilio, Dept Internal Med, Granada 18003, Spain; [Jesus Castillo, Maria] Hosp Univ Virgen Rocio, Dept Internal Med, Seville 41003, Spain; [Espinosa, Gerard] Hosp Univ Clin, Dept Autoimmune Dis, Barcelona 08036, Spain; [Grana-Gil, Genaro] Dept Rheumatol, Complejo Hosp Univ A Coruna, La Coruna 15006, Spain; [Sanchez-Burson, Juan] Hosp Univ Valme, Dept Rheumatol, Seville 41014, Spain; [Rosa Julia, Maria] Hosp Univ Son Espases, Dept Immunol, Palma de Mallorca 07120, Spain; [Solans, Roser] Univ Autonoma Barcelona, Hosp Vall Hebron, Autoimmune Syst Dis Unit, Dept Internal Med, Barcelona 08035, Spain; [Blanco, Ricardo] Hosp Univ Marques Valdecilla, Dept Rheumatol, Santander 39008, Spain; [Barnosi-Marin, Ana-Celia] Dept Internal Med, Complejo Hosp Torrecardenas, Almeria 04009, Spain; [Gomez de la Torre, Ricardo] Hosp Univ Cent Asturias, Dept Internal Med, Asturias 33011, Spain; [Fanlo, Patricia] Hosp Virgen Camino, Dept Internal Med, Pamplona 31008, Spain; [Rodriguez-Carballeira, Monica] Hosp Univ Mutua Terrassa, Dept Internal Med, Terrassa 08221, Spain; [Rodriguez-Rodriguez, Luis] Hosp Clin San Carlos, Dept Rheumatol, Madrid 28040, Spain; [Camps, Teresa] Hosp Reg Univ Malaga, Dept Internal Med, Malaga 29010, Spain; [Castaneda, Santos] IIS Princesa, Hosp Princesa, Dept Rheumatol, Madrid 28006, Spain; [Alegre-Sancho, Juan-Jose] Hosp Univ Doctor Peset, Dept Rheumatol, Valencia 46017, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Parasitologia y Biomedicina Lopez-Neyra (IPBLN); Hospital Universitario San Cecilio; Virgen del Rocio University Hospital; Complejo Hospitalario Universitario A Coruna; Universidade da Coruna; Hospital Valme; Hospital Universitari Son Espases; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Hospital Universitario Marques de Valdecilla (HUMV); Hospital Torrecardenas; Central University Hospital Asturias; Hospital Virgen del Camino; Servicio Navarro de Salud - Osasunbidea; Hospital Universitario Mutua Terrassa; Hospital Clinico San Carlos	Gonzalez-Escribano, MF (corresponding author), Hosp Univ Virgen Rocio IBiS CSIC US, Dept Immunol, Seville 41013, Spain.	mariaf.gonzalez.sspa@juntadeandalucia.es	Martin, Javier/B-8141-2008; Martín, Javier/AAV-5209-2021; Ortiz-Fernández, Lourdes/GOJ-7451-2022; Martín, María/HDL-9512-2022; Carballeir, Monica Rodriguez/AAQ-8337-2021; Carmona, F. David/F-9953-2016; Rodriguez-Rodriguez, Luis/H-5880-2013; Julia, Rosa/AAG-6185-2021; González-Escribano, María Francisca/X-5554-2019; blanco, ricardo/AAA-1248-2020; Espinosa, Gerard/J-2603-2016; Centeno, Norberto Ortego/C-4793-2019; Ortiz-Fernández, Lourdes/AAA-6647-2020; Espinosa, Gerard/AAV-2751-2020	Martin, Javier/0000-0002-2202-0622; Carballeir, Monica Rodriguez/0000-0002-8802-0238; Carmona, F. David/0000-0002-1427-7639; Rodriguez-Rodriguez, Luis/0000-0002-2869-7861; blanco, ricardo/0000-0003-2344-2285; Espinosa, Gerard/0000-0003-1336-0163; Centeno, Norberto Ortego/0000-0003-2325-0937; Ortiz-Fernández, Lourdes/0000-0002-0247-4280; Espinosa, Gerard/0000-0003-1336-0163; Grana, Jenaro/0000-0001-9041-8117; Alegre Sancho, Juan Jose/0000-0003-1641-0875	Fondo de Investigaciones Sanitarias, Instituto de Salud Carlos III (ISCIII) [13/01118]; Fondos FEDER; Plan Andaluz de Investigacion [CTS-0197]; ISCIII [FI11/00547]; RETICS Program (RIER, ISCIII) [RD12/0009/0013]	Fondo de Investigaciones Sanitarias, Instituto de Salud Carlos III (ISCIII); Fondos FEDER(European Commission); Plan Andaluz de Investigacion; ISCIII(Instituto de Salud Carlos III); RETICS Program (RIER, ISCIII)	This work was supported by Fondo de Investigaciones Sanitarias, Instituto de Salud Carlos III (ISCIII, 13/01118), Fondos FEDER and Plan Andaluz de Investigacion (CTS-0197). LOF is the recipient of a fellowship (ISCIII, FI11/00547) and FDC was funded by the RETICS Program (RIER, ISCIII, RD12/0009/0013). All these are public institutions from Spain and the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by Fondo de Investigaciones Sanitarias, Instituto de Salud Carlos III (ISCIII, 13/01118), Fondos FEDER and Plan Andaluz de Investigacion (CTS-0197). LOF is the recipient of a fellowship (ISCIII, FI11/00547) and FDC was funded by the RETICS Program (RIER, ISCIII, RD12/0009/0013).	Montes-Cano MA, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4328; Brombacher F, 2003, TRENDS IMMUNOL, V24, P207, DOI 10.1016/S1471-4906(03)00067-X; Brown WM, 2009, DIABETES OBES METAB, V11, P2, DOI 10.1111/j.1463-1326.2008.00997.x; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; Conde-Jaldon M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102100; Cortes A, 2013, NAT GENET, V45, P730, DOI 10.1038/ng.2667; Cortes A, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3204; Croxford AL, 2012, EUR J IMMUNOL, V42, P2263, DOI 10.1002/eji.201242598; Carmona FD, 2015, AM J HUM GENET, V96, P565, DOI 10.1016/j.ajhg.2015.02.009; Carmona FD, 2015, CURR OPIN RHEUMATOL, V27, P10, DOI 10.1097/BOR.0000000000000124; de Bakker PIW, 2006, NAT GENET, V38, P1166, DOI 10.1038/ng1885; de Bakker PIW, 2012, HUM MOL GENET, V21, pR29, DOI 10.1093/hmg/dds384; de Menthon M, 2009, ARTHRIT CARE RES, V61, P1287, DOI 10.1002/art.24642; Dopazo J, 2014, DRUG DISCOV TODAY, V19, P126, DOI 10.1016/j.drudis.2013.06.003; Eyre S, 2012, NAT GENET, V44, P1336, DOI 10.1038/ng.2462; Fei YP, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2695; Hou SP, 2012, ARTHRITIS RHEUM-US, V64, P4104, DOI 10.1002/art.37708; Hughes T, 2013, NAT GENET, V45, P319, DOI 10.1038/ng.2551; Jia XM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064683; Kappen JH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119085; Kirino Y, 2013, NAT GENET, V45, P202, DOI 10.1038/ng.2520; Kone-Paut I, 1999, J PEDIATR-US, V135, P89, DOI 10.1016/S0022-3476(99)70333-1; Le Clerc S, 2015, TRANSL PSYCHIAT, V5, DOI 10.1038/tp.2015.97; Lee YJ, 2013, ANN RHEUM DIS, V72, P1510, DOI 10.1136/annrheumdis-2011-200288; Lenz TL, 2015, NAT GENET, V47, P1085, DOI 10.1038/ng.3379; Li MX, 2012, HUM GENET, V131, P747, DOI 10.1007/s00439-011-1118-2; Maenaka K, 2000, J IMMUNOL, V165, P3260, DOI 10.4049/jimmunol.165.6.3260; Mayes MD, 2014, AM J HUM GENET, V94, P47, DOI 10.1016/j.ajhg.2013.12.002; McMahon RM, 2011, ACTA CRYSTALLOGR D, V67, P447, DOI 10.1107/S0907444911007888; Mendes D, 2009, J AUTOIMMUN, V32, P178, DOI 10.1016/j.jaut.2009.02.011; Mizuki N, 2010, NAT GENET, V42, P703, DOI 10.1038/ng.624; Ombrello MJ, 2014, P NATL ACAD SCI USA, V111, P8867, DOI 10.1073/pnas.1406575111; Ortiz-Fernandez L, 2014, ANN RHEUM DIS, V73, P1433, DOI 10.1136/annrheumdis-2013-205156; Parham P, 2005, NAT REV IMMUNOL, V5, P201, DOI 10.1038/nri1570; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Raychaudhuri S, 2012, NAT GENET, V44, P291, DOI 10.1038/ng.1076; Remmers EF, 2010, NAT GENET, V42, P698, DOI 10.1038/ng.625; Sakane T, 1999, NEW ENGL J MED, V341, P1284, DOI 10.1056/NEJM199910213411707; Sanjanwala B, 2008, J IMMUNOL, V181, P6293, DOI 10.4049/jimmunol.181.9.6293; Saruhan-Direskeneli G, 2013, AM J HUM GENET, V93, P298, DOI 10.1016/j.ajhg.2013.05.026; Shimoda Y, 2009, CELL ADHES MIGR, V3, P64, DOI 10.4161/cam.3.1.7764; SILMAN AJ, 1990, LANCET, V335, P1078; Takeuchi M, 2015, J AUTOIMMUN, V64, P137, DOI 10.1016/j.jaut.2015.08.013; Trynka G, 2011, NAT GENET, V43, P1193, DOI 10.1038/ng.998; Tsoi LC, 2012, NAT GENET, V44, P1341, DOI 10.1038/ng.2467	46	30	32	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2016	11	8							e0161305	10.1371/journal.pone.0161305	http://dx.doi.org/10.1371/journal.pone.0161305			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT8TP	27548383	gold, Green Published, Green Submitted			2022-12-27	WOS:000381768400040
J	Siede, J; Frohlich, A; Datsi, A; Hegazy, AN; Varga, DV; Holecska, V; Saito, H; Nakae, S; Lohning, M				Siede, Julia; Froehlich, Anja; Datsi, Angeliki; Hegazy, Ahmed N.; Varga, Domonkos V.; Holecska, Vivien; Saito, Hirohisa; Nakae, Susumu; Loehning, Max			IL-33 Receptor-Expressing Regulatory T Cells Are Highly Activated, Th2 Biased and Suppress CD4 T Cell Proliferation through IL-10 and TGF beta Release	PLOS ONE			English	Article							VISCERAL ADIPOSE-TISSUE; ACCUMULATION; INFLAMMATION; CYTOKINE; SUBSETS; CD25(+); GENE; INTERLEUKIN-10; MAINTENANCE; MECHANISMS	Immunomodulatory Foxp3(+) regulatory T cells (Tregs) form a heterogeneous population consisting of subsets with different activation states, migratory properties and suppressive functions. Recently, expression of the IL-33 receptor ST2 was shown on Tregs in inflammatory settings. Here we report that ST2 expression identifies highly activated Tregs in mice even under homeostatic conditions. ST2(+) Tregs preferentially accumulate at non-lymphoid sites, likely mediated by their high expression of several chemokine receptors facilitating tissue homing. ST2(+) Tregs exhibit a Th2-biased character, expressing GATA-3 and producing the Th2 cytokines IL-5 and IL-13 -especially in response to IL-33. Yet, IL-33 is dispensable for the generation and maintenance of these cells in vivo. Furthermore, ST2(+) Tregs are superior to ST2(-) Tregs in suppressing CD4(+) T cell proliferation in vitro independent of IL-33. This higher suppressive capacity is partially mediated by enhanced production and activation of the anti-inflammatory cytokines IL-10 and TGF beta. Thus, ST2 expression identifies a highly activated, strongly suppressive Treg subset preferentially located in non-lymphoid tissues. Here ST2(+) Tregs may be well positioned to immediately react to IL-33 alarm signals. Their specific properties may render ST2(+) Tregs useful targets for immunomodulatory therapies.	[Siede, Julia; Froehlich, Anja; Datsi, Angeliki; Varga, Domonkos V.; Holecska, Vivien; Loehning, Max] Charite Univ Med Berlin, Dept Rheumatol & Clin Immunol, Expt Immunol & Osteoarthrit Res, Berlin, Germany; [Siede, Julia; Froehlich, Anja; Datsi, Angeliki; Varga, Domonkos V.; Holecska, Vivien; Loehning, Max] German Rheumatism Res Ctr DRFZ, Leibniz Inst, Pitzer Lab Osteoarthrit Res, Berlin, Germany; [Hegazy, Ahmed N.] Univ Oxford, John Radcliffe Hosp, Div Expt Med, Translat Gastroenterol Unit,Nuffield Dept Clin Me, Oxford, England; [Hegazy, Ahmed N.] Univ Oxford, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Kennedy Inst Rheumatol, Oxford, England; [Saito, Hirohisa] Natl Res Inst Child Hlth & Dev, Dept Allergy & Immunol, Tokyo, Japan; [Nakae, Susumu] Univ Tokyo, Inst Med Sci, Ctr Expt Med & Syst Biol, Lab Syst Biol, Tokyo, Japan; [Nakae, Susumu] Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol, Saitama, Japan	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Deutsches Rheuma-Forschungszentrum (DRFZ); University of Oxford; University of Oxford; National Center for Child Health & Development - Japan; University of Tokyo; Japan Science & Technology Agency (JST)	Lohning, M (corresponding author), Charite Univ Med Berlin, Dept Rheumatol & Clin Immunol, Expt Immunol & Osteoarthrit Res, Berlin, Germany.; Lohning, M (corresponding author), German Rheumatism Res Ctr DRFZ, Leibniz Inst, Pitzer Lab Osteoarthrit Res, Berlin, Germany.	loehning@drfz.de	Datsi, Angeliki/N-1778-2016; Löhning, Max/AAL-2967-2021	Datsi, Angeliki/0000-0001-5022-8087; Löhning, Max/0000-0001-6382-7281; Hegazy, Ahmed N./0000-0002-2946-8251; Saito, Hirohisa/0000-0002-6630-8337	German Research Foundation [SFB650, TP28, GRK1121, TPB1, LO1542/3-1]; German Federal Ministry of Education and Research (e:Bio/T-Sys) [0316164G]; Swiss National Science Foundation (Sinergia) [CRSII3 160772/1]; Volkswagen Foundation (Lichtenberg Program); Willy Robert Pitzer Foundation (Osteoarthritis Research Program); International Max Planck Research School for Infectious Diseases and Immunology; European Molecular Biology Organization (EMBO) long-term fellowship [ALTF 116-2012, ALTF 314-2012];  [330621]	German Research Foundation(German Research Foundation (DFG)); German Federal Ministry of Education and Research (e:Bio/T-Sys); Swiss National Science Foundation (Sinergia)(Swiss National Science Foundation (SNSF)); Volkswagen Foundation (Lichtenberg Program); Willy Robert Pitzer Foundation (Osteoarthritis Research Program); International Max Planck Research School for Infectious Diseases and Immunology; European Molecular Biology Organization (EMBO) long-term fellowship(European Molecular Biology Organization (EMBO)); 	This work was supported by the German Research Foundation (www.dfg.de) (SFB650, grant TP28; GRK1121, grant TPB1; and grant LO1542/3-1), the German Federal Ministry of Education and Research (www.bmbf.de) (e:Bio/T-Sys, grant 0316164G), the Swiss National Science Foundation (http://www.snf.ch) (Sinergia, grant CRSII3 160772/1), Volkswagen Foundation (www.volkswagenstiftung.de) (Lichtenberg Program) (to M.L.) and Willy Robert Pitzer Foundation (www.wrp-stiftung.de) (Osteoarthritis Research Program) (to M.L.), in part by the International Max Planck Research School for Infectious Diseases and Immunology (https://www.zibi-graduateschool-berlin.de) (to J.S., A.D. and D.V.V.), a European Molecular Biology Organization (EMBO) (http://www.embo.org) long-term fellowship (ALTF 116-2012 and ALTF 314-2012) (to A.N.H.) and a Marie Sklodowska-Curie Research Fellow (http://ec.europa.eu/research/mariecurieactions) (proposal 330621) (to A.N.H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arpaia N, 2015, CELL, V162, P1078, DOI 10.1016/j.cell.2015.08.021; Beyersdorf N, 2007, EUR J IMMUNOL, V37, P3445, DOI 10.1002/eji.200737126; Burzyn D, 2013, CELL, V155, P1282, DOI 10.1016/j.cell.2013.10.054; Burzyn D, 2013, NAT IMMUNOL, V14, P1007, DOI 10.1038/ni.2683; Campbell DJ, 2011, NAT REV IMMUNOL, V11, P119, DOI 10.1038/nri2916; Chaudhry A, 2009, SCIENCE, V326, P986, DOI 10.1126/science.1172702; Chen Y, 2012, J IMMUNOL, V188, P1698, DOI 10.4049/jimmunol.1102448; Cheng GY, 2012, J IMMUNOL, V189, P1780, DOI 10.4049/jimmunol.1103768; Chung Y, 2011, NAT MED, V17, P983, DOI 10.1038/nm.2426; Cipolletta D, 2012, NATURE, V486, P549, DOI 10.1038/nature11132; Collison LW, 2009, J IMMUNOL, V182, P6121, DOI 10.4049/jimmunol.0803646; Cretney E, 2011, NAT IMMUNOL, V12, P304, DOI 10.1038/ni.2006; Duan LH, 2012, MOL MED, V18, P753, DOI 10.2119/molmed.2011.00428; Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8; Fu S, 2004, AM J TRANSPLANT, V4, P65, DOI 10.1046/j.1600-6143.2003.00293.x; Guo LY, 2009, P NATL ACAD SCI USA, V106, P13463, DOI 10.1073/pnas.0906988106; Han JM, 2015, J IMMUNOL, V194, P4777, DOI 10.4049/jimmunol.1500020; Hasegawa H, 2008, GENE THER, V15, P171, DOI 10.1038/sj.gt.3303051; Huehn J, 2004, J EXP MED, V199, P303, DOI 10.1084/jem.20031562; Huehn J, 2005, CURR TOP MICROBIOL, V293, P89, DOI 10.1007/3-540-27702-1_5; Kamanaka M, 2006, IMMUNITY, V25, P941, DOI 10.1016/j.immuni.2006.09.013; Kendal AR, 2011, J EXP MED, V208, P2043, DOI 10.1084/jem.20110767; Koch MA, 2009, NAT IMMUNOL, V10, P595, DOI 10.1038/ni.1731; Kolodin D, 2015, CELL METAB, V21, P543, DOI 10.1016/j.cmet.2015.03.005; Kuniyasu Y, 2000, INT IMMUNOL, V12, P1145, DOI 10.1093/intimm/12.8.1145; Kuswanto W, 2016, IMMUNITY, V44, P355, DOI 10.1016/j.immuni.2016.01.009; Lavenu-Bombled C, 2002, J BIOL CHEM, V277, P18313, DOI 10.1074/jbc.M110013200; Lehmann J, 2002, P NATL ACAD SCI USA, V99, P13031, DOI 10.1073/pnas.192162899; Linterman MA, 2011, NAT MED, V17, P975, DOI 10.1038/nm.2425; Liston A, 2014, NAT REV IMMUNOL, V14, P154, DOI 10.1038/nri3605; Liu T, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-40; Matta BM, 2014, J IMMUNOL, V193, P4010, DOI 10.4049/jimmunol.1400481; Moussion C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003331; Nakamura K, 2001, J EXP MED, V194, P629, DOI 10.1084/jem.194.5.629; Oboki K, 2010, P NATL ACAD SCI USA, V107, P18581, DOI 10.1073/pnas.1003059107; Ohkura N, 2013, IMMUNITY, V38, P414, DOI 10.1016/j.immuni.2013.03.002; Oida T, 2006, J IMMUNOL, V177, P2331, DOI 10.4049/jimmunol.177.4.2331; Pabst O, 2013, INT IMMUNOL, V25, P139, DOI 10.1093/intimm/dxs113; Piccirillo CA, 2002, J EXP MED, V196, P237, DOI 10.1084/jem.20020590; Pichery M, 2012, J IMMUNOL, V188, P3488, DOI 10.4049/jimmunol.1101977; Rubtsov YP, 2008, IMMUNITY, V28, P546, DOI 10.1016/j.immuni.2008.02.017; Sakaguchi S, 2009, INT IMMUNOL, V21, P1105, DOI 10.1093/intimm/dxp095; Sather BD, 2007, J EXP MED, V204, P1335, DOI 10.1084/jem.20070081; Schiering C, 2014, NATURE, V513, P564, DOI 10.1038/nature13577; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Schneider MA, 2007, J EXP MED, V204, P735, DOI 10.1084/jem.20061405; Shevach EM, 2009, IMMUNITY, V30, P636, DOI 10.1016/j.immuni.2009.04.010; Takahashi T, 1998, INT IMMUNOL, V10, P1969, DOI 10.1093/intimm/10.12.1969; Thornton AM, 1998, J EXP MED, V188, P287, DOI 10.1084/jem.188.2.287; Thornton AM, 2000, J IMMUNOL, V164, P183, DOI 10.4049/jimmunol.164.1.183; Tiemessen MM, 2007, P NATL ACAD SCI USA, V104, P19446, DOI 10.1073/pnas.0706832104; Townsend MJ, 2000, J EXP MED, V191, P1069, DOI 10.1084/jem.191.6.1069; Turnquist HR, 2011, J IMMUNOL, V187, P4598, DOI 10.4049/jimmunol.1100519; Vasanthakumar A, 2015, NAT IMMUNOL, V16, P276, DOI 10.1038/ni.3085; Vignali DAAA, 2008, EUR J IMMUNOL, V38, P908, DOI 10.1002/eji.200738114; Wang YQ, 2011, IMMUNITY, V35, P337, DOI 10.1016/j.immuni.2011.08.012; Wing K, 2008, SCIENCE, V322, P271, DOI 10.1126/science.1160062; Wohlfert EA, 2011, J CLIN INVEST, V121, P4503, DOI 10.1172/JCI57456; Worthington JJ, 2015, IMMUNITY, V42, P903, DOI 10.1016/j.immuni.2015.04.012; Zhang DH, 1998, J IMMUNOL, V161, P3817; Zhang J, 1997, J IMMUNOL, V159, P5412	61	74	76	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2016	11	8							e0161507	10.1371/journal.pone.0161507	http://dx.doi.org/10.1371/journal.pone.0161507			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT8TP	27548066	Green Published, Green Submitted, gold			2022-12-27	WOS:000381768400064
J	Callesen, MM; Berthelsen, MF; Lund, S; Fuchtbauer, AC; Fuchtbauer, EM; Jakobsen, JE				Callesen, Morten M.; Berthelsen, Martin F.; Lund, Sira; Fuchtbauer, Annette C.; Fuchtbauer, Ernst-Martin; Jakobsen, Jannik E.			Recombinase-Mediated Cassette Exchange (RMCE)-in Reporter Cell Lines as an Alternative to the Flp-in System	PLOS ONE			English	Article							TRANSGENE EXPRESSION; SLEEPING-BEAUTY; FLUORESCENT PROTEIN; ES CELLS; RMCE; TRANSPOSON; VIVO	Recombinase mediated cassette exchange (RMCE) is a powerful tool for targeted insertion of transgenes. Here we describe non-proprietary 'RMCE-in' cell lines as an alternative to the 'Flp-in' system and cell lines. RMCE-in cell lines offer a number of advantages including increased efficiency of integration of the genetic element of interest (GEI) at a single docking site, lack of bacterial backbone at the docking site both before and after GEI integration, removal of selection and visual markers initially present at the docking site upon GEI integration and the possibility to validate GEI integration by loss of a red fluorescence reporter. Moreover, the RMCE-in cell lines are compatible with GEI donors used for the Flp-in system. We demonstrate a three-step procedure for generating RMCE-in cell lines, (I) RMCE-in transposon and SB10 transposase transfection, (II) clone isolation, and (III) selecting single integrated clones with highest RFP level, which could in principle be used to turn any cell line into an RMCE-in cell line. The RMCE-in system was used as a proof of concept to produce three new RMCE-in cell lines using HEK293, HeLa, and murine embryonic stem (mES) cells. The established RMCE-in cell lines and vector are freely available from the ATCC cell bank and Addgene respectively.	[Callesen, Morten M.; Berthelsen, Martin F.; Lund, Sira; Jakobsen, Jannik E.] Aarhus Univ, Fac Hlth, Dept Biomed, Aarhus C, Denmark; [Callesen, Morten M.; Berthelsen, Martin F.; Jakobsen, Jannik E.] Aarhus Univ, Fac Hlth, Dept Clin Med, Aarhus N, Denmark; [Fuchtbauer, Annette C.; Fuchtbauer, Ernst-Martin] Aarhus Univ, Dept Mol Biol & Genet, Aarhus C, Denmark	Aarhus University; Aarhus University; Aarhus University	Fuchtbauer, EM (corresponding author), Aarhus Univ, Dept Mol Biol & Genet, Aarhus C, Denmark.	emf@mbg.au.dk		Callesen, Morten/0000-0001-6258-2171	Danish Agency for Science, Technology and Innovation [11-105224]	Danish Agency for Science, Technology and Innovation	JEJ was supported by the Danish Agency for Science, Technology and Innovation, no. 11-105224.	Ai HW, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-13; Anastassiadis K, 2013, METHOD ENZYMOL, V533, P133, DOI 10.1016/B978-0-12-420067-8.00009-X; Chen ZY, 2004, GENE THER, V11, P856, DOI 10.1038/sj.gt.3302231; Chen ZY, 2003, MOL THER, V8, P495, DOI 10.1016/S1525-0016(03)00168-0; Dalle B, 2005, MOL THER, V11, P591, DOI 10.1016/j.ymthe.2004.11.012; Geurts AM, 2003, MOL THER, V8, P108, DOI 10.1016/S1525-0016(03)00099-6; Ivics Z, 1997, CELL, V91, P501, DOI 10.1016/S0092-8674(00)80436-5; Jakobsen JE, 2011, TRANSGENIC RES, V20, P533, DOI 10.1007/s11248-010-9438-x; Jakobsen JE, 2010, BIOTECHNIQUES, V48, P313, DOI 10.2144/000113386; Jakobsen JE, 2013, TRANSGENIC RES, V22, P709, DOI 10.1007/s11248-012-9671-6; Liu GY, 2005, J MOL BIOL, V346, P161, DOI 10.1016/j.jmb.2004.09.086; Louwerse JD, 2007, PLANT PHYSIOL, V145, P1282, DOI 10.1104/pp.107.108092; Meaux S, 2006, RNA, V12, P1323, DOI 10.1261/rna.46306; Mulholland CB, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv550; OGORMAN S, 1991, SCIENCE, V251, P1351, DOI 10.1126/science.1900642; Proudfoot NJ, 2011, GENE DEV, V25, P1770, DOI 10.1101/gad.17268411; Sandhu U, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq868; SCHLAKE T, 1994, BIOCHEMISTRY-US, V33, P12746, DOI 10.1021/bi00209a003; Schnutgen F, 2011, METHODS, V53, P347, DOI 10.1016/j.ymeth.2010.12.037; Shcherbo D, 2007, NAT METHODS, V4, P741, DOI 10.1038/NMETH1083; SWIATEK PJ, 1993, GENE DEV, V7, P2071, DOI 10.1101/gad.7.11.2071; Turan S, 2013, GENE, V515, P1, DOI 10.1016/j.gene.2012.11.016; Turan S, 2010, J MOL BIOL, V402, P52, DOI 10.1016/j.jmb.2010.07.015	23	2	2	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2016	11	8							e0161471	10.1371/journal.pone.0161471	http://dx.doi.org/10.1371/journal.pone.0161471			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6UQ	27541869	Green Published, Green Submitted, gold			2022-12-27	WOS:000381620200006
J	Casas, E; Cai, G; Kuehn, LA; Register, KB; McDaneld, TG; Neill, JD				Casas, Eduardo; Cai, Guohong; Kuehn, Larry A.; Register, Karen B.; McDaneld, Tara G.; Neill, John D.			Association of MicroRNAs with Antibody Response to Mycoplasma bovis in Beef Cattle	PLOS ONE			English	Article							RESPIRATORY-DISEASE; HEME OXYGENASE-1; EXPRESSION; TRANSCRIPTOME; BIOMARKERS; INFECTION; MUSCLE; VIRUS; CELLS	The objective of this study was to identify microRNAs associated with a serum antibody response to Mycoplasma bovis in beef cattle. Serum from sixteen beef calves was collected at three points: in summer after calves were born, in fall at weaning, and in the following spring. All sera collected in the summer were ELISA-negative for anti-M. bovis. By the fall, eight animals were seropositive for IgG (positive group), while eight remained negative (negative group). By spring, all animals in both groups were seropositive. MicroRNAs were extracted from sera and sequenced on the Illumina HiSeq next-generation sequencer. A total of 1,374,697 sequences mapped to microRNAs in the bovine genome. Of these, 82% of the sequences corresponded to 27 microRNAs, each represented by a minimum of 10,000 sequences. There was a statistically significant interaction between ELISA response and season for bta-miR-24-3p (P = 0.0268). All sera collected at the initial summer had a similar number of copies of this microRNA (P = 0.773). In the fall, the positive group had an increased number of copies when compared to the negative group (P = 0.021), and this grew more significant by the following spring (P = 0.0001). There were 21 microRNAs associated (P< 0.05) with season. These microRNAs could be evaluated further as candidates to potentially improve productivity in cattle. The microRNAs bta-let-7b, bta-miR- 24-3p, bta-miR- 92a, and bta-miR-423-5p, were significatly associated with ELISA status (P< 0.05). These microRNAs have been recognized as playing a role in the host defense against bacteria in humans, mice, and dairy cattle. Further studies are needed to establish if these microRNAs could be used as diagnostic marker or indicator of exposure, or whether intervention strategies could be developed as an alternative to antibiotics for controlling disease due to M. bovis.	[Casas, Eduardo; Cai, Guohong; Register, Karen B.; Neill, John D.] ARS, USDA, Natl Anim Dis Ctr, Ames, IA 50010 USA; [Kuehn, Larry A.; McDaneld, Tara G.] ARS, USDA, US Meat Anim Res Ctr, Clay Ctr, NE 68933 USA	United States Department of Agriculture (USDA); United States Department of Agriculture (USDA)	Casas, E (corresponding author), ARS, USDA, Natl Anim Dis Ctr, Ames, IA 50010 USA.	eduardo.casas@ars.usda.gov	Cai, Guohong/N-1274-2013	Cai, Guohong/0000-0002-7700-6019; Casas, Eduardo/0000-0003-3773-4035; Kuehn, Larry/0000-0002-7573-5365	USDA	USDA(United States Department of Agriculture (USDA))	This research was conducted at a USDA research facility and all funding was provided through internal USDA research dollars. This project is an intramural project of the USDA/ARS National Animal Disease Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Angelini TG, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00240; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Berschneider B, 2014, INT J BIOCHEM CELL B, V53, P432, DOI 10.1016/j.biocel.2014.06.011; Boese AS, 2016, MOL CELL NEUROSCI, V71, P13, DOI 10.1016/j.mcn.2015.12.001; Britton LE, 2016, VET J, V209, P32, DOI 10.1016/j.tvjl.2015.10.033; Bush TJV, 2003, VET IMMUNOL IMMUNOP, V94, P23, DOI 10.1016/S0165-2427(03)00056-4; Caswell JL, 2010, VET CLIN N AM-FOOD A, V26, P365, DOI 10.1016/j.cvfa.2010.03.003; Chen X, 2012, TRENDS CELL BIOL, V22, P125, DOI 10.1016/j.tcb.2011.12.001; Chung SW, 2008, J CLIN INVEST, V118, P239, DOI 10.1172/JCI32730; Chung SW, 2009, CELL MICROBIOL, V11, P199, DOI 10.1111/j.1462-5822.2008.01261.x; Cortez MA, 2011, NAT REV CLIN ONCOL, V8, P467, DOI 10.1038/nrclinonc.2011.76; Edmonds MD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101802; Friedlander MR, 2012, NUCLEIC ACIDS RES, V40, P37, DOI 10.1093/nar/gkr688; Griffin D, 1997, VET CLIN N AM-FOOD A, V13, P367, DOI 10.1016/S0749-0720(15)30302-9; Huang YZ, 2014, SCI REP-UK, V4, P1, DOI 10.1038/srep06546; Iliopoulos D, 2009, CELL, V139, P693, DOI 10.1016/j.cell.2009.10.014; Jin WW, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-181; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Kozakowska M, 2014, ANTIOXID REDOX SIGN, V20, P1827, DOI 10.1089/ars.2013.5341; Lai LH, 2013, J BIOL CHEM, V288, P7956, DOI 10.1074/jbc.M112.445429; Lawless N, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00611; Lawless N, 2014, G3-GENES GENOM GENET, V4, P957, DOI 10.1534/g3.113.009936; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; MARTIN SW, 1990, CAN J VET RES, V54, P337; Maunsell FP, 2011, J VET INTERN MED, V25, P772, DOI 10.1111/j.1939-1676.2011.0750.x; McDaneld TG, 2009, J ANIM SCI, V87, pE21, DOI 10.2527/jas.2008-1303; Miles Delbert G., 2009, Animal Health Research Reviews, V10, P101, DOI 10.1017/S1466252309990090; Oksuz Z, 2015, MOL BIOL REP, V42, P713, DOI 10.1007/s11033-014-3819-9; Punga T, 2016, J NEUROIMMUNOL, V292, P21, DOI 10.1016/j.jneuroim.2016.01.003; Register KB, 2013, CLIN VACCINE IMMUNOL, V20, P1405, DOI 10.1128/CVI.00409-13; Shahriar FM, 2002, CAN VET J, V43, P863; Sun J, 2015, ANIM GENET, V46, P227, DOI 10.1111/age.12272; Thornburg NJ, 2012, MBIO, V3, DOI 10.1128/mBio.00220-12; Wang J, 2016, J CELL PHYSIOL, V231, P25, DOI 10.1002/jcp.25056; Wang X, 2013, ANIMAL, V7, P1567, DOI 10.1017/S1751731113001183; Xiao SQ, 2015, J VIROL, V89, P4494, DOI 10.1128/JVI.02810-14	37	14	14	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0161651	10.1371/journal.pone.0161651	http://dx.doi.org/10.1371/journal.pone.0161651			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27537842	gold, Green Published, Green Submitted			2022-12-27	WOS:000381577000129
J	Gazmuri, RJ; Kaufman, CL; Baetiong, A; Radhakrishnan, J				Gazmuri, Raul J.; Kaufman, Christopher L.; Baetiong, Alvin; Radhakrishnan, Jeejabai			Ventricular Fibrillation Waveform Changes during Controlled Coronary Perfusion Using Extracorporeal Circulation in a Swine Model	PLOS ONE			English	Article							CARDIAC-ARREST; RESUSCITATION; DEFIBRILLATION; ELECTROCARDIOGRAM	Background Several characteristics of the ventricular fibrillation (VF) waveform have been found predictive of successful defibrillation and hypothesized to reflect the myocardial energy state. In an open-chest swine model of VF, we modeled "average CPR" using extracorporeal circulation (ECC) and assessed the time course of coronary blood flow, myocardial metabolism, and myocardial structure in relation to the amplitude spectral area (AMSA) of the VF waveform without artifacts related to chest compression. Methods VF was induced and left untreated for 8 minutes in 16 swine. ECC was then started adjusting its flow to maintain a coronary perfusion pressure of 10 mmHg for 10 minutes. AMSA was calculated in the frequency domain and analyzed continuously with a 2.1 s timeframe and a Tukey window that moved ahead every 0.5 s. Results AMSA progressively declined during untreated VF. With ECC, AMSA increased from 7.0 +/- 1.9 mV.Hz (at minute 8) to 12.8 +/- 3.3 mV.Hz (at minute 14) (p < 0.05) without subsequent increase and showing a modest correlation with coronary blood flow of borderline statistical significance (r = 0.489, p = 0.0547). Myocardial energy measurements showed marked reduction in phosphocreatine and moderate reduction in ATP with increases in ADP, AMP, and adenosine along with myocardial lactate, all indicative of ischemia. Yet, ischemia did not resolve during ECC despite a coronary blood flow of similar to 30% of baseline. Conclusion AMSA increased upon return of coronary blood flow during ECC. However, the maximal level was reached after similar to 6 minutes without further change. The significance of the findings for determining the optimal timing for delivering an electrical shock during resuscitation from VF remains to be further explored.	[Gazmuri, Raul J.; Baetiong, Alvin; Radhakrishnan, Jeejabai] Rosalind Franklin Univ Med & Sci, Resuscitat Inst, N Chicago, IL 60088 USA; [Gazmuri, Raul J.] CAPT James A Lovell Fed Hlth Care Ctr, Sect Crit Care Med, N Chicago, IL 60064 USA; [Kaufman, Christopher L.] ZOLL Med Corp, Chelmsford, MA USA	Rosalind Franklin University Medical & Science	Gazmuri, RJ (corresponding author), Rosalind Franklin Univ Med & Sci, Resuscitat Inst, N Chicago, IL 60088 USA.; Gazmuri, RJ (corresponding author), CAPT James A Lovell Fed Hlth Care Ctr, Sect Crit Care Med, N Chicago, IL 60064 USA.	raul.gazmuri@rosalindfranklin.edu		Gazmuri, Raul J./0000-0002-3848-7227	VA Merit Review Grant entitled Myocardial Effects of Erythropoietin during Resuscitation from Cardiac Arrest [5I01BX000233]; ZOLL Medical Corporation	VA Merit Review Grant entitled Myocardial Effects of Erythropoietin during Resuscitation from Cardiac Arrest(US Department of Veterans Affairs); ZOLL Medical Corporation	This work was funded by a VA Merit Review Grant entitled Myocardial Effects of Erythropoietin during Resuscitation from Cardiac Arrest (#5I01BX000233) for which RJG served as Principal Investigator. The funder provided support in the form of salaries for authors AB, JR, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. It was also supported by unrestricted Funds to Support Educational and Research Activities from ZOLL Medical Corporation, for which RJG served as Principal Investigator. The funder provided partial support in the form of salaries for author AB and research materials but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. CLK is employed by ZOLL Medical Corporation and contributed to portions of the data analysis and the Methods section of the manuscript.	ANGELOS MG, 1994, RESUSCITATION, V27, P245, DOI 10.1016/0300-9572(94)90038-8; Ayoub IM, 2003, CIRCULATION, V107, P1804, DOI 10.1161/01.CIR.0000058704.45646.0D; Ayoub IM, 2007, CRIT CARE MED, V35, P2329, DOI 10.1097/01.CCM.0000280569.87413.74; Borovnik-Lesjak V, 2013, TRANSL RES, V162, P110, DOI 10.1016/j.trsl.2013.06.002; Cobb LA, 1999, JAMA-J AM MED ASSOC, V281, P1182, DOI 10.1001/jama.281.13.1182; Gazmuri RJ, 2000, CRIT CARE MED, V28, P2690, DOI 10.1097/00003246-200008000-00002; Indik JH, 2009, CIRC-ARRHYTHMIA ELEC, V2, P179, DOI 10.1161/CIRCEP.108.824862; Kolarova J, 2003, CRIT CARE MED, V31, P2022, DOI 10.1097/01.CCM.0000070446.84095.F4; Marn-Pernat A, 2001, CRIT CARE MED, V29, P2360, DOI 10.1097/00003246-200112000-00019; NIEMANN JT, 1992, CIRCULATION, V85, P281, DOI 10.1161/01.CIR.85.1.281; NOC M, 1994, J LAB CLIN MED, V124, P421; Olivecrona Goran K, 2004, Purinergic Signal, V1, P59, DOI 10.1007/s11302-004-4742-7; Reynolds JC, 2012, RESUSCITATION, V83, P1497, DOI 10.1016/j.resuscitation.2012.04.013; Ristagno G, 2008, CRIT CARE MED, V36, pS422, DOI 10.1097/CCM.0b013e31818a84c5; Salcido DD, 2012, RESUSCITATION, V83, P505, DOI 10.1016/j.resuscitation.2011.09.018; Salcido DD, 2009, RESUSCITATION, V80, P946, DOI 10.1016/j.resuscitation.2009.05.002; Sun Shijie, 2011, Resuscitation, V82 Suppl 2, pS3, DOI 10.1016/S0300-9572(11)70144-7; Tsai MS, 2009, CRIT CARE MED, V37, P2394, DOI 10.1097/CCM.0b013e3181a02ea1; Wang SF, 2007, J APPL PHYSIOL, V103, P55, DOI 10.1152/japplphysiol.01167.2006; Weisfeldt ML, 2002, JAMA-J AM MED ASSOC, V288, P3035, DOI 10.1001/jama.288.23.3035; Xie JL, 1997, CIRCULATION, V96, P683	21	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0161166	10.1371/journal.pone.0161166	http://dx.doi.org/10.1371/journal.pone.0161166			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27536996	Green Published, Green Submitted, gold			2022-12-27	WOS:000381577000063
J	Chaabane, A; Neifar, L; Gey, D; Justine, JL				Chaabane, Amira; Neifar, Lassad; Gey, Delphine; Justine, Jean-Lou			Species of Pseudorhabdosynochus (Monogenea, Diplectanidae) from Groupers (Mycteroperca spp., Epinephelidae) in the Mediterranean and Eastern Atlantic Ocean, with Special Reference to the 'Beverleyburtonae Group' and Description of Two New Species	PLOS ONE			English	Article							E-MERRA PERCIFORMES; CORAL-REEF FISH; NEW-CALEDONIA; NEMATODA PHILOMETRIDAE; PARASITE BIODIVERSITY; CYCLOPLECTANUM OLIVER; N. SP; SERRANIDAE; GILLS; PLATYHELMINTHES	Pseudorhabdosynochus Yamaguti, 1958 is a species-rich diplectanid genus, mainly restricted to the gills of groupers (Epinephelidae) and especially abundant in warm seas. Species from the Mediterranean are not fully documented. Two new and two previously known species from the gills of Mycteroperca spp. (M. costae, M. rubra, and M. marginata) in the Mediterranean and Eastern Atlantic Ocean are described here from new material and slides kept in collections. Identifications of newly collected fish were ascertained by barcoding of cytochrome c oxidase subunit I (COI) sequences. Pseudorhabdosynochus beverley-burtonae (Oliver, 1984) Kritsky & Beverley-Burton, 1986 and P. sosia Neifar & Euzet 2007 are redescribed from type-specimens and new specimens collected off Tunisia and Libya from M. marginata and M. costae, respectively. Pseudorhabdosynochus oliveri n. sp., from M. marginata (type-host) off the Mediterranean coast of France (type-locality), is described from specimens found among voucher specimens of P. beverleyburtonae deposited by Guy Oliver in the collection of the Museum National d'Histoire Naturelle, Paris. Pseudorhabdosynochus oliveri is distinguished by the shape of its sclerotised vagina; it was not found in the other localities investigated. Pseudorhabdosynochus hayet n. sp. is described from M. rubra (type host) off Senegal (type-locality) and Tunisia. Pseudorhabdosynochus hayet is morphologically similar to P. sosia (type-host: M. costae) but was distinguished by differences in measurements of the vagina and male copulatory organ, different host, and divergent COI sequences. The four species (P. beverleyburtonae, P. sosia, P. oliveri, and P. hayet) share common characteristics such as squamodiscs with 2 innermost circular rows of rodlets and a similar general structure of the sclerotised vagina; we propose to group them into a 'beverleyburtonae group' within Pseudorhabdosynochus.	[Chaabane, Amira; Neifar, Lassad] Univ Sfax, Fac Sci Sfax, Lab Biodiversite & Ecosyst Aquat, Sfax, Tunisia; [Gey, Delphine] Univ Paris 04, Museum Natl Hist Nat, UMS Serv Systemat Mol 2700, Paris, France; [Justine, Jean-Lou] Univ Paris 04, Museum Natl Hist Nat, ISYEB,CNRS,EPHE,MNHN,UPMC, Inst Systemat Evolut Biodiversite,UMR7205, Paris, France	Universite de Sfax; Faculty of Sciences Sfax; Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Sorbonne Universite	Chaabane, A (corresponding author), Univ Sfax, Fac Sci Sfax, Lab Biodiversite & Ecosyst Aquat, Sfax, Tunisia.	amirachaabene@hotmail.fr	Chaabane, Amira/AAQ-3021-2021; Justine, Jean-Lou/B-1298-2010	Chaabane, Amira/0000-0002-2931-4113; Justine, Jean-Lou/0000-0002-7155-4540; Gey, Delphine/0000-0002-5656-1793	Ministere des Affaires Etrangeres, France; Museum National d'Histoire Naturelle, France	Ministere des Affaires Etrangeres, France; Museum National d'Histoire Naturelle, France	This work was supported by Ministere des Affaires Etrangeres, France: grant BIOPARMED-ENVIMED, http://www.mistrals-home.org/spip.php?rubrique82; and Museum National d'Histoire Naturelle, France: Grant ATM Barcode, Grant PARSUDMED, https://www.mnhn.fr/fr. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Presas M, 2012, MOL PHYLOGENET EVOL, V64, P491, DOI 10.1016/j.ympev.2012.05.001; Chaabane A, 2016, PEERJ, V4, DOI 10.7717/peerj.2233; Chaabane A, 2015, PARASITE, V22, DOI 10.1051/parasite/2015005; Craig M. T., 2012, GROUPERS WORLD FIELD; Craig MT, 2007, ICHTHYOL RES, V54, P1, DOI 10.1007/s10228-006-0367-x; Dayrat B, 2005, BIOL J LINN SOC, V85, P407, DOI 10.1111/j.1095-8312.2005.00503.x; EUZET LOUIS, 1965, ANN PARASITOL HUM COMP, V40, P517; Gibson DI, 2016, MONOGENEA; Heemstra P.C., 1993, FAO SPECIES CATALOGU, V125; Hinsinger DD, 2006, SYST PARASITOL, V64, P69, DOI 10.1007/s11230-005-9018-2; Justine JL, 2007, SYST PARASITOL, V68, P195, DOI 10.1007/s11230-007-9096-4; Justine JL, 2007, SYST PARASITOL, V66, P81, DOI 10.1007/s11230-006-9057-3; Justine JL, 2015, PEERJ, V3, DOI 10.7717/peerj.1037; Justine JL, 2010, FOLIA PARASIT, V57, P237, DOI 10.14411/fp.2010.032; Justine JL, 2010, BELG J ZOOL, V140, P155; Justine JL, 2010, SYST PARASITOL, V77, P81, DOI 10.1007/s11230-010-9263-x; Justine Jean-Lou, 2007, Zootaxa, V1543, P1; Justine JL, 2009, SYST PARASITOL, V72, P113, DOI 10.1007/s11230-008-9159-1; Justine JL, 2009, SYST PARASITOL, V72, P27, DOI 10.1007/s11230-008-9171-5; Justine JL, 2006, SYST PARASITOL, V64, P147, DOI 10.1007/s11230-006-9028-8; Justine JL, 2005, SYST PARASITOL, V62, P1, DOI 10.1007/s11230-005-5480-0; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Knoff M, 2015, PARASITE, V22, DOI 10.1051/parasite/2015011; KRITSKY DC, 1986, P BIOL SOC WASH, V99, P17; Kritsky DC, 2015, PARASITE, V22, DOI 10.1051/parasite/2015024; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Littlewood DTJ, 1997, INT J PARASITOL, V27, P1289, DOI 10.1016/S0020-7519(97)00086-6; MALMBERG G., 1957, Skrifter utgivna av Sodra Sveriges Fiskeriforening, P19; Mendoza-Franco EF, 2011, J PARASITOL, V97, P20, DOI 10.1645/GE-2716.1; Moravec F, 2016, PARASITE, V23, DOI 10.1051/parasite/2016008; Moravec F, 2016, SYST PARASITOL, V93, P115, DOI 10.1007/s11230-015-9610-z; Neifar L, 2007, FOLIA PARASIT, V54, P117, DOI 10.14411/fp.2007.017; OLIVER G, 1984, ANN PARASIT HUM COMP, V59, P31, DOI 10.1051/parasite/1984591031; OLIVER G, 1968, Vie et Milieu, V19, P95; Oliver G, 1987, THESIS; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Roumbedakis K, 2013, Braz J Biol, V73, P871, DOI 10.1590/S1519-69842013000400025; Santos CP, 2000, SYST PARASITOL, V45, P145, DOI 10.1023/A:1006232029426; Schoelinck C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098198; Schoelinck C, 2012, PARASITOL INT, V61, P356, DOI 10.1016/j.parint.2012.01.009; Schoelinck C, 2011, SYST PARASITOL, V79, P41, DOI 10.1007/s11230-010-9289-0; Sigura A, 2008, ZOOTAXA, P1; Sluys R, 2013, BIODIVERS CONSERV, V22, P1095, DOI 10.1007/s10531-013-0472-x; ULMER MJ, 1981, T AM MICROSC SOC, V100, P392, DOI 10.2307/3226153; Vanhove MPM, 2013, ZOOKEYS, P355, DOI 10.3897/zookeys.365.5776; VidalMartinez VM, 1997, FOLIA PARASIT, V44, P274; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716	47	19	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2016	11	8							e0159886	10.1371/journal.pone.0159886	http://dx.doi.org/10.1371/journal.pone.0159886			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4YN	27532108	Green Published, Green Submitted, gold			2022-12-27	WOS:000381487600014
J	Khatat, SE; Sahibi, H; Hing, M; Moustain, IA; El Amri, H; Benajiba, M; Kachani, M; Duchateau, L; Daminet, S				Khatat, Sarah Elhamiani; Sahibi, Hamid; Hing, Mony; Moustain, Ismail Alaoui; El Amri, Hamid; Benajiba, Mohammed; Kachani, Malika; Duchateau, Luc; Daminet, Sylvie			Human Exposure to Anaplasma phagocytophilum in Two Cities of Northwestern Morocco	PLOS ONE			English	Article							HUMAN GRANULOCYTIC EHRLICHIOSIS; SEROLOGICAL EVIDENCE; LYME BORRELIOSIS; FORESTRY RANGERS; SEROPREVALENCE; RISK; ANTIBODIES; WORKERS; TICKS; INFECTIONS	Anaplasma phagocytophilum is an emerging tick-borne zoonosis with extensive increased interest. Epidemiological data are available in several regions of the USA, Europe and Asia in contrast to other parts of the world such as North Africa. Blood samples of 261 healthy individuals divided in two groups i.e., dog handlers and blood donors were analysed. Indirect immunofluorescent assay using a commercial kit was performed to detect specific A. phagocytophilum IgG. Two dilutions were used to assess the prevalence of seroreactive samples. Demographic variables were assessed as potential risk factors using exact logistic regression. Seropositivity rates reached 37% and 27% in dog handlers and 36% and 22% in blood donors. No statistically significant differences were found in the prevalence rates between the two groups. Analysis of risk factors such as gender, age groups, outdoor activities, self-reported previous exposure to ticks, or contact with domestic animals (dogs, cats, ruminants and horses) did not shown any significant difference. A. phagocytophilum exposure was common in both high-risk population and blood donors in Morocco.	[Khatat, Sarah Elhamiani; Sahibi, Hamid] Inst Agron & Vet Hassan II, Dept Pathol & Vet Publ Heath, Rabat, Morocco; [Khatat, Sarah Elhamiani; Daminet, Sylvie] Univ Ghent, Dept Compan Anim, Fac Vet Med, Merelbeke, Belgium; [Hing, Mony] Queen Astrid Mil Hosp, Lab Clin Biol, Natl Reference Lab Anaplasma phagocytophilum, Brussels, Belgium; [Moustain, Ismail Alaoui] Royal Gendarmery, Cent Hlth Serv, Rabat, Morocco; [El Amri, Hamid] Royal Gendarmery, Rabat, Morocco; [Benajiba, Mohammed] Reg Transfus Ctr, Rabat, Morocco; [Kachani, Malika] Western Univ Hlth Sci, Coll Vet Med, Pomona, CA USA; [Duchateau, Luc] Univ Ghent, Fac Vet Med, Dept Comparat Physiol & Biometr, Merelbeke, Belgium	Ghent University; Queen Astrid Military Hospital; Western University of Health Sciences; Ghent University	Khatat, SE (corresponding author), Inst Agron & Vet Hassan II, Dept Pathol & Vet Publ Heath, Rabat, Morocco.; Khatat, SE (corresponding author), Univ Ghent, Dept Compan Anim, Fac Vet Med, Merelbeke, Belgium.	elhamianis@yahoo.fr		Daminet, Sylvie/0000-0001-6733-7925				Adjemian J, 2012, VECTOR-BORNE ZOONOT, V12, P922, DOI 10.1089/vbz.2011.0917; Aguero-Rosenfeld ME, 2002, J CLIN MICROBIOL, V40, P2612, DOI 10.1128/JCM.40.7.2612-2615.2002; Annen K, 2012, AM J CLIN PATHOL, V137, P562, DOI 10.1309/AJCP4E4VQQQOZIAQ; Anonymous, 2008, Morbidity and Mortality Weekly Report, V57, P1145; Bakken JS, 2006, ANN NY ACAD SCI, V1078, P236, DOI 10.1196/annals.1374.042; Bakken JS, 2015, INFECT DIS CLIN N AM, V29, P341, DOI 10.1016/j.idc.2015.02.007; BROUQUI P, 1995, LANCET, V346, P782, DOI 10.1016/S0140-6736(95)91544-3; Chmielewska-Badora J, 2012, ANN AGR ENV MED, V19, P271; Chochlakis D, 2008, EUR J CLIN MICROBIOL, V27, P473, DOI 10.1007/s10096-007-0457-3; Chochlakis D, 2009, J INFECTION, V58, P87, DOI 10.1016/j.jinf.2008.11.005; Cinco M, 2004, CLIN MICROBIOL INFEC, V10, P1056, DOI 10.1111/j.1469-0691.2004.01026.x; Cisak E, 2005, ANN AGR ENV MED, V12, P127; Dumler JS, 2005, EMERG INFECT DIS, V11, P1828, DOI 10.3201/eid1112.050898; Fingerle V, 1997, J CLIN MICROBIOL, V35, P3244, DOI 10.1128/JCM.35.12.3244-3247.1997; Graf PCF, 2008, CLIN INFECT DIS, V46, P70, DOI 10.1086/524018; Groen J, 2002, EUR J CLIN MICROBIOL, V21, P46, DOI 10.1007/s10096-001-0659-z; Grzeszczuk A, 2002, EUR J CLIN MICROBIOL, V21, P6, DOI 10.1007/s10096-001-0649-1; Hao Q, 2013, BIOMED ENVIRON SCI, V26, P185, DOI 10.3967/0895-3988.2013.03.005; Henningsson AJ, 2015, TICKS TICK-BORNE DIS, V6, P787, DOI 10.1016/j.ttbdis.2015.07.005; Heyman P, 2003, J INFECTION, V47, P129, DOI 10.1016/S0163-4453(03)00056-2; Heyman P, 2010, EXPERT REV ANTI-INFE, V8, P33, DOI 10.1586/ERI.09.118; Hjetland R, 2015, INFECT DIS-NOR, V47, P52, DOI 10.3109/00365548.2014.959044; Leiby DA, 2002, TRANSFUSION, V42, P1585, DOI 10.1046/j.1537-2995.2002.00251.x; Maczka Ilona, 2013, Przegl Epidemiol, V67, P633; Oteo JA, 2001, EPIDEMIOL INFECT, V127, P353, DOI 10.1017/S0950268801005878; Otranto D, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-328; Pusterla N, 1998, EUR J CLIN MICROBIOL, V17, P207, DOI 10.1007/BF01691120; Santos AS, 2006, ANN NY ACAD SCI, V1078, P100, DOI 10.1196/annals.1374.014; Seng P, 2009, CLIN MICROBIOL INFEC, V15, P86, DOI 10.1111/j.1469-0691.2008.02251.x; Stanczak J, 2006, ANN NY ACAD SCI, V1078, P89, DOI 10.1196/annals.1374.011; Thomas DR, 1998, EPIDEMIOL INFECT, V121, P609, DOI 10.1017/S0950268898001514; von Wissmann B, 2015, INT J MED MICROBIOL, V305, P736, DOI 10.1016/j.ijmm.2015.08.026; Walder G, 2003, EUR J CLIN MICROBIOL, V22, P543, DOI 10.1007/s10096-003-0986-3; Zhang L., 2014, BIOMED RES INT, V2014, P313867, DOI [10.1155/2014/313867, DOI 10.1155/2014/313867]; Zhang LJ, 2008, EMERG INFECT DIS, V14, P938, DOI 10.3201/eid1406.071502; Zhang LJ, 2011, ASIAN PAC J TROP MED, V4, P568, DOI 10.1016/S1995-7645(11)60148-X; Zhang SY, 2009, AM J TROP MED HYG, V81, P293, DOI 10.4269/ajtmh.2009.81.293; Zhang XC, 2012, VECTOR-BORNE ZOONOT, V12, P932, DOI 10.1089/vbz.2012.0961; Zhang YongGen, 2012, Asian Pacific Journal of Tropical Disease, V2, P27; Zukiewicz-Sobczak W, 2014, ANN AGR ENV MED, V21, P767, DOI 10.5604/12321966.1129930	40	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2016	11	8							e0160880	10.1371/journal.pone.0160880	http://dx.doi.org/10.1371/journal.pone.0160880			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4YN	27532208	gold, Green Published, Green Submitted			2022-12-27	WOS:000381487600046
J	Kim, Y; Jeong, JE; Cho, H; Jung, DJ; Kwak, M; Rho, MJ; Yu, H; Kim, DJ; Choi, IY				Kim, Yejin; Jeong, Jo-Eun; Cho, Hyun; Jung, Dong-Jin; Kwak, Minjung; Rho, Mi Jung; Yu, Hwanjo; Kim, Dai-Jin; Choi, In Young			Personality Factors Predicting Smartphone Addiction Predisposition: Behavioral Inhibition and Activation Systems, Impulsivity, and Self-Control	PLOS ONE			English	Article							CELLULAR PHONE USE; COLLEGE-STUDENTS; INTERNET ADDICTION; SENSATION SEEKING; SOCIAL NETWORKING; YOUDEN INDEX; ASSOCIATION; BIS/BAS; BAS; DIMENSIONS	The purpose of this study was to identify personality factor-associated predictors of smartphone addiction predisposition (SAP). Participants were 2,573 men and 2,281 women (n = 4,854) aged 20-49 years (Mean +/- SD: 33.47 +/- 7.52); participants completed the following questionnaires: the Korean Smartphone Addiction Proneness Scale (K-SAPS) for adults, the Behavioral Inhibition System/Behavioral Activation System questionnaire (BIS/BAS), the Dickman Dysfunctional Impulsivity Instrument (DDII), and the Brief Self-Control Scale (BSCS). In addition, participants reported their demographic information and smartphone usage pattern (weekday or weekend average usage hours and main use). We analyzed the data in three steps: (1) identifying predictors with logistic regression, (2) deriving causal relationships between SAP and its predictors using a Bayesian belief network (BN), and (3) computing optimal cut-off points for the identified predictors using the Youden index. Identified predictors of SAP were as follows: gender (female), weekend average usage hours, and scores on BAS-Drive, BAS-Reward Responsiveness, DDII, and BSCS. Female gender and scores on BAS-Drive and BSCS directly increased SAP. BAS-Reward Responsiveness and DDII indirectly increased SAP. We found that SAP was defined with maximal sensitivity as follows: weekend average usage hours > 4.45, BAS-Drive > 10.0, BAS-Reward Responsiveness > 13.8, DDII > 4.5, and BSCS > 37.4. This study raises the possibility that personality factors contribute to SAP. And, we calculated cut-off points for key predictors. These findings may assist clinicians screening for SAP using cut-off points, and further the understanding of SA risk factors.	[Kim, Yejin; Yu, Hwanjo] Pohang Univ Sci & Technol, Dept Creat IT Engn, Pohang, South Korea; [Jeong, Jo-Eun; Cho, Hyun; Jung, Dong-Jin; Kwak, Minjung; Kim, Dai-Jin] Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Dept Psychiat, Seoul, South Korea; [Rho, Mi Jung; Choi, In Young] Catholic Univ Korea, Coll Med, Dept Med Informat, Seoul, South Korea	Pohang University of Science & Technology (POSTECH); Catholic University of Korea; Seoul St. Mary's Hospital; Catholic University of Korea	Kim, DJ (corresponding author), Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Dept Psychiat, Seoul, South Korea.; Choi, IY (corresponding author), Catholic Univ Korea, Coll Med, Dept Med Informat, Seoul, South Korea.	kdj922@chollian.net; iychoi@catholic.ac.kr		Jeong, Jo-Eun/0000-0002-4200-278X	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning [NRF-2014M3C7A1062893]; Department of Medical Informatics of the Catholic University of Korea	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning(National Research Foundation of Korea); Department of Medical Informatics of the Catholic University of Korea	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (NRF-2014M3C7A1062893). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank the staff at the Addiction Research Institute and Department of Medical Informatics of the Catholic University of Korea for supporting this research.	Akobeng AK, 2007, ACTA PAEDIATR, V96, P644, DOI 10.1111/j.1651-2227.2006.00178.x; Bewick V, 2004, CRIT CARE, V8, P508, DOI 10.1186/cc3000; Bianchi A, 2005, CYBERPSYCHOL BEHAV, V8, P39, DOI 10.1089/cpb.2005.8.39; Billieux J., 2015, CURR ADDICT REP, V2, P156, DOI [10.1007/s40429-015-0054-y, DOI 10.1007/S40429-015-0054-Y]; Bojunga J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042735; Braddock KH, 2011, J PERS, V79, P793, DOI 10.1111/j.1467-6494.2011.00699.x; Brettschneider J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011986; Caplan SE, 2007, CYBERPSYCHOL BEHAV, V10, P234, DOI 10.1089/cpb.2006.9963; CARVER CS, 1994, J PERS SOC PSYCHOL, V67, P319, DOI 10.1037/0022-3514.67.2.319; Chen SK, 2012, COMPUT HUM BEHAV, V28, P2219, DOI 10.1016/j.chb.2012.06.029; Chen TH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032328; CLONINGER CR, 1981, ARCH GEN PSYCHIAT, V38, P861; Corr PJ, 2008, REINFORCEMENT SENSITIVITY THEORY OF PERSONALITY, P1; Dawe S, 2004, ADDICT BEHAV, V29, P1389, DOI 10.1016/j.addbeh.2004.06.004; De Berardis D, 2009, CYBERPSYCHOL BEHAV, V12, P67, DOI 10.1089/cpb.2008.0108; DICKMAN SJ, 1990, J PERS SOC PSYCHOL, V58, P95, DOI 10.1037/0022-3514.58.1.95; Fluss R, 2005, BIOMETRICAL J, V47, P458, DOI 10.1002/bimj.200410135; Franken IHA, 2006, PERS INDIV DIFFER, V40, P1497, DOI 10.1016/j.paid.2005.12.005; Franken IHA, 2002, PERS INDIV DIFFER, V32, P349, DOI 10.1016/S0191-8869(01)00030-7; Gray J.A., 1981, MODEL PERSONALITY, P246, DOI DOI 10.1007/978-3-642-67783-0_8; Gray J. A, 1987, COGNITIVE NEUROCHEMI, P171; Gray JA, 1982, NEUROPSYCHOLOGY ANXI, DOI 10.1002/9780470720394.ch2; Griffiths M.D., 2013, J ADDICTION RES THER, V4, P36, DOI [10.4172/2155-6105.1000e118, DOI 10.4172/2155-6105.1000E118]; Ha JH, 2008, CYBERPSYCHOL BEHAV, V11, P783, DOI 10.1089/cpb.2008.0096; Haug S, 2015, J BEHAV ADDICT, V4, P299, DOI 10.1556/2006.4.2015.037; Hundt NE, 2008, PERS INDIV DIFFER, V44, P565, DOI 10.1016/j.paid.2007.09.018; Johnson SL, 2003, J PSYCHOPATHOL BEHAV, V25, P25, DOI 10.1023/A:1022247919288; Jonsson P, 2011, J ELECTROMYOGR KINES, V21, P363, DOI 10.1016/j.jelekin.2010.10.007; Jorm AF, 1999, PERS INDIV DIFFER, V26, P49; Kardefelt-Winther D, 2015, J BEHAV ADDICT, V4, P126, DOI 10.1556/2006.4.2015.019; 홍현기, 2012, [Korean Journal of Psychology: General, 한국심리학회지:일반], V31, P1193; Kim K, 2001, KOREAN J HLTH PSYCHO, V6, P19, DOI DOI 10.17315/KJHP.2011.16.2.005; Ko CH, 2010, PSYCHIAT RES, V175, P121, DOI 10.1016/j.psychres.2008.10.004; Korb K.B., 2004, COM SCI DAT; Kucer N, 2008, ELECTROMAGN BIOL MED, V27, P205, DOI 10.1080/15368370802072174; Kuss DJ, 2014, CURR PHARM DESIGN, V20, P4026, DOI 10.2174/13816128113199990617; Kuss DJ, 2011, INT J ENV RES PUB HE, V8, P3528, DOI 10.3390/ijerph8093528; Kwon M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056936; Lee HW, 2012, CYBERPSYCH BEH SOC N, V15, P373, DOI 10.1089/cyber.2012.0063; Lee J, 2014, J PHYS THER SCI, V26, P595, DOI 10.1589/jpts.26.595; Lin Y, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0097838, 10.1371/journal.pone.0098312]; MALATESTA VJ, 1981, J CONSULT CLIN PSYCH, V49, P292, DOI 10.1037/0022-006X.49.2.292; Masse LC, 1997, ARCH GEN PSYCHIAT, V54, P62; Mehroof M, 2010, CYBERPSYCH BEH SOC N, V13, P313, DOI 10.1089/cyber.2009.0229; Ministry of Science ICT and Future Planning, SURV INT ADD 2014; Mok JY, 2014, NEUROPSYCH DIS TREAT, V10, P817, DOI 10.2147/NDT.S59293; Mottram AJ, 2009, CYBERPSYCHOL BEHAV, V12, P319, DOI 10.1089/cpb.2007.0170; National Information Society Agency, 2011, DEV KOR SMARTPH ADD; O'Connor RM, 2005, PSYCHOL ADDICT BEHAV, V19, P10, DOI 10.1037/0893-164X.19.1.10; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; Reynolds B, 2006, PERS INDIV DIFFER, V40, P305, DOI 10.1016/j.paid.2005.03.024; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Schisterman EF, 2005, EPIDEMIOLOGY, V16, P73, DOI 10.1097/01.ede.0000147512.81966.ba; Scutari M, 2010, J STAT SOFTW, V35, P1, DOI 10.18637/jss.v035.i03; Takao M, 2009, CYBERPSYCHOL BEHAV, V12, P501, DOI 10.1089/cpb.2009.0022; Tangney JP, 2004, J PERS, V72, P271, DOI 10.1111/j.0022-3506.2004.00263.x; van Deursen AJAM, 2015, COMPUT HUM BEHAV, V45, P411, DOI 10.1016/j.chb.2014.12.039; Wu AMS, 2013, J BEHAV ADDICT, V2, P160, DOI 10.1556/JBA.2.2013.006; Yang YS, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-217; Yau Y, 2014, PSYCHIAT ANN, V44, P379, DOI 10.3928/00485713-20140806-05; Yau Yvonne H C, 2012, Minerva Psichiatr, V53, P153; Yen CF, 2009, J ADOLESCENCE, V32, P863, DOI 10.1016/j.adolescence.2008.10.006; Yen JY, 2009, PSYCHIAT CLIN NEUROS, V63, P218, DOI 10.1111/j.1440-1819.2009.01943.x; YOUDEN WJ, 1950, BIOMETRICS, V6, P172, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3; Zhang J, 2012, J CLIN PSYCHOL, V68, P1313, DOI 10.1002/jclp.21907; Zheng FZ, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1022	66	66	68	7	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2016	11	8							e0159788	10.1371/journal.pone.0159788	http://dx.doi.org/10.1371/journal.pone.0159788			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DT4YN	27533112	Green Published, Green Submitted, gold			2022-12-27	WOS:000381487600013
J	Paz-Soldan, VA; Yukich, J; Soonthorndhada, A; Giron, M; Apperson, CS; Ponnusamy, L; Schal, C; Morrison, AC; Keating, J; Wesson, DM				Paz-Soldan, Valerie A.; Yukich, Josh; Soonthorndhada, Amara; Giron, Maziel; Apperson, Charles S.; Ponnusamy, Loganathan; Schal, Coby; Morrison, Amy C.; Keating, Joseph; Wesson, Dawn M.			Design and Testing of Novel Lethal Ovitrap to Reduce Populations of Aedes Mosquitoes: Community-Based Participatory Research between Industry, Academia and Communities in Peru and Thailand	PLOS ONE			English	Article							TREATED-BED NETS; AEGYPTI DIPTERA; CONTROL STRATEGIES; MALARIA CONTROL; PUERTO-RICO; ZIKA VIRUS; CHIKUNGUNYA; CULICIDAE; DENGUE; PREFERENCES	Background Dengue virus (and Chikungunya and Zika viruses) is transmitted by Aedes aegypti and Aedes albopictus mosquitoes and causes considerable human morbidity and mortality. As there is currently no vaccine or chemoprophylaxis to protect people from dengue virus infection, vector control is the only viable option for disease prevention. The purpose of this paper is to illustrate the design and placement process for an attractive lethal ovitrap to reduce vector populations and to describe lessons learned in the development of the trap. Methods This study was conducted in 2010 in Iquitos, Peru and Lopburi Province, Thailand and used an iterative community-based participatory approach to adjust design specifications of the trap, based on community members' perceptions and feedback, entomological findings in the lab, and design and research team observations. Multiple focus group discussions (FGD) were held over a 6 month period, stratified by age, sex and motherhood status, to inform the design process. Trap testing transitioned from the lab to within households. Results Through an iterative process of working with specifications from the research team, findings from the laboratory testing, and feedback from FGD, the design team narrowed trap design options from 22 to 6. Comments from the FGD centered on safety for children and pets interacting with traps, durability, maintenance issues, and aesthetics. Testing in the laboratory involved releasing groups of 50 gravid Ae. aegypti in walk-in rooms and assessing what percentage were caught in traps of different colors, with different trap cover sizes, and placed under lighter or darker locations. Two final trap models were mocked up and tested in homes for a week; one model was the top choice in both Iquitos and Lopburi. Discussion The community-based participatory process was essential for the development of novel traps that provided effective vector control, but also met the needs and concerns of community members.	[Paz-Soldan, Valerie A.] Tulane Univ, Sch Publ Hlth & Trop Med, Dept Global Community Hlth & Behav Sci, 1440 Canal St, New Orleans, LA 70112 USA; [Paz-Soldan, Valerie A.] Univ Peruana Cayetano Heredia, Fac Salud Publ & Adm, Ave Honorio Delgado 430, Lima, Peru; [Paz-Soldan, Valerie A.; Yukich, Josh; Keating, Joseph] Tulane Univ, Sch Publ Hlth & Trop Med, Ctr Appl Malaria Res & Evaluat, 1440 Canal St, New Orleans, LA 70112 USA; [Yukich, Josh; Keating, Joseph; Wesson, Dawn M.] Tulane Univ, Sch Publ Hlth & Trop Med, Dept Trop Med, 1440 Canal St, New Orleans, LA 70112 USA; [Soonthorndhada, Amara] Mahidol Univ, Inst Populat & Social Res, Phuthamontol 73170, Nakornpathom, Thailand; [Giron, Maziel] San Jose State Univ, Dept Hlth Sci & Recreat, 1 Washington Sq, San Jose, CA 95192 USA; [Apperson, Charles S.; Ponnusamy, Loganathan; Schal, Coby] North Carolina State Univ, Dept Entomol & Plant Pathol, Raleigh, NC 27695 USA; [Morrison, Amy C.] Univ Calif Davis, Dept Entomol & Nematol, One Shields Ave, Davis, CA 95616 USA; [Wesson, Dawn M.] Tulane Univ, Sch Publ Hlth & Trop Med, Vector Borne Infect Dis Res Ctr, 1440 Canal St, New Orleans, LA 70112 USA	Tulane University; Universidad Peruana Cayetano Heredia; Tulane University; Tulane University; Mahidol University; California State University System; San Jose State University; University of North Carolina; North Carolina State University; University of California System; University of California Davis; Tulane University	Paz-Soldan, VA (corresponding author), Tulane Univ, Sch Publ Hlth & Trop Med, Dept Global Community Hlth & Behav Sci, 1440 Canal St, New Orleans, LA 70112 USA.; Paz-Soldan, VA (corresponding author), Univ Peruana Cayetano Heredia, Fac Salud Publ & Adm, Ave Honorio Delgado 430, Lima, Peru.; Paz-Soldan, VA (corresponding author), Tulane Univ, Sch Publ Hlth & Trop Med, Ctr Appl Malaria Res & Evaluat, 1440 Canal St, New Orleans, LA 70112 USA.	vpazsold@tulane.edu	Morrison, Amy/AAU-6511-2020; Schal, Coby/A-8717-2010	Schal, Coby/0000-0001-7195-6358; Morrison, Amy/0000-0001-6224-5984; Paz-Soldan, Valerie/0000-0002-1065-4919; Ponnusamy, Loganathan/0000-0002-0700-4472	Bill and Melinda Gates Foundation [50025]; National Institute of Allergy and Infectious Diseases (NIAID) [5 U01 AI 58303-05]; National Institutes of Health Fogarty International Center [K01TW008414-01A1]	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This study was made possible by the generous support of Bill and Melinda Gates Foundation Grant #50025 (PI: DMW), the National Institute of Allergy and Infectious Diseases (NIAID) Grant # 5 U01 AI 58303-05, and the National Institutes of Health Fogarty International Center Grant K01TW008414-01A1 (to VPS). The contents are the responsibility of the authors and do not necessarily reflect the views of either institution. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achee NL, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003655; AIKINS MK, 1994, J TROP MED HYG, V97, P81; ALLAN SA, 1994, J AM MOSQUITO CONTR, V10, P266; ALONSO PL, 1993, T ROY SOC TROP MED H, V87, P37, DOI 10.1016/0035-9203(93)90174-O; [Anonymous], 2004, COCHRANE DB SYST REV; Apperson C, 2007, AM J TROP MED HYG, V77, P254; Barnett ED, 2007, CLIN INFECT DIS, V44, P850, DOI 10.1086/511869; Bernard H. R., 2017, RES METHODS ANTHR; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; CHOI HW, 1995, AM J TROP MED HYG, V52, P377, DOI 10.4269/ajtmh.1995.52.377; D'Alessandro U, 2001, BMJ-BRIT MED J, V322, P249, DOI 10.1136/bmj.322.7281.249; Das ML, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000100; Dyer O, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h6983; Eisen L, 2009, J MED ENTOMOL, V46, P1245, DOI 10.1603/033.046.0601; Forshey BM, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004398; Forshey BM, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000787; Gubler DJ, 2002, ARCH MED RES, V33, P330, DOI 10.1016/S0188-4409(02)00378-8; Gyapong M, 1996, TROP MED INT HEALTH, V1, P328, DOI 10.1046/j.1365-3156.1996.d01-41.x; Harrington LC, 2001, J MED ENTOMOL, V38, P411, DOI 10.1603/0022-2585-38.3.411; Instituto Nacional de Estadistica e Informatica Peru, 2009, EST PROYECC POBL TOT; Lorenzi OD, 2016, MMWR-MORBID MORTAL W, V65, P479, DOI 10.15585/mmwr.mm6518e3; Lover AA, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-199; MACCORMACK CP, 1986, J TROP MED HYG, V89, P295; Maketa V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084314; Morrison AC, 2004, J MED ENTOMOL, V41, P1123, DOI 10.1603/0022-2585-41.6.1123; Morrison AC, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000670; Morrison AC, 2008, PLOS MED, V5, P362, DOI 10.1371/journal.pmed.0050068; National Statistical Office, 2010, 2010 POP HOUS CENS; Ndeffo-Mbah ML, 2016, SCI REP-UK, V6, DOI 10.1038/srep23997; Ponnusamy L, 2008, P NATL ACAD SCI USA, V105, P9262, DOI 10.1073/pnas.0802505105; Ponnusamy L, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1068-y; Ponnusamy L, 2010, J CHEM ECOL, V36, P709, DOI 10.1007/s10886-010-9806-2; Ponnusamy L, 2010, MICROB ECOL, V59, P158, DOI 10.1007/s00248-009-9565-1; Reiter P, 2014, DENGUE AND DENGUE HEMORRHAGIC FEVER, 2ND EDITION, P481, DOI 10.1079/9781845939649.0481; Scott TW, 2000, J MED ENTOMOL, V37, P77, DOI 10.1603/0022-2585-37.1.77; Sikka V, 2016, J GLOB INFECT DIS, V8, P3, DOI 10.4103/0974-777X.176140; Stoddard ST, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003003; Weaver SC, 2015, ANTIVIR RES, V120, P32, DOI 10.1016/j.antiviral.2015.04.016; Wesson DM, 2013, AM J TROP MED HYG  S, V89; Wiseman V, 2007, AM J TROP MED HYG, V76, P830, DOI 10.4269/ajtmh.2007.76.830; World Health Organization, 2008, WKLY EPIDEMIOL REC, V83, P450	41	18	18	0	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2016	11	8							e0160386	10.1371/journal.pone.0160386	http://dx.doi.org/10.1371/journal.pone.0160386			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4YN	27532497	gold, Green Submitted, Green Published			2022-12-27	WOS:000381487600028
J	Iliodromiti, S; Ghouri, N; Celis-Morales, CA; Sattar, N; Lumsden, MA; Gill, JMR				Iliodromiti, Stamatina; Ghouri, Nazim; Celis-Morales, Carlos A.; Sattar, Naveed; Lumsden, Mary Ann; Gill, Jason M. R.			Should Physical Activity Recommendations for South Asian Adults Be Ethnicity-Specific? Evidence from a Cross-Sectional Study of South Asian and White European Men and Women	PLOS ONE			English	Article							ACTIVITY GUIDELINES; INSULIN-RESISTANCE; METABOLIC SYNDROME; OBESITY; RISK; ASSOCIATION; PREVALENCE; MORTALITY	International public health guidelines recommend that adults undertake at least 150 min. week(-1) of moderate-intensity physical activity. However, the underpinning evidence has largely been obtained from studies of populations of white European descent. It is unclear whether these recommendations are appropriate for other ethnic groups, particularly South Asians, who have greater cardio-metabolic risk than white Europeans. The objective of our study was to determine the level of moderate-intensity physical activity required in South Asians adults to confer a similar cardio-metabolic risk profile to that observed in Europeans of similar age and body mass index (BMI) undertaking the currently recommended levels of 150 min. week(-1). 148 South Asians and 163 white Europeans aged 18 to 70 years were recruited. Physical activity was measured objectively via vertical axis accelerations from hip-worn accelerometers. Factor analysis was used to summarize the measured risk biomarkers into a single underlying latent "factor" describing overall cardio-metabolic risk. Sex did not modify the association between physical activity and the cardio-metabolic risk factor, so data for both sexes were combined and models adjusted for age, sex, BMI and accelerometer wear time. We estimated that South Asian adults needed to undertake 232 (95% Confidence interval: 200 to 268) min. week(-1) in order to obtain the same cardio-metabolic risk factor score as a white European undertaking 150 minutes of moderate-equivalent physical activity per week. The present findings suggest that South Asian men and women need to undertake similar to 230 minutes of moderate intensity physical activity per week. This equates to South Asians undertaking an extra 10-15 minutes of moderate intensity physical activity per day on top of existing recommendations.	[Iliodromiti, Stamatina; Lumsden, Mary Ann; Gill, Jason M. R.] Univ Glasgow, Sch Med, Dept Obstet & Gynaecol, Glasgow, Lanark, Scotland; [Ghouri, Nazim; Celis-Morales, Carlos A.; Sattar, Naveed] Univ Glasgow, Coll Med Vet & Life Sci, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland	University of Glasgow; University of Glasgow	Iliodromiti, S (corresponding author), Univ Glasgow, Sch Med, Dept Obstet & Gynaecol, Glasgow, Lanark, Scotland.	Stamatina.iliodromiti@glasgow.ac.uk	Celis-Morales, Carlos/AAJ-5103-2020	Ghouri, Noushima/0000-0002-8202-3913; Iliodromiti, Stamatina/0000-0001-6453-6654				Agyemang C, 2012, DIABETIC MED, V29, P1159, DOI 10.1111/j.1464-5491.2012.03616.x; Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Altman DG, 2006, BRIT MED J, V332, P1080, DOI 10.1136/bmj.332.7549.1080; American Diabetes Association, 2017, Diabetes Care, V40, pS11, DOI 10.2337/dc15-S005; Babakus WS, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-150; British Heart Foundation, 2000, S AS HEART DIS; Celis-Morales CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082568; Celis-Morales CA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036345; Deanfield J, 2014, HEART, V100, P1, DOI 10.1136/heartjnl-2014-305693; Department of Health, 2011, START ACT STAY ACT R; Fischbacher CM, 2004, J PUBLIC HEALTH-UK, V26, P250, DOI 10.1093/pubmed/fdh158; Freedson PS, 1998, MED SCI SPORT EXER, V30, P777, DOI 10.1097/00005768-199805000-00021; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Ghouri N, 2013, DIABETOLOGIA, V56, P2238, DOI 10.1007/s00125-013-2969-y; Gill JMR, 2008, SPORTS MED, V38, P807, DOI 10.2165/00007256-200838100-00002; Gill JMR, 2014, ATHEROSCLEROSIS, V232, P319, DOI 10.1016/j.atherosclerosis.2013.11.039; Glazer NL, 2013, MED SCI SPORT EXER, V45, P109, DOI 10.1249/MSS.0b013e31826beae5; Gray LJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026464; Gregg EW, 2003, JAMA-J AM MED ASSOC, V289, P2379, DOI 10.1001/jama.289.18.2379; Hall LML, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014197; Hansen BH, 2012, MED SCI SPORT EXER, V44, P266, DOI 10.1249/MSS.0b013e31822cb354; Jeon CY, 2007, DIABETES CARE, V30, P744, DOI 10.2337/dc06-1842; MATHER HM, 1985, BRIT MED J, V291, P1081, DOI 10.1136/bmj.291.6502.1081; MCKEIGUE PM, 1993, CIRCULATION, V87, P152, DOI 10.1161/01.CIR.87.1.152; MCKEIGUE PM, 1991, LANCET, V337, P382, DOI 10.1016/0140-6736(91)91164-P; Misra A, 2009, J Assoc Physicians India, V57, P163; Misra A, 2012, DIABETES TECHNOL THE, V14, P83, DOI 10.1089/dia.2011.0111; NICE, 2013, ASSESSING BODY MASS; Nocon M, 2008, EUR J CARDIOV PREV R, V15, P239, DOI 10.1097/HJR.0b013e3282f55e09; Razak F, 2007, CIRCULATION, V115, P2111, DOI 10.1161/CIRCULATIONAHA.106.635011; Sproston K., 2006, HLTH MINORITY ETHNIC; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; Tuomilehto J, 2003, DIABETES CARE, V26, P1770; U.S. Department of Health and Human Services, 2008, 2008 PHYS ACT GUID A; Waidyatilaka I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058328; Warburton DER, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-39; WHO, 2010, GLOB REC PHYS ACT HL, V1st, P15; Yates T, 2010, PREV MED, V51, P290, DOI 10.1016/j.ypmed.2010.06.011; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	39	32	32	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2016	11	8							e0160024	10.1371/journal.pone.0160024	http://dx.doi.org/10.1371/journal.pone.0160024			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4UN	27529339	gold, Green Accepted, Green Submitted, Green Published			2022-12-27	WOS:000381476700003
J	Molano, M; Tabrizi, SN; Garland, SM; Roberts, JM; Machalek, DA; Phillips, S; Chandler, D; Hillman, RJ; Grulich, AE; Jin, FY; Poynten, IM; Templeton, DJ; Cornall, AM				Molano, Monica; Tabrizi, Sepehr N.; Garland, Suzanne M.; Roberts, Jennifer M.; Machalek, Dorothy A.; Phillips, Samuel; Chandler, David; Hillman, Richard J.; Grulich, Andrew E.; Jin, Fengyi; Poynten, I. Mary; Templeton, David J.; Cornall, Alyssa M.		SPANC Study Team	CpG Methylation Analysis of HPV16 in Laser Capture Microdissected Archival Tissue and Whole Tissue Sections from High Grade Anal Squamous Intraepithelial Lesions: A Potential Disease Biomarker	PLOS ONE			English	Article							PAPILLOMAVIRUS TYPE-16 DNA; E2 BINDING-SITES; HIV-INFECTED MEN; 16 E6 GENE; CERVICAL-CANCER; NEOPLASIA; PROGRESSION; PRECANCER; PATTERNS; GENOMES	Incidence and mortality rates of anal cancer are increasing globally. More than 90% of anal squamous cell carcinomas (ASCC) are associated with human papillomavirus (HPV). Studies on HPV-related anogenital lesions have shown that patterns of methylation of viral and cellular DNA targets could potentially be developed as disease biomarkers. Lesion-specific DNA isolated from formalin-fixed paraffin-embedded (FFPE) tissues from existing or prospective patient cohorts may constitute a valuable resource for methylation analysis. However, low concentrations of DNA make these samples technically challenging to analyse using existing methods. We therefore set out to develop a sensitive and reproducible nested PCR-pyrosequencing based method to accurately quantify methylation at 10 CpG sites within the E2BS1, E2BS2,3,4 and Sp1 binding sites in the viral upstream regulatory region of HPV16 genome. Methylation analyses using primary and nested PCR-pyrosequencing on 52 FFPE tissue [26 paired whole tissue sections (WTS) and laser capture microdissected (LCM) tissues] from patients with anal squamous intraepithelial lesions was performed. Using nested PCR, methylation results were obtained for the E2BS1, E2BS2,3,4 and Sp1 binding sites in 86.4% of the WTS and 81.8% of the LCM samples. Methylation patterns were strongly correlated within median values of matched pairs of WTS and LCM sections, but overall methylation was higher in LCM samples at different CpG sites. High gradelesions showed low methylation levels in the E2BS1 and E2BS2 regions, with increased methylation detected in the E2BS, 3,4/Sp1 regions, showing the highest methylation at CpG site 37. The method developed is highly sensitive in samples with low amounts of DNA and demonstrated to be suitable for archival samples. Our data shows a possible role of specific methylation in the HPV16 URR for detection of HSIL.	[Molano, Monica; Tabrizi, Sepehr N.; Garland, Suzanne M.; Machalek, Dorothy A.; Phillips, Samuel; Cornall, Alyssa M.] Royal Womens Hosp, Dept Microbiol & Infect Dis, Reg HPV Labnet Reference Lab, Parkville, Vic, Australia; [Tabrizi, Sepehr N.; Garland, Suzanne M.; Machalek, Dorothy A.; Phillips, Samuel; Cornall, Alyssa M.] Murdoch Childrens Res Inst, Parkville, Vic, Australia; [Tabrizi, Sepehr N.; Garland, Suzanne M.] Univ Melbourne, Dept Obstet & Gynaecol, Parkville, Vic, Australia; [Tabrizi, Sepehr N.; Garland, Suzanne M.] Murdoch Childrens Res Inst, Parkville, Vic, Australia; [Roberts, Jennifer M.] GynaePath, Douglass Hanly Moir Pathol, Macquarie Pk, Sydney, NSW, Australia; [Chandler, David] Australian Genome Res Facil, Perth, WA, Australia; [Hillman, Richard J.] Western Sydney Local Hlth Dist, Western Sydney Sexual Hlth Ctr, Parramatta, NSW, Australia; [Hillman, Richard J.] Univ Sydney, Sydney Med Sch, Sydney, NSW, Australia; [Grulich, Andrew E.; Jin, Fengyi; Poynten, I. Mary; Templeton, David J.] Univ New South Wales, Kirby Inst, Sydney, NSW, Australia; [Templeton, David J.] Royal Prince Alfred Hosp, RPA Sexual Hlth, Camperdown, NSW, Australia	Murdoch Children's Research Institute; University of Melbourne; Murdoch Children's Research Institute; University of Sydney; University of New South Wales Sydney; Kirby Institute; University of Sydney	Cornall, AM (corresponding author), Royal Womens Hosp, Dept Microbiol & Infect Dis, Reg HPV Labnet Reference Lab, Parkville, Vic, Australia.; Cornall, AM (corresponding author), Murdoch Childrens Res Inst, Parkville, Vic, Australia.	alyssa.cornall@mcri.edu.au	McCaffery, Kirsten/K-7945-2019; Segelov, Eva/Q-7611-2019; Hillman, Richard/AAM-1177-2020; Tong, Winnie Wing Yin/H-6785-2013	McCaffery, Kirsten/0000-0003-2696-5006; Segelov, Eva/0000-0002-4410-6144; Hillman, Richard/0000-0002-1859-0761; Tong, Winnie Wing Yin/0000-0003-2235-8452; Phillips, Samuel/0000-0002-2549-8111; Templeton, David/0000-0003-2157-9587; Machalek, Dorothy/0000-0002-4101-8085; Prestage, Garrett/0000-0003-3917-8992; Howard, Kirsten/0000-0002-0918-7540; Jin, Fengyi/0000-0002-8573-637X; Law, Matthew/0000-0002-3540-8837; Christopher, Fairley/0000-0001-9081-1664	Australian National Health and Medical Research Council Program [568971, 1071269]; Cancer Council NSW, Australia;  [13-11]	Australian National Health and Medical Research Council Program(National Health and Medical Research Council (NHMRC) of Australia); Cancer Council NSW, Australia(Cancer Council New South Wales); 	This work is funded by Australian National Health and Medical Research Council (www.nhmrc.gov.au) Program Grants (#568971 and #1071269) and a Cancer Council NSW, Australia (www.cancercouncil.com.au), Strategic Research Partnership Program grant (#13-11). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramowitz L, 2007, AIDS, V21, P1457, DOI 10.1097/QAD.0b013e3281c61201; Badal V, 2003, J VIROL, V77, P6227, DOI 10.1128/JVI.77.11.6227-6234.2003; Berry JM, 2014, INT J CANCER, V134, P1147, DOI 10.1002/ijc.28431; Bhattacharjee B, 2006, VIROLOGY, V354, P280, DOI 10.1016/j.virol.2006.06.018; Brandsma JL, 2009, VIROLOGY, V389, P100, DOI 10.1016/j.virol.2009.03.029; Chaiwongkot A, 2013, INT J CANCER, V132, P2087, DOI 10.1002/ijc.27906; Cheung JLK, 2013, GYNECOL ONCOL, V131, P374, DOI 10.1016/j.ygyno.2013.08.026; Clarke MA, 2012, CANCER EPIDEM BIOMAR, V21, P2125, DOI 10.1158/1055-9965.EPI-12-0905; Cornall AM, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008439; de Ruijter TC, 2015, LAB INVEST, V95, P833, DOI 10.1038/labinvest.2015.53; Dietrich D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077771; Ding DC, 2009, EUR J OBSTET GYN R B, V147, P215, DOI 10.1016/j.ejogrb.2009.08.023; Hoots BE, 2009, INT J CANCER, V124, P2375, DOI 10.1002/ijc.24215; Hublarova P, 2009, INT J GYNECOL CANCER, V19, P321, DOI 10.1111/IGC.0b013e31819d8a5c; Jacobs MV, 1999, BRIT J CANCER, V81, P114, DOI 10.1038/sj.bjc.6690659; Jacquin E, 2013, J CLIN MICROBIOL, V51, P3207, DOI 10.1128/JCM.01106-13; Jin FY, 2011, VACCINE, V29, P2322, DOI 10.1016/j.vaccine.2011.01.015; Johannsen E, 2013, VIROLOGY, V445, P205, DOI 10.1016/j.virol.2013.07.016; Kalantari M, 2004, J VIROL, V78, P12762, DOI 10.1128/JVI.78.23.12762-12772.2004; Kalantari M, 2009, VIROLOGY, V390, P261, DOI 10.1016/j.virol.2009.05.006; Leung TW, 2015, J MED VIROL, V87, P1022, DOI 10.1002/jmv.24129; Li QL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104481; LILLSUNDE L, 2014, PLOS ONE, V0009; Macedo MP, 2015, EXP MOL PATHOL, V98, P563, DOI [10.1016/j.yexmp.2015.03.038, DOI 10.1016/J.YEXMP.2015.03.038]; Machalek DA, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-946; Machalek DA, 2012, LANCET ONCOL, V13, P487, DOI 10.1016/S1470-2045(12)70080-3; Mazumder D, 2011, GYNECOL ONCOL, V123, P597, DOI 10.1016/j.ygyno.2011.08.004; Mirabello L, 2015, INT J CANCER, V136, pE146, DOI 10.1002/ijc.29119; Mirabello L, 2012, JNCI-J NATL CANCER I, V104, P556, DOI 10.1093/jnci/djs135; Narasimhan Supraja, 2009, BMC Res Notes, V2, P104, DOI 10.1186/1756-0500-2-104; Patel DA, 2012, J VIROL METHODS, V184, P84, DOI 10.1016/j.jviromet.2012.05.022; Piyathilake CJ, 2011, CANCER-AM CANCER SOC, V117, P957, DOI 10.1002/cncr.25511; Rajeevan MS, 2006, J VIROL METHODS, V138, P170, DOI 10.1016/j.jviromet.2006.08.012; Richel O, 2014, J INFECT DIS, V210, P111, DOI 10.1093/infdis/jiu052; Siegel EM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122495; Snellenberg S, 2012, VIROLOGY, V422, P357, DOI 10.1016/j.virol.2011.11.006; Sobhani I, 2004, AIDS, V18, P1561, DOI 10.1097/01.aids.0000131335.15301.dd; Sun C, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00150; Sun C, 2011, GYNECOL ONCOL, V121, P59, DOI 10.1016/j.ygyno.2011.01.013; Thierry F, 2009, VIROLOGY, V384, P375, DOI 10.1016/j.virol.2008.11.014; Turan T, 2006, VIROLOGY, V349, P175, DOI 10.1016/j.virol.2005.12.033; Vinokurova S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024451; Wang Z, 2011, CANCER BIOL THER, V11, P490, DOI 10.4161/cbt.11.5.14550; Wiley DJ, 2005, JAIDS-J ACQ IMM DEF, V39, P143	44	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2016	11	8							e0160673	10.1371/journal.pone.0160673	http://dx.doi.org/10.1371/journal.pone.0160673			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4UN	27529629	Green Published, Green Submitted, gold			2022-12-27	WOS:000381476700016
J	Ralston, ME; Myatt, MA				Ralston, Mark E.; Myatt, Mark A.			Weight Estimation Tool for Children Aged 6 to 59 Months in Limited-Resource Settings	PLOS ONE			English	Article							BROSELOW TAPE; BODY-WEIGHT; PEDIATRIC CARE; TUBE SIZE; ACCURACY; LENGTH; RESUSCITATION; AGREEMENT; FORMULAS; STANDARD	Importance A simple, reliable anthropometric tool for rapid estimation of weight in children would be useful in limited-resource settings where current weight estimation tools are not uniformly reliable, nearly all global under-five mortality occurs, severe acute malnutrition is a significant contributor in approximately one-third of under-five mortality, and a weight scale may not be immediately available in emergencies to first-response providers. Objective To determine the accuracy and precision of mid-upper arm circumference (MUAC) and height as weight estimation tools in children under five years of age in low-to-middle income countries. Design This was a retrospective observational study. Data were collected in 560 nutritional surveys during 1992-2006 using a modified Expanded Program of Immunization two-stage cluster sample design. Setting Locations with high prevalence of acute and chronic malnutrition. Participants A total of 453,990 children met inclusion criteria (age 6-59 months; weight <= 25 kg; MUAC 80-200 mm) and exclusion criteria (bilateral pitting edema; biologically implausible weight-for-height z-score (WHZ), weight-for-age z-score (WAZ), and height-for-age z-score (HAZ) values). Exposures Weight was estimated using Broselow Tape, Hong Kong formula, and database MUAC alone, height alone, and height and MUAC combined. Main Outcomes and Measures Mean percentage difference between true and estimated weight, proportion of estimates accurate to within +/- 25% and +/- 10% of true weight, weighted Kappa statistic, and Bland-Altman bias were reported as measures of tool accuracy. Standard deviation of mean percentage difference and Bland-Altman 95% limits of agreement were reported as measures of tool precision. Results Database height was a more accurate and precise predictor of weight compared to Brose-low Tape 2007 [B], Broselow Tape 2011 [A], and MUAC. Mean percentage difference between true and estimated weight was +0.49%(SD = 10.33%); proportion of estimates accurate to within +/- 25% of true weight was 97.36% (95% CI 97.40%, 97.46%); and Bland-Altman bias and 95% limits of agreement were 0.05 kg and (-2.15 kg; 2.24 kg). The height model fitted for MUAC classes was accurate and precise. For MUAC < 115 mm, the proportion of estimates accurate to within +/- 25% of true weight was 97.15% (95% CI 96.90%, 97.42%) and the Bland-Altman bias and 95% limits of agreement were 0.08 kg and (-1.21 kg; 1.37 kg). For MUAC between 115 and 125 mm, the proportion of estimates accurate to within +/- 25% of true weight was 98.93% (95% CI 98.82%, 99.03%) and Bland-Altman bias and 95% limits of agreement were 0.05 kg and (-1.15 kg; 1.24 kg). For MUAC > 125 mm, the proportion of estimates accurate to within +/- 25% of true weight was 98.33% (95% CI 98.29%, 98.37%) and Bland-Altman bias and 95% limits of agreement were 0.05 kg and (-2.08 kg; 2.19 kg). Conclusions and Relevance Models estimating weight from height alone and height with MUAC class in children aged 6-59 months in a database from low-to-middle income countries were more accurate and precise than previous weight estimation tools. A height-based weight estimation tape stratified according to MUAC classes is proposed for children aged 6-59 months in limited-resource settings.	[Ralston, Mark E.] Uniformed Serv Univ Hlth Sci, Dept Pediat, Bethesda, MD 20814 USA; [Myatt, Mark A.] Brixton Hlth, Llawryglyn, Powys, Wales	Uniformed Services University of the Health Sciences - USA	Ralston, ME (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Pediat, Bethesda, MD 20814 USA.	mark.e.ralston.civ@mail.mil						Abdel-Rahman SM, 2012, OPEN MED DEV J, V4, P87, DOI [10.2174/1875181401204010087, DOI 10.2174/1875181401204010087]; Abdel-Rahman SM, 2014, ARCH DIS CHILD, V99, P570, DOI 10.1136/archdischild-2013-305211; Abdel-Rahman SM, 2013, ANN EMERG MED, V62, P332, DOI 10.1016/j.annemergmed.2013.02.021; Argall JAW, 2003, ARCH DIS CHILD, V88, P789, DOI 10.1136/adc.88.9.789; Asskaryar F, 2015, INT J EMERG MED, V8, DOI 10.1186/s12245-015-0078-z; Batmanabane Gitanjali, 2015, Glob Pediatr Health, V2, p2333794X14566625, DOI 10.1177/2333794X14566625; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Boelaert M, 1995, NUTR GUIDELINES FACI; Bourdeau S, 2011, CAN J RURAL MED, V16, P123; Carroll W, 2001, ARCH DIS CHILD S, V84, pA12; Cattermole GN, 2010, RESUSCITATION, V81, P1105, DOI 10.1016/j.resuscitation.2010.05.015; Clark MC, 2016, ACAD EMERG MED, V23, P21, DOI 10.1111/acem.12854; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Department of Maternal and Child Health and Community Health Ministry of Health PRC, 2009, CHILD GROWTH STAND I; Dicko A, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-270; DuBois D, 2007, PEDIATR EMERG CARE, V23, P227, DOI 10.1097/PEC.0b013e31803f5aca; English M, 2004, LANCET, V364, P1622, DOI 10.1016/S0140-6736(04)17318-2; English M, 2004, LANCET, V363, P1948, DOI 10.1016/S0140-6736(04)16408-8; EVERITT BS, 1968, BRIT J MATH STAT PSY, V21, P97, DOI 10.1111/j.2044-8317.1968.tb00400.x; FLEISS JL, 1969, PSYCHOL BULL, V72, P323, DOI 10.1037/h0028106; GARLAND JS, 1986, AM J EMERG MED, V4, P390, DOI 10.1016/0735-6757(86)90184-1; Geduld H, 2011, EMERG MED J, V28, P856, DOI 10.1136/emj.2010.098640; Golden M, 2006, MEASURING MORTALITY; Graves L, 2014, RESUSCITATION, V85, P392, DOI 10.1016/j.resuscitation.2013.11.024; HABICHT JP, 1974, B OFIC SANIT PANAM, V75, P375; Hofer CK, 2002, BRIT J ANAESTH, V88, P283, DOI 10.1093/bja/88.2.283; HOFVANDER Y., 1969, Journal of Tropical Pediatrics, V15, P251; House DR, 2013, ANN EMERG MED, V61, P1, DOI 10.1016/j.annemergmed.2012.07.110; Huber PJ, 2009, WILEY SERIES PROBABI; Jang HY, 2007, ACAD EMERG MED, V14, P489, DOI 10.1197/j.aem.2006.12.014; JELLIFFE D. B., 1966, The assessment of the nutritional status of the community (with special reference to field surveys in developing regions of the world)., P271; Khouli M, 2015, J EMERG MED, V48, P660, DOI 10.1016/j.jemermed.2014.12.082; Lack JA, 1997, BRIT J ANAESTH, V78, P601, DOI 10.1093/bja/78.5.601; Larson L L, 1985, J Emerg Nurs, V11, P246; Loo PY, 2013, J PAEDIATR CHILD H, V49, pE311, DOI 10.1111/jpc.12141; LUBITZ DS, 1988, ANN EMERG MED, V17, P576, DOI 10.1016/S0196-0644(88)80396-2; McKAY D. A., 1969, Journal of Tropical Pediatrics, V15, P213; Milne WK, 2012, CAN J EMERG MED, V14, P25, DOI 10.2310/8000.2011.110523; Molyneux E, 1999, LANCET, V354, P1616, DOI 10.1016/S0140-6736(99)04552-3; Myatt M, 2006, FOOD NUTR BULL, V27, pS7, DOI 10.1177/15648265060273S302; Nieman CT, 2006, ACAD EMERG MED, V13, P1011, DOI 10.1197/j.aem.2006.06.042; Park J, 2012, RESUSCITATION, V83, P1129, DOI 10.1016/j.resuscitation.2012.01.023; R Core Team, 2021, R LANGUAGE ENV STAT; Ramarajan N, 2008, ACAD EMERG MED, V15, P431, DOI 10.1111/j.1553-2712.2008.00081.x; Rosenberg M, 2011, AM J EMERG MED, V29, P482, DOI 10.1016/j.ajem.2009.12.002; RUTISHAUSER I. H. E., 1969, Journal of Tropical Pediatrics, V15, P196; Simoes EAF, 2003, B WORLD HEALTH ORGAN, V81, P522; Sinha M, 2012, PEDIATR EMERG CARE, V28, P544, DOI 10.1097/PEC.0b013e318258ac2e; So TY, 2009, PEDIATRICS, V123, pE1045, DOI 10.1542/peds.2008-1968; The World Bank, 2020, GNI PER CAP ATL METH; Theron Lynn, 2005, Emerg Med Australas, V17, P238; Thompson A, 2008, NIST SPECIAL PUBLICA, V811; Trakulsrichai Satariya, 2012, Journal of the Medical Association of Thailand, V95, P1194; Utley R, 1990, Dimens Crit Care Nurs, V9, P75, DOI 10.1097/00003465-199003000-00003; Wang HD, 2014, LANCET, V384, P957, DOI 10.1016/S0140-6736(14)60497-9; Wells M, 2013, RESUSCITATION, V84, P227, DOI 10.1016/j.resuscitation.2012.05.028; WHO, 2006, WHO CHILD GROWTH STA; World Health Organization, 2013, GUID UPD MAN SEV AC; Yamamoto LG, 2009, AM J EMERG MED, V27, P810, DOI 10.1016/j.ajem.2008.06.023; Young KD, 2016, ANN EMERG MED, V68, P441, DOI 10.1016/j.annemergmed.2016.02.043	60	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2016	11	8							e0159260	10.1371/journal.pone.0159260	http://dx.doi.org/10.1371/journal.pone.0159260			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4UN	27529816	Green Published, gold, Green Submitted			2022-12-27	WOS:000381476700001
J	Wei, YJ; Wu, XL; Xia, JW; Shen, X; Cai, CF				Wei, Yujie; Wu, Xinliang; Xia, Jinwen; Shen, Xue; Cai, Chongfa			Variation of Soil Aggregation along the Weathering Gradient: Comparison of Grain Size Distribution under Different Disruptive Forces	PLOS ONE			English	Article							SOUTH-CENTRAL CHINA; ORGANIC-MATTER; IRON-OXIDES; STRUCTURAL STABILITY; LASER DIFFRACTION; TROPICAL SOILS; HIERARCHY; OXISOLS; FERTILIZATION; SESQUIOXIDES	The formation and stabilization of soil aggregates play a key role in soil functions. To date, few studies have been performed on the variation of soil aggregation with increasing soil weathering degree. Here, soil aggregation and its influencing factors along the weathering gradient were investigated. Six typical zonal soils (derived from similar parent materials) were sampled from temperate to tropical regions. Grain size distribution (GSD) in aggregate fragmentation with increasing disruptive forces (air-dried, water dispersion and chemical dispersion) was determined by laser diffraction particle size analyzer. Different forms of ses-quioxides were determined by selective chemical extraction and their contributions to soil aggregation were identified by multiple stepwise regression analysis. The high variability of sesquioxides in different forms appeared with increasing free oxide content (Fed and Ald) from the temperate to tropical soils. The transformation of GSD peak to small size varied with increasing disruptive forces (p<0.05). Although in different weathering degrees, zonal soils showed a similar fragmentation process. Aggregate water stability generally increased with increasing soil weathering (p<0.01), with higher stability in eluvium (A) horizon than in illuvium (B) horizon (p<0.01). Crystalline oxides and amorphous iron oxides (Feo), especially (Fed-Feo) contributed to the formation of air-dried macroaggregates and their stability against slaking (R-2 = 55%, p<0.01), while fine particles (< 50 mu m) and Feo (excluding the complex form Fep) played a positive role in the formation of water stable aggregates (R-2 = 93%, p<0.01). Additionally, water stable aggregates (including stability, size distribution and specific surface area) were closely related with pH, organic matter, cation exchange capacity (CEC), bulk density (BD), and free oxides (including various forms) (p<0.05). The overall results indicate that soil aggregation conforms to aggregate hierarchy theory to some extent along the weathering gradient and different forms of sesquioxides perform their specific roles in the formation and stabilization of different size aggregates.	[Wei, Yujie; Wu, Xinliang; Xia, Jinwen; Cai, Chongfa] Huazhong Agr Univ, Coll Resources & Environm, Soil & Water Conservat Res Ctr,Minist Agr, Key Lab Arable Land Conservat Middle & Lower Reac, Wuhan, Peoples R China; [Shen, Xue] Huazhong Agr Univ, Coll Econ & Management, Wuhan, Peoples R China	Huazhong Agricultural University; Ministry of Agriculture & Rural Affairs; Huazhong Agricultural University	Cai, CF (corresponding author), Huazhong Agr Univ, Coll Resources & Environm, Soil & Water Conservat Res Ctr,Minist Agr, Key Lab Arable Land Conservat Middle & Lower Reac, Wuhan, Peoples R China.	hzaucfcai@163.com	xia, jinwen/ABI-2626-2020		National Natural Science Foundation of China [41471231]; Fundamental Research Funds for the Central Universities [2662015PY043]; Natural Science Foundation of Hubei Province [2014CFA016]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Natural Science Foundation of Hubei Province(Natural Science Foundation of Hubei Province)	This work was funded by the National Natural Science Foundation of China (41471231) to CC, the Fundamental Research Funds for the Central Universities (2662015PY043) and the Natural Science Foundation of Hubei Province (2014CFA016) to CC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amezketa E., 2003, Spanish Journal of Agricultural Research, V1, P83; Asano M, 2014, GEODERMA, V216, P62, DOI 10.1016/j.geoderma.2013.10.005; Barral MT, 1998, SOIL TILL RES, V46, P261, DOI 10.1016/S0167-1987(98)00092-0; Barthes BG, 2008, GEODERMA, V143, P14, DOI 10.1016/j.geoderma.2007.10.003; BLUME HP, 1969, SOIL SCI SOC AM PRO, V33, P438, DOI 10.2136/sssaj1969.03615995003300030030x; [CAS Institute of Soil Science], 2001, CHINESE SOIL TAXONOM; Chaplot V, 2015, GEODERMA, V243, P205, DOI 10.1016/j.geoderma.2014.12.013; Chrenkova K, 2014, GEODERMA, V235, P290, DOI 10.1016/j.geoderma.2014.07.025; Duiker SW, 2003, SOIL SCI SOC AM J, V67, P606, DOI 10.2136/sssaj2003.0606; EDWARDS AP, 1967, J SOIL SCI, V18, P64, DOI 10.1111/j.1365-2389.1967.tb01488.x; Eshel G, 2004, SOIL SCI SOC AM J, V68, P736, DOI 10.2136/sssaj2004.0736; Field DJ, 2006, AUST J SOIL RES, V44, P497, DOI 10.1071/SR05127; Gargiulo L, 2013, GEODERMA, V197, P151, DOI 10.1016/j.geoderma.2013.01.008; Huang L, 2010, SOIL TILL RES, V108, P59, DOI 10.1016/j.still.2010.03.003; Igwe CA, 2009, CATENA, V77, P232, DOI 10.1016/j.catena.2009.01.003; Imhoff S, 2002, SOIL SCI SOC AM J, V66, P1656, DOI 10.2136/sssaj2002.1656; Jozefaciuk G, 2014, GEODERMA, V221, P1, DOI 10.1016/j.geoderma.2014.01.020; Lado M, 2004, SOIL SCI SOC AM J, V68, P1992, DOI 10.2136/sssaj2004.1992; Lu SG, 2014, CATENA, V123, P79, DOI 10.1016/j.catena.2014.07.010; Martin MA, 2002, SOIL TILL RES, V64, P113, DOI 10.1016/S0167-1987(01)00249-5; Mbagwu J. S. C., 2006, International Agrophysics, V20, P23; MCKEAGUE JA, 1966, CAN J SOIL SCI, V46, P13, DOI 10.4141/cjss66-003; MEHRA O. P., 1960, Proceedings 7th nat. Conf. Clays, V5, P317; Miller BA, 2012, SOIL SCI SOC AM J, V76, P1719, DOI 10.2136/sssaj2011.0303; Muggler CC, 1997, SOIL SCI, V162, P219, DOI 10.1097/00010694-199703000-00008; OADES JM, 1991, AUST J SOIL RES, V29, P815, DOI 10.1071/SR9910815; Peng X, 2015, SOIL TILL RES, V146, P89, DOI 10.1016/j.still.2014.04.003; PinheiroDick D, 1996, GEODERMA, V74, P49, DOI 10.1016/S0016-7061(96)00047-X; Pronk GJ, 2011, SOIL SCI SOC AM J, V75, P2158, DOI 10.2136/sssaj2010.0455; Saygin SD, 2012, APPL SOIL ECOL, V54, P1, DOI 10.1016/j.apsoil.2011.11.012; Sheldrick B.H., 1984, LAND RESOUR RES I CO, P84; Six J, 2004, SOIL TILL RES, V79, P7, DOI 10.1016/j.still.2004.03.008; Stanchi S, 2008, SOIL SCI SOC AM J, V72, P1418, DOI 10.2136/sssaj2007.0413N; Thomas G. W., 1982, Methods of soil analysis. Part 2. Chemical and microbiological properties, P159; Tisdall JM, 1982, J SOIL SCI, V62, P141, DOI DOI 10.1111/J.1365-2389.1982.TB01755.X; Vrdoljak G, 2002, DEV SOIL SCI, V28A, P197; Wang JG, 2016, CATENA, V137, P545, DOI 10.1016/j.catena.2015.11.001; Wu X, 2016, SOIL TILL RES, V157, P11, DOI 10.1016/j.still.2015.11.005; Wuddivira MN, 2007, EUR J SOIL SCI, V58, P722, DOI 10.1111/j.1365-2389.2006.00861.x; Xue W., 2013, SPSS STAT METHODS AP; Young IM, 2004, SCIENCE, V304, P1634, DOI 10.1126/science.1097394; Zhou H, 2013, GEODERMA, V195, P23, DOI 10.1016/j.geoderma.2012.11.003	42	13	14	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2016	11	8							e0160960	10.1371/journal.pone.0160960	http://dx.doi.org/10.1371/journal.pone.0160960			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4UN	27529618	Green Published, Green Submitted, gold			2022-12-27	WOS:000381476700034
J	Zhang, WS; Ning, N; Li, XJ; Niu, G; Bai, LJ; Guo, YM; Yang, J				Zhang, Weishan; Ning, Ning; Li, Xianjun; Niu, Gang; Bai, Lijun; Guo, Youmin; Yang, Jian			Changes of Brain Glucose Metabolism in the Pretreatment Patients with Non-Small Cell Lung Cancer: A Retrospective PET/CT Study	PLOS ONE			English	Article							DORSAL ATTENTION NETWORK; BREAST-CANCER; WHITE-MATTER; CHEMOTHERAPY; SYSTEM; IMPAIRMENT; DISORDER; WOMEN	Objective The tumor-to-brain communication has been emphasized by recent converging evidences. This study aimed to compare the difference of brain glucose metabolism between patients with non-small cell lung cancer (NSCLC) and control subjects. Methods NSCLC patients prior to oncotherapy and control subjects without malignancy confirmed by 6 months follow-up were collected and underwent the resting state 18F-fluoro-D-glucose (FDG) PET/CT. Normalized FDG metabolism was calculated by a signal intensity ratio of each brain region to whole brain. Brain glucose metabolism was compared between NSCLC patients and control group using two samples t-test and multivariate test by statistical parametric maps (SPM) software. Results Compared with the control subjects (n = 76), both brain glucose hyper- and hypometabolism regions with significant statistical differences (P<0.01) were found in the NSCLC patients (n = 83). The hypermetabolism regions (bilateral insula, putamen, pallidum, thalamus, hippocampus and amygdala, the right side of cerebellum, orbital part of right inferior frontal gyrus and vermis) were component parts of visceral to brain signal transduction pathways, and the hypometabolism regions (the left superior parietal lobule, bilateral inferior parietal lobule and left fusiform gyrus) lied in dorsal attention network and visuospatial function areas. Conclusions The changes of brain glucose metabolism exist in NSCLC patients prior to oncotherapy, which might be attributed to lung-cancer related visceral sympathetic activation and decrease of dorsal attention network function.	[Zhang, Weishan; Ning, Ning; Li, Xianjun; Niu, Gang; Guo, Youmin; Yang, Jian] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Radiol, Xian, Shaanxi, Peoples R China; [Ning, Ning] Xi An Jiao Tong Univ, Dept Nucl Med, Affiliated Hosp 2, Xian, Shaanxi, Peoples R China; [Li, Xianjun; Bai, Lijun; Yang, Jian] Xi An Jiao Tong Univ, Dept Biomed Engn, Key Lab Biomed Informat Engn, Minist Educ,Sch Life Sci & Technol, Xian, Shaanxi, Peoples R China	Xi'an Jiaotong University; Xi'an Jiaotong University; Xi'an Jiaotong University	Yang, J (corresponding author), Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Radiol, Xian, Shaanxi, Peoples R China.; Yang, J (corresponding author), Xi An Jiao Tong Univ, Dept Biomed Engn, Key Lab Biomed Informat Engn, Minist Educ,Sch Life Sci & Technol, Xian, Shaanxi, Peoples R China.	cjr.yangjian@vip.163.com	Li, Xianjun/G-4472-2018	Li, Xianjun/0000-0001-7690-9155	National Natural Science Foundation of China [81171317, 81471631]; New Century Excellent Talent Support Plan from Ministry of Education of China [NCET-11-0438]; Fund of the First Affiliated Hospital of Xi'an Jiaotong University [2014YK22]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); New Century Excellent Talent Support Plan from Ministry of Education of China; Fund of the First Affiliated Hospital of Xi'an Jiaotong University	This study has received funding by the National Natural Science Foundation of China (No. 81171317, 81471631), New Century Excellent Talent Support Plan from Ministry of Education of China (NCET-11-0438), and Fund of the First Affiliated Hospital of Xi'an Jiaotong University (2014YK22). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolphs R, 2008, CURR OPIN NEUROBIOL, V18, P166, DOI 10.1016/j.conb.2008.06.006; Akechi T, 2004, J CLIN ONCOL, V22, P1957, DOI 10.1200/JCO.2004.08.149; Armaiz-Pena GN, 2009, BRAIN BEHAV IMMUN, V23, P10, DOI 10.1016/j.bbi.2008.06.007; Benveniste H, 2012, INT J CLIN EXP MED, V5, P154; Blessing W, 1997, LOWER BRAINSTEM BODI; Craig AD, 2002, NAT REV NEUROSCI, V3, P655, DOI 10.1038/nrn894; Critchley HD, 2013, NEURON, V77, P624, DOI 10.1016/j.neuron.2013.02.008; D'Agata F, 2013, EJNMMI RES, V3, DOI 10.1186/2191-219X-3-22; de Ruiter MB, 2012, HUM BRAIN MAPP, V33, P2971, DOI 10.1002/hbm.21422; de Ruiter MB, 2011, HUM BRAIN MAPP, V32, P1206, DOI 10.1002/hbm.21102; Deprez S, 2012, J CLIN ONCOL, V30, P274, DOI 10.1200/JCO.2011.36.8571; Dumas JA, 2013, BRAIN IMAGING BEHAV, V7, P524, DOI 10.1007/s11682-013-9244-1; Golan H, 2009, J NUCL MED, V50, P1072, DOI 10.2967/jnumed.108.061085; Halpern BS, 2005, J NUCL MED, V46, P603; Hanaoka K, 2010, ANN NUCL MED, V24, P707, DOI 10.1007/s12149-010-0415-5; Hegel MT, 2006, CANCER-AM CANCER SOC, V107, P2924, DOI 10.1002/cncr.22335; Husted DS, 2006, PROG NEURO-PSYCHOPH, V30, P389, DOI 10.1016/j.pnpbp.2005.11.024; Kiebel SJ, 1997, NEUROIMAGE, V5, P271, DOI 10.1006/nimg.1997.0265; Li WL, 2015, CHINESE MED J-PEKING, V128, P301, DOI 10.4103/0366-6999.150089; Mravec B, 2008, SEMIN CANCER BIOL, V18, P150, DOI 10.1016/j.semcancer.2007.12.002; Nonokuma M, 2014, J NUCL MED, V55; Ondicova K, 2010, LANCET ONCOL, V11, P596, DOI 10.1016/S1470-2045(09)70337-7; Ptak R, 2010, J NEUROSCI, V30, P12557, DOI 10.1523/JNEUROSCI.2722-10.2010; Reddick WE, 2006, CANCER-AM CANCER SOC, V106, P941, DOI 10.1002/cncr.21679; Rivest S, 2009, NAT REV IMMUNOL, V9, P429, DOI 10.1038/nri2565; Tashiro M, 1999, PSYCHO-ONCOL, V8, P283, DOI 10.1002/(SICI)1099-1611(199907/08)8:4<283::AID-PON384>3.3.CO;2-1; Tashiro M, 2001, PSYCHO-ONCOL, V10, P541, DOI 10.1002/pon.548; Turrin NP, 2001, BRAIN RES BULL, V54, P443, DOI 10.1016/S0361-9230(01)00445-2; Vardy J, 2008, ANN ONCOL, V19, P623, DOI 10.1093/annonc/mdm500; Walker MS, 2006, PSYCHO-ONCOLOGY, V15, P684, DOI 10.1002/pon.997; Zhu JN, 2006, BRAIN RES REV, V52, P93, DOI 10.1016/j.brainresrev.2006.01.003	31	6	7	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2016	11	8							e0161325	10.1371/journal.pone.0161325	http://dx.doi.org/10.1371/journal.pone.0161325			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4UN	27529342	Green Published, gold, Green Submitted			2022-12-27	WOS:000381476700066
J	Mitsuda, SH; Shimizu, N				Mitsuda, Sho-hei; Shimizu, Noriaki			Epigenetic Repeat-Induced Gene Silencing in the Chromosomal and Extrachromosomal Contexts in Human Cells	PLOS ONE			English	Article							HOMOGENEOUSLY STAINING REGIONS; REPLICATION INITIATION REGION; MAMMALIAN-CELLS; DOUBLE MINUTES; DNA METHYLATION; CANCER-CELLS; AMPLIFICATION; HETEROCHROMATIN; CHROMATIN; TRANSCRIPTION	A plasmid bearing both a replication initiation region and a matrix attachment region is spontaneously amplified in transfected mammalian cells and generates plasmid repeats in the extrachromosomal double minutes (DMs) or the chromosomal homogeneously staining region (HSR). Generally, the repeat sequences are subject to repeat-induced gene silencing, the mechanism of which remains to be elucidated. Previous research showed that gene expression from the same plasmid repeat was higher from repeats located at DMs than at the HSR, which may reflect the extrachromosomal environment of the DMs. In the current study, plasmid repeats in both DMs and HSR were associated with repressive histone modifications (H3K9me3, H3K9me2), and the levels of repressive chromatin markers were higher in HSR than in DMs. Inactive chromatin is known to spread to neighboring regions in chromosome arm. Here, we found that such spreading also occurs in extrachromosomal DMs. Higher levels of active histone modifications (H3K9Ac, H3K4me3, and H3K79me2) were detected at plasmid repeats in DMs than in HSR. The level of DNA CpG methylation was generally low in both DMs and HSR; however, there were some hypermethylated copies within the population of repeated sequences, and the frequency of such copies was higher in DMs than in HSR. Together, these data suggest a "DNA methylation-core and chromatin-spread" model for repeat-induced gene silencing. The unique histone modifications at the extrachromosomal context are discussed with regard to the model.	[Mitsuda, Sho-hei; Shimizu, Noriaki] Hiroshima Univ, Grad Sch Biosphere Sci, Higashihiroshima, Hiroshima 7398521, Japan	Hiroshima University	Shimizu, N (corresponding author), Hiroshima Univ, Grad Sch Biosphere Sci, Higashihiroshima, Hiroshima 7398521, Japan.	shimizu@hiroshima-u.ac.jp			Japan Society for the Promotion of Science [23380203, 24658290, 26660293]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by a Grant-in-Aid for Scientific Research (B) (23380203) and a Grant-in-Aid for Challenging Exploratory Research (24658290, 26660293), both from the Japan Society for the Promotion of Science (https://www.jsps.go.jp/english/) to N.S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertson DG, 2006, TRENDS GENET, V22, P447, DOI 10.1016/j.tig.2006.06.007; Araki Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041787; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bushey AM, 2008, MOL CELL, V32, P1, DOI 10.1016/j.molcel.2008.08.017; Carey MF, 2009, CHROMATIN IMMUNOPECI, V2009; Deaton AM, 2011, GENE DEV, V25, P1010, DOI 10.1101/gad.2037511; Ehrlich M, 2009, EPIGENOMICS-UK, V1, P239, DOI 10.2217/EPI.09.33; Fu HQ, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003542; Fukagawa T, 2004, NAT CELL BIOL, V6, P784, DOI 10.1038/ncb1155; Fukuma M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153338; Garrick D, 1998, NAT GENET, V18, P56, DOI 10.1038/ng0198-56; Grewal SIS, 2004, CURR OPIN CELL BIOL, V16, P230, DOI 10.1016/j.ceb.2004.04.002; Harada S, 2011, NUCLEIC ACIDS RES, V39, P958, DOI 10.1093/nar/gkq882; Henikoff S, 1998, BIOESSAYS, V20, P532, DOI 10.1002/(SICI)1521-1878(199807)20:7<532::AID-BIES3>3.3.CO;2-0; Itoh N, 1998, J CELL SCI, V111, P3275; Kanellopoulou C, 2005, GENE DEV, V19, P489, DOI 10.1101/gad.1248505; L'Abbate A, 2014, NUCLEIC ACIDS RES, V42, P9131, DOI 10.1093/nar/gku590; McBurney MW, 2002, EXP CELL RES, V274, P1, DOI 10.1006/excr.2001.5443; Mondello C, 2010, MUTAT RES-REV MUTAT, V704, P29, DOI 10.1016/j.mrrev.2010.01.008; Nathanson DA, 2014, SCIENCE, V343, P72, DOI 10.1126/science.1241328; Noguchi C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052990; Okada N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077350; Shimizu N, 2005, EXP CELL RES, V302, P233, DOI 10.1016/j.yexcr.2004.09.001; Shimizu N, 2003, CANCER RES, V63, P5281; Shimizu N, 1998, J CELL BIOL, V140, P1307, DOI 10.1083/jcb.140.6.1307; Shimizu N, 2009, CYTOGENET GENOME RES, V124, P312, DOI 10.1159/000218135; Shimizu N, 2001, EXP CELL RES, V268, P201, DOI 10.1006/excr.2001.5286; Shimizu N, 2001, CANCER RES, V61, P6987; Shimizu N, 2007, J CELL BIOCHEM, V102, P515, DOI 10.1002/jcb.21313; Shimizu N, 2007, GENE CHROMOSOME CANC, V46, P865, DOI 10.1002/gcc.20473; Solovei I, 2000, GENE CHROMOSOME CANC, V29, P297, DOI 10.1002/1098-2264(2000)9999:9999<::AID-GCC1046>3.0.CO;2-H; Soppe WJJ, 2002, EMBO J, V21, P6549, DOI 10.1093/emboj/cdf657; Tanaka SS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103439; Utani KI, 2007, MOL CANCER RES, V5, P695, DOI 10.1158/1541-7786.MCR-07-0031; Utani K, 2009, NUCLEIC ACIDS RES, V37, P393, DOI 10.1093/nar/gkn970; VONHOFF DD, 1988, P NATL ACAD SCI USA, V85, P4804; Wang FW, 2006, MOL CELL BIOL, V26, P4028, DOI 10.1128/MCB.02189-05; Yoshimura H, 2011, PROTEIN EXPRES PURIF, V80, P41, DOI 10.1016/j.pep.2011.05.009; Zhang WL, 2008, PLANT CELL, V20, P25, DOI 10.1105/tpc.107.057083	39	14	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2016	11	8							e0161288	10.1371/journal.pone.0161288	http://dx.doi.org/10.1371/journal.pone.0161288			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4SL	27525955	Green Published, Green Submitted, gold			2022-12-27	WOS:000381471100052
J	Miyazaki, S; Tashiro, F; Miyazaki, J				Miyazaki, Satsuki; Tashiro, Fumi; Miyazaki, Jun-ichi			Transgenic Expression of a Single Transcription Factor Pdx1 Induces Transdifferentiation of Pancreatic Acinar Cells to Endocrine Cells in Adult Mice	PLOS ONE			English	Article							BETA-CELL; EXOCRINE PANCREAS; RAT PANCREAS; ALPHA-CELLS; IN-VITRO; GLUCOSE-TOLERANCE; MOUSE PANCREAS; NEOGENESIS; REGENERATION; DIFFERENTIATION	A promising approach to new diabetes therapies is to generate beta cells from other differentiated pancreatic cells in vivo. Because the acinar cells represent the most abundant cell type in the pancreas, an attractive possibility is to reprogram acinar cells into beta cells. The transcription factor Pdx1 (Pancreas/duodenum homeobox protein 1) is essential for pancreatic development and cell lineage determination. Our objective is to examine whether exogenous expression of Pdx1 in acinar cells of adult mice might induce reprogramming of acinar cells into beta cells. We established a transgenic mouse line in which Pdx1 and EGFP (enhanced green fluorescent protein) could be inducibly expressed in the acinar cells. After induction of Pdx1, we followed the acinar cells for their expression of exocrine and endocrine markers using cell-lineage tracing with EGFP. The acinar cell-specific expression of Pdx1 in adult mice reprogrammed the acinar cells as endocrine precursor cells, which migrated into the pancreatic islets and differentiated into insulin-,somatostatin-, or PP (pancreatic polypeptide)-producing endocrine cells, but not into glucagon-producing cells. When the mice undergoing such pancreatic reprogramming were treated with streptozotocin (STZ), the newly generated insulin-producing cells were able to ameliorate STZ-induced diabetes. This paradigm of in vivo reprogramming indicates that acinar cells hold promise as a source for new islet cells in regenerative therapies for diabetes.	[Miyazaki, Satsuki; Tashiro, Fumi; Miyazaki, Jun-ichi] Osaka Univ, Grad Sch Med, Div Stem Cell Regulat Res, Suita, Osaka 5650871, Japan	Osaka University	Miyazaki, J (corresponding author), Osaka Univ, Grad Sch Med, Div Stem Cell Regulat Res, Suita, Osaka 5650871, Japan.	jimiyaza@nutri.med.osaka-u.ac.jp	Miyazaki, Jun-ichi/N-1976-2015	Miyazaki, Jun-ichi/0000-0003-2475-589X; Miyazaki, Satsuki/0000-0003-1781-1590	Ministry of Education, Culture, Sports, Science and Technology of Japan [20790647, 25860213]; 21st Century COE "CICET" Program from the Ministry of Education, Culture, Sports, Science and Technology of Japan; NICHD; University of Iowa, Department of Biological Sciences (Iowa City, IA 52242)	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); 21st Century COE "CICET" Program from the Ministry of Education, Culture, Sports, Science and Technology of Japan; NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); University of Iowa, Department of Biological Sciences (Iowa City, IA 52242)	This research was supported by Grants-in-Aid (20790647 and 25860213 to SM) and in part by the 21st Century COE "CICET" Program (to JM) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (http://www-shinsei.jsps.go.jp/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Rat anti-CK19 monoclonal antibody (TROMA III) and mouse anti-Nkx6.1 monoclonal antibody (N55A10) were obtained from the Developmental Studies Hybridoma Bank (DSHB) developed under the auspices of the NICHD and maintained by the University of Iowa, Department of Biological Sciences (Iowa City, IA 52242). We are grateful to Dr. Eiji Yamato and Mr. Masafumi Ashida for helpful discussion and excellent technical assistance, respectively. We acknowledge the editorial assistance of Drs. Leslie A. Miglietta and Grace E. Gray of Clarity Editing.	Artner I, 2010, DIABETES, V59, P2530, DOI 10.2337/db10-0190; Baeyens L, 2005, DIABETOLOGIA, V48, P49, DOI 10.1007/s00125-004-1606-1; Baeyens L, 2014, NAT BIOTECHNOL, V32, P76, DOI 10.1038/nbt.2747; Bertelli E, 1997, AM J PHYSIOL-CELL PH, V273, pC1641, DOI 10.1152/ajpcell.1997.273.5.C1641; Bonner-Weir S, 2000, ENDOCRINOLOGY, V141, P1926, DOI 10.1210/en.141.6.1926; BONNERWEIR S, 1993, DIABETES, V42, P1715, DOI 10.2337/diabetes.42.12.1715; Bouwens L, 2005, PHYSIOL REV, V85, P1255, DOI 10.1152/physrev.00025.2004; Chung CH, 2010, STEM CELLS, V28, P1630, DOI 10.1002/stem.482; DELISLE RC, 1990, EUR J CELL BIOL, V51, P64; Desai BM, 2007, J CLIN INVEST, V117, P971, DOI 10.1172/JCI29988; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; Goodyer WR, 2012, DEV CELL, V23, P21, DOI 10.1016/j.devcel.2012.05.014; Grippo PJ, 2002, GENESIS, V32, P277, DOI 10.1002/gene.10080; Gu DL, 1997, PANCREAS, V15, P246, DOI 10.1097/00006676-199710000-00005; GU DL, 1993, DEVELOPMENT, V118, P33; Guz Y, 2001, ENDOCRINOLOGY, V142, P4956, DOI 10.1210/en.142.11.4956; Habener JF, 2005, ENDOCRINOLOGY, V146, P1025, DOI 10.1210/en.2004-1576; HALL PA, 1992, J PATHOL, V166, P97, DOI 10.1002/path.1711660203; Heller RS, 2001, DIABETES, V50, P1553, DOI 10.2337/diabetes.50.7.1553; Inada A, 2008, P NATL ACAD SCI USA, V105, P19915, DOI 10.1073/pnas.0805803105; JONSSON J, 1994, NATURE, V371, P606, DOI 10.1038/371606a0; Lardon J, 2004, VIRCHOWS ARCH, V444, P61, DOI 10.1007/s00428-003-0930-z; LAVINE RL, 1971, DIABETES, V20, P134, DOI 10.2337/diab.20.3.134; Li WD, 2014, NAT BIOTECHNOL, V32, P1223, DOI 10.1038/nbt.3082; Minami K, 2005, P NATL ACAD SCI USA, V102, P15116, DOI 10.1073/pnas.0507567102; Miyatsuka T, 2006, GENE DEV, V20, P1435, DOI 10.1101/gad.1412806; Miyazaki S, 2004, DIABETES, V53, P1030, DOI 10.2337/diabetes.53.4.1030; Miyazaki S, 2005, BIOCHEM BIOPH RES CO, V338, P1083, DOI 10.1016/j.bbrc.2005.10.054; Miyazaki S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047536; Montanya E, 2000, DIABETES, V49, P1341, DOI 10.2337/diabetes.49.8.1341; Offield MF, 1996, DEVELOPMENT, V122, P983; Pan FC, 2013, DEVELOPMENT, V140, P751, DOI 10.1242/dev.090159; Pedersen IL, 2006, J HISTOCHEM CYTOCHEM, V54, P567, DOI 10.1369/jhc.5A6827.2006; Rankin MM, 2013, DIABETES, V62, P1634, DOI 10.2337/db12-0848; Ritz-Laser B, 2003, DIABETOLOGIA, V46, P810, DOI 10.1007/s00125-003-1115-7; Rooman I, 2000, DIABETOLOGIA, V43, P907, DOI 10.1007/s001250051468; Rooman I, 2001, GASTROENTEROLOGY, V121, P940, DOI 10.1053/gast.2001.27998; ROSENBERG L, 1995, CELL TRANSPLANT, V4, P371, DOI 10.1016/0963-6897(95)00020-X; Rosenberg L, 1998, MICROSC RES TECHNIQ, V43, P337, DOI 10.1002/(SICI)1097-0029(19981115)43:4<337::AID-JEMT8>3.0.CO;2-U; Sander M, 2000, DEVELOPMENT, V127, P5533; Sangan CB, 2010, BIOESSAYS, V32, P881, DOI 10.1002/bies.201000074; Schaffer AE, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003274; Sharma A, 1999, DIABETES, V48, P507, DOI 10.2337/diabetes.48.3.507; Strobel O, 2007, GASTROENTEROLOGY, V133, P1999, DOI 10.1053/j.gastro.2007.09.009; Suzuki T, 2003, ARCH HISTOL CYTOL, V66, P347, DOI 10.1679/aohc.66.347; Taniguchi H, 2003, GENE THER, V10, P15, DOI 10.1038/sj.gt.3301846; Thorel F, 2010, NATURE, V464, P1149, DOI 10.1038/nature08894; Waguri M, 1997, DIABETES, V46, P1281, DOI 10.2337/diabetes.46.8.1281; Xiao XW, 2013, J CLIN INVEST, V123, P2207, DOI 10.1172/JCI66323; Xu XB, 2008, CELL, V132, P197, DOI 10.1016/j.cell.2007.12.015; Yang YP, 2011, GENE DEV, V25, P1680, DOI 10.1101/gad.16875711; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314	52	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2016	11	8							e0161190	10.1371/journal.pone.0161190	http://dx.doi.org/10.1371/journal.pone.0161190			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4SL	27526291	gold, Green Submitted, Green Published			2022-12-27	WOS:000381471100041
J	Bai, ZM; Zhang, HL; Li, N; Bai, ZY; Zhang, LL; Xue, ZC; Jiang, HT; Song, Y; Zhou, DR				Bai, Zhimao; Zhang, Honglin; Li, Na; Bai, Zhiyu; Zhang, Liling; Xue, Zhencheng; Jiang, Haitao; Song, Yuan; Zhou, Dongrui			Impact of Environmental Microbes on the Composition of the Gut Microbiota of Adult BALB/c Mice	PLOS ONE			English	Article							T-CELL RESPONSES; INTESTINAL FLORA; INFANTS; ECOLOGY; COLONIZATION; DERMATITIS; LIFE	To investigate the impact of microbes within the living environment on the gut microbiota of adults, we raised three groups of BALB/c mice from 3-4 weeks age in the same specificpathogen- free animal room for 8 weeks. The control group lived in cages with sterilized bedding (pelletized cardboard), the probiotics group had three probiotics added to the sterilized bedding, and the intestinal microbes (IM) group had the intestinal microbes of a healthy goat added to the bedding. All other variables such as diet, age, genetic background, physiological status, original gut microbiota, and living room were controlled. Using high-throughput sequencing of the 16S rRNA gene, we observed that the control and probiotics groups had similar diversity and richness of gut microbiota. The two groups had significantly lower diversity than the IM group. We also observed that the IM group had a specific structure of gut microbial community compared with the control and probiotics groups. However, the dominate bacteria changed slightly upon exposure to intestinal microbes, and the abundance of the non-dominate species changed significantly. In addition, exposure to intestinal microbes inhibited DNFB-induced elevation of serum IgE levels. Our results provide new evidence in support of the microflora and hygiene hypotheses.	[Bai, Zhimao] Southeast Univ, Sch Publ Hlth, Key Lab Environm Med Engn, Minist Educ, Nanjing, Jiangsu, Peoples R China; [Zhang, Honglin; Zhang, Liling; Xue, Zhencheng; Jiang, Haitao] Nanjing Xiaozhuang Univ, Coll Food Sci, Nanjing, Jiangsu, Peoples R China; [Li, Na; Zhou, Dongrui] Southeast Univ, Key Lab Child Dev & Learning Sci, Nanjing, Jiangsu, Peoples R China; [Li, Na; Zhou, Dongrui] Southeast Univ, Suzhou Res Inst, Suzhou, Jiangsu, Peoples R China; [Bai, Zhiyu] Chengde Med Coll, Affiliated Hosp, Dept Resp Med, Chengde, Hebei, Peoples R China; [Song, Yuan] Suzhou Municipal Hosp, Dept Child Hlth, Suzhou, Jiangsu, Peoples R China	Southeast University - China; Nanjing Xiaozhuang University; Southeast University - China; Southeast University - China; Chengde Medical University	Zhou, DR (corresponding author), Southeast Univ, Key Lab Child Dev & Learning Sci, Nanjing, Jiangsu, Peoples R China.; Zhou, DR (corresponding author), Southeast Univ, Suzhou Res Inst, Suzhou, Jiangsu, Peoples R China.; Song, Y (corresponding author), Suzhou Municipal Hosp, Dept Child Hlth, Suzhou, Jiangsu, Peoples R China.	yuanyuan-sy@163.com; junbai1013@seu.edu.cn			Suzhou Science and Technology Support Program [SS201337, SNG201449]	Suzhou Science and Technology Support Program	This work was supported by Suzhou Science and Technology Support Program, Grants No. SS201337, (http://www.szkj.gov.cn/default.htm) and Suzhou Science and Technology Support Program, Grants No. SNG201449, (http://www.szkj.gov.cn/default.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adlerberth I, 2009, ACTA PAEDIATR, V98, P229, DOI 10.1111/j.1651-2227.2008.01060.x; ADLERBERTH I, 1991, ACTA PAEDIATR SCAND, V80, P602, DOI 10.1111/j.1651-2227.1991.tb11917.x; Angenent LT, 2005, P NATL ACAD SCI USA, V102, P4860, DOI 10.1073/pnas.0501235102; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cookson W, 2004, NAT REV IMMUNOL, V4, P978, DOI 10.1038/nri1500; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; Gaboriau-Routhiau V, 2009, IMMUNITY, V31, P677, DOI 10.1016/j.immuni.2009.08.020; Geuking MB, 2011, IMMUNITY, V34, P794, DOI 10.1016/j.immuni.2011.03.021; HOOGKAMPKORSTANJE JAA, 1979, A VAN LEEUW J MICROB, V45, P35, DOI 10.1007/BF00400776; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Kang DW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068322; Kim DY, 2009, J ETHNOPHARMACOL, V122, P567, DOI 10.1016/j.jep.2008.12.029; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Markle JGM, 2013, SCIENCE, V339, P1084, DOI 10.1126/science.1233521; McNulty NP, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002701; Olszak T, 2012, SCIENCE, V336, P489, DOI 10.1126/science.1219328; ROTIMI VO, 1985, J HYG-CAMBRIDGE, V94, P309, DOI 10.1017/S0022172400061532; Round JL, 2010, P NATL ACAD SCI USA, V107, P12204, DOI 10.1073/pnas.0909122107; STARK PL, 1982, J MED MICROBIOL, V15, P189, DOI 10.1099/00222615-15-2-189; Tomimori Y, 2002, LAB INVEST, V82, P789, DOI 10.1097/01.LAB.0000018827.78602.F4; Trompette A, 2014, NAT MED, V20, P159, DOI 10.1038/nm.3444; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wold AE, 1998, ALLERGY, V53, P20, DOI 10.1111/j.1398-9995.1998.tb04953.x; Wu HJ, 2010, IMMUNITY, V32, P815, DOI 10.1016/j.immuni.2010.06.001; Zhou D, 2015, ENV MICROBIOLOGY	29	7	7	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2016	11	8							e0160568	10.1371/journal.pone.0160568	http://dx.doi.org/10.1371/journal.pone.0160568			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3LI	27518814	Green Published, gold, Green Submitted			2022-12-27	WOS:000381382100018
J	Keppel, AG; Breitburg, DL; Burrell, RB				Keppel, Andrew G.; Breitburg, Denise L.; Burrell, Rebecca B.			Effects of Co-Varying Diel-Cycling Hypoxia and pH on Growth in the Juvenile Eastern Oyster, Crassostrea virginica	PLOS ONE			English	Article							MYTILUS-EDULIS; OCEAN ACIDIFICATION; FRESH-WATER; HABITAT DEGRADATION; FOOD AVAILABILITY; DISSOLVED-OXYGEN; PATUXENT RIVER; PACIFIC OYSTER; CHESAPEAKE BAY; TEMPERATURE	Shallow water provides important habitat for many species, but also exposes these organisms to daily fluctuations in dissolved oxygen (DO) and pH caused by cycles in the balance between photosynthesis and respiration that can contribute to repeated, brief periods of hypoxia and low pH (caused by elevated pCO(2)). The amplitude of these cycles, and the severity and duration of hypoxia and hypercapnia that result, can be increased by eutrophication, and are predicted to worsen with climate change. We conducted laboratory experiments to test the effects of both diel-cycling and constant low DO and pH (elevated pCO(2)) on growth of the juvenile eastern oyster (Crassostrea virginica), an economically and ecologically important estuarine species. Severe diel-cycling hypoxia (to 0.5 mg O-2 L-1) reduced shell growth in juvenile oysters, as did constant hypoxia (1.2 and 2.0 mg O-2 L-1), although effects varied among experiments, oyster ages, and exposure durations. Dielcycling pH reduced growth only in experiments in which calcite saturation state cycled to <= 0.10 and only during the initial weeks of these experiments. In other cases, cycling pH sometimes led to increased growth rates. Comparisons of treatment effects across multiple weeks of exposure, and during a longer post-experiment field deployment, indicated that juvenile oysters can acclimate to, and in some cases compensate for initial reductions in growth. As a result, some ecosystem services dependent on juvenile oyster growth rates may be preserved even under severe cycling hypoxia and pH.	[Keppel, Andrew G.] US Naval Acad, Dept Oceanog, Annapolis, MD 21402 USA; [Keppel, Andrew G.; Breitburg, Denise L.; Burrell, Rebecca B.] Smithsonian Environm Res Ctr, Edgewater, MD USA	United States Department of Defense; United States Navy; United States Naval Academy; Smithsonian Institution; Smithsonian Environmental Research Center	Keppel, AG (corresponding author), US Naval Acad, Dept Oceanog, Annapolis, MD 21402 USA.; Keppel, AG (corresponding author), Smithsonian Environm Res Ctr, Edgewater, MD USA.	Keppel@usna.edu			NOAA Center for Sponsored Coastal Ocean Research [NA10NOS4780138]; Smithsonian Hunterdon and Johnson Endowments; NSF REU program	NOAA Center for Sponsored Coastal Ocean Research; Smithsonian Hunterdon and Johnson Endowments; NSF REU program(National Science Foundation (NSF)NSF - Office of the Director (OD))	This work was funded by a grant to Denise Breitburg from the NOAA Center for Sponsored Coastal Ocean Research (NA10NOS4780138). In addition, the Smithsonian Hunterdon and Johnson Endowments provided funding for technical staff and the NSF REU program supported some interns who worked on the project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altieri AH, 2014, CLIMATE CHANGE DEAD; American Public Health Association American Water Works Association Water Pollution Control Federation, 1992, STANDARD METHODS EXA; [Anonymous], 2007, CO2SYS XLS CALCULATO; BAKER SM, 1992, BIOL BULL, V182, P265, DOI 10.2307/1542120; Bartol IK, 1999, J EXP MAR BIOL ECOL, V237, P157, DOI 10.1016/S0022-0981(98)00175-0; Barton A, 2012, LIMNOL OCEANOGR, V57, P698, DOI 10.4319/lo.2012.57.3.0698; Bayne BL, 2002, MAR ECOL PROG SER, V232, P163, DOI 10.3354/meps232163; Bell GW, 2005, MAR BIOL, V146, P761, DOI 10.1007/s00227-004-1483-7; Beniash E, 2010, MAR ECOL PROG SER, V419, P95, DOI 10.3354/meps08841; BENSON BB, 1984, LIMNOL OCEANOGR, V29, P620, DOI 10.4319/lo.1984.29.3.0620; Bockmon EE, 2013, BIOGEOSCIENCES, V10, P5967, DOI 10.5194/bg-10-5967-2013; Bogue K, 2013, INTERACTIVE EFFECTS; Boleza KA, 2001, FISH SHELLFISH IMMUN, V11, P593, DOI 10.1006/fsim.2001.0339; Breitburg DL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116223; Breitburg DL, 1998, SUCCESSES, LIMITATIONS, AND FRONTIERS IN ECOSYSTEM SCIENCE, P416; Breitburg DL, 2003, ESTUARIES, V26, P280, DOI 10.1007/BF02695967; BREITBURG DL, 1992, ECOL MONOGR, V62, P525, DOI 10.2307/2937315; Brouwer M, 2007, J EXP MAR BIOL ECOL, V341, P16, DOI 10.1016/j.jembe.2006.10.049; BROWN JR, 1988, AQUACULTURE, V70, P253, DOI 10.1016/0044-8486(88)90100-7; Burnett LE, 1997, AM ZOOL, V37, P633; Burrell RB, 2015, LIMNOLOGY OCEANOGRAP; Carter JG, 1998, J PALEONTOL, V72, P991, DOI 10.1017/S0022336000027359; Clark V, 2014, EFFECTS DIEL CYCLING; DAVIS HC, 1956, BIOL BULL, V110, P117, DOI 10.2307/1538972; DEVOOYS CGN, 1978, COMP BIOCHEM PHYS A, V60, P343, DOI 10.1016/0300-9629(78)90259-1; Diaz RJ, 1995, OCEANOGR MAR BIOL, V33, P245; Dickson A.G., 2007, GUIDE BEST PRACTICES; Eby LA, 2005, MAR ECOL PROG SER, V291, P249, DOI 10.3354/meps291249; Eby LA, 2002, CAN J FISH AQUAT SCI, V59, P952, DOI 10.1139/F02-067; Ekstrom JA, 2015, NAT CLIM CHANGE, V5, P207, DOI 10.1038/NCLIMATE2508; Folt CL, 1999, LIMNOL OCEANOGR, V44, P864, DOI 10.4319/lo.1999.44.3_part_2.0864; Ford SE, 1996, J SHELLFISH RES, V15, P45; GABBOTT PA, 1973, J MAR BIOL ASSOC UK, V53, P269, DOI 10.1017/S0025315400022268; Gazeau F, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028554; Gobler CJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083648; Grabowski JH, 2007, THEOR ECOL SER, P281; Hargis William J. Jr, 1999, P329; Heugens EHW, 2001, CRIT REV TOXICOL, V31, P247, DOI 10.1080/20014091111695; Ivanina AV, 2009, AQUAT TOXICOL, V91, P245, DOI 10.1016/j.aquatox.2008.11.016; Ivanina AV, 2011, CHEMOSPHERE, V82, P377, DOI 10.1016/j.chemosphere.2010.09.075; JOKELA J, 1995, OECOLOGIA, V104, P122, DOI 10.1007/BF00365570; Jokela J., 1997, EXS, V82, P179; Jokela J, 1997, ECOLOGY, V78, P452; Keister JE, 2000, MAR ECOL PROG SER, V205, P43, DOI 10.3354/meps205043; KEMP WM, 1980, ESTUAR COAST MAR SCI, V11, P407, DOI 10.1016/S0302-3524(80)80065-X; Keppel A, 2014, EFFECTS COVARYING DI; Keppel AG, 2015, MAR ECOL PROG SER, V538, P169, DOI 10.3354/meps11479; Keppel G, 1991, DESIGN ANAL RES HDB; Kim TW, 2013, BIOGEOSCIENCES, V10, P7255, DOI 10.5194/bg-10-7255-2013; Lannig G, 2006, AQUAT TOXICOL, V79, P278, DOI 10.1016/j.aquatox.2006.06.017; Lee K, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL027207; Lenihan HS, 1998, ECOL APPL, V8, P128, DOI 10.2307/2641316; MALONE PG, 1967, LIMNOL OCEANOGR, V12, P432, DOI 10.4319/lo.1967.12.3.0432; Mann R, 2004, J SHELLFISH RES, V23, P41; McNatt RA, 2004, J EXP MAR BIOL ECOL, V311, P147, DOI 10.1016/j.jembe.2004.05.006; MDNR, 2013, EYES ON THE BAY; Melzner F, 2013, MAR BIOL, V160, P1875, DOI 10.1007/s00227-012-1954-1; Miller AW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005661; MILLERO FJ, 1979, GEOCHIM COSMOCHIM AC, V43, P1651, DOI 10.1016/0016-7037(79)90184-4; Mukherjee J, 2013, J EXP BIOL, V216, P4580, DOI 10.1242/jeb.094516; Najjar RG, 2010, ESTUAR COAST SHELF S, V86, P1, DOI 10.1016/j.ecss.2009.09.026; Newell RIE, 1988, ADV CHESAP BAY RES, V129, P536; NIXON SW, 1973, ECOL MONOGR, V43, P463, DOI 10.2307/1942303; Norkko J, 2005, MAR ECOL PROG SER, V298, P205, DOI 10.3354/meps298205; OSMAN RW, 1994, CHANGES IN FLUXES IN ESTUARIES: IMPLICATIONS FROM SCIENCE TO MANAGEMENT, P335; Portner HO, 2012, J THERM BIOL, V37, P547, DOI 10.1016/j.jtherbio.2012.06.009; Portner HO, 2004, J OCEANOGR, V60, P705, DOI 10.1007/s10872-004-5763-0; Portner HO, 2005, J GEOPHYS RES, P110; Rabalais NN, 2010, BIOGEOSCIENCES, V7, P585, DOI 10.5194/bg-7-585-2010; Rabalais NN, 2002, ANNU REV ECOL SYST, V33, P235, DOI 10.1146/annurev.ecolsys.33.010802.150513; Sanford E, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2681; Tanner CA, 2006, COMP BIOCHEM PHYS A, V144, P218, DOI 10.1016/j.cbpa.2006.02.042; Taylor JC, 2001, J EXP MAR BIOL ECOL, V258, P195, DOI 10.1016/S0022-0981(01)00215-5; Thomsen J, 2013, GLOBAL CHANGE BIOL, V19, P1017, DOI 10.1111/gcb.12109; Tseng YC, 2013, COMP BIOCHEM PHYS A, V165, P119, DOI 10.1016/j.cbpa.2013.02.005; Tyler RM, 2009, ESTUAR COAST, V32, P123, DOI 10.1007/s12237-008-9108-x; Vaquer-Sunyer R, 2010, LIMNOL OCEANOGR, V55, P1075, DOI 10.4319/lo.2010.55.3.1075; Volstad JH, 2008, J SHELLFISH RES, V27, P525, DOI 10.2983/0730-8000(2008)27[525:EOAMRF]2.0.CO;2; Waldbusser GG, 2011, ESTUAR COAST, V34, P221, DOI 10.1007/s12237-010-9307-0; WIDDOWS J, 1989, BIOL BULL, V177, P154, DOI 10.2307/1541843; Wilberg MJ, 2011, MAR ECOL PROG SER, V436, P131, DOI 10.3354/meps09161	81	25	27	2	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2016	11	8							e0161088	10.1371/journal.pone.0161088	http://dx.doi.org/10.1371/journal.pone.0161088			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT8TP	27548256	gold, Green Published, Green Submitted			2022-12-27	WOS:000381768400029
J	Cao, GD; Chen, K; Xiong, MM; Chen, B				Cao, Guo-dong; Chen, Ke; Xiong, Mao-ming; Chen, Bo			HER3, but Not HER4, Plays an Essential Role in the Clinicopathology and Prognosis of Gastric Cancer: A Meta-Analysis	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTORS; PROTEIN EXPRESSION; BREAST-CANCER; CORRESPONDING METASTASES; ACQUIRED-RESISTANCE; PRIMARY TUMORS; MESSENGER-RNA; FAMILY; SURVIVAL; EGFR	Background and Aim Human epidermal growth factor receptor (HER) family plays an important role in gastric cancer (GC), especially HER2. Too much attention has been paid to HER2; however, the functions of HER3 and HER4 overexpression in GC are always ignored. The clinicopathological and prognostic roles of HER3 and HER4 in GC are controversial. In this study, a systematic review and meta-analysis was conducted to evaluate the use of HER3 or HER4 as a predictor of clinicopathology and survival time in GC patients. Methods Eligible studies were searched on PubMed, Ovid, Web of Science, and Cochrane databases through multiple search strategies. Data collection and statistical analysis were carried out by the Revman 5.3 software. The Newcastle-Ottawa scale was used to assess the quality of included studies. Results A total of 448 studies about HER3 overexpression and GC, and 398 studies about HER4 overexpression and GC were searched. Of these, 5 eligible studies about HER3 including 1016 GC patients and 3 eligible studies about HER4 including 793 GC patients met the inclusion criteria. The results showed that HER3 and HER4 overexpression were significantly associated with depth of tumor invasion (OR = 0.44, 95% CI 0.29-0.67, P = 0.0002 and OR = 0.50, 95% CI 0.38-0.86, P = 0.007) and lymph node metastasis (OR = 0.40, 95% CI 0.20-0.77, P = 0.007 and OR = 0.57, 95% CI 0.38-0.86, P = 0.007), and HER3 overexpression reveals a tendency of later tumor node metastases (TNM) stage (OR = 0.50, 95% CI 0.22-1.15, P = 0.10) and predicts a worse survival time (RR = 0.71, 95% CI 0.61-0.84, P<0.00001), while HER4 overexpression had no correlation with TNM stage (OR = 0.60, 95% CI 0.20-1.78) and survival time (RR = 1.09, 95% CI 0.91-1.30). Conclusions This meta-analysis indicated that HER3 plays an essential role in the clinicopathology and prognosis of GC. However, HER4 may not be an ideal prognostic factor for GC.	[Cao, Guo-dong; Chen, Ke] Anhui Med Univ, Hefei 230022, Anhui, Peoples R China; [Xiong, Mao-ming; Chen, Bo] Anhui Med Univ, Affiliated Hosp 1, Dept Gen Surg, Hefei 230022, Anhui, Peoples R China	Anhui Medical University; Anhui Medical University	Xiong, MM; Chen, B (corresponding author), Anhui Med Univ, Affiliated Hosp 1, Dept Gen Surg, Hefei 230022, Anhui, Peoples R China.	anyixmm@163.com; chenbo831116@163.com	Cao, Guodong/AAJ-1089-2020	Cao, Guo-Dong/0000-0002-4796-6430				Amin DN, 2010, SEMIN CELL DEV BIOL, V21, P944, DOI 10.1016/j.semcdb.2010.08.007; Bang YJ, 2010, LANCET, V376, P1302; Begnami MD, 2011, J CLIN ONCOL, V29, P3030, DOI 10.1200/JCO.2010.33.6313; Bieche I, 2003, INT J CANCER, V106, P758, DOI 10.1002/ijc.11273; Campbell MR, 2010, CLIN CANCER RES, V16, P1373, DOI 10.1158/1078-0432.CCR-09-1218; Cha Y, 2014, ANTICANCER RES, V34, P4275; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Ema A, 2014, CANCER SCI, V105, P1591, DOI 10.1111/cas.12556; Hayashi M, 2008, CLIN CANCER RES, V14, P7843, DOI 10.1158/1078-0432.CCR-08-1064; He XX, 2015, J CLIN PATHOL, V68, P374, DOI 10.1136/jclinpath-2014-202657; Hirata A, 2005, CANCER RES, V65, P4253, DOI 10.1158/0008-5472.CAN-04-2748; Howe LR, 2011, CANCER PREV RES, V4, P1149, DOI 10.1158/1940-6207.CAPR-11-0334; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Iida M, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-242; Jaiswal BS, 2013, CANCER CELL, V23, P603, DOI 10.1016/j.ccr.2013.04.012; Jathal Maitreyee K., 2011, Immunology Endocrine & Metabolic Agents in Medicinal Chemistry, V11, P131; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Kamangar F, 2006, J CLIN ONCOL, V24, P2137, DOI 10.1200/JCO.2005.05.2308; Kapitanovic S, 2000, J CANCER RES CLIN, V126, P205, DOI 10.1007/s004320050034; Kataoka H, 1998, LIFE SCI, V63, P553, DOI 10.1016/S0024-3205(98)00306-3; Koizumi W, 2008, LANCET ONCOL, V9, P215, DOI 10.1016/S1470-2045(08)70035-4; Kountourakis P, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-46; Lesma E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003558; Li Gang, 2013, Zhonghua Wei Chang Wai Ke Za Zhi, V16, P668; Li X, 2015, TECHNOL CANC RES TRE; Liang JW, 2014, TUMOR BIOL, V35, P4849, DOI 10.1007/s13277-014-1636-3; Low C H, 1983, Ann Acad Med Singap, V12, P570; MANTEL N, 1959, J NATL CANCER I, V22, P719; Nielsen TO, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094606; Olayioye MA, 2000, EMBO J, V19, P3159, DOI 10.1093/emboj/19.13.3159; Reschke M, 2008, CLIN CANCER RES, V14, P5188, DOI 10.1158/1078-0432.CCR-08-0186; SAKAI K, 1986, J NATL CANCER I, V77, P1047; Sakuramoto S, 2007, NEW ENGL J MED, V357, P1810, DOI 10.1056/NEJMoa072252; SANIDAS EE, 1993, INT J CANCER, V54, P935, DOI 10.1002/ijc.2910540612; Sassen A, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1843; Schlessinger J, 2004, SCIENCE, V306, P1506, DOI 10.1126/science.1105396; Seo AN, 2015, VIRCHOWS ARCH, V466, P645, DOI 10.1007/s00428-015-1747-2; Sithanandam G, 2008, CANCER GENE THER, V15, P413, DOI 10.1038/cgt.2008.15; Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z; Suo Z, 2002, J PATHOL, V196, P17, DOI 10.1002/path.1003; Tang DQ, 2015, ONCOTARGETS THER, V8, P7, DOI 10.2147/OTT.S70922; Van Cutsem E, 2006, J CLIN ONCOL, V24, P4991, DOI 10.1200/JCO.2006.06.8429; Wang YD, 2015, ONCOTARGET, V6, P42868, DOI 10.18632/oncotarget.5998; Wei QC, 2008, ANN SURG ONCOL, V15, P1193, DOI 10.1245/s10434-007-9771-3; Wei QC, 2007, INT J ONCOL, V31, P493; Wheeler DL, 2008, ONCOGENE, V27, P3944, DOI 10.1038/onc.2008.19; Witton CJ, 2003, J PATHOL, V200, P290, DOI 10.1002/path.1370; Wu XY, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0903-x; Yamashita K, 2008, GASTRIC CANCER, V11, P111, DOI 10.1007/s10120-008-0466-7; Zhang XL, 2009, WORLD J SURG, V33, P2112, DOI 10.1007/s00268-009-0142-z; Zou Wen-Bin, 2015, Zhejiang Da Xue Xue Bao Yi Xue Ban, V44, P9	51	13	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0161219	10.1371/journal.pone.0161219	http://dx.doi.org/10.1371/journal.pone.0161219			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27536774	Green Published, gold, Green Submitted			2022-12-27	WOS:000381577000070
J	Devocht, EMJ; Janssen, AML; Chalupper, J; Stokroos, RJ; George, ELJ				Devocht, Elke M. J.; Janssen, A. Miranda L.; Chalupper, Josef; Stokroos, Robert J.; George, Erwin L. J.			Monaural Beamforming in Bimodal Cochlear Implant Users: Effect of (A)symmetric Directivity and Noise Type	PLOS ONE			English	Article							WORKING-MEMORY CAPACITY; DIRECTIONAL MICROPHONE; SPEECH RECOGNITION; HEARING-AID; BACKGROUND-NOISE; FLUCTUATING MASKERS; LISTENING EFFORT; PERFORMANCE; PERCEPTION; BENEFIT	Objective To evaluate monaural beamforming in bimodally aided cochlear implant (CI) users. Design The study enrolled twelve adult bimodal listeners with at least six months of CI-experience and using a contralateral hearing aid (HA) most of the daytime. Participants were uniformly fitted with the same CI speech processor and HA, giving access to an identical monaural beamformer in both ears. A within-subject repeated measures design evaluated three directional configurations [omnidirectional, asymmetric directivity (in CI alone) and symmetric directivity (in both CI and HA)] in two noise types [stationary and fluctuating]. Bimodal speech reception thresholds (SRT) as well as listening effort ratings were assessed in a diffuse noise field. Results Symmetric monaural beamforming provided a significant SRT improvement of 2.6 dB SNR, compared to 1.6 dB SNR for asymmetric monaural beamforming. Directional benefits were similarly observed in stationary and fluctuating noise. Directivity did not contribute to less listening effort in addition to improvement in speech intelligibility. Bimodal performance was about 7 dB SNR worse in fluctuating than in stationary noise. Conclusions Monaural beamforming provided substantial benefit for speech intelligibility in noise for bimodal listeners. The greatest benefit occurred when monaural beamforming was activated symmetrically in both CI and HA. Monaural beamforming does not bridge the gap between bimodal and normal hearing performance, especially in fluctuating noise. Results advocate further bimodal co-operation.	[Devocht, Elke M. J.; Janssen, A. Miranda L.; Stokroos, Robert J.; George, Erwin L. J.] Maastricht Univ, Med Ctr, Dept ENT Audiol, Sch Mental Hlth & Neurosci MHENS, Maastricht, Netherlands; [Janssen, A. Miranda L.] Maastricht Univ, Sch Publ Hlth & Primary Care CAPHRI, Dept Methodol & Stat, Maastricht, Netherlands; [Chalupper, Josef] Adv Bion European Res Ctr, Hannover, Germany	Maastricht University; Maastricht University	Devocht, EMJ (corresponding author), Maastricht Univ, Med Ctr, Dept ENT Audiol, Sch Mental Hlth & Neurosci MHENS, Maastricht, Netherlands.	elke.devocht@mumc.nl	stokroos, robert/AAC-9814-2021					Amlani A M, 2001, J Am Acad Audiol, V12, P202; Appleton J., 2014, HEAR REV, V21, P40; Bentler Ruth A, 2005, J Am Acad Audiol, V16, P473, DOI 10.3766/jaaa.16.7.7; Bentler Ruth A, 2004, J Am Acad Audiol, V15, P649, DOI 10.3766/jaaa.15.9.6; Bionics Advanced, 2012, WHIT PAP CLEAR VOIC; Blamey PJ, 2015, EAR HEARING, V36, P408, DOI 10.1097/AUD.0000000000000150; Brand T, 2002, J ACOUST SOC AM, V111, P2801, DOI 10.1121/1.1479152; Brockmeyer AM, 2011, J AM ACAD AUDIOL, V22, P65, DOI 10.3766/jaaa.22.2.2; Buchner A, 2009, AUDIOL NEURO-OTOL, V14, P8, DOI 10.1159/000206490; Buechner A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095542; Buechner A, 2010, OTOL NEUROTOL, V31, P1386, DOI 10.1097/MAO.0b013e3181f1cdc6; Chalupper J, 2013, CIAP LAK TAH CAL; Ching T Y C, 2007, Trends Amplif, V11, P161, DOI 10.1177/1084713807304357; Chung K, 2006, J ACOUST SOC AM, V120, P2216, DOI 10.1121/1.2258500; Cord MT, 2007, J AM ACAD AUDIOL, V18, P245, DOI 10.3766/jaaa.18.3.6; Cord MT, 2011, AM J AUDIOL, V20, P111, DOI 10.1044/1059-0889(2011/10-0035); Desjardins JL, 2016, J AM ACAD AUDIOL, V27, P29, DOI 10.3766/jaaa.15030; Devocht EMJ, 2015, AUDIOL NEURO-OTOL, V20, P383, DOI 10.1159/000439344; Elko G, 1995, IEEE ASSP WORKSH APP, P169, DOI DOI 10.1109/ASPAA.1995.482983; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Fetterman BL, 2002, OTOLARYNG HEAD NECK, V126, P257, DOI 10.1067/mhn.2002.123044; Francart T, 2013, EAR HEARING, V34, P685, DOI 10.1097/AUD.0b013e31829d14cb; Francart T, 2011, INT J AUDIOL, V50, P2, DOI 10.3109/14992027.2010.505582; Frohne-Buchner C, 2004, INT CONGR SER, V1273, P93, DOI 10.1016/j.ics.2004.08.047; Fu QJ, 2005, JARO-J ASSOC RES OTO, V6, P180, DOI 10.1007/s10162-005-5061-6; GeiSSler Gunnar, 2015, Cochlear Implants Int, V16, P69, DOI 10.1179/1754762814Y.0000000088; George ELJ, 2007, J ACOUST SOC AM, V121, P2362, DOI 10.1121/1.2642072; Gifford RH, 2010, J AM ACAD AUDIOL, V21, P441, DOI 10.3766/jaaa.21.7.3; Gifford RH, 2010, EAR HEARING, V31, P186, DOI 10.1097/AUD.0b013e3181c6b831; Hallgren M, 2005, INT J AUDIOL, V44, P574, DOI 10.1080/14992020500190011; Hersbach AA, 2012, EAR HEARING, V33, pE13, DOI 10.1097/AUD.0b013e31824b9e21; Holube I., 2011, ISAAR NYB DENM; Hornsby BWY, 2007, EAR HEARING, V28, P177, DOI 10.1097/AUD.0b013e3180312639; Houben R, 2015, TRENDS HEAR, V19, DOI 10.1177/2331216515583138; Houben R, 2014, INT J AUDIOL, V53, P760, DOI 10.3109/14992027.2014.920111; Illg A, 2014, OTOL NEUROTOL, V35, pE240, DOI 10.1097/MAO.0000000000000529; Kaandorp MW, 2015, INT J AUDIOL, V54, P48, DOI 10.3109/14992027.2014.945623; Kam ACS, 2012, CLIN EXP OTORHINOLAR, V5, pS89, DOI 10.3342/ceo.2012.5.S1.S89; Keidser G, 1999, SCAND AUDIOL, V28, P3, DOI 10.1080/010503999424860; Keidser G, 2013, J AM ACAD AUDIOL, V24, P955, DOI 10.3766/jaaa.24.10.7; Keidser G, 2008, AM J AUDIOL, V17, P136, DOI 10.1044/1059-0889(2008/07-0012); Kim JS, 2011, INT J AUDIOL, V50, P290, DOI 10.3109/14992027.2010.551786; Klasen TJ, 2005, INT CONF ACOUST SPEE, P29; Klink K.B., 2012, Z F R AUDIOLOGIE AUD, V51, P60; Kokkinakis K, 2014, J ACOUST SOC AM, V135, pEL47, DOI 10.1121/1.4831955; Kompis M, 2001, J ACOUST SOC AM, V109, P1134, DOI 10.1121/1.1338558; Kramer SE, 1996, AUDIOLOGY, V35, P277; Krueger B, 2008, OTOL NEUROTOL, V29, P509, DOI 10.1097/MAO.0b013e318171972f; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Luts H, 2010, J ACOUST SOC AM, V127, P1491, DOI 10.1121/1.3299168; Mackenzie E, 2005, EAR HEARING, V26, P669, DOI 10.1097/01.aud.0000188185.78217.c5; McCreery RW, 2012, AM J AUDIOL, V21, P295, DOI 10.1044/1059-0889(2012/12-0014); Mishra S, 2013, FRONT SYST NEUROSCI, V7, DOI 10.3389/fnsys.2013.00096; Morimoto M, 2004, J ACOUST SOC AM, V116, P1607, DOI 10.1121/1.1775276; Nelson PB, 2004, J ACOUST SOC AM, V115, P2286, DOI 10.1121/1.1703538; Ng EHN, 2013, INT J AUDIOL, V52, P433, DOI 10.3109/14992027.2013.776181; Noble W, 2008, EAR HEARING, V29, P112; Peterson P M, 1987, J Rehabil Res Dev, V24, P103; Qin MK, 2003, J ACOUST SOC AM, V114, P446, DOI 10.1121/1.1579009; Ricketts T, 1999, Am J Audiol, V8, P117, DOI 10.1044/1059-0889(1999/018); Ricketts TA, 2005, EAR HEARING, V26, P473, DOI 10.1097/01.aud.0000179691.21547.01; Ricketts TA, 2013, EAR HEARING, V34, P601, DOI 10.1097/AUD.0b013e3182886d1e; Ronnberg J, 2013, FRONT SYST NEUROSCI, V7, DOI 10.3389/fnsys.2013.00031; Rudner M, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/869726; Rudner M, 2012, J AM ACAD AUDIOL, V23, P577, DOI 10.3766/jaaa.23.7.7; Sarampalis A, 2009, J SPEECH LANG HEAR R, V52, P1230, DOI 10.1044/1092-4388(2009/08-0111); Schafer EC, 2011, INT J AUDIOL, V50, P871, DOI 10.3109/14992027.2011.622300; Scherf FWAC, 2014, ACTA OTO-LARYNGOL, V134, P1151, DOI 10.3109/00016489.2014.914244; Schulte M, 2008, HEARING COMMUNICTION, P1; Schulte M., 2007, PRESENTED AT EFAS; Sheffield SW, 2014, AUDIOL NEURO-OTOL, V19, P151, DOI 10.1159/000357588; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; SOEDE W, 1993, J ACOUST SOC AM, V94, P799, DOI 10.1121/1.408181; Spriet A, 2007, EAR HEARING, V28, P62, DOI 10.1097/01.aud.0000252470.54246.54; SUNG GS, 1975, ARCH OTOLARYNGOL, V101, P316; Theelen-van den Hoek FL, 2014, INT J AUDIOL, V53, P817, DOI 10.3109/14992027.2014.922223; Weissgerber T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126133; Wouters J, 2001, EAR HEARING, V22, P420, DOI 10.1097/00003446-200110000-00006; Wu YH, 2014, EAR HEARING, V35, P623, DOI 10.1097/AUD.0000000000000079; Zirn S, 2016, INT J AUDIOL, V55, P295, DOI 10.3109/14992027.2015.1128124; Zurek P. M., 1993, ACOUSTICAL FACTORS A, V2, P255	81	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0160829	10.1371/journal.pone.0160829	http://dx.doi.org/10.1371/journal.pone.0160829			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DT6ES	27537075	gold, Green Published, Green Submitted			2022-12-27	WOS:000381577000034
J	Mowry, AV; Kavazis, AN; Sirman, AE; Potts, WK; Hood, WR				Mowry, Annelise V.; Kavazis, Andreas N.; Sirman, Aubrey E.; Potts, Wayne K.; Hood, Wendy R.			Reproduction Does Not Adversely Affect Liver Mitochondrial Respiratory Function but Results in Lipid Peroxidation and Increased Antioxidants in House Mice	PLOS ONE			English	Article							OXIDOREDUCTASE COMPLEX-I; OXIDATIVE STRESS; RAT-LIVER; GLUTATHIONE-PEROXIDASE; SUPEROXIDE-PRODUCTION; DNA MUTATIONS; LIFE-SPAN; DYSFUNCTION; MECHANISMS; DAMAGE	Reproduction is thought to come at a cost to longevity. Based on the assumption that increased energy expenditure during reproduction is associated with increased free-radical production by mitochondria, oxidative damage has been suggested to drive this trade-off. We examined the impact of reproduction on liver mitochondrial function by utilizing post-reproductive and non-reproductive house mice (Mus musculus) living under semi-natural conditions. The age-matched post-reproductive and non-reproductive groups were compared after the reproductive females returned to a non-reproductive state, so that both groups were in the same physiological state at the time the liver was collected. Despite increased oxidative damage (p = 0.05) and elevated CuZnSOD (p = 0.002) and catalase (p = 0.04) protein levels, reproduction had no negative impacts on the respiratory function of liver mitochondria. Specifically, in a post-reproductive, maintenance state the mitochondrial coupling (i.e., respiratory control ratio) of mouse livers show no negative impacts of reproduction. In fact, there was a trend (p = 0.059) to suggest increased maximal oxygen consumption by liver mitochondria during the ADP stimulated state (i.e., state 3) in post-reproduction. These findings suggest that oxidative damage may not impair mitochondrial respiratory function and question the role of mitochondria in the trade-off between reproduction and longevity. In addition, the findings highlight the importance of quantifying the respiratory function of mitochondria in addition to measuring oxidative damage.	[Mowry, Annelise V.; Sirman, Aubrey E.; Hood, Wendy R.] Auburn Univ, Dept Biol Sci, Auburn, AL 36849 USA; [Kavazis, Andreas N.] Auburn Univ, Sch Kinesiol, Auburn, AL 36849 USA; [Potts, Wayne K.] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; [Mowry, Annelise V.] Stimlabs, Prod Dev, Roswell, GA USA; [Sirman, Aubrey E.] North Dakota State Univ, Dept Biol Sci, Fargo, ND USA	Auburn University System; Auburn University; Auburn University System; Auburn University; Utah System of Higher Education; University of Utah; North Dakota State University Fargo	Hood, WR (corresponding author), Auburn Univ, Dept Biol Sci, Auburn, AL 36849 USA.	wrhood@auburn.edu	Sirman, Aubrey/AAS-3982-2021	Hood, Wendy/0000-0002-8398-3908	Auburn University, Department of Biological Sciences; Auburn University, School of Kinesiology; American Society of Mammalogist; Alabama Academy of Sciences; National Science Foundation [DBI-1453784]; Auburn University, College of Science and Mathematics; Auburn University, College of Education; Department of Biological Sciences, School of Kinesiology, College of Science and Mathematics at Auburn University; Department of Biological Sciences, School of Kinesiology College of Education at Auburn University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM109500] Funding Source: NIH RePORTER	Auburn University, Department of Biological Sciences; Auburn University, School of Kinesiology; American Society of Mammalogist; Alabama Academy of Sciences; National Science Foundation(National Science Foundation (NSF)); Auburn University, College of Science and Mathematics; Auburn University, College of Education; Department of Biological Sciences, School of Kinesiology, College of Science and Mathematics at Auburn University; Department of Biological Sciences, School of Kinesiology College of Education at Auburn University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by Auburn University, Department of Biological Sciences and College of Science and Mathematics to WRH (http://www.auburn.edu/cosam/departments/biology/index.htm); Auburn University, School of Kinesiology and College of Education to ANK (http://www.education.auburn.edu/kinesiology); American Society of Mammalogist Grant-in-Aid to AVM (http://www.mammalsociety.org/grants); Alabama Academy of Sciences Research Grant to AVM (http://www.alabamaacademyofscience.org/students.php); and National Science Foundation DBI-1453784 to WRH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank the Hood lab undergraduates for assistance with husbandry and the Hood, Hill, and Wada labs and two anonymous reviewers for valuable comments that improved the manuscript. The authors acknowledge the Department of Biological Sciences, School of Kinesiology, College of Science and Mathematics and College of Education at Auburn University, American Society of Mammalogists, Alabama Academy of Sciences and National Science Foundation DBI-1453784 provided funding for this project.	BAST A, 1991, AM J MED, V91, pS2, DOI 10.1016/0002-9343(91)90278-6; Blount JD, 2016, BIOL REV, V91, P483, DOI 10.1111/brv.12179; Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162; Carre M, 2002, J BIOL CHEM, V277, P33664, DOI 10.1074/jbc.M203834200; Costantini D, 2008, ECOL LETT, V11, P1238, DOI 10.1111/j.1461-0248.2008.01246.x; D'Autreaux B, 2007, NAT REV MOL CELL BIO, V8, P813, DOI 10.1038/nrm2256; deHaan JB, 1996, HUM MOL GENET, V5, P283, DOI 10.1093/hmg/5.2.283; Dowling DK, 2009, P ROY SOC B-BIOL SCI, V276, P1737, DOI 10.1098/rspb.2008.1791; Dumas JF, 2003, BRIT J NUTR, V90, P969, DOI 10.1079/BJN2003980; Esworthy RS, 1997, ARCH BIOCHEM BIOPHYS, V340, P59, DOI 10.1006/abbi.1997.9901; Galloway CA, 2012, J GEN PHYSIOL, V139, P455, DOI 10.1085/jgp.201210771; Garratt M, 2011, P ROY SOC B-BIOL SCI, V278, P1098, DOI 10.1098/rspb.2010.1818; Hammond KA, 1997, J MAMMARY GLAND BIOL, V2, P243, DOI 10.1023/A:1026332304435; Hansford RG, 1997, J BIOENERG BIOMEMBR, V29, P89, DOI 10.1023/A:1022420007908; HIGASHI T, 1963, J BIOL CHEM, V238, P3945; Itsara LS, 2014, OXIDATIVE STRESS IS; Kavazis AN, 2009, FREE RADICAL BIO MED, V46, P842, DOI 10.1016/j.freeradbiomed.2009.01.002; KIRKWOOD TBL, 1979, PROC R SOC SER B-BIO, V205, P531, DOI 10.1098/rspb.1979.0083; Klein J, 1975, NATURAL HIST MOUSE H; Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125; Kussmaul L, 2006, P NATL ACAD SCI USA, V103, P7607, DOI 10.1073/pnas.0510977103; Lambert AJ, 2004, BIOCHEM J, V382, P511, DOI 10.1042/BJ20040485; Larsson NG, 2010, ANNU REV BIOCHEM, V79, P683, DOI 10.1146/annurev-biochem-060408-093701; LIPSKY NG, 1981, J BIOL CHEM, V256, P8652; Loeb LA, 2005, P NATL ACAD SCI USA, V102, P18769, DOI 10.1073/pnas.0509776102; MAKINEN MW, 1968, ARCH BIOCHEM BIOPHYS, V126, P75, DOI 10.1016/0003-9861(68)90561-4; Meagher S, 2000, P NATL ACAD SCI USA, V97, P3324, DOI 10.1073/pnas.060284797; Messer JI, 2004, AM J PHYSIOL-CELL PH, V286, pC565, DOI 10.1152/ajpcell.00146.2003; MIQUEL J, 1980, EXP GERONTOL, V15, P575, DOI 10.1016/0531-5565(80)90010-8; Monaghan P, 2009, ECOL LETT, V12, P75, DOI 10.1111/j.1461-0248.2008.01258.x; Muller FL, 2007, FREE RADICAL BIO MED, V43, P477, DOI 10.1016/j.freeradbiomed.2007.03.034; Okado-Matsumoto A, 2001, J BIOL CHEM, V276, P38388, DOI 10.1074/jbc.M105395200; Pichaud N, 2013, J EXP BIOL, V216, P2889, DOI 10.1242/jeb.082685; Pinto M, 2015, FREE RADICAL BIO MED, V85, P250, DOI 10.1016/j.freeradbiomed.2015.05.005; Powers SK, 2010, INT J SPORT NUTR EXE, V20, P2, DOI 10.1123/ijsnem.20.1.2; Raha S, 2000, TRENDS BIOCHEM SCI, V25, P502, DOI 10.1016/S0968-0004(00)01674-1; RCoreTeam, 2012, R LANG ENV STAT COMP; Ristow M, 2014, DOSE-RESPONSE, V12, P288, DOI 10.2203/dose-response.13-035.Ristow; Ristow M, 2011, FREE RADICAL BIO MED, V51, P327, DOI 10.1016/j.freeradbiomed.2011.05.010; Rossignol R, 2003, BIOCHEM J, V370, P751, DOI 10.1042/BJ20021594; Salin K, 2015, P ROY SOC B-BIOL SCI, V282, P14, DOI 10.1098/rspb.2015.1028; Schieber M, 2014, CURR BIOL, V24, pR453, DOI 10.1016/j.cub.2014.03.034; Seo AY, 2010, J CELL SCI, V123, P2533, DOI 10.1242/jcs.070490; SEWELL DL, 1975, AM J PHYSIOL, V228, P526, DOI 10.1152/ajplegacy.1975.228.2.526; Speakman JR, 2014, BIOESSAYS, V36, P93, DOI 10.1002/bies.201300108; Speakman JR, 1996, PHYSIOL ZOOL, V69, P746, DOI 10.1086/physzool.69.4.30164228	46	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0160883	10.1371/journal.pone.0160883	http://dx.doi.org/10.1371/journal.pone.0160883			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27537547	Green Published, Green Submitted, gold			2022-12-27	WOS:000381577000038
J	Shukla, A; Yang, YH; Madanikia, S; Ho, Y; Li, MM; Sanchez, V; Cataisson, C; Huang, J; Yuspa, SH				Shukla, Anjali; Yang, Yihan; Madanikia, Sara; Ho, Yan; Li, Mangmang; Sanchez, Vanesa; Cataisson, Christophe; Huang, Jing; Yuspa, Stuart H.			Elevating CLIC4 in Multiple Cell Types Reveals a TGF-Dependent Induction of a Dominant Negative Smad7 Splice Variant	PLOS ONE			English	Article							BETA SUPERFAMILY; GROWTH; SKIN; INHIBITION; KERATINOCYTES; NUCLEUS; DOMAIN; ROLES; FORM	CLIC4 (Chloride intracellular channel 4) belongs to a family of putative intracellular chloride channel proteins expressed ubiquitously in multiple tissues. CLIC4 is predominantly soluble and traffics between the cytoplasm and nucleus and participates in cell cycle control and differentiation. Transforming growth factor beta (TGF-beta) elevates CLIC4, which enhances TGF-beta signaling through CLIC4 mediated stabilization of phospho-Smad2/3. CLIC4 is essential for TGF-beta induced conversion of fibroblasts to myofibroblasts and expression of matrix proteins, signaling via the p38MAPK pathway. Therefore, regulation of TGF-beta signaling is a major mechanism by which CLIC4 modifies normal growth and differentiation. We now report that elevated CLIC4 alters Smad7 function, a feedback inhibitor of the TGF-beta pathway. Overexpression of CLIC4 in keratinocytes, mouse embryonic fibroblasts and other mouse and human cell types increases the expression of Smad7 Delta, a novel truncated form of Smad7. The alternatively spliced Smad7 Delta variant is missing 94bp in exon 4 of Smad 7 and is conserved between mouse and human cells. The deletion is predicted to lack the TGF-beta signaling inhibitory MH2 domain of Smad7. Treatment with exogenous TGF-beta 1 also enhances expression of Smad7 Delta that is amplified in the presence of CLIC4. While Smad7 expression inhibits TGF-beta signaling, exogenously expressed Smad7 Delta does not inhibit TGF-beta signaling as determined by TGF-beta dependent proliferation, reporter assays and phosphorylation of Smad proteins. Instead, exogenous Smad7 Delta acts as a dominant negative inhibitor of Smad7, thus increasing TGF-beta signaling. This discovery adds another dimension to the myriad ways by which CLIC4 modifies TGF-beta signaling.	[Shukla, Anjali; Yang, Yihan; Madanikia, Sara; Ho, Yan; Li, Mangmang; Sanchez, Vanesa; Cataisson, Christophe; Huang, Jing; Yuspa, Stuart H.] NCI, Lab Canc Biol & Genet, Ctr Canc Res, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Yuspa, SH (corresponding author), NCI, Lab Canc Biol & Genet, Ctr Canc Res, Bethesda, MD 20892 USA.	yuspas@mail.nih.gov		, Yan/0000-0003-4980-9663	NCI, CCR intramural program [BC005445-30]; NATIONAL CANCER INSTITUTE [ZIABC005445] Funding Source: NIH RePORTER	NCI, CCR intramural program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was conducted with funding to SHY from the NCI, CCR intramural program under project BC005445-30.	Akhurst RJ, 2012, NAT REV DRUG DISCOV, V11, P790, DOI 10.1038/nrd3810; Bai ST, 2000, J BIOL CHEM, V275, P8267, DOI 10.1074/jbc.275.12.8267; Bornstein S, 2007, MOL CARCINOGEN, V46, P660, DOI 10.1002/mc.20336; Casellas R, 1998, DEV BIOL, V198, P1; Hallgren O, 2012, FIBROGENESIS TISSUE, V5, DOI 10.1186/1755-1536-5-6; Hanyu A, 2001, J CELL BIOL, V155, P1017, DOI 10.1083/jcb.200106023; Hata A, 1998, GENE DEV, V12, P186, DOI 10.1101/gad.12.2.186; Hayashi H, 1997, CELL, V89, P1165, DOI 10.1016/S0092-8674(00)80303-7; He W, 2001, ONCOGENE, V20, P471, DOI 10.1038/sj.onc.1204117; Imamura T, 1997, NATURE, V389, P622, DOI 10.1038/39355; Jiang YF, 2000, BLOOD, V95, P3945; Konrad L, 2008, ANDROLOGIA, V40, P358, DOI 10.1111/j.1439-0272.2008.00869.x; Lichti U, 2008, NAT PROTOC, V3, P799, DOI 10.1038/nprot.2008.50; Littler DR, 2008, PROTEINS, V71, P364, DOI 10.1002/prot.21704; Littler DR, 2010, FEBS LETT, V584, P2093, DOI 10.1016/j.febslet.2010.01.027; Littler DR, 2005, FEBS J, V272, P4996, DOI 10.1111/j.1742-4658.2005.04909.x; Liu X, 2003, CANCER RES, V63, P7760; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Mochizuki T, 2004, J BIOL CHEM, V279, P31568, DOI 10.1074/jbc.M313977200; MOSES HL, 1992, MOL REPROD DEV, V32, P179, DOI 10.1002/mrd.1080320215; Nishita M, 1999, GENES CELLS, V4, P583, DOI 10.1046/j.1365-2443.1999.00285.x; Padmakumar VC, 2012, AM J PATHOL, V181, P74, DOI 10.1016/j.ajpath.2012.03.025; Schilling Stephen H., 2008, P45; SHIPLEY GD, 1986, CANCER RES, V46, P2068; Shukla A, 2014, ONCOGENE, V33, P842, DOI 10.1038/onc.2013.18; Shukla A, 2010, NUCLEUS-PHILA, V1, P144; Shukla A, 2009, NAT CELL BIOL, V11, P777, DOI 10.1038/ncb1885; Stolfi C, 2013, INT J MOL SCI, V14, P23774, DOI 10.3390/ijms141223774; Suh KS, 2012, CARCINOGENESIS, V33, P986, DOI 10.1093/carcin/bgs115; Suh KS, 2004, J BIOL CHEM, V279, P4632, DOI 10.1074/jbc.M311632200; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Ueberham U, 2009, INT J DEV NEUROSCI, V27, P501, DOI 10.1016/j.ijdevneu.2009.04.001; Wang XJ, 2001, MICROSC RES TECHNIQ, V52, P420, DOI 10.1002/1097-0029(20010215)52:4<420::AID-JEMT1027>3.3.CO;2-Z; Wendt MK, 2014, BREAST CANCER RES, V16, P1; Zhang SP, 2007, MOL CELL BIOL, V27, P4488, DOI 10.1128/MCB.01636-06; Zhang XY, 2013, CELL CYCLE, V12, P1279, DOI 10.4161/cc.24364	36	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0161410	10.1371/journal.pone.0161410	http://dx.doi.org/10.1371/journal.pone.0161410			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27536941	gold, Green Published			2022-12-27	WOS:000381577000102
J	Abd-Elrahman, I; Kosuge, H; Sadan, TW; Ben-Nun, Y; Meir, K; Rubinstein, C; Bogyo, M; McConnell, MV; Blum, G				Abd-Elrahman, Ihab; Kosuge, Hisanori; Sadan, Tommy Wises; Ben-Nun, Yael; Meir, Karen; Rubinstein, Chen; Bogyo, Matthew; McConnell, Michael V.; Blum, Galia			Cathepsin Activity-Based Probes and Inhibitor for Preclinical Atherosclerosis Imaging and Macrophage Depletion	PLOS ONE			English	Article							PROTEASE ACTIVITY	Background and Purpose Cardiovascular disease is the leading cause of death worldwide, mainly due to an increasing prevalence of atherosclerosis characterized by inflammatory plaques. Plaques with high levels of macrophage infiltration are considered "vulnerable" while those that do not have significant inflammation are considered stable; cathepsin protease activity is highly elevated in macrophages of vulnerable plaques and contributes to plaque instability. Establishing novel tools for non-invasive molecular imaging of macrophages in plaques could aid in preclinical studies and evaluation of therapeutics. Furthermore, compounds that reduce the macrophage content within plaques should ultimately impact care for this disease. Methods We have applied quenched fluorescent cathepsin activity-based probes (ABPs) to a murine atherosclerosis model and evaluated their use for in vivo imaging using fluorescent molecular tomography (FMT), as well as ex vivo fluorescence imaging and fluorescent microscopy. Additionally, freshly dissected human carotid plaques were treated with our potent cathepsin inhibitor and macrophage apoptosis was evaluated by fluorescent microscopy. Results We demonstrate that our ABPs accurately detect murine atherosclerotic plaques non-invasively, identifying cathepsin activity within plaque macrophages. In addition, our cathepsin inhibitor selectively induced cell apoptosis of 55%+/- 10% of the macrophage within excised human atherosclerotic plaques. Conclusions Cathepsin ABPs present a rapid diagnostic tool for macrophage detection in atherosclerotic plaque. Our inhibitor confirms cathepsin-targeting as a promising approach to treat atherosclerotic plaque inflammation.	[Abd-Elrahman, Ihab; Sadan, Tommy Wises; Ben-Nun, Yael; Blum, Galia] Hebrew Univ Jerusalem, Fac Med, Sch Pharm, Inst Drug Res, IL-9112001 Jerusalem, Israel; [Kosuge, Hisanori; McConnell, Michael V.] Stanford Univ, Sch Med, Div Cardiovasc Med, Stanford, CA 94305 USA; [Meir, Karen] Hadassah Med Ctr, Dept Pathol, IL-9112001 Jerusalem, Israel; [Rubinstein, Chen] Hadassah Med Ctr, Dept Vasc Surg, IL-9112001 Jerusalem, Israel; [Bogyo, Matthew] Stanford Univ, Sch Med, Dept Pathol & Microbiol & Immunol, Stanford, CA 94305 USA; [Kosuge, Hisanori] Tokyo Med & Dent Univ, Dept Cardiovasc Med, Bunkyo Ku, Tokyo 1138519, Japan	Hebrew University of Jerusalem; Stanford University; Hebrew University of Jerusalem; Hebrew University of Jerusalem; Stanford University; Tokyo Medical & Dental University (TMDU)	Blum, G (corresponding author), Hebrew Univ Jerusalem, Fac Med, Sch Pharm, Inst Drug Res, IL-9112001 Jerusalem, Israel.	galiabl@ekmd.huji.ac.il		Bogyo, Matthew/0000-0003-3753-4412; abd-elrahman, ihab/0000-0003-2012-2024; Ben-Nun, Yael/0000-0002-5123-649X; Blum, Galia/0000-0002-9374-2489; McConnell, Michael/0000-0001-8743-0932	United States -Israel Binational Science Foundation (BSF) [2009010, 2011480]; Israel Ministry of Health Chief Scientist [3-00000-7035]	United States -Israel Binational Science Foundation (BSF)(US-Israel Binational Science Foundation); Israel Ministry of Health Chief Scientist	The sources of funding for this work are: United States -Israel Binational Science Foundation (BSF) (2009010 and 2011480 to G.B., M.V.M. and M.B.), URL: BSF.org.il; The Israel Ministry of Health Chief Scientist, 3-00000-7035 to G.B., URL: https://www.old.health.gov.il.	Abd-Elrahman I, 2016, STROKE, V47, P1101, DOI 10.1161/STROKEAHA.115.011573; Ben-Aderet L, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0586-5; Blum G, 2005, NAT CHEM BIOL, V1, P203, DOI 10.1038/nchembio728; Blum G, 2007, NAT CHEM BIOL, V3, P668, DOI 10.1038/nchembio.2007.26; Calfon MA, 2010, J BIOMEDICAL OPTICS, V15; Croons V, 2010, CURR VASC PHARMACOL, V8, P495, DOI 10.2174/157016110791330816; Jaffer FA, 2008, CIRCULATION, V118, P1802, DOI 10.1161/CIRCULATIONAHA.108.785881; Kitagawa T, 2012, MOL IMAGING BIOL, V14, P315, DOI 10.1007/s11307-011-0495-1; Li W, 2009, ATHEROSCLEROSIS, V202, P92, DOI 10.1016/j.atherosclerosis.2008.03.027; MORENO PR, 1994, CIRCULATION, V90, P775, DOI 10.1161/01.CIR.90.2.775; Salpeter SJ, 2015, ONCOGENE, V34, P6066, DOI 10.1038/onc.2015.51; Sanman LE, 2016, ELIFE, V5, DOI 10.7554/eLife.13663; Skjot-Arkil H, 2010, ASSAY DRUG DEV TECHN, V8, P542, DOI 10.1089/adt.2009.0258; Terashima M, 2011, MOL IMAGING BIOL, V13, P1061, DOI 10.1007/s11307-010-0451-5; Weissleder R, 1999, NAT BIOTECHNOL, V17, P375, DOI 10.1038/7933	15	27	28	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2016	11	8							e0160522	10.1371/journal.pone.0160522	http://dx.doi.org/10.1371/journal.pone.0160522			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4YN	27532109	gold, Green Submitted, Green Published			2022-12-27	WOS:000381487600034
J	Diniz, WJD; Coutinho, LL; Tizioto, PC; Cesar, ASM; Gromboni, CF; Nogueira, ARA; de Oliveira, PSN; de Souza, MM; Regitano, LCD				da Silva Diniz, Wellison Jarles; Coutinho, Luiz Lehmann; Tizioto, Polyana Cristine; Mello Cesar, Aline Silva; Gromboni, Caio Fernando; Araujo Nogueira, Ana Rita; Neubern de Oliveira, Priscila Silva; de Souza, Marcela Maria; de Almeida Regitano, Luciana Correia			Iron Content Affects Lipogenic Gene Expression in the Muscle of Nelore Beef Cattle	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; QUANTITATIVE TRAIT LOCI; FATTY-ACID-COMPOSITION; COMPLEMENT FACTOR C3; LONGISSIMUS MUSCLE; LIPID-METABOLISM; SKELETAL-MUSCLE; MINERAL-CONTENT; PROTEIN; MEAT	Iron (Fe) is an essential mineral for metabolism and plays a central role in a range of biochemical processes. Therefore, this study aimed to identify differentially expressed (DE) genes and metabolic pathways in Longissimus dorsi (LD) muscle from cattle with divergent iron content, as well as to investigate the likely role of these DE genes in biological processes underlying beef quality parameters. Samples for RNA extraction for sequencing and iron, copper, manganese, and zinc determination were collected from LD muscles at slaughter. Eight Nelore steers, with extreme genomic estimated breeding values for iron content (Fe-GEBV), were selected from a reference population of 373 animals. From the 49 annotated DE genes (FDR<0.05) found between the two groups, 18 were up-regulated and 31 down-regulated for the animals in the low Fe-GEBV group. The functional enrichment analyses identified several biological processes, such as lipid transport and metabolism, and cell growth. Lipid metabolism was the main pathway observed in the analysis of metabolic and canonical signaling pathways for the genes identified as DE, including the genes FASN, FABP4, and THRSP, which are functional candidates for beef quality, suggesting reduced lipogenic activities with lower iron content. Our results indicate metabolic pathways that are partially influenced by iron, contributing to a better understanding of its participation in skeletal muscle physiology.	[da Silva Diniz, Wellison Jarles; de Souza, Marcela Maria] Univ Fed Sao Carlos, Dept Genet & Evolut, Sao Carlos, SP, Brazil; [Coutinho, Luiz Lehmann; Mello Cesar, Aline Silva] Univ Sao Paulo, ESALQ, Dept Anim Sci, Piracicaba, Brazil; [Tizioto, Polyana Cristine; Araujo Nogueira, Ana Rita; Neubern de Oliveira, Priscila Silva; de Almeida Regitano, Luciana Correia] Embrapa Pecuaria Sudeste, Sao Carlos, SP, Brazil; [Gromboni, Caio Fernando] Bahia Fed Inst Educ Sci & Technol, Ilheus, Brazil	Universidade Federal de Sao Carlos; Universidade de Sao Paulo; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Instituto Federal da Bahia (IFBA)	Regitano, LCD (corresponding author), Embrapa Pecuaria Sudeste, Sao Carlos, SP, Brazil.	luciana.regitano@embrapa.br	da Silva WJSD Diniz, Wellison J./G-6593-2014; Cesar, Aline Silva Mello/E-6887-2014; Coutinho, Luiz/P-5233-2019; de Almeida Regitano, Luciana Correia/C-7002-2012; Diniz, Wellison J. S./AAF-4556-2020; Nogueira, Ana Rita/D-9319-2012; Coutinho, Luiz L/C-8455-2012	da Silva WJSD Diniz, Wellison J./0000-0003-1082-5535; Cesar, Aline Silva Mello/0000-0001-9921-214X; Coutinho, Luiz/0000-0002-7266-8881; de Almeida Regitano, Luciana Correia/0000-0001-9242-8351; Diniz, Wellison J. S./0000-0003-1082-5535; Nogueira, Ana Rita/0000-0003-3648-2956; Coutinho, Luiz L/0000-0002-7266-8881; de Souza, Marcela Maria/0000-0001-7512-5893	Sao Paulo Research Foundation (FAPESP) [2014/12652-5]; National Council of Technological and Scientific Development (CNPq) fellowships; FAPESP [2012/23638-8]	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); National Council of Technological and Scientific Development (CNPq) fellowships(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	WJSD received a scholarship from Sao Paulo Research Foundation (FAPESP, grant numbers: 2014/12652-5 <http://www.bv.fapesp.br/pt/bolsas/154947/expressao-genica-diferencial-associada-ao-conteudo-de-ferro-no-musculo-emanimais-nelore/>. LAR and LC were granted by National Council of Technological and Scientific Development (CNPq) fellowships. The thematic FAPESP grant number is 2012/23638-8.	Ahlberg CM, 2014, MEAT SCI, V98, P804, DOI 10.1016/j.meatsci.2014.07.030; Barbu A, 2015, MOL IMMUNOL, V67, P101, DOI 10.1016/j.molimm.2015.02.027; Beard JL, 2001, J NUTR, V131, p568S, DOI 10.1093/jn/131.2.568S; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bosma M, 2012, HISTOCHEM CELL BIOL, V137, P205, DOI 10.1007/s00418-011-0888-x; Casas E, 2014, ANIM GENET, V45, P283, DOI 10.1111/age.12108; Cesar ASM, 2014, BMC GENET, V15, DOI 10.1186/1471-2156-15-39; Choi YM, 2009, LIVEST SCI, V122, P105, DOI 10.1016/j.livsci.2008.08.015; Collins JF, 2005, AM J PHYSIOL-GASTR L, V288, pG964, DOI 10.1152/ajpgi.00489.2004; Corominas J, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-843; Cunningham BA, 1998, THYROID, V8, P815, DOI 10.1089/thy.1998.8.815; Damon M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033763; Dauncey M. J., 2004, Muscle development of livestock animals: physiology, genetics and meat quality, P103, DOI 10.1079/9780851998114.0103; Davis M, 2013, NUTRIENTS, V5, P2611, DOI 10.3390/nu5072611; Davis MR, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-95; Davis MR, 2012, GENES NUTR, V7, P415, DOI 10.1007/s12263-011-0278-y; De Jager N, 2013, J ANIM SCI, V91, P1112, DOI 10.2527/jas.2012-5409; Duan Q, 2012, ANIM GENET, V43, P115, DOI 10.1111/j.1365-2052.2011.02224.x; Fang L, 2013, FASEB J, V27, P907, DOI 10.1096/fj.12-220905; Gardi C, 2002, BIOCHEM PHARMACOL, V64, P1139, DOI 10.1016/S0006-2952(02)01257-1; Garmyn AJ, 2011, J ANIM SCI, V89, P2849, DOI 10.2527/jas.2010-3497; Garrick DJ, 2009, GENSEL USER MANUAL P, P23; Goff LA, 2012, CUMMERBUND VISUALIZA, P42; Griffin MJ, 2004, IUBMB LIFE, V56, P595, DOI 10.1080/15216540400022474; Hamara K, 2013, MOL BIOL REP, V40, P5573, DOI 10.1007/s11033-013-2659-3; Hansen SL, 2010, J ANIM SCI, V88, P275, DOI 10.2527/jas.2009-1846; He H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064356; Hocquette Jean-Francois, 2006, Animal Science Papers and Reports, V24, P173; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jiang ZH, 2009, INT J BIOL SCI, V5, P528; Kamei A, 2010, PHYSIOL GENOMICS, V42, P149, DOI 10.1152/physiolgenomics.00150.2009; Kayan A, 2011, MEAT SCI, V89, P76, DOI 10.1016/j.meatsci.2011.04.001; Lee SH, 2002, J ANIM SCI, V80, P1999; Li YF, 2015, J BIOL CHEM, V290, P11918, DOI 10.1074/jbc.M115.645903; Lieu Pauline T., 2001, Molecular Aspects of Medicine, V22, P1, DOI 10.1016/S0098-2997(00)00006-6; Loor J. J., 2010, Energy and protein metabolism and nutrition. 3rd EAAP International Symposium on Energy and Protein Metabolism and Nutrition, Parma, Italy, 6-10 September, 2010, P59; Maier T, 2008, SCIENCE, V321, P1315, DOI 10.1126/science.1161269; Mateescu R, 2014, P BEEF IMPR FED RES, P87; Mateescu RG, 2013, J ANIM SCI, V91, P3593, DOI 10.2527/jas.2012-6079; Mateescu RG, 2013, J ANIM SCI, V91, P1067, DOI 10.2527/jas.2012-5744; Mitchelson Keith Richard, 2015, World J Biol Chem, V6, P162, DOI 10.4331/wjbc.v6.i3.162; Montgomery SB, 2010, NATURE, V464, P773, DOI 10.1038/nature08903; Morris CA, 2013, ANIM GENET, V44, P361, DOI 10.1111/age.12012; Oexle H, 1999, BBA-BIOENERGETICS, V1413, P99, DOI 10.1016/S0005-2728(99)00088-2; Oh DY, 2014, ASIAN AUSTRAL J ANIM, V27, P1373, DOI 10.5713/ajas.2014.14101; Peiris H, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/520316; Persson L, 2004, ARTERIOSCL THROM VAS, V24, P1062, DOI 10.1161/01.ATV.0000127302.24266.40; Pritchard M., 2013, SYNDROME, P173, DOI [10.5772/52977, DOI 10.5772/52977]; Purohit A, 2015, J FOOD MEAS CHARACT, V9, P175, DOI 10.1007/s11694-015-9222-y; Rhee SY, 2008, NAT REV GENET, V9, P509, DOI 10.1038/nrg2363; Rodriguez A, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-379; Ruttkay-Nedecky B, 2013, INT J MOL SCI, V14, P6044, DOI 10.3390/ijms14036044; Sakuma K, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/721219; Sammarco MC, 2008, J BIOL CHEM, V283, P4578, DOI 10.1074/jbc.M703456200; Sharp P, 2004, P NUTR SOC, V63, P563, DOI 10.1079/PNS2004386; Shi H, 2010, COMP BIOCHEM PHYS B, V157, P357, DOI 10.1016/j.cbpb.2010.08.005; Stangl GI, 1998, LIPIDS, V33, P889, DOI 10.1007/s11745-998-0285-8; Su HS, 2000, J NUTR, V130, p315S, DOI 10.1093/jn/130.2.315S; Sun J, 2015, ANIM GENET, V46, P227, DOI 10.1111/age.12272; Tizioto PC, 2013, PHYSIOL GENOMICS, V45, P1012, DOI 10.1152/physiolgenomics.00066.2013; Tizioto PC, 2015, GENET SEL EVOL, V47, DOI 10.1186/s12711-014-0083-3; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Velleman SG, 2012, J ANIM SCI, V90, P936, DOI 10.2527/jas.2011-4497; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang H, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.207779; Wang YH, 2009, J ANIM SCI, V87, P119, DOI 10.2527/jas.2008-1082; Wight TN, 2002, CURR OPIN CELL BIOL, V14, P617, DOI 10.1016/S0955-0674(02)00375-7; Wu YJ, 2005, CELL RES, V15, P483, DOI 10.1038/sj.cr.7290318; Yujing Li ZS., 2013, INT J GENOMIC MED, V1, P34, DOI [10.4172/2332-0672.1000112, DOI 10.4172/2332-0672.1000112]; Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475; Zimmermann MB, 2002, THYROID, V12, P867, DOI 10.1089/105072502761016494	74	13	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2016	11	8							e0161160	10.1371/journal.pone.0161160	http://dx.doi.org/10.1371/journal.pone.0161160			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4YN	27532424	Green Submitted, Green Published, gold			2022-12-27	WOS:000381487600068
J	Dieleman, N; Yang, W; van der Kolk, AG; Abrigo, J; Lee, KL; Chu, WCW; Zwanenburg, JJM; Siero, JCW; Wong, KS; Hendrikse, J; Chen, FXY				Dieleman, Nikki; Yang, Wenjie; van der Kolk, Anja G.; Abrigo, Jill; Lee, Ka Lok; Chu, Winnie Chiu Wing; Zwanenburg, Jaco J. M.; Siero, Jeroen C. W.; Wong, Ka Sing; Hendrikse, Jeroen; Chen, Fiona Xiang Yan			Qualitative Evaluation of a High-Resolution 3D Multi-Sequence Intracranial Vessel Wall Protocol at 3 Tesla MRI	PLOS ONE			English	Article							MIDDLE CEREBRAL-ARTERIES; BASILAR ATHEROSCLEROSIS; INTRAPLAQUE HEMORRHAGE; 7T MRI; PLAQUE; DISEASE; LESIONS; EVENTS; STROKE	Background and Purpose Intracranial vessel wall imaging using MRI has great potential as a clinical method for assessing intracranial atherosclerosis. The purpose of the current study was to compare three 3T MRI vessel wall sequences with different contrast weightings (T(1)w, PD, T(2)w) and dedicated sagittal orientation perpendicular to the middle cerebral artery, to the reconstructed sagittal image from a transverse 3D T(1)w volumetric isotropically reconstructed turbo spin-echo acquisition (VIRTA), and provide a clinical recommendation. Materials and Methods The above-mentioned sequences were acquired in 10 consecutive Chinese ischemic stroke or TIA patients (age: 68 years, sex: 4 females) with angiographic-confirmed MCA stenosis at 3T. Institutional review board approval was obtained. Two raters qualitatively scored all images on overall image quality, presence of artifacts, and visibility of plaques. Data were compared using Repeated measures ANOVA and Sidak's adjusted post hoc tests. Results All sequences except the T(2)w sequence were able to depict the walls of the large vessels of the Circle of Willis (p<0.05). T(1)w sagittal oblique VIRTA showed significantly more artifacts (p<0.01). Peripherally located plaques were sometimes missed on the sagittal sequences, but could be appreciated on the transverse T(1)w VIRTA. Conclusion With the 3T multi-sequence vessel wall protocol we were able to assess the intracranial plaque with two different image contrast weightings. The sequence of preference to include in a clinical protocol would be the transverse 3D T(1)w VIRTA based on absence of artifacts, larger coverage including the whole Circle of Willis, and excellent lesion depiction.	[Dieleman, Nikki; van der Kolk, Anja G.; Zwanenburg, Jaco J. M.; Siero, Jeroen C. W.; Hendrikse, Jeroen] Univ Med Ctr Utrecht, Dept Radiol, Utrecht, Netherlands; [Yang, Wenjie; Wong, Ka Sing; Chen, Fiona Xiang Yan] Chinese Univ Hong Kong, Dept Med, Shatin, Hong Kong, Peoples R China; [Abrigo, Jill; Lee, Ka Lok; Chu, Winnie Chiu Wing] Chinese Univ Hong Kong, Dept Imaging & Intervent Radiol, Shatin, Hong Kong, Peoples R China; [Zwanenburg, Jaco J. M.] Univ Med Ctr Utrecht, Image Sci Inst, Utrecht, Netherlands; [Siero, Jeroen C. W.] Spinoza Ctr Neuroimaging, Amsterdam, Netherlands	Utrecht University; Utrecht University Medical Center; Chinese University of Hong Kong; Chinese University of Hong Kong; Utrecht University; Utrecht University Medical Center; Royal Netherlands Academy of Arts & Sciences; Spinoza Centre for Neuroimaging (KNAW)	Chen, FXY (corresponding author), Chinese Univ Hong Kong, Dept Med, Shatin, Hong Kong, Peoples R China.	fiona.xy2000@gmail.com	Wong, Ka Sing Lawrence/N-3434-2015; Zwanenburg, Jaco J.M./B-3857-2009; Siero, Jeroen Cornelis Willem/I-4841-2019; Abrigo, Jill M./Q-4992-2016; Chu, Winnie CW/F-8449-2014	Wong, Ka Sing Lawrence/0000-0002-2031-9866; Siero, Jeroen Cornelis Willem/0000-0001-5079-2868; Abrigo, Jill M./0000-0001-5238-709X; Chu, Winnie CW/0000-0003-4962-4132; Yang, Wenjie/0000-0003-1993-1860; van der Kolk, Anja/0000-0002-8267-8848; Zwanenburg, Jaco J.M./0000-0002-4282-5719	Lui Che Woo Fondation; Research Grants Council of the Hong Kong Special Administrative Region, China [SEG_CUHK02]; Netherlands Organization for Scientific Research (NWO) [91712322]; European Research Council [637024]	Lui Che Woo Fondation; Research Grants Council of the Hong Kong Special Administrative Region, China(Hong Kong Research Grants Council); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); European Research Council(European Research Council (ERC)European Commission)	The work described in this article was supported by Lui Che Woo Fondation and grants from the Research Grants Council of the Hong Kong Special Administrative Region, China (SEG_CUHK02). Jeroen Hendrikse is supported by the Netherlands Organization for Scientific Research (NWO) under grant no91712322 and the European Research Council under grant agreements no637024.	Arenillas JF, 2011, STROKE, V42, pS20, DOI 10.1161/STROKEAHA.110.597278; Busse RF, 2008, MAGN RESON MED, V60, P640, DOI 10.1002/mrm.21680; CAPLAN LR, 1986, STROKE, V17, P648, DOI 10.1161/01.STR.17.4.648; Chung JW, 2014, J STROKE CEREBROVASC, V23, P293, DOI 10.1016/j.jstrokecerebrovasdis.2013.02.021; Dieleman N, 2016, STROKE, DOI [10.1161/STROKEAHA.116.013007, DOI 10.1161/STROKEAHA.116.013007ABLE:<GOTOISI>://000263386100010]; Dieleman N, 2014, CIRCULATION, V130, P192, DOI 10.1161/CIRCULATIONAHA.113.006919; Hellings WE, 2010, CIRCULATION, V121, P1941, DOI 10.1161/CIRCULATIONAHA.109.887497; Li ML, 2009, ATHEROSCLEROSIS, V204, P447, DOI 10.1016/j.atherosclerosis.2008.10.019; Ma N, 2010, NEUROLOGY, V75, P253, DOI 10.1212/WNL.0b013e3181e8e714; Majidi S, 2013, AM J NEURORADIOL, V34, P2259, DOI 10.3174/ajnr.A3631; Nlizuma K, 2008, J CLIN NEUROSCI, V15, P1137, DOI 10.1016/j.jocn.2007.09.024; Qiao Y, 2012, AM J NEURORADIOL, V33, P755, DOI 10.3174/ajnr.A2863; Qiao Y, 2016, STROKE, V47, P434, DOI 10.1161/STROKEAHA.115.009955; Qiao Y, 2011, J MAGN RESON IMAGING, V34, P22, DOI 10.1002/jmri.22592; Ryu CW, 2009, CEREBROVASC DIS, V27, P433, DOI 10.1159/000209238; Saam T, 2007, RADIOLOGY, V244, P64, DOI 10.1148/radiol.2441051769; Smit EJ, 2012, RADIOLOGY, V263, P216, DOI 10.1148/radiol.11111068; Swartz RH, 2009, NEUROLOGY, V72, P627, DOI 10.1212/01.wnl.0000342470.69739.b3; Takaya N, 2006, STROKE, V37, P818, DOI 10.1161/01.STR.0000204638.91099.91; Turan TN, 2013, BRAIN BEHAV, V3, P1, DOI 10.1002/brb3.103; Turan TN, 2011, J NEUROIMAGING, V21, pe159, DOI 10.1111/j.1552-6569.2009.00442.x; van der Kolk AG, 2015, AM J NEURORADIOL, V36, P694, DOI 10.3174/ajnr.A4178; van der Kolk AG, 2015, EUR RADIOL, V25, P1692, DOI 10.1007/s00330-014-3564-4; van der Kolk AG, 2013, EUR RADIOL, V23, P2996, DOI 10.1007/s00330-013-2905-z; van der Kolk AG, 2011, STROKE, V42, P2478, DOI 10.1161/STROKEAHA.111.620443; Virmani R, 2005, ARTERIOSCL THROM VAS, V25, P2054, DOI 10.1161/01.ATV.0000178991.71605.18; Wong KS, 2000, STROKE, V31, P2641, DOI 10.1161/01.STR.31.11.2641; Zhu XJ, 2013, AM J NEURORADIOL, V34, P1717, DOI 10.3174/ajnr.A3573	28	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2016	11	8							e0160781	10.1371/journal.pone.0160781	http://dx.doi.org/10.1371/journal.pone.0160781			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4YN	27532106	Green Submitted, Green Published, gold			2022-12-27	WOS:000381487600044
J	Moon, HW; Kim, HN; Hur, M; Shim, HS; Kim, H; Yun, YM				Moon, Hee-Won; Kim, Hyeong Nyeon; Hur, Mina; Shim, Hee Sook; Kim, Heejung; Yun, Yeo-Min			Comparison of Diagnostic Algorithms for Detecting Toxigenic Clostridium difficile in Routine Practice at a Tertiary Referral Hospital in Korea	PLOS ONE			English	Article							REAL-TIME PCR; C.-DIFFICILE; INFECTION; TOXIN; DIARRHEA; GUIDELINES; SOCIETY; SAMPLES; ADULTS; ASSAY	Since every single test has some limitations for detecting toxigenic Clostridium difficile, multistep algorithms are recommended. This study aimed to compare the current, representative diagnostic algorithms for detecting toxigenic C. difficile, using VIDAS C. difficile toxin A&B (toxin ELFA), VIDAS C. difficile GDH (GDH ELFA, bioMerieux, Marcy-l'Etoile, France), and Xpert C. difficile (Cepheid, Sunnyvale, California, USA). In 271 consecutive stool samples, toxigenic culture, toxin ELFA, GDH ELFA, and Xpert C. difficile were performed. We simulated two algorithms: screening by GDH ELFA and confirmation by Xpert C. difficile (GDH + Xpert) and combined algorithm of GDH ELFA, toxin ELFA, and Xpert C. difficile (GDH + Toxin + Xpert). The performance of each assay and algorithm was assessed. The agreement of Xpert C. difficile and two algorithms (GDH + Xpert and GDH+ Toxin + Xpert) with toxigenic culture were strong (Kappa, 0.848, 0.857, and 0.868, respectively). The sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) of algorithms (GDH + Xpert and GDH + Toxin + Xpert) were 96.7%, 95.8%, 85.0%, 98.1%, and 94.5%, 95.8%, 82.3%, 98.5%, respectively. There were no significant differences between Xpert C. difficile and two algorithms in sensitivity, specificity, PPV and NPV. The performances of both algorithms for detecting toxigenic C. difficile were comparable to that of Xpert C. difficile. Either algorithm would be useful in clinical laboratories and can be optimized in the diagnostic workflow of C. difficile depending on costs, test volume, and clinical needs.	[Moon, Hee-Won; Kim, Hyeong Nyeon; Hur, Mina; Shim, Hee Sook; Yun, Yeo-Min] Konkuk Univ, Sch Med, Dept Lab Med, Seoul, South Korea; [Kim, Heejung] Yonsei Univ, Coll Med, Dept Lab Med, Seoul, South Korea	Konkuk University; Konkuk University Medical Center; Yonsei University; Yonsei University Health System	Hur, M (corresponding author), Konkuk Univ, Sch Med, Dept Lab Med, Seoul, South Korea.	dearmina@hanmail.net	Hur, Mina/AAN-4920-2021	Hur, Mina/0000-0002-4429-9978; Kim, Heejung/0000-0002-0190-703X; Yun, Yeo-Min/0000-0002-5485-8331				Bagdasarian N, 2015, JAMA-J AM MED ASSOC, V313, P398, DOI 10.1001/jama.2014.17103; Barbut F, 2014, CLIN MICROBIOL INFEC, V20, P136, DOI 10.1111/1469-0691.12221; Bartlett JG, 2008, CLIN INFECT DIS, V46, pS4, DOI 10.1086/521865; Brecher SM, 2013, CLIN INFECT DIS, V57, P1175, DOI 10.1093/cid/cit424; Cheng JW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144604; Cohen SH, 2010, INFECT CONT HOSP EP, V31, P431, DOI 10.1086/651706; Crobach MJT, 2009, CLIN MICROBIOL INFEC, V15, P1053, DOI 10.1111/j.1469-0691.2009.03098.x; Davies KA, 2015, J CLIN MICROBIOL, V53, P1931, DOI 10.1128/JCM.00649-15; Debast SB, 2014, CLIN MICROBIOL INFEC, V20, P1, DOI 10.1111/1469-0691.12418; Gilbreath JJ, 2014, DIAGN MICR INFEC DIS, V80, P13, DOI 10.1016/j.diagmicrobio.2014.06.001; Jazmati N, 2015, J CLIN MICROBIOL, V53, P1942, DOI 10.1128/JCM.00613-15; McHugh ML, 2012, BIOCHEM MEDICA, V22, P276, DOI 10.11613/bm.2012.031; Naaber P, 2011, J CLIN MICROBIOL, V49, P3656, DOI 10.1128/JCM.05115-11; Novak-Weekley SM, 2010, J CLIN MICROBIOL, V48, P889, DOI 10.1128/JCM.01801-09; Peterson LR, 2007, CLIN INFECT DIS, V45, P1152, DOI 10.1086/522185; Planche T, 2008, LANCET INFECT DIS, V8, P777, DOI 10.1016/S1473-3099(08)70233-0; Planche TD, 2013, LANCET INFECT DIS, V13, P936, DOI 10.1016/S1473-3099(13)70200-7; Rupnik M, 1998, J CLIN MICROBIOL, V36, P2240, DOI 10.1128/JCM.36.8.2240-2247.1998; Schroeder LF, 2014, J CLIN MICROBIOL, V52, P489, DOI 10.1128/JCM.02777-13; Shin BM, 2016, ANAEROBE, V40, P68, DOI 10.1016/j.anaerobe.2016.06.001; Sloan LM, 2008, J CLIN MICROBIOL, V46, P1996, DOI 10.1128/JCM.00032-08; Spigaglia P, 2004, J MED MICROBIOL, V53, P1129, DOI 10.1099/jmm.0.45682-0; Surawicz CM, 2013, AM J GASTROENTEROL, V108, P478, DOI 10.1038/ajg.2013.4; Terhes G, 2004, J CLIN MICROBIOL, V42, P4316, DOI 10.1128/JCM.42.9.4316-4318.2004; Whang DH, 2014, J CLIN LAB ANAL, V28, P124, DOI 10.1002/jcla.21655; Wilcox MH, 2012, CLIN MICROBIOL INFEC, V18, P13, DOI 10.1111/1469-0691.12057; Wilcox MH, 2010, J CLIN MICROBIOL, V48, P4347, DOI 10.1128/JCM.02028-10	27	11	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2016	11	8							e0161139	10.1371/journal.pone.0161139	http://dx.doi.org/10.1371/journal.pone.0161139			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4YN	27532104	Green Published, Green Submitted, gold			2022-12-27	WOS:000381487600064
J	Yan, HY; Hu, KS; Wu, WJ; Li, Y; Tian, H; Chu, ZH; Koeffler, HP; Yin, D				Yan, Haiyan; Hu, Kaishun; Wu, Wenjing; Li, Yu; Tian, Huan; Chu, Zhonghua; Koeffler, H. Phillip; Yin, Dong			Low Expression of DYRK2 (Dual Specificity Tyrosine Phosphorylation Regulated Kinase 2) Correlates with Poor Prognosis in Colorectal Cancer	PLOS ONE			English	Article							PROTEIN-KINASES; INHIBITS PROLIFERATION; COLON-CANCER; C-MYC; CELLS; OVEREXPRESSION; SURVIVAL; FAMILY; GENE; ADENOCARCINOMAS	Dual-specificity tyrosine-phosphorylation-regulated kinase 2 (DYRK2) is a member of dual-specificity kinase family, which could phosphorylate both Ser/Thr and Tyr substrates. The role of DYRK2 in human cancer remains controversial. For example, overexpression of DYRK2 predicts a better survival in human non-small cell lung cancer. In contrast, amplification of DYRK2 gene occurs in esophageal/lung adenocarcinoma, implying the role of DYRK2 as a potential oncogene. However, its clinical role in colorectal cancer (CRC) has not been explored. In this study, we analyzed the expression of DYRK2 from Oncomine database and found that DYRK2 level is lower in primary or metastatic CRC compared to adjacent normal colon tissue or non-metastatic CRC, respectively, in 6 colorectal carcinoma data sets. The correlation between DYRK2 expression and clinical outcome in 181 CRC patients was also investigated by real-time PCR and IHC. DYRK2 expression was significantly down-regulated in colorectal cancer tissues compared with adjacent non-tumorous tissues. Functional studies confirmed that DYRK2 inhibited cell invasion and migration in both HCT116 and SW480 cells and functioned as a tumor suppressor in CRC cells. Furthermore, the lower DYRK2 levels were correlated with tumor sites (P = 0.023), advanced clinical stages (P = 0.006) and shorter survival in the advanced clinical stages. Univariate and multivariate analyses indicated that DYRK2 expression was an independent prognostic factor (P < 0.001). Taking all, we concluded that DYRK2 a novel prognostic biomarker of human colorectal cancer.	[Yan, Haiyan; Hu, Kaishun; Wu, Wenjing; Li, Yu; Yin, Dong] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Med Res Ctr, Guangdong Prov Key Lab Malignant Tumor Epigenet &, Guangzhou 510120, Guangdong, Peoples R China; [Yan, Haiyan] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Clin Lab, Guangzhou 510120, Guangdong, Peoples R China; [Wu, Wenjing] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Breast Oncol, Guangzhou 510120, Guangdong, Peoples R China; [Tian, Huan] Tradit Chinese Med Univ Guangzhou, Guangdong Hosp Tradit Chinese Med, Dept Breast Oncol, Guangzhou 510120, Guangdong, Peoples R China; [Chu, Zhonghua] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Gastrointestinal Surg, Guangzhou, Guangdong, Peoples R China; [Koeffler, H. Phillip] Univ Calif Los Angeles, Sch Med, Div Hematol Oncol, Cedars Sinai Med Ctr, Los Angeles, CA 90024 USA; [Koeffler, H. Phillip] Natl Univ Singapore, CSI, NCIS, Singapore, Singapore	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Guangzhou University of Chinese Medicine; Sun Yat Sen University; Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; National University of Singapore	Yin, D (corresponding author), Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Med Res Ctr, Guangdong Prov Key Lab Malignant Tumor Epigenet &, Guangzhou 510120, Guangdong, Peoples R China.	yin.dong@ymail.com			Natural Science Foundation of China [81572484, 81420108026, 81272956, 81301732, 81402199]; Guangdong Science and Technology Department [2014A050503026, 2015B050501004, S2012030006287]; Guangzhou Bureau of Science and Information Technology [201400000004-2, [2013]163]; Guangdong Natural Science Foundation [S2013040016404]; Sun Yat-sen University Training Project [13ykpy25]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Science and Technology Department; Guangzhou Bureau of Science and Information Technology; Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province); Sun Yat-sen University Training Project	This study was supported by grants from the Natural Science Foundation of China (81572484, 81420108026, 81272956 to D.Y.); Guangdong Science and Technology Department (2014A050503026 to D.Y., 2015B050501004, S2012030006287); Guangzhou Bureau of Science and Information Technology (201400000004-2 to D.Y.; [2013]163); Natural Science Foundation of China (81301732 to K.S.H., 81402199 to W.J.W.); Guangdong Natural Science Foundation (Grant No. S2013040016404, to K.S.H.), Sun Yat-sen University Training Project (13ykpy25 to K.S.H.).; This study was supported by grants from the Natural Science Foundation of China (81572484, 81420108026, 81272956 to D.Y.); Guangdong Science and Technology Department (2014A050503026 to D.Y., 2015B050501004, S2012030006287); Guangzhou Bureau of Science and Information Technology (201400000004-2 to D.Y.; [2013]163). Natural Science Foundation of China (81301732 to K.S.H, 81402199 to W.J.W); Guangdong Natural Science Foundation (Grant No. S2013040016404, to K.S.H), Sun Yat-sen University Training Project (13ykpy25 to K.S.H). We thank the members of the laboratory for their helpful comments on the manuscript. We appreciate professor Rui-Hua Xu from Sun-yat Sen University Cancer Center for supplying the tumor specimens and patient data for the IHC study.	Aranda S, 2011, FASEB J, V25, P449, DOI 10.1096/fj.10-165837; Becker W, 1998, J BIOL CHEM, V273, P25893, DOI 10.1074/jbc.273.40.25893; DEredita G, 1996, AUST NZ J SURG, V66, P445, DOI 10.1111/j.1445-2197.1996.tb00780.x; Friedman E, 2007, J CELL BIOCHEM, V102, P274, DOI 10.1002/jcb.21451; Gaedcke J, 2010, GENE CHROMOSOME CANC, V49, P1024, DOI 10.1002/gcc.20811; Guo XM, 2010, J BIOL CHEM, V285, P13223, DOI 10.1074/jbc.M110.102574; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; Kaiser S, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r131; Kekelidze M, 2013, WORLD J GASTROENTERO, V19, P8502, DOI 10.3748/wjg.v19.i46.8502; Ki DH, 2007, INT J CANCER, V121, P2005, DOI 10.1002/ijc.22975; Koon N, 2004, GUT, V53, P235, DOI 10.1136/gut.2003.021238; Lagautriere F., 1998, Annali Italiani di Chirurgia, V69, P491; Lagautriere F, 1998, ANN ITAL CHIR, V69, P6; Laguna A, 2008, DEV CELL, V15, P841, DOI 10.1016/j.devcel.2008.10.014; Leiszter K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074140; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Miller CT, 2003, CLIN CANCER RES, V9, P4819; Miller CT, 2003, CANCER RES, V63, P4136; Mimoto R, 2013, CANCER LETT, V339, P214, DOI 10.1016/j.canlet.2013.06.005; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Park J, 2010, J BIOL CHEM, V285, P31895, DOI 10.1074/jbc.M110.147520; Park J, 2009, CELL MOL LIFE SCI, V66, P3235, DOI 10.1007/s00018-009-0123-2; Pelengaris S, 2002, NAT REV CANCER, V2, P764, DOI 10.1038/nrc904; Pino MS, 2010, GASTROENTEROLOGY, V138, P2059, DOI 10.1053/j.gastro.2009.12.065; Seifert A, 2008, FEBS J, V275, P6268, DOI 10.1111/j.1742-4658.2008.06751.x; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; Sitz JH, 2004, MOL CELL BIOL, V24, P5821, DOI 10.1128/MCB.24.13.5821-5834.2004; Skrzypczak M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013091; Taira N, 2007, MOL CELL, V25, P725, DOI 10.1016/j.molcel.2007.02.007; Taira N, 2012, J CLIN INVEST, V122, P859, DOI 10.1172/JCI60818; TEJEDOR F, 1995, NEURON, V14, P287, DOI 10.1016/0896-6273(95)90286-4; Teng KY, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-126; Yabut O, 2010, J NEUROSCI, V30, P4004, DOI 10.1523/JNEUROSCI.4711-09.2010; Yamashita S, 2009, J THORAC CARDIOV SUR, V138, P1303, DOI 10.1016/j.jtcvs.2009.08.003; Yamashita SI, 2009, ANTICANCER RES, V29, P2753; Zeng ZL, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-181; Zou YL, 2004, J BIOL CHEM, V279, P27790, DOI 10.1074/jbc.M403042200	37	21	21	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2016	11	8							e0159954	10.1371/journal.pone.0159954	http://dx.doi.org/10.1371/journal.pone.0159954			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4YN	27532268	gold, Green Published, Green Submitted			2022-12-27	WOS:000381487600017
J	Zeng, FM; Sun, XL; Yang, BX; Shen, H; Liu, L				Zeng, Fanmin; Sun, Xueli; Yang, Bangxiang; Shen, Hong; Liu, Ling			The Theoretical Construction of a Classification of Clinical Somatic Symptoms in Psychosomatic Medicine Theory	PLOS ONE			English	Article							PSYCHOLOGICAL-RESEARCH; SOMATIZATION; PERSPECTIVES; ALEXITHYMIA; DEPRESSION; VALIDITY	Objective This article adopts the perspective of psychosomatic medicine to present and test a theoretical model of the classification of clinical somatic symptoms. The theoretical model consists of four dimensions: emotional somatic symptoms, biological somatic symptoms, imaginative somatic symptoms, and cognitive somatic symptoms. Method A clinical somatic symptom classification scale was developed according to the theoretical model. A total of 542 participants completed the clinical somatic symptoms classification scale. The data were analyzed using exploratory and confirmatory factor analyses. Results The results confirmed the theoretical model. The analyses found that the proposed theoretical structure of the scale was good, as indicated by factor loadings and fit indices, and that the scale had good reliability and construct validity. Conclusions Based on the interpretation of the clinical symptoms of psychosomatic medicine, the treatment of chronic non-infectious diseases includes at least three dimensions: the first is the etiological treatment, the second is the pathophysiological and pathopsychological dimension, and the third is symptomatic treatment. The unified psychosomatic point of view and diverse clinical thinking modes are aimed at identifying different classes of somatic symptoms and important prerequisites for the treatment of these symptoms. We registered the study with the Chinese Clinical Trial Registry and it was approved by the West China Hospital, Sichuan University ethics committee. Trial registration: The registration number is ChiCTR-OCS-14004632 (time: 2014-05-12).	[Zeng, Fanmin] Southwest Univ Nationalities, Coll Sociol & Psychol, Chengdu, Sichuan, Peoples R China; [Sun, Xueli] Sichuan Univ, West China Hosp, Dept Psychiat, Chengdu, Sichuan, Peoples R China; [Yang, Bangxiang] Sichuan Univ, West China Hosp, Dept Pain Management, Chengdu, Sichuan, Peoples R China; [Shen, Hong] Sichuan Univ, West China Hosp, Dept Urol, Chengdu, Sichuan, Peoples R China; [Liu, Ling] Sichuan Univ, West China Hosp, Dept Digest Internal Med, Chengdu, Sichuan, Peoples R China	Southwest Minzu University; Sichuan University; Sichuan University; Sichuan University; Sichuan University	Sun, XL (corresponding author), Sichuan Univ, West China Hosp, Dept Psychiat, Chengdu, Sichuan, Peoples R China.	648488969@qq.com						ANDERSON JC, 1988, PSYCHOL BULL, V103, P411, DOI 10.1037/0033-2909.103.3.411; Brown RJ, 2004, PSYCHOL BULL, V130, P793, DOI 10.1037/0033-2909.130.5.793; DEROGATIS LR, 1977, J CLIN PSYCHOL, V33, P981, DOI 10.1002/1097-4679(197710)33:4<981::AID-JCLP2270330412>3.0.CO;2-0; Eizaguirre AE, 2004, PERS INDIV DIFFER, V36, P321, DOI 10.1016/S0191-8869(03)00099-0; Fabrigar LR, 1999, PSYCHOL METHODS, V4, P272, DOI 10.1037/1082-989X.4.3.272; Fava GA, 2000, PSYCHOTHER PSYCHOSOM, V69, P184, DOI 10.1159/000012393; Fink P, 1996, J PSYCHOSOM RES, V40, P7, DOI 10.1016/0022-3999(95)00510-2; Haynes SN, 1995, PSYCHOL ASSESSMENT, V7, P238, DOI 10.1037/1040-3590.7.3.238; Hotopf M, 2004, PSYCHOL MED, V34, P195, DOI 10.1017/S003329170300151X; KATON W, 1982, AM J MED, V72, P127, DOI 10.1016/0002-9343(82)90599-X; Kroenke K, 2002, PSYCHOSOM MED, V64, P258, DOI 10.1097/00006842-200203000-00008; LAWTON MP, 1959, J CONSULT PSYCHOL, V23, P352, DOI 10.1037/h0045248; Li T, 2010, OXFORD TXB PSYCHIAT; MacCallum RC, 2000, ANNU REV PSYCHOL, V51, P201, DOI 10.1146/annurev.psych.51.1.201; Merskey H, 1996, PAIN, V67, P209, DOI 10.1016/0304-3959(96)03236-X; Ouyang QIN, 2010, CLIN DIAGNOSTICS, P7; Reed JF, 2000, COMPUT METH PROG BIO, V63, P43, DOI 10.1016/S0169-2607(00)00074-2; Rief W, 2010, PSYCHOSOM MED, V72, P648, DOI 10.1097/PSY.0b013e3181d73fce; Shorter E., 1992, PARALYSIS FATIGUE HI; Strain JJ, 1979, PSYCCRITIQUES, V24, P11; TAYLOR GJ, 1992, J PSYCHOSOM RES, V36, P417, DOI 10.1016/0022-3999(92)90002-J; Wang X, 1999, RATING SCALES MENTAL, P23; 孙学礼, 2013, [中华精神科杂志, Chinese Journal of Psychiatry], V46, P371	23	2	2	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2016	11	8							e0161222	10.1371/journal.pone.0161222	http://dx.doi.org/10.1371/journal.pone.0161222			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DT4SL	27525701	Green Published, Green Submitted, gold			2022-12-27	WOS:000381471100044
J	de Bruin, WCC; van de Ven, EME; Hooijmans, CR				de Bruin, W. C. C.; van de Ven, E. M. E.; Hooijmans, C. R.			Efficacy of Soiled Bedding Transfer for Transmission of Mouse and Rat Infections to Sentinels: A Systematic Review	PLOS ONE			English	Review							RABBIT COLONIES; FUR MITES; MICE; RECOMMENDATIONS; PATHOGENS; QUALITY; DESIGN; RISK	Purpose This systematic review was conducted to gain insight into the efficacy of transmission of infectious agents to colony sentinels by soiled bedding transfer based on publications studying this subject in mice and rats. This information is essential to establish recommendations for the design of health monitoring programs which use sentinels to determine the microbiological status of laboratory animal colonies. Results Fifteen original articles retrieved from PubMed, Embase, and CAB abstracts met the inclusion criteria. The design of the studies varied substantially per infectious agent with regard to dose of soiled bedding, exposure time, and sentinel strains used. Conclusion With our conservative criteria for effectiveness, soiled bedding transfer appeared to be effective for MHV, MPV, TMEV, Helicobacter spp., and fur mite infections and ineffective for Sendai virus. For other infectious agents, such as MNV, EDIM, MVM, SDAV, Clostridium piliforme, and pinworms, too few data were available to be able to draw robust conclusions on the efficacy of soiled bedding transfer. Recommendation The identified evidence only pertains to a portion of the infectious organisms included in the FELASA 2014 guidelines. As many animal facilities design their health monitoring program according to these recommendations, additional studies are warranted to draw comprehensive conclusions on the effective transmission of the infectious agents listed in these guidelines by soiled bedding transfer.	[de Bruin, W. C. C.; van de Ven, E. M. E.] QM Diagnost BV, Nijmegen, Netherlands; [Hooijmans, C. R.] Radboud Univ Nijmegen, Med Ctr, SYRCLE, Cent Anim Lab, Nijmegen, Netherlands	Radboud University Nijmegen	de Bruin, WCC (corresponding author), QM Diagnost BV, Nijmegen, Netherlands.	Wieke.debruin@qmdiagnostics.org	Hooijmans, C.R./L-4390-2015	Hooijmans, C.R./0000-0001-6435-5714	Netherlands Organisation for Health Research and Development (ZonMw) [104024065]	Netherlands Organisation for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development)	This study was supported by the Netherlands Organisation for Health Research and Development (ZonMw; grant nr. 104024065).	Arbona RJR, 2010, J AM ASSOC LAB ANIM, V49, P564; Brielmeier M, 2006, LAB ANIM-UK, V40, P247, DOI 10.1258/002367706777611497; BROWNSTEIN DG, 1981, AM J PATHOL, V105, P156; Compton SR, 2004, COMPARATIVE MED, V54, P382; Compton SR, 2012, J AM ASSOC LAB ANIM, V51, P797; CUNDIFF DD, 1995, LAB ANIM SCI, V45, P219; de Vries RBM, 2011, LAB ANIM-UK, V45, P268, DOI 10.1258/la.2011.011056; DILLEHAY DL, 1990, LAB ANIM SCI, V40, P367; Henderson KS, 2013, J AM ASSOC LAB ANIM, V52, P763; Hirst JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098856; Hooijmans C, 2011, LAB ANIM-UK, V45, P61, DOI 10.1258/la.2010.010130; Hooijmans CR, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-43; Jensen ES, 2013, J AM ASSOC LAB ANIM, V52, P28; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kilkenny C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007824; LAREGINA M, 1992, LAB ANIM SCI, V42, P344; Lindstrom KE, 2011, J AM ASSOC LAB ANIM, V50, P54; Livingston RS, 1998, LAB ANIM SCI, V48, P291; Mahler M, 2014, LAB ANIM-UK, V48, P178, DOI 10.1177/0023677213516312; Manuel CA, 2008, J AM ASSOC LAB ANIM, V47, P31; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; MOTZEL SL, 1992, LAB ANIM SCI, V42, P439; Myers DD, 2003, CONTEMP TOP LAB ANIM, V42, P16; Nicklas W, 2002, LAB ANIM-UK, V36, P20, DOI 10.1258/0023677021911740; THIGPEN JE, 1989, LAB ANIM SCI, V39, P324	25	20	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2016	11	8							e0158410	10.1371/journal.pone.0158410	http://dx.doi.org/10.1371/journal.pone.0158410			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3LI	27518654	gold, Green Published, Green Submitted			2022-12-27	WOS:000381382100003
J	Navarro-Villaran, E; Tinoco, J; Jimenez, G; Pereira, S; Wang, JZ; Aliseda, S; Rodriguez-Hernandez, MA; Gonzalez, R; Marin-Gomez, LM; Gomez-Bravo, MA; Padillo, FJ; Alamo-Martinez, JM; Muntane, J				Navarro-Villaran, Elena; Tinoco, Jose; Jimenez, Granada; Pereira, Sheila; Wang, Jize; Aliseda, Sara; Rodriguez-Hernandez, Maria A.; Gonzalez, Raul; Marin-Gomez, Luis M.; Gomez-Bravo, Miguel A.; Padillo, Francisco J.; Alamo-Martinez, Jose M.; Muntane, Jordi			Differential Antitumoral Properties and Renal-Associated Tissue Damage Induced by Tacrolimus and Mammalian Target of Rapamycin Inhibitors in Hepatocarcinoma: In Vitro and In Vivo Studies	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; LIVER-TRANSPLANTATION; CYCLOSPORINE-A; INCREASED SURVIVAL; CELLS; GROWTH; FK506; SIROLIMUS; IMMUNOSUPPRESSANT; RECURRENCE	Orthotopic liver transplantation (OLT) is the recommended treatment for patients at early stages of hepatocarcinoma (HCC) with potential portal hypertension and/ or bilirubinemia, but without vascular-associated diseases. The patients are receiving immunosuppressive therapy to reduce graft rejection, but differential side effects have been related to calcineurin and mTOR inhibitor administration regarding tumor recurrence and nephrotoxicity. The in vitro studies showed that Tacrolimus exerted a more potent pro-apoptotic effect than Everolimus (Huh 7>Hep 3B>HepG2), being sirolimus only active in Hep3B cell line. Tacrolimus and Everolimus exerted potent antiproliferative properties in Huh 7 and Hep3B in which cells Sirolimus was inactive. Interestingly, Tacrolimus-and Everolimus-dependent G(0)/ G(1) cell accumulation occurred as a consequence of drastic reduction in S, as well as in S and G(2+M) phases, respectively. The in vivo studies support data on the more effective antitumoral properties of Everolimus, eventual risk of pro-angiogenic tumoral properties and nephrotoxicity of Tacrolimus, and pro-proliferative properties of Sirolimus in tumors developed in nude mice.	[Navarro-Villaran, Elena; Pereira, Sheila; Aliseda, Sara; Rodriguez-Hernandez, Maria A.; Gonzalez, Raul] Univ Seville, Virgen del Rocio Virgen Macarena Univ Hosp, CSIC, Inst Biomed Seville IBIS, Seville, Spain; [Tinoco, Jose; Jimenez, Granada; Wang, Jize; Marin-Gomez, Luis M.; Gomez-Bravo, Miguel A.; Padillo, Francisco J.; Alamo-Martinez, Jose M.; Muntane, Jordi] Univ Seville, Virgen del Rocio Virgen Macarena Univ Hosp, CSIC, IBIS,Dept Gen Surg, Seville, Spain; [Gomez-Bravo, Miguel A.; Padillo, Francisco J.; Alamo-Martinez, Jose M.; Muntane, Jordi] Ctr Invest Biomed Red Enfermedades Hepat & Digest, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD	Muntane, J (corresponding author), Univ Seville, Virgen del Rocio Virgen Macarena Univ Hosp, CSIC, IBIS,Dept Gen Surg, Seville, Spain.; Muntane, J (corresponding author), Ctr Invest Biomed Red Enfermedades Hepat & Digest, Madrid, Spain.	jmuntane-ibis@us.es	Navarro-Villarán, Elena/F-4699-2018; Padillo-Ruiz, Javier/AAF-9792-2021; Rodríguez-Hernández, Ángeles/K-9717-2015	Navarro-Villarán, Elena/0000-0003-0765-9089; Padillo-Ruiz, Javier/0000-0002-1220-0822; Rodríguez-Hernández, Ángeles/0000-0003-1846-0606; GOMEZ BRAVO, MIGUEL ANGEL/0000-0002-5155-3508	Instituto de Salud Carlos III [PI13/00021]; Consejeria de Innovacion, Ciencia y Empresa [CTS-6264]; Consejeria de Salud y Bienestar Social [PI13/00025]; Instituto de Salud Carlos III; European Development Regional Fund "A way to achieve Europe" ERDF	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Consejeria de Innovacion, Ciencia y Empresa; Consejeria de Salud y Bienestar Social; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); European Development Regional Fund "A way to achieve Europe" ERDF(European Commission)	The authors thank the Instituto de Salud Carlos III (PI13/00021), Consejeria de Innovacion, Ciencia y Empresa (CTS-6264) and Consejeria de Salud y Bienestar Social (PI13/00025) for their financial support. The authors also thank the Biomedical Research Network Center for Liver and Digestive Diseases (CIBERehd) founded by Instituto de Salud Carlos III and co-financed by European Development Regional Fund "A way to achieve Europe" ERDF for their financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almawi WY, 2000, NEPHROL DIAL TRANSPL, V15, P1916, DOI 10.1093/ndt/15.12.1916; Baksh S, 2000, ONCOGENE, V19, P2820, DOI 10.1038/sj.onc.1203585; Beuvink I, 2005, CELL, V120, P747, DOI 10.1016/j.cell.2004.12.040; Bruix J, 2016, GASTROENTEROLOGY, V150, P835, DOI 10.1053/j.gastro.2015.12.041; Cao Xiao-Wei, 2005, Hepatobiliary Pancreat Dis Int, V4, P269; Choi SJN, 2008, TRANSPL P, V40, P2734, DOI 10.1016/j.transproceed.2008.08.028; DARZYNKIEWICZ Z, 1994, METHOD CELL BIOL, V41, P15; Dumont FJ, 2000, CURR MED CHEM, V7, P731, DOI 10.2174/0929867003374723; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Giordano A, 2008, CARDIOVASC RES, V79, P519, DOI 10.1093/cvr/cvn079; Hochegger H, 2008, NAT REV MOL CELL BIO, V9, P910, DOI 10.1038/nrm2510; Huynh H, 2012, ANGIOGENESIS, V15, P59, DOI 10.1007/s10456-011-9243-z; Huynh H, 2009, J CELL MOL MED, V13, P2673, DOI 10.1111/j.1582-4934.2009.00692.x; Huynh H, 2009, J CELL MOL MED, V13, P1371, DOI 10.1111/j.1582-4934.2008.00364.x; Kawahara T, 2016, MOL CARCINOGEN, V55, P161, DOI 10.1002/mc.22265; Khanna AK, 2003, BIOCHEM BIOPH RES CO, V303, P266, DOI 10.1016/S0006-291X(03)00340-1; Liu HY, 2012, ANTICANCER RES, V32, P1627; Massoud O, 2012, J HEPATOL, V56, P288, DOI 10.1016/j.jhep.2011.06.012; Mazzoletti M, 2011, CANCER RES, V71, P4573, DOI 10.1158/0008-5472.CAN-10-4322; McAlister VC, 2006, AM J TRANSPLANT, V6, P1578, DOI 10.1111/j.1600-6143.2006.01360.x; MORTON DB, 1985, VET REC, V116, P431, DOI 10.1136/vr.116.16.431; Neuhaus P, 2001, LIVER TRANSPLANT, V7, P473, DOI 10.1053/jlts.2001.24645; Ojo AO, 2003, NEW ENGL J MED, V349, P931, DOI 10.1056/NEJMoa021744; Rodriguez-Peralvarez M, 2013, J HEPATOL, V59, P1193, DOI 10.1016/j.jhep.2013.07.012; Sangiovanni A, 2004, GASTROENTEROLOGY, V126, P1005, DOI 10.1053/j.gastro.2003.12.049; Saunders PO, 2013, ONCOGENE, V32, P4789, DOI 10.1038/onc.2012.498; Schumacher G, 2005, WORLD J GASTROENTERO, V11, P1420; SHERR CJ, 1994, CELL, V79, P551, DOI 10.1016/0092-8674(94)90540-1; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Siemann G, 1999, MOL PHARMACOL, V55, P1094, DOI 10.1124/mol.55.6.1094; Aguilar LT, 2009, TRANSPL P, V41, P2453, DOI 10.1016/j.transproceed.2009.05.012; Toso C, 2010, HEPATOLOGY, V51, P1237, DOI 10.1002/hep.23437; Vivarelli M, 2008, ANN SURG, V248, P857, DOI 10.1097/SLA.0b013e3181896278; Wang TW, 1996, CELL, V86, P435, DOI 10.1016/S0092-8674(00)80116-6; Workman P, 2010, BRIT J CANCER, V102, P1555, DOI 10.1038/sj.bjc.6605642	35	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2016	11	8							e0160979	10.1371/journal.pone.0160979	http://dx.doi.org/10.1371/journal.pone.0160979			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3LI	27518575	Green Published, gold, Green Submitted			2022-12-27	WOS:000381382100030
J	Yu, BQ; Lv, X; Su, LP; Li, JF; Yu, YY; Gu, QL; Yan, M; Zhu, ZG; Liu, BY				Yu, Beiqin; Lv, Xin; Su, Liping; Li, Jianfang; Yu, Yingyan; Gu, Qinlong; Yan, Min; Zhu, Zhenggang; Liu, Bingya			MiR-148a Functions as a Tumor Suppressor by Targeting CCK-BR via Inactivating STAT3 and Akt in Human Gastric Cancer	PLOS ONE			English	Article							DNA METHYLTRANSFERASE 1; CELL LUNG-CANCER; MICRORNA-148A SUPPRESSES; MESENCHYMAL TRANSITION; SIGNALING PATHWAYS; PANCREATIC-CANCER; BREAST-CANCER; EXPRESSION; PROLIFERATION; CARCINOMA	MicroRNAs (miRNAs) have been widely accepted as a class of gene expression regulators which post-translationally regulate protein expression. These small noncoding RNAs have been proved closely involved in the modulation of various pathobiological processes in cancer. In this research, we demonstrated that miR-148a expression was significantly downregulated in gastric cancer tissues in comparison with the matched normal mucosal tissues, and its expression was statistically associated with lymph node metastasis. Ectopic expression of miR-148a inhibited tumor cell proliferation and migration in vitro, and inhibited tumor formation in vivo. Subsequently, we identified cholecystokinin B receptor (CCK-BR) as a direct target of miR-148a using western blot and luciferase activity assay. More importantly, siRNA-induced knockdown of CCK-BR elicited similar anti-oncogenic effects (decreased proliferation and migration) as those induced by enforced miR-148a expression. We also found that miR-148a-mediated anti-cancer effects are dependent on the inhibition of STAT3 and Akt activation, which subsequently regulates the pathways involved in cell proliferation and migration. Taken together, our results suggest that miR-148a serves as a tumor suppressor in human gastric carcinogenesis by targeting CCK-BR via inactivating STAT3 and Akt.	[Yu, Beiqin; Lv, Xin; Su, Liping; Li, Jianfang; Yu, Yingyan; Gu, Qinlong; Yan, Min; Zhu, Zhenggang; Liu, Bingya] Shanghai Jiao Tong Univ, Shanghai Inst Digest Surg, Ruijin Hosp, Shanghai Key Lab Gastr Neoplasms,Sch Med, Shanghai, Peoples R China; [Lv, Xin] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 9, Dept Vasc Surg, Sch Med, Shanghai, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Liu, BY (corresponding author), Shanghai Jiao Tong Univ, Shanghai Inst Digest Surg, Ruijin Hosp, Shanghai Key Lab Gastr Neoplasms,Sch Med, Shanghai, Peoples R China.	liubingya@sjtu.edu.cn	Liu, Bingya/GMW-5655-2022	Liu, Bingya/0000-0002-4406-3762	National Natural Science Foundation of China [81172324, 81272749, 91229106, 81372187]; Science and Technology Commission of Shanghai Municipality [12XD1403700, 13ZR1425600]; Key Projects in the National Science & Technology Pillar Program of China [2014BAI09B03]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Key Projects in the National Science & Technology Pillar Program of China	This study was supported by grants from National Natural Science Foundation of China (Nos. 81172324, 81272749, 91229106, 81372187), Science and Technology Commission of Shanghai Municipality (Nos. 12XD1403700, 13ZR1425600), Key Projects in the National Science & Technology Pillar Program of China (No. 2014BAI09B03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.	Ahmad A, 2013, ANTI-CANCER AGENT ME, V13, P1014, DOI 10.2174/18715206113139990117; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bickenbach K, 2012, J GASTRIC CANCER, V12, P55, DOI 10.5230/jgc.2012.12.2.55; Borkowski R, 2015, CANCER RES, V75, P666, DOI 10.1158/0008-5472.CAN-14-1329; Braconi C, 2010, HEPATOLOGY, V51, P881, DOI 10.1002/hep.23381; Chen BL, 2013, CELL CYCLE, V12, P112, DOI 10.4161/cc.23030; Chen F, 2012, CANCER RES, V72, P379, DOI 10.1158/0008-5472.CAN-11-1982; Corcoran RB, 2011, CANCER RES, V71, P5020, DOI 10.1158/0008-5472.CAN-11-0908; Du W, 2013, ONCOGENE, V32, P3319, DOI 10.1038/onc.2012.359; Duan YT, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-127; Dun BY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081702; Feng RH, 2010, CANCER LETT, V298, P50, DOI 10.1016/j.canlet.2010.06.004; Giraud AS, 2012, EXPERT OPIN THER TAR, V16, P889, DOI 10.1517/14728222.2012.709238; Hall DP, 2014, CANCER CELL, V26, P738, DOI 10.1016/j.ccell.2014.09.015; Hamada S, 2014, CELL SIGNAL, V26, P179, DOI 10.1016/j.cellsig.2013.11.003; Hanoun N, 2010, CLIN CHEM, V56, P1107, DOI 10.1373/clinchem.2010.144709; Huang SL, 2013, INT IMMUNOPHARMACOL, V17, P585, DOI 10.1016/j.intimp.2013.07.021; ITO M, 1993, J BIOL CHEM, V268, P18300; Jiang F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096698; Jin GC, 2013, GASTROENTEROLOGY, V145, P820, DOI 10.1053/j.gastro.2013.07.034; Lin L, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-879; Lin L, 2010, CANCER RES, V70, P2445, DOI 10.1158/0008-5472.CAN-09-2468; Liu RH, 2015, CLIN CANCER RES, V21, P854, DOI 10.1158/1078-0432.CCR-14-1740; Long XR, 2014, INT J ONCOL, V44, P1915, DOI 10.3892/ijo.2014.2373; Mohr AM, 2015, SEMIN LIVER DIS, V35, P3, DOI 10.1055/s-0034-1397344; Pan LJ, 2014, EUR J MED RES, V19, DOI 10.1186/s40001-014-0068-2; Pan W, 2010, J IMMUNOL, V184, P6773, DOI 10.4049/jimmunol.0904060; Rojanasakul Y, 2013, CELL CYCLE, V12, P202, DOI 10.4161/cc.23419; Sakamoto N, 2014, CANCER SCI, V105, P236, DOI 10.1111/cas.12330; SETHI T, 1993, CANCER RES, V53, P5208; Smith JP, 2012, CANCER BIOL THER, V13, P164, DOI 10.4161/cbt.13.3.18698; Song YX, 2012, INT J CANCER, V131, P1042, DOI 10.1002/ijc.26485; Tao SF, 2014, BIOCHEM BIOPH RES CO, V451, P74, DOI 10.1016/j.bbrc.2014.07.073; Visone R, 2009, BLOOD, V114, P3872, DOI 10.1182/blood-2009-06-229211; Wang SH, 2013, TUMOR BIOL, V34, P3705, DOI 10.1007/s13277-013-0954-1; Xia JZ, 2014, J CANCER RES CLIN, V140, P1451, DOI 10.1007/s00432-014-1649-8; Xu W, 2013, CANCER LETT, V332, P11, DOI 10.1016/j.canlet.2012.12.030; Yan J, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0879-6; Yu BQ, 2012, MOL MED REP, V6, P821, DOI 10.3892/mmr.2012.1006; Zhang BG, 2012, ONCOL REP, V27, P1019, DOI 10.3892/or.2012.1645; Zhang JP, 2014, ONCOGENE, V33, P4069, DOI 10.1038/onc.2013.369; Zheng BQ, 2011, CLIN CANCER RES, V17, P7574, DOI 10.1158/1078-0432.CCR-11-1714; Zheng QZ, 2014, PROSTATE, V74, P1655, DOI 10.1002/pros.22883; Zhou JJ, 2010, MOL CELL BIOCHEM, V343, P133, DOI 10.1007/s11010-010-0507-5	44	50	52	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2016	11	8							e0158961	10.1371/journal.pone.0158961	http://dx.doi.org/10.1371/journal.pone.0158961			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3LI	27518872	Green Published, Green Submitted, gold			2022-12-27	WOS:000381382100005
J	Takele, Y; Adem, E; Getahun, M; Tajebe, F; Kiflie, A; Hailu, A; Raynes, J; Mengesha, B; Ayele, TA; Shkedy, Z; Lemma, M; Diro, E; Toulza, F; Modolell, M; Munder, M; Muller, I; Kropf, P				Takele, Y.; Adem, E.; Getahun, M.; Tajebe, F.; Kiflie, A.; Hailu, A.; Raynes, J.; Mengesha, B.; Ayele, T. A.; Shkedy, Z.; Lemma, M.; Diro, E.; Toulza, F.; Modolell, M.; Munder, M.; Mueller, I.; Kropf, P.			Malnutrition in Healthy Individuals Results in Increased Mixed Cytokine Profiles, Altered Neutrophil Subsets and Function	PLOS ONE			English	Article							PROTEIN-ENERGY MALNUTRITION; VISCERAL LEISHMANIASIS; ARGINASE ACTIVITY; IMMUNE-SYSTEM; DEVELOPING-COUNTRIES; NUTRITIONAL-STATUS; ANOREXIA-NERVOSA; CHILDREN; MACROPHAGES; MORBIDITY	Malnutrition is commonly associated with increased infectious disease susceptibility and severity. Whereas malnutrition might enhance the incidence of disease as well as its severity, active infection can in turn exacerbate malnutrition. Therefore, in a malnourished individual suffering from a severe infection, it is not possible to determine the contribution of the pre-existing malnutrition and/or the infection itself to increased disease severity. In the current study we focussed on two groups of malnourished, but otherwise healthy individuals: moderately malnourished (BMI: 18.4-16.5) and severely malnourished (BMI < 16.5) and compared several immune parameters with those of individuals with a normal BMI (>= 18.5). Our results show a similar haematological profile in all three groups, as well as a similar ratio of CD4(+) and CD8(+) T cells. We found significant correlations between low BMI and increased levels of T helper (Th) 1 (Interferon (IFN)-gamma, (interleukin (IL)-2, IL-12), Th2 (IL-4, IL-5, IL-13), as well as IL-10, IL-33 and tumor necrosis factor-alpha, but not IL-8 or C reactive protein. The activities of arginase, an enzyme associated with immunosuppression, were similar in plasma, peripheral blood mononuclear cells (PBMC) and neutrophils from all groups and no differences in the expression levels of CD3 zeta, a marker of T cell activation, were observed in CD4(+) and CD8(+) T cells. Furthermore, whereas the capacity of neutrophils from the malnourished groups to phagocytose particles was not impaired, their capacity to produce reactive oxygen species was impaired. Finally we evaluated the frequency of a subpopulation of low-density neutrophils and show that they are significantly increased in the malnourished individuals. These differences were more pronounced in the severely malnourished group. In summary, our results show that even in the absence of apparent infections, healthy malnourished individuals display dysfunctional immune responses that might contribute to increased susceptibility and severity to infectious diseases.	[Takele, Y.; Mueller, I.; Kropf, P.] Imperial Coll London, Dept Med, London, England; [Takele, Y.; Mengesha, B.] Gondar Univ, Leishmaniasis Res & Treatment Ctr, Gondar, Ethiopia; [Adem, E.; Getahun, M.; Tajebe, F.; Kiflie, A.; Lemma, M.] Univ Gondar, Dept Immunol, Gondar, Ethiopia; [Hailu, A.] Univ Addis Ababa, Dept Microbiol Immunol & Parasitol, Addis Ababa, Ethiopia; [Raynes, J.; Toulza, F.] London Sch Hyg & Trop Med, Dept Immunol & Infect, London, England; [Ayele, T. A.] Univ Gondar, Dept Epidemiol & Biostat, Gondar, Ethiopia; [Shkedy, Z.] Univ Hasselt, Dept Math & Stat, Hasselt, Belgium; [Diro, E.] Univ Gondar, Dept Internal Med, Gondar, Ethiopia; [Modolell, M.] Max Planck Inst Immunobiol & Epigenet, Dept Cellular Immunol, Freiburg, Germany; [Munder, M.] Univ Med Ctr Mainz, Dept Med Hematol Oncol & Pneumol 3, Mainz, Germany	Imperial College London; University of Gondar; University of Gondar; Addis Ababa University; University of London; London School of Hygiene & Tropical Medicine; University of Gondar; Hasselt University; University of Gondar; Max Planck Society; Johannes Gutenberg University of Mainz	Kropf, P (corresponding author), Imperial Coll London, Dept Med, London, England.	p.kropf@imperial.ac.uk	Raynes, John G/G-7932-2011; Hailu, Asrat/AAM-6982-2020; Shkedy, Ziv/AAQ-3096-2020; Munder, Markus/K-6737-2013	Raynes, John G/0000-0002-8536-1328; Shkedy, Ziv/0000-0002-6306-0823; Takele, Yegnasew/0000-0003-1070-7459; Alemayehu, Amare/0000-0002-2205-7767; Toulza, Frederic/0000-0002-1104-5795	Wellcome Trust [104028/B/14/Z]	Wellcome Trust(Wellcome TrustEuropean Commission)	The authors would like to also thank DNDi for their in-kind support in funding the staff of Gondar University Leishmaniasis Research and Treatment Centre. Yegnasew Takele is supported by a fellowship from The Wellcome Trust (104028/B/14/Z).	Abebe T, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002134; ADAMS EB, 1969, AM J CLIN NUTR, V22, P1634; Alcoba G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053184; Altman BJ, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008763; Bain LE, 2013, PAN AFR MED J, V15, DOI 10.11604/pamj.2013.15.120.2535; Bhutta ZA, 2012, ANN NUTR METAB, V61, P19, DOI 10.1159/000345167; Bowers NL, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003993; BRANCA F, 1993, EUR J CLIN NUTR, V47, P840; CHANDRA R K, 1991, Nutrition Research Reviews, V4, P83, DOI 10.1079/NRR19910009; Chandra RK, 1999, P NUTR SOC, V58, P681, DOI 10.1017/S0029665199000890; Chandra RK, 2002, EUR J CLIN NUTR, V56, pS73, DOI 10.1038/sj.ejcn.1601492; Cloke TE, 2010, J INFECT DIS, V202, P374, DOI 10.1086/653736; Corware K, 2014, NUTR METAB, V11, DOI 10.1186/1743-7075-11-51; DELAFUENTE M, 1992, ANN NUTR METAB, V36, P41, DOI 10.1159/000177697; Dubois B, 1997, BADKEY J NAME LOST, P26988, DOI [10.1186/1743-7075-11-51, DOI 10.1186/1743-7075-11-51]; Fock RA, 2010, INFLAMMATION, V33, P101, DOI 10.1007/s10753-009-9163-x; Goto H, 2009, REV I MED TROP, V51, P241, DOI 10.1590/S0036-46652009000500002; Hutter G, 2009, INT J EAT DISORDER, V42, P293, DOI 10.1002/eat.20610; Kheloufi M, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/701064; Kropf P, 2005, FASEB J, V19, P1000, DOI 10.1096/fj.04-3416fje; Kropf P, 2007, EUR J IMMUNOL, V37, P935, DOI 10.1002/eji.200636542; KUIJPERS TW, 1991, BLOOD, V78, P1105; Ma YT, 2013, IMMUNITY, V39, P211, DOI 10.1016/j.immuni.2013.07.017; MARCOS A, 1993, EUR J CLIN NUTR, V47, P787; Marcos A, 2003, EUR J CLIN NUTR, V57, pS66, DOI 10.1038/sj.ejcn.1601819; MOLOFSKY AB, 2015, IMMUNITY, V42, P1005, DOI [DOI 10.1016/j.immuni.2015.06.006, DOI 10.1016/J.IMMUNI.2015.06.006]; Muller I, 2009, TRENDS IMMUNOL, V30, P522, DOI 10.1016/j.it.2009.07.007; Muller O, 2005, CAN MED ASSOC J, V173, P279, DOI 10.1503/cmaj.050342; Munder M, 2009, BRIT J PHARMACOL, V158, P638, DOI 10.1111/j.1476-5381.2009.00291.x; Najera O, 2001, CLIN EXP IMMUNOL, V126, P461, DOI 10.1046/j.1365-2249.2001.01694.x; Nylen S, 2007, TRENDS IMMUNOL, V28, P378, DOI 10.1016/j.it.2007.07.004; Organization WH, 1995, TROP DIS RES PROGR 1, P135; Perez-Mazliah D, 2015, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00671; Qadri F, 2013, VACCINE, V31, P452, DOI 10.1016/j.vaccine.2012.11.012; REDMOND HP, 1991, ARCH SURG-CHICAGO, V126, P192, DOI 10.1001/archsurg.1991.01410260080011; Rodriguez L, 2005, CLIN DIAGN LAB IMMUN, V12, P502, DOI 10.1128/CDLI.12.4.502-507.2005; Rodriguez L, 2011, INT J ENV RES PUB HE, V8, P1174, DOI 10.3390/ijerph8041174; Schaffer MR, 1997, J AM COLL SURGEONS, V184, P37; Schaible UE, 2007, PLOS MED, V4, P806, DOI 10.1371/journal.pmed.0040115; Shankar AH, 2000, J INFECT DIS, V182, pS37, DOI 10.1086/315906; Solmi M, 2015, PSYCHONEUROENDOCRINO, V51, P237, DOI 10.1016/j.psyneuen.2014.09.031; Takele Y, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0001977; Thakur N, 2014, NUTRITION, V30, P440, DOI 10.1016/j.nut.2013.09.011; TOMKINS AM, 1989, T ROY SOC TROP MED H, V83, P282, DOI 10.1016/0035-9203(89)90681-0; Wasunna KM, 1995, T ROY SOC TROP MED H, V89, P678, DOI 10.1016/0035-9203(95)90442-5; White JV, 2012, JPEN-PARENTER ENTER, V36, P275, DOI 10.1177/0148607112440285; Woodward B, 1998, NUTR REV, V56, pS84; Yorimitsu T, 2005, CELL DEATH DIFFER, V12, P1542, DOI 10.1038/sj.cdd.4401765	48	25	26	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2016	11	8							e0157919	10.1371/journal.pone.0157919	http://dx.doi.org/10.1371/journal.pone.0157919			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT8TP	27548305	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000381768400003
J	Elhenawy, W; Davis, RM; Fero, J; Salama, NR; Felman, MF; Ruiz, N				Elhenawy, Wael; Davis, Rebecca M.; Fero, Jutta; Salama, Nina R.; Felman, Mario F.; Ruiz, Natividad			The O-Antigen Flippase Wzk Can Substitute for MurJ in Peptidoglycan Synthesis in Helicobacter pylori and Escherichia coli	PLOS ONE			English	Article							LIPID II FLIPPASE; GLYCOPROTEIN-BIOSYNTHESIS; GENE DISRUPTION; IDENTIFICATION; MVIN; PRECURSORS; RESISTANCE; SYSTEM; LIPOPOLYSACCHARIDE; RECOMBINATION	The peptidoglycan (PG) cell wall is an essential component of the cell envelope of most bacteria. Biogenesis of PG involves a lipid-linked disaccharide-pentapeptide intermediate called lipid II, which must be translocated across the cytoplasmic membrane after it is synthesized in the inner leaflet of this bilayer. Accordingly, it has been demonstrated that MurJ, the proposed lipid II flippase in Escherichia coli, is required for PG biogenesis, and thereby viability. In contrast, MurJ is not essential in Bacillus subtilis because this bacterium produces AmJ, an unrelated protein that is functionally redundant with MurJ. In this study, we investigated why MurJ is not essential in the prominent gastric pathogen, Helicobacter pylori. We found that in this bacterium, Wzk, the ABC (ATP-binding cassette) transporter that flips the lipid-linked O- or Lewis- antigen precursors across the inner membrane, is redundant with MurJ for cell viability. Heterologous expression of wzk in E. coli also suppresses the lethality caused by the loss of murJ. Furthermore, we show that this cross-species complementation is abolished when Wzk is inactivated by mutations that target a domain predicted to be required for ATPase activity. Our results suggest that Wzk can flip lipid II, implying that Wzk is the flippase with the most relaxed specificity for lipid-linked saccharides ever identified.	[Elhenawy, Wael; Felman, Mario F.] Univ Alberta, Dept Biol Sci, Edmonton, AB T6G 2E9, Canada; [Davis, Rebecca M.; Ruiz, Natividad] Ohio State Univ, Dept Microbiol, 484 W 12th Ave, Columbus, OH 43210 USA; [Fero, Jutta; Salama, Nina R.] Fred Hutchinson Canc Res Ctr, Div Human Biol, Seattle, WA 98109 USA; [Felman, Mario F.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA	University of Alberta; University System of Ohio; Ohio State University; Fred Hutchinson Cancer Center; Washington University (WUSTL)	Ruiz, N (corresponding author), Ohio State Univ, Dept Microbiol, 484 W 12th Ave, Columbus, OH 43210 USA.	ruiz.82@osu.edu	Salama, Nina Reda/AAG-2437-2019	Salama, Nina Reda/0000-0003-2762-1424; Elhenawy, Wael/0000-0002-4599-8500; Ruiz, Natividad/0000-0002-6369-2206	Natural Sciences and Engineering Research Council of Canada; National Institute of General Medical Sciences [R01GM100951]; National Institute of Allergy and Infectious Diseases of the National Institutes of Health [R01AI094839]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI094839] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100951] Funding Source: NIH RePORTER	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute of Allergy and Infectious Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Natural Sciences and Engineering Research Council of Canada (to MFF; http://www.nserc-crsng.gc.ca/index_eng.asp), and the National Institute of General Medical Sciences (award number R01GM100951 to NR) and the National Institute of Allergy and Infectious Diseases (award number R01AI094839 to NRS) of the National Institutes of Health (https://www.nih.gov/).	Alaimo C, 2006, EMBO J, V25, P967, DOI 10.1038/sj.emboj.7601024; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Barreteau H, 2008, FEMS MICROBIOL REV, V32, P168, DOI 10.1111/j.1574-6976.2008.00104.x; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Bouhss A, 2008, FEMS MICROBIOL REV, V32, P208, DOI 10.1111/j.1574-6976.2007.00089.x; Bugg TDH, 2011, TRENDS BIOTECHNOL, V29, P167, DOI 10.1016/j.tibtech.2010.12.006; Butler EK, 2014, J BACTERIOL, V196, P4111, DOI 10.1128/JB.02172-14; Butler EK, 2013, J BACTERIOL, V195, P4639, DOI 10.1128/JB.00731-13; CHATTERJEE AN, 1964, P NATL ACAD SCI USA, V51, P9, DOI 10.1073/pnas.51.1.9; CHEREPANOV PP, 1995, GENE, V158, P9, DOI 10.1016/0378-1119(95)00193-A; Cuthbertson L, 2010, MICROBIOL MOL BIOL R, V74, P341, DOI 10.1128/MMBR.00009-10; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Davidson AL, 2008, MICROBIOL MOL BIOL R, V72, P317, DOI 10.1128/MMBR.00031-07; DEBOER PAJ, 1989, CELL, V56, P641, DOI 10.1016/0092-8674(89)90586-2; Dykxhoorn DM, 1996, GENE, V177, P133, DOI 10.1016/0378-1119(96)00289-2; Fay A, 2009, J BACTERIOL, V191, P6020, DOI 10.1128/JB.00605-09; Feldman MF, 1999, J BIOL CHEM, V274, P35129, DOI 10.1074/jbc.274.49.35129; Helenius J, 2002, NATURE, V415, P447, DOI 10.1038/415447a; Hong YQ, 2014, J BACTERIOL, V196, P1713, DOI 10.1128/JB.01323-13; Hong YQ, 2012, MOL MICROBIOL, V84, P620, DOI 10.1111/j.1365-2958.2012.08048.x; HORTON RM, 1995, MOL BIOTECHNOL, V3, P93, DOI 10.1007/BF02789105; Huber J, 2009, CHEM BIOL, V16, P837, DOI 10.1016/j.chembiol.2009.05.012; Hug I, 2011, GLYCOBIOLOGY, V21, P138, DOI 10.1093/glycob/cwq148; Hug I, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000819; Humbert O, 2008, NUCLEIC ACIDS RES, V36, P6893, DOI 10.1093/nar/gkn718; Hvorup RN, 2003, EUR J BIOCHEM, V270, P799, DOI 10.1046/j.1432-1033.2003.03418.x; Inoue A, 2008, J BACTERIOL, V190, P7298, DOI 10.1128/JB.00551-08; Islam ST, 2014, CAN J MICROBIOL, V60, P697, DOI 10.1139/cjm-2014-0595; Islam ST, 2013, ENVIRON MICROBIOL, V15, P1001, DOI 10.1111/j.1462-2920.2012.02890.x; Jelk J, 2013, J BIOL CHEM, V288, P20616, DOI 10.1074/jbc.M113.479642; Jorgenson MA, 2016, MOL MICROBIOL, V100, P1, DOI 10.1111/mmi.13284; Linton D, 2005, MOL MICROBIOL, V55, P1695, DOI 10.1111/j.1365-2958.2005.04519.x; LIU D, 1994, MICROBIOL-UK, V140, P49, DOI 10.1099/13500872-140-1-49; Marolda CL, 2004, MICROBIOL-SGM, V150, P4095, DOI 10.1099/mic.0.27456-0; MEADOW PM, 1964, BIOCHEM BIOPH RES CO, V14, P382, DOI 10.1016/S0006-291X(64)80014-0; Meeske AJ, 2015, P NATL ACAD SCI USA, V112, P6437, DOI 10.1073/pnas.1504967112; MENARD R, 1993, ANTIMICROB AGENTS CH, V37, P78, DOI 10.1128/AAC.37.1.78; MENGINLECREULX D, 1991, J BACTERIOL, V173, P4625, DOI 10.1128/jb.173.15.4625-4636.1991; Mohamed YF, 2014, GLYCOBIOLOGY, V24, P564, DOI 10.1093/glycob/cwu025; Mohammadi T, 2011, EMBO J, V30, P1425, DOI 10.1038/emboj.2011.61; Musumeci MA, 2014, GLYCOBIOLOGY, V24, P39, DOI 10.1093/glycob/cwt087; Perez C, 2015, NATURE, V524, P433, DOI 10.1038/nature14953; Ranjit DK, 2016, J BACTERIOL, V198, P1230, DOI 10.1128/JB.01034-15; Rudnick PA, 2001, J BACTERIOL, V183, P2682, DOI 10.1128/JB.183.8.2682-2685.2001; Ruiz N, 2008, P NATL ACAD SCI USA, V105, P15553, DOI 10.1073/pnas.0808352105; Ruiz Natividad, 2015, Lipid Insights, V8, P21, DOI 10.4137/LPI.S31783; Ruiz N, 2009, ANTIMICROB AGENTS CH, V53, P3604, DOI 10.1128/AAC.00578-09; Salama NR, 2004, J BACTERIOL, V186, P7926, DOI 10.1128/JB.186.23.7926-7935.2004; Sanabria-Valentin E, 2007, MICROBES INFECT, V9, P1553, DOI 10.1016/j.micinf.2007.08.011; Sham LT, 2014, SCIENCE, V345, P220, DOI 10.1126/science.1254522; Silhavy T.J., 1984, EXPT GENE FUSIONS; Silhavy TJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000414; Sycuro LK, 2013, MOL MICROBIOL, V90, P869, DOI 10.1111/mmi.12405; Taylor VL, 2017, CURR TOP MICROBIOL, V404, P95, DOI 10.1007/82_2015_5014; Thanassi JA, 2002, NUCLEIC ACIDS RES, V30, P3152, DOI 10.1093/nar/gkf418; Turner RD, 2014, MOL MICROBIOL, V91, P862, DOI 10.1111/mmi.12513; Typas A, 2012, NAT REV MICROBIOL, V10, P123, DOI 10.1038/nrmicro2677; Typas A, 2010, CELL, V143, P1097, DOI 10.1016/j.cell.2010.11.038; Vasudevan P, 2009, J BACTERIOL, V191, P6012, DOI 10.1128/JB.00604-09; Vollmer W, 2008, BBA-BIOMEMBRANES, V1778, P1714, DOI 10.1016/j.bbamem.2007.06.007; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P149, DOI 10.1111/j.1574-6976.2007.00094.x; Vollmer W, 2010, TRENDS MICROBIOL, V18, P59, DOI 10.1016/j.tim.2009.12.004; Wang G, 2000, MOL MICROBIOL, V36, P1187, DOI 10.1046/j.1365-2958.2000.01934.x; Yan AX, 2007, J BIOL CHEM, V282, P36077, DOI 10.1074/jbc.M706172200; Young KD, 2014, SCIENCE, V345, P139, DOI 10.1126/science.1256585; Yu DG, 2000, P NATL ACAD SCI USA, V97, P5978, DOI 10.1073/pnas.100127597	67	20	20	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0161587	10.1371/journal.pone.0161587	http://dx.doi.org/10.1371/journal.pone.0161587			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27537185	Green Published, gold, Green Submitted			2022-12-27	WOS:000381577000124
J	Guo, J; Wang, M; Wang, ZS; Liu, XH				Guo, Jia; Wang, Min; Wang, Zhishun; Liu, Xiuheng			Overexpression of Pleomorphic Adenoma Gene-Like 2 Is a Novel Poor Prognostic Marker of Prostate Cancer	PLOS ONE			English	Article							ZINC-FINGER PROTEIN; FAMILY-MEMBERS; EXPRESSION; PLAGL2; CELLS; RISK	Pleomorphic adenoma gene like-2 (PLAGL2) is a member of the PLAG gene family. Previous studies have revealed that overexpression of PLAGL2 is associated with many human cancers. However, it has been reported that PLAGL2 also plays as a tumor suppressor. The precise role of PLAGL2 in prostate cancer (PCa) is still unknown. The aim of this study was to investigate the expression and prognostic value of PLAGL2 in PCa. Data from microarray datasets demonstrated that the DNA copy number and mRNA level of PLAGL2 were significantly increased in PCa compared with normal prostate. qRT-PCR and western blot analysis from paired PCa samples and prostate cell lines confirmed upregulated mRNA and protein expression levels in PCa. Immunohistochemistry analysis showed that staining of PLAGL2 in PCa tissues was significantly higher than that in benign prostatic hyperplasia (BPH) tissues. In addition, the high expression of PLAGL2 was only involved in preoperative PSA, but was not related to age, Gleason score, seminal vesicle invasion, surgical margin status, clinical stage and positive lymph node metastasis. Moreover, our results showed that PLAGL2 was an independent prognostic factor for biochemical recurrence (BCR)-free survival and overall survival (OS) of PCa patients, and overexpressed PLAGL2 was related to early development of BCR and poor OS. In conclusion, our findings suggest that PLAGL2 is overexpressed in PCa. The increased expression of PLAGL2 correlates to PCa progression following radical prostatectomy and may serve as a novel poor prognostic marker for PCa.	[Guo, Jia; Wang, Min; Wang, Zhishun; Liu, Xiuheng] Wuhan Univ, Renmin Hosp, Dept Urol, Wuhan, Hubei, Peoples R China	Wuhan University	Liu, XH (corresponding author), Wuhan Univ, Renmin Hosp, Dept Urol, Wuhan, Hubei, Peoples R China.	doctlxh@163.com			National Natural Science Foundation of China [2013RMFH012]; Province Natural Science Foundation of Hubei [2012FFA096]; Science Foundation of Wuhan [2015060101010049]; Fundamental Research Funds for the Central Universities [2042014kf0115]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Province Natural Science Foundation of Hubei(Natural Science Foundation of Hubei Province); Science Foundation of Wuhan; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This study is supported by the grants from the National Natural Science Foundation of China (No. 2013RMFH012), the Province Natural Science Foundation of Hubei (No. 2012FFA096), the Science Foundation of Wuhan (NO. 2015060101010049) and supported by the Fundamental Research Funds for the Central Universities (NO. 2042014kf0115).; This study was supported by the grants from the National Natural Science Foundation of China (No. 2013RMFH012), the Province Natural Science Foundation of Hubei (No. 2012FFA096), the Science Foundation of Wuhan (NO. 2015060101010049) and supported by the Fundamental Research Funds for the Central Universities (NO. 2042014kf0115). We are appreciative to Key laboratory of Hubei Province for Digestive System Disease and all the authors who contributed to this study.	Abdollahi A, 2007, J CELL PHYSIOL, V210, P16, DOI 10.1002/jcp.20835; Ambs S, 2008, CANCER RES, V68, P6162, DOI 10.1158/0008-5472.CAN-08-0144; Briganti A, 2014, CANCER TREAT REV, V40, P3, DOI 10.1016/j.ctrv.2013.07.001; Carroll PR, 2005, J UROLOGY, V173, P1061, DOI 10.1097/01.ju.0000156838.67623.10; DAUGHADAY WH, 1990, ENDOCRINOLOGY, V127, P1; Dearnaley D., 2006, PROSTATE CANC 6 INT, P277; Furukawa T, 2001, ONCOGENE, V20, P4718, DOI 10.1038/sj.onc.1204647; Garnett MJ, 2012, NATURE, V483, P570, DOI 10.1038/nature11005; Garnick MB, 1998, SCI AM, V279, P74, DOI 10.1038/scientificamerican1298-74; Hanks TS, 2012, APOPTOSIS, V17, P236, DOI 10.1007/s10495-011-0672-3; Hensen K, 2002, CANCER RES, V62, P1510; Hess KR, 2006, CANCER, V106, P1624, DOI 10.1002/cncr.21778; Kas K, 1997, NAT GENET, V15, P170, DOI 10.1038/ng0297-170; Landrette SF, 2005, BLOOD, V105, P2900, DOI 10.1182/blood-2004-09-3630; Lin DW, 2009, CANCER-AM CANCER SOC, V115, P2863, DOI 10.1002/cncr.24324; Liu B, 2014, INT J CLIN EXP PATHO, V7, P3089; Martin ES, 2007, CANCER RES, V67, P10736, DOI 10.1158/0008-5472.CAN-07-2742; Meacham CE, 2013, NATURE, V501, P328, DOI 10.1038/nature12624; Ramirez RD, 2004, CANCER RES, V64, P9027, DOI 10.1158/0008-5472.CAN-04-3703; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; Simmons MN, 2007, EUR UROL, V51, P1175, DOI 10.1016/j.eururo.2007.01.015; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Thompson Ian M, 2012, Am Soc Clin Oncol Educ Book, pe35, DOI 10.14694/EdBook_AM.2012.32.e35; Van Dyck F, 2007, INT J ONCOL, V30, P765; Yang MCW, 2005, AM J RESP CELL MOL, V32, P35, DOI 10.1165/rcmb.2003-0422OC; Yang YS, 2011, LUNG CANCER, V74, P12, DOI 10.1016/j.lungcan.2011.02.006; Zhang HT, 2013, J EXP CLIN CANC RES, V32, DOI 10.1186/1756-9966-32-77; Zheng HW, 2010, CANCER CELL, V17, P497, DOI 10.1016/j.ccr.2010.03.020	28	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0158667	10.1371/journal.pone.0158667	http://dx.doi.org/10.1371/journal.pone.0158667			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27537362	Green Published, Green Submitted, gold			2022-12-27	WOS:000381577000006
J	Jiang, F; He, JY; Navarro-Alvarez, N; Xu, J; Li, X; Li, P; Wu, WX				Jiang, Fei; He, Jinyan; Navarro-Alvarez, Nalu; Xu, Jian; Li, Xia; Li, Peng; Wu, Wenxue			Elongation Factor Tu and Heat Shock Protein 70 Are Membrane-Associated Proteins from Mycoplasma ovipneumoniae Capable of Inducing Strong Immune Response in Mice	PLOS ONE			English	Article							BIGHORN SHEEP; RECOMBINANT PROTEIN; HYOPNEUMONIAE; PNEUMONIA; FIBRONECTIN; ANTIGENS; ADHESIN; SUBUNIT; DISEASE; INNATE	Chronic non-progressive pneumonia, a disease that has become a worldwide epidemic has caused considerable loss to sheep industry. Mycoplasma ovipneumoniae (M. ovipneumoniae) is the causative agent of interstitial pneumonia in sheep, goat and bighorn. We here have identified by immunogold and immunoblotting that elongation factor Tu (EF-Tu) and heat shock protein 70 (HSP 70) are membrane-associated proteins on M. ovipneumonaiea. We have evaluated the humoral and cellular immune responses in vivo by immunizing BALB/c mice with both purified recombinant proteins rEF-Tu and rHSP70. The sera of both rEF-Tu and rHSP70 treated BALB/c mice demonstrated increased levels of IgG, IFN-gamma, TNF-alpha, IL-12(p70), IL-4, IL-5 and IL-6. In addition, ELISPOT assay showed significant increase in IFN-gamma(+) secreting lymphocytes in the rHSP70 group when compared to other groups. Collectively our study reveals that rHSP70 induces a significantly better cellular immune response in mice, and may act as a Th1 cytokine-like adjuvant in immune response induction. Finally, growth inhibition test (GIT) of M. ovipneumoniae strain Y98 showed that sera from rHSP70 or rEF-Tu-immunized mice inhibited in vitro growth of M. ovipneumoniae. Our data strongly suggest that EF-Tu and HSP70 of M. ovipneumoniae are membrane-associated proteins capable of inducing antibody production, and cytokine secretion. Therefore, these two proteins may be potential candidates for vaccine development against M. ovipneumoniae infection in sheep.	[Jiang, Fei; He, Jinyan; Xu, Jian; Li, Xia; Li, Peng; Wu, Wenxue] China Agr Univ, Coll Vet Med, Lab Rapid Diagnost Technol Anim Dis, Beijing 100193, Peoples R China; [Jiang, Fei; He, Jinyan; Xu, Jian; Li, Xia; Li, Peng; Wu, Wenxue] China Agr Univ, Coll Vet Med, Minist Agr, Key Lab Anim Epidemiol & Zoonosis, Beijing 100193, Peoples R China; [Navarro-Alvarez, Nalu] Harvard Med Sch, Massachusetts Gen Hosp, Ctr Transplantat Sci, Charlestown, MA 02129 USA	China Agricultural University; China Agricultural University; Ministry of Agriculture & Rural Affairs; Harvard University; Massachusetts General Hospital	Wu, WX (corresponding author), China Agr Univ, Coll Vet Med, Lab Rapid Diagnost Technol Anim Dis, Beijing 100193, Peoples R China.; Wu, WX (corresponding author), China Agr Univ, Coll Vet Med, Minist Agr, Key Lab Anim Epidemiol & Zoonosis, Beijing 100193, Peoples R China.	wuwenxue@cau.edu.cn	Navarro-Alvarez, Nalu/AAI-1034-2019	Navarro-Alvarez, Nalu/0000-0003-0118-4676	Special Fund for Agro-scientific Research in the Public Interest of China [201203056]	Special Fund for Agro-scientific Research in the Public Interest of China	This research was supported by Special Fund for Agro-scientific Research in the Public Interest of China, No. 201203056. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alley MR, 1999, NEW ZEAL VET J, V47, P155, DOI 10.1080/00480169.1999.36135; Alonso JMM, 2002, VET MICROBIOL, V89, P277, DOI 10.1016/S0378-1135(02)00258-4; Balasubramanian S, 2008, INFECT IMMUN, V76, P3116, DOI 10.1128/IAI.00173-08; Barbier M, 2013, MBIO, V4, DOI 10.1128/mBio.00207-13; Besser TE, 2008, J CLIN MICROBIOL, V46, P423, DOI 10.1128/JCM.01931-07; Besser TE, 2013, PREV VET MED, V108, P85, DOI 10.1016/j.prevetmed.2012.11.018; Besser TE, 2012, EMERG INFECT DIS, V18, P406, DOI 10.3201/eid1803.111554; Chen AY, 2008, VACCINE, V26, P4372, DOI 10.1016/j.vaccine.2008.06.005; Chen C, 2015, TROP ANIM HEALTH PRO, V47, P1641, DOI 10.1007/s11250-015-0908-2; Chen YL, 2003, INFECT IMMUN, V71, P1155, DOI 10.1128/IAI.71.3.1155-1160.2003; Cloward JM, 2009, MOL MICROBIOL, V71, P1296, DOI 10.1111/j.1365-2958.2009.06602.x; Dallo SF, 2002, MOL MICROBIOL, V46, P1041, DOI 10.1046/j.1365-2958.2002.03207.x; Dassanayake RP, 2010, VET MICROBIOL, V145, P354, DOI 10.1016/j.vetmic.2010.04.011; Deutscher AT, 2010, MOL MICROBIOL, V78, P444, DOI 10.1111/j.1365-2958.2010.07345.x; Floto RA, 2006, SCIENCE, V314, P454, DOI 10.1126/science.1133515; Galli V, 2012, VACCINE, V31, P135, DOI 10.1016/j.vaccine.2012.10.088; Giangaspero M, 2012, TROP ANIM HEALTH PRO, V44, P395, DOI 10.1007/s11250-011-9952-8; Guidotti LG, 2001, ANNU REV IMMUNOL, V19, P65, DOI 10.1146/annurev.immunol.19.1.65; Harvey ME, 2007, SMALL RUMINANT RES, V73, P287, DOI 10.1016/j.smallrumres.2007.01.013; Hausner M, 2013, MICROB PATHOGENESIS, V64, P23, DOI 10.1016/j.micpath.2013.07.004; Hsu T, 1997, J BACTERIOL, V179, P1317, DOI 10.1128/jb.179.4.1317-1323.1997; Jonak J, 2007, J CHROMATOGR B, V849, P141, DOI 10.1016/j.jchromb.2006.11.053; KOROLEV EV, 1994, MICROBIOL-UK, V140, P671, DOI 10.1099/00221287-140-3-671; Kunert A, 2007, J IMMUNOL, V179, P2979, DOI 10.4049/jimmunol.179.5.2979; Li M, 2011, GENET MOL RES, V10, P834, DOI 10.4238/vol10-2gmr1193; Medzhitov R, 1997, CURR OPIN IMMUNOL, V9, P4, DOI 10.1016/S0952-7915(97)80152-5; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; Murphy ME, 2013, CARCINOGENESIS, V34, P1181, DOI 10.1093/carcin/bgt111; Nicholas RAJ, 2002, SMALL RUMINANT RES, V45, P145, DOI 10.1016/S0921-4488(02)00095-0; Nieves W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014361; Okamba FR, 2010, VACCINE, V28, P4802, DOI 10.1016/j.vaccine.2010.04.089; Parham K, 2006, VET MICROBIOL, V118, P83, DOI 10.1016/j.vetmic.2006.07.005; Patel H, 2008, VET MICROBIOL, V127, P309, DOI 10.1016/j.vetmic.2007.08.030; Pettersson B, 1996, INT J SYST BACTERIOL, V46, P1093, DOI 10.1099/00207713-46-4-1093; RAZIN S, 1992, J GEN MICROBIOL, V138, P407, DOI 10.1099/00221287-138-3-407; Razin S, 1998, MICROBIOL MOL BIOL R, V62, P1094, DOI 10.1128/MMBR.62.4.1094-1156.1998; Conceicao FR, 2006, VACCINE, V24, P5734, DOI 10.1016/j.vaccine.2006.04.036; Schurwanz N, 2009, INFECT IMMUN, V77, P5007, DOI 10.1128/IAI.00268-09; Shahzad W, 2010, VET IMMUNOL IMMUNOP, V136, P116, DOI 10.1016/j.vetimm.2010.02.001; Srivastava P, 2002, NAT REV IMMUNOL, V2, P185, DOI 10.1038/nri749; Sun ZH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088328; Suzue K, 1996, J IMMUNOL, V156, P873; Uto T, 2011, FEMS IMMUNOL MED MIC, V61, P189, DOI 10.1111/j.1574-695X.2010.00762.x; Virginio VG, 2014, VACCINE, V32, P5832, DOI 10.1016/j.vaccine.2014.08.008; Wang XH, 2014, J INTEGR AGR, V13, P2562, DOI 10.1016/S2095-3119(14)60825-X; Xin JQ, 2012, VET J, V191, P166, DOI 10.1016/j.tvjl.2011.02.011; Yang FL, 2011, J BACTERIOL, V193, P5018, DOI 10.1128/JB.05363-11; Yoshida S, 2000, INFECT IMMUN, V68, P3186, DOI 10.1128/IAI.68.6.3186-3192.2000	48	16	21	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0161170	10.1371/journal.pone.0161170	http://dx.doi.org/10.1371/journal.pone.0161170			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27537186	Green Published, Green Submitted, gold			2022-12-27	WOS:000381577000064
J	Lama, JR; Karuna, ST; Grant, SP; Swann, EM; Ganoza, C; Segura, P; Montano, SM; Lacherre, M; De Rosa, SC; Buchbinder, S; Sanchez, J; McElrath, MJ; Lemos, MP				Lama, Javier R.; Karuna, Shelly T.; Grant, Shannon P.; Swann, Edith M.; Ganoza, Carmela; Segura, Patricia; Montano, Silvia M.; Lacherre, Martin; De Rosa, Stephen C.; Buchbinder, Susan; Sanchez, Jorge; McElrath, M. Juliana; Lemos, Maria P.		HVTN 914 Study Team	Transient Peripheral Immune Activation follows Elective Sigmoidoscopy or Circumcision in a Cohort Study of MSM at Risk of HIV Infection	PLOS ONE			English	Article							T-CELL RESPONSES; VIRUS-INFECTION; MEN; VACCINE; SEX; TRIAL; ACQUISITION; PREVENTION; SAFETY; COMPLICATIONS	Background Rectal and genital sampling in HIV prevention trials permits assessments at the site of HIV entry. Yet the safety and acceptability of circumcision and sigmoidoscopy (and associated abstinence recommendations) are unknown in uncircumcised men who have sex with men (MSM) at high risk of HIV infection. Methods Twenty-nine HIV-seronegative high-risk Peruvian MSM agreed to elective sigmoidoscopy biopsy collections (weeks 2 and 27) and circumcision (week 4) in a 28-week cohort study designed to mimic an HIV vaccine study mucosal collection protocol. We monitored adherence to abstinence recommendations, procedure-related complications, HIV infections, peripheral immune activation, and retention. Results Twenty-three (79.3%) underwent a first sigmoidoscopy, 21 (72.4%) were circumcised, and 16 (55.2%) completed a second sigmoidoscopy during the study period. All who underwent procedures completed the associated follow-up safety visits. Those completing the procedures reported they were well tolerated, and complication rates were similar to those reported in the literature. Immune activation was detected during the healing period (1 week post-sigmoidoscopy, 6 weeks post-circumcision), including increases in CCR5(+)CD4(+)T cells and alpha 4 beta 7(+)CD4(+)T cells. Most participants adhered to post-circumcision abstinence recommendations whereas reduced adherence occurred post-sigmoidoscopy. Conclusion Rectosigmoid mucosal and genital tissue collections were safe in high-risk MSM. Although the clinical implications of the post-procedure increase in peripheral immune activation markers are unknown, they reinforce the need to provide ongoing risk reduction counseling and support for post-procedure abstinence recommendations. Future HIV vaccine studies should also consider the effects of mucosal and tissue collections on peripheral blood endpoints in trial design and analysis.	[Lama, Javier R.; Ganoza, Carmela; Segura, Patricia; Lacherre, Martin; Sanchez, Jorge] Asociac Civil Impacta Salud & Educ, Lima, Peru; [Karuna, Shelly T.; Grant, Shannon P.; De Rosa, Stephen C.; McElrath, M. Juliana; Lemos, Maria P.] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, 1124 Columbia St, Seattle, WA 98104 USA; [Swann, Edith M.] NIAID, Vaccine Clin Res Branch, Div AIDS, US NIH, Bethesda, MD USA; [Montano, Silvia M.] US Naval Med Res Unit 6, Callao, Peru; [De Rosa, Stephen C.; Sanchez, Jorge] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [McElrath, M. Juliana] Univ Washington, Dept Lab Med, Seattle, WA 98195 USA; [McElrath, M. Juliana] Univ Washington, Dept Med, Seattle, WA USA; [Buchbinder, Susan] San Francisco Dept Hlth, San Francisco, CA USA	Fred Hutchinson Cancer Center; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Naval Medical Research Center (NMRC); Naval Medical Research Unit No. 6 (NAMRU-6); University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Lemos, MP (corresponding author), Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, 1124 Columbia St, Seattle, WA 98104 USA.	mlemos@fredhutch.org			National Institute of Allergy and Infectious Diseases of the National Institutes of Health [UM1AI068614, UM1AI068618, UM1AI068635, UM1AI069438]; National Institute of Allergy and Infectious Diseases of the U.S. National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI068614, UM1AI068635, UM1AI068618, UM1AI069496, UM1AI069438] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Allergy and Infectious Diseases of the U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Research reported in this publication was supported by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health under award numbers UM1AI068614, UM1AI068618, UM1AI068635, and UM1AI069438. The content is the responsibility of the authors and does not necessarily represent the official views, policy or position of the U.S. National Institutes of Health, Department of the Navy, Department of Defense, or U.S. Government. Silvia Montano and Edith Swann are employees of the U.S. Government, who contributed to this work as part of their official duties. No copyright protection is available for their work as defined by Title 17 U.S.C. 105 and 101.; Research reported in this publication was supported by the National Institute of Allergy and Infectious Diseases of the U.S. National Institutes of Health. The content is the responsibility of the authors and does not necessarily represent the official views, policy or position of the U.S. National Institutes of Health, the Department of the Navy, the Department of Defense, or the U.S. Government. Silvia Montano and Edith Swann are employees of the U.S. Government who contributed to this work as part of her official duties. No copyright protection is available for their work as defined by Titles 17 U.S.C. 105 and 101.	Agresti A, 1998, AM STAT, V52, P119, DOI 10.2307/2685469; Anderson ML, 2000, AM J GASTROENTEROL, V95, P3418, DOI 10.1111/j.1572-0241.2000.03356.x; Anton PA, 2012, AIDS RES HUM RETROV, V28, P1412, DOI [10.1089/aid.2012.0262, 10.1089/AID.2012.0262]; Ashley Rhoda L, 2002, Herpes, V9, P38; Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Belyakov IM, 2007, J IMMUNOL, V178, P7211, DOI 10.4049/jimmunol.178.11.7211; Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; Cooper CJ, 2010, JAMA-J AM MED ASSOC, V304, P275, DOI 10.1001/jama.2010.926; Ferre AL, 2010, J VIROL, V84, P10354, DOI 10.1128/JVI.00803-10; Francis SC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0143109; Freeman EE, 2006, AIDS, V20, P73, DOI 10.1097/01.aids.0000198081.09337.a7; Gaini S, 2006, CRIT CARE, V10, DOI 10.1186/cc4866; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Hansen SG, 2016, SCIENCE; Hiki N, 1999, CLIN DIAGN LAB IMMUN, V6, P844, DOI 10.1128/CDLI.6.6.844-850.1999; Kierstead LS, 2007, AIDS RES HUM RETROV, V23, P86, DOI 10.1089/aid.2006.0129; Kigozi G, 2008, PLOS MED, V5, P911, DOI 10.1371/journal.pmed.0050116; Kigozi G, 2014, UROLOGY, V83, P294, DOI 10.1016/j.urology.2013.08.038; Lemos MP, 2016, MUCOSAL IMMUNOL, V9, P798, DOI 10.1038/mi.2015.103; Levin TR, 2002, GASTROENTEROLOGY, V123, P1786, DOI 10.1053/gast.2002.37064; Li QS, 2014, J IMMUNOL, V193, P3113, DOI 10.4049/jimmunol.1400820; Masson L, 2015, SEXUALLY TRANSMITTED, DOI 10.1136/; McGowan I, 2007, JAIDS-J ACQ IMM DEF, V46, P417, DOI 10.1097/QAI.0b013e318156ef16; Mehta SD, 2009, AIDS, V23, P1557, DOI 10.1097/QAD.0b013e32832afe95; Ministerio de Salud del Peru, 2009, DOCUMENTO TECNICO CO; Passmore JAS, 2016, CURR OPIN HIV AIDS, V11, P156, DOI 10.1097/COH.0000000000000232; Patel P, 2014, AIDS, V28, P1509, DOI 10.1097/QAD.0000000000000298; Paxton WA, 1998, VIROLOGY, V244, P66, DOI 10.1006/viro.1998.9082; Peinado J, 2007, J SEX RES, V44, P233, DOI 10.1080/00224490701443676; Perera CL, 2010, ANN FAM MED, V8, P64, DOI 10.1370/afm.1073; Perreau M, 2011, J VIROL, V85, P9854, DOI 10.1128/JVI.00788-11; Picker LJ, 2006, CURR OPIN IMMUNOL, V18, P399, DOI 10.1016/j.coi.2006.05.001; Sanchez J, 2007, JAIDS-J ACQ IMM DEF, V44, P578, DOI 10.1097/QAI.0b013e318033ff82; Sanchez J, 2011, AIDS, V25, P519, DOI 10.1097/QAD.0b013e328340fd81; Sanchez J, 2009, JAIDS-J ACQ IMM DEF, V51, pS47, DOI 10.1097/QAI.0b013e3181a2671d; Schumann RR, 1999, CLIN CHEM LAB MED, V37, P271, DOI 10.1515/CCLM.1999.047; Thomas SM, 2006, AIDS, V20, P1879, DOI 10.1097/01.aids.0000244207.49123.ff; Vittinghoff E, 1999, AM J EPIDEMIOL, V150, P306, DOI 10.1093/oxfordjournals.aje.a010003; Wagner N, 1996, NATURE, V382, P366, DOI 10.1038/382366a0; Wald A, 2002, J INFECT DIS, V185, P45, DOI 10.1086/338231; WILCOXON F, 1946, J ECON ENTOMOL, V39, P269, DOI 10.1093/jee/39.2.269; WILLIAMS N, 1993, BRIT J SURG, V80, P1231, DOI 10.1002/bjs.1800801005; Wiysonge CS, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007496.pub2; Workowski Kimberly A, 2010, MMWR Recomm Rep, V59, P1; Yang OO, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088621; Zeng M, 2016, J IMMUNOL, V196, P2809, DOI 10.4049/jimmunol.1500156	47	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0160487	10.1371/journal.pone.0160487	http://dx.doi.org/10.1371/journal.pone.0160487			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27536938	Green Published, Green Submitted, gold			2022-12-27	WOS:000381577000022
J	Shakib, S; Dundon, BK; Maddison, J; Thomas, J; Stanners, M; Caughey, GE; Clark, RA				Shakib, Sepehr; Dundon, Benjamin K.; Maddison, John; Thomas, Josephine; Stanners, Melinda; Caughey, Gillian E.; Clark, Robyn A.			Effect of a Multidisciplinary Outpatient Model of Care on Health Outcomes in Older Patients with Multimorbidity: A Retrospective Case Control Study	PLOS ONE			English	Article							HEART-FAILURE PATIENTS; CHRONIC DISEASES; RISK; THERAPY; METAANALYSIS; TRANSITIONS; MANAGEMENT; PROGRAMS; ADULTS; DEATH	Objective To evaluate a holistic multidisciplinary outpatient model of care on hospital readmission, length of stay and mortality in older patients with multimorbidity following discharge from hospital. Design and Participants A pilot case-control study between March 2006 and June 2009 of patients referred on discharge to a multidisciplinary, integrated outpatient model of care that includes outpatient follow-up, timely GP communication and dial-in service compared with .1 ratio with cases for age, gender, index admission diagnosis and length of stay. Main outcome measures Non-elective readmission rates, total readmission length of stay and overall survival. Results A total of 252 cases and 1008 control patients were included in the study. Despite the patients referred to the multidisciplinary model of care had slightly more comorbid conditions, significantly higher total length of hospital stay in the previous 12 months and increased prevalence of diabetes and heart failure by comparison to those who received they had significantly improved survival (adjusted hazard ratio 0.70 95% CI 0.51-0.96, p = 0.029) and no excess in the number of hospitalisations observed. Conclusion Following discharge from hospital, holistic multidisciplinary outpatient management is associated with improved survival in older patients with multimorbidity. The findings of this study warrant further examination in randomised and cost-effectiveness trials.	[Shakib, Sepehr; Maddison, John; Stanners, Melinda; Caughey, Gillian E.] Royal Adelaide Hosp, Dept Clin Pharmacol, North Terrace, Adelaide, SA 5000, Australia; [Shakib, Sepehr] Univ Adelaide, Sch Med, Discipline Pharmacol, North Terrace, Adelaide, SA 5000, Australia; [Dundon, Benjamin K.] Monash Hlth, Monash Cardiovasc Res Ctr, Clayton, Vic, Australia; [Thomas, Josephine] Univ Adelaide, Sch Med, Clin Educ, Adelaide, SA 5000, Australia; [Caughey, Gillian E.] Univ South Australia, Sch Pharm & Med Sci, Adelaide, SA 5001, Australia; [Clark, Robyn A.] Flinders Univ South Australia, Dept Nursing Acute Care & Cardiovasc Res, Adelaide, SA 5001, Australia	Royal Adelaide Hospital; University of Adelaide; Monash University; University of Adelaide; University of South Australia; Flinders University South Australia	Shakib, S (corresponding author), Royal Adelaide Hosp, Dept Clin Pharmacol, North Terrace, Adelaide, SA 5000, Australia.; Shakib, S (corresponding author), Univ Adelaide, Sch Med, Discipline Pharmacol, North Terrace, Adelaide, SA 5000, Australia.	Sepehr.shakib@sa.gov.au	Stanners, Melinda/AAC-9235-2020; Clark, Robyn A/D-1604-2009	Stanners, Melinda/0000-0002-9480-9438; Clark, Robyn A/0000-0002-5063-2618; Caughey, Gillian/0000-0003-1192-4121; Thomas, Josephine/0000-0001-8124-5920	South Australian Health National Institute of Clinical Studies Fellowship	South Australian Health National Institute of Clinical Studies Fellowship	This study was supported by a South Australian Health National Institute of Clinical Studies Fellowship to Dr. Sepehr Shakib. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amarasingham R, 2010, MED CARE, V48, P981, DOI 10.1097/MLR.0b013e3181ef60d9; Boult C, 2011, ARCH INTERN MED, V171, P460, DOI 10.1001/archinternmed.2010.540; Boult C, 2009, J AM GERIATR SOC, V57, P2328, DOI 10.1111/j.1532-5415.2009.02571.x; Caughey GE, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-221; Clarke DM, 2009, MED J AUSTRALIA, V190, pS54; Coleman EA, 2004, HEALTH SERV RES, V39, P1449, DOI 10.1111/j.1475-6773.2004.00298.x; Effing T, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002990.pub2; Ellis SE, 2004, PATIENT EDUC COUNS, V52, P97, DOI 10.1016/S0738-3991(03)00016-8; Flather MD, 2000, LANCET, V355, P1575, DOI 10.1016/S0140-6736(00)02212-1; Gilbert A., 2013, AGEING WELL AGEING P; Gitlin LN, 2006, J AM GERIATR SOC, V54, P950, DOI 10.1111/j.1532-5415.2006.00733.x; Ho TH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093129; Inglis SC, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007228.pub2; Institute of Medicine, 2015, MEASURING IMPACT INT; Kwan JL, 2013, ANN INTERN MED, V158, P397, DOI 10.7326/0003-4819-158-5-201303051-00006; Lacasse Y, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003793.pub2; Lawlor DA, 2003, BRIT MED J, V327, P712, DOI 10.1136/bmj.327.7417.712; McAlister FA, 2004, J AM COLL CARDIOL, V44, P810, DOI 10.1016/j.jacc.2004.05.055; McAlister FA, 2009, ANN INTERN MED, V150, P784, DOI 10.7326/0003-4819-150-11-200906020-00006; Mosher HJ, 2015, JAMA INTERN MED, V175, P1298, DOI 10.1001/jamainternmed.2015.2430; Ouwens M, 2005, INT J QUAL HEALTH C, V17, P141, DOI 10.1093/intqhc/mzi016; Pannick S, 2015, JAMA INTERN MED, V175, P1288, DOI 10.1001/jamainternmed.2015.2421; Peytremann-Bridevaux I, 2008, AM J MED, V121, P433, DOI 10.1016/j.amjmed.2008.02.009; Renders CM, 2000, COCHRANE DATABASE SY; Reuben DB, 2012, NEW ENGL J MED, V366, P777, DOI 10.1056/NEJMp1113631; Seiler WO, 2001, NUTRITION, V17, P496, DOI 10.1016/S0899-9007(01)00558-5; Smith SM, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5205; Sommers LS, 2000, ARCH INTERN MED, V160, P1825, DOI 10.1001/archinte.160.12.1825; Wang SM, 2015, EUR J INTERN MED, V94, pe1437; Wilt TJ, 2004, ARCH INTERN MED, V164, P1427, DOI 10.1001/archinte.164.13.1427	30	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0161382	10.1371/journal.pone.0161382	http://dx.doi.org/10.1371/journal.pone.0161382			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DT6ES	27537395	Green Published, gold, Green Accepted			2022-12-27	WOS:000381577000096
J	Timucin, AC; Basaga, H				Timucin, Ahmet Can; Basaga, Huveyda			SIRT6 Is a Positive Regulator of Aldose Reductase Expression in U937 and HeLa cells under Osmotic Stress: In Vitro and In Silico Insights	PLOS ONE			English	Article							MOLECULAR-DYNAMICS; DEACETYLASE SIRT6; BINDING-SITES; PROTEIN; NFAT5; ATHEROSCLEROSIS; SUBSTRATE	SIRT6 is a protein deacetylase, involved in various intracellular processes including suppression of glycolysis and DNA repair. Aldose Reductase (AR), first enzyme of polyol pathway, was proposed to be indirectly associated to these SIRT6 linked processes. Despite these associations, presence of SIRT6 based regulation of AR still remains ambiguous. Thus, regulation of AR expression by SIRT6 was investigated under hyperosmotic stress. A unique model of osmotic stress in U937 cells was used to demonstrate the presence of a potential link between SIRT6 and AR expression. By overexpressing SIRT6 in HeLa cells under hyperosmotic stress, its role on upregulation of AR was revealed. In parallel, increased SIRT6 activity was shown to upregulate AR in U937 cells under hyperosmotic milieu by using pharmacological modulators. Since these modulators also target SIRT1, binding of the inhibitor, Ex-527, specifically to SIRT6 was analyzed in silico. Computational observations indicated that Ex-527 may also target SIRT6 active site residues under high salt concentration, thus, validating in vitro findings. Based on these evidences, a novel regulatory step by SIRT6, modifying AR expression under hyperosmotic stress was presented and its possible interactions with intracellular machinery was discussed.	[Timucin, Ahmet Can; Basaga, Huveyda] Sabanci Univ, Fac Engn & Nat Sci, Mol Biol Genet & Bioengn Program, Istanbul, Turkey	Sabanci University	Basaga, H (corresponding author), Sabanci Univ, Fac Engn & Nat Sci, Mol Biol Genet & Bioengn Program, Istanbul, Turkey.	huveyda@sabanciuniv.edu	Timucin, Ahmet Can/ABI-6250-2020	Timucin, Ahmet Can/0000-0002-9483-3593	Sabanci University internal research fund	Sabanci University internal research fund(Sabanci University)	This material is based upon work supported by Sabanci University internal research fund (https://www.sabanciuniv.edu/en/) to HB (No grant number available). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Buxade M, 2012, J EXP MED, V209, P379, DOI 10.1084/jem.20111569; Chen Y, 2007, AM J PHYSIOL-RENAL, V292, pP981, DOI 10.1152/ajprenal.00493.2005; Dmitrieva NI, 2011, P NATL ACAD SCI USA, V108, P20796, DOI 10.1073/pnas.1114677108; Eisenhaber B, 2011, CELL CYCLE, V10, P3897, DOI 10.4161/cc.10.22.18043; Feig M, 2003, J PHYS CHEM B, V107, P2831, DOI 10.1021/jp027293y; Feldman JL, 2013, J BIOL CHEM, V288, P31350, DOI 10.1074/jbc.C113.511261; Gertz M, 2013, P NATL ACAD SCI USA, V110, pE2772, DOI 10.1073/pnas.1303628110; Guerois R, 2002, J MOL BIOL, V320, P369, DOI 10.1016/S0022-2836(02)00442-4; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jin L, 2009, J BIOL CHEM, V284, P24394, DOI 10.1074/jbc.M109.014928; JORGENSEN WL, 1983, J AM CHEM SOC, V105, P1407, DOI 10.1021/ja00344a001; Kim HS, 2010, CELL METAB, V12, P224, DOI 10.1016/j.cmet.2010.06.009; Kim SJ, 2014, INT J OPHTHALMOL-CHI, V7, P935, DOI 10.3980/j.issn.2222-3959.2014.06.04; Kokkonen P, 2014, EUR J PHARM SCI, V63, P71, DOI 10.1016/j.ejps.2014.06.015; Kwon HS, 2008, TRENDS BIOCHEM SCI, V33, P517, DOI 10.1016/j.tibs.2008.08.001; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; Lopez-Rodriguez C, 1999, P NATL ACAD SCI USA, V96, P7214, DOI 10.1073/pnas.96.13.7214; MacKerell AD, 2004, J AM CHEM SOC, V126, P698, DOI 10.1021/ja036959e; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Mao ZY, 2011, SCIENCE, V332, P1443, DOI 10.1126/science.1202723; Neuhofer W, 2010, CURR GENOMICS, V11, P584, DOI 10.2174/138920210793360961; North BJ, 2003, MOL CELL, V11, P437, DOI 10.1016/S1097-2765(03)00038-8; Oates PJ, 2008, CURR DRUG TARGETS, V9, P14, DOI 10.2174/138945008783431781; Pan PW, 2011, J BIOL CHEM, V286, P14575, DOI 10.1074/jbc.M111.218990; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Ramana KV, 2010, INT J BIOCHEM CELL B, V42, P17, DOI 10.1016/j.biocel.2009.09.009; Remo A, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0492-2; SCHERER WF, 1953, J EXP MED, V97, P695, DOI 10.1084/jem.97.5.695; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schreiber V, 2006, NAT REV MOL CELL BIO, V7, P517, DOI 10.1038/nrm1963; Schymkowitz J, 2005, NUCLEIC ACIDS RES, V33, pW382, DOI 10.1093/nar/gki387; Schymkowitz JWH, 2005, P NATL ACAD SCI USA, V102, P10147, DOI 10.1073/pnas.0501980102; Sebastian C, 2012, CELL, V151, P1185, DOI 10.1016/j.cell.2012.10.047; Solomon JM, 2006, MOL CELL BIOL, V26, P28, DOI 10.1128/MCB.26.1.28-38.2006; Srivastava SK, 2005, ENDOCR REV, V26, P380, DOI 10.1210/er.2004-0028; SUNDSTROM C, 1976, INT J CANCER, V17, P565, DOI 10.1002/ijc.2910170504; Timucin AC, 2015, CELL SIGNAL, V27, P2160, DOI 10.1016/j.cellsig.2015.08.013; Tong EHY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008435; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Vance DT, 2016, ANAL BIOCHEM, V500, P24, DOI 10.1016/j.ab.2016.01.007; Vedantham Srinivasan, 2012, Cardiovascular & Hematological Agents in Medicinal Chemistry, V10, P234; Vedantham S, 2011, ARTERIOSCL THROM VAS, V31, P1805, DOI 10.1161/ATVBAHA.111.226902; Vikramadithyan RK, 2005, J CLIN INVEST, V115, P2434, DOI 10.1172/JCI24819; Wang Y, 2011, BIOCHEM BIOPH RES CO, V411, P543, DOI 10.1016/j.bbrc.2011.06.177; Wei J, 2014, FREE RADICAL BIO MED, V67, P91, DOI 10.1016/j.freeradbiomed.2013.10.811; Zhao X, 2013, J MED CHEM, V56, P963, DOI 10.1021/jm301431y; Zoete V, 2011, J COMPUT CHEM, V32, P2359, DOI 10.1002/jcc.21816	49	2	2	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0161494	10.1371/journal.pone.0161494	http://dx.doi.org/10.1371/journal.pone.0161494			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27536992	gold, Green Published, Green Submitted			2022-12-27	WOS:000381577000113
J	Gutierrez-Roig, M; Segura, C; Duch, J; Perello, J				Gutierrez-Roig, Mario; Segura, Carlota; Duch, Jordi; Perello, Josep			Market Imitation and Win-Stay Lose-Shift Strategies Emerge as Unintended Patterns in Market Direction Guesses	PLOS ONE			English	Article							FINANCIAL-MARKETS; TRADING BEHAVIOR; DECISION-MAKING; UNCERTAINTY; ADVICE; NEWS	Decisions made in our everyday lives are based on a wide variety of information so it is generally very difficult to assess what are the strategies that guide us. Stock market provides a rich environment to study how people make decisions since responding to market uncertainty needs a constant update of these strategies. For this purpose, we run a lab-in-thefield experiment where volunteers are given a controlled set of financial information - based on real data from worldwide financial indices- and they are required to guess whether the market price would go "up" or "down" in each situation. From the data collected we explore basic statistical traits, behavioural biases and emerging strategies. In particular, we detect unintended patterns of behavior through consistent actions, which can be interpreted as Market Imitation and Win-Stay Lose-Shift emerging strategies, with Market Imitation being the most dominant. We also observe that these strategies are affected by external factors: the expert advice, the lack of information or an information overload reinforce the use of these intuitive strategies, while the probability to follow them significantly decreases when subjects spends more time to make a decision. The cohort analysis shows that women and children are more prone to use such strategies although their performance is not undermined. Our results are of interest for better handling clients expectations of trading companies, to avoid behavioural anomalies in financial analysts decisions and to improve not only the design of markets but also the trading digital interfaces where information is set down. Strategies and behavioural biases observed can also be translated into new agent based modelling or stochastic price dynamics to better understand financial bubbles or the effects of asymmetric risk perception to price drops.	[Gutierrez-Roig, Mario; Segura, Carlota; Perello, Josep] Univ Barcelona, Dept Fis Mat Condensada, Barcelona, Spain; [Duch, Jordi] Univ Rovira & Virgili, Dept Engn Informat & Matemat, Tarragona, Spain; [Perello, Josep] Univ Barcelona, Inst Complex Syst UBICS, Barcelona, Spain	University of Barcelona; Universitat Rovira i Virgili; University of Barcelona	Perello, J (corresponding author), Univ Barcelona, Dept Fis Mat Condensada, Barcelona, Spain.; Perello, J (corresponding author), Univ Barcelona, Inst Complex Syst UBICS, Barcelona, Spain.	josep.perello@ub.edu	Gutiérrez-Roig, Mario/ADM-6446-2022; Duch, Jordi/A-7000-2008; Perelló, Josep/C-5893-2011	Gutiérrez-Roig, Mario/0000-0002-8488-1954; Duch, Jordi/0000-0003-2639-6333; Perelló, Josep/0000-0001-8533-6539	MINECO (Spain) [FIS2013-47532-C3-1-P, FIS2013-47532-C3-2-P]; Generalitat de Catalunya (Spain) through Complexity Lab Barcelona [2014 SGR 608]; Generalitat de Catalunya (Spain) through Secretaria d'Universitats i Recerca [2013 DI 49]; Fundacion Espanola para la Ciencia y la Tecnologia (FECYT) through the Barcelona Citizen Science Office project of the Barcelona Lab programme; EU through FET-Proactive Project MULTIPLEX [317532]	MINECO (Spain); Generalitat de Catalunya (Spain) through Complexity Lab Barcelona(Generalitat de Catalunya); Generalitat de Catalunya (Spain) through Secretaria d'Universitats i Recerca(Generalitat de Catalunya); Fundacion Espanola para la Ciencia y la Tecnologia (FECYT) through the Barcelona Citizen Science Office project of the Barcelona Lab programme; EU through FET-Proactive Project MULTIPLEX	This work was partially supported by MINECO (Spain) through grants FIS2013-47532-C3-1-P (JD), FIS2013-47532-C3-2-P (JP); by Generalitat de Catalunya (Spain) through Complexity Lab Barcelona (contract no. 2014 SGR 608, JP and MGR) and through Secretaria d'Universitats i Recerca (contract no. 2013 DI 49, JD); by Fundacion Espanola para la Ciencia y la Tecnologia (FECYT) through the Barcelona Citizen Science Office project of the Barcelona Lab programme; and by the EU through FET-Proactive Project MULTIPLEX (contract no. 317532, JD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to acknowledge the 283 anonymous volunteers who have made this research possible. We are indebted to Barcelona Lab programme through the Citizen Science Office promoted by the Direction of Creativity and Innovation from the Institute of Culture of the Barcelona City Council led by I Garriga for their help and support for setting up the experiment at the DAU Barcelona Festival at Fabra i Coats. We specially want to thank I Bonhoure, N Fernandez and P Lorente for all the logistics to make the experiment possible and to O Comas (director of the DAU) for giving us this opportunity. In particular, we would like to thank S Saavedra who highly contributed with the original idea for the game and helped us with very useful discussions and comments on the paper. We also thank J Vicens for helping us with the experiment at CAPS2015 and A Sanchez for a careful reading of the manuscript, as well as our three anonymous reviewers for their useful comments. This work was partially supported by MINECO (Spain) through grants FIS2013-47532-C3-1-P (JD), FIS2013-47532-C3-2-P (JP); by Generalitat de Catalunya (Spain) through Complexity Lab Barcelona (contract no. 2014 SGR 608, JP and MGR) and through Secretaria d'Universitats i Recerca (contract no. 2013 DI 49, JD); by Fundacion Espanola para la Ciencia y la Tecnologia (FECYT) through the Barcelona Citizen Science Office project of the Barcelona Lab programme; and by the EU through FET-Proactive Project MULTIPLEX (contract no. 317532, JD).	Alanyali M, 2013, SCI REP-UK, V3, DOI 10.1038/srep03578; Andersson P, 2005, INT J FORECASTING, V21, P565, DOI 10.1016/j.ijforecast.2005.03.004; Bachelier L., 1900, THEORIE SPECULATION; Barberis N, 2003, HANDB ECON, V21, P1053; Biondo AE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068344; Bland AR, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00085; Bordino I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040014; Bouchaud JP, ARXIV160104478; Cook R, 2011, P ROY SOC LOND B BIO, P1024; Cover T. M., 1991, ELEMENTS INFORM THEO; Cueva C, 2015, SCI REP-UK, V5, DOI 10.1038/srep11206; Curme C, 2014, P NATL ACAD SCI USA, V111, P11600, DOI 10.1073/pnas.1324054111; De Martino B, 2013, NEURON, V79, P1222, DOI 10.1016/j.neuron.2013.07.003; Domjan M., 1986, PRINCIPLES LEARNING, V2nd; Drugowitsch J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096511; Engelmann JB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004957; Farmer JD, 1999, P NATL ACAD SCI USA, V96, P9991, DOI 10.1073/pnas.96.18.9991; Farmer JD, 1999, P NATL ACAD SCI USA, V6, P41; FRENCH S, 1980, J ROY STAT SOC A STA, V143, P43, DOI 10.2307/2981768; Frydman C, 2014, J FINANC, V69, P907, DOI 10.1111/jofi.12126; Gutierrez-Roig M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5362; Harvey CR, 2000, J FINANC, V55, P1263, DOI 10.1111/0022-1082.00247; Heyes C, 2011, PSYCHOL BULL, V137, P463, DOI 10.1037/a0022288; Hommes C., 2013, BEHAV RATIONALITY HE; Hommes C, 2007, MACROECON DYN, V11, P8, DOI 10.1017/S1365100507060208; Hommes C, 2013, MACROECON DYN, V17, P373, DOI 10.1017/S1365100511000162; Jahanshahi M, 2006, NEUROPSYCHOLOGY, V20, P391, DOI 10.1037/0894-4105.20.4.391; Javarone MA, 2015, EPL-EUROPHYS LETT, V110, DOI 10.1209/0295-5075/110/58003; Javarone MA, 2015, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2015/03/P03018; Jiang ZQ, 2010, J ECON BEHAV ORGAN, V74, P149, DOI 10.1016/j.jebo.2010.02.007; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Koestner R, 1999, J PERS, V67, P851, DOI 10.1111/1467-6494.00075; Kovacevic N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130129; Lewis M., 2014, FLASH BOYS WALL STRE; Lillo F, 2015, QUANT FINANC, V15, P213, DOI 10.1080/14697688.2014.931593; Masoliver J, 2006, QUANT FINANC, V6, P423, DOI 10.1080/14697680600727547; Moat HS, 2013, SCI REPORTS, V3, P03578; Moro E, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.066102; NEURINGER A, 1986, J EXP PSYCHOL GEN, V115, P62, DOI 10.1037/0096-3445.115.1.62; NOWAK M, 1993, NATURE, V364, P56, DOI 10.1038/364056a0; Payzan-LeNestour E, 2013, NEURON, V79, P191, DOI 10.1016/j.neuron.2013.04.037; Perello J, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.037102; Piskorec M, 2014, SCI REP-UK, V4, DOI 10.1038/srep05038; Platt ML, 2008, NAT NEUROSCI, V11, P398, DOI 10.1038/nn2062; Preis T, 2013, SCI REP-UK, V3, DOI 10.1038/srep01684; Rabin M, 1998, J ECON LIT, V36, P11; Ranco G, ARXIV150602431V1; Ranco G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146576; Sagarra O, 2015, FRONT PHYS, V3, P93; SAMUELSON PA, 1965, IMR-IND MANAG REV, V6, P41; Samuelson Paul, 1937, REV ECON STUD, V4, P155, DOI [DOI 10.2307/2967612, 10.2307/2967612]; Simon H.A., 1982, MODELS BOUNDED RATIO, V3; TVERSKY A, 1971, PSYCHOL BULL, V76, P105, DOI 10.1037/h0031322; TVERSKY A, 1981, SCIENCE, V211, P453, DOI 10.1126/science.7455683; TVERSKY A, 1986, J BUS, V59, pS251, DOI 10.1086/296365; TVERSKY A, 1974, SCIENCE, V185, P1124, DOI 10.1126/science.185.4157.1124; Wang ZJ, 2014, SCI REP-UK, V4, DOI 10.1038/srep05830; Womack KL, 1996, J FINANC, V51, P137, DOI 10.2307/2329305; Zheludev I, 2014, SCI REP-UK, V4, DOI 10.1038/srep04213; Zhou WX, 2007, EUR PHYS J B, V55, P175, DOI 10.1140/epjb/e2006-00391-6	61	7	7	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2016	11	8							e0159078	10.1371/journal.pone.0159078	http://dx.doi.org/10.1371/journal.pone.0159078			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DT4YN	27532219	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000381487600005
J	Cabra-Rivas, I; Castro-Diez, P				Cabra-Rivas, Isabel; Castro-Diez, Pilar			Comparing the Sexual Reproductive Success of Two Exotic Trees Invading Spanish Riparian Forests vs. a Native Reference	PLOS ONE			English	Article							REDUCE SEED PREDATION; EARIAS-VITTELLA FAB; AILANTHUS-ALTISSIMA; PLANT INVASIONS; ROBINIA-PSEUDOACACIA; TEMPORAL VARIATION; BIOTIC RESISTANCE; RECRUITMENT; REMOVAL; BIOLOGY	A widely accepted hypothesis in invasion ecology is that invasive species have higher survival through the early stages of establishment than do non-invasive species. In this study we explore the hypothesis that the sexual reproductive success of the invasive trees Ailanthus altissima (Mill.) Swingle and Robinia pseudoacacia L. is higher than that of the native Fraxinus angustifolia Vahl., all three species coexisting within the riparian forests of Central Spain. We compared different stages of the early life cycle, namely seed rain, seed infestation by insects, seed removal by local fauna, seed germination under optimal conditions and seedling abundance between the two invasive trees and the native, in order to assess their sexual reproductive success. The exotic species did not differ from the native reference (all three species displaying high seed rain and undergoing seed losses up to 50% due to seed removal by the local fauna). Even if the exotic R. pseudoacacia showed a high percentage of empty and insect-parasited seeds along with a low seedling emergence and the exotic A. altissima was the species with more viable seeds and of higher germinability, no differences were found regarding these variables when comparing them with the native F. angustifolia. Unsuitable conditions might have hampered either seedling emergence and survival, as seedling abundance in the field was lower than expected in all species - especially in R. pseudoacacia-. Our results rather suggest that the sexual reproductive success was not higher in the exotic trees than in the native reference, but studies focusing on long-term recruitment would help to shed light on this issue.	[Cabra-Rivas, Isabel; Castro-Diez, Pilar] Univ Alcala, Fac Biol Ciencias Ambientales & Quim, Dept Ciencias Vida, Unidad Docente Ecol, N-2,Km 33-6,POB 20, Madrid 28805, Spain	Universidad de Alcala	Cabra-Rivas, I (corresponding author), Univ Alcala, Fac Biol Ciencias Ambientales & Quim, Dept Ciencias Vida, Unidad Docente Ecol, N-2,Km 33-6,POB 20, Madrid 28805, Spain.	isabel.cabra@uah.es	Castro-Diez, Pilar/L-4716-2014	Castro-Diez, Pilar/0000-0002-4841-5198	Spanish Ministry of Economy and Competitiveness [CGL2010-16388/BOS, CGL2015-65346-R]; Junta de Comunidades de Castilla-La Mancha [POII10-0179-4700]; Comunidad de Madrid [S-2013/MAE-2719, REMEDINAL3-CM MAE-2719]; Spanish Ministry of Education, Culture and Sport (FPU fellowship) [AP2010-1513]; Alcala University; Ministerio de Educacion, Cultura y Deporte of Spain (FPU fellowship) [AP2010-1513]	Spanish Ministry of Economy and Competitiveness(Spanish Government); Junta de Comunidades de Castilla-La Mancha(Junta de Comunidades de Castilla-La Mancha); Comunidad de Madrid(Comunidad de Madrid); Spanish Ministry of Education, Culture and Sport (FPU fellowship); Alcala University; Ministerio de Educacion, Cultura y Deporte of Spain (FPU fellowship)(German Research Foundation (DFG))	This study was supported by the project CGL2010-16388/BOS and CGL2015-65346-R of the Spanish Ministry of Economy and Competitiveness, POII10-0179-4700 of the Junta de Comunidades de Castilla-La Mancha and REMEDINAL network S-2013/MAE-2719 of the Comunidad de Madrid. ICR was supported by a grant of the Spanish Ministry of Education, Culture and Sport (FPU fellowship, AP2010-1513) and by a grant of Alcala University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r This study was supported by the projects CGL2011-16388/BOS and CGL2015-65346-R of the Ministerio de Economia y Competitividad of Spain and POII10-0179-4700 of the Junta de Comunidades de Castilla-La Mancha. Isabel Cabra-Rivas was supported by a grant from the Ministerio de Educacion, Cultura y Deporte of Spain (FPU fellowship, AP2010-1513). We are grateful to the support of the REMEDINAL3-CM MAE-2719 network (Comunidad de Madrid). We are in debt with Guillermo Valle Torres, Silvia Medina Villar, Alejandra Blanquez Moya, Jose Maria Sanchez Martinez, Javier Pavon Garcia and Belen Fresnillo Barba for their valuable help during field sampling and laboratory work.	Abrahamson W. A., 1980, Demography and evolution in plant populations., P89; Aguiar FCF, 2013, PLANT BIOSYST, V147, P1107, DOI 10.1080/11263504.2013.861539; ANDERSEN AN, 1989, OECOLOGIA, V81, P310, DOI 10.1007/BF00377076; Aoac, 1997, OFFICIAL METHODS ANA, DOI DOI 10.1016/0165-9936(90)87098-7; Arizpe D., 2008, RIPARIAN TREE SHRUB; Aziz MA, 2012, PAK J ZOOL, V44, P361; Baker H. G., 1965, The genetics of colonizing species., P147; Barrett SCH, 2008, MOL ECOL, V17, P373, DOI 10.1111/j.1365-294X.2007.03503.x; Barrett SCH, 2011, FIFTY YEARS OF INVASION ECOLOGY: THE LEGACY OF CHARLES ELTON, P195; Basbag M., 2010, Notulae Scientia Biologicae, V2, P125; Blanco-Castro E., 2005, BOSQUES IBERICOS INT; Bory G., 1980, REV GEN BOT, V88, P297; Burns JH, 2013, ECOLOGY, V94, P995, DOI 10.1890/12-1310.1; Cabra-Rivas I., 2015, Ecosistemas, V24, P18, DOI 10.7818/ECOS.2015.24-1.04; Carrillo-Gavilan MA, 2010, BIOL INVASIONS, V12, P2233, DOI 10.1007/s10530-009-9633-y; Castro-Diez P., 2014, ARBOLES EXOTICOS RIB; Castro-Diez P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100254; Cavieres LA, 2005, ANN BOT, V98, P193; Chytry M, 2008, J APPL ECOL, V45, P448, DOI 10.1111/j.1365-2664.2007.01398.x; Cierjacks A, 2013, J ECOL, V101, P1623, DOI 10.1111/1365-2745.12162; COETZEE JH, 1987, S AFR J BOT, V53, P61, DOI 10.1016/S0254-6299(16)31475-2; Colautti RI, 2006, BIOL INVASIONS, V8, P1023, DOI 10.1007/s10530-005-3735-y; CONNOR EF, 1980, ECOL ENTOMOL, V5, P205, DOI 10.1111/j.1365-2311.1980.tb01143.x; Constan Nava S, 2008, IBERIS, V6, P65; Converse CK, 1984, EL STEW ABSTR ROB PS; CRAWLEY MJ, 1995, J ECOL, V83, P683, DOI 10.2307/2261636; Crawley MJ, 1992, SEEDS ECOLOGY REGENE, P157; DAISIE, 2012, INV AL SPEC FACT SHE; Drenovsky RE, 2012, AM J BOT, V99, P629, DOI 10.3732/ajb.1100417; Ferreras AE, 2010, ACTA OECOL, V36, P211, DOI 10.1016/j.actao.2009.12.005; Elorrieta J, 1995, EL SOTO DE EL ENCIN; Elton C., 1958; Espenschied-Reilly AL, 2008, OHIO J SCI, V108, P16; Ferreras AE, 2015, PLANT SPEC BIOL, V30, P126, DOI 10.1111/1442-1984.12041; Fox CW, 2012, J ARID ENVIRON, V80, P10, DOI 10.1016/j.jaridenv.2011.12.008; FRAXIGEN, 2005, ASH SPECIES IN EUROP, P128; Fuentes M, 1998, EVOL ECOL, V12, P823, DOI 10.1023/A:1006594532392; Gibson MR, 2011, DIVERS DISTRIB, V17, P911, DOI 10.1111/j.1472-4642.2011.00808.x; Gimenez-Benavides L, 2008, ECOGRAPHY, V31, P731, DOI 10.1111/j.0906-7590.2008.05509.x; Gonzalez-Munoz N, 2011, ENVIRON MANAGE, V48, P764, DOI 10.1007/s00267-011-9731-3; GREENE DF, 1994, ECOLOGY, V75, P642, DOI 10.2307/1941722; Grupo Especialista en Invasiones Biologicas (GEIB), 2006, GEIB SERIE TECNICA, V2; Hale SE, 2002, AGR FOREST METEOROL, V112, P51, DOI 10.1016/S0168-1923(02)00042-4; Hastings A, 2005, ECOL LETT, V8, P91, DOI 10.1111/j.1461-0248.2004.00687.x; Heisey RM, 1996, AM J BOT, V83, P192, DOI 10.2307/2445938; HilleRisLambers J, 2003, CAN J FOREST RES, V33, P783, DOI [10.1139/X03-001, 10.1139/x03-001]; Hood WG, 2000, PLANT ECOL, V148, P105, DOI 10.1023/A:1009800327334; Hulme Philip E., 1998, Perspectives in Plant Ecology Evolution and Systematics, V1, P32, DOI 10.1078/1433-8319-00050; Jobin A, 1996, ENTOMOL EXP APPL, V79, P33, DOI 10.1007/BF00333819; Joern A., 1989, GRASSLAND STRUCTURE, P117; Johansen SM, 2014, WILSON J ORNITHOL, V126, P374, DOI 10.1676/13-066.1; Keane RM, 2002, TRENDS ECOL EVOL, V17, P164, DOI 10.1016/S0169-5347(02)02499-0; KIRKLAND A., 1961, NEW ZEALAND JOUR FOREST, V8, P482; Kitajima K., 2000, Seeds: the ecology of regeneration in plant communities, P331, DOI 10.1079/9780851994321.0331; Knapp LB, 2000, J TORREY BOT SOC, V127, P307, DOI 10.2307/3088649; Kolar CS, 2001, TRENDS ECOL EVOL, V16, P199, DOI 10.1016/S0169-5347(01)02101-2; Kolb A, 2007, PERSPECT PLANT ECOL, V9, P79, DOI 10.1016/j.ppees.2007.09.001; Kota NL, 2007, BIOL INVASIONS, V9, P197, DOI 10.1007/s10530-006-9026-4; Kowarik I, 1995, J VEG SCI, V6, P853, DOI 10.2307/3236399; Kowarik I, 1996, VERHANDLUNGEN DER GESELLSCHAFT FUR OKOLOGIE, VOL 26, P173; Kowarik I, 2007, PERSPECT PLANT ECOL, V8, P207, DOI 10.1016/j.ppees.2007.03.002; Lara F., 1996, ESTUDIO VEGETACION R; Lei Simon A., 2010, Journal of the Arizona-Nevada Academy of Science, V42, P9, DOI 10.2181/036.042.0103; Levin D. A., 2000, OX ECOL EV; Loureiro F, 2009, WILDLIFE BIOL, V15, P197, DOI 10.2981/07-046; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; Rios JM, 2012, CONDOR, V114, P44, DOI 10.1525/cond.2012.110043; Maron JL, 2000, OECOLOGIA, V124, P260, DOI 10.1007/s004420000382; Martin PH, 2010, OIKOS, V119, P807, DOI 10.1111/j.1600-0706.2009.17941.x; Masaka K, 2009, J FOREST RES-JPN, V14, P167, DOI 10.1007/s10310-009-0117-9; Mason RAB, 2008, GLOBAL ECOL BIOGEOGR, V17, P633, DOI 10.1111/j.1466-8238.2008.00402.x; Medina-Villar S, 2015, PLANT SOIL, V396, P311, DOI 10.1007/s11104-015-2592-4; Nakai Z, 2011, ARTHROPOD-PLANT INTE, V5, P227, DOI 10.1007/s11829-011-9132-9; Nield AP, 2015, PLANT ECOL, V216, P189, DOI 10.1007/s11258-014-0427-7; NIWA CG, 1992, J ECON ENTOMOL, V85, P2323, DOI 10.1093/jee/85.6.2323; Nobis M, 2005, AGR FOREST METEOROL, V128, P243, DOI 10.1016/j.agrformet.2004.10.002; Pairon M, 2006, ACTA OECOL, V30, P238, DOI 10.1016/j.actao.2006.05.002; Pearson DE, 2014, BIOL INVASIONS, V16, P1185, DOI 10.1007/s10530-013-0573-1; Pearson DE, 2012, J ECOL, V100, P1383, DOI 10.1111/j.1365-2745.2012.02025.x; Pearson DE, 2011, ECOLOGY, V92, P1748, DOI 10.1890/11-0164.1; Perea R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065573; Peterson Chris J., 1997, P263; Pimentel D, 2000, BIOSCIENCE, V50, P53, DOI 10.1641/0006-3568(2000)050[0053:EAECON]2.3.CO;2; Pysek Petr, 2007, V193, P97; R Core Team, 2021, R LANGUAGE ENV STAT; Rejmanek M, 1996, ECOLOGY, V77, P1655, DOI 10.2307/2265768; Rejmanek M, 2000, AUSTRAL ECOL, V25, P497, DOI 10.1046/j.1442-9993.2000.01080.x; Richardson DM, 2007, DIVERS DISTRIB, V13, P126, DOI 10.1111/j.1366-9516.2006.00314.x; Richardson DM, 2000, DIVERS DISTRIB, V6, P97; Rodriguez-Perez J, 2007, PERSPECT PLANT ECOL, V9, P1, DOI 10.1016/j.ppees.2007.07.003; Sanz-Elorza, 2004, ATLAS PLANTAS ALOCTO; SCHIERENBECK KA, 1994, ECOLOGY, V75, P1661, DOI 10.2307/1939626; Serrada R., 2000, APUNTES REPOBLACIONE; Shure DJ, 2006, PLANT ECOL, V185, P299, DOI 10.1007/s11258-006-9105-8; SINGH R, 1987, P INDIAN AS-ANIM SCI, V96, P361, DOI 10.1007/BF03179589; Strauss Sharon Y., 2002, P77; Stricker KB, 2013, BIOL INVASIONS, V15, P1973, DOI 10.1007/s10530-013-0425-z; SUNDARARAJ R, 1987, P INDIAN AS-ANIM SCI, V96, P329, DOI 10.1007/BF03180017; Takakura K, 2002, FUNCT ECOL, V16, P252, DOI 10.1046/j.1365-2435.2002.00619.x; Tapper PG, 1996, ECOLOGY, V77, P2567, DOI 10.2307/2265756; TAPPER PG, 1992, J VEG SCI, V3, P41, DOI 10.2307/3235996; Thompson JD., 1994, COEVOLUTIONARY PROCE; Thompson K., 1997, SOIL SEED BANKS N W; Toole E. H., 1946, JOUR AGRIC RES, V72, P201; TRAVESET A, 1993, EVOL ECOL, V7, P357, DOI 10.1007/BF01237867; van Kleunen M, 2010, ECOL LETT, V13, P947, DOI 10.1111/j.1461-0248.2010.01503.x; van Kleunen M, 2010, ECOL LETT, V13, P235, DOI 10.1111/j.1461-0248.2009.01418.x; Vander Wall SB, 2005, ECOLOGY, V86, P801, DOI 10.1890/04-0847; Verdu M, 2001, PLANT ECOL, V156, P245, DOI 10.1023/A:1012653002598; Viglas JN, 2013, CAN J FOREST RES, V43, P534, DOI 10.1139/cjfr-2013-0022; Vlam M, 2014, FOREST ECOL MANAG, V312, P108, DOI 10.1016/j.foreco.2013.10.016; Wainwright CE, 2013, BIOL INVASIONS, V15, P2253, DOI 10.1007/s10530-013-0449-4; Wang B, 2015, BEHAV PROCESS, V113, P94, DOI 10.1016/j.beproc.2015.01.012; YOSHIMURA S, 1984, B CHEM SOC JPN, V57, P2496, DOI 10.1246/bcsj.57.2496; Yuan CQ, 2013, GENET MOL RES, V12, P6249, DOI 10.4238/2013.December.4.12	115	4	4	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2016	11	8							e0160831	10.1371/journal.pone.0160831	http://dx.doi.org/10.1371/journal.pone.0160831			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4UN	27529695	Green Published, gold			2022-12-27	WOS:000381476700026
J	Sun, F; Zeng, SY; Huang, YQ; He, M				Sun, Fu; Zeng, Siyu; Huang, Yunqing; He, Miao			Parameter Identification of an Ultrafiltration Model for Organics Removal in a Full-Scale Wastewater Reclamation Plant with Sparse and Incomplete Monitoring Data	PLOS ONE			English	Article							GROUNDWATER POLLUTION SOURCES; ARTIFICIAL NEURAL-NETWORK; BATCH ULTRAFILTRATION; SIMULATION; REJECTION; PERFORMANCE; MEMBRANES; FLUX; UNCERTAINTY; PREDICTION	Ultrafiltration (UF) has become one of the dominant treatment processes for wastewater reclamation in China. Modeling is an effective instrument to understand and optimize UF systems. To this end, a previously developed UF model for organics removal was applied to the UF process in a typical, full-scale wastewater reclamation plant (WRP) in China. However, the sparse and incomplete field monitoring data from the studied WRP made the traditional model analysis approaches hardly work in this case. Therefore, two strategies, namely Strategy 1 and Strategy 2, were proposed, following a regional sensitivity analysis approach, for model parameter identification. Strategy 1 aimed to identify the model parameters and the missing model input, i.e. sampling times, simultaneously, while Strategy 2 tried to separate these two processes to reduce the dimension of the identification problem through an iteration procedure. With these two strategies, the model performed well in the Qinghe WRP with the absolute relative errors between the simulated and observed total organic carbon (TOC) generally below 10%. The four model parameters were all sensitive and identifiable, and even the sampling times could be roughly identified. Given the incomplete model input, these results were encouraging and added to the trustworthiness of model when it was applied to the Qinghe WRP.	[Sun, Fu; Zeng, Siyu; Huang, Yunqing; He, Miao] Tsinghua Univ, State Key Joint Lab Environm Simulat & Pollut Con, Sch Environm, Beijing 100084, Peoples R China	Tsinghua University	Zeng, SY (corresponding author), Tsinghua Univ, State Key Joint Lab Environm Simulat & Pollut Con, Sch Environm, Beijing 100084, Peoples R China.	szeng@tsinghua.edu.cn						BECK MB, 1987, WATER RESOUR RES, V23, P1393, DOI 10.1029/WR023i008p01393; Bhattacharjee C, 2001, SEP PURIF TECHNOL, V24, P13, DOI 10.1016/S1383-5866(00)00204-5; Bhattacharjee C, 1997, J MEMBRANE SCI, V125, P303, DOI 10.1016/S0376-7388(96)00247-5; Cheryan M, 1998, ULTRAFILTRATION MICR; Chiu KP, 2005, DEV MICROFILTRATION; Cho JW, 2002, DESALINATION, V142, P245, DOI 10.1016/S0011-9164(02)00206-0; Datta B, 2009, J HYDROL, V376, P48, DOI 10.1016/j.jhydrol.2009.07.014; Dudley J, 2002, WATER SCI TECHNOL, V45, P177, DOI 10.2166/wst.2002.0105; Ghose S, 2000, J MEMBRANE SCI, V169, P29, DOI 10.1016/S0376-7388(99)00329-4; Herrnegger M, 2015, HYDROL EARTH SYST SC, V19, P4619, DOI 10.5194/hess-19-4619-2015; Hormann G, 2007, ECOL MODEL, V209, P21, DOI 10.1016/j.ecolmodel.2007.07.019; Huang Yun-qing, 2015, China Environmental Science, V35, P420; Jun KS, 2007, WATER SCI TECHNOL, V56, P155, DOI 10.2166/wst.2007.447; Lin SH, 2008, DESALINATION, V234, P116, DOI 10.1016/j.desal.2007.09.077; Mahar PS, 2001, J WATER RES PL-ASCE, V127, P20, DOI 10.1061/(ASCE)0733-9496(2001)127:1(20); Morao A, 2008, J MEMBRANE SCI, V319, P64, DOI 10.1016/j.memsci.2008.03.019; Morao A, 2009, J MEMBRANE SCI, V336, P61, DOI 10.1016/j.memsci.2009.03.007; Muthukumaran S, 2011, DESALINATION, V279, P383, DOI 10.1016/j.desal.2011.06.040; Nyeko M, 2015, WATER RESOUR MANAG, V29, P81, DOI 10.1007/s11269-014-0828-3; Pluntke T, 2014, ENVIRON EARTH SCI, V72, P4801, DOI 10.1007/s12665-014-3252-3; Polyakoy YS, 2013, J MEMBRANE SCI, V434, P106, DOI 10.1016/j.memsci.2013.01.052; Rai P, 2005, J FOOD ENG, V71, P273, DOI 10.1016/j.jfoodeng.2005.02.003; Razavi MA, 2003, J MEMBRANE SCI, V220, P47, DOI 10.1016/S0376-7388(03)00211-4; Sun F, 2010, SCI TOTAL ENVIRON, V408, P1992, DOI 10.1016/j.scitotenv.2010.01.037; Nguyen TA, 2012, J MEMBRANE SCI, V403, P84, DOI 10.1016/j.memsci.2012.02.026; VANOERS CW, 1995, J MEMBRANE SCI, V107, P173, DOI 10.1016/0376-7388(95)00116-T; Vela MCV, 2005, DESALINATION, V184, P347, DOI 10.1016/j.desal.2005.03.052; WAGNER BJ, 1992, J HYDROL, V135, P275, DOI 10.1016/0022-1694(92)90092-A	28	7	7	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2016	11	8							e0161300	10.1371/journal.pone.0161300	http://dx.doi.org/10.1371/journal.pone.0161300			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4UN	27529845	Green Submitted, Green Published, gold			2022-12-27	WOS:000381476700064
J	Boronat-Garcia, A; Palomero-Rivero, M; Guerra-Crespo, M; Millan-Aldaco, D; Drucker-Colin, R				Boronat-Garcia, Alejandra; Palomero-Rivero, Marcela; Guerra-Crespo, Magdalena; Millan-Aldaco, Diana; Drucker-Colin, Rene			Intrastriatal Grafting of Chromospheres: Survival and Functional Effects in the 6-OHDA Rat Model of Parkinson's Disease	PLOS ONE			English	Article							ADRENAL CHROMAFFIN CELLS; EMBRYONIC STEM-CELLS; NERVE GROWTH-FACTOR; DOPAMINE NEURONS; PROGENITOR CELLS; DIFFERENTIATION; MEDULLA; NGF; GENERATION; THERAPIES	Cell replacement therapy in Parkinson's disease (PD) aims at re-establishing dopamine neurotransmission in the striatum by grafting dopamine-releasing cells. Chromaffin cell (CC) grafts produce some transitory improvements of functional motor deficits in PD animal models, and have the advantage of allowing autologous transplantation. However, CC grafts have exhibited low survival, poor functional effects and dopamine release compared to other cell types. Recently, chromaffin progenitor-like cells were isolated from bovine and human adult adrenal medulla. Under low-attachment conditions, these cells aggregate and grow as spheres, named chromospheres. Here, we found that bovine-derived chromosphere- cell cultures exhibit a greater fraction of cells with a dopaminergic phenotype and higher dopamine release than CC. Chromospheres grafted in a rat model of PD survived in 57% of the total grafted animals. Behavioral tests showed that surviving chromosphere cells induce a reduction in motor alterations for at least 3 months after grafting. Finally, we found that compared with CC, chromosphere grafts survive more and produce more robust and consistent motor improvements. However, further experiments would be necessary to determine whether the functional benefits induced by chromosphere grafts can be improved, and also to elucidate the mechanisms underlying the functional effects of the grafts.	[Boronat-Garcia, Alejandra; Palomero-Rivero, Marcela; Guerra-Crespo, Magdalena; Millan-Aldaco, Diana; Drucker-Colin, Rene] Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Dept Neuropatol Mol, Circuito Exterior S-N,Ciudad Univ, Ciudad Mexico, Mexico	Universidad Nacional Autonoma de Mexico	Drucker-Colin, R (corresponding author), Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Dept Neuropatol Mol, Circuito Exterior S-N,Ciudad Univ, Ciudad Mexico, Mexico.	drucker@unam.mx			Direccion General Asuntos del Personal Academico-Programa de Apoyo a Proyectos de Investigacion e Inovacion Tecnologica (DGAPA-PAPIIT) [IN204612]; Consejo Nacional de Ciencia y Tecnologia (CONACyT) [179927]; Secretaria de Ciencia, Tecnologia e Innovacion (SECITI) [ICyTDF/170/2012-SECITI/014/2013]; CONACyT-Mexico	Direccion General Asuntos del Personal Academico-Programa de Apoyo a Proyectos de Investigacion e Inovacion Tecnologica (DGAPA-PAPIIT); Consejo Nacional de Ciencia y Tecnologia (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Secretaria de Ciencia, Tecnologia e Innovacion (SECITI); CONACyT-Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was supported by the following grants: Direccion General Asuntos del Personal Academico-Programa de Apoyo a Proyectos de Investigacion e Inovacion Tecnologica (DGAPA-PAPIIT) [IN204612], Consejo Nacional de Ciencia y Tecnologia (CONACyT) [179927] and Secretaria de Ciencia, Tecnologia e Innovacion (SECITI) [ICyTDF/170/2012-SECITI/014/2013]. The funding source had not any involvement in the study design, in the collection, analysis and intepretation of data, in the writing or in any decision made for publication.; ABG received a PhD fellowship from CONACyT-Mexico. This work is part of the fulfillment of requirements for ABG's PhD degree in Biomedical Science from the Universidad Nacional Autonoma de Mexico. We thank the Posgrado en Ciencias Biomedicas and the Universidad Nacional Autonoma de Mexico.	ABERCROMBIE M, 1946, ANAT REC, V94, P239, DOI 10.1002/ar.1090940210; Barker RA, 2015, NAT REV NEUROL, V11, P492, DOI 10.1038/nrneurol.2015.123; Ben-David U, 2011, NAT REV CANCER, V11, P268, DOI 10.1038/nrc3034; BING G, 1990, NEUROSCIENCE, V34, P687, DOI 10.1016/0306-4522(90)90175-4; BJORKLUND A, 1979, BRAIN RES, V177, P555, DOI 10.1016/0006-8993(79)90472-4; Bjorklund A, 2013, MOVEMENT DISORD, V28, P110, DOI 10.1002/mds.25343; Bjorklund LM, 2002, P NATL ACAD SCI USA, V99, P2344, DOI 10.1073/pnas.022438099; BOUVIER MM, 1995, J NEUROSCI, V15, P7141; Braak H, 2004, CELL TISSUE RES, V318, P121, DOI 10.1007/s00441-004-0956-9; Cho MS, 2008, P NATL ACAD SCI USA, V105, P3392, DOI 10.1073/pnas.0712359105; Chung KF, 2009, STEM CELLS, V27, P2602, DOI 10.1002/stem.180; Correia AS, 2008, FRONT NEUROSCI-SWITZ, V2, P26, DOI 10.3389/neuro.01.011.2008; CREESE I, 1977, SCIENCE, V197, P596, DOI 10.1126/science.877576; CUNNINGHAM LA, 1991, BRAIN RES, V561, P192, DOI 10.1016/0006-8993(91)91595-R; Date I, 1997, EXP NEUROL, V147, P10, DOI 10.1006/exnr.1997.6579; DRUCKERCOLIN R, 1991, J NEUROSCI METH, V39, P153, DOI 10.1016/0165-0270(91)90081-A; DRUCKERCOLIN R, 1994, MOL CELL NEUROSCI, V5, P485, DOI 10.1006/mcne.1994.1060; Dunnett SB, 1989, EXP BRAIN RES, V78, P343; Ehrhart-Bornstein M, 2010, CELL MOL NEUROBIOL, V30, P1417, DOI 10.1007/s10571-010-9571-3; Ehrhart-Bornstein M, 2008, ANN NY ACAD SCI, V1148, P112, DOI 10.1196/annals.1410.053; Fernandez Espejo Emilio, 2001, Journal of Neuroscience, V21, P9888; Fernandez-Espejo E, 2005, BRAIN RES REV, V49, P343, DOI 10.1016/j.brainresrev.2005.01.004; FIANDACA MS, 1988, EXP NEUROL, V102, P76, DOI 10.1016/0014-4886(88)90080-5; FREED WJ, 1981, NATURE, V292, P351, DOI 10.1038/292351a0; Galan-Rodriguez B, 2008, NEUROBIOL DIS, V29, P529, DOI 10.1016/j.nbd.2007.11.009; Garcia-Montes J, 2012, HEALTH, V4, P1153; Garcia-Montes JR, 2012, CNS NEUROL DISORD-DR, V11, P897, DOI 10.2174/1871527311201070897; Grealish S, 2014, CELL STEM CELL, V15, P653, DOI 10.1016/j.stem.2014.09.017; Grealish S, 2010, BRAIN, V133, P482, DOI 10.1093/brain/awp328; Huber K, 2009, AUTON NEUROSCI-BASIC, V151, P10, DOI 10.1016/j.autneu.2009.07.020; Jensen MB, 2012, J STEM CELL RES S10, P003; KELLY PH, 1975, BRAIN RES, V94, P507, DOI 10.1016/0006-8993(75)90233-4; Kim DS, 2000, J NEUROSCI, V20, P4405, DOI 10.1523/JNEUROSCI.20-12-04405.2000; Kim JH, 2002, NATURE, V418, P50, DOI 10.1038/nature00900; Kriks S, 2011, NATURE, V480, P547, DOI 10.1038/nature10648; Lanau F, 1997, J NEUROCHEM, V68, P804; Lindvall Olle, 2004, NeuroRx, V1, P382; Lindvall O, 2013, MOVEMENT DISORD, V28, P268, DOI 10.1002/mds.25378; MADRAZO I, 1987, NEW ENGL J MED, V316, P831, DOI 10.1056/NEJM198704023161402; MORIHISA JM, 1984, EXP NEUROL, V84, P643, DOI 10.1016/0014-4886(84)90211-5; NIIJIMA K, 1995, J NEUROSCI, V15, P1180; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Olanow CW, 2004, MOVEMENT DISORD, V19, P997, DOI 10.1002/mds.20243; PERLOW MJ, 1979, SCIENCE, V204, P643, DOI 10.1126/science.571147; Rath A, 2013, CELL TRANSPLANT, V22, P1281, DOI 10.3727/096368912X654984; Root DH, 2015, J NEUROSCI, V35, P3460, DOI 10.1523/JNEUROSCI.4525-13.2015; Roy NS, 2006, NAT MED, V12, P1259, DOI 10.1038/nm1495; Santana MM, 2012, STEM CELL TRANSL MED, V1, P783, DOI 10.5966/sctm.2012-0022; Saxena S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064454; STEMPLE DL, 1988, NEURON, V1, P517, DOI 10.1016/0896-6273(88)90182-1; STROMBERG I, 1985, EXP BRAIN RES, V60, P335; Voutilainen MH, 2009, J NEUROSCI, V29, P9651, DOI 10.1523/JNEUROSCI.0833-09.2009; Vukicevic V, 2015, MOL CELL ENDOCRINOL, V408, P178, DOI 10.1016/j.mce.2014.12.020; Vukicevic V, 2012, CELL TRANSPLANT, V21, P2471, DOI 10.3727/096368912X638874; Vukicevic V, 2012, J MOL NEUROSCI, V48, P420, DOI 10.1007/s12031-012-9746-0	55	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2016	11	8							e0160854	10.1371/journal.pone.0160854	http://dx.doi.org/10.1371/journal.pone.0160854			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4SL	27525967	Green Submitted, Green Published, gold			2022-12-27	WOS:000381471100024
J	Munoz-Navarro, R; Cano-Vindel, A; Wood, CM; Ruiz-Rodriguez, P; Medrano, LA; Limonero, JT; Tomas-Tomas, P; Gracia-Gracia, I; Dongil-Collado, E; Iruarrizaga, MI				Munoz-Navarro, Roger; Cano-Vindel, Antonio; Mae Wood, Cristina; Ruiz-Rodriguez, Paloma; Adrian Medrano, Leonardo; Limonero, Joaquin T.; Tomas-Tomas, Patricia; Gracia-Gracia, Irene; Dongil-Collado, Esperanza; Iciar Iruarrizaga, M.		PsicAP Res Grp	The PHQ-PD as a Screening Tool for Panic Disorder in the Primary Care Setting in Spain	PLOS ONE			English	Article							PATIENT HEALTH QUESTIONNAIRE; MENTAL-DISORDERS; VALIDATION; DEPRESSION; PREVALENCE; UTILITY; ANXIETY; EUROPE; MD	Introduction Panic disorder is a common anxiety disorder and is highly prevalent in Spanish primary care centres. The use of validated tools can improve the detection of panic disorder in primary care populations, thus enabling referral for specialized treatment. The aim of this study is to determine the accuracy of the Patient Health Questionnaire-Panic Disorder (PHQ-PD) as a screening and diagnostic tool for panic disorder in Spanish primary care centres. Method We compared the psychometric properties of the PHQ-PD to the reference standard, the Structured Clinical Interview for DSM-IV Axis I Disorders (SCID-I) interview. General practitioners referred 178 patients who completed the entire PHQ test, including the PHQ-PD, to undergo the SCID-I. The sensitivity, specificity, positive and negative predictive values and positive and negative likelihood ratios of the PHQ-PD were assessed. Results The operating characteristics of the PHQ-PD are moderate. The best cut-off score was 5 (sensitivity .77, specificity .72). Modifications to the questionnaire's algorithms improved test characteristics (sensitivity .77, specificity .72) compared to the original algorithm. The screening question alone yielded the highest sensitivity score (.83). Conclusion Although the modified algorithm of the PHQ-PD only yielded moderate results as a diagnostic test for panic disorder, it was better than the original. Using only the first question of the PHQ-PD showed the best psychometric properties (sensitivity). Based on these findings, we suggest the use of the screening questions for screening purposes and the modified algorithm for diagnostic purposes.	[Munoz-Navarro, Roger; Cano-Vindel, Antonio; Mae Wood, Cristina; Ruiz-Rodriguez, Paloma; Adrian Medrano, Leonardo; Limonero, Joaquin T.; Tomas-Tomas, Patricia; Gracia-Gracia, Irene; Dongil-Collado, Esperanza; PsicAP Res Grp] Univ Complutense Madrid, PsicAP Res Grp, Madrid, Spain; [Munoz-Navarro, Roger] Univ Valencia, Fac Psychol, Valencia, Spain; [Cano-Vindel, Antonio; Mae Wood, Cristina; Gracia-Gracia, Irene; Iciar Iruarrizaga, M.] Univ Complutense Madrid, Fac Psychol, Madrid, Spain; [Ruiz-Rodriguez, Paloma] Hlth Serv Madrid, Castilla La Nueva Primary Care Ctr, Madrid, Spain; [Adrian Medrano, Leonardo] Univ Siglo 21, Fac Psychol, Cordoba, Argentina; [Limonero, Joaquin T.] Autonomous Univ Barcelona, Fac Psychol, Stress & Hlth Res Grp, Bellaterra, Spain; [Tomas-Tomas, Patricia] Hlth Serv Valencia, Malva Rosa Primary Care Ctr, Valencia, Spain; [Dongil-Collado, Esperanza] Catholic Univ Valencia, Fac Psychol, Valencia, Spain	Complutense University of Madrid; University of Valencia; Complutense University of Madrid; Autonomous University of Barcelona; Universidad Catolica de Valencia San Vicente Martir	Munoz-Navarro, R (corresponding author), Univ Complutense Madrid, PsicAP Res Grp, Madrid, Spain.; Munoz-Navarro, R (corresponding author), Univ Valencia, Fac Psychol, Valencia, Spain.	roger.munoz@uv.es	Iruarrizaga, Iciar/AHE-2341-2022; Moriana, Juan Antonio/D-7718-2015; Iruarrizaga, Itziar/G-5048-2015; Limonero, Joaquín T./G-8639-2011; Ruiz-Rodríguez, Paloma/AAA-4162-2019; Muñoz-Navarro, Roger/J-8584-2019; Medrano, Leonardo Adrián/AAC-1456-2020; Cano-Vindel, Antonio/A-2089-2011	Moriana, Juan Antonio/0000-0003-0577-821X; Iruarrizaga, Itziar/0000-0001-5495-7172; Limonero, Joaquín T./0000-0003-0573-791X; Ruiz-Rodríguez, Paloma/0000-0001-8140-0767; Muñoz-Navarro, Roger/0000-0002-7064-3699; Cano-Vindel, Antonio/0000-0002-5449-5454; Medrano, Leonardo Adrian/0000-0002-3371-5040; Salgueiro, Monika/0000-0002-2150-1221; Moretti, Luciana/0000-0001-8792-9565; Moreno Osella, Eliana M./0000-0003-3467-5316	Ministerio de Economia y Competitividad; Fundacion Mutua Madrilena; Psicofundacion, Foundation for the scientific and professional development of Psychology in Spain	Ministerio de Economia y Competitividad(Spanish Government); Fundacion Mutua Madrilena(Instituto de Salud Carlos III); Psicofundacion, Foundation for the scientific and professional development of Psychology in Spain	This work was supported by Ministerio de Economia y Competitividad; Psicofundacion, Foundation for the scientific and professional development of Psychology in Spain; and Fundacion Mutua Madrilena. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baca Baldomero E, 1999, Aten Primaria, V23, P275; Becker S, 2002, INT J PSYCHIAT MED, V32, P271, DOI 10.2190/XTDD-8L18-P9E0-JYRV; Cano-Vindel A, 2011, PAPELES PSICOLOGO, V32, P3; Diez-Quevedo C, 2001, PSYCHOSOM MED, V63, P679, DOI 10.1097/00006842-200107000-00021; First MB, 2001, STRUCTURED CLIN INTE; Haro JM, 2006, MED CLIN-BARCELONA, V126, P445, DOI 10.1157/13086324; King M, 2008, BRIT J PSYCHIAT, V192, P362, DOI 10.1192/bjp.bp.107.039966; Latorre Postigo Jm, 2005, Aten Primaria, V36, P85, DOI 10.1157/13076608; Lowe B, 2003, J PSYCHOSOM RES, V55, P515, DOI 10.1016/S0022-3999(03)00072-2; Osorio FL, 2015, J PSYCHOSOM RES, V78, P91, DOI 10.1016/j.jpsychores.2014.09.001; Pascual JC, 2008, MED CLIN-BARCELONA, V130, P281, DOI 10.1157/13116589; Roca M, 2009, J AFFECT DISORDERS, V119, P52, DOI 10.1016/j.jad.2009.03.014; Roy-Byrne PP, 1999, J CLIN PSYCHIAT; Serrano-Blanco A, 2010, SOC PSYCH PSYCH EPID, V45, P201, DOI 10.1007/s00127-009-0056-y; SPITZER RL, 1995, JAMA-J AM MED ASSOC, V274, P1511, DOI 10.1001/jama.274.19.1511; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Wittchen HU, 2005, EUR NEUROPSYCHOPHARM, V15, P357, DOI 10.1016/j.euroneuro.2005.04.012; Wittkampf KA, 2011, J AFFECT DISORDERS, V130, P260, DOI 10.1016/j.jad.2010.10.030	18	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2016	11	8							e0161145	10.1371/journal.pone.0161145	http://dx.doi.org/10.1371/journal.pone.0161145			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DT4SL	27525977	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000381471100038
J	O'Neill, S; Dierickx, S; Okebe, J; Dabira, E; Gryseels, C; d'Alessandro, U; Grietens, KP				O'Neill, Sarah; Dierickx, Susan; Okebe, Joseph; Dabira, Edgard; Gryseels, Charlotte; d'Alessandro, Umberto; Grietens, Koen Peeters			The Importance of Blood Is Infinite: Conceptions of Blood as Life Force, Rumours and Fear of Trial Participation in a Fulani Village in Rural Gambia	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; MEDICAL-RESEARCH; CLINICAL-TRIAL; VACCINE TRIAL; VULNERABILITY; CHALLENGES; MALARIA; EXPERIENCES; COMMUNITY; POVERTY	Background Clinical trials require high levels of participation and low drop-out rates to be successful. However, collecting blood samples from individuals recruited into clinical trials can be challenging when there is reticence about blood-taking. In addition to concerns regarding the feasibility of medical research, fears of 'blood-stealing' and 'blood-selling' have ethical implications related to cultural sensitivity and informed consent. This study explores anxieties around blood-taking during a malaria treatment trial in the Gambia. Methods This case study is based on ethnographic research in one theoretically selected village due to the high reticence to screening for the clinical trial 'Primaquine's gametocytocidal efficacy in malaria asymptomatic carriers treated with dihydroartemisinin-piperaquine' carried out in the Gambia between 2013 and 2014. Data collection tools included in-depth interviews, participant observation, informal conversations and group discussions. Results In total only 176 of 411 habitants (42%) in the village accepted having a bloodspot taken to screen for malaria. Although trial recruitment was initially high in the village, some families refused screening when rumours started spreading that the trial team was taking too much blood. Concerns about 'loss of blood' were equated to loss of strength and lack of good food to replenish bodily forces. Families in the study village were concerned about the weakness of their body while they had to harvest their crops at the time of recruitment for the trial. Conclusion A common recommendation to prevent and avoid rumours against public health interventions and trials is the provision of full and consistent information during the consent procedure, which is assumed to lead to more accurate knowledge of the purpose of the intervention and increased trial participation. However, even when information provision is continuous, the emergence of rumours can be related to times of uncertainty and perceptions of vulnerability, which are often a reflection of structural inequalities and diverging value orientations between communities and public health institutions.	[O'Neill, Sarah; Dierickx, Susan; Gryseels, Charlotte; d'Alessandro, Umberto; Grietens, Koen Peeters] Inst Trop Med, Dept Publ Hlth, Unit Med Anthropol, Antwerp, Belgium; [Dierickx, Susan; Gryseels, Charlotte] Univ Amsterdam, Amsterdam Inst Social Sci Res, Amsterdam, Netherlands; [Dierickx, Susan] Vrije Univ Brussels, RHEA, Ctr Expertise Gender Div & Intersect, Brussels, Belgium; [Okebe, Joseph; Dabira, Edgard; d'Alessandro, Umberto] Med Res Council Gambia, Fajara, Gambia; [Okebe, Joseph] Univ Antwerp, Antwerp, Belgium; [d'Alessandro, Umberto] London Sch Hyg & Trop Med, London, England; [Grietens, Koen Peeters] Nagasaki Univ, Sch Trop Med & Global Hlth, Nagasaki, Japan; [Grietens, Koen Peeters] Partners Appl Social Sci PASS Int, Tessenderlo, Belgium	Institute of Tropical Medicine (ITM); University of Amsterdam; Vrije Universiteit Brussel; University of London; London School of Hygiene & Tropical Medicine; University of Antwerp; University of London; London School of Hygiene & Tropical Medicine; Nagasaki University	O'Neill, S (corresponding author), Inst Trop Med, Dept Publ Hlth, Unit Med Anthropol, Antwerp, Belgium.	soneill@itg.be	Peeters Grietens, Koen/G-7028-2019; Okebe, Joseph/Y-1664-2019	Peeters Grietens, Koen/0000-0001-6570-9887; Okebe, Joseph/0000-0001-5466-1611; Gryseels, Charlotte/0000-0002-8963-4469; O'Neill, Sarah/0000-0001-8807-0991; Dierickx, Susan/0000-0003-3140-0771	Joint Global Health Trials Scheme (DFID/MRC/Wellcome Trust) [MR/K007203/1]; Institute of Social Cultural Anthropology at the University of Oxford, Oxford, UK; MRC [MC_EX_MR/J002364/1] Funding Source: UKRI; Medical Research Council [MC_EX_MR/J002364/1] Funding Source: researchfish	Joint Global Health Trials Scheme (DFID/MRC/Wellcome Trust); Institute of Social Cultural Anthropology at the University of Oxford, Oxford, UK; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work is part of the study 'Primaquine's gametocytocidal efficacy in malaria asymptomatic carriers treated with dihydroartemisinin-piperaquine' (MR/K007203/1) funded by the Joint Global Health Trials Scheme (DFID/MRC/Wellcome Trust). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r We thank the MRCG social science fieldworkers Fatou Y Manneh, Hejinkey Darboe and Michelle Demba for their assistance with data collection during fieldwork as well as for the transcription and translation of recorded interviews and discussions. We also thank the Prinogam trial fieldwork coordinator Matar Ceesay and team for good co-operation and assistance with fieldwork arrangements. This work is part of the study 'Primaquine's gametocytocidal efficacy in malaria asymptomatic carriers treated with dihydroartemisinin-piperaquine' (MR/K007203/1) funded by the Joint Global Health Trials Scheme (DFID/MRC/Wellcome Trust). The main author thanks the Institute of Social Cultural Anthropology at the University of Oxford, Oxford, UK for the visiting fellowship.	Alwang J., 2001, SOCIAL PROTECTION DI; [Anonymous], 2001, HDB ETHNOGRAPHY; Bannister-Tyrrell M, 2015, LANCET, V385, P420, DOI 10.1016/S0140-6736(14)62392-8; Baxter P, 2008, QUAL REP, V13, P544; Bernard R, 2006, RESEARCH METHODS IN; Brooks N., 2003, TYNDALL CENT CLIM CH, V38, P20; Cham M, 2000, MATERNAL MORTALITY G; Chapman RR, 2006, MED ANTHROPOL Q, V20, P487, DOI 10.1525/maq.2006.20.4.487; Clarke SE, 2003, TROP MED INT HEALTH, V8, P884, DOI 10.1046/j.1365-3156.2003.01095.x; Comaroff J, 1999, AM ETHNOL, V26, P279, DOI 10.1525/ae.1999.26.2.279; Comaroff J, 2000, PUBLIC CULTURE, V12, P291, DOI 10.1215/08992363-12-2-291; Dal-Re R, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001149; Dierickx S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148627; Fairhead J, 2006, SOC SCI MED, V63, P1109, DOI 10.1016/j.socscimed.2006.02.018; Feldman-Savelsberg P, 2000, MED ANTHROPOL Q, V14, P159, DOI 10.1525/maq.2000.14.2.159; Fischer Frank, 2000, CITIZENS EXPERTS ENV; Geissler PW, 2006, TROP MED INT HEALTH, V11, P975, DOI 10.1111/j.1365-3156.2006.01682.x; Geissler PW, 2008, SOC SCI MED, V67, P696, DOI 10.1016/j.socscimed.2008.02.004; Gikonyo C, 2008, SOC SCI MED, V67, P708, DOI 10.1016/j.socscimed.2008.02.003; Graboyes M, 2010, DEV WORLD BIOETH, V10, P34, DOI 10.1111/j.1471-8847.2009.00274.x; Grietens KP, 2014, AM J TROP MED HYG, V91, P213, DOI 10.4269/ajtmh.13-0630; Jegede AS, 2007, PLOS MED, V4, P417, DOI 10.1371/journal.pmed.0040073; Jones COH, 2004, AM J TROP MED HYG, V71, P156, DOI 10.4269/ajtmh.2004.71.156; Kaler A, 2009, SOC SCI MED, V68, P1711, DOI 10.1016/j.socscimed.2009.01.038; Kamuya DM, 2013, DEV WORLD BIOETH, V13, P1, DOI 10.1111/dewb.12009; Kathy Charmaz, 2014, CONSTRUCTING GROUNDE, V2nd; Katz J, 1996, JAMA-J AM MED ASSOC, V276, P1662, DOI 10.1001/jama.276.20.1662; Khalil Susan S, 2007, BMC Med Ethics, V8, P9, DOI 10.1186/1472-6939-8-9; Kingori P, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-556; Kirby MJ, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-2; Leach M., 2007, VACCINE ANXIETIES; Leatherman T, 2005, ETHOS, V33, P46, DOI 10.1525/eth.2005.33.1.046; Lucia S, 2013, JRAI, P42; Madiega PA, 2013, DEV WORLD BIOETH, V13, P21, DOI 10.1111/dewb.12019; Mbuagbaw L, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-145; National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research (NCPHS), 1979, BELM REP ETH PRINC G; Nichter M, 2003, RISK CULTURE AND HEALTH INEQUALITY: SHIFTING PERCEPTIONS OF DANGER AND BLAME, P13; O'Neill S, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0687-2; Oaks L, 2003, CULTURE HLTH INEQUAL; Okebe J, 2015, TRIALS, V16, DOI 10.1186/s13063-015-0597-1; Tangena JAA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074351; Toe LP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080800; Wiseman V, 2008, SOC SCI MED, V67, P487, DOI 10.1016/j.socscimed.2008.04.007; WMA General Assembly, 1964, WORLD MED ASS DECL H; Yin RK, 2003, DESIGN AND METHODS; Zainal Z., 2007, JURNAL KEMANUSIAAN, V5; Zarowsky C, 2013, GLOB HEALTH PROMOT, V20, P3, DOI 10.1177/1757975912470062	47	14	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2016	11	8							e0160464	10.1371/journal.pone.0160464	http://dx.doi.org/10.1371/journal.pone.0160464			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DT4SL	27525652	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000381471100015
J	Samad, NA; Dagher-Kharrat, MB; Hidalgo, O; El Zein, R; Douaihy, B; Siljak-Yakovlev, S				Samad, Nour Abdel; Dagher-Kharrat, Magda Bou; Hidalgo, Oriane; El Zein, Rana; Douaihy, Bouchra; Siljak-Yakovlev, Sonja			Unlocking the Karyological and Cytogenetic Diversity of Iris from Lebanon: Oncocyclus Section Shows a Distinctive Profile and Relative Stasis during Its Continental Radiation	PLOS ONE			English	Article							IN-SITU HYBRIDIZATION; PHYLOGENETIC-RELATIONSHIPS; MOLECULAR PHYLOGENY; RIBOSOMAL DNA; EVOLUTION; ASTERACEAE; IRIDACEAE; KARYOTYPE; WHEAT; HETEROCHROMATIN	Despite being an important target of conservation concern and horticultural interest, Lebanese irises yet have a confusing taxonomic history and species' delimitation is often considered problematic, more especially among royal irises (Iris section Oncocyclus). Indeed, these irises of exceptionally large and spectacular flowers have radiated across Caucasus and eastern Mediterranean giving rise to a number of strict endemic taxa, many of them being considered under threat. Whilst efforts have mostly focused on clarifying the evolutionary relationships in the group based on morphological and molecular data, karyological and cytogenetic characters have been comparatively overlooked. In this study, we established for the first time the physical mapping of 35S rDNA loci and heterochromatin, and obtained karyo-morphological data for ten Lebanese Iris species belonging to four sections (Iris, Limniris, Oncocyclus and Scorpiris). Our results evidenced distinctive genomic profiles for each one of the sections, where Oncocyclus irises, while having the lowest chromosome numbers, exhibit both the highest number of 35S loci and CMA3+ sites. The continental radiation of royal irises has been accompanied by a relative karyological and cytogenetic stasis, even though some changes were observed regarding karyotype formula and asymmetry indexes. In addition to that, our results enabled taxonomic differentiation between I. germanica and I. mesopotamica-two taxa currently considered as synonyms-and highlighted the need for further studies on populations of I. persica and I. wallasiae in the Eastern Mediterranean Region.	[Samad, Nour Abdel; Dagher-Kharrat, Magda Bou; El Zein, Rana; Douaihy, Bouchra] Univ St Joseph, Fac Sci, Dept Sci Vie & Terre, Lab Caracterisat Genom Plantes, Campus Sci & Technol, Mar Roukos Mkalles, Lebanon; [Samad, Nour Abdel; Siljak-Yakovlev, Sonja] Univ Paris 11, Univ Paris Saclay, Ecol Systemat Evolut, UMR 8079,AgroParisTech, Bat 360, F-91405 Orsay, France; [Hidalgo, Oriane] Royal Bot Gardens, Richmond TW9 3AB, Surrey, England	Saint Joseph University Beirut; AgroParisTech; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Paris Saclay; Royal Botanic Gardens, Kew	Dagher-Kharrat, MB (corresponding author), Univ St Joseph, Fac Sci, Dept Sci Vie & Terre, Lab Caracterisat Genom Plantes, Campus Sci & Technol, Mar Roukos Mkalles, Lebanon.	magda.boudagher@usj.edu.lb	Kharrat, Magda Bou Dagher/E-8473-2017; Hidalgo, Oriane/F-5985-2013	Kharrat, Magda Bou Dagher/0000-0001-7969-1673; Hidalgo, Oriane/0000-0002-1547-8627; Douaihy, Bouchra/0000-0001-7600-3409	National Council for Scientific Research Lebanon [01-06-08]; Research Council of Saint Joseph University [FS-56]	National Council for Scientific Research Lebanon; Research Council of Saint Joseph University	This work was supported by the National Council for Scientific Research Lebanon under Grant [01-06-08] to MBK and the Research Council of Saint Joseph University under Grant FS-56 to MBK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams SP, 2000, AM J BOT, V87, P1578, DOI 10.2307/2656733; Alvarez I, 2003, MOL PHYLOGENET EVOL, V29, P417, DOI 10.1016/S1055-7903(03)00208-2; AVISHAI M, 1977, BOT GAZ, V138, P502, DOI 10.1086/336956; AVISHAI M, 1980, BOT GAZ, V141, P107, DOI 10.1086/337130; Avishai M, 1977, SPECIES RELATIONSHIP; Bareka P, 2012, PLANT SYST EVOL, V298, P421, DOI 10.1007/s00606-011-0555-7; Bogunic F, 2011, PLANT BIOLOGY, V13, P194, DOI 10.1111/j.1438-8677.2010.00326.x; Cerbah M, 1998, MOL BIOL EVOL, V15, P345, DOI 10.1093/oxfordjournals.molbev.a025931; CHAUDHARY SA, 1972, BOT NOTISER, V125, P497; Clarkson JJ, 2005, NEW PHYTOL, V168, P241, DOI 10.1111/j.1469-8137.2005.01480.x; Cuadrado A, 2000, THEOR APPL GENET, V101, P711, DOI 10.1007/s001220051535; Cuadrado A, 1997, THEOR APPL GENET, V94, P347, DOI 10.1007/s001220050422; Dadejova M, 2007, NEW PHYTOL, V174, P658, DOI 10.1111/j.1469-8137.2007.02034.x; DAVIS AP, 1990, BOT J LINN SOC, V103, P281, DOI 10.1111/j.1095-8339.1990.tb00189.x; Dobigny G, 2004, SYST BIOL, V53, P470, DOI 10.1080/10635150490445698; Doronkin VM, 1987, IRIDACEAE JUSS NAUKA, P113; Garcia S, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-95; Garnatje T, 2012, GENOME, V55, P529, DOI [10.1139/G2012-041, 10.1139/g2012-041]; GEBER G, 1988, PLANT SYST EVOL, V158, P97, DOI 10.1007/BF00936336; GERLACH WL, 1980, NUCLEIC ACIDS RES, V8, P4851, DOI 10.1093/nar/8.21.4851; Glasgow K, 1997, IRISES PRACTICAL GAR; Goldblatt P, 1997, ANN MO BOT GARD, V84, P285, DOI 10.2307/2400005; Hall Tony, 2014, Curtis's Botanical Magazine, V31, P238, DOI 10.1111/curt.12080; Heslop-Harrison J. S., 1991, Technique, a Journal of Methods in Cell and Molecular Biology, V3, P109; Hidalgo O, 2007, BOT J LINN SOC, V153, P193, DOI 10.1111/j.1095-8339.2007.00598.x; Jang TS, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-136; Kocyigit M, 2013, 5 BITK K YAL TURK; Kohlein F, 1987, IRIS; Kovarik A, 2005, GENETICS, V169, P931, DOI 10.1534/genetics.104.032839; LACADENA JR, 1984, THEOR APPL GENET, V67, P207, DOI 10.1007/BF00317037; Lavi R, 2015, NEW PHYTOL, V205, P369, DOI 10.1111/nph.12982; LEVAN A, 1964, HEREDITAS-GENETISK A, V52, P201, DOI 10.1111/j.1601-5223.1964.tb01953.x; Lim KY, 2007, ANN BOT-LONDON, V100, P219, DOI 10.1093/aob/mcm116; Makarevitch I, 2003, INT J PLANT SCI, V164, P229, DOI 10.1086/346160; Martel E, 2004, PLANT SYST EVOL, V249, P139, DOI 10.1007/s00606-004-0191-6; Martinez J, 2010, PLANT SYST EVOL, V289, P223, DOI 10.1007/s00606-010-0345-7; Mathew B., 1989, IRIS; MITRA JYOTIRMAY, 1956, BOT GAZ, V117, P265, DOI 10.1086/335916; Monty A, 2006, CAN J BOT, V84, P1327, DOI 10.1139/B06-081; MOUTERDE P., 1966, NOUVELLE FLORE LIBAN; Mouterde P., 1983, NOUVELLE FLORE LIBAN; Muratovic E, 2010, ADV SCI LETT, V3, P180, DOI 10.1166/asl.2010.1116; Paszko B, 2006, PLANT SYST EVOL, V258, P39, DOI 10.1007/s00606-005-0389-2; Peruzzi L, 2013, COMP CYTOGENET, V7, P1, DOI 10.3897/CompCytogen.v7i1.4431; Pikaard CS, 2001, TRENDS GENET, V17, P675, DOI 10.1016/S0168-9525(01)02545-8; Rasoul TN, 1984, ORNAMENTAL BULBS; Rix M, 1997, GUIDE SPECIES IRISES, P62; Rodionenko G. I., 1987, GENUS IRIS L QUESTIO; Ruas CD, 2005, GENET MOL BIOL, V28, P129, DOI 10.1590/S1415-47572005000100023; Saad L, 2006, THESIS; Saad L, 2009, BOT J LINN SOC, V159, P123, DOI 10.1111/j.1095-8339.2008.00896.x; Sapir Y, 2005, PLANT BIOLOGY, V7, P417, DOI 10.1055/s-2005-837709; Sapir Y, 2002, ISR J PLANT SCI, V50, pS119, DOI 10.1560/DJXH-QX0M-5P0H-DLMW; Sapir Y, 2003, J NAT CONSERV, V11, P91, DOI 10.1078/1617-1381-00041; SCHUBERT I, 1985, CHROMOSOMA, V92, P143, DOI 10.1007/BF00328466; SCHWEIZER D, 1976, CHROMOSOMA, V58, P307, DOI 10.1007/BF00292840; Siljak-Yakovlev S, 2002, THEOR APPL GENET, V104, P505, DOI 10.1007/s001220100755; Siljak-Yakovlev S, 2005, 17 INT BOT C VIENN, P384; SiljakYakovlev S, 1996, SEX PLANT REPROD, V9, P127, DOI 10.1007/BF02221391; Simonet M., 1934, ANN SCI NAT BOT ANN, V1016, P229; SIMONET MARC, 1932, BULL SOC BOT FRANCE, V78, P696; Souza G, 2015, PLANT SYST EVOL, V301, P2013, DOI 10.1007/s00606-015-1216-z; Stace CA, 2000, TAXON, V49, P451, DOI 10.2307/1224344; The Plant List, 2013, VERS 1 1 PUBL INT; Tohme G., 2011, LEBANESE SCI J, V12, P133; Tohme G., 2007, ILLUSTRATED FLORA LE; Tohme H, 2002, 1000 ONE FLOWERS LEB; Vereecken NJ, 2013, ANN BOT-LONDON, V111, P1155, DOI 10.1093/aob/mct081; Walter KS, 1998, 1997 IUCN RED LIST T; Watanabe K, 1999, J PLANT RES, V112, P145, DOI 10.1007/PL00013869; Watts S, 2013, ANN BOT-LONDON, V111, P395, DOI 10.1093/aob/mcs292; Weiss-Schneeweiss H, 2007, NEW PHYTOL, V174, P669, DOI 10.1111/j.1469-8137.2007.02019.x; West WA, 1967, ASI YB, P64; Wilson CA, 2004, MOL PHYLOGENET EVOL, V33, P402, DOI 10.1016/j.ympev.2004.06.013; Wilson CA, 2016, TAXON, V65, P35, DOI 10.12705/651.3; WU QG, 1985, BOT J LINN SOC, V90, P253, DOI 10.1111/j.1095-8339.1985.tb00385.x; ZARCO CR, 1986, TAXON, V35, P526, DOI 10.2307/1221906	77	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2016	11	8							e0160816	10.1371/journal.pone.0160816	http://dx.doi.org/10.1371/journal.pone.0160816			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4SL	27525415	gold, Green Published, Green Submitted			2022-12-27	WOS:000381471100021
J	Heintz, TG; Eva, R; Fawcett, JW				Heintz, Tristan G.; Eva, Richard; Fawcett, James W.			Regional Regulation of Purkinje Cell Dendritic Spines by Integrins and Eph/Ephrins	PLOS ONE			English	Article							LONG-TERM POTENTIATION; CENTRAL-NERVOUS-SYSTEM; SYNAPSE FORMATION; HIPPOCAMPAL-NEURONS; GLUTAMATE TRANSPORT; EPH RECEPTORS; MOUSE-BRAIN; EXPRESSION; PLASTICITY; KINASE	Climbing fibres and parallel fibres compete for dendritic space on Purkinje cells in the cerebellum. Normally, climbing fibres populate the proximal dendrites, where they suppress the multiple small spines typical of parallel fibres, leading to their replacement by the few large spines that contact climbing fibres. Previous work has shown that ephrins acting via EphA4 are a signal for this change in spine type and density. We have used an in vitro culture model in which to investigate the ephrin effect on Purkinje cell dendritic spines and the role of integrins in these changes. We found that integrins alpha 3, alpha 5 and alpha 4 are present in many of the dendritic spines of cultured Purkinje cells. pFAK, the main downstream signalling molecule from integrins, has a similar distribution, although the intenstity of pFAK staining and the percentage of pFAK+ spines was consistently higher in the proximal dendrites. Activating integrins with Mg2+ led to an increase in the intensity of pFAK staining and an increase in the proportion of pFAK+ spines in both the proximal and distal dendrites, but no change in spine length, density or morphology. Blocking integrin binding with an RGD- containing peptide led to a reduction in spine length, with more stubby spines on both proximal and distal dendrites. Treatment of the cultures with ephrinA3- Fc chimera suppressed dendritic spines specifically on the proximal dendrites and there was also a decrease of pFAK in spines on this domain. This effect was blocked by simultaneous activation of integrins with Mn2+. We conclude that Eph/ephrin signaling regulates proximal dendritic spines in Purkinje cells by inactivating integrin downstream signalling.	[Heintz, Tristan G.; Eva, Richard; Fawcett, James W.] Univ Cambridge, John van Geest Ctr Brain Repair, Robinson Way, Cambridge CB2 0PY, England	University of Cambridge	Fawcett, JW (corresponding author), Univ Cambridge, John van Geest Ctr Brain Repair, Robinson Way, Cambridge CB2 0PY, England.	jf108@cam.ac.uk	Eva, Richard/J-7865-2017	Eva, Richard/0000-0003-0305-0452; Fawcett, James/0000-0002-7990-4568	MRC [G1000864]; ERC ECMNeuro; Christopher and Dana Reeve Foundation consortium; EU Marie Curie RTN Axregen; Medical Research Council [G1000864] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); ERC ECMNeuro; Christopher and Dana Reeve Foundation consortium; EU Marie Curie RTN Axregen; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by MRC G1000864 (www.mrc.ac.uk), ERC ECMNeuro (https://erc.europa.eu), Christopher and Dana Reeve Foundation consortium (www.christopherreeve.org), and EU Marie Curie RTN Axregen (ec.europa.eu/research/mariecurieactions).	Babayan AH, 2012, J NEUROSCI, V32, P12854, DOI 10.1523/JNEUROSCI.2024-12.2012; Bi XN, 2001, J COMP NEUROL, V435, P184, DOI 10.1002/cne.1201; Bourgin C, 2007, J CELL BIOL, V178, P1295, DOI 10.1083/jcb.200610139; Carmona MA, 2009, P NATL ACAD SCI USA, V106, P12524, DOI 10.1073/pnas.0903328106; Cesa R, 2003, J NEUROSCI, V23, P2363; Cesa R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019160; Cingolani LA, 2008, NEURON, V58, P749, DOI 10.1016/j.neuron.2008.04.011; Filosa A, 2009, NAT NEUROSCI, V12, P1285, DOI 10.1038/nn.2394; Fu WY, 2007, NAT NEUROSCI, V10, P67, DOI 10.1038/nn1811; Greferath U, 2002, MECH DEVELOP, V119, pS231, DOI 10.1016/S0925-4773(03)00122-9; Hruska M, 2012, MOL CELL NEUROSCI, V50, P35, DOI 10.1016/j.mcn.2012.03.004; Jones EV, 2011, J NEUROSCI, V31, P4154, DOI 10.1523/JNEUROSCI.4757-10.2011; Kawaguchi SY, 2006, MOL CELL NEUROSCI, V31, P416, DOI 10.1016/j.mcn.2005.10.012; Kerrisk ME, 2014, PROG BRAIN RES, V214, P101, DOI 10.1016/B978-0-444-63486-3.00005-0; Kerrisk ME, 2013, J NEUROSCI, V33, P6742, DOI 10.1523/JNEUROSCI.0528-13.2013; Lai KO, 2009, CURR OPIN NEUROBIOL, V19, P275, DOI 10.1016/j.conb.2009.04.009; Lee KJ, 2004, NEUROSCI LETT, V359, P21, DOI 10.1016/j.neulet.2004.01.071; Levy AD, 2014, FRONT NEUROANAT, V8, DOI 10.3389/fnana.2014.00116; Liebl DJ, 2003, J NEUROSCI RES, V71, P7, DOI 10.1002/jnr.10457; Mandolesi G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005243; Margolis SS, 2010, CELL, V143, P442, DOI 10.1016/j.cell.2010.09.038; Martone ME, 1997, BRAIN RES, V771, P238, DOI 10.1016/S0006-8993(97)00792-0; McGeachie AB, 2011, NEUROSCI RES, V70, P24, DOI 10.1016/j.neures.2011.02.006; Migani P, 2007, BRAIN RES, V1182, P60, DOI 10.1016/j.brainres.2007.08.065; Moeller ML, 2006, J BIOL CHEM, V281, P1587, DOI 10.1074/jbc.M511756200; Murai KK, 2011, GLIA, V59, P1567, DOI 10.1002/glia.21226; Murai KK, 2004, NEUROSCIENTIST, V10, P304, DOI 10.1177/1073858403262221; Orlando C, 2012, J NEUROSCI, V32, P18009, DOI 10.1523/JNEUROSCI.2406-12.2012; Pozo K, 2012, P NATL ACAD SCI USA, V109, P1323, DOI 10.1073/pnas.1113736109; Saywell V, 2014, CEREBELLUM, V13, P307, DOI 10.1007/s12311-014-0548-5; Senkov O, 2014, PROG BRAIN RES, V214, P53, DOI 10.1016/B978-0-444-63486-3.00003-7; Shi Y, 2006, J NEUROSCI, V26, P1813, DOI 10.1523/JNEUROSCI.4091-05.2006; Su JM, 2012, CELL REP, V2, P223, DOI 10.1016/j.celrep.2012.07.001; Troca-Marin JA, 2010, MOL CELL NEUROSCI, V43, P308, DOI 10.1016/j.mcn.2009.12.004; Vitureira N, 2012, CURR OPIN NEUROBIOL, V22, P516, DOI 10.1016/j.conb.2011.09.006; Warren MS, 2012, J NEUROSCI, V32, P2824, DOI 10.1523/JNEUROSCI.3942-11.2012; Willson CA, 2006, J MOL HISTOL, V37, P369, DOI 10.1007/s10735-006-9067-0; Yu XZ, 2013, NEURON, V80, P64, DOI 10.1016/j.neuron.2013.07.014; Zhou L, 2012, J BIOL CHEM, V287, P9346, DOI 10.1074/jbc.M111.302802	39	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2016	11	8							e0158558	10.1371/journal.pone.0158558	http://dx.doi.org/10.1371/journal.pone.0158558			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3LI	27518800	Green Published, Green Submitted, gold			2022-12-27	WOS:000381382100004
J	Prakash, A; Cao, VB; Doublie, S				Prakash, Aishwarya; Cao, Vy Bao; Doublie, Sylvie			Phosphorylation Sites Identified in the NEIL1 DNA Glycosylase Are Potential Targets for the JNK1 Kinase	PLOS ONE			English	Article							BASE EXCISION-REPAIR; HUMAN 8-OXOGUANINE-DNA GLYCOSYLASE; C-TERMINAL DOMAIN; IN-VIVO; POSTTRANSLATIONAL MODIFICATIONS; MASS-SPECTROMETRY; PROTEIN-PHOSPHORYLATION; SIGNALING NETWORKS; ENDONUCLEASE-VIII; FAMILY KINASES	The NEIL1 DNA glycosylase is one of eleven mammalian DNA glycosylases that partake in the first step of the base excision repair (BER) pathway. NEIL1 recognizes and cleaves mainly oxidized pyrimidines from DNA. The past decade has witnessed the identification of an increasing number of post-translational modifications (PTMs) in BER enzymes including phosphorylation, acetylation, and sumoylation, which modulate enzyme function. In this work, we performed the first comprehensive analysis of phosphorylation sites in human NEIL1 expressed in human cells. Mass spectrometry (MS) analysis revealed phosphorylation at three serine residues: S207, S306, and a third novel site, S61. We expressed, purified, and characterized phosphomimetic (glutamate) and phosphoablating (alanine) mutants of the three phosphorylation sites in NEIL1 revealed by the MS analysis. All mutant enzymes were active and bound tightly to DNA, indicating that phosphorylation does not affect DNA binding and enzyme activity at these three serine sites. We also characterized phosphomimetic mutants of two other sites of phosphorylation, Y263 and S269, reported previously, and observed that mutation of Y263 to E yielded a completely inactive enzyme. Furthermore, based on sequence motifs and kinase prediction algorithms, we identified the c-Jun N-terminal kinase 1 (JNK1) as the kinase involved in the phosphorylation of NEIL1. JNK1, a member of the mitogen activated protein kinase (MAPK) family, was detected in NEIL1 immunoprecipitates, interacted with NEIL1 in vitro, and was able to phosphorylate the enzyme at residues S207, S306, and S61.	[Prakash, Aishwarya] Univ S Alabama, Mitchell Canc Inst, Dept Oncol Sci, 1660 Springhill Ave, Mobile, AL 36604 USA; [Cao, Vy Bao; Doublie, Sylvie] Univ Vermont, Dept Microbiol & Mol Genet, Markey Ctr Mol Genet, Stafford Hall,95 Carrigan Dr, Burlington, VT 05405 USA	University of South Alabama; University of Vermont	Prakash, A (corresponding author), Univ S Alabama, Mitchell Canc Inst, Dept Oncol Sci, 1660 Springhill Ave, Mobile, AL 36604 USA.; Doublie, S (corresponding author), Univ Vermont, Dept Microbiol & Mol Genet, Markey Ctr Mol Genet, Stafford Hall,95 Carrigan Dr, Burlington, VT 05405 USA.	aprakash@health.southalabama.edu; Sylvie.Doublie@uvm.edu		Doublie, Sylvie/0000-0002-6294-5304; Cao, Vy/0000-0003-4703-450X; Prakash, Aishwarya/0000-0003-1441-6237	National Cancer Institute at National Institutes of Health [P01 CA098993]; National Institute of Environmental Health Sciences at the National Institutes of Health [2-K99ES024417]; National Institute of General Medical Sciences of the National Institutes of Health [P20GM103449]; NATIONAL CANCER INSTITUTE [P01CA098993] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R00ES024417] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103449] Funding Source: NIH RePORTER	National Cancer Institute at National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Environmental Health Sciences at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported by the National Cancer Institute at National Institutes of Health [P01 CA098993 to SD]; the National Institute of Environmental Health Sciences at the National Institutes of Health [2-K99ES024417 to AP]; and National Institute of General Medical Sciences of the National Institutes of Health Institutional Development Award (IDeA) grant [P20GM103449 to the Vermont Genetics Network (VGN)].; We would like to thank Drs. Robyn Maher and David Pederson for supplying us with the NEIL1-SBP construct, Dr. Scott Kathe for technical assistance with the affinity pull-down and biochemistry experiments, Drs. Cindy Burrows and Aaron Fleming (University of Utah) for the Sp- containing oligonucleotide, and Dr. Brian E. Eckenroth for critically reading the manuscript. We would also like to acknowledge Julia Ganister Fields, Bethany Ahlers, and Dr. YingWai Lam at the Vermont Genetics Network Proteomics Facility who performed the mass spectrometry analysis. The mass spectrometry work reported in this publication was supported by an Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health under grant number P20GM103449. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of NIGMS or NIH.	Abmayr Susan M, 2006, Curr Protoc Pharmacol, VChapter 12, DOI [10.1002/0471142727.mb1201s75, 10.1002/0471141755.ph1203s35]; Akbari M, 2012, MUTAT RES-FUND MOL M, V736, P33, DOI 10.1016/j.mrfmmm.2011.06.006; Almeida KH, 2007, DNA REPAIR, V6, P695, DOI 10.1016/j.dnarep.2007.01.009; Bandaru V, 2004, ACTA CRYSTALLOGR D, V60, P1142, DOI 10.1107/S0907444904007929; Bandaru V, 2002, DNA REPAIR, V1, P517, DOI 10.1016/S1568-7864(02)00036-8; Bhakat KK, 2006, MOL CELL BIOL, V26, P1654, DOI 10.1128/MCB.26.5.1654-1665.2006; Bhakat KK, 2004, NUCLEIC ACIDS RES, V32, P3033, DOI 10.1093/nar/gkh632; Bian YY, 2014, J PROTEOMICS, V96, P253, DOI 10.1016/j.jprot.2013.11.014; Brooks SC, 2013, BBA-PROTEINS PROTEOM, V1834, P247, DOI 10.1016/j.bbapap.2012.10.005; Choudhary C, 2010, NAT REV MOL CELL BIO, V11, P427, DOI 10.1038/nrm2900; Cooke MS, 2003, FASEB J, V17, P1195, DOI 10.1096/fj.02-0752rev; Cui J, 2007, ACTA PHARMACOL SIN, V28, P601, DOI 10.1111/j.1745-7254.2007.00579.x; Dantzer F, 2002, NUCLEIC ACIDS RES, V30, P2349, DOI 10.1093/nar/30.11.2349; Das A, 2004, J BIOL CHEM, V279, P47132, DOI 10.1074/jbc.M406224200; Dephoure N, 2013, MOL BIOL CELL, V24, P535, DOI 10.1091/mbc.E12-09-0677; Deribe YL, 2010, NAT STRUCT MOL BIOL, V17, P666, DOI 10.1038/nsmb.1842; Dou H, 2003, J BIOL CHEM, V278, P49679, DOI 10.1074/jbc.M308658200; Dou H, 2008, J BIOL CHEM, V283, P3130, DOI 10.1074/jbc.M709186200; Doublie S, 2004, P NATL ACAD SCI USA, V101, P10284, DOI 10.1073/pnas.0402051101; Fan JS, 2005, FREE RADICAL BIO MED, V38, P1121, DOI 10.1016/j.freeradbiomed.2005.01.012; Forbes SA, 2015, NUCLEIC ACIDS RES, V43, pD805, DOI 10.1093/nar/gku1075; Fortini P, 2003, BIOCHIMIE, V85, P1053, DOI 10.1016/j.biochi.2003.11.003; Fromme JC, 2004, ADV PROTEIN CHEM, V69, P1; Garcia BA, 2005, METHODS, V35, P256, DOI 10.1016/j.ymeth.2004.08.017; Grin IR, 2011, BIOCHEMISTRY-MOSCOW+, V76, P80, DOI 10.1134/S000629791101010X; Hagen L, 2008, EMBO J, V27, P51, DOI 10.1038/sj.emboj.7601958; Hegde ML, 2008, CELL RES, V18, P27, DOI 10.1038/cr.2008.8; Hegde ML, 2013, J MOL BIOL, V425, P2359, DOI 10.1016/j.jmb.2013.03.030; Hegde PM, 2015, J BIOL CHEM, V290, P20919, DOI 10.1074/jbc.M115.642918; Hu JP, 2005, J BIOL CHEM, V280, P40544, DOI 10.1074/jbc.M508772200; Hu JP, 2005, NUCLEIC ACIDS RES, V33, P3271, DOI 10.1093/nar/gki636; Huen MS, 2008, CELL RES, V18, P8, DOI 10.1038/cr.2007.109; Imamura K, 2009, J BIOL CHEM, V284, P26174, DOI 10.1074/jbc.M109.021907; Jaruga P, 2010, BIOCHEMISTRY-US, V49, P1053, DOI 10.1021/bi902161f; Jensen ON, 2004, CURR OPIN CHEM BIOL, V8, P33, DOI 10.1016/j.cbpa.2003.12.009; Kang LH, 2015, EXP EYE RES, V135, P102, DOI 10.1016/j.exer.2015.02.005; Karve Tejaswita M, 2011, J Amino Acids, V2011, P207691, DOI 10.4061/2011/207691; Kornyushyna O, 2002, BIOCHEMISTRY-US, V41, P15304, DOI 10.1021/bi0264925; Kundu S, 2010, DNA REPAIR, V9, P1026, DOI 10.1016/j.dnarep.2010.07.002; Leandro GS, 2015, MUTAT RES-FUND MOL M, V776, P31, DOI 10.1016/j.mrfmmm.2014.12.011; Lillenes MS, 2011, MECH AGEING DEV, V132, P449, DOI 10.1016/j.mad.2011.08.002; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Liu MM, 2010, P NATL ACAD SCI USA, V107, P4925, DOI 10.1073/pnas.0908307107; Lovejoy CA, 2009, DNA REPAIR, V8, P1004, DOI 10.1016/j.dnarep.2009.04.006; Lundby A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1871; Maynard S, 2009, CARCINOGENESIS, V30, P2, DOI 10.1093/carcin/bgn250; McCullough AK, 1999, ANNU REV BIOCHEM, V68, P255, DOI 10.1146/annurev.biochem.68.1.255; Morland I, 2002, NUCLEIC ACIDS RES, V30, P4926, DOI 10.1093/nar/gkf618; Murtaza M, 2013, NATURE, V497, P108, DOI 10.1038/nature12065; Odell ID, 2010, DNA REPAIR, V9, P134, DOI 10.1016/j.dnarep.2009.11.005; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Onizuka K, 2012, CHEMBIOCHEM, V13, P1338, DOI 10.1002/cbic.201200139; Picco Vincent, 2013, Genes Cancer, V4, P360, DOI 10.1177/1947601913486347; Prakash A, 2012, PROG MOL BIOL TRANSL, V110, P71, DOI 10.1016/B978-0-12-387665-2.00004-3; Qiu Y, 2000, ONCOGENE, V19, P5651, DOI 10.1038/sj.onc.1203958; Safaei J, 2011, PROTEOME SCI, V9, DOI 10.1186/1477-5956-9-S1-S6; Sampath H, 2012, FREE RADICAL RES, V46, P460, DOI 10.3109/10715762.2012.655730; Sheridan DL, 2008, J BIOL CHEM, V283, P19511, DOI 10.1074/jbc.M801074200; Sidorenko VS, 2009, FEBS J, V276, P5149, DOI 10.1111/j.1742-4658.2009.07212.x; Sui SH, 2008, PROTEOMICS, V8, P2024, DOI 10.1002/pmic.200700896; Tacoma R, 2016, J PROTEOMICS, V130, P200, DOI 10.1016/j.jprot.2015.09.024; Takesono A, 2002, J CELL SCI, V115, P3039; Vik ES, 2012, DNA REPAIR, V11, P766, DOI 10.1016/j.dnarep.2012.07.002; Wallace SS, 1998, RADIAT RES, V150, pS60, DOI 10.2307/3579809; Wallace SS, 2014, DNA REPAIR, V19, P14, DOI 10.1016/j.dnarep.2014.03.030; Wallace SS, 2012, CANCER LETT, V327, P73, DOI 10.1016/j.canlet.2011.12.038; Zhao XB, 2010, BIOCHEMISTRY-US, V49, P1658, DOI 10.1021/bi901852q; Zharkov DO, 2008, CELL MOL LIFE SCI, V65, P1544, DOI 10.1007/s00018-008-7543-2	68	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2016	11	8							e0157860	10.1371/journal.pone.0157860	http://dx.doi.org/10.1371/journal.pone.0157860			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3LI	27518429	gold, Green Published, Green Submitted			2022-12-27	WOS:000381382100001
J	Colin, D; Micheyl, C; Girod, A; Truy, E; Gallego, S				Colin, David; Micheyl, Christophe; Girod, Anneline; Truy, Eric; Gallego, Stephane			Binaural Diplacusis and Its Relationship with Hearing-Threshold Asymmetry	PLOS ONE			English	Article							AUDITORY-NERVE FIBERS; LONG-TERM MEASUREMENT; TONE PITCH ANOMALIES; COMPLEX TONES; FREQUENCY DISCRIMINATION; INTENSITY; CORTEX; REPRESENTATION; PERCEPTION; MATCHES	Binaural pitch diplacusis refers to a perceptual anomaly whereby the same sound is perceived as having a different pitch depending on whether it is presented in the left or the right ear. Results in the literature suggest that this phenomenon is more prevalent, and larger, in individuals with asymmetric hearing loss than in individuals with symmetric hearing. However, because studies devoted to this effect have thus far involved small samples, the prevalence of the effect, and its relationship with interaural asymmetries in hearing thresholds, remain unclear. In this study, psychometric functions for interaural pitch comparisons were measured in 55 subjects, including 12 normal-hearing and 43 hearing-impaired participants. Statistically significant pitch differences between the left and right ears were observed in normal-hearing participants, but the effect was usually small (less than 1.5/16 octave, or about 7%). For the hearing-impaired participants, statistically significant interaural pitch differences were found in about three-quarters of the cases. Moreover, for about half of these participants, the difference exceeded 1.5/16 octaves and, in some participants, was as large as or larger than 1/4 octave. This was the case even for the lowest frequency tested, 500 Hz. The pitch differences were weakly, but significantly, correlated with the difference in hearing thresholds between the two ears, such that larger threshold asymmetries were statistically associated with larger pitch differences. For the vast majority of the hearing-impaired participants, the direction of the pitch differences was such that pitch was perceived as higher on the side with the higher (i.e., 'worse') hearing thresholds than on the opposite side. These findings are difficult to reconcile with purely temporal models of pitch perception, but may be accounted for by place-based or spectrotemporal models.	[Colin, David; Truy, Eric] CNRS, Lyon Neurosci Res Ctr, INSERM, IMPACT Team,CRNL,U1028,UMR5292, Lyon, France; [Colin, David; Girod, Anneline; Gallego, Stephane] Inst Sci & Tech Readaptat, Lyon, France; [Micheyl, Christophe] Starkey France, Creteil, France; [Truy, Eric] Ctr Hosp & Univ, Hop Edouard Herriot, Dept ORL, Lyon, France; [Colin, David; Truy, Eric; Gallego, Stephane] Univ Lyon 1, Lyon, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Colin, D (corresponding author), CNRS, Lyon Neurosci Res Ctr, INSERM, IMPACT Team,CRNL,U1028,UMR5292, Lyon, France.; Colin, D (corresponding author), Inst Sci & Tech Readaptat, Lyon, France.; Colin, D (corresponding author), Univ Lyon 1, Lyon, France.	david.colin@univ-lyon1.fr	truy, eric/J-9097-2017	truy, eric/0000-0002-1769-8623	Audition Conseil, Starkey France, Hospices Civils de Lyon	Audition Conseil, Starkey France, Hospices Civils de Lyon	This study was funded by Audition Conseil, Starkey France, Hospices Civils de Lyon. The funders provided support in the form of salaries for authors DC (Audition Conseil), SG (Audition Conseil), CM (Starkey France), and ET (Hospices Civils de Lyon), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Albers GD, 1968, ARCH OTOLARYNGOL, V87, P600; Bekesy G., 1960, EXPERIMENTS IN HEARI; Brannstrom KJ, 2008, INT J AUDIOL, V47, P412, DOI 10.1080/14992020801991729; Brannstrom KJ, 2008, INT J AUDIOL, V47, P59, DOI 10.1080/14992020701643826; Brannstrom KJ, 2008, INT J AUDIOL, V47, P675, DOI 10.1080/14992020802215870; BURNS EM, 1982, J ACOUST SOC AM, V72, P1394, DOI 10.1121/1.388445; BURNS EM, 1986, J ACOUST SOC AM, V79, P1530, DOI 10.1121/1.393679; CARHART R, 1959, J SPEECH HEAR DISORD, V24, P330, DOI 10.1044/jshd.2404.330; Cariani PA, 1996, J NEUROPHYSIOL, V76, P1717, DOI 10.1152/jn.1996.76.3.1717; Cariani PA, 1996, J NEUROPHYSIOL, V76, P1698, DOI 10.1152/jn.1996.76.3.1698; Cedolin L, 2010, J NEUROSCI, V30, P12712, DOI 10.1523/JNEUROSCI.6365-09.2010; de Mare G., 1948, ACTA OTO-LARYNGOL, V74, P107; FLORENTINE M, 1983, J ACOUST SOC AM, V73, P961, DOI 10.1121/1.389021; GAETH JH, 1965, J SPEECH HEAR RES, V8, P63, DOI 10.1044/jshr.0801.63; GEISLER CD, 1974, J NEUROPHYSIOL, V37, P1156, DOI 10.1152/jn.1974.37.6.1156; GOLDSTEIN JL, 1978, J ACOUST SOC AM, V63, P486, DOI 10.1121/1.381749; HARRISON RV, 1979, ARCH OTO-RHINO-LARYN, V224, P71, DOI 10.1007/BF00455226; Henry KS, 2016, J NEUROSCI, V36, P2227, DOI 10.1523/JNEUROSCI.3944-15.2016; Henry KS, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00020; Henry KS, 2013, HEARING RES, V303, P39, DOI 10.1016/j.heares.2013.01.014; Huss M, 2005, J ACOUST SOC AM, V117, P3841, DOI 10.1121/1.1920167; Kale S, 2010, JARO-J ASSOC RES OTO, V11, P657, DOI 10.1007/s10162-010-0223-6; Kral Andrej, 2006, Adv Otorhinolaryngol, V64, P89, DOI 10.1159/000094647; LOEB GE, 1983, BIOL CYBERN, V47, P149, DOI 10.1007/BF00337005; Miller RL, 1997, J ACOUST SOC AM, V101, P3602, DOI 10.1121/1.418321; Moore B C, 2001, Trends Amplif, V5, P1, DOI 10.1177/108471380100500102; Muller M, 2010, HEARING RES, V268, P184, DOI 10.1016/j.heares.2010.05.021; Ogura M, 2003, INT J AUDIOL, V42, P297, DOI 10.3109/14992020309101321; Oxenham AJ, 2012, J NEUROSCI, V32, P13335, DOI 10.1523/JNEUROSCI.3815-12.2012; RAJAN R, 1993, J COMP NEUROL, V338, P17, DOI 10.1002/cne.903380104; ROBERTSON D, 1989, J COMP NEUROL, V282, P456, DOI 10.1002/cne.902820311; ROBINSON DO, 1975, J SPEECH HEAR RES, V18, P5, DOI 10.1044/jshr.1801.05; ROSE JE, 1971, J NEUROPHYSIOL, V34, P685, DOI 10.1152/jn.1971.34.4.685; Schouten JF, 1940, P K NED AKAD WETENSC, V43, P356; SCHWABER MK, 1993, AM J OTOL, V14, P252; SHAMMA SA, 1985, J ACOUST SOC AM, V78, P1622, DOI 10.1121/1.392800; SIEBERT WM, 1970, PR INST ELECTR ELECT, V58, P723, DOI 10.1109/PROC.1970.7727; Stevens SS, 1935, J ACOUST SOC AM, V6, P150, DOI 10.1121/1.1915715; Stevens SS, 1941, PSYCHOL BULL, V38, P548; Thomas A., 2006, R NEWS, V6, P12, DOI DOI 10.1159/000323281; TURNER CW, 1982, J SPEECH HEAR RES, V25, P34, DOI 10.1044/jshr.2501.34; VERSCHUURE J, 1975, ACUSTICA, V32, P33; WEBSTER JC, 1954, J ACOUST SOC AM, V26, P754, DOI 10.1121/1.1907412; Wever EG., 1949, THEORY HEARING; WILLOTT JF, 1993, J COMP NEUROL, V329, P402, DOI 10.1002/cne.903290310; WOOLF NK, 1981, HEARING RES, V4, P335, DOI 10.1016/0378-5955(81)90017-4; Zurmuhl G., 1930, Z SINNESPHYSIOL, V61, P40; Zwicker E., 1970, FREQUENCY ANAL PERIO, P376; ZWISLOCKI J, 1956, J ACOUST SOC AM, V28, P860, DOI 10.1121/1.1908495	49	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0159975	10.1371/journal.pone.0159975	http://dx.doi.org/10.1371/journal.pone.0159975			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27536884	Green Published, Green Submitted, gold			2022-12-27	WOS:000381577000011
J	Dickinson, MB; Hutchinson, TF; Dietenberger, M; Matt, F; Peters, MP				Dickinson, Matthew B.; Hutchinson, Todd F.; Dietenberger, Mark; Matt, Frederick; Peters, Matthew P.			Litter Species Composition and Topographic Effects on Fuels and Modeled Fire Behavior in an Oak-Hickory Forest in the Eastern USA	PLOS ONE			English	Article							SOUTHERN APPALACHIAN MOUNTAINS; HARDWOOD LEAF-LITTER; PRESCRIBED FIRES; LIGNIN CONTROL; DECOMPOSITION; FLAMMABILITY; DYNAMICS; PLANT; REGENERATION; VEGETATION	Mesophytic species (esp. Acer rubrum) are increasingly replacing oaks (Quercus spp.) in fire-suppressed, deciduous oak-hickory forests of the eastern US. A pivotal hypothesis is that fuel beds derived from mesophytic litter are less likely than beds derived from oak litter to carry a fire and, if they do, are more likely to burn at lower intensities. Species effects, however, are confounded by topographic gradients that affect overstory composition and fuel bed decomposition. To examine the separate and combined effects of litter species composition and topography on surface fuel beds, we conducted a common garden experiment in oak-hickory forests of the Ohio Hills. Each common garden included beds composed of mostly oak and mostly maple litter, representative of oak-and maple-dominated stands, respectively, and a mixture of the two. Beds were replenished each fall for four years. Common gardens (N = 16) were established at four topographic positions (ridges, benches on south-and northeast-facing slopes, and stream terraces) at each of four sites. Litter source and topographic position had largely independent effects on fuel beds and modeled fire dynamics after four years of development. Loading (kg m(-2)) of the upper litter layer (L), the layer that primarily supports flaming spread, was least in more mesic landscape positions and for maple beds, implying greater decomposition rates for those situations. Bulk density in the L layer (kg m(-3)) was least for oak beds which, along with higher loading, would promote fire spread and fireline intensity. Loading and bulk density of the combined fermentation and humic (FH) layers were least on stream terrace positions but were not related to species. Litter-and FH-layer moistures during a 5-day dry-down period after a rain event were affected by time and topographic effects while litter source effects were not evident. Characteristics of flaming combustion determined with a cone calorimeter pointed to greater fireline intensity for oak fuel beds and unexpected interactions between litter source and topography. A spread index, which synthesizes a suite of fuel bed, particle, and combustion characteristics to indicate spread (vs extinction) potential, was primarily affected by litter source and, secondarily, by the low spread potentials on mesic landscape positions early in the 5-day dry-down period. A similar result was obtained for modeled fireline intensity. Our results suggest that the continuing transition from oaks to mesophytic species in the Ohio Hills will reduce fire spread potentials and fire intensities.	[Dickinson, Matthew B.; Hutchinson, Todd F.; Peters, Matthew P.] US Forest Serv, Northern Res Stn, Delaware, OH 43015 USA; [Dietenberger, Mark; Matt, Frederick] US Forest Serv, Forest Prod Lab, Madison, WI 53726 USA	United States Department of Agriculture (USDA); United States Forest Service; United States Department of Agriculture (USDA); United States Forest Service	Dickinson, MB (corresponding author), US Forest Serv, Northern Res Stn, Delaware, OH 43015 USA.	mbdickinson@fs.fed.us		Peters, Matthew/0000-0002-4793-0075	Northern Research Station; National Fire Plan	Northern Research Station(United States Department of Agriculture (USDA)United States Forest Service); National Fire Plan	This project was funded by the Northern Research Station and National Fire Plan.; The Common Garden experiment could not have been conducted without the coordination and work in the field by the Vinton Furnace State Experimental Forest crew, especially Bill Borovicka, Levi Miller, and David Hosack. Tony Bova helped with dry-down sampling. John Stanovick, Northern Research Station Statistician, provided indispensable assistance with statistical analyses. Antoine Randolph, Mike Stambaugh, Tom Waldrop, and Joe O'Brien and one anonymous reviewer provided helpful reviews of earlier drafts. This project was funded by the Northern Research Station and National Fire Plan.	ABER JD, 1982, CAN J BOT, V60, P2263, DOI 10.1139/b82-277; Abrams MD, 2001, OAK FOREST ECOSYSTEMS, P34; Abrams MD, 1998, BIOSCIENCE, V48, P355, DOI 10.2307/1313374; BLAIR JM, 1990, ECOLOGY, V71, P1976, DOI 10.2307/1937606; Boerner REJ, 1989, LANDSCAPE ECOL, V2, P82; BOERNER REJ, 1984, CAN J FOREST RES, V14, P794, DOI 10.1139/x84-141; Brose PH, 2013, FOREST SCI, V59, P322, DOI 10.5849/forsci.12-039; Brose PH, 1998, CAN J FOREST RES, V28, P331, DOI 10.1139/cjfr-28-3-331; Byram G.M., 1959, FOREST FIRE CONTROL, P61; Chapman SK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062671; Clinton BD, 1998, SRS12 US FOR SERV; Crosby JS, 1974, NC162 US FOR SERV; Cruz MG, 2010, INT J WILDLAND FIRE, V19, P377, DOI 10.1071/WF08132; Davis MW, 1998, J WOOD CHEM TECHNOL, V18, P235, DOI 10.1080/02773819809349579; Dibble AC, 2007, INT J WILDLAND FIRE, V16, P426, DOI 10.1071/WF05103; Dickinson MB, 2013, CAN J FOREST RES, V43, P321, DOI 10.1139/cjfr-2012-0291; Dickinson MB, 2010, CAN J FOREST RES, V40, P2187, DOI 10.1139/X10-148; Dickinson M.B., 2001, FOREST FIRES, P477, DOI [10.1016/b978-012386660-8/50016-7, DOI 10.1016/B978-012386660-8/50016-7]; Dickinson MB, 2009, GTRNRSP46 USFS; Dilworth JR, 1971, VARIABLE PROBABILITY; Dyer JM, 2009, LANDSCAPE ECOL, V24, P391, DOI 10.1007/s10980-008-9316-6; Engber EA, 2012, CAN J FOREST RES, V42, P1965, DOI 10.1139/x2012-138; Fei SL, 2007, FOREST SCI, V53, P473; Fernandes PM, 2012, NEW PHYTOL, V194, P606, DOI 10.1111/j.1469-8137.2012.04065.x; Fushimi C, 2003, IND ENG CHEM RES, V42, P3929, DOI 10.1021/ie0300575; Gartner TB, 2004, OIKOS, V104, P230, DOI 10.1111/j.0030-1299.2004.12738.x; Haines DA, 1975, NC16 US FOR SERV N C; Hobbie SE, 2006, ECOLOGY, V87, P2288, DOI 10.1890/0012-9658(2006)87[2288:TSEODA]2.0.CO;2; Hutchinson TF, 2008, CAN J FOREST RES, V38, P1184, DOI 10.1139/X07-216; Hutchinson TF, 2012, CAN J FOREST RES, V42, P303, DOI [10.1139/X11-184, 10.1139/x11-184]; Iverson LR, 2008, FOREST ECOL MANAG, V255, P3035, DOI 10.1016/j.foreco.2007.09.088; Iverson LR, 1997, LANDSCAPE ECOL, V12, P331, DOI 10.1023/A:1007989813501; Kane JM, 2008, FOREST ECOL MANAG, V256, P2039, DOI 10.1016/j.foreco.2008.07.039; Keane RE, 2008, CAN J FOREST RES, V38, P1431, DOI 10.1139/X08-003; Kolaks J.J., 2004, P 14 CENTRAL HARDWOO, P168; Kreye JK, 2013, ECOL APPL, V23, P1976, DOI 10.1890/13-0503.1; Linn RR, 2013, AGR FOREST METEOROL, V173, P139, DOI 10.1016/j.agrformet.2012.11.007; LOFTIS D. L., 1993, OAK REG SER PROBL PR; Loomis RM, 1975, NC184 US FOR SERV N; Loucks E, 2008, SOUTH J APPL FOR, V32, P80, DOI 10.1093/sjaf/32.2.80; MEENTEMEYER V, 1978, ECOLOGY, V59, P465, DOI 10.2307/1936576; MELILLO JM, 1982, ECOLOGY, V63, P621, DOI 10.2307/1936780; Mell W, 2007, INT J WILDLAND FIRE, V16, P1, DOI 10.1071/WF06002; Mitchell RJ, 2009, J FOREST, V107, P391; Miyanishi K., 2001, FOREST FIRES BEHAV E, P437, DOI DOI 10.1016/B978-012386660-8/50015-5; MOORE AM, 1986, SOIL BIOL BIOCHEM, V18, P427, DOI 10.1016/0038-0717(86)90049-0; NOAA, CLIM WIND DAT US; Nowacki GJ, 2008, BIOSCIENCE, V58, P123, DOI 10.1641/B580207; QUINN PF, 1995, HYDROL PROCESS, V9, P161, DOI 10.1002/hyp.3360090204; Rothermel R. C., 1986, INT359 USDA FOR SERV; Rothermel R.C., 1972, MATH MODEL PREDICTIN; Ruefenacht B, 2008, PHOTOGRAMM ENG REM S, V74, P1379, DOI 10.14358/PERS.74.11.1379; SAS Institute Inc, 2013, SAS ACCESS 9 4 INT A; Scarff FR, 2006, FUNCT ECOL, V20, P745, DOI 10.1111/j.1365-2435.2006.01174.x; Schwilk DW, 2015, NEW PHYTOL, V206, P486, DOI 10.1111/nph.13372; SINSABAUGH RL, 1993, ECOLOGY, V74, P1594, DOI 10.2307/1940087; Sorensen R, 2005, HYDROL EARTH SYST SC, V2, P1807, DOI DOI 10.5194/HESSD-2-1807-2005; Stambaugh MC, 2008, FOREST ECOL MANAG, V254, P463, DOI 10.1016/j.foreco.2007.08.029; Stottlemyer AD, 2009, INT J WILDLAND FIRE, V18, P423, DOI 10.1071/WF08017; Suarez ER, 2006, BIOL INVASIONS, V8, P553, DOI 10.1007/s10530-005-1196-y; Tang W., 1967, FPL82 USDA FOR SERV; Tarboton DG, 1997, WATER RESOUR RES, V33, P309, DOI 10.1029/96WR03137; USDA, 2003, KEYS SOIL TAXONOMY; Varner JM, 2015, CURR FOR REP, V1, P91, DOI 10.1007/s40725-015-0012-x; Vivanco L, 2008, J ECOL, V96, P727, DOI 10.1111/j.1365-2745.2008.01393.x; Waldrop TA, 2007, CAN J FOREST RES, V37, P1134, DOI 10.1139/X06-302; Weir JR, 2013, FIRE ECOLOGY, V9; White RH, 2010, INT J WILDLAND FIRE, V19, P213, DOI 10.1071/WF07128; WHITTAKER RH, 1956, ECOL MONOGR, V26, P1, DOI 10.2307/1943577; Wilson R., 1980, INT292 DEP AGR FOR S; WILSON RA, 1985, COMBUST SCI TECHNOL, V44, P179, DOI 10.1080/00102208508960302; [No title captured]	72	18	18	2	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0159997	10.1371/journal.pone.0159997	http://dx.doi.org/10.1371/journal.pone.0159997			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27536964	gold, Green Published, Green Submitted			2022-12-27	WOS:000381577000012
J	Edwards, H; Rubenstein, M; Dombkowski, AA; Caldwell, JT; Chu, R; Xavier, AC; Thummel, R; Neely, M; Matherly, LH; Ge, YB; Taub, JW				Edwards, Holly; Rubenstein, Mara; Dombkowski, Alan A.; Caldwell, J. Timothy; Chu, Roland; Xavier, Ana C.; Thummel, Ryan; Neely, Melody; Matherly, Larry H.; Ge, Yubin; Taub, Jeffrey W.			Gene Signature of High White Blood Cell Count in B-Precursor Acute Lymphoblastic Leukemia	PLOS ONE			English	Article							EXPRESSION; CHILDHOOD; CHANNELS; RISK	In this study we sought to identify genetic factors associated with the presenting white blood cell (WBC) count in B-precursor acute lymphoblastic leukemia (BP-ALL). Using ETV6-RUNX1-positive BP-ALL patient samples, a homogeneous subtype, we identified 16 differentially expressed genes based on the presenting WBC count (< 50,000/cumm vs > 50,000). We further confirmed that IL1R1, BCAR3, KCNH2, PIR, and ZDHHC23 were differentially expressed in a larger cohort of ETV6-RUNX1-negative BP-ALL patient samples. Statistical analysis demonstrated that expression levels of these genes could accurately categorize high and low WBC count subjects using two independent patient sets, representing positive and negative ETV6-RUNX1 cases. Further studies in leukemia cell line models will better delineate the role of these genes in regulating the white blood cell count and potentially identify new therapeutic targets.	[Edwards, Holly; Matherly, Larry H.; Ge, Yubin] Wayne State Univ, Sch Med, Dept Oncol, Detroit, MI USA; [Edwards, Holly; Matherly, Larry H.; Ge, Yubin; Taub, Jeffrey W.] Wayne State Univ, Barbara Ann Karmanos Canc Inst, Mol Therapeut Program, Sch Med, Detroit, MI USA; [Rubenstein, Mara; Chu, Roland; Taub, Jeffrey W.] Childrens Hosp Michigan, Div Pediat Hematol Oncol, Detroit, MI 48201 USA; [Dombkowski, Alan A.] Childrens Hosp Michigan, Div Clin Pharmacol & Toxicol, Detroit, MI 48201 USA; [Dombkowski, Alan A.; Chu, Roland; Taub, Jeffrey W.] Wayne State Univ, Sch Med, Dept Pediat, Detroit, MI 48201 USA; [Caldwell, J. Timothy] Wayne State Univ, MD PhD Program, Sch Med, Detroit, MI USA; [Caldwell, J. Timothy] Wayne State Univ, Canc Biol Program, Sch Med, Detroit, MI USA; [Xavier, Ana C.] Univ Alabama Birmingham, Childrens Hosp Alabama, Div Pediat Hematol Oncol, Birmingham, AL USA; [Thummel, Ryan] Wayne State Univ, Sch Med, Dept Anat & Cell Biol, Detroit, MI 48201 USA; [Neely, Melody] Wayne State Univ, Sch Med, Dept Immunol & Microbiol, Detroit, MI 48201 USA; [Matherly, Larry H.] Wayne State Univ, Sch Med, Dept Pharmacol, Detroit, MI 48201 USA	Wayne State University; Barbara Ann Karmanos Cancer Institute; Wayne State University; Children's Hospital of Michigan; Children's Hospital of Michigan; Wayne State University; Wayne State University; Wayne State University; University of Alabama System; University of Alabama Birmingham; Wayne State University; Wayne State University; Wayne State University	Taub, JW (corresponding author), Wayne State Univ, Barbara Ann Karmanos Canc Inst, Mol Therapeut Program, Sch Med, Detroit, MI USA.; Taub, JW (corresponding author), Childrens Hosp Michigan, Div Pediat Hematol Oncol, Detroit, MI 48201 USA.; Taub, JW (corresponding author), Wayne State Univ, Sch Med, Dept Pediat, Detroit, MI 48201 USA.	jtaub@med.wayne.edu	Neely, Melody N/AAX-1130-2021	Neely, Melody N/0000-0003-2125-7836; Dombkowski, Alan/0000-0002-0312-8750; Ge, Yubin/0000-0002-8748-716X	National Cancer Institute [R01 CA120772, T32 CA009531]; Center for Urban Responses to Environmental Stressors [CURES: Wayne State University] P30 Center grant [P30 ES020957]; Karmanos Cancer Institute; Kids Without Cancer; Elana Fund; Herrick Foundation; Justin's Gift Charity; Buric Family; Sehn Family Foundation; Dale Meyer Memorial Endowment for Leukemia Research; Children's Hospital of Michigan Foundation; Ginopolis-Karmanos Endowment; Decerchio/Guisewite Family; Ring Screw Textron Endowed Chair for Pediatric Cancer Research	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Center for Urban Responses to Environmental Stressors [CURES: Wayne State University] P30 Center grant; Karmanos Cancer Institute; Kids Without Cancer; Elana Fund; Herrick Foundation; Justin's Gift Charity; Buric Family; Sehn Family Foundation; Dale Meyer Memorial Endowment for Leukemia Research; Children's Hospital of Michigan Foundation; Ginopolis-Karmanos Endowment; Decerchio/Guisewite Family; Ring Screw Textron Endowed Chair for Pediatric Cancer Research	This study was supported by grants from the National Cancer Institute (R01 CA120772), Center for Urban Responses to Environmental Stressors [CURES: Wayne State University] P30 Center grant (P30 ES020957), Karmanos Cancer Institute, Kids Without Cancer, Elana Fund, the Herrick Foundation, Justin's Gift Charity, The Buric Family, Sehn Family Foundation, Dale Meyer Memorial Endowment for Leukemia Research, Children's Hospital of Michigan Foundation, Ginopolis-Karmanos Endowment, Decerchio/Guisewite Family, and the Ring Screw Textron Endowed Chair for Pediatric Cancer Research. JTC is a predoctoral trainee supported by T32 CA009531 from the National Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arcangeli A., 2005, NOVART FDN SYMP, V266, P32; Arcangeli Annarosa, 2005, V266, P225; Cherubini A, 2005, MOL BIOL CELL, V16, P2972, DOI 10.1091/mbc.E04-10-0940; Licciulli S, 2010, LEUKEMIA, V24, P429, DOI 10.1038/leu.2009.247; Liu F, 2013, P NATL ACAD SCI USA, V110, P9722, DOI 10.1073/pnas.1221743110; Schrecengost RS, 2007, CANCER RES, V67, P6174, DOI 10.1158/0008-5472.CAN-06-3455; Sims JE, 2010, NAT REV IMMUNOL, V10, P89, DOI 10.1038/nri2691; Smith M, 1996, J CLIN ONCOL, V14, P18, DOI 10.1200/JCO.1996.14.1.18; Teachey DT, 2013, BRIT J HAEMATOL, V162, P606, DOI 10.1111/bjh.12442; Tian LJ, 2012, J BIOL CHEM, V287, P14718, DOI 10.1074/jbc.M111.335547; Ward E, 2014, CA-CANCER J CLIN, V64, P83, DOI 10.3322/caac.21219; Xie CZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079106	12	6	6	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0161539	10.1371/journal.pone.0161539	http://dx.doi.org/10.1371/journal.pone.0161539			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27536776	Green Submitted, Green Published, gold			2022-12-27	WOS:000381577000120
J	Hughesman, CB; Lu, XJD; Liu, KYP; Zhu, YQ; Poh, CF; Haynes, C				Hughesman, Curtis B.; Lu, X. J. David; Liu, Kelly Y. P.; Zhu, Yuqi; Poh, Catherine F.; Haynes, Charles			A Robust Protocol for Using Multiplexed Droplet Digital PCR to Quantify Somatic Copy Number Alterations in Clinical Tissue Specimens	PLOS ONE			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; INITIAL DIAGNOSIS; NUCLEIC-ACIDS; DNA INTEGRITY; CANCER; QUANTIFICATION; QUANTITATION; PROGRESSION; RESOLUTION; STRATEGIES	The ability of droplet digital PCR (ddPCR) to accurately determine the concentrations of amplifiable targets makes it a promising platform for measuring copy number alterations (CNAs) in genomic biomarkers. However, its application to clinical samples, particularly formalin-fixed paraffin-embedded specimens, will require strategies to reliably determine CNAs in DNA of limited quantity and quality. When applied to cancerous tissue, those methods must also account for global genetic instability and the associated probability that the abundance(s) of one or more chosen reference loci do not represent the average ploidy of cells comprising the specimen. Here we present an experimental design strategy and associated data analysis tool that enables accurate determination of CNAs in a panel of biomarkers using multiplexed ddPCR. The method includes strategies to optimize primer and probes design to cleanly segregate droplets in the data output from reaction wells amplifying multiple independent templates, and to correct for bias from artifacts such as DNA fragmentation. We demonstrate how a panel of reference loci can be used to determine a stable CNA-neutral benchmark. These innovations, when taken together, provide a comprehensive strategy that can be used to reliably detect biomarker CNAs in DNA extracted from either frozen or FFPE tissue biopsies.	[Hughesman, Curtis B.; Lu, X. J. David; Liu, Kelly Y. P.; Zhu, Yuqi; Poh, Catherine F.] Univ British Columbia, Dept Oral Med Biol Sci, Fac Dent, Vancouver, BC V6T 1Z3, Canada; [Hughesman, Curtis B.; Haynes, Charles] Univ British Columbia, Michael Smith Labs, Vancouver, BC V6T 1Z4, Canada; [Poh, Catherine F.] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V6T 2B5, Canada; [Poh, Catherine F.] British Columbia Canc Res Ctr, Dept Integrat Oncol, Vancouver, BC V5Z 1L3, Canada; [Haynes, Charles] Univ British Columbia, Dept Chem & Biol Engn, RESEAU NSERC Res Network, Vancouver, BC V6T 1Z3, Canada	University of British Columbia; University of British Columbia; University of British Columbia; British Columbia Cancer Agency; University of British Columbia	Poh, CF (corresponding author), Univ British Columbia, Dept Oral Med Biol Sci, Fac Dent, Vancouver, BC V6T 1Z3, Canada.; Haynes, C (corresponding author), Univ British Columbia, Michael Smith Labs, Vancouver, BC V6T 1Z4, Canada.; Poh, CF (corresponding author), Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V6T 2B5, Canada.; Poh, CF (corresponding author), British Columbia Canc Res Ctr, Dept Integrat Oncol, Vancouver, BC V5Z 1L3, Canada.; Haynes, C (corresponding author), Univ British Columbia, Dept Chem & Biol Engn, RESEAU NSERC Res Network, Vancouver, BC V6T 1Z3, Canada.	cpoh@dentistry.ubc.ca; israels@mail.ubc.ca			Genome British Columbia [SOF-7-2015]	Genome British Columbia	This work was funded by Genome British Columbia (http://www.genomebc.ca/): Grant SOF-7-2015 awarded to CFP and CH.	Abbas T, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012914; Andor N, 2016, NAT MED, V22, P105, DOI 10.1038/nm.3984; Belgrader P, 2013, CLIN CHEM, V59, P991, DOI 10.1373/clinchem.2012.197855; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Bidshahri R, 2016, J MOL DIAGN, V18, P190, DOI 10.1016/j.jmoldx.2015.09.003; Brisco MJ, 2010, BIOTECHNIQUES, V49, P893, DOI 10.2144/000113567; D'haene B, 2010, METHODS, V50, P262, DOI 10.1016/j.ymeth.2009.12.007; Day E, 2013, METHODS, V59, P101, DOI 10.1016/j.ymeth.2012.08.001; Despierre E, 2014, GYNECOL ONCOL, V135, P415, DOI 10.1016/j.ygyno.2014.09.014; Didelot A, 2013, CLIN CHEM, V59, P815, DOI 10.1373/clinchem.2012.193409; Do HD, 2015, CLIN CHEM, V61, P64, DOI 10.1373/clinchem.2014.223040; Dorazio RM, 2015, ANAL CHEM, V87, P10886, DOI 10.1021/acs.analchem.5b02429; Dube S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002876; DUNN OJ, 1961, J AM STAT ASSOC, V56, P52, DOI 10.2307/2282330; Garcia-Murillas I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083409; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hedegaard J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098187; Heyries KA, 2011, NAT METHODS, V8, P649, DOI [10.1038/NMETH.1640, 10.1038/nmeth.1640]; Hindson BJ, 2011, ANAL CHEM, V83, P8604, DOI 10.1021/ac202028g; Hu LP, 2014, BIOMARK RES, V2, DOI 10.1186/2050-7771-2-3; Hughesman C, 2015, BIOCHEMISTRY-US, V54, P1338, DOI 10.1021/bi500905b; Hurvitz SA, 2013, CANCER TREAT REV, V39, P219, DOI 10.1016/j.ctrv.2012.04.008; KALLIONIEMI A, 1992, SCIENCE, V258, P818, DOI 10.1126/science.1359641; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kim MJ, 2016, J MOL DIAGN, V18, P253, DOI 10.1016/j.jmoldx.2015.11.002; Kinugasa H, 2015, BRIT J CANCER, V112, P1652, DOI 10.1038/bjc.2015.129; Li WL, 2013, PHYSIOL GENOMICS, V45, P1, DOI 10.1152/physiolgenomics.00082.2012; Liu BA, 2013, ONCOTARGET, V4, P1868, DOI 10.18632/oncotarget.1537; Lund HL, 2016, ANAL CHEM, V88, P4879, DOI 10.1021/acs.analchem.6b00707; Lund HL, 2016, ANAL BIOANAL CHEM, V408, P1079, DOI 10.1007/s00216-015-9204-2; McDermott GP, 2013, ANAL CHEM, V85, P11619, DOI 10.1021/ac403061n; Miotke L, 2014, ANAL CHEM, V86, P2618, DOI 10.1021/ac403843j; Mizoguchi M, 2011, BRAIN TUMOR PATHOL, V28, P191, DOI 10.1007/s10014-011-0038-0; Nadauld L, 2012, TRANSLATIONAL MED, V2; Okello JBA, 2010, ANAL BIOCHEM, V400, P110, DOI 10.1016/j.ab.2010.01.014; Peiffer DA, 2006, GENOME RES, V16, P1136, DOI 10.1101/gr.5402306; Poh CF, 2012, J DENT RES, V91, P52, DOI 10.1177/0022034511425676; Salahshourifar I, 2014, ORAL ONCOL, V50, P404, DOI 10.1016/j.oraloncology.2014.02.005; Scheinin I, 2014, GENOME RES, V24, P2022, DOI 10.1101/gr.175141.114; Schouten JP, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf056; Shen ZY, 2011, J MOL CELL BIOL, V3, P1, DOI 10.1093/jmcb/mjq057; Snijders AM, 2001, NAT GENET, V29, P263, DOI 10.1038/ng754; Trypsteen W, 2015, ANAL BIOANAL CHEM, V407, P5827, DOI 10.1007/s00216-015-8773-4; Tsui IFL, 2010, HEAD NECK-J SCI SPEC, V32, P1143, DOI 10.1002/hed.21311; Tsui IFL, 2009, AM J SURG PATHOL, V33, P1732, DOI 10.1097/PAS.0b013e3181b669c2; Vogelstein B, 1999, P NATL ACAD SCI USA, V96, P9236, DOI 10.1073/pnas.96.16.9236; Whale AS, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks203; Ylstra B, 2006, NUCLEIC ACIDS RES, V34, P445, DOI 10.1093/nar/gkj456; Zack TI, 2013, NAT GENET, V45, P1134, DOI 10.1038/ng.2760; Zhang LW, 2012, CANCER PREV RES, V5, P1081, DOI 10.1158/1940-6207.CAPR-12-0173; Zhong Q, 2011, LAB CHIP, V11, P2167, DOI 10.1039/c1lc20126c	51	25	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0161274	10.1371/journal.pone.0161274	http://dx.doi.org/10.1371/journal.pone.0161274			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27537682	Green Published, Green Submitted, gold			2022-12-27	WOS:000381577000078
J	Lunde, S; Kristoffersen, EK; Sapkota, D; Risa, K; Dahl, O; Bruland, O; Mella, O; Fluge, O				Lunde, Sigrid; Kristoffersen, Einar K.; Sapkota, Dipak; Risa, Kristin; Dahl, Olav; Bruland, Ove; Mella, Olav; Fluge, Oystein			Serum BAFF and APRIL Levels, T-Lymphocyte Subsets, and Immunoglobulins after B-Cell Depletion Using the Monoclonal Anti-CD20 Antibody Rituximab in Myalgic Encephalopathy/Chronic Fatigue Syndrome	PLOS ONE			English	Article							ORTHOSTATIC TACHYCARDIA SYNDROME; PRIMARY SJOGRENS-SYNDROME; RHEUMATOID-ARTHRITIS; IMMUNOLOGICAL ABNORMALITIES; PREDICTIVE FACTORS; BAFF/APRIL SYSTEM; AUTOIMMUNE; LUPUS; EXPRESSION; DISORDERS	Myalgic Encephalopathy/Chronic Fatigue Syndrome (ME/CFS) is a disease of unknown etiology. We have previously suggested clinical benefit from B-cell depletion using the monoclonal anti-CD20 antibody rituximab in a randomized and placebo-controlled study. Prolonged responses were then demonstrated in an open-label phase-II study with maintenance rituximab treatment. Using blood samples from patients in the previous two clinical trials, we investigated quantitative changes in T-lymphocyte subsets, in immunoglobulins, and in serum levels of two B-cell regulating cytokines during follow-up. B-lymphocyte activating factor of the tumor necrosis family (BAFF) in baseline serum samples was elevated in 70 ME/CFS patients as compared to 56 healthy controls (p = 0.011). There were no significant differences in baseline serum BAFF levels between patients with mild, moderate, or severe ME/CFS, or between responders and non-responders to rituximab. A proliferation-inducing ligand (APRIL) serum levels were not significantly different in ME/CFS patients compared to healthy controls at baseline, and no changes in serum levels were seen during follow-up. Immunophenotyping of peripheral blood T-lymphocyte subsets and T-cell activation markers at multiple time points during follow-up showed no significant differences over time, between rituximab and placebo groups, or between responders and non-responders to rituximab. Baseline serum IgG levels were significantly lower in patients with subsequent response after rituximab therapy compared to non-responders (p = 0.03). In the maintenance study, slight but significant reductions in mean serum immunoglobulin levels were observed at 24 months compared to baseline; IgG 10.6-9.5 g/L, IgA 1.8-1.5 g/L, and IgM 0.97-0.70 g/L. Although no functional assays were performed, the lack of significant associations of T- and NK-cell subset numbers with B-cell depletion, as well as the lack of associations to clinical responses, suggest that B-cell regulatory effects on T-cell or NK-cell subsets are not the main mechanisms for the observed improvements in ME/CFS symptoms observed in the two previous trials. The modest increase in serum BAFF levels at baseline may indicate an activated B-lymphocyte system in a subgroup of ME/CFS patients.	[Lunde, Sigrid; Sapkota, Dipak; Risa, Kristin; Dahl, Olav; Bruland, Ove; Mella, Olav; Fluge, Oystein] Haukeland Hosp, Dept Oncol & Med Phys, Bergen, Norway; [Kristoffersen, Einar K.] Haukeland Hosp, Dept Immunol & Transfus Med, Bergen, Norway; [Kristoffersen, Einar K.; Dahl, Olav; Mella, Olav] Univ Bergen, Haukeland Univ Hosp, Dept Clin Sci, Bergen, Norway; [Sapkota, Dipak] Univ Bergen, Haukeland Univ Hosp, Dept Clin Med, Bergen, Norway; [Bruland, Ove] Haukeland Hosp, Dept Med Genet & Mol Med, Bergen, Norway	University of Bergen; Haukeland University Hospital; University of Bergen; Haukeland University Hospital; University of Bergen; Haukeland University Hospital; University of Bergen; Haukeland University Hospital; University of Bergen; Haukeland University Hospital	Fluge, O (corresponding author), Haukeland Hosp, Dept Oncol & Med Phys, Bergen, Norway.	oystein.fluge@gmail.com		Sapkota, Dipak/0000-0003-0061-825X	Kavli Foundation; Western Norway Health Authority [911557]; legacy of Torstein Hereid	Kavli Foundation; Western Norway Health Authority; legacy of Torstein Hereid	This work has received financial support from The Kavli Foundation, and from Western Norway Health Authority grant no 911557, and also from the legacy of Torstein Hereid. These funders had no role in trial design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albright F, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-62; Baecklund E, 2014, SEMIN CANCER BIOL, V24, P61, DOI 10.1016/j.semcancer.2013.12.001; Bansal AS, 2012, BRAIN BEHAV IMMUN, V26, P24, DOI 10.1016/j.bbi.2011.06.016; BARKER E, 1994, CLIN INFECT DIS, V18, pS136, DOI 10.1093/clinids/18.Supplement_1.S136; Benucci M, 2010, AUTOIMMUN REV, V9, P801, DOI 10.1016/j.autrev.2010.07.006; Bradley AS, 2013, CLIN EXP IMMUNOL, V172, P73, DOI 10.1111/cei.12043; Brenu EW, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-88; Brenu EW, 2014, INT IMMUNOL, V26, P233, DOI 10.1093/intimm/dxt068; Brink R, 2006, SEMIN IMMUNOL, V18, P276, DOI 10.1016/j.smim.2006.04.003; Broderick G, 2010, BRAIN BEHAV IMMUN, V24, P1209, DOI 10.1016/j.bbi.2010.04.012; Cambridge G, 2006, ARTHRITIS RHEUM-US, V54, P723, DOI 10.1002/art.21650; Carruthers BM, 2003, J CHRONIC FATIGUE SY, V11, P7, DOI [DOI 10.1300/J092V11N01_02, 10.1300/J092v11n01_02]; Carter LM, 2013, ARTHRITIS RHEUM-US, V65, P2672, DOI 10.1002/art.38074; Chang CM, 2012, CANCER-AM CANCER SOC, V118, P5929, DOI 10.1002/cncr.27612; Cohen SB, 2006, J RHEUMATOL, V33, P12; Couderc M, 2013, ARTHRIT CARE RES, V65, P648, DOI 10.1002/acr.21865; Curriu M, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-68; Dahan S, 2016, LUPUS, V25, P339, DOI 10.1177/0961203316629558; Fletcher MA, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-96; Fluge O, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129898; Fluge O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026358; Fluge O, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-28; FUKUDA K, 1994, ANN INTERN MED, V121, P953, DOI 10.7326/0003-4819-121-12-199412150-00009; Gayed M, 2009, LUPUS, V18, P479, DOI 10.1177/0961203309102556; Hardcastle SL, 2015, BMC IMMUNOL, V16, DOI 10.1186/s12865-015-0101-4; Hoad A, 2008, QJM-INT J MED, V101, P961, DOI 10.1093/qjmed/hcn123; Hornig M, 2016, MOL PSYCHIATR, V21, P261, DOI 10.1038/mp.2015.29; Hornig M, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1400121; Huang HC, 2010, P NATL ACAD SCI USA, V107, P4658, DOI 10.1073/pnas.1001074107; Jordan N, 2015, EXPERT REV CLIN IMMU, V11, P195, DOI 10.1586/1744666X.2015.996550; Kim JY, 2008, J NEUROIMMUNOL, V199, P151, DOI 10.1016/j.jneuroim.2008.05.010; KLIMAS NG, 1990, J CLIN MICROBIOL, V28, P1403, DOI 10.1128/JCM.28.6.1403-1410.1990; Kroese FGM, 2014, EXPERT REV CLIN IMMU, V10, P483, DOI 10.1586/1744666X.2014.891439; Leandro MJ, 2006, ARTHRITIS RHEUM-US, V54, P613, DOI 10.1002/art.21617; Lewis I, 2013, J INTERN MED, V273, P501, DOI 10.1111/joim.12022; Li HL, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000755; Loebel M, 2016, BRAIN BEHAV IMMUN, V52, P32, DOI 10.1016/j.bbi.2015.09.013; Mackay F, 1999, J EXP MED, V190, P1697, DOI 10.1084/jem.190.11.1697; Mackay F, 2007, CURR OPIN IMMUNOL, V19, P327, DOI 10.1016/j.coi.2007.04.008; Mackay F, 2009, NAT REV IMMUNOL, V9, P491, DOI 10.1038/nri2572; Maes M, 2015, NEUROENDOCRINOL LETT, V36, P439; Mensah F, 2016, CLIN EXP IMMUNOL, V184, P237, DOI 10.1111/cei.12749; Moisini I, 2009, CLIN EXP IMMUNOL, V158, P155, DOI 10.1111/j.1365-2249.2009.04007.x; Nacul LC, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-91; Nagel A, 2009, J INVEST DERMATOL, V129, P2202, DOI 10.1038/jid.2009.27; National Collaborating Centre for Primary Care, 2007, NAT I HLTH CLIN EXC; Pollard RPE, 2013, ANN RHEUM DIS, V72, P146, DOI 10.1136/annrheumdis-2012-202071; Routsias JG, 2013, SEMIN ARTHRITIS RHEU, V43, P178, DOI 10.1016/j.semarthrit.2013.04.004; Schneider P, 2005, CURR OPIN IMMUNOL, V17, P282, DOI 10.1016/j.coi.2005.04.005; Sellam J, 2011, ARTHRITIS RHEUM-US, V63, P3692, DOI 10.1002/art.30599; Sellam J, 2011, ARTHRITIS RHEUM-US, V63, P933, DOI 10.1002/art.30233; Tangye SG, 2006, SEMIN IMMUNOL, V18, P305, DOI 10.1016/j.smim.2006.04.004; Thien M, 2004, IMMUNITY, V20, P785, DOI 10.1016/j.immuni.2004.05.010; Vallerskog T, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2076; Vincent FB, 2014, NAT REV RHEUMATOL, V10, P365, DOI 10.1038/nrrheum.2014.33; Vincent FB, 2013, CYTOKINE GROWTH F R, V24, P203, DOI 10.1016/j.cytogfr.2013.04.003; Vollmer-Conna U, 2007, CLIN INFECT DIS, V45, P732, DOI 10.1086/520990	57	19	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0161226	10.1371/journal.pone.0161226	http://dx.doi.org/10.1371/journal.pone.0161226			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27536947	gold, Green Published, Green Submitted			2022-12-27	WOS:000381577000072
J	Pandey, AK; Penny, WF; Bhargava, V; Lai, NC; Xu, RH; Hammond, HK				Pandey, Amit K.; Penny, William F.; Bhargava, Valmik; Lai, N. Chin; Xu, Ronghui; Hammond, H. Kirk			Clinical Evaluation of Heart Failure: Agreement among Tests	PLOS ONE			English	Article							EXERCISE CAPACITY; VENTRICULAR CONTRACTILITY; PRESSURE; CARDIOMYOPATHY; VALIDATION; INDEXES; DP/DT; RISE	Methods commonly used clinically to assess cardiac function in patients with heart failure include ejection fraction (EF), exercise treadmill testing (ETT), and symptom evaluation. Although these approaches are useful in evaluating patients with heart failure, there are at times substantial mismatches between individual assessments. For example, ETT results are often discordant with EF, and patients with minimal symptoms sometimes have surprisingly low EFs. To better define the relationship of these methods of assessment, we studied 56 patients with heart failure with reduced EF (HFrEF) who underwent measurement of ETT duration, EF by echocardiography, quantitative symptom evaluation, and LV peak dP/dt (rate of left ventricular pressure development and decline, measured invasively). Correlations were determined among these four tests in order to assess the relationship of EF, ETT, and symptoms against LV peak dP/dt. In addition, we sought to determine whether EF, ETT, and symptoms correlated with each other. Overall, correlations were poor. Only 15 of 63 total correlations (24%) were significant (p < 0.05). EF correlated most closely with LV peak -dP/dt. Linear regression analysis indicated that EF, ETT, and symptoms taken together predicted LV peak dP/dt better than any one measure alone. We conclude that clinical tests used to assess LV function in patients with HFrEF may not be as accurate or correlate as well as expected. All three clinical measures considered together may be the best representation of cardiac function in HFrEF patients currently available.	[Pandey, Amit K.; Penny, William F.; Bhargava, Valmik; Lai, N. Chin; Hammond, H. Kirk] Univ Calif San Diego, Dept Med, San Diego, CA 92103 USA; [Pandey, Amit K.; Penny, William F.; Bhargava, Valmik; Lai, N. Chin; Hammond, H. Kirk] VA San Diego Healthcare Syst, Dept Med, San Diego, CA USA; [Xu, Ronghui] Univ Calif San Diego, Dept Family Med & Publ Hlth, San Diego, CA 92103 USA; [Xu, Ronghui] Univ Calif San Diego, Dept Math, San Diego, CA 92103 USA	University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; University of California System; University of California San Diego; University of California System; University of California San Diego	Hammond, HK (corresponding author), Univ Calif San Diego, Dept Med, San Diego, CA 92103 USA.; Hammond, HK (corresponding author), VA San Diego Healthcare Syst, Dept Med, San Diego, CA USA.	khammond@ucsd.edu			National Institutes of Health [P01HL66941]; NHLBI Gene Therapy Resource Program [HHSN2682012000021]; Renova Therapeutics, Inc. (San Diego, CA) via an NIH Public Private Partnership; Merit grant from the Department of Veteran's Affairs [1101BX001515]; National Institute of Health [P01HL66941]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL066941] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001515] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI Gene Therapy Resource Program; Renova Therapeutics, Inc. (San Diego, CA) via an NIH Public Private Partnership; Merit grant from the Department of Veteran's Affairs; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Veterans Affairs(US Department of Veterans Affairs)	The clinical trial from which the data of the current study is based was funded by National Institutes of Health grants (P01HL66941; https://grants.nih.gov/grants/oer.htm), NHLBI Gene Therapy Resource Program (HHSN2682012000021; www.gtrp.org), Renova Therapeutics, Inc. (San Diego, CA; http://renovatherapeutics.com/) via an NIH Public Private Partnership, and a Merit grant from the Department of Veteran's Affairs (1101BX001515). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by National Institute of Health grant (P01HL66941,) NHLBI Gene Therapy Resource Program (HHSN2682012000021), and a Merit grant from the Department of Veteran's Affairs (1101BX001515).	BARGIGGIA GS, 1989, CIRCULATION, V80, P1287, DOI 10.1161/01.CIR.80.5.1287; BENGE W, 1980, CIRCULATION, V61, P955, DOI 10.1161/01.CIR.61.5.955; Bhargava V, 1998, AM J CARDIOL, V81, P1130, DOI 10.1016/S0002-9149(98)00133-7; Bhargava V, 1996, CATHETER CARDIO DIAG, V37, P105, DOI 10.1002/(SICI)1097-0304(199601)37:1<105::AID-CCD26>3.0.CO;2-J; BRISTOW MR, 1993, J CLIN INVEST, V92, P2737, DOI 10.1172/JCI116891; Butler J, 1999, J AM COLL CARDIOL, V34, P1802, DOI 10.1016/S0735-1097(99)00408-8; Chung N, 1992, J Am Soc Echocardiogr, V5, P147; COLUCCI WS, 1990, CIRCULATION, V82, P44; FRANCIOSA JA, 1981, AM J CARDIOL, V47, P33, DOI 10.1016/0002-9149(81)90286-1; Gemignani V, 2010, PACE, V33, P795, DOI 10.1111/j.1540-8159.2009.02684.x; GLEASON WL, 1962, J CLIN INVEST, V41, P80, DOI 10.1172/JCI104469; Green CP, 2000, J AM COLL CARDIOL, V35, P1245, DOI 10.1016/S0735-1097(00)00531-3; Guglin M, 2012, INT J CLIN PRACT, V66, P1224, DOI 10.1111/j.1742-1241.2012.03003.x; GUNDERSEN T, 1994, EUR HEART J, V15, P1659; Hammond HK, 2016, JAMA CARDIO IN PRESS; Hare JM, 1998, CIRCULATION, V97, P161, DOI 10.1161/01.CIR.97.2.161; Harrington D, 1997, J AM COLL CARDIOL, V30, P1758, DOI 10.1016/S0735-1097(97)00381-1; KASS DA, 1987, CIRCULATION, V76, P1422, DOI 10.1161/01.CIR.76.6.1422; MASON DT, 1971, CIRCULATION, V44, P47, DOI 10.1161/01.CIR.44.1.47; MASON DT, 1969, AM J CARDIOL, V23, P516, DOI 10.1016/0002-9149(69)90005-8; Olsson LG, 2005, EUR HEART J, V26, P778, DOI 10.1093/eurheartj/ehi162; Parekh R, 2013, ECHOCARDIOGR-J CARD, V30, P267, DOI 10.1111/echo.12042; Roger VL, 2012, CIRCULATION, V125, P188, DOI 10.1161/CIR.0b013e3182456d46; SULLIVAN MJ, 1992, CHEST, V101, pS340, DOI 10.1378/chest.101.5.340S; Zhang B, 2015, JOVE-J VIS EXP, DOI 10.3791/52618	25	1	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0161536	10.1371/journal.pone.0161536	http://dx.doi.org/10.1371/journal.pone.0161536			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27537778	gold, Green Published			2022-12-27	WOS:000381577000119
J	Wang, GS; Tong, DM; Chen, XD; Yang, TH; Zhou, YT; Ma, XB				Wang, Guang-Sheng; Tong, Dao-Ming; Chen, Xiao-Dong; Yang, Tong-Hui; Zhou, Ye-Ting; Ma, Xiao-Bo			Metabolic Syndrome Is a Strong Risk Factor for Minor Ischemic Stroke and Subsequent Vascular Events	PLOS ONE			English	Article							COMPONENTS; PREVALENCE; HEALTH; ATTACK	Background Minor ischemic stroke (MIS) represents a major global public health problem worldwide due to high incidence. The aim of this study was to investigate whether metabolic syndrome (MetS) is a strong risk for MIS and subsequent vascular events (SVE). Methods A retrospective cohort study was performed examining symptomatic MIS in a Chinese neurologic outpatient population aged over 25 years without history of stroke. MetS was defined using the International Diabetes Federation criteria. MIS was diagnosed by magnetic resonance imaging-diffusion weighted images or fluid-attenuated inversion recovery. Results Of 1361 outpatients, a total of 753 (55.3%) patients were diagnosed with MIS; of them, 80% had a score of 0 using the MIS had a 0 score on the National Institutes of Health Stroke Scale. Among these, 303 (40.2%) individuals with MIS were diagnosed with MetS. Diagnosed of MIS with MetS significantly correlated with abdominal obesity (30.7% v.s 18.0%), hypertension (91.1% v.s 81.6%), increased blood glucose (6.9 +/- 2.4 v.s 5.0 +/- 0.4), dyslipidemia (78.2% v.s 48.2%), and SVE (50.5% v.s 11.3%) when compared with the controls group. On adjusted analysis, the risk of SVE was also significantly associated with three additional MetS criterion (RR, 9.0; 95% CI, 5.677-14.46). Using Cox proportional analysis, risk of SVE in patient with MIS was significantly associated with MetS (RR, 3.3; 95% CI, 1.799-6.210), older age (RR, 1.0; 95% CI, 1.001-1.048), and high blood glucose (RR, 1.1; 95% CI, 1.007-1.187). Conclusions The MetS is a strong risk factor for MIS, and patients presenting with MIS and MetS are at a high risk of SVE. Further studies are required to determine the improvement of Mets prevention in the reduction of MIS and SVE.	[Wang, Guang-Sheng; Tong, Dao-Ming; Chen, Xiao-Dong; Yang, Tong-Hui] XuZhou Med Univ, Affiliated Shu Yang Peoples Hosp, Dept Neurol, Xuzhou, Peoples R China; [Zhou, Ye-Ting] XuZhou Med Univ, Affiliated Shu Yang Peoples Hosp, Dept Clin Res, Xuzhou, Peoples R China; [Ma, Xiao-Bo] XuZhou Med Univ, Affiliated Shu Yang Peoples Hosp, Dept Sci & Educ, Xuzhou, Peoples R China	Xuzhou Medical University; Xuzhou Medical University; Xuzhou Medical University	Tong, DM (corresponding author), XuZhou Med Univ, Affiliated Shu Yang Peoples Hosp, Dept Neurol, Xuzhou, Peoples R China.	tongdaoming@163.com			Medical Research Council	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work is supported by a grant from the Medical Research Council, affiliated Shu Yang People's Hospital, XuZhou Medical University, China.; This work is supported by a grant from the Medical Research Council, affiliated Shu Yang People's Hospital, XuZhou Medical University, China.	Abboud H, 2013, INT J STROKE, V8, P4, DOI 10.1111/j.1747-4949.2012.00893.x; Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x; Bang OY, 2005, NEUROLOGY, V65, P296, DOI 10.1212/01.wnl.0000168862.09764.9f; Bos MJ, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001634; Brisset M, 2013, NEUROLOGY, V80, P662, DOI 10.1212/WNL.0b013e318281ccc2; Chandratheva A, 2010, STROKE, V41, P1108, DOI 10.1161/STROKEAHA.109.576611; Chen YC, 2014, J HUM HYPERTENS, V28, P689, DOI 10.1038/jhh.2013.152; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; Fang XH, 2016, J STROKE CEREBROVASC, V25, P626, DOI 10.1016/j.jstrokecerebrovasdis.2015.11.017; Fischer U, 2010, STROKE, V41, P661, DOI 10.1161/STROKEAHA.109.572883; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Kono Y, 2011, CEREBROVASC DIS, V31, P365, DOI 10.1159/000323233; Koren-Morag N, 2005, STROKE, V36, P1366, DOI 10.1161/01.STR.0000169945.75911.33; Li Wei, 2009, Zhonghua Yi Xue Za Zhi, V89, P2759; Lim S, 2011, DIABETES CARE, V34, P1323, DOI 10.2337/dc10-2109; Liu L, 2015, LIPIDS HEALTH DIS, V14, DOI 10.1186/s12944-015-0080-8; Lucke-Wold Brandon P., 2012, Yale Journal of Biology and Medicine, V85, P523; Mahmood SS, 2014, LANCET, V383, P999, DOI 10.1016/S0140-6736(13)61752-3; Mallmann AB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035680; Mi DH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051421; Milionis HJ, 2005, STROKE, V36, P1372, DOI 10.1161/01.STR.0000169935.35394.38; Osborn MF, 2014, J STROKE CEREBROVASC, V23, P1477, DOI 10.1016/j.jstrokecerebrovasdis.2013.12.017; Peters SAE, 2014, LANCET, V383, P1973, DOI 10.1016/S0140-6736(14)60040-4; Potter GM, 2011, STROKE, V42, P359, DOI 10.1161/STROKEAHA.110.594754; Purroy F, 2004, STROKE, V35, P2313, DOI 10.1161/01.STR.0000141703.21173.91; Suh S, 2014, ENDOCRINOL METAB, V29, P522, DOI 10.3803/EnM.2014.29.4.522; Toni D, 2014, INT J STROKE, V9, P873, DOI 10.1111/ijs.12150; Tuttolomondo A, 2014, DIABETOL METAB SYNDR, V6, DOI 10.1186/1758-5996-6-28; Tuttolomondo A, 2012, ATHEROSCLEROSIS, V225, P216, DOI 10.1016/j.atherosclerosis.2012.08.027; Wang AX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113205; Wang LY, 2013, NEUROL RES, V35, P517, DOI 10.1179/1743132813Y.0000000204; Wang X, 2006, J NEUROIMAGING, V16, P266, DOI 10.1111/j.1552-6569.2006.00027.x	32	12	14	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0156243	10.1371/journal.pone.0156243	http://dx.doi.org/10.1371/journal.pone.0156243			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27536865	Green Published, gold, Green Submitted			2022-12-27	WOS:000381577000001
J	Wang, XH; Karau, MJ; Greenwood-Quaintance, KE; Block, DR; Mandrekar, JN; Cunningham, SA; Patel, R				Wang, Xiaohui; Karau, Melissa J.; Greenwood-Quaintance, Kerryl E.; Block, Darci R.; Mandrekar, Jayawant N.; Cunningham, Scott A.; Patel, Robin			Ureaplasma urealyticum Causes Hyperammonemia in an Experimental Immunocompromised Murine Model	PLOS ONE			English	Article							FATAL HYPERAMMONEMIA; RISK	Hyperammonemia syndrome is an often fatal complication of lung transplantation which has been recently associated with Ureaplasma infection. It has not been definitely established that Ureaplasma species can cause hyperammonemia. We established a novel immunocompromised murine model of Ureaplasma urealyticum infection and used it to confirm that U. urealyticum can cause hyperammonemia. Male C3H mice were pharmacologically immunosuppressed with mycophenolate mofetil, tacrolimus and oral prednisone for seven days, and then challenged intratracheally (IT) and/or intraperitoneally (IP) with 10(7) CFU U. urealyticum over six days, while continuing immunosuppression. Spent U. urealyticum-free U9 broth was used as a negative control, with uninfected immunocompetent mice, uninfected immunosuppressed mice, and infected immunocompetent mice serving as additional controls. Plasma ammonia concentrations were compared using Wilcoxon ranks sum tests. Plasma ammonia concentrations of immunosuppressed mice challenged IT/IP with spent U9 broth (n = 14) (range 155-330 mu mol/L) were similar to those of normal mice (n = 5), uninfected immunosuppressed mice (n = 5), and U. urealyticum IT/IP challenged immunocompetent mice (n = 5) [ range 99-340 mu mol/L, p = 0.60]. However, immunosuppressed mice challenged with U. urealyticum IT/IP (n = 20) or IP (n = 15) had higher plasma ammonia concentrations (range 225-945 mu mol/L and 276-687 mu mol/L, respectively) than those challenged IT/IP with spent U9 broth (p<0.001). U. urealyticum administered IT/IP or IP causes hyperammonemia in mice pharmacologically immunosuppressed with a regimen similar to that administered to lung transplant recipients.	[Wang, Xiaohui; Karau, Melissa J.; Greenwood-Quaintance, Kerryl E.; Cunningham, Scott A.; Patel, Robin] Mayo Clin, Dept Lab Med & Pathol, Div Clin Microbiol, Rochester, MN 55905 USA; [Block, Darci R.] Mayo Clin, Div Clin Core Lab, Dept Lab Med & Pathol, Rochester, MN USA; [Mandrekar, Jayawant N.] Mayo Clin, Dept Hlth Sci Res, Rochester, MN USA; [Patel, Robin] Mayo Clin, Dept Med, Div Infect Dis, Rochester, MN 55905 USA; [Wang, Xiaohui] Sichuan Univ, West China Hosp, Ctr Infect Dis, Chengdu, Sichuan, Peoples R China; [Wang, Xiaohui] Div Infect Dis, State Key Lab Biotherapy, Chengdu, Sichuan, Peoples R China	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Sichuan University	Patel, R (corresponding author), Mayo Clin, Dept Lab Med & Pathol, Div Clin Microbiol, Rochester, MN 55905 USA.; Patel, R (corresponding author), Mayo Clin, Dept Med, Div Infect Dis, Rochester, MN 55905 USA.	patel.robin@mayo.edu	Wang, Xiaohui/X-3814-2019; Cunningham, Scott A/ABC-6171-2020	Cunningham, Scott/0000-0002-7589-1712; Patel, Robin/0000-0001-6344-4141; , Xiaohui/0000-0003-2780-2823	Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN; National Institutes of Health [R01AR056647, R01 AI91594]; State Scholarship Fund from the China Scholarship Council	Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); State Scholarship Fund from the China Scholarship Council(China Scholarship Council)	This work was supported by the Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN. R.P. is supported by the National Institutes of Health [grant numbers R01AR056647 and R01 AI91594]. X.W. is supported by the State Scholarship Fund from the China Scholarship Council as a Visiting Scientist at Mayo Clinic. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anwar S, 2014, HEMODIAL INT, V18, P185, DOI 10.1111/hdi.12088; BALLARD RA, 1978, NEW ENGL J MED, V299, P920, DOI 10.1056/NEJM197810262991704; Beeton ML, 2012, IMMUNOBIOLOGY, V217, P187, DOI 10.1016/j.imbio.2011.07.009; Bharat A, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa8419; Cunningham Scott A, 2013, Int J Bacteriol, V2013, P168742, DOI 10.1155/2013/168742; Dando SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029856; Gwee A, 2014, J INFECTION, V68, pS19, DOI 10.1016/j.jinf.2013.09.027; Lichtenstein GR, 1997, GASTROENTEROLOGY, V112, P236, DOI 10.1016/S0016-5085(97)70240-3; Lichtenstein GR, 2000, ANN INTERN MED, V132, P283, DOI 10.7326/0003-4819-132-4-200002150-00006; Moffatt-Bruce SD, 2008, J HEART LUNG TRANSPL, V27, P801, DOI 10.1016/j.healun.2008.03.019; Okogbule-Wonodi AC, 2011, INNATE IMMUN-LONDON, V17, P145, DOI 10.1177/1753425909360552; Payne MS, 2012, J CLIN MICROBIOL, V50, P909, DOI 10.1128/JCM.06625-11; Rueda JF, 1998, ANN INTERN MED, V128, P956, DOI 10.7326/0003-4819-128-11-199806010-00022; Tuchman M, 1997, ANN INTERN MED, V127, P446, DOI 10.7326/0003-4819-127-6-199709150-00005; Waites KB, 2005, CLIN MICROBIOL REV, V18, P757, DOI 10.1128/CMR.18.4.757-789.2005; Weisman LE, 2012, PEDIATR RES, V72, P502, DOI 10.1038/pr.2012.115; Winters AH, 2013, PEDIATR INFECT DIS J, V32, P898, DOI 10.1097/INF.0b013e31828fc693; Wylam ME, 2013, LANCET, V382, P1956, DOI 10.1016/S0140-6736(13)62115-7	18	20	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0161214	10.1371/journal.pone.0161214	http://dx.doi.org/10.1371/journal.pone.0161214			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27537683	gold, Green Published, Green Submitted			2022-12-27	WOS:000381577000068
J	Zhang, B; Li, BZ; Chen, D; Zong, J; Sun, F; Qu, HX; Liang, CY				Zhang, Biao; Li, Baizhi; Chen, Dai; Zong, Jie; Sun, Fei; Qu, Huixin; Liang, Chongyang			Transcriptional Regulation of Aerobic Metabolism in Pichia pastoris Fermentation	PLOS ONE			English	Article							YEAST SACCHAROMYCES-CEREVISIAE; TRANSFER-RNA MODIFICATIONS; ISOCITRATE DEHYDROGENASE; RECOMBINANT PROTEIN; CITRATE SYNTHASE; MITOCHONDRIAL; DNA	In this study, we investigated the classical fermentation process in Pichia pastoris based on transcriptomics. We utilized methanol in pichia yeast cell as the focus of our study, based on two key steps: limiting carbon source replacement (from glycerol to methonal) and fermentative production of exogenous proteins. In the former, the core differential genes in coexpression net point to initiation of aerobic metabolism and generation of peroxisome. The transmission electron microscope (TEM) results showed that yeast gradually adapted methanol induction to increased cell volume, and decreased density, via large number of peroxisomes. In the fermentative production of exogenous proteins, the Gene Ontology (GO) mapping results show that PAS_chr2-1_0582 played a vital role in regulating aerobic metabolic drift. In order to confirm the above results, we disrupted PAS_chr2-1_0582 by homologous recombination. Alcohol consumption was equivalent to one fifth of the normal control, and fewer peroxisomes were observed in.0582 strain following methanol induction. In this study we determined the important core genes and GO terms regulating aerobic metabolic drift in Pichia, as well as developing new perspectives for the continued development within this field.	[Zhang, Biao; Li, Baizhi; Sun, Fei; Qu, Huixin; Liang, Chongyang] Jilin Univ, Inst Frontier Med Sci, Changchun 130021, Peoples R China; [Chen, Dai; Zong, Jie] NovelBio Biopharm Technol Co Ltd, Shanghai 200000, Peoples R China	Jilin University	Liang, CY (corresponding author), Jilin Univ, Inst Frontier Med Sci, Changchun 130021, Peoples R China.	liang@jlu.edu.cn			National Natural Science Foundation of China [81202446, 31271478]; Jilin Provincial Science & Technology Department [20150311065YY]; NovelBio Bio-Pharm Technology Co., Ltd	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jilin Provincial Science & Technology Department; NovelBio Bio-Pharm Technology Co., Ltd	This work was supported by the National Natural Science Foundation of China (Grant No. 81202446, 31271478) and the Jilin Provincial Science & Technology Department (Grant No. 20150311065YY). The funder provided support in the form of research materials, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The NovelBio Bio-Pharm Technology Co., Ltd provided support in the form of salaries for authors [DC, JZ], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; We thank He Zhang, Xin Guang, Yunong Liu, Changchun zuanzhi Biotech Co., Ltd., for carrying out the fermentation. This work was supported by the National Natural Science Foundation of China (Grant No. 81202446, 31271478) and the Jilin Provincial Science & Technology Department (Grant No. 20150311065YY).	Anderson SL, 2002, BIOCHEMISTRY-US, V41, P7065, DOI 10.1021/bi0200662; Baumann K, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-93; Begley U, 2007, MOL CELL, V28, P860, DOI 10.1016/j.molcel.2007.09.021; Carbone A, 2005, J MOL EVOL, V61, P456, DOI 10.1007/s00239-004-0317-z; Celton M, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-317; Charoenrat T, 2005, BIOPROC BIOSYST ENG, V27, P399, DOI 10.1007/s00449-005-0005-4; Chen CC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020783; CHEN SL, 1976, BIOTECHNOL BIOENG, V18, P1455, DOI 10.1002/bit.260181012; Chen XJ, 2007, P NATL ACAD SCI USA, V104, P13738, DOI 10.1073/pnas.0703078104; Grandier-Vazeille X, 2001, BIOCHEMISTRY-US, V40, P9758, DOI 10.1021/bi010277r; Guan B, 2012, FEMS YEAST RES, V12, P969, DOI 10.1111/1567-1364.12002; Guo Meijin, 2001, Weishengwu Xuebao, V41, P617; Jablonowski D, 2006, MOL MICROBIOL, V59, P677, DOI 10.1111/j.1365-2958.2005.04972.x; Lee YJ, 2007, MOL BIOL CELL, V18, P3556, DOI 10.1091/mbc.E07-02-0118; Leihne V, 2011, NUCLEIC ACIDS RES, V39, P7688, DOI 10.1093/nar/gkr406; Nagamori E, 2013, J BIOSCI BIOENG, V115, P193, DOI 10.1016/j.jbiosc.2012.08.021; Patil A, 2012, RNA BIOL, V9, P990, DOI 10.4161/rna.20531; Prieto C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003911; Ratnakumar S, 2011, MOL BIOSYST, V7, P139, DOI 10.1039/c0mb00114g; Reid RJD, 2002, YEAST, V19, P319, DOI 10.1002/yea.817; Rossouw D, 2009, APPL ENVIRON MICROB, V75, P6600, DOI 10.1128/AEM.01251-09; SANDOR A, 1994, J BIOL CHEM, V269, P29609; Sauer M, 2004, MICROB CELL FACT, V3, DOI 10.1186/1475-2859-3-17; Syriopoulos C, 2008, MOL BIOSYST, V4, P937, DOI 10.1039/b718732g; Tolner B, 2006, NAT PROTOC, V1, P1006, DOI 10.1038/nprot.2006.126; Toyotome Takahito, 2008, Nihon Rinsho, V66, P2255; Velot C, 1999, BIOCHEMISTRY-US, V38, P16195, DOI 10.1021/bi991695n; Wang TY, 2011, BIOTECHNOL BIOFUELS, V4, DOI 10.1186/1754-6834-4-24; Wu G, 2008, CURR MICROBIOL, V57, P18, DOI 10.1007/s00284-008-9145-5; Wu SX, 2004, BIOTECHNIQUES, V36, P152, DOI 10.2144/04361DD02; Zhang Z, 2016, SCI REP-UK, V6, DOI 10.1038/srep27854; Zhang Z, 2013, ARCH TOXICOL, V87, P1557, DOI 10.1007/s00204-013-1059-8; Zhao WN, 1996, J BIOL CHEM, V271, P10347, DOI 10.1074/jbc.271.17.10347; Zheng Q, 2008, NUCLEIC ACIDS RES, V36, pW358, DOI 10.1093/nar/gkn276; Zhu J, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001301; Zimmer E, 1997, APPL ENVIRON MICROB, V63, P2779, DOI 10.1128/AEM.63.7.2779-2784.1997	36	4	4	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0161502	10.1371/journal.pone.0161502	http://dx.doi.org/10.1371/journal.pone.0161502			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27537181	Green Published, Green Submitted, gold			2022-12-27	WOS:000381577000114
J	Zhang, BH; Salam, N; Cheng, J; Li, HQ; Yang, JY; Zha, DM; Zhang, YQ; Ai, MJ; Hozzein, WN; Li, WJ				Zhang, Bing-Huo; Salam, Nimaichand; Cheng, Juan; Li, Han-Quan; Yang, Jian-Yuan; Zha, Dai-Ming; Zhang, Yu-Qin; Ai, Meng-Jie; Hozzein, Wael N.; Li, Wen-Jun			Modestobacter lacusdianchii sp nov., a Phosphate-Solubilizing Actinobacterium with Ability to Promote Microcystis Growth	PLOS ONE			English	Article							DEOXYRIBONUCLEIC-ACID; EMENDED DESCRIPTION; FRESH-WATER; GEN. NOV.; BACTERIA; STREPTOMYCES; CLASSIFICATION; PHYTOPLANKTON; AERUGINOSA; IDENTIFICATION	A novel actinobacterium, designated strain JXJ CY 19(T), was isolated from a culture mat of Microcystis aeruginosa FACHB-905 collected from Dianchi Lake, South-west China. 16S rRNA gene sequences comparison of strain JXJ CY 19(T) and the available sequences in the GenBank database showed that the strain was closely related to Modestobacter marinus 42H12-1(T) (99.1% similarity) and Modestobacter roseus KLBMP 1279(T) (99.0%). The isolate had meso-diaminopimelic in the cell wall with whole-cell sugars of mannose, rhamnose, ribose, glucose, galactose, and arabinose. The menaquinone detected was MK-9(H-4), while the major cellular fatty acids include C-17:1 omega 8c, C-15:0 iso, C-15:1 iso G and C-16:0 iso. The polar lipids were diphosphatidylglycerol, phosphatidylethanolamine, phosphatidylinositol, phosphatidylinositol mannoside and an unidentified phospholipid. The DNA-DNA hybridization values between strains JXJ CY 19(T) and the closely related type strains Modestobacter marinus CGMCC 4.5581(T) and Modestobacter roseus NBRC 108673(T) were determined to be 50.8 +/- 0.8% and 44.1 +/- 1.7%, respectively. The DNA G+C content was 71.9 mol%. On the basis of the above taxonomic data and differences in physiological characters from the closely related type strains, strain JXJ CY 19(T) was recognized as a novel species of the genus Modestobacter, for which the name Modestobacter lacusdianchii sp. nov. (JXJ CY 19(T) = KCTC 39600(T) = CPCC 204352(T)) is proposed. The type strain JXJ CY 19T can solubilize calcium phosphate tribasic (Ca-3(PO4)(2)), phytin and L-alpha-phosphatidylcholine. The phosphate-solubilizing property of the novel actinobacterium could be a possible factor for the increase in growth of Microcystis aeruginosa FACHB-905 in ecosystem where the amount of available soluble phosphate is limited such as Dianchi Lake.	[Zhang, Bing-Huo; Cheng, Juan; Li, Han-Quan; Yang, Jian-Yuan; Zha, Dai-Ming] Jiujiang Univ, Coll Life Sci, Jiujiang, Peoples R China; [Zhang, Bing-Huo; Salam, Nimaichand; Cheng, Juan; Li, Wen-Jun] Sun Yat Sen Univ, Sch Life Sci, State Key Lab Biocontrol, Guangzhou, Guangdong, Peoples R China; [Zhang, Bing-Huo; Salam, Nimaichand; Cheng, Juan; Li, Wen-Jun] Sun Yat Sen Univ, Sch Life Sci, Guangdong Prov Key Lab Plant Resources, Guangzhou, Guangdong, Peoples R China; [Zhang, Yu-Qin; Ai, Meng-Jie] Chinese Acad Med Sci, Inst Med Biotechnol, Beijing, Peoples R China; [Zhang, Yu-Qin; Ai, Meng-Jie] Peking Union Med Coll, Beijing, Peoples R China; [Hozzein, Wael N.] King Saud Univ, Coll Sci, Dept Zool, BRC, Riyadh, Saudi Arabia; [Hozzein, Wael N.] Beni Suef Univ, Fac Sci, Dept Bot & Microbiol, Bani Suwayf, Egypt	Jiujiang University; Sun Yat Sen University; Sun Yat Sen University; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Biotechnology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; King Saud University; Egyptian Knowledge Bank (EKB); Beni Suef University	Li, WJ (corresponding author), Sun Yat Sen Univ, Sch Life Sci, State Key Lab Biocontrol, Guangzhou, Guangdong, Peoples R China.; Li, WJ (corresponding author), Sun Yat Sen Univ, Sch Life Sci, Guangdong Prov Key Lab Plant Resources, Guangzhou, Guangdong, Peoples R China.	liwenjun3@mail.sysu.edu.cn	Zhang, Yu-Qin/AEH-7339-2022	Zhang, Yu-Qin/0000-0002-1739-6705	National Natural Science Foundation of China [31060010]; Deanship of Scientific Research at King Saud University [1436-27]; Environmental Conservation Department of Jiangxi Province of China [JXHBKJ2013-14]; Program of JiuJiang University [201511]; Guangdong Province Higher Vocational Colleges & Schools Pearl River Scholar Funded Scheme	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Deanship of Scientific Research at King Saud University(King Saud University); Environmental Conservation Department of Jiangxi Province of China; Program of JiuJiang University; Guangdong Province Higher Vocational Colleges & Schools Pearl River Scholar Funded Scheme	This research was supported by the funding from National Natural Science Foundation of China (No. 31060010), the Deanship of Scientific Research at King Saud University (through the research group no. 1436-27), Environmental Conservation Department of Jiangxi Province of China (No. JXHBKJ2013-14), and Program of JiuJiang University (No. 201511). W-J Li was also supported by Project Supported by Guangdong Province Higher Vocational Colleges & Schools Pearl River Scholar Funded Scheme (2014).	[Anonymous], 2010, 18472010 NYT MIN AGR, P4; Casamatta DA, 2000, MICROB ECOL, V40, P64, DOI 10.1007/s002480000035; COLLINS MD, 1980, J APPL BACTERIOL, V48, P459, DOI 10.1111/j.1365-2672.1980.tb01036.x; COLLINS MD, 1977, J GEN MICROBIOL, V100, P221, DOI 10.1099/00221287-100-2-221; de-Bashan LE, 2008, J PHYCOL, V44, P938, DOI 10.1111/j.1529-8817.2008.00533.x; Deng Jie, 2012, Hupo Kexue, V24, P429; Dziallas C, 2011, ENVIRON MICROBIOL, V13, P1632, DOI 10.1111/j.1462-2920.2011.02479.x; Elser JJ, 2007, ECOL LETT, V10, P1135, DOI 10.1111/j.1461-0248.2007.01113.x; EZAKI T, 1989, INT J SYST BACTERIOL, V39, P224, DOI 10.1099/00207713-39-3-224; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; FITCH WM, 1971, SYST ZOOL, V20, P406, DOI 10.2307/2412116; GOODFELLOW M, 1971, J GEN MICROBIOL, V69, P33, DOI 10.1099/00221287-69-1-33; Gumbo JR, 2014, PHYS CHEM EARTH, V72-75, P24, DOI 10.1016/j.pce.2014.09.004; HALEMEJKO GZ, 1984, ARCH HYDROBIOL, V101, P489; HASEGAWA T, 1983, J GEN APPL MICROBIOL, V29, P319, DOI 10.2323/jgam.29.319; HECKY RE, 1988, LIMNOL OCEANOGR, V33, P796, DOI 10.4319/lo.1988.33.4_part_2.0796; JURGENS K, 1994, MAR ECOL PROG SER, V112, P169, DOI 10.3354/meps112169; KOVACS N, 1956, NATURE, V178, P703, DOI 10.1038/178703a0; KROPPENSTEDT RM, 1982, J LIQ CHROMATOGR, V5, P2359, DOI 10.1080/01483918208067640; Liu LL, 2000, J LAKE SCI, V12, P373, DOI DOI 10.18307/2000.0412.[; Liu YM, 2006, ENVIRON TOXICOL, V21, P289, DOI 10.1002/tox.20182; MESBAH M, 1989, INT J SYST BACTERIOL, V39, P159, DOI 10.1099/00207713-39-2-159; Mevs U, 2000, INT J SYST EVOL MICR, V50, P337, DOI 10.1099/00207713-50-1-337; MINNIKIN DE, 1979, J APPL BACTERIOL, V47, P87, DOI 10.1111/j.1365-2672.1979.tb01172.x; Nautiyal CS, 1999, FEMS MICROBIOL LETT, V170, P265, DOI 10.1111/j.1574-6968.1999.tb13383.x; Niu Y, 2011, WATER RES, V45, P4169, DOI 10.1016/j.watres.2011.05.022; Normand P, 2012, BERGEYS MANUAL SYS A, V5, P528; Normand P, 2006, INT J SYST EVOL MICR, V56, P2277, DOI 10.1099/ijs.0.64298-0; Park MH, 2009, AQUAT BOT, V90, P309, DOI 10.1016/j.aquabot.2008.11.007; Parveen B, 2013, ENV MICROBIOL REP, V5, P716, DOI 10.1111/1758-2229.12071; Qin S, 2013, INT J SYST EVOL MICR, V61, P1710; Reddy GSN, 2007, INT J SYST EVOL MICR, V57, P2014, DOI 10.1099/ijs.0.64932-0; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sasser M, 1990, IDENTIFICATION BACTE; Sen A, 2014, INT J SYST EVOL MICR, V64, P3821, DOI 10.1099/ijs.0.063966-0; Shi LM, 2012, ENV MICROBIOL REP, V4, P669, DOI 10.1111/1758-2229.12001; Shi LM, 2009, J ENVIRON SCI, V21, P1581, DOI 10.1016/S1001-0742(08)62459-6; SHIRLING E. B., 1966, INT J SYST BACTERIOL, V16, P313; Stackebrandt E, 2006, MICROBIOLOGY TODAY, V06, P152, DOI DOI 10.1038/MSB.2013.22; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tang SK, 2009, INT J SYST EVOL MICR, V59, P2025, DOI 10.1099/ijs.0.007344-0; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Trujillo ME, 2015, ANTON LEEUW INT J G, V108, P311, DOI 10.1007/s10482-015-0482-7; WILLIAMS ST, 1983, J GEN MICROBIOL, V129, P1743; Xiao J, 2011, INT J SYST EVOL MICR, V61, P1710, DOI 10.1099/ijs.0.023085-0; Xu P, 2005, INT J SYST EVOL MICR, V55, P1149, DOI 10.1099/ijs.0.63407-0; Yang LY, 2010, OUTBRUST JEOPARDIZE, P212; Yuan Li-na, 2006, Journal of Ecology and Rural Environment, V22, P85; Zhang BH, 2016, APPL MICROBIOL BIOT, V100, P4627, DOI 10.1007/s00253-015-7150-8; Zhang BH, 2015, APPL MICROBIOL BIOT, V99, P7673, DOI 10.1007/s00253-015-6584-3; Zhang BH, 2014, ANTON LEEUW INT J G, V105, P763, DOI 10.1007/s10482-014-0132-5; Zhao GY, 2012, ECOL ENG, V42, P107, DOI 10.1016/j.ecoleng.2012.02.007; Zhao Jie, 2011, Hupo Kexue, V23, P49	54	12	13	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0161069	10.1371/journal.pone.0161069	http://dx.doi.org/10.1371/journal.pone.0161069			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27537546	Green Published, Green Submitted, gold			2022-12-27	WOS:000381577000048
J	Wachter, J; Hill, S				Wachter, Jenny; Hill, Stuart			Positive Selection Pressure Drives Variation on the Surface-Exposed Variable Proteins of the Pathogenic Neisseria	PLOS ONE			English	Article							OUTER-MEMBRANE PROTEINS; AMINO-ACID SITES; OPA GENE FAMILY; ANTIGENIC VARIATION; MAXIMUM-LIKELIHOOD; EPITHELIAL-CELLS; EVOLUTIONARY CONSERVATION; SUBSTITUTION RATES; DNA POLYMORPHISM; PILUS GENES	Pathogenic species of Neisseria utilize variable outer membrane proteins to facilitate infection and proliferation within the human host. However, the mechanisms behind the evolution of these variable alleles remain largely unknown due to analysis of previously limited datasets. In this study, we have expanded upon the previous analyses to substantially increase the number of analyzed sequences by including multiple diverse strains, from various geographic locations, to determine whether positive selective pressure is exerted on the evolution of these variable genes. Although Neisseria are naturally competent, this analysis indicates that only intrastrain horizontal gene transfer among the pathogenic Neisseria principally account for these genes exhibiting linkage equilibrium which drives the polymorphisms evidenced within these alleles. As the majority of polymorphisms occur across species, the divergence of these variable genes is dependent upon the species and is independent of geographical location, disease severity, or serogroup. Tests of neutrality were able to detect strong selection pressures acting upon both the opa and pil gene families, and were able to locate the majority of these sites within the exposed variable regions of the encoded proteins. Evidence of positive selection acting upon the hypervariable domains of Opa contradicts previous beliefs and provides evidence for selection of receptor binding. As the pathogenic Neisseria reside exclusively within the human host, the strong selection pressures acting upon both the opa and pil gene families provide support for host immune system pressure driving sequence polymorphisms within these variable genes.	[Wachter, Jenny; Hill, Stuart] Northern Illinois Univ, Dept Biol Sci, De Kalb, IL 60115 USA	Northern Illinois University	Wachter, J (corresponding author), Northern Illinois Univ, Dept Biol Sci, De Kalb, IL 60115 USA.	jmcconoughey@niu.edu		Wachter, Jenny/0000-0003-2175-5595				AHO EL, 1991, MOL MICROBIOL, V5, P1429, DOI 10.1111/j.1365-2958.1991.tb00789.x; AKASHI H, 1995, GENETICS, V139, P1067; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andrews TD, 2004, GENETICS, V166, P25, DOI 10.1534/genetics.166.1.25; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; BESSEN D, 1986, INFECT IMMUN, V54, P154, DOI 10.1128/IAI.54.1.154-160.1986; BHAT KS, 1992, MOL MICROBIOL, V6, P1073, DOI 10.1111/j.1365-2958.1992.tb02172.x; BHAT KS, 1991, MOL MICROBIOL, V5, P1889, DOI 10.1111/j.1365-2958.1991.tb00813.x; BIHLMAIER A, 1991, MOL MICROBIOL, V5, P2529, DOI 10.1111/j.1365-2958.1991.tb02099.x; Bilek N, 2009, J BACTERIOL, V191, P1878, DOI 10.1128/JB.01518-08; Biswas S, 2006, TRENDS GENET, V22, P437, DOI 10.1016/j.tig.2006.06.005; Bos MP, 1999, J EXP MED, V190, P331, DOI 10.1084/jem.190.3.331; Callaghan MJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000020; Celniker G, 2013, ISR J CHEM, V53, P199, DOI 10.1002/ijch.201200096; CHEN T, 1995, J EXP MED, V182, P511, DOI 10.1084/jem.182.2.511; CONNELL TD, 1990, MOL MICROBIOL, V4, P439, DOI 10.1111/j.1365-2958.1990.tb00610.x; Craig L, 2006, MOL CELL, V23, P651, DOI 10.1016/j.molcel.2006.07.004; Davies JK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086704; DEMPSEY JAF, 1991, J BACTERIOL, V173, P5476, DOI 10.1128/jb.173.17.5476-5486.1991; Fox DA, 2014, J AM CHEM SOC, V136, P9938, DOI 10.1021/ja503093y; Fraczkiewicz R, 1998, J COMPUT CHEM, V19, P319, DOI 10.1002/(SICI)1096-987X(199802)19:3<319::AID-JCC6>3.0.CO;2-W; Glaser F, 2003, BIOINFORMATICS, V19, P163, DOI 10.1093/bioinformatics/19.1.163; GOLDMAN N, 1994, MOL BIOL EVOL, V11, P725; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; HAAS R, 1992, MOL MICROBIOL, V6, P197, DOI 10.1111/j.1365-2958.1992.tb02001.x; HAAS R, 1986, CELL, V44, P107, DOI 10.1016/0092-8674(86)90489-7; HAGBLOM P, 1985, NATURE, V315, P156, DOI 10.1038/315156a0; HARTL DL, 1994, GENETICS, V138, P227; HARTL DL, 1991, J EVOLUTION BIOL, V4, P519, DOI 10.1046/j.1420-9101.1991.4040519.x; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Hobbs MM, 1998, MICROBIOL-UK, V144, P157, DOI 10.1099/00221287-144-1-157; HOBBS MM, 1994, MOL MICROBIOL, V12, P171, DOI 10.1111/j.1365-2958.1994.tb01006.x; INA Y, 1995, J MOL EVOL, V40, P190, DOI 10.1007/BF00167113; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; KELLOGG DS, 1963, J BACTERIOL, V85, P1274, DOI 10.1128/JB.85.6.1274-1279.1963; KELLOGG DS, 1968, J BACTERIOL, V96, P596, DOI 10.1128/JB.96.3.596-605.1968; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; KUPSCH EM, 1993, EMBO J, V12, P641, DOI 10.1002/j.1460-2075.1993.tb05697.x; LANAVE C, 1984, J MOL EVOL, V20, P86, DOI 10.1007/BF02101990; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Lartillot N, 2004, MOL BIOL EVOL, V21, P1095, DOI 10.1093/molbev/msh112; LEWONTIN RC, 1964, GENETICS, V49, P49; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Low DHW, 2013, J PROTEOMICS, V89, P95, DOI 10.1016/j.jprot.2013.05.034; Malorny B, 1998, J BACTERIOL, V180, P1323, DOI 10.1128/JB.180.5.1323-1330.1998; Masters TL, 2016, MICROBIOL-SGM, V162, P177, DOI 10.1099/mic.0.000199; Meyer T. F., 2003, ANTIGENIC VARIATION, P142; MEYER TF, 1984, P NATL ACAD SCI-BIOL, V81, P6110, DOI 10.1073/pnas.81.19.6110; Morelli G, 1997, MOL MICROBIOL, V25, P1047, DOI 10.1046/j.1365-2958.1997.5211882.x; Muenzner P, 2000, INFECT IMMUN, V68, P3601, DOI 10.1128/IAI.68.6.3601-3607.2000; MURPHY GL, 1989, CELL, V56, P539, DOI 10.1016/0092-8674(89)90577-1; Nassif X, 1999, Int Microbiol, V2, P133; NEI M, 1986, MOL BIOL EVOL, V3, P418; Nielsen R, 1998, GENETICS, V148, P929; OOI T, 1987, P NATL ACAD SCI USA, V84, P3086, DOI 10.1073/pnas.84.10.3086; PARGE HE, 1995, NATURE, V378, P32, DOI 10.1038/378032a0; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; POOLMAN JT, 1983, INFECT IMMUN, V40, P398, DOI 10.1128/IAI.40.1.398-406.1983; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Rich SM, 2001, P NATL ACAD SCI USA, V98, P15038, DOI 10.1073/pnas.071042098; SAWYER S, 1989, MOL BIOL EVOL, V6, P526; SAWYER SA, 1992, GENETICS, V132, P1161; Sawyer Stanley A., 1994, P77; SCHERP HW, 1955, ANNU REV MICROBIOL, V9, P319, DOI 10.1146/annurev.mi.09.100155.001535; Sethupathy Praveen, 2008, Advances in Bioinformatics, V2008, P257864, DOI 10.1155/2008/257864; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; Sintsova A, 2015, INFECT IMMUN, V83, P1372, DOI 10.1128/IAI.03123-14; SMITH NH, 1995, MOL BIOL EVOL, V12, P363; STERN A, 1986, CELL, V47, P61, DOI 10.1016/0092-8674(86)90366-1; Suyama M, 2006, NUCLEIC ACIDS RES, V34, pW609, DOI 10.1093/nar/gkl315; SWANSON J, 1987, J EXP MED, V165, P1344, DOI 10.1084/jem.165.5.1344; TAJIMA F, 1989, GENETICS, V123, P585; VANDERLEY P, 1988, MOL MICROBIOL, V2, P797; VANPUTTEN JPM, 1995, EMBO J, V14, P2144, DOI 10.1002/j.1460-2075.1995.tb07208.x; Virji M, 1999, MOL MICROBIOL, V34, P538, DOI 10.1046/j.1365-2958.1999.01620.x; Virji M, 1996, MOL MICROBIOL, V22, P941, DOI 10.1046/j.1365-2958.1996.01551.x; Wachter J, 2015, FEMS MICROBIOL LETT, V362, DOI 10.1093/femsle/fnu059; Wachter J, 2015, MICROBIOL-SGM, V161, P1124, DOI 10.1099/mic.0.000061; Wang IN, 1999, GENETICS, V151, P15; Watkins ER, 2014, SCI REP-UK, V4, DOI 10.1038/srep06554; Watt SM, 2001, BLOOD, V98, P1469, DOI 10.1182/blood.V98.5.1469; WESSON L, 1992, PROTEIN SCI, V1, P227; Wiertz EJHJ, 1996, INFECT IMMUN, V64, P298, DOI 10.1128/IAI.64.1.298-304.1996; Wong WSW, 2004, GENETICS, V168, P1041, DOI 10.1534/genetics.104.031153; Xia XH, 2003, MOL PHYLOGENET EVOL, V26, P1, DOI 10.1016/S1055-7903(02)00326-3; Xia XH, 2013, MOL BIOL EVOL, V30, P1720, DOI 10.1093/molbev/mst064; Xia XH, 2009, PHYLOGENETIC HANDBOOK: A PRACTICAL APPROACH TO PHYLOGENETIC ANALYSIS AND HYPOTHESIS TESTING, 2ND EDITION, P615; Yang ZH, 2000, MOL BIOL EVOL, V17, P32, DOI 10.1093/oxfordjournals.molbev.a026236; Yang ZH, 2000, GENETICS, V155, P431; YANG ZH, 1994, J MOL EVOL, V39, P306, DOI 10.1007/BF00160154; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; ZAK K, 1984, J INFECT DIS, V149, P166, DOI 10.1093/infdis/149.2.166	93	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2016	11	8							e0161348	10.1371/journal.pone.0161348	http://dx.doi.org/10.1371/journal.pone.0161348			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4YN	27532335	gold, Green Published, Green Submitted			2022-12-27	WOS:000381487600087
J	Langeslag, SJE; van Strien, JW				Langeslag, Sandra J. E.; van Strien, Jan W.			Regulation of Romantic Love Feelings: Preconceptions, Strategies, and Feasibility	PLOS ONE			English	Article							EMOTION-REGULATION; UNPLEASANT PICTURES; COGNITIVE CONTROL; BRAIN POTENTIALS; PSYCHOMETRIC PROPERTIES; INDIVIDUAL-DIFFERENCES; UP-REGULATION; REAPPRAISAL; ATTENTION; ATTRACTION	Love feelings can be more intense than desired (e.g., after a break-up) or less intense than desired (e.g., in long-term relationships). If only we could control our love feelings! We present the concept of explicit love regulation, which we define as the use of behavioral and cognitive strategies to change the intensity of current feelings of romantic love. We present the first two studies on preconceptions about, strategies for, and the feasibility of love regulation. Questionnaire responses showed that people perceive love feelings as somewhat uncontrollable. Still, in four open questions people reported to use strategies such as cognitive reappraisal, distraction, avoidance, and undertaking (new) activities to cope with break-ups, to maintain long-term relationships, and to regulate love feelings. Instructed up-regulation of love using reappraisal increased subjective feelings of attachment, while love down-regulation decreased subjective feelings of infatuation and attachment. We used the late positive potential (LPP) amplitude as an objective index of regulation success. Instructed love up-regulation enhanced the LPP between 300-400 ms in participants who were involved in a relationship and in participants who had recently experienced a romantic break-up, while love down-regulation reduced the LPP between 700-3000 ms in participants who were involved in a relationship. These findings corroborate the self-reported feasibility of love regulation, although they are complicated by the finding that love up-regulation also reduced the LPP between 700-3000 ms in participants who were involved in a relationship. To conclude, although people have the preconception that love feelings are uncontrollable, we show for the first time that intentional regulation of love feelings using reappraisal, and perhaps other strategies, is feasible. Love regulation will benefit individuals and society because it could enhance positive effects and reduce negative effects of romantic love.	[Langeslag, Sandra J. E.] Univ Missouri, Dept Psychol Sci, St Louis, MO 63121 USA; [Langeslag, Sandra J. E.] Univ Maryland, Dept Psychol, College Pk, MD 20742 USA; [van Strien, Jan W.] Erasmus Univ, Inst Psychol, Rotterdam, Netherlands	University of Missouri System; University of Missouri Saint Louis; University System of Maryland; University of Maryland College Park; Erasmus University Rotterdam	Langeslag, SJE (corresponding author), Univ Missouri, Dept Psychol Sci, St Louis, MO 63121 USA.; Langeslag, SJE (corresponding author), Univ Maryland, Dept Psychol, College Pk, MD 20742 USA.	langeslags@umsl.edu	Langeslag, Sandra/GRE-6148-2022	Langeslag, Sandra/0000-0001-6020-1259				Amato PR, 2000, J MARRIAGE FAM, V62, P1269, DOI 10.1111/j.1741-3737.2000.01269.x; Aron A, 2000, J PERS SOC PSYCHOL, V78, P273, DOI 10.1037/0022-3514.78.2.273; Barker C, 2002, RES METHODS CLIN PSY; Baur R, 2015, INT J PSYCHOPHYSIOL, V96, P38, DOI 10.1016/j.ijpsycho.2015.02.022; Beauregard M., 2001, J NEUROSCI, V21, P6993, DOI [DOI 10.1523/JNEUROSCI.21-18-J0001.2001, DOI 10.1523/JNEUROSCI.21-18-j0001.2001]; Berscheid E, 2010, ANNU REV PSYCHOL, V61, P1, DOI 10.1146/annurev.psych.093008.100318; Brenner RE, 2015, J COUNS PSYCHOL, V62, P476, DOI 10.1037/cou0000073; Brooks AW, 2014, J EXP PSYCHOL GEN, V143, P1144, DOI 10.1037/a0035325; Burkett JP, 2012, PSYCHOPHARMACOLOGY, V224, P1, DOI 10.1007/s00213-012-2794-x; Carver K, 2003, ADOLESCENT ROMANTIC REALTIONS AND SEXUAL BEHAVIOR: THEORY, RESEARCH, AND PRACTICAL IMPLICATIONS, P23; Cuthbert BN, 2000, BIOL PSYCHOL, V52, P95, DOI 10.1016/S0301-0511(99)00044-7; De Silva P, 1997, BEHAV RES THER, V35, P973, DOI 10.1016/S0005-7967(97)00051-X; Delgado MR, 2008, NAT NEUROSCI, V11, P880, DOI 10.1038/nn.2141; DUTTON DG, 1989, CAN J BEHAV SCI, V21, P246, DOI 10.1037/h0079815; DUTTON DG, 1974, J PERS SOC PSYCHOL, V30, P510, DOI 10.1037/h0037031; Eimer M, 2000, CLIN NEUROPHYSIOL, V111, P694, DOI 10.1016/S1388-2457(99)00285-0; Fisher H., 2000, J SEX EDUC THER, V25, P96, DOI [10.1080/01614576.2000.11074334, DOI 10.1080/01614576.2000.11074334]; Fisher HE, 1998, HUM NATURE-INT BIOS, V9, P23, DOI 10.1007/s12110-998-1010-5; Fisher HE, 2002, ARCH SEX BEHAV, V31, P413, DOI 10.1023/A:1019888024255; Gonzaga GC, 2008, EVOL HUM BEHAV, V29, P119, DOI 10.1016/j.evolhumbehav.2007.11.003; GRATTON G, 1983, ELECTROEN CLIN NEURO, V55, P468, DOI 10.1016/0013-4694(83)90135-9; Gross J. J., 1993, PERSONALITY SOCIAL P, V64, P970, DOI DOI 10.1037/0022-3514.64.6.970; Gross JJ, 2013, EMOTION, V13, P359, DOI 10.1037/a0032135; Gross JJ, 2003, J PERS SOC PSYCHOL, V85, P348, DOI 10.1037/0022-3514.85.2.348; Gross JJ, 2002, PSYCHOPHYSIOLOGY, V39, P281, DOI 10.1017/S0048577201393198; Gunaydin G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121094; Gyurak A, 2011, COGNITION EMOTION, V25, P400, DOI 10.1080/02699931.2010.544160; Hajcak G, 2006, COGN AFFECT BEHAV NE, V6, P291, DOI 10.3758/CABN.6.4.291; Hajcak G, 2010, DEV NEUROPSYCHOL, V35, P129, DOI 10.1080/87565640903526504; Hatfield E., 1998, HDB SEXUALITY RELATE, P449; Hatfield E., 1988, PSYCHOL LOVE, P191; Hatfield E.C., 2008, INTERPERSONA, V2, P35, DOI DOI 10.5964/IJPR.V2I1.17; Jackson DC, 2000, PSYCHOPHYSIOLOGY, V37, P515, DOI 10.1111/1469-8986.3740515; Kaplan GB, 2011, PHARMACOL BIOCHEM BE, V97, P619, DOI 10.1016/j.pbb.2010.08.004; Karney BR, 2000, J PERS SOC PSYCHOL, V78, P295, DOI 10.1037/0022-3514.78.2.295; Kim HK, 2002, J FAM ISSUES, V23, P885, DOI 10.1177/019251302237296; Krompinger JW, 2008, EMOTION, V8, P132, DOI 10.1037/1528-3542.8.1.132; Lang P. J., 2005, A6 U FLOR, DOI DOI 10.1027/0269-8803/A000147; Langeslag SJE, 2008, NEUROSCI LETT, V431, P236, DOI 10.1016/j.neulet.2007.11.044; Langeslag SJE, 2007, BIOL PSYCHOL, V76, P109, DOI 10.1016/j.biopsycho.2007.06.007; Langeslag SJE, 2015, SOC COGN AFFECT NEUR, V10, P136, DOI 10.1093/scan/nsu034; Langeslag SJE, 2014, HUM BRAIN MAPP, V35, P503, DOI 10.1002/hbm.22197; Langeslag SJE, 2013, J SEX RES, V50, P739, DOI 10.1080/00224499.2012.714011; Langeslag SJE, 2013, BIOL PSYCHOL, V94, P228, DOI 10.1016/j.biopsycho.2013.05.021; Langeslag SJE, 2010, J PSYCHOPHYSIOL, V24, P186, DOI 10.1027/0269-8803/a000009; Langeslag SJE, THE EFFECT OF AROUSA; Langeslag SJE, 2006, PSYCHOLOOG, V41, P260; Leary M. R., 2001, INTERPERSONAL REJECT, P145; LEE JA, 1977, PERS SOC PSYCHOL B, V3, P173, DOI 10.1177/014616727700300204; Littel M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027519; Lydon JE, 2003, PERS SOC PSYCHOL B, V29, P349, DOI 10.1177/0146167202250202; Marazziti D, 2004, PSYCHONEUROENDOCRINO, V29, P931, DOI 10.1016/j.psyneuen.2003.08.006; Mashek D., 2000, REPRESENTATIVE RES S, V24, P48; McRae K, 2012, J RES PERS, V46, P2, DOI 10.1016/j.jrp.2011.10.003; Monroe SM, 1999, J ABNORM PSYCHOL, V108, P606, DOI 10.1037/0021-843X.108.4.606; Moran TP, 2013, BRAIN RES, V1516, P66, DOI 10.1016/j.brainres.2013.04.018; Moser JS, 2014, J ABNORM PSYCHOL, V123, P91, DOI 10.1037/a0035817; Moser JS, 2010, COGN AFFECT BEHAV NE, V10, P195, DOI 10.3758/CABN.10.2.195; Moser JS, 2009, PSYCHOPHYSIOLOGY, V46, P17, DOI 10.1111/j.1469-8986.2008.00721.x; Moser JS, 2006, PSYCHOPHYSIOLOGY, V43, P292, DOI 10.1111/j.1469-8986.2006.00402.x; Murray SL, 1996, J PERS SOC PSYCHOL, V70, P79, DOI 10.1037/0022-3514.70.1.79; Nagvi NH, 2015, ALCOHOLISM CLIN EXPT, V39, P343, DOI [10.1111/acer.12637, DOI 10.1111/ACER.12637]; O'Leary KD, 2012, SOC PSYCHOL PERS SCI, V3, P241, DOI 10.1177/1948550611417015; Ochsner KN, 2002, J COGNITIVE NEUROSCI, V14, P1215, DOI 10.1162/089892902760807212; Ochsner KN, 2005, TRENDS COGN SCI, V9, P242, DOI 10.1016/j.tics.2005.03.010; Ochsner KN, 2004, NEUROIMAGE, V23, P483, DOI 10.1016/j.neuroimage.2004.06.030; ORNE MT, 1962, AM PSYCHOL, V17, P776, DOI 10.1037/h0043424; Rugg MD, 2000, NEW COGNITIVE NEUROS; Sarkar SK, 1997, J AM STAT ASSOC, V92, P1601, DOI 10.2307/2965431; Schupp HT, 2006, PROG BRAIN RES, V156, P31, DOI 10.1016/S0079-6123(06)56002-9; Sheppes G, 2011, PSYCHOL SCI, V22, P1391, DOI 10.1177/0956797611418350; Staudinger MR, 2011, CEREB CORTEX, V21, P2578, DOI 10.1093/cercor/bhr041; Staudinger MR, 2009, NEUROIMAGE, V47, P713, DOI 10.1016/j.neuroimage.2009.04.095; STERNBERG RJ, 1986, PSYCHOL REV, V93, P119, DOI 10.1037/0033-295X.93.2.119; Stone A.A., 2009, SCI SELF REPORT IMPL; Tacikowski P, 2010, BIOL PSYCHOL, V84, P318, DOI 10.1016/j.biopsycho.2010.03.009; Thornton Grant, 2012, RICHER POORER WHATS; Van Strien JW, 1992, NEDERLANDS TIJDSCHRI, V66, P205; Vangelisti AL, 2012, SAGE HDB INTERPERSON, P597; Veilleux JC, 2015, CLIN PSYCHOL REV, V36, P13, DOI 10.1016/j.cpr.2015.01.001; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063	81	15	15	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2016	11	8							e0161087	10.1371/journal.pone.0161087	http://dx.doi.org/10.1371/journal.pone.0161087			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DT4UN	27529751	Green Published, gold, Green Submitted			2022-12-27	WOS:000381476700045
J	Niemann, U; Spiliopoulou, M; Szczepanski, T; Samland, F; Grutzner, J; Senk, D; Ming, A; Kellersmann, J; Malanowski, J; Klose, S; Mertens, PR				Niemann, Uli; Spiliopoulou, Myra; Szczepanski, Thorsten; Samland, Fred; Gruetzner, Jens; Senk, Dominik; Ming, Antao; Kellersmann, Juliane; Malanowski, Jan; Klose, Silke; Mertens, Peter R.			Comparative Clustering of Plantar Pressure Distributions in Diabetics with Polyneuropathy May Be Applied to Reveal Inappropriate Biomechanical Stress	PLOS ONE			English	Article							FOOT PRESSURE; ULCERS; RISK; CLASSIFICATION	In diabetic patients, excessive peak plantar pressure has been identified as major risk factor for ulceration. Analyzing plantar pressure distributions potentially improves the identification of patients with a high risk for foot ulceration development. The goal of this study was to classify regional plantar pressure distributions. By means of a sensor-equipped insole, pressure recordings of healthy controls (n = 18) and diabetics with severe polyneuropathy (n = 25) were captured across eight foot regions. The study involved a controlled experimental protocol with multiple sessions, where a session contained several cycles of pressure exposure. Clustering was used to identify subgroups of study participants that are characterized by similar pressure distributions. For both analyzed groups, the number of clusters to best describe the pressure profiles was four. When both groups were combined, analysis again led to four distinct clusters. While three clusters did not separate between healthy and diabetic volunteers the fourth cluster was only represented by diabetics. Here the pressure distribution pattern is characterized by a focal point of pressure application on the forefoot and low pressure on the lateral region. Our data suggest that pressure clustering is a feasible means to identify inappropriate biomechanical plantar stress.	[Niemann, Uli; Spiliopoulou, Myra] Univ Magdeburg, Fac Comp Sci, Magdeburg, Germany; [Niemann, Uli; Szczepanski, Thorsten; Gruetzner, Jens] Ifak Syst GmbH, Magdeburg, Germany; [Samland, Fred] MediXmind GmbH, Magdeburg, Germany; [Senk, Dominik; Ming, Antao; Kellersmann, Juliane; Malanowski, Jan; Klose, Silke; Mertens, Peter R.] Univ Magdeburg, Clin Nephrol Hypertens Diabet & Endocrinol, Magdeburg, Germany	Otto von Guericke University; Otto von Guericke University	Niemann, U (corresponding author), Univ Magdeburg, Fac Comp Sci, Magdeburg, Germany.; Niemann, U (corresponding author), Ifak Syst GmbH, Magdeburg, Germany.; Mertens, PR (corresponding author), Univ Magdeburg, Clin Nephrol Hypertens Diabet & Endocrinol, Magdeburg, Germany.	uli.niemann@st.ovgu.de; peter.mertens@med.ovgu.de	Mertens, Peter/AAI-7310-2020		mediXmind GmbH; ifak system GmbH; German Research Foundation [SFB-854-TP1]; SFB = Special Research Field of the German Research Foundation; Chinese Scholarship Council (CSC)	mediXmind GmbH; ifak system GmbH; German Research Foundation(German Research Foundation (DFG)); SFB = Special Research Field of the German Research Foundation(German Research Foundation (DFG)); Chinese Scholarship Council (CSC)(China Scholarship Council)	DS, PRM and TS are co-founders of mediXmind GmbH and received funding in the form of salaries. UN is an employee of ifak system GmbH and received funding in the form of a salary. JK and PRM are supported by the German Research Foundation (Grant No. SFB-854-TP1); SFB = Special Research Field of the German Research Foundation (http://www.sfb854.de/). AM is supported by the Chinese Scholarship Council (CSC) (http://en.csc.edu.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong D G, 1998, J Foot Ankle Surg, V37, P303; Barn R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117443; Bennetts CJ, 2013, J BIOMECH, V46, P19, DOI 10.1016/j.jbiomech.2012.09.007; Boulton AJM, 2005, LANCET, V366, P1719, DOI 10.1016/S0140-6736(05)67698-2; Bus SA, 2012, DIABETES-METAB RES, V28, P54, DOI 10.1002/dmrr.2240; Cavanagh PR, 2010, J AM PODIAT MED ASSN, V100, P360, DOI 10.7547/1000360; CLEVELAND WS, 1981, AM STAT, V35, P54, DOI 10.2307/2683591; Dahmen R, 2001, DIABETES CARE, V24, P705, DOI 10.2337/diacare.24.4.705; De Cock A, 2006, GAIT POSTURE, V23, P339, DOI 10.1016/j.gaitpost.2005.04.011; Deschamps K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079924; Fard AS, 2007, INT J CLIN PRACT, V61, P1931, DOI 10.1111/j.1742-1241.2007.01534.x; Frykberg Robert G, 2006, J Foot Ankle Surg, V45, pS1; Grutzner J, 2015, BIOMEDICAL ENG, V60, P252; Kaufman L., 1987, Statistical Data Analysis Based on the L1-Norm and Related Methods. First International Conference, P405; Lavery LA, 2003, DIABETES CARE, V26, P1069, DOI 10.2337/diacare.26.4.1069; Maechler M., 2015, CLUSTER CLUSTER ANAL; Moulik PK, 2003, DIABETES CARE, V26, P491, DOI 10.2337/diacare.26.2.491; Rizzo L, 2012, INT J LOW EXTR WOUND, V11, P59, DOI 10.1177/1534734612438729; Singh N, 2005, JAMA-J AM MED ASSOC, V293, P217, DOI 10.1001/jama.293.2.217; Singh S.S., 2011, NAT C REC TRENDS ENG, V13, P4; VEVES A, 1992, DIABETOLOGIA, V35, P660, DOI 10.1007/BF00400259; Waaijman R, 2014, DIABETES CARE, V37, P1697, DOI 10.2337/dc13-2470; Waldecker Ute, 2012, Foot Ankle Surg, V18, P42, DOI 10.1016/j.fas.2011.03.004	23	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2016	11	8							e0161326	10.1371/journal.pone.0161326	http://dx.doi.org/10.1371/journal.pone.0161326			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4UN	27529421	gold, Green Published, Green Submitted			2022-12-27	WOS:000381476700067
J	Sachse, D; Solevag, AL; Berg, JP; Nakstad, B				Sachse, Daniel; Solevag, Anne Lee; Berg, Jens Petter; Nakstad, Britt			The Role of Plasma and Urine Metabolomics in Identifying New Biomarkers in Severe Newborn Asphyxia: A Study of Asphyxiated Newborn Pigs following Cardiopulmonary Resuscitation	PLOS ONE			English	Article							MAGNETIC-RESONANCE-SPECTROSCOPY; CARDIAC-ARREST; PERINATAL ASPHYXIA; ASPHYCTIC NEWBORN; MODEL; COMPRESSIONS; REGRESSION; TRANSPORT; HYPOXIA; PACKAGE	Background Optimizing resuscitation is important to prevent morbidity and mortality from perinatal asphyxia. The metabolism of cells and tissues is severely disturbed during asphyxia and resuscitation, and metabolomic analyses provide a snapshot of many small molecular weight metabolites in body fluids or tissues. In this study metabolomics profiles were studied in newborn pigs that were asphyxiated and resuscitated using different protocols to identify biomarkers for subject characterization, intervention effects and possibly prognosis. Methods A total of 125 newborn Noroc pigs were anesthetized, mechanically ventilated and inflicted progressive asphyxia until asystole. Pigs were randomized to resuscitation with a FiO(2) 0.21 or 1.0, different duration of ventilation before initiation of chest compressions (CC), and different CC to ventilation ratios. Plasma and urine samples were obtained at baseline, and 2 h and 4 h after return of spontaneous circulation (ROSC, heart rate > = 100 bpm). Metabolomics profiles of the samples were analyzed by nuclear magnetic resonance spectroscopy. Results Plasma and urine showed severe metabolic alterations consistent with hypoxia and acidosis 2 h and 4 h after ROSC. Baseline plasma hypoxanthine and lipoprotein concentrations were inversely correlated to the duration of hypoxia sustained before asystole occurred, but there was no evidence for a differential metabolic response to the different resuscitation protocols or in terms of survival. Conclusions Metabolic profiles of asphyxiated newborn pigs showed severe metabolic alterations. Consistent with previously published reports, we found no evidence of differences between established and alternative resuscitation protocols. Lactate and pyruvate may have a prognostic value, but have to be independently confirmed.	[Sachse, Daniel; Berg, Jens Petter] Univ Oslo, Inst Clin Med, Dept Med Biochem, Oslo, Norway; [Sachse, Daniel] Univ Oslo, Dept Chem, Oslo, Norway; [Solevag, Anne Lee; Nakstad, Britt] Akershus Univ Hosp, Dept Paediat & Adolescent Med, N-1478 Oslo, Norway; [Berg, Jens Petter] Oslo Univ Hosp, Dept Med Biochem, Oslo, Norway; [Nakstad, Britt] Univ Oslo, Campus Akershus Univ Hosp, Inst Clin Med, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Oslo	Nakstad, B (corresponding author), Akershus Univ Hosp, Dept Paediat & Adolescent Med, N-1478 Oslo, Norway.; Nakstad, B (corresponding author), Univ Oslo, Campus Akershus Univ Hosp, Inst Clin Med, Oslo, Norway.	britt.nakstad@medisin.uio.no	Solevåg, Anne Lee/AAH-9734-2021; Berg, Jens P/G-1455-2012	Solevåg, Anne Lee/0000-0002-8009-7169; Berg, Jens P/0000-0003-0157-5888				[Anonymous], 2010, R LANG ENV STAT COMP; Atzori L, 2010, J MATERN-FETAL NEO M, V23, P134, DOI 10.3109/14767058.2010.517033; Barkauskas DA, 2009, FTICRMS PROGR ANAL F; Barkauskas DA, 2010, ANAL CHIM ACTA, V657, P191, DOI 10.1016/j.aca.2009.10.043; BELL JD, 1988, CHEM BRIT, V24, P1021; Chalkias A, 2014, RESUSCITATION, V85, P595, DOI 10.1016/j.resuscitation.2014.01.025; Cloarec O, 2005, ANAL CHEM, V77, P517, DOI 10.1021/ac048803i; Dannevig I, 2013, PEDIATR RES, V73, P163, DOI 10.1038/pr.2012.167; Dannevig Ingrid, 2012, Open Respir Med J, V6, P89, DOI 10.2174/1874306401206010089; Dannevig I, 2011, NEONATOLOGY, V99, P153, DOI 10.1159/000302718; Fanos V, 2014, BIOMED RES INT; Fanos V, 2014, J MATERN-FETAL NEO M, V27, P39, DOI 10.3109/14767058.2014.955966; Fanos V, 2014, CLIN BIOCHEM, V47, P708, DOI 10.1016/j.clinbiochem.2014.05.020; Fanos V, 2014, EARLY HUM DEV, V90, pS78, DOI 10.1016/S0378-3782(14)70024-6; Feingold KR, 2011, J LIPID RES, V52, P1, DOI 10.1194/jlr.E012138; Hering-Smith KS, 2000, AM J PHYSIOL-RENAL, V278, pF492, DOI 10.1152/ajprenal.2000.278.3.F492; HOHMANN B, 1974, KIDNEY INT, V5, P261, DOI 10.1038/ki.1974.35; IWAMOTO HS, 1985, AM J PHYSIOL, V249, pF836, DOI 10.1152/ajprenal.1985.249.6.F836; Jun JC, 2013, AM J PHYSIOL-ENDOC M, V304, pE424, DOI 10.1152/ajpendo.00515.2012; KRIAT M, 1992, NMR BIOMED, V5, P179, DOI 10.1002/nbm.1940050404; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Longini M, 2015, CLIN CHIM ACTA, V444, P250, DOI 10.1016/j.cca.2015.02.004; Mevik BH, 2007, J STAT SOFTW, V18, P1, DOI 10.18637/jss.v018.i02; Ponnusamy V, 2016, PEDIATR RES, V79, P799, DOI 10.1038/pr.2015.276; Reinke SN, 2013, J PROTEOME RES, V12, P4230, DOI 10.1021/pr400617m; Sachse D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052399; Savman K, 2013, TRANSL STROKE RES, V4, P228, DOI 10.1007/s12975-012-0216-3; Skappak C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065035; Solberg R, 2010, PLOS ONE, V5; Solevag AL, 2011, ARCH DIS CHILD-FETAL, V96, pF417, DOI 10.1136/adc.2010.200386; Solevag AL, 2010, RESUSCITATION, V81, P1571, DOI 10.1016/j.resuscitation.2010.06.007; Solevag AL, 2010, NEONATOLOGY, V98, P64, DOI 10.1159/000275560; Stacklies W, 2007, BIOINFORMATICS, V23, P1164, DOI 10.1093/bioinformatics/btm069; Walsh BH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050520; Westerhuis JA, 2008, METABOLOMICS, V4, P81, DOI 10.1007/s11306-007-0099-6; Wold S, 2001, CHEMOMETR INTELL LAB, V58, P109, DOI 10.1016/S0169-7439(01)00155-1	36	23	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2016	11	8							e0161123	10.1371/journal.pone.0161123	http://dx.doi.org/10.1371/journal.pone.0161123			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4UN	27529347	Green Published, gold, Green Submitted			2022-12-27	WOS:000381476700048
J	Wang, SA; Xu, MQ; Wang, WQ; Cao, XC; Piao, MY; Khan, S; Yan, F; Cao, HL; Wang, BM				Wang, Sinan; Xu, Mengque; Wang, Weiqiang; Cao, Xiaocang; Piao, Meiyu; Khan, Samiullah; Yan, Fang; Cao, Hailong; Wang, Bangmao			Systematic Review: Adverse Events of Fecal Microbiota Transplantation	PLOS ONE			English	Review							CLOSTRIDIUM-DIFFICILE INFECTION; INFLAMMATORY-BOWEL-DISEASE; TERM-FOLLOW-UP; ULCERATIVE-COLITIS; CROHNS-DISEASE; EFFECTIVE THERAPY; NASOGASTRIC TUBE; GUT MICROBIOTA; RECURRENT; OUTCOMES	Background Fecal microbiota transplantation (FMT) is a microbiota-based therapy that shows therapeutic potential in recurrent or refractory Clostridium difficile infections and other intestinal or extra-intestinal disorders. Nonetheless, adverse events (AEs) remain a major challenge in the application of FMT. Aim To review the AEs of FMT and to address the concerns of safety during the procedure. Methods Publications were retrieved in the databases of Medline, Embase and Cochrane Library. AEs were classified according to their causality with FMT or their severity. Results A total of 7562 original articles about FMT were identified in this study, 50 of them fulfilled the inclusion criteria. Totally 78 kinds of AEs were revealed enrolled in these 50 selected publications. The total incidence rate of AEs was 28.5%. Among the 42 publications, 5 kinds were definitely and 38 kinds were probably related to FMT. The commonest FMT-attributable AE was abdominal discomfort, which was reported in 19 publications. For upper gastrointestinal routes of FMT, 43.6%(89/204) patients were compromised by FMT-attributable AE, while the incidence dropped to 17.7% (76/430) for lower gastrointestinal routes. In contrast, the incidences of serious adverse events (SAEs) were 2.0% (4/196) and 6.1% (40/659) for upper and lower gastrointestinal routes, respectively. A total of 44 kinds of SAEs occurred in 9.2% patients, including death (3.5%, 38/1089), infection (2.5%, 27/1089), relapse of inflammatory bowel diseases (0.6%, 7/1089) and Clostridium difficile infection (0.9%, 10/1089). Conclusion Consequently, both AEs and SAEs are not rare and should be carefully monitored throughout FMT. However, high quality randomized controlled trials are still needed for the more definite incidence of AEs of FMT.	[Wang, Sinan; Xu, Mengque; Wang, Weiqiang; Cao, Xiaocang; Piao, Meiyu; Khan, Samiullah; Yan, Fang; Cao, Hailong; Wang, Bangmao] Tianjin Med Univ, Gen Hosp, Dept Gastroenterol & Hepatol, Tianjin, Peoples R China; [Yan, Fang; Cao, Hailong] Vanderbilt Univ, Div Gastroenterol Hepatol & Nutr, Dept Pediat, Med Ctr, Nashville, TN 37232 USA	Tianjin Medical University; Vanderbilt University	Cao, HL; Wang, BM (corresponding author), Tianjin Med Univ, Gen Hosp, Dept Gastroenterol & Hepatol, Tianjin, Peoples R China.; Cao, HL (corresponding author), Vanderbilt Univ, Div Gastroenterol Hepatol & Nutr, Dept Pediat, Med Ctr, Nashville, TN 37232 USA.	cao_hailong@163.com; tjmughgi@hotmail.com		cao, xiaocang/0000-0001-8376-3481	National Natural Science Foundation of China [81570478, 81300272, 81470796]; Tianjin Research Program of Application Foundation and Advanced Technology of China [13JCQNJC10600, 15JCZDJC36600]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Tianjin Research Program of Application Foundation and Advanced Technology of China	This study is supported by the grants (81570478 to B.W., 81300272 to H.C. and 81470796 to F.Y.) from the National Natural Science Foundation of China, and the grants (13JCQNJC10600 to H.C. and 15JCZDJC36600 to F.Y.) from Tianjin Research Program of Application Foundation and Advanced Technology of China.	Aas J, 2003, CLIN INFECT DIS, V36, P580, DOI 10.1086/367657; Anderson JL, 2012, ALIMENT PHARM THER, V36, P503, DOI 10.1111/j.1365-2036.2012.05220.x; Angelberger S, 2013, AM J GASTROENTEROL, V108, P1620, DOI 10.1038/ajg.2013.257; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Bakken JS, 2011, CLIN GASTROENTEROL H, V9, P1044, DOI 10.1016/j.cgh.2011.08.014; Borody T, 2012, AM J GASTROENTEROL, V107, pS591, DOI 10.14309/00000434-201210001-01481; Borody T, 2011, AM J GASTROENTEROL, V106, pS352; Borody T, 2011, AM J GASTROENTEROL, V106, pS352; BORODY TJ, 1989, MED J AUSTRALIA, V150, P604, DOI 10.5694/j.1326-5377.1989.tb136704.x; Borody TJ, 2004, J CLIN GASTROENTEROL, V38, P475, DOI 10.1097/01.mcg.0000128988.13808.dc; Borody TJ, 2003, J GASTROEN HEPATOL, V18, pB8; Brandt L, 2013, AM J GASTROENTEROL, V108, pS556, DOI 10.14309/00000434-201310001-01840; Brandt LJ, 2015, AM J GASTROENTEROL, V110, P18, DOI [10.1038/ajg.2014.395, 10.1038/ajg.2014.295]; Brandt LJ, 2012, AM J GASTROENTEROL, V107, P1079, DOI 10.1038/ajg.2012.60; Cammarota G, 2015, ALIMENT PHARM THER, V41, P835, DOI 10.1111/apt.13144; Cui BT, 2015, J GASTROEN HEPATOL, V30, P51, DOI 10.1111/jgh.12727; De Leon LM, 2013, CLIN GASTROENTEROL H, V11, P1036, DOI 10.1016/j.cgh.2013.04.045; Dutta SK, 2014, CLIN GASTROENTEROL H, V12, P1572, DOI 10.1016/j.cgh.2013.12.032; EISEMAN B, 1958, SURGERY, V44, P854; Fischer M, 2014, AM J GASTROENTEROL, V109, pS487, DOI 10.14309/00000434-201410002-01643; Fischer M, 2014, AM J GASTROENTEROL, V109, pS195, DOI 10.14309/00000434-201410002-00674; Frank DN, 2011, INFLAMM BOWEL DIS, V17, P179, DOI 10.1002/ibd.21339; Friedman-Moraco RJ, 2014, AM J TRANSPLANT, V14, P477, DOI 10.1111/ajt.12577; Garborg K, 2010, SCAND J INFECT DIS, V42, P857, DOI 10.3109/00365548.2010.499541; Greenberg A, 2013, AM J GASTROENTEROL, V108, pS540, DOI 10.14309/00000434-201310001-01791; Guo B, 2012, ALIMENT PHARM THER, V35, P865, DOI 10.1111/j.1365-2036.2012.05033.x; Gustafsson A, 1998, SCAND J GASTROENTERO, V33, P721; Hamilton MJ, 2012, AM J GASTROENTEROL, V107, P761, DOI 10.1038/ajg.2011.482; Hedin CR, 2012, GUT, V61, P311, DOI 10.1136/gut.2011.238568; Hohmann EL, 2014, NEW ENGL J MED, V371, P668, DOI 10.1056/NEJMcpc1400842; Hooper LV, 2010, NAT REV IMMUNOL, V10, P159, DOI 10.1038/nri2710; Hornig M, 2013, CURR OPIN RHEUMATOL, V25, P488, DOI 10.1097/BOR.0b013e32836208de; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Ianiro G, 2014, MEDICINE, V93, DOI 10.1097/MD.0000000000000097; Joossens M, 2011, GUT, V60, P631, DOI 10.1136/gut.2010.223263; Kassam Z, 2013, AM J GASTROENTEROL, V108, P500, DOI 10.1038/ajg.2013.59; Kelly Ciaran P, 2008, N Engl J Med, V359, P1932, DOI 10.1056/NEJMra0707500; Kelly CR, 2014, AM J GASTROENTEROL, V109, P1065, DOI 10.1038/ajg.2014.133; Kelly CR, 2014, CLIN GASTROENTEROL H, V12, P283, DOI 10.1016/j.cgh.2013.09.060; Khoruts A, 2010, J CLIN GASTROENTEROL, V44, P354, DOI 10.1097/MCG.0b013e3181c87e02; Kronman MP, 2015, J PEDIATR GASTR NUTR, V60, P23, DOI 10.1097/MPG.0000000000000545; Kubinak JL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9642; Kump PK, 2013, INFLAMM BOWEL DIS, V19, P2155, DOI 10.1097/MIB.0b013e31829ea325; Kunde S, 2013, J PEDIATR GASTR NUTR, V56, P597, DOI 10.1097/MPG.0b013e318292fa0d; Landy J, 2011, ALIMENT PHARM THER, V34, P409, DOI 10.1111/j.1365-2036.2011.04737.x; Lee CH, 2014, EUR J CLIN MICROBIOL, V33, P1425, DOI 10.1007/s10096-014-2088-9; Lepage P, 2011, GASTROENTEROLOGY, V141, P227, DOI 10.1053/j.gastro.2011.04.011; Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Luckey D, 2013, INDIAN J MED RES, V138, P732; Macconnachie AA, 2009, QJM-INT J MED, V102, P781, DOI 10.1093/qjmed/hcp118; Mandalia A, 2014, GASTROENTEROLOGY, V146, pS252; Mandalia A, 2014, AM J GASTROENTEROL, V109, P1956, DOI 10.1038/ajg.2014.350; Mattila E, 2012, GASTROENTEROLOGY, V142, P490, DOI 10.1053/j.gastro.2011.11.037; Mellow M, 2010, AM J GASTROENTEROL, V105, pS135, DOI 10.14309/00000434-201010001-00367; Moayyedi P, 2015, GASTROENTEROLOGY, V149, P102, DOI 10.1053/j.gastro.2015.04.001; Mondot S, 2011, INFLAMM BOWEL DIS, V17, P185, DOI 10.1002/ibd.21436; Obi O, 2014, AM J GASTROENTEROL, V109, pS629, DOI 10.14309/00000434-201410002-02172; Pepin J, 2005, CLIN INFECT DIS, V40, P1591, DOI 10.1086/430315; Pierog A, 2014, PEDIATR INFECT DIS J, V33, P1198, DOI 10.1097/INF.0000000000000419; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Quera R, 2014, J CROHNS COLITIS, V8, P252, DOI 10.1016/j.crohns.2013.10.002; Ray A, 2014, OCHSNER J, V14, P538; Rossen NG, 2015, GASTROENTEROLOGY, V149, P110, DOI 10.1053/j.gastro.2015.03.045; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Russell GH, 2014, J PEDIATR GASTR NUTR, V58, P588, DOI 10.1097/MPG.0000000000000283; Russell SL, 2012, CURR OPIN GASTROEN, V28, P563, DOI 10.1097/MOG.0b013e3283573017; Satokari R, 2015, ALIMENT PHARM THER, V41, P46, DOI 10.1111/apt.13009; SAVAGE DC, 1977, ANNU REV MICROBIOL, V31, P107, DOI 10.1146/annurev.mi.31.100177.000543; SCHWAN A, 1983, LANCET, V2, P845; Schwartz M, 2013, AM J GASTROENTEROL, V108, P1367, DOI 10.1038/ajg.2013.164; Sha S, 2014, ALIMENT PHARM THER, V39, P1003, DOI 10.1111/apt.12699; Silverman MS, 2010, CLIN GASTROENTEROL H, V8, P471, DOI 10.1016/j.cgh.2010.01.007; Sun W, 2014, AM J GASTROENTEROL, V109, pS420, DOI 10.14309/00000434-201410002-01421; Surawicz CM, 2013, AM J GASTROENTEROL, V108, P478, DOI 10.1038/ajg.2013.4; Suskind DL, 2015, INFLAMM BOWEL DIS, V21, P556, DOI 10.1097/MIB.0000000000000307; Suskind DL, 2015, J PEDIATR GASTR NUTR, V60, P27, DOI 10.1097/MPG.0000000000000544; Tilg H, 2011, J CLIN INVEST, V121, P2126, DOI 10.1172/JCI58109; Tremaroli V, 2012, NATURE, V489, P242, DOI 10.1038/nature11552; Trubiano JA, 2013, EUR J GASTROEN HEPAT, V25, P255, DOI 10.1097/MEG.0b013e32835b2da9; van Nood E, 2013, NEW ENGL J MED, V368, P407, DOI 10.1056/NEJMoa1205037; Vandenplas Y, 2015, J PEDIATR GASTR NUTR, V61, pE12, DOI 10.1097/MPG.0000000000000281; Vermeire S, 2012, GASTROENTEROLOGY, V142, pS360; Vrieze A, 2012, GASTROENTEROLOGY, V143, P913, DOI 10.1053/j.gastro.2012.06.031; Wang M, 2013, J GASTROEN HEPATOL, V28, P590; Wilson D, 2014, AM J GASTROENTEROL, V109, pS207, DOI 10.14309/00000434-201410002-00714; Xu MQ, 2015, WORLD J GASTROENTERO, V21, P102, DOI 10.3748/wjg.v21.i1.102; Youngster I, 2014, JAMA-J AM MED ASSOC, V312, P1772, DOI 10.1001/jama.2014.13875; Zhang FM, 2013, WORLD J GASTROENTERO, V19, P7213, DOI 10.3748/wjg.v19.i41.7213; ZHANG FM, 2012, AM J GASTROENTEROL, V107, P1755, DOI DOI 10.1038/AJG.2012.251]	92	225	243	5	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2016	11	8							e0161174	10.1371/journal.pone.0161174	http://dx.doi.org/10.1371/journal.pone.0161174			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4UN	27529553	Green Submitted, gold, Green Published			2022-12-27	WOS:000381476700051
J	Zhang, XC; Brown, JC; Schmitz, KH				Zhang, Xiaochen; Brown, Justin C.; Schmitz, Kathryn H.			Association between Body Mass Index and Physical Function among Endometrial Cancer Survivors	PLOS ONE			English	Article							QUALITY-OF-LIFE; LOWER-EXTREMITY LYMPHEDEMA; LOWER-LIMB LYMPHEDEMA; EXERCISE; MORTALITY; DISABILITY; VALIDATION; COUNTRIES; STRENGTH; MOBILITY	Objectives We sought to quantify the relationship between body mass index (BMI) and physical function among endometrial cancer survivors. Understanding this relationship would help healthcare providers target efforts to refer obese endometrial cancer survivors to weight loss and exercise interventions. Methods We conducted a survey of 213 endometrial cancer survivors who received cancer care at an academic l health system between 2006 and 2010. Physical function subscale was quantified using physical functional component score from the SF-12 questionnaire. We compared physical function of endometrial cancer survivors to population-based age-standardized normative values. Results Among the 213 patients, 16% were normal weight (BMI <= 25 kg/m(2)), and 52% were obese (>= 30 kg/m(2)). Higher BMI categories were associated with lower physical function (P-trend = 0.003), as a continuous variable each 5kg/m(2) higher BMI, physical function score was lower by 0.15 points (beta = -0.15; P = 0.045). Compared to population-based age-standardized normative values, patients < 75yrs reported lower physical function, whereas patients >= 75yrs reported better physical function. BMI was the only covariate associated with differences in physical function between survivors and age-standardized normative values (P = 0.039). Conclusions Among endometrial cancer survivors, higher BMI is associated with lower physical function. Younger endometrial cancer survivors report lower physical function compared to age-standardized normative values. Healthcare providers should be aware that younger, obese endometrial cancer survivors may particularly benefit from interventions such as exercise and weight loss to increase or preserve physical function.	[Zhang, Xiaochen; Schmitz, Kathryn H.] Penn State Coll Med, Publ Hlth Sci, Hershey, PA USA; [Brown, Justin C.] Dana Farber Canc Inst, Dept Med Oncol, Div Populat Sci, Boston, MA 02115 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Harvard University; Dana-Farber Cancer Institute	Schmitz, KH (corresponding author), Penn State Coll Med, Publ Hlth Sci, Hershey, PA USA.	kschmitz@phs.psu.edu		Zhang, Xiaochen/0000-0003-3086-1285; Schmitz, Kathryn/0000-0003-2400-2935	NIH NCI [1U54CA155850-01]	NIH NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NIH NCI 1U54CA155850-01.	Alonso J, 2004, QUAL LIFE RES, V13, P283, DOI 10.1023/B:QURE.0000018472.46236.05; [Anonymous], 2015, SEER CANC STAT FACTS; Arem H, 2013, JNCI-J NATL CANCER I, V105, P342, DOI 10.1093/jnci/djs530; Bjorner JB, 2007, CURR MED RES OPIN, V23, P731, DOI 10.1185/030079907X178757; Brown JC, 2015, BRIT J CANCER, V112, P194, DOI 10.1038/bjc.2014.568; Brown JC, 2015, J CLIN ONCOL; Brown JC, 2016, J GERIATR ONCOL, V7, P108, DOI 10.1016/j.jgo.2016.01.009; Brown JC, 2014, SUPPORT CARE CANCER, V22, P3017, DOI 10.1007/s00520-014-2306-0; Brown JC, 2013, MED SCI SPORT EXER, V45, P2091, DOI 10.1249/MSS.0b013e318299afd4; Carter J, 2010, GYNECOL ONCOL, V117, P317, DOI 10.1016/j.ygyno.2010.01.022; Cesari M, 2008, BMC GERIATR, V8, P1, DOI DOI 10.1186/1471-2318-8-34; Cesari M, 2013, J GERONTOL A-BIOL, V68, P1129, DOI 10.1093/gerona/glt073; CHARLSON M, 1994, J CLIN EPIDEMIOL, V47, P1245, DOI 10.1016/0895-4356(94)90129-5; Courneya KS, 2003, MED SCI SPORT EXER, V35, P1846, DOI 10.1249/01.MSS.0000093622.41587.B6; Ferraro KF, 2002, AM J PUBLIC HEALTH, V92, P834, DOI 10.2105/AJPH.92.5.834; Gandek B, 1998, J CLIN EPIDEMIOL, V51, P1171, DOI 10.1016/S0895-4356(98)00109-7; Hall SA, 2011, AGING MALE, V14, P119, DOI 10.3109/13685538.2010.502267; Hammer SM, 2014, MED SCI SPORT EXER, V46, P2195, DOI 10.1249/MSS.0000000000000360; Hardy R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056483; Inouye SK, 1998, JAMA-J AM MED ASSOC, V279, P1187, DOI 10.1001/jama.279.15.1187; Johnson C, 2014, BMJ OPEN, V4, DOI [10.1136/bmjopen-2014-005561, 10.1136/bmjopen-2014-006629]; Jones LW, 2004, ANN BEHAV MED, V28, P105, DOI 10.1207/s15324796abm2802_5; Katz E, 2010, ARCH PHYS MED REHAB, V91, P1070, DOI 10.1016/j.apmr.2010.03.021; Li CR, 1999, MATURITAS, V31, P227, DOI 10.1016/S0378-5122(98)00106-6; Lin LL, 2014, INT J GYNECOL CANCER, V24, P1027, DOI 10.1097/IGC.0000000000000166; Pahor M, 2014, JAMA-J AM MED ASSOC, V311, P2387, DOI 10.1001/jama.2014.5616; Painter P, 1999, ADV RENAL REPLACE TH, V6, P110, DOI 10.1016/S1073-4449(99)70028-2; Park JH, 2015, CANCER; Petrick JL, 2014, J GERIATR ONCOL, V5, P359, DOI 10.1016/j.jgo.2014.06.002; Schmitz KH, 2005, CANCER EPIDEM BIOMAR, V14, P1588, DOI 10.1158/1055-9965.EPI-04-0703; Shin H, 2011, J AGING RES, DOI DOI 10.4061/2011/191896; Stafford RS, 1997, CANCER, V80, P1973, DOI 10.1002/(SICI)1097-0142(19971115)80:10<1973::AID-CNCR15>3.0.CO;2-V; Stenholm S, 2009, INT J OBESITY, V33, P635, DOI 10.1038/ijo.2009.62; Sutcliffe CG, 2015, CANCER CAUSE CONTROL, V26, P91, DOI 10.1007/s10552-014-0487-y; Sweeney C, 2006, JNCI-J NATL CANCER I, V98, P521, DOI 10.1093/jnci/djj130; US Cancer Statistics Working Group, 2014, US CANC STAT 1999 20; Villareal DT, 2011, NEW ENGL J MED, V364, P1218, DOI 10.1056/NEJMoa1008234; von Gruenigen V, 2012, GYNECOL ONCOL, V125, P699, DOI 10.1016/j.ygyno.2012.03.042; von Gruenigen VE, 2008, GYNECOL ONCOL, V109, P19, DOI 10.1016/j.ygyno.2007.12.026; Ware J, 1998, SF 12 SCORE SF 12 PH, P3; Woo J, 2007, OBESITY, V15, P1886, DOI 10.1038/oby.2007.223; Yabroff KR, 2004, JNCI-J NATL CANCER I, V96, P1322, DOI 10.1093/jnci/djh255; Zhang XC, 2015, GYNECOL ONCOL, V139, P155, DOI 10.1016/j.ygyno.2015.08.007; Zoico E, 2004, INT J OBESITY, V28, P234, DOI 10.1038/sj.ijo.0802552	44	7	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2016	11	8							e0160954	10.1371/journal.pone.0160954	http://dx.doi.org/10.1371/journal.pone.0160954			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4UN	27529546	gold, Green Submitted, Green Published			2022-12-27	WOS:000381476700033
J	Haubrock, M; Hartmann, F; Wingender, E				Haubrock, Martin; Hartmann, Fabian; Wingender, Edgar			NF-Y Binding Site Architecture Defines a C-Fos Targeted Promoter Class	PLOS ONE			English	Article							PIONEER TRANSCRIPTION FACTORS; CHROMATIN ACCESSIBILITY; REPETITIVE ELEMENTS; CANCER CELLS; GENOME; GENE; SPECIFICITY; DISCOVERY; REGIONS; TOOL	ChIP-seq experiments detect the chromatin occupancy of known transcription factors in a genome-wide fashion. The comparisons of several species-specific ChIP-seq libraries done for different transcription factors have revealed a complex combinatorial and contextspecific co-localization behavior for the identified binding regions. In this study we have investigated human derived ChIP-seq data to identify common cis-regulatory principles for the human transcription factor c-Fos. We found that in four different cell lines, c-Fos targeted proximal and distal genomic intervals show prevalences for either AP-1 motifs or CCAAT boxes as known binding motifs for the transcription factor NF-Y, and thereby act in a mutually exclusive manner. For proximal regions of co-localized c-Fos and NF-YB binding, we gathered evidence that a characteristic configuration of repeating CCAAT motifs may be responsible for attracting c-Fos, probably provided by a nearby AP-1 bound enhancer. Our results suggest a novel regulatory function of NF-Y in gene-proximal regions. Specific CCAAT dimer repeats bound by the transcription factor NF-Y define this novel cis-regulatory module. Based on this behavior we propose a new enhancer promoter interaction model based on AP-1 motif defined enhancers which interact with CCAATbox characterized promoter regions.	[Haubrock, Martin; Hartmann, Fabian; Wingender, Edgar] Univ Gottingen, Univ Med Ctr Gottingen UMG, Inst Bioinformat, Goldschmidtstr 1, D-37077 Gottingen, Germany	University of Gottingen	Haubrock, M (corresponding author), Univ Gottingen, Univ Med Ctr Gottingen UMG, Inst Bioinformat, Goldschmidtstr 1, D-37077 Gottingen, Germany.	mhaubro@uni-goettingen.de		Wingender, Edgar/0000-0002-7729-8453	German Research Foundation; Open Access Publication Funds of the Gottingen University	German Research Foundation(German Research Foundation (DFG)); Open Access Publication Funds of the Gottingen University	The authors acknowledge support by the German Research Foundation and the Open Access Publication Funds of the Gottingen University.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Bannister AJ, 2011, CELL RES, V21, P381, DOI 10.1038/cr.2011.22; Benatti P, 2016, BBA-MOL CELL RES, V1863, P673, DOI 10.1016/j.bbamcr.2015.12.019; Biddie SC, 2011, MOL CELL, V43, P145, DOI 10.1016/j.molcel.2011.06.016; Boyle AP, 2008, CELL, V132, P311, DOI 10.1016/j.cell.2007.12.014; Coss D, 2004, J BIOL CHEM, V279, P152, DOI 10.1074/jbc.M304697200; Dolfini D, 2013, CELL DEATH DIFFER, V20, P676, DOI 10.1038/cdd.2013.13; Dolfini D, 2016, NUCLEIC ACIDS RES, V44, P4684, DOI 10.1093/nar/gkw096; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Ernst J, 2012, NAT METHODS, V9, P215, DOI 10.1038/nmeth.1906; Faniello MC, 1999, J BIOL CHEM, V274, P7623, DOI 10.1074/jbc.274.12.7623; Faniello MC, 2002, BIOCHEM J, V363, P53, DOI 10.1042/0264-6021:3630053; Fleming JD, 2013, GENOME RES, V23, P1195, DOI 10.1101/gr.148080.112; Furumatsu T, 2010, INT J BIOCHEM CELL B, V42, P148, DOI 10.1016/j.biocel.2009.10.003; Gerstein MB, 2012, NATURE, V489, P91, DOI 10.1038/nature11245; Gurtner A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002047; Haubrock M, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-S2-S15; Hess J, 2004, J CELL SCI, V117, P5965, DOI 10.1242/jcs.01589; Hunt RW, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0412-4; Jolma A, 2015, NATURE, V527, P384, DOI 10.1038/nature15518; Jurka J, 2000, TRENDS GENET, V16, P418, DOI 10.1016/S0168-9525(00)02093-X; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; Kel AE, 2003, NUCLEIC ACIDS RES, V31, P3576, DOI 10.1093/nar/gkg585; Laajala TD, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-618; Lok CN, 2002, BIOCHEM J, V368, P741, DOI 10.1042/BJ20020791; Mantovani R, 1999, GENE, V239, P15, DOI 10.1016/S0378-1119(99)00368-6; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Mercer TR, 2013, GENOME RES, V23, P1081, DOI 10.1101/gr.156612.113; Mifsud B, 2015, NAT GENET, V47, P598, DOI 10.1038/ng.3286; Mullen AC, 2011, CELL, V147, P565, DOI 10.1016/j.cell.2011.08.050; Nardini M, 2013, CELL, V152, P132, DOI 10.1016/j.cell.2012.11.047; Neph S, 2012, NATURE, V489, P83, DOI 10.1038/nature11212; Oldfield AJ, 2014, MOL CELL, V55, P708, DOI 10.1016/j.molcel.2014.07.005; OSHEA EK, 1992, CELL, V68, P699, DOI 10.1016/0092-8674(92)90145-3; Preston GA, 2000, CELL DEATH DIFFER, V7, P215, DOI 10.1038/sj.cdd.4400637; R Development Core Team, 2008, R A LANGUAGE AND ENV; Robertson G, 2007, NAT METHODS, V4, P651, DOI 10.1038/NMETH1068; Sanders DA, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-1-r6; Sherwood RI, 2014, NAT BIOTECHNOL, V32, P171, DOI 10.1038/nbt.2798; Shi ZC, 2015, NUCLEIC ACIDS RES, V43, P6257, DOI 10.1093/nar/gkv568; Volkel S, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005102; Wang J, 2012, GENOME RES, V22, P1798, DOI 10.1101/gr.139105.112; Wingender E, 2008, BRIEF BIOINFORM, V9, P326, DOI 10.1093/bib/bbn016; Wingender E, 2015, NUCLEIC ACIDS RES, V43, pD97, DOI 10.1093/nar/gku1064; Xie D, 2013, CELL, V155, P713, DOI 10.1016/j.cell.2013.09.043; Zaret KS, 2011, GENE DEV, V25, P2227, DOI 10.1101/gad.176826.111	47	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2016	11	8							e0160803	10.1371/journal.pone.0160803	http://dx.doi.org/10.1371/journal.pone.0160803			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3LI	27517874	Green Published, Green Submitted, gold			2022-12-27	WOS:000381382100025
J	Javaheri, B; Hopkinson, M; Poulet, B; Pollard, AS; Shefelbine, SJ; Chang, YM; Francis-West, P; Bou-Gharios, G; Pitsillides, AA				Javaheri, Behzad; Hopkinson, Mark; Poulet, Blandine; Pollard, Andrea S.; Shefelbine, Sandra J.; Chang, Yu-Mei; Francis-West, Philippa; Bou-Gharios, George; Pitsillides, Andrew A.			Deficiency and Also Transgenic Overexpression of Timp-3 Both Lead to Compromised Bone Mass and Architecture In Vivo	PLOS ONE			English	Article							HYPERTROPHIC CHONDROCYTES UNDERGO; HUMAN TISSUE INHIBITOR; OSTEOBLAST-LIKE CELLS; EXTRACELLULAR-MATRIX; METALLOPROTEINASES-3 TIMP-3; MESENCHYMAL PROGENITORS; IMAGE-ANALYSIS; LONG BONES; DIFFERENTIATION; MICE	Tissue inhibitor of metalloproteinases-3 (TIMP-3) regulates extracellular matrix via its inhibition of matrix metalloproteinases and membrane-bound sheddases. Timp-3 is expressed at multiple sites of extensive tissue remodelling. This extends to bone where its role, however, remains largely unresolved. In this study, we have used Micro-CT to assess bone mass and architecture, histological and histochemical evaluation to characterise the skeletal phenotype of Timp-3 KO mice and have complemented this by also examining similar indices in mice harbouring a Timp-3 transgene driven via a Col-2a-driven promoter to specifically target overexpression to chondrocytes. Our data show that Timp-3 deficiency compromises tibial bone mass and structure in both cortical and trabecular compartments, with corresponding increases in osteoclasts. Transgenic overexpression also generates defects in tibial structure predominantly in the cortical bone along the entire shaft without significant increases in osteoclasts. These alterations in cortical mass significantly compromise predicted tibial load-bearing resistance to torsion in both genotypes. Neither Timp-3 KO nor transgenic mouse growth plates are significantly affected. The impact of Timp-3 deficiency and of transgenic overexpression extends to produce modification in craniofacial bones of both endochondral and intramembranous origins. These data indicate that the levels of Timp-3 are crucial in the attainment of functionally-appropriate bone mass and architecture and that this arises from chondrogenic and osteogenic lineages.	[Javaheri, Behzad; Hopkinson, Mark; Pollard, Andrea S.; Chang, Yu-Mei; Pitsillides, Andrew A.] Royal Vet Coll, Dept Comparat Biomed Sci, London, England; [Poulet, Blandine; Bou-Gharios, George] Univ Liverpool, Inst Ageing & Chron Dis, Liverpool, Merseyside, England; [Shefelbine, Sandra J.] Northeastern Univ, Dept Mech & Ind Engn, Boston, MA 02115 USA; [Francis-West, Philippa] Kings Coll London, Dept Craniofacial Dev & Stem Cell Biol, London, England	University of London; University of London Royal Veterinary College; University of Liverpool; Northeastern University; University of London; King's College London	Javaheri, B (corresponding author), Royal Vet Coll, Dept Comparat Biomed Sci, London, England.	bjavaheri@rvc.ac.uk	Javaheri, Behzad/L-5997-2018; Javaheri, Behzad/AAF-1784-2019; Francis-West, Philippa/AAR-5607-2020	Javaheri, Behzad/0000-0001-7941-3104; Javaheri, Behzad/0000-0001-7941-3104; Pollard, Andrea/0000-0001-7215-738X; Poulet, Blandine/0000-0002-9224-5253; Bou-Gharios, George/0000-0002-9563-9418; Hopkinson, Mark/0000-0002-9508-8652	BBSRC [BB/I014608/1]; Arthritis Research UK [20413, 20581, 20039]; Biotechnology and Biological Sciences Research Council [BB/I014608/1] Funding Source: researchfish; Versus Arthritis [20039, 20859, 20581] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Arthritis Research UK(Versus Arthritis); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Versus Arthritis(Versus Arthritis)	This study was supported by funding from the BBSRC BB/I014608/1 and Arthritis Research UK 20413, 20581 and 20039.	Amour A, 2000, FEBS LETT, V473, P275, DOI 10.1016/S0014-5793(00)01528-3; Amour A, 1998, FEBS LETT, V435, P39, DOI 10.1016/S0014-5793(98)01031-X; AnandApte B, 1996, BIOCHEM CELL BIOL, V74, P853, DOI 10.1139/o96-090; APTE SS, 1994, DEV DYNAM, V200, P177, DOI 10.1002/aja.1002000302; APTE SS, 1994, GENOMICS, V19, P86, DOI 10.1006/geno.1994.1016; BLAVIER L, 1995, J CELL SCI, V108, P3649; CANCEDDA FD, 1992, J CELL BIOL, V117, P427, DOI 10.1083/jcb.117.2.427; Carlos Fd, 2011, COMPUT TOMOGR, P169; Carlson B., 2004, HUMAN EMBRYOLOGY DEV, P527; Chai Y, 2006, DEV DYNAM, V235, P2353, DOI 10.1002/dvdy.20833; D'Souza RN, 2010, TOP BONE BIOL, V6, P153, DOI 10.1007/978-1-84882-822-3_10; Day TF, 2005, DEV CELL, V8, P739, DOI 10.1016/j.devcel.2005.03.016; Doube M, 2010, BONE, V47, P1076, DOI 10.1016/j.bone.2010.08.023; Edwards DR, 2008, MOL ASPECTS MED, V29, P258, DOI 10.1016/j.mam.2008.08.001; Engsig MT, 2000, J CELL BIOL, V151, P879, DOI 10.1083/jcb.151.4.879; Enishi T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104638; GALOTTO M, 1994, J BONE MINER RES, V9, P1239; GENTILI C, 1993, J CELL BIOL, V122, P703, DOI 10.1083/jcb.122.3.703; Geoffroy V, 2004, J BONE MINER RES, V19, P811, DOI 10.1359/JBMR.040119; Gomez DE, 1997, EUR J CELL BIOL, V74, P111; HALL BK, 1988, AM SCI, V76, P174; Hanken J, 1993, SKULL DEV; Hashimoto G, 2001, FEBS LETT, V494, P192, DOI 10.1016/S0014-5793(01)02323-7; Holmbeck K, 2003, J CELL BIOL, V163, P661, DOI 10.1083/jcb.200307061; Horton W. A., 1990, GROWTH GENET HORM, V6, P1; Inada M, 2004, P NATL ACAD SCI USA, V101, P17192, DOI 10.1073/pnas.0407788101; Inada M, 2001, J BONE MINER RES, V16, pS149; Inada M, 2002, J BONE MINER RES S1, V16; Jacobsen J, 2008, BIOCHEMISTRY-US, V47, P537, DOI 10.1021/bi701629c; Javaheri B, 2015, BONE, V81, P277, DOI 10.1016/j.bone.2015.07.035; Kashiwagi M, 2001, J BIOL CHEM, V276, P12501, DOI 10.1074/jbc.C000848200; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; KIRSCH T, 1992, DIFFERENTIATION, V52, P89, DOI 10.1111/j.1432-0436.1992.tb00503.x; Leco KJ, 2001, J CLIN INVEST, V108, P817, DOI 10.1172/JCI12067; LECO KJ, 1994, J BIOL CHEM, V269, P9352; Lee MH, 2007, J BIOL CHEM, V282, P6887, DOI 10.1074/jbc.M610490200; MOSKALEWSKI S, 1989, DEVELOPMENT, V107, P473; Murphy G, 2008, MOL ASPECTS MED, V29, P290, DOI 10.1016/j.mam.2008.05.002; Nagase H, 2008, THE CANC DEGRADOME, DOI [10.1007/978-0-387-69057-5_37, DOI 10.1007/978-0-387-69057-5_37]; Nah HD, 2000, J BONE MINER RES, V15, P522, DOI 10.1359/jbmr.2000.15.3.522; Nakajima H, 2010, BLOOD, V116, P4474, DOI 10.1182/blood-2010-01-266528; Noden DM, 2005, J ANAT, V207, P575, DOI 10.1111/j.1469-7580.2005.00473.x; Olafsdottir H, 2007, J ANAT, V211, P37, DOI 10.1111/j.1469-7580.2007.00751.x; Ono N, 2014, NAT CELL BIOL, V16, P1157, DOI 10.1038/ncb3067; Osteogenesis Gilbert S., DEV BIOL, V6; Park J, 2015, BIOL OPEN, V4, P608, DOI 10.1242/bio.201411031; PAVLOFF N, 1992, J BIOL CHEM, V267, P17321; Porter S, 2005, BIOCHEM J, V386, P15, DOI 10.1042/BJ20040424; Sahebjam S, 2007, ARTHRITIS RHEUM, V56, P905, DOI 10.1002/art.22427; Schiltz C, 2008, J CELL BIOCHEM, V104, P1803, DOI 10.1002/jcb.21747; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Serafini M, 2014, STEM CELL RES, V12, P659, DOI 10.1016/j.scr.2014.01.006; Shen Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013086; SILBERMANN M, 1983, ANAT REC, V206, P373, DOI 10.1002/ar.1092060404; StahleBackdahl M, 1997, LAB INVEST, V76, P717; Sternlicht MD, 2001, ANNU REV CELL DEV BI, V17, P463, DOI 10.1146/annurev.cellbio.17.1.463; Stickens D, 2004, DEVELOPMENT, V131, P5883, DOI 10.1242/dev.01461; Suzuki H, 2003, BIOSCI BIOTECH BIOCH, V67, P1737, DOI 10.1271/bbb.67.1737; Tesson L, 2002, TRANSGENIC RES, V11, P43, DOI 10.1023/A:1013928600442; THESINGH CW, 1991, BONE MINER, V12, P25, DOI 10.1016/0169-6009(91)90119-K; Van't Hof R, 2013, BONE, V05, P210; Wang WM, 2006, BIOCHEM J, V398, P515, DOI 10.1042/BJ20060630; Yang G, 2014, CELL RES, V24, P1266, DOI 10.1038/cr.2014.111; Yang L, 2014, P NATL ACAD SCI USA, V111, P12097, DOI 10.1073/pnas.1302703111; Yu WH, 2000, J BIOL CHEM, V275, P31226, DOI 10.1074/jbc.M000907200; Zeng Y, 1998, DEV DYNAM, V211, P228; Zhou X, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004820	67	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2016	11	8							e0159657	10.1371/journal.pone.0159657	http://dx.doi.org/10.1371/journal.pone.0159657			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3LI	27519049	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000381382100006
J	Park, J; Kobayashi, Y; Urayama, KY; Yamaura, H; Yatabe, Y; Hida, T				Park, Jangchul; Kobayashi, Yoshihisa; Urayama, Kevin Y.; Yamaura, Hidekazu; Yatabe, Yasushi; Hida, Toyoaki			Imaging Characteristics of Driver Mutations in EGFR, KRAS, and ALK among Treatment-Naive Patients with Advanced Lung Adenocarcinoma	PLOS ONE			English	Article							PULMONARY ADENOCARCINOMA; NEGATIVE ALK; CANCER; CHEMOTHERAPY; CRIZOTINIB; GEFITINIB; SURVIVAL; FEATURES; REARRANGEMENTS; ONCOGENE	This study aimed to identify the computed tomography characteristics of treatment-naive patients with lung adenocarcinoma and known driver mutations in EGFR, KRAS, or ALK. Patients with advanced lung adenocarcinoma (stage IIIB-IV) and known mutations in EGFR, KRAS, or ALK were assessed. The radiological findings for the main tumor and intra-thoracic status were retrospectively analyzed in each group, and the groups' characteristics were compared. We identified 265 treatment-naIve patients with non-small-cell carcinoma, who had EGFR mutations (n = 159), KRAS mutations (n = 55), or ALK rearrangements (n = 51). Among the three groups, we evaluated only patients with stage IIIB-IV lung adenocarcinoma who had EGFR mutations (n = 126), KRAS mutations (n = 35), or ALK rearrangements (n = 47). We found that ground-glass opacity at the main tumor was significantly more common among EGFR-positive patients, compared to ALK-positive patients (p = 0.009). Lymphadenopathy was significantly more common among ALK-positive patients, compared to EGFR-positive patients (p = 0.003). Extranodal invasion was significantly more common among ALK-positive patients, compared to EGFR-positive patients and KRAS-positive patients (p = 0.001 and p = 0.049, respectively). Lymphangitis was significantly more common among ALK-positive patients, compared to EGFR-positive patients (p = 0.049). Pleural effusion was significantly less common among KRAS-positive patients, compared to EGFRpositive patients and ALK-positive patients (p = 0.046 and p = 0.026, respectively). Lung metastases were significantly more common among EGFR-positive patients, compared to KRAS-positive patients and ALK-positive patients (p = 0.007 and p = 0.04, respectively). In conclusion, EGFR mutations were associated with ground-glass opacity, KRAS-positive tumors were generally solid and less likely to metastasize to the lung and pleura, and ALK-positive tumors tended to present with lymphadenopathy, extranodal invasion, and lymphangitis. These mutation-specific imaging characteristics may be related to the biological differences between these cancers.	[Park, Jangchul; Hida, Toyoaki] Aichi Canc Ctr Hosp, Dept Thorac Oncol, Nagoya, Aichi, Japan; [Park, Jangchul] Nagoya East City Med Ctr, Dept Resp Med, Nagoya, Aichi, Japan; [Kobayashi, Yoshihisa] Kinki Univ, Dept Thorac Surg, Fac Med, Osaka, Japan; [Urayama, Kevin Y.] Tokyo Med & Dent Univ, Dept Human Genet & Dis Div, Tokyo, Japan; [Yamaura, Hidekazu] Aichi Canc Ctr Hosp, Dept Diagnost & Intervent Radiol, Nagoya, Aichi, Japan; [Yatabe, Yasushi] Aichi Canc Ctr Hosp, Dept Pathol & Mol Diagnost, Nagoya, Aichi, Japan	Aichi Cancer Center; Kindai University (Kinki University); Tokyo Medical & Dental University (TMDU); Aichi Cancer Center	Park, J (corresponding author), Aichi Canc Ctr Hosp, Dept Thorac Oncol, Nagoya, Aichi, Japan.; Park, J (corresponding author), Nagoya East City Med Ctr, Dept Resp Med, Nagoya, Aichi, Japan.	samasama75@gmail.com	YATABE, Yasushi/J-6461-2014	YATABE, Yasushi/0000-0003-1788-559X; Kobayashi, Yoshihisa/0000-0003-2057-408X	National Cancer Center Research and Development Fund [23-A-18]; Health and Labour Sciences Research Grants for Clinical Research for Evidence-Based Medicine from the Ministry of Health, Labour, and Welfare of Japan	National Cancer Center Research and Development Fund(National Cancer Center - Japan); Health and Labour Sciences Research Grants for Clinical Research for Evidence-Based Medicine from the Ministry of Health, Labour, and Welfare of Japan	This study was supported by the National Cancer Center Research and Development Fund (23-A-18) and Health and Labour Sciences Research Grants for Clinical Research for Evidence-Based Medicine from the Ministry of Health, Labour, and Welfare of Japan.	Aerts HJWL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5006; Blons H, 2006, AM J SURG PATHOL, V30, P1309, DOI 10.1097/01.pas.0000213285.65907.31; Camidge DR, 2012, LANCET ONCOL, V13, P1011, DOI 10.1016/S1470-2045(12)70344-3; Choi H, 2013, LUNG CANCER, V79, P242, DOI 10.1016/j.lungcan.2012.11.021; Colen R, 2014, TRANSL ONCOL, V7, P556, DOI 10.1016/j.tranon.2014.07.007; Doebele RC, 2012, CANCER-AM CANCER SOC, V118, P4502, DOI 10.1002/cncr.27409; Enomoto Y, 2013, RESPIR INVESTIG, V51, P153, DOI 10.1016/j.resinv.2013.02.004; Fukui T, 2012, LUNG CANCER, V77, P319, DOI 10.1016/j.lungcan.2012.03.013; Halpenny DF, 2014, LUNG CANCER, V86, P190, DOI 10.1016/j.lungcan.2014.09.007; Hansell DM, 2008, RADIOLOGY, V246, P697, DOI 10.1148/radiol.2462070712; Hsu JS, 2014, J THORAC IMAG, V29, P357, DOI 10.1097/RTI.0000000000000116; Laack E, 2011, J THORAC ONCOL, V6, P199, DOI 10.1097/JTO.0b013e3181fb7cf1; Maemondo M, 2010, NEW ENGL J MED, V362, P2380, DOI 10.1056/NEJMoa0909530; Mitsudomi T, 2005, J CLIN ONCOL, V23, P2513, DOI 10.1200/JCO.2005.00.992; Mitsudomi T, 2013, NAT REV CLIN ONCOL, V10, P235, DOI 10.1038/nrclinonc.2013.22; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Paik PK, 2012, CANCER-AM CANCER SOC, V118, P5840, DOI 10.1002/cncr.27637; Pao W, 2011, LANCET ONCOL, V12, P175, DOI 10.1016/S1470-2045(10)70087-5; Park J, 2014, CANCER MED-US, V3, P118, DOI 10.1002/cam4.172; Ren SX, 2014, J THORAC ONCOL, V9, pE21, DOI 10.1097/JTO.0000000000000013; Rodig SJ, 2009, CLIN CANCER RES, V15, P5216, DOI 10.1158/1078-0432.CCR-09-0802; Sabri A, 2016, EUR RADIOL IN PRESS; Shaw AT, 2013, NEW ENGL J MED, V368, P2385, DOI 10.1056/NEJMoa1214886; Shaw AT, 2009, J CLIN ONCOL, V27, P4247, DOI 10.1200/JCO.2009.22.6993; Shin DY, 2014, J THORAC ONCOL, V9, P195, DOI 10.1097/JTO.0000000000000069; Solomon BJ, 2014, NEW ENGL J MED, V371, P2167, DOI [10.1056/NEJMoa1408440, 10.1056/NEJMx150034]; Sun JM, 2012, J THORAC ONCOL, V7, pE36, DOI 10.1097/JTO.0b013e318274694e; Yang JCH, 2015, LANCET ONCOL, V16, P141, DOI 10.1016/S1470-2045(14)71173-8; Yano M, 2006, J THORAC ONCOL, V1, P413, DOI 10.1097/01243894-200606000-00006; Yatabe Y, 2006, J MOL DIAGN, V8, P335, DOI 10.2353/jmoldx.2006.050104; Zhou CC, 2011, LANCET ONCOL, V12, P735, DOI 10.1016/S1470-2045(11)70184-X	31	32	36	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2016	11	8							e0161081	10.1371/journal.pone.0161081	http://dx.doi.org/10.1371/journal.pone.0161081			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3LI	27518729	Green Published, Green Submitted, gold			2022-12-27	WOS:000381382100045
J	Porciello, G; Daum, MM; Menghini, C; Brugger, P; Lenggenhager, B				Porciello, Giuseppina; Daum, Moritz M.; Menghini, Cristina; Brugger, Peter; Lenggenhager, Bigna			Not That Heart-Stopping After All: Visuo-Cardiac Synchrony Does Not Boost Self-Face Attribution	PLOS ONE			English	Article							MULTISENSORY STIMULATION; BODY OWNERSHIP; HAND; SKIN; SENSE; POWER; FEEL; PART	Recent experimental evidence and theoretical models suggest that an integration of exteroceptive and interoceptive signals underlies several key aspects of the bodily self. While it has been shown that self-attribution of both the hand and the full-body are altered by conflicting extero-exteroceptive (e.g. visuo-tactile) and extero-interoceptive (e.g. visuo-cardiac) information, no study has thus far investigated whether self-attribution of the face might be altered by visuo-cardiac stimulation similarly to visuo-tactile stimulation. In three independent groups of participants we presented ambiguous (i.e. morphed with a stranger's face) self-faces flashing synchronously or asynchronously with the participants' heartbeat. We then measured the subjective percentages of self-face attribution of morphed stimuli. To control for a potential effect of visuo-cardiac synchrony on familiarity, a task assessing the attribution of a familiar face was introduced. Moreover, different durations of visuo-cardiac flashing and different degrees of asynchronicity were used. Based on previous studies showing that synchronous visuo-cardiac stimulation generally increases self-attribution of the full-body and the hand, and that synchronous visuo-tactile stimulation increases self-face attribution, we predicted higher self-face attribution during the synchronous visuo-cardiac flashing of the morphed stimuli. In contrast to this hypothesis, the results showed no difference between synchronous and asynchronous stimulation on self-face attribution in any of the three studies. We thus conclude that visuo-cardiac synchrony does not boost self-attribution of the face as it does that of hand and full-body.	[Porciello, Giuseppina] Sapienza Univ Rome, Dept Psychol, Rome, Italy; [Porciello, Giuseppina] Santa Lucia Fdn, IRCCS, Social & Cognit Neurosci Lab, Rome, Italy; [Daum, Moritz M.] Univ Zurich, Dept Psychol, Zurich, Switzerland; [Porciello, Giuseppina; Menghini, Cristina; Brugger, Peter; Lenggenhager, Bigna] Univ Zurich Hosp, Dept Neurol, Zurich, Switzerland; [Brugger, Peter; Lenggenhager, Bigna] Univ Zurich, Inst Physiol, Zurich, Switzerland; [Brugger, Peter; Lenggenhager, Bigna] Univ Zurich, Zurich Ctr Integrat Human Physiol ZIHP, Zurich, Switzerland	Sapienza University Rome; IRCCS Santa Lucia; University of Zurich; University of Zurich; University Zurich Hospital; University of Zurich; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP)	Porciello, G (corresponding author), Sapienza Univ Rome, Dept Psychol, Rome, Italy.; Porciello, G (corresponding author), Santa Lucia Fdn, IRCCS, Social & Cognit Neurosci Lab, Rome, Italy.; Porciello, G; Lenggenhager, B (corresponding author), Univ Zurich Hosp, Dept Neurol, Zurich, Switzerland.; Lenggenhager, B (corresponding author), Univ Zurich, Inst Physiol, Zurich, Switzerland.; Lenggenhager, B (corresponding author), Univ Zurich, Zurich Ctr Integrat Human Physiol ZIHP, Zurich, Switzerland.	giuseppina.porciello@uniroma1.it; bigna.lenggenhager@gmail.com	Daum, Moritz/A-1441-2013; Porciello, Giuseppina/K-3460-2018	Daum, Moritz/0000-0002-4032-4574; Lenggenhager, Bigna/0000-0003-0418-9931; Porciello, Giuseppina/0000-0001-8374-5320	Swiss National Science Foundation [142601]; FENS (NENS Exchange Grant); Progetto di Avvio alla Ricerca, 'Sapienza' University of Rome [C26N148WH2]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); FENS (NENS Exchange Grant); Progetto di Avvio alla Ricerca, 'Sapienza' University of Rome	BL was funded by the Swiss National Science Foundation (grant # 142601). GP was funded by FENS (NENS Exchange Grant) and by Progetto di Avvio alla Ricerca 2014, 'Sapienza' University of Rome (Prot. Num. C26N148WH2).	Apps MAJ, 2013, CEREB CORTEX, V1; Armel K, 2003, P R SOC L B, V270; Aspell JE, 2013, PSYCHOL SCI, V24, P2445, DOI 10.1177/0956797613498395; Barnsley N, 2011, CURR BIOL, V21, pR945, DOI 10.1016/j.cub.2011.10.039; Barton JJS, 2008, J NEUROPSYCHOL, V2, P197, DOI 10.1348/174866407X214172; Blanke O, 2015, NEURON, V88, P145, DOI 10.1016/j.neuron.2015.09.029; Botvinick M, 1998, NATURE, V391, P756, DOI 10.1038/35784; Brugger P, 2014, CURR OPIN NEUROL, V27, P644, DOI 10.1097/WCO.0000000000000151; Bufalari I, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00102; Cardini F, 2013, J EXP PSYCHOL HUMAN, V44, DOI [10.1037/a0031049.It, DOI 10.1037/A0031049.IT]; Cohen J.E., 1988, STAT POWER ANAL BEHA; Craig AD, 2002, NAT REV NEUROSCI, V3, P655, DOI 10.1038/nrn894; Damasio Antonio, 2010, SELF COMES MIND CONS; Dienes Z, 2015, J MATH PSYCHOL ELSEV, P1, DOI [10.1007/s13398-014-0173-7.2, DOI 10.1007/S13398-014-0173-7.2]; Dienes Z, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00781; Ehrsson HH, 2004, SCIENCE, V305, P875, DOI 10.1126/science.1097011; Estudillo AJ, 2016, CONSCIOUS COGN, V42, P325, DOI 10.1016/j.concog.2016.04.006; Farmer H, 2012, CONSCIOUS COGN, V21, P1242, DOI 10.1016/j.concog.2012.04.011; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Feinberg T, 2005, LOST SELF PATHOLOGIE; Garfinkel SN, 2016, TRENDS COGN SCI, V20, P34, DOI 10.1016/j.tics.2015.10.005; Garfinkel SN, 2015, BIOL PSYCHOL, V104, P65, DOI 10.1016/j.biopsycho.2014.11.004; Ionta S, 2011, NEURON, V70, P363, DOI 10.1016/j.neuron.2011.03.009; Jeffreys H., 1961, THEORY PROBABILITY; Kanwisher N, 2011, OXFORD HDB FACE PERC, P111, DOI DOI 10.1093/OXFORDHB/9780199559053.013.0007; Lenggenhager B, 2007, SCIENCE, V317, P1096, DOI 10.1126/science.1143439; Lenggenhager B, 2015, NEUROPSYCHOLOGY, V29, P205, DOI 10.1037/neu0000143; Limanowski J., 2011, PSYCHOLOGY, V2, P312, DOI DOI 10.4236/PSYCH.2011.24049; Love J, 2015, JASP VERSION 0 6 6 C; Mehling WE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048230; Michel C, 2014, PERCEPTION, V43, P818, DOI 10.1068/p7733; Moseley GL, 2008, P NATL ACAD SCI USA, V105, P13169, DOI 10.1073/pnas.0803768105; Paladino MP, 2010, PSYCHOL SCI, V21, P1202, DOI 10.1177/0956797610379234; Peck TC, 2013, CONSCIOUS COGN, V22, P779, DOI 10.1016/j.concog.2013.04.016; Petkova VI, 2011, CURR BIOL, V21, P1118, DOI 10.1016/j.cub.2011.05.022; Porciello G, 2014, SCI REP-UK, V4, DOI 10.1038/srep06669; Ronchi R, 2015, NEUROPSYCHOLOGIA, V70, P11, DOI 10.1016/j.neuropsychologia.2015.02.010; SCHANDRY R, 1981, PSYCHOPHYSIOLOGY, V18, P483, DOI 10.1111/j.1469-8986.1981.tb02486.x; Seth AK, 2013, TRENDS COGN SCI, V17, P565, DOI 10.1016/j.tics.2013.09.007; Sforza A, 2010, SOC NEUROSCI-UK, V5, P148, DOI 10.1080/17470910903205503; Suzuki K, 2013, NEUROPSYCHOLOGIA, V51, P2909, DOI 10.1016/j.neuropsychologia.2013.08.014; Tajadura-Jimenez A, 2014, J EXP PSYCHOL GEN, V143, P736, DOI 10.1037/a0033171; Tajadura-Jimenez A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040682; Tieri G, 2015, SCI REP-UK, V5, DOI 10.1038/srep17139; Tsakiris M, 2007, CEREB CORTEX, V17, P2235, DOI 10.1093/cercor/bhl131; Tsakiris M, 2011, P ROY SOC B-BIOL SCI, V278, P2470, DOI 10.1098/rspb.2010.2547; Tsakiris M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004040	47	8	8	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2016	11	8							e0160498	10.1371/journal.pone.0160498	http://dx.doi.org/10.1371/journal.pone.0160498			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DT6UQ	27541587	Green Published, gold, Green Accepted			2022-12-27	WOS:000381620200004
J	Ben-Shachar, S; Yanai, H; Horev, HS; Elad, H; Baram, L; Issakov, O; Tulchinsky, H; Pasmanik-Chor, M; Shomron, N; Dotan, I				Ben-Shachar, Shay; Yanai, Henit; Horev, Hadas Sherman; Elad, Hofit; Baram, Liran; Issakov, Ofer; Tulchinsky, Hagit; Pasmanik-Chor, Metsada; Shomron, Noam; Dotan, Iris			MicroRNAs Expression in the Ileal Pouch of Patients with Ulcerative Colitis Is Robustly Up-Regulated and Correlates with Disease Phenotypes	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; QUALITY-OF-LIFE; RESTORATIVE PROCTOCOLECTOMY; ANAL ANASTOMOSIS; CROHNS-DISEASE; BIOMARKERS; EXPERIENCE; RESERVOIR; TARGETS; CELLS	Background Gene expression alterations are associated with disease behavior in inflammatory bowel disease (IBD). microRNAs (miRNAs) are dominant in the regulation of gene expression, and may affect IBD phenotype. Our aim was to assess mucosal miRNA expression in IBD and the correlation with intestinal inflammation. Methods We performed a large-scale analysis of ileal mucosal miRNA. Biopsies were retrieved from patients with ileal Crohn's disease (CD), unoperated ulcerative colitis (UC) patients, UC patients after pouch surgery, and normal controls (NC). Pouch UC patients were classified as having a normal pouch (NP), chronic pouchitis (CP), and Crohn's-like disease of the pouch (CLDP). miRNA expression was analyzed by parallel massive (next-generation) sequencing (NGS). Bioinformatics tools were applied for clustering and the detection of potential targets. Results Sixty-one subjects were recruited. The ileum of unoperated UC patients was comparable with NC. There were significant miRNA expression alterations (fold change >= 2, corrected P <=.05) in NP (n = 6), CP (n = 40) and CLDP (n = 139), but only two expression alterations were noted in CD. More than 90% of the altered miRNAs were up-regulated, and many were predicted to be associated with significantly decreased transcripts. miRNAs alterations were generally clustered with disease phenotypes. Conclusions Ileal inflammation causes increased miRNA expression. miRNA alterations correlate with IBD phenotype, apparently by controlling the down-regulation of specific mRNAs.	[Ben-Shachar, Shay] Tel Aviv Med Ctr & Sch Med, Genet Inst, Tel Aviv, Israel; [Yanai, Henit; Horev, Hadas Sherman; Elad, Hofit; Baram, Liran; Dotan, Iris] Tel Aviv Med Ctr & Sch Med, Dept Gastroenterol & Liver Dis, IBD Ctr, Tel Aviv, Israel; [Ben-Shachar, Shay; Yanai, Henit; Baram, Liran; Issakov, Ofer; Tulchinsky, Hagit; Shomron, Noam; Dotan, Iris] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel; [Tulchinsky, Hagit] Tel Aviv Med Ctr & Sch Med, Div Surg, Colorectal Unit, Tel Aviv, Israel; [Pasmanik-Chor, Metsada] Tel Aviv Univ, GSW Fac Life Sci, Bioinformat Unit, Tel Aviv, Israel	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University	Dotan, I (corresponding author), Tel Aviv Med Ctr & Sch Med, Dept Gastroenterol & Liver Dis, IBD Ctr, Tel Aviv, Israel.; Dotan, I (corresponding author), Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel.	irisd@tlvmc.gov.il			Leona M. and Harry B. Helmsley Charitable Trust [2015PG-ISL020]	Leona M. and Harry B. Helmsley Charitable Trust	This study was supported by a generous grant from the Leona M. and Harry B. Helmsley Charitable Trust, under Iris Dotan (PI) fund #2015PG-ISL020. No additional funding sources of support (either external or internal) were used.	Allison J, 2008, CLIN GASTROENTEROL H, V6, P999, DOI 10.1016/j.cgh.2008.05.022; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Ben-Shachar S, 2013, INFLAMM BOWEL DIS, V19, P2509, DOI 10.1097/01.MIB.0000437045.26036.00; Brain O, 2013, IMMUNITY, V39, P521, DOI 10.1016/j.immuni.2013.08.035; Chapman CG, 2015, THER ADV GASTROENTER, V8, P4, DOI 10.1177/1756283X14547360; Chuang AY, 2014, INFLAMM BOWEL DIS, V20, P126, DOI 10.1097/01.MIB.0000436954.70596.9b; Coskun M, 2013, WORLD J GASTROENTERO, V19, P4289, DOI 10.3748/wjg.v19.i27.4289; DOZOIS RR, 1986, INT J COLORECTAL DIS, V1, P2, DOI 10.1007/BF01648830; Esteller M, 2011, NAT REV GENET, V12, P861, DOI 10.1038/nrg3074; Fasseu M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013160; Fazio VW, 1999, ANN SURG, V230, P575, DOI 10.1097/00000658-199910000-00013; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Hubenthal M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140155; Hulsen T, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-488; Hurst RD, 1996, ARCH SURG-CHICAGO, V131, P497; Lin JM, 2014, MODERN PATHOL, V27, P602, DOI 10.1038/modpathol.2013.152; Lin JM, 2013, MODERN PATHOL, V26, P148, DOI 10.1038/modpathol.2012.131; Mahadevan U, 2003, GASTROENTEROLOGY, V124, P1636, DOI 10.1016/S0016-5085(03)00325-1; Maselli V, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-457; Meagher AP, 1998, BRIT J SURG, V85, P800; MELVILLE DM, 1994, GUT, V35, P1076, DOI 10.1136/gut.35.8.1076; Michelassi F, 2003, ANN SURG, V238, P433, DOI 10.1097/01.sla.0000086658.60555.ea; Peck BCE, 2015, INFLAMM BOWEL DIS, V21, P2178, DOI 10.1097/MIB.0000000000000478; Penna C, 1996, GUT, V38, P234, DOI 10.1136/gut.38.2.234; SANDBORN WJ, 1994, MAYO CLIN PROC, V69, P409, DOI 10.1016/S0025-6196(12)61634-6; Schaefer JS, 2015, BMC IMMUNOL, V16, DOI 10.1186/s12865-015-0069-0; Shen B, 2005, AM J GASTROENTEROL, V100, P2796, DOI 10.1111/j.1572-0241.2005.00278.x; Stahlberg D, 1996, DIS COLON RECTUM, V39, P1012, DOI 10.1007/BF02054692; Stocchi L, 2001, GASTROENTEROL CLIN N, V30, P223, DOI 10.1016/S0889-8553(05)70175-8; Tulchinsky H, 2003, ANN SURG, V238, P229, DOI 10.1097/01.sla.0000082121.84763.4c; Tulchinsky H, 2008, INFLAMM BOWEL DIS, V14, P1125, DOI 10.1002/ibd.20430; Tulchinsky H, 2010, DIS COLON RECTUM, V53, P866, DOI 10.1007/DCR.0b013e3181d98d66; WEXNER SD, 1990, AM J SURG, V159, P178, DOI 10.1016/S0002-9610(05)80625-7; Wheeler JMD, 2005, DIS COLON RECTUM, V48, P946, DOI 10.1007/s10350-004-0885-4; Wu F, 2008, GASTROENTEROLOGY, V135, P1624, DOI 10.1053/j.gastro.2008.07.068; Wu F, 2010, INFLAMM BOWEL DIS, V16, P1729, DOI 10.1002/ibd.21267; Xue XC, 2011, J IMMUNOL, V187, P5879, DOI 10.4049/jimmunol.1100535; Yanai H, 2015, GUT, V64, P756, DOI 10.1136/gutjnl-2014-307387	39	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0159956	10.1371/journal.pone.0159956	http://dx.doi.org/10.1371/journal.pone.0159956			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27536783	Green Published, Green Submitted, gold			2022-12-27	WOS:000381577000010
J	Rasmussen, JJ; Selmer, C; Ostergren, PB; Pedersen, KB; Schou, M; Gustafsson, F; Faber, J; Juul, A; Kistorp, C				Rasmussen, Jon Jarlov; Selmer, Christian; Ostergren, Peter Busch; Pedersen, Karen Boje; Schou, Morten; Gustafsson, Finn; Faber, Jens; Juul, Anders; Kistorp, Caroline			Former Abusers of Anabolic Androgenic Steroids Exhibit Decreased Testosterone Levels and Hypogonadal Symptoms Years after Cessation: A Case-Control Study	PLOS ONE			English	Article							SERUM INHIBIN-B; HORMONE-BINDING GLOBULIN; YOUNG MEN; SEMEN PARAMETERS; SENSITIVITY TEST; REFERENCE RANGES; BLOOD; REVERSIBILITY; CONSEQUENCES; BODYBUILDERS	Aims Abuse of anabolic androgenic steroids (AAS) is highly prevalent among male recreational athletes. The objective of this study was to investigate the impact of AAS abuse on reproductive hormone levels and symptoms suggestive of hypogonadism in current and former AAS abusers. Methods This study had a cross-sectional case-control design and involved 37 current AAS abusers, 33 former AAS abusers (mean (95% CI) elapsed duration since AAS cessation: 2.5 (1.7; 3.7) years) and 30 healthy control participants. All participants were aged 18-50 years and were involved in recreational strength training. Reproductive hormones (FSH, LH, testosterone, inhibin B and anti-Mullerian hormone (AMH)) were measured using morning blood samples. Symptoms of hypogonadism (depressive symptoms, fatigue, decreased libido and erectile dysfunction) were recorded systematically. Results Former AAS abusers exhibited significantly lower median (25th - 75th percentiles) total and free testosterone levels than control participants (total testosterone: 14.4 (11.9-17.7) nmol/l vs. 18.8 (16.6-22.0) nmol/l) (P < 0.01). Overall, 27.2%(13.3; 45.5) of former AAS abusers exhibited plasma total testosterone levels below the lower reference limit (12.1 nmol/l) whereas no control participants exhibited testosterone below this limit (P < 0.01). Gonadotropins were significantly suppressed, and inhibin B and AMH were significantly decreased in current AAS abusers compared with former AAS abusers and control participants (P < 0.01). The group of former AAS abusers had higher proportions of participants with depressive symptoms ((24.2%) (11.1; 42.2)), erectile dysfunction ((27.3%) (13.3; 45.6)) and decreased libido ((40.1%) (23.2; 57.0)) than the other two groups (trend analyses: P < 0.05). Conclusions Former AAS abusers exhibited significantly lower plasma testosterone levels and higher frequencies of symptoms suggestive of hypogonadism than healthy control participants years after AAS cessation. Current AAS abusers exhibited severely decreased AMH and inhibin B indicative of impaired spermatogenesis.	[Rasmussen, Jon Jarlov; Selmer, Christian; Faber, Jens; Kistorp, Caroline] Copenhagen Univ Hosp, Dept Internal Med, Herlev, Denmark; [Ostergren, Peter Busch] Copenhagen Univ Hosp, Dept Urol, Herlev, Denmark; [Pedersen, Karen Boje] Copenhagen Univ Hosp, Dept Internal Med, Slagelse, Denmark; [Schou, Morten] Copenhagen Univ Hosp, Dept Cardiol, Herlev, Denmark; [Schou, Morten] Copenhagen Univ Hosp, Dept Cardiol, Gentofte, Denmark; [Gustafsson, Finn] Rigshosp, Dept Cardiol, Ctr Heart, Copenhagen, Denmark; [Juul, Anders] Univ Copenhagen, Rigshosp, Dept Growth & Reprod, DK-1168 Copenhagen, Denmark	University of Copenhagen; University of Copenhagen; University of Copenhagen; University of Copenhagen; University of Copenhagen; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen	Rasmussen, JJ (corresponding author), Copenhagen Univ Hosp, Dept Internal Med, Herlev, Denmark.	jon.ras@dadlnet.dk	Østergren, Peter/AAR-2794-2020; Selmer, Christian/H-3314-2019; Rasmussen, Jon/H-6357-2019; Juul, Anders/F-5864-2013	Selmer, Christian/0000-0002-0534-3163; Rasmussen, Jon/0000-0003-2898-1771; Juul, Anders/0000-0002-0534-4350; Gustafsson, Finn/0000-0003-2144-341X; Ostergren, Peter Busch/0000-0003-4762-039X; Kistorp, Caroline/0000-0002-3019-6775	AntiDoping Denmark; Research Foundation of Herlev Hospital; Danish Heart Foundation [15-R99-A5797-22952]; University of Copenhagen	AntiDoping Denmark; Research Foundation of Herlev Hospital; Danish Heart Foundation; University of Copenhagen	Funded by AntiDoping Denmark (no specific grant number, URL: http://www.antidoping.dk/), Research Foundation of Herlev Hospital (no specific grant number, URL: https://www.herlevhospital.dk/), Danish Heart Foundation (grant number: 15-R99-A5797-22952, URL: https://www.hjerteforeningen.dk/), and Faculty Scholarship from University of Copenhagen to JJR (no specific grant number, URL: http://sund.ku.dk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksglaede L, 2010, J CLIN ENDOCR METAB, V95, P5357, DOI 10.1210/jc.2010-1207; Allison PD, 2012, HANDLING MISSING DAT, DOI [10.1016/j.drugalcdep.2010.01.011, DOI 10.1016/J.DRUGALCDEP.2010.01.011]; Barbotin AL, 2015, EUR J ENDOCRINOL, V172, P669, DOI 10.1530/EJE-14-0932; Barthel A, 2010, CLIN J SPORT MED, V20, P117, DOI 10.1097/JSM.0b013e3181d235ae; BARTSCH W, 1980, MATURITAS, V2, P109, DOI 10.1016/0378-5122(80)90044-4; Beck AT, 1996, MANUAL FOR THE BECK; Bhasin S, 2011, J CLIN ENDOCR METAB, V96, P2430, DOI 10.1210/jc.2010-3012; Bjorner JB, 1998, J CLIN EPIDEMIOL, V51, P1001, DOI 10.1016/S0895-4356(98)00092-4; Boregowda K, 2011, FERTIL STERIL, V96, pE7, DOI 10.1016/j.fertnstert.2011.04.029; Coward RM, 2013, J UROLOGY, V190, P2200, DOI 10.1016/j.juro.2013.06.010; Gazvani MR, 1997, HUM REPROD, V12, P1706, DOI 10.1093/humrep/12.8.1706; Hart RJ, 2015, HUM REPROD, V30, P2713, DOI 10.1093/humrep/dev244; Hengevoss J, 2015, J STEROID BIOCHEM, V150, P86, DOI 10.1016/j.jsbmb.2015.03.003; JAROW JP, 1990, AM J SPORT MED, V18, P429, DOI 10.1177/036354659001800417; Jorgensen N, 2010, FERTIL STERIL, V94, P2128, DOI 10.1016/j.fertnstert.2009.12.051; Kanayama G, 2015, ADDICTION, V110, P823, DOI 10.1111/add.12850; Kanayama G, 2010, DRUG ALCOHOL DEPEN, V109, P6, DOI 10.1016/j.drugalcdep.2010.01.011; Kelsey TW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109346; KNUTH UA, 1989, FERTIL STERIL, V52, P1041; Krause A, 2004, EXP CLIN ENDOCR DIAB, V112, P236, DOI 10.1055/s-2004-817969; Lloyd F H, 1996, BMJ, V313, P100; Nieschlag E, 2015, EUR J ENDOCRINOL, V173, pR47, DOI 10.1530/EJE-15-0080; Parkinson AB, 2006, MED SCI SPORT EXER, V38, P644, DOI 10.1249/01.mss.0000210194.56834.5d; Pope HG, 2014, ENDOCR REV, V35, P341, DOI 10.1210/er.2013-1058; Pope HG, 2000, ARCH GEN PSYCHIAT, V57, P133, DOI 10.1001/archpsyc.57.2.133; Rahnema CD, 2014, FERTIL STERIL, V101, P1271, DOI 10.1016/j.fertnstert.2014.02.002; Rosen RC, 1999, INT J IMPOT RES, V11, P319, DOI 10.1038/sj.ijir.3900472; Sagoe D, 2014, ANN EPIDEMIOL, V24, P383, DOI 10.1016/j.annepidem.2014.01.009; Sakamoto H, 2007, UROLOGY, V69, P152, DOI 10.1016/j.urology.2006.09.012; Schmidt PJ, 2004, ARCH GEN PSYCHIAT, V61, P997, DOI 10.1001/archpsyc.61.10.997; Sikaris K, 2005, J CLIN ENDOCR METAB, V90, P5928, DOI 10.1210/jc.2005-0962; SINNECKER G, 1989, J CLIN ENDOCR METAB, V68, P1195, DOI 10.1210/jcem-68-6-1195; Tan RS, 2009, MED HYPOTHESES, V72, P723, DOI 10.1016/j.mehy.2008.12.042; Torres-Calleja J, 2000, FERTIL STERIL, V74, P1055, DOI 10.1016/S0015-0282(00)01557-0; TUREK PJ, 1995, J UROLOGY, V153, P1628, DOI 10.1016/S0022-5347(01)67482-2; Urhausen A, 2003, J STEROID BIOCHEM, V84, P369, DOI 10.1016/S0960-0760(03)00105-5; van Breda E, 2003, INT J SPORTS MED, V24, P195, DOI 10.1055/s-2003-39089; Wikberg Carl, 2015, Prim Care Companion CNS Disord, V17, DOI 10.4088/PCC.14m01758	38	73	74	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2016	11	8							e0161208	10.1371/journal.pone.0161208	http://dx.doi.org/10.1371/journal.pone.0161208			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4YN	27532478	Green Published, gold, Green Submitted			2022-12-27	WOS:000381487600075
J	Dong, H; Liu, WM; Liu, MX; Xu, LQ; Li, Q; Zhang, R; Zhang, X; Liu, SG				Dong, He; Liu, Wenmiao; Liu, Meixin; Xu, Longqiang; Li, Qiang; Zhang, Ru; Zhang, Xin; Liu, Shiguo			Investigation of a Possible Role for the Histidine Decarboxylase Gene in Tourette Syndrome in the Chinese Han Population: A Family-Based Study	PLOS ONE			English	Article							EXPRESSION; ASSOCIATION	Tourette syndrome (TS) is a polygenic neuropsychiatric disease. Previous studies have indicated that dysregulation in the histaminergic system may play a crucial role in disease onset. In this study, we investigated the role of the histidine decarboxylase gene (HDC) in TS susceptibility in the Chinese Han population. After genotyping 241 TS nuclear families trios, we analyzed three tag HDC single nucleotide polymorphisms (rs854150, rs854151, and rs854157) in a family-based study using the transmission disequilibrium test (TDT) and haplotype relative risk (HRR). TDT showed no over-transmission in these SNPs across the HDC region (for rs854150: chi(2) = 0.472, P = 0.537, OR = 1.097, 95% CI = 0.738-1.630; for rs854151: chi(2) = 0.043, P = 0.889, OR = 1.145, 95% CI = 0.767-1.709; for rs854157: chi(2) = 0.984, P = 0.367, OR = 1.020, 95% CI = 0.508-2.049). HRR also showed the same tendency (for rs854150: chi(2) = 0.211, P = 0.646, OR = 1.088, 95% CI = 0.7591.559; for rs854151: chi(2) = 0.134, P = 0.714, OR = 0.935, 95% CI = 0.653-1.339; for rs854157: chi(2) = 0.841, P = 0.359, OR = 1.206, 95% CI = 0.808-1.799). Additionally, the haplo-type-based haplotype relative risk showed a negative association. Although these findings indicate an unlikely association between HDC and TS in the Chinese Han population, a potential role for HDC cannot be ruled out in TS etiology. Future research should investigate this more thoroughly using different populations and larger samples.	[Dong, He] Qingdao Univ, Affiliated Hosp, Dept Anesthesiol, Qingdao, Peoples R China; [Liu, Wenmiao; Zhang, Ru; Liu, Shiguo] Qingdao Univ, Affiliated Hosp, Prenatal Diag Ctr, Qingdao, Peoples R China; [Liu, Meixin] Qingdao Univ, Affiliated Hosp, Dept Cardiac Ultrasound, Qingdao, Peoples R China; [Xu, Longqiang] Qingdao Univ, Affiliated Hosp, Dept Clin Lab, Qingdao, Peoples R China; [Li, Qiang] Qingdao Univ, Affiliated Hosp, Dept Androl, Qingdao, Peoples R China; [Zhang, Xin] Qingdao Univ, Affiliated Hosp, Dept Resp Med, Qingdao, Peoples R China; [Liu, Shiguo] Qingdao Univ, Affiliated Hosp, Genet Lab, Qingdao, Peoples R China	Qingdao University; Qingdao University; Qingdao University; Qingdao University; Qingdao University; Qingdao University; Qingdao University	Liu, SG (corresponding author), Qingdao Univ, Affiliated Hosp, Prenatal Diag Ctr, Qingdao, Peoples R China.; Zhang, X (corresponding author), Qingdao Univ, Affiliated Hosp, Dept Resp Med, Qingdao, Peoples R China.; Liu, SG (corresponding author), Qingdao Univ, Affiliated Hosp, Genet Lab, Qingdao, Peoples R China.	zxshj@126.com; liushiguo2002@126.com			National Natural Science Foundation of China [81371499, 30971586]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (81371499 and 30971586). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank all participants for their involvement in our study. This work was supported by the National Natural Science Foundation of China (81371499 and 30971586).	Baldan LC, 2014, NEURON, V81, P77, DOI 10.1016/j.neuron.2013.10.052; Bloch M, 2011, CURR OPIN NEUROL, V24, P119, DOI 10.1097/WCO.0b013e328344648c; Conelea CA, 2008, J PSYCHOSOM RES, V65, P487, DOI 10.1016/j.jpsychores.2008.04.010; Dere E, 2003, LEARN MEMORY, V10, P510, DOI 10.1101/lm.67603; Ercan-Sencicek AG, 2010, NEW ENGL J MED, V362, P1901, DOI 10.1056/NEJMoa0907006; Felling RJ, 2011, J NEUROSCI, V31, P12387, DOI 10.1523/JNEUROSCI.0150-11.2011; Fernandez TV, 2012, BIOL PSYCHIAT, V71, P392, DOI 10.1016/j.biopsych.2011.09.034; Huertas-Fernandez I, 2015, MOVEMENT DISORD, V30, P1115, DOI 10.1002/mds.26279; HYDE TM, 1992, NEUROLOGY, V42, P652, DOI 10.1212/WNL.42.3.652; Karagiannidis I, 2013, J MED GENET, V50, P760, DOI 10.1136/jmedgenet-2013-101637; Leckman JF, 2006, J CHILD NEUROL, V21, P642, DOI 10.1177/08830738060210081001; Lei J, 2012, AM J MED GENET B, V159B, P72, DOI 10.1002/ajmg.b.32003; Liao IH, 2010, PHARMACOGENOMICS, V11, P1733, DOI 10.2217/PGS.10.160; Martino D, 2009, MOVEMENT DISORD, V24, P1267, DOI 10.1002/mds.22504; Ohtsu H, 2001, FEBS LETT, V502, P53, DOI 10.1016/S0014-5793(01)02663-1; Passani MB, 2011, TRENDS PHARMACOL SCI, V32, P242, DOI 10.1016/j.tips.2011.01.003; Rapanelli M, 2015, NEUROPHARMACOLOGY; Robertson MM, 2000, BRAIN, V123, P425, DOI 10.1093/brain/123.3.425; Shan L, 2015, TRENDS NEUROSCI, V38, P167, DOI 10.1016/j.tins.2014.12.008; Shprecher DR, 2014, CURR OPIN NEUROL, V27, P484, DOI 10.1097/WCO.0000000000000119; Sowell ER, 2008, NAT NEUROSCI, V11, P637, DOI 10.1038/nn.2121; Suzuki-Ishigaki S, 2000, NUCLEIC ACIDS RES, V28, P2627, DOI 10.1093/nar/28.14.2627; Wang LL, 2011, GENOMICS, V98, P1, DOI 10.1016/j.ygeno.2011.04.006	23	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2016	11	8							e0160265	10.1371/journal.pone.0160265	http://dx.doi.org/10.1371/journal.pone.0160265			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4UN	27529419	Green Submitted, gold, Green Published			2022-12-27	WOS:000381476700004
J	Haralambieva, IH; Zimmermann, MT; Ovsyannikova, IG; Grill, DE; Oberg, AL; Kennedy, RB; Poland, GA				Haralambieva, Iana H.; Zimmermann, Michael T.; Ovsyannikova, Inna G.; Grill, Diane E.; Oberg, Ann L.; Kennedy, Richard B.; Poland, Gregory A.			Whole Transcriptome Profiling Identifies CD93 and Other Plasma Cell Survival Factor Genes Associated with Measles-Specific Antibody Response after Vaccination	PLOS ONE			English	Article							SYSTEMS BIOLOGY APPROACH; RNA-SEQ; INTERACTION NETWORKS; SEASONAL INFLUENZA; IMMUNE-RESPONSE; POLYMORPHISMS; RECEPTOR; PERSISTENCE; INDIVIDUALS; VACCINOMICS	Background There are insufficient system-wide transcriptomic (or other) data that help explain the observed inter-individual variability in antibody titers after measles vaccination in otherwise healthy individuals. Methods We performed a transcriptome(mRNA-Seq)-profiling study after in vitro viral stimulation of PBMCs from 30 measles vaccine recipients, selected from a cohort of 764 schoolchildren, based on the highest and lowest antibody titers. We used regression and network biology modeling to define markers associated with neutralizing antibody response. Results We identified 39 differentially expressed genes that demonstrate significant differences between the high and low antibody responder groups (p-value <= 0.0002, q-value <= 0.092), including the top gene CD93 (p<1.0E(-13), q<1.0E(-09)), encoding a receptor required for antigen-driven B-cell differentiation, maintenance of immunoglobulin production and preservation of plasma cells in the bone marrow. Network biology modeling highlighted plasma cell survival (CD93, IL6, CXCL12), chemokine/cytokine activity and cell-cell communication/adhesion/ migration as biological processes associated with the observed differential response in the two responder groups. Conclusion We identified genes and pathways that explain in part, and are associated with, neutralizing antibody titers after measles vaccination. This new knowledge could assist in the identification of biomarkers and predictive signatures of protective immunity that may be useful in the design of new vaccine candidates and in clinical studies.	[Haralambieva, Iana H.; Ovsyannikova, Inna G.; Kennedy, Richard B.; Poland, Gregory A.] Mayo Clin & Mayo Fdn, Mayo Clin, Vaccine Res Grp, Dept Med, Rochester, MN USA; [Zimmermann, Michael T.; Grill, Diane E.; Oberg, Ann L.] Mayo Clin & Mayo Fdn, Div Biomed Stat & Informat, Dept Hlth Sci Res, Rochester, MN USA	Mayo Clinic; Mayo Clinic	Poland, GA (corresponding author), Mayo Clin & Mayo Fdn, Mayo Clin, Vaccine Res Grp, Dept Med, Rochester, MN USA.	poland.gregory@mayo.edu		Zimmermann, Michael/0000-0001-7073-0525; Kennedy, Rick/0000-0001-6164-4967	NIH [R37AI048793-11, R01AI033144]; National Institute of Aging [R01 AG034676]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI048793, R01AI033144] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG034676] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by NIH grants R37AI048793-11, R01AI033144 and was made possible by the Rochester Epidemiology Project (Grant Number R01 AG034676 from the National Institute of Aging). Its contents are solely the responsibility of the authors and do not necessarily represent the official view of NCRR or NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the Mayo Clinic Vaccine Research Group staff and the study participants. We thank Caroline L. Vitse for her editorial assistance with this manuscript and Nathaniel D. Warner for his programming assistance and contribution to statistical analysis. This work was supported by NIH grants R37AI048793-11, R01AI033144 and was made possible by the Rochester Epidemiology Project (Grant Number R01 AG034676 from the National Institute of Aging). Its contents are solely the responsibility of the authors and do not necessarily represent the official view of NCRR or NIH.	Amanna IJ, 2007, NEW ENGL J MED, V357, P1903, DOI 10.1056/NEJMoa066092; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Centers for Disease Control and Prevention (CDC), 2011, MMWR Morb Mortal Wkly Rep, V60, P1605; Chevrier S, 2009, P NATL ACAD SCI USA, V106, P3895, DOI 10.1073/pnas.0809736106; Dhiman N, 2005, HUM IMMUNOL, V66, P1125, DOI 10.1016/j.humimm.2005.10.002; Fiebelkorn AP, 2010, J INFECT DIS, V202, P1520, DOI 10.1086/656914; Fridley BL, 2013, SCI REP-UK, V3, DOI 10.1038/srep02898; Getahun A, 2012, J IMMUNOL, V189, P2965, DOI 10.4049/jimmunol.1201407; Hansen KD, 2012, BIOSTATISTICS, V13, P204, DOI 10.1093/biostatistics/kxr054; Haralambieva IH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062149; Haralambieva IH, 2011, VACCINE, V29, P8988, DOI 10.1016/j.vaccine.2011.09.043; Haralambieva IH, 2011, VACCINE, V29, P7883, DOI 10.1016/j.vaccine.2011.08.083; Haralambieva IH, 2011, VACCINE, V29, P4485, DOI 10.1016/j.vaccine.2011.04.037; Haralambieva IH, 2010, FUTURE MICROBIOL, V5, P1757, DOI [10.2217/fmb.10.146, 10.2217/FMB.10.146]; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Karsten CM, 2010, NAT IMMUNOL, V11, P775, DOI 10.1038/ni0910-775; Kennedy RB, 2013, GENES IMMUN, V14, P277, DOI 10.1038/gene.2013.14; Kennedy RB, 2012, VACCINE, V30, P2159, DOI 10.1016/j.vaccine.2012.01.025; Lambert ND, 2012, EXPERT REV VACCINES, V11, P985, DOI [10.1586/erv.12.61, 10.1586/ERV.12.61]; Lee I, 2011, GENOME RES, V21, P1109, DOI 10.1101/gr.118992.110; Maarof G, 2010, BLOOD, V115, P1718, DOI 10.1182/blood-2009-05-220251; Mocellin S, 2003, TRENDS IMMUNOL, V24, P36, DOI 10.1016/S1471-4906(02)00009-1; Nakaya HI, 2011, NAT IMMUNOL, V12, P786, DOI 10.1038/ni.2067; Nelder McCullagh, 1989, GEN LINEAR MODELS; Oberg AL, 2012, BMC GENOMICS, V13, P2, DOI 10.1186/1471-2164-13-304; Oberg AL, 2011, CURR OPIN IMMUNOL, V23, P436, DOI 10.1016/j.coi.2011.04.005; Obermoser G, 2013, IMMUNITY, V38, P831, DOI 10.1016/j.immuni.2012.12.008; Ovsyannikova IG, 2011, HUM HERED, V72, P206, DOI 10.1159/000331585; Painter SD, 2015, VACCINE, V33, P4422, DOI 10.1016/j.vaccine.2015.06.101; Poland GA, 2011, OMICS, V15, P625, DOI 10.1089/omi.2011.0032; Prasad TSK, 2009, METHODS MOL BIOL, V577, P67, DOI 10.1007/978-1-60761-232-2_6; Querec TD, 2009, NAT IMMUNOL, V10, P116, DOI 10.1038/ni.1688; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Radbruch A, 2006, NAT REV IMMUNOL, V6, P741, DOI 10.1038/nri1886; Rhee SY, 2008, NAT REV GENET, V9, P509, DOI 10.1038/nrg2363; Rolland T, 2014, CELL, V159, P1212, DOI 10.1016/j.cell.2014.10.050; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Team RDC, 2019, R LANG ENV STAT COMP; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Whitaker JA, 2014, VACCINE, V32, P4703, DOI 10.1016/j.vaccine.2014.06.088; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248; Zhang MY, 2005, IMMUNOLOGY, V115, P63, DOI 10.1111/j.1365-2567.2005.02120.x; Zilliox MJ, 2007, CLIN VACCINE IMMUNOL, V14, P918, DOI 10.1128/CVI.00031-07; Zilliox MJ, 2006, P NATL ACAD SCI USA, V103, P3363, DOI 10.1073/pnas.0511345103	48	16	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2016	11	8							e0160970	10.1371/journal.pone.0160970	http://dx.doi.org/10.1371/journal.pone.0160970			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4UN	27529750	gold, Green Published, Green Submitted			2022-12-27	WOS:000381476700036
J	Billeskov, R; Tan, EV; Cang, M; Abalos, RM; Burgos, J; Pedersen, BV; Christensen, D; Agger, EM; Andersen, P				Billeskov, Rolf; Tan, Esterlina V.; Cang, Marjorie; Abalos, Rodolfo M.; Burgos, Jasmin; Pedersen, Bo Vestergaard; Christensen, Dennis; Agger, Else Marie; Andersen, Peter			Testing the H56 Vaccine Delivered in 4 Different Adjuvants as a BCG-Booster in a Non-Human Primate Model of Tuberculosis	PLOS ONE			English	Article							BACILLUS-CALMETTE-GUERIN; T-CELL RESPONSES; MYCOBACTERIUM-TUBERCULOSIS; PROTECTIVE IMMUNITY; CYNOMOLGUS MACAQUES; INTERFERON-GAMMA; RHESUS MACAQUES; INFECTION; MEMORY; FREQUENCY	The search for new and improved tuberculosis (TB) vaccines has focused on IFN-gamma both for selecting antigens and for evaluating vaccine delivery strategies. The essential role of IFN-gamma in endogenous host protection is well established, but it is still uncertain whether this also holds true for vaccine protection. Here we evaluate the H56 fusion protein vaccine as a BCG booster in a non-human primate (NHP) model of TB that closely recapitulates human TB pathogenesis. To date, only a handful of novel adjuvants have been tested in the NHP model of TB, and therefore we administered H56 in 3 novel cationic liposome adjuvants of increasing immunogenicity (CAF01, CAF04, CAF05) and compared them to H56 in the IC31 (R) adjuvant previously reported to promote protection in this model. The individual clinical parameters monitored during infection (weight, ESR, X-ray) all correlated with survival, and boosting BCG with H56 in all adjuvants resulted in better survival rates compared to BCG alone. The adjuvants promoted IFN-gamma responses of increasing intensity as measured by ELISPOT in the peripheral blood, but the level of vaccine-specific IFN-gamma production did not correlate with or predict disease outcome. This study's main outcome underscores the importance of the choice of adjuvant for TB subunit vaccines, and secondly it highlights the need for better correlates of protection in preclinical models of TB.	[Billeskov, Rolf; Christensen, Dennis; Agger, Else Marie; Andersen, Peter] Statens Serum Inst, Dept Infect Dis Immunol, Copenhagen, Denmark; [Billeskov, Rolf] NCI, Vaccine Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Tan, Esterlina V.; Cang, Marjorie; Abalos, Rodolfo M.; Burgos, Jasmin] Leonard Wood Mem LWM Ctr Leprosy Res, Cebu, Philippines; [Pedersen, Bo Vestergaard] Statens Serum Inst, Dept Epidemiol Res, Copenhagen, Denmark	Statens Serum Institut; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Statens Serum Institut	Billeskov, R; Andersen, P (corresponding author), Statens Serum Inst, Dept Infect Dis Immunol, Copenhagen, Denmark.; Billeskov, R (corresponding author), NCI, Vaccine Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	rob@ssi.dk; pa@ssi.dk	Christensen, Dennis/C-6378-2008	Christensen, Dennis/0000-0003-2382-8639; Andersen, Peter/0000-0002-5869-2551; Billeskov, Rolf/0000-0003-4533-7304	European Commission [FP7-HEALTH-2011.1.4-4-280873]; National Institutes of Health [AI 105422]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI105422] Funding Source: NIH RePORTER	European Commission(European CommissionEuropean Commission Joint Research Centre); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The parts of this work that was performed at the SSI was funded by the European Commission [contract number FP7-HEALTH-2011.1.4-4-280873 (ADITEC)], and National Institutes of Health [grant number AI 105422]. The funders had no role in design of studies or preparation of the manuscript.	Aagaard C, 2011, NAT MED, V17, P189, DOI 10.1038/nm.2285; Aagaard C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005930; Andersen CAS, 2009, J IMMUNOL, V183, P2294, DOI 10.4049/jimmunol.0804091; Andersen CS, 2009, J IMMUNOL, V182, P424, DOI 10.4049/jimmunol.182.1.424; Andersen P, 2000, INFECT IMMUN, V68, P621, DOI 10.1128/IAI.68.2.621-629.2000; Andersen P, 2014, TRENDS IMMUNOL, V35, P387, DOI 10.1016/j.it.2014.04.006; Andersen P, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a018523; Billeskov R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072185; Davidsen J, 2005, BBA-BIOMEMBRANES, V1718, P22, DOI 10.1016/j.bbamem.2005.10.011; FLYNN JL, 1993, J EXP MED, V178, P2249, DOI 10.1084/jem.178.6.2249; Gallegos AM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002052; Gideon HP, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004603; Hailemichael Y, 2013, NAT MED, V19, P465, DOI 10.1038/nm.3105; Hansen J, 2012, CANCER IMMUNOL IMMUN, V61, P893, DOI 10.1007/s00262-011-1156-6; Henriksen-Lacey M, 2010, J CONTROL RELEASE, V142, P180, DOI 10.1016/j.jconrel.2009.10.022; Hervas-Stubbs S, 2006, INFECT IMMUN, V74, P3396, DOI 10.1128/IAI.02086-05; Kagina BMN, 2010, AM J RESP CRIT CARE, V182, P1073, DOI 10.1164/rccm.201003-0334OC; Kaufmann SHE, 2014, LANCET RESP MED, V2, P301, DOI 10.1016/S2213-2600(14)70033-5; Kaushal D, 2012, J MED PRIMATOL, V41, P191, DOI 10.1111/j.1600-0684.2012.00536.x; Langermans JAM, 2001, P NATL ACAD SCI USA, V98, P11497, DOI 10.1073/pnas.201404898; Lin PL, 2006, INFECT IMMUN, V74, P3790, DOI 10.1128/IAI.00064-06; Lin PL, 2014, NAT MED, V20, P75, DOI 10.1038/nm.3412; Lin PL, 2012, J CLIN INVEST, V122, P303, DOI 10.1172/JCI46252; Lin PL, 2009, INFECT IMMUN, V77, P4631, DOI 10.1128/IAI.00592-09; Lindenstrom T, 2013, J IMMUNOL, V190, P6311, DOI 10.4049/jimmunol.1300248; Lindenstrom T, 2009, J IMMUNOL, V182, P8047, DOI 10.4049/jimmunol.0801592; Logan KE, 2005, VACCINE, V23, P5526, DOI 10.1016/j.vaccine.2005.07.037; Mittrucker HW, 2007, P NATL ACAD SCI USA, V104, P12434, DOI 10.1073/pnas.0703510104; Ndiaye BP, 2015, LANCET RESP MED, V3, P190, DOI 10.1016/S2213-2600(15)00037-5; Nordly P, 2011, J CONTROL RELEASE, V150, P307, DOI 10.1016/j.jconrel.2010.11.021; Nordly P, 2011, EUR J PHARM BIOPHARM, V77, P89, DOI 10.1016/j.ejpb.2010.10.001; Nunes-Alves C, 2014, NAT REV MICROBIOL, V12, P289, DOI 10.1038/nrmicro3230; Orr MT, 2015, J INFECT DIS, V212, P495, DOI 10.1093/infdis/jiv055; Pena JC, 2015, INFECT IMMUN, V83, P852, DOI 10.1128/IAI.02850-14; Sakai S, 2014, J IMMUNOL, V192, P2965, DOI 10.4049/jimmunol.1400019; Seder RA, 2008, NAT REV IMMUNOL, V8, P247, DOI 10.1038/nri2274; Sharpe SA, 2010, CLIN VACCINE IMMUNOL, V17, P1170, DOI 10.1128/CVI.00079-10; Tameris MD, 2013, LANCET, V381, P1021, DOI 10.1016/S0140-6736(13)60177-4; Hoang T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080579; Verreck FAW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005264; Vordermeier HM, 2009, INFECT IMMUN, V77, P3364, DOI 10.1128/IAI.00287-09; Walsh GP, 1996, NAT MED, V2, P430, DOI 10.1038/nm0496-430; Yu H, 2012, INFECT IMMUN, V80, P1510, DOI 10.1128/IAI.06338-11	43	24	27	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2016	11	8							e0161217	10.1371/journal.pone.0161217	http://dx.doi.org/10.1371/journal.pone.0161217			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4SL	27525651	Green Published, gold, Green Submitted			2022-12-27	WOS:000381471100043
J	Bourgi, K; Brar, I; Baker-Genaw, K				Bourgi, Kassem; Brar, Indira; Baker-Genaw, Kimberly			Health Disparities in Hepatitis C Screening and Linkage to Care at an Integrated Health System in Southeast Michigan	PLOS ONE			English	Article							VIRUS-INFECTION; INTERVENTION; ADULTS; RACE	With recommended screening for hepatitis C among the 1945-1965 birth cohort and advent of novel highly effective therapies, little is known about health disparities in the Hepatitis C care cascade. Our objective was to evaluate hepatitis C screening rates and linkage to care, among patients who test positive, at our large integrated health system. We used electronic medical records to retrospectively identify patients, in the birth cohort, who were seen in 21 Internal Medicine clinics from July 2014 to June 2015. Patients previously screened for hepatitis C and those with established disease were excluded. We studied patients' sociodemographic and medical conditions along with provider-specific factors associated with likelihood of screening. Patients who tested positive for HCV antibody were reviewed to assess appropriate linkage to care and treatment. Of 40,561 patients who met inclusion criteria, 21.3% (8657) were screened, 1.3% (109) tested positive, and 30% (30/100) completed treatment. Multivariate logistic regression showed that African American race, male gender, electronic health engagement, residency teaching clinic visit, and having more than one clinic visit were associated with higher odds of screening. Patients had a significant decrease in the likelihood of screening with sequential interval increase in their Charlson comorbidity index. When evaluating hepatitis C treatment in patients who screened positive, electronic health engagement was associated with higher odds of treatment whereas Medicaid insurance was associated with significantly lower odds. This study shows that hepatitis C screening rates and linkage to care continue to be suboptimal with a significant impact of multiple sociodemographic and insurance factors. Electronic health engagement emerges as a tool in linking patients to the hepatitis C care cascade.	[Bourgi, Kassem; Baker-Genaw, Kimberly] Henry Ford Hosp, Dept Internal Med, Detroit, MI 48202 USA; [Brar, Indira] Henry Ford Hosp, Div Infect Dis, Detroit, MI 48202 USA	Henry Ford Health System; Henry Ford Hospital; Henry Ford Health System; Henry Ford Hospital	Bourgi, K (corresponding author), Henry Ford Hosp, Dept Internal Med, Detroit, MI 48202 USA.	kbourgi@aol.com	Bourgi, Kassem/I-8590-2017	Bourgi, Kassem/0000-0001-9734-7489	Gilead Sciences; Janssen Pharmaceutica; ViiV Healthcare	Gilead Sciences(Gilead Sciences); Janssen Pharmaceutica(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); ViiV Healthcare	The authors have read the journal's policy and the authors of this manuscript have the following competing interests: Dr. Kassem Bourgi and Dr. Kimberly Baker-Genaw have no conflicts of interest. Dr. Indira Brar has served as a speaker, advisory board member and received research funding from Gilead Sciences. Dr. Brar has served as a speaker and received research funding from Janssen Pharmaceutica. She has also received research funding from ViiV Healthcare. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	Armstrong GL, 2006, ANN INTERN MED, V144, P705, DOI 10.7326/0003-4819-144-10-200605160-00004; Assoumou SA, 2014, OPEN FORUM INFECT DI, V1, DOI 10.1093/ofid/ofu009; Barua S, 2015, ANN INTERN MED, V163, P215, DOI 10.7326/M15-0406; Benhamou PY, 2011, DIABETES METAB, V37, pS53, DOI 10.1016/S1262-3636(11)70966-1; Cahill JE, 2014, J NEURO-ONCOL, V117, P1, DOI 10.1007/s11060-013-1333-x; Celona AF, 2004, CLIN GASTROENTEROL H, V2, P459, DOI 10.1016/S1542-3565(04)00160-0; Chak E, 2011, LIVER INT, V31, P1090, DOI 10.1111/j.1478-3231.2011.02494.x; Chung RT, 2015, HEPATOLOGY, V62, P932, DOI 10.1002/hep.27950; Conjeevaram HS, 2006, GASTROENTEROLOGY, V131, P470, DOI 10.1053/j.gastro.2006.06.008; Denniston MM, 2014, ANN INTERN MED, V160, P293, DOI 10.7326/M13-1133; Fleckenstein Jaquelyn, 2004, Curr Gastroenterol Rep, V6, P66, DOI 10.1007/s11894-004-0028-z; Forde KA, 2014, CLIN GASTROENTEROL H, V12, P738, DOI 10.1016/j.cgh.2013.06.006; Hagan LM, 2013, TRENDS MICROBIOL, V21, P625, DOI 10.1016/j.tim.2013.09.008; Hanafiah KM, 2013, HEPATOLOGY, V57, P1333, DOI 10.1002/hep.26141; Hirsch AA, 2014, JT COMM J QUAL PATIE, V40, P351, DOI 10.1016/S1553-7250(14)40046-1; Holmberg SD, 2013, NEW ENGL J MED, V368, P1859, DOI 10.1056/NEJMp1302973; Irizarry T, 2015, J MED INTERNET RES, V17, DOI 10.2196/jmir.4255; Keeling MJ, 2005, J R SOC INTERFACE, V2, P295, DOI 10.1098/rsif.2005.0051; Klevens RM, 2009, EMERG INFECT DIS, V15, P1499, DOI 10.3201/eid1509.081050; Linas BP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097317; Linas BP, 2014, AM J MED, V127, P398, DOI 10.1016/j.amjmed.2014.01.012; Lo Re V, 2015, HEPATOLOGY, V62, p1382A; Loy V, 2015, HEPATOLOGY, V62, p789A; Medland NA, 2015, J INT AIDS SOC, V18, DOI 10.7448/IAS.18.1.20634; Melia MT, 2011, HEPATOLOGY, V54, P70, DOI 10.1002/hep.24358; Meyer JP, 2015, INT J DRUG POLICY, V26, P922, DOI 10.1016/j.drugpo.2015.05.002; Moorman AC, 2013, CLIN INFECT DIS, V56, P40, DOI 10.1093/cid/cis815; Moyer VA, 2013, ANN INTERN MED, V159, P349, DOI 10.7326/0003-4819-159-5-201309030-00672; Omland Lars Haukali, 2013, Clin Epidemiol, V5, P163, DOI 10.2147/CLEP.S43926; Pyrsopoulos Nikolaos, 2005, Clin Liver Dis, V9, P427, DOI 10.1016/j.cld.2005.05.005; Roblin DW, 2011, AM J MANAG CARE, V17, P548; Roumia M, 2014, CURR CARDIOL REP, V16, DOI 10.1007/s11886-013-0451-6; Saab S, 2014, AM J GASTROENTEROL, V109, P1576, DOI 10.1038/ajg.2014.243; Sidlow R, 2015, J HEALTHC QUAL, V37, P319, DOI 10.1097/JHQ.0000000000000010; Smith Bryce D., 2012, Morbidity and Mortality Weekly Report, V61, P1; Spradling PR, 2012, CLIN INFECT DIS, V55, P1047, DOI 10.1093/cid/cis616; Thomas B, 2011, ADV CHRONIC KIDNEY D, V18, P406, DOI 10.1053/j.ackd.2011.10.005; Trooskin SB, 2007, WORLD J GASTROENTERO, V13, P1074, DOI 10.3748/wjg.v13.i7.1074; Turner BJ, 2015, J HOSP MED, V10, P510, DOI 10.1002/jhm.2376; Vallet-Pichard A, 2007, HEPATOLOGY, V46, P32, DOI 10.1002/hep.21669	40	42	42	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2016	11	8							e0161241	10.1371/journal.pone.0161241	http://dx.doi.org/10.1371/journal.pone.0161241			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4SL	27525983	Green Published, gold, Green Submitted			2022-12-27	WOS:000381471100046
J	Campbell, ML				Campbell, Marnie L.			Burial Duration and Frequency Influences Resilience of Differing Propagule Types in a Subtidal Seagrass, Posidonia australis	PLOS ONE			English	Article							EELGRASS ZOSTERA-MARINA; CYMODOCEA-NODOSA; THALASSIA-TESTUDINUM; WESTERN-AUSTRALIA; SEDIMENT BURIAL; CLONAL INTEGRATION; GROWTH-RESPONSE; VERTICAL GROWTH; RESTORATION; IMPACT	Sedimentation that leads to periodic, and often prolonged, burial events is becomingmore common on the world's coastlines as human populations expand and create urbanised marine environments. Different seagrass species react differently to sediment burial but many species in the southern hemisphere are yet to be examined. How seagrasses react to burial has restoration implications. There is a need to critically assess seagrass transplant propagule responses to periodic (pulse) and prolonged (press) burial events before selecting the most appropriate species, transplant propagule, and transplant site. In my study, mesocosm experiments, coupled with field measurements were used to assess how sexual (seedlings) and vegetative (sprigs) propagules of Posidonia australis responded to pulse and press burial events. Seedlings were highly susceptible to burial (both pulse and press), with no survival at the end of the experimental period. In contrast, rhizome growth in vegetative propagules was stimulated by pulse burial, although press burial events resulted inmortality. The implication for Posidonia australis restoration efforts in areas where burial is periodic, was that vegetative propagules are optimal transplant units, in comparison to seedlings. Press burial however, renders a transplant site sub-optimal for both seedling and sprig transplants.	[Campbell, Marnie L.] Murdoch Univ, Sch Biol & Environm Sci, Perth, WA, Australia; [Campbell, Marnie L.] Univ Waikato, Environm Res Inst, Hamilton, Waikato, New Zealand	Murdoch University; University of Waikato	Campbell, ML (corresponding author), Murdoch Univ, Sch Biol & Environm Sci, Perth, WA, Australia.; Campbell, ML (corresponding author), Univ Waikato, Environm Res Inst, Hamilton, Waikato, New Zealand.	mcampbel@waikato.ac.nz		Campbell, Marnie/0000-0002-8716-0036	Cockburn Cement Limited; Great Barrier Reef Marine Park Authority	Cockburn Cement Limited; Great Barrier Reef Marine Park Authority	Cockburn Cement Limited and the Great Barrier Reef Marine Park Authority provided financial support for this research. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was conducted in part from funding from Cockburn Cement Limited and the Great Barrier Reef Marine Park Authority. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abelson A, 2016, BIOSCIENCE, V66, P156, DOI 10.1093/biosci/biv171; Balestri E, 2014, RESTOR ECOL, V22, P240, DOI 10.1111/rec.12052; BENDER EA, 1984, ECOLOGY, V65, P1, DOI 10.2307/1939452; Bos AR, 2007, ESTUAR COAST SHELF S, V74, P344, DOI 10.1016/j.ecss.2007.04.006; Cabaco S, 2008, ESTUAR COAST SHELF S, V79, P354, DOI 10.1016/j.ecss.2008.04.021; Cabaco S, 2007, J EXP MAR BIOL ECOL, V340, P204, DOI 10.1016/j.jembe.2006.09.003; Calumpong HP, 2001, GLOBAL SEAGRASS RESEARCH METHODS, P425, DOI 10.1016/B978-044450891-1/50023-2; Campbell M.L., 2000, THESIS; Campbell ML, 2002, B MAR SCI, V71, P1405; Campbell ML, 2003, MAR POLLUT BULL, V46, P828, DOI 10.1016/S0025-326X(03)00093-6; Campbell ML, 2003, AQUAT BOT, V76, P175, DOI 10.1016/S0304-3770(03)00016-0; Campbell ML, 2010, SEAGRASS RESTORATION; Celdran D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130015; Cunha AH, 2012, RESTOR ECOL, V20, P427, DOI 10.1111/j.1526-100X.2012.00878.x; DENHARTOG C, 1994, AQUAT BOT, V47, P21, DOI 10.1016/0304-3770(94)90045-0; Do VT, 2012, MAR POLLUT BULL, V64, P2340, DOI 10.1016/j.marpolbul.2012.08.025; Duarte CM, 1997, MAR ECOL PROG SER, V147, P285, DOI 10.3354/meps147285; DUARTE CM, 1990, MAR ECOL PROG SER, V67, P97, DOI 10.3354/meps067097; DUARTE CM, 1990, MAR ECOL PROG SER, V65, P193, DOI 10.3354/meps065193; Fourqurean JW, 2004, B MAR SCI, V75, P239; GALLEGOS ME, 1993, MAR ECOL PROG SER, V95, P185, DOI 10.3354/meps095185; Glasby TM, 2015, AQUAT BOT, V120, P251, DOI 10.1016/j.aquabot.2014.09.003; Glasby TM, 1996, ENVIRON MONIT ASSESS, V42, P241, DOI 10.1007/BF00414371; Green MO, 2007, ESTUAR COAST SHELF S, V72, P553, DOI 10.1016/j.ecss.2006.11.006; Grimm NB, 2008, FRONT ECOL ENVIRON, V6, P264, DOI 10.1890/070147; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Halpern BS, 2009, CONSERV LETT, V2, P189, DOI 10.1111/j.1755-263X.2009.00060.x; Han QY, 2012, MAR ECOL PROG SER, V449, P133, DOI 10.3354/meps09532; Harwell MC, 1999, AQUAT BOT, V64, P51, DOI 10.1016/S0304-3770(99)00008-X; HOCKING PJ, 1981, AQUAT BOT, V11, P245, DOI 10.1016/0304-3770(81)90064-4; HOCKING PJ, 1980, ANN BOT-LONDON, V45, P149, DOI 10.1093/oxfordjournals.aob.a085806; Ibarra-Obando SE, 2004, J EXP MAR BIOL ECOL, V301, P193, DOI 10.1016/j.jembe.2003.10.001; Jarvis JC, 2015, ESTUAR COAST, V38, P964, DOI 10.1007/s12237-014-9869-3; Jeppesen E, 2009, J ENVIRON QUAL, V38, P1930, DOI 10.2134/jeq2008.0113; Kennedy H., 2004, EUROPEAN SEAGRASSES, P54; Kirkman H, 1998, MAR POLLUT BULL, V37, P460; LITTLER MM, 1983, MAR ECOL PROG SER, V11, P129, DOI 10.3354/meps011129; Manzanera M, 2011, MAR ECOL PROG SER, V423, P47, DOI 10.3354/meps08970; MARBA N, 1994, MAR ECOL PROG SER, V107, P307, DOI 10.3354/meps107307; Marba N, 2003, AQUAT BOT, V77, P87, DOI 10.1016/S0304-3770(03)00079-2; MARBA N, 1994, LIMNOL OCEANOGR, V39, P126, DOI 10.4319/lo.1994.39.1.0126; MARBA N, 1995, J ECOL, V83, P381, DOI 10.2307/2261592; MARBA N, 1994, AQUAT BOT, V47, P1, DOI 10.1016/0304-3770(94)90043-4; Marba N, 1998, MAR ECOL PROG SER, V174, P269, DOI 10.3354/meps174269; Marba N, 2004, EUROPEAN SEAGRASSES, P11; Marion SR, 2010, RESTOR ECOL, V18, P549, DOI 10.1111/j.1526-100X.2010.00695.x; MEINESZ A, 1992, Marine Ecology, V13, P163, DOI 10.1111/j.1439-0485.1992.tb00347.x; MOLENAAR H, 1993, BOT MAR, V36, P481, DOI 10.1515/botm.1993.36.6.481; MOLENAAR H, 1992, Marine Ecology, V13, P175, DOI 10.1111/j.1439-0485.1992.tb00348.x; Munkes B, 2015, MAR POLLUT BULL, V100, P144, DOI 10.1016/j.marpolbul.2015.09.013; Nelson M. K., 1992, THESIS; Ooi JLS, 2011, CONT SHELF RES, V31, P1945, DOI 10.1016/j.csr.2011.09.005; Paling EI, 2003, RESTOR ECOL, V11, P56, DOI 10.1046/j.1526-100X.2003.00072.x; Paling EI, 2001, ECOL ENG, V16, P331, DOI 10.1016/S0925-8574(00)00119-1; Pimm SL, 1991, BALANCE NATURE ECOLO; Rasheed MA, 2004, J EXP MAR BIOL ECOL, V310, P13, DOI 10.1016/j.jembe.2004.03.022; Roca G, 2016, ECOL INDIC, V63, P310, DOI 10.1016/j.ecolind.2015.12.007; ROSE CD, 1994, BOT MAR, V37, P531, DOI 10.1515/botm.1994.37.6.531; Scavia D, 2002, ESTUARIES, V25, P149, DOI 10.1007/BF02691304; Short FT, 2002, MAR ECOL PROG SER, V227, P253, DOI 10.3354/meps227253; Statton J, 2013, RESTOR ECOL, V21, P250, DOI 10.1111/j.1526-100X.2012.00873.x; Suykerbuyk W, 2016, ECOSYSTEMS, V19, P296, DOI 10.1007/s10021-015-9932-3; Syvitski JPM, 2005, SCIENCE, V308, P376, DOI 10.1126/science.1109454; Terrados J, 1997, MAR ECOL PROG SER, V152, P295, DOI 10.3354/meps152295; THAYER GW, 1975, AM SCI, V63, P288; TOMASKO DA, 1992, ESTUARIES, V15, P214, DOI 10.2307/1352694; Tuya F, 2013, J EXP MAR BIOL ECOL, V439, P42, DOI 10.1016/j.jembe.2012.10.015; Valentine JF, 2000, MAR ECOL PROG SER, V200, P213, DOI 10.3354/meps200213; Valle M, 2015, AQUAT BOT, V127, P12, DOI 10.1016/j.aquabot.2015.07.002; van Katwijk MM, 2009, MAR POLLUT BULL, V58, P179, DOI 10.1016/j.marpolbul.2008.09.028; van Keulen M, 2003, RESTOR ECOL, V11, P50, DOI 10.1046/j.1526-100X.2003.00036.x; Waycott M, 2009, P NATL ACAD SCI USA, V106, P12377, DOI 10.1073/pnas.0905620106; Zhang PZ, 2001, NATURE, V410, P891, DOI 10.1038/35073504	73	2	2	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2016	11	8							e0161309	10.1371/journal.pone.0161309	http://dx.doi.org/10.1371/journal.pone.0161309			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4SL	27526020	Green Published, Green Submitted, gold			2022-12-27	WOS:000381471100053
J	Li, CQ; Jiang, XH; Luo, MJ; Feng, GY; Sun, QX; Chen, YP				Li, Chaoqian; Jiang, Xiaohong; Luo, Mingjie; Feng, Guangyi; Sun, Qixiang; Chen, Yiping			Mycobacterium vaccae Nebulization Can Protect against Asthma in Balb/c Mice by Regulating Th9 Expression	PLOS ONE			English	Article							DELTA-T-CELLS; BACILLUS-CALMETTE-GUERIN; AIRWAY INFLAMMATION; TGF-BETA; TUBERCULOSIS; INDUCTION; INFECTION; IMMUNITY; CD8(+); PHLEI	Asthma is a heterogeneous disease characterized by chronic airway inflammation. CD4(+) T-helper 9 (Th9) cells are closely linked to asthma, helping to regulate inflammation and immunity. Epidemiological studies showed that mycobacteria infections are negatively associated with asthma. Our previous research showed that inactivated Mycobacterium phlei nebulization alleviated the airway hyperresponsiveness and inflammation of asthma. However, the relationship between Th9 cells and mycobacteria remains unknown. Here, we evaluated the relationship between Mycobacterium vaccae nebulization and Th9 cells in asthmatic mice. Eighteen Balb/c mice were randomized into 3 groups of 6 mice each (normal control group, asthma control group, and nebulization asthma group [ Neb. group]). The Neb. group was nebulized with M. vaccae one month before establishment of the asthmatic model with ovalbumin (OVA) sensitization, and the normal and asthma control groups were nebulized with phosphate-buffered saline. The hyperresponsiveness of the mouse airways was assessed using a non-invasive lung function machine. Lung airway inflammation was evaluated by hematoxylin and eosin and periodic acid-Schiff staining. Cytokine interlukin-9 (IL-9) concentration and OVA-specific IgE in the bronchoalveolar lavage fluid were measured by enzyme-linked immunosorbent assays. The percentages of gamma delta TCR+ CD3(+), IL-9(+) CD3(+), IL-10(+) CD3(+) lymphocytes, and IL9(+)gamma delta T and IL-10(+)gamma delta T cells were detected by flow cytometry. The airway inflammation and concentration of IL-9 and OVA-specific IgE were significantly reduced in the Neb. group compared to the asthma control group. The Neb. group had lower airway hyperresponsiveness, percentages of gamma delta TCR+ CD3(+) and IL-9(+) CD3(+) lymphocytes, and IL9(+) gamma delta T cells, and higher percentages of IL-10(+) CD3(+) lymphocytes and IL-10(+)gamma delta T cells compared to the asthma control group. Thus, mouse bronchial asthma could be prevented by M. vaccae nebulization. The mechanism could involve M. vaccae-mediated effects on induction of IL-9 secretion and suppression of IL-10 secretion from gamma delta T cells. gamma delta T cells showed prominent IL-10 expression, indicating that they possibly belong to the Th9 family.	[Li, Chaoqian] Guangxi Med Coll, Dept Resp Med, Nanning, Guangxi, Peoples R China; [Li, Chaoqian; Jiang, Xiaohong] Guangxi Med Univ, Dept Geriatr Resp Med, Affiliated Hosp 1, Nanning, Guangxi, Peoples R China; [Luo, Mingjie; Feng, Guangyi] Guangxi Med Univ, Affiliated Hosp 1, Dept Resp Med, Nanning, Guangxi, Peoples R China; [Sun, Qixiang] Guangxi Med Univ, Grad Sch, Nanning, Guangxi, Peoples R China; [Chen, Yiping] Guangxi Med Univ, Natl Affiliated Hosp, Dept Geriatr Dis, Nanning, Guangxi, Peoples R China	Guangxi Medical University; Guangxi Medical University; Guangxi Medical University; Guangxi Medical University	Jiang, XH (corresponding author), Guangxi Med Univ, Dept Geriatr Resp Med, Affiliated Hosp 1, Nanning, Guangxi, Peoples R China.	285999574@qq.com	Chen, Yi/HIR-2608-2022		Guangxi Health and Family Planning Commission Self-raised Funds, People's Republic of China [z2014030]	Guangxi Health and Family Planning Commission Self-raised Funds, People's Republic of China	This work was supported by Guangxi Health and Family Planning Commission Self-raised Funds, People's Republic of China (grant number z2014030), http://www.gxws.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borish L, 1996, J ALLERGY CLIN IMMUN, V97, P1288, DOI 10.1016/S0091-6749(96)70197-5; Cheng L, 2008, J NEUROIMMUNOL, V203, P3, DOI 10.1016/j.jneuroim.2008.06.007; Cook L, 2008, J IMMUNOL, V181, P309, DOI 10.4049/jimmunol.181.1.309; Dardalhon V, 2008, NAT IMMUNOL, V9, P1347, DOI 10.1038/ni.1677; Emoto M, 1999, EUR J IMMUNOL, V29, P650, DOI 10.1002/(SICI)1521-4141(199902)29:02<650::AID-IMMU650>3.0.CO;2-M; Fu CL, 2006, J GENE MED, V8, P1393, DOI 10.1002/jgm.974; Glanville N, 2013, MUCOSAL IMMUNOLOGY; Gorman S, 2012, PEDIAT ALLERG IMM-UK, V23, P83, DOI 10.1111/j.1399-3038.2011.01146.x; Harada M, 2006, J EXP MED, V203, P2929, DOI 10.1084/jem.20062206; Jones CP, 2012, J ALLERGY CLIN IMMUN, V129, P1000, DOI 10.1016/j.jaci.2011.12.965; Kerzerho J, 2013, J ALLERGY CLIN IMMUN, V131, P1048, DOI 10.1016/j.jaci.2012.09.027; Kleinnijenhuis J, 2014, CLIN IMMUNOL, V155, P213, DOI 10.1016/j.clim.2014.10.005; Li Chaoqian, 2002, Zhonghua Jiehe He Huxi Zazhi, V25, P162; Lighter-Fisher J, 2012, PEDIAT ALLER IMM PUL, V25, P80, DOI 10.1089/ped.2012.0146; ONYEBUJOH PC, 1995, RESP MED, V89, P199, DOI 10.1016/0954-6111(95)90248-1; Rook GAW, 2007, IMMUNOBIOLOGY, V212, P461, DOI 10.1016/j.imbio.2007.03.003; Rook GAW, 2012, CLIN REV ALLERG IMMU, V42, P5, DOI 10.1007/s12016-011-8285-8; Samary CD, 2013, RESP PHYSIOL NEUROBI, V189, P614, DOI 10.1016/j.resp.2013.07.025; Schmitt E, 2014, TRENDS IMMUNOL, V35, P61, DOI 10.1016/j.it.2013.10.004; Staudt V, 2010, IMMUNITY, V33, P192, DOI 10.1016/j.immuni.2010.07.014; Strioga MM, 2014, VACCINE, V32, P4015, DOI 10.1016/j.vaccine.2014.05.006; UYTTENHOVE C, 1988, P NATL ACAD SCI USA, V85, P6934, DOI 10.1073/pnas.85.18.6934; Xing JC, 2011, J ASTHMA, V48, P115, DOI 10.3109/02770903.2011.554944; Yang XY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023826; Zhang JH, 2012, IMMUNOTHERAPY-UK, V4, P383, DOI [10.2217/imt.12.25, 10.2217/IMT.12.25]; Zhang JH, 2012, J AEROSOL MED PULM D, V25, P96, DOI 10.1089/jamp.2011.0904; Zhao Y, 2011, J ASTHMA, V48, P429, DOI 10.3109/02770903.2011.570403; Zufferey C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077334	28	8	9	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2016	11	8							e0161164	10.1371/journal.pone.0161164	http://dx.doi.org/10.1371/journal.pone.0161164			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3LI	27518187	Green Published, gold, Green Submitted			2022-12-27	WOS:000381382100055
J	Hema, MN; Ferry, T; Dupon, M; Cuzin, L; Verdon, R; Thiebaut, R; Protopopescu, C; Leport, C; Raffi, F; Le Moing, V				Hema, Mariam Noelie; Ferry, Tristan; Dupon, Michel; Cuzin, Lise; Verdon, Renaud; Thiebaut, Rodolphe; Protopopescu, Camelia; Leport, Catherine; Raffi, Francois; Le Moing, Vincent		ANRS CO 8 APROCO COPILOTE Study Gr	Low CD4/CD8 Ratio Is Associated with Non AIDS-Defining Cancers in Patients on Antiretroviral Therapy: ANRS C08 (Aproco/Copilote) Prospective Cohort Study	PLOS ONE			English	Article							HIV-INFECTED PATIENTS; INDIVIDUALS; ACTIVATION; RISK; DETERMINANTS; INFLAMMATION; SUPPRESSION; EVENTS; FRANCE	Objectives To study the association between CD4/CD8 ratio and morbidity in HIV-infected patients on antiretroviral therapy (ART). Methods The APROCO/COPILOTE cohort enrolled patients initiating a protease inhibitor-containing ART in 1997-1999. The association between occurrence of first non AIDS-defining severe events (NADE) and time-dependent measures of immune restoration was assessed by 4 Cox models with different definitions of restoration, CD4+ cell counts (CD4), CD4/CD8 ratio, both CD4 and CD4/CD8 ratio, or a composite variable (CD4<500/mm(3), CD4 > 500/mm(3) and CD4/CD8 ratio < 1, CD4 > 500/mm(3) and CD4/CD8 ratio > 1). Models adjusted on baseline characteristics and time-dependent viral load were compared using Akaike Information Criterion. Results We included 1227 patients. Median duration of follow-up was 9.2 years (IQR: 4.2-11.4). Median CD4 was 530/mm(3) at 9 years. Median CD4/CD8 ratio was 0.3 (IQR: 0.2-0.5) at baseline and 0.6 (IQR: 0.4-0.9) after 9 years. Incidence of first NADE was 7.4/100 person years, the most common being bacterial infections (21%), cardiovascular events (14%) and cancers (10%). For both bacterial infections and cardiovascular events, the CD4/CD8 ratio did not add predictive information to the CD4 cell count. However, low CD4/CD8 ratio was the best predictor of non-AIDS cancers (adjusted HR = 2.13 for CD4/CD8 < 0.5; 95% CI = 1.32-3.44). Conclusions CD4/CD8 ratio remains < 1 in most HIV-infected patients despite long-term CD4+ cell counts restoration on ART. A CD4/CD8 ratio < 0.5 could identify patients who require a more intensive strategy of cancer prevention or screening.	[Hema, Mariam Noelie; Le Moing, Vincent] Univ Montpellier, UMI IRD 233, Montpellier, France; [Ferry, Tristan] Univ Lyon 1, Hosp Civils Lyon, Lyon, France; [Dupon, Michel] CHU Bordeaux, Bordeaux, France; [Cuzin, Lise] Univ Toulouse 3, CHU Toulouse, INSERM, UMR 1027, Toulouse, France; [Verdon, Renaud] Univ Caen, CHU Caen, EA Risques Microbiens 4655, Caen, France; [Thiebaut, Rodolphe] Univ Bordeaux, INSERM, U897, Bordeaux, France; [Protopopescu, Camelia] Univ Aix Marseille, ORS PACA, INSERM UMR S SESSTIM 912, Marseille, France; [Leport, Catherine] CMIT, 46 Rue Henri Huchard, Paris, France; [Raffi, Francois] Univ Hosp, Dept Infect Dis, Nantes, France; [Le Moing, Vincent] CHU Montpellier, Montpellier, France	Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Bordeaux; CHU de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; CHU de Caen NORMANDIE; Universite de Caen Normandie; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Aix-Marseille Universite; Nantes Universite; CHU de Nantes; Universite de Montpellier; CHU de Montpellier	Le Moing, V (corresponding author), Univ Montpellier, UMI IRD 233, Montpellier, France.; Le Moing, V (corresponding author), CHU Montpellier, Montpellier, France.	v-le_moing@chu-montpellier.fr	Ferry, Tristan/M-5108-2014; Thiebaut, Rodolphe/T-6803-2019	Thiebaut, Rodolphe/0000-0002-5235-3962; ferry, tristan/0000-0003-3082-7001; Le Moing, Vincent/0000-0002-9529-2792	Agence Nationale de Recherche sur le sida et les hepatites virales; ANRS (Agence Nationale de Recherche sur le sida et les hepatites virales)	Agence Nationale de Recherche sur le sida et les hepatites virales(ANRSFrench National Research Agency (ANR)); ANRS (Agence Nationale de Recherche sur le sida et les hepatites virales)(ANRSFrench National Research Agency (ANR))	The APROCO/COPILOTE study is funded by the Agence Nationale de Recherche sur le sida et les hepatites virales.; The study was funded by ANRS (Agence Nationale de Recherche sur le sida et les hepatites virales). There are no other conflicts of interest. The authors would like to thank all participating patients, nurses and physicians in clinical sites.	Appay V, 2008, J PATHOL, V214, P231, DOI 10.1002/path.2276; Bonnet F, 2005, HIV MED, V6, P198, DOI 10.1111/j.1468-1293.2005.00290.x; Caby F, 2016, CLIN INFECT DIS, V62, P1297, DOI 10.1093/cid/ciw076; Castilho JL, 2016, AIDS, V30, P899, DOI 10.1097/QAD.0000000000001005; Clifford GM, 2009, BLOOD, V113, P5737, DOI 10.1182/blood-2009-02-204172; Collin A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152970; Deeks SG, 2012, CURR OPIN IMMUNOL, V24, P501, DOI 10.1016/j.coi.2012.05.004; FERGUSON FG, 1995, J GERONTOL A-BIOL, V50, pB378, DOI 10.1093/gerona/50A.6.B378; Ferry T, 2009, JAIDS-J ACQ IMM DEF, V51, P407, DOI 10.1097/QAI.0b013e3181acb65f; Helleberg M, 2015, J INFECT DIS, V211, P1726, DOI 10.1093/infdis/jiu669; Helleberg M, 2013, CLIN INFECT DIS, V56, P727, DOI 10.1093/cid/cis933; Hessamfar M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102671; Ingle SM, 2014, CLIN INFECT DIS, V59, P287, DOI 10.1093/cid/ciu261; Justice AC, 2012, CLIN INFECT DIS, V54, P984, DOI 10.1093/cid/cir989; Le Moing V, 2001, J ACQ IMMUN DEF SYND, V27, P372, DOI 10.1097/00126334-200108010-00007; Leung V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077665; Morlat P, 2014, AIDS, V28, P1181, DOI 10.1097/QAD.0000000000000222; Mussini C, 2015, LANCET HIV, V2, pE98, DOI 10.1016/S2352-3018(15)00006-5; Rosenthal E, 2015, HIV MED, V16, P230, DOI 10.1111/hiv.12204; Saison J, 2014, CLIN EXP IMMUNOL, V176, P401, DOI 10.1111/cei.12278; Serrano-Villar S, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004078; Serrano-Villar S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085798; Smith CJ, 2014, LANCET, V384, P241, DOI 10.1016/S0140-6736(14)60604-8; Tinago W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097011	24	44	44	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2016	11	8							e0161594	10.1371/journal.pone.0161594	http://dx.doi.org/10.1371/journal.pone.0161594			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT8TP	27548257	Green Published, Green Submitted, gold			2022-12-27	WOS:000381768400074
J	Jia, YZ; Chang, HC; Schipma, MJ; Liu, J; Shete, V; Liu, N; Sato, T; Thorp, EB; Barger, PM; Zhu, YJ; Viswakarma, N; Kanwar, YS; Ardehali, H; Thimmapaya, B; Reddy, JK				Jia, Yuzhi; Chang, Hsiang-Chun; Schipma, Matthew J.; Liu, Jing; Shete, Varsha; Liu, Ning; Sato, Tatsuya; Thorp, Edward B.; Barger, Philip M.; Zhu, Yi-Jun; Viswakarma, Navin; Kanwar, Yashpal S.; Ardehali, Hossein; Thimmapaya, Bayar; Reddy, Janardan K.			Cardiomyocyte-Specific Ablation of Med1 Subunit of the Mediator Complex Causes Lethal Dilated Cardiomyopathy in Mice	PLOS ONE			English	Article							RECEPTOR-BINDING PROTEIN; FATTY-ACID-METABOLISM; DIABETIC CARDIOMYOPATHY; MYOCARDIAL-INFARCTION; COACTIVATOR COMPLEX; EXPRESSION ANALYSIS; ENERGY-METABOLISM; GENE-EXPRESSION; HEART-FAILURE; TRANSCRIPTION	Mediator, an evolutionarily conserved multi-protein complex consisting of about 30 subunits, is a key component of the polymerase II mediated gene transcription. Germline deletion of the Mediator subunit 1 (Med1) of the Mediator in mice results in mid-gestational embryonic lethality with developmental impairment of multiple organs including heart. Here we show that cardiomyocyte-specific deletion of Med1 in mice (csMed1(-/-)) during late gestational and early postnatal development by intercrossing Med1(fl/fl) mice to alpha-MyHC-Cre transgenic mice results in lethality within 10 days after weaning due to dilated cardiomyopathy-related ventricular dilation and heart failure. The csMed1(-/-) mouse heart manifests mitochondrial damage, increased apoptosis and interstitial fibrosis. Global gene expression analysis revealed that loss of Med1 in heart down-regulates more than 200 genes including Acadm, Cacna1s, Atp2a2, Ryr2, Pde1c, Pln, PGC1 alpha, and PGC1 beta that are critical for calcium signaling, cardiac muscle contraction, arrhythmogenic right ventricular cardiomyopathy, dilated cardiomyopathy and peroxisome proliferator-activated receptor regulated energy metabolism. Many genes essential for oxidative phosphorylation and proper mitochondrial function such as genes coding for the succinate dehydrogenase subunits of the mitochondrial complex II are also down-regulated in csMed1(-/-) heart contributing to myocardial injury. Data also showed up-regulation of about 180 genes including Tgfb2, Ace, Atf3, Ctgf, Angpt14, Col9a2, Wisp2, Nppa, Nppb, and Actn1 that are linked to cardiac muscle contraction, cardiac hypertrophy, cardiac fibrosis and myocardial injury. Furthermore, we demonstrate that cardiac specific deletion of Med1 in adult mice using tamoxifen-inducible Cre approach (TmcsMed1(-/-)), results in rapid development of cardiomyopathy and death within 4 weeks. We found that the key findings of the csMed1(-/-) studies described above are highly reproducible in TmcsMed1(-/-) mouse heart. Collectively, these observations suggest that Med1 plays a critical role in the maintenance of heart function impacting on multiple metabolic, compensatory and reparative pathways with a likely therapeutic potential in the management of heart failure.	[Jia, Yuzhi; Liu, Jing; Shete, Varsha; Liu, Ning; Thorp, Edward B.; Zhu, Yi-Jun; Kanwar, Yashpal S.; Reddy, Janardan K.] Northwestern Univ, Dept Pathol, Feinberg Sch Med, Chicago, IL 60611 USA; [Chang, Hsiang-Chun; Sato, Tatsuya; Ardehali, Hossein] Northwestern Univ, Dept Med, Feinberg Sch Med, Chicago, IL 60611 USA; [Schipma, Matthew J.] Northwestern Univ, Feinberg Sch Med, Next Generat Sequencing Core Facil, Chicago, IL 60611 USA; [Barger, Philip M.] Washington Univ, Sch Med, Ctr Cardiovasc Res, St Louis, MO USA; [Viswakarma, Navin] Univ Illinois, Dept Surg, Chicago, IL 60680 USA; [Thimmapaya, Bayar] Northwestern Univ, Feinberg Sch Med, Dept Microbiol & Immunol, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Washington University (WUSTL); University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Northwestern University; Feinberg School of Medicine	Reddy, JK (corresponding author), Northwestern Univ, Dept Pathol, Feinberg Sch Med, Chicago, IL 60611 USA.; Thimmapaya, B (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Microbiol & Immunol, Chicago, IL 60611 USA.	b-thimmapaya@northwestern.edu; jkreddy@northwestern.edu	Shete, Varsha/L-8762-2019	Chang, Hsiang-Chun/0000-0002-9201-4500; Thorp, Edward/0000-0003-1387-7058	National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases (US) (NIH NIDDK) [RO1 DK097240, RO1 DK083163]; National Institutes of Health, National Institutes of Health (US), National Institute of Allergy and Infectious Diseases (NIH) [R21AI1094296]; NATIONAL CANCER INSTITUTE [P30CA060553] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL122309] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK097249, R01DK060635] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases (US) (NIH NIDDK); National Institutes of Health, National Institutes of Health (US), National Institute of Allergy and Infectious Diseases (NIH); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the following sources of funding: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases (US) (NIH NIDDK) RO1 DK097240, Recipient: Janardan K. Reddy; National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases (US) (NIH NIDDK) RO1 DK083163, Recipient: Janardan K. Reddy; and National Institutes of Health, National Institutes of Health (US), National Institute of Allergy and Infectious Diseases (NIH) (AI) R21AI1094296, Recipient: Bayar Thimmapaya.	Agah R, 1997, J CLIN INVEST, V100, P169, DOI 10.1172/JCI119509; Allen BL, 2015, NAT REV MOL CELL BIO, V16, P155, DOI 10.1038/nrm3951; Amoasii L, 2016, GENE DEV, V30, P434, DOI 10.1101/gad.273128.115; Asadollahi R, 2013, EUR J HUM GENET, V21, P1100, DOI 10.1038/ejhg.2013.17; Austin S, 2012, J CELL SCI, V125, P4963, DOI 10.1242/jcs.113662; Azhar M, 2003, CYTOKINE GROWTH F R, V14, P391, DOI 10.1016/S1359-6101(03)00044-3; Bai LA, 2011, HEPATOLOGY, V53, P1164, DOI 10.1002/hep.24155; Bergmann O, 2012, JOVE-J VIS EXP, DOI 10.3791/4205; Bidaud I, 2011, BIOCHIMIE, V93, P2080, DOI 10.1016/j.biochi.2011.05.015; Borik S, 2011, INTENS CARE MED, V37, P1664, DOI 10.1007/s00134-011-2296-z; Brenner R, 2000, NATURE, V407, P870, DOI 10.1038/35038011; Burrell LM, 2013, CLIN SCI, V124, P65, DOI 10.1042/CS20120269; Campbell CT, 2012, BBA-GENE REGUL MECH, V1819, P921, DOI 10.1016/j.bbagrm.2012.03.002; Carlsten JOP, 2013, TRENDS BIOCHEM SCI, V38, P531, DOI 10.1016/j.tibs.2013.08.007; Chen W, 2011, SEMIN CELL DEV BIOL, V22, P749, DOI 10.1016/j.semcdb.2011.07.026; Chen W, 2010, P NATL ACAD SCI USA, V107, P10196, DOI 10.1073/pnas.1005626107; Cheng LH, 2004, NAT MED, V10, P1245, DOI 10.1038/nm1116; Chu YJ, 2014, CELL RES, V24, P1250, DOI 10.1038/cr.2014.120; COLLIN T, 1993, CIRC RES, V72, P1337, DOI 10.1161/01.RES.72.6.1337; Crawford SE, 2002, J BIOL CHEM, V277, P3585, DOI 10.1074/jbc.M107995200; Digilio Mc, 2005, Images Paediatr Cardiol, V7, P23; Dobaczewski M, 2011, J MOL CELL CARDIOL, V51, P600, DOI 10.1016/j.yjmcc.2010.10.033; Fillmore N, 2014, BRIT J PHARMACOL, V171, P2080, DOI 10.1111/bph.12475; Fondell JD, 2013, BBA-GEN SUBJECTS, V1830, P3867, DOI 10.1016/j.bbagen.2012.02.012; Galaup A, 2012, CIRCULATION, V125, P140, DOI 10.1161/CIRCULATIONAHA.111.049072; Graham JM, 2013, AM J MED GENET A, V161, P2734, DOI 10.1002/ajmg.a.36183; Grueter Chad E., 2013, Genomics Proteomics & Bioinformatics, V11, P151, DOI 10.1016/j.gpb.2013.05.002; Haddad F, 2008, AM J PHYSIOL-HEART C, V294, pH29, DOI 10.1152/ajpheart.01125.2007; Hai T, 2010, GENE EXPRESSION, V15, P1, DOI 10.3727/105221610X12819686555015; Israeli-Rosenberg S, 2014, CIRC RES, V114, P572, DOI 10.1161/CIRCRESAHA.114.301275; Ito M, 2000, MOL CELL, V5, P683, DOI 10.1016/S1097-2765(00)80247-6; Jia Y, 2014, GENE EXPRESSION, V16, P63, DOI 10.3727/105221614X13919976902219; Jia YZ, 2004, J BIOL CHEM, V279, P24427, DOI 10.1074/jbc.M402391200; Jin F, 2013, MOL CANCER RES, V11, P736, DOI 10.1158/1541-7786.MCR-12-0618; Kim YK, 2006, CIRCULATION, V113, P2589, DOI 10.1161/CIRCULATIONAHA.105.598409; Koren L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068396; Kornberg RD, 2005, TRENDS BIOCHEM SCI, V30, P235, DOI 10.1016/j.tibs.2005.03.011; Koshman YE, 2015, J MOL CELL CARDIOL, V89, P214, DOI 10.1016/j.yjmcc.2015.11.003; Krebs P, 2011, P NATL ACAD SCI USA, V108, P19678, DOI 10.1073/pnas.1117835108; Kushnir A, 2010, ADV PHARMACOL, V59, P1, DOI 10.1016/S1054-3589(10)59001-X; Kuwahara K, 2010, ENDOCR J, V57, P555, DOI 10.1507/endocrj.K10E-150; Landles C, 2003, MOL ENDOCRINOL, V17, P2418, DOI 10.1210/me.2003-0097; Lee TI, 2013, DIABETES RES CLIN PR, V100, P330, DOI 10.1016/j.diabres.2013.01.008; Liepinsh E, 2014, METABOLISM, V63, P127, DOI 10.1016/j.metabol.2013.09.014; Loven J, 2012, CELL, V151, P476, DOI 10.1016/j.cell.2012.10.012; Luiken JJ, 2015, TRENDS ENDOCRINOL ME; MacLennan DH, 2003, NAT REV MOL CELL BIO, V4, P566, DOI 10.1038/nrm1151; Malik S, 2010, NAT REV GENET, V11, P761, DOI 10.1038/nrg2901; Marin-Garcia J, 2002, CARDIOVASC RES, V54, P516, DOI 10.1016/S0008-6363(01)00552-1; Marks AR, 2013, J CLIN INVEST, V123, P46, DOI 10.1172/JCI62834; Matsumoto K, 2010, CARCINOGENESIS, V31, P318, DOI 10.1093/carcin/bgp306; McNally EM, 2013, J CLIN INVEST, V123, P19, DOI 10.1172/JCI62862; Pyper Sean R, 2010, Nucl Recept Signal, V8, pe002, DOI 10.1621/nrs.08002; Roh JI, 2014, CELL REP, V8, P991, DOI 10.1016/j.celrep.2014.07.027; Russell LK, 2004, CIRC RES, V94, P525, DOI 10.1161/01.RES.0000117088.36577.EB; Schiano C, 2014, BBA-REV CANCER, V1845, P66, DOI 10.1016/j.bbcan.2013.12.001; Sohal DS, 2001, CIRC RES, V89, P20, DOI 10.1161/hh1301.092687; Spaeth JM, 2011, SEMIN CELL DEV BIOL, V22, P776, DOI 10.1016/j.semcdb.2011.07.024; Spiegelman Bruce M, 2007, Novartis Found Symp, V287, P60; Tabas-Madrid D, 2012, NUCLEIC ACIDS RES, V40, pW478, DOI 10.1093/nar/gks402; Teekakirikul P, 2010, J CLIN INVEST, V120, P3520, DOI 10.1172/JCI42028; Traister A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5533; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Valencik ML, 2006, CIRC RES, V99, P1403, DOI 10.1161/01.RES.0000252291.88540.ac; Venetucci L, 2012, NAT REV CARDIOL, V9, P561, DOI 10.1038/nrcardio.2012.93; Viswakarma N, 2013, J BIOL CHEM, V288, P27898, DOI 10.1074/jbc.M113.486696; Watanabe K, 2000, J BIOL CHEM, V275, P22293, DOI 10.1074/jbc.M000248200; Wu RX, 2014, J CLIN INVEST, V124, P4795, DOI 10.1172/JCI76737; Wu RX, 2011, CIRC RES, V108, P60, DOI 10.1161/CIRCRESAHA.110.223115; Wyatt E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013823; Xiaoli, 2013, TRENDS CARDIOVAS MED, V23, P269, DOI 10.1016/j.tcm.2013.03.002; Zhou H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026744; Zhu YJ, 2000, J BIOL CHEM, V275, P14779, DOI 10.1074/jbc.C000121200; Zhu YJ, 1999, P NATL ACAD SCI USA, V96, P10848, DOI 10.1073/pnas.96.19.10848	74	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2016	11	8							e0160755	10.1371/journal.pone.0160755	http://dx.doi.org/10.1371/journal.pone.0160755			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT8TP	27548259	Green Published, gold			2022-12-27	WOS:000381768400020
J	Zheng, XL; Fang, B; Han, DF; Yang, WX; Qi, FF; Chen, H; Li, SY				Zheng, Xianliang; Fang, Bo; Han, Dongfei; Yang, Wenxia; Qi, Feifei; Chen, Hui; Li, Shengying			Improving the Secretory Expression of an - Galactosidase from Aspergillus niger in Pichia pastoris	PLOS ONE			English	Article							HIGH-LEVEL EXPRESSION; HUMAN ALPHA-GALACTOSIDASE; ALCOHOL OXIDASE; METHYLOTROPHIC YEAST; GENE; CLONING; PURIFICATION; PRECURSOR; PROTEINS; STRAIN	alpha-Galactosidases are broadly used in feed, food, chemical, pulp, and pharmaceutical industries. However, there lacks a satisfactory microbial cell factory that is able to produce alpha-galactosidases efficiently and cost-effectively to date, which prevents these important enzymes from greater application. In this study, the secretory expression of an Aspergillus niger alpha-galactosidase (AGA) in Pichia pastoris was systematically investigated. Through codon optimization, signal peptide replacement, comparative selection of host strain, and saturation mutagenesis of the P1' residue of Kex2 protease cleavage site for efficient signal peptide removal, a mutant P. pastoris KM71H (Mut(s)) strain of AGA-I with the specific P1' site substitution (Glu to Ile) demonstrated remarkable extracellular a-galactosidase activity of 1299 U/ ml upon a 72 h methanol induction in 2.0 L fermenter. The engineered yeast strain AGA-I demonstrated approximately 12-fold higher extracellular activity compared to the initial P. pastoris strain. To the best of our knowledge, this represents the highest yield and productivity of a secreted alpha-galactosidase in P. pastoris, thus holding great potential for industrial application.	[Zheng, Xianliang; Fang, Bo; Han, Dongfei; Yang, Wenxia; Qi, Feifei; Chen, Hui; Li, Shengying] Chinese Acad Sci, Qingdao Inst Bioenergy & Bioproc Technol, Shandong Prov Key Lab Synthet Biol, 189 Songling Rd, Qingdao 266101, Shandong, Peoples R China; [Zheng, Xianliang; Fang, Bo; Han, Dongfei; Yang, Wenxia; Qi, Feifei; Chen, Hui; Li, Shengying] Chinese Acad Sci, Qingdao Inst Bioenergy & Bioproc Technol, CAS Key Lab Biofuels, 189 Songling Rd, Qingdao 266101, Shandong, Peoples R China; [Zheng, Xianliang; Fang, Bo] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Zheng, Xianliang] Sinodanish Ctr Educ & Res, Beijing 100190, Peoples R China	Chinese Academy of Sciences; Qingdao Institute of Bioenergy & Bioprocess Technology, CAS; Chinese Academy of Sciences; Qingdao Institute of Bioenergy & Bioprocess Technology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Li, SY (corresponding author), Chinese Acad Sci, Qingdao Inst Bioenergy & Bioproc Technol, Shandong Prov Key Lab Synthet Biol, 189 Songling Rd, Qingdao 266101, Shandong, Peoples R China.; Li, SY (corresponding author), Chinese Acad Sci, Qingdao Inst Bioenergy & Bioproc Technol, CAS Key Lab Biofuels, 189 Songling Rd, Qingdao 266101, Shandong, Peoples R China.	lishengying@qibebt.ac.cn	Han, Dongfei/ABB-3352-2020	Han, Dongfei/0000-0003-4007-8454	National Natural Science Foundation of China [NSFC 21406250, NSFC 31300663]; Applied Basic Research Programs of Science and Technology of Qingdao [15-9-1-106-jch]; Opening Fund of Key Laboratory of Protein Chemistry and Developmental Biology of the Ministry of Education at Hunan Normal University [2015DF05]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Applied Basic Research Programs of Science and Technology of Qingdao; Opening Fund of Key Laboratory of Protein Chemistry and Developmental Biology of the Ministry of Education at Hunan Normal University	This work was financially supported by funding from the National Natural Science Foundation of China under grant numbers NSFC 21406250 (HC) and NSFC 31300663 (DH), the Applied Basic Research Programs of Science and Technology of Qingdao, 15-9-1-106-jch (HC), and the Opening Fund of Key Laboratory of Protein Chemistry and Developmental Biology of the Ministry of Education at Hunan Normal University, 2015DF05 (SL).	Aleksieva P, 2010, BIOTECHNOL BIOTEC EQ, V24, P1620, DOI 10.2478/V10133-010-0015-5; Basco RD, 1996, BBA-MOL CELL RES, V1310, P110, DOI 10.1016/0167-4889(95)00156-5; BRAKE AJ, 1984, P NATL ACAD SCI-BIOL, V81, P4642, DOI 10.1073/pnas.81.15.4642; Cereghino JL, 2000, FEMS MICROBIOL REV, V24, P45, DOI 10.1111/j.1574-6976.2000.tb00532.x; Chen YQ, 2012, APPL BIOCHEM BIOTECH, V168, P638, DOI 10.1007/s12010-012-9806-5; Chen YS, 2000, PROTEIN EXPRES PURIF, V20, P472, DOI 10.1006/prep.2000.1325; Chen Z, 2015, PROTEIN EXPRES PURIF, V110, P107, DOI 10.1016/j.pep.2015.02.015; Chiruvolu V, 1997, ENZYME MICROB TECH, V21, P277, DOI 10.1016/S0141-0229(97)00042-2; CREGG JM, 1989, MOL CELL BIOL, V9, P1316, DOI 10.1128/MCB.9.3.1316; CREGG JM, 1987, BIO-TECHNOL, V5, P479, DOI 10.1038/nbt0587-479; DELCAMPILLO E, 1982, PLANT PHYSIOL, V69, P628, DOI 10.1104/pp.69.3.628; DENHERDER IF, 1992, MOL GEN GENET, V233, P404, DOI 10.1007/BF00265437; EDMAN P, 1950, ACTA CHEM SCAND, V4, P283, DOI 10.3891/acta.chem.scand.04-0283; ELLIS SB, 1985, MOL CELL BIOL, V5, P1111, DOI 10.1128/MCB.5.5.1111; GERMAIN D, 1993, FEBS LETT, V323, P129, DOI 10.1016/0014-5793(93)81463-A; Ghazi S, 2003, BRIT POULTRY SCI, V44, P410, DOI 10.1080/00071660310001598283; Guerfal M, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-49; KATO K, 1982, AGR BIOL CHEM TOKYO, V46, P1089, DOI 10.1080/00021369.1982.10865204; Lee J., 2012, AFR J BIOTECHNOL, V11, P12396, DOI [10.5897/ajb12.1219, DOI 10.5897/AJB12.1219]; Manzanares P, 1998, ENZYME MICROB TECH, V22, P383, DOI 10.1016/S0141-0229(97)00207-X; Mi SJ, 2007, ENZYME MICROB TECH, V40, P1373, DOI 10.1016/j.enzmictec.2006.10.017; Patil AGG, 2010, J MICROBIOL BIOTECHN, V20, P1546, DOI 10.4014/jmb.0912.12012; Puchart V, 2000, BBA-GEN SUBJECTS, V1524, P27, DOI 10.1016/S0304-4165(00)00138-0; RHOLAM M, 1995, EUR J BIOCHEM, V227, P707, DOI 10.1111/j.1432-1033.1995.tb20192.x; Schechter I, 2012, BIOCHEM BIOPH RES CO, V425, P497, DOI 10.1016/j.bbrc.2012.08.015; Shibuya H, 1998, APPL ENVIRON MICROB, V64, P4489; Tashiro K, 1999, METHOD ENZYMOL, V303, P479; TSCHOPP JF, 1987, BIO-TECHNOL, V5, P1305, DOI 10.1038/nbt1287-1305; Tsuboi K, 2012, GENET MED, V14, P779, DOI [10.1038/gim.2012.39, 10.1038/gim.2012.81]; Unzueta U, 2015, APPL MICROBIOL BIOT, V99, P5863, DOI 10.1007/s00253-014-6328-9; Viana PA, 2006, J AGR FOOD CHEM, V54, P2385, DOI 10.1021/jf0526442; Wang H, 2010, BIORESOURCE TECHNOL, V101, P8376, DOI 10.1016/j.biortech.2010.06.045; Xiong AS, 2005, J APPL MICROBIOL, V98, P418, DOI 10.1111/j.1365-2672.2004.02476.x; Yan JY, 2014, BIORESOURCE TECHNOL, V151, P43, DOI 10.1016/j.biortech.2013.10.037; Yang S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075347; Zeyland J, 2013, J APPL GENET, V54, P293, DOI 10.1007/s13353-013-0156-y; Zhang YP, 2007, CHINESE MED J-PEKING, V120, P1145, DOI 10.1097/00029330-200707010-00006	37	13	14	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2016	11	8							e0161529	10.1371/journal.pone.0161529	http://dx.doi.org/10.1371/journal.pone.0161529			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT8TP	27548309	gold, Green Published, Green Submitted			2022-12-27	WOS:000381768400066
J	Lin, SY; Lee, WJ; Chou, MY; Peng, LN; Chiou, ST; Chen, LK				Lin, Shu-Yu; Lee, Wei-Ju; Chou, Ming-Yueh; Peng, Li-Ning; Chiou, Shu-Ti; Chen, Liang-Kung			Frailty Index Predicts All-Cause Mortality for Middle-Aged and Older Taiwanese: Implications for Active-Aging Programs	PLOS ONE			English	Article							ELDERLY-PEOPLE; DEFICIT ACCUMULATION; HEALTH; PHENOTYPE; OUTCOMES; ADULTS; INCUR; HOME	Background Frailty Index, defined as an individual's accumulated proportion of listed health-related deficits, is a well-established metric used to assess the health status of old adults; however, it has not yet been developed in Taiwan, and its local related structure factors remain unclear. The objectives were to construct a Taiwan Frailty Index to predict mortality risk, and to explore the structure of its factors. Methods Analytic data on 1,284 participants aged 53 and older were excerpted from the Social Environment and Biomarkers of Aging Study (2006), in Taiwan. A consensus workgroup of geriatricians selected 159 items according to the standard procedure for creating a Frailty Index. Cox proportional hazard modeling was used to explore the association between the Taiwan Frailty Index and mortality. Exploratory factor analysis was used to identify structure factors and produce a shorter version-the Taiwan Frailty Index Short-Form. Results During an average follow-up of 4.3 +/- 0.8 years, 140 (11%) subjects died. Compared to those in the lowest Taiwan Frailty Index tertile (< 0.18), those in the uppermost tertile (> 0.23) had significantly higher risk of death (Hazard ratio: 3.2; 95% CI 1.9-5.4). Thirty-five items of five structure factors identified by exploratory factor analysis, included: physical activities, life satisfaction and financial status, health status, cognitive function, and stresses. Area under the receiver operating characteristic curves (C-statistics) of the Taiwan Frailty Index and its Short-Form were 0.80 and 0.78, respectively, with no statistically significant difference between them. Conclusion Although both the Taiwan Frailty Index and Short-Form were associated with mortality, the Short-Form, which had similar accuracy in predicting mortality as the full Taiwan Frailty Index, would be more expedient in clinical practice and community settings to target frailty screening and intervention.	[Lin, Shu-Yu; Lee, Wei-Ju; Chou, Ming-Yueh; Peng, Li-Ning; Chen, Liang-Kung] Natl Yang Ming Univ, Aging & Hlth Res Ctr, Taipei, Taiwan; [Lin, Shu-Yu; Lee, Wei-Ju; Chou, Ming-Yueh; Peng, Li-Ning; Chiou, Shu-Ti] Natl Yang Ming Univ, Inst Publ Hlth, Taipei, Taiwan; [Lee, Wei-Ju] Taipei Vet Gen Hosp, Dept Family Med, Yuanshan Branch, Taipei, Yilan County, Taiwan; [Chou, Ming-Yueh] Kaohsiung Vet Gen Hosp, Ctr Geriatr & Gerontol, Kaohsiung, Taiwan; [Peng, Li-Ning; Chen, Liang-Kung] Taipei Vet Gen Hosp, Ctr Geriatr & Gerontol, Taipei, Taiwan; [Chiou, Shu-Ti] Minist Hlth & Welf, Hlth Promot Adm, Taipei, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Kaohsiung Veterans General Hospital; Taipei Veterans General Hospital	Lee, WJ; Chen, LK (corresponding author), Natl Yang Ming Univ, Aging & Hlth Res Ctr, Taipei, Taiwan.; Lee, WJ (corresponding author), Natl Yang Ming Univ, Inst Publ Hlth, Taipei, Taiwan.; Lee, WJ (corresponding author), Taipei Vet Gen Hosp, Dept Family Med, Yuanshan Branch, Taipei, Yilan County, Taiwan.; Chen, LK (corresponding author), Taipei Vet Gen Hosp, Ctr Geriatr & Gerontol, Taipei, Taiwan.	leewju@gmail.com; lkchen2@vghtpe.gov.tw	lin, shuyu/GRF-5383-2022; Lee, Wei-Ju/AAK-1549-2021	Lee, Wei-Ju/0000-0003-4326-333X; Chen, Liang-Kung/0000-0002-2387-8508	Aging and Health Research Center, National Yang Ming University; Center for Geriatrics and Gerontology, Taipei Veterans General Hospital; Ministry of Science and Technology of Taiwan [MOST 104-2633-B-400-001, MOST 105-3011-B-010-001]	Aging and Health Research Center, National Yang Ming University; Center for Geriatrics and Gerontology, Taipei Veterans General Hospital(Taipei Veterans General Hospital); Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by the Aging and Health Research Center, National Yang Ming University; Center for Geriatrics and Gerontology, Taipei Veterans General Hospital, as well as the Ministry of Science and Technology of Taiwan (MOST 104-2633-B-400-001 and MOST 105-3011-B-010-001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrew MK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002232; Cesari M, 2016, J AM MED DIR ASSOC, V17, P448, DOI 10.1016/j.jamda.2016.02.007; Child D, 2006, ESSENTIALS FACTOR AN, V3rd; Clegg A, 2013, LANCET, V381, P752, DOI 10.1016/S0140-6736(12)62167-9; Cornman JC, 2016, INT J EPIDEMIOL, V45, P54, DOI 10.1093/ije/dyu179; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Drubbel I, 2013, J GERONTOL A-BIOL, V68, P301, DOI 10.1093/gerona/gls161; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Gill TM, 2002, NEW ENGL J MED, V347, P1068, DOI 10.1056/NEJMoa020423; Hippisley-Cox J, 2008, BMJ-BRIT MED J, V336, P1475, DOI 10.1136/bmj.39609.449676.25; Kamaruzzaman S, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-123; Kulminski AM, 2008, J AM GERIATR SOC, V56, P898, DOI 10.1111/j.1532-5415.2008.01656.x; Lee WJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157877; Lee WJ, 2014, J AM MED DIR ASSOC, V15, P256, DOI 10.1016/j.jamda.2013.12.003; Lee WJ, 2011, J AM MED DIR ASSOC, V12, P29, DOI 10.1016/j.jamda.2010.01.002; Liu LK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136968; Lu WH, 2016, J CLIN GERONTOL GERI, V7, P44, DOI 10.1016/j.jcgg.2015.08.002; Mitnitski A, 2012, EXP GERONTOL, V47, P893, DOI 10.1016/j.exger.2012.06.015; Mitnitski A B, 2001, ScientificWorldJournal, V1, P323; Mitnitski A, 2013, BIOGERONTOLOGY, V14, P709, DOI 10.1007/s10522-013-9446-3; Murray CJL, 2015, LANCET, V386, P2145, DOI 10.1016/S0140-6736(15)61340-X; Murray CJL, 2013, NEW ENGL J MED, V369, P448, DOI 10.1056/NEJMra1201534; Ottenbacher KJ, 2009, AM J PUBLIC HEALTH, V99, P673, DOI 10.2105/AJPH.2008.143958; Pett MA, 2003, MAKING SENSE FACTOR, DOI DOI 10.4135/9781412984898; Pilotto A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029090; Rockwood K, 2007, J GERONTOL A-BIOL, V62, P722, DOI 10.1093/gerona/62.7.722; Rockwood K, 2011, CAN MED ASSOC J, V183, pE487, DOI 10.1503/cmaj.101271; Rodriguez-Manas L, 2015, LANCET, V385, pE7, DOI 10.1016/S0140-6736(14)61595-6; Sampaio PYS, 2016, GERIATR GERONTOL INT, V16, P829, DOI 10.1111/ggi.12562; Schoufour JD, 2015, J AM GERIATR SOC, V63, P531, DOI 10.1111/jgs.13239; Searle Samuel D, 2008, BMC Geriatr, V8, P24, DOI 10.1186/1471-2318-8-24; Shi J, 2011, BMC GERIATR, V11, DOI 10.1186/1471-2318-11-17; Song XW, 2010, J AM GERIATR SOC, V58, P681, DOI 10.1111/j.1532-5415.2010.02764.x; Stevens JP, 2012, EXPLORATORY CONFIRMA, P325; Tabue-Teguo M, 2015, J AM MED DIR ASSOC, V16, P603, DOI 10.1016/j.jamda.2015.02.002; von Elm E, 2007, PREV MED, V45, P247, DOI 10.1016/j.ypmed.2007.08.012; Wallace LMK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090475; Woo J, 2012, J AM GERIATR SOC, V60, P1478, DOI 10.1111/j.1532-5415.2012.04074.x	38	12	12	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0161456	10.1371/journal.pone.0161456	http://dx.doi.org/10.1371/journal.pone.0161456			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DT6ES	27537684	Green Submitted, gold, Green Published			2022-12-27	WOS:000381577000108
J	Lloyd, ML; Hod, N; Jayaraman, J; Marchant, EA; Christen, L; Chiang, P; Hartmann, P; Shellam, GR; Simmer, K				Lloyd, Megan L.; Hod, Nurul; Jayaraman, Jothsna; Marchant, Elizabeth A.; Christen, Lukas; Chiang, Peter; Hartmann, Peter; Shellam, Geoffrey R.; Simmer, Karen			Inactivation of Cytomegalovirus in Breast Milk Using Ultraviolet-C Irradiation: Opportunities for a New Treatment Option in Breast Milk Banking	PLOS ONE			English	Article							PRETERM INFANTS; INFECTION; TRANSMISSION; PASTEURIZATION	Pasteurized donor human milk is provided by milk banks to very preterm babies where their maternal supply is insufficient or unavailable. Donor milk is currently processed by Holder pasteurization, producing a microbiologically safe product but significantly reducing immunoprotective components. Ultraviolet-C (UV-C) irradiation at 254 nm is being investigated as an alternative treatment method and has been shown to preserve components such as lactoferrin, lysozyme and secretory IgA considerably better than Holder pasteurization. We describe the inactivation of cytomegalovirus, a virus commonly excreted into breast milk, using UV-C irradiation. Full replication was ablated by various treatment doses. However, evidence of viral immediate early proteins within the cells was never completely eliminated indicating that some viral gene transcription was still occurring. In conclusion, UV-C may be a safe alternative to pasteurisation for the treatment of human donor milk that preserves the bioactivity. However, our data suggests that CMV inactivation will have to be carefully evaluated for each device designed to treat breast milk using UV-C irradiation.	[Lloyd, Megan L.; Hod, Nurul; Jayaraman, Jothsna; Marchant, Elizabeth A.; Chiang, Peter; Shellam, Geoffrey R.] Univ Western Australia, Sch Pathol & Lab Med, Crawley, WA, Australia; [Lloyd, Megan L.; Shellam, Geoffrey R.] Univ Western Australia, Marshall Ctr Infect Dis Res & Training, Crawley, WA, Australia; [Lloyd, Megan L.] Edith Cowan Univ, Sch Med & Hlth Sci, Joondalup, WA, Australia; [Marchant, Elizabeth A.] Univ British Columbia, Fac Med, Dept Expt Med, Vancouver, BC, Canada; [Marchant, Elizabeth A.] Child & Family Res Inst, Vancouver, BC, Canada; [Christen, Lukas; Hartmann, Peter] Univ Western Australia, Sch Chem & Biochem, Crawley, WA, Australia; [Christen, Lukas] Carag AG, Baar, Switzerland; [Simmer, Karen] Univ Western Australia, Sch Paediat & Child Hlth, Crawley, WA, Australia; [Simmer, Karen] Univ Western Australia, Ctr Neonatal Res & Educ, Perth, WA, Australia; [Simmer, Karen] King Edward Mem Hosp Women, Neonatal Clin Care Unit, Perth, WA, Australia	University of Western Australia; University of Western Australia; Edith Cowan University; University of British Columbia; Child & Family Research Institute; University of Western Australia; University of Western Australia; University of Western Australia; King Edward Memorial Hospital; University of Western Australia	Lloyd, ML (corresponding author), Univ Western Australia, Sch Pathol & Lab Med, Crawley, WA, Australia.; Lloyd, ML (corresponding author), Univ Western Australia, Marshall Ctr Infect Dis Res & Training, Crawley, WA, Australia.; Lloyd, ML (corresponding author), Edith Cowan Univ, Sch Med & Hlth Sci, Joondalup, WA, Australia.	m.lloyd@ecu.edu.au	Lloyd, Megan/B-5690-2008	Lloyd, Megan/0000-0002-0140-1215; Hartmann, Peter/0000-0002-7709-0740; Simmer, Karen/0000-0003-4777-9069	Princess Margaret Hospital Foundation [9396]	Princess Margaret Hospital Foundation	Funding for this study was received from the Princess Margaret Hospital Foundation, Grant ID 9396, [https://pmhfoundation.com]. The funder had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Bevot A, 2012, ACTA PAEDIATR, V101, pE167, DOI 10.1111/j.1651-2227.2011.02538.x; Brecht KF, 2015, J PEDIATR-US, V166, P834, DOI 10.1016/j.jpeds.2014.11.002; Capretti MG, 2009, J PEDIATR-US, V154, P842, DOI 10.1016/j.jpeds.2008.12.046; Chiavarini M, 2011, ITAL J PEDIATR, V37, DOI 10.1186/1824-7288-37-6; Christen L., 2013, PLOS ONE, V8; Christen L., 2014, Patent No. [WO Patent App. PCT/ CH2013/ 000,224, 2014094189]; Christen L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085867; Cristofalo EA, 2013, J PEDIATR-US, V163, P1592, DOI 10.1016/j.jpeds.2013.07.011; Ewaschuk JB, 2011, J PERINATOL, V31, P593, DOI 10.1038/jp.2010.209; Fischer C, 2010, NEONATOLOGY, V97, P339, DOI 10.1159/000260137; Franklin J.G., 1965, INT J DAIRY TECHNOL, V18, P115, DOI 10.1111/j.1471-0307.1965.tb00185.x; Guerrero-Beltran JA, 2004, FOOD SCI TECHNOL INT, V10, P137, DOI 10.1177/1082013204044359; Hamele M, 2010, PEDIATR INFECT DIS J, V29, P84, DOI 10.1097/INF.0b013e3181b6dbb5; Hamprecht K, 2004, PEDIATR RES, V56, P529, DOI 10.1203/01.PDR.0000139483.35087.BE; Hamprecht K, 2003, J CLIN VIROL, V28, P303, DOI 10.1016/S1386-6532(03)00074-X; Hamprecht K, 2001, LANCET, V357, P513, DOI 10.1016/S0140-6736(00)04043-5; Hartmann BT, 2007, EARLY HUM DEV, V83, P667, DOI 10.1016/j.earlhumdev.2007.07.012; Jim WT, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001835; Kelly MS, 2015, JAMA PEDIATR, V169, DOI 10.1001/jamapediatrics.2015.3785; Kurath S, 2010, CLIN MICROBIOL INFEC, V16, P1172, DOI 10.1111/j.1469-0691.2010.03140.x; Kurz SK, 1999, J VIROL, V73, P482, DOI 10.1128/JVI.73.1.482-494.1999; Lawrence RM, 2006, BREASTFEED MED, V1, P99, DOI 10.1089/bfm.2006.1.99; Maschmann J, 2006, ARCH DIS CHILD-FETAL, V91, pF288, DOI 10.1136/adc.2004.050625; Numazaki K, 1997, FEMS IMMUNOL MED MIC, V18, P91, DOI 10.1111/j.1574-695X.1997.tb01032.x; Okulu E, 2012, J PERINATOL, V32, P72, DOI 10.1038/jp.2011.58; Omarsdottir S, 2015, PEDIATR INFECT DIS J, V34, P482, DOI 10.1097/INF.0000000000000619; Rastogi RP, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/592980; REED L. J., 1938, AMER JOUR HYG, V27, P493; ROWE WP, 1958, AM J HYG, V67, P57, DOI 10.1093/oxfordjournals.aje.a119919; Seale H, 2006, CLIN VACCINE IMMUNOL, V13, P1181, DOI 10.1128/CVI.00203-06; Stock K, 2015, BREASTFEED MED, V10, P113, DOI 10.1089/bfm.2014.0108; 김지혜, 2009, Clinical and Experimental Pediatrics, V52, P1053	32	23	26	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0161116	10.1371/journal.pone.0161116	http://dx.doi.org/10.1371/journal.pone.0161116			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27537346	Green Published, gold, Green Submitted			2022-12-27	WOS:000381577000055
J	Sathyanarayana, BK; Li, P; Lin, JX; Leonard, WJ; Lee, B				Sathyanarayana, Bangalore K.; Li, Peng; Lin, Jian-Xin; Leonard, Warren J.; Lee, Byungkook			Molecular Models of STAT5A Tetramers Complexed to DNA Predict Relative GenomeWide Frequencies of the Spacing between the Two Dimer Binding Motifs of the Tetramer Binding Sites	PLOS ONE			English	Article							TRANSACTIVATION DOMAINS; GENE; TRANSCRIPTION; RECRUITMENT; ACTIVATION; INDUCTION; GROWTH; CELLS	STAT proteins bind DNA as dimers and tetramers to control cellular development, differentiation, survival, and expansion. The tetramer binding sites are comprised of two dimer-binding sites repeated in tandem. The genome-wide distribution of the spacings between the dimer binding sites shows a distinctive, non-random pattern. Here, we report on estimating the feasibility of building possible molecular models of STAT5A tetramers bound to a DNA double helix with all possible spacings between the dimer binding sites. We found that the calculated feasibility estimates correlated well with the experimentally measured frequency of tetramer-binding sites. This suggests that the feasibility of forming the tetramer complex was a major factor in the evolution of this DNA sequence variation.	[Sathyanarayana, Bangalore K.; Lee, Byungkook] NCI, Mol Biol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Li, Peng; Lin, Jian-Xin; Leonard, Warren J.] NHLBI, Lab Mol Immunol, NIH, Bethesda, MD 20892 USA; [Li, Peng; Lin, Jian-Xin; Leonard, Warren J.] NHLBI, Ctr Immunol, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Lee, B (corresponding author), NCI, Mol Biol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.; Leonard, WJ (corresponding author), NHLBI, Lab Mol Immunol, NIH, Bethesda, MD 20892 USA.; Leonard, WJ (corresponding author), NHLBI, Ctr Immunol, NIH, Bethesda, MD 20892 USA.	leonardw@nhlbi.nih.gov; BKLee@mail.nih.gov	Leonard, Warren/AAA-1397-2022; Lee, Byungkook/E-4564-2011	Lee, Byungkook/0000-0002-3339-4582	Intramural Research Program of the NIH; National Cancer Institute; Center for Cancer Research; Division of Intramural Research, National Heart, Lung, and Blood Institute; National Institutes of Health (National Center for Research Resources) [2P41RR001081]; National Institutes of Health (National Institute of General Medical Sciences) [9P41GM103311]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001081] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL005402, ZIAHL005401] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103311] Funding Source: NIH RePORTER	Intramural Research Program of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Division of Intramural Research, National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health (National Center for Research Resources)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institutes of Health (National Institute of General Medical Sciences)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research and the Division of Intramural Research, National Heart, Lung, and Blood Institute. The Chimera software we used was developed by the Resource for Biocomputing, Visualization, and Informatics at the University of California, San Francisco, with support from the National Institutes of Health (National Center for Research Resources grant 2P41RR001081, National Institute of General Medical Sciences grant 9P41GM103311). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreeva A, 2008, NUCLEIC ACIDS RES, V36, pD419, DOI 10.1093/nar/gkm993; Becker S, 1998, NATURE, V394, P145, DOI 10.1038/28101; Begitt A, 2014, NAT IMMUNOL, V15, P168, DOI 10.1038/ni.2794; BERGAD PL, 1995, J BIOL CHEM, V270, P24903, DOI 10.1074/jbc.270.42.24903; Chen XM, 2003, PROTEIN SCI, V12, P361, DOI 10.1110/ps.0218903; Chen XM, 1998, CELL, V93, P827, DOI 10.1016/S0092-8674(00)81443-9; Dajee M, 1996, MOL ENDOCRINOL, V10, P171, DOI 10.1210/me.10.2.171; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; John S, 1999, MOL CELL BIOL, V19, P1910; Leonard WJ, 1998, ANNU REV IMMUNOL, V16, P293, DOI 10.1146/annurev.immunol.16.1.293; Lin JX, 2012, IMMUNITY, V36, P586, DOI 10.1016/j.immuni.2012.02.017; Moriggl R, 2005, CANCER CELL, V7, P87, DOI 10.1016/j.ccr.2004.12.010; Neculai D, 2005, J BIOL CHEM, V280, P40782, DOI 10.1074/jbc.M507682200; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Shen Y, 2001, J VIROL, V75, P2627, DOI 10.1128/JVI.75.6.2627-2633.2001; Soldaini E, 2000, MOL CELL BIOL, V20, P389, DOI 10.1128/MCB.20.1.389-401.2000; Staab J, 2015, MOL IMMUNOL, V67, P596, DOI 10.1016/j.molimm.2015.07.015; Stark GR, 2012, IMMUNITY, V36, P503, DOI 10.1016/j.immuni.2012.03.013; Timofeeva Olga A, 2012, JAKSTAT, V1, P274, DOI 10.4161/jkst.22313; Vinkemeier U, 1998, SCIENCE, V279, P1048, DOI 10.1126/science.279.5353.1048; Vinkemeier U, 1996, EMBO J, V15, P5616, DOI 10.1002/j.1460-2075.1996.tb00946.x; Wojciak JM, 2009, EMBO J, V28, P948, DOI 10.1038/emboj.2009.30; Xu XA, 1996, SCIENCE, V273, P794, DOI 10.1126/science.273.5276.794; Zhang XK, 2001, J BIOL CHEM, V276, P33576, DOI 10.1074/jbc.M104978200	24	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0160339	10.1371/journal.pone.0160339	http://dx.doi.org/10.1371/journal.pone.0160339			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27537504	Green Published, gold, Green Submitted			2022-12-27	WOS:000381577000017
J	Beck, KK; Medeiros, AS; Finkelstein, SA				Beck, Kristen K.; Medeiros, Andrew S.; Finkelstein, Sarah A.			Drivers of Change in a 7300-Year Holocene Diatom Record from the Hemi-Boreal Region of Ontario, Canada	PLOS ONE			English	Article							EXPERIMENTAL LAKES AREA; OLD CROW FLATS; NORTHWESTERN ONTARIO; WATER DEPTH; CATCHMENT CHARACTERISTICS; LIMNOLOGICAL CONDITIONS; SOIL DEVELOPMENT; COASTAL WETLAND; NORTH-AMERICAN; FOREST FLOOR	A Holocene lake sediment record spanning the past 7300 years from Wishart Lake in the Turkey Lakes Watershed in the Hemi-Boreal of central Ontario, Canada, was used to evaluate the potential drivers of long-term change in diatom assemblages at this site. An analysis of diatom assemblages found that benthic and epiphytic taxa dominated the mid-Holocene (7300-4000 cal yr BP), indicating shallow, oligotrophic, circum-neutral conditions, with macrophytes present. A significant shift in diatom assemblages towards more planktonic species (mainly Cyclotella sensu lato, but also several species of Aulacoseira, and Tabellaria flocculosa) occurred similar to 4000 cal yr BP. This change likely reflects an increase in lake level, coincident with the onset of a more strongly positive moisture balance following the drier climates of the middle Holocene, established by numerous regional paleoclimate records. Pollen-inferred regional changes in vegetation around 4000 yrs BP, including an increase in Betula and other mesic taxa, may have also promoted changes in diatom assemblages through watershed processes mediated by the chemistry of runoff. A more recent significant change in limnological conditions is marked by further increases in Cyclotella sensu lato beginning in the late 19th century, synchronous with the Ambrosia pollen rise and increases in sediment bulk density, signaling regional and local land clearance at the time of Euro-Canadian settlement (1880 AD). In contrast to the mid-Holocene increase in planktonic diatoms, the modern increase in Cyclotella sensu lato likely indicates a response to land use and vegetation change, and erosion from the watershed, rather than a further increase in water level. The results from Wishart Lake illustrate the close connection between paleoclimate change, regional vegetation, watershed processes, and diatom assemblages and also provides insight into the controls on abundance of Cyclotella sensu lato, a diatom taxonomic group which has shown significant increases and complex dynamics in the postindustrial era in lakes spanning temperate to Arctic regions.	[Beck, Kristen K.] Univ Toronto, Dept Geog, Toronto, ON, Canada; [Medeiros, Andrew S.] York Univ, Dept Geog, Toronto, ON, Canada; [Finkelstein, Sarah A.] Univ Toronto, Dept Earth Sci, Toronto, ON, Canada; [Beck, Kristen K.] Univ Melbourne, Sch Geog, Melbourne, Vic, Australia	University of Toronto; York University - Canada; University of Toronto; University of Melbourne	Finkelstein, SA (corresponding author), Univ Toronto, Dept Earth Sci, Toronto, ON, Canada.	finkelstein@es.utoronto.ca	Beck, Kristen/Y-6561-2019; Medeiros, Andrew S./I-1947-2019; Finkelstein, Sarah/K-8202-2012	Beck, Kristen/0000-0002-8257-9639; Medeiros, Andrew S./0000-0002-7743-2560; Finkelstein, Sarah/0000-0002-8239-399X	Natural Sciences and Engineering Research Council of Canada [RGPIN 327197-11]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This study was funded by the Natural Sciences and Engineering Research Council of Canada (Discovery Grant RGPIN 327197-11 to SAF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almquist H, 2001, HOLOCENE, V11, P189, DOI 10.1191/095968301677768783; Antoniades D., 2008, ICONOGRAPHIA DIATOMO, V17, P1; Appleby PG, 2002, DEV PALEOENVIRON RES, V1, P171; Balasubramaniam AM, 2015, CAN J FISH AQUAT SCI, V72, P1058, DOI 10.1139/cjfas-2014-0340; Battarbee R. W., 2001, TRACKING ENV CHANGE, P155, DOI DOI 10.1007/0-306-47668-1_8; Beall FD, 2001, ECOSYSTEMS, V4, P514, DOI 10.1007/s10021-001-0025-0; Blaauw M, 2010, QUAT GEOCHRONOL, V5, P512, DOI 10.1016/j.quageo.2010.01.002; BRAIS S, 1995, FOREST ECOL MANAG, V76, P181, DOI 10.1016/0378-1127(95)03541-H; Brandt JP, 2009, ENVIRON REV, V17, P101, DOI 10.1139/A09-004; Brugam RB, 1998, J PALEOLIMNOL, V20, P267, DOI 10.1023/A:1007948616511; Bryant GA, 1975, THESIS; Catalan J, 2013, J PALEOLIMNOL, V49, P513, DOI 10.1007/s10933-013-9681-2; CROCKER RL, 1955, J ECOL, V43, P427, DOI 10.2307/2257005; Davis M, 2000, CONSERV BIOL, V14, P968, DOI 10.1046/j.1523-1739.2000.99219.x; Davis M.B., 1981, FOREST SUCCESSION CO, P132, DOI DOI 10.1007/978-1-4612-5950-3_10; DELORME LD, 1986, ARCH HYDROBIOL, V108, P1; Desellas AM, 2011, J LIMNOL, V70, P41, DOI 10.4081/jlimnol.2011.41; Duthie HC, 1996, J PALEOLIMNOL, V15, P79; Environment Canada, 1980, TURK LAK WAT MET DAT; Faegri K., 1975, Textbook of pollen analysis.; Fallu M.-A., 2000, FRESHWATER DIATOMS N, V45, P200; Finkelstein SA, 2006, QUATERNARY RES, V65, P33, DOI 10.1016/j.yqres.2005.08.021; Finkelstein SA, 2005, J PALEOLIMNOL, V33, P1, DOI 10.1007/s10933-004-0423-3; Fritz SC, 2013, J PALEOLIMNOL, V49, P349, DOI 10.1007/s10933-013-9684-z; Glew J, 1991, J PALEOLIMNOL, V5, P285, DOI DOI 10.1007/BF00200351; Harper NS, 1982, UNPUB; HARRISON SP, 1989, CLIM DYNAM, V3, P157; Heiri O, 2001, J PALEOLIMNOL, V25, P101, DOI 10.1023/A:1008119611481; Houk V, 2004, DIATOM RES, V19, P203; Huvane JK, 1996, J PALEOLIMNOL, V16, P323; JACOBSON GL, 1980, QUATERNARY RES, V14, P87, DOI 10.1016/0033-5894(80)90008-3; JEFFRIES DS, 1988, CAN J FISH AQUAT SCI, V45, P3; Juggins S., RIOJA R PACKAGE ANAL; Juggins S., 2003, C2 SOFTWARE FOR ECOL; Karmakar M, 2015, HOLOCENE, V25, P166, DOI 10.1177/0959683614556376; KELSO JRM, 1988, CAN J FISH AQUAT SCI, V45, P115; Kingston John C., 2003, P595, DOI 10.1016/B978-012741550-5/50017-9; KNUDSON BM, 1957, J ECOL, V45, P93, DOI 10.2307/2257078; Laird KR, 2008, QUATERNARY RES, V69, P292, DOI 10.1016/j.yqres.2007.11.003; Laird KR, 2011, QUATERNARY SCI REV, V30, P1201, DOI 10.1016/j.quascirev.2011.02.009; Lange-Beralot H, 1986, BACILLARIOPHYCEAE SU; Lavoie I., 2008, GUIDE IDENTIFICATION; LIU KB, 1990, ECOL MONOGR, V60, P179, DOI 10.2307/1943044; Mann ME, 2008, P NATL ACAD SCI USA, V105, P13252, DOI 10.1073/pnas.0805721105; McAndrews JH, 1993, PROXY CLIMATE DATA M, P22; McDowall D, 1984, STEEL AT THE SAULT; Medeiros AS, 2014, HOLOCENE, V24, P1308, DOI 10.1177/0959683614540955; Moos MT, 2011, QUATERNARY SCI REV, V30, P1232, DOI 10.1016/j.quascirev.2011.02.013; Moos MT, 2009, HOLOCENE, V19, P359, DOI 10.1177/0959683608101387; Moos MT, 2005, J PALEOLIMNOL, V34, P217, DOI 10.1007/s10933-005-2382-8; Moser K., 2004, ECOLOGY DISTRIBUTION; PARE D, 1993, J VEG SCI, V4, P811, DOI 10.2307/3235619; Patrick R.M., 1966, FRAGILARIACEAE EUNOT, V13, P1, DOI 10.2307/1351135; Pomeroy JW, 2006, HYDROL PROCESS, V20, P923, DOI 10.1002/hyp.6124; Prescott CE, 2000, CAN J FOREST RES, V30, P1742, DOI 10.1139/cjfr-30-11-1742; R Core Team, 2021, R LANGUAGE ENV STAT; Reimer PJ, 2009, RADIOCARBON, V51, P1111, DOI 10.1017/S0033822200034202; Ruhland KM, 2015, J PALEOLIMNOL, V54, P1, DOI 10.1007/s10933-015-9837-3; Ruhland K, 2008, GLOBAL CHANGE BIOL, V14, P2740, DOI 10.1111/j.1365-2486.2008.01670.x; SAARNISTO M, 1974, QUATERNARY RES, V4, P316, DOI 10.1016/0033-5894(74)90019-2; Saros JE, 2015, BIOL REV, V90, P522, DOI 10.1111/brv.12120; Shuman B, 2006, QUATERNARY RES, V65, P44, DOI 10.1016/j.yqres.2005.09.001; Shuman B, 2004, ECOLOGY, V85, P1297, DOI 10.1890/02-0286; Shuman B, 2001, QUATERNARY RES, V56, P401, DOI 10.1006/qres.2001.2273; Sirois A, 2001, ECOSYSTEMS, V4, P503, DOI 10.1007/s10021-001-0024-1; Smol JP, 2010, FRESHWATER BIOL, V55, P43, DOI 10.1111/j.1365-2427.2009.02373.x; Smol JP, 2005, P NATL ACAD SCI USA, V102, P4397, DOI 10.1073/pnas.0500245102; Sorvari S, 1998, J PALEOLIMNOL, V20, P205, DOI 10.1023/A:1007953515620; SREENIVASA MR, 1973, CAN J BOT, V51, P1599, DOI 10.1139/b73-204; St Jacques JM, 2008, J BIOGEOGR, V35, P306, DOI 10.1111/j.1365-2699.2007.01785.x; St Jacques JM, 2000, J PALEOLIMNOL, V23, P385, DOI 10.1023/A:1008178002326; Stewart KA, 2011, ARCTIC, V64, P169; Stuiver MP, 2013, CALIB 6 0; Turner KW, 2014, GLOBAL CHANGE BIOL, V20, P1585, DOI 10.1111/gcb.12465; Viau AE, 2009, J CLIMATE, V22, P316, DOI 10.1175/2008JCLI2342.1; Viau AE, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006031; Viau AE, 2001, J GEOPHYS RES-ATMOS, V106, P31703, DOI 10.1029/2000JD000237; Werner P, 2006, NOVA HEDWIGIA, P373; White MS, 2008, HYDROBIOLOGIA, V613, P21, DOI 10.1007/s10750-008-9469-y; WHITEHEAD D R, 1989, Journal of Paleolimnology, V2, P185; Wolfe AP, 2006, J PALEOLIMNOL, V36, P91, DOI 10.1007/s10933-006-0006-6; Wolin J. A., 2010, The diatoms: applications for the environmental and earth sciences, P174; Wolin JA, 2005, J PALEOLIMNOL, V33, P73, DOI 10.1007/s10933-004-1688-2; Woodside T, 1963, MARIE FOREST DISTRIC; WRIGHT HE, 1967, J SEDIMENT PETROL, V37, P975, DOI 10.1306/74D71807-2B21-11D7-8648000102C1865D; YANG JR, 1995, J GREAT LAKES RES, V21, P84, DOI 10.1016/S0380-1330(95)71023-1; Yu ZC, 1997, GEOLOGY, V25, P251, DOI 10.1130/0091-7613(1997)025<0251:MHDCCB>2.3.CO;2	87	5	5	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2016	11	8							e0159937	10.1371/journal.pone.0159937	http://dx.doi.org/10.1371/journal.pone.0159937			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4YN	27532216	Green Published, Green Accepted, gold			2022-12-27	WOS:000381487600016
J	Tran, L; Hanavan, PD; Campbell, LE; De Filippis, E; Lake, DF; Coletta, DK; Roust, LR; Mandarino, LJ; Carroll, CC; Katsanos, CS				Tran, Lee; Hanavan, Paul D.; Campbell, Latoya E.; De Filippis, Elena; Lake, Douglas F.; Coletta, Dawn K.; Roust, Lori R.; Mandarino, Lawrence J.; Carroll, Chad C.; Katsanos, Christos S.			Prolonged Exposure of Primary Human Muscle Cells to Plasma Fatty Acids Associated with Obese Phenotype Induces Persistent Suppression of Muscle Mitochondrial ATP Synthase beta Subunit	PLOS ONE			English	Article							SKELETAL-MUSCLE; MESSENGER-RNA; INSULIN-RESISTANCE; PROTEIN-SYNTHESIS; 3'-UNTRANSLATED REGION; ARACHIDONIC-ACID; METABOLISM; HYPERAMINOACIDEMIA; HYPERINSULINEMIA; HYPERGLYCEMIA	Our previous studies show reduced abundance of the beta-subunit of mitochondrial H+-ATP synthase (beta-F1-ATPase) in skeletal muscle of obese individuals. The beta-F1-ATPase forms the catalytic core of the ATP synthase, and it is critical for ATP production in muscle. The mechanism(s) impairing beta-F1-ATPase metabolism in obesity, however, are not completely understood. First, we studied total muscle protein synthesis and the translation efficiency of beta-F1-ATPase in obese (BMI, 36 +/- 1 kg/m(2)) and lean (BMI, 22 +/- 1 kg/m(2)) subjects. Both total protein synthesis (0.044 +/- 0.006 vs 0.066 +/- 0.006%.h(-1)) and translation efficiency of beta-F1-ATPase (0.0031 +/- 0.0007 vs 0.0073 +/- 0.0004) were lower in muscle from the obese subjects when compared to the lean controls (P<0.05). We then evaluated these same responses in a primary cell culture model, and tested the specific hypothesis that circulating non-esterified fatty acids (NEFA) in obesity play a role in the responses observed in humans. The findings on total protein synthesis and translation efficiency of beta-F1-ATPase in primary myotubes cultured from a lean subject, and after exposure to NEFA extracted from serum of an obese subject, were similar to those obtained in humans. Among candidate microRNAs (i.e., non-coding RNAs regulating gene expression), we identified miR-127-5p in preventing the production of beta-F1-ATPase. Muscle expression of miR-127-5p negatively correlated with beta-F1-ATPase protein translation efficiency in humans (r = -0.6744; P<0.01), and could be modeled in vitro by prolonged exposure of primary myotubes derived from the lean subject to NEFA extracted from the obese subject. On the other hand, locked nucleic acid inhibitor synthesized to target miR-127-5p significantly increased beta-F1-ATPase translation efficiency in myotubes (0.6 +/- 0.1 vs 1.3 +/- 0.3, in control vs exposure to 50 nM inhibitor; P<0.05). Our experiments implicate circulating NEFA in obesity in suppressing muscle protein metabolism, and establish impaired beta-F1-ATPase translation as an important consequence of obesity.	[Tran, Lee; Hanavan, Paul D.; Campbell, Latoya E.; Lake, Douglas F.; Coletta, Dawn K.; Mandarino, Lawrence J.; Katsanos, Christos S.] Arizona State Univ, Ctr Metab & Vasc Biol, Scottsdale, AZ USA; [Tran, Lee; Hanavan, Paul D.; Campbell, Latoya E.; Lake, Douglas F.; Coletta, Dawn K.; Mandarino, Lawrence J.; Katsanos, Christos S.] Mayo Clin Arizona, Scottsdale, AZ USA; [Coletta, Dawn K.; Mandarino, Lawrence J.] Arizona State Univ, Coll Hlth Solut, Phoenix, AZ USA; [Tran, Lee; Hanavan, Paul D.; Campbell, Latoya E.; Lake, Douglas F.; Katsanos, Christos S.] Arizona State Univ, Sch Life Sci, Tempe, AZ USA; [De Filippis, Elena; Roust, Lori R.; Mandarino, Lawrence J.] Mayo Clin, Dept Med, Scottsdale, AZ USA; [Carroll, Chad C.] Midwestern Univ, Dept Physiol, Glendale, AZ USA	Arizona State University; Mayo Clinic; Mayo Clinic Phoenix; Arizona State University; Arizona State University-Downtown Phoenix; Arizona State University; Arizona State University-Tempe; Mayo Clinic; Mayo Clinic Phoenix; Midwestern University	Katsanos, CS (corresponding author), Arizona State Univ, Ctr Metab & Vasc Biol, Scottsdale, AZ USA.; Katsanos, CS (corresponding author), Mayo Clin Arizona, Scottsdale, AZ USA.; Katsanos, CS (corresponding author), Arizona State Univ, Sch Life Sci, Tempe, AZ USA.	christos.katsanos@asu.edu	Tran, Lee/AAZ-7340-2020	Tran, Lee/0000-0001-9074-6495	NIH/National Institute of Diabetes and Digestive and Kidney Diseases [DK094062]; Mayo Clinic Metabolomics Core grants [U24DK100469, UL1TR000135]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK094062, R01DK094013] Funding Source: NIH RePORTER	NIH/National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Mayo Clinic Metabolomics Core grants; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the NIH/National Institute of Diabetes and Digestive and Kidney Diseases grant DK094062 to CSK. Also, Mayo Clinic Metabolomics Core grants U24DK100469 and UL1TR000135.	Antwi K, 2009, MOL IMMUNOL, V46, P2931, DOI 10.1016/j.molimm.2009.06.021; Boden G, 2002, EUR J CLIN INVEST, V32, P14, DOI 10.1046/j.1365-2362.32.s3.3.x; Cardel M, 2015, J NUTR, V145, P2146, DOI 10.3945/jn.115.212365; Carroll CC, 2005, AM J PHYSIOL-ENDOC M, V288, pE479, DOI 10.1152/ajpendo.00393.2004; Chevalier S, 2015, OBESITY, V23, P351, DOI 10.1002/oby.20943; Corcoran MP, 2007, AM J CLIN NUTR, V85, P662; Delarue J, 2007, CURR OPIN CLIN NUTR, V10, P142, DOI 10.1097/MCO.0b013e328042ba90; Fabian MR, 2012, NAT STRUCT MOL BIOL, V19, P586, DOI 10.1038/nsmb.2296; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Gayoso-Diz P, 2013, BMC ENDOCR DISORD, V13, DOI 10.1186/1472-6823-13-47; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Guillet C, 2011, CURR OPIN CLIN NUTR, V14, P89, DOI 10.1097/MCO.0b013e328341389e; Guillet C, 2009, J CLIN ENDOCR METAB, V94, P3044, DOI 10.1210/jc.2008-2216; Hojlund K, 2010, DIABETOLOGIA, V53, P541, DOI 10.1007/s00125-009-1624-0; HUGHES SM, 1993, DEVELOPMENT, V118, P1137; Hussey SE, 2013, MED SCI SPORT EXER, V45, P1069, DOI 10.1249/MSS.0b013e3182814917; Hwang H, 2010, DIABETES, V59, P33, DOI 10.2337/db09-0214; Izquierdo JM, 2000, BIOCHEM J, V346, P849, DOI 10.1042/0264-6021:3460849; Katchman BA, 2011, MOL CANCER RES, V9, P1621, DOI 10.1158/1541-7786.MCR-11-0018; Katsanos CS, 2008, NUTR RES, V28, P651, DOI 10.1016/j.nutres.2008.06.007; Katsanos CS, 2011, OBESITY, V19, P469, DOI 10.1038/oby.2010.290; Katsanos CS, 2009, J CLIN ENDOCR METAB, V94, P2984, DOI 10.1210/jc.2008-2686; KOISHI K, 1995, DEV DYNAM, V202, P244, DOI 10.1002/aja.1002020304; Krarnarova TV, 2008, BBA-BIOENERGETICS, V1777, P747, DOI 10.1016/j.bbabio.2008.05.446; Kristensen AR, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.47; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Lang CH, 2006, AM J PHYSIOL-ENDOC M, V291, pE666, DOI 10.1152/ajpendo.00065.2006; Tran L, 2013, J GERONTOL A-BIOL, V68, P1045, DOI 10.1093/gerona/glt106; Markworth JF, 2013, AM J PHYSIOL-CELL PH, V304, pC56, DOI 10.1152/ajpcell.00038.2012; Mokdad AH, 2003, JAMA-J AM MED ASSOC, V289, P76, DOI [10.1001/jama.289.1.76, DOI 10.1001/JAMA.289.1.76]; Newcomer B, 2001, INT J OBESITY, V25, P1309, DOI 10.1038/sj.ijo.0801673; Ozsolak F, 2008, GENE DEV, V22, P3172, DOI 10.1101/gad.1706508; Persson XMT, 2010, J LIPID RES, V51, P2761, DOI 10.1194/jlr.M008011; Petersen KF, 2004, NEW ENGL J MED, V350, P664, DOI 10.1056/NEJMoa031314; Reyes R, 2007, BIOCHEM BIOPH RES CO, V357, P1107, DOI 10.1016/j.bbrc.2007.04.088; RODEMANN HP, 1982, J BIOL CHEM, V257, P1632; Simoes AES, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-181; Smith GI, 2011, CLIN SCI, V121, P267, DOI 10.1042/CS20100597; Szendroedi J, 2007, PLOS MED, V4, P858, DOI 10.1371/journal.pmed.0040154; Tanner CJ, 2002, AM J PHYSIOL-ENDOC M, V282, pE1191, DOI 10.1152/ajpendo.00416.2001; Tardif N, 2014, AGING CELL, V13, P1001, DOI 10.1111/acel.12263; Tran L, 2015, MOL PSYCHIATR, V20, P1219, DOI 10.1038/mp.2014.122; Tran L, 2013, PSYCHONEUROENDOCRINO, V38, P898, DOI 10.1016/j.psyneuen.2012.09.016; Tran L, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12479; Velica P, 2011, MUSCLE NERVE, V44, P366, DOI 10.1002/mus.22056; VOYTIK SL, 1993, DEV DYNAM, V198, P214, DOI 10.1002/aja.1001980307; Wang CJ, 2014, DIABETES, V63, P947, DOI 10.2337/db13-1096; Willers IM, 2012, BBA-BIOENERGETICS, V1817, P838, DOI 10.1016/j.bbabio.2012.03.005; Willers IM, 2011, BBA-BIOENERGETICS, V1807, P543, DOI 10.1016/j.bbabio.2010.10.016; Zabielski P, 2013, J MASS SPECTROM, V48, P269, DOI 10.1002/jms.3120; Zheng SQ, 2011, ANTIVIR RES, V89, P219, DOI 10.1016/j.antiviral.2011.01.008	51	9	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2016	11	8							e0160057	10.1371/journal.pone.0160057	http://dx.doi.org/10.1371/journal.pone.0160057			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4YN	27532680	Green Submitted, Green Published, gold			2022-12-27	WOS:000381487600022
J	Wang, XF; Liu, DX; Liang, Y; Xing, LL; Zhao, WH; Qin, XX; Shang, DS; Li, B; Fang, WG; Cao, L; Zhao, WD; Chen, YH				Wang, Xia-Fei; Liu, Dong-Xin; Liang, Yue; Xing, Li-Li; Zhao, Wen-Hui; Qin, Xiao-Xue; Shang, De-Shu; Li, Bo; Fang, Wen-Gang; Cao, Liu; Zhao, Wei-Dong; Chen, Yu-Hua			Cystatin C Shifts APP Processing from Amyloid-beta Production towards Non-Amyloidgenic Pathway in Brain Endothelial Cells	PLOS ONE			English	Article							PRECURSOR PROTEIN PROTECT; ALZHEIMERS-DISEASE; SECRETED FORMS; UP-REGULATION; MACULAR DEGENERATION; GENE-EXPRESSION; GAMMA-SECRETASE; MOUSE MODELS; PEPTIDE; NEURONS	Amyloid-beta (A beta), the major component of neuritic plaques in Alzheimer's disease (AD), is derived from sequential proteolytic cleavage of amyloid protein precursor (APP) by secretases. In this study, we found that cystatin C (CysC), a natural cysteine protease inhibitor, is able to reduce A beta 40 secretion in human brain microvascular endothelial cells (HBMEC). The CysC-induced A beta 40 reduction was caused by degradation of beta-secretase BACE1 through the ubiquitin/proteasome pathway. In contrast, we found that CysC promoted secretion of soluble APP alpha indicating the activated non-amyloidogenic processing of APP in HBMEC. Further results revealed that a-secretase ADAM10, which was transcriptionally upregulated in response to CysC, was required for the CysC-induced sAPP alpha secretion. Knockdown of SIRT1 abolished CysC-triggered ADAM10 upregulation and sAPP alpha production. Taken together, our results demonstrated that exogenously applied CysC can direct amyloidogenic APP processing to non-amyloidgenic pathway in brain endothelial cells, mediated by proteasomal degradation of BACE1 and SIRT1-mediated ADAM10 upregulation. Our study unveils previously unrecognized protective role of CysC in APP processing.	[Zhao, Wei-Dong; Chen, Yu-Hua] China Med Univ, Minist Publ Hlth, Key Lab Cell Biol, Dept Dev Cell Biol, 77 Puhe Rd, Shenyang 110122, Peoples R China; China Med Univ, Minist Educ, Key Lab Med Cell Biol, 77 Puhe Rd, Shenyang 110122, Peoples R China	China Medical University; China Medical University	Zhao, WD; Chen, YH (corresponding author), China Med Univ, Minist Publ Hlth, Key Lab Cell Biol, Dept Dev Cell Biol, 77 Puhe Rd, Shenyang 110122, Peoples R China.	wdzhao@163.com; yhchen@mail.cmu.edu.cn			National Natural Science Foundation of China [30970120, 31171291, 31571057, 81171537, 81201255]; Innovation Team Program Foundation of Ministry of Education of China [IRT13101]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovation Team Program Foundation of Ministry of Education of China(Ministry of Education, China)	This work was supported by National Natural Science Foundation of China (30970120, 31171291, 31571057, 81171537, 81201255) and the Innovation Team Program Foundation of Ministry of Education of China (IRT13101). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attems J, 2010, J NEUROL SCI, V299, P155, DOI 10.1016/j.jns.2010.08.030; Austin SA, 2010, CIRC RES, V107, P1498, DOI 10.1161/CIRCRESAHA.110.233080; Bai Y, 2008, MOL CELL PROTEOMICS, V7, P15, DOI 10.1074/mcp.M700077-MCP200; Butler JM, 2015, HUM GENET, V134, P705, DOI 10.1007/s00439-015-1552-7; Cai HB, 2001, NAT NEUROSCI, V4, P233, DOI 10.1038/85064; De Strooper B, 2003, NEURON, V38, P9, DOI 10.1016/S0896-6273(03)00205-8; Deane R, 2004, NEURON, V43, P333, DOI 10.1016/j.neuron.2004.07.017; Deng A, 2001, AM J PATHOL, V159, P1061, DOI 10.1016/S0002-9440(10)61781-6; Farzan M, 2000, P NATL ACAD SCI USA, V97, P9712, DOI 10.1073/pnas.160115697; Gauthier Sebastien, 2011, Front Biosci (Schol Ed), V3, P541, DOI 10.2741/s170; Gong B, 2013, NEUROBIOL AGING, V34, P1581, DOI 10.1016/j.neurobiolaging.2012.12.005; GOODMAN Y, 1994, EXP NEUROL, V128, P1, DOI 10.1006/exnr.1994.1107; Greenberg SA, 2004, STROKE, V35, P2616, DOI 10.1161/01.str.0000143224.36527.44; Hansson SF, 2009, J ALZHEIMERS DIS, V16, P389, DOI 10.3233/JAD-2009-0966; Jorissen E, 2010, J NEUROSCI, V30, P4833, DOI 10.1523/JNEUROSCI.5221-09.2010; Kaeser SA, 2007, NAT GENET, V39, P1437, DOI 10.1038/ng.2007.23; Kitazume S, 2010, J BIOL CHEM, V285, P40097, DOI 10.1074/jbc.M110.144626; Koh YH, 2005, J BIOL CHEM, V280, P32499, DOI 10.1074/jbc.M506199200; Kuhn PH, 2010, EMBO J, V29, P3020, DOI 10.1038/emboj.2010.167; Lee HR, 2014, J NEUROSCI RES, V92, P1581, DOI 10.1002/jnr.23421; Liu YB, 2010, NUCLEIC ACIDS RES, V38, P6857, DOI 10.1093/nar/gkq585; Lukasiuk K, 2002, EPILEPSIA, V43, P137, DOI 10.1046/j.1528-1157.43.s.5.20.x; Martinez-Vargas M, 2014, INT J MOL SCI, V15, P5807, DOI 10.3390/ijms15045807; MATTSON MP, 1993, NEURON, V10, P243, DOI 10.1016/0896-6273(93)90315-I; Mi W, 2007, NAT GENET, V39, P1440, DOI 10.1038/ng.2007.29; Palsdottir A, 2006, BRAIN PATHOL, V16, P55; Pawlik M, 2004, J MOL NEUROSCI, V22, P13, DOI 10.1385/JMN:22:1-2:13; Peng Y, 2011, NEUROSCI LETT, V487, P211, DOI 10.1016/j.neulet.2010.10.025; Qing H, 2004, FASEB J, V18, P1571, DOI 10.1096/fj.04-1994fje; Ring S, 2007, J NEUROSCI, V27, P7817, DOI 10.1523/JNEUROSCI.1026-07.2007; Sant'Anna R, 2016, FEBS LETT, V590, P644, DOI 10.1002/1873-3468.12093; Sastre M, 2004, NEUROBIOL AGING, V25, P1033, DOI 10.1016/j.neurobiolaging.2003.11.006; Scheltens P., 2016, LANCET; Selenica ML, 2007, SCAND J CLIN LAB INV, V67, P179, DOI 10.1080/00365510601009738; Shen CY, 2008, J BIOL CHEM, V283, P17721, DOI 10.1074/jbc.M800013200; Singh AK, 2015, AGING CELL, V14, P595, DOI 10.1111/acel.12335; SMITHSWINTOSKY VL, 1994, J NEUROCHEM, V63, P781, DOI 10.1046/j.1471-4159.1994.63020781.x; Sun BG, 2008, NEURON, V60, P247, DOI 10.1016/j.neuron.2008.10.001; Tamagno E, 2012, IUBMB LIFE, V64, P943, DOI 10.1002/iub.1099; Tarasoff-Conway JM, 2015, NAT REV NEUROL, V11, P457, DOI 10.1038/nrneurol.2015.119; Thinakaran G, 2008, J BIOL CHEM, V283, P29615, DOI 10.1074/jbc.R800019200; Tizon B, 2010, J ALZHEIMERS DIS, V19, P885, DOI 10.3233/JAD-2010-1291; Tong Y, 2005, J NEURAL TRANSM, V112, P455, DOI 10.1007/s00702-004-0255-3; Turk V, 2008, FRONT BIOSCI-LANDMRK, V13, P5406, DOI 10.2741/3089; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; WOLF BA, 1995, J BIOL CHEM, V270, P4916, DOI 10.1074/jbc.270.9.4916; Yamada Toshiyuki, 2002, Rinsho Byori, V50, P613; Yan RQ, 2014, LANCET NEUROL, V13, P319, DOI 10.1016/S1474-4422(13)70276-X; Zhang YW, 2011, MOL BRAIN, V4, DOI 10.1186/1756-6606-4-3; Zhao YH, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0015816, 10.1371/journal.pone.0016470]	51	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2016	11	8							e0161093	10.1371/journal.pone.0161093	http://dx.doi.org/10.1371/journal.pone.0161093			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4YN	27532339	gold, Green Published, Green Submitted			2022-12-27	WOS:000381487600058
J	Diaz-Garcia, L; Covarrubias-Pazaran, G; Schlautman, B; Zalapa, J				Diaz-Garcia, Luis; Covarrubias-Pazaran, Giovanny; Schlautman, Brandon; Zalapa, Juan			GiNA, an Efficient and High-Throughput Software for Horticultural Phenotyping	PLOS ONE			English	Article							IMAGE-ANALYSIS; PHENOMICS; RESPONSES; CRANBERRY; DEFECTS; GROWTH; RICE	Traditional methods for trait phenotyping have been a bottleneck for research in many crop species due to their intensive labor, high cost, complex implementation, lack of reproducibility and propensity to subjective bias. Recently, multiple high-throughput phenotyping platforms have been developed, but most of them are expensive, species-dependent, complex to use, and available only for major crops. To overcome such limitations, we present the open-source software GiNA, which is a simple and free tool for measuring horticultural traits such as shape-and color-related parameters of fruits, vegetables, and seeds. GiNA is multi-platform software available in both R and MATLAB (R) programming languages and uses conventional images from digital cameras with minimal requirements. It can process up to 11 different horticultural morphological traits such as length, width, two-dimensional area, volume, projected skin, surface area, RGB color, among other parameters. Different validation tests produced highly consistent results under different lighting conditions and camera setups making GiNA a very reliable platform for high-throughput phenotyping. In addition, fivefold cross validation between manually generated and GiNA measurements for length and width in cranberry fruits were 0.97 and 0.92. In addition, the same strategy yielded prediction accuracies above 0.83 for color estimates produced from images of cranberries analyzed with GiNA compared to total anthocyanin content (TAcy) of the same fruits measured with the standard methodology of the industry. Our platform provides a scalable, easy-to-use and affordable tool for massive acquisition of phenotypic data of fruits, seeds, and vegetables.	[Diaz-Garcia, Luis; Covarrubias-Pazaran, Giovanny; Schlautman, Brandon; Zalapa, Juan] Univ Wisconsin, Dept Hort, 1575 Linden Dr, Madison, WI 53706 USA; [Diaz-Garcia, Luis] Inst Nacl Invest Forest & Agr & Pecuarias, Aguascalientes, Mexico; [Zalapa, Juan] Univ Wisconsin, USDA ARS, Vegetable Crops Res Unit, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; United States Department of Agriculture (USDA); University of Wisconsin System; University of Wisconsin Madison	Diaz-Garcia, L; Zalapa, J (corresponding author), Univ Wisconsin, Dept Hort, 1575 Linden Dr, Madison, WI 53706 USA.; Diaz-Garcia, L (corresponding author), Inst Nacl Invest Forest & Agr & Pecuarias, Aguascalientes, Mexico.; Zalapa, J (corresponding author), Univ Wisconsin, USDA ARS, Vegetable Crops Res Unit, Madison, WI 53706 USA.	diaz.antonio@inifap.gob.mx; jezalapa@wisc.edu		Schlautman, Brandon/0000-0002-9983-259X; COVARRUBIAS-PAZARAN, GIOVANNY/0000-0002-7194-3837	USDA-ARS [3655-21220-001-00]; WI-DATCP (SCBG Project) [14-002]; National Science Foundation [DBI-1228280]; Ocean Spray Cranberries, Inc.; Wisconsin Cranberry Growers Association; Cranberry Institute; Frank B. Koller Cranberry Fellowship for Graduate Students; Consejo Nacional de Ciencia y Tecnologia (CONACYT, Mexico)	USDA-ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service); WI-DATCP (SCBG Project); National Science Foundation(National Science Foundation (NSF)); Ocean Spray Cranberries, Inc.; Wisconsin Cranberry Growers Association; Cranberry Institute; Frank B. Koller Cranberry Fellowship for Graduate Students; Consejo Nacional de Ciencia y Tecnologia (CONACYT, Mexico)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This project was supported by USDA-ARS (project no. 3655-21220-001-00 provided to JZ); WI-DATCP (SCBG Project #14-002); National Science Foundation (DBI-1228280); Ocean Spray Cranberries, Inc.; Wisconsin Cranberry Growers Association; Cranberry Institute. BS was supported by the Frank B. Koller Cranberry Fellowship for Graduate Students. GCP and LDG were supported by the Consejo Nacional de Ciencia y Tecnologia (CONACYT, Mexico). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; J.Z. and B.S. wish to express their gratitude through Mt 10:32. We wish to thank Bill Hatch, Nicole Hansen, and Leah Hyatt from Cranberry Creek Cranberries Inc. for allowing us to harvest the cranberry samples used to validate GiNA. Also, thank Eric Wiesman, Walter Salazar, Yiwen Ge and Sarah Hodapp for their help in taking pictures and processing fruit samples. This project was supported by USDA-ARS (project no. 3655-21220-001-00 provided to J.Z.); WI-DATCP (SCBG Project #14-002); National Science Foundation (DBI-1228280); Ocean Spray Cranberries, Inc.; Wisconsin Cranberry Growers Association; Cranberry Institute. B.S. was supported by the Frank B. Koller Cranberry Fellowship for Graduate Students. GCP and LDG were supported by the Consejo Nacional de Ciencia y Tecnologia (CONACYT, Mexico). We thank to the anonymous reviewers who helped to enhance the quality of this paper.	Aggelopoulou AD, 2011, PRECIS AGRIC, V12, P448, DOI 10.1007/s11119-010-9187-0; Bac-Molenaar JA, 2015, J EXP BOT, V66, P5567, DOI 10.1093/jxb/erv176; Berge TW, 2012, COMPUT ELECTRON AGR, V81, P79, DOI 10.1016/j.compag.2011.11.004; Busemeyer L, 2013, SCI REP-UK, V3, DOI 10.1038/srep02442; Campbell MT, 2015, PLANT PHYSIOL, V168, P1476, DOI 10.1104/pp.15.00450; Chen DJ, 2014, PLANT CELL, V26, P4636, DOI 10.1105/tpc.114.129601; Chern CG, 2011, METHODS MOL BIOL, V678, P129, DOI 10.1007/978-1-60761-682-5_10; ElMasry G, 2007, J FOOD ENG, V81, P98, DOI 10.1016/j.jfoodeng.2006.10.016; Gonzalo MJ, 2008, THEOR APPL GENET, V116, P647, DOI 10.1007/s00122-007-0698-7; Houle D, 2010, NAT REV GENET, V11, P855, DOI 10.1038/nrg2897; Kleynen O, 2005, J FOOD ENG, V69, P41, DOI 10.1016/j.jfoodeng.2004.07.008; Li L, 2014, SENSORS-BASEL, V14, P20078, DOI 10.3390/s141120078; Lopez-Garcia F, 2010, COMPUT ELECTRON AGR, V71, P189, DOI 10.1016/j.compag.2010.02.001; Omasa K, 2007, J EXP BOT, V58, P881, DOI 10.1093/jxb/erl142; Rakun J, 2011, COMPUT ELECTRON AGR, V76, P80, DOI 10.1016/j.compag.2011.01.007; Taghadomi-Saberi S, 2015, J AGR SCI TECH-IRAN, V17, P589; Vorsa N, 2003, J AM SOC HORTIC SCI, V128, P691, DOI 10.21273/JASHS.128.5.0691; Walter A, 2015, PLANT METHODS, V11, DOI 10.1186/s13007-015-0056-8; White JW, 2012, FIELD CROP RES, V133, P101, DOI 10.1016/j.fcr.2012.04.003; Zhou Y, 2002, PLANT GROWTH REGUL, V38, P165, DOI 10.1023/A:1021322418740	20	16	16	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2016	11	8							e0160439	10.1371/journal.pone.0160439	http://dx.doi.org/10.1371/journal.pone.0160439			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4UN	27529547	Green Submitted, Green Published, gold			2022-12-27	WOS:000381476700006
J	Juffe-Bignoli, D; Brooks, TM; Butchart, SHM; Jenkins, RB; Boe, K; Hoffmann, M; Angulo, A; Bachman, S; Bohm, M; Brummitt, N; Carpenter, KE; Comer, PJ; Cox, N; Cuttelod, A; Darwall, WRT; Di Marco, M; Fishpool, LDC; Goettsch, B; Heath, M; Hilton-Taylor, C; Hutton, J; Johnson, T; Joolia, A; Keith, DA; Langhammer, PF; Luedtke, J; Lughadha, EN; Lutz, M; May, I; Miller, RM; Oliveira-Mrinda, MA; Parr, M; Pollock, CM; Ralph, G; Rodriguez, JP; Rondinini, C; Smart, J; Stuart, S; Symes, A; Tordoff, AW; Woodley, S; Young, B; Kingston, N				Juffe-Bignoli, Diego; Brooks, Thomas M.; Butchart, Stuart H. M.; Jenkins, Richard B.; Boe, Kaia; Hoffmann, Michael; Angulo, Ariadne; Bachman, Steve; Bohm, Monika; Brummitt, Neil; Carpenter, Kent E.; Comer, Pat J.; Cox, Neil; Cuttelod, Annabelle; Darwall, William R. T.; Di Marco, Moreno; Fishpool, Lincoln D. C.; Goettsch, Barbara; Heath, Melanie; Hilton-Taylor, Craig; Hutton, Jon; Johnson, Tim; Joolia, Ackbar; Keith, David A.; Langhammer, Penny F.; Luedtke, Jennifer; Lughadha, Eimear Nic; Lutz, Maiko; May, Ian; Miller, Rebecca M.; Oliveira-Mrinda, Maria A.; Parr, Mike; Pollock, Caroline M.; Ralph, Gina; Rodriguez, Jon Paul; Rondinini, Carlo; Smart, Jane; Stuart, Simon; Symes, Andy; Tordoff, Andrew W.; Woodley, Stephen; Young, Bruce; Kingston, Naomi			Assessing the Cost of Global Biodiversity and Conservation Knowledge	PLOS ONE			English	Article							BAROMETER; PROGRESS; TARGETS; SCIENCE; SITES	Knowledge products comprise assessments of authoritative information supported by standards, governance, quality control, data, tools, and capacity building mechanisms. Considerable resources are dedicated to developing and maintaining knowledge products for biodiversity conservation, and they are widely used to inform policy and advise decision makers and practitioners. However, the financial cost of delivering this information is largely undocumented. We evaluated the costs and funding sources for developing and maintaining four global biodiversity and conservation knowledge products: The IUCN Red List of Threatened Species, the IUCN Red List of Ecosystems, Protected Planet, and the World Database of Key Biodiversity Areas. These are secondary data sets, built on primary data collected by extensive networks of expert contributors worldwide. We estimate that US$160 million (range: US$116-204 million), plus 293 person-years of volunteer time (range: 278308 person-years) valued at US$14 million (range US$12-16 million), were invested in these four knowledge products between 1979 and 2013. More than half of this financing was provided through philanthropy, and nearly three-quarters was spent on personnel costs. The estimated annual cost of maintaining data and platforms for three of these knowledge products (excluding the IUCN Red List of Ecosystems for which annual costs were not possible to estimate for 2013) is US$6.5 million in total (range: US$6.2-6.7 million). We estimated that an additional US$114 million will be needed to reach pre-defined baselines of data coverage for all the four knowledge products, and that once achieved, annual maintenance costs will be approximately US$12 million. These costs are much lower than those to maintain many other, similarly important, global knowledge products. Ensuring that biodiversity and conservation knowledge products are sufficiently up to date, comprehensive and accurate is fundamental to inform decision-making for biodiversity conservation and sustainable development. Thus, the development and implementation of plans for sustainable long-term financing for them is critical.	[Juffe-Bignoli, Diego; Hoffmann, Michael; Hutton, Jon; Johnson, Tim; Stuart, Simon; Kingston, Naomi] UNESP WCMC, United Nations Environm Programme, 219 Huntingdon Rd, Cambridge CB3 0DL, England; [Brooks, Thomas M.; Butchart, Stuart H. M.; Hoffmann, Michael; Smart, Jane; Stuart, Simon] IUCN, 28 Rue Mauverney, CH-1196 Gland, Switzerland; [Brooks, Thomas M.] Univ Philippines Banos, World Agroforestry Ctr ICRAF, Laguna 4031, Philippines; [Brooks, Thomas M.] Univ Tasmania, Inst Marine & Antarct Studies, Hobart, Tas 7001, Australia; [Butchart, Stuart H. M.; Fishpool, Lincoln D. C.; Heath, Melanie; May, Ian; Symes, Andy] BirdLife Int, David Attenborough Bldg,Pembroke St, Cambridge CB2 3QZ, England; [Butchart, Stuart H. M.] Univ Cambridge, Dept Zool, Downing St, Cambridge CB2 3EJ, England; [Jenkins, Richard B.; Cuttelod, Annabelle; Darwall, William R. T.; Goettsch, Barbara; Hilton-Taylor, Craig; Joolia, Ackbar; Pollock, Caroline M.] IUCN Global Species Programme, David Attenborough Bldg,Pembroke St, Cambridge CB2 3QZ, England; [Boe, Kaia; Miller, Rebecca M.] IUCN, Nature Based Solut Grp, 28 Rue Mauverney, CH-1196 Gland, Switzerland; [Angulo, Ariadne; Luedtke, Jennifer] IUCN Species Survival Commiss, Amphibian Specialist Grp, Toronto, ON M8W 1R2, Canada; [Bachman, Steve; Lughadha, Eimear Nic; Lutz, Maiko] Royal Bot Gardens, Richmond TW9 3AB, Surrey, England; [Bohm, Monika] Zool Soc London, Inst Zool, Regents Pk, London NW1 4RY, England; [Brummitt, Neil] Nat Hist Museum, Dept Life Sci, London SW7 5BD, England; [Carpenter, Kent E.; Ralph, Gina] Old Domin Univ, IUCN Marine Biodivers Unit, Global Species Programme Biol Sci, Norfolk, VA USA; [Cox, Neil] Conservat Int, IUCN Global Species Programme, IUCN CI Biodivers Assessment, 2011 Crystal Dr,Suite 500, Arlington, VA 22202 USA; [Di Marco, Moreno] Univ Queensland, Ctr Biodivers & Conservat Sci, ARC Ctr Excellence Environm Decis, Brisbane, Qld 4072, Australia; [Di Marco, Moreno] Univ Queensland, Sch Geog Planning & Environm Management, Brisbane, Qld 4072, Australia; [Hutton, Jon] WWF Int, Luc Hoffmann Inst, CH-1196 Gland, Switzerland; [Keith, David A.] Univ New S Wales, Ctr Ecosyst Sci, Sydney, NSW 2052, Australia; [Langhammer, Penny F.] Arizona State Univ, Sch Life Sci, POB 874501, Tempe, AZ 85287 USA; [Miller, Rebecca M.] IUCN Global Ecosyst Management Programme, David Attenborough Bldg,Pembroke St, Cambridge CB2 3QZ, England; [Oliveira-Mrinda, Maria A.; Rodriguez, Jon Paul] Provita, Apdo 47552, Caracas 1041A, Venezuela; [Rodriguez, Jon Paul] Inst Venezolano Invest Cient, Ctr Ecol, Apdo 20632, Caracas 1020A, Venezuela; [Rondinini, Carlo] Sapienza Univ Rome, Dept Biol & Biotechnol, Global Mammal Assessment Program, Viale Univ 32, I-00185 Rome, Italy; [Smart, Jane] IUCN, Biodivers Conservat Grp, 28 Rue Mauverney, CH-1196 Gland, Switzerland; [Tordoff, Andrew W.] Crit Ecosyst Partnership Fund, 2011 Crystal Dr,Suite 500, Arlington, VA 22202 USA; [Woodley, Stephen] World Commiss Protected Areas IUCN, 64 Juniper Rd, Chelsea, PQ J9B 1T3, Canada; [Comer, Pat J.; Young, Bruce] NatureServe, 4600 N Fairfax Dr, Arlington, VA 22203 USA; [Parr, Mike] Amer Bird Conservancy, 1731 Connecticut Ave, Washington, DC 20009 USA; [Keith, David A.] New South Wales Off Environm & Heritage, Hurstville, NSW 2220, Australia	CGIAR; World Agroforestry (ICRAF); University of the Philippines System; University of the Philippines Los Banos; University of Tasmania; BirdLife International; University of Cambridge; Royal Botanic Gardens, Kew; Zoological Society of London; Natural History Museum London; Old Dominion University; Conservation International; University of Queensland; University of Queensland; World Wildlife Fund; University of New South Wales Sydney; Arizona State University; Arizona State University-Tempe; Venezuelan Institute Science Research; Sapienza University Rome; Nature Conservancy; Office of Environment & Heritage - New South Wales	Juffe-Bignoli, D (corresponding author), UNESP WCMC, United Nations Environm Programme, 219 Huntingdon Rd, Cambridge CB3 0DL, England.	diego.juffe-bignoli@unep-wcmc.org	Butchart, Stuart/AAJ-1852-2021; Di Marco, Moreno/J-4285-2012; Hoffmann, Michael/E-6419-2010; Böhm, Monika/E-1153-2018; Rodriguez, Jon P/A-1491-2009; Rondinini, Carlo/E-9027-2011; Butchart, Stuart HM/Y-2711-2018; Woodley, Stephen/AAA-1985-2021; Rodriguez, Jon P/G-7224-2012; Nic Lughadha, Eimear/N-4560-2014	Butchart, Stuart/0000-0002-1140-4049; Di Marco, Moreno/0000-0002-8902-4193; Hoffmann, Michael/0000-0003-4785-2254; Böhm, Monika/0000-0003-0585-0832; Rodriguez, Jon P/0000-0001-5019-2870; Woodley, Stephen/0000-0003-3074-6578; Nic Lughadha, Eimear/0000-0002-8806-4345; Lutz, Maiko/0000-0002-6695-8380; Bachman, Steven/0000-0003-1085-6075; Comer, Patrick/0000-0002-5869-2105; Rondinini, Carlo/0000-0002-6617-018X; Keith, David/0000-0002-7627-4150	MAVA foundation; Integrated Biodiversity Assessment Tool (IBAT); National Science Foundation's Dimensions of Biodiversity program [1136586]; Rufford Foundation; Integrated Biodiversity Assessment Tool (IBAT) Partnership; Direct For Biological Sciences [1136586] Funding Source: National Science Foundation	MAVA foundation; Integrated Biodiversity Assessment Tool (IBAT); National Science Foundation's Dimensions of Biodiversity program(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Rufford Foundation; Integrated Biodiversity Assessment Tool (IBAT) Partnership; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by the MAVA foundation: http://en.mava-foundation.org/ (TMB), Integrated Biodiversity Assessment Tool (IBAT): https://www.ibatforbusiness.org/ (DJ), National Science Foundation's Dimensions of Biodiversity program: http://www.nsf.gov/; award 1136586 (BY), the Rufford Foundation: http://www.rufford.org/ (MB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank the funders of this study, the MAVA Foundation and the Integrated Biodiversity Assessment Tool (IBAT) Partnership. NatureServe acknowledges support from the National Science Foundation's Dimensions of Biodiversity program (award 1136586). MB received continued funding from the Rufford Foundation. The Red List Unit would like to thank the MAVA Foundation, the Rufford Foundation, the Environment Agency Abu Dhabi, the European Commission and the Critical Ecosystem Partnership Fund. We are also grateful to: John Pilgrim, Trevor Sandwith, Pedro Rosabal, Kathy MacKinnon, Sarah Wyatt, Jerry Harrison, Brian MacSharry, Yichuan Shi, Mat Jones, Soyoung Park, Sylvia Wicander, Florent Latil, Enrique Lahmann and all the many thousands of individuals and organisations who contribute to the creation and maintenance of the four knowledge products assessed.	[Anonymous], 2010, 10 M C PART CONV BIO; [Anonymous], 2011, ECONOMIST; [Anonymous], 2014, PARKS, DOI DOI 10.1111/1365-2664.13060; Armsworth PR, 2014, ANN NY ACAD SCI, V1322, P61, DOI 10.1111/nyas.12455; Balmford A, 1999, NATURE, V398, P204, DOI 10.1038/18339; Berendsohn WG, 2011, ZOOKEYS, P71, DOI 10.3897/zookeys.150.2166; Birdlife, 2014, IMPORTANT BIRD BIODI; Bland LM, 2015, J APPL ECOL, V52, P861, DOI 10.1111/1365-2664.12459; Bohm M, 2015, CONSERV BIOL, V29, P1290, DOI 10.1111/cobi.12529; Bowles-Newark N. J., 2014, INCORPORATING UTILIS; Brooks TM, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.7; Brooks Thomas M., 2015, BIODIVERSITY-OTTAWA, V16, P157, DOI 10.1080/14888386.2015.1075903; Butchart Stuart H M, 2012, PLoS One, V7, pe32529, DOI 10.1371/journal.pone.0032529; Collen B, 2010, SCIENCE, V329, P140, DOI 10.1126/science.329.5988.140-a; Conservation International, 2006, 5 YEARS KEY BIOD AR; Costello MJ, 2014, BIOL CONSERV, V173, P155, DOI 10.1016/j.biocon.2013.07.042; Critical Ecosystem Partnership Fund, 2007, STRAT FRAM FY 2008 2; Di Marco M, 2016, CONSERV BIOL, V30, P392, DOI 10.1111/cobi.12609; Di Minin E, 2015, FRONT ENV SCI-SWITZ, V3, DOI 10.3389/fenvs.2015.00063; Dudley N., 2008, GUIDELINES APPL PROT, DOI [10.2305/IUCN.CH.2008.PAPS.2.en, DOI 10.2305/IUCN.CH.2008.PAPS.2.EN]; Dudley N., 2014, APPL KEY BIODIVERSIT; Edgar GJ, 2008, AQUAT CONSERV, V18, P969, DOI 10.1002/aqc.902; Foster Matthew N., 2012, Journal of Threatened Taxa, V4, P2733; Gardenfors U, 2010, SCIENCE, V329, P140, DOI 10.1126/science.329.5988.140-b; GCOS, 2010, IMPLEMENTATION PLAN; Goettsch B, 2015, NAT PLANTS, V1, DOI [10.1038/nplants.2015.142, 10.1038/NPLANTS.2015.142]; Griggs D, 2013, NATURE, V495, P305, DOI 10.1038/495305a; Hoffmann M., 2008, Endangered Species Research, V6, P113, DOI 10.3354/esr00087; Holland RA, 2012, BIOL CONSERV, V148, P167, DOI 10.1016/j.biocon.2012.01.016; Independent Sector, 2014, EST VAL VOL TIM; International Finance Corporation, 2012, 6 INT FIN CORP; International Union for Conservation of Nature, 2014, CONS DOC IUCN STAND; International Union for Conservation of Nature, 2013, 2013 IUCN ANN REP; International Union for Conservation of Nature, 2015, GUID APPL IUCN RED L; International Union for Conservation of Nature, 1994, IUCN RED LIST CAT CR; International Union for Conservation of Nature Natural Resources Iucn Species Survival Commission International Union for Conservation of Nature Natural Resources. Species Survival Commission, 2001, IUCN RED LIST CAT CR; International Union of Conservation of Nature, 2014, BIOD BUS GUID US KNO; James A, 2001, BIOSCIENCE, V51, P43, DOI 10.1641/0006-3568(2001)051[0043:CWATCB]2.0.CO;2; Juffe-Bignoli D, 2014, PROTECTED PLANET REP; Keith DA, 2015, CONSERV LETT, V8, P214, DOI 10.1111/conl.12167; Keith DA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062111; Knight AT, 2010, CONSERV BIOL, V24, P1348, DOI 10.1111/j.1523-1739.2010.01494.x; Lacher TE, 2012, CONSERV LETT, V5, P327, DOI 10.1111/j.1755-263X.2012.00249.x; Langhammer P. F., 2007, IUCN WORLD COMMISSIO, V15; Leadley Paul W, 2014, CBD TECHNICAL SERIES, V78; Leverington F, 2010, ENVIRON MANAGE, V46, P685, DOI 10.1007/s00267-010-9564-5; Lindgaard A., 2011, 2011 NORWEGIAN RED L; Maxwell SL, 2015, J APPL ECOL, V52, P12, DOI 10.1111/1365-2664.12373; McCarthy DP, 2012, SCIENCE, V338, P946, DOI 10.1126/science.1229803; McCrea-Strub A, 2011, MAR POLICY, V35, P1, DOI 10.1016/j.marpol.2010.07.001; Mittermeier, 2014, IUCN RED LIST 50 YEA, P9; Mwangi MAK, 2010, BIRD CONSERV INT, V20, P215, DOI 10.1017/S0959270910000456; Newton A, 2015, GLOBAL TREE ASESSMEN; Rodriguez JP, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0003; Ricketts TH, 2005, P NATL ACAD SCI USA, V102, P18497, DOI 10.1073/pnas.0509060102; Rodrigues ASL, 2006, TRENDS ECOL EVOL, V21, P71, DOI 10.1016/j.tree.2005.10.010; Rodriguez Jon Paul, 2008, Endangered Species Research, V6, P193, DOI 10.3354/esr006193; Rondinini C, 2014, CONSERV LETT, V7, P126, DOI 10.1111/conl.12040; Salamon LM, 2011, ANN PUBLIC COOP ECON, V82, P217, DOI 10.1111/j.1467-8292.2011.00437.x; Siebert SJ, 2005, TAXON, V54, P1051, DOI 10.2307/25065492; Soberon J, 2004, PHILOS T R SOC B, V359, P689, DOI 10.1098/rstb.2003.1439; Stuart SN, 2010, SCIENCE, V328, P177, DOI 10.1126/science.1188606; Theobald EJ, 2015, BIOL CONSERV, V181, P236, DOI 10.1016/j.biocon.2014.10.021; Tittensor DP, 2014, SCIENCE, V346, P241, DOI 10.1126/science.1257484; UNDP, 2009, HDB PLANN MON EV DEV; UNEP-WCMC, 2015, WORLD DAT PROT AR US; United Nations, 2012, MILLENNIUM DEV GOALS; United Nations, 2013, MILL DEV GOALS REP; United Nations, 2016, SUSTAINABLE CONSUMPT; United Nations, 2014, MILL DEV GOALS REP 2; Venter O, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001891	71	45	47	2	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2016	11	8							e0160640	10.1371/journal.pone.0160640	http://dx.doi.org/10.1371/journal.pone.0160640			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4UN	27529491	Green Published, Green Submitted, gold			2022-12-27	WOS:000381476700014
J	Sanchez, G; Berrios, D; Olmedo, I; Pezoa, J; Riquelme, JA; Montecinos, L; Pedrozo, Z; Donoso, P				Sanchez, Gina; Berrios, Daniela; Olmedo, Ivonne; Pezoa, Javier; Riquelme, Jaime A.; Montecinos, Luis; Pedrozo, Zully; Donoso, Paulina			Activation of Chymotrypsin-Like Activity of the Proteasome during Ischemia Induces Myocardial Dysfunction and Death	PLOS ONE			English	Article							20 S PROTEASOME; REPERFUSION INJURY; SARCOPLASMIC-RETICULUM; MULTIPLE-MYELOMA; CELL-DEATH; ATP CONCENTRATIONS; OXIDIZED PROTEINS; INHIBITOR MLN9708; CARDIAC-FUNCTION; 26S PROTEASOME	Inhibitors of the ubiquitin-proteasome system improve hemodynamic parameters and decrease the infarct size after ischemia reperfusion. The molecular basis of this protection is not fully understood since most available data report inhibition of the 26 proteasome after ischemia reperfusion. The decrease in cellular ATP levels during ischemia leads to the dissociation of the 26S proteasome into the 19S regulatory complex and the 20S catalytic core, which results in protein degradation independently of ubiquitination. There is scarce information on the activity of the 20S proteasome during cardiac ischemia. Accordingly, the aim of this work was to determine the effects of 30 minutes of ischemia, or 30 min of ischemia followed by 60 minutes of reperfusion on the three main peptidase activities of the 20S proteasome in Langendorff perfused rat hearts. We found that 30 min of ischemia produced a significant increase in the chymotrypsin-like activity of the proteasome, without changes in its caspase-like or trypsin-like activities. In contrast, all three activities were decreased upon reperfusion. Ixazomib, perfused before ischemia at a concentration that reduced the chymotrypsin-like activity to 50% of the control values, without affecting the other proteasomal activities, improved the hemodynamic parameters upon reperfusion and decreased the infarct size. Ixazomib also prevented the 50% reduction in RyR2 content observed after ischemia. The protection was lost, however, when simultaneous inhibition of chymotrypsin-like and caspase-like activities of the proteasome was achieved at higher concentration of ixazomib. Our results suggest that selective inhibition of chymotrypsin-like activity of the proteasome during ischemia preserves key proteins for cardiomyocyte function and exerts a positive impact on cardiac performance after reperfusion.	[Sanchez, Gina; Berrios, Daniela; Olmedo, Ivonne] Univ Chile, Inst Ciencias Biomed, Fac Med, Programa Fisiopatol, Santiago, Chile; [Sanchez, Gina; Donoso, Paulina] Univ Chile, Fac Med, Ctr Estudios Mol Celula, Santiago, Chile; [Pezoa, Javier; Montecinos, Luis; Pedrozo, Zully; Donoso, Paulina] Univ Chile, Fac Med, Programa Fisiol & Biofis, Inst Ciencias Biomed, Santiago, Chile; [Riquelme, Jaime A.; Pedrozo, Zully] Univ Chile, Adv Ctr Chron Dis, Fac Ciencias Quim & Farmaceut, Santiago, Chile	Universidad de Chile; Universidad de Chile; Universidad de Chile; Universidad de Chile	Sanchez, G (corresponding author), Univ Chile, Inst Ciencias Biomed, Fac Med, Programa Fisiopatol, Santiago, Chile.; Sanchez, G; Donoso, P (corresponding author), Univ Chile, Fac Med, Ctr Estudios Mol Celula, Santiago, Chile.; Donoso, P (corresponding author), Univ Chile, Fac Med, Programa Fisiol & Biofis, Inst Ciencias Biomed, Santiago, Chile.	gisanchez@med.uchile.cl; pdonoso@med.uchile.cl	Pedrozo, Zully/I-1069-2013; Riquelme, Jaime A/ABG-7889-2020; Pedrozo, Zully/AAN-5350-2021; Olmedo, Ivonne/N-7985-2018	Riquelme, Jaime A/0000-0003-0517-5697; Olmedo, Ivonne/0000-0003-0117-3045	Fondo Nacional de Desarrollo Cientifico y Tecnologico, FONDECYT grant [1110257, 1130407, 1150887, 3140449, 3160298]	Fondo Nacional de Desarrollo Cientifico y Tecnologico, FONDECYT grant(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	This work was supported by Fondo Nacional de Desarrollo Cientifico y Tecnologico, FONDECYT grants 1110257 to PD, 1130407 to GS, 1150887 to ZP and Post-doctoral Fellowships 3140449 to IO and 3160298 to JAR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams B, 2015, CARDIOVASC DIABETOL, V14, DOI 10.1186/s12933-015-0258-4; Asai A, 2002, J CEREBR BLOOD F MET, V22, P705, DOI 10.1097/00004647-200206000-00009; Baker TA, 2010, BIOCHEM BIOPH RES CO, V401, P548, DOI 10.1016/j.bbrc.2010.09.093; BULL R, 1989, BIOPHYS J, V56, P749, DOI 10.1016/S0006-3495(89)82722-5; Bulteau AL, 2001, J BIOL CHEM, V276, P30057, DOI 10.1074/jbc.M100142200; Campbell B, 1999, J MOL CELL CARDIOL, V31, P467, DOI 10.1006/jmcc.1998.0880; Chauhan D, 2005, ANNU REV PHARMACOL, V45, P465, DOI 10.1146/annurev.pharmtox.45.120403.100037; Chauhan D, 2011, CLIN CANCER RES, V17, P5311, DOI 10.1158/1078-0432.CCR-11-0476; Cui ZY, 2014, J MOL CELL CARDIOL, V71, P32, DOI 10.1016/j.yjmcc.2013.10.008; Davies KJA, 2001, BIOCHIMIE, V83, P301, DOI 10.1016/S0300-9084(01)01250-0; Divald A, 2010, CIRC RES, V106, P1829, DOI 10.1161/CIRCRESAHA.110.219485; Domenech RJ, 2003, J MOL CELL CARDIOL, V35, P1429, DOI 10.1016/j.yjmcc.2003.09.006; Eaton P, 2001, CARDIOVASC RES, V51, P294, DOI 10.1016/S0008-6363(01)00303-0; Garcia-Dorado D, 2012, CARDIOVASC RES, V94, P168, DOI 10.1093/cvr/cvs116; Geng Q, 2009, BIOCHEM BIOPH RES CO, V390, P1136, DOI 10.1016/j.bbrc.2009.10.067; Gomes AV, 2006, CIRC RES, V99, P362, DOI 10.1161/01.RES.0000237386.98506.f7; Gomes AV, 2009, MOL CELL PROTEOMICS, V8, P302, DOI 10.1074/mcp.M800058-MCP200; HARTREE EF, 1972, ANAL BIOCHEM, V48, P422, DOI 10.1016/0003-2697(72)90094-2; Hausenloy DJ, 2013, J CLIN INVEST, V123, P92, DOI 10.1172/JCI62874; Henderson CJ, 2005, CELL DEATH DIFFER, V12, P1240, DOI 10.1038/sj.cdd.4401729; Jung T, 2014, REDOX BIOL, V2, P388, DOI 10.1016/j.redox.2013.12.029; Kupperman E, 2010, CANCER RES, V70, P1970, DOI 10.1158/0008-5472.CAN-09-2766; Lima CF, 2010, METHODS MOL BIOL, V648, P183, DOI 10.1007/978-1-60761-756-3_12; Majetschak M, 2013, AM J PHYSIOL-HEART C, V305, pH267, DOI 10.1152/ajpheart.00206.2012; Muz B, 2016, DRUG DES DEV THER, V10, P217, DOI 10.2147/DDDT.S93602; Pedrozo Z, 2013, CARDIOVASC RES, V98, P277, DOI 10.1093/cvr/cvt029; Pedrozo Z, 2010, BBA-MOL BASIS DIS, V1802, P356, DOI 10.1016/j.bbadis.2009.12.005; Powell SR, 2007, J MOL CELL CARDIOL, V42, P265, DOI 10.1016/j.yjmcc.2006.10.010; Powell SR, 2005, ANTIOXID REDOX SIGN, V7, P538, DOI 10.1089/ars.2005.7.538; Pye J, 2003, AM J PHYSIOL-HEART C, V284, pH919, DOI 10.1152/ajpheart.00851.2002; Rastogi N, 2012, CELL DIV, V7, DOI 10.1186/1747-1028-7-26; Robin E, 2007, J BIOL CHEM, V282, P19133, DOI 10.1074/jbc.M701917200; Schmidtke G, 2000, J BIOL CHEM, V275, P22056, DOI 10.1074/jbc.M002513200; Silva GM, 2012, ANTIOXID REDOX SIGN, V16, P1183, DOI 10.1089/ars.2011.4210; Soriano GP, 2014, ANTIOXID REDOX SIGN, V21, P2419, DOI 10.1089/ars.2013.5794; Stansfield WE, 2007, ANN THORAC SURG, V84, P120, DOI 10.1016/j.athoracsur.2007.02.049; Temsah RM, 1999, AM J PHYSIOL-HEART C, V277, pH584, DOI 10.1152/ajpheart.1999.277.2.H584; Vanden Hoek TL, 1998, J BIOL CHEM, V273, P18092, DOI 10.1074/jbc.273.29.18092; Vila-Petroff M, 2007, CARDIOVASC RES, V73, P689, DOI 10.1016/j.cardiores.2006.12.003; Whelan RS, 2010, ANNU REV PHYSIOL, V72, P19, DOI 10.1146/annurev.physiol.010908.163111; Wong E, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a006734; Yu XC, 2010, CARDIOVASC RES, V85, P312, DOI 10.1093/cvr/cvp309; Zhu X, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.313	43	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2016	11	8							e0161068	10.1371/journal.pone.0161068	http://dx.doi.org/10.1371/journal.pone.0161068			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4UN	27529620	Green Submitted, gold, Green Published			2022-12-27	WOS:000381476700043
J	Yen, YC; Chu, PH; Lu, PL; Lin, YC; Shi, YY; Chou, LC; Wang, CF; Lin, YY; Su, HJ; Lin, CC; Zeng, JY; Tyan, YC; Ke, GM; Chu, PY				Yen, Yung-Chang; Chu, Pei-Huan; Lu, Po-Liang; Lin, Yung-Cheng; Shi, Yong-Ying; Chou, Li-Chiu; Wang, Chu-Feng; Lin, Yi-Ying; Su, Hui-Ju; Lin, Chien-Ching; Zeng, Jing-Yun; Tyan, Yu-Chang; Ke, Guan-Ming; Chu, Pei-Yu			Phylodynamic Characterization of an Ocular-Tropism Coxsackievirus A24 Variant	PLOS ONE			English	Article							ACUTE HEMORRHAGIC CONJUNCTIVITIS; MOLECULAR EPIDEMIOLOGY; TAIWAN; VP1	Recent phylodynamic studies have focused on using tree topology patterns to elucidate interactions among the epidemiological, evolutionary, and demographic characteristics of infectious agents. However, because studies of viral phylodynamics tend to focus on epidemic outbreaks, tree topology signatures of tissue-tropism pathogens might not be clearly identified. Therefore, this study used a novel Bayesian evolutionary approach to analyze the A24 variant of coxsackievirus (CV-A24v), an ocular-tropism agent of acute hemorrhagic conjunctivitis. Analyses of the 915-nucleotide VP1 and 690-nt 3D(pol) regions of 21 strains isolated in Taiwan and worldwide during 1985-2010 revealed a clear chronological trend in both the VP1 and 3D(pol) phylogenetic trees: the emergence of a single dominant cluster in each outbreak. The VP1 sequences included three genotypes: GI (prototype), GIII (isolated 1985-1999), and GIV (isolated after 2000); no VP1 sequences from GII strains have been deposited in GenBank. Another five genotypes identified in the 3D(pol) region had support values >0.9. Geographic and demographic transitions among CV-A24v clusters were clearly identified by Bayes algorithm. The transmission route was mapped from India to China and then to Taiwan, and each prevalent viral population declined before new clusters emerged. Notably, the VP1 and 3D(pol) genes had high nucleotide sequence similarities (94.1% and 95.2%, respectively). The lack of co-circulating lineages and narrow tissue tropism affected the CV-A24v gene pool.	[Yen, Yung-Chang] Chi Mei Med Ctr, Dept Ophthalmol, Tainan, Taiwan; [Yen, Yung-Chang] Min Hwei Coll Hlth Care Management, Dept Nursing, Tainan, Taiwan; [Chu, Pei-Huan] Wei Gong Mem Hosp, Dept Med, Div Cardiol, Miaoli, Taiwan; [Lu, Po-Liang] Kaohsiung Med Univ, Sch Med, Coll Med, Kaohsiung, Taiwan; [Lu, Po-Liang; Chou, Li-Chiu; Wang, Chu-Feng; Lin, Yi-Ying; Su, Hui-Ju; Chu, Pei-Yu] Kaohsiung Med Univ Hosp, Dept Lab Med, Kaohsiung, Taiwan; [Lin, Yung-Cheng] Natl Taiwan Ocean Univ, Inst Biosci & Biotechnol, Keelung, Taiwan; [Shi, Yong-Ying; Lin, Chien-Ching; Zeng, Jing-Yun; Chu, Pei-Yu] Kaohsiung Med Univ, Coll Hlth Sci, Dept Med Lab Sci & Biotechnol, Kaohsiung, Taiwan; [Tyan, Yu-Chang] Kaohsiung Med Univ, Dept Med Imaging & Radiol Sci, Kaohsiung, Taiwan; [Tyan, Yu-Chang] Kaohsiung Med Univ, Grad Inst Med, Coll Med, Kaohsiung, Taiwan; [Tyan, Yu-Chang] Natl Sun Yat Sen Univ, Inst Med Sci & Technol, Kaohsiung, Taiwan; [Tyan, Yu-Chang] Kaohsiung Med Univ, Ctr Infect Dis & Canc Res, Kaohsiung, Taiwan; [Ke, Guan-Ming] Natl Pingtung Univ Sci & Technol, Coll Vet Med, Grad Inst Anim Vaccine Technol, Pingtung, Taiwan	Chi Mei Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; National Taiwan Ocean University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; National Sun Yat Sen University; Kaohsiung Medical University; National Pingtung University Science & Technology	Chu, PY (corresponding author), Kaohsiung Med Univ Hosp, Dept Lab Med, Kaohsiung, Taiwan.; Chu, PY (corresponding author), Kaohsiung Med Univ, Coll Hlth Sci, Dept Med Lab Sci & Biotechnol, Kaohsiung, Taiwan.; Ke, GM (corresponding author), Natl Pingtung Univ Sci & Technol, Coll Vet Med, Grad Inst Anim Vaccine Technol, Pingtung, Taiwan.	mirage-ke@yahoo.com.tw; peiyuchu@kmu.edu.tw	Lu, Po-Liang/D-4499-2009; YEN, YUNG CHANG/AAH-9922-2021	Lu, Po-Liang/0000-0002-7423-6783; YEN, YUNG CHANG/0000-0002-6931-4409	Ministry of Science and Technology, Taiwan [MOST104-2320-B-037-018]; Chi-Mei Medical Center; Kaohsiung Medical University Research Foundation [103CM-KMU-06]; Center for Infectious Disease and Cancer Research, Kaohsiung Medical University [KMU-TP104E12]; Wei Gong Memorial Hospital [105-1-001]; Chi-Mei Foundation Medical Center [CLFHR10127]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); Chi-Mei Medical Center; Kaohsiung Medical University Research Foundation; Center for Infectious Disease and Cancer Research, Kaohsiung Medical University; Wei Gong Memorial Hospital; Chi-Mei Foundation Medical Center	This study was supported by Ministry of Science and Technology, Taiwan grant no. MOST104-2320-B-037-018 (url: http://www.most.gov.tw/) to PYC; Chi-Mei Medical Center and Kaohsiung Medical University Research Foundation grant no. 103CM-KMU-06 (URL: http://devel.kmu.edu.tw/index.php/en-GB/) to PYC; Center for Infectious Disease and Cancer Research, Kaohsiung Medical University grant no. KMU-TP104E12 (URL: http://devel.kmu.edu.tw/index.php/en-GB/) to YCT; Wei Gong Memorial Hospital grant no. 105-1-001 (URL: http://www.weigong.org.tw/eng-index.html) to PHC, and Chi-Mei Foundation Medical Center grant no. CLFHR10127 (URL: http://www.chimei.org.tw/main/clh_department/79052/index.htm) to YCY. The funders had no role in the design of the study, the collection and analysis of data, the decision to publish, or the preparation of the manuscript.	Adams MJ, 2013, ARCH VIROL, V158, P2023, DOI 10.1007/s00705-013-1688-5; Airaksinen A, 1999, J GEN VIROL, V80, P1919, DOI 10.1099/0022-1317-80-8-1919; Baele G, 2012, MOL BIOL EVOL, V29, P2157, DOI 10.1093/molbev/mss084; Bielejec F, 2011, BIOINFORMATICS, V27, P2910, DOI 10.1093/bioinformatics/btr481; Chansaenroj J, 2015, EPIDEMIOL INFECT, V143, P3087, DOI 10.1017/S0950268815000643; Chu PY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129272; Chu PY, 2011, INFECT GENET EVOL, V11, P1426, DOI 10.1016/j.meegid.2011.05.010; Chu PY, 2009, J CLIN VIROL, V45, P285, DOI 10.1016/j.jcv.2009.04.013; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Grenfell BT, 2004, SCIENCE, V303, P327, DOI 10.1126/science.1090727; Hansen JL, 1997, STRUCTURE, V5, P1109, DOI 10.1016/S0969-2126(97)00261-X; Hicks AL, 2011, J VIROL, V85, P7942, DOI 10.1128/JVI.02535-10; Huang HW, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0738-2; ISHIKO H, 1992, ARCH VIROL, V126, P179, DOI 10.1007/BF01309694; Katoh Kazutaka, 2013, Mol Biol Evol, V30, P772, DOI 10.1093/molbev/mst010; Khetsuriani Nino, 2006, Morbidity and Mortality Weekly Report, V55, P18; Kim Hong Hwan, 2004, J Prev Med Public Health, V37, P312; Leitch ECM, 2012, J VIROL, V86, P2676, DOI 10.1128/JVI.06065-11; Lin KH, 2001, J MED VIROL, V64, P269, DOI 10.1002/jmv.1046; LIN KH, 1993, J CLIN MICROBIOL, V31, P1160, DOI 10.1128/JCM.31.5.1160-1166.1993; Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467; Nidaira M, 2014, MICROBIOL IMMUNOL, V58, P227, DOI 10.1111/1348-0421.12141; Nilsson EC, 2008, J VIROL, V82, P3061, DOI 10.1128/JVI.02470-07; Oberste MS, 2003, J CLIN VIROL, V26, P375, DOI 10.1016/S1386-6532(03)00004-0; Pond SLK, 2005, BIOINFORMATICS, V21, P2531, DOI 10.1093/bioinformatics/bti320; RICOHESSE R, 1987, VIROLOGY, V160, P311, DOI 10.1016/0042-6822(87)90001-8; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Smura Teemu, 2014, PLoS One, V9, pe94579, DOI 10.1371/journal.pone.0094579; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tavares FN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023206; Wu B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086883; Xia XH, 2013, MOL BIOL EVOL, V30, P1720, DOI 10.1093/molbev/mst064	34	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2016	11	8							e0160672	10.1371/journal.pone.0160672	http://dx.doi.org/10.1371/journal.pone.0160672			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4UN	27529556	Green Submitted, gold, Green Published			2022-12-27	WOS:000381476700015
J	Leung, JM; Chen, V; Hollander, Z; Dai, D; Tebbutt, SJ; Aaron, SD; Vandemheen, KL; Rennard, SI; FitzGerald, JM; Woodruff, PG; Lazarus, SC; Connett, JE; Coxson, HO; Miller, B; Borchers, C; McManus, BM; Ng, RT; Sin, DD				Leung, Janice M.; Chen, Virginia; Hollander, Zsuzsanna; Dai, Darlene; Tebbutt, Scott J.; Aaron, Shawn D.; Vandemheen, Kathy L.; Rennard, Stephen I.; FitzGerald, J. Mark; Woodruff, Prescott G.; Lazarus, Stephen C.; Connett, John E.; Coxson, Harvey O.; Miller, Bruce; Borchers, Christoph; McManus, Bruce M.; Ng, Raymond T.; Sin, Don D.			COPD Exacerbation Biomarkers Validated Using Multiple Reaction Monitoring Mass Spectrometry	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; APOLIPOPROTEIN-A-IV; MYOCARDIAL-INFARCTION; PLASMA; DIAGNOSIS; RISK; HOSPITALIZATION; VERIFICATION; PROTEOMICS; TRIAL	Background Acute exacerbations of chronic obstructive pulmonary disease (AECOPD) result in considerable morbidity and mortality. However, there are no objective biomarkers to diagnose AECOPD. Methods We used multiple reaction monitoring mass spectrometry to quantify 129 distinct proteins in plasma samples from patients with COPD. This analytical approach was first performed in a biomarker cohort of patients hospitalized with AECOPD (Cohort A, n = 72). Proteins differentially expressed between AECOPD and convalescent states were chosen using a false discovery rate <0.01 and fold change >1.2. Protein selection and classifier building were performed using an elastic net logistic regression model. The performance of the biomarker panel was then tested in two independent AECOPD cohorts (Cohort B, n = 37, and Cohort C, n = 109) using leave-pair-out cross-validation methods. Results Five proteins were identified distinguishing AECOPD and convalescent states in Cohort A. Biomarker scores derived from this model were significantly higher during AECOPD than in the convalescent state in the discovery cohort (p<0.001). The receiver operating characteristic cross-validation area under the curve (CV-AUC) statistic was 0.73 in Cohort A, while in the replication cohorts the CV-AUC was 0.77 for Cohort B and 0.79 for Cohort C. Conclusions A panel of five biomarkers shows promise in distinguishing AECOPD from convalescence and may provide the basis for a clinical blood test to diagnose AECOPD. Further validation in larger cohorts is necessary for future clinical translation.	[Leung, Janice M.; Tebbutt, Scott J.; Coxson, Harvey O.; McManus, Bruce M.; Sin, Don D.] St Pauls Hosp, Ctr Heart Lung Innovat, Vancouver, BC, Canada; [Leung, Janice M.; Tebbutt, Scott J.; Sin, Don D.] St Pauls Hosp, Div Resp Med, Dept Med, Vancouver, BC, Canada; [Chen, Virginia; Hollander, Zsuzsanna; Dai, Darlene; Tebbutt, Scott J.; McManus, Bruce M.; Ng, Raymond T.] St Pauls Hosp, PROOF Ctr Excellence, Vancouver, BC, Canada; [Aaron, Shawn D.; Vandemheen, Kathy L.] Univ Ottawa, Ottawa Hosp Res Inst, Ottawa, ON, Canada; [Rennard, Stephen I.] Univ Nebraska Med Ctr, Div Pulm Crit Care Sleep & Allergy, Omaha, NE USA; [Rennard, Stephen I.] AstraZeneca, Cambridge, England; [FitzGerald, J. Mark] Vancouver Gen Hosp, Dept Med, Div Resp Med, Vancouver, BC, Canada; [FitzGerald, J. Mark] Inst Heart & Lung Hlth, Vancouver, BC, Canada; [Woodruff, Prescott G.; Lazarus, Stephen C.] Univ Calif San Francisco, Div Pulm Crit Care Allergy & Sleep Med, Dept Med, San Francisco, CA 94143 USA; [Woodruff, Prescott G.; Lazarus, Stephen C.] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA; [Connett, John E.] Univ Minnesota, Minneapolis, MN USA; [Miller, Bruce] GlaxoSmithKline Res & Dev Ltd, King Of Prussia, PA USA; [Borchers, Christoph] Univ Victoria, Genome British Columbia Prote Ctr, Dept Biochem & Microbiol, Victoria, BC, Canada	St. Paul's Hospital; University of Saskatchewan; St. Paul's Hospital; University of Saskatchewan; St. Paul's Hospital; University of Saskatchewan; University of Ottawa; Ottawa Hospital Research Institute; University of Nebraska System; University of Nebraska Medical Center; University of British Columbia; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Minnesota System; University of Minnesota Twin Cities; GlaxoSmithKline; University of Victoria	Sin, DD (corresponding author), St Pauls Hosp, Ctr Heart Lung Innovat, Vancouver, BC, Canada.; Sin, DD (corresponding author), St Pauls Hosp, Div Resp Med, Dept Med, Vancouver, BC, Canada.	Don.Sin@hli.ubc.ca	Coxson, Harvey O/A-9861-2017; Sin, Don/AAC-2219-2021; BORCHERS, Christoph/U-5964-2019	Coxson, Harvey O/0000-0001-5750-9711; Tebbutt, Scott/0000-0002-7908-1581; Aaron, Shawn/0000-0002-4762-3542	Genome Canada; Genome British Columbia; Genome Quebec; Canadian Institutes of Health Research; PROOF Centre of Excellence; St. Paul's Hospital Foundation; Canadian Respiratory Research Network; National Heart, Lung, and Blood Institute's COPD Clinical Research Network [U10 HL074441, U10 HL074418, U10 HL074428, U10 HL074409, U10 HL074407, U10 HL074422, U10 HL074416, U10 HL074408, U10 HL074439, U10 HL0744231, U10 HL074424]; GlaxoSmithKline	Genome Canada(Genome Canada); Genome British Columbia; Genome Quebec; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); PROOF Centre of Excellence; St. Paul's Hospital Foundation; Canadian Respiratory Research Network; National Heart, Lung, and Blood Institute's COPD Clinical Research Network; GlaxoSmithKline(GlaxoSmithKline)	Funding was provided by Genome Canada, Genome British Columbia, Genome Quebec, the Canadian Institutes of Health Research, PROOF Centre of Excellence, St. Paul's Hospital Foundation, the Canadian Respiratory Research Network, and the National Heart, Lung, and Blood Institute's COPD Clinical Research Network (Grants U10 HL074441, U10 HL074418, U10 HL074428, U10 HL074409, U10 HL074407, U10 HL074422, U10 HL074416, U10 HL074408, U10 HL074439, U10 HL0744231, and U10 HL074424). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. GlaxoSmithKline provided support in the form of salaries for author BM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Aaron SD, 2013, THORAX, V68, P142, DOI 10.1136/thoraxjnl-2012-202432; Ademowo OS, 2016, ANN RHEUM DIS, V75, P234, DOI 10.1136/annrheumdis-2014-205417; Airola A, 2011, COMPUT STAT DATA AN, V55, P1828, DOI 10.1016/j.csda.2010.11.018; Alberio T, 2014, J PROTEOME RES, V13, P3554, DOI 10.1021/pr401142p; [Anonymous], 2012, NATURE METHODS, V10, P1; Bafadhel M, 2011, AM J RESP CRIT CARE, V184, P662, DOI 10.1164/rccm.201104-0597OC; Bozinovski S, 2008, AM J RESP CRIT CARE, V177, P269, DOI 10.1164/rccm.200705-678OC; Celli BR, 2004, EUR RESPIR J, V23, P932, DOI 10.1183/09031936.04.00014304; Chen CD, 2014, J PROTEOME RES, V13, P2818, DOI 10.1021/pr4012377; Cohen RD, 1997, J CLIN INVEST, V99, P1906, DOI 10.1172/JCI119358; De Serres G, 2009, J CLIN VIROL, V46, P129, DOI 10.1016/j.jcv.2009.07.010; Donaldson GC, 2010, CHEST, V137, P1091, DOI 10.1378/chest.09-2029; Donaldson GC, 2002, THORAX, V57, P847, DOI 10.1136/thorax.57.10.847; Duverger N, 1996, SCIENCE, V273, P966, DOI 10.1126/science.273.5277.966; DVORIN E, 1986, J BIOL CHEM, V261, P5714; GOLDBERG IJ, 1990, J BIOL CHEM, V265, P4266; GREEN PHR, 1980, J CLIN INVEST, V65, P911, DOI 10.1172/JCI109745; Hernandez B, 2014, PROTEOMICS, V14, P1587, DOI 10.1002/pmic.201300377; Hurst JR, 2006, AM J RESP CRIT CARE, V174, P867, DOI 10.1164/rccm.200604-506OC; Issaq HJ, 2008, EXPERT REV PROTEOMIC, V5, P761, DOI 10.1586/14789450.5.6.761; Leidy Nancy K, 2014, Ann Am Thorac Soc, V11, P316, DOI 10.1513/AnnalsATS.201309-305OC; Leidy NK, 2011, AM J RESP CRIT CARE, V183, P323, DOI 10.1164/rccm.201005-0762OC; McAllister DA, 2012, EUR RESPIR J, V39, P1097, DOI 10.1183/09031936.00124811; Meng DQ, 2014, RESP CARE, V59, P1542, DOI 10.4187/respcare.03046; Meng ZJ, 2011, J PROTEOMICS, V74, P2650, DOI 10.1016/j.jprot.2011.04.011; Nikolakopoulou S, 2014, COPD, V11, P46, DOI 10.3109/15412555.2013.829436; Patel ARC, 2013, AM J RESP CRIT CARE, V188, P1091, DOI 10.1164/rccm.201306-1170OC; Peacock JL, 2011, THORAX, V66, P591, DOI 10.1136/thx.2010.155358; Percy AJ, 2013, J PROTEOMICS, V95, P66, DOI 10.1016/j.jprot.2013.07.026; Qin XF, 1998, AM J PHYSIOL-HEART C, V274, pH1836, DOI 10.1152/ajpheart.1998.274.5.H1836; Quon BS, 2016, THORAX, V71, P216, DOI 10.1136/thoraxjnl-2014-206710; Recalde D, 2004, ARTERIOSCL THROM VAS, V24, P756, DOI 10.1161/01.ATV.0000119353.03690.22; Seemungal T, 2001, AM J RESP CRIT CARE, V164, P1618, DOI 10.1164/ajrccm.164.9.2105011; Seemungal TAR, 1998, AM J RESP CRIT CARE, V157, P1418, DOI 10.1164/ajrccm.157.5.9709032; Sin DD, 2015, AM J RESP CRIT CARE, DOI [10. 1164/marn.201505-0871PP, DOI 10.1164/MARN.201505-0871PP]; Soler-Cataluna JJ, 2005, THORAX, V60, P925, DOI 10.1136/thx.2005.040527; Soyseth V, 2013, HEART, V99, P122, DOI 10.1136/heartjnl-2012-302685; Taylor JMG, 2008, CLIN CANCER RES, V14, P5977, DOI 10.1158/1078-0432.CCR-07-4534; UTERMANN G, 1979, EUR J BIOCHEM, V99, P333, DOI 10.1111/j.1432-1033.1979.tb13261.x; Vowinkel T, 2004, J CLIN INVEST, V114, P260, DOI 10.1172/JCI200421233; Wedzicha JA, 2000, THROMB HAEMOSTASIS, V84, P210; Woodruff PG, 2011, COPD, V8, P21, DOI 10.3109/15412555.2010.540273; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	43	12	13	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2016	11	8							e0161129	10.1371/journal.pone.0161129	http://dx.doi.org/10.1371/journal.pone.0161129			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4SL	27525416	gold, Green Submitted, Green Published			2022-12-27	WOS:000381471100035
J	Meneguette, RI; Filho, GPR; Guidoni, DL; Pessin, G; Villas, LA; Ueyama, J				Meneguette, Rodolfo I.; Filho, Geraldo P. R.; Guidoni, Daniel L.; Pessin, Gustavo; Villas, Leandro A.; Ueyama, Jo			Increasing Intelligence in Inter-Vehicle Communications to Reduce Traffic Congestions: Experiments in Urban and Highway Environments	PLOS ONE			English	Article							DATA DISSEMINATION; PROTOCOLS	Intelligent Transportation Systems (ITS) rely on Inter-Vehicle Communication (IVC) to streamline the operation of vehicles by managing vehicle traffic, assisting drivers with safety and sharing information, as well as providing appropriate services for passengers. Traffic congestion is an urban mobility problem, which causes stress to drivers and economic losses. In this context, this work proposes a solution for the detection, dissemination and control of congested roads based on inter-vehicle communication, called INCIDEnT. The main goal of the proposed solution is to reduce the average trip time, CO emissions and fuel consumption by allowing motorists to avoid congested roads. The simulation results show that our proposed solution leads to short delays and a low overhead. Moreover, it is efficient with regard to the coverage of the event and the distance to which the information can be propagated. The findings of the investigation show that the proposed solution leads to (i) high hit rate in the classification of the level of congestion, (ii) a reduction in average trip time, (iii) a reduction in fuel consumption, and (iv) reduced CO emissions	[Meneguette, Rodolfo I.] Univ Ottawa, Ottawa, ON, Canada; [Meneguette, Rodolfo I.] Fed Inst Sao Paulo IFSP, Catanduva, SP, Brazil; [Filho, Geraldo P. R.] Univ Sao Paulo, Inst Math & Comp Sci ICMC, Sao Carlos, SP, Brazil; [Guidoni, Daniel L.] Univ Fed Sao Joao del Rei, Dept Comp Sci, Sao Joao Del Rei, Brazil; [Pessin, Gustavo] Vale Inst Technol, Appl Comp Lab, Belem, Para, Brazil; [Villas, Leandro A.] Univ Estadual Campinas, UNICAMP, Inst Comp, Campinas, SP, Brazil; [Ueyama, Jo] Univ Southern Calif, Ming Hsieh Dept Elect Engn, Los Angeles, CA USA	University of Ottawa; Instituto Federal de Sao Paulo (IFSP); Universidade de Sao Paulo; Universidade Federal de Sao Joao del-Rei; Instituto Tecnologico Vale Desenvolvimento Sustentavel; Universidade Estadual de Campinas; University of Southern California	Meneguette, RI (corresponding author), Univ Ottawa, Ottawa, ON, Canada.; Meneguette, RI (corresponding author), Fed Inst Sao Paulo IFSP, Catanduva, SP, Brazil.	meneguette@ifsp.edu.br	Ueyama, Jo/HHN-1418-2022; Filho, Geraldo Pereira Rocha/Q-6497-2016; Meneguette, Rodolfo/B-2565-2014; Pessin, Gustavo/A-8524-2013	Ueyama, Jo/0000-0002-5591-3750; Filho, Geraldo Pereira Rocha/0000-0001-6795-2768; Meneguette, Rodolfo/0000-0003-2982-4006; Pessin, Gustavo/0000-0002-7411-9229	Sao Paulo Research Foundation (FAPESP) [2015/11536-4, 2015/18898-9]; FAPESP [2014/06330-5]; Office of Naval Research Global; CNPq; FAPEMIG	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Office of Naval Research Global(Office of Naval Research); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	This work was funded by the grants #2015/11536-4 and # 2015/18898-9, Sao Paulo Research Foundation (FAPESP). Geraldo P. R. Filho would like to acknowledge the financial support granted by FAPESP (process 2014/06330-5) in his doctoral research. Jo Ueyama would like to thank FAPESP and Office of Naval Research Global for funding part of his research project. Daniel L. Guidoni would like to thank CNPq and FAPEMIG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was funded by the grants #2015/11536-4 and #2015/18898-9, Sao Paulo Research Foundation (FAPESP). Geraldo P. R. Filho would like to acknowledge the financial support granted by FAPESP (process 2014/06330-5) in his doctoral research. Jo Ueyama would like to thank FAPESP and Office of Naval Research Global for funding part of his research project. Daniel L. Guidoni would like to thank CNPq and FAPEMIG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Sultan S, 2014, J NETW COMPUT APPL, V37, P380, DOI 10.1016/j.jnca.2013.02.036; Behrisch M., 2011, P 3 INT C ADV SYST S, P1; Boukerche A, 2008, COMPUT COMMUN, V31, P2838, DOI 10.1016/j.comcom.2007.12.004; Caulfield B, 2007, IEEE T INTELL TRANSP, V8, P21, DOI 10.1109/TITS.2006.888620; Cesana Matteo, 2010, 2010 European Wireless Conference (EW), P689, DOI 10.1109/EW.2010.5483535; Daraghmi YA, 2013, IEEE NETWORK, V27, P74, DOI 10.1109/MNET.2013.6678930; Doolan R., 2013, VEH TECHN C VTC SPRI, P1, DOI DOI 10.1109/VTCSPRING.2013.6692807; Fahmy MF, 2008, 2008 8TH INTERNATIONAL CONFERENCE ON ITS TELECOMMUNICATIONS, PROCEEDINGS, P367, DOI 10.1109/ITST.2008.4740288; Filho GPR, 2015, 2015 IEEE 14TH INTERNATIONAL SYMPOSIUM ON NETWORK COMPUTING AND APPLICATIONS (NCA), P9, DOI 10.1109/NCA.2015.30; Fiore M, 2013, IEEE J SEL AREA COMM, V31, P480, DOI 10.1109/JSAC.2013.SUP.0513043; Fukumoto J, 2007, 2007 7TH INTERNATIONAL CONFERENCE ON ITS TELECOMMUNICATIONS, PROCEEDINGS, P40; Hartenstein H, 2008, IEEE COMMUN MAG, V46, P164, DOI 10.1109/MCOM.2008.4539481; Karagiannis G, 2011, IEEE COMMUN SURV TUT, V13, P584, DOI 10.1109/SURV.2011.061411.00019; Kim TH, 2008, LECT NOTES COMPUT SC, V5200, P295; Lee U, 2010, COMPUT NETW, V54, P527, DOI 10.1016/j.comnet.2009.07.011; Loureiro A. A. F., 2014, COMP COMM ISCC 2014, P1; Lu H., 2011, P 8 ACM INT WORKSH V, P67, DOI DOI 10.1145/2030698.2030709; Maia Guilherme, 2012, P 2 ACM INT S DESIGN, P115, DOI DOI 10.1145/2386958.2386976; Marfia G, 2013, IEEE T VEH TECHNOL, V62, P522, DOI 10.1109/TVT.2012.2226484; Meneguette RI, 2015, 20 IEEE S COMP COMM; Mitchell T. M, 2006, DISCIPLINE MACHINE L, V9; Pan J, 2012, 2012 IEEE 8TH INTERNATIONAL CONFERENCE ON DISTRIBUTED COMPUTING IN SENSOR SYSTEMS (DCOSS), P265, DOI 10.1109/DCOSS.2012.29; Pessin G, 2014, J INTELL FUZZY SYST, V27, P3047, DOI 10.3233/IFS-141262; Schwartz RS, 2011, COMPUT COMMUN, V34, P2057, DOI 10.1016/j.comcom.2011.03.007; Silva F.A., 2013, 31 S BRAS RED COM SI, P615; Sommer C., 2014, VEHICULAR NETWORKING; Tonguz OK, 2010, IEEE WIREL COMMUN, V17, P47, DOI 10.1109/MWC.2010.5450660; Varga A., 2008, P 1 INT C SIM TOOLS, P1, DOI DOI 10.1109/ITSC.2002.1041322; Villas LA, 2012, P 15 ACM INT C MOD A, P39, DOI DOI 10.1145/2387027.2387035; Villas LA, 2013, IEEE ICC, P1439, DOI 10.1109/ICC.2013.6654713; Wei-Hsun Lee, 2012, 2012 12th International Conference on ITS Telecommunications (ITST 2012), P486, DOI 10.1109/ITST.2012.6425226; Willke TL, 2009, IEEE COMMUN SURV TUT, V11, P3, DOI 10.1109/SURV.2009.090202; Ye F, 2012, IEEE J SEL AREA COMM, V30, P769, DOI 10.1109/JSAC.2012.120511	33	33	33	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2016	11	8							e0159110	10.1371/journal.pone.0159110	http://dx.doi.org/10.1371/journal.pone.0159110			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4SL	27526048	Green Submitted, gold, Green Published			2022-12-27	WOS:000381471100004
J	Munyaneza, JE; Mustafa, T; Fisher, TW; Sengoda, VG; Horton, DR				Munyaneza, Joseph E.; Mustafa, Tariq; Fisher, Tonja W.; Sengoda, Venkatesan G.; Horton, David R.			Assessing the Likelihood of Transmission of Candidatus Liberibacter solanacearum to Carrot by Potato Psyllid, Bactericera cockerelli (Hemiptera: Triozidae)	PLOS ONE			English	Article							ZEBRA CHIP DISEASE; 1ST REPORT; ASSOCIATION; TOMATO; INOCULATION; PLANTS; ACQUISITION; HAPLOTYPES; HOMOPTERA; SYMPTOMS	Candidatus Liberibacter solanacearum' (Lso) is a phloem-limited bacterium that severely affects important Solanaceae and Apiaceae crops, including potato, tomato, pepper, tobacco, carrot and celery. This bacterium is transmitted to solanaceous species by potato psyllid, Bactericera cockerelli, and to Apiaceae by carrot psyllids, including Trioza apicalis and Bactericera trigonica. Five haplotypes of Lso have so far been described, two are associated with solanaceous species and potato psyllids, whereas the other three are associated with carrot and celery crops and carrot psyllids. Little is known about cross-transmission of Lso to carrot by potato psyllids or to potato by carrot psyllids. Thus, the present study assessed whether potato psyllid can transmit Lso to carrot and whether Lso haplotypes infecting solanaceous species can also infect carrot and lead to disease symptom development. In addition, the stylet probing behavior of potato psyllid on carrot was assessed using electropenetrography (EPG) technology to further elucidate potential Lso transmission to Apiaceae by this potato insect pest. Results showed that, while potato psyllids survived on carrot for several weeks when confined on the plants under controlled laboratory and field conditions, the insects generally failed to infect carrot plants with Lso. Only three of the 200 carrot plants assayed became infected with Lso and developed characteristic disease symptoms. Lso infection in the symptomatic carrot plants was confirmed by polymerase chain reaction assay and Lso in the carrots was determined to be of the haplotype B, which is associated with solanaceous species. EPG results further revealed that potato psyllids readily feed on carrot xylem but rarely probe into the phloem tissue, explaining why little to no Lso infection occurred during the controlled laboratory and field cage transmission trials. Results of our laboratory and field transmission studies, combined with our EPG results, suggest that the risk of Lso infection and spread between psyllid-infested solanaceous and Apiaceae crops is likely to be negligible under normal field conditions.	[Munyaneza, Joseph E.; Mustafa, Tariq; Fisher, Tonja W.; Sengoda, Venkatesan G.; Horton, David R.] USDA ARS, Yakima Agr Res Lab, Wapato, WA 98951 USA	United States Department of Agriculture (USDA)	Munyaneza, JE (corresponding author), USDA ARS, Yakima Agr Res Lab, Wapato, WA 98951 USA.	Joseph.Munyaneza@ars.usda.gov	Mustafa, Tariq/AAU-4194-2021	Mustafa, Tariq/0000-0002-6083-5806	United States Department of Agriculture (USDA)-Agricultural Research Service State Partnership Potato Research Program; Texas Department of Agriculture; USDA-National Institute of Food and Agriculture-Specialty Crop Research Initiative [2009-51181-20176]; USDA-ARS State Partnership Potato Research Program; USDA-NIFA-SCRI [2009-51181-20176]; ARS [ARS-0429561] Funding Source: Federal RePORTER	United States Department of Agriculture (USDA)-Agricultural Research Service State Partnership Potato Research Program; Texas Department of Agriculture; USDA-National Institute of Food and Agriculture-Specialty Crop Research Initiative; USDA-ARS State Partnership Potato Research Program; USDA-NIFA-SCRI; ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	Financial support for this work was partially provided by United States Department of Agriculture (USDA)-Agricultural Research Service State Partnership Potato Research Program, Texas Department of Agriculture, and USDA-National Institute of Food and Agriculture-Specialty Crop Research Initiative (Project #2009-51181-20176). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Kylie Swisher, Millie Heidt, Becky Cochran and Blaine Heilman for their invaluable technical support. Financial support for this work was partially provided by USDA-ARS State Partnership Potato Research Program, Texas Department of Agriculture, and USDA-NIFA-SCRI (Project #2009-51181-20176). The use of trade, firm, or corporation names in this publication is for information and convenience of the reader. Such use does not constitute an official endorsement or approval by the United States Department of Agriculture or the Agricultural Research Service of any product or service to the exclusion of others that may be suitable. USDA is an equal opportunity provider and employer.	Alfaro-Fernandez A, 2012, PLANT DIS, V96, P582, DOI 10.1094/PDIS-11-11-0918-PDN; Alfaro-Fernandez A, 2012, PLANT DIS, V96, P581, DOI 10.1094/PDIS-10-11-0878-PDN; Anonymous, 2013, Bulletin OEPP, V43, P197, DOI 10.1111/epp.12043; Backus EA, 2009, J INSECT PHYSIOL, V55, P869, DOI 10.1016/j.jinsphys.2009.05.007; Bertolini E., 2014, PLANT PATHOL, DOI 10.1111/ppa.12245; Buchman JL, 2012, AM J POTATO RES, V89, P159, DOI 10.1007/s12230-012-9238-3; Buchman JL, 2011, J ECON ENTOMOL, V104, P1486, DOI 10.1603/EC11123; Burckhardt D, 2014, FLA ENTOMOL, V97, P242, DOI 10.1653/024.097.0132; Burckhardt D, 2012, ZOOTAXA, P1; EPPO, 2012, EPPO REPORTING SERVI, V6, P4; Gbur EE, 2012, ACSESS PUBL, P1, DOI 10.2134/2012.generalized-linear-mixed-models; Goolsby JA, 2012, J ECON ENTOMOL, V105, P1268, DOI 10.1603/EC11435; Hansen AK, 2008, APPL ENVIRON MICROB, V74, P5862, DOI 10.1128/AEM.01268-08; Jagoueix S, 1996, MOL CELL PROBE, V10, P43, DOI 10.1006/mcpr.1996.0006; Liefting LW, 2008, PLANT DIS, V92, P1474, DOI 10.1094/PDIS-92-10-1474A; Liefting LW, 2009, PLANT DIS, V93, P208, DOI 10.1094/PDIS-93-3-0208; Loiseau M, 2014, PLANT DIS, V98, P839, DOI 10.1094/PDIS-08-13-0900-PDN; Martini X, 2013, FLA ENTOMOL, V96, P658, DOI 10.1653/024.096.0240; Munyaneza JE, 2007, J ECON ENTOMOL, V100, P656, DOI 10.1603/0022-0493(2007)100[656:AOBCHP]2.0.CO;2; Munyaneza JE, 2015, PLANT DIS, V99, P1269, DOI 10.1094/PDIS-02-15-0206-PDN; Munyaneza JE, 2012, PLANT DIS, V96, P453, DOI 10.1094/PDIS-10-11-0871; Munyaneza JE, 2012, PLANT DIS, V96, P454, DOI 10.1094/PDIS-10-11-0870; Munyaneza JE, 2010, PLANT DIS, V94, P639, DOI 10.1094/PDIS-94-5-0639A; Munyaneza JE, 2015, AM J POTATO RES, V92, P230, DOI 10.1007/s12230-015-9448-6; Munyaneza JE, 2012, AM J POTATO RES, V89, P329, DOI 10.1007/s12230-012-9262-3; Munyaneza JE, 2012, PLANT DIS, V96, P18, DOI 10.1094/PDIS-03-11-0185; Munyaneza JE, 2011, AM J POTATO RES, V88, P435, DOI 10.1007/s12230-011-9209-0; Munyaneza JE, 2010, SOUTHWEST ENTOMOL, V35, P471, DOI 10.3958/059.035.0335; Munyaneza JE, 2010, J ECON ENTOMOL, V103, P1060, DOI 10.1603/EC10027; Mustafa T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138946; Nelson WR, 2013, J PLANT PATHOL, V95, P455; Nelson WR, 2013, EUR J PLANT PATHOL, V135, P633, DOI 10.1007/s10658-012-0121-3; Nelson WR, 2011, EUR J PLANT PATHOL, V130, P5, DOI 10.1007/s10658-010-9737-3; Nissinen AI, 2014, PLANT PATHOL, V63, P812, DOI 10.1111/ppa.12144; Ouvrard D, 2015, SYST BIODIVERS, V13, P434, DOI 10.1080/14772000.2015.1046969; Pastrik KH, 2000, J PHYTOPATHOL, V148, P619, DOI 10.1046/j.1439-0434.2000.00567.x; Pearson CC, 2014, ANN ENTOMOL SOC AM, V107, P650, DOI 10.1603/AN13178; PLETSCH D. J., 1947, Bull. Mont. agric. Exp. Stn., V446; Sandanayaka WRM, 2014, ENTOMOL EXP APPL, V151, P170, DOI 10.1111/eea.12179; SAS Institute, 2012, SAS REL; Secor GA, 2009, PLANT DIS, V93, P574, DOI 10.1094/PDIS-93-6-0574; Sengoda VG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093475; Sengoda VG, 2013, J ECON ENTOMOL, V106, P1964, DOI 10.1603/EC13129; Swisher KD, 2012, ENVIRON ENTOMOL, V41, P1019, DOI 10.1603/EN12066; Tahzima R, 2014, PLANT DIS, V98, P1426, DOI 10.1094/PDIS-05-14-0509-PDN; Teresani GR, 2014, PHYTOPATHOLOGY, V104, P804, DOI 10.1094/PHYTO-07-13-0182-R; Teulon D. A. J., 2009, New Zealand Plant Protection, V62, P136; Thomas K. L., 2011, New Zealand Plant Protection, V64, P259; ULLMAN DE, 1988, ENVIRON ENTOMOL, V17, P675, DOI 10.1093/ee/17.4.675; WALLIS R. L., 1955, Technical Bulletin. United States Department of Agriculture; Wen AM, 2013, AM J POTATO RES, V90, P229, DOI 10.1007/s12230-012-9293-9; Zhang YP, 1998, J VIROL METHODS, V71, P45, DOI 10.1016/S0166-0934(97)00190-0	52	19	23	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2016	11	8							e0161016	10.1371/journal.pone.0161016	http://dx.doi.org/10.1371/journal.pone.0161016			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4SL	27525703	Green Published, gold, Green Submitted			2022-12-27	WOS:000381471100030
J	Pomies, P; Blaquiere, M; Maury, J; Mercier, J; Gouzi, F; Hayot, M				Pomies, Pascal; Blaquiere, Marine; Maury, Jonathan; Mercier, Jacques; Gouzi, Fares; Hayot, Maurice			Involvement of the FoxO1/MuRF1/Atrogin-1 Signaling Pathway in the Oxidative Stress-Induced Atrophy of Cultured Chronic Obstructive Pulmonary Disease Myotubes	PLOS ONE			English	Article							MUSCLE ATROPHY; UP-REGULATION; COPD; EXPRESSION; ACTIVATION; RESISTANCE; MYOBLASTS; ATROGIN-1; CELLS; MURF1	Oxidative stress is thought to be one of the most important mechanisms implicated in the muscle wasting of chronic obstructive pulmonary disease (COPD) patients, but its role has never been demonstrated. We therefore assessed the effects of both pro-oxidant and antioxidant treatments on the oxidative stress levels and atrophic signaling pathway of cultured COPD myotubes. Treatment of cultured COPD myotubes with the pro-oxidant molecule H2O2 resulted in increased ROS production (P = 0.002) and protein carbonylation (P = 0.050), in association with a more pronounced atrophy of the myotubes, as reflected by a reduced diameter (P = 0.003), and the activated expression of atrophic markers MuRF1 and FoxO1 (P = 0.022 and P = 0.030, respectively). Conversely, the antioxidant molecule ascorbic acid induced a reduction in ROS production (P<0.001) and protein carbonylation (P = 0.019), and an increase in the myotube diameter (P<0.001) to a level similar to the diameter of healthy subject myotubes, in association with decreased expression levels of MuRF1, atrogin-1 and FoxO1 (P<0.001, P = 0.002 and P = 0.042, respectively). A significant negative correlation was observed between the variations in myotube diameter and the variations in the expression of MuRF1 after antioxidant treatment (P = 0.047). Moreover, ascorbic acid was able to prevent the H2O2-induced atrophy of COPD myotubes. Last, the proteasome inhibitor MG132 restored the basal atrophy level of the COPD myotubes and also suppressed the H2O2-induced myotube atrophy. These findings demonstrate for the first time the involvement of oxidative stress in the atrophy of COPD peripheral muscle cells in vitro, via the FoxO1/MuRF1/atrogin-1 signaling pathway of the ubiquitin/proteasome system.	[Pomies, Pascal; Blaquiere, Marine; Maury, Jonathan; Mercier, Jacques; Gouzi, Fares; Hayot, Maurice] Univ Montpellier, PhyMedExp, INSERM U1046, CNRS UMR9214, Montpellier, France; [Blaquiere, Marine; Mercier, Jacques; Gouzi, Fares; Hayot, Maurice] CHRU Montpellier, Dept Clin Physiol, Montpellier, France; [Maury, Jonathan] Fontalvie 5 Sante Grp, Clin Souffle La Solane, Osseja, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; CHU de Montpellier	Pomies, P (corresponding author), Univ Montpellier, PhyMedExp, INSERM U1046, CNRS UMR9214, Montpellier, France.	pascal.pomies@inserm.fr	Pomiès, Pascal/AAC-8037-2020	Pomiès, Pascal/0000-0002-5301-6087	Montpellier Hospital (Programme Hospitalier de Recherche Clinique Interregional AREB-1); CIFRE grant (Conventions Industrielles de Formation par la Recherche) from the Fontalvie Corporation; French ANRT (Association Nationale de la Recherche et de la Technologie)	Montpellier Hospital (Programme Hospitalier de Recherche Clinique Interregional AREB-1); CIFRE grant (Conventions Industrielles de Formation par la Recherche) from the Fontalvie Corporation; French ANRT (Association Nationale de la Recherche et de la Technologie)(French National Research Agency (ANR))	This study was supported by a grant from the Montpellier Hospital (Programme Hospitalier de Recherche Clinique Interregional AREB-1). JM was supported by a CIFRE grant (Conventions Industrielles de Formation par la Recherche) from the Fontalvie Corporation and the French ANRT (Association Nationale de la Recherche et de la Technologie). The funder provided support in the form of salaries for authors [JM], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Alamdari N, 2012, BIOCHEM BIOPH RES CO, V417, P528, DOI 10.1016/j.bbrc.2011.11.154; Barro M, 2010, J CELL MOL MED, V14, P275, DOI 10.1111/j.1582-4934.2008.00368.x; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Caron AZ, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-185; Celli BR, 2004, NEW ENGL J MED, V350, P1005, DOI 10.1056/NEJMoa021322; Chen GQ, 2011, LIFE SCI, V89, P44, DOI 10.1016/j.lfs.2011.04.018; Couillard A, 2003, AM J RESP CRIT CARE, V167, P1664, DOI 10.1164/rccm.200209-1028OC; Dodd SL, 2010, MUSCLE NERVE, V41, P110, DOI 10.1002/mus.21526; Doucet M, 2007, AM J RESP CRIT CARE, V176, P261, DOI 10.1164/rccm.200605-704OC; Fabre O, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.104; Fermoselle C, 2012, EUR RESPIR J, V40, P851, DOI 10.1183/09031936.00137211; Gouzi F, 2013, EUR RESP J; Gouzi F, 2013, J APPL PHYSIOL, V115, P1796, DOI 10.1152/japplphysiol.00778.2013; Hayot M, 2011, MOL CELL ENDOCRINOL, V332, P38, DOI 10.1016/j.mce.2010.09.008; Hirasaka K, 2013, J NUTR SCI VITAMINOL, V59, P317, DOI 10.3177/jnsv.59.317; Koechlin C, 2004, AM J RESP CRIT CARE, V169, P1022, DOI 10.1164/rccm.200310-1465OC; Laviolette L, 2010, J MED FOOD, V13, P589, DOI 10.1089/jmf.2009.0142; Lewis A, 2012, THORAX, V67, P26, DOI 10.1136/thoraxjnl-2011-200309; Li YP, 2003, AM J PHYSIOL-CELL PH, V285, pC806, DOI 10.1152/ajpcell.00129.2003; Maltais F, 2014, AM J RESP CRIT CARE, V189, P1121, DOI 10.1164/rccrn.201402-0373ST; McClung JM, 2009, AM J PHYSIOL-CELL PH, V296, pC363, DOI 10.1152/ajpcell.00497.2008; Plant PJ, 2010, AM J RESP CELL MOL, V42, P461, DOI 10.1165/rcmb.2008-0382OC; Pomies P, 2015, J CELL MOL MED, V19, P175, DOI 10.1111/jcmm.12390; QUANJER PH, 1993, EUR RESPIR J, V6, P5, DOI 10.1183/09041950.005s1693; Rossman MJ, 2013, AM J PHYSIOL-REG I, V305, pR1163, DOI 10.1152/ajpregu.00360.2013; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Seymour JM, 2010, EUR RESPIR J, V36, P81, DOI 10.1183/09031936.00104909; Stitt TN, 2004, MOL CELL, V14, P395, DOI 10.1016/S1097-2765(04)00211-4; Theriault ME, 2014, RESP RES, V15, DOI 10.1186/1465-9921-15-35; van Helvoort HAC, 2007, CHEST, V131, P439, DOI 10.1378/chest.06-1655; Wang DT, 2014, INT IMMUNOPHARMACOL, V19, P206, DOI 10.1016/j.intimp.2014.02.002; Winokur ST, 2003, NEUROMUSCULAR DISORD, V13, P322, DOI 10.1016/S0960-8966(02)00284-5	32	31	34	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2016	11	8							e0160092	10.1371/journal.pone.0160092	http://dx.doi.org/10.1371/journal.pone.0160092			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4SL	27526027	Green Published, Green Submitted, gold			2022-12-27	WOS:000381471100011
J	Lagos, J; Couvin, D; Arata, L; Tognarelli, J; Aguayo, C; Leiva, T; Arias, F; Hormazabal, JC; Rastogi, N; Fernandez, J				Lagos, Jaime; Couvin, David; Arata, Loredana; Tognarelli, Javier; Aguayo, Carolina; Leiva, Tamara; Arias, Fabiola; Carlos Hormazabal, Juan; Rastogi, Nalin; Fernandez, Jorge			Analysis of Mycobacterium tuberculosis Genotypic Lineage Distribution in Chile and Neighboring Countries	PLOS ONE			English	Article							MOLECULAR EPIDEMIOLOGY; GENETIC DIVERSITY; DRUG-RESISTANCE; POPULATION-STRUCTURE; 1ST INSIGHT; SPOLIGOTYPES; STRAINS; COMPLEX; TOOLS; TRANSMISSION	Tuberculosis (TB), caused by the pathogen Mycobacterium tuberculosis (MTB), remains a disease of high importance to global public health. Studies into the population structure of MTB have become vital to monitoring possible outbreaks and also to develop strategies regarding disease control. Although Chile has a low incidence of MTB, the current rates of migration have the potential to change this scenario. We collected and analyzed a total of 458 M. tuberculosis isolates (1 isolate per patient) originating from all 15 regions of Chile. The isolates were genotyped using the spoligotyping method and the data obtained were analyzed and compared with the SITVIT2 database. A total of 169 different patterns were identified, of which, 119 patterns (408 strains) corresponded to Spoligotype International Types (SITs) and 50 patterns corresponded to orphan strains. The most abundantly represented SITs/lineages were: SIT53/T1 (11.57%), SIT33/LAM3 (9.6%), SIT42/LAM9 (9.39%), SIT50/H3 (5.9%), SIT37/T3 (5%); analysis of the spoligotyping minimum spanning tree as well as spoligoforest were suggestive of a recent expansion of SIT42, SIT50 and SIT37; all of which potentially evolved from SIT53. The most abundantly represented lineages were LAM (40.6%), T (34.1%) and Haarlem (13.5%). LAM was more prevalent in the Santiago (43.6%) and Concepcion (44.1%) isolates, rather than the Iquique (29.4%) strains. The proportion of X lineage was appreciably higher in Iquique and Concepcion (11.7% in both) as compared to Santiago (1.6%). Global analysis of MTB lineage distribution in Chile versus neighboring countries showed that evolutionary recent lineages (LAM, T and Haarlem) accounted together for 88.2% of isolates in Chile, a pattern which mirrored MTB lineage distribution in neighboring countries (n = 7378 isolates recorded in SITVIT2 database for Peru, Brazil, Paraguay, and Argentina; and published studies), highlighting epidemiological advantage of Euro-American lineages in this region. Finally, we also observed exclusive emergence of patterns SIT4014/X1 and SIT4015 (unknown lineage signature) that have hitherto been found exclusively in Chile, indicating that conditions specific to Chile, along with the unique genetic makeup of the Chilean population, might have allowed for a possible co-evolution leading to the success of these emerging genotypes.	[Lagos, Jaime; Arata, Loredana; Tognarelli, Javier; Aguayo, Carolina; Fernandez, Jorge] Publ Hlth Inst Chile, Subdept Mol Genet, Santiago, Chile; [Couvin, David; Rastogi, Nalin] Inst Pasteur Guadeloupe, TB & Mycobacteria Unit, WHO Supranat TB Reference Lab, Abymes, Guadeloupe, France; [Leiva, Tamara; Arias, Fabiola] Publ Hlth Inst Chile, Mycobacteria Lab, Santiago, Chile; [Carlos Hormazabal, Juan] Publ Hlth Inst Chile, Subdept Infect Dis, Santiago, Chile		Fernandez, J (corresponding author), Publ Hlth Inst Chile, Subdept Mol Genet, Santiago, Chile.; Rastogi, N (corresponding author), Inst Pasteur Guadeloupe, TB & Mycobacteria Unit, WHO Supranat TB Reference Lab, Abymes, Guadeloupe, France.	nrastogi@pasteur-guadeloupe.fr; jfernand@ispch.cl	RASTOGI, NALIN/AAP-1958-2020	RASTOGI, NALIN/0000-0002-7199-7747; Couvin, David/0000-0002-7897-9023				Abadia E, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-122; ALLAND D, 1994, NEW ENGL J MED, V330, P1710, DOI 10.1056/NEJM199406163302403; Alvarez N, 2016, GENOME ANNOUNCEMENTS, V4, DOI 10.1128/genomeA.01549-15; [Anonymous], 2014, TUB INF SIT CHIL 201; Araya P, 2011, REV MED CHILE, V139, P467, DOI /S0034-98872011000400008; Barnes PF, 2003, NEW ENGL J MED, P349; Candia N, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-75; Cerezo I, 2012, INFECT GENET EVOL, V12, P657, DOI 10.1016/j.meegid.2011.07.006; Couvin D, 2014, EUROREFERENCE J REFE, V12, P36, DOI [10.1186/1471-2407-14-960, DOI 10.1186/1471-2407-14-960]; Couvin D, 2015, TUBERCULOSIS, V95, pS177, DOI 10.1016/j.tube.2015.02.023; Cronin WA, 2001, J CLIN MICROBIOL, V39, P3709, DOI 10.1128/JCM.39.10.3709-3711.2001; Costa ERD, 2013, J CLIN MICROBIOL, V51, P1071, DOI 10.1128/JCM.01511-12; Demay C, 2012, INFECT GENET EVOL, V12, P755, DOI 10.1016/j.meegid.2012.02.004; Ellson J, 2004, MATH VIS, P127; Balcells ME, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118007; Gagneux S, 2007, LANCET INFECT DIS, V7, P328, DOI 10.1016/S1473-3099(07)70108-1; de Viedma DG, 2011, ENFERM INFEC MICR CL, V29, P8, DOI 10.1016/S0213-005X(11)70012-X; Gomes HM, 2012, INFECT GENET EVOL, V12, P649, DOI 10.1016/j.meegid.2011.08.027; Gonzalo X, 2011, EMERG INFECT DIS, V17, P528, DOI 10.3201/eid1703.100394; Grandjean L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126271; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Kremer K, 2005, J CLIN MICROBIOL, V43, P5628, DOI 10.1128/JCM.43.11.5628-5638.2005; Laszlo A, 1997, INT J TUBERC LUNG D, V1, P231; Machado LNC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107106; Mancilla E Marcos, 2006, Rev. chil. infectol., V23, P220; Meza P, 2014, REV CHIL INFECTOL, V31, P21, DOI 10.4067/S0716-10182014000100003; Millet J, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/689852; Monteserin J, 2013, INFECT GENET EVOL, V17, P195, DOI 10.1016/j.meegid.2013.04.010; Realpe T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109456; Reyes JF, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-496; Ritacco V, 2012, EMERG INFECT DIS, V18, P1802, DOI 10.3201/eid1811.120126; Shabbeer A, 2012, INFECT GENET EVOL, V12, P767, DOI 10.1016/j.meegid.2011.08.019; Sheen P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065873; Supply P, 2001, J CLIN MICROBIOL, V39, P3563, DOI 10.1128/JCM.39.10.3563-3571.2001; Supply P, 2006, J CLIN MICROBIOL, V44, P4498, DOI 10.1128/JCM.01392-06; Taype CA, 2012, INFECT GENET EVOL, V12, P577, DOI 10.1016/j.meegid.2012.02.002; VANEMBDEN JDA, 1993, J CLIN MICROBIOL, V31, P406, DOI 10.1128/JCM.31.2.406-409.1993; Vasconcellos SEG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107747; World Health Organization, 2013, WHO REPORT; Zumla A, 2013, NAT REV DRUG DISCOV, V12, P388, DOI 10.1038/nrd4001	40	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2016	11	8							e0160434	10.1371/journal.pone.0160434	http://dx.doi.org/10.1371/journal.pone.0160434			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3LI	27518286	gold, Green Submitted, Green Published			2022-12-27	WOS:000381382100014
J	Huang, DX; Lin, C; Wen, XJ; Gu, SY; Zhao, P				Huang, Daoxiang; Lin, Chao; Wen, Xuejun; Gu, Shuying; Zhao, Peng			A Potential Nanofiber Membrane Device for Filling Surgical Residual Cavity to Prevent Glioma Recurrence and Improve Local Neural Tissue Reconstruction	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; VASCULOGENIC MIMICRY; CANCER RECURRENCE; GLIOBLASTOMA; TEMOZOLOMIDE; CELLS; CHEMOTHERAPY; COMBINATION	This study aims to develop a novel device with nanofiber membrane capable of sustained release of temozolomide (TMZ) and neuron growth factor (NGF). An improved bio-availability of TMZ and NGF in surroundings proximal to the device was expected to be attained for a prolonged period of time. The device was developed by integrating TMZ-doped polycaprolactone (PCL) nanofiber (TP) membrane and NGF-coated PCL (NGFP) membrane using sodium alginate hydrogel. TP was prepared by direct electrospinning of TMZ/ PCL. NGFP membrane was developed by layer-by-layer assembling technology. The incorporation of TMZ-doped nanofiber and NGFP nanofiber in the device was confirmed by scanning electron microscopy. The number of NGF layer in NGF-coated PCL membrane could be readily measured with energy spectrum analysis. The in vitro release study showed that TP-NGFP-TP membrane could efficiently liberate TMZ to inhibit the growth of C6 glioma cells, and sufficient NGF to induce the differentiation of PC12 neuron cells over four weeks. Such TP-NGFP-TP membrane device can be employed as a tampon to fill up surgical residual cavity and afford residual glioma removal, structural support, hemostasis, and local neural tissue reconstruction in the surgical treatment of glioma. The study opens a horizon to develop multifunctional biomaterial device for maximized glioma treatment efficacy.	[Huang, Daoxiang; Lin, Chao; Wen, Xuejun; Zhao, Peng] Tongji Univ, Sch Med, Shanghai East Hosp, Inst Biomed Engn & Nanosci,Inst Translat Nanomed, Shanghai, Peoples R China; [Gu, Shuying] Tongji Univ, Sch Mat Sci & Engn, Minist Educ, Key Lab Adv Civil Engn Mat, Shanghai, Peoples R China; [Huang, Daoxiang; Gu, Shuying] Tongji Univ, Sch Mat Sci & Engn, Inst Nano & Biopolymer Mat, Shanghai, Peoples R China	Tongji University; Tongji University; Tongji University	Zhao, P (corresponding author), Tongji Univ, Sch Med, Shanghai East Hosp, Inst Biomed Engn & Nanosci,Inst Translat Nanomed, Shanghai, Peoples R China.; Gu, SY (corresponding author), Tongji Univ, Sch Mat Sci & Engn, Minist Educ, Key Lab Adv Civil Engn Mat, Shanghai, Peoples R China.; Gu, SY (corresponding author), Tongji Univ, Sch Mat Sci & Engn, Inst Nano & Biopolymer Mat, Shanghai, Peoples R China.	gushuying@tongji.edu.cn; zp@tongji.edu.cn	Zhao, Peng/HDO-7507-2022		Ministry of Science and Technology of the People's Republic of China [2014CB964600, 2012CB966300]; National Natural Science Funds of China [81271369]; Fundamental Research Funds for the Central Universities	Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China); National Natural Science Funds of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the Ministry of Science and Technology of the People's Republic of China (2014CB964600 to Dr. Peng Zhao); Ministry of Science and Technology of the People's Republic of China (2012CB966300 to Dr. Xuejun Wen); National Natural Science Funds of China (81271369 to Dr. Xuejun Wen); and Fundamental Research Funds for the Central Universities (Dr. Peng Zhao).	Aloe L, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-239; Falsini B, 2016, BRAIN, V139, P404, DOI 10.1093/brain/awv366; Feng XY, 2015, ACS APPL MATER INTER, V7, P27885, DOI 10.1021/acsami.5b09934; Gonzalez-Astorga B, 2013, EUR J CANCER, V49, pS794; Goodenberger ML, 2012, CANCER GENET-NY, V205, P613, DOI 10.1016/j.cancergen.2012.10.009; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Ju RJ, 2016, INT J NANOMED, V11, P1131, DOI 10.2147/IJN.S94467; Kaplan JA, 2016, BIOMATERIALS, V76, P273, DOI 10.1016/j.biomaterials.2015.10.060; Lacroix M, 2001, J NEUROSURG, V95, P190, DOI 10.3171/jns.2001.95.2.0190; Liu GT, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-67; Liu S, 2015, NANOMED-NANOTECHNOL, V11, P1047, DOI 10.1016/j.nano.2015.03.001; Liu YP, 2015, WORLD J SURG ONCOL, V13, DOI 10.1186/s12957-015-0558-x; Middleton MR, 2002, INT J CANCER, V100, P615, DOI 10.1002/ijc.10532; Mustafa AM, 2016, FOOD CHEM, V192, P782, DOI 10.1016/j.foodchem.2015.07.079; Naito E, 2015, IN VITRO CELL DEV-AN, V51, P1012, DOI 10.1007/s11626-015-9935-6; Narin S, 2013, FEBS J, V280, P418; Ni SL, 2014, ANN BIOMED ENG, V42, P214, DOI 10.1007/s10439-013-0903-6; Okonogi N, 2015, ANTICANCER RES, V35, P1229; Paw I, 2015, CANCER LETT, V362, P1, DOI 10.1016/j.canlet.2015.03.015; Reardon DA, 2006, ONCOLOGIST, V11, P152, DOI 10.1634/theoncologist.11-2-152; Zhu TH, 2015, J APPL POLYM SCI, V132, DOI 10.1002/app.41982; Zong S, 2015, EUR J PHARM BIOPHARM, V93, P127, DOI 10.1016/j.ejpb.2015.03.029	22	13	14	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2016	11	8							e0161435	10.1371/journal.pone.0161435	http://dx.doi.org/10.1371/journal.pone.0161435			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT8TP	27548322	Green Published, gold, Green Submitted			2022-12-27	WOS:000381768400057
J	Le, TTY; Nachev, M; Grabner, D; Hendriks, AJ; Sures, B				Le, T. T. Yen; Nachev, Milen; Grabner, Daniel; Hendriks, A. Jan; Sures, Bernd			Development and Validation of a Biodynamic Model for Mechanistically Predicting Metal Accumulation in Fish-Parasite Systems	PLOS ONE			English	Article							LEUCISCUS-CEPHALUS L.; POMPHORHYNCHUS-LAEVIS PALAEACANTHOCEPHALA; PERCH PERCA-FLUVIATILIS; TROUT SALMO-GAIRDNERI; FRESH-WATER FISH; RAINBOW-TROUT; HEAVY-METALS; TISSUE DISTRIBUTION; MORPHOLOGICAL DEVELOPMENT; PHARMACOKINETIC MODEL	Because of different reported effects of parasitism on the accumulation of metals in fish, it is important to consider parasites while interpreting bioaccumulation data from biomonitoring programmes. Accordingly, the first step is to take parasitism into consideration when simulating metal bioaccumulation in the fish host under laboratory conditions. In the present study, the accumulation of metals in fish-parasite systems was simulated by a one-compartment toxicokinetic model and compared to uninfected conspecifics. As such, metal accumulation in fish was assumed to result from a balance of different uptake and loss processes depending on the infection status. The uptake by parasites was considered an efflux from the fish host, similar to elimination. Physiological rate constants for the uninfected fish were parameterised based on the covalent index and the species weight while the parameterisation for the infected fish was carried out based on the reported effects of parasites on the uptake kinetics of the fish host. The model was then validated for the system of the chub Squalius cephalus and the acanthocephalan Pomphorhynchus tereticollis following 36-day exposure to waterborne Pb. The dissolved concentration of Pb in the exposure tank water fluctuated during the exposure, ranging from 40 to 120 mu g/L. Generally, the present study shows that the one-compartment model can be an effective method for simulating the accumulation of metals in fish, taking into account effects of parasitism. In particular, the predicted concentrations of Cu, Fe, Zn, and Pb in the uninfected chub as well as in the infected chub and the acanthocephalans were within one order of magnitude of the measurements. The variation in the absorption efficiency and the elimination rate constant of the uninfected chub resulted in variations of about one order of magnitude in the predicted concentrations of Pb. Inclusion of further assumptions for simulating metal accumulation in the infected chub led to variations of around two orders of magnitude in the predictions. Therefore, further research is required to reduce uncertainty while characterising and parameterising the model for infected fish.	[Le, T. T. Yen; Nachev, Milen; Grabner, Daniel; Sures, Bernd] Univ Duisburg Essen, Dept Aquat Ecol, Essen, Germany; [Le, T. T. Yen; Nachev, Milen; Grabner, Daniel; Sures, Bernd] Univ Duisburg Essen, Ctr Water & Environm Res ZWU, Essen, Germany; [Hendriks, A. Jan] Radboud Univ Nijmegen, Fac Sci, Dept Environm Sci, Nijmegen, Netherlands; [Sures, Bernd] Univ Johannesburg, Dept Zool, POB 524, ZA-2006 Johannesburg, South Africa	University of Duisburg Essen; University of Duisburg Essen; Radboud University Nijmegen; University of Johannesburg	Le, TTY (corresponding author), Univ Duisburg Essen, Dept Aquat Ecol, Essen, Germany.; Le, TTY (corresponding author), Univ Duisburg Essen, Ctr Water & Environm Res ZWU, Essen, Germany.	yen.le@uni-due.de	Sures, Bernd/B-6652-2013; Hendriks, Aalbert Jan/C-6767-2013	Grabner, Daniel/0000-0002-1251-7096; Sures, Bernd/0000-0001-6865-6186	Alexander von Humboldt foundation	Alexander von Humboldt foundation(Alexander von Humboldt Foundation)	T.T. Yen Le was awarded with a fellowship by the Alexander von Humboldt foundation.; T.T. Yen Le was awarded with a fellowship by the Alexander von Humboldt foundation.	Adam C, 1997, ENVIRON POLLUT, V97, P29, DOI 10.1016/S0269-7491(97)00083-3; Agah H, 2009, ENVIRON MONIT ASSESS, V157, P499, DOI 10.1007/s10661-008-0551-8; [Anonymous], 2008, BILE ACIDS TOXICOLOG; Arnot JA, 2004, ENVIRON TOXICOL CHEM, V23, P2343, DOI 10.1897/03-438; BAUDIN JP, 1989, WATER RES, V23, P817, DOI 10.1016/0043-1354(89)90004-3; Bervoets L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060805; Bevelhimer, 1997, ESTIMATION WHOLE FIS; Boalt E, 2014, MAR POLLUT BULL, V78, P130, DOI 10.1016/j.marpolbul.2013.10.051; Brazova T, 2012, SENSORS-BASEL, V12, P3068, DOI 10.3390/s120303068; Calta M, 2000, J APPL ICHTHYOL, V16, P83, DOI 10.1046/j.1439-0426.2000.00164.x; Canli M, 2003, ENVIRON POLLUT, V121, P129, DOI 10.1016/S0269-7491(02)00194-X; Creighton N, 2010, MAR POLLUT BULL, V60, P1815, DOI 10.1016/j.marpolbul.2010.05.025; Dang F, 2012, ENVIRON POLLUT, V163, P192, DOI 10.1016/j.envpol.2011.12.026; DOUBEN PET, 1989, ENVIRON POLLUT, V59, P177, DOI 10.1016/0269-7491(89)90226-1; Dutton J, 2010, AQUAT BIOL, V10, P211, DOI 10.3354/ab00276; ECONOMOU AN, 1991, J FISH BIOL, V39, P393, DOI 10.1111/j.1095-8649.1991.tb04371.x; Erdogan O, 2002, TURK J VET ANIM SCI, V26, P983; Franco-Uria A, 2010, CHEMOSPHERE, V79, P377, DOI 10.1016/j.chemosphere.2010.02.010; Gabrashanska M., 1996, PARASSITOLOGIA, V38, P58; Garnier-Laplace J, 2000, ARCH ENVIRON CON TOX, V39, P133, DOI 10.1007/s002440010089; GarnierLaplace J, 1997, WATER AIR SOIL POLL, V98, P141; Genc E, 2008, ENVIRON MONIT ASSESS, V141, P59, DOI 10.1007/s10661-007-9878-9; Gheorgiu C, 2006, PARASITOLOGY, V132, P225, DOI 10.1017/S003118200500898X; Giguere A, 2004, CAN J FISH AQUAT SCI, V61, P1702, DOI 10.1139/F04-100; HARRISON SE, 1989, ENVIRON TOXICOL CHEM, V8, P87, DOI 10.1002/etc.5620080110; Hendriks AJ, 2001, ENVIRON TOXICOL CHEM, V20, P1399, DOI 10.1002/etc.5620200703; HODSON PV, 1978, WATER RES, V12, P869, DOI 10.1016/0043-1354(78)90039-8; Hofer R, 1995, FISCHTOXIKOLOGIE THE; HONDA K, 1983, AGR BIOL CHEM TOKYO, V47, P2521, DOI 10.1080/00021369.1983.10865986; Hursky O, 2015, ENVIRON SCI TECHNOL, V49, P2469, DOI 10.1021/es5048792; Hyedayati A., 2010, WORLD J FISH MARINE, V2, P86; Jakimska A, 2011, POL J ENVIRON STUD, V20, P1117; Jankovska I, 2012, ENVIRON RES, V112, P83, DOI 10.1016/j.envres.2011.11.003; Javed M, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-390; Joiris CR, 2000, MAR POLLUT BULL, V40, P454, DOI 10.1016/S0025-326X(00)00013-8; Kalkan E, 2005, TURK J VET ANIM SCI, V29, P49; Karatas M., 2005, Journal of Biological Sciences, V5, P729; Karolus T, 2002, AKKUMULATION ELIMINA; Kupren K, 2011, CZECH J ANIM SCI, V56, P70, DOI 10.17221/312/2009-CJAS; Le TTY, 2015, CHEMOSPHERE, V124, P61, DOI 10.1016/j.chemosphere.2014.11.003; Le TTY, 2014, CHEMOSPHERE, V108, P145, DOI 10.1016/j.chemosphere.2014.01.036; Le TTY, 2011, ENVIRON TOXICOL CHEM, V30, P2825, DOI 10.1002/etc.685; Lebrun JD, 2011, AQUAT TOXICOL, V104, P161, DOI 10.1016/j.aquatox.2011.04.011; Lopa Ghosh, 2006, American Journal of Food Technology, V1, P139; Lopes PA, 2001, SCI TOTAL ENVIRON, V280, P153, DOI 10.1016/S0048-9697(01)00822-1; Luoma SN, 2005, ENVIRON SCI TECHNOL, V39, P1921, DOI 10.1021/es048947e; MAILHOT H, 1989, HEALTH PHYS, V56, P473, DOI 10.1097/00004032-198904000-00009; Marijic VF, 2013, SCI TOTAL ENVIRON, V463, P772, DOI 10.1016/j.scitotenv.2013.06.041; Mathews T, 2008, ENVIRON TOXICOL CHEM, V27, P1093, DOI 10.1897/07-318.1; Mazhar R, 2014, PARASITOL RES, V113, P3737, DOI 10.1007/s00436-014-4039-x; Mazon AF, 1999, B ENVIRON CONTAM TOX, V63, P797, DOI 10.1007/s001289901049; McCloskey JT, 1996, ENVIRON TOXICOL CHEM, V15, P1730, DOI 10.1002/etc.5620151011; McKinley AC, 2012, SCI TOTAL ENVIRON, V423, P84, DOI 10.1016/j.scitotenv.2012.02.007; Merciai R, 2014, ECOTOX ENVIRON SAFE, V107, P154, DOI 10.1016/j.ecoenv.2014.05.006; Nachev M, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-21; NEWMAN MC, 1988, AQUAT TOXICOL, V12, P17, DOI 10.1016/0166-445X(88)90016-1; Nichols JW, 2007, ENVIRON TOXICOL CHEM, V26, P1304, DOI 10.1897/06-259R.1; Nichols JW, 2013, ENVIRON TOXICOL CHEM, V32, P1611, DOI 10.1002/etc.2219; NICHOLS JW, 1990, TOXICOL APPL PHARM, V106, P433, DOI 10.1016/0041-008X(90)90338-U; NOREY CG, 1990, COMP BIOCHEM PHYS C, V96, P181, DOI 10.1016/0742-8413(90)90065-H; OPHEL IL, 1962, NATURE, V194, P1187, DOI 10.1038/1941187a0; Otero-Muras I, 2010, ENVIRON MODELL SOFTW, V25, P344, DOI 10.1016/j.envsoft.2009.08.009; Oyoo-Okoth E, 2012, AQUAT TOXICOL, V124, P34, DOI [10.1016/J.AQUATOX.2012.07.006, 10.1016/j.aquatox.2012.07.006]; Paller VGV, 2016, B ENVIRON CONTAM TOX, V96, P810, DOI 10.1007/s00128-016-1790-y; Pannetier P, 2016, SCI TOTAL ENVIRON, V569, P1435, DOI 10.1016/j.scitotenv.2016.06.232; PASCOE D, 1977, J FISH BIOL, V10, P467, DOI 10.1111/j.1095-8649.1977.tb04079.x; Peterson SA, 2007, ENVIRON SCI TECHNOL, V41, P58, DOI 10.1021/es061070u; Reinfelder JR, 1998, SCI TOTAL ENVIRON, V219, P117, DOI 10.1016/S0048-9697(98)00225-3; RODGERS DW, 1983, CAN J FISH AQUAT SCI, V40, P824, DOI 10.1139/f83-109; Rowan DJ, 1995, J APPL ECOL, V32, P739, DOI 10.2307/2404813; Schludermann C, 2003, PARASITOLOGY, V126, pS61, DOI 10.1017/S0031182003003743; Sen F, 2008, J ANIM VET ADV, V7, P1034; Siscar R, 2014, SCI TOTAL ENVIRON, V466, P898, DOI 10.1016/j.scitotenv.2013.07.081; Stefanova E, 2008, BULG J AGRIC SCI, V14, P214; Sures B, 1998, INT J PARASITOL, V28, P1173, DOI 10.1016/S0020-7519(98)00105-2; Sures B, 1999, EXP PARASITOL, V93, P66, DOI 10.1006/expr.1999.4437; Sures B, 1999, PARASITOL TODAY, V15, P16, DOI 10.1016/S0169-4758(98)01358-1; Sures B, 1999, ENVIRON TOXICOL CHEM, V18, P2574, DOI [10.1897/1551-5028(1999)018<2574:COEITZ>2.3.CO;2, 10.1897/1551-5028(1999)018&lt;2574:COEITZ&gt;2.3.CO;2, 10.1002/etc.5620181126]; Sures B, 2003, PARASITOLOGY, V126, pS53, DOI 10.1017/S003118200300372X; Sures B, 2004, TRENDS PARASITOL, V20, P170, DOI 10.1016/j.pt.2004.01.014; Sures B, 2003, INT J PARASITOL, V33, P1617, DOI 10.1016/S0020-7519(03)00251-0; Sures B, 2003, POLAR BIOL, V26, P680, DOI 10.1007/s00300-003-0538-4; Sures B., 1997, Parassitologia (Rome), V39, P213; Sures B, 2003, INT J PARASITOL, V33, P65, DOI 10.1016/S0020-7519(02)00249-7; Sures B, 2002, INT J PARASITOL, V32, P1117, DOI 10.1016/S0020-7519(02)00083-8; Sures B, 2001, INT J PARASITOL, V31, P669, DOI 10.1016/S0020-7519(01)00173-4; Tedesco PA, 2009, J FISH BIOL, V74, P312, DOI 10.1111/j.1095-8649.2008.02134.x; Thielen F, 2004, ENVIRON POLLUT, V129, P421, DOI 10.1016/j.envpol.2003.11.011; Thomann RV, 1997, ENVIRON TOXICOL CHEM, V16, P2268, DOI [10.1002/etc.5620161111, 10.1897/1551-5028(1997)016&lt;2268:APMOCI&gt;2.3.CO;2]; Trudel M, 1997, ENVIRON SCI TECHNOL, V31, P1716, DOI 10.1021/es960609t; Tsai JW, 2006, ENVIRON TOXICOL, V21, P8, DOI 10.1002/tox.20150; UGEDAL O, 1992, FRESHWATER BIOL, V28, P165, DOI 10.1111/j.1365-2427.1992.tb00573.x; Urien N, 2016, WATER RES, V95, P330, DOI 10.1016/j.watres.2016.03.023; Urien N, 2015, ENVIRON POLLUT, V203, P22, DOI 10.1016/j.envpol.2015.03.045; Blanco MV, 2014, ECOL MODEL, V274, P50, DOI 10.1016/j.ecolmodel.2013.12.002; van Kolck M, 2008, ENVIRON TOXICOL CHEM, V27, P272, DOI 10.1897/07-224R.1; VARANASI U, 1978, TOXICOL APPL PHARM, V46, P65, DOI 10.1016/0041-008X(78)90137-0; Veltman K, 2008, ENVIRON SCI TECHNOL, V42, P852, DOI 10.1021/es071331f; Veltman K, 2010, ENVIRON SCI TECHNOL, V44, P5022, DOI 10.1021/es903697c; Vlach P, 2005, CZECH J ANIM SCI, V50, P329, DOI 10.17221/4174-CJAS; Wang R, 2010, ENVIRON POLLUT, V158, P2694, DOI 10.1016/j.envpol.2010.04.019; Wang WX, 2012, AD ENVIRON RES, V1, P15, DOI 10.12989/aer.2012.1.1.015; Wang WX, 2008, COMP BIOCHEM PHYS C, V148, P315, DOI 10.1016/j.cbpc.2008.04.003; WICKLUND A, 1988, AQUAT TOXICOL, V13, P109, DOI 10.1016/0166-445X(88)90037-9; Widianarko B, 2001, ENVIRON TOXICOL CHEM, V20, P763, DOI 10.1002/etc.5620200410; Wiener J.G., 2003, HDB ECOTOXICOLOGY, V2, P409; Williams ND, 2000, ENVIRON TOXICOL, V15, P165, DOI 10.1002/1522-7278(2000)15:3<165::AID-TOX3>3.0.CO;2-Q; Woelfl S, 2008, SPECTROCHIM ACTA B, V63, P1450, DOI 10.1016/j.sab.2008.10.009; WRIGHT DA, 1985, B ENVIRON CONTAM TOX, V34, P196, DOI 10.1007/BF01609724; Xu Y, 2002, MAR ECOL PROG SER, V238, P173, DOI 10.3354/meps238173; Zhou DM, 2011, ECOTOX ENVIRON SAFE, V74, P1036, DOI 10.1016/j.ecoenv.2011.01.021; ZINCK ME, 1975, CAN J BIOCHEM CELL B, V53, P636, DOI 10.1139/o75-087	112	10	10	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2016	11	8							e0161091	10.1371/journal.pone.0161091	http://dx.doi.org/10.1371/journal.pone.0161091			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT8TP	27548282	Green Submitted, Green Published, gold			2022-12-27	WOS:000381768400030
J	Mallat, SG; Tanios, BY; Itani, HS; Lotfi, T; Akl, EA				Mallat, Samir G.; Tanios, Bassem Y.; Itani, Houssam S.; Lotfi, Tamara; Akl, Elie A.			Free versus Fixed Combination Antihypertensive Therapy for Essential Arterial Hypertension: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							BETA-BLOCKERS; MANAGEMENT; HYDROCHLOROTHIAZIDE; PROPRANOLOL; AMLODIPINE; GUIDELINES; DIURETICS; EFFICACY; SOCIETY; SAFETY	Background In a free drug combination, each Blood pressure (BP)-lowering drug is administered as a separate pill, while in a fixed drug combination several BP-lowering agents are combined in a single pill. Using a single pill may enhance compliance and simplify treatment, which would translate into better clinical outcomes. The objective of this meta-analysis is to compare the effects of using a fixed combination versus free combination of BP-lowering agents in the management of patients with essential hypertension. Methods We searched Cochrane CENTRAL, MEDLINE, and EMBASE for randomized clinical trials (RCTs) addressing the objective of the review and assessing at least one of the following outcomes: BP-lowering efficacy, rapidity in achieving BP target, compliance, incidence of side effects, mortality, and morbidity. Two review authors independently selected eligible studies, abstracted data, and assessed risk of bias of included trials. The primary meta-analyses used a random-effects model. Results We identified seven RCTs with a total of 397 participants. Meta-analysis of efficacy in controlling BP showed a non-significant reduction of mean systolic BP of 0.81 mmHg (95% CI -3.25, 1.64) favoring the fixed combination group. As for adverse events, results showed a non-significant 13% risk reduction favoring the free combination (risk ratio 1.13, 95% CI 0.85, 1.5). Low quality of evidence was noted for both outcomes. Rapidity in achieving BP target was assessed in only one trial, and the results favored the fixed combination. Adherence to treatment was assessed in three trials, no pooled analysis was possible for this outcome. None of the included trials assessed mortality and morbidity. Conclusion The available low quality evidence does not confirm or rule out a substantive difference between fixed combination and free combination therapy in the management of HTN. Well designed RCTs with a long duration of follow-up and assessment of morbidity and mortality outcomes are needed.	[Mallat, Samir G.; Tanios, Bassem Y.] Amer Univ Beirut, Div Nephrol, Dept Internal Med, Beirut, Lebanon; [Itani, Houssam S.] Makassed Gen Hosp, Div Nephrol, Dept Internal Med, Beirut, Lebanon; [Lotfi, Tamara] Amer Univ Beirut, Clin Res Inst, Beirut, Lebanon; [Akl, Elie A.] Amer Univ Beirut, Dept Internal Med, Beirut, Lebanon	American University of Beirut; American University of Beirut; American University of Beirut; American University of Beirut	Tanios, BY (corresponding author), Amer Univ Beirut, Div Nephrol, Dept Internal Med, Beirut, Lebanon.	bt08@aub.edu.lb	Akl, Elie A/R-2079-2016; Akl, Elie/K-5269-2019	Akl, Elie A/0000-0002-3444-8618; Lotfi, Tamara/0000-0001-6101-3946; Tanios, Bassem/0000-0002-8323-6910				ASPLUND J, 1984, BRIT J CLIN PHARMACO, V17, P547, DOI 10.1111/j.1365-2125.1984.tb02388.x; BENGTSSON C, 1979, CLIN THER, V2, P114; CRIQUI MH, 1992, NEW ENGL J MED, V326, P381, DOI 10.1056/NEJM199202063260605; EBBUTT AF, 1979, J INT MED RES, V7, P524, DOI 10.1177/030006057900700608; Ettehad D, 2016, LANCET, V387, P957, DOI 10.1016/S0140-6736(15)01225-8; FORREST WA, 1980, J INT MED RES, V8, P127, DOI 10.1177/030006058000800204; Furukawa TA, 2006, J CLIN EPIDEMIOL, V59, P7, DOI 10.1016/j.jclinepi.2005.06.006; Gillespie C., 2011, Morbidity and Mortality Weekly Report, V60, P103; Gupta AK, 2010, HYPERTENSION, V55, P399, DOI 10.1161/HYPERTENSIONAHA.109.139816; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1311, DOI [10.1016/j.jclinepi.2011.03.017, 10.1016/j.jclinepi.2011.06.004]; Hansson L, 1998, LANCET, V351, P1755, DOI 10.1016/S0140-6736(98)04311-6; Higgins J.P.T., 2019, COCHRANE HDB SYSTEMA, V2nd, DOI [DOI 10.1002/9781119536604, 10.1002/9780470712184.ch1, DOI 10.1002/9780470712184.CH1]; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; JAATTELA A, 1979, ANN CLIN RES, V11, P80; Jamerson K, 2008, NEW ENGL J MED, V359, P2417, DOI 10.1056/NEJMoa0806182; James PA, 2014, JAMA-J AM MED ASSOC, V311, P507, DOI 10.1001/jama.2013.284427; Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)70151-3; Kettani FZ, 2009, STROKE, V40, P213, DOI 10.1161/STROKEAHA.108.522193; Levy D, 1996, JAMA-J AM MED ASSOC, V275, P1557, DOI 10.1001/jama.275.20.1557; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Mallat SG, 2013, INTEGR BLOOD PRESS C, V6, P69, DOI 10.2147/IBPC.S33985; Mancia G, 2004, BLOOD PRESSURE, V13, P11, DOI 10.1080/08038020410035574; Mancia G, 2013, J HYPERTENS, V31, P1281, DOI 10.1097/01.hjh.0000431740.32696.cc; McLay JS, 2000, EUR J CLIN PHARMACOL, V56, P529, DOI 10.1007/s002280000198; Morgan TO, 2001, AM J HYPERTENS, V14, P241, DOI 10.1016/S0895-7061(00)01266-8; Nedogoda S, EFFICACY SAFETY STUD; NISSINEN A, 1980, PHARMATHERAPEUTICA, V2, P462; Nowak E, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000002229; OLVERA R, 1991, CURR THER RES CLIN E, V49, P155; Pecherina TB, 2014, KARDIOLOGIYA, V54, P21; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; Schweizer J, 2007, CURR MED RES OPIN, V23, P2877, DOI 10.1185/030079907X242539; Scotti L, 2013, VALUE HEALTH, V16, P318, DOI 10.1016/j.jval.2012.11.008; Sherrill B, 2011, J CLIN HYPERTENS, V13, P898, DOI 10.1111/j.1751-7176.2011.00550.x; SOLOMON LR, 1980, J INT MED RES, V8, P34, DOI 10.1177/030006058000800106; SPRINT Research Group, 2015, N Engl J Med, V373, P2103, DOI 10.1056/NEJMoa1511939; Weber MA, 2004, LANCET, V363, P2049, DOI 10.1016/S0140-6736(04)16456-8; Weber MA, 2014, J HYPERTENS, V32, P3, DOI [10.1111/jch.12237, 10.1097/HJH.0000000000000065]; Wood L, 2008, BMJ-BRIT MED J, V336, P601, DOI 10.1136/bmj.39465.451748.AD	39	29	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2016	11	8							e0161285	10.1371/journal.pone.0161285	http://dx.doi.org/10.1371/journal.pone.0161285			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT8TP	27548060	Green Submitted, Green Published, gold			2022-12-27	WOS:000381768400037
J	Sluik, D; Jankovic, N; O'Doherty, MG; Geelen, A; Schottker, B; Rolandsson, O; Kiefte-de Jong, JC; Ferrieres, J; Bamia, C; Fransen, HP; Boer, JMA; Eriksson, S; Martinez, B; Huerta, JM; Kromhout, D; de Groot, LCPGM; Franco, OH; Trichopoulou, A; Boffetta, P; Kee, F; Feskens, EJM				Sluik, Diewertje; Jankovic, Nicole; O'Doherty, Mark G.; Geelen, Anouk; Schoettker, Ben; Rolandsson, Olov; Kiefte-de Jong, Jessica C.; Ferrieres, Jean; Bamia, Christina; Fransen, Heidi P.; Boer, Jolanda M. A.; Eriksson, Sture; Martinez, Begona; Maria Huerta, Jose; Kromhout, Daan; de Groot, Lisette C. P. G. M.; Franco, Oscar H.; Trichopoulou, Antonia; Boffetta, Paolo; Kee, Frank; Feskens, Edith J. M.			Alcoholic Beverage Preference and Dietary Habits in Elderly across Europe: Analyses within the Consortium on Health and Ageing: Network of Cohorts in Europe and the United States (CHANCES) Project	PLOS ONE			English	Article							CONSUMPTION PATTERNS; DRINKING PATTERNS; LIFE-STYLE; WINE; MORTALITY; BEER; DETERMINANTS; POPULATION; GUIDELINES; SPIRITS	Introduction The differential associations of beer, wine, and spirit consumption on cardiovascular risk found in observational studies may be confounded by diet. We described and compared dietary intake and diet quality according to alcoholic beverage preference in European elderly. Methods From the Consortium on Health and Ageing: Network of Cohorts in Europe and the United States (CHANCES), seven European cohorts were included, i.e. four sub-cohorts from EPIC-Elderly, the SENECA Study, the Zutphen Elderly Study, and the Rotterdam Study. armonized data of 29,423 elderly participants from 14 European countries were analyzed. Baseline data on consumption of beer, wine, and spirits, and dietary intake were collected with questionnaires. Diet quality was assessed using the Healthy Diet Indicator (HDI). Intakes and scores across categories of alcoholic beverage preference (beer, wine, spirit, no preference, non-consumers) were adjusted for age, sex, socio-economic status, self reported prevalent diseases, and lifestyle factors. Cohort-specific mean intakes and scores were calculated as well as weighted means combining all cohorts. Results In 5 of 7 cohorts, persons with a wine preference formed the largest group. After multivariate adjustment, persons with a wine preference tended to have a higher HDI score and intake of healthy foods in most cohorts, but differences were small. The weighted estimates of all cohorts combined revealed that non-consumers had the highest fruit and vegetable intake, followed by wine consumers. Non-consumers and persons with no specific preference had a higher HDI score, spirit consumers the lowest. However, overall diet quality as measured by HDI did not differ greatly across alcoholic beverage preference categories. Discussion This study using harmonized data from similar to 30,000 elderly from 14 European countries showed that, after multivariate adjustment, dietary habits and diet quality did not differ greatly according to alcoholic beverage preference.	[Sluik, Diewertje; Jankovic, Nicole; Geelen, Anouk; Kromhout, Daan; de Groot, Lisette C. P. G. M.; Feskens, Edith J. M.] Wageningen Univ, Div Human Nutr, Wageningen, Netherlands; [Jankovic, Nicole] Univ Duisburg Essen, Fac Med, Ctr Clin Epidemiol, Inst Med Informat Biometry & Epidemiol, Essen, Germany; [O'Doherty, Mark G.; Kee, Frank] Queens Univ Belfast, UKCRC Ctr Excellence Publ Hlth, Belfast, Antrim, North Ireland; [Schoettker, Ben] German Canc Res Ctr, Div Clin Epidemiol & Aging Res, Heidelberg, Germany; [Schoettker, Ben] FOM Univ, Inst Hlth Care & Social Sci, Essen, Germany; [Rolandsson, Olov; Eriksson, Sture] Umea Univ, Dept Publ Hlth & Clin Med, Family Med, Umea, Sweden; [Kiefte-de Jong, Jessica C.] Leiden Univ Coll, Global Publ Hlth, The Hague, Netherlands; [Kiefte-de Jong, Jessica C.; Franco, Oscar H.] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [Ferrieres, Jean] Toulouse Univ, Sch Med, Dept Cardiol, Toulouse, France; [Bamia, Christina; Trichopoulou, Antonia; Boffetta, Paolo] Hellen Hlth Fdn, Athens, Greece; [Bamia, Christina; Trichopoulou, Antonia] Univ Athens, Unit Nutr Epidemiol & Nutr Publ Hlth, Dept Hyg Epidemiol & Med Stat, WHO Collaborating Ctr Nutr & Hlth,Sch Med, Athens, Greece; [Fransen, Heidi P.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Boer, Jolanda M. A.] Natl Inst Publ Hlth & Environm RIVM, Bilthoven, Netherlands; [Martinez, Begona] Univ Granada, Hosp Univ Granada, Escuela Andaluza Salud Publ, Inst Invest Biosanitaria Ibs Granada, Granada, Spain; [Martinez, Begona; Maria Huerta, Jose] CIBER Epidemiol Salud Publ CIBERESP, Madrid, Spain; [Maria Huerta, Jose] IMIB Arrixaca, Murcia Reg Hlth Council, Dept Epidemiol, Murcia, Spain; [Boffetta, Paolo] Mt Sinai Sch Med, Icahn Sch Med, New York, NY USA	Wageningen University & Research; University of Duisburg Essen; Queens University Belfast; Helmholtz Association; German Cancer Research Center (DKFZ); Umea University; Erasmus University Rotterdam; Erasmus MC; Universite de Franche-Comte; Universite Federale Toulouse Midi-Pyrenees (ComUE); Athens Medical School; National & Kapodistrian University of Athens; Utrecht University; Utrecht University Medical Center; Netherlands National Institute for Public Health & the Environment; Escuela Andaluza de Salud Publica; Instituto de Investigacion Biosanitaria IBS Granada; University of Granada; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Hospital Clinico Universitario Virgen de la Arrixaca; Murcia Regional Health Council; Icahn School of Medicine at Mount Sinai	Sluik, D (corresponding author), Wageningen Univ, Div Human Nutr, Wageningen, Netherlands.	Diewertje.Sluik@wur.nl	Schöttker, Ben/F-8183-2014; TRICHOPOULOU, ANTONIA/ABF-8727-2021; Huerta, José María/N-8654-2015; Boffetta, Paolo/AAI-7767-2021; Franco, Óscar H/ABE-2305-2020; Kiefte-de Jong, Jessica/GLV-3216-2022; Eriksson, Sture/AAF-8435-2021; Feskens, Edith/ABI-1446-2020; Ferrieres, Jean/S-7993-2016	Schöttker, Ben/0000-0002-1217-4521; TRICHOPOULOU, ANTONIA/0000-0002-7204-6396; Huerta, José María/0000-0002-9637-3869; Boffetta, Paolo/0000-0002-3811-2791; Franco, Óscar H/0000-0002-4606-4929; Kiefte-de Jong, Jessica/0000-0002-8136-0918; Eriksson, Sture/0000-0002-3098-3787; Feskens, Edith/0000-0001-5819-2488; de Groot, Lisette/0000-0003-2778-2789; Ferrieres, Jean/0000-0001-6144-1297; Sluik, Diewertje/0000-0001-6304-0913	European Foundation for Alcohol Research (ERAB); Dutch Beer Institute; FP7 framework programme of the Directorate General for Research & Innovation in the European Commission [242244]; Health Research Fund (FIS) of the Spanish Ministry of Health (Spain); CIBER de Epidemiologia y Salud Publica (CIBERESP); Spanish Regional Governments of Andalucia, Asturias, Basque Country, Murcia [6236]; Navarra (Spain); Medical Research Council [MC_CF023241] Funding Source: researchfish	European Foundation for Alcohol Research (ERAB); Dutch Beer Institute; FP7 framework programme of the Directorate General for Research & Innovation in the European Commission; Health Research Fund (FIS) of the Spanish Ministry of Health (Spain); CIBER de Epidemiologia y Salud Publica (CIBERESP); Spanish Regional Governments of Andalucia, Asturias, Basque Country, Murcia; Navarra (Spain); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The work of DS was supported by the European Foundation for Alcohol Research (ERAB) and the Dutch Beer Institute. The sponsor did not have any role in the design and conduct of the study; collection, management, analysis and interpretation of the data; and preparation, review or approval of the manuscript. This analysis was part of the Consortium on Health and Ageing (CHANCES) project funded in the FP7 framework programme of the Directorate General for Research & Innovation in the European Commission (grant 242244). The CHANCES project is coordinated by the Hellenic Health Foundation, Greece. The EPIC-Elderly Study was partially supported by the Health Research Fund (FIS) of the Spanish Ministry of Health (Spain); the CIBER de Epidemiologia y Salud Publica (CIBERESP), and the Spanish Regional Governments of Andalucia, Asturias, Basque Country, Murcia (no. 6236) and Navarra (Spain).	Alcacera MA, 2008, EUR J CLIN NUTR, V62, P1178, DOI 10.1038/sj.ejcn.1602833; Barefoot JC, 2002, AM J CLIN NUTR, V76, P466, DOI 10.1093/ajcn/76.2.466; Boffetta P, 2014, EUR J EPIDEMIOL, V29, P929, DOI 10.1007/s10654-014-9977-1; Breslow RA, 2006, AM J EPIDEMIOL, V163, P359, DOI 10.1093/aje/kwj050; Buijsse B, 2006, ARCH INTERN MED, V166, P411, DOI 10.1001/.411; Chatenoud L, 2000, EUR J CLIN NUTR, V54, P177, DOI 10.1038/sj.ejcn.1600913; Costanzo S, 2011, EUR J EPIDEMIOL, V26, P833, DOI 10.1007/s10654-011-9631-0; Carmona-Torre FD, 2008, AM J HEALTH PROMOT, V23, P27, DOI 10.4278/ajhp.07050143; DEGROOT LCPGM, 1991, EUR J CLIN NUTR, V45, P23; Evans A, 2005, INT J EPIDEMIOL, V34, P21, DOI 10.1093/ije/dyh327; FESKENS EJM, 1994, AM J EPIDEMIOL, V140, P350, DOI 10.1093/oxfordjournals.aje.a117257; Forshee RA, 2006, INT J FOOD SCI NUTR, V57, P494, DOI 10.1080/09637480600991240; Gronbaek M, 2001, J INTERN MED, V250, P291, DOI 10.1046/j.1365-2796.2001.00885.x; GRONBAEK M, 1995, BRIT MED J, V310, P1165, DOI 10.1136/bmj.310.6988.1165; Gronbaek M, 2007, ANN EPIDEMIOL, V17, pS13, DOI 10.1016/j.annepidem.2007.01.004; HOFMAN A, 1991, EUR J EPIDEMIOL, V7, P403, DOI 10.1007/BF00145007; Huijbregts P, 1997, BRIT MED J, V315, P13, DOI 10.1136/bmj.315.7099.13; I. Foods. EPIC Group of Spain, 1997, INT J EPIDEMIOL S1, V26, pS91, DOI [10.1016/j.ehj.2003.12.022, DOI 10.1016/J.EHJ.2003.12.022]; Jankovic N, 2014, AM J EPIDEMIOL, V180, P978, DOI 10.1093/aje/kwu229; Klatsky AL, 2003, AM J EPIDEMIOL, V158, P585, DOI 10.1093/aje/kwg184; Kuulasmaa K, 2015, CHANCES COHORT DESCR; Mannisto S, 1997, EUR J CLIN NUTR, V51, P326, DOI 10.1038/sj.ejcn.1600406; McCann SE, 2003, NUTR METAB CARDIOVAS, V13, P2, DOI 10.1016/S0939-4753(03)80162-X; Mullie P, 2015, MILITARY MED RES, V2, DOI 10.1186/s40779-015-0066-x; NES M, 1991, EUR J CLIN NUTR, V45, P97; Paschall M, 2005, DRUG ALCOHOL DEPEN, V78, P339, DOI 10.1016/j.drugalcdep.2004.12.004; Rehm J, 2010, ADDICTION, V105, P817, DOI 10.1111/j.1360-0443.2010.02899.x; Riboli E, 1997, INT J EPIDEMIOL, V26, pS6, DOI 10.1093/ije/26.suppl_1.S6; Rimm EB, 2002, CIRCULATION, V105, P2806, DOI 10.1161/01.CIR.0000022344.79651.CC; Rouillier P, 2004, EUR J NUTR, V43, P69, DOI 10.1007/s00394-004-0442-x; Ruidavets JB, 2004, EUR HEART J, V25, P1153, DOI 10.1016/j.ehj.2003.12.022; Sanchez-Villegas A, 2009, PUBLIC HEALTH NUTR, V12, P351, DOI 10.1017/S1368980008002127; Satija A, 2015, ADV NUTR, V6, P5, DOI 10.3945/an.114.007492; Sluik D, 2014, EUR J CLIN NUTR, V68, P287, DOI 10.1038/ejcn.2013.279; Sluik D, 2016, CRIT REV FOOD SCI, V56, P2370, DOI 10.1080/10408398.2013.841118; Tjonneland A, 1999, AM J CLIN NUTR, V69, P49; Trichopoulou A, 2005, BMJ-BRIT MED J, V330, P991, DOI 10.1136/bmj.38415.644155.8F; Truelsen T, 1998, STROKE, V29, P2467, DOI 10.1161/01.STR.29.12.2467; Valencia-Martin JL, 2011, ALCOHOL CLIN EXP RES, V35, P2075, DOI 10.1111/j.1530-0277.2011.01559.x; Willett WC, 2008, ASIA PAC J CLIN NUTR, V17, P75	40	10	10	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2016	11	8							e0161603	10.1371/journal.pone.0161603	http://dx.doi.org/10.1371/journal.pone.0161603			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT8TP	27548323	Green Published, gold, Green Submitted			2022-12-27	WOS:000381768400075
J	Beleut, M; Soeldner, R; Egorov, M; Guenther, R; Dehler, S; Morys-Wortmann, C; Moch, H; Henco, K; Schraml, P				Beleut, Manfred; Soeldner, Robert; Egorov, Mark; Guenther, Rolf; Dehler, Silvia; Morys-Wortmann, Corinna; Moch, Holger; Henco, Karsten; Schraml, Peter			Discretization of Gene Expression Data Unmasks Molecular Subgroups Recurring in Different Human Cancer Types	PLOS ONE			English	Article							DRIVER MUTATIONS; HUMAN BREAST; CLASSIFICATION	Despite the individually different molecular alterations in tumors, the malignancy associated biological traits are strikingly similar. Results of a previous study using renal cell carcinoma (RCC) as a model pointed towards cancer-related features, which could be visualized as three groups by microarray based gene expression analysis. In this study, we used a mathematic model to verify the presence of these groups in RCC as well as in other cancer types. We developed an algorithm for gene-expression deviation profiling for analyzing gene expression data of a total of 8397 patients with 13 different cancer types and normal tissues. We revealed three common Cancer Transcriptomic Profiles (CTPs) which recurred in all investigated tumors. Additionally, CTPs remained robust regardless of the functions or numbers of genes analyzed. CTPs may represent common genetic fingerprints, which potentially reflect the closely related biological traits of human cancers.	[Beleut, Manfred; Soeldner, Robert; Egorov, Mark; Guenther, Rolf; Morys-Wortmann, Corinna; Henco, Karsten] Qlaym Healthcare AG, Hans Adolf Krebs Weg 1, D-37077 Gottingen, Germany; [Dehler, Silvia] Univ Zurich Hosp, Canc Registry Zurich & Zug, Zurich, Switzerland; [Moch, Holger; Schraml, Peter] Univ Zurich Hosp, Inst Surg Pathol, Schmelzbergstr 12, CH-8091 Zurich, Switzerland	University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital	Beleut, M (corresponding author), Qlaym Healthcare AG, Hans Adolf Krebs Weg 1, D-37077 Gottingen, Germany.; Schraml, P (corresponding author), Univ Zurich Hosp, Inst Surg Pathol, Schmelzbergstr 12, CH-8091 Zurich, Switzerland.	AnManfred@gmx.de; Peter.Schraml@usz.ch	Beleut, Manfred/E-8427-2011	Beleut, Manfred/0000-0002-5610-156X	Swiss National Science Foundation [3238BO-10314]; HS Lifesciences GmbH	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); HS Lifesciences GmbH	Authors MB, RS, ME, RG, CM, KH are employed by the Qlaym Healthcare AG. The specific roles of individual authors are articulated in the "author contributions" section. The funders provided support in the form of salaries but did not have any additional role in study design, data collection and analysis, decision to publish or preparation of the manuscript. This project was also sponsored by a grant of the Swiss National Science Foundation (grant number: 3238BO-10314) to HM. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank HS Lifesciences GmbH for supporting this project, Andreas Brede-Buchenau, Martin Wiesenfeldt and Ruediger Goetz for critical proofreading and valuable comments.	Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Hirata BKB, 2014, DIS MARKERS, V2014, DOI 10.1155/2014/513158; Beleut M, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-310; Bollag G, 2012, NAT REV DRUG DISCOV, V11, P873, DOI 10.1038/nrd3847; Burgess DJ, 2013, NAT REV CANCER, V13, P380, DOI 10.1038/nrc3529; CANNINGS C, 1968, ANN HUM GENET, V31, P421, DOI 10.1111/j.1469-1809.1968.tb00575.x; Cao QY, 2011, NUCLEIC ACIDS RES, V39, pD968, DOI 10.1093/nar/gkq997; Chittenden TW, 2008, GENOMICS, V91, P508, DOI 10.1016/j.ygeno.2008.03.002; de Finetti B., 1937, ANN I HENRI POINCARE, V7, P1; Fawdar S, 2013, ONCOTARGET, V4, P1334, DOI 10.18632/oncotarget.1223; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hartigan J., 1975, CLUSTERING ALGORITHM; Hodis E, 2012, CELL, V150, P251, DOI 10.1016/j.cell.2012.06.024; Huret JL, 2013, NUCLEIC ACIDS RES, V41, pD920, DOI 10.1093/nar/gks1082; KOHONEN T, 1982, BIOL CYBERN, V43, P59, DOI 10.1007/BF00337288; Liu YJ, 2014, BRIT J CANCER, V110, P1169, DOI 10.1038/bjc.2014.61; McCall MN, 2014, NUCLEIC ACIDS RES, V42, pD938, DOI 10.1093/nar/gkt1204; Ogino S, 2012, EXPERT REV MOL DIAGN, V12, P621, DOI [10.1586/ERM.12.46, 10.1586/erm.12.46]; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Rhodes DR, 2005, NAT GENET, V37, pS31, DOI 10.1038/ng1570; Sohn KA, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-S6-S9; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Tibshirani R, 2002, P NATL ACAD SCI USA, V99, P6567, DOI 10.1073/pnas.082099299; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; West D., 2013, TERNARY EQUILIBRIUM, V2; West L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031906; Zhou JX, 2013, ANN ONCOL, V24, P1319, DOI 10.1093/annonc/mds626; Zilliox MJ, 2007, NAT METHODS, V4, P911, DOI 10.1038/NMETH1102	32	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0161514	10.1371/journal.pone.0161514	http://dx.doi.org/10.1371/journal.pone.0161514			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27537329	Green Submitted, gold, Green Accepted, Green Published			2022-12-27	WOS:000381577000115
J	Chen, Q; Zhang, Y; Ding, D; Xia, M; Li, D; Yang, YN; Li, Q; Liu, JX; Chen, XC; Hu, G; Ling, WH				Chen, Qian; Zhang, Yuan; Ding, Ding; Xia, Min; Li, Dan; Yang, Yunou; Li, Qing; Liu, Jiaxing; Chen, Xuechen; Hu, Gang; Ling, Wenhua			Estimated Glomerular Filtration Rate and Mortality among Patients with Coronary Heart Disease	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; ALL-CAUSE MORTALITY; PRACTICE GUIDELINES COMMITTEE; ASSOCIATION TASK-FORCE; RISK-FACTOR; COLLABORATIVE METAANALYSIS; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; HIGHER ALBUMINURIA; AMERICAN-COLLEGE	Objective The association between estimated glomerular filtration rate (eGFR) and the risk of mortality among patients with coronary heart disease (CHD) is complex and still unclear. The aim of this study was to evaluate the effect of eGFR on the risk prediction of all-cause and cardiovascular disease (CVD) mortality with a long follow-up period among patients with CHD in China. Methods We conducted a prospective cohort study of 3276 Chinese patients with CHD. Cox proportional hazards regression models were used to estimate the association of different levels of eGFR with the risks of mortality. Results During a mean follow-up period of 4.9 years, 293 deaths were identified. The multivariable-adjusted hazard ratios associated with different levels of eGFR (>= 90 [reference group], 60-89, 30-59, 15-29 ml/min per 1.73m(2)) at baseline were 1.00, 1.28 (95% confidence interval [CI], 0.87-1.88), 1.96 (95% CI, 1.31-2.94), and 3.91 (95% CI, 2.15-7.13) (P <0.001) for all-cause mortality, and 1.00, 1.26 (95% CI, 0.78-2.04), 1.94 (95% CI, 1.17-3.20), and 3.77 (95% CI, 1.80-7.89) (P <0.001) for CVD mortality, respectively. After excluding subjects who died during the first 2 years of follow-up (n = 113), the graded associations of eGFR with the risks of all-cause and CVD morality were still present. The addition of eGFR to a model including traditional cardiovascular risk factors resulted in significant improvement in the prediction of all-cause and CVD mortality. Conclusions Reduced eGFR (< 60 ml/min per 1.73 m(2)) at baseline is associated with increased risks of all-cause and CVD mortality among Chinese patients with CHD.	[Chen, Qian; Ding, Ding; Xia, Min; Li, Dan; Yang, Yunou; Li, Qing; Liu, Jiaxing; Chen, Xuechen; Ling, Wenhua] Sun Yat Sen Univ, Sch Publ Hlth, Guangdong Prov Key Lab Food Nutr & Hlth, Guangzhou, Guangdong, Peoples R China; [Chen, Qian; Hu, Gang] Pennington Biomed Res Ctr, Chron Dis Epidemiol Lab, 6400 Perkins Rd, Baton Rouge, LA 70808 USA; [Zhang, Yuan] Guangzhou Mil Command Peoples Liberat Army, Dept Cardiol, Gen Hosp, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center	Ling, WH (corresponding author), Sun Yat Sen Univ, Sch Publ Hlth, Guangdong Prov Key Lab Food Nutr & Hlth, Guangzhou, Guangdong, Peoples R China.; Hu, G (corresponding author), Pennington Biomed Res Ctr, Chron Dis Epidemiol Lab, 6400 Perkins Rd, Baton Rouge, LA 70808 USA.	gang.hu@pbrc.edu; lingwh@mail.sysu.edu.cn	Hu, Gang/N-1971-2017; Hu, Gang/V-7947-2019	Hu, Gang/0000-0002-6172-8017; Hu, Gang/0000-0002-6172-8017	Key Project of National Natural Science Fund [81130052]; International Program for Ph.D. Candidates, Sun Yat-Sen University	Key Project of National Natural Science Fund; International Program for Ph.D. Candidates, Sun Yat-Sen University	This study was supported and funded by the Key Project of National Natural Science Fund (grant number 81130052). Qian Chen is supported by International Program for Ph.D. Candidates, Sun Yat-Sen University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1988, J CLIN EPIDEMIOL, V41, P105, DOI 10.1016/0895-4356(88)90084-4; Antolini L, 2004, COMMUN STAT-THEOR M, V33, P2117, DOI 10.1081/STA-200026579; Astor BC, 2008, AM J EPIDEMIOL, V167, P1226, DOI 10.1093/aje/kwn033; Astor BC, 2011, KIDNEY INT, V79, P1331, DOI 10.1038/ki.2010.550; Bittencourt MS, 2015, KIDNEY INT, V88, P152, DOI 10.1038/ki.2014.426; Braunwald E, 2000, CIRCULATION, V102, P1193, DOI 10.1161/01.CIR.102.10.1193; Bruetto RG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035496; de Boer IH, 2009, DIABETES CARE, V32, P1833, DOI 10.2337/dc09-0191; Ding D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120633; Ding D, 2014, DIABETES CARE, V37, P546, DOI 10.2337/dc13-1387; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Fu S, 2013, CLIN INTERV AGING, V8, P229, DOI 10.2147/CIA.S40438; Gibbons RJ, 1999, CIRCULATION, V99, P2829, DOI 10.1161/01.CIR.99.21.2829; Go AS, 2006, CIRCULATION, V113, P2713, DOI 10.1161/CIRCULATIONAHA.105.577577; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Heagerty PJ, 2005, BIOMETRICS, V61, P92, DOI 10.1111/j.0006-341X.2005.030814.x; Hemmelgarn BR, 2010, JAMA-J AM MED ASSOC, V303, P423, DOI 10.1001/jama.2010.39; Kestenbaum BR, 2009, KIDNEY INT, V76, P991, DOI 10.1038/ki.2009.298; Levey AS, 2007, KIDNEY INT, V72, P247, DOI 10.1038/sj.ki.5002343; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; Manjunath G, 2003, J AM COLL CARDIOL, V41, P47, DOI 10.1016/S0735-1097(02)02663-3; Matsushita K, 2010, LANCET, V375, P2073, DOI 10.1016/S0140-6736(10)60674-5; Nakamura M, 2009, HYPERTENS RES, V32, P920, DOI 10.1038/hr.2009.114; Navaneethan SD, 2015, J AM SOC NEPHROL, V26, P2512, DOI 10.1681/ASN.2014101034; Rodrigues FB, 2010, CLIN J AM SOC NEPHRO, V5, P1530, DOI 10.2215/CJN.01260210; Ronco C, 2008, J AM COLL CARDIOL, V52, P1527, DOI 10.1016/j.jacc.2008.07.051; Sarnak MJ, 2003, CIRCULATION, V108, P2154, DOI 10.1161/01.CIR.0000095676.90936.80; Schiffrin EL, 2007, CIRCULATION, V116, P85, DOI 10.1161/CIRCULATIONAHA.106.678342; Smith GL, 2008, J AM SOC NEPHROL, V19, P141, DOI 10.1681/ASN.2007050554; Tonelli M, 2006, J AM SOC NEPHROL, V17, P2034, DOI 10.1681/ASN.2005101085; van der Velde M, 2011, KIDNEY INT, V79, P1341, DOI 10.1038/ki.2010.536; Vasaiwala S, 2012, CLIN CARDIOL, V35, P541, DOI 10.1002/clc.22021; Wang YJ, 2014, KIDNEY INT, V85, P1192, DOI 10.1038/ki.2013.396; Weiner DE, 2008, AM J KIDNEY DIS, V51, P212, DOI 10.1053/j.ajkd.2007.10.035; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; Yang JG, 2010, J ATHEROSCLER THROMB, V17, P395, DOI 10.5551/jat.3061; Yang ZJ, 2012, EUR HEART J, V33, P213, DOI 10.1093/eurheartj/ehr205; Zhang LX, 2012, LANCET, V379, P815, DOI 10.1016/S0140-6736(12)60033-6; Zhang R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027359; Zhang XH, 2008, HEART, V94, P1126, DOI 10.1136/hrt.2007.132423; Zhao WH, 2014, CIRCULATION, V130, P2143, DOI 10.1161/CIRCULATIONAHA.114.009098	41	5	5	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0161599	10.1371/journal.pone.0161599	http://dx.doi.org/10.1371/journal.pone.0161599			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27537335	Green Submitted, Green Published, gold			2022-12-27	WOS:000381577000125
J	Gao, D; Zhan, Y; Di, W; Moore, AR; Sher, JJ; Guan, YX; Wang, SQ; Zhang, ZD; Murphy, DA; Sawyers, CL; Chi, P; Chen, Y				Gao, Dong; Zhan, Yu; Di, Wei; Moore, Amanda R.; Sher, Jessica J.; Guan, Youxin; Wang, Shangqian; Zhang, Zeda; Murphy, Devan A.; Sawyers, Charles L.; Chi, Ping; Chen, Yu			A Tmprss2-CreER(T2) Knock-In Mouse Model for Cancer Genetic Studies on Prostate and Colon	PLOS ONE			English	Article							INTRAEPITHELIAL NEOPLASIA; ORGANOID CULTURES; LUMINAL CELLS; PTEN; MICE; EXPRESSION; PROTEASE; TMPRSS2; ORIGIN; IDENTIFICATION	Fusion between TMPRSS2 and ERG, placing ERG under the control of the TMPRSS2 promoter, is the most frequent genetic alteration in prostate cancer, present in 40-50% of cases. The fusion event is an early, if not initiating, event in prostate cancer, implicating the TMPRSS2-positive prostate epithelial cell as the cancer cell of origin in fusion-positive prostate cancer. To introduce genetic alterations into Tmprss2-positive cells in mice in a temporal-specific manner, we generated a Tmprss2-CreER(T2) knock-in mouse. We found robust tamoxifen-dependent Cre activation in the prostate luminal cells but not basal epithelial cells, as well as epithelial cells of the bladder and gastrointestinal (GI) tract. The knock-in allele on the Tmprss2 locus does not noticeably impact prostate, bladder, or gastrointestinal function. Deletion of Pten in Tmprss2-positive cells of adult mice generated neoplasia only in the prostate, while deletion of Apc in these cells generated neoplasia only in the GI tract. These results suggest that this new Tmprss2-CreER(T2) mouse model will be a useful resource for genetic studies on prostate and colon.	[Gao, Dong] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Key Lab Syst Biol, Shanghai 200031, Peoples R China; [Gao, Dong; Zhan, Yu; Di, Wei; Moore, Amanda R.; Sher, Jessica J.; Guan, Youxin; Wang, Shangqian; Zhang, Zeda; Murphy, Devan A.; Sawyers, Charles L.; Chi, Ping; Chen, Yu] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10065 USA; [Moore, Amanda R.] Cornell Univ, Weill Cornell Grad Sch Med Sci, New York, NY 10021 USA; [Chi, Ping; Chen, Yu] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10065 USA; [Chi, Ping; Chen, Yu] Weill Cornell Med Coll, Dept Med, New York, NY 10065 USA; [Chi, Ping; Chen, Yu] New York Presbyterian Hosp, New York, NY 10065 USA	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Memorial Sloan Kettering Cancer Center; Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Memorial Sloan Kettering Cancer Center; Cornell University; NewYork-Presbyterian Hospital	Gao, D (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Key Lab Syst Biol, Shanghai 200031, Peoples R China.; Gao, D; Chen, Y (corresponding author), Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10065 USA.; Chen, Y (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10065 USA.; Chen, Y (corresponding author), Weill Cornell Med Coll, Dept Med, New York, NY 10065 USA.; Chen, Y (corresponding author), New York Presbyterian Hosp, New York, NY 10065 USA.	dong.gao@sibcb.ac.cn; cheny1@mskcc.org	Zhang, Zeda/AAV-8644-2021	Zhang, Zeda/0000-0002-7225-534X; Gao, Dong/0000-0003-1821-2741	NYSTEM Stipend [C026879]; Howard Hughes Medical Institute; NCI [K08CA140946, R01CA193837, P50CA092629, K08CA151660, DP2 CA174499, U01 CA141502]; US DOD [W81XWH-10-1-0197]; Prostate Cancer Foundation; Starr Cancer Consortium; Geoffrey Beene Cancer Research Center; Gerstner Family Foundation; Bressler Scholars Fund; NATIONAL CANCER INSTITUTE [P30CA008748, R01CA193837, R01CA155169] Funding Source: NIH RePORTER	NYSTEM Stipend; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); US DOD(United States Department of Defense); Prostate Cancer Foundation; Starr Cancer Consortium; Geoffrey Beene Cancer Research Center; Gerstner Family Foundation; Bressler Scholars Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is supported in part by NYSTEM Stipend (C026879) to DG, the Howard Hughes Medical Institute (CLS), NCI (K08CA140946, YC; R01CA193837, CLS, YC; P50CA092629, CLS, YC; K08CA151660, PC; DP2 CA174499, PC; U01 CA141502, CLS), US DOD (W81XWH-10-1-0197), Prostate Cancer Foundation (YC), Starr Cancer Consortium (YC, PC, CLS), Geoffrey Beene Cancer Research Center (YC, PC), Gerstner Family Foundation (YC), Bressler Scholars Fund (YC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulkadir SA, 2002, MOL CELL BIOL, V22, P1495, DOI 10.1128/MCB.22.5.1495-1503.2002; Abeshouse A, 2015, CELL, V163, P1011, DOI 10.1016/j.cell.2015.10.025; Casey OM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041668; Chen YW, 2010, AM J PATHOL, V176, P2986, DOI 10.2353/ajpath.2010.090665; Chen Y, 2013, NAT MED, V19, P1023, DOI 10.1038/nm.3216; Choi N, 2012, CANCER CELL, V21, P253, DOI 10.1016/j.ccr.2012.01.005; Gao D, 2014, CELL, V159, P176, DOI 10.1016/j.cell.2014.08.016; Goldstein AS, 2010, SCIENCE, V329, P568, DOI 10.1126/science.1189992; Karthaus WR, 2014, CELL, V159, P163, DOI 10.1016/j.cell.2014.08.017; Kim TS, 2006, MOL CELL BIOL, V26, P965, DOI 10.1128/MCB.26.3.965-975.2006; Kuraguchi M, 2006, PLOS GENET, V2, P1362, DOI 10.1371/journal.pgen.0020146; Lin BY, 1999, CANCER RES, V59, P4180; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Luchman HA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003940; Ma XQ, 2005, CANCER RES, V65, P5730, DOI 10.1158/0008-5472.CAN-04-4519; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Matsuda T, 2007, P NATL ACAD SCI USA, V104, P1027, DOI 10.1073/pnas.0610155104; Murtaugh LC, 2003, P NATL ACAD SCI USA, V100, P14920, DOI 10.1073/pnas.2436557100; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Parisotto M, 2013, MOL ONCOL, V7, P190, DOI 10.1016/j.molonc.2013.02.005; Ratnacaram CK, 2008, P NATL ACAD SCI USA, V105, P2521, DOI 10.1073/pnas.0712021105; Robinson D, 2015, CELL, V161, P1215, DOI 10.1016/j.cell.2015.05.001; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Trotman LC, 2003, PLOS BIOL, V1, P385, DOI 10.1371/journal.pbio.0000059; Wagner KU, 2001, TRANSGENIC RES, V10, P545, DOI 10.1023/A:1013063514007; Wang X, 2009, NATURE, V461, P495, DOI 10.1038/nature08361; Wang ZA, 2014, CELL REP, V8, P1339, DOI 10.1016/j.celrep.2014.08.002; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130; Wu XT, 2001, MECH DEVELOP, V101, P61, DOI 10.1016/S0925-4773(00)00551-7; Xin L, 2005, P NATL ACAD SCI USA, V102, P6942, DOI 10.1073/pnas.0502320102	32	17	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0161084	10.1371/journal.pone.0161084	http://dx.doi.org/10.1371/journal.pone.0161084			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27536883	Green Submitted, gold, Green Published			2022-12-27	WOS:000381577000051
J	Kim, EY; Kim, YS; Seo, JY; Park, I; Ahn, HK; Jeong, YM; Kim, JH; Kim, N				Kim, Eun Young; Kim, Young Saing; Seo, Ja-Young; Park, Inkeun; Ahn, Hee Kyung; Jeong, Yu Mi; Kim, Jeong Ho; Kim, Nambeom			The Relationship between Sarcopenia and Systemic Inflammatory Response for Cancer Cachexia in Small Cell Lung Cancer	PLOS ONE			English	Article							PROGNOSTIC SCORES; NUTRITIONAL-STATUS; SKELETAL-MUSCLE; MGPS PREDICTS; SURVIVAL; OBESITY; INDEX	Background The prognostic significance of sarcopenia, an important component of cancer cachexia, has been demonstrated in oncologic patients. Catabolic drivers have been suggested to be key features of cancer cachexia. Objective To determine the relationship between systemic inflammatory markers and CT-determined muscle mass in patients with SCLC. Methods Cross-sectional muscle areas were evaluated at the level of the third lumbar vertebra (L3) using baseline CT images in 186 SCLC patients. Sarcopenia was defined as a L3 muscle index (L3MI, muscle area at L3/height(2)) of < 55 cm(2)/m(2) for men and of < 39 cm(2)/m(2) for women. Systemic inflammatory markers investigated included serum white blood cell count (WBC), neutrophil: lymphocyte ratio (NLR), C-reactive protein (CRP), and albumin. Results Mean L3MI was 47.9 +/- 9.7 cm(2)/m(2) for men and 41.6 +/- 7.0 cm(2)/m(2) for women. Sarcopenia was present in 128 patients (68.8%), and sarcopenic patients had significant serum lymphocyte counts and albumin levels (p = 0.002 and 0.041, respectively), and higher NLRs and CRP levels (p = 0.011 and 0.026) than non-sarcopenic patients. Multivariable analysis revealed that CRP independently predicted L3MI (beta = -0.208; 95% CI, -0.415 to -0.002; p = 0.048), along with gender and BMI (p values < 0.001) and performance status (p = 0.010). Conclusion The present study confirms a significant linear relationship exists between CT-determined muscle mass and CRP in SCLC patients. This association might provide a better understanding of the mechanism of cancer cachexia.	[Kim, Eun Young; Jeong, Yu Mi; Kim, Jeong Ho] Gachon Univ, Gil Med Ctr, Dept Radiol, Inchon, South Korea; [Kim, Young Saing; Park, Inkeun; Ahn, Hee Kyung] Gachon Univ, Gil Med Ctr, Dept Internal Med, Div Hematol & Oncol, Inchon, South Korea; [Seo, Ja-Young] Gachon Univ, Gil Med Ctr, Dept Lab Med, Inchon, South Korea; [Kim, Nambeom] Gachon Univ, Neurosci Res Inst, Inchon, South Korea	Gachon University; Gachon University; Gachon University; Gachon University	Kim, YS (corresponding author), Gachon Univ, Gil Med Ctr, Dept Internal Med, Div Hematol & Oncol, Inchon, South Korea.	zoomboom@hanmail.net	Kim, Jeong Ho/AAA-7538-2022; Kim, Nambeom/AAR-8047-2021	Kim, Nambeom/0000-0003-4960-1256; Kim, Young Saing/0000-0003-0207-2617				Argiles JM, 2005, INT J BIOCHEM CELL B, V37, P1609, DOI 10.1016/j.biocel.2005.03.007; Azad N, 2008, J TOXICOL ENV HEAL B, V11, P1, DOI 10.1080/10937400701436460; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Collins J, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-003697; Fearon KC, 2006, AM J CLIN NUTR, V83, P1345, DOI 10.1093/ajcn/83.6.1345; Fearon K, 2011, LANCET ONCOL, V12, P489, DOI 10.1016/S1470-2045(10)70218-7; Forrest LM, 2003, BRIT J CANCER, V89, P1028, DOI 10.1038/sj.bjc.6601242; Fruh M, 2013, ANN ONCOL, V24, P99, DOI 10.1093/annonc/mdt178; He XB, 2015, CLIN LUNG CANCER, V16, pE165, DOI 10.1016/j.cllc.2015.03.005; Kalemkerian GP, 2013, J NATL COMPR CANC NE, V11, P99, DOI 10.6004/jnccn.2013.0012; Kim EY, 2015, J THORAC ONCOL, V10, P1795, DOI 10.1097/JTO.0000000000000690; Lu HT, 2006, MOL CANCER RES, V4, P221, DOI 10.1158/1541-7786.MCR-05-0261; Martin L, 2013, J CLIN ONCOL, V31, P1539, DOI 10.1200/JCO.2012.45.2722; McMillan DC, 2009, CURR OPIN CLIN NUTR, V12, P223, DOI 10.1097/MCO.0b013e32832a7902; Morley JE, 2006, AM J CLIN NUTR, V83, P735, DOI 10.1093/ajcn/83.4.735; Prado CMM, 2008, LANCET ONCOL, V9, P629, DOI 10.1016/S1470-2045(08)70153-0; Proctor MJ, 2011, BRIT J CANCER, V104, P726, DOI 10.1038/sj.bjc.6606087; Proctor MJ, 2011, EUR J CANCER, V47, P2633, DOI 10.1016/j.ejca.2011.03.028; Richards CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041883; Sarhill N, 2003, SUPPORT CARE CANCER, V11, P652, DOI 10.1007/s00520-003-0486-0; Schaap LA, 2006, AM J MED, V119, DOI 10.1016/j.amjmed.2005.10.049; Shafique K, 2012, PROSTATE CANCER P D, V15, P195, DOI 10.1038/pcan.2011.60; Shen W, 2004, J APPL PHYSIOL, V97, P2333, DOI 10.1152/japplphysiol.00744.2004; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Yang CW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132908; Zhou T, 2015, TUMOR BIOL, V36, P337, DOI 10.1007/s13277-014-2623-4	26	47	48	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0161125	10.1371/journal.pone.0161125	http://dx.doi.org/10.1371/journal.pone.0161125			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27537502	gold, Green Published, Green Submitted			2022-12-27	WOS:000381577000057
J	Kussner, MB; de Groot, AMB; Hofman, WF; Hillen, MA				Kuessner, Mats B.; de Groot, Annette M. B.; Hofman, Winni F.; Hillen, Marij A.			EEG Beta Power but Not Background Music Predicts the Recall Scores in a Foreign-Vocabulary Learning Task	PLOS ONE			English	Article							COGNITIVE TEST-PERFORMANCE; DIFFERENTIAL DISTRACTION; INSTRUMENTAL MUSIC; INTROVERTS; AROUSAL; EXTROVERSION; PERSONALITY; NOISE; MOOD	As tantalizing as the idea that background music beneficially affects foreign vocabulary learning may seem, there is-partly due to a lack of theory-driven research-no consistent evidence to support this notion. We investigated inter-individual differences in the effects of background music on foreign vocabulary learning. Based on Eysenck's theory of personality we predicted that individuals with a high level of cortical arousal should perform worse when learning with background music compared to silence, whereas individuals with a low level of cortical arousal should be unaffected by background music or benefit from it. Participants were tested in a paired-associate learning paradigm consisting of three immediate word recall tasks, as well as a delayed recall task one week later. Baseline cortical arousal assessed with spontaneous EEG measurement in silence prior to the learning rounds was used for the analyses. Results revealed no interaction between cortical arousal and the learning condition (background music vs. silence). Instead, we found an unexpected main effect of cortical arousal in the beta band on recall, indicating that individuals with high beta power learned more vocabulary than those with low beta power. To substantiate this finding we conducted an exact replication of the experiment. Whereas the main effect of cortical arousal was only present in a subsample of participants, a beneficial main effect of background music appeared. A combined analysis of both experiments suggests that beta power predicts the performance in the word recall task, but that there is no effect of background music on foreign vocabulary learning. In light of these findings, we discuss whether searching for effects of background music on foreign vocabulary learning, independent of factors such as inter-individual differences and task complexity, might be a red herring. Importantly, our findings emphasize the need for sufficiently powered research designs and exact replications of theory-driven experiments when investigating effects of background music and inter-individual variation on task performance.	[Kuessner, Mats B.] Humboldt Univ, Inst Musikwissensch & Med Wissensch, Berlin, Germany; [de Groot, Annette M. B.; Hofman, Winni F.] Univ Amsterdam, Dept Psychol, Amsterdam, Netherlands; [Hillen, Marij A.] Univ Amsterdam, Acad Med Ctr, Dept Med Psychol, Amsterdam, Netherlands	Humboldt University of Berlin; University of Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Kussner, MB (corresponding author), Humboldt Univ, Inst Musikwissensch & Med Wissensch, Berlin, Germany.	mats.kussner@gmail.com		Kussner, Mats/0000-0002-4056-0702; Hillen, Marij/0000-0001-5724-7934				Aarts AA, 2015, SCIENCE, V349, DOI 10.1126/science.aac4716; Avila C, 2012, PSYCHOL MUSIC, V40, P84, DOI 10.1177/0305735611422672; Beauducel A, 2006, INT J PSYCHOPHYSIOL, V62, P212, DOI 10.1016/j.ijpsycho.2005.12.001; Cardenas VA, 1997, BIOL PSYCHIAT, V41, P891, DOI 10.1016/S0006-3223(96)00186-2; Cassidy G., 2007, PSYCHOL MUSIC, V35, P517, DOI [10.1177/0305735607076444, DOI 10.1177/0305735607076444]; Chamorro-Premuzic T, 2009, INT J PSYCHOL STUD, V1, P2, DOI DOI 10.5539/IJPS.V1N2P2; Cohen R.A., 2011, ENCY CLIN NEUROPSYCH, P2737, DOI [DOI 10.1007/978-0-387-79948-3_1340, 10.1007/978-0-387-79948-3_1340]; CRAWFORD HJ, 1994, PERS INDIV DIFFER, V16, P237, DOI 10.1016/0191-8869(94)90162-7; DAOUSSIS L, 1986, PERCEPT MOTOR SKILL, V62, P283, DOI 10.2466/pms.1986.62.1.283; de Groot AMB, 2006, LANG LEARN, V56, P463, DOI 10.1111/j.1467-9922.2006.00374.x; de Groot AMB, 2014, STUD SECOND LANG ACQ, V36, P681, DOI 10.1017/S0272263114000059; Dobbs S, 2011, APPL COGNITIVE PSYCH, V25, P307, DOI 10.1002/acp.1692; Elshout JJ, 1973, ARBEIDS ORGANISATIEP, P49; Elshout JJ, 1975, VIJF PERSOONLIJKNEID; Eysenck H.J., 1967, BIOL BASIS PERSONALI; Felix U, 1993, J SOC ACCELERATIVE L, V18, P277; Ferreri L, 2015, MUSIC SCI, V19, P402, DOI 10.1177/1029864915604684; Fitzgibbon SP, 2004, CLIN NEUROPHYSIOL, V115, P1802, DOI 10.1016/j.clinph.2004.03.009; Furnham A, 1999, PERS INDIV DIFFER, V27, P381, DOI 10.1016/S0191-8869(98)00249-9; Furnham A, 1999, EUR J PERSONALITY, V13, P27, DOI 10.1002/(SICI)1099-0984(199901/02)13:1<27::AID-PER318>3.0.CO;2-R; Furnham A, 2002, ERGONOMICS, V45, P203, DOI 10.1080/00140130210121932; Furnham A, 1997, APPL COGNITIVE PSYCH, V11, P445; GALE A, 1969, BRIT J PSYCHOL, V60, P209, DOI 10.1111/j.2044-8295.1969.tb01194.x; Gram PC, 2005, J PSYCHOL TYPE, V65, P33; GRATTON G, 1983, ELECTROEN CLIN NEURO, V55, P468, DOI 10.1016/0013-4694(83)90135-9; Hagemann D, 1999, PERS INDIV DIFFER, V27, P541, DOI 10.1016/S0191-8869(98)00263-3; Hagemann D, 2009, PERS INDIV DIFFER, V47, P717, DOI 10.1016/j.paid.2009.06.009; Hallam S., 2016, OXFORD HDB MUSIC PSY; Jancke L, 2014, BEHAV BRAIN FUNCT, V10, DOI 10.1186/1744-9081-10-10; Jancke L, 2010, BEHAV BRAIN FUNCT, V6, DOI 10.1186/1744-9081-6-3; Jones MH, 2006, PSYCHOL AESTHET CREA, P26, DOI DOI 10.1037/1931-3896.S.1.26; Kampfe J, 2011, PSYCHOL MUSIC, V39, P424, DOI 10.1177/0305735610376261; Kang HJ, 2014, PSYCHOL MUSIC, V42, P728, DOI 10.1177/0305735613485152; Matthews G, 1999, PERS INDIV DIFFER, V26, P583, DOI 10.1016/S0191-8869(98)00158-5; Molteni E, 2007, P ANN INT IEEE EMBS, P1298, DOI 10.1109/IEMBS.2007.4352535; Patston LLM, 2011, MUSIC PERCEPT, V29, P173, DOI 10.1525/MP.2011.29.2.173; Rangaswamy M, 2002, BIOL PSYCHIAT, V52, P831, DOI 10.1016/S0006-3223(02)01362-8; RAY WJ, 1985, SCIENCE, V228, P750, DOI 10.1126/science.3992243; rnec R., 2006, EDUC PSYCHOL-US, V26, P579, DOI [DOI 10.1080/01443410500342542, 10.1080/01443410500342542]; Savan A., 1999, PSYCHOL MUSIC, V27, P138, DOI DOI 10.1177/0305735699272005; Schellenberg E.G., 2007, PSYCHOL MUSIC, V35, P5, DOI [10.1177/0305735607068885, DOI 10.1177/0305735607068885]; Schellenberg EG, 2013, PSYCHOLOGY OF MUSIC, THIRD EDITION, P499, DOI 10.1016/B978-0-12-381460-9.00012-2; Schmidtke JI, 2004, PERS INDIV DIFFER, V36, P717, DOI 10.1016/S0191-8869(03)00129-6; Schuster DH, 1982, J SOC ACCELERATIVE L, V7, P82; Thompson WF, 2001, PSYCHOL SCI, V12, P248, DOI 10.1111/1467-9280.00345	45	13	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0161387	10.1371/journal.pone.0161387	http://dx.doi.org/10.1371/journal.pone.0161387			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27537520	Green Published, gold, Green Submitted			2022-12-27	WOS:000381577000097
J	Lievers, R; Groot, AT				Lievers, Rik; Groot, Astrid T.			Disposable Polydimethylsiloxane (PDMS)-Coated Fused Silica Optical Fibers for Sampling Pheromones of Moths	PLOS ONE			English	Article							SOLID-PHASE MICROEXTRACTION; EUROPEAN CORN-BORER; OSTRINIA-NUBILALIS HUBNER; TOBACCO BUDWORM MOTH; SEX-PHEROMONE; HELIOTHIS-VIRESCENS; SESAMIA-NONAGRIOIDES; MASS-SPECTROMETRY; INSECT PHEROMONES; IDENTIFICATION	In the past decades, the sex pheromone composition in female moths has been analyzed by different methods, ranging from volatile collections to gland extractions, which all have some disadvantage: volatile collections can generally only be conducted on (small) groups of females to detect the minor pheromone compounds, whereas gland extractions are destructive. Direct-contact SPME overcomes some of these disadvantages, but is expensive, the SPME fiber coating can be damaged due to repeated usage, and samples need to be analyzed relatively quickly after sampling. In this study, we assessed the suitability of cheap and disposable fused silica optical fibers coated with 100 mu m polydimethylsiloxane (PDMS) by sampling the pheromone of two noctuid moths, Heliothis virescens and Heliothis subflexa. By rubbing the disposable PDMS fibers over the pheromone glands of females that had called for at least 15 minutes and subsequently extracting the PDMS fibers in hexane, we collected all known pheromone compounds, and we found a strong positive correlation for most pheromone compounds between the disposable PDMS fiber rubs and the corresponding gland extracts of the same females. When comparing this method to volatile collections and the corresponding gland extracts, we generally found comparable percentages between the three techniques, with some differences that likely stem from the chemical properties of the individual pheromone compounds. Hexane extraction of cheap, disposable, PDMS coated fused silica optical fibers allows for sampling large quantities of individual females in a short time, eliminates the need for immediate sample analysis, and enables to use the same sample for multiple chemical analyses.	[Lievers, Rik; Groot, Astrid T.] Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, Sci Pk 904, Amsterdam, Netherlands; [Groot, Astrid T.] Max Planck Inst Chem Ecol, Hans Knoll Str 8, Jena, Germany	University of Amsterdam; Max Planck Society	Lievers, R (corresponding author), Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, Sci Pk 904, Amsterdam, Netherlands.	r.lievers@uva.nl			Netherlands Organization for Scientific Research NWO-ALW [822.01.012]; National Science Foundation [IOS-1052238, IOS-1456973]; Division Of Integrative Organismal Systems [1456973] Funding Source: National Science Foundation	Netherlands Organization for Scientific Research NWO-ALW(Netherlands Organization for Scientific Research (NWO)); National Science Foundation(National Science Foundation (NSF)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This project is funded by the Netherlands Organization for Scientific Research NWO-ALW (www.nwo.nl/alw) under award no. 822.01.012, and the National Science Foundation (www.nsf.gov) under award no. IOS-1052238 and IOS-1456973. The grants were awarded to ATG. The funders did not play any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Joke Westerveld for helping with thermally conditioning the PDMS fibers and Joris Haftka for helping to obtain the disposable PDMS fibers. We thank Daniel Veit for constructing the volatile collection setup. We also thank Goran Birgersson, Andres Gonzalez and Bjorn Bohman for their valuable comments, and Steph Menken for correcting the text. This project is funded by the Netherlands Organisation for Scientific Research (NWO-ALW, award no. 822.01.012) and the National Science Foundation (award no. IOS-1052238 and IOS-1456973).	ARTHUR CL, 1990, ANAL CHEM, V62, P2145, DOI 10.1021/ac00218a019; Avand-Faghih A, 2008, J CHEM ECOL, V34, P103, DOI 10.1007/s10886-007-9403-1; BAKER TC, 1981, J CHEM ECOL, V7, P961, DOI 10.1007/BF00987620; BJOSTAD LB, 1980, J INSECT PHYSIOL, V26, P493, DOI 10.1016/0022-1910(80)90122-5; BorgKarlson AK, 1996, Z NATURFORSCH C, V51, P599; CARDE AM, 1979, J CHEM ECOL, V5, P423, DOI 10.1007/BF00987927; Carde RT, 2004, ADVANCES IN INSECT CHEMICAL ECOLOGY, P283, DOI 10.1017/CBO9780511542664.009; CHARLTON RE, 1982, J INSECT PHYSIOL, V28, P423, DOI 10.1016/0022-1910(82)90069-5; Crewe RM, 2004, CHEMOECOLOGY, V14, P77, DOI 10.1007/s00049-003-0263-z; Eizaguirre M, 2009, J CHEM ECOL, V35, P779, DOI 10.1007/s10886-009-9662-0; Felix AE, 2011, CHEMOECOLOGY, V21, P107, DOI 10.1007/s00049-011-0069-3; Felix AE, 2009, J CHEM ECOL, V35, P618, DOI 10.1007/s10886-009-9638-0; Ferreira-Caliman MJ, 2014, ANAL METHODS-UK, V6, P8823, DOI 10.1039/c4ay01909a; Foster SP, 2011, J CHEM ECOL, V37, P717, DOI 10.1007/s10886-011-9982-8; Frerot B, 1997, HRC-J HIGH RES CHROM, V20, P340, DOI 10.1002/jhrc.1240200609; Gago R, 2013, J CHEM ECOL, V39, P1263, DOI 10.1007/s10886-013-0349-1; Gerhardt H, 2015, J CHROMATOGR A, V1388, P24, DOI 10.1016/j.chroma.2015.02.027; Glaser N, 2014, J CHEM ECOL, V40, P923, DOI 10.1007/s10886-014-0485-2; Groot AT, 2013, MOL ECOL, V22, P1065, DOI 10.1111/mec.12171; Groot AT, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.3054; Groot AT, 2009, EVOLUTION, V63, P1987, DOI 10.1111/j.1558-5646.2009.00702.x; Groot AT, 2006, P NATL ACAD SCI USA, V103, P5858, DOI 10.1073/pnas.0508609103; Groot AT, 2004, J CHEM ECOL, V30, P2495, DOI 10.1007/s10886-004-7946-y; Haftka JJH, 2010, ENVIRON SCI POLLUT R, V17, P1070, DOI 10.1007/s11356-009-0263-9; HEATH RR, 1991, ANN ENTOMOL SOC AM, V84, P182, DOI 10.1093/aesa/84.2.182; Hummel HE, 1984, TECHNIQUES PHEROMONE; James DG, 2001, ENVIRON ENTOMOL, V30, P663, DOI 10.1603/0046-225X-30.4.663; Judd GJR, 2012, CAN ENTOMOL, V144, P798, DOI 10.4039/tce.2012.75; KLUN JA, 1982, ENVIRON ENTOMOL, V11, P1084, DOI 10.1093/ee/11.5.1084; KLUN JA, 1980, J CHEM ECOL, V6, P177, DOI 10.1007/BF00987536; Krokos FD, 2002, J CHEM ECOL, V28, P1463, DOI 10.1023/A:1016256804745; Kuenen LPS, 2015, ENTOMOL EXP APPL, V154, P35, DOI 10.1111/eea.12253; Leniaud L, 2006, ENTOMOL EXP APPL, V120, P51, DOI 10.1111/j.1570-7458.2006.00427.x; Leppik E, 2012, CHEMOECOLOGY, V22, P119, DOI 10.1007/s00049-012-0104-z; MALOSSE C, 1995, HRC-J HIGH RES CHROM, V18, P669; Marques FD, 2000, J BRAZIL CHEM SOC, V11, P592; Mayer P, 2000, ENVIRON SCI TECHNOL, V34, P5177, DOI 10.1021/es001179g; Millar JG, 2010, J CHEM ECOL, V36, P923, DOI 10.1007/s10886-010-9831-1; Ouyang GF, 2011, CHEM REV, V111, P2784, DOI 10.1021/cr100203t; Pelozuelo L, 2006, J APPL ENTOMOL, V130, P230, DOI 10.1111/j.1439-0418.2006.01058.x; Pelozuelo L, 2004, J CHEM ECOL, V30, P335, DOI 10.1023/B:JOEC.0000017981.03762.ed; POPE MM, 1982, J CHEM ECOL, V8, P1043, DOI 10.1007/BF00987885; POTTER DW, 1992, J CHROMATOGR, V625, P247, DOI 10.1016/0021-9673(92)85209-C; ROELOFS WL, 1974, LIFE SCI, V14, P1555, DOI 10.1016/0024-3205(74)90166-0; Svensson MGE, 1997, J CHEM ECOL, V23, P1833, DOI 10.1023/B:JOEC.0000006454.84415.5f; TEAL PEA, 1987, ARCH INSECT BIOCHEM, V4, P261, DOI 10.1002/arch.940040404; TEAL PEA, 1981, J CHEM ECOL, V7, P1011, DOI 10.1007/BF00987623; Teal PEA, 1997, INSECT PHEROMONE RESEARCH, P535; TEAL PEA, 1988, J CHEM ECOL, V14, P2131, DOI 10.1007/BF01014254; TEAL PEA, 1986, J CHEM ECOL, V12, P353, DOI 10.1007/BF01020561; Thomas Y, 2003, EVOLUTION, V57, P261; Tillman JA, 1999, INSECT BIOCHEM MOLEC, V29, P481, DOI 10.1016/S0965-1748(99)00016-8; Tumlinson J, 1982, ANALYSIS OF CHEMICAL; Tumlinson JH, 1975, J CHEM ECOL, V1, P203, DOI 10.1007/BF00987869; Wang HL, 2015, J CHEM ECOL, V41, P724, DOI 10.1007/s10886-015-0611-9; WITZGALL P, 1989, J CHEM ECOL, V15, P707, DOI 10.1007/BF01014713; Zhu JW, 1996, GENETICS, V144, P757	58	7	7	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2016	11	8							e0161138	10.1371/journal.pone.0161138	http://dx.doi.org/10.1371/journal.pone.0161138			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4YN	27533064	Green Submitted, Green Published, gold			2022-12-27	WOS:000381487600063
J	Ortuno-Gutierrez, N; Zachariah, R; Woldeyohannes, D; Bangoura, A; Cherif, GF; Loua, F; Hermans, V; Tayler-Smith, K; Sikhondze, W; Camara, LM				Ortuno-Gutierrez, Nimer; Zachariah, Rony; Woldeyohannes, Desalegn; Bangoura, Adama; Cherif, Gba-Foromo; Loua, Francis; Hermans, Veerle; Tayler-Smith, Katie; Sikhondze, Welile; Camara, Lansana-Mady			Upholding Tuberculosis Services during the 2014 Ebola Storm: An Encouraging Experience from Conakry, Guinea	PLOS ONE			English	Article							FRAGILE HEALTH SYSTEMS; VIRUS-DISEASE; CARE WORKERS; OUTBREAK; AFRICA; CRISIS; FACILITIES	Setting Ten targeted health facilities supported by Damien Foundation (a Belgian Non Governmental Organization) and the National Tuberculosis (TB) Program in Conakry, Guinea. Objectives To uphold TB program performance during the Ebola outbreak in the presence of a package of pre-emptive additional measures geared at reinforcing the routine TB program, and ensuring Ebola infection control, health-workers safety and motivation. Design A retrospective comparative cohort study of a TB program assessing the performance before (2013) and during the (2014) Ebola outbreak. Results During the Ebola outbreak, all health facilities were maintained opened, there were no reported health-worker Ebola infections, drug stockouts or health staff absences. Of 2,475 presumptive pulmonary TB cases, 13% were diagnosed with TB in both periods (160/1203 in 2013 and 163/1272 in 2014). For new TB, treatment success improved from 84% before to 87% during the Ebola outbreak (P = 0.03). Adjusted Hazard-ratios (AHR) for an unfavorable outcome was alwo lower during the Ebola outbreak, AHR = 0.8, 95% CI: 0.7-0.9, P = 0.04). Treatment success improved for HIV co-infected patients (72% to 80%, P<0.01). For retreatment patients, the proportion achieving treatment success was maintained (68% to 72%, P = 0.05). Uptake of HIV-testing and Cotrimoxazole Preventive Treatment was maintained over 85%, and Anti-Retroviral Therapy uptake increased from 77% in 2013 to 86% in 2014 (P<0.01). Conclusion Contingency planning and health system and worker support during the 2014 Ebola outbreak was associated with encouraging and sustained TB program performance. This is of relevance to future outbreaks.	[Ortuno-Gutierrez, Nimer; Cherif, Gba-Foromo; Loua, Francis] Damien Fdn, Conakry, Guinea; [Zachariah, Rony; Tayler-Smith, Katie] Medecins Sans Frontieres, Med Dept Operat Res, Brussels Operat Ctr, Luxembourg, Luxembourg; [Woldeyohannes, Desalegn] Univ Addis Ababa, Aklilu Lemma Inst Pathobiol, Addis Ababa, Ethiopia; [Bangoura, Adama] Natl TB Program, Conakry, Guinea; [Hermans, Veerle] Medecins Sans Frontieres, Bo, Sierra Leone; [Sikhondze, Welile] Minist Hlth, Natl TB Control Program, Manzini, Swaziland; [Camara, Lansana-Mady] Gamal Abdel Nasser Univ, Fac Med, Conakry, Guinea	Doctors Without Borders; Addis Ababa University	Ortuno-Gutierrez, N (corresponding author), Damien Fdn, Conakry, Guinea.	Nimer.OrtunoGutierrez@damiaanactie.be		Hermans, Veerle/0000-0002-5232-992X; zachariah, rony/0000-0002-2915-9328	Damien Foundation; Medecins Sans Frontiers (MSF); Department for International Development (DFID), UK; La Fondation Veuve Emile Metz-Tesch, Luxembourg	Damien Foundation; Medecins Sans Frontiers (MSF); Department for International Development (DFID), UK; La Fondation Veuve Emile Metz-Tesch, Luxembourg	Damien Foundation funded all costs related to the study. This research was conducted through the Structured Operational Research and Training Initiative (SORT IT), a global partnership led by the Special Programme for Research and Training in Tropical Diseases at the World Health Organization (WHO/TDR), which was funded by The Union, Medecins Sans Frontiers (MSF), and the Department for International Development (DFID), UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. La Fondation Veuve Emile Metz-Tesch, Luxembourg also supported open access publication costs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awortwi N., 2012, GUID CONS OBST REL M, P1; Baize S, 2014, NEW ENGL J MED, V371, P1418, DOI 10.1056/NEJMoa1404505; Beeching NJ, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g7348; Bolkan Hakon Angell, 2014, PLoS Curr, V6, DOI 10.1371/currents.outbreaks.0307d588df619f9c9447f8ead5b72b2d; Boozary AS, 2014, JAMA-J AM MED ASSOC, V312, P1859, DOI 10.1001/jama.2014.14387; Breman J, 1976, EBOLA VIRUS HAEMORRH, P103; Coordination Nationale de Lutte Contre la Maladie a Virus Ebola, 2014, COORD NAT LUTT MAL V, P90; Delamou A, 2015, LANCET, V385, P503, DOI 10.1016/S0140-6736(15)60193-3; Delamou A, 2014, LANCET, V384, P2105, DOI 10.1016/S0140-6736(14)62364-3; Edelstein M, 2015, LANCET, V385, P2234, DOI 10.1016/S0140-6736(15)60203-3; Feldmann H, 2011, LANCET, V377, P849, DOI 10.1016/S0140-6736(10)60667-8; Harries AD, 2010, TROP MED INT HEALTH, V15, P1407, DOI 10.1111/j.1365-3156.2010.02662.x; International IDEA, 2014, EMERGENCY PLAN OF AC, P7; Kieny MP, 2014, B WORLD HEALTH ORGAN, V92, P850, DOI 10.2471/BLT.14.149278; Leuenberger D, 2015, AIDS, V29, P1883, DOI 10.1097/QAD.0000000000000784; Ndawinz JDA, 2015, LANCET, V385, P1393, DOI 10.1016/S0140-6736(15)60713-9; Philips M, 2014, LANCET, V384, P1181, DOI 10.1016/S0140-6736(14)61606-8; Piot P, 2014, LANCET INFECT DIS, V14, P1034, DOI 10.1016/S1473-3099(14)70956-9; Plucinski MM, 2015, LANCET INFECT DIS, V15, P1017, DOI 10.1016/S1473-3099(15)00061-4; Programme National de Lutte Anti-Tuberculeuse, 2015, RAPP ANN PNLAT 2014; Programme National de Lutte Anti-Tuberculeuse, 2010, GUID TECHN PERS SANT; Sloan DJ, 2015, INT J TUBERC LUNG D, V19, P1269, DOI 10.5588/ijtld.15.0776; [Systeme National dInformation Sanitaire Ministere de la Sante Publique et de lHygiene], 2011, SYST NAT INF SAN ANN; Tattevin P, 2015, RETENTION CARE HIV I, V29; Towner JS, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000212; Ulrich CM, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g6672; von Elm E, 2008, INTERNIST, V49, P688, DOI 10.1007/s00108-008-2138-4; WHO, 2015, EB RESP ROADM SIT RE, P5; World Health Organization, 2016, EB RESP ROADM SIT RE, P5; World Health Organization, THE END TB STRAT; World Health Organization, 2015, GLOB TUB REP, P204; World Health Organization, 2022, GLOB HLTH OBS; Zachariah R, 2015, INT J TUBERC LUNG D, V19, P1271, DOI 10.5588/ijtld.15.0355	33	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2016	11	8							e0157296	10.1371/journal.pone.0157296	http://dx.doi.org/10.1371/journal.pone.0157296			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4YN	27533499	gold, Green Published, Green Submitted			2022-12-27	WOS:000381487600003
J	Ramsook, SN; Ni, J; Shahangian, S; Vakiloroayaei, A; Khan, N; Kwan, JJ; Donaldson, LW				Ramsook, Sarah N.; Ni, Joyce; Shahangian, Shokofeh; Vakiloroayaei, Ana; Khan, Naveen; Kwan, Jamie J.; Donaldson, Logan W.			A Model for Dimerization of the SOX Group E Transcription Factor Family	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; CAMPOMELIC DYSPLASIA; COOPERATIVE BINDING; COMPLEX SUGGESTS; TERNARY COMPLEX; MOUSE SOX-5; DNA MOTIFS; CELL FATE; HMG BOX; PROTEIN	Group Emembers of the SOX transcription factor family include SOX8, SOX9, and SOX10. Preceding the high mobility group (HMG) domain in each of these proteins is a thirty-eight amino acid region that supports the formation of dimers on promoters containing tandemly inverted sites. The purpose of this study was to obtain new structural insights into how the dimerization region functions with the HMG domain. From a mutagenic scan of the dimerization region, the most essential amino acids of the dimerization region were clustered on the hydrophobic face of a single, predicted amphipathic helix. Consistent with our hypothesis that the dimerization region directly contacts the HMG domain, a peptide corresponding to the dimerization region bound a preassembled HMG-DNA complex. Sequence conservation among Group Emembers served as a basis to identify two surface exposed amino acids in the HMG domain of SOX9 that were necessary for dimerization. These data were combined to make a molecular model that places the dimerization region of one SOX9 protein onto the HMG domain of another SOX9 protein situated at the opposing site of a tandem promoter. The model provides a detailed foundation for assessing the impact of mutations on SOX Group E transcription factors.	[Ramsook, Sarah N.; Ni, Joyce; Shahangian, Shokofeh; Vakiloroayaei, Ana; Khan, Naveen; Kwan, Jamie J.; Donaldson, Logan W.] York Univ, Dept Biol, Toronto, ON, Canada; [Ni, Joyce] Sanofi Pasteur Pharmaceut, Toronto, ON, Canada; [Kwan, Jamie J.] Ontario Canc Inst, McEwen Ctr Regenerat Med, Toronto, ON, Canada	York University - Canada; Sanofi-Aventis; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Donaldson, LW (corresponding author), York Univ, Dept Biol, Toronto, ON, Canada.	logand@yorku.ca		Donaldson, Logan/0000-0001-5034-2699	Natural Sciences and Engineering Research Council of Canada [238934]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by the Natural Sciences and Engineering Research Council of Canada, #238934, to LWD. The funder provided support in the form of salaries for authors [JN SS NK JJK SR], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. The funder of this study had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernard P, 2003, HUM MOL GENET, V12, P1755, DOI 10.1093/hmg/ddg182; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cary PD, 2001, PROTEIN SCI, V10, P83, DOI 10.1110/ps.32801; Crane-Robinson C, 1998, J MOL BIOL, V281, P705, DOI 10.1006/jmbi.1998.1895; Deo RC, 2001, P NATL ACAD SCI USA, V98, P4414, DOI 10.1073/pnas.071552198; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Gao NN, 2013, PROTEIN PEPTIDE LETT, V20, P481, DOI 10.2174/092986613805290336; Gasteiger E., 2005, PROTEOMICS PROTOCOLS, DOI DOI 10.1385/1592598900; Genzer MA, 2007, NUCLEIC ACIDS RES, V35, P1178, DOI 10.1093/nar/gkm014; Han AD, 2003, NATURE, V422, P730, DOI 10.1038/nature01555; HARLEY VR, 1994, NUCLEIC ACIDS RES, V22, P1500, DOI 10.1093/nar/22.8.1500; Heinig M, 2004, NUCLEIC ACIDS RES, V32, pW500, DOI 10.1093/nar/gkh429; Huang YH, 2015, SCI REP-UK, V5, DOI 10.1038/srep10398; Jauch R, 2012, BIOCHEM J, V443, P39, DOI 10.1042/BJ20111768; Kamachi Y, 2013, DEVELOPMENT, V140, P4129, DOI 10.1242/dev.091793; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Lu XJ, 2008, NAT PROTOC, V3, P1213, DOI 10.1038/nprot.2008.104; McDowall S, 1999, J BIOL CHEM, V274, P24023, DOI 10.1074/jbc.274.34.24023; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Palasingam P, 2009, J MOL BIOL, V388, P619, DOI 10.1016/j.jmb.2009.03.055; Peirano RI, 2000, NUCLEIC ACIDS RES, V28, P3047, DOI 10.1093/nar/28.16.3047; Polach KJ, 1996, J MOL BIOL, V258, P800, DOI 10.1006/jmbi.1996.0288; Remenyi A, 2003, GENE DEV, V17, P2048, DOI 10.1101/gad.269303; Sarkar A, 2013, CELL STEM CELL, V12, P15, DOI 10.1016/j.stem.2012.12.007; Schlierf B, 2002, NUCLEIC ACIDS RES, V30, P5509, DOI 10.1093/nar/gkf690; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Sock E, 2003, HUM MOL GENET, V12, P1439, DOI 10.1093/hmg/ddg158; Soufi A, 2015, CELL, V161, P555, DOI 10.1016/j.cell.2015.03.017; Szymczyna BR, 2009, STRUCTURE, V17, P499, DOI 10.1016/j.str.2009.03.001; TAKAMATSU N, 1995, MOL CELL BIOL, V15, P3759; Tan S, 1998, NATURE, V391, P660, DOI 10.1038/35563; van de WM, 1993, EMBO J, V12, P3847; vanHoute LPA, 1995, J BIOL CHEM, V270, P30516, DOI 10.1074/jbc.270.51.30516; Wegner M, 2010, INT J BIOCHEM CELL B, V42, P381, DOI 10.1016/j.biocel.2009.07.006; Williams DC, 2004, J BIOL CHEM, V279, P1449, DOI 10.1074/jbc.M309790200; Yamashita S, 2012, J BIOL CHEM, V287, P22206, DOI 10.1074/jbc.M112.343194	36	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2016	11	8							e0161432	10.1371/journal.pone.0161432	http://dx.doi.org/10.1371/journal.pone.0161432			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4YN	27532129	gold, Green Submitted, Green Published			2022-12-27	WOS:000381487600094
J	Tan, X; Fujiu, K; Manabe, I; Nishida, J; Yamagishi, R; Terashima, Y; Matsushima, K; Kaburaki, T; Nagai, R; Yanagi, Y				Tan, Xue; Fujiu, Katsuhito; Manabe, Ichiro; Nishida, Junko; Yamagishi, Reiko; Terashima, Yuya; Matsushima, Kouji; Kaburaki, Toshikatsu; Nagai, Ryozo; Yanagi, Yasuo			Choroidal Neovascularization Is Inhibited in Splenic-Denervated or Splenectomized Mice with a Concomitant Decrease in Intraocular Macrophage	PLOS ONE			English	Article							MACULAR DEGENERATION AMD; HEMATOPOIETIC STEM-CELLS; BONE-MARROW; MONONUCLEAR PHAGOCYTES; MYOCARDIAL-INFARCTION; INFLAMMATORY SITES; ADOPTIVE TRANSFER; BLOOD MONOCYTES; TISSUE-INJURY; ANIMAL-MODEL	Purpose To determine the involvement of sympathetic activity in choroidal neovascularization (CNV) using laser-induced CNV in a mouse model. Methods We investigated changes in the proportions of intraocular lymphocytes, granulocytes, and three macrophage subtypes (Ly6C(hi), Ly6C(int), and Ly6C(lo)) after laser injury in mice using flow cytometry,and evaluated CNV lesion size in mice lacking inflammatory cells. Further, we evaluated the lesion size in mice administered the beta 3 receptor antagonist, splenic-denervated and splenectomized mice. We also assessed changes in the proportions of intraocular macrophages and peripheral blood monocytes in splenic-denervated and splenectomized mice. Lastly, lesion size was compared between splenic-denervated mice with or without adoptive transfer of macrophages following laser injury. After Ly5.1 mice spleen-derived Ly6C(hi) cells were transferred into Ly5.2mice, the proportions of intraocular Ly5.1(+)Ly6C(hi) cells were compared. Results In WT mice, the proportion of CD4(+) T cells recruited into the eye increased progressively from day 3 to day 7 after laser injury, whereas, intraocular CD8(+) T cells did not change significantly. Proportions of B220(+) cells, granulocytes, and two subtypes of intraocular macrophages (Ly6C(hi) and Ly6C(lo)) peaked at day 3 following laser injury. In contrast, Ly6C(int/lo)CD64(+) subtype showed a significantly higher percentage at day 7 after laser injury. There were no differences in lesion size between CD4(-/-) or Rag2(-/)-mice and controls, whereas lesion size was significantly reduced in CCR2(-/-) mice and clodronate liposome-treated mice. CNV lesion area was significantly reduced in mice with beta 3 blocker treatment, splenic-denervated and splenectomized mice compared with controls. Intraocular Ly6C(hi) macrophages were also reduced by splenic denervation or splenectomy. Adoptive transfer of spleen-derived Ly6C(hi) cells increased the lesion size in splenic-denervated mice. Compared with controls, intraocular donor-derived Ly6C(hi) cells recruited into the eye were reduced in splenic-denervated and splenectomized mice. Conclusions Although lymphocytes had little effect on CNV formation, Ly6C(hi) macrophages/monocytes exacerbated CNV in mice. Sympathetic activity might contribute to CNV via the recruitment of macrophages to the eye.	[Tan, Xue; Nishida, Junko; Yamagishi, Reiko; Kaburaki, Toshikatsu; Yanagi, Yasuo] Univ Tokyo, Grad Sch Med, Dept Ophthalmol, Tokyo, Japan; [Tan, Xue; Fujiu, Katsuhito; Nishida, Junko; Yamagishi, Reiko; Kaburaki, Toshikatsu; Yanagi, Yasuo] Univ Tokyo, Fac Med, Tokyo, Japan; [Fujiu, Katsuhito] Univ Tokyo, Grad Sch Med, Dept Cardiovasc Med, Tokyo, Japan; [Fujiu, Katsuhito] Univ Tokyo, Sch Med, Dept Ubiquitous Hlth Informat, Tokyo, Japan; [Fujiu, Katsuhito] Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol, Tokyo, Japan; [Manabe, Ichiro] Chiba Univ, Grad Sch Med, Dept Aging Res, Chiba, Japan; [Terashima, Yuya; Matsushima, Kouji] Univ Tokyo, Grad Sch Med, Dept Mol Prevent Med, Tokyo, Japan; [Nagai, Ryozo] Jichi Med Univ, Shimotsuke, Tochigi, Japan; [Yanagi, Yasuo] Singapore Eye Res Inst, Singapore, Singapore; [Yanagi, Yasuo] Singapore Natl Eye Ctr, Med Retina Dept, Singapore, Singapore; [Yanagi, Yasuo] Duke NUS Natl Univ Singapore, Grad Sch Med, Singapore, Singapore	University of Tokyo; University of Tokyo; University of Tokyo; University of Tokyo; Japan Science & Technology Agency (JST); Chiba University; University of Tokyo; Jichi Medical University; National University of Singapore; Singapore National Eye Center; Singapore National Eye Center	Yanagi, Y (corresponding author), Univ Tokyo, Grad Sch Med, Dept Ophthalmol, Tokyo, Japan.; Yanagi, Y (corresponding author), Univ Tokyo, Fac Med, Tokyo, Japan.; Yanagi, Y (corresponding author), Singapore Eye Res Inst, Singapore, Singapore.; Yanagi, Y (corresponding author), Singapore Natl Eye Ctr, Med Retina Dept, Singapore, Singapore.; Yanagi, Y (corresponding author), Duke NUS Natl Univ Singapore, Grad Sch Med, Singapore, Singapore.	yanagi-tky@umin.ac.jp	Yanagi, Yasuo/AAF-2670-2020; Kaburaki, Toshikatsu/AAH-7091-2020; Yanagi, Yasuo/AAA-5441-2022; Manabe, Ichiro/E-1529-2014; Manabe, Ichiro/AAE-5105-2021	Yanagi, Yasuo/0000-0002-0362-7285	Grants-in-Aid for Scientific Research [15H04824] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Ambati J, 2003, NAT MED, V9, P1390, DOI 10.1038/nm950; ANDREESEN R, 1990, CANCER RES, V50, P7450; Apte RS, 2006, PLOS MED, V3, P1371, DOI 10.1371/journal.pmed.0030310; Cruz-Guilloty F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088201; Davis A, 2012, ACTA OPHTHALMOL, V90, pe162, DOI 10.1111/j.1755-3768.2011.02117.x; Dutta P, 2012, NATURE, V487, P325, DOI 10.1038/nature11260; Espinosa-Heidmann DG, 2003, INVEST OPHTH VIS SCI, V44, P3586, DOI 10.1167/iovs.03-0038; Fujimura S, 2012, INVEST OPHTH VIS SCI, V53, P1999, DOI 10.1167/iovs.11-8232; Fujiu K, 2011, J CLIN INVEST, V121, P3425, DOI 10.1172/JCI57582; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Hasegawa E, 2013, J IMMUNOL, V190, P1778, DOI 10.4049/jimmunol.1202495; Heidt T, 2014, NAT MED, V20, P754, DOI 10.1038/nm.3589; Hristov M, 2011, THROMB HAEMOSTASIS, V106, P757, DOI 10.1160/TH11-07-0500; Ideta R, 2004, FEBS LETT, V557, P21, DOI 10.1016/S0014-5793(03)01315-2; Jo YJ, 2011, INVEST OPHTH VIS SCI, V52, P6089, DOI 10.1167/iovs.10-5189; Katayama Y, 2006, CELL, V124, P407, DOI 10.1016/j.cell.2005.10.041; Kelly J, 2007, J CLIN INVEST, V117, P3421, DOI 10.1172/JCI32430; Kim SJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep11872; Lech M, 2013, BBA-MOL BASIS DIS, V1832, P989, DOI 10.1016/j.bbadis.2012.12.001; Liu BY, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-111; Liu JY, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0057473, 10.1371/journal.pone.0050719, 10.1371/journal.pone.0064143]; Mattapallil MJ, 2012, INVEST OPHTH VIS SCI, V53, P2921, DOI 10.1167/iovs.12-9662; Mendez-Ferrer S, 2008, NATURE, V452, P442, DOI 10.1038/nature06685; Montero JA, 2013, RETINA-J RET VIT DIS, V33, P508, DOI 10.1097/IAE.0b013e3182695ba0; Nishida M, 2005, BIOCHEM BIOPH RES CO, V332, P11, DOI 10.1016/j.bbrc.2005.04.083; Nowak JZ, 2006, PHARMACOL REP, V58, P353; Penfold PL, 2001, PROG RETIN EYE RES, V20, P385, DOI 10.1016/S1350-9462(00)00025-2; Sakurai E, 2003, INVEST OPHTH VIS SCI, V44, P3578, DOI 10.1167/iovs.03-0097; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; Serbina NV, 2006, NAT IMMUNOL, V7, P311, DOI 10.1038/ni1309; Shivshankar P, 2014, J MOL CELL CARDIOL, V76, P84, DOI 10.1016/j.yjmcc.2014.07.020; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Steinle JJ, 2006, EXP EYE RES, V83, P16, DOI 10.1016/j.exer.2005.11.006; Steinle JJ, 2002, EXP EYE RES, V74, P761, DOI 10.1006/exer.2002.1182; Swirski FK, 2009, SCIENCE, V325, P612, DOI 10.1126/science.1175202; Takahashi H, 2008, CURR EYE RES, V33, P1002, DOI 10.1080/02713680802492440; Telander DG, 2011, SEMIN OPHTHALMOL, V26, P192, DOI 10.3109/08820538.2011.570849; Thaker PH, 2006, NAT MED, V12, P939, DOI 10.1038/nm1447; Toomey CB, 2015, P NATL ACAD SCI USA, V112, pE3040, DOI 10.1073/pnas.1424391112; Tsou CL, 2007, J CLIN INVEST, V117, P902, DOI 10.1172/JCI29919; Tsutsumi C, 2003, J LEUKOCYTE BIOL, V74, P25, DOI 10.1189/jlb.0902436; Tsutsumi-Miyahara C, 2004, BRIT J OPHTHALMOL, V88, P1217, DOI 10.1136/bjo.2003.036392; VANFURTH R, 1968, J EXP MED, V128, P415, DOI 10.1084/jem.128.3.415; Yanagi Y, 2002, INVEST OPHTH VIS SCI, V43, P3495; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001; Yuda K, 2012, AM J PATHOL, V181, P1464, DOI 10.1016/j.ajpath.2012.06.028; Zhou JH, 2005, MOL VIS, V11, P414; Ziegler-Heitbrock L, 2010, BLOOD, V116, pE74, DOI 10.1182/blood-2010-02-258558	49	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2016	11	8							e0160985	10.1371/journal.pone.0160985	http://dx.doi.org/10.1371/journal.pone.0160985			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4YN	27532664	Green Submitted, Green Published, gold			2022-12-27	WOS:000381487600052
J	Valencia-Gattas, M; Conner, GE; Fregien, NL				Valencia-Gattas, Monica; Conner, Gregory E.; Fregien, Nevis L.			Gefitinib, an EGFR Tyrosine Kinase inhibitor, Prevents Smoke-Mediated Ciliated Airway Epithelial Cell Loss and Promotes Their Recovery	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; ALPHA-CONVERTING ENZYME; CIGARETTE-SMOKE; LUNG-CANCER; DIFFERENTIATION; EXPOSURE; CILIOGENESIS; CLEARANCE; PHENOTYPE	Cigarette smoke exposure is a major health hazard. Ciliated cells in the epithelium of the airway play a critical role in protection against the noxious effects of inhaled cigarette smoke. Ciliated cell numbers are reduced in smokers which weakens host defense and leads to disease. The mechanisms for the loss of ciliated cells are not well understood. The effects of whole cigarette smoke exposure on human airway ciliated ciliated cells were examined using in vitro cultures of normal human bronchial epithelial cells and a Vitrocell (R) VC 10 (R) Smoking Robot. These experiments showed that whole cigarette smoke causes the loss of differentiated ciliated cells and inhibits differentiation of ciliated cells from undifferentiated basal cells. Furthermore, treatment with the epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, Gefitinib, during smoke exposure prevents ciliated cell loss and promotes ciliated cell differentiation from basal cells. Finally, restoration of ciliated cells was inhibited after smoke exposure was ceased but was enhanced by Gefitinib treatment. These data suggest that inhibition of EGFR activity may provide therapeutic benefit for treating smoke related diseases.	[Valencia-Gattas, Monica; Conner, Gregory E.; Fregien, Nevis L.] Univ Miami, Miller Sch Med, Dept Cell Biol, Miami, FL 33136 USA	University of Miami	Fregien, NL (corresponding author), Univ Miami, Miller Sch Med, Dept Cell Biol, Miami, FL 33136 USA.	Nevis@miami.edu	Conner, Gregory/AAI-1285-2021	Conner, Gregory/0000-0003-2217-2252	Flight Attendants Medical Research Institute FAMRI [CIA 123060, CIA 082442]; FAMRI [CIA 082442, CIA 09206]	Flight Attendants Medical Research Institute FAMRI; FAMRI	This work was supported in part by Flight Attendants Medical Research Institute FAMRI Grants CIA 123060 to GEC and CIA 082442 to NLF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. Matthias Salathe for helpful discussion and comments on this project. This work was supported in part by FAMRI Grants CIA 09206 to GEC and CIA 082442 to NF.	AUERBACH O, 1961, NEW ENGL J MED, V265, P253, DOI 10.1056/NEJM196108102650601; Aufderheide M, 2015, EXP TOXICOL PATHOL; Bernacki SH, 1999, AM J RESP CELL MOL, V20, P595, DOI 10.1165/ajrcmb.20.4.3442; Brekman A, 2014, AM J RESP CELL MOL B; Gerovac BJ, 2014, AM J RESP CELL MOL B; Goldkorn T, 2014, ANTIOXID REDOX SIGN, V21, P2149, DOI 10.1089/ars.2013.5469; Khan EM, 2008, FASEB J, V22, P910, DOI 10.1096/fj.06-7729com; Knowles MR, 2002, J CLIN INVEST, V109, P571, DOI 10.1172/JCI200215217; Lee SY, 2006, RESP MED, V100, P503, DOI 10.1016/j.rmed.2005.06.006; Lemjabbar H, 2003, J BIOL CHEM, V278, P26202, DOI 10.1074/jbc.M207018200; Leopold PL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008157; Mehta H, 2008, INFLAMM RES, V57, P497, DOI 10.1007/s00011-008-8078-6; Milara J, 2012, BRIT J PHARM; Muhsin M, 2003, NAT REV DRUG DISCOV, V2, P515, DOI 10.1038/nrd1136; Nlend MC, 2002, AM J RESP CELL MOL, V27, P436, DOI 10.1165/rcmb.2002-0012OC; Petecchia L, 2009, CHEST, V135, P1502, DOI 10.1378/chest.08-1780; Randell SH, 2001, IN VITRO CELL DEV-AN, V37, P480; Richter A, 2002, AM J RESP CELL MOL, V27, P85, DOI 10.1165/ajrcmb.27.1.4789; Schamberger AC, 2015, SCI REP-UK, V5, DOI 10.1038/srep08163; Services U.S.D.o.H.a.H, 2014, HLTH CONSMOK 50 YE; Shao MXG, 2004, AM J PHYSIOL-LUNG C, V287, pL420, DOI 10.1152/ajplung.00019.2004; Shaykhiev R, 2013, P NATL ACAD SCI USA, V110, P12102, DOI 10.1073/pnas.1303058110; Simet SM, 2010, AM J RESP CELL MOL, V43, P635, DOI 10.1165/rcmb.2009-0297OC; Stubbs JL, 2012, NAT CELL BIOL, V14, P140, DOI 10.1038/ncb2406; Takeyama K, 2001, AM J PHYSIOL-LUNG C, V280, pL165, DOI 10.1152/ajplung.2001.280.1.L165; Tamashiro E, 2009, AM J RHINOL ALLERGY, V23, P117, DOI 10.2500/ajra.2009.23.3280; Turetz ML, 2009, CTS-CLIN TRANSL SCI, V2, P260, DOI 10.1111/j.1752-8062.2009.00129.x; Wanner A, 1996, AM J RESP CRIT CARE, V154, P1868, DOI 10.1164/ajrccm.154.6.8970383; You YJ, 2004, AM J PHYSIOL-LUNG C, V286, pL650, DOI 10.1152/ajplung.00170.2003; Zhang LL, 2013, J PATHOL, V229, P74, DOI 10.1002/path.4070	30	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2016	11	8							e0160216	10.1371/journal.pone.0160216	http://dx.doi.org/10.1371/journal.pone.0160216			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4YN	27532261	gold, Green Submitted, Green Published			2022-12-27	WOS:000381487600026
J	Zhang, JZ; Miao, CK; Xu, AM; Zhao, K; Qin, ZQ; Li, X; Liang, C; Hua, YB; Chen, W; Zhang, C; Liu, YY; Su, SF; Wang, ZJ; Liu, BJ				Zhang, Jianzhong; Miao, Chenkui; Xu, Aiming; Zhao, Kai; Qin, Zhiqiang; Li, Xiao; Liang, Chao; Hua, Yibo; Chen, Wei; Zhang, Chao; Liu, Yiyang; Su, Shifeng; Wang, Zengjun; Liu, Bianjiang			Prognostic Role of Secretory Clusterin in Multiple Human Malignant Neoplasms: A Meta-Analysis of 26 Immunohistochemistry Studies	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; NEOADJUVANT HORMONAL-THERAPY; SQUAMOUS-CELL CARCINOMA; PROSTATE-CANCER CELLS; KAPPA-B ACTIVITY; APOLIPOPROTEIN-J; BREAST-CANCER; CLUSTERIN/APOLIPOPROTEIN-J; RADICAL PROSTATECTOMY; OVARIAN-CANCER	Secretory clusterin (sCLU) is a potential prognostic tumour biomarker, but results of different sCLU studies are inconsistent. We conducted this meta-analysis to evaluate the precise predictive value of sCLU. Qualified studies were identified by performing online searches in PubMed, EMBASE, and Web of Science. The selected articles were divided into three groups based on scoring method for clusterin detection. Pooled hazard ratios (HRs) with 95% confidence interval (CI) for patient survival and disease recurrence were calculated to determine the correlation between sCLU expression and cancer prognosis. Heterogeneity was assessed using I-2 statistics, and specific heterogeneity in different groups was analysed. Elevated sCLU was significantly associated with recurrence-free survival in groups 1 and 3 (group 1: pooled HR = 1.35, 95% CI = 1.01 to 1.79; group 3: pooled HR = 1.80, 95% CI = 1.22 to 2.65). However, clusterin expression was not associated with overall survival in all three groups. Results showed that only the heterogeneity of group 2 was very strong (p = 0.013, I-2 = 76.3%), in which the specimens were scored through sCLU staining intensity only. sCLU is a potential biomarker for tumour prognosis, and IHC methods can be more standardised if both intensity and staining proportion are considered.	[Wang, Zengjun; Liu, Bianjiang] Nanjing Med Univ, Affiliated Hosp 1, State Key Lab Reprod Med, Nanjing 210029, Jiangsu, Peoples R China; Nanjing Med Univ, Affiliated Hosp 1, Dept Urol, Nanjing 210029, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University	Wang, ZJ; Liu, BJ (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, State Key Lab Reprod Med, Nanjing 210029, Jiangsu, Peoples R China.	zengjunwang@njmu.edu.cn; bjliu@njmu.edu.cn		Zhang, Jianzhong/0000-0003-3326-0266	National Natural Science Foundation of China [81200467, 81270685]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was funded by National Natural Science Foundation of China (81200467) (URL: http://www.nsfc.gov.cn/) (BL received the funding), and National Natural Science Foundation of China (81270685) (URL: http://www.nsfc.gov.cn/) (ZW and BL received the funding for designing the meta-analysis, data collection and analysis, and decision to publish).; This work is supported by the grant from National Natural Science Foundation of China (81200467; 81270685).	Albert JM, 2007, CANCER EPIDEM BIOMAR, V16, P1845, DOI 10.1158/1055-9965.EPI-07-0146; Bagyinszky E, 2014, CLIN INTERV AGING, V9, P535, DOI 10.2147/CIA.S51571; Bettuzzi S, 2009, ADV CANCER RES, V104, P59, DOI 10.1016/S0065-230X(09)04005-6; Bi J, 2010, NEOPLASMA, V57, P191, DOI 10.4149/neo_2010_03_191; Bonacini M, 2015, BBA-GENE REGUL MECH, V1849, P44, DOI 10.1016/j.bbagrm.2014.11.003; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; DESILVA HV, 1990, BIOCHEMISTRY-US, V29, P5380, DOI 10.1021/bi00474a025; Djeu JY, 2009, ADV CANCER RES, V105, P77, DOI 10.1016/S0065-230X(09)05005-2; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; FRITZ IB, 1983, BIOL REPROD, V28, P1173, DOI 10.1095/biolreprod28.5.1173; Fuzio P, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1348-0; Harada K, 2012, BJU INT, V110, pE1131, DOI 10.1111/j.1464-410X.2012.11297.x; Hassan MK, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-113; He LR, 2009, CANCER SCI, V100, P2354, DOI 10.1111/j.1349-7006.2009.01349.x; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Jamieson NB, 2011, CLIN CANCER RES, V17, P3316, DOI 10.1158/1078-0432.CCR-10-3284; Jin JS, 2012, WORLD J SURG ONCOL, V10, DOI 10.1186/1477-7819-10-146; Kevans D, 2009, CANCER EPIDEM BIOMAR, V18, P393, DOI 10.1158/1055-9965.EPI-08-0302; Koltai T, 2014, ONCOTARGETS THER, V7, P447, DOI 10.2147/OTT.S58622; Kruger S, 2007, NEOPLASMA, V54, P46; Kruger S, 2006, UROLOGY, V67, P105, DOI 10.1016/j.urology.2005.04.043; Kurahashi T, 2005, BJU INT, V96, P895, DOI 10.1111/j.1464-410X.2005.05733.x; Li HC, 2010, LUNG, V188, P423, DOI 10.1007/s00408-010-9248-1; Li X, 2014, NEUROSCI BULL, V30, P162, DOI 10.1007/s12264-013-1391-2; Lin CC, 2014, J HEPATOL, V61, P984, DOI 10.1016/j.jhep.2014.06.026; Luo Jun-Hang, 2005, Ai Zheng, V24, P743; Matsuwaki R, 2014, CANCER SCI, V105, P905, DOI 10.1111/cas.12434; McShane LM, 2005, BRIT J CANCER, V93, P387, DOI 10.1038/sj.bjc.6602678; Miyake H, 2005, ONCOL REP, V14, P1371; Miyake H, 2006, UROLOGY, V68, P609, DOI 10.1016/j.urology.2006.03.017; Panico F, 2013, LUNG CANCER, V79, P294, DOI 10.1016/j.lungcan.2012.11.024; Park S, 2014, REV ENDOCR METAB DIS, V15, P45, DOI 10.1007/s11154-013-9275-3; Partheen K, 2008, INT J CANCER, V123, P2130, DOI 10.1002/ijc.23758; Redondo M, 2010, HISTOPATHOLOGY, V56, P932, DOI 10.1111/j.1365-2559.2010.03565.x; Rizzi F, 2009, ADV CANCER RES, V104, P9, DOI 10.1016/S0065-230X(09)04002-0; Sala A, 2009, ADV CANCER RES, V105, P115, DOI 10.1016/S0065-230X(09)05007-6; Santilli G, 2003, J BIOL CHEM, V278, P38214, DOI 10.1074/jbc.C300252200; Steels E, 2001, EUR RESPIR J, V18, P705, DOI 10.1183/09031936.01.00062201; Tierney JF, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-16; Tobisawa S, 2013, J DERMATOL SCI, V71, P160, DOI 10.1016/j.jdermsci.2013.04.020; Trougakos IP, 2006, FREE RADICAL RES, V40, P1324, DOI 10.1080/10715760600902310; Trougakos IP, 2002, INT J BIOCHEM CELL B, V34, P1430, DOI 10.1016/S1357-2725(02)00041-9; Wang C, 2012, INT J BIOCHEM CELL B, V44, P2308, DOI 10.1016/j.biocel.2012.09.012; Watari H, 2008, GYNECOL ONCOL, V108, P527, DOI 10.1016/j.ygyno.2007.11.026; Watari H, 2012, INT J GYNECOL CANCER, V22, P465, DOI 10.1097/IGC.0b013e31821a03d9; Watari H, 2010, PATHOL ONCOL RES, V16, P345, DOI 10.1007/s12253-009-9235-0; Williamson PR, 2002, STAT MED, V21, P3337, DOI 10.1002/sim.1303; Xie MJ, 2002, PANCREAS, V25, P234, DOI 10.1097/00006676-200210000-00004; Yang GFF, 2009, INT J GYNECOL CANCER, V19, P1342, DOI 10.1111/IGC.0b013e3181a83ed9; Yom CK, 2009, ANTICANCER RES, V29, P3909; Zhang SW, 2006, TECHNOL CANCER RES T, V5, P573, DOI 10.1177/153303460600500604; Zoubeidi A, 2010, MOL CANCER RES, V8, P119, DOI 10.1158/1541-7786.MCR-09-0277	52	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2016	11	8							e0161150	10.1371/journal.pone.0161150	http://dx.doi.org/10.1371/journal.pone.0161150			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4YN	27532124	gold, Green Submitted, Green Published			2022-12-27	WOS:000381487600065
J	Braeye, T; Verheagen, J; Mignon, A; Flipse, W; Pierard, D; Huygen, K; Schirvel, C; Hens, N				Braeye, Toon; Verheagen, Jan; Mignon, Annick; Flipse, Wim; Pierard, Denis; Huygen, Kris; Schirvel, Carole; Hens, Niel			Capture-Recapture Estimators in Epidemiology with Applications to Pertussis and Pneumococcal Invasive Disease Surveillance	PLOS ONE			English	Article							ESTIMATING ANIMAL ABUNDANCE; CLOSED POPULATION; SAMPLE COVERAGE; MODELS; BURDEN; SIZE; CENSUS; HETEROGENEITY; PROBABILITIES; MIXTURES	Introduction Surveillance networks are often not exhaustive nor completely complementary. In such situations, capture-recapture methods can be used for incidence estimation. The choice of estimator and their robustness with respect to the homogeneity and independence assumptions are however not well documented. Methods We investigated the performance of five different capture-recapture estimators in a simulation study. Eight different scenarios were used to detect and combine case-information. The scenarios increasingly violated assumptions of independence of samples and homogeneity of detection probabilities. Belgian datasets on invasive pneumococcal disease (IPD) and pertussis provided motivating examples. Results No estimator was unbiased in all scenarios. Performance of the parametric estimators depended on how much of the dependency and heterogeneity were correctly modelled. Model building was limited by parameter estimability, availability of additional information (e.g. covariates) and the possibilities inherent to the method. In the most complex scenario, methods that allowed for detection probabilities conditional on previous detections estimated the total population size within a 20-30% error-range. Parametric estimators remained stable if individual data sources lost up to 50% of their data. The investigated nonparametric methods were more susceptible to data loss and their performance was linked to the dependence between samples; overestimating in scenarios with little dependence, underestimating in others. Issues with parameter estimability made it impossible to model all suggested relations between samples for the IPD and pertussis datasets. For IPD, the estimates for the Belgian incidence for cases aged 50 years and older ranged from 44 to 58/100,000 in 2010. The estimates for pertussis (all ages, Belgium, 2014) ranged from 24.2 to30.8/100,000. Conclusion We encourage the use of capture-recapture methods, but epidemiologists should preferably include datasets for which the underlying dependency structure is not too complex, a priori investigate this structure, compensate for it within the model and interpret the results with the remaining unmodelled heterogeneity in mind.	[Braeye, Toon] Sci Inst Publ Hlth, Epidemiol, Dept Epidemiol Infect Dis, Brussels, Belgium; [Verheagen, Jan] Univ Clin Leuven, Dept Clin Microbiol, Leuven, Belgium; [Mignon, Annick] Pfizer Vaccines, Med Affairs, Brussels, Belgium; [Flipse, Wim] Flemish Agcy Care & Hlth, Infect Dis Control, Brussels, Belgium; [Pierard, Denis] Univ Hosp Brussels, Inst Med Microbiol, Brussels, Belgium; [Huygen, Kris] Sci Inst Publ Hlth, Dept Immunol Communicable & Infect Dis, Brussels, Belgium; [Schirvel, Carole] Direct Gen Sante, Cellule Surveillance Malad Infect, Brussels, Belgium; [Hens, Niel] Hasselt Univ, Interuniv Inst Biostat & Stat Bioinformat, Hasselt, Belgium; [Hens, Niel] Univ Antwerp, WHO Collaborating Ctr, Vaccine & Infect Dis Inst, CHERMID, Antwerp, Belgium; [Hens, Niel] Univ Antwerp, Epidemiol & Social Med ESOC, Antwerp, Belgium	KU Leuven; University Hospital Leuven; Pfizer; University Hospital Brussels; Hasselt University; University of Antwerp; World Health Organization; University of Antwerp	Braeye, T (corresponding author), Sci Inst Publ Hlth, Epidemiol, Dept Epidemiol Infect Dis, Brussels, Belgium.	Toon.Braeye@wiv-isp.be	Hens, Niel/M-4445-2017	Hens, Niel/0000-0003-1881-0637; Pierard, DEnis/0000-0002-7756-3691; Huygen, Kris/0000-0001-7808-0512				Amstrup S.C., 2010, HDB CAPTURE RECAPTUR; ANDERSON DR, 1994, ECOLOGY, V75, P1780, DOI 10.2307/1939637; [Anonymous], 1951, U CALIFORNIA PUBLICA; Blasi F, 2012, CLIN MICROBIOL INFEC, V18, P7, DOI 10.1111/j.1469-0691.2012.03937.x; Borchers DL, 2008, BIOMETRICS, V64, P377, DOI 10.1111/j.1541-0420.2007.00927.x; Brittain S, 2009, ASTA-ADV STAT ANAL, V93, P23, DOI 10.1007/s10182-008-0085-y; Brooks SP, 1998, J COMPUT GRAPH STAT, V7, P434, DOI 10.2307/1390675; BURNHAM KP, 1978, BIOMETRIKA, V65, P625, DOI 10.2307/2335915; Chao A, 2001, STAT MED, V20, P3123, DOI 10.1002/sim.996.abs; Chao A, 1998, J AM STAT ASSOC, V93, P283, DOI 10.2307/2669624; CHAPMAN DG, 1956, ANN MATH STAT, V27, P375, DOI 10.1214/aoms/1177728264; Cormack RM, 1999, J CLIN EPIDEMIOL, V52, P909, DOI 10.1016/S0895-4356(99)00058-X; Coull BA, 1999, BIOMETRICS, V55, P294, DOI 10.1111/j.0006-341X.1999.00294.x; Davies MLH, 2011, J STAT SOFTW, V39; Drijkoningen JJC, 2014, CLIN MICROBIOL INFEC, V20, P45, DOI 10.1111/1469-0691.12461; eCDC, 2010, SURV INV PNEUM DIS E; European Centre for Disease Prevention and Control (ECDC), 2013, ANN EP REP REP 2012; FIENBERG SE, 1972, BIOMETRIKA, V59, P591, DOI 10.1093/biomet/59.3.591; Gaetan M, 2012, ARCH PUBLIC HEALTH, V70, DOI 10.1186/0778-7367-70-16; Grimm A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098840; Holzmann H, 2006, BIOMETRICS, V62, P934, DOI 10.1111/j.1541-0420.2006.00637_1.x; Hook E.B., 2012, EPIDEMIOL METHODS, V1, P1, DOI DOI 10.1515/2161-962X.1000; Hook EB, 2000, AM J EPIDEMIOL, V152, P771, DOI 10.1093/aje/152.8.771; Hook EB, 1995, EPIDEMIOL REV, V17, P243, DOI 10.1093/oxfordjournals.epirev.a036192; Hubbard BA, 2014, STAT METHODOL, V17, P17, DOI 10.1016/j.stamet.2012.11.005; HUGGINS RM, 1989, BIOMETRIKA, V76, P133, DOI 10.1093/biomet/76.1.133; Ivan JS, 2013, ECOLOGY, V94, P817, DOI 10.1890/12-0102.1; Jones HE, 2014, AM J EPIDEMIOL, V179, P1383, DOI 10.1093/aje/kwu056; Laake JL, 2011, J AGR BIOL ENVIR ST, V16, P389, DOI 10.1007/s13253-011-0059-5; Le Pacheco M, 2013, ZOOLOGIA-CURITIBA, V30, P182, DOI 10.1590/S1984-46702013000200008; LEE SM, 1994, BIOMETRICS, V50, P88, DOI 10.2307/2533199; Link WA, 2003, BIOMETRICS, V59, P1123, DOI 10.1111/j.0006-341X.2003.00129.x; Ludwig E, 2012, CENT EUR J PUBL HEAL, V20, P121, DOI 10.21101/cejph.a3744; Moberley S, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000422.pub3; OTIS DL, 1978, WILDLIFE MONOGR, P1; Pledger S, 2005, BIOMETRICS, V61, P868, DOI 10.1111/j.1541-020X.2005.00411_1.x; Pledger S, 2008, BIOMETRICAL J, V50, P1022, DOI 10.1002/bimj.200810446; Rivest LP, 2001, CAN J STAT, V29, P555, DOI 10.2307/3316007; Royle JA, 2008, ECOLOGY, V89, P2281, DOI 10.1890/07-0601.1; Sabbe Martine, INFECTIEZIEKTEN BIJ; Salasar LEB, 2014, STATISTICS, V0, P1; Schwarz CJ, 1999, STAT SCI, V14, P427; SEBER GAF, 1986, BIOMETRICS, V42, P267, DOI 10.2307/2531049; Seber GAF, 2000, BIOMETRICS, V56, P1227, DOI 10.1111/j.0006-341X.2000.01227.x; Stoklosa J, 2011, BIOMETRICS, V67, P1659, DOI 10.1111/j.1541-0420.2011.01596.x; van Hest NAH, 2007, EPIDEMIOL INFECT, V135, P1021, DOI 10.1017/S0950268806007540; Vergne T, 2015, PREV VET MED, V120, P253, DOI 10.1016/j.prevetmed.2015.04.003; Verhaegen J, 2014, EUROSURVEILLANCE, V19, P14, DOI 10.2807/1560-7917.ES2014.19.31.20869; WALCKIERS D, 1991, EPIDEMIOL INFECT, V106, P297, DOI 10.1017/S0950268800048445; WITTES JT, 1974, J AM STAT ASSOC, V69, P93, DOI 10.2307/2285505; Wroe PC, 2012, J INFECT DIS, V205, P1589, DOI 10.1093/infdis/jis240; YIP PSF, 1995, AM J EPIDEMIOL, V142, P1047; Zhang LJ, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001478.pub6	57	9	9	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2016	11	8							e0159832	10.1371/journal.pone.0159832	http://dx.doi.org/10.1371/journal.pone.0159832			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4UN	27529167	Green Published, Green Submitted, gold			2022-12-27	WOS:000381476700002
J	Grimberg-Peters, D; Buren, C; Windolf, J; Wahlers, T; Paunel-Gorgulu, A				Grimberg-Peters, Deborah; Bueren, Carina; Windolf, Joachim; Wahlers, Thorsten; Paunel-Goerguelue, Adnana			Hyperbaric Oxygen Reduces Production of Reactive Oxygen Species in Neutrophils from Polytraumatized Patients Yielding in the Inhibition of p38 MAP Kinase and Downstream Pathways	PLOS ONE			English	Article							EXTRACELLULAR TRAPS; ACTIVATION; APOPTOSIS; CELLS; MCL-1; REPERFUSION; RECRUITMENT; RESISTANCE; EXPRESSION; NETOSIS	Trauma represents the leading cause of death among young people in western countries. Among the beneficial role of neutrophils in host defence, excessive priming and activation of neutrophils after major trauma lead to an overwhelming inflammatory response and secondary host tissue injury due to the release of toxic metabolites and enzymes. Hyperbaric oxygen (HBO) therapy has been proposed to possess antiinflammatory effects and might represent an appropriate therapeutic option to lower inflammation in a broad range of patients. Here, we studied the effects of HBO on the activity of neutrophils isolated from severely injured patients (days 1-2 after trauma), in fact on the production of reactive oxygen species (ROS) and release of neutrophil extracellular traps (NETs). We found exposure to HBO therapy to significantly diminish phorbol-12-myristate-13-acetate (PMA)-induced ROS production in neutrophils isolated from patients and healthy volunteers. At the same time, marked decrease in NETs release was found in control cells and a less pronounced reduction in patient neutrophils. Impaired ability to produce ROS following exposure to HBO was demonstrated to be linked to a strong downregulation of the activity of p38 MAPK. Only slight suppression of ERK activity could be found. In addition, HBO did not influence neutrophil chemotaxis or apoptosis, respectively. Collectively, this study shows for the first time that HBO therapy suppresses ROS production in inflammatory human neutrophils, and thus might impair ROS-dependent pathways, e.g. kinases activation and NETs release. Thus, HBO might represent a feasible therapy for patients suffering from systemic inflammation, including those with multiple trauma.	[Grimberg-Peters, Deborah; Bueren, Carina; Windolf, Joachim] Univ Hosp Dusseldorf, Dept Trauma & Hand Surg, Moorenstr 5, D-40225 Dusseldorf, Germany; [Wahlers, Thorsten; Paunel-Goerguelue, Adnana] Univ Cologne, Ctr Heart, Dept Cardiothorac Surg, Kerpener Str 62, D-50937 Cologne, Germany	Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital; University of Cologne; University of Hamburg; University Medical Center Hamburg-Eppendorf	Paunel-Gorgulu, A (corresponding author), Univ Cologne, Ctr Heart, Dept Cardiothorac Surg, Kerpener Str 62, D-50937 Cologne, Germany.	adnana.paunel-goerguelue@uk-koeln.de						Almzaiel AJ, 2015, BIOCHEM CELL BIOL, V93, P405, DOI 10.1139/bcb-2014-0157; Benson RM, 2003, CLIN EXP IMMUNOL, V134, P57, DOI 10.1046/j.1365-2249.2003.02248.x; Blanc A, 2003, INT J MOL MED, V11, P229; BOTHA AJ, 1995, SURGERY, V118, P358, DOI 10.1016/S0039-6060(05)80345-9; Calandra T, 2005, CRIT CARE MED, V33, P1538, DOI 10.1097/01.CCM.0000168253.91200.83; Chen MF, 1998, LIVER, V18, P110; Clark SR, 2007, NAT MED, V13, P463, DOI 10.1038/nm1565; Conde de la Rosa L, 2006, J HEPATOL, V44, P918, DOI 10.1016/j.jhep.2005.07.034; Dekker LV, 2000, BIOCHEM J, V347, P285, DOI 10.1042/0264-6021:3470285; Domina AM, 2004, ONCOGENE, V23, P5301, DOI 10.1038/sj.onc.1207692; Dzhagalov I, 2007, BLOOD, V109, P1620, DOI 10.1182/blood-2006-03-013771; Fuchs TA, 2007, J CELL BIOL, V176, P231, DOI 10.1083/jcb.200606027; Ganguly BJ, 2002, APOPTOSIS, V7, P499, DOI 10.1023/A:1020686908831; Gray RD, 2013, J INFLAMM-LOND, V10, DOI 10.1186/1476-9255-10-12; GREENSPAN L, 1985, J TRAUMA, V25, P60, DOI 10.1097/00005373-198501000-00010; Gupta AK, 2010, FEBS LETT, V584, P3193, DOI 10.1016/j.febslet.2010.06.006; Hakkim A, 2011, NAT CHEM BIOL, V7, P75, DOI 10.1038/NCHEMBIO.496; Hattori H, 2010, P NATL ACAD SCI USA, V107, P3546, DOI 10.1073/pnas.0914351107; Hornstein T, 2016, J LEUKOCYTE BIOL, V99, P163, DOI 10.1189/jlb.3A1114-537RR; Jones MR, 2005, J IMMUNOL, V175, P7530, DOI 10.4049/jimmunol.175.11.7530; Kalns J, 2002, IMMUNOL LETT, V83, P125, DOI 10.1016/S0165-2478(02)00068-8; Kannan S, 2002, MED HYPOTHESES, V59, P266, DOI 10.1016/S0306-9877(02)00214-1; Kendall AC, 2013, WOUND REPAIR REGEN, V21, P860, DOI 10.1111/wrr.12108; Keshari RS, 2013, J CELL BIOCHEM, V114, P532, DOI 10.1002/jcb.24391; Leach RM, 1998, BRIT MED J, V317, P1140; Li PX, 2010, J EXP MED, V207, P1853, DOI 10.1084/jem.20100239; Li ZS, 2010, FEBS LETT, V584, P2291, DOI 10.1016/j.febslet.2010.03.040; Lord JM, 2014, LANCET, V384, P1455, DOI 10.1016/S0140-6736(14)60687-5; Lustenberger T, 2016, IMMUNOBIOLOGY, V221, P427, DOI 10.1016/j.imbio.2015.11.011; Maianski NA, 2002, BLOOD, V99, P672, DOI 10.1182/blood.V99.2.672; Margraf S, 2008, SHOCK, V30, P352, DOI 10.1097/SHK.0b013e31816a6bb1; Masuoka HC, 2009, J BIOL CHEM, V284, P30039, DOI 10.1074/jbc.M109.039545; Maurer U, 2006, MOL CELL, V21, P749, DOI 10.1016/j.molcel.2006.02.009; Meng W, 2012, CRIT CARE, V16, DOI 10.1186/cc11442; Meng W, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/149560; Milot E, 2011, THESCIENTIFICWORLDJO, V11, P1948, DOI 10.1100/2011/131539; Min KJ, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.35; Moulding DA, 2001, J LEUKOCYTE BIOL, V70, P783; Oehmcke S, 2009, J INNATE IMMUN, V1, P225, DOI 10.1159/000203700; Papayannopoulos V, 2010, J CELL BIOL, V191, P677, DOI 10.1083/jcb.201006052; Pashevin DO, 2015, PATHOBIOLOGY, V82, P290, DOI 10.1159/000440982; Paunel-Gorgulu A, 2009, J IMMUNOL, V183, P6198, DOI 10.4049/jimmunol.0901264; Peng HS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100814; Probst C, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/136020; Rajalingam K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003102; Remijsen Q, 2011, CELL RES, V21, P290, DOI 10.1038/cr.2010.150; Saffarzadeh M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032366; SIMMS HH, 1991, J SURG RES, V50, P362, DOI 10.1016/0022-4804(91)90204-Y; Singer M, 2004, J IMMUNOL, V173, P4197, DOI 10.4049/jimmunol.173.6.4197; STERLING DL, 1993, CIRCULATION, V88, P1931, DOI 10.1161/01.CIR.88.4.1931; THOM SR, 1990, TOXICOL APPL PHARM, V105, P340, DOI 10.1016/0041-008X(90)90195-Z; Thom SR, 2008, J BIOL CHEM, V283, P10822, DOI 10.1074/jbc.M709200200; Tjarnstrom J, 1999, EUR SURG RES, V31, P147, DOI 10.1159/000008633; Usatyuk PV, 2003, ANTIOXID REDOX SIGN, V5, P723, DOI 10.1089/152308603770380025; Vantaggiato Chiara, 2006, J Biol, V5, P14, DOI 10.1186/jbiol38; Wolters PJ, 2009, J IMMUNOL, V182, P8056, DOI 10.4049/jimmunol.0801323; Yipp BG, 2013, BLOOD, V122, P2784, DOI 10.1182/blood-2013-04-457671; Zhang QX, 2008, J INVEST DERMATOL, V128, P2102, DOI 10.1038/jid.2008.53	58	12	14	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2016	11	8							e0161343	10.1371/journal.pone.0161343	http://dx.doi.org/10.1371/journal.pone.0161343			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4UN	27529549	Green Published, gold, Green Submitted			2022-12-27	WOS:000381476700069
J	VanDam, M; Silbert, NH				VanDam, Mark; Silbert, Noah H.			Fidelity of Automatic Speech Processing for Adult and Child Talker Classifications	PLOS ONE			English	Article							VOCAL ANALYSIS; LANGUAGE; COMMUNICATION; RECOGNITION; ENVIRONMENT; OUTCOMES	Automatic speech processing (ASP) has recently been applied to very large datasets of naturalistically collected, daylong recordings of child speech via an audio recorder worn by young children. The system developed by the LENA Research Foundation analyzes children's speech for research and clinical purposes, with special focus on of identifying and tagging family speech dynamics and the at-home acoustic environment from the auditory perspective of the child. A primary issue for researchers, clinicians, and families using the Language ENvironment Analysis (LENA) system is to what degree the segment labels are valid. This classification study evaluates the performance of the computer ASP output against 23 trained human judges who made about 53,000 judgements of classification of segments tagged by the LENA ASP. Results indicate performance consistent with modern ASP such as those using HMM methods, with acoustic characteristics of fundamental frequency and segment duration most important for both human and machine classifications. Results are likely to be important for interpreting and improving ASP output.	[VanDam, Mark] Washington State Univ, Elson S Floyd Coll Med, Dept Speech & Hearing Sci, Spokane, WA 99202 USA; [VanDam, Mark] Spokane Hearing Oral Program Excellence HOPE, Spokane, WA USA; [Silbert, Noah H.] Univ Cincinnati, Dept Commun Sci & Disorders, Cincinnati, OH USA	Washington State University; University System of Ohio; University of Cincinnati	VanDam, M (corresponding author), Washington State Univ, Elson S Floyd Coll Med, Dept Speech & Hearing Sci, Spokane, WA 99202 USA.; VanDam, M (corresponding author), Spokane Hearing Oral Program Excellence HOPE, Spokane, WA USA.	mark.vanDam@wsu.edu		VanDam, Mark/0000-0002-1906-5774	Washington State University Spokane Seed Grant Program; Hearing Oral Program of Excellence (HOPE) School of Spokane; National Institutes of Health Grants/National Institute on Deafness and Communicative Disorders (NIDCD) [R01-DC009560, R01-DC009560-01S1]; National Science Foundation, Directorate for Social, Behavioral and Economic Sciences [1539129]; Washington Research Foundation; WSU Spokane Seed Grant Program; Hearing Oral Program of Excellence (HOPE) of Spokane; National Institute on Deafness and Other Communication Disorders [R01-DC009560-01S1, NIH R01-DC009560]; National Science Foundation [SBE RIDIR 1539129]; Direct For Social, Behav & Economic Scie [1539133] Funding Source: National Science Foundation; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC009560] Funding Source: NIH RePORTER	Washington State University Spokane Seed Grant Program; Hearing Oral Program of Excellence (HOPE) School of Spokane; National Institutes of Health Grants/National Institute on Deafness and Communicative Disorders (NIDCD); National Science Foundation, Directorate for Social, Behavioral and Economic Sciences(National Science Foundation (NSF)); Washington Research Foundation; WSU Spokane Seed Grant Program; Hearing Oral Program of Excellence (HOPE) of Spokane; National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); National Science Foundation(National Science Foundation (NSF)); Direct For Social, Behav & Economic Scie(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This project was supported by Washington State University Spokane Seed Grant Program and the Hearing Oral Program of Excellence (HOPE) School of Spokane. This work was supported by National Institutes of Health Grants/National Institute on Deafness and Communicative Disorders (NIDCD) (R01-DC009560 and R01-DC009560-01S1). The content of this project is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute on Deafness and Other Communication Disorders or the National Institutes of Health. This work was supported by the National Science Foundation, Directorate for Social, Behavioral and Economic Sciences (1539129, principal investigator M. VanDam). This work was supported by the Washington Research Foundation (principal investigator M. VanDam). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to the many families and children and the volunteer judges who contributed to this project. This project was supported by WSU Spokane Seed Grant Program, the Hearing Oral Program of Excellence (HOPE) of Spokane, the National Institute on Deafness and Other Communication Disorders (NIH R01-DC009560 & R01-DC009560-01S1), the Washington Research Foundation, and the National Science Foundation (SBE RIDIR 1539129).	Ambrose SE, 2014, EAR HEARING, V35, P139, DOI 10.1097/AUD.0b013e3182a76768; [Anonymous], 2014, R LANG ENV STAT COMP; Aragon M, 2012, SEMIN SPEECH LANG, V33, P340, DOI 10.1055/s-0032-1326918; Boril H, 2014, 4 WORKSH CHILD COMP; Canault M, 2015, BEHAV RES, DOI [10.3758/s13428-015-0634-8, DOI 10.3758/s13428-015-0634-8.]; Caskey M, 2011, PEDIATRICS, V128, P910, DOI 10.1542/peds.2011-0609; Cheng J, 2015, SPEECH COMMUN, V73, P14, DOI 10.1016/j.specom.2015.07.006; Christakis DA, 2009, ARCH PEDIAT ADOL MED, V163, P554, DOI 10.1001/archpediatrics.2009.61; Das S, 1998, INT CONF ACOUST SPEE, P433, DOI 10.1109/ICASSP.1998.674460; Dykstra JR, 2013, AUTISM, V17, P582, DOI 10.1177/1362361312446206; Eskenazi M, 2009, SPEECH COMMUN, V51, P832, DOI 10.1016/j.specom.2009.04.005; Fleiss J. L., 1981, STAT METHODS RATES P, V2; Gerosa M., 2009, P 2 WORKSHOP CHILD C, P1, DOI DOI 10.1145/1640377.1640384; Gerosa M, 2007, SPEECH COMMUN, V49, P847, DOI 10.1016/j.specom.2007.01.002; Gilkerson J., 2009, POWER TALK, V2nd ed.; Giuliani D, 2003, INT CONF ACOUST SPEE, P137; Gray SS, 2014, 5 WORKSH CHILD COMP; Johnson K, 2014, PEDIATRICS, V134, pE1603, DOI 10.1542/peds.2013-4289; LEVITT H, 1995, P NATL ACAD SCI USA, V92, P9999, DOI 10.1073/pnas.92.22.9999; Meilleur AAS, 2009, J INTELL DISABIL RES, V53, P115, DOI 10.1111/j.1365-2788.2008.01134.x; Milborrow S., 2020, RPART PLOT PLOT RPAR; Oller DK, 2010, P NATL ACAD SCI USA, V107, P13354, DOI 10.1073/pnas.1003882107; Oller D.K, 2000, EMERGENCE SPEECH CAP, DOI [10.4324/9781410602565, DOI 10.4324/9781410602565]; Paul T., 2014, Patent Number, Patent No. [US 8844847 B2, 8844847]; Potamianos A., 1997, P EUR; Russell M, 1996, ICSLP 96 - FOURTH INTERNATIONAL CONFERENCE ON SPOKEN LANGUAGE PROCESSING, PROCEEDINGS, VOLS 1-4, P176, DOI 10.1109/ICSLP.1996.607069; Soderstrom M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080646; Stevens KN, 2002, J ACOUST SOC AM, V111, P1872, DOI 10.1121/1.1458026; Therneau T., 2014, RPART RECURSIVE PART; Thiemann-Bourque KS, 2014, AM J SPEECH-LANG PAT, V23, P474, DOI 10.1044/2014_AJSLP-12-0010; VanDam M, 2010, J ACOUST SOC AM, V128, P2459; VanDam M, 2016, SEMIN SPEECH LANG, V37, P128, DOI 10.1055/s-0036-1580745; VanDam M, 2015, EAR HEARING, V36, pe146, DOI [10.1097/AUD.0000000000000138, 10.1097/AUD.0000000000000209]; VanDam M, 2014, J ACOUST SOC AM, V136, pEL263, DOI 10.1121/1.4895015; VanDam M, 2012, J DEAF STUD DEAF EDU, V17, P402, DOI 10.1093/deafed/ens025; Wang ZW, 2014, COMPUT EDUC, V78, P115, DOI 10.1016/j.compedu.2014.05.010; Warlaumont AS, 2014, PSYCHOL SCI, V25, P1314, DOI 10.1177/0956797614531023; Warren SF, 2010, J AUTISM DEV DISORD, V40, P555, DOI 10.1007/s10803-009-0902-5; Weisleder A, 2013, PSYCHOL SCI, V24, P2143, DOI 10.1177/0956797613488145; Xu D, 2008, 1 WORKSH CHILD COMP; Xu D., 2009, LTR052 LENA FDN; Xu DX, 2014, J SPEECH LANG HEAR R, V57, P1638, DOI 10.1044/2014_JSLHR-S-13-0037; Yapanel U, 2008, LTR042 LENA FDN; Zimmerman FJ, 2009, PEDIATRICS, V124, P342, DOI 10.1542/peds.2008-2267	44	20	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2016	11	8							e0160588	10.1371/journal.pone.0160588	http://dx.doi.org/10.1371/journal.pone.0160588			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DT4UN	27529813	Green Published, Green Submitted, gold			2022-12-27	WOS:000381476700010
J	Vielma, AZ; Leon, L; Fernandez, IC; Gonzalez, DR; Boric, MP				Vielma, Alejandra Z.; Leon, Luisa; Fernandez, Ignacio C.; Gonzalez, Daniel R.; Boric, Mauricio P.			Nitric Oxide Synthase 1 Modulates Basal and beta-Adrenergic-Stimulated Contractility by Rapid and Reversible Redox-Dependent S-Nitrosylation of the Heart	PLOS ONE			English	Article							LEFT-VENTRICULAR MYOCYTES; RYANODINE RECEPTOR; CARDIAC MYOCYTES; IN-VIVO; SARCOPLASMIC-RETICULUM; MYOCARDIAL RELAXATION; SELECTIVE-INHIBITION; CALCIUM LEAK; CA2+ CURRENT; NO	S-nitrosylation of several Ca2+ regulating proteins in response to beta-adrenergic stimulation was recently described in the heart; however the specific nitric oxide synthase (NOS) isoform and signaling pathways responsible for this modification have not been elucidated. NOS-1 activity increases inotropism, therefore, we tested whether beta-adrenergic stimulation induces NOS-1-dependent S-nitrosylation of total proteins, the ryanodine receptor (RyR2), SERCA2 and the L-Type Ca2+ channel (LTCC). In the isolated rat heart, isoproterenol (10 nM, 3-min) increased S-nitrosylation of total cardiac proteins (+46 +/- 14%) and RyR2 (+146 +/- 77%), without affecting S-nitrosylation of SERCA2 and LTCC. Selective NOS-1 blockade with S-methyl-L-thiocitrulline (SMTC) and N.-propyl-l-arginine decreased basal contractility and relaxation (-25-30%) and basal S-nitrosylation of total proteins (-25-60%), RyR2, SERCA2 and LTCC (-60-75%). NOS-1 inhibition reduced (-25-40%) the inotropic response and protein S-nitrosylation induced by isoproterenol, particularly that of RyR2 (-85 +/-%). Tempol, a superoxide scavenger, mimicked the effects of NOS-1 inhibition on inotropism and protein S-nitrosylation; whereas selective NOS-3 inhibitor L-N-5-(1-Iminoethyl) ornithine had no effect. Inhibition of NOS-1 did not affect phospholamban phosphorylation, but reduced its oligomerization. Attenuation of contractility was abolished by PKA blockade and unaffected by guanylate cyclase inhibition. Additionally, in isolated mouse cardiomyocytes, NOS-1 inhibition or removal reduced the Ca2+-transient amplitude and sarcomere shortening induced by isoproterenol or by direct PKA activation. We conclude that 1) normal cardiac performance requires basal NOS-1 activity and S-nitrosylation of the calcium-cycling machinery; 2) beta-adrenergic stimulation induces rapid and reversible NOS-1 dependent, PKA and ROS-dependent, S-nitrosylation of RyR2 and other proteins, accounting for about one third of its inotropic effect.	[Vielma, Alejandra Z.; Leon, Luisa; Fernandez, Ignacio C.; Boric, Mauricio P.] Pontificia Univ Catolica Chile, Fac Ciencias Biol, Dept Fisiol, POB 114-D, Santiago, Chile; [Gonzalez, Daniel R.] Univ Talca, Dept Ciencias Basicas Biomed, Fac Ciencias Salud, Ave Lircay SN, Talca, Chile	Pontificia Universidad Catolica de Chile; Universidad de Talca	Boric, MP (corresponding author), Pontificia Univ Catolica Chile, Fac Ciencias Biol, Dept Fisiol, POB 114-D, Santiago, Chile.	mboric@bio.puc.cl	Boric, Mauricio P/G-1574-2013	Boric, Mauricio P/0000-0001-6735-6675; GONZALEZ, DANIEL/0000-0002-3437-8998; Fernandez, Ignacio/0000-0002-3631-9932	Fondecyt (Chilean National Fund for Science and Technology);  [1090757];  [1120595];  [1150662]	Fondecyt (Chilean National Fund for Science and Technology); ; ; 	Supported in part by Grants 1090757 (M.P. Boric), 1120595 and 1150662 (D.R. Gonzalez) and Anillos Act71 from Fondecyt (Chilean National Fund for Science and Technology).; Supported in part by Grants 1090757 (MP Boric), 1120595 and 1150662 (DR Gonzalez) and Anillos Act71 from Fondecyt (Chilean National Fund for Science and Technology). The authors thank Dr. Walter N. Duran for critical reviewing of the manuscript.	Andersson DC, 2011, J PHYSIOL-LONDON, V589, P1791, DOI 10.1113/jphysiol.2010.202838; Ashley EA, 2002, CIRCULATION, V105, P3011, DOI 10.1161/01.CIR.0000019516.31040.2D; Barouch LA, 2002, NATURE, V416, P337, DOI 10.1038/416337a; Beigi F, 2012, P NATL ACAD SCI USA, V109, P4314, DOI 10.1073/pnas.1113319109; Bencsik P, 2008, BRIT J PHARMACOL, V153, P488, DOI 10.1038/sj.bjp.0707599; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Bers DM, 2001, EXCITATION CONTRACTI; Bovo E, 2012, J PHYSIOL-LONDON, V590, P3291, DOI 10.1113/jphysiol.2012.230748; Brahmajothi MV, 1999, CIRC RES, V85, P575, DOI 10.1161/01.RES.85.7.575; Burger DE, 2009, CIRCULATION, V120, P1345, DOI 10.1161/CIRCULATIONAHA.108.846402; Campbell DL, 1996, J GEN PHYSIOL, V108, P277, DOI 10.1085/jgp.108.4.277; Carnicer R, 2012, CIRC RES, V111, P718, DOI 10.1161/CIRCRESAHA.112.274464; Curran J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087495; Cutler MJ, 2012, P NATL ACAD SCI USA, V109, P18186, DOI 10.1073/pnas.1210565109; Dedkova EN, 2009, J PHYSIOL-LONDON, V587, P851, DOI 10.1113/jphysiol.2008.165423; Fauconnier J, 2010, P NATL ACAD SCI USA, V107, P1559, DOI 10.1073/pnas.0908540107; Feron O, 1998, J BIOL CHEM, V273, P30249, DOI 10.1074/jbc.273.46.30249; FURFINE ES, 1994, J BIOL CHEM, V269, P26677; Gallo MP, 2001, PFLUG ARCH EUR J PHY, V441, P621, DOI 10.1007/s004240000475; Gonzalez DR, 2008, NITRIC OXIDE-BIOL CH, V18, P157, DOI 10.1016/j.niox.2007.09.086; Gonzalez DR, 2007, P NATL ACAD SCI USA, V104, P20612, DOI 10.1073/pnas.0706796104; Gonzalez DR, 2010, J BIOL CHEM, V285, P28938, DOI 10.1074/jbc.M110.154948; Gonzalez DR, 2009, J CARDIOVASC PHARM, V54, P188, DOI 10.1097/FJC.0b013e3181b72c9f; Hare JM, 2004, NEW ENGL J MED, V351, P2112, DOI 10.1056/NEJMe048269; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; Hintz KK, 2002, COMP BIOCHEM PHYS A, V133, P191, DOI 10.1016/S1095-6433(02)00177-0; Hsieh HY, 2010, J NEUROSCI RES, V88, P1285, DOI 10.1002/jnr.22291; Hurt KJ, 2012, P NATL ACAD SCI USA, V109, P16624, DOI 10.1073/pnas.1213790109; Irie T, 2015, CIRC RES, V117, P793, DOI 10.1161/CIRCRESAHA.115.307157; Jaffrey S R, 2001, Sci STKE, V2001, ppl1, DOI 10.1126/stke.2001.86.pl1; Jaffrey SR, 2001, NAT CELL BIOL, V3, P193, DOI 10.1038/35055104; Jian Z, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005046; Jin CZ, 2013, J MOL CELL CARDIOL, V60, P107, DOI 10.1016/j.yjmcc.2013.04.017; Jin CZ, 2012, J MOL CELL CARDIOL, V52, P1274, DOI 10.1016/j.yjmcc.2012.03.013; Koshiishi I, 2007, NITRIC OXIDE-BIOL CH, V16, P356, DOI 10.1016/j.niox.2006.12.002; Lima B, 2010, CIRC RES, V106, P633, DOI 10.1161/CIRCRESAHA.109.207381; Maier LS, 2007, CARDIOVASC RES, V73, P629, DOI 10.1016/j.cardiores.2007.01.005; Maier LS, 2009, FRONT BIOSCI-LANDMRK, V14, P486, DOI 10.2741/3257; Martin SR, 2006, CARDIOVASC RES, V70, P97, DOI 10.1016/j.cardiores.2006.02.002; Martinez-Ruiz A, 2013, ANTIOXID REDOX SIGN, V19, P1220, DOI 10.1089/ars.2012.5066; MOORE WM, 1994, J MED CHEM, V37, P3886, DOI 10.1021/jm00049a007; Murphy E, 2012, J MOL CELL CARDIOL, V52, P568, DOI 10.1016/j.yjmcc.2011.08.021; NARAYANAN K, 1995, J BIOL CHEM, V270, P11103, DOI 10.1074/jbc.270.19.11103; Ozawa K, 2008, MOL CELL, V31, P395, DOI 10.1016/j.molcel.2008.05.024; Polakova E, 2015, J PHYSIOL-LONDON, V593, P1495, DOI 10.1113/jphysiol.2014.278051; Prosser BL, 2011, SCIENCE, V333, P1440, DOI 10.1126/science.1202768; REES DD, 1990, BRIT J PHARMACOL, V101, P746, DOI 10.1111/j.1476-5381.1990.tb14151.x; Roof SR, 2015, J MOL CELL CARDIOL, V81, P54, DOI 10.1016/j.yjmcc.2015.01.003; Roof SR, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-013-0332-6; Roof SR, 2012, NITRIC OXIDE-BIOL CH, V27, P242, DOI 10.1016/j.niox.2012.08.077; Sears CE, 2003, CIRC RES, V92, pE52, DOI 10.1161/01.RES.0000064585.95749.6D; Seddon M, 2009, CIRCULATION, V119, P2656, DOI 10.1161/CIRCULATIONAHA.108.822205; Shan J, 2010, J CLIN INVEST, V120, P4388, DOI 10.1172/JCI32726; Sun JH, 2006, CIRC RES, V98, P403, DOI 10.1161/01.RES.0000202707.79018.0a; Sun JH, 2007, CIRC RES, V101, P1155, DOI 10.1161/CIRCRESAHA.107.155879; Tamargo J, 2010, CARDIOVASC RES, V87, P593, DOI 10.1093/cvr/cvq214; Tang LF, 2014, PHARMACOL THERAPEUT, V142, P306, DOI 10.1016/j.pharmthera.2013.12.013; Wang H, 2008, AM J PHYSIOL-CELL PH, V294, pC1566, DOI 10.1152/ajpcell.00367.2007; Wang H, 2008, AM J PHYSIOL-HEART C, V294, pH1473, DOI 10.1152/ajpheart.01249.2007; Wang HL, 2010, J PHYSIOL-LONDON, V588, P2905, DOI 10.1113/jphysiol.2010.192617; Wang HL, 2009, J MOL CELL CARDIOL, V47, P304, DOI 10.1016/j.yjmcc.2009.03.021; Whalen EJ, 2007, CELL, V129, P511, DOI 10.1016/j.cell.2007.02.046; Wilcox CS, 2008, PHARMACOL REV, V60, P418, DOI 10.1124/pr.108.000240; Xu KY, 1999, P NATL ACAD SCI USA, V96, P657, DOI 10.1073/pnas.96.2.657; Xu L, 1998, SCIENCE, V279, P234, DOI 10.1126/science.279.5348.234; Zhang HQ, 1997, J MED CHEM, V40, P3869, DOI 10.1021/jm970550g; Zhang YH, 2008, CIRC RES, V102, P242, DOI 10.1161/CIRCRESAHA.107.164798; Zhang YH, 2014, J PHYSIOL-LONDON, V592, P3189, DOI 10.1113/jphysiol.2013.270306; Zhang YH, 2012, J MOL CELL CARDIOL, V52, P341, DOI 10.1016/j.yjmcc.2011.09.006	69	14	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2016	11	8							e0160813	10.1371/journal.pone.0160813	http://dx.doi.org/10.1371/journal.pone.0160813			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4UN	27529477	Green Submitted, Green Published, gold			2022-12-27	WOS:000381476700023
J	Kuo, HC; Wang, CL; Yang, KD; Lo, MH; Hsieh, KS; Li, SC; Huang, YH				Kuo, Ho-Chang; Wang, Chih-Lu; Yang, Kuender D.; Lo, Mao-Hung; Hsieh, Kai-Sheng; Li, Sung-Chou; Huang, Ying-Hsien			Plasma Prostaglandin E-2 Levels Correlated with the Prevention of Intravenous Immunoglobulin Resistance and Coronary Artery Lesions Formation via CD40L in Kawasaki Disease	PLOS ONE			English	Article							REGULATORY T-CELLS; TREATMENT FAILURE; EXPRESSION; LIGAND; ASSOCIATION; INHIBITION; MECHANISMS; MACROPHAGE; INDUCTION	Background A form of systemic vasculitis, Kawasaki disease (KD) occurs most frequently in children under the age of five years old. Previous studies have found that Prostaglandin E-2 (PGE(2)) correlates with KD, although the related mechanisms are still unknown. CD40L may also be a marker of vasculitis in KD, so this study focuses on PGE(2) and CD40L expression in KD. Materials and Methods This study consisted of a total of 144 KD patients, whose intravenous immunoglobulin (IVIG)/coronary arterial lesion (CAL) formation resistance was evaluated. PGE(2) levels were evaluated in vitro to study the effect of CD40L on CD4+ T lymphocytes. Results PGE(2) levels significantly increased after IVIG treatment (p<0.05), especially in patients who responded to initial IVIG treatment (p = 0.004) and for patients without CAL formation (p = 0.016). Furthermore, an in vitro study revealed that IVIG acted as a trigger for PGE(2) expression in the acute-stage mononuclear cells of KD patients. According to our findings, both IVIG and PGE(2) can impede surface CD40L expressions on CD4+ T lymphocytes (p<0.05). Conclusions The results of this study are among the first to find that plasma PGE(2) is correlated with the prevention of IVIG resistance and CAL formation through CD40L in KD.	[Kuo, Ho-Chang; Lo, Mao-Hung; Hsieh, Kai-Sheng; Huang, Ying-Hsien] Kaohsiung Chang Gung Mem Hosp, Dept Pediat, Kaohsiung, Taiwan; [Kuo, Ho-Chang; Lo, Mao-Hung; Hsieh, Kai-Sheng; Li, Sung-Chou; Huang, Ying-Hsien] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan; [Kuo, Ho-Chang; Lo, Mao-Hung; Hsieh, Kai-Sheng; Huang, Ying-Hsien] Kaohsiung Chang Gung Mem Hosp, Kawasaki Dis Ctr, Kaohsiung, Taiwan; [Wang, Chih-Lu] Po Jen Hosp, Dept Pediat, Kaohsiung, Taiwan; [Yang, Kuender D.] Mackay Mem Hosp, Mackay Med Sch, Inst Biomed Sci, Taipei, Taiwan; [Yang, Kuender D.] Mackay Mem Hosp, Dept Pediat, Taipei, Taiwan; [Li, Sung-Chou] Kaohsiung Chang Gung Mem Hosp, Dept Med Res, Genom & Prote Core Lab, Kaohsiung, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Academia Sinica - Taiwan; Mackay Memorial Hospital; Mackay Memorial Hospital; Chang Gung Memorial Hospital	Huang, YH (corresponding author), Kaohsiung Chang Gung Mem Hosp, Dept Pediat, Kaohsiung, Taiwan.; Huang, YH (corresponding author), Chang Gung Univ, Coll Med, Kaohsiung, Taiwan.; Huang, YH (corresponding author), Kaohsiung Chang Gung Mem Hosp, Kawasaki Dis Ctr, Kaohsiung, Taiwan.	yhhuang123@yahoo.com.tw	Kuo, Ho-Chang/AAQ-6644-2020; Li, Sung-Chou/AGZ-8626-2022	Kuo, Ho-Chang/0000-0002-3295-2984; Li, Sung-Chou/0000-0002-3016-9718; Huang, Ying-Hsien/0000-0002-7127-0046; Hsieh, Kai-Sheng/0000-0002-0294-9872	Ministry of Science and Technology of Taiwan [MOST 105-2314-B-182 -050 -MY3, MOST 102-2314-B-182-053-MY3, MOST 103-2410-H-264-004]; Chang Gung Memorial Hospital in Taiwan [CMRPG8A0481, CMRPG8E0061, CMRPG8C1082, CMRPG8B0212, CMRPG8D1561, CORPG8F0011, CMRPG8D0521]	Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan); Chang Gung Memorial Hospital in Taiwan(Chang Gung Memorial Hospital)	This study was supported by funding provided by the following grants: MOST 105-2314-B-182 -050 -MY3, MOST 102-2314-B-182-053-MY3, and MOST 103-2410-H-264-004 from the Ministry of Science and Technology of Taiwan and CMRPG8A0481, CMRPG8E0061, CMRPG8C1082, CMRPG8B0212, CMRPG8D1561, CORPG8F0011, and CMRPG8D0521 from Chang Gung Memorial Hospital in Taiwan. These institutes had no influence over the collection, analysis, or interpretation of the data or on the preparation of this manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAGI T, 1990, Kurume Medical Journal, V37, P203; Burns JC, 2004, LANCET, V364, P533, DOI 10.1016/S0140-6736(04)16814-1; CAROSELLA ED, 1989, CELL IMMUNOL, V121, P261, DOI 10.1016/0008-8749(89)90024-5; Chizzolini C, 2009, IMMUNOL CELL BIOL, V87, P510, DOI 10.1038/icb.2009.56; Daniels LB, 2012, CURR OPIN CARDIOL, V27, P572, DOI 10.1097/HCO.0b013e3283588f06; Dogan Omer Faruk, 2007, Heart Surg Forum, V10, pE70, DOI 10.1532/HSF98.20061151; Gomez I, 2013, PROSTAG LEUKOTR ESS, V89, P55, DOI 10.1016/j.plefa.2013.04.004; Guo MMH, 2015, ALLERGY, V70, P310, DOI 10.1111/all.12558; Hassan GS, 2012, IMMUNOBIOLOGY, V217, P521, DOI 10.1016/j.imbio.2011.03.010; Jia S, 2010, CLIN EXP IMMUNOL, V162, P131, DOI 10.1111/j.1365-2249.2010.04236.x; Jing H, 2004, J BIOL CHEM, V279, P55176, DOI 10.1074/jbc.M409816200; Kajimoto M, 2009, INFLAMM RES, V58, P224, DOI 10.1007/s00011-008-8138-y; KATO H, 1979, PEDIATRICS, V63, P175; KAWASAKI T, 1974, PEDIATRICS, V54, P271; Khor CC, 2011, J MED GENET, V48, P467, DOI 10.1136/jmg.2010.086611; Ko TM, 2015, CIRC RES, V116, P876, DOI 10.1161/CIRCRESAHA.116.305834; Kuo HC, 2007, PEDIAT ALLERG IMM-UK, V18, P354, DOI 10.1111/j.1399-3038.2007.00516.x; Kuo HC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144603; Kuo HC, 2012, SCI WORLD J, DOI 10.1100/2012/520865; Kuo HC, 2012, J CLIN IMMUNOL, V32, P746, DOI 10.1007/s10875-012-9668-1; Kuo HC, 2011, ACTA PHARMACOL SIN, V32, P1193, DOI 10.1038/aps.2011.93; Kuo HC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017370; Kuo HC, 2011, J HUM GENET, V56, P161, DOI 10.1038/jhg.2010.154; Kuo HC, 2010, ACTA PAEDIATR, V99, P1578, DOI 10.1111/j.1651-2227.2010.01875.x; LEE T, 1988, PROSTAG LEUKOTR ESS, V31, P53, DOI 10.1016/0952-3278(88)90076-2; Liang CD, 2009, AM HEART J, V157, P584, DOI 10.1016/j.ahj.2008.11.020; Maddur MS, 2015, CELL MOL IMMUNOL, V12, P650, DOI 10.1038/cmi.2014.117; Maddur MS, 2014, IMMUNOL RES, V60, P320, DOI 10.1007/s12026-014-8580-6; Maddur MS, 2013, J CLIN IMMUNOL, V33, pS62, DOI 10.1007/s10875-012-9752-6; Maddur MS, 2011, J ALLERGY CLIN IMMUN, V127, P823, DOI 10.1016/j.jaci.2010.12.1102; Muller C, 2015, CANCER IMMUNOL IMMUN, V64, P1175, DOI 10.1007/s00262-015-1723-3; Na YR, 2015, EUR J IMMUNOL, V45, P2661, DOI 10.1002/eji.201545471; Newburger JW, 2004, CIRCULATION, V110, P2747, DOI 10.1161/01.CIR.0000145143.19711.78; NEWBURGER JW, 1991, NEW ENGL J MED, V324, P1633, DOI 10.1056/NEJM199106063242305; Onouchi Y, 2004, EUR J HUM GENET, V12, P1062, DOI 10.1038/sj.ejhg.5201266; Onouchi Y, 2012, NAT GENET, V44, P517, DOI 10.1038/ng.2220; Pamukcu B, 2011, ANN MED, V43, P331, DOI 10.3109/07853890.2010.546362; Saha A, 2014, J IMMUNOL, V193, P2330, DOI 10.4049/jimmunol.1400399; Sasai K, 1988, Arerugi, V37, P952; SCHROR K, 1993, EUR HEART J, V14, P34; Shah SV, 2011, CLIN J AM SOC NEPHRO, V6, P2329, DOI 10.2215/CJN.08340811; Shibata T, 2011, J VISION, V11, DOI 10.1167/11.8.11; SHULMAN ST, 1995, PEDIATR CLIN N AM, V42, P1205; Splawski JB, 1996, J IMMUNOL, V156, P119; Tiao MM, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/942172; Trinath J, 2013, BLOOD, V122, P1419, DOI 10.1182/blood-2012-11-468264; van Kooten C, 2000, J LEUKOCYTE BIOL, V67, P2, DOI 10.1002/jlb.67.1.2; Wang CL, 2003, PEDIATRICS, V111, DOI 10.1542/peds.111.2.e140; Weiss G, 1999, CLIN EXP IMMUNOL, V116, P435; Wiedeman AE, 2013, ARTHRITIS RHEUM-US, V65, P2713, DOI 10.1002/art.38082; Wiemer AJ, 2011, J IMMUNOL, V187, P3663, DOI 10.4049/jimmunol.1100103; Yamakawa R, 1998, J AM COLL CARDIOL, V31, P1074, DOI 10.1016/S0735-1097(98)00033-3	53	17	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2016	11	8							e0161265	10.1371/journal.pone.0161265	http://dx.doi.org/10.1371/journal.pone.0161265			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4SL	27525421	Green Submitted, gold, Green Published			2022-12-27	WOS:000381471100049
J	Guo, W; Zheng, WY; Wang, M; Li, XH; Ma, Y; Dai, HY				Guo, Wei; Zheng, Wenyan; Wang, Mei; Li, Xiaohong; Ma, Yue; Dai, Hongyan			Genome Sequences of Three Apple chlorotic leaf spot virus Isolates from Hawthorns in China	PLOS ONE			English	Article							COMPLETE NUCLEOTIDE-SEQUENCE; PEACH PRUNUS-PERSICA; COAT PROTEIN; TRICHOVIRUS	The genome sequences of Apple chlorotic leaf spot virus (ACLSV) isolates from three accessions of hawthorns (Crataegus pinnatifida) grown at Shenyang Agricultural University were determined using Illumina RNA-seq. To confirm the assembly data from the de novo sequencing, two ACLSV genomic sequences (SY01 and SY02) were sequenced using the Sanger method. The SY01 and SY02 sequences obtained with the Sanger method showed 99.5% and 99.7% nucleotide identity with the transcriptome data, respectively. The genome sequences of the hawthorn isolates SY01, SY02 and SY03 (GenBank accession nos. KM207212, KU870524 and KU870525, respectively) consisted of 7,543, 7,561 and 7,545 nucleotides, respectively, excluding poly-adenylated tails. Sequence analysis revealed that these hawthorn isolates shared an overall nucleotide identity of 82.8-92.1% and showed the highest identity of 90.3% for isolate YH (GenBank accession no. KC935955) from pear and the lowest identity of 67.7% for isolate TaTao5 (GenBank accession no. EU223295) from peach. Hawthorn isolate sequences were similar to those of 'B6 type' ACLSV. The relationship between ACLSV isolates largely depends upon the host species. This represents the first comparative study of the genome sequences of ACLSV isolates from hawthorns.	[Guo, Wei; Zheng, Wenyan; Wang, Mei; Ma, Yue; Dai, Hongyan] Shenyang Agr Univ, Coll Hort, 120 Dongling Rd, Shenyang 110866, Liaoning, Peoples R China; [Li, Xiaohong] Eastern Liaoning Univ, Coll Agron, 325 Wenhua Rd, Dandong 118003, Liaoning, Peoples R China	Shenyang Agricultural University; Liaodong University	Dai, HY (corresponding author), Shenyang Agr Univ, Coll Hort, 120 Dongling Rd, Shenyang 110866, Liaoning, Peoples R China.	daihy1970@163.com	li, xiaofeng/GXF-9442-2022; li, xiao/GSN-6181-2022		National Natural Science Foundation of China [31470678]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by National Natural Science Foundation of China (grant no. 31470678). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Rwahnih M, 2004, J PLANT PATHOL, V86, P117; Bejerman N, 2016, ARCH VIROL, V161, P2029, DOI 10.1007/s00705-016-2854-3; Chen SY, 2014, ARCH VIROL, V159, P1431, DOI 10.1007/s00705-013-1927-9; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Dai HY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072910; Dhir S, 2013, J PHYTOPATHOL, V161, P704, DOI 10.1111/jph.12121; GERMAN S, 1990, VIROLOGY, V179, P104, DOI 10.1016/0042-6822(90)90279-Z; GermanRetana S, 1997, ARCH VIROL, V142, P833, DOI 10.1007/s007050050122; GUBLER U, 1983, GENE, V25, P263, DOI 10.1016/0378-1119(83)90230-5; Jelkmann W, 1996, PHYTOPATHOLOGY, V86, P101; Khalifa ME, 2016, VIRUS RES, V219, P51, DOI 10.1016/j.virusres.2015.11.001; Kinard GR, 1996, PLANT DIS, V80, P616, DOI 10.1094/PD-80-0616; [李科 Li Ke], 2015, [中国农业科学, Scientia Agricultura Sinica], V48, P2857; Lim S, 2015, VIRUS GENES, V51, P260, DOI 10.1007/s11262-015-1225-6; Liu MY, 2016, ARCH VIROL, V161, P677, DOI 10.1007/s00705-015-2691-9; Marini DB, 2008, ARCH VIROL, V153, P1003, DOI 10.1007/s00705-008-0076-z; MARTELLI GP, 1994, ARCH VIROL, V134, P451, DOI 10.1007/BF01310583; Nemeth M., 1986, VIRUSES MYCOPLASMA R; Niu FQ, 2012, ARCH VIROL, V157, P783, DOI 10.1007/s00705-011-1195-5; SATO K, 1993, J GEN VIROL, V74, P1927, DOI 10.1099/0022-1317-74-9-1927; Song YS, 2011, EUR J PLANT PATHOL, V130, P183, DOI 10.1007/s10658-011-9744-z; Yaegashi H, 2007, J GEN VIROL, V88, P2611, DOI 10.1099/vir.0.82984-0; Yanase H, 1979, JPN J PHYTOPATHOL, V45, P369, DOI [10.3186/jjphytopath.45.369, DOI 10.3186/JJPHYTOPATH.45.369]; Yoshikawa N, 1988, PLANT PATHOL, P241; Zhu H, 2014, CAN J PLANT PATHOL, V36, P396, DOI 10.1080/07060661.2014.927399	25	9	10	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2016	11	8							e0161099	10.1371/journal.pone.0161099	http://dx.doi.org/10.1371/journal.pone.0161099			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3LI	27519059	Green Submitted, Green Published, gold			2022-12-27	WOS:000381382100048
J	Mendy, VL; Vargas, R; El-sadek, L				Mendy, Vincent L.; Vargas, Rodolfo; El-sadek, Lamees			Trends in Heart Disease Mortality among Mississippi Adults over Three Decades, 1980-2013	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASES; UNITED-STATES; YOUNG-ADULTS; DISPARITIES; DEATHS; STROKE; HEALTH; US; DECREASE; DECLINE	Heart disease (HD) remains the leading cause of death among Mississippians; however, despite the importance of the condition, trends in HD mortality in Mississippi have not been adequately explored. This study examined trends in HD mortality among adults in Mississippi from 1980 through 2013 and further examined these trends by race and sex. We used data from Mississippi Vital Statistics (1980-2013) to calculate age-adjusted HD mortality rates for Mississippians age 25 or older. Cases were identified using underlying cause of death codes from the International Classification of Diseases, Ninth Revision (ICD-9: 390398, 402, 404-429) and Tenth Revision (ICD-10), including I00-I09, I11, I13, and I20-I51. Joinpoint software was used to calculate the average annual percent change in HD mortality rates for the overall population and by race and sex. Overall, the age-adjusted HD mortality rate among Mississippi adults decreased by 36.5% between 1980 and 2013, with an average annual percent change of -1.60% (95% CI -2.00 to -1.30). This trend varied across subgroups: HD mortality rates experienced an average annual change of -1.34% (95% CI -1.98 to -0.69) for black adults; -1.60% (95% CI -1.74 to -1.46) for white adults; -1.30% (95% CI -1.50 to -1.10) for all women, and -1.90% (95% -2.20 to -1.50) for all men. From 1980 to 2013, there was a continuous decrease in HD mortality among adult Mississippians. However, the magnitude of this reduction differed by race and sex.	[Mendy, Vincent L.; Vargas, Rodolfo; El-sadek, Lamees] Mississippi Dept Hlth, Off Hlth Data & Res, Jackson, MS 39216 USA		Mendy, VL (corresponding author), Mississippi Dept Hlth, Off Hlth Data & Res, Jackson, MS 39216 USA.	vincent.mendy@msdh.ms.gov			CDC [5U50DP003088-04]	CDC(Centre National de la Recherche Scientifique (CNRS)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This research was supported by CDC grant no. 5U50DP003088-04.	Agarwal R, 2010, PREV CHRONIC DIS, V7; Anderson R N, 2001, Natl Vital Stat Rep, V49, P1; Berg J, 2014, BMC CARDIOVASC DISOR, V14, DOI 10.1186/1471-2261-14-9; Capewell S, 2012, NUTR METAB CARDIOVAS, V22, P307, DOI 10.1016/j.numecd.2012.01.005; Cayuela A, 2004, ANN ONCOL, V15; Centers for Disease Control and Prevention (CDC), 1999, MMWR Morb Mortal Wkly Rep, V48, P649; Christian AH, 2007, J WOMENS HEALTH, V16, P68, DOI 10.1089/jwh.2006.M072; Cohen J, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-283; Conrad Z, 2016, CIRCULATION, V133; Cooper R, 2000, CIRCULATION, V102, P3137; Davis AM, 2007, MED CARE RES REV, V64, p29S, DOI 10.1177/1077558707305416; Edwards BK, 2014, CANCER-AM CANCER SOC, V120, P1290, DOI 10.1002/cncr.28509; Ford ES, 2007, J AM COLL CARDIOL, V50, P2128, DOI 10.1016/j.jacc.2007.05.056; Ford ES, 2007, NEW ENGL J MED, V356, P2388, DOI 10.1056/NEJMsa053935; Frieden TR, 2011, NEW ENGL J MED, V365, DOI [10.1056/NEJMp1110421, 10.1056/NEJMP1110421]; Gerber Y, 2006, CIRCULATION, V113, P2285, DOI 10.1161/CIRCULATIONAHA.105.590463; Harriss LR, 2011, AUST NZ J PUBL HEAL, V35, P466, DOI 10.1111/j.1753-6405.2011.00739.x; Havranek EP, 2015, CIRCULATION, V132, P873, DOI 10.1161/CIR.0000000000000228; Hong YL, 2013, CIRCULATION, V128; Horner RD, 2009, AM J PUBLIC HEALTH, V99, P1996, DOI 10.2105/AJPH.2008.148221; Marmot M, 2015, LANCET, V386, P2442, DOI 10.1016/S0140-6736(15)00150-6; McWilliams JM, 2009, ANN INTERN MED, V150, P505, DOI 10.7326/0003-4819-150-8-200904210-00005; Mendy VL, 2015, PREV CHRONIC DIS, V12, DOI 10.5888/pcd12.140481; Mensah GA, 2005, CIRCULATION, V111, P1233, DOI 10.1161/01.CIR.0000158136.76824.04; Nichols M, 2013, EUR HEART J, V34, P3017, DOI 10.1093/eurheartj/eht159; O'Flaherty M, 2008, HEART, V94, P178, DOI 10.1136/hrt.2007.118323; O'Flaherty M, 2012, INT J CARDIOL, V158, P193, DOI 10.1016/j.ijcard.2011.01.016; Pilote L, 2007, CAN MED ASSOC J, V176, pS1, DOI 10.1503/cmaj.051455; Qiu D, 2009, INT J CANCER, V124, P443, DOI 10.1002/ijc.23911; Ritchey MD, 2014, JAMA-J AM MED ASSOC, V312, P2037, DOI 10.1001/jama.2014.11344; Rogers RG, 2010, DEMOGRAPHY, V47, P555, DOI 10.1353/dem.0.0119; Rooks RN, 2008, J AGING HEALTH, V20, P599, DOI 10.1177/0898264308321023; Rosamond WD, 2012, CIRCULATION, V125, P1848, DOI 10.1161/CIRCULATIONAHA.111.047480; Unal B, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1135; Vaughan AS, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.115.002567; Wexelman BA, 2013, PREV CHRONIC DIS, V10, DOI 10.5888/pcd10.120288	36	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2016	11	8							e0161194	10.1371/journal.pone.0161194	http://dx.doi.org/10.1371/journal.pone.0161194			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DT3LI	27518895	Green Submitted, gold, Green Published			2022-12-27	WOS:000381382100061
J	Mao, YP; Wang, ZP; Li, LG; Jiang, XT; Zhang, XX; Ren, HQ; Zhang, T				Mao, Yanping; Wang, Zhiping; Li, Liguan; Jiang, Xiaotao; Zhang, Xuxiang; Ren, Hongqiang; Zhang, Tong			Exploring the Shift in Structure and Function of Microbial Communities Performing Biological Phosphorus Removal	PLOS ONE			English	Article							GLYCOGEN-ACCUMULATING ORGANISMS; CANDIDATUS-ACCUMULIBACTER; WASTE-WATER; METABOLIC MODEL; PHOSPHATE REMOVAL; SLUDGE; PH; POLYPHOSPHATE; SCALE; BACTERIA	A sequencing batch reactor fed mainly by acetate was operated to perform enhanced biological phosphorus removal (EBPR). A short-term pH shock from 7.0 to 6.0 led to a complete loss of phosphate-removing capability and a drastic change of microbial communities. 16S rRNA gene pyrosequencing showed that large proportions of glycogen accumulating organisms (GAOs) (accounted for 16% of bacteria) bloomed, including Candidatus Competibacter phosphatis and Defluviicoccus-related tetrad-forming organism, causing deteriorated EBPR performance. The EBPR performance recovered with time and the dominant Candidatus Accumulibacter (Accumulibacter) clades shifted from Clade IIC to IIA while GAOs populations shrank significantly. The Accumulibacter population variation provided a good opportunity for genome binning using a bi-dimensional coverage method, and a genome of Accumulibacter Clade IIC was well retrieved with over 90% completeness. Comparative genomic analysis demonstrated that Accumulibacter clades had different abilities in nitrogen metabolism and carbon fixation, which shed light on enriching different Accumulibacter populations selectively.	[Mao, Yanping] Shenzhen Univ, Coll Chem & Environm Engn, Shenzhen, Peoples R China; [Mao, Yanping; Wang, Zhiping; Li, Liguan; Jiang, Xiaotao; Zhang, Tong] Univ Hong Kong, Dept Civil Engn, Environm Biotechnol Lab, Pokfulam Rd, Hong Kong, Hong Kong, Peoples R China; [Zhang, Xuxiang; Ren, Hongqiang] Nanjing Univ, Sch Environm, Nanjing, Jiangsu, Peoples R China	Shenzhen University; University of Hong Kong; Nanjing University	Zhang, T (corresponding author), Univ Hong Kong, Dept Civil Engn, Environm Biotechnol Lab, Pokfulam Rd, Hong Kong, Hong Kong, Peoples R China.	zhangt@hku.hk	hq, ren/AGA-1128-2022; Zhang, xiaoyu/GXA-3206-2022; Mao, Yanping/AAI-6386-2020; 張彤, Tong Zhang/C-6786-2008; zhang, xian/GYA-0290-2022; zhang, xu/GRX-9733-2022; Zhang, Tong/HGC-1090-2022; zhang, xu/GYE-3558-2022	Ren, Hong-qiang/0000-0001-6136-800X	Hong Kong General Research Fund (HKU) [172057/15E]; Shenzhen University R/D Fund [2016008]; University of Hong Kong; Hong Kong Scholar Program [XJ2012030]	Hong Kong General Research Fund (HKU); Shenzhen University R/D Fund; University of Hong Kong(University of Hong Kong); Hong Kong Scholar Program	This research was financially supported by Hong Kong General Research Fund (HKU 172057/15E) and Project supported by Shenzhen University R/D Fund (2016008). YM and LL received postdoctoral fellowships from the University of Hong Kong. XJ received postgraduate scholarship from the University of Hong Kong. ZW was financially supported by the Hong Kong Scholar Program (XJ2012030). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was financially supported by Hong Kong General Research Fund (HKU 172057/15E) and Project supported by Shenzhen University R/D Fund (2016008). YM and LL received postdoctoral fellowships from the University of Hong Kong. XJ received postgraduate scholarship from the University of Hong Kong. ZW was financially supported by the Hong Kong Scholar Program (XJ2012030). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertsen M, 2013, NAT BIOTECHNOL, V31, P533, DOI 10.1038/nbt.2579; Albertsen M, 2012, ISME J, V6, P1094, DOI 10.1038/ismej.2011.176; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Carvalho G, 2007, WATER RES, V41, P4383, DOI 10.1016/j.watres.2007.06.065; Chen YG, 2005, BIOCHEM ENG J, V27, P24, DOI 10.1016/j.bej.2005.06.003; Chen YG, 2004, WATER RES, V38, P27, DOI 10.1016/j.watres.2003.08.025; Crocetti GR, 2002, MICROBIOL-SGM, V148, P3353, DOI 10.1099/00221287-148-11-3353; Dupont CL, 2012, ISME J, V6, P1186, DOI 10.1038/ismej.2011.189; Filipe CDM, 2001, BIOTECHNOL BIOENG, V76, P17, DOI 10.1002/bit.1022; Filipe CDM, 2001, WATER ENVIRON RES, V73, P213, DOI 10.2175/106143001X139191; Filipe CDM, 2001, WATER ENVIRON RES, V73, P223, DOI 10.2175/106143001X139209; Flowers JJ, 2013, ISME J, V7, P2301, DOI 10.1038/ismej.2013.117; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; He S, 2006, WATER SCI TECHNOL, V54, P111, DOI 10.2166/wst.2006.378; He S, 2007, APPL ENVIRON MICROB, V73, P5865, DOI 10.1128/AEM.01207-07; Hess M, 2011, SCIENCE, V331, P463, DOI 10.1126/science.1200387; Hesselmann RPX, 1999, SYST APPL MICROBIOL, V22, P454, DOI 10.1016/S0723-2020(99)80055-1; Hien TTN, 2012, ENVIRON MICROBIOL, V14, P2826, DOI 10.1111/j.1462-2920.2012.02826.x; Hien TTN, 2011, FEMS MICROBIOL ECOL, V76, P256, DOI 10.1111/j.1574-6941.2011.01049.x; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Kong YH, 2006, ENVIRON MICROBIOL, V8, P479, DOI 10.1111/j.1462-2920.2005.00914.x; Kong YH, 2002, ENVIRON MICROBIOL, V4, P753, DOI 10.1046/j.1462-2920.2002.00357.x; Kristiansen R, 2013, ISME J, V7, P543, DOI 10.1038/ismej.2012.136; Leininger S, 2006, NATURE, V442, P806, DOI 10.1038/nature04983; Liu WT, 1996, WATER SCI TECHNOL, V34, P25, DOI 10.1016/0273-1223(96)00491-X; Liu WT, 2001, ENVIRON MICROBIOL, V3, P110, DOI 10.1046/j.1462-2920.2001.00164.x; Lopez-Vazquez CM, 2007, BIOTECHNOL BIOENG, V97, P483, DOI 10.1002/bit.21302; Lopez-Vazquez CM, 2009, WATER RES, V43, P450, DOI 10.1016/j.watres.2008.10.032; Mao YP, 2014, ENVIRON SCI TECHNOL, V48, P10363, DOI 10.1021/es502642b; Martin HG, 2006, NAT BIOTECHNOL, V24, P1263, DOI 10.1038/nbt1247; McIlroy S, 2009, ENV MICROBIOL REP, V1, P563, DOI 10.1111/j.1758-2229.2009.00082.x; McIlroy SJ, 2014, ISME J, V8, P613, DOI 10.1038/ismej.2013.162; McMahon KD, 2007, APPL MICROBIOL BIOT, V77, P167, DOI 10.1007/s00253-007-1122-6; Meier-Kolthoff JP, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-60; Meyer RL, 2006, MICROBIOL-SGM, V152, P419, DOI 10.1099/mic.0.28445-0; Mielczarek AT, 2013, WATER RES, V47, P1529, DOI 10.1016/j.watres.2012.12.003; Miller CS, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0056018, 10.1371/journal.pone.0081692]; Miller CS, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-5-r44; Nielsen AT, 1999, APPL ENVIRON MICROB, V65, P1251; Nobu MK, 2014, ENVIRON MICROBIOL, V16, P2739, DOI 10.1111/1462-2920.12383; Oehmen A, 2005, WATER RES, V39, P3727, DOI 10.1016/j.watres.2005.06.031; Oehmen A, 2007, WATER RES, V41, P2271, DOI 10.1016/j.watres.2007.02.030; Ong YH, 2013, WATER SCI TECHNOL, V67, P340, DOI 10.2166/wst.2012.552; Panswad T, 2003, WATER RES, V37, P409, DOI 10.1016/S0043-1354(02)00286-5; Peterson SB, 2008, ENVIRON MICROBIOL, V10, P2692, DOI 10.1111/j.1462-2920.2008.01690.x; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Richter M, 2009, P NATL ACAD SCI USA, V106, P19126, DOI 10.1073/pnas.0906412106; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Skennerton CT, 2015, ENVIRON MICROBIOL, V17, P1574, DOI 10.1111/1462-2920.12582; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tavares P, 2006, J INORG BIOCHEM, V100, P2087, DOI 10.1016/j.jinorgbio.2006.09.003; Uygur A, 2004, ENZYME MICROB TECH, V34, P313, DOI 10.1016/j.enzmictec.2003.11.010; Wang YY, 2010, BIORESOURCE TECHNOL, V101, P98, DOI 10.1016/j.biortech.2009.07.085; Wang ZP, 2014, MICROB ECOL, V68, P716, DOI 10.1007/s00248-014-0440-3; Wong MT, 2004, MICROBIOL-SGM, V150, P3741, DOI 10.1099/mic.0.27291-0; Zeng RJ, 2003, BIOTECHNOL BIOENG, V81, P92, DOI 10.1002/bit.10455; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang H, 2003, INT J SYST EVOL MICR, V53, P1155, DOI 10.1099/ijs.0.02520-0; Zhang T, 2005, BIOTECHNOL BIOENG, V92, P173, DOI 10.1002/bit.20589	60	51	53	1	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2016	11	8							e0161506	10.1371/journal.pone.0161506	http://dx.doi.org/10.1371/journal.pone.0161506			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT8TP	27547976	Green Published, Green Submitted, gold			2022-12-27	WOS:000381768400063
J	Pham, TM; Ekwaru, JP; Mastroeni, SS; Mastroeni, MF; Loehr, SA; Veugelers, PJ				Truong-Minh Pham; Ekwaru, John Paul; Mastroeni, Silmara S.; Mastroeni, Marco F.; Loehr, Sarah A.; Veugelers, Paul J.			The Effect of Serum 25-Hydroxyvitamin D on Elevated Homocysteine Concentrations in Participants of a Preventive Health Program	PLOS ONE			English	Article							PLASMA HOMOCYSTEINE; VITAMIN-D; CARDIOVASCULAR-DISEASE; PATHOGENESIS; POPULATION	Both lower serum 25-hydroxyvitamin D [25(OH) D] and elevated homocysteine concentrations are potential risk factors for cardiovascular disease (CVD). A recent analysis of the National Health and Nutrition Examination Survey reported an inverse association of serum 25(OH) D with homocysteine, however, the longitudinal relationship has yet to be investigated. We hypothesized and examined whether a temporal increase in 25(OH) D concentrations is paralleled by a reduction in the risk for elevated homocysteine. We analyzed data of 4475 participants with repeated assessments of serum 25(OH) D and homocysteine concentrations who enrolled in a preventive health program that encourages vitamin D supplementation and monitors serum 25(OH) D and homocysteine concentrations. We defined elevated homocysteine as concentrations greater than 13 micromoles per liter. Logistic regression was applied to assess the association of temporal changes in serum 25(OH) D with the risk of elevated homocysteine. We observed an inverse gradient whereby greater increases in 25(OH) D concentrations were associated with a lower prevalence of elevated homocysteine. Relative to those without temporal increases in 25(OH) D, participants who showed improvements in their serum 25(OH) D concentrations of "< 25", "25-50", "50-75", and ">= 75" nanomoles per liter at follow up were 0.92 (95% confidence interval: 0.62-1.37), 0.52 (0.33-0.80), 0.34 (0.20-0.58), and 0.32 (0.19-0.54) times as likely to have elevated homocysteine, respectively. These observations suggest that temporal improvements in vitamin D status reduce serum homocysteine concentrations, and therefore may potentially contribute to the primary prevention of CVD.	[Truong-Minh Pham; Ekwaru, John Paul; Mastroeni, Silmara S.; Mastroeni, Marco F.; Loehr, Sarah A.; Veugelers, Paul J.] Univ Alberta, Sch Publ Hlth, Populat Hlth Intervent Res Unit, Edmonton, AB, Canada	University of Alberta	Veugelers, PJ (corresponding author), Univ Alberta, Sch Publ Hlth, Populat Hlth Intervent Res Unit, Edmonton, AB, Canada.	Paul.Veugelers@ualberta.ca	MF, Mastroeni/M-5472-2014	MF, Mastroeni/0000-0001-9276-8866; Pham, Truong-Minh/0000-0001-9442-2930; Veugelers, Paul/0000-0001-8996-0822; Mastroeni, Silmara/0000-0003-0559-1797	Canada Research Chair in Population Health, an Alberta Research Chair in Nutrition and Disease Prevention; Canada Research Chair in Population Health, an Alberta Innovates Health Scholarship; Canadian Institutes for Health Research; School of Public Health at the University of Alberta; Pure North S'Energy Foundation; Alberta provincial government through Alberta Innovates Health Solutions; National Council for Scientific and Technological Development (CNPq), Brazil	Canada Research Chair in Population Health, an Alberta Research Chair in Nutrition and Disease Prevention; Canada Research Chair in Population Health, an Alberta Innovates Health Scholarship; Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); School of Public Health at the University of Alberta; Pure North S'Energy Foundation; Alberta provincial government through Alberta Innovates Health Solutions; National Council for Scientific and Technological Development (CNPq), Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This is an analysis of secondary data. The data had been collected for the purpose of lifestyle counseling of participants by a preventive health program. None of the authors were involved in the execution of this program; neither did they provide financial support. PJV holds a Canada Research Chair in Population Health, an Alberta Research Chair in Nutrition and Disease Prevention, and an Alberta Innovates Health Scholarship. The funding for the Canada Research Chair is provided through the Canadian Institutes for Health Research to the University of Alberta. The Alberta Research Chair is awarded by the School of Public Health at the University of Alberta through a thematic research contract with the Pure North S'Energy Foundation. The Health Scholarship is funded by the Alberta provincial government through Alberta Innovates Health Solutions. The funders had no role in analytic design, data analysis, decision to publish, or preparation of this manuscript.; The authors wish to thank the Pure North S'Energy Foundation for allowing their data to be analyzed for the purpose of this article. They especially wish to thank Peter Tran and Ken Fyie for management and validation of the Foundation's data. M.F.M thanks the National Council for Scientific and Technological Development (CNPq), Brazil, for granting a scholarship.	Amer M, 2014, J CLIN ENDOCR METAB, V99, P633, DOI 10.1210/jc.2013-3262; BOUSHEY CJ, 1995, JAMA-J AM MED ASSOC, V274, P1049, DOI 10.1001/jama.274.13.1049; Canada Statistics, VIT D LEV CAN 2012 2; Colapinto CK, 2011, CAN MED ASSOC J, V183, pE100, DOI 10.1503/cmaj.100568; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Eikelboom JW, 1999, ANN INTERN MED, V131, P363, DOI 10.7326/0003-4819-131-5-199909070-00008; Garcia AA, 2008, CAN J PUBLIC HEALTH, V99, P428, DOI 10.1007/BF03405255; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Holick MF, 2009, ANN EPIDEMIOL, V19, P73, DOI 10.1016/j.annepidem.2007.12.001; Kriebitzsch C, 2011, J BONE MINER RES, V26, P2991, DOI 10.1002/jbmr.493; MacFarlane AJ, 2011, AM J CLIN NUTR, V94, P1079, DOI 10.3945/ajcn.111.020230; Manson JE, 2015, JAMA-J AM MED ASSOC, V313, P1311, DOI 10.1001/jama.2015.1353; Marti-Carvajal AJ, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006612.pub4; MCCULLY KS, 1969, AM J PATHOL, V56, P111; Norman PE, 2014, CIRC RES, V114, P379, DOI 10.1161/CIRCRESAHA.113.301241; Nygard O, 1997, NEW ENGL J MED, V337, P230, DOI 10.1056/NEJM199707243370403; Ray JG, 2002, CAN J PUBLIC HEALTH, V93, P249, DOI 10.1007/BF03405010; Selhub J, 1999, ANNU REV NUTR, V19, P217, DOI 10.1146/annurev.nutr.19.1.217; SELHUB J, 1995, NEW ENGL J MED, V332, P286, DOI 10.1056/NEJM199502023320502; Sheng L, 2015, J GERIATR CARDIOL, V12, P251, DOI 10.11909/j.issn.1671-5411.2015.03.006; Pham TM, 2015, NUTRIENTS, V7, P7271, DOI 10.3390/nu7095338; Wald DS, 2002, BMJ-BRIT MED J, V325, P1202, DOI 10.1136/bmj.325.7374.1202; WILCKEN DEL, 1976, J CLIN INVEST, V57, P1079, DOI 10.1172/JCI108350	25	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2016	11	8							e0161368	10.1371/journal.pone.0161368	http://dx.doi.org/10.1371/journal.pone.0161368			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT8TP	27548258	Green Published, gold, Green Submitted			2022-12-27	WOS:000381768400047
J	Brautigam, CA; Deka, RK; Liu, WZ; Norgard, MV				Brautigam, Chad A.; Deka, Ranjit K.; Liu, Wei Z.; Norgard, Michael V.			The Tp0684 (MglB-2) Lipoprotein of Treponema pallidum: A Glucose-Binding Protein with Divergent Topology	PLOS ONE			English	Article							SIZE-DISTRIBUTION ANALYSIS; OUTER-MEMBRANE PROTEINS; CONFORMATIONAL-CHANGES; ANALYTICAL ULTRACENTRIFUGATION; SEDIMENTATION ANALYSIS; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; TRAP TRANSPORTER; GENOME SEQUENCE; SYPHILIS	Treponema pallidum, the bacterium that causes syphilis, is an obligate human parasite. As such, it must acquire energy, in the form of carbon sources, from the host. There is ample evidence that the principal source of energy for this spirochete is D-glucose acquired from its environment, likely via an ABC transporter. Further, there is genetic evidence of a D-glucose chemotaxis system in T. pallidum. Both of these processes may be dependent on a single lipidated chemoreceptor: Tp0684, also called TpMglB-2 for its sequence homology to MglB of Escherichia coli. To broaden our understanding of this potentially vital protein, we determined a 2.05-angstrom X-ray crystal structure of a soluble form of the recombinant protein. Like its namesake, TpMglB-2 adopts a bilobed fold that is similar to that of the ligand-binding proteins (LBPs) of other ABC transporters. However, the protein has an unusual, circularly permuted topology. This feature prompted a series of biophysical studies that examined whether the protein's topological distinctiveness affected its putative chemoreceptor functions. Differential scanning fluorimetry and isothermal titration calorimetry were used to confirm that the protein bound D-glucose in a cleft between its two lobes. Additionally, analytical ultracentrifugation was employed to reveal that D-glucose binding is accompanied by a significant conformational change. TpMglB-2 thus appears to be fully functional in vitro, and given the probable central importance of the protein to T. pallidum's physiology, our results have implications for the viability and pathogenicity of this obligate human pathogen.	[Brautigam, Chad A.] Univ Texas Southwestern Med Ctr, Dept Biophys, Dallas, TX 75390 USA; [Deka, Ranjit K.; Liu, Wei Z.; Norgard, Michael V.] Univ Texas Southwestern Med Ctr, Dept Microbiol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Norgard, MV (corresponding author), Univ Texas Southwestern Med Ctr, Dept Microbiol, Dallas, TX 75390 USA.	Michael.Norgard@UTSouthwestern.edu		Brautigam, Chad/0000-0001-6563-1338	National Institutes of Health [AI056305]; U.S. Department of Energy, Office of Biological and Environmental Research [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI056305] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health (grant AI056305, www.nih.gov) to MVN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by a grant (AI056305) to M.V.N. from the National Institutes of Health. Some results shown in this report are derived from work performed at Argonne National Laboratory, Structural Biology Center at the Advanced Photon Source. Argonne is operated by UChicago Argonne, LLC, for the U.S. Department of Energy, Office of Biological and Environmental Research under contract DE-AC02-06CH11357.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BARBIERI JT, 1979, INFECT IMMUN, V24, P291, DOI 10.1128/IAI.24.1.291-293.1979; BARBIERI JT, 1981, INFECT IMMUN, V31, P1071, DOI 10.1128/IAI.31.3.1071-1077.1981; BECKER PS, 1994, INFECT IMMUN, V62, P1381, DOI 10.1128/IAI.62.4.1381-1391.1994; Berntsson RPA, 2010, FEBS LETT, V584, P2606, DOI 10.1016/j.febslet.2010.04.043; Bevington PR, 1992, DATA REDUCTION AND E; Borrok MJ, 2007, PROTEIN SCI, V16, P1032, DOI 10.1110/ps.062707807; Borrok MJ, 2009, ACS CHEM BIOL, V4, P447, DOI 10.1021/cb900021q; Brautigam CA, 2016, NAT PROTOC, V11, P882, DOI 10.1038/nprot.2016.044; Brautigam CA, 2015, METHOD ENZYMOL, V562, P109, DOI 10.1016/bs.mie.2015.05.001; Brautigam CA, 2015, PROTEIN SCI, V24, P11, DOI 10.1002/pro.2576; Brautigam CA, 2012, J BACTERIOL, V194, P6771, DOI 10.1128/JB.01494-12; Brautigam CA, 2012, J MOL BIOL, V420, P70, DOI 10.1016/j.jmb.2012.04.001; Bremer V, 2012, SEX TRANSM DIS, P7; Charon NW, 2002, ANNU REV GENET, V36, P47, DOI 10.1146/annurev.genet.36.041602.134359; Cohen MS, 2006, SEX TRANSM DIS, V33, P724, DOI 10.1097/01.olq.0000245917.47692.b7; COVER WH, 1982, SEX TRANSM DIS, V9, P1, DOI 10.1097/00007435-198201000-00001; Cowtan K, 1998, ACTA CRYSTALLOGR D, V54, P487, DOI 10.1107/S0907444997011980; Cox DL, 2010, INFECT IMMUN, V78, P5178, DOI 10.1128/IAI.00834-10; COX DL, 1992, INFECT IMMUN, V60, P1076, DOI 10.1128/IAI.60.3.1076-1083.1992; Cullen PA, 2004, FEMS MICROBIOL REV, V28, P291, DOI 10.1016/j.femsre.2003.10.004; Cuneo MJ, 2008, J BIOL CHEM, V283, P32812, DOI 10.1074/jbc.M803595200; de la Torre JG, 2000, BIOPHYS J, V78, P719, DOI 10.1016/S0006-3495(00)76630-6; Deka RK, 2007, J BIOL CHEM, V282, P5944, DOI 10.1074/jbc.M610215200; Deka RK, 2016, MICROBIOLOGYOPEN, V5, P21, DOI 10.1002/mbo3.306; Deka RK, 2015, MBIO, V6, DOI 10.1128/mBio.00519-15; Deka RK, 2013, J BIOL CHEM, V288, P11106, DOI 10.1074/jbc.M113.449975; Deka RK, 2013, MBIO, V4, DOI 10.1128/mBio.00615-12; Deka RK, 2012, J MOL BIOL, V416, P678, DOI 10.1016/j.jmb.2012.01.015; Deka RK, 2006, J BIOL CHEM, V281, P8072, DOI 10.1074/jbc.M511405200; Deka RK, 2004, J BIOL CHEM, V279, P55644, DOI 10.1074/jbc.M409263200; Deka RK, 2004, J BACTERIOL, V186, P2303, DOI 10.1128/JB.186.8.2303-2308.2004; Deka RK, 2002, J BIOL CHEM, V277, P41857, DOI 10.1074/jbc.M207402200; Desrosiers DC, 2007, MOL MICROBIOL, V65, P137, DOI 10.1111/j.1365-2958.2007.05771.x; Desrosiers DC, 2011, MOL MICROBIOL, V80, P1496, DOI 10.1111/j.1365-2958.2011.07662.x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Errington N, 2003, EUR BIOPHYS J BIOPHY, V32, P511, DOI 10.1007/s00249-003-0315-x; Felder CB, 1999, AAPS PHARMSCI, V1; Fraser CM, 1998, SCIENCE, V281, P375, DOI 10.1126/science.281.5375.375; Fukami-Kobayashi K, 1999, J MOL BIOL, V286, P279, DOI 10.1006/jmbi.1998.2454; Ghirlando R, 2013, ANAL BIOCHEM, V440, P81, DOI 10.1016/j.ab.2013.05.011; Golden MR, 2003, JAMA-J AM MED ASSOC, V290, P1510, DOI 10.1001/jama.290.11.1510; Gonin S, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-11; Greene SR, 1998, INFECT IMMUN, V66, P2999, DOI 10.1128/IAI.66.6.2999-3002.1998; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Haake DA, 2000, MICROBIOL-SGM, V146, P1491, DOI 10.1099/00221287-146-7-1491; Hagman KE, 1997, INFECT IMMUN, V65, P1701, DOI 10.1128/IAI.65.5.1701-1709.1997; HAZELBAUER GL, 1971, NATURE-NEW BIOL, V230, P101, DOI 10.1038/newbio230101a0; HODEL A, 1992, ACTA CRYSTALLOGR A, V48, P851, DOI 10.1107/S0108767392006044; Hook E. W., 2009, Morbidity and Mortality Weekly Report, V58, P463; Huerta-Cepas J, 2016, MOL BIOL EV IN PRESS; Keller S, 2012, ANAL CHEM, V84, P5066, DOI 10.1021/ac3007522; Kerani RP, 2007, SEX TRANSM DIS, V34, P154, DOI 10.1097/01.olq.0000233709.93891.e5; KIRSCHNER MW, 1971, BIOCHEMISTRY-US, V10, P1900, DOI 10.1021/bi00786a027; Klock HE, 2008, PROTEINS, V71, P982, DOI 10.1002/prot.21786; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Lee YH, 1999, NAT STRUCT BIOL, V6, P628; Machius M, 2007, J MOL BIOL, V373, P681, DOI 10.1016/j.jmb.2007.08.018; Mattei PL, 2012, AM FAM PHYSICIAN, V86, P433; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Morris RJ, 2003, METHOD ENZYMOL, V374, P229, DOI 10.1016/S0076-6879(03)74011-7; NICHOLS JC, 1975, INFECT IMMUN, V12, P1044, DOI 10.1128/IAI.12.5.1044-1050.1975; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Ning C, 2000, METABOLISM, V49, P1460, DOI 10.1053/meta.2000.9512; Norris SJ, 2001, J MOL MICROB BIOTECH, V3, P37; Otwinowski Z., 1991, ISOMORPHOUS REPLACEM, P80; Pei JM, 2008, NUCLEIC ACIDS RES, V36, P2295, DOI 10.1093/nar/gkn072; RADOLF JD, 1995, INFECT IMMUN, V63, P4244, DOI 10.1128/IAI.63.11.4244-4252.1995; Riley M, 2006, NUCLEIC ACIDS RES, V34, P1, DOI 10.1093/nar/gkj405; Scheuermann TH, 2015, METHODS, V76, P87, DOI 10.1016/j.ymeth.2014.11.024; SCHILLER NL, 1977, INFECT IMMUN, V16, P60, DOI 10.1128/IAI.16.1.60-68.1977; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Schuck P, 1999, BIOPHYS J, V76, P2288, DOI 10.1016/S0006-3495(99)77384-4; Schuck P, 1998, BIOPHYS J, V75, P1503, DOI 10.1016/S0006-3495(98)74069-X; Schuck P, 2002, BIOPHYS J, V82, P1096, DOI 10.1016/S0006-3495(02)75469-6; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Shilton BH, 1996, J MOL BIOL, V264, P350, DOI 10.1006/jmbi.1996.0645; Simms I, 2005, SEX TRANSM DIS, V32, P220, DOI 10.1097/01.olq.0000149848.03733.c1; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Vedadi M, 2006, P NATL ACAD SCI USA, V103, P15835, DOI 10.1073/pnas.0605224103; Velicko I, 2012, CONTROL, P1; VYAS MN, 1989, J BIOL CHEM, V264, P20817; VYAS NK, 1987, NATURE, V327, P635, DOI 10.1038/327635a0; Zhao HY, 2015, METHODS, V76, P137, DOI 10.1016/j.ymeth.2014.11.012	87	10	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0161022	10.1371/journal.pone.0161022	http://dx.doi.org/10.1371/journal.pone.0161022			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27536942	Green Published, gold, Green Submitted			2022-12-27	WOS:000381577000042
J	Coca, SG; Nadkarni, GN; Garg, AX; Koyner, J; Thiessen-Philbrook, H; McArthur, E; Shlipak, MG; Parikh, CR				Coca, Steven G.; Nadkarni, Girish N.; Garg, Amit X.; Koyner, Jay; Thiessen-Philbrook, Heather; McArthur, Eric; Shlipak, Michael G.; Parikh, Chirag R.		TRIBE-AKI Consortium	First Post-Operative Urinary Kidney Injury Biomarkers and Association with the Duration of AKI in the TRIBE-AKI Cohort	PLOS ONE			English	Article							LONG-TERM SURVIVAL; CARDIAC-SURGERY; PREVENTION TRIALS; POOR OUTCOMES; IMPACT	Background We previously demonstrated that assessment of the duration of AKI, in addition to magnitude of rise in creatinine alone, adds prognostic information for long-term survival. We evaluated whether post-operative kidney injury biomarkers in urine collected immediately after cardiac surgery associate with duration of serum creatinine elevation. Methods We studied 1199 adults undergoing cardiac surgery in a prospective cohort study (TRIBE-AKI) and examined the association between the levels of five urinary biomarkers individually at 0-6 hours after surgery: interleukin-18 (IL-18), neutrophil gelatinase-associated lipocalin (NGAL), kidney injury molecule-1 (KIM-1), liver fatty acid binding protein (L-FABP) and albumin with duration of serum creatinine-based AKIN criteria for AKI (0 (no AKI), 1-2, 3-6, >= 7 days). Results Overall, 407 (34%) patients had at least stage 1 AKI, of whom 251 (61.7%) had duration of 1-2 days, 118 (28.9%) had duration 3-6 days, and 38 (9.3%) had duration of >= 7 days. Higher concentrations of all biomarkers (per log increase) were independently associated with a greater odds of a longer duration of AKI; odds ratios and 95% confidence intervals using ordinal logistic regression were the following: IL-18: 1.22, 1.13-1.32; KIM-1: 1.36, 1.21-1.52; albumin 1.20, 1.09-1.32; L-FABP 1.11, 1.04-1.19; NGAL 1.06, 1.00-1.14). AKI duration of 7 days or longer was associated with a 5-fold adjusted risk of mortality at 3 years. Conclusions There was an independent dose-response association between urinary levels of injury biomarkers immediately after cardiac surgery and longer duration of AKI. Duration of AKI was also associated with long term mortality. Future studies should explore the potential utility of these urinary kidney injury biomarkers to enrich enrollment of patients at risk for longer duration of AKI into trials of interventions to prevent or treat post-operative AKI.	[Coca, Steven G.; Nadkarni, Girish N.] Icahn Sch Med Mt Sinai, Dept Med, Div Nephrol, New York, NY 10029 USA; [Garg, Amit X.; Thiessen-Philbrook, Heather; McArthur, Eric] Western Univ, Dept Med, Div Nephrol, London, ON, Canada; [Koyner, Jay] Univ Chicago, Pritzker Sch Med, Dept Med, Nephrol Sect, Chicago, IL 60637 USA; [Shlipak, Michael G.] Univ Calif San Francisco, Div Gen Internal Med, San Francisco VA Med Ctr, San Francisco, CA 94143 USA; [Parikh, Chirag R.] Yale Univ, Sch Med, Dept Internal Med, Program Appl Translat Res, New Haven, CT 06510 USA	Icahn School of Medicine at Mount Sinai; Western University (University of Western Ontario); University of Chicago; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; Yale University	Parikh, CR (corresponding author), Yale Univ, Sch Med, Dept Internal Med, Program Appl Translat Res, New Haven, CT 06510 USA.	chirag.parikh@yale.edu	Garg, Amit X/G-3295-2011; Coca, Steven/L-7801-2019	Coca, Steven/0000-0002-0928-9168; Thiessen Philbrook, Heather/0000-0003-2067-0514; Swaminathan, Madhav/0000-0001-9136-8609; Chu, Michael/0000-0002-9872-399X; Parikh, Chirag/0000-0001-9051-7385	Institute for Clinical Evaluative Sciences (ICES) - Ontario Ministry of Health and Long-Term Care (MOHLTC); National Institutes of Health (NIH) [R01HL085757]; NIH [K23DK080132, T32-DK007757, K24DK090203, P30 DK079310-07, U01DK082185]; Dr. Adam Linton Chair in Kidney Health Analytics;  [K23 DK081616]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085757] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K23DK081616, K23DK080132, T32DK007757, U01DK082185, P30DK079310, K24DK090203] Funding Source: NIH RePORTER	Institute for Clinical Evaluative Sciences (ICES) - Ontario Ministry of Health and Long-Term Care (MOHLTC)(Ministry of Health and Long-Term Care, Ontario); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dr. Adam Linton Chair in Kidney Health Analytics; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by the Institute for Clinical Evaluative Sciences (ICES), which is funded by an annual grant from the Ontario Ministry of Health and Long-Term Care (MOHLTC). The opinions, results and conclusions reported in this paper are those of the authors and are independent from the funding sources. No endorsement by ICES or the MOHLTC is intended or should be inferred. This study was supported by the National Institutes of Health (NIH) (R01HL085757 to CRP) to fund the TRIBE-AKI Consortium to study novel biomarkers of AKI in cardiac surgery. SGC has been supported by an NIH Career Development Award (K23DK080132). GNN is supported in part by the NIH (T32-DK007757). JLK has been supported by K23 DK081616. C.R.P. is supported by the NIH (K24DK090203) and P30 DK079310-07 O'Brien Center Grant. SGC, AXG, and CRP are also members of the NIH-sponsored Assess, Serial Evaluation, and Subsequent Sequelae in Acute Kidney Injury Consortium (U01DK082185). AXG is supported by the Dr. Adam Linton Chair in Kidney Health Analytics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Lead Author of the TRIBE AKI consortium: Chirag R. Parikh. Email: chirag.parikh@yale.edu. Section of Nephrology, Department of Medicine, Yale University School of Medicine, VA CT Healthcare System, and the Program of Applied Translational Research, New Haven, CT, USA. Members of TRIBE-AKI consortium: U of Chicago: Dr. Jai Raman, Dr. Valluvan Jeevanandam, Dr. Shahab Akhter. U of Colorado: Dr. Charles Edelstein. Danbury Hospital: Dr. Cary Passik, Ms. Judy Nagy. Duke University: Dr. Madhav Swaminathan. London, Ontario: Dr. Michael Chu, Dr. Martin Goldbach, Dr. Lin Ruo Guo, Dr. Neil McKenzie, Dr. Mary Lee Myers, Dr. Richard Novick, Dr. Mac Quantz. Montreal Children's: Dr. Michael Zappitelli, Dr. Ana Palijan. Yale-New Haven: Dr. Michael Dewar, Dr. Umer Darr, Dr. Sabet Hashim, Dr. John Elefteriades, Dr. Arnar Geirsson, Dr. Susan Garwood, Dr. Isabel Butrymowicz, Dr. Harlan Krumholz. Additional Contributions: We thank Dr. Stephanie Dixon for her analytic support. This study was supported by the Institute for Clinical Evaluative Sciences (ICES), which is funded by an annual grant from the Ontario Ministry of Health and Long-Term Care (MOHLTC). The opinions, results and conclusions reported in this paper are those of the authors and are independent from the funding sources. No endorsement by ICES or the MOHLTC is intended or should be inferred. This study was supported by the National Institutes of Health (NIH) (R01HL085757 to C.R.P.) to fund the TRIBE-AKI Consortium to study novel biomarkers of AKI in cardiac surgery. S.G.C. has been supported by an NIH Career Development Award (K23DK080132). G.N.N is supported in part by the NIH (T32-DK007757). JLK has been supported by K23 DK081616. C.R.P. is supported by the NIH (K24DK090203) and P30 DK079310-07 O'Brien Center Grant. S.G.C., A.X.G., and C.R.P. are also members of the NIH-sponsored Assess, Serial Evaluation, and Subsequent Sequelae in Acute Kidney Injury Consortium (U01DK082185). AXG is supported by the Dr. Adam Linton Chair in Kidney Health Analytics.	Bagshaw SM, 2007, CRIT CARE, V11, DOI 10.1186/cc5949; Brown JR, 2010, ANN THORAC SURG, V90, P1142, DOI 10.1016/j.athoracsur.2010.04.039; Coca SG, 2010, KIDNEY INT, V78, P926, DOI 10.1038/ki.2010.259; Devarajan P, 2011, CURR OPIN PEDIATR, V23, P194, DOI 10.1097/MOP.0b013e328343f4dd; Endre ZH, 2010, NEPHROL DIAL TRANSPL, V25, P107, DOI 10.1093/ndt/gfp501; Lok CE, 2004, AM HEART J, V148, P430, DOI 10.1016/j.ahj.2003.12.042; Lopes JA, 2008, CRIT CARE, V12, DOI 10.1186/cc6997; Mehta RL, 2007, CRIT CARE, V11, DOI 10.1186/cc5713; Okusa MD, 2012, CLIN J AM SOC NEPHRO, V7, P851, DOI 10.2215/CJN.12811211; Parikh CR, 2013, CLIN J AM SOC NEPHRO, V8, P1079, DOI 10.2215/CJN.10971012; Parikh CR, 2011, J AM SOC NEPHROL, V22, P1748, DOI 10.1681/ASN.2010121302; Parikh CR, 2011, J AM SOC NEPHROL, V22, P1737, DOI 10.1681/ASN.2010111163; Rosner MH, 2006, CLIN J AM SOC NEPHRO, V1, P19, DOI 10.2215/CJN.00240605; Schmitt R, 2008, AM J KIDNEY DIS, V52, P262, DOI 10.1053/j.ajkd.2008.03.005; Schmitt R, 2008, AM J PHYSIOL-RENAL, V294, pF1265, DOI 10.1152/ajprenal.00543.2007	15	31	32	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0161098	10.1371/journal.pone.0161098	http://dx.doi.org/10.1371/journal.pone.0161098			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27537050	gold, Green Submitted, Green Published			2022-12-27	WOS:000381577000053
J	David, N; Skoruppa, S; Gulberti, A; Schultz, J; Engel, AK				David, Nicole; Skoruppa, Stefan; Gulberti, Alessandro; Schultz, Johannes; Engel, Andreas K.			The Sense of Agency Is More Sensitive to Manipulations of Outcome than Movement-Related Feedback Irrespective of Sensory Modality	PLOS ONE			English	Article							RUBBER HAND ILLUSION; VICARIOUS AGENCY; BODY-OWNERSHIP; PROPRIOCEPTION; CONSEQUENCES; RECOGNITION; EMBODIMENT; EXPERIENCE; AWARENESS; TOUCH	The sense of agency describes the ability to experience oneself as the agent of one's own actions. Previous studies of the sense of agency manipulated the predicted sensory feedback related either to movement execution or to the movement's outcome, for example by delaying the movement of a virtual hand or the onset of a tone that resulted from a button press. Such temporal sensorimotor discrepancies reduce the sense of agency. It remains unclear whether movement-related feedback is processed differently than outcome-related feedback in terms of agency experience, especially if these types of feedback differ with respect to sensory modality. We employed a mixed-reality setup, in which participants tracked their finger movements by means of a virtual hand. They performed a single tap, which elicited a sound. The temporal contingency between the participants' finger movements and (i) the movement of the virtual hand or (ii) the expected auditory outcome was systematically varied. In a visual control experiment, the tap elicited a visual outcome. For each feedback type and participant, changes in the sense of agency were quantified using a forced-choice paradigm and the Method of Constant Stimuli. Participants were more sensitive to delays of outcome than to delays of movement execution. This effect was very similar for visual or auditory outcome delays. Our results indicate different contributions of movement-versus outcome-related sensory feedback to the sense of agency, irrespective of the modality of the outcome. We propose that this differential sensitivity reflects the behavioral importance of assessing authorship of the outcome of an action.	[David, Nicole; Skoruppa, Stefan; Gulberti, Alessandro; Engel, Andreas K.] Univ Med Ctr Hamburg Eppendorf, Dept Neurophysiol & Pathophysiol, Hamburg, Germany; [Schultz, Johannes] Univ Bonn, Dept Psychiat, Div Med Psychol, Bonn, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Bonn	David, N (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Neurophysiol & Pathophysiol, Hamburg, Germany.	ndavid@uke.de	Schultz, Johannes/B-8613-2012; Engel, Andreas K/C-7781-2012; Engel, Andreas K./AAH-6384-2019; David, Nicole/H-1682-2012	Schultz, Johannes/0000-0003-4117-232X; Engel, Andreas K/0000-0003-4899-8466; Engel, Andreas K./0000-0003-4899-8466; David, Nicole/0000-0001-5233-1977; Gulberti, Alessandro/0000-0003-0538-5109	European Union [FP7-ICT-270212, ERC-2010-AdG-269716]	European Union(European Commission)	This work was supported by the European Union (project "eSMCs", grant no. FP7-ICT-270212; project "Multisense", grant no. ERC-2010-AdG-269716). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balslev D, 2007, J COGNITIVE NEUROSCI, V19, P1535, DOI 10.1162/jocn.2007.19.9.1535; Banakou D, 2014, P NATL ACAD SCI USA, V111, P17678, DOI 10.1073/pnas.1414936111; Blakemore SJ, 1998, NEUROPSYCHOLOGIA, V36, P521, DOI 10.1016/S0028-3932(97)00145-0; Blakemore SJ, 2002, TRENDS COGN SCI, V6, P237, DOI 10.1016/S1364-6613(02)01907-1; Botvinick M, 1998, NATURE, V391, P756, DOI 10.1038/35784; Corradi-Dell'Acqua C, 2010, NEUROPSYCHOLOGIA, V48, P689, DOI 10.1016/j.neuropsychologia.2009.11.029; David N, 2010, NEUROPSYCHOLOGY OF THE SENSE OF AGENCY: FROM CONSCIOUSNESS TO ACTION, P69, DOI 10.1007/978-88-470-1587-6_4; David N, 2013, COGN AFFECT BEHAV NE; David N, 2008, CONSCIOUS COGN, V17, P523, DOI 10.1016/j.concog.2008.03.004; David N, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00149; Dummer T, 2009, PERCEPTION, V38, P271, DOI 10.1068/p5921; Farrer, 1991, CEREB CORTEX N Y N 1, V18, P254; Farrer C, 2008, BEHAV NEUROL, V19, P53, DOI 10.1155/2008/425267; Farrer C, 2003, CONSCIOUS COGN, V12, P609, DOI 10.1016/S1053-8100(03)00047-3; Fiori F, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00734; Franck N, 2001, AM J PSYCHIAT, V158, P454, DOI 10.1176/appi.ajp.158.3.454; Fuchs X, 2016, SCI REP-UK, V6, DOI 10.1038/srep24362; Gallagher S, 2000, TRENDS COGN SCI, V4, P14, DOI 10.1016/S1364-6613(99)01417-5; Haering C, 2015, COGNITION, V136, P38, DOI 10.1016/j.cognition.2014.11.012; Haggard P, 2003, CONSCIOUS COGN, V12, P695, DOI 10.1016/S1053-8100(03)00052-7; Kalckert A, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00040; Kammers MPM, 2009, NEUROPSYCHOLOGIA, V47, P204, DOI 10.1016/j.neuropsychologia.2008.07.028; Kawabe T, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00610; Kilteni K, 2012, PRESENCE-TELEOP VIRT, V21, P373, DOI 10.1162/PRES_a_00124; Knoblich G, 2004, J EXP PSYCHOL HUMAN, V30, P657, DOI 10.1037/0096-1523.30.4.657; LEFCOURT HM, 1973, AM PSYCHOL, V28, P417, DOI 10.1037/h0034639; Lenggenhager B, 2007, SCIENCE, V317, P1096, DOI 10.1126/science.1143439; Leube DT, 2003, NEUROIMAGE, V20, P2084, DOI 10.1016/j.neuroimage.2003.07.033; Longo MR, 2008, COGNITION, V107, P978, DOI 10.1016/j.cognition.2007.12.004; Longo MR, 2012, CURR DIR PSYCHOL SCI, V21, P140, DOI 10.1177/0963721411434982; Maravita A, 2004, TRENDS COGN SCI, V8, P79, DOI 10.1016/j.tics.2003.12.008; Metcalfe J, 2013, EXP BRAIN RES, V229, P485, DOI 10.1007/s00221-012-3371-6; Michotte A. E, 1963, PERCEPTION CAUSALITY; Newport R, 2010, EXP BRAIN RES, V204, P385, DOI 10.1007/s00221-009-2104-y; Pavani F, 2000, PSYCHOL SCI, V11, P353, DOI 10.1111/1467-9280.00270; Prodoehl J, 2008, J NEUROPHYSIOL, V99, P3042, DOI 10.1152/jn.01108.2007; Roseboom W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018309; Sato A, 2005, COGNITION, V94, P241, DOI 10.1016/j.cognition.2004.04.003; Slater M, 2009, FRONT NEUROSCI-SWITZ, V3, P214, DOI 10.3389/neuro.01.029.2009; Spengler S, 2009, NEUROIMAGE, V46, P290, DOI 10.1016/j.neuroimage.2009.01.047; Synofzik M, 2008, CONSCIOUS COGN, V17, P219, DOI 10.1016/j.concog.2007.03.010; Tieri G, 2015, EXP BRAIN RES, V233, P1247, DOI 10.1007/s00221-015-4202-3; Tieri G, 2015, SCI REP-UK, V5, DOI 10.1038/srep17139; Tsakiris M, 2006, CONSCIOUS COGN, V15, P423, DOI 10.1016/j.concog.2005.09.004; Vinken PM, 2013, MULTISENS RES, V26, P533, DOI 10.1163/22134808-00002435; VONHOLST E, 1950, NATURWISSENSCHAFTEN, V37, P464, DOI 10.1007/BF00622503; Wegner DM, 2004, J PERS SOC PSYCHOL, V86, P838, DOI 10.1037/0022-3514.86.6.838; Zopf R, 2015, EXP BRAIN RES, V233, P2311, DOI 10.1007/s00221-015-4300-2	48	16	16	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0161156	10.1371/journal.pone.0161156	http://dx.doi.org/10.1371/journal.pone.0161156			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DT6ES	27536948	gold, Green Published, Green Submitted			2022-12-27	WOS:000381577000062
J	Kochanek, J; Long, RL; Lisle, AT; Flematti, GR				Kochanek, Jitka; Long, Rowena L.; Lisle, Allan T.; Flematti, Gavin R.			Karrikins Identified in Biochars Indicate Post-Fire Chemical Cues Can Influence Community Diversity and Plant Development	PLOS ONE			English	Article							SEED-GERMINATION; GROWTH REGULATORS; SMOKE; SOIL; PRODUCTIVITY; RESTORATION; BUTENOLIDES; AMENDMENT; COMPOUND; VINEGAR	Background Karrikins are smoke-derived compounds that provide strong chemical cues to stimulate seed germination and seedling growth. The recent discovery in Arabidopsis that the karrikin perception system may be present throughout angiosperms implies a fundamental plant function. Here, we identify the most potent karrikin, karrikinolide (KAR(1)), in biochars and determine its role in species unique plant responses. Methods Biochars were prepared by three distinct commercial-scale pyrolysis technologies using systematically selected sourcematerial and their chemical properties, including karrikinolide, were quantified. Dose-response assays determined the effects of biochar on seed germination for two model species that require karrikinolide to break dormancy (Solanum orbiculatum, Brassica tourneforttii) and on seedling growth using two species that display plasticity to karrikins, biochar and phytotoxins (Lactuca sativa, Lycopersicon esculentum). Multivariate analysis examined relationships between biochar properties and the plant phenotype. Findings and Conclusions Results showed that karrikin abundant biochars stimulated dormant seed germination and seedling growth via mechanisms analogous to post-fire chemical cues. The individual species response was associated with its sensitivity to karrikinolide and inhibitory compounds within the biochars. These findings are critical for understanding why biochar influences community composition and plant physiology uniquely for different species and reaffirms that future pyrolysis technologies promise by-products that concomitantly sequester carbon and enhance plant growth for ecological and broader plant related applications.	[Kochanek, Jitka] Univ Queensland, Sch Agr & Food Sci, Brisbane, Qld, Australia; [Long, Rowena L.; Flematti, Gavin R.] Univ Western Australia, Sch Chem & Biochem, Crawley, WA, Australia; [Lisle, Allan T.] Univ Queensland, Sch Agr & Food Sci, Gatton, Qld, Australia	University of Queensland; University of Western Australia; University of Queensland	Kochanek, J (corresponding author), Univ Queensland, Sch Agr & Food Sci, Brisbane, Qld, Australia.	j.kochanek@uq.edu.au	Kochanek, Jitka/AAQ-8598-2020; Flematti, Gavin R/J-2018-2012	Kochanek, Jitka/0000-0002-6727-751X; Flematti, Gavin/0000-0003-2545-6939; Long, Rowena/0000-0003-4539-1319	Horticulture Innovation Australia Ltd; Australian Government [HG10025, MT13042]; University of Queensland ECR Grant; Australian Research Council [FT110100304]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R43HG010025] Funding Source: NIH RePORTER	Horticulture Innovation Australia Ltd(Horticulture Australia Limited); Australian Government(Australian GovernmentCGIAR); University of Queensland ECR Grant; Australian Research Council(Australian Research Council); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This research and a Fellowship for JK was financially supported by Horticulture Innovation Australia Ltd using voluntary contributions from Brisbane City Council and matched funds from the Australian Government (HG10025, MT13042, http://horticulture.com.au/) and a University of Queensland ECR Grant (https://www.uq.edu.au/). An ARC Future Fellowship for GRF was financially supported by the Australian Research Council (FT110100304, http://www.arc.gov.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research and a Fellowship for J.K. was financially supported by Horticulture Innovation Australia Ltd using voluntary contributions from Brisbane City Council and matched funds from the Australian Government (HG10025, MT13042) and a University of Queensland ECR Grant. An ARC Future Fellowship for G.R.F. was financially supported by the Australian Research Council (FT110100304). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. We gratefully acknowledge three Australian biochar manufacturers for study participation, Adrian Scaffidi for preparation of the <SUP>13</SUP>C<INF>5</INF>-labeled karrikinolide, Mark Kochanek for assistance with data interpretation and Christopher George for technical assistance. We also thank three anonymous colleagues for comments on this manuscript.	Bargmann I, 2013, J AGRON CROP SCI, V199, P360, DOI 10.1111/jac.12024; Beesley L, 2011, ENVIRON POLLUT, V159, P3269, DOI 10.1016/j.envpol.2011.07.023; Biederman LA, 2013, GCB BIOENERGY, V5, P202, DOI 10.1111/gcbb.12037; Buss W, 2014, J ENVIRON MANAGE, V137, P111, DOI 10.1016/j.jenvman.2014.01.045; Cernansky R, 2015, NATURE, V517, P258, DOI 10.1038/517258a; Chiwocha SDS, 2009, PLANT SCI, V177, P252, DOI 10.1016/j.plantsci.2009.06.007; Commander LE, 2008, AUST J BOT, V56, P333, DOI 10.1071/BT07209; Crane-Droesch A, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/4/044049; Di Salvatore M, 2008, CHEMOSPHERE, V73, P1461, DOI 10.1016/j.chemosphere.2008.07.061; DIXON KW, 1995, OECOLOGIA, V101, P185, DOI 10.1007/BF00317282; Flematti GR, 2007, J AGR FOOD CHEM, V55, P2189, DOI 10.1021/jf0633241; Flematti GR, 2013, MOL PLANT, V6, P29, DOI 10.1093/mp/sss132; Flematti GR, 2011, J AGR FOOD CHEM, V59, P1195, DOI 10.1021/jf1041728; Flematti GR, 2009, J AGR FOOD CHEM, V57, P9475, DOI 10.1021/jf9028128; Flematti GR, 2004, SCIENCE, V305, P977, DOI 10.1126/science.1099944; GILLMAN GP, 1986, AUST J SOIL RES, V24, P61, DOI 10.1071/SR9860061; Graber ER, 2010, PLANT SOIL, V337, P481, DOI 10.1007/s11104-010-0544-6; Gurwick NP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075932; International Biochar Initiative, 2014, IBISTD20; Jain N, 2007, SEED SCI RES, V17, P175, DOI 10.1017/S0960258507785896; Jain N, 2006, PLANT GROWTH REGUL, V49, P263, DOI 10.1007/s10725-006-9136-0; Jeffery S, 2015, GCB BIOENERGY, V7, P1, DOI 10.1111/gcbb.12132; Kochanek J, 2016, ACTA HORTIC, V1112, P327, DOI 10.17660/ActaHortic.2016.1112.44; Kochanek J, 2012, 2012 AUSTR FRONTIERS; Kochanek J, 2011, NEW PHYTOL, V191, P223, DOI 10.1111/j.1469-8137.2011.03681.x; Lehmann J, 2007, NATURE, V447, P143, DOI 10.1038/447143a; Li WQ, 2015, TRENDS PLANT SCI, V20, P535, DOI 10.1016/j.tplants.2015.07.006; Liao SH, 2014, ENVIRON SCI TECHNOL, V48, P8581, DOI 10.1021/es404250a; Light ME, 2010, J NAT PROD, V73, P267, DOI 10.1021/np900630w; Long RL, 2011, ANN BOT-LONDON, V108, P933, DOI 10.1093/aob/mcr198; Matlwa Kopano, 2010, SPILT MILK; Mu J, 2004, J WOOD SCI, V50, P470, DOI 10.1007/s10086-003-0586-y; Mukherjee A, 2014, SOIL RES, V52, P217, DOI 10.1071/SR13359; Mungkunkamchao T, 2013, SCI HORTIC-AMSTERDAM, V154, P66, DOI 10.1016/j.scienta.2013.02.020; National Environment Protection Council Schedule B (I), 1999, GUID INV LEV SOIL GR; Oh TK, 2012, J FAC AGR KYUSHU U, V57, P55; Prithiviraj B, 2007, NEW PHYTOL, V173, P852, DOI 10.1111/j.1469-8137.2006.01964.x; Quilliam RS, 2012, AGR ECOSYST ENVIRON, V158, P192, DOI 10.1016/j.agee.2012.06.011; Rayment G.E., 2011, SOIL CHEM METHODS AU; Roorda van Eysinga JPNL, 1981, NUTR DISORDERS GLASS; Scaffidi A, 2013, PLANT J, V76, P1, DOI 10.1111/tpj.12265; Scaffidi A, 2011, TETRAHEDRON, V67, P152, DOI 10.1016/j.tet.2010.11.006; Singh N, 2012, BIOGEOSCIENCES, V9, P2847, DOI 10.5194/bg-9-2847-2012; Solaiman ZM, 2012, PLANT SOIL, V353, P273, DOI 10.1007/s11104-011-1031-4; Soos V, 2012, NEW PHYTOL, V196, P1060, DOI 10.1111/j.1469-8137.2012.04358.x; Spokas KA, 2012, J ENVIRON QUAL, V41, P973, DOI 10.2134/jeq2011.0069; Spokas KA, 2010, PLANT SOIL, V333, P443, DOI 10.1007/s11104-010-0359-5; Standards Australia, 2003, 44542003 AS; van de Voorde TFJ, 2014, ECOL APPL, V24, P1167, DOI 10.1890/13-0578.1; Vanstraelen M, 2012, ANNU REV CELL DEV BI, V28, P463, DOI 10.1146/annurev-cellbio-101011-155741; Viger M, 2015, GCB BIOENERGY, V7, P658, DOI 10.1111/gcbb.12182; Warnock DD, 2007, PLANT SOIL, V300, P9, DOI 10.1007/s11104-007-9391-5; Waters MT, 2014, PLANT J, V79, P623, DOI 10.1111/tpj.12430; Waters MT, 2013, CURR OPIN PLANT BIOL, V16, P667, DOI 10.1016/j.pbi.2013.07.005	55	36	39	4	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0161234	10.1371/journal.pone.0161234	http://dx.doi.org/10.1371/journal.pone.0161234			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27536995	Green Submitted, gold, Green Published			2022-12-27	WOS:000381577000073
J	Kurkewich, JL; Klopfenstein, N; Hallas, WM; Wood, C; Sattler, RA; Das, C; Tucker, H; Dahl, R; Dahl, KDC				Kurkewich, Jeffrey L.; Klopfenstein, Nathan; Hallas, William M.; Wood, Christian; Sattler, Rachel A.; Das, Chhaya; Tucker, Haley; Dahl, Richard; Dahl, Karen D. Cowden			Arid3b Is Critical for B Lymphocyte Development	PLOS ONE			English	Article							MOUSE BONE-MARROW; IN-VITRO; CELL; TRANSCRIPTION; EXPRESSION; BRIGHT; RESPONSES; DEFECTS; FAMILY; CANCER	Arid3a and Arid3b belong to a subfamily of ARID (AT-rich interaction domain) transcription factors. The Arid family is involved in regulating chromatin accessibility, proliferation, and differentiation. Arid3a and Arid3b are closely related and share a unique REKLES domain that mediates their homo- and hetero-multimerization. Arid3a was originally isolated as a B cell transcription factor binding to the AT rich matrix attachment regions (MARS) of the immunoglobulin heavy chain intronic enhancer. Deletion of Arid3a results in a highly penetrant embryonic lethality with severe defects in erythropoiesis and hematopoietic stem cells (HSCs). The few surviving Arid3a(-/-) (<1%) animals have decreased HSCs and early progenitors in the bone marrow, but all mature lineages are normally represented in the bone marrow and periphery except for B cells. Arid3b(-/-) animals die around E7.5 precluding examination of hematopoietic development. So it is unclear whether the phenotype of Arid3a loss on hematopoiesis is dependent or independent of Arid3b. In this study we circumvented this limitation by also examining hematopoiesis in mice with a conditional allele of Arid3b. Bone marrow lacking Arid3b shows decreased common lymphoid progenitors (CLPs) and downstream B cell populations while the T cell and myeloid lineages are unchanged, reminiscent of the adult hematopoietic defect in Arid3a mice. Unlike Arid3a(-/-) mice, HSC populations are unperturbed in Arid3b(-/-) mice. This study demonstrates that HSC development is independent of Arid3b, whereas B cell development requires both Arid3a and Arid3b transcription factors.	[Kurkewich, Jeffrey L.; Wood, Christian; Dahl, Richard] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA; [Kurkewich, Jeffrey L.; Klopfenstein, Nathan; Hallas, William M.; Wood, Christian; Sattler, Rachel A.; Dahl, Richard; Dahl, Karen D. Cowden] Harper Canc Res Inst, South Bend, IN 46617 USA; [Das, Chhaya] Univ Texas Austin, Dept Mol Biosci, Inst Cellular & Mol Biol, Austin, TX 78712 USA; [Klopfenstein, Nathan; Dahl, Richard] Indiana Univ Sch Med, Dept Microbiol & Immunol, South Bend, IN 46617 USA; [Hallas, William M.; Dahl, Karen D. Cowden] Indiana Univ Sch Med, Dept Biochem & Mol Biol, South Bend, IN 46617 USA; [Sattler, Rachel A.; Dahl, Karen D. Cowden] Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA	University of Notre Dame; University of Texas System; University of Texas Austin; Indiana University System; Indiana University South Bend; Indiana University System; Indiana University South Bend; University of Notre Dame	Dahl, R; Dahl, KDC (corresponding author), Harper Canc Res Inst, South Bend, IN 46617 USA.; Dahl, R (corresponding author), Indiana Univ Sch Med, Dept Microbiol & Immunol, South Bend, IN 46617 USA.; Dahl, KDC (corresponding author), Indiana Univ Sch Med, Dept Biochem & Mol Biol, South Bend, IN 46617 USA.; Dahl, KDC (corresponding author), Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA.	richdahl@iupui.edu; kcowdend@iupui.edu		Dahl, Richard/0000-0002-6341-5604	Indiana Clinical Translational Sciences Institute; National Institute of Health (NIH.gov); Cancer Prevention Research Institute of Texas	Indiana Clinical Translational Sciences Institute; National Institute of Health (NIH.gov); Cancer Prevention Research Institute of Texas	This work was supported by the Indiana Clinical Translational Sciences Institute (https://www. indianactsi.org/funding/all-ctsi-funding). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work was also supported by the National Institute of Health (NIH.gov) and Cancer Prevention Research Institute of Texas (http://www.cprit.state.tx.us/).	Bobbs A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131961; Casanova JC, 2011, DEVELOPMENT, V138, P1195, DOI 10.1242/dev.057570; Cho SK, 1999, P NATL ACAD SCI USA, V96, P9797, DOI 10.1073/pnas.96.17.9797; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Feng Biao, 2004, Med Immunol, V3, P1, DOI 10.1186/1476-9433-3-1; GRONOWICZ ES, 1980, J IMMUNOL, V125, P976; HARDY RR, 1991, J EXP MED, V173, P1213, DOI 10.1084/jem.173.5.1213; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; Herrscher RF, 1995, GENE DEV, V9, P3067, DOI 10.1101/gad.9.24.3067; Inlay MA, 2009, GENE DEV, V23, P2376, DOI 10.1101/gad.1836009; Jackson JT, 2015, BLOOD, V125, P803, DOI 10.1182/blood-2014-06-579813; Joseph S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042159; Kim D, 2006, MOL CELL BIOL, V26, P2187, DOI 10.1128/MCB.26.6.2187-2201.2006; Kim D, 2007, J BIOL CHEM, V282, P15768, DOI 10.1074/jbc.M700397200; Kim U, 2000, J IMMUNOL, V165, P6825, DOI 10.4049/jimmunol.165.12.6825; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; Lin C, 2014, ONCOTARGETS THER, V7, P315, DOI 10.2147/OTT.S57023; Lin DJ, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-23; Oldham AL, 2011, MOL IMMUNOL, V49, P367, DOI 10.1016/j.molimm.2011.09.008; Ratliff ML, 2015, J IMMUNOL, V194, P940, DOI 10.4049/jimmunol.1401941; Roy L, 2014, ONCOTARGET, V5, P8355, DOI 10.18632/oncotarget.2247; SHA WC, 1995, CELL, V80, P321, DOI 10.1016/0092-8674(95)90415-8; Srivastava B, 2005, J EXP MED, V202, P1225, DOI 10.1084/jem.20051038; Takebe A, 2006, DEV BIOL, V293, P25, DOI 10.1016/j.ydbio.2005.12.016; Uribe V, 2014, DEVELOPMENT, V141, P4168, DOI 10.1242/dev.109918; Webb CF, 2011, MOL CELL BIOL, V31, P1041, DOI 10.1128/MCB.01448-10; Webb CF, 1998, J IMMUNOL, V160, P4747; Wheat JC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105557; Witt CM, 2003, J IMMUNOL, V171, P2783, DOI 10.4049/jimmunol.171.6.2783; Zong RT, 2000, EMBO J, V19, P4123, DOI 10.1093/emboj/19.15.4123	30	7	8	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0161468	10.1371/journal.pone.0161468	http://dx.doi.org/10.1371/journal.pone.0161468			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27537840	Green Published, gold			2022-12-27	WOS:000381577000109
J	Langley, MC; O'Connor, S				Langley, Michelle C.; O'Connor, Sue			An Enduring Shell Artefact Tradition from Timor-Leste: Oliva Bead Production from the Pleistocene to Late Holocene at Jerimalai, Lene Hara, and Matja Kuru 1 and 2	PLOS ONE			English	Article							MODERN HUMAN COLONIZATION; EAST TIMOR; ADDITIONAL EVIDENCE; BLOMBOS CAVE; OCCUPATION; ORNAMENTS; BEHAVIOR; AURIGNACIAN; CALIBRATION; TECHNOLOGY	In this paper, we describe 485 Oliva spp. shell beads recovered from four archaeological cave sites Jerimalai, Lene Hara, Matja Kuru 1, and Matja Kuru 2, located in Timor-Leste, Island Southeast Asia. While Pleistocene-aged examples of modified marine shells used for personal ornamentation are common in African and Eurasian assemblages, they are exceedingly rare in Southeast Asia, leading some researchers to suggest that these Modern Human societies were less complex than those found further west. In Timor-Leste, the lowest Oliva bead to be recovered was directly dated to ca. 37,000 cal. BP, making it the oldest piece of personal ornamentation in Southeast Asia. Morphometric, taphonomic, use wear, and residue analyses of these beads alongside modern reference specimens, and experimentally made examples indicate that the Oliva shells were modified to be strung consecutively (as in a necklace), and while their mode of production changed remarkably little over the thousands of years they were utilised, an increase in their deposition around 6,000 cal. BP suggests that there was a change in their use coinciding with sea-level stabilisation. These tiny beads demonstrate that early Island Southeast Asian societies produced the same kinds of symbolic material culture we have come to expect from the more intensively studied African/Eurasian region, and that limited sampling and poor recovery methods have biased our perspectives of this region.	[Langley, Michelle C.; O'Connor, Sue] Australian Natl Univ, Coll Asia & Pacific, Sch Culture Hist & Language, Archaeol & Nat Hist, Canberra, ACT, Australia	Australian National University	Langley, MC (corresponding author), Australian Natl Univ, Coll Asia & Pacific, Sch Culture Hist & Language, Archaeol & Nat Hist, Canberra, ACT, Australia.	michelle.langley@anu.edu.au		O'Connor, Sue/0000-0001-9381-078X; Langley, Michelle/0000-0002-0299-5561	Australian Research Council [DP0556210, FL120100156]	Australian Research Council(Australian Research Council)	This work was supported by the Australian Research Council Discovery Grant to O'Connor (DP0556210); Australian Research Council Laureate Grant to O'Connor (FL120100156).; The fieldwork at Jerimalai was supported by an Australian Research Council Discovery Grant to O'Connor (DP0556210), while the analysis costs were funded by an Australian Research Council Laureate Grant (FL120100156). In Timor-Leste we extend our thanks and appreciation to staff of the Ministry of Education and the Ministry of Agriculture and Fisheries. Permissions for the archaeological excavation was obtained from the Ministry of Education and Culture, Timor Leste. We would particularly like to thank Mrs Cecilia Assis for facilitating this process. We would also like to acknowledge the support of the people of Tutuala who assisted with the excavation and without whom this research would not have been possible. Samantha Aird of James Cook University is thanked for her assistance in collecting the modern Oliva shells from Kewarra Beach, Queensland, and Colin Pardoe for the ochre used in the second experiment. We would also like to thank our two reviewers for constructive feedback on our manuscript.	[Anonymous], 2005, ASIAN PERSPECT, V44, P180, DOI DOI 10.1353/ASI.2005.0015; Balme J, 2006, ANTIQUITY, V80, P799, DOI 10.1017/S0003598X00094436; Bouzouggar A, 2007, P NATL ACAD SCI USA, V104, P9964, DOI 10.1073/pnas.0703877104; Caron F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021545; Cox NL, 2009, THESIS; Cristiani E, 2014, J ANTHROPOL ARCHAEOL, V36, P21, DOI 10.1016/j.jaa.2014.06.009; d'Errico F, 2005, J HUM EVOL, V48, P3, DOI 10.1016/j.jhevol.2004.09.002; d'Errico F, 2009, P NATL ACAD SCI USA, V106, P16051, DOI 10.1073/pnas.0903532106; Fallon SJ, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2008JC004722; Glover I. C., 1986, TERRA AUSTRALIS, V11; Gonzalez A, 2013, AUST ARCHAEOL, P13; Guilderson TP, 2009, J GEOPHYS RES-OCEANS, V114, DOI 10.1029/2008JC004876; HINTON A.G, 1972, SHELLS NEW GUINEA CE; Hogg AG, 2013, RADIOCARBON, V55, P1889, DOI 10.2458/azu_js_rc.55.16783; Kuhn S.L., 2007, RETHINKING HUMAN REV, P45; Kuhn SL, 2001, P NATL ACAD SCI USA, V98, P7641, DOI 10.1073/pnas.121590798; Lambeck K, 2001, SCIENCE, V292, P679, DOI 10.1126/science.1059549; Langley MC, 2016, J HUM EVOL, V97, P1, DOI 10.1016/j.jhevol.2016.04.005; Langley MC, 2015, J ARCHAEOL SCI, V62, P175, DOI 10.1016/j.jas.2015.06.012; Leavesley MG, 2007, ANTIQUITY, V81, P308, DOI 10.1017/S0003598X00095193; Mayer DEBY, 2009, J HUM EVOL, V56, P307, DOI 10.1016/j.jhevol.2008.10.005; Mellars P, 2006, SCIENCE, V313, P796, DOI 10.1126/science.1128402; MORSE K, 1993, ANTIQUITY, V67, P877, DOI 10.1017/S0003598X00063894; Norton CJ, 2009, EVOL ANTHROPOL, V18, P247, DOI 10.1002/evan.20235; O'Connor S, 2005, ANTIQUITY, V79, P249, DOI 10.1017/S0003598X0011405X; O'Connor S, 2002, ANTIQUITY, V76, P45, DOI 10.1017/S0003598X0008978X; O'Connor S, 2010, 50 YEARS ARCHAEOLOGY, P219; O'Connor S, 2007, ARCHAEOL OCEAN, V42, P82, DOI 10.1002/j.1834-4453.2007.tb00021.x; O'Connor S, 2007, ANTIQUITY, V81, P523, DOI 10.1017/S0003598X00095569; O'Connor S, 2011, SCIENCE, V334, P1117, DOI 10.1126/science.1207703; O'Connor S, 2010, AUST ARCHAEOL, P29; O'Connor S, 2010, RADIOCARBON, V52, P1158, DOI 10.1017/S0033822200046233; Ramsey CB, 2009, RADIOCARBON, V51, P337, DOI 10.1017/S0033822200033865; Reimer PJ, 2013, RADIOCARBON, V55, P1869, DOI 10.2458/azu_js_rc.55.16947; SHORT JW, 1987, SHELLS QUEENSLAND GR; Smith WHF, 1997, SCIENCE, V277, P1956, DOI 10.1126/science.277.5334.1956; Southon J, 2002, RADIOCARBON, V44, P167, DOI 10.1017/S0033822200064778; Southon J, 2013, RADIOCARBON, V55, P1164, DOI 10.1017/S0033822200048074; Stiner MC, 2013, J HUM EVOL, V64, P380, DOI 10.1016/j.jhevol.2013.01.008; Stiner MC, 1999, ANTIQUITY, V73, P735, DOI 10.1017/S0003598X00065492; Szabo K., 2013, RAIN FOREST FORAGING, V1, P299; Taborin Y, 1993, GALLIA PREHISTO S29; van Heekeren H.R., 1972, STONE AGE INDONESIA, DOI DOI 10.26530/OAPEN_613384; Vanhaeren M, 2006, SCIENCE, V312, P1785, DOI 10.1126/science.1128139; Vanhaeren M, 2006, J ARCHAEOL SCI, V33, P1105, DOI 10.1016/j.jas.2005.11.017; Vanhaeren M, 2013, J HUM EVOL, V64, P500, DOI 10.1016/j.jhevol.2013.02.001; Viet N., 2015, EMERGENCE DIVERSITY, P133; Wei Y, 2016, PLOS ONE; White R., 2007, RETHINKING HUMAN REV, P287	49	29	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0161071	10.1371/journal.pone.0161071	http://dx.doi.org/10.1371/journal.pone.0161071			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	DT6ES	27537696	Green Published, Green Submitted, gold			2022-12-27	WOS:000381577000049
J	Luo, FQ; Hu, Y; Zhao, WL; Zuo, ZY; Yu, Q; Liu, ZY; Lin, JM; Feng, YL; Li, BD; Wu, LQ; Xu, L				Luo, Foquan; Hu, Yan; Zhao, Weilu; Zuo, Zhiyi; Yu, Qi; Liu, Zhiyi; Lin, Jiamei; Feng, Yunlin; Li, Binda; Wu, Liuqin; Xu, Lin			Maternal Exposure of Rats to Isoflurane during Late Pregnancy Impairs Spatial Learning and Memory in the Offspring by Up-Regulating the Expression of Histone Deacetylase 2	PLOS ONE			English	Article							INDUCED CASPASE-3 ACTIVATION; LONG-TERM-MEMORY; SYNAPTIC PLASTICITY; LAPAROSCOPIC CHOLECYSTECTOMY; ANESTHETIC ISOFLURANE; POSTNATAL MEMORY; FEAR EXTINCTION; 3RD TRIMESTER; NITROUS-OXIDE; NEURONS	Increasing evidence indicates that most general anesthetics can harm developing neurons and induce cognitive dysfunction in a dose-and time-dependent manner. Histone deacetylase 2 (HDAC2) has been implicated in synaptic plasticity and learning and memory. Our previous results showed that maternal exposure to general anesthetics during late pregnancy impaired the offspring's learning and memory, but the role of HDAC2 in it is not known yet. In the present study, pregnant rats were exposed to 1.5% isoflurane in 100% oxygen for 2, 4 or 8 hours or to 100% oxygen only for 8 hours on gestation day 18 (E18). The offspring born to each rat were randomly subdivided into 2 subgroups. Thirty days after birth, the Morris water maze (MWM) was used to assess learning and memory in the offspring. Two hours before each MWM trial, an HDAC inhibitor (SAHA) was given to the offspring in one subgroup, whereas a control solvent was given to those in the other subgroup. The results showed that maternal exposure to isoflurane impaired learning and memory of the offspring, impaired the structure of the hippocampus, increased HDAC2 mRNA and downregulated cyclic adenosine monophosphate (cAMP) response element binding protein (CREB) mRNA, N-methyl-D-aspartate receptor 2 subunit B (NR2B) mRNA and NR2B protein in the hippocampus. These changes were proportional to the duration of the maternal exposure to isoflurane and were reversed by SAHA. These results suggest that exposure to isoflurane during late pregnancy can damage the learning and memory of the offspring rats via the HDAC2-CREB -NR2B pathway. This effect can be reversed by HDAC2 inhibition.	[Luo, Foquan; Hu, Yan; Zhao, Weilu; Yu, Qi; Liu, Zhiyi; Lin, Jiamei; Feng, Yunlin; Xu, Lin] Nanchang Univ, Affiliated Hosp 1, Dept Anesthesiol, Nanchang 33006, Peoples R China; [Hu, Yan] Jiangxi Prov Tradit Chinese Med Hosp, Dept Anesthesiol, Nanchang 33006, Peoples R China; [Zuo, Zhiyi] Univ Virginia, Dept Anesthesiol, Charlottesville, VA 22908 USA; [Li, Binda; Wu, Liuqin] Jiangxi Prov Tumor Hosp, Dept Anesthesiol, Nanchang 330006, Peoples R China	Nanchang University; Jiangxi University of Traditional Chinese Medicine; Affiliated Hospital of Jiangxi University of Traditional Chinese Medicine; University of Virginia	Luo, FQ (corresponding author), Nanchang Univ, Affiliated Hosp 1, Dept Anesthesiol, Nanchang 33006, Peoples R China.	lfqjxmc@outlook.com	Zuo, Zhiyi/F-3950-2010	Zuo, Zhiyi/0000-0002-3542-5047; Luo, Foquan/0000-0003-0106-0710	national natural science foundation of China [81460175, 81060093]; natural science foundation of Jiangxi province of China [20122BAB205012, 20132BAB205022]	national natural science foundation of China(National Natural Science Foundation of China (NSFC)); natural science foundation of Jiangxi province of China(Natural Science Foundation of Jiangxi Province)	FL received the funding from the national natural science foundation of China (NO. 81460175, NO. 81060093), http://www.nsfc.gov.cn/; from the natural science foundation of Jiangxi province of China (NO. 20122BAB205012, NO. 20132BAB205022), http://www.jxstc.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Affleck DG, 1999, AM J SURG, V178, P523, DOI 10.1016/S0002-9610(99)00244-5; Almeida S, 2010, NEUROTOX RES, V17, P399, DOI 10.1007/s12640-009-9116-z; Baldwin EA, 2015, AM J OBSTET GYNECOL, V212, DOI 10.1016/j.ajog.2014.09.001; Bambah-Mukku D, 2014, J NEUROSCI, V34, P12547, DOI 10.1523/JNEUROSCI.0324-14.2014; Barraco RD, 2010, J TRAUMA, V69, P211, DOI 10.1097/TA.0b013e3181dbe1ea; Bliss TVP, 1999, NATURE, V401, P25, DOI 10.1038/43333; Bowers ME, 2015, LEARN MEMORY, V22, P225, DOI 10.1101/lm.036699.114; BRODSKY JB, 1980, AM J OBSTET GYNECOL, V138, P1165, DOI 10.1016/S0002-9378(16)32785-5; Buser KB, 2009, JSLS-J SOC LAPAROEND, V13, P32; Choi JJ, 2011, J AM COLL SURGEONS, V213, P627, DOI 10.1016/j.jamcollsurg.2011.07.016; De Velde MV, 2007, MINERVA ANESTESIOL, V73, P235; Fass DM, 2013, NEUROPHARMACOLOGY, V64, P81, DOI 10.1016/j.neuropharm.2012.06.043; Fischer A, 2007, NATURE, V447, P178, DOI 10.1038/nature05772; Fujita Y, 2012, J PSYCHIATR RES, V46, P635, DOI 10.1016/j.jpsychires.2012.01.026; Gandal MJ, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.69; Guan JS, 2009, NATURE, V459, P55, DOI 10.1038/nature07925; Guan ZH, 2002, CELL, V111, P483, DOI 10.1016/S0092-8674(02)01074-7; Haettig J, 2011, LEARN MEMORY, V18, P71, DOI 10.1101/lm.1986911; Hofacer RD, 2013, ANN NEUROL, V73, P695, DOI 10.1002/ana.23892; Holthausen UH, 1999, WORLD J SURG, V23, P856, DOI 10.1007/s002689900589; Jevtovic-Todorovic V, 2003, NEUROSCIENCE, V122, P609, DOI 10.1016/j.neuroscience.2003.07.012; Kong FJ, 2011, EUR J PHARMACOL, V670, P168, DOI 10.1016/j.ejphar.2011.08.050; KORT B, 1993, SURG GYNECOL OBSTET, V177, P371; Korzus E, 2004, NEURON, V42, P961, DOI 10.1016/j.neuron.2004.06.002; Levenson JM, 2004, J BIOL CHEM, V279, P40545, DOI 10.1074/jbc.M402229200; [李兵达 Li Bingda], 2012, [中华麻醉学杂志, Chinese Journal of Anesthesiology], V32, P1334; Li YJ, 2007, NEUROPHARMACOLOGY, V53, P942, DOI 10.1016/j.neuropharm.2007.09.005; Machado NO, 2009, SURG LAPARO ENDO PER, V19, P439, DOI 10.1097/SLE.0b013e3181c30fed; Maddox SA, 2011, LEARN MEMORY, V18, P579, DOI 10.1101/lm.2243411; Mahgoub M, 2014, LEARN MEMORY, V21, P564, DOI 10.1101/lm.036012.114; MAZZE RI, 1986, ANESTHESIOLOGY, V64, P339, DOI 10.1097/00000542-198603000-00007; MAZZE RI, 1985, ANESTHESIOLOGY, V62, P339, DOI 10.1097/00000542-198503000-00021; MAZZE RI, 1989, AM J OBSTET GYNECOL, V161, P1178, DOI 10.1016/0002-9378(89)90659-5; Meshikhes AWN, 2008, SAUDI MED J, V29, P291; Morris MJ, 2013, J NEUROSCI, V33, P6401, DOI 10.1523/JNEUROSCI.1001-12.2013; Palanisamy A, 2011, ANESTHESIOLOGY, V114, P521, DOI 10.1097/ALN.0b013e318209aa71; Pan CX, 2011, ANESTH ANALG, V113, P145, DOI 10.1213/ANE.0b013e3182185fee; Penney J, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.aaa0069; Plattner F, 2014, NEURON, V81, P1070, DOI 10.1016/j.neuron.2014.01.022; Qaiser R, 2007, SEMIN NEUROL, V27, P476, DOI 10.1055/s-2007-991129; RODIER PM, 1980, DEV MED CHILD NEUROL, V22, P525; Rohan D, 2005, CAN J ANAESTH, V52, P137, DOI 10.1007/BF03027718; Sohal VS, 2009, NATURE, V459, P698, DOI 10.1038/nature07991; Sun YX, 2014, ANESTH ANALG, V119, P1373, DOI 10.1213/ANE.0000000000000383; Tang YP, 1999, NATURE, V401, P63, DOI 10.1038/43432; Upadhyay A, 2007, SURG ENDOSC, V21, P1344, DOI 10.1007/s00464-006-9104-9; Vecsey CG, 2007, J NEUROSCI, V27, P6128, DOI 10.1523/JNEUROSCI.0296-07.2007; Wagner FF, 2015, CHEM SCI, V6, P804, DOI 10.1039/c4sc02130d; Wang C, 2004, NEUROSCIENCE, V125, P473, DOI 10.1016/j.neuroscience.2004.02.003; Wang SP, 2009, PEDIATR RES, V66, P435, DOI 10.1203/PDR.0b013e3181b3381b; Wei HF, 2005, BRAIN RES, V1037, P139, DOI 10.1016/j.brainres.2005.01.009; Wei HF, 2008, ANESTHESIOLOGY, V108, P251, DOI 10.1097/01.anes.0000299435.59242.0e; Wei HF, 2011, ANESTH ANALG, V113, P972, DOI 10.1213/ANE.0b013e3182323261; [张勤 Zhang Qin], 2014, [中华麻醉学杂志, Chinese Journal of Anesthesiology], V34, P1051; Zhao TY, 2014, NEUROBIOL DIS, V68, P145, DOI 10.1016/j.nbd.2014.02.009; Zhao XL, 2013, ANESTHESIOLOGY, V118, P537, DOI 10.1097/ALN.0b013e3182833fae; Zhong T, 2014, BRIT J ANAESTH, V113, P634, DOI 10.1093/bja/aeu184; Zhong T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125815	58	16	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0160826	10.1371/journal.pone.0160826	http://dx.doi.org/10.1371/journal.pone.0160826			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27536989	gold, Green Submitted, Green Published			2022-12-27	WOS:000381577000033
J	Vattimo, MDF; Watanabe, M; da Fonseca, CD; Neiva, LBDM; Pessoa, EA; Borges, FT				Fernandes Vattimo, Maria de Fatima; Watanabe, Mirian; da Fonseca, Cassiane Dezoti; de Moura Neiva, Luciana Barros; Pessoa, Edson Andrade; Borges, Fernanda Teixeira			Polymyxin B Nephrotoxicity: From Organ to Cell Damage	PLOS ONE			English	Article							ACUTE KIDNEY INJURY; CYTOCHROME-C; APOPTOSIS; COLISTIN; MITOCHONDRIA; OLD; ISCHEMIA/REPERFUSION; PHARMACOKINETICS; TOXICITY; STRESS	Polymyxins have a long history of dose-limiting toxicity, but the underlying mechanism of polymyxin B-induced nephrotoxicity is unclear. This study investigated the link between the nephrotoxic effects of polymyxin B on renal metabolic functions and mitochondrial morphology in rats and on the structural integrity of LLC-PK1 cells. Fifteen Wistar rats were divided into two groups: Saline group, rats received 3 mL/kg of 0.9% NaCl intraperitoneally (i.p.) once a day for 5 days; Polymyxin B group, rats received 4 mg/kg/day of polymyxin B i.p. once a day for 5 days. Renal function, renal hemodynamics, oxidative stress, mitochondrial injury and histological characteristics were assessed. Cell membrane damage was evaluated via lactate dehydrogenase and nitric oxide levels, cell viability, and apoptosis in cells exposed to 12.5 mu M, 75 mu M and 375 mu M polymyxin B. Polymyxin B was immunolocated using Lissamine rhodamine-polymyxin B in LLC-PK1 cells. Polymyxin B administration in rats reduced creatinine clearance and increased renal vascular resistance and oxidative damage. Mitochondrial damage was confirmed by electron microscopy and cytosolic localization of cytochrome c. Histological analysis revealed tubular dilatation and necrosis in the renal cortex. The reduction in cell viability and the increase in apoptosis, lactate dehydrogenase levels and nitric oxide levels confirmed the cytotoxicity of polymyxin B. The incubation of LLC-PK1 cells resulted in mitochondrial localization of polymyxin B. This study demonstrates that polymyxin B nephrotoxicity is characterized by mitochondrial dysfunction and free radical generation in both LLC-PK1 cells and rat kidneys. These data also provide support for clinical studies on the side effects of polymyxin B.	[Fernandes Vattimo, Maria de Fatima; Watanabe, Mirian; da Fonseca, Cassiane Dezoti; de Moura Neiva, Luciana Barros] Univ Sao Paulo, Sch Nursing, LEMA, Sao Paulo, Brazil; [Pessoa, Edson Andrade; Borges, Fernanda Teixeira] Univ Fed Sao Paulo, Div Nephrol, Sao Paulo, Brazil; [de Moura Neiva, Luciana Barros] Eneas Carvalho de Aguiar Ave 419, BR-05403000 Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP)	da Fonseca, CD (corresponding author), Univ Sao Paulo, Sch Nursing, LEMA, Sao Paulo, Brazil.	cassianedezoti@usp.br	Borges, Fernanda Teixeira/Y-3439-2018; fonseca, cassiane/ABB-2703-2021; Watanabe, Mirian/J-2384-2012; da Fonseca, Cassiane Dezoti/I-5648-2013; Vattimo, MariaFatima/D-7716-2012	Borges, Fernanda Teixeira/0000-0002-9790-0915; fonseca, cassiane/0000-0002-2118-8562; Watanabe, Mirian/0000-0003-4264-3744; da Fonseca, Cassiane Dezoti/0000-0002-2118-8562; Vattimo, MariaFatima/0000-0002-7036-5676	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo;  [2013/26560-2];  [2011/24028-6]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); ; 	Financial support for this study was provided by the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo. MFFV is a recipient of a grant (2013/26560-2 and 2011/24028-6). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelraouf K, 2014, ANTIMICROB AGENTS CH, V58, P4200, DOI 10.1128/AAC.02557-14; Abdelraouf K, 2012, ANTIMICROB AGENTS CH, V56, P5724, DOI 10.1128/AAC.01333-12; Abdelraouf K, 2012, ANTIMICROB AGENTS CH, V56, P4625, DOI 10.1128/AAC.00280-12; AEBI H, 1984, METHOD ENZYMOL, V105, P121; Agarwal A, 2016, J AM SOC NEPHROL, V27, P1288, DOI 10.1681/ASN.2015070740; Akajagbor DS, 2013, CLIN INFECT DIS, V57, P1300, DOI 10.1093/cid/cit453; Akerboom T P, 1981, Methods Enzymol, V77, P373; American Veterinary Medical Association, AVMA GUID EUTH 2013; Andrades ME, 2011, CRIT CARE, V15, DOI 10.1186/cc10334; Arnold TM, 2007, AM J HEALTH-SYST PH, V64, P819, DOI 10.2146/ajhp060473; Azad MAK, 2015, ANTIMICROB AGENTS CH, V59, P2136, DOI 10.1128/AAC.04869-14; Azad MAK, 2013, ANTIMICROB AGENTS CH, V57, P4329, DOI 10.1128/AAC.02587-12; Bergen PJ, 2012, DIAGN MICR INFEC DIS, V74, P213, DOI 10.1016/j.diagmicrobio.2012.07.010; Beuge JA, 1978, METHOD ENZYMOL, V52, P306; Borges AA, 2015, NUTR NEUROSCI, V18, P265, DOI 10.1179/1476830514Y.0000000125; Borutaite V, 2001, BBA-MOL BASIS DIS, V1537, P101, DOI 10.1016/S0925-4439(01)00062-X; DANNER RL, 1989, ANTIMICROB AGENTS CH, V33, P1428, DOI 10.1128/AAC.33.9.1428; Dorea EL, 1997, J AM SOC NEPHROL, V8, P1415; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Falagas ME, 2006, CRIT CARE, V10, DOI 10.1186/cc3995; Fernandes SM, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/3019410; FILATOV MV, 1995, MUTAT RES-FUND MOL M, V327, P209, DOI 10.1016/0027-5107(94)00189-C; Fonseca CD, 2012, ANTIMICROB AGENTS CH, V56, P5082, DOI 10.1128/AAC.00925-12; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; Hall AM, 2013, KIDNEY INT, V83, P72, DOI 10.1038/ki.2012.328; Halliwell B, 2004, CURR MED CHEM, V11, P1085, DOI 10.2174/0929867043365404; Havasi A, 2011, KIDNEY INT, V80, P29, DOI 10.1038/ki.2011.120; Jassem W, 2004, KIDNEY INT, V66, P514, DOI 10.1111/j.1523-1755.2004.761_9.x; Johnson-Lyles DN, 2010, TOXICOL APPL PHARM, V248, P249, DOI 10.1016/j.taap.2010.08.008; Kasiakou SK, 2005, ANTIMICROB AGENTS CH, V49, P3136, DOI 10.1128/AAC.49.8.3136-3146.2005; Kubin CJ, 2012, J INFECTION, V65, P80, DOI 10.1016/j.jinf.2012.01.015; Kvitko CH, 2011, J ANTIMICROB CHEMOTH, V66, P175, DOI 10.1093/jac/dkq390; Markowitz GS, 2005, CLIN CHIM ACTA, V351, P31, DOI 10.1016/j.cccn.2004.09.005; Molitoris BA, 2006, ADV DRUG DELIVER REV, V58, P809, DOI 10.1016/j.addr.2006.07.017; Moncada S, 2002, NAT REV MOL CELL BIO, V3, P214, DOI 10.1038/nrm762; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Nielsen R, 1998, J AM SOC NEPHROL, V9, P1767; Ozyilmaz E, 2011, INTENS CARE MED, V37, P141, DOI 10.1007/s00134-010-2038-7; Perazella MA, 2009, CLIN J AM SOC NEPHRO, V4, P1275, DOI 10.2215/CJN.02050309; Plotnikov EY, 2007, KIDNEY INT, V72, P1493, DOI 10.1038/sj.ki.5002568; Pogue JM, 2011, CLIN INFECT DIS, V53, P879, DOI 10.1093/cid/cir611; Schetz M, 2005, CURR OPIN CRIT CARE, V11, P555, DOI 10.1097/01.ccx.0000184300.68383.95; SHIH W, 1988, KIDNEY INT, V33, P1113, DOI 10.1038/ki.1988.119; Small DM, 2012, EXPERT OPIN DRUG MET, V8, P655, DOI 10.1517/17425255.2012.679657; Velkov T, 2013, FUTURE MICROBIOL, V8, P711, DOI [10.2217/FMB.13.39, 10.2217/fmb.13.39]; Velkov T, 2010, J MED CHEM, V53, P1898, DOI 10.1021/jm900999h; Yousef JM, 2012, J ANTIMICROB CHEMOTH, V67, P452, DOI 10.1093/jac/dkr483; Yousef JM, 2011, ANTIMICROB AGENTS CH, V55, P4044, DOI 10.1128/AAC.00328-11; Yu WM, 2007, AM J PHYSIOL-RENAL, V292, pF1873, DOI 10.1152/ajprenal.00218.2006; Yun B, 2015, J ANTIMICROB CHEMOTH, V70, P827, DOI 10.1093/jac/dku441; Zavascki AP, 2007, J ANTIMICROB CHEMOTH, V60, P1206, DOI 10.1093/jac/dkm357	51	37	38	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2016	11	8							e0161057	10.1371/journal.pone.0161057	http://dx.doi.org/10.1371/journal.pone.0161057			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4YN	27532263	Green Submitted, gold, Green Published			2022-12-27	WOS:000381487600057
J	Li, XK; Liao, HF; Fan, CF; Hu, HZ; Li, Y; Li, J; Yi, ZL; Cai, XW; Peng, LC; Tu, YY				Li, Xukai; Liao, Haofeng; Fan, Chunfen; Hu, Huizhen; Li, Ying; Li, Jing; Yi, Zili; Cai, Xiwen; Peng, Liangcai; Tu, Yuanyuan			Distinct Geographical Distribution of the Miscanthus Accessions with Varied Biomass Enzymatic Saccharification	PLOS ONE			English	Article							ENERGY CROPS; LIGNIN; PRETREATMENTS; DIGESTIBILITY; GRASSES	Miscanthus is a leading bioenergy candidate for biofuels, and it thus becomes essential to characterize the desire natural Miscanthus germplasm accessions with high biomass saccharification. In this study, total 171 natural Miscanthus accessions were geographically mapped using public database. According to the equation [P(H/L vertical bar East) = P(H/L boolean AND East)/P (East)], the probability (P) parameters were calculated on relationships between geographical distributions of Miscanthus accessions in the East of China, and related factors with high(H) or low(L) values including biomass saccahrification under 1% NaOH and 1% H2SO4 pretreatments, lignocellulose features and climate conditions. Based on the maximum P value, a golden cutting line was generated from 42 degrees 25'N, 108 degrees 22'E to 22 degrees 58'N, 116 inverted perpendicular 28'E on the original locations of Miscanthus accessions with high P(H vertical bar East) values (0.800-0.813), indicating that more than 90% Miscanthus accessions were originally located in the East with high biomass saccharification. Furthermore, the averaged insolation showed high P (H broken vertical bar East) and P(East vertical bar H) values at 0.782 and 0.754, whereas other climate factors had low P(East vertical bar H) values, suggesting that the averaged insolation is unique factor on Miscanthus distributions for biomass saccharification. In terms of cell wall compositions and wall polymer features, both hemicelluloses level and cellulose crystallinity (CrI) of Miscanthus accessions exhibited relative high P values, suggesting that they should be the major factors accounting for geographic distributions of Miscanthus accessions with high biomass digestibility.	[Li, Xukai; Liao, Haofeng; Fan, Chunfen; Hu, Huizhen; Li, Ying; Peng, Liangcai; Tu, Yuanyuan] Huazhong Agr Univ, Biomass & Bioenergy Res Ctr, Wuhan, Peoples R China; [Li, Xukai; Liao, Haofeng; Fan, Chunfen; Hu, Huizhen; Li, Ying; Peng, Liangcai; Tu, Yuanyuan] Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Peoples R China; [Li, Xukai; Liao, Haofeng; Fan, Chunfen; Hu, Huizhen; Li, Ying; Li, Jing; Peng, Liangcai; Tu, Yuanyuan] Huazhong Agr Univ, Coll Plant Sci & Technol, Wuhan, Peoples R China; [Yi, Zili] Hunan Agr Univ, Dept Biotechnol, Changsha, Hunan, Peoples R China; [Cai, Xiwen] North Dakota State Univ, Dept Plant Sci, Fargo, ND 58105 USA	Huazhong Agricultural University; Huazhong Agricultural University; Huazhong Agricultural University; Hunan Agricultural University; North Dakota State University Fargo	Tu, YY (corresponding author), Huazhong Agr Univ, Biomass & Bioenergy Res Ctr, Wuhan, Peoples R China.; Tu, YY (corresponding author), Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Peoples R China.; Tu, YY (corresponding author), Huazhong Agr Univ, Coll Plant Sci & Technol, Wuhan, Peoples R China.	yuant@mail.hzau.edu.cn	李, 旭凯/AAJ-5266-2020	李, 旭凯/0000-0001-7248-1331; Cai, Xiwen/0000-0002-3937-1074	Fundamental Research Funds for the Central Universities of China [2662015PY018]; National 111 Project [B08032]; National 973 Pre-project [2010CB134401]	Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities); National 111 Project; National 973 Pre-project(National Basic Research Program of China)	This work was supported in part by grants from the Fundamental Research Funds for the Central Universities of China (Program No. 2662015PY018), the National 111 Project (B08032) and the National 973 Pre-project (2010CB134401). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Kai Guo, Qingchun Pan and Guosheng Xie for very helpful comments and discussion on the manuscript. This work was supported in part by grants from the Fundamental Research Funds for the Central Universities of China (Program No. 2662015PY018), the National 111 Project (B08032) and the National 973 Pre-project (2010CB134401). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelini LG, 2009, BIOMASS BIOENERG, V33, P635, DOI 10.1016/j.biombioe.2008.10.005; Chang VS, 2000, APPL BIOCHEM BIOTECH, V84-6, P5, DOI 10.1385/ABAB:84-86:1-9:5; Chen F, 2007, NAT BIOTECHNOL, V25, P759, DOI 10.1038/nbt1316; Clark LV, 2014, ANN BOT-LONDON, V114, P97, DOI 10.1093/aob/mcu084; Clifton-Brown JC, 2001, AGRON J, V93, P1013, DOI 10.2134/agronj2001.9351013x; Fry S. C, 1988, GROWING PLANT CELL W, DOI DOI 10.1016/0031-9422(88)83079-6; Himmel ME, 2007, SCIENCE, V315, P804, DOI 10.1126/science.1137016; Huang JF, 2012, BIORESOURCE TECHNOL, V121, P274, DOI 10.1016/j.biortech.2012.06.015; Jakob K, 2009, IN VITRO CELL DEV-PL, V45, P291, DOI 10.1007/s11627-009-9214-x; Jin WX, 2016, APPL ENERG, V175, P82, DOI 10.1016/j.apenergy.2016.04.104; Lewandowski I, 2000, BIOMASS BIOENERG, V19, P209, DOI 10.1016/S0961-9534(00)00032-5; Lewandowski I, 2003, BIOMASS BIOENERG, V25, P335, DOI 10.1016/S0961-9534(03)00030-8; Li FC, 2013, BIORESOURCE TECHNOL, V130, P629, DOI 10.1016/j.biortech.2012.12.107; Li ZL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103633; Melligan F, CHARACTERISATION PRO, P258; NASA, 2014, SURF MET SOL EN REN; Peng LC, 2000, PLANTA, V211, P406, DOI 10.1007/s004250000301; PURI VP, 1984, BIOTECHNOL BIOENG, V26, P1219, DOI 10.1002/bit.260261010; Sang T, 2011, GCB BIOENERGY, V3, P79, DOI 10.1111/j.1757-1707.2010.01064.x; Si SL, 2015, BIORESOURCE TECHNOL, V183, P248, DOI 10.1016/j.biortech.2015.02.031; Simmons BA, 2010, CURR OPIN PLANT BIOL, V13, P313, DOI 10.1016/j.pbi.2010.03.001; 정지훈, 2012, Journal of Crop Science and Biotechnology, V15, P65, DOI 10.1007/s12892-012-0023-0; Sun HY, 2013, BIOCHEM BIOPH RES CO, V430, P1151, DOI 10.1016/j.bbrc.2012.12.019; Xie GS, 2011, J INTEGR PLANT BIOL, V53, P143, DOI 10.1111/j.1744-7909.2010.01022.x; Xu N, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-58; Zhang W, 2013, BIORESOURCE TECHNOL, V130, P30, DOI 10.1016/j.biortech.2012.12.029; Zhao H, 2014, GCB BIOENERGY, V6, P768, DOI 10.1111/gcbb.12115	27	152	158	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2016	11	8							e0160026	10.1371/journal.pone.0160026	http://dx.doi.org/10.1371/journal.pone.0160026			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4YN	27532636	Green Published, gold, Green Submitted			2022-12-27	WOS:000381487600021
J	Liao, XL; Zhao, JJ; Jiao, C; Lei, L; Qiang, Y; Cui, Q				Liao, Xiaolei; Zhao, Juanjuan; Jiao, Cheng; Lei, Lei; Qiang, Yan; Cui, Qiang			A Segmentation Method for Lung Parenchyma Image Sequences Based on Superpixels and a Self-Generating Neural Forest	PLOS ONE			English	Article							CT; ALGORITHM; NETWORKS; NODULES	Background Lung parenchyma segmentation is often performed as an important pre-processing step in the computer-aided diagnosis of lung nodules based on CT image sequences. However, existing lung parenchyma image segmentation methods cannot fully segment all lung parenchyma images and have a slow processing speed, particularly for images in the top and bottom of the lung and the images that contain lung nodules. Method Our proposed method first uses the position of the lung parenchyma image features to obtain lung parenchyma ROI image sequences. A gradient and sequential linear iterative clustering algorithm (GSLIC) for sequence image segmentation is then proposed to segment the ROI image sequences and obtain superpixel samples. The SGNF, which is optimized by a genetic algorithm (GA), is then utilized for superpixel clustering. Finally, the grey and geometric features of the superpixel samples are used to identify and segment all of the lung parenchyma image sequences. Results Our proposed method achieves higher segmentation precision and greater accuracy in less time. It has an average processing time of 42.21 seconds for each dataset and an average volume pixel overlap ratio of 92.22 +/- 4.02% for four types of lung parenchyma image sequences.	[Liao, Xiaolei; Zhao, Juanjuan; Lei, Lei; Qiang, Yan; Cui, Qiang] Taiyuan Univ Technol, Coll Comp Sci & Technol, Taiyuan 030024, Peoples R China; [Jiao, Cheng] Shanxi Coal Cent Hosp, PET CT Ctr, Taiyuan 030024, Shanxi, Peoples R China	Taiyuan University of Technology	Qiang, Y (corresponding author), Taiyuan Univ Technol, Coll Comp Sci & Technol, Taiyuan 030024, Peoples R China.	2304700796@qq.com			National Natural Science Foundation of China [61373100, 61540007]; National Key Laboratory Open Foundation of China [BUAA-VR-15KF02, BUAA-VR-16KF13]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Laboratory Open Foundation of China	The work is supported by the National Natural Science Foundation of China (61373100, 61540007) and the National Key Laboratory Open Foundation of China (BUAA-VR-15KF02, BUAA-VR-16KF13).	Bellotti R, 2007, MED PHYS, V34, P4901, DOI 10.1118/1.2804720; Dehmeshi J, 2008, IEEE T MED IMAGING, V27, P467, DOI 10.1109/TMI.2007.907555; Dehmeshki J, 2007, COMPUT MED IMAG GRAP, V31, P408, DOI 10.1016/j.compmedimag.2007.03.002; Feng S, 2010, NEUR NETW IJCNN 2010, P1; Geng H, 2014, INT CONTR AUT WCICA, P5626; Hammoudi AA, 2011, LECT NOTES COMPUT SC, V7009, P317, DOI 10.1007/978-3-642-24319-6_39; Hsieh Jiang, 2009, COMPUTED TOMOGRAPHY; Inoue H, 2003, MATH COMPUT MODEL, V38, P1225, DOI 10.1016/S0895-7177(03)00335-2; Inoue H., 2003, J SYSTEMIC CYBERNETI, V1, P72; Khan A, 2015, APPL SOFT COMPUT, V32, P300, DOI 10.1016/j.asoc.2015.03.029; Law TY, 2000, PROC SPIE, V3979, P906, DOI 10.1117/12.387756; Li CM, 2011, IEEE T IMAGE PROCESS, V20, P2007, DOI 10.1109/TIP.2011.2146190; Liming D, 2011, 2011 INT C CONS EL C, P976; Lucchi A, 2010, LECT NOTES COMPUT SC, V6362, P463; Mansoor A, 2014, IEEE ENG MED BIO, P6032, DOI 10.1109/EMBC.2014.6945004; Masoumi H, 2012, BIOMED SIGNAL PROCES, V7, P429, DOI 10.1016/j.bspc.2012.01.002; Meila M, 2003, LECT NOTES ARTIF INT, V2777, P173, DOI 10.1007/978-3-540-45167-9_14; Prastawa M, 2004, MED IMAGE ANAL, V8, P275, DOI 10.1016/j.media.2004.06.007; Ren XF, 2003, NINTH IEEE INTERNATIONAL CONFERENCE ON COMPUTER VISION, VOLS I AND II, PROCEEDINGS, P10; Saghir Z, 2012, THORAX, V67, P296, DOI 10.1136/thoraxjnl-2011-200736; Shojaii R, 2007, INT CONF ACOUST SPEE, P1217; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Song YY, 2014, J MED IMAG HEALTH IN, V4, P781, DOI 10.1166/jmihi.2014.1320; Unnikrishnan R, 2005, WACV 2005: SEVENTH IEEE WORKSHOP ON APPLICATIONS OF COMPUTER VISION, PROCEEDINGS, P394; Wang J, 2012, IEEE T PATTERN ANAL, V34, P1241, DOI 10.1109/TPAMI.2012.47; Wen W. X., 1992, IJCNN International Joint Conference on Neural Networks (Cat. No.92CH3114-6), P850, DOI 10.1109/IJCNN.1992.227211; Xi-ping Luo, 2002, Journal of Software, V13, P1050; Yan-hua R, 2010, INF NETW AUT ICINA 2, V2, pV2; Yu N, 2015, SPIE MED IMAGING; Zhao JJ, 2015, INT J BIO-INSPIR COM, V7, P62, DOI 10.1504/IJBIC.2015.067999; Zhao JJ, 2016, FRONT COMPUT SCI-CHI, V10, P189, DOI 10.1007/s11704-015-4543-x; Zhao JJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123694	32	13	16	5	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2016	11	8							e0160556	10.1371/journal.pone.0160556	http://dx.doi.org/10.1371/journal.pone.0160556			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4YN	27532214	Green Published, gold, Green Submitted			2022-12-27	WOS:000381487600036
J	Neuville, M; Hustinx, R; Jacques, J; Krzesinski, JM; Jouret, F				Neuville, Marie; Hustinx, Roland; Jacques, Jessica; Krzesinski, Jean-Marie; Jouret, Francois			Diagnostic Algorithm in the Management of Acute Febrile Abdomen in Patients with Autosomal Dominant Polycystic Kidney Disease	PLOS ONE			English	Article							HEPATIC CYST INFECTION; RENAL CYSTS; PET-CT; ADPKD; TOMOGRAPHY; CRITERIA	Background Acute febrile abdomen represents a diagnostic challenge in patients with autosomal dominant polycystic kidney disease (ADPKD). Although criteria have been proposed for cyst infection (CyI) and hemorrhage (CyH), there is a lack of comparative assessments. Furthermore, distinguishing cystic from non-cystic complications remains problematic. Design ADPKD patients presenting with abdominal pain and/or fever between 01/2005 and 06/2015 were retrospectively identified in a systematic computerized billing database. CyH was defined as spontaneous intracystic density above 50 Hounsfield units on computed tomography (CT). CyI was definite if confirmed by cyst puncture, and probable if 4 criteria were met: 3-day fever, loin/liver tenderness, C-reactive protein (CRP) plasma levels > 50mg/L and no CT evidence for CyH. Other episodes were grouped as inflammation of unknown origin (IUO). Results Among a cohort of 173 ADPKD patients, 101 presented with 205 episodes of abdominal pain (n = 172) and/or fever (n = 33). 20 patients experienced 30 CyH, whereas 16 presented 23 episodes of definite (n = 11) or probable (n = 12) CyI. 35 IUO were observed in 31 patients. Clinically, fever was observed in 7% vs. 100% vs. 66% of CyH, CyI and IUO, respectively. Biologically, CRP cut-off at 70 mg/dl showed 92% sensitivity and 81% specificity in CyI diagnosis. Urine or blood cultures remained sterile in > 90% of CyH, but were contributive in 53.4% of CyI and IUO, with a 74.2% prevalence for E. coli. Radiologically, ultrasounds, CT and magnetic resonance diagnosed CyI in 2.6%, 20% and 16.7% of cases, respectively. 18F-FDG positron-emission tomography (PET)/CT was done within a median period of 7 days post antibiotics, and significantly changed patient management in 71.4%. Conclusions This retrospective single-center series underscores the usefulness of clinical-fever-and biological-CRP-parameters, but emphasizes the limitations of bacteriological and radiological investigations in cases of acute febrile abdomen in ADPKD patients. F-18-FDG-PET/CT imaging may be helpful in such condition.	[Neuville, Marie; Krzesinski, Jean-Marie; Jouret, Francois] Univ Liege Hosp ULg CHU, Dept Nephrol, Liege, Belgium; [Hustinx, Roland] Univ Liege Hosp ULg CHU, Dept Nucl Med, Liege, Belgium; [Jacques, Jessica] Univ Liege Hosp ULg CHU, Dept Medicoecon Informat, Liege, Belgium; [Krzesinski, Jean-Marie; Jouret, Francois] Univ Liege, GIGA, Cardiovasc Sci, Liege, Belgium	University of Liege; University of Liege; University of Liege; University of Liege	Jouret, F (corresponding author), Univ Liege Hosp ULg CHU, Dept Nephrol, Liege, Belgium.; Jouret, F (corresponding author), Univ Liege, GIGA, Cardiovasc Sci, Liege, Belgium.	francois.jouret@chu.ulg.ac.be		Neuville, Marie F./0000-0002-9012-5047				Akoh Jacob A, 2015, World J Nephrol, V4, P468, DOI 10.5527/wjn.v4.i4.468; Balbo BEP, 2014, BRAZ J MED BIOL RES, V47, P584, DOI 10.1590/1414-431X20143584; Bleeker-Rovers CP, 2003, AM J KIDNEY DIS, V41, DOI 10.1016/S0272-6386(03)00368-8; Bobot M, 2016, CLIN MICROBIOL INFEC, V22, P71, DOI 10.1016/j.cmi.2015.09.024; Chapman AB, 2015, KIDNEY INT, V88, P17, DOI 10.1038/ki.2015.59; Cornec-Le Gall E, 2016, J AM SOC NEPHROL, V27, P942, DOI 10.1681/ASN.2015010016; deSouza RM, 2009, TRANSPL P, V41, P1942, DOI 10.1016/j.transproceed.2008.10.102; ELZINGA LW, 1988, ANTIMICROB AGENTS CH, V32, P844, DOI 10.1128/AAC.32.6.844; FICK GM, 1995, J AM SOC NEPHROL, V5, P2048; Gans SL, 2015, DIGEST SURG, V32, P23, DOI 10.1159/000371583; Ichioka K, 2007, UROLOGY, V70, P1219, DOI 10.1016/j.urology.2007.09.040; Jouret F, 2012, NEPHROL DIAL TRANSPL, V27, P3746, DOI 10.1093/ndt/gfs352; Jouret F, 2011, CLIN J AM SOC NEPHRO, V6, P1644, DOI 10.2215/CJN.06900810; Kaim AH, 2001, RADIOLOGY, V221, P818, DOI 10.1148/radiol.2213010445; Kanaan N, 2010, AM J KIDNEY DIS, V55, P916, DOI 10.1053/j.ajkd.2009.12.023; Lantinga MA, 2015, ALIMENT PHARM THER, V41, P253, DOI 10.1111/apt.13047; Lantinga MA, 2015, CLIN NEPHROL, V84, P61, DOI 10.5414/CN108495; Lantinga MA, 2015, NEPHROL DIAL TRANSPL, V30, P744, DOI 10.1093/ndt/gfu227; Lovinfosse P, 2016, AM J TRANSPLANT, V16, P310, DOI 10.1111/ajt.13429; Meller J, 2007, J NUCL MED, V48, P35; Pei Y, 2009, J AM SOC NEPHROL, V20, P205, DOI 10.1681/ASN.2008050507; Piccoli GB, 2011, BMC NEPHROL, V12, DOI 10.1186/1471-2369-12-48; Pirson Y, 2010, ADV CHRONIC KIDNEY D, V17, P173, DOI 10.1053/j.ackd.2010.01.003; Rule AD, 2006, J AM SOC NEPHROL, V17, P854, DOI 10.1681/ASN.2005070697; Sallee M, 2009, CLIN J AM SOC NEPHRO, V4, P1183, DOI 10.2215/CJN.01870309; Schrier RW, 2014, J AM SOC NEPHROL, V25, P2399, DOI 10.1681/ASN.2013111184; Soussan M, 2008, ANN NUCL MED, V22, P529, DOI 10.1007/s12149-008-0150-3; Suwabe T, 2012, CLIN EXP NEPHROL, V16, P892, DOI 10.1007/s10157-012-0650-2; Suwabe T, 2009, NEPHRON CLIN PRACT, V112, pC157, DOI 10.1159/000214211; TELENTI A, 1990, MAYO CLIN PROC, V65, P933, DOI 10.1016/S0025-6196(12)65154-4; Torres VE, 2007, LANCET, V369, P1287, DOI 10.1016/S0140-6736(07)60601-1; Torres VE, 2011, CLIN J AM SOC NEPHRO, V6, P640, DOI 10.2215/CJN.03250410; Vaidyanathan S, 2015, CLIN RADIOL, V70, P787, DOI 10.1016/j.crad.2015.03.010	33	20	22	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2016	11	8							e0161277	10.1371/journal.pone.0161277	http://dx.doi.org/10.1371/journal.pone.0161277			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4UN	27529555	Green Published, Green Submitted, gold			2022-12-27	WOS:000381476700060
J	Otowa, T; Kawamura, Y; Tsutsumi, A; Kawakami, N; Kan, C; Shimada, T; Umekage, T; Kasai, K; Tokunaga, K; Sasaki, T				Otowa, Takeshi; Kawamura, Yoshiya; Tsutsumi, Akizumi; Kawakami, Norito; Kan, Chiemi; Shimada, Takafumi; Umekage, Tadashi; Kasai, Kiyoto; Tokunaga, Katsushi; Sasaki, Tsukasa			The First Pilot Genome-Wide Gene-Environment Study of Depression in the Japanese Population	PLOS ONE			English	Article							NATIONAL COMORBIDITY SURVEY; PROTEIN SIGNALING RGS; STRESSFUL LIFE EVENTS; MAJOR DEPRESSION; SURVEY REPLICATION; DSM-IV; ASSOCIATION; DISORDERS; ONSET; POLYMORPHISM	Stressful events have been identified as a risk factor for depression. Although gene-environment (G x E) interaction in a limited number of candidate genes has been explored, no genome-wide search has been reported. The aim of the present study is to identify genes that influence the association of stressful events with depression. Therefore, we performed a genome-wide G x E interaction analysis in the Japanese population. A genome-wide screen with 320 subjects was performed using the Affymetrix Genome-Wide Human Array 6.0. Stressful life events were assessed using the Social Readjustment Rating Scale (SRRS) and depression symptoms were assessed with self-rating questionnaires using the Center for Epidemiologic Studies Depression (CES-D) scale. The p values for interactions between single nucleotide polymorphisms (SNPs) and stressful events were calculated using the linear regression model adjusted for sex and age. After quality control of genotype data, a total of 534,848 SNPs on autosomal chromosomes were further analyzed. Although none surpassed the level of the genome-wide significance, a marginal significant association of interaction between SRRS and rs10510057 with depression were found (p = 4.5 x 10 -8). The SNP is located on 10q26 near Regulators of G-protein signaling 10 (RGS10), which encodes a regulatory molecule involved in stress response. When we investigated a similar G x E interaction between depression (K6 scale) and work-related stress in an independent sample (n = 439), a significant G x E effect on depression was observed (p = 0.015). Our findings suggest that rs10510057, interacting with stressors, may be involved in depression risk. Incorporating G x E interaction into GWAS can contribute to find susceptibility locus that are potentially missed by conventional GWAS.	[Otowa, Takeshi] Teikyo Heisei Univ Major Profess Clin Psychol, Grad Sch Clin Psychol, Tokyo, Japan; [Otowa, Takeshi; Shimada, Takafumi; Umekage, Tadashi; Kasai, Kiyoto] Univ Tokyo, Grad Sch Med, Dept Neuropsychiat, Tokyo, Japan; [Kawamura, Yoshiya] Shonan Kamakura Gen Hosp, Dept Psychiat, Kamakura, Kanagawa, Japan; [Tsutsumi, Akizumi] Kitasato Univ, Sch Med, Dept Publ Hlth, Sagamihara, Kanagawa, Japan; [Kawakami, Norito; Kan, Chiemi] Univ Tokyo, Grad Sch Med, Dept Mental Hlth, Tokyo, Japan; [Tokunaga, Katsushi] Univ Tokyo, Grad Sch Med, Dept Human Genet, Tokyo, Japan; [Sasaki, Tsukasa] Univ Tokyo, Grad Sch Educ, Lab Hlth Educ, Tokyo, Japan	University of Tokyo; Kitasato University; University of Tokyo; University of Tokyo; University of Tokyo	Otowa, T (corresponding author), Teikyo Heisei Univ Major Profess Clin Psychol, Grad Sch Clin Psychol, Tokyo, Japan.; Otowa, T (corresponding author), Univ Tokyo, Grad Sch Med, Dept Neuropsychiat, Tokyo, Japan.	totowa-psy@umin.org		Kasai, Kiyoto/0000-0002-4443-4535	Ministry of Education, Science, Sports and Culture of Japan [17019029, 21300242, 25461723, 21119002]	Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the Grants-in-Aid for Scientific Research on Priority Areas "Comprehensive Genomics" and "Applied Genomics" (T. Sasaki received No. 17019029 and No. 21300242; TO received No. 25461723) and for Scientific Research on Innovative Areas; "Elucidation of social stratification mechanism and control over health inequality in contemporary Japan: New interdisciplinary area of social and health sciences" (The Project "Social Stratification and Health": AT and NK received No. 21119002) from the Ministry of Education, Science, Sports and Culture of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEBBINGTON P, 1993, BRIT J PSYCHIAT, V162, P358, DOI 10.1192/bjp.162.3.358; Berman DM, 1996, J BIOL CHEM, V271, P27209, DOI 10.1074/jbc.271.44.27209; Brown GW, 2008, J AFFECT DISORDERS, V111, P1, DOI 10.1016/j.jad.2008.04.009; BROWN GW, 1995, PSYCHOL MED, V25, P7, DOI 10.1017/S003329170002804X; BRUGHA TS, 1985, BRIT J PSYCHIAT, V147, P641, DOI 10.1192/bjp.147.6.641; Burgon PG, 2001, J BIOL CHEM, V276, P32828, DOI 10.1074/jbc.M100960200; Cantor RM, 2010, AM J HUM GENET, V86, P6, DOI 10.1016/j.ajhg.2009.11.017; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; Caspi A, 2010, AM J PSYCHIAT, V167, P509, DOI 10.1176/appi.ajp.2010.09101452; Dunn EC, 2015, HARVARD REV PSYCHIAT, V23, P1, DOI 10.1097/HRP.0000000000000054; Eaves LJ, 2006, TWIN RES HUM GENET, V9, P1, DOI 10.1375/183242706776403073; Ensel WM, 1996, J AGING HEALTH, V8, P389, DOI 10.1177/089826439600800305; Flint J, 2014, NEURON, V81, P484, DOI [10.1016/j.neuron.2014.02.033, 10.1016/j.neuron.2014.01.027]; Gold SJ, 1997, J NEUROSCI, V17, P8024; Green JG, 2010, ARCH GEN PSYCHIAT, V67, P113, DOI 10.1001/archgenpsychiatry.2009.186; Hek K, 2013, BIOL PSYCHIAT, V73, P667, DOI 10.1016/j.biopsych.2012.09.033; Hishimoto A, 2004, PSYCHIAT CLIN NEUROS, V58, P579, DOI 10.1111/j.1440-1819.2004.01303.x; HOLMES TH, 1967, J PSYCHOSOM RES, V11, P213, DOI 10.1016/0022-3999(67)90010-4; Kawakami N, 2005, PSYCHIAT CLIN NEUROS, V59, P441, DOI 10.1111/j.1440-1819.2005.01397.x; Kawamura Y, 2010, J AFFECT DISORDERS, V127, P31, DOI 10.1016/j.jad.2010.04.014; Kendler KS, 1998, J NERV MENT DIS, V186, P661, DOI 10.1097/00005053-199811000-00001; Kendler KS, 2003, ARCH GEN PSYCHIAT, V60, P789, DOI 10.1001/archpsyc.60.8.789; Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P617, DOI 10.1001/archpsyc.62.6.617; Kessler RC, 1997, PSYCHOL MED, V27, P1101, DOI 10.1017/S0033291797005588; Kessler RC, 2003, JAMA-J AM MED ASSOC, V289, P3095, DOI 10.1001/jama.289.23.3095; Kraft P, 2007, HUM HERED, V63, P111, DOI 10.1159/000099183; Lee JK, 2012, J NEUROCHEM, V122, P333, DOI 10.1111/j.1471-4159.2012.07780.x; Lewis CM, 2010, AM J PSYCHIAT, V167, P949, DOI 10.1176/appi.ajp.2010.09091380; Lopez-Leon S, 2008, MOL PSYCHIATR, V13, P772, DOI 10.1038/sj.mp.4002088; Menke A, 2014, DIALOGUES CLIN NEURO, V16, P395; Murray CJL, 1997, LANCET, V349, P1436, DOI 10.1016/S0140-6736(96)07495-8; Narahara M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100924; Nugent NR, 2011, PSYCHOPHARMACOLOGY, V214, P175, DOI 10.1007/s00213-010-2151-x; Pinheiro AP, 2010, AM J MED GENET B, V153B, P1070, DOI 10.1002/ajmg.b.31082; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Renzaho AMN, 2014, EUR J PUBLIC HEALTH, V24, P57, DOI 10.1093/eurpub/ckt007; Rivero G, 2012, NEUROPHARMACOLOGY, V62, P1044, DOI 10.1016/j.neuropharm.2011.10.015; Rojo-Moreno L, 2002, SOC PSYCH PSYCH EPID, V37, P592, DOI 10.1007/s00127-002-0595-y; Ross EM, 2000, ANNU REV BIOCHEM, V69, P795, DOI 10.1146/annurev.biochem.69.1.795; Rudolph KD, 2009, DEV PSYCHOPATHOL, V21, P1155, DOI 10.1017/S0954579409990095; Sakurai K, 2011, PSYCHIAT CLIN NEUROS, V65, P434, DOI 10.1111/j.1440-1819.2011.02236.x; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Shi J, 2011, MOL PSYCHIATR, V16, P193, DOI 10.1038/mp.2009.124; Shima S., 1985, PSYCHIATRY, V27, P717, DOI DOI 10.11477/MF.1405203967; Sullivan PF, 2009, MOL PSYCHIATR, V14, P359, DOI 10.1038/mp.2008.125; Sullivan PF, 2013, MOL PSYCHIATR, V18, P497, DOI 10.1038/mp.2012.21; Sullivan PF, 2000, AM J PSYCHIAT, V157, P1552, DOI 10.1176/appi.ajp.157.10.1552; Suzuki T, 2013, J AFFECT DISORDERS, V150, P490, DOI 10.1016/j.jad.2013.04.044; Tennant C, 2002, AUST NZ J PSYCHIAT, V36, P173, DOI 10.1046/j.1440-1614.2002.01007.x; van der Sluis S, 2013, MOL PSYCHIATR, V18, P2, DOI 10.1038/mp.2012.65; Yamaguchi-Kabata Y, 2008, AM J HUM GENET, V83, P445, DOI 10.1016/j.ajhg.2008.08.019; ZICH JM, 1990, INT J PSYCHIAT MED, V20, P259, DOI 10.2190/LYKR-7VHP-YJEM-MKM2	54	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2016	11	8							e0160823	10.1371/journal.pone.0160823	http://dx.doi.org/10.1371/journal.pone.0160823			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4UN	27529621	Green Published, gold, Green Submitted			2022-12-27	WOS:000381476700025
J	Petersen, SO; Olsen, AB; Elsgaard, L; Triolo, JM; Sommer, SG				Petersen, Soren O.; Olsen, Anne B.; Elsgaard, Lars; Triolo, Jin Mi; Sommer, Sven G.			Estimation of Methane Emissions from Slurry Pits below Pig and Cattle Confinements	PLOS ONE			English	Article							NITROUS-OXIDE; CARBON-DIOXIDE; POTENTIAL BMP; MANURE; STORAGE; MANAGEMENT; FRACTIONS; DIGESTION; AMMONIA; HOUSES	Quantifying in-house emissions of methane (CH4) from liquid manure (slurry) is difficult due to high background emissions from enteric processes, yet of great importance for correct estimation of CH4 emissions from manure management and effects of treatment technologies such as anaerobic digestion. In this study CH4 production rates were determined in 20 pig slurry and 11 cattle slurry samples collected beneath slatted floors on six representative farms; rates were determined within 24 h at temperatures close to the temperature in slurry pits at the time of collection. Methane production rates in pig and cattle slurry differed significantly at 0.030 and 0.011 kg CH4 kg(-1) VS (volatile solids). Current estimates of CH4 emissions from pig and cattle manure management correspond to 0.032 and 0.015 kg CH4 kg(-1), respectively, indicating that slurry pits under animal confinements are a significant source. Fractions of degradable volatile solids (VSd, kg kg(-1) VS) were estimated using an aerobic biodegradability assay and total organic C analyses. The VSd in pig and cattle slurry averaged 0.51 and 0.33 kg kg(-1) VS, and it was estimated that on average 43 and 28% of VSd in fresh excreta from pigs and cattle, respectively, had been lost at the time of sampling. An empirical model of CH4 emissions from slurry was reparameterised based on experimental results. A sensitivity analysis indicated that predicted CH4 emissions were highly sensitive to uncertainties in the value of lnA of the Arrhenius equation, but much less sensitive to uncertainties in VSd or slurry temperature. A model application indicated that losses of carbon in VS as CO2 may be much greater than losses as CH4. Implications of these results for the correct estimation of CH4 emissions from manure management, and for the mitigation potential of treatments such as anaerobic digestion, are discussed.	[Petersen, Soren O.; Olsen, Anne B.; Elsgaard, Lars] Aarhus Univ, Dept Agroecol, Tjele, Denmark; [Triolo, Jin Mi; Sommer, Sven G.] Univ Southern Denmark, Inst Chem Engn Biotechnol & Environm Technol, Odense, Denmark	Aarhus University; University of Southern Denmark	Petersen, SO (corresponding author), Aarhus Univ, Dept Agroecol, Tjele, Denmark.	sop@agro.au.dk	Petersen, Soren O./E-9714-2016; Sommer, Sven Gjedde/AAH-6211-2020; Elsgaard, Lars/A-7698-2013	Sommer, Sven Gjedde/0000-0002-2673-0162; Elsgaard, Lars/0000-0003-0058-7609; Park Triolo, Jin Mi/0000-0002-1960-9823	Innovation Fund Denmark [12-132631]; Danish Department of Climate and Energy [Agr-2014-4734]	Innovation Fund Denmark; Danish Department of Climate and Energy	This work was supported by Innovation Fund Denmark (http://innovationsfonden.dk/en; formerly Danish Research Council for Strategic Research) through the project "Optimisation of value chains for biogas production in Denmark" coordinated by SGS (Grant No. 12-132631), and by the Danish Department of Climate and Energy (http://www.ens.dk/) through the project "Biogas Taskforce - Methane emissions from slurry pits and pretanks" coordinated by SOP (Grant No. Agr-2014-4734).	Aarnink AJA, 2007, ASABE PUBLICATION; Alstrup L, 2015, ANIM FEED SCI TECH, V207, P10, DOI 10.1016/j.anifeedsci.2015.05.017; Angelidaki I, 2009, WATER SCI TECHNOL, V59, P927, DOI 10.2166/wst.2009.040; [Anonymous], 2013, CONTRIBUTION WORKING, P1535; Board on Nutrient Requirements of Swine, 2012, NUTR REQ SWIN; Bouwman L, 2013, P NATL ACAD SCI USA, V110, P20882, DOI 10.1073/pnas.1012878108; Clavreul J, 2012, WASTE MANAGE, V32, P2482, DOI 10.1016/j.wasman.2012.07.008; DERIKX PJL, 1994, BIORESOURCE TECHNOL, V49, P41, DOI 10.1016/0960-8524(94)90171-6; Dinuccio E, 2008, AUST J EXP AGR, V48, P93, DOI 10.1071/EA07239; Elsgaard L, 2002, J MICROBIOL METH, V49, P19, DOI 10.1016/S0167-7012(01)00361-X; Elsgaard L, 2016, SCI TOTAL ENVIRON, V539, P78, DOI 10.1016/j.scitotenv.2015.07.145; Food and Agriculture Organization of the United Nations (FAO), 2010, GREENH GAS EM DAIR S; Ge JY, 2015, CHEM ENG J, V276, P29, DOI 10.1016/j.cej.2015.04.067; Haeussermann A, 2006, AGR ECOSYST ENVIRON, V112, P115, DOI 10.1016/j.agee.2005.08.011; IPCC. Intergovernmental Panel on Climate Change, 2006, GUID NAT GREENH GAS, V4; Lesteur M, 2010, PROCESS BIOCHEM, V45, P431, DOI 10.1016/j.procbio.2009.11.018; Leytem AB, 2011, J ENVIRON QUAL, V40, P1383, DOI 10.2134/jeq2009.0515; Li CS, 2012, NUTR CYCL AGROECOSYS, V93, P163, DOI 10.1007/s10705-012-9507-z; MACY JM, 1972, AM J CLIN NUTR, V25, P1318; Mangino J., 2001, US EPAS 17 ANN EM IN; Menzi H., 2010, Livestock in a changing landscape, Volume 1: drivers, consequences and responses, P139; Moller HB, 2004, BIOMASS BIOENERG, V26, P485, DOI 10.1016/j.biombioe.2003.08.008; Monteny GJ, 2001, NUTR CYCL AGROECOSYS, V60, P123, DOI 10.1023/A:1012602911339; Nielsen O-K, 2011, EMISSION INVENTORIES; PATNI NK, 1987, BIOL WASTE, V20, P11, DOI 10.1016/0269-7483(87)90081-4; Petersen SO, 2016, AGR ECOSYST ENVIRON, V216, P258, DOI 10.1016/j.agee.2015.09.042; Petersen SO, 2013, NUTR CYCL AGROECOSYS, V95, P103, DOI 10.1007/s10705-013-9551-3; Philippe FX, 2015, AGR ECOSYST ENVIRON, V199, P10, DOI 10.1016/j.agee.2014.08.015; Ponsa S, 2008, WASTE MANAGE, V28, P2735, DOI 10.1016/j.wasman.2007.12.002; SAFLEY LM, 1990, BIOL WASTE, V34, P133, DOI 10.1016/0269-7483(90)90014-J; Sebola MR, 2015, LECT NOTES ENG COMP, P592; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.2307/2333709; Sommer SG, 2004, NUTR CYCL AGROECOSYS, V69, P143, DOI 10.1023/B:FRES.0000029678.25083.fa; Sommer SG, 2007, NUTR CYCL AGROECOSYS, V78, P27, DOI 10.1007/s10705-006-9072-4; Stromberg S, 2014, WASTE MANAGE, V34, P1939, DOI 10.1016/j.wasman.2014.07.018; Van den Weghe HFA, 2005, PRECISION LIVESTOCK FARMING '05, P73; Viguria M, 2015, AGR ECOSYST ENVIRON, V199, P261, DOI 10.1016/j.agee.2014.09.016; Yvon-Durocher G, 2014, NATURE, V507, P488, DOI 10.1038/nature13164	38	23	23	5	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2016	11	8							e0160968	10.1371/journal.pone.0160968	http://dx.doi.org/10.1371/journal.pone.0160968			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4UN	27529692	gold, Green Submitted, Green Published			2022-12-27	WOS:000381476700035
J	van der Aa, E; Buschow, SI; Biesta, PJ; Janssen, HLA; Woltman, AM				van der Aa, Evelyn; Buschow, Sonja I.; Biesta, Paula J.; Janssen, Harry L. A.; Woltman, Andrea M.			The Effect of Chronic Hepatitis B Virus Infection on BDCA3+Dendritic Cell Frequency and Function	PLOS ONE			English	Article							MYELOID DENDRITIC CELLS; INTERFERON-LAMBDA; IFN-LAMBDA; IMMUNE-RESPONSE; RECEPTOR 1; IN-VIVO; ALPHA; EXPRESSION; INNATE; DCS	Chronic hepatitis B virus (HBV) infection results from inadequate HBV-specific immunity. BDCA3(+) dendritic cells (DCs) are professional antigen presenting cells considered to be important for antiviral responses because of specific characteristics, including high interferon-lambda production. BDCA3+ DCs may thus also have a role in the immune response against HBV, and immunotherapeutic strategies aiming to activate DCs, including BDCA3(+) DCs, in patient livers may represent an interesting treatment option for chronic HBV. However, neither the effect of chronic hepatitis B (CHB) infection on the frequency and function of BDCA3(+) DCs in liver and blood, nor the effect of the viral surface protein (HBsAg) that is abundantly present in blood of infected individuals are known. Here, we provide an overview of BDCA3(+) DC frequency and functional capacity in CHB patients. We find that intrahepatic BDCA3(+) DC numbers are increased in CHB patients. BDCA3(+) DCs from patient blood are not more mature at steady state, but display an impaired capacity to mature and to produce interferon-lambda upon polyI: C stimulation. Furthermore, in vitro experiments exposing blood and intrahepatic BDCA3(+) DCs to the viral envelope protein HBsAg demonstrate that HBsAg does not directly induce phenotypical maturation of BDCA3(+) DCs, but may reduce IFN-lambda production via an indirect unknown mechanism. These results suggest that BDCA3(+) DCs are available in the blood and on site in HBV infected livers, but measures may need to be taken to revive their function for DC-targeted therapy.	[van der Aa, Evelyn; Buschow, Sonja I.; Biesta, Paula J.; Janssen, Harry L. A.; Woltman, Andrea M.] Erasmus MC Univ Med Ctr, Dept Gastroenterol & Hepatol, Rotterdam, Netherlands; [Janssen, Harry L. A.] Univ Toronto, Univ Hlth Network, Toronto Ctr Liver Dis, Toronto, ON, Canada	Erasmus University Rotterdam; Erasmus MC; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Woltman, AM (corresponding author), Erasmus MC Univ Med Ctr, Dept Gastroenterol & Hepatol, Rotterdam, Netherlands.	a.woltman@erasmusmc.nl	Buschow, Sonja/AAD-3567-2020; Woltman, Andrea/GYV-2656-2022	Woltman, Andrea/0000-0001-9904-6751; Buschow, Sonja/0000-0002-7907-8315	Netherlands Organization for Scientific Research (NWO VIDI grant) [91712329]	Netherlands Organization for Scientific Research (NWO VIDI grant)(Netherlands Organization for Scientific Research (NWO))	This work was supported by The Netherlands Organization for Scientific Research (NWO VIDI grant 91712329 to A.M.W.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachem A, 2010, J EXP MED, V207, P1273, DOI 10.1084/jem.20100348; Bertoletti A, 2006, J GEN VIROL, V87, P1439, DOI 10.1099/vir.0.81920-0; Boltjes A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097006; Boonstra A, 2008, BEST PRACT RES CL GA, V22, P1049, DOI 10.1016/j.bpg.2008.11.015; Chan HLY, 2016, J HEPATOL, V64, P1011, DOI 10.1016/j.jhep.2015.12.018; Crozat K, 2010, J EXP MED, V207, P1283, DOI 10.1084/jem.20100223; Dandri M, 2012, GUT, V61, P6, DOI 10.1136/gutjnl-2012-302056; de Groen RA, 2014, J INTERF CYTOK RES, V34, P552, DOI 10.1089/jir.2013.0068; Duong FHT, 2014, J EXP MED, V211, P857, DOI 10.1084/jem.20131557; Egli A, 2014, EMERG MICROBES INFEC, V3, DOI 10.1038/emi.2014.51; Poulin LF, 2010, J EXP MED, V207, P1261, DOI 10.1084/jem.20092618; Gehring AJ, 2015, CELL MOL IMMUNOL, V12, P283, DOI 10.1038/cmi.2014.95; Haniffa M, 2012, IMMUNITY, V37, P60, DOI 10.1016/j.immuni.2012.04.012; Hildner K, 2008, SCIENCE, V322, P1097, DOI 10.1126/science.1164206; Jongbloed SL, 2010, J EXP MED, V207, P1247, DOI 10.1084/jem.20092140; Kelly A, 2014, J HEPATOL, V60, P135, DOI 10.1016/j.jhep.2013.08.007; Lauterbach H, 2010, J EXP MED, V207, P2703, DOI 10.1084/jem.20092720; Luangsay S, 2015, J HEPATOL, V63, P1314, DOI 10.1016/j.jhep.2015.07.014; Mihm S, 2004, LAB INVEST, V84, P1148, DOI 10.1038/labinvest.3700135; Nattermann J, 2006, HEPATOLOGY, V44, P945, DOI 10.1002/hep.21350; Nizzoli G, 2013, BLOOD, V122, P932, DOI 10.1182/blood-2013-04-495424; Pagliaccetti NE, 2010, VIROLOGY, V401, P197, DOI 10.1016/j.virol.2010.02.022; Park H, 2012, HEPATOLOGY, V56, P2060, DOI 10.1002/hep.25897; Reynolds G, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00330; Robek MD, 2005, J VIROL, V79, P3851, DOI 10.1128/JVI.79.6.3851-3854.2005; Sato S, 2015, IMMUNITY, V42, P123, DOI 10.1016/j.immuni.2014.12.016; Schulte BM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121670; Steinman RM, 2008, IMMUNITY, V29, P319, DOI 10.1016/j.immuni.2008.08.001; Manh TPV, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00260; van der Aa E, 2015, SEMIN CELL DEV BIOL, V41, P39, DOI 10.1016/j.semcdb.2014.05.016; van der Molen RG, 2004, HEPATOLOGY, V40, P738, DOI 10.1002/hep.20366; van Montfoort N, 2016, J VIROL, V90, P6187, DOI 10.1128/JVI.02903-15; van Montfoort N, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00182; Wack A, 2015, NAT IMMUNOL, V16, P802, DOI 10.1038/ni.3212; Waithman J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066136; Woltman AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015324; Xu Y, 2009, MOL IMMUNOL, V46, P2640, DOI 10.1016/j.molimm.2009.04.031; Yoshio S, 2013, HEPATOLOGY, V57, P1705, DOI 10.1002/hep.26182; Zhang SY, 2013, GASTROENTEROLOGY, V144, P414, DOI 10.1053/j.gastro.2012.10.034	39	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2016	11	8							e0161235	10.1371/journal.pone.0161235	http://dx.doi.org/10.1371/journal.pone.0161235			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4UN	27529176	gold, Green Published, Green Submitted			2022-12-27	WOS:000381476700056
J	Masago, Y; Konta, Y; Kazama, S; Inaba, M; Imagawa, T; Tohma, K; Saito, M; Suzuki, A; Oshitani, H; Omura, T				Masago, Yoshifumi; Konta, Yoshimitsu; Kazama, Shinobu; Inaba, Manami; Imagawa, Toshifumi; Tohma, Kentaro; Saito, Mayuko; Suzuki, Akira; Oshitani, Hitoshi; Omura, Tatsuo			Comparative Evaluation of Real-Time PCR Methods for Human Noroviruses in Wastewater and Human Stool	PLOS ONE			English	Article							REVERSE-TRANSCRIPTION-PCR; NORWALK-LIKE VIRUSES; RT-PCR; ENVIRONMENTAL SURVEILLANCE; UNITED-STATES; GENOGROUP-I; GASTROENTERITIS; SHELLFISH; ASSAYS	Selecting the best quantitative PCR assay is essential to detect human norovirus genome effectively from clinical and environmental samples because no cell lines have been developed to propagate this virus. The real-time PCR methods for noroviruses GI (4 assays) and GII (3 assays) were evaluated using wastewater (n = 70) and norovirus-positive stool (n = 77) samples collected in Japan between 2012 and 2013. Standard quantitative PCR assays recommended by the U.S. Environmental Protection Agency, International Organization for Standardization, and Ministry of Health, Labour and Welfare, Japan, together with recently reported assays were included. Significant differences in positive rates and quantification cycles were observed by non-parametric analysis. The present study identifies the best assay for norovirus GI and GII to amplify norovirus genomes efficiently.	[Masago, Yoshifumi; Konta, Yoshimitsu; Kazama, Shinobu; Inaba, Manami; Omura, Tatsuo] Tohoku Univ, New Ind Creat Hatchery Ctr, Sendai, Miyagi, Japan; [Imagawa, Toshifumi; Tohma, Kentaro; Saito, Mayuko; Suzuki, Akira; Oshitani, Hitoshi] Tohoku Univ, Grad Sch Med, Sendai, Miyagi, Japan; [Masago, Yoshifumi] United Nations Univ, Inst Adv Study Sustainabil, Shibuya Ku, Tokyo, Japan; [Imagawa, Toshifumi] Natl Inst Infect Dis, Dept Virol 2, Tokyo, Japan; [Suzuki, Akira] Tohoku Univ, Dept Pediat, Grad Sch Med, Sendai, Miyagi, Japan	Tohoku University; Tohoku University; United Nations University; National Institute of Infectious Diseases (NIID); Tohoku University	Masago, Y (corresponding author), Tohoku Univ, New Ind Creat Hatchery Ctr, Sendai, Miyagi, Japan.	masago@unu.edu	Oshitani, Hitoshi/AAE-4349-2019; Masago, Yoshifumi/L-7330-2016; Saito, Mayuko/J-4508-2018; Tohma, Kentaro/AAE-4751-2019	Masago, Yoshifumi/0000-0001-7418-869X; Saito, Mayuko/0000-0003-4622-7027; Tohma, Kentaro/0000-0002-0456-9355; Kazama, Shinobu/0000-0002-1657-8240; Suzuki, Akira/0000-0002-8223-0314	Japan Science and Technology Agency; Core Research for Evolutional Science and Technology; Japan Society for the Promotion of Science [15H04065]; CREST from the Japan Science and Technology Agency	Japan Science and Technology Agency; Core Research for Evolutional Science and Technology(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); CREST from the Japan Science and Technology Agency(Core Research for Evolutional Science and Technology (CREST))	Support was provided by Japan Science and Technology Agency; Core Research for Evolutional Science and Technology [http://www.jst.go.jp/kisoken/crest/en/] to TO; and Japan Society for the Promotion of Science; Grant-in-Aid for Scientific Research (15H04065) [https://www.jsps.go.jp/english/e-grants/] to YM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by CREST from the Japan Science and Technology Agency and by KAKENHI Grant Number 15H04065 from the Japan Society for the Promotion of Science.	Allen DJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088978; [Anonymous], 2013, 1521612013 ISOTS; [Anonymous], 2007, DETECTION PROTOCOL N; [Anonymous], 2014, R LANG ENV STAT COMP; Aw TG, 2010, J APPL MICROBIOL, V109, P716, DOI 10.1111/j.1365-2672.2010.04701.x; Fernandez MDB, 2012, SCI TOTAL ENVIRON, V437, P262, DOI 10.1016/j.scitotenv.2012.08.033; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Butot S, 2010, J VIROL METHODS, V167, P90, DOI 10.1016/j.jviromet.2010.03.018; Chan MCW, 2014, EMERG INFECT DIS, V20, P658, DOI [10.3201/eid2004.131457, 10.3201/eid2004.13457]; da Silva AK, 2007, APPL ENVIRON MICROB, V73, P7891, DOI 10.1128/AEM.01428-07; Duizer E, 2004, J GEN VIROL, V85, P79, DOI 10.1099/vir.0.19478-0; Eden JS, 2014, VIROLOGY, V450, P106, DOI 10.1016/j.virol.2013.12.005; Fout G.S., 2012, METHOD 1615 MEASUREM; Glass RI, 2009, NEW ENGL J MED, V361, P1776, DOI 10.1056/NEJMra0804575; Jiang X, 1999, J VIROL METHODS, V83, P145, DOI 10.1016/S0166-0934(99)00114-7; Jothikumar N, 2005, APPL ENVIRON MICROB, V71, P1870, DOI 10.1128/AEM.71.4.1870-1875.2005; Kageyama T, 2003, J CLIN MICROBIOL, V41, P1548, DOI 10.1128/JCM.41.4.1548-1557.2003; Kazama S, 2016, WATER RES, V92, P244, DOI 10.1016/j.watres.2015.10.024; Kitajima M, 2012, J APPL MICROBIOL, V112, P605, DOI 10.1111/j.1365-2672.2012.05231.x; Kitajima M., 2008, ENVIRON ENG RES, V45, P361, DOI [10.11532/proes1992.45.361, DOI 10.11532/PROES1992.45.361]; Kojima S, 2002, J VIROL METHODS, V100, P107, DOI 10.1016/S0166-0934(01)00404-9; Kroneman A, 2011, J CLIN VIROL, V51, P121, DOI 10.1016/j.jcv.2011.03.006; Leshem E, 2013, EMERG INFECT DIS, V19, P1231, DOI 10.3201/eid1908.130458; Leshem E, 2013, EMERG INFECT DIS, V19, P1317, DOI 10.3201/eid1908.130445; Loisy F, 2005, J VIROL METHODS, V123, P1, DOI 10.1016/j.jviromet.2004.08.023; Mai H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071483; Mattison K, 2011, J CLIN VIROL, V50, P109, DOI 10.1016/j.jcv.2010.10.008; Miura T, 2013, APPL ENVIRON MICROB, V79, P6585, DOI 10.1128/AEM.02112-13; Rahman M, 2013, EMERG INFECT DIS, V19, P1347, DOI 10.3201/eid1908.130227; Thongprachum A, 2014, INFECT GENET EVOL, V23, P65, DOI 10.1016/j.meegid.2014.01.030; Vega E, 2014, J CLIN MICROBIOL, V52, P147, DOI 10.1128/JCM.02680-13; Zheng DP, 2006, VIROLOGY, V346, P312, DOI 10.1016/j.virol.2005.11.015	32	5	6	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2016	11	8							e0160825	10.1371/journal.pone.0160825	http://dx.doi.org/10.1371/journal.pone.0160825			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4SL	27525654	Green Submitted, Green Published, gold			2022-12-27	WOS:000381471100022
